LOINC_NUM,COMPONENT
100002-5,Specimen care is maintained
100003-3,Team communication is maintained throughout care
100004-1,Demonstrates knowledge of the expected psychosocial responses to the procedure
100005-8,Demonstrates knowledge of nutritional management related to the procedure
100006-6,Demonstrates knowledge of medication management
100007-4,Demonstrates knowledge of pain management
10000-8,R wave duration.lead AVR
100008-2,Demonstrates knowledge of wound management
100009-0,Demonstrates knowledge of the procedure and expected results
100010-8,"No injury related to procedure equipment, medical supplies, or instrumentation"
100011-6,No injury related to an electrical source
100012-4,Participates in decisions affecting the patient's plan of care
100013-2,Participates in the discharge process
100014-0,Psychosocial health is maintained at or improved from baseline
100015-7,No injury related to positioning due to care or procedure
10001-6,R wave duration.lead I
100016-5,No injury related to a laser source
100017-3,Perioperative nursing data set outcomes panel
100018-1,Note
100019-9,ALK gene targeted mutation analysis
100020-7,GNA11 gene targeted mutation analysis
100021-5,GNAQ gene targeted mutation analysis
100022-3,IDH1 gene targeted mutation analysis
100023-1,IDH2 gene targeted mutation analysis
10002-4,R wave duration.lead II
100024-9,SETBP1 gene targeted mutation analysis
100025-6,SRSF2 gene targeted mutation analysis
100026-4,MET gene targeted mutation analysis
100027-2,SMAD4 gene targeted mutation analysis
100028-0,FBXW7 gene targeted mutation analysis
100029-8,Cancer related multigene analysis
100030-6,Axis I: Temporal aspects score
100031-4,Axis II: Spatial aspects score
10003-2,R wave duration.lead III
100032-2,Axis III: Drug taking behavior score
100033-0,Axis IV: Utilization of the health care system score
100034-8,Provider of automated external defibrillator use
100035-5,Exam finding location
100036-3,Exam finding location
100037-1,Patient contact disposition
100038-9,Patient evaluation disposition
100039-7,Crew disposition for patient care
10004-0,R wave duration.lead V1
100040-5,Patient transport disposition
100041-3,Aminoglycoside
100042-1,Atovaquone
100043-9,Azithromycin+Ethambutol
100044-7,Cefcapene
100045-4,Cefozopran
100046-2,Cefquinome
100047-0,Cefteram
100048-8,Clarithromycin+Ethambutol
100049-6,Eravacycline
100050-4,Erythromycin+Ethambutol
100051-2,Ethambutol+rifAMPin
100052-0,Flomoxef
100053-8,Fluoroquinolone
100054-6,Gamithromycin
100055-3,Optochin
100056-1,Panipenem
10005-7,R wave duration.lead V2
100057-9,Prothionamide
100058-7,Prulifloxacin
100059-5,Rifapentine
100060-3,Tildipirosin
100061-1,Tosufloxacin
100062-9,Standard Dermatology Outcome Measures panel
100063-7,Primary skin concern
100064-5,Itch severity
10006-5,R wave duration.lead V3
100065-2,Satisfied with treatment
100066-0,Specular microscopy panel
100067-8,Image magnification
100068-6,Fixation point
100069-4,Fixation point
100070-2,Cell density
100071-0,Cell density
100072-8,Coefficient of variation
10007-3,R wave duration.lead V4
100073-6,Coefficient of variation
100074-4,Hexagonality
100075-1,Hexagonality
100076-9,Endothelial cells counted
100077-7,Endothelial cells counted
100078-5,Endothelial cell area.min
100079-3,Endothelial cell area.min
100080-1,Endothelial cell area.max
10008-1,R wave duration.lead V5
100081-9,Endothelial cell area.max
100082-7,Endothelial cell area.mean
100083-5,Endothelial cell area.mean
100084-3,Cell area.standard deviation
100085-0,Cell area.standard deviation
100086-8,Analysis method
100087-6,Toxocara canis 24-35kD Ab.IgG
100088-4,Taenia solium larva Ab bands panel
100089-2,Taenia solium larva 6-8kD Ab
1000-9,DBG Ab
100090-0,Taenia solium larva 45kD Ab
100091-8,Trypanosoma cruzi Ab
100092-6,Trypanosoma cruzi Ab bands panel
100093-4,Trypanosoma cruzi 15-16kD Ab.IgG
100094-2,Trypanosoma cruzi 21-22kD Ab.IgG
100095-9,Trypanosoma cruzi 27-28kD Ab.IgG
100096-7,Trypanosoma cruzi 42kD Ab.IgG
100097-5,Trypanosoma cruzi 45-47kD Ab.IgG
100098-3,Trypanosoma cruzi 120-200kD Ab.IgG
10009-9,R wave duration.lead V6
100099-1,Trypanosoma cruzi 160kD Ab.IgG
100100-7,Fasciola sp Ab.IgG
100101-5,Fasciola sp 8-9kD Ab.IgG
100102-3,Fasciola sp 27-28kD Ab.IgG
100103-1,Fasciola sp 60kD Ab.IgG
100104-9,Fasciola sp 42kD Ab.IgG
100105-6,Filaria Ab.IgG & IgM panel
100106-4,Filaria Ab.IgG
10010-7,R' wave amplitude.lead AVF
100107-2,Leishmania sp Ab.IgG
100108-0,Leishmania sp Ab.IgG
100109-8,Leishmania sp Ab bands panel
100110-6,Leishmania sp 14kD Ab.IgG
100111-4,Leishmania sp 16kD Ab.IgG
100112-2,Fasciola sp Ab bands panel
100113-0,Helicobacter pylori Ab panel
100114-8,Toxoplasma gondii 30kD Ab
10011-5,R' wave amplitude.lead AVL
100115-5,Toxoplasma gondii 31kD Ab
100116-3,Toxoplasma gondii 33kD Ab
100117-1,Toxoplasma gondii 40kD Ab
100118-9,Toxoplasma gondii 41kD Ab
100119-7,Toxoplasma gondii 45kD Ab
100120-5,Chlamydia trachomatis Ab panel
100121-3,Chlamydia trachomatis Ab.IgA
100122-1,Chlamydophila pneumoniae Ab panel
10012-3,R' wave amplitude.lead AVR
100123-9,Chlamydophila pneumoniae Ab.IgA
100124-7,Chlamydophila pneumoniae Ab.IgA
100125-4,Chlamydophila psittaci Ab panel
100126-2,Bordetella pertussis Ab.IgG panel
100127-0,Campylobacter sp Ab panel
100128-8,Cryptococcus sp Ag panel
100129-6,Schistosoma sp Ab
100130-4,Schistosoma mansoni Ab
10013-1,R' wave amplitude.lead I
100131-2,Schistosoma sp 8kD Ab
100132-0,Schistosoma sp 9kD Ab
100133-8,Schistosoma sp 10kD Ab
100134-6,Schistosoma sp 11kD Ab
100135-3,Schistosoma sp 12-13kD Ab
100136-1,Schistosoma sp 14-15kD Ab
100137-9,Schistosoma sp 15-16kD Ab
100138-7,Schistosoma sp 18-19kD Ab
100139-5,Schistosoma sp 22-24kD Ab
100140-3,Schistosoma sp 30-34kD Ab
100141-1,Schistosoma sp 65kD Ab
100142-9,Schistosoma sp 70kD Ab
100143-7,Schistosoma sp 80kD Ab
100144-5,Schistosoma sp 95kD Ab
100145-2,Schistosoma sp 110kD Ab
100146-0,Schistosoma sp 120kD Ab
100147-8,Toxoplasma gondii Ab bands panel
100148-6,Schistosoma sp Ab bands panel
10014-9,R' wave amplitude.lead II
100149-4,6-oxo-piperidine-2-carboxylate & 6(R+S)-oxo-propylpiperidine-2-carboxylate panel
100150-2,6(R+S)-oxo-propylpiperidine-2-carboxylate
100151-0,6-oxo-piperidine-2-carboxylate
100152-8,6-oxo-piperidine-2-carboxylate/Creatinine
100153-6,6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine
100154-4,Collection supervision level
100155-1,Analysis method
10015-6,R' wave amplitude.lead III
100156-9,SARS coronavirus 2 variant
100157-7,SARS coronavirus 2 lineage
10016-4,R' wave amplitude.lead V1
1001-7,DBG Ab
10017-2,R' wave amplitude.lead V2
10018-0,R' wave amplitude.lead V3
10019-8,R' wave amplitude.lead V4
10020-6,R' wave amplitude.lead V5
10021-4,R' wave amplitude.lead V6
10022-2,R' wave duration.lead AVF
10023-0,R' wave duration.lead AVL
10024-8,R' wave duration.lead AVR
1002-5,DBG Ab
10025-5,R' wave duration.lead I
10026-3,R' wave duration.lead II
10027-1,R' wave duration.lead III
10028-9,R' wave duration.lead V1
10029-7,R' wave duration.lead V2
10030-5,R' wave duration.lead V3
10031-3,R' wave duration.lead V4
10032-1,R' wave duration.lead V5
1003-3,Indirect antiglobulin test.complement specific reagent
10033-9,R' wave duration.lead V6
10034-7,S wave amplitude.lead AVF
10035-4,S wave amplitude.lead AVL
10036-2,S wave amplitude.lead AVR
10037-0,S wave amplitude.lead I
10038-8,S wave amplitude.lead II
10039-6,S wave amplitude.lead III
10040-4,S wave amplitude.lead V1
1004-1,Direct antiglobulin test.complement specific reagent
10041-2,S wave amplitude.lead V2
10042-0,S wave amplitude.lead V3
10043-8,S wave amplitude.lead V4
10044-6,S wave amplitude.lead V5
10045-3,S wave amplitude.lead V6
10046-1,S wave duration.lead AVF
10047-9,S wave duration.lead AVL
10048-7,S wave duration.lead AVR
10049-5,S wave duration.lead I
10050-3,S wave duration.lead II
10051-1,S wave duration.lead III
10052-9,S wave duration.lead V1
10053-7,S wave duration.lead V2
10054-5,S wave duration.lead V3
10055-2,S wave duration.lead V4
10056-0,S wave duration.lead V5
10057-8,S wave duration.lead V6
1005-8,Indirect antiglobulin test.IgG specific reagent
10058-6,S' wave amplitude.lead AVF
10059-4,S' wave amplitude.lead AVL
10060-2,S' wave amplitude.lead AVR
10061-0,S' wave amplitude.lead I
10062-8,S' wave amplitude.lead II
10063-6,S' wave amplitude.lead III
10064-4,S' wave amplitude.lead V1
10065-1,S' wave amplitude.lead V2
1006-6,Direct antiglobulin test.IgG specific reagent
10066-9,S' wave amplitude.lead V3
10067-7,S' wave amplitude.lead V4
10068-5,S' wave amplitude.lead V5
10069-3,S' wave amplitude.lead V6
10070-1,S' wave duration.lead AVF
10071-9,S' wave duration.lead AVL
10072-7,S' wave duration.lead AVR
10073-5,S' wave duration.lead I
1007-4,Direct antiglobulin test.polyspecific reagent
10074-3,S' wave duration.lead II
10075-0,S' wave duration.lead III
10076-8,S' wave duration.lead V1
10077-6,S' wave duration.lead V2
10078-4,S' wave duration.lead V3
10079-2,S' wave duration.lead V4
100-8,Cefoperazone
10080-0,S' wave duration.lead V5
10081-8,S' wave duration.lead V6
1008-2,Indirect antiglobulin test.polyspecific reagent
10082-6,ST initial amplitude 6 ms.lead AVF
10083-4,ST initial amplitude 6 ms.lead AVL
10084-2,ST initial amplitude 6 ms.lead AVR
10085-9,ST initial amplitude 6 ms.lead I
10086-7,ST initial amplitude 6 ms.lead II
10087-5,ST initial amplitude 6 ms.lead III
10088-3,ST initial amplitude 6 ms.lead V1
10089-1,ST initial amplitude 6 ms.lead V2
1009-0,Direct antiglobulin test.poly specific reagent
10090-9,ST initial amplitude 6 ms.lead V3
10091-7,ST initial amplitude 6 ms.lead V4
10092-5,ST initial amplitude 6 ms.lead V5
10093-3,ST initial amplitude 6 ms.lead V6
10094-1,ST slope.lead AVF
10095-8,ST slope.lead AVL
10096-6,ST slope.lead AVR
10097-4,ST slope.lead I
10098-2,ST slope.lead II
10099-0,ST slope.lead III
10100-6,ST slope.lead V1
10101-4,ST slope.lead V2
10102-2,ST slope.lead V3
10103-0,ST slope.lead V4
10104-8,ST slope.lead V5
10105-5,ST slope.lead V6
10106-3,ST wave displacement.end.lead AVF
10107-1,ST wave displacement.end.lead AVL
1010-8,E super little w Ab
10108-9,ST wave displacement.end.lead AVR
10109-7,ST wave displacement.end.lead I
10110-5,ST wave displacement.end.lead II
10111-3,ST wave displacement.end.lead III
10112-1,ST wave displacement.end.lead V1
10113-9,ST wave displacement.end.lead V2
10114-7,ST wave displacement.end.lead V3
10115-4,ST wave displacement.end.lead V4
1011-6,E super little w Ab
10116-2,ST wave displacement.end.lead V5
10117-0,ST wave displacement.end.lead V6
10118-8,ST wave displacement.mid.lead AVF
10119-6,ST wave displacement.mid.lead AVL
10120-4,ST wave displacement.mid.lead AVR
10121-2,ST wave displacement.mid.lead I
10122-0,ST wave displacement.mid.lead II
10123-8,ST wave displacement.mid.lead III
1012-4,E super little w Ab
10124-6,ST wave displacement.mid.lead V1
10125-3,ST wave displacement.mid.lead V2
10126-1,ST wave displacement.mid.lead V3
10127-9,ST wave displacement.mid.lead V4
10128-7,ST wave displacement.mid.lead V5
10129-5,ST wave displacement.mid.lead V6
10130-3,T' wave amplitude.lead AVF
10131-1,T' wave amplitude.lead AVL
1013-2,E super little w Ag
10132-9,T' wave amplitude.lead AVR
10133-7,T' wave amplitude.lead I
10134-5,T' wave amplitude.lead II
10135-2,T' wave amplitude.lead III
10136-0,T' wave amplitude.lead V1
10137-8,T' wave amplitude.lead V2
10138-6,T' wave amplitude.lead V3
10139-4,T' wave amplitude.lead V4
1014-0,E super little w Ag
10140-2,T' wave amplitude.lead V5
10141-0,T' wave amplitude.lead V6
10142-8,T wave amplitude.lead AVF
10143-6,T wave amplitude.lead AVL
10144-4,T wave amplitude.lead AVR
10145-1,T wave amplitude.lead I
10146-9,T wave amplitude.lead II
10147-7,T wave amplitude.lead III
10148-5,T wave amplitude.lead V1
10149-3,T wave amplitude.lead V2
10150-1,T wave amplitude.lead V3
10151-9,T wave amplitude.lead V4
10152-7,T wave amplitude.lead V5
10153-5,T wave amplitude.lead V6
10154-3,Chief complaint
10155-0,Allergies
10156-8,Childhood diseases
1015-7,E super little w Ag
10157-6,History of family member diseases
10158-4,Functional status
10159-2,Industrial exposure
101-6,Cefoperazone
10160-0,Medication use
10161-8,Occupational exposure
10162-6,History of pregnancies
10163-4,History of pregnancies
10164-2,Present illness
1016-5,E Ab
10165-9,History of psychiatric symptoms & diseases
10166-7,Social function
10167-5,Surgical procedures
10168-3,Symptoms & diseases
10169-1,Symptoms & diseases
10170-9,Symptoms & diseases
10171-7,Symptoms & diseases
10172-5,Symptoms & diseases
1017-3,E Ab
10173-3,Symptoms & diseases
10174-1,Symptoms & diseases
10175-8,Symptoms & diseases
10176-6,Symptoms & diseases
10177-4,Symptoms & diseases
10178-2,Symptoms & diseases
10179-0,Symptoms & diseases
10180-8,Symptoms & diseases
1018-1,E Ab
10181-6,Symptoms & diseases
10182-4,Travel
10183-2,Hospital discharge medications
10184-0,Hospital discharge physical findings
10185-7,Hospital discharge procedures
10186-5,Identifying information
10187-3,Review of systems
10188-1,Review of systems overview
10189-9,Review of systems overview
10190-7,Mental status
10191-5,Physical findings
10192-3,Physical findings
10193-1,Physical findings
10194-9,Physical findings
10195-6,Physical findings
10196-4,Physical findings
10197-2,Physical findings
10198-0,Physical findings
1019-9,E Ag
10199-8,Physical findings
10200-4,Physical findings
10201-2,Physical findings
10202-0,Physical findings
10203-8,Physical findings
10204-6,Physical findings
10205-3,Physical findings
10206-1,Physical findings
1020-7,E Ag
10207-9,Physical findings
10208-7,Physical findings
10209-5,Physical findings
10210-3,Physical findings
10211-1,Physical findings
10212-9,Physical findings
10213-7,Surgical operation note anesthesia
10214-5,Surgical operation note anesthesia duration
1021-5,E Ag
10215-2,Surgical operation note findings
10216-0,Surgical operation note fluids
10217-8,Surgical operation note indications
10218-6,Surgical operation note postoperative Dx
10219-4,Surgical operation note preoperative Dx
10220-2,Surgical operation note prep time duration
10221-0,Surgical operation note specimens taken
10222-8,Surgical operation note surgical complications
1022-3,F little y super little a Ab
10223-6,Surgical operation note surgical procedure
10224-4,Hemodynamic method special circumstances
10225-1,Institution inventory number
10226-9,Oxygen content
10227-7,Vendor model number
10228-5,Vendor serial number
10229-3,Class
10230-1,Ejection fraction
1023-1,F little y super little a Ab
10231-9,Ejection fraction
10232-7,Oxygen content
10233-5,Oxygen content
10234-3,Oxygen content
10235-0,Oxygen content
10236-8,Oxygen content
10237-6,Oxygen content
10238-4,Oxygen content
10239-2,Oxygen content
102-4,Cefoperazone
10240-0,Oxygen content
10241-8,Oxygen content
10242-6,Oxygen content
10243-4,Oxygen content
10244-2,Oxygen content
10245-9,Oxygen content
10246-7,Oxygen content
10247-5,Oxygen content
10248-3,Oxygen content
1024-9,F little y super little a Ab
10249-1,Institution inventory number
10250-9,Vendor model number
10251-7,Vendor serial number
10252-5,Biliary drain site
10253-3,Class
10254-1,Class
10255-8,Class
1025-6,F little y super little a Ag
10256-6,Institution inventory number
10257-4,Institution inventory number
10258-2,Institution inventory number
10259-0,Institution inventory number
10260-8,Institution inventory number
10261-6,Institution inventory number
10262-4,Institution inventory number
10263-2,Institution inventory number
1026-4,F little y super little a Ag
10264-0,Institution inventory number
10265-7,Institution inventory number
10266-5,Institution inventory number
10267-3,Institution inventory number
10268-1,Institution inventory number
10269-9,Institution inventory number
10270-7,Institution inventory number
10271-5,Institution inventory number
1027-2,F little y super little a Ag
10272-3,Institution inventory number
10273-1,Institution inventory number
10274-9,Institution inventory number
10275-6,Institution inventory number
10276-4,Peritoneal drain site
10277-2,Stool collection site
10278-0,Subarachnoid drain site
10279-8,Vendor model number
1028-0,F little y super little b Ab
10280-6,Vendor model number
10281-4,Vendor model number
10282-2,Vendor model number
10283-0,Vendor model number
10284-8,Vendor model number
10285-5,Vendor model number
10286-3,Vendor model number
10287-1,Vendor model number
10288-9,Vendor model number
10289-7,Vendor model number
10290-5,Vendor model number
10291-3,Vendor model number
10292-1,Vendor model number
10293-9,Vendor model number
10294-7,Vendor model number
10295-4,Vendor model number
10296-2,Vendor model number
10297-0,Vendor model number
1029-8,F little y super little b Ab
10298-8,Vendor model number
10299-6,Vendor serial number
10300-2,Vendor serial number
10301-0,Vendor serial number
10302-8,Vendor serial number
10303-6,Vendor serial number
10304-4,Vendor serial number
10305-1,Vendor serial number
1030-6,F little y super little b Ab
10306-9,Vendor serial number
10307-7,Vendor serial number
10308-5,Vendor serial number
10309-3,Vendor serial number
10310-1,Vendor serial number
10311-9,Vendor serial number
10312-7,Vendor serial number
10313-5,Vendor serial number
1031-4,F little y super little b Ag
10314-3,Vendor serial number
10315-0,Vendor serial number
10316-8,Vendor serial number
10317-6,Vendor serial number
10318-4,Vendor serial number
10319-2,Institution inventory number
103-2,Ceforanide
10320-0,Vendor model number
10321-8,Vendor serial number
1032-2,F little y super little b Ag
10322-6,Potassium intake
10323-4,Wound drain fluid
10324-2,Institution inventory number
10325-9,Vendor model number
10326-7,Vendor serial number
10327-5,Eosinophils/100 leukocytes
10328-3,Lymphocytes/100 leukocytes
10329-1,Monocytes/100 leukocytes
1033-0,F little y super little b Ag
10330-9,Monocytes/100 leukocytes
10331-7,Rh
10332-5,Cortisol^pre 250 ug corticotropin IM
10333-3,Appearance
10334-1,Cancer Ag 125
10335-8,Color
10336-6,Gonadotropin peptide
10337-4,Procollagen type I
10338-2,Barbiturates
10339-0,Fluoxetine+Norfluoxetine
10340-8,Molindone
10341-6,Norpropoxyphene
10342-4,Sulfamethoxazole
10343-2,Temazepam
10344-0,Tranylcypromine
10345-7,Trihexyphenidyl
10346-5,Hemoglobin A
10347-3,Babesia microti identified
1034-8,Fetal cell screen
10348-1,Bordetella parapertussis Ab
10349-9,Brucella sp Ab
10350-7,Herpes simplex virus Ab.IgM
10351-5,HIV 1 RNA
10352-3,Bacteria identified
10353-1,Bacteria identified
10354-9,Bacteria identified
1035-5,Fresh frozen plasma given
10355-6,Microscopic observation
10356-4,Microscopic observation
10357-2,Microscopic observation
10358-0,Teichoate Ab
10359-8,Asialoganglioside GM1 Ab.IgM
10360-6,DNA single strand Ab.IgG
10361-4,DNA single strand Ab.IgM
10362-2,Endomysium Ab.IgA
1036-3,G Ab
10363-0,Barbiturates
10364-8,Cotinine
10365-5,Cotinine
10366-3,Cotinine
10367-1,Ethanol
10368-9,Lead
10369-7,Opiates
10370-5,Phencyclidine
1037-1,G Ab
10371-3,Bite cells
10372-1,Blister cells
10373-9,Fragments
10374-7,Helmet cells
10375-4,Irregularly contracted cells
10376-2,Macrocytes.oval
10377-0,Pencil cells
10378-8,Polychromasia
10379-6,Erythrocytes.dual population
10380-4,Stomatocytes
10381-2,Target cells
10382-0,"A,B variant NOS Ag"
10383-8,"A,B variant NOS Ag"
10384-6,"A,B variant NOS Ag"
10385-3,Albumin concentration given
10386-1,Albumin given
10387-9,Autologous erythrocytes given
10388-7,Autologous whole blood given
1038-9,G Ab
10389-5,Blood product.other
10390-3,Blood product special preparation
10391-1,Cytomegalovirus immune globulin given
10392-9,Cryoprecipitate given
10393-7,Factor IX given
10394-5,Factor IX given
10395-2,Factor VIII given
10396-0,Factor VIII given
1039-7,G Ag
10397-8,Hepatitis B virus immune globulin given
10398-6,I Ag
10399-4,I Ag
104-0,Ceforanide
10400-0,I Ag
10401-8,Immune serum globulin given
10402-6,Immune serum globulin given
10403-4,Inject immune serum globulin
10404-2,Inject Rh immune globulin
1040-5,G Ag
10405-9,Inject varicella zoster virus immune globulin
10406-7,little i Ag
10407-5,little i Ag
10408-3,little i Ag
10409-1,Pentaspan given
10410-9,Plasma given
10411-7,Plasma given
10412-5,Platelets given
1041-3,G Ag
10413-3,Rh immune globulin given
10414-1,Transfuse albumin
10415-8,Transfuse blood exchange transfusion
10416-6,Transfuse blood product.other
10417-4,Transfuse cryoprecipitate
10418-2,Transfuse factor IX
10419-0,Transfuse factor VIII
10420-8,Transfuse immune serum globulin
1042-1,H Ab
10421-6,Transfuse Pentaspan
10422-4,Transfuse plasma
10423-2,Transfuse platelets
10424-0,Transfuse erythrocytes
10425-7,Transfuse Rh immune globulin
10426-5,Transfuse whole blood
10427-3,Transfuse whole blood autologous
10428-1,Varicella zoster virus immune globulin given
10429-9,AE 1 Ag
10430-7,AE 3 Ag
10431-5,B-cell Ag
10432-3,CD30 Ag
10433-1,BR-2 Ag
10434-9,Complement C3 Ag
10435-6,C5B-9 Ag
10436-4,CD15 Ag
10437-2,CD16 Ag
10438-0,CD20 Ag
1043-9,H Ab
10439-8,CD3 Ag
10440-6,CD30 Ag
10441-4,CD34 Ag
10442-2,CD56 Ag
10443-0,CD43.T-Cell monocyte+Myeloid cell Ag
10444-8,CD57 Ag
10445-5,CD11c Ag
10446-3,Leukocyte common Ag
1044-7,H Ab
10447-1,M-5 Ag
10448-9,T-cell Ag
10449-7,Glucose^1H post meal
10450-5,Glucose^post 10H CFst
10451-3,Proinsulin^post 12H CFst
10452-1,Xylose^1H post 25 g xylose PO
10453-9,Xylose^1H post dose xylose PO
1045-4,H NOS Ab
10454-7,Xylose^2H post 25 g xylose PO
10455-4,Xylose^30M post 25 g xylose PO
10456-2,Xylose^post 6H CFst
10457-0,Actin Ag
10458-8,Alkaline phosphatase.placental Ag
10459-6,Alpha-1-Fetoprotein Ag
10460-4,Lactalbumin alpha Ag
10461-2,Alpha-1-Antichymotrypsin Ag
1046-2,H NOS Ab
10462-0,Alpha 1 antitrypsin Ag
10463-8,Amyloid A component Ag
10464-6,Amyloid P component Ag
10465-3,Amyloid.prealbumin Ag
10466-1,Anion gap 3
10467-9,Beta-2-Microglobulin amyloid Ag
10468-7,Calcitonin Ag
10469-5,Carcinoembryonic Ag
1047-0,H NOS Ab
10470-3,Choriogonadotropin Ag
10471-1,Chromogranin A Ag
10472-9,Chromogranin Ag
10473-7,Chymotrypsin Ag
10474-5,Collagen type 4 Ag
10475-2,Corticotropin Ag
10476-0,Desmin Ag
10477-8,Enolase.neuron specific Ag
10478-6,Eosinophil major basic protein Ag
10479-4,CD227 Ag
10480-2,Estrogen+Progesterone receptor Ag
10481-0,Follitropin.alpha subunit Ag
10482-8,Follitropin.beta subunit Ag
10483-6,Gastrin Ag
10484-4,Glial fibrillary acidic protein Ag
10485-1,Glucagon Ag
10486-9,Hemoglobin Ag
10487-7,HMB-45 Ag
1048-8,H NOS Ag
10488-5,IgA Ag
10489-3,IgA.heavy chain Ag
10490-1,IgE Ag
10491-9,IgG Ag
10492-7,IgG.heavy chain Ag
10493-5,IgM Ag
10494-3,IgM.heavy chain Ag
10495-0,Insulin Ag
1049-6,H NOS Ag
10496-8,Immunoglobulin light chains.kappa Ag
10497-6,Immunoglobulin light chains.kappa amyloid Ag
10498-4,Keratin Ag
10499-2,Immunoglobulin light chains.lambda Ag
10500-7,Immunoglobulin light chains.lambda amyloid Ag
10501-5,Lutropin
10502-3,Lutropin Ag
10503-1,Lysozyme Ag
1050-4,H NOS Ag
10504-9,Myelin basic protein Ag
10505-6,Myoglobin Ag
10506-4,Peanut agglutinin Ag
10507-2,Prolactin Ag
10508-0,Prostate specific Ag
10509-8,Acid phosphatase.prostatic Ag
10510-6,S-100 Ag
10511-4,Serotonin Ag
1051-2,Hemolytic disease of newborn screen
10512-2,Somatostatin Ag
10513-0,Somatotropin Ag
10514-8,Synaptophysin Ag
10515-5,Thyroglobulin Ag
10516-3,Thyrotropin Ag
10517-1,Trypsin Ag
10518-9,Ulex europaeus I lectin Ag
10519-7,Vimentin Ag
1052-0,I (int) subtype
10520-5,Coagulation factor VI Ag
10521-3,Coagulation factor VIII Ag
10522-1,Coagulation factor XIII Ag
10523-9,Fibrinogen Ag
10524-7,Microscopic observation
10525-4,Microscopic observation
10526-2,Microscopic observation
10527-0,Microscopic observation
10528-8,Acetophenazine
10529-6,Amoxapine metabolite
10530-4,Aprobarbital
10531-2,Bretylium
10532-0,Noramiodarone
10533-8,Propoxyphene+Acetaminophen
10534-6,Diazoxide
10535-3,Digoxin
10536-1,Dipyridamole
10537-9,Doxepin+Nordoxepin
1053-8,I (int) subtype
10538-7,Fluoxetine+Norfluoxetine
10539-5,glipiZIDE
10540-3,glyBURIDE
10541-1,Mepivacaine
10542-9,Metharbital
10543-7,Methsuximide+Normethsuximide
10544-5,Normeperidine
10545-2,Normephenytoin
1054-6,I (int) subtype
10546-0,Normethsuximide
10547-8,Primidone+PHENobarbital
10548-6,Phenytoin.free/Phenytoin.total
10549-4,Pirmenol
10550-2,Temazepam
10551-0,Triamterene
10552-8,Tricyclic antidepressants
1055-3,I (int) subtype
10553-6,Acid phosphatase.prostatic
10554-4,Acid phosphatase.prostatic
10555-1,Acrosin
10556-9,Adenosine triphosphatase
10557-7,Adenosine triphosphate
10558-5,Albumin
10559-3,Calcium
10560-1,Carcinoembryonic Ag
1056-1,I (int) subtype
10561-9,Carnitine
10562-7,Cells
10563-5,Cells other than spermatozoa
10564-3,Cervical mucus
10565-0,Choriogonadotropin
10566-8,Choriogonadotropin
10567-6,Citrate
10568-4,Clarity
10569-2,Color
105-7,Ceforanide
10570-0,Consistency
10571-8,Consistency
10572-6,Duration^post ejaculation
10573-4,Ferning
10574-2,Fructose
10575-9,Gamma glutamyl transferase
10576-7,Germ cells.immature
10577-5,Glucosidase
10578-3,Glycerophosphocholine
1057-9,I (int) subtype
10579-1,Leukocytes
10580-9,Liquefaction
10581-7,Number of entities
10582-5,pH
10583-3,Prostaglandin F1 alpha
10584-1,Protein
10585-8,Round cells
10586-6,Semen
1058-7,I Ab
10587-4,Sexual abstinence duration
10588-2,Spermatogonia
10589-0,Spermatids
10590-8,Spermatids
10591-6,Spermatocytes.primary
10592-4,Spermatocytes.secondary
10593-2,Spermatozoa.pyriform head/100 spermatozoa
10594-0,Spermatozoa.tapering head/100 spermatozoa
1059-5,I Ab
10595-7,Spermatozoa
10596-5,Spermatozoa Ab
10597-3,Spermatozoa Ab
10598-1,Spermatozoa Ab
10599-9,Spermatozoa penetration
10600-5,Spermatozoa penetration
10601-3,Spermatozoa penetration^post coitus
10602-1,Spermatozoa.abnormal head/100 spermatozoa
1060-3,I Ab
10603-9,Spermatozoa.abnormal midpiece/100 spermatozoa
10604-7,Spermatozoa.abnormal tail/100 spermatozoa
10605-4,Spermatozoa.agglutinated/100 spermatozoa
10606-2,Spermatozoa.amorphous head/100 spermatozoa
10607-0,Spermatozoa.coiled tail/100 spermatozoa
10608-8,Spermatozoa.cytoplasmic droplet/100 spermatozoa
10609-6,Spermatozoa.duplicate head/100 spermatozoa
10610-4,Spermatozoa.duplicate tail/100 spermatozoa
1061-1,I NOS Ab
10611-2,Spermatozoa.immotile/100 spermatozoa
10612-0,Spermatozoa.large oval head/100 spermatozoa
10613-8,Spermatozoa.viable/100 spermatozoa
10614-6,Spermatozoa.motile with IgA/100 spermatozoa
10615-3,Spermatozoa.motile with IgA/100 spermatozoa
10616-1,Spermatozoa.motile with IgG/100 spermatozoa
10617-9,Spermatozoa.motile with IgG/100 spermatozoa
10618-7,Spermatozoa.motile with IgM/100 spermatozoa
10619-5,Spermatozoa.motile with IgM/100 spermatozoa
10620-3,Spermatozoa.nonprogressive/100 spermatozoa
10621-1,Spermatozoa.normal head/100 spermatozoa
10622-9,Spermatozoa.normal/100 spermatozoa
10623-7,Spermatozoa.pin head/100 spermatozoa
10624-5,Spermatozoa.rapid/100 spermatozoa
10625-2,Spermatozoa.round head/100 spermatozoa
10626-0,Spermatozoa.slow/100 spermatozoa
10627-8,Spermatozoa.small oval head/100 spermatozoa
10628-6,Spermatozoa.tail swelling/100 spermatozoa
1062-9,I NOS Ab
10629-4,Spermatozoa.vacuolated head/100 spermatozoa
10630-2,Spinnbarkeit
10631-0,Testosterone
10632-8,Time until next menstrual period
10633-6,Zinc
10634-4,Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total
10635-1,Acanthamoeba sp identified
10636-9,Acanthamoeba sp identified
1063-7,I NOS Ab
10637-7,Microscopic observation
10638-5,Actinomycetes.thermophilic colony count
10639-3,Actinomycetes.thermophilic identified
10640-1,Adenovirus 40+41
10641-9,Amoeba identified
10642-7,Amoeba identified
10643-5,Amoeba identified
10644-3,Arthropod identified
1064-5,I NOS Ag
10645-0,Aspergillus fumigatus Ag
10646-8,Astrovirus
10647-6,Babesia sp identified
10648-4,Babesia sp identified
10649-2,Calicivirus
106-5,Ceforanide
10650-0,Candida sp DNA
10651-8,Chlamydophila pneumoniae Ag
1065-2,I NOS Ag
10652-6,Chlamydophila pneumoniae DNA
10653-4,Clotrimazole
10654-2,Clotrimazole
10655-9,Coccidia identified
10656-7,Coccidia identified
10657-5,Cryptococcus neoformans Ag
10658-3,Cyanobacterium identified
10659-1,Cyclospora sp identified
1066-0,I NOS Ag
10660-9,Cytomegalovirus Ag
10661-7,Dinoflagellate identified
10662-5,Filaria identified
10663-3,Filaria identified
10664-1,Filaria identified
10665-8,Fungus colony count
10666-6,Fungus identified
10667-4,Fungus identified
10668-2,Fungus identified
10669-0,Fungus identified
10670-8,Giardia lamblia
10671-6,Helminth identified
10672-4,Helminth+Arthropod identified
10673-2,Hepatitis B virus core Ag
10674-0,Hepatitis B virus surface Ag
10675-7,Hepatitis B virus surface Ag
10676-5,Hepatitis C virus RNA
10677-3,Herpes simplex virus 1 Ag
1067-8,J little k super little a Ab
10678-1,Herpes simplex virus 1+2 Ag
10679-9,Herpes simplex virus 2 Ag
10680-7,Herpes simplex virus identified
10681-5,Herpes simplex virus identified
10682-3,HIV 1 RNA
10683-1,Hydatid cyst identified
10684-9,Hydatid cyst identified
10685-6,Hydatid cyst identified
1068-6,J little k super little a Ab
10686-4,Leishmania sp identified
10687-2,Leishmania sp identified
10688-0,Microscopic observation
10689-8,Microscopic observation
10690-6,Microsporidia identified
10691-4,Mushroom.toxic identified
10692-2,Mushroom.toxic identified
10693-0,Mushroom.toxic identified
1069-4,J little k super little a Ab
10694-8,Naegleria sp identified
10695-5,Naegleria sp identified
10696-3,Norovirus
10697-1,Nystatin
10698-9,Nystatin
10699-7,Onchocerca sp identified
10700-3,Orthopoxvirus
10701-1,Ova & parasites identified
1070-2,J little k super little a Ag
10702-9,Ova & parasites identified
10703-7,Ova & parasites identified
10704-5,Ova & parasites identified
10705-2,Human papilloma virus Ag
10706-0,Picornavirus
10707-8,Plant.toxic identified
10708-6,Plant.toxic identified
10709-4,Plasmodium falciparum Ag
1071-0,J little k super little a Ag
10710-2,Plasmodium sp identified
10711-0,Plasmodium vivax Ag
10712-8,Pneumocystis sp identified
10713-6,Prototheca identified
10714-4,Rotavirus
10715-1,Schistosoma sp identified
10716-9,Schistosoma sp identified
10717-7,Streptococcus pneumoniae Ab
10718-5,Strongyloides sp Ab
10719-3,Taenia solium adult Ab
10720-1,Terbinafine
10721-9,Terbinafine
10722-7,Torovirus
10723-5,Toxoplasma gondii Ab.IgA
10724-3,Toxoplasma gondii Ab.IgE
10725-0,Toxoplasma gondii DNA
10726-8,Toxoplasma gondii
10727-6,Toxoplasma gondii identified
1072-8,J little k super little a Ag
10728-4,Trichomonas sp identified
10729-2,Trypanosoma sp identified
107-3,Cefotaxime
10730-0,Trypanosoma sp identified
10731-8,Trypanosoma sp identified
10732-6,Trypanosoma sp identified
10733-4,Trypanosoma sp identified
10734-2,Varicella zoster virus identified
10735-9,Viral sequencing
1073-6,J little k super little b Ab
10736-7,Virus identified
10737-5,Virus identified
10738-3,Virus identified
10739-1,Virus identified
10740-9,Aluminum.microscopic observation
10741-7,Amyloid.microscopic observation
10742-5,Amyloid.microscopic observation
10743-3,Amyloid.microscopic observation
1074-4,J little k super little b Ab
10744-1,Amyloid.microscopic observation
10745-8,Bile.microscopic observation
10746-6,Calcium.microscopic observation
10747-4,Collagen fibers+Elastic fibers.microscopic observation
10748-2,Collagen fibers+Elastic fibers.microscopic observation
10749-0,Collagen fibers.microscopic observation
10750-8,Connective tissue.microscopic observation
1075-1,J little k super little b Ab
10751-6,Copper.microscopic observation
10752-4,Fat.microscopic observation
10753-2,Fat.microscopic observation
10754-0,Fat.microscopic observation
10755-7,Fungus.microscopic observation
10756-5,Glial fibers.microscopic observation
10757-3,Hematologic+Nuclear elements.microscopic observation
10758-1,Iron.microscopic observation
10759-9,Iron.microscopic observation
10760-7,Iron.microscopic observation
10761-5,Iron.microscopic observation
10762-3,Microscopic observation
10763-1,Microscopic observation
10764-9,Microscopic observation
10765-6,Microscopic observation
10766-4,Microscopic observation
10767-2,Microscopic observation
10768-0,Microscopic observation
1076-9,J little k super little b Ag
10769-8,Microscopic observation
10770-6,Microscopic observation
10771-4,Microscopic observation
10772-2,Microscopic observation
10773-0,Microscopic observation
10774-8,Microscopic observation
10775-5,Microscopic observation
10776-3,Microscopic observation
1077-7,J little k super little b Ag
10777-1,Microscopic observation
10778-9,Microscopic observation
10779-7,Microscopic observation
10780-5,Microscopic observation
10781-3,Microscopic observation
10782-1,Microscopic observation
10783-9,Microscopic observation
10784-7,Microscopic observation
1078-5,J little k super little b Ag
10785-4,Microscopic observation
10786-2,Microscopic observation
10787-0,Microscopic observation
10788-8,Microscopic observation
10789-6,Microscopic observation
10790-4,Microscopic observation
10791-2,Microscopic observation
10792-0,Microscopic observation
1079-3,J little s super little a Ab
10793-8,Microscopic observation
10794-6,Microscopic observation
10795-3,Microscopic observation
10796-1,Microscopic observation
10797-9,Microscopic observation
10798-7,Microscopic observation
10799-5,Microscopic observation
10800-1,Microscopic observation
1080-1,J little s super little a Ab
10801-9,Microscopic observation
10802-7,Microscopic observation
10803-5,Microscopic observation
10804-3,Microscopic observation
10805-0,Microscopic observation
10806-8,Microscopic observation
10807-6,Microscopic observation
10808-4,Microscopic observation
10809-2,Microscopic observation
108-1,Cefotaxime
10810-0,Microscopic observation
10811-8,Microscopic observation
10812-6,Microscopic observation
10813-4,Microscopic observation
10814-2,Microscopic observation
10815-9,Microscopic observation
10816-7,Microscopic observation
10817-5,Microscopic observation
10818-3,Microscopic observation
1081-9,J little s super little a Ab
10819-1,Microscopic observation
10820-9,Microscopic observation
10821-7,Microscopic observation
10822-5,Mucin.microscopic observation
10823-3,Mucopolysaccharides.microscopic observation
10824-1,Myelin+Myelin breakdown products.microscopic observation
10825-8,Myelin+Nerve cells.microscopic observation
10826-6,Nissel.microscopic observation
1082-7,J little s super little a Ag
10827-4,Reticulum.microscopic observation
10828-2,Urate crystals.microscopic observation
10829-0,Silicon
10830-8,Surgical operation note complications
10831-6,Surgical operation note complications
10832-4,Glucose^15M post 50 g lactose PO
10833-2,Insulin^7H post 75 g glucose PO
10834-0,Globulin
1083-5,J little s super little a Ag
10835-7,Lipoprotein (little a)
10836-5,Niacin
10837-3,Organic acids
10838-1,Phosphoserine
10839-9,Troponin I.cardiac
10840-7,Atropine
10841-5,methazolAMIDE
10842-3,HLA-DQ1
1084-3,J little s super little a Ag
10843-1,HLA-DQ2
10844-9,HLA-DQ3
10845-6,HLA-DQ4
10846-4,Borrelia burgdorferi DNA
10847-2,Borrelia burgdorferi DNA
10848-0,Chlamydia sp Ab.IgG
10849-8,Chlamydia sp Ab.IgM
1085-0,J little s super little b Ab
10850-6,Cyclospora cayetanensis
10851-4,Escherichia coli O157:H7
10852-2,Fungus identified
10853-0,Isospora belli
10854-8,Microfilaria sp identified
10855-5,Ova & parasites identified
10856-3,Microscopic observation
10857-1,Microsporidia identified
10858-9,Teichoate Ab
10859-7,Trypanosoma sp
10860-5,Varicella zoster virus
10861-3,Progesterone receptor
10862-1,Basement membrane Ab
10863-9,Endomysium Ab.IgA
10864-7,Immune complex
10865-4,Intercellular substance Ab
10866-2,Sulfatide Ab.IgG
10867-0,Sulfatide Ab.IgM
1086-8,J little s super little b Ab
10868-8,Bacitracin
10869-6,Xylose^3H post 25 g xylose PO
10870-4,Xylose^4H post 25 g xylose PO
10871-2,Xylose^5H post 25 g xylose PO
10872-0,Xylose^baseline
10873-8,Beta-2-Microglobulin
10874-6,Bombesin
10875-3,Carnitine esters
1087-6,J little s super little b Ab
10876-1,Carnitine esters
10877-9,Carnitine.free (C0)
10878-7,Iodine.protein bound
10879-5,Isovalerylglycine
10880-3,Magnesium
10881-1,Pentacarboxylporphyrins
10882-9,Pentacarboxylporphyrins
10883-7,Phenolphthalein
1088-4,J little s super little b Ag
10884-5,Phosphate
10885-2,Porphyrins
10886-0,Prostate specific Ag.free
10887-8,Pyridinoline
10888-6,Triacylglycerol lipase
10889-4,Bisacodyl
10890-2,Normethsuximide
10891-0,Oxyphenisatin
1089-2,J little s super little b Ag
10892-8,Pentoxifylline
10893-6,Trenbolone
10894-4,Aspergillus niger Ab
10895-1,Clostridioides difficile toxin B
10896-9,Eastern equine encephalitis virus Ab.IgG
10897-7,Eastern equine encephalitis virus Ab.IgG
10898-5,Eastern equine encephalitis virus Ab.IgM
10899-3,Eastern equine encephalitis virus Ab.IgM
09-Oct,Amdinocillin
1090-0,J little s super little b Ag
10900-9,Hepatitis B virus surface Ab
10901-7,HIV 2 gp125 Ab
10902-5,HIV 2 gp36 Ab
10903-3,Hyaluronidase Ab
10904-1,La Crosse virus Ab.IgG
10905-8,La Crosse virus Ab.IgM
10906-6,Saint Louis encephalitis virus Ab.IgG
10907-4,Saint Louis encephalitis virus Ab.IgM
10908-2,Streptococcus pneumoniae 7 Ab.IgG
10909-0,Benzidine
10910-8,Borate
10911-6,Dichlorobenzidine
10912-4,Lead
10913-2,"4,4'-Methylene bis(2-Chloroaniline)"
10914-0,Methylenediamine
10915-7,Phencyclidine
10916-5,Platinum
10917-3,Zinc
1091-8,K Ab
10918-1,Zinc
10919-9,Anisakis Ab.IgE
10920-7,Phyllostachys pubescens Ab.IgE
10921-5,Blomia tropicalis Ab.IgE
10922-3,Bovine serum albumin Ab.IgE
10923-1,Bromelin Ab.IgE
10924-9,Averrhoa carambola Ab.IgE
10925-6,Scomber japonicus Ab.IgE
1092-6,K Ab
10926-4,Deer epithelium Ab.IgE
10927-2,Elk meat Ab.IgE
10928-0,Foeniculum vulgare fresh Ab.IgE
10929-8,Foeniculum vulgare seed Ab.IgE
10930-6,Artemia salina Ab.IgE
10931-4,Daphnia Ab.IgE
10932-2,Tetramin Ab.IgE
10933-0,Cyamopsis tetragonoloba Ab.IgE
1093-4,K Ab
10934-8,Psidium guajava Ab.IgE
10935-5,Horse serum proteins Ab.IgE
10936-3,Mare milk Ab.IgE
10937-1,Origanum majorana Ab.IgE
10938-9,Ephestia kuehniella Ab.IgE
10939-7,Lepidorhombus whiffiagonis Ab.IgE
10940-5,Cow milk boiled Ab.IgE
10941-3,Milk powder Ab.IgE
1094-2,K Ag
10942-1,Echinochloa crus-galli Ab.IgE
10943-9,Mink epithelium Ab.IgE
10944-7,Octopus vulgaris Ab.IgE
10945-4,Papain Ab.IgE
10946-2,Passiflora edulis Ab.IgE
10947-0,Diospyros kaki Ab.IgE
10948-8,Pigeon feather Ab.IgE
10949-6,Malassezia furfur Ab.IgE
10950-4,Reindeer epithelium Ab.IgE
10951-2,Sericin Ab.IgE
10952-0,Swine urine proteins Ab.IgE
10953-8,Phleum pratense Ab.IgG
10954-6,Pinus edulis Ab.IgE
10955-3,Pinus palustris Ab.IgE
10956-1,Pinus echinata Ab.IgE
10957-9,Pinus elliottii Ab.IgE
10958-7,Pinus virginiana Ab.IgE
1095-9,K Ag
10959-5,Pleuronectes platessa Ab.IgE
10960-3,Rabbit serum proteins Ab.IgE
10961-1,Rabbit urine proteins Ab.IgE
10962-9,Artemisia tridentata Ab.IgE
10963-7,Spondylocladium citrovirens Ab.IgE
10964-5,17-Hydroxyprogesterone^15M post 250 ug corticotropin IM
10965-2,17-Hydroxyprogesterone^30M post 250 ug corticotropin IM
10966-0,Glucose^2.5H post 75 g glucose PO
1096-7,K Ag
10967-8,Glucose^3.5H post 75 g glucose PO
10968-6,Glucose^4.5H post 75 g glucose PO
10969-4,Cystine+Homocysteine
10970-2,Galactose 1 phosphate uridyl transferase
10971-0,Lysozyme
10972-8,Organic acids
10973-6,3 methoxy O desmethylencainide
10974-4,5-Fluorocytosine
1097-5,K little p super little a Ab
10975-1,6-Monoacetylmorphine
10976-9,6-Monoacetylmorphine
10977-7,ALPRAZolam
10978-5,Amitriptyline+Nortriptyline
10979-3,Carisoprodol
10980-1,Cephapirin
10981-9,cloNIDine
10982-7,Demeclocycline
1098-3,K little p super little a Ab
10983-5,Norparamethadione
10984-3,Dicloxacillin
10985-0,Doxapram
10986-8,Doxycycline
10987-6,Fluconazole
10988-4,fluvoxaMINE
10989-2,Itraconazole
109-9,Cefotaxime
10990-0,Ketoconazole
1099-1,K little p super little a Ab
10991-8,metroNIDAZOLE
10992-6,Norclozapine
10993-4,Nafcillin
10994-2,Naltrexone
10995-9,Neomycin
10996-7,Normeperidine
10997-5,O-desmethylencainide
10998-3,oxyCODONE
10999-1,Paramethadione
11000-7,Promethazine
11001-5,Pyrazinamide
11002-3,Scopolamine
11003-1,Ticlopidine
11004-9,Tricyclic antidepressants
11005-6,Trimethoprim
11006-4,Borrelia burgdorferi Ab
1100-7,K little p super little a Ag
11007-2,Borrelia burgdorferi Ag
11008-0,Cytomegalovirus Ab.IgG
11009-8,Epstein Barr virus capsid Ab.IgG
11010-6,Epstein Barr virus capsid Ab.IgM
11011-4,Hepatitis C virus RNA
11012-2,Reovirus Ab
11013-0,DNA double strand Ab
11014-8,Somatotropin Ab
1101-5,K little p super little a Ag
11015-5,Somatotropin binding protein
11016-3,Microscopic observation
11017-1,Microscopic observation
11018-9,Microscopic observation
11019-7,Microscopic observation
11020-5,Microscopic observation
11021-3,Microscopic observation
11022-1,Barbiturates
1102-3,K little p super little a Ag
11023-9,Benzodiazepines
11024-7,Benzodiazepines
11025-4,Methadone
11026-2,Methaqualone
11027-0,Propoxyphene
11028-8,Zinc
11029-6,Consistency
11030-4,(Aspergillus fumigatus+Aspergillus niger) Ab.IgE
1103-1,K little p super little b Ab
11031-2,Lymphocytes/100 leukocytes
11032-0,Glucose^45M post 50 g lactose PO
11033-8,Thyrotropin^45M post dose TRH IV
11034-6,Acetylcholine receptor binding Ab
11035-3,Adenylate kinase
11036-1,Aldolase
11037-9,Alpha-N-acetylgalactosaminidase
11038-7,Beta+gamma tocopherol
11039-5,C reactive protein
11040-3,Cortisol.free
11041-1,Creatinine^post dialysis
11042-9,Creatinine^pre dialysis
11043-7,Cryofibrinogen
11044-5,Diphosphoglycerate mutase
11045-2,Enolase
11046-0,EPINEPHrine
11047-8,Glucose phosphate isomerase
11048-6,Glyceraldehyde 3 phosphate dehydrogenase
1104-9,K little p super little b Ab
11049-4,Hydroxyproline
11050-2,Immunoglobulin light chains.kappa
11051-0,Immunoglobulin light chains.lambda
11052-8,Ketamine
11053-6,Lactate dehydrogenase
11054-4,Cholesterol.in LDL/Cholesterol.in HDL
11055-1,Melatonin
1105-6,K little p super little b Ab
11056-9,Melatonin
11057-7,Monophosphoglyceromutase
11058-5,Phosphofructokinase
11059-3,Phosphoglycerate kinase
11060-1,Reducing substances
11061-9,11-Dehydro thromboxane beta 2
11062-7,Thyroxine.albumin bound
11063-5,Triosephosphate isomerase
1106-4,K little p super little b Ag
11064-3,Urea nitrogen^post dialysis
11065-0,Urea nitrogen^pre dialysis
11066-8,Uroporphyrinogen III synthase
11067-6,Bleeding time
11068-4,Microscopic observation
11069-2,Microscopic observation
110-7,Cefotaxime
11070-0,Microscopic observation
11071-8,Butalbital
1107-2,K little p super little b Ag
11072-6,Despropionylfentanyl
11073-4,Despropionylfentanyl
11074-2,Norfentanyl
11075-9,Norfentanyl
11076-7,Hepatitis C virus 5-1-1 Ab
11077-5,Hepatitis C virus superoxide dismutase Ab
11078-3,HIV 2 gp80 Ab
11079-1,HIV 2 p26 Ab
1108-0,K little p super little b Ag
11080-9,HIV 2 p53 Ab
11081-7,HIV 2 p56 Ab
11082-5,HIV 2 p68 Ab
11083-3,Human papilloma virus identified
11084-1,Reagin Ab
11085-8,Schistosoma sp identified
11086-6,Streptococcus pneumoniae Ag
11087-4,Insulin Ab
11088-2,Neuronal nuclear Ab
11089-0,Neuronal nuclear Ab
11090-8,Smith extractable nuclear Ab
11091-6,Alpha chlordane
11092-4,Barbiturates
11093-2,Dichlorodiphenyldichloroethylene
11094-0,Dichlorodiphenyltrichloroethane
11095-7,Dieldrin
11096-5,Gamma chlordane
11097-3,Lindane
1109-8,L little b
11098-1,Malaoxon
11099-9,Methoxychlor
11100-5,Tetrachloroethylene
11101-3,Bacteria
11102-1,Charcot-leyden crystals
11103-9,Neutrophils.band form/100 cells
11104-7,Normoblasts.basophilic/100 cells
11105-4,Basophils/100 cells
1110-6,L little e super little a Ab
11106-2,Eosinophils/100 cells
11107-0,Lymphocytes.variant/100 cells
11108-8,Lymphocytes/100 cells
11109-6,Mast cells/100 cells
11110-4,Megakaryocytes/100 cells
11111-2,Metamyelocytes/100 cells
11112-0,Monocytes/100 cells
11113-8,Myeloblasts/100 cells
1111-4,L little e super little a Ab
11114-6,Myelocytes/100 cells
11115-3,Neutrophils/100 cells
11116-1,Normoblasts.orthochromic/100 cells
11117-9,Plasma cells.immature/100 cells
11118-7,Plasma cells/100 cells
11119-5,Normoblasts.polychromatophilic/100 cells
11120-3,Promyelocytes/100 cells
11121-1,Prolymphocytes/100 cells
1112-2,L little e super little a Ab
11122-9,Promonocytes/100 cells
11123-7,Promyelocytes/100 leukocytes
11124-5,Pronormoblasts/100 cells
11125-2,Platelet morphology finding
11126-0,Platelets
11127-8,Erythrocytes
11128-6,Neutrophils.segmented/100 cells
11129-4,Pronormoblasts
1113-0,L little e super little a Ag
11130-2,Lymphocytes B
11131-0,Erythroblasts early/100 cells
11132-8,Bilirubin
11133-6,Catecholamines.free
11134-4,Appearance
11135-1,Appearance
11136-9,Erythroblasts late/100 erythrocytes
11137-7,Erythroblasts mid/100 erythrocytes
11138-5,Myeloid cells/Erythroid cells
11139-3,Metanephrine
11140-1,Metanephrine
11141-9,Phosphate/Creatinine
11142-7,Glucose^15M post 100 g glucose PO
11143-5,Glucose^45M post 100 g glucose PO
11144-3,Homovanillate
11145-0,5-Hydroxyindoleacetate/Creatinine
11146-8,Homovanillate/Creatinine
11147-6,Myoglobin/Creatinine
1114-8,L little e super little a Ag
11148-4,Potassium/Creatinine
11149-2,Sodium/Creatinine
111-5,cefoTEtan
11150-0,Blasts/100 cells
11151-8,Hematocrit
11152-6,Eosinophils/100 cells
11153-4,Hematocrit
11154-2,Cholinesterase
1115-5,L little e super little a Ag
11155-9,Cortisol/Creatinine
11156-7,Leukocyte morphology finding
11157-5,Leukocytes
11158-3,Appearance
11159-1,Alkalase Ab.IgE
11160-9,Beta lactoglobulin Ab.IgG
11161-7,Bran wheat Ab.IgE
11162-5,Theobroma cacao Ab.IgE
1116-3,L little e super little b Ab
11163-3,Carageenan Ab.IgE
11164-1,Cheese cream Ab.IgE
11165-8,Chinchilla Ab.IgE
11166-6,Chortoglyphus arcuatus Ab.IgE
11167-4,Cockatiel feather Ab.IgE
11168-2,Cupressus arizonica Ab.IgE
11169-0,Deer hair Ab.IgE
11170-8,Dematiaceae Ab.IgE
1117-1,L little e super little b Ab
11171-6,Erythromycin Ab.IgE
11172-4,Ferret epithelium Ab.IgE
11173-2,Ficus carica Ab.IgE
11174-0,Sitophilus granarius Ab.IgE
11175-7,Helminthosporium sativum Ab.IgE
11176-5,Lactalbumin alpha Ab.IgG
11177-3,Lactalbumin beta Ab.IgE
11178-1,Beta galactosidase Ab.IgE
11179-9,Tilia cordata Ab.IgE
11180-7,Lupinus spp Ab.IgE
11181-5,Lycopodium spp Ab.IgE
11182-3,Lysozyme Ab.IgE
11183-1,Macadamia spp Ab.IgE
11184-9,Trachurus japonicus Ab.IgE
11185-6,Maxatase Ab.IgE
11186-4,Setaria italica Ab.IgE
11187-2,Penicillium frequentans Ab.IgE
11188-0,Pepper cayenne Ab.IgE
1118-9,L little e super little b Ab
11189-8,Pepper jalapeno Ab.IgE
11190-6,Mentha piperita Ab.IgE
11191-4,Pollachius virens Ab.IgE
11192-2,Protamine Ab.IgE
11193-0,Cucurbita pepo seed Ab.IgE
11194-8,Brassica napus pollen Ab.IgE
11195-5,Brassica rapa Ab.IgE
11196-3,Hoplostethus atlanticus Ab.IgE
1119-7,L little e super little b Ag
11197-1,Sardina pilchardus Ab.IgE
11198-9,Shark Ab.IgE
11199-7,Silver Ab.IgE
11200-3,Helix aspersa Ab.IgE
11201-1,Succinylcholine Ab.IgE
11202-9,Artemisia dracunculus Ab.IgE
11203-7,Trichosporon pullulans Ab.IgE
11204-5,Ulocladium chartarum Ab.IgE
1120-5,L little e super little b Ag
11205-2,Polistes spp Ab.IgE
11206-0,18-Hydroxydeoxycorticosterone
11207-8,Alpha-1-Fetoprotein
11208-6,Atrial natriuretic factor
11209-4,Beta glucuronidase
11210-2,Cancer Ag 125
11211-0,Carbon dioxide
11212-8,Coproporphyrin
1121-3,L little e super little b Ag
11213-6,Corticotropin releasing hormone
11214-4,Creatinine
11215-1,Delta aminolevulinate
11216-9,Deoxypyridinoline
11217-7,Hexaporphyrin
11218-5,Albumin
11219-3,Immunoglobulin light chains
11220-1,Iodine.free
1122-1,L little e super little x Ab
11221-9,Pentacarboxylporphyrins
11222-7,Pentacarboxylporphyrins
11223-5,Phenolphthalein
11224-3,Phosphoethanolamine
11225-0,Porphyrins
11226-8,Prorenin
11227-6,Pyruvate kinase
11228-4,Uroporphyrin
11229-2,3-O-Methyldopa
112-3,cefoTEtan
11230-0,Amobarbital
11231-8,Astemizole
11232-6,Bromocriptine
11233-4,Brompheniramine
11234-2,Propoxyphene
11235-9,fentaNYL
11236-7,Gemfibrozil
11237-5,hydrALAZINE
11238-3,Hydroxyalprazolam
1123-9,L little e super little x Ab
11239-1,hydrOXYzine
11240-9,hydrOXYzine
11241-7,Hyoscyamine
11242-5,Mercaptopurine
11243-3,Methadone
11244-1,Morphine.free
11245-8,Orphenadrine
11246-6,oxyCODONE
1124-7,L little e super little x Ab
11247-4,oxyMORphone
11248-2,Pergolide
11249-0,Phenacemide
11250-8,Phenylethylmalonate
11251-6,Piroxicam
11252-4,Scopolamine
11253-2,Tacrolimus
1125-4,L little e Ab
11254-0,Chlamydophila pneumoniae Ab
11255-7,Haemophilus ducreyi
11256-5,Haemophilus influenzae B Ab.IgG
11257-3,Haemophilus influenzae B Ab.IgG
11258-1,Hepatitis B virus DNA
11259-9,Hepatitis C virus RNA
11260-7,HTLV I Ab
11261-5,Bacteria identified
1126-2,L little e Ab
11262-3,Parainfluenza virus 3 Ab.IgG
11263-1,Parainfluenza virus 3 Ab.IgM
11264-9,Salmonella paratyphi A Ab
11265-6,Salmonella paratyphi B Ab
11266-4,Streptococcus agalactiae Ag
11267-2,Streptococcus.beta-hemolytic
11268-0,Streptococcus pyogenes
11269-8,Streptococcus pyogenes Ag
1127-0,L little e NOS Ab
11270-6,Viral inclusion bodies
11271-4,Hematocrit
11272-2,Erythrocyte mean corpuscular volume
11273-0,Erythrocytes
11274-8,Elliptocytes
11275-5,Lymphocytes.large granular/100 leukocytes
11276-3,Tubular cells
11277-1,Epithelial cells.squamous
11278-9,Bladder cells
11279-7,Urine sediment comments
11280-5,Cabot rings
11281-3,Auer rods
11282-1,Cells counted.total
11283-9,Acuity assessment
11284-7,Acuity assessment practitioner identification
11285-4,Acuity assessment practitioner profession
11286-2,Alcohol binge episodes per M
11287-0,Alcoholic drinks per drinking D
1128-8,L little e NOS Ab
11288-8,Arrival time documented
11289-6,Body temperature
11290-4,Body temperature measurement site
11291-2,Breaths
11292-0,Chief complaint
11293-8,Class
11294-6,Current employment
11295-3,Current employment
1129-6,L little e NOS Ab
11296-1,ED clinical finding practitioner ID
11297-9,ED clinical finding practitioner profession
11298-7,ED consultant practitioner ID
11299-5,ED consultant practitioner profession
11300-1,ED diagnosis
11301-9,ED diagnosis
11302-7,ED discharge disposition
11303-5,ED disposition consult &or referral
1130-4,L little e NOS Ag
11304-3,ED disposition diagnosis practitioner identification
11305-0,ED disposition diagnosis practitioner profession
11306-8,ED medication practitioner identification
11307-6,ED medication practitioner profession
11308-4,ED outcome observation practitioner identification
11309-2,ED outcome observation practitioner profession
113-1,cefoTEtan
11310-0,ED patient satisfaction report type
11311-8,ED procedure practitioner profession
1131-2,L little e NOS Ag
11312-6,ED procedure practitioner ID
11313-4,ED procedure result observation
11314-2,ED procedure result type
11315-9,ED service level
11316-7,ED service level practitioner profession
11317-5,ED service level practitioner identification
11318-3,Ambulance transport agency
11319-1,Ambulance transport unit
1132-0,L little e NOS Ag
11320-9,Feeding and dietary status
11321-7,Feeding and dietary status
11322-5,General health
11323-3,General health
11324-1,Glasgow coma score.eye opening
11325-8,Glasgow coma score.motor
11326-6,Glasgow coma score.verbal
11327-4,Heart rate method
11328-2,Heart rate
11329-0,History general
11330-8,Alcohol use
11331-6,Alcohol use
11332-4,Cognitive function
11333-2,Cognitive function
11334-0,Growth+Development
11335-7,Growth+Development
11336-5,Hospitalization
11337-3,Hospitalization
1133-8,L little u super little a Ab
11338-1,Major illnesses and injuries
11339-9,Major illnesses and injuries
11340-7,Occupation
11341-5,Occupation
11342-3,Other nonmedical drug use
11343-1,Other nonmedical drug use
11344-9,Other social factors
11345-6,Other social factors
1134-6,L little u super little a Ab
11346-4,Outpatient visits
11347-2,Outpatient visits
11348-0,Past illness
11349-8,Past illness
11350-6,Sexual behavior
11351-4,Sexual behavior
11352-2,Symptoms & diseases
1135-3,L little u super little a Ab
11353-0,Symptoms & diseases
11354-8,Symptoms & diseases
11355-5,Symptoms & diseases
11356-3,Symptoms & diseases
11357-1,Symptoms & diseases
11358-9,Symptoms & diseases
11359-7,Symptoms & diseases
11360-5,Symptoms & diseases
1136-1,L little u super little a Ag
11361-3,Symptoms & diseases
11362-1,Symptoms & diseases
11363-9,Symptoms & diseases
11364-7,Symptoms & diseases
11365-4,Symptoms & diseases
11366-2,Tobacco use status
11367-0,Tobacco use status
11368-8,Illness or injury onset date and time
11369-6,Immunization
11370-4,Immunization status
11371-2,Initial visit for chief complaint
11372-0,Injury associated activity
11373-8,Injury cause
11374-6,Injury incident description
11375-3,Injury intent
11376-1,Injury location
11377-9,Intravascular diastolic
11378-7,Intravascular systolic
1137-9,L little u super little a Ag
11379-5,Highest level of education
11380-3,Marital status and living arrangements
11381-1,Marital status and living arrangements
11382-9,Medication allergy
11383-7,Patient problem outcome
11384-5,Physical examination by organ systems
11385-2,Physical findings
11386-0,Physical findings
1138-7,L little u super little a Ag
11387-8,Physical findings
11388-6,Physical findings
11389-4,Physical findings
11390-2,Physical findings
11391-0,Physical findings
11392-8,Physical findings
11393-6,Physical findings
11394-4,Physical findings
1139-5,L little u super little a super little b Ab
11395-1,Physical findings
11396-9,Physical findings
11397-7,Physical findings
11398-5,Physical findings
11399-3,Physical findings
11400-9,Physical findings
11401-7,Physical findings
11402-5,Physical findings
1140-3,L little u super little a super little b Ab
11403-3,Physical findings
11404-1,Physical findings
11405-8,Physical findings
11406-6,Physical findings
11407-4,Physical findings
11408-2,Physical findings
11409-0,Physical findings
11410-8,Physical findings
1141-1,L little u super little a super little b Ab
11411-6,Physical findings
11412-4,Physical findings
11413-2,Physical findings
11414-0,Physical findings
11415-7,Physical findings
11416-5,Physical findings
11417-3,Physical findings
11418-1,Physical findings
11419-9,Physical findings
11420-7,Physical findings
11421-5,Physical findings
11422-3,Physical findings
11423-1,Physical findings
11424-9,Physical findings
11425-6,Physical findings
11426-4,Physical findings
11427-2,Physical findings
11428-0,Physical findings
1142-9,L little u super little b Ab
11429-8,Physical findings
11430-6,Physical findings
11431-4,Physical findings
11432-2,Physical findings
11433-0,Physical findings
11434-8,Physical findings
11435-5,Physical findings
11436-3,Physical findings
1143-7,L little u super little b Ab
11437-1,Physical findings
11438-9,Physical findings
11439-7,Physical findings
11440-5,Physical findings
11441-3,Physical findings
11442-1,Physical findings
11443-9,Physical findings
11444-7,Physical findings
1144-5,L little u super little b Ab
11445-4,Physical findings
11446-2,Physical findings
11447-0,Physical findings
11448-8,Physical findings
11449-6,Pregnancy status
11450-4,Problem list
11451-2,Psychiatric findings
1145-2,L little u super little b Ag
11452-0,Psychiatric findings
11453-8,Receiving facility
11454-6,Responsiveness assessment
11455-3,Review of symptoms and diseases
11456-1,Review of symptoms and diseases
11457-9,Safety equipment used
11458-7,Clostridium tetani immunization status
11459-5,Transport mode
1146-0,L little u super little b Ag
11467-8,Bacillus anthracis Ab
11468-6,Bacillus anthracis Ab
11469-4,Bacillus anthracis
11470-2,Clostridium botulinum toxin
11471-0,Cryptococcus neoformans Ag
11472-8,Cryptococcus neoformans Ag
11473-6,Cryptococcus sp Ag
11474-4,Hydatid cyst identified
11475-1,Microorganism identified
11476-9,Microscopic observation
11477-7,Microscopic observation
1147-8,L little u super little b Ag
11478-5,Microscopic observation
11479-3,Microscopic observation
11480-1,Microscopic observation
11481-9,Human papilloma virus identified
11482-7,Rickettsia rickettsii RNA
11483-5,Varicella zoster virus DNA
11484-3,Virus identified
11485-0,Anesthesia records
1148-6,L little u NOS Ab
11486-8,Chemotherapy records
11487-6,Consultation request.total
11488-4,Consultation note
11489-2,Dictating practitioner ID
114-9,cefoTEtan
11490-0,Discharge summary note
11491-6,Emergency visit note.total
11492-6,History and physical note
11493-4,Hospital discharge studies summary
1149-4,L little u NOS Ab
11494-2,Initial assessment note
11495-9,Initial assessment note
11496-7,Initial assessment note
11497-5,Initial assessment note
11498-3,Initial assessment note
11499-1,Initial assessment note
11500-6,Initial assessment note
11501-6,Labor and delivery record.total
1150-2,L little u NOS Ab
11502-2,Laboratory report
11503-0,Medical records
11504-8,Surgical operation note
11505-5,Procedure note
11506-3,Progress note
11507-1,Progress note
11508-9,Progress note
11509-7,Progress note
1151-0,L little u NOS Ag
11510-5,Progress note
11511-3,Progress note.total
11512-1,Progress note
11513-9,Provider.signing
11514-7,Episode of care medical records
11515-4,Episode of care medical records
11516-2,Episode of care medical records
11517-0,Episode of care medical records
11518-8,Episode of care medical records
11519-6,Episode of care medical records
11520-4,Episode of care medical records
11521-2,Episode of care medical records
11522-0,Study report
11523-8,Electroencephalography study
11524-6,EKG study
11525-3,Multisection for pregnancy
11526-1,Pathology study
11527-9,Psychiatry study
1152-8,L little u NOS Ag
11528-7,Study.total
11529-5,Surgical pathology study
11530-3,Surgeon.assisting
11531-1,Surgeon.resident
11532-9,Surgeon.staff
11533-7,Surgical drains
11534-5,Temperature charts
11535-2,Hospital discharge Dx
1153-6,L little u NOS Ag
11536-0,Notes
11537-8,Surgical drains
11538-6,Study.total
11539-4,Study.total
11540-2,Study.total
11541-0,Study report
11542-8,Subsequent visit evaluation note
11543-6,Nursery records
1154-4,little c Ab
11544-4,Hospital discharge follow-up
11545-1,Microscopic observation
11546-9,Microscopic observation
11550-1,Borrelia burgdorferi
1155-1,little c Ab
11551-9,Borrelia burgdorferi DNA
11552-7,Microscopic exam
11553-5,Microscopic exam
11554-3,Magnesium
11555-0,Base excess
11556-8,Oxygen
11557-6,Carbon dioxide
11558-4,pH
11559-2,Oxyhemoglobin/Hemoglobin.total
115-6,cefOXitin
11560-0,Acetylcholine receptor binding Ab
11561-8,Acetylcholine receptor blocking Ab
11562-6,Acetylcholine receptor modulation Ab
11563-4,DNA double strand Ab
11564-2,Intrinsic factor Ab
11565-9,Jo-1 extractable nuclear Ab
11566-7,Liver kidney microsomal Ab
11567-5,Neutrophil cytoplasmic Ab
11568-3,Phosphatidylserine Ab.IgG
1156-9,little c Ab
11569-1,Phosphatidylserine Ab.IgM
11570-9,Platelet Ab.IgG
11571-7,Rheumatoid arthritis nuclear Ab
11572-5,Rheumatoid factor
11573-3,Rheumatoid factor.IgM
11574-1,Thyroperoxidase Ab
11575-8,Cefmetazole
11576-6,Erythromycin+sulfiSOXAZOLE
1157-7,little c Ag
11577-4,Sulfamethoxazole
11578-2,sulfiSOXAZOLE
11579-0,Thyrotropin
11580-8,Thyrotropin
11581-6,Ebola virus Ab
11582-4,Wuchereria bancrofti Ab
11583-2,Aspergillus fumigatus 1 Ab
11584-0,Aureobasidium pullulans Ab
1158-5,little c Ag
11585-7,Bordetella pertussis Ab
11586-5,Brucella abortus Ab
11587-3,Brucella canis Ab
11588-1,Brucella melitensis Ab
11589-9,Brucella suis Ab
11590-7,Coxsackievirus A10 Ab
11591-5,Coxsackievirus A2 Ab
11592-3,Aspergillus fumigatus 6 Ab
1159-3,little c Ag
11593-1,Coxsackievirus A4 Ab
11594-9,Echovirus 16 Ab
11595-6,Echovirus 18 Ab
11596-4,Shigella dysenteriae Ab
11597-2,Treponema pallidum Ab
11598-0,Toxoplasma gondii Ab
11599-8,Coxsackievirus A21 Ab
11600-4,Shigella flexneri Ab
1160-1,little e Ab
11601-2,Echovirus 7 Ab
11602-0,Shigella boydii Ab
11603-8,Salmonella sp Ab
11604-6,Burkholderia pseudomallei Ab
11605-3,Lymphocytic choriomeningitis virus Ab
11606-1,Leptospira interrogans Ab
11607-9,Junin virus Ab
11608-7,Japanese encephalitis virus Ab
11609-5,HTLV I Ab
11610-3,Heterophile Ab
11611-1,Shigella sonnei Ab
11612-9,Abortions
11613-7,Abortions.induced
11614-5,Abortions.spontaneous
11615-2,Activity
11616-0,Activity
11617-8,Activity
11618-6,Activity
1161-9,little e Ab
11619-4,Activity
11620-2,Activity
11621-0,Activity
11622-8,Activity
11623-6,Amniotic fluid index
11624-4,Amniotic fluid index
11625-1,Amniotic fluid index
11626-9,Amniotic fluid index
1162-7,little e Ab
11627-7,Amniotic fluid index.sum
11628-5,Binocular distance
11629-3,Binocular distance
11630-1,Biophysical profile.amniotic fluid volume
11631-9,Biophysical profile.body movement
11632-7,Biophysical profile.breathing movement
11633-5,Heart rate reactivity
11634-3,Biophysical profile.sum
1163-5,little e Ag
11635-0,Biophysical profile.tone
11636-8,Births.live
11637-6,Births.preterm
11638-4,Births.still living
11639-2,Births.term
116-4,cefOXitin
11640-0,Births.total
11641-8,A wave.max
11642-6,Blood flow.diastolic.atrial wave.max
1164-3,little e Ag
11643-4,A wave.max
11644-2,Blood flow.diastolic.atrial wave.max
11645-9,E wave.max
11646-7,Blood flow.diastolic.early wave.max
11647-5,E wave.max
11648-3,Blood flow.diastolic.early wave.max
11649-1,E wave/A wave
1165-0,little e Ag
11650-9,Blood flow.diastolic.early wave/Atrial wave ratio
11651-7,E wave/A wave
11652-5,Blood flow.diastolic.early wave/Atrial wave ratio
11653-3,Blood flow velocity.diastolic.end
11654-1,Blood flow velocity.diastolic.min
11655-8,Blood flow velocity.diastolic.min
11656-6,Blood flow velocity.diastolic.min
11657-4,Blood flow velocity.diastolic.min
11658-2,Blood flow velocity.diastolic.min
11659-0,Blood flow velocity.diastolic.min
11660-8,Blood flow velocity.diastolic.min
11661-6,Blood flow velocity.diastolic.min
11662-4,Blood flow velocity.diastolic.min
11663-2,Blood flow velocity.diastolic.min
11664-0,Blood flow velocity.diastolic.min
11665-7,Blood flow velocity.diastolic.min
11666-5,Blood flow velocity.mean
11667-3,Blood flow velocity.mean
1166-8,little f Ab
11668-1,Blood flow velocity.mean
11669-9,Blood flow velocity.mean
11670-7,Blood flow velocity.mean
11671-5,Blood flow velocity.mean
11672-3,Blood flow velocity.mean
11673-1,Blood flow velocity.mean
11674-9,Blood flow velocity.mean
11675-6,Blood flow velocity.mean
1167-6,little f Ab
11676-4,Blood flow velocity.mean
11677-2,Blood flow velocity.mean
11678-0,Blood flow velocity.mean
11679-8,Blood flow velocity.mean
11680-6,Blood flow.mean
11681-4,Blood flow velocity.mean
11682-2,Blood flow.mean
11683-0,Blood flow velocity.mean
1168-4,little f Ab
11684-8,Blood flow velocity.mean
11685-5,Blood flow velocity.mean
11686-3,Blood flow velocity.mean
11687-1,Blood flow velocity.mean
11688-9,Blood flow.mean
11689-7,Blood flow.mean
11690-5,Blood flow.mean
11691-3,Blood flow.mean
1169-2,little f Ag
11692-1,Blood flow velocity.mean.max
11693-9,Blood flow velocity.systolic.max
11694-7,Blood flow velocity.systolic.max
11695-4,Blood flow velocity.systolic.max
11696-2,Blood flow velocity.systolic.max
11697-0,Blood flow velocity.systolic.max
11698-8,Blood flow velocity.systolic.max
11699-6,Blood flow velocity.systolic.max
07-Nov,Amikacin
1170-0,little f Ag
11700-2,Blood flow velocity.systolic.max
11701-0,Blood flow velocity.systolic.max
11702-8,Blood flow velocity.systolic.max
11703-6,Blood flow velocity.systolic.max
11704-4,Blood flow velocity.systolic.max
11705-1,Blood flow velocity.systolic.max
11706-9,Blood flow.systolic.max
11707-7,Blood flow velocity.systolic.max
11708-5,Blood flow velocity.systolic.max
11709-3,Blood flow velocity.systolic.max
11710-1,Blood flow velocity.systolic.max
11711-9,Blood flow velocity.systolic.max
11712-7,Blood flow velocity.systolic.max
11713-5,Blood flow velocity.systolic.max
11714-3,Blood flow.systolic.max
11715-0,Blood flow velocity.systolic.max
11716-8,Blood flow.systolic.max
11717-6,Blood flow velocity.systolic.max
1171-8,little f Ag
11718-4,Blood flow velocity.systolic.max
11719-2,Blood flow velocity.systolic.max
117-2,cefOXitin
11720-0,Blood flow velocity.systolic.max
11721-8,Blood flow velocity.systolic.max
11722-6,Blood flow velocity.systolic.max
11723-4,Blood flow velocity.systolic.max
11724-2,Blood flow velocity.systolic.max
11725-9,Blood flow velocity.systolic.max
1172-6,little i -1 Ab
11726-7,Blood flow velocity.systolic.max
11727-5,Body weight
11728-3,Body weight
11729-1,Body weight
11730-9,Body weight
11731-7,Body weight
11732-5,Body weight
11733-3,Body weight
1173-4,little i -1 Ab
11734-1,Body weight
11735-8,Body weight
11736-6,Body weight
11737-4,Body weight
11738-2,Body weight
11739-0,Body weight
11740-8,Body weight
11741-6,Body weight
1174-2,little i -1 Ab
11742-4,Body weight
11743-2,Body weight
11744-0,Body weight
11745-7,Body weight
11746-5,Body weight
11747-3,Body weight
11748-1,Body weight
11749-9,Body weight
11750-7,Body weight
11751-5,Body weight
11752-3,Body weight
11753-1,Body weight
11754-9,Body weight
11755-6,Body weight
11756-4,Body weight
11757-2,Body weight
11758-0,Body weight
1175-9,little i -1 Ag
11759-8,Body weight
11760-6,Body weight
11761-4,Body weight
11762-2,Body weight
11763-0,Body weight
11764-8,Body weight
11765-5,Body weight
11766-3,Body weight percentile
1176-7,little i -1 Ag
11767-1,Body weight percentile
11768-9,Body weight percentile range
11769-7,Body weight percentile range
11770-5,Body weight.10th
11771-3,Body weight.25th
11772-1,Body weight.50th
11773-9,Body weight.75th
11774-7,Body weight.90th
1177-5,little i -1 Ag
11775-4,Citation
11776-2,Citation
11777-0,Cross section
11778-8,Delivery date
11779-6,Delivery date
11780-4,Delivery date
11781-2,Delivery date
11782-0,Diameter
1178-3,little i -2 Ab
11783-8,Diameter
11784-6,Diameter
11785-3,Diameter
11786-1,Diameter
11787-9,Diameter
11788-7,Diameter
11789-5,Diameter
11790-3,Diameter
1179-1,little i -2 Ab
11791-1,Diameter
11792-9,Diameter
11793-7,Diameter
11794-5,Diameter
11795-2,Diameter
11796-0,Diameter
11797-8,Diameter
11798-6,Diameter
11799-4,Diameter
118-0,cefOXitin
11800-0,Diameter
11801-8,Diameter
11802-6,Diameter
11803-4,Diameter
11804-2,Diameter
11805-9,Diameter
11806-7,Diameter
11807-5,Diameter
11808-3,Diameter
1180-9,little i -2 Ab
11809-1,Diameter
11810-9,Diameter
11811-7,Diameter
11812-5,Diameter
11813-3,Diameter
11814-1,Diameter
11815-8,Diameter
11816-6,Diameter
1181-7,little i -2 Ag
11817-4,Diameter product.largest pocket
11818-2,Diameter.anterior-posterior
11819-0,Diameter.anterior-posterior
11820-8,Diameter.biparietal
11821-6,Diameter.biparietal.mean
11822-4,Diameter.biparietal.mean
11823-2,Diameter.biparietal/Diameter.occipital
11824-0,Diameter.BPD.area-corrected
1182-5,little i -2 Ag
11825-7,Diameter.hilum-cortex
11826-5,Diameter.hilum-cortex
11827-3,Diameter.hilum-cortex
11828-1,Diameter.hilum-cortex
11829-9,Diameter.hilum-cortex
11830-7,Diameter.hilum-cortex
11831-5,Diameter.hilum-cortex.mean
11832-3,Diameter.largest pocket.max
1183-3,little i -2 Ag
11833-1,Diameter.largest pocket.mean
11834-9,Diameter.long
11835-6,Diameter.long
11836-4,Diameter.long
11837-2,Diameter.long
11838-0,Diameter.long
11839-8,Diameter.long
11840-6,Diameter.long
1184-1,little i Ab
11841-4,Diameter.long
11842-2,Diameter.long
11843-0,Diameter.long.mean
11844-8,Diameter.long.mean
11845-5,Diameter.long.mean
11846-3,Diameter.max
11847-1,Diameter.max
11848-9,Diameter.max
11849-7,Diameter.mean
11850-5,Diameter.mean
11851-3,Diameter.occipito-frontal
11852-1,Diameter.outer to outer
11853-9,Diameter.perpendicular
11854-7,Diameter.perpendicular
11855-4,Diameter.perpendicular
11856-2,Diameter.perpendicular
11857-0,Diameter.perpendicular
1185-8,little i Ab
11858-8,Diameter.perpendicular
11859-6,Diameter.perpendicular
11860-4,Diameter.sagittal
11861-2,Diameter.sagittal.mean
11862-0,Diameter.transverse
11863-8,Diameter.transverse
11864-6,Diameter.transverse
11865-3,Diameter.transverse
1186-6,little i Ab
11866-1,Diameter.transverse.mean
11867-9,Effacement
11868-7,Equation
11869-5,Equation
11870-3,Examination level.ultrasound
11871-1,Femur length/Abdominal circumference
11872-9,Femur length/Biparietal diameter
11873-7,Femur length/Head circumference
1187-4,little i NOS Ag
11874-5,Fetal position
11875-2,Fetal position
11876-0,Fetal presentation
11877-8,Fetal presentation
11878-6,Fetuses
11879-4,Follicles
11880-2,Follicles
11881-0,Fundal height
1188-2,little i NOS Ag
11882-8,Fetal sex
11883-6,Fetal sex
11884-4,Gestational age
11885-1,Gestational age
11886-9,Gestational age
11887-7,Gestational age
11888-5,Gestational age
11889-3,Gestational age
1189-0,little i NOS Ag
11890-1,Gestational age
11891-9,Gestational age
11892-7,Gestational age
11893-5,Gestational age
11894-3,Gestational age
11895-0,Gestational age
11896-8,Gestational age
11897-6,Gestational age
11898-4,Gestational age
11899-2,Gestational age
11900-8,Gestational age
11901-6,Gestational age
11902-4,Gestational age
11903-2,Gestational age
11904-0,Gestational age
11905-7,Gestational age
11906-5,Gestational age
11907-3,Gestational age
1190-8,little k Ab
11908-1,Gestational age
11909-9,Gestational age
11910-7,Gestational age
11911-5,Gestational age
11912-3,Gestational age
11913-1,Gestational age
11914-9,Gestational age
11915-6,Gestational age
1191-6,little k Ab
11916-4,Gestational age
11917-2,Gestational age
11918-0,Gestational age
11919-8,Gestational age
11920-6,Gestational age
11921-4,Gestational age
11922-2,Gestational age
11923-0,Gestational age
1192-4,little k Ab
11924-8,Gestational age
11925-5,Gestational age
11926-3,Gestational age
11927-1,Gestational age
11928-9,Gestational age
11929-7,Gestational age
11930-5,Gestational age
11931-3,Gestational age
1193-2,little k Ag
11932-1,Gestational age
11933-9,Gestational age
11934-7,Gestational age
11935-4,Gestational age
11936-2,Gestational age
11937-0,Gestational age
11938-8,Gestational age
11939-6,Gestational age
1194-0,little k Ag
11940-4,Gestational age
11941-2,Gestational age
11942-0,Gestational age
11943-8,Gestational age
11944-6,Gestational age
11945-3,Gestational age
11946-1,Grade
11947-9,Head circumference/Abdominal circumference
11948-7,Heart rate
11949-5,Identification criteria
11950-3,Identification criteria
11951-1,Identifier
11952-9,Insertion site
11953-7,Institution inventory number
11954-5,Kidney length/Abdominal circumference
11955-2,Last menstrual period
11956-0,Lateral ventricular body width/Hemispheric width
1195-7,little k Ag
11957-8,Length.crown rump
11958-6,Long axis
11959-4,Long axis
11960-2,Long axis
11961-0,Long axis
11962-8,Long axis
11963-6,Long axis
11964-4,Long axis
1196-5,Little NOS Ab
11965-1,Long axis
11966-9,Long axis
11967-7,Long axis
11968-5,Long axis
11969-3,Long axis
11970-1,Long axis.mean
11971-9,Long axis.mean
11972-7,Long axis.mean
1197-3,Little NOS Ab
11973-5,Long axis.mean
11974-3,Long axis.mean
11975-0,Long axis.mean
11976-8,Ovulation date
11977-6,Parity
11978-4,Perimeter
11979-2,Perimeter
119-8,Cefpodoxime
11980-0,Perimeter
1198-1,Little NOS Ab
11981-8,Perimeter
11982-6,Perimeter
11983-4,Perimeter
11984-2,Perimeter
11985-9,Perimeter
11986-7,Perimeter
11987-5,Perimeter
11988-3,Perimeter
11989-1,Perimeter
11990-9,Perimeter
11991-7,Perimeter.mean
11992-5,Position.heart
11993-3,Position.heart
11994-1,Position.placenta
11995-8,Position.placenta
11996-6,Pregnancies
11997-4,Pulsatility index
11998-2,Pulsatility index
1199-9,little p little k Ab
11999-0,Pulsatility index
12000-6,Pulsatility index
12001-4,Pulsatility index
12002-2,Pulsatility index
12003-0,Pulsatility index
12004-8,Pulsatility index
1200-5,little p little k Ab
12005-5,Pulsatility index
12006-3,Pulsatility index
12007-1,Pulsatility index
12008-9,Pulsatility index
12009-7,RR duration
12010-5,RR duration
12011-3,Replicate summarization
12012-1,Resistivity index
1201-3,little p little k Ab
12013-9,Resistivity index
12014-7,Resistivity index
12015-4,Resistivity index
12016-2,Resistivity index
12017-0,Resistivity index
12018-8,Resistivity index
12019-6,Resistivity index
12020-4,Resistivity index
1202-1,little p little k Ag
12021-2,Resistivity index
12022-0,Resistivity index
12023-8,Resistivity index
12024-6,Minor axis.diastole
12025-3,Minor axis.diastole
12026-1,Short axis.systole
12027-9,Minor axis.systole
12028-7,Study observation
12029-5,Study observation
12030-3,Study observation
12031-1,Study observation
12032-9,Study observation
12033-7,Study observation
12034-5,Study observation
12035-2,Study observation
12036-0,Study observation
12037-8,Study observation
12038-6,Study observation
1203-9,little p little k Ag
12039-4,Study observation
12040-2,Study observation
12041-0,Study observation
12042-8,Study observation
12043-6,Study observation
12044-4,Study observation
12045-1,Study observation
12046-9,Study observation
1204-7,little p little k Ag
12047-7,Study observation
12048-5,Study observation
12049-3,Study observation
12050-1,Study observation
12051-9,Study observation
12052-7,Study observation
12053-5,Study observation
1205-4,little p Ag
12054-3,Study observation
12055-0,Study observation
12056-8,Study observation
12057-6,Study observation
12058-4,Study observation
12059-2,Study observation
120-6,Cefpodoxime
12060-0,Study observation
12061-8,Study observation
1206-2,little p Ag
12062-6,Study observation
12063-4,Study observation
12064-2,Study observation
12065-9,Study observation
12066-7,Study observation
12067-5,Study observation
12068-3,Study observation
12069-1,Study observation
1207-0,little p Ag
12070-9,Study observation
12071-7,Study observation
12072-5,Study observation
12073-3,Study observation
12074-1,Study observation
12075-8,Study observation
12076-6,Study observation
12077-4,Study observation
12078-2,Study observation
12079-0,Study observation
12080-8,Study observation
12081-6,Study observation
12082-4,Study observation
12083-2,Study observation
12084-0,Study observation
12085-7,Study observation
12086-5,Study observation
12087-3,Study observation
1208-8,little s Ab
12088-1,Study observation
12089-9,Study observation
12090-7,Study observation
12091-5,Study observation
12092-3,Study observation
12093-1,Study observation
12094-9,Study observation
12095-6,Study observation
1209-6,little s Ab
12096-4,Study observation
12097-2,Study observation
12098-0,Study observation
12099-8,Study observation
12100-4,Study observation
12101-2,Study observation
12102-0,Study observation
12103-8,Study observation
1210-4,little s Ab
12104-6,Study observation
12105-3,Study observation
12106-1,Study observation
12107-9,Study observation
12108-7,Study observation
12109-5,Study observation
12110-3,Study observation
12111-1,Study observation
1211-2,little s Ag
12112-9,Study observation
12113-7,Study observation
12114-5,Study observation
12115-2,Study observation
12116-0,Study observation
12117-8,Study observation
12118-6,Study observation
12119-4,Study observation
1212-0,little s Ag
12120-2,Study observation
12121-0,Study observation
12122-8,Study observation
12123-6,Study observation
12124-4,Study observation
12125-1,Study observation
12126-9,Study observation
12127-7,Study observation
12128-5,Study observation
12129-3,Study observation.general
12130-1,Study observation.general
12131-9,Study observation.general
12132-7,Study observation.general
12133-5,Systolic flow/Diastolic flow
12134-3,Systolic flow/Diastolic flow
12135-0,Systolic flow/Diastolic flow
12136-8,Systolic flow/Diastolic flow
12137-6,Systolic flow/Diastolic flow
1213-8,little s Ag
12138-4,Systolic flow/Diastolic flow
12139-2,Systolic flow/Diastolic flow
121-4,Cefpodoxime
12140-0,Systolic flow/Diastolic flow
12141-8,Systolic flow/Diastolic flow
12142-6,Systolic flow/Diastolic flow
12143-4,Systolic flow/Diastolic flow
12144-2,Systolic flow/Diastolic flow
12145-9,Thickness
1214-6,LW Ab
12146-7,Thickness
12147-5,Thickness
12148-3,Thickness.diastolic
12149-1,Thickness.diastolic
12150-9,Thickness.diastolic
12151-7,Thickness.diastolic
12152-5,Thickness.systolic
1215-3,LW Ab
12153-3,Thickness.systolic
12154-1,Thickness.systolic
12155-8,Thickness.systolic
12156-6,Transducer site
12157-4,Ultrasonographer gravidity number
12158-2,Ultrasound class
12159-0,Ultrasound scan quality
12160-8,Vendor model number
1216-1,LW Ab
12161-6,Vendor serial number
12162-4,Volume
12163-2,Volume
12164-0,Volume
12165-7,Volume
12166-5,Volume
12167-3,Volume.amniotic fluid
12168-1,Volume^post void
12169-9,Volume.pre void
12170-7,Width.hemisphere
12171-5,Width.transverse
12172-3,5-Hydroxyindoleacetate
12173-1,Acid phosphatase.non-prostatic
12174-9,Albumin/Globulin
12175-6,Albumin/Globulin
12176-4,Amino acids
12177-2,Amino acids/Creatinine
12178-0,Bacteria
1217-9,LW Ag
12179-8,Basophils/100 leukocytes
12180-6,Calcium.ionized
12181-4,Calcium
12182-2,Cells
12183-0,Cholesterol
12184-8,Choriogonadotropin
12185-5,Coagulation surface induced
12186-3,Colloid oncotic pressure
1218-7,LW Ag
12187-1,Creatine kinase.MB/Creatine kinase.total
12188-9,Creatine kinase.MB/Creatine kinase.total
12189-7,Creatine kinase.MB/Creatine kinase.total
12190-5,Creatinine
12191-3,Creatinine
12192-1,Creatinine^2H post peritoneal dialysis
12193-9,Creatinine^4H post peritoneal dialysis
12194-7,Creatinine^12H post peritoneal dialysis
1219-5,LW Ag
12195-4,Creatinine renal clearance/1.73 sq M
12196-2,Cryofibrinogen
12197-0,Cryofibrinogen
12198-8,Cryofibrinogen
12199-6,Cryofibrinogen
12200-2,Cryoglobulin
12201-0,Cryoglobulin
12202-8,Cryoglobulin
1220-3,M little g Ab
12203-6,Cryoglobulin
12204-4,Cryoglobulin
12205-1,Cryoglobulin
12206-9,Cryoglobulin
12207-7,Cryoglobulin
12208-5,Eosinophils/100 leukocytes
12209-3,Eosinophils/100 leukocytes
12210-1,Eosinophils/100 leukocytes
1221-1,M little g Ab
12211-9,Epithelial cells
12212-7,Epstein Barr virus nuclear Ab.IgG
12213-5,Estradiol
12214-3,Estradiol
12215-0,Fatty acids.very long chain
12216-8,Gastrin
12217-6,Globulin
12218-4,Glucose^2H post peritoneal dialysis
12219-2,Glucose^4H post peritoneal dialysis
122-2,Cefpodoxime
12220-0,Glucose^12H post peritoneal dialysis
12221-8,Heterophile Ab
12222-6,Human papilloma virus Ag
12223-4,Human papilloma virus 16+18 Ag
12224-2,Leukocytes
12225-9,Leukocytes
12226-7,Leukocytes
12227-5,Leukocytes^^corrected for nucleated erythrocytes
12228-3,Triglyceride
1222-9,M little g Ab
12229-1,Macrophages/100 leukocytes
12230-9,Macrophages/100 leukocytes
12231-7,Prolactin^baseline
12232-5,Measles virus Ag
12233-3,Mesothelial cells/100 leukocytes
12234-1,Mesothelial cells/100 leukocytes
12235-8,Microscopic observation
12236-6,Mononuclear cells/100 leukocytes
1223-7,M little g Ag
12237-4,Mumps virus Ag
12238-2,Neutrophils/100 leukocytes
12239-0,Oligosaccharides
12240-8,Orotidine
12241-6,Osmotic fragility
12242-4,Phosphate
12243-2,Platelets
12244-0,Polymorphonuclear cells/100 leukocytes
1224-5,M little g Ag
12245-7,Porphobilinogen
12246-5,Porphyrins
12247-3,Pyruvate
12248-1,Epithelial cells.renal
12249-9,Renin
12250-7,Reticulocytes/1000 erythrocytes^^hematocrit adjusted
12251-5,Rubella virus Ag
1225-2,M little g Ag
12252-3,Somatomedin C
12253-1,Somatotropin^baseline
12254-9,Specimen volume
12255-6,Specimen volume
12256-4,Spermatozoa^post vasectomy
12257-2,Spermatozoa.motile/100 spermatozoa^post vasectomy
12258-0,Epithelial cells.squamous
12259-8,Streptococcus pyogenes enzyme Ab
1226-0,M Ab
12260-6,Sucrose hemolysis
12261-4,Toxoplasma gondii Ab.IgG
12262-2,Toxoplasma gondii Ab.IgM
12263-0,Epstein Barr virus early diffuse Ab
12264-8,Epstein Barr virus early restricted Ab
12265-5,Urea nitrogen
12266-3,Urea nitrogen^2H post peritoneal dialysis
12267-1,Urea nitrogen^4H post peritoneal dialysis
12268-9,Urea nitrogen^12H post peritoneal dialysis
12269-7,Urobilinogen
12270-5,Uroporphyrin
12271-3,Varicella zoster virus Ab
12272-1,Virus identified
12273-9,Xanthochromia
12274-7,Xylose
12275-4,Yeast
12276-2,Escherichia coli O157:H7
12277-0,DNA double strand Ab
1227-8,M Ab
12278-8,Neutrophils.band form/100 leukocytes
12279-6,Spermatozoa Ab
12280-4,Alanine
12281-2,Bacteria identified
12282-0,Warfarin
12283-8,Corticotropin releasing hormone
12284-6,Growth hormone-releasing hormone
12285-3,HLA-DP
1228-6,M Ab
12286-1,Drugs identified
12287-9,Drugs identified
12288-7,Diuretics
12289-5,Drugs identified
12290-3,Procyclidine
12291-1,Mephentermine
12292-9,Dimethyltryptamine
12293-7,Cotinine
1229-4,M Ag
12294-5,Nicotine
12295-2,Hallucinogens
12296-0,Mescaline
12297-8,Chlorate
12298-6,Erythromycin
12299-4,Ethinamate
123-0,Cefprozil
12300-0,Polythiazide
12301-8,Procaine
1230-2,M Ag
12302-6,Theobromine
12303-4,Theobromine
12304-2,Benzyl alcohol
12305-9,Chlordecone
12306-7,Cyclohexane
12307-5,Dichloroethane
12308-3,HYDROcodone
12309-1,Naltrexone
1231-0,M Ag
12310-9,Phenytoin
12311-7,Prazepam
12312-5,Cyclopropane
12313-3,Aprobarbital
12314-1,Clorazepate
12315-8,Mephobarbital
12316-6,Methopyrilene
12317-4,Phenolphthalein
12318-2,Spironolactone
12319-0,Thioridazine
12320-8,Thiothixene
12321-6,Trifluoperazine
12322-4,Triflupromazine
12323-2,Trimeprazine
12324-0,hydrOXYzine
12325-7,Tetrahydrocortisone
12326-5,Diamorphine
12327-3,Ketamine
1232-8,M little i super little a Ag
12328-1,Beta blockers
12329-9,chlorproPAMIDE
12330-7,Hypoglycemics.oral
12331-5,Phenethylamine
12332-3,Antihistamines
12333-1,Butorphanol
12334-9,Para aminophenol
12335-6,Halothane
1233-6,M little i super little a Ag
12336-4,hydrALAZINE
12337-2,Dimethylsulfoxide
12338-0,Pentachlorophenol
12339-8,Diquat
12340-6,Ethylene
12341-4,Mazindol
12342-2,oxyMORphone
12343-0,Thiazides
1234-4,M little i super little a Ag
12344-8,Antipsychotics
12345-5,Cyclothiazide
12346-3,Methyclothiazide
12347-1,metOLazone
12348-9,Quinethazone
12349-7,Trichlormethiazide
12350-5,Amphetamines
1235-1,M little i super little a Ab
12351-3,Tetrahydrocannabinol
12352-1,Benzoylecgonine
12353-9,Methaqualone
12354-7,Opiates
12355-4,Phencyclidine
12356-2,Methadone
12357-0,Propoxyphene
12358-8,Barbiturates
12359-6,Benzodiazepines
12360-4,Barbital
12361-2,Oxazepam
12362-0,Oxazepam
12363-8,carBAMazepine
12364-6,Benzodiazepines
12365-3,dimenhyDRINATE
12366-1,Disopyramide
12367-9,Mesoridazine
12368-7,Phenacetin
1236-9,M little i super little a Ab
12369-5,Sympathomimetics
12370-3,Thiopental
12371-1,Isopropyl ether
12372-9,Dimethylacetamide
12373-7,Norchlordiazepoxide
12374-5,cloBAZam
12375-2,Clozapine+Norclozapine
12376-0,Norclozapine
1237-7,M little i super little a Ab
12377-8,Demoxepam
12378-6,diazePAM
12379-4,Halazepam
12380-2,LORazepam
12381-0,Oxazepam
12382-8,Temazepam
12383-6,Hydroxytriazolam
12384-4,Triazolam
1238-5,M NOS Ab
12385-1,Desmethyldoxepin
12386-9,Nordoxepin
12387-7,Primidone
12388-5,Phenylethylmalonamide
12389-3,OLANZapine
12390-1,sulfaSALAzine
12391-9,dimenhyDRINATE
12392-7,Itraconazole
1239-3,M NOS Ab
12393-5,Ketoconazole
12394-3,Butorphanol
12395-0,Butorphanol
12396-8,chlorproPAMIDE
12397-6,Colchicine
12398-4,Diphenoxylate
12399-2,Emetine
12400-8,Emetine
1240-1,M NOS Ab
12401-6,Ethinamate
12402-4,Griseofulvin
12403-2,Mephentermine
12404-0,Nitroglycerin
12405-7,Nabumetone
12406-5,Nadolol
12407-3,6-Beta naltrexone
12408-1,Oxybutynin
12409-9,Pentoxyfylline
12410-7,Pimozide
12411-5,Promazine
12412-3,Pyridine
12413-1,Resperine
12414-9,Resperine
12415-6,Selegiline
12416-4,Sotalol
12417-2,Sulindac
12418-0,Terfenadine
1241-9,M NOS Ag
12419-8,Terfenadine
12420-6,Thiosulfate
12421-4,Thiosulfate/Creatinine
12422-2,Triflupromazine
12423-0,Trimeprazine
12424-8,Triprolidine
12425-5,Chlorzoxazone
12426-3,Brodifacoum
1242-7,M NOS Ag
12427-1,Chlormezanone
12428-9,Flurbiprofen
12429-7,Succinylcholine
12430-5,Cumene
12431-3,Norfenfluramine
12432-1,Hydroxytriazolam
12433-9,Bufotenine
12434-7,predniSONE
1243-5,M NOS Ag
12435-4,Naphthalene
12436-2,Naphthol
12437-0,traMADol
12438-8,Nortramadol
12439-6,FLUoxetine
12440-4,Midazolam
12441-2,Tolmetin
12442-0,Acetaminophen
1244-3,M1 Ab
12443-8,Trimipramine
12444-6,Nortrimipramine
12445-3,Norfluoxetine
12446-1,Hydrocarbons.halogenated
12447-9,Phenylethylmalonamide
12448-7,Ketones^post CFst
12449-5,Ketones^1H post XXX challenge
1245-0,M1 Ab
12450-3,Ketones^2H post XXX challenge
12451-1,Ketones^3H post XXX challenge
12452-9,Epithelial cells
12453-7,Phosphate crystals.amorphous
12454-5,Urate crystals.amorphous
12455-2,Histoplasma capsulatum yeast phase Ab
12456-0,Histoplasma capsulatum mycelial phase Ab
12457-8,Specimen volume
12458-6,Corticotropin^2nd specimen post XXX challenge
12459-4,Corticotropin^3rd specimen post XXX challenge
12460-2,Corticotropin^4th specimen post XXX challenge
12461-0,Corticotropin^5th specimen post XXX challenge
12462-8,Corticotropin^6th specimen post XXX challenge
12463-6,Corticotropin^7th specimen post XXX challenge
12464-4,Corticotropin^8th specimen post XXX challenge
12465-1,Ethanol
12466-9,Alpha 1 antitrypsin
12467-7,Amino acids
1246-8,M1 Ab
12468-5,Amino acids
12469-3,Cystine crystals
12470-1,Homocysteine
12471-9,Amino beta guanidinopropionate
12472-7,Amino beta guanidinopropionate
12473-5,Phosphoethanolamine
12474-3,Carnosine
12475-0,Delta aminolevulinate
1247-6,M1 Ag
12476-8,Bilirubin
12477-6,Dextromethamphetamine
12478-4,Levomethamphetamine
12479-2,Androsterone
124-8,Cefprozil
12480-0,Angiotensin converting enzyme
12481-8,Arsenic.inorganic
12482-6,Ascorbate
12483-4,Tungsten
1248-4,M1 Ag
12484-2,PHENobarbital
12485-9,Amobarbital
12486-7,Butabarbital
12487-5,Butalbital
12488-3,PENTobarbital
12489-1,Secobarbital
12490-9,Allyl-sec-butyl-barbiturate
12491-7,Methohexital
1249-2,M1 Ag
12492-5,Thiamylal
12493-3,Hexobarbital
12494-1,Amobarbital
12495-8,Barbital
12496-6,Butabarbital
12497-4,Butalbital
12498-2,Metharbital
12499-0,PENTobarbital
05-Dec,Amikacin
1250-0,Major crossmatch
12500-5,Secobarbital
12501-3,PHENobarbital
12502-1,Allobarbital
12503-9,Hemoglobin.gastrointestinal^4th specimen
12504-7,Hemoglobin.gastrointestinal^5th specimen
12505-4,Cadmium
12506-2,Calcitonin^2nd specimen post XXX challenge
12507-0,Calcitonin^3rd specimen post XXX challenge
12508-8,Calcitonin^4th specimen post XXX challenge
12509-6,Calcitonin^5th specimen post XXX challenge
12510-4,Calcitonin^6th specimen post XXX challenge
12511-2,Calcium
12512-0,Calcium hydrogen phosphate dihydrate crystals
12513-8,Bicarbonate
12514-6,Bicarbonate
12515-3,Carcinoembryonic Ag
12516-1,Catecholamines^2nd specimen post XXX challenge
12517-9,Catecholamines^3rd specimen post XXX challenge
1251-8,Major crossmatch
12518-7,Catecholamines^4th specimen post XXX challenge
12519-5,Catecholamines^5th specimen post XXX challenge
12520-3,Catecholamines^6th specimen post XXX challenge
12521-1,Catecholamines^7th specimen post XXX challenge
12522-9,Catecholamines^2nd specimen post XXX challenge
12523-7,Catecholamines^3rd specimen post XXX challenge
12524-5,Catecholamines^4th specimen post XXX challenge
12525-2,Norepinephrine^1H post XXX challenge
1252-6,Major crossmatch^post immediate spin
12526-0,Norepinephrine^2H post XXX challenge
12527-8,Norepinephrine^3H post XXX challenge
12528-6,Norepinephrine^4H post XXX challenge
12529-4,EPINEPHrine^2H post XXX challenge
12530-2,Chloride
12531-0,Cholesterol
12532-8,Meclizine
12533-6,Thiazolidine-2-Thione-4-Carboxylic acid
1253-4,Major crossmatch
12534-4,Thiazolidine-2-Thione-4-Carboxylic acid/Creatinine
12535-1,Amyl nitrite
12536-9,Butyl nitrate
12537-7,Phenylglyoxylate
12538-5,Nitrate
12539-3,2-Methylcitrate
12540-1,2-Methylcitrate
12541-9,Meta methylhippurate+Para methylhippurate
1254-2,Major crossmatch.re-crossmatch
12542-7,N-methylacetamide
12543-5,Methyl formamide
12544-3,Nefazodone
12545-0,Zomepirac
12546-8,Quinethazone
12547-6,Phorate
12548-4,Tybamate
12549-2,Turpentine
125-5,Cefprozil
12550-0,Papaverine
12551-8,Isocarboxazid
12552-6,Propylene glycol
12553-4,Stimulants
12554-2,Narcotics
12555-9,Turpentine
12556-7,Copper
12557-5,Cortisol^2nd specimen post XXX challenge
12558-3,Cortisol^3rd specimen post XXX challenge
1255-9,Minor crossmatch
12559-1,Cortisol^4th specimen post XXX challenge
12560-9,Cortisol^5th specimen post XXX challenge
12561-7,Cortisol^6th specimen post XXX challenge
12562-5,Cortisol^7th specimen post XXX challenge
12563-3,Cortisol^8th specimen post XXX challenge
12564-1,Cortisol^9th specimen post XXX challenge
12565-8,Cortisol^10th specimen post XXX challenge
12566-6,Cortisol^30M post XXX challenge
1256-7,N Ab
12567-4,Cortisol^1H post XXX challenge
12568-2,Cortisol^20M post XXX challenge
12569-0,Cortisol^2.5H post XXX challenge
12570-8,Cortisol^post XXX challenge
12571-6,Creatinine
12572-4,Creatinine^2H dwell specimen
12573-2,Creatinine^4H dwell specimen
12574-0,Creatinine^24H specimen
1257-5,N Ab
12575-7,Creatinine^baseline
12576-5,Creatinine^1st specimen
12577-3,Creatinine^2nd specimen
12578-1,Creatinine^3rd specimen
12579-9,Creatinine^4th specimen
12580-7,Creatinine^5th specimen
12581-5,Creatinine^6th specimen
12582-3,Creatinine^7th specimen
1258-3,N Ab
12583-1,Creatinine^8th specimen
12584-9,Creatinine
12585-6,Creatinine
12586-4,Creatinine
12587-2,Creatinine
12588-0,Creatinine
12589-8,Creatinine
12590-6,Dehydroepiandrosterone^2nd specimen post XXX challenge
1259-1,N Ag
12591-4,Dehydroepiandrosterone^3rd specimen post XXX challenge
12592-2,Dehydroepiandrosterone^4th specimen post XXX challenge
12593-0,Dehydroepiandrosterone^5th specimen post XXX challenge
12594-8,Dehydroepiandrosterone^6th specimen post XXX challenge
12595-5,Estradiol
12596-3,Estradiol^3H post XXX challenge
12597-1,Estrogen^2nd specimen post XXX challenge
12598-9,Fat.neutral
12599-7,Pristanate
12600-3,Pristanate/Phytanate
12601-1,Fluoride
12602-9,Hydroxyethylflurazepam
12603-7,N-desalkylflurazepam
12604-5,Hydroxyethylflurazepam
12605-2,Flurazepam
12606-0,Dolichol
12607-8,Glucose^pre dialysis
12608-6,Glucose^2H dwell specimen
1260-9,N Ag
12609-4,Glucose^4H dwell specimen
12610-2,Glucose^2H post XXX challenge
12611-0,Glucose^4H specimen
12612-8,Glucose^2H specimen
12613-6,Glucose^4H specimen
12614-4,Glucose^7H post meal
12615-1,Glucose^1st specimen post XXX challenge
12616-9,Glucose^2nd specimen post XXX challenge
1261-7,N Ag
12617-7,Glucose^3rd specimen post XXX challenge
12618-5,Glucose^4th specimen post XXX challenge
12619-3,Glucose^5th specimen post XXX challenge
12620-1,Glucose^6th specimen post XXX challenge
12621-9,Glucose^9th specimen post XXX challenge
12622-7,Glucose^10th specimen post XXX challenge
12623-5,Glucose^11th specimen post XXX challenge
12624-3,Glucose^12th specimen post XXX challenge
1262-5,N NOS Ab
12625-0,Glucose^13th specimen post XXX challenge
12626-8,Glucose^14th specimen post XXX challenge
12627-6,Glucose^15th specimen post XXX challenge
12628-4,Glucose
12629-2,Glucose
126-3,Cefprozil
12630-0,Glucose^1st specimen
12631-8,Glucose^2nd specimen
12632-6,Glucose^3rd specimen
1263-3,N NOS Ab
12633-4,Glucose^4th specimen
12634-2,Glucose^5th specimen
12635-9,Glucose^6th specimen
12636-7,Glucose^7th specimen
12637-5,Glucose^8th specimen post XXX challenge
12638-3,Glucose^pre dose lactose PO
12639-1,Glucose^15M post XXX challenge
12640-9,Glucose^6.5H post XXX challenge
1264-1,N NOS Ab
12641-7,Glucose^7H post XXX challenge
12642-5,Glucose^7.5H post XXX challenge
12643-3,Glucose^8H post XXX challenge
12644-1,Glucose^9H post XXX challenge
12645-8,Glucose^10H post XXX challenge
12646-6,Glucose^1H post XXX challenge
12647-4,Glucose^12H post XXX challenge
12648-2,Glucose^15M post dose lactose PO
12649-0,Glucose^6th specimen post dose lactose
12650-8,Glucose^3.5H post dose lactose PO
12651-6,Glucose^10M pre XXX challenge
12652-4,Glucose^2M post XXX challenge
12653-2,Glucose^8M post XXX challenge
12654-0,Glucose^10M post XXX challenge
12655-7,Glucose^20M post XXX challenge
12656-5,Glucose^4M post XXX challenge
12657-3,Glucose^40M post XXX challenge
1265-8,N NOS Ag
12658-1,Glucose^50M post XXX challenge
12659-9,Glucose^70M post XXX challenge
12660-7,Follitropin^3H post XXX challenge
12661-5,Follitropin^10M post XXX challenge
12662-3,Follitropin^20M post XXX challenge
12663-1,Follitropin^40M post XXX challenge
12664-9,Follitropin^2nd specimen post XXX challenge
12665-6,Follitropin^3rd specimen post XXX challenge
1266-6,N NOS Ag
12666-4,Follitropin^4th specimen post XXX challenge
12667-2,Follitropin^5th specimen post XXX challenge
12668-0,Follitropin^6th specimen post XXX challenge
12669-8,Follitropin^7th specimen post XXX challenge
12670-6,Follitropin^8th specimen post XXX challenge
12671-4,Follitropin^9th specimen post XXX challenge
12672-2,Lutropin^10M post XXX challenge
12673-0,Lutropin^3H post XXX challenge
1267-4,N NOS Ag
12674-8,Lutropin^15M pre XXX challenge
12675-5,Lutropin^20M post XXX challenge
12676-3,Lutropin^40M post XXX challenge
12677-1,Lutropin^2nd specimen post XXX challenge
12678-9,Lutropin^3rd specimen post XXX challenge
12679-7,Lutropin^4th specimen post XXX challenge
12680-5,Lutropin^5th specimen post XXX challenge
12681-3,Lutropin^6th specimen post XXX challenge
1268-2,NOS Ab
12682-1,Lutropin^7th specimen post XXX challenge
12683-9,Lutropin^8th specimen post XXX challenge
12684-7,Lutropin^9th specimen post XXX challenge
12685-4,Somatotropin^2nd specimen post XXX challenge
12686-2,Somatotropin^3rd specimen post XXX challenge
12687-0,Somatotropin^4th specimen post XXX challenge
12688-8,Somatotropin^5th specimen post XXX challenge
12689-6,Somatotropin^6th specimen post XXX challenge
1269-0,NOS Ab
12690-4,Somatotropin^7th specimen post XXX challenge
12691-2,Somatotropin^8th specimen post XXX challenge
12692-0,Somatotropin^9th specimen post XXX challenge
12693-8,Somatotropin^10th specimen post XXX challenge
12694-6,Somatotropin^post XXX challenge
12695-3,Somatotropin^15M pre XXX challenge
12696-1,Somatotropin^pre XXX challenge
12697-9,Somatotropin^10M post XXX challenge
12698-7,Somatotropin^15M post XXX challenge
12699-5,Somatotropin^20M post XXX challenge
12700-1,Somatotropin^45M post XXX challenge
12701-9,Somatotropin^2.5H post XXX challenge
12702-7,Antimony
12703-5,Gallium
12704-3,Length
12705-0,Strontium
12706-8,Tellurium
12707-6,Thorium
1270-8,Unidentified Ab
12708-4,Tin
12709-2,Norastemizole
127-1,Cefsulodin
12710-0,Hemoglobin pattern
12711-8,Hemoglobin A region
12712-6,Hemoglobin S+D+G region
12713-4,Hemoglobin C+E+O+A2 region
12714-2,N-methylhistamine
12715-9,Homovanillate
1271-6,O NOS Ab
12716-7,17-Hydroxyprogesterone^2nd specimen post XXX challenge
12717-5,17-Hydroxyprogesterone^3rd specimen post XXX challenge
12718-3,17-Hydroxyprogesterone^4th specimen post XXX challenge
12719-1,17-Hydroxyprogesterone^5th specimen post XXX challenge
12720-9,Hydroxyproline
12721-7,Melatonin
12722-5,Insulin-like growth factor binding protein 1
12723-3,Insulin-like growth factor binding protein 2
1272-4,O NOS Ab
12724-1,Voltage-gated calcium channel Ab.IgG
12725-8,IgA.secretory
12726-6,Leucine-enkephalin
12727-4,prednisoLONE
12728-2,Alpha subunit
12729-0,Interferon.gamma
12730-8,Interferon.beta
12731-6,Interferon.alpha
1273-2,O NOS Ab
12732-4,Interleukin 12
12733-2,Tryptase
12734-0,Soluble liver Ab
12735-7,Collagen Ab
12736-5,Hyaluronate
12737-3,Endothelin
12738-1,Insulin^pre XXX challenge
12739-9,Insulin^2nd specimen post XXX challenge
1274-0,O NOS Ag
12740-7,Insulin^3rd specimen post XXX challenge
12741-5,Insulin^4th specimen post XXX challenge
12742-3,Insulin^5th specimen post XXX challenge
12743-1,Insulin^6th specimen post XXX challenge
12744-9,Insulin^7th specimen post XXX challenge
12745-6,Insulin^8th specimen post XXX challenge
12746-4,Insulin^9th specimen post XXX challenge
12747-2,Insulin^3.5H post XXX challenge
12748-0,Insulin^4.5H post XXX challenge
12749-8,Insulin^5.5H post XXX challenge
12750-6,Insulin^7H post XXX challenge
12751-4,Insulin^7.5H post XXX challenge
12752-2,Insulin^8H post XXX challenge
12753-0,Insulin^9H post XXX challenge
12754-8,Insulin^10H post XXX challenge
12755-5,Insulin^11H post XXX challenge
12756-3,Insulin^12H post XXX challenge
1275-7,O NOS Ag
12757-1,Insulin^30M pre XXX challenge
12758-9,Insulin^15M pre XXX challenge
12759-7,Insulin^2M post XXX challenge
12760-5,Insulin^4M post XXX challenge
12761-3,Insulin^8M post XXX challenge
12762-1,Insulin^15M post XXX challenge
12763-9,Insulin^19M post XXX challenge
12764-7,Insulin^22M post XXX challenge
1276-5,O NOS Ag
12765-4,Insulin^40M post XXX challenge
12766-2,Insulin^45M post XXX challenge
12767-0,Insulin^50M post XXX challenge
12768-8,Insulin^70M post XXX challenge
12769-6,17-Ketosteroids.total neutral
12770-4,Lead
12771-2,Cholesterol.in HDL
12772-0,Cholesterol.in HDL
1277-3,P Ab
12773-8,Cholesterol.in LDL
12774-6,Mercury
12775-3,Mercury
12776-1,Mucin-like carcinoma associated Ag
12777-9,Immunoglobulin light chains.kappa.free
12778-7,Immunoglobulin light chains.lambda.free
12779-5,Nickel
12780-3,Nickel
1278-1,P Ab
12781-1,Borrelia burgdorferi Ab band pattern
12782-9,Protein fractions.oligoclonal bands
12783-7,Protein fractions.oligoclonal bands
12784-5,Codeine.free
12785-2,Dihydrocodeine.free
12786-0,HYDROcodone.free
12787-8,HYDROmorphone.free
12788-6,6-Monoacetylmorphine
12789-4,oxyCODONE.free
12790-2,Oxalate^2nd specimen post XXX challenge
12791-0,Oxalate^3rd specimen post XXX challenge
12792-8,Oxalate^4th specimen post XXX challenge
12793-6,Oxalate^5th specimen post XXX challenge
12794-4,Oxalate^6th specimen post XXX challenge
12795-1,Oxalate^7th specimen post XXX challenge
12796-9,Oxalate^8th specimen post XXX challenge
12797-7,Oxalate^9th specimen post XXX challenge
12798-5,Oxalate^10th specimen post XXX challenge
1279-9,P Ab
12799-3,Parathyrin Ab
12800-9,Trimeprazine
12801-7,Methdilazine
12802-5,Propiomazine
12803-3,Phenylalanine
12804-1,Acid phosphatase
12805-8,Alkaline phosphatase isoenzyme
12806-6,Alkaline phosphatase.lung
1280-7,P NOS Ab
12807-4,Phosphoserine
12808-2,Uroporphyrin
12809-0,Coproporphyrin
12810-8,Porphobilinogen deaminase
12811-6,Uroporphyrinogen III synthase
12812-4,Potassium^2nd specimen
12813-2,Potassium^3rd specimen
12814-0,Potassium
1281-5,P NOS Ab
12815-7,Progesterone^2nd specimen post XXX challenge
12816-5,Progesterone^3rd specimen post XXX challenge
12817-3,Progesterone^4th specimen post XXX challenge
12818-1,Progesterone^5th specimen post XXX challenge
12819-9,Progesterone^6th specimen post XXX challenge
12820-7,Progesterone
12821-5,Progesterone^30M post XXX challenge
12822-3,Progesterone^1H post XXX challenge
1282-3,P NOS Ab
12823-1,Prolactin^2nd specimen post XXX challenge
12824-9,Prolactin^3rd specimen post XXX challenge
12825-6,Prolactin^4th specimen post XXX challenge
12826-4,Prolactin^5th specimen post XXX challenge
12827-2,Prolactin^6th specimen post XXX challenge
12828-0,Prolactin^7th specimen post XXX challenge
12829-8,Prolactin^8th specimen post XXX challenge
12830-6,Prolactin^9th specimen post XXX challenge
1283-1,P NOS Ag
12831-4,Prolactin^10th specimen post XXX challenge
12832-2,Prolactin^10M post XXX challenge
12833-0,Prolactin^20M post XXX challenge
12834-8,Prolactin^15M post XXX challenge
12835-5,Prolactin^45M post XXX challenge
12836-3,Prostaglandin E2
12837-1,Prostaglandin E1
12838-9,Prostaglandin D2
12839-7,Prostaglandin D2
12840-5,Prostaglandin F2 alpha
12841-3,Prostate specific Ag.free/Prostate specific Ag.total
12842-1,Protein
12843-9,Protein
12844-7,Protein^2nd specimen
12845-4,Protein^3rd specimen
12846-2,Protein^4th specimen
12847-0,Protein^5th specimen
12848-8,Protein^6th specimen
1284-9,P NOS Ag
12849-6,Protein^7th specimen
12850-4,Protein^8th specimen
12851-2,Protein pattern
12852-0,Bovine inner ear Ag
12853-8,Purkinje cells Ab
12854-6,Neuronal nuclear type 1 Ab
12855-3,HIV 1 p23 Ab
1285-6,P NOS Ag
12856-1,HIV 1 p65 Ab
12857-9,HIV 1 p28 Ab
12858-7,HIV 1 p32 Ab
12859-5,HIV 1 p18 Ab
12860-3,Borrelia burgdorferi 39kD Ab
12861-1,Borrelia burgdorferi 88kD Ab
12862-9,Borrelia burgdorferi 66kD Ab
12863-7,Borrelia burgdorferi 41kD Ab
1286-4,P1 Ab
12864-5,Borrelia burgdorferi 25kD Ab
12865-2,Borrelia burgdorferi 29kD Ab
12866-0,Borrelia burgdorferi 18kD Ab
12867-8,Borrelia burgdorferi 58kD Ab
12868-6,Borrelia burgdorferi 47kD Ab
12869-4,Borrelia burgdorferi 30kD Ab
12870-2,HIV 1 gp34 Ab
12871-0,HIV 1 p26 Ab
1287-2,P1 Ab
12872-8,HIV 1 p15 Ab
12873-6,Borrelia burgdorferi 88kD Ab
12874-4,Borrelia burgdorferi 93kD Ab
12875-1,HIV 1 p64 Ab
12876-9,HIV 1 p53 Ab
12877-7,Borrelia burgdorferi 47kD Ab
12878-5,Borrelia burgdorferi 29kD Ab
12879-3,Borrelia burgdorferi 25kD Ab
1288-0,P1 Ab
12880-1,Borrelia burgdorferi 58kD Ab
12881-9,Borrelia burgdorferi 47kD Ab
12882-7,Borrelia burgdorferi 29kD Ab
12883-5,Borrelia burgdorferi 18kD Ab
12884-3,Borrelia burgdorferi 39kD Ab
12885-0,Borrelia burgdorferi 88kD Ab
12886-8,Borrelia burgdorferi 66kD Ab
12887-6,Borrelia burgdorferi 41kD Ab
12888-4,Borrelia burgdorferi 25kD Ab
12889-2,Borrelia burgdorferi 30kD Ab
128-9,Cefsulodin
12890-0,Borrelia burgdorferi 45kD Ab
12891-8,Borrelia burgdorferi 41kD Ab
12892-6,Borrelia burgdorferi 30kD Ab
12893-4,HIV 1 gp105 Ab
12894-2,HIV 1 p68 Ab
12895-9,HIV 1 p58 Ab
12896-7,Borrelia burgdorferi 58kD Ab
12897-5,Myelin associated glycoprotein Ab
1289-8,P1 Ag
12898-3,Chloride
12899-1,Acetylene
12900-7,Renin^2nd specimen post XXX challenge
12901-5,Renin^3rd specimen post XXX challenge
12902-3,Renin^4th specimen post XXX challenge
12903-1,Renin^5th specimen post XXX challenge
12904-9,Renin^6th specimen post XXX challenge
12905-6,Renin^7th specimen post XXX challenge
1290-6,P1 Ag
12906-4,Renin^8th specimen post XXX challenge
12907-2,Sodium
12908-0,Sodium
12909-8,Insulin-like growth factor-I^30M post XXX challenge
12910-6,Insulin-like growth factor-I^1H post XXX challenge
12911-4,Insulin-like growth factor-I^1.5H post XXX challenge
12912-2,Lipids
12913-0,Beta-N-acetylhexosaminidase
1291-4,P1 Ag
12914-8,Beta-N-acetylhexosaminidase.A/Beta-N-acetylhexosaminidase.total
12915-5,Beta galactosidase
12916-3,Porphobilinogen synthase
12917-1,Porphobilinogen synthase
12918-9,Monoamine oxidase
12919-7,Monoamine oxidase
12920-5,Sulfate
12921-3,Testosterone^3H post XXX challenge
1292-2,P2 Ab
12922-1,Testosterone^1H post XXX challenge
12923-9,Thyroxine^2nd specimen post XXX challenge
12924-7,Thyroxine^3rd specimen post XXX challenge
12925-4,Thyroxine^4th specimen post XXX challenge
12926-2,Thyroxine^5th specimen post XXX challenge
12927-0,Thyroxine^6th specimen post XXX challenge
12928-8,Thyroxine^7th specimen post XXX challenge
12929-6,Thyroxine^8th specimen post XXX challenge
1293-0,P2 Ab
12930-4,Thyroxine^9th specimen post XXX challenge
12931-2,Thyroxine^1H post XXX challenge
12932-0,Thyrotropin^post XXX challenge
12933-8,Thyrotropin^10M post XXX challenge
12934-6,Thyrotropin^15M post XXX challenge
12935-3,Thyrotropin^20M post XXX challenge
12936-1,Thyrotropin^40M post XXX challenge
12937-9,Thyrotropin^45M post XXX challenge
12938-7,Thyrotropin^1.5H post XXX challenge
12939-5,Thyrotropin^2H post XXX challenge
12940-3,Thyrotropin^30M pre XXX challenge
12941-1,Thyrotropin^2nd specimen post XXX challenge
12942-9,Thyrotropin^3rd specimen post XXX challenge
12943-7,Thyrotropin^4th specimen post XXX challenge
12944-5,Thyrotropin^5th specimen post XXX challenge
12945-2,Thyrotropin^6th specimen post XXX challenge
12946-0,Thyrotropin^7th specimen post XXX challenge
12947-8,Thyrotropin^8th specimen post XXX challenge
1294-8,P2 Ab
12948-6,Thyrotropin^9th specimen post XXX challenge
12949-4,Transferrin.carbohydrate deficient
12950-2,Triglyceride
12951-0,Triglyceride
12952-8,Thyroxine uptake^1H post XXX challenge
12953-6,Triiodothyronine^2nd specimen post XXX challenge
12954-4,Triiodothyronine^3rd specimen post XXX challenge
1295-5,P2 Ag
12955-1,Triiodothyronine^4th specimen post XXX challenge
12956-9,Triiodothyronine^5th specimen post XXX challenge
12957-7,Triiodothyronine^6th specimen post XXX challenge
12958-5,Triiodothyronine^7th specimen post XXX challenge
12959-3,Triiodothyronine^8th specimen post XXX challenge
12960-1,Alpha 1 antitrypsin fecal clearance
12961-9,Urea nitrogen
12962-7,Urea nitrogen
1296-3,P2 Ag
12963-5,Urea nitrogen
12964-3,Urea nitrogen^baseline
12965-0,Urea nitrogen^70M specimen
12966-8,Urea nitrogen^2H specimen
12967-6,Urea nitrogen
12968-4,Urea nitrogen^4H specimen
12969-2,Urea nitrogen^baseline
129-7,Cefsulodin
12970-0,Urea nitrogen^2H dwell specimen
1297-1,P2 Ag
12971-8,Urea nitrogen^4H dwell specimen
12972-6,Urea nitrogen^1st specimen
12973-4,Urea nitrogen^4th specimen
12974-2,Urea nitrogen^3rd specimen
12975-9,Urea nitrogen^5th specimen
12976-7,Urea nitrogen^6th specimen
12977-5,Urea nitrogen^8th specimen
12978-3,Urea nitrogen^7th specimen
12979-1,Urea nitrogen^24H specimen
12980-9,Urate
12981-7,Urea nitrogen^post dialysis/pre dialysis
12982-5,Vasopressin^2nd specimen post XXX challenge
12983-3,Volatiles
12984-1,"2,4 toluenediamine"
12985-8,"2,6 toluenediamine"
12986-6,"2,5-Hexanedione"
12987-4,Acetonitrile
12988-2,Acrylamide
1298-9,Packed erythrocytes given
12989-0,Allyl alcohol
12990-8,Polychlorinated biphenyl.Aroclor 1260
12991-6,Polychlorinated biphenyl.Aroclor 1254
12992-4,Isobutane
12993-2,Hydrocarbons.chlorinated
12994-0,Oxychlordane
12995-7,Cyclohexanone
12996-5,Dichlorodifluoroethane
1299-7,Platelets given
12997-3,"1,4-Dioxane"
12998-1,Methylene chloride
12999-9,Epichlorohydrin
13000-5,Mandelate
13001-3,Mandelate/Creatinine
13002-1,Mesityl oxide
1300-3,PP1 Ab
13003-9,Hydrocarbons.halogenated
13004-7,Hydrocarbons.halogenated.volatile
13005-4,"2,4,5-Trichlorophenoxyacetate"
13006-2,"1,4-Dichlorobenzene"
13007-0,Ethane
13008-8,Methyl propyl ketone
13009-6,Methyl ethyl ketone
13010-4,Methyl amyl ketone
1301-1,PP1 Ab
13011-2,Methyl ethyl ketone
13012-0,Methyl isoamyl ketone
13013-8,Methyl isobutyl ketone
13014-6,Methyl butyl ketone
13015-3,Diisobutylketone
13016-1,Nitrophenol
13017-9,Perchloroethylene
13018-7,Pesticides
13019-5,Pesticides
13020-3,Pesticides
13021-1,Pesticides
13022-9,Propane
13023-7,Trichlorofluoromethane
13024-5,Trichlorofluoroethane
13025-2,Trichlorotrifluoroethane
13026-0,Orthocresol
13027-8,Ethyl acetate
13028-6,Xylose^1.5H post XXX challenge
1302-9,PP1 Ab
13029-4,Xylose^3H post XXX challenge
13030-2,Xylose^4H post XXX challenge
13031-0,Xylose^5H post XXX challenge
13032-8,C peptide^2nd specimen post XXX challenge
13033-6,C peptide^3rd specimen post XXX challenge
13034-4,C peptide^4th specimen post XXX challenge
13035-1,C peptide^5th specimen post XXX challenge
13036-9,C peptide^6th specimen post XXX challenge
1303-7,Reverse ABO group
13037-7,C peptide^post CFst
13038-5,C peptide^30M post XXX challenge
13039-3,C peptide^1H post XXX challenge
13040-1,C peptide^1.5H post XXX challenge
13041-9,C peptide^2H post XXX challenge
13042-7,C peptide^2.5H post XXX challenge
13043-5,C peptide^3H post XXX challenge
13044-3,C peptide^5H post XXX challenge
1304-5,D Ab
13045-0,C peptide^6H post XXX challenge
13046-8,Lymphocytes.variant/100 leukocytes
13047-6,Plasma cells/100 leukocytes
13048-4,Sezary cells
13049-2,von Willebrand factor Ag
130-5,Cefsulodin
13050-0,Protein C/Coagulation factor IX
13051-8,Protein S
1305-2,D Ag
13052-6,Protein S/Coagulation factor IX
13053-4,Coagulation kaolin induced
13054-2,Fibrin+Fibrinogen fragments
13055-9,Heparin
13056-7,Platelets
13057-5,Platelets
13058-3,Coagulation surface induced^2nd specimen
13059-1,Coagulation surface induced^3rd specimen
1306-0,D NOS Ab
13060-9,Coagulation surface induced^4th specimen
13061-7,Platelet Ab.IgM
13062-5,Platelet Ab.IgA
13063-3,Drug induced platelet Ab
13064-1,Platelet associated Ab.IgA
13065-8,Platelet Ab.circulating
13066-6,Nuclear Ab
13067-4,Nuclear Ab pattern
13068-2,Nuclear Ab pattern
13069-0,Phosphatidylserine Ab.IgA
13070-8,Phosphatidate Ab.IgG
13071-6,Phosphatidate Ab.IgM
13072-4,Phosphatidate Ab.IgA
13073-2,Phosphatidylcholine Ab.IgG
13074-0,Phosphatidylcholine Ab.IgM
13075-7,Phosphatidylcholine Ab.IgA
13076-5,Phosphatidylethanolamine Ab.IgG
13077-3,Phosphatidylethanolamine Ab.IgM
1307-8,D NOS Ab
13078-1,Phosphatidylethanolamine Ab.IgA
13079-9,Phosphatidylglycerol Ab.IgG
13080-7,Phosphatidylglycerol Ab.IgM
13081-5,Phosphatidylglycerol Ab.IgA
13082-3,Phosphatidylinositol Ab.IgG
13083-1,Phosphatidylinositol Ab.IgM
13084-9,Phosphatidylinositol Ab.IgA
13085-6,C4 nephritic factor
1308-6,D NOS Ab
13086-4,C3 nephritic factor
13087-2,Complement alternate pathway AH50
13088-0,Complement total hemolytic CH100
13089-8,Asialoganglioside GM1 Ab
13090-6,Asialoganglioside GM1 Ab.IgG
13091-4,Deoxyribonucleoprotein Ab
13092-2,Endomysium Ab
13093-0,Monosialoganglioside GM1 Ab.IgM
1309-4,D NOS Ab
13094-8,Monosialoganglioside GM1 Ab.IgA
13095-5,Monosialoganglioside GM1 Ab.IgA
13096-3,Myelin associated glycoprotein Ab.IgM
13097-1,PM-SCL extractable nuclear Ab
13098-9,Sulfatide Ab.IgG
13099-7,Sulfatide Ab.IgM
13100-3,Sulfate-3-Glucuronyl paragloboside Ab.IgM
13101-1,Sulfate-3-Glucuronyl paragloboside Ab.IgM
1310-2,D NOS Ag
13102-9,Disialylganglioside GD1b Ab
13103-7,Disialylganglioside GD1b Ab.IgG
13104-5,Disialylganglioside GD1b Ab.IgM
13105-2,Tetrasialylganglioside GQ1b Ab.IgG
13106-0,Tetrasialylganglioside GQ1b Ab
13107-8,Disialylganglioside GD1a Ab
13108-6,Tetrasialylganglioside GQ1b Ab
13109-4,Disialylganglioside GD1b Ab
1311-0,D NOS Ag
13110-2,Beta tubulin Ab.IgM
13111-0,Nuclear Ab
13112-8,Nuclear Ab
13113-6,Myelin associated glycoprotein Ab.IgM
13114-4,Neuronal nuclear type 2 Ab
13115-1,Neuronal nuclear type 1 Ab
13116-9,Reticulin Ab.IgG
13117-7,Complement Sc5b-9 Ab
13118-5,Myelin associated glycoprotein Ab
13119-3,Myelin associated glycoprotein Ab
13120-1,Ovary Ab
13121-9,Ribosomal P protein Ab
13122-7,Sulfatide Ab.IgM
13123-5,Sulfate-3-Glucuronyl paragloboside Ab
13124-3,Sulfate-3-Glucuronyl paragloboside Ab
13125-0,Hepatitis C virus c33c Ab
13126-8,Hepatitis B virus DNA
13127-6,Cancer Ag DM-70K
1312-8,D NOS Ag
13128-4,Immunosuppressive acidic protein
13129-2,Pancreatic oncofetal Ag
131-3,Cefsulodin
13130-0,Motilin
13131-8,Streptococcus pneumoniae 1 Ab
13132-6,Streptococcus pneumoniae 4 Ab
13133-4,Streptococcus pneumoniae Danish serotype 6B Ab
13134-2,Streptococcus pneumoniae 8 Ab
13135-9,Streptococcus pneumoniae 12 Ab
1313-6,Rh immune globulin dosage.vials recommended
13136-7,Streptococcus pneumoniae Danish serotype 18C Ab
13137-5,Streptococcus pneumoniae 19 Ab
13138-3,Streptococcus pneumoniae 23 Ab
13139-1,Streptococcus pneumoniae 1 Ab^1st specimen
13140-9,Streptococcus pneumoniae 1 Ab^2nd specimen
13141-7,Streptococcus pneumoniae 3 Ab^1st specimen
13142-5,Streptococcus pneumoniae 3 Ab^2nd specimen
13143-3,Streptococcus pneumoniae 4 Ab^1st specimen
1314-4,Rh immune globulin screen
13144-1,Streptococcus pneumoniae 4 Ab^2nd specimen
13145-8,Streptococcus pneumoniae Danish serotype 6B Ab^1st specimen
13146-6,Streptococcus pneumoniae Danish serotype 6B Ab^2nd specimen
13147-4,Streptococcus pneumoniae Danish serotype 7F Ab^1st specimen
13148-2,Streptococcus pneumoniae Danish serotype 7F Ab^2nd specimen
13149-0,Streptococcus pneumoniae 8 Ab^1st specimen
13150-8,Streptococcus pneumoniae 8 Ab^2nd specimen
1315-1,S Ab
13151-6,Streptococcus pneumoniae 9 Ab^1st specimen
13152-4,Streptococcus pneumoniae 9 Ab^2nd specimen
13153-2,Streptococcus pneumoniae 12 Ab^1st specimen
13154-0,Streptococcus pneumoniae 12 Ab^2nd specimen/1st specimen
13155-7,Streptococcus pneumoniae 14 Ab^1st specimen
13156-5,Streptococcus pneumoniae 14 Ab^2nd specimen/1st specimen
13157-3,Streptococcus pneumoniae Danish serotype 18C Ab^1st specimen
13158-1,Streptococcus pneumoniae Danish serotype 18C Ab^2nd specimen
13159-9,Streptococcus pneumoniae 19 Ab^1st specimen
13160-7,Streptococcus pneumoniae 19 Ab^2nd specimen
13161-5,Streptococcus pneumoniae 23 Ab^1st specimen
13162-3,Streptococcus pneumoniae 23 Ab^2nd specimen
13163-1,Streptococcus pneumoniae 12 Ab
13164-9,Human antimouse Ab
13165-6,Streptococcus pneumoniae 19 Ab
13166-4,Streptococcus pneumoniae 23 Ab
13167-2,Streptococcus pneumoniae Danish serotype 7F Ab
13168-0,Streptococcus pneumoniae 6+26 Ab
1316-9,S Ab
13169-8,Interpretation
13170-6,Immune complex
13171-4,Immune complex
13172-2,Complement C1q Ag
13173-0,Fibronectin aggregate Ab.IgA
13174-8,Interpretation
13175-5,Liver cytosol Ab
13176-3,Wasp venom Ab.IgE
1317-7,S Ab
13177-1,Elaeagnus angustifolia Ab.IgE
13178-9,Wasp venom Ab.IgG
13179-7,Juglans regia Ab.IgG
13180-5,Formaldehyde Ab.IgG
13181-3,Paspalum notatum Ab.IgG
13182-1,Prosopis juliflora Ab.IgG
13183-9,Ulmus americana Ab.IgG
13184-7,Populus deltoides Ab.IgG
1318-5,S Ag
13185-4,Urtica dioica Ab.IgG
13186-2,Rumex crispus Ab.IgG
13187-0,Franseria acanthicarpa Ab.IgG
13188-8,Artemisia vulgaris Ab.IgG
13189-6,Plantago lanceolata Ab.IgG
13190-4,Formaldehyde Ab.IgM
13191-2,Rheumatoid factor
13192-0,Adenovirus Ab
1319-3,S Ag
13193-8,Aspergillus flavus Ab
13194-6,Aspergillus glaucus Ab
13195-3,Ehrlichia chaffeensis Ab
13196-1,Ehrlichia sp Ab.IgG
13197-9,Ehrlichia sp Ab.IgM
13198-7,Thermoactinomyces sp Ab
13199-5,Rickettsia conorii Ab.IgG
13200-1,Rickettsia conorii Ab.IgM
1320-1,S Ag
13201-9,Blastomyces dermatitidis Ab
13202-7,Borrelia burgdorferi Ab.IgG
13203-5,Borrelia burgdorferi Ab.IgM
13204-3,Borrelia burgdorferi Ab.IgG
13205-0,Borrelia burgdorferi Ab.IgM
13206-8,Borrelia burgdorferi Ab.IgG
13207-6,Borrelia burgdorferi Ab.IgM
13208-4,Borrelia hermsii Ab.IgG
13209-2,Borrelia hermsii Ab.IgM
132-1,cefTAZidime
13210-0,Brucella sp Ab.IgG
13211-8,Brucella sp Ab.IgA
13212-6,Brucella abortus Ab.IgG
13213-4,Brucella abortus Ab.IgM
13214-2,Brucella canis Ab.IgG
13215-9,Brucella canis Ab.IgM
13216-7,Candida albicans immune complex
13217-5,Chlamydia trachomatis B Ab
13218-3,Chlamydia trachomatis C Ab
1321-9,Transfusion duration
13219-1,Chlamydia trachomatis G+F+K Ab
13220-9,Chlamydia trachomatis C Ab.IgM
13221-7,Chlamydia trachomatis G+F+K Ab.IgM
13222-5,Chlamydia trachomatis C Ab
13223-3,Chlamydia trachomatis B Ab
13224-1,Chlamydia trachomatis G+F+K Ab
13225-8,Cytomegalovirus Ab.IgG^1st specimen
13226-6,Cytomegalovirus Ab.IgM
1322-7,Transfusion volume
13227-4,Corynebacterium diphtheriae Ab.IgG
13228-2,Eastern equine encephalitis virus Ab.IgG
13229-0,Eastern equine encephalitis virus Ab.IgM
13230-8,Saint Louis encephalitis virus Ab.IgG
13231-6,Saint Louis encephalitis virus Ab.IgM
13232-4,Coxsackievirus A Ab
13233-2,Coxsackievirus A2 Ab
13234-0,Coxsackievirus A4 Ab
1323-5,U Ab
13235-7,Coxsackievirus A16 Ab
13236-5,Epstein Barr virus early diffuse Ab
13237-3,Epstein Barr virus early restricted Ab
13238-1,Epstein Barr virus Ab
13239-9,Epstein Barr virus nuclear Ab.IgG
13240-7,Phoma herbarum Ab.IgE
13241-5,Sporothrix schenckii Ab.IgG
13242-3,Sporothrix schenckii Ab.IgM
1324-3,U Ab
13243-1,Sporothrix schenckii Ab.IgA
13244-9,Filaria Ab.IgG
13245-6,Filaria Ab.IgM
13246-4,Haemophilus influenzae B Ab
13247-2,HTLV I+II Ab
13248-0,Hepatitis D virus Ab
13249-8,Herpes simplex virus 1+2 Ab.IgG
1325-0,U Ab
13250-6,Herpes virus 6 Ab.IgG+IgM
13251-4,Herpes simplex virus 1 Ab.IgM
13252-2,Herpes simplex virus 2 Ab.IgM
13253-0,Legionella non pneumophila sp Ab
13254-8,Legionella pneumophila atypical Ab
13255-5,Legionella longbeachae 1+2 Ab
13256-3,Leishmania donovani Ab.IgG
13257-1,Leishmania donovani Ab.IgM
13258-9,Leishmania braziliensis Ab.IgG
13259-7,Leishmania braziliensis Ab.IgM
13260-5,Leishmania mexicana Ab.IgG
13261-3,Leishmania mexicana Ab.IgM
13262-1,Leishmania tropica Ab.IgG
13263-9,Leishmania tropica Ab.IgM
13264-7,Leptospira sp Ab.IgG
13265-4,Leptospira sp Ab.IgM
13266-2,Mumps virus Ab.IgG
13267-0,Mumps virus Ab.IgM
1326-8,U Ag
13268-8,Mycoplasma pneumoniae Ab^1st specimen
13269-6,Mycoplasma pneumoniae Ab^2nd specimen
13270-4,Mycoplasma pneumoniae Ab.IgA
13271-2,Neisseria meningitidis serogroup A Ab
13272-0,Neisseria meningitidis serogroup C Ab
13273-8,Sporothrix schenckii Ab
13274-6,Toxocara canis Ab
13275-3,Toxocara canis Ab.IgM
1327-6,U Ag
13276-1,Toxocara canis Ab.IgA
13277-9,Schistosoma sp Ab.IgG
13278-7,Schistosoma sp Ab.IgM
13279-5,Rubella virus Ab.IgG^1st specimen
13280-3,Rubella virus Ab.IgG^2nd specimen
13281-1,Rubella virus Ab.IgG
13282-9,Rubella virus Ab.IgM
13283-7,Measles virus Ab.IgM
1328-4,U Ag
13284-5,Salmonella typhi H D Ab
13285-2,Salmonella typhi O D Ab
13286-0,Toxoplasma gondii Ab.IgG^2nd specimen
13287-8,Toxoplasma gondii Ab
13288-6,Treponema pallidum Ab
13289-4,Hantavirus hantaan Ab
13290-2,Trypanosoma cruzi Ab.IgM
13291-0,Trypanosoma cruzi Ab.IgG
1329-2,V Ab
13292-8,Colorado tick fever virus Ab.IgG
13293-6,Colorado tick fever virus Ab.IgM
13294-4,Hepatitis E virus Ab
13295-1,Coxsackievirus A10 Ab
13296-9,Coxsackievirus A10 Ab
13297-7,Coxsackievirus A1 Ab
13298-5,HLA-A
13299-3,HLA-B
13-Mar,Amikacin
1330-0,V Ab
13300-9,HLA-A+B
13301-7,HLA-A+B+Bw
13302-5,HLA-C
13303-3,HLA-A+B+C
13304-1,HLA-DR
13305-8,HLA-DQ
13306-6,HLA-DR beta
13307-4,HLA-DQ alpha
13308-2,DNA
13309-0,Duffy group Ag
13310-8,Kell group Ag
13311-6,MNSs group Ag
13312-4,IgA Ab.IgG
13313-2,IgM Ab.IgM
13314-0,Bacteria identified
13315-7,Bacteria identified
13316-5,Enterococcus species.vancomycin resistant
13317-3,Staphylococcus aureus.methicillin resistant isolate
1331-8,V Ab
13318-1,Escherichia coli enteroinvasive identified
13319-9,Ova & parasites identified^2nd specimen
13320-7,Ova & parasites identified^3rd specimen
13321-5,Human papilloma virus Ab.IgG
13322-3,Human papilloma virus Ab.IgM
13323-1,Herpes simplex virus 2 Ab
13324-9,Herpes simplex virus 1 Ab
13325-6,Bartonella sp identified
1332-6,V Ag
13326-4,Pneumocystis sp identified
13327-2,Parainfluenza virus Ag
13328-0,Measles virus Ag
13329-8,Escherichia coli labile toxin
13330-6,Barr bodies
13331-4,Cells.CD2+CD26+/100 cells
13332-2,Cells.CD4+CD25+/100 cells
13333-0,Cells.CD3+CD25+/100 cells
1333-4,V Ag
13334-8,Cells.CD8+CD25+/100 cells
13335-5,Cells.CD4+CD29+/100 cells
13336-3,Cells.CD4+CD45RA+/100 cells
13337-1,Cells.CD8+HLA-DR+/100 cells
13338-9,Cells.CD8+CD57+/100 cells
13339-7,Cells.CD8+CD56+/100 cells
13340-5,Cells.CD3+CD38+/100 cells
13341-3,Cells.CD3+CD25+/100 cells
1334-2,V Ag
13342-1,Cells.CD3+CD26+/100 cells
13343-9,Cells.CD4+HLA-DR+/100 cells
13344-7,Cells.CD8+CD38+/100 cells
13345-4,Cells.CD8+CD11b+/100 cells
13346-2,Cells.CD35/100 cells
13347-0,RNA polymerase I+II+III Ab
13348-8,Monoclonal band observed
13349-6,Leukocytes
13350-4,Eosinophils/100 leukocytes
13351-2,Leukocytes other
13352-0,Neutrophils/100 leukocytes
13353-8,Eosinophils/100 leukocytes
13354-6,Neutrophils.band form/100 leukocytes
13355-3,Unspecified cells/100 leukocytes
13356-1,Fat
13357-9,Synovial cells
13358-7,Collection time
1335-9,Whole blood given
13359-5,Character
13360-3,Color
13361-1,Semen analysis panel
13362-9,Collection duration
13363-7,Collection duration
13364-5,Amino beta guanidinopropionate
13365-2,Amino beta guanidinopropionate
13366-0,Alpha aminoadipate
1336-7,X little g super little a Ab
13367-8,Beta aminoisobutyrate
13368-6,Beta alanine
13369-4,Carnosine
13370-2,Cystathionine
13371-0,Cystine
13372-8,Homocystine
13373-6,Hydroxylysine
13374-4,Hydroxyproline
1337-5,X little g super little a Ab
13375-1,Lysine
13376-9,Methionine
13377-7,1-Methylhistidine
13378-5,3-Methylhistidine
13379-3,Ornithine
13380-1,Sarcosine
13381-9,Tyrosine
13382-7,Amino beta guanidinopropionate
1338-3,X little g super little a Ab
13383-5,Alpha aminobutyrate
13384-3,Alpha aminoadipate
13385-0,Beta aminoisobutyrate
13386-8,Anserine
13387-6,Arginine
13388-4,Asparagine
13389-2,Aspartate
133-9,cefTAZidime
13390-0,Beta alanine
1339-1,X little g super little a Ag
13391-8,Carnosine
13392-6,Citrulline
13393-4,Cystathionine
13394-2,Cystine
13395-9,Glutamate
13396-7,Glutamine
13397-5,Glycine
13398-3,Histidine
13399-1,Homocystine
13400-7,Hydroxylysine
13401-5,Hydroxyproline
13402-3,Isoleucine
13403-1,Leucine
13404-9,Lysine
13405-6,Methionine
13406-4,1-Methylhistidine
13407-2,3-Methylhistidine
13408-0,Ornithine
1340-9,X little g super little a Ag
13409-8,Phenylalanine
13410-6,Phosphoethanolamine
13411-4,Phosphoserine
13412-2,Proline
13413-0,Sarcosine
13414-8,Serine
13415-5,Taurine
13416-3,Threonine
1341-7,X little g super little a Ag
13417-1,Tyrosine
13418-9,Tryptophan
13419-7,Valine
13420-5,EPINEPHrine^2nd specimen post XXX challenge
13421-3,EPINEPHrine^3rd specimen post XXX challenge
13422-1,EPINEPHrine^4th specimen post XXX challenge
13423-9,EPINEPHrine^5th specimen post XXX challenge
13424-7,EPINEPHrine^6th specimen post XXX challenge
1342-5,Y little t super little a Ab
13425-4,EPINEPHrine^7th specimen post XXX challenge
13426-2,Norepinephrine^2nd specimen post XXX challenge
13427-0,Norepinephrine^3rd specimen post XXX challenge
13428-8,Norepinephrine^4th specimen post XXX challenge
13429-6,Norepinephrine^5th specimen post XXX challenge
13430-4,Norepinephrine^6th specimen post XXX challenge
13431-2,Norepinephrine^7th specimen post XXX challenge
13432-0,DOPamine^2nd specimen post XXX challenge
1343-3,Y little t super little a Ab
13433-8,DOPamine^3rd specimen post XXX challenge
13434-6,DOPamine^4th specimen post XXX challenge
13435-3,DOPamine^5th specimen post XXX challenge
13436-1,DOPamine^6th specimen post XXX challenge
13437-9,DOPamine^7th specimen post XXX challenge
13438-7,Protein pattern
13439-5,Protein pattern
13440-3,Interpretation
1344-1,Y little t super little a Ab
13441-1,Creatinine renal clearance
13442-9,Creatinine renal clearance
13443-7,Creatinine renal clearance
13444-5,Calcium/Albumin
13445-2,Creatinine renal clearance/1.73 sq M
13446-0,Creatinine renal clearance/1.73 sq M
13447-8,Creatinine renal clearance/1.73 sq M
13448-6,Calcium/Osmolality
13449-4,Creatinine renal clearance/1.73 sq M
13450-2,Creatinine renal clearance/1.73 sq M
13451-0,Creatinine dialysis fluid clearance
13452-8,Iron/Transferrin
13453-6,Glucose mean value
13454-4,Calcium-phosphorus product
13455-1,Lithium.plasma/Lithium.RBC
13456-9,IgG synthesis rate
13457-7,Cholesterol.in LDL
1345-8,Y little t super little a Ag
13458-5,Cholesterol.in VLDL
13459-3,Cholesterol.in LDL/Cholesterol.total
13460-1,Cholesterol.in LDL/Cholesterol.in HDL
13461-9,Monoacetyldapsone/Dapsone
13462-7,Apolipoprotein A-I/Apolipoprotein B
13463-5,Arsenic/Creatinine
13464-3,Chromium/Creatinine
13465-0,Mercury/Creatinine
1346-6,Y little t super little a Ag
13466-8,Lead/Creatinine
13467-6,Selenium/Creatinine
13468-4,Cobalt/Creatinine
13469-2,Thallium/Creatinine
134-7,cefTAZidime
13470-0,Aluminum/Creatinine
13471-8,Cadmium/Creatinine
13472-6,Nickel/Creatinine
13473-4,Zinc/Creatinine
1347-4,Y little t super little a Ag
13474-2,Magnesium/Creatinine
13475-9,Fluoride/Creatinine
13476-7,Silver/Creatinine
13477-5,Orthocresol/Creatinine
13478-3,Tetrahydrocannabinol/Creatinine
13479-1,Benzoylecgonine/Creatinine
13480-9,18-Hydroxydeoxycortisol/Creatinine
13481-7,Gonadotropin peptide/Creatinine
1348-2,Y little t super little b Ab
13482-5,Aldosterone/Creatinine
13483-3,Oxalate/Creatinine
13484-1,Creatine/Creatinine
13485-8,Beta-2-Microglobulin/Creatinine
13486-6,Testosterone/Creatinine
13487-4,Phenol/Creatinine
13488-2,Coagulation surface induced
13489-0,Follitropin/Creatinine
1349-0,Y little t super little b Ab
13490-8,Lutropin/Creatinine
13491-6,Cells.CD4+CD25+
13492-4,Cells.CD4+HLA-DR+
13493-2,Cells.CD8+CD25+
13494-0,Specimen volume
13495-7,Specimen volume
13496-5,Triple phosphate crystals
13497-3,Dextroamphetamine/Levoamphetamine
13498-1,Dextromethamphetamine/Levomethamphetamine
13499-9,HIV 1 Ab band pattern
13500-4,Amino acid pattern
13501-2,Herpes simplex virus 2 Ab pattern
13502-0,Borrelia burgdorferi Ab.IgG band pattern
13503-8,Borrelia burgdorferi Ab.IgM band pattern
13504-6,Borrelia burgdorferi Ab
13505-3,Herpes simplex virus 1+2 Ab pattern
13506-1,Urea nitrogen renal clearance
13507-9,Lupus erythematosus cells
1350-8,Y little t super little b Ab
13508-7,Hematocrit
13509-5,Microscopic observation
13510-3,Microscopic observation
13511-1,Cyanide ascorbate screen
13512-9,Microscopic observation
13513-7,Iron.microscopic observation
13514-5,Hemoglobin pattern
13515-2,Hemoglobin pattern
1351-6,Y little t super little b Ag
13516-0,Neutrophils/100 leukocytes
13517-8,Lymphocytes.variant/100 leukocytes
13518-6,Lymphocytes.variant/100 leukocytes
13519-4,Basophils/100 leukocytes
13520-2,Basophils/100 leukocytes
13521-0,Blasts/100 leukocytes
13522-8,Blasts/100 leukocytes
13523-6,Leukocytes other/100 leukocytes
1352-4,Y little t super little b Ag
13524-4,Leukocytes other/100 leukocytes
13525-1,Nonhematic cells/100 leukocytes
13526-9,Nonhematic cells/100 leukocytes
13527-7,Unidentified cells/100 leukocytes
13528-5,Unidentified cells/100 leukocytes
13529-3,Erythrocytes.nucleated
13530-1,Erythrocytes.nucleated
13531-9,Fat.microscopic observation
1353-2,Y little t super little b Ag
13532-7,Xanthochromia
13533-5,Acid hemolysis
13534-3,Sucrose hemolysis
13535-0,Sucrose hemolysis
13536-8,Globulin
13537-6,Protein
13538-4,Carbon dioxide
13539-2,Phosphate
135-4,cefTAZidime
1354-0,11-Deoxycorticosteroids^9H post 3 g metyraPONE PO overnight
13540-0,Carbon dioxide
13541-8,Carbon dioxide
13542-6,Phosphate
13543-4,Phosphate
13544-2,4-Hydroxyglutethimide
13545-9,ALPRAZolam
13546-7,Amikacin
13547-5,Butriptyline
13548-3,chlorproMAZINE
13549-1,clomiPRAMINE
13550-9,clonazePAM
13551-7,Clorazepate
13552-5,cloZAPine
13553-3,Cocaethylene
13554-1,Cyclobenzaprine
13555-8,D-pseudoephedrine
13556-6,Demoxepam
1355-7,11-Deoxycorticosteroids^pre 3 g metyraPONE PO overnight
13557-4,Norsertraline
13558-2,Disopyramide
13559-0,Flecainide
13560-8,fluvoxaMINE
13561-6,Gentamicin
13562-4,Gentamicin
13563-2,Glutethimide
13564-0,Ibuprofen
1356-5,11-Deoxycortisol^8H post 30 mg/kg metyraPONE PO
13565-7,LORazepam
13566-5,Mesoridazine
13567-3,Mexiletine
13568-1,N-desalkylflurazepam
13569-9,Norchlordiazepoxide
13570-7,Norclomipramine
13571-5,Norclozapine
13572-3,Nordiazepam
1357-3,11-Deoxycortisol^post 750 mg metyraPONE Q4H X 6
13573-1,Nordoxepin
13574-9,Norfluoxetine
13575-6,Normaprotiline
13576-4,oxyCODONE
13577-2,PARoxetine
13578-0,Promazine
13579-8,Sertraline
13580-6,Temazepam
1358-1,Corticotropin^1.5H post dose insulin IV
13581-4,Theophylline
13582-2,Theophylline
13583-0,Thioridazine
13584-8,Tobramycin
13585-5,Trifluoperazine
13586-3,Vancomycin
13587-1,Vancomycin
13588-9,Venlafaxine
13589-7,Activated protein C resistance
13590-5,Activated protein C resistance
13591-3,Factor inhibitor XXX
13592-1,Platelet aggregation.XXX induced
13593-9,Platelet aggregation.prostaglandin induced
13594-7,Prekallikrein
13595-4,Basophils/100 leukocytes
13596-2,Histiocytes
13597-0,Neutrophils/100 leukocytes
13598-8,Promyelocytes/100 leukocytes
1359-9,Corticotropin^1H post 1 ug/kg CRH IV
13599-6,Promonocytes/100 leukocytes
13600-2,11-Deoxycortisol^15M post 250 ug corticotropin
13601-0,11-Deoxycortisol^1H post 250 ug corticotropin
13602-8,11-Deoxycortisol^30M post 250 ug corticotropin
13603-6,17-Hydroxypregnenolone^15M post 250 ug corticotropin
13604-4,17-Hydroxypregnenolone^1H post 250 ug corticotropin
13605-1,17-Hydroxypregnenolone^30M post 250 ug corticotropin
13606-9,Glucose^3H post 50 g lactose PO
1360-7,Corticotropin^1H post dose insulin IV
13607-7,Glucose^4H post 50 g lactose PO
13608-5,Insulin^1.5H post 75 g glucose PO
13609-3,Insulin^2.5H post 75 g glucose PO
13610-1,3-Beta-Androstanediol
13611-9,6-Beta-Hydroxycortisol
13612-7,Dehydroepiandrosterone
13613-5,Ethanolamine
13614-3,Etiocholanolone
1361-5,Corticotropin^1M post 1 ug/kg CRH IV
13615-0,Gamma aminobutyrate
13616-8,Nitrite
13617-6,Prostaglandin D2
13618-4,Tetrahydroaldosterone
13619-2,Specimen volume
136-2,Ceftizoxime
13620-0,Specimen volume
13621-8,Coagulation thrombin induced
13622-6,Acetaminophen
1362-3,Corticotropin^30M post 1 ug/kg CRH IV
13623-4,Dextromethorphan
13624-2,DOXOrubicin
13625-9,Methoxsalen
13626-7,Mitotane
13627-5,Erythrocytes
13628-3,Spermatozoa.motile/100 spermatozoa
13629-1,Interleukin 1 beta
13630-9,Immune complex
1363-1,Corticotropin^30M post dose insulin IV
13631-7,Immune complex
13632-5,Insulin receptor Ab
13633-3,Insulin receptor Ab
13634-1,Rheumatoid factor
13635-8,Ribosomal Ab
13636-6,Ribosomal P Ab
13637-4,Trichloroethane
13638-2,Chlordecone
13639-0,Chlordecone
13640-8,Vinyl chloride
13641-6,Codeine
13642-4,Ethylene glycol
13643-2,Lindane
13644-0,"1,3-Dimethylbenzene"
13645-7,Manganese
13646-5,Methaqualone
13647-3,Methylene chloride
13648-1,Morphine
1364-9,Corticotropin^45M post 1 ug/kg CRH IV
13649-9,Nickel
13650-7,"1,2-Dimethylbenzene"
13651-5,"1,4-Dimethylbenzene"
13652-3,Zinc
13653-1,Epithelial cells.renal
13654-9,Epithelial cells.squamous
13655-6,Leukocytes
1365-6,Corticotropin^45M post dose insulin IV
13656-4,Phosphate crystals.amorphous
13657-2,Urate crystals.amorphous
13658-0,Urobilinogen
13659-8,Epidermal growth factor receptor
13660-6,Gonadotropin releasing hormone
13661-4,Ganglioside GD1b Ab.IgM
13662-2,Ganglioside GD1b Ab.IgG
13663-0,Asialoganglioside GM1 Ab.IgG
1366-4,Corticotropin^5M post 1 ug/kg CRH IV
13664-8,Myelin associated glycoprotein-sulfated glucuronic paragloboside Ab.IgM
13665-5,1-Methylhistidine/Creatinine
13666-3,Alpha aminoadipate/Creatinine
13667-1,Alpha aminobutyrate/Creatinine
13668-9,2-Ethyl-3-Hydroxypropionate/Creatinine
13669-7,2-Hydroxy-3-Methylvalerate/Creatinine
13670-5,2-Hydroxyadipate/Creatinine
13671-3,Alpha hydroxybutyrate/Creatinine
1367-2,Corticotropin^pre 1 ug/kg CRH IV
13672-1,2-Hydroxyglutarate/Creatinine
13673-9,2-Hydroxyisocaproate/Creatinine
13674-7,2-Hydroxyisovalerate/Creatinine
13675-4,2-Methyl-3-Hydroxybutyrate/Creatinine
13676-2,"2-Oxo,3-Methylvalerate/Creatinine"
13677-0,2-Oxoadipate/Creatinine
13678-8,Alpha ketoglutarate/Creatinine
13679-6,2-Oxoisocaproate/Creatinine
1368-0,Corticotropin^pre dose insulin IV
13680-4,2-Oxoisovalerate/Creatinine
13681-2,Beta aminoisobutyrate/Creatinine
13682-0,"3-Hydroxy,3-Methylglutarate/Creatinine"
13683-8,3-Hydroxyadipate/Creatinine
13684-6,Beta hydroxybutyrate/Creatinine
13685-3,3-Hydroxyglutarate/Creatinine
13686-1,3-Hydroxyisobutyrate/Creatinine
13687-9,3-Hydroxyisovalerate/Creatinine
13688-7,3-Hydroxypropionate/Creatinine
13689-5,3-Hydroxyvalerate/Creatinine
13690-3,Vanillylmandelate/Creatinine
13691-1,3-Methylcrotonylglycine/Creatinine
13692-9,3-Methylglutaconate/Creatinine
13693-7,3-Methylglutarate/Creatinine
13694-5,3-Methylhistidine/Creatinine
13695-2,Gamma aminobutyrate/Creatinine
13696-0,4-Hydroxyphenylacetate/Creatinine
13697-8,4-Hydroxyphenyllactate/Creatinine
1369-8,Ascorbate^post dose PO
13698-6,4-Hydroxyphenylpyruvate/Creatinine
13699-4,5-Hydroxyhexanoate/Creatinine
137-0,Ceftizoxime
13700-0,5-Oxoproline/Creatinine
13701-8,Acetoacetate/Creatinine
13702-6,Aconitate/Creatinine
13703-4,Adipate/Creatinine
13704-2,Alanine/Creatinine
13705-9,Albumin/Creatinine
1370-6,Carotene^post 15000 U carotene QDx3 for 3D poly
13706-7,Amylase/Creatinine
13707-5,Anserine/Creatinine
13708-3,Arginine/Creatinine
13709-1,Argininosuccinate/Creatinine
13710-9,Asparagine/Creatinine
13711-7,Aspartate/Creatinine
13712-5,Azelate/Creatinine
13713-3,Benzoate/Creatinine
1371-4,Bromsulphthalein
13714-1,Beta alanine/Creatinine
13715-8,C peptide/Creatinine
13716-6,C peptide/Creatinine
13717-4,Calcium/Creatinine
13718-2,Carnitine.free (C0)/Creatinine
13719-0,Carnitine/Creatinine
13720-8,Carnosine/Creatinine
13721-6,Chloride/Creatinine
1372-2,Calcitonin^90s post 0.5 ug/kg pentagastrin IV
13722-4,Citrate/Creatinine
13723-2,Citrulline/Creatinine
13724-0,Cystathionine/Creatinine
13725-7,Cystine/Creatinine
13726-5,Decadienediate/Creatinine
13727-3,Decenedioate/Creatinine
13728-1,Delta aminolevulinate/Creatinine
13729-9,Deoxypyridinoline/Creatinine
1373-0,Calcitonin^10M post 2.4 mg/kg calcium short IV
13730-7,Deoxypyridinoline/Creatinine
13731-5,Deoxypyridinoline/Creatinine
13732-3,Dodecanedioate/Creatinine
13733-1,DOPamine/Creatinine
13734-9,EPINEPHrine/Creatinine
13735-6,Epinephrine+Norepinephrine/Creatinine
13736-4,Estradiol/Creatinine
13737-2,Estriol/Creatinine
13738-0,Estrogen/Creatinine
13739-8,Estrone/Creatinine
13740-6,Ethanolamine/Creatinine
13741-4,Ethylmalonate/Creatinine
13742-2,Formate/Creatinine
13743-0,Fumarate/Creatinine
13744-8,Galactose/Creatinine
13745-5,Glutaconate/Creatinine
13746-3,Glutamate/Creatinine
13747-1,Glutamine/Creatinine
1374-8,Calcitonin^3H post 15 mg/kg calcium gluconate IV
13748-9,Glutarate/Creatinine
13749-7,Glycerate/Creatinine
13750-5,Glycine/Creatinine
13751-3,Glycolate/Creatinine
13752-1,Glyoxylate/Creatinine
13753-9,Hexanoylglycine/Creatinine
13754-7,Hippurate/Creatinine
1375-5,Calcitonin^4H post 15 mg/kg calcium gluconate IV
13755-4,Histamine/Creatinine
13756-2,Histamine/Creatinine
13757-0,Histidine/Creatinine
13758-8,Homocysteine/Creatinine
13759-6,Homocystine/Creatinine
13760-4,Homovanillate/Creatinine
13761-2,Hydroxydecanedioate/Creatinine
13762-0,Hydroxylysine/Creatinine
1376-3,Calcitonin^5M post 0.5 ug/kg pentagastrin IV
13763-8,Hydroxyproline/Creatinine
13764-6,Isocitrate/Creatinine
13765-3,Isoleucine/Creatinine
13766-1,Isovalerylglycine/Creatinine
13767-9,Lactate/Creatinine
13768-7,Leucine/Creatinine
13769-5,Lysine/Creatinine
13770-3,Malate/Creatinine
1377-1,Calcitonin^5M post 2.4 mg/kg calcium short IV
13771-1,Metanephrines/Creatinine
13772-9,Methionine/Creatinine
13773-7,2-Methylcitrate/Creatinine
13774-5,Methylhippurate/Creatinine
13775-2,Methylmalonate/Creatinine
13776-0,Methylmalonate/Creatinine
13777-8,Methylsuccinate/Creatinine
13778-6,Mevalonate/Creatinine
13779-4,N-acetyl-L-aspartate/Creatinine
13780-2,N-acetyltyrosine/Creatinine
13781-0,N-methylhistamine/Creatinine
13782-8,Norepinephrine/Creatinine
13783-6,Normetanephrine/Creatinine
13784-4,Octanoate/Creatinine
13785-1,Octenedioate/Creatinine
13786-9,Ornithine/Creatinine
13787-7,Orotate/Creatinine
13788-5,Oxalate/Creatinine
1378-9,Calcitonin^pre 0.5 ug/kg pentagastrin IV
13789-3,Phosphoethanolamine/Creatinine
13790-1,Para nitrophenol/Creatinine
13791-9,Phenylacetate/Creatinine
13792-7,Phenyllactate/Creatinine
13793-5,Phenylpropionylglycine/Creatinine
13794-3,Phenylpyruvate/Creatinine
13795-0,Phosphate/Creatinine
13796-8,Phosphoserine/Creatinine
1379-7,Calcitonin^pre 2.4 mg/kg calcium short IV
13797-6,Porphobilinogen/Creatinine
13798-4,Potassium/Creatinine
13799-2,Proline/Creatinine
13800-8,Propionylglycine/Creatinine
13801-6,Protein/Creatinine
13802-4,Pyridinoline/Creatinine
13803-2,Pyridinoline/Creatinine
13804-0,Pyridinoline/Creatinine
1380-5,Calcium/Phosphate parathyroid-challenge test
13805-7,Pyruvate/Creatinine
13806-5,Sarcosine/Creatinine
13807-3,Sebacate/Creatinine
13808-1,Serine/Creatinine
13809-9,Sodium/Creatinine
13810-7,Suberate/Creatinine
13811-5,Suberylglycine/Creatinine
13812-3,Succinate/Creatinine
1381-3,Calcium^10M post 2.4 mg/kg calcium short IV
13813-1,Succinylacetone/Creatinine
13814-9,Taurine/Creatinine
13815-6,Threonine/Creatinine
13816-4,Tiglylglycine/Creatinine
13817-2,Tryptophan/Creatinine
13818-0,Tyrosine/Creatinine
13819-8,Uracil/Creatinine
13820-6,Urate/Creatinine
1382-1,Calcium^5M post 2.4 mg/kg calcium short IV
13821-4,Urea nitrogen/Creatinine
13822-2,Valine/Creatinine
13823-0,Antimony/Creatinine
13824-8,Arsenic/Creatinine
13825-5,Arsenic.inorganic/Creatinine
13826-3,Barium/Creatinine
13827-1,Beryllium/Creatinine
13828-9,Cadmium/Creatinine
13829-7,Copper/Creatinine
13830-5,Phenylglyoxylate/Creatinine
13831-3,Vanadium/Creatinine
13832-1,Dimethylbenzene/Creatinine
13833-9,Finch feather Ab.IgE
13834-7,IgE.total
13835-4,Monocytes/100 leukocytes
13836-2,Neutrophils/100 leukocytes
13837-0,Blasts.CD10/100 blasts
13838-8,Blasts.CD13/100 blasts
1383-9,Calcium^pre 2.4 mg/kg calcium short IV
13839-6,Blasts.CD14/100 blasts
13840-4,Blasts.CD19/100 blasts
13841-2,Blasts.CD2/100 blasts
13842-0,Blasts.CD20/100 blasts
13843-8,Blasts.CD33/100 blasts
13844-6,Blasts.CD34/100 blasts
13845-3,Blasts.CD5/100 blasts
13846-1,Blasts.CD7/100 blasts
1384-7,Calcium^post calcium infusion
13847-9,Blasts.terminal deoxyribonucleotidyl transferase/100 blasts
13848-7,Cells.CD3+CD26+
13849-5,Lymphocytes.CD3+CD26+/100 lymphocytes
13850-3,Cells.CD5+CD25+
13851-1,Cells.CD5+CD25+/100 cells
13852-9,Aldosterone^1H post 250 ug corticotropin IM
13853-7,Aldosterone^1H post 25 mg captopril PO
1385-4,Catecholamines.free fractionated^1H post 300 ug cloNIDine PO
13854-5,Aldosterone^2H post 25 mg captopril PO
13855-2,Aldosterone^30M post 250 ug corticotropin IM
13856-0,Androstenedione^15M post 250 ug corticotropin IM
13857-8,Androstenedione^1H post 250 ug corticotropin IM
13858-6,Androstenedione^30M post 250 ug corticotropin IM
13859-4,C peptide^10M post 1 mg glucagon IV
13860-2,C peptide^15M post 1 mg glucagon IV
13861-0,C peptide^5M post 1 mg glucagon IV
1386-2,Catecholamines.free fractionated^2H post 300 ug cloNIDine PO
13862-8,Dehydroepiandrosterone^15M post 250 ug corticotropin
13863-6,Dehydroepiandrosterone^1H post 250 ug corticotropin
13864-4,Dehydroepiandrosterone^30M post 250 ug corticotropin
13865-1,Glucose^2.5H post 50 g lactose PO
13866-9,Glucose^5H post 50 g lactose PO
13867-7,Renin^1H post 25 mg captopril PO
13868-5,Renin^2H post 25 mg captopril PO
13869-3,Thyrotropin^1.5H post dose TRH IV
1387-0,Catecholamines.free fractionated^3H post 300 ug cloNIDine PO
13870-1,Thyrotropin^15M post dose TRH IV
13871-9,Thyrotropin^2H post dose TRH IV
13872-7,11-Deoxycortisol
13873-5,Albumin.glycated/Albumin.total
13874-3,Alkaline phosphatase.liver 1
13875-0,Alkaline phosphatase.liver 2
13876-8,Beta-2 transferrin
13877-6,Bilirubin
13878-4,Collagen type 1 Ab.IgG
13879-2,Collagen type 2 Ab.IgG
138-8,Ceftizoxime
13880-0,Collagen type 4 Ab.IgG
13881-8,Deoxypyridinoline.free/Creatinine
13882-6,Androstanolone.free/Androstanolone.total
13883-4,Estradiol.bioavailable/Estradiol.total
13884-2,Estradiol.bioavailable
13885-9,Estrogen/Creatinine
13886-7,Lactate dehydrogenase 1/Lactate dehydrogenase.total
13887-5,Lactate dehydrogenase 2/Lactate dehydrogenase.total
1388-8,Catecholamines.free fractionated^pre 300 ug cloNIDine PO
13888-3,Lactate dehydrogenase 3/Lactate dehydrogenase.total
13889-1,Lactate dehydrogenase 4/Lactate dehydrogenase.total
13890-9,Lactate dehydrogenase 5/Lactate dehydrogenase.total
13891-7,Motilin
13892-5,Nitrosonaphthol
13893-3,Phenylalanine
13894-1,Pregnenolone
13895-8,Sodium
1389-6,Cortisol.free^24H post 40 ug corticotropin IM BID 3 day
13896-6,Insulin-like growth factor-I
13897-4,Thyrotropin.beta subunit
13898-2,Trichloroacetate
13899-0,Triglyceride
13900-6,Tumor necrosis factor.alpha
13901-4,Tyrosine
13902-2,Urate
13903-0,Vasopressin
1390-4,Cortisol.free^48H post 40 ug corticotropin IM BID 3 day
13904-8,Meclizine
13905-5,Meclofenamate
13906-3,Mesoridazine
13907-1,Norethindrone
13908-9,Oxipurinol
13909-7,Tamoxifen
13910-5,HLA-B22
13911-3,HLA-B27 related Ag
1391-2,Cortisol.free^48H post 500 ug dexamethasone PO 2.5 day low dose q6h
13912-1,HLA-B42
13913-9,Adenovirus Ab
13914-7,Adenovirus Ab.IgG
13915-4,Adenovirus Ab.IgM
13916-2,Bordetella parapertussis Ag
13917-0,Coccidioides immitis Ab
13918-8,Eastern equine encephalitis virus Ab
13919-6,Hepatitis B virus core Ab.IgG
1392-0,Cortisol.free^48H post 2 mg dexamethasone PO 2.5 day high dose q6h
13920-4,HIV 2 p41 Ab
13921-2,Mumps virus
13922-0,Trichinella spiralis Ab.IgA
13923-8,Trichinella spiralis Ab.IgM
13924-6,Calcitonin Ab
13925-3,Soluble liver Ab
13926-1,Glutamate decarboxylase 65 Ab
13927-9,Pancreatic islet cell Ab
13928-7,Parathyrin Ab
13929-5,Rheumatoid factor
13930-3,Rheumatoid factor
13931-1,Striated muscle Ab
13932-9,Testes Ab.IgG
13933-7,Benzodiazepines
13934-5,Butanol
13935-2,Dichlorodifluoromethane
13936-0,Diethyl ether
13937-8,Ethyl acetate
1393-8,Cortisol.free^72H post 40 ug corticotropin IM BID 3 day
13938-6,Trichloroethane
13939-4,Trichlorotrifluoroethane
13940-2,Dimethylbenzene
13941-0,Lymphocytes/100 leukocytes
13942-8,Spermatozoa.motile
13943-6,Fructose
13944-4,Phosphatase.leukocyte
13945-1,Erythrocytes
1394-6,Cortisol.free^pre 50 ug corticotropin IM 3 day
13946-9,Complement+Immunoglobulin
13947-7,Coccidioides immitis Ab.IgG
13948-5,Coccidioides immitis Ab.IgM
13949-3,Cytomegalovirus Ab.IgG
13950-1,Hepatitis A virus Ab.IgM
13951-9,Hepatitis A virus Ab
13952-7,Hepatitis B virus core Ab
1395-3,Cortisol.free^pre 500 ug dexamethasone PO 2.5 day low dose q6h
13953-5,Hepatitis B virus little e Ab
13954-3,Hepatitis B virus little e Ag
13955-0,Hepatitis C virus Ab
13956-8,Mycobacterium tuberculosis DNA
13957-6,Clostridioides difficile toxin A
13958-4,Arsenic
13959-2,Calcium.ionized
139-6,Ceftizoxime
13960-0,Coproporphyrin
1396-1,Cortisol.free^pre 2 mg dexamethasone PO 2.5 day high dose q6h
13961-8,Mercury
13962-6,Beta glucuronidase
13963-4,Orotate
13964-2,Methylmalonate
13965-9,Homocysteine
13966-7,Cystine
13967-5,Sex hormone binding globulin
13968-3,Penicillin
13969-1,Creatine kinase.MB
13970-9,Delta tocopherol
13971-7,Histoplasma capsulatum Ag
13972-5,Alpha 1 globulin/Protein.total
13973-3,Prealbumin/Protein.total
13974-1,Albumin/Protein.total
13975-8,Alpha 2 globulin/Protein.total
13976-6,Beta globulin/Protein.total
13977-4,Gamma globulin/Protein.total
13978-2,Alpha 1 globulin/Protein.total
1397-9,Cortisol^1.5H post 0.05-0.15 U insulin/kg IV post 12H CFst
13979-0,Prealbumin/Protein.total
13980-8,Albumin/Protein.total
13981-6,Alpha 2 globulin/Protein.total
13982-4,Beta globulin/Protein.total
13983-2,Gamma globulin/Protein.total
13984-0,Alpha 1 globulin/Protein.total
13985-7,Prealbumin/Protein.total
13986-5,Albumin/Protein.total
1398-7,Cortisol^1.5H post dose insulin IV
13987-3,Alpha 2 globulin/Protein.total
13988-1,Beta globulin/Protein.total
13989-9,Gamma globulin/Protein.total
13990-7,Alpha 1 globulin/Protein.total
13991-5,Prealbumin/Protein.total
13992-3,Albumin/Protein.total
13993-1,Alpha 2 globulin/Protein.total
13994-9,Beta globulin/Protein.total
1399-5,Cortisol^1H post 0.05-0.15 U insulin/kg IV post 12H CFst
13995-6,Gamma globulin/Protein.total
13996-4,Hydroxyproline/Creatinine
13997-2,Neuronal nuclear type 1 Ab
13998-0,Neuronal nuclear type 2 Ab
13999-8,Transferrin.carbohydrate deficient
14000-4,Urea nitrogen
1400-1,Cortisol^1H post 1 ug/kg CRH IV
14001-2,IgE
14002-0,IgM
14003-8,Carbon dioxide
14004-6,Prostaglandin A
14005-3,Prostaglandin E1
14006-1,Prostaglandin E2
14007-9,Prostaglandin F2 alpha
14008-7,Phosphatidylcholine Ab.IgG
14009-5,Phosphatidylcholine Ab.IgM
14010-3,Phosphatidylcholine Ab.IgA
14011-1,Platelet associated Ab.IgA
14012-9,Platelet associated Ab.IgG
14013-7,Platelet associated Ab.IgM
14014-5,Thyroxine.prealbumin bound
14015-2,Thyroxine.prealbumin bound/Prealbumin
14016-0,Thyroxine.thyroxine binding globulin bound
14017-8,Cells.CD22/100 cells
14018-6,Cells.CD23/100 cells
1401-9,Cortisol^1H post 250 ug corticotropin IM rapid
14019-4,HTLV I+II gp46 Ab
14020-2,HTLV I+II p19 Ab
14021-0,HTLV I+II p24 Ab
14022-8,HTLV I+II p26 Ab
14023-6,HTLV I+II p28 Ab
14024-4,HTLV I+II p32 Ab
14025-1,HTLV I+II p36 Ab
14026-9,HTLV I+II p53 Ab
1402-7,Cortisol^1H post 250 ug corticotropin IV rapid
14027-7,HTLV I+II rgp21 Ab
14028-5,HTLV I+II rgp46-I Ab
14029-3,HTLV I+II rgp46-II Ab
14030-1,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab
14031-9,Ciprofloxacin^peak
14032-7,Ciprofloxacin^trough
14033-5,"1,4-Dioxane"
14034-3,Rheumatoid factor
1403-5,Cortisol^1H post 250 ug corticotropin IM
14035-0,Cryptomeria japonica Ab.IgE
14036-8,Dermatophagoides microceras Ab.IgE
14037-6,Fox Ab.IgE
14038-4,Todarodes pacificus Ab.IgE
14039-2,Neutrophils/100 leukocytes
140-4,cefTRIAXone
14040-0,Carbon dioxide
14041-8,Choriogonadotropin.beta subunit
14042-6,Corticosterone
1404-3,Cortisol^1H post dose insulin IV
14043-4,Cortisol.free
14044-2,Cortisone
14045-9,D-lactate
14046-7,D-lactate
14047-5,Androstanolone.free
14048-3,Elastase.pancreatic
14049-1,Epidermal growth factor
1405-0,Cortisol^1H post dose U/kg insulin IV
14050-9,Epidermal growth factor receptor
14051-7,Estrogen binding protein
14052-5,Formate
14053-3,Homocystine
14054-1,Prostaglandin D2
14055-8,Sodium
14056-6,"carBAMazepine 10,11-Epoxide.free"
14057-4,carBAMazepine.free
14058-2,Ciprofloxacin^peak
14059-0,Ciprofloxacin^trough
14060-8,Cyclobenzaprine
14061-6,Cyclobenzaprine
14062-4,Dexamethasone
14063-2,Dezocine
14064-0,Diethylstilbestrol
14065-7,Diflunisal
14066-5,Dihydrocodeine
14067-3,Dihydrocodeine
1406-8,Cortisol^1M post 1 ug/kg CRH IV
14068-1,Triamterene+hydroCHLOROthiazide
14069-9,Estazolam
14070-7,fluPHENAZine
14071-5,Ibuprofen
14072-3,Monoacetyldapsone
14073-1,Phenytoin
14074-9,Spironolactone
14075-6,Sulfapyridine
1407-6,Cortisol^24H post 2 mg dexamethasone PO 2.5 day high dose q6h
14076-4,Complement total hemolytic CH100
14077-2,Borrelia burgdorferi Ab.IgG
14078-0,Borrelia burgdorferi Ab.IgM
14079-8,Brucella canis Ab.IgG
14080-6,Brucella canis Ab.IgM
14081-4,Coliform bacteria
14082-2,Echinococcus sp Ab.IgG
14083-0,Epstein Barr virus early Ab
1408-4,Cortisol^24H post 40 ug corticotropin IM BID 3 day
14084-8,Herpes simplex virus 1
14085-5,Herpes simplex virus 2
14086-3,Herpes simplex virus 1 Ab.IgG
14087-1,Herpes simplex virus 1 Ab.IgM
14088-9,Herpes simplex virus 1 Ab.IgM
14089-7,Herpes simplex virus 2 Ab.IgG
14090-5,Herpes simplex virus 2 Ab.IgM
14091-3,Herpes simplex virus 2 Ab.IgM
1409-2,Cortisol^24H post 500 ug corticotropin IM
14092-1,HIV 1 Ab
14093-9,Bacteria identified
14094-7,Trypanosoma cruzi Ab.IgG
14095-4,Fibronectin aggregate Ab.IgG
14096-2,Intercalated disk Ab
14097-0,Antimony
14098-8,Dimethylsulfoxide
14099-6,Nickel
14-Jan,Amikacin
1410-0,Cortisol^24H post 500 ug dexamethasone PO 2.5 day low dose q6h
14100-2,Strontium
14101-0,Strychnine
14102-8,Strychnine
14103-6,Epithelial cells
14104-4,Ustilago nuda+Ustilago tritici Ab.IgE
14105-1,Leukocytes
14106-9,Lymphocytes
14107-7,Neutrophils.segmented/100 leukocytes
14108-5,Cells.CD16c+CD56+
14109-3,Cells.CD16c+CD56+/100 cells
14110-1,Lymphocytes.CD22/100 lymphocytes
14111-9,Lymphocytes.CD23/100 lymphocytes
14112-7,Cells.CD25+CD19+/100 cells
14113-5,Cells.CD56
14114-3,17-Hydroxyprogesterone^1H post 250 ug corticotropin IM
14115-0,Collagen crosslinked N-telopeptide/Creatinine
14116-8,IgG synthesis rate
14117-6,IgG clearance/Albumin clearance
1411-8,Cortisol^26H post 500 ug dexamethasone PO 2.5 day low dose q6h
14118-4,Lactate
14119-2,Lactate dehydrogenase 1/Lactate dehydrogenase 2
141-2,cefTRIAXone
14120-0,Prostate specific Ag.free/Prostate specific Ag.total
14121-8,Pyruvate
14122-6,Pyruvate
14123-4,Thyroxine.albumin bound/Albumin
14124-2,Bacteria
14125-9,Entamoeba histolytica
1412-6,Cortisol^26H post 2 mg dexamethasone PO 2.5 day high dose q6h
14126-7,HIV 1 gp120+gp160 Ab
14127-5,Neisseria gonorrhoeae
14128-3,Rabies virus Ab
14129-1,Respiratory syncytial virus
14130-9,Estrogen receptor
14131-7,PM-1 Ab
14132-5,Color
14133-3,Maple silver Ab.IgE
1413-4,Cortisol^2D post 500 ug corticotropin IM
14134-1,Hemoglobin.free
14135-8,Cells.CD3+CD8+
14136-6,Cells.CD34
14137-4,Glucose^5.5H post 75 g glucose PO
14138-2,Ketones^30M post XXX challenge
14139-0,Ketones^4H post XXX challenge
14140-8,Ketones^5H post XXX challenge
14141-6,Ketones^6H post XXX challenge
1414-2,Cortisol^30M post 0.05-0.15 U insulin/kg IV post 12H CFst
14142-4,Somatotropin^15M post XXX challenge
14143-2,Somatotropin^20M post XXX challenge
14144-0,Somatotropin^2H post XXX challenge
14145-7,Somatotropin^40M post XXX challenge
14146-5,Somatotropin^1H post XXX challenge
14147-3,Somatotropin^1.5H post XXX challenge
14148-1,18-Hydroxycortisol
14149-9,Corticotropin.big fragment
14150-7,Beta glucuronidase
14151-5,Bicarbonate
14152-3,Bilirubin.glucuronidated+Bilirubin.albumin bound
14153-1,Carnitine esters/Creatinine
14154-9,Cholesterol sulfate
14155-6,Cholesterol.in LDL
14156-4,Coproporphyrin
14157-2,Coproporphyrin
14158-0,Cortisol
1415-9,Cortisol^30M post 1 ug/kg CRH IV
14159-8,Cortisone
14160-6,Estrone.unconjugated/Estrone.total
14161-4,Formaldehyde
14162-2,Gamma melanocyte stimulating hormone
14163-0,IgA.secretory
14164-8,Immunosuppressive acidic protein
14165-5,Lactate
14166-3,Methane
1416-7,Cortisol^30M post 250 ug corticotropin IM rapid
14167-1,N-methylimidazoleacetate
14168-9,Palatinase
14169-7,Peptide histidine isoleucine
14170-5,Pituitary glycoprotein hormone.alpha subunit
14171-3,Porphyrins
14172-1,Potassium
14173-9,Progesterone.free
14174-7,Prostaglandin F2 alpha
1417-5,Cortisol^30M post 250 ug corticotropin IV rapid
14175-4,Protoporphyrin
14176-2,Pyrroles
14177-0,Growth hormone-releasing hormone
14178-8,Sucrase
14179-6,Tissue polypeptide Ag
14180-4,Uroporphyrin
14181-2,Uroporphyrin
14182-0,Thrombin antithrombin complex Ag
1418-3,Cortisol^30M post 250 ug corticotropin IM
14183-8,Aprobarbital
14184-6,Atropine
14185-3,methIMAzole
14186-1,Methylprednisolone
14187-9,OKT3
14188-7,Omeprazole
14189-5,Phenyltoloxamine
14190-3,Phenytoin.free
1419-1,Cortisol^30M post dose insulin IV
14191-1,Prazosin
14192-9,Triazolam
14193-7,Tripelennamine
14194-5,Spermatozoa.progressive/100 spermatozoa
14195-2,Complement C3b.inactive
14196-0,Reticulocytes
14197-8,Blastomyces dermatitidis exoantigen identification
14198-6,Chlamydophila psittaci Ab
14199-4,Chlamydia trachomatis B Ab.IgA
142-0,cefTRIAXone
14200-0,Chlamydia trachomatis B Ab.IgG
14201-8,Chlamydia trachomatis B Ab.IgM
14202-6,Chlamydia trachomatis C Ab.IgA
14203-4,Chlamydia trachomatis C Ab.IgG
14204-2,Chlamydia trachomatis C Ab.IgM
14205-9,Coccidioides immitis Ag
14206-7,Coccidioides immitis exoantigen identification
14207-5,DNAse B Ab.Streptococcal
14208-3,Filaria Ab.IgG4
1420-9,Cortisol^30M post dose U/kg insulin IV
14209-1,Francisella tularensis Ab.IgA
14210-9,Giardia lamblia Ag
14211-7,Hepatitis E virus Ab.IgG
14212-5,Hepatitis E virus Ab.IgM
14213-3,Herpes simplex virus Ab.IgM
14214-1,Histoplasma capsulatum exoantigen identification
14215-8,HTLV I g46 Ab
14216-6,HTLV I gp46 Ab
1421-7,Cortisol^32H post 40 ug corticotropin IM BID 3 day
14217-4,HTLV I p19 Ab
14218-2,HTLV I p24 Ab
14219-0,HTLV I p26 Ab
14220-8,HTLV I p28 Ab
14221-6,HTLV I p32 Ab
14222-4,HTLV I p36 Ab
14223-2,HTLV I p53 Ab
14224-0,HTLV I rgp21 Ab
1422-5,Cortisol^3D post 500 ug corticotropin IM
14225-7,HTLV II g46 Ab
14226-5,Nocardia sp identified
14227-3,Salmonella typhi H D Ab
14228-1,Cells.estrogen receptor/100 cells
14229-9,P53 protein Ag
14230-7,Cells.progesterone receptor/100 cells
14231-5,H2a-H2b DNA Ab.IgG
14232-3,Adrenal Ab
1423-3,Cortisol^45M post 1 ug/kg CRH IV
14233-1,Beta tubulin Ab.IgG
14234-9,Beta tubulin Ab.IgM
14235-6,Jo-1 extractable nuclear Ab
14236-4,Mitochondria Ab
14237-2,Myelin basic protein Ab.IgA
14238-0,Myelin basic protein Ab.IgG
14239-8,Myelin basic protein Ab.IgM
14240-6,Neuronal nuclear Ab
1424-1,Cortisol^45M post dose insulin IV
14241-4,Parietal cell Ab
14242-2,Phosphatidylcholine Ab.IgA
14243-0,Phosphatidylcholine Ab.IgG
14244-8,Phosphatidylcholine Ab.IgM
14245-5,Phosphatidylserine Ab.IgG
14246-3,Phosphatidylserine Ab.IgM
14247-1,Purkinje cells Ab
14248-9,Purkinje cells Ab
14249-7,Purkinje cells Ab
14250-5,Purkinje cells Ab.IgG
14251-3,Mitochondria M2 Ab.IgG
14252-1,Smooth muscle Ab
14253-9,Somatotropin Ab
14254-7,Ganglioside GQ1b Ab.IgG
14255-4,Thyrotropin blocking Ab
14256-2,Tetrachlorodiphenylethane
14257-0,Tetrachlorodiphenylethane
1425-8,Cortisol^48H post 2 mg dexamethasone PO 2.5 day high dose q6h
14258-8,"1,4-Dioxane"
14259-6,1-Pentanol
14260-4,Bromoform
14261-2,Codeine
14262-0,Dichlorodiphenyldichloroethylene
14263-8,Dichlorodiphenyltrichloroethane
14264-6,Enflurane
14265-3,Isobutyl acetate
1426-6,Cortisol^48H post 40 ug corticotropin IM BID 3 day
14266-1,Methoxyflurane
14267-9,Methylenedioxymethamphetamine
14268-7,Butyl acetate
14269-5,Sec-butyl acetate
14270-3,Tert-butyl acetate
14271-1,Character
14272-9,Liver kidney microsomal Ab
14273-7,Reticulin Ab.IgA
1427-4,Cortisol^48H post 500 ug dexamethasone PO 2.5 day low dose q6h
14274-5,Uroporphyrin
14275-2,Immune complex
14276-0,Hemoglobin F distribution
14277-8,Neutrophil cytoplasmic Ab.classic
14278-6,Neutrophil cytoplasmic Ab.perinuclear
1428-2,Cortisol^50H post 500 ug dexamethasone PO 2.5 day low dose q6h
14282-8,Acylcarnitine
14283-6,Acylcarnitine
14284-4,Beta glucuronidase
14285-1,Carnitine.free (C0)
14286-9,Carnitine.free (C0)
14287-7,Carnitine
14288-5,Carnitine
14289-3,Coproporphyrin
1429-0,Cortisol^50H post 2 mg dexamethasone PO 2.5 day high dose q6h
14290-1,Erythrocytes
14291-9,Follitropin^baseline
14292-7,IgE
14293-5,Insulin^baseline
14294-3,Lysosomal enzymes screen
14295-0,Organic acids/Creatinine
14296-8,Thyroperoxidase Ab
14297-6,Thyrotropin
14298-4,Plasma units available
14299-2,Cryoprecipitate units available
14300-8,Plateletpheresis units available
14301-6,Platelet concentrate units available
14302-4,Packed erythrocytes units available
14303-2,Transfuse plateletpheresis
14304-0,Measles virus Ab.IgG^1st specimen
14305-7,Measles virus Ab.IgG^2nd specimen
14306-5,Varicella zoster virus Ab.IgG^1st specimen
14307-3,Varicella zoster virus Ab.IgG^2nd specimen
1430-8,Cortisol^56H post 40 ug corticotropin IM BID 3 day
14308-1,Amphetamines
14309-9,Amphetamines
14310-7,Phencyclidine
14311-5,Phencyclidine
14312-3,Tetrahydrocannabinol
14313-1,Tetrahydrocannabinol
14314-9,Benzoylecgonine
14315-6,Benzoylecgonine
1431-6,Cortisol^5M post 1 ug/kg CRH IV
14316-4,Benzodiazepines
14317-2,Microscopic observation
14318-0,Microscopic observation
14319-8,Microscopic observation
14320-6,Bacteria identified
14321-4,Haemophilus influenzae B Ag
14322-2,Streptococcus pneumoniae Ag
14323-0,Streptococcus agalactiae Ag
1432-4,Cortisol^72H post 2 mg dexamethasone PO 2.5 day high dose q6h
14324-8,Escherichia coli K1 Ag
14325-5,Bacteria identified
14326-3,Eosinophils/100 leukocytes
14327-1,Epithelial cells.squamous
14328-9,Leukocytes
14329-7,Mucus
14330-5,Polymorphonuclear cells/100 leukocytes
14331-3,Erythrocytes
1433-2,Cortisol^72H post 500 ug dexamethasone PO 2.5 day low dose q6h
14332-1,Para aminosalicylate
14333-9,Lead
14334-7,Lithium
14335-4,Optical density
14336-2,Ethanol
14337-0,Phenytoin.total/Phenytoin.free
14338-8,Prealbumin
14339-6,IgG/Protein.total
1434-0,Cortisol^8H post 1 mg dexamethasone PO overnight
14340-4,Gammopathy
14341-2,Globulin/Protein.total
14342-0,Catecholamines/Creatinine
14343-8,Eosinophils/100 leukocytes
14344-6,Eosinophils/100 leukocytes
14345-3,Specific gravity
14346-1,Specific gravity
14347-9,Specific gravity
14348-7,Specific gravity
14349-5,Specific gravity
14350-3,Specific gravity
14351-1,Specific gravity
14352-9,Specific gravity
14353-7,Microscopic observation
14354-5,Microscopic observation
14355-2,Microscopic observation
14356-0,Microscopic observation
1435-7,Cortisol^8H post 2 mg dexamethasone PO 2.5 day high dose q6h
14357-8,Microscopic observation
14358-6,Microscopic observation
14359-4,Microscopic observation
14360-2,Microscopic observation
14361-0,Microscopic observation
14362-8,Microscopic observation
14363-6,Microscopic observation
14364-4,Microscopic observation
1436-5,Cortisol^8H post 30 mg/kg metyraPONE PO
14365-1,Microscopic observation
14366-9,Trichomonas vaginalis
14367-7,Trichomonas vaginalis
14368-5,Trichomonas vaginalis
14369-3,Yeast
14370-1,Yeast
14371-9,Yeast
14372-7,Erythrocytes
1437-3,Cortisol^8H post 500 ug dexamethasone PO 2.5 day low dose q6h
14373-5,Leukocytes
14374-3,Polymorphonuclear cells/100 leukocytes
14375-0,Polymorphonuclear cells/100 leukocytes
14376-8,Polymorphonuclear cells/100 leukocytes
14377-6,Polymorphonuclear cells/100 leukocytes
14378-4,Polymorphonuclear cells/100 leukocytes
14379-2,Polymorphonuclear cells/100 leukocytes
143-8,cefTRIAXone
14380-0,Mononuclear cells/100 leukocytes
1438-1,Cortisol^8H post 40 ug corticotropin IM BID 3 day
14381-8,Mononuclear cells/100 leukocytes
14382-6,Mononuclear cells/100 leukocytes
14383-4,Mononuclear cells/100 leukocytes
14384-2,Mononuclear cells/100 leukocytes
14385-9,Mononuclear cells/100 leukocytes
14386-7,Glucose
14387-5,Protein
14388-3,Amylase
14389-1,Amylase
14390-9,Amylase
14391-7,Amylase
14392-5,Amylase
14393-3,Urea nitrogen
14394-1,Urea nitrogen
14395-8,Urea nitrogen
14396-6,Urea nitrogen
14397-4,Urea nitrogen
14398-2,Creatinine
1439-9,Cortisol^9.5H post 8 mg dexamethasone PO overnight high dose
14399-0,Creatinine
14400-6,Creatinine
14401-4,Creatinine
14402-2,Creatinine
14403-0,Lactate dehydrogenase
14404-8,Phosphate
14405-5,Phosphate
14406-3,Phosphate
1440-7,Cortisol^9H post 1 mg dexamethasone PO overnight
14407-1,Phosphate
14408-9,Phosphate
14409-7,Aspartate aminotransferase
14410-5,Aspartate aminotransferase
14411-3,Aspartate aminotransferase
14412-1,Aspartate aminotransferase
14413-9,Aspartate aminotransferase
14414-7,Aspartate aminotransferase
1441-5,Cortisol^9H post 3 g metyraPONE PO overnight
14415-4,Calcium
14416-2,Calcium
14417-0,Calcium
14418-8,Calcium
14419-6,Calcium
14420-4,Bilirubin
14421-2,Bilirubin
14422-0,Bilirubin
1442-3,Cortisol^9H post 8 mg dexamethasone PO overnight high dose
14423-8,Bilirubin
14424-6,Bilirubin
14425-3,Globulin
14426-1,Globulin
14427-9,Globulin
14428-7,Globulin
14429-5,Globulin
14430-3,Globulin
1443-1,Cortisol^pre 1 ug/kg CRH IV
14431-1,Globulin
14432-9,Albumin/Globulin
14433-7,Albumin/Globulin
14434-5,Albumin/Globulin
14435-2,Albumin/Globulin
14436-0,Albumin/Globulin
14437-8,Albumin/Globulin
14438-6,Cholesterol
14439-4,Cholesterol
14440-2,Cholesterol
14441-0,Cholesterol
14442-8,Cholesterol
14443-6,Cholesterol
14444-4,Cholesterol
14445-1,Triglyceride
14446-9,Triglyceride
14447-7,Triglyceride
14448-5,Triglyceride
1444-9,Cortisol^pre 12H CFst
14449-3,Triglyceride
14450-1,Triglyceride
14451-9,Virus identified
14452-7,Virus identified
14453-5,Virus identified
14454-3,Virus identified
14455-0,Virus identified
1445-6,Cortisol^pre 1 mg dexamethasone PO overnight
14456-8,Virus identified
14457-6,Virus identified
14458-4,Virus identified
14459-2,Virus identified
144-6,Cefuroxime.parenteral
14460-0,Virus identified
14461-8,Chlamydia trachomatis
14462-6,Chlamydia trachomatis
14463-4,Chlamydia trachomatis
1446-4,Cortisol^pre 3 g metyraPONE PO overnight
14464-2,Chlamydia trachomatis
14465-9,Chlamydia trachomatis
14466-7,Chlamydia trachomatis
14467-5,Chlamydia trachomatis
14468-3,Chlamydia trachomatis Ag
14469-1,Chlamydia trachomatis Ag
14470-9,Chlamydia trachomatis Ag
14471-7,Chlamydia trachomatis Ag
1447-2,Cortisol^pre 40 ug corticotropin IM 3 day
14472-5,Chlamydia trachomatis Ag
14473-3,Chlamydia trachomatis Ag
14474-1,Chlamydia trachomatis Ag
14475-8,Bacteria identified
14476-6,Microorganism identified
14477-4,Bacteria identified
14478-2,Bacteria identified
14479-0,Diphtheria sp identified
1448-0,Cortisol^pre 500 ug dexamethasone PO 2.5 day low dose q6h
14480-8,Diphtheria sp identified
14481-6,Diphtheria sp identified
14482-4,Diphtheria sp identified
14483-2,Diphtheria sp identified
14484-0,Mycoplasma sp & Ureaplasma sp
14485-7,Mycoplasma sp & Ureaplasma sp
14486-5,Mycoplasma sp & Ureaplasma sp
14487-3,Mycoplasma sp & Ureaplasma sp
14488-1,Virus identified
14489-9,Virus identified
14490-7,Virus identified
14491-5,Virus identified
14492-3,Virus identified
14493-1,Virus identified
14494-9,Virus identified
14495-6,Virus identified
14496-4,Virus identified
14497-2,Virus identified
1449-8,Cortisol^pre 8 mg dexamethasone PO overnight high dose
14498-0,Virus identified
14499-8,Human papilloma virus Ag
14500-3,Human papilloma virus Ag
14501-1,Human papilloma virus Ag
14502-9,Human papilloma virus Ag
14503-7,Human papilloma virus 16+18 Ag
14504-5,Human papilloma virus 16+18 Ag
14505-2,Human papilloma virus 16+18 Ag
1450-6,Cortisol^pre 2 mg dexamethasone PO 2.5 day high dose q6h
14506-0,Human papilloma virus 16+18 Ag
14507-8,Chlamydia trachomatis Ag
14508-6,Chlamydia trachomatis Ag
14509-4,Chlamydia trachomatis Ag
14510-2,Chlamydia trachomatis Ag
14511-0,Chlamydia trachomatis Ag
14512-8,Chlamydia trachomatis Ag
14513-6,Chlamydia trachomatis Ag
1451-4,Cortisol^pre dose insulin IV
14514-4,Pneumocystis jiroveci Ag
14515-1,Pneumocystis jiroveci Ag
14516-9,Pneumocystis jiroveci Ag
14517-7,Pneumocystis jiroveci Ag
14518-5,Pneumocystis jiroveci Ag
14519-3,Pneumocystis jiroveci Ag
14520-1,Pneumocystis jiroveci Ag
14521-9,Pneumocystis jiroveci Ag
1452-2,Creatinine^24H post 40 ug corticotropin IM BID 3 day
14522-7,Pneumocystis jiroveci Ag
14523-5,Rubella virus Ag
14524-3,Rubella virus Ag
14525-0,Rubella virus Ag
14526-8,Rubella virus Ag
14527-6,Rubella virus Ag
14528-4,Rubella virus Ag
14529-2,Rubella virus Ag
145-3,Cefuroxime.parenteral
1453-0,Creatinine^48H post 40 ug corticotropin IM BID 3 day
14530-0,Rubella virus Ag
14531-8,Rubella virus Ag
14532-6,Rubella virus Ag
14533-4,Rubella virus Ag
14534-2,Measles virus Ag
14535-9,Measles virus Ag
14536-7,Measles virus Ag
14537-5,Measles virus Ag
14538-3,Measles virus Ag
14539-1,Measles virus Ag
14540-9,Measles virus Ag
14541-7,Measles virus Ag
14542-5,Measles virus Ag
14543-3,Measles virus Ag
14544-1,Measles virus Ag
14545-8,Mumps virus Ag
14546-6,Mumps virus Ag
14547-4,Mumps virus Ag
1454-8,Creatinine^48H post 500 ug dexamethasone PO 2.5 day low dose q6h
14548-2,Mumps virus Ag
14549-0,Mumps virus Ag
14550-8,Mumps virus Ag
14551-6,Mumps virus Ag
14552-4,Mumps virus Ag
14553-2,Mumps virus Ag
14554-0,Mumps virus Ag
1455-5,Creatinine^48H post 2 mg dexamethasone PO 2.5 day high dose q6h
14555-7,Mumps virus Ag
14556-5,Mycobacterium tuberculosis DNA
14557-3,Mycobacterium tuberculosis DNA
14558-1,Mycobacterium tuberculosis DNA
14559-9,Mycobacterium tuberculosis DNA
14560-7,Mycobacterium tuberculosis DNA
14561-5,Mycobacterium tuberculosis DNA
14562-3,Mycobacterium tuberculosis DNA
1456-3,Creatinine^72H post 40 ug corticotropin IM BID 3 day
14563-1,Hemoglobin.gastrointestinal^1st specimen
14564-9,Hemoglobin.gastrointestinal^2nd specimen
14565-6,Hemoglobin.gastrointestinal^3rd specimen
14566-4,Calcitriol
14567-2,11-Deoxycortisol
14568-0,17-Hydroxycorticosteroids
14569-8,17-Hydroxyprogesterone
14570-6,17-Hydroxyprogesterone
1457-1,Creatinine^pre 40 ug corticotropin IM 3 day
14571-4,17-Hydroxyprogesterone
14572-2,17-Ketosteroids
14573-0,5-Hydroxyindoleacetate
14574-8,8-Hydroxyamoxapine
14575-5,Blood group antibody investigation
14576-3,Blood group antibody investigation
14577-1,ABO & Rh group
14578-9,ABO group
14579-7,ABO group
14580-5,ABO group
14581-3,Acetaminophen
14582-1,Acetone
14583-9,Acidity.titratable
14584-7,Adenosine monophosphate.cyclic
14585-4,Albumin/Creatinine
14586-2,Aldosterone
14587-0,Aldosterone
14588-8,Alkaline phosphatase isoenzymes
1458-9,Creatinine^pre 500 ug dexamethasone PO 2.5 day low dose q6h
14589-6,Amylase isoenzymes
14590-4,Alpha tocopherol
14591-2,ALPRAZolam
14592-0,Aluminum
14593-8,Aluminum
14594-6,Amitriptyline+Nortriptyline
14595-3,Amitriptyline+Nortriptyline
14596-1,Amitriptyline+Nortriptyline
1459-7,Creatinine^pre 2 mg dexamethasone PO 2.5 day high dose q6h
14597-9,Amitriptyline
14598-7,Amitriptyline+Nortriptyline
14599-5,Ammonium
14600-1,Amoxapine
14601-9,Amoxapine+8-Hydroxyamoxapine
14602-7,Amoxapine+8-Hydroxyamoxapine
14603-5,Androstenedione
14604-3,Blood group antibodies identified
1460-5,Cobalamins^post dose cyanocobalamin
14605-0,Blood group antibodies identified
14606-8,Blood group antibody screen
14607-6,Nuclear Ab
14608-4,Nuclear Ab
14609-2,Nuclear Ab
146-1,Cefuroxime.parenteral
14610-0,Nuclear Ab
14611-8,Nuclear Ab pattern
14612-6,Nuclear Ab
1461-3,Epinephrine^1H post 300 ug cloNIDine PO
14613-4,Nuclear Ab
14614-2,Nuclear Ab
14615-9,Nuclear Ab
14616-7,Nuclear Ab
14617-5,Appearance
14618-3,Appearance
14619-1,Appearance
14620-9,Appearance
1462-1,Epinephrine^2H post 300 ug cloNIDine PO
14621-7,Appearance
14622-5,Ascorbate
14623-3,Barbital
14624-1,Barbiturates
14625-8,Basophils/100 leukocytes
14626-6,Beta-2-Microglobulin
14627-4,Bicarbonate
14628-2,Bile acid
14629-0,Bilirubin.glucuronidated+Bilirubin.albumin bound
14630-8,Bilirubin.non-glucuronidated
14631-6,Bilirubin
14632-4,Buffy coat
14633-2,C peptide
14634-0,C reactive protein
14635-7,Calcidiol
14636-5,Calcium
14637-3,Calcium
14638-1,Calculus analysis
1463-9,Epinephrine^3H post 300 ug cloNIDine PO
14639-9,carBAMazepine
14640-7,Carbon dioxide
14641-5,Carbonate
14642-3,Carotene
14643-1,Catecholamines.free
14644-9,chlorproMAZINE
14645-6,chlorproMAZINE
14646-4,Cholesterol.in HDL
1464-7,Epinephrine^pre 300 ug cloNIDine PO
14647-2,Cholesterol
14648-0,Chylomicrons
14649-8,Cimetidine
14650-6,Citrate
14651-4,cloBAZam
14652-2,clomiPRAMINE
14653-0,clomiPRAMINE
1465-4,EPINEPHrine^supine
14654-8,clomiPRAMINE+Norclomipramine
14655-5,clonazePAM
14656-3,cloZAPine
14657-1,Clozapine+Norclozapine
14658-9,Cold agglutinin
14659-7,Collection duration
14660-5,Color
14661-3,Color
1466-2,Follitropin^1.5H post 100 g lutropin IV
14662-1,Color
14663-9,Color
14664-7,Color
14665-4,Copper
14666-2,Copper
14667-0,Coproporphyrin 1
14668-8,Coproporphyrin 1
14669-6,Coproporphyrin 1
1467-0,Follitropin^1.5H post dose gonadotropin releasing hormone
14670-4,Coproporphyrin 1/Porphyrins.total
14671-2,Coproporphyrin 3
14672-0,Coproporphyrin 3
14673-8,Coproporphyrin 3
14674-6,Corticotropin
14675-3,Cortisol
14676-1,Cortisol.free
14677-9,Cortisol^24H post 500 ug dexamethasone PO 2.5 day low dose q6h
14678-7,Cortisol^PM trough specimen
14679-5,Cortisol^AM peak specimen
14680-3,Creatine kinase isoenzymes
14681-1,Creatinine
14682-9,Creatinine
14683-7,Creatinine
14684-5,Creatinine
14685-2,Cobalamins
14686-0,Cystine
14687-8,Transfusion date
1468-8,Follitropin^105M post 100 ug luteinizing releasing hormone IV
14688-6,Dehydroepiandrosterone sulfate
14689-4,Delta aminolevulinate
14690-2,N-desalkylflurazepam
14691-0,Desipramine
14692-8,Desipramine
14693-6,Norclobazam
14694-4,Norclomipramine
14695-1,Nordoxepin
1469-6,Follitropin^15M post 100 ug luteinizing releasing hormone IV
14696-9,Deuteroporphyrin
14697-7,diazePAM
14698-5,Digoxin
14699-3,diphenhydrAMINE+dimenhyDRINATE
14700-9,diphenhydrAMINE+dimenhyDRINATE
14701-7,diphenhydrAMINE+dimenhyDRINATE
14702-5,Disopyramide
14703-3,DOPamine
1470-4,Follitropin^1H post 100 ug luteinizing releasing hormone IV
14704-1,Doxepin
14705-8,Doxepin
14706-6,Doxepin
14707-4,Doxepin+Nordoxepin
14708-2,Endomysium Ab
14709-0,Eosinophils/100 leukocytes
14710-8,Ephedrine+Pseudoephedrine
14711-6,EPINEPHrine
1471-2,Follitropin^1H post dose gonadotropin releasing hormone
14712-4,EPINEPHrine
14713-2,Erythrocytes
14714-0,Erythropoietin
14715-7,Estradiol
14716-5,Estriol
14717-3,Estriol
14718-1,Estriol
14719-9,Ethanol
1472-0,Follitropin^2H post 100 ug luteinizing releasing hormone IV
14720-7,Ethosuximide
14721-5,Ethylene glycol
14722-3,Extractable nuclear Ab
14723-1,Ferritin
14724-9,Ferritin
14725-6,Fluid
14726-4,Fluoride
14727-2,FLUoxetine
14728-0,FLUoxetine
14729-8,Flurazepam
14730-6,Flurazepam+N-desalkylflurazepam
14731-4,Folate
14732-2,Folate
14733-0,Folate+Cyanocobalamin
14734-8,Follitropin
14735-5,Gastrin^10M post 0.2 U/kg secretin
14736-3,Gastrin^15M post 0.2 U/kg secretin
14737-1,Gastrin^20M post 0.2 U/kg secretin
1473-8,Follitropin^30M post 100 ug luteinizing releasing hormone IV
14738-9,Gastrin^25M post 0.2 U/kg secretin
14739-7,Gastrin^2M post 0.2 U/kg secretin
14740-5,Gastrin^30M post 0.2 U/kg secretin
14741-3,Gastrin^5M post 0.2 U/kg secretin
14742-1,Gastrin^pre 0.2 U/kg secretin
14743-9,Glucose
14744-7,Glucose
14745-4,Glucose
1474-6,Follitropin^30M post dose gonadotropin releasing hormone
14746-2,Glucose
14747-0,Glucose
14748-8,Glucose
14749-6,Glucose
14750-4,Glucose
14751-2,Glucose^1.5H post 50 g lactose PO
14752-0,Glucose^1.5H post dose glucose
1475-3,Follitropin^45M post 100 ug luteinizing releasing hormone IV
14753-8,Glucose^1H post 100 g glucose PO
14754-6,Glucose^1H post 50 g glucose PO
14755-3,Glucose^1H post 50 g lactose PO
14756-1,Glucose^1H post dose glucose
14757-9,Glucose^2H post 100 g glucose PO
14758-7,Glucose^2H post 50 g lactose PO
14759-5,Glucose^2H post dose glucose
14760-3,Glucose^2H post meal
1476-1,Follitropin^75M post 100 ug luteinizing releasing hormone IV
14761-1,Glucose^2H post meal
14762-9,Glucose^30M post 50 g lactose PO
14763-7,Glucose^30M post dose glucose
14764-5,Glucose^3H post 100 g glucose PO
14765-2,Glucose^3H post dose glucose
14766-0,Glucose^4H post dose glucose
14767-8,Glucose^5H post dose glucose
14768-6,Glucose^baseline
14769-4,Glucose^pre 12H CFst
14770-2,Glucose^post CFst
14771-0,Glucose^post CFst
14772-8,Gold
14773-6,Granulocytes/100 leukocytes
14774-4,Haloperidol
14775-1,Hemoglobin
14776-9,Heptacarboxylate
14777-7,Heptacarboxylate
14778-5,Heptacarboxylate
1477-9,Follitropin^baseline
14779-3,Hexacarboxylate
14780-1,Hexacarboxylate
14781-9,Hexacarboxylate
14782-7,Homovanillate
14783-5,Homovanillate
14784-3,Hydroxyproline.free
14785-0,Hydroxyproline
14786-8,Arthropod identified
1478-7,Follitropin^pre dose gonadotropin releasing hormone
14787-6,Arthropod identified
14788-4,Helminth+Arthropod identified
14789-2,Helminth identified
147-9,Cefuroxime.parenteral
14790-0,Helminth identified
14791-8,Imipramine+Desipramine
14792-6,Imipramine+Desipramine
14793-4,Imipramine+Desipramine
14794-2,Imipramine+Desipramine
1479-5,Galactose^1.5H post 40 g galactose PO
14795-9,Immunoglobulin light chains
14796-7,Insulin
14797-5,Iron
14798-3,Iron
14799-1,Iron
14800-7,Iron binding capacity
14801-5,Iron saturation
14802-3,Isopropanol
1480-3,Galactose^1H post 40 g galactose PO
14803-1,Lactate dehydrogenase
14804-9,Lactate dehydrogenase
14805-6,Lactate dehydrogenase
14806-4,Lactose.PO
14807-2,Lead
14808-0,Lead
14809-8,Lead
14810-6,Leukocytes
1481-1,Galactose^2H post 40 g galactose PO
14811-4,Leukocytes
14812-2,Lidocaine
14813-0,Lipoprotein.alpha
14814-8,Lipoprotein.beta
14815-5,Lipoprotein.beta
14816-3,Lipoprotein.pre-beta
14817-1,LORazepam
14818-9,Lymphocytes/100 leukocytes
14819-7,Lymphocytes/100 leukocytes
14820-5,Lymphocytes/100 leukocytes
14821-3,Lymphocytes/100 leukocytes
14822-1,Lymphocytes/100 leukocytes
14823-9,Macrophages/100 leukocytes
14824-7,Magnesium
14825-4,Maprotiline
14826-2,Meperidine
14827-0,Mesoporphyrin
14828-8,Mesothelial cells/100 leukocytes
1482-9,Galactose^30M post 40 g galactose PO
14829-6,Mesothelial cells/100 leukocytes
14830-4,Mesothelial cells/100 leukocytes
14831-2,Metanephrine/Creatinine
14832-0,Metanephrines
14833-8,Metanephrines
14834-6,Methamphetamine
14835-3,Methanol
14836-1,Methotrexate
1483-7,Galactose^post 40 g dose PO
14837-9,Methsuximide
14838-7,Toxoplasma gondii
14839-5,Trypanosoma sp identified
14840-3,Trypanosoma sp identified
14841-1,Microscopic observation
14842-9,Microscopic observation
14843-7,6-Monoacetylmorphine
14844-5,6-Monoacetylmorphine
1484-5,Gastrin^10M post 0.2 U/kg secretin
14845-2,6-Monoacetylmorphine
14846-0,N-acetylprocainamide
14847-8,Neutrophils/100 leukocytes
14848-6,Neutrophils/100 leukocytes
14849-4,Nitrazepam
14850-2,Nitrazepam
14851-0,Norclozapine
1485-2,Gastrin^15M post 0.2 U/kg secretin
14852-8,Norepinephrine
14853-6,Norepinephrine
14854-4,Norepinephrine
14855-1,Norfluoxetine
14856-9,Nortriptyline
14857-7,Leukocytes other/100 leukocytes
14858-5,Leukocytes other/100 leukocytes
14859-3,Leukocytes other/100 leukocytes
1486-0,Gastrin^20M post 0.2 U/kg secretin
14860-1,Leukocytes other/100 leukocytes
14861-9,Oxalate
14862-7,Oxalate
14863-5,oxyCODONE
14864-3,Oxygen
14865-0,Parathyrin
14866-8,Parathyrin.intact
14867-6,PARoxetine
14868-4,Pathologist report
14869-2,Pathologist review
148-7,Cephalexin
14870-0,Pentacarboxylate
14871-8,Pentacarboxylate
14872-6,Pentacarboxylate
14873-4,pH
14874-2,PHENobarbital
14875-9,Phenylalanine
14876-7,Phenylpropanolamine
14877-5,Phenytoin
1487-8,Gastrin^25M post 0.2 U/kg secretin
14878-3,Phosphate
14879-1,Phosphate
14880-9,Phosphate
14881-7,Phosphate
14882-5,Porphobilinogen
14883-3,Porphyrins
14884-1,Porphyrins
14885-8,Pregnanediol
1488-6,Gastrin^30M post 0.2 U/kg secretin
14886-6,Pregnanetriol
14887-4,Primidone
14888-2,Procainamide
14889-0,Procainamide+N-acetylprocainamide
14890-8,Progesterone
14891-6,Propranolol
14892-4,Propranolol
14893-2,Propranolol
1489-4,Gastrin^5M post 0.2 U/kg secretin
14894-0,Propylene glycol
14895-7,Protein pattern
14896-5,Protein pattern
14897-3,Protein
14898-1,Protriptyline
14899-9,quiNIDine
14900-5,raNITIdine
14901-3,raNITIdine
1490-2,Gastrin^pre 0.2 U/kg secretin
14902-1,raNITIdine
14903-9,Folate
14904-7,Reagin Ab
14905-4,Retinol
14906-2,Rh
14907-0,Rh
14908-8,Rh
14909-6,Salicylates
1491-0,Glucose^30M post 100 g glucose PO
14910-4,Serotonin
14911-2,Sertraline
14912-0,Smudge cells/100 leukocytes
14913-8,Testosterone
14914-6,Testosterone.free
14915-3,Theophylline
14916-1,Thiocyanate
14917-9,Thioridazine
14918-7,Thyroglobulin
14919-5,Thyrotropin binding inhibitory immunoglobulins
14920-3,Thyroxine.free
14921-1,Thyroxine
14922-9,Toxoplasma gondii Ab.IgA+IgE
14923-7,Toxoplasma gondii Ab
14924-5,Transfusion reaction
14925-2,traZODone
14926-0,Triazolam
14927-8,Triglyceride
1492-8,Glucose^1.5H post 0.5 g/kg glucose IV
14928-6,Triiodothyronine.free
14929-4,Triiodothyronine.reverse
14930-2,Triiodothyronine
14931-0,Trimipramine
14932-8,Urate
14933-6,Urate
14934-4,Urate
14935-1,Urate
1493-6,Glucose^1.5H post 0.05-0.15 U insulin/kg IV post 12H CFst
14936-9,Urea nitrogen
14937-7,Urea nitrogen
14938-5,Urea nitrogen
14939-3,Urea nitrogen
14940-1,Uroporphyrin 1 isomer
14941-9,Uroporphyrin 1 isomer
14942-7,Uroporphyrin 1 isomer
14943-5,Uroporphyrin 3 isomer
1494-4,Glucose^1.5H post 100 g glucose PO
14944-3,Uroporphyrin 3 isomer
14945-0,Uroporphyrin 3 isomer
14946-8,Valproate
14947-6,Vanillylmandelate
14948-4,Vanillylmandelate/Creatinine
14949-2,Vasopressin
149-5,Cephalexin
14950-0,Viscosity
1495-1,Glucose^1.5H post 100 g glucose PO
14951-8,Volatile drugs positive
14952-6,Xylose^1H post 25 g xylose PO
14953-4,Xylose^2H post 25 g xylose PO
14954-2,Xylose^post dose PO
14955-9,Zinc
14956-7,Albumin
14957-5,Albumin
14958-3,Albumin/Creatinine
14959-1,Albumin/Creatinine
14960-9,Estradiol.free/Estradiol.total
14961-7,Abnormal blood cells.CD10/Abnormal blood cells.total
14962-5,Abnormal blood cells.CD13/Abnormal blood cells.total
14963-3,Abnormal blood cells.CD14/Abnormal blood cells.total
14964-1,Abnormal blood cells.CD19/Abnormal blood cells.total
14965-8,Abnormal blood cells.CD2/Abnormal blood cells.total
14966-6,Abnormal blood cells.CD20/Abnormal blood cells.total
14967-4,Abnormal blood cells.CD33/Abnormal blood cells.total
14968-2,Abnormal blood cells.CD5/Abnormal blood cells.total
1496-9,Glucose^1.5H post 75 g glucose PO
14969-0,Abnormal blood cells.CD7/Abnormal blood cells.total
14970-8,Estrone.bioavailable
14971-6,Estrone.bioavailable/Estrone.total
14972-4,Mycobacterium sp DNA
14973-2,Mycobacterium sp DNA
14974-0,Mycobacterium sp DNA
14975-7,Human antimouse Ab
14976-5,Lecithin/Sphingomyelin
1497-7,Glucose^1.5H post dose insulin IV
14977-3,Immunoglobulin light chains.free
14978-1,cycloSPORINE
14979-9,Coagulation surface induced
14980-7,A variant subtype Ab
14981-5,A variant subtype Ab
14982-3,A variant subtype Ab
14983-1,I (int) subtype
14984-9,I (int) subtype
1498-5,Glucose^10M post 0.5 g/kg glucose IV
14985-6,I (int) subtype
14986-4,little i-1 subtype
14987-2,little i-1 subtype
14988-0,little i-1 subtype
14989-8,little i-2 subtype
14990-6,little i-2 subtype
14991-4,little i-2 subtype
14992-2,O group
1499-3,Glucose^1H post 0.5 g/kg glucose IV
14993-0,O group
14994-8,O group
14995-5,Glucose^2H post 75 g glucose PO
14996-3,Glucose^pre 75 g glucose PO
14997-1,Thyrotropin^30M post dose TRH IV
14998-9,Thyrotropin^1H post dose TRH IV
14999-7,Thyrotropin^baseline
15000-3,Thyrotropin^pre dose TRH IV
15001-1,Xylose^1H post 25 g xylose PO
15002-9,Xylose^2H post 25 g xylose PO
15003-7,11-Hydroxyandrosterone
15004-5,11-Hydroxyetiocholanolone
15005-2,11-Ketoandrosterone
15006-0,11-Ketoetiocholanolone
15007-8,"2,3-Diphosphoglycerate"
1500-8,Glucose^1H post 0.05-0.15 U insulin/kg IV post 12H CFst
15008-6,3-Alpha-Androstanediol glucuronide
15009-4,5-Hydroxyindoleacetate
15010-2,Aldosterone
15011-0,Aldosterone^supine
15012-8,Aldosterone^upright
15013-6,Alkaline phosphatase.bone/Alkaline phosphatase.total
15014-4,Alkaline phosphatase.intestinal/Alkaline phosphatase.total
15015-1,Alkaline phosphatase.liver/Alkaline phosphatase.total
1501-6,Glucose^1H post 100 g glucose PO
15016-9,Alkaline phosphatase.placental/Alkaline phosphatase.total
15017-7,Alkaline phosphatase.regan/Alkaline phosphatase.total
15018-5,Alkaline phosphatase.renal/Alkaline phosphatase.total
15019-3,Alpha-1-Fetoprotein
15020-1,Amylase.P1/Amylase.total
15021-9,Amylase.P2/Amylase.total
15022-7,Amylase.P3/Amylase.total
15023-5,Amylase.S1/Amylase.total
1502-4,Glucose^1H post 100 g glucose PO
15024-3,Amylase.S2/Amylase.total
15025-0,Amylase.S3/Amylase.total
15026-8,Androstanediol
15027-6,Androstenedione
15028-4,Androstenedione
15029-2,Androsterone
150-3,Cephalexin
15030-0,Androsterone
15031-8,Angiotensin I
1503-2,Glucose^1H post 100 g glucose PO
15032-6,Angiotensin II
15033-4,Ascorbate
15034-2,Bromide
15035-9,Calcitonin
15036-7,Catecholamines
15037-5,Chymotrypsin
15038-3,Citrate
15039-1,Cobalamin
1504-0,Glucose^1H post 50 g glucose PO
15040-9,Coproporphyrin
15041-7,Coproporphyrin
15042-5,Corticotropin
15043-3,Cortisol
15044-1,Cortisol.free
15045-8,Creatine
15046-6,Creatine
15047-4,Creatine
15048-2,Creatine kinase.BB/Creatine kinase.total
15049-0,Creatine kinase.MM/Creatine kinase.total
15050-8,Creatinine
15051-6,Creatinine
15052-4,Cobalamins.unsaturated binding capacity
15053-2,Dehydroepiandrosterone sulfate
15054-0,Dehydroepiandrosterone
15055-7,Deoxypyridinoline
15056-5,Deoxypyridinoline
1505-7,Glucose^1H post 50 g glucose PO
15057-3,Androstanolone
15058-1,DOPamine
15059-9,DOPamine
15060-7,Enolase.neuron specific
15061-5,Erythropoietin
15062-3,Estradiol.unconjugated
15063-1,Estriol.conjugated
15064-9,Estriol.unconjugated
1506-5,Glucose^1H post 50 g lactose PO
15065-6,Etiocholanolone
15066-4,Fatty acids.nonesterified
15067-2,Follitropin
15068-0,Follitropin
15069-8,Fructosamine
15070-6,Fructose
15071-4,Galactose
15072-2,Gastrin
1507-3,Glucose^1H post 75 g glucose PO
15073-0,Glucagon
15074-8,Glucose
15075-5,Glucose
15076-3,Glucose
15077-1,Glucose
15078-9,Lactate
15079-7,Lutropin
15080-5,Lutropin
1508-1,Glucose^1H post 75 g glucose PO
15081-3,Prolactin
15082-1,Methemoglobin
15083-9,Normetanephrine
15084-7,Osteocalcin
15085-4,Oxalate
15086-2,Oxalate
15087-0,Parathyrin related protein
15088-8,Parathyrin.C-terminal
15089-6,Phospholipid
15090-4,Porphyrins
15091-2,Pregnanediol
15092-0,Pregnanetriol
15093-8,Protoporphyrin.free
15094-6,Testosterone
15095-3,Testosterone
15096-1,Uroporphyrin
15097-9,Vanillylmandelate
15098-7,Amikacin^random
1509-9,Glucose^1H post 75 g glucose PO
15099-5,Amiodarone
15100-1,Barbiturates
15101-9,Chloramphenicol
15102-7,Codeine
15103-5,cycloSPORINE
15104-3,Digitoxin
15105-0,Flecainide
15106-8,Gentamicin^random
1510-7,Glucose^1H post dose insulin IV
15107-6,Imipramine
15108-4,Methadone
15109-2,Midazolam
151-1,Cephalexin
15110-0,Morphine
15111-8,Tricyclic antidepressants
15112-6,Phosphatase.leukocyte
15113-4,Aluminum
15114-2,Arsenic
1511-5,Glucose^1H post dose U/kg insulin IV
15115-9,Arsenic
15116-7,Arsenic
15117-5,Cadmium
15118-3,Chromium
15119-1,Cobalt
15120-9,Ethanol
15121-7,Lipoprotein.alpha/Lipoprotein.total
15122-5,Lipoprotein.beta/Lipoprotein.total
1512-3,Glucose^1M post 0.5 g/kg glucose IV
15123-3,Lipoprotein.pre-beta/Lipoprotein.total
15124-1,Albumin/Protein.total
15125-8,Alpha 1 globulin/Protein.total
15126-6,Alpha 2 globulin/Protein.total
15127-4,Beta globulin/Protein.total
15128-2,Gamma globulin/Protein.total
15129-0,Fibrin D-dimer
15130-8,Methionine+Tryptophan
1513-1,Glucose^20M post 0.5 g/kg glucose IV
15131-6,Isoleucine+Leucine
15132-4,Beta aminoisobutyrate+Proline
15133-2,Anserine+Carnosine+Cysteine+Histidine+Ornithine
15134-0,Glutamate+Glutamine+Threonine
15135-7,Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline
15136-5,Arginine+Argininosuccinate+Lysine+Serine+Taurine
15137-3,Alanine+Ethanolamine
15138-1,Isoleucine+Leucine
15139-9,Anserine+Carnosine+Cysteine+Histidine+Ornithine
15140-7,Arginine+Argininosuccinate+Lysine+Serine+Taurine
15141-5,Beta aminoisobutyrate+Proline
15142-3,Alanine+Ethanolamine
15143-1,Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline
15144-9,Glutamate+Glutamine+Threonine
15145-6,Methionine+Tryptophan
15146-4,Acetone
15147-2,Acetone
15148-0,Alkaline phosphatase
1514-9,Glucose^2H post 100 g glucose PO
15149-8,Ammonia
15150-6,Anisocytosis
15151-4,Aspergillus fumigatus 3 Ab
15152-2,Bilirubin.glucuronidated
15153-0,Bilirubin.non-glucuronidated
15154-8,Blasts
15155-5,Calcium
1515-6,Glucose^2H post 100 g glucose PO
15156-3,Cancer Ag 125
15157-1,Cancer Ag 125
15158-9,Chloride
15159-7,Coagulation factor.extrinsic pathway
15160-5,Coagulation factor.intrinsic factor
15161-3,Complement C1 esterase inhibitor.functional
15162-1,Complement C1q
15163-9,Complement C2
1516-4,Glucose^2H post 100 g glucose PO
15164-7,Complement C3
15165-4,Complement C4
15166-2,Complement C5
15167-0,Complement C6
15168-8,Complement total hemolytic C50
15169-6,Complement total hemolytic C50
15170-4,Complement total hemolytic C50
15171-2,Cryoglobulin.IgA
1517-2,Glucose^2H post 50 g lactose PO
15172-0,Cryoglobulin.IgG
15173-8,Cryoglobulin.IgM
15174-6,Cryoglobulin/Serum.total
15175-3,Cryoproteins
15176-1,Cryoproteins identified
15177-9,DNA double strand Ab
15178-7,Complement factor B
15179-5,Fibrin D-dimer
1518-0,Glucose^2H post 75 g glucose PO
15180-3,Hypochromia
15181-1,IgA
15182-9,IgA
15183-7,IgG
15184-5,IgG
15185-2,IgM
15186-0,IgM
15187-8,Immunoglobulin light chains.lambda
15188-6,Immunoglobulin light chains.kappa
15189-4,Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda
15190-2,Leukocytes other
15191-0,Lupus anticoagulant neutralization.dilute phospholipid
15192-8,Lymphocytes.variant
15193-6,Cells.CD3-CD16+
15194-4,Cells.CD3-CD16+/100 cells
15195-1,Cells.CD3-CD19+
15196-9,Cells.CD3-CD19+/100 cells
15197-7,Lymphocytes.clefted/100 leukocytes
1519-8,Glucose^2H post 75 g glucose PO
15198-5,Macrocytes
15199-3,Microcytes
15200-9,Osmolality
15201-7,Platelets.large fragments
15202-5,Potassium
15203-3,Rheumatoid factor
15204-1,Rheumatoid factor
15205-8,Rheumatoid factor
1520-6,Glucose^2H post 75 g glucose PO
15206-6,Rheumatoid factor
15207-4,Sodium
15208-2,Taurine
15209-0,Saccharomonospora viridis Ab
15210-8,Thyroglobulin Ab
15211-6,Biopsy
15212-4,Triacylglycerol lipase
15213-2,(Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) Ab.IgE
1521-4,Glucose^2H post meal
15214-0,(Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) Ab.IgE
15215-7,(Chicken feather+Duck feather+Goose feather+Turkey feather) Ab.IgE
15216-5,(Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) Ab.IgE
15217-3,(Arachis hypogaea+Bertholletia excelsa+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE
15218-1,(Gadus morhua+Mytilus edulis+Pandalus borealis+Salmo salar+Thunnus albacares) Ab.IgE
15219-9,(Avena sativa+Fagopyrum esculentum+Sesamum indicum+Triticum aestivum+Zea mays) Ab.IgE
15220-7,(Arachis hypogaea+Cow milk+Egg white+Glycine max+Triticum aestivum) Ab.IgE
15221-5,(Fagopyrum esculentum+Glycine max+Oryza sativa+Sesamum indicum+Triticum aestivum) Ab.IgE
1522-2,Glucose^30M post 0.5 g/kg glucose IV
15222-3,(Cancer pagurus+Fagopyrum esculentum+Pandalus borealis+Sesamum indicum+Zea mays) Ab.IgE
15223-1,(Artemisia dracunculus+Levisticum officinale+Origanum majorana) Ab.IgE
15224-9,(Carum carvi+Elettaria cardamomum+Mace+Syzygium aromaticum) Ab.IgE
15225-6,(Foeniculum vulgare seed+Ocimum basilicum+Pimpinella anisum+Zingiber officinale) Ab.IgE
15226-4,(Beef+Chicken meat+Pork+Pleuronectes platessa) Ab.IgE
15227-2,(Clupea harengus+Gadus morhua+Pleuronectes platessa+Scomber scombrus) Ab.IgE
15228-0,(Anthoxanthum odoratum+Holcus lanatus+Lolium perenne+Phragmites communis+Secale cereale) Ab.IgE
15229-8,(Anthoxanthum odoratum+Lolium perenne+Phleum pratense+Secale cereale+Holcus lanatus) Ab.IgE
1523-0,Glucose^30M post 0.05-0.15 U insulin/kg IV post 12H CFst
15230-6,(Bromus inermis+Cynodon dactylon+Holcus lanatus+Paspalum notatum+Phleum pratense+Sorghum halepense) Ab.IgE
15231-4,(Blatella germanica+Dermatophagoides farinae+Dermatophagoides pteronyssinus+House dust Greer) Ab.IgE
15232-2,(Ambrosia elatior+Artemisia vulgaris+Cryptomeria japonica+Dactylis glomerata+Phleum pratense) Ab.IgE
15233-0,(Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Penicillium notatum) Ab.IgE
15234-8,(Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) Ab.IgE
15235-5,(Chicken feather+Cow dander+Goose feather+Horse dander) Ab.IgE
15236-3,(Acarus siro+Lepidoglyphus destructor+Gasterophilus intestinalis+Sitophilus granarius) Ab.IgE
15237-1,(Alternaria alternata+Aspergillus fumigatus+Rye pollen+Wheat pollen) Ab.IgE
15238-9,(Amylase+Glycine max+Sitophilus granarius+Triticum sativum) Ab.IgE
15239-7,(Hexamethylene diisocyanate (HDI)+Diphenylmethane diisocyanate (MDI)+Toluene diisocyanate (TDI)+Phthalic anhydride) Ab.IgE
15240-5,(Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) Ab.IgE
15241-3,(Beef+Chicken meat+Egg yolk+Pork+Turkey meat) Ab.IgE
15242-1,(Brassica oleracea var italica+Daucus carota+Phaseolus vulgaris+Pisum sativum+Zea mays) Ab.IgE
15243-9,(Agaricus hortensis+Cucurbita pepo+Oryza sativa+Secale cereale+Solanum tuberosum) Ab.IgE
15244-7,(Daucus carota+Phaseolus vulgaris+Pisum sativum+Solanum tuberosum) Ab.IgE
15245-4,(Brassica oleracea var capitata+Capsicum annuum+Lycopersicon lycopersicum+Spinacia oleracea) Ab.IgE
15246-2,(Citrus sinensis+Malus sylvestris+Musa spp+Prunus persica) Ab.IgE
15247-0,(Ananas comosus+Citrus limon+Fragaria vesca+Persea americana) Ab.IgE
1524-8,Glucose^30M post 0.1 U/kg insulin
15248-8,(Arachis hypogaea+Glycine max+Pisum sativum) Ab.IgE
15249-6,(Cucumis sativus+Daucus carota+Solanum tuberosum+Spinacia oleracea) Ab.IgE
15250-4,(Hordeum vulgare+Oryza sativa+Secale cereale+Triticum aestivum) Ab.IgE
15251-2,(Actinidia chinensis+Ananas comosus+Cucumis melo+Musa spp+Prunus persica) Ab.IgE
15252-0,(Anacardium occidentale+Carya illinoinensis+Juglans spp+Pistacia vera) Ab.IgE
15253-8,(Allium cepa+Allium sativum+Apium graveolens+Lycopersicon lycopersicum+Yeast) Ab.IgE
15254-6,(Bertholletia excelsa+Citrus sinensis+Corylus avellana+Malus sylvestris+Theobroma cacao) Ab.IgE
1525-5,Glucose^30M post 100 g glucose PO
15255-3,(Actinidia chinensis+Cucumis melo+Musa spp+Prunus dulcis+Vitis vinifera) Ab.IgE
15256-1,(Artemisia vulgaris+Betula verrucosa+Parietaria judaica+phleum pratense+Plantago lanceolata) Ab.IgE
15257-9,(Alternaria alternata+Cat dander+Dermatophagoides farinae+Dog dander+Horse dander) Ab.IgE
15258-7,(Ambrosia elatior+Chenopodium album+Cynodon dactylon+Lolium perenne+Paspalum notatum) Ab.IgE
15259-5,(Cynodon dactylon+Lolium perenne+Bromus inermis+Ambrosia elatior+Artemisia vulgaris+Plantago lanceolata) Ab.IgE
15260-3,(Alnus incana+Betula verrucosa+Corylus avellana+Fraxinus americana) Ab.IgE
15261-1,(Ambrosia elatior+Ambrosia psilostachya+Ambrosia trifida) Ab.IgE
15262-9,(Acer negundo+Betula verrucosa+Quercus alba+Ulmus americana+Juglans californica) Ab.IgE
1526-3,Glucose^30M post 50 g lactose PO
15263-7,(Cottonwood+Elm+Maple+Oak+Pecan tree) Ab.IgE
15264-5,(Juniperus sabinoides+Quercus alba+Ulmus americana+Populus deltoides+Prosopis juliflora) Ab.IgE
15265-2,(Platanus occidentalis+Populus deltoides+Quercus alba+Salix caprea+Ulmus americana) Ab.IgE
15266-0,(Alnus incana+Corylus avellana+Ulmus americana+Salix caprea+Populus deltoides) Ab.IgE
15267-8,(Acer negundo+Betula verrucosa+Fagus grandifolia+Quercus alba+Juglans californica) Ab.IgE
15268-6,(Olea europaea+Salix caprea+Pinus strobus+Eucalyptus spp+Acacia longifolia+Melaleuca leucadendron) Ab.IgE
15269-4,(Alnus incana+Betula verrucosa+Corylus avellana+Quercus alba+Salix caprea) Ab.IgE
15270-2,(Acer negundo+Betula verrucosa+Corylus avellana+Quercus alba+Platanus acerifolia) Ab.IgE
1527-1,Glucose^30M post 75 g glucose PO
15271-0,(Ambrosia elatior+Artemisia vulgaris+Chenopodium album+Plantago lanceolata+Salsola kali) Ab.IgE
15272-8,(Ambrosia psilostachya+Artemisia vulgaris+Atriplex lentiformis+Chenopodium album+Plantago lanceolata) Ab.IgE
15273-6,(Artemisia vulgaris+Chenopodium album+Plantago lanceolata+Solidago virgaurea+Urtica dioica) Ab.IgE
15274-4,(Ambrosia elatior+Artemisia vulgaris+Chrysanthemum leucathemum+Taraxacum vulgare+Solidago virgaurea) Ab.IgE
15275-1,(Plantago lanceolata+Chenopodium album+Salsola kali+Rumex acetosella) Ab.IgE
15276-9,(Chrysanthemum leucanthemum+Taraxacum vulgare+Plantago lanceolata+Chenopodium album+Solidago virgaurea) Ab.IgE
15277-7,Turkey feather Ab.IgE
15278-5,Levisticum officinale Ab.IgE
15279-3,Elettaria cardamomum Ab.IgE
15280-1,Mace Ab.IgE
15281-9,Gasterophilus intestinalis Ab.IgE
15282-7,Secale cereale pollen Ab.IgE
15283-5,Betula verrucosa Ab.IgE
15284-3,Alnus incana Ab.IgE
15285-0,Platanus acerifolia Ab.IgE
15286-8,Height
15287-6,Width
15288-4,Length
1528-9,Glucose^30M post dose insulin IV
15289-2,Height
152-9,Cephaloglycin
15290-0,Width
15291-8,Length
15292-6,Height
15293-4,Width
15294-2,Length
15295-9,Height
15296-7,Width
1529-7,Glucose^30M post dose U/kg insulin IV
15297-5,Length
15298-3,Height
15299-1,Width
15300-7,Length
15301-5,Height
15302-3,Width
15303-1,Length
15304-9,Volume
1530-5,Glucose^3H post 100 g glucose PO
15305-6,Volume
15306-4,Volume
15307-2,Volume
15308-0,Volume
15309-8,Volume
15310-6,Volume
15311-4,Volume
15312-2,Volume
1531-3,Glucose^3H post 100 g glucose PO
15313-0,Volume
15314-8,Volume
15315-5,Volume
15316-3,Stepsize
15317-1,Volume
15318-9,Volume
15319-7,Volume
15320-5,Volume
1532-1,Glucose^3H post 100 g glucose PO
15321-3,Volume
15323-9,Prostate specific Ag/Prostate volume
15324-7,Prostate specific Ag/Prostate volume
15325-4,Prostate specific Ag/Prostate volume
15326-2,Volume
15327-0,Volume
15328-8,Blood flow.systolic.max^baseline
15329-6,Blood flow.systolic.max^post XXX challenge
15330-4,Blood flow.diastolic.end^baseline
15331-2,Blood flow.diastolic.end^post XXX challenge
15332-0,Resistance.index^baseline
15333-8,Resistance.index^post XXX challenge
15334-6,Challenge
15335-3,Pulsativity.index
15336-1,Antibiotic XXX
15337-9,Antibiotic XXX^peak
15338-7,Antibiotic XXX^trough
1533-9,Glucose^3H post 75 g glucose PO
15339-5,Trogoderma angustum Ab.IgE
15340-3,Cedar italian Ab.IgE
15341-1,Simulium venustum Ab.IgE
15342-9,Vespa crabro Ab.IgE
15343-7,Blood group antibody screen
15344-5,little i Ab
15345-2,Aldosterone^1H post XXX challenge
15346-0,Aldosterone^30M post XXX challenge
1534-7,Glucose^3M post 0.5 g/kg glucose IV
15347-8,Somatotropin^30M post XXX challenge
15348-6,Alkaline phosphatase.liver 1/Alkaline phosphatase.total
15349-4,Alkaline phosphatase.liver 2/Alkaline phosphatase.total
15350-2,Amylase
15351-0,Apolipoprotein E2
15352-8,Apolipoprotein E3
15353-6,Apolipoprotein E4
1535-4,Glucose^40M post 0.5 g/kg glucose IV
15354-4,Bombesin Ag
15355-1,Estrone sulfate
15356-9,Globulin
15357-7,Iron
15358-5,Macroamylase
15359-3,Coagulation dilute Russell viper venom induced actual/Normal
15360-1,Coagulation dilute Russell viper venom induced actual/Normal
15361-9,Coagulation surface induced.factor substitution^immediately after 1:4 addition of normal plasma
1536-2,Glucose^45M post dose insulin IV
15362-7,Coagulation surface induced.inhibitor sensitive
15363-5,Busulfan
15364-3,Codeine
15365-0,Codeine
15366-8,Dextroamphetamine
15367-6,Ganciclovir
15368-4,Hypoglycemics.sulfonyluric
15369-2,Lithium.saliva/Lithium.serum
153-7,Cephaloglycin
1537-0,Glucose^4H post 100 g glucose PO
15370-0,Morphine
15371-8,Morphine
15372-6,Nordiazepam
15373-4,Phenyltoloxamine
15374-2,Sulfonylurea
15375-9,Valproate.free
15376-7,Spermatozoa.abnormal/100 spermatozoa
15377-5,Cytomegalovirus Ab
15378-3,Fungus identified
15379-1,Haemophilus influenzae B Ag
15380-9,Leishmania braziliensis Ab.IgG
15381-7,Leishmania braziliensis Ab.IgM
15382-5,Leishmania donovani Ab.IgG
15383-3,Leishmania donovani Ab.IgM
15384-1,Leishmania mexicana Ab.IgG
15385-8,Leishmania mexicana Ab.IgM
15386-6,Leishmania tropica Ab.IgG
15387-4,Leishmania tropica Ab.IgM
1538-8,Glucose^4H post 100 g glucose PO
15388-2,Mycoplasma hominis
15389-0,Parainfluenza virus 1 Ab.IgG
15390-8,Parainfluenza virus 1 Ab.IgM
15391-6,Parainfluenza virus 1 Ab.IgM
15392-4,Parainfluenza virus 2 Ab.IgG
15393-2,Parainfluenza virus 2 Ab.IgM
15394-0,Parainfluenza virus 3 Ab.IgG
15395-7,Parainfluenza virus 3 Ab.IgM
1539-6,Glucose^4H post 75 g glucose PO
15396-5,Toxoplasma sp Ab.IgG
15397-3,Trypanosoma cruzi Ab.IgM
15398-1,Neuronal nuclear Ab
15399-9,Neuronal nuclear Ab.IgG
15400-5,Platelet Ab.IgG
15401-3,Drugs identified
15402-1,Ethanol
15403-9,Isopropanol
1540-4,Glucose^5H post 100 g glucose PO
15404-7,Levomethamphetamine/Amphetamines.total
15405-4,Methamphetamine
15406-2,Methamphetamine
15407-0,Methanol
15408-8,Thallium
15409-6,Thallium
15410-4,Varicella zoster virus Ab.IgG
15411-2,Ergosterol
1541-2,Glucose^5H post 100 g glucose PO
15412-0,Service comment 21
15413-8,Service comment 22
15414-6,Service comment 23
15415-3,Service comment 24
15416-1,Service comment 25
15417-9,Service comment 26
15418-7,Service comment 27
15419-5,Service comment 28
1542-0,Glucose^5H post 75 g glucose PO
15420-3,Service comment 29
15421-1,Service comment 30
15422-9,Service comment 31
15423-7,Service comment 32
15424-5,Service comment 33
15425-2,Service comment 34
15426-0,Service comment 35
15427-8,Service comment 36
15428-6,Service comment 37
15429-4,Service comment 38
15430-2,Service comment 39
15431-0,Service comment 40
15432-8,Testosterone.free/Testosterone.total
15433-6,Anaplasma marginale Ab
15434-4,Avian adenovirus Ab
15435-1,Avian adenovirus 2 Ab
15436-9,Avian encephalomyelitis virus Ab
15437-7,Avian encephalomyelitis virus Ab
1543-8,Glucose^5M post 0.5 g/kg glucose IV
15438-5,Avian hemorrhagic enteritis virus Ab
15439-3,Infectious bronchitis virus Ark-99 Ab
15440-1,Infectious bronchitis virus Mass-41 Ab
15441-9,Infectious bronchitis virus Conn-42 Ab
15442-7,Avian infectious laryngotracheitis virus Ab
15443-5,Avian infectious laryngotracheitis virus Ab
15444-3,Influenza virus A Ab
15445-0,Avian leukosis virus Ag
1544-6,Glucose^6H post 100 g glucose PO
15446-8,Avian leukosis virus Ag
15447-6,Avian paramyxovirus 1 Ab
15448-4,Avian paramyxovirus 1 Ab
15449-2,Avian paramyxovirus 2 Ab
154-5,Cephaloglycin
15450-0,Avian paramyxovirus 3 Ab
15451-8,Avian pox virus Ab
15452-6,Avian reovirus Ab
1545-3,Glucose^6H post 100 g glucose PO
15453-4,Avian reovirus Ab
15454-2,Reticuloendotheliosis virus Ab
15455-9,Bluetongue virus Ab
15456-7,Bluetongue virus Ab
15457-5,Bordetella avium Ab
15458-3,Bordetella avium Ab
15459-1,Bovine herpesvirus 1 Ab.Neut
15460-9,Bovine leukemia virus Ab
1546-1,Glucose^6H post 100 g glucose PO
15461-7,Bovine leukemia virus Ab
15462-5,Bovine diarrhea virus 1 Ab.Neut
15463-3,Bovine diarrhea virus 2 Ab.Neut
15464-1,Caprine arthritis encephalitis virus Ab
15465-8,Caprine arthritis encephalitis virus Ab
15466-6,Epizootic hemorrhagic disease virus Ab
15467-4,Equine herpesvirus 1 Ab.Neut
15468-2,Equine infectious anemia virus Ab
15469-0,Equine influenza virus A1 Ab
15470-8,Equine influenza virus A2 Ab
15471-6,Equine influenza virus A2 Ab
15472-4,Equine influenza virus Ag
15473-2,Equine arteritis virus Ab.Neut
15474-0,Infectious bursal disease virus Ab
15475-7,Infectious bursal disease virus Ab
15476-5,Leptospira interrogans serovar Bratislava Ab
15477-3,Leptospira interrogans serovar Canicola Ab
15478-1,Leptospira interrogans serovar Grippotyphosa Ab
1547-9,Glucose^baseline
15479-9,Leptospira interrogans serovar Hardjo Ab
15480-7,Leptospira interrogans serovar Icterohaemorrhagiae Ab
15481-5,Leptospira interrogans serovar Pomona Ab
15482-3,Mycobacterium avium subspecies paratuberculosis Ab
15483-1,Mycobacterium avium subspecies paratuberculosis Ab
15484-9,Mycoplasma gallisepticum Ab
15485-6,Mycoplasma gallisepticum Ab
15486-4,Mycoplasma gallisepticum rRNA
1548-7,Glucose^pre 0.5 g/kg glucose IV
15487-2,Mycoplasma meleagridis Ab
15488-0,Mycoplasma meleagridis Ab
15489-8,Mycoplasma synoviae Ab
15490-6,Mycoplasma synoviae Ab
15491-4,Mycoplasma synoviae rRNA
15492-2,Neospora caninum Ab
15493-0,Parainfluenza virus 3 Ab
15494-8,Pasteurella multocida Ab
1549-5,Glucose^pre 100 g glucose PO
15495-5,Porcine reproductive and respiratory syndrome virus Ab
15496-3,Porcine reproductive and respiratory syndrome virus Ab
15497-1,Pseudorabies virus Ab
15498-9,Pseudorabies virus Ab
15499-7,Pseudorabies virus Ab.Neut
15500-2,Pseudorabies virus.ClinEase gene deletion Ab
15501-0,Pseudorabies virus.HerdCheck gene deletion Ab
15502-8,Pseudorabies virus.OmniMark gene deletion Ab
1550-3,Glucose^pre 12H CFst
15503-6,Pseudorabies virus.Tolvid gene deletion Ab
15504-4,Salmonella arizonae Ab
15505-1,Salmonella pullorum Ab
15506-9,Salmonella typhimurium Ab
15507-7,Progress note
15508-5,Labor and delivery records
15509-3,Rationale for scheduled transport
15510-1,Distance transported
1551-1,Glucose^pre 50 g lactose PO
15511-9,Origination site information
15512-7,Destination site information
15513-5,Reason for scheduled trip
15514-3,Ordering practitioner ID
15515-0,Medical reason for transport
15516-8,Justification for extra attendants
15517-6,Transport direction
15518-4,Haliotis spp Ab.IgE.RAST class
15519-2,Acacia longifolia Ab.IgE.RAST class
155-2,Cephaloglycin
15520-0,Corticotropin Ab.IgE.RAST class
15521-8,Alnus rhombifolia Ab.IgE.RAST class
15522-6,Alder Ab.IgE.RAST class
15523-4,Alnus rugosa Ab.IgE.RAST class
15524-2,Medicago sativa Ab.IgE.RAST class
15525-9,Alkalase Ab.IgE.RAST class
15526-7,Pimenta dioica Ab.IgE.RAST class
15527-5,Prunus dulcis Ab.IgE.RAST class
15528-3,Prunus dulcis tree Ab.IgE.RAST class
1552-9,Glucose^pre 75 g glucose PO
15529-1,Lactalbumin alpha Ab.IgE.RAST class
15530-9,Alternaria alternata Ab.IgE.RAST class
15531-7,Alternaria alternata Ab.IgE.RAST class
15532-5,Amoxicillin Ab.IgE.RAST class
15533-3,Ampicillin Ab.IgE.RAST class
15534-1,Engraulis encrasicolus Ab.IgE.RAST class
15535-8,Anisakis Ab.IgE.RAST class
15536-6,Pimpinella anisum Ab.IgE.RAST class
1553-7,Glucose^pre dose insulin IV
15537-4,Solenopsis invicta Ab.IgE.RAST class
15538-2,Solenopsis invicta Ab.IgE.RAST class
15539-0,Malus sylvestris Ab.IgE.RAST class
15540-8,Malus sylvestris tree Ab.IgE.RAST class
15541-6,Prunus armeniaca Ab.IgE.RAST class
15542-4,Maranta arundinacea Ab.IgE.RAST class
15543-2,Cynara scolymus Ab.IgE.RAST class
15544-0,Ascaris sp Ab.IgE.RAST class
1554-5,Glucose^post 12H CFst
15545-7,Fraxinus velutina Ab.IgE.RAST class
15546-5,Fraxinus americana Ab.IgE.RAST class
15547-3,Asparagus officinalis Ab.IgE.RAST class
15548-1,Populus tremula Ab.IgE.RAST class
15549-9,Aspergillus fumigatus Ab.IgE.RAST class
15550-7,Aspergillus niger Ab.IgE.RAST class
15551-5,Persea americana Ab.IgE.RAST class
1555-2,Glucose^post 12H CFst
15552-3,Baccharis spp Ab.IgE.RAST class
15553-1,Phyllostachys pubescens Ab.IgE.RAST class
15554-9,Musa spp Ab.IgE.RAST class
15555-6,Hordeum vulgare Ab.IgE.RAST class
15556-4,Hordeum vulgare pollen Ab.IgE.RAST class
15557-2,Ocimum basilicum Ab.IgE.RAST class
15558-0,Micropterus salmoides Ab.IgE.RAST class
15559-8,Bassia hyssopifolia Ab.IgE.RAST class
1556-0,Glucose^post CFst
15560-6,Myrica spp Ab.IgE.RAST class
15561-4,Laurus nobilis Ab.IgE.RAST class
15562-2,Ricinus communis Ab.IgE.RAST class
15563-0,Coffee bean green Ab.IgE.RAST class
15564-8,Bean green Ab.IgE.RAST class
15565-5,Bean kidney red Ab.IgE.RAST class
15566-3,Phaseolus limensis Ab.IgE.RAST class
15567-1,Bean pinto Ab.IgE.RAST class
15568-9,Glycine max Ab.IgE.RAST class
15569-7,Bean white Ab.IgE.RAST class
15570-5,Apis mellifera Ab.IgE.RAST class
15571-3,Fagus grandifolia Ab.IgE.RAST class
15572-1,Beef Ab.IgE.RAST class
15573-9,Beet Ab.IgE.RAST class
15574-7,Beta vulgaris seed Ab.IgE.RAST class
15575-4,Trogoderma angustum Ab.IgE.RAST class
15576-2,Lactalbumin beta Ab.IgE.RAST class
15577-0,Beta lactoglobulin Ab.IgE.RAST class
1557-8,Glucose^post CFst
15578-8,Birch Ab.IgE.RAST class
15579-6,Betula verrucosa Ab.IgE.RAST class
15580-4,Rubus fruticosus Ab.IgE.RAST class
15581-2,Blomia tropicalis Ab.IgE.RAST class
15582-0,Chironomus thummi Ab.IgE.RAST class
15583-8,Vaccinium myrtillus Ab.IgE.RAST class
15584-6,Botrytis cinerea Ab.IgE.RAST class
15585-3,Acer negundo Ab.IgE.RAST class
1558-6,Glucose^post CFst
15586-1,Bertholletia excelsa Ab.IgE.RAST class
15587-9,Brassica oleracea var italica Ab.IgE.RAST class
15588-7,Bromelin Ab.IgE.RAST class
15589-5,Brassica oleracea var gemmifera Ab.IgE.RAST class
15590-3,Bovine serum albumin Ab.IgE.RAST class
15591-1,Fagopyrum esculentum Ab.IgE.RAST class
15592-9,Budgerigar feather Ab.IgE.RAST class
15593-7,Bombus terrestris Ab.IgE.RAST class
1559-4,Insulin^1.5H post dose TOLBUTamide IV
15594-5,Hymenoclea salsola Ab.IgE.RAST class
15595-2,Iva xanthifolia Ab.IgE.RAST class
15596-0,Brassica oleracea var capitata Ab.IgE.RAST class
15597-8,Theobroma cacao Ab.IgE.RAST class
15598-6,Canary feather Ab.IgE.RAST class
15599-4,Candida albicans Ab.IgE.RAST class
156-0,Cephaloridine
15600-0,Cucumis melo spp Ab.IgE.RAST class
15601-8,Averrhoa carambola Ab.IgE.RAST class
1560-2,Insulin^1H post dose TOLBUTamide IV
15602-6,Carum carvi Ab.IgE.RAST class
15603-4,Amaranthus palmeri Ab.IgE.RAST class
15604-2,Ceratonia siliqua Ab.IgE.RAST class
15605-9,Daucus carota Ab.IgE.RAST class
15606-7,Casein Ab.IgE.RAST class
15607-5,Anacardium occidentale Ab.IgE.RAST class
15608-3,Cat Ab.IgE.RAST class
15609-1,Cat dander Ab.IgE.RAST class
1561-0,Insulin^1H post 75 g glucose PO
15610-9,Cat epithelium Ab.IgE.RAST class
15611-7,Ictalurus punctatus Ab.IgE.RAST class
15612-5,Brassica oleracea var botrytis Ab.IgE.RAST class
15613-3,Cedar italian Ab.IgE.RAST class
15614-1,Cryptomeria japonica Ab.IgE.RAST class
15615-8,Juniperus sabinoides Ab.IgE.RAST class
15616-6,Juniperus virginiana Ab.IgE.RAST class
15617-4,Tamarix spp Ab.IgE.RAST class
15618-2,Apium graveolens Ab.IgE.RAST class
15619-0,Acremonium sp Ab.IgE.RAST class
15620-8,Chaetomium globosum Ab.IgE.RAST class
15621-6,Matricaria chamomilla Ab.IgE.RAST class
15622-4,Cheese American Ab.IgE.RAST class
15623-2,Cheese cheddar type Ab.IgE.RAST class
15624-0,Cheese cottage Ab.IgE.RAST class
15625-7,Cheese mozzarella Ab.IgE.RAST class
15626-5,Cheese parmesan Ab.IgE.RAST class
15627-3,Cheese swiss Ab.IgE.RAST class
1562-8,Insulin^2.5H post dose TOLBUTamide IV
15628-1,Prunus avium Ab.IgE.RAST class
15629-9,Castanea sativa Ab.IgE.RAST class
15630-7,Aesculus hippocastanum Ab.IgE.RAST class
15631-5,Castanea sativa Ab.IgE.RAST class
15632-3,Castanea sativa pollen Ab.IgE.RAST class
15633-1,Chicken feather Ab.IgE.RAST class
15634-9,Chicken meat Ab.IgE.RAST class
15635-6,Cichorium intybus Ab.IgE.RAST class
1563-6,Insulin^2H post dose TOLBUTamide IV
15636-4,Chinchilla Ab.IgE.RAST class
15637-2,Chloramin T Ab.IgE.RAST class
15638-0,Chortoglyphus arcuatus Ab.IgE.RAST class
15639-8,Chymofast Ab.IgE.RAST class
15640-6,Chymopapain Ab.IgE.RAST class
15641-4,Cinnamomum spp Ab.IgE.RAST class
15642-2,Cladosporium herbarum Ab.IgE.RAST class
15643-0,Ruditapes spp Ab.IgE.RAST class
1564-4,Insulin^2H post 75 g glucose PO
15644-8,Syzygium aromaticum Ab.IgE.RAST class
15645-5,Clover Ab.IgE.RAST class
15646-3,Xanthium commune Ab.IgE.RAST class
15647-1,Blatella germanica Ab.IgE.RAST class
15648-9,Theobroma cacao Ab.IgE.RAST class
15649-7,Cocos nucifera Ab.IgE.RAST class
15650-5,Gadus morhua Ab.IgE.RAST class
1565-1,Insulin^30M post dose TOLBUTamide IV
15651-3,Coffea spp Ab.IgE.RAST class
15652-1,Cola Ab.IgE.RAST class
15653-9,Zea mays Ab.IgE.RAST class
15654-7,Zea mays pollen Ab.IgE.RAST class
15655-4,Cotton cultivated Ab.IgE.RAST class
15656-2,Cotton fibers Ab.IgE.RAST class
15657-0,Cotton western Ab.IgE.RAST class
15658-8,Cottonseed Ab.IgE.RAST class
15659-6,Populus deltoides Ab.IgE.RAST class
15660-4,Populus fremontii Ab.IgE.RAST class
15661-2,Cow dander Ab.IgE.RAST class
15662-0,Cow epithelium Ab.IgE.RAST class
15663-8,Cancer pagurus Ab.IgE.RAST class
15664-6,Vaccinium oxycoccos Ab.IgE.RAST class
15665-3,Astacus astacus Ab.IgE.RAST class
15666-1,Cryptococcus terreus Ab.IgE.RAST class
15667-9,Cucumis sativus Ab.IgE.RAST class
15668-7,Curry Ab.IgE.RAST class
1566-9,Insulin^3H post dose TOLBUTamide IV
15669-5,Curvularia lunata Ab.IgE.RAST class
15670-3,Curvularia specifera Ab.IgE.RAST class
15671-1,Cupressus arizonica Ab.IgE.RAST class
15672-9,Taxodium distichum Ab.IgE.RAST class
15673-7,Cupressus sempervirens Ab.IgE.RAST class
15674-5,Bellis perennis Ab.IgE.RAST class
15675-2,Chrysanthemum leucanthemum Ab.IgE.RAST class
15676-0,Taraxacum vulgare Ab.IgE.RAST class
1567-7,Insulin^3H post 75 g glucose PO
15677-8,Daphnia Ab.IgE.RAST class
15678-6,Phoenix canariensis pollen Ab.IgE.RAST class
15679-4,Deer epithelium Ab.IgE.RAST class
15680-2,Dermatophagoides farinae Ab.IgE.RAST class
15681-0,Dermatophagoides microceras Ab.IgE.RAST class
15682-8,Dermatophagoides pteronyssinus Ab.IgE.RAST class
15683-6,Anethum graveolens Ab.IgE.RAST class
15684-4,Rumex crispus Ab.IgE.RAST class
1568-5,Insulin^4H post 75 g glucose PO
15685-1,Dog dander Ab.IgE.RAST class
15686-9,Dog epithelium Ab.IgE.RAST class
15687-7,Duck feather Ab.IgE.RAST class
15688-5,Echinococcus sp Ab.IgE.RAST class
15689-3,Egg white Ab.IgE.RAST class
15690-1,Egg whole Ab.IgE.RAST class
15691-9,Egg yolk Ab.IgE.RAST class
15692-7,Solanum melongena Ab.IgE.RAST class
1569-3,Insulin^5H post 75 g glucose PO
15693-5,Iva ciliata Ab.IgE.RAST class
15694-3,Sambucus nigra Ab.IgE.RAST class
15695-0,Sambucus nigra Ab.IgE.RAST class
15696-8,Elk meat Ab.IgE.RAST class
15697-6,Ulmus americana Ab.IgE.RAST class
15698-4,Ulmus pumila Ab.IgE.RAST class
15699-2,Cichorium endivia Ab.IgE.RAST class
15700-8,Epicoccum purpurascens Ab.IgE.RAST class
1570-1,Insulin^baseline
15701-6,Epidermophyton floccosum Ab.IgE.RAST class
15702-4,Ethylene oxide Ab.IgE.RAST class
15703-2,Eucalyptus spp Ab.IgE.RAST class
15704-0,Euroglyphus maynei Ab.IgE.RAST class
15705-7,Anthemis cotula Ab.IgE.RAST class
15706-5,Foeniculum vulgare fresh Ab.IgE.RAST class
15707-3,Foeniculum vulgare seed Ab.IgE.RAST class
15708-1,Ferret epithelium Ab.IgE.RAST class
15709-9,Festuca elatior Ab.IgE.RAST class
15710-7,Finch feather Ab.IgE.RAST class
15711-5,Pseudotsuga taxifolia Ab.IgE.RAST class
15712-3,Kochia scoparia Ab.IgE.RAST class
15713-1,Fiscus sp Ab.IgE.RAST class
15714-9,Ctenocephalides sp Ab.IgE.RAST class
15715-6,Flounder Ab.IgE.RAST class
15716-4,Simulium venustum Ab.IgE.RAST class
15717-2,Tabanus spp Ab.IgE.RAST class
15718-0,Formaldehyde Ab.IgE.RAST class
1571-9,Insulin^pre dose TOLBUTamide IV
15719-8,Fox Ab.IgE.RAST class
15720-6,Alopercurus pratensis Ab.IgE.RAST class
15721-4,Fusarium culmorum Ab.IgE.RAST class
15722-2,Fusarium moniliforme Ab.IgE.RAST class
15723-0,Fusarium solani Ab.IgE.RAST class
15724-8,Allium sativum Ab.IgE.RAST class
15725-5,Gelatin Ab.IgE.RAST class
15726-3,Geotrichum candidum Ab.IgE.RAST class
1572-7,Insulin^pre 75 g glucose PO
15727-1,Gerbil Ab.IgE.RAST class
15728-9,Zingiber officinale Ab.IgE.RAST class
15729-7,Gluten Ab.IgE.RAST class
15730-5,Glycyphagus domesticus Ab.IgE.RAST class
15731-3,Goat epithelium Ab.IgE.RAST class
15732-1,Goat milk Ab.IgE.RAST class
15733-9,Solidago virgaurea Ab.IgE.RAST class
15734-7,Goose feather Ab.IgE.RAST class
1573-5,Insulin^post 12H CFst
15735-4,Vitis vinifera Ab.IgE.RAST class
15736-2,Citrus paradisis Ab.IgE.RAST class
15737-0,Paspalum notatum Ab.IgE.RAST class
15738-8,Cynodon dactylon Ab.IgE.RAST class
15739-6,Poa compressa Ab.IgE.RAST class
15740-4,Bromus inermis Ab.IgE.RAST class
15741-2,Arrhenatherum elatius Ab.IgE.RAST class
15742-0,Bouteloua gracilis Ab.IgE.RAST class
1574-3,17-Ketogenic steroids^24H post 40 ug corticotropin IM BID 3 day
15743-8,Sorghum halepense Ab.IgE.RAST class
15744-6,Poa pratensis Ab.IgE.RAST class
15745-3,Grass koehlers Ab.IgE.RAST class
15746-1,Dactylis glomerata Ab.IgE.RAST class
15747-9,Agropyron repens Ab.IgE.RAST class
15748-7,Agrostis stolonifera Ab.IgE.RAST class
15749-5,Lolium perenne Ab.IgE.RAST class
1575-0,17-Ketogenic steroids^48H post 40 ug corticotropin IM BID 3 day
15750-3,Lolium perenne Ab.IgE.RAST class
15751-1,Elymus triticoides Ab.IgE.RAST class
15752-9,Distichlis spicata Ab.IgE.RAST class
15753-7,Grass sorghum Ab.IgE.RAST class
15754-5,Sorghum sudanense Ab.IgE.RAST class
15755-2,Anthoxanthum odoratum Ab.IgE.RAST class
15756-0,Holcus lanatus Ab.IgE.RAST class
15757-8,Cyamopsis tetragonoloba Ab.IgE.RAST class
15758-6,Psidium guajava Ab.IgE.RAST class
15759-4,Guinea pig epithelium Ab.IgE.RAST class
15760-2,Gum arabic Ab.IgE.RAST class
15761-0,Liquidambar styraciflua Ab.IgE.RAST class
15762-8,Celtis occidentalis Ab.IgE.RAST class
15763-6,Melanogrammus aeglefinus Ab.IgE.RAST class
15764-4,Hippoglossus hippoglossus Ab.IgE.RAST class
15765-1,Hamster epithelium Ab.IgE.RAST class
15766-9,Corylus avellana Ab.IgE.RAST class
15767-7,Corylus avellana pollen Ab.IgE.RAST class
1576-8,17-Ketogenic steroids^48H post 500 ug dexamethasone PO 2.5 day low dose q6h
15768-5,Helminthosporium sp Ab.IgE.RAST class
15769-3,Setomelanomma rostrata Ab.IgE.RAST class
15770-1,Tsuga canadensis Ab.IgE.RAST class
15771-9,Amaranthus tuberculatus Ab.IgE.RAST class
15772-7,Clupea harengus Ab.IgE.RAST class
15773-5,Carya illinoinensis nut Ab.IgE.RAST class
15774-3,Carya illinoinensis tree Ab.IgE.RAST class
15775-0,Carya laciniosa Ab.IgE.RAST class
1577-6,17-Ketogenic steroids^48H post 2 mg dexamethasone PO 2.5 day high dose q6h
15776-8,Carya tomentosa Ab.IgE.RAST class
15777-6,Honey Ab.IgE.RAST class
15778-4,Honeysuckle Ab.IgE.RAST class
15779-2,Humulus lupus Ab.IgE.RAST class
157-8,Cephaloridine
15780-0,Carpinus betulus Ab.IgE.RAST class
15781-8,Hornet Ab.IgE.RAST class
15782-6,Dolichovespula maculata Ab.IgE.RAST class
15783-4,Dolichovespula arenaria Ab.IgE.RAST class
1578-4,17-Ketogenic steroids^72H post 40 ug corticotropin IM BID 3 day
15784-2,Horse dander Ab.IgE.RAST class
15785-9,Horse epithelium Ab.IgE.RAST class
15786-7,Horse serum proteins Ab.IgE.RAST class
15787-5,Armoracia rusticana Ab.IgE.RAST class
15788-3,House dust Ab.IgE.RAST class
15789-1,House dust Greer Ab.IgE.RAST class
15790-9,House dust Hausstaub Ab.IgE.RAST class
15791-7,House dust Hollister Stier Ab.IgE.RAST class
1579-2,17-Ketogenic steroids^pre 50 ug corticotropin IM 3 day
15792-5,Insulin bovine Ab.IgE.RAST class
15793-3,Insulin human Ab.IgE.RAST class
15794-1,Insulin porcine Ab.IgE.RAST class
15795-8,Allenrolfea occidentalis Ab.IgE.RAST class
15796-6,Hexamethylene diisocyanate (HDI) Ab.IgE.RAST class
15797-4,Diphenylmethane diisocyanate (MDI) Ab.IgE.RAST class
15798-2,Toluene diisocyanate (TDI) Ab.IgE.RAST class
15799-0,Ispaghula laxative Ab.IgE.RAST class
15-Aug,Amoxicillin
1580-0,17-Ketogenic steroids^pre 500 ug dexamethasone PO 2.5 day low dose q6h
15800-6,Juniper Ab.IgE.RAST class
15801-4,Kapok Ab.IgE.RAST class
15802-2,Actinidia chinensis Ab.IgE.RAST class
15803-0,Lamb Ab.IgE.RAST class
15804-8,Mutton Ab.IgE.RAST class
15805-5,Chenopodium album Ab.IgE.RAST class
15806-3,Latex Ab.IgE.RAST class
15807-1,Latex glove extract Ab.IgE.RAST class
15808-9,Latex glove extract ammoniated Ab.IgE.RAST class
15809-7,Latex glove extract buffered Ab.IgE.RAST class
15810-5,Legume Ab.IgE.RAST class
15811-3,Citrus limon Ab.IgE.RAST class
15812-1,Atriplex lentiformis Ab.IgE.RAST class
15813-9,Lens esculenta Ab.IgE.RAST class
15814-7,Lepidoglyphus destructor Ab.IgE.RAST class
15815-4,Lactuca sativa Ab.IgE.RAST class
15816-2,Syringa vulgaris Ab.IgE.RAST class
15817-0,Lilium longiflorum Ab.IgE.RAST class
1581-8,17-Ketogenic steroids^pre 2 mg dexamethasone PO 2.5 day high dose q6h
15818-8,Citrus aurantifolia Ab.IgE.RAST class
15819-6,Tilia cordata Ab.IgE.RAST class
15820-4,Liver beef Ab.IgE.RAST class
15821-2,Homarus gammarus Ab.IgE.RAST class
15822-0,Palinurus spp Ab.IgE.RAST class
15823-8,Robinia pseudoacacia Ab.IgE.RAST class
15824-6,Lupinus spp Ab.IgE.RAST class
15825-3,Lycopodium spp Ab.IgE.RAST class
1582-6,Lactose^1H post 50 g lactose PO
15826-1,Lysozyme Ab.IgE.RAST class
15827-9,Scomber scombrus Ab.IgE.RAST class
15828-7,Scomber japonicus Ab.IgE.RAST class
15829-5,Trachurus japonicus Ab.IgE.RAST class
15830-3,Zea mays Ab.IgE.RAST class
15831-1,Malt Ab.IgE.RAST class
15832-9,Mangifera indica Ab.IgE.RAST class
15833-7,Acer macrophyllum Ab.IgE.RAST class
1583-4,Lactose^2H post 50 g lactose PO
15834-5,Acer rubrum Ab.IgE.RAST class
15835-2,Maple silver Ab.IgE.RAST class
15836-0,Maple sugar Ab.IgE.RAST class
15837-8,Mare milk Ab.IgE.RAST class
15838-6,Origanum majorana Ab.IgE.RAST class
15839-4,Maxatase Ab.IgE.RAST class
15840-2,Lepidorhombus whiffiagonis Ab.IgE.RAST class
15841-0,Melaleuca leucadendron Ab.IgE.RAST class
1584-2,Lactose^30M post 50 g lactose PO
15842-8,Cucumis melo spp Ab.IgE.RAST class
15843-6,Prosopis juliflora Ab.IgE.RAST class
15844-4,Chenopodium ambrosioides Ab.IgE.RAST class
15845-1,Cladotanytarsus lewisi Ab.IgE.RAST class
15846-9,Milk Ab.IgE.RAST class
15847-7,Cow milk boiled Ab.IgE.RAST class
15848-5,Milk powder Ab.IgE.RAST class
15849-3,Panicum milliaceum Ab.IgE.RAST class
15850-1,Setaria italica Ab.IgE.RAST class
15851-9,Echinochloa crus-galli Ab.IgE.RAST class
15852-7,Mink epithelium Ab.IgE.RAST class
15853-5,Mentha piperita Ab.IgE.RAST class
15854-3,Cheese mold type Ab.IgE.RAST class
15855-0,Chrysonilia sitophila Ab.IgE.RAST class
15856-8,Aedes communis Ab.IgE.RAST class
15857-6,Moth Ab.IgE.RAST class
15858-4,Ephestia kuehniella Ab.IgE.RAST class
1585-9,Lactose^pre 12H CFst
15859-2,Mouse epithelium Ab.IgE.RAST class
158-6,Cephaloridine
15860-0,Mouse serum proteins Ab.IgE.RAST class
15861-8,Mouse urine proteins Ab.IgE.RAST class
15862-6,Mucor racemosus Ab.IgE.RAST class
15863-4,Artemisia vulgaris Ab.IgE.RAST class
15864-2,Morus alba Ab.IgE.RAST class
15865-9,Morus alba Ab.IgE.RAST class
15866-7,Agaricus hortensis Ab.IgE.RAST class
1586-7,Lead^post EDTA therapy
15867-5,Cucumis melo spp Ab.IgE.RAST class
15868-3,Mussel Ab.IgE.RAST class
15869-1,Mytilus edulis Ab.IgE.RAST class
15870-9,Mustard Ab.IgE.RAST class
15871-7,Prunus persica var nucipersica Ab.IgE.RAST class
15872-5,Urtica dioica Ab.IgE.RAST class
15873-3,Nigrospora sphaerica Ab.IgE.RAST class
15874-1,Nutmeg Ab.IgE.RAST class
1587-5,Lutropin^1.5H post 100 g lutropin IV
15875-8,Quercus alba Ab.IgE.RAST class
15876-6,Quercus kelloggii Ab.IgE.RAST class
15877-4,Quercus parvula Ab.IgE.RAST class
15878-2,Quercus gambelii Ab.IgE.RAST class
15879-0,Chenopodium botrys Ab.IgE.RAST class
15880-8,Quercus virginiana Ab.IgE.RAST class
15881-6,Quercus rubra Ab.IgE.RAST class
15882-4,Quercus lobata Ab.IgE.RAST class
1588-3,Lutropin^1.5H post dose gonadotropin releasing hormone
15883-2,Quercus virginiana Ab.IgE.RAST class
15884-0,Quercus alba Ab.IgE.RAST class
15885-7,Avena sativa Ab.IgE.RAST class
15886-5,Avena sativa cultivated Ab.IgE.RAST class
15887-3,Avena sativa cultivated Ab.IgE.RAST class
15888-1,Octopus vulgaris Ab.IgE.RAST class
15889-9,Oidiodendrum spp Ab.IgE.RAST class
15890-7,Abelmoschus esculentus Ab.IgE.RAST class
1589-1,Lutropin^105M post 100 g lutropin IV
15891-5,Olive Ab.IgE.RAST class
15892-3,Olea europaea pollen Ab.IgE.RAST class
15893-1,Allium cepa Ab.IgE.RAST class
15894-9,Citrus sinensis Ab.IgE.RAST class
15895-6,Origanum vulgare Ab.IgE.RAST class
15896-4,Iris germanica var florentina Ab.IgE.RAST class
15897-2,Ovalbumin Ab.IgE.RAST class
15898-0,Ovomucoid Ab.IgE.RAST class
15899-8,Ostrea edulis Ab.IgE.RAST class
15900-4,Syagrus romanzoffianum Ab.IgE.RAST class
15901-2,Carica papaya Ab.IgE.RAST class
15902-0,Capsicum annuum Ab.IgE.RAST class
15903-8,Parakeet feather Ab.IgE.RAST class
15904-6,Budgerigar droppings Ab.IgE.RAST class
15905-3,Budgerigar feather Ab.IgE.RAST class
15906-1,Budgerigar serum proteins Ab.IgE.RAST class
15907-9,Parrot droppings Ab.IgE.RAST class
15908-7,Parrot feather Ab.IgE.RAST class
1590-9,Lutropin^15M post 100 g lutropin IV
15909-5,Parrot serum proteins Ab.IgE.RAST class
15910-3,Petroselinum crispum Ab.IgE.RAST class
15911-1,Pastinaca sativa Ab.IgE.RAST class
15912-9,Passiflora edulis Ab.IgE.RAST class
15913-7,Pisum sativum Ab.IgE.RAST class
15914-5,Vigna sinensis Ab.IgE.RAST class
15915-2,Cicer arietinus Ab.IgE.RAST class
15916-0,Prunus persica Ab.IgE.RAST class
1591-7,Lutropin^1H post 100 g lutropin IV
15917-8,Arachis hypogaea Ab.IgE.RAST class
15918-6,Pyrus communis Ab.IgE.RAST class
15919-4,Carya illinoinensis nut Ab.IgE.RAST class
15920-2,Carya illinoinensis tree Ab.IgE.RAST class
15921-0,Penicillin G Ab.IgE.RAST class
15922-8,Penicillin V Ab.IgE.RAST class
15923-6,Penicillium frequentans Ab.IgE.RAST class
15924-4,Penicillium notatum Ab.IgE.RAST class
1592-5,Lutropin^1H post dose gonadotropin releasing hormone
15925-1,Piper nigrum Ab.IgE.RAST class
15926-9,Pepper cayenne Ab.IgE.RAST class
15927-7,Capsicum frutescens Ab.IgE.RAST class
15928-5,Pepper green Ab.IgE.RAST class
15929-3,Schinus molle Ab.IgE.RAST class
15930-1,Perca spp Ab.IgE.RAST class
15931-9,Phoma betae Ab.IgE.RAST class
15932-7,Phospholipase Ab.IgE.RAST class
1593-3,Lutropin^2H post 100 g lutropin IV
15933-5,Phthalic anhydride Ab.IgE.RAST class
15934-3,Pigeon droppings Ab.IgE.RAST class
15935-0,Pigeon feather Ab.IgE.RAST class
15936-8,Pigweed common Ab.IgE.RAST class
15937-6,Pigweed rough Ab.IgE.RAST class
15938-4,Pigweed spiny Ab.IgE.RAST class
15939-2,Pinus nigra Ab.IgE.RAST class
159-4,Cephaloridine
15940-0,Pinus taeda Ab.IgE.RAST class
1594-1,Lutropin^2H post dose gonadotropin releasing hormone
15941-8,Pinus palustris Ab.IgE.RAST class
15942-6,Pinus radiata Ab.IgE.RAST class
15943-4,Pinus edulis Ab.IgE.RAST class
15944-2,Pinus echinata Ab.IgE.RAST class
15945-9,Pinus elliottii Ab.IgE.RAST class
15946-7,Pinus virginiana Ab.IgE.RAST class
15947-5,Pinus strobus Ab.IgE.RAST class
15948-3,Ananas comosus Ab.IgE.RAST class
15949-1,Pistacia vera Ab.IgE.RAST class
15950-9,Malassezia furfur Ab.IgE.RAST class
15951-7,Pleuronectes platessa Ab.IgE.RAST class
15952-5,Plantago lanceolata Ab.IgE.RAST class
15953-3,Prunus domestica Ab.IgE.RAST class
15954-1,Populus nigra Ab.IgE.RAST class
15955-8,Papaver somniferum Ab.IgE.RAST class
15956-6,Pork Ab.IgE.RAST class
15957-4,Solanum tuberosum Ab.IgE.RAST class
1595-8,Lutropin^30M post 100 g lutropin IV
15958-2,Ipomoea batatas Ab.IgE.RAST class
15959-0,Iva axillaris Ab.IgE.RAST class
15960-8,Ligustrum vulgare Ab.IgE.RAST class
15961-6,Protamine Ab.IgE.RAST class
15962-4,Prune Ab.IgE.RAST class
15963-2,Psyllium seed Ab.IgE.RAST class
15964-0,Aureobasidium pullulans Ab.IgE.RAST class
15965-7,Pullularia pullulans Ab.IgE.RAST class
1596-6,Lutropin^30M post dose gonadotropin releasing hormone
15966-5,Cucurbita pepo Ab.IgE.RAST class
15967-3,Cucurbita pepo seed Ab.IgE.RAST class
15968-1,Chrysanthemum cinerariifolium Ab.IgE.RAST class
15969-9,Rabbit meat Ab.IgE.RAST class
15970-7,Chrysothamnus nauseosus Ab.IgE.RAST class
15971-5,Rabbit epithelium Ab.IgE.RAST class
15972-3,Rabbit serum proteins Ab.IgE.RAST class
15973-1,Rabbit urine proteins Ab.IgE.RAST class
1597-4,Lutropin^45M post 100 g lutropin IV
15974-9,Raphanus sativus Ab.IgE.RAST class
15975-6,Ambrosia elatior Ab.IgE.RAST class
15976-4,Ambrosia dumosa Ab.IgE.RAST class
15977-2,Franseria acanthicarpa Ab.IgE.RAST class
15978-0,Ambrosia trifida Ab.IgE.RAST class
15979-8,Ambrosia elatior Ab.IgE.RAST class
15980-6,Ambrosia bidentata Ab.IgE.RAST class
15981-4,Ambrosia psilostachya Ab.IgE.RAST class
1598-2,Lutropin^75M post 100 g lutropin IV
15982-2,Brassica rapa Ab.IgE.RAST class
15983-0,Rubus idaeus Ab.IgE.RAST class
15984-8,Rat epithelium Ab.IgE.RAST class
15985-5,Rat serum proteins Ab.IgE.RAST class
15986-3,Rat urine proteins Ab.IgE.RAST class
15987-1,Sequoia spp Ab.IgE.RAST class
15988-9,Phalaris arundinacea Ab.IgE.RAST class
15989-7,Phragmites communis Ab.IgE.RAST class
1599-0,Lutropin^baseline
15990-5,Reindeer epithelium Ab.IgE.RAST class
15991-3,Rhizopus nigricans Ab.IgE.RAST class
15992-1,Rhodotorula spp Ab.IgE.RAST class
15993-9,Rheum spp Ab.IgE.RAST class
15994-7,Oryza sativa Ab.IgE.RAST class
15995-4,Zizania spp Ab.IgE.RAST class
15996-2,Rosa spp hip Ab.IgE.RAST class
15997-0,Secale cereale pollen Ab.IgE.RAST class
15998-8,Secale cereale Ab.IgE.RAST class
15999-6,Secale cereale pollen Ab.IgE.RAST class
16000-2,Lolium perenne Ab.IgE.RAST class
16001-0,Carthamus tinctorius Ab.IgE.RAST class
16002-8,Salvia officinalis Ab.IgE.RAST class
16003-6,Artemisia tridentata Ab.IgE.RAST class
16004-4,Artemisia tridentata Ab.IgE.RAST class
16005-1,Saline fish feed Ab.IgE.RAST class
1600-6,Lutropin^pre dose gonadotropin releasing hormone
16006-9,Salmo salar Ab.IgE.RAST class
16007-7,Saltbush Ab.IgE.RAST class
16008-5,Sardina pilchardus Ab.IgE.RAST class
16009-3,Savinase Ab.IgE.RAST class
16010-1,Atriplex lentiformis Ab.IgE.RAST class
16011-9,Pecten spp Ab.IgE.RAST class
16012-7,Cytisus scoparius Ab.IgE.RAST class
16013-5,Sericin Ab.IgE.RAST class
1601-4,Norepinephrine^supine
16014-3,Sesamum indicum Ab.IgE.RAST class
16015-0,Sheep epithelium Ab.IgE.RAST class
16016-8,Rumex acetosella Ab.IgE.RAST class
16017-6,Sheep wool Ab.IgE.RAST class
16018-4,Pandalus borealis Ab.IgE.RAST class
16019-2,Silk Ab.IgE.RAST class
160-2,Cephalothin
16020-0,Silk waste Ab.IgE.RAST class
16021-8,Silver Ab.IgE.RAST class
1602-2,Norepinephrine^10M post standing
16022-6,Ustilago cynodontis Ab.IgE.RAST class
16023-4,Sphacelotheca cruenta Ab.IgE.RAST class
16024-2,Helix aspersa Ab.IgE.RAST class
16025-9,Snapper red Ab.IgE.RAST class
16026-7,Solea solea Ab.IgE.RAST class
16027-5,Spinacia oleracea Ab.IgE.RAST class
16028-3,Spondylocladium citrovirens Ab.IgE.RAST class
16029-1,Picea excelsa Ab.IgE.RAST class
1603-0,Norepinephrine^1H post 300 ug clonidine PO
16030-9,Squash Ab.IgE.RAST class
16031-7,Loligo sp Ab.IgE.RAST class
16032-5,Todarodes pacificus Ab.IgE.RAST class
16033-3,Stemphylium botryosum Ab.IgE.RAST class
16034-1,Stemphylium solani Ab.IgE.RAST class
16035-8,Acarus siro Ab.IgE.RAST class
16037-4,Tyrophagus putrescentiae Ab.IgE.RAST class
16038-2,Fragaria vesca Ab.IgE.RAST class
16039-0,Succinylcholine Ab.IgE.RAST class
16040-8,Saccharum officinarum Ab.IgE.RAST class
16041-6,Helianthus annuus pollen Ab.IgE.RAST class
16042-4,Helianthus annuus seed Ab.IgE.RAST class
16043-2,Swine epithelium Ab.IgE.RAST class
16044-0,Swine urine proteins Ab.IgE.RAST class
16045-7,Xiphias gladius Ab.IgE.RAST class
16046-5,Platanus occidentalis Ab.IgE.RAST class
16047-3,Citrus reticulata Ab.IgE.RAST class
1604-8,Norepinephrine^2H post 300 ug clonidine PO
16048-1,Manihot esculenta crantz Ab.IgE.RAST class
16049-9,Artemisia dracunculus Ab.IgE.RAST class
16050-7,Camellia sinensis Ab.IgE.RAST class
16051-5,Tetramin Ab.IgE.RAST class
16052-3,Salsola kali Ab.IgE.RAST class
16053-1,Thymus vulgaris Ab.IgE.RAST class
16054-9,Phleum pratense Ab.IgE.RAST class
1605-5,Norepinephrine^3H post 300 ug clonidine PO
16055-6,Nicotiana tabacum cigarette Ab.IgE.RAST class
16056-4,Nicotiana tabacum Ab.IgE.RAST class
16057-2,Lycopersicon lycopersicum Ab.IgE.RAST class
16058-0,Astragalus spp Ab.IgE.RAST class
16059-8,Trichoderma viride Ab.IgE.RAST class
16060-6,Trichophyton Ab.IgE.RAST class
16061-4,Trichophyton rubrum Ab.IgE.RAST class
16062-2,Trichosporon spp Ab.IgE.RAST class
1606-3,Norepinephrine^pre 300 ug clonidine PO
16063-0,Trimellitic anhydride Ab.IgE.RAST class
16064-8,Oncorhynchus mykiss Ab.IgE.RAST class
16065-5,Thunnus albacares Ab.IgE.RAST class
16066-3,Turkey meat Ab.IgE.RAST class
16067-1,Turnip Ab.IgE.RAST class
16069-7,Ulocladium chartarum Ab.IgE.RAST class
16070-5,Ustilago nuda Ab.IgE.RAST class
1607-1,Osmolality^post 12H FFst
16071-3,Vanilla planifolia Ab.IgE.RAST class
16072-1,Veal Ab.IgE.RAST class
16073-9,Wall pellitory Ab.IgE.RAST class
16074-7,Juglans spp Ab.IgE.RAST class
16075-4,Juglans nigra Ab.IgE.RAST class
16076-2,Juglans nigra pollen Ab.IgE.RAST class
16077-0,Juglans regia pollen Ab.IgE.RAST class
16078-8,Juglans california pollen Ab.IgE.RAST class
16079-6,Juglans california pollen Ab.IgE.RAST class
16080-4,Polistes spp Ab.IgE.RAST class
16081-2,Polistes spp Ab.IgE.RAST class
16082-0,Vespula spp Ab.IgE.RAST class
16083-8,Citrullus lanatus Ab.IgE.RAST class
16084-6,Sitophilus granarius Ab.IgE.RAST class
16085-3,Triticum aestivum Ab.IgE.RAST class
16086-1,Triticum aestivum pollen Ab.IgE.RAST class
16087-9,Triticum aestivum pollen Ab.IgE.RAST class
16088-7,Puccinia graminis triticu Ab.IgE.RAST class
1608-9,Osmolality^post 8H FFst
16089-5,Cow whey Ab.IgE.RAST class
16090-3,Whitefish Ab.IgE.RAST class
16091-1,Salix caprea Ab.IgE.RAST class
16092-9,Salix nigra Ab.IgE.RAST class
16093-7,Salix discolor Ab.IgE.RAST class
16094-5,Atriplex canescens Ab.IgE.RAST class
16095-2,Artemisia absinthium Ab.IgE.RAST class
16096-0,Saccharomyces cerevisiae Ab.IgE.RAST class
1609-7,Prolactin^1.5H post dose insulin IV
16097-8,Yeast bakers Ab.IgE.RAST class
16098-6,Yeast brewer's Ab.IgE.RAST class
16099-4,Ethionamide
161-0,Cephalothin
16100-0,Rifabutin
16101-8,Cuminum cyminum Ab.IgE
16102-6,Gelatin bovine Ab.IgE
16103-4,Gelatin porcine Ab.IgE
16104-2,Broussonetia papyrifera Ab.IgE
1610-5,Prolactin^1H post dose L-Dopa PO
16105-9,Pheasant Ab.IgE
16106-7,Cells.CD8+CD28+
16107-5,Cells.CD8+HLA-DR+
16108-3,17-Hydroxyprogesterone^45M post 250 ug corticotropin IM
16109-1,Prolactin^2H post XXX challenge
16110-9,11-Deoxycorticosterone
16111-7,Epinephrine+Norepinephrine
16112-5,Estrogen receptor
1611-3,Prolactin^1H post dose TRH IV
16113-3,Progesterone receptor
16114-1,Amitriptyline
16115-8,Doxepin
16116-6,Tetrahydrocortisone
16117-4,Babesia microti Ab.IgG
16118-2,Babesia microti Ab.IgM
16119-0,Brucella abortus Ab.IgG
16120-8,Brucella abortus Ab.IgM
1612-1,Prolactin^1H post dose insulin IV
16121-6,Colorado tick fever virus Ab.IgG
16122-4,Colorado tick fever virus Ab.IgM
16123-2,Cryptococcus sp Ab
16124-0,Cryptococcus sp Ab
16125-7,Helicobacter pylori Ab.IgA
16126-5,Helicobacter pylori Ab.IgG
16127-3,Helicobacter pylori Ab.IgM
16128-1,Hepatitis C virus Ab
16129-9,Hepatitis C virus Ab.IgG
16130-7,Herpes simplex virus 1 DNA
16131-5,Herpes simplex virus 2 DNA
16132-3,HIV 1 p15+p18 Ab
16133-1,Legionella pneumophila Ab.IgM
16134-9,Neisseria meningitidis
16135-6,Beta 2 glycoprotein 1 Ab.IgG
16136-4,Beta 2 glycoprotein 1 Ab.IgM
16137-2,Centromere Ab
16138-0,Ganglioside GM1 Ab.IgA
1613-9,Prolactin^2H post dose L-Dopa PO
16139-8,Neuronal nuclear Ab
16140-6,Tellurium
16141-4,Nitrogen
16142-2,Fat
16143-0,Butane
16144-8,Droperidol
16145-5,Mescaline
16146-3,Psilocin
1614-7,Prolactin^30M post dose TRH IV
16147-1,Aldosterone^3rd specimen post XXX challenge
16148-9,Aldosterone^4th specimen post XXX challenge
16149-7,Aldosterone^5th specimen post XXX challenge
16150-5,Carboxy tetrahydrocannabinol
16151-3,Dechlorane
16152-1,Gastrin^2nd specimen post XXX challenge
16153-9,Gastrin^3rd specimen post XXX challenge
1615-4,Prolactin^30M post dose insulin IV
16154-7,Gastrin^4th specimen post XXX challenge
16155-4,Gastrin^5th specimen post XXX challenge
16156-2,Gastrin^6th specimen post XXX challenge
16157-0,Gastrin^7th specimen post XXX challenge
16158-8,Gastrin^8th specimen post XXX challenge
16159-6,Gastrin^9th specimen post XXX challenge
16160-4,Gastrin^10th specimen post XXX challenge
16161-2,Gastrin^post XXX challenge
1616-2,Prolactin^30M post dose U/kg insulin IV
16162-0,Parathyrin.intact^30M post XXX challenge
16163-8,Parathyrin.intact^1H post XXX challenge
16164-6,Parathyrin.intact^2H post XXX challenge
16165-3,Glucose^10 AM specimen
16166-1,Glucose^11 AM specimen
16167-9,Glucose^2 PM specimen
16168-7,Glucose^3 PM specimen
16169-5,Glucose^4 PM specimen
1617-0,Prolactin^3H post dose L-Dopa PO
16170-3,Glucose^5 PM specimen
16171-1,Cocaethylene
16172-9,Magnesium
16173-7,Amyl ether
16174-5,Bartonella henselae Ab.IgG
16175-2,Bartonella henselae Ab.IgM
16176-0,Bartonella quintana Ab.IgG
16177-8,Bartonella quintana Ab.IgM
16178-6,Beryllium
16179-4,Polychlorinated biphenyl
16180-2,Zinc
16181-0,Tricyclic antidepressants
16182-8,Alkaline phosphatase isoenzymes
16183-6,Phenolphthalein
16184-4,Temazepam
16185-1,chlordiazePOXIDE
16186-9,Hydroxyalprazolam
16187-7,ALPRAZolam
1618-8,Prolactin^45M post dose insulin IV
16188-5,Creatinine^2H specimen
16189-3,Creatinine^4H specimen
16190-1,Amobarbital
16191-9,Butabarbital
16192-7,PHENobarbital
16193-5,PENTobarbital
16194-3,Secobarbital
16195-0,Benzodiazepines
1619-6,Prolactin^pre dose L-dopa PO
16196-8,Morphine
16197-6,Codeine
16198-4,Diamorphine
16199-2,Methadone
16200-8,Propoxyphene
16201-6,Oxazepam
16202-4,Nordiazepam
16203-2,ALPRAZolam
1620-4,Prolactin^pre dose TRH IV
16204-0,clonazePAM
16205-7,LORazepam
16206-5,Temazepam
16207-3,Meperidine
16208-1,Buprenorphine
16209-9,Chlorpheniramine
16210-7,Diethylpropion
16211-5,Dihydrocodeine
1621-2,Prolactin^pre dose insulin IV
16212-3,Ethylamphetamine
16213-1,Levorphanol
16214-9,Lysergate diethylamide
16215-6,Mephobarbital
16216-4,MethylePHEDrine
16217-2,Methyprylon
16218-0,Nalbuphine
16219-8,Pentazocine
1622-0,Renin^5H post 600 ug furosemide PO
16220-6,Phenmetrazine
16221-4,Phenothiazines
16222-2,Phentermine
16223-0,Thiopental
16224-8,Triazolam
16225-5,Amitriptyline
16226-3,Benzoylecgonine
16227-1,diazePAM
16228-9,Nordiazepam
16229-7,clonazePAM
16230-5,N-desalkylflurazepam
16231-3,Flurazepam
16232-1,Triazolam
16233-9,Midazolam
16234-7,Amphetamine
16235-4,Methamphetamine
16236-2,Butabarbital
16237-0,Butalbital
1623-8,Renin^pre 600 ug furosemide PO
16238-8,Secobarbital
16239-6,Amobarbital
16240-4,PENTobarbital
16241-2,PHENobarbital
16242-0,Propoxyphene
16243-8,Cannabinoids
16244-6,Methaqualone
16245-3,Hydroxyethylflurazepam
1624-6,Retinol^3H post 5000 units
16246-1,Methadone
16247-9,Dextromethorphan
16248-7,6-Monoacetylmorphine.free
16249-5,oxyCODONE
16250-3,Codeine
16251-1,Morphine
16252-9,HYDROcodone
1625-3,Retinol^6H post 5000 units
16253-7,Meperidine
16254-5,Phencyclidine
16255-2,Troponin I.cardiac
16257-8,Sodium urate crystals
16258-6,Ammonium urate crystals
16259-4,Urate dihydrate crystals
16260-2,Triamterene crystals
1626-1,Retinol^pre 5000 units
16261-0,Calcium bilirubinate crystals
16262-8,Newberyite crystals
16263-6,Calcium oxalate dihydrate crystals
16264-4,Calcium oxalate monohydrate crystals
16265-1,Triple phosphate crystals
16266-9,Calcium hydrogen phosphate crystals
16267-7,Calcium carbonate crystals
16268-5,Calcium phosphate crystals
16269-3,Urate crystals
16270-1,Calcium^1H post XXX challenge
16271-9,Calcium^30M post XXX challenge
16272-7,Calcium^2H post XXX challenge
16273-5,Calcium
16274-3,Cells.CD4/Cells.C4
16275-0,Bartonella sp DNA
16276-8,Bartonella henselae DNA
16277-6,Bartonella quintana DNA
16278-4,Mycobacterium tuberculosis DNA
1627-9,Somatotropin^1.5H post dose insulin IV
16279-2,Toxoplasma gondii DNA
162-8,Cephalothin
16280-0,Human papilloma virus DNA
16281-8,traZODone
16282-6,Acetaminophen
16283-4,Escherichia coli verotoxin
16284-2,Polio virus Ab
16285-9,Creatinine/Protein
16286-7,Testosterone.free/Testosterone.total
1628-7,Somatotropin^1H post 1 g/kg glucose PO
16287-5,Sulfatide Ab
16288-3,Monosialoganglioside GM1 Ab.IgG+IgM
16289-1,Monosialoganglioside GM1 Ab
16290-9,Neutrophils
16291-7,Herpes simplex virus 1
16292-5,"1,4-Dioxane"
16293-3,11-Deoxycorticosteroids
16294-1,11-Deoxycorticosterone^post XXX challenge
1629-5,Somatotropin^1H post dose insulin IV
16295-8,11-Deoxycortisol^post XXX challenge
16296-6,11-Hydroxyandrosterone
16297-4,17-Hydroxypregnenolone
16298-2,17-Hydroxypregnenolone^45M post XXX challenge
16299-0,17-Hydroxypregnenolone^6H post XXX challenge
16300-6,17-Ketogenic steroids
16301-4,17-Ketogenic steroids^baseline
16302-2,1-Methylhistidine
1630-3,Somatotropin^2H post 1 g/kg glucose PO
16303-0,2-Hexanol
16304-8,2-Hexanol/Creatinine
16305-5,2-Methoxyethanol
16306-3,3-Methylhistidine
16307-1,Acetate
16308-9,acetaZOLAMIDE
16309-7,acetaZOLAMIDE
16310-5,Acetone
1631-1,Somatotropin^30M post dose insulin IV
16311-3,Acetone
16312-1,Acetonitrile
16313-9,Acetylene
16314-7,Acetylsalicylate
16315-4,Acid phosphatase
16316-2,Acid phosphatase.tartrate resistant
16317-0,Acid phosphatase.prostatic
16318-8,Acrylamide
16319-6,Acrylamide
16320-4,Acyclovir
16321-2,Acyl carnitine
16322-0,Biperiden
16323-8,Alanine
16324-6,Alanine aminotransferase
16325-3,Alanine aminotransferase/Aspartate aminotransferase
16327-9,Allyl alcohol
16328-7,Benzyl alcohol
1632-9,Somatotropin^3H post 1 g/kg glucose PO
16329-5,Aldosterone^6th specimen post XXX challenge
16330-3,Aldosterone^7th specimen post XXX challenge
16331-1,Aldosterone^8th specimen post XXX challenge
16332-9,Aldosterone^9th specimen post XXX challenge
16333-7,Aldrin
16334-5,Alfentanil
16335-2,Hydrocarbons.aliphatic
16336-0,Alkaline phosphatase.placental
1633-7,Somatotropin^45M post dose insulin IV
16337-8,Alkaline phosphatase
16338-6,Alpha aminoadipate
16339-4,Alpha aminoisobutyrate
16340-2,Alpha aminoisobutyrate
16341-0,Alpha aminoisobutyrate
16342-8,Alpha aminoisobutyrate
16343-6,Alpha aminoisobutyrate
16344-4,Alpha aminoisobutyrate
1634-5,Somatotropin^52H post 250 ug L-Dopa TID 2day PO
16345-1,Alpha aminobutyrate
16346-9,Alpha chlordane
16347-7,Alpha chlordane
16348-5,Alpha hydroxyalprazolam
16349-3,Aluminum
16350-1,Amantadine
16351-9,aMILoride
1635-2,Somatotropin^pre 1 g/kg glucose PO
16352-7,aMILoride
16353-5,Amino beta guanidinopropionate
16354-3,Amino beta guanidinopropionate
16355-0,Amino beta guanidinopropionate
16356-8,Amino beta guanidinopropionate
16357-6,Amino beta guanidinopropionate
16358-4,Amino beta guanidinopropionate
16359-2,Amiodarone+Desethylamiodarone
163-6,Cephalothin
1636-0,Somatotropin^pre 250 ug L-Dopa TID 2day PO
16360-0,Amitriptyline^peak
16361-8,Amitriptyline^trough
16362-6,Ammonia
16363-4,Ammonia
16364-2,Amobarbital
16365-9,Amoxicillin+Clavulanate
16366-7,Diethylpropion
16367-5,Amphetamine/Methamphetamine
16369-1,Amphetamines
16370-9,Amphotericin B
16373-3,Amyl ether
16374-1,Amyl nitrite
1637-8,Somatotropin^pre dose insulin IV
16378-2,Androstenedione^2nd specimen post XXX challenge
16379-0,Androstenedione^3rd specimen post XXX challenge
16380-8,Androstenedione^4th specimen post XXX challenge
16381-6,Androstenedione^5th specimen post XXX challenge
16382-4,Androstenedione^6th specimen post XXX challenge
16383-2,Androstenedione^7th specimen post XXX challenge
16384-0,Androstenedione^8th specimen post XXX challenge
16385-7,Androstenedione^9th specimen post XXX challenge
1638-6,Testosterone^96H post 5000 U HCG IM
16386-5,Rifabutin
16387-3,Rifabutin+Ethambutol
16388-1,Anticonvulsants
16389-9,Antidepressants
16390-7,Antidiuretics
16391-5,Antimony
16392-3,Nuclear Ab
16393-1,Nuclear Ab
1639-4,Testosterone^pre 5000 U HCG IM
16394-9,Nuclear Ab
16395-6,Antipsychotics
16400-4,Appearance
16401-2,Arginine
1640-2,Thyrotropin^30M post dose TRH IV
16402-0,Aromatic solvents
16403-8,Arsenic
16404-6,Arsenic
16405-3,Arylamidase
16406-1,Arylamidase
16407-9,Asbestos identified
16408-7,Ascorbate
16409-5,Ascorbate^post dose
1641-0,Thyrotropin^1H post dose TRH IV
16410-3,Asparagine
16411-1,Aspartate
16412-9,Aspartate aminotransferase
16414-5,Aspergillus amstelodami Ab
16415-2,Aspergillus flavus Ab
16416-0,Aspergillus terreus Ab
16417-8,Aspergillus versicolor Ab
16418-6,Azatadine
16419-4,azaTHIOprine
16420-2,Azithromycin
16421-0,Azithromycin+Ethambutol
16422-8,Azlocillin
16423-6,Aztreonam
16424-4,Salicylazosulfapyridine
16425-1,Babesia sp Ab.IgM
16426-9,Babesia sp Ab.IgM
16427-7,Babesia microti Ab
1642-8,Thyrotropin^baseline
16428-5,Bacitracin
16429-3,Barbiturates
16430-1,Barbiturates
16431-9,Barium
16432-7,Barium
16433-5,Basement membrane Ab
16434-3,Basement membrane Ab
16435-0,Bean white Ab.IgE
1643-6,Thyrotropin^pre dose TRH IV
16436-8,Bean wax Ab.IgE
16437-6,Bendroflumethiazide
16438-4,Benzaldehyde
16439-2,Benzene
164-4,Cephapirin
16440-0,Benzene ring Ab.IgE
16441-8,Benzene ring Ab.IgG
16442-6,Benzene ring Ab.IgM
16443-4,Benzonatate
1644-4,Triglyceride^post 12H CFst
16444-2,Benzophenone
16446-7,Benzoylecgonine
16447-5,Cocaine
16448-3,Cocaine
16449-1,Benzthiazide
16450-9,Benzylhydrazine
1645-1,Xylose^2H post 25 g xylose PO
16451-7,Beryllium
16452-5,Beta alanine
16453-3,Beta aminoisobutyrate
16454-1,Beta galactosidase
16455-8,Beta hydroxybutyrate
16456-6,Beta hydroxybutyrate
16457-4,Beta-N-acetylhexosaminidase.A
16458-2,Bethanechol
16459-0,Bicarbonate
16460-8,Bicarbonate
16461-6,Bicarbonate
16462-4,Bicarbonate
16463-2,Bile acid.dihydroxy
16464-0,Bile acid
16465-7,Bile acid
16466-5,Bile acid.trihydroxy
16467-3,Bismuth
16468-1,Bismuth
1646-9,Xylose^post dose PO
16469-9,Bismuth/Creatinine
16470-7,Blastomyces dermatitidis Ab
16471-5,Blastomyces dermatitidis Ab
16472-3,Blastomyces dermatitidis rRNA
16473-1,Bordetella parapertussis Ab
16474-9,Bordetella pertussis Ab
16475-6,Borrelia burgdorferi Ab
16476-4,Borrelia burgdorferi Ab
1647-7,Tuberculosis reaction wheal^3D post 25 TU ID
16477-2,Borrelia burgdorferi Ab
16478-0,Borrelia burgdorferi Ab.IgA
16479-8,Borrelia burgdorferi Ab.IgA
16480-6,Borrelia burgdorferi Ab.IgG
16481-4,Borrelia burgdorferi Ab.IgG
16482-2,Borrelia burgdorferi Ab.IgM
16483-0,Borrelia hermsii
16484-8,Boysenberry Ab.IgE
1648-5,Tuberculosis reaction wheal^3D post 5 TU ID
16485-5,Bromodiphenhydramine
16486-3,Brucella abortus Ab.IgA+IgG+IgM
16487-1,Brucella abortus Ab.IgG
16488-9,Brucella abortus Ab.IgG
16489-7,Brucella melitensis Ab
16490-5,Brucella suis Ab
16491-3,Brush border Ab
16492-1,Bufotenine
1649-3,Calcitriol
16493-9,Bufotenine
16494-7,Bumetanide
16495-4,Buprenorphine
16496-2,Buprenorphine
16497-0,Butabarbital
16498-8,Butalbital
16499-6,Butorphanol
16500-1,Butyrate
1650-1,"1,4-Alpha glucan branching enzyme"
16501-9,C peptide^7th specimen post XXX challenge
16502-7,C peptide^8th specimen post XXX challenge
16503-5,C reactive protein
16504-3,Calcitonin^1.5M post XXX challenge
16505-0,Calcitonin^10M post XXX challenge
16506-8,Calcitonin^3H post XXX challenge
16507-6,Calcitonin^4H post XXX challenge
16508-4,Calcitonin^5M post XXX challenge
16509-2,Calcitonin^7th specimen post XXX challenge
165-1,Cephapirin
16510-0,Calcitonin^8th specimen post XXX challenge
16511-8,Calcitonin^9th specimen post XXX challenge
16512-6,Calcium.ionized^2nd specimen post XXX challenge
16513-4,Calcium.ionized^3rd specimen post XXX challenge
16514-2,Calcium.ionized^4th specimen post XXX challenge
16515-9,Calcium.ionized^5th specimen post XXX challenge
16516-7,Calcium.ionized^6th specimen post XXX challenge
16517-5,Calcium.ionized^7th specimen post XXX challenge
16518-3,Calcium
1651-9,1-Methylhistidine
16519-1,Calcium^10M post XXX challenge
16520-9,Calcium^2nd specimen post XXX challenge
16521-7,Calcium^3rd specimen post XXX challenge
16522-5,Calcium^4th specimen post XXX challenge
16523-3,Calcium^5M post XXX challenge
16524-1,Calcium^6H post XXX challenge
16525-8,Calcium/Phosphate
16526-6,Calcium/Protein
1652-7,1-Methylhistidine
16527-4,Calcium/Sodium
16528-2,Campylobacter coli rRNA
16529-0,Campylobacter jejuni rRNA
16530-8,Campylobacter jejuni rRNA
16531-6,Campylobacter lari rRNA
16532-4,Campylobacter lari rRNA
16533-2,Helicobacter pylori Ab
16534-0,Campylobacter sp rRNA
1653-5,1-Methylhistidine
16535-7,Canary droppings Ab.IgE
16536-5,Canary serum proteins Ab
16537-3,Candida albicans Ab
16538-1,Candida sp Ab.IgA
16539-9,Candida sp Ag
16540-7,Cannabinoids
16542-3,Cannabinoids
1654-3,1-Naphthalene
16543-1,Cannabinoids
16544-9,Canrenone
16545-6,Capreomycin
16546-4,Captopril
16547-2,Carbamate pesticides
16548-0,carBAMazepine
16549-8,Carbinoxamine
1655-0,11-Deoxy/11-Oxy steroids
16550-6,Carbohydrates
16551-4,Carbon dioxide
16553-0,Carnitine
16555-5,Carnitine
16556-3,Carnitine
16557-1,Carnosine
16558-9,Catecholamines^2H post XXX challenge
16559-7,Catecholamines^3H post XXX challenge
16560-5,Catecholamines^5th specimen post XXX challenge
16561-3,Catecholamines^6th specimen post XXX challenge
16562-1,Cathartic laxatives
16563-9,Cathepsin D
16564-7,Cefaclor
16565-4,Cefadroxil
16566-2,ceFAZolin
16567-0,Cefixime
1656-8,11-Deoxycorticosterone
16568-8,Cefuroxime Ab.IgE
16569-6,cefTRIAXone Ab.IgE
16570-4,Centromere Ab
16571-2,Cephadrine
16572-0,Cephaloridine
16573-8,Cerebroside sulfatase
16574-6,Cerebroside sulfatase
16575-3,Cerebroside sulfatase B
1657-6,11-Deoxycortisol
16576-1,Cerebroside sulfatase B
16577-9,Cerebroside sulfatase B
16578-7,Cerebroside sulfatase B
16579-5,Cerebroside sulfatase B
16580-3,Cerebroside sulfatase B
16581-1,Chlamydophila pneumoniae Ab.IgA
16582-9,Chlamydophila pneumoniae Ab.IgG
16583-7,Chlamydophila pneumoniae Ab.IgM
1658-4,11-Hydroxyandrostenedione
16584-5,Chlamydophila pneumoniae rRNA
16585-2,Chlamydophila pneumoniae rRNA
16586-0,Chlamydophila psittaci Ab.IgA
16587-8,Chlamydophila psittaci Ab.IgG
16588-6,Chlamydophila psittaci Ab.IgM
16589-4,Chlamydia sp Ab
16590-2,Chlamydia sp Ab
16591-0,Chlamydia sp Ab.IgG
1659-2,11-Hydroxyandrosterone
16592-8,Chlamydia sp Ab.IgM
16593-6,Chlamydia sp Ag
16594-4,Chlamydia trachomatis Ab.IgA
16595-1,Chlamydia trachomatis Ab.IgG
16596-9,Chlamydia trachomatis Ab.IgM
16597-7,Chlamydia trachomatis B Ab.IgG
16598-5,Chlamydia trachomatis C Ab.IgG
16599-3,Chlamydia trachomatis DNA
16-Jun,Amoxicillin
1660-0,11-Hydroxyetiocholanolone
16600-9,Chlamydia trachomatis rRNA
16601-7,Chlamydia trachomatis rRNA
16602-5,Chlamydia trachomatis rRNA
16603-3,Chloramphenicol^peak
16604-1,Chloramphenicol^trough
16605-8,Chlorocycline
16606-6,Chlorine
16607-4,Chlorine
16608-2,Chlorpheniramine
16609-0,Chlorphentermine
16610-8,Chlorphentermine
16611-6,Chlorpyrifos
16612-4,Chlorthalidone
16613-2,Cholesterol crystals
16614-0,Cholesterol crystals
16615-7,Cholesterol.total/Cholesterol.in LDL
16616-5,Cholesterol.in HDL/Cholesterol.in LDL
16617-3,Choriogonadotropin.intact
1661-8,11-Ketoandrosterone
16618-1,Cladosporium herbarum Ab
16619-9,Clarithromycin
16620-7,Clarithromycin+Ethambutol
16621-5,Clindamycin^peak
16622-3,Clindamycin^trough
16623-1,Clofazimine
16624-9,clomiPRAMINE
16625-6,clomiPRAMINE
1662-6,11-Ketoetiocholanolone
16626-4,Clostridium tetani Ab^1st specimen
16627-2,Clostridium tetani Ab^2nd specimen
16628-0,Cloxacillin
16629-8,Coagulation surface induced
16630-6,Coagulation surface induced
16631-4,Coagulation surface induced
16632-2,Cocaethylene
16633-0,Cocaine
1663-4,11-Oxycorticosterone
16634-8,Coccidioides immitis Ab
16635-5,Coccidioides immitis Ab.IgA
16636-3,Coccidioides immitis Ab.IgA
16637-1,Coccidioides immitis Ab.IgE
16638-9,Coccidioides immitis Ab.IgG
16639-7,Coccidioides immitis Ab.IgM
16640-5,Coccidioides reaction wheal
16641-3,Cockatiel droppings Ab
1664-2,17-Hydroxycorticosteroids
16642-1,Cockatiel droppings Ab.IgG
16643-9,Cockatoo droppings Ab
16644-7,Codeine.free
16645-4,Colistin
16647-0,Collagen Ab
16648-8,Copper
16649-6,Coproporphyrinogen oxidase
16650-4,Coriandrum sativum Ab.IgE
16651-2,Corticosterone^post XXX challenge
16652-0,Corticotropin
16653-8,Corticotropin.canine
16654-6,Corticotropin^1.5H post XXX challenge
16655-3,Corticotropin^10M post XXX challenge
16656-1,Corticotropin^15M post XXX challenge
16657-9,Corticotropin^1H post XXX challenge
16658-7,Corticotropin^1M post XXX challenge
1665-9,17-Hydroxycorticosteroids
16659-5,Corticotropin^2.5H post XXX challenge
16660-3,Corticotropin^20M post XXX challenge
16661-1,Corticotropin^2H post XXX challenge
16662-9,Corticotropin^30M post XXX challenge
16663-7,Corticotropin^3H post XXX challenge
16664-5,Corticotropin^45M post XXX challenge
16665-2,Corticotropin^5M post XXX challenge
16666-0,Corticotropin^9th specimen post XXX challenge
1666-7,17-Hydroxycorticosteroids
16667-8,Cortisol.free
16668-6,Cortisol.free
16669-4,Cortisol^10M post XXX challenge
16670-2,Cortisol^15M post XXX challenge
16671-0,Cortisol^1M post XXX challenge
16672-8,Cortisol^40M post XXX challenge
16673-6,Cortisol^50M post XXX challenge
16674-4,Cortisol^70M post XXX challenge
1667-5,17-Hydroxyketosteroids
16675-1,Cortisol^80M post XXX challenge
16676-9,Corynebacterium diphtheriae
16677-7,Coxiella burnetii Ab.IgG
16678-5,Coxiella burnetii Ab.IgM
16679-3,Coxsackievirus A Ab
16680-1,Coxsackievirus A Ab.IgG
16681-9,Coxsackievirus A Ab.IgM
16682-7,Coxsackievirus A2 Ab
1668-3,17-Hydroxyprogesterone
16683-5,Coxsackievirus A4 Ab
16684-3,Coxsackievirus B Ab
16685-0,Coxsackievirus B Ab.IgG
16686-8,Coxsackievirus B Ab.IgM
16687-6,Creatine
16688-4,Creatine kinase
16689-2,Creatinine
166-9,Cephapirin
16690-0,Creatinine
1669-1,17-Hydroxyprogesterone
16691-8,Cresols
16692-6,Cryptococcus sp Ag
16693-4,Cryptococcus sp Ag
16694-2,Cumene
16695-9,Cobalamins
16696-7,Cobalamins^post XXX challenge
16697-5,Cyclohexane
16698-3,Cyclohexanol
16699-1,Cyclohexanol
16700-7,Cyclohexanol/Creatinine
16701-5,Cyclopropane
16702-3,cycloSERINE
16703-1,cycloSPORINE
16704-9,Cyproheptadine
16705-6,Cystathionine
16706-4,Taenia solium larva Ab.IgM
16707-2,Taenia solium larva Ab.IgM
16708-0,Taenia solium larva Ab
1670-9,17-Hydroxyprogesterone
16709-8,Cystine
16710-6,Cystine crystals
16711-4,Cystine+Homocystine
16712-2,Cytomegalovirus Ab
16713-0,Cytomegalovirus Ab
16714-8,Cytomegalovirus Ab
16715-5,Cytomegalovirus Ab.IgG
16716-3,Cytomegalovirus Ab.IgG^2nd specimen
1671-7,17-Ketogenic steroids
16717-1,Cytomegalovirus Ag
16718-9,Cytomegalovirus Ag
16719-7,Cytomegalovirus inclusion bodies
16720-5,Dechlorane
16721-3,Dehydroepiandrosterone sulfate
16722-1,Dehydroepiandrosterone sulfate^10th specimen post XXX challenge
16723-9,Dehydroepiandrosterone sulfate^2nd specimen post XXX challenge
16724-7,Dehydroepiandrosterone sulfate^3rd specimen post XXX challenge
1672-5,17-Ketogenic steroids
16725-4,Dehydroepiandrosterone sulfate^4th specimen post XXX challenge
16726-2,Dehydroepiandrosterone sulfate^5th specimen post XXX challenge
16727-0,Dehydroepiandrosterone sulfate^6th specimen post XXX challenge
16728-8,Dehydroepiandrosterone sulfate^7th specimen post XXX challenge
16729-6,Dehydroepiandrosterone sulfate^8th specimen post XXX challenge
16730-4,Dehydroepiandrosterone sulfate^9th specimen post XXX challenge
16731-2,Dehydroepiandrosterone.unconjugated
16732-0,Dehydroepiandrosterone^7th specimen post XXX challenge
1673-3,17-Ketogenic steroids
16733-8,Dehydroepiandrosterone^9th specimen post XXX challenge
16734-6,Dehydroepiandrosterone^baseline
16735-3,Dehydroepiandrosterone^post XXX challenge
16736-1,Dengue virus 1 Ab
16737-9,Dengue virus 2 Ab
16738-7,Dengue virus 3 Ab
16739-5,Dengue virus 4 Ab
16740-3,Dengue virus Ab
1674-1,18-Hydroxycorticosterone
16741-1,Dermatophagoides farinae Ab.IgG
16742-9,Dermatophagoides pteronyssinus Ab.IgG
16743-7,Nordiazepam
16744-5,Nordiazepam
16745-2,Desmethylmethsuximide
16746-0,Nortrimipramine
16747-8,Dextromoramide
16748-6,Propoxyphene
16749-4,Propoxyphene+Norpropoxyphene
16750-2,Dezocine
16751-0,Dezocine
16752-8,Diacetate
16753-6,Dialtrazene
16754-4,Diamorphine
16755-1,Diamorphine
16756-9,Diamorphine
16757-7,Diazepam+Nordiazepam
1675-8,"2,3-Diphosphoglycerate"
16758-5,Dicamba
16759-3,Dicamba
16760-1,Dicarboxylporphyrin
16761-9,Protoporphyrin
16762-7,Dichlorobenzene
16763-5,Dichlorodiphenyldichloroethylene
16764-3,Dichlorodiphenyldichloroethylene
16765-0,Dichlorodiphenyltrichloroethane
1676-6,"2,3-Diphosphoglycerate"
16766-8,Dichloroethane
16767-6,"2,4-Dichlorophenoxyacetate"
16768-4,Dichlorvos
16769-2,Dicloxacillin
167-7,Cephapirin
16770-0,Dicoumarol
16771-8,Dicyclomine
16772-6,Dieldrin
16773-4,Dieldrin
1677-4,Alpha hydroxybutyrate dehydrogenase
16774-2,Diethylcarbamazepine
16775-9,Dihydrocodeine.free
16776-7,dilTIAZem
16777-5,Dimethylacetamide
16778-3,Dinitrophenol
16779-1,Dinitrophenol
16780-9,Disopyramide
16781-7,Disulfiram
1678-2,20-Hydroxyprogesterone
16782-5,DNA double strand Ab
16784-1,DOPamine^2nd specimen post XXX challenge
16785-8,DOPamine^3rd specimen post XXX challenge
16786-6,DOPamine^4th specimen post XXX challenge
16787-4,DOPamine^5th specimen post XXX challenge
16788-2,DOPamine^6th specimen post XXX challenge
16789-0,DOPamine^7th specimen post XXX challenge
1679-0,24r-Hydroxycalcidiol
16790-8,Doxepin+Desmethyldoxepin
16791-6,Doxylamine
16792-4,Doxylamine
16793-2,Drugs identified
16794-0,Echinococcus sp Ab.IgM
16795-7,Echovirus Ab
16796-5,Echovirus Ab
16797-3,Echovirus 1 Ab
16798-1,Echovirus 14 Ab
16799-9,Echovirus 140 Ab
16800-5,Echovirus 19 Ab
16801-3,Echovirus 3 Ab
16802-1,Echovirus 30 Ab
16803-9,Echovirus 4 Ab
16804-7,Echovirus 40 Ab
16805-4,Echovirus 6 Ab
16806-2,Echovirus 6+18+30 Ab
16807-0,Echovirus 9 Ab
1680-8,3-Alpha-Androstanediol glucuronide
16808-8,Anaplasma phagocytophilum Ab.IgG
16809-6,Anaplasma phagocytophilum Ab.IgM
16811-2,Arachidate
16812-0,Emetine
16813-8,Emetine
16814-6,Endomysium Ab
16815-3,Endomysium Ab
1681-6,Beta hydroxybutyrate dehydrogenase
16816-1,Enoxacin
16817-9,Entamoeba histolytica Ab
16818-7,Entamoeba histolytica Ab
16819-5,Entamoeba histolytica Ab
16820-3,Entamoeba histolytica Ab
16821-1,EPINEPHrine^4H post XXX challenge
16822-9,Epithelial cells
16823-7,Epstein Barr virus early Ab
1682-4,Beta hydroxybutyrate dehydrogenase
16824-5,Epstein Barr virus nuclear Ab
16825-2,Epstein Barr virus nuclear Ab.IgG
16826-0,Epstein Barr virus capsid Ab.IgG
16827-8,Epstein Barr virus capsid Ab.IgG
16828-6,Erythrocytes
16829-4,Erythromycin
16830-2,Erythromycin+Ethambutol
1683-2,3-Hydroxyisovalerate
16832-8,Escherichia coli enterotoxic identified
16833-6,Escherichia coli K1 Ag
16834-4,Escherichia coli K1 Ag
16835-1,Escherichia coli shiga-like toxin identified
16836-9,Escherichia coli verotoxic identified
16838-5,Estriol
1684-0,3-Methoxy-4-Hydroxyphenylglycol
16840-1,Ethacrynate
16841-9,Ethambutol+rifAMPin
16842-7,Ethanol
16843-5,Ethanol
16844-3,Ethinamate
16845-0,Ethionamide
16847-6,Ethoheptazine
16848-4,Ethoheptazine
16849-2,Ethyl benzene
168-5,Cephradine
16850-0,Ethylene oxide
16851-8,Ethylmorphine
16852-6,Etodolac
16853-4,Fat
16855-9,Fat
16856-7,Fat.microscopic observation
1685-7,3-Methylhistidine
16857-5,Fenclorvos
16858-3,fentaNYL
16859-1,Fibrinogen
16860-9,Fibrinopeptide A Ag
16861-7,Fibrinopeptide A Ag
16862-5,Fibrinopeptide B Ag
16863-3,Fibrinopeptide B beta (1-14) Ag
16864-1,Fibrinopeptide B beta (1-42) Ag
1686-5,3-Methylhistidine
16865-8,Fibrinopeptide B beta (15-42) Ag
16866-6,Fibrinopeptide B beta (43-47) Ag
16867-4,Fibronectin aggregate Ab.IgG
16868-2,Finch droppings Ab.IgE
16869-0,Flubiprofen
16870-8,Fluconazole
16871-6,Fluoride
16872-4,Fluorocarbons
1687-3,3-Methylhistidine
16873-2,Follitropin^105M post XXX challenge
16874-0,Formate+Formaldehyde
16875-7,Francisella tularensis Ab
16876-5,Francisella tularensis Ab.IgA
16877-3,Francisella tularensis Ab.IgG
16878-1,Francisella tularensis Ab.IgM
16879-9,Francisella tularensis Ag
1688-1,4-Pyridoxate
16881-5,Gallium
16882-3,Gamma aminobutyrate
16883-1,Gamma aminobutyrate
16884-9,Gamma aminobutyrate
16885-6,Gamma aminobutyrate
16886-4,Gamma aminobutyrate
16887-2,Gamma aminobutyrate
16888-0,Gamma chlordane
16890-6,Gastrin^10M post XXX challenge
16891-4,Gastrin^11th specimen post XXX challenge
16892-2,Gastrin^15M post XXX challenge
16893-0,Gastrin^20M post XXX challenge
16894-8,Gastrin^25M post XXX challenge
16895-5,Gastrin^30M post XXX challenge
16896-3,Gastrin^5M post XXX challenge
16898-9,Giardia lamblia 65 Ag
1689-9,5'-Nucleotidase
16899-7,Giardia lamblia Ag
16900-3,Gliadin Ab
16901-1,Gliadin Ab.IgA
16902-9,Gliadin Ab.IgG
16903-7,Glucose
16904-5,Glucose^1st specimen post XXX challenge
16905-2,Glucose^2nd specimen post XXX challenge
16906-0,Glucose^3rd specimen post XXX challenge
1690-7,5'-Nucleotidase
16907-8,Glucose^4th specimen post XXX challenge
16908-6,Glucose^5th specimen post XXX challenge
16909-4,Glucose^6th specimen post XXX challenge
16910-2,Glucose^7th specimen post XXX challenge
16911-0,Glucose^8th specimen post XXX challenge
16912-8,Glucose^9th specimen post XXX challenge
16913-6,Glucose^post CFst
16914-4,Glucose^post XXX challenge
1691-5,"5,10-Methylenetetrahydrofolate reductase"
16915-1,Glucose^post meal
16916-9,Glutamate
16917-7,Glutamine
16918-5,Glutathione
16919-3,Glycine
16920-1,Glycoproteins
16921-9,Stenotaphrum secundatum Ab.IgE
16922-7,Elymus triticoides Ab.IgE
1692-3,5-Hydroxyindoleacetate
16923-5,guaiFENesin
16924-3,Haemophilus influenzae Ab.IgG
16925-0,Haemophilus influenzae A Ag
16926-8,Haemophilus influenzae A Ag
16927-6,Haemophilus influenzae B Ab.IgG
16928-4,Hantavirus puumala Ab.IgG+IgM
16929-2,Helicobacter pylori Ab
169-3,Cephradine
16930-0,Helminth Ab.IgE
1693-1,5-Hydroxyindoleacetate
16931-8,Hematocrit/Hemoglobin
16932-6,Hemoglobin A3/Hemoglobin.total
16933-4,Hepatitis B virus core Ab
16934-2,Hepatitis B virus polymerase DNA
16935-9,Hepatitis B virus surface Ab
16936-7,Hepatitis C virus Ab.IgG
16937-5,Hepatitis G virus RNA
16938-3,Heptacarboxylporphyrin
16939-1,Heptachlor
16940-9,Heptachlorepoxide
16941-7,Herbicide
16942-5,Herpes simplex virus Ab
16943-3,Herpes simplex virus Ab.IgG
16944-1,Herpes simplex virus Ab.IgM
16945-8,Herpes simplex virus Ag
16947-4,Herpes simplex virus 1 Ab
16948-2,Herpes simplex virus 1 Ab.IgG
1694-9,5-Hydroxyindoleacetate
16949-0,Herpes simplex virus 1 Ab.IgG^1st specimen
16950-8,Herpes simplex virus 1 Ab.IgG^2nd specimen
16952-4,Herpes simplex virus 1 DNA
16953-2,Herpes simplex virus 1 DNA
16954-0,Herpes simplex virus 2 Ab
16955-7,Herpes simplex virus 2 Ab.IgG
1695-6,5-Hydroxyindoleacetate
16956-5,Herpes simplex virus 2 Ab.IgG
16957-3,Herpes simplex virus 2 Ab.IgG^1st specimen
16958-1,Herpes simplex virus 2 Ab.IgG^2nd specimen
16959-9,Herpes simplex virus 2 DNA
16960-7,Herpes simplex virus 2 DNA
16962-3,Heterophile Ab
16963-1,Hexacarboxylporphyrin
1696-4,5-Methyltetrahydrofolate homocysteine methyltransferase
16964-9,Hexacarboxylporphyrin
16965-6,Lindane
16966-4,Hexachloroethane
16967-2,Hexokinase 1
16968-0,Hexokinase 3
16969-8,Histone H2a+H2b Ab
16970-6,Histoplasma capsulatum Ab
16971-4,Histoplasma capsulatum Ab.IgA
1697-2,6-Phosphogluconate dehydrogenase
16972-2,Histoplasma capsulatum Ab.IgE
16973-0,Histoplasma capsulatum Ab.IgM
16974-8,HIV 1 Ab
16975-5,HIV 1 Ab.IgG
16976-3,HIV 1 Ag
16977-1,HIV 1 Ag
16978-9,HIV 1 p24 Ab
16979-7,HIV 1 p24 Ag
1698-0,8-Hydroxyamoxapine
16980-5,HTLV II DNA
16981-3,HTLV I DNA
16982-1,HTLV I+II Ab
16983-9,hydrALAZINE
16984-7,Hydrastine
16985-4,Hydrogen/Expired gas^1.5H post dose glucose
16986-2,Hydrogen/Expired gas^1H post dose glucose
16987-0,Hydrogen/Expired gas^2.5H post dose glucose
16988-8,Hydrogen/Expired gas^2H post dose glucose
16989-6,Hydrogen/Expired gas^3.5H post dose glucose
16990-4,Hydrogen/Expired gas^3H post dose glucose
16991-2,Hydrogen/Expired gas^4.5H post dose glucose
16992-0,Hydrogen/Expired gas^4H post dose glucose
16993-8,Hydrogen/Expired gas^5.5H post dose glucose
16994-6,Hydrogen/Expired gas^5H post dose glucose
16995-3,Hydrogen/Expired gas^6H post dose glucose
16996-1,Hydrogen/Expired gas^pre dose glucose
16997-9,Hydrogen/Expired gas^post dose glucose
1699-8,Alpha-L-iduronidase
16998-7,HYDROmorphone
16999-5,Hydroquinone
17000-1,Hydroxylysine
17001-9,Hydroxyproline
17002-7,Hydroxytriazolam
17003-5,Serotonin
1700-4,Acetaldehyde
17004-3,Hypoxanthine
17005-0,IgA subclass 1
17006-8,IgA subclass 2
17007-6,IgG
17008-4,IgG/Beta tubulin
17009-2,IgM
170-1,Cephradine
17010-0,Imipenem
1701-2,Acetaldehyde
17012-6,Influenza virus A Ab
17013-4,Influenza virus A+B Ab
17014-2,Influenza virus B Ab
17015-9,Influenza virus B Ab.IgG
17016-7,Influenza virus B Ab.IgM
17017-5,Insulin^10M post XXX challenge
17018-3,Insulin^20M post XXX challenge
17019-1,Insulin-like growth factor-I^2H post XXX challenge
1702-0,Acetoacetate
17020-9,Intercellular substance Ab
17021-7,Intercellular substance Ab
17022-5,Interleukin 1+2
17023-3,Interleukin 7
17024-1,Iodine.inorganic
17025-8,Iron
17026-6,Isocyanate Ab.IgE
17027-4,Isocyanate Ab.IgG
17028-2,Isocyanate Ab.IgM
17029-0,Isoleucine
17030-8,Isopropyl ether
17031-6,Jo-1 extractable nuclear Ab
17032-4,Jo-1 extractable nuclear Ab
17033-2,Ketamine
17034-0,Ketoprofen
17035-7,Ketorolac
17036-5,La Crosse virus Ab
17037-3,La Crosse virus Ab
1703-8,Acetoacetate
17038-1,La Crosse virus Ab.IgG
17039-9,La Crosse virus Ab.IgM
17040-7,Labetalol
17041-5,Lactate dehydrogenase
17042-3,Lactoglobulin Ab.IgE
17043-1,Lactose
17044-9,Lamellar bodies
17045-6,Latex Ab.IgE
1704-6,Acetoacetate
17046-4,Latex Ab.IgG
17047-2,Latex Bencard Ab.IgE
17048-0,Latex glove extract Ab.IgE
17049-8,Latex glove extract ammoniated Ab.IgE
17050-6,Latex glove extract buffered Ab.IgE
17051-4,Laxatives
17052-2,Lead
1705-3,Acetoacetate
17053-0,Legionella longbeachae 1 Ab.IgG
17054-8,Legionella longbeachae 1 Ab.IgM
17055-5,Legionella longbeachae 2 Ab.IgG
17056-3,Legionella longbeachae 2 Ab.IgM
17057-1,Legionella pneumophila Ag
17058-9,Legionella pneumophila Ag
17059-7,Legionella pneumophila Ag
17060-5,Legionella pneumophila 1 Ab
1706-1,Acetonitrile
17061-3,Legionella pneumophila 1 Ab.IgM
17062-1,Legionella pneumophila 2 Ab
17063-9,Legionella pneumophila 2 Ab.IgM
17064-7,Legionella pneumophila 3 Ab
17065-4,Legionella pneumophila 3 Ab.IgM
17066-2,Legionella pneumophila 4 Ab
17067-0,Legionella pneumophila 4 Ab.IgM
17068-8,Legionella pneumophila 5 Ab
17069-6,Legionella pneumophila 5 Ab.IgM
17070-4,Legionella pneumophila 6 Ab
17071-2,Legionella pneumophila 7 Ab
17072-0,Legionella pneumophila 8 Ab
17073-8,Legionella pneumophila 9 Ab
17074-6,Leucine
17075-3,Lidocaine
17076-1,Lidocaine
17077-9,Lindane
17078-7,Fatty acids.esterified
1707-9,Acetylcholine
17079-5,Fatty acids.long chain
17080-3,Fatty acids.very long chain
17081-1,Triglyceride^post CFst
17082-9,Lipoprotein.alpha
17083-7,Lipoprotein.beta
17084-5,Lipoprotein.pre-beta
17085-2,Lipoprotein
17086-0,Lithium
1708-7,Acetylcholinesterase
17087-8,Loperamide
17088-6,LORazepam
17089-4,Lorcainide
17090-2,Loxapine+8-Hydroxyloxapine
17091-0,Lumpfish roe Ab.IgE
17092-8,Lupus erythematosus factor
17094-4,Lutropin^105M post XXX challenge
1709-5,Acetylcholinesterase
17095-1,Lutropin^75M post XXX challenge
17096-9,Lymphocytes.kappa/100 lymphocytes
17097-7,Cells.CD10+CD20+/100 cells
17098-5,Cells.CD100/100 cells
17099-3,Cells.CD102/100 cells
17100-9,Cells.CD103/100 cells
17101-7,Cells.CD104/100 cells
17102-5,Cells.CD105/100 cells
1710-3,Acetylcholinesterase
17103-3,Cells.CD106/100 cells
17104-1,Cells.CD107a/100 cells
17105-8,Cells.CD107b/100 cells
17106-6,Cells.CD115/100 cells
17107-4,Cells.CD117/100 cells
17108-2,Cells.CD118/100 cells
17109-0,Cells.CD11a/100 cells
17110-8,Cells.CD11b/100 cells
1711-1,Acid phosphatase
17111-6,Cells.CD12/100 cells
17112-4,Cells.CD120a/100 cells
17113-2,Cells.CD120b/100 cells
17114-0,Cells.CD122/100 cells
17115-7,Cells.CD126/100 cells
17116-5,Cells.CD128/100 cells
17117-3,Cells.CD15/100 cells
17118-1,Cells.CD16b/100 cells
17119-9,Cells.CD16-CD34+/100 cells
17120-7,Cells.CD17/100 cells
17121-5,Cells.CD18/100 cells
17122-3,Cells.CD19+Kappa+/100 cells
17123-1,Cells.CD19+Lambda+/100 cells
17124-9,Cells.CD2+CD20+/100 cells
17125-6,Cells.CD22+CD19+/100 cells
17126-4,Cells.CD24/100 cells
17127-2,Cells.CD26/100 cells
17128-0,Cells.CD27/100 cells
1712-9,Acid phosphatase.prostatic
17129-8,Cells.CD28/100 cells
17130-6,Cells.CD29/100 cells
17131-4,Cells.CD3+CD69+/100 cells
17132-2,Cells.CD3+IL2R1+/100 cells
17133-0,Cells.CD3+CD16+/100 cells
17135-5,Cells.CD3+CD56+/100 cells
17136-3,Cells.CD3+DR+/100 cells
1713-7,Acid phosphatase.prostatic
17137-1,Cells.CD30/100 cells
17138-9,Cells.CD31/100 cells
17139-7,Cells.CD32/100 cells
17140-5,Cells.CD34+DR+/100 cells
17141-3,Cells.CD36/100 cells
17142-1,Cells.CD37/100 cells
17143-9,Cells.CD39/100 cells
17144-7,Cells.CD4+CD69+/100 cells
1714-5,Acid phosphatase.prostatic
17145-4,Cells.CD4+2H4/100 cells
17146-2,Cells.CD4+CD8+/100 cells
17147-0,Cells.CD40/100 cells
17148-8,Cells.CD41/100 cells
17149-6,Cells.CD42a/100 cells
17150-4,Cells.CD42b/100 cells
17151-2,Cells.CD42c/100 cells
1715-2,Acid phosphatase
17152-0,Cells.CD42d/100 cells
17153-8,Cells.CD4+CD45RA+/Cells.CD8
17154-6,Cells.CD43/100 cells
17155-3,Cells.CD44/100 cells
17156-1,Cells.CD44R/100 cells
17157-9,Cells.CD45RA/100 cells
17158-7,Cells.CD45RB/100 cells
17159-5,Cells.CD45RO/100 cells
1716-0,Acidity.titratable
17160-3,Cells.CD46/100 cells
17161-1,Cells.CD47/100 cells
17162-9,Cells.CD48/100 cells
17163-7,Cells.CD49a/100 cells
17164-5,Cells.CD49b/100 cells
17165-2,Cells.CD49c/100 cells
17166-0,Cells.CD49d/100 cells
17167-8,Cells.CD49e/100 cells
17168-6,Cells.CD49f/100 cells
17169-4,Cells.CD5+CD2-/100 cells
17170-2,Cells.CD50/100 cells
17171-0,Cells.CD51/100 cells
17172-8,Cells.CD52/100 cells
17173-6,Cells.CD53/100 cells
17174-4,Cells.CD54/100 cells
17175-1,Cells.CD55/100 cells
17176-9,Cells.CD58/100 cells
17177-7,Cells.CD59/100 cells
1717-8,Acylcarnitine
17178-5,Cells.CD6/100 cells
17179-3,Cells.CD62E/100 cells
17180-1,Cells.CD62L/100 cells
17181-9,Cells.CD62P/100 cells
17182-7,Cells.CD63/100 cells
17183-5,Cells.CD64/100 cells
17184-3,Cells.CD66a/100 cells
17185-0,Cells.CD66b/100 cells
1718-6,Acyl CoA dehydrogenase
17186-8,Cells.CD66c/100 cells
17187-6,Cells.CD66d/100 cells
17188-4,Cells.CD66e/100 cells
17189-2,Cells.CD68/100 cells
171-9,Cephradine
17190-0,Cells.CD69/100 cells
17191-8,Cells.CD3-CD7+/100 cells
17192-6,Cells.CD72/100 cells
17193-4,Cells.CD73/100 cells
1719-4,Adenine
17194-2,Cells.CD74/100 cells
17195-9,Cells.CD77/100 cells
17196-7,Cells.CD79a/100 cells
17197-5,Cells.CD79b/100 cells
17198-3,Cells.CD8+CD28+/100 cells
17199-1,Cells.CD80/100 cells
17200-7,Cells.CD82/100 cells
17201-5,Cells.CD83/100 cells
1720-2,Adenine phosphoribosyltransferase
17202-3,Cells.CD85/100 cells
17203-1,Cells.CD86/100 cells
17204-9,Cells.CD87/100 cells
17205-6,Cells.CD88/100 cells
17206-4,Cells.CD9/100 cells
17207-2,Cells.CD91/100 cells
17208-0,Cells.CD93/100 cells
17209-8,Cells.CD94/100 cells
1721-0,Adenosine triphosphate
17210-6,Cells.CD95/100 cells
17211-4,Cells.CD96/100 cells
17212-2,Cells.CD97/100 cells
17213-0,Cells.CD98/100 cells
17214-8,Cells.CD99/100 cells
17215-5,Lymphocytes.CV/100 lymphocytes
17216-3,Cells.cytoplasmic CD3/100 cells
17217-1,Cells.cytoplasmic CD79/100 cells
17218-9,Cells.cytoplasmic Ig mu/100 cells
17219-7,Cells.cytoplasmic Ig/100 cells
17220-5,Cells.FMC7/100 cells
17221-3,Cells.CD235a/100 cells
17222-1,Lymphocytes.HLE/100 lymphocytes
17223-9,Cells.CD14/100 cells
17224-7,Lymphocytes.lambda/100 lymphocytes
17225-4,Lymphocytes.SmIg/100 lymphocytes
17226-2,Cells.SmIg-CD79/100 cells
17227-0,Lymphocytes/100 leukocytes
1722-8,Adenosine deaminase
17228-8,Lymphocytic choriomeningitis virus Ab
17229-6,Lymphocytic choriomeningitis virus Ab.IgM
17230-4,Lysine
17231-2,Lysosomal enzymes
17232-0,Lysozyme
17234-6,Magnesium.plasma/Magnesium.RBC
17235-3,Magnesium
1723-6,Adenosine deaminase binding protein
17236-1,Magnesium
17237-9,Magnesium
17238-7,Malignin Ab
17241-1,Prolactin^3H post XXX challenge
17242-9,Prolactin^40M post XXX challenge
17243-7,Prolactin^pre XXX challenge
1724-4,Adenosine diphosphate
17244-5,Manganese
17245-2,Meclizine
17246-0,Mefenamate
17247-8,Melanin
17248-6,Melanin
17249-4,Menthol
17250-2,Mephobarbital
1725-1,Adenosine monophosphate deaminase
17251-0,Mepivacaine
17252-8,Mercaptopurine
17253-6,Mercury
17254-4,Mercury
17255-1,Mercury
17256-9,Mesoridazine
17257-7,Mesothelial cells
17258-5,Metandienone
17259-3,Methadone.long acting metabolite
17260-1,Methamphetamine
17261-9,Methapyrilene
17263-5,Methemalbumin
17264-3,Methionine
17265-0,Methocarbamol
17266-8,Methotrexate
17267-6,Methoxychlor
17268-4,Methsuximide+Desmethylmethsuximide
1726-9,Adenosine monophosphate.cyclic
17269-2,Methyl isobutyl ketone
172-7,Chloramphenicol
17270-0,Methylacrylate
17271-8,"1,1,1-Trichloroethane"
17272-6,Methylenedianiline
17273-4,MethylePHEDrine
17274-2,Methylergonovine
17275-9,Methylfentanyl
17276-7,2-Methylpentane
1727-7,Adenosine monophosphate.cyclic
17277-5,metOLazone
17278-3,Miconazole
17279-1,Bacteria identified
17280-9,Plasmodium sp identified
17281-7,Microscopic observation
17282-5,Minoxidil
17283-3,Mirtazapine
17284-1,Mitochondria Ab
1728-5,Adenosine monophosphate.cyclic/Creatinine
17285-8,Mitochondria Ab
17286-6,Monocytes/100 leukocytes
17287-4,Monocytes/100 leukocytes
17288-2,Ganglioside GM1 Ab
17289-0,Monosodium glutamate Ab.IgE
17290-8,Morphine
17291-6,Morus alba Ab.IgE
17292-4,Mumps virus Ab
1729-3,Adenosine triphosphatase
17293-2,Mumps virus Ab.IgG+IgM
17294-0,Mushroom toxins
17296-5,Mycobacterium tuberculosis complex rRNA
17297-3,Mycobacterium tuberculosis rRNA
17298-1,Mycobacterium tuberculosis rRNA
17299-9,Mycoplasma fermentans Ab
17300-5,Mycoplasma hominis Ab
1730-1,Adenosine triphosphatase
17301-3,Mycoplasma hominis Ab
17302-1,Mycoplasma pneumoniae Ab
17303-9,Mycoplasma pneumoniae Ab
17304-7,Mycoplasma pneumoniae Ab.IgG+IgM
17305-4,Myelin Ab.IgA
17306-2,Myelin Ab.IgG
17307-0,Myelin Ab.IgM
17308-8,Myelin associated glycoprotein Ab
17310-4,Myelin associated glycoprotein Ab
17311-2,Myelin associated glycoprotein Ab.IgA
17312-0,Myelin associated glycoprotein Ab.IgG
17313-8,Myelin associated glycoprotein Ab.IgG
17314-6,Myelin associated glycoprotein Ab.IgM
17315-3,Myelin basic protein Ab
17316-1,Myeloperoxidase Ab
17317-9,N-acetylprocainamide
17318-7,Nalbuphine
1731-9,Adenylate kinase
17319-5,Nalidixate
17320-3,Nefazodone
17321-1,Neisseria meningitidis serogroups A+Y Ag
17322-9,Neisseria meningitidis Ab
17323-7,Neisseria meningitidis Ag
17324-5,Neisseria meningitidis Ag
17325-2,Neisseria meningitidis serogroups C+w135 Ag
17326-0,Neisseria meningitidis serogroup A Ag
1732-7,Adenylosuccinate lyase
17327-8,Neisseria meningitidis serogroup B Ab
17328-6,Neisseria meningitidis serogroup B Ag
17329-4,Neisseria meningitidis serogroup C Ag
17330-2,Neisseria meningitidis serogroup Y Ag
17331-0,Neisseria meningitidis polyvalent Ab
17332-8,Neisseria meningitidis polyvalent Ag
17333-6,Neisseria meningitidis serogroup w135 Ag
17334-4,Neopterin/Creatinine
1733-5,Adipate
17335-1,Neostigmine
17336-9,Neuronal Ab
17337-7,Neuronal Ab
17338-5,Neuronal Ab
17339-3,Neuronal Ab
17340-1,Neuronal Ab.IgG
17341-9,Neuronal nuclear Ab
17342-7,Neuronal nuclear type 2 Ab
1734-3,Aldosterone renal clearance
17343-5,Neuronal nuclear type 2 Ab
17344-3,Neuronal nuclear type 2 Ab
17345-0,Neutrophil Ab
17346-8,Neutrophil Ab
17347-6,Neutrophil Ab
17348-4,Neutrophil Ab.IgA
17349-2,Neutrophil Ab.IgG
173-5,Chloramphenicol
1735-0,Alanine
17350-0,Neutrophil Ab.IgM
17351-8,Neutrophil cytoplasmic Ab
17352-6,Neutrophil cytoplasmic Ab
17353-4,Neutrophil cytoplasmic Ab.classic
17354-2,Neutrophil cytoplasmic Ab.IgA
17355-9,Neutrophil cytoplasmic Ab.IgG
17356-7,Neutrophil cytoplasmic Ab.IgM
17357-5,Neutrophil cytoplasmic Ab.perinuclear
17358-3,Neutrophil cytoplasmic Ab.atypical
17359-1,Neutrophils
17360-9,Heptane
17361-7,Hexane
17362-5,Nicotinamide
17363-3,Nitrazepam
17364-1,Nitrophenol
17365-8,Nitroprusside
17366-6,Nizatidine
17367-4,Nomifensine
1736-8,Alanine
17368-2,Norepinephrine^standing
17369-0,Norepinephrine^2nd specimen post XXX challenge
17370-8,Norepinephrine^3rd specimen post XXX challenge
17371-6,Norepinephrine^4th specimen post XXX challenge
17372-4,Norepinephrine^5th specimen post XXX challenge
17373-2,Norepinephrine^6th specimen post XXX challenge
17374-0,Norepinephrine^7th specimen post XXX challenge
17375-7,Norflunitrazepam
1737-6,Alanine
17376-5,Norpropoxyphene
17377-3,Norpropoxyphene
17378-1,Novobiocin
17379-9,Propanol
17380-7,Nuclear Ab.histone reactive
17381-5,Uroporphyrin
17382-3,Octadecanoate
1738-4,Alanine
17384-9,Opiates
17385-6,Organic acids
17386-4,Organic acids
17387-2,Organic acids
17388-0,Organochlorine pesticides
17389-8,Ornithine
17390-6,Orphenadrine
17391-4,Orthocresol
1739-2,Alanine
17392-2,Osmium
17393-0,Ovary Ab
17394-8,Oxychlordane
17395-5,oxyMORphone
17396-3,Oxytetracycline
17397-1,Oxytriphylline
17398-9,Human papilloma virus 11 Ag
17399-7,Human papilloma virus 16 Ag
17-Apr,Amoxicillin
1740-0,Alanine aminopeptidase
17400-3,Human papilloma virus 16+18 Ag
17401-1,Human papilloma virus 18 Ag
17402-9,Human papilloma virus 31 Ag
17403-7,Human papilloma virus 31+33+35 Ag
17404-5,Human papilloma virus 33 Ag
17405-2,Human papilloma virus 42 Ag
17406-0,Human papilloma virus 43 Ag
17407-8,Human papilloma virus 44 Ag
17408-6,Human papilloma virus 45 Ag
17409-4,Human papilloma virus 5 Ag
17410-2,Human papilloma virus 51 Ag
17411-0,Human papilloma virus 6 Ag
17412-8,Human papilloma virus 6+11 Ag
17413-6,Papova virus SV40 Ab
17414-4,Parainfluenza virus 1+2+3 Ag
17415-1,Parainfluenza virus A Ab
17416-9,Parakeet droppings Ab
17417-7,Parakeet droppings Ab.IgG
1741-8,Alanine aminotransferase
17418-5,Parakeet serum Ab
17419-3,Parathion
17420-1,Parrot droppings Ab
17421-9,Parrot serum Ab
17422-7,Parvovirus B19 Ab.IgG+IgM
17423-5,Parvovirus B19 Ab.IgM
17424-3,"1,4-Dichlorobenzene"
1742-6,Alanine aminotransferase
17426-8,Penicillium roqueforti Ab.IgE
17427-6,Penicillium sp Ab
17428-4,Pentacarboxylporphyrins
17429-2,Pentachlorophenol
174-3,Chloramphenicol
17430-0,Pentane
17431-8,PENTobarbital
17432-6,Tetrachloroethylene
17433-4,pH
1743-4,Alanine aminotransferase
17434-2,Phenazopyridine
17435-9,Pheniramine
17436-7,PHENobarbital
17437-5,Phenolphthalein
17438-3,Phenolphthalein
17439-1,Phenols
17440-9,Phenothiazines
17441-7,Phenothiazines
1744-2,Alanine aminotransferase
17442-5,Phenylephrine
17443-3,Phenylpropanolamine
17444-1,Phenytoin
17445-8,Phoma herbarum Ab.IgG
17446-6,Phoma sp Ab.IgE
17447-4,Phosphate
17448-2,Phosphatidylethanolamine Ab.IgA
17449-0,Phosphatidylethanolamine Ab.IgG
17450-8,Phosphatidylethanolamine Ab.IgM
17451-6,Phosphatidylglycerol Ab.IgA
17452-4,Phosphatidylglycerol Ab.IgG
17453-2,Phosphatidylglycerol Ab.IgM
17454-0,Phosphatidylinositol Ab.IgA
17455-7,Phosphatidylinositol Ab.IgG
17456-5,Phosphatidylinositol Ab.IgM
17457-3,Phosphoethanolamine
17458-1,Phosphoethanolamine
1745-9,Albumin
17459-9,Phospholipid Ab.IgA
17460-7,Phosphoserine
17461-5,Phosphoserine
17462-3,Picloram
17463-1,Pigeon droppings Ab
17464-9,Pigeon feather Ab.IgE
17465-6,Pigeon serum Ab.IgE
17466-4,Plasminogen activator inhibitor 1 Ag
1746-7,Albumin
17467-2,Plasminogen activator inhibitor 2 Ag
17468-0,Plutonium
17469-8,PM-1 Ab
17470-6,PM-1 Ab
17471-4,PM-1 Ab
17472-2,Polybrominated biphenyl
17473-0,Polymyxin B
17474-8,Porphobilinogen
1747-5,Albumin
17475-5,Porphyrins
17476-3,Porphyrins
17477-1,Porphyrins
17478-9,Porphyrins
17479-7,Prazepam
17480-5,Pregnenolone
17481-3,Probenecid
17482-1,Procainamide
1748-3,Albumin
17483-9,Progesterone
17484-7,Progesterone^1.5H post XXX challenge
17485-4,Progesterone^15M post XXX challenge
17486-2,Progesterone^2H post XXX challenge
17487-0,Progesterone^45M post XXX challenge
17488-8,Progesterone^7th specimen post XXX challenge
17489-6,Progesterone^8th specimen post XXX challenge
17490-4,Progesterone^9th specimen post XXX challenge
1749-1,Albumin
17491-2,Proinsulin^baseline
17492-0,Proline
17493-8,Prostaglandin E
17494-6,Prostaglandin F2 alpha
17495-3,Prostaglandins
17496-1,Alpha 1 globulin
17497-9,Alpha 2 globulin
17498-7,Beta globulin
17499-5,Gamma globulin
175-0,Chloramphenicol
17501-8,Protoporphyrin
17502-6,Pseudomonas aeruginosa Ab
17504-2,Psilocybin
17505-9,Psilocybin/Psilocin
17506-7,Quinacrine
17507-5,quiNIDine
17508-3,quiNINE
1750-9,Albumin
17509-1,Ragweed marsh Ab.IgE
17510-9,Raisin Ab.IgE
17511-7,Red dye Ab.IgE
17512-5,Redfish Ab.IgE
17513-3,Renin^5H post XXX challenge
17514-1,Renin^9th specimen post XXX challenge
17515-8,Renin^baseline
17516-6,Renin^supine
1751-7,Albumin
17517-4,Respiratory syncytial virus Ab.IgG
17518-2,Respiratory syncytial virus Ab.IgG
17519-0,Respiratory syncytial virus Ab.IgM
17520-8,Respiratory syncytial virus identified
17521-6,Reticulin Ab
17522-4,Reticulin Ab.IgA
17523-2,Reticulin Ab.IgG
17524-0,Reticulin Ab.IgG
1752-5,Albumin
17525-7,Retinoate esters
17526-5,Retinyl esters
17527-3,Retinol.free
17528-1,Retinol^3H post dose
17529-9,Retinol^6H post dose
17530-7,Retrovirus identified
17531-5,Rh
17532-3,Rheumatoid arthritis nuclear Ab
1753-3,Albumin
17533-1,Rheumatoid arthritis nuclear Ab
17534-9,Rheumatoid factor
17535-6,Ribonucleoprotein extractable nuclear Ab
17536-4,Ribonucleoprotein extractable nuclear Ab
17537-2,Rickettsia spotted fever group RNA
17538-0,Rickettsia spotted fever group RNA
17539-8,Rickettsia typhi Ab
17540-6,Rickettsia typhi Ab.IgA
1754-1,Albumin
17541-4,Rickettsia typhi Ab.IgG
17544-8,Bartonella quintana Ab.IgG
17545-5,Bartonella quintana Ab.IgM
17546-3,Bartonella quintana rRNA
17547-1,Rotavirus Ag
17548-9,Rotavirus RNA
17549-7,Rubella virus Ab
17550-5,Rubella virus Ab
17551-3,Rubella virus Ab.IgG
17552-1,Rubella virus Ab.IgM
17553-9,Measles virus Ab
17554-7,Measles virus Ab.IgA
17555-4,Measles virus Ab^1st specimen
17556-2,Measles virus Ab^2nd specimen
17557-0,Saccharomonospora viridis Ab.IgG
1755-8,Albumin
17558-8,Saint Louis encephalitis virus Ab
17559-6,Salicylates
17560-4,Salicylates
17561-2,Salmo salar roe Ab.IgE
17562-0,Salmonella sp Ab
17563-8,Salmonella sp identified
17564-6,Salmonella typhi O D Ab
17565-3,Salmonella typhi H D Ab
1756-6,Albumin.CSF/Albumin.SerPl
17566-1,Salmonella typhi O Ab
17567-9,Sasapyrine
17568-7,Sarcosine
17569-5,SCL-70 extractable nuclear Ab
17570-3,SCL-70 extractable nuclear Ab.IgG
17571-1,Scopolamine
17572-9,2-Butanol
17573-7,Secobarbital
1757-4,Albumin renal clearance
17574-5,Selenium
17575-2,Serine
17576-0,Shigella sp identified
17577-8,Ganglioside GQ1a Ab.IgM
17578-6,Ganglioside GQ1b Ab
17579-4,Ganglioside GQ1b Ab.IgG
17580-2,Ganglioside GQ1b Ab.IgG
17581-0,Ganglioside GQ1b Ab.IgM
1758-2,Albumin.glycated
17582-8,Silver
17583-6,Sjogrens syndrome-A extractable nuclear Ab
17584-4,Sjogrens syndrome-A extractable nuclear Ab
17585-1,Sjogrens syndrome-A extractable nuclear Ab.IgG
17586-9,Sjogrens syndrome-B extractable nuclear Ab
17587-7,Sjogrens syndrome-B extractable nuclear Ab
17588-5,Sjogrens syndrome-B extractable nuclear Ab.IgG
17589-3,Smith extractable nuclear Ab
1759-0,Albumin/Globulin
17590-1,Smith extractable nuclear Ab
17591-9,Smith extractable nuclear Ab
17592-7,Smith extractable nuclear Ab
17593-5,Smooth muscle Ab
17594-3,Somatotropin^1.5H post XXX challenge
17595-0,Somatotropin^1H post XXX challenge
17597-6,Somatotropin^52H post XXX challenge
17598-4,Specific gravity
17599-2,Specimen volume
17600-8,Specimen volume
17601-6,Specimen volume
17602-4,Specimen volume
17603-2,Specimen volume
17604-0,Specimen volume
17605-7,Specimen volume
17606-5,Specimen volume
17607-3,Specimen volume
1760-8,Alcohol dehydrogenase
17608-1,Specimen weight
17609-9,Specimen weight
17610-7,Spermatozoa.motile^30M post collection
17611-5,Stimulants
17612-3,Streptococcus pneumoniae 1 Ab^1st specimen
17613-1,Streptococcus pneumoniae 1 Ab^2nd specimen
17614-9,Streptococcus pneumoniae 12 Ab
17615-6,Streptococcus pneumoniae 12f Ab^1st specimen
1761-6,Aldolase
17616-4,Streptococcus pneumoniae 12f Ab^2nd specimen/Streptococcus pneumoniae 12f Ab^1st specimen
17617-2,Streptococcus pneumoniae 14 Ab^1st specimen
17618-0,Streptococcus pneumoniae 14 Ab^2nd specimen
17619-8,Streptococcus pneumoniae 14 Ab^2nd specimen/1st specimen
17620-6,Streptococcus pneumoniae 18c Ab^1st specimen
17621-4,Streptococcus pneumoniae 18c Ab^2nd specimen
17622-2,Streptococcus pneumoniae 18 Ab^1st specimen
17623-0,Streptococcus pneumoniae 19f Ab^2nd specimen
1762-4,Aldosterone
17624-8,Streptococcus pneumoniae 23f Ab^1st specimen
17625-5,Streptococcus pneumoniae 23f Ab^2nd specimen
17626-3,Streptococcus pneumoniae 3 Ab^1st specimen
17627-1,Streptococcus pneumoniae 3 Ab^1st specimen
17628-9,Streptococcus pneumoniae 3 Ab^2nd specimen
17629-7,Streptococcus pneumoniae 3 Ab^2nd specimen
17630-5,Streptococcus pneumoniae 3 Ab^2nd specimen/1st specimen
17631-3,Streptococcus pneumoniae 36a+6b Ab.IgG
1763-2,Aldosterone
17632-1,Streptococcus pneumoniae 4 Ab.IgG
17633-9,Streptococcus pneumoniae 4 Ab^1st specimen
17634-7,Streptococcus pneumoniae 4 Ab^2nd specimen
17635-4,Streptococcus pneumoniae Danish serotype 18C Ab.IgG
17636-2,Streptococcus pneumoniae 6b Ab^1st specimen
17637-0,Streptococcus pneumoniae 6b Ab^2nd specimen
17638-8,Streptococcus pneumoniae Danish serotype 7F Ab^1st specimen
17639-6,Streptococcus pneumoniae Danish serotype 7F Ab^2nd specimen
1764-0,Aldosterone
17640-4,Streptococcus pneumoniae Danish serotype 7F Ab^2nd specimen/1st specimen
17641-2,Streptococcus pneumoniae 8 Ab
17642-0,Streptococcus pneumoniae 8 Ab
17643-8,Streptococcus pneumoniae 9 Ab
17644-6,Streptococcus pneumoniae 9 Ab^1st specimen/2nd specimen
17645-3,Streptococcus pneumoniae 9 Ab^1st specimen
17646-1,Streptococcus pneumoniae 9 Ab^2nd specimen
17647-9,Streptococcus pneumoniae Ab
17648-7,Streptococcus pneumoniae Ab
17649-5,Streptococcus pneumoniae Ab.IgG^1st specimen/2nd specimen
17650-3,Streptococcus pneumoniae Ab.IgG^1st specimen
17651-1,Streptococcus pneumoniae Ab.IgG^2nd specimen
17652-9,Streptococcus pneumoniae Ag
17653-7,Streptococcus pneumoniae group A Ag
17654-5,Streptococcus pneumoniae group B Ab
17655-2,Streptococcus pneumoniae group B Ag
17656-0,Streptococcus pyogenes
1765-7,Aldosterone
17657-8,Streptolysin O Ab
17658-6,Strontium/Creatinine
17659-4,Strychnine
17660-2,Strychnine
17661-0,Succinylcholine
17662-8,Succinylpurines
17663-6,sulfADIAZINE Ab.IgE
17664-4,Sulfalazine Ab.IgE
1766-5,Aldosterone receptors
17665-1,Sulfamedraxozole Ab.IgE
17666-9,Sulfate
17667-7,Sulfate.organic/Sulfate.total
17668-5,Sulfatide Ab.IgG
17669-3,Sulfatide Ab.IgG
17670-1,Sulfatide Ab.IgM
17671-9,Sulfatide Ab.IgM
17672-7,Sulfide
1767-3,Aldosterone^supine
17673-5,sulfiSOXAZOLE Ab.IgE
17674-3,Sulfonamide
17675-0,Sulfonamide
17676-8,Sulindac sulfide metabolite
17677-6,Helianthus annuus Ab.IgE
17678-4,Taurine
17679-2,Taurine
176-8,Chlortetracycline
1768-1,Aldosterone^upright
17681-8,Tellurium
17682-6,Terpineol
17683-4,2-Methyl-2-Propanol
17685-9,Testosterone.free
17686-7,Testosterone.weakly bound
17687-5,Testosterone/Epitestosterone
17688-3,Testosterone^1.5H post XXX challenge
17689-1,Testosterone^15M post XXX challenge
17690-9,Testosterone^2H post XXX challenge
17691-7,Testosterone^30M post XXX challenge
17692-5,Testosterone^45M post XXX challenge
17693-3,Testosterone^4D post XXX challenge
17694-1,Coproporphyrin
17695-8,Tetrachlorodiphenylethane
17696-6,Tetrachlorodiphenylethane
17697-4,Tetrachloroethane
17698-2,Tetraethyl lead
1769-9,Fatty acids.nonesterified
17699-0,Thebaine
17700-6,Theophylline
17701-4,Thiazides
17703-0,Thorium
17704-8,Threonine
17705-5,Thyroglobulin Ab.IgM
17706-3,Thyroperoxidase Ab
1770-7,Aliphatic carboxylate C14-C26.absorption
17707-1,Thyroperoxidase Ab.IgM
17708-9,Thyroid stimulating immunoglobulins
17709-7,Ticlopidine
17710-5,Tin/Creatinine
17712-1,Toluene diisocyanate
17713-9,Topiramate
17714-7,Toxaphene
1771-5,Aliphatic carboxylate C14-C26.esters
17715-4,Toxocara canis Ab
17716-2,Toxoplasma gondii Ab.IgE
17717-0,Toxoplasma gondii Ab.IgG+IgM
17718-8,traMADol
17719-6,traMADol
17720-4,Trans nonachlor
17721-2,Trans nonachlor
1772-3,Aliphatic carboxylate C14-C26.esters
17723-8,Treponema pallidum Ab
17724-6,Treponema pallidum Ab
17725-3,Treponema pallidum Ab
17726-1,Treponema pallidum Ab.IgG
17727-9,Treponema pallidum Ab.IgG
17728-7,Treponema pallidum Ab.IgM
17729-5,Treponema pallidum Ab.IgM
17730-3,Triamterene
1773-1,Fatty acids.very long chain.C24:0/C22:0
17732-9,Trichinella spiralis Ab
17733-7,Trichinella spiralis Ab.IgA
17734-5,Trichinella spiralis Ab.IgG
17735-2,Trichinella spiralis Ab.IgM
17736-0,Trichloroacetate
17737-8,Trichloroethane
17738-6,Chloral hydrate
17739-4,Chloral hydrate
17740-2,Trichlorophenoxyacetate
17741-0,Trichlorophenoxyacetate
17742-8,Trichlorothiazide
17743-6,Triiodothyronine resin uptake (T3RU)^1H post XXX challenge
17744-4,Trimellitic anhydride Ab.IgG
17745-1,Trimellitic anhydride Ab.IgM
17746-9,Trimeprazine
17747-7,Trimethoprim
17748-5,Trimethylamine
1774-9,Fatty acids.very long chain.C26:0/C22:0
17749-3,Tromethamine
17750-1,Trypsinogen
17751-9,Tryptamine
17752-7,Tryptophan
17753-5,Tungsten
17754-3,Tyrosine
17755-0,Urate
1775-6,Alkaline phosphatase
17756-8,Urate
17757-6,Urea nitrogen
17758-4,Urea nitrogen
17759-2,Urea nitrogen^post dialysis
177-6,Chlortetracycline
17760-0,Urea nitrogen^pre dialysis
17761-8,Urobilinogen
17762-6,Valproate
17763-4,Varicella zoster virus Ab.IgG
1776-4,Alkaline phosphatase
17764-2,Varicella zoster virus Ab.IgG
17765-9,Varicella zoster virus Ab.IgG
17766-7,Varicella zoster virus Ab.IgM
17767-5,Verapamil
17768-3,Vinyl chloride
17769-1,Western equine encephalitis virus Ab
17770-9,Western equine encephalitis virus Ab
17771-7,Whitefish roe Ab.IgE
1777-2,Alkaline phosphatase.bone
17772-5,Dimethylbenzene
17773-3,Yeast
17774-1,Yellow dye Ab.IgE
17775-8,Yersinia sp Ab.IgA
17776-6,Yersinia sp Ab.IgG
17777-4,Yersinia sp Ab.IgM
17778-2,Zinc
1778-0,Alkaline phosphatase.intestinal
17780-8,Helicobacter pylori Ag
17781-6,21-Hydroxylase Ab
17782-4,Lipoprotein.beta.subparticle
17783-2,Hemosiderin
17784-0,Parasite identified
17785-7,Radioactive iodine.thyroid/Radioactive iodine.dose
17786-5,Thyrotropin^post dose TRH
17787-3,Study report
17788-1,Large unstained cells/100 leukocytes
17789-9,Large unstained cells
17790-7,Leukocytes.left shift
17791-5,Sjogrens syndrome-B extractable nuclear Ab
17792-3,Sjogrens syndrome-A extractable nuclear Ab
17793-1,Immunoglobulin light chains
17794-9,Osmolality
17795-6,Potassium
17796-4,Sodium
17797-2,Thyroid colloidal Ab
1779-8,Alkaline phosphatase.liver
17798-0,Amikacin
17799-8,Promyelocytes/100 leukocytes
17800-4,Myelocytes/100 leukocytes
17801-2,Metamyelocytes/100 leukocytes
17802-0,Prolymphocytes/100 leukocytes
17803-8,Plasma cells/100 leukocytes
17804-6,Promonocytes/100 leukocytes
17805-3,Procainamide
1780-6,Alkaline phosphatase.placental
17806-1,N-acetylprocainamide
17807-9,cycloSPORINE
17808-7,Tobramycin
17809-5,Hematocrit
17810-3,Prealbumin/Protein.total
17811-1,Alpha 1 globulin/Protein.total
17812-9,Alpha 1 globulin/Protein.total
17813-7,Alpha 2 globulin/Protein.total
1781-4,Alkaline phosphatase.regan
17814-5,Alpha 2 globulin/Protein.total
17815-2,Beta globulin/Protein.total
17816-0,Beta globulin/Protein.total
17817-8,Gamma globulin/Protein.total
17818-6,Gamma globulin/Protein.total
17819-4,Albumin/Protein.total
17820-2,Albumin/Protein.total
17821-0,Protein fractions.oligoclonal bands
1782-2,Alkaline phosphatase.renal
17822-8,Cells.CD3+CD4+/100 cells
17823-6,Cells.CD45/100 cells
17824-4,Cells.CD3+CD8+/100 cells
17825-1,Cells.CD41a/100 cells
17826-9,Cells.CD3/100 cells
17827-7,Cells.CD2/100 cells
17828-5,Cells.CD16/100 cells
17829-3,Cells.CD19/100 cells
1783-0,Alkaline phosphatase
17830-1,Centromere Ab
17831-9,5-Fluorocytosine
17832-7,5-Fluorocytosine
17833-5,Basophils/100 leukocytes
17834-3,Eosinophils/100 leukocytes
17835-0,Monocytes/100 leukocytes
17836-8,Neutrophils/100 leukocytes
17837-6,Acid phosphatase.tartrate resistant
17838-4,Alkaline phosphatase.bone
17839-2,Alpha fucosidase
178-4,Chlortetracycline
17840-0,Alpha-L-iduronidase
17841-8,Amylase
17842-6,Cancer Ag 27-29
17843-4,Cancer Ag 72-4
17844-2,Estradiol.albumin bound
17845-9,Lipoprotein.alpha
17846-7,Lipoprotein.beta
17847-5,Lipoprotein.pre-beta
1784-8,Alpha amino acid nitrogen
17848-3,Reticulocytes/1000 erythrocytes
17849-1,Reticulocytes/100 erythrocytes
17850-9,Herpes simplex virus 1 Ab.IgG
17851-7,Herpes simplex virus 2 Ab.IgG
17852-5,Ureaplasma urealyticum
17853-3,Ganglioside GM1b Ab.IgG
17854-1,Ganglioside GM1b Ab.IgM
1785-5,Alpha amino acid nitrogen
17855-8,Hemoglobin A1c/Hemoglobin.total
17856-6,Hemoglobin A1c/Hemoglobin.total
17857-4,Rheumatoid factor
17858-2,Gamma glutamyl transferase
17859-0,Helicobacter pylori Ab.IgG
17860-8,3-Methylhistidine
17861-6,Calcium
17862-4,Calcium
1786-3,Alpha aminobutyrate
17863-2,Calcium.ionized
17864-0,Calcium.ionized
17865-7,Glucose^post 8H CFst
17866-5,Carnitine/Creatinine
17867-3,Carnitine.free (C0)/Creatinine
17868-1,Acylcarnitine/Creatinine
17869-9,Orotate/Creatinine
17870-7,Orotidine/Creatinine
1787-1,Alpha aminobutyrate
17871-5,Hemoglobin H
17872-3,Tetrahydrocannabinol
17873-1,Bacteria identified^^^2
17874-9,Bacteria identified^^^3
17875-6,Bacteria identified^^^4
17876-4,Bacteria identified^^^5
17877-2,Bacteria identified^^^6
17878-0,Bacteria identified^^^2
17879-8,Bacteria identified^^^3
17880-6,Bacteria identified^^^4
17881-4,Bacteria identified^^^5
17882-2,Bacteria identified^^^6
17883-0,Bacteria identified^^^2
17884-8,Bacteria identified^^^3
17885-5,Bacteria identified^^^4
17886-3,Bacteria identified^^^5
17887-1,Bacteria identified^^^6
17888-9,Bacteria identified^^^2
1788-9,Alpha aminobutyrate
17889-7,Bacteria identified^^^3
17890-5,Bacteria identified^^^4
17891-3,Bacteria identified^^^5
17892-1,Bacteria identified^^^6
17893-9,Bacteria identified^^^2
17894-7,Bacteria identified^^^3
17895-4,Bacteria identified^^^4
17896-2,Bacteria identified^^^5
1789-7,Alpha aminobutyrate
17897-0,Bacteria identified^^^6
17898-8,Bacteria identified
17899-6,Bacteria identified^^^2
17900-2,Bacteria identified^^^3
17901-0,Bacteria identified^^^4
17902-8,Bacteria identified^^^5
17903-6,Bacteria identified^^^6
17904-4,Bacteria identified^^^2
1790-5,Alpha aminobutyrate
17905-1,Bacteria identified^^^3
17906-9,Bacteria identified^^^4
17907-7,Bacteria identified^^^5
17908-5,Bacteria identified^^^6
17909-3,Bacteria identified
17910-1,Bacteria identified^^^2
17911-9,Bacteria identified^^^3
17912-7,Bacteria identified^^^4
1791-3,Alpha aminoadipate
17913-5,Bacteria identified^^^5
17914-3,Bacteria identified^^^6
17915-0,Bacteria identified
17916-8,Bacteria identified^^^2
17917-6,Bacteria identified^^^3
17918-4,Bacteria identified^^^4
17919-2,Bacteria identified^^^5
179-2,Chlortetracycline
17920-0,Bacteria identified^^^6
1792-1,Alpha aminoadipate
17921-8,Bacteria identified^^^2
17922-6,Bacteria identified^^^3
17923-4,Bacteria identified^^^2
17924-2,Bacteria identified^^^3
17925-9,Bacteria identified
17926-7,Bacteria identified^^^2
17927-5,Bacteria identified^^^3
17928-3,Bacteria identified
17929-1,Bacteria identified^^^2
17930-9,Bacteria identified^^^3
17931-7,Bacteria identified^^^4
17932-5,Bacteria identified^^^5
17933-3,Bacteria identified^^^6
17934-1,Bacteria identified
17935-8,Bacteria identified^^^2
17936-6,Bacteria identified^^^3
17937-4,Bacteria identified^^^2
17938-2,Bacteria identified^^^3
1793-9,Alpha aminoadipate
17939-0,Bacteria identified^^^4
17940-8,Bacteria identified^^^5
17941-6,Bacteria identified^^^6
17942-4,Bacteria identified^^^2
17943-2,Bacteria identified^^^3
17944-0,Bacteria identified^^^4
17945-7,Bacteria identified^^^5
17946-5,Bacteria identified^^^6
1794-7,Amylase
17947-3,Fungus identified^^^2
17948-1,Fungus identified^^^3
17949-9,Fungus identified^^^4
17950-7,Microorganism identified
17951-5,Bacteria identified^^^2
17952-3,Bacteria identified^^^3
17953-1,Bacteria identified^^^4
1795-4,Amylase
17954-9,Bacteria identified^^^5
17955-6,Bacteria identified^^^6
17956-4,Bacteria identified
17957-2,Bacteria identified^^^2
17958-0,Bacteria identified^^^3
17959-8,Bacteria identified^^^2
17960-6,Bacteria identified^^^3
17961-4,Bacteria identified^^^4
1796-2,Amylase
17962-2,Bacteria identified^^^5
17963-0,Bacteria identified^^^6
17964-8,Bacteria identified^^^2
17965-5,Bacteria identified^^^3
17966-3,Bacteria identified^^^4
17967-1,Bacteria identified^^^5
17968-9,Bacteria identified^^^6
17969-7,Bacteria identified
1797-0,Amylase
17970-5,Bacteria identified^^^2
17971-3,Bacteria identified^^^3
17972-1,Bacteria identified^^^4
17973-9,Bacteria identified^^^5
17974-7,Bacteria identified^^^6
17975-4,Virus identified^^^2
17976-2,Virus identified^^^3
17977-0,Area
17978-8,A wave.max
17979-6,A-C duration
17980-4,A-C slope
17981-2,Acceleration
17982-0,Acceleration
17983-8,Acceleration
17984-6,Aortic valve area method
17985-3,AP dimension.left atrium/AP dimension.aorta root
17986-1,Apical 2 chamber.diastole.max
17987-9,Apical 2 chamber.systole.min
1798-8,Amylase
17988-7,Apical 4 chamber
17989-5,Apical 4 chamber.diastole.max
17990-3,Apical 4 chamber.systole.min
17991-1,Cardiac echo LV volume method
17992-9,Cardiac output
17993-7,Cardiac output
17994-5,Cardiac output
17995-2,Coarctation.pressure gradient.max
1799-6,Amylase
17996-0,Cusp separation.max
17997-8,D-E excursion
17998-6,Regurgitant jet deceleration
17999-4,Deceleration
08-Jan,Acyclovir
180-0,Cinoxacin
18000-0,Deceleration
18001-8,Deceleration.pressure.half time
1800-2,Amylase
18002-6,Deceleration slope
18003-4,Regurgitant deceleration time slope
18004-2,Defect.diameter
18005-9,Defect.diameter
18006-7,Diameter
18007-5,Diameter
18008-3,Defect.pressure gradient.systole.max
18009-1,Defect.pressure gradient.systole.mean
1801-0,Amylase renal clearance
18010-9,Diameter
18011-7,Diameter
18012-5,Diameter
18013-3,Diameter
18014-1,Diameter
18015-8,Diameter
18016-6,Diameter
18017-4,Diameter
18018-2,Diameter
18019-0,Diameter
18020-8,Diameter
18021-6,Diameter
18022-4,Diameter
18023-2,Diameter
18024-0,Diameter.anterior-posterior.systole
18025-7,Diameter.anterior-posterior.systole/Diameter.aorta root
18026-5,End-diastolic volume
18027-3,End-diastolic volume
1802-8,Amylase.P1
18028-1,End-diastolic volume
18029-9,End-diastolic volume
18030-7,A wave.max
18031-5,E wave.max
18032-3,Pressure half time.diastole
18033-1,Diastole-systole
18034-9,Regurgitation dP/dT (1 M/S to 3 M/S).systole
18035-6,Regurgitation dP/dT (1M/S to 3 M/S)
1803-6,Amylase.P2
18036-4,E point to septal separation
18037-2,E wave.max
18038-0,E wave.max/A wave.max
18039-8,E wave.max/A wave.max
18040-6,E-F slope
18041-4,Ejection time
18042-2,Ejection time
18043-0,Ejection fraction
1804-4,Amylase.P3
18044-8,Ejection fraction
18045-5,Ejection fraction
18046-3,Ejection fraction
18047-1,Ejection fraction
18048-9,Ejection fraction
18049-7,Ejection fraction
18050-5,Fractional collapse^inspiration
1805-1,Amylase.pancreatic
18051-3,Fractional shortening.minor axis
18052-1,Fractional thickening.freewall
18053-9,Thickening.fractional change
18054-7,Fractional thickness; fractional change
18055-4,Pressure gradient.diastole.max
18056-2,Pressure gradient.diastole.mean
18057-0,Pressure gradient.max
18058-8,Pressure gradient.max
18059-6,Pressure gradient.mean
18060-4,Pressure gradient.mean
18061-2,Pressure gradient.systole.max
18062-0,Pressure gradient.systole.max
18063-8,Gradient.systole.mean
18064-6,Pressure gradient.systole.max
18065-3,Regurgitant pressure gradient.systole.max
18066-1,Pressure gradient.systole.mean
18067-9,Image quality
18068-7,Pre ejection time
1806-9,Amylase.S1
18069-5,Intrachamber.systole.mean
18070-3,Intrachamber.systole.mean
18071-1,Isovolumic relaxation time
18072-9,Major axis.diastole
18073-7,Major axis.systole
18074-5,Major axis.diastole
18075-2,Major axis.systole
18076-0,Major axis.apical.systole
1807-7,Amylase.S2
18077-8,Major axis.apical.diastole
18078-6,Major axis.diastole.max
18079-4,Major axis.systole.min
18080-2,Blood flow velocity.systole.max
18081-0,Minor axis.end diastole
18082-8,Minor axis.end systole.apical 4 chamber
18083-6,Internal diameter.minor axis.diastole
18084-4,Minor axis.end diastole
1808-5,Amylase.S3
18085-1,Internal diameter.minor axis.systole
18086-9,Minor axis.end systole
18087-7,Myocardial mass
18088-5,Myocardial mass
18089-3,Orifice area
18090-1,Orifice area
18091-9,Orifice area
18092-7,Orifice area
1809-3,Amylase.salivary
18093-5,Orifice area
18094-3,Orifice area
18095-0,Crossection
18096-8,Orifice area
18097-6,Orifice area.min
18098-4,Orifice area.minor axis.min
18099-2,Plane.diastole
18100-8,Plane.systole
1810-1,Amylase/Creatinine
18101-6,Plane.diastole
18102-4,Plane.systole
18103-2,Planimetry.parasternal short axis
18104-0,Pressure half time
18105-7,Regurgitant blood flow pressure half-time
18106-5,Procedure
18107-3,Procedure stress method
18108-1,Prosthetic valve type
18109-9,Prosthetic valve type
18110-7,Prosthetic valve type
18111-5,Prosthetic valve type
18112-3,Regurgitation degree
18113-1,Regurgitation degree
18114-9,Regurgitation degree
18115-6,Regurgitation degree
18116-4,Segmental wall appearance
18117-2,Segmental wall motion
18118-0,Segmental wall motion
1811-9,Amylase/Creatinine renal clearance
18119-8,Segmental wall motion
18120-6,Segmental wall motion
18121-4,Segmental wall motion
18122-2,Segmental wall motion
18123-0,Segmental wall motion
18124-8,Segmental wall motion
18125-5,Segmental wall motion
18126-3,Segmental wall motion
1812-7,Alpha fucosidase
18127-1,Segmental wall motion
18128-9,Segmental wall motion
18129-7,Segmental wall motion
18130-5,Segmental wall motion
18131-3,Segmental wall motion
18132-1,Segmental wall motion
18133-9,Segmental wall motion
18134-7,Segmental wall motion
1813-5,Alpha galactosidase A
18135-4,Minor axis.mitral level.diastole
18136-2,Minor axis.mitral level.systole
18137-0,Minor axis.papillary level.diastole
18138-8,Minor axis.papillary level.systole
18139-6,Stage
18140-4,Study observation
18141-2,Study observation
18142-0,Study observation
1814-3,Acid alpha glucosidase
18143-8,Study observation
18144-6,Study observation
18145-3,Study observation
18146-1,Study observation.overall
18147-9,Study observation.overall
18148-7,End-systolic volume
18149-5,End-systolic volume
1815-0,Acid alpha glucosidase
18150-3,End-systolic volume
18151-1,End-systolic volume
18152-9,Thickness.diastole
18153-7,Thickness.diastole
18154-5,Thickness.diastole
18155-2,Thickness.septal wall/Thickness.posterior wall
18156-0,Thickness.systole
18157-8,Thickness.systole
18158-6,Thickness.systole
18159-4,Transducer site
18160-2,Ultrasound class
18161-0,Blood flow velocity.max
18162-8,Blood flow velocity.max
18163-6,Blood flow velocity.systole.max
18164-4,Blood flow.systole.max
18165-1,Regurgitant blood flow velocity.diastole.max
18166-9,Regurgitant blood flow velocity.systole.max
18167-7,Blood flow velocity.systole.mean
1816-8,Acid alpha glucosidase
18168-5,Blood velocity-time integral
18169-3,Blood velocity-time integral
18170-1,Blood velocity-time integral
18171-9,Blood velocity-time integral
18172-7,Blood velocity-time integral
18173-5,Blood velocity-time integral
18174-3,Blood velocity-time integral
18175-0,Blood velocity-time integral.diastole
1817-6,Alpha ketoglutarate
18176-8,Vendor model number
18177-6,Vendor serial number
18178-4,Wall motion index
18179-2,Wall segment
181-8,Cinoxacin
18180-0,Albumin
18182-6,Osmolality
18183-4,Melatonin
1818-4,Alpha mannosidase
18184-2,Erythrocyte sedimentation rate
18185-9,Gestational age
18186-7,Calcium
18187-5,LORazepam
18188-3,Acebutolol
18189-1,Acetone
18190-9,Acid phosphatase.tartrate resistant
18191-7,Amino acids
1819-2,Alpha mannosidase
18192-5,Bacteria
18194-1,Barium
18195-8,Glucosylceramidase
18196-6,Beta-N-acetylhexosaminidase.A
18197-4,Blastomyces dermatitidis Ab
18198-2,Blastomyces dermatitidis Ab.IgE
18199-0,Blastomyces dermatitidis Ab.IgG
18-Feb,Amoxicillin
1820-0,Alpha melanocyte stimulating hormone
18200-6,Blastomyces dermatitidis Ab.IgM
18201-4,Borrelia burgdorferi Ab.IgA
18202-2,Borrelia burgdorferi Ab.IgA
18203-0,Borrelia burgdorferi Ab.IgG+IgM
18204-8,Caffeine renal clearance
18205-5,Carbon disulfide
18206-3,Catecholamines^7th specimen post XXX challenge
18208-9,Cocaine
18209-7,Ubiquinone 10
18210-5,Complement C1 esterase inhibitor bound Ab.IgG
18211-3,Complement C1 esterase inhibitor bound Ab.IgM
18212-1,Complement C1 esterase inhibitor free Ab.IgG
18213-9,Complement C1 esterase inhibitor free Ab.IgM
18214-7,Delta 5-Pregnanetriol
18215-4,Delta alanine
18216-2,Dezocine
18217-0,Epidermis Ab.IgA
1821-8,Alpha naphthylesterase
18218-8,Epidermis Ab.IgM
18219-6,EPINEPHrine^2nd specimen post XXX challenge
18220-4,EPINEPHrine^3rd specimen post XXX challenge
18221-2,EPINEPHrine^4th specimen post XXX challenge
18222-0,EPINEPHrine^5th specimen post XXX challenge
18223-8,EPINEPHrine^6th specimen post XXX challenge
18224-6,EPINEPHrine^7th specimen post XXX challenge
18225-3,Erythrocyte shape
1822-6,Alpha thymosin
18226-1,Erythrocyte size
18227-9,Glucose
18228-7,Glucose-6-Phosphate dehydrogenase
18229-5,Heparan sulfate
18230-3,Histone H2a+H2b Ab
18231-1,Histone H2a+H2b Ab
18232-9,Hydrocorticosterone
18233-7,Influenza virus Ab
1823-4,Alpha tocopherol
18234-5,Insulin
18235-2,Ketone solvents
18236-0,Lead
18237-8,Legionella pneumophila atypical Ab.IgM
18238-6,Lithium
18239-4,Lupus erythematosus factor
18240-2,"1,3-Dichlorobenzene"
18241-0,cefOXitin Ab.IgE
1824-2,Alpha-1-Antichymotrypsin
18242-8,Methyprylon
18243-6,Mycoplasma pneumoniae Ab.IgG
18244-4,Niacin
18245-1,Nickel
18246-9,Nitrogen
18247-7,Nitrogen
18248-5,Nordiazepam
18249-3,Para aminobenzoate
18250-1,Pentacarboxylporphyrins
18251-9,Polychlorinated biphenyl
18252-7,predniSONE
18253-5,Serotonin
18254-3,Silicate
18255-0,Sulfonylurea
18256-8,Sulfonylurea
18257-6,Coproporphyrin
18258-4,Trimethoprim Ab.IgE
1825-9,Alpha 1 antitrypsin
18259-2,Vasoactive intestinal peptide
182-6,Cinoxacin
18260-0,Zinc
18261-8,Cholesterol.in LDL
18262-6,Cholesterol.in LDL
18263-4,Cholesterol.in HDL
18264-2,Bilirubin.glucuronidated+Bilirubin.albumin bound
18265-9,Acetaminophen
18266-7,Cells.CD3+CD4+/Cells.CD3+CD8+
1826-7,Alpha 1 antitrypsin.MM
18267-5,Cells.CD16+CD56+/100 cells
18268-3,Cells.CD16+CD56+/100 cells
18269-1,Immune complex
18270-9,"carBAMazepine 10,11-Epoxide"
18271-7,Alpha 1 antitrypsin fecal clearance
18272-5,RNA Ab
18273-3,Blood group antibody screen
18274-1,Blood group antibody screen
1827-5,Alpha 1 antitrypsin.MS
18275-8,Blood group antigens present
18276-6,Blood group antigens absent
18277-4,Hemoglobin F
18278-2,Hemoglobin F
18279-0,Hemoglobin F
18280-8,Background stain
18281-6,Calcium^^corrected for total protein
18282-4,Cannabinoids
1828-3,Alpha 1 antitrypsin.MZ
18283-2,Cells.CD11/100 cells
18284-0,Cells.CD198/100 cells
18285-7,Cells.CDA/100 cells
18286-5,Donath Landsteiner Ab
18287-3,Donath Landsteiner Ab
18288-1,Donath Landsteiner Ab
18289-9,Erythrocytes
18290-7,Erythrocytes
1829-1,Alpha 1 antitrypsin.SS
18291-5,Hemoglobin F/Hemoglobin.total
18292-3,Hemoglobin.fetal/Hemoglobin.total^post amniocentesis
18293-1,Hemoglobin.fetal/Hemoglobin.total^post partum
18294-9,Hemoglobin.fetal/Hemoglobin.total^pre amniocentesis
18295-6,Hemoglobin.fetal/Hemoglobin.total^pre partum
18296-4,Glucose^post dose glucose
18297-2,Acid hemolysis
18298-0,High titer low avidity Ab
18299-8,IgA
18300-4,IgA
18301-2,IgG
18302-0,IgG
18303-8,IgM
18304-6,IgM
18305-3,Amoeba identified
18306-1,Hydatid cyst identified
18307-9,Ova & parasites identified
18308-7,Pneumocystis sp identified
1830-9,Alpha 1 antitrypsin.SZ
18309-5,Erythrocytes.nucleated/100 leukocytes
18310-3,Hemoglobin.other/Hemoglobin.total
18311-1,Pelger Huet cells
18312-9,Platelet satellitism
18313-7,Coagulation
18314-5,Morphology
1831-7,Alpha 1 antitrypsin.ZZ
18319-4,Neutrophils.vacuolated
18320-2,Globulin
18321-0,Benzidine
18322-8,Norketamine
18323-6,Smith extractable nuclear Ab.IgG
18324-4,Cockatiel serum Ab.IgE
1832-5,Alpha-1-Fetoprotein
18325-1,oxyMORphone
18326-9,Microscopic observation
18327-7,Microscopic observation
18328-5,Microscopic observation
18329-3,Neutrophil cytoplasmic Ab.IgA
18330-1,Neutrophil cytoplasmic Ab.IgG
18331-9,Neutrophil cytoplasmic Ab.IgM
18332-7,Thyroperoxidase Ab.IgG
1833-3,Alpha-1-Fetoprotein
18333-5,Echovirus 7 Ab
18334-3,Naltrexone
18335-0,Antihistamines
18336-8,Methyl tert-butyl ether
18337-6,Hydroxyitraconazole
18338-4,Nortramadol
18339-2,Nortramadol
183-4,Cinoxacin
18340-0,Nortramadol
1834-1,Alpha-1-Fetoprotein
18341-8,Propylene glycol
18342-6,Glucose^3H post XXX challenge
18343-4,6-Monoacetylmorphine
18344-2,Beta-N-acetylhexosaminidase
18345-9,Protein S Ag/Coagulation factor VII Ag
18346-7,Streptococcus pneumoniae 18c Ab.IgG
18347-5,Streptococcus pneumoniae 12 Ab^2nd specimen
18348-3,Toxoplasma gondii Ab.IgM
18349-1,Cells.CD8+CD25+
18350-9,Cells.CD8+CD57+
18351-7,11-Deoxycortisol^2nd specimen post XXX challenge
18352-5,Specimen volume
18353-3,Glucose^6H post 50 g lactose PO
18354-1,Glucose^12H post 50 g lactose PO
18355-8,Methylenedioxyamphetamine
18356-6,Methylenedioxymethamphetamine
18357-4,Methylenedioxymethamphetamine
1835-8,Alpha-2-Macroglobulin
18358-2,Methylenedioxymethamphetamine
18359-0,Methylenedioxyamphetamine
18360-8,8-Hydroxyamoxapine
18361-6,Adenosine monophosphate.cyclic/Creatinine
18362-4,Retinol binding protein
18363-2,Carnitine.free (C0)
18364-0,Chondroitin sulfate
18365-7,Cortisol.free
1836-6,Retinol binding protein
18366-5,Cytochrome C oxidase
18367-3,Iodine.free
18368-1,Magnesium
18369-9,Magnesium
18370-7,Nitrite
18371-5,Methyl parathion
18372-3,Potassium
18373-1,Protein
1837-4,Alpha-N-acetylglucosaminidase
18374-9,Riboflavin
18375-6,Serotonin
18376-4,Sodium
18377-2,Sodium
18378-0,Transcortin
18379-8,Urate
18380-6,Uroporphyrinogen decarboxylase
18381-4,Uroporphyrinogen decarboxylase
1838-2,Alpha-N-acetylglucosaminidase
18382-2,Specimen.dry weight
18383-0,Alfentanil
18384-8,Butabarbital
18385-5,Butalbital
18386-3,Chlorothiazide
18387-1,Diamorphine
18388-9,diazePAM
18389-7,Methaqualone
1839-0,Ammonia
18390-5,Opiates
18391-3,Paraldehyde
18392-1,Phencyclidine
18393-9,quiNIDine+Quinine
18394-7,HLA-A24(9)
18395-4,Aspergillus niger Ab
18396-2,HIV 1 p24 Ag
18397-0,Polio virus 1 Ab
18398-8,Polio virus 2 Ab
18399-6,Polio virus 3 Ab
18400-2,Spermatozoa Ab.IgA
18401-0,Spermatozoa Ab.IgG
18402-8,Spermatozoa Ab.IgA
18403-6,Spermatozoa Ab.IgG
18404-4,Spermatozoa Ab.IgM
18405-1,Arsenate
18406-9,Arsenic trioxide
18407-7,Leukocytes
1840-8,Ammonia
18408-5,Cells.CD3+HLA-DR+/100 cells
18409-3,Curvularia lunata Ab.IgG
18410-1,Epicoccum purpurascens Ab.IgG
18411-9,Rhizopus nigricans Ab.IgG
18412-7,Stemphylium botryosum Ab.IgG
18413-5,HLA-DR16
18414-3,Psilocin
18415-0,Psilocin
1841-6,Ammonia
18416-8,Aspergillus nidulans Ab.IgG
18417-6,Bean black Ab.IgG
18418-4,Casein Ab.IgA
18419-2,Cephalosporine mold Ab.IgG
184-2,Ciprofloxacin
18420-0,Chaetomium globosum Ab.IgG
18421-8,Fusarium oxysporum Ab.IgG
18422-6,Microcytes
18423-4,Phthalic anhydride Ab.IgG
1842-4,Ammonia
18424-2,Phthalic anhydride Ab.IgM
18425-9,Squash zucchini Ab.IgG
18426-7,Aspergillus sp Ab
18427-5,Epstein Barr virus early Ab
18428-3,Epstein Barr virus nuclear Ab.IgG
18429-1,Rickettsia rickettsii Ab.IgG
18430-9,Rickettsia rickettsii Ab.IgM
18431-7,Amphetamines
1843-2,Ammonia nitrogen
18432-5,Tetrahydrocannabinol
18433-3,"1,3-Dichlorobenzene"
18434-1,"1,2-Dichlorobenzene"
18435-8,SUFentanil
18436-6,Acetylcarnitine (C2)
18437-4,Acrylylcarnitine (C3:1)
18438-2,Propionylcarnitine (C3)
18439-0,Butyrylcarnitine (C4)
1844-0,Ammonium ion
18440-8,Crotonylcarnitine (C4:1)
18441-6,Isovalerylcarnitine (C5)
18442-4,3-Hydroxybutyrylcarnitine (C4-OH)
18443-2,Hexanoylcarnitine (C6)
18444-0,3-Hydroxyisovalerylcarnitine (C5-OH)
18445-7,Benzoylcarnitine (BzCn)
18446-5,Methylmalonylcarnitine (C4-DC)
18447-3,Octenoylcarnitine (C8:1)
18448-1,Octanoylcarnitine (C8)
18449-9,Glutarylcarnitine (C5-DC)
18450-7,Adipoylcarnitine (C6-DC)
18451-5,Cis-4-decenoylcarnitine (Cis 4 C10:1)
18452-3,Decanoylcarnitine (C10)
18453-1,Suberylcarnitine (C8-DC)
18454-9,Dodecenoylcarnitine (C12:1)
18455-6,Dodecanoylcarnitine (C12)
18456-4,Tetradecadienoylcarnitine (C14:2)
1845-7,Ammonium ion
18457-2,Tetradecenoylcarnitine (C14:1)
18458-0,3-Hydroxytetradecadienoylcarnitine (C14:2-OH)
18459-8,3-Hydroxytetradecenoylcarnitine (C14:1-OH)
18460-6,Palmitoylcarnitine (C16)
18461-4,3-Hydroxypalmitoylcarnitine (C16-OH)
18462-2,Linoleoylcarnitine (C18:2)
18463-0,Oleoylcarnitine (C18:1)
18464-8,3-Hydroxylinoleoylcarnitine (C18:2-OH)
1846-5,"Amylo-alpha-1,6-glucosidase"
18465-5,3-Hydroxyoleoylcarnitine (C18:1-OH)
18466-3,Dicarboxyoleylcarnitine (C18:1-DC)
18467-1,Venlafaxine
18468-9,Aspergillus fumigatus Ab
18469-7,Methyclothiazide
18470-5,Norclomipramine
18471-3,Metoclopramide
18472-1,Organophosphate pesticides
1847-3,Amyloid associated protein
18473-9,HYDROmorphone
18474-7,HER2 Ag
18475-4,Phenylalanine/Creatinine
18476-2,Uroporphyrinogen decarboxylase
18477-0,Lithium
18478-8,Human papilloma virus 16+18 DNA
18479-6,Human papilloma virus 31+35+51 DNA
18480-4,Human papilloma virus 6+11 DNA
1848-1,Androstanolone
18481-2,Streptococcus pyogenes Ag
18482-0,Yeast
18483-8,Yeast
18484-6,Ku Ab
18485-3,Mi-2 Ab
18486-1,Methylenediamine
18487-9,Broad casts
18488-7,Calcium
18489-5,Valproate.protein bound
18490-3,Chlamydia trachomatis G+F+K Ab.IgA
18491-1,Chlamydia trachomatis G+F+K Ab.IgG
18492-9,Chlamydia trachomatis G+F+K Ab.IgM
18493-7,Ova & parasites identified^3rd specimen
18494-5,Ova & parasites identified^2nd specimen
18495-2,Ova & parasites identified^3rd specimen
18496-0,Ova & parasites identified^2nd specimen
18497-8,Microscopic observation
18498-6,Microscopic observation
1849-9,Androstanolone
18499-4,Microscopic observation
18500-9,Microscopic observation
18501-7,Microscopic observation
18502-5,Microscopic observation
18503-3,Microscopic observation
18504-1,PP interval
18505-8,RR interval
18506-6,P wave axis.horizontal plane
1850-7,Androstanediol
18507-4,QRS axis.horizontal plane
18508-2,R wave axis.horizontal plane
18509-0,T wave axis.horizontal plane
18510-8,ST segment axis.horizontal plane
18511-6,P wave onset
18512-4,P wave offset
18513-2,QRS onset
18514-0,QRS offset
1851-5,Androstenedione
18515-7,T wave offset
18516-5,P wave axis.frontal plane
18517-3,QRS axis.frontal plane
18518-1,T wave axis.frontal plane
18519-9,Reference beat
18520-7,PR interval
18521-5,PR interval
18522-3,PR interval
1852-3,Androstenedione
18523-1,PR interval
18524-9,PR interval
18525-6,PR interval
18526-4,PR interval
18527-2,PR interval
18528-0,PR interval
18529-8,PR interval
18530-6,PR interval
1853-1,Androstenedione
18531-4,PR interval
18532-2,QT interval
18533-0,QT interval
18534-8,QT interval
18535-5,QT interval
18536-3,QT interval
18537-1,QT interval
18538-9,QT interval
18539-7,QT interval
18540-5,QT interval
18541-3,QT interval
18542-1,QT interval
18543-9,QT interval
18544-7,ST amplitude.J point+20 ms
18545-4,ST amplitude.J point+20 ms
18546-2,ST amplitude.J point+20 ms
18547-0,ST amplitude.J point+20 ms
18548-8,ST amplitude.J point+20 ms
1854-9,Androstenedione
18549-6,ST amplitude.J point+20 ms
18550-4,ST amplitude.J point+20 ms
18551-2,ST amplitude.J point+20 ms
18552-0,ST amplitude.J point+20 ms
18553-8,ST amplitude.J point+20 ms
18554-6,ST amplitude.J point+20 ms
18555-3,ST amplitude.J point+20 ms
1855-6,Androstenedione
18556-1,ST amplitude.J point+60 ms
18557-9,ST amplitude.J point+60 ms
18558-7,ST amplitude.J point+60 ms
18559-5,ST amplitude.J point+60 ms
18560-3,ST amplitude.J point+60 ms
18561-1,ST amplitude.J point+60 ms
18562-9,ST amplitude.J point+60 ms
18563-7,ST amplitude.J point+60 ms
1856-4,Androsterone
18564-5,ST amplitude.J point+60 ms
18565-2,ST amplitude.J point+60 ms
18566-0,ST amplitude.J point+60 ms
18567-8,ST amplitude.J point+60 ms
18568-6,ST amplitude.J point+80 ms
18569-4,ST amplitude.J point+80 ms
18570-2,ST amplitude.J point+80 ms
18571-0,ST amplitude.J point+80 ms
1857-2,Angiotensin converting enzyme
18572-8,ST amplitude.J point+80 ms
18573-6,ST amplitude.J point+80 ms
18574-4,ST amplitude.J point+80 ms
18575-1,ST amplitude.J point+80 ms
18576-9,ST amplitude.J point+80 ms
18577-7,ST amplitude.J point+80 ms
18578-5,ST amplitude.J point+80 ms
18579-3,ST amplitude.J point+80 ms
1858-0,Angiotensin I
18580-1,Origination site
18581-9,Origination site
18582-7,Destination site
18583-5,Destination site
18584-3,Body weight^at ambulance transport
18588-4,Purpose of stretcher
18589-2,Admitted at destination facility
185-9,Ciprofloxacin
18591-8,Confined to bed^before Ambulance transport
18592-6,Confined to bed^after Ambulance transport
18593-4,Discharged from origin institution
18594-2,Rehabilitation.psychiatric service attachment
1859-8,Angiotensin II
18598-3,Control number identification.claims attachment
18600-7,Primary practitioner ID
18601-5,Primary practitioner profession
18602-3,ED practitioner ID
18605-6,Medication.current
1860-6,Angiotensin II
18606-4,Name + ID
18607-2,Medication XXX
18608-0,Timing + Quantity
18609-8,Route
18610-6,Medication.administered
18611-4,Name + ID
18612-2,Route
1861-4,Angiotensinogen
18614-8,Timing
18615-5,Medication XXX
18616-3,Strength
18617-1,Medication.discharge
18618-9,Name + ID
18619-7,Medication XXX
18620-5,Timing + Quantity
18621-3,Route
1862-2,Aniline
18622-1,Amount dispensed
18623-9,Refills
18624-7,ED problem
18626-2,New &or revised
18627-0,Date.onset or exacerbation
18628-8,Date.start
18629-6,Clinical discipline
1863-0,Anion gap 4
18630-4,Diagnosis.primary
18631-2,Diagnosis.addressed by plan
18632-0,Author of treatment plan
18633-8,Author name
18634-6,Author profession
18635-3,Signature date
18637-9,Visit frequency
18638-7,Visit duration
18639-5,Date range (from_through) described by plan
18640-3,Start date
18641-1,Date.end
18642-9,Date range
18643-7,Start date
18644-5,End date
18645-2,Continuation status
18646-0,Date attending MD referred patient for
18647-8,Date attending MD signed
1864-8,Anserine
18648-6,Date rehabilitation professional signed
18649-4,Signature of responsible attending physician on file
18650-2,Signature of responsible rehabilitation professional on file
18651-0,Medication administered
18652-8,Prognosis for rehabilitation
18653-6,Estimated date of completion
18654-4,Date of last plan of treatment certification
1865-5,Anserine
18655-1,Past medical history+Level of function
18656-9,Initial evaluation note
18657-7,Plan of treatment
18658-5,Progress note+attainment of goals
18659-3,Reason to continue
18660-1,Justification
18661-9,Psychiatric symptoms
18662-7,Chief complaint+Reason for referral+Reason for relapse if known
1866-3,Anserine
18663-5,History of present alcohol &or substance abuse
18664-3,Follow-up approach
18665-0,Agency that will follow up
18666-8,Person that will follow up after
18667-6,Methodology for follow up
18668-4,Frequency of assessments for follow up
18669-2,Level of patient participation
186-7,Ciprofloxacin
18670-0,Date of next planned rehabilitation treatment
1867-1,Anserine
18671-8,Next plan of treatment
18672-6,Alcohol or substance abuse symptoms with physiological dependence indicator
18673-4,Rehabilitation problem remission status
18674-2,Longest period of sobriety for abused substance
18675-9,Substance abused
18676-7,Longest period of sobriety
18677-5,Rehabilitation.service claims attachment
18679-1,ED claims attachment
18682-5,Ambulance records
18684-1,Blood pressure
18685-8,Blood pressure special circumstances
18686-6,Respiration rate
18687-4,Respiration rate special circumstances
18688-2,Body temperature
1868-9,Antithrombin Ag
18689-0,Body temperature special circumstances
18690-8,Body weight
18692-4,Body weight special circumstances
18693-2,ED consultant practitioner
18694-0,ED consultant practitioner name
18695-7,ED clinical finding type
18696-5,ED clinical finding
1869-7,Apolipoprotein A-I
18697-3,ED clinical finding data source
18698-1,ED clinical finding information
18699-9,ED practitioner
18700-5,ED practitioner name
18701-3,ED practitioner profession
18702-1,ED practitioner role
18703-9,ED diagnostic procedure results
18704-7,ED referring practitioner
1870-5,Apolipoprotein A-II
18705-4,ED referring practitioner name
18706-2,ED referring practitioner ID
18707-0,ED referring practitioner profession
18708-8,Heart rate
18709-6,Heart rate special circumstances
18710-4,Primary practitioner
18711-2,Primary practitioner name
1871-3,Apolipoprotein B-100
18716-1,Allergy studies
18717-9,Blood bank studies
18718-7,Cell marker studies
18719-5,Chemistry studies
18720-3,Coagulation studies
1872-1,Apolipoprotein B-150
18721-1,Therapeutic drug monitoring studies
18722-9,Fertility studies
18723-7,Hematology studies
18724-5,HLA studies
18725-2,Microbiology studies
18726-0,Radiology studies
18727-8,Serology studies
18728-6,Toxicology studies
18729-4,Urinalysis studies
18730-2,Author ID
18733-6,Progress note
18734-4,Initial evaluation note
18735-1,Initial evaluation note
18736-9,Initial evaluation note
18737-7,Initial evaluation note
18738-5,Initial evaluation note
1873-9,Apolipoprotein B-48
18739-3,Initial evaluation note
18740-1,Initial evaluation note
18741-9,Subsequent visit evaluation note
18742-7,Arthroscopy study
18743-5,Autopsy report
18744-3,Bronchoscopy study
18745-0,Cardiac catheterization study
18746-8,Colonoscopy study
1874-7,Apolipoprotein B/Apolipoprotein A-I
18747-6,Study
18748-4,Diagnostic imaging study
18749-2,Electromyogram study
187-5,Ciprofloxacin
18750-0,Cardiac electrophysiology study
18751-8,Endoscopy study
18752-6,Exercise stress test study
18753-4,Flexible sigmoidoscopy study
1875-4,Apolipoprotein C-I
18754-2,Ambulatory cardiac rhythm monitor study
18755-9,Study report
18756-7,Study report
18757-5,Study report
18758-3,Study
18759-1,Polysomnography study
18760-9,Study
18761-7,Transfer summary note
1876-2,Apolipoprotein C-II
18762-5,Subsequent evaluation note
18763-3,Initial evaluation note
18764-1,Subsequent evaluation note
18765-8,Subsequent visit evaluation note
18766-6,Subsequent visit evaluation note
18767-4,Blood gas studies
18768-2,Cell counts+Differential studies
18769-0,Microbial susceptibility tests
1877-0,Apolipoprotein C-III
18770-8,Dictating practitioner name
18771-6,Provider.signing name
18772-4,Surgeon.resident name
18773-2,Surgeon.staff name
18774-0,Staff practitioner name
18775-7,Staff practitioner ID
18776-5,Plan of care note
18777-3,Diagnosis.primary
18779-9,Comparison.study
18780-7,Ordering practitioner ID
18781-5,Ordering practitioner name
18782-3,Study observation
18783-1,Study recommendation
18785-6,Reason for study
1878-8,Apolipoprotein A-III
18789-8,Include all data of the selected type within the date window associated with the service
18790-6,Include all data of the selected type on or before the date of service
18791-4,Include all data of the selected type within or aligned to an encounter by the same service or encounter
18792-2,Include all data of the selected type on or after the date of service
18793-0,Use no fixed time limit on data (any of the selected type are relevant no matter when obtained)
18794-8,Send all items of the specified type within the time window
18795-5,Send all items of the specified type within the time window relevant to the service
1879-6,Apolipoprotein E2
18796-3,Send all abnormals within the time window
18797-1,Send the first abnormals within the time window
18798-9,Send the last abnormals within the time window
18799-7,"Send the first (i.e., oldest) result for each kind of observation in the time window"
18800-3,Send the worst abnormal result for each kind of observation in the time window
18802-9,Send the last (most recent) within the time window
18803-7,Include all data of the selected type that represents observations made 30D or fewer before the starting date of service
1880-4,Beta 2 glycoprotein 1
18804-5,Include all data of the selected type that represents observations made 3Mo or fewer before the starting date of service
18805-2,Include all data of the selected type that represents observations made six Mo or fewer before the starting date of service
18806-0,Include all data of the selected type that represents observations made nine Mo or fewer before the starting date of service
18807-8,Include all data of the selected type that represents observations made one year or less before the starting date of service
18810-2,Study observation.overall
1881-2,Apolipoprotein LPA
18812-8,Ordering practitioner
18813-6,Ordering practitioner
18814-4,Reason for scheduled trip
18815-1,Reason for scheduled trip additional service information
18816-9,Medication name + ID
18817-7,Medication XXX
18818-5,Medication timing + Quantity
18819-3,Medication route
1882-0,Apolipoprotein LPQ
18820-1,Diagnosis.primary
18821-9,Diagnosis.addressed by plan
18822-7,Diagnosis.addressed by plan
18823-5,Rehabilitation.alcohol &or substance abuse service attachment
18824-3,Rehabilitation.cardiac service attachment
18825-0,Rehabilitation.medical social services attachment
18826-8,Rehabilitation.occupational therapy service attachment
188-3,Clarithromycin
18833-4,Body weight
18834-2,Comparison.study
18835-9,Aortic valve area method
18836-7,Procedure
18837-5,Segmental wall appearance
1883-8,Apolipoprotein A
18838-3,Transducer site
18839-1,Ultrasound class
18840-9,Wall motion index
18841-7,Hospital consultations
18842-5,Discharge summary note
18843-3,Comparison.study
18844-1,EKG impression
18845-8,Reference beat type
1884-6,Apolipoprotein B
18846-6,Examination level.ultrasound
18847-4,Fetal position
18848-2,Fetal position
18849-0,Fetal presentation
18850-8,Fetal presentation
18851-6,Grade
18852-4,Surgical drains
1885-3,Apolipoprotein C
18855-7,5-Fluorocytosine
18857-3,Almecillin
18859-9,Amdinocillin
18860-7,Amikacin
1886-1,Apolipoprotein E
18861-5,Amoxicillin
18862-3,Amoxicillin+Clavulanate
18863-1,Amphotericin B
18864-9,Ampicillin
18865-6,Ampicillin+Sulbactam
18866-4,Azithromycin
18867-2,Azlocillin
18868-0,Aztreonam
18869-8,Bacampicillin
18870-6,Bacitracin
18871-4,Butirosin
18872-2,Capreomycin
18873-0,Carbenicillin
18874-8,Cefaclor
18875-5,Cefadroxil
18876-3,Cefamandole
18877-1,Cefatrizine
18878-9,ceFAZolin
1887-9,Appearance
18879-7,Cefepime
18880-5,Cefixime
18881-3,Cefmetazole
18882-1,Cefodizime
18883-9,Cefonicid
18884-7,Cefoperazone
18885-4,Ceforanide
18886-2,Cefotaxime
1888-7,Aquacobalamin
18887-0,cefoTEtan
18888-8,cefOXitin
18889-6,Cefpirome
18890-4,Cefpodoxime
18891-2,Cefprozil
18892-0,Cefsulodin
18893-8,cefTAZidime
18894-6,Ceftizoxime
1889-5,Arachidonate
18895-3,cefTRIAXone
18896-1,Cefuroxime.parenteral
18897-9,Cephalexin
18898-7,Cephaloglycin
18899-5,Cephaloridine
18900-1,Cephalothin
18901-9,Cephapirin
18902-7,Cephradine
1890-3,Arginase
18903-5,Chloramphenicol
18904-3,Chlortetracycline
18905-0,Cinoxacin
18906-8,Ciprofloxacin
18907-6,Clarithromycin
18908-4,Clindamycin
18909-2,Clotrimazole
189-1,Clarithromycin
18910-0,Cloxacillin
1891-1,Arginine
18911-8,Colistimethate
18912-6,Colistin
18913-4,Cyclacillin
18914-2,cycloSERINE
18915-9,Demeclocycline
18916-7,Dicloxacillin
18917-5,Doxycycline
18918-3,Enoxacin
18919-1,Erythromycin
18920-9,Erythromycin+sulfiSOXAZOLE
18921-7,Ethambutol
18922-5,Ethionamide
18923-3,Floxacillin
18924-1,Fluconazole
18925-8,5-Fluorocytosine
18926-6,Framycetin
18927-4,Fusidate
18928-2,Gentamicin
1892-9,Arginine
18929-0,Gentamicin.high potency
18930-8,Gramicidin D
18931-6,Hetacillin
18932-4,Imipenem
18933-2,Imipenem+Cilastatin
18934-0,Isoniazid
18935-7,Kanamycin
18936-5,Kanamycin.high potency
1893-7,Arginine
18937-3,Ketoconazole
18938-1,Lincomycin
18939-9,Lomefloxacin
18940-7,Loracarbef
18941-5,Lymecycline
18942-3,Meclocycline
18943-1,Meropenem
18944-9,Methacycline
1894-5,Arginine
18945-6,Methicillin
18946-4,metroNIDAZOLE
18947-2,Mezlocillin
18948-0,Minocycline
18949-8,Miocamycin
18950-6,Moxalactam
18951-4,Nafcillin
1895-2,Arginine
18952-2,Nalidixate
18953-0,Neomycin
18954-8,Netilmicin
18955-5,Nitrofurantoin
18956-3,Norfloxacin
18957-1,Novobiocin
18958-9,Nystatin
18959-7,Ofloxacin
1896-0,Argininosuccinate
18960-5,Oleandomycin
18961-3,Oxacillin
18962-1,Oxytetracycline
18963-9,Pefloxacin
18964-7,Penicillin
18965-4,Penicillin G
18966-2,Penicillin V
18967-0,Phenethicillin
18968-8,Pipemidate
18969-6,Piperacillin
18970-4,Piperacillin+Tazobactam
18971-2,Pivampicillin
18972-0,Polymyxin B
18973-8,Pyrazinamide
18974-6,rifAMPin
18975-3,Ristocetin
18976-1,Rolitetracycline
18977-9,Rosoxacin
1897-8,Argininosuccinate
18978-7,Roxithromycin
18979-5,Sisomicin
18980-3,Spectinomycin
18981-1,Spiramycin
18982-9,Streptomycin
18983-7,Streptomycin.high potency
18984-5,sulfADIAZINE
18985-2,Sulfamethoxazole
1898-6,Argininosuccinate lyase
18986-0,sulfiSOXAZOLE
18987-8,Sulfonamide
18988-6,Talampicillin
18989-4,Teicoplanin
18990-2,Temafloxacin
18991-0,Temocillin
18992-8,Terbinafine
18993-6,Tetracycline
1899-4,Argininosuccinate synthase
18994-4,Ticarcillin
18995-1,Ticarcillin+Clavulanate
18996-9,Tobramycin
18997-7,Trimethoprim
18998-5,Trimethoprim+Sulfamethoxazole
18999-3,Troleandomycin
19-0,Amoxicillin+Clavulanate
1900-0,Arylamidase
19000-9,Vancomycin
19001-7,Viomycin
19002-5,Rehabilitation.physical therapy service attachment
19003-3,Rehabilitation.respiratory therapy service attachment
19004-1,Rehabilitation.skilled nursing service attachment
19005-8,Imaging study
19006-6,Image quality
19007-4,Diagnosis.primary
19008-2,Transducer site
19009-0,Medication.current
19010-8,Medication.discharge
19011-6,Medication.administered
19012-4,Substitution instruction
19013-2,Medications.current.report request
19014-0,Medications.discharge.report request
19015-7,Medications.administered.report request
19016-5,"X12 277, all requests for information that are included in this transaction are stated for individual services"
Aug-01,Arylsulfatase
19021-5,Study observation
19022-3,Neisseria meningitidis serogroups C+w135 Ag
19023-1,Granulocytes/100 leukocytes
Jun-02,Ascorbate
Apr-03,Ascorbate
Feb-04,Ascorbate
19044-7,Artemia salina Ab.IgE.RAST class
19045-4,Salmo salar Ab.IgG.RAST class
19046-2,Bovine serum albumin Ab.IgE.RAST class
19047-0,Thunnus albacares Ab.IgG.RAST class
19048-8,Erythrocytes.nucleated/100 leukocytes
19049-6,Metanephrine
19050-4,Metanephrines
19051-2,Saquinavir
19052-0,Borrelia burgdorferi DNA
19053-8,Brucella sp Ab
19054-6,Mycoplasma pneumoniae
19055-3,Carboxy tetrahydrocannabinol/Creatinine
19056-1,Mercury
19057-9,ABO & Rh group
19058-7,Allergens identified
Sep-05,Ascorbate
19059-5,Amphetamines cutoff
19060-3,Antibodies identified
19064-5,Benzodiazepines cutoff
19065-2,Benzoylecgonine cutoff
19066-0,Blood bank comment
Jul-06,Asparagine
19071-0,Blood removed from patient
19072-8,Calcium.ionized^^adjusted to pH 7.4
19073-6,Cannabinoids cutoff
19074-4,Carnitine esters
May-07,Asparagine
19075-1,Cells counted.total
19076-9,Cells counted.total
19077-7,Cells identified
19078-5,Cells.CD23/100 cells
19079-3,Cells.CD43/100 cells
19080-1,Choriogonadotropin
Mar-08,Asparagine
19085-0,Collection duration
19086-8,Collection end date
19087-6,Collection end time
19088-4,Collection start date
19089-2,Collection start time
190-9,Clarithromycin
19090-0,Colony count
Jan-09,Asparagine
19091-8,Colony count
19092-6,Cotinine cutoff
19096-7,Electrolytes
19098-3,Erythrocytes
19099-1,Events counted
19101-5,Fungus colony count
19102-3,Genetic screen
19104-9,Glucose^1H post dose glucose
19105-6,Glucose^3H post dose glucose
19106-4,Herpes simplex virus Ab.IgG
19107-2,Histoplasma capsulatum Ag
19108-0,Histoplasma capsulatum Ag
Sep-10,Asparagine
19109-8,Histoplasma capsulatum Ag
19110-6,HIV 1 gp41+gp43 Ab
19111-4,Hospital number
19113-0,IgE
19114-8,Lamellar bodies
Jul-11,Aspartate
19122-1,Cells.CD42/100 cells
19123-9,Magnesium
19124-7,Magnesium
May-12,Aspartate
19125-4,Meconium
19126-2,Bacteria identified
19127-0,Bacteria identified
19128-8,Bacteria identified
19129-6,Microscopic observation
19132-0,Name
Mar-13,Aspartate
19133-8,Neisseria meningitidis serogroups A+C+w135+Y Ag
19134-6,Neisseria meningitidis serogroup B+Escherichia coli K1 Ag
19137-9,Neuronal nuclear Ab
19138-7,Opiates cutoff
19139-5,Pathologist name
19140-3,Phospholipid Ab
Jan-14,Aspartate
19141-1,Propoxyphene
19144-5,Reason for drug test
19145-2,Referral lab test name
19146-0,Referral lab test results
19147-8,Referral lab test reference range
19148-6,Rh immune globulin candidate (yes/no)
19149-4,Rifabutin
19150-2,Specimen creatinine acceptable
19151-0,Specimen drawn
19152-8,Specimen specific gravity acceptable
19153-6,Specimen volume
19156-9,Susceptibility method
19157-7,Tube number
Aug-15,Aspartate
19158-5,Urea nitrogen comment
19159-3,Urinalysis specimen collection method
19161-9,Urobilinogen
19162-7,Varicella zoster virus Ab.IgG
19163-5,Cancer Ag 19-9
19164-3,Cancer Ag 72-4
19165-0,Cancer Ag 125
Jun-16,Aspartate aminotransferase/Alanine aminotransferase
19166-8,Carcinoembryonic Ag
19167-6,Carcinoembryonic Ag
19168-4,Carcinoembryonic Ag
19169-2,Carcinoembryonic Ag
191-7,Clarithromycin
19170-0,Carcinoembryonic Ag
19171-8,Alpha-1-Fetoprotein
19172-6,Alpha-1-Fetoprotein
19173-4,Alpha-1-Fetoprotein
Apr-17,Aspartate aminotransferase
19174-2,Choriogonadotropin.beta subunit
19175-9,Choriogonadotropin.beta subunit
19176-7,Alpha-1-Fetoprotein
19177-5,Alpha-1-Fetoprotein
19178-3,Choriogonadotropin.beta subunit.free
19179-1,Choriogonadotropin.beta subunit.free
19180-9,Choriogonadotropin.beta subunit.free
Feb-18,Aspartate aminotransferase
19182-5,Cytokeratin 19
19183-3,Cytokeratin 19
19184-1,Tissue polypeptide specific Ag
19185-8,Tissue polypeptide specific Ag
19186-6,Cancer Ag 15-3
19187-4,Cancer Ag 27-29
19188-2,Mucin-like carcinoma associated Ag
19189-0,Cancer Ag 549
1919-0,Aspartate aminotransferase
19190-8,Cancer Ag 549
19193-2,Enolase.neuron specific
19194-0,Enolase.neuron specific
19195-7,Prostate specific Ag
19197-3,Prostate specific Ag
19198-1,Prostate specific Ag
19199-9,Prostate specific Ag
19200-5,Prostate specific Ag
19201-3,Prostate specific Ag.free
19203-9,Prostate specific Ag.free
19204-7,Prostate specific Ag.free
19205-4,Prostate specific Ag.free
19206-2,Prostate specific Ag.free
19207-0,Squamous cell carcinoma Ag
Aug-20,Aspartate aminotransferase
19208-8,Squamous cell carcinoma Ag
19209-6,Squamous cell carcinoma Ag
19210-4,Squamous cell carcinoma Ag
19211-2,Oxygen
19212-0,Carbon dioxide
19213-8,pH
19214-6,Oxygen^^saturation adjusted to 0.5
19215-3,Oxygen^^saturation adjusted to 0.5
Jun-21,Atrial natriuretic factor
19216-1,Oxygen^^saturation adjusted to 0.5
19217-9,Oxygen^^saturation adjusted to 0.5
19218-7,Oxygen content
19219-5,Oxygen content
19220-3,Oxygen content
19221-1,Oxygen content
19223-7,Carbon dioxide
Apr-22,Base deficit
19224-5,Oxygen saturation
19225-2,Deoxyhemoglobin/Hemoglobin.total
19226-0,Deoxyhemoglobin/Hemoglobin.total
19227-8,Deoxyhemoglobin/Hemoglobin.total
19228-6,Deoxyhemoglobin/Hemoglobin.total
19229-4,Bicarbonate
19230-2,Bicarbonate^^standard
19231-0,Bicarbonate^^standard
Feb-23,Base deficit
19232-8,Bicarbonate^^standard
19233-6,Bicarbonate^^standard
19234-4,Base excess
19235-1,Base excess^^standard
19236-9,Base excess^^standard
19237-7,Base excess^^standard
19238-5,Base excess^^standard
19239-3,Lactate
1924-0,Base deficit
19240-1,Lactate
19242-7,Corticotropin^post XXX challenge
19243-5,Brucella abortus Ab
19244-3,Character
19245-0,clonazePAM
19247-6,Doxepin+Metabolites
19248-4,Lactate dehydrogenase 2
19249-2,Lactose^3H post 50 g lactose PO
192-5,Clindamycin
19250-0,Lipoprotein.alpha
19251-8,Prolactin^post XXX challenge
19252-6,Megakaryocytes/100 leukocytes
19253-4,Trichinella spiralis Ab
19254-2,Oxygen^^adjusted to patient's actual temperature
19255-9,Oxygen^^adjusted to patient's actual temperature
19256-7,Oxygen^^adjusted to patient's actual temperature
Jul-25,Base excess
19257-5,Oxygen^^adjusted to patient's actual temperature
19258-3,Oxygen^^adjusted to patient's actual temperature
19259-1,Neisseria meningitidis serogroups A+C+w135+Y Ag
19260-9,Neisseria meningitidis serogroup B+Escherichia coli K1 Ag
19261-7,Amphetamines
19262-5,Amphetamines tested for
19263-3,Amphetamines tested for
May-26,Base excess
19265-8,Amphetamines positive
19266-6,Amphetamines cutoff
19267-4,Amphetamines cutoff
19268-2,Amphetamines screen method
19269-0,Amphetamines confirm method
19270-8,Barbiturates
19271-6,Barbiturates tested for
19272-4,Barbiturates tested for
Mar-27,Base excess
19274-0,Barbiturates positive
19275-7,Barbiturates cutoff
19276-5,Barbiturates cutoff
19277-3,Barbiturates screen method
19278-1,Barbiturates confirm method
19279-9,Benzodiazepines tested for
19280-7,Benzodiazepines tested for
Jan-28,Immunoglobulin light chains
19282-3,Benzodiazepines positive
19283-1,Benzodiazepines cutoff
19284-9,Benzodiazepines cutoff
19285-6,Benzodiazepines screen method
19286-4,Benzodiazepines confirm method
19287-2,Cannabinoids tested for
19288-0,Cannabinoids tested for
19289-8,Cannabinoids
19290-6,Cannabinoids positive
19291-4,Cannabinoids cutoff
19292-2,Cannabinoids cutoff
19293-0,Cannabinoids screen method
19294-8,Cannabinoids confirm method
19295-5,Opiates
19296-3,Opiates tested for
19297-1,Opiates tested for
19298-9,Opiates positive
Sep-29,Immunoglobulin light chains
19299-7,Opiates cutoff
19300-3,Opiates cutoff
19301-1,Opiates screen method
19302-9,Opiates confirm method
19303-7,Thiazides
19304-5,Thiazides tested for
19305-2,Thiazides tested for
19306-0,Thiazides
Jul-30,Benzoate
19307-8,Thiazides positive
19308-6,Thiazides cutoff
19309-4,Thiazides cutoff
19310-2,Thiazides screen method
19311-0,Thiazides confirm method
19312-8,Tricyclic antidepressants
19313-6,Tricyclic antidepressants tested for
19314-4,Tricyclic antidepressants tested for
May-31,Beta alanine
19315-1,Tricyclic antidepressants
19316-9,Tricyclic antidepressants positive
19317-7,Tricyclic antidepressants cutoff
19318-5,Tricyclic antidepressants cutoff
19319-3,Tricyclic antidepressants screen method
19320-1,Tricyclic antidepressants confirm method
19321-9,6-Monoacetylmorphine
19322-7,6-Monoacetylmorphine
Mar-32,Beta alanine
19323-5,6-Monoacetylmorphine cutoff
19324-3,6-Monoacetylmorphine cutoff
19325-0,Alpha hydroxyalprazolam
19326-8,Alpha hydroxyalprazolam
19328-4,Alpha hydroxyalprazolam
19329-2,Alpha hydroxyalprazolam cutoff
193-3,Clindamycin
19330-0,Alpha hydroxyalprazolam cutoff
Jan-33,Beta alanine
19331-8,Amitriptyline
19333-4,Amitriptyline cutoff
19334-2,Amitriptyline cutoff
19335-9,Amitriptyline+Nortriptyline
19336-7,Amitriptyline+Nortriptyline
19337-5,Amitriptyline+Nortriptyline cutoff
19338-3,Amitriptyline+Nortriptyline cutoff
19339-1,Amobarbital
19341-7,Amobarbital cutoff
19342-5,Amobarbital cutoff
19343-3,Amphetamine
19344-1,Amphetamine
19346-6,Amphetamine
19347-4,Amphetamine cutoff
19348-2,Amphetamine cutoff
Sep-34,Beta aminoisobutyrate
19349-0,Aprobarbital
19350-8,Aprobarbital
19351-6,Aprobarbital cutoff
19352-4,Aprobarbital cutoff
19353-2,Barbital
19354-0,Barbital
19355-7,Barbital cutoff
Jun-35,Beta aminoisobutyrate
19356-5,Barbital cutoff
19357-3,Benzoylecgonine cutoff
19358-1,Benzoylecgonine cutoff
19359-9,Cocaine
19360-7,Cocaine
19361-5,Cocaine
19362-3,Cocaine cutoff
19363-1,Cocaine cutoff
Apr-36,Beta aminoisobutyrate
19364-9,Bromazepam
19365-6,Bromazepam
19366-4,Bromazepam cutoff
19367-2,Bromazepam cutoff
19368-0,Butabarbital
19370-6,Butabarbital
19371-4,Butabarbital cutoff
Feb-37,Beta endorphin
19372-2,Butabarbital cutoff
19373-0,Butalbital
19375-5,Butalbital cutoff
19376-3,Butalbital cutoff
19377-1,Butorphanol
19378-9,Butorphanol
19379-7,Butorphanol cutoff
1938-0,Beta fructofuranosidase
19380-5,Butorphanol cutoff
19381-3,Carboxy tetrahydrocannabinol
19382-1,Carboxy tetrahydrocannabinol
19383-9,Carboxy tetrahydrocannabinol cutoff
19384-7,Carboxy tetrahydrocannabinol cutoff
19385-4,chlordiazePOXIDE
19386-2,chlordiazePOXIDE
19387-0,chlordiazePOXIDE cutoff
19388-8,chlordiazePOXIDE cutoff
19389-6,Chlorpheniramine
19391-2,Chlorpheniramine
19392-0,Chlorpheniramine
19393-8,Chlorpheniramine cutoff
19394-6,Chlorpheniramine cutoff
19395-3,chlorproMAZINE
19396-1,chlorproMAZINE
19397-9,chlorproMAZINE cutoff
Aug-39,Beta fructofuranosidase
19398-7,chlorproMAZINE cutoff
19399-5,clonazePAM
19402-7,clonazePAM
19403-5,clonazePAM cutoff
19404-3,clonazePAM cutoff
19405-0,Cocaethylene
Jun-40,Beta galactosidase
19406-8,Cocaethylene
19408-4,Cocaethylene
19409-2,Cocaethylene cutoff
194-1,Clindamycin
19410-0,Cocaethylene cutoff
19411-8,Codeine
19413-4,Codeine cutoff
Apr-41,Beta galactosidase
19414-2,Codeine cutoff
19415-9,Tetrahydrocannabinol
19416-7,Tetrahydrocannabinol
19417-5,Tetrahydrocannabinol cutoff
19418-3,Tetrahydrocannabinol cutoff
19419-1,Dextroamphetamine
19420-9,Dextroamphetamine
19421-7,Dextroamphetamine cutoff
Feb-42,Beta galactosidase
19422-5,Dextroamphetamine cutoff
19423-3,Dextromethamphetamine
19424-1,Dextromethamphetamine
19425-8,Dextromethamphetamine
19426-6,Dextromethamphetamine
19427-4,Dextromethamphetamine cutoff
19428-2,Dextromethamphetamine cutoff
19429-0,Propoxyphene
1943-0,Glucosylceramidase
19431-6,Propoxyphene cutoff
19432-4,Propoxyphene cutoff
19433-2,Propoxyphene+Norpropoxyphene
19434-0,Propoxyphene+Norpropoxyphene
19435-7,Propoxyphene+Norpropoxyphene
19436-5,Propoxyphene+Norpropoxyphene
19437-3,Propoxyphene+Norpropoxyphene cutoff
19438-1,Propoxyphene+Norpropoxyphene cutoff
19439-9,Diamorphine
19441-5,Diamorphine cutoff
19442-3,Diamorphine cutoff
19443-1,diazePAM
19444-9,diazePAM cutoff
19445-6,diazePAM cutoff
19446-4,Dihydrocodeine
Aug-44,Beta glucuronidase
19448-0,Dihydrocodeine
19449-8,Dihydrocodeine
19450-6,Dihydrocodeine cutoff
19451-4,Dihydrocodeine cutoff
19452-2,Dimetamphetamine
19453-0,Dimetamphetamine
19454-8,Dimetamphetamine cutoff
May-45,Beta glucuronidase
19455-5,Dimetamphetamine cutoff
19456-3,Ethylamphetamine
19458-9,Ethylamphetamine
19459-7,Ethylamphetamine
19460-5,Ethylamphetamine cutoff
19461-3,Ethylamphetamine cutoff
19462-1,Ethylmorphine
Mar-46,Beta hydroxybutyrate
19463-9,Ethylmorphine
19464-7,Ethylmorphine cutoff
19465-4,Ethylmorphine cutoff
19466-2,Flunitrazepam
19467-0,Flunitrazepam
19468-8,Flunitrazepam cutoff
19469-6,Flunitrazepam cutoff
19470-4,FLUoxetine
Jan-47,Beta hydroxybutyrate
19471-2,FLUoxetine
19472-0,FLUoxetine cutoff
19473-8,FLUoxetine cutoff
19474-6,Flurazepam
19475-3,Flurazepam
19476-1,Flurazepam cutoff
19477-9,Flurazepam cutoff
19478-7,Haloperidol
19479-5,Haloperidol
19480-3,Haloperidol cutoff
19481-1,Haloperidol cutoff
19482-9,HYDROcodone
19483-7,HYDROcodone
19484-5,HYDROcodone cutoff
19485-2,HYDROcodone cutoff
19486-0,HYDROmorphone
19487-8,HYDROmorphone cutoff
19488-6,HYDROmorphone cutoff
Sep-48,Beta hydroxybutyrate dehydrogenase
19489-4,Hydroxyalprazolam
19490-2,Hydroxyalprazolam
19491-0,Hydroxyalprazolam cutoff
19492-8,Hydroxyalprazolam cutoff
19493-6,Hydroxyethylflurazepam
19494-4,Hydroxyethylflurazepam
19495-1,Hydroxyethylflurazepam cutoff
19496-9,Hydroxyethylflurazepam cutoff
Jul-49,Beta lipotropin
19497-7,Hydroxytriazolam
19499-3,Ketamine
19500-8,Ketamine cutoff
19501-6,Ketamine cutoff
19502-4,Methotrimeprazine
19503-2,Methotrimeprazine
19504-0,Methotrimeprazine cutoff
May-50,Beta melanocyte stimulating hormone
19505-7,Methotrimeprazine cutoff
19506-5,Levomepromazine
19507-3,Levomepromazine
19508-1,Levomepromazine cutoff
19509-9,Levomepromazine cutoff
19510-7,Levomethamphetamine
19511-5,Levomethamphetamine
19512-3,Levomethamphetamine
Mar-51,Beta-2-Microglobulin
19514-9,Levomethamphetamine cutoff
19515-6,Levomethamphetamine cutoff
19516-4,Levorphanol
19518-0,Levorphanol cutoff
19519-8,Levorphanol cutoff
19520-6,LORazepam
Jan-52,Beta-2-Microglobulin
19522-2,LORazepam cutoff
19523-0,LORazepam cutoff
19524-8,Lormetazepam
19525-5,Lormetazepam
19526-3,Lormetazepam cutoff
19527-1,Lormetazepam cutoff
19528-9,Lysergate diethylamide
19530-5,Lysergate diethylamide cutoff
19531-3,Lysergate diethylamide cutoff
19532-1,Meperidine
19534-7,Meperidine cutoff
19535-4,Meperidine cutoff
19536-2,Mephobarbital
19537-0,Mephobarbital
Sep-53,Beta-2-Microglobulin
19539-6,Mephobarbital
19540-4,Mephobarbital cutoff
19541-2,Mephobarbital cutoff
19542-0,Mescaline
19543-8,Mescaline
19544-6,Mescaline cutoff
19545-3,Mescaline cutoff
19546-1,Mesoridazine
Jul-54,Beta-N-acetylhexosaminidase
19547-9,Mesoridazine
19548-7,Mesoridazine cutoff
19549-5,Mesoridazine cutoff
19550-3,Methadone
19552-9,Methadone cutoff
19553-7,Methadone cutoff
Apr-55,Beta-N-acetylhexosaminidase
19554-5,Methamphetamine
19555-2,Methamphetamine
19556-0,Methamphetamine cutoff
19557-8,Methamphetamine cutoff
19558-6,Methaqualone
19559-4,Methaqualone cutoff
19560-2,Methaqualone cutoff
19561-0,Methylenediamine
Feb-56,Beta-N-acetylhexosaminidase.A
19562-8,Methylenediamine
19563-6,Methylenediamine cutoff
19564-4,Methylenediamine cutoff
19565-1,Methylenedioxyamphetamine
19566-9,Methylenedioxyamphetamine
19567-7,Methylenedioxyamphetamine cutoff
19568-5,Methylenedioxymethamphetamine
19569-3,Methylenedioxymethamphetamine
1957-0,Beta-N-acetylhexosaminidase.B
19570-1,Methylenedioxymethamphetamine
19571-9,Methylenedioxymethamphetamine cutoff
19572-7,Methylenedioxymethamphetamine cutoff
19573-5,MethylePHEDrine
19575-0,MethylePHEDrine cutoff
19576-8,MethylePHEDrine cutoff
19577-6,Methylphenidate
19578-4,Methylphenidate
19579-2,Methylphenidate cutoff
195-8,Clindamycin
19580-0,Methylphenidate cutoff
19581-8,Methyprylon
19583-4,Methyprylon cutoff
19584-2,Methyprylon cutoff
19585-9,Midazolam
19586-7,Midazolam
Aug-58,Beta-N-acetylhexosaminidase.I
19588-3,Midazolam
19589-1,Midazolam cutoff
19590-9,Midazolam cutoff
19591-7,6-Monoacetylmorphine
19592-5,6-Monoacetylmorphine
19593-3,6-Monoacetylmorphine
19594-1,6-Monoacetylmorphine
19595-8,6-Monoacetylmorphine cutoff
Jun-59,Bicarbonate
19596-6,6-Monoacetylmorphine cutoff
19597-4,Morphine
19599-0,Morphine cutoff
19600-6,Morphine cutoff
19601-4,Morphine.free
19602-2,Morphine.free
19603-0,Morphine.free cutoff
Apr-60,Bicarbonate
19604-8,Morphine.free cutoff
19605-5,Nalbuphine
19607-1,Nalbuphine cutoff
19608-9,Nalbuphine cutoff
19609-7,Naltrexone
19610-5,Naltrexone
19611-3,Naltrexone
Feb-61,Bicarbonate
19612-1,Naltrexone cutoff
19613-9,Naltrexone cutoff
19614-7,N-desalkylflurazepam
19615-4,N-desalkylflurazepam
19617-0,N-desalkylflurazepam
19618-8,N-desalkylflurazepam cutoff
19619-6,N-desalkylflurazepam cutoff
1962-0,Bicarbonate
19620-4,Nitrazepam
19621-2,Nitrazepam
19622-0,Nitrazepam cutoff
19623-8,Nitrazepam cutoff
19624-6,Nordiazepam
19626-1,Nordiazepam cutoff
19627-9,Nordiazepam cutoff
19628-7,Norfluoxetine
19629-5,Norfluoxetine
19630-3,Norfluoxetine cutoff
19631-1,Norfluoxetine cutoff
19632-9,Norpropoxyphene
19635-2,Norpropoxyphene
19636-0,Norpropoxyphene cutoff
19637-8,Norpropoxyphene cutoff
Aug-63,Bicarbonate
19638-6,Oxazepam
19639-4,Oxazepam
19640-2,Oxazepam cutoff
19641-0,Oxazepam cutoff
19642-8,oxyCODONE
19643-6,oxyCODONE
19644-4,oxyCODONE cutoff
19645-1,oxyCODONE cutoff
Jun-64,Bicarbonate
19646-9,oxyMORphone
19648-5,oxyMORphone
19649-3,oxyMORphone cutoff
19650-1,oxyMORphone cutoff
19651-9,Para hydroxyamphetamine
19652-7,Para hydroxyamphetamine
Mar-65,Bile
19653-5,Para hydroxyamphetamine cutoff
19654-3,Para hydroxyamphetamine cutoff
19655-0,PENTobarbital
19657-6,PENTobarbital cutoff
19658-4,PENTobarbital cutoff
19659-2,Phencyclidine
196-6,Cloxacillin
19660-0,Phencyclidine cutoff
Jan-66,Bile acid
19661-8,Phencyclidine cutoff
19662-6,Phenmetrazine
19664-2,Phenmetrazine cutoff
19665-9,Phenmetrazine cutoff
19666-7,PHENobarbital
19668-3,PHENobarbital cutoff
19669-1,PHENobarbital cutoff
19670-9,Phenothiazines
19672-5,Phenothiazines cutoff
19673-3,Phenothiazines cutoff
19674-1,Phentermine
19676-6,Phentermine cutoff
19677-4,Phentermine cutoff
19678-2,Prazepam
Sep-67,Bile acid
19679-0,Prazepam
19680-8,Prazepam cutoff
19681-6,Prazepam cutoff
19682-4,Psilocin
19683-2,Psilocin
19684-0,Psilocin cutoff
19685-7,Psilocin cutoff
19686-5,Psilocybin
Jul-68,Bilirubin.glucuronidated+Bilirubin.albumin bound
19687-3,Psilocybin
19688-1,Psilocybin
19689-9,Psilocybin
19690-7,Psilocybin cutoff
19691-5,Psilocybin cutoff
19692-3,Secobarbital
May-69,Bilirubin renal clearance
19695-6,Secobarbital
19696-4,Secobarbital cutoff
19697-2,Secobarbital cutoff
19698-0,Temazepam
19700-4,Temazepam cutoff
19701-2,Temazepam cutoff
19702-0,Tetrahydrocannabinol
Mar-70,Bilirubin.albumin bound
19703-8,Tetrahydrocannabinol
19704-6,Tetrahydrocannabinol cutoff
19705-3,Tetrahydrocannabinol cutoff
19706-1,Thioridazine
19707-9,Thioridazine
19708-7,Thioridazine cutoff
19709-5,Thioridazine cutoff
19710-3,traMADol
Jan-71,Bilirubin.non-glucuronidated
19712-9,traMADol cutoff
19713-7,traMADol cutoff
19714-5,Triazolam
19716-0,Triazolam cutoff
19717-8,Triazolam cutoff
19718-6,Trichlorothiazide
19719-4,Trichlorothiazide
19720-2,Trichlorothiazide
19721-0,Trichlorothiazide
19722-8,Trichlorothiazide cutoff
19723-6,Trichlorothiazide cutoff
19724-4,Triplochiton scleroxylon Ab.IgE
19725-1,Aspergillus flavus Ab.IgG
19726-9,Aspergillus fumigatus Ab.IgG
19727-7,Aspergillus niger Ab.IgG
19728-5,Beet Ab.IgE
Sep-72,Bilirubin
19729-3,Lathyrus sativus Ab.IgE
19730-1,Budgerigar droppings Ab.IgE
19731-9,Budgerigar serum proteins Ab.IgE
19732-7,Cat serum albumin Ab.IgE
19733-5,Cefaclor Ab.IgE
19734-3,Chicken droppings Ab.IgE
19735-0,Dactylis glomerata Ab.IgE
19736-8,Coralbumin Ab.IgE
Jul-73,Bilirubin
19737-6,Cotton fibers Ab.IgE
19738-4,Dog serum albumin Ab.IgE
19739-2,Trigonella foenum-graecum Ab.IgE
197-4,Cloxacillin
19740-0,Fox epithelium Ab.IgE
19741-8,Merluccius merluccius Ab.IgE
19742-6,Hexahydrophthalic anhydride Ab.IgE
19743-4,Horse meat Ab.IgE
19744-2,Artocarpus heterophyllus Ab.IgE
May-74,Bilirubin
19745-9,Linum usitatissimum Ab.IgE
19746-7,Maleic anhydride Ab.IgE
19747-5,Tenebrio mollitor Ab.IgE
19748-3,Methyltetrahydrophthalic anhydride Ab.IgE
19749-1,Saccharopolyspora rectivirgula Ab.IgG
19750-9,Mentha piperita Ab.IgE
19751-7,Mouse epithelium+Serum proteins+Urine proteins Ab.IgE
Feb-75,Bilirubin
19752-5,Pigeon serum Ab.IgG
19753-3,Rat epithelium+Serum proteins+Urine proteins Ab.IgE
19754-1,Ribes sylvestre Ab.IgE
19755-8,Crocus sativus Ab.IgE
19756-6,Sheep milk Ab.IgE
19757-4,Sheep whey Ab.IgE
19758-2,Silk waste Ab.IgE
19759-0,Swine serum albumin Ab.IgE
1976-0,Bilirubin
19760-8,Clostridium tetani toxoid Ab.IgE
19761-6,Thermoactinomyces vulgaris Ab.IgG
19762-4,General categories
19763-2,Specimen source
19764-0,Statement of adequacy
19765-7,Microscopic observation
19766-5,Microscopic observation
19767-3,Cytologist
19768-1,Reviewing cytologist
19769-9,Pathologist
19770-7,Specimen source
19771-5,Screen techniques
19772-3,Preparation techniques
19773-1,Recommended follow-up
19774-9,Cytology study comment
19775-6,Relevant Hx and Px for procedure
19776-4,Relevant Hx and Px for procedure
19777-2,Indications
Aug-77,Bilirubin
19778-0,Indications description
19779-8,Procedure
19780-6,Procedure description
19781-4,Procedure monitoring parameters
19782-2,Procedure monitoring description
19783-0,Class
19784-8,Institution inventory number
19785-5,Vendor model number
Jun-78,Bilirubin
19786-3,Vendor serial number
19787-1,Cleaning method
19788-9,Date and time of cleaning
19789-7,Medications
19790-5,Medication administration
19791-3,Insertion depth
19792-1,Examination extent landmark
19793-9,Examination extent landmark
Apr-79,Biopterin
19794-7,Examination extent landmark
19795-4,Insertion depth
19796-2,Examination extent landmark
19797-0,Examination extent landmark
19798-8,Limitations of examination
19799-6,Limitations of examination
19800-2,Number of specimens obtained
19801-0,Specimen obtained
Feb-80,Biotin
19802-8,Specimen obtained
19803-6,Specimen site
19804-4,Study observation
19805-1,Study observation
19806-9,Diagnosis
19807-7,Diagnosis
19808-5,Diagnosis
19809-3,Diagnosis
1981-0,Biotinidase
19810-1,Diagnosis
19811-9,Diagnosis
19812-7,Therapeutic intervention
19813-5,Therapeutic intervention
19814-3,Therapeutic results
19815-0,Therapeutic results
19816-8,Images taken
19817-6,Complications
19818-4,Complications
19819-2,Instructions post GI procedure
198-2,Cloxacillin
19820-0,Return visit post GI procedure
19821-8,Return visit post GI procedure
19822-6,Return visit clinic post GI procedure
19823-4,Return visit post GI procedure
19824-2,Return visit conditions
19825-9,Facility location
19826-7,Informed consent obtained
19827-5,Apnea monitor alarm type
Aug-82,Biotinidase
19828-3,Breaths max setting
19829-1,Breaths max setting
19830-9,Breaths max setting
19831-7,Breaths min setting
19832-5,Breaths min setting
19833-3,Breaths min setting
19834-1,Breaths setting
19835-8,Breaths setting
Jun-83,Bradykinin
19836-6,Breaths setting
19837-4,Breaths setting
19838-2,Breaths.sigh setting
19839-0,Breaths.spontaneous^on ventilator
19840-8,Breaths.spontaneous+mechanical^on ventilator
19841-6,Breaths^at maximum voluntary ventilation
19842-4,Breaths^at maximum voluntary ventilation
19843-2,Capacity.functional residual
Apr-84,Bromide
19844-0,Capacity.functional residual
19845-7,Capacity.functional residual
19846-5,Capacity.functional residual
19847-3,Capacity.functional residual
19848-1,Capacity.inspiratory
19849-9,Capacity.inspiratory
19850-7,Capacity.inspiratory
Jan-85,Bromide
19851-5,Capacity.inspiratory
19852-3,Capacity.inspiratory
19853-1,Capacity.inspiratory.bs/Capacity.inspiratory.preop
19854-9,Capacity.inspiratory.bs/Capacity.inspiratory.preop
19855-6,Capacity.inspiratory/predicted
19856-4,Capacity.inspiratory/predicted
19857-2,Capacity.total
19858-0,Capacity.total
19859-8,Capacity.total
19860-6,Capacity.total
19861-4,Capacity.total
19862-2,Capacity.total
19863-0,Vital capacity
19864-8,Vital capacity
19865-5,Vital capacity
19866-3,Vital capacity
19867-1,Vital capacity
19868-9,Forced vital capacity
Sep-86,C peptide
19869-7,Forced vital capacity
19870-5,Forced vital capacity
19871-3,Forced vital capacity/Forced vital capacity.predicted^pre bronchodilation
19872-1,Forced vital capacity/Forced vital capacity.predicted
19873-9,Forced vital capacity/Forced vital capacity.predicted^post bronchodilation
19874-7,Forced vital capacity^post bronchodilation
19875-4,Forced vital capacity^post bronchodilation
19876-2,Forced vital capacity^pre bronchodilation
Jul-87,C peptide
19877-0,Forced vital capacity^pre bronchodilation
19878-8,Carbon dioxide
19879-6,Carbon dioxide
19880-4,Carbon dioxide
19881-2,Carbon dioxide
19882-0,Carbon dioxide
19883-8,Carbon dioxide
19884-6,Carbon dioxide
May-88,C reactive protein
19885-3,Carbon dioxide
19886-1,Carbon dioxide
19887-9,Carbon dioxide
19888-7,Carbon dioxide/Gas.total.at end expiration
19889-5,Carbon dioxide/Gas.total.at end expiration
19890-3,Carbon dioxide^at end expiration
19891-1,Carbon dioxide^at end expiration
19892-9,Carbon dioxide^during bronchodilation
Mar-89,Calcidiol
19893-7,Carbon dioxide^during bronchodilation
19894-5,Carbon dioxide^during chest physiotherapy
19895-2,Carbon dioxide^during chest physiotherapy
19896-0,Carbon dioxide^during XXX treatment
19897-8,Carbon dioxide^during XXX treatment
19898-6,Carbon dioxide^post bronchodilation
19899-4,Carbon dioxide^post bronchodilation
199-0,Cloxacillin
19900-0,Carbon dioxide^post chest physiotherapy
Jan-90,Cholecalciferol
19901-8,Carbon dioxide^post chest physiotherapy
19902-6,Carbon dioxide^post XXX treatment
19903-4,Carbon dioxide^post XXX treatment
19904-2,Carbon dioxide^pre bronchodilation
19905-9,Carbon dioxide^pre bronchodilation
19906-7,Carbon dioxide^pre chest physiotherapy
19907-5,Carbon dioxide^pre chest physiotherapy
19908-3,Carbon dioxide^pre XXX treatment
19909-1,Carbon dioxide^pre XXX treatment
19910-9,Diffusion capacity.carbon monoxide
19911-7,Diffusion capacity.carbon monoxide
19912-5,Diffusion capacity.carbon monoxide^^adjusted for hemoglobin
19913-3,Diffusion capacity.carbon monoxide^^adjusted for hemoglobin
19914-1,Diffusion capacity/Alveolar volume
19915-8,Diffusion capacity/Alveolar volume
19916-6,Diffusion capacity/Alveolar volume
19917-4,Diffusion capacity^^adjusted to body conditions
19918-2,Diffusion capacity^^adjusted to body conditions
Sep-91,Calciferol binding proteins
19919-0,Endotracheal suction catheter types
19920-8,Expiration setting
19921-6,Expiratory reserve
19922-4,Expiratory reserve
19923-2,Expiratory reserve
19924-0,Expiratory reserve
19925-7,Volume expired during 1.0 s of forced expiration/Forced vital capacity
19926-5,Volume expired during 1.0 s of forced expiration/Forced vital capacity
Jul-92,Calcitonin
19927-3,Gas flow at 25-75% of forced expiration
19928-1,Gas delivery source
19929-9,Gas flow
19930-7,Gas flow
19931-5,Gas flow.peak inspiratory setting
19932-3,Gas flow.constant setting
19933-1,Gas flow.constant^baseline setting
19934-9,Gas flow.delivered setting
May-93,Calcium renal clearance
19935-6,Expiratory gas flow.max
19936-4,Gas flow.max
19937-2,Expiratory gas flow.max^post therapy
19938-0,Expiratory gas flow.max^post therapy
19939-8,Gas flow.min^pre therapy
19940-6,Gas flow.min^pre therapy
19941-4,Gas flow.oxygen
19942-2,Gas flow.oxygen setting
Mar-94,Calcium.ionized
19943-0,Gas flow.secondary gas setting
19944-8,Gas flow^at 25-75% of forced expiration
19945-5,Gas flow at 25-75% of forced expiration
19946-3,Heart rate max setting
19947-1,Heart rate min setting
19948-9,Oxyhemoglobin/Hemoglobin.total
19949-7,Oxyhemoglobin/Hemoglobin.total
1995-0,Calcium.ionized
19950-5,Oxyhemoglobin/Hemoglobin.total
19951-3,Oxyhemoglobin/Hemoglobin.total
19952-1,Oxyhemoglobin/Hemoglobin.total
19953-9,Oxyhemoglobin/Hemoglobin.total
19954-7,Oxyhemoglobin/Hemoglobin.total
19955-4,Oxyhemoglobin/Hemoglobin.total
19956-2,Oxyhemoglobin/Hemoglobin.total^during bronchodilation
19957-0,Oxyhemoglobin/Hemoglobin.total^during bronchodilation
19958-8,Oxyhemoglobin/Hemoglobin.total^during treatment
19959-6,Oxyhemoglobin/Hemoglobin.total^during treatment
19960-4,Oxyhemoglobin/Hemoglobin.total^on room air
19961-2,Oxyhemoglobin/Hemoglobin.total^on room air
19962-0,Oxyhemoglobin/Hemoglobin.total^post bronchodilation
19963-8,Oxyhemoglobin/Hemoglobin.total^post bronchodilation
19964-6,Oxyhemoglobin/Hemoglobin.total^post treatment
19965-3,Oxyhemoglobin/Hemoglobin.total^post treatment
19966-1,Oxyhemoglobin/Hemoglobin.total^pre bronchodilation
19967-9,Oxyhemoglobin/Hemoglobin.total^pre bronchodilation
Aug-96,Calcium
19968-7,Oxyhemoglobin/Hemoglobin.total^pre physiotherapy
19969-5,Oxyhemoglobin/Hemoglobin.total^pre physiotherapy
19970-3,Oxyhemoglobin/Hemoglobin.total^pre treatment
19971-1,Oxyhemoglobin/Hemoglobin.total^pre treatment
19972-9,Humidifier types
19973-7,Inspiration setting
19974-5,Inspiration/Expiration setting
19975-2,Max^during inspiration on ventilator
Jun-97,Calcium
19976-0,Max^during inspiration on ventilator
19977-8,Max^during inspiration on ventilator
19978-6,Max^during inspiration on ventilator
19979-4,Nasal cannula type
19980-2,Oxygen
19981-0,Oxygen
19982-8,Oxygen
19983-6,Oxygen
Apr-98,Calcium
19984-4,Oxygen
19985-1,Oxygen
19986-9,Oxygen
19987-7,Oxygen
19988-5,Oxygen
19989-3,Oxygen max setting
19990-1,Oxygen min setting
19991-9,Oxygen.alveolar - arterial
Feb-99,Calcium
19992-7,Oxygen/Gas.total
19993-5,Oxygen/Gas.total
19994-3,Oxygen/Gas.total setting
19995-0,Oxygen/Inspired gas^on ventilator
19996-8,Oxygen/Inspired gas^on ventilator
19997-6,Oxygen^during bronchodilation
19998-4,Oxygen^during bronchodilation
19999-2,Oxygen^during chest physiotherapy
20000-6,Oxygen^during chest physiotherapy
20001-4,Oxygen^during treatment
20002-2,Oxygen^on oxygen.high flow & asleep
20003-0,Oxygen^on oxygen.high flow & asleep
20004-8,Oxygen^on oxygen.high flow & awake
20005-5,Oxygen^on oxygen.high flow & awake
20006-3,Oxygen^on oxygen.high flow & eating
20007-1,Oxygen^on oxygen.high flow & eating
Aug-00,Calcium
20008-9,Oxygen^on oxygen.low flow & asleep
20009-7,Oxygen^on oxygen.low flow & asleep
20010-5,Oxygen^on oxygen.low flow & awake
20011-3,Oxygen^on oxygen.low flow & awake
20012-1,Oxygen^on oxygen.low flow & eating
20013-9,Oxygen^on oxygen.low flow & eating
20014-7,Oxygen^on room air and asleep
20015-4,Oxygen^on room air and asleep
Jun-01,Calcium
20016-2,Oxygen^on room air and awake
20017-0,Oxygen^on room air and awake
20018-8,Oxygen^on room air and eating
20019-6,Oxygen^on room air and eating
20020-4,Oxygen^post bronchodilation
20021-2,Oxygen^post bronchodilation
20022-0,Oxygen^post chest physiotherapy
20023-8,Oxygen^post chest physiotherapy
Apr-02,Calcium
20024-6,Oxygen^post treatment
20025-3,Oxygen^post treatment
20026-1,Oxygen^pre bronchodilation
20027-9,Oxygen^pre bronchodilation
20028-7,Oxygen^pre chest physiotherapy
20029-5,Oxygen^pre chest physiotherapy
20030-3,Oxygen^pre treatment
20031-1,Oxygen^pre treatment
Feb-03,Calcium
20032-9,Peak inspiratory flow^at 0.5 liter per second on ventilator
20033-7,Peak inspiratory flow^at 0.5 liter per second on ventilator
20034-5,Peak inspiratory flow^at 0.5 liter per second on ventilator
20035-2,Peak inspiratory flow^at 0.5 liter per second on ventilator
20036-0,Peak inspiratory flow^at 1.0 liter per second on ventilator
20037-8,Peak inspiratory flow^at 1.0 liter per second on ventilator
20038-6,Peak inspiratory flow^at 1.0 liter per second on ventilator
20039-4,Peak inspiratory flow^at 1.0 liter per second on ventilator
2004-0,Calcium
20040-2,Peak inspiratory flow^at 1.5 liter per second on ventilator
20041-0,Peak inspiratory flow^at 1.5 liter per second on ventilator
20042-8,Peak inspiratory flow^at 1.5 liter per second on ventilator
20043-6,Peak inspiratory flow^at 1.5 liter per second on ventilator
20044-4,Peak inspiratory flow^at 2.0 liter per second on ventilator
20045-1,Peak inspiratory flow^at 2.0 liter per second on ventilator
20046-9,Peak inspiratory flow^at 2.0 liter per second on ventilator
20047-7,Peak inspiratory flow^at 2.0 liter per second on ventilator
20048-5,Peak inspiratory flow^at 2.5 liter per second on ventilator
20049-3,Peak inspiratory flow^at 2.5 liter per second on ventilator
20050-1,Peak inspiratory flow^at 2.5 liter per second on ventilator
20051-9,Peak inspiratory flow^at 2.5 liter per second on ventilator
20052-7,Pressure
20053-5,Pressure
20054-3,Pressure max setting
20055-0,Pressure min setting
20056-8,Pressure.airway^at mean expiratory flow on ventilator
Jul-05,Calcium^post 12H CFst
20057-6,Pressure.airway^at peak inspiratory flow max setting
20058-4,Pressure.airway^at peak inspiratory flow setting
20059-2,Pressure.airway^at zero inspiratory flow on ventilator
200-6,Colistimethate
20060-0,Pressure.airway^at zero inspiratory flow on ventilator
20061-8,Pressure.airway^on ventilator.pressure targeted control
20062-6,Pressure.airway^on ventilator.pressure targeted control
20063-4,Pressure.airway^on ventilator.volume targeted assist & control
20064-2,Pressure.airway^on ventilator.volume targeted assist & control
May-06,Cancer Ag 125
20065-9,Pressure.airway^on ventilator.volume targeted control
20066-7,Pressure.airway^on ventilator.volume targeted control
20067-5,Pressure.drive max setting
20068-3,Pressure.drive min setting
20069-1,Pressure.inflation.mean
20070-9,Pressure.inspiratory min setting
20071-7,Pressure.mean
20072-5,Pressure.mean max setting
Mar-07,Cancer Ag 15-3
20073-3,Pressure.mean min setting
20074-1,Pressure.negative inspiratory setting
20075-8,Pressure.positive end expiratory
20076-6,Pressure.positive end expiratory min setting
20077-4,Pressure.positive end expiratory setting
20078-2,Pressure.pulmonary airway max setting
20079-0,Pressure.support setting
20080-8,Pulmonary function test method
Jan-08,Cancer Ag 19-5
20081-6,Pulse oximetry site
20082-4,Rescuscitator types
20083-2,Resistance.airway
20084-0,Resistance.airway
20085-7,Resistance.airway
20086-5,Respiration.pause setting
20087-3,Respiratory mask
20088-1,Respiratory test prediction method
20089-9,Secondary gas/Gas.total setting
20090-7,Sighs/Respiratory event setting
20091-5,Temperature
20092-3,Temperature
20093-1,Temperature
20094-9,Temperature
20095-6,Temperature
20096-4,Temperature.airway max setting
20097-2,Temperature.airway min setting
20098-0,Temperature setting
Sep-09,Cancer Ag 19-9
20099-8,Tidal volume max setting
20100-4,Tidal volume min setting
20101-2,Tidal volume.expired/Pressure.peak inspiratory^on ventilator
20102-0,Tidal volume.expired/Pressure.peak inspiratory^on ventilator
20103-8,Tidal volume.expired/Pressure.plateau^post 1.5-2.0 s inspiratory hold on ventilator
20104-6,Tidal volume.expired/Pressure.plateau^post 1.5-2.0 s inspiratory hold on ventilator
20105-3,Tidal volume.expired.spontaneous^^uncorrected for compressible gas volume setting
20106-1,Tidal volume.expired.spontaneous^on ventilator^corrected for compressible gas volume
Jul-10,Cancer Ag 19-9
20107-9,Tidal volume.expired.spontaneous+mechanical^on ventilator
20108-7,Tidal volume.expired.spontaneous+mechanical^on ventilator^corrected for compressible gas volume
20109-5,Tidal volume.inspired.spontaneous+mechanical^on ventilator
20110-3,Tidal volume.inspired.spontaneous+mechanical^on ventilator
20111-1,Tidal volume.inspired.spontaneous+mechanical^on ventilator^corrected for compressible gas volume
20112-9,Tidal volume setting
20113-7,Tidal volume setting
20114-5,Tidal volume.sigh.spontaneous+mechanical^on ventilator
May-11,Cancer Ag 242
20115-2,Tidal volume.spontaneous/Body weight^on ventilator
20116-0,Tidal volume.spontaneous^on ventilator
20117-8,Tidal volume.spontaneous+mechanical/Body weight^on ventilator
20118-6,Tidal volume.spontaneous+mechanical^on ventilator
20119-4,Tidal volume.spontaneous+mechanical^on ventilator^corrected for compressible gas volume
20120-2,Tidal volume.spontaneous+mechanical/Body weight^on ventilator^corrected for compressible gas volume
20121-0,Tidal volume.spontaneous+mechanical^on ventilator^uncorrected for compressible gas volume
20122-8,Transcutaneous monitor site
Mar-12,Cancer Ag 27-29
20123-6,Tubing types
20124-4,Ventilation mode
20125-1,Ventilator type
20126-9,Ventilator.wave form
20127-7,Volume
20128-5,Volume
20129-3,Volume
20130-1,Volume
Jan-13,Cancer Ag 50
20131-9,Volume
20132-7,Volume
20133-5,Volume max setting
20134-3,Volume min setting
20135-0,Volume at 25-75% of forced expiration.post bronchodilation/Volume at 25-75% of forced expiration.predicted
20136-8,Volume at 25-75% of forced expiration.pre bronchodilation/Volume at 25-75% of forced expiration.predicted
20137-6,Volume at 25-75% of forced expiration/Volume at 25-75% of forced expiration.predicted
20138-4,Volume.compressed gas
20139-2,Volume.expired
201-4,Colistimethate
20140-0,Volume.expired
20141-8,Volume.expired per minute/Body weight^on ventilator
20142-6,Volume.forced expiration.total
20143-4,Volume.residual
20144-2,Volume.residual
20145-9,Volume.residual
20146-7,Volume.residual
20147-5,Volume expired during 0.5 s of forced expiration
20148-3,Volume expired during 0.5 s of forced expiration
Sep-14,Cancer Ag 549
20149-1,Volume expired during 1.0 s of forced expiration
20150-9,Volume expired during 1.0 s of forced expiration
20151-7,Volume expired during 1.0 s of forced expiration measured/Predicted
20152-5,Volume expired during 1.0 s of forced expiration/Predicted
20153-3,Volume expired during 1.0 s of forced expiration/Volume.forced expiration.total
20154-1,Volume expired during 1.0 s of forced expiration^post bronchodilation
20155-8,Volume expired during 1.0 s of forced expiration^post bronchodilation
Jun-15,Cancer Ag 72-4
20156-6,Volume expired during 1.0 s of forced expiration^pre bronchodilation
20157-4,Volume expired during 1.0 s of forced expiration^pre bronchodilation
20158-2,Voluntary ventilation.max
20159-0,Voluntary ventilation.max
20160-8,Voluntary ventilation.max^post bronchodilator
20161-6,Voluntary ventilation.max^post bronchodilator/Voluntary ventilation.max predicted
20162-4,Voluntary ventilation.max^pre bronchodilator
20163-2,Voluntary ventilation.max^pre bronchodilator
Apr-16,Carbamoyl phosphate synthetase
20164-0,Voluntary ventilation.max^pre bronchodilator/Voluntary ventilation.max predicted
20165-7,Region
20166-5,Diameter
20167-3,Acceleration slope
20168-1,Acceleration
20169-9,Acceleration
20170-7,Acceleration 2
20171-5,Acceleration/Acceleration 2
Feb-17,Carbamoyl phosphate synthetase(ammonia)
20172-3,Regurgitant blood flow velocity.end diastole
20173-1,Regurgitant blood flow velocity.diastole.max
20174-9,Acceleration slope
20175-6,Deceleration slope
20176-4,Deceleration
20177-2,Crossection
20178-0,Crossection
20179-8,RR interval^at aortic flow measurement
2018-0,Carbon dioxide
20180-6,Area
20181-4,Area 2
20182-2,Area.XXX/Area 2.XXX
20183-0,Blood flow velocity.max^at stenosis
20184-8,Intravascular diastolic
20185-5,Intravascular end systolic.XXX
20186-3,Intravascular peak systolic.XXX
20187-1,Cardiac output/Body surface area
20188-9,Cardiac output/Body surface area
20189-7,Cardiac output/Body surface area
20190-5,Cardiac output/Body surface area
20191-3,Cardiac output/Body surface area
20192-1,Cardiac output/Body surface area
20193-9,Cardiac output/Body surface area.2 chamber
20194-7,Cardiac output/Body surface area.4 chamber
20195-4,Cardiac output/Body surface area
20196-2,Cardiac output/Body surface area
20197-0,Cardiac output/Body surface area
Aug-19,Carbon dioxide
20198-8,Cardiac output/Body surface area
20199-6,Cardiac output/Body surface area
20200-2,Circumference.XXX/Circumference 2.XXX
20201-0,Circulatory system
20202-8,Circumference
20203-6,Circumference 2
20204-4,Cardiac output
20205-1,Cardiac output
Jun-20,Carbon dioxide
20206-9,Cardiac output
20207-7,Cardiac output
20208-5,Cardiac output
20209-3,Cardiac output
20210-1,Cardiac output.2 chamber
20211-9,Cardiac output.4 chamber
20212-7,Cardiac output
20213-5,Cardiac output
Apr-21,Carbon dioxide
20214-3,Cardiac output
20215-0,Deceleration.max
20216-8,Deceleration slope
20217-6,Deceleration
20218-4,Deceleration
20219-2,Deceleration 2
202-2,Colistimethate
20220-0,Deceleration.XXX/Deceleration 2.XXX
20221-8,Ejection time
Feb-22,Carbon dioxide
20222-6,Ejection time
20223-4,Ejection time 2
20224-2,Ejection time/Ejection time 2
20225-9,Regurgitant blood flow velocity.diastole.min.end
20226-7,Flow.XXX
20227-5,Height
20228-3,Laterality
20229-1,Length.XXX/Length 2.XXX
2023-0,Carbon dioxide
20230-9,Length
20231-7,Length 2
20232-5,Blood flow velocity.mean
20233-3,Pressure gradient.systole.mean
20234-1,End-diastolic volume
20235-8,End-diastolic volume
20236-6,End-diastolic volume
20237-4,End-diastolic volume
20238-2,End-diastolic volume
20239-0,Plane.apical.diastole
20240-8,Short axis.papillary level.diastole
20241-6,Plane.apical.systole
20242-4,Short axis.papillary level.systole
20243-2,Internal diameter.minor axis.diastole
20244-0,Internal diameter.minor axis.systole
20245-7,Region crossection
20246-5,Pre ejection period
20247-3,Pressure gradient.max
Aug-24,Carbon dioxide.dissolved
20248-1,Pressure gradient 2.max
20249-9,Regurgitant pressure gradient.max
20250-7,Regurgitant pressure gradient.max
20251-5,Regurgitant pressure gradient.max
20252-3,Systole.max/Systole 2.max
20253-1,Blood flow.max
20254-9,Regurgitant blood flow 2.max
May-25,Carbon dioxide.dissolved
20255-6,Pressure gradient.mean
20256-4,Pressure gradient.mean
20257-2,Pressure gradient 2.mean
20258-0,Pressure gradient 2.mean
20259-8,Pressure gradient.mean.XXX/Pressure gradient 2.mean.XXX
20260-6,Systole.mean/Systole 2.mean
20261-4,Regurgitant blood flow velocity.mean
20262-2,Regurgitant blood flow 2.mean
Mar-26,Carbon dioxide
20263-0,RR interval^at mitral flow measurement
20264-8,Region crossection
20265-5,Slope
20266-3,Slope 2
20267-1,Slope.XXX/Slope 2.XXX
20268-9,Regurgitant blood flow velocity.systole.max
20269-7,Acceleration slope
20270-5,Acceleration
Jan-27,Carbon dioxide
20271-3,Filling period.diastole
20272-1,Diameter
20273-9,Diameter 2
20274-7,Flow
20275-4,Deceleration.pressure half-time
20276-2,Blood flow velocity.systole.max^for peak half-time calculation
20277-0,Blood flow velocity.max
20278-8,Blood velocity.mean
20279-6,Area orifice
20280-4,Pressure half time.XXX
20281-2,Acceleration slope
20282-0,Deceleration slope
20283-8,Deceleration
20284-6,Blood flow velocity.mean
20285-3,Pre ejection period
20286-1,RR interval^at pulmonic flow measurement
20287-9,Region orifice area
20288-7,Region orifice area
Sep-28,Carbon dioxide
20289-5,Region orifice area
20290-3,Region orifice area
20291-1,Pulmonic flow/Systemic flow
20292-9,Pulmonic flow/Systemic flow
20293-7,Pulmonic flow/Systemic flow
20294-5,Pulmonic flow/Systemic flow
20295-2,Q-wave to closure
20296-0,Q-wave to open
Jul-29,Carboxyhemoglobin
20297-8,Intrachamber.diastole
20298-6,Region of interest
20299-4,Pressure gradient.max
203-0,Colistimethate
20300-0,Pressure gradient.mean
20301-8,Pre ejection time
20302-6,Blood flow velocity.mean
20303-4,Pressure gradient.systole.mean
20304-2,Minor axis.max
May-30,Carboxyhemoglobin/Hemoglobin.total
20305-9,Diameter.systole
20306-7,Region crossection
20307-5,Diameter
20308-3,Stroke volume/Body surface area
20309-1,Stroke volume/Body surface area
20310-9,Stroke volume/Body surface area
20311-7,Stroke volume/Body surface area
20312-5,Stroke volume/Body surface area
Mar-31,Carboxyhemoglobin/Hemoglobin.total
20313-3,Stroke volume/Body surface area
20314-1,Stroke volume/Body surface area
20315-8,Stroke volume/Body surface area
20316-6,Stroke volume/Body surface area.2 chamber
20317-4,Stroke volume/Body surface area.4 chamber
20318-2,Stroke volume/Body surface area
20319-0,Stroke volume/Body surface area
20320-8,Stroke volume/Body surface area
Jan-32,Carboxyhemoglobin/Hemoglobin.total
20321-6,Stroke volume/Body surface area
20322-4,Stroke volume/Body surface area
20323-2,Stroke volume
20324-0,Stroke volume
20325-7,Stroke volume
20326-5,Stroke volume
20327-3,Stroke volume
20328-1,Stroke volume
20329-9,Stroke volume
20330-7,Stroke volume
20331-5,Cardiac output/Heart rate.2 chamber
20332-3,Cardiac output/Heart rate.4 chamber
20333-1,Stroke volume
20334-9,Stroke volume
20335-6,Stroke volume
20336-4,Stroke volume
20337-2,Stroke volume
20338-0,Time
Sep-33,Carbonate
20339-8,Time
20340-6,Time 2
20341-4,Time.XXX/Time 2.XXX
20342-2,RR interval^at tricuspid flow measurement
20343-0,Acceleration slope
20344-8,Region crossection
20345-5,Deceleration slope
20346-3,Filling period.diastole
Jul-34,Carbonate
20347-1,Flow
20348-9,Diameter.4 chamber
20349-7,Pressure half time.velocity.max
20350-5,Blood flow velocity.mean
20351-3,Blood flow velocity.max
20352-1,Blood flow velocity.mean
20353-9,Pressure gradient
Apr-35,Carbonate
20354-7,Blood velocity-time integral
20355-4,Blood flow 2.max
20356-2,Blood flow 2.mean
20357-0,Pressure gradient 2
20358-8,Blood velocity-time integral 2
20359-6,Region
20360-4,Region
20361-2,Region
Feb-36,Carbonate dehydratase
20362-0,Region
20363-8,Velocity slope
20364-6,Velocity slope 2
20365-3,Volume.XXX/Volume 2.XXX
20366-1,Volume
20367-9,Volume 2
20368-7,Blood flow velocity.max
20369-5,Velocity slope.XXX/Velocity slope 2.XXX
2037-0,Carcinoembryonic Ag
20370-3,Velocity-time integral.XXX
20371-1,Velocity-time integral.XXX/Velocity-time integral 2.XXX
20372-9,Velocity-time integral 2.XXX
20373-7,Amikacin
20374-5,Ampicillin+Sulbactam
20375-2,Clarithromycin
20376-0,Clofazimine
20377-8,Ciprofloxacin
20378-6,Ceftizoxime
20379-4,Doxycycline
20380-2,Erythromycin
20381-0,Ethambutol
20382-8,Ethionamide
20383-6,Isoniazid
20384-4,Ofloxacin
20385-1,rifAMPin
20386-9,Rifabutin
20387-7,Trimethoprim+Sulfamethoxazole
Aug-38,Carcinoembryonic Ag
20388-5,Nitrofurazone
20389-3,Mupirocin
20390-1,Silver sulfADIAZINE
20391-9,Mafenide
20392-7,Sample icteric
20393-5,Sample hemolyzed
20394-3,Sample lipemic
20395-0,Sample integrity
Jun-39,Carcinoembryonic Ag
20396-8,levoFLOXacin
20397-6,Sparfloxacin
20398-4,Nuclear Ab pattern.homogeneous
20399-2,Nuclear Ab pattern.nucleolar
20400-8,Nuclear Ab pattern.smooth nuclear envelope
20401-6,Nuclear Ab pattern.speckled
20402-4,Cells.CD16+CD56+
20403-2,Fibronectin.fetal
Apr-40,Cardiolipin
20404-0,Fibronectin.fetal
20405-7,Urobilinogen
20406-5,Glucose
20407-3,Nitrite
20408-1,Leukocytes
20409-9,Erythrocytes
20410-7,Amphetamines
20411-5,Barbiturates
Feb-41,Carnitine acyltransferase
20412-3,Benzodiazepines
20413-1,Cannabinoids
20414-9,Thiazides
20415-6,Choriogonadotropin.beta subunit
20416-4,Hepatitis C virus RNA
20417-2,Histoplasma capsulatum mycelial phase Ab
20418-0,Histoplasma capsulatum yeast phase Ab
20419-8,Lutropin
2042-0,Carnitine.free (C0)
20420-6,Acid phosphatase.prostatic
20421-4,Barbiturates
20422-2,Alpha 1 antitrypsin
20423-0,Beta lactamase organism identified
20424-8,Cardiolipin Ab.IgG
20425-5,Cardiolipin Ab.IgM
20426-3,Alkaline phosphatase.bile
20427-1,Acetylcholine receptor Ab
20428-9,Phospholipid Ab.IgG
20429-7,Phospholipid Ab.IgM
20430-5,Culture medium
20431-3,Microscopic observation
20432-1,Epstein Barr virus nuclear Ab
20433-9,Follitropin
20434-7,Prolactin
20435-4,Unidentified extractable nuclear Ab
20436-2,Glucose^2H post dose glucose
20437-0,Glucose^3H post dose glucose
Aug-43,Carnitine.free (C0)
20438-8,Glucose^1H post dose glucose
20439-6,Glucose^30M post dose glucose
20440-4,Glucose^1.5H post dose glucose
20441-2,Glucose^post 50 g glucose
20442-0,Hepatitis B virus DNA
20444-6,Herpes simplex virus 1+2 DNA
20445-3,Herpes virus identified
Jun-44,Carnitine
20446-1,Herpes simplex virus Ab.IgG
20447-9,HIV 1 RNA
20448-7,Insulin
20449-5,Borrelia burgdorferi Ab
20450-3,Alpha-1-Fetoprotein
20451-1,Thyroxine
20452-9,Thyrotropin
Mar-45,Carnitine
20453-7,Epithelial cells
20454-5,Protein
20455-2,Leukocytes
20456-0,Fungi.yeastlike
20457-8,Fungi.filamentous
20458-6,Rubella virus Ab.IgG
20459-4,Streptococcus agalactiae Ag
20460-2,Cefuroxime.oral
Jan-46,Carnitine
20461-0,Pyrazinamide
20462-8,Streptomycin
20463-6,Mycobacterium avium complex rRNA
20464-4,Toxoplasma gondii Ab
20465-1,Choriogonadotropin
20466-9,Estriol.unconjugated
20467-7,Blood bank alert
20468-5,Thiamine
20469-3,Acetone
20470-1,Ethanol
20471-9,Isopropanol
20472-7,Eosinophils
20473-5,Polymorphonuclear cells
20474-3,Bacteria identified
20475-0,Cytomegalovirus Ab.IgG
20476-8,Cells.CD1a/100 cells
20477-6,Cells.CD33+CD44+/100 cells
20478-4,Cells.CD61/100 cells
Sep-47,Carnitine
20479-2,Measles virus Ab.IgG
204-8,Colistin
20480-0,Benzoylecgonine
20481-8,Opiates
20482-6,Granulocytes
20483-4,Mitochondria Ab
20484-2,Cardiolipin Ab.IgG
20485-9,Cardiolipin Ab.IgM
20486-7,Haemophilus influenzae B Ag
Jul-48,Carnitine/Creatinine
20487-5,Neisseria meningitidis serogroups A+Y Ag
20488-3,Streptococcus agalactiae Ag
20489-1,Streptococcus pneumoniae Ag
20490-9,Epstein Barr virus capsid Ab.IgG
20491-7,Epstein Barr virus capsid Ab.IgM
20492-5,Hemoglobin pattern imp
20493-3,Histiocytes/100 cells
20494-1,Lymphocytes/100 leukocytes
May-49,Carnosine
20495-8,Gliadin Ab.IgA
20496-6,Gliadin Ab.IgG
20497-4,Histoplasma capsulatum mycelial phase Ab
20498-2,Histoplasma capsulatum yeast phase Ab
20499-0,Phosphatidylglycerol/Surfactant.total
20500-5,Hydroxyalprazolam
20501-3,Hydroxytriazolam
20502-1,Clue cells
Mar-50,Carnosine
20503-9,Cells.CD22+CD11c+/100 cells
20504-7,Histiocytes/100 cells
20505-4,Bilirubin
20506-2,Specimen drawn from
20507-0,Reagin Ab
20508-8,Reagin Ab
20509-6,Hemoglobin
20510-4,Lipoprotein pattern
Jan-51,Carnosine
20511-2,Creatinine
20512-0,Turbidity
20513-8,Turbidity
20514-6,6-Monoacetylmorphine
20515-3,Amitriptyline
20516-1,Amitriptyline+Nortriptyline
20517-9,Aprobarbital
20518-7,Barbital
20519-5,Cocaine
20520-3,Bromazepam
20521-1,Carboxy tetrahydrocannabinol
20522-9,chlordiazePOXIDE
20523-7,chlorproMAZINE
20524-5,Tetrahydrocannabinol
20525-2,Dextroamphetamine
20526-0,Dimetamphetamine
20527-8,Ethylmorphine
20528-6,Flunitrazepam
Sep-52,Carotene
20529-4,FLUoxetine
20530-2,Haloperidol
20531-0,Hydroxyalprazolam
20532-8,Hydroxyethylflurazepam
20533-6,Hydroxytriazolam
20534-4,Hydroxytriazolam
20535-1,Hydroxytriazolam cutoff
20536-9,Hydroxytriazolam cutoff
Jul-53,Carotene
20537-7,Ketamine
20538-5,Methotrimeprazine
20539-3,Levomepromazine
20540-1,Levorphanol
20541-9,Lormetazepam
20542-7,Lysergate diethylamide
20543-5,Mescaline
20544-3,Mesoridazine
May-54,Catalase
20545-0,Methylenedioxyamphetamine
20546-8,Methylenedioxyamphetamine cutoff
20547-6,MethylePHEDrine
20548-4,Methylphenidate
20549-2,Methyprylon
205-5,Colistin
20550-0,Morphine.free
20551-8,Nalbuphine
Feb-55,Catecholamines
20552-6,Nitrazepam
20553-4,Norfluoxetine
20554-2,Para hydroxyamphetamine
20555-9,Phenmetrazine
20556-7,Phenothiazines
20557-5,Phentermine
20558-3,Psilocin
20559-1,Temazepam
2056-0,Catecholamines
20560-9,Thioridazine
20561-7,traMADol
20562-5,Stroke volume
20563-3,Carboxyhemoglobin/Hemoglobin.total
20564-1,Oxygen saturation
20565-8,Carbon dioxide
20566-6,Colony count
20567-4,Ferritin
20568-2,Prolactin
20569-0,Creatine kinase.MB/Creatine kinase.total
20570-8,Hematocrit
20571-6,Hepatitis C virus RNA
20572-4,Hemoglobin A/Hemoglobin.total
20573-2,Histoplasma capsulatum mycelial phase Ab
20574-0,Histoplasma capsulatum yeast phase Ab
20575-7,Hepatitis A virus Ab
20576-5,Galactose 1 phosphate uridyl transferase
20577-3,Protein
Aug-57,Catecholamines
20578-1,Vancomycin
20579-9,Methanol
20584-9,Leukocytes
20585-6,Lymphocytes
Jun-58,Catecholamines
20586-4,Cells.CD1/100 cells
20587-2,Cells.CD10/100 cells
20588-0,Cells.CD13/100 cells
20589-8,Cells.CD14/100 cells
20590-6,Cells.CD15/100 cells
20591-4,Cells.CD16+CD57-/100 cells
20592-2,Cells.CD19
20593-0,Cells.CD19/100 cells
Apr-59,Cerebroside sulfatase
20594-8,Cells.CD2/100 cells
20595-5,Cells.CD20/100 cells
20596-3,Cells.CD22/100 cells
20597-1,Cells.CD24/100 cells
20598-9,Cells.CD3
20599-7,Cells.CD3/100 cells
20600-3,Cells.CD30/100 cells
20601-1,Cells.CD33/100 cells
Feb-60,Cerebroside sulfatase
20602-9,Cells.CD34/100 cells
20603-7,Cells.CD38/100 cells
20604-5,Cells.CD3-CD16+CD56+
20605-2,Cells.CD4
20606-0,Cells.CD4/100 cells
20607-8,Cells.CD3+CD4+/Cells.CD3+CD8+
20608-6,Cells.CD41/100 cells
20609-4,Cells.CD42/100 cells
2061-0,Cerebroside sulfatase
20610-2,Cells.CD45/100 cells
20611-0,Cells.CD5/100 cells
20612-8,Cells.CD7/100 cells
20613-6,Cells.CD8
20614-4,Cells.CD8/100 cells
20615-1,Lymphocytes.IgD/100 lymphocytes
20616-9,Lymphocytes.IgM/100 lymphocytes
20617-7,Lymphocytes.kappa/100 lymphocytes
20618-5,Lymphocytes.lambda/100 lymphocytes
20619-3,Lymphocytes/100 leukocytes
20620-1,Cells.CD16+CD56+/100 cells
20621-9,Albumin/Creatinine
20622-7,Cortisol
20623-5,Coproporphyrin
20624-3,Creatinine
20625-0,Lead
20626-8,Reducing substances
20627-6,Turbidity
Aug-62,Cerebroside sulfatase
20628-4,Blasts.terminal deoxyribonucleotidyl transferase/100 blasts
20629-2,levoFLOXacin
206-3,Colistin
20631-8,Lymphocytes.activated T cells/100 lymphocytes.small
20632-6,Lymphocytes.activated T cells/100 lymphocytes.small
20633-4,1-Methylhistidine
20634-2,Alpha aminobutyrate
20635-9,3-Methylhistidine
Jun-63,Cerebroside sulfatase
20636-7,Alanine
20637-5,Arginine
20638-3,Asparagine
20639-1,Aspartate
20640-9,Citrulline
20641-7,Cysteine
20642-5,Glutamate
20643-3,Glutamine
Apr-64,Ceruloplasmin
20644-1,Glycine
20645-8,Histidine
20646-6,Homocystine
20647-4,Hydroxyproline
20648-2,Isoleucine
20649-0,Leucine
20650-8,Lysine
Jan-65,Chenodeoxycholate
20651-6,Methionine
20652-4,Ornithine
20653-2,Phenylalanine
20654-0,Phosphoserine
20655-7,Proline
20656-5,Serine
20657-3,Taurine
20658-1,Threonine
20659-9,Tryptophan
20660-7,Tyrosine
20661-5,Valine
20662-3,Allergens tested for
20663-1,Tricyclic antidepressants
20664-9,Barbiturates
20665-6,Echovirus 14 Ab.Neut
20666-4,Echovirus Ab
Sep-66,Chenodeoxycholylglycine
20669-8,Cardiolipin Ab.IgA
20671-4,Amino acids
20672-2,Actinobacillus pleuropneumoniae serotype
20673-0,Actinobacillus pleuropneumoniae Ab
20674-8,Avian adenovirus 2 Ag
20675-5,Bovine adenovirus 3 Ag
20676-3,Bovine adenovirus 5 Ag
Jul-67,Chenodeoxycholylglycine.conjugated
20677-1,Equine adenovirus Ag
20678-9,Alkaloid identified
20679-7,Alkaloid identified
20680-5,Alkaloid identified
20681-3,Alpha tocopherol
20682-1,Ammonia
20683-9,Ammonia
20684-7,Ammonia
May-68,Chloride
20685-4,Anaplasma marginale Ab
20686-2,Anaplasma marginale Ab
20687-0,Arsenic
20688-8,Aspergillus sp identified
20689-6,Babesia caballi Ab
20690-4,Theileria equi Ab
20691-2,Bacillus anthracis
20692-0,Bacillus cereus
Mar-69,Chloride
20693-8,Bacteria identified
20694-6,Bacteria identified
20695-3,Bacteria
20696-1,Bifidobacterium sp
20697-9,Amines.biogenic
20698-7,Bluetongue virus serotype
20699-5,Bluetongue virus Ab
20700-1,Bluetongue virus RNA
Jan-70,Chloride
20701-9,Bluetongue virus Ag
20702-7,Bluetongue virus
20703-5,Border disease virus Ag
20704-3,Border disease virus Ag
20705-0,Clostridium botulinum toxin
20706-8,Clostridium botulinum toxin
20707-6,Bovine leukosis virus Ab
20708-4,Bovine papular stomatitis virus Ag
20709-2,Bovine diarrhea virus RNA
207-1,Colistin
20710-0,Bovine diarrhea virus RNA
20711-8,Bovine diarrhea virus Ag
20712-6,Bovine diarrhea virus Ag
20713-4,Bovine diarrhea virus Ag
20714-2,Bovine diarrhea virus Ag
20715-9,Bovine diarrhea virus Ag
20716-7,Bovine diarrhea virus
20717-5,Bovine diarrhea virus 2 Ag
20718-3,Bromide
Sep-71,Chloride
20719-1,Brucella abortus Ab
20720-9,Brucella abortus Ab
20721-7,Brucella abortus Ab
20722-5,Brucella abortus Ab
20723-3,Brucella abortus Ab
20724-1,Brucella abortus Ab
20725-8,Brucella abortus Ab
20726-6,Brucella abortus Ab
Jul-72,Chloride
20727-4,Brucella abortus Ab
20728-2,Brucella abortus Ab
20729-0,Brucella abortus Ab
20730-8,Brucella abortus Ab
20731-6,Brucella abortus Ab
20732-4,Brucella ovis Ab
20733-2,Brucella ovis Ab
20734-0,Brucella sp identified
May-73,Chloride
20735-7,Brucella sp identified
20736-5,Cache valley virus Ab.Neut
20737-3,Cadmium
20738-1,Campylobacter sp identified
20739-9,Campylobacter sp identified
20740-7,Campylobacter sp identified
20741-5,Canarypox virus Ag
20742-3,Canine distemper virus Ag
Mar-74,Chloride
20743-1,Caprine arthritis encephalitis virus Ab
20744-9,Caprine arthritis encephalitis virus Ab
20745-6,Carbamates
20746-4,Carbamates
20747-2,Carbamates
20748-0,Carbamates
20749-8,Carbamates
2075-0,Chloride
20750-6,Chicken anemia virus Ab.Neut
20751-4,Chicken anemia virus Ab
20752-2,Chlamydophila psittaci
20753-0,Chlamydophila psittaci Ag
20754-8,Chlamydophila psittaci Ab
20755-5,Chlamydia sp Ag
20756-3,Chlamydia sp Ag
20757-1,Chlamydia sp Ag
20758-9,Cholinesterase
20759-7,Chromium
20760-5,Clostridium chauvoei Ag
20761-3,Clostridioides difficile
20762-1,Clostridioides difficile
20763-9,Clostridium novyii Ag
20764-7,Clostridium perfringens genotype
20765-4,Clostridium septicum Ag
20766-2,Clostridium sordellii Ag
20767-0,Coccidioides immitis
Aug-76,Chloride
20768-8,Coccidioides immitis Ab
20769-6,Coliform bacteria
20770-4,Coliform bacteria
20771-2,Coliform bacteria
20772-0,Coliform colony count
20773-8,Colony count
20774-6,Colony count
20775-3,Colony count
Jun-77,Chloride
20776-1,Caprine parapoxvirus Ab
20777-9,Caprine parapoxvirus Ab
20778-7,Copper
20779-5,Bovine coronavirus Ag
20780-3,Cryptosporidium sp
20781-1,Cryptosporidium sp
20782-9,Cyanide
20783-7,Cyanide
Apr-78,Chloride
20784-5,Cyanide
20785-2,Drugs identified
20786-0,Drugs identified
20787-8,Drugs identified
20788-6,Duck enteritis virus Ab.Neut
20789-4,Escherichia coli serotype
20790-2,Eastern equine encephalitis virus Ab
20791-0,Eastern equine encephalitis virus Ab
Feb-79,Chloride
20792-8,Eastern equine encephalitis virus Ab
20793-6,Eastern equine encephalitis virus Ab
20794-4,Eastern equine encephalitis virus Ab
20795-1,Eastern equine encephalitis virus Ab.Neut
20796-9,Endophyte identified
20797-7,Endotoxin identified
20798-5,Clostridium perfringens enterotoxin
20799-3,Clostridium perfringens enterotoxin
20-Aug,Amoxicillin+Clavulanate
2080-0,Cholate
20800-9,Clostridium perfringens enterotoxin
20801-7,Encephalitozoon cuniculi Ab
20802-5,Epizootic hemorrhagic disease virus Ab.Neut
20803-3,Epizootic hemorrhagic disease virus Ab
20804-1,Epizootic hemorrhagic disease virus Ag
20805-8,Epizootic hemorrhagic disease virus Ag
20806-6,Saint Louis encephalitis virus Ab
20807-4,Equine arteritis virus
20808-2,Ergot alkaloid
20809-0,Ergot alkaloid
20810-8,Anaplasma phagocytophilum Ab
20811-6,Escherichia coli
20812-4,Escherichia coli 987P
20813-2,Escherichia coli F41
20814-0,Escherichia coli F41
20815-7,Escherichia coli K88
20816-5,Escherichia coli K88
20817-3,Escherichia coli K88
Aug-81,Cholecystokinin
20818-1,Escherichia coli K99
20819-9,Escherichia coli K99
20820-7,Escherichia coli K99
20821-5,Escherichia coli K99
20822-3,Escherichia coli K99
20823-1,Escherichia coli O157:H7
20824-9,Freezing point
20825-6,Fumonisin
Jun-82,Cholestanol
20826-4,Gallotannin
20827-2,Gallotannin
20828-0,Gallotannin
20829-8,Glycol
20830-6,Glycol
20831-4,Glycolate
20832-2,Gossypol
20833-0,Haemophilus paragallinarum serotype
Apr-83,Cholesterol esterase
20834-8,Herbicide
20835-5,Herbicide
20836-3,Herbicide
20837-1,Herbicide
20838-9,Herbicide
20839-7,Herbicide
20840-5,Herbicide
20841-3,Herbicide
Feb-84,Cholesterol esters
20842-1,Herbicide
20843-9,Avian infectious laryngotracheitis virus Ag
20844-7,Avian infectious laryngotracheitis virus Ag
20845-4,Bovine herpesvirus 1 Ab
20846-2,Bovine herpesvirus 1 Ag
20847-0,Bovine herpesvirus 2 Ag
20848-8,Bovine herpesvirus 2 Ag
20849-6,Bovine herpesvirus 4 Ag
20850-4,Bovine herpesvirus 4 Ag
20851-2,Bovine herpesvirus 5 Ag
20852-0,Duck enteritis virus Ag
20853-8,Equine herpesvirus 1 Ag
20854-6,Equine herpesvirus 1 Ag
20855-3,IgG.bovine
20856-1,IgG.equine
20857-9,IgG.equine
20858-7,Infectious bronchitis virus genotype
Sep-85,Cholesterol.in HDL
20859-5,Infectious bronchitis virus serotype
20860-3,Infectious bronchitis virus
20861-1,Infectious bronchitis virus genotype
20862-9,Influenza virus A Ab
20863-7,Iodine
20864-5,Iodine
20865-2,Iodine
20866-0,Lactobacillus acidophilus colony count
Jul-86,Cholesterol.in HDL
20867-8,Lead
20868-6,Leptospira sp
20869-4,Leptospira sp
20870-2,Listeria sp
20871-0,Listeria sp
20872-8,Magnesium
20873-6,Alcelaphine herpesvirus 1 Ab.Neut
20874-4,Manganese
May-87,Cholesterol.in IDL
20875-1,Manganese
20876-9,Mercury
20877-7,Bacteria identified
20878-5,Bacteria identified
20879-3,Bacteria identified
20881-9,Microscopic observation
20882-7,Microscopic observation
Mar-88,Cholesterol.in IDL
20883-5,Microscopic observation
20884-3,Microscopic observation
20885-0,Microscopic observation
20886-8,Molybdenum
20887-6,Molybdenum
20888-4,Molybdenum
20889-2,Monensin
208-9,Cyclacillin
20890-0,Monensin
Jan-89,Cholesterol.in LDL
20891-8,Mushroom identified
20892-6,Mycobacterium avium subspecies paratuberculosis
20893-4,Mycobacterium avium subspecies paratuberculosis
20894-2,Mycobacterium avium subspecies paratuberculosis Ab
20895-9,Mycoplasma gallisepticum Ag
20896-7,Mycoplasma sp
20897-5,Mycoplasma sp serotype
20898-3,Mycoplasma sp
20899-1,Mycoplasma sp
20900-7,Mycoplasma sp Ab
20901-5,Mycoplasma sp Ag
20902-3,Mycoplasma sp+Ureaplasma sp
20903-1,Mycotoxin identified
20904-9,Neospora caninum Ab
20905-6,Oleandrin
20906-4,Oleandrin
20907-2,Organochlorine pesticides
20908-0,Organochlorine pesticides
Sep-90,Cholesterol.in LDL
20909-8,Organochlorine pesticides
20910-6,Organochlorine pesticides
20911-4,Organochlorine pesticides
20912-2,Organochlorine pesticides
20913-0,Organochlorine pesticides
20914-8,Organochlorine pesticides
20915-5,Organochlorine pesticides
20916-3,Organochlorine pesticides
Jul-91,Cholesterol.in VLDL
20917-1,Organophosphate pesticides
20918-9,Organophosphate pesticides
20919-7,Organophosphate pesticides
20920-5,Organophosphate pesticides
20921-3,Organophosphate pesticides
20922-1,Organophosphate pesticides
20923-9,Organophosphate pesticides
20924-7,Ova & parasites identified
May-92,Cholesterol.in VLDL
20925-4,Ova & parasites identified
20926-2,Ova & parasites identified
20927-0,Oxalate
20928-8,Oxalate
20929-6,Paraquat
20930-4,Paraquat
20931-2,Parasites
20932-0,Parasite identified
Mar-93,Cholesterol
20933-8,Parasite identified
20934-6,Bovine parvovirus Ag
20935-3,Pasteurella multocida serotype
20936-1,Pentachlorophenol
20937-9,Pentachlorophenol
20938-7,Phenols
20939-5,Phosphide
20940-3,Phosphide
Jan-94,Cholesterol.non-esterified
20941-1,Phosphate
20942-9,Plant identified
20943-7,Bovine respiratory syncytial virus Ag
20944-5,Bovine respiratory syncytial virus Ag
20945-2,Bovine respiratory syncytial virus Ag
20946-0,Retinol
20947-8,Retinol
20948-6,Retinol
20949-4,Rickettsia sp
20950-2,Bovine rotavirus Ag
20951-0,Salmonella sp serotype
20952-8,Salmonella sp identified
20953-6,Salmonella sp identified
20954-4,Salmonella sp identified
20955-1,Salmonella sp identified
20956-9,Sarcocystis neurona Ab
20957-7,Sarcocystis neurona Ab
Aug-95,Cholesterol.in HDL/Cholesterol.total
20958-5,Sarcocystis neurona Ab
20959-3,Sarcocystis neurona Ag
20960-1,Selenium
20961-9,Selenium
20962-7,Serpulina hyodysenteria
20963-5,Serpulina hyodysenteria
20964-3,Shigella sp identified
20965-0,Somatic cells
Jun-96,Cholesterol/Triglyceride
20966-8,Staphylococcus sp identified
20967-6,Staphylococcus sp identified
20968-4,Staphylococcus sp identified
20969-2,Strychnine
209-7,Cyclacillin
20970-0,Strychnine
20972-6,Strychnine
20973-4,Sulfate
Apr-97,Cholinesterase
20974-2,Sulfate
20975-9,Thallium
20976-7,Tritrichomonas foetus
20977-5,Urea
20978-3,Urea
20979-1,Urea
20980-9,Venezuelan equine encephalitis virus Ab.Neut
20981-7,Verotoxin identified
Feb-98,Cholinesterase
20982-5,Western equine encephalitis virus Ab.Neut
20983-3,Western equine encephalitis virus Ab
20984-1,Western equine encephalitis virus Ab
20985-8,Western equine encephalitis virus Ab
20986-6,Western equine encephalitis virus Ab
20987-4,Yersinia sp identified
20988-2,Zinc phosphide
20989-0,Zinc phosphide
2099-0,Cholinesterase
20990-8,APC gene targeted mutation analysis
20991-6,Antithrombin
20992-4,Bordetella pertussis Ab
20993-2,Chlamydia trachomatis rRNA
20994-0,Choriogonadotropin
20995-7,Cortisol^1H post dose corticotropin
20996-5,Coxsackievirus B1+B2+B3+B4+B5+B6 Ab
20997-3,Cryptosporidium
20998-1,Cell fractions
20999-9,Cell fractions
21000-5,Erythrocyte distribution width
21001-3,Coagulation factor VIII
21002-1,Fibrinogen
21003-9,Fungus identified
21004-7,Glucose tolerance
21005-4,Hepatitis B virus core Ab
Jun-00,Cholylglycine
21006-2,Hepatitis B virus surface Ab
21007-0,HIV 1 Ab
21008-8,HIV 1 RNA
21009-6,HIV 1
21010-4,Cells.CD1
21011-2,Cells.CD13
21012-0,Cells.CD15
21013-8,Cells.CD22
Apr-01,Cholylglycine.conjugated
21014-6,Cells.CD24
21015-3,Cells.CD33
21016-1,Cells.CD41
21017-9,Cells.CD57
21018-7,Cells.CD61
21019-5,Metanephrine
21020-3,Bacteria identified
21021-1,Microscopic observation
Feb-02,Chondroitin sulfate
21022-9,Microscopic observation
21023-7,Neutrophil cytoplasmic Ab
21024-5,Pathologist interpretation
21025-2,Pathologist interpretation
21026-0,Pathologist interpretation
21027-8,Platelet aggregation
21028-6,Protein
2103-0,Choriomammotropin
21030-2,Reagin Ab
21031-0,Saint Louis encephalitis virus
21032-8,Coagulation thrombin induced
21033-6,Yeast.budding
21034-4,11-Deoxycortisol^evening specimen
21035-1,11-Deoxycortisol^morning specimen
21036-9,17-Hydroxycorticosteroids
21037-7,17-Hydroxypregnenolone
21038-5,17-Ketosteroids
21039-3,18-Hydroxycortisol
21040-1,Alpha ketoglutarate/Creatinine
21041-9,3-Hydroxydodecanedioate/Creatinine
21042-7,3-Hydroxydodecanoate/Creatinine
21043-5,3-Methoxy-4-Hydroxyphenylglycol
21044-3,5-Alpha tetrahydrocortisol
21045-0,5-Hydroxytryptophan
21046-8,7-Aminoflunitrazepam
21047-6,8-Hydroxyloxapine
Aug-04,Choriomammotropin
21048-4,Acetaldehyde
21049-2,Acetone
210-5,Cyclacillin
21050-0,6-Monoacetylmorphine
21051-8,Acrylaldehyde
21052-6,Adenosine monophosphate.cyclic.nephrogenous
21053-4,Adenovirus Ab.IgG
21054-2,Adenovirus Ab.IgM
May-05,Choriogonadotropin
21055-9,Adenovirus DNA
21056-7,Alanine+Cystine+Histidine+Homocysteine+Leucine+Phenylalanine+Tyrosine
21057-5,Alanine+Histidine+Leucine+Phenylalanine+Tyrosine
21058-3,Albumin^2H post peritoneal dialysis
21059-1,Albumin
21060-9,Alnus incana Ab.IgE.RAST class
21061-7,Medicago sativa Ab.IgG.RAST class
21062-5,Allobarbital
Mar-06,Choriogonadotropin (pregnancy test)
21063-3,Prunus dulcis Ab.IgG.RAST class
21064-1,Acid alpha glucosidase
21065-8,Alternaria alternata Ab.IgG.RAST class
21066-6,Ampicillin
21067-4,Monomorium minimum Ab.IgE.RAST class
21068-2,Pogonomyrmex barbatus Ab.IgE.RAST class
21070-8,Antibiotic XXX
Jan-07,Choriogonadotropin
21071-6,Antimony
21072-4,Malus sylvestris Ab.IgG.RAST class
21073-2,Prunus armeniaca Ab.IgG.RAST class
21074-0,Arsenic
21075-7,Ascaris lumbricoides Ab.IgE
21076-5,Ascaris lumbricoides Ab.IgE.RAST class
21077-3,Fraxinus nigra Ab.IgE
21078-1,Fraxinus pennsylvanica Ab.IgE
21079-9,Fraxinus pennsylvanica Ab.IgE.RAST class
21080-7,Asialoganglioside GM1 Ab
21081-5,ASPA gene targeted mutation analysis
21082-3,Asparagus officinalis Ab.IgG.RAST class
21083-1,Populus tremula Ab.IgE.RAST class
21084-9,Aspergillus flavus Ab
21085-6,Aspergillus fumigatus Ab
21086-4,Aspergillus niger Ab
21087-2,Aspergillus terreus Ab.IgE.RAST class
21088-0,Azinphos-methyl
Sep-08,Choriogonadotropin.alpha subunit
21089-8,Babesia microti DNA
21090-6,Musa spp Ab.IgG.RAST class
21091-4,Barbiturates present
21092-2,Hordeum vulgare Ab.IgG.RAST class
21093-0,Basement membrane Ab.IgG
21094-8,Basophils/100 leukocytes
21095-5,BCL2 gene rearrangements
21096-3,Bean black Ab.IgE
Jul-09,Choriogonadotropin.alpha subunit
21097-1,Bean black Ab.IgE.RAST class
21098-9,Bean green Ab.IgG.RAST class
21099-7,Bean kidney red Ab.IgG.RAST class
21100-3,Vigna radiata Ab.IgG.RAST class
21101-1,Bean pinto Ab.IgG.RAST class
21102-9,Glycine max Ab.IgG.RAST class
21104-5,Glycine max dust Ab.IgE.RAST class
May-10,Choriogonadotropin.beta subunit (pregnancy test)
21105-2,Bean yellow Ab.IgG.RAST class
21106-0,Beef Ab.IgG.RAST class
21107-8,Bendiocarb
21108-6,Beta 2 glycoprotein 1 Ab.IgA
21109-4,Beta lactoglobulin Ab.IgG.RAST class
21110-2,Beta-N-acetylhexosaminidase.B/Beta-N-acetylhexosaminidase.total
21111-0,Beta-N-acetylhexosaminidase.B/Beta-N-acetylhexosaminidase.total
21112-8,Birth date
Mar-11,Choriogonadotropin.beta subunit
21113-6,Bismuth
21114-4,Blasts/100 leukocytes
21115-1,Vaccinium myrtillus Ab.IgG.RAST class
21116-9,Borrelia burgdorferi 66kD Ab.IgM
21117-7,Borrelia burgdorferi 93kD Ab.IgM
21118-5,Borrelia burgdorferi Ab.IgG
21119-3,Borrelia burgdorferi Ab.IgM
21120-1,Borrelia burgdorferi DNA
Jan-12,Choriogonadotropin.beta subunit (pregnancy test)
21121-9,Borrelia hermsii Ab.IgG
21122-7,Borrelia hermsii Ab.IgM
21123-5,Bran wheat Ab.IgE.RAST class
21124-3,Brassica oleracea var italica Ab.IgG.RAST class
21125-0,Brush border Ab
21126-8,Brassica oleracea var gemmifera Ab.IgG.RAST class
21127-6,Brassica oleracea var capitata Ab.IgG.RAST class
21128-4,Cadmium
21129-2,Cadmium
211-3,Cyclacillin
21130-0,Cadmium
21131-8,Calcitonin^10M post 0.5 ug/kg pentagastrin IV
21132-6,Calcitonin^1M post 0.5 ug/kg pentagastrin IV
21133-4,Calcitonin^2M post 0.5 ug/kg pentagastrin IV
21134-2,Calcitonin^3M post 0.5 ug/kg pentagastrin IV
21135-9,Canrenone
21136-7,Cucumis melo spp Ab.IgG.RAST class
21137-5,Carageenan Ab.IgE.RAST class
21138-3,Carbaryl
Sep-13,Choriogonadotropin.beta subunit
21139-1,Carbofuran
21140-9,Carbophenothion
21141-7,Elettaria cardamomum Ab.IgE.RAST class
21142-5,Carisoprodol
21143-3,Carp Ab.IgE
21144-1,Carp Ab.IgE.RAST class
21145-8,Daucus carota Ab.IgG.RAST class
21146-6,Casein Ab.IgG.RAST class
Jul-14,Choriogonadotropin.beta subunit
21147-4,Brassica oleracea var botrytis Ab.IgG.RAST class
21148-2,Cedar white Ab.IgE
21149-0,Cefaclor Ab.IgE
21150-8,Cefaclor Ab.IgE.RAST class
21151-6,cefTAZidime
21152-4,Apium graveolens Ab.IgG.RAST class
21153-2,Cells.CD10/Gated cells.total
Apr-15,Choriogonadotropin.beta subunit.free
21154-0,Cells.CD11c/100 cells
21155-7,Cells.CD13/Gated cells.total
21156-5,Cells.CD14/Gated cells.total
21157-3,Cells.CD19/Gated cells.total
21158-1,Cells.CD20/Gated cells.total
21159-9,Cells.CD23/Gated cells.total
21160-7,Cells.CD3/Gated cells.total
21161-5,Cells.CD33/Gated cells.total
Feb-16,Choriogonadotropin.intact
21162-3,Cells.CD34/Gated cells.total
21163-1,Cells.CD38/Gated cells.total
21164-9,Cells.CD4/Gated cells.total
21165-6,Cells.CD5/Gated cells.total
21166-4,Cells.CD56/100 cells
21167-2,Cells.CD61/100 cells
21168-0,Cells.CD7/Gated cells.total
21169-8,Cells.CD71/100 cells
2117-0,Choriogonadotropin.intact
21170-6,Cells.CD8/Gated cells.total
21171-4,Cells.FMC7/100 cells
21172-2,Cells.XXX/100 cells
21173-0,Cephaeline
21174-8,Cephaeline
21175-5,Cephalexin
21176-3,Cerebroventricular lining cells
21177-1,CFTR gene mutation analysis
21178-9,Cheese cheddar type Ab.IgG.RAST class
21179-7,Cheese cream Ab.IgE.RAST class
21180-5,Cheese roquefort Ab.IgE.RAST class
21181-3,Prunus avium Ab.IgG.RAST class
21182-1,Chicken Ab.IgG.RAST class
21183-9,Chicken meat Ab.IgG.RAST class
21184-7,Chlamydophila pneumoniae
21185-4,Chlamydia sp Ab.IgG
21186-2,Chlamydia sp Ab.IgM
21187-0,Chlamydia trachomatis DNA
Aug-18,Choriogonadotropin (pregnancy test)
21188-8,Chlamydia trachomatis rRNA
21189-6,Chlamydia trachomatis DNA
21190-4,Chlamydia trachomatis DNA
21191-2,Chlamydia trachomatis DNA
21192-0,Chlamydia trachomatis rRNA
21193-8,Chlordiazepoxide+Norchlordiazepoxide
21194-6,Chloride
21195-3,Chlorzoxazone
Jun-19,Choriogonadotropin
21196-1,Chocolate Ab.IgG.RAST class
21197-9,Cholesterol esters/Cholesterol.total
21198-7,Choriogonadotropin.beta subunit
21199-5,Chromium
21200-1,Chromium
21201-9,Chromium
21202-7,Cinnamomum spp Ab.IgG.RAST class
21203-5,Citrate
Apr-20,Chylomicrons
21204-3,Ruditapes spp Ab.IgG.RAST class
21205-0,Syzygium aromaticum Ab.IgG.RAST class
21206-8,Clover sweet Ab.IgE
21207-6,CCR5 gene targeted mutation analysis
21208-4,Cobalt
21209-2,Coccidioides immitis Ab
212-1,cycloSERINE
21210-0,Cockatiel droppings Ab.IgE.RAST class
21211-8,Cockatiel feather Ab.IgE.RAST class
Feb-21,Chylomicrons
21212-6,Cocos nucifera Ab.IgG.RAST class
21213-4,Gadus morhua Ab.IgG.RAST class
21214-2,Coffea spp Ab.IgG.RAST class
21215-9,Collagen crosslinked N-telopeptide
21216-7,Collagen crosslinked N-telopeptide/Creatinine
21217-5,Complement C4d
21218-3,Complement total hemolytic CH50
21219-1,Copper
2122-0,Chymopapain
21220-9,Coriandrum sativum Ab.IgE.RAST class
21221-7,Zea mays Ab.IgG.RAST class
21222-5,Cortisol^11 PM specimen
21223-3,Cortisol^1st specimen post XXX challenge
21224-1,Cortisol^2H post XXX challenge
21225-8,Cortisol^3H post XXX challenge
21226-6,Cortisol^4 PM specimen
21227-4,Cotton linters Ab.IgE.RAST class
21228-2,Cottonseed Ab.IgG.RAST class
21229-0,Coumaphos
21230-8,Cow milk Ab.IgG.RAST class
21231-6,Cancer pagurus Ab.IgG.RAST class
21232-4,Creatinine
21233-2,Cryptosporidium sp Ag
21234-0,Cucumis sativus Ab.IgG.RAST class
21235-7,Cuminum cyminum Ab.IgE.RAST class
21236-5,Cyclohexanone
21237-3,Cytomegalovirus Ab.IgM
Aug-23,Chymotrypsin
21238-1,Deer hair Ab.IgE.RAST class
21239-9,Desalkylhalazepam
21240-7,Dextromethorphan
21241-5,Diazepam+Nordiazepam
21242-3,Protoporphyrin
21243-1,Diethyl ether
21244-9,Diethylpropion
21245-6,Diisobutylketone
Jun-24,Chymotrypsin
21246-4,Dimethoate
21247-2,DMD gene targeted mutation analysis
21248-0,DOBUTamine
21249-8,Dolichol
21250-6,Doxycycline
21251-4,Echinococcus granulosus Ab.IgE.RAST class
21252-2,Echinococcus granulosus Ab.IgG
Mar-25,Chymotrypsin
21253-0,Egg white Ab.IgG.RAST class
21254-8,Egg yolk Ab.IgG.RAST class
21255-5,Solanum melongena Ab.IgG.RAST class
21256-3,Iva xanthifolia Ab.IgE.RAST class
21257-1,Iva xanthifolia Ab.IgE.RAST class
21258-9,Cichorium endivia Ab.IgG.RAST class
21259-7,Entamoeba histolytica Ab
21260-5,Epstein Barr virus nuclear Ab
Jan-26,Citrate
21261-3,Erythromycin Ab.IgE.RAST class
21262-1,Escherichia coli shiga-like toxin
21263-9,Estradiol
21264-7,Estriol.unconjugated^^adjusted
21265-4,Estriol.unconjugated^^unadjusted
21266-2,Ethion
21267-0,O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate
21268-8,Fenchlorphos
21269-6,Fenthion
21270-4,Ficus carica Ab.IgE.RAST class
21271-2,Chamerion angustifolium Ab.IgE
21272-0,Chamerion angustifolium Ab.IgE.RAST class
21273-8,Linum usitatissimum Ab.IgE.RAST class
21274-6,Flounder Ab.IgG.RAST class
21275-3,Follitropin^15M post dose gonadotropin releasing hormone
21276-1,Follitropin^1H post XXX challenge
21277-9,Follitropin^2H post dose gonadotropin releasing hormone
21278-7,Follitropin^45M post dose gonadotropin releasing hormone
Sep-27,Citrate
21279-5,Follitropin^1.5H post XXX challenge
21280-3,Fonofos
21281-1,Fusarium oxysporum Ab.IgE.RAST class
21282-9,Ganglioside GD1a Ab.IgM
21283-7,Ganglioside GD1a Ab.IgG
21284-5,Gardnerella vaginalis
21285-2,Allium sativum Ab.IgG.RAST class
21286-0,Gastrin^1.5H post 0.2 U/kg secretin
Jul-28,Citrate
21287-8,Gastrin^1H post 0.2 U/kg secretin
21288-6,Gastrin^2.5H post 0.2 U/kg secretin
21289-4,Gastrin^2H post 0.2 U/kg secretin
21290-2,Gastrin^3.5H post 0.2 U/kg secretin
21291-0,Gastrin^3H post 0.2 U/kg secretin
21292-8,Gastrin^40M post 0.2 U/kg secretin
21293-6,Gastrin^45M post 0.2 U/kg secretin
21294-4,Gastrin^4H post 0.2 U/kg secretin
May-29,Citrulline
21295-1,Gastrin^50M post 0.2 U/kg secretin
21296-9,Gastrin^7M post 0.2 U/kg secretin
21297-7,Gelatin bovine Ab.IgE.RAST class
21298-5,Gelatin porcine Ab.IgE.RAST class
21299-3,Gestational age method
21300-9,Giardia lamblia Ab.IgA
21301-7,Giardia lamblia Ab.IgM
21302-5,Giardia lamblia Ag^2nd specimen
Mar-30,Citrulline
21303-3,Giardia lamblia Ag^3rd specimen
21304-1,Zingiber officinale Ab.IgG.RAST class
21305-8,Glucose
21306-6,Glucose
21307-4,Glucose
21308-2,Glucose^105M post XXX challenge
21309-0,Glucose^45M post XXX challenge
21310-8,Glucose^75M post XXX challenge
Jan-31,Citrulline
21311-6,Gluten Ab.IgG.RAST class
21312-4,Gold
21313-2,Grain elevator dust Ab.IgE.RAST class
21314-0,Vitis vinifera Ab.IgG.RAST class
21315-7,Citrus paradisis Ab.IgG.RAST class
21316-5,Grepafloxacin
21317-3,Baccharis spp Ab.IgE
21318-1,Baccharis spp Ab.IgE.RAST class
21319-9,Melanogrammus aeglefinus Ab.IgG.RAST class
21320-7,Haemophilus influenzae B Ag
21321-5,Hippoglossus hippoglossus Ab.IgG.RAST class
21322-3,Hantavirus puumala Ab.IgG
21323-1,Hantavirus puumala Ab.IgM
21324-9,Helminthosporium sativum Ab.IgE.RAST class
21325-6,Helminthosporium sp Ab.IgE.RAST class
21326-4,Herpes simplex virus 1 Ab.IgM
21327-2,Herpes simplex virus 2 Ab.IgM
21328-0,Beta-N-acetylhexosaminidase A & B
Sep-32,Cobalamins
21329-8,Carya ovata Ab.IgE.RAST class
21330-6,Histoplasma capsulatum Ab
21331-4,HIV 1 p24 Ab
21332-2,HIV 1 p41 Ab
21333-0,HIV 1 RNA
21334-8,HIV 2 gp105 Ab
21335-5,HIV 2 gp120 Ab
21336-3,HIV 2 gp15 Ab
Jul-33,Collagenase
21337-1,HIV 2 gp34 Ab
21338-9,HIV 2 p31 Ab
21339-7,HIV 2 p55 Ab
21340-5,HIV 2 p58 Ab
21341-3,HLA-DR locus
21342-1,HLA-DR locus 2
21343-9,HLA-DR+DQ
21344-7,House dust Greer Ab.IgG.RAST class
May-34,Coproporphyrin
21345-4,HTLV I+II Ab
21346-2,HTLV I+II Ab band pattern
21347-0,HTLV I+II Ab band pattern
21348-8,HTLV I+II Ab.IgG
21349-6,IgA
21350-4,IgG
21351-2,IgM
Feb-35,Coproporphyrin
21352-0,Intercellular substance Ab.IgG
21353-8,Juniperus occidentalis Ab.IgE.RAST class
21354-6,Karaya gum Ab.IgE.RAST class
21355-3,Ketones^2.5H post XXX challenge
21356-1,Ketones^3.5H post XXX challenge
21357-9,Ketones^1.5H post XXX challenge
21358-7,Lactalbumin alpha Ab.IgG.RAST class
21359-5,Beta galactosidase Ab.IgE.RAST class
2136-0,Coproporphyrin
21360-3,Lamb Ab.IgG.RAST class
21361-1,Laxatives present
21362-9,Legionella pneumophila Ab.IgG
21363-7,Legionella pneumophila DNA
21364-5,Citrus limon Ab.IgG.RAST class
21365-2,Leptin
21366-0,Lactuca sativa Ab.IgG.RAST class
21367-8,levoFLOXacin
21368-6,levoFLOXacin
21369-4,Glycyrrhiza lepidota Ab.IgE.RAST class
21370-2,Citrus aurantifolia Ab.IgG.RAST class
21371-0,Homarus gammarus Ab.IgG.RAST class
21372-8,Lymphocytes.abnormal/100 leukocytes
21373-6,Lymphocytes.abnormal/100 leukocytes
21374-4,Cells.CD8+CD38+
21375-1,Lymphocytes.kappa/Lymphocytes.lambda
21376-9,Macadamia spp Ab.IgE.RAST class
21377-7,Magnesium
Aug-37,Coproporphyrin
21378-5,Malathion
21379-3,Malt Ab.IgG.RAST class
21380-1,Prolactin
21381-9,Prolactin^1.5H post XXX challenge
21382-7,Manganese
21383-5,Mercury
21384-3,Mesothelial cells
21385-0,Metasystox
Jun-38,Coproporphyrinogen oxidase
21386-8,Methamphetamine
21387-6,Methylhippurate
21388-4,Mevinphos
21389-2,Saccharopolyspora rectivirgula Ab.IgE
213-9,cycloSERINE
21390-0,Saccharopolyspora rectivirgula Ab.IgE.RAST class
21391-8,Microscopic observation
21392-6,Panicum milliaceum Ab.IgE.RAST class
21393-4,Monkey epithelium Ab.IgE.RAST class
Apr-39,Corticosterone
21394-2,Monocytes+Macrophages/100 leukocytes
21395-9,Monocytes+Macrophages/100 leukocytes
21396-7,Mononuclear cells
21397-5,Mononuclear cells
21398-3,Mononuclear cells
21399-1,Broussonetia papyrifera Ab.IgE.RAST class
21400-7,Morus rubra Ab.IgE.RAST class
21401-5,Mumps virus Ab.IgG
Feb-40,Corticotropin
21402-3,Mumps virus Ab.IgM
21403-1,Agaricus hortensis Ab.IgG.RAST class
21404-9,Mustard Ab.IgG.RAST class
21405-6,Mycobacterium sp DNA
21406-4,Mycoplasma pneumoniae Ab.IgM
21407-2,Myelin Ab.IgA
21408-0,Myelin Ab.IgG
21409-8,Myelin Ab.IgM
2141-0,Corticotropin
21410-6,Myelin associated glycoprotein Ab.IgM
21411-4,Myelin associated glycoprotein Ab.IgM
21412-2,Myocardium Ab pattern
21413-0,N-Acetylgalactosamine-4-Sulfatase
21414-8,Neisseria gonorrhoeae DNA
21415-5,Neisseria gonorrhoeae DNA
21416-3,Neisseria gonorrhoeae DNA
21417-1,Neurokinin A
21418-9,Neutrophil Ab
21419-7,Neutrophil cytoplasmic Ab pattern
21420-5,Nitrate
21421-3,Norketamine
21422-1,Normetanephrine
21423-9,Nuclear Ab
21424-7,Nuclear Ab.IgG
21425-4,Nutmeg Ab.IgG.RAST class
21426-2,Avena sativa Ab.IgG.RAST class
21427-0,Avena sativa Ab.IgE.RAST class
Aug-42,Cortisol
21428-8,Olea europaea Ab.IgE
21429-6,Olea europaea Ab.IgE.RAST class
21430-4,Allium cepa Ab.IgG.RAST class
21431-2,Opiates
21432-0,Citrus sinensis Ab.IgG.RAST class
21433-8,Citrus sinensis tree Ab.IgE.RAST class
21434-6,Origanum vulgare Ab.IgG.RAST class
21435-3,Osteocalcin.bovine
Jun-43,Cortisol
21436-1,Ovary Ab
21437-9,Oxychlordane
21438-7,Ostrea edulis Ab.IgG.RAST class
21439-5,Papain Ab.IgE.RAST class
21440-3,Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA
21441-1,Human papilloma virus 6+11+42+43+44 DNA
21442-9,Parainfluenza virus identified
21443-7,Paraoxon
Apr-44,Cortisol
21444-5,Petroselinum crispum Ab.IgG.RAST class
21445-2,Pisum sativum Ab.IgG.RAST class
21446-0,Prunus persica Ab.IgG.RAST class
21447-8,Arachis hypogaea Ab.IgG.RAST class
21448-6,Pyrus communis Ab.IgG.RAST class
21449-4,Piper nigrum Ab.IgG.RAST class
21450-2,Pepper cayenne Ab.IgG.RAST class
Jan-45,Cortisol.free
21451-0,Capsicum frutescens Ab.IgG.RAST class
21452-8,Pepper green Ab.IgG.RAST class
21453-6,Pepper jalapeno Ab.IgE.RAST class
21454-4,Pepper white Ab.IgG.RAST class
21455-1,Mentha piperita Ab.IgE.RAST class
21456-9,Pheasant Ab.IgE.RAST class
21457-7,Phorate
21458-5,Phosphate
21459-3,Salicornia spp Ab.IgE.RAST class
21460-1,Stizostedion vitreum Ab.IgE.RAST class
21461-9,(Pinus contorta+Pinus ponderosa ) Ab.IgE
21462-7,(Pinus contorta+Pinus ponderosa ) Ab.IgE.RAST class
21463-5,Ananas comosus Ab.IgG.RAST class
21464-3,Plasminogen activator urokinase type
21465-0,Plasmodium falciparum Ab
21466-8,Plasmodium malariae Ab
21467-6,Plasmodium ovale Ab
21468-4,Plasmodium vivax Ab
Sep-46,Cortisol.free
21469-2,Prunus domestica Ab.IgG.RAST class
214-7,cycloSERINE
21470-0,Pollachius virens Ab.IgE.RAST class
21471-8,Punica granatum Ab.IgE
21472-6,Punica granatum Ab.IgE.RAST class
21473-4,Populus alba Ab.IgE
21474-2,Populus alba Ab.IgE.RAST class
21475-9,Pork Ab.IgG.RAST class
21476-7,Potassium
Jul-47,Cortisol.free
21477-5,Solanum tuberosum Ab.IgE
21478-3,Solanum tuberosum Ab.IgE.RAST class
21479-1,Solanum tuberosum Ab.IgG.RAST class
21480-9,Propoxur
21481-7,Propranolol
21482-5,Protein
21483-3,quiNIDine^peak
21484-1,Race
May-48,Creatine
21485-8,Raphanus sativus Ab.IgG.RAST class
21486-6,Brassica napus pollen Ab.IgE.RAST class
21487-4,Ribosomal P Ab
21488-2,Oryza sativa Ab.IgG.RAST class
21489-0,Rickettsia (Proteus OX19) Ab
21490-8,Rickettsia (Proteus OX2) Ab
21491-6,Rickettsia (Proteus OXK) Ab
21492-4,Rickettsia conorii Ab.IgG
Mar-49,Creatine
21493-2,Rickettsia conorii Ab.IgM
21494-0,Rickettsia spotted fever group Ab.IgG
21495-7,Rickettsia spotted fever group Ab.IgM
21496-5,Rickettsia typhus group Ab.IgG
21497-3,Rickettsia typhus group Ab.IgM
21498-1,Orientia tsutsugamushi Ab.IgG
21499-9,Hoplostethus atlanticus Ab.IgE.RAST class
21500-4,Measles virus Ab.IgG
Jan-50,Creatine
21501-2,Measles virus Ab.IgG
21502-0,Measles virus Ab.IgM
21503-8,Measles virus Ab.IgM
21504-6,Secale cereale Ab.IgG.RAST class
21505-3,Secale cereale Ab.IgG.RAST class
21506-1,Carthamus tinctorius Ab.IgG.RAST class
21507-9,Salvia officinalis Ab.IgG.RAST class
21508-7,Artemisia californica Ab.IgE.RAST class
21509-5,Saint Louis encephalitis virus Ab.IgG
21510-3,Saint Louis encephalitis virus Ab.IgM
21511-1,Salmonella paratyphi A H Ab
21512-9,Salmonella paratyphi A H Ab
21513-7,Salmonella paratyphi B H Ab
21514-5,Salmonella paratyphi B H Ab
21515-2,Saltbush annual Ab.IgE.RAST class
21516-0,Pecten spp Ab.IgG.RAST class
21517-8,Schistosoma sp Ab.IgE.RAST class
21518-6,SCL-70 extractable nuclear Ab.IgG
Sep-51,Creatine kinase
21519-4,Sesamum indicum Ab.IgG.RAST class
21520-2,Shark Ab.IgE.RAST class
21521-0,Pandalus borealis Ab.IgG.RAST class
21522-8,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab.IgG
21523-6,Smith extractable nuclear Ab.IgG
21524-4,Snapper red Ab.IgG.RAST class
21525-1,Sodium
21526-9,Sodium
Jul-52,Creatine kinase.BB
21527-7,Sodium
21528-5,Solea solea Ab.IgG.RAST class
21529-3,Specimen volume
21530-1,Specimen volume
21531-9,Spermatozoa.motile/100 spermatozoa^1H post ejaculation
21532-7,Spermatozoa.motile/100 spermatozoa^2H post ejaculation
21533-5,Spermatozoa.motile/100 spermatozoa^3H post ejaculation
21534-3,Spermatozoa.motile/100 spermatozoa^4H post ejaculation
May-53,Creatine kinase.macromolecular
21535-0,Spermatozoa.motile/100 spermatozoa^6H post ejaculation
21536-8,Acid sphingomyelinase
21537-6,Spinacia oleracea Ab.IgG.RAST class
21538-4,Picea pungens Ab.IgE.RAST class
21539-2,Squash summer Ab.IgE.RAST class
215-4,cycloSERINE
21540-0,Squash zucchini Ab.IgE.RAST class
21541-8,Squash zucchini Ab.IgG.RAST class
21542-6,Fragaria vesca Ab.IgG.RAST class
Mar-54,Creatine kinase.MB
21543-4,Saccharum officinarum Ab.IgG.RAST class
21544-2,Sulfamethoxazole Ab.IgE.RAST class
21545-9,Sulfatide Ab.IgG
21546-7,Sulfatide Ab.IgM
21547-5,Helianthus annuus seed Ab.IgG.RAST class
21548-3,Ipomoea batatas Ab.IgG.RAST class
21549-1,Liquidambar styraciflua Ab.IgE.RAST class
2155-0,Creatine kinase.MM
21550-9,Synovial lining cells
21551-7,"t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript"
21552-5,Citrus reticulata Ab.IgG.RAST class
21553-3,Camellia sinensis Ab.IgG.RAST class
21554-1,Terbufos
21555-8,Testosterone^^adjusted for sex hormone binding globulin
21556-6,Tetrahydrocannabinol
21557-4,Tetrahydrocannabinol
21558-2,Thallium
21559-0,Theophylline
21560-8,Thermoactinomyces candidus Ab
21561-6,Thermoactinomyces sacchari Ab
21562-4,Thiocyanate/Creatinine
21563-2,Thiopurine methyltransferase
21564-0,Thiosulfate
21565-7,tiaGABine
21566-5,TOLAZamide
21567-3,TOLBUTamide
Aug-56,Creatine kinase
21568-1,Lycopersicon lycopersicum Ab.IgG.RAST class
21569-9,Toxoplasma gondii Ab.IgG
21570-7,Toxoplasma gondii Ab.IgG
21571-5,Toxoplasma gondii Ab.IgM
21572-3,Transferrin.carbohydrate deficient.asialo/Transferrin.total
21573-1,Transferrin.carbohydrate deficient.disialo/Transferrin.total
21574-9,Transferrin.carbohydrate deficient.monosialo/Transferrin.total
21575-6,Transferrin.carbohydrate deficient.pentasialo/Transferrin.total
Jun-57,Creatine kinase
21576-4,Transferrin.carbohydrate deficient.tetrasialo/Transferrin.total
21577-2,Transferrin.carbohydrate deficient.trisialo/Transferrin.total
21578-0,Ailanthus altissima Ab.IgE.RAST class
21579-8,Trichloroethylene
21580-6,Trimethobenzamide
21581-4,Oncorhynchus mykiss Ab.IgG.RAST class
21582-2,Tryptase
21583-0,Turkey Ab.IgG.RAST class
Apr-58,Creatine kinase.total/Creatine kinase.MB
21584-8,Turkey feather Ab.IgE.RAST class
21585-5,Uranium
21586-3,Uranium
21587-1,Urate
21588-9,Urobilinogen
21589-7,Ustilago nuda+Ustilago tritici Ab.IgE.RAST class
21590-5,Valproate.bound/Valproate.total
21591-3,Vanilla planifolia Ab.IgG.RAST class
Feb-59,Creatinine
21592-1,Varicella zoster virus Ab
21594-7,Varicella zoster virus Ab
21595-4,Varicella zoster virus Ab.IgG
21596-2,Varicella zoster virus Ab.IgM
21597-0,Varicella zoster virus Ab.IgM
21598-8,Varicella zoster virus DNA
21599-6,Venison Ab.IgE.RAST class
21-Jun,Amoxicillin+Clavulanate
2160-0,Creatinine
21600-2,Juglans regia Ab.IgE.RAST class
21601-0,Citrullus lanatus Ab.IgG.RAST class
21602-8,Triticum aestivum Ab.IgG.RAST class
21603-6,Wheat dust Ab.IgE
21604-4,Wheat dust Ab.IgE.RAST class
21605-1,Whitefish Ab.IgG.RAST class
21606-9,Xylose^2nd specimen post XXX challenge
21607-7,Saccharomyces cerevisiae Ab.IgG.RAST class
21608-5,Yeast brewer's Ab.IgG.RAST class
21609-3,Yogurt Ab.IgE.RAST class
21610-1,Zinc
21611-9,Age
21612-7,Age
21613-5,Chlamydia trachomatis DNA
21614-3,CDKN2A gene deletion
21615-0,CDKN2B gene deletion
21616-8,APC gene mutation analysis
21617-6,APC gene.p.Ile1307Lys
Aug-61,Creatinine
21618-4,APC gene mutations tested for
21619-2,APOE gene targeted mutation analysis
216-2,Demeclocycline
21620-0,STS gene deletion
21622-6,ASPA gene.p.Glu285Ala
21623-4,ASPA gene mutations tested for
21624-2,ATM gene targeted mutation analysis
21625-9,ATM gene mutations tested for
Jun-62,Creatinine
21626-7,ATP7B gene targeted mutation analysis
21627-5,ATP7B gene.c.2010_2016del
21628-3,ATP7B gene.c.2337delC
21629-1,ATP7B gene.c.2487insT
21630-9,ATP7B gene.c.1711G>C
21631-7,ATP7B gene.p.Gly1267Arg
21632-5,ATP7B gene.p.His1070Gln
21633-3,ATP7B gene.p.His714Gln
Apr-63,Creatinine renal clearance
21634-1,ATP7B gene.p.Asn915Ser
21635-8,ATP7B gene.p.Arg778Leu
21636-6,BRCA1 gene targeted mutation analysis
21637-4,BRCA1 gene.c.185delAG
21638-2,BRCA1 gene.c.5382insC
21639-0,BRCA1 gene mutations tested for
21640-8,BRCA2 gene.c.6174delT
21641-6,CACNA1S gene targeted mutation analysis
Feb-64,Creatinine renal clearance
21642-4,CACNA1S gene.p.Arg1239Gly
21643-2,CACNA1S gene.p.Arg1239His
21644-0,CACNA1S gene.p.Arg528His
21645-7,CACNA1S gene mutations tested for
21646-5,CBS gene targeted mutation analysis
21647-3,CBS gene.p.G307S
21648-1,CBS gene.p.I278T
21649-9,CBS gene mutations tested for
21650-7,CCR5 gene mutation analysis
21651-5,CCR5 gene mutations tested for
21652-3,CDH1 gene targeted mutation analysis
21653-1,CDH1 gene mutations tested for
21654-9,CFTR gene targeted mutation analysis
21655-6,CFTR gene.p.Phe508del
21656-4,CFTR gene mutations tested for
21657-2,COL2A1 gene targeted mutation analysis
21658-0,COL2A1 gene mutations tested for
Sep-65,Cryofibrinogen
21659-8,CTNNB1 gene targeted mutation analysis
21660-6,CTNNB1 gene mutations tested for
21661-4,CYP2D6 gene deletion
21662-2,CYP2D6 gene.c.2637delA
21663-0,CYP2D6 gene mutation analysis G-A NT1 X4
21664-8,CYP2D6 gene.p.Gly169Ter
21665-5,EGFR gene targeted mutation analysis
21666-3,EGFR gene mutations tested for
Jul-66,Cryoglobulin
21667-1,F5 gene targeted mutation analysis
21668-9,F5 gene.p.Arg506Gln
21669-7,F5 gene mutations tested for
21670-5,F7 gene targeted mutation analysis
21671-3,F7 gene mutations tested for
21672-1,F8 gene targeted mutation analysis
21673-9,F8 gene mutations tested for
21674-7,FGFR2 gene targeted mutation analysis
May-67,Cryoglobulin
21675-4,FGFR2 gene mutations tested for
21676-2,FGFR3 gene targeted mutation analysis
21677-0,FGFR3 gene.p.Gly375Cys
21678-8,FGFR3 gene.p.Gly380Arg
21679-6,FGFR3 gene.p.Lys650Glu
21680-4,G6PD gene targeted mutation analysis
21681-2,G6PD gene mutations tested for
21682-0,Gauchers disease type 1 gene mutations tested for
Mar-68,Cryoglobulin
21683-8,Gauchers disease type 2 gene mutations tested for
21684-6,Gauchers disease type 3 gene mutations tested for
21685-3,HADHB gene targeted mutation analysis
21686-1,HADHB gene mutations tested for
21687-9,HBA1 gene targeted mutation analysis
21688-7,HBA1 gene mutations tested for
21689-5,HBB gene targeted mutation analysis
21690-3,HBB gene.p.Glu6Val
Jan-69,Cobalamins renal clearance
21691-1,HBB gene mutations tested for
21692-9,PRSS1 gene targeted mutation analysis
21693-7,Hereditary pancreatitis gene mutations tested for
21694-5,HFE gene targeted mutation analysis
21695-2,HFE gene.p.Cys282Tyr
21696-0,HFE gene.p.His63Asp
21697-8,HFE gene mutations tested for
21698-6,HRAS gene targeted mutation analysis
21699-4,HRAS gene mutations tested for
217-0,Demeclocycline
21700-0,Kallmann syndrome gene targeted mutation analysis
21701-8,Kallmann syndrome gene mutations tested for
21702-6,KRAS gene targeted mutation analysis
21703-4,KRAS gene mutations tested for
21704-2,MT-ATP6 gene targeted mutation analysis
21705-9,MT-ND4 gene.m.11696G>A
21706-7,MT-ND4 gene.p.R304H
21707-5,MT-ND4 gene.p.Thr109Ala
21708-3,MT-ATP6 gene.p.L156R
Sep-70,Cyanocobalamin.true
21709-1,MTHFR gene targeted mutation analysis
21710-9,MTHFR gene.p.Ala677Val
21711-7,MTHFR gene.p.Cys677Glu
21712-5,MTHFR gene mutations tested for
21713-3,MT-TK gene.m.8344A>G
21714-1,MT-TL1 gene.m.3243A>G
21715-8,MXI1 gene targeted mutation analysis
21716-6,NB gene targeted mutation analysis
Jul-71,Cobalamins.unsaturated binding capacity
21717-4,NF1 gene targeted mutation analysis
21718-2,NF1 gene mutations tested for
21719-0,NRAS gene targeted mutation analysis
21720-8,NRAS gene mutations tested for
21721-6,OTC gene targeted mutation analysis
21722-4,OTC gene mutations tested for
21723-2,SERPINA1 gene targeted mutation analysis
21724-0,SERPINA1 gene.p.Glu264Val
May-72,Cystathionine
21725-7,SERPINA1 gene.p.Glu342Lys
21726-5,SERPINA1 gene mutations tested for
21727-3,PMP22 gene targeted mutation analysis
21728-1,PMP22 gene mutations tested for
21729-9,PSAP gene targeted mutation analysis
21730-7,PSAP gene mutations tested for
21731-5,RB1 gene targeted mutation analysis
21732-3,RB1 gene mutations tested for
Mar-73,Cystathionine
21733-1,RET gene targeted mutation analysis
21734-9,RET gene mutations tested for
21735-6,SNCA gene targeted mutation analysis
21736-4,SNCA gene.p.Ala30Pro
21737-2,SNCA gene.p.Ala53Thr
21738-0,SNCA gene mutations tested for
21739-8,TP53 gene targeted mutation analysis
21740-6,TRAF3 gene targeted mutation analysis
Jan-74,Cystathionine
21741-4,TRAF3 gene mutations tested for
21742-2,WT1 gene targeted mutation analysis
21743-0,WT1 gene mutations tested for
21744-8,CCND1 gene rearrangements
21745-5,BCL2 gene rearrangements
21746-3,BCL6 gene rearrangements
21747-1,Immunoglobulin heavy chain gene rearrangements
21748-9,Immunoglobulin kappa light chain gene rearrangements
21749-7,Immunoglobulin lambda light chain gene rearrangements
21750-5,MYC gene rearrangements
21751-3,TCRB gene rearrangements
21752-1,TCRD gene rearrangements
21753-9,TCRG gene rearrangements
21754-7,AR gene.CAG repeats
21755-4,CACNA1A gene.CAG repeats
21756-2,ATN1 gene.CAG repeats
21757-0,DMPK gene.CTG repeats
Aug-75,Cystine
21759-6,FMR1 gene.CGG repeats
21760-4,FRAXE gene.CGG repeats
21761-2,FRAXE gene.CGG repeats
21762-0,FXN gene.GAA repeats
21763-8,HTT gene.CAG repeats
21764-6,MJD gene.CAG repeats
21765-3,SCA1 gene.CAG repeats
Jun-76,Cystine
21766-1,SCA2 gene.CAG repeats
21767-9,SCA7 gene.CAG repeats
21768-7,Spinocerebellar ataxia gene mutations tested for
21769-5,Spinocerebellar ataxia genes.CAG repeats
21770-3,Chromosome 12 trisomy
21771-1,Chromosome 21 trisomy
21772-9,Chromosome 7 trisomy
21773-7,Chromosome 8 trisomy
Apr-77,Cystine
21774-5,Chromosome 9 trisomy
21775-2,"Cells.t(1;13)(p36.13;q14.1)(PAX7,FOXO1)/Cells.total"
21776-0,"Cells.t(1;19)(q23.3;p13.3)(PBX1,TCF3)/Cells.total"
21777-8,"Cells.t(11;14)(q13;q32)(CCND1,IGH)/Cells.total"
21778-6,"Cells.t(11;19)(q23;p13.3)(MLL,MLLT1)/Cells.total"
21779-4,"Cells.t(11;22)(q24;q12.2)(FLI1,EWSR1)/Cells.total"
21780-2,"Cells.t(11;22)(p13;q12.2)(WT1,EWSR1)/Cells.total"
21781-0,"Cells.t(12;16)(q13;p11.2)(DDIT3,FUS)/Cells.total"
Feb-78,Cystine
21782-8,"Cells.t(12;21)(p13;q22.3)(ETV6,RUNX1)/Cells.total"
21783-6,"Cells.t(12;22)(q13;q12.2)(ATF1,EWSR1)/Cells.total"
21784-4,"Cells.t(14;18)(q32;q21.3)(IGH,BCL2)/Cells.total"
21785-1,"Cells.t(15;17)(q24.1;q21.1)(PML,RARA)/Cells.total"
21786-9,"Cells.t(2;13)(q36.1;q14.4)(PAX3,FOXO1)/Cells.total"
21787-7,"Cells.t(2;5)(p23;q35.1)(ALK,NPM1)/Cells.total"
21788-5,"Cells.t(21;22)(q22.3;q12.2)(ERG,EWSR1)/Cells.total"
21789-3,"Cells.t(4;11)(q21.3;q23)(AFF1,MLL)/Cells.total"
2179-0,Cystine
21790-1,"Cells.t(5;12)(q33.1;p13)(PDGFRB,ETV6)/Cells.total"
21791-9,"Cells.t(6;9)(p22;q34)(DEK,NUP214)/Cells.total"
21792-7,"Cells.t(8;14)(q24;q32)(MYC,IGH)/Cells.total"
21793-5,"Cells.t(8;21)(q22;q22.3)(RUNX1T1,RUNX1)/Cells.total"
21794-3,"Cells.t(9;11)(p22;q23)(MLLT3,MLL)/Cells.total"
21795-0,"Cells.t(9;22)(q34.1;q11)(ABL1,BCR)/Cells.total"
21796-8,"Cells.t(9;22)(q22;q12.2)(NR4A3,EWSR1)/Cells.total"
21797-6,"Cells.t(X;18)(q11.2;p11.23)(SS18,SSX1)/Cells.total"
21798-4,"Cells.t(X;18)(q11.2;p11.22)(SS18,SSX2)/Cells.total"
21799-2,"t(1;13)(p36.13;q14.1)(PAX7,FOXO1) fusion transcript"
21800-8,"t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript"
21801-6,"t(11;14)(q13;q32)(CCND1,IGH) fusion transcript"
21802-4,"t(11;19)(q23;p13.3)(MLL,MLLT1) fusion transcript"
21803-2,"t(11;22)(q24;q12.2)(FLI1,EWSR1) fusion transcript"
21804-0,"t(11;22)(p13;q12.2)(WT1,EWSR1) fusion transcript"
21805-7,"t(12;16)(q13;p11.2)(DDIT3,FUS) fusion transcript"
21806-5,"t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript"
21807-3,"t(12;22)(q13;q12.2)(ATF1,EWSR1) fusion transcript"
Aug-80,Cystine+Cysteine
21808-1,"t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript"
21809-9,"t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points"
21810-7,"t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points"
21811-5,"t(15,17) (PML,RARA) gene translocation"
21812-3,"t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript"
21813-1,"t(2;5)(p23;q35.1)(ALK,NPM1) fusion transcript"
21814-9,"t(21;22)(q22.3;q12.2)(ERG,EWSR1) fusion transcript"
21815-6,"t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript"
Jun-81,Cystinyl aminopeptidase
21816-4,"t(5;12)(q33.1;p13)(PDGFRB,ETV6) fusion transcript"
21817-2,"t(6;9)(p22;q34)(DEK,NUP214) fusion transcript"
21818-0,"t(8;14)(q24;q32)(MYC,IGH) fusion transcript"
21819-8,"t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript"
21820-6,"t(9;11)(p22;q23)(MLLT3,MLL) fusion transcript"
21821-4,"t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript"
21822-2,"t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript major break points"
21823-0,"t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript minor break points"
Apr-82,Cytochrome B reductase
21824-8,"t(9;22)(q22;q12.2)(NR4A3,EWSR1) fusion transcript"
21825-5,"t(X;18)(q11.2;p11.23)(SS18,SSX1) fusion transcript"
21826-3,"t(X;18)(q11.2;p11.22)(SS18,SSX2) fusion transcript"
21827-1,Transmitted record type
21828-9,Cancer registry
21829-7,Institution data source
21830-5,Version
21831-3,Unique tumor case ID
Feb-83,Cytochrome B5 reductase
21832-1,Coding system 1970&80&90
21833-9,Alternate census tract at cancer XXX Dx
21834-7,Coding system
21835-4,Coding system.current
21836-2,Coding system.original
21837-0,Hispanic origin
21838-8,Ethnicity
21839-6,Derivation method
2184-0,Cytochrome C oxidase
21840-4,Sex
21841-2,Age at cancer Dx
21842-0,Birthplace
21843-8,Usual occupation
21844-6,Usual industry
21845-3,Information source
21846-1,Information source
21847-9,Usual occupation
21848-7,Usual industry
21849-5,Coding system
21850-3,Cancer
21851-1,Address at cancer XXX Dx
21852-9,Census tract certainty 1970&80&90
21853-7,Sequence number central.patient
21854-5,Date first Dx
21855-2,Primary site
21856-0,Histology ICD-O-2
Jul-85,Cytochrome C oxidase
21857-8,Behavior ICD-O-2
21858-6,Grade
21859-4,Coding system.original
21860-2,Coding system.original
21861-0,Dx confirmed by
21862-8,Source of document used to abstract
21863-6,Date last screened
21864-4,Most recent screening result for
May-86,Cytochrome C oxidase
21865-1,Hospital.reporting
21866-9,Patient ID.hospital
21867-7,Sequence number.hospital
21868-5,User ID.hospital assigned
21869-3,Hospital admission.first contact
21870-1,Date of inpatient admission
21871-9,Date of inpatient discharge
21872-7,Relationship between this hospital and cancer Dx
Mar-87,Cytosol aminopeptidase
21873-5,Y first seen at this hospital for
21874-3,Cancer conference.presentation status at reporting facility
21875-0,Cancer conference
21876-8,Surgery procedure for primary site at facility.YYY
21877-6,Surgery procedure for regional nodes at facility.YYY
21878-4,Other regional disease at facility.YYY most definitive procedure
21879-2,Surgery.regional nodes examined at facility.YYY most definitive procedure
218-8,Demeclocycline
21880-0,Radiation Rx therapy
Jan-88,Cytosol aminopeptidase
21881-8,Chemotherapy Rx at facility.YYY
21882-6,Hormone Rx at facility.YYY
21883-4,Transplant Rx at facility.YYY
21884-2,Other Rx at facility.YYY
21885-9,Surgery.not cancer Rx at facility.YYY
21886-7,Breast-prostate staging.NAACCR
21887-5,SEER summary stage 1977
21888-3,Stage.summary abbreviated at Dx
21889-1,Size
21890-9,Extension
21891-7,Extent of disease
21892-5,Lymph node involvement
21893-3,Regional lymph nodes positive
21894-1,Regional lymph nodes examined
21895-8,Extent of disease.NAACCR.old 13 digit
21896-6,Extent of disease.NAACCR.old 2 digit
21897-4,Extent of disease.NAACCR.old 4 digit
21898-2,Version used
Sep-89,Cytosol aminopeptidase
21899-0,Primary tumor.pathology
21900-6,Regional lymph nodes.pathology
21901-4,Distant metastases.pathology
21902-2,Stage group.pathology
21903-0,Descriptor.pathology
21904-8,Stager.pathology
21905-5,Primary tumor.clinical
21906-3,Regional lymph nodes.clinical
Jul-90,Dehydroepiandrosterone sulfate
21907-1,Distant metastases.clinical
21908-9,Stage group.clinical
21909-7,Descriptor.clinical
21910-5,Stager.clinical
21911-3,Primary tumor.other
21912-1,Regional lymph nodes.other
21913-9,Distant metastases.other
21914-7,Stage group.other
May-91,Dehydroepiandrosterone sulfate
21915-4,Stager.other
21916-2,Descriptor.other
21917-0,Version used
21918-8,Other staging classification
21919-6,Date 1st positive Bx
21920-4,Site of distant metastasis
21921-2,Pediatric stage
21922-0,Coding system used
Mar-92,Dehydroepiandrosterone sulfate
21923-8,Pediatric cancer stager
21924-6,Tumor marker
21925-3,Date 1st surgery treatment
21926-1,Date 1st radiation treatment
21927-9,Date 1st chemotherapy treatment
21928-7,Date 1st hormone treatment
21929-5,Date 1st immunotherapy treatment
21930-3,Date 1st other treatment
Jan-93,Dehydroepiandrosterone
21931-1,Date 1st cancer Rx (any).SEERS
21932-9,Date 1st cancer Rx (any).COC
21933-7,Date non cancer directed surgery Rx as part of 1st cancer
21934-5,Surgery site.primary
21935-2,Surgery scope
21936-0,Surgery.other regional disease
21937-8,Surgery regional nodes examined
21938-6,Surgical approach
21939-4,Surgical margins cancer involvement
21940-2,Surgery reconstruction
21941-0,Reason for no cancer directed surgery
21942-8,Non cancer directed surgery summary
21943-6,Radiation Rx
21944-4,Lung & leukemia CNS radiation status
21945-1,Surgery-radiation sequence
21946-9,Chemotherapy Rx
21947-7,Hormone Rx
21948-5,Biological response modifier Rx
Sep-94,Dehydroepiandrosterone
21949-3,Other Rx
21950-1,Reason for no radiation Rx
21951-9,Reason for no chemotherapy Rx
21952-7,Reason for no hormone Rx
21953-5,Coding system for Rx
21954-3,Protocol eligibility status
21955-0,Source of protocol in which patient enrolled
Jun-95,Dehydroepiandrosterone
21956-8,Referred to support services
21957-6,Method for calculating time interval of 1st course of treatment
21958-4,Regional radiation Rx
21959-2,Number of radiation Rx
219-6,Demeclocycline
21960-0,Duration
21961-8,Organ target(s)
21962-6,Where performed
21963-4,Curative intent of Rx
Apr-96,Dehydroepiandrosterone.unconjugated
21964-2,Modality
21965-9,Completion status
21966-7,Regional outcomes of
21967-5,Chemotherapy
21968-3,Surgery
21969-1,Dx &or stage
21970-9,2nd course treatment start date
21971-7,2nd course treatment
Feb-97,Dehydroepiandrosterone.unconjugated
21972-5,2nd course treatment.surgery.other regional disease
21973-3,3rd course treatment
21974-1,Surgery reconstruction
21975-8,Date last contact
21976-6,Cancer outcome status
21977-4,Survival quality
21978-2,Source of follow-up information
21979-0,Planned &or next follow-up
2198-0,Delta aminolevulinate
21980-8,Other follow-up method
21981-6,Recurrence date
21982-4,Recurrence distant site(s)
21983-2,Recurrence type
21984-0,Cause of death
21985-7,ICD revision number
21986-5,Autopsy status
21987-3,Geographic place of death
21988-1,Site.ICD-O-1
21989-9,Morphology.ICD-O-1
21990-7,ICD-O-1 to ICD-O-2 conversion method
21991-5,Age&site&morphology override flag
21992-3,Sequence number&diagnosis confirm override flag
21993-1,Site&laterality&sequence number override flag
21994-9,Surgery&diagnosis confirm override flag
21995-6,Site&type override flag
21996-4,Histology override flag
21997-2,Report source override flag
Aug-99,Delta aminolevulinate
21998-0,Ill defined site override flag
21999-8,Leukemia & lymphoma override flag
22000-4,Site & behavior override flag
22001-2,Site & extent of disease & diagnosis date override flag
22002-0,Site & laterality & extent of disease override flag
22003-8,Site & laterality & morphology override flag
Apr-00,Delta aminolevulinate
22004-6,CRC checksum
22005-3,Date case completed
22006-1,Date case last changed
22007-9,Date case report exported
22008-7,Date case report received
22009-5,Date case report loaded
22010-3,Date tumor record available
22011-1,Coding system.current.SEER
Feb-01,Deoxycholate
22012-9,Coding system.original.SEER
22013-7,Coding system.current.COC
22014-5,Coding system.original.COC
22015-2,Follow-up expectation
22016-0,SEER record number
22017-8,State defined narrative
22018-6,Military patient number
22019-4,Death certificate number
2202-0,Deoxycholylglycine
22020-2,Maiden name
22021-0,Institution referred from
22022-8,Institution referred to
22023-6,Last follow-up hospital
22024-4,Following registry
22025-1,Physician managing
22026-9,Physician follow up
22027-7,Surgeon primary
22028-5,Physician
22029-3,Physical exam.total
22030-1,Xray/Scan.total
22031-9,Scopic exam.total
22032-7,Lab tests.total
22033-5,Operations (?).total
22034-3,Pathology report.total
22035-0,Primary site
22036-8,Histology
22037-6,Staging
Aug-03,Dermatan sulfate
22038-4,Surgery Rx
22039-2,Radiation beam Rx
220-4,Dicloxacillin
22040-0,Radiation other Rx
22041-8,Chemotherapy Rx
22042-6,Hormone Rx
22043-4,Transplant Rx
22044-2,Other Rx
22045-9,Remarks recorded
Jun-04,Dermatan sulfate
22046-7,Place of 1st Dx
22047-5,Record ID battery
22048-3,Patient demographics battery
22049-1,Cancer identification battery
22050-9,Hospital specific battery
22051-7,State & prognostic factors battery
22052-5,Treatment battery.first
Mar-05,Diacetate
22053-3,Treatment battery.subsequent
22054-1,Followup&recurrent&death battery
22055-8,Overrides&conversion&system administration battery
22056-6,Special use battery
22057-4,Patient confidential battery
22058-2,Hospital confidential battery
22059-0,Other confidential battery
22060-8,Text diagnosis battery
Jan-06,Dicarboxylate C6-C8-C10
22061-6,Text treatment battery
22062-4,Text miscellaneous battery
22063-2,Correction comments battery
22064-0,Alpha 1 globulin
22065-7,Propoxyphene
22066-5,PRSS1 gene mutations tested for
22067-3,NB gene mutations tested for
22068-1,MXI1 gene mutations tested for
22069-9,MT-ATP6 gene mutations tested for
22070-7,Hereditary pancreatitis gene targeted mutation analysis
22071-5,Gauchers disease type 3 gene targeted mutation analysis
22072-3,Gauchers disease type 2 gene targeted mutation analysis
22073-1,Gauchers disease type 1 gene targeted mutation analysis
22074-9,FGFR3 gene mutations tested for
22075-6,DMD gene mutations tested for
22076-4,CMKBR5 gene mutations tested for
22077-2,Acanthamoeba sp Ab
22078-0,Acanthamoeba sp Ab
Sep-07,Dicarboxylate C6-C8-C10
22079-8,Actinomyces sp Ab
22080-6,Adenovirus Ab
22081-4,Afipia felis Ab.IgG
22082-2,Afipia felis Ab.IgM
22083-0,Alcelaphine herpesvirus 1 Ab
22084-8,Anaplasma marginale Ab
22085-5,Aspergillus fumigatus 3 Ab
22086-3,Aspergillus niger Ab
Jul-08,Diethyl ether
22087-1,Aspergillus sp Ab
22088-9,Avian adenovirus 2 Ab
22089-7,Avian adenovirus Ab
22090-5,Avian encephalomyelitis virus Ab
22091-3,Avian hemorrhagic enteritis virus Ab
22092-1,Infectious bronchitis virus Ark-99 Ab
22093-9,Infectious bronchitis virus Conn-42 Ab
22094-7,Infectious bronchitis virus Mass-41 Ab
May-09,Dihydrofolate
22095-4,Avian infectious laryngotracheitis virus Ab
22096-2,Influenza virus A Ab
22097-0,Avian paramyxovirus 1 Ab
22098-8,Avian paramyxovirus 1 Ab
22099-6,Avian paramyxovirus 2 Ab
22100-2,Avian paramyxovirus 3 Ab
22101-0,Avian pox virus Ab
22102-8,Avian reovirus Ab
Mar-10,Dihydrolipoamide acetyl transferase
22103-6,Reticuloendotheliosis virus Ab
22104-4,Babesia caballi Ab
22105-1,Theileria equi Ab
22106-9,Babesia sp Ab
22107-7,Babesia sp Ab.IgG
22108-5,Babesia sp Ab.IgM
22109-3,Bacillus anthracis Ab
22110-1,Bartonella henselae Ab.IgG
Jan-11,Dihydrolipoamide dehydrogenase
22111-9,Bartonella henselae Ab.IgM
22112-7,Blastomyces dermatitidis Ab
22113-5,Bluetongue virus Ab
22114-3,Bordetella avium Ab
22115-0,Bordetella avium Ab
22116-8,Bordetella pertussis Ab
22117-6,Bordetella pertussis Ab
22118-4,Borrelia burgdorferi Ab
22119-2,Borrelia burgdorferi Ab
221-2,Dicloxacillin
22120-0,Borrelia burgdorferi Ab
22121-8,Borrelia burgdorferi Ab
22122-6,Borrelia burgdorferi Ab
22123-4,Borrelia burgdorferi Ab.IgA
22124-2,Borrelia burgdorferi Ab.IgA
22125-9,Borrelia burgdorferi Ab.IgG
22126-7,Borrelia burgdorferi Ab.IgG
22127-5,Borrelia burgdorferi Ab.IgG
22128-3,Borrelia burgdorferi Ab.IgG
Sep-12,Dihydropteridine reductase
22129-1,Borrelia burgdorferi Ab.IgG
22130-9,Borrelia burgdorferi Ab.IgG
22131-7,Borrelia burgdorferi Ab.IgG+IgM
22132-5,Borrelia burgdorferi Ab.IgM
22133-3,Borrelia burgdorferi Ab.IgM
22134-1,Borrelia burgdorferi Ab.IgM
22135-8,Borrelia burgdorferi Ab.IgM
22136-6,Borrelia burgdorferi Ab.IgM
Jul-13,Dimethadione
22137-4,Borrelia burgdorferi Ab.IgM
22138-2,Borrelia hermsii Ab.IgG
22139-0,Borrelia hermsii Ab.IgM
22140-8,Bovine diarrhea virus 1 Ab
22141-6,Bovine diarrhea virus 2 Ab
22142-4,Bovine herpesvirus 1 Ab
22143-2,Bovine herpesvirus 1 Ab
22144-0,Bovine leukemia virus Ab
May-14,Dinitrobenzene
22145-7,Bovine leukosis virus Ab
22146-5,Brucella abortus Ab
22147-3,Brucella abortus Ab
22148-1,Brucella abortus Ab
22149-9,Brucella abortus Ab
22150-7,Brucella abortus Ab
22151-5,Brucella abortus Ab.IgM
Feb-15,Dipalmitoylphosphatidylcholine
22152-3,Brucella canis Ab
22153-1,Brucella canis Ab.IgG
22154-9,Brucella canis Ab.IgG
22155-6,Brucella canis Ab.IgM
22156-4,Brucella canis Ab.IgM
22157-2,Brucella melitensis Ab
22158-0,Brucella ovis Ab
22159-8,Brucella sp Ab
2216-0,DOPamine
22160-6,Brucella suis Ab
22161-4,Cache valley virus Ab
22162-2,Candida albicans Ab
22163-0,Candida albicans Ab
22164-8,Caprine arthritis encephalitis virus Ab
22165-5,Caprine arthritis encephalitis virus Ab
22166-3,Caprine parapoxvirus Ab
22167-1,Caprine parapoxvirus Ab
22168-9,Chicken anemia virus Ab
22169-7,Chlamydophila pneumoniae Ab.IgA
22170-5,Chlamydophila pneumoniae Ab.IgA
22171-3,Chlamydophila pneumoniae Ab.IgG
22172-1,Chlamydophila pneumoniae Ab.IgG
22173-9,Chlamydophila pneumoniae Ab.IgM
22174-7,Chlamydophila pneumoniae Ab.IgM
22175-4,Chlamydophila psittaci Ab
22176-2,Chlamydophila psittaci Ab
22177-0,Chlamydophila psittaci Ab.IgA
Aug-17,DOPamine
22178-8,Chlamydophila psittaci Ab.IgA
22179-6,Chlamydophila psittaci Ab.IgG
22180-4,Chlamydophila psittaci Ab.IgG
22181-2,Chlamydophila psittaci Ab.IgM
22182-0,Chlamydia sp Ab
22183-8,Chlamydia sp Ab.IgG
22184-6,Chlamydia sp Ab.IgG
22185-3,Chlamydia sp Ab.IgM
Jun-18,DOPamine
22186-1,Chlamydia sp Ab.IgM
22187-9,Chlamydia trachomatis Ab
22188-7,Chlamydia trachomatis Ab.IgA
22189-5,Chlamydia trachomatis Ab.IgA
22190-3,Chlamydia trachomatis Ab.IgG
22191-1,Chlamydia trachomatis Ab.IgG
22192-9,Chlamydia trachomatis Ab.IgM
22193-7,Chlamydia trachomatis Ab.IgM
Apr-19,Dopamine beta-hydroxylase
22194-5,Chlamydia trachomatis B Ab.IgA
22195-2,Chlamydia trachomatis B Ab.IgG
22196-0,Chlamydia trachomatis B Ab.IgM
22197-8,Chlamydia trachomatis C Ab.IgA
22198-6,Chlamydia trachomatis C Ab.IgG
22199-4,Chlamydia trachomatis C Ab.IgM
222-0,Dicloxacillin
22200-0,Chlamydia trachomatis G+F+K Ab.IgA
22201-8,Chlamydia trachomatis G+F+K Ab.IgG
Feb-20,Elastase.pancreatic.free
22202-6,Chlamydia trachomatis G+F+K Ab.IgM
22203-4,Clostridium tetani Ab.IgG
22204-2,Coccidioides immitis Ab
22205-9,Coccidioides immitis Ab
22206-7,Coccidioides immitis Ab
22207-5,Coccidioides immitis Ab
22208-3,Coccidioides immitis Ab
22209-1,Coccidioides immitis Ab.IgG
2221-0,Elastase.pancreatic
22210-9,Coccidioides immitis Ab.IgM
22211-7,Coxiella burnetii Ab
22212-5,Coxsackievirus A10 Ab
22213-3,Coxsackievirus A10 Ab
22214-1,Coxsackievirus A16 Ab
22215-8,Coxsackievirus A16 Ab
22216-6,Coxsackievirus A2 Ab
22217-4,Coxsackievirus A21 Ab
22218-2,Coxsackievirus A4 Ab
22219-0,Coxsackievirus A7 Ab
22220-8,Coxsackievirus A7 Ab
22221-6,Coxsackievirus A9 Ab
22222-4,Coxsackievirus A9 Ab
22223-2,Coxsackievirus B Ab.IgG
22224-0,Coxsackievirus B Ab.IgM
22225-7,Coxsackievirus B1 Ab
22226-5,Coxsackievirus B1 Ab
22227-3,Coxsackievirus B2 Ab
Aug-22,Elastase.pancreatic 2
22228-1,Coxsackievirus B2 Ab
22229-9,Coxsackievirus B3 Ab
22230-7,Coxsackievirus B3 Ab
22231-5,Coxsackievirus B4 Ab
22232-3,Coxsackievirus B4 Ab
22233-1,Coxsackievirus B5 Ab
22234-9,Coxsackievirus B5 Ab
22235-6,Coxsackievirus B6 Ab
Jun-23,Elastase.leukocyte
22236-4,Coxsackievirus B6 Ab
22237-2,Cryptococcus neoformans Ab
22238-0,Taenia solium larva Ab
22239-8,Cytomegalovirus Ab
22240-6,Cytomegalovirus Ab
22241-4,Cytomegalovirus Ab
22242-2,Cytomegalovirus Ab
22243-0,Cytomegalovirus Ab.IgG
Apr-24,Enolase
22244-8,Cytomegalovirus Ab.IgG
22245-5,Cytomegalovirus Ab.IgG
22246-3,Cytomegalovirus Ab.IgG
22247-1,Cytomegalovirus Ab.IgG^2nd specimen
22248-9,Cytomegalovirus Ab.IgM
22249-7,Cytomegalovirus Ab.IgM
22250-5,Dengue virus 1 Ab
Jan-25,Enolase.neuron specific
22251-3,Dengue virus 2 Ab
22252-1,Dengue virus 3 Ab
22253-9,Dengue virus 4 Ab
22254-7,Duck enteritis virus Ab
22255-4,Eastern equine encephalitis virus Ab
22256-2,Eastern equine encephalitis virus Ab
22257-0,Eastern equine encephalitis virus Ab
22258-8,Eastern equine encephalitis virus Ab.IgG
22259-6,Eastern equine encephalitis virus Ab.IgG
22260-4,Eastern equine encephalitis virus Ab.IgM
22261-2,Eastern equine encephalitis virus Ab.IgM
22262-0,Eastern equine encephalitis virus Ab
22263-8,Ebola virus Ab
22264-6,Echinococcus granulosus Ab.IgG
22265-3,Echinococcus sp Ab.IgG
22266-1,Echovirus 1 Ab
22267-9,Echovirus 11 Ab
22268-7,Echovirus 11 Ab
Sep-26,Enteroglucagon
22269-5,Echovirus 14 Ab
22270-3,Echovirus 140 Ab
22271-1,Echovirus 16 Ab
22272-9,Echovirus 18 Ab
22273-7,Echovirus 19 Ab
22274-5,Echovirus 3 Ab
22275-2,Echovirus 30 Ab
22276-0,Echovirus 4 Ab
Jul-27,Enteropeptidase
22277-8,Echovirus 4 Ab
22278-6,Echovirus 6 Ab
22279-4,Echovirus 7 Ab
22280-2,Echovirus 9 Ab
22281-0,Echovirus 9 Ab
22282-8,Echovirus NOS Ab
22283-6,Ehrlichia chaffeensis Ab.IgG
22284-4,Ehrlichia chaffeensis Ab.IgG
May-28,Enterotoxin
22285-1,Entamoeba histolytica Ab
22286-9,Entamoeba histolytica Ab
22287-7,Entamoeba histolytica Ab.IgA
22288-5,Entamoeba histolytica Ab.IgG
22289-3,Entamoeba histolytica Ab.IgM
22290-1,Epstein Barr virus capsid Ab.IgA
22291-9,Epstein Barr virus capsid Ab.IgG
22292-7,Epstein Barr virus capsid Ab.IgM
Mar-29,Epiandrosterone
22293-5,Epstein Barr virus early Ab
22294-3,Epstein Barr virus early Ab
22295-0,Epstein Barr virus early Ab.IgG
22296-8,Epstein Barr virus nuclear Ab
22297-6,Epstein Barr virus nuclear Ab
22298-4,Epstein Barr virus nuclear Ab.IgG
22299-2,Equine arteritis virus Ab
22300-8,Equine herpesvirus 1 Ab
Jan-30,EPINEPHrine
22301-6,Equine infectious anemia virus Ab
22302-4,Equine influenza virus A1 Ab
22303-2,Equine influenza virus A2 Ab
22304-0,Giardia lamblia Ab
22305-7,Giardia lamblia Ab.IgA
22306-5,Giardia lamblia Ab.IgG
22307-3,Giardia lamblia Ab.IgM
22308-1,Hantavirus puumala Ab.IgG
22309-9,Hantavirus puumala Ab.IgM
22310-7,Helicobacter pylori Ab
22311-5,Helicobacter pylori Ab
22312-3,Hepatitis A virus Ab
22313-1,Hepatitis A virus Ab.IgG
22314-9,Hepatitis A virus Ab.IgM
22315-6,Hepatitis A virus Ab.IgM
22316-4,Hepatitis B virus core Ab
22317-2,Hepatitis B virus core Ab
22318-0,Hepatitis B virus core Ab.IgG
Sep-31,EPINEPHrine
22319-8,Hepatitis B virus core Ab.IgM
22320-6,Hepatitis B virus little e Ab
22321-4,Hepatitis B virus little e Ab
22322-2,Hepatitis B virus surface Ab
22323-0,Hepatitis B virus surface Ab
22324-8,Hepatitis C virus 100-3 Ab
22325-5,Hepatitis C virus 22-3 Ab
22326-3,Hepatitis C virus 5-1-1 Ab
Jul-32,EPINEPHrine
22327-1,Hepatitis C virus Ab
22328-9,Hepatitis C virus superoxide dismutase Ab
22329-7,Hepatitis C virus c33c Ab
22330-5,Hepatitis D virus Ab
22331-3,Herpes simplex virus 1 Ab
22332-1,Herpes simplex virus 1 Ab
22333-9,Herpes simplex virus 1 Ab.IgG
22334-7,Herpes simplex virus 1 Ab.IgM
May-33,Epitestosterone
22335-4,Herpes simplex virus 2 Ab
22336-2,Herpes simplex virus 2 Ab.IgG
22337-0,Herpes simplex virus 2 Ab.IgG
22338-8,Herpes simplex virus 2 Ab.IgM
22339-6,Herpes simplex virus Ab
22340-4,Herpes simplex virus Ab
22341-2,Herpes simplex virus Ab
22342-0,Herpes simplex virus Ab.IgG
Mar-34,Epitestosterone
22343-8,Herpes simplex virus Ab.IgM
22344-6,Heterophile Ab after absorption
22345-3,Histoplasma capsulatum Ab
22346-1,Histoplasma capsulatum Ab
22347-9,Histoplasma capsulatum Ab
22348-7,Histoplasma capsulatum Ab.IgA
22349-5,Histoplasma capsulatum Ab.IgA
2235-0,Epitestosterone
22350-3,Histoplasma capsulatum Ab.IgE
22351-1,Histoplasma capsulatum Ab.IgG
22352-9,Histoplasma capsulatum Ab.IgM
22353-7,Histoplasma capsulatum Ab.IgM
22354-5,Histoplasma capsulatum mycelial phase Ab
22355-2,Histoplasma capsulatum yeast phase Ab
22356-0,HIV 1 Ab
22357-8,HIV 1+2 Ab
22358-6,HIV 2 Ab
22359-4,HTLV I Ab
22360-2,HTLV I Ab.IgG
22361-0,HTLV I+II Ab
22362-8,HTLV I+II Ab
22363-6,HTLV I+II Ab
22364-4,Infectious bursal disease virus Ab
22365-1,Influenza virus A Ab
22366-9,Influenza virus A+B Ab
22367-7,Influenza virus B Ab
Aug-36,Calciferol
22368-5,Influenza virus C Ab
22369-3,Japanese encephalitis virus Ab
22370-1,Japanese encephalitis virus Ab
22371-9,Junin virus Ab
22372-7,La Crosse virus Ab
22373-5,La Crosse virus Ab.IgG
22374-3,La Crosse virus Ab.IgG
22375-0,La Crosse virus Ab.IgM
Jun-37,Erythropoietin
22376-8,La Crosse virus Ab.IgM
22377-6,Lassa virus Ab.IgG
22378-4,Lassa virus Ab.IgG
22379-2,Lassa virus Ab.IgM
223-8,Dicloxacillin
22380-0,Lassa virus Ab.IgM
22381-8,Legionella pneumophila 1 Ab.IgG
22382-6,Legionella pneumophila 1 Ab.IgM
22383-4,Legionella pneumophila 2 Ab.IgG
Apr-38,Estradiol
22384-2,Legionella pneumophila 2 Ab.IgM
22385-9,Legionella pneumophila 3 Ab.IgG
22386-7,Legionella pneumophila 3 Ab.IgM
22387-5,Legionella pneumophila 4 Ab.IgG
22388-3,Legionella pneumophila 4 Ab.IgM
22389-1,Legionella pneumophila 5 Ab.IgG
22390-9,Legionella pneumophila 5 Ab.IgM
22391-7,Legionella pneumophila 6 Ab.IgG
Feb-39,Estradiol
22392-5,Legionella pneumophila 6 Ab.IgM
22393-3,Legionella pneumophila 7 Ab
22394-1,Legionella pneumophila 8 Ab
22395-8,Legionella pneumophila 9 Ab
22396-6,Legionella pneumophila Ab
22397-4,Legionella pneumophila Ab.IgG
22398-2,Legionella pneumophila Ab.IgM
22399-0,Legionella sp Ab
22-Apr,Amoxicillin+Clavulanate
2240-0,Estradiol.free
22400-6,Leptospira interrogans serovar Bratislava Ab
22401-4,Leptospira interrogans serovar Canicola Ab
22402-2,Leptospira interrogans serovar Grippotyphosa Ab
22403-0,Leptospira interrogans serovar Hardjo Ab
22404-8,Leptospira interrogans serovar Icterohaemorrhagiae Ab
22405-5,Leptospira interrogans serovar Pomona Ab
22406-3,Listeria monocytogenes Ab
22407-1,little d little s DNA (Crithidia lucilia) Ab
22408-9,Lymphocytic choriomeningitis virus Ab
22409-7,Lymphocytic choriomeningitis virus Ab.IgG
22410-5,Lymphocytic choriomeningitis virus Ab.IgG
22411-3,Lymphocytic choriomeningitis virus Ab.IgM
22412-1,Saccharopolyspora rectivirgula Ab
22413-9,Mumps virus Ab
22414-7,Mumps virus Ab
22415-4,Mumps virus Ab.IgG
22416-2,Mumps virus Ab.IgG
22417-0,Mumps virus Ab.IgG
Aug-41,Estradiol.free
22418-8,Mumps virus Ab.IgM
22419-6,Mumps virus Ab.IgM
22420-4,Mumps virus Ab.IgM
22421-2,Mycobacterium avium subspecies paratuberculosis Ab
22422-0,Mycoplasma gallisepticum Ab
22423-8,Mycoplasma hominis Ab
22424-6,Mycoplasma meleagridis Ab
22425-3,Mycoplasma pneumoniae Ab
Jun-42,Estradiol.free
22426-1,Mycoplasma pneumoniae Ab.IgG
22427-9,Mycoplasma pneumoniae Ab.IgM
22428-7,Mycoplasma sp Ab
22429-5,Mycoplasma synoviae Ab
22430-3,Neisseria gonorrhoeae Ab
22431-1,Neisseria meningitidis serogroup Y Ab
22432-9,Neospora caninum Ab
22433-7,Neospora caninum Ab
Apr-43,Estradiol
22434-5,Human papilloma virus Ab
22435-2,Paracoccidioides brasiliensis Ab
22436-0,Paragonimus sp Ab
22437-8,Parainfluenza virus 1 Ab
22438-6,Parainfluenza virus 2 Ab
22439-4,Parainfluenza virus 3 Ab
22440-2,Pasteurella multocida Ab
22441-0,Plasmodium falciparum Ab
Feb-44,Estradiol
22442-8,Plasmodium malariae Ab
22443-6,Plasmodium ovale Ab
22444-4,Plasmodium vivax Ab
22445-1,Polio virus 1 Ab
22446-9,Polio virus 1 Ab
22447-7,Polio virus 2 Ab
22448-5,Polio virus 2 Ab
22449-3,Polio virus 3 Ab
22450-1,Polio virus 3 Ab
22451-9,Porcine reproductive and respiratory syndrome virus Ab
22452-7,Pseudorabies virus Ab
22453-5,Pseudorabies virus Ab
22454-3,Pseudorabies virus.ClinEase gene deletion Ab
22455-0,Pseudorabies virus.HerdCheck gene deletion Ab
22456-8,Pseudorabies virus.OmniMark gene deletion Ab
22457-6,Pseudorabies virus.Tolvid gene deletion Ab
22458-4,Rabies virus Ab
Sep-45,Estradiol
22459-2,Reagin Ab
224-6,Doxycycline
22460-0,Reagin Ab
22461-8,Reagin Ab
22462-6,Reagin Ab
22463-4,Reagin Ab
22464-2,Reagin Ab
22465-9,Reovirus Ab
22466-7,Respiratory syncytial virus Ab
Jul-46,Estradiol.unconjugated
22467-5,Respiratory syncytial virus Ab.IgM
22468-3,Rickettsia (Proteus OX19) Ab
22469-1,Rickettsia (Proteus OX19) Ab
22470-9,Rickettsia (Proteus OX2) Ab
22471-7,Rickettsia (Proteus OX2) Ab
22472-5,Rickettsia (Proteus OXK) Ab
22473-3,Rickettsia (Proteus OXK) Ab
22474-1,Rickettsia spotted fever group Ab
May-47,Estriol.conjugated
22475-8,Rickettsia spotted fever group Ab
22476-6,Rickettsia spotted fever group Ab.IgG
22477-4,Rickettsia spotted fever group Ab.IgG
22478-2,Rickettsia spotted fever group Ab.IgM
22479-0,Rickettsia spotted fever group Ab.IgM
22480-8,Rickettsia typhus group Ab.IgG
22481-6,Rickettsia typhus group Ab.IgM
22482-4,Rickettsia rickettsii Ab.IgG
Mar-48,Estriol
22483-2,Rickettsia rickettsii Ab.IgM
22484-0,Rickettsia sp Ab
22485-7,Orientia tsutsugamushi Ab
22486-5,Rickettsia typhi Ab
22487-3,Rickettsia typhi Ab.IgA
22488-1,Rickettsia typhi Ab.IgG
22489-9,Rickettsia typhi Ab.IgG
22490-7,Rickettsia typhi Ab.IgM
Jan-49,Estriol.unconjugated
22491-5,Rickettsia typhus group Ab
22492-3,Rickettsia typhus group Ab
22493-1,Rickettsia typhus group Ab.IgG
22494-9,Rickettsia typhus group Ab.IgM
22495-6,Rotavirus Ab
22496-4,Rubella virus Ab
22497-2,Rubella virus Ab
22498-0,Measles virus Ab
22499-8,Measles virus Ab
22500-3,Measles virus Ab.IgG
22501-1,Measles virus Ab.IgG
22502-9,Measles virus Ab.IgG
22503-7,Measles virus Ab.IgG^1st specimen
22504-5,Measles virus Ab.IgG^2nd specimen
22505-2,Measles virus Ab.IgM
22506-0,Measles virus Ab.IgM
22507-8,Saint Louis encephalitis virus Ab
22508-6,Saint Louis encephalitis virus Ab
Sep-50,Estriol.unconjugated
22509-4,Saint Louis encephalitis virus Ab
22510-2,Saint Louis encephalitis virus Ab
22511-0,Saint Louis encephalitis virus Ab.IgG
22512-8,Saint Louis encephalitis virus Ab.IgG
22513-6,Saint Louis encephalitis virus Ab.IgM
22514-4,Saint Louis encephalitis virus Ab.IgM
22515-1,Salmonella arizonae Ab
22516-9,Salmonella paratyphi A Ab
Jul-51,Estriol
22517-7,Salmonella paratyphi A H Ab
22518-5,Salmonella paratyphi A H Ab
22519-3,Salmonella paratyphi A O Ab
22520-1,Salmonella paratyphi B Ab
22521-9,Salmonella paratyphi B H Ab
22522-7,Salmonella paratyphi B H Ab
22523-5,Salmonella paratyphi B O Ab
22524-3,Salmonella paratyphi C H Ab
May-52,Estriol
22525-0,Salmonella paratyphi C O Ab
22526-8,Salmonella pullorum Ab
22527-6,Salmonella sp Ab
22528-4,Salmonella typhi D Ab
22529-2,Salmonella typhi H Ab
225-3,Doxycycline
22530-0,Salmonella typhi little d Ab
22531-8,Salmonella typhimurium Ab
22532-6,Sarcocystis neurona Ab
Mar-53,Estriol
22533-4,Sarcocystis neurona Ab
22534-2,Sarcocystis neurona Ab
22535-9,Schistosoma japonicum Ab
22536-7,Schistosoma mansoni Ab
22537-5,Shigella boydii Ab
22538-3,Shigella dysenteriae Ab
22539-1,Shigella flexneri Ab
22540-9,Shigella sonnei Ab
Jan-54,Estrogen
22541-7,Streptococcus pneumoniae 1 Ab.IgG
22542-5,Streptococcus pneumoniae 12 Ab.IgG
22543-3,Streptococcus pneumoniae 14 Ab.IgG
22544-1,Streptococcus pneumoniae 14 Ab^1st specimen
22545-8,Streptococcus pneumoniae 14 Ab^2nd specimen
22546-6,Streptococcus pneumoniae 14 Ab^2nd specimen/Streptococcus pneumoniae 14 Ab^1st specimen
22547-4,Streptococcus pneumoniae 19 Ab.IgG
22548-2,Streptococcus pneumoniae 23 Ab.IgG
22549-0,Streptococcus pneumoniae 3 Ab.IgG
22550-8,Streptococcus pneumoniae 6+26 Ab.IgG
22551-6,Streptococcus pneumoniae 7 Ab.IgG
22552-4,Streptococcus pneumoniae Danish serotype 7F Ab.IgG
22553-2,Streptococcus pneumoniae 7f Ab^1st specimen
22554-0,Streptococcus pneumoniae 7f Ab^2nd specimen
22555-7,Streptococcus pneumoniae Danish serotype 7F Ab^2nd specimen/1st specimen
22556-5,Streptococcus pneumoniae 8 Ab.IgG
22557-3,Streptococcus pneumoniae 9 Ab
Aug-55,Estrogen
22558-1,Streptococcus pneumoniae 9 Ab.IgG
22559-9,Streptococcus pneumoniae 9n Ab^1st specimen
22560-7,Streptococcus pneumoniae 9 Ab^1st specimen/2nd specimen
22561-5,Streptococcus pneumoniae 9n Ab^2nd specimen
22562-3,Streptococcus pneumoniae Ab.IgG^1st specimen
22563-1,Streptococcus pneumoniae Ab.IgG^1st specimen/2nd specimen
22564-9,Streptococcus pneumoniae Ab.IgG^2nd specimen
22565-6,Streptococcus pneumoniae group B Ab
Jun-56,Estrogen
22566-4,Streptococcus pyogenes enzyme Ab
22567-2,Streptococcus pyogenes enzyme Ab
22568-0,Streptolysin O Ab
22569-8,Strongyloides sp Ab
22570-6,Taenia solium Ab
22571-4,Teichoate Ab
22572-2,Saccharomonospora viridis Ab
22573-0,Thermoactinomyces vulgaris Ab
Apr-57,Estrone
22574-8,Toxocara canis Ab.IgA
22575-5,Toxocara canis Ab.IgG
22576-3,Toxocara canis Ab.IgM
22577-1,Toxoplasma gondii Ab
22578-9,Toxoplasma gondii Ab.IgA
22579-7,Toxoplasma gondii Ab.IgA+IgE
22580-5,Toxoplasma gondii Ab.IgG
22581-3,Toxoplasma gondii Ab.IgG
Feb-58,Estrone
22582-1,Toxoplasma gondii Ab.IgG
22583-9,Toxoplasma gondii Ab.IgM
22584-7,Toxoplasma gondii Ab.IgM
22585-4,Treponema pallidum Ab
22586-2,Treponema pallidum Ab
22587-0,Treponema pallidum Ab
22588-8,Treponema pallidum Ab
22589-6,Treponema pallidum Ab
2259-0,Estrone
22590-4,Treponema pallidum Ab
22591-2,Treponema pallidum Ab.IgG
22592-0,Treponema pallidum Ab.IgG
22593-8,Treponema pallidum Ab.IgM
22594-6,Treponema pallidum Ab.IgM
22595-3,Trichinella spiralis Ab
22596-1,Trichinella spiralis Ab
22597-9,Trichinella spiralis Ab.IgA
22598-7,Trichinella spiralis Ab.IgM
22599-5,Trypanosoma cruzi Ab
22600-1,Varicella zoster virus Ab
22601-9,Varicella zoster virus Ab.IgG
22602-7,Varicella zoster virus Ab.IgG
22603-5,Varicella zoster virus Ab.IgG^1st specimen
22604-3,Varicella zoster virus Ab.IgG^2nd specimen
22605-0,Varicella zoster virus Ab.IgM
22606-8,Varicella zoster virus Ab.IgM
22607-6,Venezuelan equine encephalitis virus Ab
Aug-60,Estrone.unconjugated
22608-4,Escherichia coli verotoxin 1 Ab
22609-2,Escherichia coli verotoxin 2 Ab
226-1,Doxycycline
22610-0,Western equine encephalitis virus Ab
22611-8,Western equine encephalitis virus Ab
22612-6,Western equine encephalitis virus Ab
22613-4,Western equine encephalitis virus Ab.IgG
22614-2,Western equine encephalitis virus Ab.IgG
22615-9,Western equine encephalitis virus Ab.IgM
Jun-61,Estrone.unconjugated
22616-7,Western equine encephalitis virus Ab.IgM
22617-5,Wuchereria bancrofti Ab
22618-3,Yellow fever virus Ab
22619-1,Yersinia enterocolitica Ab.IgA
22620-9,Yersinia enterocolitica Ab.IgG
22621-7,Yersinia enterocolitica Ab.IgM
22622-5,Xylose^1H post 25 g xylose PO
22623-3,Xylose^2H post 25 g xylose PO
Apr-62,Estrone.unconjugated
22624-1,Xylose^2H post 5 g xylose PO
22625-8,Xylose^2H post dose xylose PO
22626-6,Xylose^post 25 g xylose PO
22627-4,Xylose^post 5 g xylose PO
22628-2,Xylose^post 25 g xylose PO
22629-0,Xylose^post 5 g xylose PO
22630-8,Xylose/Xylose.dose^post 25 g xylose PO
22631-6,Xylose/Xylose.dose^post 5 g xylose PO
Feb-63,Ethanolamine
22632-4,Xylose/Xylose.dose^post dose xylose PO
22633-2,Path report.site of origin
22634-0,Path report.gross observation
22635-7,Path report.microscopic observation
22636-5,Path report.relevant Hx
22637-3,Path report.final diagnosis
22638-1,Path report.comments
22639-9,Path report.supplemental reports
2264-0,Ethanolamine
22640-7,Path report.staging evidence
22641-5,Glutamine
22642-3,Tyrosine
22643-1,Threonine
22644-9,Serine
22645-6,Proline
22646-4,Phenylalanine
22647-2,Ornithine
22648-0,Methionine
22649-8,Valine
22650-6,Glycine
22651-4,Lysine
22652-2,Glutamate
22653-0,Cystine
22654-8,Citrulline
22655-5,Aspartate
22656-3,Arginine
Jul-65,Ethylmalonate
22657-1,Alanine
22658-9,Alloisoleucine
22659-7,Isoleucine
22660-5,Homocystine
22661-3,Coproporphyrin
22662-1,Uroporphyrin
22663-9,Estrone
22664-7,Urea
May-66,Etiocholanolone
22665-4,Bilirubin.albumin bound
22666-2,Busulfan
22667-0,Fatty acids.nonesterified
22668-8,Propylene glycol
22669-6,Glutamate
22670-4,Alloisoleucine
22671-2,Phytanate
22672-0,Cystine
Mar-67,Etiocholanolone
22673-8,Homocystine
22674-6,Transferrin
22675-3,Angiotensin converting enzyme
22676-1,7-Dehydrocholesterol
22677-9,Aspartate
22678-7,Ethylene glycol
22679-5,Lysine/Creatinine
22680-3,Mercury/Creatinine
Jan-68,Etiocholanolone
22681-1,Methionine/Creatinine
22682-9,Ornithine/Creatinine
22683-7,Phenylalanine/Creatinine
22684-5,Serine/Creatinine
22685-2,Tyrosine/Creatinine
22686-0,Protoporphyrin
22687-8,Cystine/Creatinine
22688-6,Threonine/Creatinine
22689-4,Zinc
22690-2,Proline/Creatinine
22691-0,Aspartate/Creatinine
22692-8,Valine/Creatinine
22693-6,Leucine/Creatinine
22694-4,Citrulline/Creatinine
22695-1,Carnitine/Creatinine
22696-9,Cadmium/Creatinine
22697-7,Arginine/Creatinine
22698-5,Alanine/Creatinine
Sep-69,Complement factor B
22699-3,Alloisoleucine/Creatinine
22700-9,Urea
22701-7,Salicylates
22702-5,Ketones
22703-3,Histidine/Creatinine
22704-1,Carnitine.free (C0)/Creatinine
22705-8,Glucose
22706-6,Isoleucine/Creatinine
Jul-70,Fat
22707-4,Homocystine/Creatinine
22708-2,Homovanillate/Creatinine
22709-0,Glycine/Creatinine
22710-8,Glutamine/Creatinine
22711-6,Glutamate/Creatinine
22712-4,Adenosine monophosphate.cyclic
22713-2,Lysine
22714-0,Isoleucine
May-71,Fat
22715-7,Homocystine
22716-5,Methionine
22717-3,Histidine
22718-1,Glycine
22719-9,Leucine
22720-7,Glutamine
22721-5,Glutamate
22722-3,Citrulline
Mar-72,Fat
22723-1,Aspartate
22724-9,Alanine
22725-6,Ornithine
22726-4,Creatinine
22727-2,Arginine
22728-0,Cystine
22729-8,Valine
22730-6,Alloisoleucine
Jan-73,Fatty acids.esterified
22731-4,Triglyceride
22732-2,Salicylates
22733-0,Phosphate
22734-8,Ethylene glycol
22735-5,Bicarbonate
22736-3,Acetaminophen
22737-1,Phenylalanine
22738-9,Urea
22739-7,Tyrosine
22740-5,Threonine
22741-3,Serine
22742-1,Propylene glycol
22743-9,Proline
22744-7,Copper
22745-4,Ethanol
22746-2,Gentamicin^peak
22747-0,Gentamicin^trough
22748-8,Cholesterol.in LDL
Sep-74,Fatty acids.nonesterified
22749-6,Amylase.pancreatic
22750-4,Tobramycin^random
22751-2,Tobramycin^peak
22752-0,Tobramycin^trough
22753-8,Iron binding capacity.unsaturated
22754-6,Dibucaine number
22755-3,Haemophilus influenzae B Ab
Jun-75,Fatty acids
22756-1,HLA-DR
22757-9,Metanephrine
22758-7,Plasminogen activator inhibitor 1 Ag
22759-5,Platelet Ab
22760-3,Potassium
22761-1,Pristanate
22762-9,Streptococcus pneumoniae 12 Ab.IgG
22763-7,Ammonia
Apr-76,Ferritin
22764-5,Actinobacillus pleuropneumoniae Ab
22765-2,Adult fly identified
22766-0,African horse sickness virus Ab
22767-8,African horse sickness virus Ab
22768-6,African horse sickness virus Ab
22769-4,African horse sickness virus Ab.Neut
22770-2,African horse sickness virus Ab
22771-0,African horse sickness virus Ab
Feb-77,Ferrochelatase
22772-8,African horse sickness virus Ag
22773-6,African horse sickness virus Ag
22774-4,African horse sickness virus RNA
22775-1,African horse sickness virus serotype
22776-9,African horse sickness virus serotype
22777-7,African swine fever virus Ab
22778-5,African swine fever virus Ab
22779-3,African swine fever virus Ab
2278-0,Fibrinopeptide B
22780-1,African swine fever virus Ab
22781-9,African swine fever virus Ag
22782-7,African swine fever virus Ag
22783-5,African swine fever virus Ag
22784-3,African swine fever virus Ag
22785-0,African swine fever virus DNA
22786-8,Alcelaphine herpesvirus 1 Ab
22787-6,Alcelaphine herpesvirus 1 Ab
22788-4,Alcelaphine herpesvirus 1 Ab.Neut
22789-2,Alcelaphine herpesvirus 1 Ag
227-9,Doxycycline
22790-0,Alcelaphine herpesvirus 1 Ag
22791-8,Alcelaphine herpesvirus 1 DNA
22792-6,Aleutian disease virus Ab
22793-4,Aleutian disease virus Ab
22794-2,Anaplasma marginale Ab
22795-9,Anaplasma marginale Ab
22796-7,Anaplasma marginale Ag
22797-5,Anaplasma marginale DNA
Aug-79,Fibrinopeptide A
22798-3,Anaplasma marginale rRNA
22799-1,Anaplasma sp identified
22800-7,Anaplasma sp identified
22801-5,Infectious bronchitis virus Ab
22802-3,Infectious bronchitis virus Ab
22803-1,Infectious bronchitis virus Ab
22804-9,Infectious bronchitis virus Ab.Neut
22805-6,Infectious bronchitis virus Ag
Jun-80,Fibronectin
22806-4,Infectious bronchitis virus Ag
22807-2,Infectious bronchitis virus Ag
22808-0,Infectious bronchitis virus
22809-8,Infectious bronchitis virus RNA
22810-6,Infectious bronchitis virus RNA
22811-4,Avian infectious laryngotracheitis virus
22812-2,Avian infectious laryngotracheitis virus
22813-0,Avian infectious laryngotracheitis virus Ab
Apr-81,Flavin adenine dinucleotide
22814-8,Avian infectious laryngotracheitis virus Ab.Neut
22815-5,Avian infectious laryngotracheitis virus Ab
22816-3,Avian infectious laryngotracheitis virus Ag
22817-1,Avian infectious laryngotracheitis virus Ag
22818-9,Avian infectious laryngotracheitis virus Ag
22819-7,Avian infectious laryngotracheitis virus Ag
22820-5,Avian orthoreovirus Ag
22821-3,Influenza virus A Ab
Feb-82,Folate
22822-1,Influenza virus A Ab
22823-9,Influenza virus A Ab
22824-7,Influenza virus A Ab
22825-4,Influenza virus A Ag
22826-2,Influenza virus A identified
22827-0,Influenza virus A subtype
22828-8,Influenza virus A subtype
22829-6,Avian paramyxovirus 1 Ab
2283-0,Folate
22830-4,Avian paramyxovirus 1 Ab
22831-2,Avian paramyxovirus 1 Ag
22832-0,Avian paramyxovirus 1 identified
22833-8,Avian paramyxovirus 1
22834-6,Avian metapneumovirus Ab
22835-3,Avian pneumovirus Ab
22836-1,Avian pox virus
22837-9,Avian pox virus Ab
22838-7,Avian pox virus Ab
22839-5,Avian pox virus Ab.Neut
22840-3,Avian pox virus Ab
22841-1,Avian pox virus Ab
22842-9,Avian pox virus DNA
22843-7,Avian pox virus DNA
22844-5,Babesia bigemina Ab
22845-2,Babesia bigemina Ab
22846-0,Babesia bigemina Ab
22847-8,Babesia bovis Ab
Aug-84,Folate
22848-6,Babesia bovis Ab
22849-4,Babesia bovis Ab
22850-2,Babesia caballi Ab
22851-0,Babesia caballi Ab
22852-8,Babesia caballi Ab
22853-6,Babesia caballi rRNA
22854-4,Babesia divergens Ab
May-85,Follitropin
22855-1,Babesia divergens Ab
22856-9,Babesia sp rRNA
22857-7,Babesia sp DNA
22858-5,Babesia sp identified
22859-3,Bacillus anthracis Ab
22860-1,Bacillus anthracis Ab
22861-9,Bacillus anthracis Ab
22862-7,Bacillus anthracis Ab
Mar-86,Follitropin
22863-5,Bacillus anthracis Ab
22864-3,Bacillus anthracis Ab
22865-0,Bacillus anthracis Ab
22866-8,Bacillus anthracis Ag
22867-6,Bacillus anthracis Ag
22868-4,Bluetongue virus Ab.Neut
22869-2,Bluetongue virus Ag
228-7,Enoxacin
22870-0,Bluetongue virus Ag
Jan-87,Follitropin
22871-8,Bluetongue virus Ag
22872-6,Bluetongue virus Ag
22873-4,Bluetongue virus Ag
22874-2,Bluetongue virus serotype
22875-9,Border disease virus Ab
22876-7,Border disease virus Ab
22877-5,Border disease virus Ab
22878-3,Border disease virus Ab.Neut
22879-1,Border disease virus Ag
22880-9,Border disease virus Ag
22881-7,Border disease virus Ag
22882-5,Border disease virus Ag
22883-3,Border disease virus RNA
22884-1,Border disease virus RNA
22885-8,Border disease virus RNA
22886-6,Bordetella bronchiseptica Ab
22887-4,Bordetella bronchiseptica Ab
22888-2,Bordetella bronchiseptica Ag
Sep-88,Follitropin.alpha subunit
22889-0,Bovine diarrhea virus Ab
22890-8,Bovine diarrhea virus Ab
22891-6,Bovine diarrhea virus Ab
22892-4,Bovine diarrhea virus Ab.Neut
22893-2,Bovine diarrhea virus Ab.Neut
22894-0,Bovine diarrhea virus Ab
22895-7,Bovine diarrhea virus Ab
22896-5,Bovine diarrhea virus Ag
Jul-89,Follitropin.beta subunit
22897-3,Bovine diarrhea virus Ag
22898-1,Bovine diarrhea virus Ag
22899-9,Bovine diarrhea virus RNA
22900-5,Bovine diarrhea virus RNA
22901-3,Bovine herpesvirus 1 Ab
22902-1,Bovine herpesvirus 1 Ab
22903-9,Bovine herpesvirus 1 Ab
22904-7,Bovine herpesvirus 1 Ab.Neut
May-90,Follitropin/Lutropin
22905-4,Bovine herpesvirus 1 Ab
22906-2,Bovine herpesvirus 1 Ag
22907-0,Bovine herpesvirus 1 Ag
22908-8,Bovine herpesvirus 1 Ag
22909-6,Bovine herpesvirus 1 Ag
22910-4,Bovine herpesvirus 1 Ag
22911-2,Bovine herpesvirus 1 Ag
22912-0,Bovine herpesvirus 1 Ag
Mar-91,Formate
22913-8,Bovine herpesvirus 1 DNA
22914-6,Bovine herpesvirus 1 DNA
22915-3,Bovine leukemia virus Ab
22916-1,Bovine leukemia virus Ab
22917-9,Bovine leukemia virus Ag
22918-7,Bovine leukemia virus RNA
22919-5,Bovine leukemia virus RNA
22920-3,Brucella abortus Ab
Jan-92,Formate
22921-1,Brucella abortus Ab
22922-9,Brucella abortus Ab.IgG1
22923-7,Brucella abortus Ab.IgG1
22924-5,Brucella abortus Ab.IgG1
22925-2,Brucella abortus Ab.IgG1
22926-0,Brucella abortus rRNA
22927-8,Brucella abortus DNA
22928-6,Brucella canis Ab
22929-4,Brucella canis Ab
22930-2,Brucella canis Ab
22931-0,Brucella melitensis Ab
22932-8,Brucella melitensis Ab
22933-6,Brucella melitensis Ab
22934-4,Brucella melitensis Ab
22935-1,Brucella melitensis Ab
22936-9,Brucella melitensis DNA
22937-7,Brucella ovis Ab
22938-5,Brucella ovis Ab
Sep-93,Fructokinase
22939-3,Brucella ovis Ab
22940-1,Brucella ovis Ab
22941-9,Brucella reaction wheal^2D post 0.1 mL brucellin ID
22942-7,Brucella reaction wheal^3D post 0.1 mL brucellin ID
22943-5,Brucella sp Ag
22944-3,Brucella sp Ag
22945-0,Brucella sp Ag
22946-8,Brucella sp Ag
Jul-94,Fructosamine
22947-6,Brucella sp Ag
22948-4,Brucella sp Ag
22949-2,Brucella sp Ag
229-5,Enoxacin
22950-0,Brucella suis Ab
22951-8,Brucella suis Ab
22952-6,Brucella suis Ab
22953-4,Brucella suis Ab
Apr-95,Fructose
22954-2,Brucella suis rRNA
22955-9,Brucella suis DNA
22956-7,Burkholderia mallei Ab
22957-5,Burkholderia mallei Ab
22958-3,Burkholderia mallei Ab
22959-1,Burkholderia mallei Ab
22960-9,Burkholderia mallei reaction^1D post 0.1 mL mallein ID
22961-7,Burkholderia mallei reaction^2D post 0.1 mL mallein ID
Feb-96,Fructose
22962-5,Campylobacter fetus Ab
22963-3,Campylobacter fetus Ab
22964-1,Campylobacter fetus Ag
22965-8,Campylobacter fetus Ag
22966-6,Campylobacter fetus Ag
22967-4,Campylobacter fetus subspecies venerealis Ab
22968-2,Campylobacter fetus subspecies venerealis Ab
22969-0,Campylobacter fetus subspecies venerealis Ab.IgA
2297-0,Fructose
22970-8,Campylobacter fetus subspecies venerealis Ab.IgA
22971-6,Caprine arthritis encephalitis virus
22972-4,Caprine arthritis encephalitis virus Ab
22973-2,Caprine arthritis encephalitis virus Ab
22974-0,Caprine arthritis encephalitis virus Ab
22975-7,Caprine arthritis encephalitis virus Ag
22976-5,Caprine arthritis encephalitis virus Ag
22977-3,Caprine arthritis encephalitis virus DNA
22978-1,Caprine arthritis encephalitis virus DNA
22979-9,Caprine herpesvirus 1 Ab
22980-7,Caprine herpesvirus 1 Ab.Neut
22981-5,Capripox virus
22982-3,Capripox virus Ab
22983-1,Capripox virus Ab
22984-9,Capripox virus Ab.Neut
22985-6,Capripox virus Ab
22986-4,Capripox virus Ag
22987-2,Capripox virus Ag
Aug-98,Aldolase
22988-0,Capripox virus Ag
22989-8,Capripox virus Ag
22990-6,Capripox virus Ag
22991-4,Capripox virus DNA
22992-2,Chlamydophila psittaci
22993-0,Chlamydophila psittaci
22994-8,Chlamydophila psittaci Ab
22995-5,Chlamydophila psittaci Ab
Jun-99,Aldolase
22996-3,Chlamydophila psittaci Ab
22997-1,Chlamydophila psittaci Ag
22998-9,Chlamydophila psittaci Ag
22999-7,Chlamydophila psittaci Ag
23000-3,Chlamydophila psittaci Ag
23001-1,Chlamydophila psittaci DNA
Feb-00,Aldolase
23002-9,Classical swine fever virus Ab
23003-7,Classical swine fever virus Ab.Neut
23004-5,Classical swine fever virus Ab
23005-2,Classical swine fever virus Ag
23006-0,Classical swine fever virus Ag
23007-8,Classical swine fever virus Ag
23008-6,Classical swine fever virus RNA
23009-4,Cowdria ruminantium
2301-0,Aldolase
23010-2,Cowdria ruminantium Ab
23011-0,Cowdria ruminantium Ab
23012-8,Cowdria ruminantium Ab
23013-6,Cowdria ruminantium Ab
23014-4,Cowdria ruminantium DNA
23015-1,Cowdria ruminantium rRNA
23016-9,Coxiella burnetii
23017-7,Coxiella burnetii Ab
23018-5,Coxiella burnetii Ab
23019-3,Coxiella burnetii Ab
23020-1,Coxiella burnetii Ab
23021-9,Coxiella burnetii Ag
23022-7,Coxiella burnetii Ag
23023-5,Coxiella burnetii Ag
23024-3,Coxiella burnetii DNA
23025-0,Dermatophilus congolensis
23026-8,Dermatophilus congolensis Ab
23027-6,Dermatophilus congolensis Ab
Aug-02,Fumarase
23028-4,Dermatophilus congolensis Ag
23029-2,Dirofilaria immitis Ag
230-3,Enoxacin
23030-0,Duck enteritis virus
23031-8,Duck enteritis virus Ag
23032-6,Duck enteritis virus Ag
23033-4,Duck hepatitis virus 1 Ab.Neut
23034-2,Duck hepatitis virus 1 Ab
23035-9,Duck hepatitis virus 1 Ag
Jun-03,Fumarate
23036-7,Duck hepatitis virus 2 Ab
23037-5,Duck hepatitis virus 2 Ab.Neut
23038-3,Duck hepatitis virus 2 Ag
23039-1,Duck hepatitis virus 3 Ab
23040-9,Duck hepatitis virus 3 Ab.Neut
23041-7,Duck hepatitis virus 3 Ag
23042-5,Eastern equine encephalitis virus Ab
23043-3,Eastern equine encephalitis virus Ab
Apr-04,Fumarylacetoacetate
23044-1,Eastern equine encephalitis virus Ab.Neut
23045-8,Eastern equine encephalitis virus Ab.IgM
23046-6,Eastern equine encephalitis virus Ab.IgM
23047-4,Eastern equine encephalitis virus Ag
23048-2,Eastern equine encephalitis virus Ag
23049-0,Eastern equine encephalitis virus Ag
23050-8,Eastern equine encephalitis virus Ag
Jan-05,Galactokinase
23051-6,Eastern equine encephalitis virus RNA
23052-4,Eastern equine encephalitis virus RNA
23053-2,Echinococcus sp Ag
23054-0,Ehrlichia canis Ab
23055-7,Ehrlichia risticii Ab
23056-5,Ehrlichia risticii Ab
23057-3,Ephemeral fever virus Ab.Neut
23058-1,Ephemeral fever virus Ab
23059-9,Epizootic hemorrhagic disease virus Ab
23060-7,Epizootic hemorrhagic disease virus Ab
23061-5,Epizootic hemorrhagic disease virus Ag
23062-3,Epizootic hemorrhagic disease virus Ag
23063-1,Epizootic hemorrhagic disease virus Alberta Ab
23064-9,Epizootic hemorrhagic disease virus Alberta Ab
23065-6,Epizootic hemorrhagic disease virus New Jersey Ab
23066-4,Epizootic hemorrhagic disease virus New Jersey Ab
23067-2,Epizootic hemorrhagic disease virus RNA
23068-0,Equine arteritis virus Ab
Sep-06,Galactose
23069-8,Equine arteritis virus Ab
23070-6,Equine arteritis virus Ab
23071-4,Equine arteritis virus Ab.Neut
23072-2,Equine arteritis virus Ab
23073-0,Equine arteritis virus Ab
23074-8,Equine arteritis virus Ag
23075-5,Equine arteritis virus Ag
23076-3,Equine arteritis virus Ag
Jul-07,Galactose
23077-1,Equine arteritis virus Ag
23078-9,Equine arteritis virus Ag
23079-7,Equine arteritis virus RNA
23080-5,Equine herpesvirus 1 Ag
23081-3,Equine herpesvirus 1 Ag
23082-1,Equine herpesvirus 1 DNA
23083-9,Equine herpesvirus 1 DNA
23084-7,Equine herpesvirus 1 DNA
May-08,Galactose
23085-4,Equine herpesvirus 1+4 Ab.Neut
23086-2,Equine herpesvirus 1+4 Ab
23087-0,Equine herpesvirus 1+4 Ab
23088-8,Equine herpesvirus 1+4 Ab
23089-6,Equine herpesvirus 1+4 Ab.Neut
23090-4,Equine herpesvirus 1+4 Ab
23091-2,Equine herpesvirus 1+4 Ag
23092-0,Equine herpesvirus 4 Ag
Mar-09,Galactose
23093-8,Equine herpesvirus 4 DNA
23094-6,Equine herpesvirus 4 DNA
23095-3,Equine herpesvirus 4 DNA
23096-1,Equine infectious anemia virus Ab
23097-9,Equine infectious anemia virus Ab
23098-7,Equine infectious anemia virus Ag
23099-5,Equine infectious anemia virus Ag
23100-1,Equine influenza virus A1 Ab
Jan-10,Galactose
23101-9,Equine influenza virus A1 Ab
23102-7,Equine influenza virus A1 Ag
23103-5,Equine influenza virus A2 Ab
23104-3,Equine influenza virus A2 Ag
23105-0,Fly larvae identified
23106-8,Foot and mouth disease virus Ab
23107-6,Foot and mouth disease virus Ab.Neut
23108-4,Foot and mouth disease virus Ab
23109-2,Foot and mouth disease virus Ab
231-1,Enoxacin
23110-0,Foot and mouth disease virus Ag
23111-8,Foot and mouth disease virus Ag
23112-6,Foot and mouth disease virus Ag
23113-4,Foot and mouth disease virus Ag
23114-2,Foot and mouth disease virus RNA
23115-9,Foot and mouth disease virus serotype
23116-7,Foot and mouth disease virus serotype
23117-5,Foot and mouth disease virus serotype
23118-3,Foot and mouth disease virus serotype
Sep-11,Galactose renal clearance
23119-1,Foot and mouth disease virus serotype
23120-9,Foot and mouth disease virus serotype
23121-7,Foot and mouth disease virus serotype
23122-5,Francisella tularensis A DNA
23123-3,Francisella tularensis A rRNA
23124-1,Francisella tularensis Ab
23125-8,Francisella tularensis Ab
23126-6,Francisella tularensis Ag
Jul-12,Galactose 1 phosphate
23127-4,Francisella tularensis Ag
23128-2,Francisella tularensis B DNA
23129-0,Francisella tularensis B rRNA
23130-8,Francisella tularensis DNA
23131-6,Francisella tularensis rRNA
23132-4,Histoplasma capsulatum farciminosum Ab
23133-2,Histoplasma capsulatum farciminosum Ab
23134-0,Histoplasma capsulatum farciminosum Ab
May-13,Galactose 1 phosphate uridyl transferase
23135-7,Histoplasma capsulatum farciminosum Ab
23136-5,Histoplasma capsulatum farciminosum reaction wheal^1D post dose ID
23137-3,Histoplasma capsulatum farciminosum reaction wheal^2D post dose ID
23138-1,Histoplasma capsulatum farciminosum reaction wheal^3D post dose ID
23139-9,Infectious bursal disease virus Ab
23140-7,Infectious bursal disease virus Ab
23141-5,Infectious bursal disease virus Ab.Neut
23142-3,Infectious bursal disease virus Ag
Mar-14,Galactose 1 phosphate uridyl transferase
23143-1,Infectious bursal disease virus Ag
23144-9,Japanese encephalitis virus Ab.Neut
23145-6,Japanese encephalitis virus Ab
23146-4,Japanese encephalitis virus Ab
23147-2,Japanese encephalitis virus Ab
23148-0,Japanese encephalitis virus Ag
23149-8,Japanese encephalitis virus Ag
2315-0,Galactosylceramidase
23150-6,Leishmania donovani Ag
23151-4,Leishmania reaction wheal^3D post 0.1 mL leishmanin ID
23152-2,Leishmania sp Ab
23153-0,Leishmania sp Ab
23154-8,Leishmania sp Ab
23155-5,Leishmania sp Ab
23156-3,Leishmania sp Ab
23157-1,Leishmania sp Ab
23158-9,Leishmania sp rRNA
23159-7,Leishmania sp DNA
23160-5,Leishmania sp identified
23161-3,Leishmania sp identified
23162-1,Leishmania sp identified
23163-9,Leptospira interrogans serovar Australis Ab
23164-7,Leptospira interrogans serovar Australis Ab
23165-4,Leptospira interrogans serovar Autumnalis Ab
23166-2,Leptospira interrogans serovar Autumnalis Ab
23167-0,Leptospira borgpetersenii serovar Ballum Ab
Aug-16,Galactosylgalactosylglucosylceramidase
23168-8,Leptospira borgpetersenii serovar Ballum Ab
23169-6,Leptospira interrogans serovar Bataviae Ab
23170-4,Leptospira interrogans serovar Bataviae Ab
23171-2,Leptospira interrogans serovar Bratislava Ab
23172-0,Leptospira interrogans serovar Bratislava Ab
23173-8,Leptospira interrogans serovar Canicola Ab
23174-6,Leptospira interrogans serovar Canicola Ab
23175-3,Leptospira interrogans serovar Copenhageni Ab
Jun-17,Gamma aminobutyrate
23176-1,Leptospira interrogans serovar Copenhageni Ab
23177-9,Leptospira interrogans serovar Grippotyphosa Ab
23178-7,Leptospira interrogans serovar Grippotyphosa Ab
23179-5,Leptospira interrogans serovar Hardjo Ab
23180-3,Leptospira interrogans serovar Hardjo Ab
23181-1,Leptospira interrogans serovar Hardjo Ab
23182-9,Leptospira interrogans serovar Hebdomadis Ab
23183-7,Leptospira interrogans serovar Hebdomadis Ab
Apr-18,Gamma aminobutyrate
23184-5,Leptospira interrogans serovar Icterohaemorrhagiae Ab
23185-2,Leptospira interrogans serovar Icterohaemorrhagiae Ab
23186-0,Leptospira interrogans Ab
23187-8,Leptospira interrogans Ab
23188-6,Leptospira interrogans Ab
23189-4,Leptospira interrogans serovar Mitis Ab
23190-2,Leptospira interrogans serovar Mitis Ab
23191-0,Leptospira interrogans serovar Pomona Ab
Feb-19,Gamma aminobutyrate
23192-8,Leptospira interrogans serovar Pomona Ab
23193-6,Leptospira borgpetersenii serovar Sejroe Ab
23194-4,Leptospira borgpetersenii serovar Sejroe Ab
23195-1,Leptospira sp Ab
23196-9,Leptospira sp Ab
23197-7,Leptospira sp Ab
23198-5,Leptospira sp Ab
23199-3,Leptospira sp Ab.IgG
23-Feb,Amphotericin B
2320-0,Gamma glutamyl cysteine synthetase
23200-9,Leptospira sp Ab.IgG
23201-7,Leptospira sp Ab.IgM
23202-5,Leptospira sp Ab.IgM
23203-3,Leptospira sp Ag
23204-1,Leptospira sp Ag
23205-8,Leptospira sp DNA
23206-6,Leptospira sp DNA
23207-4,Leptospira sp subtype
23208-2,Leptospira borgpetersenii serovar Tarrasovi Ab
23209-0,Leptospira borgpetersenii serovar Tarrasovi Ab
23210-8,Listeria sp Ab
23211-6,Listeria sp Ab
23212-4,Lumpy skin disease virus
23213-2,Lumpy skin disease virus Ab
23214-0,Lumpy skin disease virus Ab
23215-7,Lumpy skin disease virus Ab.Neut
23216-5,Lumpy skin disease virus Ab
23217-3,Lumpy skin disease virus Ab
Aug-21,Gamma glutamyl cysteine synthetase
23218-1,Lumpy skin disease virus Ag
23219-9,Lumpy skin disease virus Ag
23220-7,Lumpy skin disease virus Ag
23221-5,Lumpy skin disease virus Ag
23222-3,Lumpy skin disease virus Ag
23223-1,Lumpy skin disease virus DNA
23224-9,Mareks disease virus Ab
23225-6,Mareks disease virus Ab
Jun-22,Gamma glutamyl transferase
23226-4,Mareks disease virus Ab
23227-2,Mareks disease virus Ab.Neut
23228-0,Mareks disease virus Ab
23229-8,Mareks disease virus Ag
23230-6,Mareks disease virus Ag
23231-4,Mareks disease virus DNA
23232-2,Mite identified
23233-0,Mite identified
Apr-23,Gamma glutamyl transferase
23234-8,Mycobacterium avium subspecies avium Ab
23235-5,Mycobacterium avium subspecies avium Ab
23236-3,Mycobacterium avium subspecies avium rRNA
23237-1,Mycobacterium avium subspecies avium identified
23238-9,Mycobacterium avium subspecies avium serotype
23239-7,Mycobacterium bovis Ab
23240-5,Mycobacterium bovis Ab
23241-3,Mycobacterium bovis Ag
Feb-24,Gamma glutamyl transferase
23242-1,Mycobacterium bovis Ag
23243-9,Mycobacterium avium subspecies paratuberculosis
23244-7,Mycobacterium avium subspecies paratuberculosis
23245-4,Mycobacterium avium subspecies paratuberculosis DNA
23246-2,Mycobacterium avium subspecies paratuberculosis DNA
23247-0,Mycobacterium sp DNA
23248-8,Mycoplasma agalactiae Ab.Neut
23249-6,Mycoplasma agalactiae Ab
23250-4,Mycoplasma agalactiae Ab
23251-2,Mycoplasma agalactiae Ab
23252-0,Mycoplasma agalactiae DNA
23253-8,Mycoplasma arginini Ab
23254-6,Mycoplasma arginini Ab
23255-3,Mycoplasma bovis Ab
23256-1,Mycoplasma bovis Ab
23257-9,Mycoplasma capricolum subspecies capricolum Ab
23258-7,Mycoplasma capricolum subspecies capricolum Ab
Sep-25,Gamma glutamyl transferase/Aspartate aminotransferase
23259-5,Mycoplasma capricolum subspecies capricolum Ab
23260-3,Mycoplasma capricolum subspecies capripneumonia Ab
23261-1,Mycoplasma capricolum subspecies capripneumonia Ab
23262-9,Mycoplasma capricolum subspecies capripneumonia Ab
23263-7,Mycoplasma capricolum subspecies capripneumonia Ab
23264-5,Mycoplasma capricolum subspecies capripneumonia Ab
23265-2,Mycoplasma capricolum subspecies capripneumonia Ab
23266-0,Mycoplasma capricolum subspecies capripneumonia Ab
Jul-26,Gastric inhibitory polypeptide
23267-8,Mycoplasma capricolum subspecies capripneumonia Ag
23268-6,Mycoplasma capricolum subspecies capripneumonia Ag
23269-4,Mycoplasma capricolum subspecies capripneumonia Ag
23270-2,Mycoplasma capricolum subspecies capripneumonia Ag
23271-0,Mycoplasma capricolum subspecies capripneumonia rRNA
23272-8,Mycoplasma capricolum subspecies capripneumonia rRNA
23273-6,Mycoplasma gallisepticum Ab
23274-4,Mycoplasma gallisepticum Ab
May-27,Gastrin releasing polypeptide
23275-1,Mycoplasma gallisepticum Ab
23276-9,Mycoplasma gallisepticum Ag
23277-7,Mycoplasma gallisepticum Ag
23278-5,Mycoplasma gallisepticum Ag
23279-3,Mycoplasma gallisepticum DNA
23280-1,Mycoplasma meleagridis Ab
23281-9,Mycoplasma mycoides subspecies capri Ab
23282-7,Mycoplasma mycoides subspecies capri Ab
Mar-28,Gastrin releasing polypeptide
23283-5,Mycoplasma mycoides subspecies mycoides large colony Ab
23284-3,Mycoplasma mycoides subspecies mycoides large colony Ab
23285-0,Mycoplasma mycoides subspecies mycoides small colony Ab
23286-8,Mycoplasma mycoides subspecies mycoides small colony Ab
23287-6,Mycoplasma mycoides subspecies mycoides small colony Ab
23288-4,Mycoplasma mycoides subspecies mycoides small colony Ab
23289-2,Mycoplasma mycoides subspecies mycoides small colony Ab
232-9,Erythromycin
23290-0,Mycoplasma mycoides subspecies mycoides small colony Ag
Jan-29,Gastrin releasing polypeptide
23291-8,Mycoplasma mycoides subspecies mycoides small colony Ag
23292-6,Mycoplasma mycoides subspecies mycoides small colony Ag
23293-4,Mycoplasma mycoides subspecies mycoides small colony DNA
23294-2,Mycoplasma putrefaciens Ab
23295-9,Mycoplasma putrefaciens Ab
23296-7,Mycoplasma putrefaciens Ab
23297-5,Mycoplasma sp Ab
23298-3,Mycoplasma sp Ag
23299-1,Mycoplasma sp Ag
23300-7,Mycoplasma sp rRNA
23301-5,Mycoplasma sp DNA
23302-3,Mycoplasma synoviae Ab
23303-1,Myxoma virus Ab
23304-9,Myxoma virus Ab
23305-6,Myxoma virus Ab
23306-4,Myxoma virus Ab
23307-2,Myxoma virus Ab
23308-0,Myxoma virus Ab.Neut
Sep-30,Gastrin.34 residue fragment
23309-8,Myxoma virus Ab
23310-6,Myxoma virus Ag
23311-4,Myxoma virus Ag
23312-2,Nairobi sheep disease virus Ab
23313-0,Nairobi sheep disease virus Ab
23314-8,Nairobi sheep disease virus Ab
23315-5,Nairobi sheep disease virus Ab
23316-3,Nairobi sheep disease virus Ab
Jul-31,Gastrin.17 residue fragment
23317-1,Nairobi sheep disease virus Ab
23318-9,Nairobi sheep disease virus Ag
23319-7,Nairobi sheep disease virus Ag
23320-5,Nairobi sheep disease virus Ag
23321-3,Ovine herpesvirus 2 Ab
23322-1,Ovine herpesvirus 2 Ab
23323-9,Ovine herpesvirus 2 Ab
23324-7,Ovine herpesvirus 2 Ab
May-32,Gastrin.14 residue fragment
23325-4,Ovine herpesvirus 2 Ab
23326-2,Ovine herpesvirus 2 Ab
23327-0,Ovine herpesvirus 2 DNA
23328-8,Ovine progressive pneumonia virus Ab
23329-6,Ovine progressive pneumonia virus Ab
23330-4,Ovine progressive pneumonia virus Ab
23331-2,Ovine progressive pneumonia virus Ab
23332-0,Ovine progressive pneumonia virus Ab
Mar-33,Gastrin
23333-8,Ovine progressive pneumonia virus Ab
23334-6,Ovine progressive pneumonia virus Ag
23335-3,Ovine progressive pneumonia virus Ag
23336-1,Ovine progressive pneumonia virus DNA
23337-9,Ovine progressive pneumonia virus DNA
23338-7,Ovine pulmonary adenomatosis retrovirus RNA
23339-5,Paratuberculosis reaction wheal^3D post 0.1 mL avian tuberculin ID
23340-3,Paratuberculosis reaction wheal^3D post 0.1 mL johnin ID
Jan-34,Hemoglobin.gastrointestinal
23341-1,Pasteurella multocida Ab
23342-9,Pasteurella multocida Ab
23343-7,Pasteurella multocida Ag
23344-5,Pasteurella multocida rRNA
23345-2,Pasteurella multocida serotype
23346-0,Pasteurella multocida serotype
23347-8,Pasteurella multocida serotype
23348-6,Pasteurella multocida serotype
23349-4,Pasteurella multocida toxin
23350-2,Peste des petits ruminants virus Ab
23351-0,Peste des petits ruminants virus Ab
23352-8,Peste des petits ruminants virus Ab.Neut
23353-6,Peste des petits ruminants virus Ab
23354-4,Peste des petits ruminants virus Ab
23355-1,Peste des petits ruminants virus Ag
23356-9,Peste des petits ruminants virus Ag
23357-7,Peste des petits ruminants virus Ag
Aug-35,Hemoglobin.gastrointestinal
23358-5,Peste des petits ruminants virus RNA
23359-3,Peste des petits ruminants virus RNA
23360-1,Porcine enterovirus Ag
23361-9,Porcine enterovirus Ab
23362-7,Porcine enterovirus Ab.Neut
23363-5,Porcine enterovirus Ab
23364-3,Porcine enterovirus Ag
23365-0,Porcine parvovirus Ab
Jun-36,Globulin
23366-8,Porcine parvovirus Ab
23367-6,Porcine reproductive and respiratory syndrome virus Ab
23368-4,Porcine reproductive and respiratory syndrome virus Ab.Neut
23369-2,Porcine reproductive and respiratory syndrome virus Ag
233-7,Erythromycin
23370-0,Porcine reproductive and respiratory syndrome virus Ag
23371-8,Porcine reproductive and respiratory syndrome virus RNA
23372-6,Porcine respiratory coronavirus Ab
23373-4,Porcine respiratory coronavirus Ab.Neut
Apr-37,Glucagon
23374-2,Porcine respiratory coronavirus Ab
23375-9,Porcine respiratory coronavirus Ab
23376-7,Porcine respiratory coronavirus Ag
23377-5,Porcine respiratory coronavirus Ag
23378-3,Porcine respiratory coronavirus RNA
23379-1,Prion protein.abnormal
23380-9,Prion protein.abnormal
23381-7,Prion protein.abnormal
Feb-38,Glucagon
23382-5,Pseudorabies virus Ab.Neut
23383-3,Pseudorabies virus Ag
23384-1,Pseudorabies virus Ag
23385-8,Pseudorabies virus Ag
23386-6,Pseudorabies virus Ag
23387-4,Pseudorabies virus DNA
23388-2,Rabies virus
23389-0,Rabies virus Ag
2339-0,Glucose
23390-8,Rabies virus Ag
23391-6,Rabies virus Ag
23392-4,Rabies virus DNA
23393-2,Rabies virus DNA
23394-0,Reticuloendotheliosis virus Ab
23395-7,Reticuloendotheliosis virus Ab
23396-5,Rift valley fever virus Ab.Neut
23397-3,Rift valley fever virus Ab
23398-1,Rift valley fever virus Ab
23399-9,Rift valley fever virus Ab
23400-5,Rift valley fever virus Ab
23401-3,Rift valley fever virus Ag
23402-1,Rift valley fever virus Ag
23403-9,Rift valley fever virus Ag
23404-7,Rift valley fever virus Ag
23405-4,Rift valley fever virus Ag
23406-2,Rift valley fever virus Ag
23407-0,Rinderpest virus Ab.Neut
Aug-40,Glucose
23408-8,Rinderpest virus Ab
23409-6,Rinderpest virus Ab.Neut
23410-4,Rinderpest virus Ab
23411-2,Rinderpest virus Ab
23412-0,Rinderpest virus Ag
23413-8,Rinderpest virus Ag
23414-6,Rinderpest virus Ag
23415-3,Rinderpest virus Ag
Jun-41,Glucose
23416-1,Rinderpest virus Ag
23417-9,Rinderpest virus RNA
23418-7,Salmonella abortus equi Ab
23419-5,Salmonella abortus equi Ab
23420-3,Salmonella abortus ovis Ab
23421-1,Salmonella abortus ovis Ab
23422-9,Salmonella enteritidis Ab.IgG
23423-7,Salmonella enteritidis Ab.IgG
Apr-42,Glucose
23424-5,Salmonella enteritidis Ab.IgG
23425-2,Salmonella enteritidis Ab.IgG
23426-0,Salmonella gallinarum Ab
23427-8,Salmonella gallinarum Ab
23428-6,Salmonella gallinarum Ab
23429-4,Salmonella gallinarum Ab
23430-2,Salmonella gallinarum Ab
23431-0,Salmonella gallinarum DNA
Feb-43,Glucose
23432-8,Salmonella gallinarum rRNA
23433-6,Salmonella pullorum Ab
23434-4,Salmonella pullorum Ab
23435-1,Salmonella pullorum DNA
23436-9,Salmonella pullorum rRNA
23437-7,Swine influenza virus Ab
23438-5,Swine influenza virus Ab
23439-3,Swine vesicular disease virus Ab
2344-0,Glucose
23440-1,Swine vesicular disease virus Ab.Neut
23441-9,Swine vesicular disease virus Ab
23442-7,Swine vesicular disease virus Ab
23443-5,Swine vesicular disease virus Ab
23444-3,Swine vesicular disease virus Ag
23445-0,Swine vesicular disease virus Ag
23446-8,Swine vesicular disease virus Ag
23447-6,Swine vesicular disease virus Ag
23448-4,Swine vesicular disease virus RNA
23449-2,Taenia hydatigena Ag
234-5,Erythromycin
23450-0,Taenia sp Ag
23451-8,Taenia sp eggs
23452-6,Taenia sp eggs
23453-4,Taylorella equigenitalis Ab
23454-2,Taylorella equigenitalis Ab
23455-9,Taylorella equigenitalis Ag
23456-7,Taylorella equigenitalis Ag
Jul-45,Glucose
23457-5,Taylorella equigenitalis Ag
23458-3,Taylorella equigenitalis DNA
23459-1,Theileria annulata Ab
23460-9,Theileria annulata Ab
23461-7,Theileria annulata Ab
23462-5,Theileria annulata Ab
23463-3,Theileria annulata rRNA
23464-1,Theileria equi Ab
May-46,Glucose
23465-8,Theileria equi rRNA
23466-6,Theileria equi Ab
23467-4,Theileria mutans Ab
23468-2,Theileria mutans Ab
23469-0,Theileria mutans Ab
23470-8,Theileria mutans Ab
23471-6,Theileria mutans Ab
23472-4,Theileria mutans rRNA
Mar-47,Glucose
23473-2,Theileria mutans DNA
23474-0,Theileria parva Ab
23475-7,Theileria parva Ab
23476-5,Theileria parva Ab
23477-3,Theileria parva Ab
23478-1,Theileria parva Ab
23479-9,Theileria parva rRNA
23480-7,Theileria parva DNA
Jan-48,Glucose
23481-5,Theileria parva rRNA
23482-3,Theileria sp
23483-1,Theileria sp
23484-9,Toxoplasma sp Ab
23485-6,Toxoplasma gondii Ab
23486-4,Toxoplasma gondii Ab
23487-2,Transmissible gastroenteritis virus Ab
23488-0,Transmissible gastroenteritis virus Ab.Neut
23489-8,Transmissible gastroenteritis virus Ab
23490-6,Transmissible gastroenteritis virus Ab
23491-4,Transmissible gastroenteritis virus Ab
23492-2,Transmissible gastroenteritis virus Ab.Neut
23493-0,Transmissible gastroenteritis virus Ag
23494-8,Transmissible gastroenteritis virus Ag
23495-5,Transmissible gastroenteritis virus Ag
23496-3,Transmissible gastroenteritis virus Ag
23497-1,Transmissible gastroenteritis virus Ag
23498-9,Transmissible gastroenteritis virus RNA
Sep-49,Glucose
23499-7,Trichinella spiralis
23500-2,Tritrichomonas foetus Ab
23501-0,Tritrichomonas foetus Ab
23502-8,Tritrichomonas foetus Ag
23503-6,Tritrichomonas foetus Ag
23504-4,Tritrichomonas foetus DNA
23505-1,Tritrichomonas foetus DNA
23506-9,Tritrichomonas foetus reaction wheal^post 0.1 mL tricin ID
Jul-50,Glucose
23507-7,Trypanosoma brucei DNA
23508-5,Trypanosoma congolense DNA
23509-3,Trypanosoma equiperdum
23510-1,Trypanosoma equiperdum Ab
23511-9,Trypanosoma equiperdum Ab
23512-7,Trypanosoma equiperdum Ab
23513-5,Trypanosoma equiperdum Ab
23514-3,Trypanosoma equiperdum Ab
May-51,Glucose
23515-0,Trypanosoma equiperdum Ab
23516-8,Trypanosoma equiperdum Ab
23517-6,Trypanosoma equiperdum Ab
23518-4,Trypanosoma evansi
23519-2,Trypanosoma evansi
235-2,Erythromycin
23520-0,Trypanosoma evansi
23521-8,Trypanosoma evansi Ab
23522-6,Trypanosoma evansi Ab
Mar-52,Glucose CSF/Glucose plas
23523-4,Trypanosoma evansi Ab
23524-2,Trypanosoma evansi Ab
23525-9,Trypanosoma evansi Ab
23526-7,Trypanosoma evansi Ab
23527-5,Trypanosoma evansi Ag
23528-3,Trypanosoma evansi Ag
23529-1,Trypanosoma evansi DNA
23530-9,Trypanosoma evansi rRNA
Jan-53,Glucose phosphate isomerase
23531-7,Trypanosoma sp Ab
23532-5,Trypanosoma sp Ab
23533-3,Trypanosoma sp Ab
23534-1,Trypanosoma sp Ab
23535-8,Trypanosoma sp Ag
23536-6,Trypanosoma sp identified
23537-4,Tuberculosis reaction wheal^2D post dose mammalian tuberculin ID
23538-2,Tuberculosis reaction wheal^3D post dose avian tuberculin ID
23539-0,Tuberculosis reaction wheal^3D post dose mammalian tuberculin ID
23540-8,Turkey enteritis coronavirus
23541-6,Venezuelan equine encephalitis virus Ab
23542-4,Venezuelan equine encephalitis virus Ab
23543-2,Venezuelan equine encephalitis virus Ab
23544-0,Venezuelan equine encephalitis virus Ab
23545-7,Venezuelan equine encephalitis virus Ab.Neut
23546-5,Venezuelan equine encephalitis virus Ab.IgM
23547-3,Venezuelan equine encephalitis virus Ab.IgM
23548-1,Venezuelan equine encephalitis virus Ag
Sep-54,Glucose-6-Phosphatase
23549-9,Venezuelan equine encephalitis virus Ag
23550-7,Venezuelan equine encephalitis virus Ag
23551-5,Venezuelan equine encephalitis virus Ag
23552-3,Venezuelan equine encephalitis virus subtype
23553-1,Venezuelan equine encephalitis virus subtype
23554-9,Venezuelan equine encephalitis virus subtype
23555-6,Vesicular stomatitis virus Ab
Jun-55,Glucose-6-Phosphatase
23556-4,Vesicular stomatitis virus Ab
23557-2,Vesicular stomatitis virus Ag
23558-0,Vesicular stomatitis virus Ag
23559-8,Vesicular stomatitis virus Ag
23560-6,Vesicular stomatitis virus Ag
23561-4,Vesicular stomatitis Indiana virus Ab
23562-2,Vesicular stomatitis Indiana virus Ab.Neut
23563-0,Vesicular stomatitis Indiana virus Ab
Apr-56,Glucose-6-Phosphate dehydrogenase
23564-8,Vesicular stomatitis Indiana virus Ab
23565-5,Vesicular stomatitis New Jersey virus Ab
23566-3,Vesicular stomatitis New Jersey virus Ab
23567-1,Vesicular stomatitis New Jersey virus Ab.Neut
23568-9,Vesicular stomatitis New Jersey virus Ab
23569-7,Vesicular stomatitis virus serotype
23570-5,Vesicular stomatitis virus serotype
23571-3,Vesicular stomatitis virus serotype
Feb-57,Glucose-6-Phosphate dehydrogenase
23572-1,Vesicular stomatitis virus serotype
23573-9,Rabbit hemorrhagic disease virus
23574-7,Rabbit hemorrhagic disease virus Ab
23575-4,Rabbit hemorrhagic disease virus Ab
23576-2,Rabbit hemorrhagic disease virus Ab
23577-0,Rabbit hemorrhagic disease virus Ab
23578-8,Rabbit hemorrhagic disease virus Ab
23579-6,Rabbit hemorrhagic disease virus Ag
2358-0,Glucose-6-Phosphate dehydrogenase
23580-4,Rabbit hemorrhagic disease virus Ag
23581-2,Rabbit hemorrhagic disease virus Ag
23582-0,Rabbit hemorrhagic disease virus Ag
23583-8,Western equine encephalitis virus Ab
23584-6,Western equine encephalitis virus Ab
23585-3,Western equine encephalitis virus Ab.Neut
23586-1,Western equine encephalitis virus Ab
23587-9,Western equine encephalitis virus Ab.IgM
23588-7,Western equine encephalitis virus Ab.IgM
23589-5,Western equine encephalitis virus Ag
23590-3,Western equine encephalitis virus Ag
23591-1,Western equine encephalitis virus Ag
23592-9,African swine fever virus Ab
23593-7,Bovine leukemia virus
23594-5,Brucella sp identified
23595-2,Dermatophilus congolensis
23596-0,Dermatophilus congolensis
23597-8,Dermatophilus congolensis
Aug-59,Glucose-6-Phosphate dehydrogenase
23598-6,Dermatophilus congolensis Ag
23599-4,Leptospira sp identified
236-0,Erythromycin+sulfiSOXAZOLE
23600-0,Leptospira sp identified
23601-8,Mareks disease virus serotype
23602-6,Salmonella enteritidis
23603-4,Taylorella equigenitalis
23604-2,Tritrichomonas foetus
23605-9,Tritrichomonas foetus
Jun-60,Glucose-6-Phosphate dehydrogenase
23606-7,Tritrichomonas foetus
23607-5,Capreomycin
23608-3,cycloSERINE
23609-1,Kanamycin
23610-9,Sparfloxacin
23611-7,Para aminosalicylate
23612-5,Azithromycin
23613-3,Imipenem
Apr-61,Glucosylceramidase
23614-1,Trimethoprim
23615-8,Vancomycin
23616-6,Viomycin
23617-4,Ethionamide
23618-2,Ampicillin+Sulbactam
23619-0,Clarithromycin
23620-8,Clofazimine
23621-6,Ciprofloxacin
Feb-62,Glutamate
23622-4,Ceftizoxime
23623-2,Doxycycline
23624-0,Amikacin
23625-7,Ethambutol
23626-5,Streptomycin
23627-3,Clofazimine
23628-1,Sparfloxacin
23629-9,Para aminosalicylate
2363-0,Glutamate
23630-7,Rifabutin
23631-5,Trimethoprim+Sulfamethoxazole
23632-3,Pyrazinamide
23633-1,Erythromycin
23634-9,Erythropoietin given
23635-6,Erythropoietin given
23636-4,Cefdinir
23637-2,Cefdinir
23638-0,Grepafloxacin
23639-8,Grepafloxacin
23640-6,Quinupristin+Dalfopristin
23641-4,Quinupristin+Dalfopristin
23642-2,Trovafloxacin
23643-0,Trovafloxacin
23644-8,Actinobacillus pleuropneumoniae serotype 1 Ab
23645-5,Actinobacillus pleuropneumoniae serotype 3 Ab
23646-3,Actinobacillus pleuropneumoniae serotype 5 Ab
23647-1,Actinobacillus pleuropneumoniae serotype 7 Ab
Aug-64,Glutamate
23648-9,Actinobacillus pleuropneumoniae Ab
23649-7,Actinobacillus pleuropneumoniae biovar 2 serotype
23650-5,Actinobacillus pleuropneumoniae serotype
23651-3,Actinobacillus suis serotype
23652-1,Aeromonas salmonicida DNA
23653-9,Aflatoxin
23654-7,Aflatoxin
May-65,Glutamate
23655-4,Aflatoxin
23656-2,Ammonia
23657-0,Anaplasma marginale Ab
23658-8,Antibiotic XXX
23659-6,Apramycin
23660-4,Aspergillus sp Ab
23661-2,Avian paramyxovirus 1 Ab
23662-0,Babesia bigemina Ab
Mar-66,Glutamate
23663-8,Babesia bovis Ab
23664-6,Babesia canis Ab
23665-3,Babesia divergens Ab
23666-1,Babesia sp Ab
23667-9,Bacteria identified
23668-7,Bartonella henselae Ab
23669-5,Biochanin A
23670-3,Blastomyces sp Ab
Jan-67,Glutamate dehydrogenase
23671-1,Bluetongue virus 10 Ab.Neut
23672-9,Bluetongue virus 11 Ab.Neut
23673-7,Bluetongue virus 13 Ab.Neut
23674-5,Bluetongue virus 17 Ab.Neut
23675-2,Bluetongue virus 2 Ab.Neut
23676-0,Borrelia burgdorferi Ab
23677-8,Bovine leukemia virus Ab
23678-6,Bovine parainfluenza virus 3 Ag
23679-4,Bovine respiratory syncytial virus Ag
23680-2,Bromide
23681-0,Brucella canis Ab
23682-8,Brucella canis Ab
23683-6,Brucella canis Ab
23684-4,Brucella ovis Ab
23685-1,Canine adenovirus 1 Ab.Neut
23686-9,Canine adenovirus Ag
23687-7,Canine coronavirus Ab
23688-5,Canine coronavirus Ag
Sep-68,Glutamate dehydrogenase.NAD
23689-3,Canine distemper virus Ab
23690-1,Canine distemper virus Ab
23691-9,Canine distemper virus Ab.IgG
23692-7,Canine distemper virus Ab.IgG
23693-5,Canine distemper virus Ab.IgM
23694-3,Canine distemper virus Ab.IgM
23695-0,Canine distemper virus Ag
23696-8,Canine distemper virus Ag
Jul-69,Glutamate dehydrogenase.NADP
23697-6,Canine herpesvirus Ab.Neut
23698-4,Canine herpesvirus Ag
23699-2,Canine parainfluenza virus 2 Ag
23700-8,Canine parvovirus Ab
23701-6,Canine parvovirus Ab
23702-4,Canine parvovirus Ab
23703-2,Canine parvovirus Ab.IgG
23704-0,Canine parvovirus Ab.IgM
May-70,Glutamine
23705-7,Canine parvovirus Ag
23706-5,Canine parvovirus Ag
23707-3,Canine parvovirus DNA
23708-1,Caprine arthritis encephalitis virus Ag
23709-9,Ceftiofur
23710-7,Dirofilaria immitis Ag
23711-5,Ehrlichia canis Ab
23712-3,Enrofloxacin
Mar-71,Glutamine
23713-1,Ethylene glycol
23714-9,Fat
23715-6,Feline calicivirus Ab
23716-4,Feline coronavirus Ab
23717-2,Feline coronavirus Ab
23718-0,Feline coronavirus Ab
23719-8,Feline herpesvirus 1 Ab.Neut
23720-6,Feline herpesvirus 1 Ag
Jan-72,Glutamine
23721-4,Feline herpesvirus 1 DNA
23722-2,Feline herpesvirus Ab.Neut
23723-0,Feline immunodeficiency virus Ab
23724-8,Feline immunodeficiency virus Ab
23725-5,Feline immunodeficiency virus Ab
23726-3,Feline infectious peritonitis virus Ab
23727-1,Feline infectious peritonitis virus Ab
23728-9,Feline infectious peritonitis virus Ab
23729-7,Feline infectious peritonitis virus Ag
23730-5,Feline infectious peritonitis virus Ag
23731-3,Feline leukemia provirus
23732-1,Feline leukemia virus Ab
23733-9,Feline leukemia virus Ab
23734-7,Feline leukemia virus Ab
23735-4,Feline leukemia virus Ab.Neut
23736-2,Feline leukemia virus Ag
23737-0,Feline panleukopenia virus Ab
23738-8,Feline herpesvirus 1 Ab
Sep-73,Glutamine
23739-6,Feline syncytial virus Ab
23740-4,Florfenicol
23741-2,Francisella tularensis Ab
23742-0,Fumonisin
23743-8,Genistein
23744-6,Giardia lamblia Ag
23745-3,Gossypol
23746-1,Gossypol.free
Jul-74,Glutamine
23747-9,Heavy metals
23748-7,Histoplasma sp Ab
23749-5,Lead
23750-3,Leptospira sp Ag
23751-1,Metaldehyde
23752-9,Mite identified
23753-7,Mycoplasma hyopneumoniae Ab
Apr-75,Glutaryl CoA dehydrogenase
23754-5,Mycoplasma sp Ab
23755-2,Mycoplasma synoviae Ab
23756-0,Neospora caninum Ab
23757-8,Neospora caninum Ab
23758-6,Neospora caninum Ab
23759-4,Neospora caninum Ag
23760-2,Neospora caninum Ag
23761-0,Neutrophils/100 leukocytes
Feb-76,Glutathione peroxidase
23762-8,Nitrate+Nitrite
23763-6,Pasteurella multocida serotype
23764-4,Pesticides
23765-1,Porcine adenovirus Ag
23766-9,Porcine circovirus Ag
23767-7,Porcine circovirus Ag
23768-5,Porcine influenza virus A Ab
23769-3,Porcine influenza virus A Ag
2377-0,Glutathione peroxidase
23770-1,Porcine parvovirus Ab
23771-9,Porcine parvovirus Ag
23772-7,Porcine reproductive and respiratory syndrome virus Ab
23773-5,Porcine rotavirus Ag
23774-3,Pseudorabies virus Ag
23775-0,Rhodococcus equi Ab
23776-8,Rickettsia spotted fever group Ab
23777-6,Salmonella pullorum Ab
23778-4,Salmonella typhimurium Ab
23779-2,Selenium
237-8,Erythromycin+sulfiSOXAZOLE
23780-0,Strychnine
23781-8,Swine influenza virus Ag
23782-6,Swine influenza virus Ag
23783-4,Taylorella equigenitalis Ab
23784-2,Toxoplasma gondii Ab
23785-9,Trypanosoma cruzi Ab
23786-7,Urea
23787-5,Venezuelan equine encephalitis virus Ab
Aug-78,Glutathione reductase
23788-3,Vesicular stomatitis Indiana virus Ab
23789-1,Vesicular stomatitis Indiana virus Ab.Neut
23790-9,Vesicular stomatitis New Jersey virus Ab
23791-7,Vesicular stomatitis New Jersey virus Ab.Neut
23792-5,Western equine encephalitis virus Ab
23793-3,Canine parvovirus Ag
23794-1,(Avena sativa+Hordeum vulgare+Oryza sativa+Secale cereale+Triticum aestivum+Zea mays) Ab.IgE
23795-8,(Blatella germanica+Dermatophagoides farinae+Dermatophagoides pteronyssinus+House dust Hollister Stier) Ab.IgE
Jun-79,Glutathione S-transferase
23796-6,(Acer negundo+Betula verrucosa+Quercus alba+Ulmus americana+Juglans californica) Ab.IgE
23797-4,(Acer negundo+Quercus alba+Ulmus americana+Populus deltoides+Carya illinoinensis) Ab.IgE
23798-2,(Cat dander+Cow dander+Dog dander+Horse dander) Ab.IgE
23799-0,(Chicken feather+Duck feather+Goose feather+Parrot feather) Ab.IgE
23800-6,(Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) Ab.IgE
23801-4,(Arachis hypogaea+Cow milk+Egg white+Gadus morhua+Glycine max+Triticum aestivum) Ab.IgE
23802-2,(Cynodon dactylon+Lolium perenne+Phleum pratense+Poa pratensis+Sorghum halepense) Ab.IgE
23803-0,(Dactylis glomerata+Festuca elatior+Lolium perenne+Phleum pratense+Poa pratensis) Ab.IgE
Apr-80,Glutathione synthase
23804-8,(Gadus morhua+Mytilus edulis+Pandalus borealis+Salmo salar+Thunnus albacares) Ab.IgE
23805-5,5-Fluorocytosine
23806-3,Albumin^2H post peritoneal dialysis
23807-1,Albumin^4H post peritoneal dialysis
23808-9,Aldosterone.free
23809-7,Alloisoleucine
23810-5,Alpha fucosidase
23811-3,Alpha-1-Fetoprotein^^adjusted
Feb-81,Glutathione.oxidized
23812-1,Alpha-1-Fetoprotein^^unadjusted
23813-9,Alternaria sp Ab.IgE.RAST class
23814-7,Amantadine
23815-4,Androstanediol
23816-2,Antibiotic XXX
23817-0,Antibiotic XXX^peak
23818-8,Antibiotic XXX^trough
23819-6,Antibody coated bacteria
2382-0,Glutathione.reduced
23820-4,Aspergillus flavus Ab
23821-2,Aspergillus fumigatus Ab
23822-0,Azinphos-methyl
23823-8,Basophils/100 leukocytes
23824-6,Beta-N-acetylhexosaminidase.A/Beta-N-acetylhexosaminidase.total
23825-3,Beta-N-acetylhexosaminidase.A/Beta-N-acetylhexosaminidase.total
23826-1,Bordetella pertussis DNA
23827-9,Bordetella pertussis.filamentous hemagglutinin Ab.IgA
23828-7,Bordetella pertussis.filamentous hemagglutinin Ab.IgG
23829-5,Bordetella pertussis.filamentous hemagglutinin Ab.IgM
23830-3,Bordetella pertussis.pertussis toxin Ab.IgA
23831-1,Bordetella pertussis.pertussis toxin Ab.IgG
23832-9,Bordetella pertussis.pertussis toxin Ab.IgM
23833-7,Borrelia burgdorferi Ab index
23834-5,Canary droppings Ab.IgE.RAST class
23835-2,Carbon disulfide
23836-0,Carbon disulfide
23837-8,Chicken serum proteins Ab.IgE.RAST class
Aug-83,Glutathione
23838-6,Chlamydia trachomatis rRNA
23839-4,Cholinesterase
23840-2,Choriogonadotropin.beta subunit^^unadjusted
23841-0,Choriogonadotropin.beta subunit^^adjusted
23842-8,Cobalt
23843-6,Cockatiel droppings Ab
23844-4,C3 nephritic factor
23845-1,Coproporphyrin 1
Jun-84,Glyceraldehyde 3 phosphate dehydrogenase
23846-9,Coproporphyrin 3
23847-7,Cotton fibers Ab.IgE
23848-5,Creosol
23849-3,Creosol
23850-1,Creosol
23851-9,Cyclohexanone
23852-7,Deuteroporphyrin
Mar-85,Glycerate
23853-5,Dimethylformamide/Creatinine
23854-3,Dioxin
23855-0,Echinococcus granulosus Ab.IgE
23856-8,Endrin
23857-6,Epidermis Ab
23858-4,Epstein Barr virus DNA
23859-2,Erythrocytes
238-6,Erythromycin+sulfiSOXAZOLE
23860-0,Erythrocytes
Jan-86,Glycerate
23861-8,Ethanol
23862-6,Famotidine
23863-4,Finch droppings Ab.IgE.RAST class
23864-2,Flunitrazepam
23865-9,Fluoxetine+Norfluoxetine
23866-7,Glutaraldehyde
23867-5,Hantavirus sin nombre Ab.IgG
23868-3,Hantavirus sin nombre Ab.IgM
23869-1,Hepatitis B virus DNA
23870-9,Hepatitis C virus 100+5-1-1 Ab
23871-7,Hepatitis C virus NS5 Ab
23872-5,Heptacarboxylporphyrin I
23873-3,Heptacarboxylporphyrin III
23874-1,Hexacarboxylporphyrin I
23875-8,Hexacarboxylporphyrin III
23876-6,HIV 1 RNA
23877-4,Anaplasma phagocytophilum Ab.IgG
23878-2,Anaplasma phagocytophilum Ab.IgM
Sep-87,Glycerol
23879-0,Immune complex
23880-8,Immune complex
23881-6,Immune complex
23882-4,Immune complex
23883-2,Inhibin A
23884-0,Interleukin 2 receptor
23885-7,Isoheptacarboxylporphyrin
23886-5,Isohexacarboxylporphyrin
Jul-88,Glycerol
23887-3,Isopentacarboxylporphyrin
23888-1,Isopropanol
23889-9,Kanamycin
23890-7,Lead
23891-5,Magnesium
23892-3,Magnesium
23893-1,Malaoxon
23894-9,Maple Ab.IgE.RAST class
May-89,Glycine
23895-6,Mattress dust Ab.IgE.RAST class
23896-4,Mercury
23897-2,Mesothelial cells
23898-0,Mesothelial cells
23899-8,Methanol
23900-4,Methanol
23901-2,Microscopic observation
23902-0,Monocyte+Macrophage/100 leukocytes
Mar-90,Glycine
23903-8,Monocytes+Macrophages/100 leukocytes
23904-6,Monocytes+Macrophages/100 leukocytes
23905-3,Mycophenolate
23906-1,Mycophenolate glucuronide
23907-9,Myelin associated glycoprotein-sulfated glucuronic paragloboside Ab.IgM
23908-7,Neisseria gonorrhoeae rRNA
23909-5,Trisetum paniceum Ab.IgE.RAST class
23910-3,Osmotic fragility^0.0% sodium chloride
Jan-91,Glycine
23911-1,Osmotic fragility^0.30% sodium chloride
23912-9,Osmotic fragility^0.35% sodium chloride
23913-7,Osmotic fragility^0.40% sodium chloride
23914-5,Osmotic fragility^0.45% sodium chloride
23915-2,Osmotic fragility^0.50% sodium chloride
23916-0,Osmotic fragility^0.55% sodium chloride
23917-8,Osmotic fragility^0.60% sodium chloride
23918-6,Osmotic fragility^0.60% sodium chloride 24H 37 deg C incubation
23919-4,Osmotic fragility^0.65% sodium chloride
23920-2,Osmotic fragility^0.65% sodium chloride 24H 37 deg C incubation
23921-0,Osmotic fragility^0.75% sodium chloride 24H 37 deg C incubation
23922-8,Osmotic fragility^0.85% sodium chloride
23923-6,Parakeet droppings Ab.IgE.RAST class
23924-4,Parakeet serum Ab.IgE.RAST class
23925-1,Penicillin
23926-9,Pepper bell Ab.IgE.RAST class
23927-7,Pepper white Ab.IgE.RAST class
23928-5,Protoporphyrin
Sep-92,Glycine
23929-3,Ribonucleoprotein extractable nuclear Ab.IgG
23930-1,Salmonella typhi O D Ab
23931-9,Salmonella typhi O D
23932-7,Squash zucchini Ab.IgE.RAST class
23933-5,Staphylococcus aureus enterotoxin B
23934-3,Staphylococcus aureus enterotoxin B Ab
23935-0,Staphylococcus aureus toxic shock syndrome toxin 1
23936-8,Staphylococcus aureus toxic shock syndrome toxin 1 Ab
Jul-93,Glycine
23937-6,Trans nonachlor
23938-4,Trapa natans Ab.IgE.RAST class
23939-2,Xylose^1H post 5 g xylose PO
239-4,Erythromycin+sulfiSOXAZOLE
23940-0,Xylose^1H post dose xylose PO
23941-8,Xylose^2H post 25 g xylose PO
23942-6,Xylose^2H post 5 g xylose PO
23943-4,Xylose^2H post dose xylose PO
23944-2,Xylose^1H post 25 g xylose PO
May-94,Glycogen synthase
23945-9,Xylose^1H post 5 g xylose PO
23946-7,Xylose^1H post dose xylose PO
23947-5,Isoniazid
23948-3,Ofloxacin
23949-1,rifAMPin
23950-9,Adenovirus Ab
23951-7,Asialoganglioside GM1 Ab.IgG
Feb-95,Glycolate
23952-5,Asialoganglioside GM1 Ab.IgM
23953-3,Aspergillus sp Ab
23954-1,Bartonella henselae Ab.IgG
23955-8,Bartonella henselae Ab.IgM
23956-6,Aspergillus sp Ab
23957-4,Bartonella henselae Ab.IgG
23958-2,Dengue virus Ab.IgG
23959-0,Blastomyces dermatitidis Ab
2396-0,Glycolate
23960-8,Bartonella quintana Ab.IgM
23961-6,Bartonella quintana Ab.IgG
23962-4,Bartonella henselae Ab.IgM
23963-2,Brucella abortus Ab.IgG
23964-0,Brucella abortus Ab.IgM
23965-7,Burkholderia pseudomallei Ab.IgG
23966-5,Borrelia burgdorferi Ab.IgG
23967-3,Chlamydia sp Ab
23968-1,Dengue virus Ab.IgM
23969-9,Echovirus 7 Ab
23970-7,Epstein Barr virus nuclear Ab.IgG
23971-5,Epstein Barr virus early Ab.IgG
23972-3,Epstein Barr virus early Ab.IgG
23973-1,Burkholderia pseudomallei Ab.IgM
23974-9,Bartonella quintana Ab.IgG
23975-6,Bartonella quintana Ab.IgM
23976-4,Blastomyces dermatitidis Ab
23977-2,Borrelia burgdorferi Ag
Aug-97,Glycoproteins
23978-0,Borrelia burgdorferi Ab.IgG
23979-8,Borrelia burgdorferi Ab.IgG band pattern
23980-6,Borrelia burgdorferi Ab.IgG
23981-4,Borrelia burgdorferi Ab.IgG band pattern
23982-2,Borrelia burgdorferi Ab.IgM
23983-0,Borrelia burgdorferi Ab.IgM band pattern
23984-8,Borrelia burgdorferi Ab.IgM
23985-5,Borrelia burgdorferi Ab.IgM band pattern
Jun-98,Glycosaminoglycans
23986-3,Brucella abortus Ab.IgG
23987-1,Brucella abortus Ab.IgM
23988-9,Burkholderia pseudomallei Ab.IgG
23989-7,Burkholderia pseudomallei Ab.IgM
23990-5,Chlamydia sp Ab
23991-3,Dengue virus Ab.IgG
23992-1,Dengue virus Ab.IgM
23993-9,Echovirus 7 Ab
Apr-99,Glycosaminoglycans
23994-7,Epstein Barr virus nuclear Ab.IgG
23995-4,Epstein Barr virus early Ab.IgG
23996-2,Epstein Barr virus early Ab.IgG
23997-0,Ganglioside GD1a Ab.IgG
23998-8,Ganglioside GD1a Ab.IgM
23999-6,Ganglioside GD1b Ab.IgG
24-0,Amphotericin B
2400-0,Guanine deaminase
24000-2,Ganglioside GD1b Ab.IgM
24001-0,Ganglioside GQ1b Ab.IgG
24002-8,Microscopic observation
24003-6,Brucella sp identified
24004-4,Chlamydophila pneumoniae Ab.IgM
24005-1,Chlamydia sp identified
24006-9,Eastern equine encephalitis virus Ab.IgG & IgM
24007-7,Epstein Barr virus early Ab.IgG
24008-5,Echovirus 14 Ab
24009-3,Fungus identified
24010-1,Haemophilus influenzae B Ag
24011-9,Hepatitis C virus Ab band pattern
24012-7,HIV 1 Ag
24013-5,HIV 1 RNA
24014-3,Herpes simplex virus 2 Ab.IgG
24015-0,Influenza virus A+B Ag
24016-8,La Crosse virus Ab
24017-6,Neisseria meningitidis serogroup B Ag
Aug-01,Guanine deaminase
24018-4,Neisseria meningitidis serogroup B Ag
24019-2,Neisseria meningitdis B Ag
240-2,Ethambutol
24020-0,Streptococcus agalactiae Ag
24021-8,Streptococcus pneumoniae 12 Ab
24022-6,Streptococcus pneumoniae 14 Ab
24023-4,Streptococcus pneumoniae 3 Ab
24025-9,Streptococcus pneumoniae 8 Ab
Jun-02,Guanosine monophosphate.cyclic
24027-5,Streptococcus pneumoniae Ag
24028-3,Toxocara canis Ab.IgA
24029-1,Toxocara canis Ab.IgG
24030-9,Toxocara canis Ab.IgM
24031-7,14-3-3 Ag
24032-5,Rifabutin
24033-3,Bordetella pertussis.filamentous hemagglutinin Ab.IgG
Apr-03,Hemopexin
24034-1,Bordetella pertussis.filamentous hemagglutinin Ab.IgA
24035-8,Bordetella pertussis.filamentous hemagglutinin Ab.IgM
24036-6,Borrelia sp Ag
24037-4,Coccidioides immitis rRNA
24038-2,Cryoglobulin type
24039-0,Taenia solium larva Ab.IgG band pattern
24040-8,Taenia solium larva Ab.IgG band pattern
24041-6,Cytomegalovirus DNA
Feb-04,Hemopexin
24042-4,Ehrlichia chaffeensis DNA
24043-2,Acetyl-CoA:glucosamine acetyltransferase
24044-0,Acetyl-CoA:glucosamine acetyltransferase
24045-7,Alpha fucosidase
24046-5,Alpha fucosidase
24047-3,Alpha fucosidase
24048-1,Alpha galactosidase A
24049-9,Alpha galactosidase A
24050-7,Acid alpha glucosidase
24051-5,Acid alpha glucosidase
24052-3,Alpha mannosidase
24053-1,Alpha mannosidase
24054-9,Alpha-N-acetylgalactosaminidase
24055-6,Alpha-N-acetylgalactosaminidase
24056-4,Alpha-L-iduronidase
24057-2,Alpha-L-iduronidase
24058-0,Aspartylglucosaminidase
Sep-05,Heparan sulfate
24059-8,Aspartylglucosaminidase
24060-6,Beta galactosidase
24061-4,Beta galactosidase
24064-8,Beta glucuronidase
24065-5,Beta glucuronidase
24066-3,Beta mannosidase
Jul-06,Heparan sulfate
24067-1,Beta mannosidase
24068-9,Beta mannosidase
24069-7,Beta N-acetylhexosaminidase.B/Beta N-acetyl hexosaminidase.total
24070-5,Beta-N-acetylhexosaminidase.B/Beta-N-acetylhexosaminidase.total
24071-3,Beta-N-acetylhexosaminidase.B/Beta-N-acetylhexosaminidase.total
24072-1,Beta-N-acetylhexosaminidase.B
24073-9,Beta-N-acetylhexosaminidase.B
24074-7,Beta-N-acetylhexosaminidase
May-07,Heptacarboxylporphyrin
24075-4,Beta-N-acetylhexosaminidase
24076-2,Cerebroside sulfatase
24077-0,Cerebroside sulfatase
24078-8,Cerebroside sulfatase
24079-6,Cholesterol esterase
24080-4,Cholesterol esterase
24081-2,Dihydroxyacetone phosphate acylcoa acyl transferase
24082-0,Galactose 1 phosphate uridyl transferase
Mar-08,Hexachlorophene
24083-8,Galactosylceramidase
24084-6,Galactosylceramidase
24085-3,Heparan-N-sulfatase
24086-1,Heparan-N-sulfatase
24087-9,Iduronate-2-Sulfatase
24088-7,Iduronate-2-Sulfatase
24089-5,Iduronate-2-Sulfatase
24090-3,Alpha-N-acetylglucosaminidase
Jan-09,Hexokinase
24091-1,Alpha-N-acetylglucosaminidase
24092-9,Alpha-N-acetylglucosaminidase
24093-7,N-Acetylgalactosamine-4-Sulfatase
24094-5,N-Acetylgalactosamine-4-Sulfatase
24095-2,N-Acetylgalactosamine-6-Sulfatase
24096-0,N-Acetylgalactosamine-6-Sulfatase
24097-8,N-Acetylglucosamine-6-Sulfatase
24098-6,N-Acetylglucosamine-6-Sulfatase
24099-4,Sialidase
241-0,Ethambutol
24100-0,Acid sphingomyelinase
24101-8,Acid sphingomyelinase
24102-6,Corynebacterium spp toxin
24103-4,Plasma cells
24104-2,Lymphoma cells/100 leukocytes
24105-9,Lymphoma cells
24106-7,Hairy cells/100 leukocytes
24107-5,Hairy cells
24108-3,Cancer Ag 19-9
Sep-10,Hexokinase
24109-1,Progesterone
24110-9,Treponema pallidum Ab
24111-7,Neisseria gonorrhoeae DNA
24112-5,Trichomonas vaginalis rRNA
24113-3,Hepatitis B virus core Ab.IgM
24114-1,Epstein Barr virus capsid Ab.IgG
24115-8,Epstein Barr virus capsid Ab.IgM
24116-6,Rubella virus Ab.IgM
Jul-11,Hexokinase 1/Hexokinase.total
24117-4,Ross river virus Ab.IgG
24118-2,Barmah forest virus Ab.IgM
24119-0,Cytomegalovirus Ab.IgM
24120-8,Ross river virus Ab.IgM
24121-6,Barmah forest virus Ab.IgG
24122-4,Leukocytes
24123-2,Epithelial cells
24124-0,Casts
May-12,Hexokinase 3/Hexokinase.total
24125-7,Androgen.free index
24126-5,Adenovirus type
24127-3,Bordetella pertussis.pertussis toxin Ab.IgG
24128-1,Bordetella pertussis.pertussis toxin Ab.IgA
24129-9,Bordetella pertussis.pertussis toxin Ab.IgM
24130-7,Bordetella pertussis.secretory Ab.IgA
24131-5,(Avena sativa+Fagopyrum esculentum+Sesamum indicum+Triticum aestivum+Zea mays) Ab.IgE
24132-3,(Anthoxanthum odoratum+Lolium perenne+Phragmites communis+Secale cereale+Holcus lanatus) Ab.IgE
Mar-13,Hippuran renal clearance
24133-1,(Alnus incana+Corylus avellana+Ulmus americana+Salix caprea+Populus deltoides) Ab.IgE
24134-9,(Acer negundo+Betula verrucosa+Fagus grandifolia+Quercus alba+Juglans californica) Ab.IgE
24135-6,(Alnus incana+Betula verrucosa+Corylus avellana+Quercus alba+Salix caprea) Ab.IgE
24136-4,Juglans nigra Ab.IgG
24137-2,Carya tomentosa Ab.IgG
24138-0,Sorghum halepense Ab.IgG
24139-8,Blatella germanica Ab.IgG
24140-6,Fraxinus americana Ab.IgG
Jan-14,Hippurate
24141-4,Iva ciliata Ab.IgG
24142-2,Morus rubra Ab.IgG
24143-0,Rumex acetosella Ab.IgG
24144-8,Bromus inermis Ab.IgG
24145-5,Platanus occidentalis Ab.IgG
24146-3,Acnida tamariscina Ab.IgG
24147-1,(Chicken feather+Duck feather+Goose feather) Ab.IgE
24148-9,Poa pratensis Ab.IgG
24149-7,(Brassica oleracea var botrytis+Brassica oleracea var capitata+Brassica oleracea var gemmifera+Brassica oleracea var italica) Ab.IgG
24150-5,Acer rubrum Ab.IgG
24151-3,Ambrosia trifida Ab.IgG
24152-1,Alternaria alternata Ab.IgG
24153-9,Kamut flour Ab.IgG
24154-7,Chenopodium album Ab.IgG
24155-4,Mangifera indica Ab.IgG
24156-2,Maple syrup Ab.IgG
24157-0,Quercus virginiana Ab.IgE
Aug-15,Histamine
24158-8,Pepper white+Pepper black Ab.IgG
24159-6,Pepper white+Pepper black Ab.IgE
24160-4,Bean wax Ab.IgE
24161-2,Cucumis melo spp Ab.IgE
24162-0,Aspergillus fumigatus Ab.IgG.RAST class
24163-8,(Beef+Chicken+Pork) Ab.IgE
24164-6,Citrus reticulata Ab.IgE
24165-3,Beta vulgaris seed Ab.IgE
Jun-16,Histamine
24166-1,Pinus radiata Ab.IgE
24167-9,Rat Ab.IgE
24168-7,Cat hair+Cat dander Ab.IgG
24169-5,Polio virus 1 Ab.Neut^1st specimen
24170-3,Polio virus 1 Ab.Neut^2nd specimen
24171-1,Polio virus 2 Ab.Neut^1st specimen
24172-9,Polio virus 2 Ab.Neut^2nd specimen
24173-7,Polio virus 3 Ab.Neut^1st specimen
Apr-17,Histamine
24174-5,Polio virus 3 Ab.Neut^2nd specimen
24175-2,Adenovirus Ab^1st specimen
24176-0,Adenovirus Ab^2nd specimen
24177-8,Coxsackievirus B1 Ab^1st specimen
24178-6,Coxsackievirus B1 Ab^2nd specimen
24179-4,Coxsackievirus B1 Ab.Neut^1st specimen
24180-2,Coxsackievirus B1 Ab.Neut^2nd specimen
24181-0,Coxsackievirus B2 Ab^1st specimen
Feb-18,Histidine
24182-8,Coxsackievirus B2 Ab^2nd specimen
24183-6,Coxsackievirus B2 Ab.Neut^1st specimen
24184-4,Coxsackievirus B2 Ab.Neut^2nd specimen
24185-1,Coxsackievirus B3 Ab^1st specimen
24186-9,Coxsackievirus B3 Ab^2nd specimen
24187-7,Coxsackievirus B3 Ab.Neut^1st specimen
24188-5,Coxsackievirus B3 Ab.Neut^2nd specimen
24189-3,Coxsackievirus B4 Ab^1st specimen
2419-0,Histidine
24190-1,Coxsackievirus B4 Ab^2nd specimen
24191-9,Coxsackievirus B4 Ab.Neut^1st specimen
24192-7,Coxsackievirus B4 Ab.Neut^2nd specimen
24193-5,Coxsackievirus B5 Ab^1st specimen
24194-3,Coxsackievirus B5 Ab^2nd specimen
24195-0,Coxsackievirus B5 Ab.Neut^1st specimen
24196-8,Coxsackievirus B5 Ab.Neut^2nd specimen
24197-6,Coxsackievirus B6 Ab^1st specimen
24198-4,Coxsackievirus B6 Ab^2nd specimen
24199-2,Coxsackievirus B6 Ab.Neut^1st specimen
24200-8,Coxsackievirus B6 Ab.Neut^2nd specimen
24201-6,Saint Louis encephalitis virus Ab^1st specimen
24202-4,Saint Louis encephalitis virus Ab^2nd specimen
24203-2,Legionella pneumophila Ab^1st specimen
24204-0,Legionella pneumophila Ab^2nd specimen
24205-7,Rickettsia typhi Ab.IgG^1st specimen
24206-5,Rickettsia typhi Ab.IgG^2nd specimen
24207-3,Rickettsia spotted fever group Ab.IgG^1st specimen
Aug-20,Histidine
24208-1,Rickettsia spotted fever group Ab.IgG^2nd specimen
24209-9,La Crosse virus Ab^1st specimen
24210-7,La Crosse virus Ab^2nd specimen
24211-5,Western equine encephalitis virus Ab^1st specimen
24212-3,Western equine encephalitis virus Ab^2nd specimen
24213-1,Eastern equine encephalitis virus Ab^1st specimen
24214-9,Eastern equine encephalitis virus Ab^2nd specimen
24215-6,Influenza virus A Ab^1st specimen
Jun-21,Histidine
24216-4,Influenza virus A Ab^2nd specimen
24217-2,Influenza virus B Ab^1st specimen
24218-0,Influenza virus B Ab^2nd specimen
24219-8,Parainfluenza virus 1 Ab^1st specimen
24220-6,Parainfluenza virus 2 Ab^1st specimen
24221-4,Parainfluenza virus 2 Ab^2nd specimen
24222-2,Parainfluenza virus 3 Ab^1st specimen
24223-0,Parainfluenza virus 3 Ab^2nd specimen
Apr-22,Histidine
24224-8,Respiratory syncytial virus Ab^1st specimen
24225-5,Respiratory syncytial virus Ab^2nd specimen
24226-3,Coxsackievirus A10 Ab^1st specimen
24227-1,Coxsackievirus A10 Ab^2nd specimen
24228-9,Coxsackievirus A16 Ab^1st specimen
24229-7,Coxsackievirus A16 Ab^2nd specimen
24230-5,Coxsackievirus A7 Ab^1st specimen
24231-3,Coxsackievirus A7 Ab^2nd specimen
Feb-23,Histidine
24232-1,Coxsackievirus A9 Ab^1st specimen
24233-9,Coxsackievirus A9 Ab^2nd specimen
24234-7,Mycoplasma pneumoniae Ab.IgG^1st specimen
24235-4,Mycoplasma pneumoniae Ab.IgG^2nd specimen
24236-2,Mycoplasma pneumoniae Ab^1st specimen
24237-0,Mycoplasma pneumoniae Ab^2nd specimen
24238-8,Chlamydia sp Ab.IgG^1st specimen
24239-6,Chlamydia sp Ab.IgG^2nd specimen
2424-0,Histidine
24240-4,Mumps virus Ab.IgG^1st specimen
24241-2,Mumps virus Ab.IgG^2nd specimen
24242-0,Toxoplasma gondii Ab.IgG^1st specimen
24243-8,Polio virus 1 Ab^1st specimen
24244-6,Polio virus 1 Ab^2nd specimen
24245-3,Polio virus 2 Ab^1st specimen
24246-1,Polio virus 2 Ab^2nd specimen
24247-9,Polio virus 3 Ab^1st specimen
24248-7,Polio virus 3 Ab^2nd specimen
24249-5,Adenovirus Ab^1st specimen
24250-3,Adenovirus Ab^2nd specimen
24251-1,Coxsackievirus B1 Ab^1st specimen
24252-9,Coxsackievirus B1 Ab^2nd specimen
24255-2,Coxsackievirus B2 Ab^1st specimen
24256-0,Coxsackievirus B2 Ab^2nd specimen
Jul-25,Histidine ammonia lyase
24259-4,Coxsackievirus B3 Ab^1st specimen
24260-2,Coxsackievirus B3 Ab^2nd specimen
24263-6,Coxsackievirus B4 Ab^1st specimen
24264-4,Coxsackievirus B4 Ab^2nd specimen
May-26,Homocarnosine
24267-7,Coxsackievirus B5 Ab^1st specimen
24268-5,Coxsackievirus B5 Ab^2nd specimen
24271-9,Coxsackievirus B6 Ab^1st specimen
24272-7,Coxsackievirus B6 Ab^2nd specimen
Mar-27,Homocitrulline
24275-0,Saint Louis encephalitis virus Ab^1st specimen
24276-8,Saint Louis encephalitis virus Ab^2nd specimen
24277-6,Legionella pneumophila Ab^1st specimen
24278-4,Legionella pneumophila Ab^2nd specimen
24279-2,Rickettsia typhi Ab.IgG^1st specimen
242-8,Ethambutol
24280-0,Rickettsia typhi Ab.IgG^2nd specimen
Jan-28,Homocysteine
24281-8,Rickettsia spotted fever group Ab.IgG^1st specimen
24282-6,Rickettsia spotted fever group Ab.IgG^2nd specimen
24283-4,La Crosse virus Ab^1st specimen
24284-2,La Crosse virus Ab^2nd specimen
24285-9,Western equine encephalitis virus Ab^1st specimen
24286-7,Western equine encephalitis virus Ab^2nd specimen
24287-5,Eastern equine encephalitis virus Ab^1st specimen
24288-3,Eastern equine encephalitis virus Ab^2nd specimen
24289-1,Influenza virus A Ab^1st specimen
24290-9,Influenza virus A Ab^2nd specimen
24291-7,Influenza virus B Ab^1st specimen
24292-5,Influenza virus B Ab^2nd specimen
24293-3,Parainfluenza virus 1 Ab^1st specimen
24294-1,Parainfluenza virus 2 Ab^1st specimen
24295-8,Parainfluenza virus 2 Ab^2nd specimen
24296-6,Parainfluenza virus 3 Ab^1st specimen
24297-4,Parainfluenza virus 3 Ab^2nd specimen
24298-2,Respiratory syncytial virus Ab^1st specimen
Sep-29,Homocystine
24299-0,Respiratory syncytial virus Ab^2nd specimen
24300-6,Coxsackievirus A10 Ab^1st specimen
24301-4,Coxsackievirus A10 Ab^2nd specimen
24302-2,Coxsackievirus A16 Ab^1st specimen
24303-0,Coxsackievirus A16 Ab^2nd specimen
24304-8,Coxsackievirus A7 Ab^1st specimen
24305-5,Coxsackievirus A7 Ab^2nd specimen
24306-3,Coxsackievirus A9 Ab^1st specimen
Jul-30,Homocystine
24307-1,Coxsackievirus A9 Ab^2nd specimen
24310-5,Mycoplasma pneumoniae Ab^1st specimen
24311-3,Mycoplasma pneumoniae Ab^2nd specimen
24312-1,Treponema pallidum Ab
24313-9,Hepatitis 1996 panel
24314-7,TORCH 1996 panel
May-31,Homocystine
24315-4,Cytomegalovirus Ab.IgG & IgM panel
24316-2,Epstein Barr virus capsid Ab.IgG & IgM panel
24317-0,Hemogram & platelets WO differential panel
24318-8,Manual Differential panel
24319-6,Cardiolipin Ab.IgG & IgM panel
24320-4,Basic metabolic 1998 panel
24321-2,Basic metabolic 2000 panel
24322-0,Comprehensive metabolic 1998 panel
Mar-32,Homogentisate
24323-8,Comprehensive metabolic 2000 panel
24324-6,Hepatic function 1996 panel
24325-3,Hepatic function 2000 panel
24326-1,Electrolytes 1998 panel
24327-9,Electrolytes 3 panel
24328-7,Electrolytes 3 panel
24329-5,Electrolytes 3 panel
Jan-33,Homogentisate
24331-1,Lipid 1996 panel
24332-9,Alkaline phosphatase isoenz panel
24333-7,Amylase isoenz 3 panel
24334-5,Amylase isoenz 7 panel
24335-2,Creatine kinase panel
24336-0,Gas panel
24337-8,Gas panel
24338-6,Gas panel
24339-4,Gas panel
24340-2,Gas panel
24341-0,Gas & CO panel
24342-8,Gas & CO panel
24343-6,Gas & CO panel
24344-4,Gas & CO panel
24345-1,Gas & CO panel
24346-9,Parathyrin.intact & Calcium panel
24347-7,Parathyrin.mid molecule & Calcium panel
24348-5,Free T4 & TSH panel
Sep-34,Homovanillate
24349-3,Drugs of abuse 5 panel
24350-1,Volatiles panel
24351-9,Protein fractions panel
24352-7,Protein fractions panel
24353-5,Glucose tolerance 2H gestational panel
24355-0,Urinalysis macroscopic panel
Jun-35,Homovanillate
24356-8,Urinalysis complete panel
24357-6,Urinalysis macro (dipstick) panel
24358-4,Hemogram WO platelets panel
24359-2,Hemogram WO Platelets & W Manual Differential panel
243-6,Ethambutol
24360-0,Hemoglobin & Hematocrit panel
24361-8,"Hemogram, platelets & Differential panel"
24362-6,Renal function 2000 panel
24363-4,Acute hepatitis 2000 panel
Apr-36,Homovanillate
24364-2,Obstetric 1996 panel
24365-9,Urinalysis microscopic panel
24369-1,RR interval^during XXX measurement
24370-9,Intravascular peak systolic^during MR max vel measurement
24371-7,Intravascular peak systolic^during AS max vel measurement
Feb-37,Hydrogen/Expired gas^post 50 g glucose PO
24372-5,Intravascular peak systolic^during RVSP max vel measurement
24373-3,Ferritin
24374-1,Platelet associated Ab
24375-8,Platelet Ab
24376-6,von Willebrand factor multimers
24377-4,Platelet aggregation.adenosine diphosphate induced
24378-2,Platelet aggregation.EPINEPHrine induced
24379-0,Platelet aggregation.collagen induced
2438-0,Hydrogen sulfide
24380-8,Platelet aggregation.ristocetin induced
24381-6,Platelet aggregation.arachidonate induced
24382-4,Neutrophil associated Ab
24383-2,Intrinsic factor Ab
24384-0,little c Ab
24385-7,Cardiolipin Ab.IgG
24386-5,Cardiolipin Ab.IgM
24387-3,Brucella sp Ab.IgG
24388-1,Brucella sp Ab.IgM
24389-9,Cortisol^pre 250 ug corticotropin IM
24390-7,Cortisol^30M post 250 ug corticotropin IM
24391-5,Cortisol^1H post 250 ug corticotropin IM
24392-3,Cortisol^pre 1 mg dexamethasone PO overnight
24393-1,Cortisol^10H post 1 mg dexamethasone PO overnight
24394-9,Cortisol^17H post 1 mg dexamethasone PO overnight
24395-6,Cortisol^24H post 1 mg dexamethasone PO overnight
24396-4,Brucella sp Ab.IgG
24397-2,Brucella sp Ab.IgM
Aug-39,Hydroxycalcidiol
24398-0,Toxoplasma sp Ab.IgM
24399-8,Toxoplasma sp Ab.IgM
24400-4,Neuronal nuclear type 1 Ab
24401-2,Neuronal nuclear type 2 Ab
24402-0,Chlamydophila pneumoniae+Chlamydophila psittaci DNA
24403-8,Neuronal nuclear type 1 Ab
24404-6,Neuronal nuclear type 2 Ab
24405-3,Aeromonas salmonicida
Jun-40,Hydroxocobalamin
24406-1,Aeromonas salmonicida serotype
24407-9,Androstenedione^baseline
24408-7,Babesia canis
24409-5,Brachyspira sp identified
24410-3,Brucella canis Ab
24411-1,Canine parvovirus Ab
24412-9,Coccidia identified
24413-7,Eperythrozoon sp
Apr-41,Hydroxylysine
24414-5,Estradiol^baseline
24415-2,Feline panleukopenia virus Ag
24416-0,Filovirus Ab
24417-8,Follitropin^1st specimen post XXX challenge
24418-6,Formononetin
24419-4,Path report.gross observation
24420-2,Haemophilus somnus Ab
24421-0,Haemobartonella felis
Feb-42,Hydroxylysine
24422-8,Hydrocarbons.chlorinated
24427-7,Mycobacterium avium subspecies paratuberculosis
24428-5,Mycoplasma hyopneumoniae Ab
24429-3,Parasite identified
2443-0,Hydroxylysine
24430-1,Streptococcus suis serotype
24431-9,IgA.canine
24432-7,IgG.canine
24433-5,IgG.equine
24434-3,IgM.canine
24435-0,2-Methylbutyrylglycine/Creatinine
24436-8,3-Methylcrotonylglycine/Creatinine
24437-6,Butyrylglycine/Creatinine
24438-4,Hexanoylglycine/Creatinine
24439-2,Isobutyrylglycine/Creatinine
244-4,Floxacillin
24440-0,Isovalerylglycine/Creatinine
24441-8,Phenylpropionylglycine/Creatinine
24442-6,Propionylglycine/Creatinine
24443-4,Suberylglycine/Creatinine
24444-2,Tiglylglycine/Creatinine
24445-9,Valerylglycine/Creatinine
24446-7,Porphobilinogen
24447-5,Magnesium
Aug-44,Hydroxymethylglutaryl CoA lyase
24448-3,Carnitine
24449-1,Carnitine esters
24450-9,Carnitine esters
24451-7,Carnitine
24452-5,Carnitine.free (C0)
24453-3,Carnitine
24454-1,Collection duration
May-45,Hydroxyproline
24456-6,Deoxypyridinoline/Creatinine
24457-4,Tryptophan
24458-2,Interleukin 2 receptor
24459-0,Thyrotropin^20M post dose TRH
24461-6,Fatty acids
24462-4,Heptacarboxylporphyrin
Mar-46,Hydroxyproline
24463-2,Keratan sulfate
24464-0,Chondroitin sulfate
24465-7,Urea nitrogen
24466-5,Cells.CD56/100 cells
24467-3,Cells.CD3+CD4+
24468-1,Cells.CD14+CD16+CD59+
24469-9,Hemoglobin XXX/Hemoglobin.total
24470-7,Hemoglobin A2+XXX/Hemoglobin.total
Jan-47,Hydroxyproline
24471-5,Platelet function.collagen+EPINEPHrine induced
24472-3,Platelet function.collagen+Adenosine diphosphate induced
24473-1,Cells.CD23/100 cells
24474-9,Cancer associated serum Ag
24475-6,F2 gene.c.20210G>A
24476-4,F2 gene targeted mutation analysis
24477-2,F2 gene mutations tested for
24478-0,(Dactylis glomerata+Festuca elatior+Lolium perenne+Phleum pratense+Poa pratensis) Ab.IgE.RAST class
24479-8,(Acer negundo+Betula verrucosa+Quercus alba+Ulmus americana+Juglans californica) Ab.IgE.RAST class
24480-6,(Ambrosia elatior+Artemisia vulgaris+Chenopodium album+Plantago lanceolata+Salsola kali) Ab.IgE
24481-4,(Ambrosia elatior+Artemisia vulgaris+Chenopodium album+Plantago lanceolata+Salsola kali) Ab.IgE.RAST class
24482-2,(Hordeum vulgare+Oryza sativa+Secale cereale+Triticum aestivum) Ab.IgE.RAST class
24483-0,(Cat dander+Cow dander+Dog dander+Horse dander) Ab.IgE.RAST class
24484-8,(Arachis hypogaea+Cow milk+Egg white+Gadus morhua+Glycine max+Triticum aestivum) Ab.IgE.RAST class
24485-5,(Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) Ab.IgE.RAST class
24486-3,(Cynodon dactylon+Lolium perenne+Phleum pratense+Poa pratensis+Sorghum halepense+Paspalum notatum) Ab.IgE.RAST class
24487-1,(Gadus morhua+Mytilus edulis+Pandalus borealis+Salmo salar+Thunnus albacares) Ab.IgE.RAST class
24488-9,(Chicken feather+Duck feather+Goose feather+Parrot feather) Ab.IgE.RAST class
Sep-48,Hydroxyproline.free
24489-7,(Acer negundo+Quercus alba+Ulmus americana+Populus deltoides+Carya illinoinensis) Ab.IgE.RAST class
24490-5,(Juniperus sabinoides+Quercus alba+Ulmus americana+Populus deltoides+Prosopis juliflora) Ab.IgE.RAST class
24491-3,(Quercus alba+Ulmus americana+Platanus acerifolia+Salix caprea+Populus deltoides) Ab.IgE
24492-1,(Quercus alba+Ulmus americana+Platanus acerifolia+Salix caprea+Populus deltoides) Ab.IgE.RAST class
24493-9,(Ambrosia psilostachya+Artemisia vulgaris+Atriplex lentiformis+Chenopodium album+Plantago lanceolata) Ab.IgE
24494-7,(Ambrosia psilostachya+Artemisia vulgaris+Atriplex lentiformis+Chenopodium album+Plantago lanceolata) Ab.IgE.RAST class
24495-4,(Chicken feather+Duck feather+Goose feather+Turkey feather) Ab.IgE.RAST class
24496-2,(Avena sativa+Hordeum vulgare+Oryza sativa+Secale cereale+Triticum aestivum+Zea mays) Ab.IgE.RAST class
Jul-49,Hydroxyproline.free
24497-0,Canary serum proteins Ab
24498-8,Chicken serum Ab
24499-6,Cryptostroma corticale Ab
24500-1,Parrot serum Ab
24501-9,Parrot droppings Ab
24502-7,Parakeet serum Ab
24503-5,Parakeet droppings Ab
24504-3,Pullularia sp Ab
May-50,Hydroxyproline.free
24505-0,Pigeon droppings Ab
24506-8,(Blatella germanica+Dermatophagoides farinae+Dermatophagoides pteronyssinus+House dust Hollister Stier) Ab.IgE.RAST class
24507-6,Aspergillus clavatus Ab
24508-4,Aspergillus nidulans Ab
24509-2,Aspergillus terreus Ab
245-1,Floxacillin
24510-0,Vespa crabro Ab.IgE.RAST class
24511-8,Pascopyrum smithii Ab.IgE
24512-6,(Citharexylum caudatum+Juniperus monosperma+Juniperus scopulorum) Ab.IgE
Mar-51,Hydroxyproline
24513-4,(Citharexylum caudatum+Juniperus monosperma+Juniperus scopulorum) Ab.IgE.RAST class
24514-2,Maple syrup Ab.IgE.RAST class
24515-9,(Anthoxanthum odoratum+Cynodon dactylon+Lolium perenne+Phleum pratense+Sorghum halepense) Ab.IgE
24516-7,Pascopyrum smithii Ab.IgE.RAST class
24517-5,Phoma sp Ab.IgG
24518-3,Calcium/Creatinine
24519-1,Phosphate
24520-9,Phosphate
Jan-52,Hypoxanthine
24521-7,EPINEPHrine
24522-5,EPINEPHrine/Creatinine
24523-3,Norepinephrine/Creatinine
24524-1,DOPamine/Creatinine
24525-8,Cardiac output/Body surface area
24526-6,Cardiac output
24527-4,Myocardial mass
24528-2,Myocardial mass
24529-0,End-systolic volume
24530-8,End-systolic volume
24531-6,Multisection
24532-4,Multisection
24533-2,Multisection^W contrast IV
24534-0,Multisection
24535-7,Views
24536-5,Views
24537-3,Guidance for aspiration of amniotic fluid
24538-1,Multisection
Sep-53,Hypoxanthine
24539-9,Multisection^WO & W contrast IV
24540-7,Views 2
24541-5,Views
24542-3,Multisection
24543-1,Guidance for angioplasty^W contrast IA
24544-9,Multisection
24545-6,Multisection^W contrast IV
24546-4,Views^W contrast IA
Jul-54,Hypoxanthine phosphoribosyltransferase
24547-2,Multisection
24548-0,Multisection
24549-8,Multisection^W contrast IV
24550-6,Views^W contrast IV
24551-4,Views^W contrast IA
24552-2,Views^W contrast intra stent
24553-0,Guidance for removal of embolus^W contrast IV
Apr-55,Hypoxanthine phosphoribosyltransferase
24554-8,Guidance for embolization^W contrast IA
24555-5,Guidance for placement of stent
24556-3,Multisection
24557-1,Multisection^WO & W contrast IV
24558-9,Multisection
24559-7,Guidance for drainage+placement of drainage catheter
24560-5,View AP L-lateral-decubitus
24561-3,View AP L-lateral-decubitus
Feb-56,Iduronate-2-Sulfatase
24562-1,Views L-lateral-decubitus + R-lateral-decubitus
24563-9,View AP R-lateral-decubitus
24564-7,View AP upright
24565-4,Views AP (KUB & upright) & upright chest
24566-2,Multisection
24567-0,Multisection^W contrast
24568-8,Guidance for atherectomy^W contrast IV
24569-6,Views^W contrast IV
2457-0,IgA
24570-4,Guidance for removal of calculus^W contrast retrograde intra biliary
24571-2,Views for patency of biliary structures+ejection fraction^W sincalide+W radionuclide IV
24572-0,Views for patency of biliary structures^W Tc-99m IV
24573-8,Views^W contrast IV
24574-6,Views^during surgery W contrast biliary duct
24575-3,Views^W contrast percutaneous transhepatic
24576-1,Views^W contrast IA
24577-9,Views^during surgery
24578-7,Multisection^W radionuclide IV
24579-5,Views survey
24580-3,Guidance for angioplasty^W contrast IA
24581-1,Views^W contrast IA
24582-9,Multisection
24583-7,Multisection^WO & W contrast IV
24584-5,Multisection^W contrast IV
24585-2,Guidance for stereotactic biopsy^W contrast IV
24586-0,Multisection^W anesthesia
24587-8,Multisection^WO & W contrast IV
Aug-58,IgA
24588-6,Multisection^WO & W contrast IV+W anesthesia
24589-4,Multisection^W contrast IV
24590-2,Multisection
24591-0,Views brain death protocol^W Tc-99m HMPAO IV
24592-8,Views^W 99m Tc DISIDA or MIBIDA
24593-6,Multisection^W contrast IV
24594-4,Guidance for percutaneous aspiration of cyst
24595-1,Guidance for needle localization of mass
Jun-59,IgA.monoclonal
24596-9,Multisection
24597-7,Views
24598-5,Guidance for percutaneous aspiration of fluid
24599-3,Multisection limited
24600-9,Guidance for needle localization
24601-7,Multisection
24602-5,Guidance for percutaneous biopsy
24603-3,Guidance for percutaneous biopsy
Apr-60,IgD
24604-1,Views limited diagnostic
24605-8,Views diagnostic
24606-6,Views screening
24609-0,Guidance for percutaneous biopsy.core needle
24610-8,Views limited
24611-6,Confirmatory consultation note
Feb-61,IgD.monoclonal
24612-4,Views
24613-2,Guidance for placement of catheter in artery
24614-0,Guidance for angioplasty^W contrast IA
24615-7,Guidance for angioplasty^W contrast IA
24616-5,Multisection
24617-3,Views^W contrast IA
24619-9,Views
2462-0,IgE
24620-7,Views for patency check^W contrast via catheter
24621-5,Guidance for percutaneous drainage+placement of drainage catheter
24622-3,Views^W contrast IA
24623-1,Guidance for nerve block
24624-9,Guidance for change of central venous catheter^W contrast IV
24625-6,Guidance for placement of central venous catheter^W contrast IV
24626-4,Guidance for reposition of central venous catheter^W contrast IV
24627-2,Multisection
24628-0,Multisection^W contrast IV
24629-8,Multisection
24630-6,Multisection
24631-4,Views for placement check of central venous catheter
24632-2,Views AP
24634-8,Views^W inspiration + W expiration
24635-5,Views PA upright^W inspiration + W expiration
24636-3,View AP L-lateral-decubitus
24637-1,View AP L-lateral-decubitus
Aug-63,IgE.monoclonal
24638-9,View L-lateral upright
24639-7,View L-lateral upright
24640-5,View apical lordotic
24641-3,View L-oblique
24642-1,Views AP + PA upright
24643-9,Views PA + lateral + oblique upright
24644-7,Views PA + lateral upright
24645-4,Views PA + R-lateral + R-oblique + L-oblique upright
Jun-64,IgG
24646-2,Views PA + R-lateral + R-oblique + L-oblique upright
24647-0,Views PA + lateral upright
24648-8,View PA upright
24649-6,Views R-lateral-decubitus + L-lateral-decubitus
24650-4,Views R-lateral-decubitus + L-lateral-decubitus
24651-2,Views R-oblique + L-oblique upright
24652-0,View AP R-lateral-decubitus
Mar-65,IgG
24653-8,Views AP + AP R-lateral-decubitus
24654-6,Views AP + AP R-lateral-decubitus
24655-3,Image intensifier^during surgery
24656-1,View^during surgery
24657-9,Multisection
24658-7,Views^W contrast IA
24659-5,Multisection^W contrast IV
24660-3,Multisection
Jan-66,IgG subclass 1
24661-1,Views^W contrast intra pleural space
24662-9,Guidance for percutaneous aspiration of fluid
24663-7,Views^W radionuclide IT
24664-5,Views
24665-2,Views
24666-0,Views^W air contrast PR+W barium contrast PR
24667-8,Views^W contrast PR
24668-6,View for transit^post solid contrast PO
24669-4,Views^W water soluble contrast PR
24670-2,Guidance for biopsy of cyst
24671-0,Guidance for percutaneous aspiration of cyst
24672-8,Multisection for motion
24673-6,Views^W contrast PO+hypotonic agent per ng
24674-4,Multisection
24675-1,Multisection^WO & W contrast IV
24676-9,Views
24677-7,Multisection transvaginal
24678-5,Views^W contrast PO
Sep-67,IgG subclass 2
24679-3,Views^W gastrografin PO
24680-1,Guidance for dilation
24681-9,Views^W contrast PO+during swallowing
24682-7,Views^W liquid contrast PO+W paste contrast PO+during swallowing
24683-5,Views^W Tc-99m SC PO
24684-3,Guidance for removal of embolus^W contrast IA
24685-0,Views^W contrast IV
24686-8,Views
Jul-68,IgG subclass 3
24687-6,Multisection
24688-4,Multisection
24689-2,Views
246-9,Floxacillin
24690-0,Multisection
24691-8,Multisection^W contrast IV
24692-6,Guidance for drainage+placement of drainage catheter
24693-4,Multisection
24694-2,Multisection^WO & W contrast IV
May-69,IgG subclass 4
24695-9,Views
24696-7,Multisection
24697-5,Multisection^W contrast IV
24698-3,Guidance for angioplasty^W contrast IA
24699-1,View runoff^W contrast IA
24700-7,Views for leg length
24701-5,Views for bone density
24702-3,Multisection
Mar-70,IgG/Albumin
24703-1,Multisection^WO & W contrast IV
24704-9,Views
24705-6,Multisection
24706-4,Views
24707-2,Multisection
24708-0,Views^W standing
24709-8,Views
24710-6,Multisection
Jan-71,IgM
24711-4,Multisection
24712-2,Views^W contrast PO
24713-0,Views^48H post contrast PO intrabiliary
24714-8,Views for gastrointestinal bleeding^W Tc-99m tagged RBC IV
24715-5,View^W contrast PO
24716-3,Guidance for placement of decompression tube
24717-1,Loopogram
24718-9,Guidance for transjugular biopsy^W contrast IV
24719-7,Multisection
24720-5,Multisection
24721-3,Views 2
24722-1,Views 3
24723-9,View arthritis
24724-7,Views bone age
24725-4,Multisection
24726-2,Multisection^WO & W contrast IV
24727-0,Multisection^W contrast IV
24728-8,Multisection
Sep-72,IgM
24729-6,Multisection^WO & W contrast IV
24730-4,Views^W radionuclide IV
24731-2,Multisection
24732-0,Multisection^during surgery
24733-8,Multisection
24734-6,Multisection^W contrast IT
24735-3,Multisection
Jul-73,IgM.monoclonal
24740-3,Multisection^WO & W contrast IV
May-74,Indicans
24745-2,Views
24746-0,Multisection
24747-8,Multisection^W contrast IV
24748-6,Multisection
24750-2,Views^at rest+W Tl-201 IV
24751-0,Views^W TI-201 subtraction Tc-99m IV
Feb-75,Indicans
24752-8,Views
24753-6,Multisection^W contrast IV
24754-4,Administration of vasodilator into catheter
24755-1,Guidance for atherectomy^W contrast IV
24756-9,Guidance for placement of stent
24757-7,Multisection
2476-0,Indolamine
24760-1,Multisection
24761-9,View
24762-7,Views
24764-3,Views^W contrast IS
24765-0,Views 2
24766-8,Guidance for angioplasty^W contrast IA
24767-6,Multisection
24769-2,Guidance for injection
247-7,Floxacillin
24770-0,Views^W In-111 intrajoint
24771-8,Guidance for percutaneous aspiration of fluid
24772-6,Guidance for percutaneous biopsy
24773-4,Views^W radionuclide transplant scan
24774-2,Multisection
24775-9,Multisection^W contrast IV
24776-7,Views^W radionuclide IV
24777-5,Multisection
Aug-77,Indole
24778-3,Views 3 serial^WO & W contrast IV
24779-1,Guidance for percutaneous placement of nephrostomy tube^W contrast via tube
24780-9,Views^W contrast via nephrostomy tube
24781-7,Guidance for percutaneous exchange of nephrostomy tube^W contrast
24782-5,Guidance for percutaneous placement of nephroureteral stent^W contrast via stent
24783-3,Views for urodynamics
24784-1,Multisection^WO & W contrast IV
24785-8,View 1
Jun-78,Inhibin
24786-6,Multisection^W & WO contrast IV
24787-4,Multisection^WO contrast+10M post contrast IV
24788-2,Views^W contrast IV
24789-0,Multisection
24790-8,Multisection^W contrast IV
24791-6,Multisection
24792-4,Views AP + AP L-lateral-decubitus
24793-2,Views AP + lateral
Apr-79,Inosine
24794-0,Views AP + lateral
24795-7,Views supine + upright
24796-5,Views AP + AP L-lateral-decubitus
24797-3,Views AP + oblique prone
24798-1,Views supine + upright
24799-9,View AP
24800-5,Views^W contrast IS
24801-3,View Merchants
Feb-80,Inositol.free
24802-1,Multisection
24803-9,Multisection^WO & W contrast IV
24804-7,Views^W radionuclide IV
24805-4,Views AP + lateral^W standing
24806-2,Views 2
24807-0,View AP^W standing
24808-8,Views AP + PA^W standing
24809-6,Views^W standing
2481-0,Insulin Ab
24811-2,Guidance for percutaneous aspiration of fluid
24812-0,Guidance for percutaneous biopsy
24813-8,Guidance for biopsy.core needle
24814-6,Multisection
24815-3,Multisection^W contrast IV
24816-1,Guidance for percutaneous biopsy
24817-9,Multisection^W Tc-99m IV
24818-7,Multisection
24819-5,Views^W Tc-99m calcium colloid IV
24820-3,Multisection^W contrast IV
24821-1,Multisection
24822-9,Guidance for percutaneous aspiration of fluid
24823-7,Guidance for percutaneous biopsy
24824-5,Views portable^W radionuclide IV
24825-2,Views^W contrast intrabronchial
24826-0,Views^W radionuclide intra lymphatic
24827-8,Views^W contrast intra lymphatic
Aug-82,Insulin Ab
24828-6,View panoramic
24829-4,Views
24830-2,Views
24831-0,Views for Meckel's diverticulum^W Tc-99m M04 IV
24832-8,Guidance for angioplasty^W contrast IA
24833-6,Views^W contrast IA
24834-4,Views
24835-1,Multisection
Jun-83,Insulin-like growth factor binding protein 3
24836-9,Multisection^W contrast IV
24837-7,Guidance for percutaneous aspiration of fluid
24838-5,Guidance for percutaneous biopsy
24839-3,Multisection
24840-1,Multisection^WO & W contrast IV
24841-9,Multisection^W contrast IV
24842-7,Multisection
24843-5,View lateral
Apr-84,Insulin-like growth factor-I
24844-3,Multisection^W contrast IV
24845-0,Views^W contrast intra larynx
24846-8,Views
24848-4,Multisection
24849-2,Multisection^WO & W contrast IV
248-5,Fluconazole
24850-0,Multisection^W contrast IV
Jan-85,Insulin-like growth factor-II
24851-8,Multisection^WO & W contrast IV
24852-6,Multisection^W contrast IV
24853-4,Multisection
24854-2,Views
24855-9,Views
24856-7,Guidance for percutaneous aspiration of fluid
24857-5,Multisection
24858-3,Multisection^W contrast IV
24859-1,Multisection
24860-9,Views^W contrast IA
24861-7,Views 2
24862-5,Views^W contrast IA
24863-3,Guidance for percutaneous aspiration of fluid
24864-1,Guidance for percutaneous biopsy
24865-8,Multisection
24866-6,Multisection^W contrast IV
24867-4,Multisection
24868-2,Guidance for drainage+placement of drainage catheter
Sep-86,Somatomedins
24869-0,Multisection
24870-8,Multisection
24871-6,View pelvimetry
24872-4,Multisection
24873-2,Multisection^W contrast IV
24874-0,Views^W contrast IA
24875-7,Peripheral plane
24876-5,Views for shunt patency^W Tc-99m DTPA IT
Jul-87,Inter alpha trypsin inhibitor
24877-3,Multisection
24878-1,Multisection^W contrast IV
24879-9,Multisection^WO & W contrast IV
24880-7,Multisection
24881-5,Multisection
24882-3,Guidance for percutaneous transluminal angioplasty^W contrast IA
24883-1,Guidance for percutaneous biopsy
24884-9,Multisection transrectal
May-88,Intrinsic factor
24885-6,Guidance for repair
24886-4,Views^W contrast in pulmonary artery
24887-2,Guidance for removal of embolus^W contrast IA
24888-0,Views ventilation+perfusion^W Xe-133 IH+W Tc-99m MAA IV
24889-8,Multisection for pyloric stenosis
24890-6,Views for bone density
24891-4,Views
24892-2,Multisection
Mar-89,Intrinsic factor blocking Ab
24893-0,View^post contrast PR+during defecation
24894-8,Views^W contrast PR+W contrast intra bladder+during defecation+during voiding
24896-3,Guidance for drainage+placement of drainage catheter
24899-7,Views
24900-3,Views
Jan-90,Inulin
24901-1,Guidance for injection
24902-9,Views^W contrast intra salivary duct
24903-7,Views
24904-5,Multisection^WO & W contrast IV
24905-2,Multisection
24906-0,Multisection^WO & W contrast IV
24907-8,Multisection
24908-6,Views 3
24909-4,Views
24910-2,Views^W contrast IS
24911-0,Views
24912-8,Views^W contrast intra sinus tract
24913-6,Multisection limited
24914-4,Multisection
24915-1,Multisection^W contrast IV
24916-9,Views
24917-7,View
24918-5,Views 3
Sep-91,Inulin renal clearance
24919-3,Views AP + lateral
24920-1,View lateral
24921-9,View Waters
24922-7,Views 5
24923-5,Views^W positive contrast via enteroclysis tube
24924-3,Views^W contrast PO
24925-0,Views^W contrast IA
24926-8,Multisection
Jul-92,Iodine
24927-6,Views^W contrast intradisc
24928-4,Views AP + lateral
24929-2,Views for scoliosis^W flexion + W extension
249-3,Fluconazole
24930-0,Views for scoliosis
24931-8,Guidance for injection
24932-6,Multisection
24933-4,Multisection^W contrast IV
24934-2,Multisection^W contrast IT
May-93,Iodine.free
24935-9,Multisection
24936-7,Multisection^W anesthesia
24937-5,Multisection^WO & W contrast IV
24938-3,Multisection^W contrast IV
24939-1,Views 5
24940-9,View
24941-7,Views 3
24942-5,Views AP + lateral
Mar-94,Iodine
24943-3,View lateral
24944-1,View Swimmers
24945-8,Views^W flexion + W extension
24946-6,Views
24947-4,Views^W contrast IT
24948-2,View AP
2495-0,Iodine
24963-1,Multisection
24964-9,Multisection^W contrast IV
24965-6,Multisection^W contrast IT
24966-4,Views for bone density
24967-2,Multisection^WO & W contrast IV
Aug-96,Iodohippuran renal clearance
24968-0,Multisection
24969-8,View lateral
24970-6,Views AP + lateral
24971-4,Views^W flexion + W extension
24972-2,Views
24973-0,Guidance for percutaneous aspiration of fluid
24974-8,Views^W contrast IT
24975-5,Views
Jun-97,Iron
24977-1,Multisection^W anesthesia
24978-9,Multisection
24979-7,Multisection^W contrast IV
24980-5,Multisection
24981-3,Multisection^WO & W contrast IV
24982-1,Multisection^W contrast IV
24983-9,Views
Apr-98,Iron
24984-7,Views 2
24985-4,Views^W contrast IT
24986-2,Guidance for percutaneous biopsy
24987-0,Multisection^W contrast IV
24988-8,Multisection
24989-6,Multisection^WO & W contrast IV
24990-4,Multisection
24991-2,Views^W contrast IA
Feb-99,Iron
24992-0,Views^W contrast IA
24993-8,Views
24994-6,Views
24995-3,Guidance for placement of tube
24996-1,Guidance for percutaneous replacement of gastrostomy
24997-9,Views for gastric emptying solid phase^W Tc-99m SC PO
24998-7,Views for placement check of gastrostomy tube^W contrast via GI tube
24999-5,Multisection
25000-1,Views
25001-9,Views^W Tc-99m pertechnetate IV
25002-7,Multisection
25003-5,Multisection^W contrast IV
25004-3,Multisection
25005-0,Views^W contrast
25006-8,Views
Jul-00,Iron binding capacity
25007-6,Views^W I-131 IV
25008-4,Views+views uptake^W I-131 IV
25009-2,Guidance for percutaneous biopsy
250-1,Fluconazole
25010-0,Multisection
25011-8,Views
25012-6,Guidance for angioplasty^W contrast IA
25013-4,Views
25014-2,Views^W contrast
May-01,Iron binding capacity.unsaturated
25015-9,Replacement of percutaneous gastrojejunostomy
25016-7,Views^W contrast intra urethra
25017-5,Views^W contrast intra bladder
25018-3,Views^W radionuclide IV
25019-1,Multisection
25020-9,Views^W contrast retrograde via urethra
25021-7,Views^W voiding
25022-5,Views^W contrast IU
Mar-02,Iron saturation
25023-3,Views^W contrast IV
25024-1,Guidance for placement of peripherally-inserted central venous catheter
25025-8,Views^W contrast IV
25026-6,Guidance for placement of venous filter^W contrast IV
25027-4,Guidance for placement of large bore central venous catheter
25028-2,Guidance for placement of catheter for infusion of thrombolytic^W contrast intravascular
25029-0,Guidance for placement of catheter for vasoconstrictor infusion
25030-8,Views^W contrast IA
Jan-03,Iron.chelated
25031-6,Views^W radionuclide IV
25032-4,Views^W In-111 tagged WBC IV
25033-2,Multisection
25034-0,Views^W contrast IS
25035-7,Multisection^WO & W contrast IV
25036-5,Multisection
25037-3,Views
25038-1,Courtesy consultation.XXX
25039-9,Multisection limited
25040-7,Multisection
25041-5,Guidance for aspiration or biopsy^W contrast IV
25042-3,Guidance for aspiration or biopsy
25043-1,Guidance for percutaneous aspiration of fluid
25044-9,Guidance for percutaneous biopsy
25045-6,Multisection
25046-4,Multisection^W anesthesia
25047-2,Multisection^W conscious sedation
Sep-04,Iron
25049-8,Views multiple sagittal & coronal
25050-6,Multisection sagittal & coronal disarticulation
25051-4,Multisectional sagittal
25052-2,Multisection sagittal & coronal
25053-0,Guidance for radiosurgery
25054-8,Guidance for radiosurgery^W contrast IV
25055-5,Multisection additional sequence
Jun-05,Iron/Iron binding capacity.total
25056-3,Multisection
25057-1,Multisection^W conscious sedation
25058-9,Multisection^W contrast IV
25059-7,Guidance for percutaneous biopsy
25060-5,No charge
25061-3,Multisection
25062-1,View comparison
25063-9,View^W contrast IA
Apr-06,Isocitrate dehydrogenase
25064-7,Views for angioplasty^W contrast IA
25065-4,View
25066-2,View
25067-0,View
25068-8,View
25069-6,Guidance for percutaneous biopsy
25070-4,Views^during surgery
25071-2,Multisection
Feb-07,Isoleucine
25072-0,Guidance for placement of infusion port
25073-8,Guidance for removal of foreign body
25074-6,Views
25076-1,Views^W contrast IA
25077-9,Guidance for placement of catheter^W contrast IA
25078-7,Guidance for placement of stent
25079-5,Views^W contrast IA
2508-0,Isoleucine
25080-3,Views for renin sampling^W contrast IV
25081-1,Guidance for angioplasty^W contrast IA
25082-9,2-Methyl-3-Hydroxybutyrate/Creatinine
25083-7,"2-Oxo,3-Methylvalerate/Creatinine"
25084-5,2-Oxoisocaproate/Creatinine
25085-2,2-Oxoisovalerate/Creatinine
25086-0,Beta aminoisobutyrate/Creatinine
25087-8,3-Methylglutaconate/Creatinine
25088-6,4-Hydroxyphenylacetate/Creatinine
25089-4,4-Hydroxyphenyllactate/Creatinine
25090-2,Benzoate/Creatinine
25091-0,C peptide/Creatinine
25092-8,Cystathionine/Creatinine
25093-6,Decadienediate/Creatinine
25094-4,Decenedioate/Creatinine
25095-1,Deoxypyridinoline/Creatinine
25096-9,Deoxypyridinoline/Creatinine
25097-7,Dodecanedioate/Creatinine
Aug-09,Isoleucine
25098-5,Ethanolamine/Creatinine
25099-3,Ethylmalonate/Creatinine
25100-9,Formate/Creatinine
25101-7,Fumarate/Creatinine
25102-5,Galactose/Creatinine
25103-3,Glutaconate/Creatinine
25104-1,Glutarate/Creatinine
25105-8,Glycerate/Creatinine
Jun-10,Isoleucine
25106-6,Glycolate/Creatinine
25107-4,Glyoxylate/Creatinine
25108-2,Hydroxydecanedioate/Creatinine
25109-0,Hydroxylysine/Creatinine
25110-8,Hydroxyproline/Creatinine
25111-6,Isocitrate/Creatinine
25112-4,Lactate/Creatinine
25113-2,Malate/Creatinine
Apr-11,Keratan sulfate
25114-0,2-Methylcitrate/Creatinine
25115-7,Methylmalonate/Creatinine
25116-5,Methylmalonate/Creatinine
25117-3,Methylsuccinate/Creatinine
25118-1,Mevalonate/Creatinine
25119-9,N-acetyltyrosine/Creatinine
25120-7,Octanoate/Creatinine
25121-5,Octenedioate/Creatinine
Feb-12,Keratan sulfate
25122-3,Phosphoethanolamine/Creatinine
25123-1,Para nitrophenol/Creatinine
25124-9,Phenylacetate/Creatinine
25125-6,Phenyllactate/Creatinine
25126-4,Phenylpyruvate/Creatinine
25127-2,Phosphate/Creatinine
25128-0,Phosphoserine/Creatinine
25129-8,Pyridinoline/Creatinine
2513-0,Ketones
25130-6,Pyridinoline/Creatinine
25131-4,Pyridinoline/Creatinine
25132-2,Pyruvate/Creatinine
25133-0,Sarcosine/Creatinine
25134-8,Sebacate/Creatinine
25135-5,Suberate/Creatinine
25136-3,Succinate/Creatinine
25137-1,Succinylacetone/Creatinine
25138-9,Taurine/Creatinine
25139-7,Tryptophan/Creatinine
25140-5,Uracil/Creatinine
25141-3,Carnitine esters/Creatinine
25142-1,5-Fluorocytosine^peak
25143-9,5-Fluorocytosine^trough
25144-7,Ammonium urate crystals
25145-4,Bacteria
25146-2,Bilirubin crystals
25147-0,Calcium carbonate crystals
Aug-14,Ketones
25148-8,Calcium oxalate crystals
25149-6,Calcium phosphate crystals
25150-4,Calcium sulfate crystals
25153-8,Cholesterol crystals
25154-6,Crystals.unidentified
May-15,Kynurenate
25155-3,Cystine crystals
25156-1,Eosinophils
25157-9,Epithelial casts
25158-7,Oval fat bodies (globules)
25159-5,Fatty casts
25160-3,Granular casts
25161-1,Hippurate crystals
25162-9,Hyaline casts
Mar-16,L-iditol dehydrogenase
25163-7,Leucine crystals
25164-5,Cells.CD21
25165-2,Cells.CD23
25166-0,Uroporphyrin
25167-8,Coproporphyrin
25168-6,Perhexiline
25169-4,Nickel
25170-2,Mercury
Jan-17,L-iditol dehydrogenase
25171-0,Bromide
25172-8,Fluoride
25173-6,Thallium
25174-4,Amikacin 8.0 ug/mL
25175-1,Amikacin 16.0 ug/mL
25176-9,Amikacin 32.0 ug/mL
25177-7,Amikacin 12.0 ug/mL
25178-5,Amikacin 30.0 ug/mL
25179-3,Amikacin 6.0 ug/mL
25180-1,Ciprofloxacin 2.0 ug/mL
25181-9,Ciprofloxacin 4.0 ug/mL
25182-7,Kanamycin 5.0 ug/mL
25183-5,Ethionamide 11.0 ug/mL
25184-3,rifAMPin 14.0 ug/mL
25185-0,Streptomycin 6.0 ug/mL
25186-8,Pyrazinamide 25.0 ug/mL
25187-6,Ethambutol 7.5 ug/mL
25188-4,Ciprofloxacin 8.0 ug/mL
Sep-18,Lactate
25189-2,Ciprofloxacin 5.0 ug/mL
251-9,Fluconazole
25190-0,Clarithromycin 8.0 ug/mL
25191-8,Clarithromycin 16.0 ug/mL
25192-6,Clarithromycin 32.0 ug/mL
25194-2,Ethambutol 5.0 ug/mL
25195-9,Ethambutol 10.0 ug/mL
25196-7,Ethionamide 5.0 ug/mL
Jul-19,Lactate
25198-3,Ethionamide 15.0 ug/mL
25199-1,Rifabutin 1.0 ug/mL
25200-7,Rifabutin 2.0 ug/mL
25201-5,Rifabutin 4.0 ug/mL
25202-3,rifAMPin 1.0 ug/mL
25203-1,rifAMPin 2.0 ug/mL
25204-9,rifAMPin 5.0 ug/mL
May-20,Lactate
25205-6,Streptomycin 2.0 ug/mL
25206-4,Streptomycin 10.0 ug/mL
25207-2,cycloSERINE 10.0 ug/mL
25208-0,cycloSERINE 20.0 ug/mL
25209-8,cycloSERINE 30.0 ug/mL
25210-6,Capreomycin 10.0 ug/mL
25211-4,Capreomycin 20.0 ug/mL
25212-2,Capreomycin 30.0 ug/mL
Mar-21,Lactate
25213-0,Kanamycin 6.0 ug/mL
25214-8,Kanamycin 30.0 ug/mL
25215-5,Para aminosalicylate 2.0 ug/mL
25216-3,Para aminosalicylate 8.0 ug/mL
25217-1,Isoniazid 0.1 ug/mL
25218-9,Isoniazid 0.2 ug/mL
25219-7,Isoniazid 1.0 ug/mL
25220-5,cefOXitin 30.0 ug/mL
Jan-22,Lactate
25221-3,Imipenem 10.0 ug/mL
25222-1,Cefmetazole 30.0 ug/mL
25223-9,Doxycycline 30.0 ug/mL
25224-7,Erythromycin 15.0 ug/mL
25225-4,Minocycline 30.0 ug/mL
25226-2,sulfiSOXAZOLE 300.0 ug/mL
25227-0,Tobramycin 10.0 ug/mL
25228-8,Vancomycin 30.0 ug/mL
25229-6,Pyrazinamide 100.0 ug/mL
25230-4,Ethambutol 2.5 ug/mL
25231-2,Ethionamide 10.0 ug/mL
25232-0,Nafcillin
25233-8,Azithromycin
25234-6,Aztreonam
25235-3,ceFAZolin
25236-1,Cefixime
25237-9,Cefonicid
25238-7,Cefotaxime
Sep-23,Lactate
25239-5,cefoTEtan
25240-3,cefOXitin
25241-1,Cefpodoxime
25242-9,Cefsulodin
25243-7,Ceftizoxime
25244-5,cefTRIAXone
25245-2,Cefuroxime.parenteral
25246-0,Cephalothin
Jul-24,Lactate
25247-8,Chloramphenicol
25248-6,Ciprofloxacin
25249-4,Clindamycin
25250-2,Cloxacillin
25251-0,cycloSERINE
25252-8,Dicloxacillin
25253-6,Clarithromycin
Apr-25,Lactate
25254-4,Ticarcillin
25255-1,Fluconazole
25256-9,Ganciclovir
25257-7,Imipenem
25258-5,Itraconazole
25259-3,Ketoconazole
25261-9,Nalidixate
Feb-26,Lactate
25262-7,Neomycin
25263-5,Netilmicin
25264-3,Ofloxacin
25265-0,Oxacillin
25266-8,Oxytetracycline
25267-6,Penicillin
25268-4,Piperacillin
25269-2,Polymyxin B
252-7,5-Fluorocytosine
2527-0,Lactate dehydrogenase
25270-0,Pyrazinamide
25271-8,Sulfamethoxazole
25272-6,Tetracycline
25273-4,Trimethoprim+Sulfamethoxazole
25274-2,Amoxicillin
25275-9,Erythromycin
25276-7,Streptococcus pneumoniae 9 Ab.IgG^2nd specimen/1st specimen
25277-5,Streptococcus pneumoniae 8 Ab.IgG^2nd specimen/1st specimen
25278-3,Streptococcus pneumoniae Danish serotype 7F Ab.IgG^2nd specimen/1st specimen
25279-1,Streptococcus pneumoniae Danish serotype 6B Ab.IgG^1st specimen
25280-9,Streptococcus pneumoniae Danish serotype 6B Ab.IgG^2nd specimen/1st specimen
25281-7,Streptococcus pneumoniae 4 Ab.IgG^2nd specimen/1st specimen
25282-5,Streptococcus pneumoniae 3 Ab.IgG^2nd specimen/1st specimen
25283-3,Streptococcus pneumoniae 23 Ab.IgG^2nd specimen/1st specimen
25284-1,Streptococcus pneumoniae 19 Ab.IgG^2nd specimen/1st specimen
25285-8,Streptococcus pneumoniae Danish serotype 18C Ab.IgG^2nd specimen/1st specimen
25286-6,Streptococcus pneumoniae 1 Ab.IgG^2nd specimen/1st specimen
25287-4,Streptococcus pneumoniae 19 Ab.IgG^1st specimen
Aug-28,Lactate dehydrogenase
25288-2,Streptococcus pneumoniae 19 Ab.IgG^2nd specimen
25289-0,Streptococcus pneumoniae Danish serotype 18C Ab.IgG^2nd specimen
25290-8,Streptococcus pneumoniae 14 Ab.IgG^1st specimen
25291-6,Streptococcus pneumoniae 14 Ab.IgG^2nd specimen
25292-4,Streptococcus pneumoniae 12 Ab.IgG^1st specimen
25293-2,Streptococcus pneumoniae 12 Ab.IgG^2nd specimen
25294-0,Streptococcus pneumoniae 1 Ab.IgG^2nd specimen
25295-7,Streptococcus pneumoniae Danish serotype 6B Ab.IgG
Jun-29,Lactate dehydrogenase
25296-5,Streptococcus pneumoniae Danish serotype 7F Ab.IgG
25297-3,Parainfluenza virus 1 Ab^2nd specimen
25298-1,Rubella virus Ab.IgG^1st specimen/2nd specimen
25299-9,Measles virus Ab.IgG^1st specimen/2nd specimen
25300-5,Toxoplasma gondii Ab.IgG^1st specimen/2nd specimen
25301-3,Alanine
25302-1,Alanine aminotransferase
25303-9,Alpha 1 antitrypsin
Apr-30,Lactate dehydrogenase
25304-7,Alpha aminoadipate
25305-4,Alpha aminobutyrate
25306-2,Alternaria alternata Ab.IgG
25307-0,Alternaria alternata Ab.IgG.RAST class
25308-8,Ammonia
25309-6,Amobarbital
25310-4,Amoxicillin+Clavulanate
25311-2,Amylase
Feb-31,Lactate dehydrogenase
25312-0,Amylase.pancreatic/Amylase.total
25313-8,Amylase.salivary/Amylase.total
25314-6,Androstenediol
25315-3,11-Deoxycortisol
25316-1,17-Hydroxypregnenolone
25317-9,17-Ketosteroids
25318-7,1-Methylhistidine
25319-5,3-Methylhistidine
2532-0,Lactate dehydrogenase
25320-3,Anserine
25321-1,Antimony
25322-9,Arginine
25323-7,Arsenic
25324-5,Arsenic/Creatinine
25325-2,Ascaris sp Ab.IgE
25326-0,Asparagine
25327-8,Aspartate
25328-6,Aspergillus versicolor Ab.IgE.RAST class
25329-4,Aureobasidium pullulans Ab.IgE.RAST class
25331-0,Bordetella pertussis Ab.IgG
25332-8,Bordetella pertussis Ab.IgM
25333-6,Campylobacter fetus Ab
25335-1,Coxiella burnetii Ab.IgG
25336-9,Coxiella burnetii Ab.IgM
25337-7,Taenia solium larva Ab.IgG
Aug-33,Lactate dehydrogenase
25338-5,Dengue virus Ab.IgM
25339-3,Echinococcus sp Ab
25342-7,Fasciola sp Ab
25343-5,Fasciola sp Ab.IgG
25344-3,Filaria Ab
25345-0,Beet red Ab.IgE.RAST class
Jun-34,Lactate dehydrogenase
25346-8,Beta alanine
25347-6,Filaria Ab.IgG
25348-4,Beta aminoisobutyrate
25349-2,Betula verrucosa Ab.IgG
253-5,5-Fluorocytosine
25350-0,Betula verrucosa Ab.IgG.RAST class
25351-8,Bismuth
25352-6,Bordetella pertussis Ab.IgG
Mar-35,Lactate dehydrogenase 1
25353-4,Bordetella pertussis Ab.IgM
25354-2,Bran wheat Ab.IgG
25355-9,Bran wheat Ab.IgG.RAST class
25356-7,Budgerigar droppings Ab.IgE.RAST class
25357-5,Butabarbital
25358-3,C peptide
25359-1,Cadmium
25360-9,Cadmium
Jan-36,Lactate dehydrogenase 1/Lactate dehydrogenase.total
25361-7,Caffeine
25362-5,Calcium
25363-3,Campylobacter fetus Ab
25364-1,Campylobacter jejuni Ab
25365-8,Carnosine
25366-6,cefOXitin
25367-4,cefTRIAXone
25368-2,Cheese blue Ab.IgE.RAST class
25369-0,Chlamydia sp Ab.IgA
25370-8,Chocolate Ab.IgE.RAST class
25371-6,Cholesterol.in VLDL
25372-4,Choriogonadotropin
25373-2,Choriogonadotropin.beta subunit.free
25374-0,Chromium
25375-7,Chymotrypsin
25376-5,Citrulline
25377-3,Coagulation calcium ion induced
25378-1,Cobalt
Sep-37,Lactate dehydrogenase 1
25379-9,Cobalt
25380-7,Dactylis glomerata Ab.IgE.RAST class
25381-5,Corticosterone
25382-3,Cortisone
25383-1,Cow milk Ab.IgE.RAST class
25384-9,Coxiella burnetii Ab.IgG
25385-6,Coxiella burnetii Ab.IgM
25386-4,Creatinine
Jul-38,Lactate dehydrogenase 2
25387-2,Cyanide
25388-0,Cystathionine
25389-8,Taenia solium larva Ab.IgG
25390-6,Cytokeratin 19
25391-4,Dehydroepiandrosterone
25392-2,Dengue virus Ab.IgM
25393-0,Desethylamiodarone
25394-8,Nortrimipramine
May-39,Lactate dehydrogenase 2/Lactate dehydrogenase.total
25395-5,Dog serum albumin Ab.IgE.RAST class
25396-3,Duck meat Ab.IgE.RAST class
25397-1,Echinococcus sp Ab
25398-9,Echinococcus sp Ab
25399-7,Endomysium Ab
25400-3,Entamoeba histolytica Ab
25401-1,Estradiol
25402-9,Estrogen
Mar-40,Lactate dehydrogenase 2
25403-7,Estrone
25404-5,Ethambutol
25405-2,Ethanolamine
25406-0,Fasciola sp Ab
25407-8,Fasciola sp Ab.IgG
25408-6,Trigonella foenum-graecum Ab.IgE.RAST class
25409-4,Filaria Ab
25410-2,Filaria Ab.IgG
Jan-41,Lactate dehydrogenase 3
25411-0,Fleroxacin
25412-8,Flunitrazepam
25413-6,Fluoride
25414-4,Gasterophilus intestinalis Ab.IgE.RAST class
25415-1,Folate
25416-9,Herpes virus 6 Ab.IgG
25417-7,Herpes virus 6 Ab.IgM
25418-5,Mumps virus Ab.IgG
25419-3,Mumps virus Ab.IgM
25420-1,Rubella virus Ab.IgM
25421-9,Measles virus Ab.IgM
25422-7,Schistosoma sp Ab
25423-5,Trichinella spiralis Ab.IgG
25424-3,Trypanosoma sp Ab
25425-0,Gabapentin
25426-8,Galactose
25427-6,Gamma aminobutyrate
25428-4,Glucose
Sep-42,Lactate dehydrogenase 3/Lactate dehydrogenase.total
25429-2,Glutamate
254-3,5-Fluorocytosine
25430-0,Glutamine
25431-8,Glycine
25432-6,Haemophilus influenzae Ab
25433-4,Hemoglobin.free
25434-2,Heptacarboxylporphyrin
25435-9,Herpes simplex virus Ab.IgM
Jul-43,Lactate dehydrogenase 3
25438-3,Hexacarboxylporphyrin
25439-1,Histamine
25440-9,Histidine
25441-7,Homocystine
25442-5,Horse meat Ab.IgE.RAST class
25443-3,Hydroxylysine
25444-1,IgA
May-44,Lactate dehydrogenase 4
25445-8,IgG
25446-6,IgM
25447-4,Insulin.free
25448-2,Iodine
25449-0,Iodine
25450-8,Isoleucine
25451-6,Isoniazid
Feb-45,Lactate dehydrogenase 4/Lactate dehydrogenase.total
25452-4,Itraconazole
25453-2,Lactalbumin alpha Ab.IgA
25454-0,Lactalbumin alpha Ab.IgA.RAST class
25455-7,Lactoglobulin Ab.IgA
25456-5,Lactoglobulin Ab.IgA.RAST class
25457-3,Lactoglobulin Ab.IgE.RAST class
25458-1,lamoTRIgine
25459-9,Lead
2546-0,Lactate dehydrogenase 4
25460-7,Leucine
25461-5,Lithium
25462-3,Lithium
25463-1,Lithium
25464-9,Lysine
25465-6,Maleic anhydride Ab.IgE.RAST class
25466-4,Manganese
25467-2,Manganese
25468-0,Mephenytoin
25469-8,Meprobamate
25470-6,Mercury
25471-4,Mercury
25472-2,Mesoridazine
25473-0,Metanephrine
25474-8,Metanephrines
25475-5,Methaqualone
25476-3,Methionine
25477-1,Methionine sulfoxide
Aug-47,Lactate dehydrogenase 5
25478-9,Methyprylon
25479-7,Saccharopolyspora rectivirgula Ab.IgG
25480-5,Saccharopolyspora rectivirgula Ab.IgG.RAST class
25481-3,Molybdenum
25484-7,Nefazodone
25485-4,Neurospora sitophila Ab.IgE.RAST class
Jun-48,Lactate dehydrogenase 5/Lactate dehydrogenase.total
25486-2,Nickel
25487-0,Nickel
25488-8,Nicotinamide
25489-6,Normetanephrine
25490-4,Olive green Ab.IgE.RAST class
25491-2,Ornithine
25492-0,Oxipurinol
25493-8,Penicillium brevicompactum Ab.IgE.RAST class
Apr-49,Lactate dehydrogenase 5
25494-6,Pentacarboxylporphyrins
25495-3,Phenylalanine
25496-1,Triplochiton scleroxylon Ab.IgE.RAST class
25497-9,Acarus siro Ab.IgE.RAST class
25498-7,Adenosine monophosphate.cyclic
25499-5,Adrenal cortex Ab
255-0,5-Fluorocytosine
25500-0,Phenylbutazone
25501-8,Phosphate
Feb-50,Lactate/Pyruvate
25502-6,Phosphoethanolamine
25503-4,Phosphoserine
25504-2,Pinus radiata Ab.IgE.RAST class
25505-9,Pituitary glycoprotein hormone.alpha subunit
25506-7,Potassium
25507-5,Pregnenolone
25508-3,Progesterone^2nd specimen post XXX challenge
25509-1,Progesterone^3rd specimen post XXX challenge
2551-0,Lactoferrin
25510-9,Proline
25511-7,Propafenone
25512-5,Protoporphyrin
25513-3,Renin^1st specimen post XXX challenge
25514-1,Rubella virus Ab.IgG
25517-4,Crocus sativus Ab.IgE.RAST class
25518-2,Sarcosine
25520-8,Secobarbital
25521-6,Selenium
25522-4,Seminal fluid Ab.IgE.RAST class
25523-2,Serine
25524-0,Serotonin
25525-7,Serpula lacrymans Ab.IgE.RAST class
25526-5,Silicon
25527-3,Silver
Aug-52,Lactose
25528-1,Insulin-like growth factor
25529-9,Somatotropin
25530-7,Specimen weight
25531-5,Streptococcus pneumoniae Ab
25532-3,Swine serum albumin Ab.IgE.RAST class
25533-1,Taurine
25534-9,Teicoplanin^peak
25535-6,Teicoplanin^trough
Jun-53,Lactose
25536-4,Clostridium tetani toxoid Ab.IgE.RAST class
25537-2,Thallium
25538-0,Thermoactinomyces vulgaris Ab.IgG
25539-8,Thermoactinomyces vulgaris Ab.IgG.RAST class
25540-6,Threonine
25541-4,Topiramate
25542-2,Toxoplasma gondii Ab.IgM
25543-0,Triacylglycerol lipase
Apr-54,Lactose
25546-3,Tryptophan
25547-1,Tyrosine
25548-9,Urate
25549-7,Urea
25550-5,Urea
Jan-55,Lecithin cholesterol acyltransferase
25551-3,Urobilinogen
25552-1,Uroporphyrin
25553-9,Valine
25554-7,Tenebrio mollitor Ab.IgE.RAST class
25555-4,Wuchereria bancrofti Ag
25556-2,Xylose
25557-0,Zinc
25558-8,Zinc
25559-6,Zolpidem
25560-4,Allobarbital
25561-2,11-Deoxycorticosterone
25562-0,Angiotensin II^supine
25563-8,Angiotensin II^upright
25564-6,Bilirubin.glucuronidated+Bilirubin.albumin bound
25565-3,Bougainvillea Ab.IgE
25566-1,Bougainvillea Ab.IgE.RAST class
25567-9,Budgerigar serum proteins Ab.IgE.RAST class
25568-7,C peptide^10th specimen post XXX challenge
Sep-56,Lecithin phosphorus
25569-5,C peptide^11th specimen post XXX challenge
25570-3,C peptide^12th specimen post XXX challenge
25571-1,C peptide^13th specimen post XXX challenge
25572-9,C peptide^14th specimen post XXX challenge
25573-7,C peptide^15th specimen post XXX challenge
25574-5,C peptide^1st specimen post XXX challenge
25575-2,C peptide^2nd specimen post XXX challenge
25576-0,C peptide^3rd specimen post XXX challenge
Jul-57,Lecithin/Sphingomyelin
25577-8,C peptide^4th specimen post XXX challenge
25578-6,C peptide^5th specimen post XXX challenge
25579-4,C peptide^6th specimen post XXX challenge
25580-2,C peptide^7th specimen post XXX challenge
25581-0,C peptide^8th specimen post XXX challenge
25582-8,C peptide^9th specimen post XXX challenge
25583-6,Calcium
25584-4,Calcium^5H post 500 mg calcium PO
May-58,Leucine
25585-1,Cat serum albumin Ab.IgE.RAST class
25586-9,Chicken droppings Ab.IgE.RAST class
25587-7,Chromogranin A
25589-3,Citalopram
Mar-59,Leucine
25593-5,Rotavirus Ab.IgG
25594-3,Schistosoma sp Ab.IgG
25595-0,Econazole
25596-8,Fosfomycin
25597-6,Josamycine
25598-4,Cladosporium cladosporioides Ab.IgG
25599-2,Rotavirus Ab.IgG
25600-8,Rotavirus Ab.IgM
Jan-60,Leucine
25601-6,Rotavirus Ab.IgM
25603-2,Rickettsia prowazekii Ab.IgG
25604-0,Rickettsia prowazekii Ab.IgM
25607-3,Miconazole
25608-1,Nitroxoline
25609-9,Cochineal extract Ab.IgE
25610-7,Cochineal extract Ab.IgE.RAST class
25611-5,Blatta orientalis Ab.IgE
25612-3,Blatta orientalis Ab.IgE.RAST class
25613-1,Periplaneta fuliginosa Ab.IgE
25614-9,Periplaneta fuliginosa Ab.IgE.RAST class
25615-6,Conalbumin Ab.IgE
25616-4,Conalbumin Ab.IgE.RAST class
25617-2,Cortisol^1H post 250 ug cortrosyn IM
25618-0,Cortisol^1st specimen post XXX challenge
Sep-61,Leucine
25619-8,Cortisol^2nd specimen post XXX challenge
25620-6,Cortisol^30M post 250 ug cortrosyn IM
25621-4,Cortisol^3rd specimen post XXX challenge
25622-2,Cortisol^4th specimen post XXX challenge
25623-0,Cortisol^5th specimen post XXX challenge
25624-8,Cortisol^6th specimen post XXX challenge
25625-5,Cortisol^7th specimen post XXX challenge
25626-3,Cortisol^8H post 2 mg dexamethasone PO 2.5 day high dose q6h
Jul-62,Leucine
25627-1,Cortisol^8th specimen post XXX challenge
25628-9,Cortisol^9th specimen post XXX challenge
25629-7,Cortisol^pre 250 ug cortrosyn IM
25630-5,Parvovirus B19 Ab.IgG
25631-3,Parvovirus B19 Ab.IgM
25632-1,Plasmodium sp Ab
25633-9,Leishmania donovani Ab
25634-7,Ribes sylvestre Ab.IgE.RAST class
May-63,Leukocyte esterase
25637-0,Econazole
25638-8,Eosinophil cationic protein
25639-6,Follitropin
25640-4,Follitropin^1.5H post 100 ug luteinizing releasing hormone IV
25641-2,Follitropin^1H post 100 ug luteinizing releasing hormone IV
25642-0,Follitropin^1st specimen post XXX challenge
Mar-64,Linoleate
25643-8,Follitropin^2H post 100 ug luteinizing releasing hormone IV
25644-6,Follitropin^2nd specimen post XXX challenge
25645-3,Follitropin^30M post 100 ug luteinizing releasing hormone IV
25646-1,Follitropin^3rd specimen post XXX challenge
25647-9,Follitropin^4th specimen post XXX challenge
25648-7,Follitropin^5th specimen post XXX challenge
25649-5,Follitropin^6th specimen post XXX challenge
2565-0,Cholesterol
25650-3,Follitropin^7th specimen post XXX challenge
25651-1,Follitropin^8th specimen post XXX challenge
25652-9,Follitropin^9th specimen post XXX challenge
25653-7,Fosfomycin
25654-5,Gastrin^1st specimen post XXX challenge
25655-2,Gastrin^2nd specimen post XXX challenge
25656-0,Gastrin^3rd specimen post XXX challenge
25657-8,Gastrin^4th specimen post XXX challenge
25658-6,Gastrin^5th specimen post XXX challenge
25659-4,Gastrin^6th specimen post XXX challenge
25660-2,Gastrin^7th specimen post XXX challenge
25661-0,Gastrin^8th specimen post XXX challenge
25662-8,Gastrin^9th specimen post XXX challenge
25663-6,Glucose^15M post dose glucose
25664-4,Glucose^1H post dose glucose
25665-1,Glucose^1H post XXX challenge
25666-9,Glucose^2.5H post dose glucose
25667-7,Glucose^2H post dose glucose
Aug-66,Fatty acids.nonesterified
25668-5,Glucose^2H post XXX challenge
25669-3,Glucose^3.5H post dose glucose
25670-1,Glucose^30M post dose glucose
25671-9,Glucose^30M post XXX challenge
25672-7,Glucose^4.5H post dose glucose
25673-5,Glucose^45M post dose glucose
25674-3,Glucose^45M post XXX challenge
25675-0,Glucose^4H post dose glucose
Jun-67,Phospholipid phosphorus
25676-8,Glucose^5.5H post dose glucose
25677-6,Glucose^6H post dose glucose
25678-4,Glucose^1.5H post dose glucose
25679-2,Glucose^1.5H post XXX challenge
256-8,Foscarnet
25680-0,Glucose^pre 50 g glucose PO
25681-8,Immunoglobulin light chains.kappa
25682-6,Immunoglobulin light chains.kappa
25683-4,Immunoglobulin light chains.lambda
Apr-68,Phospholipid
25684-2,Immunoglobulin light chains.lambda
25685-9,Insulin^10th specimen post XXX challenge
25686-7,Insulin^11th specimen post XXX challenge
25687-5,Insulin^12th specimen post XXX challenge
25688-3,Insulin^13th specimen post XXX challenge
25689-1,Insulin^14th specimen post XXX challenge
25690-9,Insulin^15th specimen post XXX challenge
25691-7,Insulin^1st specimen post XXX challenge
Feb-69,Lipids
25692-5,Insulin^2nd specimen post XXX challenge
25693-3,Insulin^3rd specimen post XXX challenge
25694-1,Insulin^4th specimen post XXX challenge
25695-8,Insulin^5th specimen post XXX challenge
25696-6,Insulin^7.5H post XXX challenge
25697-4,Insulin^7th specimen post XXX challenge
25698-2,Insulin^8th specimen post XXX challenge
25699-0,Insulin^9th specimen post XXX challenge
25-Jul,Amphotericin B
2570-0,Fat
25700-6,Interpretation
25701-4,Artocarpus heterophyllus Ab.IgE.RAST class
25702-2,Josamycine
25703-0,Ziziphus jujuba Ab.IgE
25704-8,Ziziphus jujuba Ab.IgE.RAST class
25705-5,Ketones^1H post 50 g glucose PO
25706-3,Ketones^2H post dose glucose
25707-1,Ketones^4H post dose glucose
25708-9,Leishmania donovani Ab
25709-7,Leptospira interrogans serovar Canicola Ab
25710-5,Leptospira interrogans serovar Grippotyphosa Ab
25711-3,Leptospira interrogans serovar Icterohaemorrhagiae Ab
25712-1,Leptospira interrogans serovar Pomona Ab
25713-9,Linum usitatissimum Ab.IgE.RAST class
25714-7,Litchi chinensis Ab.IgE
25715-4,Litchi chinensis Ab.IgE.RAST class
25716-2,Lutropin
25717-0,Lutropin^1.5H post 100 ug luteinizing releasing hormone IV
Aug-71,Triglyceride
25718-8,Lutropin^1H post 100 ug luteinizing releasing hormone IV
25719-6,Lutropin^2H post 100 ug luteinizing releasing hormone IV
25720-4,Lutropin^30M post 100 ug luteinizing releasing hormone IV
25721-2,Mianserin
25722-0,Miconazole
25723-8,Nitroxoline
25724-6,Norsertraline
25725-3,Ovary Ab
Jun-72,Lipoprotein lipase
25726-1,OXcarbazepine
25728-7,Parkinsonia florida Ab.IgE.RAST class
25729-5,Parvovirus B19 Ab.IgG
25730-3,Parvovirus B19 Ab.IgM
25731-1,Plasmodium sp Ab
25732-9,Pregnanetriolone
25733-7,Procollagen type III
Apr-73,Lipoprotein.alpha
25734-5,Prolactin^10M post 200 ug TRH IV
25735-2,Prolactin^1H post 200 ug TRH IV
25736-0,Prolactin^1st specimen post XXX challenge
25737-8,Prolactin^20M post 200 ug TRH IV
25738-6,Prolactin^2H post 200 ug TRH IV
25739-4,Prolactin^30M post 200 ug TRH IV
25740-2,Prolactin^40M post 200 ug TRH IV
25741-0,Prolactin^50M post 200 ug TRH IV
Feb-74,Lipoprotein.beta
25742-8,Prothrombin fragment 1+2
25743-6,Chenopodium quinoa Ab.IgE
25744-4,Chenopodium quinoa Ab.IgE.RAST class
25745-1,Rheumatoid factor
25746-9,Rheumatoid factor
25747-7,Ribosomal Ab
25748-5,Ribosomal Ab
25749-3,Rickettsia conorii Ab.IgG
25750-1,Rickettsia conorii Ab.IgM
25751-9,Rickettsia prowazekii Ab.IgG
25752-7,Rickettsia prowazekii Ab.IgM
25753-5,Rotavirus Ab.IgG
25754-3,Rotavirus Ab.IgG
25755-0,Rotavirus Ab.IgM
25756-8,Rotavirus Ab.IgM
25757-6,Schistosoma sp Ab.IgG
25758-4,Insulin-like growth factor^10th specimen post XXX challenge
Sep-75,Lipoprotein.pre-beta
25759-2,Insulin-like growth factor^11th specimen post XXX challenge
257-6,Framycetin
25760-0,Insulin-like growth factor^12th specimen post XXX challenge
25761-8,Insulin-like growth factor^13th specimen post XXX challenge
25762-6,Insulin-like growth factor^14th specimen post XXX challenge
25763-4,Insulin-like growth factor^1st specimen post XXX challenge
25764-2,Insulin-like growth factor^2nd specimen post XXX challenge
25765-9,Insulin-like growth factor^3rd specimen post XXX challenge
25766-7,Insulin-like growth factor^4th specimen post XXX challenge
Jul-76,Lipoprotein
25767-5,Insulin-like growth factor^5th specimen post XXX challenge
25768-3,Insulin-like growth factor^6th specimen post XXX challenge
25769-1,Insulin-like growth factor^7th specimen post XXX challenge
25770-9,Insulin-like growth factor^8th specimen post XXX challenge
25771-7,Insulin-like growth factor^9th specimen post XXX challenge
25772-5,Somatotropin^11th specimen post XXX challenge
25773-3,Somatotropin^12th specimen post XXX challenge
25774-1,Somatotropin^13th specimen post XXX challenge
May-77,Lithocholate
25775-8,Somatotropin^14th specimen post XXX challenge
25776-6,Somatotropin^1st specimen post XXX challenge
25777-4,Somatotropin^40M post XXX challenge
25778-2,Somatotropin^50M post XXX challenge
25779-0,Stachybotrys chartarum Ab.IgG
25780-8,Stachybotrys chartarum Ab.IgG.RAST class
Mar-78,Lutropin
25788-1,Streptolysin O Ab
25789-9,Thyrotropin^1st specimen post XXX challenge
25790-7,Thyroxine.free^1st specimen post XXX challenge
Jan-79,Lutropin
25791-5,Thyroxine.free^2nd specimen post XXX challenge
25792-3,Thyroxine.free^3rd specimen post XXX challenge
25793-1,Thyroxine.free^4th specimen post XXX challenge
25794-9,Thyroxine.free^5th specimen post XXX challenge
25795-6,Thyroxine.free^6th specimen post XXX challenge
25796-4,Thyroxine.free^7th specimen post XXX challenge
25797-2,Thyroxine.free^8th specimen post XXX challenge
25798-0,Thyroxine.free^9th specimen post XXX challenge
25799-8,Tissue polypeptide specific Ag
25800-4,Tobramycin
25801-2,Trichophyton mentagrophytes var interdigitale Ab.IgE
25802-0,Trichophyton mentagrophytes var interdigitale Ab.IgE.RAST class
25803-8,Triiodothyronine.free^1st specimen post XXX challenge
25804-6,Triiodothyronine.free^2nd specimen post XXX challenge
25805-3,Triiodothyronine.free^3rd specimen post XXX challenge
25806-1,Triiodothyronine.free^4th specimen post XXX challenge
25807-9,Triiodothyronine.free^5th specimen post XXX challenge
25808-7,Triiodothyronine.free^6th specimen post XXX challenge
Sep-80,Lutropin
25809-5,Triiodothyronine.free^7th specimen post XXX challenge
25810-3,Triiodothyronine.free^8th specimen post XXX challenge
25811-1,Triiodothyronine.free^9th specimen post XXX challenge
25812-9,Trimipramine+Nortrimipramine
25813-7,Trypanosoma cruzi Ab
25814-5,Lathyrus sativus Ab.IgE
25815-2,Lathyrus sativus Ab.IgE.RAST class
25816-0,Vigabatrin
Jul-81,Gonadotropin releasing hormone
25817-8,Xylose^1.5H post dose xylose PO
25818-6,Xylose^1H post dose xylose PO
25819-4,Xylose^baseline
25820-2,Cysteate
25821-0,Staphylococcus aureus enterotoxin A Ab.IgE
25822-8,Staphylococcus aureus enterotoxin B Ab.IgE
25823-6,Staphylococcus aureus enterotoxin B Ab.IgE.RAST class
25824-4,Staphylococcus aureus enterotoxin C Ab.IgE
May-82,Lutropin.alpha subunit
25825-1,Staphylococcus aureus enterotoxin C Ab.IgE.RAST class
25826-9,Staphylococcus aureus enterotoxin D Ab.IgE
25827-7,Staphylococcus aureus enterotoxin D Ab.IgE.RAST class
25828-5,Parkinsonia florida Ab.IgE
25829-3,Glucosylceramidase
25830-1,Beta glucosidase activator
25831-9,Beta-N-acetylhexosaminidase.A
25832-7,Beta-N-acetylhexosaminidase.A activator
Mar-83,Lutropin.beta subunit
25833-5,Cerebroside sulfatase activator
25834-3,Cancer associated retinopathy Ab
25835-0,HIV 1 RNA
25836-8,HIV 1 RNA
25837-6,Herpes simplex virus 1 Ab
25838-4,Herpes simplex virus 1 Ab
25839-2,Herpes simplex virus 2 Ab
258-4,Framycetin
25840-0,Herpes simplex virus 2 Ab
Jan-84,Lysine
25841-8,HIV 2 proviral DNA
25842-6,HIV 2 proviral DNA
25843-4,Alanine
25844-2,Alanine/Creatinine
25845-9,Aldosterone
25846-7,Alpha aminoadipate
25847-5,Alpha aminoadipate/Creatinine
25848-3,Alpha aminobutyrate
25849-1,Alpha aminobutyrate/Creatinine
25850-9,Ammonia
25851-7,Ammonia/Creatinine
25852-5,17-Hydroxycorticosteroids
25853-3,1-Methylhistidine
25854-1,1-Methylhistidine/Creatinine
25855-8,3-Alpha-Androstanediol glucuronide
25856-6,3-Methylhistidine
25857-4,3-Methylhistidine/Creatinine
Aug-85,Lysine
25858-2,Anserine
25859-0,Anserine/Creatinine
25860-8,Arginine
25861-6,Arginine/Creatinine
25862-4,Asparagine
25863-2,Asparagine/Creatinine
25864-0,Aspartate
25865-7,Aspartate/Creatinine
Jun-86,Lysine
25866-5,Leptospira borgpetersenii serovar Sejroe Ab
25867-3,Echinococcus sp Ab
25868-1,Beta alanine
25869-9,Beta alanine/Creatinine
25870-7,Beta aminoisobutyrate
25871-5,Beta aminoisobutyrate/Creatinine
25872-3,C peptide
25873-1,Calcium^pre 500 mg calcium PO
Apr-87,Lysine
25874-9,Carnosine
25875-6,Carnosine/Creatinine
25876-4,Citrate
25877-2,Citrulline
25878-0,Citrulline/Creatinine
25879-8,Copper
25880-6,Copper/Creatinine
25881-4,Coproporphyrin
Feb-88,Lysolecithin acyltransferase
25882-2,Cortisol.free
25883-0,Cortisol.free
25884-8,Cortisol.free
25885-5,Cortisol.free
25886-3,Creatinine
25887-1,Cystathionine
25888-9,Cystathionine/Creatinine
25889-7,Cysteate
2589-0,Lysozyme
25890-5,Cysteate/Creatinine
25891-3,Cysteine
25892-1,Cysteine
25893-9,Cysteine/Creatinine
25894-7,Cystine/Creatinine
25895-4,Dehydroepiandrosterone
25896-2,Delta aminolevulinate
25897-0,Delta aminolevulinate/Creatinine
25898-8,Deoxypyridinoline
25899-6,D-Lactate^1st specimen post exercise
25900-2,D-Lactate^2nd specimen post exercise
25901-0,D-Lactate^3rd specimen post exercise
25902-8,D-Lactate^4th specimen post exercise
25903-6,D-Lactate^5th specimen post exercise
25904-4,D-Lactate^6th specimen post exercise
25905-1,D-lactate^pre exercise
25906-9,DOPamine
25907-7,Elastase.pancreatic
Aug-90,Lysozyme
25908-5,EPINEPHrine
25909-3,EPINEPHrine/Creatinine
25910-1,Ethanolamine
25911-9,Ethanolamine/Creatinine
25912-7,Fluoride
25913-5,Fluoride/Creatinine
25914-3,Gamma aminobutyrate
25915-0,Gamma aminobutyrate/Creatinine
Jun-91,Macroamylase
25916-8,Glucose
25917-6,Glutamate
25918-4,Glutamate/Creatinine
25919-2,Glutamine
259-2,Framycetin
25920-0,Glutamine/Creatinine
25921-8,Glycine
25922-6,Glycine/Creatinine
25923-4,Heptacarboxylporphyrin
Apr-92,Macroglobulin
25924-2,Hexacarboxylporphyrin
25925-9,Histamine/Creatinine
25926-7,Histidine
25927-5,Histidine/Creatinine
25928-3,Homocystine
25929-1,Homocystine/Creatinine
25930-9,Homovanillate
25931-7,Homovanillate/Creatinine
Feb-93,Magnesium
25932-5,Hydroxylysine
25933-3,Hydroxylysine/Creatinine
25934-1,Hydroxyproline
25935-8,Hydroxyproline/Creatinine
25936-6,Iodine
25937-4,Iron
25938-2,Isoleucine
25939-0,Isoleucine/Creatinine
2594-0,Magnesium
25940-8,Leptospira borgpetersenii serovar Sejroe Ab
25941-6,Leucine
25942-4,Leucine/Creatinine
25943-2,Lutropin^1st specimen post XXX challenge
25944-0,Lutropin^2nd specimen post XXX challenge
25945-7,Lutropin^3rd specimen post XXX challenge
25946-5,Lutropin^4th specimen post XXX challenge
25947-3,Lutropin^5th specimen post XXX challenge
25948-1,Lutropin^6th specimen post XXX challenge
25949-9,Lutropin^7th specimen post XXX challenge
25950-7,Lutropin^8th specimen post XXX challenge
25951-5,Lutropin^9th specimen post XXX challenge
25952-3,Lysine
25953-1,Lysine/Creatinine
25954-9,Magnesium
25955-6,Metanephrine
25956-4,Methionine
Jul-95,Magnesium
25957-2,Methionine sulfoxide
25958-0,Methionine sulfoxide/Creatinine
25959-8,Methionine/Creatinine
25960-6,Methyltetrahydrophthalic anhydride Ab.IgE.RAST class
25961-4,Nickel
25962-2,Nickel/Creatinine
25963-0,Norepinephrine
25964-8,Normetanephrine
May-96,Magnesium
25965-5,Ornithine
25966-3,Ornithine/Creatinine
25967-1,Penicillium roqueforti Ab.IgE.RAST class
25968-9,Pentacarboxylporphyrins
25969-7,Phenylalanine
25970-5,Phenylalanine/Creatinine
25971-3,5-Hydroxyindoleacetate
25972-1,Adenosine monophosphate.cyclic/Creatinine
Mar-97,Magnesium
25973-9,Phosphate
25974-7,Phosphoserine/Creatinine
25975-4,Proline
25976-2,Proline/Creatinine
25977-0,Pyridinoline
25978-8,Sarcosine/Creatinine
25979-6,Serine
25980-4,Serine/Creatinine
Jan-98,Magnesium
25981-2,Serotonin
25982-0,Sheep milk Ab.IgE.RAST class
25983-8,Sheep whey Ab.IgE.RAST class
25984-6,Somatotropin^30M post XXX challenge
25985-3,Taurine/Creatinine
25986-1,Testosterone
25987-9,Testosterone.free
25988-7,Threonine
25989-5,Threonine/Creatinine
25990-3,Thyrotropin^30M post dose TRH IN
25991-1,Thyrotropin^pre dose TRH IN
25992-9,Triacylglycerol lipase
25993-7,Trichinella spiralis Ab
25994-5,Tryptophan/Creatinine
25995-2,Tyrosine
25996-0,Tyrosine/Creatinine
25997-8,Urate
25998-6,Urea
Sep-99,Magnesium
25999-4,Urea/Creatinine
06-Feb,Almecillin
260-0,Framycetin
26000-0,Uroporphyrin
26001-8,Valine
26002-6,Valine/Creatinine
26003-4,Vanillylmandelate
26004-2,Vanillylmandelate/Creatinine
May-00,Magnesium.ionized
26005-9,Xylose^2H post dose xylose PO
26006-7,Borrelia burgdorferi Ab
26007-5,Echinococcus sp Ab
26008-3,Echinococcus sp Ab
26009-1,Treponema pallidum Ab
26010-9,Alkaline phosphatase.other fractions/Alkaline phosphatase.total
26011-7,Macroamylase/Amylase.total
26012-5,17-Hydroxycorticosteroids^1D post XXX challenge
Mar-01,Magnesium
26013-3,17-Hydroxycorticosteroids^2D post XXX challenge
26014-1,Arbovirus NOS Ab
26015-8,Cholesterol.in HDL 2
26016-6,Cholesterol.in HDL 2
26017-4,Cholesterol.in HDL 3
26018-2,Cladosporium cladosporioides Ab.IgG.RAST class
26019-0,Creatine kinase.macromolecular.type 1/Creatine kinase.total
26020-8,Creatine kinase.macromolecular.type 2/Creatine kinase.total
Jan-02,Malate dehydrogenase
26021-6,Nordiazepam
26022-4,Enterovirus NOS Ab
26023-2,Extractable nuclear Ab identified
26024-0,Gastrin^post meal
26025-7,Festuca elatior Ab.IgE.RAST class
26026-5,Hexahydrophthalic anhydride Ab.IgE.RAST class
26027-3,Histiocytes
26028-1,HLA-B27
26029-9,Lactoferrin bovine Ab.IgE
26030-7,Lactoferrin bovine Ab.IgE.RAST class
26031-5,Sialate.lipid bound
26032-3,Pepsin Ab.IgE.RAST class
26033-1,Pronormoblasts/100 cells
26034-9,Protein
26035-6,Serotonin
26036-4,Staphylococcus aureus enterotoxin A Ab.IgE.RAST class
26037-2,Trichophyton mentagrophytes var goetzii Ab.IgE
26038-0,Trichophyton mentagrophytes var goetzii Ab.IgE.RAST class
Sep-03,Malonate
26039-8,Norflunitrazepam
26040-6,Norcitalopram
26041-4,Normephenytoin
26042-2,Didesmethylcitalopram
26043-0,HLA-B27
26044-8,Pepsin Ab.IgE
26045-5,Pheneturide
26046-3,5-Hydroxypropafenone
Jul-04,Mannitol renal clearance
26047-1,Phytate
26048-9,Canary serum proteins Ab.IgE.RAST class
26049-7,Libocedrus decurrens Ab.IgE
26050-5,Libocedrus decurrens Ab.IgE.RAST class
26051-3,Epithelial cells.extrarenal
26052-1,Epithelial cells.renal
26053-9,N-methylhistamine
Apr-05,Meat fibers
26054-7,Mitochondria M2 Ab
26055-4,Pyridoxine^pre 250 mg pyridoxine PO
26056-2,Pyridoxine^post 250 mg pyridoxine PO
26057-0,Pyridoxine^post pyridoxine PO
26058-8,European tick borne encephalitis virus Ab
26059-6,European tick borne encephalitis virus Ab.IgG
26060-4,European tick borne encephalitis virus Ab.IgM
26061-2,European tick borne encephalitis virus Ab
Feb-06,Melanin
26062-0,European tick borne encephalitis virus Ab.IgG
26063-8,European tick borne encephalitis virus Ab.IgM
26064-6,Views^W contrast IV
26065-3,Views^W contrast IV
26066-1,Views^W contrast IV
26067-9,Views^W contrast intra salivary duct
26068-7,Views^W contrast intra salivary duct
26069-5,Views^W contrast intra salivary duct
2607-0,Melanin
26070-3,Views^W contrast IS
26071-1,Views^W contrast IS
26072-9,Views^W contrast IS
26073-7,Views^W contrast IS
26074-5,Views^W contrast IS
26075-2,Views^W contrast IS
26076-0,Views^W contrast IS
26077-8,Views^W contrast IS
26078-6,Views^W contrast IS
26079-4,Views^W contrast IA
26080-2,Views^W contrast IA
26081-0,Views^W contrast IA
26082-8,Views^W contrast IA
26083-6,Views^W contrast IA
26084-4,Views^W contrast IA
26085-1,Views^W standing
26086-9,Views^W standing
26087-7,Views^W standing
Aug-08,Metanephrines
26088-5,Views^W radionuclide IV
26089-3,Views^W radionuclide IV
26090-1,Views^W radionuclide IV
26091-9,Views^W Tc-99m pertechnetate IV
26092-7,Views^W Tc-99m pertechnetate IV
26093-5,Views^W Tc-99m pertechnetate IV
26094-3,Views^W standing
26095-0,Views^W standing
Jun-09,Metanephrines
26096-8,Views^W standing
26097-6,Views
26098-4,Views
26099-2,Views
26100-8,Views
26101-6,Views
26102-4,Views
26103-2,Views
Apr-10,Methane
26104-0,Views
26105-7,Views
26106-5,Views
26107-3,Views
26108-1,Views
26109-9,Views
26110-7,Views
26111-5,Views
Feb-11,Methcoproporphyrin
26112-3,Views
26113-1,Views
26114-9,Views
26115-6,Views
26116-4,Views
26117-2,Views
26118-0,Views
26119-8,Views
2612-0,Methemalbumin
26120-6,Views
26121-4,Views
26122-2,Views
26123-0,Views
26124-8,Views
26125-5,Views
26126-3,Views
26127-1,Views
26128-9,Views
26129-7,Views
26130-5,Views
26131-3,Views
26132-1,Views
26133-9,Views
26134-7,Views
26135-4,Views
26136-2,Views
26137-0,Views
Aug-13,Methemoglobin
26138-8,Views
26139-6,Views
26140-4,Views
26141-2,Views
26142-0,Views
26143-8,Views
26144-6,Views
26145-3,Views
Jun-14,Methemoglobin/Hemoglobin.total
26146-1,Views
26147-9,Views
26148-7,Views
26149-5,Views
26150-3,Views
26151-1,Views
26152-9,Views
Mar-15,Methemoglobin/Hemoglobin.total
26153-7,Views
26154-5,Views
26155-2,Views
26156-0,Views
26157-8,Views
26158-6,Views
26159-4,Views
26160-2,Views
Jan-16,Methemoglobin/Hemoglobin.total
26161-0,Views
26162-8,Views
26163-6,Views
26164-4,Views
26165-1,Views
26166-9,Views
26167-7,Views
26168-5,Views
26169-3,Views
26170-1,Views
26171-9,Views
26172-7,Views
26173-5,Views
26174-3,Views
26175-0,Views screening
26176-8,Views screening
26177-6,Views screening
26178-4,View runoff^W contrast IA
Sep-17,Methemoglobin/Hemoglobin.total
26179-2,View runoff^W contrast IA
261-8,Fusidate
26180-0,View runoff^W contrast IA
26181-8,Multisection^W contrast IV
26182-6,Multisection^W contrast IV
26183-4,Multisection^W contrast IV
26184-2,Multisection^W contrast IV
26185-9,Multisection^W contrast IV
26186-7,Multisection^W contrast IV
Jul-18,Methemoglobin/Hemoglobin.total
26187-5,Multisection^WO & W contrast IV
26188-3,Multisection^WO & W contrast IV
26189-1,Multisection^WO & W contrast IV
26190-9,Multisection^WO & W contrast IV
26191-7,Multisection^WO & W contrast IV
26192-5,Multisection^WO & W contrast IV
26193-3,Multisection^WO & W contrast IV
26194-1,Multisection^WO & W contrast IV
May-19,Methemoglobin
26195-8,Multisection^WO & W contrast IV
26196-6,Multisection^WO & W contrast IV
26197-4,Multisection^WO & W contrast IV
26198-2,Multisection^WO & W contrast IV
26199-0,Multisection^WO & W contrast IV
26200-6,Multisection^WO & W contrast IV
26201-4,Multisection^WO & W contrast IV
26202-2,Multisection^WO & W contrast IV
Mar-20,Methionine
26203-0,Multisection^WO & W contrast IV
26204-8,Multisection^WO & W contrast IV
26205-5,Multisection^WO & W contrast IV
26206-3,Multisection^WO & W contrast IV
26207-1,Multisection^WO & W contrast IV
26208-9,Multisection
26209-7,Multisection
26210-5,Multisection
Jan-21,Methionine
26211-3,Multisection
26212-1,Multisection
26213-9,Multisection
26214-7,Multisection
26215-4,Multisection
26216-2,Multisection
26217-0,Multisection
26218-8,Multisection
26219-6,Multisection
26220-4,Multisection
26221-2,Multisection
26222-0,Multisection
26223-8,Multisection
26224-6,Multisection
26225-3,Multisection
26226-1,Multisection
26227-9,Multisection
26228-7,Multisection
Sep-22,Methionine
26229-5,Multisection
26230-3,Multisection
26231-1,Multisection
26232-9,Multisection
26233-7,Multisection
26234-5,Multisection
26235-2,Multisection
26236-0,Multisection
Jul-23,Methionine
26237-8,Multisection
26238-6,Multisection
26239-4,Multisection
26240-2,Multisection
26241-0,Multisection
26242-8,Multisection
26243-6,Multisection
26244-4,Multisection
May-24,Methionine
26245-1,Multisection
26246-9,Multisection
26247-7,Multisection
26248-5,Multisection
26249-3,Multisection
26250-1,Multisection
26251-9,Multisection
Feb-25,Methionine adenosyltransferase
26252-7,Multisection
26253-5,Multisection
26254-3,Multisection
26255-0,Multisection
26256-8,Multisection
26257-6,Multisection
26258-4,Multisection
26259-2,Multisection
262-6,Fusidate
2626-0,Methoxyacetate
26260-0,Multisection
26261-8,Multisection
26262-6,Multisection
26263-4,Multisection
26264-2,Multisection
26265-9,Multisection
26266-7,Multisection
26267-5,Multisection
26268-3,Multisection
26269-1,Multisection
26270-9,Multisection
26271-7,Multisection
26272-5,Multisection
26273-3,Multisection
26274-1,Multisection
26275-8,Multisection
26276-6,Multisection
26277-4,Multisection
Aug-27,Methylenetetrahydrofolate dehydrogenase.NAD
26278-2,Multisection
26279-0,Multisection
26280-8,Multisection
26281-6,Multisection
26282-4,Multisection
26283-2,View Merchants
26284-0,View Merchants
26285-7,View Merchants
Jun-28,Methylenetetrahydrofolate dehydrogenase.NADP
26286-5,Multisection limited
26287-3,Views limited
26288-1,Multisection limited
26289-9,Views limited
26290-7,Multisection limited
26291-5,Views limited
26292-3,Guidance for percutaneous biopsy
26293-1,Guidance for percutaneous biopsy
Apr-29,Methylmalonate
26294-9,Guidance for percutaneous biopsy
26295-6,Guidance for reposition of central venous catheter^W contrast IV
26296-4,Guidance for reposition of central venous catheter^W contrast IV
26297-2,Guidance for reposition of central venous catheter^W contrast IV
26298-0,Guidance for atherectomy^W contrast IV
26299-8,Guidance for atherectomy^W contrast IV
26300-4,Guidance for atherectomy^W contrast IV
26301-2,Guidance for placement of stent
Feb-30,Methylmalonate
26302-0,Guidance for placement of stent
26303-8,Guidance for placement of stent
26304-6,Guidance for placement of peripherally-inserted central venous catheter
26305-3,Guidance for placement of peripherally-inserted central venous catheter
26306-1,Guidance for placement of peripherally-inserted central venous catheter
26307-9,Guidance for placement of large bore central venous catheter
26308-7,Guidance for placement of large bore central venous catheter
26309-5,Guidance for placement of large bore central venous catheter
2631-0,Methylmalonyl CoA mutase
26310-3,Guidance for placement of central venous catheter^W contrast IV
26311-1,Guidance for placement of central venous catheter^W contrast IV
26312-9,Guidance for placement of central venous catheter^W contrast IV
26313-7,Guidance for needle localization
26314-5,Guidance for needle localization
26315-2,Guidance for needle localization of mass
26316-0,Guidance for needle localization of mass
26317-8,Guidance for needle localization of mass
26318-6,Guidance for needle localization
26319-4,Guidance for injection
26320-2,Guidance for injection
26321-0,Guidance for injection
26322-8,Guidance for injection
26323-6,Guidance for injection
26324-4,Guidance for injection
26325-1,Guidance for drainage+placement of drainage catheter
26326-9,Guidance for drainage+placement of drainage catheter
26327-7,Guidance for drainage+placement of drainage catheter
Aug-32,methylTESTOSTERone
26328-5,Guidance for drainage+placement of drainage catheter
26329-3,Guidance for drainage+placement of drainage catheter
26330-1,Guidance for drainage+placement of drainage catheter
26331-9,Guidance for change of central venous catheter^W contrast IV
26332-7,Guidance for change of central venous catheter^W contrast IV
26333-5,Guidance for change of central venous catheter^W contrast IV
26334-3,Guidance for percutaneous biopsy.core needle
26335-0,Guidance for percutaneous biopsy.core needle
Jun-33,methylTESTOSTERone
26336-8,Guidance for percutaneous biopsy.core needle
26337-6,Guidance for percutaneous biopsy
26338-4,Guidance for percutaneous biopsy
26339-2,Guidance for percutaneous biopsy
263-4,Fusidate
26340-0,Guidance for percutaneous biopsy
26341-8,Guidance for percutaneous biopsy
26342-6,Guidance for percutaneous biopsy
26343-4,Guidance for percutaneous aspiration of cyst
Apr-34,methylTESTOSTERone
26344-2,Guidance for percutaneous aspiration of cyst
26345-9,Guidance for percutaneous aspiration of cyst
26346-7,Views diagnostic
26347-5,Views diagnostic
26348-3,Views diagnostic
26349-1,Views limited diagnostic
26350-9,Views limited diagnostic
Jan-35,Mianserin
26351-7,Views limited diagnostic
26352-5,Views bone age
26353-3,Views bone age
26354-1,Views bone age
26355-8,View arthritis
26356-6,View arthritis
26357-4,View arthritis
26358-2,View AP^W standing
26359-0,View AP^W standing
26360-8,View AP^W standing
26361-6,Views AP + PA^W standing
26362-4,Views AP + PA^W standing
26363-2,Views AP + PA^W standing
26364-0,Views AP + lateral^W standing
26365-7,Views AP + lateral^W standing
26366-5,Views AP + lateral^W standing
26367-3,Angioplasty^W contrast IA
26368-1,Angioplasty^W contrast IA
Sep-36,Mianserin
26369-9,Angioplasty^W contrast IA
26370-7,Guidance for angioplasty^W contrast IA
26371-5,Guidance for angioplasty^W contrast IA
26372-3,Guidance for angioplasty^W contrast IA
26373-1,Guidance for angioplasty^W contrast IA
26374-9,Guidance for angioplasty^W contrast IA
26375-6,Guidance for angioplasty^W contrast IA
26376-4,Administration of vasodilator into catheter
Jul-37,Mucoprotein
26377-2,Administration of vasodilator into catheter
26378-0,Administration of vasodilator into catheter
26379-8,Views 3
26380-6,Views 3
26381-4,Views 3
26382-2,Views 3
26383-0,Views 3
26384-8,Views 3
May-38,Myelin basic protein
26385-5,Views 2
26386-3,Views 2
26387-1,Views 2
26388-9,Views 2
26389-7,Views 2
26390-5,Views 2
26391-3,Views 2
26392-1,Views 2
Mar-39,Myoglobin
26393-9,Views 2
26394-7,Views 2
26395-4,Views 2
26396-2,Views 2
26397-0,Views 2
26398-8,Views 2
26399-6,Views 2
26400-2,View
Jan-40,Myoglobin
26401-0,View
26402-8,View
26403-6,Alternaria alternata Ab.IgG4
26404-4,Alternaria alternata Ab.IgG4.RAST class
26405-1,Aspergillus fumigatus Ab.IgG4
26406-9,Aspergillus fumigatus Ab.IgG4.RAST class
26407-7,Apis mellifera Ab.IgG4
26408-5,Apis mellifera Ab.IgG4.RAST class
26409-3,Betula verrucosa Ab.IgG4
26410-1,Betula verrucosa Ab.IgG4.RAST class
26411-9,Bran wheat Ab.IgG4
26412-7,Bran wheat Ab.IgG4.RAST class
26413-5,Candida albicans Ab.IgG4
26414-3,Candida albicans Ab.IgG4.RAST class
26415-0,Casein Ab.IgG4
26416-8,Casein Ab.IgG4.RAST class
26417-6,Cladosporium herbarum Ab.IgG4
26418-4,Cladosporium herbarum Ab.IgG4.RAST class
Sep-41,Myoglobin
26419-2,Dermatophagoides farinae Ab.IgG4
264-2,Fusidate
26420-0,Dermatophagoides farinae Ab.IgG4.RAST class
26421-8,Dermatophagoides pteronyssinus Ab.IgG4
26422-6,Dermatophagoides pteronyssinus Ab.IgG4.RAST class
26423-4,Egg white Ab.IgG4
26424-2,Egg white Ab.IgG4.RAST class
26425-9,Lactalbumin alpha Ab.IgG4
26426-7,Lactalbumin alpha Ab.IgG4.RAST class
Jul-42,Myoglobin
26427-5,Lactoglobulin Ab.IgG4
26428-3,Oryza sativa Ab.IgG4
26429-1,Oryza sativa Ab.IgG4.RAST class
26430-9,Phleum pratense Ab.IgG4
26431-7,Phleum pratense Ab.IgG4.RAST class
26432-5,Wasp venom Ab.IgG4
26433-3,Wasp venom Ab.IgG4.RAST class
26434-1,Lactoglobulin Ab.IgG4.RAST class
May-43,N-acetyl-beta-glucosaminidase
26435-8,Molecular pathology studies
26436-6,Laboratory studies
26437-4,Chemistry challenge studies
26438-2,Cytology studies
26439-0,Surgical pathology studies
26441-6,Cardiology studies
26442-4,Obstetrical studies
Mar-44,Alpha-N-acetylglucosaminidase
26443-2,Clinical reports.non lab claims attachment
26444-0,Basophils
26445-7,Basophils/100 leukocytes
26446-5,Blasts/100 leukocytes
26447-3,Blasts/100 leukocytes
26448-1,Blasts/100 leukocytes
26449-9,Eosinophils
2645-0,N-Acetylgalactosamine-4-Sulfatase
26450-7,Eosinophils/100 leukocytes
26451-5,Eosinophils/100 leukocytes
26452-3,Eosinophils/100 leukocytes
26453-1,Erythrocytes
26454-9,Erythrocytes
26455-6,Erythrocytes
26456-4,Erythrocytes
26457-2,Erythrocytes
26458-0,Erythrocytes
26459-8,Erythrocytes.nucleated
26460-6,Erythrocytes.nucleated
26461-4,Erythrocytes.nucleated/100 erythrocytes
26462-2,Large unstained cells
26463-0,Large unstained cells/100 leukocytes
26464-8,Leukocytes
26465-5,Leukocytes
26466-3,Leukocytes
26467-1,Leukocytes
Aug-46,N-Acetylgalactosamine-4-Sulfatase
26468-9,Leukocytes
26469-7,Leukocytes
26470-5,Leukocytes other
26471-3,Leukocytes other/100 leukocytes
26472-1,Leukocytes other/100 leukocytes
26473-9,Leukocytes other/100 leukocytes
26474-7,Lymphocytes
26475-4,Lymphocytes
Jun-47,N-Acetylgalactosamine-4-Sulfatase
26476-2,Lymphocytes
26477-0,Lymphocytes.variant
26478-8,Lymphocytes/100 leukocytes
26479-6,Lymphocytes/100 leukocytes
26480-4,Lymphocytes/100 leukocytes
26481-2,Lymphocytes/100 leukocytes
26482-0,Lymphocytes/100 leukocytes
26483-8,Lymphocytes/100 leukocytes
Apr-48,N-Acetylgalactosamine-4-Sulfatase
26484-6,Monocytes
26485-3,Monocytes/100 leukocytes
26486-1,Monocytes/100 leukocytes
26487-9,Monocytes/100 leukocytes
26488-7,Monocytes/100 leukocytes
26489-5,Mononuclear cells
26490-3,Mononuclear cells
26491-1,Mononuclear cells
Feb-49,N-Acetylgalactosamine-6-Sulfatase
26492-9,Mononuclear cells/100 leukocytes
26493-7,Mononuclear cells/100 leukocytes
26494-5,Mononuclear cells/100 leukocytes
26495-2,Mononuclear cells/100 leukocytes
26496-0,Mononuclear cells/100 leukocytes
26497-8,Mononuclear cells/100 leukocytes
26498-6,Myelocytes/100 leukocytes
26499-4,Neutrophils
26-May,Amphotericin B
2650-0,N-Acetylglucosamine-6-Sulfatase
26500-9,Neutrophils
26501-7,Neutrophils
26502-5,Neutrophils
26503-3,Neutrophils
26504-1,Neutrophils
26505-8,Neutrophils.segmented/100 leukocytes
26506-6,Neutrophils.segmented/100 leukocytes
26507-4,Neutrophils.band form
26508-2,Neutrophils.band form/100 leukocytes
26509-0,Neutrophils.band form/100 leukocytes
26510-8,Neutrophils.band form/100 leukocytes
26511-6,Neutrophils/100 leukocytes
26512-4,Neutrophils/100 leukocytes
26513-2,Neutrophils/100 leukocytes
26514-0,Neutrophils/100 leukocytes
26515-7,Platelets
26516-5,Platelets
26517-3,Polymorphonuclear cells/100 leukocytes
Aug-51,NADH dehydrogenase
26518-1,Polymorphonuclear cells/100 leukocytes
26519-9,Polymorphonuclear cells/100 leukocytes
26520-7,Polymorphonuclear cells/100 leukocytes
26521-5,Polymorphonuclear cells/100 leukocytes
26522-3,Polymorphonuclear cells/100 leukocytes
26523-1,Promyelocytes
26524-9,Promyelocytes/100 leukocytes
26525-6,Cortisol.free^24H post dose corticotropin
Jun-52,NADH dehydrogenase
26526-4,Cortisol.free^48H post dose corticotropin
26527-2,Cortisol.free^72H post dose corticotropin
26528-0,Cortisol^1H post dose corticotropin
26529-8,Cortisol^24H post dose corticotropin
26530-6,Cortisol^30M post dose corticotropin
26531-4,Cortisol^32H post dose corticotropin
26532-2,Cortisol^48H post dose corticotropin
26533-0,Cortisol^56H post dose corticotropin
Apr-53,Cytochrome b5 reductase
26534-8,Cortisol^8H post dose corticotropin
26535-5,Cortisol^30M post dose corticotropin
26536-3,Cortisol^1H post dose corticotropin
26537-1,Glucose^2.5H post dose glucose
26538-9,Glucose^3.5H post dose glucose
26539-7,Glucose^45M post dose glucose
26540-5,Glucose^3H post dose glucose
26541-3,Glucose^4H post dose glucose
Feb-54,Neurophysin
26542-1,Glucose^5H post dose glucose
26543-9,Glucose^5H post dose glucose
26544-7,Glucose^6H post dose glucose
26545-4,Glucose^6H post dose glucose
26546-2,Glucose^1H post dose glucose
26547-0,Glucose^2H post dose glucose
26548-8,Glucose^30M post dose glucose
26549-6,Glucose^3H post dose glucose
26550-4,Glucose^4H post dose glucose
26551-2,Glucose^5H post dose glucose
26552-0,Glucose^6H post dose glucose
26553-8,Glucose^1.5H post dose glucose
26554-6,Glucose^2.5H post dose glucose
26555-3,Glucose^3.5H post dose glucose
26556-1,Cells.CD103/100 cells
26557-9,Cells.CD11b+CD56+/100 cells
26558-7,Cells.CD11c+CD25+/100 cells
Sep-55,Neurotensin
26559-5,Cells.CD38+CD56+/100 cells
26560-3,Cells.CD16/100 cells
26561-1,Cells.CD16+CD56+
26562-9,Cells.CD19+CD38+/100 cells
26563-7,Cells.CD1a/100 cells
26564-5,Cells.CD30
26565-2,Cells.CD19+Kappa+/100 cells
26566-0,Cells.CD19+Lambda+/100 cells
Jul-56,Niacin
26567-8,Lymphocytes.IgA/100 lymphocytes
26568-6,Cells.CD3+HLA-DR+
26569-4,Cells.CD4+CD29+
26570-2,Cells.CD4+CD45+
26571-0,Cells.CD16
26572-8,Cells.CD2+CD7+/100 cells
26573-6,Cells.CD4+CD45+/100 cells
26574-4,1-Methylhistidine/Creatinine
May-57,Nitrite
26575-1,3-Methylhistidine/Creatinine
26576-9,Anserine/Creatinine
26577-7,Asparagine/Creatinine
26578-5,Beta alanine/Creatinine
26579-3,Beta aminoisobutyrate/Creatinine
26580-1,Carnosine/Creatinine
26581-9,Gamma aminobutyrate/Creatinine
26582-7,Homocysteine/Creatinine
Mar-58,Nitrogen
26583-5,"3-Hydroxy,3-Methylglutarate/Creatinine"
26584-3,1-Methylhistidine
26585-0,3-Methylhistidine
26586-8,Alpha aminobutyrate
26587-6,Alpha aminoadipate
26588-4,Anserine
26589-2,Beta alanine
265-9,Ganciclovir
26590-0,Beta aminoisobutyrate
Jan-59,Nitrogen
26591-8,Carnosine
26592-6,Cystathionine
26593-4,Ethanolamine
26594-2,Gamma aminobutyrate
26595-9,Hydroxylysine
26596-7,Hydroxyproline
26597-5,Phosphoethanolamine
26598-3,Sarcosine
26599-1,Anserine
26600-7,Alpha aminoadipate
26601-5,Alpha aminoadipate/Creatinine
26602-3,Tryptophan
26603-1,Asparagine
26604-9,Beta alanine
26605-6,Beta aminoisobutyrate
26606-4,Carnosine
26607-2,Cystathionine
26608-0,Ethanolamine
Sep-60,Nitrogen
26609-8,Gamma aminobutyrate
26610-6,Hydroxylysine
26611-4,Phosphoethanolamine
26612-2,Phosphoethanolamine
26613-0,Sarcosine
26614-8,Taurine
26615-5,Erythrocytes.CD55
26616-3,Erythrocytes.CD59
Jul-61,Nitrogen.nonprotein
26617-1,Trypanosoma brucei gambiense Ab
26618-9,Trypanosoma brucei rhodesiense Ab
26619-7,Campylobacter sp Ab
26620-5,Hantavirus Ab.IgG
26621-3,Legionella sp Ag
26622-1,Babesia duncani Ab
26623-9,Chikungunya virus Ab
26624-7,Rickettsia conorii Ab
May-62,Nitrogen.nonprotein
26625-4,Coccidioides sp Ab
26626-2,Chlamydia trachomatis L2 Ab
26627-0,Legionella polyvalent A Ab
26628-8,Legionella polyvalent B Ab
26629-6,Legionella polyvalent C Ab
26630-4,Corynebacterium diphtheriae toxin Ab
26631-2,Borrelia hermsii Ab
26632-0,Legionella dumoffii Ab
Mar-63,Nitrogen.nonprotein
26633-8,Legionella bozemaniae Ab
26634-6,Legionella gormanii Ab
26635-3,Legionella micdadei Ab
26636-1,Candida sp Ab
26637-9,Leishmania braziliensis Ab
26638-7,Leishmania donovani Ab
26639-5,Leishmania tropica Ab
26640-3,Paracoccidioides brasiliensis Ab
Jan-64,Nitrogen
26641-1,Histoplasma sp Ab
26642-9,Jamestown canyon virus Ab
26643-7,Clostridium tetani toxoid Ab
26644-5,Getah virus Ab
26645-2,BK virus Ab
26646-0,Powassan virus Ab
26647-8,Semliki forest virus Ab
26648-6,Sindbis virus Ab
26649-4,Snowshoe hare virus Ab
26650-2,Hantavirus sin nombre Ab.IgM
26651-0,Rhizopus arrhizus Ab
26652-8,Banzi virus Ab
26653-6,Colorado tick fever virus Ab
26654-4,Hantavirus sin nombre Ab.IgG
26655-1,Entamoeba sp Ab
26656-9,HTLV II Ab
26657-7,Schistosoma haematobium Ab
Aug-65,Nitrogen
26658-5,Treponema sp Ab
26659-3,Leptospira autumnalis Ab
26660-1,Toxocara sp Ab
26661-9,Trichinella sp Ab
26662-7,Bebaru virus Ab
26663-5,Chlamydia trachomatis D Ab
26664-3,Chlamydia trachomatis E Ab
26665-0,Chlamydia trachomatis F Ab
Jun-66,Norepinephrine
26666-8,Chlamydia trachomatis H Ab
26667-6,Chlamydia trachomatis I Ab
26668-4,Chlamydia trachomatis L1 Ab
26669-2,Absidia corymbifera Ab
266-7,Gentamicin
26670-0,Rhizomucor pusillus Ab
26671-8,Ascaris sp Ab
26672-6,Ross river virus Ab
26673-4,Echinococcus granulosus Ab
Apr-67,Norepinephrine
26674-2,Legionella longbeachae 1 Ab
26675-9,Legionella longbeachae 2 Ab
26676-7,Bartonella henselae Ab
26677-5,Bartonella quintana Ab
26678-3,Bartonella elizabethae Ab
26679-1,Secobarbital
26680-9,Aspartate
26681-7,Streptococcus pneumoniae 23 Ab
Feb-68,Norepinephrine
26682-5,Glycolate
26683-3,Estazolam
26684-1,Mycoplasma pneumoniae Ab.IgA
26685-8,3-Hydroxyisovalerate
26686-6,Triazolam
26687-4,Amobarbital
26688-2,Mercury/Creatinine
26689-0,Butabarbital
2669-0,Normetanephrine
26690-8,Western equine encephalitis virus RNA
26691-6,Uroporphyrin 1 isomer
26692-4,Streptococcus pneumoniae 19 Ab
26693-2,Streptococcus pneumoniae 12f Ab
26694-0,Clostridioides difficile Ab.IgM
26695-7,Glucose^7th specimen post XXX challenge
26696-5,Morphine.free
26697-3,Clostridioides difficile Ab.IgA
26698-1,Listeria monocytogenes Ab.IgG
26699-9,Indicans
26700-5,Amino beta guanidinopropionate
26701-3,Streptococcus pneumoniae 9 Ab
26702-1,Clostridioides difficile Ab.IgG
26703-9,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab.IgG
26704-7,Isospora belli
26705-4,Epstein Barr virus nuclear Ab.IgM
26706-2,Vanillylmandelate
26707-0,Aluminum
Aug-70,Normetanephrine
26708-8,Magnesium
26709-6,Xylose^5th specimen post XXX challenge
26710-4,Leucine
26711-2,Phendimetrazine
26712-0,Phenmetrazine
26713-8,Phentermine
26714-6,Phenylpropanolamine
26715-3,Chlamydia trachomatis Ab.IgG
Jun-71,Normetanephrine
26716-1,Chlorphentermine
26717-9,Phosphoethanolamine
26718-7,HYDROmorphone
26719-5,HYDROcodone
26720-3,Codeine
26721-1,6-Monoacetylmorphine
26722-9,oxyCODONE
26723-7,Varicella zoster virus Ab
Apr-72,Octopamine
26724-5,Sarcosine
26725-2,Alpha aminoadipate
26726-0,Proline
26727-8,Ephedrine+Pseudoephedrine
26728-6,Cells.CD38
26729-4,Ovary Ab.IgG
26730-2,Isoleucine
26731-0,Tetrahydrocannabinol
Feb-73,Oleate
26732-8,Carboxy tetrahydrocannabinol
26733-6,Butabarbital
26734-4,Methamphetamine
26735-1,Rhodococcus equi Ab
26736-9,Promethazine
26737-7,Phosphoserine
26738-5,Phosphoserine
26739-3,Xylose^4th specimen post XXX challenge
2674-0,Ornithine
26740-1,Hydroxyproline
26741-9,Serine
26742-7,Methylenedioxyamphetamine
26743-5,Carboxy tetrahydrocannabinol
26744-3,Opiates
26745-0,Citrulline
26746-8,Magnesium
26747-6,Cannabinoids/Creatinine
26748-4,Osmium
26749-2,Urea nitrogen^2nd specimen
267-5,Gentamicin
26750-0,Carnosine
26751-8,Adipate
26752-6,Creatinine renal clearance
26753-4,Carnitine esters
26754-2,Streptococcus pneumoniae Danish serotype 7F Ab
26755-9,Streptococcus pneumoniae Danish serotype 18C Ab
26756-7,Isoniazid
Jul-75,Ornithine
26757-5,Carnitine.free (C0)
26758-3,Cocaine
26759-1,Cells.CD4+CD45RA+
26760-9,Cannabinoids
26761-7,Sodium renal clearance
26762-5,Chloride
26763-3,Sodium
26764-1,Cannabinoids
May-76,Organic acids
26765-8,Antimony
26766-6,Bacteroides fragilis Ab.IgG
26767-4,Clostridium perfringens Ab.IgG
26768-2,Clostridium perfringens Ab.IgM
26769-0,Endothelin
26770-8,Trichloroacetate/Creatinine
26771-6,Ephedrine+Pseudoephedrine
26772-4,Mephentermine
Mar-77,Organochloride
26773-2,Benzfetamine
26774-0,Flurazepam
26775-7,Myelin associated glycoprotein Ab
26776-5,QUEtiapine
26777-3,Glucose^30M post dose lactose PO
26778-1,Glucose^1H post dose lactose PO
26779-9,Glucose^1.5H post dose lactose PO
26780-7,Glucose^2H post dose lactose PO
Jan-78,Ornithine
26781-5,Glucose^3H post dose lactose PO
26782-3,Glucose^4H post dose lactose PO
26783-1,Glucose^5H post dose lactose PO
26784-9,diazePAM
26785-6,Ephedrine+Pseudoephedrine
26786-4,Mephentermine
26787-2,Anserine
26788-0,Carnitine
26789-8,Escherichia coli Ab.IgM
26790-6,chlordiazePOXIDE
26791-4,Amphetamine
26792-2,Methylenedioxyamphetamine
26793-0,Methylenedioxymethamphetamine
26794-8,Alpha aminobutyrate
26795-5,Alanine
26796-3,Oxalate
26797-1,Alpha hydroxybutyrate
26798-9,Succinate
Sep-79,Ornithine
26799-7,Fumarate
26800-3,Escherichia coli Ab.IgG
26801-1,Protein
26802-9,Midazolam
26803-7,Ethanolamine
26804-5,Gamma aminobutyrate
26805-2,Glutamate
26806-0,Glutamine
Jul-80,Ornithine
26807-8,Glycine
26808-6,Histidine
26809-4,Homocystine
26810-2,Hydroxyproline
26811-0,2-Methylcitrate
26812-8,Xylose^3rd specimen post XXX challenge
26813-6,Acidity.titratable
26814-4,IgG.monoclonal
May-81,Ornithine
26815-1,Cocaethylene
26816-9,Nordiazepam
26817-7,Glucose^11H post XXX challenge
26818-5,Campylobacter jejuni Ab
26819-3,Alpha aminobutyrate
26820-1,Stachybotrys chartarum Ab.IgA
26821-9,Lipoprotein.beta
26822-7,Lipoprotein.alpha
Mar-82,Ornithine carbamoyltransferase
26823-5,Lutropin.beta subunit
26824-3,Phosphoserine
26825-0,Eastern equine encephalitis virus RNA
26826-8,Testosterone
26827-6,Testosterone/Creatinine
26828-4,Cortisol
26829-2,Phencyclidine
268-3,Gentamicin
26830-0,Prochlorperazine
Jan-83,Ornithine carbamoyltransferase
26831-8,Suberate
26832-6,Aconitate
26833-4,Hippurate
26834-2,Temazepam
26835-9,Sebacate
26836-7,Hydroxyethylflurazepam
26837-5,diazePAM
26838-3,LORazepam
26839-1,Oxazepam
26840-9,Nordiazepam
26841-7,N-desalkylflurazepam
26842-5,Iodine
26843-3,Cystine
26844-1,Methionine
26845-8,Sialate.lipid bound
26846-6,Perphenazine
26847-4,Haloperidol
26848-2,Interleukin 10
Sep-84,Alpha-1-Acid glycoprotein
26849-0,IgA.secretory
26850-8,Oxazepam
26851-6,LORazepam
26852-4,Amino beta guanidinopropionate
26853-2,Glucose^7th specimen post XXX challenge
26854-0,Glucose^8th specimen post XXX challenge
26855-7,Parainfluenza virus Ab
Jun-85,Alpha-1-Acid glycoprotein
26856-5,Cannabinoids
26857-3,Mephentermine
26858-1,Cells.CD3+CD56+
26859-9,Phencyclidine
26860-7,Morphine
26861-5,Gamma aminobutyrate
26862-3,HYDROmorphone
26863-1,HYDROcodone
Apr-86,Orotate
26864-9,Sporothrix schenckii Ab
26865-6,Codeine
26866-4,N-desalkylflurazepam
26867-2,fentaNYL
26868-0,Phenolphthalein
26869-8,oxyCODONE
26870-6,Ganglioside GD1b Ab
26871-4,IgA
Feb-87,Orotate phosphoribosyltransferase
26872-2,Orotate
26873-0,Valine
26874-8,Follitropin.beta subunit
26875-5,Streptococcus pneumoniae 4 Ab
26876-3,Streptococcus pneumoniae 1 Ab
26877-1,Hydroxytriazolam
26878-9,ALPRAZolam
26879-7,Triiodothyronine
2688-0,Orotidine-5'-Phosphate decarboxylase
26880-5,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab
26881-3,Interleukin 6
26882-1,Homocystine
26883-9,Amino beta guanidinopropionate
26884-7,Ketones^3H post XXX challenge
26885-4,Ova & parasites identified
26886-2,ALPRAZolam
26887-0,Alpha hydroxyalprazolam
26888-8,Sulfate
26889-6,Sulfate
26890-4,Canine distemper virus Ab.IgM
26891-2,Nordiazepam
26892-0,Intrinsic factor blocking Ab.IgG
26893-8,Tetrahydrocannabinol
26894-6,Glutamine
26895-3,Amphetamines
26896-1,Taurine
26897-9,Threonine
Aug-89,Osmolality
26898-7,Temazepam
26899-5,Midazolam
26900-1,chlordiazePOXIDE
26901-9,Flurazepam
26902-7,Doxycycline
26903-5,Canine distemper virus Ab.IgG
26904-3,2-Methylcitrate
26905-0,PHENobarbital
Jun-90,Osmolality
26906-8,Mephobarbital
26907-6,Listeria sp Ab
26908-4,17-Hydroxyprogesterone
26909-2,Alpha aminoadipate
269-1,Gentamicin
26910-0,Alpha hydroxyalprazolam
26911-8,ALPRAZolam
26912-6,Hydroxytriazolam
26913-4,Triazolam
Apr-91,Osmolality
26914-2,Estazolam
26915-9,Pyridoxine
26916-7,Cobalamins
26917-5,Streptococcus pneumoniae 23 Ab
26918-3,PENTobarbital
26919-1,Alpha aminobutyrate/Creatinine
26920-9,Amobarbital
26921-7,Cells.CD2+CD26+
Feb-92,Osmolality
26922-5,Cells.CD4+CD45RA+/100 cells
26923-3,Butabarbital
26924-1,Cancer Ag 19-9
26925-8,Acetophenazine
26926-6,Ganglioside GD1b Ab
26927-4,Herpes simplex virus 2 Ab.IgM
26928-2,Vasopressin
26929-0,Glycine
2693-0,Osmolality
26930-8,Secobarbital
26931-6,Complement C4
26932-4,Sarcosine
26933-2,Oxazepam
26934-0,LORazepam
26935-7,diazePAM
26936-5,Hydroxyethylflurazepam
26937-3,Temazepam
26938-1,chlordiazePOXIDE
26939-9,Streptococcus pneumoniae 19 Ab
26940-7,Myelin basic protein
26941-5,Streptococcus pneumoniae 9 Ab
26942-3,Mumps virus Ab
26943-1,11-Ketoandrosterone
26944-9,11-Ketoandrosterone
26945-6,Triazolam
26946-4,Mycoplasma pneumoniae Ab.IgM
26947-2,Mycoplasma pneumoniae Ab.IgG
Aug-94,Osmolality
26948-0,Saccharopolyspora rectivirgula Ab.IgG
26949-8,Thermoactinomyces sp Ab.IgG
26950-6,11-Hydroxyetiocholanolone
26951-4,Alternaria alternata Ab.IgG
26952-2,Phoma herbarum Ab.IgG
26953-0,Dichlorodiphenyltrichloroethane
26954-8,Aspergillus fumigatus Ab.IgG
May-95,Osmolality
26955-5,Aureobasidium pullulans Ab.IgG
26956-3,Cocaine
26957-1,Penicillium notatum Ab.IgG
26958-9,IgM
26959-7,Amphetamine
26960-5,Trypsin
26961-3,Valine
26962-1,Cystine
Mar-96,Osmolality
26963-9,Methionine
26964-7,Cystathionine
26965-4,Isoleucine
26966-2,Tyrosine
26967-0,Phenylalanine
26968-8,Beta alanine
26969-6,Parietal cell Ab
26970-4,Reticulin Ab.IgG
Jan-97,Osteocalcin
26971-2,Smooth muscle Ab
26972-0,Herpes virus 7 Ab.IgG
26973-8,Beta aminoisobutyrate
26974-6,Delta aminolevulinate
26975-3,SCL-70 extractable nuclear Ab
26976-1,Hydroxytriazolam
26977-9,Coproporphyrin 1
26978-7,Protriptyline
26979-5,Flurazepam
26980-3,Coccidioides immitis Ab
26981-1,Phenylalanine
26982-9,Cells.CD4+CD25+
26983-7,Cells.CD4+HLA-DR+
26984-5,Helicobacter pylori Ab.IgG
26985-2,Arginine
26986-0,Trichoderma viride Ab.IgG
26987-8,Pentachlorophenol/Creatinine
26988-6,18-Hydroxydeoxycorticosterone
Sep-98,Osteonectin
26989-4,Trypanosoma cruzi Ab.IgM
26990-2,Phentermine
26991-0,Phenylpropanolamine
26992-8,Mephentermine
26993-6,Benzfetamine
26994-4,Phencyclidine
26995-1,Carboxy tetrahydrocannabinol
26996-9,Complement C7
Jul-99,Oxalate
26997-7,Cells.CD3+CD25+
26998-5,Thyrotropin
26999-3,Homocystine
27000-9,Thyroxine
27001-7,Diethyl ether
27002-5,Secobarbital
Mar-00,Oxalate
27003-3,Mephobarbital
27004-1,Benzfetamine
27005-8,Xylose^9th specimen post XXX challenge
27006-6,Xylose^8th specimen post XXX challenge
27007-4,acetoHEXAMIDE
27008-2,Xylose^6th specimen post XXX challenge
27009-0,Coccidioides sp Ab.IgG
27010-8,Mesoporphyrin
Jan-01,Oxalate
27011-6,Cells.CD14
27012-4,Benzaldehyde
27013-2,Alanine
27014-0,Inhibin A
27015-7,Polychlorinated biphenyl
27016-5,Xylose^7th specimen post XXX challenge
27017-3,Allyl alcohol
27018-1,IgG.monoclonal
27019-9,IgA.monoclonal
27020-7,IgM.monoclonal
27021-5,Neisseria gonorrhoeae Ab
27022-3,Para aminophenol/Creatinine
27023-1,Cells.CD8+CD11b+
27024-9,Cannabinoids
27025-6,glipiZIDE
27026-4,Benzoylecgonine
27027-2,Cystine
27028-0,Ketones^2H post XXX challenge
Sep-02,Oxalate renal clearance
27029-8,Norpropoxyphene
27030-6,Myelin associated glycoprotein Ab.IgM
27031-4,Oxyphenisatin
27032-2,Zirconium
27033-0,Proline
27034-8,Drugs identified
27035-5,Dihydrocodeine+Hydrocodeinone
27036-3,Norchlordiazepoxide
Jul-03,Oxygen
27037-1,Calcium/Creatinine
27038-9,Endomysium Ab.IgA
27039-7,Ammonia
27040-5,Ketones^1H post XXX challenge
27041-3,Norpropoxyphene
27042-1,Methohexital
27043-9,Glutamine
27044-7,1-Methylhistidine
May-04,Oxygen
27045-4,Microscopic exam
27046-2,3-Methylhistidine
27047-0,Anserine
27048-8,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab
27049-6,Secobarbital
27050-4,Mephobarbital
27051-2,PHENobarbital
Feb-05,Oxygen
27052-0,Methadone
27053-8,Morphine
27054-6,Morphine.free
27055-3,Catecholamines.free
27056-1,Citrulline
27057-9,Serotonin
27058-7,Beta alanine
27059-5,traZODone
2706-0,Oxygen
27060-3,Melatonin
27061-1,Butabarbital
27062-9,Ketones^1H post XXX challenge
27063-7,Benzodiazepines
27064-5,Opiates
27065-2,Ketones^2H post XXX challenge
27066-0,Ketones^3H post XXX challenge
27067-8,Propoxyphene
27068-6,Purkinje cells Ab
27069-4,Cisapride
27070-2,Loratadine
27071-0,Cells.CD45
27072-8,14-3-3 Ag
27073-6,6-Monoacetylmorphine
27074-4,Methylenedioxyethylamphetamine
27075-1,Lycopene
27076-9,Dextromethorphan+Levorphanol
27077-7,Enterococcus sp Ab.IgM
Aug-07,Oxygen affinity
27078-5,Carotene.alpha
27079-3,Methylenedioxyethylamphetamine
27080-1,Methylenedioxyethylamphetamine
27081-9,Itraconazole+Hydroxyitraconazole
27082-7,Delavirdine
27083-5,Norflunitrazepam
27084-3,7-Aminoflunitrazepam
27085-0,Methylenedioxyethylamphetamine
Jun-08,Oxygen saturation
27086-8,Cannabinoids
27087-6,Herpes simplex virus 2 Ab
27088-4,Folate
27089-2,Asparagine
270-9,Gramicidin D
27090-0,Entamoeba histolytica Ab.IgA
27091-8,Calcium
27092-6,Streptococcus pneumoniae 1 Ab.IgG
27093-4,Leptospira sp Ab.IgG
Apr-09,Oxygen saturation
27094-2,Streptococcus pneumoniae 4 Ab.IgG
27095-9,Parvovirus B19 Ab.IgG
27096-7,Streptococcus pneumoniae 3 Ab.IgG
27097-5,2-Methylbutyrylglycine/Creatinine
27098-3,Methionine
27099-1,Riboflavin
27100-7,Probenecid
27101-5,Phenmetrazine
Feb-10,Oxygen saturation
27102-3,Phendimetrazine
27103-1,Procyclidine
27104-9,Glutamate
27105-6,Amphetamines
27106-4,Zinc
27107-2,Lysine
27108-0,Oleate
27109-8,PARoxetine
2711-0,Oxygen saturation
27110-6,Androsterone
27111-4,Histidine
27112-2,Microscopic observation
27113-0,Streptococcus pneumoniae 8 Ab.IgG
27114-8,Cocaine
27115-5,Parvovirus B19 Ab.IgM
27116-3,Methamphetamine
27117-1,Cadmium
27118-9,Streptococcus pneumoniae Danish serotype 6B Ab.IgG
27119-7,Streptococcus pneumoniae 23 Ab^2nd specimen
27120-5,Streptococcus pneumoniae Danish serotype 7F Ab^2nd specimen
27121-3,Streptococcus pneumoniae Danish serotype 18C Ab^2nd specimen
27122-1,Magnesium
27123-9,Phosphate
27124-7,Copper
27125-4,Zinc
27126-2,Streptococcus pneumoniae 14 Ab^2nd specimen
27127-0,Arsenic
Aug-12,Oxygen saturation.calc from carbon dioxide.partial pressure
27128-8,Streptococcus pneumoniae 12 Ab^2nd specimen
27129-6,Lead
27130-4,Mercury
27131-2,Phencyclidine
27132-0,Acetoacetate
27133-8,Citrate
27134-6,Argininosuccinate
27135-3,Tryptophan
Jun-13,Oxygen saturation
27136-1,Opiates
27137-9,Antimony
27138-7,Streptococcus pneumoniae 23 Ab^1st specimen
27139-5,Streptococcus pneumoniae 7f Ab.IgG
27140-3,Follitropin.alpha subunit
27141-1,Streptococcus pneumoniae 1 Ab^1st specimen
27142-9,Streptococcus pneumoniae 3 Ab^1st specimen
27143-7,Streptococcus pneumoniae 4 Ab^1st specimen
Apr-14,Oxyhemoglobin/Hemoglobin.total
27144-5,Streptococcus pneumoniae 8 Ab^1st specimen
27145-2,Streptococcus pneumoniae 9 Ab^1st specimen
27146-0,Streptococcus pneumoniae 12 Ab^1st specimen
27147-8,Streptococcus pneumoniae 19 Ab^2nd specimen
27148-6,Streptococcus pneumoniae 19 Ab^1st specimen
27149-4,Thiamine
27150-2,Streptococcus pneumoniae Danish serotype 7F Ab^1st specimen
Jan-15,Oxyhemoglobin/Hemoglobin.total
27151-0,Streptococcus pneumoniae Danish serotype 18C Ab^1st specimen
27152-8,Streptococcus pneumoniae 1 Ab^2nd specimen
27153-6,Streptococcus pneumoniae 3 Ab^2nd specimen
27154-4,Streptococcus pneumoniae 4 Ab^2nd specimen
27155-1,Streptococcus pneumoniae 6 Ab^2nd specimen
27156-9,Streptococcus pneumoniae 8 Ab^2nd specimen
27157-7,Streptococcus pneumoniae 9 Ab^2nd specimen
27158-5,Streptococcus pneumoniae 14 Ab^1st specimen
27159-3,Herpes virus 6 Ab.IgM
27160-1,Hydrastine
27161-9,Interleukin 4
27162-7,1-Methylhistidine
27163-5,N-methylacetamide/Creatinine
27164-3,acetoHEXAMIDE
27165-0,Hexobarbital
27166-8,TOLAZamide
27167-6,Chlamydia trachomatis Ab.IgM
27168-4,Herpes virus 6 Ab.IgG
Sep-16,Oxyhemoglobin/Hemoglobin.total
27169-2,Butyrate
271-7,Gramicidin D
27170-0,TOLBUTamide
27171-8,Chlorphentermine
27172-6,Calcium
27173-4,Propylthiouracil
27174-2,Inhibin
27175-9,glyBURIDE
27176-7,3-Methylhistidine
Jul-17,Oxyhemoglobin/Hemoglobin.total
27177-5,Herpes virus 7 Ab.IgM
27178-3,Phendimetrazine
27179-1,Threonine
27180-9,Bisacodyl
27181-7,Hydroxyproline
27182-5,Calcium
27183-3,Cardiolipin Ab.IgG
27184-1,Alpha 1 globulin
May-18,Oxytocin
27185-8,Chlamydia trachomatis Ab.IgG
27186-6,Lysozyme
27187-4,Methohexital
27188-2,Methylenedioxymethamphetamine
27189-0,Methylenedioxyamphetamine
27190-8,Propoxyphene
27191-6,PHENobarbital
27192-4,diazePAM
Mar-19,Palmitate
27193-2,Tetrahydrocannabinol
27194-0,N-desalkylflurazepam
27195-7,Hydroxylysine
27196-5,HYDROmorphone.free
27197-3,Benzodiazepines
27198-1,Bilirubin
27199-9,18-Hydroxycortisol/Creatinine
27200-5,Nuclear Ab
Jan-20,Palmitoylphosphatidyl choline
27201-3,Zinc/Creatinine
27202-1,Halothane
27203-9,Follitropin
27204-7,Cocaine
27205-4,Amphetamines
27206-2,Morphine.free
27207-0,Methadone
27208-8,Drugs identified
27209-6,Histoplasma capsulatum yeast phase Ab
27210-4,Magnesium
27211-2,Norpropoxyphene
27212-0,DOPamine
27213-8,Carboxy tetrahydrocannabinol
27214-6,Purkinje cells Ab
27215-3,Mitochondria M2 Ab.IgG
27216-1,sulfADIAZINE
27217-9,Beta aminoisobutyrate
27218-7,quiNINE
Sep-21,Pancreatic polypeptide
27219-5,Ornithine
27220-3,Histoplasma capsulatum mycelial phase Ab
27221-1,Norepinephrine
27222-9,Oxalate
27223-7,Serine
27224-5,Barbiturates
27225-2,Estriol
27226-0,Cocaethylene
Jul-22,Pantothenate
27227-8,Streptococcus pneumoniae 1 Ab.IgG
27228-6,Streptococcus pneumoniae 3 Ab.IgG
27229-4,Streptococcus pneumoniae 14 Ab.IgG
27230-2,Streptococcus pneumoniae 19 Ab.IgG
27231-0,Streptococcus pneumoniae 23 Ab.IgG
27232-8,Lead
27233-6,Lecithin
27234-4,Phentermine
May-23,Para aminohippurate renal clearance
27235-1,PHENobarbital
27236-9,Azatadine
27237-7,LORazepam
27238-5,Oxazepam
27239-3,Nordiazepam
27240-1,PHENobarbital
27241-9,Mephobarbital
27242-7,Secobarbital
Mar-24,Para aminohippurate
27243-5,PENTobarbital
27244-3,Methylenedioxyamphetamine
27245-0,Amobarbital
27246-8,Butalbital
27247-6,Hydroxyethylflurazepam
27248-4,Benzoylecgonine
27249-2,Temazepam
272-5,Gramicidin D
2725-0,Para methylhippurate
27250-0,Phenmetrazine
27251-8,Phenylpropanolamine
27252-6,Choriogonadotropin.alpha subunit
27253-4,Chlorphentermine
27254-2,Amino beta guanidinopropionate/Creatinine
27255-9,Magnesium
27256-7,Aspartate
27257-5,Sodium
27258-3,Protein
27259-1,Estriol.unconjugated
27260-9,Schistosoma sp Ab.IgG
27261-7,Polio virus Ab
27262-5,Methaqualone
27263-3,Amphetamines
27264-1,Aluminum
27265-8,Giardia sp Ag
27266-6,Histoplasma capsulatum Ab
27267-4,Homovanillate
Aug-26,Para nitrophenol
27268-2,Hydroxydecanedioate
27269-0,Isocitrate
27270-8,4-Hydroxyphenylacetate
27271-6,Alpha ketoglutarate
27272-4,3-Hydroxyisobutyrate
27273-2,Chlamydia sp Ab
27274-0,Benzfetamine
27275-7,diazePAM
Jun-27,Para nitrophenol
27276-5,Azatadine
27277-3,Methamphetamine
27278-1,Phosphoethanolamine
27279-9,Paraoxon
27280-7,Tripelennamine
27281-5,Propoxyphene
27282-3,Carbinoxamine
27283-1,Methadone
Apr-28,Parathion
27284-9,Brompheniramine
27285-6,Estazolam
27286-4,Triazolam
27287-2,Flurazepam
27288-0,Midazolam
27289-8,Methamphetamine
27290-6,Phenmetrazine
27291-4,Hydroxylysine
Feb-29,Parathyrin related protein
27292-2,Ornithine
27293-0,oxyCODONE.free
27294-8,Carnosine
27295-5,Cocaethylene
27296-3,Arginine
27297-1,Leukocyte esterase
27298-9,Protein
27299-7,Methylenedioxyethylamphetamine
27-Mar,Ampicillin
2730-0,Parathyrin.C-terminal
27300-3,Mephentermine
27301-1,Glutarate
27302-9,Midazolam
27303-7,Phendimetrazine
27304-5,Lysine
27305-2,Phentermine
27306-0,Testosterone
27307-8,Chlorphentermine
27308-6,PENTobarbital
27309-4,Aspergillus flavus Ab
27310-2,Taurine
27311-0,Codeine.free
27312-8,HYDROcodone.free
27313-6,Aspergillus niger Ab
27314-4,HYDROmorphone.free
27315-1,Herpes simplex virus 2 Ab.IgG
27316-9,Dioxin
27317-7,Asparagine
Aug-31,Parathyrin.intact
27318-5,Mycoplasma pneumoniae Ab
27319-3,Reducing substances
27320-1,Parietal cell Ab
27321-9,Opiates
27322-7,Threonine
27323-5,Leucine
27324-3,Amobarbital
27325-0,Glycine
Jun-32,Parathyrin.mid molecule
27326-8,Alanine
27327-6,Spermatozoa.motile/100 spermatozoa^12H post ejaculation
27328-4,Somatotropin^6th specimen post XXX challenge
27329-2,Feline panleukopenia virus Ab.IgM
273-3,Gramicidin D
27330-0,Insulin^1.5H post XXX challenge
27331-8,Imipenem
27332-6,Feline panleukopenia virus Ab.IgG
27333-4,Lysine
Apr-33,Parathyrin.N-terminal
27334-2,Tryptophan
27335-9,Ornithine
27336-7,Amino acids
27337-5,Amino beta guanidinopropionate
27338-3,"2,4-Dichlorophenoxyacetate"
27339-1,Nicotinamide
27340-9,Cholesterol.in HDL
27341-7,Alpha aminobutyrate
Feb-34,Pentoses
27342-5,Fasciola hepatica Ab
27343-3,Molybdenum
27344-1,Aspartate aminotransferase
27345-8,Hemoglobin A2
27346-6,Benzfetamine
27347-4,Methaqualone
27348-2,DOPamine^2H post XXX challenge
27349-0,Cystathionine
27350-8,Cystine
27351-6,Pantothenate
27352-4,Homocystine
27353-2,Estimated average glucose
27354-0,Toxoplasma gondii Ab.IgE
27355-7,Lipoprotein.pre-beta
27356-5,Phencyclidine
27357-3,HYDROcodone.free
27358-1,Benzoylecgonine
Sep-35,Pepsinogen
27359-9,Somatotropin^15th specimen post XXX challenge
27360-7,Myelin basic protein Ab
27361-5,Tyrosine
27362-3,Phenylalanine
27363-1,DOPamine^3H post XXX challenge
27364-9,Aspergillus niger Ab
27365-6,Immunoglobulin light chains.kappa
27366-4,Somatotropin^22nd specimen post XXX challenge
Jul-36,Pepsinogen I
27367-2,Manganese/Creatinine
27368-0,Chlamydia trachomatis B Ab
27369-8,Somatotropin^2.5H post XXX challenge
27370-6,Chlamydia trachomatis C Ab
27371-4,Chlamydia trachomatis G+F+K Ab
27372-2,Insulin^20M post XXX challenge
27373-0,Calcium
27374-8,Streptococcus pneumoniae 12 Ab.IgG
May-37,Pepsinogen I
27375-5,Aspergillus fumigatus Ab
27376-3,C peptide
27377-1,Aspergillus flavus Ab
27378-9,pH
27379-7,Insulin^1H post XXX challenge
27380-5,DOPamine^4H post XXX challenge
27381-3,Alloisoleucine
27382-1,Porphobilinogen
Mar-38,Pepsinogen II
27383-9,Feline herpesvirus 1 Ab
27384-7,Leptospira sp Ab.IgM
27385-4,Somatotropin^18th specimen post XXX challenge
27386-2,Blastomyces dermatitidis Ab
27387-0,Streptococcus pneumoniae 14 Ab.IgG
27388-8,Streptococcus pneumoniae 26 Ab.IgG
27389-6,Streptococcus pneumoniae 23 Ab.IgG
27390-4,Streptococcus pneumoniae 19 Ab.IgG
Jan-39,Pepsinogen
27391-2,Candida sp Ab.IgM
27392-0,Streptococcus pneumoniae 9 Ab.IgG
27393-8,Streptococcus pneumoniae 23f Ab.IgG
27394-6,Immunoglobulin light chains.lambda
27395-3,Streptococcus pneumoniae Danish serotype 18C Ab.IgG
27396-1,Hemoglobin.gastrointestinal
27397-9,Streptococcus pneumoniae 12f Ab.IgG
27398-7,Streptococcus pneumoniae 9n Ab.IgG
27399-5,1-Methylhistidine
27400-1,Hexacarboxylporphyrin
27401-9,Hemoglobin.gastrointestinal^6th specimen
27402-7,Norparamethadione
27403-5,Gamma glutamyl transferase
27404-3,Chlamydophila psittaci Ab.IgM
27405-0,Streptococcus pneumoniae 56 Ab.IgG
27406-8,Streptococcus pneumoniae 19f Ab.IgG
27407-6,Streptococcus pneumoniae 14 Ab.IgG^1st specimen
27408-4,C peptide^20M post XXX challenge
Sep-40,Pepsins
27409-2,Methylenedianiline
274-1,Hetacillin
27410-0,Spermatozoa.motile/100 spermatozoa^24H post ejaculation
27411-8,Iron/Creatinine
27412-6,Ephedrine+Pseudoephedrine
27413-4,Dextromethorphan
27414-2,Fungus identified
27415-9,Interferon.gamma
27416-7,SCL-70 extractable nuclear Ab
Jul-41,Pepsins
27417-5,Candida sp Ab.IgA
27418-3,chlordiazePOXIDE
27419-1,Sodium
27420-9,Phosphatidylglycerol
27421-7,C peptide^40M post XXX challenge
27422-5,Streptococcus pneumoniae 3 Ab.IgG^2nd specimen
27423-3,"1,4-Dioxane"
27424-1,Deoxypyridinoline
May-42,Angiotensin converting enzyme
27425-8,Streptococcus pneumoniae 14 Ab.IgG^2nd specimen
27426-6,Trichinella sp Ab.IgM
27427-4,Streptococcus pneumoniae Danish serotype 7F Ab.IgG^2nd specimen
27428-2,Streptococcus pneumoniae 1 Ab.IgG^1st specimen
27429-0,Streptococcus pneumoniae 19 Ab.IgG^2nd specimen
27430-8,Streptococcus pneumoniae 3 Ab.IgG^1st specimen
27431-6,Streptococcus pneumoniae 1 Ab.IgG^2nd specimen
27432-4,Glucose^8th specimen post XXX challenge
Mar-43,pH
27433-2,Streptococcus pneumoniae Danish serotype 7F Ab.IgG^1st specimen
27434-0,Streptococcus pneumoniae 23 Ab.IgG^1st specimen
27435-7,Streptococcus pneumoniae 19 Ab.IgG^1st specimen
27436-5,N-desalkylflurazepam
27437-3,Streptococcus pneumoniae 23 Ab.IgG^2nd specimen
27438-1,Protein C Ag/Coagulation factor VII Ag
27439-9,Alpha hydroxyalprazolam
27440-7,Candida sp Ag
Jan-44,pH
27441-5,Potassium
27442-3,Phenylpropanolamine
27443-1,DOPamine^1H post XXX challenge
27444-9,Insulin^40M post XXX challenge
27445-6,Initial evaluation note
27446-4,Plan of treatment
27447-2,Progress note+attainment of goals
27448-0,Reason to continue
27449-8,Justification
27450-6,Psychiatric symptoms
27456-3,Author ID
27457-1,Diagnosis.primary
Aug-45,pH
27458-9,Start date
27459-7,End date
27460-5,Diagnosis.primary
27461-3,Medication name + ID
27462-1,Medication XXX
27463-9,Medication timing + Quantity
27464-7,Diagnosis.primary
27465-4,Diagnosis.addressed by plan
Jun-46,pH
27466-2,Diagnosis.addressed by plan
27468-8,Medication route
27470-4,New &or revised
27471-2,Date.onset or exacerbation
27472-0,Date.start
27473-8,Clinical discipline
Apr-47,pH
27474-6,New &or revised
27475-3,Date.start
27476-1,Clinical discipline
27477-9,Diagnosis.addressed by plan
27478-7,Author of treatment plan
27479-5,Author name
27480-3,Author profession
27481-1,Signature date
Feb-48,pH
27482-9,Visit frequency
27483-7,New &or revised
27484-5,Date.onset or exacerbation
27485-2,Date.start
27486-0,Visit duration
27487-8,Date range (from_through) described by plan
27488-6,Start date
27489-4,Date.end
2749-0,pH
27490-2,Date range
27491-0,Continuation status
27492-8,Date attending MD referred patient for
27493-6,Date attending MD signed
27494-4,Date rehabilitation professional signed
27495-1,Signature of responsible attending physician on file
27496-9,Signature of responsible rehabilitation professional on file
27497-7,Clinical discipline
27498-5,Medication administered
27499-3,Prognosis for rehabilitation
27500-8,Estimated date of completion
27501-6,Date of last plan of treatment certification
27502-4,Past medical history+Level of function
27503-2,Initial evaluation note
27504-0,Plan of treatment
27505-7,Progress note+attainment of goals
27506-5,Reason to continue
27507-3,Justification
Aug-50,pH
27508-1,Psychiatric symptoms
27514-9,Author ID
27515-6,Diagnosis.primary
Jun-51,pH
27516-4,Start date
27517-2,End date
27518-0,Diagnosis.addressed by plan
27519-8,Author of treatment plan
27520-6,Author name
27521-4,Author profession
27522-2,Signature date
27523-0,Diagnosis.primary
Apr-52,pH
27524-8,Medication name + ID
27525-5,Medication XXX
27526-3,Medication timing + Quantity
27527-1,Diagnosis.primary
27528-9,Diagnosis.addressed by plan
27529-7,Diagnosis.addressed by plan
27531-3,Visit frequency
Feb-53,pH
27532-1,Visit duration
27533-9,Date range (from_through) described by plan
27534-7,Start date
27535-4,Date.end
27536-2,Date range
27537-0,Medication route
27539-6,Continuation status
2754-0,pH
27540-4,Date attending MD referred patient for
27541-2,Date attending MD signed
27542-0,Date rehabilitation professional signed
27543-8,Signature of responsible attending physician on file
27544-6,Signature of responsible rehabilitation professional on file
27545-3,Medication administered
27546-1,Prognosis for rehabilitation
27547-9,Estimated date of completion
27548-7,Date of last plan of treatment certification
27549-5,Past medical history+Level of function
27550-3,Diagnosis.addressed by plan
27551-1,Author of treatment plan
27552-9,Author name
27553-7,Author profession
27554-5,Signature date
27555-2,Visit frequency
27556-0,Visit duration
Jul-55,pH
27557-8,Date range (from_through) described by plan
27558-6,Start date
27559-4,Date.end
27560-2,Date range
27561-0,Continuation status
27562-8,Date attending MD referred patient for
27563-6,Date attending MD signed
27564-4,Date rehabilitation professional signed
May-56,pH
27565-1,Signature of responsible attending physician on file
27566-9,Signature of responsible rehabilitation professional on file
27567-7,Medication administered
27568-5,Prognosis for rehabilitation
27569-3,Estimated date of completion
27570-1,Date of last plan of treatment certification
27571-9,Past medical history+Level of function
27572-7,Initial evaluation note
Mar-57,Phenol
27573-5,Plan of treatment
27574-3,Progress note+attainment of goals
27575-0,Reason to continue
27576-8,Justification
27577-6,Psychiatric symptoms
275-8,Hetacillin
Jan-58,Phenol
27583-4,Author ID
27584-2,Diagnosis.primary
27585-9,Start date
27586-7,End date
27587-5,Diagnosis.primary
27588-3,Medication name + ID
27589-1,Medication XXX
27590-9,Medication timing + Quantity
27591-7,Diagnosis.primary
27592-5,Diagnosis.addressed by plan
27593-3,Diagnosis.addressed by plan
27595-8,Medication route
27597-4,New &or revised
27598-2,Date.onset or exacerbation
Sep-59,Phenols
27599-0,Date.start
27600-6,Clinical discipline
27601-4,Diagnosis.addressed by plan
27602-2,Author of treatment plan
27603-0,Author name
27604-8,Author profession
27605-5,Signature date
27606-3,Visit frequency
Jul-60,Phenolsulphonphthalein
27607-1,Visit duration
27608-9,Date range (from_through) described by plan
27609-7,Start date
27610-5,Date.end
27611-3,Date range
27612-1,Continuation status
27613-9,Date attending MD referred patient for
27614-7,Date attending MD signed
May-61,Phenylketones
27615-4,Date rehabilitation professional signed
27616-2,Signature of responsible attending physician on file
27617-0,Signature of responsible rehabilitation professional on file
27618-8,Medication administered
27619-6,Prognosis for rehabilitation
27620-4,Estimated date of completion
27621-2,Date of last plan of treatment certification
27622-0,Past medical history+Level of function
Mar-62,Phenylalanine
27623-8,Assessment.initial
27624-6,Plan of treatment
27625-3,Progress note+attainment of goals
27626-1,Reason to continue
27627-9,Justification
27628-7,Psychiatric symptoms
Jan-63,Phenylalanine
27634-5,Author ID
27635-2,Diagnosis.primary
27636-0,Start date
27637-8,End date
27638-6,Diagnosis.primary
27639-4,Medication name + ID
27640-2,Medication XXX
27641-0,Medication timing + Quantity
27642-8,Diagnosis.primary
27643-6,Diagnosis.addressed by plan
27644-4,Diagnosis.addressed by plan
27646-9,Medication route
27648-5,Start date
Sep-64,Phenylalanine
27649-3,End date
27650-1,Diagnosis.primary
27651-9,Medication name + ID
27652-7,Medication XXX
27653-5,Medication timing + Quantity
27654-3,Diagnosis.primary
27655-0,Diagnosis.addressed by plan
Jun-65,Phenylalanine
27656-8,Diagnosis.addressed by plan
27658-4,Medication route
276-6,Hetacillin
27660-0,New &or revised
27661-8,Date.onset or exacerbation
27662-6,Date.start
27663-4,Clinical discipline
Apr-66,Phenylalanine
27664-2,Diagnosis.addressed by plan
27665-9,Author of treatment plan
27666-7,Author name
27667-5,Author profession
27668-3,Signature date
27669-1,Visit frequency
27670-9,Visit duration
27671-7,Date range (from_through) described by plan
Feb-67,Phenylalanine
27672-5,Start date
27673-3,Date.end
27674-1,Date range
27675-8,Continuation status
27676-6,Date attending MD referred patient for
27677-4,Date attending MD signed
27678-2,Date rehabilitation professional signed
27679-0,Signature of responsible attending physician on file
2768-0,Phenylalanine/Tyrosine
27680-8,Signature of responsible rehabilitation professional on file
27681-6,Medication administered
27682-4,Prognosis for rehabilitation
27683-2,Estimated date of completion
27684-0,Date of last plan of treatment certification
27685-7,Past medical history+Level of function
27686-5,Assessment.initial
27687-3,Plan of treatment
27688-1,Progress note+attainment of goals
27689-9,Reason to continue
27690-7,Justification
27691-5,Psychiatric symptoms
27697-2,Author ID
Aug-69,Phenylketones
27698-0,Diagnosis.primary
27699-8,New &or revised
27700-4,Date.onset or exacerbation
27701-2,Date.start
27702-0,Clinical discipline
27703-8,Diagnosis.addressed by plan
27704-6,Author of treatment plan
27705-3,Author name
Jun-70,Phenylpyruvate
27706-1,Author profession
27707-9,Signature date
27708-7,Visit frequency
27709-5,Visit duration
27710-3,Date range (from_through) described by plan
27711-1,Start date
27712-9,Date.end
27713-7,Date range
Apr-71,Phenylpyruvate
27714-5,Continuation status
27715-2,Date attending MD referred patient for
27716-0,Date attending MD signed
27717-8,Date rehabilitation professional signed
27718-6,Signature of responsible attending physician on file
27719-4,Signature of responsible rehabilitation professional on file
27720-2,Medication administered
27721-0,Prognosis for rehabilitation
Feb-72,Phenylpyruvate
27722-8,Estimated date of completion
27723-6,Date of last plan of treatment certification
27724-4,Past medical history+Level of function
27725-1,Initial evaluation note
27726-9,Plan of treatment
27727-7,Progress note+attainment of goals
27728-5,Reason to continue
27729-3,Justification
2773-0,Phenylpyruvate
27730-1,Psychiatric symptoms
27736-8,Author ID
27737-6,Diagnosis.primary
27738-4,Start date
27739-2,End date
277-4,Hetacillin
27740-0,Diagnosis.primary
27741-8,Medication name + ID
27742-6,Medication XXX
27743-4,Medication timing + Quantity
27744-2,Diagnosis.primary
27745-9,Diagnosis.addressed by plan
27746-7,Diagnosis.addressed by plan
Aug-74,Phosphate
27748-3,Medication route
27750-9,New &or revised
27751-7,Date.onset or exacerbation
27752-5,Date.start
27753-3,Clinical discipline
27754-1,Diagnosis.addressed by plan
May-75,Phosphate
27755-8,Author of treatment plan
27756-6,Author name
27757-4,Author profession
27758-2,Signature date
27759-0,Visit frequency
27760-8,Visit duration
27761-6,Date range (from_through) described by plan
27762-4,Start date
Mar-76,Phosphate renal clearance
27763-2,Date.end
27764-0,Date range
27765-7,Continuation status
27766-5,Date attending MD referred patient for
27767-3,Date attending MD signed
27768-1,Date rehabilitation professional signed
27769-9,Signature of responsible attending physician on file
27770-7,Signature of responsible rehabilitation professional on file
Jan-77,Phosphate
27771-5,Medication administered
27772-3,Prognosis for rehabilitation
27773-1,Estimated date of completion
27774-9,Date of last plan of treatment certification
27775-6,Past medical history+Level of function
27776-4,Initial evaluation note
27777-2,Plan of treatment
27778-0,Progress note+attainment of goals
27779-8,Reason to continue
27780-6,Justification
27781-4,Psychiatric symptoms
27787-1,Author ID
27788-9,Diagnosis.primary
Sep-78,Phosphate
27789-7,Start date
27790-5,End date
27791-3,Diagnosis.primary
27792-1,Medication name + ID
27793-9,Medication XXX
27794-7,Medication timing + Quantity
27795-4,Diagnosis.primary
27796-2,Diagnosis.addressed by plan
Jul-79,Phosphate
27797-0,Diagnosis.addressed by plan
27799-6,Medication route
27801-0,Date.onset or exacerbation
May-80,Phosphate
27810-1,Plasmin inhibitor actual/Normal
27811-9,Antithrombin actual/Normal
27812-7,Antithrombin Ag actual/Normal
Mar-81,Phosphate
27813-5,Prothrombin Ag actual/Normal
27814-3,Coagulation factor VII+Coagulation factor X activity actual/Normal
27815-0,Coagulation factor XIII activity actual/Normal
27816-8,von Willebrand factor Ag actual/Normal
27817-6,Beta 2 glycoprotein 1 Ab
27818-4,Protein C actual/Normal
27819-2,Protein C actual/Normal
278-2,Imipenem
27820-0,Protein C Ag actual/Normal
Jan-82,Phosphate
27821-8,Protein S.free Ag actual/Normal
27822-6,Protein S actual/Normal
27823-4,Protein S Ag actual/Normal
27824-2,Prothrombin fragment 1+2 Ag
27825-9,Platelet associated Ab
27826-7,Insulin^2H post XXX challenge
27827-5,Insulin^30M post XXX challenge
27828-3,Insulin^3H post XXX challenge
27829-1,Somatotropin^8th specimen post XXX challenge
27830-9,Insulin^1H post 75 g glucose PO
27831-7,Immune complex
27832-5,Insulin^4th specimen post XXX challenge
27833-3,Insulin^7H post 75 g glucose PO
27834-1,Insulin^1.5H post 75 g glucose PO
27835-8,Somatotropin^11th specimen post XXX challenge
27836-6,Somatotropin^12th specimen post XXX challenge
27837-4,Somatotropin^13th specimen post XXX challenge
27838-2,Somatotropin^14th specimen post XXX challenge
Sep-83,Lecithin
27839-0,C peptide^4H post XXX challenge
27840-8,Somatotropin^16th specimen post XXX challenge
27841-6,Somatotropin^17th specimen post XXX challenge
27842-4,Somatotropin^19th specimen post XXX challenge
27843-2,Somatotropin^20th specimen post XXX challenge
27844-0,Somatotropin^21st specimen post XXX challenge
27845-7,Somatotropin^23rd specimen post XXX challenge
27846-5,Somatotropin^24th specimen post XXX challenge
Jul-84,Phosphatidylcholine.saturated
27847-3,Somatotropin^25th specimen post XXX challenge
27848-1,Lutropin^2nd specimen post XXX challenge
27849-9,Aldosterone^2nd specimen post XXX challenge
27850-7,Somatotropin^10M post XXX challenge
27851-5,Lutropin^3rd specimen post XXX challenge
27852-3,Insulin^5H post XXX challenge
27853-1,Lutropin^4th specimen post XXX challenge
Apr-85,Phosphatidylglycerol
27854-9,Lutropin^5th specimen post XXX challenge
27855-6,Lutropin^6th specimen post XXX challenge
27856-4,Proinsulin^2H post XXX challenge
27857-2,Proinsulin^3H post XXX challenge
27858-0,Lutropin^7th specimen post XXX challenge
27859-8,Sporothrix schenckii Ab
27860-6,Insulin^2H post 75 g glucose PO
27861-4,Insulin^3H post 75 g glucose PO
Feb-86,Phosphatidylglycerol
27862-2,Insulin^4H post 75 g glucose PO
27863-0,Insulin^2.5H post XXX challenge
27864-8,Follitropin^9th specimen post XXX challenge
27865-5,Follitropin^3rd specimen post XXX challenge
27866-3,17-Ketogenic steroids
27867-1,Insulin^7th specimen post XXX challenge
27868-9,Follitropin^5th specimen post XXX challenge
27869-7,Follitropin^8th specimen post XXX challenge
2787-0,Phosphatidylinositol
27870-5,Follitropin^4th specimen post XXX challenge
27871-3,Interferon.beta Ab.IgG
27872-1,Insulin^6H post 75 g glucose PO
27873-9,Insulin^post CFst
27874-7,Insulin^5th specimen post XXX challenge
27875-4,Insulin^6th specimen post XXX challenge
27876-2,Cells.CD14+CD11b+/100 cells
27877-0,Cells.CD33+CD11b+/100 cells
27878-8,Cells.CD14+HLA-DR+/100 cells
27879-6,Cells.CD33+HLA-DR+/100 cells
27880-4,Follitropin^6th specimen post XXX challenge
27881-2,Somatotropin^4th specimen post XXX challenge
27882-0,Proinsulin
27883-8,Lutropin^15M post XXX challenge
27884-6,Lutropin^40M post XXX challenge
27885-3,Lutropin^1.5H post XXX challenge
27886-1,Follitropin^40M post XXX challenge
27887-9,Follitropin^15M post XXX challenge
Aug-88,Phosphoenolpyruvate carboxykinase
27888-7,Somatotropin^2nd specimen post XXX challenge
27889-5,Somatotropin^3rd specimen post XXX challenge
27890-3,Somatotropin^5th specimen post XXX challenge
27891-1,Thyroxine^baseline
27892-9,Butyrylglycine/Creatinine
27893-7,Cells.CD19+CD23+/100 cells
27894-5,Sulfatide Ab.IgG
27895-2,Gastroenterology endoscopy studies
Jun-89,Phosphoethanolamine
27896-0,Pulmonary studies
27897-8,Neuromuscular electrophysiology studies
27898-6,Pathology studies
27899-4,Diagnostic studies.non lab
279-0,Imipenem
27900-0,Lactobacillus sp Ab.IgG
27901-8,Lactobacillus sp Ab.IgM
27902-6,Enterococcus sp Ab.IgG
27903-4,Coxsackievirus B2 Ab
Apr-90,Phosphoethanolamine
27904-2,Histidine
27905-9,Bacteroides fragilis Ab.IgM
27906-7,Lymphocytes.immature/100 leukocytes
27907-5,Cryptosporidium sp
27908-3,Coxsackievirus B1 Ab
27909-1,Calcium^1st specimen post XXX challenge
27910-9,Calcium^6th specimen post XXX challenge
27911-7,Gamma aminobutyrate
Feb-91,Phosphofructokinase
27912-5,Butalbital
27913-3,Calcium^7th specimen post XXX challenge
27914-1,Gamma aminoadipate
27915-8,Alpha-1-Antichymotrypsin
27916-6,Calcium^2nd specimen post XXX challenge
27917-4,Coxsackievirus B3 Ab
27918-2,Coxsackievirus B4 Ab
27919-0,Calcium^3rd specimen post XXX challenge
2792-0,Phosphofructokinase
27920-8,Normeperidine
27921-6,Alpha hydroxyalprazolam
27922-4,Echovirus 4 RNA
27923-2,Ubiquinone 10
27924-0,Ascaris sp Ab
27925-7,Hemoglobin.gastrointestinal^7th specimen
27926-5,Hemoglobin.gastrointestinal^8th specimen
27927-3,Butalbital
27928-1,Echovirus 30 RNA
27929-9,Mandelate
27930-7,Neutrophils/100 leukocytes
27931-5,Bile acid^2H post meal
27932-3,Neutrophils/100 leukocytes
27933-1,Calcium^5th specimen post XXX challenge
27934-9,Echovirus 11 RNA
27935-6,Calcium^4th specimen post XXX challenge
27936-4,Lymphocytes/100 leukocytes
27937-2,Sporothrix schenckii Ab
Aug-93,Phosphofructokinase.F subunit/Phosphofructokinase.total
27938-0,Salmonella paratyphi B O Ab
27939-8,Collagen crosslinked N-telopeptide
27940-6,Insulin^1.5H post 75 g glucose PO
27941-4,Lactate
27942-2,Follitropin
27943-0,Interferon.omega
27944-8,C peptide
27945-5,Coxiella burnetii phase 2 Ab
Jun-94,Phosphofructokinase.F subunit/Phosphofructokinase.total
27946-3,Lactate^1H post XXX challenge
27947-1,Coxsackievirus A7 RNA
27948-9,Herpes simplex virus 1+2 Ab.IgG
27949-7,Lactate^4H post XXX challenge
27950-5,Saint Louis encephalitis virus RNA
27951-3,Coxiella burnetii phase 1 Ab
27952-1,Enterovirus RNA
Mar-95,Phosphofructokinase.L subunit/Phosphofructokinase.total
27953-9,Methionine
27954-7,Coxsackievirus B6 RNA
27955-4,Lactate^2H post XXX challenge
27956-2,Proinsulin^1H post XXX challenge
27957-0,Pyruvate^4H post XXX challenge
27958-8,Proinsulin^4H post XXX challenge
27959-6,Pyruvate^baseline
27960-4,Coxsackievirus B5 RNA
Jan-96,Phosphofructokinase.M subunit/Phosphofructokinase.total
27961-2,Lactate^3H post XXX challenge
27962-0,Butalbital
27963-8,Pyruvate^1H post XXX challenge
27964-6,Streptococcus pneumoniae 6+26 Ab
27965-3,Babesia microti Ab.IgM
27966-1,Legionella pneumophila atypical Ab
27967-9,Progesterone^baseline
27968-7,Pyruvate^2H post XXX challenge
27969-5,Coxsackievirus A9 RNA
27970-3,Pyruvate^3H post XXX challenge
27971-1,Catecholamines^4H post XXX challenge
27972-9,Histidine
27973-7,3-Methylhistidine
27974-5,Arginine
27975-2,Thyrotropin
27976-0,Lactate^post CFst
27977-8,Norepinephrine/Creatinine
27978-6,Metanephrines/Creatinine
Sep-97,Phosphoglucomutase
27979-4,17-Ketogenic steroids
27980-2,Thyroxine binding globulin
27981-0,2-Hydroxyisobutyrate
27982-8,Borrelia burgdorferi 66kD Ab
27983-6,Borrelia burgdorferi 41kD Ab
27984-4,SCA8 gene.CAG repeats
27985-1,Borrelia burgdorferi 18kD Ab
27986-9,Borrelia burgdorferi 28kD Ab
Jul-98,Phosphoglycerate kinase
27987-7,Thyroxine.free^baseline
27988-5,Aldosterone^baseline
27989-3,Thyroxine.free^1H post XXX challenge
27990-1,Fibrinogen fragments
27991-9,Fibrinogen fragments
27992-7,Borrelia burgdorferi 23kD Ab
27993-5,Sympathomimetics
27994-3,Ehrlichia chaffeensis DNA
May-99,Phosphoglyceromutase
27995-0,Asparagine
27996-8,17-Hydroxyprogesterone^baseline
27997-6,Beta aminoadipate/Creatinine
27998-4,Estrone
27999-2,Toxoplasma gondii DNA
28000-8,von Willebrand factor Ag
Jan-00,Glucose phosphate isomerase
28001-6,Herpes simplex virus 1 Ab.IgG
28002-4,Borrelia burgdorferi 39kD Ab
28003-2,Sodium/Potassium
28004-0,HIV 1 Ab.IgG
28005-7,MTHFR gene.c.677C>T
28006-5,Hemoglobin F
28007-3,Urobilinogen
28008-1,Cytomegalovirus DNA
28009-9,Specimen volume
28010-7,Report.total
28011-5,Medical records
28012-3,Esophagoscopy study
28013-1,Study observation
28014-9,Esophagogastroduodenoscopy study
28015-6,Study observation
28016-4,ERCP study
28017-2,Study observation
28018-0,Enteroscopy study
Sep-01,Phospholipid
28019-8,Study observation
28020-6,Enteroscopy study through stoma
28021-4,Study observation
28022-2,Study observation
28023-0,Study observation
28024-8,Study observation
28025-5,Study observation
28026-3,Study observation
Jul-02,Phosphoserine
28027-1,Study observation
28028-9,Anoscopy study
28029-7,Study observation
28032-1,Report.total
28033-9,Colonoscopy study through stoma
28034-7,Study observation
May-03,Phytanate
28035-4,Escherichia coli shiga-like toxin
28036-2,Borrelia burgdorferi 39kD Ab.IgG
28037-0,Borrelia burgdorferi 39kD Ab.IgM
28038-8,Gamma hydroxybutyrate
28039-6,Borrelia burgdorferi 66kD Ab.IgG
28040-4,Borrelia burgdorferi 41kD Ab.IgG
28041-2,Gamma hydroxybutyrate
28042-0,Organophosphate pesticides
Mar-04,Phytanate
28043-8,Borrelia burgdorferi 41kD Ab.IgM
28044-6,Gamma hydroxybutyrate
28045-3,Cortisol^1st specimen
28046-1,Cortisol^2nd specimen
28047-9,Carbamate pesticides
28048-7,Borrelia burgdorferi 58kD Ab.IgG
28049-5,"1,2,4-Trichlorobenzene"
2805-0,Pipecolate
28050-3,"1,2,3-Trichlorobenzene"
28051-1,"1,3,5-Trichlorobenzene"
28052-9,HIV 1 Ab.IgG band pattern
28053-7,Borrelia burgdorferi 30kD Ab.IgG
28054-5,Borrelia burgdorferi 93kD Ab.IgG
28055-2,Borrelia burgdorferi 45kD Ab.IgG
28056-0,Borrelia burgdorferi 28kD Ab.IgG
28057-8,Borrelia burgdorferi 23kD Ab.IgG
28058-6,Borrelia burgdorferi 21kD Ab.IgG
28059-4,7-Aminoclonazepam
28060-2,MTHFR gene.c.1298A>C
28061-0,Naloxone
28062-8,Borrelia burgdorferi 23kD Ab.IgM
28063-6,Mercury^2nd specimen
28064-4,amLODIPine
28065-1,Gamma hydroxybutyrate
28066-9,Celecoxib
28067-7,Hemoglobin F
Aug-06,Pipecolate
28068-5,Beta aminobutyrate
28069-3,Meat fibers
28070-1,Vegetable fibers
28071-9,E selectin
28072-7,Dihydrocodeine+Hydrocodeinone
28073-5,7-Aminoclonazepam
28074-3,Tritium
28075-0,Sildenafil citrate
Jun-07,Pipecolate
28076-8,SUMAtriptan
28077-6,Hexachlorobutadiene
28078-4,Bladder tumor Ag
28079-2,Activities of daily living alteration
280-8,Imipenem
28080-0,Activity alteration
28081-8,Activity intolerance
28082-6,Activity intolerance risk
28083-4,Acute pain
Apr-08,Porphobilin
28084-2,Adjustment impairment
28085-9,Airway clearance impairment
28086-7,Decisional conflict
28087-5,Defensive coping
28088-3,Denial
28089-1,Diarrhea
28090-9,Disabled family coping
28091-7,Disuse syndrome
Feb-09,Porphobilinogen
28092-5,Diversional activity deficit
28093-3,Dressing &or grooming deficit
28094-1,Dying process
28095-8,Dysfunctional grieving
28096-6,Autonomic dysreflexia
28097-4,Endocrine alteration
28098-2,Family coping impairment
28099-0,Family process alteration
28-Jan,Ampicillin
2810-0,Porphobilinogen
28100-6,Fatigue
28101-4,Fear
28102-2,Fecal impaction
28103-0,Feeding deficit
28104-8,Fluid volume alteration
28105-5,Fluid volume deficit
28106-3,Fluid volume deficit risk
28107-1,Fluid volume excess
28108-9,Fluid volume excess risk
28109-7,Functional urinary incontinence
28110-5,Gas exchange impairment
28111-3,Gastrointestinal alteration
28112-1,Grieving
28113-9,Growth and development alteration
28114-7,Gustatory alteration
28115-4,Health maintenance alteration
28116-2,Health-seeking behavior alteration
28117-0,Home maintenance alteration
Aug-11,Porphobilinogen
28118-8,Hopelessness
28119-6,Hypothermia
28120-4,Hyperthermia
28121-2,Immunologic alteration
28122-0,Individual coping impairment
28123-8,Infection risk
28124-6,Infection
28125-3,Injury risk
Jun-12,Porphobilinogen deaminase
28126-1,Instrumental activity of daily living (IADLS) alteration
28127-9,Kinesthetic alteration
28128-7,Knowledge deficit
28129-5,Knowledge deficit of diagnostic test
28130-3,Knowledge deficit of dietary regimen
28131-1,Knowledge deficit of disease process
28132-9,Knowledge deficit of fluid volume
28133-7,Knowledge deficit of medication regimen
Apr-13,Porphobilinogen synthase
28134-5,Anticipatory grieving
28135-2,Anxiety
28136-0,Aspiration risk
28137-8,Auditory alteration
28138-6,Bathing &or hygiene deficit
28139-4,Blood pressure alteration
28140-2,Body image disturbance
28141-0,Body nutrition deficit
Feb-14,Porphyrins
28142-8,Body nutrition deficit risk
28143-6,Body nutrition excess
28144-4,Body nutrition excess risk
28145-1,Bowel elimination alteration
28146-9,Bowel incontinence
28147-7,Breastfeeding impairment
28148-5,Breathing pattern impairment
28149-3,Cardiac output alteration
28150-1,Cardiovascular alteration
28151-9,Cerebral alteration
28152-7,Chronic low self-esteem disturbance
28153-5,Chronic pain
28154-3,Colonic constipation
28155-0,Comfort alteration
28156-8,Communication impairment
28157-6,Compromised family coping
28158-4,May choose to self-deliver at the end
Sep-15,Porphyrins
28159-2,Meaningful life
281-6,Imipenem
28160-0,Medications are taking over my life
28161-8,Need help letting go
28162-6,No energy to fight back
28163-4,Not enjoying life
28164-2,Pain is hard to manage
28165-9,So many things yet undone
28166-7,Somewhat disconnected
Jul-16,Porphyrins
28167-5,Stay at home and receive treatment
28168-3,Take time for important things
28169-1,Use time wisely
28170-9,Want to die at home
28171-7,Knowledge deficit of safety precautions
28172-5,Knowledge deficit of therapeutic regimen
28173-3,Meaningfulness alteration
28174-1,Medication risk
May-17,Porphyrins
28175-8,Musculoskeletal alteration
28176-6,Noncompliance
28177-4,Noncompliance with diagnostic test
28178-2,Noncompliance with dietary regimen
28179-0,Noncompliance with safety precautions
28180-8,Noncompliance with therapeutic regimen
28181-6,Nutrition alteration
28182-4,Olfactory alteration
Mar-18,Porphyrins
28183-2,Oral mucous membranes impairment
28184-0,Parental role conflict
28185-7,Parenting alteration
28186-5,Perceived constipation
28187-3,Peripheral alteration
28188-1,Personal identity disturbance
28189-9,Physical mobility impairment
28190-7,Physical regulation alteration
Jan-19,Potassium
28191-5,Poisoning risk
28192-3,Polypharmacy
28193-1,Post-trauma response
28194-9,Powerlessness
28195-6,Protection alteration
28196-4,Rape trauma syndrome
28197-2,Reflex urinary incontinence
28198-0,Renal alteration
28199-8,Respiration alteration
28200-4,Role performance alteration
28201-2,Self-care deficit
28202-0,Self-concept alteration
28203-8,Sensory perceptual alteration
28204-6,Sexual dysfunction
28205-3,Sexuality patterns alteration
28206-1,Situational self-esteem disturbance
28207-9,Skin incision
28208-7,Skin integrity impairment
Sep-20,Potassium
28209-5,Skin integrity impairment risk
28210-3,Sleep pattern disturbance
28211-1,Social interaction alteration
28212-9,Social isolation
28213-7,Spiritual distress
28214-5,Spiritual state alteration
28215-2,Stress urinary incontinence
28216-0,Suffocation risk
Jul-21,Potassium
28217-8,Sanitation.behavior
28218-6,Sanitation.knowledge
28219-4,Sanitation.status
28220-2,Residence.behavior
28221-0,Residence.knowledge
28222-8,Residence.status
28223-6,Neighborhood &or workplace safety.behavior
28224-4,Neighborhood &or workplace safety.knowledge
May-22,Potassium
28225-1,Neighborhood &or workplace safety.status
28226-9,Swallowing impairment
28227-7,Tactile alteration
28228-5,Thermoregulation impairment
28229-3,Thought process alteration
28230-1,Tissue perfusion alteration
28231-9,Toileting deficit
28232-7,Total urinary incontinence
Mar-23,Potassium
28233-5,Trauma risk
28234-3,Unilateral neglect
28235-0,Constipation
28236-8,Pain
28237-6,Urge urinary incontinence
28238-4,Urinary elimination alteration
28239-2,Urinary retention
282-4,Imipenem+Cilastatin
28240-0,Verbal impairment
Jan-24,Potassium
28241-8,Violence risk
28242-6,Visual alteration
28243-4,Abuse.behavior
28244-2,Abuse.knowledge
28245-9,Abuse.status
28246-7,Antepartum &or postpartum.behavior
28247-5,Antepartum &or postpartum.status
28248-3,Bowel function.behavior
28249-1,Bowel function.knowledge
28250-9,Bowel function.status
28251-7,Caretaking &or parenting.behavior
28252-5,Caretaking &or parenting.knowledge
28253-3,Caretaking &or parenting.status
28254-1,Circulation.behavior
28255-8,Circulation.knowledge
28256-6,Circulation.status
28257-4,Cognition.behavior
Aug-25,Potassium
28258-2,Cognition.knowledge
28259-0,Cognition.status
28260-8,Communication with community resources.behavior
28261-6,Communication with community resources.knowledge
28262-4,Communication with community resources.status
28263-2,Consciousness.behavior
28264-0,Consciousness.knowledge
28265-7,Consciousness.status
Jun-26,Potassium
28266-5,Dentition.behavior
28267-3,Dentition.knowledge
28268-1,Dentition.status
28269-9,Digestion-hydration.behavior
28270-7,Digestion-hydration.knowledge
28271-5,Digestion-hydration.status
28272-3,Mental health.behavior
28273-1,Mental health.knowledge
Apr-27,Potassium
28274-9,Mental health.status
28275-6,Family planning.behavior
28276-4,Family planning.knowledge
28277-2,Family planning.status
28278-0,Genito-urinary function.behavior
28279-8,Genito-urinary function.knowledge
28280-6,Genito-urinary function.status
28281-4,Grief.behavior
Feb-28,Potassium
28282-2,Grief.knowledge
28283-0,Grief.status
28284-8,Growth and development.behavior
28285-5,Growth and development.knowledge
28286-3,Growth and development.status
28287-1,Health care supervision.behavior
28288-9,Health care supervision.knowledge
28289-7,Health care supervision.status
2829-0,Potassium
28290-5,Hearing.behavior
28291-3,Hearing.knowledge
28292-1,Hearing.status
28293-9,Sexuality.behavior
28294-7,Sexuality.knowledge
28295-4,Sexuality.status
28296-2,Income.behavior
28297-0,Income.knowledge
28298-8,Income.status
28299-6,Skin.behavior
28300-2,Skin.knowledge
28301-0,Skin.status
28302-8,Interpersonal relationship.behavior
28303-6,Interpersonal relationship.knowledge
28304-4,Interpersonal relationship.status
28305-1,Neglect.behavior
28306-9,Neglect.knowledge
28307-7,Neglect.status
Aug-30,Potassium renal clearance
28308-5,Neighborhood &or workplace safety.behavior
28309-3,Neighborhood &or workplace safety.knowledge
28310-1,Neighborhood &or workplace safety.status
28311-9,Neuro-musculo-skeletal function.behavior
28312-7,Neuro-musculo-skeletal function.knowledge
28313-5,Neuro-musculo-skeletal function.status
28314-3,Nutrition.behavior
28315-0,Nutrition.knowledge
Jun-31,Pregnancy specific protein 1
28316-8,Nutrition.status
28317-6,Pain.behavior
28318-4,Pain.knowledge
28319-2,Pain.status
283-2,Imipenem+Cilastatin
28320-0,Personal care.behavior
28321-8,Personal care.knowledge
28322-6,Personal care.status
28323-4,Physical activity.behavior
Apr-32,Pregnanediol
28324-2,Physical activity.knowledge
28325-9,Physical activity.status
28326-7,Medication regimen.behavior
28327-5,Medication regimen.knowledge
28328-3,Medication regimen.status
28329-1,Residence.behavior
28330-9,Residence.knowledge
28331-7,Residence.status
Feb-33,Pregnanediol
28332-5,Respiration.behavior
28333-3,Respiration.knowledge
28334-1,Respiration.status
28335-8,Role change.behavior
28336-6,Role change.knowledge
28337-4,Role change.status
28338-2,Sanitation.behavior
28339-0,Sanitation.knowledge
2834-0,Pregnanediol
28340-8,Sanitation.status
28341-6,Sleep and rest pattern.behavior
28342-4,Sleep and rest pattern.knowledge
28343-2,Sleep and rest pattern.status
28344-0,Social contact.behavior
28345-7,Social contact.knowledge
28346-5,Social contact.status
28347-3,Speech and language.behavior
28348-1,Speech and language.knowledge
28349-9,Speech and language.status
28350-7,Spirituality.behavior
28351-5,Spirituality.knowledge
28352-3,Spirituality.status
28353-1,Substance use.behavior
28354-9,Substance use.knowledge
28355-6,Substance use.status
28356-4,Technical procedure.behavior
Jul-35,Pregnanetriol
28357-2,Technical procedure.knowledge
28358-0,Technical procedure.status
28359-8,Vision.behavior
28360-6,Vision.knowledge
28361-4,Vision.status
28362-2,Anxiety
28363-0,Fear
28364-8,Afraid of pain and suffering
May-36,Pregnanetriol
28365-5,Afraid to die
28366-3,Comfortable and well cared for
28367-1,Don't want high technology to keep me alive
28368-9,Don't have to keep fighting
28369-7,Embarrassed by the way I look
28370-5,Extra effort to do things
28371-3,Feel spiritual as I near the end
28372-1,Financial situation is distressing
Mar-37,Pregnenolone
28373-9,Frightened over little control
28374-7,Giving up things
28375-4,Anxiety
28376-2,Chills
28377-0,Day sweats
28378-8,Depression
28379-6,Diarrhea
28380-4,Difficulty concentrating
Jan-38,Progesterone
28381-2,Disorientation
28382-0,Dry mouth
28383-8,Fatigue
28384-6,Fear
28385-3,Fever
28386-1,Gas &or bloating
28387-9,Lack of appetite
28388-7,Loose stools
28389-5,Memory loss
28390-3,Muscle aches
28391-1,Nausea
28392-9,Night sweats
28393-7,Painful joints
28394-5,Shortness of breath at rest
28395-2,Shortness of breath with activity
28396-0,Thirsty
28397-8,Vomiting
28398-6,Weakness
Sep-39,Progesterone
28399-4,Wheezing
284-0,Imipenem+Cilastatin
28400-0,I live for today
28401-8,Important to be in charge
28402-6,Important to be surrounded by those I love
28403-4,Independence
28404-2,Live life day to day
28405-9,Losing my looks is devastating
28406-7,Loss of independence
Jul-40,Proinsulin
28407-5,Lots of regrets
28408-3,Toileting
28409-1,Dressing
28410-9,Grooming
28411-7,Personal hygiene
28412-5,Physical performance
28413-3,Ambulation
28414-1,Activity
May-41,Prolactin
28415-8,Communication with community resources.behavior
28416-6,Communication with community resources.knowledge
28417-4,Communication with community resources.status
28418-2,Social contact.behavior
28419-0,Social contact.knowledge
28420-8,Social contact.status
28421-6,Role change.behavior
28422-4,Role change.knowledge
Mar-42,Prolactin
28423-2,Role change.status
28424-0,Interpersonal relationship.knowledge
28425-7,Interpersonal relationship.status
28426-5,Neglect.behavior
28427-3,Spirituality.behavior
28428-1,Spirituality.knowledge
28429-9,Spirituality.status
28430-7,Grief.behavior
Jan-43,Proline
28431-5,Grief.knowledge
28432-3,Grief.status
28433-1,Mental health.behavior
28434-9,Mental health.knowledge
28435-6,Mental health.status
28436-4,Sexuality.behavior
28437-2,Sexuality.knowledge
28438-0,Sexuality.status
28439-8,Interpersonal relationship.behavior
28440-6,Caretaking &or parenting.behavior
28441-4,Caretaking &or parenting.knowledge
28442-2,Caretaking &or parenting.status
28443-0,Neglect.knowledge
28444-8,Neglect.status
28445-5,Abuse.behavior
28446-3,Abuse.knowledge
28447-1,Abuse.status
28448-9,Growth and development.behavior
Sep-44,Proline
28449-7,Growth and development.knowledge
28450-5,Growth and development.status
28451-3,Hearing.behavior
28452-1,Hearing.status
28453-9,Vision.behavior
28454-7,Vision.knowledge
28455-4,Vision.status
Jun-45,Proline
28456-2,Speech and language.behavior
28457-0,Speech and language.knowledge
28458-8,Speech and language.status
28459-6,Dentition.behavior
28460-4,Dentition.knowledge
28461-2,Dentition.status
28462-0,Cognition.behavior
28463-8,Cognition.knowledge
Apr-46,Proline
28464-6,Cognition.status
28465-3,Pain.behavior
28466-1,Pain.knowledge
28467-9,Pain.status
28468-7,Consciousness.behavior
28469-5,Consciousness.knowledge
28470-3,Consciousness.status
28471-1,Skin.behavior
Feb-47,Proline
28472-9,Skin.knowledge
28473-7,Skin.status
28474-5,Neuro-musculo-skeletal function.behavior
28475-2,Neuro-musculo-skeletal function.knowledge
28476-0,Neuro-musculo-skeletal function.status
28477-8,Respiration.behavior
28478-6,Respiration.knowledge
28479-4,Respiration.status
2848-0,Proline dipeptidase
28480-2,Circulation.behavior
28481-0,Circulation.knowledge
28482-8,Circulation.status
28483-6,Digestion-hydration.behavior
28484-4,Digestion-hydration.knowledge
28485-1,Digestion-hydration.status
28486-9,Bowel function.behavior
28487-7,Bowel function.knowledge
28488-5,Bowel function.status
28489-3,Genito-urinary function.behavior
28490-1,Genito-urinary function.knowledge
28491-9,Genito-urinary function.status
28492-7,Antepartum &or postpartum.behavior
28493-5,Antepartum &or postpartum.status
28494-3,Antepartum &or postpartum.knowledge
28495-0,Nutrition.behavior
28496-8,Nutrition.knowledge
28497-6,Nutrition.status
Aug-49,Propionate
28498-4,Sleep and rest pattern.behavior
28499-2,Sleep and rest pattern.knowledge
28500-7,Sleep and rest pattern.status
28501-5,Physical activity.behavior
28502-3,Physical activity.knowledge
28503-1,Physical activity.status
28504-9,Personal care.behavior
28505-6,Personal care.knowledge
Jun-50,Propionyl CO-A carboxylase
28506-4,Personal care.status
28507-2,Substance use.behavior
28508-0,Substance use.knowledge
28509-8,Substance use.status
28510-6,Family planning.behavior
28511-4,Family planning.knowledge
28512-2,Family planning.status
28513-0,Health care supervision.behavior
Apr-51,Prostaglandin E
28514-8,Health care supervision.knowledge
28515-5,Health care supervision.status
28516-3,Medication regimen.behavior
28517-1,Medication regimen.knowledge
28518-9,Medication regimen.status
28519-7,Technical procedure.behavior
28520-5,Technical procedure.knowledge
28521-3,Technical procedure.status
Feb-52,Prostaglandin E1
28522-1,Income.status
28523-9,Noncompliance with fluid volume
28524-7,Noncompliance with medication regimen
28525-4,Socialization alteration
28526-2,Skin integrity alteration
28527-0,Family embarrassed
28528-8,No good church experience
28529-6,Strength from family
2853-0,Prostaglandin E2
28530-4,Family does what needs done
28531-2,My hometown means a lot
28532-0,No purpose in life
28533-8,Antepartum &or postpartum.knowledge
28534-6,Bathing
28535-3,Income.knowledge
28536-1,Income.behavior
28537-9,Hearing.knowledge
28538-7,Abdominal pain
28539-5,Erythrocyte mean corpuscular hemoglobin
28540-3,Erythrocyte mean corpuscular hemoglobin concentration
28541-1,Metamyelocytes/100 leukocytes
28542-9,Platelet mean volume
28543-7,Basophils/100 leukocytes
28544-5,Mesothelial cells/100 leukocytes
28545-2,Mucus
28546-0,Neisseria meningitidis serogroup A Ab.IgG
28547-8,Neisseria meningitidis serogroup C Ab.IgG
Aug-54,Prostaglandin F
28548-6,Mycoplasma pneumoniae Ab
28549-4,Yersinia sp identified
28550-2,Cortisol
28551-0,Bladder tumor Ag
28552-8,Cladosporium herbarum Ab.IgM
28553-6,Streptococcus pneumoniae 6+26 Ab^1st specimen
28554-4,Triglyceride
May-55,Prostaglandin F2
28555-1,Nicotine+Cotinine
28556-9,Chlamydia trachomatis D+K Ab.IgG
28557-7,Chlamydia trachomatis D+K Ab.IgA
28558-5,Chlamydia trachomatis D+K Ab.IgM
28559-3,Hemoglobin A2
28560-1,Neuronal thread protein
28561-9,Views
28562-7,Chart section
Mar-56,Prostaglandin
28563-5,Care provider notes
28564-3,Views
28565-0,Views
28566-8,Multisection
28567-6,Views
28568-4,Note
28569-2,Progress note
285-7,Imipenem+Cilastatin
28570-0,Procedure note
Jan-57,Prostate specific Ag
28571-8,Note
28572-6,Initial evaluation note
28573-4,Surgical operation note
28574-2,Discharge note
28575-9,Progress note
28576-7,Multisection
28577-5,Procedure note
28578-3,Note
28579-1,Note
28580-9,Progress note
28581-7,Initial evaluation note
28582-5,Views
28583-3,Surgical operation note
28584-1,2-Oxoadipate/Creatinine
28585-8,4-Hydroxyphenylacetate/Creatinine
28586-6,4-Hydroxyphenyllactate/Creatinine
28587-4,Benzoate/Creatinine
28588-2,Beta alanine/Creatinine
Sep-58,Protein.CSF/Protein.serum
28589-0,Carnitine esters/Creatinine
28590-8,Alpha aminobutyrate/Creatinine
28591-6,Amino beta guanidinopropionate/Creatinine
28592-4,Beta aminoadipate/Creatinine
28593-2,Gamma aminobutyrate/Creatinine
28594-0,3-Methylhistidine/Creatinine
28595-7,Taurine/Creatinine
28596-5,Anserine/Creatinine
Jul-59,Protein kinase
28597-3,Carnosine/Creatinine
28598-1,Alpha aminoadipate/Creatinine
28599-9,Cystathionine/Creatinine
28600-5,Phosphoserine/Creatinine
28601-3,Hydroxyproline/Creatinine
28602-1,Beta aminoisobutyrate/Creatinine
28603-9,Asparagine/Creatinine
28604-7,Phosphoethanolamine/Creatinine
May-60,Protein nitrogen
28605-4,Ethanolamine/Creatinine
28606-2,1-Methylhistidine/Creatinine
28607-0,Canine parvovirus Ab
28608-8,Tryptophan/Creatinine
28609-6,Alpha aminobutyrate/Creatinine
28610-4,Sarcosine/Creatinine
28611-2,Amino beta guanidinopropionate/Creatinine
28612-0,Legionella sp Ab.IgM
Mar-61,Albumin
28613-8,Views
28614-6,Multisection
28615-3,Audiology study
28616-1,Transfer summary note
28617-9,Progress note
28618-7,Note
28619-5,Ophthalmology studies
28620-3,Urology studies
Jan-62,Albumin
28621-1,Initial evaluation note
28622-9,Discharge assessment note
28623-7,Progress note
28624-5,Surgical operation note
28625-2,Procedure note
28626-0,History and physical note
28627-8,Progress note
28628-6,Note
28629-4,Perimetry study
28630-2,Tonometry study
28631-0,Visual acuity study
28632-8,Heterophoria study
28633-6,Polysomnography study
28634-4,Miscellaneous studies
28635-1,Initial evaluation note
28636-9,Initial evaluation note
28637-7,Base deficit
28638-5,Base excess
Sep-63,Albumin
28639-3,Base excess
28640-1,Bicarbonate
28641-9,Bicarbonate
28642-7,Oxygen saturation
28643-5,Oxygen saturation
28644-3,Carbon dioxide
28645-0,Carbon dioxide
28646-8,pH
Jul-64,Alpha 1 globulin
28647-6,pH
28648-4,Oxygen
28649-2,Oxygen
286-5,Isoniazid
28650-0,Clinical notes and chart sections
28651-8,Transfer summary note
28652-6,Heparinoid
28653-4,Note
Apr-65,Alpha 1 globulin
28654-2,Initial evaluation note
28655-9,Discharge summary note
28656-7,Progress note
28657-5,Coagulation factor X activated actual/Normal
28658-3,Plasmin inhibitor actual/Normal
28659-1,Prekallikrein actual/Normal
28660-9,Plasminogen actual/Normal
28661-7,Pupillary distance.binocular
Feb-66,Alpha 1 globulin
28662-5,Refraction comment
28663-3,Sphere far
28664-1,Cylinder far
28665-8,Axis far
28666-6,HSA distance
28667-4,Visual acuity.far
28668-2,Sphere far
28669-0,Cylinder far
2867-0,Alpha 2 globulin
28670-8,Corneal indentation depth
28671-6,Corneal indentation depth
28672-4,Tonometry time
28673-2,Tonometry comment
28674-0,Corneal indentation depth
28675-7,Corneal indentation depth
28676-5,Sphere
28677-3,Cylinder
28678-1,Axis
28679-9,Visual acuity
28680-7,Sphere
28681-5,Cylinder
28682-3,Axis
28683-1,Visual acuity
28684-9,Visual acuity.binocular
28685-6,Pupillary distance.binocular
28686-4,Refraction comment
28687-2,Sphere
Aug-68,Alpha 2 globulin
28688-0,Cylinder
28689-8,Axis
28690-6,Visual acuity
28691-4,Sphere
28692-2,Cylinder
28693-0,Axis
28694-8,Visual acuity
28695-5,Visual acuity.binocular
Jun-69,Alpha 2 globulin
28696-3,Pupillary distance.binocular
28697-1,Refraction comment
28698-9,Sphere
28699-7,Cylinder
28700-3,Axis
28701-1,Visual acuity
28702-9,Sphere
28703-7,Cylinder
Apr-70,Beta globulin
28704-5,Axis
28705-2,Visual acuity
28706-0,Visual acuity.binocular
28707-8,Axis far
28708-6,Prism base direction
28709-4,HSA distance
28710-2,Visual acuity.far
28711-0,Visual acuity far.binocular
Feb-71,Beta globulin
28712-8,Sphere near 1
28713-6,Cylinder near
28714-4,Axis near
28715-1,Sphere near 2
28716-9,Cylinder near 2
28717-7,Axis near 2
28718-5,HSA N
28719-3,Visual acuity.near
2872-0,Beta globulin
28720-1,Add 1
28721-9,Add 1.binocular
28722-7,Add 2
28723-5,Add 2.binocular
28724-3,Sphere near 1
28725-0,Cylinder near
28726-8,Axis near
28727-6,Sphere near 2
28728-4,Cylinder near 2
28729-2,Axis near 2
287-3,Isoniazid
28730-0,HSA N
28731-8,Visual acuity N LI
28732-6,Add 1
28733-4,Add 2
28734-2,Far vision comment
28735-9,Far vision comment
28736-7,Comment N
28737-5,Visual acuity N.binocular
Aug-73,Gamma globulin
28738-3,Distance signs
28739-1,Distance signs
28740-9,Distance signs.binocular
28741-7,Red green balance
28742-5,Red green balance
28743-3,Red green balance.binocular
28744-1,Polarization
28745-8,Polarization
Jun-74,Gamma globulin
28746-6,Polarization.binocular
28747-4,Vision.binocular
28748-2,Accommodation width.absolute
28749-0,Accommodation width.absolute
28750-8,Accommodation width.relative
28751-6,Accommodation width.measured 1
28752-4,Accommodation width.measured 2
Mar-75,Gamma globulin
28753-2,Accommodation width.measured 3
28754-0,Accommodation width.absolute
28755-7,Accommodation width.absolute
28756-5,Accommodation width.relative
28757-3,Accommodation width.measured 1
28758-1,Accommodation width.measured 2
28759-9,Accommodation width.measured 3
28760-7,Accommodation width.absolute
Jan-76,Prealbumin
28761-5,Accommodation width.absolute
28762-3,Accommodation width.relative
28763-1,Accommodation width.measured 1
28764-9,Heterophoria
28765-6,Heterophoria
28766-4,Heterophoria
28767-2,Heterophoria
28768-0,Heterophoria
28769-8,Heterophoria
28770-6,Heterophoria
28771-4,Type
28772-2,Type description
28773-0,Since when
28774-8,Physician code
28775-5,Physician
28776-3,Type
28777-1,Type
28778-9,Type
Sep-77,Prealbumin
28779-7,Type
28780-5,Sphere far
28781-3,Axis far
28782-1,Pupillary distance.monocular
28783-9,HSA distance
28784-7,SBM visual acuity far
28785-4,SBM sphere far
28786-2,Cylinder far
Jul-78,Protein
28787-0,Axis far
28788-8,Prism base direction
28789-6,Pupillary distance.monocular
28790-4,HSA distance
28791-2,Visual acuity.far
28792-0,Pupillary distance.binocular
28793-8,Sphere near 1
28794-6,Cylinder near
May-79,Protein
28795-3,Axis near
28796-1,Sphere near 2
28797-9,Cylinder near 2
28798-7,Axis near 2
28799-5,Pupillary distance.monocular near
28800-1,HSA N
28801-9,Visual acuity.near
28802-7,Sphere near 1
Mar-80,Protein
28803-5,Cylinder near
28804-3,Axis near
28805-0,Sphere near 2
28806-8,Cylinder near 2
28807-6,Axis near 2
28808-4,PO N
28809-2,HSA N
288-1,Isoniazid
28810-0,Add 1
Jan-81,Protein
28811-8,Add 2
28812-6,Add 1
28813-4,Add 2
28814-2,Add 1.binocular
28815-9,Add 2.binocular
28816-7,Comment
28817-5,Comment
28818-3,Glasses type
28819-1,Subject to charges
28820-9,Private prescription
28821-7,First glasses
28822-5,Lens type far
28823-3,Lens type far
28824-1,Lens type N
28825-8,Lens type N
28826-6,Sphere far
28827-4,Cylinder far
28828-2,Axis far
Sep-82,Protein
28829-0,Prism base direction
28830-8,HSA distance
28831-6,Visual acuity.far
28832-4,Sphere near 1
28833-2,Cylinder near
28834-0,Axis near
28835-7,Sphere near 2
28836-5,Cylinder near 2
Jul-83,Protein
28837-3,Axis near 2
28838-1,HSA N
28839-9,Visual acuity.near
28840-7,Pupillary distance.monocular
28841-5,Pupillary distance.monocular near
28842-3,Sphere far
28843-1,Cylinder far
28844-9,Axis far
May-84,Protein
28845-6,Prism base direction
28846-4,HSA distance
28847-2,Visual acuity.far
28848-0,Distance N.binocular
28849-8,Sphere near 1
28850-6,Cylinder near
28851-4,Axis near
Feb-85,Protein
28852-2,Sphere near 2
28853-0,Cylinder near 2
28854-8,Axis near 2
28855-5,HSA N
28856-3,Visual acuity.near
28857-1,Pupillary distance.monocular
28858-9,Pupillary distance.binocular
28859-7,PO N
2886-0,Protein
28860-5,PO N.binocular
28861-3,Correction code
28862-1,Correction text
28863-9,Correction code
28864-7,Correction text
28865-4,Correction since
28866-2,Prescription code
28867-0,Prescription text
28868-8,Dispenser code
28869-6,Dispenser text
28870-4,Material
28871-2,Type
28872-0,Manufacturer code
28873-8,Producer text
28874-6,Color
28875-3,Color
28876-1,Base curve 1
28877-9,Base curve 2
Aug-87,Protein
28878-7,Sphere
28879-5,Cylinder
28880-3,Axis
28881-1,Axis.DS
28882-9,Diameter
28883-7,DOZ.inside
28884-5,DOZ.outside
28885-2,Bevel width
Jun-88,Protein
28886-0,Bevel radius
28887-8,Geometry
28888-6,Torus
28889-4,Add
28890-2,Visual acuity.far
28891-0,Visual acuity.near
28892-8,Lens fitting
28893-6,Material
Apr-89,Protein
28894-4,Type
28895-1,Manufacturer code
28896-9,Manufacturer name
28897-7,Color
28898-5,Color
28899-3,Base curve 1
28900-9,Base curve 2
28901-7,Sphere
Feb-90,Protein/Creatinine
28902-5,Cylinder
28903-3,Axis
28904-1,Axis.DS
28905-8,Radius
28906-6,DOZ.inside
28907-4,DOZ.outside
28908-2,Bevel width
28909-0,Bevel radius
2891-0,Protoporphyrin
28910-8,Lenticulation
28911-6,Geometry
28912-4,Torus
28913-2,Add
28914-0,Visual acuity.far
28915-7,Visual acuity.near
28916-5,Lens fitting
28917-3,Over refraction sphere
28918-1,Over refraction cylinder
28919-9,Over refraction axis
28920-7,Material
28921-5,Type
28922-3,Producer code
28923-1,Producer text
28924-9,Color
28925-6,Color
28926-4,Explanation
28927-2,Base curve 1
Aug-92,Protoporphyrin.free
28928-0,Base curve 2
28929-8,Sphere
28930-6,Cylinder
28931-4,Axis
28932-2,Axis.DS
28933-0,Radius
28934-8,DOZ.inside
28935-5,DOZ.outside
Jun-93,Protoporphyrin.zinc
28936-3,Bevel width
28937-1,Bevel radius
28938-9,Geometry
28939-7,Torus
28940-5,Add
28941-3,Visual acuity.far
28942-1,Visual acuity.near
28943-9,Lens fitting
Apr-94,Protoporphyrin.zinc
28944-7,Over refraction sphere
28945-4,Over refraction cylinder
28946-2,Over refraction axis
28947-0,Material
28948-8,Type
28949-6,Producer code
28950-4,Producer text
Jan-95,Protoporphyrin.zinc
28951-2,Color
28952-0,Color
28953-8,Explanation
28954-6,Base curve 1
28955-3,Base curve 2
28956-1,Sphere
28957-9,Cylinder
28958-7,Axis
28959-5,Axis.DS
28960-3,Radius
28961-1,DOZ.inside
28962-9,DOZ.outside
28963-7,Bevel width
28964-5,Bevel radius
28965-2,Geometry
28966-0,Torus
28967-8,Add
28968-6,Visual acuity.far
Sep-96,Protoporphyrin
28969-4,Visual acuity.near
28970-2,Linsensitz
28971-0,Over refraction sphere
28972-8,Over refraction cylinder
28973-6,Over refraction axis
28974-4,Base curve 1
28975-1,Axis
28976-9,Base curve 2
Jul-97,Protoporphyrin
28977-7,Axis 2
28978-5,Comment
28979-3,Sagittal radius.superior
28980-1,Sagittal radius.inferior
28981-9,Sagittal radius.temporal
28982-7,Sagittal radius.nasal
28983-5,Longitudinal radius
28984-3,Base curve 1
May-98,Protoporphyrin
28985-0,Axis
28986-8,Base curve 2
28987-6,Axis 2
28988-4,Comment
28989-2,Sagittal radius.superior
289-9,Isoniazid
28990-0,Sagittal radius.inferior
28991-8,Sagittal radius.temporal
28992-6,Sagittal radius.nasal
Mar-99,Purine nucleoside phosphorylase
28993-4,Longitudinal radius
28994-2,Refractive power.flat
28995-9,Refractive power.steep
28996-7,Refractive power.flat
28997-5,Refractive power.steep
28998-3,Exopthalmia
28999-1,Exopthalmia
29000-7,Exopthalmia base
29001-5,Exopthalmia comment
29002-3,Exopthalmia comment
29003-1,Tear secretion 1
29004-9,Tear secretion 1
29005-6,Tear secretion 2
29006-4,Tear secretion 2
29007-2,Tear secretion break up
29008-0,Tear secretion break up
Sep-00,Pyridoxine
29009-8,Tear secretion comment
29010-6,Tear secretion comment
29011-4,Argon laser coagulation Rx effects
29012-2,Argon laser coagulation Rx
29013-0,Argon laser coagulation Rx spot size
29014-8,Argon laser coagulation Rx localization
29015-5,Argon laser coagulation Rx comment
29016-3,Argon laser coagulation Rx effects
Jul-01,Pyridoxine congeners
29017-1,Argon laser coagulation Rx
29018-9,Argon laser coagulation Rx spot size
29019-7,Argon laser coagulation Rx localization
29020-5,Argon laser coagulation Rx comment
29021-3,Argon laser trabeculoplasty Rx effects
29022-1,Argon laser trabeculoplasty Rx
29023-9,Argon laser trabeculoplasty Rx spot size
29024-7,Argon laser trabeculoplasty Rx localization
May-02,Pyrimidine-5'-Nucleotidase
29025-4,Argon laser trabeculoplasty Rx comment
29026-2,Argon laser trabeculoplasty Rx effects
29027-0,Argon laser trabeculoplasty Rx
29028-8,Argon laser trabeculoplasty Rx spot size
29029-6,Argon laser trabeculoplasty Rx localization
29030-4,Argon laser trabeculoplasty Rx comment
29031-2,YAG Rx mode
29032-0,YAG Rx intensity
Mar-03,Pyrimidine-5'-Nucleotidase
29033-8,YAG Rx
29034-6,YAG Rx comment
29035-3,YAG Rx mode
29036-1,YAG Rx intensity
29037-9,YAG Rx
29038-7,YAG Rx comment
29039-5,KW
29040-3,KW impression code
Jan-04,Pyrophosphate crystals
29041-1,KW impression comment
29042-9,KW
29043-7,KW impression code
29044-5,KW impression comment
29045-2,Perimeter format
29046-0,Perimeter format
29047-8,Perimeter format
29048-6,Perimeter format
29049-4,Perimeter format
29050-2,Perimeter format
29051-0,Perimeter format
29052-8,Perimeter format
29053-6,Perimeter format
29054-4,Perimeter format
29055-1,Perimeter format
29056-9,Pressure device type
29057-7,Pressure result code
Aug-05,Pyruvate
29058-5,Pressure result text
29059-3,GF border code
29060-1,Pressure border text
29061-9,Pressure spot code
29062-7,Pressure spot text
29063-5,Pressure Skotome code
29064-3,Pressure Skotome text
29065-0,Pressure result code
Jun-06,Pyruvate
29066-8,Pressure result text
29067-6,Pressure border code
29068-4,Pressure border text
29069-2,Pressure spot code
290-7,Kanamycin
29070-0,Pressure spot text
29071-8,Pressure Skotome code
29072-6,Pressure Skotome text
29073-4,Position
Apr-07,Pyruvate
29074-2,Position
29075-9,Motility
29076-7,Motility
29077-5,Convergence
29078-3,Heterophoria
29079-1,Prism cover
29080-9,Fusion width
29081-7,Pupil motoric
Feb-08,Pyruvate
29082-5,Pupil motoric
29083-3,Binocular status code
29084-1,Binocular status text
29085-8,Nystagmus examination
29086-6,Nystagmus examination
29087-4,Physical findings
29088-2,Physical findings
29089-0,Physical findings
2909-0,Pyruvate carboxylase
29090-8,Physical findings
29091-6,Physical findings
29092-4,Physical findings
29093-2,Physical findings
29094-0,Physical findings
29095-7,Physical findings
29096-5,Physical findings
29097-3,Physical findings
29098-1,Physical findings
29099-9,Physical findings
29100-5,Physical findings
29101-3,Physical findings
29102-1,Physical findings
29103-9,Physical findings
29104-7,Physical findings
29105-4,Physical findings
29106-2,Physical findings
29107-0,Physical findings
Aug-10,Pyruvate dehydrogenase.cytochrome
29108-8,Physical findings
29109-6,Multisection
29110-4,Multisection
29111-2,Photo documentation
29112-0,Photo documentation
29113-8,Abacavir
29114-6,Amprenavir
29115-3,Delavirdine
Jun-11,Pyruvate dehydrogenase.lipoamide
29116-1,Didanosine
29117-9,Efavirenz
29118-7,Indinavir
29119-5,lamiVUDine
29120-3,Nelfinavir
29121-1,Nevirapine
29122-9,Ritonavir
29123-7,Saquinavir
Apr-12,Pyruvate kinase
29124-5,Stavudine
29125-2,Zalcitabine
29126-0,Zidovudine
29127-8,Corneal indentation depth
29128-6,Corneal indentation depth
29129-4,Weight on cornea
29130-2,Weight on cornea
29131-0,Accommodation width.measured 2
Feb-13,Pyruvate kinase
29132-8,Accommodation width.measured 3
29133-6,Heterophoria
29134-4,Cylinder far
29135-1,Glasses type
29136-9,Argon laser coagulation Rx
29137-7,Argon laser trabeculoplasty Rx
29138-5,Pressure device type
29139-3,Argon laser coagulation Rx
2914-0,Pyruvate oxidase
29140-1,Argon laser trabeculoplasty Rx
29141-9,Metanephrine
29142-7,Metanephrines
29143-5,"1,4-Dimethylbenzene"
29144-3,"1,2-Dimethylbenzene"
29145-0,"1,3-Dimethylbenzene"
29146-8,Alpha 1 antitrypsin
29147-6,"carBAMazepine 10,11-Epoxide.bound"
29148-4,carBAMazepine.bound
29149-2,Mefloquine
291-5,Kanamycin
29150-0,Mefloquine
29151-8,Somatotropin^4H post XXX challenge
29152-6,Somatotropin^5H post XXX challenge
29153-4,Cancer Ag 15-3
29154-2,Choriogonadotropin.beta subunit
29155-9,Follitropin/Creatinine
29156-7,Lutropin
Jul-15,Renin
29157-5,Lutropin/Creatinine
29158-3,Opiates
29159-1,Methadone
29160-9,Benzodiazepines
29161-7,Barbiturates
29162-5,New &or revised
29163-3,Date.onset or exacerbation
29164-1,Date start
May-16,Renin renal clearance
29165-8,Clinical discipline
29166-6,Diagnosis.primary
29167-4,Diagnosis.addressed by plan
29168-2,Author of treatment plan
29169-0,Visit frequency
29170-8,Date range (from_through) described by plan
29171-6,Continuation status
29172-4,Date attending MD referred patient for
Mar-17,Renin^supine
29173-2,Date attending MD signed
29174-0,Signature of responsible attending physician on file
29175-7,Date rehabilitation professional signed
29176-5,Signature of responsible rehabilitation professional on file
29177-3,Medication administered
29178-1,Prognosis for rehabilitation
29179-9,Estimated date of completion
29180-7,Date of last plan of treatment certification
Jan-18,Renin^upright
29181-5,Past medical history+Level of function
29182-3,Assessment.initial
29183-1,Plan of treatment
29184-9,Progress note+attainment of goals
29185-6,Reason to continue
29186-4,Justification
29187-2,Psychiatric symptoms
29188-0,Author ID
29189-8,Author name
29190-6,Author profession
29191-4,Date end
29192-2,Diagnosis.addressed by plan
29193-0,Diagnosis.addressed by plan
29194-8,Diagnosis.primary
29195-5,Diagnosis.primary
29196-3,Medication name + ID
29197-1,Medication route
29198-9,Medication timing + Quantity
Sep-19,Reticulin
29199-7,Medication XXX
29200-3,Signature date
29201-1,Start date
29202-9,Visit duration
29203-7,Date range
29204-5,End date
29205-2,Start date
29206-0,Rehabilitation.speech therapy service attachment
Jul-20,Retinal
29207-8,Amiodarone
29208-6,Streptolysin O Ab
29209-4,Benzodiazepines
29210-2,Bilirubin.non-glucuronidated
29211-0,Caffeine
29212-8,carBAMazepine
29213-6,Ceruloplasmin
29214-4,Chloramphenicol
May-21,Retinoate
29215-1,Digitoxin
29216-9,Digoxin
29217-7,Disopyramide
29218-5,Ethosuximide
29219-3,FLUoxetine
29220-1,Haptoglobin
29221-9,Mercury
29222-7,Mexiletine
Mar-22,Retinol
29223-5,PHENobarbital
29224-3,Phenytoin
29225-0,Primidone
29226-8,quiNIDine
29227-6,Salicylates
29228-4,Tricyclic antidepressants
29229-2,Valproate
292-3,Kanamycin
29230-0,Coxsackievirus B1 Ab
Jan-23,Retinol
29231-8,Coxsackievirus B2 Ab
29232-6,Coxsackievirus B3 Ab
29233-4,Coxsackievirus B4 Ab
29234-2,Coxsackievirus B5 Ab
29235-9,Coxsackievirus B6 Ab
29236-7,Herpes simplex virus 2 Ab
29237-5,Herpes simplex virus 1 Ab
29238-3,Insulin
29239-1,Triiodothyronine.free
29240-9,Hyaluronate
29241-7,Mumps virus Ab.IgG
29242-5,Measles virus Ab.IgG
29243-3,Thiodiglycolate
29244-1,Thiodiglycolate/Creatinine
29245-8,Zinc
29246-6,Lactate
29247-4,Sirolimus
29248-2,Varicella zoster virus DNA
Sep-24,Riboflavin
29249-0,Varicella zoster virus Ab.IgG
29250-8,Brucella sp Ab^1st specimen
29251-6,Brucella sp Ab^2nd specimen
29252-4,Multisection^WO contrast
29253-2,Alpha-1-Fetoprotein^^adjusted
29254-0,Linezolid
29255-7,Linezolid
Jun-25,Ribonuclease
29256-5,Fat.microscopic observation
29257-3,Mycoplasma pneumoniae DNA
29258-1,Linezolid
29259-9,Monocytes.abnormal/100 leukocytes
29260-7,Monocytes.abnormal
29261-5,Lymphocytes.abnormal/100 leukocytes
29262-3,Lymphocytes.abnormal
29263-1,Fibrin degradation products
Apr-26,Ribose
29264-9,Collection time
29265-6,Calcium^^corrected for albumin
29266-4,Coproporphyrin
29267-2,Protoporphyrin
29268-0,Contact lens measurements
29269-8,Eye glasses measurements
29270-6,Retinal treatments
29271-4,Eye physical examination
Feb-27,Ribulose
29272-2,Eye ultrasound study
29273-0,Clinical measurements
29274-8,Vital signs measurements
29275-5,Body measurements
29276-3,Calcium
29277-1,Carbon disulfide
29278-9,Codeine
29279-7,Ethylene glycol
2928-0,Beta fructofuranosidase
29280-5,Fibrin D-dimer
29281-3,Glutathione reductase
29282-1,Glutethimide
29283-9,Hydrogen sulfide
29284-7,Leucine
29285-4,Methadone
29286-2,Methamphetamine
29287-0,Morphine
29288-8,Orphenadrine
29289-6,Phenylethylmalonamide
29290-4,Carbon disulfide
29291-2,Glutethimide
29292-0,Hydrogen sulfide
29293-8,Leucine
29294-6,Methadone
29295-3,Phenylethylmalonamide
29296-1,Dimethylbenzene
29297-9,Color
Aug-29,Saccharides
29298-7,Reason for visit
29299-5,Reason for visit
29300-1,Procedure
29301-9,Physical findings
29302-7,Physical findings
29303-5,Medication administered
29304-3,Medication dispensed
29305-0,Medication prescribed
Jun-30,Sarcosine
29306-8,Surgery procedure
29307-6,Physical findings
29308-4,Diagnosis
29309-2,Physical findings
293-1,Kanamycin
29310-0,Treponema pallidum
29311-8,Neisseria gonorrhoeae Ag
Apr-31,Sarcosine
29314-2,Adenovirus Ab
29315-9,Isoniazid 0.4 ug/mL
29316-7,Thyrotropin^30M post XXX challenge
29317-5,Thyrotropin^1H post XXX challenge
29318-3,Streptococcus pneumoniae group B Ag
29319-1,Streptococcus pneumoniae group B Ag
29320-9,Streptococcus pneumoniae group B Ag
29321-7,Rickettsia typhi Ab.IgG
Feb-32,Sarcosine
29322-5,Rickettsia typhi Ab.IgM
29323-3,Cocaine
29324-1,Cocaethylene
29325-8,Cocaethylene
29326-6,Carboxy tetrahydrocannabinol
29327-4,HIV 1 Ab
29328-2,Xylose^2.5H post dose xylose PO
29329-0,Glucose^3.5H post XXX challenge
2933-0,Secretin
29330-8,Glucose^4H post XXX challenge
29331-6,Glucose^5H post XXX challenge
29332-4,Glucose^2.5H post XXX challenge
29333-2,Saccharomonospora viridis Ab
29334-0,Aspergillus fumigatus 2 Ab
29335-7,Mexiletine
29336-5,Mexiletine
29337-3,Morphine.free
29338-1,Flecainide
29339-9,Flecainide
29340-7,Cells.CD71
29341-5,Cells.CD11b
29342-3,Methylmalonate
29343-1,Rubella virus Ab.IgG
29344-9,LORazepam
29345-6,6-Monoacetylmorphine
29346-4,Chloramphenicol
29347-2,Chloramphenicol
Aug-34,Serine
29348-0,ALPRAZolam
29349-8,Potassium^post dialysis
29350-6,Cells.CD42
29351-4,Rheumatoid factor
29352-2,Salicylates
29353-0,17-Ketosteroids.total neutral
29354-8,Reovirus Ab
May-35,Serine
29355-5,Reovirus Ab
29356-3,fentaNYL
29357-1,Cyanide
29358-9,Cortisol^pre XXX challenge
29359-7,Parainfluenza virus 2 Ab
29360-5,Streptococcus pneumoniae group B Ag
29361-3,Streptococcus pneumoniae group B Ag
29362-1,Streptococcus pneumoniae group B Ag
Mar-36,Serine
29363-9,Cortisol^1.5H post XXX challenge
29364-7,Magnesium
29365-4,Magnesium
29366-2,Parainfluenza virus 1 Ab
29367-0,Parainfluenza virus 2 Ab
29368-8,Parainfluenza virus 3 Ab
29369-6,N-acetylprocainamide/Procainamide
29370-4,cloZAPine^trough
Jan-37,Serine
29371-2,cloZAPine^peak
29372-0,Codeine
29373-8,Ethchlorvynol
29374-6,Ribonucleoprotein extractable nuclear Ab
29375-3,Methanol
29376-1,Narcotics
29377-9,Narcotics
29378-7,Insulin^4H post XXX challenge
29379-5,Insulin^6H post XXX challenge
29380-3,chlordiazePOXIDE
29381-1,Meprobamate
29382-9,Warfarin
29383-7,Warfarin
29384-5,diazePAM
29385-2,Nordiazepam
29386-0,chlorproMAZINE
29387-8,Norpropoxyphene
29388-6,Methaqualone
Sep-38,Serine
29389-4,Acetaminophen
29390-2,Parathyrin.mid molecule
29391-0,Gastrin^2H post XXX challenge
29392-8,Gastrin^1H post XXX challenge
29393-6,Gastrin^3H post XXX challenge
29394-4,Gastrin^2.5H post XXX challenge
29395-1,Gastrin^post CFst
29396-9,Gastrin^1.5H post XXX challenge
Jul-39,Serotonin
29397-7,Gastrin^30M pre XXX challenge
29398-5,Gastrin^1M pre XXX challenge
29399-3,clonazePAM
29400-9,Meperidine
29401-7,Disopyramide
29402-5,Trimipramine
29403-3,Thiothixene
29404-1,Thiothixene
May-40,Serotonin
29405-8,Maprotiline
29406-6,Amitriptyline
29407-4,Nortriptyline
29408-2,Imipramine
29409-0,Desipramine
29410-8,Doxepin
29411-6,Nordoxepin
29412-4,Glucose^6H post XXX challenge
Mar-41,Serotonin
29413-2,Reovirus Ab
29414-0,Parainfluenza virus 3 Ab
29415-7,Reovirus Ab
29416-5,Adenovirus Ab
29417-3,Parainfluenza virus 1 Ab
29418-1,Blood flow velocity.diastole.max
29419-9,Blood flow velocity.systole.max/Blood flow velocity.diastole.max
29420-7,Blood flow velocity.systole.max
Jan-42,Sex hormone binding globulin
29421-5,Blood flow velocity.diastole.max
29422-3,Blood flow velocity.systole.max/Blood flow velocity.diastole.max
29423-1,Blood flow velocity.systole.max
29424-9,Blood flow velocity.diastole.max
29425-6,Blood flow velocity.systole.max/Blood flow velocity.diastole.max
29426-4,Blood flow velocity.systole.max
29427-2,Blood flow velocity.diastole.max
29428-0,Blood flow velocity.systole.max/Blood flow velocity.diastole.max
29429-8,Diameter^inspiration
29430-6,Thickness.diastole
29431-4,Thickness.diastole
29432-2,Thickness.systole
29433-0,Thickness.systole
29434-8,Fractional shortening.minor axis
29435-5,Fractional shortening.minor axis
29436-3,Internal diameter.minor axis.diastole
29437-1,Internal diameter.minor axis.diastole
29438-9,Internal diameter.minor axis.systole
Sep-43,Sialate
29439-7,Internal diameter.minor axis.systole
29440-5,Thickness.septal wall/Thickness.posterior wall
29441-3,Thickness.septal wall/Thickness.posterior wall
29442-1,Thickness.diastole
29443-9,Thickness.diastole
29444-7,Thickness.systole
29445-4,Thickness.systole
29446-2,Thickening.fractional change
Jul-44,Sialate
29447-0,Thickening.fractional change
29448-8,Effective regurgitant orifice area
29449-6,Regurgitant volume
29450-4,Blood flow velocity.systole.max
29451-2,Blood flow velocity.diastole.max
29452-0,Blood flow velocity.systole.max/Blood flow velocity.diastole.max
29453-8,A wave reversal.max
Apr-45,Sialidase
29454-6,Blood flow velocity.systole.max
29455-3,Blood flow velocity.systole.max/Blood flow velocity.diastole.max
29456-1,Blood flow velocity.systole.max/Blood flow velocity.diastole.max
29457-9,Blood flow velocity.systole.max/Blood flow velocity.diastole.max
29458-7,Blood flow velocity.systole.max/Blood flow velocity.diastole.max
29459-5,Diameter^expiration
29460-3,Coarctation.flow.max
29461-1,Defect.velocity.systole.max
Feb-46,Sialidase
29462-9,Pulmonic flow/Systemic flow
29463-7,Body weight
29464-5,Blood flow velocity.systole.max/Blood flow velocity.diastole.max
29465-2,End-systolic volume
29466-0,Superior-Inferior
29467-8,Superior-Inferior
29468-6,Diameter.anterior-posterior.systole
29469-4,Major axis.diameter.anterior-posterior.systole
2947-0,Sodium
29470-2,Blood velocity-time integral
29471-0,Blood flow velocity.systole.max
29472-8,Blood flow velocity.diastole.max
29473-6,Blood flow velocity.systole.max/Blood flow velocity.diastole.max
29474-4,A wave reversal.max
29475-1,Blood flow velocity.systole.max^inspiration
29476-9,Blood flow velocity.diastole.max^inspiration
29477-7,Blood flow velocity.systole.max/Blood flow velocity.diastole.max^inspiration
29478-5,A wave reversal.max^inspiration
29479-3,Blood flow velocity.systole.max^expiration
29480-1,Blood flow velocity.diastole.max^expiration
29481-9,Blood flow velocity.systole.max/Blood flow velocity.diastole.max^expiration
29482-7,A wave reversal.max^expiration
29483-5,Blood flow velocity.systole.max/Blood flow velocity.diastole.max
29484-3,Blood flow velocity.systole.max/Blood flow velocity.diastole.max^inspiration
29485-0,Blood flow velocity.systole.max/Blood flow velocity.diastole.max^expiration
29486-8,Emptying.max
29487-6,Orifice area
Aug-48,Sodium
29488-4,LOINC attachment modifier codes
29489-2,Time window attachment request modifier codes
294-9,Ketoconazole
29490-0,Selection item attachment request modifier codes
29491-8,Special attachment request modifier codes
29492-6,Methicillin
29493-4,Colistin
29494-2,Demeclocycline
29495-9,Herpes virus 6 DNA
Jun-49,Sodium
29496-7,Platelet associated Ab.IgA
29497-5,Platelet associated Ab.IgG
29498-3,Platelet associated Ab.IgM
29499-1,Selenium
29500-6,2-Hydroxyadipate/Creatinine
29501-4,2-Hydroxyisobutyrate/Creatinine
29502-2,2-Hydroxyglutarate/Creatinine
29503-0,2-Hydroxyisocaproate/Creatinine
Apr-50,Sodium
29504-8,2-Hydroxyisovalerate/Creatinine
29505-5,2-Hydroxy-3-Methylvalerate/Creatinine
29506-3,2-Oxoadipate/Creatinine
29507-1,Alpha ketoglutarate/Creatinine
29508-9,3-Hydroxyadipate/Creatinine
29509-7,Beta hydroxybutyrate/Creatinine
29510-5,3-Hydroxyglutarate/Creatinine
29511-3,3-Hydroxyisobutyrate/Creatinine
Feb-51,Sodium
29512-1,Beta hydroxybutyrate
29513-9,Cysticercus Ab
29514-7,3-Hydroxyisovalerate/Creatinine
29515-4,3-Hydroxypropionate/Creatinine
29516-2,3-Hydroxyvalerate/Creatinine
29517-0,Vanillylmandelate/Creatinine
29518-8,3-Methylglutarate/Creatinine
29519-6,4-Hydroxyphenylpyruvate/Creatinine
2952-0,Sodium
29520-4,5-Hydroxyindoleacetate/Creatinine
29521-2,5-Hydroxyhexanoate/Creatinine
29522-0,5-Oxoproline/Creatinine
29523-8,2-Ethyl-3-Hydroxypropionate/Creatinine
29524-6,Acetoacetate/Creatinine
29525-3,Aconitate/Creatinine
29526-1,Azelate/Creatinine
29527-9,Citrate/Creatinine
29528-7,Hippurate/Creatinine
29529-5,Acetaminophen
29530-3,Amphetamines
29531-1,diphenhydrAMINE
29532-9,Methadone
29533-7,Cryptococcus sp Ag
29534-5,Anguilla anguilla Ab.IgE.RAST class
29535-2,West Nile virus Ab.IgG
29536-0,West Nile virus Ab.IgM
29537-8,West Nile virus Ab.IgG
Aug-53,Sodium
29538-6,West Nile virus Ab.IgM
29539-4,HIV 1 RNA
29540-2,E-cadherin
29541-0,HIV 1 RNA
29542-8,Beta-N-acetylhexosaminidase
29543-6,Beta-N-acetylhexosaminidase.A/Beta-N-acetylhexosaminidase.total
29544-4,Physical findings
29545-1,Physical findings
Jun-54,Sodium
29546-9,Symptoms & diseases
29547-7,Symptoms & diseases
29548-5,Diagnosis
29549-3,Medication administered
29550-1,Medication dispensed
29551-9,Medication prescribed
29552-7,Color
Mar-55,Sodium
29553-5,Age
29554-3,Procedure
29555-0,Milk production
29556-8,Symptoms & diseases
29557-6,Symptoms & diseases
29558-4,Enterovirus RNA
29559-2,Haemophilus ducreyi DNA
295-6,Ketoconazole
29560-0,Anaplasma phagocytophilum DNA
Jan-56,Sodium
29561-8,Jamestown canyon virus Ab.IgG
29562-6,Jamestown canyon virus Ab.Neut
29563-4,La Crosse virus Ab.Neut
29564-2,Powassan virus Ab.IgG
29565-9,Powassan virus Ab.IgM
29566-7,West Nile virus Ab.IgG
29567-5,West Nile virus Ab.IgM
29568-3,West Nile virus Ab.Neut
29569-1,West Nile virus Ab.IgM
29570-9,West Nile virus Ab.Neut
29571-7,Phenylalanine
29572-5,Phenylalanine
29573-3,Phenylalanine
29574-1,Thyrotropin
29575-8,Thyrotropin
29576-6,Bacterial susceptibility panel
29577-4,Fungal susceptibility panel
29578-2,Viral susceptibility panel
Sep-57,Sodium renal clearance
29579-0,Mycobacterial susceptibility panel
29580-8,Differential panel
29581-6,Differential panel
29582-4,Differential panel
29583-2,Differential panel
29584-0,Differential panel
29585-7,Immunoelectrophoresis panel
29586-5,Immunoelectrophoresis panel
Jul-58,Sodium/Potassium
29587-3,Toxicology panel
29588-1,Heavy metals panel
29589-9,Heavy metals panel
29590-7,Cytomegalovirus DNA
29591-5,Enterovirus RNA
29592-3,Amphetamine
29593-1,Cells.Ki-67 nuclear Ag/100 cells
29594-9,CD45RO Ag
May-59,Sodium/Potassium
29595-6,Alpha-1-Fetoprotein
29596-4,CD25 Ag
29597-2,Mephentermine
29598-0,Methylenedioxyamphetamine
29599-8,Methylenedioxyethylamphetamine
29600-4,Benzfetamine
29601-2,Phenylpropanolamine
29602-0,Chlorphentermine
Mar-60,Somatostatin
29603-8,CD5 Ag
29604-6,Cytomegalovirus DNA
29605-3,Appearance
29606-1,Appearance
29607-9,Tropheryma whipplei DNA
29608-7,Phentermine
29609-5,Hepatitis C virus RNA
29610-3,Hepatitis B virus DNA
Jan-61,Somatostatin
29611-1,Ethchlorvynol
29612-9,Ephedrine+Pseudoephedrine
29613-7,Phendimetrazine
29614-5,Phenmetrazine
29615-2,Hepatitis B virus DNA
29616-0,Stachybotrys chartarum Ab.IgE
29617-8,CD23 Ag
29618-6,Stachybotrys chartarum Ab.IgE.RAST class
29619-4,Methylenedioxymethamphetamine
29620-2,Zonisamide
29621-0,3-Hydroxyadipate
29622-8,Beta hydroxybutyrate
29623-6,3-Hydroxydodecanoate
29624-4,3-Hydroxyglutarate
29625-1,3-Hydroxypropionate
29626-9,3-Hydroxysebacate
29627-7,3-Hydroxyvalerate
29628-5,3-Methylcrotonylglycine
Sep-62,Somatotropin
29629-3,3-Methylglutaconate
29630-1,3-Methylglutarate
29631-9,N-acetylaspartate
29632-7,N-acetyltyrosine
29633-5,CD122 Ag
29634-3,Terbutaline
29635-0,Albuterol
29636-8,Appearance
Jul-63,Somatotropin
29637-6,Time last dose
29638-4,Specimen weight
29639-2,Alkaline phosphatase
296-4,Ketoconazole
29640-0,Isomaltase
29641-8,Neutrophil cytoplasmic Ab.atypical
29642-6,Neutrophil cytoplasmic Ab.classic.atypical
29643-4,Myeloperoxidase Ab
29644-2,Proteinase 3
May-64,Specific gravity
29645-9,Echovirus+Coxsackievirus Ab.IgA
29646-7,Parainfluenza virus 2 Ab.IgM
29647-5,Interferon.beta Ab
29648-3,Rickettsia australis Ab
29649-1,Rickettsia australis Ab
29650-9,Rickettsia honei Ab
29651-7,Rickettsia honei Ab
Feb-65,Specific gravity
29652-5,Dothiepin
29653-3,Dothiepin
29654-1,Temazepam
29655-8,Oxazepam
29656-6,Sympathomimetics
29657-4,Bordetella pertussis Ab.IgA
29658-2,Bordetella pertussis Ab.IgM
29659-0,Bordetella pertussis Ab.IgG
2966-0,Specific gravity
29660-8,Parvovirus B19 Ab.IgG
29661-6,Dengue virus Ab.IgG
29662-4,Varicella zoster virus Ab.IgM
29663-2,Dengue virus Ab.IgM
29664-0,Chlamydia sp Ab.IgA
29665-7,Rickettsia conorii Ab
29666-5,Echovirus+Coxsackievirus Ab.IgA
29667-3,Parainfluenza virus 2 Ab.IgM
29668-1,Rickettsia australis Ab
29669-9,Rickettsia australis Ab
29670-7,Rickettsia honei Ab
29671-5,Rickettsia honei Ab
29672-3,Bordetella pertussis Ab.IgA
29673-1,Bordetella pertussis Ab.IgM
29674-9,Bordetella pertussis Ab.IgG
29675-6,Parvovirus B19 Ab.IgG
29676-4,Dengue virus Ab.IgG
29677-2,Chlamydia sp Ab.IgA
Aug-67,Starch granules
29678-0,Rickettsia conorii Ab
29679-8,Rickettsia sibirica Ab
29680-6,Rickettsia akari Ab
29681-4,Rickettsia akari Ab
29682-2,Rickettsia prowazekii Ab
29683-0,Rickettsia prowazekii Ab
29684-8,Rickettsia typhi Ab
29685-5,Rickettsia typhi Ab
Jun-68,Starch granules
29686-3,Orientia tsutsugamushi Gilliam Ab
29687-1,Orientia tsutsugamushi Gilliam Ab
29688-9,Orientia tsutsugamushi Karp Ab
29689-7,Orientia tsutsugamushi Karp Ab
29690-5,Orientia tsutsugamushi Kato Ab
29691-3,Orientia tsutsugamushi Kato Ab
29692-1,Orientia tsutsugamushi Litchfield Ab
29693-9,Orientia tsutsugamushi Litchfield Ab
Apr-69,Stercobilin
29694-7,Leptospira interrogans serovar Celledoni Ab
29695-4,Leptospira interrogans serovar Bulgarica Ab
29696-2,Leptospira interrogans serovar Cynopteri Ab
29697-0,Leptospira interrogans serovar Djasiman Ab
29698-8,Leptospira interrogans serovar Javanica Ab
29699-6,Leptospira interrogans serovar Panama Ab
29700-2,Leptospira interrogans serovar Shermani Ab
29701-0,Leptospira interrogans serovar Zanoni Ab
Feb-70,Streptomyces proteinase
29702-8,Rickettsia conorii Ab
29703-6,Rickettsia sibirica Ab
29704-4,Rickettsia sibirica Ab
29705-1,Rickettsia rickettsii Ab
29706-9,Rickettsia rickettsii Ab
29707-7,Rickettsia akari Ab
29708-5,Rickettsia akari Ab
29709-3,Rickettsia prowazekii Ab
2971-0,Substance P
29710-1,Rickettsia prowazekii Ab
29711-9,Rickettsia typhi Ab
29712-7,Rickettsia typhi Ab
29713-5,Orientia tsutsugamushi Gilliam Ab
29714-3,Orientia tsutsugamushi Gilliam Ab
29715-0,Orientia tsutsugamushi Karp Ab
29716-8,Orientia tsutsugamushi Karp Ab
29717-6,Orientia tsutsugamushi Kato Ab
29718-4,Orientia tsutsugamushi Kato Ab
29719-2,Orientia tsutsugamushi Litchfield Ab
297-2,Ketoconazole
29720-0,Orientia tsutsugamushi Litchfield Ab
29721-8,Influenza virus C Ag
29722-6,Chlamydophila pneumoniae Ag
29723-4,Bordetella parapertussis DNA
29724-2,Leptospira interrogans serovar Celledoni Ab
29725-9,Leptospira interrogans serovar Bulgarica Ab
29726-7,Leptospira interrogans serovar Cynopteri Ab
29727-5,Leptospira interrogans serovar Djasiman Ab
Aug-72,Succinate
29728-3,Leptospira interrogans serovar Javanica Ab
29729-1,Leptospira interrogans serovar Panama Ab
29730-9,Leptospira interrogans serovar Shermani Ab
29731-7,Leptospira interrogans serovar Zanoni Ab
29732-5,Leptospira interrogans serovar Robinsoni Ab
29733-3,Leptospira interrogans serovar Kremastos Ab
29734-1,Leptospira interrogans serovar Szwajizak Ab
29735-8,Leptospira interrogans serovar Medanensis Ab
Jun-73,Succinylacetone
29736-6,Rickettsia sibirica Ab
29737-4,Rickettsia rickettsii Ab
29738-2,Leptospira interrogans serovar Robinsoni Ab
29739-0,Leptospira interrogans serovar Kremastos Ab
29740-8,Leptospira interrogans serovar Szwajizak Ab
29741-6,Leptospira interrogans serovar Medanensis Ab
29742-4,Date last dose
29743-2,Cryofibrinogen
Apr-74,Sucrose
29744-0,Cryofibrinogen
29745-7,Cryoglobulin
29746-5,Cryoglobulin
29747-3,Tocopherols
29748-1,Protein
29749-9,Dialysis records
29750-7,Neonatal intensive care records
Jan-75,Sulfate
29751-5,Critical care records
29752-3,Perioperative records
29753-1,Initial evaluation note
29754-9,Nystagmogram study
29755-6,Nerve conduction study
29756-4,Peritoneoscopy study
29757-2,Colposcopy study
29758-0,Nystagmus examination
29759-8,Nystagmus examination
29760-6,Bilirubin.glucuronidated
29761-4,Discharge summary note
29762-2,Social history
29763-0,Protoporphyrin.zinc
29764-8,Iron
29765-5,Cholesterol
29766-3,Triglyceride
29767-1,Bilirubin
29768-9,Date vaccine information statement published
Sep-76,Sulfate.inorganic
29769-7,Date vaccine information statement presented
29770-5,Karyotype
29771-3,Hemoglobin.gastrointestinal.lower
29772-1,Coxiella burnetii phase 2 Ab
29773-9,Coxiella burnetii phase 2 Ab.IgM
29774-7,Coxiella burnetii phase 1 Ab
29775-4,Insulin-like growth factor-I
29776-2,Microscopic observation
Jul-77,Sulfite oxidase
29777-0,Coxiella burnetii phase 2 Ab.IgG
29778-8,West Nile virus Ab.IgM
29779-6,West Nile virus Ab.Neut
29780-4,West Nile virus Ab.IgM
29781-2,West Nile virus Ab
29782-0,Trivittatus virus Ab.Neut
29783-8,Saint Louis encephalitis virus Ab.Neut
29784-6,Highlands J virus Ab.Neut
May-78,Superoxide dismutase
29785-3,Eastern equine encephalitis virus Ab.IgG
29786-1,Jamestown canyon virus Ab.IgM
29787-9,Jamestown canyon virus Ab.IgM
29788-7,Jamestown canyon virus Ab.IgG
29789-5,La Crosse virus Ab.IgG
29790-3,La Crosse virus Ab.IgM
29791-1,Powassan virus Ab.IgG
29792-9,Powassan virus Ab.IgM
Mar-79,Taurine
29793-7,Anaplasma phagocytophilum Ab.IgG
29794-5,Anaplasma phagocytophilum Ab.IgM
29795-2,Trivittatus virus Ab.Neut
29796-0,Saint Louis encephalitis virus Ab.Neut
29797-8,Highlands J virus Ab.Neut
29798-6,Eastern equine encephalitis virus Ab.IgG
29799-4,Jamestown canyon virus Ab.IgM
298-0,Lincomycin
29800-0,Jamestown canyon virus Ab.IgM
Jan-80,Taurine
29801-8,Jamestown canyon virus Ab.IgG
29802-6,La Crosse virus Ab.IgG
29803-4,La Crosse virus Ab.IgM
29804-2,Powassan virus Ab.IgG
29805-9,Powassan virus Ab.IgM
29806-7,Anaplasma phagocytophilum Ab.IgG
29807-5,Anaplasma phagocytophilum Ab.IgM
29808-3,Trivittatus virus Ab.Neut
29809-1,Saint Louis encephalitis virus Ab.Neut
29810-9,Highlands J virus Ab.Neut
29811-7,Eastern equine encephalitis virus Ab.IgG
29812-5,Jamestown canyon virus Ab.IgM
29813-3,Jamestown canyon virus Ab.IgM
29814-1,Jamestown canyon virus Ab.IgG
29815-8,La Crosse virus Ab.IgG
29816-6,La Crosse virus Ab.IgM
29817-4,Powassan virus Ab.IgG
29818-2,Powassan virus Ab.IgM
Sep-81,Taurine
29819-0,Anaplasma phagocytophilum Ab.IgG
29820-8,Anaplasma phagocytophilum Ab.IgM
29821-6,Trivittatus virus Ab
29822-4,Saint Louis encephalitis virus Ab
29823-2,Highlands J virus Ab
29824-0,Eastern equine encephalitis virus Ab.IgG
29825-7,Jamestown canyon virus Ab.IgM
29826-5,Jamestown canyon virus Ab.IgM
Jul-82,Taurine
29827-3,Jamestown canyon virus Ab.IgG
29828-1,La Crosse virus Ab.IgG
29829-9,La Crosse virus Ab.IgM
29830-7,Powassan virus Ab.IgG
29831-5,Powassan virus Ab.IgM
29832-3,Anaplasma phagocytophilum Ab.IgG
29833-1,Anaplasma phagocytophilum Ab.IgM
29834-9,Trivittatus virus Ab
May-83,Terminal deoxyribonucleotidyl transferase
29835-6,Highlands J virus Ab
29836-4,Eastern equine encephalitis virus Ab.IgG
29837-2,Jamestown canyon virus Ab.IgM
29838-0,Jamestown canyon virus Ab.IgM
29839-8,Jamestown canyon virus Ab.IgG
29840-6,La Crosse virus Ab.IgG
29841-4,La Crosse virus Ab.IgM
29842-2,Powassan virus Ab.IgG
Mar-84,Testosterone
29843-0,Powassan virus Ab.IgM
29844-8,Anaplasma phagocytophilum Ab.IgG
29845-5,Anaplasma phagocytophilum Ab.IgM
29846-3,Trivittatus virus Ab
29847-1,Highlands J virus Ab
29848-9,Eastern equine encephalitis virus Ab.IgG
29849-7,Jamestown canyon virus Ab.IgM
2985-0,Testosterone
29850-5,Jamestown canyon virus Ab.IgM
29851-3,Jamestown canyon virus Ab.IgG
29852-1,La Crosse virus Ab.IgG
29853-9,La Crosse virus Ab.IgM
29854-7,Powassan virus Ab.IgG
29855-4,Powassan virus Ab.IgM
29856-2,Anaplasma phagocytophilum Ab.IgG
29857-0,Anaplasma phagocytophilum Ab.IgM
29858-8,Alpha hydroxybutyrate/Creatinine
29859-6,Adipate/Creatinine
29860-4,Cardiolipin Ab
29861-2,Levisticum officinale Ab.IgE.RAST class
29862-0,Diospyros kaki Ab.IgE.RAST class
29863-8,IgD Ag
29864-6,"2-Oxo,3-Methylvalerate"
29865-3,2-Oxoisocaproate
29866-1,2-Oxoisovalerate
29867-9,"3-Hydroxy,3-Methylglutarate"
Aug-86,Testosterone
29868-7,Gamma hydroxybutyrate
29869-5,4-Hydroxycyclohexylacetate
29870-3,4-Hydroxyphenyllactate
29871-1,4-Hydroxyphenylpyruvate
29872-9,5-Oxoproline
29873-7,Isobutyrylglycine
29874-5,Isovalerylglycine
29875-2,Lactate
Jun-87,Testosterone
29876-0,2-Methylcitrate
29877-8,Methylmalonate
29878-6,Argininosuccinate/Creatinine
29879-4,Dehydroepiandrosterone/Creatinine
29880-2,2-Hydroxy-3-Methylvalerate
29881-0,2-Hydroxyglutarate
29882-8,2-Hydroxyisovalerate
29883-6,2-Hydroxyphenylacetate
Apr-88,Testosterone
29884-4,2-Methylbutyrylglycine
29885-1,Actinobacillus sp identified
29886-9,Encephalomyocarditis virus Ab.Neut
29887-7,Pasteurella multocida type
29888-5,Pseudorabies virus.G1 gene deletion Ab
29889-3,Encephalomyocarditis virus Ab
29890-1,Pseudorabies virus.G1 gene deletion Ab
29891-9,Carbon dioxide^post dose urea
Feb-89,Testosterone
29892-7,Carbon dioxide^post dose urea
29893-5,HIV 1 Ab
29894-3,Phosphorus
29895-0,Phosphorus
29896-8,Cryptococcus sp Ag
29897-6,Styrene
29898-4,Borrelia burgdorferi Ab.IgG
29899-2,Gamma globulin
29-Sep,Ampicillin
2990-0,Testosterone.free+weakly bound
29900-8,Hepatitis B virus DNA
29901-6,HTLV I+II Ab
29902-4,Chlorobenzene
29903-2,Cryptococcus sp Ag
29904-0,Toxoplasma gondii DNA
29905-7,Entamoeba histolytica Ag
29906-5,Haemophilus influenzae A DNA
29907-3,Haemophilus influenzae B DNA
29908-1,Parainfluenza virus 1 RNA
29909-9,Parainfluenza virus 2 RNA
29910-7,Parainfluenza virus 3 RNA
29911-5,Magnesium
29912-3,Magnesium
29913-1,Xylose^2H post 5 g xylose PO
29914-9,Arsenic
29915-6,Tellurium
29916-4,Cobalt
29917-2,Selenium/Creatinine
Aug-91,Testosterone.free
29918-0,Bismuth
29919-8,Chromium/Creatinine
29920-6,Beryllium/Creatinine
29921-4,Boron
29922-2,Boron/Creatinine
29923-0,Scandium
29924-8,Scandium
29925-5,Scandium/Creatinine
Jun-92,Testosterone
29926-3,Boron
29927-1,Beryllium
29928-9,Titanium
29929-7,Titanium
29930-5,Titanium/Creatinine
29931-3,Vanadium
29932-1,Vanadium
29933-9,Vanadium/Creatinine
Apr-93,Testosterone
29934-7,Cobalt/Creatinine
29935-4,Manganese/Creatinine
29936-2,Nickel
29937-0,Aluminum/Creatinine
29938-8,Thallium/Creatinine
29939-6,Tellurium/Creatinine
29940-4,Bismuth/Creatinine
29941-2,Antimony/Creatinine
Feb-94,Testosterone.free
29942-0,Copper/Creatinine
29943-8,Lead/Creatinine
29944-6,Alpha-2-Macroglobulin
29945-3,Alpha 1 globulin
29946-1,Albumin
29947-9,Alpha 2 globulin
29948-7,Sjogrens syndrome-A extractable nuclear Ab
29949-5,Sjogrens syndrome-B extractable nuclear Ab
29950-3,Nuclear Ab.IgG
29951-1,Beta globulin
29952-9,Borrelia burgdorferi Ag
29953-7,Nuclear Ab
29954-5,Extractable nuclear Ab
29955-2,Legionella pneumophila Ab.IgG
29956-0,Lysozyme
29957-8,Herpes simplex virus Ag
29958-6,Ribonucleoprotein extractable nuclear Ab.IgG
Sep-95,Tetrahydrocortisol
29959-4,Ganglioside GM1 Ab.IgG
29960-2,Ganglioside GM1 Ab.IgM
29961-0,Asialoganglioside GM1 Ab.IgG
29962-8,Asialoganglioside GM1 Ab.IgM
29963-6,Parietal cell Ab.IgG
29964-4,Sjogrens syndrome-A extractable nuclear Ab.IgG
29965-1,Sjogrens syndrome-B extractable nuclear Ab.IgG
29966-9,Centromere Ab.IgG
Jul-96,Tetrahydrodeoxycortisol
29967-7,Neutrophil cytoplasmic Ab.IgG
29968-5,Rubidium
29969-3,Rubidium
29970-1,Rubidium/Creatinine
29971-9,Strontium
29972-7,Strontium
29973-5,Strontium/Creatinine
29974-3,Molybdenum
May-97,Tetrahydrofolate
29975-0,Molybdenum
29976-8,Molybdenum/Creatinine
29977-6,Silver
29978-4,Silver/Creatinine
29979-2,Tin
299-8,Lincomycin
29980-0,Tin
29981-8,Tin/Creatinine
29982-6,Cesium
Mar-98,Thiamine
29983-4,Cesium
29984-2,Cesium/Creatinine
29985-9,Barium
29986-7,Barium/Creatinine
29987-5,Gold
29988-3,Gold/Creatinine
29989-1,Uranium/Creatinine
29990-9,Spermatozoa^post vasectomy
Jan-99,Thiamine
29991-7,Fibrin+Fibrinogen fragments
29992-5,Eosinophils
29993-3,Eosinophils
29994-1,Basement membrane Ab.IgG
29995-8,Basement membrane Ab.IgA
29996-6,Histone Ab.IgG
29997-4,Basement membrane Ab.IgG
29998-2,Striated muscle Ab.IgG
29999-0,Xylose
30000-4,Albumin/Creatinine
30001-2,Albumin/Creatinine
30002-0,Creatinine
30003-8,Albumin
30004-6,Creatinine
30005-3,CYP21A2 gene targeted mutation analysis
30006-1,Transfuse granulocytes
Jul-00,Thiamine pyrophosphate
30007-9,Transfuse cryoprecipitate poor plasma
30008-7,Blood group antibody screen
30009-5,Fibrin+Fibrinogen fragments
30010-3,Borrelia burgdorferi 93kD Ab.IgG
30011-1,Borrelia burgdorferi 45kD Ab.IgG
30012-9,Borrelia burgdorferi 28kD Ab.IgG
30013-7,Borrelia burgdorferi 23kD Ab.IgG
30014-5,Borrelia burgdorferi 21kD Ab.IgG
May-01,Thiocyanate
30015-2,Borrelia burgdorferi 41kD Ab.IgG
30016-0,Borrelia burgdorferi 66kD Ab.IgG
30017-8,Borrelia burgdorferi 58kD Ab.IgG
30018-6,Borrelia burgdorferi 30kD Ab.IgG
30019-4,Borrelia burgdorferi 41kD Ab.IgM
30020-2,Borrelia burgdorferi 39kD Ab.IgM
30021-0,Borrelia burgdorferi 23kD Ab.IgM
30022-8,Botrytis cinerea Ab.IgG
Mar-02,Thiocyanate
30023-6,Bacillus subtilis Ab.IgE
30024-4,Carbophenothion
30025-1,Coumaphos
30026-9,Dichlorvos
30027-7,Dimethoate
30028-5,O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate
30029-3,Dehydroepiandrosterone
30030-1,Iron
Jan-03,Thiocyanate
30031-9,(Alternaria alternata+Dermatophagoides farinae) Ab.IgG
30032-7,Phoma betae Ab.IgG
30033-5,Homocystine^6H post dose methionine
30034-3,Bovine herpesvirus 1 Ab
30035-0,Homocystine^post CFst
30036-8,Aspergillus fumigatus 2 Ab
30037-6,(Alternaria alternata+Dermatophagoides farinae) Ab.IgE
30038-4,Toxoplasma gondii Ab.IgG
30039-2,Anaplasma phagocytophilum DNA
300-4,Lincomycin
30040-0,Dirofilaria immitis Ab
30041-8,Curcuma longa Ab.IgE
30042-6,Vigabatrin
30043-4,Rosmarinus officinalis Ab.IgE
30044-2,Dirofilaria immitis Ab
30045-9,Mycobacterium sp identified
30046-7,Legionella pneumophila Ab
30047-5,Histidine/Creatinine
30048-3,Lysine/Creatinine
Sep-04,Thiocyanate
30049-1,Ornithine/Creatinine
30050-9,Hydroxylysine/Creatinine
30051-7,Homocystine/Creatinine
30052-5,Isoleucine/Creatinine
30053-3,Leucine/Creatinine
30054-1,Tyrosine/Creatinine
30055-8,Phenylalanine/Creatinine
Jun-05,Thiosulfate renal clearance
30056-6,Glutamine/Creatinine
30057-4,Threonine/Creatinine
30058-2,Serine/Creatinine
30059-0,Glutamate/Creatinine
30060-8,Amino beta guanidinopropionate
30061-6,Aspartate/Creatinine
30062-4,Arginine/Creatinine
30063-2,Methionine/Creatinine
Apr-06,Threonine
30064-0,Valine/Creatinine
30065-7,Cystine/Creatinine
30066-5,Glycine/Creatinine
30067-3,Proline/Creatinine
30068-1,Alanine/Creatinine
30069-9,Tyrosine
30070-7,Cystathionine
30071-5,Trichoderma viride Ab.IgG
Feb-07,Threonine
30072-3,Cortisone
30073-1,Voltage-gated calcium channel Ab
30074-9,Hemoglobin F
30075-6,Respiratory syncytial virus A RNA
30076-4,Respiratory syncytial virus B RNA
30077-2,Amylase/Creatinine renal clearance
30078-0,Specimen weight
30079-8,Renal tubular casts
3008-0,Threonine
30080-6,Cathepsin D
30081-4,IgD
30082-2,IgE
30083-0,Epstein Barr virus nuclear Ab.IgG
30084-8,Lupus erythematosus deoxynucleoproteins Ab.IgG
30085-5,Legionella pneumophila Ab.IgG
30086-3,Coagulation factor IX inhibitor
30087-1,Cow hair+Cow dander Ab.IgE
30088-9,Horse hair+Horse dander Ab.IgE
30089-7,Transitional cells
30090-5,Burkholderia pseudomallei Ab.IgG
30091-3,Burkholderia pseudomallei Ab.IgM
30092-1,Brucella canis Ab.IgG
30093-9,Brucella canis Ab.IgM
30094-7,Neisseria meningitidis serogroup A Ag
30095-4,Neisseria meningitidis serogroup B Ag
30096-2,Neisseria meningitidis serogroup C Ag
30097-0,Neisseria meningitidis serogroup w135 Ag
Aug-09,Threonine
30098-8,Neisseria meningitidis serogroup Y Ag
30099-6,Neisseria gonorrhoeae
30100-2,Yersinia enterocolitica O:3 Ab
30101-0,Yersinia enterocolitica O:5 Ab
30102-8,Yersinia enterocolitica O:8 Ab
30103-6,Yersinia enterocolitica O:9 Ab
30104-4,Trypanosoma cruzi Ab.IgG
30105-1,Trypanosoma cruzi Ab.IgM
Jun-10,Threonine
30106-9,Acetylcholinesterase
30107-7,Ecgonine methyl ester
30108-5,Ecgonine methyl ester
30109-3,Ecgonine methyl ester
30110-1,Ecgonine methyl ester
30111-9,Thermoactinomyces vulgaris 2 Ab
30112-7,Amphetamine
30113-5,Lymphocytes.IgG
Apr-11,Thromboxane alpha 2
30114-3,Lymphocytes.lambda
30115-0,Lymphocytes.kappa
30116-8,Cells.terminal deoxyribonucleotidyl transferase/100 cells
30117-6,Cells.terminal deoxyribonucleotidyl transferase/100 cells
30118-4,Lymphocytes.IgA
30119-2,Lymphocytes.IgM
301-2,Lincomycin
30120-0,Lymphocytes.IgD
30121-8,Colony count
Feb-12,Thromboxane beta 2
30122-6,Aeromonas sp
30123-4,Testosterone.bound
30124-2,Amylase
30125-9,Gerbil hair Ab.IgE.RAST class
30126-7,Platanus acerifolia Ab.IgE.RAST class
30127-5,Gerbil hair Ab.IgE
30128-3,Borrelia burgdorferi Ab^2nd specimen
30129-1,Brucella sp Ab^1st specimen
3013-0,Thyroglobulin
30130-9,Brucella sp Ab^2nd specimen
30131-7,Complement total hemolytic CH50
30132-5,Coxsackievirus Ab^1st specimen
30133-3,Coxsackievirus Ab^2nd specimen
30134-1,Echovirus Ab^1st specimen
30135-8,Echovirus Ab^2nd specimen
30136-6,Epstein Barr virus capsid Ab.IgG^2nd specimen
30137-4,Epstein Barr virus capsid Ab.IgM^2nd specimen
30138-2,Epstein Barr virus nuclear Ab^2nd specimen
30139-0,Hydroxyproline.free
30140-8,IgA
30141-6,IgG
30142-4,IgM
30143-2,Legionella sp Ab^1st specimen
30144-0,Legionella sp Ab^2nd specimen
30145-7,Monocytes
30146-5,Mumps virus Ab^2nd specimen
30147-3,Respiratory syncytial virus Ab^1st specimen
Aug-14,Thyroid stimulating immunoglobulins
30148-1,Respiratory syncytial virus Ab^2nd specimen
30149-9,Streptolysin O Ab^1st specimen
30150-7,Streptolysin O Ab^2nd specimen
30151-5,Thyrotropin.long acting
30152-3,Mannose-binding protein
30153-1,Streptococcus pneumoniae Danish serotype 9V Ab.IgG
30154-9,Protein/Creatinine
May-15,Thyrotropin
30155-6,Reticulocytes.punctate/100 erythrocytes
30156-4,Reticulocytes.aggregate/100 erythrocytes
30157-2,Heterophils/100 leukocytes
30158-0,Toxoplasma gondii
30159-8,HTLV I+II DNA
30160-6,Tau protein
30161-4,Citrulline/Creatinine
30162-2,Cynara scolymus Ab.IgG
Mar-16,Thyrotropin
30163-0,Agapostemon texanus Ab.IgE
30164-8,(Anacardium occidentale+Carya illinoinensis+Juglans regia) Ab.IgE
30165-5,Phosphatidylcholine/Albumin
30166-3,Thyroid stimulating immunoglobulins actual/Normal
30167-1,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA
30168-9,Juniperus monosperma Ab.IgE
30169-7,Chromogranin A
30170-5,Periplaneta americana Ab.IgE
Jan-17,Thyrotropin binding inhibitory immunoglobulins
30171-3,Cortisol.free/Creatinine
30172-1,Cortisol.free/Creatinine
30173-9,Cortisol.free
30174-7,Jamestown canyon virus Ab.IgG
30175-4,Jamestown canyon virus Ab.Neut
30176-2,La Crosse virus Ab.Neut
30177-0,Powassan virus Ab.IgG
30178-8,West Nile virus Ab.IgG
30179-6,Powassan virus Ab.IgM
30180-4,Basophils/100 leukocytes
30181-2,Lymphocytes.clefted
30182-0,(Olea europaea+Salix caprea+Pinus strobus+Eucalyptus spp+Acacia longifolia+Melaleuca leucadendron) Ab.IgE
30183-8,(Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) Ab.IgE
30184-6,(Acer negundo+Betula verrucosa+Quercus alba+Ulmus americana+Juglans californica) Ab.IgE
30185-3,(Cat dander+Cow dander+Dog dander+Horse dander) Ab.IgE
30186-1,(Blatella germanica+Dermatophagoides farinae+Dermatophagoides pteronyssinus+House dust Greer) Ab.IgE
30187-9,(Arachis hypogaea+Cow milk+Egg white+Gadus morhua+Glycine max+Triticum aestivum) Ab.IgE
30188-7,(Cynodon dactylon+Lolium perenne+Phleum pratense+Poa pratensis+Sorghum halepense+Paspalum notatum) Ab.IgE
Sep-18,Thyrotropin releasing hormone
30189-5,(Dactylis glomerata+Festuca elatior+Lolium perenne+Phleum pratense+Poa pratensis) Ab.IgE
30190-3,3-Hydroxytetradecenoylcarnitine (C14:1-OH)
30191-1,Acetylcarnitine (C2)
30192-9,Acetylcholine receptor modulation Ab/Acetylcholine Ab.total
30193-7,Acylcarnitine/Carnitine.free (C0)
30194-5,Fatty acids.very long chain.C22:0
30195-2,Fatty acids.very long chain.C24:0
30196-0,Fatty acids.very long chain.C24:0/C22:0
Jul-19,Thyrotropin.long acting
30197-8,Fatty acids.very long chain.C26:0
30198-6,Fatty acids.very long chain.C26:0/C22:0
30199-4,Alpha subunit
302-0,Lomefloxacin
30200-0,Asialoganglioside GM1 Ab.IgM
30201-8,B Ab
30202-6,Brucella sp Ab
30203-4,Candida albicans reaction wheal^2D post 0.1 mL Candida albicans ID
30204-2,Chlamydia trachomatis Ab
May-20,Thyroxine binding globulin
30205-9,Chlamydophila pneumoniae Ab
30206-7,Choriogonadotropin.alpha subunit.free
30207-5,Coccidioides immitis Ab.IgG
30208-3,Coccidioides immitis Ab.IgM
30209-1,Coccidioides immitis Ab
30210-9,Coccidioides reaction wheal^2D post 0.1 mL coccidioidin ID
30211-7,Collection duration
30212-5,Coxiella burnetii Ab.IgG
Mar-21,Thyroxine binding globulin
30213-3,Coxiella burnetii Ab.IgM
30214-1,Coxsackievirus A10 Ab
30215-8,Coxsackievirus A16 Ab
30216-6,Coxsackievirus A2 Ab
30217-4,Coxsackievirus A4 Ab
30218-2,Coxsackievirus A7 Ab
30219-0,Coxsackievirus A9 Ab
30220-8,Coxsackievirus B1 Ab
Jan-22,Thyroxine free index
30221-6,Coxsackievirus B2 Ab
30222-4,Coxsackievirus B3 Ab
30223-2,Coxsackievirus B4 Ab
30224-0,Coxsackievirus B5 Ab
30225-7,Coxsackievirus B6 Ab
30226-5,Fibrin+Fibrinogen fragments
30227-3,Histoplasma capsulatum farciminosum reaction wheal^2D post 0.1 mL histoplasmin ID
30228-1,Mumps reaction wheal^2D post 0.1 mL mumps ID
30229-9,Neutrophils.band form
30230-7,Neutrophils.segmented/100 leukocytes
30231-5,Rheumatoid factor
30232-3,Trichophyton reaction wheal^2D post 0.1ml trichophyton ID
30233-1,3-Hydroxydodecanoylcarnitine (C12-OH)
30234-9,3-Hydroxypalmitoylcarnitine (C16-OH)
30235-6,3-Hydroxypalmitoleylcarnitine (C16:1-OH)
30236-4,3-Hydroxyhexanoylcarnitine (C6-OH)
30237-2,3-Hydroxylinoleoylcarnitine (C18:2-OH)
30238-0,3-Hydroxytetradecanoylcarnitine (C14-OH)
Sep-23,Thyroxine uptake
30239-8,Aspartate aminotransferase
30240-6,Fibrin D-dimer
30241-4,Lactate
30242-2,Lactate
30243-0,Choriogonadotropin.intact
30244-8,Acetylcholinesterase
30245-5,HIV 1 DNA
30246-3,Cytomegalovirus DNA
Jul-24,Thyroxine.free
30247-1,Cytomegalovirus DNA
30248-9,Transferrin receptor.soluble
30249-7,Barbiturates
30250-5,Benzodiazepines
30251-3,Glucose^2.6H post dose glucose
30252-1,Glucose^3.3H post dose glucose
30253-9,Glucose^3.6H post dose glucose
Apr-25,Thyroxine
30254-7,Insulin^15M post XXX challenge
30255-4,Insulin^45M post XXX challenge
30256-2,Insulin^1.3H post XXX challenge
30257-0,Insulin^1.6H post XXX challenge
30258-8,Insulin^2.3H post XXX challenge
30259-6,Insulin^2.6H post XXX challenge
30260-4,Insulin^3.3H post XXX challenge
30261-2,Insulin^3.5H post XXX challenge
Feb-26,Thyroxine
30262-0,Insulin^3.6H post XXX challenge
30263-8,Glucose^20M post dose glucose
30264-6,Glucose^40M post dose glucose
30265-3,Glucose^1.3H post dose glucose
30266-1,Glucose^1.6H post dose glucose
30267-9,Glucose^2.3H post dose glucose
30268-7,Zidovudine
30269-5,lamiVUDine
3027-0,Thyroxine/Thyroxine binding globulin
30270-3,Didanosine
30271-1,Zalcitabine
30272-9,Stavudine
30273-7,Abacavir
30274-5,Adefovir
30275-2,Nevirapine
30276-0,Delavirdine
30277-8,Efavirenz
30278-6,Indinavir
30279-4,Ritonavir
30280-2,Nelfinavir
30281-0,Saquinavir
30282-8,Zidovudine
30283-6,lamiVUDine
30284-4,Didanosine
30285-1,Zalcitabine
30286-9,Stavudine
30287-7,Abacavir
Aug-28,Thyroxine/Triiodothyronine uptake index
30288-5,Adefovir
30289-3,Nevirapine
30290-1,Delavirdine
30291-9,Efavirenz
30292-7,Indinavir
30293-5,Ritonavir
30294-3,Nelfinavir
30295-0,Saquinavir
Jun-29,Transcobalamin I
30296-8,Amprenavir
30297-6,Amprenavir
30298-4,lamiVUDine
30299-2,Amprenavir
30300-8,Didanosine
30301-6,Zalcitabine
30302-4,Stavudine
30303-2,Abacavir
Apr-30,Transcobalamin II
30304-0,Adefovir
30305-7,Delavirdine
30306-5,Efavirenz
30307-3,Indinavir
30308-1,Ritonavir
30309-9,Nelfinavir
30310-7,Saquinavir
30311-5,Nevirapine
Feb-31,Transcobalamin III
30312-3,3-Hydroxyoleoylcarnitine (C18:1-OH)
30313-1,Hemoglobin
30314-9,A Ab
30315-6,Acid alpha glucosidase
30316-4,Alpha subunit.free
30317-2,Base deficit
30318-0,Base deficit
30319-8,Beta galactosidase
3032-0,Transcobalamin
30320-6,Cells.CD3+IL2R1+
30321-4,Coagulation surface induced.factor substitution^1H post incubation
30322-2,Coagulation surface induced.factor substitution^1H post incubation
30323-0,Coagulation surface induced.factor substitution^1H post incubation after addition of normal plasma
30324-8,Cryptococcus sp Ag
30325-5,Cytomegalovirus Ab.IgM
30326-3,Cytomegalovirus DNA
30327-1,Decanoylcarnitine (C10)
30328-9,Decenoylcarnitine (C10:1)
30329-7,Disialylganglioside GD1b Ab.IgG
30330-5,Disialylganglioside GD1b Ab.IgM
30331-3,Dodecanoylcarnitine (C12)
30332-1,Dodecenoylcarnitine (C12:1)
30333-9,Echovirus 11 Ab
30334-7,Echovirus 30 Ab
30335-4,Echovirus 4 Ab
30336-2,Echovirus 7 Ab
30337-0,Echovirus 9 Ab
Aug-33,Transcortin
30338-8,Anaplasma phagocytophilum Ab
30339-6,Epstein Barr virus capsid Ab.IgG
30340-4,Epstein Barr virus capsid Ab.IgM
30341-2,Erythrocyte sedimentation rate
30342-0,Extractable nuclear Ab
30343-8,Glomerular basement membrane Ab.IgG
30344-6,Glucose^1H post 1.2 g/kg lactose PO
30345-3,Glucose^2H post 1.2 g/kg lactose PO
Jun-34,Transferrin
30346-1,Glucose^3H post 1.2 g/kg lactose PO
30347-9,Glutamate decarboxylase 65 Ab
30348-7,Glutamate
30349-5,Glutarylcarnitine (C5-DC)
30350-3,Hemoglobin
30351-1,Hemoglobin
30352-9,Hemoglobin
Mar-35,Transferrin
30353-7,Hemoglobin
30354-5,Hemoglobin
30355-2,Herpes simplex virus 1+2 Ab.IgM
30356-0,Palmitoylcarnitine (C16)
30357-8,Palmitoleylcarnitine (C16:1)
30358-6,Hexanoylcarnitine (C6)
30359-4,Histone Ab
30360-2,Histoplasma capsulatum mycelial phase Ab
Jan-36,Transketolase
30361-0,HIV 2 Ab
30362-8,Insulin^30M post 75 g glucose PO
30363-6,Insulin^post 12H CFst
30364-4,Lymphocytes
30365-1,Lymphocytes/100 leukocytes
30366-9,Metamyelocytes/100 leukocytes
30367-7,Myeloblasts/100 leukocytes
30368-5,Myelocytes/100 leukocytes
30369-3,Oxyhemoglobin/Hemoglobin.total
30370-1,Oxyhemoglobin/Hemoglobin.total
30371-9,Promyelocytes/100 leukocytes
30372-7,Sucrase
30373-5,Basophils/100 leukocytes
30374-3,Basophils/100 leukocytes
30375-0,Basophils/100 leukocytes
30376-8,Blasts
30377-6,Eosinophils/100 leukocytes
30378-4,Eosinophils/100 leukocytes
Sep-37,Prealbumin
30379-2,Eosinophils/100 leukocytes
303-8,Lomefloxacin
30380-0,Eosinophils/100 leukocytes
30381-8,Eosinophils/100 leukocytes
30382-6,Eosinophils/100 leukocytes
30383-4,Epithelial cells
30384-2,Erythrocyte distribution width
30385-9,Erythrocyte distribution width
30386-7,Erythrocyte mean corpuscular diameter
Jul-38,Trehalase
30387-5,Erythrocytes
30388-3,Erythrocytes
30389-1,Erythrocytes
30390-9,Erythrocytes
30391-7,Erythrocytes
30392-5,Erythrocytes.nucleated
30393-3,Erythrocytes.nucleated/100 leukocytes
30394-1,Granulocytes
May-39,Triacylglycerol lipase
30395-8,Granulocytes/100 leukocytes
30396-6,Granulocytes/100 leukocytes
30397-4,Hairy cells
30398-2,Hematocrit
30399-0,Hemoglobin distribution width
30400-6,Hypochromia
30401-4,Leukocytes
30402-2,Leukocytes
Mar-40,Triacylglycerol lipase
30403-0,Leukocytes
30404-8,Leukocytes
30405-5,Leukocytes
30406-3,Leukocytes other
30407-1,Leukocytes other/100 leukocytes
30408-9,Leukocytes other/100 leukocytes
30409-7,Leukocytes other/100 leukocytes
30410-5,Leukocytes other/100 leukocytes
Jan-41,Trichloroacetate
30411-3,Leukocytes.left shift
30412-1,Lymphocytes.abnormal
30413-9,Lymphocytes.abnormal/100 leukocytes
30414-7,Lymphocytes.abnormal/100 leukocytes
30415-4,Lymphocytes.abnormal/100 leukocytes
30416-2,Lymphocytes.variant/100 leukocytes
30417-0,Lymphocytes.variant/100 leukocytes
30418-8,Lymphocytes.clefted
30419-6,Lymphocytes.clefted/100 leukocytes
30420-4,Lymphocytes.large granular/100 leukocytes
30421-2,Lymphocytes/100 leukocytes
30422-0,Lymphoma cells
30423-8,Lymphoma cells/100 leukocytes
30424-6,Macrocytes
30425-3,Macrophages/100 leukocytes
30426-1,Macrophages/100 leukocytes
30427-9,Macrophages/100 leukocytes
30428-7,Erythrocyte mean corpuscular volume
Sep-42,Chloral hydrate
30429-5,Mesothelial cells/100 leukocytes
30430-3,Mesothelial cells/100 leukocytes
30431-1,Mesothelial cells/100 leukocytes
30432-9,Mesothelial cells/100 leukocytes
30433-7,Metamyelocytes
30434-5,Microcytes
30435-2,Monocytes
30436-0,Monocytes+Macrophages/100 leukocytes
Jul-43,Triglyceride
30437-8,Monocytes+Macrophages/100 leukocytes
30438-6,Monocytes+Macrophages/100 leukocytes
30439-4,Monocytes+Macrophages/100 leukocytes
30440-2,Monocytes.abnormal
30441-0,Monocytes.abnormal/100 leukocytes
30442-8,Monocytes/100 leukocytes
30443-6,Mononuclear cells/100 leukocytes
30444-4,Myeloblasts
May-44,Triglyceride+ester.in HDL
30445-1,Myeloblasts/100 leukocytes
30446-9,Myelocytes
30447-7,Myelocytes/100 leukocytes
30448-5,Neutrophils
30449-3,Neutrophils.hypersegmented
30450-1,Neutrophils.hypersegmented/100 leukocytes
30451-9,Neutrophils.segmented
Feb-45,Triglyceride+ester.in IDL
30452-7,Neutrophils.segmented
30453-5,Neutrophils.segmented/100 leukocytes
30454-3,Neutrophils/100 leukocytes
30455-0,Neutrophils/100 leukocytes
30456-8,Nonhematic cells/100 leukocytes
30457-6,Nonhematic cells/100 leukocytes
30458-4,Plasma cells
30459-2,Platelet mean diameter
304-6,Lomefloxacin
3046-0,Triglyceride+ester.in LDL
30460-0,Polymorphonuclear cells/100 leukocytes
30461-8,Polymorphonuclear cells/100 leukocytes
30462-6,Polymorphonuclear cells/100 leukocytes
30463-4,Promyelocytes/100 leukocytes
30464-2,Prolymphocytes
30465-9,Prolymphocytes/100 leukocytes
30466-7,Promonocytes/100 leukocytes
30467-5,Promyelocytes/100 leukocytes
30468-3,Unidentified cells/100 leukocytes
30469-1,Unspecified cells/100 leukocytes
30470-9,Cardiolipin Ab.IgA
30471-7,levETIRAcetam
30472-5,Ethylmalonate
30473-3,Glutaconate
30474-1,Glutarate
30475-8,Glycerate
30476-6,Glyoxylate
30477-4,Hexanoylglycine
Aug-47,Triglyceride+ester.in VLDL
30478-2,Malonate
30479-0,Methylsuccinate
30480-8,Orotate
30481-6,Pyruvate
30482-4,Suberylglycine
30483-2,Succinylacetone
30484-0,Tiglylglycine
30485-7,Uracil
Jun-48,Triglyceride^post CFst
30486-5,Catecholamines^baseline
30487-3,Catecholamines^1H post XXX challenge
30488-1,Streptococcus pneumoniae 12 Ab.IgG^1st specimen
30489-9,Streptococcus pneumoniae 12 Ab.IgG^2nd specimen
30490-7,Streptococcus pneumoniae Danish serotype 18C Ab.IgG^1st specimen
30491-5,Streptococcus pneumoniae Danish serotype 18C Ab.IgG^2nd specimen
30492-3,Streptococcus pneumoniae 19 Ab.IgG^1st specimen
30493-1,Streptococcus pneumoniae 19 Ab.IgG^2nd specimen
Apr-49,Triglyceride
30494-9,Streptococcus pneumoniae 23 Ab.IgG^1st specimen
30495-6,Streptococcus pneumoniae 23 Ab.IgG^2nd specimen
30496-4,Streptococcus pneumoniae 4 Ab.IgG^1st specimen
30497-2,Streptococcus pneumoniae 4 Ab.IgG^2nd specimen
30498-0,Streptococcus pneumoniae Danish serotype 6B Ab.IgG^1st specimen
30499-8,Streptococcus pneumoniae Danish serotype 6B Ab.IgG^2nd specimen
30500-3,Phosphatidylserine Ab.IgA
30501-1,Streptococcus pneumoniae Danish serotype 7F Ab.IgG^1st specimen
Feb-50,Triiodothyronine resin uptake (T3RU)
30502-9,Streptococcus pneumoniae Danish serotype 7F Ab.IgG^2nd specimen
30503-7,Streptococcus pneumoniae 8 Ab.IgG^1st specimen
30504-5,Streptococcus pneumoniae 8 Ab.IgG^2nd specimen
30505-2,Streptococcus pneumoniae 9 Ab.IgG^1st specimen
30506-0,Streptococcus pneumoniae 9 Ab.IgG^2nd specimen
30507-8,Cumene
30508-6,Etiocholanolone/Creatinine
30509-4,Androsterone/Creatinine
3051-0,Triiodothyronine.free
30510-2,Estriol/Creatinine
30511-0,Cortisone/Creatinine
30512-8,Pregnanetriol/Creatinine
30513-6,Pregnanetriolone/Creatinine
30514-4,Tetrahydrocortisone/Creatinine
30515-1,Tetrahydroaldosterone/Creatinine
30516-9,Bromodiphenhydramine
30517-7,Carbinoxamine
30518-5,Cholate
30519-3,Chenodeoxycholate
30520-1,Deoxycholate
30521-9,Inhibin B
30522-7,C reactive protein
30523-5,Mycobacterium sp DNA
30524-3,Triglyceride^post 12H CFst
30525-0,Age
30526-8,Borrelia burgdorferi Ab.IgM
30527-6,Calcium
Aug-52,Triiodothyronine.reverse
30528-4,Heptacarboxylporphyrin
30529-2,Hexacarboxylporphyrin
305-3,Lomefloxacin
30530-0,Intrinsic factor Ab
30531-8,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)
30532-6,levoFLOXacin^peak
30533-4,levoFLOXacin^trough
30534-2,Linoleoylcarnitine (C18:2)
30535-9,Liver kidney microsomal 1 Ab
Jun-53,Triiodothyronine
30536-7,Magnesium
30537-5,Myocardium Ab
30538-3,Neutrophil cytoplasmic Ab.classic
30539-1,Neutrophil cytoplasmic Ab.perinuclear
30540-9,Octanoylcarnitine (C8)
30541-7,Octenoylcarnitine (C8:1)
30542-5,Oleoylcarnitine (C18:1)
30543-3,Osmotic fragility^0.75% sodium chloride
Apr-54,Triiodothyronine.true
30544-1,Phosphate
30545-8,Platelet Ab
30546-6,Polio virus 1 Ab
30547-4,Polio virus 2 Ab
30548-2,Polio virus 3 Ab
30549-0,Potassium
30550-8,Pristanate/Phytanate
Jan-55,Triiodothyronine/Triiodothyronine uptake index
30551-6,Propionylcarnitine (C3)
30552-4,Pyridoxal phosphate
30553-2,Rabies virus Ab
30554-0,HIV reverse transcriptase gene mutations detected
30555-7,Rickettsia typhus group Ab.IgG
30556-5,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab
30557-3,Smooth muscle Ab.IgG
30558-1,Sodium
30559-9,Spermatozoa Ab
30560-7,Stearoylcarnitine (C18)
30561-5,Streptococcus pneumoniae 6 Ab.IgG
30562-3,Surfactant/Albumin
30563-1,Taurine
30564-9,Tetradecadienoylcarnitine (C14:2)
30565-6,Tetradecanoylcarnitine (C14)
30566-4,Tetradecenoylcarnitine (C14:1)
30567-2,Thyroid stimulating immunoglobulins
30568-0,Toxoplasma gondii Ab.IgG
Sep-56,Trimethylamine
30569-8,Toxoplasma gondii Ab.IgM
30570-6,Triglyceride
30571-4,Vanillylmandelate/Creatinine
30572-2,Pyridoxal
30573-0,Date of wound healing
30574-8,Acetoacetate+Acetone
30575-5,Xylose^baseline
30576-3,2-Ethyl-3-Hydroxypropionate
Jul-57,Triokinase
30577-1,2-Methyl-3-Hydroxybutyrate
30578-9,Guidance for drainage of abscess+placement of drainage catheter
30579-7,Guidance for injection
30580-5,Guidance for percutaneous aspiration.fine needle
30581-3,Guidance for radiation treatment^W contrast IV
30582-1,Guidance for radiation treatment^WO contrast
30583-9,Multisection^W contrast IV
30584-7,Multisection^WO contrast
May-58,Triosephosphate isomerase
30585-4,Multisection^WO contrast
30586-2,Multisection^WO & W contrast IV
30587-0,Multisection^WO contrast
30588-8,Multisection
30589-6,Multisection^WO contrast
30590-4,Multisection^W contrast IV
30591-2,Multisection^WO contrast
30592-0,Multisection^WO contrast
Mar-59,Trypsin
30593-8,Multisection^WO & W contrast IV
30594-6,Multisection^WO & W contrast IV
30595-3,Guidance for percutaneous aspiration.fine needle
30596-1,Multisection^W contrast IT
30597-9,Multisection^WO contrast
30598-7,Multisection^WO & W contrast IV
30599-5,Multisection^W contrast
30600-1,Multisection^W positive contrast via enteroclysis tube
Jan-60,Trypsin
30601-9,Guidance for percutaneous biopsy
30602-7,Guidance for percutaneous aspiration.fine needle
30603-5,Guidance for percutaneous aspiration.fine needle
30604-3,Guidance for percutaneous biopsy
30605-0,Guidance for percutaneous aspiration.fine needle
30606-8,Guidance for percutaneous aspiration.fine needle
30607-6,Guidance for percutaneous biopsy
30608-4,Guidance for percutaneous aspiration.fine needle
30609-2,Guidance for percutaneous biopsy
306-1,Loracarbef
30610-0,Guidance for percutaneous aspiration.fine needle
30611-8,Multisection^WO contrast
30612-6,Multisection^WO & W contrast IV
30613-4,Multisection^WO contrast
30614-2,Multisection^WO & W contrast IV
30615-9,Multisection^WO contrast
30616-7,Multisection^WO & W contrast IV
30617-5,Multisection^WO contrast
30618-3,Multisection^W & WO contrast IV
Sep-61,Trypsin
30619-1,Multisection
30620-9,Multisection^WO contrast
30621-7,Multisection^WO contrast
30622-5,Multisection^W contrast IV
30623-3,Multisection^WO & W contrast IV
30624-1,Multisection^W contrast IV
30625-8,Multisection^WO contrast
30626-6,Multisection^W contrast IV
Jul-62,Trypsin
30627-4,Multisection^WO contrast
30628-2,Guidance for substance removal of foreign body
30629-0,Guidance for procedure
30630-8,Views^W contrast
30631-6,Views
30632-4,Multisection for motion
30633-2,Views^W barium contrast PO
30634-0,Guidance for percutaneous biopsy
May-63,Trypsin
30635-7,View AP && Views^W contrast PO
30636-5,Views for reduction^W contrast PR
30637-3,Guidance for placement of tube
30638-1,Guidance for injection
30639-9,View^W contrast
30640-7,Guidance for angioplasty^W contrast IV
30641-5,Guidance additional for angioplasty^W contrast IV
30642-3,View
Mar-64,Trypsin+Trypsinogen
30643-1,Guidance for placement of central venous catheter
30644-9,Guidance for placement of tunneled central venous catheter
30645-6,Views^W contrast IV
30646-4,Guidance for change of tube^W contrast
30647-2,Views^W contrast via T-tube
30648-0,Views for angioplasty^W contrast IA
30649-8,Guidance additional for angioplasty^W contrast IA
3065-0,Trypsinogen
30650-6,Views for shunt
30651-4,Guidance for percutaneous biopsy.core needle
30652-2,Guidance for percutaneous biopsy.fine needle
30653-0,Guidance for percutaneous aspiration of cyst
30654-8,Multisection^WO contrast
30655-5,Multisection
30656-3,Guidance for stereotactic localization^W contrast IV
30657-1,Multisection^WO contrast
30658-9,Multisection^WO contrast
30659-7,Multisection^WO & W contrast IV
30660-5,Multisection^WO contrast
30661-3,Multisection^WO contrast
30662-1,Multisection^WO contrast
30663-9,Multisection^WO & W contrast IV
30664-7,Guidance for radiation treatment^W contrast IV
30665-4,Guidance for radiation treatment^WO contrast
30666-2,Multisection^WO contrast
30667-0,Multisection^WO contrast
Aug-66,Trypsinogen
30668-8,Multisection^WO contrast
30669-6,Multisection^WO contrast
30670-4,Multisection^WO & W contrast IV
30671-2,Multisection^WO contrast
30672-0,Multisection^WO & W contrast IV
30673-8,Multisection^WO contrast
30674-6,Multisection^WO & W contrast IV
30675-3,Multisection
Jun-67,Trypsinogen I.free
30676-1,Multisection^WO contrast
30677-9,Multisection^W & WO contrast IV
30678-7,Multisection^W contrast IV
30679-5,Multisection^WO contrast
30680-3,Multisection^WO contrast
30681-1,Multisection^WO contrast
30682-9,Multisection^WO & W contrast IV
30683-7,Multisection^WO contrast
Apr-68,Tryptophan
30684-5,Multisection^WO & W contrast IV
30685-2,Multisection^WO contrast
30686-0,Multisection^WO & W contrast IV
30687-8,Multisection^WO contrast
30688-6,Multisection^WO & W contrast IV
30689-4,Multisection^WO contrast
30690-2,Multisection^WO & W contrast IV
30691-0,Multisection^WO contrast
Feb-69,Tryptophan
30692-8,Multisection
30693-6,Multisection^WO contrast
30694-4,Views+view uptake^W radionuclide IV
30695-1,Views^W radionuclide IV
30696-9,Views^W radionuclide IV
30697-7,Views ventilation+perfusion^W radionuclide IH+W radionuclide IV
30698-5,Guidance for percutaneous aspiration of cyst
30699-3,Guidance for drainage+placement of drainage catheter
30-Jul,Ampicillin
3070-0,Tryptophan
30700-9,Guidance for biopsy.needle
30701-7,Multisection^during surgery
30702-5,Guidance for injection
30703-3,Guidance for percutaneous aspiration of fluid
30704-1,Multisection limited
30705-8,Multisection
30706-6,Multisection^during surgery
30707-4,Study observation.general.follow-up
30708-2,Study observation.general.limited
30709-0,Multisection
30710-8,Multisection
30711-6,Multisection^developmental joint assessment
30712-4,Multisection^WO developmental joint assessment
30713-2,Views^W R-bending + W L-bending
30714-0,View AP for scoliosis
30715-7,(Views AP + lateral) for scoliosis
30716-5,Views lateral for scoliosis
30717-3,Views for scoliosis^W standing
Aug-71,Tryptophan
30718-1,Views PA & lateral
30719-9,Multisection
30720-7,Views for foreign body
30721-5,Views PA + lateral
30722-3,View
30723-1,Views
30724-9,View
30725-6,View AP
Jun-72,Tryptophan
30726-4,Views AP + lateral
30727-2,View AP
30728-0,Views^flexion & extension
30729-8,View AP
30730-6,Views
30731-4,Views
30732-2,R & L-oblique views
30733-0,Views R-oblique + L-oblique
Apr-73,Tryptophan.free
30734-8,View AP lateral-decubitus
30735-5,View AP lateral-decubitus
30736-3,Views^W inspiration + W expiration
30737-1,View L-lateral
30738-9,View L-lateral
30739-7,View oblique
30740-5,View oblique
30741-3,Views PA + lateral + apical lordotic upright
Feb-74,Tumor necrosis factor.alpha
30742-1,Views PA + lateral + R-oblique + L-oblique
30743-9,Views PA + lateral + R-oblique + L-oblique
30744-7,Views PA + lateral + oblique
30745-4,Views
30746-2,Views
30747-0,Views
30748-8,View
30749-6,View
30750-4,Views 5
30751-2,View West Point
30752-0,View AP
30753-8,Views AP + lateral
30754-6,Views AP + lateral
30755-3,View AP
30756-1,View lateral
30757-9,View lateral
30758-7,View oblique
Sep-75,Tyramine
30759-5,View oblique
30760-3,Multisection 3 views^W contrast IV
30761-1,Views^W contrast retrograde via urethra
30762-9,Multisection
30763-7,Views AP + lateral crosstable
30764-5,Views
30765-2,Views
30766-0,Views 3
Jul-76,Tyramine
30767-8,Views
30768-6,Views
30769-4,Views max abduction
30770-2,Views AP + lateral frog
30771-0,Views inlet + outlet
30772-8,Views
30773-6,View
30774-4,View
May-77,Tyrosine
30775-1,Views 3
30776-9,Views 3
30777-7,View AP
30778-5,View oblique
30779-3,Views AP + lateral
30780-1,Views
30781-9,Views
30782-7,Views
Mar-78,Tyrosine
30783-5,Views
30784-3,Views 2
30785-0,Views^W forced dorsiflexion
30786-8,View lateral frog
30787-6,View
30788-4,Views 3
30789-2,Views 4
307-9,Loracarbef
30790-0,View tunnel
Jan-79,Tyrosine
30791-8,Views
30792-6,Views
30793-4,Views AP + lateral
30794-2,Multisection
30795-9,Multisection
30796-7,Multisection^WO contrast
30797-5,Views 5
30798-3,Views^W contrast.XXX IV
30799-1,Multisection^WO contrast
30800-7,Guidance for stereotactic localization^WO contrast
30801-5,Multisection^W contrast IV
30802-3,Multisection^WO contrast
30803-1,Multisection^WO & W contrast IV
30804-9,Multisection^WO & W contrast IV
30805-6,Multisection^WO & W contrast IV
30806-4,Multisection^W & WO contrast IV
30807-2,Multisection^WO & W contrast IV
30808-0,Views^W contrast IT
Sep-80,Tyrosine
30809-8,View^W contrast PO
30810-6,Views^W contrast intra lacrimal duct
30811-4,Views^W contrast IT
30812-2,Guidance for injection
30813-0,Views^W contrast intrabronchial
30814-8,Guidance for injection
30815-5,Guidance for endoscopy^W contrast retrograde
30816-3,Views^W contrast percutaneous intraperitoneal
Jul-81,Tyrosine
30817-1,Guidance for injection
30818-9,Guidance for placement of catheter^transcervical
30819-7,Views^W contrast IV
30820-5,Views^W contrast IA
30821-3,Views^W contrast IA
30822-1,Views^W contrast IA
30823-9,Views^W contrast IA
30824-7,Views^W contrast
May-82,Tyrosine aminotransferase
30825-4,Views^W contrast IV
30826-2,Views^W contrast IV
30827-0,Views^W contrast IV
30828-8,Views^W contrast IA
30829-6,Views^W contrast IA
30830-4,Views^W contrast IA
30831-2,Views^W contrast IA
30832-0,Views^W contrast IA
Mar-83,Urate
30833-8,Views^W contrast IA
30834-6,Views^W contrast IA
30835-3,View^W contrast.XXX IA
30836-1,Guidance for angioplasty^W contrast IA
30837-9,Views^W contrast IA
30838-7,Views runoff^W contrast IA
30839-5,Views^W contrast intra lymphatic
30840-3,Views^W contrast intra lymphatic
Jan-84,Urate
30841-1,Views^W contrast transhepatic
30842-9,Views for hemodynamics^W contrast transhepatic
30843-7,Views^W contrast IV
30844-5,Views^W contrast IV
30845-2,Views^W contrast IV
30846-0,Views^W contrast IV
30847-8,Views^W contrast IV
30848-6,Views^W contrast IA
30849-4,Views^W contrast IA
30850-2,Views^W contrast intra lymphatic
30851-0,Views^W contrast intra lymphatic
30852-8,Views^W contrast IV
30853-6,Multisection^W contrast intra duct
30854-4,Multisection^WO contrast
30855-1,Multisection^WO & W contrast IV
30856-9,Multisection
30857-7,Multisection
Aug-85,Urate
30858-5,Multisection
30859-3,Multisection
30860-1,Multisection
30861-9,Multisection
30862-7,Multisection
30863-5,Multisection
30864-3,Multisection
30865-0,Multisection
Jun-86,Urate
30866-8,Multisection
30867-6,Multisection
30868-4,Multisection
30869-2,Multisection^WO contrast
308-7,Loracarbef
30870-0,Multisection^WO & W contrast IV
30871-8,Multisection
30872-6,Multisection
30873-4,Multisection
Apr-87,Urate
30874-2,Multisection
30875-9,Multisection
30876-7,Multisection
30877-5,Views^W radionuclide IV
30878-3,Guidance for percutaneous aspiration of fluid
30879-1,Guidance for drainage
30880-9,Multisection
30881-7,Multisection
Feb-88,Urate renal clearance
30882-5,Multisection
30883-3,Views
30884-1,Views
30885-8,Views
30886-6,Multisection^W contrast.XXX IV
30887-4,Multisection^W contrast IV
30888-2,Multisection
30889-0,Views
3089-0,Urate/Creatinine
30890-8,Views
30891-6,Views^W contrast IA
30892-4,Guidance for placement of catheter^W contrast retrograde
30893-2,Multisection
30894-0,Aldosterone/Renin
30895-7,Renin
30896-5,Referral lab test identifier
30897-3,Erythrocyte volume
30898-1,Plasma volume
30899-9,Blood volume
30900-5,Cold agglutinin
30901-3,Cold agglutinin
30902-1,Fibrinogen
30903-9,Neutrophil oxidative burst
30904-7,Cobalamins^post dose cyanocobalamin
30905-4,Cobalamins^post dose cyanocobalamin+intrinsic factor/Cobalamins^post cyanocobalamin
30906-2,Cobalamins^post dose cyanocobalamin+intrinsic factor
30907-0,Date of next planned rehabilitation treatment
Aug-90,Urea
30908-8,Next planned treatment start date
30909-6,Next planned treatment end date
30910-4,Antimicrobials
30911-2,DNA ploidy
30912-0,DNA index
30913-8,Cells.S phase/100 cells
30914-6,Cells.hyperdiploid/100 cells
30915-3,Cells.aneuploid/100 cells
Jun-91,Urea
30916-1,Cells.euploid+Cells.aneuploid/100 cells
30917-9,DNA ploidy
30918-7,Gold
30919-5,Iron
30920-3,Copper
30921-1,Mercury
30922-9,Magnesium
30923-7,Chromium
Apr-92,Urea
30924-5,Arsenic
30925-2,Cadmium
30926-0,Aluminum
30927-8,Selenium
30928-6,Silver
30929-4,Thallium
30930-2,Zinc
30931-0,Lead
Feb-93,Urea nitrogen
30932-8,Manganese
30933-6,Nickel
30934-4,Natriuretic peptide.B
30935-1,ST deviation
30936-9,Corynebacterium diphtheriae+Clostridium tetani+Bordetella pertussis dose count in combination vaccine
30937-7,Hepatitis B virus dose count in combination vaccine
30938-5,Haemophilus influenzae B dose count in combination vaccine
30939-3,Measles virus dose count in combination vaccine
3094-0,Urea nitrogen
30940-1,Measles virus+Mumps virus+Rubella virus dose count in combination vaccine
30941-9,Mumps virus dose count in combination vaccine
30942-7,Rubella virus dose count in combination vaccine
30943-5,Varicella zoster virus dose count in combination vaccine
30944-3,Date of vaccination temporary contraindication &or precaution expiration
30945-0,Vaccination contraindication &or precaution
30946-8,Date.vaccination contraindication &or precaution effective
30947-6,Date form completed
30948-4,Vaccination adverse event
30949-2,Vaccination adverse event outcome
309-5,Loracarbef
30950-0,Number of D hospitalized due to vaccination adverse event
30951-8,Patient recovered
30952-6,Date and time of vaccination
30953-4,Date and time of onset of vaccination adverse event
30954-2,Relevant diagnostic tests &or laboratory data
30955-9,Vaccines given on same date as vaccine causing adverse event
30956-7,Type
Jul-95,Urea nitrogen
30957-5,Manufacturer name
30958-3,Route
30959-1,Lot number
30960-9,Number of previous doses
30961-7,Other vaccines given within 4W prior to vaccination that caused adverse reaction
30962-5,Vaccinated at
30963-3,Funds vaccine purchased with
30964-1,Other medications
May-96,Urea nitrogen
30965-8,Illness at time of vaccination
30966-6,"Pre-existing physician-diagnosed allergies, birth defects, medical conditions"
30967-4,Adverse event previously reported
30968-2,Adverse event following prior vaccination in patient
30969-0,Adverse event following prior vaccination
30970-8,Adverse event following prior vaccination
30971-6,Adverse event
30972-4,Age at onset of adverse event
Mar-97,Urea nitrogen/Creatinine
30973-2,Dose number
30974-0,Number of brothers and sisters
30975-7,Creator report number
30976-5,Date received
30977-3,15 day report
30978-1,Type
30979-9,Vaccines due next
30980-7,Date vaccine due
Jan-98,Urea renal clearance
30981-5,Earliest date to give
30982-3,Reason applied by forecast logic to project this vaccine
30983-1,Aesculus hippocastanum Ab.IgE
30984-9,Betula verrucosa recombinant (rBet v) 1 Ab.IgE
30985-6,Betula verrucosa recombinant (rBet v) 2 Ab.IgE
30986-4,Aspergillus fumigatus recombinant (rAsp f) 1 Ab.IgE
30987-2,Chinchilla epithelium Ab.IgE
30988-0,Panicum milliaceum Ab.IgE
30989-8,Sardinops melanostictus Ab.IgE
30990-6,Aspergillus fumigatus recombinant (rAsp f) 2 Ab.IgE
30991-4,Aspergillus fumigatus recombinant (rAsp f) 3 Ab.IgE
30992-2,Aspergillus fumigatus recombinant (rAsp f) 4 Ab.IgE
30993-0,Aspergillus fumigatus recombinant (rAsp f) 6 Ab.IgE
30994-8,Phleum pratense recombinant (rPhl p) 1 Ab.IgE
30995-5,Phleum pratense recombinant (rPhl p) 2 Ab.IgE
30996-3,Phleum pratense recombinant (rPhl p) 5 Ab.IgE
30997-1,Phleum pratense native (nPhl p) 4 Ab.IgE
30998-9,Phleum pratense recombinant (rPhl p) 6 Ab.IgE
Sep-99,Uridine diphosphate glucose-4-Epimerase
30999-7,Phleum pratense recombinant (rPhl p) 7 Ab.IgE
31000-3,Phleum pratense recombinant (rPhl p) 11 Ab.IgE
31001-1,Parietaria judaica Ab.IgE.RAST class
31002-9,Phoenix dactylifera Ab.IgE
31003-7,(Bromus inermis+Cynodon dactylon+Holcus lanatus+Lolium perenne+Paspalum notatum+Sorghum halepense) Ab.IgE
31004-5,(Staphylococcus aureus enterotoxin A+Staphylococcus aureus enterotoxin B) Ab.IgE
May-00,Uridyl transferase
31005-2,(Budgerigar feather+Canary feather+Parrot feather+Finch feather) Ab.IgE
31006-0,(Ananas comosus+ Citrus limon+ Fragaria vesca+ Pyrus communis) Ab.IgE
31007-8,(Beef+Chicken meat+Pork+Turkey meat) Ab.IgE
31008-6,(Actinidia chinensis+Corylus avellana+Musa spp+Pandalus borealis) Ab.IgE
31009-4,(Allium cepa+Allium sativum+Sesamum indicum+Yeast) Ab.IgE
31010-2,(Artemisia dracunculus+Levisticum officinale+Origanum majorana+Thymus vulgaris) Ab.IgE
31011-0,Sardinops melanostictus Ab.IgE.RAST class
31012-8,Vancomycin
Mar-01,Uridyl transferase
31013-6,Dehydrochlormethyltestosterone
31014-4,Corynebacterium diphtheriae Ab^2nd specimen
31015-1,Ethylestrenol
31016-9,Levoamphetamine/Amphetamines.total
31017-7,Tissue transglutaminase Ab.IgA
31018-5,Haemophilus influenzae B Ab.IgG^2nd specimen
31019-3,10-Hydroxycarbazepine
31020-1,Dehydroepiandrosterone
Jan-02,Urobilin
31021-9,Interferon.beta 1 Ab.Neut
31022-7,Filaria identified
31023-5,Myelin associated glycoprotein Ab.IgM
31024-3,Voltage-gated calcium channel Ab
31025-0,Dextroamphetamine/Amphetamines.total
31026-8,Dextromethamphetamine/Amphetamines.total
31027-6,Ritonavir
31028-4,Amprenavir
31029-2,Stenbolone
310-3,Lymecycline
31030-0,Testosterone/Epitestosterone
31031-8,Saccharomyces cerevisiae Ab.IgG
31032-6,Saccharomyces cerevisiae Ab.IgA
31033-4,Indinavir
31034-2,Vaccination body site
31035-9,Date of other vaccinations given within 4W prior to the date of vaccine causing adverse event
31036-7,Gatifloxacin
31037-5,Moxifloxacin
31038-3,Gatifloxacin
Sep-03,Urobilin
31039-1,Moxifloxacin
31040-9,Gatifloxacin
31041-7,Moxifloxacin
31042-5,Gatifloxacin
31043-3,Moxifloxacin
31044-1,Immunization reaction
31045-8,Creatinine/Urea nitrogen
31046-6,Rheumatoid factor
Jul-04,Urobilin
31047-4,Rubella virus Ab.IgM
31048-2,Coccidioides immitis Ab
31049-0,Coxsackievirus A7 Ab
31050-8,Coxsackievirus A9 Ab
31051-6,Coxsackievirus A10 Ab
31052-4,Coxsackievirus A16 Ab
31053-2,Coxsackievirus B1 Ab
Apr-05,Urobilinogen
31054-0,Coxsackievirus B2 Ab
31055-7,Coxsackievirus B3 Ab
31056-5,Coxsackievirus B4 Ab
31057-3,Coxsackievirus B5 Ab
31058-1,Coxsackievirus B6 Ab
31059-9,Echovirus 4 Ab
31060-7,Echovirus 9 Ab
31061-5,Echovirus 11 Ab
Feb-06,Urobilinogen
31062-3,Echovirus 30 Ab
31063-1,Polio virus 1 Ab
31064-9,Polio virus 2 Ab
31065-6,Polio virus 3 Ab
31066-4,Herpes simplex virus 1 Ab.IgG
31067-2,Herpes simplex virus 2 Ab.IgG
31068-0,Herpes simplex virus 1 Ab.IgM
31069-8,Herpes simplex virus 2 Ab.IgM
3107-0,Urobilinogen
31070-6,Histoplasma capsulatum yeast phase Ab
31071-4,Histoplasma capsulatum mycelial phase Ab
31072-2,HIV 1 p41 Ab
31073-0,HIV 2 Ab band pattern
31074-8,Cells.CD30
31075-5,Legionella pneumophila 1 Ab.IgM
31076-3,Rickettsia typhi Ab.IgG
31077-1,Rickettsia typhi Ab.IgM
31078-9,Casuarina equisetifolia Ab.IgE.RAST class
31079-7,Gerbil epithelium Ab.IgE.RAST class
31080-5,Cannabinoids
31081-3,Benzodiazepines
31082-1,Ethylene glycol
31083-9,Lead
31084-7,Methadone
31085-4,Methaqualone
31086-2,Morphine.free
31087-0,Thioridazine
Aug-08,Urobilinogen
31088-8,Narcotics
31089-6,Acetaminophen
31090-4,Ethchlorvynol
31091-2,Gentamicin^peak post extended interval dosing
31092-0,Gentamicin^trough post extended interval dosing
31093-8,Gentamicin^random post extended interval dosing
31094-6,Tobramycin^peak post extended interval dosing
31095-3,Tobramycin^trough post extended interval dosing
Jun-09,Urobilinogen
31096-1,Tobramycin^random post extended interval dosing
31097-9,Amikacin^peak post extended interval dosing
31098-7,Amikacin^trough post extended interval dosing
31099-5,Amikacin^random post extended interval dosing
31100-1,Hematocrit
31101-9,Creatinine
31102-7,Protein S actual/Normal
31103-5,Osmotic fragility^0.0% sodium chloride 24H 37 deg C incubation
Apr-10,Uronate
31104-3,Osmotic fragility^0.85% sodium chloride 24H 37 deg C incubation
31105-0,Osmotic fragility^0.55% sodium chloride 24H 37 deg C incubation
31106-8,Osmotic fragility^0.50% sodium chloride 24H 37 deg C incubation
31107-6,Osmotic fragility^0.45% sodium chloride 24H 37 deg C incubation
31108-4,Osmotic fragility^0.40% sodium chloride 24H 37 deg C incubation
31109-2,Osmotic fragility^0.35% sodium chloride 24H 37 deg C incubation
311-1,Lymecycline
31110-0,Osmotic fragility^0.30% sodium chloride 24H 37 deg C incubation
31111-8,Reticulocytes/100 erythrocytes^^hematocrit adjusted
Feb-11,Uroporphyrin 1 isomer
31112-6,Reticulocytes/100 erythrocytes
31113-4,Cells.HLA-DR+/100 cells
31114-2,Cells.aneuploid.population 1/100 cells
31115-9,Cells.aneuploid.population 2/100 cells
31116-7,Cells.euploid+Cells.aneuploid.population 1/100 cells
31117-5,Cells.euploid+Cells.aneuploid.population 2/100 cells
31118-3,Cells.G2+M phase/100 cells
31119-1,Cells.CD227/100 cells
3112-0,Uroporphyrin
31120-9,Cells.CD227
31121-7,Cells.CD235a/100 cells
31122-5,Cells.CD235a
31123-3,Cells.CD25
31124-1,Cells.CD20+CD25+/100 cells
31125-8,Cells.CD20+CD25+
31126-6,Cells.CD20+CD25-/100 cells
31127-4,Cells.CD20+CD25-
31128-2,Cells.CD11c-CD20+/100 cells
31129-0,Cells.CD11c-CD20+
31130-8,Mumps virus soluble Ab
31131-6,Mumps virus particle-bound Ab
31132-4,Mumps virus soluble Ab
31133-2,Mumps virus particle-bound Ab
31134-0,Nuclear matrix protein 22
31135-7,Cocaethylene
31136-5,Carboxy tetrahydrocannabinol
31137-3,Cocaine
Aug-13,Uroporphyrin
31138-1,Cefotaxime
31139-9,Cefotaxime
31140-7,cefTRIAXone
31141-5,cefTRIAXone
31142-3,Cefepime
31143-1,Cefepime
31144-9,Thyroxine
31145-6,Thyroxine
Jun-14,Uroporphyrinogen decarboxylase
31146-4,Reagin Ab
31147-2,Reagin Ab
31148-0,Heavy metals
31149-8,P53 protein Ag/100 cells
31150-6,ERBB2 gene duplication
31151-4,Alpha-2-Microglobulin
31152-2,Immunoglobulin light chains
Mar-15,Uroporphyrinogen III synthase
31153-0,Coccidioides sp Ab
31154-8,Coccidioides sp Ab.IgG
31155-5,Borrelia burgdorferi Ab
31156-3,Hemoglobin Barts/Hemoglobin.total
31157-1,Carboxyhemoglobin
31158-9,Fibrinogen Ag/Fibrinogen
31159-7,Heparin anti Xa
31160-5,Polymorphonuclear cells/100 leukocytes
Jan-16,Valine
31161-3,(Chicken feather+Duck feather+Goose feather+Parrot feather) Ab.IgE
31162-1,Sulfate-3-Glucuronyl paragloboside Ab
31163-9,Ganglioside GD1b Ab
31164-7,Ganglioside GQ1b Ab
31165-4,Methyl butyl ketone
31166-2,Methyl isoamyl ketone
31167-0,Methyl propyl ketone
31168-8,Mesityl oxide
31169-6,Theobromine
31170-4,"2,5-Hexanedione"
31171-2,"2,5-Hexanedione/Creatinine"
31172-0,Fonofos
31173-8,Mevinphos
31174-6,Terbufos
31175-3,Metasystox
31176-1,Estradiol
31177-9,Estrone
31178-7,Toxoplasma gondii Ab.IgM
Sep-17,Valine
31179-5,Lopinavir
31180-3,Toxoplasma gondii Ab.IgM
31181-1,Toxoplasma gondii Ab.IgM
31182-9,7-Aminonitrazepam
31183-7,Streptococcus pneumoniae 5 Ab.IgG
31184-5,Methyl amyl ketone
31185-2,Platelet Ab.IgA
31186-0,Platelet Ab.IgM
Jul-18,Valine
31187-8,Microscopic observation
31188-6,Microscopic observation
31189-4,Microscopic observation
31190-2,Microscopic observation
31191-0,Microscopic observation
31192-8,Microscopic observation
31193-6,Microscopic observation
31194-4,Microscopic observation
May-19,Valine
31195-1,Microscopic observation
31196-9,Microscopic observation
31197-7,Microscopic observation
31198-5,Microscopic observation
31199-3,Microscopic observation
31200-9,Histoplasma capsulatum Ab.IgG
31201-7,HIV 1+2 Ab
31202-5,Mycoplasma pneumoniae Ab
Mar-20,Valine
31203-3,5-Hydroxyindoleacetate
31204-1,Hepatitis B virus core Ab.IgM
31205-8,Histology ICD-O-3
31206-6,Behavior ICD-O-3
31207-4,Progesterone receptor
31208-2,Specimen source
31209-0,Islet cell 512 Ab
31210-8,Vital status
Jan-21,Vanillylmandelate
31211-6,Date of death
31212-4,Actinobacillus pleuropneumoniae serotype 1 Ab
31213-2,Actinobacillus pleuropneumoniae serotype 3 Ab
31214-0,Actinobacillus pleuropneumoniae serotype 5 Ab
31215-7,Actinobacillus pleuropneumoniae serotype 7 Ab
31216-5,Actinobacillus pleuropneumoniae Ab
31217-3,Adenovirus Ab
31218-1,Afipia felis Ab.IgG
31219-9,Afipia felis Ab.IgM
31220-7,African horse sickness virus Ab
31221-5,Alcelaphine herpesvirus 1 Ab
31222-3,Anaplasma marginale Ab
31223-1,Arbovirus NOS Ab
31224-9,Ascaris sp Ab
31225-6,Asialoganglioside GM1 Ab
31226-4,Asialoganglioside GM1 Ab.IgG
31227-2,Asialoganglioside GM1 Ab.IgM
31228-0,Aspergillus clavatus Ab
Sep-22,Vanillylmandelate
31229-8,Aspergillus flavus Ab
31230-6,Aspergillus flavus Ab
31231-4,Aspergillus nidulans Ab
31232-2,Aspergillus niger Ab
31233-0,Aspergillus sp Ab
31234-8,Aspergillus terreus Ab
31235-5,Aureobasidium pullulans Ab.IgG
31236-3,Infectious bronchitis virus Ab
Jul-23,Vanillylmandelate/Creatine
31237-1,Infectious bronchitis virus Ark-99 Ab
31238-9,Infectious bronchitis virus Conn-42 Ab
31239-7,Infectious bronchitis virus Mass-41 Ab
31240-5,Avian infectious laryngotracheitis virus Ab
31241-3,Influenza virus A Ab
31242-1,Avian paramyxovirus 1 Ab
31243-9,Avian paramyxovirus 2 Ab
31244-7,Babesia microti Ab.IgG
May-24,Vanillylmandelate/Creatinine
31245-4,Babesia microti Ab.IgM
31246-2,Babesia sp Ab.IgG
31247-0,Barmah forest virus Ab.IgG
31248-8,Barmah forest virus Ab.IgM
31249-6,Bartonella henselae Ab
31250-4,Bartonella henselae Ab.IgG
31251-2,Bartonella henselae Ab.IgM
Feb-25,Vasoactive intestinal peptide
31252-0,Basement membrane Ab
31253-8,Basement membrane Ab.IgA
31254-6,Basement membrane Ab.IgG
31255-3,Basement membrane Ab.IgG
31256-1,Beta 2 glycoprotein 1 Ab
31257-9,Beta tubulin Ab.IgG
31258-7,Beta tubulin Ab.IgM
31259-5,Blastomyces dermatitidis Ab
3126-0,Vasopressin
31260-3,Bluetongue virus 10 Ab
31261-1,Bluetongue virus 11 Ab
31262-9,Bluetongue virus 13 Ab
31263-7,Bluetongue virus 17 Ab
31264-5,Bluetongue virus 2 Ab
31265-2,Bordetella avium Ab
31266-0,Bordetella pertussis Ab
31267-8,Bordetella pertussis.secretory Ab.IgA
31268-6,Borrelia burgdorferi Ab.IgG
31269-4,Borrelia burgdorferi Ab.IgM
31270-2,Bovine diarrhea virus 1 Ab
31271-0,Bovine diarrhea virus 2 Ab
31272-8,Bovine diarrhea virus Ab
31273-6,Bovine herpesvirus 1 Ab
31274-4,Bovine leukemia virus Ab
31275-1,Brush border Ab
31276-9,Burkholderia pseudomallei Ab.IgG
31277-7,Burkholderia pseudomallei Ab.IgM
Aug-27,Viscosity
31278-5,Campylobacter fetus Ab
31279-3,Campylobacter jejuni Ab
31280-1,Canary serum proteins Ab
31281-9,Cancer associated retinopathy Ab
31282-7,Canine adenovirus 1 Ab
31283-5,Canine coronavirus Ab
31284-3,Canine distemper virus Ab
31285-0,Canine distemper virus Ab
Jun-28,Viscosity
31286-8,Canine parvovirus Ab
31287-6,Canine parvovirus Ab
31288-4,Canine parvovirus Ab.IgG
31289-2,Canine parvovirus Ab.IgM
312-9,Lymecycline
31290-0,Centromere Ab.IgG
31291-8,Chicken serum Ab
31292-6,Chlamydia sp Ab
31293-4,Chlamydia trachomatis Ab.IgA
Apr-29,Menadione
31294-2,Chlamydia trachomatis B Ab.IgA
31295-9,Chlamydia trachomatis B Ab.IgM
31296-7,Chlamydia trachomatis D+K Ab.IgA
31297-5,Chlamydia trachomatis D+K Ab.IgG
31298-3,Chlamydia trachomatis D+K Ab.IgM
31299-1,Chlamydophila pneumoniae Ab.IgA
31300-7,Chlamydophila pneumoniae Ab.IgA
31301-5,Chlamydophila pneumoniae Ab.IgG
Feb-30,Vitronectin
31302-3,Chlamydophila pneumoniae Ab.IgG
31303-1,Chlamydophila pneumoniae Ab.IgM
31304-9,Chlamydophila pneumoniae Ab.IgM
31305-6,Chlamydophila psittaci Ab.IgA
31306-4,Chlamydophila psittaci Ab.IgA
31307-2,Chlamydophila psittaci Ab.IgG
31308-0,Clostridioides difficile Ab
31309-8,Coccidioides immitis Ab
3131-0,Xanthine
31310-6,Cockatiel droppings Ab
31311-4,Coxiella burnetii phase 1 Ab
31312-2,Coxiella burnetii phase 1 Ab.IgA
31313-0,Coxiella burnetii phase 2 Ab
31314-8,Coxiella burnetii phase 2 Ab.IgG
31315-5,Coxiella burnetii phase 2 Ab.IgM
31316-3,Coxiella burnetii phase 2 Ab.IgA
31317-1,Coxsackievirus A10 Ab
31318-9,Coxsackievirus A16 Ab
31319-7,Coxsackievirus A7 Ab
31320-5,Coxsackievirus A7 Ab
31321-3,Coxsackievirus A9 Ab
31322-1,Coxsackievirus A9 Ab
31323-9,Coxsackievirus B1 Ab
31324-7,Coxsackievirus B1 Ab
31325-4,Coxsackievirus B2 Ab
31326-2,Coxsackievirus B2 Ab
31327-0,Coxsackievirus B3 Ab
Aug-32,Xanthine
31328-8,Coxsackievirus B3 Ab
31329-6,Coxsackievirus B4 Ab
31330-4,Coxsackievirus B4 Ab
31331-2,Coxsackievirus B5 Ab
31332-0,Coxsackievirus B5 Ab
31333-8,Coxsackievirus B6 Ab
31334-6,Coxsackievirus B6 Ab
31335-3,Cryptococcus sp Ab
Jun-33,Xanthurenate
31336-1,Cryptostroma corticale Ab
31337-9,Cytotoxic percent reactive Ab
31338-7,Dengue virus 1 Ab
31339-5,Dengue virus 2 Ab
31340-3,Dengue virus 3 Ab
31341-1,Dengue virus 4 Ab
31342-9,Dengue virus Ab
31343-7,Dengue virus Ab
Apr-34,Xylose
31344-5,Ganglioside GD1a Ab
31345-2,Ganglioside GD1b Ab
31346-0,Ganglioside GD1b Ab.IgG
31347-8,Ganglioside GD1b Ab.IgM
31348-6,DNA double strand Ab
31349-4,Eastern equine encephalomyelitis virus Ab
31350-2,Echovirus 11 Ab
Jan-35,Xylose
31351-0,Echovirus 30 Ab
31352-8,Echovirus 30 Ab
31353-6,Echovirus 30 Ab
31354-4,Echovirus 4 Ab
31355-1,Echovirus 4 Ab
31356-9,Echovirus 4 Ab
31357-7,Echovirus 7 Ab
31358-5,Echovirus 9 Ab
31359-3,Echovirus 9 Ab
31360-1,Echovirus 9 Ab
31361-9,Ehrlichia canis Ab
31362-7,Ehrlichia chaffeensis Ab.IgM
31363-5,Anaplasma phagocytophilum Ab
31364-3,Encephalomyocarditis virus Ab
31365-0,Endomysium Ab
31366-8,Endomysium Ab.IgA
31367-6,Enterovirus NOS Ab
31368-4,Epidermis Ab
Sep-36,Xylulose
31369-2,Epstein Barr virus capsid Ab.IgA
313-7,Lymecycline
31370-0,Epstein Barr virus capsid Ab.IgM
31371-8,Epstein Barr virus early Ab.IgG
31372-6,Epstein Barr virus nuclear Ab
31373-4,Epstein Barr virus nuclear Ab.IgG
31374-2,Epstein Barr virus nuclear Ab.IgG
31375-9,Epstein Barr virus nuclear Ab.IgM
31376-7,Equine arteritis virus Ab
Jul-37,Body height
31377-5,Equine herpesvirus 1 Ab
31378-3,Equine herpesvirus 1+4 Ab
31379-1,Equine influenza virus A1 Ab
31380-9,Equine influenza virus A2 Ab
31381-7,Escherichia coli verotoxin 1 Ab
31382-5,Escherichia coli verotoxin 2 Ab
31383-3,European tick borne encephalitis virus Ab
31384-1,Feline calicivirus Ab
May-38,Body height
31385-8,Feline coronavirus Ab
31386-6,Feline herpesvirus 1 Ab
31387-4,Feline herpesvirus Ab
31388-2,Feline immunodeficiency virus Ab
31389-0,Feline leukemia virus Ab
31390-8,Feline panleukopenia virus Ab
31391-6,Feline panleukopenia virus Ab.IgG
31392-4,Feline panleukopenia virus Ab.IgM
Mar-39,Body surface
31393-2,Feline herpesvirus 1 Ab
31394-0,Feline syncytial virus Ab
31395-7,Filovirus Ab
31396-5,Francisella tularensis Ab
31397-3,Ganglioside GD1a Ab.IgG
31398-1,Ganglioside GD1a Ab.IgM
31399-9,Ganglioside GD1a Ab.IgM
31400-5,Ganglioside GD1b Ab
Jan-40,Body surface
31401-3,Ganglioside GD1b Ab.IgG
31402-1,Ganglioside GD1b Ab.IgG
31403-9,Ganglioside GD1b Ab.IgM
31404-7,Ganglioside GM1b Ab.IgG
31405-4,Ganglioside GM1b Ab.IgM
31406-2,Glomerular basement membrane Ab.IgG
31407-0,Haemophilus somnus Ab
31408-8,Hantavirus sin nombre Ab.IgG
31409-6,Hantavirus sin nombre Ab.IgM
31410-4,Herpes simplex virus 1 Ab
31411-2,Herpes simplex virus 1+2 Ab.IgG
31412-0,Herpes simplex virus 2 Ab.IgM
31413-8,Herpes simplex virus Ab
31414-6,Herpes virus 6 Ab.IgG
31415-3,Herpes virus 6 Ab.IgM
31416-1,Herpes virus 7 Ab.IgG
31417-9,Herpes virus 7 Ab.IgM
31418-7,Heterophile Ab
Sep-41,Body weight
31419-5,Heterophile Ab
31420-3,Highlands J virus Ab
31421-1,Highlands J virus Ab
31422-9,Highlands J virus Ab
31423-7,Histone Ab.IgG
31424-5,Histone H2a+H2b Ab
31425-2,Histoplasma capsulatum mycelial phase Ab
31426-0,Histoplasma capsulatum mycelial phase Ab
Jul-42,Body weight
31427-8,Histoplasma capsulatum yeast phase Ab
31428-6,Histoplasma capsulatum yeast phase Ab
31429-4,Histoplasma sp Ab
31430-2,HIV 1 Ab.IgG
31431-0,HTLV I+II Ab.IgG
31432-8,Human antimouse Ab
31433-6,Anaplasma phagocytophilum Ab.IgG
31434-4,Anaplasma phagocytophilum Ab.IgM
May-43,Donor relation to patient
31435-1,Hyaluronidase Ab
31436-9,Infectious bursal disease virus Ab
31437-7,Influenza virus A Ab.IgG
31438-5,Influenza virus A Ab.IgM
31439-3,Insulin receptor Ab
31440-1,Intercalated disk Ab
31441-9,Intercellular substance Ab
31442-7,Interferon.beta 1 Ab
Mar-44,Menstrual period duration.last
31443-5,Intrinsic factor blocking Ab
31444-3,Intrinsic factor blocking Ab
31445-0,Intrinsic factor blocking Ab.IgG
31446-8,Jamestown canyon virus Ab
31447-6,Jo-1 extractable nuclear Ab
31448-4,La Crosse virus Ab
31449-2,La Crosse virus Ab
314-5,Meclocycline
3145-0,Menstrual period start.last
31450-0,La Crosse virus Ab.IgG
31451-8,La Crosse virus Ab.IgM
31452-6,Lassa virus Ab.IgG
31453-4,Lassa virus Ab.IgM
31454-2,Legionella pneumophila 1 Ab
31455-9,Legionella pneumophila 1 Ab.IgG
31456-7,Legionella pneumophila 1 Ab.IgM
31457-5,Legionella pneumophila 2 Ab
31458-3,Legionella pneumophila 2 Ab.IgG
31459-1,Legionella pneumophila 3 Ab
31460-9,Legionella pneumophila 3 Ab.IgG
31461-7,Legionella pneumophila 4 Ab
31462-5,Legionella pneumophila 4 Ab.IgG
31463-3,Legionella pneumophila 5 Ab
31464-1,Legionella pneumophila 5 Ab.IgG
31465-8,Legionella pneumophila 6 Ab
31466-6,Legionella pneumophila 6 Ab.IgG
31467-4,Legionella pneumophila 6 Ab.IgM
Aug-46,Menstrual status
31468-2,Legionella pneumophila 7 Ab
31469-0,Legionella pneumophila 8 Ab
31470-8,Legionella pneumophila 9 Ab
31471-6,Legionella pneumophila Ab
31472-4,Legionella pneumophila Ab.IgM
31473-2,Legionella pneumophila atypical Ab
31474-0,Legionella sp Ab.IgM
31475-7,Leishmania donovani Ab
Jun-47,Oxygen
31476-5,Leptospira borgpetersenii serovar Sejroe Ab
31477-3,Leptospira interrogans serovar Bratislava Ab
31478-1,Leptospira interrogans serovar Canicola Ab
31479-9,Leptospira interrogans serovar Grippotyphosa Ab
31480-7,Leptospira interrogans serovar Hardjo Ab
31481-5,Leptospira interrogans serovar Icterohaemorrhagiae Ab
31482-3,Leptospira interrogans serovar Pomona Ab
31483-1,Leptospira sp Ab
Apr-48,Oxygen
31484-9,Leptospira sp Ab.IgG
31485-6,Leptospira sp Ab.IgG
31486-4,Leptospira sp Ab.IgM
31487-2,Leptospira sp Ab.IgM
31488-0,Listeria sp Ab
31489-8,Lumpy skin disease virus Ab
31490-6,Lupus erythematosus deoxynucleoproteins Ab.IgG
31491-4,Lymphocytic choriomeningitis virus Ab
Feb-49,Oxygen
31492-2,Lymphocytic choriomeningitis virus Ab.IgG
31493-0,Lymphocytic choriomeningitis virus Ab.IgG
31494-8,Lymphocytic choriomeningitis virus Ab.IgM
31495-5,Lymphocytic choriomeningitis virus Ab.IgM
31496-3,Ganglioside GM1 Ab
31497-1,Ganglioside GM1 Ab
31498-9,Ganglioside GM1 Ab.IgA
31499-7,Ganglioside GM1 Ab.IgG
31-May,Ampicillin+Sulbactam
3150-0,Oxygen/Gas.total
31500-2,Ganglioside GM1 Ab.IgG+IgM
31501-0,Ganglioside GM1 Ab.IgG+IgM
31502-8,Ganglioside GM1 Ab.IgM
31503-6,Mumps virus Ab
31504-4,Mumps virus soluble Ab
31505-1,Mumps virus soluble Ab
31506-9,Mumps virus particle-bound Ab
31507-7,Mumps virus particle-bound Ab
31508-5,Mycoplasma capricolum subspecies capripneumonia Ab
31509-3,Mycoplasma capricolum subspecies capripneumonia Ab
31510-1,Mycoplasma capricolum subspecies capripneumonia Ab
31511-9,Mycoplasma gallisepticum Ab
31512-7,Mycoplasma hominis Ab
31513-5,Mycoplasma hyopneumoniae Ab
31514-3,Mycoplasma mycoides subspecies mycoides large colony Ab
31515-0,Mycoplasma pneumoniae Ab.IgA
31516-8,Mycoplasma pneumoniae Ab.IgM
31517-6,Mycoplasma sp Ab
Aug-51,Oxygen inhaled
31518-4,Mycoplasma synoviae Ab
31519-2,Myelin associated glycoprotein Ab
315-2,Meclocycline
31520-0,Myelin associated glycoprotein Ab
31521-8,Myelin associated glycoprotein Ab
31522-6,Myelin associated glycoprotein Ab.IgM
31523-4,Myxoma virus Ab
31524-2,Nairobi sheep disease virus Ab
31525-9,Neisseria gonorrhoeae Ab
Jun-52,Oxygen inhaled mechanism
31526-7,Neisseria meningitidis serogroup A Ab.IgG
31527-5,Neisseria meningitidis serogroup C Ab.IgG
31528-3,Neisseria meningitidis serogroup Y Ab
31529-1,Neospora caninum Ab
31530-9,Neuronal Ab
31531-7,Neuronal Ab
31532-5,Neuronal Ab
31533-3,Neuronal Ab
Apr-53,Specimen weight
31534-1,Neuronal Ab.IgG
31535-8,Neuronal nuclear Ab
31536-6,Neuronal nuclear Ab.IgG
31537-4,Neuronal nuclear type 1 Ab
31538-2,Neuronal nuclear type 2 Ab
31539-0,Neuronal nuclear type 2 Ab
31540-8,Nuclear Ab
31541-6,Nuclear Ab
Feb-54,Specimen weight
31542-4,Nuclear Ab
31543-2,Nuclear Ab
31544-0,Nuclear Ab
31545-7,Nuclear Ab.IgG
31546-5,Ovary Ab.IgG
31547-3,Pancreatic islet cell Ab
31548-1,Parainfluenza virus 1 Ab
31549-9,Parainfluenza virus 1 Ab.IgM
31550-7,Parainfluenza virus 2 Ab
31551-5,Parainfluenza virus 2 Ab.IgM
31552-3,Parainfluenza virus 3 Ab
31553-1,Parainfluenza virus 3 Ab.IgG
31554-9,Parainfluenza virus 3 Ab.IgM
31555-6,Parainfluenza virus Ab
31556-4,Parietal cell Ab.IgG
31557-2,Parvovirus B19 Ab.IgG
31558-0,Parvovirus B19 Ab.IgM
Sep-55,Specimen mass
31559-8,Pasteurella multocida Ab
31560-6,Peste des petits ruminants virus Ab
31561-4,Phospholipid Ab.IgA
31562-2,PM-SCL extractable nuclear Ab
31563-0,PM-SCL extractable nuclear Ab
31564-8,Polio virus 1 Ab
31565-5,Polio virus 1 Ab
31566-3,Polio virus 2 Ab
Jul-56,Specimen volume
31567-1,Polio virus 2 Ab
31568-9,Polio virus 3 Ab
31569-7,Polio virus 3 Ab
31570-5,Porcine influenza virus A Ab
31571-3,Porcine parvovirus Ab
31572-1,Porcine reproductive and respiratory syndrome virus Ab
31573-9,Powassan virus Ab.IgG
31574-7,Powassan virus Ab.IgG
May-57,Specimen volume
31575-4,Powassan virus Ab.IgM
31576-2,Powassan virus Ab.IgM
31577-0,Pseudorabies virus Ab
31578-8,Pullularia sp Ab
31579-6,Purkinje cells Ab
31580-4,Purkinje cells Ab.IgG
31581-2,Reovirus Ab
31582-0,Reovirus Ab
Mar-58,Specimen volume
31583-8,Respiratory syncytial virus Ab.IgG
31584-6,Reticulin Ab.IgG
31585-3,Reticulin Ab.IgG
31586-1,Rhodococcus equi Ab
31587-9,Rhodococcus equi Ab
31588-7,Ribonucleoprotein extractable nuclear Ab.IgG
31589-5,Ribosomal Ab
31590-3,Ribosomal Ab
Jan-59,Specimen volume
31591-1,Ribosomal P Ab
31592-9,Ribosomal P Ab
31593-7,Rickettsia (Proteus OX19) Ab
31594-5,Rickettsia (Proteus OXK) Ab
31595-2,Rickettsia akari Ab
31596-0,Rickettsia australis Ab
31597-8,Rickettsia conorii Ab
31598-6,Rickettsia honei Ab
31599-4,Rickettsia prowazekii Ab.IgG
316-0,Meclocycline
31600-0,Rickettsia prowazekii Ab.IgM
31601-8,Rickettsia spotted fever group Ab.IgM
31602-6,Rickettsia typhus group Ab.IgM
31603-4,Rickettsia rickettsii Ab
31604-2,Rickettsia rickettsii Ab
31605-9,Rickettsia sibirica Ab
31606-7,Orientia tsutsugamushi Ab.IgG
31607-5,Orientia tsutsugamushi Gilliam Ab
31608-3,Orientia tsutsugamushi Karp Ab
Sep-60,Specimen volume
31609-1,Orientia tsutsugamushi Kato Ab
31610-9,Orientia tsutsugamushi Litchfield Ab
31611-7,Rickettsia typhi Ab.IgM
31612-5,Rift valley fever virus Ab
31613-3,Rinderpest virus Ab
31614-1,Ross river virus Ab.IgG
31615-8,Ross river virus Ab.IgM
31616-6,Rubella virus Ab.IgM
Jul-61,Specimen volume
31617-4,Saint Louis encephalitis virus Ab
31618-2,Salmonella paratyphi B H Ab
31619-0,Salmonella paratyphi B O Ab
31620-8,Salmonella pullorum Ab
31621-6,Salmonella typhi H D Ab
31622-4,Salmonella typhi O D Ab
31623-2,Salmonella typhimurium Ab
31624-0,Schistosoma sp Ab.IgG
May-62,Specimen volume
31625-7,Sjogrens syndrome-A extractable nuclear Ab.IgG
31626-5,Sjogrens syndrome-B extractable nuclear Ab.IgG
31627-3,Smith extractable nuclear Ab
31628-1,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab
31629-9,Smooth muscle Ab
31630-7,Spermatozoa Ab
31631-5,Spermatozoa Ab
31632-3,Spermatozoa Ab
Mar-63,Specimen volume
31633-1,Sporothrix schenckii Ab
31634-9,Stachybotrys chartarum Ab.IgA
31635-6,Streptococcus pneumoniae 1 Ab.IgG^1st specimen
31636-4,Streptococcus pneumoniae 14 Ab
31637-2,Streptococcus pneumoniae 23 Ab.IgG^1st specimen
31638-0,Streptococcus pneumoniae 23 Ab.IgG^2nd specimen
31639-8,Streptococcus pneumoniae Danish serotype 6B Ab.IgG^2nd specimen
31640-6,Streptococcus pneumoniae 3 Ab
Jan-64,Specimen volume
31641-4,Streptococcus pneumoniae 3 Ab.IgG^1st specimen
31642-2,Streptococcus pneumoniae 3 Ab.IgG^2nd specimen
31643-0,Streptococcus pneumoniae 4 Ab.IgG^1st specimen
31644-8,Streptococcus pneumoniae 4 Ab.IgG^2nd specimen
31645-5,Streptococcus pneumoniae Danish serotype 7F Ab.IgG^1st specimen
31646-3,Streptococcus pneumoniae Danish serotype 7F Ab.IgG^2nd specimen
31647-1,Streptococcus pneumoniae Danish serotype 18C Ab.IgG^1st specimen
31648-9,Streptococcus pneumoniae 6 Ab.IgG
31649-7,Streptococcus pneumoniae 6 Ab^2nd specimen
31650-5,Streptococcus pneumoniae Danish serotype 9V Ab.IgG
31651-3,Streptococcus pneumoniae 6a+6b Ab
31652-1,Streptococcus pneumoniae 6+26 Ab^1st specimen
31653-9,Streptococcus pneumoniae 8 Ab.IgG^1st specimen
31654-7,Streptococcus pneumoniae 8 Ab.IgG^2nd specimen
31655-4,Streptococcus pneumoniae 9 Ab
31656-2,Streptococcus pneumoniae 9 Ab.IgG^1st specimen
31657-0,Streptococcus pneumoniae 9 Ab.IgG^2nd specimen
Aug-65,Specimen volume
31658-8,Streptococcus pyogenes enzyme Ab
31659-6,Striated muscle Ab
31660-4,Striated muscle Ab.IgG
31661-2,Sulfate-3-Glucuronyl paragloboside Ab
31662-0,Sulfate-3-Glucuronyl paragloboside Ab
31663-8,Sulfate-3-Glucuronyl paragloboside Ab.IgM
31664-6,Sulfate-3-Glucuronyl paragloboside Ab.IgM
31665-3,Sulfate-3-Glucuronyl paragloboside Ab.IgM
Jun-66,Specimen volume
31666-1,Sulfate-3-Glucuronyl paragloboside Ab.IgM
31667-9,Sulfatide Ab
31668-7,Sulfatide Ab
31669-5,Sulfatide Ab.IgG
31670-3,Sulfatide Ab.IgG
31671-1,Sulfatide Ab.IgM
31672-9,Taylorella equigenitalis Ab
31673-7,Teichoate Ab
Apr-67,Specimen volume
31674-5,Ganglioside GQ1b Ab
31675-2,Tetrasialylganglioside GQ1b Ab
31676-0,Ganglioside GQ1b Ab.IgG
31677-8,Tetrasialylganglioside GQ1b Ab.IgG
31678-6,Ganglioside GQ1b Ab.IgG
31679-4,Tetrasialylganglioside GQ1b Ab.IgG
31680-2,Theileria annulata Ab
31681-0,Theileria mutans Ab
Feb-68,Specimen volume
31682-8,Theileria parva Ab
31683-6,Thermoactinomyces sp Ab.IgG
31684-4,Toxoplasma gondii Ab.IgG
31685-1,Toxoplasma gondii Ab.IgG
31686-9,Transmissible gastroenteritis virus Ab
31687-7,Trichinella sp Ab.IgM
31688-5,Trivittatus virus Ab
31689-3,Trivittatus virus Ab
3169-0,Specimen volume
31690-1,Trivittatus virus Ab
31691-9,Trypanosoma cruzi Ab.IgG
31692-7,Trypanosoma equiperdum Ab
31693-5,Unidentified extractable nuclear Ab
31694-3,Varicella zoster virus Ab
31695-0,Varicella zoster virus Ab.IgM
31696-8,Vesicular stomatitis Indiana virus Ab
31697-6,Vesicular stomatitis New Jersey virus Ab
31698-4,Vibrio cholerae Ab
31699-2,Rabbit hemorrhagic disease virus Ab
31700-8,West Nile virus Ab
31701-6,West Nile virus Ab.IgG
31702-4,West Nile virus Ab.IgG
31703-2,West Nile virus Ab.IgM
31704-0,West Nile virus Ab.IgM
31705-7,Western equine encephalitis virus Ab
31706-5,Western equine encephalitis virus Ab.IgG
31707-3,Yersinia enterocolitica O:5 Ab
Aug-70,Specimen volume
31708-1,Yersinia enterocolitica Ab
31709-9,Adenovirus 40+41 Ag
31710-7,Adenovirus Ag
31711-5,Adenovirus Ag
31712-3,Adenovirus Ag
31713-1,Adenovirus Ag
31714-9,Adenovirus Ag
31715-6,African horse sickness virus Ag
Jun-71,Specimen.dry weight
31716-4,African swine fever virus Ag
31717-2,Alcelaphine herpesvirus 1 Ag
31718-0,Astrovirus Ag
31719-8,Infectious bronchitis virus Ag
31720-6,Avian infectious laryngotracheitis virus Ag
31721-4,Avian infectious laryngotracheitis virus Ag
31722-2,Avian infectious laryngotracheitis virus Ag
31723-0,Avian leukosis virus Ag
Apr-72,Time^post exercise
31724-8,Avian leukosis virus Ag
31725-5,Avian paramyxovirus 1 Ag
31726-3,Bacillus anthracis Ag
31727-1,Bacteroides fragilis Ag
31728-9,Bacteroides melaninogenicus Ag
31729-7,Bladder tumor Ag
31730-5,Bladder tumor Ag
31731-3,Blastomyces dermatitidis Ag
Feb-73,Coagulation surface induced
31732-1,Bluetongue virus Ag
31733-9,Border disease virus Ag
31734-7,Border disease virus Ag
31735-4,Bordetella bronchiseptica Ag
31736-2,Bordetella parapertussis Ag
31737-0,Bordetella pertussis Ag
31738-8,Borrelia burgdorferi Ag
31739-6,Borrelia sp Ag
3174-0,Antithrombin
31740-4,Bovine diarrhea virus Ag
31741-2,Bovine diarrhea virus Ag
31742-0,Bovine diarrhea virus Ag
31743-8,Bovine diarrhea virus Ag
31744-6,Bovine herpesvirus 1 Ag
31745-3,Bovine herpesvirus 1 Ag
31746-1,Bovine herpesvirus 1 Ag
31747-9,Bovine herpesvirus 1 Ag
31748-7,Bovine herpesvirus 2 Ag
31749-5,Bovine herpesvirus 4 Ag
31750-3,Bovine inner ear Ag
31751-1,Bovine respiratory syncytial virus Ag
31752-9,Bovine virus diarrhea virus Ag
31753-7,Brucella sp Ag
31754-5,Brucella sp Ag
31755-2,Campylobacter fetus Ag
31756-0,Campylobacter fetus Ag
Jul-75,Antithrombin Ag
31757-8,Canarypox virus Ag
31758-6,Candida albicans Ag
31759-4,Candida albicans Ag
31760-2,Candida sp Ag
31761-0,Canine parvovirus Ag
31762-8,Capripox virus Ag
31763-6,Chlamydia sp Ag
31764-4,Chlamydia sp Ag
May-76,Antithrombin
31765-1,Chlamydia sp Ag
31766-9,Chlamydia sp Ag
31767-7,Chlamydia sp Ag
31768-5,Chlamydia trachomatis Ag
31769-3,Chlamydia trachomatis Ag
31770-1,Chlamydia trachomatis Ag
31771-9,Chlamydia trachomatis Ag
31772-7,Chlamydia trachomatis Ag
Mar-77,Antithrombin Ag
31773-5,Chlamydia trachomatis Ag
31774-3,Chlamydia trachomatis Ag
31775-0,Chlamydia trachomatis Ag
31776-8,Chlamydia trachomatis Ag
31777-6,Chlamydia trachomatis Ag
31778-4,Chlamydophila pneumoniae Ag
31779-2,Chlamydophila psittaci Ag
317-8,Meclocycline
31780-0,Chlamydophila psittaci Ag
Jan-78,Bleeding time
31781-8,Classical swine fever virus Ag
31782-6,Coccidioides immitis Ag
31783-4,Coxiella burnetii Ag
31784-2,Coxiella burnetii Ag
31785-9,Cryptococcus neoformans Ag
31786-7,Cryptococcus neoformans Ag
31787-5,Cryptococcus neoformans Ag
31788-3,Cryptococcus sp Ag
31789-1,Cryptococcus sp Ag
31790-9,Cryptococcus sp Ag
31791-7,Cryptococcus sp Ag
31792-5,Cryptococcus sp Ag
31793-3,Cryptosporidium sp Ag
31794-1,Cryptosporidium sp Ag
31795-8,Cytomegalovirus Ag
31796-6,Cytomegalovirus Ag
31797-4,Cytomegalovirus Ag
31798-2,Dengue virus Ag
Sep-79,Bleeding time
31799-0,Dengue virus Ag
31800-6,Dermatophilus congolensis Ag
31801-4,Dirofilaria immitis Ag
31802-2,Duck enteritis virus Ag
31803-0,Duck hepatitis virus 1 Ag
31804-8,Duck hepatitis virus 2 Ag
31805-5,Duck hepatitis virus 3 Ag
31806-3,Eastern equine encephalitis virus Ag
Jul-80,Cardiolipin Ab
31807-1,Eastern equine encephalitis virus Ag
31808-9,Eastern equine encephalitis virus Ag
31809-7,Echinococcus sp Ag
31810-5,Entamoeba histolytica Ag
31811-3,Entamoeba histolytica Ag
31812-1,Entamoeba histolytica Ag
31813-9,Epizootic hemorrhagic disease virus Ag
31814-7,Equine adenovirus Ag
May-81,Cardiolipin Ab.IgG
31815-4,Equine arteritis virus Ag
31816-2,Equine herpesvirus 1 Ag
31817-0,Equine herpesvirus 1 Ag
31818-8,Equine herpesvirus 1+4 Ag
31819-6,Equine herpesvirus 4 Ag
31820-4,Equine infectious anemia virus Ag
31821-2,Equine influenza virus A1 Ag
31822-0,Equine influenza virus A2 Ag
Mar-82,Cardiolipin Ab.IgM
31823-8,Equine influenza virus Ag
31824-6,Escherichia coli K1 Ag
31825-3,Escherichia coli K1 Ag
31826-1,Feline infectious peritonitis virus Ag
31827-9,Foot and mouth disease virus Ag
31828-7,Francisella tularensis Ag
31829-5,Francisella tularensis Ag
31830-3,Giardia lamblia Ag
Jan-83,Clotting time
31831-1,Giardia lamblia Ag^2nd specimen
31832-9,Giardia lamblia Ag^3rd specimen
31833-7,Haemophilus influenzae A Ag
31834-5,Haemophilus influenzae B Ag
31835-2,Haemophilus influenzae C Ag
31836-0,Haemophilus influenzae C Ag
31837-8,Haemophilus influenzae D Ag
31838-6,Haemophilus influenzae D Ag
31839-4,Haemophilus influenzae E Ag
31840-2,Haemophilus influenzae E Ag
31841-0,Haemophilus influenzae F Ag
31842-8,Haemophilus influenzae F Ag
31843-6,Helicobacter pylori Ag
31844-4,Hepatitis B virus little e Ag
31845-1,Hepatitis B virus little e Ag
31846-9,Herpes simplex virus 1 Ag
31847-7,Herpes simplex virus 1 Ag
31848-5,Herpes simplex virus 1 Ag
Sep-84,Activated clotting time
31849-3,Herpes simplex virus 2 Ag
31850-1,Herpes simplex virus 2 Ag
31851-9,Herpes simplex virus 2 Ag
31852-7,Herpes simplex virus Ag
31853-5,Herpes simplex virus Ag
31854-3,Herpes simplex virus Ag
31855-0,Histoplasma capsulatum Ag
Jun-85,Coagulation factor IX inhibitor
31856-8,Histoplasma capsulatum Ag
31857-6,Infectious bursal disease virus Ag
31858-4,Influenza virus A Ag
31859-2,Influenza virus A Ag
318-6,Methacycline
31860-0,Influenza virus A+B Ag
31861-8,Influenza virus A+B+C Ag
31862-6,Influenza virus A+B+C Ag
31863-4,Influenza virus B Ag
Apr-86,Coagulation factor IX activated activity
31864-2,Influenza virus B Ag
31865-9,Influenza virus C Ag
31866-7,Japanese encephalitis virus Ag
31867-5,Lassa virus Ag
31868-3,Legionella pneumophila 1 Ag
31869-1,Legionella pneumophila Ag
31870-9,Legionella pneumophila Ag
31871-7,Leptospira interrogans Ag
Feb-87,Coagulation factor IX activity actual/Normal
31872-5,Leptospira sp Ag
31873-3,Mareks disease virus Ag
31874-1,Mareks disease virus Ag
31875-8,Measles virus Ag
31876-6,Measles virus Ag
31877-4,Measles virus Ag
31878-2,Measles virus Ag
31879-0,Measles virus Ag
3188-0,Coagulation factor IX activity
31880-8,Measles virus Ag
31881-6,Measles virus Ag
31882-4,Measles virus Ag
31883-2,Measles virus Ag
31884-0,Measles virus Ag
31885-7,Measles virus Ag
31886-5,Measles virus Ag
31887-3,Measles virus Ag
31888-1,Mumps virus Ag
31889-9,Mumps virus Ag
31890-7,Mumps virus Ag
31891-5,Mumps virus Ag
31892-3,Mumps virus Ag
31893-1,Mumps virus Ag
31894-9,Mumps virus Ag
31895-6,Mumps virus Ag
31896-4,Mumps virus Ag
31897-2,Mumps virus Ag
Aug-89,Coagulation factor IX Ag
31898-0,Mumps virus Ag
31899-8,Mumps virus Ag
31900-4,Mumps virus Ag
31901-2,Mycoplasma gallisepticum Ag
31902-0,Mycoplasma mycoides subspecies mycoides small colony Ag
31903-8,Myxoma virus Ag
31904-6,Nairobi sheep disease virus Ag
31905-3,Neisseria gonorrhoeae Ag
Jun-90,Coagulation factor IX Ag actual/Normal
31906-1,Neisseria gonorrhoeae Ag
31907-9,Neisseria meningitidis serogroup A Ag
31908-7,Neisseria meningitidis serogroup A Ag
31909-5,Neisseria meningitidis serogroups A+C+w135+Y Ag
31910-3,Neisseria meningitidis serogroups A+C+w135+Y Ag
31911-1,Neisseria meningitidis Ag
31912-9,Neisseria meningitidis Ag
31913-7,Neisseria meningitidis serogroup B Ag
Apr-91,Coagulation factor V inhibitor
31914-5,Neisseria meningitidis serogroup B+Escherichia coli K1 Ag
31915-2,Neisseria meningitidis serogroup B+Escherichia coli K1 Ag
31916-0,Neisseria meningitidis serogroup C Ag
31917-8,Neisseria meningitidis serogroup C Ag
31918-6,Neisseria meningitidis serogroup w135 Ag
31919-4,Neisseria meningitidis serogroup w135 Ag
31920-2,Neisseria meningitidis serogroup w135 Ag
31921-0,Neisseria meningitidis serogroup Y Ag
Feb-92,Coagulation factor V activated activity
31922-8,Ovine progressive pneumonia virus Ag
31923-6,Parainfluenza virus 1 Ag
31924-4,Parainfluenza virus 1 Ag
31925-1,Parainfluenza virus 2 Ag
31926-9,Parainfluenza virus 2 Ag
31927-7,Parainfluenza virus 3 Ag
31928-5,Parainfluenza virus 3 Ag
31929-3,Parainfluenza virus Ag
3193-0,Coagulation factor V activity actual/Normal
31930-1,Pasteurella multocida Ag
31931-9,Plasmodium vivax Ag
31932-7,Pneumocystis jiroveci Ag
31933-5,Pneumocystis jiroveci Ag
31934-3,Pneumocystis jiroveci Ag
31935-0,Pneumocystis jiroveci Ag
31936-8,Pneumocystis jiroveci Ag
31937-6,Pneumocystis jiroveci Ag
31938-4,Pneumocystis jiroveci Ag
31939-2,Pneumocystis jiroveci Ag
319-4,Methacycline
31940-0,Pneumocystis jiroveci Ag
31941-8,Pneumocystis jiroveci Ag
31942-6,Pneumocystis jiroveci Ag
31943-4,Pneumocystis jiroveci Ag
31944-2,Porcine enterovirus Ag
31945-9,Pseudorabies virus Ag
31946-7,Rabies virus Ag
31947-5,Rabies virus Ag
Aug-94,Coagulation factor V Ag
31948-3,Rabies virus Ag
31949-1,Respiratory syncytial virus Ag
31950-9,Respiratory syncytial virus Ag
31951-7,Rift valley fever virus Ag
31952-5,Rinderpest virus Ag
31953-3,Rinderpest virus Ag
31954-1,Rinderpest virus Ag
May-95,Coagulation factor V Ag actual/Normal
31955-8,Rubella virus Ag
31956-6,Rubella virus Ag
31957-4,Rubella virus Ag
31958-2,Rubella virus Ag
31959-0,Rubella virus Ag
31960-8,Rubella virus Ag
31961-6,Rubella virus Ag
31962-4,Rubella virus Ag
Mar-96,Coagulation factor VII inhibitor
31963-2,Rubella virus Ag
31964-0,Rubella virus Ag
31965-7,Rubella virus Ag
31966-5,Rubella virus Ag
31967-3,Streptococcus agalactiae Ag
31968-1,Streptococcus pneumoniae Ag
31969-9,Streptococcus pneumoniae Ag
31970-7,Streptococcus pyogenes Ag
Jan-97,Coagulation factor VII activated activity
31971-5,Streptococcus pyogenes Ag
31972-3,Swine vesicular disease virus Ag
31973-1,Swine vesicular disease virus Ag
31974-9,Taenia hydatigena Ag
31975-6,Taenia sp Ag
31976-4,Taylorella equigenitalis Ag
31977-2,Transmissible gastroenteritis virus Ag
31978-0,Trichomonas vaginalis Ag
31979-8,Trypanosoma evansi Ag
31980-6,Trypanosoma sp Ag
31981-4,Varicella zoster virus Ag
31982-2,Varicella zoster virus Ag
31983-0,Venezuelan equine encephalitis virus Ag
31984-8,Venezuelan equine encephalitis virus Ag
31985-5,Vesicular stomatitis virus Ag
31986-3,Vesicular stomatitis virus Ag
31987-1,Western equine encephalitis virus Ag
31988-9,Western equine encephalitis virus Ag
Sep-98,Coagulation factor VII activity actual/Normal
31989-7,14-3-3 Ag
31990-5,14-3-3 Ag
31991-3,Acylcarnitine
31992-1,Aldosterone
31993-9,Alpha-1-Fetoprotein
31994-7,Basophils/100 leukocytes
31995-4,Basophils/100 leukocytes
31996-2,Basophils/100 leukocytes
Jul-99,Coagulation factor VII activity
31997-0,Biotin
31998-8,Bordetella pertussis Ab
31999-6,Broad casts
32000-2,Catecholamines
32001-0,Chlamydia sp Ag
32002-8,Chlamydia sp Ag
Mar-00,Coagulation factor VII activity actual/Normal
32003-6,Chlamydia sp Ag
32004-4,Chlamydia sp Ag
32005-1,Chlamydia trachomatis B Ab
32006-9,Chlamydia trachomatis C Ab
32007-7,Chlamydia trachomatis G+F+K Ab
32008-5,Coproporphyrin/Creatinine
32009-3,Cortisol.free/Creatinine
32010-1,Diuretics
Jan-01,Coagulation factor VII Ag
32011-9,Ehrlichia sp Ab.IgG
32012-7,Ehrlichia sp Ab.IgM
32013-5,Eosinophils/100 leukocytes
32014-3,Eosinophils/100 leukocytes
32015-0,EPINEPHrine
32016-8,Glucose
32017-6,Hemoglobin.other/Hemoglobin.total
32018-4,Hepatitis A virus Ab.IgG
32019-2,Hepatitis B virus surface Ab
320-2,Methacycline
32020-0,Homocysteine
32021-8,HTLV I DNA
32022-6,Hydroxyproline.free
32023-4,Insulin-like growth factor-I
32024-2,Magnesium
32025-9,Malignin Ab
32026-7,Microscopic observation
32027-5,Monocytes+Macrophages/100 leukocytes
32028-3,Monocytes+Macrophages/100 leukocytes
Sep-02,Coagulation factor VII+Acarboxy Ag
32029-1,Monocytes+Macrophages/100 leukocytes
32030-9,Nitrate
32031-7,Phosphatidylserine Ab.IgA
32032-5,Phosphatidylserine Ab.IgG
32033-3,Phosphatidylserine Ab.IgM
32034-1,Polymorphonuclear cells
32035-8,Polymorphonuclear cells
32036-6,Polymorphonuclear cells
Jul-03,Coagulation factor VII+Acarboxy Ag activity actual/Normal
32037-4,Polymorphonuclear cells
32038-2,Polymorphonuclear cells
32039-0,Polymorphonuclear cells
32040-8,Respiratory syncytial virus Ag
32041-6,Sjogrens syndrome-A extractable nuclear Ab+Sjogrens syndrome-B extractable nuclear Ab
32042-4,Thyroperoxidase Ab
32043-2,Uroporphyrin/Creatinine
32044-0,Volatiles
May-04,Coagulation factor VIII inhibitor
32045-7,Parathyrin.biointact
32046-5,Pregnancy associated plasma protein A
32047-3,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+68+70 DNA
32048-1,Amitriptyline+Nortriptyline
32049-9,Amobarbital
32050-7,Barbital
32051-5,Barbital
Feb-05,Coagulation factor VIII Ab
32052-3,Benzodiazepines
32053-1,Bupivacaine
32054-9,Butabarbital
32055-6,Butalbital
32056-4,Butalbital
32057-2,Butalbital
32058-0,carBAMazepine.free
32059-8,chlordiazePOXIDE
3206-0,Coagulation factor VIII inhibitor
32060-6,Chloroquine
32061-4,chlorproMAZINE
32062-2,chlorproPAMIDE
32063-0,Cimetidine
32064-8,Clorazepate
32065-5,cloZAPine
32066-3,cloZAPine
32067-1,Digoxin.free
32068-9,diphenhydrAMINE+dimenhyDRINATE
32069-7,Ephedrine+Pseudoephedrine
32070-5,Ethanol
32071-3,Ethchlorvynol
32072-1,FLUoxetine
32073-9,fluvoxaMINE
32074-7,fluvoxaMINE
32075-4,fluvoxaMINE
32076-2,Glutethimide
32077-0,Glutethimide
Aug-07,Coagulation factor VIII inhibitor
32078-8,glyBURIDE
32079-6,Gold
32080-4,HYDROcodone
32081-2,HYDROmorphone
32082-0,Ibuprofen
32083-8,Imipramine+Desipramine
32084-6,Isopropanol
32085-3,Isopropanol
Jun-08,Coagulation factor VIII activated activity
32086-1,Lidocaine
32087-9,Loxapine
32088-7,Meperidine
32089-5,Mephobarbital
32090-3,Mepivacaine
32091-1,Meprobamate
32092-9,Meprobamate
32093-7,Methadone
Apr-09,Coagulation factor VIII activity actual/Normal
32094-5,Methanol
32095-2,Methanol
32096-0,Methaqualone
32097-8,Methyprylon
32098-6,Mexiletine
32099-4,6-Monoacetylmorphine
321-0,Methacycline
32100-0,Morphine
32101-8,oxyCODONE
Feb-10,Coagulation factor VIII activity
32102-6,PARoxetine
32103-4,PENTobarbital
32104-2,PENTobarbital
32105-9,Perphenazine
32106-7,Perphenazine
32107-5,Phencyclidine
32108-3,PHENobarbital
32109-1,Phenytoin.free
3211-0,Coagulation factor VIII activity actual/Normal
32110-9,Procyclidine
32111-7,Secobarbital
32112-5,Sertraline
32113-3,Sertraline
32114-1,Thallium
32115-8,Theophylline^peak
32116-6,Theophylline^trough
32117-4,Thiopental
32118-2,TOLBUTamide
32119-0,Valproate.free
32120-8,Venlafaxine
32121-6,Venlafaxine
32122-4,Choriogonadotropin.beta subunit.free
32123-2,Pregnancy associated plasma protein A
32124-0,Bromazepam
32125-7,Propoxyphene
32126-5,Propylene glycol
32127-3,raNITIdine
Aug-12,Coagulation factor VIII activity.X(little a) activator
32128-1,risperiDONE
32129-9,risperiDONE
32130-7,risperiDONE
32131-5,Hantavirus Ab.IgM
32132-3,Lactate
32133-1,Lactate
32134-9,Adenovirus+Rotavirus
32135-6,Alkaline phosphatase.liver
Jun-13,Coagulation factor VIII Ag
32136-4,Antidepressants
32137-2,Calcium phosphate/Total
32138-0,Cystine/Total
32139-8,Haemophilus influenzae Ag
32140-6,Hemoglobin F
32141-4,Herpes simplex virus 1+2 DNA
32142-2,Leukocytes
32143-0,Triple phosphate/Total
Apr-14,Coagulation factor VIII Ag
32144-8,Pathologist review
32145-5,Phosphate crystals.amorphous
32146-3,Platelets.large
32147-1,Reducing substances
32148-9,Substance.toxic identified
32149-7,Urate/Total
32150-5,Urate crystals.amorphous
Jan-15,Coagulation factor VIII Ag
32151-3,Microscopic observation
32152-1,17-Hydroxyketosteroids
32153-9,Alpha-Phenyl-2-Piperidine acetate
32154-7,Basophils+Eosinophils+Monocytes
32155-4,Basophils+Eosinophils+Monocytes/100 leukocytes
32156-2,Calcium carbonate/Total
32157-0,Calcium oxalate/Total
32158-8,Klebsiella granulomatis
32159-6,Carbonated calcium phosphate/Total
32160-4,Carboxyhemoglobin
32161-2,Catecholamines
32162-0,Cells
32163-8,Cells
32164-6,Cells
32165-3,Cells counted.total
32166-1,Choriogonadotropin^^adjusted
32167-9,Clarity
32168-7,Color
Sep-16,Coagulation factor X inhibitor
32169-5,Cystine
32170-3,Cytomegalovirus Ab
32171-1,Echinococcus sp Ab.IgG
32172-9,Ehrlichia chaffeensis Ab
32173-7,Eosinophils
32174-5,Glucose
32175-2,Granular casts.coarse
32176-0,Granular casts.fine
Jul-17,Coagulation factor X activated activity
32177-8,Granulocytes/100 leukocytes
32178-6,Hepatitis B virus little e Ag
32179-4,Heptacarboxylporphyrin/Creatinine
32180-2,Herpes simplex virus 1 Ab
32181-0,Herpes simplex virus 2 Ab
32182-8,Herpes virus 6 Ab.IgM
32183-6,Hydroxyproline.free
32184-4,Itraconazole^peak
May-18,Coagulation factor X activity actual/Normal
32185-1,Itraconazole^trough
32186-9,Microscopic observation
32187-7,Microscopic observation
32188-5,Microscopic observation
32189-3,Microscopic observation
32190-1,Microscopic observation
32191-9,Monocytes+Macrophages
32192-7,Monocytes+Macrophages
Mar-19,Coagulation factor X activity
32193-5,Monocytes+Macrophages
32194-3,Monocytes+Macrophages
32195-0,Monocytes+Macrophages
32196-8,Monocytes+Macrophages
32197-6,Myoglobin
32198-4,Neisseria gonorrhoeae rRNA
32199-2,Neisseria gonorrhoeae rRNA
32200-8,Neutrophils.segmented/100 leukocytes
Jan-20,Coagulation factor X Ag
32201-6,Unidentified cells
32202-4,Unidentified cells
32203-2,Unidentified cells
32204-0,Unidentified cells
32205-7,Unidentified cells
32206-5,Plasmodium sp identified
32207-3,Platelet distribution width
32208-1,Platelets.small
32209-9,Protein
32210-7,Protein pattern
32211-5,Reducing substances
32212-3,Salmonella paratyphi A Ab
32213-1,Salmonella paratyphi B Ab
32214-9,Thyroid stimulating immunoglobulins
32215-6,Thyroxine free index
32216-4,Uroporphyrin
32217-2,von Willebrand factor multimers
32218-0,Cyclic citrullinated peptide Ab
Sep-21,Coagulation factor X Ag actual/Normal
32219-8,Soluble liver Ab
32220-6,Liver kidney microsomal 1 Ab
32221-4,Alanine
32222-2,Alanine
32223-0,Alpha aminobutyrate
32224-8,Alpha aminobutyrate
32225-5,Arginine
32226-3,Arginine
Jul-22,Coagulation factor X+Acarboxy Ag
32227-1,Argininosuccinate
32228-9,Argininosuccinate
32229-7,Argininosuccinate/Creatinine
32230-5,Asparagine
32231-3,Aspartate
32232-1,Aspartate
32233-9,Carbamoyl phosphate synthetase
32234-7,Citrulline
May-23,Coagulation factor X+Acarboxy Ag actual/Normal
32235-4,Citrulline
32236-2,Cystathionine
32237-0,Cystine
32238-8,Cystine
32239-6,Ethanolamine
32240-4,Fructose
32241-2,Glutamate
32242-0,Glutamine
Mar-24,Coagulation factor XI inhibitor
32243-8,Glutamine
32244-6,Glycine
32245-3,Glycine
32246-1,Histidine
32247-9,Histidine
32248-7,Homocitrulline/Creatinine
32249-5,Hydroxyproline
3225-0,Coagulation factor XI activated activity
32250-3,Hydroxyproline
32251-1,Isoleucine
32252-9,Isoleucine
32253-7,Leucine
32254-5,Leucine
32255-2,Lysine
32256-0,Lysine
32257-8,Methionine
32258-6,Methionine
32259-4,Methylmalonate
32260-2,Ornithine
32261-0,Ornithine
32262-8,Orotate/Creatinine
32263-6,Phenylalanine
32264-4,Phenylalanine
32265-1,Phenylalanine/Tyrosine
32266-9,Proline
32267-7,Proline
Aug-26,Coagulation factor XI activity actual/Normal
32268-5,Ribose
32269-3,Serine
32270-1,Serine
32271-9,Taurine
32272-7,Threonine
32273-5,Threonine
32274-3,Thiosulfate/Creatinine
32275-0,Tryptophan
Jun-27,Coagulation factor XI activity
32276-8,Tyrosine
32277-6,Tyrosine
32278-4,Valine
32279-2,Valine
322-8,Methicillin
32280-0,Acylglycines
32281-8,Carnitine.free (C0)/Carnitine.total
32282-6,Succinylpurines
32283-4,Valproate.free/Valproate.total
Apr-28,Coagulation factor XI Ag
32284-2,BK virus DNA
32285-9,BK virus DNA
32286-7,Hepatitis C virus genotype
32287-5,Methylmalonate
32288-3,17-Hydroxyprogesterone^baseline
32289-1,7-Dehydrocholesterol
32290-9,Acetone
32291-7,Acetone
Feb-29,Coagulation factor XI Ag actual/Normal
32292-5,Acetone
32293-3,Albumin
32294-1,Albumin/Creatinine
32295-8,Aluminum
32296-6,Amino acid pattern
32297-4,Amino acids
32298-2,Amylase
32299-0,Androstenedione^baseline
Mar-32,Ampicillin+Sulbactam
3230-0,Coagulation factor XII inhibitor
32300-6,Base excess
32301-4,Beta-2-Microglobulin
32302-2,Beta-2-Microglobulin
32303-0,Bilirubin
32304-8,Cadmium
32305-5,Calcium
32306-3,Carbon dioxide
32307-1,Chloride
32308-9,Cholesterol
32309-7,Cholesterol.total/Cholesterol.in HDL
32310-5,Cortisol
32311-3,Cortisol^1H post XXX challenge
32312-1,Cortisol^2H post XXX challenge
32313-9,Cortisol^30M post XXX challenge
32314-7,Cortisol^1.5H post XXX challenge
32315-4,Cortisol^baseline
32316-2,Follitropin^30M post XXX challenge
32317-0,Follitropin^baseline
Aug-31,Coagulation factor XII activated activity
32318-8,Glucose
32319-6,Glucose^30M post 75 g glucose PO
32320-4,Glucose^3H post 75 g glucose PO
32321-2,Glucose^4H post 75 g glucose PO
32322-0,Glucose^5H post 75 g glucose PO
32323-8,Ketones
32324-6,Lactate dehydrogenase
32325-3,Lead
Jun-32,Coagulation factor XII activity actual/Normal
32326-1,Lutropin^30M post XXX challenge
32327-9,Lutropin^1H post XXX challenge
32328-7,Lutropin^baseline
32329-5,Magnesium
32330-3,Mercury
32331-1,Myoglobin
32332-9,Neopterin/Biopterin
32333-7,Phenylpropanolamine
Apr-33,Coagulation factor XII activity
32334-5,Pipecolate
32335-2,Pipecolate
32336-0,Potassium
32337-8,Protein
32338-6,Pyruvate
32339-4,Serotonin
32340-2,Sodium
32341-0,Transcobalamin II
Feb-34,Coagulation factor XII Ag
32342-8,Trimethoprim+Sulfamethoxazole
32343-6,Urate
32344-4,Urobilin
32345-1,Uroporphyrin
32346-9,Uroporphyrin
32347-7,Xylose
32348-5,Zinc
32349-3,Basophils+Eosinophils+Monocytes
32350-1,Basophils+Eosinophils+Monocytes/100 leukocytes
32351-9,Alkaline phosphatase.heat labile
32352-7,Alkaline phosphatase.heat stable
32353-5,Estriol
32354-3,Hematocrit
32355-0,Bacteria identified
32356-8,Yeast
32357-6,Ova+Parasites identified
32358-4,Protein fractions.oligoclonal bands
Sep-35,Coagulation factor XII Ag actual/Normal
32359-2,Glucose^10M post dose glucose
323-6,Methicillin
32360-0,Insulin^10M post XXX challenge
32361-8,West Nile virus RNA
32362-6,BK virus DNA
32363-4,JC virus DNA
32364-2,Herpes virus 8 DNA
32365-9,Torque teno virus DNA
32366-7,Hepatitis B virus genotype
Jul-36,Coagulation factor XIII inhibitor
32367-5,Bacteria identified
32368-3,Ureaplasma sp identified
32369-1,Clostridium perfringens enterotoxin
32370-9,West Nile virus RNA
32371-7,West Nile virus Ag
32372-5,Fleroxacin
32373-3,Arbekacin
32374-1,Cefotiam
May-37,Coagulation factor XIII activated activity
32375-8,Cefmenoxime
32376-6,Clinafloxacin
32377-4,Cefetamet
32378-2,Caspofungin
32379-0,Voriconazole
32380-8,Dicloxacillin
32381-6,Isepamicin
32382-4,Nitroxoline
Mar-38,Coagulation factor XIII Ag
32383-2,Pristinamycin
32384-0,Thiacetazone
32385-7,Babinski reflex
32386-5,Birth injury
32387-3,Chest tube output.total
32388-1,Chest tube output.total
32389-9,Deep tendon reflex
32390-7,Deep tendon reflex
Jan-39,Coagulation factor XIII Ag actual/Normal
32391-5,Deep tendon reflex
32392-3,Deep tendon reflex
32393-1,Deep tendon reflex
32394-9,Calorie intake.enteral.total
32395-6,Infant monitor type
32396-4,Labor duration
32397-2,Liver span below costal margin
32398-0,Secondary male genitalia development
32399-8,Maternal risk factors
32400-4,Menses finding
32401-2,Color^10M post birth
32402-0,Heart rate^10M post birth
32403-8,Muscle tone^10M post birth
32404-6,Reflex irritability^10M post birth
32405-3,Respiratory effort^10M post birth
32406-1,Color^1M post birth
32407-9,Heart rate^1M post birth
32408-7,Muscle tone^1M post birth
Sep-40,Coagulation factor XIII coagulum dissolution
32409-5,Reflex irritability^1M post birth
32410-3,Respiratory effort^1M post birth
32411-1,Color^5M post birth
32412-9,Heart rate^5M post birth
32413-7,Muscle tone^5M post birth
32414-5,Reflex irritability^5M post birth
32415-2,Respiratory effort^5M post birth
32416-0,Newborn complication
Jul-41,Coagulation factor XIII coagulum dissolution at 24H
32417-8,Newborn intensive care unit admission diagnosis
32418-6,Obstetric trimester
32419-4,Pain quality
32420-2,Physical findings
32421-0,Physical findings
32422-8,Physical findings
32423-6,Physical findings
32424-4,Physical findings
May-42,Coagulation calcium ion induced
32425-1,Physical findings
32426-9,Physical findings
32427-7,Physical findings
32428-5,Physical findings
32429-3,Physical findings
32430-1,Physical findings
32431-9,Physical findings
32432-7,Physical findings
Mar-43,Coagulation thrombin induced
32433-5,Physical findings
32434-3,Physical findings
32435-0,Symptoms & diseases
32436-8,Physical findings
32437-6,Physical findings
32438-4,Physical findings
32439-2,Physical findings
324-4,Methicillin
32440-0,Physical findings
Jan-44,Coagulum lysis
32441-8,Physical findings
32442-6,Symptoms & diseases
32443-4,Physical findings
32444-2,Physical findings
32445-9,Physical findings
32446-7,Physical findings
32447-5,Physical findings
32448-3,Physical findings
32449-1,Physical findings
32450-9,Physical findings
32451-7,Physical findings
32452-5,Physical findings
32453-3,Physical findings
32454-1,Physical findings
32455-8,Physical findings
32456-6,Physical findings
32457-4,Physical findings
Aug-45,Coagulum retraction
32458-2,Physical findings
32459-0,Physical findings
32460-8,Physical findings
32461-6,Physical findings
32462-4,Physical findings
32463-2,Physical findings
32464-0,Physical findings
32465-7,Physical findings
Jun-46,Fibrin D-dimer
32466-5,Physical findings
32467-3,Physical findings
32468-1,Physical findings
32469-9,Physical findings
32470-7,Physical findings
32471-5,Physical findings
32472-3,Symptoms & diseases
32473-1,Physical findings.sensation
Apr-47,Fibrin D-dimer
32474-9,Physical findings.shoulder shrug
32475-6,Physical findings.skin ulcer
32476-4,Physical findings
32477-2,Physical findings
32478-0,Physical findings
32479-8,Physical findings
32480-6,Physical findings
32481-4,Physical findings
Feb-48,Fibrin fragments Ag
32482-2,Physical findings
32483-0,Physical findings
32484-8,Physical findings
32485-5,Physical findings
32486-3,Physical findings
32487-1,Physical findings
32488-9,Physical findings
32489-7,Spleen tip distance below costal margin
3249-0,Fibrin fragments
32490-5,Tocolysis method
32491-3,Deep tendon reflex
32492-1,Body fluid quality
32493-9,Cells.CD25/100 cells
32494-7,Cells.CD25/100 cells
32495-4,Cells.CD25/100 cells
32496-2,Cells.CD57/100 cells
32497-0,Cells.CD57/100 cells
32498-8,Cells.CD57/100 cells
32499-6,Cells.CD7-CD13+CD33+/100 cells
32500-1,Cells.CD10+CD19+/100 cells
32501-9,Cells.CD10+CD19+/100 cells
32502-7,Cells.CD10+CD19+/100 cells
32503-5,Cells.CD13+CD33+/100 cells
32504-3,Cells.CD13+CD33+/100 cells
32505-0,Cells.CD13+CD33+/100 cells
32506-8,Cells.CD14/100 cells
32507-6,Cells.CD14/100 cells
Aug-50,Fibrin monomer
32508-4,Cells.CD3-CD16+CD56+/100 cells
32509-2,Cells.CD3-CD16+CD56+/100 cells
325-1,Methicillin
32510-0,Cells.CD5+CD19+/100 cells
32511-8,Cells.CD5+CD19+/100 cells
32512-6,Cells.CD2
32513-4,Cells.CD3+CD25+
32514-2,Cells.CD3+CD25+/100 cells
32515-9,Cells.CD3+CD4+
Jun-51,Fibrin+Fibrinogen fragments
32516-7,Cells.CD3+CD4+/100 cells
32517-5,Cells.CD3+CD8+
32518-3,Cells.CD3+CD8+/100 cells
32519-1,Cells.CD3-CD16+CD56+/100 cells
32520-9,Cells.CD7-CD13+CD33+/100 cells
32521-7,Cells.CD10+CD19+/100 cells
32522-5,Cells.CD13+CD33+/100 cells
32523-3,Cells.CD5+CD19+/100 cells
Apr-52,Fibrin+Fibrinogen fragments
32524-1,Cells.CD19
32525-8,Cells.CD19/100 cells
32526-6,Cells.CD2
32527-4,Cells.CD2/100 cells
32528-2,Cells.CD3
32529-0,Cells.CD3/100 cells
32530-8,Cells.CD3+CD25+
32531-6,Cells.CD3+CD25+/100 cells
Feb-53,Fibrin.soluble
32532-4,Cells.CD3+CD4+
32533-2,Cells.CD3+CD4+/100 cells
32534-0,Cells.CD3+CD8+
32535-7,Cells.CD3+CD8+/100 cells
32536-5,Cells.CD3-CD16+CD56+
32537-3,Cells.CD3+CD4+/Cells.CD3+CD8+
32538-1,17-Hydroxyprogesterone^2H post XXX challenge
32539-9,17-Hydroxyprogesterone^1H post XXX challenge
3254-0,Fibrin.soluble
32540-7,Glucosylceramidase
32541-5,Calcium
32542-3,Chloride
32543-1,Creatinine
32544-9,Fat intake
32545-6,Fat
32546-4,Glucose-6-Phosphate dehydrogenase
32547-2,Ketones
32548-0,Nitroprusside reacting substances
32549-8,Norepinephrine/Creatinine
32550-6,Potassium
32551-4,Protein
32552-2,Pyruvate kinase
32553-0,Sodium
32554-8,Thiamine
32555-5,Urate
32556-3,Urea
Jul-55,Fibrinogen
32557-1,Candida albicans reaction wheal^1D post 50 ug Candida albicans ID
32558-9,Mumps reaction wheal^1D post 0.1 mL mumps ID
32559-7,Tau protein
32560-5,Trichophyton reaction wheal^2D post 50 ug trichophyton ID
32561-3,Tuberculosis reaction wheal^1D post dose mammalian tuberculin ID
32562-1,Lymphocytes.IgG/100 lymphocytes
32563-9,Lymphocytes.IgG/100 lymphocytes
32564-7,Cells.CD3+CD7+/100 cells
May-56,Fibrinogen Ag
32565-4,SCA3 gene.CAG repeats
32566-2,Coxiella burnetii Ab
32567-0,Candida albicans reaction wheal^2D post 50 ug Candida albicans ID
32568-8,Trichophyton reaction wheal^1D post 50 ug trichophyton ID
32569-6,Corynebacterium diphtheriae Ab^1st specimen
32570-4,Tetrahydroaldosterone/Creatinine
32571-2,HIV 1 Ab
32572-0,Tilapia Ab.IgE
Mar-57,Fibrinogen
32573-8,Tilapia Ab.IgE.RAST class
32574-6,Zaleplon
32575-3,Bartonella henselae Ab.IgG
32576-1,Bartonella henselae Ab.IgM
32577-9,Bartonella quintana Ab.IgG
32578-7,Bartonella quintana Ab.IgM
32579-5,Phentermine
32580-3,Chromatin Ab.IgG
Jan-58,Fibrinogen Ag
32581-1,Epidermal growth factor receptor Ag
32582-9,Phenylpropionylglycine
32583-7,Phenyllactate
32584-5,Propionylglycine
32585-2,Epstein Barr virus DNA
32586-0,Follitropin^20M post XXX challenge
32587-8,Androstenedione^2H post XXX challenge
32588-6,Androstenedione^1H post XXX challenge
32589-4,Gabapentin
32590-2,Granulocytes units available
32591-0,Heavy metals
32592-8,Cryoprecipitate poor plasma units available
32593-6,Eosinophils/100 leukocytes
32594-4,Tacrolimus
32595-1,Topiramate
32596-9,Trifluoperazine
32597-7,Natamycin
32598-5,Sertraline
Sep-59,Fibrinogen fragments Ag
32599-3,Lutropin^30M post XXX challenge
32600-9,Felbamate
32601-7,Cells.CD59/100 cells
32602-5,HIV 1+2 Ab
32603-3,Itraconazole
32604-1,Leptospira sp Ab^1st specimen
32605-8,Leptospira sp Ab^2nd specimen
32606-6,Lutropin^1H post XXX challenge
Jul-60,Fibrinopeptide B beta (1-14) Ag
32607-4,Clorazepate
32608-2,cloZAPine
32609-0,Amino acids
32610-8,Amino acids
32611-6,Amino acids
32612-4,Amino acids
32613-2,Carnitine.free (C0)/Carnitine.total
32614-0,Glutamate
May-61,Fibrinopeptide B beta (1-42) Ag
32615-7,Homocysteine cysteine disulfide
32616-5,Homocysteine cysteine disulfide/Creatinine
32617-3,Ornithine carbamoyltransferase
32618-1,3-Methoxytyramine
32619-9,Biotinidase
32620-7,Corynebacterium diphtheriae Ab
32621-5,HLA-DR
32622-3,Hyaluronidase Ab
Mar-62,Fibrinopeptide B beta (15-42) Ag
32623-1,Platelet mean volume
32624-9,Race
32625-6,Spermatozoa Ab.IgA
32626-4,Spermatozoa Ab.IgG
32627-2,Argininosuccinate lyase
32628-0,ACADM gene.c.985A>G
32629-8,Protein.monoclonal/Protein.total
32630-6,MSH2 gene+MLH1 gene targeted mutation analysis
Jan-63,Fibrinopeptide B beta (43-47) Ag
32631-4,Nitroblue tetrazolium test
32632-2,HEXA gene targeted mutation analysis
32633-0,Susceptibility organism^^^4
32634-8,Metanephrine.free
32635-5,Coagulation factor II inhibitor
32636-3,Islet cell 512 Ab
32637-1,Urease
32638-9,Blood group antibody screen
32639-7,FANCC gene targeted mutation analysis
32640-5,BLM gene targeted mutation analysis
32641-3,SMPD1 gene targeted mutation analysis
32642-1,Dextroamphetamine/Levoamphetamine
32643-9,Dextromethamphetamine/Levomethamphetamine
32644-7,Coxiella burnetii phase 1 Ab.IgG
32645-4,Coxiella burnetii phase 1 Ab.IgM
32646-2,Nevirapine
32647-0,Nelfinavir
32648-8,Hydroxyethylflurazepam
Sep-64,Fibrinopeptide A Ag
32649-6,Hydroxytriazolam
32650-4,Norflunitrazepam
32651-2,Ethion
32652-0,Fenthion
32653-8,DYS gene targeted mutation analysis
32654-6,6-Methylmercaptopurine
32655-3,Metanephrines/Creatinine
Jun-65,Fibrinopeptide B Ag
32656-1,Aflatoxin Ab.IgG
32657-9,Aflatoxin Ab.IgA
32658-7,Aflatoxin Ab.IgM
32659-5,Aflatoxin Ab.IgE
32660-3,6-Thioguanine
32661-1,Adrenal Ab
32662-9,Afipia felis Ab.IgG
32663-7,Afipia felis Ab.IgM
Apr-66,Heparin Ab
32664-5,Ammonia
32665-2,Anticonvulsants
32666-0,Borrelia burgdorferi 25kD Ab.IgM
32667-8,Borrelia burgdorferi DNA
32668-6,Borrelia burgdorferi DNA
32669-4,Borrelia burgdorferi DNA
32670-2,Cells counted.total
32671-0,Chlamydia sp Ag
Feb-67,Heparin Ab
32672-8,Cold agglutinin
32673-6,Creatine kinase.MB
32674-4,Cryptococcus sp Ag
32675-1,Cytomegalovirus
32676-9,Diuretics
32677-7,DNA double strand Ab
32678-5,Ehrlichia chaffeensis Ab.IgG
32679-3,Ehrlichia chaffeensis Ab.IgM
3268-0,Heparin cofactor II Ag
32680-1,Granular casts.fine
32681-9,Hemoglobin C/Hemoglobin.total
32682-7,Hemoglobin F/Hemoglobin.total
32683-5,Hemoglobin S/Hemoglobin.total
32684-3,Heparin.low molecular weight
32685-0,Hepatitis B virus core Ab.IgG
32686-8,Hepatitis B virus DNA
32687-6,Herpes simplex virus 1 Ab.IgM
32688-4,Herpes simplex virus 2 Ab.IgM
32689-2,Herpes simplex virus identified
326-9,metroNIDAZOLE
32690-0,Homocysteine
32691-8,Anaplasma phagocytophilum Ab.IgG
32692-6,Anaplasma phagocytophilum Ab.IgM
32693-4,Lactate
32694-2,Legionella longbeachae 1+2 Ab
32695-9,Legionella pneumophila atypical Ab
32696-7,Legionella pneumophila 1+2+3+4+5+6 Ab
32697-5,Lymphocytes
Aug-69,Heparin neutralization
32698-3,Magnesium.ionized
32699-1,Microscopic observation
32700-7,Microscopic observation
32701-5,Microsporidia identified
32702-3,Muscle sarcolemma Ab
32703-1,Cytochrome b5 reductase
32704-9,Neisseria gonorrhoeae Ab
32705-6,Neisseria gonorrhoeae DNA
Jun-70,Heparin.low molecular weight
32706-4,Neisseria meningitidis serogroups A+C+w135+Y Ag
32707-2,Neisseria meningitidis serogroup B+Escherichia coli K1 Ag
32708-0,Neutrophil cytoplasmic Ab.classic
32709-8,Neutrophils
32710-6,Nitrite
32711-4,Platelet mean volume
32712-2,Platelets.giant/100 leukocytes
32713-0,Potassium
Apr-71,Heparin.low molecular weight
32714-8,Rickettsia typhus group Ab.IgM
32715-5,SCL-70 extractable nuclear Ab
32716-3,Sjogrens syndrome-A extractable nuclear Ab
32717-1,Sodium
32718-9,Spermatozoa Ab.IgA
32719-7,Spermatozoa Ab.IgG
32720-5,Spermatozoa Ab.IgM
32721-3,Tacrolimus
Feb-72,Heparin.low molecular weight
32722-1,Triacylglycerol lipase
32723-9,Trichinella sp Ab.IgG
32724-7,Trichomonas sp
32725-4,Trypanosoma cruzi Ab.IgG
32726-2,Trypanosoma cruzi Ab.IgM
32727-0,Urobilinogen
32728-8,Beta 1 globulin/Protein.total
32729-6,Beta 2 globulin/Protein.total
3273-0,Heparin.unfractionated
32730-4,Beta 1 globulin
32731-2,Beta 2 globulin
32732-0,Beta 1 globulin/Protein.total
32733-8,Beta 2 globulin/Protein.total
32734-6,Beta 1 globulin
32735-3,Beta 2 globulin
32736-1,Beta 1 globulin/Protein.total
32737-9,Beta 2 globulin/Protein.total
32738-7,Beta 1 globulin
32739-5,Beta 2 globulin
32740-3,Beta 1 globulin/Protein.total
32741-1,Beta 2 globulin/Protein.total
32742-9,Cells.CD117/100 cells
32743-7,Cells.CD138/100 cells
32744-5,Cells.CD55/100 cells
32745-2,Cells.CD62E/100 cells
32746-0,Cells.CD62P/100 cells
32747-8,Cells.CD64/100 cells
Aug-74,Heparin.unfractionated
32748-6,Cells.CD90/100 cells
32749-4,Cells.cyclin D1/100 cells
32750-2,Cells.CD235a/100 cells
32751-0,Cells.HLA-DR+/100 cells
32752-8,Cells.CD3/100 cells
32753-6,Cells.CD4/100 cells
32754-4,Cells.CD8/100 cells
May-75,Heparin.unfractionated
32755-1,Cells.CD19/100 cells
32756-9,Cells.CD3+CD4+/Cells.CD3+CD8+
32757-7,Cells.BCL2/100 cells
32758-5,Cells.CD11b/100 cells
32759-3,Cells.myeloperoxidase/100 cells
32760-1,Cell type
32761-9,Leukocytes
32762-7,Epithelial cells
Mar-76,Kininogen.high molecular weight
32763-5,Bacteria
32764-3,Clue cells
32765-0,Yeast
32766-8,Trichomonas vaginalis
32767-6,Borrelia burgdorferi 25kD Ab.IgM
32768-4,Trichinella sp Ab.IgG
32769-2,Alpha 1 antitrypsin phenotype
327-7,metroNIDAZOLE
32770-0,Transfusion band number
Jan-77,Kininogen.high molecular weight
32771-8,Carbon dioxide^^adjusted to patient's actual temperature
32772-6,Cells.CD14
32773-4,Cells.CD24
32774-2,Chlamydia sp DNA
32775-9,Clostridium tetani toxoid Ab
32776-7,Erythrocytes
32777-5,Escherichia coli O157:H7 Ag
32778-3,Fibrin strands
32779-1,Glucose-6-Phosphatase
32780-9,Histoplasma sp Ag
32781-7,Legionella sp Ag
32782-5,Leukocyte esterase+Nitrite
32783-3,Leucine+Isoleucine+Valine
32784-1,Mean peroxidase activity index
32785-8,Microscopic observation
32786-6,Thyroperoxidase Ab
32787-4,Neutrophil cytoplasmic Ab.perinuclear
32788-2,Polymorphonuclear cells/Monocytes
Sep-78,Kininogen.high molecular weight actual/Normal
32789-0,Viscosity
32790-8,Herpes simplex virus 2 Ab.IgG^1st specimen/2nd specimen
32791-6,Cytomegalovirus Ab.IgG^1st specimen/2nd specimen
32792-4,Parvovirus B19 Ab.IgG^2nd specimen
32793-2,Parvovirus B19 Ab.IgG^1st specimen/2nd specimen
32794-0,Parvovirus B19 Ab.IgM^1st specimen
32795-7,Parvovirus B19 Ab.IgM^2nd specimen
32796-5,Parvovirus B19 Ab.IgM^1st specimen/2nd specimen
Jul-79,Kininogen.low molecular weight
32797-3,Drugs identified
32798-1,Microscopic observation
32799-9,Glycosaminoglycans/Creatinine
32800-5,Neisseria meningitidis serogroups C+w135 Ag
32801-3,Specimen volume
32802-1,Color
32803-9,Appearance
32804-7,Neutrophils/100 leukocytes
May-80,Kininogen.low molecular weight
32805-4,Lymphocytes.variant/100 leukocytes
32806-2,Monocytes+Macrophages/100 leukocytes
32807-0,Mononuclear cells/100 leukocytes
32808-8,Leukocytes other/100 leukocytes
32809-6,Fungus identified
32810-4,Bacteria identified
32811-2,Microscopic observation
32812-0,Microscopic observation
Mar-81,Lupus anticoagulant
32813-8,Pathologist interpretation
32814-6,Microscopic observation
32815-3,Microscopic observation
32816-1,Microscopic observation
32817-9,Microscopic observation
32818-7,Microscopic observation
32819-5,Microsporidia identified
32820-3,Glucose^45M post dose lactose PO
Jan-82,Coagulation surface induced.hexagonal phase phospholipid
32821-1,Interpretation
32822-9,Epithelial cells.squamous/100 cells
32823-7,Columnar cells/100 cells
32824-5,Microscopic observation
32825-2,Leukocytes
32826-0,Parvovirus B19 Ab.IgG^1st specimen
32827-8,HIV 1 p17+p18 Ab
32828-6,Epstein Barr virus capsid Ab.IgG^1st specimen
32829-4,Epstein Barr virus capsid Ab.IgG^2nd specimen
32830-2,Epstein Barr virus capsid Ab.IgG^1st specimen/2nd specimen
32831-0,Herpes simplex virus 1 Ab.IgG^1st specimen/2nd specimen
32832-8,Lymphocytes.variant/100 leukocytes
32833-6,Monocytes+Macrophages/100 leukocytes
32834-4,Herpes simplex virus 2 Ab.IgG^1st specimen/2nd specimen
32835-1,Cytomegalovirus Ab.IgG^1st specimen/2nd specimen
32836-9,Parvovirus B19 Ab.IgG^1st specimen
32837-7,Parvovirus B19 Ab.IgG^2nd specimen
32838-5,Parvovirus B19 Ab.IgG^1st specimen/2nd specimen
Sep-83,Lupus anticoagulant neutralization.high phospholipid
32839-3,Parvovirus B19 Ab.IgM^2nd specimen
32840-1,Parvovirus B19 Ab.IgM^1st specimen/2nd specimen
32841-9,Neisseria meningitidis serogroups C+w135 Ag
32842-7,HIV 1 p17+p18 Ab
32843-5,Epstein Barr virus capsid Ab.IgG^1st specimen
32844-3,Epstein Barr virus capsid Ab.IgG^2nd specimen
32845-0,Epstein Barr virus capsid Ab.IgG^1st specimen/2nd specimen
32846-8,Herpes simplex virus 1 Ab.IgG^1st specimen/2nd specimen
Jul-84,Lupus anticoagulant neutralization.platelet
32847-6,Streptococcus pneumoniae 18 Ab.IgG
32848-4,Neisseria meningitidis serogroups A+Y Ag
32849-2,Streptococcus pneumoniae 18 Ab.IgG
328-5,metroNIDAZOLE
32850-0,Streptococcus pneumoniae 5 Ab.IgG
32851-8,Neisseria meningitidis serogroups A+Y Ag
32852-6,carBAMazepine.free/carBAMazepine.total
32853-4,Neuronal Ab
Apr-85,Phospholipid Ab
32854-2,17-Hydroxyprogesterone
32855-9,Cells.CD62/100 cells
32856-7,Cells.cytoplasmic CD22/100 cells
32857-5,Cells.cytoplasmic CD3/100 cells
32858-3,Cells.IgG/100 cells
32859-1,Cells.multiple drug resistance/100 cells
32860-9,Cells.TCR alpha beta/100 cells
32861-7,Cells.TCR gamma delta/100 cells
Feb-86,Phospholipid Ab.IgG
32862-5,Osmotic fragility^incubated
32863-3,Osmotic fragility^fresh
32864-1,Frankfort horizontal plane to mandibular plane
32865-8,Frankfort horizontal plane to mandibular plane
32866-6,Frankfort horizontal plane to mandibular plane
32867-4,First tooth space boundary
32868-2,Second tooth space boundary
32869-0,Tooth space
3287-0,Phospholipid Ab.IgM
32870-8,First facial landmark
32871-6,Second facial landmark
32872-4,Facial measurement
32873-2,Facial measurement method
32874-0,Dental treatment anatomical site access
32875-7,Guardian previously informed of patient condition
32876-5,Guardian informed of patient condition
32877-3,Guardian previous action taken
32878-1,Guardian current action taken
32879-9,Noncompliance with dental treatment
32880-7,Dental procedure
32881-5,Dental probing response
32882-3,Reason for dental evaluation
32883-1,Dental arch
32884-9,Identification
32885-6,Identification
32886-4,Identification
32887-2,Identification
Aug-88,Prothrombin Ag
32888-0,Probe site
32889-8,Surface
32890-6,Canal
32891-4,Root palpation location
32892-2,Side
32893-0,First interdental papilla boundary
32894-8,Second interdental papilla boundary
32895-5,Tooth space available
Jun-89,Prothrombin.activity actual/Normal
32896-3,Width
32897-1,Height
32898-9,Tooth space required
32899-7,Tooth space required
32900-3,Tooth space discrepancy
32901-1,Tooth space discrepancy
32902-9,Superhelix of ear to side of head distance
32903-7,Superhelix of ear to side of head distance
Apr-90,2-Oxoisocaproate
32904-5,Midhelix of ear to side of head distance
32905-2,Midhelix of ear to side of head distance
32906-0,Cuspid to cuspid distance
32907-8,Crown length
32908-6,Root length
32909-4,Interproximal space height
32910-2,Probing depth
32911-0,Recession
Feb-91,2-Pyridone
32912-8,Attachment level
32913-6,Mucogingival junction level
32914-4,Bone attachment level
32915-1,Bone attachment level
32916-9,Horizontal overlap
32917-7,Vertical overlap
32918-5,Openbite
32919-3,Vertical dimension of occlusion
3292-0,2-Pyridone/N'-Methylnicotinamide
32920-1,Excursive distance.max
32921-9,Centric relation maximum intercuspation anterior shift
32922-7,Centric relation maximum intercuspation lateral shift
32923-5,Closest speaking space
32924-3,Single tooth area
32925-0,Sella-nasion plane to nasion-B point line
32926-8,Sella-nasion plane to nasion-B point line
32927-6,Sella-nasion plane to nasion-B point line
32928-4,A point-nasion line to nasion-B point line
32929-2,A point-nasion line to nasion-B point line
329-3,metroNIDAZOLE
32930-0,A point-nasion line to nasion-B point line
32931-8,Sella-nasion plane to Frankfort horizontal plane
32932-6,Sella-nasion plane to Frankfort horizontal plane
32933-4,Sella-nasion plane to Frankfort horizontal plane
32934-2,Nasion-glabella line to nasion-pronasale line
32935-9,Nasion-glabella line to nasion-pronasale line
32936-7,Nasion-glabella line to nasion-pronasale line
32937-5,Frankfort horizontal plane to nasion-pogonion line
Aug-93,Acebutolol
32938-3,Frankfort horizontal plane to nasion-pogonion line
32939-1,Frankfort horizontal plane to nasion-pogonion line
32940-9,Freeway space
32941-7,Maximum intercuspation left midline discrepancy
32942-5,Maximum intercuspation right midline discrepancy
32943-3,First contact left midline discrepancy
32944-1,First contact right midline discrepancy
32945-8,Sella-nasion plane to nasion-A point line
Jun-94,Acebutolol
32946-6,Sella-nasion plane to nasion-A point line
32947-4,Sella-nasion plane to nasion-A point line
32948-2,Size
32949-0,Size
32950-8,Bleeding on probing index
32951-6,Bleeding on probing index
32952-4,Plaque index
Mar-95,Acebutolol
32953-2,Plaque index
32954-0,Root development
32955-7,Vertical overlap
32956-5,Alveolar ridge
32957-3,Palate
32958-1,Crown
32959-9,Root
32960-7,Transverse section
Jan-96,Acepromazine
32961-5,Anterior segment
32962-3,Caries risk
32963-1,Peridontal risk
32964-9,Dental prognosis
32965-6,Dental prognosis
32966-4,Dental prognosis
32967-2,Root apex development
32968-0,Eruption
32969-8,Eruption
32970-6,Eruption
32971-4,Exfoliation
32972-2,Exfoliation
32973-0,Exfoliation
32974-8,Size
32975-5,Vertical displacement
32976-3,Vertical displacement
32977-1,Vertical displacement
32978-9,Vertical displacement
Sep-97,Acetaminophen
32979-7,Stability
32980-5,Stability
32981-3,Stability
32982-1,Stability
32983-9,Retention
32984-7,Retention
32985-4,Retention
32986-2,Retention
Jul-98,Acetaminophen
32987-0,Support
32988-8,Support
32989-6,Support
32990-4,Support
32991-2,Aesthetics
32992-0,Aesthetics
32993-8,Aesthetics
32994-6,Aesthetics
May-99,Acetaminophen
32995-3,Lutropin^20M post XXX challenge
32996-1,HER2
32997-9,cycloSPORINE^2H post dose
32998-7,Tissue transglutaminase Ab.IgG
32999-5,Rickettsia spotted fever group Ab.IgG
33000-1,Rickettsia spotted fever group Ab.IgM
Jan-00,acetaZOLAMIDE
33001-9,Rickettsia typhi Ab.IgM
33002-7,Triticum spelta Ab.IgE
33003-5,Triticum spelta Ab.IgE.RAST class
33004-3,Kelp Ab.IgE
33005-0,Kelp Ab.IgE.RAST class
33006-8,Cytomegalovirus DNA
33007-6,Protoporphyrin.zinc
33008-4,Neuronal nuclear type 2 Ab
33009-2,Chylomicrons
330-1,Mezlocillin
33010-0,Cheese colby Ab.IgE
33011-8,Cheese colby Ab.IgE.RAST class
33012-6,Cheese provolone Ab.IgE
33013-4,Cheese provolone Ab.IgE.RAST class
33014-2,Cheese romano Ab.IgE
33015-9,Cheese romano Ab.IgE.RAST class
33016-7,Methylenedioxyethylamphetamine
33017-5,Parasites
33018-3,Protein.monoclonal
Sep-01,acetaZOLAMIDE
33019-1,Pseudocasts
33020-9,Triple phosphate crystals
33021-7,Tyrosine crystals
33022-5,Carbon dioxide
33023-3,Cells.CD34/100 cells
33024-1,Glucose^30M post 1.2 g/kg lactose PO
33025-8,Hemoglobin
33026-6,Hemoglobin
Jul-02,acetaZOLAMIDE
33027-4,Herpes simplex virus+Varicella zoster virus DNA
33028-2,Leukocytes
33029-0,Cells.CD3+TCR/100 cells
33030-8,Cells.CD34
33031-6,Sodium urate crystals
33032-4,Spermatozoa.progressive
33033-2,CD45 positive events
33034-0,CD45 negative events
May-03,acetaZOLAMIDE
33035-7,Reason for lab test
33036-5,Fatty acids.very long chain.C26:1
33037-3,Anion gap
33038-1,Candida sp identified
33039-9,Fungus identified
33040-7,Hypnotics
33041-5,Hypnotics
33042-3,Interpretation
Mar-04,Acetyldigitoxin
33043-1,Ketones
33044-9,Pyknosis
33045-6,Respiratory syncytial virus Ag
33046-4,Tranquilizers
33047-2,Tranquilizers
33048-0,Eosin-5-Maleimide binding
33049-8,Hypertonic cryohemolysis
3305-0,Acetylsalicylate
33050-6,Pseudocholinesterase phenotype
33051-4,Erythrocytes
33052-2,Leukocytes
33053-0,Protoporphyrin
33054-8,BCL2 Ag
33055-5,Ki-67 nuclear Ag
33056-3,Sezary cells
33057-1,Heinz bodies/100 erythrocytes
33058-9,Ketones
33059-7,Fluorescence polarization
33060-5,chlordiazePOXIDE+Metabolites
33061-3,Homocystine^6H post dose methionine - post CFst
33062-1,Blood group antigens tested for
33063-9,Alkaline phosphatase isoenzymes
33064-7,Chromate
33065-4,Ectopic pregnancy
33066-2,Last menstrual period
33067-0,Conception date
Aug-06,Acetylsalicylate
33068-8,Thoracic area
33069-6,Width.translucency
33070-4,Diameter.inner orbital
33071-2,Length from T6 to L3
33072-0,Gestational age
33073-8,Gestational age
33074-6,Gestational age
33075-3,Gestational age
Jun-07,Alfentanil
33076-1,Gestational age
33077-9,Gestational age
33078-7,Gestational age
33079-5,Gestational age
33080-3,Gestational age
33081-1,Gestational age
33082-9,Gestational age
33083-7,Gestational age
Apr-08,Alphaprodine
33084-5,Gestational age
33085-2,Gestational age
33086-0,Gestational age
33087-8,Gestational age
33088-6,Gestational age
33089-4,Gestational age
33090-2,Gestational age
33091-0,Gestational age
Feb-09,Alphaprodine
33092-8,Gestational age
33093-6,Gestational age
33094-4,Gestational age
33095-1,Gestational age
33096-9,Gestational age
33097-7,Gestational age
33098-5,Gestational age
33099-3,Gestational age
Jan-33,Ampicillin+Sulbactam
3310-0,Alphaprodine
33100-9,Gestational age
33101-7,Gestational age
33102-5,Gestational age
33103-3,Gestational age
33104-1,Gestational age
33105-8,Gestational age
33106-6,Gestational age
33107-4,Gestational age
33108-2,Gestational age
33109-0,Gestational age
33110-8,Gestational age
33111-6,Gestational age
33112-4,Gestational age
33113-2,Gestational age
33114-0,Gestational age
33115-7,Gestational age
33116-5,Gestational age
33117-3,Gestational age
Aug-11,Alphaprodine
33118-1,Gestational age
33119-9,Gestational age
33120-7,Gestational age
33121-5,Gestational age
33122-3,Gestational age
33123-1,Gestational age
33124-9,Gestational age
33125-6,Gestational age
Jun-12,ALPRAZolam
33126-4,Gestational age
33127-2,Gestational age
33128-0,Gestational age
33129-8,Gestational age
33130-6,Gestational age
33131-4,Gestational age
33132-2,Gestational age
33133-0,Gestational age
Apr-13,ALPRAZolam
33134-8,Gestational age
33135-5,Gestational age
33136-3,Gestational age
33137-1,Gestational age
33138-9,Gestational age
33139-7,Body weight
33140-5,Body weight
33141-3,Body weight
Feb-14,Alprenolol
33142-1,Body weight
33143-9,Body weight
33144-7,Body weight
33145-4,Perimeter
33146-2,Perimeter
33147-0,Perimeter
33148-8,Perimeter
33149-6,Perimeter
33150-4,Diameter product
33151-2,Diameter.biparietal
33152-0,Diameter.biparietal outer to outer
33153-8,Diameter.biparietal
33154-6,Diameter.biparietal
33155-3,Diameter.biparietal
33156-1,Diameter.biparietal
33157-9,Diameter.biparietal/Diameter.occipital
33158-7,Diameter.biparietal/Diameter.occipital
Sep-15,Alprenolol
33159-5,Length.crown rump
33160-3,Length.crown rump
33161-1,Length.crown rump
33162-9,Body weight
33163-7,Body weight
33164-5,Long axis
33165-2,Long axis
33166-0,Long axis
Jul-16,Alprenolol
33167-8,Long axis
33168-6,Long axis
33169-4,Long axis
33170-2,Long axis
33171-0,Diameter
33172-8,Perimeter
33173-6,Perimeter
33174-4,Perimeter
May-17,Amantadine
33175-1,Perimeter
33176-9,Perimeter
33177-7,Long axis
33178-5,Occipital frontal diameter
33179-3,Occipital frontal diameter
33180-1,Long axis
33181-9,Diameter.transverse
33182-7,Head circumference/Abdominal circumference
Mar-18,Amdinocillin
33183-5,Body weight growth percentile
33184-3,Body weight growth percentile
33185-0,Body weight growth percentile
33186-8,Body weight growth percentile
33187-6,Body weight growth percentile
33188-4,Body weight growth percentile
33189-2,Body weight growth percentile
331-9,Mezlocillin
33190-0,Body weight growth percentile
Jan-19,Amikacin^peak
33191-8,Diameter product
33192-6,Volume
33193-4,Viable cells/100 cells
33194-2,Viable cells/100 cells
33195-9,Viable cells/100 cells
33196-7,Width.posterior horn
33197-5,Width.anterior horn
33198-3,Diameter.biparietal
33199-1,Body weight growth percentile
33200-7,Amyloid beta 42 peptide
33201-5,Cells.CD11c/100 cells
33202-3,Cells.CD11c/100 cells
33203-1,Amyloid beta 42 peptide
33204-9,Troponin T.cardiac
33205-6,Cells.CD235a/100 cells
33206-4,Cells.CD235a/100 cells
33207-2,Cells.CD235a/100 cells
33208-0,Cells.CD235a/100 cells
Sep-20,Amikacin^random
33209-8,Cells.CD235a/100 cells
33210-6,Transferrin receptor.soluble
33211-4,Interleukin 8
33212-2,N-acetyl-L-aspartate
33213-0,Glycine plas/Glycine CSF
33214-8,Taurine
33215-5,Neutrophils.agranular
33216-3,Platelets.agranular
Jul-21,Amikacin^trough
33217-1,Spermatozoa.agglutinated
33218-9,Bacteria
33219-7,Epithelial cells.squamous
33220-5,Transitional cells
33221-3,Epithelial cells.renal
33222-1,Oval fat bodies (globules)
33223-9,Hyaline casts
33224-7,Granular casts.fine
May-22,aMILoride
33225-4,Granular casts.fine
33226-2,Granular casts.coarse
33227-0,Granular casts.coarse
33228-8,Leukocyte casts
33229-6,Erythrocyte casts
33230-4,Waxy casts
33231-2,Fatty casts
33232-0,Spermatozoa
Mar-23,aMILoride
33233-8,Urate crystals
33234-6,Calcium oxalate crystals
33235-3,Calcium phosphate crystals
33236-1,Bilirubin crystals
33237-9,Sulfonamide crystals
33238-7,Triple phosphate crystals
33239-5,Ammonium urate crystals
33240-3,Cystine crystals
Jan-24,aMILoride
33241-1,Calcium carbonate crystals
33242-9,Fungi.filamentous
33243-7,Trichomonas vaginalis
33244-5,Guanidinoacetate
33245-2,Amylase
33246-0,Ovary Ab
33247-8,Specimen weight
33248-6,Diabetes status
33249-4,Hyperchromia
33250-2,Cells.CD55
33251-0,Monocytes
33252-8,Monocytes
33253-6,Nuclear Ab
33254-4,pH^^adjusted to patient's actual temperature
33255-1,Cell fractions
33256-9,Leukocytes^^corrected for nucleated erythrocytes
33257-7,Cortisol
Aug-25,aMILoride
33258-5,Thyrotropin^30M post dose TRH
33259-3,Thyrotropin^1H post dose TRH
33260-1,Thyrotropin^1.5H post dose TRH
33261-9,Thyrotropin^2H post dose TRH
33262-7,Metamyelocytes/100 leukocytes
33263-5,Metamyelocytes/100 leukocytes
33264-3,Osmol gap
33265-0,Toxoplasma gondii Ab.IgA
Jun-26,Aminocaproate^trough
33266-8,Aspergillus sp Ab
33267-6,Aspergillus sp Ab.IgG
33268-4,Bordetella pertussis.pertussis toxin Ab.IgG
33269-2,Thyrotropin^pre dose TRH
332-7,Mezlocillin
33270-0,Microscopic observation
33271-8,Microscopic observation
33272-6,Cryoglobulin
33273-4,3-Methylglutaconate
Apr-27,Aminopyrine
33274-2,5-Methyltetrahydrofolate
33275-9,7-Dehydrocholesterol
33276-7,Aureobasidium pullulans Ab.IgG.RAST class
33277-5,Acetaminophen+Phenacetin
33278-3,Acetylcholine receptor blocking Ab
33279-1,Acetylcholine receptor modulation Ab
33280-9,Amphetamine+Methamphetamine
33281-7,Curvularia specifera Ab.IgG.RAST class
Feb-28,Aminopyrine
33282-5,Cannabinoids
33283-3,Ictalurus punctatus Ab.IgG.RAST class
33284-1,Clinafloxacin
33285-8,Cytomegalovirus Ab.IgM
33286-6,Fusarium moniliforme Ab.IgG.RAST class
33287-4,Glucose-6-Phosphate dehydrogenase
33288-2,Galactose 1 phosphate uridyl transferase
33289-0,Helminthosporium sp Ab.IgG.RAST class
3329-0,Aminosalicylate
33290-8,Histamine
33291-6,Herpes simplex virus 1 Ab.IgG
33292-4,Herpes simplex virus 1+2 Ab
33293-2,Herpes simplex virus 1+2 Ab.IgG
33294-0,Herpes simplex virus 1+2 Ab.IgM
33295-7,JC virus DNA
33296-5,Actinidia chinensis Ab.IgG.RAST class
33297-3,Mucor racemosus Ab.IgG.RAST class
33298-1,Amdinocillin
33299-9,N-acetyl-L-aspartate
33300-5,Naproxen
33301-3,Norchlordiazepoxide
33302-1,Phthalic anhydride Ab.IgG.RAST class
33303-9,Phoma betae Ab.IgG.RAST class
33304-7,Penicillium notatum Ab.IgG.RAST class
33305-4,Perca spp Ab.IgG.RAST class
33306-2,Phosphatidate Ab
33307-0,Phosphatidylcholine Ab
Aug-30,Amiodarone
33308-8,Phosphatidylethanolamine Ab
33309-6,Phosphatidylinositol Ab
33310-4,Phosphatidylserine Ab
33311-2,Porphyrins
33312-0,Rhizopus nigricans Ab.IgG.RAST class
33313-8,Rheumatoid factor.IgA
33314-6,Rheumatoid factor.IgG
33315-3,Stemphylium botryosum Ab.IgG.RAST class
Jun-31,Amiodarone+Desethylamiodarone
33316-1,Salmonella paratyphi A O Ab
33317-9,Schistosoma sp Ab.IgG
33318-7,Spermatozoa Ab.IgM
33319-5,Toxoplasma gondii Ab.IgE
33320-3,Toxoplasma gondii Ab.IgG
33321-1,Toxoplasma gondii Ab.IgM
33322-9,Toxoplasma gondii DNA
33323-7,Theophylline
Apr-32,Amitriptyline
33324-5,Trichophyton Ab.IgG.RAST class
33325-2,Trypsin
33326-0,Turbidity
33327-8,Varicella zoster virus Ab
33328-6,West Nile virus Ab.IgG
33329-4,West Nile virus Ab.IgG
33330-2,West Nile virus Ab.IgM
33331-0,West Nile virus Ab.IgM
Feb-33,Amitriptyline
33332-8,Linezolid
33333-6,Colistin
33334-4,Quinupristin+Dalfopristin
33335-1,Diphenylmethoxyacetate
33336-9,Toxoplasma gondii Ab.IgM
33337-7,Toxoplasma gondii Ab
33338-5,Zolpidem
33339-3,Zolpidem
3334-0,Amitriptyline
33340-1,Zolpidem
33341-9,Granular casts
33342-7,Epithelial cells
33343-5,Leukotriene E4/Creatinine
33344-3,Leukotriene E4
33345-0,Histrelin
33346-8,Cortisol.free
33347-6,17-Ketosteroids/Creatinine
33348-4,Pemoline
33349-2,Pemoline
333-5,Mezlocillin
33350-0,Lysergate diethylamide
33351-8,11-Dehydro thromboxane beta 2
33352-6,Glucose/Creatinine
33353-4,Alanine aminopeptidase
33354-2,N-acetyl-beta-glucosaminidase
33355-9,Urea nitrogen
33356-7,Coagulation tissue factor induced.factor substitution^1H post incubation after addition of normal plasma
Jul-35,Amitriptyline+Nortriptyline
33357-5,Coagulation tissue factor induced.factor substitution^1H post incubation
33358-3,Protein.monoclonal
33359-1,Branched chain keto-acid dehydrogenase complex
33360-9,Galactose 1 phosphate
33361-7,Neutrophils.band form/100 leukocytes
33362-5,Monocytes/100 leukocytes
33363-3,Normocytic
33364-1,Normochromic
May-36,Amitriptyline^trough >12h post dose
33365-8,Mesothelial cells/100 leukocytes
33366-6,Chloride
33367-4,Lactate dehydrogenase
33368-2,Amylase
33369-0,Lymphocytes.variant/100 leukocytes
33370-8,Lymphocytes.variant/100 leukocytes
33371-6,Lymphocytes.variant/100 leukocytes
33372-4,Blasts/100 leukocytes
Mar-37,Amobarbital
33373-2,Blasts/100 leukocytes
33374-0,Blasts/100 leukocytes
33375-7,Chylomicrons
33376-5,Macrophages/100 leukocytes
33377-3,Blastomyces sp Ab
33378-1,Blastomyces sp Ab
33379-9,Coccidioides sp Ab
33380-7,Coccidioides sp Ab
Jan-38,Amobarbital
33381-5,Coccidioides sp Ab
33382-3,Respiratory syncytial virus Ab
33383-1,Influenza virus A Bangkok Ab
33384-9,Neutrophils.segmented/100 leukocytes
33385-6,Neutrophils.segmented/100 leukocytes
33386-4,Neutrophils.segmented/100 leukocytes
33387-2,Neutrophils.segmented/100 leukocytes
33388-0,Neutrophils.band form/100 leukocytes
33389-8,Monocytes/100 leukocytes
33390-6,Respiratory syncytial virus Ab
33391-4,Coxsackievirus A8 Ab
33392-2,Coxsackievirus A8 Ab
33393-0,Granular casts.coarse
33394-8,Myelin associated glycoprotein Ab
33395-5,Epstein Barr virus capsid Ab
33396-3,Neisseria meningitidis serogroups A+C+w135+Y Ag
33397-1,Neisseria meningitidis serogroups A+C+w135+Y Ag
33398-9,Neisseria meningitidis serogroups A+C+w135+Y Ag
Sep-39,Amobarbital
33399-7,Neisseria meningitidis serogroup B+Escherichia coli K1 Ag
33400-3,Neisseria meningitidis serogroup B+Escherichia coli K1 Ag
33401-1,Neisseria meningitidis serogroup B+Escherichia coli K1 Ag
33402-9,Coccidioides sp Ab
33403-7,Fatty acids.very long chain.C26:0
33404-5,Platelet associated Ab.IgG/Platelet associated Ab.IgM
33405-2,Glucose
33406-0,Candida albicans Ab
Jul-40,Amoxapine
33407-8,Protein
33408-6,Complement C2
33409-4,Lymphocytes.variant/100 leukocytes
33410-2,Chlamydia sp Ab.IgG
33411-0,Hemoglobin.free
33412-8,Blasts/100 leukocytes
33413-6,Lipoprotein.beta/Lipoprotein.total
33414-4,Lipoprotein.pre-beta/Lipoprotein.total
May-41,Amoxapine
33415-1,IgG
33416-9,Coccidioides sp Ab
33417-7,pH
33418-5,Neuronal Ab.IgG
33419-3,Histoplasma sp Ag
33420-1,Histoplasma sp Ag
33421-9,Alkaline phosphatase.other fractions
33422-7,Amphiphysin Ab
Mar-42,Amoxapine
33423-5,Amphiphysin Ab
33424-3,Breath sound qualifier
33425-0,Minute volume setting
33426-8,Inspiratory.pause setting
33427-6,Inspiratory.pause setting
33428-4,Inspiration.duration setting
33429-2,Inspiration.duration setting
334-3,Minocycline
33430-0,Breath termination sensitivity setting
Jan-43,Amoxapine
33431-8,Volume expired max setting
33432-6,Volume expired min setting
33433-4,Pop off setting
33434-2,Volume.expired
33435-9,Inspiratory breath^on ventilator
33436-7,Pressure.drive
33437-5,Oxygen
33438-3,Breaths.mechanical^on ventilator
33439-1,Class
33440-9,Airway suction location
33441-7,Diameter
33442-5,Lavage amount
33443-3,Class
33444-1,Intubation tube depth
33445-8,Tube cuff pressure
33446-6,Temperature.airway setting
33447-4,Temperature.airway
33448-2,Tubing compliance
Sep-44,Amoxicillin
33449-0,Respiratory therapy goal
33450-8,Ventilator adverse event
33451-6,Class
33452-4,Expiratory gas flow.max
33453-2,Expiratory resistance.max
33454-0,Tidal volume.expired/Pressure.peak inspiratory^last 20% of breath on ventilator
33455-7,Appearance
Jun-45,Diethylpropion
33456-5,Endotracheal tube leak
33457-3,Compliance of last 20% of breath/Compliance of entire breath
33458-1,Bilirubin.glucuronidated
33459-9,Toxoplasma gondii Ab.IgA
33460-7,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab.IgG
33461-5,Candida albicans Ab
33462-3,Hepatitis C virus Ab.IgG
33463-1,Hepatitis B virus little e Ab.IgG
Apr-46,Diethylpropion
33464-9,Hepatitis D virus Ag
33465-6,Francisella tularensis Ab.IgG
33466-4,Francisella tularensis Ab.IgM
33467-2,Prealbumin
33468-0,West Nile virus Ab
33469-8,Clostridium tetani Ab.IgG
33470-6,Salmonella paratyphi A O Ab
33471-4,Hydrogen/Expired gas^post XXX challenge
Feb-47,Diethylpropion
33472-2,Acylcarnitine pattern
33473-0,Bile acid pattern
33474-8,Glycosaminoglycans pattern
33475-5,Organic acids pattern
33476-3,Organic acids pattern
33477-1,Organic acids pattern
33478-9,Fatty acids.very long chain pattern
33479-7,Epstein Barr virus early restricted Ab
3348-0,Amphetamines
33480-5,Methane/Expired gas^2H post dose lactose PO
33481-3,Methane/Expired gas^2.5H post dose lactose PO
33482-1,Methane/Expired gas^3H post dose lactose PO
33483-9,Patient symptoms^pre dose lactose PO
33484-7,Patient symptoms^30M post dose lactose PO
33485-4,Patient symptoms^1H post dose lactose PO
33486-2,Patient symptoms^1.5H post dose lactose PO
33487-0,Patient symptoms^2H post dose lactose PO
33488-8,Patient symptoms^2.5H post dose lactose PO
33489-6,Hydrogen+Methane/Expired gas^3H post dose lactose PO
33490-4,Hydrogen/Expired gas^pre dose lactose PO
33491-2,Hydrogen/Expired gas^30M post dose lactose PO
33492-0,Hydrogen/Expired gas^1H post dose lactose PO
33493-8,Hydrogen/Expired gas^1.5H post dose lactose PO
33494-6,Hydrogen/Expired gas^2H post dose lactose PO
33495-3,Hydrogen/Expired gas^2.5H post dose lactose PO
33496-1,Hydrogen/Expired gas^3H post dose lactose PO
33497-9,Methane/Expired gas^pre dose lactose PO
Aug-49,Amphetamines
33498-7,Methane/Expired gas^30M post dose lactose PO
33499-5,Methane/Expired gas^1H post dose lactose PO
335-0,Minocycline
33500-0,Methane/Expired gas^1.5H post dose lactose PO
33501-8,Hydrogen+Methane/Expired gas^30M post dose lactose PO
33502-6,Hydrogen+Methane/Expired gas^1.5H post dose lactose PO
33503-4,Hydrogen+Methane/Expired gas^2H post dose lactose PO
33504-2,Hydrogen+Methane/Expired gas^pre dose lactose PO
33505-9,Hydrogen+Methane/Expired gas^1H post dose lactose PO
Jun-50,Amphetaminil
33506-7,Hydrogen+Methane/Expired gas^2.5H post dose lactose PO
33507-5,Alpha-Phenyl-2-Piperidine acetate
33508-3,HIV 1 p65+p66 Ab
33509-1,Hemoglobin
33510-9,Coccidioides immitis Ab.IgM
33511-7,Appearance
33512-5,Color
33513-3,Specific gravity
Apr-51,Amphetaminil
33514-1,Specimen volume
33515-8,Clarity
33516-6,Reticulocytes.immature/Reticulocytes.total
33517-4,Hemoglobin
33518-2,Platelet aggregation.adenosine diphosphate induced^high dose
33519-0,Platelet aggregation.adenosine diphosphate induced^low dose
33520-8,Platelet aggregation.collagen induced^high dose
33521-6,Platelet aggregation.collagen induced^low dose
Feb-52,Amphetaminil
33522-4,Platelet aggregation.ristocetin induced^high dose
33523-2,Platelet aggregation.ristocetin induced^low dose
33524-0,Coagulum lysis
33525-7,Coagulation thrombin induced.factor substitution^immediately after addition of normal plasma
33526-5,Coagulation reptilase induced.factor substitution^immediately after addition of normal plasma
33527-3,Methadone.long acting metabolite
33528-1,Platelet aggregation.adenosine diphosphate induced^high dose
33529-9,Platelet aggregation.adenosine diphosphate induced^low dose
3353-0,Amphotericin B
33530-7,Platelet aggregation.EPINEPHrine induced
33531-5,Platelet aggregation.arachidonate induced
33532-3,Platelet aggregation.ristocetin induced^high dose
33533-1,Platelet aggregation.ristocetin induced^low dose
33534-9,Coccidioides immitis Ab.IgM
33535-6,Influenza virus A+B Ag
33536-4,Allergen.miscellaneous Ab.IgE.RAST class
33537-2,Gestational age
33538-0,Gestational age
33539-8,Gestational age
33540-6,Gestational age
33541-4,Gestational age
33542-2,Gestational age
33543-0,Gestational age
33544-8,Gestational age
33545-5,Gestational age
33546-3,Perimeter
33547-1,Creatine kinase.aberrant band/Creatine kinase.total
Aug-54,Amphotericin B
33548-9,Lymphocytes.abnormal/100 leukocytes
33549-7,Hantavirus sin nombre Ab
33550-5,Platelet aggregation.ristocetin induced^1500 ug/mL
33551-3,Platelet aggregation.ristocetin induced^1200 ug/mL
33552-1,Platelet aggregation.ristocetin induced^900 ug/mL
33553-9,Platelet aggregation.ristocetin induced^600 ug/mL
33554-7,Platelet aggregation.ristocetin induced^300 ug/mL
May-55,Ampicillin
33555-4,Inactivated poliovirus vaccine dose count in combination vaccine
33556-2,Diameter.biparietal outer to inner
33557-0,Completion status
33558-8,Creatinine renal clearance
33559-6,Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda
33560-4,Benzodiazepines
33561-2,Cannabinoids
33562-0,Ampicillin^peak
Mar-56,Anileridine
33563-8,Pancreatic islet cell Ab.IgG
33564-6,Smith extractable nuclear Ab.IgG
33565-3,Smith extractable nuclear Ab.IgG
33566-1,Sjogrens syndrome-A extractable nuclear Ab
33567-9,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab.IgG
33568-7,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab.IgG
33569-5,Sjogrens syndrome-A extractable nuclear Ab
33570-3,Sjogrens syndrome-B extractable nuclear Ab
Jan-57,Anileridine
33571-1,Jo-1 extractable nuclear Ab.IgG
33572-9,Aureobasidium pullulans Ab.IgG
33573-7,Bactericidal permeability increasing protein Ab.IgG
33574-5,Chlamydia trachomatis I Ab.IgM
33575-2,Chlamydia trachomatis I Ab
33576-0,Francisella tularensis Ab.IgA
33577-8,Rheumatoid factor.IgM
33578-6,Dengue virus Ab
33579-4,Anaplasma phagocytophilum Ab.IgM
33580-2,Anaplasma phagocytophilum Ab.IgG
33581-0,Anaplasma phagocytophilum Ab
33582-8,Cells.CD13+CD33+
33583-6,Sjogrens syndrome-A extractable nuclear Ab.IgG
33584-4,Gastrin^10M pre XXX challenge
33585-1,Uroporphyrin 3 isomer
33586-9,Cells.CD2+CD7+
33587-7,Trichinella sp Ab.IgA
33588-5,Phosphatidylethanolamine Ab
Sep-58,Anileridine
33589-3,Phosphatidylinositol Ab
33590-1,Neuronal nuclear Ab.IgG
33591-9,Neuronal nuclear Ab.IgG
33592-7,Cells.CD10+HLA-DR+
33593-5,Hemoglobin G-Coushatta/Hemoglobin.total
33594-3,Platelet factor 4
33595-0,Cells.CD5+CD20+
33596-8,Cells.CD10+CD20+
Jul-59,Anileridine
33597-6,Borrelia burgdorferi 34kD Ab.IgM
33598-4,Sjogrens syndrome-B extractable nuclear Ab.IgG
33599-2,Amylase
33600-8,Neuronal nuclear Ab
33601-6,Cells.CD23+CD38+
33602-4,Myelin associated glycoprotein Ab.IgG
33603-2,Bactericidal permeability increasing protein Ab.IgG
33604-0,Chlamydia trachomatis I Ab.IgM
May-60,Atenolol
33605-7,Chlamydia trachomatis I Ab
33606-5,Dengue virus Ab
33607-3,Anaplasma phagocytophilum Ab.IgM
33608-1,Anaplasma phagocytophilum Ab.IgG
33609-9,Anaplasma phagocytophilum Ab
33610-7,Sjogrens syndrome-A extractable nuclear Ab.IgG
33611-5,Phosphatidylethanolamine Ab
33612-3,Phosphatidylinositol Ab
Mar-61,Atenolol
33613-1,Sjogrens syndrome-B extractable nuclear Ab.IgG
33614-9,Transferrin.carbohydrate deficient.XXX/Transferrin.total
33615-6,Neuronal nuclear type 1 Ab
33616-4,Cytomegalovirus early Ag
33617-2,Cells.HLA-DR+
33618-0,Coproporphyrin 3/Coproporphyrin 1
33619-8,Deuteroporphyrin.semi-proto
33620-6,Tricarboxylporphyrin 1
Jan-62,Atenolol
33621-4,Tricarboxylporphyrin 3
33622-2,Isotricarboxylporphyrin
33623-0,Pentacarboxylporphyrin I
33624-8,Pentacarboxylporphyrin III
33625-5,Isocoproporphyrin
33626-3,Hematoporphyrin
33627-1,Tenofovir
33628-9,Cidofovir
33629-7,Hepatitis B virus sequencing
33630-5,HIV protease gene mutations detected
33631-3,Cytomegalovirus UL54 gene mutations detected
33632-1,Cytomegalovirus UL54+UL97 gene mutations detected
33633-9,Hepatitis B virus precore TAG mutation
33634-7,Mycobacterium tuberculosis rifAMPin resistance gene
33635-4,PM-SCL extractable nuclear Ab
33636-2,IgA.secretory
33637-0,Phagocytic index
33638-8,Lymphocyte proliferation.phytohemagglutinin stimulation
Sep-63,Anthraquinone
33639-6,Lymphocyte proliferation.Candida albicans stimulation
33640-4,Lymphocyte proliferation.tetanus toxoid stimulation
33641-2,Lymphocyte proliferation.tuberculin stimulation
33642-0,Lymphocyte Ab
33643-8,Limulus amebocyte lysate test
33644-6,A1 Ab
33645-3,A2 Ab
33646-1,Methylenedianiline
Jul-64,Antipyrine
33647-9,Protein.monoclonal/Protein.total
33648-7,Cryoglobulin.rheumatoid factor
33649-5,Cryoglobulin.IgG
33650-3,Cryoglobulin.IgA
33651-1,Cryoglobulin.IgM
33652-9,Cells.CD56/Cells.CD38
33653-7,Beta galactosidase
Apr-65,Antipyrine renal clearance
33654-5,Insulin-like growth factor binding protein 3^1H post XXX challenge
33655-2,Beta-N-acetylhexosaminidase
33656-0,Beta-N-acetylhexosaminidase.B
33657-8,Beta-N-acetylhexosaminidase.A
33658-6,Insulin-like growth factor binding protein 3^2H post XXX challenge
33659-4,Pipecolate/Creatinine
33660-2,HIV 1 p24 Ag
33661-0,Glucosylceramidase
Feb-66,Atenolol
33662-8,Erythrocytes.CD59 deficient/100 Cells.235a
33663-6,Cells.CD59 deficient/100 cells
33664-4,Cells.CD59
33665-1,HTLV I+II Ab band pattern
33666-9,Erythrocytes.dysmorphic
33667-7,Prostate specific Ag.protein bound
33668-5,Erythrocytes
33669-3,Trypsin
3367-0,Atropine
33670-1,Platelet aggregation.collagen induced lag^high dose
33671-9,Platelet aggregation.collagen induced lag^high dose
33672-7,Platelet aggregation.ristocetin+Control PPP induced
33673-5,Coagulation thrombin induced.factor substitution^immediately after addition of protamine sulfate
33674-3,Platelet aggregation.ristocetin+Control PRP induced
33675-0,Microscopic observation
33676-8,Francisella tularensis
33677-6,Francisella tularensis
33678-4,Francisella tularensis Ag
33679-2,Francisella tularensis DNA
336-8,Minocycline
33680-0,Francisella tularensis DNA
33681-8,Francisella tularensis
33682-6,Francisella tularensis
33683-4,Francisella tularensis Ab
33684-2,Francisella tularensis Ab
33685-9,Yersinia pestis
33686-7,Yersinia pestis
33687-5,Yersinia pestis Ag
Aug-68,Azlocillin
33688-3,Yersinia pestis Ag
33689-1,Yersinia pestis Ab
33690-9,Yersinia pestis Ab
33691-7,Yersinia pestis DNA
33692-5,Yersinia pestis DNA
33693-3,Yersinia pestis
33694-1,Clostridium botulinum
33695-8,Clostridium botulinum
Jun-69,Aztreonam
33696-6,Clostridium botulinum toxin
33697-4,Bacillus anthracis Ag
33698-2,Bacillus anthracis
33699-0,Microscopic observation
33700-6,Spore identification
33701-4,Clostridium botulinum toxin A
33702-2,Clostridium botulinum toxin E
33703-0,Clostridium botulinum toxin F
Apr-70,Barbital
33704-8,Clostridium botulinum toxin A+B+E
33705-5,Clostridium botulinum toxin B
33706-3,Yersinia pestis Ab
33707-1,Yersinia pestis Ab
33708-9,Clostridium botulinum toxin
33709-7,Clostridium botulinum toxin A
33710-5,Clostridium botulinum toxin E
33711-3,Clostridium botulinum toxin F
Feb-71,Barbital
33712-1,Clostridium botulinum toxin A+B+E
33713-9,Clostridium botulinum toxin B
33714-7,Francisella tularensis Ab
33715-4,Francisella tularensis Ab
33716-2,Non-gyn cytology study
33717-0,Cervical &or Vaginal cytology study
33718-8,Cytology report
33719-6,Flow cytometry study
3372-0,Barbiturate screen absent
33720-4,Blood bank consult
33721-2,Pathology biopsy report
33722-0,Collection method
33723-8,Specimen length
33724-6,Collection method
33725-3,Tumor site
33726-1,Macroscopic tumor configuration
33727-9,Macroscopic tumor configuration
33728-7,Size.max.dimension
33729-5,Size.additional dimension
33730-3,Resection completeness
33731-1,Histology type
33732-9,Histology grade
33733-7,Sites of distant metastasis
33734-5,Surgical margin tumor involvement.proximal
33735-2,Surgical margin tumor involvement.distant
33736-0,Surgical margin tumor involvement.circumferential
33737-8,Distance of tumor from closest margin
Aug-73,Barbiturate screen absent
33738-6,Closest margin
33739-4,Lymphatic.small vessel.invasion
33740-2,Venous.large vessel.invasion
33741-0,Perineural invasion
33742-8,Tumor border configuration
33743-6,Intratumoral + Peritumoral lymphocytic response
33744-4,Additional pathological findings
33745-1,Polyps
Jun-74,Barbiturate screen present
33746-9,Pathologic findings
33747-7,Number of fragmented pieces
33748-5,Distance from anal verge
33749-3,Distance from anal verge unknown
33750-1,Margins cannot be assessed
33751-9,Surgical margin tumor involvement.lateral
33752-7,Distance of carcinoma from closest lateral margin
Mar-75,Barbiturate screen present
33753-5,Lateral margin location
33754-3,Surgical margin tumor involvement.deep
33755-0,Distance of carcinoma from deep margin
33756-8,Polyp size greatest dimension
33757-6,Polyp size additional dimensions
33758-4,Polyp stalk length
33759-2,Extent of invasion deepest
337-6,Minocycline
33760-0,Surgical margin tumor involvement.mucosal
Jan-76,Barbiturates
33761-8,Venous + Lymphatic small vessel invasion
33762-6,Natriuretic peptide.B prohormone N-Terminal
33763-4,Natriuretic peptide.B prohormone N-Terminal
33764-2,Shiga toxin stx gene
33765-9,Leukocytes
33766-7,Radioactivity^pre dose radioactive cyanocobalamin
33767-5,Acidity.total
33768-3,Leukocyte clumps
33769-1,Mucin clot^15M post incubation
33770-9,Mucin clot^30M post incubation
33771-7,Pl-12 Ab
33772-5,Pl-7 Ab
33773-3,Karyotype
33774-1,Karyotype
33775-8,Cells.CD41a/100 cells
33776-6,Cells.CD235a/100 cells
33777-4,Cells.SmIg/100 cells
33778-2,SmIg Ag
Sep-77,Barbiturates
33779-0,IgG+IgM+IgA heavy chain Ag
33780-8,Galactose 1 phosphate uridyl transferase phenotype
33781-6,Alpha-1-Acid glycoprotein
33782-4,Retinol binding protein
33783-2,Atrial natriuretic factor
33784-0,Bacterial casts
33785-7,Basophils.immature
33786-5,Basophils.immature/100 leukocytes
Jul-78,Bendroflumethiazide
33787-3,Calcitonin^10th specimen post XXX challenge
33788-1,Calcitonin^1st specimen post XXX challenge
33789-9,Calcium^10th specimen post XXX challenge
33790-7,Calcium^1st specimen post XXX challenge
33791-5,Calcium^5th specimen post XXX challenge
33792-3,Calcium^6th specimen post XXX challenge
33793-1,Calcium^7th specimen post XXX challenge
33794-9,Calcium^8th specimen post XXX challenge
May-79,Bendroflumethiazide
33795-6,Calcium^9th specimen post XXX challenge
33796-4,Cotinine
33797-2,Creatine
33798-0,Creatinine
33799-8,DNA double strand Ab.IgG
33800-4,DNA double strand Ab.IgG
33801-2,E selectin
33802-0,Eosinophils.immature
Mar-80,Bendroflumethiazide
33803-8,Eosinophils.immature/100 leukocytes
33804-6,Erythrocyte casts
33805-3,Fructosamine
33806-1,HIV 2 Ab.IgG
33807-9,HIV 2 Ab.IgG
33808-7,Insulin-like growth factor binding protein 3
33809-5,Insulin^10th specimen post XXX challenge
33810-3,Insulin^11th specimen post XXX challenge
Jan-81,Benzfetamine
33811-1,Insulin^12th specimen post XXX challenge
33812-9,Insulin^13th specimen post XXX challenge
33813-7,Insulin^14th specimen post XXX challenge
33814-5,Insulin^15th specimen post XXX challenge
33815-2,Insulin^1st specimen post XXX challenge
33816-0,Insulin^2nd specimen post XXX challenge
33817-8,Insulin^3rd specimen post XXX challenge
33818-6,Insulin^8th specimen post XXX challenge
33819-4,Insulin^9th specimen post XXX challenge
33820-2,Interferon.alpha
33821-0,Interleukin 1 alpha
33822-8,Interleukin 13
33823-6,Interleukin 18
33824-4,Iron
33825-1,Leukocyte casts
33826-9,Lutropin^10th specimen post XXX challenge
33827-7,Lutropin^1st specimen post XXX challenge
33828-5,Lutropin^8th specimen post XXX challenge
Sep-82,Benzfetamine
33829-3,Lutropin^9th specimen post XXX challenge
33830-1,Lymphoblasts
33831-9,Lymphoblasts/100 leukocytes
33832-7,Lymphocytes.immunoblastic
33833-5,Lymphocytes.immunoblastic/100 leukocytes
33834-3,Lymphocytes.plasmacytoid
33835-0,Lymphocytes.plasmacytoid/100 leukocytes
33836-8,Malignant cells
Jul-83,Benzfetamine
33837-6,Malignant cells/100 leukocytes
33838-4,Mannitol
33839-2,Monoblasts
338-4,Miocamycin
33840-0,Monoblasts/100 leukocytes
33841-8,Monocytes.immature
33842-6,Monocytes.immature/100 leukocytes
33843-4,Norepinephrine^standing
33844-2,Norepinephrine^supine
May-84,Benzfetamine
33845-9,Parathyrin.intact^1H post XXX challenge
33846-7,Parathyrin.intact^2H post XXX challenge
33847-5,Parathyrin.intact^30M post XXX challenge
33848-3,Plasma cell precursor
33849-1,Plasma cell precursor/100 leukocytes
33850-9,Plasma cells.immature
33851-7,Progesterone^10th specimen post XXX challenge
Feb-85,Benzodiazepines negative
33852-5,Progesterone^1st specimen post XXX challenge
33853-3,Progesterone^1st specimen post XXX challenge
33854-1,Progesterone^4th specimen post XXX challenge
33855-8,Promonocytes
33856-6,Sezary cells
33857-4,Sezary cells/100 leukocytes
33858-2,Somatotropin
33859-0,Somatotropin/Creatinine
3386-0,Benzodiazepines negative
33860-8,Somatotropin/Creatinine
33861-6,Starch granules
33862-4,Waxy casts
33863-2,Cystatin C
33864-0,Elastase.leukocyte
33865-7,Staphylococcus aureus enterotoxin
33866-5,HIV 1 Ab
33867-3,Blood velocity/Blood velocity 2
33868-1,Blood flow velocity.max.stenosis.internal carotid artery/Blood flow velocity.max.unobstructed.common carotid artery
33869-9,Blood flow velocity.max.kidney artery/Blood flow velocity.max.aorta
33870-7,Bilirubin
33871-5,Xylose^1H post 5 g xylose PO
33872-3,Cystine
33873-1,DOPamine/Creatinine
33874-9,EPINEPHrine/Creatinine
33875-6,Oligosaccharides pattern
33876-4,Sulfocysteine/Creatinine
33877-2,Tetrahydrobiopterin/Biopterin
Aug-87,Benzodiazepines positive
33878-0,Blood flow rate.mean
33879-8,Protein.monoclonal
33880-6,Coagulation tissue factor induced.factor substitution^2H post incubation after addition of normal plasma
33881-4,Coagulation tissue factor induced.factor substitution^immediately after 1:4 addition of normal plasma
33882-2,Collection date
33883-0,Coagulation tissue factor induced.factor substitution^1H post incubation after 1:4 addition of normal plasma
33884-8,Coagulation tissue factor induced.factor substitution^1H post incubation after addition of normal plasma
33885-5,Coagulation tissue factor induced.factor substitution^2H post incubation after 1:4 addition of normal plasma
Jun-88,Benzodiazepines positive
33886-3,Coagulation tissue factor induced.factor substitution^2H post incubation after 1:4 addition of normal plasma
33887-1,Coagulation tissue factor induced.factor substitution^2H post incubation after addition of normal plasma
33888-9,Coagulation surface induced.factor substitution^1H post incubation after 1:4 addition of normal plasma
33889-7,Coagulation surface induced.factor substitution^2H post incubation after 1:4 addition of normal plasma
33890-5,Coagulation surface induced.factor substitution^2H post incubation after addition of normal plasma
33891-3,Coagulation surface induced.factor substitution^2H post incubation after addition of normal plasma
33892-1,Coagulation surface induced.factor substitution^immediately after 1:4 addition of normal plasma
33893-9,Karyotype
Apr-89,Benzodiazepines
33894-7,Coagulation tissue factor induced.factor substitution^1H post incubation after 1:4 addition of normal plasma
33895-4,Coagulation tissue factor induced.factor substitution^2H post incubation
33896-2,Orientia tsutsugamushi Ab.IgM
33897-0,Orientia tsutsugamushi Ab.IgM
33898-8,Bilirubin.glucuronidated+Bilirubin.non-glucuronidated
33899-6,Bilirubin.glucuronidated+Bilirubin.non-glucuronidated
33900-2,Fetal cell screen
33901-0,Gestational age
Feb-90,Benzodiazepines
33902-8,Immune complex
33903-6,Ketones
33904-4,Neisseria gonorrhoeae rRNA
33905-1,Trichomonas sp
33906-9,Prolactin^30M post 200 ug TRH IV
33907-7,Prolactin^1H post 200 ug TRH IV
33908-5,Prolactin^1.5H post 200 ug TRH IV
33909-3,Prolactin^2H post 200 ug TRH IV
3391-0,Benzoylecgonine
33910-1,Rheumatoid factor
33911-9,Complement C1r actual/Normal
33912-7,Complement C1s actual/Normal
33913-5,pH
33914-3,Glomerular filtration rate/1.73 sq M.predicted
33915-0,Anabasine
33916-8,Trans-3-Hydroxycotinine
33917-6,Nornicotine
33918-4,Acetoacetate
33919-2,Ampicillin^trough
339-2,Miocamycin
33920-0,S Ab
33921-8,Signal recognition particle Ab
33922-6,Wasp venom Ab.IgE.RAST class
33923-4,Hemosiderin
33924-2,Neuronal nuclear type 3 Ab
33925-9,Purkinje cell cytoplasmic type 2 Ab
33926-7,Purkinje cell cytoplasmic type Tr Ab
33927-5,Amphiphysin Ab
Aug-92,Benzoylecgonine
33928-3,Efavirenz
33929-1,Tacrolimus^trough
33930-9,Coagulation surface induced.hexagonal phase phospholipid
33931-7,Lymphocyte proliferation.Borrelia burgdorferi stimulation
33932-5,Borrelia burgdorferi Ab
33933-3,Glutaraldehyde Ab.IgE
33934-1,Methylmethacrylate Ab.IgE
33935-8,Cyclic citrullinated peptide Ab.IgG
Jun-93,Benzoylecgonine
33936-6,Homocystine.free
33937-4,Homocystine.free
33938-2,Interleukin 5
33939-0,Interleukin 2
33940-8,Herpes virus 6 DNA
33941-6,Herpes virus 6 DNA
33942-4,Herpes virus 6 DNA
33943-2,Chlamydophila pneumoniae+Chlamydophila psittaci DNA
Apr-94,Benzoylecgonine
33944-0,Immunoglobulin light chains.lambda.free
33945-7,Brucella abortus Ab
33946-5,Ziprasidone
33947-3,Clostridioides difficile toxin Ab.Neut
33948-1,IgG/Creatinine
33949-9,Potassium/Creatinine
33950-7,Magnesium/Creatinine
Jan-95,Cocaine
33951-5,Sodium/Creatinine
33952-3,Immune complex.IgM
33953-1,Immune complex.IgA
33954-9,Immune complex.IgG
33955-6,cycloSPORINE.monoclonal
33956-4,cycloSPORINE.polyclonal
33957-2,Normoblasts/100 blasts
33958-0,Cholecalciferol
33959-8,Procalcitonin
33960-6,Immune complex.IgE
33961-4,Sulthiame
33962-2,Melanoma inhibitory activity protein
33963-0,Granulocytes/100 leukocytes
33964-8,SARS coronavirus Urbani RNA
33965-5,SARS coronavirus Urbani RNA
33966-3,SARS coronavirus Urbani RNA
33967-1,SARS coronavirus Urbani RNA
33968-9,SARS coronavirus Urbani Ab
Sep-96,Cocaine
33969-7,SARS coronavirus Urbani Ab
33970-5,SARS coronavirus Urbani Ab
33971-3,SARS coronavirus Urbani Ab
33972-1,SARS coronavirus Urbani Ab
33973-9,SARS coronavirus Urbani Ab
33974-7,SARS coronavirus Urbani Ab
33975-4,SARS coronavirus Urbani RNA
33976-2,Plasminogen activator inhibitor 1 Ag
Jul-97,Cocaine
33977-0,F little y super little a Ab
33978-8,BK virus DNA
33979-6,Voltage-gated calcium channel N type binding Ab
33980-4,Voltage-gated calcium channel PQ type binding Ab
33981-2,TBP gene.CAG repeats
33982-0,Juglans california pollen Ab.IgE
33983-8,U1 small nuclear ribonucleoprotein Ab.IgG
33984-6,Coagulation factor X activity actual/Normal
May-98,Cocaine
33985-3,Bartonella henselae DNA
33986-1,Bartonella henselae DNA
33987-9,Heparin cofactor II actual/Normal
33988-7,Thymidine phosphorylase
33989-5,quiNINE induced platelet Ab
33990-3,Normoblasts/100 leukocytes
33991-1,Cells.CD79b/100 cells
33992-9,Pain trigger point
Mar-99,Benzthiazide
33993-7,Subject tooth
33994-5,Reference tooth
33995-2,Tooth development evaluation
33996-0,Tooth size discrepancy
33997-8,Tooth size discrepancy
33998-6,Tooth size discrepancy
33999-4,Status
04-Mar,Almecillin
340-0,Miocamycin
34000-0,Treatment urgency
34001-8,Etiological factors.dental
34002-6,Tooth position
34003-4,Tooth impaction
34004-2,Tooth impaction position
34005-9,Tooth mobility
34006-7,Orthodontic treatment
34007-5,Type of dentition
34008-3,Status
Sep-00,Benzthiazide
34009-1,Tooth previously extracted
34010-9,Time since last tooth extraction
34011-7,Previous dental surgery
34012-5,Previous dental appliance wear
34013-3,Periodontal evaluation
34014-1,Periodontal screening and recording special finding
34015-8,Furcation classification
34016-6,Dental plaque
Jul-01,Benzthiazide
34017-4,Tooth out of bone/Tooth in bone
34018-2,Bone density
34019-0,Bone volume
34020-8,First bone reference
34021-6,Second bone reference
34022-4,Bone adequate
34023-2,Bone resorption pattern
34024-0,Reason tooth lost
May-02,Bolasterone
34025-7,Previous dental prosthesis wear
34026-5,Dental prosthesis
34027-3,Age
34028-1,Well maintained
34029-9,Prosthesis complaint
34030-7,Reason for prosthesis complaint
34031-5,Denture base evaluation
34032-3,Denture teeth evaluation
Mar-03,Bolasterone
34033-1,Denture occlusion
34034-9,Alveolar ridge trauma
34035-6,Alveolar ridge pathology
34036-4,Keratinized gingiva
34037-2,Size
34038-0,Problematic maxillary tuberosity
34039-8,Edentulous ridge relationship
34040-6,Edentulous ridge relationship
Jan-04,Bolasterone
34041-4,Partial edentulism classification
34042-2,Partially endentulous maxillectomy classification
34043-0,Dental examination method
34044-8,Magnification instrument
34045-5,Oral evaluation exam
34046-3,Medical history contribution
34047-1,Dental history contribution
34048-9,Dental material used &or Proposed
34049-7,Number of impressions
34050-5,Bone height
34051-3,Bone width
34052-1,Bone length
34053-9,Xylose^2H post 5 g xylose PO
34054-7,Thyrotropin^pre or post dose TRH
34055-4,Lutropin^pre or post XXX challenge
34056-2,Glucose^pre or post dose arginine
34057-0,Glucose^pre or post dose cloNIDine
Aug-05,Bromazepam
34058-8,Glucose^pre or post dose glucagon
34059-6,Glucose^pre or post dose glucose
34060-4,Glucose^pre or post dose insulin
34061-2,Somatotropin^pre or post dose arginine
34062-0,Somatotropin^pre or post dose cloNIDine
34063-8,Somatotropin^pre or post dose glucagon
34064-6,Somatotropin^pre or post dose insulin
34065-3,Cortisol^pre or post dose corticotropin
Jun-06,Bromazepam
34066-1,Boxed warning section
34067-9,Indications & usage section
34068-7,Dosage & administration section
34069-5,How supplied section
34070-3,Contraindications section
34071-1,Warnings section
34072-9,General precautions section
34073-7,Drug interactions section
Apr-07,Brompheniramine
34074-5,Drug &or laboratory test interactions section
34075-2,Laboratory tests section
34076-0,Information for patients section
34077-8,Teratogenic effects section
34078-6,Nonteratogenic effects section
34079-4,Labor & delivery section
34080-2,Nursing mothers section
34081-0,Pediatric use section
Feb-08,Brompheniramine
34082-8,Geriatric use section
34083-6,Carcinogenesis & mutagenesis & impairment of fertility section
34084-4,Adverse reactions section
34085-1,Controlled substance section
34086-9,Abuse section
34087-7,Dependence section
34088-5,Overdosage section
34089-3,Description section
3409-0,Bumetanide
34090-1,Clinical pharmacology section
34091-9,Animal pharmacology &or toxicology section
34092-7,Clinical studies section
34093-5,References section
34094-3,Admission history and physical note
34095-0,Comprehensive history and physical note
34096-8,Comprehensive history and physical note
34097-6,Conference note
34098-4,Conference note
34099-2,Consultation note
34100-8,Consultation note
34101-6,Consultation note
34102-4,Consultation note
34103-2,Consultation note
34104-0,Consultation note
34105-7,Discharge summary note
34106-5,Discharge summary note
34107-3,Education note
Aug-10,Bumetanide
34108-1,Note
34109-9,Note
34110-7,Note
34111-5,Note
34112-3,Note
34113-1,Note
34114-9,Group counseling note
34115-6,History and physical note
Jun-11,Bumetanide
34116-4,History and physical note
34117-2,History and physical note
34118-0,Initial evaluation note
34119-8,Initial evaluation note
34120-6,Initial evaluation note
34121-4,Interventional procedure note
34122-2,Procedure note
34123-0,Preoperative evaluation and management note
Apr-12,Bupivacaine
34124-8,Progress note
34125-5,Progress note
34126-3,Progress note
34127-1,Progress note
34128-9,Progress note
34129-7,Progress note
34130-5,Progress note
34131-3,Progress note
Feb-13,Buprenorphine
34132-1,Progress note
34133-9,Summary of episode note
34134-7,Supervisory note
34135-4,Supervisory note
34136-2,Supervisory note
34137-0,Surgical operation note
34138-8,Targeted history and physical note
34139-6,Note
3414-0,Buprenorphine
34140-4,Transfer of care referral note
34141-2,Blood flow rate.max
34142-0,Paraneoplastic Ab
34143-8,HLA-DQ locus 2
34144-6,HLA-DR W locus 2
34145-3,Human antichimeric Ab
34146-1,Neopterin
34147-9,Treponema pallidum Ab.IgG+IgM
34148-7,Borrelia burgdorferi Ab.IgG+IgM
34149-5,N-acetyl-L-aspartate
34150-3,Mycoplasma fermentans DNA
34151-1,Cells.CD10+CD25+
34152-9,Herpes simplex virus 1+2 Ab.IgM
34153-7,Influenza virus A Ab
34154-5,Influenza virus B Ab
34155-2,Guanidinoacetate/Creatinine
34156-0,Insulin.bound
Jul-15,Buprenorphine
34157-8,little e Ab
34158-6,Histoplasma capsulatum Ag
34159-4,Tau protein
34160-2,Creatine kinase
34161-0,Cancer Ag 72-4
34162-8,Hepatitis C virus Ab.IgG band pattern
34163-6,Oxygen content
34164-4,N-Acetylglucosamine-6-Sulfatase
May-16,Buprenorphine
34165-1,Granulocytes.immature
34166-9,Microscopic observation
34167-7,Platelets.large
34168-5,Sulfocysteine/Creatinine
34169-3,Fatty acids.very long chain
34170-1,Biopterin
34171-9,Histoplasma capsulatum Ag
34172-7,Streptococcus pneumoniae Danish serotype 6B Ab
Mar-17,Butabarbital
34173-5,Mixed cellular casts
34174-3,Hemoglobin casts
34175-0,Analgesics
34176-8,Tricyclic antidepressants
34177-6,Opiates
34178-4,Phenothiazines
34179-2,Herpes virus 6 Ab.IgG
341-8,Miocamycin
34180-0,Ethanol
Jan-18,Butabarbital
34181-8,Methanol
34182-6,Methaqualone metabolite
34183-4,Beta globulin/Protein.total
34184-2,Gamma globulin/Protein.total
34185-9,methIMAzole
34186-7,Para aminobenzoate
34187-5,DNA double strand Ab
34188-3,Erythrocytes.nucleated
34189-1,Coagulation surface induced.factor substitution^30M post incubation after addition of normal plasma
34190-9,Thermoactinomyces vulgaris Ab.IgG
34191-7,Beta glucuronidase
34192-5,Beta galactosidase
34193-3,SMPD1 gene mutations tested for
34194-1,Fructose
34195-8,little e Ab
34196-6,C Ab
34197-4,Salicylamide^trough
34198-2,Salicylamide^peak
Sep-19,Butabarbital
34199-0,Neutrophils.hypersegmented
34200-6,Erythrocytes.nucleated
34201-4,Cytomegalovirus
34202-2,Linezolid
34203-0,SCA12 gene.CAG repeats
34204-8,11-Deoxycortisol
34205-5,11-Deoxycortisol
34206-3,11-Deoxycortisol/Creatinine
Jul-20,Butalbital
34207-1,11-Hydroxyandrosterone
34208-9,11-Hydroxyandrosterone
34209-7,11-Hydroxyandrosterone/Creatinine
34210-5,11-Hydroxyetiocholanolone
34211-3,11-Hydroxyetiocholanolone
34212-1,11-Hydroxyetiocholanolone/Creatinine
34213-9,11-Ketoandrosterone
34214-7,11-Ketoandrosterone
May-21,Butalbital
34215-4,11-Ketoandrosterone/Creatinine
34216-2,11-Ketoetiocholanolone
34217-0,11-Ketoetiocholanolone
34218-8,17-Hydroxycorticosteroids
34219-6,17-Hydroxycorticosteroids/Creatinine
34220-4,17-Hydroxyprogesterone
34221-2,17-Hydroxyprogesterone/Creatinine
34222-0,17-Ketosteroids
Mar-22,Caffeine
34223-8,17-Ketosteroids/Creatinine
34224-6,3-Alpha-Androstanediol glucuronide
34225-3,3-Alpha-Androstanediol glucuronide
34226-1,3-Alpha-Androstanediol glucuronide/Creatinine
34227-9,Acylcarnitine
34228-7,Acylcarnitine
34229-5,Acylcarnitine/Creatinine
34230-3,Adenosine monophosphate.cyclic
Jan-23,Caffeine
34231-1,Aldosterone/Creatinine
34232-9,Pseudallescheria boydii Ab.IgG
34233-7,Alternaria sp Ab.IgG
34234-5,Ampicillin Ab.IgG
34235-2,Amylase/Creatinine
34236-0,Androstenediol
34237-8,Androstenediol
34238-6,Androstenediol/Creatinine
34239-4,Androstenedione
34240-2,Androstenedione/Creatinine
34241-0,Androsterone
34242-8,Androsterone
34243-6,Androsterone/Creatinine
34244-4,Arsenic
34245-1,Arsenic
34246-9,Ascorbate
34247-7,Ascorbate
34248-5,Ascorbate/Creatinine
Sep-24,Caffeine
34249-3,Asialoganglioside GM2 Ab
34250-1,Betula verrucosa recombinant (rBet v) 4 Ab.IgE
34251-9,Borrelia garinii Ab.IgG
34252-7,Borrelia garinii Ab.IgM
34253-5,C peptide
34254-3,Cadmium
34255-0,Cadmium
Jun-25,Cannabinoids
34256-8,Cancer Ag 50
34257-6,Carnitine
34258-4,Carnitine.free (C0)
34259-2,Carnitine.free (C0)
342-6,Moxalactam
34260-0,Catecholamines
34261-8,Catecholamines
34262-6,Catecholamines/Creatinine
34263-4,Cefaclor Ab.IgG
Apr-26,Tetrahydrocannabinol
34264-2,Chlamydia sp Ab.IgA
34265-9,Chloride/Creatinine
34266-7,Citrate
34267-5,Cladosporium sp Ab.IgG
34268-3,Cobalt
34269-1,Cobalt
34270-9,Cobalt/Creatinine
34271-7,Collagen crosslinked N-telopeptide
Feb-27,Cannabinoids
34272-5,Collagen crosslinked N-telopeptide/Creatinine
34273-3,Copper
34274-1,Creatine
34275-8,Creatine/Creatinine
34276-6,Cysteate
34277-4,Cysteine
34278-2,Cystine
34279-0,Dehydroepiandrosterone
3428-0,Canrenone
34280-8,Dehydroepiandrosterone sulfate
34281-6,Dehydroepiandrosterone sulfate
34282-4,Dehydroepiandrosterone sulfate/Creatinine
34283-2,Dehydroepiandrosterone/Creatinine
34284-0,Delta aminolevulinate
34285-7,Ehrlichia sp Ab
34286-5,Estradiol
34287-3,Estradiol
34288-1,Estradiol.unconjugated
34289-9,Estradiol.unconjugated
34290-7,Estradiol.unconjugated/Creatinine
34291-5,Estradiol/Creatinine
34292-3,Estriol
34293-1,Estriol/Creatinine
34294-9,Estrogen
34295-6,Estrogen
34296-4,Estrogen/Creatinine
34297-2,Estrone
Aug-29,Canrenone
34298-0,Estrone
34299-8,Estrone/Creatinine
34300-4,Ethanolamine
34301-2,Etiocholanolone
34302-0,Etiocholanolone
34303-8,Etiocholanolone/Creatinine
34304-6,Fluoride
34305-3,Flupenthixol
Jun-30,Canrenone
34306-1,Follitropin
34307-9,Fructose
34308-7,Fructose
34309-5,Fructose/Creatinine
34310-3,Galactose
34311-1,Galactose
34312-9,Glucose/Creatinine
34313-7,Heptacarboxylporphyrin
Apr-31,carBAMazepine
34314-5,Heptacarboxylporphyrin
34315-2,Hexacarboxylporphyrins
34316-0,Histamine
34317-8,Histamine
34318-6,HTLV I+II Ab
34319-4,Inhibin B
34320-2,Iodine
34321-0,Iodine/Creatinine
Feb-32,carBAMazepine
34322-8,Iron/Creatinine
34323-6,Lactate
34324-4,Lactate
34325-1,Lead
34326-9,Lead/Creatinine
34327-7,Lead/Creatinine
34328-5,Levodopa
34329-3,Fat
3433-0,carBAMazepine.free
34330-1,Lithium
34331-9,Lithium/Creatinine
34332-7,Lormetazepam
34333-5,Lutropin
34334-3,Lutropin/Creatinine
34335-0,Lysozyme
34336-8,Lysozyme/Creatinine
34337-6,Mercury
34338-4,Mercury
34339-2,Metanephrine
343-4,Moxalactam
34340-0,Methionine sulfoxide
34341-8,Mianserin+Normianserin
34342-6,Niacin
34343-4,Nickel
34344-2,N-methylhistamine
34345-9,N-methylhistamine
34346-7,N-methylhistamine/Creatinine
34347-5,Normetanephrine
Aug-34,Carbenicillin
34348-3,Normetanephrine/Creatinine
34349-1,Oxalate
34350-9,Oxalate/Creatinine
34351-7,Pentacarboxylporphyrins
34352-5,Pentacarboxylporphyrins
34353-3,Pentacarboxylporphyrins/Creatinine
34354-1,Phosphate/Creatinine
May-35,Carboxy tetrahydrocannabinol
34355-8,Phosphoethanolamine
34356-6,Porphobilinogen
34357-4,Porphobilinogen/Creatinine
34358-2,Pregnanediol
34359-0,Pregnanediol/Creatinine
34360-8,Pregnanetriol
34361-6,Pregnanetriol/Creatinine
34362-4,Pregnanetriolone
Mar-36,Carboxy tetrahydrocannabinol
34363-2,Pregnanetriolone
34364-0,Pregnanetriolone/Creatinine
34365-7,Primidone+PHENobarbital
34366-5,Protein/Creatinine
34367-3,Pyridinoline
34368-1,Pyridinoline
34369-9,Salmonella paratyphi C H Ab
34370-7,Salmonella paratyphi C O Ab
Jan-37,Carisoprodol
34371-5,Salmonella typhi H Ab
34372-3,Salmonella typhi O Ab
34373-1,Serotonin
34374-9,Serotonin/Creatinine
34375-6,Streptokinase Ab
34376-4,Strongyloides sp Ab.IgG
34377-2,Sulthiame
34378-0,Teicoplanin^peak
34379-8,Teicoplanin^trough
34380-6,Testosterone/Creatinine
34381-4,Thioguanine
34382-2,Treponema pallidum Ab
34383-0,Trypanosoma brucei Ab
34384-8,Tryptophan
34385-5,Urate/Creatinine
34386-3,Venlafaxine
34387-1,Zinc
34388-9,Zinc
Sep-38,Cathine
34389-7,Zinc/Creatinine
34390-5,Human OTC drug label
34391-3,Human prescription drug label
34392-1,(Malus sylvestris+Musa spp+Prunus persica+Pyrus communis) Ab.IgE
34393-9,(Actinidia chinensis+Beef+Pandalus borealis+Sesamum indicum) Ab.IgE
34394-7,(Arachis hypogaea+Cow milk+Egg white+Mustard) Ab.IgE
34395-4,(Corylus avellana+Gadus morhua+Glycine max+Triticum aestivum) Ab.IgE
34396-2,11-Ketoetiocholanolone/Creatinine
Jul-39,Cathine
34397-0,Amilsulpride
34398-8,Biotin
34399-6,Buccal mucosa Ab
34400-2,Colon Ab
34401-0,Complement C3d
34402-8,Coproporphyrin/Hemoglobin
34403-6,Cytomegalovirus Ab avidity
34404-4,Cytoskeleton Ab
May-40,Cathine
34405-1,Escitalopram
34406-9,Exocrine pancreas Ab
34407-7,Interleukin 1
34408-5,Interleukin 2 receptor.soluble
34409-3,Keratin Ab
34410-1,Saccharopolyspora rectivirgula Ab.IgG
34411-9,Mitochondria M4 Ab
34412-7,Mitochondria M9 Ab
Mar-41,Cefamandole
34413-5,Moclobemide
34414-3,Normianserin
34415-0,Normirtazapine
34416-8,Nucleosome Ab
34417-6,Protoporphyrin.zinc
34418-4,Protoporphyrin
34419-2,Reticulocytes.mature/Reticulocytes.total
344-2,Moxalactam
34420-0,Reticulocytes.mid/Reticulocytes.total
Jan-42,ceFAZolin
34421-8,Rubella virus Ab.IgG avidity
34422-6,Toxoplasma gondii Ab.IgG avidity
34423-4,Salmonella enteritidis H Ab
34424-2,Salmonella typhimurium H Ab
34425-9,Betula verrucosa recombinant (rBet v) 1+2 Ab.IgE
34426-7,cycloSPORINE.monoclonal
34427-5,Methadone.R
34428-3,Phleum pratense recombinant (rPhl p) 12 Ab.IgE
34429-1,Phleum pratense recombinant (rPhl p) 1+5b Ab.IgE
34430-9,Phleum pratense recombinant (rPhl p) 7+12 Ab.IgE
34431-7,Salmonella enteritidis H Ab
34432-5,Salmonella typhimurium H Ab
34433-3,Bartonella henselae Ab
34434-1,Lutropin/Follitropin
34435-8,Protein pattern
34436-6,Diethylene glycol
34437-4,Coxsackievirus B Ab
34438-2,Apolipoprotein E phenotype
Sep-43,ceFAZolin
34439-0,Natural killer cell function
34440-8,Interpretation
34441-6,Spermatozoa
34442-4,Bilirubin.glucuronidated/Bilirubin.total
34443-2,ZOLMitriptan
34444-0,Acarboxyprothrombin
34445-7,Leukocytes
34446-5,Erythrocytes
Jul-44,Cefonicid
34447-3,Cache valley virus RNA
34448-1,Cache valley virus RNA
34449-9,Eastern equine encephalitis virus RNA
34450-7,Eastern equine encephalitis virus RNA
34451-5,Herpes simplex virus DNA
34452-3,Jamestown canyon virus RNA
34453-1,Jamestown canyon virus RNA
Apr-45,Cefoperazone
34454-9,La Crosse virus RNA
34455-6,La Crosse virus RNA
34456-4,Powassan virus RNA
34457-2,Powassan virus RNA
34458-0,Saint Louis encephalitis virus RNA
34459-8,Saint Louis encephalitis virus RNA
34460-6,West Nile virus RNA
34461-4,West Nile virus RNA
Feb-46,Cefotaxime
34462-2,California serogroup virus RNA
34463-0,California serogroup virus RNA
34464-8,B Ab
34465-5,B Ab
34466-3,Carbohydrates
34467-1,Cholesterol.in chylomicrons
34468-9,Clostridioides difficile toxin A+B
34469-7,Leukocytes
3447-0,cefoTEtan
34470-5,Giardia lamblia Ag
34471-3,Calcium bilirubinate crystals
34472-1,Cholesterol crystals
34473-9,Neutrophils.vacuolated+Segmented
34474-7,ABO & Rh group
34475-4,Cells.CD4+CD45RO+
34476-2,Cortisol^1H post 250 ug corticotropin
34477-0,Blood group antibodies identified
34478-8,Blood group antibodies identified
34479-6,Blood group antibodies identified
34480-4,Blood group antibodies identified
34481-2,Blood group antibodies identified
34482-0,Blood group antibodies identified
34483-8,Medications.report request
34484-6,Time administration started
34485-3,Avian paramyxovirus 1.exotic RNA
34486-1,Avian paramyxovirus 1 RNA
34487-9,Influenza virus A RNA
Aug-48,cefOXitin
34488-7,Avian paramyxovirus 1 subtype
34489-5,TOR1A gene deletion
34490-3,MT-TK gene targeted mutation analysis
34491-1,PRF1 gene targeted mutation analysis
34492-9,NOTCH3 gene targeted mutation analysis
34493-7,PRF1 gene targeted mutation analysis
34494-5,SCA10 gene.ATTCT repeats
34495-2,TOR1A gene targeted mutation analysis
Jun-49,cefTAZidime
34496-0,Chromosome 7 uniparental disomy
34497-8,SPINK1 gene targeted mutation analysis
34498-6,ACADS gene targeted mutation analysis
34499-4,GPC3 gene targeted mutation analysis
34500-9,SHOX gene targeted mutation analysis
34501-7,HADHA gene.c.1528G>C
34502-5,VHL gene targeted mutation analysis
34503-3,Chromosome 15 uniparental disomy
Apr-50,Ceftizoxime
34504-1,GJB6 gene targeted mutation analysis
34505-8,NPDC gene targeted mutation analysis
34506-6,EGR2 gene targeted mutation analysis
34507-4,PRX gene targeted mutation analysis
34508-2,PANK2 gene targeted mutation analysis
34509-0,UGT1A1 gene targeted mutation analysis
34510-8,SDHB gene targeted mutation analysis
34511-6,SDHD gene targeted mutation analysis
Feb-51,cefTRIAXone
34512-4,NPHS1 gene targeted mutation analysis
34513-2,NPHS1 gene targeted mutation analysis
34514-0,SLC22A18 gene targeted mutation analysis
34515-7,GLA gene targeted mutation analysis
34516-5,SPAST gene targeted mutation analysis
34517-3,CATCH22 syndrome gene targeted mutation analysis
34518-1,SMPD1 gene targeted mutation analysis
34519-9,HFE gene targeted mutation analysis
3452-0,Cefuroxime.parenteral
34520-7,Carbon dioxide
34521-5,Carnitine acyltransferase
34522-3,Phosphorylase kinase
34523-1,Succinate semialdehyde dehydrogenase
34524-9,Neutrophils.band form
34525-6,Erythrocytes.lytic resistant
34526-4,Sialooligosaccharides/Creatinine
34527-2,"Hemogram, Platelets, Differential & Reticulocyte panel"
34528-0,PT panel
34529-8,PT & aPTT panel
34530-6,ABO & Rh group panel
34531-4,Blood type & Crossmatch panel
34532-2,Blood type & Indirect antibody screen panel
34533-0,Odor
34534-8,12 lead EKG panel
34535-5,Microalbumin/Creatinine ratio panel
34536-3,Fluid intake & output panel
34537-1,Fluid intake & output panel
Aug-53,Cephalexin
34538-9,Orthostatic blood pressure
34539-7,Protein fractions panel
34540-5,Phenytoin free & total panel
34541-3,ACTH stimulation test using IM corticosteroids
34542-1,ACTH stimulation test using IV corticosteroids
34543-9,Bilirubin direct & total panel
34544-7,Complement C3 & C4 panel
34545-4,carBAMazepine free & total panel
Jun-54,Cephalothin
34546-2,Protein & Glucose panel
34547-0,Complement profile panel
34548-8,Sodium & Potassium panel
34549-6,Follitropin & Lutropin panel
34550-4,Immunoglobulin panel
34551-2,Catecholamines 3 panel
34552-0,Cardiac 2D echo panel
Mar-55,Chloramphenicol
34553-8,Orthostatic blood pressure panel
34554-6,Electrolytes 1998 & Venous pH panel
34555-3,Creatinine renal clearance panel
34556-1,Cell count panel
34557-9,Cell count & Differential panel
34558-7,Cell count panel
34559-5,Cell count panel
34560-3,Cell count & Differential panel
Jan-56,chlordiazePOXIDE
34561-1,Cell count panel
34562-9,Cell count & Differential panel
34563-7,Cell count panel
34564-5,Cell count & Differential panel
34565-2,"Vital signs, weight & height panel"
34566-0,Vital signs with method details panel
34567-8,Cell count & Differential panel
34568-6,Alkaline phosphatase
34569-4,Coagulation dilute Russell viper venom induced.factor substitution^immediately after 1:2 addition of normal plasma
34570-2,Lupus anticoagulant neutralization.high phospholipid.factor substitution^immediately after 1:2 addition of normal plasma
34571-0,Coagulation surface induced.lupus sensitive
34572-8,Coagulation surface induced.lupus sensitive
34573-6,Coagulation surface induced.lupus sensitive.factor substitution^immediately after 1:2 addition of normal plasma
34574-4,Path report.final diagnosis
34575-1,8-Hydroxyloxapine
34576-9,Adenovirus Ab
34577-7,Apheresis.therapeutic
34578-5,Barbiturates
Sep-57,chlordiazePOXIDE
34579-3,Basophils
34580-1,Blastomyces dermatitidis Ab
34581-9,Calcium.ionized
34582-7,Candida sp Ab.IgA
34583-5,Candida sp Ab.IgG
34584-3,Candida sp Ab.IgM
34585-0,Inner Ear 68kD Ab
34586-8,JC virus DNA
Jul-58,chlordiazePOXIDE
34587-6,Palmitoyl protein thioesterase
34588-4,Feeding duration
34589-2,von Willebrand factor cleaving protease
345-9,Moxalactam
34590-0,von Willebrand factor cleaving protease inhibitor
34591-8,HIV 1 Ab
34592-6,HIV 1 Ab
34593-4,Epstein Barr virus DNA
34594-2,Schistosoma sp Ab
May-59,chlordiazePOXIDE
34595-9,Collection time
34596-7,3-O-Methyldopa
34597-5,Hepatitis D virus Ab.IgM
34598-3,Sialate
34599-1,Methotrexate
34600-7,Immunoglobulin heavy chain gene rearrangements
34601-5,Drugs identified
34602-3,E Ab
Mar-60,Chlormerodrin
34603-1,I Ab
34604-9,M Ab
34605-6,Collagen type 2 Ab
34606-4,Minocycline
34607-2,Interferon.beta Ab
34608-0,Leishmania sp Ab.IgG
34609-8,Transketolase
34610-6,N-acetylaspartate/Creatinine
Jan-61,Chlormerodrin
34611-4,Prostate specific Ag
34612-2,Iron
34613-0,Herpes simplex virus 1+2 Ab.IgG
34614-8,Spermatozoa Ab.IgM
34615-5,Iron.microscopic observation
34616-3,Amino acids
34617-1,Antibiotic XXX
34618-9,Hemoglobin
34619-7,Complement C1 esterase inhibitor.functional
34620-5,Camphor
34621-3,Liver cytosol Ab
34622-1,Cells.CD4+CD25+/100 cells
34623-9,Colorado tick fever virus Ab
34624-7,Cystine.free
34625-4,Corynebacterium diphtheriae toxin Ab
34626-2,2-Methylcitrate
34627-0,Methylmalonate
34628-8,Methotrexate
Sep-62,Chlormerodrin
34629-6,CISplatin
34630-4,Substance P
34631-2,Cyproheptadine
34632-0,hydrALAZINE
34633-8,Hypoglycemics.sulfonyluric
34634-6,Cells.CD11+CD18+
34635-3,Citalopram
34636-1,Ciprofloxacin
Jul-63,Chloroquine
34637-9,5-Methyltetrahydrofolate
34638-7,Clarithromycin
34639-5,Epstein Barr virus capsid Ab.IgA
34640-3,Bile acid
34641-1,Protein pattern
34642-9,Thyroid colloidal Ab
34643-7,Lopinavir
34644-5,Tenofovir
May-64,Chlorothiazide
34645-2,Chlamydophila pneumoniae DNA
34646-0,Sulfatides
34647-8,PPT1 gene targeted mutation analysis
34648-6,Specimen weight
34649-4,MERRF gene targeted mutation analysis
34650-2,TSC gene targeted mutation analysis
34651-0,CYP21A2 gene targeted mutation analysis
Feb-65,Chlorpheniramine
34652-8,Pancreatic islet cell Ab
34653-6,GJB1 gene targeted mutation analysis
34654-4,MPZ gene targeted mutation analysis
34655-1,Herpes simplex virus 1+2 DNA
34656-9,KEL gene targeted mutation analysis
34657-7,Spermatozoa.immotile
34658-5,MCOLN1 gene targeted mutation analysis
34659-3,ATP7A gene targeted mutation analysis
3466-0,Chlorpheniramine
34660-1,Hemoglobin A2/Hemoglobin.total
34661-9,Actin Ab.IgG
34662-7,Mephenytoin+Normephenytoin
34663-5,Hemoglobin S
34664-3,Clostridium botulinum toxin A Ab
34665-0,TORCH panel
34666-8,Carisoprodol+Meprobamate
34667-6,Heavy metals panel
34668-4,Prilocaine
34669-2,Pyrimethamine
346-7,Nafcillin
34670-0,Choriogonadotropin
34671-8,8-Dehydrocholesterol
34672-6,Immunoelectrophoresis panel
34673-4,Propofol
34674-2,Tripeptide aminopeptidase
34675-9,Mitochondria DNA targeted mutation analysis
34676-7,SMA@ gene mutation analysis
34677-5,Mitotic spindle apparatus Ab
Aug-67,Chlorpheniramine
34678-3,MT-RNR1 gene.m.1555A>G
34679-1,PTPN11 gene targeted mutation analysis
34680-9,Ceramide trihexoside
34681-7,Biopsy
34682-5,Coagulation tissue factor induced.factor substitution^immediately after addition of factor V depleted plasma
34683-3,Coagulation surface induced.factor substitution^immediately after addition of factor IX depleted plasma
34684-1,Coagulation surface induced.factor substitution^immediately after addition of factor XIII depleted plasma
34685-8,Coagulation tissue factor induced.factor substitution^immediately after addition of factor X depleted plasma
Jun-68,Chlorphentermine
34686-6,Coagulation tissue factor induced.factor substitution^immediately after addition of factor II depleted plasma
34687-4,Coagulation surface induced.factor substitution^immediately after addition of factor XI depleted plasma
34688-2,Coagulation surface induced.factor substitution^immediately after addition of factor XII depleted plasma
34689-0,Sulfatidase
34690-8,CV2 Ab
34691-6,Erythroamino alcohol
34692-4,Threoamino alcohol
34693-2,GALOP Ab
Apr-69,Chlorphentermine
34694-0,Vascular endothelial growth factor
34695-7,Cholesterol.in VLDL/Triglyceride
34696-5,Collection method
34697-3,Alpha 1 antitrypsin actual/Normal
34698-1,CSTB gene targeted mutation analysis
34699-9,HIV 2 proviral DNA
34700-5,HIV reverse transcriptase+Protease gene mutations tested for
34701-3,Platelet factor 4 heparin complex induced Ab
Feb-70,Chlorphentermine
34702-1,Mycoplasma sp
34703-9,Hepatitis C virus RNA
34704-7,Hepatitis C virus RNA
34705-4,Carbon dioxide^^adjusted to patient's actual temperature
34706-2,CFTR gene.c.3199del6
34707-0,Chlamydophila pneumoniae rRNA
34708-8,Chlamydia sp DNA
34709-6,Chlamydia trachomatis Ag
3471-0,chlorproMAZINE
34710-4,Chlamydia trachomatis Ag
34711-2,Cholinesterase
34712-0,Clostridioides difficile
34713-8,Clostridioides difficile toxin A+B
34714-6,Coagulation tissue factor induced.INR
34715-3,Cocaine
34716-1,Coxiella burnetii phase 1 Ab.IgG
34717-9,Coxiella burnetii phase 2 Ab.IgG
34718-7,CFTR gene targeted mutation analysis
34719-5,Cytomegalovirus DNA
34720-3,Cytomegalovirus DNA
34721-1,Dengue virus Ab.IgM
34722-9,EGR2 gene targeted mutation analysis
34723-7,Eastern equine encephalitis virus Ab
34724-5,Echovirus 4 Ab
34725-2,Echovirus 7 Ab
34726-0,Eosinophils
34727-8,DMPK gene targeted mutation analysis
Aug-72,chlorproMAZINE
34728-6,Carbon dioxide
34729-4,CFTR gene.p.Arg117His+5T variant
34730-2,Chromosome breakage
34731-0,APOE gene allele 1
34732-8,APOE gene allele 2
34733-6,APOE gene allele 3
34734-4,APOE gene gentoype
34735-1,APOE gene allele 4
Jun-73,chlorproMAZINE
34736-9,Calcium oxalate index
34737-7,Nuclear mitotic apparatus Ab
34738-5,K Ab
34739-3,NR0B1 gene targeted mutation analysis
34740-1,NEFL gene targeted mutation analysis
34741-9,RHCE gene allele
34742-7,Chromosome breakage
34743-5,Hemoglobin.stable
Apr-74,chlorproPAMIDE
34744-3,Admission evaluation note
34745-0,Discharge summary note
34746-8,Note
34747-6,Preoperative evaluation and management note
34748-4,Note
34749-2,Consultation note
347-5,Nafcillin
34750-0,Note
Jan-75,Chlorprothixene
34751-8,Preoperative evaluation and management note
34752-6,Note
34753-4,Note
34754-2,Note
34755-9,Transfer summary note
34756-7,Consultation note
34757-5,Evaluation note
34758-3,Consultation note
34759-1,Note
34760-9,Consultation note
34761-7,Consultation note
34762-5,Note
34763-3,Admission history and physical note
34764-1,Consultation note
34765-8,Note
34766-6,Note
34767-4,Note
34768-2,Note
Sep-76,Chlorprothixene
34769-0,Note
34770-8,Transfer summary note
34771-6,Consultation note
34772-4,Note
34773-2,Note
34774-0,History and physical note
34775-7,Preoperative evaluation and management note
34776-5,Consultation note
Jul-77,Chlorprothixene
34777-3,Consultation note
34778-1,Note
34779-9,Consultation note
34780-7,Note
34781-5,Consultation note
34782-3,Note
34783-1,Consultation note
34784-9,Note
May-78,Chlorthalidone
34785-6,Consultation note
34786-4,Note
34787-2,Group counseling note
34788-0,Consultation note
34789-8,Note
34790-6,Group counseling note
34791-4,Consultation note
34792-2,Note
Mar-79,Chlorthalidone
34793-0,Group counseling note
34794-8,Note
34795-5,Consultation note
34796-3,Note
34797-1,Consultation note
34798-9,Consultation note
34799-7,Note
34800-3,Consultation note
Jan-80,Chlorthalidone
34801-1,Note
34802-9,Note
34803-7,Consultation note
34804-5,Note
34805-2,Consultation note
34806-0,Note
34807-8,Consultation note
34808-6,Note
34809-4,Preoperative evaluation and management note
34810-2,Consultation note
34811-0,Note
34812-8,Consultation note
34813-6,Note
34814-4,Consultation note
34815-1,Note
34816-9,Consultation note
34817-7,Note
34818-5,Surgical operation note
Sep-81,Cimetidine
34819-3,Note
34820-1,Consultation note
34821-9,Note
34822-7,Consultation note
34823-5,Note
34824-3,Consultation note
34825-0,Evaluation note
34826-8,Consultation note
Jul-82,Cimetidine
34827-6,Note
34828-4,Consultation note
34829-2,Note
348-3,Nafcillin
34830-0,Note
34831-8,Consultation note
34832-6,Note
34833-4,Consultation note
34834-2,Note
May-83,Cimetidine
34835-9,Consultation note
34836-7,Note
34837-5,Consultation note
34838-3,Note
34839-1,Consultation note
34840-9,Note
34841-7,Consultation note
34842-5,Evaluation note
Mar-84,Ciprofloxacin
34843-3,Group counseling note
34844-1,Note
34845-8,Consultation note
34846-6,Note
34847-4,Consultation note
34848-2,Note
34849-0,Consultation note
3485-0,CISplatin
34850-8,Note
34851-6,Consultation note
34852-4,Note
34853-2,Consultation note
34854-0,Note
34855-7,Consultation note
34856-5,Evaluation and management of anticoagulation note
34857-3,Note
34858-1,Note
34859-9,Evaluation and management of hyperlipidemia note
34860-7,Evaluation and management of hypertension note
34861-5,Note
34862-3,Admission evaluation note
34863-1,Post-operative evaluation and management note
34864-9,Counseling note
34865-6,Counseling note
34866-4,Counseling note
34867-2,Postoperative evaluation and management note
Aug-86,Clindamycin
34868-0,Surgical operation note
34869-8,Counseling note
34870-6,Surgical operation note
34871-4,Surgical operation note
34872-2,Counseling note
34873-0,Admission evaluation note
34874-8,Surgical operation note
34875-5,Postoperative evaluation and management note
Jun-87,cloBAZam
34876-3,Preoperative evaluation and management note
34877-1,Surgical operation note
34878-9,Note
34879-7,Consultation note
34880-5,Postoperative evaluation and management note
34881-3,Preoperative evaluation and management note
34882-1,Ethanol
34883-9,Mycoplasma sp Ag
Apr-88,Clobenzorex
34884-7,Haemophilus paragallinarum Ab
34885-4,African horse sickness virus Ab
34886-2,Rabbit hemorrhagic disease virus Ab.Neut
34887-0,Peste des petits ruminants virus Ag
34888-8,Aino virus Ab.Neut
34889-6,Akabane virus Ab.Neut
34890-4,Coliform bacteria
34891-2,Salmonella enteritidis
Feb-89,Clobenzorex
34892-0,West Nile virus RNA
34893-8,Aino virus Ab
34894-6,Akabane virus Ab
34895-3,Education note
34896-1,Interventional procedure note
34897-9,Education note
34898-7,Note
34899-5,Interventional procedure note
Sep-34,Ampicillin+Sulbactam
3490-0,Clofibrate
34900-1,Progress note
34901-9,Progress note
34902-7,Education note
34903-5,Note
34904-3,Progress note
34905-0,Note
34906-8,Note
34907-6,Calcium^^corrected for total protein
34908-4,Neopterin
34909-2,Cortisol.free
349-1,Nafcillin
34910-0,Basophils.immature
34911-8,Basophils.immature/100 leukocytes
34912-6,Eosinophils.immature
34913-4,Eosinophils.immature/100 leukocytes
34914-2,Malignant cells
34915-9,Malignant cells/100 leukocytes
34916-7,Plasma cell precursor
34917-5,Plasma cell precursor/100 leukocytes
Aug-91,clomiPRAMINE
34918-3,Sezary cells
34919-1,Sezary cells/100 leukocytes
34920-9,Lymphocytes.immunoblastic/100 leukocytes
34921-7,Lymphocytes.plasmacytoid/100 leukocytes
34922-5,Lymphoblasts/100 leukocytes
34923-3,Monoblasts/100 leukocytes
34924-1,Monocytes.immature
34925-8,Monocytes.immature/100 leukocytes
Jun-92,clomiPRAMINE
34926-6,Promonocytes
34927-4,Urobilinogen
34928-2,Urobilinogen
34929-0,Cells.CD3+CD4+CD45RO+CD45RA-/100 cells
34930-8,Cells.CD3+CD4+CD45RO+CD45RA+/100 cells
34931-6,Cells.CD3+CD4+CD45RO-CD45RA-/100 cells
34932-4,Cells.CD3+CD4+CD45RO-CD45RA+/100 cells
34933-2,Cells.CD3+CD8+CD45RO+CD45RA-/100 cells
Apr-93,clomiPRAMINE+Norclomipramine
34934-0,Cells.CD3+CD8+CD45RO+CD45RA+/100 cells
34935-7,Cells.CD3+CD8+CD45RO-CD45RA-/100 cells
34936-5,Cells.CD3+CD8+CD45RO-CD45RA+/100 cells
34937-3,Fibrinopeptide A
34938-1,Phosphate
34939-9,Tumor necrosis factor.alpha
34940-7,Babesia microti Ab.IgG & IgM panel
34941-5,Bordetella pertussis Ab.IgG & IgM panel
Feb-94,clonazePAM
34942-3,Borrelia burgdorferi Ab.IgG & IgM panel
34943-1,Borrelia burgdorferi Ab.IgG & IgM panel
34944-9,Cytomegalovirus Ab.IgG & IgM panel
34945-6,Herpes virus 6 Ab.IgG & IgM panel
34946-4,Herpes virus 6 Ab.IgG & IgM panel
34947-2,Herpes virus 7 Ab.IgG & IgM panel
34948-0,Measles virus Ab.IgG & IgM panel
34949-8,Measles virus Ab.IgG & IgM panel
34950-6,Parvovirus B19 Ab.IgG & IgM panel
34951-4,Phosphatidylserine Ab.IgG & IgM panel
34952-2,Rubella virus Ab.IgG & IgM panel
34953-0,Rubella virus Ab.IgG & IgM panel
34954-8,Treponema pallidum Ab.IgG & IgM panel
34955-5,Western equine encephalitis virus Ab.IgG & IgM panel
34956-3,Western equine encephalitis virus Ab.IgM
34957-1,Eosinophils
34958-9,Eosinophils
Sep-95,cloNIDine
34959-7,Microscopic observation
34960-5,HLA Ab
34961-3,Rh
34962-1,Cells.CD3+TCR alpha beta+/100 cells
34963-9,Cells.CD3+TCR alpha beta+
34964-7,Osmotic fragility
34965-4,Osmotic fragility^0.10% sodium chloride 24H 37 deg C incubation
34966-2,Osmotic fragility^0.10% sodium chloride
Jul-96,Clopenthixol
34967-0,Osmotic fragility^0.20% sodium chloride 24H 37 deg C incubation
34968-8,Osmotic fragility^0.20% sodium chloride
34969-6,Oxyhemoglobin/Hemoglobin.total
34970-4,Date ultrasound
34971-2,Neutrophil associated Ab
34972-0,DNA index 3
34973-8,DNA index 2
34974-6,DNA index 3
May-97,Clopenthixol
34975-3,DNA index
34976-1,DNA index 2
34977-9,Platelet genotype
34978-7,Specimen volume
34979-5,Specimen volume
34980-3,Specimen volume
34981-1,Specimen volume
34982-9,Unidentified cells/100 leukocytes
Mar-98,Clorazepate
34983-7,Unidentified cells/100 leukocytes
34984-5,Unidentified cells/100 leukocytes
34985-2,Unidentified cells/100 leukocytes
34986-0,Unidentified cells
34987-8,Unidentified cells
34988-6,Unidentified cells
34989-4,Unidentified cells
34990-2,Unidentified cells
Jan-99,Clorprenaline
34991-0,Unidentified cells
34992-8,Smudge cells/100 leukocytes
34993-6,Smudge cells
34994-4,Smear morphology panel
34995-1,Promyelocytes
34996-9,Promyelocytes
34997-7,Promonocytes
34998-5,Prolymphocytes
34999-3,Polymorphonuclear cells/100 leukocytes
35000-9,Polymorphonuclear cells
35001-7,Polymorphonuclear cells
35002-5,Polymorphonuclear cells
35003-3,Polymorphonuclear cells
35004-1,Polymorphonuclear cells
35005-8,Polymorphonuclear cells
Jun-00,Clorprenaline
35006-6,Plasma cells
35007-4,Nonhematic cells
35008-2,Nonhematic cells
35009-0,Neutrophils.segmented
35010-8,Neutrophils.segmented
35011-6,Neutrophils.segmented
35012-4,Neutrophils.segmented
35013-2,Neutrophils.band form
Apr-01,Clorprenaline
35014-0,Neutrophils.band form
35015-7,Neutrophils.band form
35016-5,Myelocytes
35017-3,Myelocytes
35018-1,Mononuclear cells
35019-9,Monocytes+Macrophages/100 lymphocytes
35020-7,Monocytes+Macrophages/100 leukocytes
35021-5,Monocytes+Macrophages/100 leukocytes
Feb-02,Clostebol
35022-3,Monocytes+Macrophages
35023-1,Monocytes+Macrophages
35024-9,Monocytes+Macrophages
35025-6,Monocytes+Macrophages
35026-4,Monocytes
35027-2,Monocytes
35028-0,Monocytes
35029-8,Monoblasts
3503-0,Clostebol
35030-6,Metamyelocytes
35031-4,Metamyelocytes
35032-2,Mesothelial cells
35033-0,Mesothelial cells
35034-8,Mesothelial cells
35035-5,Mesothelial cells
35036-3,Macrophages
35037-1,Macrophages
35038-9,Macrophages
35039-7,Lymphocytes.plasmacytoid
35040-5,Lymphocytes.immunoblastic
35041-3,Lymphocytes.variant
35042-1,Lymphocytes.variant
35043-9,Lymphocytes.variant
35044-7,Lymphocytes.variant
35045-4,Lymphocytes.variant
35046-2,Lymphocytes.abnormal
35047-0,Lymphocytes.abnormal
Aug-04,Clostebol
35048-8,Lymphocytes.abnormal
35049-6,Lymphocytes
35050-4,Lymphoblasts
35051-2,Leukocytes other
35052-0,Leukocytes other
35053-8,Leukocytes other
35054-6,Leukocytes other
May-05,Codeine
35055-3,Histiocytes/100 leukocytes
35056-1,Histiocytes
35057-9,Histiocytes
35058-7,Hairy cells/100 leukocytes
35059-5,Granulocytes
35060-3,Eosinophils
35061-1,Eosinophils
35062-9,Eosinophils
Mar-06,Codeine
35063-7,Eosinophils
35064-5,Blasts
35065-2,Blasts
35066-0,Blasts
35067-8,Blasts
35068-6,Blasts
35069-4,Basophils/100 leukocytes
35070-2,Basophils/100 leukocytes
Jan-07,Codeine
35071-0,Basophils
35072-8,Basophils
35073-6,Basophils
35074-4,Basophils
35075-1,Basophils
35076-9,Monocytes
35077-7,Lymphocytes.abnormal/100 leukocytes
35078-5,Unspecified cells
35079-3,Mesothelial cells
35080-1,Mononuclear cells
35081-9,Lymphocytes+Monocytes
35082-7,Lymphocytes.large granular
35083-5,Amino acids panel
35084-3,Fetal lung maturity
35085-0,Newborn screening panel
35086-8,Second trimester triple maternal screen panel
35087-6,Amino acids panel
35088-4,Glasgow coma scale
Sep-08,Codeine
35089-2,History and physical panel
350-9,Nalidixate
35090-0,Patient history
35091-8,Patient physical
35092-6,Urology testicular ultrasound
35093-4,Urology urinary tract ultrasound
35094-2,Blood pressure panel
35095-9,Body temperature panel
35096-7,OB ultrasound panel
Jul-09,Prochlorperazine
35097-5,Lymphocytes
35098-3,Lymphocytes
35099-1,Monocytes+Macrophages
35100-7,Enterovirus Ab.IgM
35101-5,Intrathecal pressure
35102-3,Acenocoumarol
35103-1,Acyclovir^trough
35104-9,Acyclovir^peak
May-10,Prochlorperazine
35105-6,Bromperidol
35106-4,Norcitalopram
35107-2,Norclobazam
35108-0,Normaprotiline
35109-8,Phenprocoumon
35110-6,Flecainide^trough
35111-4,Flecainide^peak
35112-2,Floxacillin
Mar-11,Cropropamide
35113-0,Nelfinavir M8
35114-8,Nordothiepin
35115-5,Pipamperone
35116-3,Sulforidazine
35117-1,Sulpiride
35118-9,Acetaldehyde
35119-7,Chloral hydrate
35120-5,Dothiepin sulfoxide
Jan-12,Cropropamide
35121-3,E-10-Hydroxynortriptyline
35122-1,MTM1 gene targeted mutation analysis
35123-9,Chromosome 14 uniparental disomy
35124-7,Dysferlin
35125-4,Hemoglobin Lepore/Hemoglobin.total
35126-2,Hemoglobin O-Arab/Hemoglobin.total
35127-0,Hemoglobin A2.prime/Hemoglobin.total
35128-8,Perforin
35129-6,Karyotype
35130-4,Salicylates
35131-2,L-dopa decarboxylase
35132-0,MELAS gene targeted mutation analysis
35133-8,Glutarate
35134-6,Thyrotropin Ab
35135-3,Adenosine triphosphate/Adenosine diphosphate
35136-1,Patient symptoms^3H post dose lactose PO
35137-9,MECP2 gene targeted mutation analysis
35138-7,MEFV gene mutations tested for
Sep-13,Cropropamide
35139-5,Interferon.beta Ab
35140-3,Trans-3-Hydroxycotinine
35141-1,Purine nucleoside phosphorylase
35142-9,Amphiphysin Ab
35143-7,Purkinje cell cytoplasmic type 2 Ab
35144-5,Neuronal nuclear type 3 Ab
35145-2,Octanoate
35146-0,Decanoate
Jul-14,Crotetamide
35147-8,Decenoate
35148-6,Tetradecadienoate
35149-4,Octadecanoate
35150-2,Laurate
35151-0,Lauroleate
35152-8,Fatty acids.very long chain.C26:0
35153-6,Fatty acids.very long chain.C26:1
Apr-15,Crotetamide
35154-4,Hexadecadienoate
35155-1,Hexadecenoate
35156-9,Fatty acids.very long chain.C24:0
35157-7,Myristate
35158-5,Myristoleate
35159-3,Fatty acids.very long chain.C22:0
35160-1,Docosenoate
35161-9,Palmitate
Feb-16,Crotetamide
35162-7,Palmitoleate
35163-5,Gamma linolenate
35164-3,Alpha linolenate
35165-0,Linoleate
35166-8,Oleate
35167-6,Vaccenate
35168-4,Arachidonate
35169-2,Arachidate
351-7,Nalidixate
3517-0,Cyclacillin
35170-0,Nervonate
35171-8,Homo-gamma linolenate
35172-6,Mead acid
35173-4,Eicosapentaenoate
35174-2,Docosahexaenoate
35175-9,Fatty acids.saturated
35176-7,Fatty acids.monounsaturated
35177-5,Fatty acids.polyunsaturated
35178-3,Fatty acids.omega 3
35179-1,Fatty acids.omega 6
35180-9,Docosapentaenate w3
35181-7,Docosapentaenate w6
35182-5,Docosatetraenoate
35183-3,Hemoglobin
35184-1,Glucose^post CFst
35185-8,Aldosterone
35186-6,Aldosterone
35187-4,Aldosterone^supine
Aug-18,Cyclizine
35188-2,Aldosterone^upright
35189-0,Androstanolone
35190-8,Androstenedione
35191-6,Bilirubin.glucuronidated+Bilirubin.albumin bound
35192-4,Bilirubin.non-glucuronidated
35193-2,Bilirubin
35194-0,Bilirubin
35195-7,C peptide
Jun-19,cycloSERINE
35196-5,Calcidiol
35197-3,Cholesterol.in HDL
35198-1,Cholesterol.in LDL
35199-9,Cholesterol.in VLDL
35200-5,Cholesterol
35201-3,Cobalamins
35202-1,Cortisol
35203-9,Creatinine
Apr-20,cycloSPORINE
35204-7,Creatinine
35205-4,Dehydroepiandrosterone sulfate
35206-2,Dehydroepiandrosterone
35207-0,Estradiol
35208-8,Estrone
35209-6,Ferritin
35210-4,Folate
35211-2,Glucose
Feb-21,cycloSPORINE
35212-0,Glucose
35213-8,Insulin-like growth factor-I
35214-6,Iron
35215-3,Iron binding capacity
35216-1,Iron binding capacity.unsaturated
35217-9,Triglyceride
35218-7,Osteocalcin
35219-5,Parathyrin.intact
3522-0,cycloSPORINE+Metabolites
35220-3,Phosphate
35221-1,Phosphate
35222-9,Phosphate
35223-7,Progesterone
35224-5,Testosterone
35225-2,Testosterone.free
35226-0,Thyroxine
35227-8,Thyroxine binding globulin
35228-6,Thyroxine.free
35229-4,Transferrin
35230-2,Triiodothyronine.free
35231-0,Triiodothyronine
35232-8,Urate
35233-6,Urate
35234-4,Urea nitrogen
35235-1,Urea nitrogen
35236-9,Urobilinogen
35237-7,carBAMazepine
Aug-23,cycloSPORINE^12H post dose
35238-5,Theophylline
35239-3,Tobramycin^trough
35240-1,Ethanol
35241-9,Urea nitrogen
35242-7,Creatinine
35243-5,Cholesterol.in HDL 3
35244-3,Digoxin
35245-0,Lactate
Jun-24,cycloSPORINE^12H post dose
35246-8,Calcium
35247-6,Calcium
35248-4,Calcium
35249-2,Magnesium
352-5,Nalidixate
35250-0,Magnesium
35251-8,Creatinine
35252-6,Magnesium
Mar-25,cycloSPORINE^24H post dose
35253-4,Urate
35254-2,Ammonia
35255-9,Beta hydroxybutyrate
35256-7,Iron
35257-5,Natriuretic peptide.B
35258-3,Calcium^^corrected for total protein
35259-1,Neopterin
35260-9,Histamine
Jan-26,cycloSPORINE^24H post dose
35261-7,Cortisol.free
35262-5,Creatinine
35263-3,Phosphate
35264-1,Calcium intake
35265-8,Path report.addendum
35266-6,Gleason score
35267-4,Age at pathology Dx
35268-2,Mycobacterium avium subspecies paratuberculosis Ab
35269-0,Bartonella henselae Ab
35270-8,Candida sp Ab
35271-6,Candida sp Ag
35272-4,Centromere Ab.IgG
35273-2,Hepatitis D virus Ab.IgG
35274-0,Histone Ab.IgG
35275-7,Measles virus Ab.IgG
35276-5,Measles virus Ab.IgM
35277-3,Myocardium Ab.IgG
35278-1,Neuronal nuclear Ab
Sep-27,Dantron
35279-9,Neutrophil cytoplasmic Ab
35280-7,Tissue transglutaminase Ab.IgA
35281-5,Toxoplasma gondii Ab.IgG
35282-3,Toxoplasma gondii Ab.IgM
35283-1,Hepatitis D virus Ab.IgG
35284-9,Histone Ab.IgG
35285-6,Tissue transglutaminase Ab.IgA
35286-4,Adverse event following prior vaccination
Jul-28,Tetrahydrocannabinol
35287-2,Toxoplasma gondii HS Ab
35288-0,MEN1 gene targeted mutation analysis
35289-8,Peroxide hemolysis
35290-6,RPS6KA3 gene targeted mutation analysis
35291-4,UBE3A gene targeted mutation analysis
35292-2,Chromosome 11 uniparental disomy
35293-0,TYR gene targeted mutation analysis
35294-8,PYGM gene targeted mutation analysis
May-29,Tetrahydrocannabinol
35295-5,BTK gene targeted mutation analysis
35296-3,PAX3 gene targeted mutation analysis
35297-1,LMNA gene targeted mutation analysis
35298-9,FXN gene targeted mutation analysis
35299-7,PSEN1 gene targeted mutation analysis
35300-3,GJB2 gene targeted mutation analysis
35301-1,Transferrin.carbohydrate deficient.asialo
35302-9,HYAL1 gene targeted mutation analysis
Mar-30,Tetrahydrocannabinol
35303-7,Glucosylceramidase
35304-5,CLA2 gene targeted mutation analysis
35305-2,Toxoplasma gondii AC Ab
35306-0,TTR gene allele 2
35307-8,TTR gene allele 1
35308-6,Trypsin^5th specimen post dose sincalide
35309-4,Trypsin^4th specimen post dose sincalide
35310-2,Trypsin^3rd specimen post dose sincalide
Jan-31,Desipramine
35311-0,Trypsin^2nd specimen post dose sincalide
35312-8,Trypsin^1st specimen post dose sincalide
35313-6,Triacylglycerol lipase^5th specimen post dose sincalide
35314-4,Triacylglycerol lipase^4th specimen post dose sincalide
35315-1,Triacylglycerol lipase^3rd specimen post dose sincalide
35316-9,Triacylglycerol lipase^2nd specimen post dose sincalide
35317-7,Thermoactinomyces vulgaris 1 Ab
35318-5,Thermoactinomyces sacchari Ab
35319-3,Protein^5th specimen post dose sincalide
35320-1,Protein^4th specimen post dose sincalide
35321-9,Protein^3rd specimen post dose sincalide
35322-7,Protein^2nd specimen post dose sincalide
35323-5,Protein^1st specimen post dose sincalide
35324-3,PMP22 gene allele 1
35325-0,PMP22 gene allele 2
35326-8,pH^5th specimen post dose sincalide
35327-6,pH^4th specimen post dose sincalide
35328-4,pH^3rd specimen post dose sincalide
Sep-32,Desipramine
35329-2,pH^2nd specimen post dose sincalide
353-3,Nalidixate
35330-0,pH^1st specimen post dose sincalide
35331-8,OXcarbazepine
35332-6,Neutrophils.band form/100 leukocytes
35333-4,Jo-1 extractable nuclear Ab
35334-2,Collagen crosslinked N-telopeptide
35335-9,Chymotrypsin^5th specimen post dose sincalide
35336-7,Chymotrypsin^4th specimen post dose sincalide
Jul-33,Desipramine
35337-5,Chymotrypsin^3rd specimen post dose sincalide
35338-3,Chymotrypsin^2nd specimen post dose sincalide
35339-1,Chymotrypsin^1st specimen post dose sincalide
35340-9,ASPA gene.p.Tyr231Ter
35341-7,ASPA gene.p.Ala305Glu
35342-5,Amylase^5th specimen post dose sincalide
35343-3,Amylase^4th specimen post dose sincalide
35344-1,Amylase^3rd specimen post dose sincalide
May-34,Desipramine
35345-8,Amylase^2nd specimen post dose sincalide
35346-6,Amylase^1st specimen post dose sincalide
35347-4,Microscopic observation
35348-2,Corynebacterium diphtheriae Ab
35349-0,Taenia solium larva Ab
35350-8,NAACCR survival to last contact (in months)
35351-6,Myotonic dystrophy gene targeted mutation analysis
Feb-35,Desipramine^trough
35352-4,Mycobacterium tuberculosis genotype
35353-2,FSHD gene targeted mutation analysis
35354-0,COL1A1+COL1A2 gene targeted mutation analysis
35355-7,PABPN1 gene targeted mutation analysis
35356-5,TWIST1 gene targeted mutation analysis
35357-3,PEO gene targeted mutation analysis
35358-1,LHON syndrome gene targeted mutation analysis
35359-9,AR gene targeted mutation analysis
3536-0,Norclomipramine
35360-7,Triglyceride.in lipoprotein (little a)
35361-5,Triglyceride.in lipoprotein (little a)
35362-3,Triglyceride.in chylomicrons
35363-1,Triglyceride.in chylomicrons
35364-9,Triacylglycerol lipase^1st specimen post dose sincalide
35365-6,Vitamin D+Metabolites
35366-4,SCA2 gene allele 2.CAG repeats
35367-2,SCA2 gene allele 1.CAG repeats
35368-0,SCA1 gene allele 2.CAG repeats
35369-8,SCA1 gene allele 1.CAG repeats
35370-6,GBA gene.g.S84GG
35371-4,GBA gene.g.N370S
35372-2,GBA gene.p.Leu444Pro
35373-0,Platelet aggregation.XXX induced
35374-8,DMPK gene allele 2.CTG repeats
35375-5,DMPK gene allele 1.CTG repeats
35376-3,MJD gene allele 2.CAG repeats
35377-1,MJD gene allele 1.CAG repeats
Aug-37,Nordiazepam
35378-9,HNPCC genes mutations tested for
35379-7,HNPCC genes targeted mutation analysis
35380-5,HEXA gene.c.IVS7+1G>A
35381-3,HEXA gene.c.IVS12+1G>C
35382-1,HEXA gene.p.Gly269Ser
35383-9,Galactomannan Ag
35384-7,Estradiol
35385-4,CV2 Ab.IgG
Jun-38,Dextromethorphan
35386-2,CV2 Ab.IgG
35387-0,Cholesterol.in lipoprotein (little a)
35388-8,Cholesterol.in lipoprotein (little a)
35389-6,Cholesterol.in chylomicrons
35390-4,Vaccinia virus DNA
35391-2,Taenia solium larva Ab.IgG
35392-0,Hantavirus Ab.IgG
35393-8,Hantavirus Ab.IgM
Apr-39,Dextromethorphan
35394-6,Legionella pneumophila 1 Ab.IgG
35395-3,Legionella pneumophila 1 Ab.IgM
35396-1,Enterovirus RNA
35397-9,Epstein Barr virus DNA
35398-7,Epstein Barr virus DNA
35399-5,Varicella zoster virus DNA
35400-1,Varicella zoster virus DNA
35401-9,Cytomegalovirus DNA
Feb-40,Dextromoramide
35402-7,Leishmania donovani Ab.IgG
35403-5,Leishmania donovani Ab.IgM
35404-3,Leishmania braziliensis Ab.IgG
35405-0,Leishmania braziliensis Ab.IgM
35406-8,Leishmania mexicana Ab.IgG
35407-6,Leishmania mexicana Ab.IgM
35408-4,Leishmania tropica Ab.IgG
35409-2,Leishmania tropica Ab.IgM
354-1,Neomycin
3541-0,Dextromoramide
35410-0,Pressure.continuous positive airway
35411-8,Trienoate/Arachidonate
35412-6,Chlamydia sp DNA
35413-4,Coxsackievirus A4+A16 Ab
35414-2,Specific gravity
35415-9,Oxytocin
35416-7,Echinococcus granulosus Ab
35417-5,Herpes simplex virus identified
35418-3,Herpes simplex virus identified
35419-1,Herpes simplex virus identified
35420-9,Herpes simplex virus identified
35421-7,Herpes simplex virus identified
35422-5,Herpes simplex virus identified
35423-3,Herpes simplex virus identified
35424-1,Herpes simplex virus identified
35425-8,Herpes simplex virus identified
35426-6,Herpes simplex virus identified
35427-4,Herpes simplex virus identified
Aug-42,Propoxyphene
35428-2,Herpes simplex virus identified
35429-0,Herpes simplex virus identified
35430-8,Herpes simplex virus identified
35431-6,Herpes simplex virus identified
35432-4,Herpes simplex virus identified
35433-2,Herpes simplex virus identified
35434-0,Herpes simplex virus identified
35435-7,Histoplasma capsulatum yeast phase Ab
Jun-43,Propoxyphene
35436-5,Spermatozoa^post reanastomosis
35437-3,HIV 1 Ab
35438-1,HIV 1 Ab
35439-9,HIV 1 Ab
35440-7,HIV 1 gp160 Ab
35441-5,HIV 1 gp120 Ab
35442-3,HIV 1 p66 Ab
35443-1,HIV 1 p65 Ab
Apr-44,Propoxyphene
35444-9,HIV 1 p55 Ab
35445-6,HIV 1 p51 Ab
35446-4,HIV 1 gp41 Ab
35447-2,HIV 1 p31 Ab
35448-0,HIV 1 p24 Ab
35449-8,HIV 1 p17 Ab
35450-6,HIV 1 p18 Ab
Jan-45,Propoxyphene
35451-4,Herpes simplex virus identified
35452-2,HIV 1 gp40 Ab
35453-0,ARSA gene PD allele
35454-8,MLL gene rearrangements
35455-5,X chromosome inactivation
35456-3,Y chromosome deletion
35457-1,Maternal cell contamination
35458-9,Ma+Ta Ab
35459-7,T cell crossmatch
35460-5,Platelet genotype
35461-3,ELN gene targeted mutation analysis
35462-1,SMN1 gene targeted mutation analysis
35463-9,Telomere analysis
35464-7,CMT axonal gene targeted mutation analysis
35465-4,RHD gene allele
35466-2,AS+PWS gene targeted mutation analysis
35467-0,M-chlorophenylpiperazine
35468-8,Cells.FLAER
Sep-46,Diamorphine
35469-6,Transferrin.carbohydrate deficient.disialo/Transferrin.carbohydrate deficient.tetrasialo
35470-4,Mitochondria DNA deletion
35471-2,HLA Ab
35472-0,HEXA gene.c.1277insTATC
35473-8,HEXA gene 7.6kb deletion
35474-6,Gene XXX targeted mutation analysis
35475-3,Transferrin.carbohydrate deficient.asialo/Transferrin.carbohydrate deficient.tetrasialo
35476-1,OKT3 blocking Ab
Jul-47,Diamorphine
35477-9,Ciliated columnar lining cells/100 leukocytes
35478-7,Cytosol aminopeptidase
35479-5,Diazinon
35480-3,1-Naphthol
35481-1,Terbufos
35482-9,Para nitrophenol
35483-7,Mevinphos
35484-5,Methyl parathion
May-48,diazePAM
35485-2,Metasystox
35486-0,Fonofos
35487-8,Fenchlorphos
35488-6,Diazinon
35489-4,Chlorpyrifos
35490-2,Azinphos-methyl
35491-0,Leptospira sp DNA
35492-8,Staphylococcus aureus.methicillin resistant DNA
Mar-49,diazePAM
35493-6,Ricin
35494-4,Succinate dehydrogenase
35495-1,Citrate synthase
35496-9,NADH dehydrogenase
35497-7,NADH cytochrome C reductase
35498-5,Succinate cytochrome C reductase
35499-3,Pesticide & Insecticide panel
35500-8,Pesticide & Insecticide panel
Jan-50,diazePAM
35501-6,Pesticide & Insecticide panel
35502-4,Mitochondrial myopathy enzyme panel
35503-2,Arterial patency^pre arterial puncture
35504-0,Para aminobenzoate^6H post XXX bentiromide PO
35505-7,Lipoprotein.beta.subparticle
35506-5,Chronic lymphocytic leukemia gene targeted mutation analysis
35507-3,Amino acids panel
35508-1,Amino acids panel
35509-9,Amino acids panel
35510-7,General information section
35511-5,Background information section
35512-3,Trial objectives & purpose section
35513-1,Trial design section
35514-9,Subject selection and withdrawal section
35515-6,Subject participation+Epochs section
35516-4,Treatment of subjects+Epochs section
35517-2,Assessment section
35518-0,Efficacy assessment section
Sep-51,diazePAM
35519-8,Assessment of safety section
35520-6,Statistics section
35521-4,Direct access to source data+documents section
35522-2,Quality control and quality assurance section
35523-0,Ethics section
35524-8,Data handling and record keeping section
35525-5,Financing and insurance section
35526-3,Publication policy section
Jul-52,diazePAM^trough
35527-1,Supplements section
35528-9,Clinical trial protocol.total
35529-7,Beef Ab.IgG
35530-5,Candida albicans Ab.IgG
35531-3,Saccharum officinarum Ab.IgG
35532-1,Chicken Ab.IgG
35533-9,Coffea spp Ab.IgG
35534-7,Zea mays Ab.IgG
May-53,Dibenzepin
35535-4,Egg white Ab.IgG
35536-2,Egg yolk Ab.IgG
35537-0,Triticum aestivum Ab.IgG
35538-8,Saccharomyces cerevisiae Ab.IgG
35539-6,Cow milk Ab.IgG
35540-4,Agaricus hortensis Ab.IgG
35541-2,Allium cepa Ab.IgG
35542-0,Arachis hypogaea Ab.IgG
Mar-54,Dibucaine number
35543-8,Pork Ab.IgG
35544-6,Solanum tuberosum Ab.IgG
35545-3,Oryza sativa Ab.IgG
35546-1,Glycine max Ab.IgG
35547-9,Lycopersicon lycopersicum Ab.IgG
35548-7,Fusarium moniliforme Ab.IgG
35549-5,Mucor racemosus Ab.IgG
3555-0,Dichlorphenamide
35550-3,Phthalic anhydride Ab.IgG
35551-1,Phoma betae Ab.IgG
35552-9,Rhizopus nigricans Ab.IgG
35553-7,Stemphylium botryosum Ab.IgG
35554-5,Chocolate Ab.IgG
35555-2,Setomelanomma rostrata Ab.IgG
35556-0,Trichophyton rubrum Ab.IgG
35557-8,Cladosporium cladosporioides Ab.IgG
35558-6,Cholinesterase panel
35559-4,Protein.monoclonal band 2
35560-2,Protein.monoclonal
35561-0,Protein.monoclonal band 2
35562-8,Bile acid^post CFst
35563-6,Rickettsia rickettsii Ab.IgG & IgM panel
35564-4,HIV 1 p31+p32 Ab
35565-1,HIV 1 p40 Ab
35566-9,Parathyrin^baseline
35567-7,Parathyrin^10M post excision
Aug-56,Dichlorphenamide
35568-5,Protein fractions.oligoclonal bands
35569-3,Protein fractions.oligoclonal bands
35570-1,Renin
35571-9,Tyrosine
35572-7,Phenylalanine/Tyrosine
35573-5,Procollagen+Collagen
35574-3,Fatty acid oxidation
35575-0,Pigeon antibody panel
Jun-57,Dichlorphenamide
35576-8,Hydrocarbon and oxygenated volatiles panel
35577-6,Hypersensitivity pneumonitis panel
35578-4,"1,2-Glyceryl dinitrate"
35579-2,Tetrahydrofuran
355-8,Neomycin
35580-0,N-methyl valine
35581-8,Hydroxyethyl valine
35582-6,Hydrazine
35583-4,Hydrazine/Creatinine
Apr-58,Dicoumarol
35584-2,Aniline
35585-9,2-Butoxyacetate
35586-7,4-Tert-Butylphenol
35587-5,2-Ethoxyacetate
35588-3,Ethylene glycol dinitrate
35589-1,Furoate/Creatinine
35590-9,Aniline
35591-7,Creatinine renal clearance.predicted
Feb-59,Digitoxin
35592-5,Creatinine renal clearance/1.73 sq M.predicted
35593-3,Creatinine renal clearance/1.73 sq M
35594-1,Creatinine renal clearance/1.73 sq M
35595-8,Acetaminophen
35596-6,Theophylline
35597-4,Salicylates
35598-2,Butalbital
35599-0,carBAMazepine
Jun-35,Azithromycin
3560-0,Digitoxin
35600-6,chlordiazePOXIDE
35601-4,chlorproMAZINE
35602-2,clomiPRAMINE
35603-0,clonazePAM
35604-8,Cyclobenzaprine
35605-5,N-desalkylflurazepam
35606-3,Desipramine
35607-1,diazePAM
35608-9,diphenhydrAMINE
35609-7,Doxepin
35610-5,FLUoxetine
35611-3,Flurazepam
35612-1,fluvoxaMINE
35613-9,Glutethimide
35614-7,Ibuprofen
35615-4,Lidocaine
35616-2,LORazepam
35617-0,Meperidine
Aug-61,Digitoxin>6H post dose
35618-8,Methadone
35619-6,Methaqualone
35620-4,Metoprolol
35621-2,Norclomipramine
35622-0,Nordiazepam
35623-8,Nordoxepin
35624-6,Norfluoxetine
35625-3,Normeperidine
Jun-62,Digoxin.free
35626-1,Norpropoxyphene
35627-9,Nortriptyline
35628-7,Norverapamil
35629-5,Oxazepam
35630-3,PENTobarbital
35631-1,PHENobarbital
35632-9,Phenytoin
35633-7,Propranolol
Apr-63,Digoxin>12H post dose
35634-5,Secobarbital
35635-2,traZODone
35636-0,Amitriptyline
35637-8,4-Hydroxyglutethimide
35638-6,Borrelia burgdorferi DNA
35639-4,Chlamydophila pneumoniae+Chlamydophila psittaci DNA
35640-2,Cells.CD5/100 cells
35641-0,Cells.CD7/100 cells
Feb-64,Dimetamphetamine
35642-8,Cotinine
35643-6,Collagen type 2 Ab
35644-4,Metanephrine/Creatinine
35645-1,NSD1 gene deletion
35646-9,Deoxypyridinoline/Creatinine
35647-7,Pyridinoline+Deoxypyridinoline/Creatinine
35648-5,C reactive protein
35649-3,Propoxyphene
35650-1,Lymphocytic choriomeningitis virus Ab.IgG & IgM panel
35651-9,Synovial lining cells/100 cells
35652-7,Epithelial cells/100 cells
35653-5,Cells.CD158
35654-3,Creatinine/body weight
35655-0,Butyrylcarnitine (C4)
35656-8,3-Hydroxystearoylcarnitine (C18-OH)
35657-6,Urea nitrogen/body weight
35658-4,Tumor survival (in months)
Sep-65,Dimetamphetamine
35659-2,Age at specimen collection
356-6,Neomycin
35660-0,Path report.final diagnosis section - text
35661-8,JC virus DNA
35662-6,Glucose
35663-4,Protein
35664-2,Ethanol
35665-9,Acetone
35666-7,Lymphocytic choriomeningitis virus Ab.IgG & IgM panel
Jul-66,Dimetamphetamine
35667-5,Atomoxetine
35668-3,Gentamicin
35669-1,Amikacin
35670-9,Tobramycin
35671-7,Galactomannan Ag
35672-5,Bilirubin.glucuronidated+Bilirubin.albumin bound/Bilirubin.total
35673-3,Phosphate
35674-1,Creatinine
May-67,Dimethyltryptamine
35675-8,Calcium
35676-6,Chloride
35677-4,Potassium
35678-2,Sodium
35679-0,Varicella zoster virus Ab.IgG & IgM panel
35680-8,Hepatitis E virus Ab panel
35681-6,Tissue transglutaminase Ab panel
35682-4,Trypanosoma cruzi Ab.IgG & IgM panel
Mar-68,Dimethyltryptamine
35683-2,Burkholderia pseudomallei Ab.IgG & IgM panel
35684-0,Colorado tick fever virus Ab.IgG & IgM panel
35685-7,Carbon dioxide
35686-5,GBA gene.c.1226A>G
35687-3,GBA gene.c.1297G>T
35688-1,GBA gene.c.1448T>G & 1448T>C
35689-9,GBA gene.c.84insG
35690-7,GBA gene.c.IVS2(+1)G>A & IVS2(+1)G>T
Jan-69,diphenhydrAMINE
35691-5,XXX microorganism DNA
35692-3,Cells.G0+G1 phase/100 cells
35693-1,GBA gene targeted mutation analysis
35694-9,California encephalitis virus Ab.IgG
35695-6,California encephalitis virus Ab.IgM
35696-4,California encephalitis virus Ab
35697-2,La Crosse virus Ab
35698-0,metFORMIN
35699-8,Anti-hyperglycemics
35700-4,Acetaminophen
35701-2,Acetylcholinesterase
35702-0,Acid hemolysis
35703-8,Adenosine deaminase
35704-6,Adenosine deaminase
35705-3,Adenovirus Ag
35706-1,Albumin/Protein.total
35707-9,Alkaline phosphatase.macrohepatic/Alkaline phosphatase.total
35708-7,Alpha 1 globulin
Sep-70,diphenhydrAMINE
35709-5,La Crosse virus Ab
35710-3,Chlamydia sp DNA
35711-1,Chlamydia sp DNA
35712-9,Chlamydia sp rRNA
35713-7,Chlamydia sp DNA
35714-5,Chlamydia sp rRNA
35715-2,Chlamydia sp rRNA
35716-0,Chlamydia sp DNA
Jul-71,diphenhydrAMINE
35717-8,Chlamydia sp rRNA
35718-6,Chlamydia sp rRNA
35719-4,Chlamydia sp DNA
35720-2,Chlamydia sp rRNA
35721-0,Chlamydia sp rRNA
35722-8,Chlamydia sp DNA
35723-6,Chlamydia sp rRNA
35724-4,Chlamydia sp DNA
May-72,diphenhydrAMINE
35725-1,Chlamydia sp rRNA
35726-9,Chlamydia sp rRNA
35727-7,Chlamydia sp DNA
35728-5,Chlamydia sp rRNA
35729-3,Chlamydia sp DNA
35730-1,Chlamydia sp rRNA
35731-9,Corylus avellana Ab.IgG.RAST class
35732-7,Histoplasma capsulatum H Ab
Mar-73,Dipipanone
35733-5,Histoplasma capsulatum M Ab
35734-3,Histoplasma capsulatum Ag
35735-0,Neisseria gonorrhoeae DNA
35736-8,Chlamydia sp rRNA
35737-6,Microscopic observation
35738-4,Inhibin A
35739-2,Brucella sp Ab.IgG & IgM panel
357-4,Neomycin
35740-0,Rickettsia sp Ab.IgG & IgM panel
Jan-74,Dipipanone
35741-8,Prostate specific Ag
35742-6,SH2D1A gene targeted mutation analysis
35743-4,Eastern equine encephalitis virus Ab.IgG & IgM panel
35744-2,TP73L gene targeted mutation analysis
35745-9,Fat/Solids.total
35746-7,Hyperchromia
35747-5,Hydrogen ion
35748-3,Hydrogen ion^^adjusted to patient's actual temperature
35749-1,DMPK phenotype
35750-9,DMPK gene allele 2.CTG repeats
35751-7,DMPK gene allele 1.CTG repeats
35752-5,Escherichia coli O157:H7 Ab.IgG & IgM panel
35753-3,Mitochondrial myopathy gene targeted mutation analysis
35754-1,Avilamycin
35755-8,Avilamycin
35756-6,Avilamycin
35757-4,Cefdinir
Aug-75,Dipipanone
35758-2,Cefdinir
35759-0,Cefditoren
35760-8,Cefditoren
35761-6,Cefditoren
35762-4,Cefditoren
35763-2,Cefepime+Clavulanate
35764-0,Cefetamet
35765-7,Cefetamet
Jun-76,Disopyramide
35766-5,Cefixime
35767-3,Cefoperazone
35768-1,Cefoperazone+Sulbactam
35769-9,Cefotaxime+Clavulanate
35770-7,Cefotaxime+Clavulanate
35771-5,Cefotaxime+Clavulanate
35772-3,Cefotiam
35773-1,Cefotiam
Apr-77,Disulfiram
35774-9,cefTAZidime+Clavulanate
35775-6,cefTAZidime+Clavulanate
35776-4,cefTAZidime+Clavulanate
35777-2,Ceftibuten
35778-0,Ceftibuten
35779-8,Ceftibuten
35780-6,Ceftiofur
35781-4,Ceftiofur
Feb-78,Doxepin
35782-2,Cefuroxime.oral
35783-0,Cefuroxime.oral
35784-8,Cephalexin
35785-5,Clinafloxacin
35786-3,Clinafloxacin
35787-1,DAPTOmycin
35788-9,DAPTOmycin
35789-7,DAPTOmycin
3579-0,Doxepin
35790-5,Difloxacin
35791-3,Difloxacin
35792-1,Difloxacin
35793-9,Dirithromycin
35794-7,Dirithromycin
35795-4,Dirithromycin
35796-2,Enrofloxacin
35797-0,Enrofloxacin
35798-8,Enrofloxacin
35799-6,Ertapenem
35800-2,Ertapenem
35801-0,Ertapenem
35802-8,Ertapenem
35803-6,Bambermycins
35804-4,Bambermycins
35805-1,Bambermycins
35806-9,Fleroxacin
35807-7,Florfenicol
Aug-80,Doxepin
35808-5,Florfenicol
35809-3,Fosfomycin
35810-1,Fosfomycin
35811-9,Garenoxacin
35812-7,Garenoxacin
35813-5,Garenoxacin
35814-3,Gemifloxacin
35815-0,Gemifloxacin
Jun-81,Doxepin
35816-8,Gemifloxacin
35817-6,Gentamicin.high potency
35818-4,Grepafloxacin
35819-2,Imipenem+EDTA
358-2,Netilmicin
35820-0,Isepamicin
35821-8,Isepamicin
35822-6,Mupirocin
35823-4,Mupirocin
Apr-82,Doxepin+Nordoxepin
35824-2,Nystatin
35825-9,Orbifloxacin
35826-7,Orbifloxacin
35827-5,Orbifloxacin
35828-3,Pefloxacin
35829-1,Pirlimycin
35830-9,Pirlimycin
35831-7,Pirlimycin
Feb-83,Doxepin+Metabolites
35832-5,Polymyxin B
35833-3,Pristinamycin
35834-1,Pristinamycin
35835-8,Quinupristin+Dalfopristin
35836-6,Salinomycin
35837-4,Salinomycin
35838-2,Salinomycin
35839-0,Sparfloxacin
3584-0,Doxepin^trough
35840-8,Spectinomycin
35841-6,Streptomycin.high potency
35842-4,Sulfonamide
35843-2,Telithromycin
35844-0,Telithromycin
35845-7,Telithromycin
35846-5,Tiamulin
35847-3,Tiamulin
35848-1,Tiamulin
35849-9,Tilmicosin
35850-7,Tilmicosin
35851-5,Tilmicosin
35852-3,Trospectinomycin
35853-1,Trospectinomycin
35854-9,Trospectinomycin
35855-6,Trovafloxacin
35856-4,Tylosin
Jul-85,Doxylamine
35857-2,Tylosin
35858-0,Tylosin
35859-8,Virginiamycin
35860-6,Virginiamycin
35861-4,Virginiamycin
35862-2,Voriconazole
35863-0,Voriconazole
35864-8,Chronic lymphocytic leukemia gene mutations tested for
May-86,Doxylamine
35865-5,Lipoprotein.intermediate density
35866-3,Organic acids panel
35867-1,Acetoacetate
35868-9,2-Oxoisovalerate
35869-7,"2-Oxo,3-Methylvalerate"
35870-5,2-Oxoisocaproate
35871-3,Succinate
35872-1,Penicillin+Novobiocin
Mar-87,Dyphylline
35873-9,Penicillin+Novobiocin
35874-7,Penicillin+Novobiocin
35875-4,Herpes simplex virus 1+2 Ab
35876-2,Rickettsia sp Ab.IgM
35877-0,Rickettsia sp Ab.IgG
35878-8,Escherichia coli O157:H7 Ab.IgM
35879-6,Escherichia coli O157:H7 Ab.IgG
35880-4,Tissue transglutaminase Ab.IgM
Jan-88,Emetine
35881-2,Guidance for angioplasty^W contrast IA
35882-0,Guidance for angioplasty^W contrast IV
35883-8,Guidance for atherectomy^W contrast IA
35884-6,Guidance for drainage of abscess+placement of drainage catheter
35885-3,Guidance for drainage of abscess+placement of drainage catheter
35886-1,Guidance for percutaneous aspiration of fluid
35887-9,Guidance for percutaneous aspiration of cyst
35888-7,Guidance for percutaneous aspiration of fluid
35889-5,Guidance for bronchoscopy
35890-3,Guidance for percutaneous biopsy
35891-1,Guidance for percutaneous biopsy
35892-9,Guidance for percutaneous biopsy
35893-7,Guidance for percutaneous biopsy
35894-5,Guidance for percutaneous biopsy
35895-2,Guidance for percutaneous biopsy
35896-0,Guidance for percutaneous biopsy
35897-8,Guidance for percutaneous biopsy
35898-6,Guidance for percutaneous biopsy
Sep-89,Encainide
35899-4,Guidance for percutaneous biopsy
359-0,Netilmicin
35900-0,Guidance for percutaneous biopsy
35901-8,Guidance for percutaneous biopsy
35902-6,Guidance for percutaneous biopsy
35903-4,Guidance for biopsy
35904-2,Guidance for percutaneous biopsy
35905-9,Guidance for percutaneous biopsy
35906-7,Guidance for percutaneous biopsy
Jul-90,Enoxacin
35907-5,Guidance for percutaneous biopsy
35908-3,Guidance for percutaneous biopsy
35909-1,Guidance for percutaneous biopsy^W contrast IV
35910-9,Guidance for percutaneous biopsy^WO & W contrast IV
35911-7,Guidance for percutaneous biopsy^WO contrast
35912-5,Guidance for placement of catheter
35913-3,Guidance for drainage+placement of drainage catheter
35914-1,Guidance for drainage+placement of drainage catheter
May-91,ePHEDrine
35915-8,Guidance for drainage+placement of drainage catheter
35916-6,Guidance for drainage+placement of drainage catheter
35917-4,Guidance for drainage+placement of drainage catheter
35918-2,Guidance for drainage+placement of drainage catheter
35919-0,Guidance for drainage+placement of drainage catheter
35920-8,Guidance for drainage
35921-6,Guidance for drainage+placement of drainage catheter
35922-4,Guidance for drainage+placement of drainage catheter
Mar-92,ePHEDrine
35923-2,Guidance for drainage+placement of drainage catheter^W contrast IV
35924-0,Guidance for drainage+placement of drainage catheter^WO contrast
35925-7,Guidance for endoscopy
35926-5,Guidance for gastrostomy
35927-3,Guidance for injection
35928-1,Guidance for localization
35929-9,Guidance for localization
35930-7,Guidance for nerve block
Jan-93,ePHEDrine
35931-5,Guidance for nerve block
35932-3,Guidance for nerve block
35933-1,Guidance for percutaneous vertebroplasty
35934-9,Guidance for percutaneous vertebroplasty
35935-6,Guidance for percutaneous vertebroplasty
35936-4,Guidance for percutaneous vertebroplasty
35937-2,Guidance for placement of radiation therapy fields
35938-0,Guidance for placement of tube
35939-8,Multisection
35940-6,Multisection
35941-4,Multisection
35942-2,Multisection
35943-0,Multisection
35944-8,Multisection
35945-5,Multisection
35946-3,Multisection
35947-1,Multisection
35948-9,Multisection
Sep-94,Ephedrine+Pseudoephedrine
35949-7,Multisection
35950-5,Multisection
35951-3,Multisection
35952-1,Multisection
35953-9,Multisection
35954-7,Multisection
35955-4,Multisection
Jun-95,Ephedrine+Pseudoephedrine
35956-2,Multisection
35957-0,Multisection
35958-8,Multisection
35959-6,Multisection
35960-4,Multisection
35961-2,Multisection
35962-0,Multisection
35963-8,Multisection
Apr-96,Ephedrine+Pseudoephedrine
35964-6,Multisection
35965-3,Multisection
35966-1,Multisection
35967-9,Multisection
35968-7,Multisection
35969-5,Multisection
35970-3,Multisection
35971-1,Multisection
Feb-97,Erythromycin
35972-9,Multisection
35973-7,Multisection
35974-5,Multisection
35975-2,Multisection
35976-0,Multisection
35977-8,Multisection
35978-6,Multisection
35979-4,Multisection
3598-0,Estazolam
35980-2,Multisection
35981-0,Multisection
35982-8,Multisection
35983-6,Multisection
35984-4,Multisection
35985-1,Multisection
35986-9,Multisection
35987-7,Multisection
35988-5,Multisection
35989-3,Multisection
35990-1,Multisection
35991-9,Multisection
35992-7,Multisection
35993-5,Multisection
35994-3,Multisection
35995-0,Multisection
35996-8,Multisection
35997-6,Multisection
Aug-99,Etafedrine
35998-4,Multisection
35999-2,Multisection
36000-8,Multisection
36001-6,Multisection
36002-4,Multisection
36003-2,Multisection
Apr-00,Etafedrine
36004-0,Multisection
36005-7,Multisection
36006-5,Multisection
36007-3,Multisection
36008-1,Multisection
36009-9,Multisection
36010-7,Multisection
36011-5,Multisection
Feb-01,Etafedrine
36012-3,Multisection
36013-1,Multisection
36014-9,Multisection
36015-6,Multisection
36016-4,Multisection
36017-2,Multisection
36018-0,Multisection
36019-8,Multisection
3602-0,Etamivan
36020-6,Multisection
36021-4,Multisection
36022-2,Multisection
36023-0,Multisection
36024-8,Multisection
36025-5,Multisection
36026-3,Multisection
36027-1,Multisection
36028-9,Multisection
36029-7,Multisection
36030-5,Multisection
36031-3,Multisection
36032-1,Multisection
36033-9,Multisection
36034-7,Multisection
36035-4,Multisection
36036-2,Multisection
36037-0,Multisection
Aug-03,Etamivan
36038-8,Multisection
36039-6,Multisection
36040-4,Multisection
36041-2,Multisection
36042-0,Multisection
36043-8,Multisection
36044-6,Multisection
36045-3,Multisection
Jun-04,Etamivan
36046-1,Multisection
36047-9,Multisection
36048-7,Multisection
36049-5,Multisection
36050-3,Multisection
36051-1,Multisection
36052-9,Multisection
Mar-05,Ethacrynate
36053-7,Multisection
36054-5,Multisection
36055-2,Multisection
36056-0,Multisection
36057-8,Multisection
36058-6,Multisection
36059-4,Multisection
36060-2,Multisection
Jan-06,Ethacrynate
36061-0,Multisection
36062-8,Multisection
36063-6,Multisection
36064-4,Multisection
36065-1,Multisection
36066-9,Multisection
36067-7,Multisection
36068-5,Multisection
36069-3,Multisection
36070-1,Multisection
36071-9,Multisection
36072-7,Multisection
36073-5,Multisection
36074-3,Multisection
36075-0,Multisection
36076-8,Multisection
36077-6,Multisection
36078-4,Multisection
Sep-07,Ethambutol
36079-2,Multisection
360-8,Netilmicin
36080-0,Multisection
36081-8,Multisection
36082-6,Multisection
36083-4,Multisection
36084-2,Multisection
36085-9,Multisection
36086-7,Multisection limited
Jul-08,Ethchlorvynol
36087-5,Multisection limited
36088-3,Multisection limited
36089-1,Multisection limited
36090-9,Multisection limited
36091-7,Multisection limited
36092-5,Multisection limited
36093-3,Multisection limited
36094-1,Multisection limited
May-09,Ethchlorvynol
36095-8,Multisection limited^W contrast IV
36096-6,Multisection limited^W contrast IV
36097-4,Multisection limited^W contrast IV
36098-2,Multisection limited^W contrast IV
36099-0,Multisection limited^W contrast IV
36100-6,Multisection limited^W contrast IV
36101-4,Multisection limited^W contrast IV
36102-2,Multisection limited^WO & W contrast IV
Mar-10,Ethchlorvynol
36103-0,Multisection limited^WO contrast
36104-8,Multisection limited^WO contrast
36105-5,Multisection limited^WO contrast
36106-3,Multisection limited^WO contrast
36107-1,Multisection limited^WO contrast
36108-9,Multisection limited^WO contrast
36109-7,Multisection limited^WO contrast
36110-5,Multisection limited^WO contrast
Jan-11,Ethchlorvynol
36111-3,Multisection limited^WO contrast
36112-1,Multisection limited^WO contrast
36113-9,Multisection^W contrast IV
36114-7,Multisection dynamic^W contrast IV
36115-4,Multisection^W contrast IS
36116-2,Multisection^W contrast IS
36117-0,Multisection^W contrast IS
36118-8,Multisection^W contrast IS
36119-6,Multisection^W contrast IS
36120-4,Multisection^W contrast IS
36121-2,Multisection^W contrast IS
36122-0,Multisection^W contrast IS
36123-8,Multisection^W contrast IS
36124-6,Multisection^W contrast IS
36125-3,Multisection^W contrast IS
36126-1,Multisection^W contrast IS
36127-9,Multisection^W contrast IS
36128-7,Multisection^W contrast IS
Sep-12,Ethchlorvynol
36129-5,Multisection^W contrast IS
36130-3,Multisection^W contrast IS
36131-1,Multisection^W contrast IS
36132-9,Multisection^W contrast IS
36133-7,Multisection^W contrast IT
36134-5,Multisection^W contrast IV
36135-2,Multisection^W contrast IV
36136-0,Multisection^W contrast IV
Jul-13,Ethoheptazine
36137-8,Multisection^W contrast IV
36138-6,Multisection^W contrast IV
36139-4,Multisection^W contrast IV
36140-2,Multisection^W contrast IV
36141-0,Multisection^W contrast IV
36142-8,Multisection^W contrast IV
36143-6,Multisection^W contrast IV
36144-4,Multisection^W contrast IV
May-14,Ethoheptazine
36145-1,Multisection^W contrast IV
36146-9,Multisection^W contrast IV
36147-7,Multisection^W contrast IV
36148-5,Multisection^W contrast IV
36149-3,Multisection^W contrast IV
36150-1,Multisection^W contrast IV
36151-9,Multisection^W contrast IV
Feb-15,Ethoheptazine
36152-7,Multisection^W contrast IV
36153-5,Multisection^W contrast IV
36154-3,Multisection^W contrast IV
36155-0,Multisection^W contrast IV
36156-8,Multisection^W contrast IV
36157-6,Multisection^W contrast IV
36158-4,Multisection^W contrast IV
36159-2,Multisection^W contrast IV
361-6,Netilmicin
3616-0,Ethosuximide
36160-0,Multisection^W contrast IV
36161-8,Multisection^W contrast IV
36162-6,Multisection^W contrast IV
36163-4,Multisection^W contrast IV
36164-2,Multisection^W contrast IV
36165-9,Multisection^W contrast IV
36166-7,Multisection^W contrast IV
36167-5,Multisection^W contrast IV
36168-3,Multisection^W contrast IV
36169-1,Multisection^W contrast IV
36170-9,Multisection^W contrast IV
36171-7,Multisection^W contrast IV
36172-5,Multisection^W contrast IV
36173-3,Multisection^W contrast IV
36174-1,Multisection^W contrast IV
36175-8,Multisection^W contrast IV
36176-6,Multisection^W contrast IV
36177-4,Multisection^W contrast IV
Aug-17,Ethotoin
36178-2,Multisection^W contrast IV
36179-0,Multisection^W contrast IV
36180-8,Multisection^W contrast IV
36181-6,Multisection^W contrast IV
36182-4,Multisection^W contrast IV
36183-2,Multisection^W contrast IV
36184-0,Multisection^W contrast IV
36185-7,Multisection^W contrast IV
Jun-18,Ethylmorphine
36186-5,Multisection^W contrast IV
36187-3,Multisection^W contrast IV
36188-1,Multisection^W contrast IV
36189-9,Multisection^W contrast IV
36190-7,Multisection^W contrast IV
36191-5,Multisection^W contrast IV
36192-3,Multisection^W contrast IV
36193-1,Multisection^W contrast IV
Apr-19,Ethylmorphine
36194-9,Multisection^W contrast IV
36195-6,Multisection^W contrast IV
36196-4,Multisection^W contrast IV
36197-2,Multisection^W contrast IV
36198-0,Multisection^W contrast IV
36199-8,Multisection^W contrast IV
36200-4,Multisection^W contrast IV
36201-2,Multisection^W contrast IV
Feb-20,N-ethylnicotinamide
36202-0,Multisection^W contrast IV
36203-8,Multisection^W contrast IV
36204-6,Multisection^W contrast IV
36205-3,Multisection^W contrast IV
36206-1,Multisection^W contrast IV
36207-9,Multisection^W contrast IV
36208-7,Multisection^W contrast IV
36209-5,Multisection^W contrast IV
3621-0,Etilefrine
36210-3,Multisection^W contrast IV
36211-1,Multisection^W contrast IV
36212-9,Multisection^W contrast IV
36213-7,Multisection^W contrast IV
36214-5,Multisection^W contrast IV
36215-2,Multisection^W contrast IV
36216-0,Multisection^W contrast IV
36217-8,Multisection^W contrast IV
36218-6,Multisection^W contrast IV
36219-4,Multisection^W contrast IV
36220-2,Multisection^W contrast IV
36221-0,Multisection^W contrast IV
36222-8,Multisection^W contrast IV
36223-6,Multisection^W contrast IV
36224-4,Multisection^W contrast IV
36225-1,Multisection^W contrast IV
36226-9,Multisection^W contrast IV
36227-7,Multisection^W contrast IV
Aug-22,Etilefrine
36228-5,Multisection^W contrast IV
36229-3,Multisection^W contrast IV
36230-1,Multisection^W contrast IV
36231-9,Multisection^W contrast IV
36232-7,Multisection^W contrast IV
36233-5,Multisection^W contrast IV
36234-3,Multisection^W contrast IV
36235-0,Multisection^W contrast IV
Jun-23,Etilefrine
36236-8,Multisection^W contrast IV
36237-6,Multisection^W contrast IV
36238-4,Multisection^W contrast IV
36239-2,Multisection^W contrast IV
362-4,Nitrofurantoin
36240-0,Multisection^W contrast IV
36241-8,Multisection^W contrast IV
36242-6,Multisection^W contrast IV
36243-4,Multisection^W contrast IV
Apr-24,Fencamfamin
36244-2,Multisection^W contrast IV
36245-9,Multisection^W contrast IV
36246-7,Multisection^W contrast IV
36247-5,Multisection^W contrast IV
36248-3,Multisection^W contrast IV
36249-1,Multisection^W contrast IV
36250-9,Multisection^W contrast IV
Jan-25,Fencamfamin
36251-7,Multisection^W contrast IV
36252-5,Multisection^W contrast IV
36253-3,Multisection^W contrast IV
36254-1,Multisection^W contrast IV
36255-8,Multisection^W contrast IV
36256-6,Multisection^W contrast IV
36257-4,Multisection^W contrast IV
36258-2,Multisection^W contrast IV
36259-0,Multisection^W contrast IV
36260-8,Multisection^W contrast IV
36261-6,Multisection^W contrast IV
36262-4,Multisection^W contrast IV
36263-2,Multisection^W contrast IV
36264-0,Multisection^W contrast IV
36265-7,Multisection^W contrast IV
36266-5,Multisection^W contrast IV
36267-3,Multisection^WO & W contrast IV
36268-1,Multisection^WO & W contrast IV
Sep-26,Fencamfamin
36269-9,Multisection^WO & W contrast IV
36270-7,Multisection^WO & W contrast IV
36271-5,Multisection^WO & W contrast IV
36272-3,Multisection^WO & W contrast IV
36273-1,Multisection^WO & W contrast IV
36274-9,Multisection^WO & W contrast IV
36275-6,Multisection^WO & W contrast IV
36276-4,Multisection^WO & W contrast IV
Jul-27,Fenetylline
36277-2,Multisection^WO & W contrast IV
36278-0,Multisection^WO & W contrast IV
36279-8,Multisection^WO & W contrast IV
36280-6,Multisection^WO & W contrast IV
36281-4,Multisection^WO & W contrast IV
36282-2,Multisection^WO & W contrast IV
36283-0,Multisection^WO & W contrast IV
36284-8,Multisection^WO & W contrast IV
May-28,Fenetylline
36285-5,Multisection^WO & W contrast IV
36286-3,Multisection^WO & W contrast IV
36287-1,Multisection^WO & W contrast IV
36288-9,Multisection^WO & W contrast IV
36289-7,Multisection^WO & W contrast IV
36290-5,Multisection^WO & W contrast IV
36291-3,Multisection^WO & W contrast IV
36292-1,Multisection^WO & W contrast IV
Mar-29,Fenetylline
36293-9,Views 3
36294-7,Views 3
36295-4,Views 3
36296-2,Views 3
36297-0,Views 3
36298-8,Views 3
36299-6,Views 3
36300-2,Views 3
Jan-30,Fenfluramine
36301-0,Views 3
36302-8,Views 3
36303-6,Views 3
36304-4,Views 3
36305-1,Views 3
36306-9,Views 3
36307-7,Views 3
36308-5,Views 3
36309-3,Views 3
36310-1,Views 3
36311-9,Views 3
36312-7,Views 3
36313-5,Views 3
36314-3,Views 3
36315-0,Views 3
36316-8,Views 3
36317-6,Views 4
36318-4,Views 4
Sep-31,Fenfluramine
36319-2,Views 4
363-2,Nitrofurantoin
36320-0,Views 4
36321-8,Views 4 && Views
36322-6,Views 4
36323-4,Views 4
36324-2,Views 4
36325-9,Views 4
36326-7,Views 4
Jul-32,Fenoprofen
36327-5,Views 4
36328-3,Views 4
36329-1,Views 4
36330-9,Views 4
36331-7,Views 4
36332-5,Views 4
36333-3,Multisection^WO & W contrast IV
36334-1,Multisection^WO & W contrast IV
May-33,Fenproporex
36335-8,Multisection^WO & W contrast IV
36336-6,Multisection^WO & W contrast IV
36337-4,Multisection^WO & W contrast IV
36338-2,Multisection^WO & W contrast IV
36339-0,Multisection^WO & W contrast IV
36340-8,Multisection^WO & W contrast IV
36341-6,Multisection^WO & W contrast IV
36342-4,Multisection^WO & W contrast IV
Mar-34,Fenproporex
36343-2,Multisection^WO & W contrast IV
36344-0,Multisection^WO & W contrast IV
36345-7,Multisection^WO & W contrast IV
36346-5,Multisection^WO & W contrast IV
36347-3,Multisection^WO & W contrast IV
36348-1,Multisection^WO & W contrast IV
36349-9,Multisection^WO & W contrast IV
3635-0,Fenproporex
36350-7,Multisection^WO & W contrast IV
36351-5,Multisection^WO & W contrast IV
36352-3,Multisection^WO & W contrast IV
36353-1,Multisection^WO & W contrast IV
36354-9,Multisection^WO & W contrast IV
36355-6,Multisection^WO & W contrast IV
36356-4,Multisection^WO & W contrast IV
36357-2,Multisection^WO & W contrast IV
36358-0,Multisection^WO & W contrast IV
36359-8,Multisection^WO & W contrast IV
36360-6,Multisection^WO & W contrast IV
36361-4,Multisection^WO & W contrast IV
36362-2,Multisection^WO & W contrast IV
36363-0,Multisection^WO & W contrast IV
36364-8,Multisection^WO & W contrast IV
36365-5,Multisection^WO & W contrast IV
36366-3,Multisection^WO & W contrast IV
36367-1,Multisection^WO & W contrast IV
Aug-36,fentaNYL
36368-9,Multisection^WO & W contrast IV
36369-7,Multisection^WO & W contrast IV
36370-5,Multisection^WO & W contrast IV
36371-3,Multisection^WO & W contrast IV
36372-1,Multisection^WO & W contrast IV
36373-9,Multisection^WO & W contrast IV
36374-7,Multisection^WO & W contrast IV
36375-4,Multisection^WO & W contrast IV
Jun-37,fentaNYL
36376-2,Multisection^WO & W contrast IV
36377-0,Multisection^WO & W contrast IV
36378-8,Multisection^WO & W contrast IV
36379-6,Multisection^WO & W contrast IV
36380-4,Multisection^WO & W contrast IV
36381-2,Multisection^WO & W contrast IV
36382-0,Multisection^WO & W contrast IV
36383-8,Multisection^WO & W contrast IV
Apr-38,Flecainide
36384-6,Multisection^WO & W contrast IV
36385-3,Multisection^WO & W contrast IV
36387-9,Multisection^WO & W contrast IV
36388-7,Multisection^WO & W contrast IV
36389-5,Multisection^WO & W contrast IV
36390-3,Multisection^WO & W contrast IV
36391-1,Multisection^WO & W contrast IV
Feb-39,5-Fluorocytosine
36392-9,Multisection^WO & W contrast IV
36393-7,Multisection^WO & W contrast IV
36394-5,Multisection^WO & W contrast IV
36395-2,Multisection^WO & W contrast IV
36396-0,Multisection^WO & W contrast IV
36397-8,Multisection^WO & W contrast IV
36398-6,Multisection^WO & W contrast IV
36399-4,Multisection^WO & W contrast IV
Apr-36,Azithromycin
364-0,Nitrofurantoin
3640-0,Flunitrazepam
36400-0,Multisection^WO & W contrast IV
36401-8,Multisection^WO & W contrast IV
36402-6,Multisection^WO & W contrast IV
36403-4,Multisection^WO & W contrast IV
36404-2,Multisection^WO & W contrast IV
36405-9,Multisection^WO & W contrast IV
36406-7,Multisection^WO & W contrast IV
36407-5,Multisection^WO & W contrast IV
36408-3,Multisection^WO & W contrast IV
36409-1,Multisection^WO & W contrast IV
36410-9,Multisection^WO & W contrast IV
36411-7,Multisection^WO & W contrast IV
36412-5,Multisection^WO & W contrast IV
36413-3,Multisection^WO & W contrast IV
36414-1,Multisection^WO & W contrast IV
36415-8,Multisection^WO & W contrast IV
36416-6,Multisection^WO & W contrast IV
36417-4,Multisection^WO & W contrast IV
Aug-41,Flunitrazepam
36418-2,Multisection^WO & W contrast IV
36419-0,Multisection^WO & W contrast IV
36420-8,Multisection^WO & W contrast IV
36421-6,Multisection^WO & W contrast IV
36422-4,Multisection^WO & W contrast IV
36423-2,Multisection^WO & W contrast IV
36424-0,Multisection^WO contrast
36425-7,Multisection^WO contrast
Jun-42,Fluorouracil
36426-5,Multisection^WO contrast
36427-3,Multisection^WO contrast
36428-1,Multisection^WO contrast
36429-9,Multisection^WO contrast
36430-7,Multisection^WO contrast
36431-5,Multisection^WO contrast
36432-3,Multisection^WO contrast
36433-1,Multisection^WO contrast
Apr-43,FLUoxetine
36434-9,Multisection^WO contrast
36435-6,Multisection^WO contrast
36436-4,Multisection^WO contrast
36437-2,Multisection^WO contrast
36438-0,Multisection^WO contrast
36439-8,Multisection^WO contrast
36440-6,Multisection^WO contrast
36441-4,Multisection^WO contrast
Feb-44,FLUoxetine
36442-2,Multisection^WO contrast
36443-0,Multisection^WO contrast
36444-8,Multisection^WO contrast
36445-5,Multisection^WO contrast
36446-3,Multisection^WO contrast
36447-1,Multisection^WO contrast
36448-9,Multisection^WO contrast
36449-7,Multisection^WO contrast
36450-5,Multisection^WO contrast
36451-3,Multisection^WO contrast
36452-1,Multisection^WO contrast
36453-9,Multisection^WO contrast
36454-7,Multisection^WO contrast
36455-4,Multisection^WO contrast
36456-2,Multisection^WO contrast
36457-0,Multisection^WO contrast
36458-8,Multisection^WO contrast
Sep-45,FLUoxetine
36459-6,Multisection^WO contrast
36460-4,Multisection^WO contrast
36461-2,Multisection^WO contrast
36462-0,Multisection^WO contrast
36463-8,Multisection^WO contrast
36464-6,Multisection^WO contrast
36465-3,Multisection^WO contrast
36466-1,Multisection^WO contrast
Jul-46,Fluoxymesterone
36467-9,Multisection^WO contrast
36468-7,Multisection^WO contrast
36469-5,Multisection^WO contrast
36470-3,Multisection^WO contrast
36471-1,Multisection^WO contrast
36472-9,Multisection^WO contrast
36473-7,Multisection^WO contrast
36474-5,Multisection^WO contrast
May-47,Fluoxymesterone
36475-2,Multisection^WO contrast
36476-0,Multisection^WO contrast
36477-8,Multisection^WO contrast
36478-6,Multisection^WO contrast
36479-4,Multisection^WO contrast
36480-2,Multisection^WO contrast
36481-0,Multisection^WO contrast
36482-8,Multisection^WO contrast
Mar-48,Fluoxymesterone
36483-6,Multisection^WO contrast
36484-4,Multisection^WO contrast
36485-1,Multisection^WO contrast
36486-9,Multisection^WO contrast
36487-7,Multisection^WO contrast
36488-5,Multisection^WO contrast
36489-3,Multisection^WO contrast
36490-1,Multisection^WO contrast
Jan-49,Flupenthixol
36491-9,Multisection^WO contrast
36492-7,Multisection^WO contrast
36493-5,Multisection^WO contrast
36494-3,Multisection^WO contrast
36495-0,Multisection^WO contrast
36496-8,Multisection^WO contrast
36497-6,Multisection^WO contrast
36498-4,Multisection^WO contrast
36499-2,Multisection^WO contrast
36500-7,Multisection^WO contrast
36501-5,Multisection^WO contrast
36502-3,Multisection^WO contrast
36503-1,Multisection^WO contrast
36504-9,Multisection^WO contrast
36505-6,Multisection^WO contrast
36506-4,Multisection^WO contrast
36507-2,Multisection^WO contrast
36508-0,Multisection^WO contrast
Sep-50,fluPHENAZine
36509-8,Multisection^WO contrast
36510-6,Multisection^WO contrast
36511-4,Multisection^WO contrast
36512-2,Multisection^WO contrast
36513-0,Multisection^WO contrast
36514-8,Multisection^WO contrast
36515-5,Multisection^WO contrast
36516-3,Multisection^WO contrast
Jul-51,fluPHENAZine
36517-1,Multisection^WO contrast
36518-9,Multisection^WO contrast
36519-7,Multisection^WO contrast
36520-5,Multisection^WO contrast
36521-3,Multisection^WO contrast
36522-1,Multisection^WO contrast
36523-9,Multisection^WO contrast
36524-7,Multisection^WO contrast
May-52,Flurazepam
36525-4,Multisection^WO contrast
36526-2,Multisection^WO contrast
36527-0,Multisection^WO contrast
36528-8,Multisection^WO contrast
36529-6,Multisection^WO contrast
36530-4,Multisection^WO contrast
36531-2,Multisection^WO contrast
36532-0,Multisection^WO contrast
Mar-53,Flurazepam
36533-8,Multisection^WO contrast
36534-6,Multisection^WO contrast
36535-3,Multisection^WO contrast
36536-1,Multisection^WO contrast
36537-9,Multisection^WO contrast
36538-7,Multisection^WO contrast
36539-5,Multisection^WO contrast
36540-3,Multisection^WO contrast
Jan-54,Flurazepam
36541-1,Multisection^WO contrast
36542-9,Multisection^WO contrast
36543-7,Multisection^WO contrast
36544-5,Multisection^WO contrast
36545-2,Multisection^WO contrast
36546-0,Multisection^WO contrast
36547-8,Multisection^WO contrast
36548-6,Multisection^WO contrast
36549-4,Multisection^WO contrast
36550-2,View
36551-0,View
36554-4,View
36555-1,View
36556-9,View
36557-7,View
Aug-55,Flurazepam
36558-5,View
36559-3,View
36560-1,View
36561-9,View
36563-5,View
36564-3,View
36565-0,View
Jun-56,Furfenorex
36566-8,View
36567-6,View
36568-4,View
36569-2,View
365-7,Nitrofurantoin
36570-0,View
36571-8,View AP
36572-6,View AP
36573-4,View AP
Apr-57,Furfenorex
36574-2,View AP
36575-9,View AP
36576-7,View AP
36577-5,View AP
36578-3,View AP
36579-1,View AP
36580-9,View AP
36581-7,View AP
Feb-58,Furfenorex
36582-5,View AP
36583-3,View AP
36584-1,View AP
36585-8,View AP
36586-6,View AP
36587-4,View AP
36588-2,View AP
36589-0,View AP
3659-0,Furosemide
36590-8,Views AP + lateral
36591-6,View lateral
36592-4,View lateral
36593-2,View lateral
36594-0,View lateral
36595-7,View lateral
36596-5,View lateral
36597-3,View lateral
36598-1,View lateral
36599-9,View lateral
36600-5,View lateral
36601-3,View lateral
36602-1,View lateral
36603-9,View lateral
36604-7,View lateral
36605-4,View lateral
36606-2,View lateral
36607-0,View oblique
Aug-60,Furosemide
36608-8,Views oblique
36609-6,View oblique
36610-4,View oblique
36611-2,View oblique
36612-0,View oblique
36613-8,View oblique
36614-6,View oblique
36615-3,View oblique
Jun-61,Furosemide
36616-1,View oblique
36617-9,View oblique
36618-7,View oblique
36619-5,Views oblique
36620-3,View L-anterior oblique
36621-1,View PA
36622-9,View PA
36623-7,View PA
Apr-62,Furosemide
36624-5,View PA
36625-2,Views
36626-0,Views
36627-8,Views
36628-6,Views
36629-4,Views
36630-2,Views
36631-0,Views
Feb-63,Gentamicin^peak
36632-8,Views
36633-6,Views
36634-4,Views
36635-1,Views
36636-9,Views
36637-7,Views
36638-5,Views
36639-3,Views
3664-0,Gentamicin^random
36640-1,Views
36641-9,Views 2
36642-7,Views 2
36643-5,Views 2
36644-3,Views 2 && Views
36645-0,Views 2
36646-8,Views 2
36647-6,Views 2
36648-4,Views 2
36649-2,Views 2
366-5,Norfloxacin
36650-0,Views 2
36651-8,Views 2
36652-6,Views 2
36653-4,Views 2
36654-2,Views 2
36655-9,Views 2
36656-7,Views 2
Jul-65,Gentamicin^trough
36657-5,Views 2
36658-3,Views 2
36659-1,Views 2
36660-9,Views 2
36661-7,Views 2
36662-5,Views 2
36663-3,Views 2
36664-1,Views 2
May-66,Glutethimide
36665-8,Views 2
36666-6,Views 2
36667-4,Views 2
36668-2,Views 2
36669-0,Views 2
36670-8,Views 2
36671-6,Views 2
36672-4,Views 2
Mar-67,Glutethimide
36673-2,Views 2
36674-0,Views 2
36675-7,Views 5
36676-5,Views 5
36677-3,Views 5
36678-1,Views 6
36679-9,Views 6
36680-7,Views 7
Jan-68,Glutethimide
36681-5,Views 7
36682-3,Views 8
36683-1,Views 8
36684-9,Views AP + lateral
36685-6,Views AP + lateral
36686-4,Views AP + lateral
36687-2,Views AP + lateral
36688-0,Views AP + lateral
36689-8,Views AP + lateral
36690-6,Views AP + lateral
36691-4,Views AP + lateral
36692-2,Views AP + lateral
36693-0,Views AP + lateral
36694-8,Views AP + lateral
36695-5,Views AP + lateral
36696-3,Views AP + lateral
36697-1,Views AP + lateral
36698-9,Views AP + lateral
Sep-69,Haloperidol
36699-7,Views AP + lateral
36700-3,Views AP + lateral
36701-1,Views AP + lateral
36702-9,Views AP + lateral
36703-7,Views AP + lateral
36704-5,Views AP + lateral
36705-2,Views AP + lateral
36706-0,Views AP + lateral
Jul-70,Haloperidol
36707-8,Views AP + lateral
36708-6,Views AP + lateral
36709-4,Views AP + lateral
36710-2,Views AP + lateral
36711-0,Views AP + lateral
36712-8,Views AP + lateral
36713-6,Views AP + lateral
36714-4,Views AP + lateral
May-71,Haloperidol
36715-1,Views AP + lateral
36716-9,Views AP + lateral
36717-7,Views AP + lateral
36718-5,Views AP + lateral
36719-3,Views AP + lateral
36720-1,Views AP + lateral + oblique
36721-9,Views AP + lateral + oblique
36722-7,Views AP + lateral + oblique
Mar-72,Heptaminol
36723-5,Views AP + lateral + oblique
36724-3,Views AP + lateral + oblique
36725-0,Views AP + lateral + oblique
36726-8,Views AP + lateral + oblique
36727-6,Views AP + lateral + oblique
36728-4,Views AP + lateral + oblique
36729-2,Views AP + lateral + oblique
367-3,Norfloxacin
36730-0,Views AP + lateral + oblique
Jan-73,Heptaminol
36731-8,Views AP + lateral + oblique
36732-6,Views AP + lateral + oblique
36733-4,Views AP + lateral + oblique
36734-2,Views AP + lateral + oblique
36735-9,Views AP + lateral + oblique
36736-7,Views AP + lateral + oblique
36737-5,Views limited
36738-3,Views limited
36739-1,Views limited
36740-9,Views oblique
36741-7,Views oblique
36742-5,Views oblique
36743-3,Views oblique
36744-1,Views oblique
36745-8,Views oblique
36746-6,Views oblique
36747-4,Views oblique
36748-2,Views oblique
Sep-74,Heptaminol
36749-0,Views oblique
36750-8,Views PA + AP lateral-decubitus
36751-6,Views PA + lateral && Views
36752-4,Views PA + lateral
36753-2,Views PA + lateral
36754-0,Views PA + lateral
36755-7,Views PA + lateral + oblique
Jun-75,hydroCHLOROthiazide
36756-5,Views PA + lateral + oblique
36757-3,Views PA + lateral + oblique
36758-1,Views PA + lateral + oblique + apical lordotic
36759-9,Views PA + apical lordotic
36760-7,Guidance for angioplasty^W contrast
36761-5,Guidance for balloon dilatation^W contrast
36762-3,Guidance for angioplasty^W contrast
36763-1,Guidance for angioplasty^W contrast IA
Apr-76,hydroCHLOROthiazide
36764-9,Guidance for atherectomy^W contrast
36765-6,Guidance for atherectomy^W contrast
36766-4,Guidance for atherectomy^W contrast IA
36767-2,Guidance for percutaneous biopsy
36768-0,Guidance for percutaneous biopsy
36769-8,Guidance for exchange of nephrostomy tube
36770-6,Guidance for drainage+placement of drainage catheter
36771-4,Guidance for injection
Feb-77,hydroCHLOROthiazide
36772-2,Guidance for placement of nephrostomy tube
36773-0,Multisection
36774-8,Multisection
36775-5,Multisection
36776-3,Multisection
36777-1,Multisection
36778-9,Multisection
36779-7,Multisection
3678-0,hydroCHLOROthiazide
36780-5,Multisection
36781-3,Multisection
36782-1,Multisection
36783-9,Multisection
36784-7,Multisection
36785-4,Multisection
36786-2,Multisection
36787-0,Multisection
36788-8,Multisection
36789-6,Multisection
36790-4,Multisection
36791-2,Multisection
36792-0,Multisection
36793-8,Multisection
36794-6,Multisection
36795-3,Multisection
36796-1,Multisection
36797-9,Multisection
Aug-79,HYDROcodone
36798-7,Multisection
36799-5,Multisection
36800-1,Multisection
36801-9,Multisection
36802-7,Multisection
36803-5,Multisection
36804-3,Multisection
36805-0,Multisection
Jun-80,HYDROcodone
36806-8,Multisection
36807-6,Multisection
36808-4,Multisection limited
36809-2,Multisection^W contrast IA
368-1,Norfloxacin
36810-0,Multisection^W contrast IS
36811-8,Multisection^W contrast IS
36812-6,Multisection^W contrast IS
36813-4,Multisection^W contrast IV
Apr-81,HYDROcodone
36814-2,Multisection^W contrast IV
36815-9,Multisection^W contrast IV
36816-7,Multisection^W contrast IV
36817-5,Multisection^W contrast IV
36818-3,Multisection^W contrast IV
36819-1,Multisection^W contrast IV
36820-9,Multisection^W contrast IV
36821-7,Multisection^W contrast IV
Feb-82,HYDROmorphone
36822-5,Multisection^W contrast IV
36823-3,Multisection^W contrast IV
36824-1,Multisection^W contrast IV
36825-8,Multisection^W contrast IV
36826-6,Multisection^W contrast IV
36827-4,Multisection^W contrast IV
36828-2,Multisection^W contrast IV
36829-0,Multisection^W contrast IV
3683-0,HYDROmorphone
36830-8,Multisection^W contrast IV
36831-6,Multisection^W contrast IV
36832-4,Multisection^W contrast IV
36833-2,Multisection^W contrast IV
36834-0,Multisection^W contrast IV
36835-7,Multisection^WO & W contrast IV
36836-5,Multisection^W & WO contrast IV
36837-3,Multisection^WO & W contrast IV
36838-1,Views 3
36839-9,Views 4
36840-7,Multisection^WO & W contrast IV
36841-5,Multisection^WO & W contrast IV
36842-3,Multisection^WO & W contrast IV
36843-1,Multisection^WO & W contrast IV
36844-9,Multisection^WO & W contrast IV
36845-6,Multisection^WO & W contrast IV
36846-4,Multisection^WO & W contrast IV
36847-2,Multisection^WO & W contrast IV
Aug-84,Hydroxychloroquine
36848-0,Multisection^WO & W contrast IV
36849-8,Multisection^WO & W contrast IV
36850-6,Multisection^WO & W contrast IV
36851-4,Multisection^WO & W contrast IV
36852-2,Multisection^WO & W contrast IV
36853-0,Multisection^WO & W contrast IV
36854-8,Multisection^WO & W contrast IV
May-85,Hydroxymethoxyphenamine
36855-5,Multisection^WO & W contrast IV
36856-3,Multisection^WO & W contrast IV
36857-1,Multisection^WO & W contrast IV
36858-9,Multisection^WO & W contrast IV
36859-7,Multisection^WO & W contrast IV
36860-5,Multisection^WO & W contrast IV
36861-3,Multisection^WO & W contrast IV
36862-1,Multisection^WO & W contrast IV
Mar-86,hydrOXYzine
36863-9,Multisection^WO & W contrast IV
36864-7,Multisection^WO & W contrast IV
36865-4,Multisection^WO & W contrast IV
36866-2,Multisection^WO contrast
36867-0,Multisection^WO contrast
36868-8,Multisection^WO contrast
36869-6,Multisection^WO contrast
36870-4,Multisection^WO contrast
Jan-87,Ibuprofen
36871-2,Multisection^WO contrast
36872-0,Multisection^WO contrast
36873-8,Multisection^WO contrast
36874-6,Multisection^WO contrast
36875-3,Multisection^WO contrast
36876-1,Multisection^WO contrast
36877-9,Multisection^WO contrast
36878-7,Multisection^WO contrast
36879-5,Multisection^WO contrast
36880-3,Multisection^WO contrast
36881-1,Multisection^WO contrast
36882-9,Multisection^WO contrast
36883-7,Multisection^WO contrast
36886-0,Views
36887-8,Views
Sep-88,Imipenem+Cilastatin
36890-2,Views 5
36893-6,Views limited
36894-4,Views oblique
36895-1,Arbovirus Ab
36896-9,West Nile virus polyvalent E Ab
Jul-89,Imipramine
36897-7,West Nile virus Ab
36898-5,West Nile virus NS5 Ab
36899-3,Arbovirus Ab
36900-9,West Nile virus polyvalent E Ab
36901-7,West Nile virus NS5 Ab
36902-5,Chlamydia trachomatis+Neisseria gonorrhoeae DNA
36903-3,Chlamydia trachomatis & Neisseria gonorrhoeae DNA
36904-1,Inhibin A^^adjusted
May-90,Imipramine
36905-8,Inhibin A^^unadjusted
36906-6,Complement C1 esterase inhibitor
36907-4,Chromosome 8 trisomy
36908-2,Gene mutations tested for
36909-0,Cells.G0+G1 phase/100 cells
36910-8,Cells.S phase/100 cells
36911-6,Spinocerebellar ataxia gene targeted mutation analysis
36912-4,CATCH22 syndrome gene mutations tested for
Mar-91,Imipramine
36913-2,FMR1 gene targeted mutation analysis
36914-0,FMR1 gene mutations tested for
36915-7,AS+PWS gene mutations tested for
36916-5,Immunoglobulin light chains.kappa.free
36917-3,Chromosome uniparental disomy
36918-1,ALDOB gene targeted mutation analysis
36919-9,ELN gene mutations tested for
36920-7,PROP1 gene targeted mutation analysis
Jan-92,Imipramine
36921-5,Herpes simplex virus 1+2 Ab.IgG
36922-3,TPMT gene targeted mutation analysis
36923-1,Epstein Barr virus DNA
36924-9,14-3-3 Ag
36925-6,MEFV gene targeted mutation analysis
36926-4,Guidance for aspiration+placement of drainage tube
36927-2,Guidance for percutaneous biopsy
36928-0,Guidance for stereotactic biopsy
36929-8,Guidance for stereotactic biopsy^WO contrast
36930-6,Multisection
36931-4,Multisection
36932-2,Multisection
36933-0,Multisection
36934-8,Multisection for calcium score
36935-5,Multisection for calcium score^W contrast IV
36936-3,Guidance for stereotactic biopsy
36937-1,Multisection limited
36938-9,Multisection limited^WO contrast
Sep-93,Imipramine^trough
36939-7,Multisection stereotactic
36940-5,Multisection stereotactic
36941-3,Multisection^W contrast intra salivary duct
36942-1,Multisection^W contrast IV
36943-9,Multisection^W contrast IV
36944-7,Multisection^WO & W contrast IV
36945-4,Views 2^W standing
36946-2,Views 2^W standing
Jul-94,Indomethacin
36947-0,Views 3^W standing
36948-8,Views 3^W standing
36949-6,Views 3^W standing
36950-4,Multisection^WO & W contrast IV
36951-2,Multisection^WO & W contrast IV
36952-0,Multisection^WO contrast
36953-8,Multisection^WO contrast
Apr-95,Insulin
36954-6,Multisection^WO contrast
36955-3,Multisection^WO contrast
36956-1,Multisection^WO contrast
36957-9,Multisection & 3D reconstruction
36958-7,View AP
36959-5,View AP
36960-3,View AP upright
36961-1,Views AP + West Point + outlet
Feb-96,Insulin renal clearance
36962-9,View axillary
36963-7,View axillary
36964-5,View axillary
36965-2,View Ball Catcher
36966-0,View Brewerton
36967-8,View Brewerton
36968-6,View^W clenched fist
36969-4,View decubitus
3697-0,Isoniazid
36970-2,View decubitus portable
36971-0,View lateral^W extension
36972-8,View lateral^W flexion
36973-6,View Friedman
36974-4,View Garth
36975-1,View Harris
36976-9,View Harris
36977-7,View Harris
36978-5,View Holmblad
36979-3,View Jones
36980-1,View Jones
36981-9,View Judet
36982-7,View Judet
36983-5,View Judet
36984-3,View lateral crosstable
36985-0,View lateral crosstable
36986-8,View lateral crosstable
36987-6,View lateral crosstable
Aug-98,Kanamycin^peak
36988-4,View lateral crosstable
36989-2,View lateral crosstable
369-9,Norfloxacin
36990-0,View lateral crosstable
36991-8,View lateral crosstable
36992-6,View lateral crosstable
36993-4,View lateral frog
36994-2,View lateral frog
36995-9,View L-lateral
Jun-99,Kanamycin^random
36996-7,View R-lateral
36997-5,View lateral^W extension
36998-3,View lateral^W flexion
36999-1,View lateral^W extension
37000-7,View lateral^W extension
37001-5,View lateral^W standing
Feb-00,Kanamycin^trough
37002-3,View lateral^W standing
37003-1,View lateral^W standing
37004-9,View Laurin
37005-6,View magnification
37006-4,View MLO
37007-2,View Mortise
37008-0,View L-oblique
37009-8,View L-oblique
3701-0,Ketamine
37010-6,View R-oblique
37011-4,View R-oblique
37012-2,View outlet
37013-0,View outlet
37014-8,View PA^W standing
37015-5,View PA prone
37016-3,Views rolled
37017-1,Views rolled
37018-9,View Rosenberg^W standing
37019-7,View Rosenberg^W standing
37020-5,View Rosenberg^W standing
37021-3,Views ski jump
37022-1,Views ski jump
37023-9,Views ski jump
37024-7,View Stryker Notch
37025-4,View Stryker Notch
37026-2,View submentovertex
37027-0,View Sunrise
Aug-02,Ketobemidone
37028-8,View tangential
37029-6,View tangential
37030-4,View tangential
37031-2,View transthoracic
37032-0,View transthoracic
37033-8,View transthoracic
37034-6,View transthoracic
37035-3,View Grashey
Jun-03,Ketobemidone
37037-9,View true lateral
37038-7,View true lateral
37039-5,View true lateral
37040-3,View true lateral
37041-1,View tunnel
37042-9,View tunnel
37043-7,View tunnel^W standing
Apr-04,Labetalol
37044-5,View ulnar deviation
37045-2,View ulnar deviation
37046-0,View upright
37047-8,View Velpeau axillary
37048-6,View Velpeau axillary
37049-4,View Von Rosen
37050-2,View West Point
Jan-05,Labetalol
37051-0,View West Point
37052-8,View XCCL
37053-6,View XCCL
37054-4,View Y
37055-1,View Y
37056-9,View Zanca
37057-7,View Zanca
37058-5,View^W standing
37059-3,View^W standing
37060-1,Views
37062-7,Views
37063-5,Views of foreign body
37064-3,Views 2
37066-8,Views 2
37067-6,Views 2^W nipple markers
37068-4,Views 2^W standing
Sep-06,Labetalol
37069-2,Views 2^W standing
370-7,Novobiocin
37070-0,Views 4
37071-8,Views 4
37072-6,Views 5
37073-4,Views 5^W standing
37074-2,Views 6
37075-9,Views AP
37076-7,Views supine + lateral-decubitus
Jul-07,Labetalol
37077-5,Views AP + lateral crosstable
37078-3,Views AP + lateral
37079-1,Views AP + lateral + odontoid
37080-9,Views AP + axillary
37081-7,Views AP + axillary + outlet
37082-5,Views AP + axillary + outlet
37083-3,Views AP + axillary + outlet + Zanca
37084-1,Views AP + axillary + Y
May-08,Methotrimeprazine
37085-8,Views supine + lateral-decubitus
37086-6,Views AP + lateral crosstable
37087-4,Views AP + lateral crosstable
37088-2,Views AP + lateral crosstable
37089-0,Views AP + lateral crosstable
37090-8,Views AP + lateral crosstable
37091-6,Views AP + lateral frog
37092-4,Views AP + lateral frog
Mar-09,Levomepromazine
37093-2,Views AP + lateral frog
37094-0,Views AP + lateral frog
37095-7,Views AP + lateral + Mortise
37096-5,Views AP + lateral + Mortise
37097-3,Views AP + lateral + Mortise
37098-1,(Views AP + oblique) + (View lateral^W flexion + W extension)
37099-9,Views AP + lateral + oblique + odontoid
37100-5,(Views AP + oblique + odontoid) + (View lateral^W flexion + W extension)
Jan-10,Levorphanol
37101-3,Views AP + lateral + oblique + spot
37102-1,Views AP + lateral + oblique + Sunrise
37103-9,Views AP + lateral + odontoid
37104-7,(Views AP + odontoid) + (View lateral^W flexion + W extension)
37105-4,Views AP + lateral + spot
37106-2,Views AP + lateral + Sunrise
37107-0,Views AP + lateral + Sunrise
37108-8,Views AP + lateral + Sunrise
37109-6,Views AP + lateral + Sunrise
37110-4,Views AP + lateral + Sunrise
37111-2,Views AP + lateral + Sunrise + tunnel
37112-0,Views AP + lateral + tunnel
37113-8,Views AP + lateral + tunnel
37114-6,Views AP + lateral + tunnel
37115-3,Views AP + lateral + oblique + tunnel
37116-1,Views AP + lateral + Sunrise + tunnel
37117-9,Views AP + lateral + Sunrise + tunnel
37118-7,Views AP + lateral + oblique + Sunrise + tunnel
Sep-11,Levorphanol
37119-5,Views AP + oblique
37120-3,Views AP + odontoid + lateral crosstable
37121-1,Views AP + Serendipity
37122-9,Views AP + Stryker Notch
37123-7,Views AP + West Point
37124-5,Views AP + Y
37125-2,Views AP + Y
37126-0,Views AP + axillary + Y
Jul-12,Levorphanol
37127-8,Views axillary + Y
37128-6,Views axillary + Y
37129-4,Views AP & axillary & Y
37131-0,Views R-lateral + L-lateral
37132-8,Views lateral^W flexion + W extension
37133-6,Views lateral^W flexion + W extension
37134-4,Views lateral + Mortise
May-13,Levorphanol
37135-1,Views lateral + Mortise
37136-9,Views lateral + Y
37137-7,Views limited^W contrast IV
37138-5,Views R-oblique + L-oblique
37139-3,(View oblique) + (View lateral^W flexion + W extension)
37140-1,Views outlet + Y
37141-9,Views PA + R-lateral
37142-7,Views PA + lateral + Ball Catcher
Mar-14,Lidocaine
37143-5,Views PA + lateral + AP lateral-decubitus
37144-3,Views PA + lateral + AP L-lateral-decubitus
37145-0,Views PA + lateral + AP R-lateral-decubitus
37146-8,Views PA + lateral + L-oblique
37147-6,Views PA + lateral + R-oblique
37148-4,Views PA + lateral + oblique + Towne
37149-2,Views PA + lateral + Sunrise
371-5,Novobiocin
3715-0,Lidocaine
37150-0,Views PA + R-oblique + L-oblique
37151-8,Views
37152-6,Views outlet + Y
37153-4,Views Stenver + Arcelin
37154-2,Views oblique + Sunrise
37155-9,Views oblique + Sunrise + tunnel
37156-7,Views Sunrise + tunnel
37157-5,Views Grashey + outlet
37158-3,Views Grashey + axillary + outlet
37159-1,Views tarsal
37160-9,Views Grashey + axillary
37161-7,Views Grashey + axillary + outlet + Zanca
37162-5,Views Grashey + outlet + Serendipity
37163-3,Views Sunrise + tunnel
37164-1,Views lateral + Caldwell + Waters
37165-8,Views lateral + Caldwell + Waters + submentovertex
37166-6,Views lateral + Caldwell + Waters + submentovertex + Towne
37167-4,Views Grashey + West Point
Aug-16,Lidocaine
37168-2,Views
37169-0,Views
37170-8,Views
37171-6,Views
37172-4,Views
37173-2,Views^W contrast IA
37174-0,Views^W contrast IA
37175-7,Views^W contrast IA
Jun-17,Lidocaine^>45m post bolus dose
37176-5,Views^W contrast IA
37177-3,Views^W contrast IA
37178-1,Views^W contrast IA
37179-9,Views^W contrast IA
37180-7,Views^W contrast IA
37181-5,Views^W contrast IA
37182-3,Views^W contrast IA
37183-1,Views^W contrast IS
Apr-18,Lithium
37184-9,Views^W contrast IS
37185-6,Views^W contrast IS
37186-4,Views^W contrast IS
37187-2,Views^W contrast IS
37188-0,Views^W contrast IS
37189-8,Views^W contrast IS
37190-6,Views^W contrast IS
37191-4,Views^W contrast IS
Feb-19,Lithium
37192-2,Views^W contrast intradisc
37193-0,Views^W contrast intradisc
37195-5,Views^W contrast IV
37196-3,Views^W contrast IV
37197-1,Views^W contrast IV
37198-9,Views^W contrast PO
37199-7,Views^W contrast PO
Feb-37,Azithromycin
3720-0,Lithium
37200-3,Views^W contrast PO
37201-1,Views^W standing
37202-9,Views^W standing
37203-7,Views^W standing
37204-5,Views^W standing
37205-2,Views^W standing
37206-0,Views^W standing
37207-8,View^W standing
37208-6,Views^W standing
37209-4,Views^W standing
37210-2,Guidance for percutaneous aspiration of cyst
37211-0,Guidance for percutaneous biopsy
37212-8,Guidance for percutaneous biopsy
37213-6,Guidance for percutaneous biopsy
37214-4,Guidance for superficial biopsy
37215-1,Multisection^W contrast IV
37216-9,Multisection
37217-7,Multisection
Aug-21,Lithium
37218-5,Multisection
37219-3,Multisection
37220-1,Multisection
37221-9,Multisection for fistula
37222-7,Multisection
37223-5,Multisection
37224-3,Multisection
37225-0,Multisection
Jun-22,Lithium renal clearance
37226-8,Multisection
37227-6,Multisection
37228-4,Multisection
37229-2,Multisection
372-3,Novobiocin
37230-0,Multisection
37231-8,Multisection
37232-6,Multisection
37233-4,Multisection
Apr-23,Lithium^trough
37234-2,Multisection
37235-9,Multisection
37236-7,Multisection
37237-5,Multisection^W contrast intra sinus tract
37238-3,Multisection^W contrast IS
37239-1,Multisection^W contrast IV
37240-9,Multisection^W contrast IV
37241-7,Multisection^W contrast IV
Feb-24,LORazepam
37242-5,Multisection^W contrast IV
37243-3,Multisection^W contrast IV
37244-1,Multisection^W contrast IV
37245-8,Multisection^W contrast IV
37246-6,Multisection^W contrast IV
37247-4,Multisection^W contrast IV
37248-2,Multisection^W contrast IV
37249-0,Multisection^W contrast IV
37253-2,Multisection^W contrast IV
37254-0,Multisection^W contrast IV
37256-5,Views 3
37257-3,Views 3
Sep-25,LORazepam
37259-9,Views 3
37260-7,Views 3
37261-5,Views 3
37265-6,Multisection^WO & W contrast IV
37266-4,Multisection^WO & W contrast IV
Jul-26,Lormetazepam
37267-2,Multisection^WO & W contrast IV
37268-0,Multisection^WO & W contrast IV
37269-8,Multisection^WO & W contrast IV
37270-6,Multisection^WO & W contrast IV
37271-4,Multisection^WO & W contrast IV
37272-2,Multisection^WO & W contrast IV
May-27,Loxapine
37277-1,Multisection^WO & W contrast IV
37278-9,Multisection^WO contrast
37279-7,Multisection^WO contrast
37280-5,Multisection^WO contrast
37281-3,Multisection^WO contrast
37282-1,Multisection^WO contrast
Mar-28,Loxapine
37283-9,Multisection^WO contrast
37284-7,Multisection^WO contrast
37285-4,Multisection^WO contrast
37286-2,Multisection^WO contrast
37287-0,Multisection^WO contrast
37288-8,Multisection^WO contrast
Jan-29,Loxapine
37293-8,Multisection^WO contrast
37294-6,Multisection & 3D reconstruction
37295-3,Multisection anteversion measurement
37297-9,View for fetal age
37298-7,View Serendipity
37299-5,View Serendipity
37300-1,View true AP
37302-7,Views scaphoid
37303-5,Views
37304-3,Views scaphoid
Sep-30,Lysergate diethylamide
373-1,Novobiocin
Jul-31,Lysergate diethylamide
37319-1,Views
37320-9,Views
37321-7,Views
37323-3,Views
37324-1,Views
May-32,Lysergate diethylamide
37325-8,Views
37332-4,Views
Mar-33,Lysergate diethylamide
37338-1,Views
37340-7,Views
Jan-34,Maprotiline
37341-5,Views
37342-3,Views
37348-0,Views 2
37350-6,Views 5
37351-4,Views 5
37353-0,Views 5
37355-5,Views 5
37356-3,Views 5
37357-1,Views 5
Aug-35,Maprotiline
37361-3,Views AP + lateral
37362-1,Views bone age
37363-9,Views runoff^W contrast IA
37364-7,Views runoff^W contrast IA
37365-4,Views survey for metastasis
Jun-36,Maprotiline
37366-2,Views^W contrast IA
Apr-37,Maprotiline
37379-5,Views^W contrast IA
37380-3,Views^W contrast IA
37381-1,Views^W contrast IA
Feb-38,Maprotiline
37382-9,Views^W contrast IA
37383-7,Views^W contrast IA
37384-5,Views^W contrast IA
37385-2,Views^W contrast IA
37386-0,Views^W contrast IA
37387-8,Views^W contrast IA
37388-6,Views^W contrast IA
37389-4,Views^W contrast IA
3739-0,Medazepam
37390-2,Views^W contrast IA
37391-0,Views^W contrast IA
37392-8,Views^W contrast IA
37393-6,Views^W contrast IA
37394-4,Views^W contrast IA
37395-1,Views^W contrast IA
37396-9,Views^W contrast IA
37397-7,Views^W contrast IA
37398-5,Views^W contrast IA
37399-3,Views^W contrast IA
37401-7,Views^W contrast IA
37402-5,Views^W contrast IA
37403-3,Views^W contrast IA
37404-1,Views^W contrast IA
37405-8,Views^W contrast IA
37406-6,Views^W contrast IA
37407-4,Views^W contrast IA
Aug-40,Medazepam
37409-0,Views^W contrast IS
37410-8,Views^W contrast IS
37411-6,Views^W contrast IV
37412-4,Views^W contrast IV
37413-2,Views^W contrast IV
37414-0,Views^W contrast IV
37415-7,Views^W contrast IV
Jun-41,Mefenorex
37416-5,Views^W contrast IV
37419-9,Views^W contrast IV
37420-7,Views^W contrast IV
37421-5,Views^W contrast IV
37422-3,Views^W contrast IV
37423-1,Views^W contrast IV
Apr-42,Mefenorex
37424-9,Perchlorate
37425-6,Prion protein.abnormal
37426-4,Guidance for angioplasty^W contrast IV
37427-2,Guidance for injection
37428-0,Multisection
37429-8,Multisection
37430-6,Multisection
37431-4,Multisection
Feb-43,Mefenorex
37432-2,Multisection
37433-0,Multisection
37434-8,Multisection cine for function
37435-5,Multisection cine
37436-3,Multisection diffusion weighted
37437-1,Multisection dynamic^W contrast IV
37438-9,Multisection dynamic^W contrast IV
37439-7,Multisection
3744-0,Meperidine
37440-5,Multisection^W contrast IV
37441-3,Multisection^WO contrast
37442-1,Multisection
37443-9,Multisection
37444-7,Multisection^W contrast IS
37445-4,Multisection^W contrast IS
37446-2,Multisection^W contrast IS
37447-0,Multisection^W contrast IV
37448-8,Multisection^W contrast IV
37449-6,Multisection^W contrast IV
37450-4,Multisection^W contrast IV
37451-2,Multisection^W contrast IV
37452-0,Multisection^W contrast IV
37453-8,Multisection^W contrast IV
37454-6,Views 3
37455-3,Views 3
Jul-45,Meperidine
37457-9,Multisection^WO & W contrast IV
37458-7,Multisection^WO & W contrast IV
37459-5,Multisection^WO contrast
37460-3,Multisection^WO contrast
37461-1,Multisection^WO contrast
37462-9,Multisection^WO contrast
37463-7,Multisection^WO contrast
37464-5,Multisection^WO contrast
May-46,Meperidine
37465-2,Multisection^WO contrast
37466-0,Multisection^WO contrast
37467-8,View 10 degree cephalic angle
37468-6,View 30 degree caudal angle
37469-4,View 45 degree cephalic angle
37470-2,View 45 degree cephalic angle
37471-0,View Bora
37472-8,View Bora
Mar-47,Meperidine
37473-6,View Grashey
37474-4,Views lateral^W manual stress
37475-1,View Mortise^W manual stress
37476-9,View PA 45 degree flexion
37477-7,View PA 45 degree flexion^W standing
Jan-48,Meperidine
37481-9,Views
37482-7,Views 2
37483-5,Views 2
37484-3,Views AP^W manual stress
37485-0,Views AP + transthoracic
37486-8,Views Broden^W manual stress
37487-6,Views^W contrast IA
37488-4,Views^W contrast IA
37489-2,Views^W contrast IA
374-9,Ofloxacin
37490-0,Views^W contrast IA
37491-8,Guidance for percutaneous aspiration of fluid
37492-6,Guidance for percutaneous biopsy
37493-4,Guidance for injection
37494-2,Guidance for injection
37495-9,Multisection
37496-7,Multisection^W contrast intradisc
37497-5,Multisection
37498-3,Multisection^W contrast IV
Sep-49,Mephenytoin
37499-1,Multisection^W contrast IV
37500-6,Multisection^W contrast IV
37501-4,Multisection^W contrast IV
37502-2,Multisection^W contrast IV
37503-0,Multisection^W contrast IV
37505-5,Multisection^WO & W contrast IV
37506-3,Multisection^WO & W contrast IV
Jul-50,Mephobarbital
37507-1,Multisection^WO & W contrast IV
37508-9,Multisection^WO & W contrast IV
37509-7,Multisection^W contrast intradisc
37510-5,Multisection^WO contrast
37511-3,Multisection^WO contrast
37512-1,Multisection^WO contrast
37513-9,View 10 degree caudal angle
37514-7,View 10 degree caudal angle
May-51,Mephobarbital
37515-4,View lateral spot
37516-2,View lateral spot^W standing
37517-0,Views
37518-8,Views
37519-6,Views
37520-4,Views
37521-2,Views
37522-0,Views
Mar-52,Meprobamate
37523-8,Views
37524-6,Views
37530-3,Views
Jan-53,Meprobamate
37531-1,Views
37532-9,Views
37533-7,Views
37534-5,Views
37535-2,Views
37538-6,Views Grashey + axillary + Y
37539-4,Views grid
37540-2,Views Holmblad^W standing
37541-0,Views Law + Mayer + Stenver + Towne
37542-8,Views magnification
37543-6,Views magnification
37544-4,Views oblique
37545-1,View oblique crosstable
37546-9,Views open mouth + closed mouth
37547-7,Views PA + lateral
37548-5,Views PA + lateral
Sep-54,Meprobamate
37549-3,Views PA + lateral + oblique
37550-1,Views PA + lateral + oblique
37551-9,Views spot
37552-7,Views spot
37553-5,Views spot^compression
37554-3,Views magnification+spot
37555-0,Views ulnar deviation + radial deviation
Jun-55,Meprobamate
37556-8,Views^W manual stress
37557-6,Views^W manual stress
37558-4,Views^W manual stress
37559-2,Views^W manual stress
375-6,Ofloxacin
37560-0,Views^W manual stress
37561-8,Views^W manual stress
37562-6,Views^W manual stress
37563-4,Views^W manual stress
Apr-56,Mersalyl
37564-2,Views^W manual stress
37565-9,Views^W barium contrast via fistula
37566-7,Views^W contrast via catheter
37567-5,Views^W contrast via colostomy
37568-3,Views^W contrast via fistula
37569-1,Views^W contrast via suprapubic tube
37570-9,Views^W contrast IS
37571-7,Views^W contrast IS
Feb-57,Mersalyl
37572-5,Views^W contrast IT
37573-3,Views^W contrast IV
37574-1,Views^W contrast IV
37575-8,Views^post fatty meal+W contrast PO
37576-6,Views^W gastrografin via fistula
37577-4,Views^W weight
37578-2,Views^W weight
37579-0,Views^WO & W weight
3758-0,Mersalyl
37580-8,Views^WO & W weight
37581-6,Views^WO & W weight
37582-4,Views^WO weight
37583-2,Views + lateral frog
37584-0,Views^W standing
37585-7,Views^W contrast
37586-5,Views^W contrast intra corpus cavernosum
37587-3,Views^W contrast IA
37588-1,Views^W contrast IA
37589-9,Views^W contrast IA
37590-7,Views^W contrast IA
37591-5,Views^W contrast IA
37592-3,Views^W contrast IA
37593-1,Views^W contrast IA
37594-9,Views^W contrast IA
37595-6,Views for graft^W contrast IA
37596-4,Views^W contrast intra lymphatic
37597-2,Views^W contrast intra lymphatic
Aug-59,Mesantoin
37598-0,Views^W contrast intra lymphatic
37599-8,Views^W contrast intra lymphatic
37600-4,Views^W contrast intra lymphatic
37601-2,Views^W contrast intra lymphatic
37602-0,Views^W contrast IV
37603-8,Views lateral & PA chest
37604-6,Views 3
37605-3,Views lateral + Waters
Jun-60,Mesoridazine
37606-1,Multisection
37607-9,Views^W contrast IV
37608-7,Guidance for localization of foreign body
37609-5,Views 4
37611-1,Multisection
37612-9,Views 4
37613-7,View Waters
Apr-61,Mesterolone
37614-5,View
37615-2,Views^W contrast
37616-0,View
37617-8,Views 2
37618-6,Views AP + inlet
37619-4,Views AP + Judet
37620-2,Views AP + lateral
37621-0,Views AP + oblique
Feb-62,Mesterolone
37622-8,View AP
37623-6,Views AP + inlet + outlet
37624-4,Views AP + lateral + oblique
37625-1,View Ferguson
37626-9,View lateral frog
37627-7,Views inlet + outlet + oblique
37628-5,View inlet
37629-3,View lateral
3763-0,Mesterolone
37630-1,Views oblique
37631-9,View outlet
37632-7,Multisection
37633-5,View^W standing
37634-3,View AP 20 degree cephalic angle
37635-0,Views 3
37636-8,Views
37637-6,Views
37639-2,Views
376-4,Ofloxacin
37640-0,Views^W contrast
37641-8,Views^W contrast IS
37642-6,Views limited
37643-4,Views oblique
37644-2,Multisection
37645-9,View ulnar deviation
37646-7,Views limited
37647-5,Views^W contrast IS
Aug-64,Metandienone
37648-3,Views 3
37649-1,Views AP + oblique
37650-9,View Ferguson
37651-7,Views 2
37652-5,Views AP + lateral
37653-3,Multisection
37654-1,View
May-65,Metandienone
37655-8,Views 2
37656-6,View Y
37658-2,Views 2 for scoliosis
37659-0,View AP for scoliosis^W standing
37660-8,View lateral for scoliosis^W standing
37661-6,Views 2
37662-4,View AP
Mar-66,Metandienone
37663-2,Views^WO & W weight
37664-0,Views 2
37665-7,Views 3
37666-5,Views AP + lateral + Mortise
37667-3,Views AP + lateral
37668-1,Views AP + lateral + oblique
37669-9,Views lateral^W manual stress
37670-7,Views lateral + Mortise
Jan-67,Metaraminol
37671-5,View Mortise^W manual stress
37672-3,Views 2^W manual stress
37673-1,Views^W manual stress
37674-9,Multisection
37675-6,Views 2^W standing
37676-4,Views^W standing
37677-2,View carpal tunnel
37678-0,Views 2 carpal tunnel
37679-8,Views 2
37680-6,Views AP + Serendipity
37681-4,Views 2
37682-2,Views 3
37683-0,Views 4
37684-8,Views AP + lateral
37685-5,Views AP + lateral + oblique
37686-3,Views 2 oblique
37687-1,Views oblique
37688-9,Multisection
Sep-68,Metenolone
37689-7,View
37690-5,Views 2
37691-3,Views 4
37692-1,Views AP + lateral
37693-9,Views^W standing
37694-7,Views 2
37695-4,Views 3
37696-2,Views AP + lateral + oblique
Jul-69,Metenolone
37697-0,Views 2
37698-8,Views 2^W standing
37699-6,Views 3
37700-2,Views 3^W standing
37701-0,Views AP + lateral
37702-8,Views AP + lateral + oblique
37703-6,View lateral
37704-4,View oblique
May-70,Metenolone
37705-1,Views^W manual stress
37706-9,Multisection
37707-7,Views 2
37708-5,Views AP + lateral
37709-3,Views oblique
37710-1,Views AP + lateral
37711-9,Views AP + lateral + oblique
37712-7,View lateral
Mar-71,Methadone
37713-5,Views PA + lateral
37714-3,View PA
37715-0,Views PA + lateral + oblique
37716-8,Views
37717-6,Multisection
37718-4,Views 2
37719-2,Views AP + lateral
377-2,Ofloxacin
37720-0,Views^W standing
Jan-72,Methadone
37721-8,Views 2
37722-6,Views 3
37723-4,Views AP + lateral crosstable
37724-2,Views AP + lateral frog
37725-9,Views AP + lateral
37726-7,View AP
37727-5,View lateral crosstable
37728-3,View oblique crosstable
37729-1,View lateral frog
37730-9,View lateral
37731-7,View^W standing
37732-5,View Judet
37733-3,View AP^W standing
37734-1,View^W standing
37735-8,Multisection
37736-6,Views AP + lateral
37737-4,Views oblique
37738-2,Views
Sep-73,Methadone
37739-0,Views^W contrast IA
37740-8,Views AP + lateral + Sunrise + tunnel
37741-6,View
37742-4,Views 3
37743-2,Views 4
37744-0,Views 5
37745-7,Views AP + lateral
37746-5,Views AP^W manual stress
Jul-74,Methadone
37747-3,Views AP + lateral + tunnel
37748-1,Views AP + lateral + oblique
37749-9,Views AP + lateral + Sunrise
37750-7,View lateral^W extension
37751-5,View lateral
37752-3,View Rosenberg^W standing
37753-1,Views^W manual stress
Apr-75,Methadone
37754-9,View lateral^W standing
37755-6,View PA^W standing
37756-4,View tunnel^W standing
37757-2,Views oblique
37758-0,Views
37759-8,Views Sunrise + tunnel
37760-6,Multisection
37761-4,View tunnel
Feb-76,Methamphetamine
37762-2,Views 2^W standing
37763-0,Views 4^W standing
37764-8,View
37765-5,Views^W contrast
37766-3,Multisection
37767-1,Views^W contrast IV
37768-9,Views 2
37769-7,Views magnification+spot
3777-0,Methamphetamine
37770-5,View tangential
37771-3,View true lateral
37772-1,View XCCL
37773-9,View magnification
37774-7,Views
37775-4,Views rolled
37776-2,Views AP + lateral
37777-0,Views
37778-8,Views^W contrast IA
37779-6,Views^W contrast IA
37780-4,Views 2
37781-2,Views 3
37782-0,Views anterior + lateral
37783-8,View AP
37784-6,View lateral
37785-3,Views^W contrast IS
37786-1,Views
37787-9,Views 2
Aug-78,Methamphetamine
37788-7,Views AP + lateral
37789-5,Views AP + Y
37790-3,View Y
37791-1,View Stryker Notch
37792-9,View
37793-7,Views 2
37794-5,Views 4
37795-2,Views 5
Jun-79,Methamphetamine
37796-0,Views 6
37797-8,Views AP + Stryker Notch
37798-6,View AP
37799-4,Views AP + West Point + outlet
378-0,Oleandomycin
37800-0,View axillary
37801-8,View Garth
37802-6,View outlet
37803-4,Views lateral + Y
Apr-80,Methamphetamine
37804-2,Views outlet + Y
37805-9,View Y
37806-7,Views Grashey + axillary + outlet
37807-5,Views axillary + Y
37808-3,View Serendipity
37809-1,View West Point
37810-9,View Zanca
37811-7,Multisection
Feb-81,Methapyrilene
37812-5,Views 3
37813-3,Views AP + lateral + oblique
37814-1,Views^W manual stress
37815-8,Views 2
37816-6,Views AP + lateral
37817-4,Views oblique
37818-2,Views^W contrast IS
37819-0,Multisection
3782-0,Methapyrilene
37820-8,Views 3
37821-6,Views 2
37822-4,Views AP + lateral
37823-2,Views^W standing
37824-0,Views^W contrast IV
37825-7,View
37826-5,Views 2
37827-3,Views 3
37828-1,Views 4
37829-9,Views 5
37830-7,Views 6
37831-5,Views 8
37832-3,Views AP + lateral
37833-1,View lateral^W extension
37834-9,View lateral^W flexion
37835-6,Views PA + lateral
37836-4,Views PA + lateral + oblique
37837-2,Views 3
Aug-83,Methapyrilene
37838-0,Views 4
37839-8,Views AP + lateral + axillary
37840-6,Views 2
37841-4,Views AP + lateral
37842-2,View AP
37843-0,View Garth
37844-8,View Grashey
37845-5,View outlet
Jun-84,Methaqualone
37846-3,View Serendipity
37847-1,View Y
37848-9,View Zanca
37849-7,View axillary
37850-5,Multisection
37851-3,View
37852-1,Views Caldwell + Waters
Mar-85,Methaqualone
37853-9,Views 2
37854-7,Views 3
37855-4,Views 4
37856-2,Views 5
37857-0,View Caldwell
37858-8,View lateral
37859-6,Views PA + lateral + Waters
37860-4,Views PA + lateral + Caldwell + Waters
Jan-86,Methaqualone
37861-2,View submentovertex
37862-0,Views lateral + Waters
37863-8,View Waters
37864-6,Views lateral + Caldwell + Waters
37865-3,View 1 limited
37866-1,Multisection
37867-9,Views 2
37868-7,Views 4
37869-5,Views lateral + Towne
37870-3,View Towne
37871-1,Views lateral + Caldwell + Waters + Towne
37872-9,View lateral crosstable
37873-7,View 1 limited
37874-5,Multisection
37875-2,View
37876-0,Views 4
37877-8,View AP
37878-6,View lateral crosstable
Sep-87,Methaqualone
37879-4,Views 2
37880-2,View AP
37881-0,Views 3
37882-8,Views 4
37883-6,Views 2
37884-4,Views PA + lateral + oblique
37885-1,Multisection
37886-9,Views^W contrast IA
Jul-88,Methicillin
37887-7,Guidance for percutaneous aspiration of fluid
37888-5,Views 3
37889-3,Views AP + lateral
37890-1,View AP
37891-9,View lateral
37892-7,View oblique
37893-5,View lateral
37894-3,View
May-89,Methocarbamol
37895-0,Views 2
37896-8,Views AP + lateral
37897-6,View AP
37898-4,Multisection
37899-2,Views^W standing
37900-8,Views^W contrast IA
37901-6,Views^W contrast IS
37902-4,Views 2
Mar-90,Methocarbamol
37903-2,View lateral crosstable
37904-0,View
37905-7,Views 2
37906-5,Views 3
37907-3,Views 4
37908-1,Views AP + lateral + oblique
37909-9,View lateral^W hyperextension
37910-7,View lateral^W standing
Jan-91,Methocarbamol
37911-5,Multisection
37912-3,Guidance for percutaneous biopsy
37913-1,Guidance for percutaneous biopsy
37914-9,Guidance for percutaneous biopsy
37915-6,Guidance for percutaneous biopsy
37916-4,Guidance for biopsy.needle
37917-2,Guidance for percutaneous biopsy
37918-0,Guidance for percutaneous biopsy
37919-8,Guidance for percutaneous biopsy
37920-6,Guidance for percutaneous biopsy
37921-4,Guidance for needle localization
37922-2,Views 2
37923-0,Multisection
37924-8,View
37925-5,Views 2
37926-3,Views 3
37927-1,Views AP + lateral + oblique
37928-9,View Brewerton
Sep-92,Methotrexate
37929-7,Views lateral^W flexion + W extension
37930-5,View lateral
37931-3,View PA
37932-1,Multisection
37933-9,Views 3
37934-7,Views 4
37935-4,Views^W contrast IA
37936-2,Views^W contrast
Jul-93,Methotrexate
37937-0,Views
37938-8,Views
37939-6,Views^W contrast IA
37940-4,Views^W contrast IV
37941-2,Views^W contrast IA
37942-0,Views^W contrast IS
37943-8,Views^W contrast IA
37944-6,Views^W contrast IA
May-94,Methotrexate^1-2w post dose
37945-3,Views^W contrast IA
37947-9,Views^W contrast IS
37948-7,Views^W contrast IA
37949-5,Views^W contrast IA
37950-3,Views^W contrast IV
Feb-95,Methotrexate^24H post dose
37952-9,Views^W contrast IA
37953-7,Views^W contrast IA
37954-5,Views^W contrast IV
37958-6,Views^W contrast IV
37959-4,Views^W contrast IV
3796-0,Methotrexate^48H post dose
37960-2,Views
37961-0,Views
37962-8,Views
37963-6,Views
37964-4,Views
37965-1,Views
37966-9,Views^W contrast IA
37967-7,Views^W contrast IA
37968-5,Views^W contrast IA
37969-3,Views^W contrast IV
37970-1,Views^W contrast IV
37971-9,Views^W contrast IV
37972-7,Views^W contrast IV
37973-5,Views^W contrast
37974-3,Views AP + lateral
37975-0,Views
37976-8,Views^W contrast
37977-6,Views^W contrast IA
Aug-97,Methotrexate^72H post dose
37979-2,Views^W contrast IA
379-8,Oleandomycin
37980-0,Views^W contrast
37981-8,Views^W contrast
37982-6,Avian paramyxovirus
37983-4,Eastern equine encephalitis virus RNA
37984-2,Saint Louis encephalitis virus RNA
37985-9,West Nile virus RNA
Jun-98,Methoxyphenamine
37986-7,California serogroup virus RNA
37987-5,(Blatella germanica+Dermatophagoides farinae+Dermatophagoides pteronyssinus+House dust Hollister Stier) Ab.IgE
37988-3,(Aspergillus fumigatus+Blatella germanica+Cat dander+Dermatophagoides pteronyssinus) Ab.IgE
37989-1,(Artemisia vulgaris+Betula verrucosa+Cat dander+Cladosporium herbarum+Dermatophagoides pteronyssinus+Dog dander+Phleum pratense+Secale cereale) Ab.IgE
37990-9,Corticotropin releasing hormone
37991-7,Neutrophil cytoplasmic Ab.perinuclear
37992-5,Neutrophil cytoplasmic Ab.classic
37993-3,DNA double strand Ab
Apr-99,Methoxyphenamine
37994-1,Multisection^WO contrast
37995-8,Views Broden
37996-6,Views Broden
37997-4,Views Broden
37998-2,View radial head capitellar
37999-0,View radial head capitellar
38-0,Azithromycin
3800-0,Methoxyphenamine
38000-6,View radial head capitellar
38001-4,View^W expiration
38002-2,View^W inspiration
38003-0,Views AP^W standing
38004-8,Views Grashey^WO & W weight
38006-3,View radial head capitellar
38007-1,View transthoracic
38008-9,Views
38009-7,Views AP + lateral + Swimmers
38010-5,Views lateral^W flexion + W extension
38011-3,Multisection limited
38012-1,Guidance for percutaneous aspiration of cyst
38013-9,Multisection
38014-7,Multisection
38015-4,Multisection limited
38016-2,Multisection
38017-0,Guidance for aspiration.fine needle
Aug-01,Methsuximide
38018-8,Guidance for percutaneous aspiration.fine needle
38019-6,Guidance for percutaneous aspiration.fine needle
38020-4,Multisection limited
38021-2,Multisection
38022-0,Multisection^W cholecystokinin
38023-8,Guidance for percutaneous biopsy.core needle
38024-6,Guidance for biopsy.core needle
38025-3,Guidance for percutaneous biopsy.core needle
Jun-02,Methyldopa
38026-1,Guidance for percutaneous aspiration.fine needle
38027-9,Guidance for biopsy.needle
38028-7,Guidance for biopsy.needle
38029-5,Guidance for biopsy.needle
38030-3,Guidance for percutaneous biopsy
38031-1,Guidance for biopsy.needle
38032-9,Guidance for needle localization
38033-7,Guidance for percutaneous aspiration.fine needle
Apr-03,MethylePHEDrine
38034-5,Multisection limited
38035-2,Multisection limited
38036-0,Multisection
38037-8,Multisection
38038-6,Multisection
38039-4,Multisection limited
38040-2,Multisection
38041-0,Multisection
Feb-04,MethylePHEDrine
38042-8,Multisection limited
38043-6,Multisection
38044-4,Multisection
38045-1,Multisection
38046-9,Multisection limited
38047-7,Multisection limited
38048-5,Multisection
38049-3,Multisection
38050-1,Multisection limited
38051-9,Multisection
38052-7,Multisection
38053-5,Multisection
38054-3,Multisection
38055-0,Multisection^W contrast
38056-8,SPL supplemental patient material
38057-6,Multisection for implant
38058-4,Multisection for implant
Sep-05,MethylePHEDrine
38059-2,Multisection
380-6,Oleandomycin
38060-0,Multisection sagittal
38061-8,Multisection^W contrast IV
38062-6,Multisection for implant^WO & W contrast IV
38064-2,Multisection for implant^WO contrast
38065-9,View^during surgery
38066-7,View lateral^during surgery
Jul-06,Methylphenidate
38067-5,View nipple profile
38068-3,View R-anterior oblique
38069-1,View L-posterior oblique
38070-9,Views for implant
38071-7,Views for implant
38072-5,Views for implant
38073-3,Views
38074-1,Views
May-07,Methylphenidate
38079-0,Views
38080-8,Views
38082-4,Views AP + transthoracic
Mar-08,Methylphenidate
38083-2,Views AP + lateral + oblique + odontoid + swimmers
38084-0,Views AP + L-posterior oblique
38085-7,Views magnification & spot^compression
38086-5,Views Merchants 30 degrees + Merchants 45 degrees + Merchants 60 degrees
38087-3,Views Sunrise 20 degrees + Sunrise 40 degrees + Sunrise 60 degrees
38088-1,Views Sunrise 20 degrees + Sunrise 40 degrees + Sunrise 60 degrees
38089-9,Views survey limited for metastasis
38090-7,Views air gap
Jan-09,Methylphenidate
38091-5,Views air gap
38092-3,Views^W chain intra bladder+W contrast intra bladder
38093-1,Views^W nipple markers
38094-9,Views^W contrast
38095-6,Views^W contrast intra duct
38096-4,Views^W contrast intra duct
38097-2,Views^W contrast intra salivary duct
38098-0,Views^W contrast intra lacrimal duct
38099-8,Views^W contrast intra lacrimal duct
38100-4,Views^W contrast antegrade
38101-2,Views^W contrast antegrade
38102-0,Views^W contrast antegrade via pyelostomy
38103-8,Views^W contrast IT
38104-6,Views^W contrast IT
38105-3,Views^W contrast retrograde
38107-9,Views scaphoid
38108-7,Views 2 oblique
Sep-10,Methylphenidate
38112-9,Views^W contrast via nephrostomy tube
38113-7,Views^W contrast retrograde via urethra
38114-5,Views 2 oblique
38115-2,Views scaphoid
38116-0,Views^W contrast intra salivary duct
Jul-11,Methyprylon
38117-8,View Waters upright
38118-6,Views 2 lateral
38119-4,Views^W contrast IA
38120-2,Views limited^W contrast IT
38121-0,View
38123-6,Views AP + lateral
38124-4,Views^W standing
May-12,Methyprylon
38125-1,Views limited^W contrast IT
38126-9,Guidance for percutaneous aspiration of cyst
38127-7,Guidance for aspiration of CSF
38128-5,Multisection
38129-3,Multisection
38130-1,Multisection
38131-9,Multisection
38132-7,Guidance for percutaneous biopsy
Mar-13,Methyprylon
38133-5,Guidance for percutaneous aspiration of cyst
38134-3,Multisection
38135-0,Guidance for deep aspiration.fine needle
38136-8,Guidance for superficial aspiration.fine needle
38137-6,Multisection
38138-4,Multisection
38139-2,Multisection
381-4,Oleandomycin
38140-0,Multisection
Jan-14,Methyprylon
38141-8,Multisection
38142-6,Guidance for drainage+placement of drainage catheter
38143-4,Multisection limited
38144-2,Views
38145-9,Views
38146-7,Views
38147-5,Views
38148-3,Views
38149-1,Views
38150-9,Views
38151-7,Views
38152-5,Views
38153-3,Views^W contrast intra salivary duct
38154-1,Guidance for superficial biopsy
38155-8,Views 4
38156-6,Views 6
38157-4,Parathyrin.intact^5M post excision
Aug-15,Metoprolol
38158-2,Parathyrin.intact^baseline
38159-0,levETIRAcetam
38160-8,Porphyrins/Creatinine
38161-6,Pentacarboxylporphyrins/Creatinine
38162-4,Coproporphyrin/Creatinine
38163-2,Heptacarboxylporphyrin/Creatinine
38164-0,Hexacarboxylporphyrin/Creatinine
38165-7,Uroporphyrin/Creatinine
Jun-16,Metoprolol
38166-5,West Nile virus Ab.IgM
38167-3,Major crossmatch
38168-1,Major crossmatch
38169-9,Immunoglobulin light chains.lambda.free
38170-7,Cells.CD18/100 cells
38171-5,Cells.CD3-CD19+/100 cells
38172-3,Organic acids
38173-1,Borrelia burgdorferi C6 Ab
Apr-17,Metoprolol
38174-9,Borrelia burgdorferi C6 Ab
38175-6,Heptacarboxylate/Creatinine
38176-4,Immunoglobulin light chains.kappa.free
38177-2,Immunoglobulin light chains.kappa.free
38178-0,Immunoglobulin light chains.lambda.free
38179-8,Peripheral neuropathy gene targeted mutation analysis
38180-6,Hepatitis C virus RNA
38181-4,Diameter.lateral
Feb-18,Metoprolol
38182-2,Parainfluenza virus 1 Ab.IgG
38183-0,Parainfluenza virus 2 Ab.IgG
38184-8,Basophils/100 leukocytes
38185-5,Beta galactosidase
38186-3,Beta globulin
38187-1,Bile acid.dihydroxy
38188-9,Bile acid.trihydroxy
38189-7,Alpha 2 globulin
3819-0,Mexiletine
38190-5,Alpha 2 globulin
38191-3,Ammonium urate/Total
38192-1,Amylase
38193-9,Amylase
38194-7,Antidepressants
38195-4,Antihistamines
38196-2,Appearance
38197-0,Bordetella parapertussis Ag
38198-8,Bordetella pertussis Ag
38199-6,Pressure.positive end expiratory.intrinsic
38200-2,Specimen volume
38201-0,Pain onset
38202-8,Pain onset.hours ago
38203-6,Speed of pain onset
38204-4,Pain primary location
38205-1,Pain radiation
38206-9,Pain temporal pattern
38207-7,Pain duration
Aug-20,Mezlocillin
38208-5,Pain severity
38209-3,Pain exacerbating factors
38210-1,Pain alleviating factors
38211-9,Pain initiating event
38212-7,Pain assessment panel
38213-5,FLACC pain assessment panel
38214-3,Pain severity
38215-0,Pain severity.total
Jun-21,Midazolam
38216-8,Pain severity.face
38217-6,Pain severity.legs
38218-4,Pain severity.activity
38219-2,Pain severity.cry
382-2,Oxacillin
38220-0,Pain severity.consolability
38221-8,Pain severity
38222-6,Sensory perception
38223-4,Physical activity
Apr-22,Minocycline
38224-2,Physical mobility
38225-9,Nutrition intake pattern
38226-7,Friction & shear
38227-5,Braden scale score.total
38228-3,Braden scale skin assessment panel
38229-1,Moisture exposure
38230-9,Calcium.ionized
38231-7,Cells.CD11b+HLA-DR+/100 cells
Feb-23,Morazone
38232-5,Cells.CD13+CD16+/100 cells
38233-3,Cells.CD3+CD62L+
38234-1,Cells.CD3+CD62L+/100 cells
38235-8,Cells.CD3+TCR gamma delta+
38236-6,Cells.CD3+TCR gamma delta+/100 cells
38237-4,Cells.CD4+CD28+
38238-2,Cells.CD4+CD28+/100 cells
38239-0,Cells.CD4+CD95+
3824-0,Morazone
38240-8,Cells.CD4+CD95+/100 cells
38241-6,Cells.CD8+CD95+
38242-4,Cells.CD8+CD95+/100 cells
38243-2,Brucella abortus Ab.IgG
38244-0,Brucella abortus Ab.IgM
38245-7,Brucella canis Ab.IgG
38246-5,Brucella canis Ab.IgM
38247-3,Brucella sp Ab.IgG
38248-1,Brucella sp Ab.IgM
38249-9,C peptide^15M post XXX challenge
38250-7,Calcium
38251-5,Calcium oxalate
38252-3,Calcium oxalate monohydrate/Total
38253-1,Carbon dioxide
38254-9,Carbonated calcium phosphate
38255-6,Cat dander Ab.IgE/IgE.total
38256-4,Cells counted.total
Jul-25,Morazone
38257-2,Cells counted.total
38258-0,Cells counted.total
38259-8,Cells counted.total
38260-6,Cells counted.total
38261-4,Views for bone density
38262-2,Views for bone density
38263-0,Views for bone density
38264-8,Views for bone density
May-26,Morphine
38265-5,Views for bone density
38266-3,Views for bone density
38267-1,Views for bone density
38268-9,Views for bone density
38269-7,Study report
38270-5,Influenza virus A H7 RNA
38271-3,Influenza virus A H6 RNA
38272-1,Influenza virus A H5 RNA
Mar-27,Morphine
38273-9,Influenza virus A Ab
38274-7,Columbid circovirus DNA
38275-4,Transmissible spongiform encephalopathy
38276-2,Coagulation surface induced^1H post incubation
38277-0,Lymphocyte proliferation. 0.5 ug/mL Candida albicans stimulation
38278-8,Lymphocyte proliferation. 1.0 ug/mL Candida albicans stimulation
38279-6,Lymphocyte proliferation. 2.5 ug/mL Candida albicans stimulation
38280-4,Lymphocyte proliferation. 5.0 ug/mL Candida albicans stimulation
Jan-28,Morphine.free
38281-2,Lymphocyte proliferation. 2.41 ug/mL tetanus toxoid stimulation
38282-0,Lymphocyte proliferation. 4.83 ug/mL tetanus toxoid stimulation
38283-8,Lymphocyte proliferation. 9.67 ug/mL tetanus toxoid stimulation
38284-6,Lymphocyte proliferation. 19.3 ug/mL tetanus toxoid stimulation
38285-3,Erythrocytes
38286-1,"2,4-Dichlorophenoxyacetate"
38287-9,"2,2-Dichloropropionate"
38288-7,"1,2-Dibromo-3-Chloropropane"
38289-5,"1,2-Dichlorobenzene"
38290-3,"1,4-Dichlorobenzene"
38291-1,"1,2-Dichloroethane"
38292-9,"1,1-Dichloroethylene"
38293-7,"cis-1,2-Dichloroethylene"
38294-5,"Trans-1,2-Dichloroethylene"
38295-2,Methylene chloride
38296-0,"1,2-Dichloropropane"
38297-8,Di(2-Ethylhexyl) phthalate
38298-6,Dinoseb
Sep-29,Morphine.free
38299-4,Dioxin
383-0,Oxacillin
38300-0,Diquat
38301-8,Endothall
38302-6,Endrin
38303-4,Epichlorohydrin
38304-2,Ethylene dibromide
38305-9,Glyphosate
38306-7,Heptachlor
Jul-30,Morphine
38307-5,Heptachlorepoxide
38308-3,Antimony
38309-1,Asbestos
38310-9,Beryllium
38311-7,Thallium
38312-5,Tetrachloroethylene
38313-3,Toluene
38314-1,Cyclohexanone
May-31,Morphine
38315-8,Dichlorobenzene
38316-6,Dichloroethane
38317-4,Hexane
38318-2,Acrylamide
38319-0,Alachlor
38320-8,Benzo alpha pyrene
38321-6,Carbofuran
38322-4,Carbon tetrachloride
Mar-32,Morphine
38323-2,Lindane
38324-0,Methoxychlor
38325-7,Oxamyl
38326-5,Pentachlorophenol
38327-3,Picloram
38328-1,Simazine
38329-9,Styrene
38330-7,Toxaphene
Jan-33,Moxalactam
38331-5,"2,4,5-Trichlorophenoxyacetate"
38332-3,"1,2,4-Trichlorobenzene"
38333-1,Trichloroethane
38334-9,"1,1,2-Trichloroethane"
38335-6,Vinyl chloride
38336-4,Ethyl benzene
38337-2,Hexachlorocyclopentadiene
38338-0,Cyanide
38339-8,Benzene
38340-6,Dichlorodiphenyltrichloroethane
38341-4,Chlordane
38342-2,Hexachlorobenzene
38343-0,Chlorobenzene
38344-8,Trichloroethylene
38345-5,Sporothrix schenckii Ab
38346-3,Sporothrix schenckii Ab
38347-1,XXX microorganism DNA
38348-9,Herpes virus 6 DNA
Sep-34,N-acetylprocainamide
38349-7,Herpes virus 6 DNA
38350-5,Herpes virus 6 DNA
38351-3,Herpes virus 6 DNA panel
38352-1,Interleukin 2 receptor
38353-9,Streptococcus sp identified
38354-7,Bartonella sp identified
38355-4,Chitotriosidase
Jun-35,N-ethylnicotinamide
38356-2,Thyroxine Ab
38357-0,B cell crossmatch
38358-8,A Ab
38359-6,A Ab
38360-4,Isobutyrylglycine/Creatinine
38361-2,(Chicken feather+Duck feather+Goose feather+Turkey feather) Ab.IgG
38362-0,Muscle specific receptor tyrosine kinase Ab
38363-8,Cefepime
Apr-36,Nadolol
38364-6,Haloperidol.reduced
38365-3,Hexadecadienoate/Creatinine
38366-1,Hypoxanthine/Creatinine
38367-9,N-octanoylglycine/Creatinine
38368-7,Pigeon droppings Ab.IgG
38369-5,U1 small nuclear ribonucleoprotein Ab.IgG
38370-3,Voriconazole
38371-1,Xanthine/Creatinine
Feb-37,Nadolol
38372-9,Human papilloma virus 6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA
38373-7,Buprenorphine+Norbuprenorphine
38374-5,Tenofovir
38375-2,Adenovirus DNA
38376-0,Cryptococcus sp identified
38377-8,Cryptococcus neoformans
38378-6,Mycobacterium tuberculosis complex rRNA
38379-4,Mycobacterium tuberculosis complex DNA
3838-0,Nadolol
38380-2,HFE gene.p.Ser65Cys
38381-0,Influenza virus A cDNA
38382-8,Influenza virus B
38383-6,Enterococcus sp rRNA
38384-4,Cocaine
38385-1,Coccidioides immitis Ag
38386-9,Color
38387-7,C3 nephritic factor
38388-5,Complement C3
38389-3,Coxiella burnetii phase 2 Ab
38390-1,Cryptococcus neoformans Ag
38391-9,Cryptococcus neoformans Ag
38392-7,Legionella sp Ab
38393-5,Legionella sp identified
38394-3,Legionella sp identified
38395-0,Parainfluenza virus 1 Ag
38396-8,Parainfluenza virus 1 Ag
38397-6,Crystals
Aug-39,Nalbuphine
38398-4,Crystals
38399-2,Crystals
38400-8,Parainfluenza virus 1+2+3 Ab
38401-6,Protozoa identified
38402-4,Parasite identified
38403-2,Cyclospora sp Ag
38404-0,CFTR gene targeted mutation analysis
38405-7,MT-ATP6 gene targeted mutation analysis
Jun-40,Nalbuphine
38406-5,PABPN1 gene targeted mutation analysis
38407-3,PAX3 gene targeted mutation analysis
38408-1,PEO gene targeted mutation analysis
38409-9,SERPINA1 gene targeted mutation analysis
38410-7,Basement membrane zone Ab
38411-5,TOR1A gene targeted mutation analysis
38412-3,FGFR2 gene targeted mutation analysis
38413-1,FGFR3 gene targeted mutation analysis
Apr-41,Nalbuphine
38414-9,Iron
38415-6,MTHFR gene targeted mutation analysis
38416-4,Parasite identified
38417-2,Trans-cinnamoylglycine/Creatinine
38418-0,Pigeon droppings Ab.IgG
38419-8,Cells.CD21/100 cells
38420-6,Soluble liver Ab.IgG
38421-4,C peptide^30M post XXX challenge
Feb-42,Nalorphine
38422-2,C peptide^1H post XXX challenge
38423-0,C peptide^1.5H post XXX challenge
38424-8,C peptide^2H post XXX challenge
38425-5,C peptide^2.5H post XXX challenge
38426-3,C peptide^3H post XXX challenge
38427-1,Thiocyanate
38428-9,Ibuprofen^pre dose
38429-7,Ibuprofen^30M post dose
3843-0,Nandrolone
38430-5,Ibuprofen^1H post dose
38431-3,Ibuprofen^1.5H post dose
38432-1,Ibuprofen^2H post dose
38433-9,Ibuprofen^2.5H post dose
38434-7,Ibuprofen^3H post dose
38435-4,Cells.terminal deoxyribonucleotidyl transferase/100 cells
38436-2,Colony count
38437-0,Anacardium occidentale Ab.IgE/IgE.total
38438-8,Aspergillus fumigatus Ab.IgE/IgE.total
38439-6,Barbiturates
38440-4,Basement membrane zone Ab
38441-2,Benzodiazepines
38442-0,Bilirubin crystals
38443-8,Blastomyces dermatitidis Ab.IgM
38444-6,Bromide
38445-3,Calprotectin
38446-1,Catecholamines
38447-9,CFTR gene.c.711+1G>T
Aug-44,Nandrolone
38448-7,CFTR gene.p.Ala455Glu
38449-5,CFTR gene.c.1078delT
38450-3,CFTR gene.c.2184delA
38451-1,CFTR gene.c.2789+5G>A
38452-9,CFTR gene.c.3120+1G>A
38453-7,CFTR gene.c.3659delC
38454-5,CFTR gene.p.Gly85Glu
May-45,Nandrolone
38455-2,CFTR gene.c.621+1G>T
38456-0,CFTR gene.c.3849+10kbC>T
38457-8,Immune complex.C3d+IgG
38458-6,Crystals
38459-4,Crystals
38460-2,Legionella sp Ag
38461-0,Legionella sp Ag
38462-8,Legionella sp Ag
Mar-46,Naproxen
38463-6,Legionella sp Ag
38464-4,Juniperus sabinoides Ab.IgE/IgE.total
38465-1,Chicken Ab.IgE/IgE.total
38466-9,Chicken serum proteins Ab.IgG
38467-7,Chlamydia sp Ab.IgG
38468-5,Chlamydia sp Ab
38469-3,Chlamydia trachomatis rRNA
38470-1,chlorproPAMIDE
Jan-47,Neopterin
38471-9,Karyotype
38472-7,17-Hydroxycorticosteroids/Creatinine
38473-5,17-Hydroxyprogesterone
38474-3,Acylcarnitine
38475-0,Acid alpha glucosidase
38476-8,Mullerian inhibiting substance
38477-6,Glucosylceramidase
38478-4,Biotinidase
38479-2,Branched chain keto-acid dehydrogenase complex
384-8,Oxacillin
38480-0,Carnitine
38481-8,Carnitine.free (C0)
38482-6,Creatine kinase.MB
38483-4,Creatinine
38484-2,Cysteine
38485-9,Galactose 1 phosphate
38486-7,Homocystine
38487-5,IgA
38488-3,IgG
Sep-48,Netilmicin^peak
38489-1,Insulin bovine Ab
38490-9,Insulin porcine Ab
38491-7,Insulin-like growth factor binding protein 3.acid labile
38492-5,Insulin-like growth factor-I
38493-3,Ketones
38494-1,Metanephrine.free
38495-8,Phenylalanine+Tyrosine
38496-6,Retinyl palmitate
Jul-49,Netilmicin^random
38497-4,Spermatozoa.amorphous head
38498-2,Spermatozoa.nonviable/100 spermatozoa
38499-0,Spermatozoa.progressive^4H post ejaculation
38500-5,Spermatozoa.progressive.grade 1/100 spermatozoa
38501-3,Spermatozoa.progressive.grade 2/100 spermatozoa
38502-1,Spermatozoa.progressive.grade 4/100 spermatozoa
38503-9,Spermatozoa.progressive.grade 3/100 spermatozoa
38504-7,Thyroglobulin Ab
May-50,Netilmicin^trough
38505-4,Thyroglobulin recovery
38506-2,Thyroxine
38507-0,Urobilinogen
38508-8,Uroporphyrin/Creatinine
38509-6,Viscosity^30M post collection
38510-4,Cells.CD11b+CD11c+/100 cells
38511-2,Cells.CD19+CD33+/100 cells
38512-0,Cells.CD2+CD3+/100 cells
Mar-51,Nicomorphine
38513-8,Cells.CD2+CD3+
38514-6,Cells.CD33+CD34+/100 cells
38515-3,Cells.cytoplasmic Ig mu
38516-1,Cells.terminal deoxyribonucleotidyl transferase/100 cells
38517-9,Coagulation surface induced.factor substitution^2H post incubation
38518-7,Granulocytes.immature/100 leukocytes
38519-5,Microscopic observation
38520-3,Capillary fragility
Jan-52,Nicotinamide
38521-1,Coagulation factor VIII Ag actual/Normal
38522-9,Complement C4b binding protein actual/Normal
38523-7,Fibrinopeptide A
38524-5,Hemoglobin F/Hemoglobin.total
38525-2,Protein fractions.oligoclonal bands
38526-0,Number of specimens tested
38527-8,Number of specimens received
38528-6,Protein.abnormal band
38529-4,CMTX2 gene targeted mutation analysis
38530-2,BRCA2 gene targeted mutation analysis
38531-0,BRCA2 gene mutations tested for
38532-8,SPG3A gene targeted mutation analysis
38533-6,TCOF1 gene targeted mutation analysis
38534-4,COL5A1 gene targeted mutation analysis
38535-1,LAMA2 gene targeted mutation analysis
38536-9,MLH1 gene targeted mutation analysis
38537-7,ARX gene targeted mutation analysis
38538-5,Fatty acids.very long chain.C26:1/C22:0
Sep-53,Nicotine
38539-3,Spermatozoa.motile/100 spermatozoa^post washing
38540-1,Spermatozoa.motile/100 spermatozoa^pre washing
38541-9,Spermatozoa.motile^pre washing
38542-7,Repaglinide
38543-5,Spermatozoa^post washing
38544-3,Spermatozoa^pre washing
38545-0,Methylmercury
38546-8,HLA-B locus
Jul-54,Nicotine
38547-6,HLA-C locus
38548-4,HLA-A locus
38549-2,HLA-B W locus
385-5,Oxacillin
38550-0,MSH2 gene targeted mutation analysis
38551-8,Cortisol^pre or post dose dexamethasone
38552-6,Acylcarnitine.short chain
38553-4,Narcolepsy associated Ag
Apr-55,Nikethamide
38554-2,Spermatozoa.head.motile with IgA/100 spermatozoa
38555-9,Spermatozoa.head.motile with IgG/100 spermatozoa
38556-7,Spermatozoa.head.motile with IgM/100 spermatozoa
38557-5,Spermatozoa.midpiece.motile with IgA/100 spermatozoa
38558-3,Spermatozoa.midpiece.motile with IgG/100 spermatozoa
38559-1,Spermatozoa.midpiece.motile with IgM/100 spermatozoa
38560-9,Spermatozoa.tail.motile with IgA/100 spermatozoa
38561-7,Spermatozoa.tail.motile with IgG/100 spermatozoa
Feb-56,Nikethamide
38562-5,Spermatozoa.tail.motile with IgM/100 spermatozoa
38563-3,Spermatozoa.tail tip.motile with IgA/100 spermatozoa
38564-1,Spermatozoa.tail tip.motile with IgG/100 spermatozoa
38565-8,Spermatozoa.tail tip.motile with IgM/100 spermatozoa
38566-6,Spermatozoa.motile^post washing
38567-4,Aniline
38568-2,Asbestos
38569-0,Arsenic
3857-0,Nikethamide
38570-8,Azinphos-methyl
38571-6,Barium
38572-4,Benzidine
38573-2,Acrylamide
38574-0,Beryllium
38575-7,Bromoform
38576-5,Butane
38577-3,Carbon disulfide
38578-1,Carbon tetrachloride
38579-9,Chlordane
38580-7,Cresols
38581-5,Cumene
38582-3,"2,4-Dichlorophenoxyacetate"
38583-1,"1,2-Dibromo-3-Chloropropane"
38584-9,Acetaldehyde
38585-6,Acetone
38586-4,Acetonitrile
38587-2,Acrylaldehyde
Aug-58,Nitrazepam
38588-0,Acrylonitrile
38589-8,Ammonia
38590-6,"1,4-Dichlorobenzene"
38591-4,Dichlorvos
38592-2,Dimethylformamide
38593-0,"1,4-Dioxane"
38594-8,Epichlorohydrin
38595-5,Ethylene dibromide
Jun-59,Nitrazepam
38596-3,Ethylene glycol
38597-1,Heptachlor
38598-9,Hexachlorobenzene
38599-7,Hexachlorobutadiene
38600-3,Hexachloroethane
38601-1,Hexane
38602-9,Hydrazine
38603-7,Hydrogen sulfide
Apr-60,Nitrofurantoin
38604-5,Hydroquinone
38605-2,Lindane
38606-0,Maleic anhydride
38607-8,Methoxychlor
38608-6,Methyl bromide
38609-4,Methyl tert-butyl ether
38610-2,Methylene chloride
38611-0,Methyl isobutyl ketone
Feb-61,Nordiazepam
38612-8,Naphthalene
38613-6,Parathion
38614-4,Pentachlorophenol
38615-1,Phenol
38616-9,Propoxur
38617-7,"1,2-Dichloropropane"
38618-5,Styrene
38619-3,Dioxin
3862-0,Nordoxepin
38620-1,Tetrachloroethylene
38621-9,Toluene
38622-7,Toxaphene
38623-5,"1,2,4-Trichlorobenzene"
38624-3,"1,1,2-Trichloroethane"
38625-0,Trichloroethylene
38626-8,Vinyl chloride
38627-6,Benzene
38628-4,Benzo alpha pyrene
38629-2,Acetamide
386-3,Oxytetracycline
38630-0,Acrylate
38631-8,Allyl chloride
38632-6,4-Biphenylamine
38633-4,Benzotrichloride
38634-2,Benzyl chloride
38635-9,Biphenyl
38636-7,Di(2-Ethylhexyl) phthalate
38637-5,Bis(chloromethyl)ether
Aug-63,Norethandrolone
38638-3,Boron oxide
38639-1,Boron trifluoride
38640-9,Bromine
38641-7,Ethyl bromide
38642-5,"1,3-Butadiene"
38643-3,Calcium cyanamide
38644-1,Caprolactam
38645-8,Captan
Jun-64,Norethandrolone
38646-6,Catechol
38647-4,Chlorine
38648-2,Chlorobenzene
38649-0,Chloroform
38650-8,Chloromethyl methyl ether
38651-6,"2-Chloro-1,3-Butadiene"
38652-4,Carbonyl sulfide
Mar-65,Norethandrolone
38653-2,Amiben
38654-0,Chloroacetate
38655-7,2-Chloroacetophenone
38656-5,Chlorobenzilate
38657-3,Diazomethane
38658-1,Acetate
38659-9,Acetophenone
38660-7,Acetylene
Jan-66,Norfenefrine
38661-5,Aldrin
38662-3,Aluminum oxide
38663-1,Dichlorobenzidine
38664-9,Bis(2-Chloroethyl) ether
38665-6,Diethanolamine
38666-4,Diethylsulfate
38667-2,"3,3'-Dimethoxybenzidine"
38668-0,Dimethylaniline
38669-8,Dichlorodiphenyldichloroethylene
38670-6,Orthocresol
38671-4,M-cresol
38672-2,P-cresol
38673-0,Dimethylphthalate
38674-8,Spermatozoa.head Ab.IgA/100 spermatozoa
38675-5,Spermatozoa.midpiece Ab.IgA/100 spermatozoa
38676-3,Spermatozoa.tail tip Ab.IgA/100 spermatozoa
38677-1,Spermatozoa.tail Ab.IgA/100 spermatozoa
38678-9,Spermatozoa.head Ab.IgG/100 spermatozoa
Sep-67,Norfloxacin
38679-7,Spermatozoa.midpiece Ab.IgG/100 spermatozoa
38680-5,Spermatozoa.tail tip Ab.IgG/100 spermatozoa
38681-3,Spermatozoa.tail Ab.IgG/100 spermatozoa
38682-1,Spermatozoa.head Ab.IgM/100 spermatozoa
38683-9,Spermatozoa.midpiece Ab.IgM/100 spermatozoa
38684-7,Spermatozoa.tail tip Ab.IgM/100 spermatozoa
38685-4,Spermatozoa.tail Ab.IgM/100 spermatozoa
38686-2,Spermatozoa Ab.IgA+IgG/100 spermatozoa
Jul-68,Norfluoxetine
38687-0,2-Acetylaminofluorene
38688-8,"1,1-Dimethylhydrazine"
38689-6,Dimethyl sulfate
38690-4,"4,6-Dinitro-O-Cresol"
38691-2,"1,2-Diphenylhydrazine"
38692-0,1-Butene oxide
38693-8,Ethyl acrylate
38694-6,Chloroethane
May-69,Normeperidine
38695-3,"1,2-Dichloroethane"
38696-1,Ethylene oxide
38697-9,Ethylene thiourea
38698-7,Ethyleneimine
38699-5,"1,1-Dichloroethane"
38700-1,Formaldehyde
38701-9,Hexachlorocyclopentadiene
38702-7,Hexamethylene diisocyanate
Mar-70,Norpropoxyphene
38703-5,Hexamethylphosphoramide
38704-3,Isophorone
38705-0,Methanol
38706-8,Chloromethane
38707-6,Trichloroethane
38708-4,Methyl hydrazine
38709-2,Methyl iodide
387-1,Oxytetracycline
38710-0,Nitrobenzene
Jan-71,Norpropoxyphene
38711-8,2-Nitropropane
38712-6,N-nitrosodimethylamine
38713-4,N-nitrosomorpholine
38714-2,Pentachloronitrobenzene
38715-9,Phosgene
38716-7,Phosphine
38717-5,Phosphate
38718-3,Phthalic anhydride
38719-1,"1,3-Propane sultone"
38720-9,Beta-propiolactone
38721-7,Propionaldehyde
38722-5,Propyleneimine
38723-3,"1,4-Benzoquinone"
38724-1,Quinoline
38725-8,"Styrene-7,8-Oxide"
38726-6,Titanium tetrachloride
38727-4,"2,4 toluenediamine"
38728-2,2-Aminotoluene
Sep-72,Nortriptyline
38729-0,"2,4,5-Trichlorophenol"
38730-8,"2,4,6-Trichlorophenol"
38731-6,Triethylamine
38732-4,Trifluralin
38733-2,Vinyl acetate
38734-0,Vinyl bromide
38735-7,"1,1-Dichloroethylene"
38736-5,Animal hair+Epithelium
Jul-73,Nortriptyline
38737-3,O-anisidine
38738-1,Carbaryl
38739-9,"1,3-Dichloropropene"
38740-7,Dimethylcarbamoyl chloride
38741-5,"2,4-Dinitrophenol"
38742-3,"2,4-Dinitrotoluene"
38743-1,Hydrogen chloride
38744-9,Hydrogen fluoride
May-74,Nortriptyline
38745-6,Diphenylmethane diisocyanate (MDI)
38746-4,"4,4'-Methylene bis(2-Chloroaniline)"
38747-2,Methyl isocyanate
38748-0,Methylenedianiline
38749-8,P-nitrobiphenyl
38750-6,Para nitrophenol
38751-4,"1,4-Benzenediamine"
Feb-75,Nortriptyline
38752-2,Polychlorinated biphenyl
38753-0,Tetrachloroethane
38754-8,"2,4-Toluene diisocyanate"
38755-5,Dimethylbenzene
38756-3,"1,2-Dimethylbenzene"
38757-1,"1,3-Dimethylbenzene"
38758-9,"1,4-Dimethylbenzene"
38759-7,Aluminum
3876-0,Nortriptyline^trough >12h post dose
38760-5,Dibenzofuran
38761-3,Asphalt
38762-1,Isooctane
38763-9,Eastern equine encephalitis virus Ab.IgM
38764-7,Eastern equine encephalitis virus Ab.IgG
38765-4,Guidance for biopsy of transplanted liver
38766-2,Guidance for biopsy of transplanted kidney
38767-0,Multisection
38768-8,Multisection
38769-6,Multisection limited^WO contrast
38770-4,Multisection^WO contrast
38771-2,Views
38772-0,View true lateral
38773-8,Multisection^WO contrast
38774-6,Views
38775-3,View Brewerton
38776-1,View Harris
38777-9,View Jones
Aug-77,Ofloxacin
38778-7,Views ski jump
38779-5,View transthoracic
38780-3,View Velpeau axillary
38781-1,Views AP + axillary + outlet
38782-9,Views AP + axillary + outlet + Zanca
38783-7,Views AP + axillary + Y
38784-5,Views AP + lateral crosstable
38785-2,Views AP + lateral frog
Jun-78,Opiates
38786-0,Views AP + lateral + Sunrise
38787-8,Views AP + West Point
38788-6,Views AP + Y
38789-4,Views Grashey + axillary + Y
38790-2,Views PA + lateral + Sunrise
38791-0,Views Grashey + outlet
38792-8,Views tarsal
38793-6,Views Grashey + axillary
Apr-79,Opiates
38794-4,Views Grashey + outlet + Serendipity
38795-1,Views Grashey + West Point
38796-9,Views
38797-7,Views
38798-5,Views
38799-3,Views runoff^W contrast IA
38800-9,Views^W contrast IA
38801-7,Views^W contrast IA
Feb-80,Orphenadrine
38802-5,Multisection^WO & W contrast IV
38803-3,View 45 degree cephalic angle
38804-1,View Bora
38805-8,View Grashey
38806-6,View 10 degree caudal angle
38807-4,Views spot
38808-2,Views ulnar deviation + radial deviation
38809-0,Views^W contrast IA
3881-0,Ouabain
38810-8,Views^W standing
38811-6,Views^W contrast intra lymphatic
38812-4,Views^W contrast intra lymphatic
38813-2,Views^W contrast intra lymphatic
38814-0,Views Broden
38815-7,Views AP^W standing
38816-5,Views Grashey^WO & W weight
38817-3,Multisection for implant^WO contrast
38818-1,View^during surgery
38819-9,View lateral^during surgery
38820-7,Views for implant
38821-5,Views
38822-3,Views AP + transthoracic
38823-1,Views magnification & spot^compression
38824-9,Views Sunrise 20 degrees + Sunrise 40 degrees + Sunrise 60 degrees
38825-6,Views^W contrast intra duct
38826-4,Views^W contrast intra salivary duct
38827-2,Views^W contrast intra lacrimal duct
Aug-82,Oxacillin
38828-0,Multisection^W contrast IS
38829-8,Multisection^W contrast IV
38830-6,Multisection^W contrast IV
38831-4,Multisection^WO & W contrast IV
38832-2,Multisection^WO contrast
38833-0,Multisection^WO contrast
38834-8,Multisection^WO contrast
38835-5,Multisection^W contrast IV
Jun-83,Oxandrolone
38836-3,Multisection
38837-1,Multisection^WO & W contrast IV
38838-9,Views limited
38839-7,Views oblique
38840-5,Views 2^W manual stress
38841-3,Views 2^W standing
38842-1,View carpal tunnel
38843-9,Views 2 carpal tunnel
Apr-84,Oxandrolone
38844-7,Views 2 oblique
38845-4,Views^W standing
38846-2,Views 2
38847-0,Views AP + lateral
38848-8,Views AP + lateral + oblique
38849-6,View AP^W standing
38850-4,View^W standing
Jan-85,Oxandrolone
38851-2,Views 2^W standing
38852-0,Views 4^W standing
38853-8,Views^W contrast
38854-6,Views magnification+spot
38855-3,View true lateral
38856-1,Views anterior + lateral
38857-9,View lateral
38858-7,View Y
38859-5,Views^W contrast IV
38860-3,Views AP + lateral
38861-1,Views^W contrast IA
38862-9,Views^W contrast IA
38863-7,Views^W contrast IA
38864-5,Views^W contrast IA
38865-2,Views^W contrast IA
38866-0,Views
38867-8,Views
38868-6,Views
Sep-86,Oxazepam
38869-4,Views
38870-2,Multisection for implant^WO & W contrast IV
38871-0,Views 2 oblique
38872-8,Views^W contrast via nephrostomy tube
38873-6,Views^W contrast retrograde via urethra
38874-4,Views 2 oblique
38875-1,Coagulation tissue factor induced.INR
38876-9,Respiratory contraindications to elevating head of bed greater than 30 degrees
Jul-87,Oxazepam
38877-7,Oral care given
38878-5,Ventilator mode change reason
38879-3,Ventilator disconnect reason
38880-1,Ventilator alarm reason
38881-9,Emotional stability behavior^pre {event}
38882-7,Emotional stability behavior^post {event}
38883-5,Reintubated urgency
38884-3,Vendor serial number
May-88,Oxedrine
38885-0,Extubation urgency
38886-8,Endotracheal tube secure method
38887-6,Person present^at time of {event}
38888-4,Status of nursing unit activity level
38889-2,Personnel notified of {event}
388-9,Oxytetracycline
38890-0,Vaccine component type
38891-8,ABCC8 gene targeted mutation analysis
38892-6,Anisocytosis
Mar-89,Oxprenolol
38893-4,ARIPiprazole
38894-2,Cells.CD158
38895-9,ELA2 gene targeted mutation analysis
38896-7,F9 gene targeted mutation analysis
38897-5,Fibers
38898-3,Fibrin D-dimer
38899-1,fluPHENAZine
38900-7,HEXA gene mutations tested for
Jan-90,Oxprenolol
38901-5,Leflunomide
38902-3,LITAF gene targeted mutation analysis
38903-1,Lymphocytes
38904-9,MFN2 gene targeted mutation analysis
38905-6,MLL gene mutations tested for
38906-4,MSH6 gene targeted mutation analysis
38907-2,NIPA1 gene targeted mutation analysis
38908-0,Poikilocytosis
38909-8,PTCH gene targeted mutation analysis
38910-6,Schistocytes
38911-4,SDHC gene targeted mutation analysis
38912-2,Succinylacetone
38913-0,TBX5 gene targeted mutation analysis
38914-8,RS1 gene targeted mutation analysis
38915-5,Zinc finger protein of the cerebellum 4 Ab
38916-3,Calicivirus RNA
38917-1,Human metapneumovirus RNA
38918-9,ABCC8 gene targeted mutation analysis
Sep-91,Oxprenolol
38919-7,LITAF gene targeted mutation analysis
38920-5,MFN2 gene targeted mutation analysis
38921-3,MSH6 gene targeted mutation analysis
38922-1,PTCH gene targeted mutation analysis
38923-9,SDHC gene targeted mutation analysis
38924-7,TBX5 gene targeted mutation analysis
38925-4,RS1 gene targeted mutation analysis
38926-2,Macroprolactin
Jul-92,Oxprenolol
38927-0,TRPS1 gene targeted mutation analysis
38928-8,FAH gene targeted mutation analysis
38929-6,FAH gene targeted mutation analysis
38930-4,EXT1 gene targeted mutation analysis
38931-2,TRPS1 gene targeted mutation analysis
38932-0,VA C&P exam.acromegaly note
38933-8,VA C&P exam.aid and attendance &or housebound note
38934-6,VA C&P exam.arrhythmias note
May-93,oxyCODONE
38935-3,VA C&P exam.miscellaneous arteries &or veins note
38936-1,VA C&P exam.audio note
38937-9,VA C&P exam.bones fractures &or bone disease note
38938-7,VA C&P exam.brain &or spinal cord note
38939-5,VA C&P exam.chronic fatigue syndrome note
38940-3,VA C&P exam.cold injury protocol note
38941-1,VA C&P exam.cranial nerves note
38942-9,VA C&P exam.Cushings syndrome note
Mar-94,Oxymesterone
38943-7,VA C&P exam.dental &or oral note
38944-5,VA C&P exam.diabetes mellitus note
38945-2,VA C&P exam.miscellaneous digestive conditions note
38946-0,VA C&P exam.ear disease note
38947-8,VA C&P exam.mental health eating disorders note
38948-6,VA C&P exam.miscellaneous endocrine diseases note
38949-4,VA C&P exam.epilepsy &or narcolepsy note
3895-0,Oxymesterone
38950-2,VA C&P exam.esophagus &or hiatal hernia note
38951-0,VA C&P exam.eye note
38952-8,VA C&P exam.feet note
38953-6,VA C&P exam.fibromyalgia note
38954-4,VA C&P exam.general medical note
38955-1,VA C&P exam.genitourinary note
38956-9,VA C&P exam.disability in gulf war veterans note
38957-7,VA C&P exam.gynecological conditions &or disorders of the breast note
38958-5,VA C&P exam.hand &or thumb &or fingers note
38959-3,VA C&P exam.heart note
38960-1,VA C&P exam.hemic disorders note
38961-9,VA C&P exam.HIV-related illness note
38962-7,VA C&P exam.hypertension note
38963-5,VA C&P exam.infectious &or immune &or nutritional disabilities note
38964-3,VA C&P exam.initial evaluation post-traumatic stress disorder note
38965-0,VA C&P exam.large &or small intestines note
38966-8,VA C&P exam.extremity joints note
38967-6,VA C&P exam.liver &or gall bladder &or pancreas note
Aug-96,Oxymesterone
38968-4,VA C&P exam.lymphatic disorders note
38969-2,VA C&P exam.general mental disorders note
389-7,Oxytetracycline
38970-0,VA C&P exam.mouth &or lips &or tongue note
38971-8,VA C&P exam.muscles note
38972-6,VA C&P exam.miscellaneous neurological disorders note
38973-4,VA C&P exam.nose &or sinus &or larynx &or pharynx note
38974-2,VA C&P exam.peripheral nerves note
38975-9,VA C&P exam.prisoner of war protocol note
Jun-97,Oxymetholone
38976-7,VA C&P exam.pulmonary tuberculosis &or mycobacterial diseases note
38977-5,VA C&P exam.rectum &or anus note
38978-3,VA C&P exam.residuals of amputations note
38979-1,VA C&P exam.obstructive &or restrictive &or interstitial respiratory diseases note
38980-9,VA C&P exam.miscellaneous respiratory diseases note
38981-7,VA C&P exam.review evaluation post-traumatic stress disorder note
38982-5,VA C&P exam.scars note
38983-3,VA C&P exam.sense of smell &or taste note
Apr-98,Oxymetholone
38984-1,VA C&P exam.skin diseases other than scars note
38985-8,VA C&P exam.social &or industrial survey note
38986-6,VA C&P exam.spine note
38987-4,VA C&P exam.stomach &or duodenum &or peritoneal adhesions note
38988-2,VA C&P exam.thyroid &or parathyroid diseases note
38989-0,Clostridium botulinum toxin A+B+E+F+G
38990-8,Escherichia coli O157:H7 DNA
38991-6,Amylase
Feb-99,Oxymetholone
38992-4,Amylase
38993-2,Calcium oxalate dihydrate crystals
38994-0,Histiocytes
38995-7,Mixed cellular casts
38996-5,Neutrophils
38997-3,West Nile virus Ab.IgG
38998-1,HIV 1+Hepatitis C virus RNA
38999-9,Hospital discharge DRG
39000-5,3-Hydroxybutyrylcarnitine (C4-OH)
39001-3,3-Hydroxyisovalerylcarnitine (C5-OH)
39002-1,Adipoylcarnitine (C6-DC)
39003-9,Cytomegalovirus DNA
39004-7,Epidermal growth factor receptor Ag
39005-4,Hepatitis B virus core Ab
39006-2,Hepatitis B virus little e Ab
39007-0,Hepatitis B virus little e Ag
Aug-00,Oxyphenbutazone
39008-8,Hepatitis C virus Ab
39009-6,Isovalerylcarnitine (C5)
39010-4,Methylmalonylcarnitine (C4-DC)
39011-2,Mumps virus Ab.IgG
39012-0,Mycoplasma pneumoniae Ab
39013-8,Rubella virus Ab.IgG
39014-6,Suberylcarnitine (C8-DC)
39015-3,Treponema pallidum Ab
Jun-01,Para hydroxyamphetamine
39016-1,Age at death
39017-9,Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon
39018-7,Coliform bacteria
39019-5,Escherichia coli O157:H7 Ag
39020-3,Prion protein.abnormal
39021-1,Prion protein.abnormal
39022-9,Sarcocystis neurona Ab
39023-7,Vesicular stomatitis Indiana virus RNA
Apr-02,Para hydroxyamphetamine
39024-5,Vesicular stomatitis New Jersey virus RNA
39025-2,Influenza virus A hemagglutinin cDNA
39026-0,Guidance for needle localization
39027-8,Guidance for needle localization
39028-6,Guidance for needle localization
39029-4,Multisection^WO & W contrast IV
39030-2,Multisection
39031-0,Multisection
Feb-03,Para hydroxyamphetamine
39032-8,Multisection for transplanted kidney
39033-6,Multisection^WO contrast
39034-4,Multisection^WO & W contrast IV
39035-1,Multisection
39036-9,Multisection
39037-7,Multisection^W contrast IV
39038-5,Multisection^W contrast IV
39039-3,Multisection
3904-0,Paraldehyde
39040-1,Multisection
39041-9,Multisection^W contrast intrauterine
39042-7,Multisection
39043-5,Multisection & 3D reconstruction
39044-3,Multisection limited
39045-0,Multisection limited
39046-8,Multisection limited for pelvimetry^WO contrast
39047-6,View^during surgery
39048-4,View AP
39049-2,View AP
390-5,Pefloxacin
39050-0,View AP
39051-8,View lateral
39052-6,View lateral
39053-4,View lateral
39054-2,Views^W contrast intra duct
39055-9,Views^W contrast IV
39056-7,Views^W manual stress
Jul-05,Paraldehyde
39057-5,Views^W contrast IA
39058-3,Views
39059-1,View && Views^W air contrast PR+W barium contrast PO
39060-9,Views 2
39061-7,Views 3
39062-5,Views 3
39063-3,Views 5^W flexion + W extension
39064-1,Views anterior + lateral
May-06,Pefloxacin
39065-8,Views AP + inlet + outlet + oblique
39066-6,Views AP + lateral && Views
39067-4,Views AP + lateral
39068-2,Views AP + lateral^W standing
39069-0,Views AP + lateral
39070-8,Views AP + lateral + apical lordotic
39071-6,Views AP + lateral + Merchants
39072-4,Views AP + lateral + oblique
Mar-07,Pemoline
39073-2,Views AP + lateral + R-oblique + L-oblique
39074-0,Views AP + lateral + R-oblique + L-oblique
39075-7,Views AP + oblique
39076-5,Views AP + oblique
39077-3,Views AP + transthoracic
39078-1,Views PA + lateral + oblique
39079-9,Views PA + oblique
39080-7,EPM2A gene targeted mutation analysis
Jan-08,Pemoline
39081-5,Gadus morhua Ab.IgE/IgE.total
39082-3,Gentamicin^peak
39083-1,Herpes virus 8 Ab
39084-9,Iva ciliata Ab.IgE/IgE.total
39085-6,Juglans california pollen Ab.IgE/IgE.total
39086-4,Microscopic observation
39087-2,Myelin associated glycoprotein Ab.IgM
39088-0,Pecten spp Ab.IgE/IgE.total
39089-8,PLP1 gene targeted mutation analysis
39090-6,Ruditapes spp Ab.IgE/IgE.total
39091-4,Sorghum halepense Ab.IgE/IgE.total
39092-2,Vancomycin^peak
39093-0,Views^W contrast IV
39094-8,Views^W contrast IA
39095-5,Views^W contrast IA
39096-3,Views for hemodynamics^W contrast IV
39097-1,Views^W contrast IA
39098-9,Views^W contrast IA
Sep-09,Pemoline
39099-7,Views 4 && view PA
39100-3,Views lateral & PA chest
39101-1,Views lateral & PA chest
39102-9,Influenza virus A hemagglutinin cDNA
39103-7,Influenza virus A neuraminidase cDNA
39104-5,Appearance
39105-2,Appearance
39106-0,Temperature
Jul-10,Pemoline
39107-8,Color
39108-6,Body hair distribution
39109-4,Turgor
39110-2,Protection
39111-0,Body site
39112-8,Body location qualifier
39113-6,Nail angle
39114-4,Depth
May-11,Penicillin
39115-1,Drainage description
39116-9,Drainage amount
39117-7,Saturated 2x2 gauze dressings
39118-5,Saturated 4x4 gauze dressings
39119-3,Saturated 4x8 gauze dressings
39120-1,Saturated abdominal dressings
39121-9,Dressing
39122-7,Fluid output.wound drain
Mar-12,Penicillin
39123-5,Wound status
39124-3,Clinical trend
39125-0,Width
39126-8,Length
39127-6,Depth
39128-4,Wound irrigation &or cleaning fluid
39129-2,Moisture
391-3,Penicillin G
39130-0,Firmness
Jan-13,Penicillin G
39131-8,Color
39132-6,Color
39133-4,Color
39134-2,Color
39135-9,Wound assessment panel
39136-7,Skin assessment panel
39137-5,Oral assessment panel
39138-3,Guidance for vascular access
39139-1,Guidance for vascular access
39140-9,Multisection cine for blood flow velocity mapping
39141-7,Multisection
39142-5,Multisection^W contrast IV
39143-3,View^W contrast retrograde PR
39144-1,View^W air contrast PO
39145-8,Views^W contrast intra multiple ducts
39146-6,Views^W contrast intra multiple ducts
39147-4,Views^W contrast intra multiple ducts
39148-2,Views^W contrast intra multiple ducts
Sep-14,Penicillin V
39149-0,View for foreign body
39150-8,Views^post localization
39151-6,Views^W contrast intra vas deferens
39152-4,Views diagnostic
39153-2,Views screening
39154-0,Views diagnostic
39155-7,Family history or condition or disease and action
Jun-15,Pentazocine
39156-5,Body mass index
39157-3,Screen type indicator
39158-1,Screening on schedule to patient age
39159-9,Screening extent
39160-7,Visit was for recheck
39161-5,Date next screen visit
39162-3,Chronic illness indicator
39163-1,History and physical results indicator
Apr-16,Pentazocine
39164-9,History and physical follow-up status
39165-6,History and physical finding recency
39166-4,Behavioral &or mental health screen assessment
39167-2,Behavioral &or mental health screen results indicator
39168-0,Behavioral &or mental health screen follow-up status
39169-8,Behavioral &or mental health screen finding recency
39170-6,Cardiac screen results indicator
39171-4,Cardiac screen follow-up status
Feb-17,Pentazocine
39172-2,Cardiac screen finding recency
39173-0,Dental screen assessment
39174-8,Dental screen results indicator
39175-5,Dental screen follow-up status
39176-3,Dental screen finding recency
39177-1,Endocrine screen assessment
39178-9,Endocrine screen results indicator
39179-7,Endocrine screen follow-up status
3918-0,Pentazocine
39180-5,Endocrine screen finding recency
39181-3,Genitourinary screen assessment
39182-1,Genitourinary screen results indicator
39183-9,Genitourinary screen follow-up status
39184-7,Genitourinary screen finding recency
39185-4,Growth and development (includes speech) screen assessment
39186-2,Growth and development (includes speech) screen results indicator
39187-0,Growth and development (includes speech) screen follow-up status
39188-8,Growth and development (includes speech) screen finding recency
39189-6,Hearing screen assessment
39190-4,Hearing screen results indicator
39191-2,Hearing screen follow-up status
39192-0,Hearing screen finding recency
39193-8,Lead (exposure to) screen assessment
39194-6,Lead (exposure to) screen results indicator
39195-3,Lead (exposure to) screen follow-up status
39196-1,Lead (exposure to) screen finding recency
39197-9,Neurologic screen results indicator
Aug-19,Pentazocine
39198-7,Neurologic screen follow-up status
39199-5,Neurologic screen finding recency
39200-1,Nutrition screen assessment
39201-9,Nutrition screen results indicator
39202-7,Nutrition screen follow-up status
39203-5,Nutrition screen finding recency
39204-3,Orthopedic screen assessment
39205-0,Orthopedic screen results indicator
Jun-20,Pentetrazol
39206-8,Orthopedic screen follow-up status
39207-6,Orthopedic screen finding recency
39208-4,Tuberculosis exposure screen assessment
39209-2,Tuberculosis exposure screen results indicator
392-1,Penicillin G
39210-0,Tuberculosis exposure screen follow-up status
39211-8,Tuberculosis exposure screen finding recency
39212-6,Vision screen assessment
39213-4,Vision screen results indicator
Apr-21,Pentetrazol
39214-2,Vision screen follow-up status
39215-9,Vision screen finding recency
39216-7,Other screen assessment
39217-5,Other screen name
39218-3,Other screen results indicator
39219-1,Other screen follow-up status
39220-9,Other screen finding recency
39221-7,Diagnosis recommendations
Feb-22,Pentetrazol
39222-5,"Diagnosis recommendations, ICD9-CM"
39223-3,"Diagnosis recommendations, description"
39224-1,Chlamydia screen test status
39225-8,Gonorrhea screen test status
39226-6,Hemoglobin test status
39227-4,Hematocrit test status
39228-2,Lead screen test status
39229-0,Lipid screen test status
3923-0,PENTobarbital
39230-8,Sickle cell screen test status
39231-6,Syphilis screen test status
39232-4,"Screen test, other"
39233-2,"Screen test, other name"
39234-0,"Screen test, other status"
39235-7,Immunization data
39236-5,Vaccine code (CPT)
39237-3,Immunization status
39238-1,Anticipatory guidance indicator
39239-9,Anticipatory guidance or health education type
39240-7,Tobacco use status
39241-5,Tobacco use counselled
39242-3,Tobacco prevention referred
39243-1,Second hand smoke exposure
39244-9,Patient drug or alcohol use
39245-6,Drug or alcohol abuse counselled
39246-4,Risk assessment provided
39247-2,Prenatal assessment provided
Aug-24,PENTobarbital
39248-0,Prenatal interview w infants primary care provider indicator
39249-8,Program participation
39250-6,"Program participation, name"
39251-4,Other program participation name
39252-2,Foster care indicator
39253-0,Primary care practitioner (PCP) indicator
39254-8,Primary care practitioner (PCP) perform screen indicator
May-25,PENTobarbital
39255-5,Date previous screen visit
39256-3,History and physical screen assessment
39257-1,Cardiac screen assessment
39258-9,ENT screen assessment
39259-7,ENT screen results indicator
39260-5,ENT screen follow-up status
39261-3,ENT screen finding recency
39262-1,Neurologic screen assessment
Mar-26,PENTobarbital
39263-9,Tuberculin screen test status
39264-7,Urinalysis dipstick test status
39265-4,Urinalysis complete status
39266-2,Follow-up (referred to) provider &or specialist
39267-0,Reason for follow-up (referred to) provider &or specialist
39268-8,"Follow-up (referred to) provider &or specialist, name"
39269-6,"Follow-up (referred to) provider &or specialist, provider type"
39270-4,"Follow-up (referred to) provider &or specialist, address"
Jan-27,Perphenazine
39271-2,"Follow-up (referred to) provider &or specialist, phone"
39272-0,"Follow-up (referred to) provider &or specialist, network location indicator"
39273-8,Follow-up (referred to) program
39274-6,Reason for follow-up (referred to) program
39275-3,"Follow-up (referred to) program, name"
39276-1,"Follow-up (referred to) program, address"
39277-9,"Follow-up (referred to) program, phone"
39278-7,Tobacco use counselled
39279-5,Tobacco prevention referred
39280-3,Responsible party
39281-1,"Responsible party, name"
39282-9,"Responsible party, home phone number"
39283-7,"Responsible party, work number"
39284-5,Patient escort information panel
39285-2,Name
39286-0,Relationship to patient
39287-8,"Patient escort, other escort relationship"
39288-6,Pre-paid health plan indicator
Sep-28,Perphenazine
39289-4,"Follow-up (referred to) provider &or specialist, appointment date"
39290-2,"Follow-up (referred to) program, appointment date"
39291-0,Multisection^WO & W contrast IV
39292-8,Multisection^WO contrast
39293-6,Multisection^W contrast IV
39294-4,Children's preventive health services attachment
39295-1,Influenza virus A Ab
39296-9,Influenza virus A H1 Ab
Jul-29,Phenacetin
39297-7,Influenza virus A H10 Ab
39298-5,Influenza virus A H11 Ab
39299-3,Influenza virus A H12 Ab
39300-9,Influenza virus A H13 Ab
39301-7,Influenza virus A H14 Ab
39302-5,Influenza virus A H15 Ab
39303-3,Influenza virus A H2 Ab
39304-1,Influenza virus A H3 Ab
May-30,Phenacetin
39305-8,Influenza virus A H4 Ab
39306-6,Influenza virus A H5 Ab
39307-4,Influenza virus A H6 Ab
39308-2,Influenza virus A H7 Ab
39309-0,Influenza virus A H8 Ab
39310-8,Influenza virus A H9 Ab
39311-6,Influenza virus A N1 Ab.Neut
39312-4,Influenza virus A N2 Ab.Neut
Mar-31,Phenazocine
39313-2,Influenza virus A N3 Ab.Neut
39314-0,Influenza virus A N4 Ab.Neut
39315-7,Influenza virus A N5 Ab.Neut
39316-5,Influenza virus A N6 Ab.Neut
39317-3,Influenza virus A N7 Ab.Neut
39318-1,Influenza virus A N8 Ab.Neut
39319-9,Influenza virus A N9 Ab.Neut
39320-7,Prion protein.abnormal
Jan-32,Phenazocine
39321-5,Views AP internal rotation + AP external rotation + axillary
39322-3,Multisection^W contrast intradisc
39323-1,View R-posterior oblique
39324-9,View PA^W clenched fist
39325-6,View AP internal rotation + Grashey + axillary + outlet
39326-4,Views
39327-2,Views for fetal age
39328-0,Views AP internal rotation + AP external rotation
39329-8,Views AP internal rotation + AP external rotation
39330-6,Views AP + lateral^W standing
39331-4,Views AP + lateral^W standing
39332-2,Views AP + lateral^W standing
39333-0,Views AP + lateral^W standing
39334-8,Views AP + lateral + oblique^W standing
39335-5,Views AP internal rotation + AP external rotation + axillary
39336-3,Views AP internal rotation + AP external rotation + axillary
39337-1,Views AP internal rotation + AP external rotation + axillary + outlet
39338-9,Views AP internal rotation + AP external rotation + axillary + Y
Sep-33,Phenazocine
39339-7,Views AP + axillary + outlet + 30 degree caudal angle
39340-5,Views lateral^W standing + W flexion + W extension
39341-3,Views lateral + PA^W inspiration + W expiration
39342-1,Views PA & oblique^W nipple markers
39343-9,Views AP internal rotation + AP external rotation + Y
39344-7,Views AP internal rotation + AP external rotation + axillary + Y
39345-4,(View Sunrise) + (View tunnel^W standing)
39346-2,View AP internal rotation + West Point
Jul-34,Phencyclidine
39347-0,View AP internal rotation + West Point
39348-8,Views AP internal rotation + AP external rotation + Y
39349-6,Views^W contrast retrograde
39350-4,Views Grashey + outlet + Serendipity
39351-2,Views
39352-0,Views
39353-8,Views
Apr-35,Phencyclidine
39354-6,Cholinesterase^dibucaine/Cholinesterase
39355-3,Cholinesterase.fluoride inhibited/Cholinesterase
39356-1,Cholinesterase.scoline inhibited/Cholinesterase
39357-9,Cholinesterase.chloride inhibited/Cholinesterase
39358-7,Cholinesterase.RO 020683 inhibited/Cholinesterase
39359-5,Multisection^WO contrast
39360-3,Views + inlet + outlet
39361-1,Guidance for drainage of abscess+placement of drainage catheter
Feb-36,Phencyclidine
39362-9,Guidance for placement of tube
39363-7,Views^W contrast retrograde
39364-5,Views 3 + radial deviation
39365-2,Views 3 + ulnar deviation
39366-0,Views lateral + outlet
39367-8,(Views AP + lateral) for scoliosis^W standing
39368-6,Views AP + lateral^W standing
39369-4,(Views AP + lateral + oblique) + (view^W manual stress)
3937-0,Phencyclidine
39370-2,(Views) + (view^W manual stress)
39371-0,Views AP + lateral + oblique^W standing
39372-8,Views + Mortise
39373-6,Views + oblique
39374-4,Views AP + lateral^W standing
39375-1,Views AP + lateral + oblique^W standing
39376-9,Views + oblique
39377-7,Views + lateral crosstable
39378-5,Views 2 + oblique
39379-3,Views 2 + Sunrise
39380-1,Views 2 + Sunrise + tunnel
39381-9,Views 2 + tunnel
39382-7,(Views 2) + (view tunnel^W standing)
39383-5,Views 3 + Sunrise
39384-3,(Views 4) + (view AP^W standing)
39385-0,Views 4 + oblique
39386-8,Views 4 + tunnel
39387-6,Views 4 + Sunrise + tunnel
Aug-38,Phendimetrazine
39388-4,Views AP + lateral + R-oblique + L-oblique
39389-2,Views + tunnel
393-9,Penicillin G
39390-0,Views + oblique
39391-8,Views + Sunrise
39392-6,Views internal rotation + external rotation + axillary
39393-4,Views 3 + axillary
39394-2,Views 3 + Y
39395-9,Views AP internal rotation + AP external rotation
Jun-39,Phendimetrazine
39396-7,View AP internal rotation + West Point
39397-5,Views AP internal rotation + AP external rotation + West Point
39398-3,Views + oblique
39399-1,Views 3 + carpal tunnel
39400-7,Views + carpal tunnel
39401-5,Views AP + Grashey + axillary
39402-3,Views AP internal rotation + AP external rotation
39403-1,Views axillary + transcapular
Apr-40,Phendimetrazine
39404-9,Views 3 + submentovertex
39405-6,Views lateral + R-oblique + L-oblique
39406-4,Views lateral + R-anterior oblique
39407-2,Views 5 + oblique
39408-0,Multisection AP
39409-8,Multisection lateral
39410-6,View AP^W L-bending
39411-4,View AP^W R-bending
Feb-41,Phendimetrazine
39412-2,Views + Swimmers
39413-0,Views 4 + oblique
39414-8,Views + oblique
39415-5,Multisection
39416-3,Multisection
39417-1,Multisection
39418-9,Multisection
39419-7,Multisection
3942-0,Pheniramine
39420-5,Multisection
39421-3,Multisection
39422-1,Multisection
39423-9,Multisection
39424-7,Multisection limited
39425-4,Multisection
39426-2,Multisection
39427-0,Multisection
39428-8,Multisection
39429-6,Multisection
39430-4,Multisection limited
39431-2,Multisection
39432-0,Multisection
39433-8,Multisection
39434-6,Multisection
39435-3,Multisection
39436-1,Multisection limited
39437-9,Multisection
Aug-43,Phenmetrazine
39438-7,Multisection
39439-5,Multisection
39440-3,Multisection
39441-1,Multisection limited
39442-9,Multisection
39443-7,Multisection
39444-5,Multisection
39445-2,Multisection
Jun-44,Phenmetrazine
39446-0,Multisection
39447-8,Multisection
39448-6,Multisection
39449-4,Multisection
39450-2,Multisection^W contrast PO
39451-0,Guidance for drainage of abscess+placement of drainage catheter
39452-8,Guidance for percutaneous aspiration of fluid
Mar-45,Phenmetrazine
39453-6,Multisection
39454-4,Multisection for transplanted liver
39455-1,9-Hydroxyrisperidone
39456-9,Acetaminophen
39457-7,Beta aminobutyrate
39458-5,Beta-2-Microglobulin
39459-3,Bicarbonate^^standard
39460-1,Bicarbonate^^standard
Jan-46,Phenmetrazine
39461-9,Bilirubin
39462-7,Bilirubin.glucuronidated
39463-5,Bilirubin.non-glucuronidated
39464-3,Carbon dioxide
39465-0,Carbon dioxide
39466-8,Carbon dioxide
39467-6,Chloride
39468-4,Cholesterol
39469-2,Cholesterol.in LDL
394-7,Penicillin G
39470-0,Prochlorperazine
39471-8,Creatinine
39472-6,Creatinine
39473-4,Creatinine
39474-2,Creatinine
39475-9,dimenhyDRINATE
39476-7,diphenhydrAMINE
39477-5,fluPHENAZine
39478-3,Glucose
Sep-47,PHENobarbital
39479-1,Glucose
39480-9,Glucose
39481-7,Glucose
39482-5,Trimeprazine
39483-3,Normethsuximide
39484-1,OLANZapine
39485-8,pH^^adjusted to patient's actual temperature
39486-6,pH^^adjusted to patient's actual temperature
Jul-48,PHENobarbital
39487-4,PHENobarbital
39488-2,Phensuximide
39489-0,Views
39490-8,Views for leg length
39491-6,Views
39492-4,Views
39493-2,Views
39494-0,Multisection
May-49,PHENobarbital
39495-7,Multisection
39496-5,Multisection
39497-3,Multisection
39498-1,Multisection
39499-9,Multisection
39500-4,Multisection
39501-2,Multisection
39502-0,Multisection
Mar-50,PHENobarbital
39503-8,Multisection
39504-6,Multisection
39505-3,Multisection
39506-1,Multisection
39507-9,Multisection
39508-7,Multisection
39509-5,Multisection for transplanted pancreas
39510-3,Views^W contrast intra lymphatic
Jan-51,PHENobarbital.free
39511-1,Views + oblique
39512-9,Views AP + Danelius Miller
39513-7,Views + Danelius Miller
39514-5,View Danelius Miller
39515-2,Views lateral^W flexion + W extension
39516-0,View Stryker Notch
39517-8,Views Stryker Notch + West Point
39518-6,Views survey limited
39519-4,Views PA + R-lateral + L-lateral
39520-2,Views PA + R-lateral + L-lateral + Towne
39521-0,Views PA + R-lateral + L-lateral + Caldwell + Towne
39522-8,Guidance for percutaneous biopsy
39523-6,Multisection
39524-4,Multisection limited
39525-1,Multisection
39526-9,Multisection limited
39527-7,Multisection for foreign body
39528-5,Adenovirus DNA
Sep-52,Phenothiazines
39529-3,Acetone
39530-1,Isopropanol
39531-9,Acetaldehyde
39532-7,Inhibin B
39533-5,Deoxyhemoglobin
39534-3,Cryptosporidium sp Ag
39535-0,Hepatitis B virus surface Ab
39536-8,Influenza virus A Ab
Jul-53,Phenothiazines
39537-6,Influenza virus B Ab
39538-4,Finch droppings Ab.IgG
39539-2,Cockatiel droppings Ab.IgG
395-4,Penicillin V
39540-0,Uranium/Creatinine
39541-8,Legionella sp Ag
39542-6,Prunus dulcis Ab.IgE/IgE.total
39543-4,Corylus avellana Ab.IgE/IgE.total
39544-2,Dolichovespula arenaria Ab.IgE/IgE.total
May-54,Phenothiazines
39545-9,Cancer pagurus Ab.IgE/IgE.total
39546-7,Homarus gammarus Ab.IgE/IgE.total
39547-5,Thunnus albacares Ab.IgE/IgE.total
39548-3,Salmo salar Ab.IgE/IgE.total
39549-1,Helix aspersa Ab.IgE/IgE.total
39550-9,Horse dander Ab.IgE/IgE.total
39551-7,Cow dander Ab.IgE/IgE.total
Feb-55,Phensuximide
39552-5,Lamb Ab.IgE/IgE.total
39553-3,Penicillin V Ab.IgE/IgE.total
39554-1,Endomysium Ab.IgG
39555-8,West Nile virus Ab
39556-6,Coagulation factor X inhibitor
39557-4,Neisseria gonorrhoeae rRNA
39558-2,West Nile virus Ab
39559-0,Legionella sp Ab.IgM
3956-0,Phentermine
39560-8,Sulfate.inorganic
39561-6,Glucose^1st specimen post dose lactose
39562-4,Glucose^2nd specimen post dose lactose
39563-2,Glucose^3rd specimen post dose lactose
39564-0,Corticotropin^1st specimen post XXX challenge
39565-7,Complement C4d
39566-5,Pregnanetriol/Creatinine
39567-3,TOLAZamide
39568-1,TOLBUTamide
39569-9,Trichoderma viride Ab
39570-7,Alternaria sp Ab.IgG
39571-5,Herpes simplex virus 1+2 Ab.IgM
39572-3,West Nile virus Ab.IgG
39573-1,West Nile virus Ab.IgM
39574-9,Hexacarboxylporphyrin
39575-6,Fungus.microscopic observation
39576-4,Sulfate
39577-2,Leishmania sp Ab.IgM
Aug-57,Phentermine
39578-0,Alternaria alternata Ab
39579-8,Penicillium notatum Ab
39580-6,Phoma herbarum Ab
39581-4,Rubella virus Ab
39582-2,Amino beta guanidinopropionate/Creatinine
39583-0,Mercury
39584-8,Mercury
39585-5,Tritium
Jun-58,Phentermine
39586-3,Disialylganglioside GD1b Ab
39587-1,Neutrophil Ab
39588-9,Histoplasma capsulatum Ab.IgG
39589-7,HTLV I p19 Ab
39590-5,HTLV I+II p19 Ab
39591-3,PARoxetine
39592-1,Bertholletia excelsa Ab.IgE/IgE.total
39593-9,Cocos nucifera Ab.IgE/IgE.total
Apr-59,Phentermine
39594-7,Carya illinoinensis nut Ab.IgE/IgE.total
39595-4,Hippoglossus hippoglossus Ab.IgE/IgE.total
39596-2,Mytilus edulis Ab.IgE/IgE.total
39597-0,Cucurbita pepo Ab.IgE/IgE.total
39598-8,Curvularia lunata Ab.IgE/IgE.total
39599-6,Epicoccum purpurascens Ab.IgE/IgE.total
39600-2,Fusarium moniliforme Ab.IgE/IgE.total
39601-0,Stemphylium botryosum Ab.IgE/IgE.total
Feb-60,Phenylbutazone
39602-8,Hamster epithelium Ab.IgE/IgE.total
39603-6,Guinea pig epithelium Ab.IgE/IgE.total
39604-4,Artemisia vulgaris Ab.IgE/IgE.total
39605-1,Goose feather Ab.IgE/IgE.total
39606-9,Rabbit epithelium Ab.IgE/IgE.total
39607-7,Spermatozoa.motile
39608-5,Spermatozoa.immotile
39609-3,Vaccinium myrtillus Ab.IgE/IgE.total
3961-0,Phenylbutazone
39610-1,Neisseria meningitidis serogroup w135 Ab
39611-9,Silicone Ab.IgG
39612-7,Silicone Ab.IgA
39613-5,Silicone Ab.IgM
39614-3,Silicone Ab.IgE
39615-0,Benzoylcarnitine (BzCn)
39616-8,Palmitoylcarnitine
39617-6,3-Hydroxypalmitoylcarnitine
39618-4,Neisseria meningitidis serogroup Y Ab
39619-2,Views^W radionuclide IV
396-2,Penicillin V
39620-0,Guidance limited for localization of abscess^W radionuclide IV
39621-8,Guidance for localization of abscess^W radionuclide IV
39622-6,Guidance for localization of abscess^W radionuclide IV
39623-4,Guidance for localization of abscess^W radionuclide IV
39624-2,Views^W I-131 NP59 IV
39625-9,Views^W Tc-99m DTPA IA
39626-7,Views^W radionuclide IV
39627-5,Views limited^W radionuclide IV
Aug-62,Phenylephrine
39628-3,Multisection for Meckel's diverticulum^W radionuclide IV
39629-1,Views for Meckel's diverticulum^W radionuclide IV
39630-9,Views^W Tc-99m HMPAO IV
39631-7,Multisection^W Tc-99m HMPAO IV
39632-5,Multisection^W radionuclide IV
39633-3,Views static^W radionuclide IV
39634-1,Views limited^W radionuclide IV
39635-8,Views^W Tl-201 IV
Jun-63,Phenylpropanolamine
39636-6,Views for blood flow^W radionuclide IV
39637-4,Multisection for blood flow^W radionuclide IV
39638-2,Multisection^W I-123 IV
39639-0,Multisection^W Tl-201 IV
39640-8,Multisection^W Tc-99m DTPA IV
39641-6,Multisection^W Tc-99m glucoheptonate IV
39642-4,Views^W Tc-99m glucoheptonate IV
39643-2,Views^W radionuclide IV
Apr-64,Phenylpropanolamine
39644-0,Multisection^W radionuclide IV
39645-7,Views limited^W radionuclide IV
39646-5,Views^W radionuclide IV
39647-3,Multisection^W Tc-99m Tetrofosmin IV
39648-1,Multisection^W dipyridamole IV+W radionuclide IV
39649-9,Multisection^W radionuclide IV
39650-7,Views^W radionuclide IV
Jan-65,Phenylpropanolamine
39651-5,Views^W adenosine+W Tl-201 IV
39652-3,Views^W DOBUTamine+W Tl-201 IV
39653-1,Views for infarct^W radionuclide IV
39654-9,Multisection for infarct^W Tc-99m PYP IV
39655-6,Multisection for infarct^W Tc-99m Sestamibi IV
39656-4,Multisection for infarct^W radionuclide IV
39657-2,Views for infarct^W Tc-99m PYP IV
39658-0,Multisection^at rest+W radionuclide IV
39659-8,Views^at rest & W 201 TI IV
39660-6,Views^at rest+W dipyridamole IV+W radionuclide IV
39661-4,Views^at rest+W DOBUTamine+W radionuclide IV
39662-2,Multisection^at rest+W stress+W Tc-99m Sestamibi IV
39663-0,Views^at rest+W stress+W radionuclide IV
39664-8,Views for shunt detection^W Tc-99m MAA IV
39665-5,Views for shunt detection^W radionuclide IV
39666-3,Views^W stress+W 201 TH IV
39667-1,Views^W stress+W radionuclide IV
39668-9,Multisection^W stress+W radionuclide IV
Sep-66,Phenylpropanolamine
39669-7,Views^W Tc-99m Arcitumomab IV
39670-5,Views^W radionuclide intra lacrimal duct
39671-3,Views^W radionuclide PO
39672-1,Views for motility^W radionuclide PO
39673-9,Views for reflux^W radionuclide PO
39674-7,Views^W Tc-99m DISIDA IV
39675-4,Multisection for infection^W Ga-67 IV
39676-2,Views static for infection^W Ga-67 IV
Jul-67,Phenytoin
39677-0,Views for infection^W Ga-67 IV
39678-8,Multisection for tumor^W Ga-67 IV
39679-6,Views for tumor^W Ga-67 IV
39680-4,Multisection^W Ga-67 IV
39681-2,Multisection limited^W Ga-67 IV
39682-0,Multisection^W Ga-67 IV
39683-8,Views^W Ga-67 IV
39684-6,Multisection for abscess^W Ga-67 IV
May-68,Phenytoin
39685-3,Views for abscess^W Ga-67 IV
39686-1,Views for lymphoma^W Ga-67 IV
39687-9,Views limited^W Ga-67 IV
39688-7,Views^W Ga-67 IV
39689-5,Views^W Tc-99m SC IV
39690-3,Views^W Tc-99m tagged RBC IV
39691-1,Multisection^W Tc-99m tagged RBC IV
39692-9,Multisection^W radionuclide IV
Mar-69,Phenytoin.free
39693-7,Views^W radionuclide IV
39694-5,Views for transplanted liver^W radionuclide IV
39695-2,Views limited^W radionuclide IV
39696-0,Views^W depreotide+W radionuclide IV
39697-8,Views perfusion^W radionuclide IV
39698-6,Views^W I-131 MIBG IV
39699-4,Views perfusion^at rest+W Tc-99m Sestamibi IV
397-0,Penicillin V
39700-0,Multisection perfusion^W adenosine+W radionuclide IV
Jan-70,Pholedrine
39701-8,Views perfusion^W adenosine+W radionuclide IV
39702-6,Views perfusion^W DOBUTamine+W Tc-99m Sestamibi IV
39703-4,Views perfusion^W DOBUTamine+W radionuclide IV
39704-2,Views perfusion^W Tc-99m Sestamibi IV
39705-9,Views perfusion^W dipyridamole IV+W Tc-99m Sestamibi IV
39706-7,Views perfusion^W dipyridamole & W 99m Tc mibi IV
39707-5,Views perfusion^W dipyridamole IV+W Tl-201 IV
39708-3,Views perfusion^W dipyridamole IV+W radionuclide IV
39709-1,Views perfusion^W dipyridamole IV+W Tc-99m IV
39710-9,Multisection perfusion^W Tc-99m Sestamibi IV
39711-7,Multisection perfusion^W Tl-201 IV
39712-5,Multisection perfusion^W radionuclide IV
39713-3,Views perfusion^W Tl-201 IV+W Tc-99m Tetrofosmin IV
39714-1,Views perfusion^W Tl-201 IV
39715-8,Views perfusion^W stress+W Tl-201 IV
39716-6,Views perfusion^W radionuclide IV
39717-4,Views perfusion^at rest & W 99m Tc mibi IV
39718-2,Multisection perfusion^at rest+W radionuclide IV
Sep-71,Pindolol
39719-0,Views perfusion^at rest+W adenosine+W radionuclide IV
39720-8,Views perfusion^at rest+W dipyridamole IV+W Tc-99m Sestamibi IV
39721-6,Views perfusion^at rest & W stress & W 99m Tc Sestamibi IV
39722-4,Views perfusion^at rest+W dipyridamole IV+W radionuclide IV
39723-2,Multisection perfusion^at rest+W stress+W Tl-201 IV
39724-0,Multisection perfusion^at rest+W stress+W radionuclide IV
39725-7,Multisection perfusion^at rest+W adenosine+W Tl-201 IV
39726-5,Views perfusion^at rest+W stress+W radionuclide IV
Jul-72,Piperacillin
39727-3,Views perfusion^at rest+W stress+W Tc-99m Sestamibi IV
39728-1,Views perfusion^at rest+W radionuclide IV
39729-9,Multisection perfusion^at rest+W Tl-201 IV
39730-7,Views perfusion^W stress+W radionuclide IV
39731-5,Views perfusion^W adenosine+W Tc-99m Sestamibi IV
39732-3,Views perfusion^W stress+W Tc-99m Sestamibi IV
39733-1,Views perfusion^W DOBUTamine+W Tl-201 IV
39734-9,Multisection perfusion^W stress+W radionuclide IV
May-73,Pipradrol
39735-6,Views perfusion^W adenosine+W Tl-201 IV
39736-4,Multisection perfusion^W stress+W Tc-99m Sestamibi IV
39737-2,Views^W radionuclide IV
39738-0,Views^W In-111 Satumomab IV
39739-8,Views^W radionuclide IV
39740-6,Multisection^W radionuclide IV
39741-4,Views delayed^W radionuclide IV
39742-2,Views^W radionuclide IV
Mar-74,Pipradrol
39743-0,Multisection^W Tc-99m capromab pendatide IV
39744-8,Views^W Tc-99m capromab pendatide IV
39745-5,Views^W Tc-99m DTPA IV
39746-3,Views^W Tc-99m Mertiatide IV
39747-1,Views^W radionuclide IV
39748-9,Multisection for tumor^W Tc-99m Sestamibi IV
39749-7,Views for tumor^W Tc-99m Sestamibi IV
3975-0,Pipradrol
39750-5,Views for tumor^W Tc-99m Sestamibi IV
39751-3,Views^W radionuclide IV
39752-1,Views^W radionuclide tagged heat damaged RBC IV
39753-9,Views^W Tc-99m DTPA IV
39754-7,Views limited^W I-131 IV
39755-4,Multisection^W I-131 IV
39756-2,Views^W Tc-99m Sestamibi IV
39757-0,Views^W Tc-99m IV
39758-8,Guidance for localization of tumor^W radionuclide IV
39759-6,Guidance limited for localization of tumor^W radionuclide IV
39760-4,Guidance limited for localization of tumor^W radionuclide IV
39761-2,Guidance limited for localization of tumor^W Tc-99m Sestamibi IV
39762-0,Guidance for localization of tumor^W radionuclide IV
39763-8,Guidance for localization of tumor^W radionuclide IV
39764-6,Views^W Tc-99m SC IV
39765-3,Views^W Tc-99m DTPA IV
39766-1,Views^W Tc-99m HDP IV
39767-9,Views for gastric emptying liquid phase^W radionuclide PO
Aug-76,Practolol
39768-7,Views for gastric emptying ^W Tc-99m SC PO
39769-5,Views for gastric emptying^W radionuclide PO
39770-3,Multisection^W radionuclide IV
39771-1,Porphyrins
39772-9,Sulfamethoxazole
39773-7,Beta-2-Microglobulin/Creatinine
39774-5,Porphyrins
39775-2,Protoporphyrin.free
Jun-77,Prazepam
39776-0,Urea^post dialysis
39777-8,Urea^pre dialysis
39778-6,Iron/Iron binding capacity.total
39779-4,Urea
39780-2,Urea
39781-0,Urea
39782-8,Delta aminolevulinate/Creatinine
39783-6,Urea/Creatinine
Apr-78,Primidone
39784-4,Porphyrins
39785-1,Potassium
39786-9,Pyridoxine
39787-7,Sodium
39788-5,Urate
39789-3,Potassium
39790-1,Potassium
39791-9,Sodium
Feb-79,Probenecid
39792-7,Sodium
39793-5,Coproporphyrin 3/Coproporphyrin 1
39794-3,Tocainide
39795-0,Trifluoperazine
39796-8,Vancomycin^peak
39797-6,Vancomycin^trough
39798-4,Warfarin
39799-2,risperiDONE
Aug-39,Azlocillin
3980-0,Probenecid
39800-8,Risperidone+9-Hydroxyrisperidone
39801-6,Triglyceride
39802-4,Creatinine dial fld/Creatinine ser_plas
39803-2,inFLIXimab
39804-0,Lipoprotein associated phospholipase A2
39805-7,Rabbit hair Ab.IgE
39806-5,Stage.summary at Dx 2000 revised
39807-3,Surgery site.98-02
39808-1,Date 1st most definitive surgery Rx for
39809-9,Date 1st systemic treatment
39810-7,RuralUrban continuum 1993
39811-5,Multisection for abscess^W radionuclide IV
39812-3,Views^W Tc-99m HMPAO IV
39813-1,Multisection limited^W radionuclide IV
39814-9,Views static limited ^W radionuclide IV
39815-6,Views static^W radionuclide IV
39816-4,Multisection^W radionuclide IV
39817-2,Views static^W radionuclide IV
Aug-81,Probenecid
39818-0,Views^W radionuclide IV
39819-8,Views delayed^W radionuclide IV
39820-6,Views^W Sm-153 IV
39821-4,Multisection limited^W radionuclide IV
39822-2,Views limited^W radionuclide IV
39823-0,Multisection^W radionuclide IV
39824-8,Views^W radionuclide IV
39825-5,Multisection^W radionuclide IV
Jun-82,Procainamide
39826-3,Views^W radionuclide IV
39827-1,Views for endocrine tumor^W I-131 MIBG IV
39828-9,Views for endocrine tumor^W In-111 pentetreotide IV
39829-7,Views for tumor^W Ga-67 IV
39830-5,Views for infection^W Ga-67 IV
39831-3,Views limited for tumor^W Ga-67 IV
39832-1,Views static^W radionuclide IV
39833-9,Views perfusion^W radionuclide gaseous IH
Apr-83,Procainamide+N-acetylprocainamide
39834-7,Views ventilation^W Tc-99m DTPA aerosol IH
39835-4,Views ventilation^W radionuclide aerosol IH
39836-2,Views ventilation^W radionuclide gaseous IH
39837-0,Views ventilation^W radionuclide IH
39838-8,Multisection ventilation+perfusion^W radionuclide IH+W radionuclide IV
39839-6,Multisection^W I-131 MIBG IV
39840-4,Views delayed^W I-131 MIBG IV
39841-2,Views^W I-131 MIBG IV
Feb-84,Prolintane
39842-0,Views delayed^W In-111 Satumomab IV
39843-8,Views limited^W In-111 Satumomab IV
39844-6,Multisection^W In-111 Satumomab IV
39845-3,Views^W In-111 Satumomab IV
39846-1,Views^W In-111 Satumomab IV
39847-9,Views for blood flow^W radionuclide IV
39848-7,Views for shunt patency^W In-111 IT
39849-5,Views for shunt patency^W radionuclide IT
39850-3,Views^W I-131 IV
39851-1,Multisection^W Tc-99m Mertiatide IV
39852-9,Multisection^W radionuclide IV
39853-7,Views static^W radionuclide IV
39854-5,Views static^W Tc-99m DMSA IV
39855-2,Views static^W radionuclide IV
39856-0,Views for blood flow^W radionuclide IV
39857-8,Views^W I-131 MIBG IV
39858-6,Views for blood flow^W radionuclide IV
Sep-85,Prolintane
39859-4,Views delayed^W radionuclide IV
39860-2,Views blood pool^W stress+W radionuclide IV
39861-0,Views blood pool^W radionuclide IV
39862-8,Multisection blood pool^at rest+W radionuclide IV
39863-6,Views first pass^at rest+W stress+W radionuclide IV
39864-4,Views first pass^W radionuclide IV
39865-1,Views first pass^W radionuclide IV
39866-9,Views first pass^at rest+W Tc-99m Sestamibi IV
Jul-86,Prolintane
39867-7,Views first pass^at rest+W radionuclide IV
39868-5,Views first pass^W stress+W Tc-99m Sestamibi IV
39869-3,Views first pass^W stress+W radionuclide IV
39870-1,Views for blood flow^W Tc-99m pertechnetate IV
39871-9,Views for blood flow^W radionuclide IV
39872-7,Multisection wall motion^W radionuclide IV
39873-5,Views wall motion^W radionuclide IV
39874-3,Views delayed^W radionuclide IT
May-87,Promazine
39875-0,Views delayed^W Ga-67 IV
39876-8,Multisection^W radionuclide IV
39877-6,Views^W radionuclide IV
39878-4,Views static^W radionuclide IV
39879-2,Multisection^W radionuclide IV
398-8,Penicillin V
39880-0,Views 2 phase^W radionuclide IV
39881-8,Multisection 3 phase^W radionuclide IV
39882-6,Views 3 phase^W radionuclide IV
Mar-88,Promethazine
39883-4,Views 3 phase^W radionuclide IV
39884-2,Views blood pool^W radionuclide IV
39885-9,Views first pass+ventricular volume^W radionuclide IV
39886-7,Views first pass+wall motion^at rest+W radionuclide IV
39887-5,Views first pass+ejection fraction^at rest+W radionuclide IV
39888-3,Views first pass+wall motion^W stress+W radionuclide IV
39889-1,Views first pass+ejection fraction^W radionuclide IV
39890-9,Views first pass+wall motion^W radionuclide IV
Jan-89,Promethazine
39891-7,Views for infarct+first pass^W Tc-99m PYP IV
39892-5,Views for infarct+first pass^W radionuclide IV
39893-3,Views for blood flow+shunt detection^W radionuclide IV
39894-1,Views static for shunt detection^W radionuclide IV
39895-8,Views for ejection fraction^W Tc-99m DISIDA IV
39896-6,Views static for tumor^W Ga-67 IV
39897-4,Views^W radionuclide IV
39898-2,Multisection ventilation^W radionuclide aerosol IH
39899-0,Views for blood flow^W radionuclide IV
39900-6,Views static^W radionuclide IV
39901-4,Views 3 phase multiple areas ^W radionuclide IV
39902-2,Views 3 phase single area ^W radionuclide IV
39903-0,Views static multiple areas^W radionuclide IV
39904-8,Views multiple areas^W radionuclide IV
39905-5,Multisection multiple areas^W radionuclide IV
39906-3,Multisection multiple areas^W radionuclide IV
39907-1,Views multiple areas^W radionuclide IV
39908-9,Views first pass+wall motion+ventricular volume^W stress+W radionuclide IV
Sep-90,Propranolol
39909-7,Views first pass+wall motion+ventricular volume+ejection fraction^W stress+W radionuclide IV
39910-5,Views first pass+wall motion+ejection fraction^W radionuclide IV
39911-3,View first pass & wall motion & ejection fraction^W radionuclide IV
39912-1,Views first pass+wall motion+ventricular volume+ejection fraction^W radionuclide IV
39913-9,Multisection gated+ejection fraction^W radionuclide IV
39914-7,Views gated^W Tc-99m Sestamibi IV
39915-4,Views gated^W radionuclide IV
39916-2,Multisection gated^W radionuclide IV
Jul-91,Propranolol
39917-0,Views gated+ejection fraction^W radionuclide IV
39918-8,Multisection gated+wall motion^W radionuclide IV
39919-6,Views gated+first pass^W radionuclide IV
39920-4,Views gated^at rest+W Tc-99m Sestamibi IV
39921-2,Views gated^at rest+W radionuclide IV
39922-0,Views gated^at rest+W Tc-99m pertechnetate IV
39923-8,Views gated+ejection fraction^at rest+W radionuclide IV
39924-6,Views gated^at rest+W stress+W radionuclide IV
May-92,Propranolol
39925-3,Views gated+wall motion+ejection fraction^at rest+W radionuclide IV
39926-1,View gated^W stress & W radionuclide IV
39927-9,Views gated^W stress+W Tc-99m pertechnetate IV
39928-7,Views gated^W stress+W radionuclide IV
39929-5,Views gated+wall motion^W stress+W radionuclide IV
39930-3,Multisection gated^W stress+W radionuclide IV
39931-1,Views gated+wall motion+ejection fraction^W radionuclide IV
39932-9,Views wall motion+ejection fraction^W radionuclide IV
Mar-93,Propranolol
39933-7,Views for infection multiple areas^W Ga-67 IV
39934-5,Views for tumor multiple areas^W Ga-67 IV
39935-2,Views multiple areas^W Ga-67 IV
39936-0,Views limited^W radionuclide IV
39937-8,Views multiple areas^W radionuclide XXX
39938-6,Multisection^W radionuclide IV
39939-4,Views^W radionuclide IV
39940-2,Views for clearance^W Tc-99m DTPA aerosol IH
Jan-94,Propranolol
39941-0,Views perfusion^W particulate radionuclide IV
39942-8,Views ventilation+perfusion^W radionuclide IH+W radionuclide IV
39943-6,Views ventilation & perfusion^W radionuclide IH & W particulate radionuclide IV
39944-4,Views ventilation+equilibrium+washout^W radionuclide IH
39945-1,Views ventilation^W radionuclide gaseous IH single breath
39946-9,Views ventilation+perfusion+differential^W radionuclide IH+W radionuclide IV
39947-7,Views ventilation+equilibrium^W radionuclide IH
39948-5,Views ventilation & equilibrium & washout^W radionuclide IH single breath
39949-3,Views multiple areas^W In-111 Satumomab IV
39950-1,Views multiple areas^W Tc-99m capromab pendatide IV
39951-9,Views for tumor multiple areas^W Tc-99m Sestamibi IV
39952-7,Views for blood flow+function^W radionuclide IV
39953-5,Guidance for localization of tumor multiple areas^W radionuclide IV
39954-3,Views for thrombosis^W radionuclide IV
39955-0,Creatinine^pre XXX challenge
39956-8,Creatinine^1.5H pre XXX challenge
39957-6,Creatinine^1H pre XXX challenge
Aug-95,Propylhexedrine
39958-4,Creatinine^45M pre XXX challenge
39959-2,Creatinine^30M pre XXX challenge
399-6,Phenethicillin
39960-0,Creatinine^45M post XXX challenge
39961-8,Creatinine^3.5H post XXX challenge
39962-6,Creatinine^3.75H post XXX challenge
39963-4,Creatinine^4H post XXX challenge
39964-2,Creatinine^4.5H post XXX challenge
39965-9,Creatinine^5.25H post XXX challenge
Jun-96,Propylhexedrine
39966-7,Creatinine^5.5H post XXX challenge
39967-5,Creatinine^6.5H post XXX challenge
39968-3,Creatinine^8H post XXX challenge
39969-1,Creatinine^9H post XXX challenge
39970-9,Creatinine^10H post XXX challenge
39971-7,Creatinine^12H post XXX challenge
39972-5,Creatinine^16H post XXX challenge
39973-3,Creatinine^18H post XXX challenge
Apr-97,Propylhexedrine
39974-1,Creatinine^2D post XXX challenge
39975-8,Creatinine^4D post XXX challenge
39976-6,Creatinine^7D post XXX challenge
39977-4,Creatinine^pre XXX challenge
39978-2,Creatinine^2.25H pre XXX challenge
39979-0,Creatinine^1.5H pre XXX challenge
39980-8,Creatinine^1H pre XXX challenge
39981-6,Creatinine^30M pre XXX challenge
Feb-98,Propylhexedrine
39982-4,Creatinine^baseline
39983-2,Creatinine^30M post XXX challenge
39984-0,Creatinine^1H post XXX challenge
39985-7,Creatinine^1.5H post XXX challenge
39986-5,Creatinine^2H post XXX challenge
39987-3,Creatinine^2.5H post XXX challenge
39988-1,Creatinine^3H post XXX challenge
39989-9,Creatinine^3.5H post XXX challenge
3999-0,Protriptyline
39990-7,Creatinine^4H post XXX challenge
39991-5,Creatinine^4.5H post XXX challenge
39992-3,Creatinine^5H post XXX challenge
39993-1,Creatinine^5.5H post XXX challenge
39994-9,Creatinine^6H post XXX challenge
39995-6,Creatinine^8H post XXX challenge
39996-4,Creatinine^1D post XXX challenge
39997-2,Glucose^pre XXX challenge
39998-0,Glucose^30M pre XXX challenge
39999-8,Glucose^15M pre XXX challenge
40000-2,Glucose^5M pre XXX challenge
40001-0,Glucose^5M post XXX challenge
40002-8,Glucose^80M post XXX challenge
40003-6,Glucose^1.5H post XXX challenge
40004-4,Glucose^100M post XXX challenge
40005-1,Glucose^110M post XXX challenge
Jun-00,Protriptyline
40006-9,Glucose^8.5H post XXX challenge
40007-7,Glucose^9.5H post XXX challenge
40008-5,Glucose^11.5H post XXX challenge
40009-3,Glucose^12.5H post XXX challenge
40010-1,Glucose^13H post XXX challenge
40011-9,Glucose^13.5H post XXX challenge
40012-7,Glucose^14H post XXX challenge
40013-5,Glucose^15.5H post XXX challenge
Apr-01,Protriptyline
40014-3,Glucose^16H post XXX challenge
40015-0,Glucose^17.5H post XXX challenge
40016-8,Glucose^18H post XXX challenge
40017-6,Glucose^18.5H post XXX challenge
40018-4,Glucose^19.5H post XXX challenge
40019-2,Glucose^20H post XXX challenge
400-2,Phenethicillin
40020-0,Glucose^20.5H post XXX challenge
40021-8,Glucose^21.5H post XXX challenge
Feb-02,Protriptyline^trough
40022-6,Glucose^22H post XXX challenge
40023-4,Glucose^23.5H post XXX challenge
40024-2,Glucose^1D post XXX challenge
40025-9,Glucose^3M post XXX challenge
40026-7,Glucose^ 6M post XXX challenge
40027-5,Glucose^9M post XXX challenge
40028-3,Glucose^12M post XXX challenge
40029-1,Glucose^14M post XXX challenge
4003-0,Pseudoephedrine
40030-9,Glucose^16M post XXX challenge
40031-7,Glucose^19M post XXX challenge
40032-5,Glucose^22M post XXX challenge
40033-3,Glucose^25M post XXX challenge
40034-1,Glucose^27M post XXX challenge
40035-8,Glucose^4.5H post XXX challenge
40036-6,Glucose^5.5H post XXX challenge
40037-4,Glucose^25H post XXX challenge
40038-2,Glucose^26H post XXX challenge
40039-0,Glucose^27H post XXX challenge
40040-8,Glucose^28H post XXX challenge
40041-6,Glucose^29H post XXX challenge
40042-4,Glucose^30H post XXX challenge
40043-2,Glucose^31H post XXX challenge
40044-0,Glucose^36H post XXX challenge
40045-7,Glucose^2D post XXX challenge
40046-5,Albumin^pre XXX challenge
40047-3,Albumin^45M pre XXX challenge
Aug-04,Pseudoephedrine
40048-1,Albumin^30M post XXX challenge
40049-9,Albumin^45M post XXX challenge
40050-7,Albumin^1H post XXX challenge
40051-5,Albumin^1.5H post XXX challenge
40052-3,Albumin^2H post XXX challenge
40053-1,Albumin^3H post XXX challenge
40054-9,Albumin^4H post XXX challenge
May-05,Pseudoephedrine
40055-6,Albumin^5H post XXX challenge
40056-4,Albumin^6H post XXX challenge
40057-2,Albumin^6.5H post XXX challenge
40058-0,Albumin^8H post XXX challenge
40059-8,Albumin^12H post XXX challenge
40060-6,Albumin^1D post XXX challenge
40061-4,Albumin^2D post XXX challenge
40062-2,Albumin^3D post XXX challenge
Mar-06,Pyrilamine
40063-0,Albumin^4D post XXX challenge
40064-8,Calcium^pre XXX challenge
40065-5,Calcium^45M pre XXX challenge
40066-3,Calcium^15M pre XXX challenge
40067-1,Calcium^baseline
40068-9,Calcium^45M post XXX challenge
40069-7,Calcium^1.5H post XXX challenge
40070-5,Calcium^2.5H post XXX challenge
Jan-07,Pyrilamine
40071-3,Calcium^3H post XXX challenge
40072-1,Calcium^4H post XXX challenge
40073-9,Calcium^5H post XXX challenge
40074-7,Calcium^6H post XXX challenge
40075-4,Calcium^6.5H post XXX challenge
40076-2,Calcium^7.5H post XXX challenge
40077-0,Calcium^8H post XXX challenge
40078-8,Calcium^12H post XXX challenge
40079-6,Calcium^13H post XXX challenge
40080-4,Calcium^14H post XXX challenge
40081-2,Calcium^16H post XXX challenge
40082-0,Calcium^20H post XXX challenge
40083-8,Calcium^1D post XXX challenge
40084-6,Calcium^36H post XXX challenge
40085-3,Calcium^2D post XXX challenge
40086-1,Calcium^3D post XXX challenge
40087-9,Coagulation tissue factor induced^2H pre XXX challenge
40088-7,Coagulation tissue factor induced^baseline
Sep-08,Pyrilamine
40089-5,Coagulation tissue factor induced^30M post XXX challenge
40090-3,Coagulation tissue factor induced^1H post XXX challenge
40091-1,Coagulation tissue factor induced^1.5H post XXX challenge
40092-9,Coagulation tissue factor induced^2H post XXX challenge
40093-7,Coagulation tissue factor induced^3H post XXX challenge
40094-5,Coagulation tissue factor induced^4H post XXX challenge
40095-2,Coagulation tissue factor induced^6H post XXX challenge
40096-0,Coagulation tissue factor induced^8H post XXX challenge
Jul-09,Pyrilamine
40097-8,Coagulation tissue factor induced^12H post XXX challenge
40098-6,Coagulation tissue factor induced^1D post XXX challenge
40099-4,Coagulation surface induced^2H pre XXX challenge
401-0,Phenethicillin
40100-0,Coagulation surface induced^baseline
40101-8,Coagulation surface induced^30M post XXX challenge
40102-6,Coagulation surface induced^1H post XXX challenge
40103-4,Coagulation surface induced^1.5H post XXX challenge
40104-2,Coagulation surface induced^2H post XXX challenge
May-10,Pyrilamine
40105-9,Coagulation surface induced^3H post XXX challenge
40106-7,Coagulation surface induced^4H post XXX challenge
40107-5,Coagulation surface induced^6H post XXX challenge
40108-3,Coagulation surface induced^8H post XXX challenge
40109-1,Coagulation surface induced^12H post XXX challenge
40110-9,Coagulation surface induced^1D post XXX challenge
40111-7,Coagulation surface induced^18H post XXX challenge
40112-5,Creatinine^pre XXX challenge
Mar-11,Pyrovalerone
40113-3,Creatinine^1.5H pre XXX challenge
40114-1,Creatinine^1H pre XXX challenge
40115-8,Creatinine^45M pre XXX challenge
40116-6,Creatinine^30M pre XXX challenge
40117-4,Creatinine^45M post XXX challenge
40118-2,Creatinine^3.5H post XXX challenge
40119-0,Creatinine^4H post XXX challenge
40120-8,Creatinine^8H post XXX challenge
Jan-12,Pyrovalerone
40121-6,Creatinine^9H post XXX challenge
40122-4,Creatinine^10H post XXX challenge
40123-2,Creatinine^12H post XXX challenge
40124-0,Creatinine^16H post XXX challenge
40125-7,Creatinine^18H post XXX challenge
40126-5,Creatinine^2D post XXX challenge
40127-3,Creatinine^4D post XXX challenge
40128-1,Creatinine^7D post XXX challenge
40129-9,Creatinine^pre XXX challenge
40130-7,Creatinine^1.5H pre XXX challenge
40131-5,Creatinine^1H pre XXX challenge
40132-3,Creatinine^30M pre XXX challenge
40133-1,Creatinine^baseline
40134-9,Creatinine^30M post XXX challenge
40135-6,Creatinine^1H post XXX challenge
40136-4,Creatinine^1.5H post XXX challenge
40137-2,Creatinine^2H post XXX challenge
40138-0,Creatinine^2.5H post XXX challenge
Sep-13,Pyrovalerone
40139-8,Creatinine^3H post XXX challenge
40140-6,Creatinine^3.5H post XXX challenge
40141-4,Creatinine^4H post XXX challenge
40142-2,Creatinine^4.5H post XXX challenge
40143-0,Creatinine^5H post XXX challenge
40144-8,Creatinine^5.5H post XXX challenge
40145-5,Creatinine^6H post XXX challenge
40146-3,Creatinine^8H post XXX challenge
Jul-14,quiNIDine
40147-1,Creatinine^1D post XXX challenge
40148-9,Glucose^pre XXX challenge
40149-7,Glucose^30M pre XXX challenge
40150-5,Glucose^15M pre XXX challenge
40151-3,Glucose^10M pre XXX challenge
40152-1,Glucose^5M pre XXX challenge
40153-9,Glucose^5M post XXX challenge
Apr-15,quiNIDine
40154-7,Glucose^10M post XXX challenge
40155-4,Glucose^15M post XXX challenge
40156-2,Glucose^20M post XXX challenge
40157-0,Glucose^40M post XXX challenge
40158-8,Glucose^50M post XXX challenge
40159-6,Glucose^70M post XXX challenge
40160-4,Glucose^75M post XXX challenge
40161-2,Glucose^2.5H post XXX challenge
Feb-16,quiNIDine+Quinine
40162-0,Glucose^3H post XXX challenge
40163-8,Glucose^4H post XXX challenge
40164-6,Glucose^5H post XXX challenge
40165-3,Glucose^6H post XXX challenge
40166-1,Glucose^6.5H post XXX challenge
40167-9,Glucose^7H post XXX challenge
40168-7,Glucose^7.5H post XXX challenge
40169-5,Glucose^8H post XXX challenge
4017-0,quiNIDine^trough
40170-3,Glucose^8.5H post XXX challenge
40171-1,Glucose^9H post XXX challenge
40172-9,Glucose^9.5H post XXX challenge
40173-7,Glucose^10H post XXX challenge
40174-5,Glucose^10.75H post XXX challenge
40175-2,Glucose^11.5H post XXX challenge
40176-0,Glucose^12H post XXX challenge
40177-8,Glucose^12.5H post XXX challenge
40178-6,Glucose^13H post XXX challenge
40179-4,Glucose^13.5H post XXX challenge
40180-2,Glucose^14H post XXX challenge
40181-0,Glucose^15.5H post XXX challenge
40182-8,Glucose^16H post XXX challenge
40183-6,Glucose^17.5H post XXX challenge
40184-4,Glucose^18H post XXX challenge
40185-1,Glucose^18.5H post XXX challenge
40186-9,Glucose^19.5H post XXX challenge
40187-7,Glucose^20H post XXX challenge
Aug-18,quiNINE
40188-5,Glucose^20.5H post XXX challenge
40189-3,Glucose^21.5H post XXX challenge
40190-1,Glucose^22H post XXX challenge
40191-9,Glucose^23.5H post XXX challenge
40192-7,Glucose^1D post XXX challenge
40193-5,Glucose^pre-meal
40194-3,Glucose^20M pre XXX challenge
40195-0,Glucose^13M pre XXX challenge
Jun-19,quiNINE
40196-8,Glucose^8M pre XXX challenge
40197-6,Glucose^3M pre XXX challenge
40198-4,Glucose^2M post XXX challenge
40199-2,Glucose^3M post XXX challenge
40200-8,Glucose^4M post XXX challenge
40201-6,Glucose^6M post XXX challenge
40202-4,Glucose^8M post XXX challenge
40203-2,Glucose^9M post XXX challenge
Apr-20,quiNINE
40204-0,Glucose^12M post XXX challenge
40205-7,Glucose^14M post XXX challenge
40206-5,Glucose^16M post XXX challenge
40207-3,Glucose^19M post XXX challenge
40208-1,Glucose^22M post XXX challenge
40209-9,Glucose^25M post XXX challenge
40210-7,Glucose^27M post XXX challenge
40211-5,Glucose^3.5H post XXX challenge
Feb-21,rifAMPin
40212-3,Glucose^4.5H post XXX challenge
40213-1,Glucose^5.5H post XXX challenge
40214-9,Glucose^25H post XXX challenge
40215-6,Glucose^26H post XXX challenge
40216-4,Glucose^27H post XXX challenge
40217-2,Glucose^28H post XXX challenge
40218-0,Glucose^29H post XXX challenge
40219-8,Glucose^30H post XXX challenge
4022-0,Salicylamide
40220-6,Glucose^31H post XXX challenge
40221-4,Glucose^36H post XXX challenge
40222-2,Glucose^2D post XXX challenge
40223-0,Calcium^pre XXX challenge
40224-8,Calcium^45M pre XXX challenge
40225-5,Calcium^15M pre XXX challenge
40226-3,Calcium^baseline
40227-1,Calcium^30M post XXX challenge
40228-9,Calcium^45M post XXX challenge
40229-7,Calcium^1H post XXX challenge
40230-5,Calcium^1.5H post XXX challenge
40231-3,Calcium^2H post XXX challenge
40232-1,Calcium^2.5H post XXX challenge
40233-9,Calcium^3H post XXX challenge
40234-7,Calcium^4H post XXX challenge
40235-4,Calcium^5H post XXX challenge
40236-2,Calcium^6.5H post XXX challenge
40237-0,Calcium^7.5H post XXX challenge
Aug-23,Salicylates
40238-8,Calcium^8H post XXX challenge
40239-6,Calcium^12H post XXX challenge
40240-4,Calcium^13H post XXX challenge
40241-2,Calcium^14H post XXX challenge
40242-0,Calcium^16H post XXX challenge
40243-8,Calcium^20H post XXX challenge
40244-6,Calcium^1D post XXX challenge
40245-3,Calcium^36H post XXX challenge
Jun-24,Salicylates
40246-1,Calcium^2D post XXX challenge
40247-9,Calcium^3D post XXX challenge
40248-7,Creatinine^baseline
40249-5,Creatinine^30M post XXX challenge
40250-3,Creatinine^1H post XXX challenge
40251-1,Creatinine^1.5H post XXX challenge
40252-9,Creatinine^2H post XXX challenge
Mar-25,Salicylates
40253-7,Creatinine^2.25H post XXX challenge
40254-5,Creatinine^2.5H post XXX challenge
40255-2,Creatinine^3H post XXX challenge
40256-0,Creatinine^5H post XXX challenge
40257-8,Creatinine^6H post XXX challenge
40258-6,Creatinine^1D post XXX challenge
40259-4,Glucose^10.5H post XXX challenge
40260-2,Glucose^10.75H post XXX challenge
Jan-26,Salicylates
40261-0,Glucose^13M pre XXX challenge
40262-8,Glucose^3M pre XXX challenge
40263-6,Glucose^30M post XXX challenge
40264-4,Creatinine^baseline
40265-1,Creatinine^30M post XXX challenge
40266-9,Creatinine^1H post XXX challenge
40267-7,Creatinine^1.5H post XXX challenge
40268-5,Creatinine^2H post XXX challenge
40269-3,Creatinine^2.5H post XXX challenge
40270-1,Creatinine^3H post XXX challenge
40271-9,Creatinine^5H post XXX challenge
40272-7,Creatinine^6H post XXX challenge
40273-5,Creatinine^1D post XXX challenge
40274-3,Cortisol^15M post XXX challenge
40275-0,Cortisol^45M post XXX challenge
40276-8,Glucose^30M post dose lactose PO
40277-6,Glucose^1H post dose lactose PO
40278-4,Glucose^1.5H post dose lactose PO
Sep-27,Secobarbital
40279-2,Glucose^2H post dose lactose PO
402-8,Phenethicillin
40280-0,Glucose^3H post dose lactose PO
40281-8,Lactose^30M post dose lactose PO
40282-6,Lactose^1H post dose lactose PO
40283-4,Lactose^1.5H post dose lactose PO
40284-2,Lactose^2H post dose lactose PO
40285-9,Glucose^75M post dose glucose
40286-7,Glucose^105M post dose glucose
Jul-28,Secobarbital
40287-5,Glucose^1H post meal
40288-3,Insulin^30M post XXX challenge
40289-1,Insulin^1H post XXX challenge
40290-9,Insulin^1.5H post XXX challenge
40291-7,Insulin^2H post XXX challenge
40292-5,Insulin^2.5H post XXX challenge
40293-3,Insulin^3H post XXX challenge
40294-1,Insulin^pre or post dose glucose
May-29,Secobarbital
40295-8,Triiodothyronine.free^2H post XXX challenge
40296-6,Xylose^post CFst
40297-4,Somatotropin^3.5H post XXX challenge
40298-2,Somatotropin^pre dose cloNIDine
40299-0,Somatotropin^1H post dose cloNIDine
40300-6,Somatotropin^1.5H post dose cloNIDine
40301-4,Somatotropin^2H post dose cloNIDine
40302-2,Somatotropin^pre dose arginine
Mar-30,Sotalol
40303-0,Somatotropin^1H post dose arginine
40304-8,Somatotropin^1.5H post dose arginine
40305-5,Somatotropin^2H post dose arginine
40306-3,Somatotropin^3H post dose arginine
40307-1,Somatotropin^3.5H post dose arginine
40308-9,Somatotropin^4H post dose arginine
40309-7,Somatotropin^pre or post dose glucose
40310-5,Cortisol^pre dose triple bolus
Jan-31,Sotalol
40311-3,Cortisol^15M post dose triple bolus
40312-1,Cortisol^30M post dose triple bolus
40313-9,Cortisol^45M post dose triple bolus
40314-7,Cortisol^1H post dose triple bolus
40315-4,Cortisol^1.5H post dose triple bolus
40316-2,Cortisol^2H post dose triple bolus
40317-0,Cortisol^3H post dose triple bolus
40318-8,Glucose^pre dose triple bolus
40319-6,Glucose^15M post dose triple bolus
40320-4,Glucose^30M post dose triple bolus
40321-2,Glucose^45M post dose triple bolus
40322-0,Glucose^1H post dose triple bolus
40323-8,Glucose^2H post dose triple bolus
40324-6,Glucose^3H post dose triple bolus
40325-3,Testosterone^pre dose triple bolus
40326-1,Testosterone^3H post dose triple bolus
40327-9,Triiodothyronine.free^pre dose triple bolus
40328-7,Triiodothyronine.free^2H post dose triple bolus
Sep-32,Sotalol
40329-5,Prolactin^pre dose triple bolus
40330-3,Prolactin^15M post dose triple bolus
40331-1,Prolactin^20M post dose triple bolus
40332-9,Prolactin^30M post dose triple bolus
40333-7,Prolactin^1H post dose triple bolus
40334-5,Somatotropin^pre dose triple bolus
40335-2,Somatotropin^15M post dose triple bolus
40336-0,Somatotropin^30M post dose triple bolus
Jul-33,Spironolactone
40337-8,Somatotropin^45M post dose triple bolus
40338-6,Somatotropin^1H post dose triple bolus
40339-4,Somatotropin^2H post dose triple bolus
40340-2,Somatotropin^3H post dose triple bolus
40341-0,MT-ATP6 gene.m.8993T>G
40342-8,MT-TL1 gene.m.3271T>C
40343-6,MT-TK gene.m.8296A>G
40344-4,Mttl1 gene.c.A3243G
May-34,Spironolactone
40345-1,MT-TK gene.m.8356T>C
40346-9,MT-CO1 gene.m.7445A>G
40347-7,MT-TL1 gene.m.3256C>T
40348-5,MT-TL1 gene.m.3252T>C
40349-3,MT-TK gene.m.8363G>A
40350-1,MT-TL1 gene.m.3291T>C
40351-9,MT-ND4 gene.m.11778G>A
Feb-35,Spironolactone
40352-7,MT-ND5 gene.m.13513G>A
40353-5,MT-ND6 gene.m.14484T>C
40354-3,MT-ND1 gene.m.3460G>A
40355-0,Cotinine
40356-8,Creatinine
40357-6,Creatinine
40358-4,Desipramine
40359-2,Dextromethorphan
403-6,Pipemidate
4036-0,Stanozolol
40360-0,Follitropin^15M post dose triple bolus
40361-8,Follitropin^1H post dose triple bolus
40362-6,Follitropin^20M post dose triple bolus
40363-4,Follitropin^2H post dose triple bolus
40364-2,Follitropin^30M post dose triple bolus
40365-9,Follitropin^pre dose triple bolus
40366-7,Glucose
40367-5,Heptacarboxylate
40368-3,Hexacarboxylate
40369-1,HYDROmorphone
40370-9,Imipramine
40371-7,Isoniazid
40372-5,Isopropanol
40373-3,Lutropin^15M post dose triple bolus
40374-1,Lutropin^1H post dose triple bolus
40375-8,Lutropin^20M post dose triple bolus
40376-6,Lutropin^2H post dose triple bolus
40377-4,Lutropin^30M post dose triple bolus
Aug-37,Stanozolol
40378-2,Lutropin^pre dose triple bolus
40379-0,Maprotiline
40380-8,Meprobamate
40381-6,Methamphetamine
40382-4,Methaqualone
40383-2,Methyprylon
40384-0,Morphine
40385-7,Nicotine
Jun-38,Stanozolol
40386-5,Nicotine
40387-3,Nicotine
40388-1,Nitrogen
40389-9,Nortriptyline
40390-7,OLANZapine
40391-5,Para aminobenzoate.free
40392-3,Pentacarboxylate
40393-1,Pentazocine
Apr-39,Streptomycin
40394-9,Phencyclidine
40395-6,Phentermine
40396-4,Porphyrins
40397-2,Thyrotropin^15M post dose triple bolus
40398-0,Thyrotropin^1H post dose triple bolus
40399-8,Thyrotropin^20M post dose triple bolus
40400-4,Thyrotropin^30M post dose triple bolus
40401-2,Thyrotropin^pre dose triple bolus
Feb-40,Sulfonamide
40402-0,traZODone
40403-8,Trimipramine
40404-6,Tripelennamine
40405-3,Urea
40406-1,Urea
40407-9,Uroporphyrin 1 isomer
40408-7,Uroporphyrin 3 isomer
40409-5,3-Methoxytyramine
4041-0,Sulfonamide
40410-3,Alkaline phosphatase
40411-1,Amitriptyline
40412-9,Barbiturates
40413-7,Barbiturates
40414-5,Benzodiazepines
40415-2,Benzodiazepines
40416-0,Caffeine
40417-8,Chromium
40418-6,Cotinine
40419-4,Amphetamine+Methamphetamine
40420-2,Amphetamine+Methamphetamine
40421-0,Amphetamine+Methamphetamine
40422-8,Methotrimeprazine
40423-6,Methotrimeprazine
40424-4,Methotrimeprazine
40425-1,CYP2D6 gene allele
40426-9,FGD1 gene targeted mutation analysis
40427-7,FGF23 gene targeted mutation analysis
Aug-42,Sulfonamide
40428-5,NIPBL gene targeted mutation analysis
40429-3,NOD2 gene targeted mutation analysis
40430-1,TH gene targeted mutation analysis
40431-9,Osmotic fragility^fresh
40432-7,Osmotic fragility^incubated
40433-5,Sucrose hemolysis
40434-3,APTX gene targeted mutation analysis
40435-0,Fungus identified
Jun-43,Teicoplanin
40436-8,Parainfluenza virus identified
40437-6,HIV 1 p24 Ab
40438-4,HIV 1 gp41 Ab
40439-2,HIV 1 gp120+gp160 Ab
404-4,Pipemidate
40440-0,XXX microorganism serotype
40441-8,Breaths^post exercise
40442-6,Heart rate^post exercise
40443-4,Heart rate^resting
Apr-44,Tetracaine
40444-2,Cytomegalovirus gene mutations detected
40445-9,Gas delivery source^resting
40446-7,Gas delivery source^post exercise
40447-5,Gas flow.oxygen^resting
40448-3,Gas flow.oxygen^post exercise
40449-1,Oxygen saturation^resting
40450-9,Oxygen saturation^post exercise
Jan-45,Tetracycline
40451-7,Lead
40452-5,Sialate/Creatinine
40453-3,Sialooligosaccharides
40454-1,Coagulum lysis
40455-8,Ceruloplasmin actual/Normal
40456-6,Beta 2 glycoprotein 1 Ab
40457-4,Prothrombin Ab
40458-2,Coagulation tissue factor induced.factor substitution^immediately after addition of factor VIII depleted plasma
40459-0,Hepatitis B virus DNA
40460-8,Phenytoin.bound
40461-6,GJB1 gene allele 1
40462-4,GJB1 gene allele 2
40463-2,TNFRSF1A gene targeted mutation analysis
40464-0,Drugs identified
40465-7,Glimepiride
40466-5,Herpes simplex virus 1 Ab.IgM
40467-3,U1 small nuclear ribonucleoprotein Ab.IgG
40468-1,SLC26A4 gene targeted mutation analysis
Sep-46,Tetrahydrocortisone
40469-9,Hydroflumethiazide
40470-7,Lymphocytes
40471-5,FBN1 gene targeted mutation analysis
40472-3,Tetradecadienoate/Creatinine
40473-1,Thermoactinomyces vulgaris 1 Ab
40474-9,Volatiles
40475-6,WFS1 gene targeted mutation analysis
40476-4,PARK2 gene targeted mutation analysis
Jul-47,Theophylline
40477-2,L1CAM gene targeted mutation analysis
40478-0,MAPT gene targeted mutation analysis
40479-8,Virus identified
40480-6,Virus identified
40481-4,Methylenedioxymethamphetamine
40482-2,Crystals.unidentified
40483-0,Phosphate crystals.amorphous
40484-8,Urate crystals.amorphous
May-48,Theophylline
40485-5,Urate crystals
40486-3,Protein/Creatinine
40487-1,Urea/Creatinine
40488-9,Glucose/Creatinine
40489-7,Histiocytes/100 cells
40490-5,Macrophages/100 leukocytes
40491-3,Neutrophils/100 leukocytes
40492-1,Plasma cells/100 leukocytes
Mar-49,Theophylline
40493-9,Methylenedioxymethamphetamine
40494-7,Yersinia pseudotuberculosis Ab
40495-4,Yersinia pseudotuberculosis 3 Ab
40496-2,Yersinia pseudotuberculosis 2 Ab
40497-0,Yersinia pseudotuberculosis 1 Ab
40498-8,Yersinia enterocolitica Ab
40499-6,Lymphocytic choriomeningitis virus Ab.IgM
40500-1,Lymphocytic choriomeningitis virus Ab.IgG
Jan-50,Thiopental
40501-9,Candida sp Ab
40502-7,Saint Louis encephalitis virus Ab
40503-5,Sindbis virus Ab
40504-3,Powassan virus Ab
40505-0,Chikungunya virus Ab
40506-8,Jamestown canyon virus Ab
40507-6,Jamestown canyon virus Ab
40508-4,Jamestown canyon virus Ab.IgM
40509-2,Snowshoe hare virus Ab.IgM
405-1,Pipemidate
40510-0,Snowshoe hare virus Ab
40511-8,Snowshoe hare virus Ab
40512-6,Semliki forest virus Ab
40513-4,Powassan virus Ab
40514-2,Saint Louis encephalitis virus Ab
40515-9,Dengue virus Ab
40516-7,Histiocytes/100 cells
40517-5,Macrophages/100 leukocytes
40518-3,Plasma cells/100 leukocytes
Sep-51,Thioridazine
40519-1,Histiocytes/100 cells
40520-9,Macrophages/100 leukocytes
40521-7,Monocytes/100 leukocytes
40522-5,Plasma cells/100 leukocytes
40523-3,Histiocytes/100 cells
40524-1,Macrophages/100 leukocytes
40525-8,Monocytes/100 leukocytes
40526-6,Plasma cells/100 leukocytes
Jul-52,Thioridazine
40527-4,Cocaine
40528-2,Opiates
40529-0,Amphetamines
40530-8,Ethanol
40531-6,Methylenedioxyamphetamine
40532-4,Methanol
40533-2,Leukocytes
40534-0,Erythrocytes
May-53,Thioridazine
40535-7,Leukocytes other/100 leukocytes
40536-5,Neutrophils/100 leukocytes
40537-3,Monocytes/100 leukocytes
40538-1,Lymphocytes/100 leukocytes
40539-9,Eosinophils/100 leukocytes
40540-7,Basophils/100 leukocytes
40541-5,Plasma cells/100 leukocytes
40542-3,Rubella virus Ab
Mar-54,Ticarcillin
40543-1,Leukocytes other/100 leukocytes
40544-9,Monocytes/100 leukocytes
40545-6,Hemoglobin C
40546-4,Hemoglobin E
40547-2,Hemoglobin H
40548-0,Mononuclear cells.atypical
40549-8,Hemoglobin F
4055-0,Ticarcillin+Clavulanate
40550-6,Hemoglobin H
40551-4,CD10 Ag
40552-2,CD117 Ag
40553-0,CD19 Ag
40554-8,CD45 Ag
40555-5,CD66e Ag
40556-3,Estrogen receptor Ag
40557-1,Progesterone receptor Ag
40558-9,Cytokeratin 20 Ag
40559-7,Cytokeratin 7 Ag
40560-5,Cytokeratin AE1+AE3 Ag
40561-3,Cytokeratin Cam5.2 Ag
40562-1,Actin.muscle specific Ag
40563-9,Actin.smooth muscle Ag
40564-7,Thyroid transcription factor 1 Ag
40565-4,Promyelocytes
40566-2,Neutrophils
40567-0,Myelocytes
Aug-56,Timolol
40568-8,Metamyelocytes
40569-6,Eosinophils
40570-4,Blasts
40571-2,Basophils
40572-0,Neutrophils.band form
40573-8,Lymphocytes.variant
40574-6,Platelets
40575-3,"Yersinia enterocolitica O:5,27 Ab"
Jun-57,Tobramycin^peak
40576-1,Yersinia enterocolitica O:8 Ab
40577-9,Yersinia enterocolitica O:3 Ab
40578-7,Cryoglobulin.IgM
40579-5,Cryoglobulin.IgG
40580-3,Cryoglobulin.IgA
40581-1,Cryoglobulin.IgM
40582-9,Cryoglobulin.IgG
40583-7,Invasive trophoblast Ag
Apr-58,Tobramycin^random
40584-5,Arbovirus Ab.IgM
40585-2,Drugs identified
40586-0,Heart beat^pre exercise
40587-8,Heart rate^post exercise
40588-6,Inulin
40589-4,Oxygen^post exercise
40590-2,Oxygen saturation^pre exercise
40591-0,Oxyhemoglobin/Hemoglobin.total^post exercise
Feb-59,Tobramycin^trough
40592-8,Oxyhemoglobin/Hemoglobin.total^resting
40593-6,Platelet aggregation.EPINEPHrine induced^50 umol/L
40594-4,Platelet aggregation.EPINEPHrine induced^100 umol/L
40595-1,Prothrombin Ab.IgG
40596-9,Prothrombin Ab.IgM
40597-7,7-Dehydrocholesterol
40598-5,Acetone
40599-3,Albumin
Jun-40,Azlocillin
4060-0,Tocainide
40600-9,Alpha-1-Acid glycoprotein
40601-7,Alpha-1-Acid glycoprotein
40602-5,Alpha 1 antitrypsin
40603-3,Alpha 1 antitrypsin
40604-1,Alpha-2-Macroglobulin
40605-8,Alpha-2-Macroglobulin
40606-6,Appearance
40607-4,Ascaris lumbricoides Ab.IgG
40608-2,Ascaris lumbricoides Ab.IgM
40609-0,Benzoylecgonine
40610-8,Beta-2 transferrin
40611-6,Blasts
40612-4,Borrelia burgdorferi Ab.IgM
40613-2,Brucella sp Ab
40614-0,Brucella sp Ab
40615-7,Calcium oxalate crystals
40616-5,Campylobacter sp Ab.IgA
40617-3,Campylobacter sp Ab.IgG
Aug-61,TOLBUTamide
40618-1,Cancer Ag 125
40619-9,Carbon dioxide^^adjusted to patient's actual temperature
40620-7,Carbon dioxide^^adjusted to patient's actual temperature
40621-5,Carcinoembryonic Ag
40622-3,Carcinoembryonic Ag
40623-1,Cells.CD3+CD4+/100 cells
40624-9,Cells.CD3+CD8+/100 cells
40625-6,Cocaine
Jun-62,Tranylcypromine
40626-4,Codeine
40627-2,Coproporphyrin
40628-0,Cryoglobulin.IgA
40629-8,Doxepin
40630-6,Erythrocytes.nucleated
40631-4,Erythrocytes.nucleated/100 leukocytes
40632-2,Gamma globulin/Beta globulin
40633-0,Hemopexin
Apr-63,traZODone
40634-8,HYDROcodone
40635-5,Immunoglobulin light chains.kappa
40636-3,Immunoglobulin light chains.kappa
40637-1,Immunoglobulin light chains.kappa.free
40638-9,Immunoglobulin light chains.lambda
40639-7,Immunoglobulin light chains.lambda
40640-5,Immunoglobulin light chains.lambda.free
40641-3,Ketones
Feb-64,traZODone
40642-1,Leptospira autumnalis Ab
40643-9,Leptospira borgpetersenii serovar Ballum Ab
40644-7,Leptospira borgpetersenii serovar Sejroe Ab
40645-4,Leptospira borgpetersenii serovar Tarrasovi Ab
40646-2,Leukocytes other/100 leukocytes
40647-0,Lupus anticoagulant neutralization.platelet
40648-8,Measles virus Ab.IgG
40649-6,Measles virus Ab.IgM
40650-4,Mesothelial cells/100 leukocytes
40651-2,Metamyelocytes
40652-0,Methamphetamine
40653-8,Myelocytes/100 leukocytes
40654-6,Neutrophils.hypogranulated
40655-3,Nuclear Ab
40656-1,Parasite identified
40657-9,Parvovirus B19 Ab.IgG
40658-7,Parvovirus B19 Ab.IgM
Sep-65,traZODone
40659-5,Parvovirus B19 Ab.IgM
40660-3,Promyelocytes/100 leukocytes
40661-1,Protein.monoclonal
40662-9,Protein^resting
40663-7,Protein^upright
40664-5,Pyrophosphate crystals
40665-2,Reticulocytes
40666-0,Rubella virus Ab
Jul-66,Triamterene
40667-8,Rubella virus Ab.IgG
40668-6,Rubella virus Ab.IgG
40669-4,Rubella virus Ab.IgM
40670-2,Smudge cells/100 leukocytes
40671-0,Specimen volume
40672-8,Sucrose
40673-6,Thyrotropin binding inhibitory immunoglobulins
40674-4,Toxocara canis Ab.IgG
May-67,Triamterene
40675-1,Toxocara canis Ab.IgM
40676-9,Toxoplasma gondii Ab
40677-7,Toxoplasma gondii Ab.IgG
40678-5,Toxoplasma gondii Ab.IgM
40679-3,Treponema pallidum Ab.IgG
40680-1,Treponema pallidum Ab.IgM
40681-9,Turbidity
40682-7,Urate crystals
Mar-68,Triamterene
40683-5,Bentiromide
40684-3,Acinetobacter sp.multidrug resistant identified
40685-0,Interpretation
40686-8,Platelet factor 3
40687-6,Myeloid cells/100 cells
40688-4,Megakaryocytes
40689-2,Erythroid cells/100 cells
406-9,Pipemidate
40690-0,Tumor Ag 90
Jan-69,Triazolam
40691-8,Specimen volume^post washing
40692-6,Specimen volume^pre washing
40693-4,RET gene targeted mutation analysis
40694-2,Sulfamethoxazole Ab.IgE
40695-9,Spermatozoa^post concentration
40696-7,Spermatozoa.motile^post concentration
40697-5,Toxoplasma gondii Ab.IgM index
40698-3,Mycoplasma sp identified
40699-1,Mycobacterium sp identified
40700-7,Aromatic solvents
40701-5,Arsenic
40702-3,Fibrin monomer
40703-1,Lactoferrin
40704-9,Maternal cell contamination
40705-6,Brodifacoum
40706-4,Colchicine
40707-2,Amphotericin B^peak
40708-0,Polio virus Ab.IgG^2nd specimen
Sep-70,Triazolam
40709-8,Polio virus Ab
40710-6,Chlamydia trachomatis Ab.IgM
40711-4,Clostridium tetani Ab
40712-2,Coccidioides immitis Ab
40713-0,Giardia lamblia Ab.IgG
40714-8,Giardia lamblia Ab.IgM
40715-5,Granulocytes.immature
40716-3,Hairy cells
Jul-71,Chloral hydrate
40717-1,Haptoglobin
40718-9,Heinz bodies/100 erythrocytes
40719-7,Hemoglobin
40720-5,Hemoglobin C
40721-3,Hemoglobin F
40722-1,Hemosiderin
40723-9,Heparin Ab
40724-7,Hepatitis A virus Ab.IgG
May-72,Chloral hydrate
40725-4,Hepatitis B virus core Ab.IgG
40726-2,Hepatitis C virus Ab.IgG
40727-0,Hepatitis D virus Ab
40728-8,Herpes simplex virus Ab.IgG
40729-6,Herpes simplex virus Ab.IgM
40730-4,Herpes virus 6 Ab.IgG
40731-2,Herpes virus 6 Ab.IgM
40732-0,HIV 1 Ab.IgG
Mar-73,Tricyclic antidepressants
40733-8,HIV 1+2 Ab.IgG
40734-6,HLA Ab
40735-3,HTLV I+II Ab.IgG
40736-1,La Crosse virus Ab
40737-9,Mumps virus Ab.IgG
40738-7,Mumps virus Ab.IgM
40739-5,Osmotic fragility^unincubated
40740-3,Osmotic fragility^incubated
Jan-74,Trifluoperazine
40741-1,Platelet clump
40742-9,Rabies virus Ab.IgG
40743-7,Plasma cells
40744-5,Factor inhibitor XXX
40745-2,Filaria identified
40746-0,Fragments
40747-8,Complement C2
40748-6,Dengue virus Ab
40749-4,Echinococcus sp Ab
40750-2,Epstein Barr virus capsid Ab.IgG
40751-0,Epstein Barr virus capsid Ab.IgM
40752-8,Epstein Barr virus early Ab.IgG
40753-6,Epstein Barr virus nuclear Ab.IgG
40754-4,17-Hydroxyprogesterone
40755-1,Amiodarone^peak
40756-9,Amiodarone^trough
40757-7,Amphotericin B^trough
Aug-75,Trimeperidine
40758-5,Coxsackievirus A Ab
40759-3,Coxsackievirus A Ab.IgM^1st specimen
40760-1,Coxsackievirus A Ab^2nd specimen
40761-9,Coxsackievirus A Ab^2nd specimen
40762-7,Coxsackievirus A Ab^1st specimen
40763-5,Coxsackievirus B Ab.IgM^1st specimen
40764-3,Coxsackievirus B Ab.IgG^2nd specimen
40765-0,Coxsackievirus B Ab
Jun-76,Trimeperidine
40766-8,Coxsackievirus B Ab.IgM^1st specimen
40767-6,Coxsackievirus B Ab.IgG^2nd specimen
40768-4,Cryptococcus sp Ag
40769-2,Ethosuximide^peak
407-7,Piperacillin
40770-0,Ethosuximide^trough
40771-8,Haemophilus influenzae Ag
40772-6,Heavy metals
40773-4,Histoplasma capsulatum Ab.IgM^1st specimen
Apr-77,Trimeperidine
40774-2,Histoplasma capsulatum Ab.IgG^2nd specimen
40775-9,Histoplasma capsulatum Ab.IgM^1st specimen
40776-7,Histoplasma capsulatum Ag
40777-5,Histoplasma sp Ab
40778-3,Histoplasma capsulatum Ab.IgG^2nd specimen
40779-1,Mexiletine^trough
40780-9,Mexiletine^peak
40781-7,Polio virus Ab.IgM^1st specimen
Feb-78,Trimethadione
40782-5,Polio virus Ab.IgM^1st specimen
40783-3,Polio virus Ab.IgG^2nd specimen
40784-1,Streptococcus agalactiae Ag
40785-8,Toxoplasma gondii Ab.IgM^1st specimen
40786-6,Toxoplasma gondii Ab.IgG^2nd specimen
40787-4,Calculus analysis
40788-2,Chamaecyparis obtusa Ab.IgE
40789-0,Humulus japonicus Ab.IgE
4079-0,Trimethoprim
40790-8,Elaeis guineensis Ab.IgE
40791-6,Coproporphyrin 3
40792-4,Coproporphyrin 1
40793-2,Alkaline phosphatase.placental
40794-0,Alkaline phosphatase.intestinal
40795-7,Alkaline phosphatase.liver 2
40796-5,Alkaline phosphatase.liver 1
40797-3,Alkaline phosphatase.bone
40798-1,Amphetamines
40799-9,Amphetamines
40800-5,Cannabinoids
40801-3,Cannabinoids
40802-1,Cocaine
40803-9,Methamphetamine
40804-7,Methamphetamine
40805-4,Opiates
40806-2,Opiates
40807-0,Phencyclidine
Aug-80,Trimethoprim
40808-8,Phencyclidine
40809-6,11-Deoxycortisol^1H post XXX challenge
40810-4,11-Deoxycortisol^baseline
40811-2,11-Deoxycorticosterone
40812-0,11-Hydroxyandrosterone/Creatinine
40813-8,11-Hydroxyetiocholanolone/Creatinine
40814-6,11-Ketoandrosterone/Creatinine
40815-3,11-Ketoetiocholanolone/Creatinine
Jun-81,Trimethoprim+Sulfamethoxazole
40816-1,11-Deoxycorticosterone^1H post XXX challenge
40817-9,Tetrachlorodiphenylethane
40818-7,11-Deoxycorticosterone
40819-5,Disialylganglioside GD1a Ab.IgM
40820-3,Helicobacter pylori Ab.IgA
40821-1,Helicobacter pylori Ab.IgM
40822-9,HTLV I Ab
40823-7,HTLV II Ab
Apr-82,Trimipramine
40824-5,von Willebrand factor cleaving protease inhibitor
40825-2,Candida sp Ab.IgG
40826-0,Blastomyces dermatitidis Ab
40827-8,Histoplasma capsulatum Ab
40828-6,Aspergillus fumigatus Ab
40829-4,Ornithine
40830-2,Toxocara sp Ab
40831-0,Adenovirus+Rotavirus Ag
Feb-83,Trimipramine
40832-8,Pistacia vera Ab.IgE/IgE.total
40833-6,SOD1 gene allele 1
40834-4,Herpes virus 8 Ab.IgG
40835-1,Fragaria vesca Ab.IgG
40836-9,Sulfonamide crystals
40837-7,Alternaria sp Ab.IgG
40838-5,Argininosuccinate
40839-3,fentaNYL
4084-0,Trimipramine
40840-1,Legionella pneumophila 1 Ab
40841-9,Lycopersicon lycopersicum Ab.IgE/IgE.total
40842-7,Galactose 1 phosphate
40843-5,Chicken meat Ab.IgE/IgE.total
40844-3,Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda
40845-0,Turkey meat Ab.IgE/IgE.total
40846-8,Homovanillate
40847-6,Bromus inermis Ab.IgG4
40848-4,3-Methylcrotonylglycine
40849-2,Glucose^1st specimen post XXX challenge
408-5,Piperacillin
40850-0,Glucose^2nd specimen post XXX challenge
40851-8,Normetanephrine.free
40852-6,Leishmania sp Ab.IgG
40853-4,Leishmania sp Ab.IgG
40854-2,Chlamydia trachomatis L2 Ab.IgG
40855-9,Chlamydia trachomatis L2 Ab.IgA
40856-7,Chlamydia trachomatis L2 Ab.IgM
Jul-85,Tripelennamine
40857-5,Prealbumin
40858-3,Glucose^baseline
40859-1,SOD1 gene allele 2
40860-9,Cytokines
40861-7,Cells.CD103/100 cells
40862-5,Methylparaben Ab.IgE
40863-3,Norovirus genogroup I Ag
40864-1,11-Hydroxy delta-9 tetrahydrocannabinol
May-86,Valproate
40865-8,11-Oxo-Androsterone
40866-6,11-Oxo-Androsterone/Creatinine
40867-4,11-Oxo-Etiocholanolone
40868-2,11-Oxo-Etiocholanolone/Creatinine
40869-0,Carnitine esters/Carnitine.free (C0)
40870-8,Cystine.free
40871-6,CNBP gene targeted mutation analysis
40872-4,CBS gene.c.833T>C
Mar-87,Valproate.free
40873-2,CBS gene.c.919G>A
40874-0,Glucose^1st specimen
40875-7,Glucose^3rd specimen
40876-5,AMPD1 gene.p.Gln12Ter+AMPD1 gene.p.Pro48Leu
40877-3,CPT2 gene.p.Pro50His+Ser113Leu
40878-1,CPT2 gene.p.Gln413FSer+Gly549Asp
40879-9,Chicken Ab.IgE
40880-7,Cells.CD3-CD56+/100 cells
Jan-88,Valproate^trough
40881-5,Cells.CD3-CD57+/100 cells
40882-3,Cells.CD3-CD57+/100 cells
40883-1,Cells.CD19+CD103+/100 cells
40884-9,Cells.CD19+CD103+/100 cells
40885-6,Cells.CD19+CD103+/100 cells
40886-4,Cells.CD19+CD103+/100 cells
40887-2,Cells.CD11c+CD19+/100 cells
40888-0,Cells.CD11c+CD19+/100 cells
40889-8,Cells.CD25+CD19+/100 cells
40890-6,Cells.CD25+CD19+/100 cells
40891-4,Cells.CD3-CD57+
40892-2,Cells.CD3-CD16+/100 cells
40893-0,Cells.CD3-CD16+/100 cells
40894-8,Cells.CD3-CD16+/100 cells
40895-5,Cells.CD3+CD56+
40896-3,Cells.CD3+CD56+
40897-1,Cells.CD3+CD56+
40898-9,Cells.CD3+CD4+
Sep-89,Vancomycin.free
40899-7,Cells.CD3+CD8+
40900-3,Cells.CD3+CD4+/Cells.CD3+CD8+
40901-1,3-Hydroxybenzoylecgonine
40902-9,Streptococcus pneumoniae 12 Ab.IgG^2nd specimen
40903-7,Streptococcus pneumoniae 12 Ab.IgG
40904-5,Streptococcus pneumoniae 12 Ab.IgG^1st specimen
40905-2,Streptococcus pneumoniae Danish serotype 6B Ab.IgG
40906-0,Streptococcus pneumoniae Danish serotype 6B Ab.IgG^1st specimen
Jul-90,Vancomycin^peak
40907-8,Streptococcus pneumoniae Danish serotype 6B Ab.IgG^2nd specimen
40908-6,Streptococcus pneumoniae 4 Ab.IgG
40909-4,Streptococcus pneumoniae 4 Ab.IgG^1st specimen
40910-2,Streptococcus pneumoniae 4 Ab.IgG^2nd specimen
40911-0,Streptococcus pneumoniae Danish serotype 7F Ab.IgG
40912-8,Streptococcus pneumoniae Danish serotype 18C Ab.IgG^2nd specimen
40913-6,Streptococcus pneumoniae Danish serotype 18C Ab.IgG
40914-4,Streptococcus pneumoniae Danish serotype 18C Ab.IgG^1st specimen
May-91,Vancomycin^random
40915-1,Streptococcus pneumoniae Danish serotype 19A Ab.IgG
40916-9,Streptococcus pneumoniae Danish serotype 19A Ab.IgG^1st specimen
40917-7,Streptococcus pneumoniae Danish serotype 19A Ab.IgG^2nd specimen
40918-5,Streptococcus pneumoniae Danish serotype 9V Ab.IgG^1st specimen
40919-3,Streptococcus pneumoniae Danish serotype 9V Ab.IgG^2nd specimen
40920-1,Streptococcus pneumoniae 8 Ab.IgG
40921-9,Streptococcus pneumoniae 8 Ab.IgG^1st specimen
40922-7,Streptococcus pneumoniae 8 Ab.IgG^2nd specimen
Mar-92,Vancomycin^trough
40923-5,Streptococcus pneumoniae 9 Ab.IgG
40924-3,Streptococcus pneumoniae 9 Ab.IgG^1st specimen
40925-0,Streptococcus pneumoniae 9 Ab.IgG^2nd specimen
40926-8,Streptococcus pneumoniae Danish serotype 9V Ab.IgG
40927-6,3-Methylcrotonylglycine
40928-4,Cortisol^pre dose dexamethasone
40929-2,Parathyrin.intact^10M post excision
409-3,Piperacillin
40930-0,PYGM gene.p.Arg50Ter+Gly205Ser
Jan-93,Verapamil
40931-8,Yersinia sp Ab
40932-6,Yersinia enterocolitica O:3 Ab
40933-4,Yersinia enterocolitica O:5 Ab
40934-2,Yersinia enterocolitica O:8 Ab
40935-9,Yersinia enterocolitica O:9 Ab
40936-7,Yersinia pseudotuberculosis Ab
40937-5,Zinc
40938-3,Yersinia sp Ab.IgG
40939-1,Yersinia sp Ab.IgM
40940-9,Yersinia sp Ab
40941-7,Yersinia enterocolitica Ab
40942-5,Yersinia sp Ab.IgM
40943-3,Vespula spp Ab.IgE
40944-1,Yohimbine
40945-8,Yersinia enterocolitica Ab.IgA
40946-6,Yersinia enterocolitica Ab.IgG
40947-4,Zinc
40948-2,Yersinia enterocolitica O:3 Ab
Sep-94,Verapamil
40949-0,Yersinia enterocolitica O:5 Ab
40950-8,Yersinia enterocolitica O:8 Ab
40951-6,Yersinia enterocolitica O:9 Ab
40952-4,Vespula spp Ab.IgG4
40953-2,Yersinia enterocolitica O:3 Ab
40954-0,Yersinia enterocolitica O:8 Ab
40955-7,Yersinia enterocolitica O:9 Ab
Jun-95,Verapamil
40956-5,Yersinia sp Ab
40957-3,Zinc
40958-1,Cryptosporidium parvum identified
40959-9,MUTYH gene targeted mutation analysis
40960-7,Parietal cell Ab.IgG
40961-5,SFTPB gene targeted mutation analysis
40962-3,SFTPC gene targeted mutation analysis
40963-1,Streptococcus pneumoniae 17 Ab.IgG
Apr-96,Volatile drugs negative
40964-9,Streptococcus pneumoniae 2 Ab.IgG
40965-6,Streptococcus pneumoniae 20 Ab.IgG
40966-4,Streptococcus pneumoniae 22 Ab.IgG
40967-2,Streptococcus pneumoniae 34 Ab.IgG
40968-0,Streptococcus pneumoniae 43 Ab.IgG
40969-8,Streptococcus pneumoniae Danish serotype 33F Ab.IgG
40970-6,VWF gene targeted mutation analysis
40971-4,XXX microorganism DNA
Feb-97,Volatile drugs positive
40972-2,XXX microorganism DNA
40973-0,Streptococcus pneumoniae Danish serotype 15B Ab.IgG
40974-8,Streptococcus pneumoniae Danish serotype 19A Ab.IgG
40975-5,Adenovirus DNA
40976-3,Adenovirus DNA
40977-1,Adenovirus Ab.IgG
40978-9,Human metapneumovirus RNA
40979-7,Human metapneumovirus Ag
4098-0,Warfarin
40980-5,Human metapneumovirus Ab.IgG
40981-3,Influenza virus A RNA
40982-1,Influenza virus B RNA
40983-9,Parainfluenza virus 1 Ab.IgG
40984-7,Parainfluenza virus 2 Ab.IgG
40985-4,Parainfluenza virus 3 Ab.IgG
40986-2,Parainfluenza virus 4 Ag
40987-0,Respiratory syncytial virus RNA
40988-8,Respiratory syncytial virus RNA
40989-6,Respiratory syncytial virus Ab.IgG
40990-4,Rhinovirus RNA
40991-2,Rhinovirus+Enterovirus RNA
40992-0,Rhinovirus+Enterovirus Ag
40993-8,Rhinovirus Ag
40994-6,CPEO syndrome gene targeted mutation analysis
40995-3,Mitochondria DNA targeted mutation analysis
40996-1,Alternaria alternata Ab.IgE/IgE.total
40997-9,Apis mellifera Ab.IgE/IgE.total
Aug-99,Zimelidine
40998-7,Calcium hydrogen phosphate dihydrate/Total
40999-5,Calcium hydrogen phosphate dihydrate
41000-1,Human coronavirus RNA
41001-9,Human coronavirus RNA
41002-7,Human coronavirus 229E Ab.IgG
41003-5,Human coronavirus 229E RNA
Apr-00,2-Oxoisocaproate
41004-3,Human coronavirus 229E Ag
41005-0,Human coronavirus NL63 RNA
41006-8,Human coronavirus NL63 Ab.IgG
41007-6,Human coronavirus OC43 Ag
41008-4,Human coronavirus OC43 Ab.IgG
41009-2,Human coronavirus OC43 RNA
410-1,Piperacillin
41010-0,Parainfluenza virus 4 RNA
41011-8,Human metapneumovirus Ab.IgG
Feb-01,2-Pyridone
41012-6,Respiratory syncytial virus Ab.IgG
41013-4,Human coronavirus 229E Ab.IgG
41014-2,Human coronavirus NL63 Ab.IgG
41015-9,Human coronavirus OC43 Ab.IgG
41016-7,Bilirubin
41017-5,Protoporphyrin
41018-3,Testosterone.free+weakly bound
41019-1,Beta endorphin
4102-0,5-Fluorocytosine
41020-9,Flunitrazepam
41021-7,Cocaine
41022-5,Citrate
41023-3,Aldosterone
41024-1,Glucose^2H post 50 g glucose PO
41025-8,Ribonucleoprotein extractable nuclear Ab
41026-6,Fungus identified
41027-4,Tau protein/Amyloid beta 42 peptide
41028-2,Listeria monocytogenes O1 Ab
41029-0,Listeria monocytogenes H1 Ab
41030-8,Listeria monocytogenes O4b Ab
41031-6,Lopinavir
41032-4,Uroporphyrin
41033-2,Herpes simplex virus 1 Ab
41034-0,Herpes simplex virus 2 Ab
41035-7,Norovirus RNA
41036-5,Cocaine
41037-3,Cocaine
Aug-03,Acebutolol
41038-1,Codeine
41039-9,3-Methylcrotonylglycine
41040-7,Palmitoylcarnitine (C16)
41041-5,3-Hydroxypalmitoylcarnitine (C16-OH)
41042-3,WFS1 gene targeted mutation analysis
41043-1,VHL gene targeted mutation analysis
41044-9,UGT1A1 gene targeted mutation analysis
41045-6,TYR gene targeted mutation analysis
Jun-04,Acepromazine
41046-4,TWIST1 gene targeted mutation analysis
41047-2,TSC gene targeted mutation analysis
41048-0,TPMT gene targeted mutation analysis
41049-8,TNFRSF1A gene targeted mutation analysis
41050-6,TH gene targeted mutation analysis
41051-4,SPINK1 gene targeted mutation analysis
41052-2,SPAST gene targeted mutation analysis
Mar-05,Acetaminophen
41053-0,SMN1 gene targeted mutation analysis
41054-8,SMA@ gene mutation analysis
41055-5,SLC26A4 gene targeted mutation analysis
41056-3,SLC22A18 gene targeted mutation analysis
41057-1,SHOX gene targeted mutation analysis
41058-9,SH2D1A gene targeted mutation analysis
41059-7,SFTPC gene targeted mutation analysis
41060-5,SFTPB gene targeted mutation analysis
Jan-06,acetaZOLAMIDE
41061-3,SDHD gene targeted mutation analysis
41062-1,SDHB gene targeted mutation analysis
41063-9,RPS6KA3 gene targeted mutation analysis
41064-7,PYGM gene targeted mutation analysis
41065-4,PTPN11 gene targeted mutation analysis
41066-2,PRX gene targeted mutation analysis
41067-0,PRF1 gene targeted mutation analysis
41068-8,PRF1 gene targeted mutation analysis
41069-6,PPT1 gene targeted mutation analysis
41070-4,Peripheral neuropathy gene targeted mutation analysis
41071-2,PARK2 gene targeted mutation analysis
41072-0,PANK2 gene targeted mutation analysis
41073-8,NR0B1 gene targeted mutation analysis
41074-6,NPHS1 gene targeted mutation analysis
41075-3,NPHS1 gene targeted mutation analysis
41076-1,NPDC gene targeted mutation analysis
41077-9,NOTCH3 gene targeted mutation analysis
41078-7,NIPBL gene targeted mutation analysis
Sep-07,Acyclovir
41079-5,NEFL gene targeted mutation analysis
41080-3,Myotonic dystrophy gene targeted mutation analysis
41081-1,MUTYH gene targeted mutation analysis
41082-9,MT-TK gene targeted mutation analysis
41083-7,MTM1 gene targeted mutation analysis
41084-5,MSH2 gene targeted mutation analysis
41085-2,MPZ gene targeted mutation analysis
41086-0,MLH1 gene targeted mutation analysis
Jul-08,Adenine
41087-8,Mitochondrial myopathy gene targeted mutation analysis
41088-6,MERRF gene targeted mutation analysis
41089-4,MEN1 gene targeted mutation analysis
41090-2,MELAS gene targeted mutation analysis
41091-0,MEFV gene targeted mutation analysis
41092-8,MAPT gene targeted mutation analysis
41093-6,LHON syndrome gene targeted mutation analysis
41094-4,LAMA2 gene targeted mutation analysis
May-09,Alfentanil
41095-1,L1CAM gene targeted mutation analysis
41096-9,KEL gene allele
41097-7,HADHA gene.c.1528G>C
41098-5,GPC3 gene targeted mutation analysis
41099-3,GLA gene targeted mutation analysis
41100-9,GJB6 gene targeted mutation analysis
41101-7,GJB2 gene targeted mutation analysis
41102-5,GJB1 gene targeted mutation analysis
Mar-10,Alphaprodine
41103-3,Gene XXX targeted mutation analysis
41104-1,GBA gene targeted mutation analysis
41105-8,FSHD gene targeted mutation analysis
41106-6,FXN gene targeted mutation analysis
41107-4,FMR1 gene targeted mutation analysis
41108-2,FGF23 gene targeted mutation analysis
41109-0,FGD1 gene targeted mutation analysis
41110-8,CSTB gene targeted mutation analysis
Jan-11,ALPRAZolam
41111-6,COL5A1 gene targeted mutation analysis
41112-4,CMT axonal gene targeted mutation analysis
41113-2,Chronic lymphocytic leukemia gene targeted mutation analysis
41114-0,CATCH22 syndrome gene targeted mutation analysis
41115-7,NOD2 gene targeted mutation analysis
41116-5,ATP7A gene targeted mutation analysis
41117-3,AS+PWS gene targeted mutation analysis
41118-1,AR gene targeted mutation analysis
41119-9,APTX gene targeted mutation analysis
41120-7,ALDOB gene targeted mutation analysis
41121-5,ACADS gene targeted mutation analysis
41122-3,Treponema pallidum Ab
41123-1,Toxoplasma gondii HS Ab
41124-9,Toxoplasma gondii AC Ab
41125-6,Strongyloides sp Ab.IgG
41126-4,Salmonella typhi O D Ab
41127-2,Salmonella gallinarum Ab
41128-0,Rabies virus Ab.IgG
Sep-12,Alprenolol
41129-8,Parvovirus B19 Ab.IgM^1st specimen
41130-6,Mycobacterium avium subspecies paratuberculosis Ab
41131-4,Mumps virus Ab.IgM
41132-2,Measles virus Ab.IgG
41133-0,Jamestown canyon virus Ab
41134-8,Influenza virus A N9 Ab
41135-5,Influenza virus A N8 Ab
41136-3,Influenza virus A N7 Ab
Jul-13,Amantadine
41137-1,Influenza virus A N6 Ab
41138-9,Influenza virus A N5 Ab
41139-7,Influenza virus A N4 Ab
41140-5,Influenza virus A N3 Ab
41141-3,Influenza virus A N2 Ab
41142-1,Influenza virus A N1 Ab
41143-9,HIV 1 Ab
41144-7,HIV 1 Ab
May-14,Amdinocillin
41145-4,HIV 1 Ab
41146-2,Herpes virus 8 Ab.IgG
41147-0,Herpes virus 6 Ab.IgM
41148-8,Herpes virus 6 Ab.IgG
41149-6,Herpes simplex virus 1+2 Ab.IgM
41150-4,Herpes simplex virus 1+2 Ab.IgM
41151-2,Hepatitis B virus little e Ab.IgG
Feb-15,Amikacin
41152-0,Haemophilus paragallinarum Ab
41153-8,Giardia lamblia Ab.IgM
41154-6,Giardia lamblia Ab.IgG
41155-3,Cytomegalovirus Ab.IgM
41156-1,Coccidioides sp Ab.IgG
41157-9,Chlamydia trachomatis Ab.IgM
41158-7,Canine herpesvirus Ab
41159-5,Campylobacter sp Ab.IgG
4116-0,aMILoride
41160-3,Ascaris lumbricoides Ab.IgM
41161-1,Ascaris lumbricoides Ab.IgG
41162-9,Adenovirus Ab.IgG
41163-7,Treponema pallidum DNA
41164-5,Uranium.depleted
41165-2,Uranium 235/Uranium 238
41166-0,Uranium.depleted/Creatinine
41167-8,Listeria monocytogenes H Ab
41168-6,Arginine
41169-4,Valine
41170-2,Phenylalanine+Tyrosine
41171-0,Collagen crosslinked C-telopeptide
41172-8,Yeast.budding
41173-6,Xylose^2H post dose xylose PO
41174-4,Waxy casts.broad
41175-1,Western equine encephalitis virus Ab
41176-9,Trichophyton reaction wheal^2D post dose trichophyton ID
41177-7,Trichophyton reaction wheal^1D post dose trichophyton ID
Aug-17,Aminopyrine
41178-5,Mumps reaction wheal^2D post dose mumps ID
41179-3,Mumps reaction wheal^1D post mumps ID
41180-1,Candida albicans reaction wheal^2D post dose Candida albicans ID
41181-9,Candida albicans reaction wheal^1D post dose Candida albicans ID
41182-7,Histoplasma capsulatum farciminosum reaction wheal^2D post dose histoplasmin ID
41183-5,Western equine encephalitis virus Ab
41184-3,Warfarin
41185-0,Xylose^5H post dose xylose PO
Jun-18,Aminosalicylate
41186-8,Yeast
41187-6,Waxy casts
41188-4,Xylose^post CFst
41189-2,Xylose^post CFst
411-9,Piperacillin+Tazobactam
41190-0,Waxy casts
41191-8,Xylose^2H post dose xylose PO
41192-6,Dolichovespula arenaria Ab.IgG4
41193-4,Dolichovespula maculata Ab.IgG4
Apr-19,Amiodarone
41194-2,West Nile virus Ab
41195-9,West Nile virus Ab.IgM
41196-7,West Nile virus Ab.IgG
41197-5,Xylose^30M post dose xylose PO
41198-3,Juglans spp Ab.IgE/IgE.total
41199-1,Voriconazole
41200-7,Voriconazole
41201-5,Voltage-gated calcium channel Ab.IgG
Feb-20,Amitriptyline
41202-3,Saccharomyces cerevisiae Ab.IgE/IgE.total
41203-1,Vespula spp Ab.IgE/IgE.total
41204-9,Polistes spp Ab.IgE/IgE.total
41205-6,Citrullus lanatus Ab.IgG
41206-4,West Nile virus Ab
41207-2,Triticum aestivum Ab.IgE/IgE.total
41208-0,Viscosity+Liquefaction
41209-8,VWF gene.p.Arg854Gln
4121-0,Amobarbital
41210-6,VWF gene.p.Arg816Trp
41211-4,West Nile virus Ab.IgG+IgM
41212-2,West Nile virus RNA
41213-0,Xanthan gum Ab.IgE
41214-8,Volatiles
41215-5,Yeast
41216-3,Yellow fever virus Ab.IgM
41217-1,Yellow fever virus Ab.IgG
41218-9,Xipamid
41219-7,Polistes spp Ab.IgG
41220-5,Xanthurenate
41221-3,Xanthurenate+Kynurenate
41222-1,Yeast
41223-9,Waxy casts
41224-7,West Nile virus Ab
41225-4,West Nile virus Ab
41226-2,Viscosity
41227-0,Xanthine
Aug-22,Amoxapine
41228-8,Xanthine
41229-6,Vespula spp Ab.IgG
41230-4,Xanthine
41231-2,Xanthurenate+Kynurenate
41232-0,West Nile virus Ab
41233-8,Volume expired during 3.0 s of forced expiration
41234-6,Volume expired during 3.0 s of forced expiration/Volume.forced expiration.total
41235-3,Polistes spp Ab.IgE
Jun-23,Amoxicillin
41236-1,West Nile virus Ab.IgG
41237-9,Xylose^5H post dose xylose PO
41238-7,Viscosity
41239-5,Yellow fever virus Ab
41240-3,Xanthurenate
41241-1,Viscosity
41242-9,Yeast
41243-7,Yeast
Apr-24,Diethylpropion
41244-5,Western equine encephalitis virus Ab.IgG
41245-2,Viscosity
41246-0,Yellow fever virus Ab^2nd specimen
41247-8,Yellow fever virus Ab^1st specimen
41248-6,Xanthurenate
41249-4,Yellow fever virus Ab
41250-2,Xylose^baseline
Jan-25,Amphetaminil
41251-0,Xylose^5H post 25 g xylose PO
41252-8,Xylose^5H post 25 g xylose PO
41253-6,Xylose^4H post 25 g xylose PO
41254-4,Xylose^4H post 25 g xylose PO
41255-1,Xylose^3H post 25 g xylose PO
41256-9,Xylose^3H post 25 g xylose PO
41257-7,Xylose^2H post 25 g xylose PO
41258-5,Xylose^1H post 25 g xylose PO
41259-3,Western equine encephalitis virus Ab.IgM
41260-1,Western equine encephalitis virus Ab.IgG
41261-9,Voltage-gated calcium channel Ab.IgG
41262-7,Viscosity
41263-5,Viscosity
41264-3,Viscosity
41265-0,Width
41266-8,Volatiles
41267-6,Xylose^post dose xylose PO
41268-4,VWF gene.p.Thr791Met
Sep-26,Amphotericin B
41269-2,Beta hydroxybutyrate+Gamma aminobutyrate
412-7,Piperacillin+Tazobactam
41270-0,Drugs identified
41271-8,Dermatophagoides sp Ab.IgE
41272-6,Dog dander+Dog epithelium Ab.IgE.RAST class
41273-4,Alpha-1-Fetoprotein interpretation
41274-2,Alpha-1-Fetoprotein interpretation
41275-9,Amino acids intense band position
41276-7,Anion gap
Jul-27,Ampicillin
41277-5,Gross blood
41278-3,Gross blood
41279-1,Borrelia burgdorferi Ab.IgG/Borrelia burgdorferi Ab.IgM
41280-9,Appearance
41281-7,Burr cells
41282-5,Erythrocytes.nucleated/100 leukocytes
41283-3,HLA-DQ8
41284-1,Epithelial cells.non-squamous
May-28,Anileridine
41285-8,Uranium.depleted/Creatinine
41286-6,Uranium 235/Uranium 238
41287-4,Epithelial cells.parabasal
41288-2,Egg whole Ab.IgE/IgE.total
41289-0,11-Deoxycortisol^post dose metyraPONE
41290-8,HIV 1+2 Ab.IgM
41291-6,Immunization
41292-4,Soluble mesothelin related proteins
Mar-29,Anthraquinone
41293-2,Clot
41294-0,Cells.S phase
41295-7,Flexion.active range of motion
41296-5,Flexion.passive range of motion
41297-3,Extension.active range of motion
41298-1,Extension.passive range of motion
41299-9,Abduction.active range of motion
41300-5,Abduction.passive range of motion
Jan-30,Antipyrine
41301-3,Adduction.active range of motion
41302-1,Adduction.passive range of motion
41303-9,Internal rotation.active range of motion
41304-7,Internal rotation.passive range of motion
41305-4,External rotation.active range of motion
41306-2,External rotation.passive range of motion
41307-0,Flexion.active range of motion
41308-8,Flexion.passive range of motion
41309-6,Extension.active range of motion
41310-4,Extension.passive range of motion
41311-2,Abduction.active range of motion
41312-0,Abduction.passive range of motion
41313-8,Adduction.active range of motion
41314-6,Adduction.passive range of motion
41315-3,Internal rotation.active range of motion
41316-1,Internal rotation.passive range of motion
41317-9,External rotation.active range of motion
41318-7,External rotation.passive range of motion
Sep-31,Ascorbate.PO
41319-5,Flexion.active range of motion
41320-3,Flexion.passive range of motion
41321-1,Extension.active range of motion
41322-9,Extension.passive range of motion
41323-7,Abduction.active range of motion
41324-5,Abduction.passive range of motion
41325-2,Adduction.active range of motion
41326-0,Adduction.passive range of motion
Jul-32,Atenolol
41327-8,Internal rotation.active range of motion
41328-6,Internal rotation.passive range of motion
41329-4,External rotation.active range of motion
41330-2,External rotation.passive range of motion
41331-0,Flexion.active range of motion
41332-8,Flexion.passive range of motion
41333-6,Extension.active range of motion
41334-4,Extension.passive range of motion
May-33,Atropine
41335-1,Abduction.active range of motion
41336-9,Abduction.passive range of motion
41337-7,Adduction.active range of motion
41338-5,Adduction.passive range of motion
41339-3,Internal rotation.active range of motion
41340-1,Internal rotation.passive range of motion
41341-9,External rotation.active range of motion
41342-7,External rotation.passive range of motion
Mar-34,Azlocillin
41343-5,Flexion.active range of motion
41344-3,Flexion.passive range of motion
41345-0,Extension.active range of motion
41346-8,Extension.passive range of motion
41347-6,Flexion.active range of motion
41348-4,Flexion.passive range of motion
41349-2,Extension.active range of motion
413-5,Piperacillin+Tazobactam
4135-0,Aztreonam
41350-0,Extension.passive range of motion
41351-8,Flexion.active range of motion
41352-6,Flexion.passive range of motion
41353-4,Extension.active range of motion
41354-2,Extension.passive range of motion
41355-9,Flexion.active range of motion
41356-7,Flexion.passive range of motion
41357-5,Extension.active range of motion
41358-3,Extension.passive range of motion
41359-1,Active range of motion panel
41360-9,Passive range of motion panel
41361-7,Extension.active range of motion
41362-5,Extension.passive range of motion
41363-3,Flexion.active range of motion
41364-1,Flexion.passive range of motion
41365-8,Abduction.active range of motion
41366-6,Abduction.passive range of motion
41367-4,Adduction.active range of motion
Aug-36,Barbital
41368-2,Adduction.passive range of motion
41369-0,Extension.active range of motion
41370-8,Extension.passive range of motion
41371-6,External rotation.active range of motion
41372-4,External rotation.passive range of motion
41373-2,Flexion.active range of motion
41374-0,Flexion.passive range of motion
41375-7,Internal rotation.active range of motion
Jun-37,Barbiturates
41376-5,Internal rotation.passive range of motion
41377-3,Extension.active range of motion
41378-1,Extension.passive range of motion
41379-9,Flexion.active range of motion
41380-7,Flexion.passive range of motion
41381-5,Abduction.active range of motion
41382-3,Abduction.passive range of motion
41383-1,Adduction.active range of motion
Apr-38,Bendroflumethiazide
41384-9,Adduction.passive range of motion
41385-6,Extension.active range of motion
41386-4,Extension.passive range of motion
41387-2,External rotation.active range of motion
41388-0,External rotation.passive range of motion
41389-8,Flexion.active range of motion
41390-6,Flexion.passive range of motion
41391-4,Internal rotation.active range of motion
Feb-39,Benzfetamine
41392-2,Internal rotation.passive range of motion
41393-0,Collection date
41394-8,Collection date
41395-5,Collection date
41396-3,Tenofovir
41397-1,Beta lactoglobulin Ab.IgE
41398-9,Alloisoleucine
41399-7,Herpes simplex virus 1+2 Ab.IgM
Apr-41,Azlocillin
4140-0,Benzoylecgonine
41400-3,Yersinia sp Ab.IgA
41401-1,Yersinia sp Ab.IgG
41402-9,Emtricitabine
41403-7,Atazanavir
41404-5,17-Hydroxycorticosteroids/Creatinine
41405-2,Parainfluenza virus 2 Ab.IgG
41406-0,Meropenem
41407-8,Cortisol^pre dose corticotropin
41408-6,Ofloxacin 1.0 ug/mL
41409-4,Ofloxacin 2.0 ug/mL
41410-2,Ofloxacin 4.0 ug/mL
41411-0,Angiostrongylus cantonensis Ab
41412-8,Angiostrongylus costaricensis Ab
41413-6,Babesia divergens Ab
41414-4,Babesia microti Ab
41415-1,Babesia duncani Ab
41416-9,Echinococcus sp Ab
41417-7,Filaria Ab
Aug-41,Benzthiazide
41418-5,Gnathostoma sp Ab
41419-3,Leishmania braziliensis Ab
41420-1,Leishmania tropica Ab
41421-9,Paragonimus sp Ab
41422-7,Schistosoma haematobium Ab
41423-5,Schistosoma japonicum Ab
41424-3,Schistosoma mansoni Ab
41425-0,Toxocara canis Ab
Jun-42,Bisacodyl
41426-8,Trichinella spiralis Ab
41427-6,Trypanosoma brucei gambiense Ab
41428-4,Trypanosoma brucei rhodesiense Ab
41429-2,Acanthamoeba sp DNA
414-3,Piperacillin+Tazobactam
41430-0,Angiostrongylus cantonensis DNA
41431-8,Angiostrongylus costaricensis DNA
41432-6,Balamuthia mandrillaris DNA
41433-4,Cryptosporidium hominis DNA
Apr-43,Bolasterone
41434-2,Cryptosporidium parvum DNA
41435-9,Cyclospora carcopitheci DNA
41436-7,Cyclospora cayetanensis DNA
41437-5,Cyclospora colobi DNA
41438-3,Cyclospora papionis DNA
41439-1,Encephalitozoon cuniculi DNA
41440-9,Encephalitozoon hellem DNA
41441-7,Encephalitozoon intestinalis DNA
Feb-44,Bromazepam
41442-5,Entamoeba dispar DNA
41443-3,Enterocytozoon bieneusi DNA
41444-1,Naegleria fowleri DNA
41445-8,Ova+Parasites identified
41446-6,Parasite identified
41447-4,Plasmodium falciparum DNA
41448-2,Plasmodium malariae DNA
41449-0,Plasmodium ovale DNA
41450-8,Plasmodium vivax DNA
41451-6,Plasmodium stage
41452-4,Adenovirus serotype
41453-2,Human coronavirus Ag
41454-0,Human coronavirus identified
41455-7,Human metapneumovirus genotype
41456-5,Respiratory syncytial virus genotype
41457-3,Rhinovirus serotype
41458-1,SARS coronavirus RNA
Sep-45,Brompheniramine
41459-9,SARS coronavirus
41460-7,SARS coronavirus Ab.IgG
41461-5,Virus identified
41462-3,Taenia solium larva Ab
41463-1,Wuchereria bancrofti+Brugia malayi Ag
41464-9,Amphetamines/Creatinine
41465-6,Opiates/Creatinine
41466-4,Methadone/Creatinine
Jul-46,Bumetanide
41467-2,Benzodiazepines/Creatinine
41468-0,Barbiturates/Creatinine
41469-8,Ribavirin
41470-6,Atazanavir
41471-4,Phenethicillin
41472-2,carBAMazepine
41473-0,"carBAMazepine 10,11-Epoxide"
41474-8,Diethylcarbamazepine
May-47,Buprenorphine
41475-5,Rickettsia rickettsii Ab.IgM
41476-3,Rickettsia rickettsii Ab.IgG
41477-1,Bacterial sialidase
41478-9,Bartonella henselae Ab.IgG & IgM panel
41479-7,BK virus DNA
41480-5,BK virus DNA
41481-3,Blastomyces sp Ab
41482-1,Chlamydia sp Ab.IgG & IgM panel
Mar-48,Butabarbital
41483-9,Clostridium tetani toxoid Ab
41484-7,Coxsackievirus A Ab panel
41485-4,Coxsackievirus B Ab panel
41486-2,Coxsackievirus B Ab.Neut panel
41487-0,Cryptosporidium parvum Ag
41488-8,Cryptosporidium sp
41489-6,Echovirus 11 Ab.Neut
41490-4,Echovirus 16 Ab.Neut
Jan-49,Butalbital
41491-2,Echovirus 30 Ab.Neut
41492-0,Echovirus 7 Ab.Neut
41493-8,Febrile agglutinin Ab panel
41494-6,Gatifloxacin
41495-3,Haemophilus influenzae B Ag
41496-1,Herpes virus 6 Ab.IgG
41497-9,HIV 1 RNA
41498-7,HIV 1 RNA
41499-5,Legionella pneumophila 1 Ag
415-0,Pivampicillin
41500-0,Linezolid
41501-8,Measles virus Ab
41502-6,Moxifloxacin
41503-4,Neisseria meningitidis serogroup B Ag
41504-2,Norfloxacin
41505-9,Parainfluenza virus Ag panel
41506-7,Polio virus Ab.Neut panel
41507-5,Rabies virus Ab
41508-3,Streptococcus agalactiae Ag
Sep-50,Caffeine
41509-1,Toxoplasma sp Ab.IgG
41510-9,Toxoplasma sp Ab.IgM
41511-7,Trichomonas vaginalis Ag
41512-5,Varicella zoster virus Ab.IgG
41513-3,HIV 1 RNA
41514-1,HIV 1 RNA
41515-8,HIV 1 RNA
41516-6,HIV 1 RNA
Jul-51,Canrenone
May-52,carBAMazepine
Mar-53,Carbenicillin
Jan-54,Carbromal
Aug-55,Carisoprodol
Jun-56,Cathine
Apr-57,Cefamandole
Feb-58,ceFAZolin
4159-0,ceFAZolin
41598-4,Bacteria
41599-2,Bacteria
41600-8,Bacteria
41601-6,Bacteria
41602-4,Bacteria
41603-2,Bacteria
41604-0,Glucose^post CFst
41605-7,Lactose^pre CFst
41606-5,Lactose^3H post dose lactose PO
41607-3,Methemoglobin/Hemoglobin.total
Aug-60,Cefonicid
41608-1,Prolactin^30M post XXX challenge
41609-9,Prolactin^1H post XXX challenge
41610-7,Tube number
41611-5,Tube number
41612-3,Tube number
41613-1,Tube number
41614-9,Tube number
41615-6,Xanthurenate
Jun-61,Cefoperazone
41616-4,Platelet Ab
41617-2,Neutrophil Ab
41618-0,HLA Ab
41619-8,Hemoglobin.unstable
41620-6,Xylose^5H post 5 g xylose PO
41621-4,Arenavirus RNA
41622-2,Bacillus anthracis DNA
41623-0,Bacillus anthracis DNA
Apr-62,Cefotaxime
41624-8,Brucella sp Ag
41625-5,Brucella sp DNA
41626-3,Brucella sp DNA
41627-1,Burkholderia sp Ag
41628-9,Burkholderia sp DNA
41629-7,Burkholderia sp DNA
41630-5,Clostridium botulinum toxin A
41631-3,Clostridium botulinum toxin A botA gene
Feb-63,cefoTEtan
41632-1,Clostridium botulinum toxin B
41633-9,Clostridium botulinum toxin B botB gene
41634-7,Clostridium botulinum toxin E
41635-4,Clostridium botulinum toxin F
41636-2,Ebola virus RNA
41637-0,Ebola virus Ag
41638-8,Marburg virus RNA
41639-6,Ricin toxin Ab.IgM
4164-0,cefOXitin
41640-4,Ricin toxin Ab.IgG
41641-2,Ricin toxin
41642-0,West Nile virus Ab.IgM
41643-8,West Nile virus Ag
41644-6,Calcium.ionized
41645-3,Calcium.ionized
41646-1,Calcium.ionized
41647-9,Carbon dioxide
41648-7,Carboxyhemoglobin/Hemoglobin.total
41649-5,Chloride
41650-3,Chloride
41651-1,Glucose
41652-9,Glucose
41653-7,Glucose
41654-5,Hematocrit
41655-2,Hematocrit
41656-0,Potassium
Jul-65,Cefsulodin
41657-8,Sodium
41658-6,ABT492
41659-4,ABT492
41660-2,ABT492
41661-0,Azlocillin
41662-8,Aztreonam+Clavulanate
41663-6,Aztreonam+Clavulanate
41664-4,Aztreonam+Clavulanate
May-66,cefTAZidime
41665-1,Biapenem
41666-9,Biapenem
41667-7,Biapenem
41668-5,Carbenicillin
41669-3,Cefamandole
41670-1,ceFAZolin
41671-9,Cefotaxime+Clavulanate
41672-7,cefoTEtan+Clavulanate
Mar-67,Ceftizoxime
41673-5,cefoTEtan+Clavulanate
41674-3,cefoTEtan+Clavulanate
41675-0,cefOXitin+Clavulanate
41676-8,cefOXitin+Clavulanate
41677-6,cefOXitin+Clavulanate
41678-4,Cefpodoxime+Clavulanate
41679-2,Cefpodoxime+Clavulanate
416-8,Pivampicillin
41680-0,Cefpodoxime+Clavulanate
Jan-68,cefTRIAXone
41681-8,cefTRIAXone+Clavulanate
41682-6,cefTRIAXone+Clavulanate
41683-4,cefTRIAXone+Clavulanate
41684-2,Cephaloridine
41685-9,Clavulanate
41686-7,Clavulanate
41687-5,Clavulanate
41688-3,Dalbavancin
41689-1,Dalbavancin
41690-9,Dalbavancin
41691-7,DAPTOmycin
41692-5,Enoxacin
41693-3,Ethionamide
41694-1,Everninomicin
41695-8,Everninomicin
41696-6,Everninomicin
41697-4,Gemifloxacin
41698-2,Josamycine
Sep-69,Cefuroxime.parenteral
41699-0,Josamycine
41700-6,Lincomycin
41701-4,Lomefloxacin
41702-2,Mezlocillin
41703-0,Moxalactam
41704-8,Nafcillin
41705-5,Neomycin
41706-3,Novobiocin
Jul-70,Cephalexin
41707-1,Oritavancin
41708-9,Oritavancin
41709-7,Oritavancin
41710-5,Ramoplanin
41711-3,Ramoplanin
41712-1,Ramoplanin
41713-9,Rosamicin
41714-7,Rosamicin
May-71,Cephalothin
41715-4,Rosamicin
41716-2,Sulbactam
41717-0,Sulbactam
41718-8,Sulbactam
41719-6,Tazobactam
41720-4,Tazobactam
41721-2,Tazobactam
41722-0,Telithromycin
Mar-72,Chloral hydrate
41723-8,Thiamphenicol
41724-6,Thiamphenicol
41725-3,Thiamphenicol
41726-1,ABT492
41727-9,Aztreonam+Clavulanate
41728-7,Biapenem
41729-5,cefoTEtan+Clavulanate
41730-3,cefOXitin+Clavulanate
Jan-73,Chloramphenicol
41731-1,Cefpodoxime+Clavulanate
41732-9,cefTRIAXone+Clavulanate
41733-7,Clavulanate
41734-5,Dalbavancin
41735-2,Everninomicin
41736-0,Oritavancin
41737-8,Ramoplanin
41738-6,Rosamicin
41739-4,Sulbactam
41740-2,Tazobactam
41741-0,Bacteria identified
41742-8,(Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) Ab.IgE
41743-6,BBS1 gene targeted mutation analysis
41744-4,Beclomethasone dipropionate
41745-1,Betamethasone
41746-9,Blastomyces dermatitidis Ag
41747-7,Budesonide
41748-5,CAPN3 gene targeted mutation analysis
Sep-74,Clorazepate
41749-3,CHIC2 gene targeted mutation analysis
41750-1,COCH gene targeted mutation analysis
41751-9,COL3A1 gene targeted mutation analysis
41752-7,Ehrlichia chaffeensis Ab
41753-5,FKRP gene targeted mutation analysis
41754-3,Fludrocortisone
41755-0,Flunisolide
Jun-75,chlordiazePOXIDE
41756-8,Fluorometholone
41757-6,Fluticasone propionate
41758-4,GNAS1 gene targeted mutation analysis
41759-2,Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free
417-6,Pivampicillin
41760-0,Interleukin 12
41761-8,lamoTRIgine
41762-6,Megestrol acetate
41763-4,Rubella virus Ab.IgG
Apr-76,Chlormerodrin
41764-2,SBDS gene targeted mutation analysis
41765-9,SCN1A gene targeted mutation analysis
41766-7,Triamcinolone
41767-5,Triamcinolone acetonide
41768-3,VWF gene targeted mutation analysis
41769-1,Neuronal nuclear type 1 Ab
41770-9,Views^W cholecystokinin+W radionuclide IV
41771-7,Views^W Tc-99m DMSA IV
Feb-77,Chlorothiazide
41772-5,Multisection^W In-111 tagged WBC IV
41773-3,Views
41774-1,View lateral
41775-8,View
41776-6,Views AP + lateral frog
41777-4,Views AP + lateral
41778-2,Views
41779-0,Views
4178-0,Chlorpheniramine
41780-8,Views
41781-6,Views portable
41782-4,Views
41783-2,Views
41784-0,Views
41785-7,Views limited
41786-5,Views
41787-3,Views
41788-1,Views
41789-9,Views limited
41790-7,View^during surgery
41791-5,Views
41792-3,Views R-oblique + L-oblique
41793-1,View^during surgery
41794-9,View AP portable
41795-6,View^W air contrast PO
41796-4,Views & AP KUB^W air contrast PO
41797-2,Views limited^W air contrast PR+W barium contrast PR
Aug-79,chlorproMAZINE
41798-0,Guidance for drainage+placement of drainage catheter
41799-8,Guidance for placement of tube
41800-4,Guidance for drainage+placement of drainage catheter
41801-2,Guidance for placement of catheter^W contrast IV
41802-0,Guidance for biopsy
41803-8,Guidance for percutaneous biopsy
41804-6,Multisection & 3D reconstruction
41805-3,Multisection^W radionuclide IV
Jun-80,chlorproPAMIDE
41806-1,Multisection
41807-9,Multisection
41808-7,Multisection
41809-5,Guidance for drainage+placement of drainage catheter
41810-3,Guidance for removal of fluid
41811-1,Views && view PA
41812-9,Multisection limited
41813-7,Multisection limited
Apr-81,Chlorprothixene
41814-5,Multisection
41815-2,Multisection
41816-0,Multisection
41817-8,Views AP + lateral
41818-6,Views
41819-4,Views 2 + tunnel
41820-2,Views
41821-0,Views
Feb-82,Chloroquine
41822-8,Views portable
41823-6,Views
41824-4,Views
41825-1,Views
41826-9,Views limited
41827-7,Views
41828-5,Views
41829-3,Views
4183-0,Chlorthalidone
41830-1,Views limited
41831-9,Views
41832-7,Views && view PA
41833-5,Multisection
41834-3,Multisection
41835-0,Multisection
41836-8,Views limited^W In-111 tagged WBC IV
41837-6,Multisection^W Tc-99m Arcitumomab IV
41838-4,Multisection^W In-111 Satumomab IV
41839-2,Burkholderia pseudomallei Ab.IgG & IgM panel
418-4,Pivampicillin
41840-0,Coxiella burnetii phase 1 & 2 Ab.IgG panel
41841-8,Coxiella burnetii phase 1 & 2 Ab.IgM panel
41842-6,Herpes virus 7 Ab.IgG & IgM panel
41843-4,Lymphocytic choriomeningitis virus Ab.IgG & IgM panel
41844-2,Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag
41845-9,Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag
41846-7,Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag
41847-5,Armoracia rusticana Ab.IgG
Aug-84,Cilastatin
41848-3,Capsicum annuum Ab.IgG
41849-1,Curry Ab.IgG
41850-9,Lidocaine Ab.IgE
41851-7,Thymus vulgaris Ab.IgG
41852-5,Microorganism or agent identified
41853-3,Orthopoxvirus DNA
41854-1,Ricinus communis DNA
May-85,Cimetidine
41855-8,Staphylococcus aureus enterotoxin B
41856-6,Variola virus DNA
41857-4,Vibrio parahaemolyticus DNA
41858-2,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine"
41859-0,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine"
41860-8,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine"
41861-6,Yeast.hyphae
41862-4,Viscosity^20M post collection
Mar-86,Ciprofloxacin
41863-2,Yeast.pseudohyphae
41864-0,Yeast.hyphae
41865-7,Yeast.hyphae
41866-5,von Willebrand factor Ag actual/Normal
41867-3,von Willebrand factor Ag
41868-1,Waxy casts
41869-9,Testosterone.bioavailable+Free/Testosterone.total
41870-7,Tryptase.mature
Jan-87,CISplatin
41871-5,Voltage-gated potassium channel Ab
41872-3,PDCD10 gene targeted mutation analysis
41873-1,Alnus rugosa Ab.IgG
41874-9,Betula populifolia Ab.IgE
41875-6,Bordetella pertussis & Bordetella parapertussis DNA panel
41876-4,Rickettsia typhi & Rickettsia spotted fever group Ab.IgG & IgM panel
41877-2,Bordetella pertussis Ab.IgA & IgG & IgM panel
41878-0,Dengue virus Ab.IgG & IgM panel
Sep-88,Clavulanate
41896-2,Class
Jul-89,Clindamycin
41897-0,Vendor device name
41898-8,Vendor device model code
41899-6,Vendor serial number
41900-2,Vendor software version
41901-0,Class
41902-8,Vendor device model code
41903-6,Vendor software version
41904-4,Blood pressure measurement site
May-90,cloBAZam
41905-1,Altitude
41906-9,Vendor device name
41907-7,Vendor device model code
41908-5,Vendor software version
41909-3,Body mass index
41910-1,Class
41911-9,Vendor device name
41912-7,Vendor device model code
Mar-91,Clobenzorex
41913-5,Vendor serial number
41914-3,Class
41915-0,Vendor device name
41916-8,Vendor device model code
41917-6,Vendor serial number
41918-4,Vendor software version
41919-2,Vendor software version
419-2,Polymyxin B
41920-0,Heart rate
Jan-92,Clofibrate
41921-8,Heart rate
41922-6,Heart rate
41923-4,Heart rate
41924-2,Heart rate
41925-9,Class
41926-7,Vendor device name
41927-5,Vendor device model code
41928-3,Vendor serial number
41929-1,Vendor software version
41930-9,Class
41931-7,Vendor device name
41932-5,Vendor device model code
41933-3,Vendor serial number
41934-1,Vendor software version
41935-8,Peak flow measure duration
41936-6,Class
41937-4,Vendor serial number
41938-2,Bolus requested
Sep-93,clomiPRAMINE
41939-0,Bolus delivered
41940-8,Bolus type
41941-6,Basal rate
41942-4,Insulin type
41943-2,Insulin name + ID
41944-0,Totals.basal
41945-7,Totals.bolus
41946-5,Class
Jul-94,clonazePAM
41947-3,Vendor device name
41948-1,Vendor device model code
41949-9,Vendor software version
41950-7,Number of steps
41951-5,Number of steps
41952-3,Number of steps
41953-1,Walking distance
Apr-95,cloNIDine
41954-9,Walking distance
41955-6,Walking distance
41956-4,Walking speed
41957-2,Walking speed
41958-0,Walking speed
41959-8,Walking speed
41960-6,Class
41961-4,Vendor device name
Feb-96,Clopenthixol
41962-2,Vendor device model code
41963-0,Vendor serial number
41964-8,Vendor software version
41965-5,Class
41966-3,Vendor device name
41967-1,Vendor device model code
41968-9,Vendor serial number
41969-7,Vendor software version
4197-0,Clorprenaline
41970-5,Type
41971-3,Total metabolism
41972-1,Name
41973-9,Medication XXX
41974-7,Timing + Quantity
41975-4,Route
41976-2,Vendor device name
41977-0,Vendor software version
41978-8,Vendor serial number
41979-6,Calories burned
41980-4,Calories burned
41981-2,Calories burned
41982-0,Body fat percentage
41983-8,Vendor device model code
41984-6,Lipoprotein analysis status &or results
41985-3,Lead screen test status &or results
41986-1,Hematocrit test status &or results
41987-9,Hemoglobin test status &or results
Aug-98,Clostebol
41988-7,"Follow-up (referred to) provider &or specialist, catchment location indicator"
41989-5,"Follow-up (referred to) provider &or specialist, state location indicator"
41990-3,Parainfluenza virus 4 Ab.IgG
41991-1,SARS coronavirus Ab.IgM
41992-9,Arsenic.inorganic
41993-7,Atazanavir
41994-5,Cells.CD4+CD45RO+/100 cells
41995-2,Hemoglobin A1c
Jun-99,Codeine
41996-0,Hepatitis C virus DNA
41997-8,Heptacarboxylporphyrin
41998-6,Hexacarboxylporphyrin
41999-4,Lipoprotein.pre-beta
02-Apr,Almecillin
420-0,Polymyxin B
42000-0,Lopinavir+Ritonavir
42001-8,Nickel/Creatinine
Feb-00,Prochlorperazine
42002-6,Pentacarboxylporphyrins
42003-4,Hepatitis C virus RNA
42004-2,Eastern equine encephalitis virus Ab.IgM
42005-9,Saint Louis encephalitis virus Ab.IgM
42006-7,Saint Louis encephalitis virus Ab.IgM
42007-5,Views limited
42008-3,View^during surgery
42009-1,Views 2 + apical lordotic
4201-0,Cropropamide
42010-9,Views && view PA
42011-7,View PA && View AP
42012-5,Views^W water soluble contrast PO
42013-3,Views^W water soluble contrast PR
42014-1,Views^W contrast
42015-8,Views^W non-ionic contrast IT
42016-6,Views^W non-ionic contrast IT
42017-4,Guidance for percutaneous replacement of cholecystostomy
42018-2,Guidance for percutaneous transluminal angioplasty^W contrast IA
42019-0,Views upright + L-lateral-decubitus
42020-8,Guidance for needle localization
42021-6,Guidance for needle localization
42022-4,NAACCR hospital tumor registration.permanent
42023-2,NAACCR facility identification system coding system
42024-0,NAACCR hispanic identification algorithm hispanic origin
42025-7,NAACCR Indian Health Service linkage
42026-5,Census tract certainty 2000
42027-3,Geographic information system coordinate quality
Aug-02,Crotetamide
42028-1,NAACCR ambiguous terminology as basis for diagnosis
42029-9,Date of conclusive diagnosis
42030-7,Multiple tumors reported as single primary
42031-5,Date of diagnosis of multiple tumors
42032-3,Number of tumors at diagnosis
42033-1,Number of tumors & histologies
42034-9,Coding system.current
42035-6,Casefinding source
Jun-03,Cyanocobalamin.PO
42036-4,Cancer-Directed surgery at this facility 98-02
42037-2,Scope of regional lymph node surgery at this facility 98-02
42038-0,"Surgery of other regional site(s), distant site(s), or distant lymph node(s) at this facility 98-02"
42039-8,Systemic therapy &or surgery sequence
42040-6,Cancer-Directed surgery 98-02
42041-4,Scope of regional lymph node surgery 98-02
42042-2,"Surgery of other regional site(s), distant site(s) or distant lymph nodes 98-02"
42043-0,2nd course treatment.surgery
Apr-04,Cyclacillin
42044-8,2nd course treatment.radiation
42045-5,2nd course treatment.chemotherapy
42046-3,2nd course treatment.hormonal therapy
42047-1,2nd course treatment.biological reponse modifier therapy
42048-9,2nd course treatment.other therapy
42049-7,3rd course treatment.surgery
42050-5,3rd course treatment.radiation
Jan-05,Cyclizine
42051-3,3rd course treatment.chemotherapy
42052-1,3rd course treatment.hormonal therapy
42053-9,3rd course treatment.biological response modifier therapy
42054-7,3rd course treatment.other therapy
42055-4,4th course treatment.surgery
42056-2,4th course treatment.radiation
42057-0,4th course treatment.chemotherapy
42058-8,4th course treatment.hormonal therapy
42059-6,4th course treatment.biological response modifier therapy
42060-4,4th course treatment.other therapy
42061-2,Follow-up source
42062-0,County--current
42063-8,Recurrence distant site 1
42064-6,Recurrence distant site 2
42065-3,Recurrence distant site 3
42066-1,Histology ICD-O-1
42067-9,Stage.summary & regional lymph nodes positive override flag
42068-7,Stage.summary & TNM-N override flag
Sep-06,cycloSERINE
42069-5,Stage.summary & TNM-M override flag
42070-3,Stage.summary & distant metastasis 1 override flag
42071-1,Accession number & class of case & sequence number override flag
42072-9,Hospital sequence number & diagnostic confirmation override flag
42073-7,COC site & type override flag
42074-5,Hospital sequence & site override flag
42075-2,Primary site & TNM-stage group override flag
42076-0,ICD-O-2 to ICD-O-3 conversion method
Jul-07,cycloSPORINE
42077-8,Phone number
42078-6,Follow-up contact supplemental information
42079-4,Tumor size.collaborative staging
42080-2,Extension.collaborative staging
42081-0,Collaborative staging tumor size extension evaluation
42082-8,Collaborative staging lymph nodes
42083-6,Collaborative staging regional nodes evaluation
42084-4,Collaborative staging metastasis at diagnosis
May-08,Dantron
42085-1,Collaborative staging metastasis evaluation
42086-9,Collaborative staging site-specific factor 1
42087-7,Collaborative staging site-specific factor 2
42088-5,Collaborative staging site-specific factor 3
42089-3,Collaborative staging site-specific factor 4
42090-1,Collaborative staging site-specific factor 5
42091-9,Collaborative staging site-specific factor 6
42092-7,Collaborative staging version.first
Mar-09,clomiPRAMINE
42093-5,Collaborative staging version.latest
42094-3,Derived American Joint Committee on Cancer T
42095-0,Derived American Joint Committee on Cancer T descriptor
42096-8,Derived American Joint Committee on Cancer N
42097-6,Derived American Joint Committee on Cancer N descriptor
42098-4,Derived American Joint Committee on Cancer M
42099-2,Derived American Joint Committee on Cancer M descriptor
42100-8,Derived American Joint Committee on Cancer stage group
Jan-10,Nordoxepin
42101-6,Derived SEER summary stage 1977
42102-4,Derived SEER summary stage 2000
42103-2,Derived American Joint Committee on Cancer conversion method
42104-0,Derived SEER summary stage 1977 conversion method
42105-7,Derived SEER summary stage 2000 conversion method
42106-5,Archive facility identification number
42107-3,Comorbidities and complications 2
42108-1,Comorbidities and complications 3
42109-9,Comorbidities and complications 4
42110-7,Comorbidities and complications 5
42111-5,Comorbidities and complications 6
42112-3,Comorbidities and complications 7
42113-1,Comorbidities and complications 8
42114-9,Comorbidities and complications 9
42115-6,Comorbidities and complications 10
42116-4,ICD revision comorbidities
42117-2,Date of surgical discharge
42118-0,Readmission to the same hospital within 30D of surgical discharge
Sep-11,Desethylamiodarone
42119-8,Boost radiation dose
42120-6,Date radiation ended
42121-4,Hematologic transplant & endocrine procedures
42122-2,Pain assessment
42123-0,Palliative procedure at facility.XXX
42124-8,Palliative procedure at this facility
42125-5,RuralUrban continuum 2000
42126-3,Comorbidities and complications 1
Jul-12,Desipramine
42127-1,Name of follow-up contact
42128-9,Boost radiation treatment modality
42129-7,Site coding system.current
42130-5,Latitude
42131-3,Longitude
42132-1,Multisection screening
42133-9,Guidance for drainage of abscess+placement of drainage catheter
42134-7,Guidance for percutaneous aspiration of fluid
May-13,Nordiazepam
42135-4,Guidance for superficial biopsy
42136-2,Guidance for percutaneous biopsy
42137-0,Guidance for percutaneous biopsy
42138-8,Guidance for localization of placenta
42139-6,Guidance for percutaneous biopsy
42140-4,Guidance for placement of tube
42141-2,Guidance for removal of tunneled central venous catheter
42142-0,Guidance for percutaneous biopsy.core needle
Mar-14,Dextromethorphan
42143-8,Multisection^W saline IU
42144-6,Multisection
42145-3,Multisection
42146-1,Multisection
42147-9,Multisection
42148-7,Multisection
42149-5,Multisection limited
4215-0,Dextromoramide
42150-3,Multisection limited
42151-1,Multisection limited
42152-9,Multisection limited
42153-7,View
42154-5,View AP
42155-2,View AP lateral-decubitus
42156-0,Views^W contrast IA
42157-8,Views^W contrast IV
42158-6,Views^W radionuclide IV
42159-4,Views
42160-2,Views for shunt patency
42161-0,Views^W DOBUTamine+W radionuclide IV
42162-8,View AP && Views^W water soluble contrast PO
42163-6,Views + oblique
42164-4,Views + oblique
42165-1,Views && view PA
42166-9,Views 2^at rest+W Tl-201 IV
42167-7,Views AP + lateral frog
Aug-16,Diamorphine
42168-5,Views diagnostic
42169-3,Views diagnostic
42170-1,Views for lymphoma^W radionuclide IV
42171-9,Views for tumor^W radionuclide IV
42172-7,Views portable
42173-5,Views portable
42174-3,Views screening
42175-0,Views^W radionuclide IV
Jun-17,diazePAM
42176-8,"1,3 beta glucan"
42177-6,Fc epsilon RI Ab
42178-4,Lipoprotein.X
42179-2,PLP1 gene duplication
421-8,Polymyxin B
42180-0,C peptide^post CFst
42181-8,Myocardium Ab
42182-6,Gossypol.bound
42183-4,Gossypol.negative isomer
Apr-18,Dibenzepin
42184-2,Gossypol.positive isomer
42185-9,Number of specimens obtained
42186-7,Number of specimens received
42187-5,Number of specimens tested
42188-3,Cells.CD3+CD16+CD56+
42189-1,Cells.CD3+CD16+CD56+/100 cells
42190-9,Shigella sp DNA
42191-7,Hepatitis A & B & C 7a panel
Feb-19,Dibucaine nbr
42192-5,Nidus
42193-3,Cells.CD3/100 cells
42194-1,Cells.CD4/100 cells
42195-8,Cells.CD8/100 cells
42196-6,Centromere Ab
42197-4,Centromere Ab
42198-2,Curvularia specifera Ab.IgE
42199-0,Soluble liver Ab
Feb-42,Azlocillin
4220-0,Dichlorphenamide
42200-6,DNA double strand Ab
42201-4,DNA single strand Ab.IgG
42202-2,GALOP Ab.IgM
42203-0,Ganglioside GM1 Ab
42204-8,Hairy cells/100 leukocytes
42205-5,Human antimouse Ab.IgG
42206-3,IgA.CSF/IgA.serum
42207-1,IgG.CSF/IgG.serum
42208-9,IgM.CSF/IgM.serum
42209-7,Microscopic observation
42210-5,Microscopic observation
42211-3,Myelin associated glycoprotein-sulfated glucuronic paragloboside Ab
42212-1,Nuclear Ab pattern.nucleolar
42213-9,Nuclear Ab pattern.smooth nuclear envelope
42214-7,Nuclear Ab pattern.speckled
42215-4,Erythrocytes.nucleated/100 cells
42216-2,Referral lab name
42217-0,Striated muscle Ab.IgG
Aug-21,Digitoxin
42218-8,Sulfatide Ab.IgG & Ab.IgM panel
42219-6,Chromium
42220-4,Chromium/Creatinine
42221-2,Manganese
42222-0,Manganese
42223-8,Manganese/Creatinine
42224-6,Thallium
42225-3,Thallium
Jun-22,Digoxin
42226-1,Thallium/Creatinine
42227-9,Drug abuse and dependence section
42228-7,Pregnancy section
42229-5,SPL unclassified section
42230-3,SPL patient package insert section
42231-1,SPL medguide section
42232-9,Precautions section
42233-7,Acetylcholine receptor ganglionic neuronal Ab
Apr-23,HYDROmorphone
42234-5,Alpha subunit.free
42235-2,Benzodiazepine metabolites
42236-0,Borrelia burgdorferi DNA
42237-8,Borrelia burgdorferi 18kD Ab.IgG
42238-6,Borrelia burgdorferi 23kD Ab
42239-4,Borrelia burgdorferi 39kD Ab.IgG
42240-2,CHD7 gene targeted mutation analysis
42241-0,Cocaine+Benzoylecgonine
Feb-24,diphenhydrAMINE
42242-8,Ethanol
42243-6,Hemoglobin
42244-4,Hemoglobin A/Hemoglobin.total
42245-1,Hemoglobin A2/Hemoglobin.total
42246-9,Hemoglobin F/Hemoglobin.total
42247-7,Hemoglobin pattern
42248-5,Hemoglobin.other/Hemoglobin.total
42249-3,levETIRAcetam
42250-1,Lymphocytes.variant/100 leukocytes
42251-9,Methadone+Metabolite
42252-7,Methaqualone+Metabolite
42253-5,Methylenedioxyamphetamine
42254-3,Nuclear Ab
42255-0,Salmonella & Shigella sp identified
42256-8,Shigella boydii Ag
42257-6,Shigella dysenteriae Ag
42258-4,Shigella flexneri Ag
Sep-25,Phenytoin
42259-2,Shigella sonnei Ag
422-6,Polymyxin B
42260-0,Guidance for percutaneous biopsy^W contrast IV
42261-8,Views for blood flow^W radionuclide IV
42262-6,Views for blood flow^W radionuclide IV
42263-4,Views for blood flow^W radionuclide IV
42264-2,Views^W non-ionic contrast IT
42265-9,Guidance for superficial biopsy
42266-7,Guidance for superficial biopsy.needle
Jul-26,Diphenylhydramine
42267-5,Guidance for biopsy.needle
42268-3,Multisection^WO & W contrast IV
42269-1,Views
42270-9,Multisection^W flexion + W extension
42271-7,Views+views uptake^W I-123 IV
42272-5,Views PA + lateral
42273-3,Views 6
42274-1,Multisection^WO & W contrast IV
May-27,Dipipanone
42275-8,Multisection^W contrast IV
42276-6,Multisection^WO contrast
42277-4,Multisection^WO & W contrast IV
42278-2,Multisection^WO contrast
42279-0,Guidance for percutaneous biopsy
42280-8,Guidance for drainage of abscess+placement of drainage catheter
42281-6,Guidance for drainage of abscess+placement of drainage catheter
42282-4,Guidance for drainage of abscess+placement of drainage catheter
Mar-28,Disopyramide
42283-2,Guidance for drainage+placement of drainage catheter
42284-0,Guidance for drainage of abscess+placement of chest tube
42285-7,Guidance for drainage of abscess+placement of drainage catheter
42286-5,Guidance for drainage of abscess+placement of drainage catheter
42287-3,Guidance for drainage+placement of drainage catheter
42288-1,Guidance for biopsy.needle
42289-9,Guidance for biopsy.needle
42290-7,Guidance for biopsy.needle
Jan-29,Disulfiram
42291-5,Multisection^WO contrast
42292-3,Multisection for tumor^W Tl-201 IV
42293-1,Multisection^WO contrast
42294-9,Multisection^W contrast IV
42295-6,Multisection^W contrast IV
42296-4,Guidance for localization
42297-2,Guidance for localization
42298-0,Multisection^WO & W contrast IV
42299-8,Multisection^WO & W contrast IV
42300-4,Multisection
42301-2,Multisection
42302-0,Multisection^WO contrast
42303-8,Multisection
42304-6,Multisection
42305-3,Views for tumor^W Tl-201 IV
42306-1,Views gated+wall motion^W radionuclide IV
42307-9,Guidance for placement of infusion port
42308-7,Views for blood flow^W radionuclide IV
Sep-30,Doxepin
42309-5,Views^at rest+W stress+W Tl-201 IV
42310-3,Multisection^W radionuclide IV
42311-1,Views for foreign body
42312-9,Views for foreign body
42313-7,View
42314-5,View
42315-2,APOE gene alleles e2 & e3 & e4
42316-0,RHD gene allele
Jul-31,Doxylamine
42317-8,Foscarnet
42318-6,GALT gene targeted mutation analysis
42319-4,Glucose-6-Phosphate dehydrogenase phenotype
42320-2,Glutathione reductase phenotype
42321-0,HTT gene targeted mutation analysis
42322-8,Hepatitis B virus S+pol gene
42323-6,HLA-DR Ag
42324-4,I group phenotype
May-32,Dyphylline
42325-1,RHD gene allele & RHCE gene allele
42326-9,Drugs identified
42327-7,Leukocytes
42328-5,Bordetella pertussis Ab.IgA
42329-3,Bordetella pertussis Ab.IgM
42330-1,Bordetella pertussis Ab.IgG
42331-9,Nuclear Ab.IgG
42332-7,Alpha-1-Fetoprotein.L3/Alpha-1-Fetoprotein.total
Mar-33,Emetine
42333-5,Guidance for percutaneous biopsy
42334-3,Guidance for injection
42335-0,Views limited^W contrast IT
42336-8,Cytomegalovirus Ag
42337-6,Herpes simplex virus 1 glycoprotein G Ab.IgG
42338-4,Herpes simplex virus 2 glycoprotein G Ab.IgG
42339-2,HIV 1 p24 Ag
423-4,Pyrazinamide
42340-0,HTLV I p42 Ab
Jan-34,Encainide
42341-8,Neisseria meningitidis serogroups A+w135 Ag
42342-6,Rickettsia (Proteus) Ab panel
42343-4,Toxoplasma gondii identified
42344-2,Discharge diet
42345-9,Discharge functional status
42346-7,Medications on admission
42347-5,Admission diagnosis
42348-3,Advance directives
42349-1,Reason for referral
42350-9,Cefepime+Clavulanate
42351-7,Cefepime+Clavulanate
42352-5,cefTAZidime+Clavulanate
42353-3,Cefepime+Clavulanate
42354-1,Tigecycline
42355-8,Tigecycline
42356-6,Tigecycline
42357-4,Tigecycline
Aug-35,Enoxacin
42358-2,HLA-B*57:01
42359-0,Streptococcus pneumoniae 14 serotypes Ab.IgG panel B
42360-8,Streptococcus pneumoniae 14 serotypes Ab.IgG panel A
42361-6,Streptococcus pneumoniae 12 serotypes Ab.IgG panel
42362-4,Streptococcus pneumoniae 7 serotypes Ab.IgG panel B
42363-2,Streptococcus pneumoniae 7 serotypes Ab.IgG panel A
42364-0,Streptococcus pneumoniae 6 serotypes Ab.IgG panel
42365-7,Streptococcus pneumoniae 4 serotypes Ab.IgG panel
Jun-36,ePHEDrine
42366-5,Streptococcus pneumoniae 23 serotypes Ab.IgG panel
42367-3,Streptococcus pneumoniae Danish serotype 19B Ab.IgG
42368-1,Neisseria meningitidis serogroup w135 Ag
42369-9,Neisseria meningitidis serogroup A Ag
42370-7,Neisseria meningitidis serogroup B Ag
42371-5,Neisseria meningitidis serogroup C Ag
42372-3,Neisseria meningitidis serogroup D Ag
42373-1,Neisseria meningitidis serogroup X Ag
Apr-37,Erythromycin
42374-9,Neisseria meningitidis serogroup Y Ag
42375-6,Neisseria meningitidis serogroup Z Ag
42376-4,Neisseria meningitidis serogroup Z' Ag
42377-2,Multisection^W Xe-133 IH+WO & W contrast IV
42378-0,View AP^W L-bending
42379-8,View AP^W R-bending
42380-6,Views AP + lateral^W standing
42381-4,Views
Feb-38,Estazolam
42382-2,Views lateral + Mortise + Broden^W manual stress
42383-0,Views^W contrast PO+W contrast PO
42384-8,Views^W contrast intra multiple ducts
42385-5,Multisection
42386-3,Multisection cine for CSF flow
42387-1,Multisection cine for CSF flow
42388-9,Multisection endorectal
42389-7,Multisection endorectal
4239-0,Etafedrine
42390-5,Multisection endovaginal
42391-3,Multisection^W contrast IV
42392-1,Multisection^WO & W contrast IV
42393-9,Multisection^WO contrast
42394-7,Multisection^W Xe-133 IH
42395-4,View axial
42396-2,View axial
42397-0,Views frontal
42398-8,(View oblique) + (Views AP + lateral^W standing)
42399-6,Views
42400-2,Views
42401-0,(Views AP^W R-bending + W L-bending + WO bending) + (view lateral)
42402-8,Views post mortem
42403-6,Views AP^W R-bending + W L-bending
42404-4,Views AP + lateral for measurement
42405-1,(Views AP^W standing) + (view lateral^W extension)
42406-9,Views AP^WO & W L-bending
42407-7,Views AP^WO & W R-bending
Aug-40,Etamivan
42408-5,Views AP^W R-bending + W L-bending + WO bending
42409-3,Views AP + lateral
42410-1,Views AP + lateral + oblique + spot^W standing
42411-9,(Views AP^W R-bending + W L-bending) + (view lateral^W flexion + W extension)
42412-7,Views 90 degree abduction
42413-5,Views^W R-bending + W L-bending
42414-3,Views R-oblique + L-oblique^W nipple markers
42415-0,Views^post wire placement
Jun-41,Ethacrynate
42416-8,Views^post wire placement
42417-6,(Views AP + lateral + oblique) + (view^W manual stress)
42418-4,(Views AP + lateral + oblique) + (view^W manual stress)
42419-2,View
424-2,Pyrazinamide
42420-0,View AP^W standing
42421-8,Guidance for percutaneous drainage of abscess+placement of drainage catheter
42422-6,Guidance for percutaneous drainage of abscess+placement of drainage catheter
42423-4,Guidance for percutaneous drainage of abscess+placement of drainage catheter
Apr-42,Ethambutol
42424-2,(Views AP + lateral) for scoliosis^W sitting
42425-9,Views AP for scoliosis^W standing + W R-bending + W L-bending + WO bending
42426-7,View AP for scoliosis^W sitting
42427-5,View lateral for scoliosis^W sitting
42428-3,View AP for scoliosis^W standing in brace
42429-1,View AP for scoliosis^W standing + W R-bending
42430-9,(Views 2) + (views^W standing)
42431-7,View PA 30 degree flexion^W standing
Feb-43,Ethchlorvynol
42432-5,(View Sunrise) + (views^W standing)
42433-3,Guidance for percutaneous biopsy.core needle
42434-1,Views
42435-8,Views 2
42436-6,Views lateral + Towne
42437-4,Multisection
42438-2,Views AP + lateral
42439-0,View AP
4244-0,Ethoheptazine
42440-8,View lateral
42441-6,View magnification
42442-4,View lateral^W standing
42443-2,Views 3^W standing
42444-0,Views AP^W R-bending + W L-bending + WO bending
42445-7,Views AP^W L-bending + WO bending
42446-5,Views AP^W R-bending + WO bending
42447-3,Guidance for percutaneous aspiration of cyst
42448-1,Guidance for biopsy.excisional
42449-9,Guidance for percutaneous biopsy
42450-7,Guidance for percutaneous aspiration of cyst
42451-5,Study observation.general transvaginal 1st trimester
42452-3,Study observation.general 1st trimester
42453-1,Study observation.general 2nd trimester
42454-9,Study observation.general 3rd trimester
42455-6,Multisection transabdominal + transvaginal
42456-4,Guidance for placement of needle wire
Jul-45,Ethosuximide
42457-2,Guidance for percutaneous biopsy
42458-0,Guidance for percutaneous aspiration of cyst
42459-8,Views^W contrast PO
42460-6,Views^W contrast intra salivary duct
42461-4,Multisection for graft
42462-2,Multisection for graft
42463-0,Guidance for percutaneous biopsy
42464-8,Study observation.general 1st trimester
May-46,Ethotoin
42465-5,Study observation.general 2nd trimester
42466-3,Study observation.general 3rd trimester
42467-1,Study observation.general.limited
42468-9,Multisection
42469-7,View^W contrast PO
42470-5,View^W contrast PO
42471-3,View
42472-1,Views AP for scoliosis^in traction
Mar-47,Ethylmorphine
42473-9,View Waters
42474-7,View
42475-4,Multisection for graft
42476-2,Multisection for graft
42477-0,Multisection for transplanted kidney vessels
42478-8,Guidance for drainage of cyst+placement of drainage catheter
42479-6,Study observation.general
42480-4,Multisection transabdominal
Jan-48,N-ethylnicotinamide
42481-2,Human papilloma virus 6+11+42+43+44 DNA
42482-0,Protein.monoclonal
42483-8,Protein.monoclonal/Protein.total
42484-6,Protein.monoclonal/Protein.total
42485-3,Anion gap
42486-1,Aspergillus fumigatus 1 Ab
42487-9,Aspergillus fumigatus 6 Ab
42488-7,Aspergillus sp Ab
42489-5,Aureobasidium pullulans Ab
42490-3,Blastomyces dermatitidis Ab
42491-1,Cannabinoids
42492-9,Carboxy tetrahydrocannabinol
42493-7,Catecholamines.free fractionated
42494-5,Coccidioides immitis Ab
42495-2,Cytomegalovirus Ab.IgG
42496-0,Echinococcus sp Ab
42497-8,Epstein Barr virus early Ab
42498-6,Epstein Barr virus nuclear Ab
Sep-49,Etilefrine
42499-4,Fibrin D-dimer
42500-9,Fosamprenavir
42501-7,Glutamate decarboxylase 65 Ab
42502-5,Glycolate
42503-3,Hantavirus Ab
42504-1,Hepatitis B virus surface Ab
42505-8,Hepatitis B virus surface Ag
42506-6,Hepatitis C virus Ab
Jul-50,Fencamfamin
42507-4,Herpes simplex virus 1 Ab.IgG
42508-2,Herpes virus 8 Ab.IgG
42509-0,Histoplasma capsulatum Ab
42510-8,IgD
42511-6,IgD
42512-4,IgE
42513-2,IgE
42514-0,Inhibin Ag
May-51,Fenetylline
42515-7,Jamestown canyon virus RNA
42516-5,Legionella sp Ab
42517-3,Leishmania sp Ab
42518-1,Leptospira sp Ab
42519-9,Measles virus Ab.IgG
42520-7,Methylmalonate
42521-5,Saccharopolyspora rectivirgula Ab
42522-3,Mitochondria Ab
Mar-52,Fenfluramine
42523-1,Molindone
42524-9,Mucus
42525-6,Mycoplasma pneumoniae Ab.IgM
42526-4,Mycoplasma pneumoniae Ab.IgG
42527-2,Parietal cell Ab
42528-0,Phenothiazines
42529-8,Pigeon serum Ab
42530-6,Smooth muscle Ab
Jan-53,Fenoprofen
42531-4,Spermatozoa.motile
42532-2,Thermoactinomyces candidus Ab
42533-0,Saccharomonospora viridis Ab
42534-8,Thermoactinomyces vulgaris Ab
42535-5,Tipranavir
42536-3,Tropheryma whipplei DNA
42537-1,Varicella zoster virus Ab.IgG
42538-9,Hydroxyperhexiline
42539-7,Hydroxyperhexiline/Perhexiline
42540-5,Contributing factor.environment
42541-3,Contributing factor.patient-related
42542-1,Contributing factor.staff-related
42543-9,Contributing factor.delay &or premature
42544-7,Contributing factor.other
42545-4,Event outcome
42546-2,Event battery.MERS-TH
42547-0,Event
42548-8,Service
Sep-54,Fenproporex
42549-6,Event type
42550-4,Event description.medication
42551-2,Event description.procedure &or treatment &or surgery
42552-0,Event description.food &or nutrition
42553-8,Event description.fall
42554-6,Event description.accident
42555-3,Event description.general nursing care
Jun-55,fentaNYL
42556-1,Event description.equipment &or device
42557-9,Event description.laboratory
42558-7,Event description.transfusion service
42559-5,Event description.administrative
42560-3,Event description.complaint
42561-1,Event description.environmental hazard &or safety
42562-9,Event description.crime &or intentional harm/Patient disappearance
42563-7,Event description.adverse event
Apr-56,Flecainide
42564-5,Contributing factor.technical
42565-2,Contributing factor.organization
42566-0,Contributing factor.communication &or documentation
42567-8,Calcium.ionized
42568-6,Fibrinogen
42569-4,Potassium
42570-2,Sodium
42571-0,Urea
Feb-57,5-Fluorocytosine
42572-8,11-Deoxycortisol
42573-6,18-Hydroxycorticosterone
42574-4,1-Naphthol
42575-1,Amoxicillin Ab.IgE/IgE.total
42576-9,Amphetamine
42577-7,Ampicillin Ab.IgE/IgE.total
42578-5,Artifact
42579-3,Aspergillus fumigatus Ab.IgM
4258-0,Flunitrazepam
42580-1,Babesia sp Ab.IgM
42581-9,Babesia sp Ab.IgG
42582-7,Barbiturates
42583-5,Bean string Ab.IgE.RAST class
42584-3,Beet Ab.IgG
42585-0,Bendiocarb
42586-8,Benzodiazepines
42587-6,BK virus DNA
42588-4,Bordetella parapertussis DNA
42589-2,Borrelia burgdorferi DNA
425-9,Pyrazinamide
42590-0,Borrelia sp Ab
42591-8,Botrytis cinerea Ab.IgG
42592-6,Brucella abortus Ab.IgG
42593-4,Calcium
42594-2,Fraxinus americana Ab.IgE/IgE.total
42595-9,Hepatitis B virus DNA
42596-7,Corticotropin^30M post XXX challenge
42597-5,Corticotropin^1.5H post XXX challenge
Aug-59,Fluorouracil
42598-3,Corticotropin^baseline
42599-1,Corticotropin^1H post XXX challenge
42600-7,HIV 1+2 Ab
42601-5,Immune complex.IgG
42602-3,Tropheryma whipplei DNA
42603-1,Coxsackievirus A6 Ab
42604-9,Glucose^3H post dose lactose PO
42605-6,Dialysis bag number
Jun-60,FLUoxetine
42606-4,Herpes simplex virus 2 Ab.IgM
42607-2,Prolactin.monomeric
42608-0,Cells.CD10+CD20+/100 cells
42609-8,Glucose^6H post dose lactose PO
42610-6,Salicylurate
42611-4,Glucose^1H post dose lactose PO
42612-2,Salicylurate
42613-0,Glucose^2H post dose lactose PO
Apr-61,Fluoxymesterone
42614-8,Colorado tick fever virus Ab
42615-5,Glucose^30M post dose lactose PO
42616-3,Magnesium
42617-1,Hepatitis C virus RNA
42618-9,Naloxone
42619-7,Cells.CD28/100 cells
42620-5,Cells.terminal deoxyribonucleotidyl transferase/100 cells
42621-3,Mycoplasma hominis DNA
Feb-62,Flupenthixol
42622-1,Cells.CD13+CD56+/100 cells
42623-9,Coxsackievirus A3 Ab
42624-7,Gastrin^2M post XXX challenge
42625-4,Coxsackievirus A6 Ab
42626-2,Toxoplasma gondii DNA
42627-0,HIV 1 Ab
42628-8,Cells.CD9+CD41+/100 cells
42629-6,Glucose^4H post dose lactose PO
4263-0,fluPHENAZine
42630-4,Cannabinoids
42631-2,Glucose^5H post dose lactose PO
42632-0,Grade ICD-O-1
42633-8,Behavior ICD-O-1
42634-6,1p & 19q chromosome deletion
42635-3,Chromosome 12p tetrasomy
42636-1,Urease^3H post incubation
42637-9,Natriuretic peptide.B
42638-7,Coagulation tissue factor induced
42639-5,Immune complex.IgG
42640-3,Urease^1D post incubation
42641-1,Babesia sp DNA
42642-9,Amikacin 2.0 ug/mL
42643-7,Capreomycin 10.0 ug/mL
42644-5,Ciprofloxacin 2.0 ug/mL
42645-2,Ethambutol 10.0 ug/mL
42646-0,Ethambutol 5.0 ug/mL
42647-8,Ethionamide 10.0 ug/mL
Aug-64,Flurazepam
42648-6,Ethionamide 5.0 ug/mL
42649-4,Isoniazid 0.2 ug/mL
42650-2,Isoniazid 1.0 ug/mL
42651-0,Isoniazid 5.0 ug/mL
42652-8,Kanamycin 5.0 ug/mL
42653-6,Ofloxacin 2.0 ug/mL
42654-4,Para aminosalicylate 2.0 ug/mL
May-65,Furfenorex
42655-1,Rifabutin 0.5 ug/mL
42656-9,Rifabutin 2.0 ug/mL
42657-7,rifAMPin 1.0 ug/mL
42658-5,Streptomycin 10.0 ug/mL
42659-3,Streptomycin 2.0 ug/mL
42660-1,Alpha 2 laminin
42661-9,Bacteria identified
42662-7,Benzodiazepines
Mar-66,Furosemide
42663-5,HLA-Cw locus
42664-3,HLA-Cw
42665-0,Dantron
42666-8,Fat.neutral
42667-6,Fatty acids
42668-4,Fatty acids
42669-2,Fatty acids
426-7,Pyrazinamide
42670-0,pH
Jan-67,Galactose.PO
42671-8,Serotonin
42672-6,Debris
42673-4,Calcium hydrogen phosphate dihydrate
42674-2,Fat.neutral
42675-9,HLA Ag
42676-7,Spermatozoa.normal.motile
42677-5,Succinylacetone
42678-3,Urate
42679-1,Heparin
42680-9,View XCCL
42681-7,Views^W gastrografin PR
42682-5,Succinyladenosine
42683-3,View && Views^W barium contrast PO
42684-1,Views^W gastrografin PO
42685-8,Views 2
42686-6,Views 2
42687-4,Views 2
42688-2,Guidance for nerve block
Sep-68,Gentamicin
42689-0,View oblique
42690-8,Views^W flexion + W extension
42691-6,Views 6
42692-4,Views
42693-2,Multisection cine
42694-0,Multisection^W contrast IV
42695-7,Multisection^W contrast IV
42696-5,Multisection
Jul-69,Glucose.PO
42697-3,Multisection^WO & W contrast IV
42698-1,Multisection
42699-9,View
42700-5,Views^W Tc-99m tagged WBC IV
42701-3,Guidance for localization of placenta
42702-1,View
42703-9,View
42704-7,Diameter^baseline
May-70,Glutethimide
42705-4,Guidance for drainage of abscess+placement of drainage catheter
42706-2,Guidance for injection
42707-0,Multisection limited
42708-8,Views^W In-111 tiuxetan IV
42709-6,Views blood pool^W radionuclide IV
42710-4,Views limited
42711-2,Views^W In-111 tagged WBC IV
42712-0,AML+MDS gene 7q31 deletion
Mar-71,Gonadotropin releasing hormone
42713-8,AML+MDS gene CEP 8 trisomy
42714-6,"t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript"
42715-3,Del(5)(q12-35) gene deletion
42716-1,Mycobacterium sp rRNA
42717-9,Mycobacterium tuberculosis complex genotype
42718-7,Alkaline phosphatase.heat labile/Alkaline phosphatase.total
42719-5,Bilirubin
42720-3,Clindamycin.induced
Jan-72,Haloperidol
42721-1,Staphylococcus sp.oxacillin resistant isolate
42722-9,OmpC Ab
42723-7,OmpC Ab
42724-5,OmpC Ab
42725-2,Bromide
42726-0,Cerebroside sulfatase
42727-8,Fibrin D-dimer DDU
42728-6,pH
42729-4,Cardiolipin Ab.IgA.B2GP1 dependent
42730-2,Cardiolipin Ab.IgA.B2GP1 independent
42731-0,Cardiolipin Ab.IgG.B2GP1 dependent
42732-8,Cardiolipin Ab.IgG.B2GP1 independent
42733-6,Cardiolipin Ab.IgM.B2GP1 dependent
42734-4,Cardiolipin Ab.IgM.B2GP1 independent
42735-1,Cells.CD20+CD117+/100 cells
42736-9,Cells.CD20+CD23+/100 cells
42737-7,Cells.CD4+CD7+/100 cells
42738-5,Cells.CD7+CD8+/100 cells
Sep-73,Heptaminol
42739-3,Phosphatidylcholine Ab.IgA.B2GP1 dependent
42740-1,Phosphatidylcholine Ab.IgA.B2GP1 independent
42741-9,Phosphatidylcholine Ab.IgG.B2GP1 dependent
42742-7,Phosphatidylcholine Ab.IgG.B2GP1 independent
42743-5,Phosphatidylcholine Ab.IgM.B2GP1 dependent
42744-3,Phosphatidylcholine Ab.IgM.B2GP1 independent
42745-0,Phosphatidylethanolamine Ab.IgA.B2GP1 dependent
42746-8,Phosphatidylethanolamine Ab.IgA.B2GP1 independent
Jul-74,Hippurate
42747-6,Phosphatidylethanolamine Ab.IgG.B2GP1 dependent
42748-4,Phosphatidylethanolamine Ab.IgG.B2GP1 independent
42749-2,Phosphatidylethanolamine Ab.IgM.B2GP1 dependent
427-5,rifAMPin
42750-0,Phosphatidylethanolamine Ab.IgM.B2GP1 independent
42751-8,Phosphatidylserine Ab.IgA.B2GP1 dependent
42752-6,Phosphatidylserine Ab.IgA.B2GP1 independent
42753-4,Phosphatidylserine Ab.IgG.B2GP1 dependent
Apr-75,hydroCHLOROthiazide
42754-2,Phosphatidylserine Ab.IgG.B2GP1 independent
42755-9,Phosphatidylserine Ab.IgM.B2GP1 dependent
42756-7,Phosphatidylserine Ab.IgM.B2GP1 independent
42757-5,Troponin I.cardiac
42758-3,Reticulocytes
42759-1,Lymphocytes B
42760-9,Inflammatory bowel disease Ab panel
Feb-76,HYDROcodone
42764-1,Crystals
42765-8,Tube number
42766-6,Aspergillus sp Ab
42767-4,Borrelia burgdorferi Ab.IgG & IgM
42768-2,HIV 1 & 2 Ab
42769-0,HTLV I+II Ab
4277-0,HYDROmorphone
42770-8,Human papilloma virus high & Low risk DNA panel
42771-6,Streptococcus pneumoniae serotype Ab.IgG
42772-4,Fibrinogen Ag
42773-2,Multiple drug resistant organism identified
42774-0,Multiple drug resistant organism identified
42775-7,Multiple drug resistant organism identified
42776-5,Views for AV shunt^W radionuclide IV
42777-3,AKT1 gene targeted mutation analysis
42778-1,BRCA1 Ag
42779-9,BRCA2 Ag
42780-7,CCND1 gene targeted mutation analysis
42781-5,Surgical operation date
42782-3,Epidermal growth factor receptor.phosphorylated Ag
42783-1,ERBB2 gene targeted mutation analysis
42784-9,Ethnic background
42785-6,FGFR1 gene targeted mutation analysis
42786-4,HER3 Ag
42787-2,HER4 Ag
Aug-78,Hydroxychloroquine
42788-0,Insulin-like growth factor-I receptor Ag
42789-8,Mitogen-Activated protein kinase 14 Ag
42790-6,MAP kinase 14
42791-4,Mitogen-Activated protein kinase 3 Ag
42792-2,Mitogen-Activated protein kinase 8 Ag
42793-0,Mitogen-Activated protein kinase 9 Ag
42794-8,MYC gene targeted mutation analysis
42795-5,Retinoblastoma protein
Jun-79,Hydroxymethoxyphenamine
42796-3,Trial name
42797-1,Age at first pregnancy
42798-9,Age at menarche
42799-7,Quadrant
42800-3,ECOG performance status grade
42801-1,Histology grade
42802-9,Age at menopause
42803-7,Bacteria identified
Apr-80,hydrOXYzine
42804-5,Fungus identified
42805-2,Fungus identified
42806-0,Bacteria identified
42807-8,Parasite identified
42808-6,Virus identified
42809-4,Fungus identified
42810-2,Hemoglobin
42811-0,View scaphoid
Feb-81,Ibuprofen
42812-8,View scaphoid
42813-6,View scaphoid
42814-4,View scaphoid
42815-1,Stachybotrys chartarum Ab.IgE
42816-9,Stachybotrys chartarum Ab.IgG
42817-7,Cells.CD38+Kappa+/100 cells
42818-5,Cells.CD38+Lambda+/100 cells
42819-3,Failure to thrive
4282-0,Imipenem
42820-1,Intracranial adaptive capacity impairment
42821-9,Caregiver role strain
42822-7,Relocation stress syndrome
42823-5,Suicide risk
42824-3,Self mutilation risk
42825-0,Perioperative injury risk
42826-8,Perioperative positioning injury
42827-6,Surgical recovery delay
42828-4,Substance abuse
42829-2,Tobacco abuse
428-3,rifAMPin
42830-0,Alcohol abuse
42831-8,Drug abuse
42832-6,Latex allergy response
42833-4,Reproductive risk
42834-2,Fertility risk
42835-9,Infertility risk
42836-7,Contraception risk
42837-5,Perinatal risk
Aug-83,Imipramine
42838-3,Pregnancy risk
42839-1,Labor risk
42840-9,Delivery risk
42841-7,Postpartum risk
42842-5,Newborn behavior alteration
42843-3,Infant behavior alteration
42844-1,Child behavior alteration
42845-8,Adolescent behavior alteration
Jun-84,Indomethacin
42846-6,Adult behavior alteration
42847-4,Sleep deprivation
42848-2,Nausea
42849-0,Confusion
42850-8,Memory impairment
42851-6,Infant feeding pattern impairment
42852-4,Older adult behavior alteration.sixty five Y and older
Mar-85,Insulin Lente
42853-2,Ventilatory weaning impairment
42854-0,Community coping impairment
42855-7,11-Deoxycorticosterone
42856-5,Benzoylecgonine
42857-3,Calcium
42859-9,Candida albicans Ab
42860-7,Cannabinoids
Jan-86,Insulin NPH
42861-5,Carbaryl
42862-3,Carbofuran
42863-1,Libocedrus decurrens Ab.IgE/IgE.total
42864-9,Cells.CD103/100 cells
42865-6,Cells.CD117/100 cells
42866-4,Cells.CD117/100 cells
42867-2,Cells.CD117/100 cells
42868-0,Cells.CD11c+CD19+/100 cells
42869-8,Cells.CD138/100 cells
42870-6,Cells.CD138/100 cells
42871-4,Cells.CD138/100 cells
42872-2,Cells.CD138/100 cells
42873-0,Cells.CD18/100 cells
42874-8,Cells.CD18/100 cells
42875-5,Cells.CD22/100 cells
42876-3,Cells.CD25+CD19+/100 cells
42877-1,Cells.CD3-CD16+
42878-9,Cells.CD3-CD16+
Sep-87,Insulin regular
42879-7,Cells.CD3-CD16+
42880-5,Cells.CD3-CD57+
42881-3,Cells.CD3-CD57+
42882-1,Cells.CD3-CD57+/100 cells
42883-9,Cells.CD52/100 cells
42884-7,Cells.CD52/100 cells
42885-4,Cells.CD52/100 cells
42886-2,Cells.CD52/100 cells
Jul-88,Insulin semilente
42887-0,Cells.CD79b/100 cells
42888-8,Cells.CD79b/100 cells
42889-6,Cells.CD79b/100 cells
42890-4,Cells.myeloperoxidase/100 cells
42891-2,Choriogonadotropin
42892-0,Citrulline
42893-8,Cladosporium herbarum Ab.IgG
42894-6,Clindamycin Ab.IgE
May-89,Insulin ultralente
42895-3,Colorado tick fever virus Ab.IgG
42896-1,Colorado tick fever virus Ab.IgM
42897-9,Coxiella burnetii phase 1 Ab.IgM
42898-7,Cyclic citrullinated peptide Ab.IgG
42899-5,Cytomegalovirus Ab.IgM
42900-1,Daucus carota Ab.IgE/IgE.total
42901-9,Dihydrocodeine
42902-7,Elastase.pancreatic
Mar-90,Isoniazid
42903-5,Enterovirus NOS Ab
42904-3,Epicoccum purpurascens Ab.IgG
42905-0,Formate/Creatinine
42906-8,Galactose 1 phosphate uridyl transferase
42907-6,Helminthosporium sp Ab.IgG
42908-4,Hematocrit
42909-2,Hemoglobin.gastrointestinal^1st specimen
429-1,rifAMPin
42910-0,Hemoglobin.gastrointestinal^2nd specimen
Jan-91,Kanamycin
42911-8,Hemoglobin.gastrointestinal^3rd specimen
42912-6,Hemoglobin.gastrointestinal^2nd specimen
42913-4,Hemoglobin.gastrointestinal^1st specimen
42914-2,HER2
42915-9,Herpes virus 6 Ab.IgM
42916-7,Histoplasma capsulatum Ag
42917-5,HIV 1 RNA
42918-3,Hydroflumethiazide
42919-1,Insulin^pre 100 g glucose PO
42920-9,Isovalerylcarnitine (C5)
42921-7,JC virus DNA
42922-5,Ketamine
42923-3,Kochia scoparia Ab.IgE/IgE.total
42924-1,Lactoferrin
42925-8,Myeloid cells/100 cells
42926-6,Myeloid cells/100 cells
42927-4,Myeloid cells/100 cells
42928-2,Filaria Ag
Sep-92,Ketamine
42929-0,Lactate dehydrogenase panel
42930-8,Cells.CD11+CD18+
42931-6,Chlamydia trachomatis rRNA
42932-4,Cells.CD40/100 cells
42933-2,Cells.CD79a/100 cells
42934-0,Cells.CD83/100 cells
42935-7,Pyrazinamide 100.0 ug/mL
42936-5,Intercellular substance Ab.IgA
Jul-93,Ketobemidone
42937-3,Acetylcholine receptor blocking Ab/Acetylcholine Ab.total
42938-1,CFTR gene allele 1
42939-9,CFTR gene allele 2
42940-7,GALT gene allele 1
42941-5,GALT gene allele 2
42942-3,Yersinia sp Ab.IgM
42943-1,"Yersinia enterocolitica O:5,27 Ab"
42944-9,Vesicular stomatitis New Jersey virus Ab
May-94,Levodopa.PO
42945-6,Vesicular stomatitis Indiana virus Ab
42946-4,Trypanosoma brucei rhodesiense Ab
42947-2,Trypanosoma brucei Ab
42948-0,Toxoplasma sp Ab.IgM
42949-8,Toxoplasma gondii Ab
42950-6,Toxocara canis Ab
42951-4,Taylorella equigenitalis Ab
Feb-95,Labetalol
42952-2,Snowshoe hare virus Ab
42953-0,Snowshoe hare virus Ab.IgM
42954-8,Sindbis virus Ab
42955-5,Semliki forest virus Ab
42956-3,SARS coronavirus Ab.IgM
42957-1,SARS coronavirus Ab.IgG
42958-9,Salmonella typhimurium Ab
42959-7,Salmonella typhi O Ab
4296-0,Methotrimeprazine
42960-5,Salmonella typhi H Ab
42961-3,Salmonella pullorum Ab
42962-1,Salmonella paratyphi C O Ab
42963-9,Salmonella paratyphi C H Ab
42964-7,Salmonella paratyphi B O Ab
42965-4,Saint Louis encephalitis virus Ab.IgM
42966-2,Saint Louis encephalitis virus Ab.IgM
42967-0,Rubella virus Ab
42968-8,Rickettsia rickettsii Ab.IgG
42969-6,Rickettsia rickettsii Ab.IgM
42970-4,Pseudallescheria boydii Ab.IgG
42971-2,Powassan virus Ab.IgM
42972-0,Powassan virus Ab.IgM
42973-8,Powassan virus Ab.IgG
42974-6,Powassan virus Ab.IgG
42975-3,Powassan virus Ab
42976-1,Porcine reproductive and respiratory syndrome virus Ab
42977-9,Porcine influenza virus A Ab
Aug-97,Levomepromazine
42978-7,Polio virus 2 Ab
42979-5,Polio virus 3 Ab
42980-3,Polio virus Ab
42981-1,Polio virus 1 Ab
42982-9,Parainfluenza virus Ab
42983-7,Parainfluenza virus 4 Ab.IgG
42984-5,Parainfluenza virus 1 Ab^2nd specimen
42985-2,Neisseria meningitidis serogroup C Ab.IgG
Jun-98,Levorphanol
42986-0,Neisseria meningitidis serogroup A Ab.IgG
42987-8,Neisseria gonorrhoeae Ab
42988-6,Mycoplasma synoviae Ab
42989-4,Mycoplasma pneumoniae Ab.IgG
42990-2,Mycoplasma pneumoniae Ab.IgM
42991-0,Mycoplasma pneumoniae Ab.IgM
42992-8,Mycoplasma pneumoniae Ab.IgG
42993-6,Mycoplasma pneumoniae Ab
Apr-99,Lidocaine
42994-4,Leptospira sp Ab
42995-1,Leptospira borgpetersenii serovar Tarrasovi Ab
42996-9,Leptospira borgpetersenii serovar Ballum Ab
42997-7,Leptospira autumnalis Ab
42998-5,Leishmania tropica Ab
42999-3,Leishmania sp Ab
43-0,Aztreonam
4300-0,Lithium
43000-9,Leishmania braziliensis Ab
43001-7,Legionella sp Ab
43002-5,Legionella pneumophila 1 Ab.IgM
43003-3,Jamestown canyon virus Ab.IgM
43004-1,Jamestown canyon virus Ab.IgG
43005-8,Jamestown canyon virus Ab.IgG
43006-6,Jamestown canyon virus Ab
43007-4,HTLV I+II Ab
43008-2,HIV 1+2 Ab.IgM
43009-0,HIV 1+2 Ab.IgG
43010-8,HIV 1+2 Ab
43011-6,HIV 1 p24 Ab
43012-4,HIV 1 gp41 Ab
43013-2,HIV 1 gp120+gp160 Ab
43014-0,Histoplasma sp Ab
43015-7,Histoplasma capsulatum yeast phase Ab
43016-5,Histoplasma capsulatum yeast phase Ab
43017-3,Histoplasma capsulatum mycelial phase Ab
Aug-01,LORazepam
43018-1,Histoplasma capsulatum mycelial phase Ab
43019-9,Histoplasma capsulatum Ab
43020-7,Heterophile Ab
43021-5,Herpes virus 8 Ab.IgG
43022-3,Herpes virus 7 Ab.IgM
43023-1,Herpes virus 7 Ab.IgG
43024-9,Herpes virus 6 Ab.IgG
43025-6,Herpes virus 6 Ab.IgM
Jun-02,Lormetazepam
43026-4,Herpes simplex virus 2 Ab.IgM
43027-2,Herpes simplex virus 2 Ab.IgM
43028-0,Herpes simplex virus 2 Ab
43029-8,Herpes simplex virus 2 Ab
43030-6,Herpes simplex virus 1+2 Ab.IgM
43031-4,Herpes simplex virus 1 Ab
43032-2,Herpes simplex virus 1 Ab
43033-0,Herpes simplex virus 1+2 Ab
Apr-03,Loxapine
43034-8,Feline leukemia virus Ab
43035-5,Feline immunodeficiency virus Ab
43036-3,Feline herpesvirus Ab
43037-1,Fasciola hepatica Ab
43038-9,Enterovirus NOS Ab
43039-7,Ehrlichia sp Ab
43040-5,Echovirus 30 Ab
43041-3,Echovirus 9 Ab
Feb-04,Maprotiline
43042-1,Echovirus 4 Ab
43043-9,Echovirus 11 Ab
43044-7,Eastern equine encephalitis virus Ab.IgM
43045-4,Cytomegalovirus Ab.IgM
43046-2,Coxsackievirus A16 Ab
43047-0,Coxsackievirus A7 Ab
43048-8,Coxsackievirus A9 Ab
43049-6,Coxsackievirus A10 Ab
43050-4,Coxiella burnetii phase 1 Ab
43051-2,Colorado tick fever virus Ab.IgG
43052-0,Coccidioides sp Ab
43053-8,Coccidioides immitis Ab
43054-6,Clostridium tetani toxin Ab
43055-3,Clostridioides difficile toxin Ab
43056-1,Cladosporium sp Ab.IgG
43057-9,Chlamydophila psittaci Ab.IgM
43058-7,Chlamydia trachomatis D+K Ab.IgM
Sep-05,Medazepam
43059-5,Chlamydia trachomatis D+K Ab.IgG
43060-3,Chlamydia trachomatis D+K Ab.IgA
43061-1,Chlamydia trachomatis Ab.IgM
43062-9,Chlamydia trachomatis Ab.IgG
43063-7,Chlamydia sp Ab.IgA
43064-5,Chikungunya virus Ab
43065-2,Canine distemper virus Ab.IgM
43066-0,Canine distemper virus Ab.IgG
Jul-06,Mefenorex
43067-8,Candida sp Ab
43068-6,Campylobacter sp Ab.IgA
43069-4,Burkholderia pseudomallei Ab.IgM
43070-2,Burkholderia pseudomallei Ab.IgG
43071-0,Brucella canis Ab.IgM
43072-8,Brucella canis Ab.IgG
43073-6,Bovine leukemia virus Ab
43074-4,Borrelia burgdorferi C6 Ab
May-07,Meperidine
43075-1,Borrelia burgdorferi C6 Ab
43076-9,Borrelia burgdorferi Ab.IgM
43077-7,Borrelia burgdorferi Ab
43078-5,Bluetongue virus 2 Ab
43079-3,Bluetongue virus 17 Ab
43080-1,Bluetongue virus 13 Ab
43081-9,Bluetongue virus 11 Ab
43082-7,Bluetongue virus 10 Ab
Mar-08,Mephenytoin
43083-5,Blastomyces sp Ab
43084-3,Blastomyces dermatitidis Ab
43085-0,Babesia duncani Ab
43086-8,Babesia divergens Ab
43087-6,Babesia canis Ab
43088-4,Aspergillus sp Ab
43089-2,Aspergillus niger Ab
430-9,rifAMPin
43090-0,Aspergillus flavus Ab
Jan-09,Mephobarbital
43091-8,Ascaris sp Ab
43092-6,Arbovirus NOS Ab
43093-4,Angiostrongylus costaricensis Ab
43094-2,Angiostrongylus cantonensis Ab
43095-9,Anaplasma marginale Ab
43096-7,Eastern equine encephalitis virus Ab.IgM
43097-5,COL3A1 gene targeted mutation analysis
43098-3,Yersinia sp Ab panel
43099-1,Vanillylmandelate & Creatinine panel
43100-7,Sjogrens syndrome-A & B extractable nuclear Ab panel
43101-5,Phosphatidylserine Ab.IgA & IgG & IgM panel
43102-3,Neuronal nuclear type 3 Ab
43103-1,CV2 Ab.IgG
43104-9,Paraneoplastic Ab panel
43105-6,Acetaldehyde & Paraldehyde panel
43106-4,Amitriptyline & Nortriptyline panel
43107-2,Mycoplasma sp & Ureaplasma sp panel
43108-0,Metanephrine & Normetanephrine panel
Sep-10,Meprobamate
43109-8,Leishmania sp Ab.IgG & IgM panel
43110-6,Immunoglobulin light chains panel
43111-4,Herpes simplex virus 1 Ab
43112-2,Herpes simplex virus Ab panel
43113-0,Hemoglobin panel
43114-8,Porphyrin fractions
43115-5,Hexacarboxylporphyrin
43116-3,Porphyrin fractions panel
Jul-11,Mersalyl
43117-1,Fluoxetine & Norfluoxetine panel
43118-9,Fat panel
43119-7,Extractable nuclear Ab panel
43120-5,Echovirus Ab panel
43121-3,Echovirus 6 Ab
43122-1,Doxepin & Nordoxepin panel
43123-9,Imipramine & Desipramine panel
43124-7,Cystine panel
May-12,Mesantoin
43125-4,Nicotine & Metabolites panel
43126-2,Cortisol.free panel
43127-0,clomiPRAMINE & Norclomipramine panel
43128-8,Chloride panel
43129-6,Brucella abortus Ab.IgG & IgM panel
43130-4,Bile acid fractions panel
43131-2,Bacterial Ag panel
43132-0,California encephalitis virus Ab
Mar-13,Mesoridazine
43133-8,Allopurinol & Oxipurinol panel
43134-6,Calcidiol & Calciferol & Calcitriol panel
43135-3,17-Ketosteroids & 17-Ketogenic steroids panel
43136-1,Clinical finding absent
43137-9,Clinical finding present
43138-7,Population size
43139-5,Clinical finding absent
43140-3,Clinical finding present
Jan-14,Mesterolone
43141-1,Synthetic glucocorticoid panel
43142-9,Height measurement device panel
43143-7,Weighing device panel
43144-5,Pedometer device panel
43145-2,Peak flow meter device panel
43146-0,Oxygen saturation device panel
43147-8,Metabolism measurement device panel
43148-6,Insulin delivery device panel
43149-4,Heart rate device panel
43150-2,HbA1c measurement device panel
43151-0,Glucose meter device panel
43152-8,Blood pressure device panel
43153-6,Blood coagulation device panel
43154-4,Spermatozoa^post concentration
43155-1,Spermatozoa.motile/100 spermatozoa^post concentration
43156-9,Lot number
43157-7,Vendor serial number
Aug-15,Metandienone
43158-5,Chlorine.free
43159-3,Formaldehyde
43160-1,Glutaraldehyde
43161-9,Microorganism
43162-7,Monochloramine
43163-5,Quaternary ammonium compound
43164-3,Silica
43165-0,Dissolved solids
Jun-16,Metaraminol
43166-8,Carbon.organic
43169-2,Bromide
431-7,Ristocetin
43170-0,Human papilloma virus 31+33 DNA
43171-8,Interleukin 2 receptor
43172-6,Triiodothyronine Ab
43173-4,Chlamydia trachomatis L2 Ab.IgG
Apr-17,Metenolone
43174-2,Chlamydia trachomatis L2 Ab.IgA
43175-9,Chlamydia trachomatis L2 Ab.IgM
43176-7,Lithium
43177-5,Phenmetrazine
43178-3,Phentermine
43179-1,Asialoganglioside GM1 Ab.IgM
43180-9,Herpes simplex virus 2 Ab.IgG
43181-7,Arsenic.organic
Feb-18,Methadone
43182-5,Smith extractable nuclear Ab
43183-3,Cyanide
43184-1,6-Monoacetylmorphine
43185-8,HIV 1 & 2 Ab band pattern
43186-6,Acylcarnitine/Carnitine.free (C0)
43187-4,Neuronal nuclear type 2 Ab
43188-2,Neuronal nuclear type 2 Ab
43189-0,Saccharomyces cerevisiae Ab.IgA
4319-0,Methamphetamine
43190-8,Myelin associated glycoprotein-sulfated glucuronic paragloboside Ab.IgM
43191-6,FANCC gene targeted mutation analysis
43192-4,Legionella pneumophila 2+3+4+5+6+8 Ab
43193-2,Legionella non pneumophila sp Ab
43194-0,Gamma hydroxybutyrate
43195-7,Nicotine
43196-5,Cotinine
43197-3,Gamma hydroxybutyrate
43198-1,Gamma hydroxybutyrate
43199-9,Norfentanyl
43200-5,Norfentanyl
43201-3,BK virus DNA
43202-1,Liver kidney microsomal 1 Ab.IgG
43203-9,Parainfluenza virus 1 Ab
43204-7,Parainfluenza virus 2 Ab
43205-4,Parainfluenza virus 3 Ab
43206-2,Tetrachloroethylene
43207-0,Invasive trophoblast Ag
Aug-20,Methapyrilene
43208-8,Invasive trophoblast Ag
43209-6,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA
43210-4,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68+70 DNA
43211-2,Human papilloma virus 6+11+42+43+44 DNA
43212-0,Albumin
43213-8,Polychlorinated biphenyl
43214-6,Bacteria identified
43215-3,Cortisol^baseline
Jun-21,Methaqualone
43216-1,Chlamydophila pneumoniae+Chlamydophila psittaci DNA
43217-9,Cortisol^15M post dose corticotropin IM
43218-7,Nicotine+Cotinine
43219-5,traMADol
43220-3,Erythrocytes.nucleated
43221-1,Chloride/Creatinine
43222-9,Potassium/Creatinine
43223-7,Sodium/Creatinine
Apr-22,Methicillin
43224-5,Coccidioides sp Ab
43225-2,Toxocara sp Ab
43226-0,2-Hydroxyisocaproate
43227-8,Ova & parasites identified
43228-6,Cryptococcus sp Ag
43229-4,Cryptococcus sp Ag
43230-2,Benzoylecgonine
43231-0,Histone Ab
Feb-23,Methocarbamol
43232-8,Saint Louis encephalitis virus Ab.IgG
43233-6,OTC gene targeted mutation analysis
43234-4,Liver kidney microsomal 1 Ab.IgG
43235-1,Acrylylcarnitine (C3:1)
43236-9,Streptococcus pneumoniae Ab.IgG
43237-7,Thrombopoietin
43238-5,Treponema pallidum Ab
43239-3,Norsildenafil
4324-0,Methotrexate
43240-1,Ganglioside GM1 Ab.IgG
43241-9,Ganglioside GM1 Ab.IgM
43242-7,ACADM gene targeted mutation analysis
43243-5,Isobutyrylcarnitine (C4)
43244-3,Herpes virus 6 DNA
43245-0,Erythrocytes
43246-8,PHOX2B gene targeted mutation analysis
43247-6,Catecholamines/Creatinine
43248-4,EPINEPHrine/Creatinine
43249-2,X ray dye crystals
432-5,Ristocetin
43250-0,Xanthine derivatives
43251-8,Volume^at 1.0 s post forced inspiration
43252-6,Volume.residual/Capacity.total
43253-4,Volume expired during 1.0 s of forced expiration^pre dose methacholine
43254-2,Volume expired during 1.0 s of forced expiration^pre exercise
43255-9,Volume expired during 1.0 s of forced expiration^post dose methacholine
43256-7,Volume expired during 1.0 s of forced expiration^post 25 mg/mL methacholine
Jul-25,Methoxyphenamine
43257-5,Volume expired during 1.0 s of forced expiration^post 2.5 mg/mL methacholine
43258-3,Volume expired during 1.0 s of forced expiration^post 10 mg/mL methacholine
43259-1,Volume expired during 1.0 s of forced expiration^post 0.25 mg/mL methacholine
43260-9,Volume expired during 1.0 s of forced expiration^post 0.025 mg/mL methacholine
43261-7,Volume expired during 1.0 s of forced expiration^5M post exercise
43262-5,Volume expired during 1.0 s of forced expiration^15M post exercise
43263-3,Volume expired during 1.0 s of forced expiration^10M post exercise
43264-1,Volume^at 1.0 s post forced inspiration/Volume.forced inspiration.total
May-26,Methsuximide
43265-8,Benztropine
43266-6,Leishmania chagasi K39 Ab
43267-4,Uranium.depleted cutoff
43268-2,Cells.CD3-CD57+/100 cells
43269-0,Ceftobiprole
43270-8,Ceftobiprole
43271-6,Ceftobiprole
43272-4,Ceftobiprole
Mar-27,Methyldopa
43273-2,Cells.CD19+CD27+IgD+/100 cells
43274-0,Cells.CD1c+CD22+/100 cells
43275-7,Cells.CD3/Cells.CD4
43276-5,Dermatophagoides sp Ab.IgE.RAST class
43277-3,GDAP1 gene targeted mutation analysis
43278-1,Glucose^2H post meal
43279-9,Hepatitis B virus YMDD mutation
43280-7,Hepatitis D virus Ag
Jan-28,MethylePHEDrine
43281-5,Hepatitis D virus Ag
43282-3,Heterophile Ab
43283-1,Myeloid cells/100 cells
43284-9,Spermatozoa IgA binding location
43285-6,Spermatozoa Ab.IgM/100 spermatozoa
43286-4,Spermatozoa Ab.IgG/100 spermatozoa
43287-2,Spermatozoa IgG binding location
43288-0,Spermatozoa Ab.IgA/100 spermatozoa
43289-8,Methylcrotonylcarnitine (C5:1)
43290-6,HLA-DRB1
43291-4,HLA-DQB1
43292-2,Neutrophil oxidative burst stimulated/unstimulated
43293-0,HTLV I+II p28 Ab
43294-8,HTLV I+II p26 Ab
43295-5,HTLV I+II p53 Ab
43296-3,HTLV I+II gp46 Ab
43297-1,HTLV I+II p32 Ab
43298-9,HTLV I+II rgp21 Ab
Sep-29,Methylphenidate
43299-7,HTLV I+II p19 Ab
43300-3,HTLV I+II p24 Ab
43301-1,HTLV I+II p36 Ab
43302-9,Platelet glycoprotein Ab
43303-7,Immune complex.C3d
43304-5,Chlamydia trachomatis rRNA
43305-2,Neisseria gonorrhoeae rRNA
43306-0,Chromosome 21 trisomy
Jul-30,Methyprylon
43307-8,Bacteria identified
43308-6,Lupus anticoagulant neutralization.buffer
43309-4,Desmoglein 1 & Desmoglein 3 Ab panel
43310-2,FBN2 gene targeted mutation analysis
43311-0,Desmoglein 1 Ab
43312-8,Desmoglein 3 Ab
43313-6,Avian adenovirus 127 Ab
43314-4,Avian paramyxovirus 6 Ab
May-31,Metoprolol
43315-1,Avian paramyxovirus 7 Ab
43316-9,Avian paramyxovirus 8 Ab
43317-7,Avian paramyxovirus 9 Ab
43318-5,Avian metapneumovirus A Ab
43319-3,Avian metapneumovirus A Ab
43320-1,Avian metapneumovirus B Ab
43321-9,Avian metapneumovirus B Ab
43322-7,Avian metapneumovirus C Ab
Mar-32,Mexiletine
43323-5,Avian metapneumovirus C Ab
43324-3,Avian reovirus Ab
43325-0,Chicken anemia virus Ab
43326-8,Classical swine fever virus Ab.Neut
43327-6,Classical swine fever virus Ag
43328-4,Duck enteritis virus Ab
43329-2,Eastern equine encephalitis virus Ab
433-3,Ristocetin
43330-0,Eastern equine encephalitis virus Ab.IgM
Jan-33,Mezlocillin
43331-8,Ehrlichia risticii Ab
43332-6,Equine herpesvirus 1 Ab.Neut
43333-4,Equine herpesvirus 2 Ab.Neut
43334-2,Equine herpesvirus 3 Ab.Neut
43335-9,Fowl adenovirus 1 Ab
43336-7,Goose parvovirus Ab
43337-5,Goose parvovirus RNA
43338-3,Infectious bronchitis virus JMK Ab
43339-1,Porcine adenovirus Ab
43340-9,Psittacid herpesvirus 1 Ab
43341-7,Venezuelan equine encephalitis virus Ab
43342-5,West Nile virus Ab.IgM
43343-3,West Nile virus Ab.IgM
43344-1,Avian adenovirus 127 Ab
43345-8,Avian paramyxovirus 6 Ab
43346-6,Avian paramyxovirus 7 Ab
43347-4,Avian paramyxovirus 8 Ab
43348-2,Avian paramyxovirus 9 Ab
Sep-34,Midazolam
43349-0,Avian metapneumovirus A Ab
43350-8,Avian metapneumovirus A Ab
43351-6,Avian metapneumovirus B Ab
43352-4,Avian metapneumovirus B Ab
43353-2,Avian metapneumovirus C Ab
43354-0,Avian metapneumovirus C Ab
43355-7,Chlamydia trachomatis D+E+F+G+H+I+J+K Ab.IgG
Jun-35,Minocycline
43356-5,Chlamydia trachomatis D+E+F+G+H+I+J+K Ab.IgA
43357-3,Chlamydia trachomatis D+E+F+G+H+I+J+K Ab.IgM
43358-1,UNC13D gene targeted mutation analysis
43359-9,11-Ketoetiocholanolone
43360-7,Bordetella sp Ag
43361-5,Cardiolipin Ab.IgA
43362-3,Cardiolipin Ab.IgG
43363-1,Cardiolipin Ab.IgM
Apr-36,Morazone
43364-9,Enterovirus identified
43365-6,Nocardia sp identified
43366-4,Parainfluenza virus Ag
43367-2,Trichomonas sp
43368-0,Microsatellite instability
43369-8,PlA1 Ab
43370-6,CFTR gene.p.IVS8 polyT
43371-4,Salmonella & Shigella sp identified
Feb-37,Morphine
43372-2,Figure associated with report or note
43373-0,Rat epithelium+Serum proteins+Urine proteins Ab.IgE.RAST class
43374-8,Parietaria officinalis Ab.IgE.RAST class
43375-5,Phoenix dactylifera Ab.IgE.RAST class
43376-3,Spermatozoa.progressive^post washing
43377-1,Spermatozoa.progressive^pre washing
43378-9,Spermatozoa.motile^post washing
43379-7,HLA-DRB3
4338-0,Moxalactam
43380-5,Coccidioides immitis Ab.IgG
43381-3,Bordetella pertussis Ab
43382-1,Alkaline phosphatase.heat stable/Alkaline phosphatase.total
43383-9,Neisseria sp identified
43384-7,Neisseria sp identified
43385-4,Neisseria sp identified
43386-2,Neisseria sp identified
43387-0,Neisseria sp identified
43389-6,Streptococcus sp identified
43390-4,Streptococcus sp identified
43391-2,Bacterial vaginosis score
43392-0,LDL 1
43393-8,LDL 4
43394-6,Cholesterol.in LDL.acetylated
43395-3,Cholesterol.in VLDL.acetylated
43396-1,Cholesterol.non HDL
43397-9,Coagulation dilute Russell viper venom induced.factor substitution^immediately after addition of normal plasma
Aug-39,N-acetylprocainamide
43398-7,Gardnerella vaginalis+Prevotella sp morphotypes
43399-5,JAK2 gene.p.Val617Phe
43400-1,Lactobacillus sp morphotypes
43401-9,Cryofibrinogen
43402-7,Erythrocyte sedimentation rate
43403-5,Neisseria gonorrhoeae DNA
43404-3,Chlamydia trachomatis DNA
43405-0,Chlamydia trachomatis & Neisseria gonorrhoeae DNA
Jun-40,N-ethylnicotinamide
43406-8,Chlamydia trachomatis+Neisseria gonorrhoeae DNA
43407-6,Bacteria identified
43408-4,Bacteria identified
43409-2,Bacteria identified
434-1,Ristocetin
43410-0,Bacteria identified
43411-8,Bacteria identified
43412-6,Blood product units issued
43413-4,Blood product units requested
Apr-41,Nadolol
43414-2,Blood product units available
43415-9,Unidentified cells/100 cells
43416-7,Hematocrit
43417-5,Microscopic observation
43418-3,Stem cell product given
43419-1,Tuberculosis reaction wheal^3D post 1 TU ID
43420-9,Uranium dose assessment
43421-7,Thiopurine methyltransferase
Feb-42,Nalbuphine
43422-5,Rabbit dander Ab.IgE
43423-3,Sodium urate
43424-1,Bartonella sp Ab.IgM
43425-8,Bartonella sp Ab.IgG
43426-6,Bacteria identified
43427-4,Microscopic observation
43428-2,Bilirubin.microscopic observation
43429-0,Haemophilus influenzae B Ag
4343-0,Nalorphine
43430-8,Neisseria meningitidis serogroup B Ag
43431-6,Escherichia coli K1 Ag
43432-4,Escherichia coli K1 Ag
43433-2,Acylcarnitine panel
43434-0,Bacterial Ag panel
43435-7,Bartonella henselae & Bartonella quintana Ab.IgM panel
43436-5,Bartonella henselae & Bartonella quintana Ab.IgG panel
43437-3,Bartonella henselae & Bartonella quintana Ab.IgG & IgM panel
43438-1,Bartonella henselae & Bartonella quintana Ab.IgG & IgM panel
43439-9,Bartonella henselae & Bartonella quintana Ab.IgG panel
43440-7,Bartonella henselae & Bartonella quintana Ab.IgM panel
43441-5,Bacteria identified
43442-3,Bacteria identified
43443-1,Bacterial Ag panel
43444-9,Guidance for percutaneous drainage of abscess+placement of drainage catheter
43445-6,Multisection
43446-4,Multisection for tumor whole body
43447-2,Guidance for biopsy.needle
Aug-44,Nandrolone
43448-0,Multisection^WO & W ferumoxides IV
43449-8,Multisection dynamic^W contrast IV
43450-6,Multisection dynamic^W contrast IV
43451-4,Multisection dynamic^W contrast IV
43452-2,Multisection dynamic^W contrast IV
43453-0,Multisection dynamic^W contrast IV
43454-8,Multisection
May-45,Naproxen
43455-5,Multisection
43456-3,Multisection^WO & W contrast IV
43457-1,Multisection
43458-9,Multisection^WO & W contrast IV
43459-7,Views^during electroconvulsive shock treatment
43460-5,Views^during electroconvulsive shock treatment
43461-3,Views^W furosemide IV+W radionuclide IV
43462-1,Guidance for biopsy.needle
Mar-46,Neopterin
43463-9,View PA && Views supine + upright
43464-7,Views lateral & PA chest
43465-4,View AP L-lateral-decubitus
43466-2,View AP R-lateral-decubitus
43467-0,Views 2 + R-Oblique + L-Oblique
43468-8,Views
43469-6,Views of foreign body
43470-4,Views LE 3
Jan-47,Netilmicin
43471-2,View
43472-0,View
43473-8,Guidance for endoscopy^2H post contrast retrograde intrabiliary
43474-6,Guidance for endoscopy^15M post contrast retrograde intrabiliary
43475-3,Guidance for endoscopy^30M post contrast retrograde intrabiliary
43476-1,Guidance for endoscopy^45M post contrast retrograde intrabiliary
43477-9,Guidance for endoscopy^1H post contrast retrograde intrabiliary
43478-7,Guidance for endoscopy^1.5H post contrast retrograde intrabiliary
43479-5,Views runoff^W contrast IA
43480-3,Views lateral^W manual stress
43481-1,Views^W flexion + W extension
43482-9,Views GE 3
43483-7,Views 3 or 4
43484-5,Guidance for localization of bleeding site^W radionuclide IV
43485-2,Views^during surgery W contrast retrograde
43486-0,Views GE 3
43487-8,Guidance for placement of radiation therapy fields
43488-6,Views GE 3
Sep-48,Nicomorphine
43489-4,Views GE 3
43490-2,Views GE 3
43491-0,Views GE 3
43492-8,Views GE 3
43493-6,Views GE 3
43494-4,Views GE 3
43495-1,Views GE 3
43496-9,Views GE 3
Jul-49,Nicotinamide
43497-7,Views GE 3
43498-5,Views GE 3
43499-3,Views 3 or 4
43500-8,Views for blood flow^W radionuclide IV
43501-6,Views^W radionuclide IV
43502-4,Guidance for drainage of abscess+placement of drainage catheter
43503-2,Multisection^W contrast IV
43504-0,Multisection^W contrast IV
May-50,Nicotine
43505-7,Multisection^W contrast IV
43506-5,Multisection
43507-3,Multisection
43508-1,Multisection
43509-9,Multisection^WO & W contrast IV
43510-7,Multisection
43511-5,Multisection^WO & W contrast IV
43512-3,Multisection^W contrast IV
Mar-51,Nikethamide
43513-1,Multisection
43514-9,Multisection^WO contrast
43515-6,Multisection^WO contrast
43516-4,Multisection^WO contrast
43517-2,Multisection^WO contrast
43518-0,Views survey
43519-8,Views survey limited
43520-6,Views AP (R-lateral-decubitus & L-lateral-decubitus)
Jan-52,Nitrazepam
43521-4,Views 1 or 2
43522-2,Views 1 or 2
43523-0,Views 1 or 2
43524-8,Views GE 5
43525-5,Multisection^WO contrast
43526-3,Multisection^W radionuclide IV
43527-1,Multisection dynamic^W contrast IV
43528-9,Multisection^WO & W contrast IV
43529-7,Views
43530-5,Multisection
43531-3,Guidance for localization of bleeding site
43532-1,View PA && View upright
43533-9,Views
43534-7,Views 4
43535-4,Views 4
43536-2,Views
43537-0,Guidance for drainage+placement of drainage catheter
43538-8,Views
Sep-53,Nitrofurantoin
43539-6,Views 2 or 3
43540-4,Views GE 3
43541-2,Views GE 3
43542-0,Views GE 3
43543-8,Views GE 3
43544-6,Views GE 3
43545-3,Views GE 3
43546-1,Views GE 3
Jul-54,Nordiazepam
43547-9,Views GE 3
43548-7,Views GE 3
43549-5,Views perfusion^W stress
43550-3,Views for blood flow+function^W radionuclide IV
43551-1,Guidance for abscess drainage
43552-9,Multisection
43553-7,Study observation.general
Apr-55,Nordoxepin
43554-5,Views^W contrast IV
43555-2,Multisection dynamic^W contrast IV
43556-0,Multisection
43557-8,Views^W radionuclide IV
43558-6,Guidance for change of dialysis catheter^W contrast IV
43559-4,Views^W contrast intra bladder+during voiding
43560-2,Views^W gastrografin PO & W barium contrast PR
43561-0,View AP && View upright
Feb-56,Norepinephrine
43562-8,Views for bone density
43563-6,Views for bone density
43564-4,Guidance for superficial biopsy
43565-1,Guidance for deep biopsy
43566-9,Multisection
43567-7,Guidance for deep biopsy
43568-5,Guidance for deep biopsy.needle
43569-3,Views AP for scoliosis^upright & supine
4357-0,Norethandrolone
43570-1,Views
43571-9,Guidance for biopsy.needle
43572-7,Multisection limited
43573-5,Borrelia burgdorferi Ab.IgM
43574-3,Views^W barium contrast PO
43575-0,Complement C3
43576-8,Acylcarnitine/Carnitine.free (C0)
43577-6,Histamine/Creatinine
43578-4,Complement C3
43579-2,Complement C3
435-8,Rolitetracycline
43580-0,Complement C4
43581-8,Complement C4
43582-6,Complement C4
43583-4,Lipoprotein (little a)
43584-2,Bizarre cells
43585-9,TYMP gene targeted mutation analysis
43586-7,Yersinia pseudotuberculosis Ab
43587-5,Vitis vinifera Ab.IgE/IgE.total
Aug-58,Norfenefrine
43588-3,Varicella zoster virus Ab.IgM
43589-1,Shigella sp Ab
43590-9,Rabies virus Ab
43591-7,Prunus persica Ab.IgE/IgE.total
43592-5,Prunus domestica Ab.IgE/IgE.total
43593-3,Plasmodium malariae Ab.IgG
43594-1,Nidus
43595-8,Methadone
Jun-59,Norfloxacin
43596-6,Malus sylvestris Ab.IgE/IgE.total
43597-4,Inner Ear 68kD Ab
43598-2,Indicans
43599-0,HIV 1 Ab
43600-6,Ganglioside GD1b Ab.IgM
43601-4,Ganglioside GD1b Ab.IgG
43602-2,Echinococcus granulosus Ab
43603-0,Androstenedione^1st specimen post XXX challenge
Apr-60,Normetanephrine
43604-8,Aldosterone^1st specimen post XXX challenge
43605-5,Albumin
43606-3,Albumin
43607-1,Albumin
43608-9,Adrenal cortex Ab
43609-7,Adipate
43610-5,Adenovirus Ag
43611-3,Adenovirus Ag
Feb-61,Nortriptyline
43612-1,Adenovirus Ag
43613-9,Adenovirus Ag
43614-7,Adenovirus Ag
43615-4,Adenovirus Ag
43616-2,Adenovirus Ab
43617-0,Adenovirus Ab
43618-8,Adenovirus Ab
43619-6,Actinomyces sp Ab
4362-0,Ofloxacin
43620-4,Actinomyces israelii Ab
43621-2,Actinomyces bovis Ab
43622-0,Aconitate
43623-8,Acetylcholine receptor blocking Ab
43624-6,Acetylcholine receptor binding Ab
43625-3,Acetylcholine receptor Ab
43626-1,acetoHEXAMIDE
43627-9,acetaZOLAMIDE
43628-7,Acetaminophen crystals
43629-5,8-Hydroxyamoxapine
43630-3,6-Thioguanine
43631-1,6-Methylmercaptopurine metabolite
43632-9,6-Methylmercaptopurine
43633-7,5-Oxoproline
43634-5,3-Methoxy-4-Hydroxyphenylglycol
43635-2,2-Hydroxyglutarate
43636-0,Plasminogen activator tissue type
43637-8,Parrot droppings Ab.IgG
Aug-63,Orphenadrine
43638-6,Aquaporin 4 water channel Ab.IgG
43639-4,Mercaptopurine
43640-2,Aldosterone-18-glucuronide
43641-0,Views
43642-8,Views for blood flow^W Tc-99m DTPA IV
43643-6,Views for blood flow^W Tc-99m glucoheptonate IV
43644-4,Views limited for blood flow^W radionuclide IV
43645-1,Views qualitative for infarct^W radionuclide IV
Jun-64,Ouabain
43646-9,Views qualitative+quantitative for infarct^W radionuclide IV
43647-7,Views quantitative for infarct^W radionuclide IV
43648-5,Views for endocrine tumor multiple areas^W I-131 MIBG IV
43649-3,Views for endocrine tumor multiple areas^W In-111 pentetreotide IV
43650-1,Views^W cholecystokinin+W radionuclide IV
43651-9,Views^W sincalide+W radionuclide IV
43652-7,Multisection for blood flow^W radionuclide IV
Mar-65,Oxacillin
43653-5,Views for blood flow^W radionuclide IV
43654-3,Views for blood flow^W Tc-99m tagged RBC IV
43655-0,Multisection for blood flow^W radionuclide IV
43656-8,Views perfusion quantitative^W radionuclide IV
43657-6,Views quantitative^W radionuclide IV
43658-4,Views perfusion quantitative^W radionuclide IV
43659-2,Multisection perfusion qualitative^at rest+W radionuclide IV
436-6,Rolitetracycline
43660-0,Views perfusion qualitative^at rest+W radionuclide IV
Jan-66,Oxandrolone
43661-8,Views perfusion quantitative^at rest+W radionuclide IV
43662-6,Multisection for blood flow^W Tc-99m glucoheptonate IV
43663-4,Views for blood flow^W Tc-99m glucoheptonate IV
43664-2,Views for blood flow^W Tc-99m DTPA IV
43665-9,Views for blood flow^W Tc-99m Mertiatide IV
43666-7,Views for blood flow^W Tc-99m glucoheptonate IV
43667-5,Views^W Tc-99m DTPA IV
43668-3,Views^W Tc-99m Mertiatide IV
43669-1,Views^W radionuclide IV
43670-9,Multisection for blood flow^W radionuclide IV
43671-7,View spot^W radionuclide IV
43672-5,Views+views uptake^W radionuclide IV
43673-3,Multisection for blood flow^W radionuclide IV
43674-1,Fatty acid panel.comprehensive C8-C26
43675-8,Fatty acid panel.mitochondrial C8-C18
43676-6,Fatty acid panel.essential C12-C22
43677-4,Fatty acid panel.very long chain C22-C26
43678-2,Dosage forms and strengths section
Sep-67,Oxazepam
43679-0,Mechanism of action section
43680-8,Nonclinical toxicology section
43681-6,Pharmacodynamics section
43682-4,Pharmacokinetics section
43683-2,Recent major changes section
43684-0,Use in specific populations section
43685-7,Warnings and precautions section
43686-5,Salivary gland Ab.IgA
Jul-68,Oxedrine
43687-3,Powassan virus polyvalent E Ab
43688-1,16-Alpha hydroxypregnenolone/Creatinine
43689-9,HLA-DQ2 & HLA-DQ8
43690-7,Triamterene/Total
43691-5,Cladosporium sp Ab.IgE
43692-3,Fusarium sp Ab.IgE.RAST class
43693-1,Varicella zoster virus identified
43694-9,Inner Ear 68kD Ab
May-69,Oxprenolol
43695-6,Herpes virus identified
43696-4,Herpes simplex virus identified
43697-2,Herpes simplex virus identified
43698-0,Enterovirus identified
43699-8,Enterovirus identified
43700-4,Cytomegalovirus
43701-2,Cytomegalovirus
43702-0,Cytomegalovirus
Mar-70,oxyCODONE
43703-8,Cytomegalovirus
43704-6,Cytomegalovirus
43705-3,Cytomegalovirus
43706-1,Cytomegalovirus
43707-9,Cytomegalovirus
43708-7,Alkaline phosphatase.liver+bone
43709-5,Alkaline phosphatase.intestinal+renal
43710-3,Alkaline phosphatase.heat stable
Jan-71,Oxymesterone
43711-1,Albumin
43712-9,Albumin
43713-7,Albumin
43714-5,Adenovirus Ab
43715-2,Acylcarnitine
43716-0,Acylcarnitine
43717-8,Acylcarnitine
43718-6,Acid phosphatase.prostatic
43719-4,Acetaminophen+oxyCODONE
43720-2,Acetaminophen+Codeine
43721-0,Acetaldehyde+Paraldehyde
43722-8,5-Ethyl-5-Phenylhydantoin
43723-6,"5,10-Methylenetetrahydrofolate reductase"
43724-4,"2,5-Dichlorophenol"
43725-1,"2,4-Dichlorophenol"
43726-9,17-Ketogenic steroids
43727-7,Lipoprotein.beta.subparticle.small
43728-5,Lipoprotein.pre-beta.subparticle.large
Sep-72,Oxymetholone
43729-3,Lipoprotein.alpha.subparticle.large
43730-1,Epstein Barr virus DNA
43731-9,Alkaline phosphatase.fetal+lung+lymphocyte
43732-7,4-Hydroxybenzoate
43733-5,4-Hydroxybenzoate
43734-3,Coagulation surface induced
43735-0,Coagulation surface induced.factor substitution^immediately after addition of normal plasma
43736-8,Fosamprenavir
Jul-73,Oxyphenbutazone
43737-6,Tipranavir
43738-4,Coagulation dilute Russell viper venom induced.factor substitution^immediately after addition of normal plasma
43739-2,Blood group Ag
437-4,Rolitetracycline
43740-0,Glucose/Insulin
43741-8,Temperature
43742-6,Time next dose
43743-4,Lymphocytes.variant
43744-2,COX10 gene targeted mutation analysis
May-74,Para methylhippurate
43745-9,DYS gene mutations tested for
43746-7,KCNQ1 gene targeted mutation analysis
43747-5,OCA2 gene targeted mutation analysis
43748-3,SCO1 gene targeted mutation analysis
43749-1,SCO2 gene targeted mutation analysis
43750-9,SURF1 gene targeted mutation analysis
43751-7,Moxifloxacin
Feb-75,Para hydroxyamphetamine
43752-5,Aquaporin 4 water channel Ab.IgG
43753-3,Spermatozoa IgM binding location
43754-1,Sulfate
43755-8,Casts
43756-6,Guidance for percutaneous aspiration of fluid
43757-4,Guidance for percutaneous aspiration.fine needle
43758-2,Guidance for localization
43759-0,Guidance for localization
4376-0,Paraldehyde
43760-8,Guidance for localization
43761-6,Guidance for thrombectomy^W contrast IV
43762-4,Guidance for thrombectomy^W contrast IV
43763-2,Guidance for thrombectomy^W contrast IV
43764-0,Guidance for thrombectomy^W contrast IV
43765-7,Multisection
43766-5,Multisection^W contrast IV
43767-3,Multisection
43768-1,Multisection^WO & W contrast IV
43769-9,Multisection^WO & W contrast IV
43770-7,Multisection^WO contrast
43771-5,Multisection
43772-3,Multisection
43773-1,Multisection^WO contrast
43774-9,Multisection
43775-6,Multisection^WO & W contrast IV
43776-4,Multisection limited
43777-2,Views perfusion^at rest+W adenosine+W Tl-201 IV
Aug-77,Pefloxacin
43778-0,View AP supine
43779-8,View Sunrise
43780-6,View Sunrise
43781-4,Views
43782-2,Views^W contrast IA
43783-0,Views for renin sampling^W contrast IV
43784-8,Views 2
43785-5,Views AP + lateral
Jun-78,Pemoline
43786-3,Views AP (supine KUB & upright) & PA upright chest
43787-1,Views for dental measurement
43788-9,Views for patency^W contrast via tube
43789-7,Views for patency^W Tc-99m IV
43790-5,Views Grashey + Y
43791-3,Views oblique
43792-1,Guidance for angioplasty^W contrast IA
43793-9,Guidance for angioplasty^W contrast IA
Apr-79,Penicillin G benzathine
43794-7,Guidance for angioplasty^W contrast IA
43795-4,Guidance for angioplasty^W contrast IA
43796-2,Views Carpal tunnel
43797-0,Guidance for superficial biopsy
43798-8,Alpha-1-Fetoprotein
43799-6,Choriogonadotropin.beta subunit
43800-2,Choriogonadotropin.beta subunit
43801-0,Choriogonadotropin.intact
Feb-80,Penicillin G potassium
43802-8,Estriol
43803-6,Estriol^^adjusted
43804-4,Amino acid pattern
43805-1,Urease^1H post incubation
43806-9,Urease^20M post incubation
43807-7,Urease^4H post incubation
43808-5,Urease^30M post incubation
43809-3,Arsenic
4381-0,Penicillin G procaine
43810-1,Rubella virus Ab
43811-9,Propoxyphene
43812-7,Influenza virus A Ab
43813-5,Reagin Ab
43814-3,Basement membrane Ab.IgG
43815-0,Arsenic
43816-8,Amylase
43817-6,Androstenedione
43818-4,Beta-2-Microglobulin
43819-2,Beta-2-Microglobulin
438-2,Rolitetracycline
43820-0,Bilirubin.glucuronidated+Bilirubin.albumin bound
43821-8,Amylase
43822-6,Aspartate aminotransferase
43823-4,Aspergillus glaucus Ab
43824-2,Bilirubin
43825-9,Arsenic
43826-7,Androstanolone
43827-5,Barbiturates
Aug-82,Penicillin V potassium
43828-3,Benzodiazepines
43829-1,Caffeine
43830-9,Nicotine
43831-7,Phenytoin
43832-5,quiNIDine
43833-3,quiNINE
43834-1,Tetrahydrocannabinol
43835-8,Apolipoprotein E
Jun-83,Pentazocine
43836-6,Beta globulin
43837-4,Influenza virus A Ab.IgG
43838-2,Influenza virus A Ab.IgM
43839-0,Influenza virus B Ab.IgG
43840-8,Influenza virus B Ab.IgM
43841-6,Betula populifolia Ab.IgE.RAST class
43842-4,Borrelia burgdorferi Ab
43843-2,Brucella abortus Ab.IgG
Apr-84,Pentetrazol
43844-0,Chlamydophila pneumoniae Ab.IgM
43845-7,Chlamydophila pneumoniae Ab
43846-5,Chlamydophila sp Ab
43847-3,Chlamydophila sp Ab
43848-1,Chlamydia trachomatis Ab.IgG
43849-9,Coccidioides sp Ab.IgG
43850-7,Coccidioides sp Ab.IgM
Jan-85,PENTobarbital
43851-5,Influenza virus A Ab.IgA
43852-3,Influenza virus B Ab.IgA
43853-1,Legionella pneumophila 1+3+4+5+6+8 Ab.IgM
43854-9,Mycobacterium sp rRNA
43855-6,Urease^2H post incubation
43856-4,Cells.CD3+CD25+/100 cells
43857-2,Benztropine
43858-0,Beta-2 transferrin
43859-8,Bolasterone
43860-6,Amphetamine+Methamphetamine
43861-4,Asialoganglioside GM1 Ab
43862-2,Aspergillus sp Ab.IgE.RAST class
43863-0,Benzthiazide
43864-8,Blastomyces dermatitidis Ab.IgG
43865-5,Blastomyces dermatitidis Ab.IgG
43866-3,Bartonella sp Ab
43867-1,Beta-2 transferrin
43868-9,Chlamydophila psittaci Ab.IgG
Sep-86,Perphenazine
43869-7,Antithrombin Ag
43870-5,Aspergillus sp Ab
43871-3,Aspergillus sp Ab.IgA
43872-1,Aspergillus sp Ab.IgG
43873-9,Aspergillus sp Ab.IgM
43874-7,Influenza virus A Ag
43875-4,Basement membrane Ab.IgM
43876-2,Antimony
Jul-87,Phenacetin
43877-0,Bile acid
43878-8,Bismuth
43879-6,Bordetella parapertussis
43880-4,Bordetella pertussis.filamentous hemagglutinin Ab.IgA
43881-2,Bordetella pertussis.filamentous hemagglutinin Ab.IgG
43882-0,Bordetella pertussis.filamentous hemagglutinin Ab.IgM
43883-8,Ampicillin
43884-6,Ampicillin
May-88,Phenazocine
43885-3,Beryllium
43886-1,Bismuth
43887-9,Bilirubin
43888-7,Bile acid
43889-5,Bile acid
43890-3,Bordetella pertussis
43891-1,Bordetella pertussis Ag
43892-9,Borate
Mar-89,Phencyclidine
43893-7,Babesia microti Ab.IgG
43894-5,Bismuth
43895-2,Influenza virus B Ag
43896-0,Bordetella pertussis
43897-8,Baclofen
43898-6,Beta hydroxybutyrate
43899-4,Beta lipotropin
439-0,Rosoxacin
43900-0,Blastomyces dermatitidis Ab
Jan-90,Phendimetrazine
43901-8,Barium
43902-6,Azinphos-methyl
43903-4,Azinphos-methyl
43904-2,Azinphos-methyl
43905-9,Arbovirus Ab.IgG
43906-7,Anserine
43907-5,Argininosuccinate
43908-3,Avian encephalomyelitis virus Ab
43909-1,Bordetella pertussis Ag
43910-9,Ascaris sp Ab.IgM
43911-7,Aspergillus versicolor Ab
43912-5,Bisacodyl
43913-3,Bordetella pertussis DNA
43914-1,Beta 2 glycoprotein 1 Ab.IgG
43915-8,Beta 2 glycoprotein 1 Ab.IgA
43916-6,Beta 2 glycoprotein 1 Ab.IgM
43917-4,Benzene
43918-2,Babesia microti Ab
Sep-91,Pheniramine
43919-0,Beta-2-Microglobulin
43920-8,Bartonella sp Ab.IgG
43921-6,Bartonella sp Ab.IgM
43922-4,Beta endorphin
43923-2,Beta hydroxybutyrate
43924-0,azaTHIOprine
43925-7,Bordetella parapertussis
43926-5,Babesia sp Ab
Jul-92,Phenmetrazine
43927-3,Arginine
43928-1,Coxiella burnetii phase 2 Ab.IgM
43929-9,Anthraquinone
43930-7,Yersinia enterocolitica Ab
43931-5,California encephalitis virus Ab
43932-3,Rheumatoid factor
43933-1,Cathine
43934-9,Amphetamines
May-93,PHENobarbital
43935-6,Cells.CD55/100 cells
43936-4,Cells.CD55/100 cells
43937-2,Cells.CD59/100 cells
43938-0,Cells.CD59/100 cells
43939-8,Alkaline phosphatase.liver
43940-6,Immunoglobulin light chains.kappa.free
43941-4,Agrostis stolonifera Ab.IgE/IgE.total
43942-2,Insulin.free
Mar-94,Phenothiazines
43943-0,Cat epithelium Ab.IgE
43944-8,Cells.CD4+CD45+/100 cells
43945-5,Cells.CD4+CD45RO+/100 cells
43946-3,Cells.CD4+CD45RO+/100 cells
43947-1,Cells.CD4+CD45+/100 cells
43948-9,Cells.CD4+CD45RO+/100 cells
43949-7,Cells.CD2
4395-0,Phensuximide
43950-5,Cells.CD2
43951-3,Cells.CD2
43952-1,Cells.CD4+CD45RO+
43953-9,Cells.CD4+CD45RO+
43954-7,Cells.CD4+CD45RO+
43955-4,Cells.CD4+CD45RO+
43956-2,Cells.CD4+CD45RO+
43957-0,Cells.CD3+HLA-DR+
43958-8,Cells.CD3+HLA-DR+
43959-6,Cells.CD3+HLA-DR+
43960-4,Cells.CD3+HLA-DR+
43961-2,Cells.CD3+HLA-DR+
43962-0,Cells.CD4+CD45RA+/100 cells
43963-8,Cells.CD4+CD45RA+/100 cells
43964-6,Cells.CD4+CD45RA+/100 cells
43965-3,Cells.CD4+CD45RA+/100 cells
43966-1,Cells.CD4+CD45RA+/100 cells
43967-9,Cells.CD3+CD25+/100 cells
Aug-96,Phentermine
43968-7,Cells.CD3+HLA-DR+/100 cells
43969-5,Cells.CD3+CD25+
43970-3,Cells.CD3+CD4+/100 cells
43971-1,Cells.CD3+CD8+/100 cells
43972-9,Cells.CD19
43973-7,Zinc
43974-5,Coccidioides sp Ab
43975-2,Aprobarbital
Jun-97,Phenylbutazone
43976-0,Measles virus Ab
43977-8,Anabolic steroids
43978-6,Varicella zoster virus Ab
43979-4,Aspergillus sp identified
43980-2,Rabies virus Ab.Neut
43981-0,Choriogonadotropin.intact^^adjusted
43982-8,Choriogonadotropin.intact
43983-6,Amphetamines
Apr-98,Phenylephrine
43984-4,Benzoylecgonine
43985-1,Benzoylecgonine
43986-9,Clofazimine 2.0 ug/mL
43987-7,Clarithromycin 12.0 ug/mL
43988-5,Clofazimine 0.5 ug/mL
43989-3,Clofazimine 1.0 ug/mL
43990-1,Clarithromycin 3.0 ug/mL
43991-9,Clarithromycin 6.0 ug/mL
Feb-99,Phenylpropanolamine
43992-7,Anaplasma phagocytophilum Ab
43993-5,Age.at delivery
43994-3,Fetal trisomy 18 risk
43995-0,Fetal trisomy 21 risk
43996-8,Alpha-1-Fetoprotein^^adjusted for diabetes+weight
43997-6,Alpha-1-Fetoprotein^^adjusted for weight
43998-4,Alpha-1-Fetoprotein^^adjusted for diabetes
43999-2,Choriogonadotropin
44000-8,Choriogonadotropin
44001-6,Choriogonadotropin
44002-4,Choriogonadotropin^^adjusted
44003-2,Choriogonadotropin.beta subunit.free
44004-0,Estriol.unconjugated
44005-7,Chlamydia trachomatis D & K Ab.IgA & IgG & IgM
44006-5,Coxiella burnetii phase 1 & 2 Ab.IgG & IgM
44007-3,Erythrocytes.CD55 & CD59
Aug-00,Phenytoin
44008-1,Herpes simplex virus 1 & 2 Ab.IgM
44009-9,Herpes simplex virus 1 & 2 Ab.IgG
44010-7,Influenza virus A & B Ab
44011-5,Measles virus Ab.IgG & IgM
44012-3,Measles virus Ab.IgG & IgM
44013-1,Metanephrine & Normetanephrine
44014-9,Porphyrins
44015-6,Helicobacter pylori
Jun-01,Pholedrine
44016-4,Bile
44017-2,Blasts
44018-0,Basophils
44019-8,Bordetella parapertussis Ab
44020-6,Borrelia burgdorferi Ab
44021-4,Coxiella burnetii Ab
44022-2,Bacteria
44023-0,Bacteria
Apr-02,Pindolol
44024-8,Boldenone
44025-5,Aspergillus flavus B Ab
44026-3,Aspergillus flavus H Ab
44027-1,Aspergillus fumigatus B Ab
44028-9,Aspergillus fumigatus H Ab
44029-7,Aspergillus nidulans B Ab
44030-5,Aspergillus nidulans H Ab
44031-3,Aspergillus niger B Ab
Feb-03,Piperacillin
44032-1,Aspergillus niger H Ab
44033-9,Bilirubin
44034-7,Bile canalicular Ab
44035-4,Analgesics.non-narcotic
44036-2,Analgesics.non-narcotic
44037-0,Glucosylceramidase
44038-8,Bacteria
44039-6,Bacteria
4404-0,Pipradrol
44040-4,Basophils
44041-2,Basophils
44042-0,Basophils
44043-8,Basophils
44044-6,Basophils
44045-3,Aspergillus fumigatus O Ab
44046-1,Bordetella pertussis Higashi-Hama Ab
44047-9,Bordetella pertussis Yamaguchi Ab
44048-7,Basophils
44049-5,Tetrahydrocannabinol
44050-3,Glucose phosphate isomerase
44051-1,Adenylate kinase
44052-9,Phosphofructokinase
44053-7,Phosphoglycerate kinase
44054-5,Triosephosphate isomerase
44055-2,Pyrimidine-5'-Nucleotidase
44056-0,Cells.CD4+CD45RA+CD45RB+CD45RC+
Jul-05,Practolol
44057-8,Cells.CD4+CD45RA+CD45RB+CD45RC+
44058-6,Cells.CD4+CD45RA+CD45RB+CD45RC+
44059-4,Cells.CD4+CD45RA+CD45RB+CD45RC+
44060-2,Cells.CD4+CD45RA+CD45RB+CD45RC+
44061-0,Cells.CD20+FMC7+/100 cells
44062-8,Cells.CD20+FMC7+/100 cells
44063-6,Cells.CD20+FMC7+/100 cells
44064-4,Cells.CD20+FMC7+/100 cells
May-06,Prazepam
44065-1,Cells.CD20+FMC7+
44066-9,Cells.CD20+FMC7+
44067-7,Cells.CD20+FMC7+
44068-5,Cells.CD20+FMC7+
44069-3,Cells.CD20+FMC7+
44070-1,Cells.CD20+CD52+/100 cells
44071-9,Cells.CD20+CD52+/100 cells
44072-7,Cells.CD20+CD52+/100 cells
Mar-07,Primidone
44073-5,Cells.CD20+CD52+/100 cells
44074-3,Arbovirus Ab
44075-0,Bilirubin casts
44076-8,Alpha tocopherol & Beta+gamma tocopherol
44077-6,Brucella canis Ab.IgG & IgM
44078-4,Catecholamines
44079-2,Chlamydia trachomatis Ab.IgA & IgG & IgM
440-8,Rosoxacin
44080-0,Chlamydophila pneumoniae Ab.IgG & IgM
Jan-08,Probenecid
44081-8,Chlamydophila psittaci Ab.IgA & IgG & IgM
44082-6,Cryoglobulin IgA & IgG & IgM
44083-4,Extractable nuclear Ab
44084-2,Fatty acids pattern
44085-9,Xylose absorption
44086-7,ABO & Rh group
44087-5,Escherichia coli O157 Ag
44088-3,Escherichia coli O157:H7 DNA
44089-1,Escherichia coli O157:H7
44090-9,Escherichia coli O157:H7
44091-7,Influenza virus A hemagglutinin H5 RNA
44092-5,Leukocytes
44093-3,Neisseria meningitidis
44094-1,Epithelial cells.squamous
44095-8,Unidentified cells/100 leukocytes
44096-6,Unidentified cells/100 leukocytes
44097-4,Unidentified cells/100 leukocytes
44098-2,Microscopic observation
Sep-09,Procainamide
44099-0,Galactomannan Ag
44100-6,Medical problem
44101-4,Guidance for ablation of tissue
44102-2,Guidance for procedure
44103-0,Guidance for percutaneous aspiration.fine needle
44104-8,Guidance for percutaneous aspiration.fine needle
44105-5,Guidance for percutaneous aspiration.fine needle
44106-3,Guidance for aspiration.fine needle
Jul-10,Prolintane
44107-1,Guidance for percutaneous aspiration.fine needle
44108-9,Guidance for percutaneous aspiration.fine needle
44109-7,Guidance for deep biopsy
44110-5,Guidance for needle localization
44111-3,Multisection^WO & W contrast IV
44112-1,Multisection^WO contrast
44113-9,Multisection^WO & W contrast IT
44114-7,Multisection^WO & W contrast IT
May-11,Promazine
44115-4,Multisection
44116-2,Multisection limited
44117-0,Guidance for percutaneous biopsy
44118-8,Guidance for needle localization^WO & W contrast IV
44119-6,Multisection^WO contrast
44120-4,Multisection
44121-2,Guidance for percutaneous biopsy.needle
44122-0,Guidance for stereotactic localization^WO & W contrast IV
Mar-12,Promethazine
44123-8,Multisection^WO contrast
44124-6,Multisection^W contrast IV
44125-3,Multisection^W contrast IV
44126-1,Multisection cine for blood flow velocity mapping^W contrast IV
44127-9,Multisection limited cine for function
44128-7,Multisection^WO & W contrast IV
44129-5,Multisection^WO contrast
44130-3,Multisection^WO contrast
Jan-13,Propanol
44131-1,Multisection^WO & W contrast IV
44132-9,Multisection^WO contrast
44133-7,Multisection^WO contrast
44134-5,Multisection^WO & W contrast IV
44135-2,Multisection^W contrast IV
44136-0,Multisection^W radionuclide IV
44137-8,Multisection^W radionuclide IV
44138-6,Multisection^W radionuclide IV
44139-4,Multisection^W radionuclide IV
44140-2,Views for tumor
44141-0,Views^W Tc-99m MAA IV
44142-8,Views^W Tc-99m medronate IV
44143-6,Views^W Tc-99m tagged RBC IV
44144-4,Views^W Xe-133 IH
44145-1,Views^W Tc-99m Sestamibi IV
44146-9,Views^W Tc-99m SC IV
44147-7,Views+views uptake^W Tc-99m pertechnetate IV
44148-5,Views for blood flow^W Tc-99m bicisate IV
Sep-14,Propranolol
44149-3,Views for shunt patency^W Tc-99m MAA inj
44150-1,Views^W Tc-99m bicisate IV
44151-9,Multisection^W Tc-99m Sestamibi IV
44152-7,Multisection^W Tc-99m bicisate IV
44153-5,Multisection^W Tc-99m glucoheptonate IV
44154-3,Multisection^W dipyridamole IV+W Tc-99m Sestamibi IV
44155-0,Guidance for ablation of tissue
Jun-15,Propylhexedrine
44156-8,Guidance for ablation of tissue
44157-6,Guidance for percutaneous aspiration.fine needle
44158-4,Guidance for percutaneous aspiration.fine needle
44159-2,Guidance for percutaneous aspiration.fine needle
441-6,Rosoxacin
44160-0,Guidance for percutaneous aspiration.fine needle
44161-8,Guidance for percutaneous biopsy
44162-6,Guidance for percutaneous biopsy
44163-4,Multisection
Apr-16,Protriptyline
44164-2,Multisection
44165-9,Multisection & 3D reconstruction
44166-7,Guidance for drainage of abscess+placement of drainage catheter
44167-5,Guidance for drainage of abscess+placement of drainage catheter
44168-3,Guidance for drainage of abscess+placement of drainage catheter
44169-1,Guidance for drainage of abscess+placement of drainage catheter
44170-9,Guidance for biopsy.needle
44171-7,Guidance for biopsy.needle
Feb-17,Pseudoephedrine
44172-5,Guidance for drainage+placement of drainage catheter
44173-3,Multisection limited
44174-1,Multisection
44175-8,Multisection
44176-6,View
44177-4,View AP^W standing
44178-2,(View oblique) + (views^W R-bending + W L-bending)
44179-0,Views 2
4418-0,Pyrilamine
44180-8,Views 2 limited
44181-6,Views 2 or 3
44182-4,Views 2
44183-2,Views 2
44184-0,Views 2
44185-7,Views AP + lateral
44186-5,Views AP + lateral
44187-3,(Views AP + oblique + odontoid) + (View lateral^W flexion + W extension)
44188-1,Views GE 3
44189-9,Views GE 3
44190-7,Views GE 3
44191-5,Views GE 3 && view PA
44192-3,Views GE 3
44193-1,Views GE 3
44194-9,Views GE 4^W R-Bending + W L-Bending
44195-6,Views GE 5
44196-4,Views GE 5^W R-Bending + W L-Bending
44197-2,Views GE 5^W standing
Aug-19,quiNIDine
44198-0,Views 1 or 2
44199-8,Views 1 or 2
44200-4,Views 1 or 2 limited
44201-2,Views 1 or 2
44202-0,Views 1 or 2
44203-8,Views
44204-6,Guidance for percutaneous biopsy.needle
44205-3,View^W standing
Jun-20,quiNINE
44206-1,View for scoliosis
44207-9,Views AP^standing
44208-7,Views for foreign body
44209-5,Views limited
44210-3,Views GE 3
44211-1,Views GE 4
44212-9,Views GE 4
44213-7,Guidance for endoscopy^W contrast retrograde
Apr-21,rifAMPin
44214-5,Guidance for endoscopy^W contrast retrograde
44215-2,Guidance for percutaneous aspiration.fine needle
44216-0,Guidance for percutaneous aspiration.fine needle
44217-8,Guidance for percutaneous aspiration.fine needle
44218-6,Guidance for percutaneous aspiration.fine needle
44219-4,Guidance for percutaneous aspiration.fine needle
44220-2,Guidance for percutaneous aspiration.fine needle
44221-0,Guidance for deep aspiration.fine needle
Feb-22,Salicylamide
44222-8,Guidance for procedure
44223-6,Guidance for percutaneous drainage of abscess+placement of drainage catheter
44224-4,Guidance for placement of tube
44225-1,Guidance for percutaneous biopsy^W contrast IV
44226-9,Views for reduction^W barium contrast PR
44227-7,Views^W barium contrast PR
44228-5,Guidance for ablation of tissue
44229-3,Multisection
4423-0,Salicylates
44230-1,Multisection^WO contrast
44231-9,Multisection^WO & W contrast IV
44232-7,Views^WO & W Tc-99m Mertiatide IV
44233-5,Views^WO & W Tc-99m DTPA IV
44234-3,Views^W Tc-99m glucoheptonate IV
44235-0,Multisection
44236-8,Multisection for graft
44237-6,Multisection limited for graft
44238-4,Views
44239-2,Views GE 3 && view PA
442-4,Rosoxacin
44240-0,Views^W contrast IA
44241-8,Clue cells
44242-6,Erythrocytes
44243-4,Bacteria
44244-2,Trichomonas vaginalis
44245-9,Fungi.filamentous
44246-7,Yeast
44247-5,Spermatozoa.motile
Aug-24,Secobarbital
44248-3,Spermatozoa.immotile
44249-1,PHQ-9 quick depression assessment panel
44250-9,Little interest or pleasure in doing things in last 2W
44251-7,Poor appetite or overeating in last 2W
44252-5,"Trouble concentrating on things, such as reading the newspaper or watching television in last 2W"
44253-3,Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2W
44254-1,Feeling tired or having little energy in last 2W
May-25,Sotalol
44255-8,"Feeling down, depressed, or hopeless in last 2W"
44256-6,Perceived difficulty in last 2W
44257-4,Patient health questionnaire 9 item
44258-2,Feeling bad about yourself - or that you are a failure or have let yourself or your family down in last 2W
44259-0,"Trouble falling or staying asleep, or sleeping too much in last 2W"
44260-8,"Thoughts that you would be better off dead, or of hurting yourself in some way in last 2W"
44261-6,Patient health questionnaire 9 item total score
44262-4,PHQ-9 interpretation
Mar-26,Spironolactone
44263-2,Influenza virus A RNA
44264-0,Influenza virus A H5 RNA
44265-7,Influenza virus A H6 RNA
44266-5,Influenza virus A H7 RNA
44267-3,Avian paramyxovirus 1 RNA
44268-1,Avian paramyxovirus 1.exotic RNA
44269-9,Bacillus anthracis cell wall Ag
44270-7,Bacillus anthracis spore Ag
Jan-27,Stanozolol
44271-5,Brucella sp Ag
44272-3,Cache valley virus Ab.Neut
44273-1,Classical swine fever virus RNA
44274-9,Clostridium botulinum toxin
44275-6,Coxiella burnetii
44276-4,Equine adenovirus Ag
44277-2,"15 Beta, 17 Alpha-Dihydroxypregnanolone/Creatinine"
44278-0,16-Alpha hydroxydehydroepiandrosterone/Creatinine
44279-8,16-Alpha hydroxypregnenolone/16-Alpha hydroxydehydroepiandrosterone
44280-6,17 alpha-Hydroxypregnanolone/Creatinine
44281-4,17-Ketosteroids/Creatinine
44282-2,2-Hydroxyisocaproate/Creatinine
44283-0,2-Hydroxyphenylacetate/Creatinine
44284-8,2-Methylcitrate/Creatinine
44285-5,3-Methylcrotonylglycine/Creatinine
44286-3,3-Methylhistidine/Creatinine
44287-1,5-Hydroxyhexanoate/Creatinine
44288-9,5-Hydroxyindoleacetate/Creatinine
Sep-28,Streptomycin
44289-7,Adenovirus Ab
44290-5,Adenovirus Ab
44291-3,Alanine/Creatinine
44292-1,Albumin/Creatinine
44293-9,Albumin/Globulin
44294-7,Albumin/Globulin
44295-4,Aldosterone/Creatinine
44296-2,Alpha aminobutyrate/Creatinine
Jul-29,Sulbactam
44297-0,Androsterone/Creatinine
44298-8,Apis mellifera Ab.IgG.RAST class
44299-6,Arginine/Creatinine
44300-2,Arsenic.inorganic/Creatinine
44301-0,Asparagine/Creatinine
44302-8,Aspartate/Creatinine
44303-6,Beta-2-Microglobulin/Creatinine
44304-4,Carnosine/Creatinine
May-30,sulfADIAZINE
44305-1,Chloral hydrate/Creatinine
44306-9,Citrate/Creatinine
44307-7,Citrulline/Creatinine
44308-5,Collagen crosslinked N-telopeptide/Creatinine
44309-3,Cortisol.free/Creatinine
44310-1,Cortisol/Creatinine
44311-9,Cotinine/Creatinine
44312-7,Cystine/Creatinine
Mar-31,Sulfamethoxazole
44313-5,Delta aminolevulinate/Creatinine
44314-3,D-lactate/Creatinine
44315-0,Dolichovespula maculata Ab.IgG.RAST class
44316-8,DOPamine/Creatinine
44317-6,Insulin human Ab
44318-4,Insulin porcine Ab
44319-2,Insulin.bound
443-2,Roxithromycin
44320-0,Interferon.alpha
Jan-32,sulfiSOXAZOLE
44321-8,Interleukin 5
44322-6,Interleukin 6
44323-4,Iodine
44324-2,Iodine.inorganic
44325-9,Iron
44326-7,Iron
44327-5,Iron
44328-3,Isocitrate
44329-1,Isoleucine/Creatinine
44330-9,Isospora belli
44331-7,Isovalerylglycine/Creatinine
44332-5,Jo-1 extractable nuclear Ab.IgG
44333-3,Lactate/Creatinine
44334-1,Leucine/Creatinine
44335-8,Lysine/Creatinine
44336-6,Magnesium/Creatinine
44337-4,Metanephrine.free/Creatinine
44338-2,Methionine/Creatinine
Sep-33,Sulfonamide
44340-8,N-methylhistamine/Creatinine
44341-6,Norepinephrine/Creatinine
44342-4,Normetanephrine/Creatinine
44343-2,Organic acids/Creatinine
44344-0,Ornithine/Creatinine
44345-7,Orotate/Creatinine
44346-5,Phenol/Creatinine
Jul-34,Sulfonamide
44347-3,Phenol/Creatinine
44348-1,Phenylalanine/Creatinine
44349-9,Phenylalanine/Creatinine
44350-7,Phenylpropionylglycine/Creatinine
44351-5,Phosphoethanolamine/Creatinine
44352-3,Phosphoethanolamine/Creatinine
44353-1,Porphyrins/Creatinine
Apr-35,Teicoplanin
44354-9,Ethylmalonate/Creatinine
44355-6,Etiocholanolone/Creatinine
44356-4,Follitropin/Creatinine
44357-2,Galactomannan Ag
44358-0,Gamma hydroxybutyrate/Creatinine
44359-8,Glutamate/Creatinine
44360-6,Glutamate+Glutamine/Creatinine
44361-4,Glutamate+Glutamine/Creatinine
Feb-36,Tetracaine
44362-2,Glutamine/Creatinine
44363-0,Glutarate/Creatinine
44364-8,Glutarate/Creatinine
44365-5,Glycine/Creatinine
44366-3,Glycosaminoglycans/Creatinine
44367-1,Glycosaminoglycans/Creatinine
44368-9,Hexanoylglycine/Creatinine
44369-7,Hexokinase
4437-0,Tetracycline
44370-5,Hippurate/Creatinine
44371-3,Histamine/Creatinine
44372-1,Histidine/Creatinine
44373-9,Homocysteine
44374-7,Homocysteine
44375-4,Homocysteine
44376-2,Homocysteine
44377-0,Homocysteine/Creatinine
44378-8,Homocystine/Creatinine
44379-6,Horse hair+Horse dander Ab.IgE.RAST class
44380-4,House dust Hollister Stier Ab.IgG.RAST class
44381-2,Humulus japonicus Ab.IgE.RAST class
44382-0,Hyaline casts.broad
44383-8,Hyaluronate
44384-6,hydroCHLOROthiazide
44385-3,Hydroflumethiazide
44386-1,Hydroxyproline/Creatinine
44387-9,Hypnotics
Aug-38,Tetrahydrocannabinol
44388-7,IgA
44389-5,IgA
44390-3,Imipramine
44391-1,Immune complex
44392-9,Immune complex
44393-7,Immune complex
44394-5,Immunoglobulin light chains.kappa
44395-2,Immunoglobulin light chains.lambda
Jun-39,Tetrahydrocortisone
44396-0,Insulin
44397-8,Insulin bovine Ab
44398-6,Proline/Creatinine
44399-4,Propionylglycine/Creatinine
444-0,Roxithromycin
44400-0,Pyruvate/Creatinine
44401-8,Sarcosine/Creatinine
44402-6,Selenium/Creatinine
44403-4,Serine/Creatinine
Apr-40,Theophylline
44404-2,Silicon/Creatinine
44405-9,Sodium/Creatinine
44406-7,Sodium/Potassium
44407-5,Somatotropin/Creatinine
44408-3,Suberate/Creatinine
44409-1,Succinate/Creatinine
44410-9,Superoxide dismutase
44411-7,Taurine/Creatinine
Feb-41,Thiopental
44412-5,Tetrahydrodeoxycortisol/Creatinine
44413-3,Threonine/Creatinine
44414-1,Tryptophan/Creatinine
44415-8,Tyrosine/Creatinine
44416-6,Urea nitrogen/Creatinine
44417-4,Valine/Creatinine
44418-2,Vanillylmandelate/Creatine
44419-0,CIAS1 gene targeted mutation analysis
4442-0,Thioridazine
44420-8,CACNA1A gene targeted mutation analysis
44421-6,PKD1 gene+PKD2 gene targeted mutation analysis
44422-4,Interleukin 2 receptor alpha chain.soluble
44423-2,Herpes virus 7 DNA
44424-0,Methylenedioxymethamphetamine/Creatinine
44425-7,Storage and handling section
44426-5,3-Hydroxyphenylacetate/Creatinine
44427-3,3-Hydroxyphenylacetate/Creatinine
44428-1,Adenosine monophosphate.cyclic.nephrogenous/Creatinine
44429-9,Albumin/Globulin
44430-7,Alpha cortolone/Creatinine
44431-5,Annexin V Ab.IgG
44432-3,Annexin V Ab.IgM
44433-1,Antibiotic XXX^peak
44434-9,Antibiotic XXX^trough
44435-6,Ascaris lumbricoides adult Ab.IgG
44436-4,Ascaris lumbricoides larva Ab.IgG
44437-2,Ascaris sp Ab.IgG
Aug-43,Ticarcillin
44438-0,Aspergillus fumigatus 1 Ab
44439-8,Aspergillus fumigatus 3 Ab
44440-6,Aspergillus fumigatus 6 Ab
44441-4,Aspergillus niger Ab
44442-2,Bartonella henselae Ab
44443-0,Bartonella sp Ab.IgG
44444-8,Bartonella sp Ab.IgM
44445-5,Basement membrane Ab.IgA
Jun-44,Timolol
44446-3,Basement membrane Ab.IgG
44447-1,Beta 2 glycoprotein 1 Ab.IgA
44448-9,Beta 2 glycoprotein 1 Ab.IgG
44449-7,Beta 2 glycoprotein 1 Ab.IgM
44450-5,Beta cortolone/Creatinine
44451-3,Blastomyces dermatitidis Ab
44452-1,Borrelia burgdorferi Ab
Mar-45,Tobramycin
44453-9,Borrelia burgdorferi Ab
44454-7,Borrelia burgdorferi Ab
44455-4,Borrelia burgdorferi Ab^1st specimen
44456-2,Borrelia burgdorferi Ab^1st specimen
44457-0,Borrelia sp Ab
44458-8,Brucella abortus Ab.IgG+IgM
44459-6,C peptide/Creatinine^2nd specimen post XXX challenge
44460-4,Cladosporium herbarum Ab
Jan-46,Tocainide
44461-2,Dermatophagoides farinae Ab
44462-0,Insulin.free+Bound
44463-8,Herpes simplex virus 1
44464-6,Herpes simplex virus 1
44465-3,Herpes simplex virus 1
44466-1,Herpes simplex virus 1
44467-9,Herpes simplex virus 1
44468-7,Herpes simplex virus 1
44469-5,Herpes simplex virus 1 Ab
44470-3,Herpes simplex virus 1 Ag
44471-1,Herpes simplex virus 1 Ag
44472-9,Herpes simplex virus 1 Ag
44473-7,Herpes simplex virus 1 Ag
44474-5,Herpes simplex virus 1 Ag
44475-2,Herpes simplex virus 1 Ag
44476-0,Herpes simplex virus 1 Ag
44477-8,Herpes simplex virus 1 Ag
44478-6,Herpes simplex virus 1 DNA
Sep-47,TOLBUTamide
44479-4,Herpes simplex virus 1+2 Ab
44480-2,Herpes simplex virus 1+2 Ab
44481-0,Herpes simplex virus 1+2 Ab.IgG
44482-8,Herpes simplex virus 1+2 Ab.IgG
44483-6,Herpes simplex virus 1+2 Ab.IgM
44484-4,Herpes simplex virus 2
44485-1,Herpes simplex virus 2
44486-9,Herpes simplex virus 2
Jul-48,TOLBUTamide.IV
44487-7,Herpes simplex virus 2
44488-5,Herpes simplex virus 2
44489-3,Herpes simplex virus 2
44490-1,Herpes simplex virus 2
44491-9,Herpes simplex virus 2 Ab
44492-7,Herpes simplex virus 2 Ab
44493-5,Herpes simplex virus 2 Ab
44494-3,Herpes simplex virus 2 Ab.IgM
May-49,Tranylcypromine
44495-0,Herpes simplex virus 2 Ag
44496-8,Herpes simplex virus 2 Ag
44497-6,Herpes simplex virus 2 Ag
44498-4,Herpes simplex virus 2 Ag
44499-2,Herpes simplex virus 2 Ag
44500-7,Herpes simplex virus 2 Ag
44501-5,Herpes simplex virus 2 Ag
44502-3,Herpes simplex virus 2 Ag
Mar-50,traZODone
44503-1,Herpes simplex virus 2 DNA
44504-9,Herpes simplex virus Ab
44505-6,Herpes simplex virus Ab.IgG
44506-4,Herpes simplex virus Ab
44507-2,Herpes simplex virus Ab.IgM
44508-0,Herpes simplex virus Ag
44509-8,Herpes simplex virus Ag
44510-6,Herpes simplex virus Ag
Jan-51,Triamterene
44511-4,Herpes simplex virus Ag
44512-2,Herpes simplex virus Ag
44513-0,Herpes simplex virus Ag
44514-8,Herpes simplex virus Ag
44515-5,Herpes simplex virus Ag
44516-3,Herpes simplex virus Ag
44517-1,Herpes simplex virus DNA
44518-9,Herpes simplex virus DNA
44519-7,Herpes virus 6 Ab
44520-5,Herpes virus 6 Ab.IgG
44521-3,Herpes virus 6 Ab.IgG
44522-1,Histoplasma capsulatum Ab
44523-9,Histoplasma capsulatum Ab.IgG
44524-7,Histoplasma capsulatum Ag
44525-4,Histoplasma capsulatum Ag
44526-2,Histoplasma capsulatum H Ab
44527-0,Histoplasma capsulatum H Ab
44528-8,Histoplasma capsulatum M Ab
Sep-52,Triazolam
44529-6,Histoplasma capsulatum mycelial phase Ab
44530-4,Histoplasma capsulatum yeast phase Ab
44531-2,HIV 1 Ag
44532-0,HIV 1 gp120 Ab
44533-8,HIV 1+2 Ab
44534-6,HLA Ab
44535-3,HTLV I Ab
44536-1,HTLV I DNA
Jul-53,Trimeperidine
44537-9,HTLV I DNA
44538-7,HTLV I+II Ab
44539-5,HTLV II Ab
44540-3,HTLV II Ab.IgG
44541-1,HTLV II DNA
44542-9,HTLV II DNA
44543-7,Human papilloma virus 31+33 Ag
44544-5,Human papilloma virus 35 Ag
May-54,Trimethadione
44545-2,Human papilloma virus DNA
44546-0,Human papilloma virus DNA
44547-8,Human papilloma virus DNA
44548-6,Human papilloma virus DNA
44549-4,Human papilloma virus DNA
44550-2,Human papilloma virus DNA
44551-0,Human papilloma virus DNA
Feb-55,Trimethoprim
44552-8,hydroCHLOROthiazide
44553-6,Hydroxyitraconazole
44554-4,Hymenopterase Ab.IgE.RAST class
44555-1,Immunoglobulin light chains.kappa.free
44556-9,Influenza virus A Ab
44557-7,Influenza virus A Ab
44558-5,Influenza virus A Ag
44559-3,Influenza virus A Ag
4456-0,Trimipramine
44560-1,Influenza virus A Ag
44561-9,Influenza virus A Ag
44562-7,Influenza virus A Ag
44563-5,Influenza virus A Ag
44564-3,Influenza virus A Ag
44565-0,Influenza virus A+B Ab
44566-8,Influenza virus A+B Ag
44567-6,Influenza virus A+B Ag
44568-4,Influenza virus B Ab
44569-2,Influenza virus B Ab
445-7,Roxithromycin
44570-0,Influenza virus B Ab
44571-8,Influenza virus B Ag
44572-6,Influenza virus B Ag
44573-4,Influenza virus B Ag
44574-2,Influenza virus B Ag
44575-9,Influenza virus B Ag
44576-7,Influenza virus B Ag
44577-5,Influenza virus B Ag
Aug-57,Tripelennamine
44578-3,Influenza virus C Ab
44579-1,Influenza virus C Ab
44580-9,HTLV I+II p21 env Ab
44581-7,HTLV I+II p38 tax Ab
44582-5,IgA
44583-3,IgA Ab
44584-1,IgA Ab
44585-8,IgA Ab.IgG
Jun-58,Valproate
44586-6,IgA Ab.IgM
44587-4,IgA.monoclonal
44588-2,IgA.monoclonal
44589-0,IgA.monoclonal
44590-8,IgA.secretory
44591-6,IgD
44592-4,IgD
44593-2,IgE
Apr-59,Vancomycin
44594-0,IgE
44595-7,IgG
44596-5,IgG Ag
44597-3,IgG.monoclonal
44598-1,IgG.monoclonal
44599-9,IgG.monoclonal
44600-5,IgM
44601-3,IgM.monoclonal
Feb-60,Verapamil
44602-1,IgM.monoclonal
44603-9,IgM.monoclonal
44604-7,Immunoglobulin light chains.kappa.free
44605-4,Immunoglobulin light chains.kappa
44606-2,ALOX3+ALOX12B gene targeted mutation analysis
44607-0,HIV 1
44608-8,KCNQ1 gene mutations tested for
44609-6,Heart rate
4461-0,Warfarin
44610-4,Heart rate
44611-2,Heart rate
44612-0,Oxygen saturation
44613-8,Oxygen saturation
44614-6,Oxygen saturation
44615-3,Device error code
44616-1,Pulse oximetry panel
44617-9,PWS gene targeted mutation analysis
44618-7,Total linear mm of carcinoma
44619-5,Length of tissue core(s)
44620-3,Other quantitation
44621-1,Regional lymph nodes examined
44622-9,Regional lymph nodes containing metastases
44623-7,Matted nodes
44624-5,Additional pathological findings
44625-2,Periprostatic fat invasion
44626-0,Seminal vesicle invasion
44627-8,Extraprostatic extension
Aug-62,Xylose.PO
44628-6,Reason specimen size cannot be determined
44629-4,Specimen size.max dimension
44630-2,Specimen size.additional dimension 1
44631-0,Specimen size.additional dimension 2
44632-8,Satellite nodule presence
44633-6,Tumor pigmentation
44634-4,Reason invasive component size cannot be determined
44635-1,Invasive component size.max.dimension
Jun-63,Motility & count panel
44636-9,Invasive component size.additional dimension 1
44637-7,Invasive component size.additional dimension 2
44638-5,Histologic type
44639-3,Histologic type
44640-1,Histologic type
44641-9,Gleason pattern.primary
44642-7,Gleason pattern.secondary
44643-5,Gleason pattern.tertiary
Apr-64,Spermatozoa evaluation.cervical mucus penetration test
44644-3,Tubule formation
44645-0,Nuclear pleomorphism
44646-8,Nottingham mitotic count.25x obj
44647-6,Nottingham mitotic count.40x obj
44648-4,Histologic grade
44649-2,Grading system
446-5,Roxithromycin
44650-0,Mitotic count per 10 HPF
Jan-65,Spermatozoa evaluation.hamster ova penetration test
44651-8,Tissue cores.positive.carcinoma
44652-6,Total number of cores
44653-4,Tumor quantitation.incidental
44654-2,Prostatic tissue involved by tumor
44655-9,Tissue chips.positive.carcinoma
44656-7,Number of tissue chips
44657-5,Dominant nodule.max.dimension
44658-3,Dominant nodule.additional dimension 1
44659-1,Dominant nodule.additional dimension 2
44660-9,Tumor involved by ulceration
44661-7,Depth of invasion by tumor
44662-5,Depth of invasion by tumor cannot be determined comment
44663-3,T classification
44664-1,T classification
44665-8,T classification
44666-6,M stage of distant metastasis
44667-4,Site of distant metastasis
44668-2,M stage of distant metastasis
Sep-66,Stain.vital
44669-0,Margin involvement
44670-8,Margin involvement
44671-6,Margin involvement
44672-4,Invasive carcinoma.uninvolved margin distance.closest
44673-2,DCIS.uninvolved margin distance.closest
44674-0,Invasive carcinoma.uninvolved margin.closest
44675-7,DCIS.uninvolved margin.closest
44676-5,Margin(s) involved by invasive carcinoma
Jul-67,Spinnbarkeit test
44677-3,Margin(s) involved by DCIS
44678-1,Margin(s) involved by invasive carcinoma
44679-9,Margin(s) involved by invasive melanoma
44680-7,Margin(s) involved by melanoma in situ
44681-5,Invasive melanoma.uninvolved margin.closest
44682-3,Invasive melanoma in situ.uninvolved margin.closest
44683-1,Distance of invasive melanoma to closest lateral margin
44684-9,Distance of melanoma in situ to closest lateral margin
May-68,Carbonyl hemoglobin/Hemoglobin.total
44685-6,Distance of invasive melanoma to closest deep margin
44686-4,Invasive melanoma.location relative to closest uninvolved lateral margin
44687-2,Melanoma in situ.location relative to closest uninvolved lateral margin
44688-0,Invasive melanoma.location relative to involved lateral margin
44689-8,Melanoma in situ.location relative to involved lateral margin
44690-6,Invasive melanoma.location relative to closest uninvolved deep margin
44691-4,Invasive melanoma.location relative to involved deep margin
44692-2,Microcalcifications
Mar-69,Cellano Ag
44693-0,Tumor infiltrating lymphocytes
44694-8,Tumor regression
44695-5,Mitotic index
44696-3,Inflammation type
44697-1,Lesion size.max.dimension
44698-9,Lesion size.additional dimension 1
44699-7,Extent of margin involvement
44700-3,ACTA1 gene targeted mutation analysis
Jan-70,Choleglobin/Hemoglobin.total
44701-1,BHD gene targeted mutation analysis
44702-9,Complement C1q Ab
44703-7,MC4R gene targeted mutation analysis
44704-5,NEB gene targeted mutation analysis
44705-2,ALS4 gene targeted mutation analysis
44706-0,Actin.smooth muscle Ab.IgG
44707-8,Albumin/Creatinine
44708-6,Asialoganglioside GM1 Ab.IgG
44709-4,Asialoganglioside GM1 Ab.IgM
44710-2,Carnitine/Acylcarnitine
44711-0,Cholesterol.in LDL/Apolipoprotein B
44712-8,Collagen crosslinked N-telopeptide/Creatinine
44713-6,Collagen crosslinked N-telopeptide/Creatinine
44714-4,Complement C3/Protein
44715-1,Complement C4/Protein
44716-9,Creatinine/Calcium
44717-7,Lipoprotein.beta/Lipoprotein.alpha
44718-5,Lipoprotein.pre-beta/Triglyceride
Sep-71,Complement activity.cell surface induced
44719-3,Methylmalonate/Homocysteine
44720-1,Methylmalonate/Homocystine
44721-9,Histiocytes
44722-7,Histiocytes
44723-5,Histiocytes
44724-3,HLA-A29
44725-0,HLA-B1
44726-8,HLA-B51
Jul-72,Complement C'2 esterase
44727-6,HLA-DP2
44728-4,HLA-DQA1
44729-2,Progesterone/11-Deoxycorticosterone
447-3,Sisomicin
44730-0,Progesterone/Estradiol
44731-8,Transferrin.carbohydrate deficient.asialo/Transferrin.carbohydrate deficient.disialo
44732-6,Transferrin.carbohydrate deficient.monosialo/Transferrin.carbohydrate deficient.disialo
44733-4,Triglyceride/Cholesterol.in HDL
44734-2,Urea nitrogen/Creatinine
May-73,Complement C'3 esterase
44735-9,Urea nitrogen/Creatinine
44736-7,Asialoganglioside GM1 Ab
44737-5,Asialoganglioside GM1 Ab
44738-3,Asialoganglioside GM1 Ab.IgG
44739-1,Beta tubulin Ab.IgM
44740-9,Ganglioside GD1a Ab
44741-7,Disialylganglioside GD1b Ab
44742-5,Disialylganglioside GD1b Ab.IgG
Mar-74,Complement C'4 esterase
44743-3,Disialylganglioside GD1b Ab.IgM
44744-1,La Crosse virus Ab
44745-8,La Crosse virus Ab
44746-6,La Crosse virus Ab
44747-4,La Crosse virus Ab
44748-2,La Crosse virus Ab
44749-0,Ganglioside GM1 Ab.IgA
4475-0,Complement C1
44750-8,Ganglioside GM1 Ab.IgM
44751-6,Nuclear Ab
44752-4,Nuclear Ab
44753-2,Sulfatide Ab.IgM
44754-0,Hepatitis D virus Ag
44755-7,Hepatitis D virus Ag
44756-5,Reason for transplant
44757-3,Blood product units given
44758-1,Transplant risk factors
44759-9,Volume
44760-7,Model for end-stage liver disease score
44761-5,Graft portion
44762-3,Liver transplant anastomosis site
44763-1,Native inferior vena cava liver graft attachment
44764-9,Biliary anastomosis procedure
44765-6,Time clamp removed from portal vein
44766-4,Time clamp removed from artery
44767-2,Relationship of subject to patient
Aug-76,Complement C1 esterase inhibitor.functional
44768-0,Neuronal nuclear type 1 Ab
44769-8,Neuronal nuclear type 1 Ab
44770-6,Neuronal nuclear Ab.IgG
44771-4,Varicella zoster virus Ab
44772-2,Hepatic artery anatomy
44773-0,Liver transplant anastomosis site
44774-8,Interposition graft
44775-5,Liver transplant anastomosis site
Jun-77,Complement C1 esterase inhibitor
44776-3,Time cross clamp applied
44777-1,Time removed from cold
44778-9,Cold ischemic time
44779-7,Warm ischemic time
44780-5,Organ donor ID number
44781-3,Functional status of graft
44782-1,Cause of graft failure
44783-9,Sodium
Apr-78,Complement C1q
44784-7,Creatinine
44785-4,Alanine aminotransferase
44786-2,Aspartate aminotransferase
44787-0,Preservation fluid
44788-8,Organ donor
44789-6,Amylase & Creatinine clearance panel
44790-4,Iodide
44791-2,Menorrhagia coagulation panel
Feb-79,Complement C1q Ag
44792-0,Immunoglobulin light chains panel
44793-8,Immunoglobulin light chains panel
44794-6,Aquaporin 4 water channel Ab.IgG
44795-3,Influenza virus A H5 Asian RNA
44796-1,Clostridium botulinum toxin
44797-9,Brucella sp
44798-7,Burkholderia sp identified
44799-5,Coxiella burnetii
Aug-44,Aztreonam
4480-0,Complement C1q binding
44800-1,Burkholderia sp
44801-9,Aldolase
44802-7,Enolase.neuron specific
44803-5,GNE gene targeted mutation analysis
44804-3,Taenia solium Ab.IgG
44805-0,BK virus DNA
44806-8,Chlamydia trachomatis+Neisseria gonorrhoeae DNA
44807-6,Chlamydia trachomatis+Neisseria gonorrhoeae DNA
44808-4,Histoplasma capsulatum H Ab band pattern
44809-2,Histoplasma capsulatum M Ab band pattern
448-1,Sisomicin
44810-0,HTLV I gp21e Ab
44811-8,Coccidioides sp Ab.IgA
44812-6,Yeast.hyphae
44813-4,Hepatitis C virus c22p Ab
44814-2,Coxiella burnetii phase 2 Ab.IgM
44815-9,Brucella abortus Ab.IgM
44816-7,Trypanosoma cruzi Ab.IgG
44817-5,Cytomegalovirus Ab.IgM
Aug-81,Complement C1r
44818-3,Brucella abortus Ab.IgG
44819-1,Leishmania donovani Ab.IgM
44820-9,Leishmania braziliensis Ab.IgM
44821-7,Leishmania braziliensis Ab.IgG
44822-5,La Crosse virus Ab.IgM
44823-3,Bartonella quintana Ab.IgM
44824-1,Leishmania donovani Ab.IgG
44825-8,Bartonella quintana Ab.IgM
Jun-82,Complement C1r2+C1s2
44826-6,Hepatitis D virus Ab.IgM
44827-4,Bartonella quintana Ab.IgG
44828-2,Teriflunomide
44829-0,Acremonium sp Ab.IgG.RAST class
44830-8,Phosphorylase
44831-6,Hepatitis C virus c100p+5-1-1 Ab
44832-4,Glycogen synthase I/Glycogen synthase.total
44833-2,Diagnosis.preliminary
Apr-83,Complement C1s
44834-0,Acid phosphatase.tartrate resistant
44835-7,Acid phosphatase.tartrate resistant
44836-5,5-Hydroxymethyl-2-Furoate
44837-3,Epinephrine+Norepinephrine
44838-1,Catecholamines
44839-9,Choriogonadotropin
44840-7,Fungus identified^^^5
44841-5,Bacteria identified^^^2
Feb-84,Complement C2
44842-3,Bacteria identified^^^3
44843-1,Bacteria identified^^^2
44844-9,Bacteria identified^^^4
44845-6,Bacteria identified^^^5
44846-4,Bacteria identified^^^6
44847-2,Bacteria identified^^^7
44848-0,Bacteria identified^^^7
44849-8,Bacteria identified^^^8
44850-6,Bacteria identified^^^8
44851-4,Mycobacterium sp identified^^^2
44852-2,Mycobacterium sp identified^^^3
44853-0,Bacteria identified^^^3
44854-8,Mycobacterium sp identified^^^4
44855-5,Mycobacterium sp identified^^^5
44856-3,Bacteria identified^^^4
44857-1,Bacteria identified^^^5
44858-9,Bacteria identified^^^6
Sep-85,Complement C3
44859-7,Bacteria identified^^^7
44860-5,Methoxyacetate/Creatinine
44861-3,4-Hydroxymandelate/Creatinine
44862-1,5-Alpha tetrahydro-11-Dehydrocorticosterone/Creatinine
44863-9,6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone/Creatinine
44864-7,6-Alpha hydroxytetrahydro-11-Deoxycortisol/Creatinine
44865-4,Ammonium urate
Jul-86,Complement C3 fragment
44867-0,Iron.microscopic observation
44868-8,Herpes simplex virus 1+2 DNA
44869-6,Histoplasma capsulatum Ab
44870-4,Histoplasma capsulatum Ag
44871-2,HIV 1 proviral DNA
44872-0,HIV 1 p24 Ag
44873-8,HIV 1+2 Ab
44874-6,HTLV I+II RNA
May-87,Complement C3 fragment
44875-3,IgM Ag
44876-1,Influenza virus A Ab
44877-9,Insulin dependent diabetes mellitus
44878-7,Staphylococcus aureus enterotoxin A sea gene
44879-5,Staphylococcus aureus enterotoxin E see gene
44880-3,Staphylococcus aureus enterotoxin B seb gene
44881-1,Staphylococcus aureus toxic shock syndrome toxin gene
44882-9,Malignant cells
Mar-88,Complement C3a
44883-7,Malignant cells
44884-5,Malignant cells
44885-2,Malignant cells
44886-0,Malignant cells
44887-8,Malignant cells
44888-6,Malignant cells
44889-4,Malignant cells
44890-2,Malignant cells
Jan-89,Complement C3b
44891-0,Malignant cells
44892-8,Malignant cells/100 cells
44893-6,Malignant cells/100 cells
44894-4,Malignant cells/100 cells
44895-1,Malignant cells/100 cells
44896-9,Malignant cells/100 cells
44897-7,Malignant cells/100 cells
44898-5,Malignant cells/100 cells
44899-3,Malignant cells/100 cells
44900-9,Malignant cells/100 cells
44901-7,Malignant cells/100 cells
44902-5,Malignant cells/100 cells
44903-3,Malignant cells/100 cells
44904-1,Malignant cells/100 cells
44905-8,Malignant cells/100 cells
44906-6,Homovanillate panel
44907-4,5-Hydroxyindoleacetate panel
44908-2,Homovanillate & Creatinine
Sep-90,Complement C3b-C4b receptor
44909-0,5-Hydroxyindoleacetate & Creatinine
44910-8,Alpha-1-Fetoprotein
44911-6,Beta 2 globulin+Gamma globulin
44912-4,Beta 2 globulin+Gamma globulin/Protein.total
44913-2,Beta globulin+Gamma globulin
44914-0,Beta globulin+Gamma globulin/Protein.total
44915-7,Cholesterol.in LDL/Cholesterol.in HDL
44916-5,Cortisol^pre XXX challenge
Jul-91,Complement C3c
44917-3,Cortisol^post dose dexamethasone
44918-1,DOPamine/Creatinine
44919-9,Glucose^1.5H post meal
44920-7,Hemoglobin C/Hemoglobin.total
44921-5,Hemoglobin D/Hemoglobin.total
44922-3,Hemoglobin E/Hemoglobin.total
44923-1,Hemoglobin S/Hemoglobin.total
44924-9,Normetanephrine/Creatinine
May-92,Complement C3d
44925-6,Prolactin^1H post dose TRH IV
44926-4,Prolactin^1.5H post dose TRH IV
44927-2,Prolactin^30M post dose TRH IV
44928-0,Prolactin^15M pre dose TRH IV
44929-8,Prolactin^15M post dose TRH IV
44930-6,Prolactin^2H post dose TRH IV
44931-4,Prolactin^pre dose TRH IV
44932-2,Protein.monoclonal band 2/Protein.total
Mar-93,Complement C3d+G
44933-0,Specific gravity
44934-8,Thymidine kinase
44935-5,Thyrotropin^15M post dose TRH IV
44936-3,Thyrotropin^15M pre dose TRH IV
44937-1,Thyrotropin^pre dose TRH IV
44938-9,Hepatitis D virus Ab.IgM
44939-7,Adverse drug reaction
44940-5,Alcoholic drinks per W
Jan-94,Complement C3d+G
44941-3,Barriers to self management
44942-1,First nations living status
44943-9,Self management
44944-7,Other alert
44945-4,Australian cervix cytology code
44946-2,Borrelia burgdorferi 31kD Ab.IgG
44947-0,Borrelia burgdorferi 31kD Ab.IgM
44948-8,Borrelia burgdorferi 34kD Ab.IgM
44949-6,Borrelia burgdorferi 34kD Ab.IgG
44950-4,Coagulation surface induced.factor substitution^1H post incubation after addition of normal plasma
44951-2,Physician NPI
44952-0,Surgeon primary NPI
44953-8,Physician follow up NPI
44954-6,Physician managing NPI
44955-3,Archive facility identification number NPI
44956-1,Following registry NPI
44957-9,Institution referred to NPI
Aug-95,Complement C3d+G
44958-7,Institution referred from NPI
44959-5,Hospital.reporting NPI
44960-3,Institution data source NPI
44961-1,Homans sign
44962-9,Homans sign
44963-7,Capillary refill
44964-5,Capillary refill
44965-2,Jugular vein distention^head raised 30 degrees
Jun-96,Complement C3d-C3d+Gg-IC3b receptors
44966-0,Edema
44967-8,Electrocardiograph lead
44968-6,Temperature
44969-4,Heart rate rhythm
44970-2,Cardiac monitor interpretation
44971-0,Capillary refill
44972-8,Edema site
44973-6,QRS duration
Apr-97,Complement C3PA
44974-4,Arterial pulse intensity
44975-1,QT interval
44976-9,PR interval
44977-7,Chlamydophila psittaci Ab.IgM
44978-5,Chlamydophila psittaci Ab.IgA
44979-3,Chlamydophila pneumoniae Ab^2nd specimen
44980-1,Chlamydophila pneumoniae Ab^1st specimen
44981-9,Chlamydophila pneumoniae Ab.IgG
Feb-98,Complement C4
44982-7,Chlamydophila pneumoniae Ab.IgA
44983-5,Chlamydia trachomatis L2 Ab.IgM
44984-3,Chlamydia trachomatis L2 Ab.IgG
44985-0,Chlamydia trachomatis L2 Ab.IgA
44986-8,Chlamydia trachomatis G+F+K Ab.IgM
44987-6,Chlamydia trachomatis G+F+K Ab.IgA
44988-4,Chlamydia trachomatis D+K Ab.IgM
44989-2,Chlamydia trachomatis D+K Ab.IgG
449-9,Sisomicin
4499-0,Complement C4 activated
44990-0,Chlamydia trachomatis D+K Ab.IgA
44991-8,Chlamydia trachomatis C Ab.IgM
44992-6,Chlamydia trachomatis C Ab.IgG
44993-4,Chlamydia trachomatis C Ab.IgA
44994-2,Chlamydia trachomatis B Ab.IgM
44995-9,Chlamydia trachomatis B Ab.IgG
44996-7,Chlamydia trachomatis B Ab.IgA
44997-5,Chlamydia trachomatis Ab^2nd specimen
44998-3,Chlamydia trachomatis Ab^1st specimen
44999-1,Chlamydia trachomatis Ab.IgM
45000-7,Chlamydia trachomatis Ab.IgM
45001-5,Chlamydia trachomatis Ab.IgM
45002-3,Chlamydia trachomatis Ab.IgG
45003-1,Chlamydia trachomatis Ab.IgG
45004-9,Chlamydia trachomatis Ab.IgA
May-00,Complement C4 CH50
45005-6,Chlamydia trachomatis Ab.IgA
45006-4,Chlamydia trachomatis Ab.IgA
45007-2,Chlamydia trachomatis Ab
45008-0,Chlamydia trachomatis Ab
45009-8,Chlamydia trachomatis Ab
45010-6,Chlamydia sp Ab.IgG
45011-4,Chlamydia sp Ab
45012-2,Chlamydia sp Ab
Mar-01,Complement C4a
45013-0,Adenosine monophosphate.cyclic^2H post XXX challenge
45014-8,Adenosine monophosphate.cyclic^6H post XXX challenge
45015-5,Adenosine monophosphate.cyclic^baseline
45016-3,Adenosine monophosphate.cyclic^4H post XXX challenge
45017-1,Adenosine monophosphate.cyclic/Creatinine^baseline
45018-9,Adenosine monophosphate.cyclic/Creatinine^6H post XXX challenge
45019-7,Adenosine monophosphate.cyclic/Creatinine^2H post XXX challenge
45020-5,Adenosine monophosphate.cyclic/Creatinine^4H post XXX challenge
Jan-02,Complement C4b binding protein
45021-3,Metanephrine & Normetanephrine
45022-1,Methadone+Metabolite
45023-9,HLA typing for celiac disease panel
45024-7,HLA typing for narcolepsy panel
45025-4,HLA-A SBT
45026-2,HLA-A2 SBT
45027-0,HLA-A2 panel
45028-8,HLA-B SBT
45029-6,HLA-DQB1 SBT
45030-4,HLA-DRB1 SBT
45031-2,HLA-C SBT
45032-0,Tyrosine
45033-8,Cardiovascular assessment panel
45034-6,Bacteria producing catalase
45035-3,Bacterial virulence
45036-1,Bacteria producing oxidase
45037-9,Bacteria producing urease
45038-7,Bacteria producing arginine decarboxylase
Sep-03,Complement C4b binding protein
45039-5,Clostridium botulinum toxin
45040-3,Francisella tularensis Ab
45041-1,Francisella tularensis Ag
45042-9,XXX microorganism Ag
45043-7,Microscopic observation
45044-5,Bacteria producing indole
45045-2,Yersinia pestis Ab
45046-0,Bacteria producing X & V factors
Jul-04,Complement C4d
45047-8,Cortisol^12 AM specimen
45048-6,Cortisol^12 PM specimen
45049-4,Cortisol^4 PM specimen
45050-2,Cortisol^8 AM specimen
45051-0,Cortisol^8 PM specimen
45052-8,Glucose^12 AM specimen
45053-6,Glucose^8 AM specimen
Apr-05,Complement C5
45054-4,Glucose^12 PM specimen
45055-1,Glucose^4 PM specimen
45056-9,Glucose^8 PM specimen
45057-7,Cardiolipin Ab.IgA & IgG & IgM panel
45058-5,cycloSPORINE.monoclonal & polyclonal panel
45059-3,Ehrlichia chaffeensis Ab.IgG & IgM panel
45060-1,Protein & Glucose panel
45061-9,Spermatozoa Ab.IgA & IgG & IgM panel
Feb-06,Complement C5a
45062-7,C reactive protein
45063-5,Varicella zoster virus Ab.IgG & IgM panel
45064-3,Basic metabolic panel & Glomerular filtration rate.predicted
45065-0,Comprehensive metabolic panel & Glomerular filtration rate.predicted
45066-8,Creatinine & Glomerular filtration rate.predicted panel
45067-6,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA
45068-4,Chlamydia trachomatis+Neisseria gonorrhoeae DNA
45069-2,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA
450-7,Sisomicin
4507-0,Complement C6
45070-0,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA
45071-8,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA
45072-6,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA
45073-4,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA
45074-2,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA
45075-9,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA
45076-7,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA
45077-5,Chlamydia trachomatis rRNA
45078-3,Chlamydia trachomatis rRNA
45079-1,Chlamydia trachomatis rRNA
45080-9,Chlamydia trachomatis rRNA
45081-7,Chlamydia trachomatis rRNA
45082-5,Chlamydia trachomatis rRNA
45083-3,Chlamydia trachomatis rRNA
45084-1,Chlamydia trachomatis DNA
45085-8,Chlamydia trachomatis rRNA
45086-6,Chlamydia trachomatis DNA
45087-4,Chlamydia trachomatis DNA
Aug-08,Complement C7
45088-2,Chlamydia trachomatis rRNA
45089-0,Chlamydia trachomatis rRNA
45090-8,Chlamydia trachomatis DNA
45091-6,Chlamydia trachomatis Ag
45092-4,Chlamydia trachomatis Ag
45093-2,Chlamydia trachomatis
45094-0,Chlamydia trachomatis
45095-7,Chlamydia trachomatis
Jun-09,Complement C8
45096-5,Chlamydia trachomatis
45097-3,Chlamydia sp identified
45098-1,Chlamydia sp identified
45099-9,Chlamydia sp identified
45100-5,Chlamydia sp identified
45101-3,Chlamydia sp identified
45102-1,Chlamydia sp identified
45103-9,Chlamydia sp Ag
Apr-10,Complement C9
45104-7,Chlamydia sp Ag
45105-4,Chlamydia sp Ag
45106-2,Chlamydia sp Ag
45107-0,Chlamydia sp Ag
45108-8,Chlamydia sp Ag
45109-6,Chlamydia sp Ag
45110-4,Chlamydia sp Ag
45111-2,Chlamydia sp Ag
Feb-11,Complement total hemolytic CH50
45112-0,Chlamydia sp Ag
45113-8,Chlamydia sp Ag
45114-6,Chlamydia sp Ag
45115-3,Chlamydia sp Ag
45116-1,Mycobacterium gordonae rRNA
45117-9,Mycobacterium kansasii rRNA
45118-7,Vesicular stomatitis Indiana virus Ag
45119-5,Vesicular stomatitis Indiana virus 1 Ab
4512-0,Complement CH50
45120-3,Vesicular stomatitis Indiana virus Ag
45121-1,Cocal virus Ag
45122-9,Cocal virus Ag
45123-7,Cocal virus Ab.Neut
45124-5,Vesicular stomatitis Alagoas virus Ab.Neut
45125-2,Vesicular stomatitis Alagoas virus Ag
45126-0,Vesicular stomatitis Alagoas virus Ag
45127-8,Vesicular stomatitis New Jersey virus Ag
45128-6,Vesicular stomatitis New Jersey virus Ag
45129-4,Human prescription drug label with highlights
45130-2,Chlamydia trachomatis Ab
45131-0,Chlamydia sp Ag
45132-8,Chlamydia sp Ag
45133-6,Chlamydia sp Ag
45134-4,Campylobacter jejuni Ab.IgM
45135-1,Chlamydia trachomatis Ab.IgG
45136-9,Endomysium Ab.IgG
45137-7,IgA.secretory
Aug-13,Complement C1r2+C1s2
45138-5,Listeria monocytogenes O4b Ab.IgG
45139-3,Listeria monocytogenes O4b Ab.IgM
45140-1,Phenols
45141-9,Platelet associated Ab
45142-7,Sjogrens syndrome-B extractable nuclear Ab
45143-5,Methylenedioxyethylamphetamine
45144-3,clomiPRAMINE
45145-0,Methdilazine
Jun-14,Complement decay accelerating factor
45146-8,Triflupromazine
45147-6,Propiomazine
45148-4,OmpC Ab.IgA
45149-2,Ej Ab
451-5,Spectinomycin
45150-0,Neutrophil Ab
45151-8,Neutrophil cytoplasmic Ab
45152-6,OJ Ab
Mar-15,Complement factor B
45153-4,HLA Ab
45154-2,Phenylalanine hydroxylase Ab
45155-9,Platelet factor 4 heparin complex induced Ab
45156-7,Rheumatoid factor
45157-5,U2 small nuclear ribonucleoprotein Ab.IgG
45158-3,Immune complex
45159-1,Hepatitis B virus & Hepatitis D virus Ab
45160-9,Acremonium sp Ab
Jan-16,Complement factor Ba
45161-7,Hepatitis B virus DNA
45162-5,Escherichia coli O157 Ag
45163-3,Alternaria alternata Ab
45164-1,Asialoganglioside GM2 Ab
45165-8,Borrelia burgdorferi Ab.IgA
45166-6,Corynebacterium diphtheriae Ab.IgG
45167-4,IgE
45168-2,Malonate
45169-0,Ganglioside GM1 Ab.IgG
45170-8,Myelin associated glycoprotein Ab
45171-6,Pancreatic islet cell Ab
45172-4,Purkinje cells Ab
45173-2,Thyrotropin.alpha subunit
45174-0,Herpes gestationis Ab panel
45175-7,HIV nucleoside reverse transcriptase gene mutations detected
45176-5,HIV nonnucleoside reverse transcriptase gene mutations detected
45177-3,Herpes gestationis Ab.IgG.non-complement fixing
45178-1,Basement membrane zone Ab.IgG
Sep-17,Complement factor Bb
45179-9,Herpes gestationis Ab.IgG.complement fixing
45180-7,1p chromosome deletion
45181-5,19q chromosome deletion
45182-3,HIV phenotype
45183-1,Neisseria meningitidis
45184-9,11-Deoxycortisol/Cortisol
45185-6,2-Oxo-3-Hydroxy-Lysergate diethylamide
45186-4,Actinidia chinensis Ab.IgE/IgE.total
Jul-18,Complement factor D
45187-2,Antibiotic XXX
45188-0,Basement membrane zone BP180 Ab
45189-8,Borrelia burgdorferi Ab
45190-6,CASR gene targeted mutation analysis
45191-4,CAPN3 gene targeted mutation analysis
45192-2,Carnitine esters/Carnitine.free (C0)
45193-0,Cells.CD20+CD52+/100 cells
45194-8,Choriogonadotropin.intact+Beta subunit
May-19,Complement factor H
45195-5,Cow epithelium+Cow dander Ab.IgE
45196-3,Cytokines
45197-1,Decanoylcarnitine (C10)
45198-9,Decenoylcarnitine (C10:1)
45199-7,Dodecanoylcarnitine (C12)
45200-3,Dodecenoylcarnitine (C12:1)
45201-1,Egg whole Ab.IgG
45202-9,Ganglioside GD1a Ab
Mar-20,Complement factor I
45203-7,Ganglioside GQ1b Ab
45204-5,Glucose^3rd specimen post XXX challenge
45205-2,Glucose^4th specimen post XXX challenge
45206-0,Glucose^5th specimen post XXX challenge
45207-8,Glutarylcarnitine (C5-DC)
45208-6,Hemoglobin A
45209-4,Heptacarboxylporphyrin
45210-2,Herpes simplex virus 2 Ab.IgM
Jan-21,Complement factor P
45211-0,Hexanoylcarnitine (C6)
45212-8,HIV 2 p31+p34 Ab
45213-6,Isobutyrylcarnitine (C4)
45214-4,Isoleucine+Leucine
45215-1,Isoniazid 2.0 ug/mL
45216-9,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)
45217-7,Linoleoylcarnitine (C18:2)
45218-5,Lymphocytic choriomeningitis virus Ab.IgG
45219-3,Lymphocytic choriomeningitis virus Ab.IgG
45220-1,Lymphocytic choriomeningitis virus Ab.IgM
45221-9,Lymphocytic choriomeningitis virus Ab.IgM
45222-7,Methylmalonylcarnitine (C4-DC)
45223-5,Moxifloxacin
45224-3,Mycoplasma pneumoniae Ab.IgG
45225-0,Pancreatic islet cell complement fixing Ab
45226-8,Ribosomal P Ab.IgG
45227-6,Rubus fruticosus Ab.IgE/IgE.total
45228-4,Streptolysin O Ab
Sep-22,Complement iC3
45229-2,Toxocara cati Ab
452-3,Spectinomycin
45230-0,District where patient entered HIV Rx
45231-8,HIV Rx prior to enrollment
45232-6,Reason medically eligible for HIV Rx
45233-4,WHO HIV stage
45234-2,Date eligible and selected to start HIV Rx
45235-9,Date original clinic HIV Rx start
45236-7,HIV Rx cohort
Jul-23,Complement iC3b receptors
45237-5,Date lost to HIV Rx follow-up
45238-3,Date lost to HIV Rx therapy
45239-1,Current HIV Rx therapy duration
45240-9,Isoniazid therapy start date
45241-7,Tuberculosis status
45242-5,Tuberculosis treatment start date
45243-3,Reason for discontinuation of anti-infective phrophylaxis medication
45244-1,HIV ART medication dose number taken/Medication dose number prescribed
May-24,Complement membrane attack complex (C5b-C6-C7-C8-C9n)
45245-8,Degree of adherence to co-trimoxazole
45246-6,Degree of adherence to anti-retroviral drug regimen
45247-4,Reason for missing HIV Rx administration schedule
45248-2,Number of hospital D since last outpatient visit
45249-0,Evidence of tuberculosis resistance
45250-8,HIV confirmation facility
45251-6,HIV confirmation facility
Feb-25,Complement membrane C3b-C4b cofactor protein
45252-4,Institutional entry point HIV Rx
45253-2,HIV Rx prior clinic transferred from
45254-0,HIV Rx prior clinic transferred from
45255-7,HIV Rx clinic transferred to
45256-5,HIV Rx clinic transferred to
45257-3,Date dropped from HIV Rx
45258-1,HIV ART medication dose number taken/Medication dose number prescribed
45259-9,HIV ART actual prescription fills number/Ideal prescription fills number
4526-0,Complement protein
45260-7,HIV ART medication
45261-5,{HIV ART medication} doses missed yesterday
45262-3,{HIV ART medication} doses missed 2D ago
45263-1,{HIV ART medication} doses missed 3D ago
45264-9,{HIV ART medication} doses missed 4D ago
45265-6,Immunodeficiency markers
45266-4,Chronic leukemia markers
45267-2,Acute leukemia markers
45268-0,Immunodeficiency panel
45269-8,Chronic leukemia panel
45270-6,Acute leukemia panel
45271-4,Bordetella bronchiseptica DNA
45272-2,Sympathomimetics
45273-0,Pregnancy associated plasma protein A multiple of the median
45274-8,Low molecular weight heparin induced platelet Ab
45275-5,Bacteria identified
45276-3,Bacteria identified
45277-1,Lymphocytic choriomeningitis virus Ab.IgM
Aug-27,Complement receptor 1
45278-9,Lymphocytic choriomeningitis virus Ab.IgG
45279-7,Influenza virus A+B Ab
45280-5,Echovirus 9 Ab
45281-3,Echovirus 7 Ab
45282-1,Echovirus 30 Ab
45283-9,Echovirus 11 Ab
45284-7,DPYD gene targeted mutation analysis
45285-4,Date and time
Jun-28,Complement receptor 2
45286-2,Cytomegalovirus Ab.IgA
45287-0,Coxsackievirus B6 Ab
45288-8,Coxsackievirus B5 Ab
45289-6,Coxsackievirus B4 Ab
45290-4,Coxsackievirus B3 Ab
45291-2,Coxsackievirus B2 Ab
45292-0,Coxsackievirus B1 Ab
45293-8,Choriogonadotropin.beta subunit.free multiple of the median
Apr-29,Complement receptor 3
45294-6,Bordetella bronchiseptica DNA
45295-3,Acetylcholinesterase/Cholinesterase
45296-1,Cortisol^pre dose dexamethasone
45297-9,Glucose
45298-7,Glucose^2.5H post 50 g lactose PO
45299-5,Glucose^45M post dose lactose PO
45300-1,Glycerol
45301-9,Nortriptyline
Feb-30,Complement receptor 4
45302-7,Urea
45303-5,Urea^2H specimen
45304-3,Urea^4H specimen
45305-0,Coproporphyrin 1
45306-8,Coproporphyrin 3
45307-6,Deuteroporphyrin
45308-4,Heptacarboxylate
45309-2,Hexacarboxylate
453-1,Spectinomycin
4531-0,Complement total hemolytic
45310-0,Mesoporphyrin
45311-8,Pentacarboxylate
45312-6,Uroporphyrin 3 isomer
45313-4,Coproporphyrin 1/Creatinine
45314-2,Coproporphyrin 3/Coproporphyrin 1
45315-9,Coproporphyrin 3/Creatinine
45316-7,Hexacarboxylate/Creatinine
45317-5,Pentacarboxylate/Creatinine
45318-3,Uroporphyrin 3 isomer/Creatinine
45319-1,Uroporphyrin/Creatinine
45320-9,Ecgonine methyl ester
45321-7,FMR1 gene allele 1.CGG repeats
45322-5,FMR1 gene allele 2.CGG repeats
45323-3,Mycobacterium tuberculosis tuberculin stimulated gamma interferon
45324-1,Ethyl glucuronide
45325-8,Campylobacter jejuni Ab.IgG
45326-6,Cytomegalovirus Ab.IgG avidity
45327-4,FMR1 gene targeted mutation analysis
Aug-32,Complement total hemolytic CH50
45328-2,Glutathione peroxidase
45329-0,Glutathione reductase
45330-8,Leptospira interrogans Ab.IgG
45331-6,NF1 gene targeted mutation analysis
45332-4,NF2 gene targeted mutation analysis
45333-2,Superoxide dismutase
45334-0,Tryptase
45335-7,Bacteria identification test
Jun-33,Complement+Immunoglobulin
45336-5,Bacteria producing hemolysis
45337-3,Bacterial biochemical profile
45338-1,Proinsulin/Insulin
45339-9,Tick identified^^^4
45340-7,Tick identified^^^3
45341-5,Tick identified^^^2
45342-3,Tick identified
45343-1,Sex&Stage
Apr-34,Cyanmethemoglobin/Hemoglobin.total
45344-9,Mouth intact
45345-6,Engorgement
45346-4,Date tick removed
45347-2,Date tick attached
45348-0,Date tick acquired
45349-8,Condition of tick
45350-6,Tick identification panel
Jan-35,Cytotoxic percent reactive Ab
45351-4,Date of skin test
45352-2,Date skin test interpreted
45353-0,Date of analysis
45354-8,Date next dose
45355-5,Date Rh immune globulin given
45356-3,Time Rh immune globulin given
45357-1,Erythrocytes.filamented
45358-9,Length of calorie fast
45359-7,Length of time post dose
45360-5,Lymphocyte proliferation. 0.125 ug pokeweed mitogen stimulation
45361-3,Lymphocyte proliferation. 0.25 ug pokeweed mitogen stimulation
45362-1,Lymphocyte proliferation. 0.50 ug pokeweed mitogen stimulation
45363-9,Lymphocyte proliferation. 1.0 ug phytohemagglutinin stimulation
45364-7,Lymphocyte proliferation. 1.0 ug pokeweed mitogen stimulation
45365-4,Lymphocyte proliferation. 10 ug concanavalin A stimulation
45366-2,Lymphocyte proliferation. 2.0 ug phytohemagglutinin stimulation
45367-0,Lymphocyte proliferation. 20 ug concanavalin A stimulation
45368-8,Lymphocyte proliferation. 5 ug concanavalin A stimulation
Sep-36,Deoxyhemoglobin/Hemoglobin.total
45369-6,Lymphocyte proliferation. 0.5 ug phytohemagglutinin stimulation
45370-4,Platelet crossmatch
45371-2,Multiple pregnancy
45372-0,Blood pressure systolic & diastolic^post phlebotomy
45373-8,Medication route
45374-6,Specimen expiration date
45375-3,Time of analysis
45376-1,Date of transfusion reaction
Jul-37,Erythrocyte sedimentation rate
45377-9,Time of transfusion reaction
45378-7,Glutathione peroxidase
45379-5,Eosinophils
45380-3,Basophilic stippling.fine
45381-1,Basophilic stippling.coarse
45382-9,Epidermis Ab
45383-7,Leukocytes
45384-5,Leucine crystals
May-38,Erythrocyte sedimentation rate
45385-2,Hippurate crystals
45386-0,Epithelial casts
45387-8,Cystine crystals
45388-6,Calcium phosphate crystals
45389-4,Calcium carbonate crystals
45390-2,Epithelial cells.squamous
45391-0,Epithelial cells.renal
45392-8,First name
Mar-39,Erythrocyte sedimentation rate.Zeta
45393-6,Middle initial
45394-4,Last name
45395-1,Name suffix
45396-9,Social Security number
45397-7,Medicare or comparable number
45398-5,State provider number
45399-3,Federal provider number
45400-9,Medicaid number
Jan-40,Ethanol gelation
45401-7,Postal code
45402-5,Language.primary
45403-3,Room number
45404-1,Marital status
45405-8,Ability to understand others
45406-6,Change in communication &or hearing
45407-4,Vision
45408-2,Primary reason for assessment
45409-0,Codes for assessments required for Medicare PPS or the State
45410-8,Admitted from (at entry)
45411-6,Lived alone prior to admission
45412-4,History of prior stay at this nursing home
45413-2,History of stay in other nursing home
45414-0,History of stay in other residential facility
45415-7,History of stay at mental health &or psychiatric setting
45416-5,History of stay in mental retardation and developmental disabilities setting
45417-3,None of the listed prior residential settings
45418-1,Lifetime occupations
Sep-41,Euglobulin clot lysis
45419-9,Language.other
45420-7,Mental health history
45421-5,No mental retardation and developmental disabilities
45422-3,Down's syndrome
45423-1,Autism
45424-9,Epilepsy
45425-6,Other organic condition related to mental retardation and developmental disabilities
45426-4,Mental retardation and developmental disabilities with no organic condition
Jul-42,Haptoglobin
45427-2,Date background information form completed
45428-0,Stays up late at night
45429-8,Naps regularly during day
45430-6,Goes out 1 or more D a W
45431-4,"Stays busy with hobbies, reading or fixed daily routine"
45432-2,Spends most time alone or watching TV
45433-0,Moves independently indoors
45434-8,Use of tobacco products at least daily
May-43,Haptoglobin
45435-5,None of the listed cycle of daily events
45436-3,Distinct food preferences
45437-1,Eats between meals all or most D
45438-9,Use of alcohol at least weekly
45439-7,None of the listed eating patterns
45440-5,In bedclothes much of day
45441-3,Wakens to toilet all or most nights
45442-1,Has irregular bowel movement pattern
Mar-44,Hematocrit
45443-9,Showers for bathing
45444-7,Bathing in PM
45445-4,None of the listed additional ADL patterns
45446-2,Daily contact with relatives &or close friends
45447-0,"Usually attends church, temple, etc."
45448-8,Finds strength in faith
45449-6,Daily animal companion &or presence
4545-0,Hematocrit
45450-4,Involved in group activities
45451-2,None of the listed involvement patterns
45452-0,Unknown customary routine - resident &or family unable to provide information
45453-8,Date of last day of MDS observation period
45454-6,Original or corrected copy of form
45455-3,Date of reentry to facility
45456-1,Medicaid per diem
45457-9,Medicare per diem
45458-7,Medicare ancillary part A
45459-5,Medicare ancillary part B
45460-3,CHAMPUS Per Diem
45461-1,VA Per Diem
45462-9,Self or family pays for full per diem
45463-7,Medicaid resident liability or Medicare copayment
45464-5,Private insurance per diem
45465-2,Other per diem
45466-0,Legal guardian
45467-8,Other legal oversight
Aug-46,Hemoglobin A/Hemoglobin.total
45468-6,Health care durable power attorney
45469-4,Financial durable power attorney
45470-2,Family member responsible
45471-0,Patient responsible for self
45472-8,Responsibility - none of above
45473-6,Advance directive &or living will completed
45474-4,Advance directive - do not resuscitate
45475-1,Advance directive - do not hospitalize
Jun-47,Hemoglobin A1/Hemoglobin.total
45476-9,Advance directive - organ donation
45477-7,Advance directive - autopsy request
45478-5,Advance directive - feeding restrictions
45479-3,Advance directive - medication restrictions
45480-1,Advance directive - other treatment restrictions
45481-9,Advance directive - none
45482-7,Comatose
45483-5,Short-term memory OK
Apr-48,Hemoglobin A1c/Hemoglobin.total
45484-3,Long-term memory OK
45485-0,Can recall current season
45486-8,Can recall location of own room
45487-6,Can recall staff names &or faces
45488-4,Can recall that he or she is in nursing home
45489-2,Memory &or recall - none of above are recalled
454-9,Spectinomycin
45490-0,Cognitive skills for daily decision making
45491-8,Easily distracted
Feb-49,Hemoglobin A1c/Hemoglobin.total
45492-6,Periods of altered perception or awareness of surroundings
45493-4,Episodes of disorganized speech
45494-2,Periods of restlessness
45495-9,Periods of lethargy
45496-7,Mental function varies over the course of the day
45497-5,Change in cognitive status
45498-3,Hearing
45499-1,Hearing aid present & used
May-45,Aztreonam
4550-0,Hemoglobin A2
45500-6,Hearing aid present & not used regularly
45501-4,Other receptive communication techniques used
45502-2,No communication device
45503-0,Uses speech
45504-8,Uses written messages to express or clarify needs
45505-5,Uses American sign language or Braille
45506-3,Uses signs &or gestures &or sounds
45507-1,Uses communication board
45508-9,Uses other modes of expression
45509-7,Modes of expression - none of above
45510-5,Making self understood
45511-3,Speech clarity
45512-1,Side vision problems
45513-9,"Sees halos or rings around lights, flashes of light, or curtains over eyes"
45514-7,No visual limitations
45515-4,Visual appliances
45516-2,Resident made negative statements
45517-0,Repetitive questions
Aug-51,Hemoglobin A2/Hemoglobin.total
45518-8,Repetitive verbalizations
45519-6,Persistent anger with self or others
45520-4,Self deprecation
45521-2,Expression of what appear to be unrealistic fears
45522-0,Recurrent statements that something terrible is about to happen
45523-8,"Balance while sitting - position, trunk control"
45524-6,Range of motion
45525-3,Voluntary movement
Jun-52,Hemoglobin A2/Hemoglobin.total
45526-1,Range of motion
45527-9,Voluntary movement
45528-7,Range of motion
45529-5,Voluntary movement
45530-3,Range of motion
45531-1,Voluntary movement
45532-9,Range of motion
45533-7,Voluntary movement
Apr-53,Hemoglobin A2/Hemoglobin.total
45534-5,Other limitation or loss - range of motion
45535-2,Other limitation or loss - voluntary movement
45536-0,"Uses cane, walker or crutch"
45537-8,Wheeled self
45538-6,Other person wheeled
45539-4,Wheelchair primary mode of locomotion
45540-2,No modes of locomotion
45541-0,Bedfast all or most of the time
Feb-54,Hemoglobin A2/Hemoglobin.total
45542-8,Bed rails used for bed mobility or transfer
45543-6,Lifted manually
45544-4,Lifted mechanically
45545-1,Transfer aid
45546-9,No mode of transfer
45547-7,Repetitive health complaints
45548-5,Repetitive anxious complaints or concerns
45549-3,Unpleasant mood in morning
45550-1,Insomnia &or change in sleeping pattern
45551-9,"Sad, pained, or worried facial expressions"
45552-7,Crying or tearfulness
45553-5,Repetitive physical movements
45554-3,Withdrawal from activities of interest
45555-0,Reduced social interaction
45556-8,Mood persistence
45557-6,Change in mood
45558-4,Frequency of wandering
Sep-55,Hemoglobin A3/Hemoglobin.total
45559-2,Alterability of wandering
455-6,Spiramycin
45560-0,Frequency of verbally abusive behavioral symptoms
45561-8,Alterability of verbally abusive behavioral symptoms
45562-6,Frequency of physically abusive behavioral symptoms
45563-4,Alterability of physically abusive behavioral symptoms
45564-2,Frequency of socially inappropriate or disruptive behavioral symptoms
45565-9,Alterability of socially inappropriate or disruptive behavioral symptoms
45566-7,Frequency of resists care
Jul-56,Hemoglobin Abruzzo
45567-5,Alterability of resists care
45568-3,Change in behavioral symptoms
45569-1,At ease interacting with others
45570-9,At ease doing planned or structured activities
45571-7,At ease doing self-initiated activities
45572-5,Establishes own goals
45573-3,Pursues involvement in life of facility
45574-1,Accepts invitations to most group activities
May-57,Hemoglobin Abruzzo
45575-8,Sense of initiative - none of above
45576-6,Covert &or open conflict with or repeated criticism of staff
45577-4,Unhappy with roommate
45578-2,Unhappy with residents other than roommate
45579-0,Openly expresses conflict &or anger with family &or friends
45580-8,Absence of contact with family &or friends
45581-6,Recent loss of close family member &or friend
45582-4,Does not adjust easily to change in routines
Mar-58,Hemoglobin Barts
45583-2,No unsettled relationships
45584-0,Strong identification with past roles and life status
45585-7,Expresses sadness &or anger &or empty feeling over lost roles &or status
45586-5,"Resident perceives that daily routine (customary routine, activities) is very different from prior pattern in the community"
45587-3,Past roles - none of above
45588-1,Bed mobility - self-performance during assessment period
45589-9,Bed mobility - support provided during assessment period
45590-7,Transfer - self-performance during assessment period
Jan-59,Hemoglobin Barts
45591-5,Transfer - support provided during assessment period
45592-3,Walk in room - self-performance during assessment period
45593-1,Walk in room - support provided during assessment period
45594-9,Walk in corridor - self-performance during assessment period
45595-6,Walk in corridor - support provided during assessment period
45596-4,Locomotion on unit - self-performance during assessment period
45597-2,Locomotion on unit - support provided during assessment period
45598-0,Locomotion off unit - self-performance during assessment period
45599-8,Locomotion off unit - support provided during assessment period
45600-4,Dressing - self-performance during assessment period
45601-2,Dressing - support provided during assessment period
45602-0,Eating - self-performance during assessment period
45603-8,Eating - support provided during assessment period
45604-6,Toilet use - self-performance during assessment period
45605-3,Toilet use - support provided during assessment period
45606-1,Personal hygiene - self-performance during assessment period
45607-9,Personal hygiene - support provided during assessment period
45608-7,Bathing - self-performance during assessment period
Sep-60,Hemoglobin Bethesda
45609-5,Bathing - support provided during assessment period
45610-3,Balance while standing
45611-1,Task segmentation
45612-9,Resident believes he or she is capable of increased independence in at least some ADLs
45613-7,Direct care staff believe resident is capable of increased independence in at least some ADLs
45614-5,Resident able to perform tasks or activity but is very slow
45615-2,"Difference in ADL Self-Performance or ADL Support, comparing mornings to evenings"
45616-0,Activities of daily living rehabilitation potential - none of above
Jul-61,Hemoglobin C/Hemoglobin.total
45617-8,Change in activities of daily living function
45618-6,Bowel continence
45619-4,Bladder continence
45620-2,Bowel elimination pattern regular - at least one movement every three D
45621-0,Constipation
45622-8,Diarrhea
45623-6,Fecal impaction
45624-4,Bowel elimination pattern - none of above
May-62,Hemoglobin C/Hemoglobin.total
45625-1,Any scheduled toileting plan
45626-9,Bladder retraining program
45627-7,External catheter
45628-5,Indwelling catheter
45629-3,Intermittent catheter
45630-1,Did not use toilet room &or commode &or urinal
45631-9,Pads &or briefs used
45632-7,Enemas &or irrigation
Mar-63,Hemoglobin C/Hemoglobin.total
45633-5,Ostomy present
45634-3,Continence appliances and programs - none of above
45635-0,Change in urinary continence
45636-8,Diabetes mellitus
45637-6,Hyperthyroidism
45638-4,Hypothyroidism
45639-2,Arteriosclerotic heart disease
456-4,Spiramycin
45640-0,Cardiac dysrhythmias
Jan-64,Hemoglobin C-Harlem
45641-8,Congestive heart failure
45642-6,Deep vein thrombosis
45643-4,Hypertension
45644-2,Hypotension
45645-9,Peripheral vascular disease
45646-7,Other cardiovascular disease
45647-5,Arthritis
45648-3,Hip fracture
45649-1,Missing limb
45650-9,Osteoporosis
45651-7,Pathological bone fracture
45652-5,Alzheimer's disease
45653-3,Aphasia
45654-1,Cerebral palsy
45655-8,Cerebrovascular accident
45656-6,Dementia other than Alzheimer's disease
45657-4,Hemiplegia or hemiparesis
Aug-65,Hemoglobin Chesapeake
45658-2,Multiple sclerosis
45659-0,Paraplegia
45660-8,Parkinson's disease
45661-6,Quadriplegia
45662-4,Seizure disorder
45663-2,Transient ischemic attack
45664-0,Traumatic brain injury
45665-7,Anxiety disorder
Jun-66,Hemoglobin Chesapeake
45666-5,Depression
45667-3,Manic depression
45668-1,Schizophrenia
45669-9,Asthma
45670-7,Emphysema or COPD
45671-5,Cataracts
45672-3,Diabetic retinopathy
45673-1,Glaucoma
Apr-67,Hemoglobin Constant Spring
45674-9,Macular degeneration
45675-6,Allergies
45676-4,Anemia
45677-2,Cancer
45678-0,Renal failure
45679-8,None of the listed diseases or conditions
45680-6,Antibiotic resistant infection
45681-4,Infection with Clostridioides difficile
Feb-68,Hemoglobin Constant Spring
45682-2,Conjunctivitis
45683-0,HIV infection
45684-8,Pneumonia
45685-5,Respiratory infection
45686-3,Septicemia
45687-1,Sexually transmitted diseases
45688-9,Tuberculosis
45689-7,Urinary tract infection in last 30D
4569-0,Hemoglobin D/Hemoglobin.total
45690-5,Viral hepatitis
45691-3,Wound infection
45692-1,Infections - none of above
45693-9,Other current or more detailed diagnoses & ICD9 codes
45694-7,Weight gain or loss of 3+ Lbs. within a 7D period
45695-4,Inability to lie flat due to shortness of breath
45696-2,Dehydrated
45697-0,Insufficient fluid; did NOT consume all or almost all liquids provided during last 3D
45698-8,Delusions
45699-6,Dizziness or vertigo
45700-2,Edema
45701-0,Fever
45702-8,Hallucinations
45703-6,Internal bleeding
45704-4,Recurrent lung aspirations in last 90D
45705-1,Shortness of breath
45706-9,Syncope
45707-7,Unsteady gait
Aug-70,Hemoglobin D-Punjab
45708-5,Vomiting
45709-3,Problem conditions - none of above
45710-1,Pain frequency
45711-9,Pain intensity
45712-7,Back pain
45713-5,Bone pain
45714-3,Chest pain while doing usual activities
45715-0,Headache
Jun-71,Hemoglobin D-Punjab
45716-8,Hip pain
45717-6,Incisional pain
45718-4,Joint pain
45719-2,Soft tissue pain
457-2,Spiramycin
45720-0,Stomach pain
45721-8,Other pain
45722-6,Fell in past 30D
45723-4,Fell in past 31D-180D
Apr-72,Hemoglobin Denver
45724-2,Hip fracture in last 180D
45725-9,Other fracture in last 180D
45726-7,Accidents - none of above
45727-5,"Conditions &or diseases make resident's cognitive, ADL, mood or behavior patterns unstable"
45728-3,Resident experiencing an acute episode or a flare-up of a recurrent or chronic problem
45729-1,"End-Stage disease, 6 or fewer Mo to live"
45730-9,Stability of conditions - none of above
45731-7,Chewing problem
Feb-73,Hemoglobin E/Hemoglobin.total
45732-5,Swallowing problem
45733-3,Mouth pain
45734-1,Oral problems - none of above
45735-8,Weight loss
45736-6,Weight gain
45737-4,Complains about the taste of many foods
45738-2,Regular or repetitive complaints of hunger
45739-0,Leaves 25%+ food uneaten at most meals
4574-0,Hemoglobin E/Hemoglobin.total
45740-8,Nutritional problems - none of above
45741-6,Parenteral IV
45742-4,Feeding tube
45743-2,Mechanically altered diet
45744-0,Syringe or oral feeding
45745-7,Therapeutic diet
45746-5,Dietary supplement between meals
45747-3,"Plate guard, stabilized built-up utensil, etc."
45748-1,On a planned weight change program
45749-9,Nutritional approaches - none of above
45750-7,Proportion of total calories received through parenteral or tube feeding in last 7D
45751-5,Average fluid intake per D by IV or tube in last 7D
45752-3,Ventilator or respirator
45753-1,Alcohol or drug treatment program
45754-9,Alzheimer's or dementia special care unit
45755-6,Hospice care
45756-4,Pediatric unit
Jul-75,Hemoglobin E/Hemoglobin.total
45757-2,Respite care
45758-0,Training in skills required to return to the community
45759-8,Special treatments &or programs - none of above
45760-6,Number of D with at least 15M of speech language pathology and audiology services in the last 7D
45761-4,Total minutes of speech language pathology and audiology services in the last 7D
45762-2,Number of D with at least 15M of occupational therapy in the last 7D
45763-0,Total minutes of occupational therapy in the last 7D
45764-8,Number of D with at least 15M of physical therapy in the last 7D
May-76,Hemoglobin F/Hemoglobin.total
45765-5,Total minutes of physical therapy in the last 7D
45766-3,Number of D with at least 15M of respiratory therapy in the last 7D
45767-1,Total minutes of respiratory therapy in the last 7D
45768-9,Number of D with at least 15M of psychological therapy by any licensed mental health professional in the last 7D
45769-7,"Debris - soft, easily movable substances - present in mouth prior to going to bed at night"
45770-5,Has dentures or removable bridge
45771-3,Some or all natural teeth lost but does not have or use dentures or partial plates
45772-1,"Broken, loose, or carious teeth"
Mar-77,Hemoglobin F-Texas
45773-9,"Inflamed, swollen, or bleeding gums, oral abscesses; ulcers or rashes"
45774-7,Daily cleaning of teeth or dentures or mouth care by resident or staff
45775-4,Oral status &or disease prevention - none of above
45776-2,Ulcers.stage 1
45777-0,Ulcers.stage 2
45778-8,Ulcers.stage 3
45779-6,Ulcers.stage 4
45780-4,Pressure injury stage
Jan-78,Hemoglobin F-Texas
45781-2,Stasis ulcer stage
45782-0,History of resolved ulcers
45783-8,Abrasions or bruises
45784-6,Second or third degree burns
45785-3,"Open lesions other than ulcers, rashes, cuts"
45786-1,Rashes
45787-9,Skin desensitized to pain or pressure
45788-7,Skin tears or cuts (other than surgery)
45789-5,Surgical wounds
45790-3,Other skin problems - none of above
45791-1,Pressure relieving devices for chair
45792-9,Pressure relieving devices for bed
45793-7,Turning or repositioning program
45794-5,Nutrition or hydration intervention to manage skin problems
45795-2,Ulcer care
45796-0,Surgical wound care
45797-8,Application of dressings (with or without topical medications) other than to feet
45798-6,Application of ointments or medications other than to feet
Sep-79,Hemoglobin F
45799-4,Other preventative or protective skin care other than to feet
458-0,Spiramycin
45800-0,Skin treatments - none of above
45801-8,One or more foot problems
45802-6,Infection of foot
45803-4,Open lesions on the foot
45804-2,Nails &or calluses trimmed during last 90D
45805-9,Received preventative or protective foot care
45806-7,Application of dressings (foot) - with or without topical medications
Jul-80,Hemoglobin F1/Hemoglobin.total
45807-5,Foot problems and care - none of above
45808-3,Awake in morning
45809-1,Awake in afternoon
45810-9,Awake in evening
45811-7,Time awake - none of above
45812-5,Average time involved in activities
45813-3,Preferred activity setting - own room
45814-1,Preferred activity setting - day or activity room
May-81,Hemoglobin G-Coushatta
45815-8,Preferred activity setting - inside NH &or off unit
45816-6,Preferred activity setting - outside facility
45817-4,Preferred activitty setting - none of above
45818-2,Activity preferences - cards or other games
45819-0,Activity preferences - crafts or arts
45820-8,Activity preferences - exercise or sports
45821-6,Activity preferences - music
45822-4,Activity preferences - reading or writing
Mar-82,Hemoglobin G-Coushatta
45823-2,Activity preferences - spiritual or religious activities
45824-0,Activity preferences - trips or shopping
45825-7,Activity preferences - walking or wheeling outdoors
45826-5,Activity preferences - watching TV
45827-3,Activity preferences - gardening or plants
45828-1,Activity preferences - talking or conversing
45829-9,Activity preferences - helping others
45830-7,Activity preferences - none of above
Jan-83,Hemoglobin G-Georgia
45831-5,Type of activities in which resident is currently involved
45832-3,Extent of resident involvement in activities
45833-1,Number of medications
45834-9,New medications
45835-6,Number of D injections received
45836-4,Number of D antipsychotic medication received
45837-2,Number of D antianxiety medication received
45838-0,Number of D antidepressant medication received
45839-8,Number of D hypnotic medication received
45840-6,Number of D diuretic medication received
45841-4,Chemotherapy
45842-2,Dialysis
45843-0,IV medication
45844-8,Intake &or output
45845-5,Monitoring of acute medical condition
45846-3,Ostomy care
45847-1,Oxygen therapy
45848-9,Radiation
Sep-84,Hemoglobin G-Georgia
45849-7,Suctioning
45850-5,Tracheostomy care
45851-3,Transfusions
45852-1,Total minutes of psychological therapy by any licensed mental health professional in the last 7D
45853-9,Special behavior symptom evaluation program
45854-7,Evaluation by a licensed mental health specialist in last 90D
45855-4,Group therapy
Jun-85,Hemoglobin G-Philadelphia
45856-2,Resident-specific deliberate changes in the environment to address mood &or behavior patterns
45857-0,Reorientation
45858-8,"Mood, behavior, cognitive loss programs - none of above"
45859-6,Number of D of passive range of motion
45860-4,Number of D of active range of motion
45861-2,Number of D of splint or brace assistance
45862-0,Number of D of training & skill practice in bed mobility
45863-8,Number of D of training & skill practice in transfer
Apr-86,Hemoglobin G-Philadelphia
45864-6,Number of D of training & skill practice in walking
45865-3,Number of D of training & skill practice in dressing or grooming
45866-1,Number of D of training & skill practice in eating or swallowing
45867-9,Number of D of training & skill practice in amputation or prosthesis care
45868-7,Number of D of training & skill practice in communication
45869-5,Number of D of other rehabilitation or restorative techniques or procedures
45870-3,Bed rails - full bed rails on all open sides of bed
45871-1,Bed rails - other types of side rails used
Feb-87,Hemoglobin H/Hemoglobin.total
45872-9,Trunk restraint
45873-7,Limb restraint
45874-5,Chair prevents rising
45875-2,Number hospital admissions in last 90D
45876-0,Number of emergency room visits in last 90D
45877-8,Number of physician visits in last 14D
45878-6,Number of D physician orders changed in last 14D
45879-4,Abnormal lab values in last 90D
4588-0,Hemoglobin H/Hemoglobin.total
45880-2,Resident expresses &or indicates preference to return to the community
45881-0,Resident has a support person who is positive towards discharge
45882-8,Stay projected to be of a short duration - discharge projected within 90D
45883-6,Overall change in care needs
45884-4,Participation in assessment
45885-1,Participation in assessment
45886-9,Number of D recreation therapy administered for greater than 15M
45887-7,Total recreation therapy in last 7D
45888-5,Therapy orders to begin in 1st 14D of stay
45889-3,"Through D 15, provide an estimate of the number of D when at least 1 therapy service can be expected to have been delivered"
45890-1,"Through day 15, provide an estimate of the number of therapy minutes (across the therapies) that can be expected to be delivered"
45891-9,Furthest distance walked without sitting down during this episode
45892-7,Time walked without sitting down during this episode
45893-5,Self-Performance in walking during this episode
45894-3,Walking support provided
45895-0,Parallel bars used by resident in association with this episode
45896-8,Delirium trigger
45897-6,Cognitive loss or dementia trigger
Aug-89,Hemoglobin Hasharon
45898-4,Visual function trigger
45899-2,Communication trigger
45900-8,ADL-rehabilitation trigger A
45901-6,ADL-rehabilitation trigger B
45902-4,Urinary incontinence and indwelling catherter trigger
45903-2,Psychosocial well being trigger
45904-0,Mood state trigger
45905-7,Behavioral symptoms trigger
Jun-90,Hemoglobin Hasharon
45906-5,Activities trigger A
45907-3,Activities trigger B
45908-1,Falls trigger
45909-9,Nutritional status trigger
45910-7,Feeding tubes trigger
45911-5,Dehydration &or fluid maintenance trigger
45912-3,Dental care trigger
45913-1,Pressure injuries trigger
Apr-91,Hemoglobin Hope
45914-9,Psychotropic drug use trigger
45915-6,Physical restraints trigger
45916-4,Resident assessment protocol 1--Delirium - triggered
45917-2,Resident assessment protocol 1--Delirium - proceed with care
45918-0,Resident assessment protocol 2--Cognitive loss - triggered
45919-8,Resident assessment protocol 2--Cognitive loss - proceed with care
45920-6,Resident assessment protocol 3--Visual function - triggered
45921-4,Resident assessment protocol 3--Visual function - proceed with care
Feb-92,Hemoglobin Hope
45922-2,Resident assessment protocol 4--Communication - triggered
45923-0,Resident assessment protocol 4--Communication - proceed with care
45924-8,Resident assessment protocol 5--ADL functional &or rehab - triggered
45925-5,Resident assessment protocol 5--ADL functional &or rehab - proceed with care
45926-3,Resident assessment protocol 6--Urinary incontinence - triggered
45927-1,Resident assessment protocol 6--Urinary incontinence - proceed with care
45928-9,Resident assessment protocol 7--Psychosocial - triggered
45929-7,Resident assessment protocol 7--Psychosocial - proceed with care
4593-0,Hemoglobin I
45930-5,Resident assessment protocol 8--Mood state - triggered
45931-3,Resident assessment protocol 8--Mood state - proceed with care
45932-1,Resident assessment protocol 9--Behavioral symptoms - triggered
45933-9,Resident assessment protocol 9--Behavioral symptoms - proceed with care
45934-7,Resident assessment protocol 10--Activities - triggered
45935-4,Resident assessment protocol 10--Activities - proceed with care
45936-2,Resident assessment protocol 11--Falls - triggered
45937-0,Resident assessment protocol 11--Falls - proceed with care
45938-8,Resident assessment protocol 12--Nutritional status - triggered
45939-6,Resident assessment protocol 12--Nutritional status - proceed with care
45940-4,Resident assessment protocol 13--Feeding tubes - triggered
45941-2,Resident assessment protocol 13--Feeding tubes - proceed with care
45942-0,Resident assessment protocol 14--Dehydration &or Fluid maint - triggered
45943-8,Resident assessment protocol 14--Dehydration &or Fluid maint - proceed with care
45944-6,Resident assessment protocol 15--Dental care - triggered
45945-3,Resident assessment protocol 15--Dental care - proceed with care
45946-1,Resident assessment protocol 16--Pressure injuries - triggered
45947-9,Resident assessment protocol 16--Pressure injuries - proceed with care
Aug-94,Hemoglobin I
45948-7,Resident assessment protocol 17--Psychotropic drug - triggered
45949-5,Resident assessment protocol 17--Psychotropic drug - proceed with care
45950-3,Resident assessment protocol 18--Physical restraints - triggered
45951-1,Resident assessment protocol 18--Physical restraints - proceed with care
45952-9,National provider ID
45953-7,Influenza virus vaccine received in facility
45954-5,Reason influenza virus vaccine not received
May-95,Hemoglobin J-Baltimore
45955-2,Pneumococcal vaccine status up to date
45956-0,Reason pneumococcal vaccine not received
45957-8,Participation in assessment
45958-6,Other current or more detailed diagnoses & ICD9 codes^^^2
45959-4,Other current or more detailed diagnoses & ICD9 codes^^^3
45960-2,Other current or more detailed diagnoses & ICD9 codes^^^4
45961-0,Other current or more detailed diagnoses & ICD9 codes^^^5
45962-8,Minimum data set for nursing home resident assessment and care screen
Mar-96,Hemoglobin J-Baltimore
45963-6,MDS basic assessment tracking form - version 2.0
45964-4,Identification information section
45965-1,Name
45966-9,Social Security & Medicare numbers
45967-7,Facility provider numbers
45968-5,Reasons for assessment (basic)
45969-3,MDS background information at admission form - version 2.0
45970-1,Demographic information section
Jan-97,Hemoglobin J-Capetown
45971-9,Residential history 5Y prior to entry
45972-7,Language
45973-5,Conditions related to mental retardation and developmental disabilities status
45974-3,Mental retardation and developmental disabilities with organic condition
45975-0,Customary routine section
45976-8,Customary routine in year prior to date of entry
45977-6,Cycle of daily events
45978-4,Eating patterns
45979-2,ADL patterns
459-8,Streptomycin
45980-0,Involvement patterns
45981-8,MDS full assessment form - version 2.0
45982-6,Identification and background information section
45983-4,Assessment reference date
45984-2,Current payment sources for nursing home stay
45985-9,Responsibility &or legal guardian
45986-7,Advance directives
45987-5,Cognitive patterns section
45988-3,Memory
Sep-98,Hemoglobin J-Oxford
45989-1,Memory recall &or ability
45990-9,Indicators of delirium - periodic disorded thinking or awareness
45991-7,Communication and hearing patterns section
45992-5,Communication devices and techniques
45993-3,Modes of expression
45994-1,Vision patterns section
45995-8,Visual limitations and dificulties
45996-6,Mood and behavior patterns section
Jul-99,Hemoglobin J-Oxford
45997-4,"Indicators of depression, anxiety, sad mood"
45998-2,Verbal expressions of distress
45999-0,Sleep-cycle issues
46000-6,"Sad, apethetic, anxious appearance"
46001-4,Behavioral symptoms
46002-2,Psychosocial well being section
Mar-00,Hemoglobin Kansas
46003-0,Sense of initiative &or involvement
46004-8,Unsettled releationships
46005-5,Past roles
46006-3,Physical functioning and stuctural problems section
46007-1,ADL self performance or support
46008-9,Bathing
46009-7,Test for balance
46010-5,Functional limitation in range of motion
Jan-01,Hemoglobin Kempsey
46011-3,Modes of locomotion
46012-1,Modes of transfer
46013-9,ADL functional rehabilitation potential
46014-7,Continence in last 14D section
46015-4,Continence self-control categories
46016-2,Bowel elimination pattern
46017-0,Continence appliances and programs
46018-8,Disease or condition diagnoses section
46019-6,Diseases or conditions
46020-4,"Endocrine, metabolic or nutritional diseases or conditions"
46021-2,Heart or circulation diseases or conditions
46022-0,Musculoskeletal diseases or conditions
46023-8,Neurological diseases or conditions
46024-6,Psychiatric or mood diseases or conditions
46025-3,Pulmonary diseases or conditions
46026-1,Sensory diseases or conditions
46027-9,Other diseases or conditions
46028-7,Infections
Sep-02,Hemoglobin Kempsey
46029-5,Other current or more detailed diagnoses & ICD9 codes
46030-3,Health conditions section
46031-1,Indicators of fluid status
46032-9,Other indicators
46033-7,Pain symptoms
46034-5,Pain site
46035-2,Accidents
46036-0,Stability of conditions
Jul-03,Hemoglobin Koln
46037-8,Oral and nutritional status section
46038-6,Oral problems
46039-4,Height & weight
46040-2,Weight change
46041-0,Nutritional problems
46042-8,Nutritional approaches
46043-6,Parenteral or enteral intake
46044-4,Oral or dental status section
May-04,Hemoglobin Lepore
46045-1,Oral status and disease prevention
46046-9,Skin condition section
46047-7,Ulcers
46048-5,Type of ulcer
46049-3,Other skin problems or lesions present
46050-1,Skin treatments
46051-9,Foot problems and care
Feb-05,Hemoglobin Lepore
46052-7,Activity pursuit patterns section
46053-5,Time awake
46054-3,Preferred activity settings
46055-0,General activity preferences
46056-8,Prefers change in daily routine
46057-6,Medications section
46058-4,Days received the following medication
46059-2,Special treatments and procedures section
460-6,Streptomycin
4606-0,Hemoglobin M-Boston
46060-0,"Special treatments, procedures and programs"
46061-8,Special care
46062-6,Treatments
46063-4,Programs
46064-2,Therapies
46065-9,"Intervention programs for mood, behavior and cognitive loss"
46066-7,Nursing rehabilitation and restorative care
46067-5,Devices and restraints
46068-3,Discharge potential and overall status section
46069-1,Discharge potential
46070-9,Assessment information section
46071-7,Participation in assessment
46072-5,Therapy supplement for Medicare PPS section
46073-3,Special treatments and procedures
46074-1,Recreational therapy
46075-8,Walking when most self sufficient
46076-6,MDS supplemental items section - version 2.0
46077-4,Influenza vaccine
Aug-07,Hemoglobin M-Hyde park
46078-2,Pneumococcal vaccine
46079-0,Resident assessment protocol summary section
46080-8,Erythrocytes.CD55/100 erythrocytes
46081-6,Theophylline
46082-4,Influenza virus A Ag
46083-2,Influenza virus B Ag
46084-0,Immunoglobulin light chains
46085-7,Gamma hydroxybutyrate
Jun-08,Hemoglobin M-Iwate
46086-5,Creatinine^2H specimen
46087-3,Erythrocytes^2nd tube
46088-1,Leukocytes^2nd tube
46089-9,Leukocytes^3rd tube
46090-7,Leukocytes^4th tube
46091-5,Erythrocytes^3rd tube
46092-3,Erythrocytes^4th tube
46093-1,Calcium.ionized
Apr-09,Hemoglobin M-Milwaukee
46094-9,Plasmodium sp Ag
46095-6,Anabolic steroids
46096-4,Arsenic
46097-2,Time corticotropin given
46098-0,Sex
46099-8,Calcium^^corrected for albumin
46100-4,Pregnenolone^1H post 250 ug corticotropin
46101-2,Ordered therapies
Feb-10,Hemoglobin M-Saskatoon
46102-0,MDS quarterly assessment form - version 2.0
46103-8,MDS quarterly assessment form - version 2.0 - optional version for RUG-III
46104-6,MDS quarterly assessment form - version 2.0 - optional version for RUG-III 1997 update
46105-3,Problem conditions
46106-1,Medical record number
46107-9,Loss of interest
46108-7,18q chromosome deletion
46109-5,Rubella virus Ab.IgM
4611-0,Hemoglobin Malmo
46110-3,Rubella virus Ab.IgG
46111-1,Mycoplasma sp DNA
46112-9,Borrelia burgdorferi 18kD Ab.IgG
46113-7,Borrelia burgdorferi 23kD Ab.IgM
46114-5,Borrelia burgdorferi 23kD Ab.IgG
46115-2,Borrelia burgdorferi 28kD Ab.IgG
46116-0,Borrelia burgdorferi 30kD Ab.IgG
46117-8,Borrelia burgdorferi 39kD Ab.IgM
46118-6,Borrelia burgdorferi 39kD Ab.IgG
46119-4,Borrelia burgdorferi 41kD Ab.IgM
46120-2,Borrelia burgdorferi 41kD Ab.IgG
46121-0,Borrelia burgdorferi 45kD Ab.IgG
46122-8,Borrelia burgdorferi 58kD Ab.IgG
46123-6,Borrelia burgdorferi 66kD Ab.IgG
46124-4,Borrelia burgdorferi 93kD Ab.IgG
46125-1,Cardiolipin Ab
46126-9,Endomysium Ab.IgA
46127-7,Haptoglobin
Aug-12,Hemoglobin Malmo
46128-5,Tissue transglutaminase Ab.IgA
46129-3,Alpha 1 antitrypsin
46130-1,Prealbumin
46131-9,Clostridioides difficile toxin B
46132-7,Glycosaminoglycans/Creatinine
46133-5,Epithelial cells
46134-3,Granular casts
46135-0,Hyaline casts
Jun-13,Hemoglobin N-Baltimore
46136-8,Transitional cells
46137-6,Triple phosphate crystals
46138-4,Urate crystals
46139-2,Nutritional approaches (quarterly)
461-4,Streptomycin
46140-0,Problem conditions (quarterly)
46141-8,Other current diagnoses & ICD9 codes (quarterly)
46142-6,Infections (quarterly)
46143-4,Continence appliances and programs (quarterly)
Apr-14,Hemoglobin N-Baltimore
46144-2,Bowel elimination pattern (quarterly)
46145-9,Modes of transfer (quarterly)
46146-7,Bathing (quarterly)
46147-5,ADL self performance or support (quarterly)
46148-3,Nutritional approaches (quarterly RUG-III)
46149-1,Problem conditions (quarterly RUG-III)
46150-9,Diseases (quarterly RUG-III)
Jan-15,Hemoglobin N-Seattle
46151-7,Bowel elimination pattern (quarterly RUG-III)
46152-5,Diseases (quarterly RUG-III 97 update)
46153-3,Oral problems (quarterly RUG-II)
46154-1,Trichomonas vaginalis rRNA
46155-8,Ascaris lumbricoides adult Ab.IgG
46156-6,Ascaris lumbricoides larva Ab.IgG
46157-4,Aspergillus glaucus Ab
46158-2,Bartonella sp Ab.IgG
46159-0,Bartonella sp Ab.IgM
46160-8,Blastomyces dermatitidis Ab.IgG
46161-6,Borrelia burgdorferi 18kD Ab.IgG
46162-4,Borrelia burgdorferi 23kD Ab.IgG
46163-2,Borrelia burgdorferi 23kD Ab.IgM
46164-0,Borrelia burgdorferi 28kD Ab.IgG
46165-7,Borrelia burgdorferi 30kD Ab.IgG
46166-5,Borrelia burgdorferi 39kD Ab.IgG
46167-3,Borrelia burgdorferi 39kD Ab.IgM
46168-1,Borrelia burgdorferi 41kD Ab.IgG
Sep-16,Hemoglobin N-Seattle
46169-9,Borrelia burgdorferi 41kD Ab.IgM
46170-7,Borrelia burgdorferi 45kD Ab.IgG
46171-5,Borrelia burgdorferi 58kD Ab.IgG
46172-3,Borrelia burgdorferi 66kD Ab.IgG
46173-1,Borrelia burgdorferi 93kD Ab.IgG
46174-9,Borrelia burgdorferi Ab.IgA
46175-6,Cache valley virus Ab
46176-4,Chlamydia trachomatis D+E+F+G+H+I+J+K Ab.IgA
Jul-17,Hemoglobin O-Arab
46177-2,Chlamydia trachomatis D+E+F+G+H+I+J+K Ab.IgG
46178-0,Chlamydia trachomatis D+E+F+G+H+I+J+K Ab.IgM
46179-8,Chlamydophila sp Ab
46180-6,Classical swine fever virus Ab
46181-4,Coccidioides sp Ab.IgA
46182-2,Coccidioides sp Ab.IgG
46183-0,Coccidioides sp Ab.IgM
46184-8,Echinococcus granulosus Ab
May-18,Hemoglobin O-Arab
46185-5,Ehrlichia risticii Ab
46186-3,Equine herpesvirus 1 Ab
46187-1,Equine herpesvirus 2 Ab
46188-9,Equine herpesvirus 3 Ab
46189-7,Goose parvovirus Ab
46190-5,Herpes simplex virus Ab
46191-3,Histoplasma capsulatum Ab.IgG
46192-1,HTLV II Ab.IgG
Mar-19,Hemoglobin Ranier
46193-9,Infectious bronchitis virus JMK Ab
46194-7,Legionella non pneumophila sp Ab
46195-4,Legionella pneumophila 2+3+4+5+6+8 Ab
46196-2,Leptospira interrogans Ab.IgG
46197-0,Measles virus Ab
46198-8,Mycoplasma pneumoniae Ab.IgG
46199-6,Parainfluenza virus 1 Ab
46200-2,Parainfluenza virus 3 Ab
Jan-20,Hemoglobin S
46201-0,Porcine adenovirus Ab
46202-8,Psittacid herpesvirus 1 Ab
46203-6,Reagin Ab
46204-4,Salmonella typhi O D Ab
46205-1,Streptococcus pneumoniae Ab.IgG
46206-9,Treponema pallidum Ab
46207-7,PKD1 gene+PKD2 gene targeted mutation analysis
46208-5,Nursing notes
46209-3,Provider orders
46210-1,Note
46211-9,Postoperative photo
46212-7,Preoperative photo
46213-5,Tilt table study
46214-3,Intracardiac ablation study
46215-0,Note
46216-8,Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon
46217-6,Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells
46218-4,5-Fluorocytosine
Sep-21,Hemoglobin S
46219-2,Creatinine^4H specimen
462-2,Streptomycin
46220-0,Creatinine^overnight
46221-8,Glucose^2H specimen
46222-6,Glucose^4H specimen
46223-4,Glucose^overnight
46224-2,Coagulation thrombin induced^after addition of heparinase
46225-9,ABCA3 gene targeted mutation analysis
46226-7,SGCA gene targeted mutation analysis
Jul-22,Hemoglobin S
46227-5,DULoxetine
46228-3,Clenbuterol
46229-1,Furazabol
46230-9,Methanolone
46231-7,Cells.ZAP70/100 cells
46232-5,Cells.ZAP70/100 cells
46233-3,Cells.ZAP70/100 cells
46234-1,Cells.ZAP70/100 cells
May-23,Hemoglobin S
46235-8,Cells.ZAP70/100 cells
46236-6,HLA-B*51
46237-4,Lymphocytes.kappa/100 lymphocytes
46238-2,Lymphocytes.kappa/100 lymphocytes
46239-0,Chief complaint+Reason for visit
46240-8,Hospitalizations+Outpatient visits
46241-6,Hospital admission Dx
46242-4,Vital signs measurements
Mar-24,Hemoglobin S
46243-2,Urea^overnight
46244-0,Mycobacterium tuberculosis complex rpoB gene rifAMPin resistance mutation identified
46245-7,Mycobacterium tuberculosis pncA gene pyrazinamide resistance mutation
46246-5,Mycobacterium tuberculosis katG gene isoniazid high level resistance mutation
46247-3,Mycobacterium tuberculosis embB gene ethambutol resistance mutation
46248-1,Borrelia burgdorferi Ab.IgG & IgM
46249-9,Vaccination take-response type
4625-0,Hemoglobin S/Hemoglobin.total
46250-7,Vaccination take-response date
46251-5,Age group
46252-3,Acylcarnitine pattern
46253-1,Bordetella pertussis.filamentous hemagglutinin Ab.IgG
46254-9,Bordetella pertussis.pertussis toxin Ab.IgG
46255-6,Methyl ethyl ketone
46256-4,oxyCODONE.free
46257-2,Dihydrocodeine+Hydrocodol
46258-0,oxyMORphone.free
46259-8,Morphine.free
46260-6,HYDROmorphone.free
46261-4,HYDROcodone.free
46262-2,Codeine.free
46263-0,6-Monoacetylmorphine.free
46264-8,History of medical device use
46265-5,Cryofibrinogen
46266-3,Myeloperoxidase Ab
46267-1,Proteinase 3 Ab
Aug-26,Hemoglobin Yakima
46268-9,ABO & Rh group^post transfusion reaction
46269-7,Ercalcidiol
46270-5,ABO group^post transfusion reaction
46271-3,Blood group antibody screen^post transfusion reaction
46272-1,Appearance^post transfusion reaction
46273-9,Appearance^post transfusion reaction
46274-7,Direct antiglobulin test.polyspecific reagent^post transfusion reaction
46275-4,Major crossmatch^post transfusion reaction
Jun-27,Hemoglobin Yoshizuka
46276-2,Rh^post transfusion reaction
46277-0,Rh immune globulin given by
46278-8,Views for bone density
46279-6,Views for bone density
46280-4,Bone density
46281-2,Guidance for aspiration or injection of cyst
46282-0,Guidance for aspiration or injection of cyst
46283-8,Guidance for percutaneous aspiration.fine needle
Apr-28,Hemoglobin Ypsilanti
46284-6,Guidance for percutaneous aspiration.fine needle
46285-3,Guidance for biopsy.core needle
46286-1,Guidance for biopsy.needle
46287-9,Guidance for biopsy.needle
46288-7,Guidance for biopsy
46289-5,Guidance for percutaneous biopsy^WO & W contrast IV
46290-3,Guidance for percutaneous biopsy^WO contrast
46291-1,Guidance for drainage+placement of drainage catheter^WO & W contrast IV
Feb-29,Hemoglobin Zurich
46292-9,Guidance for drainage+placement of drainage catheter^W contrast IV
46293-7,Guidance for drainage+placement of drainage catheter^WO contrast
46294-5,Guidance for percutaneous replacement of drainage catheter
46295-2,Guidance for percutaneous biopsy.core needle
46296-0,Guidance for percutaneous biopsy.core needle
46297-8,Multisection^W radionuclide IV
46298-6,Multisection
46299-4,Multisection
Mar-46,Aztreonam
463-0,sulfADIAZINE
4630-0,Hemoglobin Zurich
46300-0,Multisection coronal
46301-8,Multisection limited
46302-6,Multisection limited
46303-4,Multisection limited
46304-2,Multisection limited^WO contrast
46305-9,Multisection
46306-7,Multisection^W contrast IV
46307-5,Multisection^WO & W contrast IV
46308-3,Multisection^WO & W contrast IV
46309-1,Multisection^WO & W contrast IV
46310-9,Multisection^WO & W contrast IV
46311-7,Multisection^WO & W contrast IV
46312-5,Multisection^WO & W contrast IV
46313-3,Multisection^WO & W reduced contrast volume IV
46314-1,Multisection^WO & W reduced contrast volume IV
46315-8,Multisection^WO & W reduced contrast volume IV
46316-6,Multisection^WO & W reduced contrast volume IV
46317-4,Multisection^WO & W reduced contrast volume IV
Aug-31,Hemoglobin F
46318-2,Multisection^WO & W reduced contrast volume IV
46319-0,Multisection^W contrast IS
46320-8,Multisection^W contrast IV
46321-6,Multisection^W contrast IV
46322-4,Multisection^W contrast IV
46323-2,Multisection^W contrast IV
46324-0,Multisection^W contrast IV
46325-7,Multisection^W reduced contrast volume IV
Jun-32,Hemoglobin F
46326-5,Multisection^W reduced contrast volume IV
46327-3,Multisection^W reduced contrast volume IV
46328-1,Multisection^W reduced contrast volume IV
46329-9,Multisection^W reduced contrast volume IV
46330-7,Multisection^W reduced contrast volume IV
46331-5,Multisection^WO contrast
46332-3,Multisection^WO contrast
46333-1,Multisection^WO contrast
Apr-33,Hemoglobin F/Hemoglobin.total
46334-9,Guidance for stone removal^W contrast intra biliary duct
46335-6,View
46336-4,View
46337-2,View
46338-0,View
46339-8,Views
46340-6,Views
46341-4,Views
Feb-34,Hemoglobin.fetal
46342-2,Views
46343-0,Views GE 3
46344-8,Views GE 3
46345-5,Views GE 3
46346-3,Views GE 3
46347-1,Views GE 3
46348-9,Views GE 2 + PA + lateral
46349-7,Views AP + transthoracic
46350-5,Views diagnostic
46351-3,Views displacement for implant
46352-1,Views^during surgery W contrast intra duct
46353-9,Views PA & lateral & oblique
46354-7,Views screening
46355-4,Views screening
46356-2,Views screening
46357-0,Views^W air contrast PR
46358-8,Multisection
Sep-35,Hemoglobin.free
46359-6,Multisection
46360-4,Multisection^WO & W contrast IV
46361-2,Views ventilation^W Xe-133 IH
46362-0,Multisection
46363-8,Multisection
46364-6,Multisection
46365-3,Guidance for ablation of tissue
46366-1,Guidance for percutaneous biopsy^W radionuclide IV
Jul-36,Hemoglobin.free
46367-9,Guidance for biopsy.needle
46368-7,Guidance for biopsy.needle
46369-5,Guidance for biopsy
46370-3,Guidance for biopsy
46371-1,Guidance for change of percutaneous tube^W contrast
46372-9,Guidance for percutaneous drainage+placement of drainage catheter
46373-7,Guidance for placement of tube^W radionuclide IV
46374-5,Multisection
May-37,Hemoglobin.glycated
46375-2,Multisection
46376-0,Views^W contrast antegrade
46377-8,Views GE 3
46378-6,Views PA^W standing + W flexion
46379-4,Multisection
46380-2,Views for implant
46381-0,Views
46382-8,Multisection
Mar-38,Hemoglobin.thermolabile/Hemoglobin.total
46383-6,Views for bone density
46384-4,Guidance for superficial biopsy^W radionuclide IV
46385-1,Multisection for graft
46386-9,Views bitewing
46387-7,Guidance for percutaneous aspiration.fine needle
46388-5,Multisection
46389-3,Views + radial head capitellar
46390-1,Views GE 3
Jan-39,Hemoglobin.unstable
46391-9,Views
46392-7,Guidance for injection
46393-5,Multisection^W Xe-133 IH
46394-3,Multisection dynamic^W contrast IV
46395-0,Multisection gated+ejection fraction^at rest+W stress+W radionuclide IV
46396-8,Multisection gated^at rest+W Tc-99m Sestamibi IV
46397-6,Cortisol^15M post 1 ug/kg CRH IV
46398-4,Cortisol^1.5H post 1 ug/kg CRH IV
46399-2,Cortisol^2H post 1 ug/kg CRH IV
46400-8,Corticotropin^15M post 1 ug/kg CRH IV
46401-6,Corticotropin^1.5H post 1 ug/kg CRH IV
46402-4,Corticotropin^2H post 1 ug/kg CRH IV
46403-2,Cortisol^2H post dose insulin IV
46404-0,Somatotropin^2H post dose insulin IV
46405-7,Somatotropin^30M pre 1 g/kg glucose PO
46406-5,Somatotropin^30M post 1 g/kg glucose PO
46407-3,Somatotropin^1.5H post 1 g/kg glucose PO
46408-1,Somatotropin^15M pre dose arginine
Sep-40,Hemolysin.cold
46409-9,Somatotropin^15M post dose arginine
46410-7,Somatotropin^30M post dose arginine
46411-5,Somatotropin^45M post dose arginine
46412-3,Somatotropin^105M post dose arginine
46413-1,Calcitonin^7M post 0.5 ug/kg pentagastrin IV
46414-9,Lutropin^15M post dose gonadotropin releasing hormone
46415-6,Lutropin^45M post dose gonadotropin releasing hormone
46416-4,Cortisol^8H post 8 mg dexamethasone PO overnight high dose
Jul-41,Hemolysin.warm
46417-2,Coagulation tissue factor induced
46418-0,Coagulation tissue factor induced.INR
46419-8,Erythrocytes
46420-6,Leukocyte clumps
46421-4,Mucus
46422-2,Trichomonas vaginalis
46423-0,Hemoglobin distribution width
46424-8,Hemolysis interference index
May-42,Hemopexin
46425-5,Lipemic interference index
46426-3,Icteric interference index
46427-1,Beta fructofuranosidase
46428-9,Xylose^15M post 25 g xylose PO
46429-7,Alpha 1 antitrypsin
46430-5,Alpha 1 antitrypsin
46431-3,Alpha 1 antitrypsin
46432-1,Hydrogen/Expired gas^post 50 g lactose PO
Mar-43,Hemosiderin
46433-9,Hydrogen/Expired gas^post 10 g lactulose PO
46434-7,"t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript"
46435-4,Rheumatoid factor & Cyclic citrullinated peptide Ab.IgG
46436-2,Histamine
46437-0,Rheumatoid factor & Cyclic citrullinated peptide Ab.IgG panel
46438-8,Cancer identification section
46439-6,Demographic section
46440-4,Edit overrides &or Conversion history &or System admin section
Jan-44,Hemosiderin
46441-2,Follow-up &or Recurrence &or Death section
46442-0,Hospital-confidential section
46443-8,Hospital-specific section
46444-6,Other-confidential section
46445-3,Patient-confidential section
46446-1,Record ID section
46447-9,Special use section
46448-7,Stage &or prognostic factors section
46449-5,Text-diagnosis section
46450-3,Text-miscellaneous section
46451-1,Text-treatment section
46452-9,Treatment-1st course section
46453-7,Treatment-subsequent & other section
46454-5,Shigella sp
46455-2,Shigella sp DNA
46456-0,CMS certification number
46457-8,Inpatient discharge facility
Aug-45,Hemosiderin
46458-6,Inpatient facililty diagnoses
46459-4,Changed medical regimen diagnoses
46460-2,Number of pressure injuries at each stage
46461-0,Emergent care
46462-8,Outcome and assessment information set (OASIS) form - version B1
46463-6,Race or ethnicity
46464-4,Current payment sources for home care
46465-1,Conditions prior to medical or treatment regimen change or inpatient stay within past 14D
Jun-46,Heparin
46466-9,Therapeutic substance administered at home
46467-7,Risk factors
46468-5,Current living arrangement
46469-3,Assisting person(s) other than home care agency staff
46470-1,Type of primary caregiver assistance
46471-9,At home respiratory treatments
46472-7,Depressive feelings
46473-5,"Cognitive, behavioral, and psychiatric symptoms demonstrated at least one time per W"
Apr-47,Heparin
46474-3,Emergent care reason
46475-0,Discharge support services or assistance
46476-8,Reason for hospitalization
46477-6,Reason for nursing home admission
46478-4,Grooming
46479-2,Ability to dress upper body
464-8,sulfADIAZINE
46480-0,Ability to dress lower body
46481-8,Toileting
Feb-48,Homologous restriction factor
46482-6,Transferring
46483-4,Locomotion
46484-2,Feeding or eating
46485-9,Planning & preparing light meals
46486-7,Transportation
46487-5,Laundry
46488-3,Housekeeping
46489-1,Shopping
4649-0,Interferon
46490-9,Ability to use telephone
46491-7,Management of oral medications
46492-5,Management of inhalant &or mist medications
46493-3,Medicaid provider number
46494-1,State location of agency branch
46495-8,Branch number
46496-6,Agency patient number
46497-4,Start of care date
46498-2,Resumption of care date
46499-0,State of residence
46500-5,Discipline of person completing assessment
46501-3,Date assessment information completed
46502-1,Reason for assessment
46503-9,Most recent inpatient discharge date
46504-7,Inpatient stay within last 14D - ICD code
46505-4,Inpatient stay within last 14D - ICD code^^^2
46506-2,Medical or treatment regimen change in past 14D
46507-0,Regimen change in past 14D - ICD code
Aug-50,Interleukin 1
46508-8,Regimen change in past 14D - ICD code^^^2
46509-6,Regimen change in past 14D - ICD code^^^3
46510-4,Regimen change in past 14D - ICD code ^^^4
46511-2,Primary diagnosis ICD code
46512-0,Primary diagnosis severity rating
46513-8,Other diagnosis 1 - ICD code
46514-6,Other diagnosis 1 - severity rating
46515-3,Other diagnosis 2 - ICD code
Jun-51,Interleukin 2
46516-1,Other diagnosis 2 - severity rating
46517-9,Other diagnosis 3 - ICD code
46518-7,Other diagnosis 3 - severity rating
46519-5,Other diagnosis 4 - ICD code
46520-3,Other diagnosis 4 - severity rating
46521-1,Other diagnosis 5 - ICD code
46522-9,Other diagnosis 5 - severity rating
46523-7,Overall prognosis for recovery from this episode
Apr-52,Interleukin 3
46524-5,Rehabilitative prognosis
46525-2,Life expectancy
46526-0,Current residence
46527-8,Primary caregiver
46528-6,Frequency of primary caregiver assistance
46529-4,Sensory status - vision
46530-2,Sensory status - hearing and ability to understand spoken language
46531-0,Sensory status - speech and oral expression of language
Feb-53,Interleukin 4
46532-8,Sensory status - frequency of pain
46533-6,Experiencing intractable pain
46534-4,Skin lesion or open wound
46535-1,Pressure injury
46536-9,Number of pressure injuries - stage 1
46537-7,Number of pressure ulcers - stage 2
46538-5,Number of pressure ulcers - stage 3
46539-3,Number of pressure ulcers - stage 4
4654-0,Interleukin 5
46540-1,Unobserved pressure injury
46541-9,Stage of most problematic pressure injury
46542-7,Status of most problematic pressure injury
46543-5,Stasis ulcer
46544-3,Number of stasis ulcers
46545-0,Unobserved stasis ulcer
46546-8,Status of most problematic stasis ulcer
46547-6,Surgical wound
46548-4,Number of surgical wounds
46549-2,Unobserved surgical wound
465-5,sulfADIAZINE
46550-0,Status of most problematic surgical wound
46551-8,When short of breath
46552-6,Treated for urinary tract infection in past 14D
46553-4,Urinary incontinence or urinary catheter present
46554-2,Prior - ambulation
46555-9,Current ability - ambulation
46556-7,Prior - feeding
Jul-55,Interleukin 6
46557-5,Current ability - feeding
46558-3,Prior - prepare light meals
46559-1,Current ability - prepare light meals
46560-9,Prior - transportation
46561-7,Current ability - transportation
46562-5,Prior - laundry
46563-3,Current ability - laundry
46564-1,Prior - housekeeping
May-56,Interleukin 7
46565-8,Current ability - housekeeping
46566-6,Prior - shopping
46567-4,Current ability - shopping
46568-2,Prior - telephone use
46569-0,Telephone use - functional ability
46570-8,Prior - management of oral medications
46571-6,Current ability - management of oral medications
46572-4,Prior - management of inhalant medications
Mar-57,Kallikrein
46573-2,Current ability - management of inhalant medications
46574-0,Prior - management of injectable medications
46575-7,Current ability - management of injectable medications
46576-5,Management of equipment
46577-3,Management of equipment
46578-1,Admitted to
46579-9,Discharge disposition
46580-7,Acute care hospitalization reason
Jan-58,Kallikrein.tissue type
46581-5,Date of last home visit
46582-3,"Discharge, transfer, death date"
46583-1,Therapy need
46584-9,Payment diagnosis - primary ICD code
46585-6,Payment diagnosis - first secondary ICD
46586-4,When urinary incontinence occurs
46587-2,Bowel incontinence frequency
46588-0,Ostomy for bowel elimination
46589-8,Cognitive functioning
46590-6,When confused
46591-4,When anxious
46592-2,Frequency of behavior problems
46593-0,Receives psychiatric nursing
46594-8,Prior - grooming
46595-5,Grooming - functional ability
46596-3,Prior - dress upper body
46597-1,Dress upper body - functional ability
46598-9,Prior - dress lower body
Sep-59,Phosphatase.leukocyte
46599-7,Dress lower body - functional ability
46600-3,Prior - bathing
46601-1,Current ability - bathing
46602-9,Prior - toileting
46603-7,Current ability - toileting
46604-5,Prior - transferring
46605-2,Current ability - transferring
46606-0,Bathing ability
Jul-60,Leukocyte.detection Ab
46607-8,Gender
46608-6,Primary referring physician ID
46609-4,Diagnosis and severity index
46610-2,Payment diagnosis
46611-0,Mental residual functional capacity (RFC) assessment form
46612-8,Summary conclusions
46613-6,Remembers locations & worklike procedures
46614-4,Understands & remembers very short & simple instructions
May-61,Lupus erythematosus factor
46615-1,Understands & remembers detailed instructions
46616-9,Carries out very short & simple instructions
46617-7,Carries out detailed instructions
46618-5,Maintains attention & concentration for extended periods
46619-3,"Performs activities within a schedule, maintains regular attendance, is punctual within customary tolerances"
46620-1,Sustains an ordinary routine without special supervision
46621-9,Works in coordination with or proximity to others without being distracted by them
46622-7,Makes simple work-related decisions
Mar-62,Lymphocytes+Monocytes/100 leukocytes
46623-5,Completes normal workday & week WO interruptions from psych symptoms & performs at consistent pace WO unreasonable number & length of rests
46624-3,Interacts appropriately with the general public
46625-0,Asks simple questions or request assistance
46626-8,Accepts instructions & respond appropriately to criticism from supervisors
46627-6,Gets along with coworkers or peers WO distracting them or exhibiting behavioral extremes
46628-4,Maintains socially appropriate behavior & adheres to basic standards of neatness & cleanliness
46629-2,Responds appropriately to changes in the work setting
466-3,sulfADIAZINE
46630-0,Aware of normal hazards & take appropriate precautions
Jan-63,Lymphocytotoxicity
46631-8,Travels in unfamiliar places or use public transportation
46632-6,Sets realistic goals or make plans independently of others
46633-4,Remarks
46634-2,Functional capacity assessment
46635-9,Categories
46636-7,Date form completed
46637-5,Residual physical functional capacity (RFC) assessment form
46638-3,IP CDB claim numberholder
46639-1,Diagnosis.primary
46640-9,Secondary diagnosis
46641-7,Other alleged impairments
46642-5,Limitations section
46643-3,Exertional limitations
46644-1,No exertional limitations
46645-8,Occasionally lift &or carry
46646-6,Frequently lift &or carry
46647-4,Stand &or walk
46648-2,Sit
Sep-64,Lymphocytotoxicity
46649-0,Push &or pull
46650-8,Exertional limitations
46651-6,Postural limitations
46652-4,No postural limitations
46653-2,Climbing
46654-0,Balancing
46655-7,Stooping
Jun-65,Lysozyme
46656-5,Kneeling
46657-3,Crouching
46658-1,Crawling
46659-9,Postural limitations
46660-7,Manipulative limitations
46661-5,No manipulative limitations
46662-3,Reaching in all directions
46663-1,Handling
Apr-66,Osmotic fragility
46664-9,Fingering
46665-6,Feeling
46666-4,Manipulative limitations
46667-2,Visual limitations
46668-0,No visual limitations
46669-8,Near acuity
46670-6,Far acuity
46671-4,Depth perception
Feb-67,Osmotic fragility
46672-2,Accommodation
46673-0,Color vision
46674-8,Field of vision
46675-5,Visual limitations
46676-3,Communicative limitation
46677-1,No communicative limitations
46678-9,Hearing
46679-7,Speaking
4668-0,Plasminogen Ag
46680-5,Communicative limitation
46681-3,Environmental limitations
46682-1,Extreme cold
46683-9,Extreme heat
46684-7,Wetness
46685-4,Humidity
46686-2,Noise
46687-0,Vibrations
46688-8,"Fumes, odors, dusts, gases, poor ventilation, etc"
46689-6,Hazards
46690-4,Environmental limitations
46691-2,Symptoms
46692-0,Treatment or examining source statements
46693-8,Treating or examining source statement regarding claimant's physical capacities in file
46694-6,Treating or examining source conclusions about the claimant's limitations or restrictions which are significantly different from your file
46695-3,Why conclusions are not supported by the evidence in file
46696-1,Additional comments
46697-9,Date
Aug-69,Prekallikrein
46698-7,Cyanide
46699-5,Fibroblast growth factor 23
46700-1,7-Dehydrocholesterol
46701-9,Adenosine triphosphate
46702-7,Leukocytes
46703-5,Dihydrocodeine.free+Hydrocodol.free
46704-3,Dihydrocodeine.free+Hydrocodol.free
46705-0,Clostridium botulinum toxin gene
Jun-70,Thrombomodulin factor B
46706-8,Clostridium perfringens toxin gene
46707-6,(Anacardium occidentale+Carya illinoinensis+Juglans spp+Pistacia vera) Ab.IgE
46708-4,(Arachis hypogaea+Bertholletia excelsa+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE
46709-2,(Artemisia vulgaris+Chenopodium album+Plantago lanceolata+Solidago virgaurea+Urtica dioica) Ab.IgE
467-1,Sulfamethoxazole
46710-0,(Beef+Chicken meat+Pork+Turkey meat) Ab.IgE
46711-8,(Brassica oleracea var italica+Daucus carota+Phaseolus vulgaris+Pisum sativum+Zea mays) Ab.IgE
46712-6,(Gadus morhua+Mytilus edulis+Pandalus borealis+Salmo salar+Thunnus albacares) Ab.IgE
46713-4,(Hordeum vulgare+Oryza sativa+Secale cereale+Triticum aestivum) Ab.IgE
Apr-71,Protein C
46714-2,(Malus sylvestris+Musa spp+Prunus persica+Pyrus communis) Ab.IgE
46715-9,B cell crossmatch
46716-7,Ceruloplasmin
46717-5,Coagulation thrombin induced.factor substitution^immediately after addition of bovine thrombin
46718-3,Aquaporin 4 water channel Ab.IgG
46719-1,Streptomycin 4.0 ug/mL
46720-9,T cell crossmatch
46721-7,Ustilago nuda Ab.IgE
Feb-72,Protein C Ag
46722-5,Cells.ZAP70
46723-3,Alpha-1-Microglobulin
46724-1,CYP2C9 gene allele
46725-8,Tropheryma whipplei DNA
46726-6,HTR2A gene+HTR2C gene targeted mutation analysis
46727-4,Prolactin.monomeric
46728-2,Weight
46729-0,Weight container+Specimen
4673-0,HLA-B27
46730-8,Bacterial vaginosis whiff test
46731-6,RHCE gene allele Cc
46732-4,Francisella tularensis subtype
46733-2,Amino acidemias
46734-0,Citrullinemias &or arginosuccinic aciduria
46735-7,Endocrine disorders
46736-5,Fatty acid oxidation defects
46737-3,Galactosemias
46738-1,Genetic disorders
46739-9,Glutaric acidemia type 1
46740-7,Hemoglobin disorders
46741-5,Homocystinuria &or other hypermethioninemias
46742-3,Isovaleric acidemia &or 2-Methylbutyric acidemia
46743-1,Maple syrup urine disease
46744-9,Organic acidemias
46745-6,Other amino acidopathies
46746-4,Phenylketonuria and variants &or biopterin defects
46747-2,Propionic &or methylmalonic acidemias
Aug-74,Protein C inhibitor.activated
46748-0,Tyrosinemias
46749-8,3-Methylcrotonic &or hydroxymethylglutaric &or methylglutaconic
46750-6,2-Methyl-3-Hydroxybutyric acidemias &or beta ketothiolase deficiency
46751-4,Other organic acidemias
46752-2,Medium chain acyl dehydrogenase deficiency &or glutaric acidemia type 2
46753-0,Very long chain hydroxy acyl dehydrogenase deficiency
46754-8,Long chain hydroxy acyl dehydrogenase &or trifunctional protein deficiencies
May-75,HLA-B35
46755-5,Carnitine uptake defect &or CPT1 deficiency
46756-3,Other fatty acid oxidation disorders
46757-1,Congenital hypothyroidism
46758-9,Congenital adrenal hyperplasia
46759-7,"Hb SS, Hb SC, Hb SB thal"
46760-5,Other hemoglobinopathies
46761-3,Biotinidase deficiency
46762-1,Congenital hypothyroidism
Mar-76,HLA-B35
46763-9,Secondary congenital hypothyroidism
46764-7,Thyroid binding globulin deficiency
46765-4,Sickle cell anemia
46766-2,Hemoglobin SC disease
46767-0,Hemoglobin S beta thalassemia
46768-8,Sickle cell carrier (trait)
46769-6,Cystic fibrosis
46770-4,Hearing loss
Jan-77,Protein S.free Ag
46771-2,Classical galactosemia
46772-0,Galactokinase deficiency
46773-8,Galactose epimerase deficiency
46774-6,Carnitine uptake deficiency
46775-3,Carnitine palmitoyltransferase 1 deficiency
46776-1,CPT2 &or CACT
46777-9,Glutaric acidemia 2 &or ethylmalonic encephalopathy
46778-7,MCAD
46779-5,Medium &or short chain acyl-CoA dehydrogenase deficiency
46780-3,Short-chain acyl-CoA deficiency &or ethylmalonic encephalopathy &or isobutyryl-CoA dehydrogenase deficiency
46781-1,Malonic acidemia
46782-9,Argininemia
46783-7,Abuse.behavior
46784-5,Abuse.knowledge
46785-2,Abuse.status
46786-0,Bowel function.behavior
46787-8,Bowel function.knowledge
46788-6,Bowel function.status
Sep-78,Protein S
46789-4,Caretaking &or parenting.behavior
46790-2,Caretaking &or parenting.knowledge
46791-0,Caretaking &or parenting.status
46792-8,Circulation.behavior
46793-6,Circulation.knowledge
46794-4,Circulation.status
46795-1,Cognition.behavior
46796-9,Cognition.knowledge
Jul-79,Reticulocytes/100 erythrocytes
46797-7,Cognition.status
46798-5,Communicable &or infectious condition function.behavior
46799-3,Communicable &or infectious condition function.knowledge
46800-9,Communicable &or infectious condition function.status
46801-7,Communication with community resources.behavior
46802-5,Communication with community resources.knowledge
46803-3,Communication with community resources.status
46804-1,Consciousness.behavior
May-80,von Willebrand factor.ristocetin cofactor
46805-8,Consciousness.knowledge
46806-6,Consciousness.status
46807-4,Digestion-hydration.behavior
46808-2,Digestion-hydration.knowledge
46809-0,Digestion-hydration.status
46810-8,Family planning.behavior
46811-6,Family planning.knowledge
46812-4,Family planning.status
Mar-81,Streptokinase
46813-2,Grief.behavior
46814-0,Grief.knowledge
46815-7,Grief.status
46816-5,Growth and development.behavior
46817-3,Growth and development.knowledge
46818-1,Growth and development.status
46819-9,Health care supervision.behavior
46820-7,Health care supervision.knowledge
Jan-82,Streptokinase
46821-5,Health care supervision.status
46822-3,Hearing.behavior
46823-1,Hearing.knowledge
46824-9,Hearing.status
46825-6,Income.behavior
46826-4,Income.knowledge
46827-2,Income.status
46828-0,Interpersonal relationship.behavior
46829-8,Interpersonal relationship.knowledge
46830-6,Interpersonal relationship.status
46831-4,Medication regimen.behavior
46832-2,Medication regimen.knowledge
46833-0,Medication regimen.status
46834-8,Mental health.behavior
46835-5,Mental health.knowledge
46836-3,Mental health.status
46837-1,Neglect.behavior
46838-9,Neglect.knowledge
Sep-83,Sulfhemoglobin
46839-7,Neglect.status
46840-5,Neighborhood &or workplace safety.behavior
46841-3,Neighborhood &or workplace safety.knowledge
46842-1,Neighborhood &or workplace safety.status
46843-9,Neuro-musculo-skeletal function.behavior
46844-7,Neuro-musculo-skeletal function.knowledge
46845-4,Neuro-musculo-skeletal function.status
46846-2,Nutrition.behavior
Jul-84,Sulfhemoglobin
46847-0,Nutrition.knowledge
46848-8,Nutrition.status
46849-6,Oral health.behavior
46850-4,Oral health.knowledge
46851-2,Oral health.status
46852-0,Pain.behavior
46853-8,Pain.knowledge
Apr-85,Sulfhemoglobin/Hemoglobin.total
46854-6,Pain.status
46855-3,Personal care.behavior
46856-1,Personal care.knowledge
46857-9,Personal care.status
46858-7,Physical activity.behavior
46859-5,Physical activity.knowledge
46860-3,Physical activity.status
46861-1,Postpartum function.behavior
Feb-86,Thromboglobulin
46862-9,Postpartum function.knowledge
46863-7,Postpartum function.status
46864-5,Pregnancy function.behavior
46865-2,Pregnancy function.knowledge
46866-0,Pregnancy function.status
46867-8,Reproductive function.behavior
46868-6,Reproductive function.knowledge
46869-4,Reproductive function.status
4687-0,Thromboglobulin beta
46870-2,Residence.behavior
46871-0,Residence.knowledge
46872-8,Residence.status
46873-6,Respiration.behavior
46874-4,Respiration.knowledge
46875-1,Respiration.status
46876-9,Role change.behavior
46877-7,Role change.knowledge
46878-5,Role change.status
46879-3,Sanitation.behavior
46880-1,Sanitation.knowledge
46881-9,Sanitation.status
46882-7,Sexuality.behavior
46883-5,Sexuality.knowledge
46884-3,Sexuality.status
46885-0,Skin.behavior
46886-8,Skin.knowledge
46887-6,Skin.status
Aug-88,Thrombomodulin
46888-4,Sleep and rest pattern.behavior
46889-2,Sleep and rest pattern.knowledge
468-9,Sulfamethoxazole
46890-0,Sleep and rest pattern.status
46891-8,Social contact.behavior
46892-6,Social contact.knowledge
46893-4,Social contact.status
46894-2,Speech and language.behavior
46895-9,Speech and language.knowledge
Jun-89,Verdohemoglobin
46896-7,Speech and language.status
46897-5,Spirituality.behavior
46898-3,Spirituality.knowledge
46899-1,Spirituality.status
46900-7,Substance use.behavior
46901-5,Substance use.knowledge
46902-3,Substance use.status
46903-1,Urinary function.behavior
Apr-90,Viscosity
46904-9,Urinary function.knowledge
46905-6,Urinary function.status
46906-4,Vision.behavior
46907-2,Vision.knowledge
46908-0,Vision.status
46909-8,Communicable &or infectious condition function.behavior
46910-6,Communicable &or infectious condition function.knowledge
46911-4,Communicable &or infectious condition function.status
Feb-91,Viscosity
46912-2,Oral health.behavior
46913-0,Oral health.knowledge
46914-8,Oral health.status
46915-5,Postpartum function.behavior
46916-3,Postpartum function.knowledge
46917-1,Postpartum function.status
46918-9,Pregnancy function.behavior
46919-7,Pregnancy function.knowledge
4692-0,HLA Ag
46920-5,Pregnancy function.status
46921-3,Reproductive function.behavior
46922-1,Reproductive function.knowledge
46923-9,Reproductive function.status
46924-7,Urinary function.behavior
46925-4,Urinary function.knowledge
46926-2,Urinary function.status
46927-0,Communicable &or infectious condition function.behavior
46928-8,Communicable &or infectious condition function.knowledge
46929-6,Communicable &or infectious condition function.status
46930-4,Oral health.behavior
46931-2,Oral health.knowledge
46932-0,Oral health.status
46933-8,Postpartum function.behavior
46934-6,Postpartum function.knowledge
46935-3,Postpartum function.status
46936-1,Pregnancy function.behavior
46937-9,Pregnancy function.knowledge
Aug-93,HLA Ag absent
46938-7,Pregnancy function.status
46939-5,Reproductive function.behavior
46940-3,Reproductive function.knowledge
46941-1,Reproductive function.status
46942-9,Urinary function.behavior
46943-7,Urinary function.knowledge
46944-5,Urinary function.status
46945-2,Beclomethasone dipropionate
Jun-94,HLA Ag present
46946-0,Betamethasone
46947-8,Budesonide
46948-6,Dexamethasone
46949-4,Fludrocortisone
46950-2,Flunisolide
46951-0,Fluorometholone
46952-8,Fluticasone propionate
Mar-95,HLA-A19
46953-6,Megestrol acetate
46954-4,Methylprednisolone
46955-1,prednisoLONE
46956-9,predniSONE
46957-7,Triamcinolone
46958-5,Triamcinolone acetonide
46959-3,Synthetic glucocorticoid panel
46960-1,TCR alpha beta Ag
Jan-96,HLA-A19
46961-9,TCR gamma delta Ag
46962-7,Vasoactive intestinal peptide Ag
46963-5,Tube number
46964-3,Cryptococcus sp Ag
46965-0,MCOLN1 gene targeted mutation analysis
46966-8,Cells.CD69
46967-6,Cells.CD40
46968-4,Cells.CD122
46969-2,Asialoganglioside GM1 Ab.IgG
469-7,Sulfamethoxazole
46970-0,BK virus DNA
46971-8,HYDROmorphone.free
46972-6,6-Monoacetylmorphine.free
46973-4,oxyCODONE.free
46974-2,oxyMORphone.free
46975-9,oxyMORphone.free
46976-7,Benzodiazepines
46977-5,Benzodiazepines
46978-3,Salicylates
Sep-97,HLA-A33(19)
46979-1,Flurazepam
46980-9,N-desalkylflurazepam
46981-7,Silicon
46982-5,Liver kidney microsomal Ab.IgG
46983-3,Ethanol
46984-1,LDL 2
46985-8,LDL 3
46986-6,Cholesterol.in VLDL 3
Jul-98,HLA-A33(19)
46987-4,Helicobacter pylori Ab.IgM
46988-2,GBA gene mutations tested for
46989-0,CFTR gene targeted mutation analysis
46990-8,ASPA gene targeted mutation analysis
46991-6,BLM gene targeted mutation analysis
46992-4,DYS gene targeted mutation analysis
46993-2,HLA Ab panel
46994-0,HLA-A+B+C Ab
May-99,HLA-A34(10)
46995-7,HLA-DP+DQ+DR Ab
46996-5,HLA Ab positive cells
46997-3,HLA Ab cells tested
46998-1,TCRB & Immunoglobulin heavy chain gene rearrangements
46999-9,Bacterial vaginosis & vaginitis rRNA panel
47000-5,Candida sp rRNA
Jan-00,HLA-A34(10)
47001-3,Brucella sp Ag
47002-1,Varicella zoster virus DNA
47003-9,Varicella zoster virus DNA
47004-7,6-Monoacetylmorphine.free
47005-4,Spermatozoa Ab.IgM/100 spermatozoa
47006-2,Spermatozoa Ab.IgG/100 spermatozoa
47007-0,Spermatozoa Ab.IgA/100 spermatozoa
47008-8,Platelet associated Ab.IgG
47009-6,BCL6 Ag
47010-4,Ber-EP4 Ag
47011-2,Calretinin Ag
47012-0,Cancer Ag 72-4
47013-8,CD1a Ag
47014-6,CD21 Ag
47015-3,CD31 Ag
47016-1,CD4 Ag
47017-9,CD68 Ag
47018-7,CD79a Ag
Sep-01,HLA-A36
47019-5,CD8 Ag
47020-3,CD99 Ag
47021-1,CDX2 Ag
47022-9,Cells.CD11c+CD19+/100 cells
47023-7,Cells.CD19+CD23+/100 cells
47024-5,Choriogonadotropin.beta subunit Ag
47025-2,Cytokeratin 5+6 Ag
47026-0,Cytokeratin HMW Ag
Jul-02,HLA-A36
47027-8,DBA44 Ag
47028-6,Follitropin Ag
47029-4,HIV 2 Ab
47030-2,Phosphatidate Ab.IgA
47031-0,Melan-A Ag
47032-8,MyoD1 Ag
47033-6,Myogenin Ag
47034-4,Neurofilament Ag
May-03,HLA-A43
47035-1,NKI-C3 Ag
47036-9,Streptococcus pneumoniae 34 Ab.IgG^1st specimen
47037-7,Streptococcus pneumoniae Danish serotype 9V Ab.IgG^2nd specimen/1st specimen
47038-5,Villin Ag
47039-3,Admission history and physical note
47040-1,Confirmatory consultation note
47041-9,Confirmatory consultation note
47042-7,Counseling note
Mar-04,HLA-A43
47043-5,Group counseling note
47044-3,Initial evaluation note
47045-0,Study report
47046-8,Summary of death note
47047-6,Supervisory note
47048-4,Diagnostic interventional radiology study
47049-2,Communication note
470-5,Sulfamethoxazole
4705-0,HLA-A66(10)
47050-0,Herpes virus 8 Ab.IgG
47051-8,Treponema pallidum Ab.IgG
47052-6,Chlamydophila pneumoniae Ab
47053-4,Enolase.neuron specific
47054-2,Legionella pneumophila 10 Ab.IgM
47055-9,Legionella pneumophila 11 Ab.IgG
47056-7,Legionella pneumophila 11 Ab.IgM
47057-5,Legionella pneumophila 12 Ab.IgG
47058-3,Legionella pneumophila 12 Ab.IgM
47059-1,Legionella pneumophila 13 Ab.IgG
47060-9,Legionella pneumophila 13 Ab.IgM
47061-7,Legionella pneumophila 14 Ab.IgG
47062-5,Legionella pneumophila 14 Ab.IgM
47063-3,Treponema pallidum Ab.IgM
47064-1,Epstein Barr virus capsid Ab.IgG
47065-8,Rickettsia typhi Ab.IgG
47066-6,Epstein Barr virus capsid Ab.IgM
47067-4,Rickettsia typhi Ab.IgM
Aug-06,HLA-A66(10)
47068-2,Epstein Barr virus early Ab.IgG
47069-0,Rickettsia rickettsii Ab.IgG
47070-8,Rickettsia rickettsii Ab.IgM
47071-6,Babesia microti Ab.IgG
47072-4,Epstein Barr virus early Ab.IgA
47073-2,Babesia microti Ab.IgM
47074-0,PCNA extractable nuclear Ab
47075-7,Coxiella burnetii phase 1 Ab.IgM
Jun-07,HLA-A68(28)
47076-5,Legionella pneumophila 7 Ab.IgG
47077-3,Legionella pneumophila 7 Ab.IgM
47078-1,Legionella pneumophila 8 Ab.IgG
47079-9,Legionella pneumophila 8 Ab.IgM
47080-7,Legionella pneumophila 9 Ab.IgG
47081-5,Legionella pneumophila 9 Ab.IgM
47082-3,Legionella pneumophila 10 Ab.IgG
47083-1,IgG
Apr-08,HLA-A68(28)
47084-9,Platelet glycoprotein Ia-IIa Ab
47085-6,Plasmodium sp DNA
47086-4,11-Hydroxyandrostenedione
47087-2,Angiotensinogen
47088-0,Delta aminolevulinate
47089-8,Indicans
47090-6,Indicans/Creatinine
47091-4,Methylmalonate
Feb-09,HLA-A69(28)
47092-2,Natriuretic peptide.B
47093-0,Parathyrin.biointact
47094-8,Calciferol
47095-5,Acetaminophen
47096-3,Aluminum
47097-1,"carBAMazepine 10,11-Epoxide.free"
47098-9,Chromium
47099-7,Chromium
Jan-47,Bacampicillin
4710-0,HLA-A69(28)
47100-3,Copper
47101-1,Copper
47102-9,Copper
47103-7,Copper
47104-5,Doxepin
47105-2,ePHEDrine
47106-0,ePHEDrine
47107-8,Ethanol
47108-6,Furosemide
47109-4,Gentamicin
47110-2,Glutethimide
47111-0,Glutethimide
47112-8,Gold
47113-6,Gold/Creatinine
47114-4,LORazepam
47115-1,LORazepam
47116-9,Manganese
47117-7,Maprotiline
Aug-11,HLA-A74(19)
47118-5,Maprotiline
47119-3,Meprobamate
47120-1,Meprobamate
47121-9,Mercury
47122-7,Methyprylon
47123-5,Nickel
47124-3,PHENobarbital
47125-0,Primidone
Jun-12,HLA-A74(19)
47126-8,Protriptyline
47127-6,Protriptyline
47128-4,Salicylates
47129-2,Silver
471-3,sulfiSOXAZOLE
47130-0,Thallium
47131-8,Thioridazine
47132-6,Thioridazine
47133-4,Trimipramine
Apr-13,HLA-A10
47134-2,Trimipramine
47135-9,Ascorbate^post dose
47136-7,Epinephrine^1H post 300 ug cloNIDine PO
47137-5,Epinephrine^2H post 300 ug cloNIDine PO
47138-3,EPINEPHrine^2H post XXX challenge
47139-1,EPINEPHrine^2nd specimen post XXX challenge
47140-9,EPINEPHrine^2nd specimen post XXX challenge
47141-7,Epinephrine^3H post 300 ug cloNIDine PO
Feb-14,HLA-A10
47142-5,EPINEPHrine^3rd specimen post XXX challenge
47143-3,EPINEPHrine^3rd specimen post XXX challenge
47144-1,EPINEPHrine^4H post XXX challenge
47145-8,EPINEPHrine^4th specimen post XXX challenge
47146-6,EPINEPHrine^4th specimen post XXX challenge
47147-4,EPINEPHrine^5th specimen post XXX challenge
47148-2,EPINEPHrine^5th specimen post XXX challenge
47149-0,EPINEPHrine^6th specimen post XXX challenge
47150-8,EPINEPHrine^6th specimen post XXX challenge
47151-6,EPINEPHrine^7th specimen post XXX challenge
47152-4,EPINEPHrine^7th specimen post XXX challenge
47153-2,Epinephrine^pre 300 ug cloNIDine PO
47154-0,Lead^post EDTA therapy
47155-7,Norepinephrine^10M post standing
47156-5,Norepinephrine^1H post 300 ug clonidine PO
47157-3,Norepinephrine^1H post XXX challenge
47158-1,Norepinephrine^2H post 300 ug clonidine PO
Sep-15,HLA-A11
47159-9,Norepinephrine^2H post XXX challenge
47160-7,Norepinephrine^2nd specimen post XXX challenge
47161-5,Norepinephrine^2nd specimen post XXX challenge
47162-3,Norepinephrine^3H post 300 ug clonidine PO
47163-1,Norepinephrine^3H post XXX challenge
47164-9,Norepinephrine^3rd specimen post XXX challenge
47165-6,Norepinephrine^3rd specimen post XXX challenge
47166-4,Norepinephrine^4H post XXX challenge
Jul-16,HLA-A11
47167-2,Norepinephrine^4th specimen post XXX challenge
47168-0,Norepinephrine^4th specimen post XXX challenge
47169-8,Norepinephrine^5th specimen post XXX challenge
47170-6,Norepinephrine^5th specimen post XXX challenge
47171-4,Norepinephrine^6th specimen post XXX challenge
47172-2,Norepinephrine^6th specimen post XXX challenge
47173-0,Catecholamines^7th specimen post XXX challenge
47174-8,Norepinephrine^7th specimen post XXX challenge
May-17,HLA-A1
47175-5,Norepinephrine^pre 300 ug clonidine PO
47176-3,Parathyrin.intact^10M post excision
47177-1,Parathyrin.intact^5M post excision
47178-9,Parathyrin.intact^baseline
47179-7,Parathyrin^10M post excision
47180-5,Parathyrin^baseline
47181-3,Progesterone^1.5H post XXX challenge
47182-1,Progesterone^10th specimen post XXX challenge
Mar-18,HLA-A1
47183-9,Progesterone^15M post XXX challenge
47184-7,Progesterone^1H post XXX challenge
47185-4,Progesterone^2H post XXX challenge
47186-2,Progesterone^30M post XXX challenge
47187-0,Progesterone^45M post XXX challenge
47188-8,Progesterone^5th specimen post XXX challenge
47189-6,Progesterone^baseline
47190-4,Proinsulin^baseline
Jan-19,HLA-A23(9)
47191-2,Triiodothyronine^2nd specimen post XXX challenge
47192-0,Triiodothyronine^3rd specimen post XXX challenge
47193-8,Triiodothyronine^4th specimen post XXX challenge
47194-6,Triiodothyronine^5th specimen post XXX challenge
47195-3,Triiodothyronine^6th specimen post XXX challenge
47196-1,Triiodothyronine^7th specimen post XXX challenge
47197-9,Triiodothyronine^8th specimen post XXX challenge
47198-7,Vasopressin^1st specimen post XXX challenge
47199-5,Methionine
47200-1,Methionine+Homocysteine
47201-9,Bentiromide
47202-7,Sincalide
47203-5,Pyridoxine
47204-3,glipiZIDE
47205-0,metyraPONE
47206-8,Corticotropin
47207-6,Secretin
47208-4,Arginine
Sep-20,HLA-A23(9)
47209-2,Glucagon
472-1,sulfiSOXAZOLE
47210-0,Triglyceride^post CFst
47211-8,Chlamydia trachomatis L2 DNA
47212-6,Chlamydia trachomatis DNA
47213-4,Cholesterol.in LDL real size pattern
47214-2,Homeostasis model assessment
47215-9,Lipoprotein.beta.subparticle.medium
47216-7,Hepatitis B virus DNA
Jul-21,HLA-A24(9)
47217-5,Immune complex.C3d
47218-3,Cholesterol.in VLDL 3+4
47219-1,Cholesterol.in VLDL 5+6
47220-9,Cholesterol.in HDL 4+5
47221-7,Cholesterol.in HDL 1+2
47222-5,Trisomy 21 risk based on maternal age + Alpha-1-Fetoprotein + Choriogonadotropin + Estriol.unconjugated
47223-3,Fetal trisomy 18 risk
47224-1,In vitro fertilization pregnancy
May-22,HLA-A25(10)
47225-8,Bilirubin
47226-6,Fetal lung maturity
47227-4,Blood.dried
47228-2,Cholesterol.non HDL/Cholesterol.total
47229-0,Herpes simplex virus Ag
47230-8,Herpes simplex virus glycoprotein G Ab.IgG
47231-6,IgM Ab
47232-4,Influenza virus A Ab^1st specimen
Mar-23,HLA-A25(10)
47233-2,Influenza virus A Ab^2nd specimen
47234-0,Chlamydia trachomatis Ag
47235-7,Reagin Ab
47236-5,Treponema pallidum Ab.IgG+IgM
47237-3,Treponema pallidum Ab.IgM
47238-1,Treponema pallidum Ab.IgG
47239-9,Reason for stopping HIV Rx
47240-7,Date determined medically eligible to start HIV Rx
Jan-24,HLA-A26(10)
47241-5,Date determined medically eligible and ready to start HIV Rx
47242-3,Medication or other side effects associated with HIV Rx
47243-1,Severity of side effect to HIV Rx
47244-9,"Symptom, diagnosis, or opportunistic infection related to HIV Rx"
47245-6,HIV Rx Form
47246-4,Demographic information section
47247-2,Outpatient encounter-level information section
47248-0,Antiretroviral therapy status section
47249-8,HIV care & family status section
47250-6,Adenosine monophosphate.cyclic^2nd specimen post XXX challenge
47251-4,BK virus DNA
47252-2,Hepatitis C virus RNA
47253-0,Coproporphyrin 1
47254-8,Coproporphyrin 3
47255-5,Procollagen type I.N-terminal propeptide
47256-3,Creatinine^2nd specimen post XXX challenge
47257-1,Creatinine^1st specimen post XXX challenge
Aug-25,HLA-A26(10)
47258-9,Creatinine^3rd specimen post XXX challenge
47259-7,Creatinine^4th specimen post XXX challenge
47260-5,Plasmodium sp DNA
47261-3,Creatinine^6th specimen post XXX challenge
47262-1,Adenosine monophosphate.cyclic^6th specimen post XXX challenge
47263-9,Adenosine monophosphate.cyclic^3rd specimen post XXX challenge
47264-7,Adenosine monophosphate.cyclic^1st specimen post XXX challenge
47265-4,Adenosine monophosphate.cyclic^4th specimen post XXX challenge
Jun-26,HLA-A28
47266-2,Adenosine monophosphate.cyclic^5th specimen post XXX challenge
47267-0,Adenosine monophosphate.cyclic^6th specimen post XXX challenge
47268-8,Adenosine monophosphate.cyclic/Creatinine^6th specimen post XXX challenge
47269-6,Adenosine monophosphate.cyclic/Creatinine^2nd specimen post XXX challenge
47270-4,Adenosine monophosphate.cyclic/Creatinine^3rd specimen post XXX challenge
47271-2,Adenosine monophosphate.cyclic/Creatinine^4th specimen post XXX challenge
47272-0,Adenosine monophosphate.cyclic/Creatinine^5th specimen post XXX challenge
47273-8,Creatinine^5th specimen post XXX challenge
Apr-27,HLA-A28
47274-6,S100 calcium binding protein B
47275-3,S100 calcium binding protein B
47276-1,Complement Sc5b-9 Ab
47277-9,Erythrocyte distribution width
47278-7,Erythrocyte mean corpuscular hemoglobin
47279-5,Erythrocyte mean corpuscular hemoglobin concentration
47280-3,Erythrocytes
47281-1,Leukocytes
Feb-28,HLA-A29(19)
47282-9,Erythrocyte mean corpuscular volume
47283-7,Platelet mean volume
47284-5,Platelets
47285-2,Heparin cofactor II Ag
47286-0,Differential panel
47287-8,Hemogram WO platelets panel
47288-6,Complete blood count WO Differential panel
47289-4,IgG & IgG subclass panel
4729-0,HLA-A29(19)
47290-2,IgG subclass panel
47291-0,Fungus identified^^^6
47292-8,Fungus identified^^^7
47293-6,Bacteria identified^^^7
47294-4,Bacteria identified^^^7
47295-1,Bacteria identified^^^8
47296-9,Clostridium tetani toxoid Ab^2nd specimen/1st specimen
47297-7,Corynebacterium diphtheriae toxin Ab^1st specimen
47298-5,Corynebacterium diphtheriae Ab^2nd specimen/1st specimen
47299-3,DNA double strand Ab
47300-9,Phosphatidate Ab.IgM
47301-7,Ribosomal P Ab
47302-5,(Allium cepa+Allium sativum+Apium graveolens+Lycopersicon lycopersicum+Yeast) Ab.IgE
47303-3,Anaplastic lymphoma kinase Ag
47304-1,Borrelia burgdorferi Ab.IgG index
47305-8,BRST 2 Ag
47306-6,Cartilage oligomeric matrix protein
47307-4,Cytomegalovirus Ab.IgG Index
Aug-30,HLA-A2
47308-2,Echinococcus granulosus Ab.IgG
47309-0,Haemophilus influenzae B Ab.IgG^2nd specimen/1st specimen
47310-8,Haemophilus influenzae B Ab.IgG^1st specimen
47311-6,Haemophilus influenzae B Ab.IgG^2nd specimen
47312-4,Influenza virus A Ab.IgM
47313-2,Influenza virus A Ab.IgG
47314-0,Influenza virus B Ab.IgG
47315-7,Influenza virus B Ab.IgM
Jun-31,HLA-A2
47316-5,Inner Ear 68kD Ab
47317-3,Interleukin 12
47318-1,Liver kidney microsomal 1 Ab.IgG
47319-9,Myelin basic protein Ab
47320-7,Saccharomyces cerevisiae Ab.IgA
47321-5,Saccharomyces cerevisiae Ab.IgG
47322-3,SCL-70 extractable nuclear Ab.IgG
47323-1,Streptococcus pneumoniae 17 Ab.IgG
Apr-32,HLA-A30(19)
47324-9,Streptococcus pneumoniae 17 Ab.IgG^1st specimen
47325-6,Streptococcus pneumoniae 17 Ab.IgG^2nd specimen
47326-4,Streptococcus pneumoniae 17 Ab.IgG^2nd specimen/1st specimen
47327-2,Streptococcus pneumoniae 2 Ab.IgG
47328-0,Streptococcus pneumoniae 2 Ab.IgG^1st specimen
47329-8,Streptococcus pneumoniae 2 Ab.IgG^2nd specimen
47330-6,Streptococcus pneumoniae 2 Ab.IgG^2nd specimen/1st specimen
47331-4,Streptococcus pneumoniae 20 Ab.IgG
Feb-33,HLA-A30(19)
47332-2,Streptococcus pneumoniae 20 Ab.IgG^1st specimen
47333-0,Streptococcus pneumoniae 20 Ab.IgG^2nd specimen
47334-8,Streptococcus pneumoniae 20 Ab.IgG^2nd specimen/1st specimen
47335-5,Streptococcus pneumoniae 22 Ab.IgG
47336-3,Streptococcus pneumoniae 22 Ab.IgG^1st specimen
47337-1,Streptococcus pneumoniae 22 Ab.IgG^2nd specimen
47338-9,Streptococcus pneumoniae 22 Ab.IgG^2nd specimen/1st specimen
47339-7,Streptococcus pneumoniae 34 Ab.IgG
4734-0,HLA-A31(19)
47340-5,Streptococcus pneumoniae 34 Ab.IgG^2nd specimen
47341-3,Streptococcus pneumoniae 34 Ab.IgG^2nd specimen/1st specimen
47342-1,Streptococcus pneumoniae 43 Ab.IgG
47343-9,Streptococcus pneumoniae 43 Ab.IgG^1st specimen
47344-7,Streptococcus pneumoniae 43 Ab.IgG^2nd specimen
47345-4,Streptococcus pneumoniae 43 Ab.IgG^2nd specimen/1st specimen
47346-2,Streptococcus pneumoniae Danish serotype 15B Ab.IgG^2nd specimen
47347-0,Streptococcus pneumoniae Danish serotype 15B Ab.IgG^2nd specimen/1st specimen
47348-8,Streptococcus pneumoniae Danish serotype 19A Ab.IgG^2nd specimen/1st specimen
47349-6,Streptococcus pneumoniae Danish serotype 33F Ab.IgG
47350-4,Streptococcus pneumoniae Danish serotype 33F Ab.IgG^2nd specimen/1st specimen
47351-2,Streptococcus pneumoniae Danish serotype 33F Ab.IgG^1st specimen
47352-0,Streptococcus pneumoniae Danish serotype 33F Ab.IgG^2nd specimen
47353-8,Streptococcus pneumoniae 5 Ab.IgG^1st specimen
47354-6,Streptococcus pneumoniae 5 Ab.IgG^2nd specimen
47355-3,Streptococcus pneumoniae 5 Ab.IgG^2nd specimen/1st specimen
47356-1,Streptococcus pneumoniae Danish serotype 15B Ab.IgG
Jul-35,HLA-A31(19)
47357-9,Streptococcus pneumoniae Danish serotype 15B Ab.IgG^1st specimen
47358-7,Hepatitis B virus core Ab
47359-5,HIV 1 RNA
47360-3,Reagin Ab
47361-1,Treponema pallidum Ab.IgG
47362-9,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA
47363-7,Cytomegalovirus Ab
47364-5,Hepatitis B virus surface Ag
May-36,HLA-A32(19)
47365-2,Hepatitis C virus Ab
47366-0,Multisection limited^WO contrast
47367-8,Views GE 4 && Views
47368-6,Views GE 4 + PA + lateral
47369-4,Calcitonin
47370-2,Views GE 3
47371-0,Views GE 3
47372-8,Views^during surgery
Mar-37,HLA-A32(19)
47373-6,Views 1 or 2
47374-4,Views GE 4
47375-1,Views 1 or 2
47376-9,Views GE 4
47377-7,Views LE 4
47378-5,Multisection blood pool^W radionuclide IV
47379-3,Views GE 4
47380-1,Views LE 3
Jan-38,HLA-A3
47381-9,Views GE 3
47382-7,Views GE 4
47383-5,Nuclear Ab
47384-3,Cephalosporine mold Ab.IgE.RAST class
47385-0,Netilmicin
47386-8,Carboxy tetrahydrocannabinol
47387-6,Neisseria gonorrhoeae DNA
47388-4,Salmonella typhi H D Ab
47389-2,Toxoplasma gondii Ab.IgG avidity
473-9,sulfiSOXAZOLE
47390-0,Toxoplasma gondii Ab.IgG
47391-8,Sulfonylurea
47392-6,chlorproPAMIDE
47393-4,Gliadin peptide Ab.IgA
47394-2,Gliadin peptide Ab.IgG
47395-9,Kanamycin
47396-7,Babesia microti DNA
47397-5,BCS1L gene targeted mutation analysis
47398-3,Beta mannosidase actual/Normal
Sep-39,HLA-A3
47399-1,Cells.ZAP70+CD19+/100 cells
47400-7,Cocaine+Benzoylecgonine
47401-5,CV2 Ab.IgG
47402-3,CV2 Ab
47403-1,CYP2D6 gene targeted mutation analysis
47404-9,N-desalkylflurazepam
47405-6,Ehrlichia chaffeensis Ab.IgG
47406-4,Entamoeba histolytica Ab
Jul-40,HLA-A9
47407-2,Fibers
47408-0,Fosphenytoin
47409-8,Herpes simplex virus 1+2 DNA
47410-6,Herpes virus 6 DNA
47411-4,Methadone
47412-2,Mumps virus Ab
47413-0,Plasma cells/100 leukocytes
47414-8,Pregabalin
May-41,HLA-A9
47415-5,Propoxyphene+Norpropoxyphene
47416-3,RB1 gene targeted mutation analysis
47417-1,Red dye Ab.IgE.RAST class
47418-9,Triacylglycerol lipase
47419-7,Varicella zoster virus Ab
47420-5,Functional status assessment note
47421-3,Aspergillus flavus B Ab
47422-1,Aspergillus flavus H Ab
Mar-42,HLA-B22
47423-9,Aspergillus fumigatus B Ab
47424-7,Aspergillus fumigatus H Ab
47425-4,Aspergillus nidulans B Ab
47426-2,Aspergillus nidulans H Ab
47427-0,Aspergillus niger B Ab
47428-8,Aspergillus niger H Ab
47429-6,Corynebacterium diphtheriae toxin Ab^1st specimen
47430-4,Cytomegalovirus Ab
Jan-43,HLA-B22
47431-2,Echinococcus granulosus Ab.IgG
47432-0,Epstein Barr virus capsid Ab.IgG
47433-8,Epstein Barr virus capsid Ab.IgM
47434-6,Epstein Barr virus early diffuse Ab
47435-3,Epstein Barr virus early Ab.IgA
47436-1,Epstein Barr virus early Ab.IgG
47437-9,Epstein Barr virus early restricted Ab
47438-7,Fowl adenovirus 1 Ab
47439-5,Haemophilus influenzae B Ab.IgG^1st specimen
47440-3,Hepatitis B virus core Ab
47441-1,Hepatitis C virus Ab
47442-9,Herpes virus 8 Ab.IgG
47443-7,Influenza virus A Ab
47444-5,Influenza virus A H1 Ab
47445-2,Influenza virus A H10 Ab
47446-0,Influenza virus A H11 Ab
47447-8,Influenza virus A H12 Ab
47448-6,Influenza virus A H13 Ab
Sep-44,HLA-B41
47449-4,Influenza virus A H14 Ab
47450-2,Influenza virus A H15 Ab
47451-0,Influenza virus A H2 Ab
47452-8,Influenza virus A H3 Ab
47453-6,Influenza virus A H4 Ab
47454-4,Influenza virus A H5 Ab
47455-1,Influenza virus A H6 Ab
Jun-45,HLA-B41
47456-9,Influenza virus A H7 Ab
47457-7,Influenza virus A H8 Ab
47458-5,Influenza virus A H9 Ab
47459-3,Legionella pneumophila 10 Ab.IgG
47460-1,Legionella pneumophila 10 Ab.IgM
47461-9,Legionella pneumophila 11 Ab.IgG
47462-7,Legionella pneumophila 11 Ab.IgM
47463-5,Legionella pneumophila 12 Ab.IgG
Apr-46,HLA-B42
47464-3,Legionella pneumophila 12 Ab.IgM
47465-0,Legionella pneumophila 13 Ab.IgG
47466-8,Legionella pneumophila 13 Ab.IgM
47467-6,Legionella pneumophila 14 Ab.IgG
47468-4,Legionella pneumophila 14 Ab.IgM
47469-2,Legionella pneumophila 7 Ab.IgG
474-7,sulfiSOXAZOLE
47470-0,Legionella pneumophila 7 Ab.IgM
47471-8,Legionella pneumophila 8 Ab.IgG
Feb-47,HLA-B42
47472-6,Legionella pneumophila 8 Ab.IgM
47473-4,Legionella pneumophila 9 Ab.IgG
47474-2,Legionella pneumophila 9 Ab.IgM
47475-9,Powassan virus polyvalent E Ab
47476-7,Reagin Ab
47477-5,Rickettsia rickettsii Ab.IgG
47478-3,Rickettsia rickettsii Ab.IgM
47479-1,Rickettsia typhi Ab.IgG
4748-0,HLA-B46
47480-9,Rickettsia typhi Ab.IgM
47481-7,Streptococcus pneumoniae 1 Ab.IgG^1st specimen
47482-5,Streptococcus pneumoniae 1 Ab.IgG^2nd specimen
47483-3,Streptococcus pneumoniae 14 Ab.IgG^1st specimen
47484-1,Streptococcus pneumoniae 14 Ab.IgG^2nd specimen
47485-8,Streptococcus pneumoniae 17 Ab.IgG^1st specimen
47486-6,Streptococcus pneumoniae 17 Ab.IgG^2nd specimen
47487-4,Streptococcus pneumoniae 2 Ab.IgG^1st specimen
47488-2,Streptococcus pneumoniae 2 Ab.IgG^2nd specimen
47489-0,Streptococcus pneumoniae 20 Ab.IgG^1st specimen
47490-8,Streptococcus pneumoniae 20 Ab.IgG^2nd specimen
47491-6,Streptococcus pneumoniae 22 Ab.IgG^1st specimen
47492-4,Streptococcus pneumoniae 22 Ab.IgG^2nd specimen
47493-2,Streptococcus pneumoniae 3 Ab.IgG^1st specimen
47494-0,Streptococcus pneumoniae 3 Ab.IgG^2nd specimen
47495-7,Streptococcus pneumoniae 34 Ab.IgG^1st specimen
47496-5,Streptococcus pneumoniae 34 Ab.IgG^2nd specimen
47497-3,Streptococcus pneumoniae 43 Ab.IgG^1st specimen
Aug-49,HLA-B46
47498-1,Streptococcus pneumoniae 43 Ab.IgG^2nd specimen
47499-9,Streptococcus pneumoniae 5 Ab.IgG^1st specimen
47500-4,Streptococcus pneumoniae 5 Ab.IgG^2nd specimen
47501-2,Streptococcus pneumoniae Danish serotype 15B Ab.IgG^1st specimen
47502-0,Streptococcus pneumoniae Danish serotype 15B Ab.IgG^2nd specimen
47503-8,Streptococcus pneumoniae Danish serotype 19A Ab.IgG^1st specimen
47504-6,Streptococcus pneumoniae Danish serotype 19A Ab.IgG^2nd specimen
47505-3,Streptococcus pneumoniae 6 Ab.IgG
Jun-50,HLA-B47
47506-1,Streptococcus pneumoniae Danish serotype 9V Ab.IgG^1st specimen
47507-9,Streptococcus pneumoniae Danish serotype 9V Ab.IgG^2nd specimen
47508-7,Streptococcus pneumoniae Danish serotype 9V Ab.IgG^2nd specimen/1st specimen
47509-5,Streptococcus pneumoniae Danish serotype 33F Ab.IgG^1st specimen
47510-3,Streptococcus pneumoniae Danish serotype 33F Ab.IgG^2nd specimen
47511-1,Treponema pallidum Ab
47512-9,Treponema pallidum Ab.IgG
47513-7,Treponema pallidum Ab.IgG
Apr-51,HLA-B47
47514-5,Treponema pallidum Ab.IgM
47515-2,Vesicular stomatitis Indiana virus 1 Ab
47516-0,Cocal virus Ab
47517-8,Vesicular stomatitis Alagoas virus Ab
47518-6,Yersinia pestis Ab
47519-4,History of procedures
47520-2,Cytology report
47521-0,Cytology report
Feb-52,HLA-B48
47522-8,Cytology report
47523-6,Cytology report
47524-4,Cytology report
47525-1,Cytology report
47526-9,Cytology report
47527-7,Cytology report
47528-5,Cytology report
47529-3,Cytology report
4753-0,HLA-B48
47530-1,Cytology report
47531-9,Wet mount panel
47532-7,Mumps virus RNA
47533-5,17-Hydroxyprogesterone^pre 250 ug corticotropin IM
47534-3,2-Hydroxyphenylacetate/Creatinine
47535-0,"2-Methyl,3-Hydroxybutyrate/Creatinine"
47536-8,3-Hydroxypropionate
47537-6,3-Hydroxysebacate/Creatinine
47538-4,3-Methoxy-4-Hydroxyphenylglycol
47539-2,3-Methylhistidine
475-4,Sulfonamide
47540-0,3-Methylhistidine
47541-8,4-Hydroxybenzoate/Creatinine
47542-6,Gamma hydroxybutyrate/Creatinine
47543-4,4-Hydroxymandelate/Creatinine
47544-2,5-Hydroxyindoleacetate
47545-9,5-Hydroxyindoleacetate/Creatinine
47546-7,5-Hydroxytryptophan
47547-5,5-Methyltetrahydrofolate
Aug-54,HLA-B w4
47548-3,Adenosine deaminase
47549-1,Adenosine deaminase
47550-9,Adenosine deaminase
47551-7,Alanine
47552-5,Alanine/Amino acids.total
47553-3,Alanine/Amino acids.total
47554-1,Alanine/Amino acids.total
May-55,HLA-B w4
47555-8,Alanine/Amino acids.total
47556-6,Alanine/Amino acids.total
47557-4,Alanine/Amino acids.total
47558-2,Albumin/Protein.total
47559-0,Alpha aminobutyrate
47560-8,Androstenedione^pre 250 ug corticotropin IM
47561-6,Anion gap
47562-4,Arginine
Mar-56,HLA-B50(21)
47563-2,Arginine/Amino acids.total
47564-0,Arginine/Amino acids.total
47565-7,Arginine/Amino acids.total
47566-5,Arginine/Amino acids.total
47567-3,Arginine/Amino acids.total
47568-1,Arginine/Amino acids.total
47569-9,Argininosuccinate lyase
47570-7,Argininosuccinate lyase
Jan-57,HLA-B50(21)
47571-5,Argininosuccinate synthase
47572-3,Asparagine
47573-1,Aspartate
47574-9,Aspartate/Amino acids.total
47575-6,Aspartate/Amino acids.total
47576-4,Aspartate/Amino acids.total
47577-2,Aspartate/Amino acids.total
47578-0,Aspartate/Amino acids.total
47579-8,Bicarbonate
47580-6,Bicarbonate
47581-4,Biopterin
47582-2,Biopterin/Creatinine
47583-0,C peptide^1.5H post dose glucose
47584-8,C peptide^10M post dose glucose
47585-5,C peptide^15M post dose glucose
47586-3,C peptide^1H post dose glucose
47587-1,C peptide^1M post dose glucose
47588-9,C peptide^2H post dose glucose
Sep-58,HLA-B52(5)
47589-7,C peptide^30M post dose glucose
47590-5,C peptide^3H post dose glucose
47591-3,C peptide^3M post dose glucose
47592-1,C peptide^5M post dose glucose
47593-9,C peptide^5M pre dose glucose
47594-7,C peptide^pre dose glucagon
47595-4,C peptide^pre dose glucose
47596-2,Calcium.ionized
Jul-59,HLA-B52(5)
47597-0,Calcium^^corrected for total protein
47598-8,Calcium.ionized^^adjusted to pH 7.4
47599-6,Carbon dioxide^^adjusted to patient's actual temperature
47600-2,Ceruloplasmin
47601-0,Choriogonadotropin.beta subunit.free
47602-8,Citrate synthase
47603-6,Citrate synthase
47604-4,Cortisol^1.5H post 1 ug/kg CRH IV
May-60,HLA-B53
47605-1,Cortisol^15M post 1 ug/kg CRH IV
47606-9,Cortisol^1H post 1 ug/kg CRH IV
47607-7,Cortisol^30M post 1 ug/kg CRH IV
47608-5,Cortisol^pre dose corticotropin
47609-3,Cortisol^pre 1 ug/kg CRH IV
47610-1,Creatinine
47611-9,Crystals
47612-7,Cystatin C
Mar-61,HLA-B53
47613-5,Decanoate/Creatinine
47614-3,Decenoate/Creatinine
47615-0,Dermatan sulfate
47616-8,Estradiol^1H post dose corticotropin
47617-6,Estradiol^pre dose corticotropin
47618-4,Follitropin^15M post 100 ug luteinizing releasing hormone IV
47619-2,Follitropin^2.5H post 100 ug luteinizing releasing hormone IV
476-2,Sulfonamide
47620-0,Glucose
Jan-62,HLA-B54(22)
47621-8,Glucose.IV
47622-6,Glucose^pre dose glucose
47623-4,Glutamate
47624-2,Glutamate/Amino acids.total
47625-9,Glutamate/Amino acids.total
47626-7,Glutamate/Amino acids.total
47627-5,Glutamate/Amino acids.total
47628-3,Glutamate/Amino acids.total
47629-1,Glutamate/Amino acids.total
47630-9,Glutamine
47631-7,Glutathione.oxidized
47632-5,Glycerol/Creatinine
47633-3,Glycine
47634-1,Glycine/Amino acids.total
47635-8,Glycine/Amino acids.total
47636-6,Glycine/Amino acids.total
47637-4,Glycine/Amino acids.total
47638-2,Glycine/Amino acids.total
Sep-63,HLA-B54(22)
47639-0,Glycine/Amino acids.total
47640-8,Hematocrit
47641-6,Palmitate/Creatinine
47642-4,Hexadecenoate/Creatinine
47643-2,Histidine
47644-0,Histidine/Amino acids.total
47645-7,Histidine/Amino acids.total
47646-5,Histidine/Amino acids.total
Jul-64,HLA-B55(22)
47647-3,Histidine/Amino acids.total
47648-1,Histidine/Amino acids.total
47649-9,Histidine/Amino acids.total
47650-7,Homogentisate/Creatinine
47651-5,Hydroxyproline
47652-3,Hypoxanthine phosphoribosyltransferase
47653-1,Insulin^10M post dose glucagon
Apr-65,HLA-B55(22)
47654-9,Insulin^10M post dose glucose
47655-6,Insulin^15M post dose glucagon
47656-4,Insulin^1M post dose glucose
47657-2,Insulin^1H post dose glucose
47658-0,Insulin^1.5H post dose glucose
47659-8,Insulin^2H post dose glucose
47660-6,Insulin^2.5H post dose glucose
47661-4,Insulin^20M post dose glucose
Feb-66,HLA-B56(22)
47662-2,Insulin^3H post dose glucose
47663-0,Insulin^30M post dose glucose
47664-8,Insulin^3M post dose glucose
47665-5,Insulin^5M post dose glucose
47666-3,Insulin^5M pre dose glucose
47667-1,Insulin^6M post dose glucagon
47668-9,Insulin^pre dose glucose
47669-7,Insulin^pre dose glucagon
4767-0,HLA-B56(22)
47670-5,Insulin^pre-meal
47671-3,Isoleucine
47672-1,Isoleucine/Amino acids.total
47673-9,Isoleucine/Amino acids.total
47674-7,Isoleucine/Amino acids.total
47675-4,Isoleucine/Amino acids.total
47676-2,Isoleucine/Amino acids.total
47677-0,Isoleucine/Amino acids.total
47678-8,Lactate dehydrogenase
47679-6,Leucine
47680-4,Leucine/Amino acids.total
47681-2,Leucine/Amino acids.total
47682-0,Leucine/Amino acids.total
47683-8,Leucine/Amino acids.total
47684-6,Leucine/Amino acids.total
47685-3,Leucine/Amino acids.total
47686-1,Linoleate/Creatinine
47687-9,Lutropin^15M post 100 ug luteinizing releasing hormone IV
Aug-68,HLA-B57(17)
47688-7,Lutropin^pre 100 ug luteinizing releasing hormone IV
47689-5,Lysine
47690-3,Lysine/Amino acids.total
47691-1,Lysine/Amino acids.total
47692-9,Lysine/Amino acids.total
47693-7,Lysine/Amino acids.total
47694-5,Lysine/Amino acids.total
47695-2,Lysine/Amino acids.total
Jun-69,HLA-B57(17)
47696-0,Malonate/Creatinine
47697-8,Mandelate/Creatinine
47698-6,Mannitol/Creatinine
47699-4,Metanephrine/Creatinine
477-0,Sulfonamide
47700-0,Methionine
47701-8,Methionine/Amino acids.total
47702-6,Methionine/Amino acids.total
47703-4,Methionine/Amino acids.total
Apr-70,HLA-B58(17)
47704-2,Methionine/Amino acids.total
47705-9,Methionine/Amino acids.total
47706-7,Methionine/Amino acids.total
47707-5,Methylmalonate/Urea
47708-3,Methylmalonate/Urea
47709-1,Methylmalonate/Urea
47710-9,N-acetylaspartate/Creatinine
47711-7,Neopterin/Creatinine
Feb-71,HLA-B58(17)
47712-5,Nitrogen
47713-3,Oleate/Creatinine
47714-1,Ornithine
47715-8,Oxalate
47716-6,Oxygen^^adjusted to patient's actual temperature
47717-4,Parathyrin^2H post dose calcium
47718-2,Parathyrin^4H post dose calcium
47719-0,Parathyrin^pre dose calcium
4772-0,HLA-B59
47720-8,pH^^adjusted to patient's actual temperature
47721-6,Phenylalanine/Amino acids.total
47722-4,Phenylalanine/Amino acids.total
47723-2,Phenylalanine/Amino acids.total
47724-0,Phenylalanine/Amino acids.total
47725-7,Phenylalanine/Amino acids.total
47726-5,Phytanate/Creatinine
47727-3,Pipecolate/Creatinine
47728-1,Procollagen type III/Creatinine
47729-9,Prolactin^1.5H post dose TRH IV
47730-7,Prolactin^15M post dose TRH IV
47731-5,Prolactin^2H post dose TRH IV
47732-3,Proline
47733-1,Proline/Amino acids.total
47734-9,Proline/Amino acids.total
47735-6,Proline/Amino acids.total
47736-4,Proline/Amino acids.total
47737-2,Proline/Amino acids.total
Aug-73,HLA-B59
47738-0,Prostate specific Ag
47739-8,Protein
47740-6,Purine nucleoside phosphorylase
47741-4,Purine nucleoside phosphorylase
47742-2,Serine
47743-0,Serine/Amino acids.total
47744-8,Serine/Amino acids.total
47745-5,Serine/Amino acids.total
Jun-74,HLA-B60(40)
47746-3,Serine/Amino acids.total
47747-1,Serine/Amino acids.total
47748-9,Serine/Amino acids.total
47749-7,Somatotropin^1.5H post dose glucagon
47750-5,Somatotropin^1.5H post dose glucose PO
47751-3,Somatotropin^1.5H post dose TRH
47752-1,Somatotropin^1.5H post dose arginine
Mar-75,HLA-B60(40)
47753-9,Somatotropin^1.5H post dose insulin IV
47754-7,Somatotropin^10M post dose TRH
47755-4,Somatotropin^10th specimen post XXX challenge
47756-2,Somatotropin^15M pre dose arginine
47757-0,Somatotropin^15M post dose arginine
47758-8,Somatotropin^15M post dose glucagon
47759-6,Somatotropin^15M post dose insulin IV
47760-4,Somatotropin^1H post dose arginine
Jan-76,HLA-B61(40)
47761-2,Somatotropin^1H post dose glucose PO
47762-0,Somatotropin^1H post dose insulin IV
47763-8,Somatotropin^1st specimen post XXX challenge
47764-6,Somatotropin^2H post dose arginine
47765-3,Somatotropin^2H post dose glucose PO
47766-1,Somatotropin^2H post dose insulin IV
47767-9,Somatotropin^2nd specimen post XXX challenge
47768-7,Somatotropin^30M post dose arginine
47769-5,Somatotropin^30M post dose glucose PO
47770-3,Somatotropin^30M post dose insulin IV
47771-1,Somatotropin^3H post dose glucose PO
47772-9,Somatotropin^45M post dose arginine
47773-7,Somatotropin^45M post dose insulin IV
47774-5,Somatotropin^pre dose arginine
47775-2,Somatotropin^pre dose glucagon
47776-0,Somatotropin^pre dose glucose PO
47777-8,Somatotropin^pre dose insulin IV
47778-6,Somatotropin^pre dose TRH
Sep-77,HLA-B61(40)
47779-4,Octadecanoate/Creatinine
47780-2,Sulfate
47781-0,Sulfocysteine
47782-8,Taurine
47783-6,Myristate/Creatinine
47784-4,Threonine
47785-1,Threonine/Amino acids.total
47786-9,Threonine/Amino acids.total
Jul-78,HLA-B62(15)
47787-7,Threonine/Amino acids.total
47788-5,Threonine/Amino acids.total
47789-3,Threonine/Amino acids.total
47790-1,Threonine/Amino acids.total
47791-9,Tocopherols
47792-7,Tyrosine/Amino acids.total
47793-5,Tyrosine/Amino acids.total
47794-3,Tyrosine/Amino acids.total
May-79,HLA-B62(15)
47795-0,Tyrosine/Amino acids.total
47796-8,Tyrosine/Amino acids.total
47797-6,Tyrosine/Amino acids.total
47798-4,Urea
47799-2,Valine
47800-8,Valine/Amino acids.total
47801-6,Valine/Amino acids.total
47802-4,Valine/Amino acids.total
Mar-80,HLA-B63(15)
47803-2,Valine/Amino acids.total
47804-0,Valine/Amino acids.total
47805-7,Valine/Amino acids.total
47806-5,Xylose
47807-3,2-Deoxytetronate/Creatinine
47808-1,2-Ethylhydracrylate/Creatinine
47809-9,2-Hydroxysebacate/Creatinine
47810-7,2-Methyl-3-Hydroxyvalerate
Jan-81,HLA-B63(15)
47811-5,2-Methyl-3-Oxobutyrate/Creatinine
47812-3,2-Methylglutaconate/Creatinine
47813-1,2-Methylglutarate/Creatinine
47814-9,"3,4-Dihydroxyphenyllactate/Creatinine"
47815-6,"3,4-Hydroxymandelate/Creatinine"
47816-4,3-Deoxytetronate/Creatinine
47817-2,"3-Hydroxy,4-Methoxybenzoate/Creatinine"
47818-0,3-Hydroxyhexanoate/Creatinine
47819-8,3-Hydroxysuberate/Creatinine
47820-6,3-Hydroxyvalerate
47821-4,3-Indolelactate/Creatinine
47822-2,3-Methyladipate/Creatinine
47823-0,4-Hydroxy-3-Methoxyphenyllactate/Creatinine
47824-8,5-Hydroxycaproate/Creatinine
47825-5,7-Hydroxyoctanoate/Creatinine
47826-3,Adenosine deaminase
47827-1,Adenosyl homocysteine hydrolase
47828-9,Adiponectin
Sep-82,HLA-B64(14)
47829-7,Arabitol/Creatinine
47830-5,Argininosuccinate synthase
47831-3,Argininosuccinate synthase
47832-1,C peptide^4M post 1 mg glucagon
47833-9,C peptide^6M post dose glucagon
47834-7,C peptide^8M post dose glucagon
47835-4,Carnitine acyltransferase I
47836-2,Carnitine acyltransferase I
Jul-83,HLA-B64(14)
47837-0,Carnitine acyltransferase II
47838-8,Carnitine acyltransferase II
47839-6,Carnitine acyltransferase II
47840-4,Carnitine acyltransferase II
47841-2,Citrate synthase
47842-0,Collection duration
47843-8,Corticotropin^post dose dexamethasone
47844-6,Cortisol^post 1 mg dexamethasone PO overnight
May-84,HLA-B65(14)
47845-3,Cortisol^post 1 mg dexamethasone PO overnight
47846-1,Cortisol^post 2 mg dexamethasone PO 2.5 day high dose q6h
47847-9,Cortisol^post 2 mg dexamethasone PO 2.5 day high dose q6h
47848-7,Cortisol^post 500 ug dexamethasone PO 2.5 day low dose q6h
47849-5,Cortisol^post 500 ug dexamethasone PO 2.5 day low dose q6h
47850-3,Cortisol^post dose corticotropin
47851-1,Cortisol^post dose dexamethasone
Feb-85,HLA-B65(14)
47852-9,Dehydroepiandrosterone^pre 250 ug corticotropin
47853-7,Diphosphoglycerate phosphatase
47854-5,Fibroblast growth factor 23.intact
47855-2,Fibroblast growth factor 23.C-terminal
47856-0,Follitropin^pre 100 ug luteinizing releasing hormone IV
47857-8,Galactitol/Creatinine
47858-6,Gentisate/Creatinine
47859-4,Glucose^5M post dose glucose
4786-0,HLA-B67
47860-2,Glutamate dehydrogenase
47861-0,Hypoxanthine phosphoribosyltransferase
47862-8,Insulin^post meal
47863-6,Lactate dehydrogenase
47864-4,Lutropin^2.5H post 100 ug luteinizing releasing hormone IV
47865-1,Malondialdehyde
47866-9,Phosphoribosylpyrophosphate synthetase
47867-7,Phosphoribosylpyrophosphate synthetase
47868-5,Prolactin^1.5H post dose metoclopramide
47869-3,Prolactin^1H post dose metoclopramide
47870-1,Prolactin^2.5H post dose TRH IV
47871-9,Prolactin^30M post dose metoclopramide
47872-7,Prolactin^pre dose metoclopramide
47873-5,Propionyl CO-A carboxylase
47874-3,Propionyl CO-A carboxylase
47875-0,Propionyl CO-A carboxylase
47876-8,Propionyl CO-A carboxylase
47877-6,Propionyl CO-A carboxylase
Aug-87,HLA-B67
47878-4,Propionylglycine
47879-2,Pyruvate carboxylase
478-8,Sulfonamide
47880-0,Pyruvate carboxylase
47881-8,Pyruvate carboxylase
47882-6,Pyruvate carboxylase
47883-4,Renin^upright
47884-2,Ribitol/Creatinine
47885-9,Somatotropin^1.5H post dose arginine+insulin
Jun-88,HLA-B w6
47886-7,Somatotropin^1.5H post dose betaxolol+glucagon
47887-5,Somatotropin^1.5H post dose ornithine
47888-3,Somatotropin^1.75H post dose arginine+insulin
47889-1,Somatotropin^1.75H post dose ornithine
47890-9,Somatotropin^15M post dose arginine+insulin
47891-7,Somatotropin^15M post dose growth hormone releasing factor
47892-5,Somatotropin^15M post dose ornithine
47893-3,Somatotropin^1H post dose glucagon
Apr-89,HLA-B w6
47894-1,Somatotropin^1H post dose growth hormone releasing factor
47895-8,Somatotropin^1H post dose ornithine
47896-6,Somatotropin^1H post dose propranolol+glucagon
47897-4,Somatotropin^1H post dose TRH
47898-2,Somatotropin^2.25H post dose arginine+insulin
47899-0,Somatotropin^2.5H post dose propranolol+glucagon
47900-6,Somatotropin^20M post dose TRH
47901-4,Somatotropin^2H post dose arginine+insulin
Feb-90,HLA-B70
47902-2,Somatotropin^2H post dose betaxolol+glucagon
47903-0,Somatotropin^2H post dose glucagon
47904-8,Somatotropin^2H post dose growth hormone releasing factor
47905-5,Somatotropin^2H post dose ornithine
47906-3,Somatotropin^2H post dose propranolol+glucagon
47907-1,Somatotropin^2H post dose TRH
47908-9,Somatotropin^2H pre dose propranolol+glucagon
47909-7,Somatotropin^30M post dose arginine+insulin
4791-0,HLA-B70
47910-5,Somatotropin^30M post dose betaxolol+glucagon
47911-3,Somatotropin^30M post dose glucagon
47912-1,Somatotropin^30M post dose growth hormone releasing factor
47913-9,Somatotropin^30M post dose ornithine
47914-7,Somatotropin^30M post dose TRH
47915-4,Somatotropin^3H post dose betaxolol+glucagon
47916-2,Somatotropin^3H post dose glucagon
47917-0,Somatotropin^3H post dose propranolol+glucagon
47918-8,Somatotropin^3rd specimen post XXX challenge
47919-6,Somatotropin^45M post dose arginine+insulin
47920-4,Somatotropin^45M post dose glucagon
47921-2,Somatotropin^45M post dose growth hormone releasing factor
47922-0,Somatotropin^45M post dose ornithine
47923-8,Somatotropin^4th specimen post XXX challenge
47924-6,Somatotropin^5M post dose arginine
47925-3,Somatotropin^5M post dose arginine+insulin
47926-1,Somatotropin^5M post dose ornithine
47927-9,Somatotropin^5th specimen post XXX challenge
Aug-92,HLA-B71(70)
47928-7,Somatotropin^1H post dose betaxolol+glucagon
47929-5,Somatotropin^6th specimen post XXX challenge
47930-3,Somatotropin^7th specimen post XXX challenge
47931-1,Somatotropin^8th specimen post XXX challenge
47932-9,Somatotropin^9th specimen post XXX challenge
47933-7,Somatotropin^pre dose arginine+insulin
47934-5,Somatotropin^pre dose betaxolol+glucagon
47935-2,Somatotropin^pre dose growth hormone releasing factor
Jun-93,HLA-B71(70)
47936-0,Somatotropin^pre dose ornithine
47937-8,Somatotropin^pre dose propranolol+glucagon
47938-6,Specimen source
47939-4,Sulfocysteine
47940-2,Testosterone^12H post 5000 U HCG IM
47941-0,Testosterone^1H post dose corticotropin
47942-8,Testosterone^1D post 5000 U HCG IM
47943-6,Testosterone^2D post 5000 U HCG IM
Apr-94,HLA-B72(70)
47944-4,Testosterone^4H post 5000 U HCG IM
47945-1,Testosterone^3D post 5000 U HCG IM
47946-9,Testosterone^pre dose corticotropin
47947-7,Thyrotropin^1.5H post dose luteinizing releasing hormone IV
47948-5,Thyrotropin^15M post dose luteinizing releasing hormone IV
47949-3,Thyrotropin^15M pre dose luteinizing releasing hormone IV
47950-1,Thyrotropin^1H post dose luteinizing releasing hormone IV
Jan-95,HLA-B72(70)
47951-9,Thyrotropin^2H post dose luteinizing releasing hormone IV
47952-7,Thyrotropin^30M post dose luteinizing releasing hormone IV
47953-5,Thyrotropin^pre dose luteinizing releasing hormone IV
47954-3,Tiglylglycine
47955-0,EYA1 gene targeted mutation analysis
47956-8,CNR1 gene targeted mutation analysis
47957-6,Deoxyuridine
47958-4,FLT3 gene targeted mutation analysis
47959-2,GFAP gene targeted mutation analysis
479-6,Talampicillin
47960-0,GLRA1 gene targeted mutation analysis
47961-8,ACVRL1 gene targeted mutation analysis
47962-6,JAG1 gene targeted mutation analysis
47963-4,JAK3 gene targeted mutation analysis
47964-2,MVK gene targeted mutation analysis
47965-9,Mycoplasma penetrans DNA
47966-7,NCF2 gene targeted mutation analysis
47967-5,NSD1 gene targeted mutation analysis
47968-3,PINK1 gene targeted mutation analysis
Sep-96,HLA-B73
47969-1,PTEN gene targeted mutation analysis
47970-9,SGCB gene targeted mutation analysis
47971-7,SGSH gene targeted mutation analysis
47972-5,TGFBR1 gene targeted mutation analysis
47973-3,TGFBR2 gene targeted mutation analysis
47974-1,THRB gene targeted mutation analysis
47975-8,tiZANidine
47976-6,Selenium
Jul-97,HLA-B73
47977-4,Smooth muscle Ab.IgG
47978-2,17-Ketosteroids
47979-0,Tranylcypromine
47980-8,Mirtazapine
47981-6,Phenylalanine/Creatinine
47982-4,Epstein Barr virus DNA
47983-2,Views 1 or 2
47984-0,Views
May-98,HLA-B75(15)
47985-7,Multisection^W contrast IT
47986-5,Views^W contrast IA
47987-3,Views^W contrast IA
47988-1,Progesterone^6th specimen post XXX challenge
47989-9,Progesterone^7th specimen post XXX challenge
47990-7,Progesterone^8th specimen post XXX challenge
47991-5,Progesterone^9th specimen post XXX challenge
Mar-99,HLA-B75(15)
47994-9,Bilirubin
47995-6,Glucose
47996-4,Adenosine deaminase binding protein
47997-2,Genetic variant clinical significance
47998-0,DNA sequence variation display name
47999-8,DNA region name
48000-4,Chromosome
48001-2,Chromosome region
48002-0,Genomic source class
48003-8,DNA sequence variation identifier
48004-6,DNA change
48005-3,Amino acid change
48006-1,Amino acid change type
48007-9,Genetic variant allelic state
48008-7,Allele name
Sep-00,HLA-B76(15)
48009-5,Genechip manufacturer ID
48010-3,Genechip ID
48011-1,Genechip version
48012-9,Reference sequence
48013-7,Genomic reference sequence identifier
48014-5,Sequence variation panel
48015-2,Individual allele panel
48016-0,Genechip kit panel
Jul-01,HLA-B76(15)
48017-8,Sequencing methodology panel
48018-6,Gene identifier
48019-4,DNA change type
48020-2,Forward primer
48021-0,Reverse primer
48022-8,Coagulation surface induced.lupus sensitive actual/Normal
48023-6,HIV 1 proviral DNA
48024-4,AS gene targeted mutation analysis
May-02,HLA-B77(15)
48025-1,Gene mutations tested for
48026-9,ITGA2B gene targeted mutation analysis
48027-7,MT-ND4 gene.c.G15257A
48028-5,SERPINE1 gene targeted mutation analysis
48029-3,PKLR gene targeted mutation analysis
48030-1,RHCE gene allele Ee
48031-9,SCA10 gene.CAG repeats
48032-7,THRB gene.p.Ala317Thr
Mar-03,HLA-B77(15)
48033-5,TTR gene targeted mutation analysis
48034-3,Leukocytes^^corrected for nucleated erythrocytes
48035-0,Hemoglobin
48036-8,Glucose
48037-6,pH
48038-4,Pathologist interpretation
48039-2,Fibronectin.fetal
480-4,Talampicillin
48040-0,Erythrocytes.nucleated/100 leukocytes
Jan-04,HLA-B12
48041-8,Anthraquinone cutoff
48042-6,Bisacodyl cutoff
48043-4,Oxyphenisatin cutoff
48044-2,Phenolphthalein cutoff
48045-9,Magnesium cutoff
48046-7,Phosphate cutoff
48047-5,Hemoglobin.gastrointestinal
48048-3,Neutrophils
48049-1,Eosinophils
48050-9,Neutrophils
48051-7,Erythrocytes
48052-5,Leukocytes^^corrected for nucleated erythrocytes
48053-3,Turbidity
48054-1,Coagulation kaolin induced
48055-8,Pneumocystis jiroveci
48056-6,Human bocavirus Ag
48057-4,Human bocavirus Ab.IgG
Aug-05,HLA-B12
48058-2,Fibrin D-dimer DDU
48059-0,Giardia lamblia+Cryptosporidium sp Ag
48060-8,Giardia lamblia+Cryptosporidium sp Ag
48061-6,Giardia lamblia+Cryptosporidium sp Ag
48062-4,Giardia lamblia+Cryptosporidium parvum Ag
48063-2,Giardia lamblia+Cryptosporidium parvum Ag
48064-0,Giardia lamblia+Cryptosporidium parvum Ag
48065-7,Fibrin D-dimer FEU
Jun-06,HLA-B13
48066-5,Fibrin D-dimer DDU
48067-3,Fibrin D-dimer FEU
48068-1,Heinz bodies
48069-9,Spherocytes.micro
48070-7,Hepatitis B virus surface Ab.IgG
48071-5,Complement total hemolytic CH50
48072-3,Synthetic glucocorticoid drug
48073-1,Thyroxine binding globulin panel
Apr-07,HLA-B13
48074-9,Somatotropin^2.5H post dose arginine+insulin
48075-6,Somatotropin^2.5H post dose betaxolol+glucagon
48076-4,Somatotropin^2.5H post dose glucagon
48077-2,Thyrotropin^2.5H post dose luteinizing releasing hormone IV
48078-0,"3,6-Epoxydecanedioate/Creatinine"
48079-8,"3,6-Epoxydodecanedioate/Creatinine"
48080-6,"3,6-Epoxyoctanedioate/Creatinine"
48081-4,"3,6-Epoxytetradecanedioate/Creatinine"
Feb-08,HLA-B14
48082-2,"3-Hydroxyadipate 3,6-lactone/Creatinine"
48083-0,3-Hydroxydodecanedienedioate/Creatinine
48084-8,3-Hydroxydodecanedioate/Creatinine
48085-5,3-Hydroxydodecenedioate/Creatinine
48086-3,3-Hydroxytetradecadienedioate/Creatinine
48087-1,3-Hydroxytetradecanedioate/Creatinine
48088-9,3-Hydroxytetradecenedioate/Creatinine
48089-7,Cholesterol/Apolipoprotein B
4809-0,HLA-B14
48090-5,Cholesterol.in HDL/Cholesterol.in HDL+Cholesterol.in VLDL
48091-3,Corticotropin^12 AM specimen
48092-1,Corticotropin^12 PM specimen
48093-9,Corticotropin^15M pre 1 ug/kg CRH IV
48094-7,Corticotropin^4 AM specimen
48095-4,Corticotropin^4 PM specimen
48096-2,Corticotropin^8 AM specimen
48097-0,Corticotropin^8 PM specimen
48098-8,Cortisol^12 AM specimen
48099-6,Cortisol^12 PM specimen
48100-2,Cortisol^15M pre 1 ug/kg CRH IV
48101-0,Cortisol^15M pre 1 ug/kg CRH IV
48102-8,Cortisol^4 AM specimen
48103-6,Cortisol^4 AM specimen
48104-4,Cortisol^8 AM specimen
48105-1,Cortisol^8 PM specimen
48106-9,"4,5-Dihydroxyhexanolactone/Creatinine"
48107-7,Erythritol/Creatinine
Aug-10,HLA-B15
48108-5,Follitropin^15M pre 100 ug luteinizing releasing hormone IV
48109-3,Glucose^15M pre dose glucose
48110-1,Glutathione.oxidized/glutathione.reduced
48111-9,Glutathione.reduced
48112-7,Glutathione.reduced
48113-5,Heptadecenoate/Creatinine
48114-3,Hexadecanedioate/Creatinine
48115-0,Homocysteine.free/Creatinine
Jun-11,HLA-B15
48116-8,Insulin^10M pre dose glucose
48117-6,Isovalerylglycine/Urea
48118-4,Lutropin^15M pre 100 ug luteinizing releasing hormone IV
48119-2,Pentadecanoate/Creatinine
481-2,Talampicillin
48120-0,Prolactin^15M pre dose TRH IV
48121-8,Quinolinate/Creatinine
48122-6,Somatotropin^15M post dose TRH
48123-4,Somatotropin^15M pre dose arginine+insulin
Apr-12,HLA-B16
48124-2,Somatotropin^15M pre dose glucagon
48125-9,Somatotropin^15M pre dose insulin IV
48126-7,Somatotropin^15M pre dose ornithine
48127-5,Somatotropin^15M pre dose TRH
48128-3,Somatotropin^1H post dose arginine+insulin
48129-1,Somatotropin^30M pre dose betaxolol+glucagon
48130-9,Somatotropin^30M pre dose propranolol+glucagon
48131-7,Somatotropin^30M pre dose TRH
Feb-13,HLA-B16
48132-5,Xylitol/Creatinine
48133-3,3-Oxovalerate
48134-1,Alanine aminotransferase.macromolecular
48135-8,Acadesine
48136-6,Aspartate aminotransferase.macromolecular
48137-4,"4,5-Dihydroxyhexanoate/Creatinine"
48138-2,Enolase.neuron specific
48139-0,"Erythro-4,5-Dihydroxyhexanoate/Creatinine"
4814-0,HLA-B17
48140-8,Erythro-4-Deoxytetronate/Creatinine
48141-6,Ferritin
48142-4,Indole-3-Acetate/Creatinine
48143-2,LDL.oxidized Ab
48144-0,Mannose
48145-7,Mevalonolactone/Creatinine
48146-5,Myeloperoxidase
48147-3,Oligosaccharides/Creatinine
48148-1,Osmolality
48149-9,Osmolality.urine/Osmolality.ser
48150-7,Perseitol/Creatinine
48151-5,Sedoheptitol/Creatinine
48152-3,Sorbitol/Creatinine
48153-1,Threitol/Creatinine
48154-9,"Threo-4,5-Dihydrohexanoate/Creatinine"
48155-6,"Threo-4,5-Dihydrohexanolactone/Creatinine"
48156-4,Threo-4-Deoxytetronate/Creatinine
Jul-15,HLA-B17
48157-2,Thymine/Creatinine
48158-0,Vanillate/Creatinine
48159-8,Hepatitis C virus Ab Signal/Cutoff
48160-6,HTLV I rgp21 Ab
48161-4,PROS1 gene targeted mutation analysis
48162-2,Thymidine
48163-0,Cytokeratin 19
48164-8,Enolase.neuron specific
May-16,HLA-B18
48165-5,Squamous cell carcinoma Ag
48166-3,Beta-2-Microglobulin
48167-1,Prostate specific Ag/Creatinine
48168-9,5-Hydroxyindoleacetate
48169-7,Amikacin 1.5 ug/mL
48170-5,Capreomycin 3.0 ug/mL
48171-3,Isoniazid 0.1 ug/mL
48172-1,Isoniazid 0.4 ug/mL
Mar-17,HLA-B18
48173-9,levoFLOXacin 1.5 ug/mL
48174-7,Mycobacterium tuberculosis complex rRNA
48175-4,Mycobacterium tuberculosis katG+inhA genes isoniazid resistance mutation
48176-2,Mycobacterium tuberculosis rifAMPin resistance (rpoB) gene
48177-0,Streptomycin 1.0 ug/mL
48178-8,Reference change value 0.99
48179-6,Reference change value 0.99
48180-4,Reference change value 0.95
Jan-18,HLA-B21
48181-2,Reference change value 0.95
48182-0,Vespa crabro leukotriene release
48183-8,Polistes spp leukotriene release
48184-6,Vespula spp leukotriene release
48185-3,Apis mellifera leukotriene release
48186-1,Amylase leukotriene release
48187-9,Chloramin T leukotriene release
48188-7,Latex leukotriene release
48189-5,Formaldehyde leukotriene release
48190-3,Phthalic anhydride leukotriene release
48191-1,Monosodium glutamate leukotriene release
48192-9,Sunset yellow FCF leukotriene release
48193-7,Succinylcholine leukotriene release
48194-5,Lidocaine leukotriene release
48195-2,Trimethoprim leukotriene release
48196-0,Cephalosporin C leukotriene release
48197-8,Cefuroxime leukotriene release
48198-6,Amoxicillin leukotriene release
Sep-19,HLA-B21
48199-4,Ampicillin leukotriene release
482-0,Talampicillin
48200-0,Penicillin V leukotriene release
48201-8,Penicillin G leukotriene release
48202-6,Ambrosia elatior+Ambrosia trifida leukotriene release
48203-4,Apium graveolens leukotriene release
48204-2,Casein leukotriene release
48205-9,Beta lactoglobulin leukotriene release
48206-7,Lactalbumin alpha leukotriene release
Jul-20,HLA-B27
48207-5,Egg yolk leukotriene release
48208-3,Saccharomyces cerevisiae leukotriene release
48209-1,Citrus sinensis leukotriene release
48210-9,Daucus carota leukotriene release
48211-7,Beef leukotriene release
48212-5,Pork leukotriene release
48213-3,Lycopersicon lycopersicum leukotriene release
48214-1,Pandalus borealis leukotriene release
May-21,HLA-B27
48215-8,Cancer pagurus leukotriene release
48216-6,Corylus avellana leukotriene release
48217-4,Glycine max leukotriene release
48218-2,Arachis hypogaea leukotriene release
48219-0,Sesamum indicum leukotriene release
48220-8,Avena sativa leukotriene release
48221-6,Hordeum vulgare leukotriene release
48222-4,Secale cereale leukotriene release
Mar-22,HLA-B35
48223-2,Triticum aestivum leukotriene release
48224-0,Gadus morhua leukotriene release
48225-7,Cow milk leukotriene release
48226-5,Egg white leukotriene release
48227-3,Human serum albumin leukotriene release
48228-1,Bovine serum albumin leukotriene release
48229-9,Dog epithelium leukotriene release
48230-7,Cat dander leukotriene release
Jan-23,HLA-B35
48231-5,Glycyphagus domesticus leukotriene release
48232-3,Tyrophagus putrescentiae leukotriene release
48233-1,Lepidoglyphus destructor leukotriene release
48234-9,Acarus siro leukotriene release
48235-6,Dermatophagoides farinae leukotriene release
48236-4,Dermatophagoides pteronyssinus leukotriene release
48237-2,Ctenocephalides sp leukotriene release
48238-0,Blatella germanica leukotriene release
48239-8,Alternaria alternata leukotriene release
48240-6,Candida albicans leukotriene release
48241-4,Aspergillus fumigatus leukotriene release
48242-2,Cladosporium herbarum leukotriene release
48243-0,Penicillium notatum leukotriene release
48244-8,Juniperus virginiana leukotriene release
48245-5,Cryptomeria japonica leukotriene release
48246-3,Olea europaea pollen leukotriene release
48247-1,Quercus alba leukotriene release
48248-9,Corylus avellana pollen leukotriene release
Sep-24,HLA-B37
48249-7,Betula verrucosa leukotriene release
48250-5,Parietaria judaica leukotriene release
48251-3,Parietaria officinalis leukotriene release
48252-1,Salsola kali leukotriene release
48253-9,Plantago lanceolata leukotriene release
48254-7,Artemisia vulgaris leukotriene release
48255-4,Ambrosia trifida leukotriene release
Jun-25,HLA-B37
48256-2,Ambrosia elatior leukotriene release
48257-0,Holcus lanatus leukotriene release
48258-8,Secale cereale pollen leukotriene release
48259-6,Poa pratensis leukotriene release
48260-4,Phleum pratense leukotriene release
48261-2,Lolium perenne leukotriene release
48262-0,Festuca elatior leukotriene release
48263-8,Dactylis glomerata leukotriene release
Apr-26,HLA-B38(16)
48264-6,Cynodon dactylon leukotriene release
48265-3,(Acarus siro+Lepidoglyphus destructor+Tyrophagus putrescentiae+Glycyphagus domesticus) leukotriene release
48266-1,(Dactylis glomerata+Festuca elatior+Holcus lanatus+Lolium perenne+Phleum pratense+Poa pratensis) leukotriene release
48267-9,Benzylpenicilloyl-polylysine leukotriene release
48268-7,Minor determinant mixture leukotriene release
48269-5,Cefamandole leukotriene release
48270-3,ceFAZolin leukotriene release
48271-1,Tetracycline leukotriene release
Feb-27,HLA-B38(16)
48272-9,Ciprofloxacin leukotriene release
48273-7,Lysine acetylsalicylate leukotriene release
48274-5,Diclofenac leukotriene release
48275-2,Ibuprofen leukotriene release
48276-0,Indomethacin leukotriene release
48277-8,Acetaminophen leukotriene release
48278-6,Mefenamate leukotriene release
48279-4,Propyphenazone leukotriene release
4828-0,HLA-B39(16)
48280-2,Dipyrone leukotriene release
48281-0,Sulfamethoxazole leukotriene release
48282-8,Atracurium leukotriene release
48283-6,Mivacurium leukotriene release
48284-4,Pancuronium leukotriene release
48285-1,Propofol leukotriene release
48286-9,Rocuronium leukotriene release
48287-7,Suxamethonium leukotriene release
48288-5,Vecuronium leukotriene release
48289-3,Sodium benzoate leukotriene release
48290-1,Sodium nitrite leukotriene release
48291-9,Potassium metabisulfite leukotriene release
48292-7,Sodium salicylate leukotriene release
48293-5,Tartrazine leukotriene release
48294-3,Food colorant mix I leukotriene release
48295-0,Food colorant mix II leukotriene release
48296-8,Quinoline yellow leukotriene release
48297-6,Chromotrope 2B leukotriene release
Aug-29,HLA-B39(16)
48298-4,Pigweed leukotriene release
48299-2,New coccine leukotriene release
48300-8,Erythrosine leukotriene release
48301-6,Patent blue V leukotriene release
48302-4,Indigo carmine leukotriene release
48303-2,Brilliant black BN leukotriene release
48304-0,Glutamate leukotriene release
48305-7,Coproporphyrin 1/Creatinine
Jun-30,HLA-B40
48306-5,Coproporphyrin 3/Creatinine
48307-3,Didanosine
48308-1,DNA double strand Ab
48309-9,BK virus DNA
48310-7,Influenza virus A
48311-5,Lysosomal enzymes screen
48312-3,Yersinia enterocolitica O:5 Ab
48313-1,Yersinia enterocolitica O:9 Ab
Apr-31,HLA-B40
48314-9,Leishmania mexicana Ab.IgG
48315-6,Leishmania mexicana Ab.IgM
48316-4,Leishmania tropica Ab.IgG
48317-2,Leishmania tropica Ab.IgM
48318-0,Cat hair+Cat epithelium Ab.IgE.RAST class
48319-8,glipiZIDE
48320-6,glyBURIDE
48321-4,TOLBUTamide
Feb-32,HLA-B44(12)
48322-2,acetoHEXAMIDE
48323-0,TOLAZamide
48324-8,chlorproPAMIDE
48325-5,Glimepiride
48326-3,glipiZIDE
48327-1,glyBURIDE
48328-9,Repaglinide
48329-7,chlorproPAMIDE
4833-0,HLA-B44(12)
48330-5,MCOLN1 gene mutations tested for
48331-3,BLM gene mutations tested for
48332-1,Apgar panel^10M post birth
48333-9,Apgar panel^5M post birth
48334-7,Apgar panel^1M post birth
48335-4,Aspergillus sp Ag
48336-2,Candida sp Ag
48337-0,Cryptococcus neoformans Ag
48338-8,Histoplasma capsulatum Ag
48339-6,Sporothrix schenckii Ag
48340-4,17-Hydroxyprogesterone^30M post XXX challenge
48341-2,17-Hydroxyprogesterone^1H post XXX challenge
48342-0,Ethanol+Methanol+Isopropyl alcohol+Acetone
48343-8,Hemoglobin.other/Hemoglobin.total
48344-6,Activated clotting time.kaolin induced
48345-3,HIV 1+O+2 Ab
48346-1,HIV 1+O+2 Ab
48347-9,levETIRAcetam
Aug-34,HLA-B45(12)
48348-7,10-Hydroxycarbazepine
48349-5,Pregabalin
48350-3,Venlafaxine+O-desmethylvenlafaxine
48351-1,Methotrimeprazine
48352-9,Reboxetine
48353-7,Chlorprothixene
48354-5,ARIPiprazole
May-35,HLA-B45(12)
48355-2,traMADol
48356-0,Prazepam
48357-8,Testosterone
48358-6,Herpes virus 8 Ab.IgM
48359-4,Echinococcus granulosus Ab
48360-2,Borrelia afzelii Ab.IgG
48361-0,Borrelia valaisiana Ab.IgG
48362-8,O-desmethylvenlafaxine
Mar-36,HLA-B49(21)
48363-6,Morphine-6-Glucuronide
48364-4,Morphine-3-Glucuronide
48365-1,Methadone.R
48366-9,Pentadecanoate
48367-7,cis-Vaccenate
48368-5,trans-Octadecanoate
48369-3,trans-Vaccenate
48370-1,Dihomogammalinolenate
Jan-37,HLA-B49(21)
48371-9,Docosapentaenoate
48372-7,Spermatozoa.isolated head/100 spermatozoa
48373-5,Spermatozoa.angled midpiece/100 spermatozoa
48374-3,Spermatozoa.isolated tail/100 spermatozoa
48375-0,Spermatozoa.short tail/100 spermatozoa
48376-8,Collagen type 1 Ab
48377-6,Mullerian inhibiting substance
48378-4,Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free
48379-2,Zopiclone
483-8,Teicoplanin
48380-0,3-Methoxytyramine
48381-8,3-Methoxytyramine/Creatinine
48382-6,Fatty acids.omega 6/Fatty acids.omega 3
48383-4,Collagen.bovine type 1 Ab
48384-2,Collagen.bovine type 2 Ab
48385-9,Collagen.injectable Ab
48386-7,Platelets.large/Platelets
48387-5,Thyroglobulin recovery
48388-3,Heparin Ab.IgE
Sep-38,HLA-B51(5)
48389-1,Macroprolactin/Prolactin
48390-9,B cell crossmatch
48391-7,Carbon dioxide
48392-5,Coccidioides immitis Ab
48393-3,Coccidioides immitis Ab.IgM
48394-1,Coccidioides sp Ab
48395-8,Coproporphyrin/Creatinine
48396-6,Ganglioside GD1b Ab
Jul-39,HLA-B51(5)
48397-4,Ganglioside GQ1b Ab
48398-2,Hepatitis B virus DNA
48399-0,Herpes simplex virus 1 glycoprotein G Ab.IgG
48400-6,Herpes simplex virus 1+2 Ag
48401-4,Herpes simplex virus 2 glycoprotein G Ab.IgG
48402-2,Latex Ab.IgE/IgE.total
48403-0,Methadone+Metabolite
48404-8,Myeloperoxidase Ab.IgG
May-40,HLA-B5
48405-5,Neuronal nuclear Ab.IgG
48406-3,Parietal cell Ab.IgG
48407-1,Pregnancy associated plasma protein A
48408-9,Proteinase 3 Ab.IgG
48409-7,T cell crossmatch
48410-5,Yersinia sp Ab.IgM
48411-3,Fungus identified
48412-1,Zygomycete sp Ag
Mar-41,HLA-B5
48413-9,Alpha-1-Microglobulin
48414-7,Alpha-1-Microglobulin
48415-4,Alpha-1-Microglobulin/Creatinine
48416-2,Alpha-1-Acid glycoprotein
48417-0,Staphylolysin Ab
48418-8,Staphylolysin Ab
48419-6,Immune complex.IgG
48420-4,Complement C3c
Jan-42,HLA-B7
48421-2,C reactive protein
48422-0,Protein fractions.oligoclonal bands
48423-8,Protein pattern
48424-6,Protein pattern
48425-3,Troponin T.cardiac
48426-1,Troponin T.cardiac
48427-9,Erythrocytes.Plasmodium sp infected/1000 erythrocytes
48428-7,Rumenate
48429-5,Lavandula angustifolia Ab.IgE
48430-3,Carnitine
48431-1,Zinc
48432-9,Fructose
48433-7,Views 2
48434-5,Guidance for percutaneous aspiration of fluid
48435-2,Guidance for injection
48436-0,Multisection^W contrast IT
48437-8,Multisection^W contrast IV
48438-6,Multisection^WO contrast
Sep-43,HLA-B7
48439-4,Multisection^W contrast IT
48440-2,Multisection^W contrast IV
48441-0,Multisection^WO & W contrast IT
48442-8,Multisection^WO & W contrast IT
48443-6,Multisection^WO & W contrast IV
48444-4,Multisection^W contrast IV
48445-1,Multisection^WO contrast
48446-9,Multisection^W contrast IV
Jul-44,HLA-B8
48447-7,Multisection^W contrast IT
48448-5,Multisection
48449-3,Multisection^W contrast IV
48450-1,Multisection^WO & W contrast IT
48451-9,Multisection^WO & W contrast IV
48452-7,Multisection^WO & W contrast IT
48453-5,Multisection^WO contrast
Apr-45,HLA-B8
48454-3,Multisection^WO & W contrast IV
48455-0,Multisection^WO & W contrast IV
48456-8,Multisection^W contrast IV
48457-6,Multisection^W contrast IV
48458-4,Multisection^WO contrast
48459-2,Multisection^WO contrast
484-6,Teicoplanin
48460-0,Multisection limited
48461-8,Multisection limited
Feb-46,HLA-Cw10(w3)
48462-6,View AP
48463-4,View AP
48464-2,Views
48465-9,Views
48466-7,Views limited
48467-5,Views 1 or 2
48468-3,Views 2 && View PA
48469-1,Views 2 or 3
4847-0,HLA-Cw10(w3)
48470-9,Views 3
48471-7,Views 3
48472-5,Views 3 + Swimmers
48473-3,Views 4
48474-1,Views AP + lateral
48475-8,Views diagnostic for implant
48476-6,Views GE 3
48477-4,Views GE 3
48478-2,Views GE 3
48479-0,Views GE 3
48480-8,Views GE 3
48481-6,Views GE 3
48482-4,Views GE 3
48483-2,Views GE 3
48484-0,Views GE 3 && view PA
48485-7,Views GE 3 && view PA
48486-5,Views GE 3 && view PA
48487-3,Views GE 4
Aug-48,HLA-Cw11
48488-1,Views 1 or 2
48489-9,Views 1 or 2
48490-7,Views open mouth + closed mouth
48491-5,Views open mouth + closed mouth
48492-3,Views screening for implant
48493-1,Beta-trace protein
48494-9,Complement C1 esterase inhibitor actual/Normal
48495-6,Transferrin.carbohydrate deficient/Transferrin.total
Jun-49,HLA-Cw11
48496-4,Complement total hemolytic CH50 actual/Normal
48497-2,Pro-hepcidin
48498-0,Amyloid A
48499-8,Beta-trace protein
48500-3,Borrelia burgdorferi 18kD Ab.IgG
48501-1,HLA Ab
48502-9,Platelet glycoprotein Ia-IIa Ab.IgG
48503-7,Platelet glycoprotein Ib-Ix Ab.IgG
Apr-50,HLA-Cw1
48504-5,Platelet glycoprotein IIb-IIIa Ab.IgG
48505-2,Platelet glycoprotein IIb-IIIa Ab
48506-0,Platelet glycoprotein Ib-Ix Ab
48507-8,Saint Louis encephalitis virus Ab.IgM
48508-6,Measles virus RNA
48509-4,Influenza virus A & B RNA
48510-2,HIV 1 RNA
48511-0,HIV 1 RNA
Feb-51,HLA-Cw1
48512-8,Are you basically satisfied with your life
48513-6,Have you dropped many of your activities and interests
48514-4,Do you feel that your life is empty
48515-1,Do you often get bored
48516-9,Are you hopeful about the future
48517-7,Are you bothered by thoughts you cannot get out of your head
48518-5,Are you in good spirits most of the time
48519-3,Are you afraid that something bad is going to happen to you
4852-0,HLA-Cw2
48520-1,Do you feel happy most of the time
48521-9,Do you often feel helpless
48522-7,Do you often get restless and fidgety
48523-5,"Do you prefer to stay at home, rather than going out and doing new things"
48524-3,Do you frequently worry about the future
48525-0,Do you feel you have more problems with memory than most
48526-8,Do you think it is wonderful to be alive now
48527-6,Often feel depressed
48528-4,Do you feel pretty worthless the way you are now
48529-2,Do you worry a lot about the past
485-3,Teicoplanin
48530-0,Do you find life very exciting
48531-8,Is it hard for you to get started on new projects
48532-6,Do you feel full of energy
48533-4,Do you feel that your situation is hopeless
48534-2,Do you think that most people are better off than you are
48535-9,Do you frequently get upset over little things
48536-7,Do you frequently feel like crying
48537-5,Do you have trouble concentrating
Aug-53,HLA-Cw2
48538-3,Do you enjoy getting up in the morning
48539-1,Do you prefer to avoid social gatherings
48540-9,Is it easy for you to make decisions
48541-7,Is your mind as clear as it used to be
48542-5,Geriatric depression scale (GDS) panel
48543-3,Geriatric depression scale (GDS).short version panel
48544-1,Geriatric depression scale total
48545-8,Geriatric depression scale.short version total
Jun-54,HLA-Cw3
48546-6,Clinical Care Classification (CCC) v2.5 panel
48547-4,Omaha System 2005 panel
48548-2,Living with HIV (LIV-HIV) panel
48549-0,HIV-Signs and Symptoms Checklist (SSC) panel
48550-8,Quality Audit Marker (QAM) panel
48551-6,HIV 1 RNA
48552-4,HIV 1 RNA
Mar-55,HLA-Cw3
48553-2,Muscle sarcolemma Ab
48554-0,Myocardium Ab
48555-7,Fetal blood
48556-5,Erythrocytes.fetal/1000 erythrocytes
48557-3,Origin
48558-1,HIV genotype
48559-9,HIV genotype
48560-7,Human papilloma virus genotype
Jan-56,HLA-Cw4
48561-5,Bacteria identified^^^2
48562-3,Bacteria identified^^^3
48563-1,Bacteria identified^^^4
48564-9,Bacteria identified^^^5
48565-6,Bacteria identified^^^6
48566-4,Bacteria identified^^^7
48567-2,Bacteria identified^^^3
48568-0,Bacteria identified^^^7
48569-8,Bacteria identified^^^8
48570-6,Follitropin^on cycle day 10
48571-4,Follitropin^on cycle day 11
48572-2,Follitropin^on cycle day 21
48573-0,Follitropin^on cycle day 3
48574-8,Hepatitis C virus genotype
48575-5,Hepatitis C virus genotype
48576-3,Hepatitis C virus RNA
48577-1,HFE gene.c.845G>A
48578-9,HFE gene.c.187G>C
Sep-57,HLA-Cw4
48579-7,HFE gene.c.187C>G
48580-5,KCNQ1OT1 gene targeted mutation analysis
48581-3,Lutropin^on cycle day 11
48582-1,Lutropin^on cycle day 3
48583-9,Lutropin^on cycle day 21
48584-7,Gastric emptying time^post 100 mg sodium octanoate PO
48585-4,Gastric emptying time^post 100 mg sodium acetate PO
48586-2,Collagen crosslinked C-telopeptide
Jul-58,HLA-Cw5
48587-0,Collagen crosslinked C-telopeptide/Creatinine
48588-8,Coccidioides sp rRNA
48589-6,Coccidioides sp rRNA
48590-4,Coagulation surface induced^after addition of APC
48591-2,Activated protein C resistance
48592-0,Fibrin+Fibrinogen fragments
48593-8,von Willebrand panel
48594-6,Platelet glycoprotein IIb-IIIa Ab
May-59,HLA-Cw5
48595-3,von Willebrand evaluation
48596-1,Activated protein C resistance panel
48597-9,cycloSPORINE^trough
48598-7,BBS2 gene targeted mutation analysis
48599-5,CLCN1 gene targeted mutation analysis
48600-1,VPS13B gene targeted mutation analysis
48601-9,OPA1 gene targeted mutation analysis
48602-7,TGM1 gene targeted mutation analysis
Mar-60,HLA-Cw6
48604-3,Yellow dye Ab.IgE.RAST class
48605-0,Glucose^1H post dose fructose PO
48606-8,Glucose^pre dose fructose PO
48607-6,Glucose^30M post dose fructose PO
48608-4,2-Hydroxyvalerate/Creatinine
48609-2,Adenovirus DNA
486-1,Teicoplanin
48610-0,7-Dehydrocholesterol
Jan-61,HLA-Cw6
48611-8,Antibiotic tested
48612-6,Hydrogen/Expired gas^45M post dose lactose PO
48613-4,Hydrogen/Expired gas^15M post dose lactose PO
48614-2,Cryoglobulin
48615-9,Insulin.free & Insulin.total panel
48616-7,17-Hydroxyprogesterone
48617-5,Phosphate^post dialysis
48618-3,Cholesterol.in VLDL
48619-1,Apolipoprotein E1
48620-9,Cholesterol
48621-7,Hexacarboxylporphyrin/Creatinine
48622-5,Urea nitrogen^24H post peritoneal dialysis
48623-3,Bilirubin.glucuronidated+Bilirubin.albumin bound
48624-1,Bilirubin
48625-8,Choriogonadotropin.intact
48626-6,Creatinine^24H post peritoneal dialysis
48627-4,Protein.monoclonal
48628-2,Insulin-like growth factor binding protein 3
Sep-62,HLA-Cw7
48629-0,Urea nitrogen^post dialysis
48630-8,Creatinine^pre dialysis
48631-6,Bicarbonate^post dialysis
48632-4,Heptacarboxylporphyrin
48633-2,Trypsinogen I.free
48634-0,Coproporphyrin/Creatinine
48635-7,Cholesterol.in LDL pattern A
48636-5,Cholesterol.in LDL pattern BII
Jul-63,HLA-Cw7
48637-3,Cholesterol.in LDL pattern BI
48638-1,Cryoglobulin type
48639-9,Urea nitrogen^post dialysis
48640-7,Second trimester triple maternal screen
48641-5,Phosphate^pre dialysis
48642-3,Glomerular filtration rate/1.73 sq M.predicted.non black
48643-1,Glomerular filtration rate/1.73 sq M.predicted.black
48644-9,"Vanillylmandelate, Homovanillate & Creatinine panel"
May-64,HLA-Cw8
48645-6,Pseudomonas sp DNA
48646-4,Yersinia sp DNA
48647-2,Ej Ab
48648-0,MART-1
48649-8,OJ Ab
48650-6,Hepatitis B virus DNA
48651-4,Borrelia burgdorferi Ab.IgM index
Feb-65,HLA-Cw8
48652-2,Clostridium tetani toxoid Ab.IgG^2nd specimen
48653-0,Clostridium tetani toxoid Ab.IgG^1st specimen
48654-8,Corynebacterium diphtheriae toxin Ab.IgG
48655-5,Corynebacterium diphtheriae toxin Ab^2nd specimen
48656-3,Ganglioside GD1a Ab
48657-1,Ganglioside GM2 Ab
48658-9,Ganglioside GQ1b Ab
48659-7,Hepatitis B virus precore codon 28
4866-0,HLA-Cw9(w3)
48660-5,Ganglioside GM1 Ab
48661-3,Lymphocyte proliferation.100 umol beryllium stimulation^5D post incubation
48662-1,Lymphocyte proliferation.phytohemagglutinin stimulation
48663-9,YKL-40
48664-7,Fibrinogen
48665-4,IgA.intrathecally synthesized
48666-2,IgG.intrathecally synthesized
48667-0,IgM.intrathecally synthesized
48668-8,Protein fractions.oligoclonal bands.IT
48669-6,Albumin & Immunoglobulin Quotient
48670-4,IgVH gene targeted mutation analysis
48671-2,Prostate cancer risk
48672-0,Clinical cytogeneticist
48673-8,EBV-LMP Ag
48674-6,Genetic diseases
48675-3,HER2
48676-1,HER2
48677-9,Cancer Ag 125
Aug-67,HLA-Cw9(w3)
48678-7,P57 Ag
48679-5,Pancytokeratin Ag
48680-3,PAX5 Ag
48681-1,Plasma cell Ag
48682-9,Smooth muscle myosin heavy chain Ag
48683-7,Streptococcus agalactiae DNA
48684-5,X & Y chromosome^post bone marrow transplant
48685-2,Para aminosalicylate 10.0 ug/mL
Jun-68,HLA-Dw10
48686-0,Salmonella paratyphi C Ab
48687-8,Multisection^WO contrast
48688-6,Multisection
48689-4,Multisection
48690-2,Multisection
48691-0,Multisection
48692-8,Multisection
48693-6,Multisection
Apr-69,HLA-Dw10
48694-4,Multisection^WO & W contrast IV
48695-1,View
48696-9,Views^W contrast intra salivary duct
48697-7,Views
48698-5,Views^W contrast intra salivary duct
48699-3,Views open mouth + closed mouth
48700-9,Thyrotropin releasing hormone
48701-7,Luteinizing releasing hormone
Feb-70,HLA-Dw11(w7)
48702-5,Spermatozoa.immature/100 spermatozoa
48703-3,Hematocrit
48704-1,Unidentified cells
48705-8,Leukocytes+Platelets
48706-6,Reticulocyte mean volume
48707-4,Hemoglobin C crystals
48708-2,Erythrocytes.fresh/100 erythrocytes
48709-0,Burr cells/100 erythrocytes
4871-0,HLA-Dw11(w7)
48710-8,Eosinophils
48711-6,Hemoglobin.free^post transfusion reaction
48712-4,Microscopic observation
48713-2,Bartonella quintana Ab.IgG
48714-0,Leishmania tropica Ab.IgM
48715-7,Leishmania tropica Ab.IgG
48716-5,La Crosse virus Ab.IgG
48717-3,Leishmania mexicana Ab.IgM
48718-1,Leishmania mexicana Ab.IgG
48719-9,Coxiella burnetii phase 2 Ab.IgG
48720-7,Coxiella burnetii phase 1 Ab.IgG
48721-5,Bartonella henselae Ab.IgG
48722-3,Microscopic observation
48723-1,Epstein Barr virus Ab
48724-9,Bacteria identified^^^3
48725-6,Hemoglobin^pre therapeutic phlebotomy
48726-4,JAK2 gene targeted mutation analysis
48727-2,Bacteria identified^^^2
Aug-72,HLA-Dw12
48728-0,NCF1+NCF2+CYBB gene targeted mutation analysis
48729-8,CYBA gene targeted mutation analysis
48730-6,X linked heterotaxy
48731-4,Complement C4
48732-2,NCF1 gene targeted mutation analysis
48733-0,NCF2 gene targeted mutation analysis
48734-8,CYBB gene targeted mutation analysis
48735-5,Guidance for localization
Jun-73,HLA-Dw12
48736-3,Guidance for injection of sentinel lymph node
48737-1,Views 3
48738-9,Views 3
48739-7,Guidance for injection of sentinel lymph node
48740-5,Guidance for injection of sentinel lymph node
48741-3,Bordetella pertussis
48742-1,Multisection
48743-9,Multisection^WO & W contrast IV
Apr-74,HLA-Dw13
48744-7,View 1
48745-4,Views
48746-2,Views GE 3
48747-0,Views GE 4
48748-8,Views oblique
48749-6,Views oblique
48750-4,3-Hydroxy fatty acids pattern
Jan-75,HLA-Dw13
48751-2,3-Hydroxypalmitate.free
48752-0,3-Hydroxymyristate.free
48753-8,3-Hydroxydodecanoate.free
48754-6,3-Hydroxydodecanoate
48755-3,3-Hydroxydecanoate.free
48756-1,3-Hydroxyoctanoate.free
48757-9,3-Hydroxyoctanoate
48758-7,3-Hydroxyhexanoate.free
48759-5,3-Hydroxyhexanoate
48760-3,3-Hydroxy fatty acid panel
48761-1,3-Hydroxypalmitate
48762-9,3-Hydroxymyristate
48763-7,3-Hydroxydecanoate
48764-5,Summary purpose
48765-2,Allergies &or adverse reactions
48766-0,Information source
48767-8,Annotation comment
48768-6,Payment sources
Sep-76,HLA-Dw14
48769-4,Continuity of Care panel
48770-2,Biophysical profile panel
48771-0,Immunoglobulin light chains.kappa
48772-8,Immunoglobulin light chains.lambda
48773-6,Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda
48774-4,Immunoglobulin light chains.kappa.free
48775-1,Immunoglobulin light chains.lambda.free
48776-9,Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free
Jul-77,HLA-Dw14
48777-7,Immunoglobulin light chains.kappa.free/Albumin
48778-5,Erythrocytes.nucleated/100 cells
48779-3,SPL indexing data elements section
48780-1,SPL listing data elements section
48781-9,CYP21A2 gene targeted mutation analysis
48782-7,Dipyrone Ab.IgE.RAST class
48783-5,Dipyrone Ab.IgE
48784-3,Herpes simplex virus 2 Ab
May-78,HLA-Dw15
48785-0,Prostaglandin D2
48786-8,Renin^30M pre XXX challenge
48787-6,Glucose^24H post peritoneal dialysis
48788-4,Creatinine peritoneal dialysis clearance
48789-2,Creatinine peritoneal dialysis clearance/1.73 sq M
487-9,Temafloxacin
48790-0,Creatinine
48791-8,Urea nitrogen peritoneal dialysis clearance/1.73 sq M
48792-6,Necroinflammatory activity score
Mar-79,HLA-Dw15
48793-4,Necroinflammatory activity grade
48794-2,Fibrosis stage
48795-9,Liver fibrosis score
48796-7,Hepatitis C virus FibroSURE panel
48797-5,Organic acids panel
48798-3,First trimester maternal screen panel
48799-1,Second trimester penta maternal screen panel
48800-7,Second trimester quad maternal screen panel
Jan-80,HLA-Dw16
48802-3,Alpha-1-fetoprotein panel
48803-1,Neural tube defect risk
48804-9,Taenia solium Ag
48805-6,Platelet aggregation panel
48806-4,Salmonella sp+Shigella sp+Escherichia coli enterotoxic identified
48807-2,Bone marrow aspiration report
48808-0,Leukogram panel
48809-8,Erythrogram panel
48810-6,Glucose^5H post 50 g glucose PO
48811-4,Protein fractions 3 panel
48812-2,Spermatozoa morphology panel
48813-0,Bacterial methicillin resistance mecA gene
48814-8,Bacterial vancomycin resistance vanA gene
48815-5,Herpes simplex virus+Varicella zoster virus DNA
48816-3,Staphylococcus aureus Panton-Valentine leukocidin gene
48817-1,Donath Landsteiner Ab
48818-9,Karyotype
Sep-81,HLA-Dw16
48819-7,Karyotype
48820-5,Karyotype
48821-3,"t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript"
48822-1,Tubular basement membrane Ab.IgG
48823-9,Tubular basement membrane Ab.IgG
48824-7,"Respiratory allergen panel, US - North Atlantic states a"
48825-4,"Respiratory allergen panel, US - Mid Atlantic states"
48826-2,"Respiratory allergen panel, US - South Atlantic states a"
Jul-82,HLA-Dw17(w7)
48827-0,"Respiratory allergen panel, US - Subtropical Florida"
48828-8,"Respiratory allergen panel, US - Greater Ohio valley a"
48829-6,"Respiratory allergen panel, US - South central states"
48830-4,"Respiratory allergen panel, US - Northern midwest states a"
48831-2,"Respiratory allergen panel, US - Central midwest a"
48832-0,"Respiratory allergen panel, US - Great plains states a"
48833-8,"Respiratory allergen panel, US - Southwestern grassland states"
48834-6,"Respiratory allergen panel, US - Rocky mountain states a"
May-83,HLA-Dw17(w7)
48835-3,"Respiratory allergen panel, US - Arid southwest"
48836-1,"Respiratory allergen panel, US - Southern coastal California"
48837-9,"Respiratory allergen panel, US - California central valley"
48838-7,"Respiratory allergen panel, US - Intermountain west a"
48839-5,"Respiratory allergen panel, US - Inland northwest a"
48840-3,"Respiratory allergen panel, US - Cascade Pacific northwest a"
48841-1,"Respiratory allergen panel, US - Alaska a"
48842-9,Bartonella bacilliformis Ab.IgG
Mar-84,HLA-Dw18(w6)
48843-7,Bartonella bacilliformis Ab.IgM
48844-5,Bartonella elizabethae Ab.IgG
48845-2,Bartonella elizabethae Ab.IgM
48846-0,Bartonella vinsonii berkhoffii Ab.IgM
48847-8,Bartonella vinsonii berkhoffii Ab.IgG
48848-6,Coxiella burnetii phase 1 Ab.IgA
48849-4,Coxiella burnetii phase 2 Ab.IgA
4885-0,HLA-Dw18(w6)
48850-2,Ehrlichia chaffeensis Ab.IgM
48851-0,Orientia tsutsugamushi Gilliam Ab.IgM
48852-8,Orientia tsutsugamushi Gilliam Ab.IgG
48853-6,Orientia tsutsugamushi Karp Ab.IgG
48854-4,Orientia tsutsugamushi Karp Ab.IgM
48855-1,Orientia tsutsugamushi Kato Ab.IgG
48856-9,Orientia tsutsugamushi Kato Ab.IgM
48857-7,Rickettsia africae Ab.IgM
48858-5,Rickettsia africae Ab.IgG
48859-3,Rickettsia akari Ab.IgG
48860-1,Rickettsia akari Ab.IgM
48861-9,Rickettsia parkeri Ab.IgM
48862-7,Rickettsia parkeri Ab.IgG
48863-5,Rickettsia sp DNA
48864-3,Bartonella sp DNA
48865-0,Ehrlichia ewingii DNA
48866-8,Ehrlichia sp DNA
48867-6,Orientia tsutsugamushi DNA
Aug-86,HLA-Dw19(w6)
48868-4,Rickettsia rickettsii DNA
48869-2,Rickettsia sp DNA
488-7,Temafloxacin
48870-0,Rickettsia spotted fever group DNA
48871-8,Rickettsia typhus group DNA
48872-6,Anaplasma phagocytophilum
48873-4,Ehrlichia sp identified
48874-2,Neorickettsia sp
48875-9,Orientia tsutsugamushi
Jun-87,HLA-Dw19(w6)
48876-7,Anaplasma phagocytophilum Ab.IgM
48877-5,Anaplasma phagocytophilum Ab.IgG
48878-3,Bartonella bacilliformis Ab.IgG
48879-1,Bartonella bacilliformis Ab.IgM
48880-9,Bartonella elizabethae Ab.IgG
48881-7,Bartonella elizabethae Ab.IgM
48882-5,Bartonella henselae Ab.IgM
48883-3,Bartonella henselae Ab.IgG
Apr-88,HLA-Dw1
48884-1,Bartonella quintana Ab.IgG
48885-8,Bartonella quintana Ab.IgM
48886-6,Bartonella vinsonii berkhoffii Ab.IgM
48887-4,Bartonella vinsonii berkhoffii Ab.IgG
48888-2,Coxiella burnetii phase 1 Ab.IgG
48889-0,Coxiella burnetii phase 1 Ab.IgA
48890-8,Coxiella burnetii phase 1 Ab.IgM
48891-6,Coxiella burnetii phase 2 Ab.IgA
Feb-89,HLA-Dw1
48892-4,Coxiella burnetii phase 2 Ab.IgM
48893-2,Coxiella burnetii phase 2 Ab.IgG
48894-0,Ehrlichia chaffeensis Ab.IgG
48895-7,Ehrlichia chaffeensis Ab.IgM
48896-5,Orientia tsutsugamushi Gilliam Ab.IgM
48897-3,Orientia tsutsugamushi Gilliam Ab.IgG
48898-1,Orientia tsutsugamushi Karp Ab.IgG
48899-9,Orientia tsutsugamushi Karp Ab.IgM
Sep-48,Bacampicillin
4890-0,HLA-Dw20
48900-5,Orientia tsutsugamushi Kato Ab.IgG
48901-3,Orientia tsutsugamushi Kato Ab.IgM
48902-1,Rickettsia africae Ab.IgM
48903-9,Rickettsia africae Ab.IgG
48904-7,Rickettsia akari Ab.IgG
48905-4,Rickettsia akari Ab.IgM
48906-2,Rickettsia conorii Ab.IgM
48907-0,Rickettsia conorii Ab.IgG
48908-8,Rickettsia parkeri Ab.IgM
48909-6,Rickettsia parkeri Ab.IgG
48910-4,Rickettsia prowazekii Ab.IgM
48911-2,Rickettsia prowazekii Ab.IgG
48912-0,Rickettsia rickettsii Ab.IgM
48913-8,Rickettsia rickettsii Ab.IgG
48914-6,Rickettsia typhi Ab.IgG
48915-3,Rickettsia typhi Ab.IgM
48916-1,"Respiratory allergen panel, US - North Atlantic states b"
48917-9,"Respiratory allergen panel, US - South Atlantic states b"
Aug-91,HLA-Dw20
48918-7,"Respiratory allergen panel, US - NC, PA, SC, VA, WV"
48919-5,"Respiratory allergen panel, US - Central Florida"
48920-3,"Respiratory allergen panel, US - Southern Florida"
48921-1,"Respiratory allergen panel, US - Southeast coast"
48922-9,"Respiratory allergen panel, US - West south central states"
48923-7,"Respiratory allergen panel, US - Greater Ohio valley b"
48924-5,"Respiratory allergen panel, US - Northern midwest states b"
48925-2,"Respiratory allergen panel, US - Central midwest b"
Jun-92,HLA-Dw21
48926-0,"Respiratory allergen panel, US - Great plains states b"
48927-8,"Respiratory allergen panel, US - Rocky mountain states b"
48928-6,"Respiratory allergen panel, US - Inland northwest b"
48929-4,"Respiratory allergen panel, US - Cascade Pacific northwest b"
48930-2,"Respiratory allergen panel, US - Intermountain west b"
48931-0,"Respiratory allergen panel, US - AZ, Southeastern CA, Western NM"
48932-8,"Respiratory allergen panel, US - Alaska b"
48933-6,"Respiratory allergen panel, US - Hawaii"
Apr-93,HLA-Dw21
48934-4,11-Hydroxy delta-9 tetrahydrocannabinol
48935-1,11-Hydroxy delta-9 tetrahydrocannabinol
48936-9,Acylcarnitine pattern
48937-7,Alpha hydroxyalprazolam
48938-5,ALPRAZolam
48939-3,Amphetamines
48940-1,Benzodiazepines
48941-9,Benzodiazepines
Feb-94,HLA-Dw22
48942-7,Cannabinoids
48943-5,Cannabinoids
48944-3,Carboxy tetrahydrocannabinol
48945-0,chlordiazePOXIDE
48946-8,Cocaethylene
48947-6,Cocaine
48948-4,diazePAM
48949-2,Estazolam
489-5,Temafloxacin
48950-0,Flurazepam
48951-8,Guidance for injection
48952-6,Histoplasma capsulatum Ag
48953-4,Hydroxyethylflurazepam
48954-2,Hydroxytriazolam
48955-9,LORazepam
48956-7,Methadone
48957-5,Methadone
48958-3,Midazolam
Sep-95,HLA-Dw22
48959-1,Nordiazepam
48960-9,Norpropoxyphene
48961-7,Opiates
48962-5,Oxazepam
48963-3,Propoxyphene
48964-1,Propoxyphene
48965-8,Temazepam
48966-6,Triazolam
Jul-96,HLA-Dw23
48967-4,Brucella abortus Ab
48968-2,PKHD1 gene targeted mutation analysis
48969-0,DCX gene targeted mutation analysis
48970-8,ELN gene targeted mutation analysis
48971-6,EYA1 gene targeted mutation analysis
48972-4,FGFR2 gene+FGFR3 gene targeted mutation analysis
48973-2,Leukocytes^2nd specimen
48974-0,MDCR gene targeted mutation analysis
May-97,HLA-Dw23
48975-7,GPR143 gene targeted mutation analysis
48976-5,POLG gene targeted mutation analysis
48977-3,SGCG gene targeted mutation analysis
48978-1,CDKL5 gene targeted mutation analysis
48979-9,TSC1 gene targeted mutation analysis
48980-7,TSC2 gene targeted mutation analysis
48981-5,Anaplasma sp
48982-3,Ehrlichia sp
Mar-98,HLA-Dw24
48983-1,Glucose^20M pre XXX challenge
48984-9,Glucose^10M post dose glucose
48985-6,Glucose^20M post dose glucose
48986-4,Glucose^8 AM specimen
48987-2,Pyridinoline.free/Creatinine
48988-0,Glucose^12 PM specimen
48989-8,Glucose^6 PM specimen
48990-6,Glucose^8 PM specimen
Jan-99,HLA-Dw24
48991-4,Glucose^10 PM specimen
48992-2,Glucose^12 AM specimen
48993-0,Glucose^3 AM specimen
48994-8,Glucose^6 AM specimen
48995-5,N-acetyl-beta-glucosaminidase/Creatinine
48996-3,Amylase.pancreatic
48997-1,Immune complex.IgG
48998-9,6-Phosphogluconate dehydrogenase
48999-7,Urea
49000-3,Hemoglobin.free
49001-1,Osmolality
49002-9,Albumin
49003-7,Urate
49004-5,Creatinine
49005-2,Calcium
49006-0,Phosphate
Jul-00,HLA-Dw25
49007-8,Magnesium
49008-6,Coagulum retraction
49009-4,Norepinephrine^7th specimen post XXX challenge
49010-2,Platelet aggregation.adenosine diphosphate induced
49011-0,Platelet aggregation.arachidonate induced
49012-8,Influenza virus A & B identified
49013-6,Pancreastatin
49014-4,PAH gene targeted mutation analysis
May-01,HLA-Dw25
49015-1,SCA15 gene.CAG repeats
49016-9,Streptococcus sp exoenzyme Ab
49017-7,"Respiratory allergen panel, US - North Atlantic states c"
49018-5,"Respiratory allergen panel, US - Intermountain west c"
49019-3,"Respiratory allergen panel, US - Puerto Rico"
49020-1,"Respiratory allergen panel, US - Coastal California"
49021-9,"Respiratory allergen panel, US - Greater Ohio valley c"
49022-7,"Respiratory allergen panel, US - Northern midwest states c"
Mar-02,HLA-Dw26
49023-5,Albumin
49024-3,Differential cell count method
49025-0,Cells.CD25+CD127Low/Cells.CD4
49026-8,LDL 6
49027-6,LDL 7
49028-4,Microdeletion syndromes
49029-2,Cortisol.free/Cortisone.free
490-3,Temafloxacin
49030-0,Trisomy 21 risk based on maternal age + Pregnancy associated plasma protein A + Choriogonadotropin + Nuchal translucency
Jan-03,HLA-Dw26
49031-8,Erythrocytes.CD59/100 erythrocytes
49032-6,Second trimester penta maternal screen
49033-4,Menstrual History
49034-2,Microorganism identified
49035-9,Thickness
49036-7,Parathyrin.intact^post excision
49037-5,Respiratory syncytial virus Ab.IgG & IgM panel
49038-3,Riboflavin
49039-1,Subtelomere analysis
49040-9,Subtelomere analysis
49041-7,Testosterone
49042-5,Testosterone.free
49043-3,Testosterone.free/Testosterone.total
49044-1,Diazepam & Nordiazepam panel
49045-8,PT & aPTT & Fibrinogen panel
49046-6,Drugs of abuse panel
49047-4,Globulin
49048-2,Protein feed time
Sep-04,HLA-Dw2
49049-0,Collection time
49050-8,Microscopic observation
49051-6,Gestational age in W
49052-4,Gestational age in D
49053-2,Neural tube defect
49054-0,Ercalcidiol
49055-7,Ribonucleoprotein extractable nuclear 52kD Ab
Jun-05,HLA-Dw2
49056-5,Shigella sp serotype
49057-3,Blood group antibody score
49058-1,Coagulation surface induced
49059-9,Trisomy 21+Trisomy 18 risk
49060-7,Fondaparinux
49061-5,Hepatic iron index
49062-3,Lipid risk factors
49063-1,Microdeletion syndromes
Apr-06,HLA-Dw3
49064-9,Gamma 2 globulin
49065-6,Eastern equine encephalitis virus Ab.IgG & IgM
49066-4,Western equine encephalitis virus Ab.IgG & IgM
49067-2,La Crosse virus Ab.IgG & IgM
49068-0,Saint Louis encephalitis virus Ab.IgG & IgM
49069-8,Epstein Barr virus Ab
49070-6,Specimen drawn
49071-4,Urea nitrogen^post dialysis/pre dialysis
Feb-07,HLA-Dw3
49072-2,Cocaethylene
49073-0,Influenza virus A Ab.IgG
49074-8,Influenza virus A Ab.IgA
49075-5,Influenza virus A Ab.IgM
49076-3,Influenza virus B Ab.IgA
49077-1,Influenza virus B Ab.IgG
49078-9,Influenza virus B Ab.IgM
49079-7,Periplaneta americana Ab.IgE.RAST class
4908-0,HLA-Dw4
49080-5,Kanamycin 1.0 ug/mL
49081-3,Beta-2-Microglobulin
49082-1,Western equine encephalitis virus Ab.IgG & IgM
49083-9,"North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel"
49084-7,Census block group 1970&80&90
49085-4,First & Second trimester integrated maternal screen panel
49086-2,First trimester maternal screen with nuchal translucency panel
49087-0,Maternal screen clinical predictors panel
49088-8,Sonographer name
49089-6,Sonographer
49090-4,Fetal trisomy 21 risk
49091-2,Neural tube defect risk
49092-0,Second trimester quad maternal screen
49093-8,Arbovirus Ab.IgG & IgM panel
49094-6,Arbovirus Ab.IgG & IgM panel
49095-3,Saint Louis encephalitis virus Ab.IgG & IgM
49096-1,Chlamydia trachomatis DNA
49097-9,Creatine
Aug-09,HLA-Dw4
49098-7,Cryptococcus neoformans rRNA
49099-5,Gadus morhua Ab.IgG
49100-1,H2a-H2b DNA Ab.IgG
49101-9,Helicobacter pylori DNA
49102-7,Herpes virus 8 DNA
49103-5,Leukocyte casts
49104-3,Mycoplasma pneumoniae DNA
49105-0,Phenolphthalein
Jun-10,HLA-Dw5
49106-8,Phenols
49107-6,Rubella virus Ab.IgM
49108-4,Titanium
49109-2,Toxoplasma gondii Ab
491-1,Temocillin
49110-0,Mycoplasma sp identified
49111-8,Spermatozoa
49112-6,Borna disease virus Ab
49113-4,ZAP70 Ag
Apr-11,HLA-Dw5
49114-2,Flavivirus rRNA
49115-9,Thiamine.free
49116-7,Trichosporon sp DNA
49117-5,Norovirus Ag
49118-3,Views^W radionuclide IV
49119-1,Monosaccharides.sulfated
49120-9,Immunodeficiency follow-up panel
49121-7,Erythrocyte inclusion bodies
Feb-12,HLA-Dw6
49122-5,Anaplasma sp identified
49123-3,Bartonella sp identified
49124-1,Coxiella burnetii identified
49125-8,Ehrlichia sp identified
49126-6,Orientia tsutsugamushi identified
49127-4,Rickettsia sp identified
49128-2,Rickettsia typhus group identified
49129-0,Creatine kinase.MiMi/Creatine kinase.total
4913-0,HLA-Dw6
49130-8,Cholesterol.in HDL
49131-6,Chylomicrons/Lipoprotein.total
49132-4,Cholesterol.in LDL
49133-2,Cholesterol.in VLDL
49134-0,Glucose^2H post dose glucose
49135-7,Fractional excretion of sodium
49136-5,Creatine kinase.MB/Creatine kinase.total
49137-3,Hemoglobin
49138-1,California encephalitis virus Ab.IgG
49139-9,California encephalitis virus Ab.IgM
49140-7,California encephalitis virus Ab.IgG
49141-5,California encephalitis virus Ab.IgM
49142-3,La Crosse virus Ab.IgG & IgM
49143-1,"North American Association of Central Cancer Registries, Inc (NAACCR, Inc) Pathology Laboratory Electronic Reporting panel"
49144-9,Saint Louis encephalitis virus Ab.IgM
49145-6,Rickettsia rickettsii Ab.IgG
49146-4,Rickettsia rickettsii Ab.IgM
49147-2,Rickettsia prowazekii Ab.IgM
Aug-14,HLA-Dw7
49148-0,Rickettsia prowazekii Ab.IgG
49149-8,Rickettsia parkeri Ab.IgG
49150-6,Rickettsia parkeri Ab.IgM
49151-4,Rickettsia parkeri Ab.IgG
49152-2,Rickettsia parkeri Ab.IgM
49153-0,Rickettsia conorii Ab.IgM
49154-8,Rickettsia conorii Ab.IgG
May-15,HLA-Dw7
49155-5,Rickettsia akari Ab.IgM
49156-3,Rickettsia akari Ab.IgM
49157-1,Rickettsia akari Ab.IgG
49158-9,Rickettsia akari Ab.IgG
49159-7,Rickettsia africae Ab.IgG
49160-5,Rickettsia africae Ab.IgM
49161-3,Rickettsia africae Ab.IgG
49162-1,Rickettsia africae Ab.IgM
Mar-16,HLA-Dw8
49163-9,Orientia tsutsugamushi Kato Ab.IgM
49164-7,Orientia tsutsugamushi Kato Ab.IgM
49165-4,Orientia tsutsugamushi Kato Ab.IgG
49166-2,Orientia tsutsugamushi Kato Ab.IgG
49167-0,Orientia tsutsugamushi Karp Ab.IgM
49168-8,Orientia tsutsugamushi Karp Ab.IgM
49169-6,Orientia tsutsugamushi Karp Ab.IgG
49170-4,Orientia tsutsugamushi Karp Ab.IgG
Jan-17,HLA-Dw8
49171-2,Orientia tsutsugamushi Gilliam Ab.IgM
49172-0,Orientia tsutsugamushi Gilliam Ab.IgM
49173-8,Orientia tsutsugamushi Gilliam Ab.IgG
49174-6,Orientia tsutsugamushi Gilliam Ab.IgG
49175-3,Human bocavirus Ab.IgG
49176-1,Herpes virus 8 Ab.IgM
49177-9,Hepatitis B virus surface Ab.IgG
49178-7,Epstein Barr virus Ab
49179-5,Ehrlichia chaffeensis Ab.IgM
49180-3,Ehrlichia chaffeensis Ab.IgG
49181-1,Echinococcus granulosus Ab
49182-9,Coxiella burnetii phase 2 Ab.IgM
49183-7,Coxiella burnetii phase 2 Ab.IgG
49184-5,Coxiella burnetii phase 2 Ab.IgA
49185-2,Coxiella burnetii phase 1 Ab.IgM
49186-0,Coxiella burnetii phase 1 Ab.IgG
49187-8,Coxiella burnetii phase 1 Ab.IgA
49188-6,Corynebacterium diphtheriae toxin Ab^2nd specimen
Sep-18,HLA-Dw9
49189-4,Corynebacterium diphtheriae toxin Ab.IgG
49190-2,Coccidioides sp Ab
49191-0,Clostridium tetani toxoid Ab.IgG^1st specimen
49192-8,Clostridium tetani toxoid Ab.IgG^2nd specimen
49193-6,California encephalitis virus Ab.IgM
49194-4,California encephalitis virus Ab.IgG
49195-1,California encephalitis virus Ab.IgG
49196-9,Brucella abortus Ab
Jul-19,HLA-Dw9
49197-7,Bartonella vinsonii berkhoffii Ab.IgG
49198-5,Bartonella vinsonii berkhoffii Ab.IgM
49199-3,Bartonella vinsonii berkhoffii Ab.IgG
49200-9,Bartonella vinsonii berkhoffii Ab.IgM
49201-7,Bartonella quintana Ab.IgM
49202-5,Bartonella quintana Ab.IgG
49203-3,Bartonella henselae Ab.IgG
49204-1,Bartonella henselae Ab.IgM
May-20,HLA-DPw1
49205-8,Bartonella elizabethae Ab.IgM
49206-6,Bartonella elizabethae Ab.IgG
49207-4,Bartonella elizabethae Ab.IgM
49208-2,Bartonella elizabethae Ab.IgG
49209-0,Bartonella bacilliformis Ab.IgM
49210-8,Bartonella bacilliformis Ab.IgG
49211-6,Bartonella bacilliformis Ab.IgM
49212-4,Bartonella bacilliformis Ab.IgG
Mar-21,HLA-DPw1
49213-2,Anaplasma phagocytophilum Ab.IgG
49214-0,Anaplasma phagocytophilum Ab.IgM
49215-7,PKHD1 gene targeted mutation analysis
49216-5,Hexokinase
49217-3,"2,3-Diphosphoglycerate"
49218-1,Phosphatidylinositol/Surfactant.total
49219-9,Galactose
49220-7,Prolactin
Jan-22,HLA-DPw2
49221-5,Catalase
49222-3,Food allergen panel
49223-1,Colony count
49224-9,Leukocytes
49225-6,Heptacarboxylate/Creatinine
49226-4,lamiVUDine
49227-2,Stavudine
49228-0,Porphobilinogen deaminase
49229-8,Erythrocytes.nucleated/100 leukocytes
49230-6,Acetylcholinesterase
49231-4,Cholinesterase
49232-2,Giardia lamblia+Cryptosporidium sp Ag
49233-0,Giardia lamblia+Cryptosporidium parvum Ag
49234-8,Patient symptoms^1.5H post dose lactose PO
49235-5,Patient symptoms^1H post dose lactose PO
49236-3,Patient symptoms^2.5H post dose lactose PO
49237-1,Patient symptoms^2H post dose lactose PO
49238-9,Patient symptoms^30M post dose lactose PO
Sep-23,HLA-DPw2
49239-7,Patient symptoms^3H post dose lactose PO
49240-5,Patient symptoms^pre dose lactose PO
49241-3,Xylose absorption
49242-1,Acylcarnitine pattern
49243-9,Alkaline phosphatase isoenzymes
49244-7,Alpha 1 antitrypsin phenotype
49245-4,Alpha tocopherol & Beta+gamma tocopherol
49246-2,Alpha-1-Fetoprotein interpretation
Jul-24,HLA-DPw3
49247-0,Amino acid pattern
49248-8,Amino acid pattern
49249-6,Amino acids
49250-4,Amino acids
49251-2,Amylase isoenzymes
49252-0,Calculus analysis
49253-8,Beta-N-acetylhexosaminidase A & B
Apr-25,HLA-DPw3
49254-6,Bile acid pattern
49255-3,Calculus analysis
49256-1,Catecholamines
49257-9,Catecholamines
49258-7,Creatine kinase isoenzymes
49259-5,Creatine kinase isoenzymes
49260-3,Cryoglobulin IgA & IgG & IgM
49261-1,Cryoproteins
Feb-26,HLA-DPw4
49262-9,Fatty acids pattern
49263-7,Fatty acids.very long chain pattern
49264-5,Folate+Cyanocobalamin
49265-2,Gammopathy
49266-0,Glucose-6-Phosphate dehydrogenase phenotype
49267-8,Glutathione reductase phenotype
49268-6,Glycosaminoglycans pattern
49269-4,Homovanillate & Creatinine
4927-0,HLA-DPw4
49270-2,Immunoglobulin light chains
49271-0,Interpretation
49272-8,Interpretation
49273-6,Interpretation
49274-4,Interpretation
49275-1,Interpretation
49276-9,Interpretation
49277-7,Interpretation
49278-5,Interpretation
49279-3,Lactate dehydrogenase isoenzymes
49280-1,Lipoprotein pattern
49281-9,Lipoprotein pattern
49282-7,Metanephrine & Normetanephrine
49283-5,Metanephrine & Normetanephrine
49284-3,Oligosaccharides pattern
49285-0,Organic acids pattern
49286-8,Organic acids pattern
49287-6,Organic acids pattern
Aug-28,HLA-DPw5
49288-4,Parathyrin
49289-2,Porphyrins
492-9,Temocillin
49290-0,Porphyrins
49291-8,Porphyrins
49292-6,Porphyrin fractions
49293-4,Protein fractions.oligoclonal bands
49294-2,Protein fractions.oligoclonal bands
49295-9,Protein pattern
Jun-29,HLA-DPw5
49296-7,Protein pattern
49297-5,Protein pattern
49298-3,Protein pattern
49299-1,Protein pattern
49300-7,Protein pattern
49301-5,Protein pattern
49302-3,Protein pattern
49303-1,Amino acid pattern
Apr-30,HLA-DPw6
49304-9,Uranium dose assessment
49305-6,Spermatozoa evaluation.cervical mucus penetration test
49306-4,Spermatozoa evaluation.hamster ova penetration test
49307-2,Myocardium Ab pattern
49308-0,Neutrophil cytoplasmic Ab pattern
49309-8,Nuclear Ab pattern
49310-6,Nuclear Ab pattern
49311-4,Nuclear Ab pattern
Feb-31,HLA-DPw6
49312-2,Acute leukemia markers
49313-0,Chronic leukemia markers
49314-8,Immunodeficiency markers
49315-5,Hemolytic disease of newborn screen
49316-3,Hemoglobin pattern
49317-1,Hemoglobin pattern
49318-9,Alpha-1-Fetoprotein interpretation
49319-7,Beta glucosidase activator
4932-0,HLA-DQ1
49320-5,Beta-N-acetylhexosaminidase.A activator
49321-3,Cerebroside sulfatase activator
49322-1,Hemoglobin pattern
49323-9,Hemoglobin pattern
49324-7,11-Deoxycortisol^2H post dose metyraPONE
49325-4,17-Hydroxypregnenolone^1H post XXX challenge
49326-2,Aldosterone^2H post XXX challenge
49327-0,Androstenedione^1H post XXX challenge
49328-8,Clavulanate Ab.IgE
49329-6,Interferon.alpha Ab
49330-4,Renin^3H post XXX challenge
49331-2,Renin^2H post XXX challenge
49332-0,Vasopressin^30M post XXX challenge
49333-8,Galactitol
49334-6,Adenovirus DNA
49335-3,Adenovirus DNA
49336-1,Adenovirus DNA
49337-9,Adenovirus DNA
Aug-33,HLA-DQ1
49338-7,Adenovirus DNA
49339-5,Adenovirus DNA
49340-3,Adenovirus DNA
49341-1,Adenovirus DNA
49342-9,BK virus DNA
49343-7,BK virus DNA
49344-5,BK virus DNA
49345-2,BK virus DNA
Jun-34,HLA-DQ2
49346-0,BK virus DNA
49347-8,Cytomegalovirus DNA
49348-6,Cytomegalovirus DNA
49349-4,Cytomegalovirus DNA
49350-2,Cytomegalovirus DNA
49351-0,Cytomegalovirus DNA
49352-8,Epstein Barr virus DNA
Mar-35,HLA-DQ2
49353-6,Epstein Barr virus DNA
49354-4,Epstein Barr virus DNA
49355-1,Epstein Barr virus DNA
49356-9,Epstein Barr virus DNA
49357-7,Hepatitis B virus DNA
49358-5,Hepatitis B virus DNA
49359-3,Hepatitis B virus DNA
49360-1,Hepatitis B virus DNA
Jan-36,HLA-DQ3
49361-9,Hepatitis B virus DNA
49362-7,Hepatitis B virus DNA
49363-5,Hepatitis B virus DNA
49364-3,Hepatitis B virus DNA
49365-0,Hepatitis B virus DNA
49366-8,Hepatitis B virus DNA
49367-6,Hepatitis B virus DNA
49368-4,Hepatitis B virus DNA
49369-2,Hepatitis C virus RNA
493-7,Temocillin
49370-0,Hepatitis C virus RNA
49371-8,Hepatitis C virus RNA
49372-6,Hepatitis C virus RNA
49373-4,Hepatitis C virus RNA
49374-2,Hepatitis C virus RNA
49375-9,Hepatitis C virus RNA
49376-7,Hepatitis C virus RNA
49377-5,Hepatitis C virus RNA
49378-3,Hepatitis C virus RNA
Sep-37,HLA-DQ3
49379-1,Hepatitis C virus RNA
49380-9,Hepatitis C virus RNA
49381-7,Herpes simplex virus 1+2 DNA
49382-5,Herpes simplex virus 1+2 DNA
49383-3,Herpes simplex virus 1+2 DNA
49384-1,Herpes simplex virus 1+2 DNA
49385-8,Herpes simplex virus 1+2 DNA
49386-6,Herpes simplex virus 1+2 DNA
Jul-38,HLA-DQ4
49387-4,Herpes virus 6 DNA
49388-2,Herpes virus 6 DNA
49389-0,Herpes virus 6 DNA
49390-8,Herpes virus 6 DNA
49391-6,Herpes virus 6 DNA
49392-4,Herpes virus 6 DNA
49393-2,Herpes virus 6 DNA
49394-0,Herpes virus 7 DNA
May-39,HLA-DQ4
49395-7,Herpes virus 7 DNA
49396-5,Herpes virus 7 DNA
49397-3,Herpes virus 7 DNA
49398-1,Herpes virus 7 DNA
49399-9,Herpes virus 7 DNA
49400-5,Herpes virus 7 DNA
49401-3,Herpes virus 7 DNA
49402-1,Herpes virus 8 DNA
Mar-40,HLA-DQ5(1)
49403-9,Herpes virus 8 DNA
49404-7,Herpes virus 8 DNA
49405-4,Herpes virus 8 DNA
49406-2,Herpes virus 8 DNA
49407-0,Herpes virus 8 DNA
49408-8,Herpes virus 8 DNA
49409-6,Herpes virus 8 DNA
49410-4,JC virus DNA
Jan-41,HLA-DQ5(1)
49411-2,JC virus DNA
49412-0,JC virus DNA
49413-8,JC virus DNA
49414-6,JC virus DNA
49415-3,JC virus DNA
49416-1,JC virus DNA
49417-9,JC virus DNA
49418-7,Papova virus SV40 DNA
49419-5,Papova virus SV40 DNA
49420-3,Papova virus SV40 DNA
49421-1,Papova virus SV40 DNA
49422-9,Papova virus SV40 DNA
49423-7,Papova virus SV40 DNA
49424-5,Papova virus SV40 DNA
49425-2,Papova virus SV40 DNA
49426-0,Papova virus SV40 DNA
49427-8,Parvovirus B19 DNA
49428-6,Parvovirus B19 DNA
Sep-42,HLA-DQ6(1)
49429-4,Parvovirus B19 DNA
49430-2,Parvovirus B19 DNA
49431-0,Parvovirus B19 DNA
49432-8,Parvovirus B19 DNA
49433-6,Parvovirus B19 DNA
49434-4,Parvovirus B19 DNA
49435-1,Parvovirus B19 DNA
49436-9,Pneumocystis jiroveci DNA
Jul-43,HLA-DQ6(1)
49437-7,Pneumocystis jiroveci DNA
49438-5,Pneumocystis jiroveci DNA
49439-3,Pneumocystis jiroveci DNA
49440-1,Pneumocystis jiroveci DNA
49441-9,Pneumocystis jiroveci DNA
49442-7,Pneumocystis jiroveci DNA
49443-5,Toxoplasma gondii DNA
49444-3,Toxoplasma gondii DNA
May-44,HLA-DQ7(3)
49445-0,Toxoplasma gondii DNA
49446-8,Toxoplasma gondii DNA
49447-6,Toxoplasma gondii DNA
49448-4,Toxoplasma gondii DNA
49449-2,Toxoplasma gondii DNA
494-5,Temocillin
49450-0,Varicella zoster virus DNA
49451-8,Varicella zoster virus DNA
Feb-45,HLA-DQ7(3)
49452-6,Varicella zoster virus DNA
49453-4,Varicella zoster virus DNA
49454-2,Varicella zoster virus DNA
49455-9,Varicella zoster virus DNA
49456-7,Alpha synuclein Ag
49457-5,Androgen receptor Ag
49458-3,Annexin 1 Ag
49459-1,Alzheimer precursor protein Ag
4946-0,HLA-DQ8(3)
49460-9,Beta catenin Ag
49461-7,C4d Ag
49462-5,Calponin Ag
49463-3,CD1 Ag
49464-1,CD13 Ag
49465-8,CD14 Ag
49466-6,CD2 Ag
49467-4,CD22 Ag
49468-2,CD27 Ag
49469-0,CD33 Ag
49470-8,CD35 Ag
49471-6,IgG subclass 4 Ag
49472-4,Mammaglobin Ag
49473-2,CD123 Ag
49474-0,CD163 Ag
49475-7,CD41-Bf Ag
49476-5,Cyclooxygenase 2 Ag
49477-3,CXCL13 Ag
Aug-47,HLA-DQ8(3)
49478-1,CXCR5 Ag
49479-9,FOXP3 Ag
49480-7,Herpes virus 8 latent nuclear Ag
49481-5,TCL-1A Ag
49482-3,Vascular endothelial growth factor Ag
49483-1,HIV 1
49484-9,Phenylalanine
49485-6,Platelet aggregation.ristocetin induced^1800 ug/mL
Jun-48,HLA-DQ9(3)
49486-4,Alphapinene
49487-2,Nateglinide
49488-0,Collection time
49489-8,Microbiology section
49490-6,BCR-ABL1 b2a2 fusion protein
49491-4,BCR-ABL1 b3a2 fusion protein
49492-2,Leukemia markers
49493-0,Leukemia markers
Apr-49,HLA-DQ9(3)
49494-8,Leukemia markers
49495-5,Hepatitis B virus surface Ab Actual/Negative control
49496-3,BCR-ABL1 e1a1 fusion protein
49497-1,Platelets
49498-9,Leukocytes
49499-7,Blood.dried/Total
49500-2,Calcium oxalate dihydrate/Total
49501-0,Calcium oxalate monohydrate/Total
Feb-50,HLA-DR10
49502-8,Glucose-6-Phosphate dehydrogenase
49503-6,Neutrophil cytoplasmic Ab.perinuclear.atypical
49504-4,CMT demyelinating gene targeted mutation analysis
49505-1,Erythrocyte clumps
49506-9,MYOC gene targeted mutation analysis
49507-7,Multisection^W contrast IV
49508-5,Study observation.general
49509-3,View^W contrast intra duct
4951-0,HLA-DR10
49510-1,View^W contrast intra duct
49511-9,View runoff^WO & W contrast IA
49512-7,Views
49513-5,Study observation
49514-3,Acetaldehyde
49515-0,Bisacodyl
49516-8,Topiramate^peak
49517-6,Topiramate^trough
49518-4,Influenza virus Ab
49519-2,Influenza virus A H16 Ab
495-2,Tetracycline
49520-0,Influenza virus A H1 RNA
49521-8,Influenza virus A H1 RNA
49522-6,Influenza virus A H3 Ag
49523-4,Influenza virus A H3 RNA
49524-2,Influenza virus A H3 RNA
49525-9,Influenza virus A H5 Ab
49526-7,Influenza virus A H5 RNA
49527-5,Influenza virus A H7 RNA
Aug-52,HLA-DR11(5)
49528-3,Influenza virus A H9 RNA
49529-1,Influenza virus A Ag
49530-9,Influenza virus A neuraminidase cDNA
49531-7,Influenza virus A RNA
49532-5,Influenza virus A hemagglutinin type RNA
49533-3,Influenza virus B Ab
49534-1,Influenza virus B Ag
49535-8,Influenza virus B RNA
Jun-53,HLA-DR11(5)
49536-6,Influenza virus B RNA
49537-4,Influenza virus A & B RNA
49538-2,Influenza virus identified
49539-0,Cytomegalovirus Ab.IgM
49540-8,Acid citrate dextrose
49541-6,Fasting status
49542-4,Date and time of pheresis procedure
49543-2,Calcidiol+Calciferol
Apr-54,HLA-DR12(5)
49544-0,Newborn screening recommended follow-up
49545-7,JC virus DNA
49546-5,Specimen age
49547-3,JC virus DNA
49548-1,Date referral lab test sent
49549-9,Referral lab test method
49550-7,Leukocytes.CD59 deficient/100 cells
Jan-55,HLA-DR12(5)
49551-5,Creatine kinase.MB
49552-3,Epinephrine+Norepinephrine
49553-1,Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free
49554-9,Beta F1 Ag
49555-6,HLA-A+B+C Ag
49556-4,p16INK4a Ag
49557-2,PDGFR-beta Ag
49558-0,TAU 3 Ag
49559-8,TAU 4 Ag
49560-6,Payment procedure
49561-4,Payment diagnosis
49562-2,Holoprosencephaly gene targeted mutation analysis
49563-0,Troponin I.cardiac
49564-8,Epstein Barr virus band pattern
49565-5,Multisection
49566-3,Multisection^at rest+W Tc-99m Sestamibi IV
49567-1,Multisection perfusion^W adenosine+W Tc-99m Sestamibi IV
49568-9,Multisection perfusion^at rest+W stress+W Tl-201 IV+W Tc-99m Sestamibi IV
Sep-56,HLA-DR13(6)
49569-7,Multisection perfusion+wall motion^at rest+W stress+W Tl-201 IV+W Tc-99m Sestamibi IV
49570-5,Views GE 6
49571-3,Views limited^W I-131 MIBG IV
49572-1,Second trimester triple maternal screen
49573-9,HIV genotype
49574-7,Phosphatidylinositol+Phosphatidylserine/Surfactant.total
49575-4,Sphingomyelin/Surfactant.total
49576-2,Phosphatidylethanolamine/Surfactants.total
Jul-57,HLA-DR13(6)
49577-0,Lecithin/Surfactant.total
49578-8,Aminocaproate cutoff
49579-6,Aminocaproate
49580-4,HIV 1+2 Ab
49581-2,Referral lab test identifier and name
49582-0,Trisomy 18 risk cutoff
49583-8,Trisomy 21 risk cutoff
49584-6,Neural tube defect risk cutoff
May-58,HLA-DR14(6)
49585-3,Alpha-1-Fetoprotein multiple of the median cutoff
49586-1,First & Second trimester integrated maternal screen
49587-9,Protein.abnormal band
49588-7,First trimester maternal screen with nuchal translucency
49589-5,Bacterial susceptibility panel
49590-3,Calcidiol & Calciferol panel
49591-1,Calcidiol & Calciferol
49592-9,Satratoxin Ab.IgM
Mar-59,HLA-DR14(6)
49593-7,Trichothecene Ab.IgA
49594-5,Trichothecene Ab.IgG
49595-2,Trichothecene Ab.IgM
49596-0,Uroporphyrinogen decarboxylase
49597-8,Trichothecene Ab.IgE
49598-6,Natalizumab Ab
49599-4,Granulocytes.CD55
496-0,Tetracycline
49600-0,Hepatitis B virus DNA
Jan-60,HLA-DR15(2)
49601-8,Hepatitis B virus DNA
49602-6,Hepatitis B virus DNA
49603-4,Hepatitis C virus RNA
49604-2,Hepatitis C virus RNA
49605-9,Hepatitis C virus RNA
49606-7,Hepatitis B virus DNA
49607-5,Hepatitis C virus genotype
49608-3,Hepatitis C virus RNA
49609-1,Vibrio sp DNA
49610-9,Streptococcus pyogenes DNA
49611-7,Streptococcus pneumoniae DNA
49612-5,Salmonella sp DNA
49613-3,Enterococcus sp DNA
49614-1,Campylobacter sp DNA
49615-8,Borrelia sp DNA
49616-6,Legionella sp DNA
49617-4,Bacterial carbapenem resistance blaKPC gene
49618-2,Atazanavir+Ritonavir
Sep-61,HLA-DR15(2)
49619-0,Indinavir+Ritonavir
49620-8,lamiVUDine or Emtricitabine
49621-6,Saquinavir+Ritonavir
49622-4,Tipranavir+Ritonavir
49623-2,Amprenavir or Fosamprenavir
49624-0,Cholesterol.in VLDL 1+2
49625-7,Granulocytes.CD59
49626-5,Muscle sarcolemma Ab
Jul-62,HLA-DR16(2)
49627-3,Muscle sarcolemma Ab
49628-1,Remnant lipoprotein
49629-9,Citrulline
49630-7,Darunavir+Ritonavir
49631-5,ATN1 gene allele 1.CAG repeats
49632-3,ATN1 gene allele 2.CAG repeats
49633-1,Ethanolamine
49634-9,FXN gene allele 1.GAA repeats
May-63,HLA-DR16(2)
49635-6,FXN gene allele 2.GAA repeats
49636-4,Ganglioside GM1 Ab
49637-2,HTT gene allele 1.CAG repeats
49638-0,HTT gene allele 2.CAG repeats
49639-8,Protein C/Coagulation factor X
49640-6,Protein S Ag/Coagulation factor X Ag
49641-4,SCA1 gene allele 1.CAG repeats
49642-2,SCA1 gene allele 2.CAG repeats
Mar-64,HLA-DR17(3)
49643-0,SCA10 gene allele 1.ATTCT repeats
49644-8,SCA10 gene allele 2.ATTCT repeats
49645-5,SCA2 gene allele 1.CAG repeats
49646-3,SCA2 gene allele 2.CAG repeats
49647-1,MJD gene allele 1.CAG repeats
49648-9,MJD gene allele 2.CAG repeats
49649-7,CACNA1A gene allele 1.CAG repeats
4965-0,HLA-DR17(3)
49650-5,CACNA1A gene allele 2.CAG repeats
49651-3,SCA7 gene allele 1.CAG repeats
49652-1,SCA7 gene allele 2.CAG repeats
49653-9,TPMT gene.c.719A>G
49654-7,TPMT gene.c.238G>C
49655-4,TPMT gene.c.460G>A
49656-2,HIV protease gene mutations
49657-0,HIV nonnucleoside reverse transcriptase susceptibility panel
49658-8,HIV nucleoside reverse transcriptase susceptibility panel
49659-6,HIV reverse transcriptase susceptibility panel
49660-4,HIV susceptibility panel
49661-2,HIV protease gene mutations
49662-0,HIV nonnucleoside reverse transcriptase susceptibility panel
49663-8,HIV nucleoside reverse transcriptase susceptibility panel
49664-6,HIV reverse transcriptase susceptibility panel
49665-3,HIV susceptibility panel
49666-1,Darunavir
49667-9,Tipranavir
Aug-66,HLA-DR18(3)
49668-7,Atazanavir
49669-5,Emtricitabine
49670-3,Uranium.depleted panel
49671-1,Neisseria meningitidis DNA
49672-9,Streptococcus pneumoniae DNA
49673-7,Lymphocyte proliferation.100 umol beryllium stimulation^7D post incubation
49674-5,Lymphocyte proliferation.10 umol beryllium stimulation^5D post incubation
49675-2,Lymphocyte proliferation.10 umol beryllium stimulation^7D post incubation
Jun-67,HLA-DR18(3)
49676-0,Lymphocyte proliferation.1 umol beryllium stimulation^5D post incubation
49677-8,Lymphocyte proliferation.1 umol beryllium stimulation^7D post incubation
49678-6,CPT2 gene targeted mutation analysis
49679-4,Cells.CD36/100 cells
49680-2,Cells.CD36/100 cells
49681-0,Cells.CD36/100 cells
49682-8,Lymphocyte proliferation.phytohemagglutinin stimulation^3D post incubation
49683-6,ERBB2 gene copy number/Chromosome 17 copy number
Apr-68,HLA-DR52
49684-4,CPT2 gene.p.Arg503Cys
49685-1,CPT2 gene.p.R549DC
49686-9,CPT2 gene.p.Arg631Cys
49687-7,Trichoderma viride Ab.IgG
49688-5,Glucose tolerance^post 75 g glucose PO
49689-3,Glucose tolerance^post 100 g glucose PO
49690-1,Mirtazapine
49691-9,Nortrimipramine
Feb-69,HLA-DR52
49692-7,Striated muscle Ab.IgG
49693-5,Hepatitis E virus Ab.IgG
49694-3,Carbon dioxide^^adjusted to patient's actual temperature
49695-0,Carbon dioxide^^adjusted to patient's actual temperature
49696-8,Oxygen^^adjusted to patient's actual temperature
49697-6,Oxygen^^adjusted to patient's actual temperature
49698-4,pH^^adjusted to patient's actual temperature
49699-2,pH^^adjusted to patient's actual temperature
Jul-49,Bacampicillin
4970-0,HLA-DR53
49700-8,Metanephrine.free
49701-6,pH^^adjusted to patient's actual temperature
49702-4,Nateglinide
49704-0,SH3TC2 gene targeted mutation analysis
49705-7,LMNA gene targeted mutation analysis
49706-5,ARSA gene targeted mutation analysis
49707-3,KCNQ2 gene targeted mutation analysis
49708-1,TTR gene targeted mutation analysis
49709-9,predniSONE
49710-7,SOD1 gene targeted mutation analysis
49711-5,Listeria sp Ab
49712-3,Coccidioides sp Ab
49713-1,Parainfluenza virus Ab
49714-9,Interleukin 8
49715-6,Musca domestica Ab.IgE
49716-4,Dehydroepiandrosterone
49717-2,Interleukin 1 beta
Aug-71,HLA-DR53
49718-0,HIV 1 p24 Ag
49719-8,Poa pratensis Ab.IgG
49720-6,Festuca elatior Ab.IgG
49721-4,Haemophilus influenzae type
49722-2,Neisseria meningitidis type
49723-0,Camellia sinensis Ab.IgG
49724-8,Aldolase
49725-5,Melatonin
Jun-72,HLA-DR6
49726-3,Endomysium Ab.IgG
49727-1,Homocysteine
49728-9,Neurokinin A
49729-7,Penicillin G Ab.IgG
49730-5,Aspergillus sp Ab
49731-3,Herpes simplex virus 1+2 Ab.IgM
49732-1,Interleukin 6
49733-9,Interleukin 10
Apr-73,HLA-DR6
49734-7,11-Dehydro thromboxane beta 2/Creatinine
49735-4,FBN1 gene targeted mutation analysis
49736-2,Clarity
49737-0,Sirolimus
49738-8,Neuronal nuclear Ab
49739-6,Apis mellifera Ab.IgG
49740-4,Dolichovespula arenaria Ab.IgG
49741-2,Plasmodium malariae Ab.IgG
Feb-74,HLA-DR8
49742-0,Plasmodium vivax Ab.IgG
49743-8,Plasmodium falciparum Ab.IgG
49744-6,Plasmodium ovale Ab.IgG
49745-3,Dolichovespula maculata Ab.IgG
49746-1,Carboxy tetrahydrocannabinol
49747-9,Cocaine+Benzoylecgonine
49748-7,Lipoprotein.alpha
49749-5,6-Monoacetylmorphine.free
49750-3,Dihydrocodeine.free+Hydrocodol.free
49751-1,Norbuprenorphine
49752-9,Buprenorphine
49753-7,Norbuprenorphine
49754-5,Epithelial cells.squamous
49755-2,Crystals
49756-0,Norethindrone
49757-8,Minocycline
49758-6,Hepatitis C virus RNA
Sep-75,HLA-DR8
49759-4,Adenosine deaminase
49760-2,Adenosine deaminase
49761-0,Alpha-1-Fetoprotein
49762-8,Alpha-1-Fetoprotein
49763-6,Bilirubin
49764-4,Calcium
49765-1,Calcium
49766-9,Chymotrypsin
Jul-76,HLA-DR1
49767-7,Filaria Ab.IgG2
49768-5,Filaria Ab.IgG3
49769-3,Filaria Ab.IgG4
49770-1,Filaria Ab.IgG1
49771-9,Onchocerca sp Ab.IgG
49772-7,Fructose
49773-5,Galactitol
49774-3,Glomerular basement membrane Ab
May-77,HLA-DR1
49775-0,Hepatitis D virus Ab.IgG
49776-8,Hepatitis E virus Ab
49777-6,Hepatitis G virus Ab
49778-4,Immune complex
49779-2,Ketones
497-8,Tetracycline
49780-0,Leishmania sp DNA
49781-8,Mitochondria M2 Ab
49782-6,Mononuclear cells/100 leukocytes
Mar-78,HLA-DR2
49783-4,Onchocerca sp Ab.IgG4
49784-2,Onchocerca sp Ab.IgG
49785-9,Onchocerca sp Ab.IgG2
49786-7,Onchocerca sp Ab.IgG3
49787-5,Polymorphonuclear cells/100 leukocytes
49788-3,Potassium
49789-1,Potassium
49790-9,Sodium
Jan-79,HLA-DR2
49791-7,Sodium
49792-5,Somatostatin
49793-3,"t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points"
49794-1,"t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points"
49795-8,"t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript"
49796-6,"t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript"
49797-4,"t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript"
49798-2,Taenia solium larva Ab
49799-0,Treponema pallidum DNA
49800-6,Treponema pallidum Ab
49801-4,Trypanosoma cruzi DNA
49802-2,Urea
49803-0,Streptococcus pneumoniae 1 Ab^1st specimen
49804-8,Streptococcus pneumoniae 19 Ab^1st specimen
49805-5,Streptococcus pneumoniae 23 Ab^1st specimen
49806-3,Streptococcus pneumoniae 1 Ab^2nd specimen
49807-1,Streptococcus pneumoniae 19 Ab^2nd specimen
49808-9,Streptococcus pneumoniae 23 Ab^2nd specimen
Sep-80,HLA-DR3
49809-7,2-Ethyl-3-Hydroxypropionate/Creatinine
49810-5,2-Hydroxy-3-Methylvalerate/Creatinine
49811-3,2-Hydroxyadipate/Creatinine
49812-1,2-Hydroxyglutarate/Creatinine
49813-9,2-Hydroxyisocaproate/Creatinine
49814-7,2-Hydroxyisovalerate/Creatinine
49815-4,2-Methyl-3-Hydroxybutyrate/Creatinine
49816-2,"2-Oxo,3-Methylvalerate/Creatinine"
Jul-81,HLA-DR3
49817-0,2-Oxoisocaproate/Creatinine
49818-8,2-Oxoisovalerate/Creatinine
49819-6,"3-Hydroxy,3-Methylglutarate/Creatinine"
49820-4,3-Hydroxyadipate/Creatinine
49821-2,3-Hydroxyglutarate/Creatinine
49822-0,3-Hydroxyisobutyrate/Creatinine
49823-8,3-Hydroxyisovalerate/Creatinine
49824-6,3-Hydroxypropionate/Creatinine
May-82,HLA-DR4
49825-3,16-Alpha hydroxyestrone
49826-1,2-Hydroxyestrone
49827-9,2-Hydroxyestrone/16-Alpha hydroxyestrone
49828-7,2-Hydroxyestrone & 16-Alpha hydroxyestrone panel
49829-5,Norcodeine
49830-3,Norcodeine
49831-1,Normorphine
49832-9,Specimen drawn^1st specimen
Mar-83,HLA-DR4
49833-7,Specimen drawn^2nd specimen
49834-5,Leucine
49835-2,Cells.CD19+IgD+/100 cells
49836-0,Platelet function
49837-8,Dimethylphosphatidyl ethanolamine/Surfactant.total
49838-6,Neural tube defect risk
49839-4,Eosinophils
49840-2,Cells.CD19+IgG+/100 cells
Jan-84,HLA-DR5
49841-0,Cells.CD19+IgM+/100 cells
49842-8,Cells.CD19+IgA+/100 cells
49843-6,Coagulation surface induced.factor substitution^2H post incubation after 1:4 addition of normal plasma
49844-4,Coagulation surface induced.factor substitution^1H post incubation after 1:4 addition of normal plasma
49845-1,Coagulation surface induced.factor substitution^after addition of normal plasma 1H post incubation separate tubes
49846-9,Hepatitis C virus core Ag
49847-7,Enterovirus RNA
49848-5,Herpes simplex virus 1+2 Ab.IgG
49849-3,Hydroxylysine.free/Creatinine
49850-1,Insulin-like growth factor-I^baseline
49851-9,Cholinesterase
49852-7,Protein fractions.oligoclonal bands
49853-5,Transforming growth factor beta 1
49854-3,COL5A1 gene+COL5A2 gene targeted mutation analysis
49855-0,Tetracycline Ab.IgE
49856-8,methylTESTOSTERone
49857-6,SMN1 gene+SMN2 gene targeted mutation analysis
Aug-85,HLA-DR5
49858-4,Peptide YY
49859-2,Amphotericin B
498-6,Tetracycline
49860-0,Sporothrix schenckii Ab
49861-8,Toxocara canis Ab
49862-6,G6PC gene targeted mutation analysis
49863-4,Aspergillus sp DNA
49864-2,Procaine Ab.IgE
49865-9,Coagulation factor VIII activity actual/Normal
Jun-86,HLA-DR7
49866-7,Neuropeptide Y
49867-5,Endothelin I
49868-3,Ibuprofen Ab.IgE
49869-1,Camel dander Ab.IgE
49870-9,Coagulation factor VII Ag actual/Normal
49871-7,Codeine Ab.IgE
49872-5,FH gene targeted mutation analysis
49873-3,POU3F4 gene targeted mutation analysis
Apr-87,HLA-DR7
49874-1,ABCB4 gene targeted mutation analysis
49875-8,Juniperus californica Ab.IgE
49876-6,Alpha hydroxytriazolam
49877-4,Hepatitis B virus codon 173
49878-2,Hepatitis B virus codon 180
49879-0,Hepatitis B virus codon 181
49880-8,Hepatitis B virus codon 204
49881-6,Hepatitis B virus codon 236
Feb-88,HLA-DR9
49882-4,Hepatitis B virus codon 80
49883-2,Hepatitis B virus resistance panel
49884-0,Lymphocyte proliferation.tetanus toxoid stimulation^7D post incubation
49885-7,Lymphocyte proliferation.beryllium stimulation panel
49886-5,Adenosine monophosphate.cyclic/Creatinine^1st specimen post XXX challenge
49887-3,Dehydroepiandrosterone^1st specimen post XXX challenge
49888-1,Dehydroepiandrosterone sulfate^1H post dose corticotropin
49889-9,Dehydroepiandrosterone sulfate^pre dose corticotropin
4989-0,HLA-DR9
49890-7,HIV 1 RNA
49891-5,Human papilloma virus DNA
49892-3,Somatotropin^1st specimen post XXX challenge
49893-1,Somatotropin^7th specimen post XXX challenge
49894-9,Somatotropin^9th specimen post XXX challenge
49895-6,Somatotropin^10th specimen post XXX challenge
49896-4,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA
49897-2,Insulin^pre XXX challenge
49898-0,Metabolic syndrome
49899-8,Setomelanomma rostrata Ab.IgE/IgE.total
49900-4,Heptacarboxylporphyrin I
49901-2,Heptacarboxylporphyrin III
49902-0,Hexanoylglycine/Creatinine
49903-8,Hippurate/Creatinine
49904-6,Histoplasma capsulatum M Ab
49905-3,HIV 1 Ab
49906-1,Hydroxydecanedioate/Creatinine
49907-9,IgA Ag
Aug-90,Blastomyces dermatitidis rRNA
49908-7,Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda
49909-5,Interleukin 10
49910-3,Isocitrate/Creatinine
49911-1,Isovalerylglycine/Creatinine
49912-9,Japanese encephalitis virus Ab
49913-7,Legionella pneumophila Ab.IgG
49914-5,Legionella pneumophila 1+2+3+4+5+6 Ab.IgM
49915-2,Legionella sp Ab.IgG
Jun-91,Borrelia burgdorferi DNA
49916-0,Liquidambar styraciflua Ab.IgE/IgE.total
49917-8,Lymphocyte proliferation.10 umol beryllium stimulation^6D post incubation
49918-6,Heptacarboxylporphyrin II
49919-4,Interleukin 6
49920-2,Isopropyl ether
49921-0,Lymphocyte proliferation.concanavalin A stimulation
49922-8,Lymphocyte proliferation.phytohemagglutinin stimulation
49923-6,Lymphocyte proliferation.pokeweed mitogen stimulation
Apr-92,Campylobacter sp rRNA
49924-4,Alkaline phosphatase.macro/Alkaline phosphatase.total
49925-1,Glucose-6-Phosphate dehydrogenase
49926-9,Glucose-6-Phosphate dehydrogenase
49927-7,Amylase.fld/Amylase.serum
49928-5,Leukocytes
49929-3,Protein.plr fld/Protein.serum
49930-1,Lactate dehydrogenase.plr fld/Lactate dehydrogenase.serum
49931-9,3-Hydroxysebacate.unsaturated/Creatinine
Feb-93,Chlamydia trachomatis rRNA
49932-7,3-Hydroxysuberate.unsaturated/Creatinine
49933-5,Adipate.unsaturated/Creatinine
49934-3,Adipolactone/Creatinine
49935-0,Calcium.ionized/Calcium.total^^corrected for albumin
49936-8,Calcium.ionized/Calcium.total^^corrected for albumin
49937-6,Calcium/Oxalate
49938-4,Citrate synthase
49939-2,Dodecenedioate/Creatinine
499-4,Ticarcillin
4994-0,Coccidioides immitis rRNA
49940-0,Glutamate dehydrogenase
49941-8,Sepiapterin
49942-6,Somatotropin^1 AM specimen
49943-4,Somatotropin^1.30 AM specimen
49944-2,Somatotropin^10 PM specimen
49945-9,Somatotropin^10.30 PM specimen
49946-7,Somatotropin^11 PM specimen
49947-5,Somatotropin^11.30 PM specimen
49948-3,Somatotropin^12 PM specimen
49949-1,Somatotropin^12.30 PM specimen
49950-9,Somatotropin^2 AM specimen
49951-7,Somatotropin^2.30 AM specimen
49952-5,Somatotropin^3 AM specimen
49953-3,Somatotropin^3.30 AM specimen
49954-1,Somatotropin^4 AM specimen
49955-8,Somatotropin^4.30 AM specimen
49956-6,Somatotropin^5 AM specimen
Jul-95,Cryptococcus neoformans rRNA
49957-4,Somatotropin^5.30 AM specimen
49958-2,Somatotropin^6 AM specimen
49959-0,Specific gravity^^adjusted to pH 7.4
49960-8,Suberate.unsaturated/Creatinine
49961-6,Urate renal clearance
49962-4,Urate renal clearance/1.73 sq M
49963-2,Fibrillarin Ab
49964-0,Siderocytes
May-96,Cytomegalovirus DNA
49965-7,HIV 1 Ab/HIV 2 Ab
49966-5,Polymorphonuclear cells/100 leukocytes
49967-3,Charcoal
49968-1,Cortisol^1H post 250 ug corticotropin IM
49969-9,Cortisol^30M post 250 ug corticotropin IM
49970-7,Collection time^4th specimen
49971-5,Collection time^3rd specimen
49972-3,Collection time^2nd specimen
Mar-97,Cytomegalovirus DNA
49973-1,Borrelia burgdorferi 31kD Ab.IgG
49974-9,Borrelia burgdorferi 31kD Ab.IgM
49975-6,Borrelia burgdorferi 34kD Ab.IgG
49976-4,Borrelia burgdorferi 34kD Ab.IgM
49977-2,Borrelia burgdorferi 35kD Ab.IgG
49978-0,Borrelia burgdorferi 35kD Ab.IgG
49979-8,Borrelia burgdorferi 35kD Ab.IgM
49980-6,Borrelia burgdorferi 35kD Ab.IgM
Jan-98,Cytomegalovirus DNA
49981-4,Borrelia burgdorferi 37kD Ab.IgG
49982-2,Borrelia burgdorferi 37kD Ab.IgG
49983-0,Borrelia burgdorferi 37kD Ab.IgM
49984-8,Borrelia burgdorferi 37kD Ab.IgM
49985-5,Herpes simplex virus 1 DNA
49986-3,Herpes simplex virus 1 DNA
49987-1,Herpes simplex virus 1 DNA
49988-9,Herpes simplex virus 2 DNA
49989-7,Herpes simplex virus 2 DNA
49990-5,Herpes simplex virus 2 DNA
49991-3,Borrelia burgdorferi 18_20kD Ab.IgG
49992-1,Borrelia burgdorferi 18_20kD Ab.IgG
49993-9,Borrelia burgdorferi 18_20kD Ab.IgM
49994-7,Borrelia burgdorferi 18_20kD Ab.IgM
49995-4,Borrelia burgdorferi 83_93kD Ab.IgG
49996-2,Borrelia burgdorferi 83_93kD Ab.IgG
49997-0,Borrelia burgdorferi 83_93kD Ab.IgM
49998-8,Borrelia burgdorferi 83_93kD Ab.IgM
Sep-99,Cytomegalovirus DNA
49999-6,Platelet aggregation.collagen induced
50000-9,Hydrogen/Expired gas^30M post XXX challenge
50001-7,Hydrogen/Expired gas^1H post XXX challenge
50002-5,Hydrogen/Expired gas^1.5H post XXX challenge
50003-3,Hydrogen/Expired gas^2H post XXX challenge
50004-1,Hydrogen/Expired gas^3H post XXX challenge
May-00,Cytomegalovirus DNA
50005-8,Methaqualone
50006-6,Human antimouse Ab
50007-4,Cytology report
50008-2,Mixing studies
50009-0,Fetal lung maturity panel
50010-8,Transfusion end time
50011-6,Transfusion start time
50012-4,Indirect antiglobulin test.polyspecific reagent
Mar-01,Enterococcus sp rRNA
50013-2,Hydrogen/Expired gas^2.5H post XXX challenge
50014-0,"t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript"
50015-7,West Nile virus Ag
50016-5,Sugar
50017-3,Hemoglobin.gastrointestinal
50018-1,Cytomegalovirus Ab.IgG
50019-9,HLA-DP+DQ+DR
50020-7,Microdeletion syndromes
Jan-02,Epstein Barr virus DNA
50021-5,oxyCODONE
50022-3,Ethanol+Methanol+Isopropyl alcohol+Acetone
50023-1,Hepatitis C virus RNA panel
50024-9,Virus identified
50025-6,Volatiles panel
50026-4,(Arachis hypogaea+Bean white+Glycine max+Lens esculenta+Pisum sativum) Ab.IgE
50027-2,Narcissus sp Ab.IgE
50028-0,Escherichia coli Ab.IgE
50029-8,Mahogany wood dust Ab.IgE
50030-6,Oak wood dust Ab.IgE
50031-4,Sulfamethoxazole Ab.IgE
50032-2,Callistephus chinesi Ab.IgE
50033-0,Cephalosporin Ab.IgE
50034-8,Arbovirus Ab.Neut
50035-5,Colorado tick fever virus Ab.Neut
50036-3,Dengue virus Ab.Neut
50037-1,Powassan virus Ab.Neut
50038-9,Snowshoe hare virus Ab.Neut
Sep-03,Epstein Barr virus DNA
50039-7,5-Methyltetrahydrofolate/Folate
50040-5,Advanced oxidation protein products
50041-3,Bilirubin+Urobilinogen
50042-1,Basal metabolic rate index
50043-9,Protein carbonyl/protein
50044-7,Glomerular filtration rate/1.73 sq M.predicted.female
50045-4,Hemicystine
50046-2,Hemicystine
Jul-04,Epstein Barr virus DNA
50047-0,Hemicystine
50048-8,Hemicystine
50049-6,Hemicystine/Amino acids.total
50050-4,Hemicystine/Amino acids.total
50051-2,Hemicystine/Amino acids.total
50052-0,Hemicystine/Amino acids.total
50053-8,Hemicystine/Amino acids.total
Apr-05,Epstein Barr virus DNA
50054-6,Hemicystine/Creatinine
50055-3,Iohexol renal clearance
50056-1,Nutritional risk index
50057-9,Fractional excretion of phosphate
50058-7,Phosphate renal clearance
50059-5,Protein fractions.oligoclonal bands/Protein.total
50060-3,Fatty acids.very long chain.C24:0/Creatinine
50061-1,Tetradecanedioate/Creatinine
Feb-06,Haemophilus influenzae rRNA
50062-9,Tetradecenedioate/Creatinine
50063-7,Urea renal clearance/1.73 sq M
50064-5,Body weight ideal
50065-2,1-Methylhistidine
50066-0,1-Methylhistidine
50067-8,11-Hydroxyandrostenedione
50068-6,11-Hydroxyandrostenedione^pre 250 ug corticotropin
50069-4,11-Hydroxyandrostenedione^30M post 250 ug corticotropin
5007-0,Hepatitis B virus DNA
50070-2,11-Hydroxyandrostenedione^1H post 250 ug corticotropin
50071-0,11-Deoxycortisol
50072-8,11-Deoxycortisol^pre 250 ug corticotropin
50073-6,11-Deoxycortisol^30M post 250 ug corticotropin
50074-4,11-Deoxycortisol^45M post 250 ug corticotropin
50075-1,11-Deoxycortisol^1H post 250 ug corticotropin
50076-9,17-Ketosteroids^post dose dexamethasone
50077-7,17-Ketosteroids^2D post dose dexamethasone
50078-5,17-Hydroxypregnenolone^pre 250 ug corticotropin
50079-3,17-Hydroxypregnenolone^1H post 250 ug corticotropin
50080-1,17-Hydroxyprogesterone^pre 250 ug corticotropin IM
50081-9,18-Hydroxydeoxycorticosterone
50082-7,18-Hydroxycorticosterone
50083-5,Alpha aminoadipate
50084-3,Alpha aminoadipate
50085-0,2-Methyl-3-Hydroxyvalerate/Creatinine
50086-8,2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH)
50087-6,2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH)
Aug-08,Hepatitis B virus DNA
50088-4,2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH)
50089-2,2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH)
500-9,Ticarcillin
50090-0,2-Methyl-3-Hydroxybutyrylcarnitine (C5-OH)
50091-8,2-methyl-3-hydroxybutyrylcarnitine (C5-OH)/Creatinine
50092-6,2-Methylcitrate
50093-4,21-Deoxycortisol
50094-2,21-Deoxycortisol^45M post 250 ug corticotropin
50095-9,21-Deoxycortisol^pre 250 ug corticotropin
Jun-09,Hepatitis B virus DNA
50096-7,21-Deoxycortisol^30M post 250 ug corticotropin
50097-5,21-Deoxycortisol^1H post 250 ug corticotropin
50098-3,3-Hydroxyvalerate
50099-1,Beta hydroxybutyrate/Acetoacetate
50100-7,Beta hydroxybutyrate/Acetoacetate
50101-5,3-Hydroxybutyrylcarnitine (C4-OH)
50102-3,3-Hydroxybutyrylcarnitine (C4-OH)
50103-1,3-Hydroxybutyrylcarnitine (C4-OH)
Apr-10,Hepatitis C virus RNA
50104-9,3-Hydroxyisovalerylcarnitine (C5-OH)
50105-6,3-Hydroxyisovalerylcarnitine (C5-OH)
50106-4,3-Hydroxyisovalerylcarnitine (C5-OH)
50107-2,3-Hydroxyisovalerylcarnitine (C5-OH)
50108-0,3-Hydroxylinoleoylcarnitine (C18:2-OH)
50109-8,3-Hydroxylinoleoylcarnitine (C18:2-OH)
50110-6,3-Hydroxylinoleoylcarnitine (C18:2-OH)
50111-4,3-Hydroxylinoleoylcarnitine (C18:2-OH)
Feb-11,Hepatitis C virus RNA
50112-2,3-Hydroxylinoleoylcarnitine (C18:2-OH)/Creatinine
50113-0,3-Hydroxyoleoylcarnitine (C18:1-OH)
50114-8,3-Hydroxyoleoylcarnitine (C18:1-OH)
50115-5,3-Hydroxyoleoylcarnitine (C18:1-OH)
50116-3,3-Hydroxyoleoylcarnitine (C18:1-OH)
50117-1,3-Hydroxyoleoylcarnitine (C18:1-OH)/Creatinine
50118-9,3-Hydroxypalmitoleylcarnitine (C16:1-OH)
50119-7,3-Hydroxypalmitoleylcarnitine (C16:1-OH)
5012-0,Hepatitis C virus RNA
50120-5,3-Hydroxypalmitoleylcarnitine (C16:1-OH)
50121-3,3-Hydroxypalmitoleylcarnitine (C16:1-OH)
50122-1,3-Hydroxypalmitoleylcarnitine (C16:1-OH)/Creatinine
50123-9,3-Hydroxypalmitoylcarnitine (C16-OH)
50124-7,3-Hydroxypalmitoylcarnitine (C16-OH)
50125-4,3-Hydroxypalmitoylcarnitine (C16-OH)
50126-2,3-Hydroxypalmitoylcarnitine (C16-OH)
50127-0,3-Hydroxypalmitoylcarnitine (C16-OH)/Creatinine
50128-8,3-Hydroxypropionate
50129-6,3-Hydroxypropionate
50130-4,3-Hydroxystearoylcarnitine (C18-OH)
50131-2,3-Hydroxystearoylcarnitine (C18-OH)
50132-0,3-Hydroxystearoylcarnitine (C18-OH)
50133-8,3-Hydroxystearoylcarnitine (C18-OH)
50134-6,3-Hydroxystearoylcarnitine (C18-OH)/Creatinine
50135-3,3-Methoxy-4-Hydroxyphenylglycol
50136-1,3-Methoxy-4-Hydroxyphenylglycol
50137-9,3-Methoxy-4-Hydroxyphenylglycol
Aug-13,Herpes simplex virus DNA
50138-7,3-Methoxy-4-Hydroxyphenylglycol/Creatinine
50139-5,3-Methoxytyramine
50140-3,3-Methoxytyramine
50141-1,3-O-Methyldopa
50142-9,3-O-Methyldopa
50143-7,3-O-Methyldopa
50144-5,3-O-Methyldopa/Creatinine
50145-2,3-Dechloroethylifosfamide^pre dose ifosfamide
Jun-14,Herpes simplex virus DNA
50146-0,Gamma aminobutyrate
50147-8,Gamma aminobutyrate
50148-6,Gamma hydroxybutyrate
50149-4,5-Hydroxyindoleacetate
50150-2,5-Hydroxytryptophan
50151-0,5-Hydroxytryptophan
50152-8,5-Hydroxytryptophan/Creatinine
Mar-15,Histoplasma capsulatum DNA
50153-6,5-Methyltetrahydrofolate
50154-4,Acetoacetate
50155-1,Acetylcarnitine (C2)
50156-9,Acetylcarnitine (C2)
50157-7,Acetylcarnitine (C2)
50158-5,Acetylcarnitine (C2)
50159-3,Acetylcarnitine (C2)/Creatinine
50160-1,Amino acids
Jan-16,Histoplasma capsulatum rRNA
50161-9,Organic acids pattern
50162-7,Acylcarnitine
50163-5,Acylcarnitine
50164-3,Acylcarnitine pattern
50165-0,Adenine phosphoribosyltransferase
50166-8,Adipoylcarnitine+Methylglutarylcarnitine (C6-DC)
50167-6,Alanine
50168-4,Alanine aminotransferase
50169-2,Aldosterone^post XXX challenge
501-7,Ticarcillin
50170-0,Aldosterone^pre XXX challenge
50171-8,Aldosterone^pre 250 ug corticotropin IM
50172-6,Aldosterone^30M post 250 ug corticotropin IM
50173-4,Aldosterone^1H post 250 ug corticotropin IM
50174-2,Alloisoleucine
50175-9,Alloisoleucine
50176-7,Alpha-2-Macroglobulin/Protein.total
50177-5,Hemicystine
50178-3,Lymphocyte proliferation.100 umol beryllium stimulation^6D post incubation
Sep-17,HIV 1 RNA
50179-1,Calcitonin Calcium & Pentagastrin challenge panel
50180-9,Calcitonin^10M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV
50181-7,Calcitonin^5M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV
50182-5,Calcitonin^2M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV
50183-3,Calcitonin^1M post 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV
50184-1,Calcitonin^pre 2 mg/kg calcium & 0.5 ug/kg pentagastrin IV
50185-8,Magnolia grandiflora Ab.IgE
50186-6,Wine vinegar Ab.IgE
Jul-18,HIV 1 RNA
50187-4,Arterial-mixed venous oxygen saturation difference
50188-2,Arterial-venous oxygen saturation difference
50189-0,Neonatal bilirubin panel
50190-8,Iron & Iron binding capacity panel
50191-6,Occult blood panel
50192-4,Cholesterol.in VLDL 1+2+3
50193-2,Cholesterol.in LDL.narrow density
50194-0,Cholesterol.in IDL+Cholesterol.in VLDL 3
May-19,HTLV I+II RNA
50195-7,"t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript"
50196-5,Occult blood panel
50197-3,aPTT panel
50198-1,Iron^1st specimen
50199-9,Iron^2nd specimen
50200-5,Iron^3rd specimen
50201-3,Iron^4th specimen
50202-1,Iron^5th specimen
Mar-20,Legionella sp rRNA
50203-9,Iron^6th specimen
50204-7,Iron^7th specimen
50205-4,Iron^8th specimen
50206-2,Glucose^1st specimen
50207-0,Glucose^7th specimen
50208-8,Glucose^10th specimen
50209-6,Albumin^supine
50210-4,Glomerular filtration rate/1.73 sq M.predicted
Jan-21,Listeria monocytogenes rRNA
50211-2,Functional shunt volume
50212-0,Glucose^2nd specimen
50213-8,Glucose^3rd specimen
50214-6,Glucose^4th specimen
50215-3,Glucose^5th specimen
50216-1,Glucose^6th specimen
50217-9,Glucose^8th specimen
50218-7,Glucose^9th specimen
50219-5,Respiratory pathogens DNA & RNA 12a panel
50220-3,Collection interval from baseline
50221-1,Bacteria
50222-9,Broad casts
50223-7,Cholesterol crystals
50224-5,Epithelial casts
50225-2,Epithelial cells.non-squamous
50226-0,Erythrocyte clumps
50227-8,Fat
50228-6,Oval fat bodies (globules)
Sep-22,Mycobacterium avium complex rRNA
50229-4,Fatty casts
50230-2,Granular casts
50231-0,Hyaline casts
50232-8,Leucine crystals
50233-6,Leukocyte clumps
50234-4,Mixed cellular casts
50235-1,Mucus
50236-9,Phosphate crystals.amorphous
Jul-23,Mycobacterium avium subspecies avium rRNA
50237-7,Trichomonas sp
50238-5,Tyrosine crystals
50239-3,Urate crystals.amorphous
50240-1,Yeast.budding
50241-9,17-Ketosteroids^post high dose dexamethasone
50242-7,17-Ketosteroids^2D post high dose dexamethasone
50243-5,17-Ketosteroids^post dose dexamethasone
50244-3,17-Ketosteroids^2D post dose dexamethasone
May-24,Mycobacterium gordonae rRNA
50245-0,17-Hydroxycorticosteroids^post high dose dexamethasone
50246-8,17-Hydroxycorticosteroids^2D post high dose dexamethasone
50247-6,17-Hydroxycorticosteroids^post dose dexamethasone
50248-4,17-Hydroxycorticosteroids^2D post dose dexamethasone
50249-2,17-Hydroxypregnenolone^30M post 250 ug corticotropin
502-5,Ticarcillin
50250-0,21-Deoxycortisol
50251-8,3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine
Feb-25,Mycobacterium intracellulare rRNA
50252-6,3-Hydroxyisovalerylcarnitine (C5-OH)/Creatinine
50253-4,Fatty acids.nonesterified^1st specimen post CFst
50254-2,Fatty acids.nonesterified^2nd specimen post CFst
50255-9,Fatty acids.nonesterified^3rd specimen post CFst
50256-7,Fatty acids.nonesterified^4th specimen post CFst
50257-5,Fatty acids.nonesterified^5th specimen post CFst
50258-3,Aldosterone^post 25 mg captopril PO
50259-1,Aldosterone^pre 25 mg captopril PO
5026-0,Mycobacterium kansasii rRNA
50260-9,Prekeratocytes
50261-7,Renal function panel & Glomerular filtration rate.predicted
50262-5,Reticulocytes panel
50263-3,17-Ketosteroids^post high dose dexamethasone
50264-1,17-Ketosteroids^2D post high dose dexamethasone
50265-8,2-Dechloroethylifosfamide^pre dose ifosfamide
50266-6,2-Dechloroethylifosfamide^1D post dose ifosfamide
50267-4,2-Dechloroethylifosfamide^2D post dose ifosfamide
50268-2,2-Dechloroethylifosfamide^3D post dose ifosfamide
50269-0,2-Dechloroethylifosfamide^4D post dose ifosfamide
50270-8,2-Dechloroethylifosfamide^5D post dose ifosfamide
50271-6,2-Dechloroethylifosfamide^3H post dose ifosfamide
50272-4,2-Dechloroethylifosfamide^6H post dose ifosfamide
50273-2,3-Hydroxymyristoleylcarnitine (C14:1-OH)
50274-0,3-Hydroxymyristoleylcarnitine (C14:1-OH)
50275-7,3-Hydroxymyristoleylcarnitine (C14:1-OH)
50276-5,3-Hydroxymyristoleylcarnitine (C14:1-OH)
50277-3,3-Hydroxymyristoleylcarnitine (C14:1-OH)
Aug-27,Mycobacterium tuberculosis rRNA
50278-1,3-Hydroxymyristoleylcarnitine (C14:1-OH)/Creatinine
50279-9,3-Hydroxytetradecanoylcarnitine (C14-OH)
50280-7,3-Hydroxytetradecanoylcarnitine (C14-OH)
50281-5,3-Hydroxytetradecanoylcarnitine (C14-OH)
50282-3,3-Hydroxytetradecanoylcarnitine (C14-OH)
50283-1,3-Hydroxytetradecanoylcarnitine
50284-9,3-Hydroxytetradecanoylcarnitine (C14-OH)/Creatinine
50285-6,3-Dechloroethylifosfamide^1D post dose ifosfamide
Jun-28,Neisseria gonorrhoeae rRNA
50286-4,3-Dechloroethylifosfamide^2D post dose ifosfamide
50287-2,3-Dechloroethylifosfamide^3D post dose ifosfamide
50288-0,3-Dechloroethylifosfamide^4D post dose ifosfamide
50289-8,3-Dechloroethylifosfamide^6D post dose ifosfamide
50290-6,3-Dechloroethylifosfamide^3H post dose ifosfamide
50291-4,3-Dechloroethylifosfamide^6H post dose ifosfamide
50292-2,4-Hydroxyifosfamide^pre dose ifosfamide
50293-0,4-Hydroxyifosfamide^1D post dose ifosfamide
Apr-29,Neisseria meningitidis rRNA
50294-8,4-Hydroxyifosfamide^2D post dose ifosfamide
50295-5,4-Hydroxyifosfamide^3D post dose ifosfamide
50296-3,4-Hydroxyifosfamide^4D post dose ifosfamide
50297-1,4-Hydroxyifosfamide^5D post dose ifosfamide
50298-9,4-Hydroxyifosfamide^3H post dose ifosfamide
50299-7,4-Hydroxyifosfamide^6H post dose ifosfamide
50300-3,6-Hydroxyheptanoate
50301-1,Adipoylcarnitine+Methylglutarylcarnitine (C6-DC)
Feb-30,Parvovirus B19 RNA
50302-9,Adipoylcarnitine+Methylglutarylcarnitine (C6-DC)
50303-7,Adipoylcarnitine+Methylglutarylcarnitine (C6-DC)
50304-5,Adipoylcarnitine+Methylglutarylcarnitine (C6-DC)
50305-2,Adipoylcarnitine+Methylglutarylcarnitine (C6-DC)/Creatinine
50306-0,Allantoine
50307-8,BCL10 Ag
50308-6,Caldesmon Ag
50309-4,CD138 Ag
5031-0,Parvovirus B19 RNA
50310-2,CD7 Ag
50311-0,Chlamydia trachomatis DNA
50312-8,Clusterin Ag
50313-6,Cyclospora sp identified
50314-4,Cytokeratin 19 Ag
50315-1,Cytokeratin 5 Ag
50316-9,Galectin 3 Ag
50317-7,CD235a Ag
50318-5,Granzyme B Ag
50319-3,HBME-1 Ag
50320-1,Helicobacter pylori Ag
50321-9,Hepatocyte Ag
50322-7,MLH-1 Ag
50323-5,MSH-2 Ag
50324-3,MSH-6 Ag
50325-0,MUM-1 Ag
50326-8,Neisseria gonorrhoeae DNA
50327-6,Neu-N Ag
Aug-32,Parvovirus B19 RNA
50328-4,PMS-2 Ag
50329-2,Respiratory syncytial virus Ag
503-3,Ticarcillin+Clavulanate
50330-0,SLC6A4 gene targeted mutation analysis
50331-8,WT-1 Ag
50332-6,Hexadecanedioate/Creatinine
50333-4,Tetradecanedioate/Creatinine
50334-2,Acylglycines panel
50335-9,Alpha-beta crystallin Ag
Jun-33,Staphylococcus aureus rRNA
50336-7,Beta cortolone/Cortisol
50337-5,carBAMazepine & metabolites panel
50338-3,Cannabinoids
50339-1,Cholesterol
50340-9,Eosinophils
50341-7,Eosinophils
50342-5,Ependymal+Choroid plexus cells/100 leukocytes
50343-3,Ethanol
Apr-34,Streptococcus agalactiae rRNA
50344-1,Parvovirus B19 DNA
50345-8,Parvovirus B19 DNA
50346-6,Parvovirus B19 DNA
50347-4,Parvovirus B19 DNA
50348-2,Parvovirus B19 DNA
50349-0,Parvovirus B19 DNA
50350-8,Mustard Ab.IgE/IgE.total
Jan-35,Streptococcus pneumoniae rRNA
50351-6,Casuarina equisetifolia Ab.IgE/IgE.total
50352-4,Papain Ab.IgE/IgE.total
50353-2,Parrot feather Ab.IgE/IgE.total
50354-0,Paspalum notatum Ab.IgE/IgE.total
50355-7,Perca spp Ab.IgE/IgE.total
50356-5,Phalaris arundinacea Ab.IgE/IgE.total
50357-3,Phenolphthalein
50358-1,Phenylacetate/Creatinine
50359-9,Phenyllactate/Creatinine
50360-7,Phenylpropionylglycine/Creatinine
50361-5,Phenylpyruvate/Creatinine
50362-3,Phoma betae Ab.IgE/IgE.total
50363-1,Pigweed common Ab.IgE/IgE.total
50364-9,Piper nigrum Ab.IgE/IgE.total
50365-6,Platelet glycoprotein IIb-IIIa Ab
50366-4,Prolactin.monomeric/Prolactin.total
50367-2,Propionylglycine/Creatinine
50368-0,Protoporphyrin
Sep-36,Streptococcus pyogenes rRNA
50369-8,Quercus alba Ab.IgE/IgE.total
50370-6,Syagrus romanzoffianum Ab.IgE/IgE.total
50371-4,Protoporphyrin
50372-2,Protoporphyrin
50373-0,Eosinophils.band form/100 cells
50374-8,Myelocytes.eosinophilic/100 cells
50375-5,Nucleated cells
50376-3,Lupus anticoagulant neutralization.dilute phospholipid actual/Normal
Jul-37,Acetylcholine receptor binding Ab
50377-1,von Willebrand factor.collagen binding activity actual/Normal
50378-9,von Willebrand factor.collagen binding activity/von Willebrand factor Ag
50379-7,Creatinine dialysis fluid clearance/1.73 sq M
50380-5,Creatinine renal clearance/1.73 sq M.predicted.female
50381-3,Creatinine renal clearance/1.73 sq M.predicted.male
50382-1,Glutathione reductase
50383-9,Glomerular filtration rate.predicted
50384-7,Glomerular filtration rate/1.73 sq M.predicted
May-38,Acetylcholine receptor blocking Ab
50385-4,Alpha-1-Microglobulin.placental
50386-2,Parakeet+Parrot droppings Ab.IgE/IgE.total
50387-0,Chlamydia trachomatis rRNA
50388-8,Neisseria gonorrhoeae rRNA
50389-6,Microscopic observation
50390-4,Coagulation factor II circulating inhibitor
50391-2,Coagulation surface induced circulating inhibitor
50392-0,3-Keto n-Valerate
Mar-39,Acetylcholine receptor modulation Ab
50393-8,3-Keto n-Valerate/Creatinine
50394-6,Adenine phosphoribosyltransferase
50395-3,Adenosine deaminase
50396-1,Molecular diagnostic major findings for display
50397-9,Molecular diagnostic overall interpretation
50398-7,Narrative diagnostic report
50399-5,Clinical genetic report summary panel
50400-1,Body temperature^post transfusion reaction
Jan-40,Actinomyces sp Ab
50401-9,Blood group antibody titered
50402-7,Blood pressure systolic & diastolic^post transfusion
50403-5,Blood pressure systolic & diastolic^pre transfusion
50404-3,Other cells/100 leukocytes
50405-0,Patient symptoms^post transfusion reaction
50406-8,Cannabinoids
50407-6,Other cells/100 leukocytes
50408-4,Protein.abnormal band/Protein.total
50409-2,Cholesterol.in HDL 2+3
504-1,Ticarcillin+Clavulanate
50410-0,Coagulation dilute Russell viper venom induced/Coagulation dilute Russell viper venom induced.excess phospholipid
50411-8,Chlamydia trachomatis rRNA
50412-6,Neisseria gonorrhoeae rRNA
50413-4,Corticotropin^pre 1 mg dexamethasone PO overnight
50414-2,Corticotropin^post 1 mg dexamethasone PO overnight
50415-9,Cortisol^pre 2 mg dexamethasone PO overnight
50416-7,Cortisol^post 2 mg dexamethasone PO overnight
50417-5,Corticotropin^pre 2 mg dexamethasone PO overnight
50418-3,Corticotropin^post 2 mg dexamethasone PO overnight
Sep-41,Adenovirus Ab
50419-1,Corticotropin^pre 500 ug dexamethasone PO 2.5 day low dose q6h
50420-9,Corticotropin^post 500 ug dexamethasone PO 2.5 day low dose q6h
50421-7,Cortisol^pre 100 ug CRH IV
50422-5,Cortisol^20M post 100 ug CRH IV
50423-3,Cortisol^40M post 100 ug CRH IV
50424-1,Cortisol^1H post 100 ug CRH IV
50425-8,Corticotropin^pre 100 ug CRH IV
50426-6,Corticotropin^20M post 100 ug CRH IV
Jul-42,Adenovirus Ab.IgM
50427-4,Corticotropin^40M post 100 ug CRH IV
50428-2,Corticotropin^1H post 100 ug CRH IV
50429-0,Cortisol^9 AM specimen
50430-8,Cortisol^3 PM specimen
50431-6,Cortisol^6 PM specimen
50432-4,Cortisol^9 PM specimen
50433-2,Cortisol^3 AM specimen
50434-0,Cortisol^6 AM specimen
May-43,Adrenal Ab
50435-7,Corticotropin^9 AM specimen
50436-5,Corticotropin^3 PM specimen
50437-3,Corticotropin^6 PM specimen
50438-1,Corticotropin^9 PM specimen
50439-9,Corticotropin^3 AM specimen
50440-7,Corticotropin^6 AM specimen
50441-5,Cortisol^30M pre dose insulin IV
50442-3,Cortisol^20M post dose insulin IV
Mar-44,Adrenal cortex Ab
50443-1,Somatotropin^30M pre dose arginine
50444-9,Somatotropin^20M post dose arginine
50445-6,Corticotropin^1st specimen
50446-4,Corticotropin^2nd specimen
50447-2,Corticotropin^3rd specimen
50448-0,Corticotropin^4th specimen
50449-8,Corticotropin^5th specimen
5045-0,Ancylostoma sp Ab
50450-6,Corticotropin^6th specimen
50451-4,Corticotropin^7th specimen
50452-2,Corticotropin^8th specimen
50453-0,Cortisol^1st specimen
50454-8,Cortisol^2nd specimen
50455-5,Cortisol^3rd specimen
50456-3,Cortisol^4th specimen
50457-1,Cortisol^5th specimen
50458-9,Cortisol^6th specimen
50459-7,Cortisol^7th specimen
50460-5,Cortisol^8th specimen
50461-3,C peptide^1st specimen
50462-1,C peptide^2nd specimen
50463-9,C peptide^3rd specimen
50464-7,C peptide^4th specimen
50465-4,C peptide^5th specimen
50466-2,C peptide^6th specimen
50467-0,C peptide^7th specimen
Aug-46,Hantavirus Ab
50468-8,C peptide^8th specimen
50469-6,Calcitonin^1st specimen
50470-4,Calcitonin^2nd specimen
50471-2,Calcitonin^3rd specimen
50472-0,Calcitonin^4th specimen
50473-8,Calcitonin^5th specimen
50474-6,Calcitonin^6th specimen
50475-3,Calcitonin^7th specimen
Jun-47,Nuclear Ab
50476-1,Calcitonin^8th specimen
50477-9,Follitropin^1st specimen
50478-7,Follitropin^2nd specimen
50479-5,Follitropin^3rd specimen
50480-3,Follitropin^4th specimen
50481-1,Follitropin^5th specimen
50482-9,Follitropin^6th specimen
50483-7,Follitropin^7th specimen
Apr-48,Nuclear Ab
50484-5,Follitropin^8th specimen
50485-2,Gastrin^1st specimen
50486-0,Gastrin^2nd specimen
50487-8,Gastrin^3rd specimen
50488-6,Gastrin^4th specimen
50489-4,Gastrin^5th specimen
50490-2,Gastrin^6th specimen
50491-0,Gastrin^7th specimen
Feb-49,Ascaris lumbricoides Ab
50492-8,Gastrin^8th specimen
50493-6,Somatotropin^1st specimen
50494-4,Somatotropin^2nd specimen
50495-1,Somatotropin^3rd specimen
50496-9,Somatotropin^4th specimen
50497-7,Somatotropin^5th specimen
50498-5,Somatotropin^6th specimen
50499-3,Somatotropin^7th specimen
May-50,Bacampicillin
5050-0,Aspergillus fumigatus Ab
50500-8,Somatotropin^8th specimen
50501-6,Insulin^1st specimen
50502-4,Insulin^2nd specimen
50503-2,Insulin^3rd specimen
50504-0,Insulin^4th specimen
50505-7,Insulin^5th specimen
50506-5,Insulin^6th specimen
50507-3,Insulin^7th specimen
50508-1,Insulin^8th specimen
50509-9,Lutropin^1st specimen
50510-7,Lutropin^2nd specimen
50511-5,Lutropin^3rd specimen
50512-3,Lutropin^4th specimen
50513-1,Lutropin^5th specimen
50514-9,Lutropin^6th specimen
50515-6,Lutropin^7th specimen
50516-4,Lutropin^8th specimen
50517-2,Prolactin^1st specimen
Aug-51,Aspergillus niger Ab
50518-0,Prolactin^2nd specimen
50519-8,Prolactin^3rd specimen
50520-6,Prolactin^4th specimen
50521-4,Prolactin^5th specimen
50522-2,Prolactin^6th specimen
50523-0,Prolactin^7th specimen
50524-8,Prolactin^8th specimen
50525-5,Parathyrin.intact^1st specimen
Jun-52,Aspergillus sp Ab
50526-3,Parathyrin.intact^2nd specimen
50527-1,Parathyrin.intact^3rd specimen
50528-9,Parathyrin.intact^4th specimen
50529-7,Parathyrin.intact^5th specimen
50530-5,Parathyrin.intact^6th specimen
50531-3,Parathyrin.intact^7th specimen
50532-1,Parathyrin.intact^8th specimen
50533-9,Thyrotropin^1st specimen
Apr-53,Aspergillus sp Ab
50534-7,Thyrotropin^2nd specimen
50535-4,Thyrotropin^3rd specimen
50536-2,Thyrotropin^4th specimen
50537-0,Thyrotropin^5th specimen
50538-8,Thyrotropin^6th specimen
50539-6,Thyrotropin^7th specimen
50540-4,Thyrotropin^8th specimen
50541-2,Thyrotropin^20M post dose TRH
Feb-54,Babesia sp Ab
50542-0,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine"
50543-8,Tricyclic antidepressants
50544-6,Everolimus
50545-3,Bacterial susceptibility panel
50546-1,Bacterial susceptibility panel
50547-9,Eastern equine encephalitis virus RNA
50548-7,Respiratory virus DNA+RNA
50549-5,Cytomegalovirus+Epstein Barr virus DNA
50550-3,Malondialdehyde.free
50551-1,Bilirubin
50552-9,Clarity
50553-7,Color
50554-5,Urinalysis microscopic panel
50555-2,Glucose
50556-0,Urinalysis dipstick panel
50557-8,Ketones
50558-6,Nitrite
Sep-55,Bacillus anthracis Ab
50559-4,Hemoglobin
50560-2,pH
50561-0,Protein
50562-8,Specific gravity
50563-6,Urobilinogen
50564-4,Urinalysis panel
50565-1,OTC - Keep out of reach of children section
50566-9,OTC - Stop use section
Jul-56,Basement membrane Ab
50567-7,OTC - When using section
50568-5,OTC - Ask doctor or pharmacist section
50569-3,OTC - Ask doctor section
50570-1,OTC - Do not use section
50571-9,VFD Type C medicated feed animal drug label
50572-7,VFD Type B medicated feed animal drug label
50573-5,OTC Type C medicated feed animal drug label
50574-3,OTC Type B medicated feed animal drug label
May-57,Blastomyces dermatitidis Ab
50575-0,VFD Type A medicated article animal drug label
50576-8,OTC Type A medicated article animal drug label
50577-6,OTC animal drug label
50578-4,Prescription animal drug label
50579-2,Gastric analysis panel
505-8,Ticarcillin+Clavulanate
50580-0,"Maternal screen for fetal abnormalities such as Open Neural Tube Defects, Trisomy 21 or Trisomy 18 panel"
50581-8,Adenosine monophosphate.cyclic stimulation panel
50582-6,Glucose tolerance gestational panel
Mar-58,Blastomyces dermatitidis Ab
50583-4,Glucose screen gestational panel
50584-2,Lactose challenge panel
50585-9,Triple bolus stimulation panel
50586-7,Glucose tolerance 3H panel
50587-5,Glucose tolerance 4H panel
50588-3,Glucose tolerance 5H panel
50589-1,Glucose tolerance 6H panel
50590-9,Adenine phosphoribosyltransferase
Jan-59,Bordetella pertussis Ab
50591-7,Adenosine deaminase
50592-5,Ecgonine methyl ester
50593-3,3-Hydroxybenzoylecgonine
50594-1,3-Hydroxybenzoylecgonine
50595-8,Pathologist interpretation
50596-6,HPA-1a
50597-4,HPA-2
50598-2,HPA-15
50599-0,HPA-1
50600-6,HPA-3
50601-4,HPA-4
50602-2,HPA-5
50603-0,HPA-6
50604-8,HPA panel
50605-5,Hydrogen/Expired gas^pre XXX challenge
50606-3,Hydrogen/Expired gas^4H post XXX challenge
50607-1,Neisseria meningitidis serogroups Ag panel
50608-9,Glucose tolerance 3H gestational panel
Sep-60,Borrelia burgdorferi Ab
50609-7,Nitroblue tetrazolium test
50610-5,Alpha-1-Fetoprotein^^adjusted for multiple gestations
50611-3,Felbamate
50612-1,Chlamydophila pneumoniae Ab.IgA & IgG & IgM
50613-9,Hydrogen/Expired gas^3.5H post XXX challenge
50614-7,Hydrogen/Expired gas^4.5H post XXX challenge
50615-4,Hydrogen/Expired gas^5H post XXX challenge
50616-2,Hydrogen/Expired gas^5.5H post XXX challenge
Jul-61,Borrelia burgdorferi Ab
50617-0,Hydrogen/Expired gas^6H post XXX challenge
50618-8,Phosphatidylcholine.saturated/Surfactant.total
50619-6,Karyotype
50620-4,Opiates cutoff
50621-2,HTT gene targeted mutation analysis
50622-0,Allergen.miscellaneous Ab.IgG
50623-8,AS gene targeted mutation analysis
50624-6,HIV 1 RNA panel
May-62,Borrelia burgdorferi Ab.IgG
50625-3,Ova & parasites identified
50626-1,DMD gene targeted mutation analysis
50627-9,Immunoglobulin heavy chain gene rearrangements
50628-7,Heptacarboxylporphyrin/Creatinine
50629-5,Liver kidney microsomal Ab.IgG
50630-3,Gentamicin
50631-1,Cefepime
50632-9,Cefotaxime
Mar-63,Borrelia burgdorferi Ab.IgG
50633-7,cefTRIAXone
50634-5,Populus balsamifera Ab.IgE
50635-2,Cupressus macrocarpa Ab.IgE
50636-0,Macrocheira kaempferi Ab.IgE
50637-8,Coagulation factor XIII inhibitor
50638-6,Bixa orellana seed Ab.IgE
50639-4,Harmonia axyridis Ab.IgE
50640-2,Cells.CD3+CD57+
Jan-64,Borrelia burgdorferi Ab.IgM
50641-0,Cells.CD3+CD8+CD57+
50642-8,Human papilloma virus 6+11+42+43+44 DNA
50643-6,Pregnanetriolone
50644-4,Tetrahydrocorticosterone/Creatinine
50645-1,Tetrahydrocortisol/Creatinine
50646-9,Latex recombinant (rHev b) 1 Ab.IgE
50647-7,Latex recombinant (rHev b) 11 Ab.IgE
50648-5,Latex recombinant (rHev b) 6.01 Ab.IgE
50649-3,Latex recombinant (rHev b) 6.02 Ab.IgE
50650-1,Lupinus albus seed Ab.IgE
50651-9,(Arachis hypogaea+Cow milk+Egg white+Mustard) Ab.IgE
50652-7,(Actinidia chinensis+Beef+Pandalus borealis+Sesamum indicum) Ab.IgE
50653-5,(Acer negundo+Betula verrucosa+Corylus avellana+Quercus alba+Platanus acerifolia) Ab.IgE
50654-3,(Anthoxanthum odoratum+Lolium perenne+Phleum pratense+Secale cereale+Holcus lanatus) Ab.IgE
50655-0,(Actinidia chinensis+Corylus avellana+Musa spp+Pandalus borealis) Ab.IgE
50656-8,(Corylus avellana+Gadus morhua+Glycine max+Triticum aestivum) Ab.IgE
50657-6,(Allium cepa+Allium sativum+Sesamum indicum+Yeast) Ab.IgE
Aug-65,Borrelia burgdorferi Ab.IgM
50658-4,Basophils.band form/100 leukocytes
50659-2,Chromosome analysis.interphase
506-6,Ticarcillin+Clavulanate
50660-0,Herpes simplex virus 1 DNA
50661-8,Herpes simplex virus 1 DNA
50662-6,Herpes simplex virus 2 DNA
50663-4,Herpes simplex virus 2 DNA
50664-2,Cells.CD19+Kappa+
50665-9,Cells.CD19+Lambda+
Jun-66,Brucella abortus Ab
50666-7,Nuclear matrix protein 22
50667-5,Glucose tolerance
50668-3,Microscopic observation
50669-1,Transfuse antithrombin
50670-9,Erythrocyte agglutination
50671-7,Corticotropin releasing hormone
50672-5,Leukocyte toxic vacuoles
50673-3,Insulin XXX challenge panel
Apr-67,Brucella abortus Ab
50674-1,Spherocytes
50675-8,Calcium-phosphorus product
50676-6,Calcium-phosphorus product panel
50677-4,Semen analysis post vasectomy panel
50678-2,Spondylocladium sp Ab.IgE.Rast Class
50679-0,First trimester maternal screen with nuchal translucency
50680-8,Paecilomyces variottii Ab.IgE
50681-6,Thyroxine binding protein pattern
Feb-68,Brucella canis Ab
50682-4,PRKCG gene.CAG repeats
50683-2,Staphylococcus aureus toxic shock syndrome toxin 1+Staphylococcus aureus enterotoxin B Ab
50684-0,Chromosome analysis.interphase
50685-7,Somatotropin
50686-5,11-Dehydro thromboxane beta 2/Creatinine
50687-3,Plasmodium sp Ag
50688-1,Plasmodium sp lactate dehydrogenase
50689-9,Treponema pallidum Ab
5069-0,Brucella melitensis Ab
50690-7,Reagin Ab
50691-5,Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab
50692-3,Parainfluenza virus 1+2+3 Ab
50693-1,Influenza virus A+B Ab
50694-9,Rubella virus Ab
50695-6,Treponema pallidum Ab
50696-4,Influenza virus A Ab.Neut
50697-2,Influenza virus A Ag
50698-0,Influenza virus A.adamantane resistance
50699-8,Influenza virus A.adamantane resistance
50700-4,Influenza virus A.adamantane resistant RNA
50701-2,Influenza virus A H1 Ag
50702-0,Influenza virus A matrix protein RNA
50703-8,Influenza virus A.neuraminidase inhibitor resistance
50704-6,Influenza virus A nucleoprotein RNA
50705-3,Influenza virus A non-structural protein RNA
50706-1,Influenza virus A polymerase A RNA
50707-9,Influenza virus A polymerase B1 cDNA
Aug-70,Brucella sp Ab.IgM
50708-7,Influenza virus A polymerase B2 RNA
50709-5,Influenza virus B Ab
50710-3,Influenza virus susceptibility panel
50711-1,Influenza virus A polymerase RNA
50712-9,Influenza virus.neuraminidase inhibitor resistance
50713-7,Influenza virus.neuraminidase inhibitor resistance
50714-5,Rumex obtusifolius Ab.IgE
50715-2,Trisomy 21
Jun-71,Brucella suis Ab
50716-0,11-Deoxycortisol^7th specimen post XXX challenge
50717-8,11-Deoxycortisol^6th specimen post XXX challenge
50718-6,11-Deoxycortisol^5th specimen post XXX challenge
50719-4,11-Deoxycortisol^4th specimen post XXX challenge
50720-2,11-Deoxycortisol^3rd specimen post XXX challenge
50721-0,11-Deoxycortisol^1st specimen post XXX challenge
50722-8,VKORC1 gene targeted mutation analysis
50723-6,Cells.CD38+Lambda+
Apr-72,Brush border Ab
50724-4,Lymphoblasts/100 leukocytes
50725-1,Monoblasts/100 leukocytes
50726-9,Reticulum cell/100 cells
50727-7,Serotonin release 100 IU/mL heparin.unfractionated
50728-5,Serotonin release 0.1 IU/mL heparin.unfractionated
50729-3,Serotonin release 100 U/mL heparin.porcine
50730-1,Serotonin release 0.1 U/mL heparin.porcine
50731-9,Serotonin release 100 IU/mL heparin.low molecular weight
Feb-73,La Crosse virus Ab
50732-7,Serotonin release 0.1 IU/mL heparin.low molecular weight
50733-5,Serotonin release interpretation
50734-3,Serotonin release.heparin.porcine interpretation
50735-0,Serotonin release.heparin.low molecular weight interpretation
50736-8,Serotonin release.heparin.unfractionated panel
50737-6,Serotonin release.heparin.porcine panel
50738-4,Serotonin release.heparin.low molecular weight panel
50739-2,Serotonin release.heparin.porcine & low molecular weight panel
507-4,Tobramycin
5074-0,Candida albicans Ab
50740-0,Guaranteed analysis of feed section
50741-8,Safe handling warning section
50742-6,Environmental warning section
50743-4,Food safety warning section
50744-2,Information for owners or caregivers section
50745-9,Veterinary indications section
50746-7,Hirudin
50747-5,Platelet factor 4 Ag
50748-3,Alpha-2-Macroglobulin/Creatinine
50749-1,Protein
50750-9,F13A1 gene.p.Val34Leu
50751-7,Glucose^15M post 0.1 U/kg insulin
50752-5,Cortisol^15M post dose insulin IV
50753-3,Somatotropin^15M post dose insulin IV
50754-1,Coagulation surface induced
50755-8,Multisection^W contrast IV
50756-6,Creatine kinase
Jul-75,Candida albicans Ag
50757-4,Creatine kinase.total/Creatine kinase.MB
50758-2,Herpes simplex virus 1 Ab.IgM
50759-0,Beta-N-acetylhexosaminidase.A
50760-8,Coagulation surface induced.lupus sensitive.factor substitution^1H post incubation after addition of normal plasma
50761-6,A Ab.IgG
50762-4,A Ab.IgM
50763-2,B Ab.IgM
50764-0,B Ab.IgG
May-76,Cardiolipin Ab.IgA
50765-7,Hemoglobin Hasharon/Hemoglobin.total
50766-5,Fungus identified ^^^8
50767-3,Ganglioside GD1a Ab.IgG/Ganglioside GD1a Ab.IgM
50768-1,Ganglioside GD1b Ab.IgG/Ganglioside GD1b Ab.IgM
50769-9,Asialoganglioside GM1 Ab.IgG/Asialoganglioside GM1 Ab.IgM
50770-7,Ganglioside GM1 Ab.IgG/Ganglioside GM1 Ab.IgM
50771-5,Ganglioside GM2 Ab.IgG/Ganglioside GM2 Ab.IgM
50772-3,Ganglioside GQ1b Ab.IgG/Ganglioside GQ1b Ab.IgM
Mar-77,Centromere Ab
50773-1,ABO & Rh group^post transfusion reaction
50774-9,Nucleated cells
50775-6,Cancer Ag 125
50776-4,Cancer Ag 15-3
50777-2,Cancer Ag 15-3
50778-0,Cancer Ag 15-3
50779-8,Cancer Ag 19-9
50780-6,Cancer Ag 19-9
Jan-78,Chlamydophila pneumoniae Ab
50781-4,Cancer Ag 19-9
50782-2,Cancer Ag 27-29
50783-0,Cells.CD15 actual/normal
50784-8,Cells.CD16 actual/normal
50785-5,Cells.CD18 actual/normal
50786-3,Date of entry
50787-1,Primary reason for assessment
50788-9,Cytokeratin cells/100 cells
50789-7,Cytokeratin cells
50790-5,HIV 1 RNA tropism
50791-3,Hemoglobin pattern
50792-1,Protein.monoclonal band 3/Protein.total
50793-9,Protein.monoclonal band 4/Protein.total
50794-7,Osmotic fragility.beginning hemolysis
50795-4,Osmotic fragility.full hemolysis
50796-2,Protein.monoclonal band 3
50797-0,Protein.monoclonal band 4
50798-8,17-Ketogenic steroids
Sep-79,Chlamydophila psittaci Ab
50799-6,7-Dehydrocholesterol
50800-2,Acetone
50801-0,Aluminum
50802-8,Amikacin^peak
50803-6,Amikacin^trough
50804-4,Amitriptyline
50805-1,Amitriptyline
50806-9,Antimony
Jul-80,Chlamydophila psittaci Ab.IgG
50807-7,Antimony
50808-5,Antimony
50809-3,Antimony
50810-1,Antimony
50811-9,Antimony
50812-7,Arsenic
50813-5,Arsenic
50814-3,Arsenic.inorganic
May-81,Chlamydophila psittaci Ab.IgM
50815-0,Arsenic.inorganic
50816-8,Arsenic.organic
50817-6,Arsenic/Creatinine
50818-4,Barium
50819-2,Barium
508-2,Tobramycin
50820-0,Base excess
50821-8,Beryllium
50822-6,Beryllium
Mar-82,Chlamydia sp Ab
50823-4,Beryllium
50824-2,Beta-2-Microglobulin
50825-9,Bile acid
50826-7,Bismuth
50827-5,Boron
50828-3,Boron
50829-1,Boron
50830-9,Boron
Jan-83,Chlamydia sp Ab
50831-7,Boron/Creatinine
50832-5,Boron/Creatinine
50833-3,Cadmium
50834-1,Cadmium
50835-8,Cadmium/Creatinine
50836-6,Calcium
50837-4,Calcium.ionized
50838-2,Calcium.ionized^^adjusted to pH 7.4
50839-0,Calcium/Creatinine
50840-8,Cholesterol.in HDL
50841-6,Chromium
50842-4,Chromium
50843-2,clonazePAM
50844-0,cloZAPine
50845-7,Cobalt
50846-5,Cobalt
50847-3,Cobalt
50848-1,Cortisol
Sep-84,Chlamydia sp Ab
50849-9,Diazepam+Nordiazepam
50850-7,Fluoride/Creatinine
50851-5,Germanium
50852-3,Gold
50853-1,Heptacarboxylporphyrin
50854-9,Heptaporphyrin
50855-6,Hexacarboxylporphyrin
Jun-85,Chlamydia sp Ab.IgG
50856-4,Hexaporphyrin
50857-2,Histamine
50858-0,Hydrogen ion
50859-8,Hydrogen ion
50860-6,Hydrogen ion
50861-4,Hydrogen ion
50862-2,Hydrogen ion
50863-0,Hydrogen ion
Apr-86,Chlamydia sp Ab.IgM
50864-8,Hydrogen ion
50865-5,Hydrogen ion
50866-3,Indicans/Creatinine
50867-1,Insulin
50868-9,Iodine
50869-7,Iron
50870-5,Isopropanol
50871-3,Lead
Feb-87,Chlamydia trachomatis Ab
50872-1,Lithium
50873-9,Magnesium/Creatinine
50874-7,Manganese
50875-4,Manganese
50876-2,Mercury
50877-0,Mercury
50878-8,Mercury
50879-6,Methyl ethyl ketone
5088-0,Chlamydia trachomatis Ab
50880-4,Methyl ethyl ketone
50881-2,Molybdenum
50882-0,Molybdenum
50883-8,Molybdenum
50884-6,Molybdenum
50885-3,Naproxen
50886-1,Nickel
50887-9,Nickel
50888-7,Nitrogen
50889-5,Nitrogen
50890-3,Norclozapine
50891-1,OLANZapine
50892-9,Palladium
50893-7,Paraquat
50894-5,Pentacarboxylporphyrins
50895-2,pH
50896-0,pH
50897-8,pH
Aug-89,Chlamydia trachomatis Ab.IgG
50898-6,Phosphate
50899-4,Platinum
509-0,Tobramycin
50900-0,Platinum
50901-8,Porphyrins
50902-6,Potassium
50903-4,Selenium
50904-2,Selenium
50905-9,Silicon
Jun-90,Chlamydia trachomatis Ab.IgM
50906-7,Silicon
50907-5,Silicon
50908-3,Silver
50909-1,Silver
50910-9,Silver
50911-7,Sodium
50912-5,Sodium
50913-3,Strontium
Apr-91,Chymotrypsin Ab
50914-1,Strontium
50915-8,Strontium
50916-6,Sucrose
50917-4,Thallium
50918-2,Thallium
50919-0,Thorium
50920-8,Thorium
50921-6,Tin
Feb-92,Clostridium tetani Ab
50922-4,Tin
50923-2,Tin
50924-0,Titanium
50925-7,Titanium
50926-5,Titanium
50927-3,Tobramycin
50928-1,Uranium
50929-9,Uranium
5093-0,Clostridium tetani Ab
50930-7,Uranium
50931-5,Uroporphyrin 1 isomer
50932-3,Uroporphyrin/Porphyrins.total
50933-1,Vanadium
50934-9,Vanadium
50935-6,Vanadium
50936-4,Vanadium
50937-2,Vanadium
50938-0,Vancomycin
50939-8,Zinc
50940-6,Zinc/Creatinine
50941-4,Mycobacterium sp
50942-2,Acarboxyprothrombin
50943-0,Reasons for assessment (full)
50944-8,Platelet aggregation.adenosine diphosphate induced^20 umol/L
50945-5,Platelet aggregation.adenosine diphosphate induced^2 umol/L
50946-3,Platelet aggregation.adenosine diphosphate induced^4 umol/L
50947-1,Platelet aggregation.collagen induced^190 ug/mL
Aug-94,Coccidioides immitis Ab
50948-9,Vanillylmandelate & Creatinine
50949-7,Albumin
50950-5,Phosphoethanolamine Ab.IgA
50951-3,Phosphoserine Ab.IgA
50952-1,Phosphoserine Ab.IgG
50953-9,Phosphoethanolamine Ab.IgM
50954-7,Phosphoethanolamine Ab.IgG
May-95,Coccidioides immitis Ab
50955-4,Phosphoserine Ab.IgM
50956-2,HLA-B*57:01
50957-0,Manual differential performed
50958-8,Indirect antiglobulin test.XXX reagent^post transfusion
50959-6,Indirect antiglobulin test.XXX reagent
50960-4,Rabbit Ab
50961-2,Rabbit Ab
50962-0,XXX blood group Ab.IgG
Mar-96,Coccidioides immitis Ab
50963-8,XXX blood group Ab.IgM
50964-6,Liley Zone
50965-3,Gamma hydroxybutyrate cutoff
50966-1,Flunitrazepam
50967-9,Hepatitis B virus surface Ag
50968-7,HLA Ab
50969-5,Epstein Barr virus early diffuse Ab.IgG
50970-3,XXX blood group Ab
Jan-97,Cold agglutinin
50971-1,Cytology report
50972-9,Cells.CD138
50973-7,Cells.CD38+CD138+
50974-5,Cells.CD38+CD138+/100 cells
50975-2,Cells.TCR alpha beta
50976-0,Cells.TCR gamma delta
50977-8,Echovirus 5 Ab
50978-6,Immunoglobulin light chains.lambda.free
50979-4,CBir1 Ab
50980-2,pH^^adjusted to patient's actual temperature
50981-0,Carbon dioxide^^adjusted to patient's actual temperature
50982-8,Horowitz index
50983-6,Horowitz index
50984-4,Horowitz index
50985-1,Horowitz index
50986-9,Horowitz index
50987-7,Horowitz index^^adjusted to patient's actual temperature
50988-5,Horowitz index^^adjusted to patient's actual temperature
Sep-98,Cold agglutinin
50989-3,Horowitz index^^adjusted to patient's actual temperature
50990-1,Horowitz index^^adjusted to patient's actual temperature
50991-9,Horowitz index^^adjusted to patient's actual temperature
50992-7,IgM
50993-5,Laxatives
50994-3,CMT demyelinating gene targeted mutation analysis
50995-0,BRCA1+BRCA2 gene targeted mutation analysis
50996-8,HBB gene targeted mutation analysis
Jul-99,Coronavirus Ab
50997-6,Complement C8.functional
50998-4,CFTR gene mutations tested for
50999-2,Leishmania donovani Ab.IgG & IgM
51000-8,Leishmania tropica Ab.IgG & IgM
51001-6,Iodide
51002-4,Lipoprotein midband A
Mar-00,Coxiella burnetii Ab
51003-2,Lipoprotein midband B
51004-0,Lipoprotein midband C
51005-7,Testosterone.free+weakly bound
51006-5,Direct antiglobulin test.XXX reagent
51007-3,Direct antiglobulin test.XXX reagent^post transfusion
51008-1,Triticum aestivum native (nTri a) 19 Ab.IgE
51009-9,Cells.CD3-CD16+CD56+CD244+/100 cells
51010-7,Cells.CD3-CD16+CD56+CD244+/100 cells
Jan-01,Coxsackievirus A7 Ab.Neut
51011-5,Cells.CD3-CD16+CD56+CD244+/100 cells
51012-3,Cells.BCLXL/100 cells
51013-1,Blasts.CD1/100 blasts
51014-9,Blasts.CD1/100 blasts
51015-6,Blasts.CD1/100 blasts
51016-4,Blasts.CD1
51017-2,Blasts.CD1
51018-0,Blasts.CD10/100 blasts
51019-8,Blasts.CD10/100 blasts
51020-6,Blasts.CD10
51021-4,Blasts.CD10
51022-2,Blasts.cytoplasmic CD117/100 cells
51023-0,Blasts.cytoplasmic CD117/100 cells
51024-8,Blasts.cytoplasmic CD117/100 cells
51025-5,Blasts.CD117/100 blasts
51026-3,Blasts.CD117/100 blasts
51027-1,Blasts.CD117/100 blasts
51028-9,Blasts.CD117
Sep-02,Coxsackievirus A9 Ab.Neut
51029-7,Blasts.CD117
51030-5,Blasts.CD117
51031-3,Blasts.CD11a/100 blasts
51032-1,Blasts.CD11a/100 blasts
51033-9,Blasts.CD11a/100 blasts
51034-7,Blasts.CD11a
51035-4,Blasts.CD11a
51036-2,Blasts.CD11a
Jul-03,Coxsackievirus B1 Ab.Neut
51037-0,Blasts.CD11b/100 blasts
51038-8,Blasts.CD11b/100 blasts
51039-6,Blasts.CD11b/100 blasts
51040-4,Blasts.CD11c/100 blasts
51041-2,Blasts.CD11c/100 blasts
51042-0,Blasts.CD11c/100 blasts
51043-8,Blasts.CD123/100 blasts
51044-6,Blasts.CD123/100 blasts
May-04,Coxsackievirus B1 Ab
51045-3,Blasts.CD123/100 blasts
51046-1,Blasts.CD123
51047-9,Blasts.CD123
51048-7,Blasts.CD123
51049-5,Blasts.CD126/100 blasts
51050-3,Blasts.CD126/100 blasts
51051-1,Blasts.CD126/100 blasts
Feb-05,Coxsackievirus B2 Ab.Neut
51052-9,Blasts.CD126
51053-7,Blasts.CD126
51054-5,Blasts.CD126
51055-2,Blasts.CD127/100 blasts
51056-0,Blasts.CD127/100 blasts
51057-8,Blasts.CD127/100 blasts
51058-6,Blasts.CD127
51059-4,Blasts.CD127
5106-0,Coxsackievirus B2 Ab
51060-2,Blasts.CD127
51061-0,Blasts.cytoplasmic CD13/100 blasts
51062-8,Blasts.cytoplasmic CD13/100 blasts
51063-6,Blasts.cytoplasmic CD13/100 blasts
51064-4,Blasts.CD13/100 blasts
51065-1,Blasts.CD13/100 blasts
51066-9,Blasts.CD13
51067-7,Blasts.CD13
51068-5,Blasts.CD13
51069-3,Blasts.CD135/100 blasts
51070-1,Blasts.CD135/100 blasts
51071-9,Blasts.CD135/100 blasts
51072-7,Blasts.CD135
51073-5,Blasts.CD135
51074-3,Blasts.CD135
51075-0,Blasts.CD14/100 blasts
51076-8,Blasts.CD14/100 blasts
51077-6,Blasts.CD14
Aug-07,Coxsackievirus B3 Ab.Neut
51078-4,Blasts.CD14
51079-2,Blasts.CD14
510-8,Tobramycin
51080-0,Blasts.CD15/100 blasts
51081-8,Blasts.CD15/100 blasts
51082-6,Blasts.CD15/100 blasts
51083-4,Blasts.CD15
51084-2,Blasts.CD15
51085-9,Blasts.CD15
Jun-08,Coxsackievirus B3 Ab
51086-7,Blasts.CD16/100 blasts
51087-5,Blasts.CD16/100 blasts
51088-3,Blasts.CD16/100 blasts
51089-1,Blasts.cytoplasmic CD179a/100 blasts
51090-9,Blasts.cytoplasmic CD179a/100 blasts
51091-7,Blasts.cytoplasmic CD179a/100 blasts
51092-5,Blasts.cytoplasmic CD179a
51093-3,Blasts.cytoplasmic CD179a
Apr-09,Coxsackievirus B4 Ab.Neut
51094-1,Blasts.cytoplasmic CD179a
51095-8,Blasts.CD179a/100 blasts
51096-6,Blasts.CD179a/100 blasts
51097-4,Blasts.CD179a/100 blasts
51098-2,Blasts.CD179a
51099-0,Blasts.CD179a
51100-6,Blasts.CD179a
51101-4,Blasts.CD19/100 blasts
Feb-10,Coxsackievirus B4 Ab
51102-2,Blasts.CD19/100 blasts
51103-0,Blasts.CD19
51104-8,Blasts.CD19
51105-5,Blasts.CD19
51106-3,Blasts.CD1a/100 blasts
51107-1,Blasts.CD1a/100 blasts
51108-9,Blasts.CD1a/100 blasts
51109-7,Blasts.cytoplasmic CD2/100 blasts
5111-0,Coxsackievirus B5 Ab.Neut
51110-5,Blasts.CD2/100 blasts
51111-3,Blasts.CD2/100 blasts
51112-1,Blasts.CD2
51113-9,Blasts.CD2
51114-7,Blasts.CD2
51115-4,Blasts.CD20/100 blasts
51116-2,Blasts.CD20/100 blasts
51117-0,Blasts.CD21/100 blasts
51118-8,Blasts.cytoplasmic CD22/100 blasts
51119-6,Blasts.cytoplasmic CD22/100 blasts
51120-4,Blasts.cytoplasmic CD22/100 blasts
51121-2,Blasts.cytoplasmic CD22
51122-0,Blasts.cytoplasmic CD22
51123-8,Blasts.cytoplasmic CD22
51124-6,Blasts.CD22/100 blasts
51125-3,Blasts.CD22/100 blasts
51126-1,Blasts.CD22/100 blasts
51127-9,Blasts.CD22
Aug-12,Coxsackievirus B5 Ab
51128-7,Blasts.CD22
51129-5,Blasts.CD22
51130-3,Blasts.CD23/100 blasts
51131-1,Blasts.CD23/100 blasts
51132-9,Blasts.CD23/100 blasts
51133-7,Blasts.CD24/100 blasts
51134-5,Blasts.CD25/100 blasts
51135-2,Blasts.CD25/100 blasts
Jun-13,Coxsackievirus B6 Ab.Neut
51136-0,Blasts.CD25/100 blasts
51137-8,Blasts.cytoplasmic CD3/100 blasts
51138-6,Blasts.cytoplasmic CD3/100 blasts
51139-4,Blasts.cytoplasmic CD3/100 blasts
51140-2,Blasts.cytoplasmic CD3
51141-0,Blasts.cytoplasmic CD3
51142-8,Blasts.cytoplasmic CD3
51143-6,Blasts.CD3/100 blasts
Apr-14,Coxsackievirus B6 Ab
51144-4,Blasts.CD3/100 blasts
51145-1,Blasts.CD3/100 blasts
51146-9,Blasts.CD3
51147-7,Blasts.CD3
51148-5,Blasts.CD3
51149-3,Blasts.CD3+CD16+CD56+/100 blasts
51150-1,Blasts.CD3+CD16+CD56+/100 blasts
Jan-15,Corynebacterium diphtheriae Ab
51151-9,Blasts.CD3+CD16+CD56+/100 blasts
51152-7,Blasts.CD30/100 blasts
51153-5,Blasts.CD30/100 blasts
51154-3,Blasts.CD30/100 blasts
51155-0,Blasts.CD33/100 blasts
51156-8,Blasts.CD33/100 blasts
51157-6,Blasts.CD33
51158-4,Blasts.CD33
51159-2,Blasts.CD33
511-6,Trimethoprim
51160-0,Blasts.CD33+CD34+/100 blasts
51161-8,Blasts.cytoplasmic CD34/100 blasts
51162-6,Blasts.CD34/100 blasts
51163-4,Blasts.CD34/100 blasts
51164-2,Blasts.CD34
51165-9,Blasts.CD34
51166-7,Blasts.CD34
51167-5,Blasts.CD34+CD117+/100 blasts
51168-3,Blasts.CD34+CD117+/100 blasts
Sep-16,Corynebacterium diphtheriae Ab
51169-1,Blasts.CD34+CD117+/100 blasts
51170-9,Blasts.CD34+CD117+
51171-7,Blasts.CD34+CD117+
51172-5,Blasts.CD34+CD117+
51173-3,Blasts.CD36/100 blasts
51174-1,Blasts.CD36/100 blasts
51175-8,Blasts.CD36/100 blasts
51176-6,Blasts.CD36
Jul-17,Cryoglobulin
51177-4,Blasts.CD36
51178-2,Blasts.CD36
51179-0,Blasts.CD36+CD235a+/100 blasts
51180-8,Blasts.CD36+CD235a+/100 blasts
51181-6,Blasts.CD1
51182-4,Blasts.CD10
51183-2,CD117 Ag
51184-0,CD117 Ag
May-18,Cryptococcus neoformans Ag
51185-7,CD117 Ag
51186-5,CD15 Ag
51187-3,CD15 Ag
51188-1,CD15 Ag
51189-9,4-Hydroxybupivacaine
51190-7,Albumin
51191-5,Antimony
51192-3,Barium
Mar-19,Cryptococcus neoformans Ag
51193-1,Cadmium
51194-9,Cobalt
51195-6,Desbutylbupivacaine
51196-4,Hemoglobin A1/Hemoglobin.total
51197-2,Iron
51198-0,Manganese
51199-8,Molybdenum
51200-4,Nickel
Jan-20,Taenia solium larva Ab
51201-2,Palladium
51202-0,Platinum
51203-8,Ropivacaine
51204-6,Silicon
51205-3,Sodium
51206-1,Strontium
51207-9,Thallium
51208-7,Tin
51209-5,Tin
51210-3,Titanium
51211-1,Uranium
51212-9,Vanadium
51213-7,Acetaminophen crystals
51214-5,Cells.CD10/100 cells
51215-2,Cells.CD10/100 cells
51216-0,Cells.CD10/100 cells
51217-8,Cells.CD10/100 cells
51218-6,Cells.CD10+CD19+/100 cells
Sep-21,Cytomegalovirus Ab
51219-4,Cells.CD10+CD19+/100 cells
51220-2,Cells.CD103/100 cells
51221-0,Cells.CD103/100 cells
51222-8,Cells.CD105/100 cells
51223-6,Cells.CD105/100 cells
51224-4,Cells.CD105/100 cells
51225-1,Cells.CD105/100 cells
51226-9,Cells.CD117/100 cells
Jul-22,Cytomegalovirus Ab
51227-7,Cells.CD11b/100 cells
51228-5,Cells.CD11b/100 cells
51229-3,Cells.CD11b/100 cells
51230-1,Cells.CD11b/100 cells
51231-9,Cells.CD11c/100 cells
51232-7,Cells.CD11c/100 cells
51233-5,Cells.CD11c+CD19+/100 cells
51234-3,Cells.CD11c+CD19+/100 cells
May-23,Cytomegalovirus Ab
51235-0,Cells.CD13/100 cells
51236-8,Cells.CD13/100 cells
51237-6,Cells.CD13/100 cells
51238-4,Cells.CD13/100 cells
51239-2,Cells.CD13+CD33+/100 cells
512-4,Trimethoprim
51240-0,Cells.CD13+CD33+/100 cells
51241-8,Cells.CD13+CD33+HLA-DR+/100 cells
51242-6,Cells.CD13+CD33+HLA-DR+/100 cells
Mar-24,Cytomegalovirus Ab.IgG
51243-4,Cells.CD13+CD33+HLA-DR+/100 cells
51244-2,Cells.CD13+CD33+HLA-DR+/100 cells
51245-9,Cells.CD13+CD33+HLA-DR+/100 cells
51246-7,Cells.CD138/100 cells
51247-5,Cells.CD14/100 cells
51248-3,Cells.CD14/100 cells
51249-1,Cells.CD15/100 cells
5125-0,Cytomegalovirus Ab.IgG
51250-9,Cells.CD15/100 cells
51251-7,Cells.CD15/100 cells
51252-5,Cells.CD15/100 cells
51253-3,Cells.CD16+CD56+/100 cells
51254-1,Cells.CD16+CD56+/100 cells
51255-8,Cells.CD16+CD56+/100 cells
51256-6,Cells.CD16+CD57+/100 cells
51257-4,Cells.CD16+CD57+/100 cells
51258-2,Cells.CD16+CD57+/100 cells
51259-0,Cells.CD16+CD57+/100 cells
51260-8,Cells.CD16b/100 cells
51261-6,Cells.CD16b/100 cells
51262-4,Cells.CD16b/100 cells
51263-2,Cells.CD16b/100 cells
51264-0,Cells.CD19/100 cells
51265-7,Cells.CD19/100 cells
51266-5,Cells.CD23/100 cells
51267-3,Cells.CD23/100 cells
Aug-26,Cytomegalovirus Ab.IgM
51268-1,Cells.CD23/100 cells
51269-9,Cells.CD23/100 cells
51270-7,Cells.CD25/100 cells
51271-5,Cells.CD25/100 cells
51272-3,Cells.CD25+CD19+/100 cells
51273-1,Cells.CD3/100 cells
51274-9,Cells.CD3+CD16+/100 cells
51275-6,Cells.CD3+CD16+/100 cells
Jun-27,Cytomegalovirus Ab.IgM
51276-4,Cells.CD3+CD16+/100 cells
51277-2,Cells.CD3+CD16+/100 cells
51278-0,Cells.CD3+CD56+/100 cells
51279-8,Cells.CD3+CD56+/100 cells
51280-6,Cells.CD3+CD56+/100 cells
51281-4,Cells.CD3+CD56+/100 cells
51282-2,Cells.CD3+CD57+/100 cells
51283-0,Cells.CD3+CD57+/100 cells
Apr-28,Neutrophil cytoplasmic Ab
51284-8,Cells.CD3+CD57+/100 cells
51285-5,Cells.CD3+CD57+/100 cells
51286-3,Cells.CD3+CD57+/100 cells
51287-1,Cells.CD30/100 cells
51288-9,Cells.CD30/100 cells
51289-7,Cells.CD30/100 cells
51290-5,Cells.CD30/100 cells
51291-3,Cells.CD33/100 cells
Feb-29,Deoxyribonuclease Ab
51292-1,Cells.CD33/100 cells
51293-9,Cells.CD33/100 cells
51294-7,Cells.CD33/100 cells
51295-4,Cells.CD36/100 cells
51296-2,Cells.CD38/100 cells
51297-0,Cells.CD38/100 cells
51298-8,Cells.CD38/100 cells
51299-6,Cells.CD38/100 cells
Mar-51,Butirosin
5130-0,DNA double strand Ab
51300-2,Cells.CD3+CD4+/100 cells
51301-0,Cells.CD4/100 cells
51302-8,Cells.CD4+CD7-/100 cells
51303-6,Cells.CD4+CD7-/100 cells
51304-4,Cells.CD4+CD7-/100 cells
51305-1,Cells.CD4+CD7-/100 cells
51306-9,Cells.CD4+CD7-/100 cells
51307-7,Cells.CD4+CD7-CD26-/100 cells
51308-5,Cells.CD4+CD7-CD26-/100 cells
51309-3,Cells.CD4+CD7-CD26-/100 cells
51310-1,Cells.CD4+CD7-CD26-/100 cells
51311-9,Cells.CD4+CD7-CD26-/100 cells
51312-7,Cells.CD4+CD7-CD49d-/100 cells
51313-5,Cells.CD4+CD7-CD49d-/100 cells
51314-3,Cells.CD4+CD7-CD49d-/100 cells
51315-0,Cells.CD4+CD7-CD49d-/100 cells
51316-8,Cells.CD4+CD7-CD49d-/100 cells
51317-6,Cells.CD41/100 cells
Aug-31,DNA double strand Ab
51318-4,Cells.CD41/100 cells
51319-2,Cells.CD41/100 cells
513-2,Trimethoprim
51320-0,Cells.CD41/100 cells
51321-8,Cells.CD42/100 cells
51322-6,Cells.CD42/100 cells
51323-4,Cells.CD42/100 cells
51324-2,Cells.CD42/100 cells
51325-9,Cells.CD42b/100 cells
Jun-32,DNA single strand Ab
51326-7,Cells.CD42b/100 cells
51327-5,Cells.CD42b/100 cells
51328-3,Cells.CD42b/100 cells
51329-1,Cells.CD43/100 cells
51330-9,Cells.CD43/100 cells
51331-7,Cells.CD43/100 cells
51332-5,Cells.CD43/100 cells
51333-3,Cells.CD19+CD43+/100 cells
Apr-33,DNAse B Ab.Streptococcal
51334-1,Cells.CD19+CD43+/100 cells
51335-8,Cells.CD19+CD43+/100 cells
51336-6,Cells.CD19+CD43+/100 cells
51337-4,Cells.CD19+CD43+/100 cells
51338-2,Cells.CD45/100 cells
51339-0,Cells.CD45/100 cells
51340-8,Cells.CD45/100 cells
51341-6,Cells.CD5+CD19+/100 cells
Feb-34,Eastern equine encephalitis virus Ab
51342-4,Cells.CD5+CD19+/100 cells
51343-2,Cells.CD55/100 cells
51344-0,Cells.CD55/100 cells
51345-7,Cells.CD56+CD57+/100 cells
51346-5,Cells.CD56+CD57+/100 cells
51347-3,Cells.CD56+CD57+/100 cells
51348-1,Cells.CD56+CD57+/100 cells
51349-9,Cells.CD56+CD57+/100 cells
51350-7,Cells.CD57/100 cells
51351-5,Cells.CD57/100 cells
51352-3,Cells.CD19+CD58+/100 cells
51353-1,Cells.CD19+CD58+/100 cells
51354-9,Cells.CD19+CD58+/100 cells
51355-6,Cells.CD19+CD58+/100 cells
51356-4,Cells.CD19+CD58+/100 cells
51357-2,Cells.CD59/100 cells
51358-0,Cells.CD59/100 cells
Sep-35,Echinococcus sp Ab
51359-8,Cells.CD61/100 cells
51360-6,Cells.CD61/100 cells
51361-4,Cells.CD61/100 cells
51362-2,Cells.CD61/100 cells
51363-0,Cells.CD64/100 cells
51364-8,Cells.CD64/100 cells
51365-5,Cells.CD64/100 cells
51366-3,Cells.CD64/100 cells
Jul-36,Echovirus 1 Ab.Neut
51367-1,Cells.CD79a/100 cells
51368-9,Cells.CD79a/100 cells
51369-7,Cells.CD79b/100 cells
51370-5,Cells.CD8+HLA-DR+/100 cells
51371-3,Cells.CD8+HLA-DR+/100 cells
51372-1,Cells.CD8+HLA-DR+/100 cells
51373-9,Cells.CD8+HLA-DR+/100 cells
51374-7,Cells.CD9/100 cells
May-37,Echovirus 1 Ab
51375-4,Cells.CD9/100 cells
51376-2,Cells.CD9/100 cells
51377-0,Cells.CD9/100 cells
51378-8,Cells.HLA-DR+/100 cells
51379-6,Cells.HLA-DR+/100 cells
51380-4,Cells.HLA-DR+/100 cells
51381-2,Cells.HLA-DR+/100 cells
51382-0,Erythrocytes
Mar-38,Echovirus 19 Ab.Neut
51383-8,Leukocytes other
51384-6,Mononuclear cells/100 leukocytes
51385-3,Plasma cells/100 leukocytes
51386-1,Plasma cells/100 leukocytes
51387-9,(Views) + (view AP^W standing)
51388-7,Views
51389-5,Views^W Tl-201 IV
51390-3,Views AP & lateral
Jan-39,Echovirus 19 Ab
51391-1,Guidance for transjugular placement of transjugular intrahepatic portosystemic shunt
51392-9,Views
51393-7,Esophageal manometry study
51394-5,Views
51395-2,Views
51396-0,Cells.CD65w/100 cells
51397-8,Cells.CD65w/100 cells
51398-6,Cells.CD65w/100 cells
51399-4,Cells.CD65w/100 cells
514-0,Trimethoprim
51400-0,Cells.CD65w/100 cells
51401-8,Cells.CD81/100 cells
51402-6,Cells.CD81/100 cells
51403-4,Cells.CD81/100 cells
51404-2,Cells.CD81/100 cells
51405-9,Cells.CD81/100 cells
51406-7,Immunoglobulin light chains.free
51407-5,Streptococcus pneumoniae capsular polysaccharide Ab.IgG
51408-3,Streptococcus pneumoniae capsular polysaccharide Ab.IgG2
Sep-40,Echovirus 3 Ab.Neut
51409-1,Fosamprenavir+Ritonavir
51410-9,Environmental stressors panel
51411-7,Environmental stressors panel
51412-5,"3-Hydroxyisovalerylcarnitine+2-Methyl,3-Hydroxybutyrylcarnitine (C5-OH)"
51413-3,Butyrylcarnitine+Isobutyrylcarnitine (C4)
51414-1,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)
51415-8,Methylmalonylcarnitine+Succinylcarnitine (C4-DC)
51416-6,Tiglylcarnitine (C5:1)
Jul-41,Echovirus 3 Ab
51417-4,Coproporphyrin/Porphyrins.total
51418-2,Domperidone
51419-0,Sodium^^corrected for glucose
51420-8,17-Hydroxyprogesterone^pre or post XXX challenge
51421-6,Testosterone^pre or post XXX challenge
51422-4,Aldosterone^pre or post XXX challenge
51423-2,Corticotropin^pre or post XXX challenge
51424-0,Cortisol^pre or post XXX challenge
May-42,Echovirus 4 Ab.Neut
51425-7,EPINEPHrine^pre or post XXX challenge
51426-5,Glucose^pre or post XXX challenge
51427-3,Insulin^pre or post XXX challenge
51428-1,Lactate^pre or post XXX challenge
51429-9,Norepinephrine^pre or post XXX challenge
51430-7,Calcitonin^pre or post XXX challenge
51431-5,Gastrin^pre or post XXX challenge
51432-3,Prolactin^pre or post XXX challenge
Mar-43,Echovirus 4 Ab
51433-1,Renin^pre or post XXX challenge
51434-9,Somatotropin^pre or post XXX challenge
51435-6,Protein.monoclonal band 1
51436-4,Protein.monoclonal
51437-2,Protein.monoclonal band 2
51438-0,Protein.monoclonal band 2
51439-8,Protein.monoclonal band 3
51440-6,Protein.monoclonal band 3
Jan-44,Echovirus 6 Ab.Neut
51441-4,Macroprolactin/Prolactin
51442-2,Domperidone
51443-0,Cells.CD117
51444-8,Cells.CD19+CD38+
51445-5,Cells.CD41a
51446-3,Cells.CD64
51447-1,Cells.CD79a
51448-9,Dihydrocodeine+Hydrocodol
51449-7,Paragonimus sp Ab
51450-5,Paragonimus sp Ab
51451-3,Bartonella quintana Ab.IgG
51452-1,Coccidioides immitis Ab
51453-9,Coxsackievirus A9+B1+B2+B3+B4+B5+B6 Ab
51454-7,Epstein Barr virus early diffuse Ab
51455-4,Filaria Ab.IgG1
51456-2,Filaria Ab.IgG2
51457-0,Filaria Ab.IgG3
Aug-45,Echovirus 6 Ab
51458-8,Hepatitis D virus Ab.IgG
51459-6,Hepatitis E virus Ab
51460-4,Influenza virus A H16 Ab
51461-2,Listeria sp Ab
51462-0,Onchocerca sp Ab.IgG2
51463-8,Onchocerca sp Ab.IgG3
51464-6,Onchocerca sp Ab.IgG4
51465-3,Paragonimus sp Ab
Jun-46,Echovirus 9 Ab.Neut
51466-1,Parainfluenza virus 1+2+3 Ab
51467-9,Plasmodium falciparum Ab.IgG
51468-7,Plasmodium ovale Ab.IgG
51469-5,Plasmodium vivax Ab.IgG
51470-3,Satratoxin Ab.IgM
51471-1,Sporothrix schenckii Ab
51472-9,Streptococcus pneumoniae capsular polysaccharide Ab.IgG
51473-7,Streptococcus pneumoniae capsular polysaccharide Ab.IgG2
Apr-47,Echovirus 9 Ab
51474-5,Treponema pallidum Ab
51475-2,Treponema pallidum Ab
51476-0,ABCB4 gene targeted mutation analysis
51477-8,Coccidioides sp Ab.IgM
51478-6,Mucus
51479-4,Spermatozoa
51480-2,Bacteria
51481-0,Yeast
Feb-48,Echovirus NOS Ab.Neut
51482-8,Crystals
51483-6,Casts
51484-4,Hyaline casts
51485-1,Epithelial cells.non-squamous
51486-9,Epithelial cells.squamous
51487-7,Leukocytes
51488-5,Cortisol^6th specimen post XXX challenge
51489-3,Cortisol^7th specimen post XXX challenge
5149-0,Echovirus NOS Ab
51490-1,Cortisol^5th specimen post XXX challenge
51491-9,Cortisol^4th specimen post XXX challenge
51492-7,Cortisol^3rd specimen post XXX challenge
51493-5,Cortisol^2nd specimen post XXX challenge
51494-3,Cortisol^1st specimen post XXX challenge
51495-0,Cortisol^baseline
51496-8,Estradiol^4th specimen post XXX challenge
51497-6,Estradiol^5th specimen post XXX challenge
51498-4,Estradiol^3rd specimen post XXX challenge
51499-2,Estradiol^1st specimen post XXX challenge
51500-7,Estradiol^7th specimen post XXX challenge
51501-5,Estradiol^2nd specimen post XXX challenge
51502-3,Estradiol^6th specimen post XXX challenge
51503-1,Penicillin G procaine
51504-9,Penicillin G benzathine
51505-6,Creatine kinase.BB
51506-4,Creatine kinase.MB
51507-2,Creatine kinase.MM
Aug-50,Entamoeba histolytica Ab
51508-0,Lactate dehydrogenase 1/Lactate dehydrogenase.total
51509-8,Lactate dehydrogenase 1/Lactate dehydrogenase.total
51510-6,Lactate dehydrogenase 1/Lactate dehydrogenase.total
51511-4,Lactate dehydrogenase 2/Lactate dehydrogenase.total
51512-2,Lactate dehydrogenase 2/Lactate dehydrogenase.total
51513-0,Lactate dehydrogenase 2/Lactate dehydrogenase.total
51514-8,Lactate dehydrogenase 3/Lactate dehydrogenase.total
51515-5,Lactate dehydrogenase 3/Lactate dehydrogenase.total
Jun-51,Entamoeba histolytica Ab
51516-3,Lactate dehydrogenase 3/Lactate dehydrogenase.total
51517-1,Lactate dehydrogenase 4/Lactate dehydrogenase.total
51518-9,Lactate dehydrogenase 4/Lactate dehydrogenase.total
51519-7,Lactate dehydrogenase 4/Lactate dehydrogenase.total
51520-5,Lactate dehydrogenase 5/Lactate dehydrogenase.total
51521-3,Lactate dehydrogenase 5/Lactate dehydrogenase.total
51522-1,Lactate dehydrogenase 5/Lactate dehydrogenase.total
51523-9,(Cynodon dactylon+Lolium perenne+Phleum pratense+Poa pratensis+Sorghum halepense+Paspalum notatum) Ab.IgE
Apr-52,Epidermis Ab
51524-7,Betula verrucosa recombinant (rBet v) 2+4 Ab.IgE
51525-4,(Ambrosia elatior+Chenopodium album+Cynodon dactylon+Lolium perenne+Plantago lanceolata+Paspalum notatum) Ab.IgE
51526-2,(Aspergillus fumigatus+Blatella germanica+Cat dander+Dermatophagoides pteronyssinus) Ab.IgE
51527-0,(Quercus alba+Ulmus americana+Platanus acerifolia+Salix caprea+Populus deltoides) Ab.IgE
51528-8,(Citrus sinensis+Citrus limon+Citrus paradisi+Citrus reticulata) Ab.IgE
51529-6,(Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) Ab.IgE
51530-4,Lactalbumin alpha Ab.IgG
51531-2,Beta lactoglobulin Ab.IgG
Feb-53,Epstein Barr virus early Ab
51532-0,Casein Ab.IgG
51533-8,Dermatophagoides pteronyssinus Ab.IgG
51534-6,Dermatophagoides farinae Ab.IgG
51535-3,Phleum pratense Ab.IgG
51536-1,Egg white Ab.IgG
51537-9,Betula verrucosa Ab.IgG
51538-7,Cladosporium herbarum Ab.IgG
51539-5,Candida albicans Ab.IgG
5154-0,Epstein Barr virus early Ab
51540-3,Alternaria alternata Ab.IgG
51541-1,Stachybotrys chartarum Ab.IgG
51542-9,Aspergillus versicolor Ab.IgG
51543-7,Cladosporium cladosporioides Ab.IgG
51544-5,Penicillium sp Ab.IgG
51545-2,Budgerigar droppings Ab.IgG
51546-0,Chicken feather Ab.IgG
51547-8,Canary feather Ab.IgG
51548-6,Parrot feather Ab.IgG
51549-4,Pigeon feather Ab.IgG
51550-2,Mouse epithelium+Serum proteins+Urine proteins Ab.IgE.RAST class
51551-0,Chinchilla epithelium Ab.IgE.RAST class
51552-8,Fox epithelium Ab.IgE.RAST class
51553-6,Mace Ab.IgE.RAST class
51554-4,Merluccius merluccius Ab.IgE.RAST class
51555-1,Phleum pratense recombinant (rPhl p) 1 Ab.IgE.RAST class
51556-9,Phleum pratense recombinant (rPhl p) 2 Ab.IgE.RAST class
Jul-55,Epstein Barr virus nuclear Ab.IgG
51557-7,Phleum pratense native (nPhl p) 4 Ab.IgE.RAST class
51558-5,Phleum pratense recombinant (rPhl p) 6 Ab.IgE.RAST class
51559-3,Phleum pratense recombinant (rPhl p) 7 Ab.IgE.RAST class
51560-1,Phleum pratense recombinant (rPhl p) 11 Ab.IgE.RAST class
51561-9,Phleum pratense recombinant (rPhl p) 12 Ab.IgE.RAST class
51562-7,Phleum pratense recombinant (rPhl p) 1+5b Ab.IgE.RAST class
51563-5,Phleum pratense recombinant (rPhl p) 7+12 Ab.IgE.RAST class
51564-3,Phleum pratense recombinant (rPhl p) 5 Ab.IgE.RAST class
May-56,Epstein Barr virus nuclear Ab.IgG
51565-0,Ficus sp Ab.IgE.RAST class
51566-8,Amylase Ab.IgE.RAST class
51567-6,Trichosporon pullulans Ab.IgE.RAST class
51568-4,Aspergillus fumigatus recombinant (rAsp f) 1 Ab.IgE.RAST class
51569-2,Aspergillus fumigatus recombinant (rAsp f) 2 Ab.IgE.RAST class
515-7,Trimethoprim+Sulfamethoxazole
51570-0,Aspergillus fumigatus recombinant (rAsp f) 3 Ab.IgE.RAST class
51571-8,Aspergillus fumigatus recombinant (rAsp f) 4 Ab.IgE.RAST class
51572-6,Aspergillus fumigatus recombinant (rAsp f) 6 Ab.IgE.RAST class
Mar-57,Epstein Barr virus capsid Ab.IgG
51573-4,Betula verrucosa recombinant (rBet v) 1 Ab.IgE.RAST class
51574-2,Betula verrucosa recombinant (rBet v) 2 Ab.IgE.RAST class
51575-9,Betula verrucosa recombinant (rBet v) 4 Ab.IgE.RAST class
51576-7,Betula verrucosa recombinant (rBet v) 2+4 Ab.IgE.RAST class
51577-5,Elaeis guineensis Ab.IgE.RAST class
51578-3,Chlamydia trachomatis DNA
51579-1,Normoblasts/100 cells
51580-9,Macrophages/100 leukocytes
Jan-58,Epstein Barr virus capsid Ab.IgG
51581-7,Other cells/100 cells
51582-5,Anisochromasia
51583-3,Anulocytes
51584-1,Granulocytes.immature
51585-8,Other cells
51586-6,Other cells/100 leukocytes
51587-4,Plasmodium sp
51588-2,Granulocytes
51589-0,Dyserythropoiesis
51590-8,Chloride
51591-6,Cholesterol
51592-4,Creatinine
51593-2,Fructose
51594-0,Galactose
51595-7,Glucose
51596-5,Glucose
51597-3,Glucose^1H post 75 g glucose PO
51598-1,Lactose
Sep-59,Epstein Barr virus capsid Ab.IgM
51599-9,Methotrexate^12H post dose
51600-5,Methotrexate^24H post dose
51601-3,Methotrexate^4H post dose
51602-1,Methotrexate^72H post dose
51603-9,Cytochrome b5 reductase
51604-7,Phosphate
51605-4,Triglyceride
51606-2,Xylose^3H post dose xylose PO
Jul-60,Epstein Barr virus capsid Ab.IgM
51607-0,Xylose^3H post XXX challenge
51608-8,Xylose^30M post dose xylose PO
51609-6,Xylose^30M post XXX challenge
51610-4,Calcium
51611-2,Methotrexate^48H post dose
51612-0,Sucrose
51613-8,Hemoglobin J/Hemoglobin.total
51614-6,Hemoglobin M/Hemoglobin.total
May-61,Erythrocyte Ab
51615-3,Hemoglobin A2+C/Hemoglobin.total
51616-1,Hemoglobin A2+E/Hemoglobin.total
51617-9,Color
51618-7,Potassium^pre dialysis
51619-5,Creatinine^pre dialysis
51620-3,Creatinine^post dialysis
51621-1,Macrophages/100 leukocytes
51622-9,Mesothelial cells/100 leukocytes
Mar-62,Fasciola hepatica Ab
51623-7,Spermatozoa^post vasectomy
51624-5,Malignant cells/100 cells
51625-2,Malignant cells/100 cells
51626-0,Coagulation tissue factor induced.factor substitution^after addition of 1:4 normal plasma 1H post incubation separate tubes
51627-8,Lymphocytes
51628-6,Morphology
51629-4,Macroblasts/100 cells
51630-2,Schistocytes/1000 erythrocytes
Jan-63,Fasciola sp Ab
51631-0,Platelet distribution width
51632-8,Platelets.reticulated
51633-6,Platelets.reticulated/100 platelets
51634-4,Reticulocytes.mid
51635-1,Reticulocytes.mature
51636-9,Reticulocytes.immature
51637-7,Plateletcrit
51638-5,Erythrocyte aggregates
51639-3,Acanthocytes/1000 erythrocytes
51640-1,Platelet anisocytosis
51641-9,Mean sphered cell volume
51642-7,Reticulocytes.high light scatter/Reticulocytes.total
51643-5,Reticulocytes.high light scatter
51644-3,Megakaryocytic nuclei
51645-0,Micromegakaryocytes
51646-8,Rabies virus RNA
51647-6,Rabies virus RNA
51648-4,Monocytoid cells/100 leukocytes
Sep-64,Fc fragment Ab
51649-2,Hepatitis C virus c100p+5-1-1 Ab
516-5,Trimethoprim+Sulfamethoxazole
51650-0,HLA-B
51651-8,IgE Ab
51652-6,SLC14A1 gene targeted mutation analysis
51653-4,Hepatitis E virus Ab
51654-2,Hepatitis D virus Ab
51655-9,Hepatitis C virus RNA
Jun-65,Filaria Ab
51656-7,Hepatitis C virus Ab Signal/Cutoff
51657-5,Hepatitis C virus Ab
51658-3,Hepatitis B virus core Ab.IgM
51659-1,Hepatitis B virus surface Ag
51660-9,Hepatitis A virus Ab.IgM
51661-7,Hepatitis A virus Ab
51662-5,Core respiratory allergens panel
51663-3,Alphavirus RNA
Apr-66,Francisella tularensis Ab
51664-1,Chikungunya virus RNA
51665-8,Flavivirus RNA
51666-6,Japanese encephalitis virus RNA
51667-4,Lymphocytic choriomeningitis virus RNA
51668-2,Streptococcus pneumoniae DNA & Haemophilus influenza DNA & Pseudomonas aeruginosa DNA
51669-0,Parechovirus A RNA
51670-8,17-Hydroxypregnenolone^baseline
51671-6,Brucella sp Ab
Feb-67,Francisella tularensis Ab
51672-4,17-Hydroxypregnenolone^4th specimen post XXX challenge
51673-2,17-Hydroxypregnenolone^5th specimen post XXX challenge
51674-0,17-Hydroxypregnenolone^6th specimen post XXX challenge
51675-7,17-Hydroxypregnenolone^7th specimen post XXX challenge
51676-5,17-Hydroxypregnenolone^2nd specimen post XXX challenge
51677-3,17-Hydroxypregnenolone^1st specimen post XXX challenge
51678-1,17-Hydroxypregnenolone^3rd specimen post XXX challenge
51679-9,17-Hydroxyprogesterone^6th specimen post XXX challenge
5168-0,Gall canaliculi Ab
51680-7,17-Hydroxyprogesterone^1st specimen post XXX challenge
51681-5,17-Hydroxyprogesterone^7th specimen post XXX challenge
51682-3,Pregnenolone^3rd specimen post XXX challenge
51683-1,Pregnenolone^baseline
51684-9,Pregnenolone^6th specimen post XXX challenge
51685-6,Pregnenolone^1st specimen post XXX challenge
51686-4,Pregnenolone^2nd specimen post XXX challenge
51687-2,Pregnenolone^7th specimen post XXX challenge
51688-0,Pregnenolone^4th specimen post XXX challenge
51689-8,Pregnenolone^5th specimen post XXX challenge
51690-6,Amphetamines
51691-4,Opiates
51692-2,Phencyclidine
51693-0,Albumin
51694-8,Carumonam
51695-5,Chloride
51696-3,Corticotropin^afternoon specimen
51697-1,CV2 Ab
Aug-69,Giardia lamblia Ab
51698-9,Dapsone
51699-7,Endomysium Ab.IgG
51700-3,Microscopic observation
51701-1,Ganglioside Ab.IgG
51702-9,Ganglioside Ab.IgM
51703-7,Ganglioside GM1 Ab.IgM
51704-5,Herpes virus 6 Ab
51705-2,Homogentisate
Jun-70,Gliadin Ab.IgG
51706-0,Hyaluronate
51707-8,Inner Ear 68kD Ab
51708-6,Intercellular substance Ab
51709-4,Leishmania sp identified
51710-2,Leishmania sp identified
51711-0,Leishmania sp Ab
51712-8,Ma+Ta Ab
51713-6,Metamyelocytes/100 leukocytes
Apr-71,Neutrophil Ab
51714-4,Microscopic observation
51715-1,Mitochondria M2 Ab
51716-9,Muscle specific receptor tyrosine kinase Ab
51717-7,Normoblasts.orthochromic/100 cells
51718-5,Normoblasts.polychromatophilic/100 cells
51719-3,Paromomycin
51720-1,Potassium
51721-9,Purkinje cells Ab
Feb-72,Streptococcus pyogenes enzyme Ab
51722-7,Reticulin Ab
51723-5,Fungus
51724-3,Cefuroxime
51725-0,Establishment registration
51726-8,NDC labeler code request
51727-6,Inactive ingredient section
51728-4,Platelet aggregation.adenosine diphosphate induced^10 umol/L
51729-2,Ganglioside GM1 Ab.IgG
517-3,Trimethoprim+Sulfamethoxazole
5173-0,Streptococcus pyogenes enzyme Ab
51730-0,Herpes virus 6 Ab.IgG & IgM
51731-8,Oxygen saturation
51732-6,Oxygen saturation
51733-4,Oxygen saturation
51734-2,Chlamydia trachomatis L2 Ab.IgA & IgG & IgM
51735-9,Urea nitrogen renal clearance
51736-7,oxyMORphone.free
51737-5,HYDROmorphone.free
51738-3,HYDROcodone.free
51739-1,Codeine.free
51740-9,6-Monoacetylmorphine.free
51741-7,Blastomyces dermatitidis Ab
51742-5,Borrelia burgdorferi 49736 Ab.IgM
51743-3,Borrelia burgdorferi 49736 Ab.IgG
51744-1,Borrelia burgdorferi 49736 Ab.IgA
51745-8,Borrelia burgdorferi G39_40 Ab.IgG
51746-6,Borrelia burgdorferi 49736 Ab.IgG
51747-4,Borrelia burgdorferi Ab.IgA & IgG & IgM
Aug-74,Helicobacter pylori Ab
51748-2,Purkinje cell cytoplasmic type Tr Ab
51749-0,Jo-1 extractable nuclear Ab
51750-8,Pyruvate
51751-6,Pyruvate
51752-4,Heptaporphyrin/Creatinine
51753-2,Histoplasma capsulatum Ag
51754-0,Histoplasma capsulatum Ag
May-75,Helicobacter pylori Ab
51755-7,Cells.CD3+CD4-CD8-CD45+/100 cells
51756-5,ATP7B gene targeted mutation analysis
51757-3,POMT1 gene targeted mutation analysis
51758-1,POMT2 gene targeted mutation analysis
51759-9,RAI1 gene targeted mutation analysis
51760-7,Ehrlichia chaffeensis Ab.IgG+IgM
51761-5,Giardia lamblia Ab.IgA & IgG & IgM
51762-3,Helicobacter pylori Ab.IgA & IgG & IgM
Mar-76,Helicobacter pylori Ab.IgG
51763-1,Muscle specific receptor tyrosine kinase Ab
51764-9,Trypanosoma cruzi Ab.IgG & IgM
51765-6,Dihydrocodeine+Hydrocodol
51766-4,Glucose^2.5H post dose fructose PO
51767-2,Glucose^1.5H post dose fructose PO
51768-0,Glucose^3H post dose fructose PO
51769-8,Glucose^2H post dose fructose PO
51770-6,Leukocytes
Jan-77,Helicobacter pylori Ab.IgM
51771-4,Histoplasma capsulatum DNA
51772-2,F9 gene mutations tested for
51773-0,HEXA gene targeted mutation analysis
51774-8,Cefuroxime
51775-5,Chromatin Ab
51776-3,7-Aminoclonazepam
51777-1,7-Aminoflunitrazepam
51778-9,YY1 gene targeted mutation analysis
51779-7,CFH gene targeted mutation analysis
51780-5,HIV 1 RNA
51781-3,Carbon dioxide
51782-1,Drugs of abuse 7 & Alcohol & Tricyclics panel
51783-9,Reagin Ab
51784-7,Lot number
51785-4,Dengue virus Ab.IgG & IgM
51786-2,HIV 2 Ab Signal/Cutoff
51787-0,Blastomyces dermatitidis Ab
51788-8,Coccidioides sp Ab
Sep-78,Haemophilus influenzae Ab
51789-6,Histoplasma capsulatum mycelial phase Ab
51790-4,Erythrocyte casts
51791-2,Tetrahydrocannabinol
51792-0,Citrate/Creatinine
51793-8,Xylose^1H post 5 g xylose PO
51794-6,Mitochondria M2 Ab
51795-3,Complement C1 esterase inhibitor bound Ab
51796-1,Purkinje cell cytoplasmic type Tr Ab
Jul-79,Hepatitis A virus Ab.IgG
51797-9,CV2 Ab
51798-7,Hepatitis E virus Ab.IgM
51799-5,Adenosine deaminase
51800-1,Homogentisate
51801-9,Myeloperoxidase Ab
51802-7,Phosphatidylserine Ab.IgM
51803-5,Fibrillarin Ab
51804-3,Rickettsia conorii Ab.IgG
May-80,Hepatitis A virus Ab.IgG
51805-0,Rickettsia conorii Ab.IgM
51806-8,Chlamydophila pneumoniae Ab.IgG
51807-6,Chlamydophila pneumoniae Ab.IgM
51808-4,Chlamydophila psittaci Ab.IgG
51809-2,Chlamydophila psittaci Ab.IgM
518-1,Trimethoprim+Sulfamethoxazole
51810-0,Coxiella burnetii phase 1 Ab.IgG
51811-8,Coxiella burnetii phase 1 Ab.IgM
51812-6,Coxiella burnetii phase 2 Ab.IgG
Mar-81,Hepatitis A virus Ab.IgM
51813-4,Coxiella burnetii phase 2 Ab.IgM
51814-2,Legionella pneumophila Ab.IgM
51815-9,Leptospira sp Ab.IgG
51816-7,Bartonella quintana Ab.IgG
51817-5,Coxsackievirus B Ab.IgG
51818-3,Coxsackievirus B Ab.IgM
51819-1,Leptospira sp Ab.IgM
51820-9,Listeria monocytogenes Ab.IgG
Jan-82,Hepatitis A virus Ab.IgM
51821-7,Bartonella quintana Ab.IgM
51822-5,Adenovirus Ab.IgG
51823-3,Adenovirus Ab.IgM
51824-1,Hepatitis C virus Ab.IgM
51825-8,Bordetella parapertussis Ab
51826-6,Herpes virus 8 Ab.IgG
51827-4,Trypanosoma cruzi Ab.IgM
51828-2,(Clupea harengus+Gadus morhua+Pleuronectes platessa+Scomber scombrus) Ab.IgE
51829-0,Lactate
51830-8,Prolymphocytes/100 leukocytes
51831-6,Beta-2 transferrin
51832-4,Brucella abortus Ab
51833-2,14-3-3 protein
51834-0,Tryptase
51835-7,Angiotensin converting enzyme
51836-5,Angiotensin II^upright
51837-3,Bordetella parapertussis Ab.IgG
51838-1,Treponema pallidum Ab.IgG
Sep-83,Hepatitis A virus Ab
51839-9,Treponema pallidum Ab.IgM
51840-7,Echovirus Ab.IgG
51841-5,Echovirus Ab.IgM
51842-3,Plasmodium falciparum Ab.IgM
51843-1,Malonate/Creatinine
51844-9,Cortisol
51845-6,Consultation note
51846-4,Consultation note
Jul-84,Hepatitis A virus Ab
51847-2,Evaluation+Plan note
51848-0,Evaluation note
51849-8,Admission history and physical note
51850-6,Physical findings
51851-4,Administrative note
51852-2,Letter
51853-0,Consultation note
Apr-85,Hepatitis B virus core Ab.IgM
51854-8,Consultation note
51855-5,Note
51856-3,Staphylococcus aureus TSST-1 Ab.IgE
51857-1,Malassezia sp Ab.IgE
51858-9,Budgerigar serum proteins+feathers+droppings Ab.IgG
51859-7,Pigeon serum proteins+feathers+droppings Ab.IgG
51860-5,Parrot serum proteins+feathers+droppings Ab.IgG
51861-3,(Alternaria alternata+Cladosporium herbarum+Mucor racemosus+Penicillium notatum) Ab.IgG
Feb-86,Hepatitis B virus core Ab.IgM
51862-1,(Saccharopolyspora rectivirgula+Thermoactinomyces vulgaris) Ab.IgG
51863-9,Staphylococcus aureus TSST-1 Ab.IgE.RAST class
51864-7,Malassezia sp Ab.IgE.RAST class
51865-4,Plasmodium sp Ag
51866-2,HIV 1 Ab+Ag
51867-0,"t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript"
51868-8,Coagulation thrombin induced.factor substitution^immediately after addition of XXX
51869-6,Washed packed erythrocytes given
5187-0,Hepatitis B virus core Ab
51870-4,Frozen erythrocytes given
51871-2,Direct antiglobulin test.polyspecific reagent
51872-0,Transfuse platelet concentrate units
51873-8,Platelet concentrate units given
51874-6,Varicella zoster virus immune globulin ordered
51875-3,Varicella zoster virus immune globulin units given
51876-1,Whole blood units given
51877-9,Transfuse fresh frozen plasma units
51878-7,Fresh frozen plasma units given
51879-5,Transfuse packed erythrocytes units
51880-3,Packed erythrocytes units given
51881-1,Transfuse cryoprecipitate units
51882-9,Cryoprecipitate units given
51883-7,Transfuse whole blood units
51884-5,Transfuse pooled platelets units
51885-2,Transfuse whole blood autologous units
51886-0,Autologous whole blood units given
51887-8,Transfuse Rh immune globulin units
Aug-88,Hepatitis B virus core Ab
51888-6,Rh immune globulin units given
51889-4,Transfuse factor VIII units
51890-2,Factor VIII units given
51891-0,Transfuse factor IX units
51892-8,ABO group
51893-6,Transfuse cryoprecipitate poor plasma units
51894-4,Fresh frozen plasma given
51895-1,Lot number
Jun-89,Hepatitis B virus little e Ab
51896-9,Healthcare associated infection report - recommended CDA R2 sections
51897-7,Healthcare Associated Infection report
51898-5,Risk factors
51899-3,Details
51900-9,Population summary report
51901-7,Avena sativa Ab.IgG
51902-5,Cadmium
51903-3,Chromium
Apr-90,Hepatitis B virus little e Ab
51904-1,Citrus sinensis Ab.IgG
51905-8,Collection end time
51906-6,Collection start time
51907-4,Efavirenz^trough
51908-2,Efavirenz^peak
51909-0,Ependymal cells/100 cells
51910-8,Erythrocytes
51911-6,Giardia lamblia+Cryptosporidium sp Ag^3rd specimen
Feb-91,Hepatitis B virus little e Ag
51912-4,Giardia lamblia+Cryptosporidium sp Ag^2nd specimen
51913-2,Hepatitis A virus Ab.IgG+IgM
51914-0,Hepatitis B virus core Ab.IgG+IgM
51915-7,Herpes simplex virus Ab.IgG
51916-5,Herpes simplex virus 1 Ab.IgG
51917-3,Hordeum vulgare Ab.IgG
51918-1,Indinavir^trough
51919-9,Lactuca sativa Ab.IgG
5192-0,Hepatitis B virus little e Ag
51920-7,Legionella sp Ab^2nd specimen
51921-5,Lopinavir^trough
51922-3,Malt Ab.IgG
51923-1,Nelfinavir^peak
51924-9,Neutrophil cytoplasmic Ab
51925-6,Nevirapine^peak
51926-4,Nucleated cells
51927-2,Other cells/100 leukocytes
51928-0,Ribonucleoprotein extractable nuclear Ab
51929-8,Ritonavir^peak
51930-6,Ritonavir^trough
51931-4,Rubella virus Ab
51932-2,Saquinavir^trough
51933-0,Secale cereale Ab.IgG
51934-8,Spermatozoa.slow/100 spermatozoa ^1H post ejaculation
51935-5,Trypsinogen I.free
51936-3,Yeast bakers Ab.IgG
51937-1,HLA-A+B+Bw+DR
Aug-93,Hepatitis B virus surface Ab
51938-9,HLA-A+B+Bw+DR
51939-7,Escherichia coli shiga-like toxin 2
51940-5,Escherichia coli shiga-like toxin 1
51941-3,Package label.Back panel
51942-1,Package label.Side panel.right
51943-9,Package label.Side panel.left
51944-7,Package label.Side panel
51945-4,Package label.Principal display panel
Jun-94,Hepatitis B virus surface Ab
51946-2,Package label.Top panel
51947-0,Package label.Bottom panel
51948-8,Package label.Flap panel
51949-6,History of trisomy 21
51950-4,Calcium^post dialysis
51951-2,UGT1A1 gene allele 1
51952-0,UGT1A1 gene allele 2
Mar-95,Hepatitis B virus surface Ag
51953-8,Collection date
51954-6,oxyCODONE.free
51955-3,Dihydrocodeine.free+Hydrocodol.free
51956-1,DNA region analysis test coverage panel
51957-9,Placer DNA analysis test identifier
51958-7,Transcript reference sequence identifier
51959-5,DNA region of interest
51960-3,DNA marker results panel
Jan-96,Hepatitis B virus surface Ag
51961-1,Drug efficacy sequence variation interpretation
51962-9,Pharmacogenetic DNA analysis panel
51963-7,Medication assessed
51964-5,Drug efficacy analysis overall interpretation
51965-2,Pharmacogenetic analysis report
51966-0,Genetic disease DNA analysis panel
51967-8,Genetic disease assessed
51968-6,Genetic disease analysis overall interpretation
51969-4,Genetic analysis summary report
51970-2,Individual allele identifier
51971-0,Gene product metabolic activity interpretation
51972-8,Gas panel
51973-6,Gas panel
51974-4,Gas panel
51975-1,Individual allele results panel
51976-9,Bacillus anthracis capsule Ag
51977-7,Chromium
51978-5,Coxsackievirus A Ab
Sep-97,Hepatitis B virus surface Ag
51979-3,Donepezil
51980-1,Glomerular basement membrane Ab
51981-9,HER2
51982-7,lamoTRIgine
51983-5,Levodopa
51984-3,Meperidine+Normeperidine
51985-0,Modafinil
51986-8,niCARdipine
Jul-98,Hepatitis C virus Ab
51987-6,Ubiquinone 10
51988-4,Ureaplasma urealyticum DNA
51989-2,Vasoactive intestinal peptide
519-9,Troleandomycin
51990-0,Basic metabolic panel
51991-8,Referral lab test panel
51992-6,Heavy metals panel
51993-4,Metanephrine & Normetanephrine panel
51994-2,Homovanillate/Creatinine
May-99,Hepatitis C virus Ab
51995-9,Rationale for type of transport
51996-7,Distance and time transported information
51997-5,Distance transported - loaded indicator
51998-3,Rationale for excess or additional mileage
51999-1,Time ambulance arrived at scene
52000-7,Origination site latitude
Jan-00,Hepatitis D virus Ab
52001-5,Origination site longitude
52002-3,Destination site latitude
52003-1,Destination site longitude
52004-9,Rationale for wait time
52005-6,Rationale for wait time
52006-4,Rationale for wait time
52007-2,Number of patients
52008-0,Reason for multiple patients
52009-8,Other patients information
52010-6,Other patient name
52011-4,Other patient identifier
52012-2,Receiving individual accepting responsibility for patient
52013-0,Receiving individual accepting responsibility for patient
52014-8,Receiving individual accepting responsibility for patient
52015-5,Ordering practitioner or agency
52016-3,Physician certification for transport information
52017-1,Physician certification for transport statement
52018-9,Physician certification for transport indicator
Sep-01,Hepatitis D virus Ab
52019-7,Description of services performed to support level of service
52020-5,Medical reason for unscheduled trip
52021-3,Justification for extra attendants
52022-1,Type of extra attendant(s)
52023-9,Origination site name and address
52024-7,Rationale for choice of destination
52025-4,Confined to bed or chair^at ambulance transport
52026-2,Destination site name & address
Jul-02,Herpes simplex virus Ab
52027-0,Abortion consent
52028-8,Hysterectomy consent
52029-6,Sterilization consent
52030-4,Explanation of benefits attachment
52031-2,Explanation of benefits to subscriber attachment
52032-0,Appeal denial letter attachment
52033-8,General correspondence attachment
52034-6,Payer letter attachment
May-03,Herpes simplex virus Ab
52035-3,Home health claims attachment
52036-1,Home health prior authorization attachment
52037-9,Member ID card copy attachment
52038-7,Subscriber Information including retroactive and presumptive eligibility attachment
52039-5,Skilled Nursing Facility record attachment
52040-3,Dental X-rays and other images (not DICOM) attachment
52041-1,Blood glucose monitors attachment
52042-9,Continuous positive airway pressure attachment
Mar-04,Herpes simplex virus Ab
52043-7,Enteral nutrition attachment
52044-5,External infusion pump attachment
52045-2,Gait trainers attachment
52046-0,Hospital beds attachment
52047-8,Immunosuppressive drugs attachment
52048-6,Lymphedema pumps attachment
52049-4,Manual wheelchair attachment
5205-0,Herpes simplex virus 1 Ab
52050-2,Motorized wheelchair attachment
52051-0,Orthotics + prosthetics attachment
52052-8,Osteogenesis stimulators attachment
52053-6,Oxygen attachment
52054-4,Parenteral attachment
52055-1,Power operated vehicles attachment
52056-9,Repair of durable medical equipment attachment
52057-7,Seat lift mechanism attachment
52058-5,Seating systems attachment
52059-3,Speech generating device attachment
52060-1,Standers + standing frames attachment
52061-9,Support surfaces attachment
52062-7,Transcutaneous electrical neural stimulation attachment
52063-5,Prescription for durable medical equipment attachment
52064-3,First report of injury attachment
52065-0,Automobile liability attachment
52066-8,Notice of Discharge Medicare Appeal Rights Form attachment
52067-6,Past filing limit justification attachment
Aug-06,Herpes simplex virus 1 Ab.IgG
52068-4,Property and casualty state mandated forms attachment
52069-2,Tax ID number - IRS form W9 attachment
520-7,Troleandomycin
52070-0,Workers compensation attachment
52071-8,Employee assistance program attachment
52072-6,Non-emergency transportation attachment
52073-4,Vision attachment
52074-2,Extra attendants information
52075-9,Purchase invoice attachment
Jun-07,Herpes simplex virus 1 Ab.IgM
52076-7,Date range
52077-5,Date range
52078-3,Referral information
52079-1,Referral information
52080-9,Referring person name
52081-7,Referring person identifier
52082-5,Date patient referred for treatment
52083-3,Communication to referring physician indicator
Apr-08,Herpes simplex virus 2 Ab
52084-1,Responsible attending physician information
52085-8,Responsible rehabilitation professional information
52086-6,Medication rate
52087-4,Medication timing
52088-2,Date range certifying the plan of care
52089-0,Physician certification statement
52090-8,Actual start of care date
52091-6,Past medical history
Feb-09,Herpes simplex virus 2 Ab.IgG
52092-4,Level of function
52093-2,Prior level of function
52094-0,Current level of function
52095-7,Assessment information
52096-5,Assessment
52097-3,Assessment indicator
52098-1,Treatment encounter
52099-9,Progress note+attainment of goals
Jan-52,Butirosin
5210-0,Herpes simplex virus 2 Ab.IgM
52100-5,Progress note+attainment of goals date range
52101-3,Chief complaint+Reason for relapse if known
52102-1,Past treatment attempts
52103-9,Follow-up approach
52104-7,Level of patient participation
52105-4,Next plan of treatment
52106-2,Date range of next planned treatment
52107-0,Bacterial capsule
52108-8,C little o super little b Ab
52109-6,C little o super little a Ab
52110-4,Blood product unit 4 expiration
52111-2,Blood product unit 3 expiration
52112-0,Blood product unit 2 expiration
52113-8,Blood product unit 1 expiration
52114-6,Direct antiglobulin test.IgG specific reagent
52115-3,D Ab
52116-1,Date blood product unit received
52117-9,B little x Ab
Aug-11,Herpes virus 6 Ab.IgG
52118-7,Pooled platelets units available
52119-5,Apheresis available
52120-3,Coagulation tissue factor induced.factor substitution^after addition of normal plasma 1H post incubation separate tubes
52121-1,Biopsy
52122-9,Coagulation tissue factor induced^post heparin neutralization
52123-7,Coagulation surface induced^post heparin neutralization
52124-5,Osmotic fragility^0.90% sodium chloride
52125-2,Osmotic fragility^0.90% sodium chloride 24H 37 deg C incubation
Jun-12,Herpes virus 6 Ab.IgM
52126-0,Acid glycerol lysis
52127-8,Megaloblasts/100 cells
52128-6,Cefotaxime
52129-4,Coagulation tissue factor induced.INR^post heparin neutralization
52130-2,"t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript/control transcript"
52131-0,"t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript/control transcript"
52132-8,"t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript"
52133-6,Coagulation dilute Russell viper venom induced.factor substitution^immediately after 4:1 addition of normal plasma
Apr-13,Heterophile Ab
52134-4,Coagulation surface induced.lupus sensitive.factor substitution^immediately after 4:1 addition of normal plasma
52135-1,"t(9;22)(q34.1;q11)(ABL1,BCR) transcript detection panel"
52136-9,New &or revised
52137-7,Diagnosis.primary
52138-5,Diagnosis.primary
52139-3,Date.onset or exacerbation
52140-1,Date range
52141-9,Visit frequency
Feb-14,Heterophile Ab
52142-7,Diagnosis.addressed by plan
52143-5,Author of treatment plan
52144-3,Author name
52145-0,Author ID
52146-8,Author profession
52147-6,Date range
52148-4,Continuation status
52149-2,Referral information
521-5,Troleandomycin
52150-0,Referral information
52151-8,Referring person name
52152-6,Referring person identifier
52153-4,Date patient referred for treatment
52154-2,Responsible attending physician information
52155-9,Signature of responsible attending physician on file
52156-7,Date attending MD signed
52157-5,Responsible rehabilitation professional information
52158-3,Signature of responsible rehabilitation professional on file
Sep-15,Heterophile Ab
52159-1,Date rehabilitation professional signed
52160-9,Medication administered
52161-7,Medication name + ID
52162-5,Medication XXX
52163-3,Medication rate
52164-1,Medication timing
52165-8,Medication route
52166-6,Prognosis for rehabilitation
Jul-16,Heterophile Ab after absorption
52167-4,Date range certifying the plan of care
52168-2,Physician certification statement
52169-0,Actual start of care date
52170-8,Past medical history
52171-6,Level of function
52172-4,Prior level of function
52173-2,Current level of function
52174-0,Assessment information
May-17,Histone Ab
52175-7,Assessment
52176-5,Assessment indicator
52177-3,Plan of treatment
52178-1,Treatment encounter
52179-9,Progress note+attainment of goals
52180-7,Progress note+attainment of goals
52181-5,Progress note+attainment of goals date range
52182-3,Reason to continue
Mar-18,Histoplasma capsulatum Ab
52183-1,Justification
52184-9,Rehabilitation.pulmonary therapy service attachment
52185-6,Functional status
52186-4,Activities permitted
52187-2,Mental status
52188-0,Additional assessment
52189-8,Date range
52190-6,Date range
Jan-19,Histoplasma capsulatum Ab
52191-4,Referral information
52192-2,Referral information
52193-0,Referring person name
52194-8,Referring person identifier
52195-5,Date patient referred for treatment
52196-3,Responsible attending physician information
52197-1,Responsible rehabilitation professional information
52198-9,Medication rate
52199-7,Medication timing
52200-3,Date range certifying the plan of care
52201-1,Physician certification statement
52202-9,Actual start of care date
52203-7,Past medical history
52204-5,Level of function
52205-2,Prior level of function
52206-0,Current level of function
52207-8,Assessment information
52208-6,Assessment indicator
Sep-20,HIV 1 Ab
52209-4,Functional status
52210-2,Activities permitted
52211-0,Mental status
52212-8,Additional assessment
52213-6,Treatment encounter
52214-4,Progress note+attainment of goals
52215-1,Progress note+attainment of goals date range
52216-9,Date range
Jul-21,HIV 1 Ab
52217-7,Date range
52218-5,Referral information
52219-3,Referral information
52220-1,Referring person name
52221-9,Referring person identifier
52222-7,Date patient referred for treatment
52223-5,Responsible attending physician information
52224-3,Responsible rehabilitation professional information
May-22,HIV 1 Ag
52225-0,Medication rate
52226-8,Medication timing
52227-6,Date range certifying the plan of care
52228-4,Physician certification statement
52229-2,Actual start of care date
522-3,Troleandomycin
52230-0,Past medical history
52231-8,Level of function
52232-6,Prior level of function
Mar-23,HIV 1+2 Ab
52233-4,Current level of function
52234-2,Assessment information
52235-9,Assessment indicator
52236-7,Functional status
52237-5,Activities permitted
52238-3,Mental status
52239-1,Additional assessment
52240-9,Treatment encounter
Jan-24,HIV 2 Ab
52241-7,Progress note+attainment of goals
52242-5,Progress note+attainment of goals date range
52243-3,Date range
52244-1,Referral information
52245-8,Referral information
52246-6,Referring person name
52247-4,Referring person identifier
52248-2,Responsible attending physicican information
52249-0,Responsible rehabilitation professional information
52250-8,Medication timing
52251-6,Date range certifying the plan of care
52252-4,Physician certification statement
52253-2,Actual start of care date
52254-0,Past medical history
52255-7,Level of function
52256-5,Prior level of function
52257-3,Current level of function
Aug-25,HIV 2 Ab
52258-1,Assessment information
52259-9,Assessment indicator
52260-7,Functional status
52261-5,Activities permitted
52262-3,Mental status
52263-1,Additional assessment
52264-9,Treatment encounter
52265-6,Individual education plan information
Jun-26,HTLV I+II Ab
52266-4,Defined school year
52267-2,Individual education plan
52268-0,Progress note+attainment of goals date range
52269-8,Date patient referred for treatment
52270-6,Medication rate
52271-4,Date range
52272-2,Date range
52273-0,Referral information
Apr-27,Streptococcal hyaluronidase Ab
52274-8,Referral information
52275-5,Referring person name
52276-3,Referring person identifier
52277-1,Date patient referred for treatment
52278-9,Responsible attending physician information
52279-7,Responsible rehabilitation professional information
52280-5,Medication rate
52281-3,Medication timing
Feb-28,Immune complex
52282-1,Date range certifying the plan of care
52283-9,Physician certification statement
52284-7,Actual start of care date
52285-4,Past medical history
52286-2,Level of function
52287-0,Prior level of function
52288-8,Current level of function
52289-6,Assessment information
5229-0,Influenza virus A Ab
52290-4,Assessment indicator
52291-2,Functional status
52292-0,Activities permitted
52293-8,Mental status
52294-6,Additional assessment
52295-3,Treatment encounter
52296-1,Individual education plan information
52297-9,Defined school year
52298-7,Individual education plan
52299-5,Progress note+attainment of goals
52300-1,Progress note+attainment of goals date range
52301-9,Date range
52302-7,Diagnosis.addressed by plan
52303-5,Date range
52304-3,Referral information
52305-0,Referral information
52306-8,Referring person name
52307-6,Referring person identifier
Aug-30,Influenza virus B Ab
52308-4,Date patient referred for treatment
52309-2,Communication to referring physician indicator
523-1,Vancomycin
52310-0,Responsible attending physician information
52311-8,Responsible rehabilitation professional information
52312-6,Medication name + ID
52313-4,Medication XXX
52314-2,Medication rate
52315-9,Medication timing
Jun-31,Influenza virus C Ab
52316-7,Date range certifying the plan of care
52317-5,Physician certification statement
52318-3,Actual start of care date
52319-1,Past medical history
52320-9,Level of function
52321-7,Prior level of function
52322-5,Current level of function
52323-3,Assessment information
Apr-32,Insulin Ab
52324-1,Assessment indicator
52325-8,Functional status
52326-6,Activities permitted
52327-4,Mental status
52328-2,Additional assessment
52329-0,Treatment encounter
52330-8,Past treatment attempts
52331-6,Progress note+attainment of goals
Feb-33,Intrinsic factor Ab
52332-4,Progress note+attainment of goals date range
52333-2,Date range
52334-0,Date range
52335-7,Referral information
52336-5,Referral information
52337-3,Referring person name
52338-1,Referring person identifier
52339-9,Date patient referred for treatment
5234-0,Jo-1 extractable nuclear Ab
52340-7,Responsible attending physician information
52341-5,Responsible rehabilitation professional information
52342-3,Medication rate
52343-1,Medication timing
52344-9,Date range certifying the plan of care
52345-6,Physician certification statement
52346-4,Actual start of care date
52347-2,Level of function
52348-0,Prior level of function
52349-8,Current level of function
52350-6,Assessment information
52351-4,Assessment indicator
52352-2,Assessment
52353-0,Treatment encounter
52354-8,Progress note+attainment of goals
52355-5,Progress note+attainment of goals date range
52356-3,Date range
Jul-35,Jo-1 extractable nuclear Ab
52357-1,Date range
52358-9,Referral information
52359-7,Referral information
52360-5,Referring person name
52361-3,Referring person identifier
52362-1,Date patient referred for treatment
52363-9,Responsible attending physician information
52364-7,Responsible rehabilitation professional information
May-36,Legionella pneumophila Ab
52365-4,Medication rate
52366-2,Medication timing
52367-0,Date range certifying the plan of care
52368-8,Physician certification statement
52369-6,Actual start of care date
52370-4,Past medical history
52371-2,Level of function
52372-0,Prior level of function
Mar-37,Legionella pneumophila Ab
52373-8,Current level of function
52374-6,Assessment information
52375-3,Assessment indicator
52376-1,Functional status
52377-9,Activities permitted
52378-7,Mental status
52379-5,Additional assessment
52380-3,Treatment encounter
Jan-38,Leishmania sp Ab
52381-1,Progress note+attainment of goals date range
52382-9,Progress note+attainment of goals
52383-7,Date range
52384-5,Date range
52385-2,Referral information
52386-0,Referral information
52387-8,Referring person name
52388-6,Referring person identifier
52389-4,Date patient referred for treatment
52390-2,Responsible attending physician information
52391-0,Responsible rehabilitation professional information
52392-8,Medication rate
52393-6,Medication timing
52394-4,Date range certifying the plan of care
52395-1,Physician certification statement
52396-9,Actual start of care date
52397-7,Past medical history
52398-5,Level of function
Sep-39,Leptospira sp Ab
52399-3,Prior level of function
52400-9,Current level of function
52401-7,Assessment indicator
52402-5,Functional status
52403-3,Activities permitted
52404-1,Mental status
52405-8,Additional assessment
52406-6,Treatment encounter
Jul-40,Listeria monocytogenes Ab
52407-4,Individual education plan information
52408-2,Individual education plan
52409-0,Defined school year
52410-8,Progress note+attainment of goals
52411-6,Progress note+attainment of goals date range
52412-4,Assessment information
52413-2,Date range
52414-0,Past medical history
May-41,Lymphocytic choriomeningitis virus Ab
52415-7,Progress note+attainment of goals
52416-5,Body weight
52417-3,Identifier
52418-1,Name
52419-9,Rate
52420-7,Timing
52421-5,Name
52422-3,Rate
Mar-42,Measles virus Ab
52423-1,Timing
52424-9,Identifier
52425-6,Name
52426-4,Rate
52428-0,Identifier
52429-8,Medication identifier
52430-6,Medication name
Jan-43,Measles virus Ab
52431-4,Medication identifier
52432-2,Medication name
52433-0,Medication identifier
52434-8,Medication name
52435-5,Medication name
52436-3,Medication name ID
52437-1,Medication name
52438-9,Medication identifier
52439-7,Medication name
52440-5,Medication identifier
52441-3,Medication identifier
52442-1,Medication name
52443-9,Medication identifier
52444-7,Medication name
52445-4,Medication identifier
52446-2,Medication name
52447-0,Medication identifier
52448-8,Medication name
Sep-44,Measles virus Ab.IgG
52449-6,Prior Functioning
52450-4,Current Medical Information
52451-2,Continuity assessment record and evaluation tool - master document - core and supplemental items
52452-0,Administrative Items
52453-8,Assessment Type
52454-6,Reason for assessment
52455-3,Admission date
Jun-45,Measles virus Ab.IgM
52456-1,Assessment reference date
52457-9,Provider Information
52458-7,Name
52459-5,CMS certification number
52460-3,Patient information
52461-1,Middle name
52462-9,Nickname
52463-7,Patient Identification Number or Provider Account Number
Apr-46,Saccharopolyspora rectivirgula Ab
52464-5,"Primary and Other Diagnoses, Comorbidities, and Complications"
52465-2,"Other Diagnoses, Comorbidities, and Complications"
52466-0,"Major Procedures (Diagnostic, Surgical, and Therapeutic Interventions)"
52467-8,Procedure
52468-6,Major Treatments
52469-4,Major treatments admitted &or discharged with panel
52470-2,Major treatments used at any time during stay panel
52471-0,Medications
Feb-47,Mitochondria Ab
52472-8,Allergies & Adverse Drug Reactions
52473-6,Allergy or cause of reaction
52474-4,Skin integrity panel
52475-1,Presence of pressure ulcers
52476-9,Number of unhealed pressure ulcers at each stage - at assessment and onset during this service
52477-7,Largest Ulcer Measurements
52478-5,Number of Major Wounds
52479-3,Physiologic Factors
5248-0,Mucor sp Ab
52480-1,Anthropometric Measures
52481-9,Vital signs - acute
52482-7,Laboratory
52483-5,Other
52484-3,Arterial Blood Gases (ABGs)
52485-0,Pulmonary Function Tests
52486-8,Volume expired during 2.0 s of forced expiration/Volume.forced expiration.total
52487-6,"Cognitive Status, Mood and Pain"
52488-4,Temporal Orientation &or Mental Status
52489-2,Interview attempted
524-9,Vancomycin
52490-0,Temporal orientation - CARE
52491-8,Brief interview for mental status
52492-6,"Year, Month, Day"
52493-4,Recall
52494-2,Observational Assessment of Cognitive Status at 2D Assessment Period
52495-9,Confusion Assessment Method (CAM)
52496-7,Behavioral Signs & Symptoms
52497-5,Mood
Aug-49,Mumps virus Ab
52498-3,Patient health questionnaire 2 item
52499-1,Feeling sad
52500-6,Pain
52501-4,Pain Effect on Function during last 2D
52502-2,Impairments
52503-0,Bladder and Bowel Management - Use of Device(s) and Incontinence
52504-8,Swallowing
52505-5,"Hearing, Vision, and Communication"
Jun-50,Mumps virus Ab
52506-3,Weight-bearing
52507-1,Weight-bearing restrictions panel
52508-9,Grip Strength
52509-7,Grip strength panel
52510-5,Respiratory status
52511-3,Endurance
52512-1,Mobility devices and aids needed
52513-9,Functional Status - Usual Performance
Apr-51,Muscle sarcolemma Ab
52514-7,Core Self Care
52515-4,Core Functional Mobility
52516-2,Mode of Mobility - All Patients
52517-0,Level of independence on longest distance walked
52518-8,Level of independence on longest distance wheeled
52519-6,Supplemental Functional Ability
52520-4,Mode of Mobility - PAC Patients
52521-2,Overall Plan of Care &or Advance Care Directives
Feb-52,Mycoplasma pneumoniae Ab
52522-0,Overall Plan of Care &or Advance Care Directives - Subheading
52523-8,Discharge status
52524-6,Discharge Information
52525-3,Discharge date
52526-1,Attending physician name
52527-9,Residential Information
52528-7,Support Needs &or Caregiver Assistance
52529-5,Discharge Care Options
5253-0,Mycoplasma pneumoniae Ab
52530-3,Discharge Location Information
52531-1,Provider city
52532-9,Provider state
52533-7,Medical Coding Information
52534-5,Principal Diagnosis
52535-2,Other useful information
52536-0,Admission Information
52537-8,Pre-admission Service Use
52538-6,"Patient History Prior to this Current Illness, Exacerbation, or Injury"
52539-4,Prior postal code
52540-2,Zip code unknown
52541-0,Prior help
52542-8,Patient lived with prior to this illness
52543-6,Structural barriers in prior residence that could interfere with the patient's discharge
52544-4,Structural barrier.other specified
52545-1,Prior functioning.self care
52546-9,Prior functioning.mobility - ambulation
52547-7,Prior functioning.stairs - ambulation
Aug-54,Mycoplasma pneumoniae Ab
52548-5,Prior functioning.mobility - wheelchair
52549-3,Prior functioning.functional cognition
52550-1,"Mobility devices and aids used prior to current illness, exacerbation, or injury"
52551-9,Prior mobility device.other specified
52552-7,Falls in the past Y
52553-5,Language.primary is English
52554-3,Language.primary not English
May-55,Mycoplasma pneumoniae Ab.IgG
52555-0,Interpreter needed
52556-8,Payment sources
52557-6,"Clinician diagnosis, comorbidity, and complication list is complete"
52558-4,Procedure this admission
52559-2,Procedure.other
525-6,Vancomycin
52560-0,Procedure.left
52561-8,Procedure.right
52562-6,Procedure.side not applicable
Mar-56,Mycoplasma pneumoniae Ab.IgM
52563-4,Procedure list is complete
52564-2,Major treatments admitted &or discharged with
52565-9,Reason for continuous cardiac monitoring
52566-7,Suctioning frequency per H during stay.max
52567-5,Reason for one on one 24H supervision
52568-3,Other major treatments received.other specified
52569-1,Major treatments used at any time during stay
52570-9,Drug list is complete
Jan-57,Mycoplasma pneumoniae Ab.IgM
52571-7,Known allergies or adverse drug reactions
52572-5,Allergy list is complete
52573-3,Risk of developing pressure ulcers
52574-1,One or more unhealed pressure ulcer(s) at stage 2 or higher
52575-8,Number of pressure ulcers at assessment - stage 2
52576-6,Number of pressure ulcers at assessment - stage 3
52577-4,Number of pressure ulcers at assessment - stage 4
52578-2,Number of pressure ulcers at assessment - unstageable
52579-0,Number of pressure ulcers onset during this service - stage 2
52580-8,Number of pressure ulcers onset during this service - stage 3
52581-6,Number of pressure ulcers onset during this service - stage 4
52582-4,Number of pressure ulcers onset during this service - unstageable
52583-2,Number of unhealed stage 2 ulcers known to be present for more than 1 month
52584-0,Date of ulcer measurement
52585-7,Major wound (excluding pressure ulcers)
52586-5,Delayed healing of surgical wound
52587-3,Trauma-related wound
52588-1,Diabetic foot ulcer(s)
Sep-58,Mycoplasma pneumoniae Ab.IgM
52589-9,Vascular ulcer (arterial or venous including diabetic ulcers not located on the foot)
52590-7,Major wound.other
52591-5,Major wound.other
52592-3,Turning surfaces not intact
52593-1,Oxygen therapy source and amount
52594-9,Brief interview for mental status was attempted
52595-6,Reason brief interview for mental status was not attempted
52596-4,Memory &or recall ability during 2D assessment period
Jul-59,Myelin basic protein Ab
52597-2,Unable to assess memory &or recall ability during 2D assessment period .specified reason
52598-0,Physical behavioral symptoms directed toward others during 2D assessment period
52599-8,Verbal behavioral symptoms directed towards others during 2D assessment period
52600-4,"Other disruptive or dangerous behavioral symptoms not directed towards others, including self-injurious behaviors during 2D assessment period"
52601-2,Mood interview was attempted
52602-0,Feeling sad
52603-8,Pain interview was attempted
52604-6,Pain presence during last 2D
May-60,Myocardium Ab
52605-3,Pain has made it hard to sleep during last 2D
52606-1,Limited activities because of pain during last 2D
52607-9,Pain Observational Assessment
52608-7,Impairments with bladder or bowel management
52609-5,Bladder - external or indwelling device or intermittent catheterization
52610-3,Bowel - external or indwelling device or intermittent catheterization
52611-1,Bladder - frequency of incontinence during 2D assessment period
52612-9,Bowel - frequency of incontinence during 2D assessment period
Mar-61,Neisseria gonorrhoeae Ab
52613-7,Bladder - needs assistance to manage bladder care equipment
52614-5,Bowel - needs assistance to manage bowel care equipment
52615-2,"Bladder - incontinent immediately prior to current illness, exacerbation, or injury"
52616-0,"Bowel - incontinent immediately prior to current illness, exacerbation, or injury"
52617-8,Any impairments with swallowing
52618-6,Swallowing disorder
52619-4,Swallowing disorder.other specified
52620-2,Swallowing usual ability
Jan-62,Neutrophil cytoplasmic Ab
52621-0,"Any impairments with hearing, vision, or communication"
52622-8,Understanding verbal content - excluding language barriers
52623-6,Expression of ideas and wants
52624-4,Seeing in adequate light - with glasses or other visual appliances
52625-1,Hearing - with hearing aid or hearing appliance if normally used
52626-9,Any impairments with weight-bearing
52627-7,Weight-bearing restrictions during 2D assessment period
52628-5,Weight-bearing restrictions during 2D assessment period
52629-3,Weight-bearing restrictions during 2D assessment period
52630-1,Weight-bearing restrictions during 2D assessment period
52631-9,Any impairments with grip strength
52632-7,Grip strength during 2D assessment period
52633-5,Grip strength during 2D assessment period
52634-3,Any impairments with respiratory status
52635-0,Respiratory status with oxygen therapy during 2D assessment period
52636-8,Respiratory status without oxygen therapy during 2D assessment period
52637-6,Any impairments with endurance
52638-4,Mobility endurance - able to walk or wheel 50 feet during 2D assessment period
Sep-63,Nocardia sp Ab
52639-2,Sitting endurance - able to tolerate sitting for 15M during 2D assessment period
526-4,Vancomycin
52640-0,Mobility devices and aids needed
52641-8,Mobility device.other specified
52642-6,Eating during 2D assessment period
52643-4,Tube feeding during 2D assessment period
52644-2,Oral hygiene during 2D assessment period
52645-9,Toilet hygiene during 2D assessment period
52646-7,Upper body dressing during 2D assessment period
Jul-64,Onchocerca sp Ab
52647-5,Lower body dressing during 2D assessment period
52648-3,Lying to sitting on side of bed during 2D assessment period
52649-1,Sit to stand during 2D assessment period
52650-9,Chair-bed to chair transfer during 2D assessment period
52651-7,Toilet transfer during 2D assessment period
52652-5,Primarily uses wheelchair for mobility during 2D assessment period
52653-3,Walk 150 ft (45 m) during 2D assessment period
Apr-65,Pancreatic islet cell Ab
52654-1,Walk 100 ft (30 m) during 2D assessment period
52655-8,Walk 50 ft (15 m) during 2D assessment period
52656-6,Walk 10 ft (3 m) during 2D assessment period
52657-4,Wheel 150 ft (45 m) during 2D assessment period
52658-2,Wheel 100 ft (30 m) during 2D assessment period
52659-0,Wheel 50 ft (15 m) during 2D assessment period
52660-8,Wheel 10 ft (3 m) during 2D assessment period
52661-6,Wash upper body during 2D assessment period
Feb-66,Paracoccidioides brasiliensis Ab
52662-4,Shower &or bathe self during 2D assessment period
52663-2,Roll left and right during 2D assessment period
52664-0,Sit to lying during 2D assessment period
52665-7,Picking up objects during 2D assessment period
52666-5,Putting on &or taking off footwear during 2D assessment period
52667-3,One step (curb) during 2D assessment period
52668-1,Walk 50 feet with two turns during 2D assessment period
52669-9,12 steps-interior during 2D assessment period
5267-0,Paragonimus sp Ab
52670-7,Four steps-exterior during 2D assessment period
52671-5,Walking 10 feet on uneven surfaces during 2D assessment period
52672-3,Car transfer during 2D assessment period
52673-1,Wheel short ramp during 2D assessment period
52674-9,Wheel long ramp during 2D assessment period
52675-6,Telephone-answering during 2D assessment period
52676-4,Telephone-placing call during 2D assessment period
52677-2,Medication management-oral medications during 2D assessment period
52678-0,Medication management-inhalant &or mist medications during 2D assessment period
52679-8,Medication management-injectable medications during 2D assessment period
52680-6,Make light meal during 2D assessment period
52681-4,Wipe down surface during 2D assessment period
52682-2,Light shopping during 2D assesssment
52683-0,Laundry during 2D assessment period
52684-8,Use public transportation during 2D assessment period
52685-5,Care goals documented
52686-3,Overall status
52687-1,Decision authority documented
Aug-68,Parainfluenza virus 1 Ab
52688-9,Discharge disposition
52689-7,Frequency of assistance at discharge
52690-5,Discharge destination influenced by caregiver availability
52691-3,Willing caregiver
52692-1,Types of caregiver
52693-9,Patient will live with at discharge
52694-7,ADL assistance needed
52695-4,IADL assistance needed
Jun-69,Parainfluenza virus 2 Ab
52696-2,Medication administration assistance needed
52697-0,Medical procedures &or treatments assistance needed
52698-8,Management of equipment assistance needed
52699-6,Supervision and safety assistance needed
52700-2,Advocacy assistance needed
52701-0,No assistance needed
52702-8,Home health care considered appropriate
52703-6,Skilled nursing facility considered appropriate
Apr-70,Parainfluenza virus 3 Ab
52704-4,Inpatient rehabilitation hospital considered appropriate
52705-1,Long term care hospital considered appropriate
52706-9,Psychiatric hospital considered appropriate
52707-7,Outpatient services considered appropriate
52708-5,Acute hospital admission considered appropriate
52709-3,Hospice considered appropriate
52710-1,Long-term personal care services considered appropriate
52711-9,Long term care nursing facility considered appropriate
Feb-71,Parietal cell Ab
52712-7,Other service considered appropriate
52713-5,Discharged with referral for additional services
52714-3,Provider type
52715-0,Provider type.other specified
52716-8,Discharge delayed at least 24H
52717-6,Reason for discharge delay
52718-4,Reason for discharge delay.other specified
52719-2,Patient requested information not be shared with next provider
527-2,Viomycin
5272-0,Parvovirus B19 Ab
52720-0,Other useful information
52721-8,Current payment source.other specified
52722-6,Admitted from
52723-4,Admitted from.other specified
52724-2,Primary diagnosis code from previous setting
52725-9,Medical services received in the last 2Mo
52726-7,Prior residence
52727-5,Lives outside U.S.
52728-3,Diameter.any.max
52729-1,Diameter.transverse
52730-9,Undermining or tunneling present
52731-7,Repetition of three words
52732-5,Temporal orientation - current year
52733-3,Temporal orientation - current month
52734-1,Temporal orientation - current day of the week
52735-8,Recall - sock
52736-6,Recall - blue
52737-4,Recall - bed
Aug-73,Parvovirus B19 Ab.IgG
52738-2,Inattention during 2D assessment period
52739-0,Disorganized thinking during 2D assessment period
52740-8,Altered level of consciousness &or alertness during 2D assessment period
52741-6,Psychomotor retardation during 2D assessment period
52742-4,Pain severity during last 2D
52743-2,Continuity assessment record and evaluation tool - Acute care
52744-0,Continuity assessment record and evaluation tool - Post acute care - admission
52745-7,Continuity assessment record and evaluation tool - Post acute care - discharge
Jun-74,Parvovirus B19 Ab.IgM
52746-5,Continuity assessment record and evaluation tool - Interim
52747-3,Continuity assessment record and evaluation tool - Expired
52748-1,Continuity assessment record and evaluation tool - Home health admission
52749-9,Etravirine
52750-7,Activated protein C resistance
52751-5,Coagulation surface induced.factor sensitive
52752-3,Coagulation tissue factor induced.PIVKA insensitive actual/Normal
Mar-75,PCNA extractable nuclear Ab
52753-1,Coagulation tissue factor induced.PIVKA insensitive actual/Normal
52754-9,Kininogen.high molecular weight activity actual/Normal
52755-6,Coagulation surface induced.lupus sensitive
52756-4,Coagulation dilute Russell viper venom induced.excess phospholipid
52757-2,SERPINE1 gene.c.-675 4G+5G
52758-0,SERPINE1 gene.c.-844A>G
52759-8,Prekallikrein activity actual/Normal
52760-6,Coagulation tissue factor induced.PIVKA sensitive actual/Normal
Jan-76,PCNA extractable nuclear Ab
52761-4,Coagulation tissue factor induced.PIVKA sensitive actual/Normal
52762-2,Intrinsic coagulation system thromboelastography panel
52763-0,Extrinsic coagulation system thromboelastography panel
52764-8,Extrinsic coagulation system with fibrinolysis inhibition thromboelastography panel
52765-5,Thromboelastography without activation panel
52766-3,Coagulation surface induced^after addition of protein C activator+Factor V depleted plasma/Coagulation surface induced
52767-1,Coagulation surface induced^after addition of protein C activator/Coagulation surface induced
52768-9,Clot formation
52769-7,Clot formation.extrinsic coagulation system activated.fibrinolysis suppressed
52770-5,Clot formation.extrinsic coagulation system activated
52771-3,Clot formation.intrinsic coagulation system activated
52772-1,Clot formation.intrinsic coagulation system activated.heparin insensitive
52773-9,Clotting time.extrinsic coagulation system activated
52774-7,Clotting time.extrinsic coagulation system activated.fibrinolysis suppressed
52775-4,Clotting time.intrinsic coagulation system activated.heparin insensitive
52776-2,Clotting time.intrinsic coagulation system activated
52777-0,Intrinsic coagulation system with heparin inhibition thromboelastography panel
52778-8,Maximum clot firmness
Sep-77,Penicillium roqueforti Ab
52779-6,Maximum clot firmness.extrinsic coagulation system activated.fibrinolysis suppressed
52780-4,Maximum clot firmness.extrinsic coagulation system activated.platelets inhibited
52781-2,Maximum clot firmness.intrinsic coagulation system activated
52782-0,Maximum clot firmness.intrinsic coagulation system activated.heparin insensitive
52783-8,Maximum clot firmness.extrinsic coagulation system activated
52784-6,Maximum lysis
52785-3,Maximum lysis.extrinsic coagulation system activated.fibrinolysis suppressed
52786-1,Maximum lysis.extrinsic coagulation system activated
Jul-78,Plasmodium falciparum Ab
52787-9,Maximum lysis.intrinsic coagulation system activated
52788-7,Maximum lysis.intrinsic coagulation system activated.heparin insensitive
52789-5,Clot initiation
52790-3,Guidance for percutaneous replacement of drainage catheter
52791-1,Guidance for percutaneous replacement of drainage catheter
52792-9,Rh
52793-7,ABO group
52794-5,Ova & parasites identified^3rd specimen
May-79,Plasmodium sp Ab
52795-2,Ova & parasites identified^2nd specimen
52796-0,Planned stop date
52797-8,Diagnosis ICD code
52798-6,"Medical coding diagnosis, comorbidity, and complication list is complete"
52799-4,Major treatments used on or 1D prior to day of death panel
528-0,Viomycin
52800-0,Major treatments used on or 1D prior to day of death
52801-8,Major treatments admitted with panel
52802-6,Major treatments admitted with
Mar-80,Plasmodium vivax Ab
52803-4,Major treatments discharged with panel
52804-2,Major treatments discharged with
52805-9,Major treatments used within 2D interim period panel
52806-7,Major treatments used within 2D interim period
52807-5,"Medical Coding Other Diagnoses, Comorbidities, and Complications"
52808-3,"Medical Coding Major Procedures (Diagnostic, Surgical, and Therapeutic Interventions)"
52809-1,Dose form
52810-9,Frequency
Jan-81,Polio virus 1 Ab.Neut
52811-7,HIPAA attachments
52812-5,Appearance
52813-3,Appearance
52814-1,Appearance
52815-8,Nucleated cells
52816-6,Nucleated cells
52817-4,Nucleated cells
52818-2,Nucleated cells
52819-0,Nucleated cells
52820-8,Appearance
52821-6,Saint Louis encephalitis virus Ab.IgG
52822-4,Eastern equine encephalitis virus Ab.IgG
52823-2,La Crosse virus Ab.IgG
52824-0,La Crosse virus Ab.IgM
52825-7,La Crosse virus Ab.IgM
52826-5,Nursing management minimum data set panel
52827-3,Facility unique identifier panel
52828-1,Federal provider name
Sep-82,Polio virus 1 Ab
52829-9,Place of service
52830-7,"State, district or territory federal abbreviation"
52831-5,Postal code
52832-3,Survey reporting period start date
52833-1,Survey reporting period end date
52834-9,Nursing delivery unit or service panel
52835-6,Nursing unit name
52836-4,Nursing unit cost center
Jul-83,Polio virus 2 Ab.Neut
52837-2,Type of nursing unit or service
52838-0,Population distribution panel
52839-8,Total patient population
52840-6,Total population of fetal age
52841-4,Total population of age birth to 28D
52842-2,Total population of age 29D to 1Y
52843-0,Total population of age 1-4Y
52844-8,Total population of age 5-9Y
May-84,Polio virus 2 Ab
52845-5,Total population of age 10-14Y
52846-3,Total population of age 15-19Y
52847-1,Total population of age 20-24Y
52848-9,Total population of age 25-29Y
52849-7,Total population of age 30-34Y
52850-5,Total population of age 35-39Y
52851-3,Total population of age 40-44Y
Feb-85,Polio virus 3 Ab.Neut
52852-1,Total population of age 45-49Y
52853-9,Total population of age 50-54Y
52854-7,Total population of age 55-59Y
52855-4,Total population of age 60-64Y
52856-2,Total population of age 65-69Y
52857-0,Total population of age 70-74Y
52858-8,Total population of age 75-79Y
52859-6,Total population of age 80-84Y
5286-0,Polio virus 3 Ab
52860-4,Total population of age GE 85Y
52861-2,Catchment area panel
52862-0,Neighborhood catchment area
52863-8,City or town catchment area
52864-6,District catchment area
52865-3,County catchment area
52866-1,Parish catchment area
52867-9,State catchment area
52868-7,Region catchment area
52869-5,Nation catchment area
52870-3,World catchment area
52871-1,Aerospace catchment area
52872-9,Nautical catchment area
52873-7,Cells.CD1a/100 cells
52874-5,Cells.CD1a/100 cells
52875-2,Cells.CD1a/100 cells
52876-0,Cells.CD1a/100 cells
52877-8,Cells.cytoplasmic CD22/100 cells
Aug-87,Burkholderia pseudomallei Ab
52878-6,Cells.cytoplasmic CD22/100 cells
52879-4,Cells.cytoplasmic CD22/100 cells
52880-2,Cells.cytoplasmic CD22/100 cells
52881-0,Cells.cytoplasmic CD22/100 cells
52882-8,Cells.cytoplasmic CD3/100 cells
52883-6,Cells.cytoplasmic CD3/100 cells
52884-4,Cells.cytoplasmic CD3/100 cells
52885-1,Cells.cytoplasmic CD3/100 cells
Jun-88,Rabies virus Ab
52886-9,Tellurium
52887-7,Bismuth
52888-5,Silicon
52889-3,Selenium
52890-1,Lead
52891-9,Chromium
52892-7,Aluminum
52893-5,Vanadium
Apr-89,Reagin Ab
52894-3,Titanium
52895-0,Tellurium
52896-8,Silver
52897-6,Platinum
52898-4,Bismuth
52899-2,Beryllium
52900-8,Vanadium/Creatinine
52901-6,Vanadium/Creatinine
Feb-90,Reagin Ab
52902-4,Uranium/Creatinine
52903-2,Uranium/Creatinine
52904-0,Silver/Creatinine
52905-7,Silver/Creatinine
52906-5,Bismuth/Creatinine
52907-3,Bismuth/Creatinine
52908-1,Selenium
52909-9,Platinum
5291-0,Reagin Ab
52910-7,Zinc
52911-5,Magnesium
52912-3,Copper
52913-1,Selenium
52914-9,Boron
52915-6,Aluminum
52916-4,Tin/Creatinine
52917-2,Tin/Creatinine
52918-0,Thallium/Creatinine
52919-8,Tellurium/Creatinine
52920-6,Tellurium/Creatinine
52921-4,Strontium/Creatinine
52922-2,Strontium/Creatinine
52923-0,Selenium/Creatinine
52924-8,Platinum/Creatinine
52925-5,Platinum/Creatinine
52926-3,Nickel/Creatinine
52927-1,Molybdenum/Creatinine
Aug-92,Reagin Ab
52928-9,Molybdenum/Creatinine
52929-7,Mercury/Creatinine
52930-5,Manganese/Creatinine
52931-3,Lead/Creatinine
52932-1,Copper/Creatinine
52933-9,Cobalt/Creatinine
52934-7,Chromium/Creatinine
52935-4,Beryllium/Creatinine
Jun-93,Reovirus Ab
52936-2,Beryllium/Creatinine
52937-0,Barium/Creatinine
52938-8,Barium/Creatinine
52939-6,Arsenic.inorganic/Creatinine
52940-4,Arsenic.inorganic/Creatinine
52941-2,Antimony/Creatinine
52942-0,Antimony/Creatinine
52943-8,Aluminum/Creatinine
Apr-94,Respiratory syncytial virus Ab
52944-6,Aluminum/Creatinine
52945-3,LORazepam
52946-1,diazePAM
52947-9,Dextromethorphan
52948-7,cloBAZam
52949-5,chlordiazePOXIDE
52950-3,Barbital
Jan-95,Respiratory syncytial virus Ab
52951-1,Phencyclidine
52952-9,Opiates
52953-7,Cocaine
52954-5,Cannabinoids
52955-2,Benzodiazepines
52956-0,Barbiturates
52957-8,Amphetamine
52958-6,Methadone
52959-4,cloBAZam
52960-2,cloNIDine
52961-0,Paraquat
52962-8,Tobramycin
52963-6,Flurazepam
52964-4,cloBAZam
52965-1,clonazePAM
52966-9,Bacteria identified
52967-7,Bacteria identified
52968-5,Streptococcus agalactiae
Sep-96,Reticulin Ab
52969-3,Staphylococcus aureus.methicillin resistant isolate
52970-1,CV2 Ab
52971-9,Immune complex
52972-7,(Avena sativa+Fagopyrum esculentum+Sesamum indicum+Triticum aestivum+Zea mays) Ab.IgE
52973-5,Bacteria identified
52974-3,Influenza virus B Ab
52975-0,Respiratory syncytial virus Ab
52976-8,Cytomegalovirus Ab
Jul-97,Rheumatoid factor
52977-6,Herpes simplex virus Ab
52978-4,Varicella zoster virus Ab
52979-2,Trichinella spiralis Ab.IgG
529-8,Viomycin
52980-0,Plasmodium sp Ab.IgG
52981-8,Herpes simplex virus Ab.IgG
52982-6,Echinococcus sp Ab.IgG1
52983-4,Echinococcus sp Ab.IgG4
52984-2,Cytomegalovirus Ab.IgG avidity
May-98,Rheumatoid factor
52985-9,Leishmania sp Ab.IgG
52986-7,Rubella virus Ab.IgG avidity
52987-5,Mycoplasma pneumoniae Ab
52988-3,Leptospira sp DNA
52989-1,Leptospira sp DNA
52990-9,Leptospira sp DNA
52991-7,Cells.cytoplasmic CD79a/100 cells
52992-5,Cells.cytoplasmic CD79a/100 cells
Mar-99,Rheumatoid factor
52993-3,Cells.cytoplasmic CD79a/100 cells
52994-1,Cells.cytoplasmic CD79a/100 cells
52995-8,Cells.cytoplasmic CD79a/100 cells
52996-6,Cells.terminal deoxyribonucleotidyl transferase/100 cells
52997-4,Cells.terminal deoxyribonucleotidyl transferase/100 cells
52998-2,Cells.terminal deoxyribonucleotidyl transferase/100 cells
52999-0,Leukocytes.disintegrated
53000-6,Mitochondria M4 Ab
53001-4,Mitochondria M9 Ab
53002-2,Nuclear Ab pattern.fine speckled
53003-0,Mitotic spindle apparatus Ab
53004-8,Mitotic spindle apparatus Ab
53005-5,Fibrillarin Ab
53006-3,PCNA extractable nuclear Ab
53007-1,PM-SCL extractable nuclear Ab
53008-9,PM-SCL extractable nuclear Ab
Sep-00,Rheumatoid factor
53009-7,Ribosomal Ab
53010-5,Signal recognition particle Ab
53011-3,Signal recognition particle Ab
53012-1,Neutrophil cytoplasmic Ab.atypical
53013-9,Bactericidal permeability increasing protein Ab
53014-7,Nucleosome Ab
53015-4,Nucleosome Ab
53016-2,Sjogrens syndrome-A extractable nuclear 52kD Ab
Jul-01,Ribonucleoprotein extractable nuclear Ab
53017-0,Sjogrens syndrome-A extractable nuclear 52kD Ab
53018-8,Sjogrens syndrome-A extractable nuclear 60kD Ab
53019-6,Sjogrens syndrome-A extractable nuclear 60kD Ab
53020-4,Complement C1q Ab
53021-2,Salivary gland Ab
53022-0,U1 small nuclear ribonucleoprotein Ab
53023-8,Tissue transglutaminase Ab
53024-6,Saccharomyces cerevisiae Ab
May-02,Ribonucleoprotein extractable nuclear Ab
53025-3,Gliadin Ab
53026-1,Tissue transglutaminase Ab.IgG
53027-9,Cyclic citrullinated peptide Ab
53028-7,Cyclic citrullinated peptide Ab
53029-5,Neutrophil cytoplasmic Ab.perinuclear.atypical
53030-3,Liver kidney microsomal Ab
53031-1,Signal recognition particle Ab
53032-9,U1 small nuclear ribonucleoprotein 70kD Ab
Mar-03,Rickettsia (Proteus OX19) Ab
53033-7,Include all data of the selected type that represents observations made two Y or less before the starting date of service
53034-5,Allelic state
53035-2,DNA marker assessed
53036-0,Filler DNA analysis test identifier
53037-8,Genetic disease sequence variation interpretation
53038-6,Genetic disease analysis overall diagnostic interpretation
53039-4,Genetic disease analysis overall carrier interpretation
53040-2,Drug metabolism sequence variation interpretation
Jan-04,Rickettsia (Proteus OX2) Ab
53041-0,DNA region of interest panel
53042-8,DNA marker assessed panel
53043-6,DNA marker analysis test coverage panel
53044-4,DNA marker identified panel
53045-1,Reference sequence alteration
53046-9,Beta globulin+Gamma globulin
53047-7,Chromogranin A
53048-5,Ferritin
53049-3,Glucose^pre-meal
53050-1,Glucose
53051-9,Beta globulin+Gamma globulin/Protein.total
53052-7,Collagen crosslinked C-telopeptide
53053-5,Carnitine
53054-3,Carnitine.free (C0)
53055-0,Creatine
53056-8,Decanoylcarnitine (C10)
53057-6,Decenoylcarnitine (C10:1)
Aug-05,Rickettsia (Proteus OXK) Ab
53058-4,Dodecanoylcarnitine (C12)
53059-2,Dodecenoylcarnitine (C12:1)
530-6,Viomycin
53060-0,Butyrylcarnitine (C4)
53061-8,Ketones
53062-6,Argininosuccinate
53063-4,Beta alanine
53064-2,Beta aminoisobutyrate
53065-9,Butyrylcarnitine (C4)
Jun-06,Rickettsia sp Ab
53066-7,Cystathionine
53067-5,Argininosuccinate
53068-3,Beta alanine
53069-1,Cystathionine
53070-9,Butyrylcarnitine (C4)
53071-7,Carnitine
53072-5,Carnitine.free (C0)
53073-3,Ceruloplasmin
Apr-07,Rickettsia rickettsii Ab.IgG
53074-1,Creatine
53075-8,Decanoylcarnitine (C10)
53076-6,Decenoylcarnitine (C10:1)
53077-4,Levodopa
53078-2,Dodecanoylcarnitine (C12)
53079-0,Dodecenoylcarnitine (C12:1)
53080-8,Cystine
53081-6,Ammonia
Feb-08,Rickettsia rickettsii Ab.IgM
53082-4,Cholesterol
53083-2,Bilirubin.glucuronidated
53084-0,Glucose
53085-7,Base excess
53086-5,Bicarbonate
53087-3,Calcium.ionized^^adjusted to pH 7.4
53088-1,Calcium.ionized
53089-9,Carbon dioxide
5309-0,Rickettsia spotted fever group Ab
53090-7,Carbon dioxide
53091-5,Nitrogen.nonprotein
53092-3,Collagen crosslinked C-telopeptide
53093-1,Glucose^post XXX challenge
53094-9,Glucose^post meal
53095-6,Carnitine.free (C0)/Carnitine.total
53096-4,Carnitine.free (C0)/Carnitine.total
53097-2,3-O-Methyldopa
53098-0,3-Methoxy-4-Hydroxyphenylglycol
53099-8,Chloride
53100-4,Calcium
53101-2,Kynurenate
53102-0,Decanoylcarnitine (C10)
53103-8,Decenoylcarnitine (C10:1)
53104-6,Dodecenoylcarnitine (C12:1)
53105-3,3-Hydroxybutyrylcarnitine (C4-OH)
53106-1,Butyrylcarnitine (C4)
53107-9,Kynurenate/Creatinine
Aug-10,Rickettsia spotted fever group Ab
53108-7,Decenoylcarnitine (C10:1)/Creatinine
53109-5,Docosenoate/Creatinine
53110-3,5-Hydroxytryptophan/Creatinine
53111-1,Butyrylcarnitine (C4)/Creatinine
53112-9,Carnitine.free (C0)/Carnitine.total
53113-7,Spermatids/100 spermatozoa
53114-5,Glucose^post CFst
53115-2,Granulocytes.immature
Jun-11,Rickettsia spotted fever group Ab
53116-0,Base deficit
53117-8,Hemoglobin.thermolabile
53118-6,Sulfonamide crystals
53119-4,Tyrosine crystals
53120-2,Creatinine
53121-0,Protein
53122-8,Sodium
53123-6,Potassium
Apr-12,Rickettsia spotted fever group Ab.IgG
53124-4,Calcium
53125-1,Monocytes+Macrophages/100 leukocytes
53126-9,Monocytes+Macrophages/100 leukocytes
53127-7,Monocytes+Macrophages/100 leukocytes
53128-5,Bacterial casts
53129-3,Sodium urate crystals
53130-1,Ammonium urate crystals
53131-9,Calcium oxalate crystals
Feb-13,Rickettsia spotted fever group Ab.IgG
53132-7,Epithelial cells.non-squamous
53133-5,Cholesterol.in LDL
53134-3,Amylase isoenzymes
53135-0,Cholesterol.in HDL
53136-8,Organic acids pattern
53137-6,Urea
53138-4,Calcium.ionized^^adjusted to pH 7.4
53139-2,Calcium.ionized^^adjusted to pH 7.4
531-4,Zidovudine
5314-0,Rickettsia spotted fever group Ab.IgM
53140-0,Calcium.ionized^^adjusted to pH 7.4
53141-8,17-Hydroxyprogesterone^30M post XXX challenge
53142-6,Nitrogen
53143-4,Hydrogen ion
53144-2,Somatotropin^75M post XXX challenge
53145-9,Lutropin^45M post XXX challenge
53146-7,Follitropin^45M post XXX challenge
53147-5,Follitropin^2H post XXX challenge
53148-3,DNA double strand Ab
53149-1,Iron/Creatinine
53150-9,Alanine+Beta Alanine+Sarcosine
53151-7,Valine/Phenylalanine
53152-5,Alloisoleucine+Isoleucine+Leucine+Hydroxyproline
53153-3,Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Phenylalanine
53154-1,Alloisoleucine+Isoleucine+Leucine+Hydroxyproline/Alanine
53155-8,Asparagine+Ornithine
53156-6,Methionine/Phenylalanine
Jul-15,Rickettsia spotted fever group Ab.IgM
53157-4,Citrulline/Phenylalanine
53158-2,Homocitrulline
53159-0,Tryptophan
53160-8,Propionylcarnitine (C3)
53161-6,Propionylcarnitine (C3)/Methionine
53162-4,Propionylcarnitine (C3)/Carnitine.free (C0)
53163-2,Propionylcarnitine (C3)/Acetylcarnitine (C2)
53164-0,Propionylcarnitine (C3)/Palmitoylcarnitine (C16)
May-16,Rickettsia typhus group Ab
53165-7,Formiminoglutamate
53166-5,Butyrylcarnitine+Isobutyrylcarnitine (C4)
53167-3,Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2)
53168-1,Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3)
53169-9,Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8)
53170-7,Tiglylcarnitine (C5:1)
53171-5,3-Hydroxyisovalerylcarnitine (C5-OH)/Carnitine.free (C0)
53172-3,3-Hydroxyisovalerylcarnitine (C5-OH)/Octanoylcarnitine (C8)
Mar-17,Rickettsia typhus group Ab
53173-1,3-Hydroxyhexanoylcarnitine (C6-OH)
53174-9,Octenoylcarnitine (C8:1)
53175-6,Octanoylcarnitine (C8)
53176-4,Octanoylcarnitine (C8)/Acetylcarnitine (C2)
53177-2,Octanoylcarnitine (C8)/Decanoylcarnitine (C10)
53178-0,3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)
53179-8,3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10)
53180-6,Decadienoylcarnitine (C10:2)
Jan-18,Rickettsia typhus group Ab
53181-4,Methylmalonylcarnitine (C4-DC)/3-Hydroxyisovalerylcarnitine (C5-OH)
53182-2,3-Hydroxydecenoylcarnitine (C10:1-OH)
53183-0,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)
53184-8,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH)
53185-5,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8)
53186-3,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16)
53187-1,Methylglutarylcarnitine (C6-DC)
53188-9,3-Hydroxydodecenoylcarnitine (C12:1-OH)
53189-7,3-Hydroxydodecanoylcarnitine (C12-OH)
53190-5,Tetradecadienoylcarnitine (C14:2)
53191-3,Tetradecenoylcarnitine (C14:1)
53192-1,Tetradecanoylcarnitine (C14)
53193-9,Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2)
53194-7,Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1)
53195-4,Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16)
53196-2,3-Hydroxytetradecadienoylcarnitine (C14:2-OH)
53197-0,3-Hydroxytetradecenoylcarnitine (C14:1-OH)
53198-8,Palmitoleylcarnitine (C16:1)
Sep-19,Rickettsia typhus group Ab.IgG
53199-6,Palmitoylcarnitine (C16)
53200-2,Argininosuccinate/Arginine
53201-0,3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16)
53202-8,Oleoylcarnitine (C18:1)
53203-6,Hexenoylcarnitine (C6:1)
53204-4,Heptanoylcarnitine (C7)
53205-1,Phenylacetylcarnitine (PheC2)
53206-9,Salicylylcarnitine (Salc)
Jul-20,Rickettsia typhus group Ab.IgG
53207-7,Nonanoylcarnitine (C9)
53208-5,Decatrienoylcarnitine (C10:3)
53209-3,Dehydrosuberylcarnitine (C8:1-DC)
53210-1,Suberylcarnitine (C8-DC)
53211-9,Dehydrosebacylcarnitine (C10:1-DC)
53212-7,Sebacylcarnitine (C10-DC)
53213-5,Dicarboxydodecenoylcarnitine (C12:1-DC)
53214-3,Dicarboxydodecanoylcarnitine (C12-DC)
May-21,Rickettsia typhus group Ab.IgM
53215-0,Dicarboxytetradecenoylcarnitine (C14:1-DC)
53216-8,Dicarboxytetradecanoylcarnitine (C14-DC)
53217-6,Dicarboxypalmitoleylcarnitine (C16:1-DC)
53218-4,Dicarboxypalmitoylcarnitine (C16-DC)
53219-2,Dicarboxyoleylcarnitine (C18:1-DC)
532-2,Mycobacterium sp identified
53220-0,Dicarboxystearoylcarnitine (C18-DC)
53221-8,Coagulation dilute Russell viper venom induced
53222-6,Coagulation factor XI activated activity
Mar-22,Rickettsia typhus group Ab.IgM
53223-4,Hemoglobin G/Hemoglobin.total
53224-2,Hemoglobin M
53225-9,Leukocytes
53226-7,Leukocytes
53227-5,Leukocytes
53229-1,Prealbumin
53230-9,Coagulation tissue factor induced.factor substitution^immediately after 1:4 addition of normal plasma
Jan-23,Orientia tsutsugamushi Ab
53231-7,Succinylacetone
53232-5,5-Oxoproline+Pipecolate
53233-3,Carnitine.free (C0)/Palmitoylcarnitine (C16)
53234-1,Carnitine.free (C0)/Stearoylcarnitine (C18)
53235-8,Carnitine.free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18)
53236-6,Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline
53237-4,Acrylylcarnitine (C3:1)
53238-2,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0)
53239-0,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Acetylcarnitine (C2)
53240-8,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Propionylcarnitine (C3)
53241-6,Stearoylcarnitine (C18)
53242-4,Charge ticket or encounter form attachment
53243-2,Advanced beneficiary notice attachment
53244-0,Notice of privacy practices receipt attachment
53245-7,Driver license
53246-5,Non-medical services attachment
53247-3,Eligibility acknowledgement attachment
53248-1,Plasmodium sp lactate dehydrogenase
Sep-24,Rickettsia typhi Ab.IgG
53249-9,Human metapneumovirus RNA
53250-7,Influenza virus A RNA
53251-5,Influenza virus B RNA
53252-3,Parainfluenza virus 1 RNA
53253-1,Parainfluenza virus 2 RNA
53254-9,Parainfluenza virus 3 RNA
53255-6,Mycoplasma pneumoniae DNA
Jun-25,Rickettsia typhi Ab.IgM
53256-4,Enterovirus RNA
53257-2,Mycobacterium tuberculosis DNA
53258-0,Beta vulgaris Ab.IgE.RAST class
53259-8,Glomerular basement membrane Ab
53260-6,Glomerular basement membrane Ab
53261-4,Amino acid newborn screen panel
53262-2,Carnitine newborn screen panel
53263-0,Urinalysis yeast variants panel
Apr-26,Bartonella henselae Ab.IgG
53264-8,Urinalysis yeast variants panel
53265-5,Yeast.hyphae
53266-3,Yeast.budding
53267-1,Urinalysis yeast variants panel
53268-9,Yeast.hyphae
53269-7,Yeast.budding
53270-5,Urinalysis type of non-squamous epithelial cells panel
53271-3,Epithelial cells.renal
Feb-27,Bartonella henselae Ab.IgM
53272-1,Transitional cells
53273-9,Urinalysis type of non-squamous epithelial cells panel
53274-7,Epithelial cells.renal
53275-4,Transitional cells
53276-2,Urinalysis type of non-squamous epithelial cells panel
53277-0,Urinalysis type of cast panel
53278-8,Erythrocyte casts
53279-6,Leukocyte casts
5328-0,Rotavirus Ab
53280-4,Casts type not specified
53281-2,Urinalysis type of cast panel
53282-0,Granular casts
53283-8,Mixed cellular casts
53284-6,Broad casts
53285-3,Erythrocyte casts
53286-1,Leukocyte casts
53287-9,Epithelial casts
53288-7,Fatty casts
53289-5,Mixed cellular casts
53290-3,Broad casts
53291-1,Epithelial casts
53292-9,Erythrocytes
53293-7,Urinalysis microscopic panel
53294-5,Epithelial cells.non-squamous
53295-2,Urinalysis type of crystal panel
53296-0,Calcium oxalate crystals
53297-8,Crystals unspecified
Aug-29,Rotavirus Ab
53298-6,Triple phosphate crystals
53299-4,Calcium phosphate crystals
533-0,Mycobacterium sp identified
53300-0,Leucine crystals
53301-8,Urate crystals
53302-6,Calcium carbonate crystals
53303-4,Cystine crystals
53304-2,Tyrosine crystals
53305-9,Urinalysis type of crystal panel
Jun-30,Rubella virus Ab
53306-7,Calcium oxalate crystals
53307-5,Crystals unspecified
53308-3,Triple phosphate crystals
53309-1,Calcium phosphate crystals
53310-9,Leucine crystals
53311-7,Urate crystals
53312-5,Calcium carbonate crystals
53313-3,Cystine crystals
Apr-31,Rubella virus Ab
53314-1,Tyrosine crystals
53315-8,Urinalysis microscopic panel
53316-6,Leukocytes
53317-4,Leukocyte clumps
53318-2,Epithelial cells.squamous
53319-0,Crystals
53320-8,Casts
53321-6,Mucus
Feb-32,Rubella virus Ab
53322-4,Crystals
53323-2,Casts type not specified
53324-0,Spermatozoa
53325-7,Urinalysis type of crystal panel
53326-5,Specific gravity
53327-3,Bilirubin
53328-1,Glucose
53329-9,Crystals.amorphous
5333-0,Rubella virus Ab
53330-7,Urinalysis type of cast panel
53331-5,Crystals.amorphous
53332-3,Crystals.amorphous
53333-1,Urinalysis other formed elements panel
53334-9,Crystals unspecified
53335-6,Casts type not specified
53336-4,17-Hydroxyprogesterone+Androstenedione/Cortisol
53337-2,17-Hydroxyprogesterone+Androstenedione/Cortisol
53338-0,11-Deoxycortisol
53339-8,11-Deoxycortisol
53340-6,17-Hydroxyprogesterone
53341-4,21-Deoxycortisol
53342-2,21-Deoxycortisol
53343-0,Androstenedione
53344-8,Androstenedione
53345-5,Cortisol
53346-3,Cortisol
53347-1,11-Deoxycorticosterone
Aug-34,Rubella virus Ab.IgG
53348-9,11-Deoxycorticosterone
53349-7,Thyroxine.free
53350-5,Thyroxine.free
53351-3,Urinalysis other formed elements panel
53352-1,Oval fat bodies (globules)
53353-9,Urinalysis other formed elements panel
53354-7,Oval fat bodies (globules)
May-35,Rubella virus Ab.IgM
53355-4,Trichomonas sp
53356-2,Fat
53357-0,Trichomonas sp
53358-8,Erythrocyte clumps
53359-6,Fat
53360-4,Erythrocyte clumps
53361-2,Bordetella parapertussis Ab.IgG
53362-0,Borrelia burgdorferi 49736 Ab.IgA
Mar-36,Saccharomonospora viridis Ab
53363-8,Borrelia burgdorferi 49736 Ab.IgG
53364-6,Borrelia burgdorferi 49736 Ab.IgM
53367-9,Coccidioides sp Ab.IgM
53368-7,Colorado tick fever virus Ab
53369-5,Echinococcus sp Ab.IgG1
53370-3,Echinococcus sp Ab.IgG4
Jan-37,Salivary gland Ab
53371-1,Echovirus Ab.IgG
53372-9,Echovirus Ab.IgM
53373-7,Francisella tularensis Ab
53374-5,Francisella tularensis Ab
53376-0,Hepatitis C virus Ab.IgM
53377-8,Herpes simplex virus Ab.IgG
53378-6,Herpes virus 6 Ab
53379-4,HIV 1 Ab
53381-0,Influenza virus A Ab
53382-8,Plasmodium falciparum Ab.IgM
53383-6,Plasmodium sp Ab.IgG
53384-4,Powassan virus Ab
53385-1,Snowshoe hare virus Ab
53386-9,Toxocara canis Ab
53387-7,Trichinella spiralis Ab.IgG
53388-5,Trichothecene Ab.IgA
Sep-38,Salmonella sp Ab
53389-3,Trichothecene Ab.IgE
53390-1,Trichothecene Ab.IgG
53391-9,Trichothecene Ab.IgM
53392-7,Proline/Phenylalanine
53393-5,Alloisoleucine+Isoleucine+Leucine+Hydroxyproline+Valine/Phenylalanine+Tyrosine
53394-3,5-Oxoproline+Pipecolate/Phenylalanine
53395-0,Asparagine+Ornithine/Serine
53396-8,Asparagine+Ornithine/Phenylalanine
Jul-39,Salmonella paratyphi A H Ab
53397-6,Methionine/Alloisoleucine+Isoleucine+Leucine+Hydroxyproline
53398-4,Arginine/Phenylalanine
53399-2,Citrulline/Tyrosine
53400-8,Stearoylcarnitine (C18)/Propionylcarnitine (C3)
53401-6,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Octanoylcarnitine (C8)
53402-4,3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4)
53403-2,Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4)
53404-0,Vaccine label
May-40,Salmonella paratyphi A O Ab
53405-7,Non-standardized allergenic label
53406-5,Licensed vaccine bulk intermediate label
53407-3,Licensed blood intermediate &or paste label
53408-1,Licensed minimally manipulated cells label
53409-9,Bulk ingredient
53410-7,No change notification
53411-5,Out of business notification
53412-3,Residue warning section
Mar-41,Salmonella paratyphi B H Ab
53413-1,OTC - Questions section
53414-9,OTC - Pregnancy or breast feeding section
53415-6,Bilirubin
53416-4,Alpha naphthylesterase
53417-2,Alpha naphthylesterase
53418-0,Fibroblast growth factor 23.intact ^pre XXX challenge
53419-8,Fibroblast growth factor 23.intact ^1st specimen post XXX challenge
53420-6,Fibroblast growth factor 23.intact ^2nd specimen post XXX challenge
Jan-42,Salmonella paratyphi B O Ab
53421-4,Fibroblast growth factor 23.intact ^3rd specimen post XXX challenge
53422-2,Fibroblast growth factor 23.intact ^4th specimen post XXX challenge
53423-0,Fibroblast growth factor 23.intact ^5th specimen post XXX challenge
53424-8,Fibroblast growth factor 23.intact ^6th specimen post XXX challenge
53425-5,Fibroblast growth factor 23 ^pre XXX challenge
53426-3,Fibroblast growth factor 23 ^1st specimen post XXX challenge
53427-1,Fibroblast growth factor 23 ^2nd specimen post XXX challenge
53428-9,Fibroblast growth factor 23 ^3rd specimen post XXX challenge
53429-7,Fibroblast growth factor 23 ^4th specimen post XXX challenge
53430-5,Fibroblast growth factor 23 ^5th specimen post XXX challenge
53431-3,Fibroblast growth factor 23 ^6th specimen post XXX challenge
53432-1,Gamma glutamyl transferase
53433-9,Creatine kinase
53434-7,Carnitine palmitoyltransferase 2
53435-4,Argininosuccinate lyase
53436-2,Carnitine palmitoyltransferase 2
53437-0,Carnitine palmitoyltransferase 1
53438-8,Carnitine palmitoyltransferase 2
Sep-43,Salmonella paratyphi C H Ab
53439-6,Argininosuccinate lyase
53440-4,Argininosuccinate synthase
53441-2,Carnitine palmitoyltransferase 1
53442-0,Carnitine palmitoyltransferase 2
53443-8,Carnitine palmitoyltransferase 2
53444-6,Citrate synthase
53445-3,Carnitine palmitoyltransferase 2/Citrate synthase
53446-1,Carnitine palmitoyltransferase 2/Citrate synthase
Jul-44,Salmonella paratyphi C O Ab
53447-9,Carboxymefloquine
53448-7,Cycloguanil
53449-5,Cyclophosphamide
53450-3,Cytarabine
53451-1,Uracil arabinoside
53452-9,Gamma 3 globulin.abnormal band
53453-7,Cyclophosphamide
Apr-45,Salmonella typhi H Ab
53454-5,Iron^post dose deferoxamine
53455-2,Calcium
53456-0,Iron
53457-8,Gamma 3 globulin.abnormal band/Protein.total
53458-6,Carbon dioxide
53459-4,Decadienoylcarnitine (C10:2)
53460-2,Sebacylcarnitine (C10-DC)
53461-0,Eicosanoylcarnitine (C20)
Feb-46,Salmonella typhi O Ab
53462-8,Eicosanoylcarnitine (C20)
53463-6,Beta aminoisobutyrate
53464-4,Decadienoylcarnitine (C10:2)
53465-1,Sebacylcarnitine (C10-DC)
53466-9,Eicosanoylcarnitine (C20)
53467-7,3-Keto n-Valerate
53468-5,Anthranilate
53469-3,Kynurenate
5347-0,Schistosoma sp Ab
53470-1,Kynurenin
53471-9,Decadienoylcarnitine (C10:2)
53472-7,Sebacylcarnitine (C10-DC)
53473-5,Eicosanoylcarnitine (C20)
53474-3,Glucose^4 AM specimen
53475-0,Glucose^pre dose betaxolol
53476-8,Glucose^2H post dose betaxolol
53477-6,Levodopa/Tyrosine
53478-4,Anthranilate
53479-2,Dihydroxycholestanoate
534-8,Mycobacterium sp identified
53480-0,Glucose^2.5H post dose betaxolol
53481-8,Glucose^15M pre dose betaxolol
53482-6,Glucose^3H post dose betaxolol
53483-4,Glucose^30M post dose betaxolol
53484-2,Glucose^30M pre dose betaxolol
53485-9,Glucose^45M post dose betaxolol
53486-7,Glucose^1H post dose betaxolol
53487-5,Glucose^1.5H post dose betaxolol
Aug-48,SCL-70 extractable nuclear Ab
53488-3,3-O-Methyldopa
53489-1,Kynurenate
53490-9,Kynurenin
53491-7,Kynurenin
53492-5,Decadienoylcarnitine (C10:2)
53493-3,Sebacylcarnitine (C10-DC)
53494-1,Eicosanoylcarnitine (C20)
53495-8,Iron^post dose deferoxamine
Jun-49,SCL-70 extractable nuclear Ab
53496-6,3-Methoxy-4-Hydroxyphenylglycol
53497-4,5-Hydroxytryptophan
53498-2,Anthranilate
53499-0,Creatinine
53500-5,Ammonia
53501-3,Iron
53502-1,Calcium
53503-9,Iron
Apr-50,Shigella sp Ab
53504-7,Decanoylcarnitine (C10)/Creatinine
53505-4,Asparagine/Amino acids.total
53506-2,Citrulline/Amino acids.total
53507-0,Kynurenin/Creatinine
53508-8,Decadienoylcarnitine (C10:2)/Creatinine
53509-6,Sebacylcarnitine (C10-DC)/Creatinine
53510-4,Dodecanoylcarnitine (C12)/Creatinine
53511-2,Dodecenoylcarnitine (C12:1)/Creatinine
Feb-51,Sjogrens syndrome-A extractable nuclear Ab
53512-0,Eicosanoylcarnitine (C20)/Creatinine
53513-8,Anthranilate/Creatinine
53514-6,Carnitine palmitoyltransferase 2
53515-3,Citrate synthase
53516-1,Basophils/100 leukocytes
53517-9,Erythrocytes
53518-7,Leukocytes
53519-5,Monocytes/100 leukocytes
5352-0,Sjogrens syndrome-A extractable nuclear Ab
53520-3,Neutrophils/100 leukocytes
53521-1,Polymorphonuclear cells
53522-9,Microscopic observation
53523-7,Vasoactive intestinal peptide
53524-5,Alkaline phosphatase.bile/Alkaline phosphatase.total
53525-2,Protein
53526-0,Triglyceride.in VLDL
53527-8,Triglyceride.in HDL 2
53528-6,Triglyceride.in HDL 3
53529-4,Albumin
53530-2,Albumin
53531-0,Albumin
53532-8,Albumin
53533-6,Herpes simplex virus Ab.IgG
53534-4,Varicella zoster virus Ab.IgG
53535-1,Varicella zoster virus Ab.IgM
53536-9,Measles virus Ab.IgG
53537-7,Measles virus Ab.IgM
Aug-53,Sjogrens syndrome-B extractable nuclear Ab
53538-5,Herpes simplex virus Ab.IgM
53539-3,Alpha globulin.abnormal band
53540-1,Alpha globulin.abnormal band/Protein.total
53541-9,Epithelial cells
53542-7,Dodeicosanoylcarnitine (C22)
53543-5,Dodeicosanoylcarnitine (C22)
53544-3,"3,4-Dihydroxyphenylacetate"
53545-0,Dodeicosanoylcarnitine (C22)
Jun-54,Sjogrens syndrome-B extractable nuclear Ab
53546-8,Dodeicosanoylcarnitine (C22)
53547-6,"3,4-Dihydroxyphenylacetate"
53548-4,"3,4-Dihydroxyphenylacetate"
53549-2,Dodeicosanoylcarnitine (C22)
535-5,Mycobacterium sp identified
53550-0,Fructosamine/Protein
53551-8,"3,4-Dihydroxyphenylacetate/Creatinine"
53552-6,Dodeicosanoylcarnitine (C22)/Creatinine
Mar-55,Smith extractable nuclear Ab
53553-4,Estimated average glucose
53554-2,Nitrogen
53555-9,Specific gravity
53556-7,Erythrocytes.Plasmodium sp infected/100 erythrocytes
53557-5,Nucleated cells
53558-3,Bacteria identified
53559-1,Beta-2 transferrin
53560-9,Herpes simplex virus Ab.IgM
Jan-56,Smith extractable nuclear Ab
53561-7,Lactate dehydrogenase/Creatinine
53562-5,Rheumatoid factor
53563-3,Platelet aggregation.adenosine diphosphate induced^20 umol/mL
53564-1,Platelet aggregation.adenosine diphosphate induced^50 umol/mL
53565-8,Platelet aggregation.adenosine diphosphate induced^100 umol/mL
53566-6,Platelet aggregation.collagen induced^8.0 ug/mL
53567-4,Platelet aggregation.EPINEPHrine induced^0.1 ug/mL
53568-2,Platelet aggregation.arachidonate induced^500 ug/mL
53569-0,Platelet aggregation.ristocetin induced^800 ug/mL
53570-8,Coagulation surface induced.lupus insensitive
53571-6,Yeast identified
53572-4,Staphylococcus aureus.methicillin resistant isolate
53573-2,cycloSPORINE^post dose
53574-0,Immunoglobulin light chains.lambda.free
53575-7,VAP panel
53576-5,Personal health monitoring report
53577-3,Reason for study additional note
53578-1,Alkaline phosphatase.intestinal 2/Alkaline phosphatase.total
Sep-57,Smith extractable nuclear Ab
53579-9,Alkaline phosphatase.intestinal 3/Alkaline phosphatase.total
53580-7,Galactosylceramidase
53581-5,Angiotensin converting enzyme
53582-3,Echovirus Ab
53583-1,Echovirus Ab.IgM
53584-9,Loa loa DNA
53585-6,Toxocara canis Ab.IgE
53586-4,HLA-B6
Jul-58,Smooth muscle Ab
53587-2,Beta globulin.abnormal band
53588-0,Beta globulin+Gamma globulin.abnormal band
53589-8,Beta globulin.abnormal band/Protein.total
53590-6,Gamma globulin.abnormal band/Protein.total
53591-4,Gamma globulin.abnormal band
53592-2,Gamma 2 globulin.abnormal band
53593-0,Gamma 2 globulin.abnormal band/Protein.total
53594-8,Chitobioside Ab.IgA
May-59,Somatotropin Ab
53595-5,Homovanillate
53596-3,Laminaribioside Ab.IgG
53597-1,Mannobioside Ab.IgG
53598-9,Irritable bowel disease prognostic panel
53599-7,ZIP code of prior primary residence
53600-3,pH
53601-1,HIV 1 p24 Ag
53602-9,Taenia solium larva Ag
Mar-60,Spermatozoa Ab
53603-7,Mumps virus RNA
53604-5,Brucella sp DNA
53605-2,Treponema pallidum DNA
53606-0,Neisseria meningitidis DNA
53607-8,Haemophilus influenzae B DNA
53608-6,Rickettsia sp DNA
53609-4,Parasite identified
53610-2,Erythroid cells
Jan-61,Spermatozoa Ab
53611-0,Toxoplasma gondii
53612-8,Urate
53613-6,Benzoylcarnitine (BzCn)
53614-4,Bacteria identified^^^2
53615-1,Bacteria identified^^^3
53616-9,Bacteria identified^^^4
53617-7,Bacteria identified
53618-5,Cells.ZAP70
53619-3,Cells.ZAP70
53620-1,KRAS gene targeted mutation analysis
53621-9,NRAS gene targeted mutation analysis
53622-7,von Willebrand factor cleaving protease actual/normal
53623-5,HRAS gene targeted mutation analysis
53624-3,Carnitine esters
53625-0,Leishmania sp identified
53626-8,Cerebral atrophic index
53627-6,Chloride
53628-4,20q chromosome deletion
Sep-62,Spermatozoa Ab
53629-2,Alpha cortol
536-3,Mycobacterium sp identified
53630-0,Alpha cortol/Creatinine
53631-8,Alpha cortol/Creatinine
53632-6,Breast Cancer Ag 225
53633-4,BCL1 Ag
53634-2,Beta cortol
53635-9,Beta cortol/Creatinine
53636-7,Beta cortol/Creatinine
Jul-63,Spirillum minus Ab
53637-5,BOB1 Ag
53638-3,CD45RB Ag
53639-1,CD52 Ag
53640-9,Chloride/Creatinine
53641-7,OCT2 Ag
53642-5,Glutathione.reduced/glutathione.oxidized
53643-3,Dichlorodiphenyltrichloroethane
53644-1,Carbaryl
May-64,Sporothrix schenckii Ab
53645-8,Polio virus identified
53646-6,Aldicarb
53647-4,Flavin adenine dinucleotide
53648-2,Flavin mononucleotide
53649-0,Parathion
53650-8,Methyl parathion
53651-6,pH
Feb-65,Saint Louis encephalitis virus Ab
53652-4,pH
53653-2,pH
53654-0,pH
53655-7,Diameter.transverse
53656-5,Diameter.anterior-posterior
53657-3,Perimeter
53658-1,Diameter
53659-9,Blood flow velocity.mean
5366-0,Staphylolysin Ab
53660-7,Study observation
53661-5,Reliability of last menstrual period observation
53662-3,Conception method
53663-1,Date of prior gestational age estimate
53664-9,Method of prior gestational age estimate
53665-6,Date of best overall gestational age estimate
53666-4,Method of best overall gestational age estimate
53667-2,Method of best overall fetal weight estimate
53668-0,Length.max
53669-8,Diameter
53670-6,Length.max
53671-4,Diameter
53672-2,Diameter
53673-0,Diameter.diastole
53674-8,Length
53675-5,Length.max
53676-3,Length.max
53677-1,Long axis
Aug-67,Streptobacillus moniliformis Ab
53678-9,Long axis
53679-7,Long axis
53680-5,Width.transverse
53681-3,Long axis
53682-1,Diameter.transverse
53683-9,Diameter.anterior-posterior
53684-7,Length.max
53685-4,Diameter.diastole
Jun-68,Streptococcus pneumoniae Ab.IgG
53686-2,Study observation
53687-0,Study observation
53688-8,Study observation
53689-6,Study observation
53690-4,Study observation
53691-2,Gestational age
53692-0,Delivery date
53693-8,Gestational age
Apr-69,Streptokinase Ab
53694-6,Delivery date
53695-3,Gestational age
53696-1,Long axis
53697-9,Long axis
53698-7,Long axis
53699-5,Long axis
53700-1,Long axis
53701-9,Length
Feb-70,Streptolysin O Ab
53702-7,Mycobacterium bovis tuberculin stimulated gamma interferon-Mycobacterium avium tuberculin stimulated gamma interferon
53703-5,Mycobacterium bovis tuberculin stimulated gamma interferon panel
53704-3,Mycobacterium bovis tuberculin stimulated gamma interferon-control stimulated gamma interferon
53705-0,Myasthenia gravis evaluation pediatric panel
53706-8,Myasthenia gravis evaluation adult reflex panel
53707-6,CV2 Ab.IgG
53708-4,Glutamate decarboxylase 65 Ab
53709-2,Glial nuclear type 1 Ab
537-1,Mycobacterium sp identified
5371-0,Streptolysin O Ab
53710-0,Hyperoxaluria panel
53711-8,Neuronal nuclear type 1 Ab
53712-6,Neuronal nuclear type 2 Ab
53713-4,Purkinje cell cytoplasmic type 1 Ab
53714-2,Glial nuclear type 1 Ab
53715-9,Paraneoplastic Ab
53716-7,levoFLOXacin
53717-5,Purkinje cell cytoplasmic type 1 Ab
53718-3,Acylglycines
53719-1,Date of death - Canada
53720-9,Race
53721-7,Amino acid marker assessed
53722-5,SLC26A4 gene.p.Glu384Gly
53723-3,SLC26A4 gene.p.Leu236Pro
53724-1,SLC26A4 gene.p.Thr416Pro
53725-8,SLC25A4 gene targeted mutation analysis
53726-6,KCNC3 gene targeted mutation analysis
53727-4,SOS1 gene targeted mutation analysis
Aug-72,Striated muscle Ab
53728-2,WS2A gene targeted mutation analysis
53729-0,Borrelia burgdorferi 49736 Ab.IgG
53730-8,Borrelia burgdorferi G39_40 Ab.IgG
53731-6,Posaconazole
53732-4,GCK gene targeted mutation analysis
53733-2,Color
53734-0,Kynurenine
53735-7,Barbiturates.other
Jun-73,Strongyloides sp Ab
53736-5,Benzodiazepines.other
53737-3,HLA-DQA1*01:02
53738-1,HLA-DQB1*2
53739-9,HLA-DQB1*9
53740-7,HLA-DRB1*17
53741-5,HLA-DRB1*7
53742-3,Legionella pneumophila 2+3+4+5+6+8 Ab
53743-1,Cocaine metabolites.other
Apr-74,Taenia saginata Ab
53744-9,Direct antiglobulin test.complement specific reagent
53745-6,Benzodiazepines panel
53746-4,Barbiturates panel
53747-2,Cocaine panel
53748-0,Lupus anticoagulant neutralization.dilute phospholipid
53749-8,Collection time^5th specimen
53750-6,Hydrogen/Expired gas^15M post XXX challenge
Jan-75,Taenia solium adult Ab
53751-4,Hydrogen/Expired gas^2.75H post XXX challenge
53752-2,Hydrogen/Expired gas^1.75H post XXX challenge
53753-0,Hydrogen/Expired gas^2.25H post XXX challenge
53754-8,Hydrogen/Expired gas^45M post XXX challenge
53755-5,Hydrogen/Expired gas^1.25H post XXX challenge
53756-3,Respiratory status
53758-9,HLA-DRB1 SBT
53759-7,Natural killer cell panel
53760-5,Cladosporium sp Ab.IgE
53761-3,JAK2 gene.p.Val617Phe mutant/normal
53762-1,Neisseria gonorrhoeae Ab.IgG
53763-9,Cytomegalovirus DNA
53764-7,Prostate specific Ag panel
53765-4,Estrogen
53766-2,Estrogen fraction panel
53767-0,HLA-A+B+C SBT
53768-8,Erythrocytes.CD55+CD59 actual/normal
Sep-76,Thermoactinomyces candidus Ab
53769-6,Erythrocytes.CD55+CD59 deficient actual/normal
53770-4,Legionella pneumophila 1+2+3+4+5+6 Ab.IgG
53771-2,Alpha 2 globulin
53772-0,Beta globulin
53773-8,Gamma globulin
53774-6,Epstein Barr virus DNA
53775-3,Hepatitis A virus Ab panel
53776-1,Hepatitis A virus Ab
Jul-77,Thermoactinomyces sacchari Ab
53777-9,Cortisone.free
53778-7,Arsenic.organic
53779-5,Arsenic.methylated
53780-3,Chromium panel
53781-1,Acetaminophen & Propoxyphene panel
53782-9,HTT gene.CAG repeats
53783-7,HTT gene mutation panel
53784-5,Legionella pneumophila 1+2+3+4+5+6 Ab.IgM
May-78,Thermoactinomyces vulgaris Ab
53785-2,Microscopic observation
53786-0,Microscopic observation
53787-8,Zolpidem
53788-6,Sodium urate crystals
53789-4,CFTR gene.p.IVS8 polyT 7T/9T variant
53790-2,CILD2 gene targeted mutation analysis
53791-0,PTPN11 gene targeted mutation analysis.tier 1
53792-8,PTPN11 gene targeted mutation analysis.tier 3
Mar-79,Platelet Ab
53793-6,RPS6KA3 gene targeted mutation analysis.tier 1
53794-4,RPS6KA3 gene targeted mutation analysis.tier 2
53795-1,STK11 gene targeted mutation analysis
53796-9,Interferon drug given
53797-7,Neutrophils.immature/100 leukocytes
53798-5,HIV reverse transcriptase+Protease gene mutations detected
53799-3,Major crossmatch
53800-9,Platelets panel
Jan-80,Thyroglobulin Ab
53801-7,Multisection
53802-5,Arbovirus Ab.IgG
53803-3,Transferrin.carbohydrate deficient panel
53804-1,Arbovirus Ab.IgG panel
53805-8,LDL apheresis procedure
53806-6,LDL apheresis procedure
53807-4,Basement membrane zone BP230 Ab.IgG
53808-2,Oligosaccharides pattern
53809-0,Oxygen.alveolar - arterial^^adjusted to patient's actual temperature
53810-8,Lymphocyte proliferation
53811-6,Triple phosphate
53812-4,Micafungin
53813-2,Platelet aggregation.adenosine diphosphate induced
53814-0,Platelet aggregation.arachidonate induced
53815-7,Platelet glycoprotein IIb-IIIa Ab
53816-5,Alpha hydroxytriazolam
53817-3,Carnosine
53818-1,Arbekacin
Sep-81,Thyroglobulin Ab
53819-9,Thiopurine methyltransferase
53820-7,Cefozopran
53821-5,Chloroamphetamine
53822-3,Flomoxef
53823-1,Panipenem
53824-9,Paromomycin
53825-6,HIV 1+Hepatitis C virus RNA
53826-4,Trisomy 21
Jul-82,Thyroperoxidase Ab
53827-2,Neural tube defect
53828-0,cycloSPORINE^trough
53829-8,Casein Ab.IgG
53830-6,Granulocytes.CD55 deficient/100 cells
53831-4,Granulocytes.CD59 deficient/100 cells
53832-2,Erythrocytes.CD55 deficient/100 erythrocytes
53833-0,Myoglobin
53834-8,cycloSPORINE^peak
May-83,Thyroperoxidase Ab
53835-5,"1,5-Anhydroglucitol"
53836-3,ABCD1 gene targeted mutation analysis
53837-1,ACVRL1 gene+ENG gene targeted mutation analysis
53838-9,Arsenic.inorganic
53839-7,Arsenic.organic
53840-5,TGFB3 gene targeted mutation analysis
53841-3,ATRX gene targeted mutation analysis
53842-1,Basement membrane zone BP180 Ab.IgG
Mar-84,Thyrotropin Ab
53843-9,Basement membrane zone BP230 Ab.IgG
53844-7,BRAF gene targeted mutation analysis
53845-4,BTD gene targeted mutation analysis
53846-2,Buprenorphine
53847-0,CACT gene targeted mutation analysis
53848-8,Mixed cellular casts
53849-6,HTC2 gene targeted mutation analysis
5385-0,Thyrotropin receptor Ab
53850-4,HTC2 gene mutations tested for
53851-2,COL10A1 gene targeted mutation analysis
53852-0,COL2A1 gene+COL11A1 gene targeted mutation analysis
53853-8,COL4A5 gene targeted mutation analysis
53854-6,CPS1 gene targeted mutation analysis
53855-3,DNAI1+DNAH5 gene targeted mutation analysis
53856-1,DYSF gene targeted mutation analysis
53857-9,Hemoglobin F
53858-7,EXT1 gene targeted mutation analysis
53859-5,Fatty acids.very long chain.C22:0
53860-3,Fatty acids.very long chain.C24:0
53861-1,FKTN gene targeted mutation analysis
53862-9,FIG4 gene targeted mutation analysis
53863-7,FLNA gene targeted mutation analysis
53864-5,GAA gene targeted mutation analysis
53865-2,Galactomannan Ag
53866-0,GCH1 gene targeted mutation analysis
53867-8,GYS2 gene targeted mutation analysis
Aug-86,Toxocara canis Ab
53868-6,Glucose tetrasaccharide/Creatinine
53869-4,HPRT1 gene targeted mutation analysis
53870-2,HPS1 gene targeted mutation analysis
53871-0,HRAS gene targeted mutation analysis
53872-8,Iodine
53873-6,IRF6 gene targeted mutation analysis
53874-4,Jamestown canyon virus RNA
53875-1,LMX1B gene targeted mutation analysis
Jun-87,Toxoplasma gondii Ab
53876-9,LRRK2 gene targeted mutation analysis
53877-7,NAGS gene targeted mutation analysis
53878-5,Neisseria gonorrhoeae rRNA
53879-3,Neisseria gonorrhoeae rRNA
53880-1,Norbuprenorphine
53881-9,Norbuprenorphine
53882-7,O-desmethylvenlafaxine
53883-5,OCRL1 gene targeted mutation analysis
Apr-88,Toxoplasma gondii Ab.IgG
53884-3,OTOF gene targeted mutation analysis
53885-0,Parvovirus B19 Ab.IgG
53886-8,Parvovirus B19 Ab.IgM
53887-6,PCCA gene+PCCB gene targeted mutation analysis
53888-4,PHEX gene targeted mutation analysis
53889-2,Platelet aggregation.arachidonate induced
538-9,Mycobacterium sp identified
53890-0,PLOD1 gene targeted mutation analysis
53891-8,PNKD gene targeted mutation analysis
Feb-89,Toxoplasma gondii Ab.IgG
53892-6,Ribosomal P Ab.IgG
53893-4,RNA polymerase III Ab
53894-2,TRAPPC2 gene targeted mutation analysis
53895-9,SH3BP2 gene targeted mutation analysis
53896-7,SMC1A gene targeted mutation analysis
53897-5,SPAST gene+KIAA0196 gene targeted mutation analysis
53898-3,KIAA0196 gene targeted mutation analysis
53899-1,TGFBR1 gene+TGFBR2 gene targeted mutation analysis
Sep-53,Butirosin
5390-0,Toxoplasma gondii Ab.IgM
53900-7,C10orf2 gene targeted mutation analysis
53901-5,USH2A gene targeted mutation analysis
53902-3,Voriconazole
53903-1,Collection method
53904-9,Microscopic observation
53905-6,Microscopic observation
53906-4,Microscopic observation
53907-2,Microscopic observation
53908-0,Bacteria identified
53909-8,Mycobacterium sp identified
53910-6,Microscopic observation
53911-4,Bacteria identified
53912-2,Microscopic observation
53913-0,Microscopic observation
53914-8,Microscopic observation
53915-5,Microscopic observation
53916-3,Microscopic observation
53917-1,Streptococcus pneumoniae DNA
Aug-91,Toxoplasma gondii Ab.IgM
53918-9,Microscopic observation
53919-7,Thyroglobulin Ab
53920-5,Thyroglobulin
53921-3,Thyroglobulin Ab
53922-1,Thyroglobulin
53923-9,HIV 1 tropism
53924-7,Rheumatoid factor
53925-4,Chlamydia trachomatis rRNA
Jun-92,Treponema pallidum Ab
53926-2,Chlamydia trachomatis rRNA
53927-0,Neisseria gonorrhoeae rRNA
53928-8,Glucose^20M post 50 g lactose PO
53929-6,Glucose^40M post 50 g lactose PO
53930-4,Histoplasma capsulatum Ag
53931-2,Histoplasma capsulatum Ag
53932-0,Streptococcus pneumoniae 14 serotypes & Corynebacterium diphtheriae toxin & Clostridium tetani toxin Ab.IgG panel
53933-8,Lactate dehydrogenase.pericard fld/Lactate dehydrogenase.serum
Apr-93,Treponema pallidum Ab
53934-6,Lactate dehydrogenase.periton fld/Lactate dehydrogenase.serum
53935-3,Clostridium tetani toxoid Ab.IgG
53936-1,Cells.CD3-CD56+
53937-9,HLA-B w4+w6
53938-7,HLA-DQB1
53939-5,CD4 stimulated ATP immune response
53940-3,CD4 stimulated ATP immune response
53941-1,Vibrio cholerae toxin Ag
Feb-94,Treponema pallidum Ab
53942-9,Vibrio cholerae toxin ctx gene
53943-7,Bacterial cytolethal distending toxin cdt gene
53944-5,Escherichia coli enteroinvasive
53945-2,Escherichia coli adherence pattern
53946-0,Escherichia coli shiga-like toxin identified
53947-8,Escherichia coli Stx1 & Stx2 toxin stx1 & stx2 & H7 flagellar fliC genes
53948-6,Donated egg
53949-4,HPA 1a-1a+HPA 3b-3b
53950-2,HPA 1a-1a+Glycoprotein IIb-IIIa
53951-0,HPA 1b-1b+HPA 3a-3a
53952-8,HPA 1b-1b+Glycoprotein IIb-IIIa
53953-6,HPA 5a-5a+Glycoprotein Ia-IIa
53954-4,HPA 5a-5b+Glycoprotein Ia-IIa
53955-1,Escherichia coli O157 identified
53956-9,Salmonella typhi
53957-7,Choriogonadotropin.tumor marker
53958-5,Choriogonadotropin.tumor marker
Sep-95,Trichinella spiralis Ab
53959-3,Choriogonadotropin.tumor marker
53960-1,Alpha-1-Fetoprotein.tumor marker
53961-9,Alpha-1-Fetoprotein.tumor marker
53962-7,Alpha-1-Fetoprotein.tumor marker
53963-5,Blood
53964-3,Leukocytes
53965-0,Brickdust deposit
53966-8,Erythrocytes.dysmorphic G1/100 erythrocytes
Jul-96,Triiodothyronine Ab
53967-6,Erythrocytes.dysmorphic/100 erythrocytes
53968-4,Erythrocytes.non-dysmorphic
53969-2,Microcytes
539-7,Mycobacterium sp identified
53970-0,Macrocytes
53971-8,Spherocytes
53972-6,Burr cells
53973-4,Erythrocytes.ghost cells
53974-2,Erythrocyte morphology
May-97,Trypanosoma brucei Ab
53975-9,Drug crystals
53976-7,Pseudocasts
53977-5,Dimagnesium phosphate crystals
53978-3,Epithelial cells.non-squamous
53979-1,Actin Ab
53980-9,Actin Ab
53981-7,Centromere protein B Ab
53982-5,Centromere protein B Ab
Mar-98,Trypanosoma cruzi Ab
53983-3,Nuclear Ab pattern.homogeneous
53984-1,Nuclear Ab pattern.fine speckled
53985-8,Nuclear Ab pattern.coarse speckled
53986-6,Nuclear Ab pattern.coarse speckled
53987-4,Nuclear Ab pattern.atypic speckled
53988-2,Nuclear Ab pattern.atypic speckled
53989-0,Nuclear Ab pattern.chromosomal
53990-8,Nuclear Ab pattern.chromosomal
Jan-99,Trypanosoma sp Ab
53991-6,Nuclear Ab pattern.nucleolar
53992-4,Nuclear Ab pattern.nucleolar
53993-2,Nuclear Ab pattern.centrosomal
53994-0,Nuclear Ab pattern.centrosomal
53995-7,Nuclear Ab pattern.nuclear matrix
53996-5,Nuclear Ab pattern.nuclear matrix
53997-3,Nuclear Ab pattern.nuclear dots
53998-1,Nuclear Ab pattern.nuclear dots
53999-9,Nuclear Ab pattern.multiple nuclear dots
54000-5,Nuclear Ab pattern.multiple nuclear dots
54001-3,Centromere protein F Ab
54002-1,Centromere protein F Ab
54003-9,Human upstream binding factor Ab
54004-7,Human upstream binding factor Ab
54005-4,Nuclear Ab pattern.nuclear membrane pores
54006-2,Nuclear Ab pattern.nuclear membrane pores
Jul-00,Vaccinia virus Ab
54007-0,Golgi apparatus Ab
54008-8,Golgi apparatus Ab
54009-6,Lysosome Ab
54010-4,Lysosome Ab
54011-2,Vimentin Ab
54012-0,Vimentin Ab
54013-8,Vinculin Ab
54014-6,Vinculin Ab
May-01,Varicella zoster virus Ab
54015-3,Azurocidin Ab
54016-1,Cathepsin G Ab
54017-9,Elastase Ab
54018-7,Lactoferrin Ab
54019-5,Lysozyme Ab
54020-3,Actin.filamentous Ab
54021-1,Actin.filamentous Ab
54022-9,Mutated citrullinated vimentin Ab
Mar-02,Varicella zoster virus Ab
54023-7,U1 small nuclear ribonucleoprotein C Ab
54024-5,sp100 Ab
54025-2,Nuclear pore protein gp210 Ab
54026-0,Soluble liver Ab
54027-8,Lamin Ab
54028-6,Lamin Ab
54029-4,Soluble liver Ab
54030-2,Smith extractable nuclear B Ab
Jan-03,Varicella zoster virus Ab.IgG
54031-0,Smith extractable nuclear D Ab
54032-8,U1 small nuclear ribonucleoprotein A Ab
54033-6,Rickettsia spotted fever group Ag
54034-4,Anaplasma phagocytophilum Ag
54035-1,Ehrlichia chaffeensis Ag
54036-9,Western equine encephalitis virus RNA
54037-7,HEDIS 2009 panel
54038-5,HEDIS 2009-2013 Codes to identify cervical cancer screening tests (CCS-A)
54039-3,HEDIS 2009-2011 Codes to identify HbA1c tests (CDC-D)
54040-1,HEDIS 2009 Codes to identify LDLc screening (CDC-H)
54041-9,HEDIS 2009 Codes to identify nephropathy screening tests (CDC-J)
54042-7,HEDIS 2009 Codes to identify evidence of nephropathy (CDC-K)
54043-5,HEDIS 2009 Codes to identify sexually active women (CHL-B)
54044-3,HEDIS 2009 Codes to identify Chlamydia screening (CHL-C)
54045-0,"HEDIS 2009, 2010 Codes to identify exclusions (CHL-D)"
54046-8,HEDIS 2009 Codes to identify LDLc screening (CMC-D)
54047-6,HEDIS 2009 Codes to identify colorectal cancer screening (COL-A)
54048-4,HEDIS 2009 Codes to identify group A Streptococcus tests (CWP-D)
Sep-04,Varicella zoster virus Ab.IgM
54049-2,HEDIS 2009-2013 Codes to identify lead (LSC-A)
540-5,Mycobacterium sp identified
54050-0,HEDIS 2009 Codes to identify physiologic monitoring tests (MPM-A)
54051-8,HEDIS 2009 Codes to identify physiologic monitoring tests - Blood urea nitrogen (BUN) (MPM-A)
54052-6,HEDIS 2009 Codes to identify physiologic monitoring tests - Serum creatinine (SCr) (MPM-A)
54053-4,HEDIS 2009 Codes to identify physiologic monitoring tests - Serum potassium (MPM-A)
54054-2,HEDIS 2009 Codes to identify anticonvulsant serum concentration monitoring tests (MPM-E)
54055-9,HEDIS 2009 Codes to identify anticonvulsant serum concentration monitoring tests - carBAMazepine (MPM-E)
Jun-05,Vibrio cholerae Ab
54056-7,HEDIS 2009-2011 Codes to identify anticonvulsant serum concentration monitoring tests - PHENobarbital (MPM-E)
54057-5,"HEDIS 2009, 2010 Codes to identify anticonvulsant serum concentration monitoring tests - Phenytoin (MPM-E)"
54058-3,HEDIS 2009-2013 Codes to identify anticonvulsant serum concentration monitoring tests - Valproate (MPM-E)
54059-1,HEDIS 2009 Tests used in early prenatal care (PPC-C)
54060-9,HEDIS 2009 Tests used in early prenatal care - ABO & Rh (PPC-C)
54061-7,HEDIS 2009-2011 Tests used in early prenatal care - Cytomegalovirus (PPC-C)
54062-5,"HEDIS 2009, 2010 Tests used in early prenatal care - Herpes simplex (PPC-C)"
54063-3,HEDIS 2009 Tests used in early prenatal care - Rubella (PPC-C)
Apr-06,Western equine encephalitis virus Ab
54064-1,HEDIS 2009 Tests used in early prenatal care - Toxoplasma (PPC-C)
54065-8,HEDIS 2009-2013 Codes to identify postpartum visits (PPC-E)
54066-6,Post acute care or personal assistance anticipated following discharge
54067-4,Clostridioides difficile toxin genes
54068-2,Hemoglobin O-Arab/Hemoglobin.total
54069-0,Hemoglobin Barts/Hemoglobin.total
54070-8,Hemoglobin D/Hemoglobin.total
54071-6,Hemoglobin E/Hemoglobin.total
Feb-07,Yersinia enterocolitica O:3 Ab
54072-4,Hemoglobin A/Hemoglobin.total
54073-2,Hemoglobin C/Hemoglobin.total
54074-0,Hemoglobin F/Hemoglobin.total
54075-7,Endocrine newborn screening panel (SI units)
54076-5,Endocrine newborn screening panel
54077-3,Thyroid newborn screening panel (SI units)
54078-1,Cystic fibrosis newborn screening panel
54079-9,Galactosemia newborn screening panel
5408-0,Yersinia enterocolitica O:8 Ab
54080-7,Galactosemia newborn screening panel (SI units)
54081-5,Hemoglobinopathies newborn screening panel
54082-3,Infectious diseases newborn screening panel
54083-1,CFTR gene targeted mutation analysis
54084-9,Galactose
54085-6,Galactose
54086-4,HIV 1+2 Ab.IgG
54087-2,Toxoplasma gondii Ab.IgG
54088-0,Toxoplasma gondii Ab.IgM
54089-8,Newborn screening panel
54090-6,Thyroid newborn screening panel
54091-4,Rubella virus RNA
54092-2,Citrulline/Arginine
54093-0,Pesticides
54094-8,Triage note
54095-5,Chemotherapy effectiveness panel
54096-3,Identity testing
54097-1,Organophosphonate nerve agent metabolite panel
Aug-09,Yersinia enterocolitica O:9 Ab
54098-9,Isopropyl methylphosphonate
54099-7,"1,2,2-Trimethylpropyl methylphosphonate"
54100-3,Monocyclohexyl methylphosphonate
54101-1,2-Methylpropyl methylphosphonate
54102-9,Monoethyl methylphosphonate
54103-7,Hemoglobin pattern
54104-5,Hemoglobin pattern
54105-2,Hemoglobin pattern
Jun-10,Yersinia pseudotuberculosis Ab
54106-0,Newborn hearing screen method
54107-8,Newborn hearing screen
54108-6,Newborn hearing screen
54109-4,Newborn hearing screen
54110-2,Newborn hearing screen
54111-0,Newborn hearing screening panel
54112-8,Cause of death
54113-6,Age range at death
Apr-11,Yersinia sp Ab
54114-4,Family member health history
54115-1,Age range at onset of disease
54116-9,History of diseases
54117-7,Diseases history panel
54118-5,Parents related
54119-3,Race
54120-1,Ethnicity
54121-9,Twin
Feb-12,B-B4
54122-7,Adopted
54123-5,Sex
54124-3,Birth date
54125-0,Name
54126-8,My health history
54127-6,US Surgeon General family health portrait
54128-4,Adopted
54129-2,Age range at death
541-3,Mycobacterium sp identified
5413-0,CD1
54130-0,Age range at onset of disease
54131-8,Sex
54132-6,Twin
54133-4,Ethnicity
54134-2,Race
54135-9,Parents related
54136-7,Relationship to patient
54137-5,Diseases history panel
54138-3,Name
54139-1,Living
54140-9,History of diseases
54141-7,Current age
54142-5,Candida sp DNA
54143-3,Gardnerella vaginalis DNA
54144-1,Trichomonas vaginalis DNA
54145-8,Bacterial vaginosis & vaginitis DNA panel
54146-6,Mycobacterium tuberculosis Ab.IgG
54147-4,Autoantibodies
Aug-14,CD10
54148-2,Autoantibodies
54149-0,Nuclear Ab pattern.homogeneous
54150-8,Centriole Ab
54151-6,Centriole Ab
54152-4,Nuclear mitotic apparatus Ab
54153-2,Nuclear mitotic apparatus Ab
54154-0,Nuclear Ab pattern.intercellular bridge
May-15,CD10+CD20+
54155-7,Nuclear Ab pattern.intercellular bridge
54156-5,RNA polymerase I Ab
54157-3,RNA polymerase I Ab
54158-1,Pancytokeratin Ab
54159-9,Pancytokeratin Ab
54160-7,Ki Ab
54161-5,Cytoplasmic Ab pattern.PL-7+PL-12
54162-3,Cytoplasmic Ab pattern.PL-7+PL-12
Mar-16,CD100
54163-1,Cytomegalovirus DNA
54164-9,Cytomegalovirus immediate-early Ag
54165-6,Tumor necrosis factor binding protein
54166-4,Cefoperazone+Sulbactam
54167-2,Cefoperazone+Sulbactam
54168-0,Cefoperazone+Sulbactam
54169-8,Thiamphenicol
54170-6,Imipenem+EDTA
Jan-17,CD102
54171-4,Imipenem+EDTA
54172-2,Imipenem+EDTA
54173-0,Arbekacin
54174-8,Cefmenoxime
54175-5,Caspofungin
54176-3,Caspofungin
54177-1,Clotrimazole
54178-9,Econazole
54179-7,Itraconazole
54180-5,Miconazole
54181-3,Nitroxoline
54182-1,Para aminosalicylate
54183-9,Rifabutin
54184-7,Thiacetazone
54185-4,Caspofungin
54186-2,Posaconazole
54187-0,Posaconazole
54188-8,Posaconazole
Sep-18,CD103
54189-6,Posaconazole
54190-4,Temocillin
54191-2,Cefotaxime+Sulbactam
54192-0,Cefotaxime+Sulbactam
54193-8,Cefotaxime+Sulbactam
54194-6,Mezlocillin+Sulbactam
54195-3,Mezlocillin+Sulbactam
54196-1,Mezlocillin+Sulbactam
Jul-19,CD104
54197-9,Piperacillin+Sulbactam
54198-7,Piperacillin+Sulbactam
54199-5,Piperacillin+Sulbactam
54200-1,Griseofulvin
54201-9,Griseofulvin
54202-7,Griseofulvin
54203-5,Cefmenoxime
54204-3,Thiacetazone
May-20,CD105
54205-0,Legionella pneumophila 7+8+9+10+11+12+13+14 Ab
54206-8,Cytomegalovirus DNA
54207-6,Coagulation surface induced.factor substitution^immediately after addition of factor V depleted plasma
54208-4,Coagulation surface induced.factor substitution^immediately after addition of factor V depleted plasma+APC
54209-2,Hemoglobin C-Harlem/Hemoglobin.total
542-1,Mycobacterium sp identified
54210-0,Hepatitis B virus basal core promoter mutation
54211-8,Cortisol^24H post dose dexamethasone
54212-6,Cortisol^3D post dose dexamethasone
Mar-21,CD106
54213-4,Cortisol^4D post dose corticotropin
54214-2,Cortisol^5D post dose dexamethasone
54215-9,Cortisol^5H post dose corticotropin
54216-7,Insulin-like growth factor binding protein 1^pre or post XXX challenge
54217-5,Public health notifiable condition
54218-3,Cells.CD3+CD4+/Cells.CD3+CD8+
54219-1,Coagulation thrombin induced.factor substitution^immediately after 1:4 addition of normal plasma
54220-9,Immune response markers
Jan-22,CD107a
54221-7,Lymphoma markers
54222-5,Lymphoma - acute screen markers
54223-3,Lymphoma - CLL screen markers
54224-1,Lymphoma - T-cell markers
54225-8,Immune response panel
54226-6,Lymphoma panel
54227-4,Lymphoma - acute screen panel
54228-2,Lymphoma - CLL screen panel
54229-0,Lymphoma - T-cell screen panel
54230-8,Cell count & Differential panel with Glucose & Protein
54231-6,Semen analysis fertility panel
54232-4,Metabolic panel.large animal
54233-2,Metabolic panel.small animal
54234-0,Cell count & Differential panel with Glucose & Protein
54235-7,Cortisol challenge panel
54236-5,Cortisol^9 AM 2nd day specimen
54237-3,Corticotropin^9 AM 2nd day specimen
54238-1,LDL.oxidized
Sep-23,CD107b
54239-9,Cytopathic effect
54240-7,Influenza virus Ag
54241-5,Influenza virus B Ag
54242-3,Influenza virus identified
54243-1,Influenza virus RNA
54244-9,Influenza virus identified
54245-6,Respiratory virus Ag
54246-4,Protein & Glucose panel
Jul-24,CD115
54247-2,Drug screen comment
54248-0,Glucose^10M pre dose glucagon
54249-8,Glucose^15M post dose glucagon
54250-6,Glucose^15M pre dose glucagon
54251-4,Glucose^20M post dose glucagon
54252-2,Glucose^2M post dose glucagon
54253-0,Glucose^4M post dose glucagon
Apr-25,CD117
54254-8,Glucose^5M pre dose glucagon
54255-5,Glucose^6M post dose glucagon
54256-3,Glucose^8M post dose glucagon
54257-1,Glucose^pre dose insulin IV
54258-9,Glucose^2H post dose insulin IV
54259-7,Glucose^2.5H post dose insulin IV
54260-5,Glucose^15M post dose insulin IV
54261-3,Glucose^15M pre dose insulin IV
Feb-26,CD11a
54262-1,Glucose^3H pre dose insulin IV
54263-9,Glucose^30M post dose insulin IV
54264-7,Glucose^45M post dose insulin IV
54265-4,Glucose^1H post dose insulin IV
54266-2,Glucose^1.3H post dose insulin IV
54267-0,Glucose^1.5H post dose insulin IV
54268-8,Glucose^pre dose ornithine alpha-ketoglutarate
54269-6,Glucose^2H post dose ornithine alpha-ketoglutarate
5427-0,CD11b
54270-4,Glucose^2.5H post dose ornithine alpha-ketoglutarate
54271-2,Glucose^15M post dose ornithine alpha-ketoglutarate
54272-0,Glucose^15M pre dose ornithine alpha-ketoglutarate
54273-8,Glucose^3H post dose ornithine alpha-ketoglutarate
54274-6,Glucose^30M post dose ornithine alpha-ketoglutarate
54275-3,Glucose^45M post dose ornithine alpha-ketoglutarate
54276-1,Glucose^1H post dose ornithine alpha-ketoglutarate
54277-9,Glucose^1.5H post dose ornithine alpha-ketoglutarate
54278-7,Glutarate
54279-5,Glutarylcarnitine (C5-DC)/Creatinine
54280-3,Glutarylcarnitine (C5-DC)
54281-1,Glutarylcarnitine (C5-DC)
54282-9,Glutarylcarnitine (C5-DC)
54283-7,Glycerol
54284-5,Glycerol
54285-2,Glycerol
54286-0,Glycolate
54287-8,Guanidinoacetate
Aug-28,CD11c
54288-6,Guanidinoacetate
54289-4,Hemoglobin
54290-2,Heptanoylcarnitine (C7)/Creatinine
54291-0,Heptanoylcarnitine (C7)
54292-8,Heptanoylcarnitine (C7)
54293-6,Heptanoylcarnitine (C7)
54294-4,Fatty acids.very long chain.C26:0/Creatinine
54295-1,Hexanoylcarnitine (C6)/Creatinine
Jun-29,CD120a
54296-9,Hexanoylcarnitine (C6)
54297-7,Hexanoylcarnitine (C6)
54298-5,Hexanoylcarnitine (C6)
54299-3,Homocitrulline
54300-9,Homocysteine
54301-7,Homocysteine
54302-5,Homocystine
54303-3,Hydroxylysine
Apr-30,CD120b
54304-1,Isobutyrylglycine
54305-8,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)
54306-6,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)
54307-4,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)
54308-2,Isovalerylglycine
54309-0,Lactate/Pyruvate
54310-8,Linoleoylcarnitine (C18:2)/Creatinine
54311-6,Linoleoylcarnitine (C18:2)
Feb-31,CD122
54312-4,Linoleoylcarnitine (C18:2)
54313-2,Linoleoylcarnitine (C18:2)
54314-0,Malonylcarnitine (C3-DC)/Creatinine
54315-7,Methylmalonate
54316-5,Methylmalonylcarnitine (C4-DC)/Creatinine
54317-3,Methylmalonylcarnitine (C4-DC)
54318-1,Methylmalonylcarnitine (C4-DC)
54319-9,Methylmalonylcarnitine (C4-DC)
5432-0,CD126
54320-7,Octanoylcarnitine (C8)/Creatinine
54321-5,Octanoylcarnitine (C8)
54322-3,Octanoylcarnitine (C8)
54323-1,Palmitoylcarnitine (C16)/Creatinine
54324-9,Palmitoylcarnitine (C16)
54325-6,Palmitoylcarnitine (C16)
54326-4,Phosphoethanolamine
54327-2,Pipecolate
54328-0,Pipecolate
54329-8,Propionylcarnitine (C3)/Creatinine
54330-6,Propionylcarnitine (C3)
54331-4,Propionylcarnitine (C3)
54332-2,Propionylglycine
54333-0,Stearoylcarnitine (C18)/Creatinine
54334-8,Stearoylcarnitine (C18)
54335-5,Stearoylcarnitine (C18)
54336-3,Sulfocysteine
54337-1,Sulfocysteine
Aug-33,CD128
54338-9,Tetradecanoylcarnitine (C14)/Creatinine
54339-7,Tetradecanoylcarnitine (C14)
54340-5,Tetradecanoylcarnitine (C14)
54341-3,Myristoleate/Creatinine
54342-1,Tiglylglycine
54343-9,3-Methoxytyramine/Creatinine
54344-7,3-Methoxytyramine
54345-4,Acetylcarnitine (C2)
Jun-34,CD13
54346-2,Albumin
54347-0,Albumin
54348-8,Alpha-1-Fetoprotein
54349-6,Ammonia
54350-4,Ascorbate+Dehydroascorbate
54351-2,Ascorbate+Dehydroascorbate
54352-0,Nitrogen
Mar-35,CD14
54353-8,Beta 1 globulin
54354-6,Beta 2 globulin
54355-3,Beta-2-Microglobulin.CSF/Beta-2-Microglobulin.serum
54356-1,Beta-2-Microglobulin
54357-9,Beta 2 globulin+Gamma globulin/Protein.total
54358-7,Beta globulin/Protein.total
54359-5,Bicarbonate^post dialysis
54360-3,Bicarbonate
Jan-36,CD15
54361-1,Bicarbonate
54362-9,Bilirubin
54363-7,Bilirubin
54364-5,Calcium
54365-2,Calcium
54366-0,Calcium.ionized^^adjusted to pH 7.4
54367-8,Calcium.ionized
54368-6,Catalase
54369-4,Chloride^post dialysis
54370-2,Chloride
54371-0,Cholesterol
54372-8,Cholesterol.in HDL
54373-6,Cholesterol.non-esterified
54374-4,Creatinine/body weight
54375-1,Creatinine
54376-9,Cobalamins
54377-7,Cobalamins
54378-5,Cobalamins
Sep-37,CD16
54379-3,Cystatin C/Creatinine
54380-1,Cystatin C
54381-9,Cystatin C
54382-7,Cytochrome C oxidase
54383-5,Cytochrome C oxidase
54384-3,Cytochrome C oxidase
54385-0,Dehydroascorbate/Ascorbate
54386-8,Dehydroascorbate
Jul-38,CD16+CD56+CD3-
54387-6,Dihydroxycholestanoate
54388-4,Dihydroxycholestanoate
54389-2,Dodecanoylcarnitine (C12)
543-9,Mycobacterium sp identified
54390-0,Fibroblast growth factor 23.intact
54391-8,Gamma globulin/Protein.total
54392-6,Glucose^1st specimen post XXX challenge
54393-4,Glucose^10th specimen post XXX challenge
54394-2,Glucose^11th specimen post XXX challenge
May-39,CD16+CD57+
54395-9,Glucose^12th specimen post XXX challenge
54396-7,Glucose^2nd specimen post XXX challenge
54397-5,Glucose^3rd specimen post XXX challenge
54398-3,Glucose^4th specimen post XXX challenge
54399-1,Glucose^9th specimen post XXX challenge
54400-7,Glucose^pre dose glucagon
54401-5,Glucose^10M post dose glucagon
54402-3,4-Hydroxymidazolam
Mar-40,CD16+CD57-
54403-1,Transfuse 5% plasma protein fraction units
54404-9,Pooled platelet concentrate units given
54405-6,Transfuse pooled cryoprecipitate units
54406-4,Pooled cryoprecipitate units given
54407-2,Transfuse pooled fresh frozen plasma units
54408-0,Pooled fresh frozen plasma units given
54409-8,Direct antiglobulin test.complement C3+C4 specific reagent
54410-6,Direct antiglobulin test.complement C3 specific reagent
Jan-41,CD16-CD57-
54411-4,Rh immune globulin given
54412-2,Cryoprecipitate poor plasma units given
54413-0,Transfuse leukocyte-poor plateletpheresis units
54414-8,Leukocyte-poor plateletpheresis units given
54415-5,Transfuse leukocyte-poor platelets units
54416-3,Rh
54417-1,ABO & Rh group
54418-9,Transfuse fresh frozen plasma pediatric units
54419-7,Whole blood pediatric units given
54420-5,Frozen erythrocytes newborn units given
54421-3,Transfuse frozen erythrocytes pediatric units
54422-1,Frozen erythrocytes pediatric units given
54423-9,Transfuse plateletpheresis half units
54424-7,Plateletpheresis half units given
54425-4,Weak D Ag
54426-2,Fresh frozen plasma pediatric units given
54427-0,Transfuse frozen erythrocytes newborn units
54428-8,Frozen packed erythrocytes given
Sep-42,CD16b
54429-6,5% plasma protein fraction given
54430-4,Pooled platelets given
54431-2,Pooled cryoprecipitate given
54432-0,Pooled fresh frozen plasma given
54433-8,User safety warnings section
54434-6,Lipoprotein.beta.subparticle
54435-3,Aspergillus fumigatus Ab
54436-1,Urate dihydrate/Total
Jul-43,CD18
54437-9,Sodium urate/Total
54438-7,Cholesterol/Total
54439-5,Calcium bilirubinate/Total
54440-3,Newberyite/Total
54441-1,Lipoprotein goals
54442-9,Carnitine esters/Carnitine.free (C0)
54443-7,Echovirus 2 Ab
54444-5,Echovirus 8 Ab
May-44,CD19
54445-2,Fatty acids.very long chain.C22:1n9
54446-0,Fatty acids.very long chain.C26:1
54447-8,FLT3 gene targeted mutation analysis
54448-6,NPM1 gene targeted mutation analysis
54449-4,SMN2 gene targeted mutation analysis
54450-2,CYP2C9 & VKORC1 panel
54451-0,CYP2C9 & VKORC1
Feb-45,CD19+SmIg kappa+
54452-8,Ferning
54453-6,Test method
54454-4,Arsenic fractions panel
54455-1,Blastomyces dermatitidis Ag
54456-9,Urea reduction ratio
54457-7,Biotinidase
54458-5,Granulocyte colony stimulating factor
54459-3,Dicarboxypalmitoylcarnitine (C16-DC)/Creatinine
5446-0,CD19+SmIg lambda+
54460-1,Malonylcarnitine (C3-DC)
54461-9,Malonylcarnitine (C3-DC)
54462-7,Malonylcarnitine (C3-DC)
54463-5,Malonylcarnitine (C3-DC)
54464-3,Albumin/Protein.total
54465-0,Alpha 1 globulin/Protein.total
54466-8,Alpha 2 globulin/Protein.total
54467-6,Cholesterol.in HDL 2a/Cholesterol.in HDL.total
54468-4,Cholesterol.in HDL 2b/Cholesterol.in HDL.total
54469-2,Cholesterol.in HDL 3a/Cholesterol.in HDL.total
544-7,Bacteroides fragilis Ag
54470-0,Cholesterol.in HDL 3b/Cholesterol.in HDL.total
54471-8,Cholesterol.in HDL 3c/Cholesterol.in HDL.total
54472-6,Amylase.macromolecular/Amylase.total
54473-4,Pimeloylcarnitine (C7-DC)
54474-2,Pimeloylcarnitine (C7-DC)
54475-9,Pimeloylcarnitine (C7-DC)
54476-7,Pimeloylcarnitine (C7-DC)
54477-5,Dicarboxypalmitoylcarnitine (C16-DC)
Aug-47,CD2
54478-3,Dicarboxypalmitoylcarnitine (C16-DC)
54479-1,Dicarboxypalmitolycarnitine (C16-DC)
54480-9,Dicarboxypalmitoylcarnitine (C16-DC)
54481-7,Dicarboxystearoylcarnitine (C18-DC)/Creatinine
54482-5,Dicarboxystearoylcarnitine (C18-DC)
54483-3,Dicarboxystearoylcarnitine (C18-DC)
54484-1,Octadecanedioylcarnitine (C18-DC)
54485-8,Dicarboxystearoylcarnitine (C18-DC)
Jun-48,CD20
54486-6,Glucose
54487-4,Glucose
54488-2,Pimeloylcarnitine (C7-DC)/Creatinine
54489-0,Phosphoserine
54490-8,Pipecolate
54491-6,Alanine aminotransferase
54492-4,Alanine aminotransferase
54493-2,Allantoine
Apr-49,CD21
54494-0,Chloride
54495-7,Glucose^post dialysis
54496-5,Glucose^5th specimen post XXX challenge
54497-3,Glucose^6th specimen post XXX challenge
54498-1,Glucose^7th specimen post XXX challenge
54499-9,Glucose^8th specimen post XXX challenge
54500-4,Aspartate aminotransferase.macromolecular/Aspartate aminotransferase.total
54501-2,Identification information
Feb-50,CD22
54502-0,Assessment &or tracking type
54503-8,Legal name of patient
54504-6,Social Security and Medicare numbers
54505-3,Language
54506-1,Optional resident items
54507-9,Medicare stay
54508-7,"Hearing, speech, and vision"
54509-5,Cognitive patterns
5451-0,CD22+CD19+
54510-3,"Temporal orientation (orientation to year, month, and day)"
54511-1,Behavior
54512-9,Psychosis in last 7D
54513-7,Behavioral symptoms
54514-5,Behavioral symptom - presence & frequency
54515-2,Impact on resident
54516-0,Impact on others
54517-8,Wandering - impact
54518-6,Preferences for customary routine and activities
54519-4,Interview for daily preferences
54520-2,Interview for activity preferences
54521-0,Staff assessment of daily and activity preferences
54522-8,Functional status
54523-6,Activities of Daily Living (ADL) assistance in last 7D
54524-4,Balance during transitions and walking
54525-1,Functional limitation in range of motion
54526-9,Mobility devices
54527-7,Functional rehabilitation potential
Aug-52,CD23
54528-5,Bladder and bowel
54529-3,Appliances
54530-1,Urinary toileting program
54531-9,Active disease diagnosis
54532-7,Cancer
54533-5,Heart &or circulation
54534-3,Gastrointestinal
54535-0,Genitourinary
Jun-53,CD24
54536-8,Infections
54537-6,Metabolic
54538-4,Musculoskeletal
54539-2,Neurological
545-4,Bacteroides melaninogenicus Ag
54540-0,Nutritional
54541-8,Psychiatric &or mood disorder
54542-6,Pulmonary
54543-4,Vision
Apr-54,CD25
54544-2,None of above active diagnoses
54545-9,Additional diagnoses
54546-7,Additional ICD diagnosis 1 in last 7D
54547-5,Additional ICD diagnosis 2 in last 7D
54548-3,Additional ICD diagnosis 3 in last 7D
54549-1,Additional ICD diagnosis 4 in last 7D
54550-9,Additional ICD diagnosis 5 in last 7D
Jan-55,CD26
54551-7,Additional ICD diagnosis 6 in last 7D
54552-5,Additional ICD diagnosis 7 in last 7D
54553-3,Additional ICD diagnosis 8 in last 7D
54554-1,Additional ICD diagnosis 9 in last 7D
54555-8,Additional ICD diagnosis 10 in last 7D
54556-6,Health conditions
54557-4,Pain management
54558-2,Pain assessment interview
54559-0,Pain effect on function
54560-8,Pain intensity
54561-6,Staff assessment for pain
54562-4,Indicators of pain or possible pain
54563-2,Other health conditions
54564-0,Shortness of breath
54565-7,Swallowing &or nutritional status
54566-5,Swallowing disorder
54567-3,Height and weight
54568-1,Nutritional approaches panel
Sep-56,CD27
54569-9,Percent intake by artificial route
54570-7,Oral &or dental status
54571-5,Dental
54572-3,Skin conditions
54573-1,Determination of pressure injury risk
54574-9,Presence of pressure injury
54575-6,Current number of unhealed (non-epithelialized) pressure injuries at each stage
54576-4,Pressure injuries - stage 2
Jul-57,CD28
54577-2,Pressure injuries - stage 3
54578-0,Pressure injuries - stage 4
54579-8,Pressure injuries - unstageable due to non-removable dressing
54580-6,Minimum Data Set - version 3.0
54581-4,Facility provider numbers
54582-2,Provider type
54583-0,Federal OBRA reason for assessment
54584-8,PPS Assessment
May-58,CD29
54585-5,PPS Other Medicare Required Assessment - OMRA
54586-3,State required assessment
54587-1,First assessment since the most recent admission &or reentry
54588-9,Interpreter needed
54589-7,Preadmission Screening and Resident Review (PASRR)
54590-5,Entry type
54591-3,Admitted from
54592-1,Previous assessment reference date for significant correction
Mar-59,CD3
54593-9,Assessment reference date - observation end date
54594-7,Medicare-covered stay since the most recent entry
54595-4,Start date of most recent Medicare stay
54596-2,End date of most recent Medicare stay
54597-0,Comatose
54598-8,Hearing.ability to hear in last 7D
54599-6,Hearing aid used during assessment period
54600-2,Speech clarity.description of speech pattern
Jan-60,CD3+DR+
54601-0,Express ideas and wants in last 7D
54602-8,Understanding verbal content
54603-6,Vision.ability to see in adequate light in last 7D
54604-4,Corrective lenses used
54605-1,Brief interview for mental status should be conducted
54606-9,Repetition of three words
54607-7,Temporal orientation - current year
54608-5,Temporal orientation - current month
54609-3,Temporal orientation - current day of the week
54610-1,Recall
54611-9,Recall - sock
54612-7,Recall - blue
54613-5,Recall - bed
54614-3,Brief interview for mental status - summary score
54615-0,Should staff assessment for mental status be conducted
54616-8,Short-term memory OK
54617-6,Long-term memory OK
54618-4,Memory &or recall ability
Sep-61,CD30
54619-2,Can recall current season in last 7D
546-2,Streptococcus.beta-hemolytic
54620-0,Can recall location of own room in last 7D
54621-8,Can recall staff names and faces in last 7D
54622-6,Can recall that he or she is in a nursing home in last 7D
54623-4,None of the above were recalled in last 7D
54624-2,Cognitive skills for daily decision making
54625-9,Procedural memory OK in last 7D
54626-7,Delirium
Jul-62,CD31
54627-5,Signs and symptoms of delirium (from CAM)
54628-3,Inattention in last 7D
54629-1,Disorganized thinking in last 7D
54630-9,Altered level of consciousness in last 7D
54631-7,Psychomotor retardation in last 7D
54632-5,Acute onset mental status change
54633-3,Mood
54634-1,Should resident mood interview be conducted
May-63,CD32
54635-8,Resident mood interview (PHQ-9)
54636-6,Little interest or pleasure in doing things in last 2W.presence
54637-4,Little interest or pleasure in doing things in last 2W.frequency
54638-2,"Feeling down, depressed or hopeless in last 2W.presence"
54639-0,"Feeling down, depressed or hopeless in last 2W.frequency"
54640-8,"Trouble falling or staying asleep, or sleeping too much in last 2W.presence"
54641-6,"Trouble falling or staying asleep, or sleeping too much in last 2W.frequency"
54642-4,Feeling tired or having little energy in last 2W.presence
Mar-64,CD33
54643-2,Feeling tired or having little energy in last 2W.frequency
54644-0,Poor appetite or overeating in last 2W.presence
54645-7,Poor appetite or overeating in last 2W.frequency
54646-5,Feeling bad about yourself - or that you are a failure or have let yourself or your family down in last 2W.presence
54647-3,Feeling bad about yourself - or that you are a failure or have let yourself or your family down in last 2W.frequency
54648-1,"Trouble concentrating on things, such as reading the newspaper or watching television in last 2W.presence"
54649-9,"Trouble concentrating on things, such as reading the newspaper or watching television in last 2W.frequency"
5465-0,CD34
54650-7,Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2W.presence
54651-5,Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2W.frequency
54652-3,"Thoughts that you would be better off dead, or of hurting yourself in some way in last 2W.presence"
54653-1,"Thoughts that you would be better off dead, or of hurting yourself in some way in last 2W.frequency"
54654-9,Mood interview total severity score
54655-6,Responsible staff or provider was informed of potential for resident self harm
54656-4,Staff assessment of mood should be conducted
54657-2,Staff assessment of resident mood (PHQ-9-OV)
54658-0,Little interest or pleasure in doing things in last 2W.presence
54659-8,Little interest or pleasure in doing things in last 2W.frequency
54660-6,"Feeling or appearing down, depressed or hopeless in last 2W.presence"
54661-4,"Feeling or appearing down, depressed, or hopeless in last 2W.frequency"
54662-2,"Trouble falling or staying asleep, or sleeping too much in last 2W.presence"
54663-0,"Trouble falling or staying asleep, or sleeping too much in last 2W.frequency"
54664-8,Feeling tired or having little energy in last 2W.presence
54665-5,Feeling tired or having little energy in last 2W.frequency
54666-3,Poor appetite or overeating in last 2W.presence
54667-1,Poor appetite or overeating in last 2W.frequency
Aug-66,CD34+DR+
54668-9,"Indicating that (s)he feels bad about self, is a failure, or has let self or family down in last 2W.presence"
54669-7,"Indicating that (s)he feels bad about self, is a failure, or has let self or family down in last 2W.frequency"
54670-5,"Trouble concentrating on things, such as reading the newspaper or watching television in last 2W.presence"
54671-3,"Trouble concentrating on things, such as reading the newspaper or watching television in last 2W.frequency"
54672-1,Moving or speaking so slowly that other people have noticed. Or the opposite - being so fidgety or restless that (s)he has been moving around a lot more than usual in last 2W.presence
54673-9,"States that life isn't worth living, wishes for death, or attempts to harm self in last 2W.presence"
54674-7,"States that life isn't worth living, wishes for death, or attempts to harm self in last 2W.frequency"
54675-4,"Being short-tempered, easily annoyed in last 2W.presence"
Jun-67,CD35
54676-2,"Being short-tempered, easily annoyed in last 2W.frequency"
54677-0,Staff assessment of resident mood total severity score
54678-8,Hallucinations in last 7D
54679-6,Illusions in last 7D
54680-4,Delusions in last 7D
54681-2,Psychoses - none of the above in last 7D
54682-0,Physical behavioral symptoms directed toward others
54683-8,Verbal behavioral symptoms directed toward others
Apr-68,CD36
54684-6,Other behavioral symptoms not directed toward others
54685-3,Overall presence of behavioral symptoms
54686-1,Put the resident at significant risk for physical illness or injury
54687-9,Significantly interfere with the resident's care
54688-7,Significantly interfere with the resident's participation in activities or social interactions
54689-5,Put others at significant risk for physical injury
54690-3,Significantly intrude on the privacy or activity of others
54691-1,Significantly disrupt care or living environment
Feb-69,CD37
54692-9,Rejection of care - presence and frequency in last 7D
54693-7,Wandering - presence and frequency in last 7D
54694-5,Wandering places resident at significant risk of getting to a potentially dangerous place in last 7D
54695-2,Wandering significantly intrudes on the privacy or activities of others in last 7D
54696-0,Change in behavioral or other symptoms in last 7D
54697-8,Interview for daily and activity preferences should be conducted
54698-6,How important it is to choose what clothes to wear while in this facility
54699-4,How important it is to take care of your personal belongings or things while in this facility
Jul-54,Butirosin
547-0,Streptococcus.beta-hemolytic
5470-0,CD38
54700-0,"How important it is to choose between a tub bath, shower, bed bath, or sponge bath while in this facility"
54701-8,How important it is to have snacks available between meals while in this facility
54702-6,How important it is to choose your own bedtime while in this facility
54703-4,How important it is to have your family or a close friend involved in discussions about your care while in this facility
54704-2,How important it is to be able to use the phone in private while in this facility
54705-9,How important it is to have a place to lock your things to keep them safe while in this facility
54706-7,"How important it is to have books, newspapers, and magazines to read while in this facility"
54707-5,How important it is to listen to music you like while in this facility
54708-3,How important it is to be around animals such as pets while in this facility
54709-1,How important it is to keep up with the news while in this facility
54710-9,How important it is to do things with groups of people while in this facility
54711-7,How important it is to do your favorite activities while in this facility
54712-5,How important it is to go outside to get fresh air when the weather is good while in this facility
54713-3,How important it is to participate in religious services or practices while in this facility
54714-1,Primary respondent for daily and activity preferences
54715-8,Staff assessment of daily and activity preferences should be conducted
54716-6,Resident prefers choosing clothes to wear
54717-4,Resident prefers caring for personal belongings
Aug-71,CD39
54718-2,Resident prefers receiving tub bath
54719-0,Resident prefers receiving shower
54720-8,Resident prefers receiving bed bath
54721-6,Resident prefers receiving sponge bath
54722-4,Resident prefers snacks between meals
54723-2,Resident prefers staying up past 8:00 p.m.
54724-0,Resident prefers family or significant other involvement in care discussions
54725-7,Resident prefers use of phone in private
Jun-72,CD4
54726-5,Resident prefers place to lock personal belongings
54727-3,"Resident prefers reading books, newspapers, magazines"
54728-1,Resident prefers listening to music
54729-9,Resident prefers being around animals such as pets
54730-7,Resident prefers keeping up with the news
54731-5,Resident prefers doing things with groups of people
54732-3,Resident prefers participating in favorite activities
54733-1,Resident prefers spending time away from the nursing home
Apr-73,CD4+CD8+
54734-9,Resident prefers spending time outdoors
54735-6,Resident prefers participating in religious activities or practices
54736-4,Resident prefers none of the above
54737-2,Bed mobility in last 7D
54738-0,Transfer in last 7D
54739-8,Toilet transfer in last 7D
54740-6,Toileting in last 7D
54741-4,Walk in room in last 7D
Feb-74,CD4/CD8 ratio
54742-2,Walk in facility in last 7D
54743-0,Locomotion in last 7D
54744-8,Dressing upper body in last 7D
54745-5,Dressing lower body in last 7D
54746-3,Eating in last 7D
54747-1,Grooming &or personal hygiene in last 7D
54748-9,Bathing in last 7D
54749-7,Moving from seated to standing position
54750-5,Walking (with assistive device if used)
54751-3,Turning around and facing the opposite direction while walking
54752-1,Moving on and off toilet
54753-9,Surface-to-surface transfer
54754-7,Range of motion
54755-4,Range of motion
54756-2,Cane &or crutch normally used in last 7D
54757-0,Walker normally used in last 7D
54758-8,Wheelchair (manual or electric) normally used in last 7D
Sep-75,CD40
54759-6,Limb prosthesis normally used in last 7D
54760-4,Mobility aids - none of the above were normally used in last 7D
54761-2,Bedfast
54762-0,Indwelling catheter used in last 7D
54763-8,External catheter used in last 7D
54764-6,"Ostomy (including suprapubic catheter, ileostomy, and colostomy) present in last 7D"
54765-3,Intermittent catheterization used in last 7D
54766-1,Appliances - none of the above used in last 7D
Jul-76,CD41
54767-9,Trial of toileting program has been attempted on admission or reentry or since urinary incontinence was noted in this facility
54768-7,Response to toileting program
54769-5,Current toileting program or trial
54770-3,Urinary continence in last 7D
54771-1,Bowel continence in last 7D
54772-9,Bowel toileting program currently being used
54773-7,Constipation present
54774-5,Cancer in last 30D
May-77,CD42a
54775-2,Anemia in last 7D
54776-0,Atrial fibrillation and other dysrhythmias in last 7D
54777-8,Coronary artery disease in last 7D
54778-6,Deep venous thrombosis &or pulmonary embolus or pulmonary thrombo-embolism in last 7D
54779-4,Heart failure in last 7D
54780-2,Hypertension in last 7D
54781-0,Orthostatic hypotension in last 7D
54782-8,Peripheral vascular disease in last 7D
Mar-78,CD42b
54783-6,Cirrhosis in last 7D
54784-4,Gastroesophageal reflux disease &or ulcer in last 7D
54785-1,Ulcerative colitis &or Crohn's disease &or inflammatory bowel disease in last 7D
54786-9,Benign prostatic hyperplasia in last 7D
54787-7,Renal insufficiency or renal failure &or end-stage renal disease in last 7D
54788-5,HIV infection in last 30D
54789-3,Staphylococcus aureus.methicillin resistant or Enterococcus species.vancomycin resistant or Clostridium difficile infections &or colonization in last 30D
54790-1,Pneumonia in last 7D
Jan-79,CD42c
54791-9,Septicemia in last 7D
54792-7,Tuberculosis in last 7D
54793-5,Urinary tract infection in last 7D
54794-3,Viral hepatitis in last 7D
54795-0,Diabetes mellitus in last 7D
54796-8,Hyponatremia in last 7D
54797-6,Hyperkalemia in last 7D
54798-4,Hyperlipidemia in last 7D
54799-2,Thyroid disorder in last 7D
54800-8,Arthritis in last 7D
54801-6,Osteoporosis in last 7D
54802-4,Hip fracture in last 7D
54803-2,Other fracture in last 7D
54804-0,Alzheimer's disease in last 7D
54805-7,Aphasia in last 7D
54806-5,Cerebral palsy in last 7D
54807-3,Cerebrovascular accident &or transient ischemic attack &or stroke in last 7D
54808-1,Non-Alzheimer's dementia in last 7D
Sep-80,CD42d
54809-9,Hemiplegia &or hemiparesis in last 7D
54810-7,Paraplegia in last 7D
54811-5,Quadriplegia in last 7D
54812-3,Multiple sclerosis in last 7D
54813-1,Parkinson's disease in last 7D
54814-9,Seizure disorder in last 7D
54815-6,Traumatic brain injury in last 7D
54816-4,Protein or calorie malnutrition or at risk for malnutrition in last 7D
Jul-81,CD43
54817-2,Anxiety disorder in last 7D
54818-0,Depression other than bipolar in last 7D
54819-8,Manic depression other than schizophrenia in last 7D
54820-6,Schizophrenia in last 7D
54821-4,Post-traumatic stress disorder in last 7D
54822-2,Asthma &or chronic obstructive lung disease or chronic lung disease in last 7D
54823-0,Cataracts &or glaucoma or macular degeneration in last 7D
54824-8,None of the above active diagnoses in last 7D
May-82,CD44
54825-5,On scheduled pain medication regimen in last 7D
54826-3,Received PRN pain medications in last 7D
54827-1,Received non-medication intervention for pain in last 7D
54828-9,Pain assessment interview should be conducted
54829-7,Pain presence
54830-5,Pain frequency
54831-3,Pain has made it hard to sleep
54832-1,Limited activities because of pain
Mar-83,CD44R
54833-9,Pain severity
54834-7,Rate pain severity using verbal descriptor scale
54835-4,Non-verbal sounds of pain in last 5D
54836-2,Vocal complaints of pain in last 5D
54837-0,Facial expressions of pain in last 5D
54838-8,Protective body movements or postures in last 5D
54839-6,None of these signs of pain observed or documented in last 5D
54840-4,Adequacy of current therapeutic regimen to control pain in last 7D
Jan-84,CD45
54841-2,Shortness of breath or trouble breathing with exertion in last 7D
54842-0,Shortness of breath or trouble breathing when sitting at rest in last 7D
54843-8,Shortness of breath or trouble breathing when lying flat in last 7D
54844-6,None of the above shortness of breath symptoms in last 7D
54845-3,Tobacco use
54846-1,Life expectancy of less than 6M
54847-9,Problem conditions
54848-7,Problem conditions - none of above
54849-5,Fall history on admission
54850-3,Fall one or more times in the last Mo prior to admission
54851-1,Fall one or more times in the last 2 to 6Mo prior to admission
54852-9,Any fracture related to a fall in the 6Mo prior to admission
54853-7,Has the patient had any falls since admission or prior assessment
54854-5,Number of falls since admission or prior assessment
54855-2,Number of falls since admission or prior assessment - no injury
54856-0,Number of falls since admission or prior assessment - injury except major
54857-8,Number of falls since admission or prior assessment - major injury
Aug-85,CD45RA
54858-6,Loss of liquids &or solids from mouth when eating or drinking in last 7D
54859-4,Holding food in mouth &or cheeks or residual food in mouth after meals in last 7D
54860-2,Coughing or choking during meals or when swallowing medications in last 7D
54861-0,Complaints of difficulty or pain with swallowing in last 7D
54862-8,Signs or symptoms of possible swallowing disorder - none of the above
54863-6,Weight loss of 5% or more in the last Mo or loss of 10% or more in last 6Mo
54864-4,Parenteral &or IV feeding in last 7D
54865-1,Nasogastric or abdominal feeding tube in last 7D
Jun-86,CD45RB
54866-9,Mechanically altered diet - require change in texture of food or liquids in last 7D
54867-7,Therapeutic diet in last 7D
54868-5,Nutritional approaches in last 7D - none of the above
54869-3,Average fluid intake per day by parenteral or tube feedings in the 7D
54870-1,Able to perform dental exam
54871-9,Broken or loosely fitting full or partial denture in last 7D
54872-7,No natural teeth or tooth fragments in last 7D
54873-5,Abnormal mouth tissue in last 7D
Apr-87,CD45RO
54874-3,Obvious or likely cavity or broken natural teeth in last 7D
54875-0,Inflamed or bleeding gums or loose natural teeth in last 7D
54876-8,"Mouth or facial pain, discomfort or difficulty with chewing in last 7D"
54877-6,Dental status - none of the above in last 7D
54878-4,"Pressure injury risk by resident has a stage 1 or greater, a scar over bony prominence, or a non-removable dressing, device in last 7D"
54879-2,Pressure injury risk by formal assessment
548-8,Bordetella pertussis
54880-0,Pressure injury risk by clinical judgment
54881-8,Pressure injury risk - none of the above
Feb-88,CD46
54882-6,Risk of developing pressure injuries
54883-4,Date of most recent routine pressure ulcer assessment
54884-2,Number of pressure injuries - stage 1
54885-9,"One or more unhealed pressure ulcer(s) at Stage 2 or higher, or one or more likely pressure ulcers that are unstageable"
54886-7,Number of pressure injuries present upon admission &or reentry - stage 2
54887-5,Number of pressure injuries present upon admission &or reentry - stage 3
54888-3,Date of onset of pressure injuries onset in this facility - oldest or only stage 3
54889-1,Date of onset of pressure ulcers onset in this facility - newest stage 3
5489-0,CD47
54890-9,Number of pressure injuries present upon admission &or reentry - stage 4
54891-7,Date of onset of pressure injuries onset in this facility - oldest or only stage 4
54892-5,Date of onset of pressure ulcers onset in this facility - newest stage 4
54893-3,Number of pressure injuries - unstageable due to non-removable dressing or device
54894-1,Number of pressure injuries present upon admission &or reentry - unstageable due to non-removable dressing
54895-8,Staff assessment for mental status
54896-6,Submission requirement
54897-4,Proportion of total calories the resident received through parenteral or tube feedings in the last 7D
54898-2,Other disease diagnoses in last 7D
54899-0,Language.preferred
54900-6,IgA
54901-4,IgG
54902-2,IgM
54904-8,Moving or speaking so slowly that other people have noticed. Or the opposite - being so fidgety or restless that (s)he has been moving around a lot more than usual in last 2W.frequency
54905-5,Norovirus genogroup I RNA
54906-3,Norovirus genogroup II RNA
54907-1,Alkaline phosphatase
Aug-90,CD48
54908-9,Cefminox
54909-7,Culex pipiens Ab.IgE
54910-5,DNA double strand Ab
54911-3,Epinephelus lanceolatus Ab.IgE
54912-1,Fosfomycin Ab.IgE
54913-9,Gentamicin Ab.IgE
54914-7,Hepatitis C virus core Ag
54915-4,Chlorophora excelsa Ab.IgE
Jun-91,CD49a
54916-2,Lophius piscatorius Ab.IgE
54917-0,Lysozyme
54918-8,Ma+Ta Ab
54919-6,Magnesium
54920-4,Myrmecia pilosula Ab.IgE
54921-2,Neuronal nuclear type 2 Ab
54922-0,Phosphate
54923-8,Propyphenazone Ab.IgE
Apr-92,CD49B
54924-6,Purkinje cells Ab
54925-3,Selenium
54926-1,"t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript"
54927-9,Tetranychus urticae Ab.IgE
54928-7,Tinidazole
54929-5,Tissue transglutaminase Ab
54930-3,Vicia faba Ab.IgE
54931-1,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Creatinine
Feb-93,CD49c
54932-9,CEH abrine & ricinine panel
54933-7,Abrine
54934-5,Ricinine
54935-2,"1,2-Dichloroethane"
54936-0,Carbon tetrachloride
54937-8,Chloroform
54938-6,Ethyl benzene
54939-4,Meta methylhippurate+Para methylhippurate
5494-0,CD49d
54940-2,Styrene
54941-0,Tungsten
54942-8,N-ethyldiethanolamine
54943-6,N-methyldiethanolamine
54944-4,Monofluoroacetate
54945-1,Monochloroacetate
54946-9,Number of pressure injuries - unstageable due to coverage of wound bed by slough &or eschar
54947-7,Number of pressure injuries present upon admission &or reentry - unstageable due to coverage of wound bed by slough &or eschar
54948-5,Date of onset of pressure ulcers onset in this facility - oldest or only unstageable due to coverage of wound bed by slough &or eschar
54949-3,Date of onset of pressure ulcers onset in this facility - newest unstageable due to coverage of wound bed by slough &or eschar
54950-1,Number of pressure injuries - unstageable with suspected deep tissue injury in evolution
54951-9,Number of pressure injuries present upon admission &or reentry - unstageable with suspected deep tissue injury in evolution
54952-7,"Worsening in pressure injury status since last assessment (OBRA, PPS, or Discharge)"
54953-5,Number of current pressure injuries not present or were at a lesser stage on prior assessment - stage 2
54954-3,Number of current pressure injuries not present or were at a lesser stage on prior assessment - stage 3
54955-0,Number of current pressure injuries not present or were at a lesser stage on prior assessment - stage 4
54956-8,Healed pressure injuries
Jul-95,CD49E
54957-6,Pressure injuries were present on the prior assessment
54958-4,Number of pressure injuries noted on prior assessment that have completely closed - stage 2
54959-2,Number of pressure injuries noted on prior assessment that have completely closed - stage 3
549-6,Bordetella pertussis
54960-0,Number of pressure injuries noted on prior assessment that have completely closed - stage 4
54961-8,"Other Ulcers, Wounds and Skin Problems"
54962-6,Venous or arterial ulcers in last 7D
54963-4,Diabetic foot ulcer(s) in last 7D
54964-2,Other foot or lower extremity open lesion(s) or infections in last 7D
May-96,CD49f
54965-9,Wound infection other than on foot or lower extremity in last 7D
54966-7,Surgical wound(s) in last 7D
54967-5,"Open lesion(s) other than ulcers, rashes, cuts in last 7D"
54968-3,Second or third degree burns in last 7D
54969-1,"Other ulcers, wounds, and skin problems - none of above in last 7D"
54970-9,Number of venous and arterial ulcers in last 7D
54971-7,Skin and ulcer treatments in last 7D
54972-5,Pressure reducing device for chair provided in last 7D
Mar-97,CD5
54973-3,Pressure reducing device for bed provided in last 7D
54974-1,Turning &or repositioning provided in last 7D
54975-8,Nutrition or hydration intervention to manage skin problems provided in last 7D
54976-6,Ulcer care provided in last 7D
54977-4,Surgical wound care provided in last 7D
54978-2,Application of nonsurgical dressings (with or without topical medications) other than to feet provided in last 7D
54979-0,Applications of ointments &or medications other than to feet provided in last 7D
54980-8,Application of dressings to feet (with or without topical medications) provided in last 7D
Jan-98,CD5+CD2-
54981-6,Skin and ulcer treatments - none of above provided in last 7D
54982-4,Number of D injectable substances received in last 7D or since admission &or reentry if less than 7D
54983-2,Medications received in last 7D or since admission &or reentry if less than 7D
54984-0,Antipsychotic received in last 7D or since admission &or reentry if less than 7D
54985-7,Antianxiety received in last 7D or since admission &or reentry if less than 7D
54986-5,Antidepressant received in last 7D or since admission &or reentry if less than 7D
54987-3,Hypnotic received in last 7D or since admission &or reentry if less than 7D
54988-1,Anticoagulant received in last 7D or since admission &or reentry if less than 7D
54989-9,Medications received - none of the above were received in last 7D or since admission &or reentry if less than 7D
54990-7,Special treatments and procedures
54991-5,Special treatments and programs in last 14D
54992-3,Chemotherapy in last 14D - while not a resident
54993-1,Chemotherapy in last 14D - while a resident
54994-9,Radiation in last 14D - while not a resident
54995-6,Radiation in last 14D - while a resident
54996-4,Oxygen therapy in last 14D - while not a resident
54997-2,Oxygen therapy in last 14D - while a resident
54998-0,Suctioning in last 14D - while not a resident
Sep-99,CD50
54999-8,Suctioning in last 14D - while a resident
55000-4,Tracheostomy care in last 14D - while not a resident
55001-2,Tracheostomy care in last 14D - while a resident
55002-0,Ventilator or respirator in last 14D - while not a resident
55003-8,Ventilator or respirator in last 14D - while a resident
Apr-00,CD51
55004-6,BIPAP &or CPAP machine in last 14D - while not a resident
55005-3,BIPAP &or CPAP machine in last 14D - while a resident
55006-1,IV medications in last 14D - while not a resident
55007-9,IV medications in last 14D - while a resident
55008-7,Transfusions in last 14D - while not a resident
55009-5,Transfusions in last 14D - while a resident
55010-3,Dialysis in last 14D - while not a resident
55011-1,Dialysis in last 14D - while a resident
Feb-01,CD52
55012-9,Hospice care in last 14D - while not a resident
55013-7,Hospice care in last 14D - while a resident
55014-5,Respite care in last 14D - while not a resident
55015-2,Respite care in last 14D - while a resident
55016-0,Isolation or quarantine for active infectious disease in last 14D - while not a resident
55017-8,Isolation or quarantine for active infectious disease in last 14D - while a resident
55018-6,Influenza vaccine
55019-4,Influenza virus vaccine received in facility
5502-0,CD53
55020-2,Reason influenza virus vaccine not received
55021-0,Pneumococcal vaccine
55022-8,Pneumococcal vaccination up to date
55023-6,Reason pneumococcal vaccine not received
55024-4,Therapies in last 7D
55025-1,Start date of speech language pathology and audiology services
55026-9,End date of speech language pathology and audiology services
55027-7,Start date of occupational therapy
55028-5,End date of occupational therapy
55029-3,Start date of physical therapy
55030-1,End date of physical therapy
55031-9,Start date of respiratory therapy
55032-7,End date of respiratory therapy
55033-5,Start date of psychological therapy by any licensed mental health professional
55034-3,End date of psychological therapy by any licensed mental health professional
55035-0,Total minutes of recreational and music therapy in last 7D
55036-8,Number of D with at least 15M of recreational and music therapy in last 7D
55037-6,Start date of recreational and music therapy
Aug-03,CD54
55038-4,End date of recreational and music therapy
55039-2,Nursing rehabilitation &or restorative care in last 7D
550-4,Bordetella pertussis Ag
55040-0,Number of D physician examined the patient in last 14D
55041-8,Number of D physician orders changed in last 14D
55042-6,Restraints
55043-4,Physical restraints
55044-2,Physical restraints used in bed - bed rail of any type
55045-9,Physical restraints used in bed - trunk restraint
Jun-04,CD55
55046-7,Physical restraints used in bed - limb restraint
55047-5,Physical restraints used in bed - other
55048-3,Physical restraints used in chair or out of bed - trunk restraint
55049-1,Physical restraints used in chair or out of bed - limb restraint
55050-9,Physical restraints used in chair or out of bed - chair prevents rising
55051-7,Physical restraints used in chair or out of bed - other
55052-5,Participation in assessment and goal setting
Mar-05,CD56
55053-3,Participation in assessment
55054-1,Participation in assessment
55055-8,Return to community
55056-6,Resident's overall goals
55057-4,Goals established during assessment process
55058-2,Information source for resident's overall goal
55059-0,Therapy supplement for Medicare PPS
55060-8,Ordered therapies
Jan-06,CD57
55061-6,Therapies ordered to begin in first 14D of stay
55062-4,Therapy evaluations completed
55063-2,Assessment administration
55064-0,Medicare part A billing
55065-7,Medicare part A - HIPPS code for billing
55066-5,Medicare part A - RUG version code
55067-3,State Medicaid billing
55068-1,State case mix - RUG group
55069-9,State case mix - RUG version code
55070-7,Insurance billing
55071-5,Insurance case mix - RUG group
55072-3,Insurance case mix - RUG version code
55073-1,Tissue type
55074-9,Participation in assessment
55075-6,Version code
55076-4,Production or test indicator
55077-2,State assigned facility submission ID
55078-0,Federal employer tax ID
Sep-07,CD58
55079-8,Vendor company name
55080-6,Product name
55081-4,Product version code
55082-2,Transaction code
55083-0,Item subset code
55084-8,Other special treatments and programs in last 14D
55085-5,Respiratory treatments in last 14D
55086-3,Cancer treatments in last 14D
Jul-08,CD59
55087-1,Number of pressure injuries noted on prior assessment that have completely closed
55088-9,Pressure injuries - unstageable with suspected deep tissue injury in evolution
55089-7,Pressure injuries - unstageable due to coverage of wound bed by slough &or eschar
55090-5,Cells.CD3-CD56+/100 cells
55091-3,Darunavir
55092-1,PDGFRA gene rearrangements
55093-9,Vendor email address
55094-7,Medications
May-09,CD6
55095-4,Adenovirus
55096-2,Nocardia sp identified
55097-0,Parainfluenza virus 1
55098-8,Parainfluenza virus 2
55099-6,Parainfluenza virus 3
55100-2,Respiratory syncytial virus
55101-0,Respiratory pathogens panel
55102-8,Surgical operation note disposition
Mar-10,CD61
55103-6,Surgical operation note estimated blood loss
55104-4,Surgical operation note planned procedure
55105-1,OTC - Purpose section
55106-9,OTC - Active ingredient section
55107-7,Addendum
55108-5,Clinical presentation
55109-3,Complications
55110-1,Conclusions
Jan-11,CD62E
55111-9,Current imaging procedure descriptions
55112-7,Document summary
55113-5,Key images
55114-3,Prior imaging procedure descriptions
55115-0,Requested imaging studies information
55116-8,CEH volatile organic compounds panel
55117-6,CEH trace metals screen panel
55118-4,CEH trace metals panel
55119-2,CEH nitrogen mustard metabolite panel
551-2,Brucella sp identified
55120-0,CEH metabolic toxin panel
55121-8,Multiple sclerosis panel
55122-6,Surgical operation note implants
55123-4,Resident believes he or she is capable of increased independence in at least some ADLs
55124-2,Number of pressure injuries - stage 2
55125-9,Number of pressure injuries - stage 3
55126-7,Number of pressure injuries - stage 4
55127-5,Number of unhealed stage 2 ulcers known to be present for more than 1 month
55128-3,Discharge disposition
Sep-12,CD62L
55129-1,Physical restraints used in bed
55130-9,Physical restraints used in chair or out of bed
55131-7,Number of D of rehabilitative or restorative techniques
55132-5,Number of D of rehabilitative or restorative training and skill practice
55133-3,Influenza virus A hemagglutinin cDNA
55134-1,Influenza virus A neuraminidase RNA
55135-8,BCR-ABL1 kinase domain targeted mutation analysis
55136-6,Penicillin.parenteral
Jul-13,CD62P
55137-4,Penicillin.parenteral
55138-2,Cortisol^post dose dexamethasone PO overnight
55139-0,SCN5A gene targeted mutation analysis
55140-8,Vaccine Adverse Event Reporting System panel
55141-6,Fc epsilon RI + RII Ab
55142-4,Cache valley virus RNA
55143-2,California serogroup virus RNA
55144-0,Powassan virus RNA
May-14,CD63
55145-7,Saint Louis encephalitis virus RNA
55146-5,Familial long QTS syndrome gene targeted mutation analysis
55147-3,"t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript"
55148-1,BCR-ABL1 b2a2+b3a2 fusion transcript
55149-9,BCR-ABL1 e1a2 fusion protein
55150-7,Anaplasma phagocytophilum Ab.IgG & IgM panel
55151-5,Aldosterone & renin activity panel
Feb-15,CD64
55152-3,Amiodarone & Desethylamiodarone panel
55153-1,Biotinidase panel
55154-9,Ethambutol+rifAMPin
55155-6,Flunitrazepam & 7-Aminoflunitrazepam panel
55156-4,Minocycline
55157-2,Risperidone & 9-Hydroxyrisperidone panel
55158-0,Tigecycline
55159-8,Ursodeoxycholate
5516-0,CD66a
55160-6,Adenovirus Ab.IgG & IgM panel
55161-4,Bordetella pertussis Ab.IgA & IgG panel
55162-2,HTLV I+II Ab panel
55163-0,Streptococcus pyogenes enzyme Ab panel
55164-8,Paroxysmal nocturnal panel
55165-5,Echinococcus sp Ab.IgG4
55166-3,Hepatitis G virus E2 Ab
55167-1,Mycoplasma sp Ab
55168-9,Data Elements for Emergency Department Systems (DEEDS) Release 1.1
55169-7,Data Elements for Emergency Department Systems (DEEDS) Release 1.0
55170-5,Cytoplasmic Ab
55171-3,Cytoplasmic Ab pattern
55172-1,ED procedures and results
55173-9,ED disposition and diagnosis data
55174-7,Patient identification data
55175-4,Facility and Practitioner identification data
55176-2,ED arrival and first assessment data
55177-0,ED History and Physical Examination Data
Aug-17,CD66b
55178-8,Calcium phosphate crystals
55179-6,Sodium urate crystals
55180-4,Human epididymis protein 4
55181-2,Quality Reporting Document Architecture panel
55182-0,Quality Reporting Document Architecture incidence report
55183-8,Quality Reporting Document Architecture patient list report
55184-6,Quality Reporting Document Architecture calculated summary report
55185-3,Measure set
Jun-18,CD66c
55186-1,Measure
55187-9,Reporting parameters
55188-7,Patient data
55189-5,Cefotaxime
55190-3,cefTRIAXone
55192-9,Chromosome analysis.interphase
55193-7,Chromosome analysis.interphase
Apr-19,CD66d
55194-5,Ciprofloxacin 1.0 ug/mL
55195-2,DHCR7 gene targeted mutation analysis
55196-0,Terconazole
55197-8,Transfusion status
55198-6,Zygosity
55199-4,Cells karyotyped.total
552-0,Brucella sp identified
55200-0,Carnitine
55201-8,KIT gene targeted mutation analysis
Feb-20,CD66e
55202-6,Coagulation surface induced.factor substitution^5M post incubation after addition of normal plasma
55203-4,Coagulation surface induced.factor substitution^5M post incubation after addition of normal plasma
55204-2,Macroamylase
55205-9,Vasoactive intestinal peptide
55206-7,Platelet mass
55207-5,Genetic analysis discrete result panel
55208-3,DNA analysis discrete sequence variation panel
55209-1,Date and time of most recent arrival in U.S.
5521-0,CD68
55210-9,Geotemporal history
55211-7,"Shared razor, toothbrushes or nail care items"
55212-5,Occupation related direct blood or body fluid exposure frequency
55213-3,Number of male sexual partners in 6Mo before symptom onset
55214-1,Number of female sexual partners in 6Mo before symptom onset
55215-8,Total number of lifetime sexual partners
55216-6,Physical assault on exposed person involving blood or semen
55217-4,Stick or puncture with a needle or other object contaminated with blood
55218-2,Date of actual exposure to blood &or body fluid
55219-0,Antioxidants
55220-8,Asialoglycoprotein receptor Ab
55221-6,Carbohydrates
55222-4,Microscopic observation
55223-2,Mycobacterium tuberculosis A60 Ab.IgM
55224-0,Mycobacterium tuberculosis A60 Ab
55225-7,Aucoumea klaineana Ab.IgE
55226-5,Pancreatic polypeptide
55227-3,Entandrophragma cylindricum Ab.IgE
Aug-22,CD69
55228-1,Cytogenetics study
55229-9,Immune stain study
55230-7,Immunophenotyping study
55231-5,Electrolytes panel
55232-3,Genetic analysis summary panel
55233-1,Genetic analysis master panel
55234-9,Alpha thalassemia gene panel
55235-6,Abnormal hemoglobin gene panel
Jun-23,CD7
55236-4,HBA2 gene alpha 4.2kb deletion
55237-2,HBA2 gene.c.427T>C
55238-0,HBA2 gene.c.429A>T
55239-8,HBB gene.c.441_442insAC
55240-6,HBB gene.c.251G>A
55241-4,HBB gene.c.19G>A
55242-2,HBB gene.c.20A>T
55243-0,HBB gene.c.364G>C
Apr-24,CD7+CD3-
55244-8,HPFH-6 gene
55245-5,HBB gene.c.220G>A
55246-3,HBA2 gene.c.84G>C
55247-1,HBA1 gene.c.223G>C
55248-9,HBB gene.c.79G>A
55249-7,HBA2 gene SEA deletion
55250-5,HBA2 gene THAI+FIL+MED+alpha 20.5 deletion
Jan-25,CD71
55251-3,HBA2 gene alpha 3.7kb deletion
55252-1,Methoxsalen 0.02 mg per mL given
55253-9,Heparin 10000 U per mL given
55254-7,Heparin 5000 U per mL given
55255-4,Pyridinoline panel
55256-2,ED payment data
55257-0,Date of last Clostridium tetani immunization
55258-8,Problem alleviating factors
55259-6,Time last ate solid food
55260-4,Time last drank liquid
55261-2,Rabies virus immunization status
55262-0,Influenza virus immunization status
55263-8,Bordetella pertussis immunization status
55264-6,Hepatitis A virus immunization status
55265-3,Measles virus status
55266-1,Haemophilus influenzae B immunization status
55267-9,Human papilloma virus immunization status
55268-7,Rotavirus immunization status
Sep-26,CD72
55269-5,Neisseria meningitidis immunization status
55270-3,Streptococcus pneumoniae polyvalent immunization status
55271-1,Streptococcus pneumoniae conjugated immunization status
55272-9,Corynebacterium diphtheriae immunization status
55273-7,Polio virus immunization status
55274-5,Varicella zoster virus status
55275-2,Hepatitis B virus status
55276-0,Hepatitis C virus status
Jul-27,CD73
55277-8,HIV status
55278-6,Rubella virus status
55279-4,Cytomegalovirus status
55280-2,Military service
55281-0,Fetuses
55282-8,Date symptoms of pregnancy first noted
55283-6,Heart rate
55284-4,Blood pressure systolic & diastolic
May-28,CD74
55285-1,Glasgow coma score special circumstances
55286-9,Physical examination by body areas
55287-7,Time of death
55288-5,ED medication data
55289-3,Sulopenem
55290-1,Sulopenem
55291-9,Sulopenem
55292-7,Linopristin+Flopristin
Mar-29,CD77
55293-5,Linopristin+Flopristin
55294-3,Linopristin+Flopristin
55295-0,Protein fractions & Immunoglobulins panel
55296-8,CAV3 gene targeted mutation analysis
55297-6,FIP1L1+PDGFRA gene rearrangements
55298-4,Human papilloma virus 6+11+42+43+44 DNA
55299-2,Human papilloma virus 6+11+42+43+44 DNA
55300-8,JAK2 gene exon 12 targeted mutation analysis
Jan-30,CD79a
55301-6,JAK2 gene exon 13 targeted mutation analysis
55302-4,Paraneoplastic pemphigus Ab
55303-2,Fungus
55304-0,Fungus
55305-7,Fungus
55306-5,Fungus
55307-3,Fungus
55308-1,Yeast.pseudohyphae
55309-9,Yeast.pseudohyphae
55310-7,Yeast.pseudohyphae
55311-5,Yeast.pseudohyphae
55312-3,Yeast.pseudohyphae
55313-1,Yeast
55314-9,Yeast
55315-6,Yeast
55316-4,Yeast
55317-2,Yeast
55318-0,Fungus
Sep-31,CD79b
55319-8,Yeast.pseudohyphae
55320-6,Yeast
55321-4,C super little w Ab
55322-2,F little y super little b Ab
55323-0,J little k super little a Ab
55324-8,J little k super little b Ab
55325-5,J little s super little a Ab
55326-3,K little p super little a Ab
Jul-32,CD8
55327-1,K little p super little b Ab
55328-9,L little e super little a Ab
55329-7,L little e super little b Ab
55330-5,L little u super little a Ab
55331-3,L little u super little b Ab
55332-1,little c Ab
55333-9,little f Ab
55334-7,little k Ab
May-33,CD80
55335-4,little s Ab
55336-2,N Ab
55337-0,P1 Ab
55338-8,S little d super little a Ab
55339-6,S little d super little a Ab
55340-4,V Ab
55341-2,X little g super little a Ab
55342-0,S little d super little a Ag
Mar-34,CD81
55343-8,Anidulafungin
55344-6,Platelet aggregation.ristocetin induced^1000 ug/mL
55345-3,VIM gene methylation
55346-1,Clobazam+Norclobazam
55347-9,Coagulation ecarin induced
55348-7,Cortisol^20M post XXX challenge
55349-5,Ethyl glucuronide
5535-0,CD82
55350-3,Fenfluramine
55351-1,Glucose^1.5H post 75 g glucose PO
55352-9,Glucose^45M post 75 g glucose PO
55353-7,Hirudin
55354-5,Osmolality^post 4H FFst
55355-2,Osmolality^post 7H FFst
55356-0,Osmolality^post 5H FFst
55357-8,Osmolality^post 3H FFst
55358-6,Osmolality^post 2H FFst
55359-4,Osmolality^post 1H FFst
55360-2,Osmolality^post 6H FFst
55361-0,Osmolality^baseline
55362-8,Thyrotropin^pre XXX challenge
55363-6,Argatroban
55364-4,Cells.CD5+CD19+CD38+/100 cells
55365-1,Cells.CD138+Kappa+/100 cells
55366-9,Cells.CD138+Lambda+/100 cells
55367-7,Cholesterol crystals
Aug-36,CD83
55368-5,Crystals.amorphous
55369-3,Dengue virus Ab
55370-1,Hemoglobin A2+C+E+O/Hemoglobin.total
55371-9,Hemoglobin A2+E+O/Hemoglobin.total
55372-7,Hemoglobin Constant Spring/Hemoglobin.total
55373-5,Hemoglobin D+G/Hemoglobin.total
55374-3,Hemoglobin N+I/Hemoglobin.total
55375-0,Megaloblasts
Jun-37,CD85
55376-8,Megaloblasts/100 leukocytes
55377-6,Mononuclear cells.immature/100 leukocytes
55378-4,Phosphate crystals.amorphous
55379-2,Snowshoe hare virus Ab.IgM
553-8,Candida sp identified
55380-0,West Nile virus Ab
55381-8,Glucose^2.5H post 75 g glucose PO
55382-6,Insulin^5M post XXX challenge
55383-4,Insulin^10M post XXX challenge
Apr-38,CD86
55384-2,Insulin^3M post XXX challenge
55385-9,Insulin^15M post XXX challenge
55386-7,Insulin^2M post XXX challenge
55387-5,Insulin^45M post XXX challenge
55388-3,Insulin^4H post XXX challenge
55389-1,Insulin^5H post XXX challenge
55390-9,Insulin^6H post XXX challenge
55391-7,Insulin^4M post XXX challenge
Feb-39,CD87
55392-5,Insulin^1M post XXX challenge
55393-3,Lead
55394-1,Protein & Glucose panel
55395-8,Phospholipid Ab.IgA & IgG & IgM panel
55396-6,Beta 2 glycoprotein 1 Ab.IgA & IgG panel
55397-4,Short myasthenia gravis panel
55398-2,Short Fibrin D-dimer FEU & DDU panel
55399-0,Diabetes tracking panel
Apr-55,Capreomycin
5540-0,CD88
55400-6,Date of last eye examination
55401-4,Warfarin tracking panel
55402-2,West Nile virus Ab.IgG & IgM panel
55403-0,Asthma tracking panel
55404-8,Asthma spells
55405-5,Heart failure tracking panel
55406-3,Cardiac ejection fraction method
55407-1,Pitting edema severity
55408-9,Exercise tolerance
55409-7,Exercise tracking panel
55410-5,Exercise type
55411-3,Exercise duration
55412-1,Exercise distance
55413-9,Pedometer tracking panel
55414-7,Seizures per month
55415-4,Oxygen saturation & therapy panel
55416-2,Oxymetry special circumstances
55417-0,Short blood pressure panel
Aug-41,CD89
55418-8,Weight & Height tracking panel
55419-6,Home drug screening panel
55420-4,Hours after meal
55421-2,Calories burned
55422-0,Heart rate
55423-8,Number of steps
55424-6,Calories burned
55425-3,Heart rate
Jun-42,CD9
55426-1,Heart rate
55427-9,Seizure disorder tracking panel
55428-7,Drug test kit name
55429-5,Short blood count panel
55430-3,Walking distance
55431-1,Cells.HLA-B27
55432-9,Immature cells
55433-7,Immature cells/100 leukocytes
Apr-43,CD91
55434-5,Insulin^20M post XXX challenge
55435-2,Mononuclear cells.immature
55436-0,Myeloblasts/100 leukocytes
55437-8,Neoplastic cells/100 leukocytes
55438-6,Dengue virus Ab.Neut
55439-4,Medical device
55440-2,Cholesterol.in LDL
55441-0,Antithrombin Ag
Feb-44,CD93
55442-8,Antithrombin
55443-6,Cardiolipin Ab
55444-4,Cardiolipin Ab.IgA
55445-1,Cardiolipin Ab.IgM
55446-9,Cardiolipin Ab.IgG
55447-7,Coagulation factor VIII Ag
55448-5,Complement total hemolytic CH50
55449-3,Fibrin D-dimer
55450-1,Fibrin+Fibrinogen fragments
55451-9,Fibrin+Fibrinogen fragments
55452-7,Fibrinogen
55453-5,Haptoglobin
55454-3,Hemoglobin A1c
55455-0,Hemoglobin F
55456-8,Hemoglobin S
55457-6,Hemoglobin.free
55458-4,Interferon.alpha
Sep-45,CD94
55459-2,Prekallikrein
554-6,Candida sp identified
55460-0,Protein C Ag
55461-8,Protein C
55462-6,Thyrotropin
55463-4,Influenza virus A swine origin RNA
55464-2,Influenza virus A swine origin RNA
55465-9,Influenza virus A H1 2009 pandemic RNA
55466-7,Influenza virus A H1 2009 pandemic RNA panel
Jul-46,CD95
55467-5,11-Deoxycortisol^baseline
55468-3,11-Deoxycortisol^1H post dose corticotropin
55469-1,17-Hydroxyprogesterone^30M post dose corticotropin
55470-9,17-Hydroxyprogesterone^1H post dose corticotropin
55471-7,Aldosterone^1H post dose corticotropin
55472-5,Cortisol^2.5H post XXX challenge
55473-3,Cortisol^3H post XXX challenge
55474-1,Dehydroepiandrosterone^baseline
May-47,CD96
55475-8,Dehydroepiandrosterone^1H post dose corticotropin
55476-6,Estradiol^baseline
55477-4,Estradiol^4H post XXX challenge
55478-2,Follitropin^4H post XXX challenge
55479-0,Insulin^7M post dose glucose IV
55480-8,Insulin^5M pre dose glucose
55481-6,Insulin^10M pre dose glucose
55482-4,Insulin^4H post dose glucose IV
Mar-48,CD97
55483-2,Insulin^1.5H post dose glucose IV
55484-0,Insulin^10M post dose glucose IV
55485-7,Insulin^1H post dose glucose IV
55486-5,Insulin^1M post dose glucose IV
55487-3,Insulin^2.5H post dose glucose IV
55488-1,Insulin^1H post dose glucagon
55489-9,Insulin^1.5H post dose glucagon
55490-7,Insulin^45M post dose glucagon
Jan-49,CD98
55491-5,Insulin^2H post dose glucagon
55492-3,Insulin^30M post dose glucose IV
55493-1,Insulin^3H post dose glucose IV
55494-9,Insulin^5M post dose glucose IV
55495-6,Insulin^45M post dose glucose IV
55496-4,Insulin^2H post dose glucose IV
55497-2,Insulin^3M post dose glucose IV
55498-0,Insulin^7M pre dose glucose
55499-8,Insulin^15M post dose glucose IV
55500-3,Insulin^30M post dose glucagon
55501-1,Lutropin^4H post XXX challenge
55502-9,Prolactin^20M post dose TRH IV
55503-7,Prolactin^40M post dose TRH IV
55504-5,Somatotropin^2H post dose glucagon
55505-2,Somatotropin^30M post dose glucose
55506-0,Somatotropin^10M post exercise
55507-8,Somatotropin^2H post dose glucose
55508-6,Somatotropin^1H post dose glucose
Sep-50,CD99
55509-4,Somatotropin^45M post dose cloNIDine
55510-2,Somatotropin^1.5H post dose glucose
55511-0,Somatotropin^3H post dose glucagon
55512-8,Somatotropin^30M post dose glucagon
55513-6,Somatotropin^30M post dose cloNIDine
55514-4,Somatotropin^20M post exercise
55515-1,Somatotropin^2.5H post dose glucagon
55516-9,Somatotropin^1.5H post dose glucagon
Jul-51,CyCD3
55517-7,Somatotropin^1H post dose glucagon
55518-5,Testosterone^4H post dose gonadotropin releasing hormone
55519-3,Testosterone^baseline
55520-1,6-Monoacetylmorphine
55521-9,Acebutolol
55522-7,acetaZOLAMIDE
55523-5,Anileridine
55524-3,Atropine
May-52,CyCD79
55525-0,Benzoylecgonine
55526-8,Brompheniramine
55527-6,buPROPion
55528-4,Chloral hydrate
55529-2,Clopenthixol
555-3,Candida sp identified
55530-0,Cocaethylene
55531-8,Cyclobenzaprine
55532-6,Diethylpropion
Mar-53,CyIg
55533-4,dilTIAZem
55534-2,Doxylamine
55535-9,ePHEDrine
55536-7,Fenoprofen
55537-5,fentaNYL
55538-3,Flupenthixol
55539-1,Flurbiprofen
55540-9,Furosemide
Jan-54,CyIg mu
55541-7,hydroCHLOROthiazide
55542-5,Hydroxybupropion
55543-3,Hydroxychloroquine
55544-1,hydrOXYzine
55545-8,Indomethacin
55546-6,Ketoprofen
55547-4,Labetalol
55548-2,metFORMIN
55549-0,Methocarbamol
55550-8,Methsuximide+Normethsuximide
55551-6,Methylenedioxyamphetamine
55552-4,Methylphenidate
55553-2,Metoprolol
55554-0,Mirtazapine
55555-7,Molybdenum
55556-5,Nadolol
55557-3,Nicotine
Aug-55,FMC7
55558-1,Nicotine
55559-9,Norpropoxyphene
55560-7,Orphenadrine
55561-5,Oxprenolol
55562-3,Oxyphenbutazone
55563-1,Paraldehyde
55564-9,Pentazocine
55565-6,Phenacetin
Jun-56,GPA
55566-4,Phenelzine
55567-2,Pheniramine
55568-0,Phenolphthalein
55569-8,Phentermine
55570-6,predniSONE
55571-4,Prilocaine
55572-2,Procaine
55573-0,Promethazine
Apr-57,HLA-DR
55574-8,Propoxyphene+Norpropoxyphene
55575-5,Pseudoephedrine
55576-3,QUEtiapine
55577-1,Salicylamide
55578-9,Sildenafil citrate
55579-7,Sotalol
55580-5,Sulfapyridine
55581-3,sulfaSALAzine
Feb-58,Myeloperoxidase
55582-1,Timolol
55583-9,Tranylcypromine
55584-7,Trimethoprim
55585-4,Tripelennamine
55586-2,Verapamil
55587-0,Methamphetamine
55588-8,OXcarbazepine+10-Hydroxycarbazepine
55589-6,Budgerigar feather Ab.IgE
5559-0,RFD9
55590-4,Canary feather Ab.IgE
55591-2,Chicken feather Ab.IgE
55592-0,Cockatiel feather Ab.IgE
55593-8,Creatinine
55594-6,Duck feather Ab.IgE
55595-3,Finch feather Ab.IgE
55596-1,Goose feather Ab.IgE
55597-9,J little s super little b Ab
55598-7,Leukocytes.disintegrated/100 leukocytes
55599-5,Leukocytes.disintegrated/100 leukocytes
55600-1,Microscopic observation
55601-9,Microscopic observation
55602-7,Microscopic observation
55603-5,Microscopic observation
55604-3,Microscopic observation
55605-0,Parakeet feather Ab.IgE
55606-8,Parrot feather Ab.IgE
55607-6,Triglyceride/Cholesterol.in HDL
Aug-60,SmIg
55608-4,Turkey feather Ab.IgE
55609-2,Urea
556-1,Chlamydia sp identified
55610-0,Follitropin^2nd specimen post XXX challenge
55611-8,Follitropin^1st specimen post XXX challenge
55612-6,Follitropin^7th specimen post XXX challenge
55613-4,Number of D to wean patient who is now independent from ventilator
55614-2,Amoxicillin+Sulbactam
55615-9,Amoxicillin+Sulbactam
Jun-61,SmIg kappa
55616-7,Amoxicillin+Sulbactam
55617-5,Antibiotic XXX
55618-3,Atovaquone
55619-1,Avilamycin
55620-9,Bacampicillin
55621-7,Bambermycins
55622-5,Butirosin
55623-3,Capreomycin
Apr-62,SmIg lambda
55624-1,Cefacetrile
55625-8,Cefacetrile
55626-6,Cefacetrile
55627-4,Cefacetrile
55628-2,Cefadroxil
55629-0,Cephaloglycin
55630-8,Cephalothin+Sulbactam
55631-6,Cephalothin+Sulbactam
Feb-63,SmIg-CD79
55632-4,Cephalothin+Sulbactam
55633-2,Cephalothin+Sulbactam
55634-0,Cefamandole+Sulbactam
55635-7,Cefamandole+Sulbactam
55636-5,Cefamandole+Sulbactam
55637-3,Cefamandole+Sulbactam
55638-1,Cephapirin
55639-9,Cefatrizine
5564-0,TCR-CD3
55640-7,Cefetamet
55641-5,Cefmenoxime
55642-3,Cefonicid
55643-1,Ceforanide
55644-9,Cefotaxime+Sulbactam
55645-6,Cefotiam
55646-4,Cephradine
55647-2,Cefsulodin
55648-0,cefTAZidime+Sulbactam
55649-8,cefTAZidime+Sulbactam
55650-6,cefTAZidime+Sulbactam
55651-4,cefTAZidime+Sulbactam
55652-2,Ceftiofur
55653-0,Cefuroxime.oral
55654-8,Cefuroxime
55655-5,Chlortetracycline
55656-3,Cinoxacin
Jul-65,Terminal deoxyribonucleotidyl transferase
55657-1,Clindamycin.high potency
55658-9,Clindamycin.high potency
55659-7,Clindamycin.high potency
55660-5,Clindamycin.high potency
55661-3,Clofazimine
55662-1,Clofazimine
55663-9,Clotrimazole
55664-7,Cloxacillin
May-66,Acetone
55665-4,Colistimethate
55666-2,Cyclacillin
55667-0,cycloSERINE
55668-8,Dicloxacillin
55669-6,Dibekacin
55670-4,Dibekacin
55671-2,Dibekacin
55672-0,Dibekacin
Mar-67,Acetone
55673-8,Econazole
55674-6,Ethambutol 2.0 ug/mL
55675-3,Flumequine
55676-1,Flumequine
55677-9,Flumequine
55678-7,Flumequine
55679-5,Framycetin
55680-3,Isepamicin
Jan-68,Acetone
55681-1,Isoconazole
55682-9,Isoconazole
55683-7,Isoconazole
55684-5,Isoconazole
55685-2,Isoniazid 10.0 ug/mL
55686-0,Miconazole
55687-8,Miocamycin
55688-6,Nitroxoline
55689-4,Nystatin
55690-2,Oleandomycin
55691-0,Ornidazole
55692-8,Ornidazole
55693-6,Ornidazole
55694-4,Ornidazole
55695-1,Oxolinate
55696-9,Oxolinate
55697-7,Oxolinate
55698-5,Oxolinate
Sep-69,Acetone
55699-3,Oxytetracycline
55700-9,Paromomycin
55701-7,Paromomycin
55702-5,Paromomycin
55703-3,Pipemidate
55704-1,Piperacillin+Sulbactam
55705-8,Piromidate
55706-6,Piromidate
Jul-70,Acetone
55707-4,Piromidate
55708-2,Piromidate
55709-0,Pristinamycin
55710-8,Pyrazinamide
55711-6,Pyrazinamide 200.0 ug/mL
55712-4,rifAMPin 40.0 ug/mL
55713-2,Rosoxacin
55714-0,Sisomicin
May-71,Acrylonitrile
55715-7,Spiramycin
55716-5,Ticarcillin+Sulbactam
55717-3,Ticarcillin+Sulbactam
55718-1,Ticarcillin+Sulbactam
55719-9,Ticarcillin+Sulbactam
55720-7,Tinidazole
55721-5,Tinidazole
55722-3,Tinidazole
Mar-72,Aluminum
55723-1,Virginiamycin
55724-9,Apolipoprotein A-I & A-II & B & C panel
55725-6,Cerebroside sulfatase & N-Acetylgalactosamine-4-Sulfatase panel
55726-4,Borrelia burgdorferi Ab.IgA & IgG & IgM panel
55727-2,Tissue transglutaminase Ab.IgA & IgG panel
55728-0,Yersinia sp Ab.IgG & IgM panel
55729-8,Erythrocytes.fetal/100 erythrocytes
55730-6,Fetal blood
Jan-73,Aluminum
55731-4,Inject Rh immune globulin
55737-1,Cefotiam hexetil
55738-9,Cefotiam hexetil
55739-7,Cefotiam hexetil
55740-5,Cefotiam hexetil
55744-7,howRu panel
55745-4,How are you today: pain or discomfort
55746-2,How are you today: feeling low or worried
55747-0,How are you today: limited in what I can do
55748-8,Require help from others
Sep-74,Aluminum
55749-6,howRu score
55750-4,Patient safety report
55751-2,Case report
55752-0,Clinical information
55753-8,Treatment information
55754-6,Frequency of assistance at admission for home health
55755-3,Residential Information - Home Health Admission
Jun-75,Aluminum
55756-1,Patient lives with on admission for home health
55757-9,Patient health questionnaire 2 item
55758-7,Patient health questionnaire 2 item total score
55759-5,Temporal Orientation - CARE Acute Care
55760-3,Other service considered appropriate.other specified
55761-1,No services needed after discharge
55762-9,Comatose
55763-7,Number of unhealed pressure ulcers at each stage - at assessment
Apr-76,Aluminum
55764-5,EGFR gene exon 19 deletion
55765-2,EGFR gene.c.2156G>C+2155G>A+2155G>T
55766-0,EGFR gene.c.2573T>G
55767-8,EGFR gene.c.2582T>A
55768-6,EGFR gene.c.2303G>T
55769-4,EGFR gene.c.2369C>T
55770-2,EGFR gene exon 20 insertion
55771-0,Basophils
Feb-77,Aluminum
55772-8,Cardiolipin Ab.IgG
55773-6,Cardiolipin Ab.IgM
55774-4,Direct antiglobulin test.complement C3d specific reagent
55775-1,Direct antiglobulin test.IgA specific reagent
55776-9,Direct antiglobulin test.IgG specific reagent
55777-7,Direct antiglobulin test.IgM specific reagent
55778-5,Eosinophils
55779-3,Erythrocytes
5578-0,Antimony
55780-1,Erythrocytes.nucleated
55781-9,Hematocrit
55782-7,Hemoglobin
55783-5,Hemoglobin Barts
55784-3,Leukocytes^^corrected for nucleated erythrocytes
55785-0,Lupus anticoagulant neutralization.high phospholipid.factor substitution^immediately after 1:2 addition of saline
55786-8,Lupus anticoagulant neutralization.high phospholipid.factor substitution^immediately after 1:2 addition of platelet lysate
55787-6,Lymphocytes
55788-4,Mononuclear cells
55789-2,Myelocytes
557-9,Chlamydia sp identified
55790-0,Neutrophils.band form
55791-8,Neutrophils
55792-6,Nucleated cells
55793-4,Nucleated cells
55794-2,Other cells
55795-9,Phosphatidylserine Ab.IgG
55796-7,Phosphatidylserine Ab.IgM
55797-5,Platelet aggregation.adenosine diphosphate induced^2.5 umol/L
Aug-79,Antimony
55798-3,Platelet aggregation.adenosine diphosphate induced^5 umol/L
55799-1,Platelet aggregation.ristocetin induced^1125 mg/L
55800-7,Platelet aggregation.ristocetin induced^1000 mg/L
55801-5,Platelet aggregation.ristocetin induced^500 mg/L
55802-3,Platelets
55803-1,Promyelocytes
55804-9,Phosphatase.leukocyte
55805-6,cycloSPORINE
Jun-80,Antimony
55806-4,Mycophenolate
55807-2,Mycophenolate glucuronide
55808-0,11-Deoxycorticosterone
55809-8,11-Deoxycortisol
55810-6,18-Hydroxycortisol
55811-4,18-Hydroxycortisol
55812-2,18-Hydroxycortisol
55813-0,Alpha aminobutyrate/Amino acids.total
Apr-81,Antimony
55814-8,Calcidiol
55815-5,Dehydroepiandrosterone
55816-3,"3,4-Dihydroxyphenylacetate"
55817-1,Amino acids
55818-9,Organic acids
55819-7,Adiponectin.high molecular weight
55820-5,Allo-pregnanediol
55821-3,Allo-pregnanediol
Feb-82,Arsenic
55822-1,Allo-tetrahydrodeoxycortisol
55823-9,Allo-tetrahydrodeoxycortisol
55824-7,Allo-tetrahydrocorticosterone
55825-4,Allo-tetrahydrocorticosterone
55826-2,Allo-tetrahydrocortisol
55827-0,Acid alpha glucosidase
55828-8,Aliphatic carboxylate C14-C26.esters
55829-6,Catalase
5583-0,Arsenic
55830-4,Catecholamines
55831-2,Catecholamines
55832-0,Cathepsin K
55833-8,Cathepsin L
55834-6,Cathepsin S
55835-3,Vegetable fibers
55836-1,Chitotriosidase
55837-9,Chloride
55838-7,Cholesterol/Phospholipid
55839-5,Cholesterol ester transfer protein
55840-3,Cholesterol esters
55841-1,Corticosterone
55842-9,Corticosterone
55843-7,Corticosterone
55844-5,Cortisol.free
55845-2,Cortisol.free
55846-0,Cryoglobulin.IgA.monoclonal
55847-8,Cryoglobulin.IgG.monoclonal
Aug-84,Arsenic
55848-6,Cryoglobulin.IgG
55849-4,Cryoglobulin.IgM.monoclonal
55850-2,Cobalamins
55851-0,Androstenediol
55852-8,Dicarboxydodecanoylcarnitine (C12-DC)/Creatinine
55853-6,Dicarboxydodecanoylcarnitine (C12-DC)
55854-4,Dicarboxydodecanoylcarnitine (C12-DC)
May-85,Arsenic
55855-1,Dicarboxydodecanoylcarnitine (C12-DC)
55856-9,Dicarboxydodecanoylcarnitine (C12-DC)
55857-7,Estradiol
55858-5,Estradiol
55859-3,Folate
55860-1,Glucose
55861-9,Glutamate
55862-7,Glycine
Mar-86,Arsenic
55863-5,Glycolate
55864-3,Glycolate
55865-0,Glycolate
55866-8,Choriogonadotropin.beta subunit.free
55867-6,Choriogonadotropin.beta subunit.free
55868-4,Choriogonadotropin.beta subunit
55869-2,Choriogonadotropin.beta subunit
558-7,Chlamydia sp identified
55870-0,Choriogonadotropin
Jan-87,Arsenic
55871-8,Heptanoylcarnitine (C7)
55872-6,Dicarboxypalmitoylcarnitine (C16-DC)
55873-4,Palmitate/Laurate
55874-2,Histidine
55875-9,Homocitrulline
55876-7,Homocitrulline
55877-5,Homocysteine
55878-3,Homocysteine
55879-1,Homocystine
55880-9,Homovanillate
55881-7,Hydroxocobalamin
55882-5,Hydroxocobalamin
55883-3,Hydroxocobalamin
55884-1,Hydroxocobalamin
55885-8,Hydroxocobalamin
55886-6,3-Hydroxyanthranilate/Creatinine
55887-4,3-Hydroxyanthranilate
55888-2,3-Hydroxyanthranilate
Sep-88,Barium
55889-0,3-Hydroxyanthranilate
55890-8,Hydroxylysine/Amino acids.total
55891-6,Hydroxylysine
55892-4,Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase
55893-2,Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase
55894-0,Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase
55895-7,Hypoxanthine phosphoribosyltransferase/Adenine phosphoribosyltransferase
55896-5,Hypoxanthine phosphoribosyltransferase
Jul-89,Barium
55897-3,Immunoglobulin light chains.free
55898-1,Immunoglobulin light chains.free
55899-9,Immunoglobulin light chains.free
55900-5,Immunoglobulin light chains.free
55901-3,IgA.monoclonal
55902-1,IgA
55903-9,IgD.monoclonal
55904-7,IgE.monoclonal
May-90,Barium
55905-4,Alpha cortol
55906-2,Alpha cortolone
55907-0,Alpha cortolone
55908-8,Alpha galactosidase A
55909-6,Alpha-L-iduronidase
55910-4,Alpha mannosidase
55911-2,Arginine
55912-0,Arylsulfatase
Mar-91,Benzene
55913-8,Aspartate
55914-6,Beta 1 globulin
55915-3,Beta 2 globulin
55916-1,Beta galactosidase
55917-9,Glucosylceramidase
55918-7,C peptide^post meal
55919-5,C peptide^post meal
55920-3,C peptide
Jan-92,Benzene
55921-1,IgG.monoclonal
55922-9,IgG
55923-7,IgG
55924-5,IgM.monoclonal
55925-2,IgM
55926-0,Interleukin 1 receptor alpha chain
55927-8,Interleukin 1 receptor alpha chain.soluble
55928-6,Iodine/Creatinine
55929-4,Isoleucine
55930-2,Isovalerylglycine
55931-0,Lactate
55932-8,Lactate
55933-6,Leucine
55934-4,Triacylglycerol lipase
55935-1,Lysine
55936-9,Lysozyme
55937-7,Magnesium^post dialysis
55938-5,Magnesium
Sep-93,Beryllium
55939-3,Malondialdehyde
55940-1,Malonylcarnitine (C3-DC)
55941-9,Mannitol
55942-7,Methemoglobin/Hemoglobin.total
55943-5,Methionine
55944-3,Neopterin
55945-0,Neopterin
55946-8,Neopterin
Jul-94,Beryllium
55947-6,Nitrite
55948-4,Nitrite
55949-2,Dicarboxystearoylcarnitine (C18-DC)
559-5,Chlamydia sp identified
55950-0,Octanoylcarnitine (C8)
55951-8,Octenoylcarnitine (C8:1)/Creatinine
55952-6,Octenoylcarnitine (C8:1)
55953-4,Octenoylcarnitine (C8:1)
Apr-95,Beryllium
55954-2,Octenoylcarnitine (C8:1)
55955-9,Oleoylcarnitine (C18:1)/Creatinine
55956-7,Oleoylcarnitine (C18:1)
55957-5,Oleoylcarnitine (C18:1)
55958-3,Oleoylcarnitine (C18:1)
55959-1,Ornithine/Amino acids.total
55960-9,Osmolality
55961-7,Oxalate
Feb-96,Beryllium
55962-5,Oxygen content
55963-3,Palmitoleylcarnitine (C16:1)/Creatinine
55964-1,Palmitoleylcarnitine (C16:1)
55965-8,Palmitoleylcarnitine (C16:1)
55966-6,Palmitoleylcarnitine (C16:1)
55967-4,Palmitoylcarnitine (C16)
55968-2,pH
55969-0,Phenylalanine/Amino acids.total
5597-0,Bismuth
55970-8,Phenylalanine
55971-6,Alkaline phosphatase
55972-4,Phosphate^post dialysis
55973-2,Phosphate
55974-0,IgG
55975-7,IgG
55976-5,pH
55977-3,Sphere far
55978-1,Visual acuity.near
55979-9,Visual acuity.far
55980-7,SBM sphere far
55981-5,SBM visual acuity far
55982-3,Prism base direction
55983-1,N PO
55984-9,Sphere near 1
55985-6,Pupillary distance.monocular near
55986-4,N PO
55987-2,Visual acuity.near
Aug-98,Bismuth
55988-0,Prism base direction
55989-8,Pressure border code
55990-6,GF border code
55991-4,Comment N
55992-2,Lens fitting
55993-0,Linsensitz
55994-8,Producer text
55995-5,Diameter
Jun-99,Boldenone
55996-3,Radius
55997-1,Over refraction sphere
55998-9,Over refraction cylinder
55999-7,Over refraction axis
56000-3,Manufacturer name
56001-1,Lenticulation
Feb-00,Boldenone
56002-9,Platelet aggregation.adenosine diphosphate induced ATP secretion^5 umol/L
56003-7,Platelet aggregation.adenosine diphosphate induced ATP secretion^10 umol/L
56004-5,Platelet aggregation.adenosine diphosphate induced ATP secretion^5 umol/L
56005-2,Platelet aggregation.adenosine diphosphate induced^5 umol/L
56006-0,Platelet aggregation.adenosine diphosphate induced^10 umol/L
56007-8,Platelet aggregation.arachidonate induced^500 umol/L
56008-6,Platelet aggregation.collagen induced^1 ug/mL
56009-4,Platelet aggregation.collagen induced^5 ug/mL
5601-0,Boldenone
56010-2,Platelet aggregation.ristocetin induced^250 ug/mL
56011-0,Platelet aggregation.adenosine diphosphate induced ATP secretion^10 umol/L
56012-8,Platelet aggregation.arachidonate induced ATP secretion^500 umol/L
56013-6,Platelet aggregation.arachidonate induced ATP secretion^500 umol/L
56014-4,Platelet aggregation.collagen induced ATP secretion^5 ug/mL
56015-1,Platelet aggregation.collagen induced ATP secretion^1 ug/mL
56016-9,Platelet aggregation.collagen induced ATP secretion^1 ug/mL
56017-7,Platelet aggregation.collagen induced ATP secretion^5 ug/mL
56018-5,Platelet aggregation.thrombin induced ATP secretion^5 U/mL
56019-3,Platelet aggregation.thrombin induced ATP secretion^1 U/mL
56020-1,Platelet aggregation.thrombin induced ATP secretion^5 U/mL
56021-9,Platelet aggregation.thrombin induced ATP secretion^1 U/mL
56022-7,ACE gene targeted mutation analysis
56023-5,Foot and mouth disease virus RNA
56024-3,Influenza virus A N1 RNA
56025-0,Ethambutol 8.0 ug/mL
56026-8,Pyrazinamide 300.0 ug/mL
56027-6,Platelet aggregation.ristocetin induced^1.0 mg/mL
Aug-02,Borate
56028-4,Cells.CD3-CD56+/100 cells
56029-2,Cells.CD3-CD56+/100 cells
560-3,Chlamydia sp identified
56030-0,Karyotype
56031-8,Doripenem
56032-6,Lithium
56033-4,Androstenediol
56034-2,Hydroxylysine
56035-9,Apolipoprotein A-I/Cholesterol.in HDL
Jun-03,Borate
56036-7,Apolipoprotein B/Cholesterol.in LDL
56037-5,Protein phosphatase 3
56038-3,Lysozyme
56039-1,Lysozyme
56040-9,Methemoglobin
56041-7,Beta defensin
56042-5,Beta defensin
56043-3,Horizontal adduction.passive range of motion
Apr-04,Boron
56044-1,Horizontal adduction.active range of motion
56045-8,Horizontal adduction.passive range of motion
56046-6,Horizontal adduction.passive range of motion
56047-4,Horizontal adduction.active range of motion
56048-2,Horizontal adduction.active range of motion
56049-0,PhenX measure - current age
56050-8,PhenX measure - ethnicity
Jan-05,Boron
56051-6,Hispanic or Latino
56052-4,PhenX measure - race
56053-2,PhenX measure - gender
56054-0,PhenX measure - arm span
56055-7,PhenX measure - birth weight
56056-5,Body weight^at birth
56057-3,Body weight more or less than 5.5 pounds (2500 g)^at birth
56058-1,PhenX measure - child head circumference
56059-9,PhenX measure - hand dominance
56060-7,PhenX measure - height
56061-5,Knee height
56062-3,PhenX measure - hip circumference
56063-1,Circumference.at maximal protrusion of gluteus muscles
56064-9,PhenX measure - maximum adult height
56065-6,Self-Reported Maximum Adult Height
56066-4,Body height^at age 25
56067-2,PhenX measure - maximum adult weight
56068-0,Self-Reported Maximum Adult Weight
Sep-06,Boron
56069-8,Body weight.max
56070-6,Age^at body weight.max
56071-4,PhenX measure - mid upper arm circumference
56072-2,Circumference
56073-0,PhenX measure - neck circumference
56074-8,Circumference
56075-5,PhenX measure - pregnancy weight gain
56076-3,Pregnancy weight gain.current
Jul-07,Boron
56077-1,Body weight^pre current pregnancy
56078-9,Weight gain^during current pregnancy
56079-7,Body weight^pre most recent pregnancy
56080-5,Weight gain^during most recent pregnancy
56081-3,Gestational age in W^at most recent delivery
56082-1,PhenX measure - weight loss or gain
56083-9,Body weight^XXX time ago
56084-7,PhenX measure - weight
May-08,Bufotenine
56085-4,PhenX measure - waist circumference
56086-2,Adult Waist Circumference Protocol
56087-0,Child Waist Circumference Protocol
56088-8,PhenX panel
56089-6,Pregnancy weight gain.most recent
56090-4,Hispanic origin
56091-2,Race
56092-0,Body weight^at birth
Mar-09,Cadmium
56093-8,Body weight^at birth
56094-6,Body weight^at birth
56095-3,Body weight more or less than 9.0 pounds (4100 g)^at birth
56096-1,Phenx - hand dominance - 42Mo and older protocol 020601
56097-9,Hand dominance - drawing
56098-7,Hand dominance - throwing a ball
56099-5,Hand dominance - coloring
56100-1,Hand dominance - holding a toothbrush
Jan-10,Cadmium
56101-9,PhenX - hand dominance - 12Y and older protocol 020602
56102-7,Hand dominance - write
56103-5,Hand dominance - draw
56104-3,Hand dominance - throw
56105-0,Hand dominance - hold a racquet
56106-8,Hand dominance - clean teeth
56107-6,Hand dominance - hammer
56108-4,Hand dominance - strike a match
56109-2,Hand dominance - use an eraser
561-1,Chlamydia sp Ag
56110-0,Hand dominance - deal cards
56111-8,Hand dominance - thread a needle
56112-6,Hand dominance - cut food with a knife
56113-4,Hand dominance - Total score
56114-2,Circumference
56115-9,Circumference
56116-7,Width
56117-5,Circumference
56118-3,Proxy name
Sep-11,Cadmium
56119-1,Cellular material
56120-9,Amphetamine+Methamphetamine
56121-7,IgA
56122-5,IgG
56123-3,IgM
56124-1,Glucose^1H post meal
56125-8,Immunoglobulin light chains.free
56126-6,Copper
Jul-12,Cadmium
56127-4,CD38 Ag
56128-2,Chikungunya virus Ab.IgG
56129-0,Chikungunya virus Ab.IgG
56130-8,Chikungunya virus Ab.IgM
56131-6,Chikungunya virus Ab.IgM
56132-4,Cholesterol.in HDL 2a
56133-2,Cholesterol.in HDL 2b
56134-0,Cholesterol.in IDL 1
May-13,Carbon disulfide
56135-7,Cholesterol.in IDL 2
56136-5,LDL 1
56137-3,LDL 2
56138-1,LDL 3
56139-9,LDL 4
56140-7,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA
56141-5,MPL gene.p.Ser505Asn
56142-3,MPL gene.p.Trp515Leu+Trp515Lys
Mar-14,Cesium
56143-1,Potassium/Creatinine
56144-9,CHIC2 gene 4q12 deletion
56145-6,Erythrocytes+Granulocytes.CD55+CD59 deficient
56146-4,Fungal Ab panel
56147-2,Parietal cell Ab
56148-0,Smith extractable nuclear Ab & Ribonucleoprotein extractable nuclear Ab panel
56149-8,Beta 2 glycoprotein & Cardiolipin Ab & Phosphatidylserine panel
5615-0,Cesium
56150-6,Candida albicans Ab.IgM
56151-4,Candida albicans Ab.IgA
56152-2,Beta 2 glycoprotein 1 Ab.IgA & IgG & IgM panel
56153-0,Albumin.serum/Albumin.Periton fld
56154-8,Protein.abnormal band/Protein.total
56155-5,Date referral lab test results received
56156-3,Candida albicans Ab.IgA & IgG & IgM panel
56157-1,HOXB13 gene/IL17BR gene
56158-9,PCSK9 gene targeted mutation analysis
56159-7,LDLR gene targeted mutation analysis
56160-5,Glucose^4H post peritoneal dialysis
56161-3,Calculus analysis with calculus photography
56162-1,Hand dominance - 42Mo
56163-9,Hand dominance - 12Y
56164-7,CYP2C9 gene allele 2
56165-4,CYP2C9 gene allele 3
56166-2,Gum arabic Ab.IgG4
56167-0,Corticotropin Ab.IgG4
Aug-16,Cesium
56168-8,Pimenta dioica Ab.IgG4
56169-6,Prunus dulcis Ab.IgG4
56170-4,Alternaria alternata Ab.IgG4
56171-2,Fagus grandifolia Ab.IgG4
56172-0,Cheese American Ab.IgG4
56173-8,Periplaneta americana Ab.IgG4
56174-6,Ulmus americana Ab.IgG4
56175-3,Platanus occidentalis Ab.IgG4
Jun-17,Cesium
56176-1,Malus sylvestris Ab.IgG4
56177-9,Prunus armeniaca Ab.IgG4
56178-7,Cynara scolymus Ab.IgG4
56179-5,Asparagus officinalis Ab.IgG4
56180-3,Aspergillus fumigatus Ab.IgG4
56181-1,Aspergillus niger Ab.IgG4
56182-9,Aspergillus versicolor Ab.IgG4
56183-7,Casuarina equisetifolia Ab.IgG4
Apr-18,Cesium
56184-5,Persea americana Ab.IgG4
56185-2,Paspalum notatum Ab.IgG4
56186-0,Musa spp Ab.IgG4
56187-8,Hordeum vulgare Ab.IgG4
56188-6,Ocimum basilicum Ab.IgG4
56189-4,Laurus nobilis Ab.IgG4
56190-2,Cynodon dactylon Ab.IgG4
56191-0,Prunus avium Ab.IgG4
Feb-19,Chromium
56192-8,Micropterus salmoides Ab.IgG4
56193-6,Salix nigra Ab.IgG4
56194-4,Rubus fruticosus Ab.IgG4
56195-1,Vigna sinensis Ab.IgG4
56196-9,Vaccinium myrtillus Ab.IgG4
56197-7,Insulin bovine Ab.IgG4
56198-5,Bertholletia excelsa Ab.IgG4
56199-3,Yeast brewer's Ab.IgG4
Feb-56,Capreomycin
5620-0,Chromium
56200-9,Brassica oleracea var italica Ab.IgG4
56201-7,Brassica oleracea var gemmifera Ab.IgG4
56202-5,Fagopyrum esculentum Ab.IgG4
56203-3,Brassica oleracea var capitata Ab.IgG4
56204-1,Candida albicans Ab.IgG4
56205-8,Amaranthus palmeri Ab.IgG4
56206-6,Daucus carota Ab.IgG4
56207-4,Casein Ab.IgG4
56208-2,Anacardium occidentale Ab.IgG4
56209-0,Ricinus communis Ab.IgG4
56210-8,Cat dander Ab.IgG4
56211-6,Ictalurus punctatus Ab.IgG4
56212-4,Brassica oleracea var botrytis Ab.IgG4
56213-2,Apium graveolens Ab.IgG4
56214-0,Acremonium sp Ab.IgG4
56215-7,Cheese cheddar type Ab.IgG4
56216-5,Cheese mold type Ab.IgG4
56217-3,Cicer arietinus Ab.IgG4
Aug-21,Chromium
56218-1,Chicken Ab.IgG4
56219-9,Cichorium intybus Ab.IgG4
56220-7,Capsicum frutescens Ab.IgG4
56221-5,Ulmus pumila Ab.IgG4
56222-3,Chocolate Ab.IgG4
56223-1,Cinnamomum spp Ab.IgG4
56224-9,Cladosporium herbarum Ab.IgG4
56225-6,Ruditapes spp Ab.IgG4
Jun-22,Chromium
56226-4,Xanthium commune Ab.IgG4
56227-2,Cocos nucifera Ab.IgG4
56228-0,Gadus morhua Ab.IgG4
56229-8,Coffea spp Ab.IgG4
56230-6,Phragmites communis Ab.IgG4
56231-4,Zea mays Ab.IgG4
56232-2,Ustilago maydis Ab.IgG4
56233-0,Populus deltoides Ab.IgG4
Apr-23,Chromium
56234-8,Cow milk Ab.IgG4
56235-5,Cancer pagurus Ab.IgG4
56236-3,Vaccinium oxycoccos Ab.IgG4
56237-1,Astacus astacus Ab.IgG4
56238-9,Cucumis sativus Ab.IgG4
56239-7,Curry Ab.IgG4
56240-5,Loligo sp Ab.IgG4
56241-3,Dermatophagoides farinae Ab.IgG4
Feb-24,Chromium
56242-1,Dermatophagoides pteronyssinus Ab.IgG4
56243-9,Taraxacum vulgare Ab.IgG4
56244-7,Phoenix dactylifera Ab.IgG4
56245-4,Chrysops flavidus (whole body) Ab.IgG4
56246-2,Anethum graveolens Ab.IgG4
56247-0,Dog epithelium Ab.IgG4
56248-8,Dog dander Ab.IgG4
56249-6,Pseudotsuga taxifolia Ab.IgG4
56250-4,Duck feather Ab.IgG4
56251-2,Duck meat Ab.IgG4
56252-0,Anguilla anguilla Ab.IgG4
56253-8,Egg white Ab.IgG4
56254-6,Egg yolk Ab.IgG4
56255-3,Egg whole Ab.IgG4
56256-1,Solanum melongena Ab.IgG4
56257-9,Plantago lanceolata Ab.IgG4
56258-7,Eucalyptus spp Ab.IgG4
Sep-25,Cobalt
56259-5,(Chicken feather+Duck feather+Goose feather+Turkey feather) Ab.IgG4
56260-3,Solenopsis invicta Ab.IgG4
56261-1,Linum usitatissimum Ab.IgG4
56262-9,Ctenocephalides sp Ab.IgG4
56263-7,Flounder Ab.IgG4
56264-5,Glycyphagus domesticus Ab.IgG4
56265-2,Allium sativum Ab.IgG4
56266-0,Blatella germanica Ab.IgG4
Jul-26,Cobalt
56267-8,Zingiber officinale Ab.IgG4
56268-6,Gluten Ab.IgG4
56269-4,Goat milk Ab.IgG4
56270-2,Hamster epithelium Ab.IgG4
56271-0,Solidago virgaurea Ab.IgG4
56272-8,Goose feather Ab.IgG4
56273-6,Vitis vinifera Ab.IgG4
56274-4,Citrus paradisis Ab.IgG4
May-27,Cobalt
56275-1,Bean green Ab.IgG4
56276-9,Olea europaea Ab.IgG4
56277-7,Pisum sativum Ab.IgG4
56278-5,Pepper green Ab.IgG4
56279-3,Guinea pig epithelium Ab.IgG4
56280-1,Melanogrammus aeglefinus Ab.IgG4
56281-9,Hippoglossus hippoglossus Ab.IgG4
56282-7,Corylus avellana pollen Ab.IgG4
Mar-28,Cobalt
56283-5,Corylus avellana Ab.IgG4
56284-3,Clupea harengus Ab.IgG4
56285-0,Honey Ab.IgG4
56286-8,Apis mellifera Ab.IgG4
56287-6,Cucumis melo spp Ab.IgG4
56288-4,Humulus lupus Ab.IgG4
56289-2,Armoracia rusticana Ab.IgG4
562-9,Clostridioides difficile
56290-0,House dust Greer Ab.IgG4
Jan-29,Copper
56291-8,(Blatella germanica+Dermatophagoides farinae+Dermatophagoides pteronyssinus+House dust Hollister Stier) Ab.IgG4
56292-6,Insulin human Ab.IgG4
56293-4,Cupressus sempervirens Ab.IgG4
56294-2,Sorghum halepense Ab.IgG4
56295-9,Karaya gum Ab.IgG4
56296-7,Poa pratensis Ab.IgG4
56297-5,Bean kidney red Ab.IgG4
56298-3,Actinidia chinensis Ab.IgG4
56299-1,Kochia scoparia Ab.IgG4
56300-7,Lepidoglyphus destructor Ab.IgG4
56301-5,Lactalbumin alpha Ab.IgG4
56302-3,Beta lactoglobulin Ab.IgG4
56303-1,Chenopodium album Ab.IgG4
56304-9,Citrus limon Ab.IgG4
56305-6,Atriplex lentiformis Ab.IgG4
56306-4,Lens esculenta Ab.IgG4
56307-2,Lactuca sativa Ab.IgG4
56308-0,Phaseolus limensis Ab.IgG4
Sep-30,Copper
56309-8,Citrus aurantifolia Ab.IgG4
56310-6,Homarus gammarus Ab.IgG4
56311-4,Locust tree Ab.IgG4
56312-2,Malt Ab.IgG4
56313-0,Mangifera indica Ab.IgG4
56314-8,Maple syrup Ab.IgG4
56315-5,Acer negundo Ab.IgG4
56316-3,Iva ciliata Ab.IgG4
Jul-31,Copper
56317-1,Festuca elatior Ab.IgG4
56318-9,Alopercurus pratensis Ab.IgG4
56319-7,Melaleuca leucadendron Ab.IgG4
56320-5,Prosopis juliflora Ab.IgG4
56321-3,Panicum milliaceum Ab.IgG4
56322-1,Aedes communis Ab.IgG4
56323-9,Juniperus sabinoides Ab.IgG4
56324-7,Mucor racemosus Ab.IgG4
May-32,Copper
56325-4,Artemisia vulgaris Ab.IgG4
56326-2,Agaricus hortensis Ab.IgG4
56327-0,Mytilus edulis Ab.IgG4
56328-8,Mustard Ab.IgG4
56329-6,Prunus persica var nucipersica Ab.IgG4
56330-4,Urtica dioica Ab.IgG4
56331-2,(Anacardium occidentale+Carya illinoinensis+Castanea sativa+Juglans spp+Pistacia vera) Ab.IgG4
56332-0,Nutmeg Ab.IgG4
Mar-33,Copper
56333-8,Avena sativa Ab.IgG4
56334-6,Avena sativa cultivated Ab.IgG4
56335-3,Abelmoschus esculentus Ab.IgG4
56336-1,Olea europaea pollen Ab.IgG4
56337-9,Allium cepa Ab.IgG4
56338-7,Citrus sinensis Ab.IgG4
56339-5,Dactylis glomerata Ab.IgG4
56340-3,Origanum vulgare Ab.IgG4
Jan-34,Cyanide
56341-1,Chrysanthemum leucanthemum Ab.IgG4
56342-9,Ostrea edulis Ab.IgG4
56343-7,Carica papaya Ab.IgG4
56344-5,Polistes spp Ab.IgG4
56345-2,Capsicum annuum Ab.IgG4
56346-0,Cheese parmesan Ab.IgG4
56347-8,Parrot feather Ab.IgG4
56348-6,Petroselinum crispum Ab.IgG4
56349-4,Pastinaca sativa Ab.IgG4
56350-2,Prunus persica Ab.IgG4
56351-0,Arachis hypogaea Ab.IgG4
56352-8,Pyrus communis Ab.IgG4
56353-6,Carya illinoinensis nut Ab.IgG4
56354-4,Carya illinoinensis tree Ab.IgG4
56355-1,Penicillium notatum Ab.IgG4
56356-9,Perca spp Ab.IgG4
56357-7,Lolium perenne Ab.IgG4
Aug-35,Cyanide
56358-5,Ananas comosus Ab.IgG4
56359-3,Bean pinto Ab.IgG4
56360-1,Pistacia vera Ab.IgG4
56361-9,Prunus domestica Ab.IgG4
56362-7,Papaver somniferum Ab.IgG4
56363-5,Insulin porcine Ab.IgG4
56364-3,Iva axillaris Ab.IgG4
56365-0,Syagrus romanzoffianum Ab.IgG4
Jun-36,Cyanide
56366-8,Rabbit Ab.IgG4
56367-6,Rabbit epithelium Ab.IgG4
56368-4,Raphanus sativus Ab.IgG4
56369-2,Franseria acanthicarpa Ab.IgG4
563-7,Clostridioides difficile
56370-0,Ambrosia trifida Ab.IgG4
56371-8,Ambrosia elatior Ab.IgG4
56372-6,Ambrosia psilostachya Ab.IgG4
56373-4,Rubus idaeus Ab.IgG4
Apr-37,Cyanide
56374-2,Rat epithelium Ab.IgG4
56375-9,Beet red Ab.IgG4
56376-7,Snapper red Ab.IgG4
56377-5,Agrostis stolonifera Ab.IgG4
56378-3,Rheum spp Ab.IgG4
56379-1,Oryza sativa Ab.IgG4
56380-9,Salsola kali Ab.IgG4
56381-7,Secale cereale pollen Ab.IgG4
Feb-38,Diazinon
56382-5,Carthamus tinctorius Ab.IgG4
56383-3,Salmo salar Ab.IgG4
56384-1,Sardina pilchardus Ab.IgG4
56385-8,Pecten spp Ab.IgG4
56386-6,Sesamum indicum Ab.IgG4
56387-4,Rumex acetosella Ab.IgG4
56388-2,Pandalus borealis Ab.IgG4
56389-0,Solea solea Ab.IgG4
5639-0,Ethanol
56390-8,Glycine max Ab.IgG4
56391-6,Spinacia oleracea Ab.IgG4
56392-4,Pigweed spiny Ab.IgG4
56393-2,Fragaria vesca Ab.IgG4
56394-0,Saccharum officinarum Ab.IgG4
56395-7,Helianthus annuus seed Ab.IgG4
56396-5,Castanea sativa Ab.IgG4
56397-3,Ipomoea batatas Ab.IgG4
56398-1,Anthoxanthum odoratum Ab.IgG4
56399-9,Cheese swiss Ab.IgG4
56400-5,Citrus reticulata Ab.IgG4
56401-3,Camellia sinensis Ab.IgG4
56402-1,Thymus vulgaris Ab.IgG4
56403-9,Phleum pratense Ab.IgG4
56404-7,Nicotiana tabacum Ab.IgG4
56405-4,Lycopersicon lycopersicum Ab.IgG4
56406-2,Trichoderma viride Ab.IgG4
56407-0,Oncorhynchus mykiss Ab.IgG4
Aug-40,Ethanol
56408-8,Thunnus albacares Ab.IgG4
56409-6,Turkey Ab.IgG4
56410-4,Vanilla planifolia Ab.IgG4
56411-2,Holcus lanatus Ab.IgG4
56412-0,Venison Ab.IgG4
56413-8,Quercus virginiana Ab.IgG4
56414-6,Juglans spp Ab.IgG4
56415-3,Citrullus lanatus Ab.IgG4
Jun-41,Ethanol
56416-1,Acnida tamariscina Ab.IgG4
56417-9,Triticum aestivum Ab.IgG4
56418-7,Triticum aestivum pollen Ab.IgG4
56419-5,Cow whey Ab.IgG4
56420-3,Fraxinus americana Ab.IgG4
56421-1,Bean white Ab.IgG4
56422-9,Betula populifolia Ab.IgG4
56423-7,Carya tomentosa Ab.IgG4
Apr-42,Ethanol
56424-5,Dolichovespula maculata Ab.IgG4
56425-2,Morus alba Ab.IgG4
56426-0,Quercus alba Ab.IgG4
56427-8,Pinus strobus Ab.IgG4
56428-6,Populus alba Ab.IgG4
56429-4,Solanum tuberosum Ab.IgG4
56430-2,Whitefish Ab.IgG4
56431-0,Wine Vinegar Ab.IgG4
Feb-43,Ethanol
56432-8,Artemisia absinthium Ab.IgG4
56433-6,Dolichovespula arenaria Ab.IgG4
56434-4,Vespula spp Ab.IgG4
56435-1,Yogurt Ab.IgG4
56436-9,Squash zucchini Ab.IgG4
56437-7,Chicken feather Ab.IgG4
56438-5,Beef Ab.IgG4
56439-3,Scomber japonicus Ab.IgG4
5644-0,Ethanol
56440-1,Syzygium aromaticum Ab.IgG4
56441-9,Latex Ab.IgG4
56442-7,Pork Ab.IgG4
56443-5,Secale cereale Ab.IgG4
56444-3,Healthcare communication
56445-0,Medication summary
56446-8,Appointment summary
56447-6,Plan of care note
56448-4,Chloride
56449-2,Saccharomyces cerevisiae Ab.IgG4
564-5,Colony count
56450-0,Piper nigrum Ab.IgG4
56451-8,Chymopapain Ab.IgG4
56452-6,Cottonseed Ab.IgG4
56453-4,Cow dander Ab.IgG4
56454-2,Cuminum cyminum Ab.IgG4
56455-9,Gelatin Ab.IgG4
56456-7,Horse dander Ab.IgG4
Jul-45,Ethanol
56457-5,Lamb Ab.IgG4
56458-3,Acacia longifolia Ab.IgG4
56459-1,Ustilago avenae Ab.IgG4
56460-9,Schinus molle Ab.IgG4
56461-7,Alnus rubra Ab.IgG4
56462-5,Pepper red Ab.IgG4
56463-3,Pigweed rough Ab.IgG4
56464-1,Salvia officinalis Ab.IgG4
May-46,Ethylene glycol
56465-8,Distichlis spicata Ab.IgG4
56466-6,Xiphias gladius Ab.IgG4
56467-4,Tabanus spp Ab.IgG4
56468-2,Cucurbita pepo Ab.IgG4
56469-0,Cardiac heart disease risk
56470-8,Blasts
56471-6,Direct antiglobulin test.complement C3c specific reagent
56472-4,Erythrocytes.nucleated
Mar-47,Ethylene glycol
56473-2,Metamyelocytes
56474-0,Salmonella sp identified
56475-7,Salmonella sp antigenic formula
56476-5,Hemoglobin S/Hemoglobin.total
56477-3,Thyroperoxidase Ab
56478-1,Ethanol
56479-9,Superoxide dismutase
56480-7,Taenia solium larva Ab
Jan-48,Fluoride
56481-5,Immunoglobulin light chains.lambda.free
56482-3,Insulin^baseline
56483-1,Porphobilinogen
56484-9,Uroporphyrin
56485-6,Taenia solium Ab.IgG
56486-4,Taenia solium Ab.IgG
56487-2,Androsterone
56488-0,Etiocholanolone
56489-8,Acidity.titratable
56490-6,Hemoglobin.gastrointestinal.lower^2nd specimen
56491-4,Hemoglobin.gastrointestinal.lower^3rd specimen
56492-2,Insulin^6M post XXX challenge
56493-0,Lutropin^10M post XXX challenge
56494-8,Lutropin^2H post XXX challenge
56495-5,Lutropin^3H post XXX challenge
56496-3,Prolactin^2H post XXX challenge
56497-1,Choriogonadotropin.beta subunit
56498-9,Androstenedione^30M post XXX challenge
Sep-49,Fluoride
56499-7,Somatotropin^45M post XXX challenge
56500-2,Somatotropin^3H post XXX challenge
56501-0,Somatotropin^6H post XXX challenge
56502-8,Somatotropin^7H post XXX challenge
56503-6,Somatotropin^8H post XXX challenge
56504-4,Corticotropin^15M post XXX challenge
56505-1,Corticotropin^45M post XXX challenge
56506-9,Corticotropin^2H post XXX challenge
Jul-50,Fluoride
56507-7,Dehydroepiandrosterone sulfate^30M post XXX challenge
56508-5,Dehydroepiandrosterone sulfate^1H post XXX challenge
56510-1,Dehydroepiandrosterone^1H post XXX challenge
56511-9,Calcitonin^2M post XXX challenge
56512-7,Porphyrins
56513-5,Hepatitis E virus Ab.IgG
56514-3,Legionella pneumophila Ab.IgG
May-51,Fluoride
56515-0,Plasmodium falciparum Ab.IgG
56516-8,C peptide^6M post XXX challenge
56517-6,11-Deoxycortisol^2H post XXX challenge
56518-4,11-Deoxycortisol^15M post XXX challenge
56519-2,11-Deoxycortisol^30M post XXX challenge
565-2,Colony count
56520-0,11-Deoxycortisol^45M post XXX challenge
56521-8,11-Deoxycortisol^1.5H post XXX challenge
56522-6,17-Hydroxypregnenolone^30M post XXX challenge
Mar-52,Formaldehyde
56523-4,Insulin-like growth factor-I^15M post XXX challenge
56524-2,Insulin-like growth factor-I^45M post XXX challenge
56525-9,5-Hydroxytryptophan
56526-7,Somatotropin^30M post exercise
56527-5,Vasopressin^1H post XXX challenge
56528-3,Androstenedione^20M post XXX challenge
56529-1,Ma+Ta Ab
56530-9,CV2 Ab
Jan-53,Formaldehyde
56531-7,Amphiphysin Ab
56532-5,Asialoglycoprotein receptor Ab
56533-3,Insulin Ab.IgG
56534-1,Calcitonin^15M post XXX challenge
56535-8,8-Dehydrocholesterol
56536-6,Thyroglobulin Ab
56537-4,Tissue transglutaminase Ab.IgG
56538-2,Beta 2 glycoprotein 1 Ab
56539-0,Intrinsic factor Ab
56540-8,Glutamate decarboxylase 65 Ab
56541-6,Ganglioside GD1b Ab.IgG
56542-4,Ganglioside GD1b Ab.IgM
56543-2,Ganglioside GM2 Ab.IgG
56544-0,Ganglioside GM2 Ab.IgM
56545-7,Ganglioside GQ1b Ab.IgM
56546-5,Insulin Ab
56547-3,Tubular basement membrane Ab.IgG
56548-1,U1 small nuclear ribonucleoprotein Ab.IgG
Sep-54,Gallium
56549-9,Sjogrens syndrome-A extractable nuclear 52kD Ab
56550-7,Purkinje cell cytoplasmic type Tr Ab
56551-5,Purkinje cell cytoplasmic type Tr Ab
56552-3,Dehydroepiandrosterone sulfate^baseline
56553-1,Albumin
56554-9,Porphyrins
56555-6,11-Deoxycorticosterone^baseline
Jun-55,Germanium
56556-4,11-Deoxycorticosterone^30M post XXX challenge
56557-2,Renin^10M post XXX challenge
56558-0,Aldosterone^10M post XXX challenge
56559-8,Norepinephrine^pre/post XXX challenge
56560-6,Somatotropin^4.5H post XXX challenge
56561-4,Somatotropin^5.5H post XXX challenge
56562-2,Somatotropin^6.5H post XXX challenge
56563-0,Somatotropin^7.5H post XXX challenge
Apr-56,Gold
56564-8,Somatotropin^8H post XXX challenge
56565-5,Somatotropin^9H post XXX challenge
56566-3,Somatotropin^9.5H post XXX challenge
56567-1,Somatotropin^10H post XXX challenge
56568-9,Somatotropin^10.5H post XXX challenge
56569-7,Somatotropin^11H post XXX challenge
56570-5,Somatotropin^11.5H post XXX challenge
56571-3,Somatotropin^post exercise
Feb-57,Gold
56572-1,Somatotropin^20H post XXX challenge
56573-9,Renin^30M post XXX challenge
56574-7,Renin^1H post XXX challenge
56575-4,17-Hydroxyprogesterone^15M post XXX challenge
56576-2,17-Hydroxyprogesterone^45M post XXX challenge
56577-0,Renin^1.5H post XXX challenge
56578-8,Aldosterone^1.5H post XXX challenge
56579-6,Aldosterone^20M post XXX challenge
5658-0,Gold
56580-4,Renin^20M post XXX challenge
56581-2,Insulin^12M post XXX challenge
56582-0,C peptide^10M post XXX challenge
56583-8,C peptide^45M post XXX challenge
56584-6,C peptide^12M post XXX challenge
56585-3,Cortisol^45M post XXX challenge
56586-1,Dehydroepiandrosterone^15M post XXX challenge
56587-9,Dehydroepiandrosterone^30M post XXX challenge
56588-7,Dehydroepiandrosterone sulfate^45M post XXX challenge
56589-5,Dehydroepiandrosterone^1.5H post XXX challenge
56590-3,Dehydroepiandrosterone^2H post XXX challenge
56591-1,Dehydroepiandrosterone sulfate^3H post XXX challenge
56592-9,Follitropin^10M post XXX challenge
56593-7,Follitropin^3H post XXX challenge
56594-5,Thyrotropin^3H post XXX challenge
56595-2,Latex recombinant (rHev b) 3 Ab.IgE
56596-0,Latex recombinant (rHev b) 5 Ab.IgE
56597-8,Latex recombinant (rHev b) 8 Ab.IgE
Aug-59,Gold
56598-6,Epstein Barr virus early Ab.IgM
56599-4,Epstein Barr virus capsid Ab.IgM
566-0,Cryptosporidium sp Ag
56600-0,Vespa crabro Ab.IgG
56601-8,Hyaluronate
56602-6,11-Deoxycorticosterone^1st specimen post XXX challenge
56603-4,11-Deoxycorticosterone^2nd specimen post XXX challenge
56604-2,11-Deoxycorticosterone^3rd specimen post XXX challenge
56605-9,11-Deoxycorticosterone^4th specimen post XXX challenge
Jun-60,Gold
56606-7,11-Deoxycorticosterone^pre XXX challenge
56608-3,11-Deoxycorticosterone^15M post XXX challenge
56609-1,11-Deoxycorticosterone^20M post XXX challenge
56610-9,11-Deoxycorticosterone^40M post XXX challenge
56611-7,11-Deoxycorticosterone^1.5H post XXX challenge
56612-5,11-Deoxycorticosterone^2H post XXX challenge
56613-3,11-Deoxycorticosterone^2.5H post XXX challenge
Apr-61,Gold
56614-1,17-Hydroxyprogesterone^10M post XXX challenge
56615-8,17-Hydroxyprogesterone^20M post XXX challenge
56616-6,17-Hydroxyprogesterone^1.5H post XXX challenge
56617-4,17-Hydroxyprogesterone^2H post XXX challenge
56618-2,Insulin-like growth factor-I^10M post XXX challenge
56619-0,Insulin-like growth factor-I^20M post XXX challenge
56620-8,Elastase Ab
56621-6,Coxsackievirus A9 Ab.IgG
Feb-62,Heavy metals
56622-4,Echovirus Ab.IgG
56623-2,Echovirus Ab.IgM
56624-0,Fructose
56625-7,Methylene chloride
56626-5,Tetrachloroethylene
56627-3,Procollagen type III
56628-1,Amikacin
56629-9,Myelin Ab
5663-0,Heavy metals positive
56630-7,Brucella sp Ab.IgG
56631-5,Brucella sp Ab.IgM
56632-3,Mitochondria M2 Ab.IgG
56633-1,Myocardium Ab.IgG
56634-9,Nuclear Ab.IgG
56635-6,Thyroglobulin Ab.IgG
56636-4,Bordetella parapertussis Ab.IgM
56637-2,Mi-2 Ab
56638-0,Rheumatoid arthritis nuclear Ab
56639-8,Methyl ethyl ketone
56640-6,Aspartate/Creatinine
56641-4,Threonine/Creatinine
56642-2,Serine/Creatinine
56643-0,Asparagine/Creatinine
56644-8,Glutamate/Creatinine
56645-5,Vanillylmandelate/Creatine
56646-3,Trichloroacetate/Creatinine
56647-1,Phenol/Creatinine
Aug-64,Heavy metals negative
56648-9,Phenylglyoxylate/Creatinine
56649-7,Hippurate/Creatinine
56650-5,Chromium/Creatinine
56651-3,Cadmium/Creatinine
56652-1,Arsenic/Creatinine
56653-9,Mercury/Creatinine
56654-7,Nickel/Creatinine
May-65,Indium
56655-4,Bromide/Creatinine
56656-2,Fluoride/Creatinine
56657-0,Tetrahydrocortisone
56658-8,Delta aminolevulinate/Creatinine
56659-6,Para aminophenol/Creatinine
56660-4,Methyl formamide/Creatinine
56661-2,Myelin basic protein
56662-0,Beta-2-Microglobulin
Mar-66,Indium
56663-8,5-Hydroxytryptophan
56664-6,Methylmalonate/Creatinine
56665-3,Taenia solium Ab.IgG
56666-1,1-Methylhistidine/Creatinine
56667-9,3-Methylhistidine/Creatinine
56668-7,Alpha aminoadipate/Creatinine
56669-5,Carotene.alpha
56670-3,Adrenal cortex Ab.IgG
Jan-67,Isopropanol
56671-1,Alanine/Creatinine
56672-9,Arginine/Creatinine
56673-7,Beta aminoisobutyrate/Creatinine
56674-5,Beta alanine/Creatinine
56675-2,Carnosine/Creatinine
56676-0,Citrulline/Creatinine
56677-8,Cystine/Creatinine
56678-6,Ethanolamine/Creatinine
56679-4,Gamma aminobutyrate/Creatinine
56680-2,Glutamine/Creatinine
56681-0,Glycine/Creatinine
56682-8,Homocystine/Creatinine
56683-6,Histidine/Creatinine
56684-4,Hydroxylysine/Creatinine
56685-1,Hydroxyproline.free
56686-9,Hydroxyproline.free/Creatinine
56687-7,Pancreatic islet cell Ab.IgG
56688-5,IgD
Sep-68,Isopropanol
56689-3,Isoleucine/Creatinine
56690-1,Insulin^16H post XXX challenge
56691-9,Insulin^20H post XXX challenge
56692-7,Insulin^1D post XXX challenge
56693-5,SCL-70 extractable nuclear Ab
56694-3,Chicken droppings Ab
56695-0,Cephalexin Ab.IgE
56696-8,Cloxacillin Ab.IgE
Jul-69,Isopropanol
56697-6,Thiopental Ab.IgE
56698-4,Atropine Ab.IgE
56699-2,Bupivacaine Ab.IgE
56700-8,Naproxen Ab.IgE
56701-6,Diclofenac Ab.IgE
56702-4,Ciprofloxacin Ab.IgE
56703-2,Piroxicam Ab.IgE
56704-0,Droperidol Ab.IgE
May-70,Isopropanol
56705-7,Tobramycin Ab.IgE
56706-5,Doxycycline Ab.IgE
56707-3,Spiramycin Ab.IgE
56708-1,metroNIDAZOLE Ab.IgE
56709-9,Tartrazine Ab.IgE
56710-7,Clarithromycin Ab.IgE
56711-5,Sodium benzoate Ab.IgE
56712-3,Dexamethasone Ab.IgE
Mar-71,Lead
56713-1,Dog dander+Dog epithelium Ab.IgE
56714-9,Bacteria identified
56715-6,Bacteria identified
56716-4,Nuclear pore protein gp210 Ab
56717-2,Histone Ab
56718-0,Islet cell 512 Ab
56719-8,Liver cytosol Ab
56720-6,Ma+Ta Ab
Jan-72,Lead
56721-4,PM-SCL extractable nuclear Ab
56722-2,Soluble liver Ab
56723-0,Ribonucleoprotein extractable nuclear Ab
56724-8,Sjogrens syndrome-A extractable nuclear Ab
56725-5,Sjogrens syndrome-B extractable nuclear Ab
56726-3,Lolium perenne recombinant profilin Ab.IgE
56727-1,Olea europaea recombinant (rOle e) 2 Ab.IgE
56728-9,Thermoactinomyces vulgaris Ab.IgE
56729-7,Cladosporium cladosporioides Ab.IgE
56730-5,Smith extractable nuclear Ab
56731-3,Jo-1 extractable nuclear Ab
56732-1,Ribosomal P Ab
56733-9,PCNA extractable nuclear Ab
56734-7,Centromere protein B Ab
56735-4,Mitochondria M2 Ab
56736-2,Purkinje cells Ab
56737-0,Ganglioside GM2 Ab.IgG
56738-8,Ganglioside GM2 Ab.IgM
Sep-73,Lead
56739-6,Ganglioside GD1b Ab.IgG
56740-4,Ganglioside GD1b Ab.IgM
56741-2,Ganglioside GQ1b Ab.IgG
56742-0,Ganglioside GQ1b Ab.IgM
56743-8,Mi-2 Ab
56744-6,Pl-7 Ab
56745-3,Pl-12 Ab
56746-1,Allium ampeloprasum Ab.IgE
Jul-74,Lead
56747-9,Azithromycin Ab.IgE
56748-7,Norovirus RNA
56749-5,Estradiol^30M post XXX challenge
56750-3,Estradiol^1H post XXX challenge
56751-1,Glucose^2.17H post XXX challenge
56752-9,APOB gene+LDLR gene targeted mutation analysis
56753-7,PML Ab
Apr-75,Lead
56754-5,sp100 Ab
56755-2,Aldosterone^100M post XXX challenge
56756-0,Aldosterone^70M post XXX challenge
56757-8,Renin^100M post XXX challenge
56758-6,Renin^70M post XXX challenge
56759-4,Lactate dehydrogenase
56760-2,Liver kidney microsomal Ab
56761-0,Saccharomyces cerevisiae Ab
Feb-76,Lead
56762-8,Protein fractions.oligoclonal bands.IgG
56763-6,Protein fractions.oligoclonal bands.IgM
56764-4,Protein fractions.oligoclonal bands.IgG
56765-1,Protein fractions.oligoclonal bands.IgM
56766-9,Protein.monoclonal band 1/Protein.total
56767-7,Protein.monoclonal.beta
56768-5,Protein.monoclonal.beta/Protein.total
56769-3,Lymphocytes/100 leukocytes
5677-0,Lead
56770-1,Neutrophils/100 leukocytes
56771-9,Eosinophils/100 leukocytes
56772-7,Macrophages/100 leukocytes
56773-5,Cells.CD1a/100 cells
56774-3,Lymphocytes/100 leukocytes
56775-0,Cells.CD3-CD16+CD56+
56776-8,Amylase.S3+S4/Amylase.total
56777-6,Lipoprotein.pre-beta/Lipoprotein.beta
56778-4,Articaine Ab.IgE
56779-2,Ascorbate
567-8,Diphtheria sp identified
56780-0,CYP21A2 gene mutations tested for
56781-8,(Canary feather+Parakeet feather+Parrot feather) Ab.IgE
56782-6,Amylase.S4/Amylase.total
56783-4,Trichloroethane
56784-2,Fibrinogen fragments
56785-9,Saccharomyces cerevisiae Ab
56786-7,Beta-2-Microglobulin.tumor marker
56787-5,Cytokeratin 19
Aug-78,Lysergate diethylamide
56788-3,Insulin^28H post XXX challenge
56789-1,Insulin^32H post XXX challenge
56790-9,Insulin^36H post XXX challenge
56791-7,Entecavir
56792-5,Telbivudine
56793-3,Tenefovir
56794-1,Internal identifier
56795-8,Account number
Jun-79,Lysergate diethylamide
56796-6,Emergency contact information panel
56797-4,Episode unique identifier
56798-2,Alias
56799-0,Address
56800-6,Date and time ED consult request initiated
56801-4,Date and time ED consult starts
56802-2,Primary care provider
56803-0,ED attending physician
Apr-80,Malathion
56804-8,ED nurse
56805-5,ED accepting or admitting provider
56806-3,ED transferring provider
56807-1,ED transferring facility
56808-9,ED accepting or admitting facility
56809-7,ED tech
56810-5,ED triage nurse
56811-3,Primary care clinic or system
Feb-81,Manganese
56812-1,Provider who accepted patient in transfer to another facility
56813-9,Individuals accompanying patient to ED
56814-7,Prehospital care
56815-4,Time placed into treatment area
56816-2,Patient location
56817-0,Presenting problem
56818-8,Problem description
56819-6,Problem prior evaluation
5682-0,Manganese
56820-4,Problem context
56821-2,Problem exacerbating factors
56822-0,Problem response to therapy
56823-8,Problem quality or description
56824-6,Problem location
56825-3,Problem time course
56826-1,Problem frequency
56827-9,Symptom duration during occurrences or episodes
56828-7,Time contractions became regular
56829-5,Time membranes ruptured
56830-3,Limitations in obtaining history
56831-1,Problem associated signs and symptoms
56832-9,Substance abused
56833-7,Pregnancy related history
56834-5,Movement
56835-2,Viability of current pregnancy
56836-0,Blood transfusion
56837-8,Neoplastic disease
Aug-83,Manganese
56838-6,Infectious disease
56839-4,Acuity assessment
56840-2,Pain severity verbal numeric scale
56841-0,Pain severity descriptive category
56842-8,Chronic pain assessment
56843-6,Physical findings
56844-4,Intraocular pressure
56845-1,Pulse strength on exam
Jun-84,Manganese
56846-9,Cardiac biomarkers
56847-7,Calculated & derived values
56848-5,Invasive hemodynamic monitoring
56849-3,Cardiac rhythm monitoring
56850-1,Interpretation and review of laboratory results
56851-9,Care process or plan
56852-7,Amount of ED discharge medication to be dispensed
Mar-85,Mercury
56853-5,ED outcome
56854-3,Inpatient practitioner
56855-0,Provider assuming ultimate responsibility for care for patient upon ED disposition
56856-8,Provider assuming care for patient upon ED disposition
56857-6,Time accepted for admission or transfer
56858-4,Time received by accepting facility or unit
56859-2,Date and time of ED departure
568-6,Fungus identified
56860-0,ED follow-up care assistance
Jan-86,Mercury
56861-8,Name
56862-6,Address
56863-4,Phone number
56864-2,Relationship to patient
56865-9,Problem diagnostic considerations
56866-7,Onset of painful contractions
56867-5,Physical findings
56868-3,ED procedure indication
56869-1,Continuous ST segment monitoring
56870-9,ED facility ID
56871-7,Symptoms & diseases
56872-5,Constitutional symptoms
56873-3,Physical findings
56874-1,Serology & blood bank studies
56875-8,Mixed venous oxygen saturation monitoring
56876-6,Physical findings
56877-4,Mepivacaine Ab.IgE
56878-2,Phenylbutazone Ab.IgE
Sep-87,Mercury
56879-0,Lactose Ab.IgE
56880-8,TCRB gene+TCRD gene+TCRG gene rearrangements
56881-6,Rickettsia typhi Ab.IgG
56882-4,Parietaria judaica recombinant (rPar j) 2 Ab.IgE
56883-2,BCHE gene targeted mutation analysis
56884-0,Somatotropin^160M post exercise
56885-7,Somatotropin^3H post exercise
56886-5,Indirect antiglobulin test.XXX reagent
Jul-88,Mercury
56887-3,Myoglobin
56888-1,HIV 1+2 Ab+HIV1 p24 Ag
56889-9,Cells.CD13+HLA-DR+/100 cells
56890-7,Cells.CD13+HLA-DR+/100 cells
56891-5,Cells.CD13+HLA-DR+/100 cells
56892-3,Cells.CD13+HLA-DR+/100 cells
56893-1,Cells.CD13+HLA-DR+/100 cells
56894-9,Cells.CD13+HLA-DR+/100 cells
May-89,Mercury
56895-6,Cells.CD13+HLA-DR+/100 cells
56896-4,Cells.CD33+CD34+/100 cells
56897-2,Cells.CD3-CD56+/100 cells
56898-0,Cells.CD5+FMC7+/100 cells
56899-8,Cells.CD5+FMC7+/100 cells
56900-4,Cells.terminal deoxyribonucleotidyl transferase/100 cells
56901-2,Amino acid pattern
56902-0,Amylase/Creatinine
Mar-90,Methanol
56903-8,Anserine/Creatinine
56904-6,APOE gene mutation analysis
56905-3,Bilirubin.glucuronidated+Bilirubin.albumin bound
56906-1,Bilirubin.glucuronidated+Bilirubin.albumin bound
56907-9,Cells.CD3+CD45+/100 cells
56908-7,Cells.CD3+CD8+CD45+/100 cells
56909-5,Chlamydia sp Ab.IgG
56910-3,Chlamydia sp Ab.IgG^1st specimen
Jan-91,Methanol
56911-1,Chlamydia sp Ab.IgG^2nd specimen
56912-9,Cholesterol
56913-7,Corticotropin^morning specimen
56914-5,Corticotropin^evening specimen
56915-2,Coxiella burnetii Ab.IgG
56916-0,Coxiella burnetii Ab.IgM^2nd specimen
56917-8,Coxiella burnetii Ab.IgM
56918-6,Coxiella burnetii Ab.IgM^1st specimen
56919-4,Coxiella burnetii Ab.IgG^2nd specimen
56920-2,Coxiella burnetii Ab.IgG^1st specimen
56921-0,Entamoeba histolytica Ab
56922-8,Entamoeba histolytica Ab.IgG
56923-6,Fasciola hepatica Ab
56924-4,Fasciola hepatica Ab
56925-1,Fractional excretion of phosphate
56926-9,Hepatitis C virus c1 Ab
56927-7,Hepatitis C virus c2 Ab
56928-5,Hepatitis C virus E2 Ab
Sep-92,Methanol
56929-3,Hepatitis C virus NS3 Ab
56930-1,Hepatitis C virus NS4 Ab
56931-9,Hydrogen/Expired gas^pre dose lactulose
56932-7,Hydrogen/Expired gas^1H post dose lactulose
56933-5,Hydrogen/Expired gas^2H post dose lactulose
56934-3,Hydrogen/Expired gas^2.5H post dose lactulose
56935-0,Hydrogen/Expired gas^3.5H post dose lactulose
56936-8,Hydrogen/Expired gas^1.5H post dose lactulose
Jul-93,Methanol
56937-6,Hydrogen/Expired gas^30M post dose glucose
56938-4,Hydrogen/Expired gas^30M post dose lactulose
56939-2,Hydroxyproline/Creatinine
569-4,Fungus identified
56940-0,Inhibin B
56941-8,Insulin^8H post XXX challenge
56942-6,Insulin^64H post XXX challenge
56943-4,Insulin^68H post XXX challenge
56944-2,Insulin^3D post XXX challenge
May-94,Methanol
56945-9,Insulin^56H post XXX challenge
56946-7,Insulin^2D post XXX challenge
56947-5,Insulin^60H post XXX challenge
56948-3,Insulin^44H post XXX challenge
56949-1,Insulin^40H post XXX challenge
56950-9,Legionella pneumophila Ab.IgG^2nd specimen
56951-7,Leishmania sp Ab.IgG
Feb-95,Methanol
56952-5,Leptospira interrogans Ab
56953-3,Leptospira interrogans Ab.IgM
56954-1,Leucine/Creatinine
56955-8,Lysine/Creatinine
56956-6,Magnesium/Creatinine
56957-4,Methionine/Creatinine
56958-2,Mycoplasma pneumoniae Ab.IgG^1st specimen
56959-0,Neuronal nuclear type 2 Ab
5696-0,Molybdenum
56960-8,Neutrophils.segmented/100 leukocytes
56961-6,Nicotinamide
56962-4,Ovary Ab.IgG
56963-2,pH
56964-0,Phosphate/Creatinine
56965-7,Phosphate/Creatinine
56966-5,Phosphoethanolamine/Creatinine
56967-3,Plasmodium falciparum Ab
56968-1,Plasmodium sp Ab
56969-9,Polistes spp Ab.IgG4
56970-7,Porphyrins
56971-5,Potassium/Creatinine
56972-3,Prolactin^post precipitation
56973-1,Proline/Creatinine
56974-9,Protein fractions.oligoclonal bands
56975-6,Renin^upright+30M post XXX challenge
56976-4,Renin^upright+1H post XXX challenge
56977-2,Rheumatoid arthritis nuclear Ab
Aug-97,Molybdenum
56978-0,Serotonin
56979-8,Sodium
56980-6,Sodium/Creatinine
56981-4,Somatotropin^30M post resting
56982-2,Somatotropin^90M post resting
56983-0,Somatotropin^1H post resting
56984-8,Taenia solium larva Ab
56985-5,Taurine/Creatinine
Jun-98,Molybdenum
56986-3,Thyroxine.free^1H post XXX challenge
56987-1,Thyroxine.free^40M post XXX challenge
56988-9,Thyroxine.free^1.5H post XXX challenge
56989-7,Thyroxine.free^20M post XXX challenge
56990-5,Toxoplasma gondii Ab.IgG avidity
56991-3,Toxoplasma gondii Ab.IgG avidity
56992-1,Trichinella sp Ab.IgG
56993-9,Tryptophan/Creatinine
Apr-99,Molybdenum
56994-7,Tyrosine/Creatinine
56995-4,Urea
56996-2,Urea/Creatinine
56997-0,Urea/Creatinine
56998-8,Valine/Creatinine
56999-6,Vespa crabro Ab.IgG4
57-0,Capreomycin
5700-0,Nickel
57000-2,Vespula spp Ab.IgG4
57001-0,Yersinia sp Ab.IgA
57002-8,11-Deoxycortisol^4D post XXX challenge
57003-6,17-Hydroxyprogesterone^4H post XXX challenge
57004-4,Glucose/Creatinine
57005-1,Glutathione
57006-9,Hepatitis C virus Ab.IgG
57007-7,Insulin^52H post XXX challenge
57008-5,Legionella pneumophila Ab.IgG^1st specimen
57009-3,Mycoplasma pneumoniae Ab.IgG^2nd specimen
57010-1,Nuclear Ab
57011-9,Ornithine/Creatinine
57012-7,Osteoblasts/100 cells
57013-5,Phosphoserine/Creatinine
57014-3,Iron/Creatinine
57015-0,Lactulose.PO
57016-8,Privacy policy acknowledgment
57017-6,Privacy policy
Aug-01,Nickel
57018-4,Hydrogen/Expired gas^3H post dose lactulose
57019-2,Urinalysis dipstick W Reflex Culture panel
570-2,Fungus identified
57020-0,Urinalysis dipstick W Reflex Microscopic panel
57021-8,Complete blood count W Auto Differential panel
57022-6,Complete blood count W Reflex Manual Differential panel
57023-4,Auto Differential panel
57024-2,Health Quality Measure document
57025-9,Data criteria
Jun-02,Nickel
57026-7,Population criteria
57027-5,Measure observations
57028-3,Iron
57029-1,Fetal chromosome 13+18+21+X+Y aneuploidy
57030-9,Chromosome 13+18+21+X+Y aneuploidy
57031-7,Herpesviruses 6 DNA panel
57032-5,Treponema pallidum Ab
57033-3,Alternaria alternata Ab
Apr-03,Nickel
57034-1,Penicillium sp Ab
57035-8,Cow milk Ab
57036-6,Phadiatop inhalant allergen Ab.IgE
57037-4,Chromosome 13+18+21+X+Y aneuploidy
57038-2,Chromosome 12 aneuploidy
57039-0,Outcome and assessment information set (OASIS) form - version C
57040-8,Clinical record items
57041-6,Patient history and diagnoses
Feb-04,Nickel
57042-4,Sensory status
57043-2,Living arrangements
57044-0,Integumentary status
57045-7,Cardiac status
57046-5,Elimination status
57047-3,Neuro & emotional & behavioral status - start of care or resumption of care
57048-1,ADL & IADLs
57049-9,Care management
57050-7,Therapy need and plan of care
57051-5,Data items collected at inpatient facility admission or agency discharge only
57052-3,Emergent care
57053-1,Note
57054-9,Triage+Care note
57055-6,Antepartum summary note
57056-4,Labor and delivery admission history and physical note
57057-2,Labor and delivery summary note
57058-0,Maternal discharge summary note
Sep-05,Nickel
57059-8,Pregnancy visit summary note
57060-6,Estimated date of delivery
57061-4,Antepartum flowsheet panel
57062-2,Births.stillborn
57063-0,Delivery date
57064-8,Delivery date
57065-5,Quickening date
57066-3,Date fundal height reaches umbilicus
Jul-06,Opiates
57067-1,Body weight
57068-9,Heart rate
57069-7,Preterm labor symptoms
57070-5,Date next clinic visit
57071-3,Obstetric delivery method
57072-1,Intravenous fluids administered
57073-9,Prenatal records
57074-7,Labor and delivery process
May-07,Opiates
57075-4,Newborn delivery information
57076-2,Postpartum hospitalization treatment
57077-0,Newborn status at maternal discharge
57078-8,Antenatal testing and surveillance
57079-6,Birth plan
57080-4,Implanted medical device
57081-2,Anesthesia risk review of systems
57082-0,Antepartum record panel
Mar-08,Paraquat
57083-8,Labor and Delivery record panel
57084-6,Fatty acid oxidation newborn screen panel
57085-3,Organic acid newborn screen panel
57086-1,Congenital adrenal hyperplasia newborn screening panel
57087-9,Biotinidase newborn screening panel
57088-7,Movement
57089-5,Eosinophil cationic protein
57090-3,HLA-DQA1*05:01
Jan-09,Paraquat
57091-1,HLA-DQB1*02:01
57092-9,IgE
57093-7,Cyclic citrullinated peptide Ab.IgA+IgG
57094-5,Phenol^^adjusted to specific gravity 1.024
57095-2,Anidulafungin
57096-0,HPA 1a-1a+HPA 3a-3a
57097-8,Follitropin^10M pre dose gonadotropin releasing hormone
57098-6,Follitropin^1.5H post dose gonadotropin releasing hormone
57099-4,Follitropin^1H post dose gonadotropin releasing hormone
571-0,Fungus identified
57100-0,Follitropin^30M post dose gonadotropin releasing hormone
57101-8,Follitropin^20M post dose gonadotropin releasing hormone
57102-6,Lutropin^2H post dose gonadotropin releasing hormone
57103-4,Lutropin^1.5H post dose gonadotropin releasing hormone
57104-2,Lutropin^1H post dose gonadotropin releasing hormone
57105-9,Lutropin^30M post dose gonadotropin releasing hormone
57106-7,Lutropin^20M post dose gonadotropin releasing hormone
57107-5,Lutropin^10M pre dose gonadotropin releasing hormone
57108-3,Macular grid.center point thickness
Sep-10,Pentachlorophenol
57109-1,Macular grid.center subfield thickness
57110-9,Macular grid.inner superior subfield thickness
57111-7,Macular grid.inner nasal subfield thickness
57112-5,Macular grid.inner inferior subfield thickness
57113-3,Macular grid.inner temporal subfield thickness
57114-1,Macular grid.outer superior subfield thickness
57115-8,Macular grid.outer nasal subfield thickness
57116-6,Macular grid.outer inferior subfield thickness
Jul-11,Pentachlorophenol
57117-4,Macular grid.outer temporal subfield thickness
57118-2,Macular grid.total volume
57119-0,Optical coherence tomography panel
57120-8,Type of nursing provider
57121-6,Type of client
57122-4,Type of encounter
57123-2,Hours designated
57124-0,Care capacity
May-12,Pentachlorophenol
57125-7,Care provided
57126-5,Volume of nursing delivery unit or service panel
57127-3,Method of care delivery
57128-1,Newborn Screening Report summary panel
57129-9,Full newborn screening summary report for display or printing
57130-7,Newborn screening report - overall interpretation
57131-5,Newborn conditions with positive markers
57132-3,CYP2C19 gene allele
Mar-13,Platinum
57133-1,Referral note
57134-9,Referral note
57135-6,Referral note
57136-4,Referral note
57137-2,Referral note
57138-0,Referral note
57139-8,Referral note
57140-6,Referral note
Jan-14,Platinum
57141-4,Referral note
57142-2,Referral note
57143-0,Referral note
57144-8,Referral note
57145-5,Referral note
57146-3,Referral note
57147-1,Referral note
57148-9,Referral note
57149-7,Referral note
57150-5,Referral note
57151-3,Referral note
57152-1,Referral note
57153-9,Referral note
57154-7,Referral note
57155-4,Referral note
57156-2,Referral note
57157-0,Referral note
Aug-15,Platinum
57158-8,Referral note
57159-6,Referral note
57160-4,Referral note
57161-2,Referral note
57162-0,Referral note
57163-8,Referral note
57164-6,Referral note
57165-3,Referral note
Jun-16,Polychlorinated biphenyl
57166-1,Referral note
57167-9,Referral note
57168-7,Referral note
57169-5,Referral note
57170-3,Referral note
57171-1,Referral note
57172-9,Referral note
57173-7,Referral note
Apr-17,Polychlorinated biphenyl
57174-5,Referral note
57175-2,Referral note
57176-0,Referral note
57177-8,Referral note
57178-6,Referral note
57179-4,Referral note
57180-2,Neisseria gonorrhoeae DNA
57181-0,Lupus anticoagulant neutralization.dilute phospholipid/Lupus anticoagulant neutralization.high phospholipid
Feb-18,Rubidium
57182-8,HIV 1 RNA tropism
57183-6,Inpatient procedure relevant to plan of care
57184-4,Risk of developing pressure injuries
57185-1,Current number of unhealed pressure ulcers
57186-9,Number of pressure injuries at each stage
57187-7,Number of pressure injuries present at admission
57188-5,Stage 3 or 4 pressure injury with largest surface dimensions
57189-3,Medication follow-up
5719-0,Rubidium
57190-1,Outcome and assessment information set (OASIS) form - version C - Start of care
57191-9,Outcome and assessment information set (OASIS) form - version C - Resumption of Care
57192-7,Outcome and assessment information set (OASIS) form - version C - Follow-Up
57193-5,Outcome and assessment information set (OASIS) form - version C - Transfer to facility
57194-3,Outcome and assessment information set (OASIS) form - version C - Discharge from agency
57195-0,Patient &or caregiver drug education intervention
57196-8,Prior medication management
57197-6,Plan of care synopsis
57198-4,Intervention synopsis
57199-2,Current payment sources for home care
57200-8,Reason for assessment
57201-6,Date of Physician-ordered Start of Care (Resumption of Care)
57202-4,Date of Referral
57203-2,Episode Timing
57204-0,Inpatient discharge facility within the past 14D
57205-7,Inpatient stay within last 14D - ICD code
57206-5,Overall status
57207-3,Risk factors affecting health status and or outcome
Aug-20,Rubidium
57208-1,Influenza virus vaccination received
57209-9,Reason influenza virus vaccine not received
57210-7,Pneumococcal vaccine
57211-5,Reason pneumococcal vaccine not given
57212-3,Patient lives alone
57213-1,Patient lives with other person
57214-9,Patient lives in congregated situtation
57215-6,Vision
Jun-21,Rubidium
57216-4,Ability to hear
57217-2,Understanding of verbal content
57218-0,Speech and oral expression of language
57219-8,Formal pain assessment using standardized tool
57220-6,Frequency of pain interfering with activity or movement
57221-4,Pressure injury assessment was conducted
57222-2,Oldest non-epithelialized stage 2 pressure injury present at discharge
57223-0,Number of pressure ulcers - unstageable due to non-removable dressing or device
Apr-22,Selenium
57224-8,Number of pressure ulcers - unstageable due to coverage of wound bed by slough and or eschar
57225-5,Number of pressure ulcers - unstageable suspected deep tissue injury in evolution
57226-3,Diameter.long
57227-1,Pressure ulcer width
57228-9,Depth
57229-7,Status of most problematic pressure injury
57230-5,Current number of stage 1 pressure ulcers
57231-3,Stage of most problematic pressure injury
Feb-23,Selenium
57232-1,Stasis ulcer
57233-9,Number of stasis ulcers
57234-7,Status of most problematic stasis ulcer
57235-4,Surgical wound
57236-2,Status of most problematic surgical wound
57237-0,Exertion level causing shortness of breath
57238-8,Respiratory treatments administered at home
57239-6,Symptoms in heart failure patients
5724-0,Selenium
57240-4,Heart failure follow-up
57241-2,When urinary incontinence occurs
57242-0,Standardized depression screening was conducted
57243-8,Bathing - functional ability
57244-6,Toilet transferring - functional ability
57245-3,Toileting hygiene - functional ability
57246-1,Transferring - functional ability
57247-9,Locomotion - functional ability
57248-7,Feeding - functional ability
57249-5,Prepare light meals - functional ability
57250-3,Self-care
57251-1,Ambulation
57252-9,Transfer
57253-7,Household tasks
57254-5,Standardized fall risk assessment was conducted
57255-2,Drug regimen review identified potential medication issues
57256-0,Medication intervention since admission &or reentry
Jul-25,Selenium
57257-8,Patient &or caregiver received high risk drug education
57258-6,Oral medication management - prior ability
57259-4,Injectable medication management - prior ability
57260-2,Non-agency caregiver ability and willingness to assist with ADL
57261-0,Non-agency caregiver ability and willingness to assist with IADL
57262-8,Non-agency caregiver ability and willingness to assist with medication administration
57263-6,Non-agency caregiver ability and willingness to assist with medical procedures &or treatments
57264-4,Non-agency caregiver ability and willingness to assist with management of equipment
May-26,Selenium
57265-1,Non-agency caregiver ability and willingness to assist with supervision and safety
57266-9,Non-agency caregiver ability and willingness to assist with advocacy or facilitation of patient participation
57267-7,ADL or IADL assistance frequency from any caregiver
57268-5,Therapy need
57269-3,Plan of care includes patient-specific parameters for notifying physician of changes
57270-1,Plan of care includes diabetic foot care
57271-9,Plan of care includes fall prevention interventions
57272-7,Plan of care includes depression intervention
Mar-27,Selenium
57273-5,Plan of care includes intervention to monitor and mitigate pain
57274-3,Plan of care includes intervention to prevent pressure injuries
57275-0,Plan of care includes pressure injury treatment - moist healing
57276-8,Emergent care utilized
57277-6,Reason for emergent care
57278-4,Discharge disposition
57279-2,Reason for hospitalization
572-8,Fungus identified
57280-0,Risk of developing pressure injuries
Jan-28,Silicon
57281-8,Medication follow-up
57282-6,Patient &or caregiver drug education intervention
57283-4,Cognitive functioning
57284-2,Management of injectable medications - ability
57285-9,Management of oral medications - ability
57286-7,Behaviors demonstrated at least once a week
57287-5,Chlamydia trachomatis rRNA
57288-3,Chlamydia trachomatis rRNA
57289-1,Neisseria gonorrhoeae rRNA
57290-9,HLA-A
57291-7,HLA-B
57292-5,HLA-B57*01
57293-3,HLA-DRB1
57294-1,HLA-DRB3
57295-8,HLA-DRB4
57296-6,HLA-DRB5
57297-4,HLA-Cw
57298-2,HLA-DRB1
Sep-29,Silicate
57299-0,HLA-DQB1
57300-6,6-Monoacetylmorphine
57301-4,Benzoylecgonine
57302-2,Temazepam
57303-0,7-Aminonitrazepam
57304-8,Codeine
57305-5,Tropomyosin Ab.IgE
57306-3,Types and sources of assistance
Jul-30,Silicate
57307-1,Unhealed pressure injury at Stage 2 or higher or designated as unstageable
57308-9,CYP11B1 gene targeted mutation analysis
57309-7,PRNP gene targeted mutation analysis
57310-5,SRY gene targeted mutation analysis
57311-3,CYP11B1 gene mutations tested for
57312-1,PRNP gene mutations tested for
57313-9,Pyrazole Ab.IgE
57314-7,SRY gene mutations tested for
May-31,Silicate
57315-4,Sulphonamide Ab.IgE
57316-2,Tropomyosin Ab.IgE
57317-0,Chromosome 13+18+21+X+Y aneuploidy
57318-8,Chromosome 13+18+21+X+Y aneuploidy
57319-6,Risk for hospitalization
57320-4,Trypanosoma cruzi Ab
57321-2,Herpes simplex virus 2 Ab.IgG^2nd specimen
57322-0,Varicella zoster virus Ab.IgM^1st specimen
Mar-32,Silver
57323-8,Varicella zoster virus Ab.IgM^2nd specimen
57324-6,Influenza virus A Ab.IgG^1st specimen
57325-3,Influenza virus A Ab.IgG^2nd specimen
57326-1,Influenza virus A Ab.IgM^1st specimen
57327-9,Influenza virus A Ab.IgM^2nd specimen
57328-7,Influenza virus B Ab.IgM^1st specimen
57329-5,Influenza virus B Ab.IgM^2nd specimen
57330-3,Corticotropin^40M post XXX challenge
Jan-33,Silver
57332-9,Urate
57333-7,Calcium.ionized^^adjusted to pH 7.4
57334-5,Calcium
57335-2,Calcium
57336-0,Beta hydroxybutyrate^1H post XXX challenge
57337-8,Citrate
57338-6,Citrate
57339-4,Citrate
57340-2,Chloride
57341-0,Chloride
57342-8,Chloride
57344-4,Creatinine
57345-1,Creatinine^overnight
57346-9,Creatinine
57347-7,Copper
57348-5,Phosphate
Sep-34,Silver
57349-3,Phosphate
57350-1,Glucose^1M post XXX challenge
57353-5,Insulin^5M post XXX challenge
57355-0,Potassium
Jun-35,Silver
57356-8,Lactate^1M post XXX challenge
57357-6,Lactate^10M post XXX challenge
57358-4,Lactate^2H post XXX challenge
57359-2,Lactate^3H post XXX challenge
573-6,Fungus identified
57360-0,Lactate^20M post XXX challenge
57361-8,Lactate^3M post XXX challenge
57362-6,Lactate^30M post XXX challenge
57363-4,Lactate^5M post XXX challenge
Apr-36,Strontium
57364-2,Lactate^1H post XXX challenge
57365-9,Lactate^1.5H post XXX challenge
57366-7,Lactate^pre XXX challenge
57367-5,Magnesium
57368-3,Magnesium
57369-1,Albumin
57370-9,Sodium
57371-7,Enolase.neuron specific
Feb-37,Strychnine
57372-5,Osmolality
57373-3,Oxalate
57374-1,Oxalate
57375-8,Oxalate
57376-6,C peptide^baseline
57377-4,Pyruvate^5M post XXX challenge
57378-2,Porphyrins/Creatinine
57379-0,Potassium
5738-0,Strychnine
57380-8,Potassium
57382-4,Sodium
57383-2,Tipranavir
57385-7,Urea
57386-5,Urate
57387-3,Urate
57388-1,Urea
57389-9,Urea
57390-7,Specimen volume
57391-5,Eosinophils/100 leukocytes
57392-3,Urea
57393-1,Cells.CD11a/100 cells
57394-9,Cells.CD19+CD34+/100 cells
57395-6,Cells.CD19+CD38+/100 cells
57396-4,Cells.CD19+CD56+/100 cells
57397-2,Cells.CD19+CD20+/100 cells
Aug-39,Strychnine
57398-0,Cells.CD22+CD19+/100 cells
57399-8,Cells.CD19+CD23+/100 cells
57400-4,Cells.CD34/100 cells
57401-2,Cells.CD4+CD8+/100 cells
57402-0,Cells.CD42a/100 cells
57403-8,Cells.CD45RA/100 cells
57404-6,Cells.CD45RO/100 cells
57405-3,Cells.CD8+CD56+/100 cells
Jun-40,Strychnine
57406-1,Cells.CD8+CD57+/100 cells
57407-9,Cells.CD8+CD45RA+/100 cells
57408-7,Cells.CD8+CD45RO+/100 cells
57409-5,Cells.CD3+TCR alpha beta+/100 cells
57410-3,Actin.filamentous Ab
57411-1,Desmoglein 1 Ab
57412-9,Desmoglein 3 Ab
57413-7,Mitochondria Ab
Apr-41,Strychnine
57414-5,Reticulin Ab
57415-2,Saccharomyces cerevisiae Ab.IgA
57416-0,Thyrotropin receptor Ab
57417-8,Cells.CD18/100 cells
57418-6,Cells.CD20/100 cells
57419-4,Cells.CD21/100 cells
57420-2,Cells.CD27/100 cells
57421-0,Cells.CD34/100 cells
Feb-42,Tellurium
57422-8,Cells.CD40/100 cells
57423-6,Cells.CD5/100 cells
57424-4,Cells.CD56/100 cells
57425-1,Cells.CD7/100 cells
57426-9,Cells.CD71/100 cells
57427-7,Cells.CD10+FMC7+/100 cells
57428-5,Cells.FMC7/100 cells
57429-3,Cells.CD3+TCR gamma delta+/100 cells
5743-0,Thallium
57430-1,Cells.CD235a/100 cells
57431-9,Extractable nuclear Ab
57432-7,Cells.CD19+Kappa+/100 cells
57433-5,Cells.CD19+Lambda+/100 cells
57434-3,Liver kidney microsomal 1 Ab
57435-0,Cells.myeloperoxidase
57436-8,Muscle specific receptor tyrosine kinase Ab
57437-6,Cells.CD56+CD138+/100 cells
57438-4,Cells.CD56-CD138+/100 cells
57439-2,Cells.terminal deoxyribonucleotidyl transferase
574-4,Fungus identified
57440-0,Platelet Ab
57441-8,Toxoplasma gondii DNA
57442-6,Specimen volume^post concentration
57443-4,Spermatozoa.progressive.grade 3/100 spermatozoa^post concentration
57444-2,Spermatozoa.progressive.grade 2/100 spermatozoa^post concentration
57445-9,Spermatozoa.progressive.grade 1/100 spermatozoa^post concentration
57446-7,Spermatozoa.immotile/100 spermatozoa^post concentration
57447-5,Nuclear Ab
Aug-44,Thallium
57448-3,Nuclear Ab pattern
57449-1,Tubular basement membrane Ab
57450-9,Soluble liver Ab
57451-7,CV2 Ab
57452-5,Ma+Ta Ab
57453-3,Chromosome 18 aneuploidy
57454-1,Chromosome 13 aneuploidy
May-45,Thallium
57455-8,Taenia solium Ab.IgG
57456-6,Spermatozoa.progressive^post concentration
57457-4,Interpretation
57458-2,Neisseria gonorrhoeae rRNA
57459-0,Outcome and assessment information set (OASIS) form - version C - Death at home
57460-8,Lymphocytes.activated T cells/100 lymphocytes.small
57461-6,Lymphocytes.activated T cells/100 lymphocytes.small
57462-4,Normetanephrine.free
Mar-46,Thallium
57463-2,Cortisol^12th specimen
57464-0,Cortisol^11th specimen
57465-7,Cortisol^10th specimen
57466-5,Cortisol^9th specimen
57467-3,Calcitriol^pre dose calcium
57468-1,Calcitriol^pre dose calcium
57469-9,Calcitriol^2H post dose calcium
57470-7,Calcitriol^2H post dose calcium
Jan-47,Tin
57471-5,Calcitriol^3H post dose calcium
57472-3,Calcitriol^3H post dose calcium
57473-1,Calcitriol^1H post dose calcium
57474-9,Calcitriol^1H post dose calcium
57475-6,11-Ketoandrosterone^pre high dose dexamethasone
57476-4,11-Ketoandrosterone^pre high dose dexamethasone
57477-2,11-Ketoandrosterone^2D post high dose dexamethasone
57478-0,11-Ketoandrosterone^2D post high dose dexamethasone
57479-8,11-Ketoandrosterone^pre dose dexamethasone
57480-6,11-Ketoandrosterone^pre dose dexamethasone
57481-4,11-Ketoandrosterone^2D post dose dexamethasone
57482-2,11-Ketoandrosterone^2D post dose dexamethasone
57483-0,11-Ketoetiocholanolone^pre high dose dexamethasone
57484-8,11-Ketoetiocholanolone^pre high dose dexamethasone
57485-5,11-Ketoetiocholanolone^2D post high dose dexamethasone
57486-3,11-Ketoetiocholanolone^2D post high dose dexamethasone
57487-1,11-Ketoetiocholanolone^pre dose dexamethasone
57488-9,11-Ketoetiocholanolone^pre dose dexamethasone
Sep-48,Tin
57489-7,11-Ketoetiocholanolone^2D post dose dexamethasone
57490-5,11-Ketoetiocholanolone^2D post dose dexamethasone
57491-3,11-Deoxycorticosterone^pre 250 ug corticotropin
57492-1,11-Deoxycorticosterone^30M post 250 ug corticotropin
57493-9,11-Deoxycorticosterone^1H post 250 ug corticotropin
57494-7,11-Deoxycortisol^pre dose dexamethasone
57495-4,11-Deoxycortisol^pre dose dexamethasone
57496-2,11-Deoxycortisol^1D post dose dexamethasone
Jul-49,Titanium
57497-0,11-Deoxycortisol^1D post dose dexamethasone
57498-8,11-Deoxycortisol^2D post dose dexamethasone
57499-6,11-Deoxycortisol^2D post dose dexamethasone
57500-1,11-Deoxycortisol^pre dose metyraPONE
57501-9,11-Deoxycortisol^pre dose metyraPONE
57502-7,11-Deoxycortisol^1D post dose metyraPONE
57503-5,11-Deoxycortisol^1D post dose metyraPONE
57504-3,11-Deoxycortisol^2D post dose metyraPONE
May-50,Toluene
57505-0,11-Deoxycortisol^2D post dose metyraPONE
57506-8,11-Deoxycortisol^pre 250 ug corticotropin
57507-6,11-Deoxycortisol^45M post 250 ug corticotropin
57508-4,11-Hydroxyandrosterone^pre high dose dexamethasone
57509-2,11-Hydroxyandrosterone^pre high dose dexamethasone
575-1,Fungus identified
57510-0,11-Hydroxyandrosterone^2D post high dose dexamethasone
57511-8,11-Hydroxyandrosterone^2D post high dose dexamethasone
57512-6,11-Hydroxyandrosterone^pre dose dexamethasone
Mar-51,Uranium
57513-4,11-Hydroxyandrosterone^pre dose dexamethasone
57514-2,11-Hydroxyandrosterone^2D post dose dexamethasone
57515-9,11-Hydroxyandrosterone^2D post dose dexamethasone
57516-7,11-Hydroxyetiocholanolone^pre high dose dexamethasone
57517-5,11-Hydroxyetiocholanolone^pre high dose dexamethasone
57518-3,11-Hydroxyetiocholanolone^2D post high dose dexamethasone
57519-1,11-Hydroxyetiocholanolone^2D post high dose dexamethasone
57520-9,11-Hydroxyetiocholanolone^pre dose dexamethasone
Jan-52,Uranium
57521-7,11-Hydroxyetiocholanolone^pre dose dexamethasone
57522-5,11-Hydroxyetiocholanolone^2D post dose dexamethasone
57523-3,11-Hydroxyetiocholanolone^2D post dose dexamethasone
57524-1,17-Ketogenic steroids^pre dose dexamethasone
57525-8,17-Ketogenic steroids^2D post dose dexamethasone
57526-6,17-Hydroxycorticosteroids^pre high dose dexamethasone
57527-4,17-Hydroxycorticosteroids^2D post high dose dexamethasone
57528-2,17-Hydroxycorticosteroids^pre dose dexamethasone
57529-0,17-Hydroxycorticosteroids^2D post dose dexamethasone
57530-8,17-Hydroxypregnenolone^pre dose dexamethasone
57531-6,17-Hydroxypregnenolone^1D post dose dexamethasone
57532-4,17-Hydroxypregnenolone^2D post dose dexamethasone
57533-2,17-Hydroxyprogesterone^10th specimen post XXX challenge
57534-0,17-Hydroxyprogesterone^11th specimen post XXX challenge
57535-7,17-Hydroxyprogesterone^12th specimen post XXX challenge
57536-5,17-Hydroxyprogesterone^8th specimen post XXX challenge
57537-3,17-Hydroxyprogesterone^9th specimen post XXX challenge
57538-1,17-Hydroxyprogesterone^1st specimen post dose gonadotropin releasing hormone
Sep-53,Vanadium
57539-9,17-Hydroxyprogesterone^2nd specimen post dose gonadotropin releasing hormone
57540-7,17-Hydroxyprogesterone^3rd specimen post dose gonadotropin releasing hormone
57541-5,17-Hydroxyprogesterone^4th specimen post dose gonadotropin releasing hormone
57542-3,17-Hydroxyprogesterone^5th specimen post dose gonadotropin releasing hormone
57543-1,17-Hydroxyprogesterone^6th specimen post dose gonadotropin releasing hormone
57544-9,17-Hydroxyprogesterone^7th specimen post dose gonadotropin releasing hormone
57545-6,17-Hydroxyprogesterone^pre dose dexamethasone
57546-4,17-Hydroxyprogesterone^pre dose dexamethasone
Jul-54,Vanadium
57547-2,17-Hydroxyprogesterone^1D post dose dexamethasone
57548-0,17-Hydroxyprogesterone^1D post dose dexamethasone
57549-8,17-Hydroxyprogesterone^2D post dose dexamethasone
57550-6,17-Hydroxyprogesterone^2D post dose dexamethasone
57551-4,18-Hydroxydeoxycorticosterone^pre dose corticotropin
57552-2,18-Hydroxydeoxycorticosterone^30M post dose corticotropin
57553-0,18-Hydroxydeoxycorticosterone^1H post dose corticotropin
Apr-55,Vanadium
57554-8,18-Hydroxycorticosterone^pre dose corticotropin
57555-5,18-Hydroxycorticosterone^30M post dose corticotropin
57556-3,18-Hydroxycorticosterone^1H post dose corticotropin
57557-1,18-Hydroxycortisol^pre dose corticotropin
57558-9,18-Hydroxycortisol^30M post dose corticotropin
57559-7,18-Hydroxycortisol^1H post dose corticotropin
57560-5,21-Deoxycorticosterone^pre dose corticotropin
57561-3,21-Deoxycorticosterone^30M post dose corticotropin
Feb-56,Vanadium
57562-1,21-Deoxycorticosterone^1H post dose corticotropin
57563-9,21-Deoxycortisol^pre dose dexamethasone
57564-7,21-Deoxycortisol^1D post dose dexamethasone
57565-4,21-Deoxycortisol^2D post dose dexamethasone
57566-2,Calcidiol^pre dose calcium
57567-0,Calcidiol^2H post dose calcium
57568-8,Calcidiol^3H post dose calcium
57569-6,Calcidiol^1H post dose calcium
5757-0,Vanadium
57570-4,3-Alpha-Androstanediol glucuronide^pre dose dexamethasone
57571-2,3-Alpha-Androstanediol glucuronide^1D post dose dexamethasone
57572-0,3-Alpha-Androstanediol glucuronide^2D post dose dexamethasone
57573-8,3-Alpha-Androstanediol glucuronide^pre dose corticotropin
57574-6,3-Alpha-Androstanediol glucuronide^30M post dose corticotropin
57575-3,3-Alpha-Androstanediol glucuronide^1H post dose corticotropin
57576-1,Androstanolone^pre dose corticotropin
57577-9,Androstanolone^30M post dose corticotropin
57578-7,Androstanolone^1H post dose corticotropin
57579-5,Aldosterone^post 25 mg captopril PO
57580-3,Aldosterone^post XXX challenge
57581-1,Aldosterone^pre XXX challenge
57582-9,Aldosterone^pre 25 mg captopril PO
57583-7,Aldosterone^2H post 25 mg captopril PO
57584-5,Aldosterone^3H post 25 mg captopril PO
57585-2,Aldosterone^3H post 25 mg captopril PO
57586-0,Aldosterone^1H post 25 mg captopril PO
57587-8,Aldosterone^2H post XXX challenge
Aug-58,Dimethylbenzene
57588-6,Aldosterone^15M post XXX challenge
57589-4,Aldosterone^15M post XXX challenge
57590-2,Aldosterone^3H post XXX challenge
57591-0,Aldosterone^3H post XXX challenge
57592-8,Aldosterone^30M post XXX challenge
57593-6,Aldosterone^30M pre XXX challenge
57594-4,Aldosterone^30M pre XXX challenge
57595-1,Aldosterone^1H post XXX challenge
Jun-59,Dimethylbenzene
57596-9,Aldosterone^pre 250 ug corticotropin IM
57597-7,6-Alpha hydroxytetrahydro-11-Deoxycortisol^pre high dose dexamethasone
57598-5,6-Alpha hydroxytetrahydro-11-Deoxycortisol^pre high dose dexamethasone
57599-3,6-Alpha hydroxytetrahydro-11-Deoxycortisol^2D post high dose dexamethasone
57600-9,6-Alpha hydroxytetrahydro-11-Deoxycortisol^2D post high dose dexamethasone
57601-7,6-Alpha hydroxytetrahydro-11-Deoxycortisol^pre dose dexamethasone
57602-5,6-Alpha hydroxytetrahydro-11-Deoxycortisol^pre dose dexamethasone
57603-3,6-Alpha hydroxytetrahydro-11-Deoxycortisol^2D post dose dexamethasone
Apr-60,Zinc
57604-1,6-Alpha hydroxytetrahydro-11-Deoxycortisol^2D post dose dexamethasone
57605-8,6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^pre high dose dexamethasone
57606-6,6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^pre high dose dexamethasone
57607-4,6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^2D post high dose dexamethasone
57608-2,6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^2D post high dose dexamethasone
57609-0,6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^pre dose dexamethasone
57610-8,6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^pre dose dexamethasone
57611-6,6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^2D post dose dexamethasone
Feb-61,Zinc
57612-4,6-Alpha hydroxytetrahydro-11-Dehydrocorticosterone^2D post dose dexamethasone
57613-2,5-Alpha tetrahydrocortisol^pre high dose dexamethasone
57614-0,5-Alpha tetrahydrocortisol^pre high dose dexamethasone
57615-7,5-Alpha tetrahydrocortisol^2D post high dose dexamethasone
57616-5,5-Alpha tetrahydrocortisol^2D post high dose dexamethasone
57617-3,5-Alpha tetrahydrocortisol^pre dose dexamethasone
57618-1,5-Alpha tetrahydrocortisol^pre dose dexamethasone
57619-9,5-Alpha tetrahydrocortisol^2D post dose dexamethasone
5762-0,Zinc
57620-7,5-Alpha tetrahydrocortisol^2D post dose dexamethasone
57621-5,Alpha cortol^pre high dose dexamethasone
57622-3,Alpha cortol^pre high dose dexamethasone
57623-1,Alpha cortol^2D post high dose dexamethasone
57624-9,Alpha cortol^2D post high dose dexamethasone
57625-6,Alpha cortol^pre dose dexamethasone
57626-4,Alpha cortol^pre dose dexamethasone
57627-2,Alpha cortol^2D post dose dexamethasone
57628-0,Alpha cortol^2D post dose dexamethasone
57629-8,Alpha cortolone^pre high dose dexamethasone
57630-6,Alpha cortolone^pre high dose dexamethasone
57631-4,Alpha cortolone^2D post high dose dexamethasone
57632-2,Alpha cortolone^2D post high dose dexamethasone
57633-0,Alpha cortolone^pre dose dexamethasone
57634-8,Alpha cortolone^pre dose dexamethasone
57635-5,Alpha cortolone^2D post dose dexamethasone
57636-3,Alpha cortolone^2D post dose dexamethasone
57637-1,Androsterone^pre high dose dexamethasone
Aug-63,Zinc
57638-9,Androsterone^pre high dose dexamethasone
57639-7,Androsterone^2D post high dose dexamethasone
57640-5,Androsterone^2D post high dose dexamethasone
57641-3,Androsterone^pre dose dexamethasone
57642-1,Androsterone^pre dose dexamethasone
57643-9,Androsterone^2D post dose dexamethasone
57644-7,Androsterone^2D post dose dexamethasone
57645-4,C peptide^10M pre XXX challenge
Jun-64,Zinc
57646-2,C peptide^190M post XXX challenge
57647-0,C peptide^3.3H post XXX challenge
57648-8,C peptide^5M pre XXX challenge
57649-6,C peptide^1H pre XXX challenge
57650-4,C peptide^70M pre XXX challenge
57651-2,C peptide^1.3H post XXX challenge
57652-0,Humidifier heated wire temperature differential setting
Mar-65,Zinc
57653-8,Tidal volume.spontaneous min setting
57654-6,Tidal volume.inspired max setting
57655-3,Tidal volume.exhaled max setting
57656-1,Flow trigger setting
57657-9,Disconnect sensitivity setting
57658-7,Rise time setting
57660-3,Ganglioside GQ1b Ab.IgG
Jan-66,Ammonium urate crystals
57661-1,Tubular basement membrane Ab
57662-9,U1 small nuclear ribonucleoprotein Ab
57663-7,Norepinephrine^post XXX challenge
57664-5,Lactate dehydrogenase
57665-2,Protein fractions.oligoclonal bands.IgG
57666-0,Protein fractions.oligoclonal bands.IgM
57667-8,Protein.monoclonal.beta
57668-6,Insulin-like growth factor binding protein 3^10M post XXX challenge
57669-4,Insulin-like growth factor binding protein 3^20M post XXX challenge
57670-2,Brucella melitensis Ab.IgG
57671-0,Brucella melitensis Ab.IgM
57672-8,11-Deoxycortisol^2D post XXX challenge
57673-6,Coxiella burnetii Ab.IgM^1st specimen
57674-4,Coxiella burnetii Ab.IgM^2nd specimen
57675-1,Legionella pneumophila Ab.IgG^1st specimen
57676-9,Legionella pneumophila Ab.IgG^2nd specimen
57677-7,Mycoplasma pneumoniae Ab.IgG^1st specimen
57678-5,Mycoplasma pneumoniae Ab.IgG^2nd specimen
Sep-67,Appearance
57679-3,Chlamydia sp Ab.IgG^1st specimen
57680-1,Chlamydia sp Ab.IgG^2nd specimen
57681-9,Coxiella burnetii Ab.IgG^1st specimen
57682-7,Coxiella burnetii Ab.IgG^2nd specimen
57683-5,Plasmodium falciparum Ab.IgM
57684-3,Cortisol^11th specimen
57685-0,Cortisol^2nd specimen
57686-8,Cortisol^12th specimen
Jul-68,Ascorbate
57687-6,Cortisol^1st specimen
57688-4,Cortisol^3rd specimen
57689-2,Cortisol^4th specimen
576-9,Fungus identified
57690-0,Cortisol^10th specimen
57691-8,Cortisol^9th specimen
57692-6,Cortisol^5th specimen
57693-4,Cortisol^6th specimen
57694-2,Cortisol^7th specimen
May-69,Bacteria
57695-9,Cortisol^8th specimen
57696-7,Pain severity
57697-5,Protein Z Ag
57698-3,Lipid panel with direct LDL
57699-1,Biotinidase deficiency newborn screening comment-discussion
57700-7,Hearing loss newborn screening comment-discussion
57701-5,Infectious diseases newborn screening comment-discussion
57702-3,Infectious diseases
Mar-70,Bilirubin
57703-1,Hemoglobin disorders newborn screening comment-discussion
57704-9,Galactosemias newborn screening comment-discussion
57705-6,Congenital hypothyroidism newborn screening comment-discussion
57706-4,Congenital adrenal hyperplasia newborn screening comment-discussion
57707-2,Cystic fibrosis newborn screening comment-discussion
57708-0,Organic acidemias defects newborn screening comment-discussion
57709-8,Fatty acid oxidation defects newborn screening comment-discussion
57710-6,Amino acidemias newborn screening comment-discussion
Jan-71,Bilirubin crystals
57711-4,Unique bar code number
57712-2,Highest level of education
57713-0,Infant factors that affect newborn screening interpretation
57714-8,Obstetric estimation of gestational age
57715-5,Birth time
57716-3,State printed on filter paper card
57717-1,Newborn screen card data panel
57718-9,Sample condition
57719-7,Conditions tested for in this newborn screening study
57720-5,Newborn conditions with equivocal markers
57721-3,Reason for lab test
57722-1,Birth plurality
57723-9,Unique bar code number
57724-7,Newborn screening short narrative summary
57725-4,Corticotropin^20M post XXX challenge
57726-2,Creatinine
57727-0,Norolanzapine
57728-8,Lactate^40M post XXX challenge
Sep-72,Calcium carbonate crystals
57729-6,Lactate^6M post XXX challenge
57731-2,Osmolality^2nd specimen
57732-0,Osmolality^3rd specimen
57733-8,Beta-trace protein
57734-6,Ketones
57735-3,Protein
57736-1,Cells.CD154/100 cells
Jul-73,Calcium carbonate crystals
57737-9,Basement membrane Ab
57738-7,Basement membrane zone BP180 Ab
57739-5,Centromere Ab
57740-3,Cells.CD3+HLA-DR+/100 cells
57741-1,Lymphocyte proliferation.OKT3 stimulation
57742-9,Phadiatop Infant Ab.IgE
57743-7,ABO group
57744-5,Striated muscle Ab
May-74,Calcium oxalate crystals
57745-2,Adrenal Ab
57746-0,Gamma hydroxybutyrate
57747-8,Erythrocytes
57748-6,Liver cytosol Ab
57749-4,Amphiphysin Ab
57750-2,Amphiphysin Ab
57751-0,Hemoglobin
Feb-75,Calcium phosphate crystals
57752-8,Urea^overnight
57753-6,IKBKG gene targeted mutation analysis
57754-4,TNFRSF13B gene mutations tested for
57755-1,WAS gene mutations tested for
57756-9,Procollagen type III.N-terminal propeptide
57757-7,IKBKG gene mutations tested for
57758-5,TNFRSF13B gene targeted mutation analysis
57759-3,WAS gene targeted mutation analysis
5776-0,Calcium sulfate crystals
57760-1,Coagulation factor XIII inhibitor
57761-9,Platelet factor 4 heparin complex induced Ab
57762-7,Cells.CD55+CD59
57763-5,Coagulation surface induced.factor substitution^immediately after addition of normal plasma/Coagulation surface induced
57764-3,Microscopic exam
57765-0,Disaccharidases panel
57766-8,Histoplasma capsulatum Ag
57767-6,Trimipramine & Nortrimipramine panel
57768-4,Campylobacter jejuni+Campylobacter coli Ag
57769-2,Salmonella typhi O Vi Ab
577-7,Fungus identified
57770-0,Toxoplasma gondii Ab.IgG & IgM panel
57771-8,Paraneoplastic Ab
57772-6,Metanephrine.free & Normetanephrine.free panel
57773-4,Colorado tick fever virus Ab.IgG & IgM
57774-2,Colorado tick fever virus Ab.IgG & IgM panel
57775-9,Valproate.free & Valproate panel
57776-7,Gliadin peptide Ab.IgA & IgG panel
57777-5,Myeloperoxidase Ab & Proteinase 3 panel
Aug-77,Cholesterol crystals
57778-3,Immunoglobulin light chains.free panel
57779-1,Disaccharidases
57780-9,Thyroglobulin & Thyrogobulin Ab panel
57781-7,Chromosome breakage
57782-5,Complete blood count W Ordered Manual Differential panel
57783-3,Dehydroepiandrosterone^pre high dose dexamethasone
57784-1,Dehydroepiandrosterone^pre high dose dexamethasone
57785-8,Dehydroepiandrosterone^2D post high dose dexamethasone
Jun-78,Color
57786-6,Dehydroepiandrosterone^2D post high dose dexamethasone
57787-4,Dehydroepiandrosterone^pre dose dexamethasone
57788-2,Dehydroepiandrosterone^pre dose dexamethasone
57789-0,Dehydroepiandrosterone^2D post dose dexamethasone
57790-8,Dehydroepiandrosterone^2D post dose dexamethasone
57791-6,Organic acidemia conditions suspected
57792-4,Fatty acid oxidation conditions suspected
57793-2,Amino acidemia disorder suspected
Apr-79,Crystals
57794-0,Newborn screening test results panel
57795-7,Fecal hydrolysis panel
57796-5,Reducing substances
57797-3,Glucose
57798-1,Progesterone^20M post XXX challenge
57800-5,Oxygen content
57801-3,Oximetry site
Feb-80,Crystals
57802-1,Chromosome analysis.interphase
57803-9,Occult blood panel
57804-7,Number of occult blood specimens recommended by testing kit protocol
57805-4,HEDIS 2010 Tests used in early prenatal care - ABO & Rh (PPC-C)
57806-2,HEDIS 2010-2013 Tests used in early prenatal care - Rubella (PPC-C)
57807-0,HEDIS 2010 Tests used in early prenatal care (PPC-C)
57808-8,HEDIS 2010-2013 Codes to identify anticonvulsant serum concentration monitoring tests - carBAMazepine (MPM-E)
57809-6,"HEDIS 2010, 2011 Codes to identify anticonvulsant serum concentration monitoring tests (MPM-E)"
5781-0,Crystals
57810-4,"HEDIS 2010, 2011 Codes to identify physiologic monitoring tests - Blood urea nitrogen (BUN) (MPM-A)"
57811-2,"HEDIS 2010,2011 Codes to identify physiologic monitoring tests - Serum creatinine (SCr) (MPM-A)"
57812-0,HEDIS 2010 Codes to identify physiologic monitoring tests (MPM-A)
57813-8,HEDIS 2010 Codes to identify evidence of nephropathy (CDC-K)
57814-6,HEDIS 2010 Codes to identify nephropathy screening tests (CDC-J)
57815-3,HEDIS 2010 Codes to identify LDLc screening (CDC-H)
57816-1,HEDIS 2010 Codes to identify LDLc screening (CMC-D)
57817-9,HEDIS 2010-2013 Codes to identify Chlamydia screening (CHL-C)
57818-7,HEDIS 2010 Codes to identify sexually active women (CHL-B)
57819-5,HEDIS 2010 Codes to identify colorectal cancer screening (COL-A)
57820-3,HEDIS 2010 panel
57821-1,HEDIS 2010 Codes to identify physiologic monitoring tests - Serum potassium (MPM-A)
57822-9,Multisection^W radionuclide IV
57823-7,Multisection^W radionuclide IV
57824-5,Cortisol.free^AM peak specimen
57825-2,Cortisol.free^PM trough specimen
57826-0,Co-payment amount
57827-8,Reason for co-payment exemption
Aug-82,Crystals
57828-6,Prescription list
57829-4,Prescription for medical equipment or product
57830-2,Admission request
57831-0,Prescription for rehabilitation
57832-8,Prescription for diagnostic or specialist care
57833-6,Prescription for medication
57834-4,Patient transportation request
57835-1,Appearance
Jun-83,Crystals.unidentified
57836-9,Basophils/100 leukocytes
57837-7,Beta-1 transferrin
57838-5,Coagulation dilute Russell viper venom induced.excess phospholipid
57839-3,Activated clotting time.kaolin induced
57840-1,Eosinophils/100 leukocytes
57841-9,Erythrocytes
57842-7,Erythrocytes
57843-5,Erythrocytes
Apr-84,Cystine crystals
57844-3,Imatinib mesylate
57845-0,Leukocytes
57846-8,Leukocytes
57847-6,Leukocytes
57848-4,Maltose
57849-2,Medication allergy
578-5,Fungus identified
57850-0,Mesothelial cells/100 leukocytes
Jan-85,Eosinophils
57851-8,Microscopic observation
57852-6,Problem list
57853-4,Snowshoe hare virus Ab.IgG
57854-2,Thyrotropin^5M post XXX challenge
57855-9,Atenolol
57856-7,Carisoprodol
57857-5,Chlorpheniramine
57858-3,Normaprotiline
57859-1,Dextromethorphan
57860-9,Diethylamine
57861-7,HYDROcodone
57862-5,Hydrocortisone
57863-3,HYDROmorphone
57864-1,Meperidine
57865-8,oxyCODONE
57866-6,PENTobarbital
57867-4,Pericyazine
57868-2,Perphenazine
Sep-86,Epithelial casts
57869-0,Phencyclidine
57870-8,Phenylpropanolamine
57871-6,quiNINE
57872-4,Strychnine
57873-2,Thiothixene
57874-0,Cucumis melo cantalupensis basophil bound Ab
57875-7,Cucumis melo cantalupensis Ab.IgG4
57876-5,Cucumis melo spp Ab.IgG4
Jul-87,Epithelial cells
57877-3,Cucumis melo cantalupensis Ab.IgG.RAST class
57878-1,Cucumis melo spp Ab.IgG.RAST class
57879-9,Cucumis melo cantalupensis Ab.IgG
57880-7,Cucumis melo spp Ab.IgG
57881-5,Cucumis melo cantalupensis Ab.IgE.RAST class
57882-3,Cucumis melo spp Ab.IgE.RAST class
57883-1,Cucumis melo cantalupensis Ab.IgE
57884-9,Cucumis melo spp Ab.IgE
May-88,Oval fat bodies (globules)
57885-6,Cucumis melo spp basophil bound Ab
57886-4,Pregnanediol^pre high dose dexamethasone
57887-2,Pregnanediol^pre high dose dexamethasone
57888-0,Pregnanediol^2D post high dose dexamethasone
57889-8,Pregnanediol^2D post high dose dexamethasone
57890-6,Pregnanediol^pre dose dexamethasone
57891-4,Pregnanediol^pre dose dexamethasone
57892-2,Pregnanediol^2D post dose dexamethasone
Mar-89,Fatty casts
57893-0,Pregnanediol^2D post dose dexamethasone
57894-8,C peptide^100M post XXX challenge
57895-5,Influenza virus A H1.neuraminidase inhibitor resistance
57896-3,Influenza virus A 2009 H1N1v.neuraminidase inhibitor resistance
57897-1,Influenza virus A+B.neuraminidase inhibitor resistance
57898-9,Cocaine
57899-7,Triiodothyronine/Triiodothyronine.reverse
57900-3,Specimen age
Jan-90,Fungi.filamentous
57901-1,Clostridioides difficile glutamate dehydrogenase
57902-9,B little g super little a Ab
57903-7,B little g super little a Ab
57904-5,B little g super little a Ag
57905-2,Hemoglobin.gastrointestinal.lower^1st specimen
57906-0,9p21 chromosome deletion
57907-8,Atazanavir+Ritonavir
57908-6,AIRE gene targeted mutation analysis
57909-4,ADNFLE gene targeted mutation analysis
57910-2,Bartonella quintana DNA
57911-0,Basement membrane zone BP230 Ab
57912-8,Bean green Ab.IgE/IgE.total
57913-6,Bean white Ab.IgE/IgE.total
57914-4,Beta lactoglobulin Ab.IgE/IgE.total
57915-1,Bombus terrestris Ab.IgE/IgE.total
57916-9,Borrelia burgdorferi C6 Ab
57917-7,Budgerigar droppings Ab.IgG
57918-5,CACNA1S+SCN4A gene targeted mutation analysis
Sep-91,Fungi.yeastlike
57919-3,Calcium
57920-1,Carbon dioxide
57921-9,Carbon dioxide
57922-7,Carbon dioxide
57923-5,Carbon dioxide
57924-3,Carboxy tetrahydrocannabinol
57925-0,Castanea sativa Ab.IgE/IgE.total
Jul-92,Glucose
57927-6,CDKN2A+CDK4 gene targeted mutation analysis
579-3,Fungus identified
57930-0,CFTR gene.p.Asp1152His
57931-8,CFTR+PRSS1+SPINK1 gene targeted mutation analysis
57932-6,Cheese cheddar type Ab.IgE/IgE.total
57933-4,Cheese mold type Ab.IgE/IgE.total
57934-2,Chikungunya virus Ab.IgM
May-93,Granular casts
57935-9,Chocolate Ab.IgE/IgE.total
57936-7,Cholesterol.in HDL 2a
57937-5,Cholesterol.in HDL 3a
57938-3,LDL 5
57939-1,Chromium
57940-9,Citrullus lanatus Ab.IgE/IgE.total
57941-7,Citrus aurantifolia Ab.IgE/IgE.total
57942-5,Cladosporium sp Ab.IgG4
Mar-94,Hemoglobin
57943-3,Clenbuterol
57944-1,Cobalt
57945-8,Cocaethylene
57946-6,Coccidioides immitis Ab.IgG
57947-4,Coffee bean Ab.IgE.RAST class
57948-2,Collagen crosslinked C-telopeptide
57949-0,Complement C4c
5795-0,Hippurate crystals
57950-8,Cow whey Ab.IgE/IgE.total
57951-6,CPVT1 gene targeted mutation analysis
57952-4,Cucumis melo spp Ab.IgE/IgE.total
57953-2,Ethisterone
57954-0,Darunavir
57955-7,Darunavir+Ritonavir
57956-5,Desoxymethyltestosterone
57957-3,Difenacoum
57958-1,DPYD2A gene targeted mutation analysis
57959-9,Drostanolone
57960-7,Erythrocytes
57961-5,Etravirine
57962-3,FECH gene targeted mutation analysis
57963-1,FLCN gene targeted mutation analysis
57964-9,Formebolone metabolite
57965-6,Fosamprenavir+Ritonavir
57966-4,Furazabol metabolite
57967-2,Galactitol
Aug-96,Hyaline casts
57968-0,Ganglioside GD1a Ab.IgG
57969-8,Ganglioside GD1a Ab.IgM
57970-6,Glucose^3H post 75 g glucose PO
57971-4,Glucose^4th specimen post dose lactose
57972-2,Glucose^5th specimen post dose lactose
57973-0,Histoplasma capsulatum Ab.IgM
57974-8,HIV 1 Ab
57975-5,HIV 1+O+2 Ab
Jun-97,Ketones
57976-3,HIV 2 gp140 Ab
57977-1,HIV 2 p16 Ab
57978-9,HIV 2 p34 Ab
57979-7,HLA-B*15:02
57980-5,HLA-B51
57981-3,HYDROcodone
57982-1,HYDROmorphone
57983-9,IDUA gene targeted mutation analysis
Apr-98,Leucine crystals
57984-7,Indinavir+Ritonavir
57985-4,Influenza virus A H2 RNA
57986-2,Insulin-like growth factor^1st specimen post XXX challenge
57987-0,Ipomoea batatas Ab.IgE/IgE.total
57988-8,Iron
57990-4,KRIT1 gene targeted mutation analysis
57991-2,Lactalbumin Ab.IgE/IgE.total
Feb-99,Leukocyte esterase
57992-0,Legionella pneumophila 1+3+4+5+6+8 Ab
57993-8,Lepidoglyphus destructor Ab.IgE/IgE.total
57994-6,Leucine/Alanine
57995-3,Leucine/Phenylalanine
57996-1,Leucine+Isoleucine
57997-9,Lopinavir+Ritonavir
57998-7,Magnesium
57999-5,Manganese
58000-1,Maple sugar Ab.IgE/IgE.total
58001-9,Matrix metallopeptidase 9
58002-7,Mestanolone metabolite
58003-5,Methylandrostenediol
58004-3,Methasterone
58005-0,Methylnortestosterone
58006-8,Mibolerone
Aug-00,Lipids
58008-4,Morus alba Ab.IgG.RAST class
58009-2,MPL gene.p.Trp515
580-1,Fungus identified
58010-0,MSH2 gene+MLH1 gene+MSH6 gene targeted mutation analysis
58011-8,Myelin Ab.IgG
58012-6,Natalizumab Ab
58013-4,Norclomipramine
58014-2,Nordoxepin
58015-9,Nortrimipramine
Jun-01,Magnesium ammonium phosphate crystals
58016-7,Octreotide
58017-5,Olea europaea pollen Ab.IgE/IgE.total
58018-3,Oxabolone
58019-1,Phosphate
58020-9,PKD2 gene targeted mutation analysis
58021-7,Populus deltoides Ab.IgG.RAST class
58022-5,Prostanozol
58023-3,Rabies virus Ab.IgG
Apr-02,Nitrite
58024-1,Saquinavir+Ritonavir
58025-8,Secale cereale pollen Ab.IgE/IgE.total
58026-6,Selenium
58027-4,Testolactone
58028-2,Tetrahydrogestrinone
58029-0,Tipranavir+Ritonavir
58030-8,Tranylcypromine
58031-6,Treponema pallidum Ab.IgG
Feb-03,pH
58032-4,Ulmus americana Ab.IgG
58033-2,Urtica dioica Ab.IgE/IgE.total
58034-0,Ustilago cynodontis Ab.IgE/IgE.total
58035-7,Vaccinium myrtillus Ab.IgG
58036-5,Xanthine/Total
58037-3,Zinc
58038-1,Gestrinone
58039-9,HLA-B SBT
5804-0,Protein
58041-5,Norclostebol
58042-3,Phencyclidine
58043-1,Platanus occidentalis Ab.IgE/IgE.total
58044-9,RYR1 gene targeted mutation analysis
58045-6,SCN4A gene targeted mutation analysis
58046-4,Strongyloides stercoralis Ab
58047-2,Tetrahydrocannabinol
58050-6,Inpatient procedure relevant to plan of care
58051-4,Payment diagnosis
58052-2,Date pressure injury first identified
58053-0,C little h super little a Ag
58054-8,C little h super little a Ab
58055-5,C little o super little a Ag
58056-3,C little o super little b Ag
Jul-05,Pyrophosphate crystals
58057-1,C little s super little a Ab
58058-9,C little s super little a Ag
58059-7,D little o super little b Ab
58060-5,D little o super little b Ag
58061-3,G little o super little a Ab
58062-1,I little n super little b Ag
58063-9,I little n super little b Ab
58064-7,J little r super little a Ag
May-06,Pyrophosphate crystals
58065-4,J little r super little a Ab
58066-2,K little n super little a Ag
58067-0,K little n super little a Ab
58068-8,K little n super little b Ab
58069-6,K little n super little b Ag
58070-4,M little c C super little a Ab
58071-2,R little g super little a Ag
58072-0,R little g super little a Ab
Mar-07,Erythrocyte casts
58073-8,W little r super little a Ag
58074-6,W little r super little a Ab
58075-3,Y little k super little a Ag
58076-1,Y little k super little a Ab
58077-9,Urinalysis complete W Reflex Culture panel
58078-7,IH Ab
58079-5,JMH Ab
58080-3,Penicillin.parenteral
Jan-08,Erythrocytes
58081-1,Vel Ab
58082-9,Vel Ag
58083-7,Vw Ag
58084-5,Vw Ab
58085-2,Penicillin.parenteral
58086-0,NOS Ab
58087-8,NOS Ab
58088-6,Acylcarnitine
58089-4,Glucose-6-Phosphate dehydrogenase
58090-2,Glucose-6-Phosphate dehydrogenase newborn screening comment-discussion
58091-0,Glucose-6-Phosphate dehydrogenase newborn screen panel
58092-8,Acylcarnitine newborn screen panel
58093-6,Acylcarnitine newborn screening comment-discussion
58094-4,Number of pressure ulcers at assessment - stage 3
58095-1,Number of pressure ulcers at assessment - stage 4
58096-9,Number of pressure ulcers present upon admission &or reentry - stage 2
58097-7,Number of pressure ulcers present upon admission &or reentry - stage 3
58098-5,Number of pressure ulcers present upon admission &or reentry - stage 4
Sep-09,Reducing substances
58099-3,Number of pressure ulcers present upon admission &or reentry - unstageable due to non-removable dressing
58100-9,Number of pressure ulcers present upon admission &or reentry - unstageable due to coverage of wound bed by slough &or eschar
58101-7,Number of pressure ulcers present upon admission &or reentry - unstageable with suspected deep tissue injury in evolution
58102-5,Current number of unhealed (non-epithelialized) pressure injuries at each stage
58103-3,Number of pressure ulcers at assessment - stage 2
58104-1,When confused within the last 14D
58105-8,Current payment sources for home care.other specified
58106-6,Inpatient discharge facility.other specified
Jul-10,Specific gravity
58107-4,Swing bed clinical change assessment
58108-2,Entry &or discharge reporting
58109-0,Multidrug-resistant organism (MDRO) in last 7D
58110-8,Wound infection (other than foot) in last 7D
58111-6,Neurogenic bladder in last 7D
58112-4,Obstructive uropathy in the last 7D
58113-2,Huntington's disease in last 7D
58114-0,Tourette's syndrome in last 7D
May-11,Specific gravity
58115-7,Psychotic disorder (other than schizophrenia) in last 7D
58116-5,Respiratory failure in last 7D
58117-3,Staff pain assessment interview should be conducted
58118-1,Frequency of indicator of pain or possible pain
58119-9,Unable to examine oral or dental status
58120-7,Patient health questionnaire 2 item
58121-5,Prior Functioning ADL and IADL
58122-3,Resident has one or more unhealed pressure injuries at stage 1 or higher
Mar-12,Sulfonamide crystals
58123-1,Date of oldest stage 2 pressure injury
58124-9,Diabetic foot ulcers
58125-6,Other open lesion(s) on the foot
58126-4,Number of D injection of any type were received in last 5D or since admission &or reentry if less than 7D
58127-2,Number of D insulin injections were received in last 7D or since admission &or reentry if less than 7D
58128-0,Number of D the physician changed the resident's insulin orders in last 7D or since admission &or reentry if less than 7D
58129-8,Antibiotic received in last 7D or since admission &or reentry if less than 7D
58130-6,Diuretic received in last 7D or since admission &or reentry if less than 7D
Jan-13,Trichomonas vaginalis
58131-4,Date of influenza vaccination
58132-2,Speech-language pathology and audiology services
58133-0,Speech-language pathology and audiology services - concurrent minutes in the last 7D
58134-8,Speech-language pathology and audiology services - group minutes in the last 7D
58135-5,Occupational therapy
58136-3,Occupational therapy - concurrent minutes in the last 7D
58137-1,Occupational therapy - group minutes in the last 7D
58138-9,Physical therapy
58139-7,Physical therapy - concurrent minutes in the last 7D
58140-5,Physical therapy - group minutes in the last 7D
58141-3,Respiratory therapy
58142-1,Psychological therapy
58143-9,Recreational therapy
58144-7,Resident's overall goal established during assessment process
58145-4,Information source for overall goal
58146-2,Active discharge planning in place for resident return to community
58147-0,Determination made by resident and core planning team regarding discharge to community
58148-8,Resident has been asked about returning to the community
Sep-14,Triple phosphate crystals
58149-6,Wants to talk to someone about the possibility of returning to the community
58150-4,Referral has been made to the local contact agency
58151-2,Prior assessment brief interview for mental status summary score
58152-0,Prior assessment resident mood interview (PHQ-9) total severity score
58153-8,Prior assessment staff assessment of resident mood interview (PHQ-9) total severity score
58154-6,Care Area Assessment (CAA) Summary
58155-3,Care Area Assessment (CAA) and care planning
Jun-15,Tyrosine crystals
58156-1,Care Area Assessment (CAA) results
58157-9,Delirium - care area triggered
58158-7,Delirium - addressed in care plan
58159-5,Cognitive loss &or dementia - care area triggered
58160-3,Cognitive loss &or dementia - addressed in care plan
58161-1,Communication - care area triggered
58162-9,Communication - addressed in care plan
58163-7,ADL functional &or rehabilitation potential - care area triggered
Apr-16,Urate crystals
58164-5,ADL functional &or rehabilitation potential - addressed in care plan
58165-2,Urinary incontinence and indwelling catheter - care area triggered
58166-0,Urinary incontinence and indwelling catheter - addressed in care plan
58167-8,Psychosocial well being - care area triggered
58168-6,Psychosocial well being - addressed in care plan
58169-4,Mood state - care area triggered
58170-2,Mood state - addressed in care plan
58171-0,Behavioral symptoms - care area triggered
Feb-17,Urate crystals
58172-8,Behavioral symptoms - addressed in care plan
58173-6,Activities - care area triggered
58174-4,Activities - addressed in care plan
58175-1,Falls - care area triggered
58176-9,Falls - addressed in care plan
58177-7,Nutritional status - care area triggered
58178-5,Nutritional status - addressed in care plan
58179-3,Feeding tube - care area triggered
5818-0,Urobilinogen
58180-1,Feeding tube - addressed in care plan
58181-9,Dehydration &or fluid maintenance - care area triggered
58182-7,Dehydration &or fluid maintenance - addressed in care plan
58183-5,Dental care - care area triggered
58184-3,Dental care - addressed in care plan
58185-0,Pressure injury - care area triggered
58186-8,Pressure injury - addressed in care plan
58187-6,Psychotropic drug use - care area triggered
58188-4,Psychotropic drug use - addressed in care plan
58189-2,Physical restraints - care area triggered
581-9,Streptococcus agalactiae
58190-0,Physical restraints - addressed in care plan
58191-8,Pain - care area triggered
58192-6,Pain - addressed in care plan
58193-4,Return to community referral - care area triggered
58194-2,Return to community referral - addressed in care plan
58195-9,Date of Care Area Assessment (CAA) information
58196-7,Location of Care Area Assessment (CAA) information
58197-5,Correction request
Aug-19,Waxy casts
58198-3,Type of record
58199-1,Reasons for modification
58200-7,Correction number
58201-5,Transcription error
58202-3,Data entry error
58203-1,Item coding error
58204-9,Other error requiring modification
58205-6,Other error requiring modification.other specified
Jun-20,Leukocyte casts
58206-4,Reasons for inactivation
58207-2,Reasons for inactivation - event did not occur
58208-0,Other error requiring error requiring inactivation
58209-8,Other error requiring error requiring inactivation.other specified
58210-6,Medicare non-therapy Part A HIPPS code
58211-4,Medicare non-therapy Part A - RUG version code
58212-2,Alternate state Medicaid billing - RUG group
58213-0,Alternate state Medicaid billing - RUG version code
Apr-21,Leukocytes
58214-8,One or more unhealed pressure injuries stage 1 or higher
58215-5,Stage 1
58216-3,Depth
58217-1,Insulin
58218-9,Speech-language pathology and audiology services - individual minutes in the last 7D
58219-7,Occupational therapy - individual minutes in the last 7D
58220-5,Physical therapy - individual minutes in the last 7D
58221-3,Participation in assessment
Feb-22,Yeast
58222-1,Discharge plan
58223-9,Return to community
58224-7,Items from most recent prior OBRA or scheduled PPS assessment
58225-4,Visual function - addressed in care plan
58226-2,Visual function - care area triggered
58227-0,Software product error
58228-8,Infection of the foot
58229-6,Body weight^when specimen taken
5823-0,Adenovirus Ag
58230-4,Maple syrup urine disease newborn screening comment-discussion
58231-2,Phenylketonuria and variants &or biopterin defects newborn screening comment-discussion
58232-0,Hearing loss risk indicators
58233-8,Age when the first heart attack occurred
58234-6,Date of trauma or procedure
58235-3,Type of trauma or procedure
58236-1,Date of myocardial infarction
58237-9,Name
58238-7,PhenX measure - family history of heart attack
58239-5,PhenX measure - lipid profile
58240-3,PhenX measure - blood pressure
58241-1,PhenX measure - high blood pressure during pregnancy
58242-9,PhenX measure - heart valve function
58243-7,PhenX measure - angina
58244-5,PhenX measure - sudden cardiac arrest
58245-2,PhenX measure - myocardial infarction
58246-0,PhenX measure - peripheral arterial disease
58247-8,PhenX measure - abdominal aortic aneurysm
Aug-24,Adenovirus Ag
58248-6,PhenX measure - arrhythmia
58249-4,PhenX measure - deep venous thrombosis
58250-2,PhenX measure - pulmonary embolism
58251-0,PhenX measure - rheumatic fever
58252-8,Discomfort or pain diagnosed as having a non-cardiac origin
58253-6,Electrocardiograms recorded
58254-4,Cardiac enzyme measurements performed during this admission
May-25,Adenovirus Ag
58255-1,Participant had active liver disease
58256-9,Evidence of hemolytic disease during this hospitalization
58257-7,"Mention of the participant having either trauma, a surgical procedure, or rhabdomyolysis within 1W prior to the cardiac enzymes measurement"
58258-5,Myocardial infarction
58259-3,Chest pain
58260-1,Cardiac enzymes
58261-9,Electrocardiogram serial reading
58262-7,Ever told by doctor that you had claudication or peripheral arterial disease
Mar-26,Adenovirus Ag
58263-5,Ever had angiography for claudication or peripheral arterial disease
58264-3,Ever had angioplasty for claudication or peripheral arterial disease
58265-0,Ever had surgery to improve blood flow in legs for claudication or peripheral arterial disease
58266-8,Ever diagnosed by a doctor as having an abdominal aortic aneurysm
58267-6,Surgery or other repair for aneurysm
58268-4,Ever told you have or had atrial fibrillation
58269-2,Date of first episode of atrial fibrillation
582-7,Streptococcus agalactiae
58270-0,Emergency room visit or hospitalized or saw doctor for atrial fibrillation
Jan-27,Adenovirus Ag
58271-8,Permanent pacemaker insertion
58272-6,Y permanent pacemaker inserted
58273-4,Taking any anticoagulants for treatment of atrial fibrillation
58274-2,Taking any antiarrhythmics for treatment of atrial fibrillation
58275-9,Ever told by doctor that you had deep venous thrombosis
58276-7,Ever had outpatient test(s) performed for deep vein thrombosis
58277-5,Deep vein thrombosis diagnosis
58278-3,Date of deep vein thrombosis diagnosis
58279-1,Pulmonary embolism diagnosis category
58280-9,Source of evidence for deep vein thrombosis diagnosis
58281-7,Deep vein thrombosis diagnosis reporting source
58282-5,Ever told by doctor that you had pulmonary embolus
58283-3,Pulmonary embolism requiring hospitalization
58284-1,Date of pulmonary embolus diagnosis
58285-8,Deep vein thrombosis diagnosis category
58286-6,Source of evidence for pulmonary embolism diagnosis
58287-4,Ever told by doctor that you had rheumatic fever
58288-2,Rheumatic fever in the past 12Mo
Sep-28,Adenovirus Ag
58289-0,Taking medication for rheumatic fever
58290-8,Name of medication for rheumatic fever
58291-6,"Mother, father, full-blooded sisters, full-blooded brothers, daughters, or sons ever have a heart attack or myocardial infarction"
58292-4,Ever told by doctor or nurse that you have high blood cholesterol
58293-2,Taken medication for high blood cholesterol
58294-0,Age began taking high blood pressure medication
58295-7,Ever told by doctor or nurse that you have high blood pressure
58296-5,Age when told have high blood pressure
Jul-29,Adenovirus Ag
58297-3,Diagnosis of high blood pressure during pregnancy only
58298-1,Medication taken for high blood pressure
58299-9,Age began taking high blood cholesterol medication
58300-5,"Toxemia including high blood pressure, albumin in urine and swelling of ankles during this pregnancy"
58301-3,High blood pressure without toxemia during this pregnancy
58302-1,Ever told by doctor that you had rheumatic heart or heart valve problems
58303-9,Ever told by doctor that you had angina
58304-7,Chest discomfort ever or since last exam or medical history update
May-30,Adenovirus Ag
58305-4,Chest discomfort with exertion or excitement
58306-2,Chest discomfort when quiet or resting
58307-0,Date of onset of chest discomfort
58308-8,Usual duration of chest discomfort
58309-6,Longest duration of chest discomfort
58310-4,Location of chest discomfort
58311-2,Radiation of chest discomfort
58312-0,Frequency (number in past Mo) of chest discomfort
Mar-31,Adenovirus Ag
58313-8,Frequency (number in past year) of chest discomfort
58314-6,Type of chest discomfort
58315-3,Relief of chest discomfort by nitroglycerine in <15 minutes
58316-1,Relief of chest discomfort by rest in <15 minutes
58317-9,Relief of chest discomfort spontaneously in <15 minutes
58318-7,Relief of chest discomfort by other cause in <15 minutes
58319-5,Since your last exam told by a doctor you had a heart attack
58320-3,Angina pectoris in interim
Jan-32,Adenovirus Ag
58321-1,Angina pectoris since revascularization procedure
58322-9,Coronary insufficiency in interim
58323-7,Myocardial infarction in interim
58324-5,Provider familiar with the events surrounding the decedent's death
58325-2,Provider witnessed decedent's death
58326-0,"Pain in the chest, left arm or shoulder or jaw within 72H of death"
58327-8,Pain included chest
58328-6,Pain was of a cardiac origin
58329-4,Cardiopulmonary resuscitation &or cardioversion performed within 24H of death
58330-2,Time between onset of acute symptoms to death
58331-0,Decedent's cause of death due to coronary heart disease
58332-8,Location of death
58333-6,Death witnessed
58334-4,Multi-Ethnic Study of Atherosclerosis (MESA) classification of underlying cause of death
58335-1,Type of fatal coronary heart disease
58336-9,Estimated time between onset of acute cardiac symptoms and death
58337-7,Mechanism of death in patient's dying of cardiovascular causes
58338-5,Ever told by doctor that you had a myocardial infarction or heart attack
Sep-33,Adenovirus Ag
58339-3,Outpatient or day surgery procedure to unblock blocked or narrowed blood vessels of the heart
58340-1,"Acute episode of pain, discomfort or tightness in the chest, left arm or jaw within 72H of the hospitalization or in-hospital event"
58341-9,Ever treated by a doctor or a nurse with shots at home or as an outpatient for deep vein thrombosis
58342-7,Age when the first heart attack occurred
58343-5,PhenX domain - Cardiovascular
58344-3,Age when the first heart attack occurred
58345-0,Age when the first heart attack occurred
58346-8,Age when the first heart attack occurred
Jul-34,Adenovirus Ag
58347-6,Age when the first heart attack occurred
58348-4,MethylePHEDrine
58349-2,Procedure-related
583-5,Streptococcus agalactiae
58350-0,Plasma cells.immature/100 cells
58351-8,Connective tissue growth factor
58352-6,Connective tissue growth factor
58353-4,Human antihuman Ab
Apr-35,Cytomegalovirus
58354-2,Human antihuman Ab
58355-9,Plasma cells.immature
58356-7,Ethanol/Creatinine
58357-5,Amphetamine/Creatinine
58358-3,Methamphetamine/Creatinine
58359-1,Buprenorphine+Norbuprenorphine
58360-9,Buprenorphine/Creatinine
58361-7,Norbuprenorphine/Creatinine
Feb-36,Cytomegalovirus
58362-5,Norbuprenorphine
58363-3,Alpha hydroxyalprazolam/Creatinine
58364-1,7-Aminoclonazepam/Creatinine
58365-8,7-Aminoclonazepam
58366-6,LORazepam/Creatinine
58367-4,Nordiazepam/Creatinine
58368-2,Oxazepam/Creatinine
58369-0,Temazepam/Creatinine
5837-0,Cytomegalovirus
58370-8,Carisoprodol+Meprobamate
58371-6,Carisoprodol/Creatinine
58372-4,Meprobamate/Creatinine
58373-2,Meprobamate
58374-0,Meprobamate
58375-7,Ethyl glucuronide
58376-5,Ethyl glucuronide/Creatinine
58377-3,Ethyl glucuronide
58378-1,Ethyl glucuronide
58379-9,Fentanyl+Norfentanyl
58380-7,fentaNYL/Creatinine
58381-5,fentaNYL
58382-3,Norfentanyl/Creatinine
58383-1,Norfentanyl
58384-9,6-Monoacetylmorphine/Creatinine
58385-6,Meperidine+Normeperidine
58386-4,Meperidine/Creatinine
58387-2,Normeperidine/Creatinine
Aug-38,Cytomegalovirus
58388-0,Normeperidine
58389-8,Normeperidine
58390-6,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine/Creatinine"
58391-4,Codeine/Creatinine
58392-2,Morphine/Creatinine
58393-0,HYDROcodone/Creatinine
58394-8,HYDROmorphone/Creatinine
58395-5,oxyCODONE/Creatinine
Jun-39,Enterovirus identified
58396-3,oxyMORphone/Creatinine
58397-1,Phencyclidine/Creatinine
58398-9,Propoxyphene/Creatinine
58399-7,Norpropoxyphene/Creatinine
58400-3,Specimen pH acceptable
58401-1,Tapentadol
58402-9,Tapentadol
58403-7,Tricyclic antidepressants/Creatinine
Apr-40,Enterovirus identified
58404-5,traMADol/Creatinine
58405-2,Hepatitis B virus surface Ab Signal/Cutoff
58406-0,Platelet morphology panel
58407-8,Leukocyte morphology panel
58408-6,Erythrocyte morphology panel
58409-4,Other cells/100 leukocytes
58410-2,Complete blood count panel
58411-0,Clinical research drug XXX
Feb-41,Enterovirus identified
58412-8,Cefepime
58413-6,Erythrocytes.nucleated/100 leukocytes
58414-4,Herpes simplex virus 1+2 DNA
58415-1,BRAF gene.p.Val600Glu
58416-9,MLH1 gene methylation
58417-7,dilTIAZem
58418-5,Micafungin
58419-3,Caspofungin
5842-0,Enterovirus identified
58420-1,Anidulafungin
58421-9,Medicare short stay assessment
58422-7,Alternate state Medicaid billing
58423-5,Ethyl sulfate/Creatinine
58424-3,Ethyl sulfate
58425-0,Ethyl sulfate
58426-8,Carisoprodol
58427-6,Carisoprodol
58428-4,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine"
58429-2,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine"
584-3,Streptococcus agalactiae
58430-0,oxyCODONE+Oxymorphone
58431-8,Microalbumin panel
58432-6,Casts panel
58433-4,Crystals panel
58434-2,Cells panel
58435-9,Microorganisms panel
58436-7,Casts
58437-5,Microorganisms seen
Aug-43,Enterovirus identified
58438-3,Cells
58439-1,Clinical research drug XXX
58440-9,Classical swine fever virus E2 Ab
58441-7,Other elements
58442-5,Other elements
58443-3,Other cells
58444-1,Erythrocytes.dysmorphic
58445-8,Manual differential comment
Jun-44,Herpes simplex virus 1 Ag
58446-6,Creatinine renal clearance adjusted for body surface area panel
58447-4,Microalbumin/Creatinine ratio panel
58448-2,Albumin ug/min
58449-0,Erythrocyte clumps
58450-8,Bilirubin
58451-6,Glutamate decarboxylase 65 Ab
58452-4,Hepatitis B virus surface Ag
Mar-45,Herpes simplex virus 1 Ag
58453-2,Hemoglobin.gastrointestinal.lower
58454-0,Subtelomere analysis
58455-7,Taenia solium Ab
58456-5,Bladder cells
58457-3,Sulfites
58458-1,Mitochondria Ab pattern
58459-9,Ganglioside GT1b Ab
58460-7,Endothelial cell Ab
Jan-46,Herpes simplex virus 1 Ag
58461-5,Intestinal goblet cell Ab
58462-3,Complement functional activity
58463-1,Tau protein/Protein.total
58464-9,Campesterol
58465-6,DNA double strand Ab.IgG
58466-4,DNA double strand Ab.IgG
58467-2,Gasterophilus intestinalis Ab.IgG4
58468-0,Pimpinella anisum Ab.IgG4
58469-8,Cells
58470-6,Nucleated cells
58471-4,Erythrocytes.pitted/Erythrocytes.total
58472-2,Other cells
58473-0,Haemophilus influenzae serotype DNA
58474-8,Cosmetic
58475-5,Medical food
58476-3,Dietary supplement
58477-1,Pulmonary function study
58478-9,Bombus sp Ab.IgG
Sep-47,Herpes simplex virus 2 Ag
58479-7,Fatty acids.nonesterified^7th specimen post CFst
58480-5,Fatty acids.nonesterified^6th specimen post CFst
58481-3,Protein C Ag/Coagulation factor IX Ag
58482-1,Protein S Ag/Coagulation factor IX Ag
58483-9,BRAF gene targeted mutation analysis
58484-7,Estradiol^8th specimen post XXX challenge
58485-4,Estradiol^baseline
58486-2,Estradiol^7th specimen post XXX challenge
Jul-48,Herpes simplex virus 2 Ag
58487-0,Estradiol^6th specimen post XXX challenge
58488-8,Estradiol^5th specimen post XXX challenge
58489-6,Estradiol^4th specimen post XXX challenge
58490-4,Estradiol^3rd specimen post XXX challenge
58491-2,Estradiol^2nd specimen post XXX challenge
58492-0,Estradiol^1st specimen post XXX challenge
58493-8,Coagulation factor VIII Ab
58494-6,C peptide^1.5H post dose glucose
May-49,Herpes simplex virus 2 Ag
58495-3,C peptide^10M post 1 mg glucagon IV
58496-1,C peptide^10th specimen post XXX challenge
58497-9,C peptide^11th specimen post XXX challenge
58498-7,C peptide^12th specimen post XXX challenge
58499-5,C peptide^15M post 1 mg glucagon IV
585-0,Streptococcus agalactiae
58500-0,C peptide^15M post dose glucose
58501-8,C peptide^15M pre XXX challenge
58502-6,C peptide^15M pre XXX challenge
Mar-50,Herpes simplex virus Ag
58503-4,C peptide^1H post dose glucose
58504-2,C peptide^1st specimen post XXX challenge
58505-9,C peptide^2.5H post dose glucose
58506-7,C peptide^2.5H post dose glucose
58507-5,C peptide^2M post 1 mg glucagon IV
58508-3,C peptide^3.5H post dose glucose
58509-1,C peptide^3.5H post dose glucose
58510-9,C peptide^30M post dose glucose
Jan-51,Herpes simplex virus Ag
58511-7,C peptide^3H post dose glucose
58512-5,C peptide^4.5H post dose glucose
58513-3,C peptide^4.5H post dose glucose
58514-1,C peptide^45M post dose glucose
58515-8,C peptide^45M post dose glucose
58516-6,C peptide^4H post dose glucose
58517-4,C peptide^4H post dose glucose
58518-2,C peptide^5H post dose glucose
58519-0,C peptide^5H post dose glucose
58520-8,C peptide^5M post 1 mg glucagon IV
58521-6,C peptide^9th specimen post XXX challenge
58522-4,C peptide^pre dose glucose
58523-2,Corticosterone^30M post 250 ug corticotropin
58524-0,Corticosterone^1H post 250 ug corticotropin
58525-7,Corticosterone^pre 250 ug corticotropin
58526-5,Corticotropin^1.5H post dose glucagon
58527-3,Corticotropin^1.5H post dose glucagon
58528-1,Corticotropin^1.5H post dose glucose
Sep-52,Herpes simplex virus Ag
58529-9,Corticotropin^1.5H post dose glucose
58530-7,Corticotropin^1.5H post 1 ug/kg CRH IV
58531-5,Corticotropin^1.5H post dose insulin IV
58532-3,Corticotropin^10 AM specimen
58533-1,Corticotropin^10 AM specimen
58534-9,Corticotropin^10 PM specimen
58535-6,Corticotropin^10 PM specimen
58536-4,Corticotropin^105M post dose insulin IV
Jul-53,Herpes simplex virus Ag
58537-2,Corticotropin^105M post dose insulin IV
58538-0,Corticotropin^10th specimen post XXX challenge
58539-8,Corticotropin^10th specimen post XXX challenge
58540-6,Corticotropin^11th specimen post XXX challenge
58541-4,Corticotropin^11th specimen post XXX challenge
58542-2,Corticotropin^12 AM specimen
58543-0,Corticotropin^12 PM specimen
58544-8,Corticotropin^12th specimen post XXX challenge
May-54,Herpes simplex virus Ag
58545-5,Corticotropin^12th specimen post XXX challenge
58546-3,Corticotropin^15M post 1 ug/kg CRH IV
58547-1,Corticotropin^15M post dose insulin IV
58548-9,Corticotropin^15M post dose insulin IV
58549-7,Corticotropin^15M post XXX challenge
58550-5,Corticotropin^15M pre 1 ug/kg CRH IV
58551-3,Corticotropin^15M pre dose insulin IV
Feb-55,Herpes simplex virus Ag
58552-1,Corticotropin^15M pre dose insulin IV
58553-9,Corticotropin^1H post 1 ug/kg CRH IV
58554-7,Corticotropin^1H post dose glucagon
58555-4,Corticotropin^1H post dose glucagon
58556-2,Corticotropin^1H post dose glucose
58557-0,Corticotropin^1H post dose glucose
58558-8,Corticotropin^1H post dose insulin IV
58559-6,Corticotropin^1H post XXX challenge
5856-0,Herpes simplex virus identified
58560-4,Corticotropin^1st specimen post XXX challenge
58561-2,Corticotropin^2 PM specimen
58562-0,Corticotropin^2 PM specimen
58563-8,Corticotropin^2.5H post dose glucagon
58564-6,Corticotropin^2.5H post dose glucagon
58565-3,Corticotropin^2.5H post dose insulin IV
58566-1,Corticotropin^2.5H post dose insulin IV
58567-9,Corticotropin^2.5H post dose glucose
58568-7,Corticotropin^2.5H post dose glucose
58569-5,Corticotropin^1D post dose metyraPONE
58570-3,Corticotropin^1D post dose metyraPONE
58571-1,Corticotropin^2H post 1 ug/kg CRH IV
58572-9,Corticotropin^2H post dose glucagon
58573-7,Corticotropin^2H post dose glucagon
58574-5,Corticotropin^2H post dose glucose
58575-2,Corticotropin^2H post dose glucose
58576-0,Corticotropin^2H post dose insulin IV
58577-8,Corticotropin^2H post dose insulin IV
Aug-57,Herpes simplex virus identified
58578-6,Corticotropin^2H post XXX challenge
58579-4,Corticotropin^2nd specimen post XXX challenge
58580-2,Corticotropin^30M post 1 ug/kg CRH IV
58581-0,Corticotropin^30M post dose glucagon
58582-8,Corticotropin^30M post dose glucagon
58583-6,Corticotropin^30M post dose glucose
58584-4,Corticotropin^30M post dose glucose
58585-1,Corticotropin^30M post dose insulin IV
Jun-58,Herpes simplex virus identified
58586-9,Corticotropin^30M post XXX challenge
58587-7,Corticotropin^30M pre 1 ug/kg CRH IV
58588-5,Corticotropin^30M pre 1 ug/kg CRH IV
58589-3,Corticotropin^30M pre dose glucagon
58590-1,Corticotropin^30M pre dose glucagon
58591-9,Corticotropin^30M pre dose insulin IV
58592-7,Corticotropin^30M pre XXX challenge
58593-5,Corticotropin^30M pre XXX challenge
Apr-59,Herpes simplex virus identified
58594-3,Corticotropin^3H post dose glucagon
58595-0,Corticotropin^3H post dose glucagon
58596-8,Corticotropin^3H post dose glucose
58597-6,Corticotropin^3H post dose glucose
58598-4,Corticotropin^3H post dose insulin IV
58599-2,Corticotropin^3H post dose insulin IV
58600-8,Corticotropin^3H post XXX challenge
58601-6,Corticotropin^3H post XXX challenge
Feb-60,Influenza virus A Ag
58602-4,Corticotropin^3rd specimen post XXX challenge
58603-2,Corticotropin^4 AM specimen
58604-0,Corticotropin^4 PM specimen
58605-7,Corticotropin^45M post 1 ug/kg CRH IV
58606-5,Corticotropin^45M post dose insulin IV
58607-3,Corticotropin^2D post dose metyraPONE
58608-1,Corticotropin^4th specimen post XXX challenge
58609-9,Corticotropin^5th specimen post XXX challenge
5861-0,Influenza virus A Ag
58610-7,Corticotropin^6 PM specimen
58611-5,Corticotropin^6th specimen post XXX challenge
58612-3,Corticotropin^75M post dose insulin IV
58613-1,Corticotropin^75M post dose insulin IV
58614-9,Corticotropin^7th specimen post XXX challenge
58615-6,Corticotropin^8 AM specimen
58616-4,Corticotropin^8 PM specimen
58617-2,Corticotropin^8th specimen post XXX challenge
58618-0,Corticotropin^post dose dexamethasone
58619-8,Corticotropin^pre 1 ug/kg CRH IV
58620-6,Corticotropin^pre dose dexamethasone
58621-4,Corticotropin^pre dose dexamethasone
58622-2,Corticotropin^pre dose glucagon
58623-0,Corticotropin^pre dose glucagon
58624-8,Corticotropin^pre dose glucose
58625-5,Corticotropin^pre dose glucose
58626-3,Corticotropin^pre dose insulin IV
58627-1,Corticotropin^pre dose metyraPONE
Aug-62,Influenza virus A Ag
58628-9,Corticotropin^pre dose metyraPONE
58629-7,Corticotropin^pre XXX challenge
58630-5,Corticotropin^pre XXX challenge
58631-3,Cortisol^1.5H post 1 ug/kg CRH IV
58632-1,Cortisol^1.5H post 1 ug/kg CRH IV
58633-9,Cortisol^10 AM specimen
58634-7,Cortisol^10 AM specimen
58635-4,Cortisol^10 PM specimen
Jun-63,Influenza virus A Ag
58636-2,Cortisol^10 PM specimen
58637-0,Cortisol^10th specimen post XXX challenge
58638-8,Cortisol^10th specimen post XXX challenge
58639-6,Cortisol^10th specimen post XXX challenge
58640-4,Cortisol^11th specimen post XXX challenge
58641-2,Cortisol^11th specimen post XXX challenge
58642-0,Cortisol^12 AM specimen
58643-8,Cortisol^12 AM specimen
Apr-64,Influenza virus B Ag
58644-6,Cortisol^12 PM specimen
58645-3,Cortisol^12 PM specimen
58646-1,Cortisol^12th specimen post XXX challenge
58647-9,Cortisol^12th specimen post XXX challenge
58648-7,Cortisol^15M post 1 ug/kg CRH IV
58649-5,Cortisol^15M post 1 ug/kg CRH IV
58650-3,Cortisol^15M pre 1 ug/kg CRH IV
Jan-65,Influenza virus B Ag
58651-1,Cortisol^15M pre 1 ug/kg CRH IV
58652-9,Cortisol^1H post 1 ug/kg CRH IV
58653-7,Cortisol^1H post 1 ug/kg CRH IV
58654-5,Cortisol^1st specimen post XXX challenge
58655-2,Cortisol^2 PM specimen
58656-0,Cortisol^2 PM specimen
58657-8,Cortisol^2H post 1 ug/kg CRH IV
58658-6,Cortisol^2H post 1 ug/kg CRH IV
58659-4,Cortisol^2H post 1 ug/kg CRH IV
58660-2,Cortisol^2nd specimen post XXX challenge
58661-0,Cortisol^30M pre 1 ug/kg CRH IV
58662-8,Cortisol^30M pre 1 ug/kg CRH IV
58663-6,Cortisol^30M pre 1 ug/kg CRH IV
58664-4,Cortisol^30M pre 1 ug/kg CRH IV
58665-1,Cortisol^3rd specimen post XXX challenge
58666-9,Cortisol^4 AM specimen
58667-7,Cortisol^4 AM specimen
58668-5,Cortisol^4 PM specimen
Sep-66,Influenza virus B Ag
58669-3,Cortisol^4 PM specimen
58670-1,Cortisol^45M post 1 ug/kg CRH IV
58671-9,Cortisol^45M post 1 ug/kg CRH IV
58672-7,Cortisol^45M post 1 ug/kg CRH IV
58673-5,Cortisol^4th specimen post XXX challenge
58674-3,Cortisol^8 AM specimen
58675-0,Cortisol^8 AM specimen
58676-8,Cortisol^8 PM specimen
Jul-67,Influenza virus B Ag
58677-6,Cortisol^8 PM specimen
58678-4,Cortisol^pre 1 ug/kg CRH IV
58679-2,Cortisol^pre 1 ug/kg CRH IV
586-8,Streptococcus agalactiae
58680-0,Cortisol^pre 2 mg dexamethasone PO 2.5 day high dose q6h
58681-8,Temperature
58682-6,Sulfatides
58683-4,Complement C5
58684-2,Uroporphyrin 1 isomer/Creatinine
May-68,Parainfluenza virus 1 Ag
58685-9,Beta hydroxybutyrate
58686-7,C peptide^2H post dose glucose
58687-5,Corticotropin^9th specimen post XXX challenge
58688-3,Cortisol^11th specimen post XXX challenge
58689-1,Cortisol^11th specimen post XXX challenge
58690-9,Cortisol^12th specimen post XXX challenge
58691-7,Cortisol^12th specimen post XXX challenge
58692-5,Cortisol^5th specimen post XXX challenge
Mar-69,Parainfluenza virus 1 Ag
58693-3,Cortisol^6th specimen post XXX challenge
58694-1,Cortisol^7th specimen post XXX challenge
58695-8,Cortisol^8th specimen post XXX challenge
58696-6,Cortisol^8th specimen post XXX challenge
58697-4,Cortisol^9th specimen post XXX challenge
58698-2,Cortisol^9th specimen post XXX challenge
Jan-70,Parainfluenza virus 2 Ag
58705-5,cefTAZidime
58706-3,OmpC Ab.IgA
58707-1,Ephedrine+Pseudoephedrine
58708-9,Mycoplasma pneumoniae Ab.IgM
58709-7,Gliadin peptide Ab.IgA
58710-5,Gliadin peptide Ab.IgG
58711-3,Doripenem
58712-1,Quinupristin+Dalfopristin
58713-9,DNAse B Ab.Streptococcal & Streptolysin O Ab panel
58714-7,Oxidants
58715-4,Adulterants panel
58716-2,Testosterone.free+weakly bound & total panel
58717-0,Lymphocyte proliferation.concanavalin A stimulation
58718-8,Lymphocyte proliferation. 10 ug concanavalin A stimulation actual/Normal
Sep-71,Parainfluenza virus 2 Ag
58719-6,Lymphocyte proliferation. 5 ug concanavalin A stimulation actual/Normal
58720-4,Lymphocyte proliferation. 2.0 ug concanavalin A stimulation actual/Normal
58721-2,Lymphocyte proliferation. 0.5 ug concanavalin A stimulation actual/Normal
58722-0,Lymphocyte proliferation.pokeweed mitogen stimulation
58723-8,Lymphocyte proliferation. 10 ug pokeweed mitogen stimulation actual/Normal
58724-6,Lymphocyte proliferation. 5 ug pokeweed mitogen stimulation actual/Normal
58725-3,Lymphocyte proliferation. 1.0 ug pokeweed mitogen stimulation actual/Normal
58726-1,Lymphocyte proliferation. 0.50 ug pokeweed mitogen stimulation actual/Normal
Jul-72,Parainfluenza virus 3 Ag
58727-9,Lymphocyte proliferation.phytohemagglutinin stimulation
58728-7,Lymphocyte proliferation. 5 ug phytohemagglutinin stimulation actual/Normal
58729-5,Lymphocyte proliferation. 2.5 ug phytohemagglutinin stimulation actual/Normal
58730-3,Lymphocyte proliferation. 1.0 ug phytohemagglutinin stimulation actual/Normal
58731-1,Lymphocyte proliferation. 0.5 ug phytohemagglutinin stimulation actual/Normal
58732-9,Porphyrin fractions panel
58733-7,Mycoplasma pneumoniae Ab.IgG & IgM panel
58734-5,Collection date
May-73,Parainfluenza virus 3 Ag
58735-2,Alpha-1-fetoprotein panel
58736-0,Manganese panel
58737-8,Parvovirus B19 Ab.IgG & IgM
58738-6,Drugs of abuse
58739-4,Haemophilus influenzae serotype
58740-2,Guidance for endoscopy^WO contrast
58741-0,Multisection^W radionuclide IV
58742-8,Multisection^W radionuclide IV
Mar-74,Respiratory syncytial virus Ag
58743-6,Guidance for ablation of tissue
58744-4,Multisection
58745-1,Multisection & 3D reconstruction^W contrast IV
58746-9,Views^W contrast IV
58747-7,Guidance for ablation of tissue
58748-5,Multisection
58749-3,Multisection^W stress+WO & W contrast IV
5875-0,Respiratory syncytial virus Ag
58750-1,Multisection^W stress
58751-9,Treponema pallidum Ab.IgG
58752-7,Triticum aestivum recombinant (rTri a) 19 Ab.IgE
58753-5,Corylus avellana recombinant (rCor a) 8 Ab.IgE
58754-3,Olea europaea native (nOle e) 1 Ab.IgE
58755-0,Varicella zoster virus Ab.IgG
58756-8,Parvovirus B19 Ab.IgM
58757-6,Parvovirus B19 Ab.IgG
58758-4,Chlamydophila pneumoniae Ab.IgG
58759-2,Echovirus Ab
587-6,Helicobacter pylori
58760-0,Epstein Barr virus capsid Ab.IgG
58761-8,Coxiella burnetii phase 2 Ab.IgG
58762-6,Coxiella burnetii phase 2 Ab.IgG
58763-4,IgA
58764-2,IgM
58765-9,Histone Ab
58766-7,Epithelial cells
58767-5,Erythrocytes
Aug-76,Respiratory syncytial virus Ag
58768-3,Gamma glutamyl transferase
58769-1,Fetal trisomy 13 risk
58770-9,Clostridium tetani toxoid Ab.IgG
58771-7,Bactericidal permeability increasing protein Ab
58772-5,Dog recombinant (rCan f) 2 Ab.IgE
58773-3,Dog recombinant (rCan f) 1 Ab.IgE
58774-1,Alternaria alternata recombinant (rAlt a) 1 Ab.IgE
58775-8,Prunus persica recombinant (rPru p) 4 Ab.IgE
Jun-77,Respiratory syncytial virus Ag
58776-6,Prunus persica recombinant (rPru p) 1 Ab.IgE
58777-4,Arachis hypogaea recombinant (rAra h) 3 Ab.IgE
58778-2,Arachis hypogaea recombinant (rAra h) 2 Ab.IgE
58779-0,Arachis hypogaea recombinant (rAra h) 1 Ab.IgE
58780-8,Coxsackievirus B Ab.IgG
58781-6,Calcium
58782-4,Mycoplasma pneumoniae Ab.IgM
58783-2,Herpes simplex virus 2 Ab.IgM
Apr-78,Rickettsia sp identified
58784-0,Herpes simplex virus 1 Ab.IgM
58785-7,Herpes simplex virus 2 Ab.IgG
58786-5,Herpes simplex virus 1 Ab.IgG
58787-3,Corynebacterium diphtheriae Ab.IgG
58788-1,Campylobacter jejuni Ab.IgM
58789-9,Campylobacter jejuni Ab.IgG
58790-7,Coxsackievirus B Ab.IgM
58791-5,Coxsackievirus A9 Ab.IgM
Feb-79,Rotavirus Ag
58792-3,Coxsackievirus A9 Ab.IgG
58793-1,Phytonadione
58794-9,5-Hydroxytryptophan
58795-6,Glomerular basement membrane Ab.IgG
58796-4,Glomerular basement membrane Ab.IgG
58797-2,Yersinia enterocolitica Ab
58798-0,Legionella pneumophila 2 Ab.IgM
58799-8,Legionella pneumophila 1 Ab.IgG
Aug-58,Capreomycin
5880-0,Rotavirus Ag
58800-4,Protein fractions.oligoclonal bands
58801-2,Polymorphonuclear cells/100 leukocytes
58802-0,Mononuclear cells/100 leukocytes
58803-8,Acetone/Creatinine
58804-6,Polistes dominulus Ab.IgE
58805-3,Leukocytes
58806-1,Brucella sp Ab
58807-9,Conalbumin native (nGal d) 3 Ab.IgE
58808-7,Aspergillus sp Ab
58809-5,Rickettsia conorii Ab.IgG
58810-3,Testosterone^2nd specimen
58811-1,Renin^post XXX challenge
58812-9,Renin^3rd specimen
58813-7,Renin^2nd specimen
58814-5,17-Hydroxyprogesterone^3rd specimen
58815-2,17-Hydroxyprogesterone^2nd specimen
58816-0,C peptide^2nd specimen
58817-8,Estradiol^3rd specimen
Aug-81,Varicella zoster virus Ag
58818-6,Estrogen^2nd specimen
58819-4,Cortisol^21st specimen
58820-2,Cortisol^24th specimen
58821-0,Cortisol^23rd specimen
58822-8,Cortisol^22nd specimen
58823-6,Cortisol^20th specimen
58824-4,Cortisol^19th specimen
58825-1,Cortisol^18th specimen
Jun-82,Varicella zoster virus Ag
58826-9,Cortisol^17th specimen
58827-7,Cortisol^16th specimen
58828-5,Cortisol^14th specimen
58829-3,Cortisol^15th specimen
58830-1,Cortisol^13th specimen
58831-9,Urea
58832-7,Insulin-like growth factor binding protein 3^45M post XXX challenge
58833-5,Thyrotropin^20M pre XXX challenge
Apr-83,Virus identified
58834-3,Thyrotropin^15M pre XXX challenge
58835-0,Testosterone^baseline
58836-8,Thyroxine.free^3H post XXX challenge
58837-6,Thyroxine.free^2H post XXX challenge
58838-4,Thyroxine.free^baseline
58839-2,Triiodothyronine.free^3H post XXX challenge
588-4,Legionella pneumophila Ag
58840-0,Triiodothyronine.free^baseline
58841-8,C peptide^5M post XXX challenge
Feb-84,Virus identified
58842-6,Somatotropin^25th specimen
58843-4,Somatotropin^24th specimen
58844-2,Somatotropin^20th specimen
58845-9,Somatotropin^19th specimen
58846-7,Somatotropin^18th specimen
58847-5,Somatotropin^17th specimen
58848-3,Somatotropin^16th specimen
58849-1,Somatotropin^15th specimen
58850-9,Somatotropin^14th specimen
58851-7,Testosterone^3D post XXX challenge
58852-5,Osmolality^post 1.5H FFst
58853-3,Osmolality^post 30M FFst
58854-1,Estradiol^4D post XXX challenge
58855-8,Somatotropin^13th specimen
58856-6,Somatotropin^10th specimen
58857-4,Somatotropin^9th specimen
58858-2,Parathyrin.intact^post XXX challenge
Sep-85,Virus identified
58859-0,Homocyst(e)ine^post XXX challenge
58860-8,Somatotropin^48th specimen
58861-6,Somatotropin^47th specimen
58862-4,Somatotropin^46th specimen
58863-2,Somatotropin^45th specimen
58864-0,Somatotropin^44th specimen
58865-7,Somatotropin^43rd specimen
58866-5,Somatotropin^42nd specimen
Jul-86,Virus identified
58867-3,Somatotropin^41st specimen
58868-1,Somatotropin^40th specimen
58869-9,Somatotropin^39th specimen
58870-7,Somatotropin^38th specimen
58871-5,Somatotropin^37th specimen
58872-3,Somatotropin^36th specimen
58873-1,Somatotropin^35th specimen
58874-9,Somatotropin^33rd specimen
May-87,Virus identified
58875-6,Somatotropin^32nd specimen
58876-4,Somatotropin^31st specimen
58877-2,Somatotropin^30th specimen
58878-0,Somatotropin^29th specimen
58879-8,Somatotropin^28th specimen
58880-6,Somatotropin^27th specimen
58881-4,Somatotropin^26th specimen
58882-2,Somatotropin^23rd specimen
Mar-88,Virus identified
58883-0,Somatotropin^22nd specimen
58884-8,Somatotropin^21st specimen
58885-5,Urea
58886-3,Pyruvate^30M post XXX challenge
58887-1,Pyruvate^15M post XXX challenge
58888-9,Pyruvate^10M post XXX challenge
58889-7,Pyruvate^3M post XXX challenge
58890-5,Pyruvate^1M post XXX challenge
Jan-89,Protein S.free
58891-3,Calcitonin^1M post XXX challenge
58892-1,Calcitonin^baseline
58893-9,Vasopressin^1.5H post XXX challenge
58894-7,Vasopressin^baseline
58895-4,Pyruvate^post exercise
58896-2,C peptide^post XXX challenge
58897-0,Methyl ethyl ketone/Creatinine
58898-8,Renin^4H post XXX challenge
58899-6,Aldosterone^4H post XXX challenge
58900-2,HIV 1+2 Ab+HIV1 p24 Ag
58901-0,Spermatozoa.progressive
58902-8,F12 gene mutations tested for
58903-6,Neomycin Ab.IgE
58904-4,Nucleated cells
58905-1,Nucleated cells
58906-9,Nucleated cells
58907-7,Liver kidney microsomal 1 Ab
58908-5,11-Deoxycortisol^40M post XXX challenge
Sep-90,Protein S+Acarboxy.free Ag
58909-3,11-Deoxycortisol^20M post XXX challenge
58910-1,11-Deoxycortisol^2.5H post XXX challenge
58911-9,Chicken droppings Ab.IgG
58912-7,Pigeon feather Ab.IgG
58913-5,Parrot feather Ab.IgG
58914-3,Aspergillus niger Ab.IgG
58915-0,Parakeet feather Ab.IgG
58916-8,Canary feather Ab.IgG
Jul-91,Protein S+Acarboxy Ag
58917-6,Androstanolone^1H post XXX challenge
58918-4,Androstanolone^30M post XXX challenge
58919-2,Androstenedione^1.5H post XXX challenge
589-2,Legionella sp identified
58920-0,Cells.CD4+CD45RO+/Cells.CD3+CD4+
58921-8,Glutamine+Histidine
58922-6,Vasopressin^2H post XXX challenge
58923-4,Lolium perenne Ab.IgG
58924-2,LCT gene mutations tested for
May-92,Protein S
58925-9,Dextromethamphetamine
58927-5,Glutamine+Histidine/Creatinine
58928-3,HLA-DQA1*03:01
58929-1,HLA-DQB1*03:02
58930-9,Glutamine+Histidine
58931-7,Mycobacterium tuberculosis DNA
58932-5,Protoporphyrin
Mar-93,Protein S
58933-3,Endothelial cell Ab
58934-1,Fat
58935-8,Yersinia pseudotuberculosis Ab
58936-6,Hepatitis E virus Ab
58937-4,F12 gene targeted mutation analysis
58938-2,LCT gene targeted mutation analysis
58939-0,Cells.CD34
58940-8,Bacteria identified
Jan-94,Coagulation tissue factor induced actual/Normal
58941-6,Bilirubin
58942-4,Microscopic observation
58943-2,Microscopic observation
58944-0,Microscopic observation
58945-7,Microscopic observation
58946-5,Lutropin^pre XXX challenge
58947-3,Follitropin^pre XXX challenge
58948-1,Somatotropin^pre XXX challenge
58949-9,Somatotropin^12th specimen
58950-7,Somatotropin^11th specimen
58951-5,Creatinine^2nd specimen
58952-3,Testosterone free & total panel
58953-1,Meperidine & Normeperidine panel
58954-9,Deoxypyridinoline/Pyridinoline
58955-6,Pyridinoline & Deoxypyridinoline
58956-4,Direct antiglobulin test.complement C3b+C4d specific reagent
Jul-95,Coagulation tissue factor induced.INR
58957-2,Heparin given
58958-0,Fusarium oxysporum Ab.IgG
58959-8,BIPAP &or CPAP setting
58960-6,Pressure.bilevel positive airway
58961-4,Ganglioside GT1b Ab.IgM
58962-2,Ganglioside GT1b Ab.IgG
58963-0,Ganglioside GT1a Ab.IgM
58964-8,Ganglioside GT1a Ab.IgG
May-96,Coagulation tissue factor induced.normal/Actual
58965-5,Ganglioside GM4 Ab.IgM
58966-3,Ganglioside GM4 Ab.IgG
58967-1,Ganglioside GM3 Ab.IgM
58968-9,Asialoganglioside GM1 Ab.IgG
58969-7,Ganglioside GD1a Ab.IgG
58970-5,Ganglioside GD1a Ab.IgM
58971-3,Ganglioside GD1b Ab.IgG
58972-1,Ganglioside GM1 Ab.IgG
Mar-97,Coagulation dilute Russell viper venom induced
58973-9,Ganglioside GM2 Ab.IgG
58974-7,Ganglioside GM2 Ab.IgM
58975-4,Ganglioside GQ1b Ab.IgG
58976-2,Ganglioside GQ1b Ab.IgM
58977-0,Ganglioside GD1b Ab.IgM
58978-8,Ganglioside GD3 Ab.IgM
58979-6,Ganglioside GD3 Ab.IgG
58980-4,Ganglioside GD2 Ab.IgM
58981-2,Phleum pratense recombinant (rPhl p) 5b Ab.IgE
Feb-98,Coagulation surface induced
58982-0,Quercus ilex Ab.IgE
58983-8,Apis mellifera phospholipase A2 native (nApi m) 1 Ab.IgE
58984-6,Bromelin MUXF3 Ab.IgE
58985-3,11-Deoxycortisol^pre XXX challenge
58986-1,Penaeus aztecus tropomyosin recombinant (rPen a) 1 Ab.IgE
58987-9,ITGB3 gene targeted mutation analysis
58988-7,FGB gene targeted mutation analysis
58989-5,Specimen volume
5899-0,Coagulation surface induced normal/Actual
58990-3,Urate
58991-1,Urea
58992-9,Protein
58993-7,Phosphate
58994-5,Sodium
58995-2,Magnesium
58996-0,Potassium
58997-8,Glucose
58998-6,Creatinine
58999-4,Chloride
09-May,Almecillin
590-0,Legionella sp identified
59000-0,Calcium
59001-8,Amylase
59002-6,Paliperidone
59003-4,Lactoferrin Ab
59004-2,Lactate^baseline
59005-9,Lactate^1M post XXX challenge
Jun-00,Prothrombin fragment 1+2
59006-7,Lactate^3M post XXX challenge
59007-5,Lactate^5M post XXX challenge
59008-3,Insulin-like growth factor binding protein 3^15M post XXX challenge
59009-1,Fractional excretion of urea
59010-9,Fractional excretion of potassium
59011-7,Lactate^10M post XXX challenge
59012-5,Lactate^15M post XXX challenge
59013-3,Lactate^30M post XXX challenge
Apr-01,Coagulation tissue factor induced
59014-1,Sjogrens syndrome-A extractable nuclear 60kD Ab
59015-8,Carbohydrates
59016-6,Water
59017-4,HLA-DPB1
59018-2,HLA-DPA1
59019-0,HLA-DQA1
59020-8,HLA-DRB5
59021-6,HLA-DRB4
Feb-02,Coagulation tissue factor induced
59022-4,HLA-DRB3
59023-2,Adenosine deaminase
59024-0,Renin^supine+30M post XXX challenge
59025-7,Neutrophil Ab
59026-5,U1 small nuclear ribonucleoprotein 70kD Ab
59027-3,Asialoganglioside GM1 Ab.IgM
59028-1,Ganglioside GM1 Ab.IgM
59029-9,HLA-DRB1*15:01
5903-0,Coagulation Russell viper venom induced
59030-7,Cells.CD45+CD103+/100 cells
59031-5,Cells.CD25+C69+/100 cells
59032-3,Lactate
59033-1,Ganglioside GM3 Ab.IgG
59034-9,Ganglioside GD2 Ab.IgG
59035-6,Cells.CD54/100 cells
59036-4,Triglyceride
59037-2,Phosphate
59038-0,Cholesterol
59039-8,Amylase
59040-6,Cancer Ag 125
59041-4,BRCA1+BRCA2 gene mutations tested for
59042-2,Cells.TCR gamma delta/100 cells
59043-0,Somatotropin^34th specimen
59044-8,ACE gene mutations tested for
59045-5,ITGB3 gene mutations tested for
59046-3,FGB gene mutations tested for
59047-1,F5 gene.p.His1299Arg
Aug-04,Coagulation Russell viper venom induced
59048-9,Lactate/Pyruvate
59049-7,Coccidioides sp Ab.IgG & IgM panel
59050-5,Chromosome analysis.interphase
59051-3,Bacteria identified^^^4
59052-1,HIV 1+Hepatitis C virus RNA+Hepatitis B virus DNA
59053-9,Glucagon^5th specimen post CFst
59054-7,Glucagon^4th specimen post CFst
May-05,Monocytes/100 leukocytes
59055-4,Glucagon^3rd specimen post CFst
59056-2,Glucagon^2nd specimen post CFst
59057-0,Glucagon^1st specimen post CFst
59058-8,Cow whey Ab.IgG
59059-6,Inflammatory bowel disease Ab 7 panel
59060-4,Inflammatory bowel disease Ab 7
59061-2,Adulterants
59062-0,Lipoprofile panel
Mar-06,Neutrophils
59063-8,Lymphocyte proliferation panel
59064-6,PAX6 gene targeted mutation analysis
59065-3,Chlamydophila psittaci
59066-1,sp100 Ab
59067-9,ALAS2 gene targeted mutation analysis
59068-7,RPS19 gene targeted mutation analysis
59069-5,Nuclear Ab
59070-3,Paraquat
Jan-07,Platelets
59071-1,Tropheryma whipplei Ab
59072-9,Liver kidney microsomal 1 Ab
59073-7,Circumference.transverse
59074-5,Circumference.transverse.heart/Circumference.thorax
59075-2,Cross section.transverse
59076-0,Cross section.transverse.heart/Transverse.thorax
59077-8,Diameter.foramen ovale/Diameter.aorta root
59078-6,Diameter.left ventricle/Diameter.right ventricle
59079-4,Blood flow.reverse.max^during atrial contraction
59080-2,E wave.max
59081-0,A wave.max
59082-8,Closure to opening
59083-6,Isovolumic relaxation time
59084-4,Isovolumic contraction time
59085-1,Pre ejection time
59086-9,Ejection time^^corrected for heart rate
59087-7,Pre ejection time^^corrected for heart rate
59088-5,Pre ejection time/Ejection time
Sep-08,Platelets.giant
59089-3,Thickness
59090-1,Internal Dimension
59091-9,D-E excursion
59092-7,Thickening
59093-5,Epicardial area
59094-3,Endocardial area
59095-0,QRS to S wave.max
59096-8,QRS to E wave.max
Jul-09,Blood smear finding
59097-6,Meridional wall stress
59098-4,E wave to septal separation
59099-2,Myocardial performance index
59100-8,A wave amplitude
59101-6,Pressure
59102-4,Flow radius
59103-2,A-C duration
59104-0,E wave.max/A wave.max
May-10,Lactate dehydrogenase isoenzymes
59105-7,A wave duration
59106-5,Pressure gradient.max^at stenosis
59107-3,Velocity.max^at stenosis
59108-1,Measure duration
59109-9,Leaflet separation
59110-7,Leaflet thickness
59111-5,Blood flow velocity E wave/Annulus velocity E wave
59112-3,A wave duration.pulmonary vein/A wave duration.mitral valve
Mar-11,Lipoprotein pattern
59113-1,Velocity-time integral.pulmonary vein A wave/Velocity-time integral.mitral valve A wave
59114-9,A wave duration.pulmonary vein - A wave duration.mitral valve
59115-6,Flow propagation velocity
59116-4,Diameter.aortic sinotubular junction/Diameter.aorta root
59117-2,Circumferential fiber shortening.mean
59118-0,Circumferential fiber shortening.mean^^corrected for heart rate
59119-8,Filling period.diastole
59120-6,dP/dt
Jan-12,Creatine kinase isoenzymes
59121-4,Time to peak
59122-2,C-E excursion
59123-0,Cross section.jet
59124-8,Blood velocity-time integral.E wave
59125-5,Blood velocity-time integral.A wave
59126-3,B-C slope
59127-1,D-E slope
59128-9,E-F slope
59129-7,E wave/A wave
59130-5,Alias velocity
59131-3,Volume.atrium.left/Volume.atrium.right
59132-1,Fractional shortening
59133-9,Tissue velocity
59134-7,ePHEDrine
59135-4,Benzylpiperazine
59136-2,Cells.CD11c+CD103+/100 cells
59137-0,Cells.CD5+CD23+/100 cells
59138-8,Cells.CD7+CD34+/100 cells
Sep-13,Hemoglobin F/Hemoglobin.total
59139-6,Cells.CD19+CD34+/100 cells
59140-4,Cells.CD13+CD34+/100 cells
59141-2,Cells.CD11c-CD103+/100 cells
59142-0,Cells.CD11c-CD25+/100 cells
59143-8,Cells.CD19+CD38+/100 cells
59144-6,Cells.CD5+CD23+/100 cells
59145-3,Cells.CD11c+CD103+
59146-1,Cells.CD11c+CD25+
Jul-14,Glucose
59147-9,Cells.CD19+CD38+
59148-7,Calcium^post dialysis
59149-5,Creatine kinase.macromolecular
59150-3,Enterococcus species.vancomycin resistant
59151-1,Enterococcus species.vancomycin resistant
59152-9,Enterococcus species.vancomycin resistant DNA
59153-7,Cortisol^5H post XXX challenge
59154-5,Base deficit
59155-2,17-Hydroxyprogesterone^20M post XXX challenge
59156-0,Glucose
59157-8,Glucose^pre dose lactose PO
59158-6,Ketones
59159-4,Albumin/Creatinine
59160-2,Cannabinoids
59161-0,Phosphate
59162-8,Potassium
59163-6,Sodium
59164-4,Alkaline phosphatase
59165-1,Carbon dioxide
59166-9,Bilirubin
59167-7,Phosphate
59168-5,Urea
59169-3,buPROPion
5917-0,???lead
59170-1,Citalopram
59171-9,Norclozapine
59172-7,Methotrimeprazine metabolite
59174-3,QUEtiapine
59175-0,QUEtiapine metabolite
59176-8,Zopiclone
59177-6,Beta-2-Microglobulin/Creatinine
59178-4,Chloride
59179-2,Insulin^post CFst
591-8,Legionella sp
59180-0,Monoethylglycinexylidide
59181-8,Interferon.beta given
59182-6,C reactive protein
59183-4,Epstein Barr virus early diffuse Ab.IgG
59185-9,Hemoglobin H inclusion bodies
59186-7,Cyanide
59187-5,Urea renal clearance/1.73 sq M
Aug-18,Urea nitrogen
59188-3,Alkaline phosphatase.placental
59189-1,Methyl ethyl ketone/Creatinine
59190-9,2-Hydroxycaproate/Creatinine
59191-7,2-Ketobutyrate/Creatinine
59192-5,3-Methyl crotonate/Creatinine
59193-3,Deoxyuridine/Creatinine
59194-1,Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1)
59195-8,3-Hydroxydodecenoylcarnitine (C12:1-OH)
Jun-19,Creatinine
59196-6,3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16)
59197-4,Propionylcarnitine (C3)/Palmitoylcarnitine (C16)
59198-2,Propionylcarnitine (C3)/Acetylcarnitine (C2)
59199-0,Deoxyadenosine/Creatinine
59200-6,Octanoylcarnitine (C8)/Acetylcarnitine (C2)
59201-4,Deoxyguanosine/Creatinine
59202-2,Deoxyinosine/Creatinine
59203-0,Adenine/Creatinine
Apr-20,Protein
59204-8,Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2)
59205-5,Gamma tocopherol
59206-3,Carnitine.free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18)
59207-1,Dicarboxyoleylcarnitine (C18:1-DC)
59208-9,Octanoylcarnitine (C8)/Decanoylcarnitine (C10)
59209-7,Gamma hydroxybutyrate
59210-5,Inosine/Creatinine
59211-3,Transcobalamin I+Transcobalamin III
Feb-21,Lactate dehydrogenase
59212-1,Alloisoleucine
59213-9,Alloisoleucine
59214-7,Succinyladenosine/Creatinine
59215-4,Thymidine/Creatinine
59216-2,Uridine/Creatinine
59217-0,Beta-2-Microglobulin
59218-8,Beta-2-Microglobulin
59219-6,Testosterone
5922-0,Gastric acid
59220-4,Chromogranin A
59221-2,Prostate specific Ag
59222-0,Squamous cell carcinoma Ag
59223-8,Prostate specific Ag
59224-6,Prostate specific Ag.free
59225-3,Squamous cell carcinoma Ag
59226-1,Chromogranin A
59227-9,Chromogranin A
59228-7,Squamous cell carcinoma Ag
59229-5,Testosterone
59230-3,Prostate specific Ag
59231-1,Prostate specific Ag.free
59232-9,Prostate specific Ag.free
59233-7,Testosterone
59234-5,Reducing substances
59235-2,Prostate specific Ag.free/Prostate specific Ag.total
59236-0,Prostate specific Ag.free/Prostate specific Ag.total
59237-8,Prostate specific Ag.free/Prostate specific Ag.total
Aug-23,Gastric acid.free
59238-6,Prostate specific Ag.free/Prostate specific Ag.total
59239-4,Prostate specific Ag.free
59240-2,Testosterone
59241-0,Chromogranin A
59242-8,Reducing substances
59243-6,Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)/Acetylcarnitine (C2)
59244-4,Arylsulfatase C
59245-1,Alanine glyoxylate aminotransferase
Jun-24,pH
59246-9,Palmitoyl protein thioesterase
59247-7,Tetrahydrobiopterin
59248-5,Cholesterol esterase
59249-3,Acylcarnitine/Acylcarnitine+Carnitine Free (C0)
59250-1,Tocopherols/Cholesterol
59251-9,N-carbamoyl beta alanine/Creatinine
59252-7,Homocysteine cysteine disulfide
Mar-25,Gastric acid
59253-5,Homocysteine cysteine disulfide
59254-3,Acylcarnitine/Acylcarnitine+Carnitine Free (C0)
59255-0,Multisection & 3D reconstruction^W contrast IV
59256-8,Cytologist
59257-6,Cell count & Differential panel
59258-4,Discharge summary note
59259-2,Discharge summary note
592-6,Legionella sp
59260-0,Hemoglobin
Jan-26,Sodium
59261-8,Hemoglobin A1c/Hemoglobin.total
59262-6,Leukocyte esterase
59263-4,Human papilloma virus 16 DNA
59264-2,Human papilloma virus 18 DNA
59265-9,8-Hydroxydeoxyguanosine/Creatinine
59266-7,Maternal cell contamination
59267-5,Karyotype
59268-3,Neonatal care report
59269-1,Respiratory severity score
59270-9,Surgical operative note panel
59271-7,Hospital discharge summary panel
59272-5,Power setting
59273-3,Cortisol^post 6 mg dexamethasone PO overnight
59274-1,Oxygen content
59275-8,Oxygen capacity
59276-6,Calcium hydrogen phosphate dihydrate crystals
59277-4,Cystine crystals
59278-2,Calcium oxalate dihydrate crystals
Sep-27,Potassium
59279-0,Urate crystals
59280-8,Urate dihydrate crystals
Jan-28,Chloride
59281-6,Multisection transthoracic
59282-4,Cardiac stress echo study
59283-2,Well child visit note
59284-0,Consent
59285-7,Benzylpiperazine
59286-5,Benzylpiperazine
59287-3,Benzylpiperazine
59288-1,Bisphenol A
59289-9,Iloperidone
59290-7,Iloperidone
59291-5,Levamisole
59292-3,Levamisole
59293-1,Levamisole
59294-9,Levamisole
May-29,Candida albicans reaction wheal^3D post 50 ug Candida albicans ID
59295-6,Levamisole
59296-4,Lacosamide
59297-2,Lacosamide
59298-0,Lacosamide
59299-8,Desloratadine
59300-4,Desloratadine
59301-2,Desloratadine
59302-0,Memantine
Mar-30,Mumps reaction wheal^3D post 0.1 mL mumps ID
59303-8,Memantine
59304-6,Memantine
59305-3,Memantine
59306-1,Memantine
59307-9,Metaxalone
59308-7,Metaxalone
59309-5,Metaxalone
59310-3,Milnacipran
Jan-31,Trichophyton reaction wheal^3D post 50 ug trichophyton ID
59311-1,Milnacipran
59312-9,Milnacipran
59313-7,Ramelteon M-II
59314-5,Ramelteon
59315-2,Ramelteon M-II
59316-0,Ramelteon
59317-8,Ramelteon M-II
59318-6,Ramelteon
59319-4,Ramelteon M-II
59320-2,Ramelteon
59321-0,Ramelteon M-II
59322-8,Ramelteon
59323-6,Rufinamide
59324-4,Salvinorin A
59325-1,Salvinorin B
59326-9,Salvinorin A
59327-7,Salvinorin B
59328-5,Salvinorin A
Sep-32,Cholesterol
59329-3,Salvinorin B
59330-1,Norsibutramine
59331-9,Dinorsibutramine
59332-7,Sibutramine
59333-5,Norsibutramine
59334-3,Dinorsibutramine
59335-0,Sibutramine
59336-8,Norsibutramine
Jul-33,Lead
59337-6,Dinorsibutramine
59338-4,Sibutramine
59339-2,Stiripentol
593-4,Legionella sp identified
59340-0,Stiripentol
59341-8,Stiripentol
59342-6,Tadalafil
59343-4,Tadalafil
59344-2,Tadalafil
May-34,Blood group antigens absent
59345-9,Endoxifen
59346-7,4-Hydroxy-Tamoxifen
59347-5,Tamoxifen
59348-3,Nortamoxifen
59349-1,Endoxifen
59350-9,4-Hydroxy-Tamoxifen
59351-7,Nortamoxifen
Feb-35,Benzoylecgonine
59352-5,Tapentadol
59353-3,Tapentadol
59354-1,Tapentadol
59355-8,Tapentadol
59356-6,Desethylvardenafil
59357-4,Vardenafil
59358-2,Desethylvardenafil
59359-0,Vardenafil
5936-0,Benzoylecgonine
59360-8,Desethylvardenafil
59361-6,Vardenafil
59362-4,Race or ethnicity
59363-2,Leptospira interrogans serovar Manhao Ab
59364-0,Leptospira interrogans serovar Pyrogenes Ab
59365-7,Leptospira interrogans serovar Mini Ab
59366-5,Leptospira interrogans serovar Sejroe Ab
59367-3,Leptospira interrogans serovar Tarassovi Ab
59368-1,Leptospira interrogans serovar Bataviae Ab
59369-9,Leptospira interrogans serovar Hebdomadis Ab
59370-7,Leptospira interrogans serovar Australis Ab
59371-5,Leptospira interrogans serovar Autumnalis Ab
59372-3,Leptospira interrogans serovar Ballum Ab
59373-1,Special treatments &or programs - none of above - while a resident
59374-9,Special treatments &or programs - none of above - while NOT a resident
59375-6,Medicare non-therapy Part A billing
59376-4,"3-Keto, 2-Methylvalerate/Creatinine"
59377-2,2-Methylacetoacetate/Creatinine
Aug-37,Cocaine
59378-0,Amikacin^post dialysis
59379-8,Gentamicin^post dialysis
59380-6,Tobramycin^post dialysis
59381-4,Vancomycin^post dialysis
59382-2,Aspergillus versicolor Ab.IgG
59383-0,Hydroxyproline/Creatinine
59384-8,Acetaminophen
59385-5,Nitrogen
Jun-38,Benzoylecgonine
59386-3,Starch
59387-1,Trypanosoma cruzi Ab.IgG
59388-9,Taenia solium larva DNA
59389-7,Androstanolone^1.5H post XXX challenge
59390-5,Neuronal nuclear Ab
59391-3,Prunus persica recombinant (rPru p) 3 Ab.IgE
59392-1,Hydroxyproline
59393-9,Trypanosoma cruzi Ab.IgG
Apr-39,Benzoylecgonine
59394-7,Glomerular basement membrane Ab
59395-4,Latex recombinant (rHev b) 9 Ab.IgE
59396-2,Echovirus Ab.IgM
59397-0,Echovirus Ab.IgG
59398-8,Ascorbate
59399-6,PM-1 Ab
59400-2,RNA Ab
59401-0,Echovirus Ab.IgG
Feb-40,Cocaine
59402-8,Mi-1+Mi-2 Ab
59403-6,Ku Ab
59404-4,Oxygen capacity
59405-1,Oxygen saturation
59406-9,Oxygen saturation
59407-7,Oxygen saturation
59408-5,Oxygen saturation
59409-3,Oxygen saturation^during treatment
5941-0,Cocaine
59410-1,Oxygen saturation^on room air
59411-9,Oxygen saturation^post bronchodilation
59412-7,Oxygen saturation^post exercise
59413-5,Oxygen saturation^post treatment
59414-3,Oxygen saturation^pre bronchodilation
59415-0,Oxygen saturation^pre physiotherapy
59416-8,Oxygen saturation^pre treatment
59417-6,Oxygen saturation^resting
59418-4,Oxygen saturation
59419-2,HIV 1 RNA
594-2,Leptospira sp identified
59420-0,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA
59421-8,Neisseria meningitidis serogroups A+B+C+w135+Y Ag
59422-6,Leptospira interrogans serovar Javanica Ab
59423-4,Influenza virus A hemagglutinin type RNA
59424-2,Influenza virus A hemagglutinin type RNA
Aug-42,Coagulation reptilase induced
Jun-43,Coagulation reptilase induced
Apr-44,Coagulation Russell viper venom induced
Jan-45,Coagulation Russell viper venom induced
59453-1,Morse Fall Scale panel
59454-9,History of falling; immediate or within 3Mo
59455-6,Secondary diagnosis is present
59456-4,Ambulatory aid
59457-2,Intravenous apparatus
59458-0,Gait
59459-8,Mental status
59460-6,Fall risk total
59461-4,Fall risk level
59462-2,Clinical biochemist review
59463-0,Lymphocytes/100 leukocytes
59464-8,Microbiologist review
59465-5,Pathologist review
59466-3,Hematologist review
59467-1,Erythrocyte mean corpuscular hemoglobin concentration
59468-9,Erythrocyte mean corpuscular hemoglobin
Sep-46,Coagulation surface induced.factor substitution^immediately after addition of normal plasma
59470-5,Calcium.ionized
59471-3,Calcium.ionized
59472-1,Calcium.ionized^^adjusted to pH 7.4
59473-9,Calcium.ionized^^adjusted to pH 7.4
59474-7,Microscopic observation
59475-4,Collaborative staging metastasis at diagnosis - bone involvement
59476-2,Collaborative staging metastasis at diagnosis - brain involvement
Jul-47,Coagulation surface induced.factor substitution^20M post incubation after addition of normal plasma
59477-0,Collaborative staging metastasis at diagnosis - liver involvement
59478-8,Collaborative staging metastasis at diagnosis - lung involvement
59479-6,Collaborative staging post treatment extension
59480-4,Collaborative staging post treatment lymph nodes
59481-2,Collaborative staging post treatment metastasis at diagnosis
59482-0,Collaborative staging post treatment tumor size
59483-8,Collaborative staging pre treatment lymph nodes
59484-6,Collaborative staging pre treatment metastasis at diagnosis
May-48,Coagulation surface induced.factor substitution^immediately after addition of normal plasma
59485-3,Collaborative staging pre treatment metastasis evaluation
59486-1,Collaborative staging pre treatment regional nodes evaluation
59487-9,Collaborative staging pre treatment tumor size and extension evaluation
59488-7,Collaborative staging pre treatment tumor size
59489-5,Collaborative staging site-specific factor 7
59490-3,Collaborative staging site-specific factor 8
59491-1,Collaborative staging site-specific factor 9
59492-9,Collaborative staging site-specific factor 10
Mar-49,Coagulation surface induced.factor substitution^immediately after addition of normal plasma
59493-7,Collaborative staging site-specific factor 11
59494-5,Collaborative staging site-specific factor 12
59495-2,Collaborative staging site-specific factor 13
59496-0,Collaborative staging site-specific factor 14
59497-8,Collaborative staging site-specific factor 15
59498-6,Collaborative staging site-specific factor 16
59499-4,Collaborative staging site-specific factor 17
59500-9,Collaborative staging site-specific factor 18
Jan-50,Coagulation surface induced.factor substitution^20M post incubation after addition of normal plasma
59501-7,Collaborative staging site-specific factor 19
59502-5,Collaborative staging site-specific factor 20
59503-3,Collaborative staging site-specific factor 21
59504-1,Collaborative staging site-specific factor 22
59505-8,Collaborative staging site-specific factor 23
59506-6,Collaborative staging site-specific factor 24
59507-4,Collaborative staging site-specific factor 25
59508-2,Collaborative staging version.current
59509-0,Date case completed.COC
59510-8,Date case initiated
59511-6,Flag for Date of conclusive diagnosis not populated
59512-4,Flag for Hospital admission.first contact not populated
59513-2,Flag for Date 1st cancer Rx (any).COC not populated
59514-0,Flag for Date of birth not populated
59515-7,Flag for Date of death - Canada not populated
59516-5,Flag for Date first Dx not populated
59517-3,Flag for Date 1st cancer Rx (any).SEERS not populated
59518-1,Flag for Date of inpatient admission not populated
Sep-51,Coagulation surface induced.factor substitution^immediately after addition of normal plasma
59519-9,Flag for Date of inpatient discharge not populated
59520-7,Flag for Date last contact not populated
59521-5,Flag for Date of diagnosis of multiple tumors not populated
59522-3,Derived American Joint Committee on Cancer-7 M
59523-1,Derived American Joint Committee on Cancer-7 M descriptor
59524-9,Derived American Joint Committee on Cancer-7 N
59525-6,Derived American Joint Committee on Cancer-7 N descriptor
59526-4,Derived American Joint Committee on Cancer-7 stage group
Jul-52,Coagulation surface induced.factor substitution^20M post incubation.37 deg c after addition of normal plasma
59527-2,Derived American Joint Committee on Cancer-7 T
59528-0,Derived American Joint Committee on Cancer-7 T descriptor
59529-8,Flag for Derived neoadjuvant therapy not populated
59530-6,Derived post treatment-7 M
59531-4,Derived post treatment-7 N
59532-2,Derived post treatment-7 stage group
59533-0,Derived post treatment-7 T
59534-8,Derived pre treatment-7 M
May-53,Coagulation surface induced.factor substitution^20M post incubation.37 deg c after addition of normal plasma
59535-5,Derived pre treatment-7 M descriptor
59536-3,Derived pre treatment-7 N
59537-1,Derived pre treatment-7 N descriptor
59538-9,Derived pre treatment-7 stage group
59539-7,Derived pre treatment-7 T
59540-5,Derived pre treatment-7 T descriptor
59541-3,Grade pathology system
59542-1,Grade pathology value
Mar-54,Coagulation thrombin induced
59543-9,Inpatient status
59544-7,Lymph-vascular invasion
59545-4,Flag for Recurrence date not populated
59546-2,Flag for Date 1st most definitive surgery Rx for not populated
59547-0,Flag for Date radiation ended not populated
59548-8,Flag for Date of surgical discharge not populated
59549-6,Flag for Date 1st systemic treatment not populated
5955-0,Coagulation thrombin induced
59550-4,Flag for Date 1st immunotherapy treatment not populated
59551-2,Flag for Date 1st chemotherapy treatment not populated
59552-0,Flag for Date non cancer directed surgery Rx as part of 1st cancer not populated
59553-8,Flag for Date 1st hormone treatment not populated
59554-6,Flag for Date 1st other treatment not populated
59555-3,Flag for Date 1st radiation treatment not populated
59556-1,Flag for Date 1st surgery treatment not populated
59557-9,Treatment status
59558-7,Flag for 2nd course treatment start date not populated
59559-5,Collaborative staging pre treatment extension
59560-3,Surgical approach at facility.YYY 2010
59561-1,Propofol glucuronide
59562-9,DNA index
59563-7,Protein.monoclonal band 4
59564-5,Alpha-1-Fetoprotein
59565-2,Netilmicin^trough
59566-0,Netilmicin
59567-8,Netilmicin^peak
Aug-56,Coagulation tissue factor induced.factor substitution^immediately after addition of normal plasma
59568-6,Orotate
59569-4,Calcitonin^post XXX challenge
59570-2,Urea nitrogen
59571-0,Triglyceride
59572-8,Triglyceride
59573-6,Cannabinoids
59574-4,Body mass index
59575-1,Body mass index
Jun-57,Coagulation tissue factor induced.factor substitution^20M post incubation after addition of normal plasma
59576-9,Body mass index
59577-7,Glucagon^7th specimen post CFst
59578-5,Glucagon^6th specimen post CFst
59579-3,Coxsackievirus A24 Ab.IgM
59580-1,Coxsackievirus A16 Ab.IgM
59581-9,Coxsackievirus A7 Ab.IgM
59582-7,Coxsackievirus A24 Ab.IgG
59583-5,Coxsackievirus A16 Ab.IgG
Apr-58,Coagulation tissue factor induced.factor substitution^20M post incubation after addition of normal plasma
59584-3,Coxsackievirus A7 Ab.IgG
59585-0,GSTP1 gene+APC gene methylation
59586-8,HLA Ab.IgG
59587-6,Homovanillate
59588-4,1-Hydroxymidazolam
59589-2,1-Hydroxymidazolam
595-9,Bacteria identified
59590-0,1-Hydroxymidazolam
59591-8,7-Aminoclonazepam
Feb-59,Coagulation tissue factor induced.factor substitution^immediately after addition of normal plasma
59592-6,7-Aminoclonazepam
59593-4,7-Aminoclonazepam
59594-2,7-Aminoclonazepam
59595-9,7-Aminoclonazepam
59596-7,7-Aminoclonazepam
59597-5,7-Aminoclonazepam
59598-3,acetaZOLAMIDE
59599-1,Alpha hydroxyalprazolam
Jun-59,Carbenicillin
5960-0,Coagulation tissue factor induced.factor substitution^20M post incubation.37 deg c after addition of normal plasma
59600-7,Alpha hydroxyalprazolam
59601-5,Alpha hydroxyalprazolam
59602-3,Alpha hydroxyalprazolam
59603-1,Alpha hydroxyalprazolam
59604-9,Alpha hydroxyalprazolam
59605-6,Alpha hydroxyalprazolam
59606-4,Alpha hydroxyalprazolam
59607-2,ALPRAZolam
59608-0,ALPRAZolam
59609-8,ALPRAZolam
59610-6,ALPRAZolam
59611-4,ALPRAZolam
59612-2,ALPRAZolam
59613-0,ALPRAZolam
59614-8,ALPRAZolam
59615-5,ALPRAZolam
59616-3,Benzoylecgonine
59617-1,chlordiazePOXIDE
Aug-61,Coagulation tissue factor induced.factor substitution^20M post incubation.37 deg c after addition of normal plasma
59618-9,chlordiazePOXIDE
59619-7,chlordiazePOXIDE
59620-5,chlordiazePOXIDE
59621-3,chlordiazePOXIDE
59622-1,chlordiazePOXIDE
59623-9,chlordiazePOXIDE
59624-7,chlordiazePOXIDE
59625-4,chlordiazePOXIDE
Jun-62,Coagulation tissue factor induced.factor substitution^immediately after addition of normal plasma
59626-2,cloBAZam
59627-0,cloBAZam
59628-8,cloBAZam
59629-6,cloBAZam
59630-4,cloBAZam
59631-2,cloBAZam
59632-0,cloBAZam
59633-8,cloBAZam
Apr-63,Coagulation tissue factor induced.factor substitution^immediately after addition of normal plasma
59634-6,cloBAZam
59635-3,cloBAZam
59636-1,clonazePAM
59637-9,clonazePAM
59638-7,clonazePAM
59639-5,clonazePAM
59640-3,clonazePAM
59641-1,clonazePAM
Feb-64,Coagulation tissue factor induced
59642-9,clonazePAM
59643-7,Cocaethylene
59644-5,Cocaine
59645-2,Cotinine
59646-0,Cotinine
59647-8,N-desalkylflurazepam
59648-6,N-desalkylflurazepam
59649-4,N-desalkylflurazepam
59650-2,N-desalkylflurazepam
59651-0,N-desalkylflurazepam
59652-8,N-desalkylflurazepam
59653-6,N-desalkylflurazepam
59654-4,diazePAM
59655-1,diazePAM
59656-9,diazePAM
59657-7,diazePAM
59658-5,diazePAM
Sep-65,Plasmin inhibitor
59659-3,diazePAM
59660-1,diazePAM
59661-9,diazePAM
59662-7,Diclofenac
59663-5,Diclofenac
59664-3,Estazolam
59665-0,Estazolam
59666-8,Estazolam
Jul-66,Plasmin inhibitor Ag
59667-6,Estazolam
59668-4,Estazolam
59669-2,Estazolam
596-7,Bacteria identified
59670-0,Estazolam
59671-8,Estazolam
59672-6,Estazolam
59673-4,fentaNYL
59674-2,Flurazepam
May-67,Plasmin inhibitor Ag
59675-9,Flurazepam
59676-7,Flurazepam
59677-5,Flurazepam
59678-3,Flurazepam
59679-1,Flurazepam
59680-9,Gabapentin
59681-7,Gamma hydroxybutyrate
59682-5,Hydroxyethylflurazepam
Mar-68,Plasminogen activator tissue type^20M post venistasis
59683-3,Hydroxyethylflurazepam
59684-1,Hydroxyethylflurazepam
59685-8,Hydroxyethylflurazepam
59686-6,Hydroxyethylflurazepam
59687-4,Hydroxyethylflurazepam
59688-2,Hydroxyethylflurazepam
59689-0,Hydroxyethylflurazepam
59690-8,Hydroxytriazolam
Jan-69,Plasmin-plasmin inhibitor complex
59691-6,Hydroxytriazolam
59692-4,Hydroxytriazolam
59693-2,Hydroxytriazolam
59694-0,Hydroxytriazolam
59695-7,Hydroxytriazolam
59696-5,Hydroxytriazolam
59697-3,Iodide
59699-9,LORazepam
59700-5,LORazepam
59701-3,LORazepam
59702-1,LORazepam
59703-9,LORazepam
59704-7,LORazepam
59705-4,Methadone
59706-2,MethylePHEDrine
59707-0,Midazolam
59708-8,Midazolam
Sep-70,Plasminogen
59709-6,Midazolam
59710-4,Midazolam
59711-2,Midazolam
59712-0,Midazolam
59713-8,Midazolam
59714-6,Nitrous oxide
59715-3,Nitrous oxide
59716-1,Nordiazepam
Jul-71,Plasminogen activator tissue type Ag
59717-9,Nordiazepam
59718-7,Nordiazepam
59719-5,Nordiazepam
59720-3,Nordiazepam
59721-1,Nordiazepam
59722-9,Nordiazepam
59723-7,Nordiazepam
59724-5,Cathine
May-72,Plasminogen activator tissue type Ag^20M post venistasis
59725-2,Oxazepam
59726-0,Oxazepam
59727-8,Oxazepam
59728-6,Oxazepam
59729-4,Oxazepam
59730-2,Oxazepam
59731-0,Oxazepam
59732-8,Oxazepam
Mar-73,Plasminogen activator tissue type Ag^10M post venistasis
59733-6,Potassium
59734-4,Propoxyphene
59735-1,Salicylamide
59736-9,Salicylamide
59737-7,Selenium
59738-5,Silver
59739-3,Silver
59740-1,Silver
Jan-74,Plasminogen activator inhibitor 1
59741-9,Silver
59742-7,sulfADIAZINE
59743-5,SUMAtriptan
59744-3,SUMAtriptan
59745-0,Temazepam
59746-8,Temazepam
59747-6,Temazepam
59748-4,Temazepam
59749-2,Temazepam
597-5,Bacteria identified
59750-0,Temazepam
59751-8,Temazepam
59752-6,Temazepam
59753-4,Titanium
59754-2,Titanium
59755-9,Titanium
59756-7,Titanium
59757-5,tiZANidine
Aug-75,Plasminogen activator inhibitor 1 Ag
59758-3,Triazolam
59759-1,Triazolam
59760-9,Triazolam
59761-7,Triazolam
59762-5,Triazolam
59763-3,Triazolam
59764-1,Triazolam
59765-8,Tungsten
Jun-76,Plasminogen activator inhibitor 1
59766-6,Tungsten
59767-4,Ziprasidone
59768-2,Procedure indications
59769-0,Postprocedure diagnosis
59770-8,Procedure estimated blood loss
59771-6,Procedure implants
59772-4,Planned procedure
59773-2,Procedure specimens taken
Apr-77,Plasminogen activator inhibitor 2 Ag
59774-0,Procedure anesthesia
59775-7,Procedure disposition
59776-5,Procedure findings
59777-3,Latest date to give immunization
59778-1,Date when overdue for immunization
59779-9,Immunization schedule used
59780-7,Immunization series
59781-5,Dose validity
Feb-78,Plasminogen activator inhibitor 2
59782-3,Number of doses in primary immunization series
59783-1,Status in immunization series
59784-9,Disease with presumed immunity
59785-6,Indication for Immunization
59786-4,Urea/Creatinine
59787-2,Catecholamines
59788-0,Coagulation dilute Russell viper venom induced.factor substitution^1H post incubation after addition of normal plasma
59789-8,Coagulation dilute Russell viper venom induced.factor substitution^2H post incubation after addition of normal plasma
5979-0,Plasminogen activator inhibitor 2 Ag
59790-6,Hexacarboxylporphyrin
59791-4,Glucose^30M post XXX challenge
59792-2,Glucose^1H post XXX challenge
59793-0,Glucose^1.5H post XXX challenge
59794-8,Glucose^2H post XXX challenge
59795-5,Glucose^3H post XXX challenge
59796-3,Glucose^4H post XXX challenge
59797-1,Glucose^5H post XXX challenge
59798-9,Ganciclovir^peak
59799-7,Ganciclovir^trough
59800-3,Protein.monoclonal band 2/Protein.total
59801-1,Protein.monoclonal band 3/Protein.total
59802-9,Protein.monoclonal band 4/Protein.total
59803-7,Cortisol^30M post XXX challenge
59804-5,Cortisol^1H post XXX challenge
59805-2,Epstein Barr virus DNA
59806-0,Coagulation surface induced.lupus sensitive.factor substitution^2H post incubation after addition of normal plasma
59807-8,Phosphatidylglycerol
Aug-80,Plasminogen activator inhibitor Ag
59808-6,Lymphocytes.large granular
59809-4,Lymphoma cells
59810-2,Caffeine^trough
59811-0,Caffeine^peak
59812-8,Glucose^11 AM specimen
59813-6,Glucose^7 AM specimen
59814-4,Glucose^7 AM specimen
59815-1,Glucose^3 PM specimen
Jun-81,Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex
59816-9,Neutrophils.immature/100 leukocytes
59817-7,Uroporphyrin 1 isomer/Creatinine
59818-5,Uroporphyrin 3 isomer/Creatinine
59819-3,Pentacarboxylporphyrins/Creatinine
59820-1,Coproporphyrin 1/Creatinine
59821-9,Coproporphyrin 3/Creatinine
59822-7,Tacrolimus^4H post dose
59823-5,Tacrolimus^2H post dose
Apr-82,Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex^20M post venistasis
59824-3,Cyanide
59825-0,Phenols
59826-8,Creatinine
59827-6,Bilirubin
59828-4,Bilirubin
59829-2,Leukocytes
598-3,Bacteria identified
59830-0,Erythrocytes
59831-8,Gastrin^baseline
Feb-83,Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex^10M post venistasis
59832-6,Gastrin^1st specimen post XXX challenge
59833-4,Antibiotic XXX
59834-2,Creatinine reduction ratio
59835-9,Parathyrin.intact
59836-7,Mycoplasma sp+Ureaplasma urealyticum DNA
59837-5,Methylenedioxyamphetamine
59838-3,Cytomegalovirus Ab
59839-1,Urate crystals
5984-0,Plasminogen activator urokinase type
59840-9,Dehydroepiandrosterone^8th specimen post XXX challenge
59841-7,Vendor name
59842-5,Apnea interval
59843-3,Procedure note - recommended C-CDA R1.1 sections
59844-1,Methylenedioxyethylamphetamine
59845-8,Instructions for use section
59846-6,Salmonella sp identified
59847-4,Histology and Behavior ICD-O-3
59848-2,Morphology.ICD-O-3
59849-0,Lactate^post exercise
59850-8,Wuchereria bancrofti Ag
59852-4,"North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel"
59853-2,Pathology specimen collection date 1
59854-0,Pathology specimen collection date 2
59855-7,Pathology specimen collection date 3
59856-5,Pathology specimen collection date 4
Jul-85,Plasminogen activator urokinase type
59857-3,Pathology specimen collection date 5
59858-1,SEER site-specific fact 1
59859-9,SEER site-specific fact 2
59860-7,SEER site-specific fact 3
59861-5,SEER site-specific fact 4
59862-3,SEER site-specific fact 5
59863-1,SEER site-specific fact 6
59864-9,Acetone
May-86,Plasminogen activator tissue type
59865-6,Amobarbital
59866-4,Amobarbital
59867-2,Amoxapine
59868-0,Amoxapine
59869-8,Benztropine
59870-6,Benztropine
59871-4,Benztropine
59872-2,Bromazepam
Mar-87,Plasminogen activator tissue type
59873-0,Bromazepam
59874-8,Brompheniramine
59875-5,Brompheniramine
59876-3,carBAMazepine
59877-1,Chloral hydrate
59878-9,Chloral hydrate
59879-7,chlordiazePOXIDE
59880-5,chlordiazePOXIDE
Jan-88,Plasminogen activator tissue type^10M post venistasis
59881-3,Chlorpheniramine
59882-1,Chlorpheniramine
59883-9,Chlorpheniramine
59884-7,chlorproMAZINE
59885-4,chlorproMAZINE
59886-2,Citalopram
59887-0,Citalopram
59888-8,cloBAZam
59889-6,clomiPRAMINE
59890-4,cloZAPine
59891-2,Cotinine
59892-0,Cotinine
59893-8,Desipramine
59894-6,Dextromethorphan
59895-3,Dextromethorphan
59896-1,Dextromethorphan
59897-9,Disopyramide
59898-7,Disopyramide
Sep-89,Plasminogen activator tissue type^10M post venistasis
59899-5,Ethylene glycol
59900-1,Fenoprofen
59901-9,Fenoprofen
59902-7,FLUoxetine
59903-5,FLUoxetine
59904-3,fluPHENAZine
59905-0,fluPHENAZine
59906-8,fluvoxaMINE
Jul-90,Plasminogen activator tissue type^20M post venistasis
59907-6,fluvoxaMINE
59908-4,hydrOXYzine
59909-2,hydrOXYzine
599-1,Bacteria identified
59910-0,Ibuprofen
59911-8,Ibuprofen
59912-6,Imipramine
59913-4,Imipramine
59914-2,Indomethacin
May-91,Plasminogen Ag
59915-9,Indomethacin
59916-7,Isopropanol
59917-5,Ketoprofen
59918-3,Ketoprofen
59919-1,lamoTRIgine
59920-9,lamoTRIgine
59921-7,Mefenamate
59922-5,Mefenamate
Mar-92,Platelet aggregation.adenosine diphosphate induced
59923-3,Mefenamate
59924-1,Meperidine
59925-8,Mesoridazine
59926-6,Mesoridazine
59927-4,Methanol
59928-2,Methaqualone
59929-0,Methaqualone
59930-8,Methotrimeprazine
Jan-93,Platelet aggregation.arachidonate induced
59931-6,Methotrimeprazine
59932-4,Mexiletine
59933-2,Mexiletine
59934-0,Naproxen
59935-7,Naproxen
59936-5,Nicotine
59937-3,Nicotine
59938-1,Norclobazam
59939-9,Norclobazam
59940-7,Norclomipramine
59941-5,Norclomipramine
59942-3,Nordoxepin
59943-1,Nordoxepin
59944-9,Normeperidine
59945-6,Nortriptyline
59946-4,OLANZapine
59947-2,OXcarbazepine
59948-0,OXcarbazepine
Sep-94,Platelet aggregation.calcium ionophore induced
59949-8,PARoxetine
59950-6,PARoxetine
59951-4,Pentazocine
59952-2,Pentazocine
59953-0,Perphenazine
59954-8,Perphenazine
59955-5,Perphenazine
Jun-95,Platelet aggregation.collagen induced
59956-3,Phencyclidine
59957-1,Promazine
59958-9,Promazine
59959-7,Promazine
59960-5,Propoxyphene
59961-3,Propoxyphene
59962-1,Propranolol
59963-9,QUEtiapine
Apr-96,Platelet aggregation.EPINEPHrine induced
59964-7,QUEtiapine
59965-4,quiNINE
59966-2,quiNINE
59967-0,quiNINE
59968-8,Strychnine
59969-6,Strychnine
59970-4,Strychnine
59971-2,Sulfamethoxazole
Feb-97,Platelet aggregation.norepinephrine induced
59972-0,Sulfamethoxazole
59973-8,Thiocyanate
59974-6,Thiocyanate
59975-3,traZODone
59976-1,traZODone
59977-9,Venlafaxine
59978-7,Venlafaxine
59979-5,Warfarin
5998-0,Platelet aggregation.ristocetin induced
59980-3,Warfarin
59981-1,Zopiclone
59982-9,Zopiclone
59983-7,Dehydroepiandrosterone sulfate^1st specimen post XXX challenge
59984-5,11-Deoxycorticosterone^8th specimen post XXX challenge
59985-2,11-Deoxycorticosterone^7th specimen post XXX challenge
59986-0,11-Deoxycorticosterone^6th specimen post XXX challenge
59987-8,11-Deoxycorticosterone^5th specimen post XXX challenge
59988-6,Testosterone^8th specimen post XXX challenge
59989-4,Testosterone^7th specimen post XXX challenge
59990-2,Testosterone^6th specimen post XXX challenge
59991-0,Testosterone^5th specimen post XXX challenge
59992-8,Testosterone^4th specimen post XXX challenge
59993-6,Testosterone^3rd specimen post XXX challenge
59994-4,Testosterone^2nd specimen post XXX challenge
59995-1,Testosterone^1st specimen post XXX challenge
59996-9,Insulin-like growth factor binding protein 3^8th specimen post XXX challenge
59997-7,Insulin-like growth factor binding protein 3^7th specimen post XXX challenge
Aug-99,Platelet aggregation.serotonin induced
59998-5,Insulin-like growth factor binding protein 3^6th specimen post XXX challenge
59999-3,Insulin-like growth factor binding protein 3^5th specimen post XXX challenge
60000-7,Insulin-like growth factor binding protein 3^4th specimen post XXX challenge
60001-5,Insulin-like growth factor binding protein 3^3rd specimen post XXX challenge
60002-3,Insulin-like growth factor binding protein 3^2nd specimen post XXX challenge
60003-1,Insulin-like growth factor binding protein 3^baseline
Apr-00,Platelet aggregation.thrombin induced
60004-9,Insulin-like growth factor binding protein 3^1st specimen post XXX challenge
60005-6,Insulin-like growth factor-I^8th specimen post XXX challenge
60006-4,Insulin-like growth factor-I^7th specimen post XXX challenge
60007-2,Insulin-like growth factor-I^6th specimen post XXX challenge
60008-0,Insulin-like growth factor-I^5th specimen post XXX challenge
60009-8,Insulin-like growth factor-I^4th specimen post XXX challenge
60010-6,Insulin-like growth factor-I^3rd specimen post XXX challenge
60011-4,Insulin-like growth factor-I^2nd specimen post XXX challenge
Feb-01,Platelet factor 3
60012-2,Insulin-like growth factor-I^1st specimen post XXX challenge
60013-0,Cortisol^40M post XXX challenge
60014-8,Corticotropin^baseline
60015-5,Corticotropin^5M post XXX challenge
60016-3,Corticotropin^1.5H post XXX challenge
60017-1,Lactate dehydrogenase
60018-9,Lactate dehydrogenase
60019-7,Lactate dehydrogenase
6002-0,Platelet factor 4
60020-5,Lactate dehydrogenase
60021-3,Lactate dehydrogenase
60022-1,Lactate dehydrogenase
60023-9,Lactate dehydrogenase
60024-7,Lactate dehydrogenase
60025-4,Urobilinogen
60026-2,Leukocyte esterase
60027-0,Specific gravity
60028-8,West Nile Virus Ab.IgG avidity
60029-6,West Nile Virus Ab.IgG avidity
60030-4,West Nile virus Ab.IgG
60032-0,Bacteria identified
60033-8,PIK3CA gene targeted mutation analysis
60034-6,PIK3CA gene targeted mutation analysis
60035-3,10-Hydroxycarbazepine
60036-1,1-Naphthol
60037-9,1-Naphthol
Aug-03,Platelet factor 4 Ag
60038-7,1-Naphthol
60039-5,Acebutolol
60040-3,Acebutolol
60041-1,Acebutolol
60042-9,N-acetylprocainamide
60043-7,Acepromazine
60044-5,Acepromazine
60045-2,Acetaldehyde
Jun-04,Prekallikrein
60046-0,Acetaldehyde
60047-8,Acetaldehyde
60048-6,Acetaminophen
60049-4,Acetaminophen
60050-2,Acetaminophen
60051-0,Acetophenazine
60052-8,Alphapinene
Mar-05,Prekallikrein
60053-6,aMILoride
60054-4,Amiodarone
60055-1,Astemizole
60056-9,Astemizole
60057-7,Bismuth
60058-5,Bismuth
60059-3,Bismuth
60060-1,Boron
Jan-06,Protein C
60061-9,buPROPion
60062-7,buPROPion
60063-5,buPROPion
60064-3,buPROPion
60065-0,Cobalt
60066-8,Cobalt
60067-6,Cobalt
60068-4,Colchicine
60069-2,Dantrolene
600-7,Bacteria identified
60070-0,Dichlorvos
60071-8,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine"
60072-6,Fexofenadine
60073-4,Fexofenadine
60074-2,Fexofenadine
60075-9,Finasteride
60076-7,Gallium
60077-5,Ganciclovir
60078-3,Ganciclovir
Sep-07,Protein C
60079-1,Germanium
60080-9,Germanium
60081-7,Germanium
60082-5,Gold
60083-3,Hydroxybupropion
60084-1,Hydroxybupropion
60085-8,Hydroxybupropion
60086-6,Hydroxybupropion
Jul-08,Protein C+Acarboxy Ag
60087-4,Hyoscyamine
60088-2,Hyoscyamine
60089-0,Indium
60090-8,Indium
60091-6,Ketoconazole
60092-4,Ketoconazole
60093-2,Ketoprofen
60094-0,Ketoprofen
May-09,Protein C Ag
60095-7,Loperamide
60096-5,Loperamide
60097-3,Loratadine
60098-1,Loratadine
60099-9,Loxapine
60100-5,Loxapine
60101-3,Molybdenum
60102-1,O-desmethylvenlafaxine
Mar-10,Protein C inhibitor
60103-9,O-desmethylvenlafaxine
60104-7,O-desmethylvenlafaxine
60105-4,OLANZapine
60106-2,OLANZapine
60107-0,OLANZapine
60108-8,Oxychlordane
60109-6,Oxychlordane
60110-4,Oxyphenbutazone
Jan-11,Protein C cofactor
60111-2,Oxyphenbutazone
60112-0,Oxipurinol
60113-8,Oxypurinol
60114-6,PACLitaxel
60115-3,9-Hydroxyrisperidone
60116-1,9-Hydroxyrisperidone
60117-9,Palladium
60118-7,Palladium
60119-5,Palladium
60120-3,Palladium
60121-1,Pancuronium
60122-9,Pancuronium
60123-7,Pancuronium
60124-5,Pancuronium
60125-2,Papaverine
60126-0,Papaverine
60127-8,Paramethadione
60128-6,Paramethadione
Sep-12,von Willebrand factor Ag
60129-4,Paraoxon
60130-2,Paraoxon
60131-0,Paraoxon
60132-8,Parathion
60133-6,Parathion
60134-4,Parathion
60135-1,Pargyline
60136-9,PARoxetine
Jul-13,von Willebrand factor multimers
60137-7,PARoxetine
60138-5,PARoxetine
60139-3,Pemoline
60140-1,Penciclovir
60141-9,Penciclovir
60142-7,Pendimethalin
60143-5,Pendimethalin
60144-3,Pendimethalin
May-14,von Willebrand factor.ristocetin cofactor activity actual/Normal
60145-0,Pentane
60146-8,Pentane
60147-6,Pentane
60148-4,Pentane
60149-2,Pentazocine
601-5,Fungus identified
60150-0,Pentazocine
60151-8,PENTobarbital
Feb-15,Acacia longifolia Ab.IgE
60152-6,PENTobarbital
60153-4,PENTobarbital
60154-2,Pentoxifylline
60155-9,Pentoxifylline
60156-7,Perfluorooctanoate
60157-5,Perfluorooctanoate
60158-3,Pergolide
60159-1,Pergolide
6016-0,Corticotropin Ab.IgE
60160-9,Perphenazine
60161-7,Phenacemide
60162-5,Phenacemide
60163-3,Phenolphthalein
60164-1,Phensuximide
60165-8,Phensuximide
60166-6,Platinum
60167-4,Platinum
60168-2,Platinum
60169-0,Rubidium
60170-8,Silicon
60171-6,Silicon
60172-4,Strontium
60173-2,Strontium
60174-0,Strontium
60175-7,Sulfamethizole
60176-5,Sulfamethizole
60177-3,Sulfamethizole
Aug-17,Alder Ab.IgE
60178-1,Tellurium
60179-9,Tellurium
60180-7,Tellurium
60181-5,Tellurium
60182-3,Temephos
60183-1,Terazosin
60184-9,Terazosin
60185-6,Thallium
Jun-18,House dust Allergopharma Ab.IgE
60186-4,Thiethylperazine
60187-2,Thiethylperazine
60188-0,Thiethylperazine
60189-8,Tin
60190-6,Tin
60191-4,Tin
60192-2,Topiramate
60193-0,Topiramate
Apr-19,Prunus dulcis Ab.IgE
60194-8,Triamterene
60195-5,Trichlormethiazide
60196-3,Trichlormethiazide
60197-1,Triclopyr
60198-9,Trifluralin
60199-7,Trifluralin
60200-3,Trifluralin
60201-1,Salicylates
Feb-20,Alternaria alternata Ab.IgE
60204-5,Trimethadione
60205-2,Trimethadione
60206-0,Tripelennamine
60207-8,Vanadium
60208-6,Venlafaxine
60209-4,Venlafaxine
6021-0,Malus sylvestris Ab.IgE
60210-2,Venlafaxine
60211-0,Zolazepam
60212-8,Zolazepam
60213-6,Zolazepam
60214-4,ZOLMitriptan
60215-1,ZOLMitriptan
60216-9,Zomepirac
60217-7,Chloride
60218-5,Potassium
60219-3,Ubiquinone 10/Protein
60220-1,Sodium
60221-9,Intrinsic factor Ab.IgG
60224-3,Beta-trace protein
60225-0,Hydrogen/Expired gas^3H post dose fructose PO
60226-8,Hydrogen/Expired gas^2.5H post dose fructose PO
60227-6,Hydrogen/Expired gas^2H post dose fructose PO
Aug-22,Ascaris sp Ab.IgE
60228-4,Hydrogen/Expired gas^1.5H post dose fructose PO
60229-2,Hydrogen/Expired gas^1H post dose fructose PO
602-3,Bacteria identified
60230-0,Hydrogen/Expired gas^30M post dose fructose PO
60231-8,Hydrogen/Expired gas^pre dose fructose PO
60232-6,Hydrogen/Expired gas^2.75H post dose lactose PO
60233-4,Hydrogen/Expired gas^2.25H post dose lactose PO
60234-2,Hydrogen/Expired gas^1.75H post dose lactose PO
60235-9,Hydrogen/Expired gas^1.25H post dose lactose PO
Jun-23,Aspergillus amstelodami Ab.IgE
60236-7,Penaeus aztecus tropomyosin recombinant (rPen a) 1 Ab.IgE.RAST class
60237-5,Fraxinus excelsior Ab.IgE.RAST class
60238-3,Fraxinus excelsior Ab.IgE
60239-1,Vespula vulgaris recombinant (rVes v) 5 Ab.IgE.RAST class
60240-9,Vespula vulgaris recombinant (rVes v) 5 Ab.IgE
60241-7,Apis mellifera phospholipase A2 recombinant (rApi m) 1 Ab.IgE.RAST class
60242-5,Coagulation ecarin induced
60243-3,Matrix metallopeptidase 9
Apr-24,Aspergillus flavus Ab.IgE
60244-1,Androstanolone^8th specimen post XXX challenge
60245-8,Androstanolone^7th specimen post XXX challenge
60246-6,Androstanolone^6th specimen post XXX challenge
60247-4,Androstanolone^5th specimen post XXX challenge
60248-2,Androstanolone^4th specimen post XXX challenge
60249-0,Androstanolone^3rd specimen post XXX challenge
60250-8,Androstanolone^2nd specimen post XXX challenge
Jan-25,Aspergillus fumigatus Ab.IgE
60251-6,Androstanolone^1st specimen post XXX challenge
60252-4,MGMT gene methylation
60253-2,DNA index 4
60254-0,Parainfluenza virus 1+2+3 RNA
60255-7,Neisseria gonorrhoeae rRNA
60256-5,Neisseria gonorrhoeae rRNA
60257-3,Bacteria identified
60258-1,Bacteria identified
60259-9,Adenovirus DNA
60260-7,Chikungunya virus RNA
60261-5,Coxiella burnetii DNA
60262-3,Dengue virus 1 RNA
60263-1,Enterovirus RNA
60264-9,Hantavirus Ab
60265-6,Human coronavirus RNA
60266-4,Human metapneumovirus RNA
60267-2,Influenza virus C RNA
60268-0,Orientia tsutsugamushi DNA
Sep-26,Aspergillus terreus Ab.IgE
60269-8,Parainfluenza virus 1 RNA
60270-6,Rabies virus RNA
60271-4,Respiratory syncytial virus RNA
60272-2,Rickettsia typhus group DNA
60273-0,Rotavirus RNA
60274-8,Rubella virus RNA
60275-5,SARS coronavirus RNA
60276-3,oxyCODONE+Oxymorphone cutoff
Jul-27,Aspergillus versicolor Ab.IgE
60277-1,Complement C3 Ag
60278-9,Fibrinogen Ag
60279-7,IL28B gene associated variant rs12979860
60280-5,Discharge instructions
60281-3,Discharge instructions
60282-1,ALPRAZolam
Mar-28,Parrot australian droppings Ab.IgE
60283-9,Amitriptyline
60284-7,Amobarbital
May-28,Aureobasidium pullulans Ab.IgE
60285-4,Amoxapine
60286-2,Ascorbate
60287-0,Benztropine
60288-8,Bromazepam
60289-6,Brompheniramine
60290-4,Caffeine
60291-2,carBAMazepine
60292-0,Chloral hydrate
Mar-29,Aureobasidium pullulans Ab.IgE
60293-8,chlordiazePOXIDE
60294-6,chlorproMAZINE
60295-3,Citalopram
60296-1,cloBAZam
60297-9,clomiPRAMINE
60298-7,cloZAPine
60299-5,Cotinine
60300-1,Desipramine
Jan-30,Budgerigar feather Ab.IgE
60301-9,Disopyramide
60302-7,Doxepin
60303-5,Fenoprofen
60304-3,FLUoxetine
60305-0,fluPHENAZine
60306-8,fluvoxaMINE
60307-6,hydrOXYzine
60308-4,Ibuprofen
60309-2,Imipramine
603-1,Bacteria identified
60310-0,Indomethacin
60311-8,Ketoprofen
60312-6,lamoTRIgine
60313-4,Maprotiline
60314-2,Mefenamate
60315-9,Mesoridazine
60316-7,Methaqualone
60317-5,Methotrimeprazine
60318-3,Mexiletine
Sep-31,Budgerigar serum proteins Ab.IgE
60319-1,Naproxen
60320-9,Nicotine
60321-7,Norclobazam
60322-5,Norclomipramine
60323-3,Nordoxepin
60324-1,Nortriptyline
60325-8,OLANZapine
60326-6,OXcarbazepine
Jul-32,Casuarina equisetifolia Ab.IgE
60327-4,PARoxetine
60328-2,Pentazocine
60329-0,Promazine
60330-8,Propoxyphene
60331-6,Propranolol
60332-4,QUEtiapine
60333-2,Sulfamethoxazole
60334-0,Thiocyanate
May-33,Persea americana Ab.IgE
60335-7,traZODone
60336-5,Trimipramine
60337-3,Venlafaxine
60338-1,Warfarin
60339-9,Zopiclone
60340-7,Crystals.amorphous
60341-5,Sodium urate crystals
60342-3,Borrelia burgdorferi Ab.IgG bands panel
Mar-34,Paspalum notatum Ab.IgE
60343-1,Borrelia burgdorferi Ab.IgM bands panel
60344-9,Lipoprotein (little a)/Lipoprotein.total
60345-6,Viable CD34 cells/100 cells
60346-4,Viable CD34 cells/100 cells.CD34
60347-2,Viable CD34 cells
60348-0,Prunus dulcis Ab.IgG
60349-8,Malus sylvestris Ab.IgG
6035-0,Musa spp Ab.IgE
60350-6,Prunus armeniaca Ab.IgG
60351-4,Cynara scolymus Ab.IgG
60352-2,Musa spp Ab.IgG
60353-0,Bean green Ab.IgG
60354-8,Bean kidney red Ab.IgG
60355-5,Bean pinto Ab.IgG
60356-3,Brassica oleracea var italica Ab.IgG
60357-1,Brassica oleracea var gemmifera Ab.IgG
60358-9,Brassica oleracea var capitata Ab.IgG
60359-7,Cucumis melo cantalupensis Ab.IgG
60360-5,Daucus carota Ab.IgG
60361-3,Brassica oleracea var botrytis Ab.IgG
60362-1,Asparagus officinalis Ab.IgG
60363-9,Apium graveolens Ab.IgG
60364-7,Cheese mold type Ab.IgG
60365-4,Prunus avium Ab.IgG
60366-2,Capsicum frutescens Ab.IgG
60367-0,Cinnamomum spp Ab.IgG
Aug-36,Hordeum vulgare Ab.IgE
60368-8,Ruditapes spp Ab.IgG
60369-6,Syzygium aromaticum Ab.IgG
60370-4,Cancer pagurus Ab.IgG
60371-2,Cucumis sativus Ab.IgG
60372-0,Solanum melongena Ab.IgG
60373-8,Flounder Ab.IgG
60374-6,Allium sativum Ab.IgG
60375-3,Zingiber officinale Ab.IgG
Jun-37,Hordeum vulgare Ab.IgE
60376-1,Vitis vinifera Ab.IgG
60377-9,Citrus paradisis Ab.IgG
60378-7,Melanogrammus aeglefinus Ab.IgG
60379-5,Hippoglossus hippoglossus Ab.IgG
60380-3,Lamb Ab.IgG
60381-1,Citrus limon Ab.IgG
60382-9,Citrus aurantifolia Ab.IgG
60383-7,Homarus gammarus Ab.IgG
Apr-38,Fagus grandifolia Ab.IgE
60384-5,Mustard Ab.IgG
60385-2,Nutmeg Ab.IgG
60386-0,Olive green Ab.IgG
60387-8,Origanum vulgare Ab.IgG
60388-6,Ostrea edulis Ab.IgG
60389-4,Pisum sativum Ab.IgG
60390-2,Prunus persica Ab.IgG
60391-0,Pyrus communis Ab.IgG
Feb-39,Beef Ab.IgE
60392-8,Piper nigrum Ab.IgG
60393-6,Pepper green Ab.IgG
60394-4,Ananas comosus Ab.IgG
60395-1,Prunus domestica Ab.IgG
60396-9,Ipomoea batatas Ab.IgG
60397-7,Raphanus sativus Ab.IgG
60398-5,Persea americana Ab.IgG
60399-3,Salvia officinalis Ab.IgG
Apr-60,Carbenicillin
6040-0,House dust Bencard Ab.IgE
60400-9,Salmo salar Ab.IgG
60401-7,Pecten spp Ab.IgG
60402-5,Sesamum indicum Ab.IgG
60403-3,Pandalus borealis Ab.IgG
60404-1,Snapper red Ab.IgG
60405-8,Solea solea Ab.IgG
60406-6,Spinacia oleracea Ab.IgG
60407-4,Helianthus annuus seed Ab.IgG
60408-2,Citrus reticulata Ab.IgG
60409-0,Oncorhynchus mykiss Ab.IgG
60410-8,Thunnus albacares Ab.IgG
60411-6,Turkey Ab.IgG
60412-4,Vanilla planifolia Ab.IgG
60413-2,Yeast brewer's Ab.IgG
60414-0,Squash zucchini Ab.IgG
60415-7,Parainfluenza virus 4 RNA
60416-5,Parainfluenza virus 3 RNA
60417-3,Parainfluenza virus 2 RNA
Aug-41,Cynodon dactylon Ab.IgE
60418-1,Dengue virus 4 RNA
60419-9,Dengue virus 3 RNA
60420-7,Dengue virus 2 RNA
60421-5,Apis mellifera phospholipase A2 recombinant (rApi m) 1 Ab.IgE
60422-3,Measles virus genotype
60423-1,Measles virus identified
60424-9,Parainfluenza virus 4 Ag
60425-6,Human metapneumovirus Ag
Jun-42,Beta lactoglobulin MF77 Ab.IgE
60426-4,SARS coronavirus Ab
60427-2,Norovirus RNA
60428-0,Toxoplasma gondii Ab.IgA
60429-8,Enterovirus 71 RNA
60430-6,Hepatitis E virus genotype
60431-4,Date of previous biopsy
60432-2,Date of previous PAP smear
60433-0,Leukocytes
Apr-43,Birch Ab.IgE
60434-8,Cells.CD19+CD103+
60435-5,Cells.CD10+CD19+
60436-3,Cells.CD19+CD25+
60437-1,Cells.CD5+CD23+
60438-9,Diamine oxidase
60439-7,Lymphocytes.large granular/100 leukocytes
60440-5,Oseltamivir
60441-3,Oseltamivir+Zanamivir
Feb-44,Monomorium minimum Ab.IgE
60442-1,HEDIS 2011 panel
60443-9,HEDIS 2011 Codes to identify colorectal cancer screening (COL-A)
60444-7,HEDIS 2011 Codes to identify sexually active women (CHL-B)
60445-4,HEDIS 2011 Codes to identify exclusions (CHL-D)
60446-2,HEDIS 2011 Codes to identify nephropathy screening tests (CDC-J)
60447-0,HEDIS 2011-2013 Codes to identify evidence of nephropathy (CDC-K)
60448-8,HEDIS 2011 Codes to identify physiologic monitoring tests (MPM-A)
60449-6,HEDIS 2011-2013 Codes to identify physiologic monitoring tests - Serum potassium (MPM-A)
60450-4,HEDIS 2011 Tests used in early prenatal care (PPC-C)
60451-2,HEDIS 2011-2013 Tests used in early prenatal care - Herpes simplex (PPC-C)
60452-0,HEDIS 2011-2013 Tests used in early prenatal care - Toxoplasma (PPC-C)
60453-8,HEDIS 2011 Tests used in early prenatal care - ABO & Rh (PPC-C)
60454-6,Bixa orellana seed Ab.IgE.RAST class
60455-3,Bizarre platelets
60456-1,Cells.CD3+CD8+CD57+/100 cells
60457-9,Cells.CD4+CD26-
60458-7,Collection time^6th specimen
Sep-45,Piper nigrum Ab.IgE
60459-5,Complement C6.functional
60461-1,Herpes simplex virus 1 DNA
60462-9,Herpes simplex virus 2 DNA
60463-7,Insulin Ab
60464-5,Monosodium glutamate Ab.IgE.RAST class
60465-2,Neisseria meningitidis serogroup w135 Ab.IgG
60466-0,Neisseria meningitidis serogroup Y Ab.IgG
Jul-46,Juglans nigra pollen Ab.IgE
60467-8,oxyMORphone
60468-6,PHENobarbital
60469-4,Urate
60470-2,Toxocara canis Ab
60471-0,busPIRone
60472-8,Complement C5.functional
60473-6,Lymphocytes.vacuolated
60474-4,Reticulocytes
May-47,Chironomus thummi Ab.IgE
60475-1,Serotonin release 0.2 IU/mL heparin.low molecular weight
60476-9,Stage
60477-7,Thickness^^adjusted for maternal weight
60478-5,Sex
60479-3,HEDIS 2011-2013 Codes to identify LDLc screening (CMC-D)
60480-1,HEDIS 2010-11 Codes to identify group A Streptococcus tests (CWP-D)
60481-9,HEDIS 2011-2013 Codes to identify LDLc screening (CDC-H)
60482-7,HEDIS 2011-2013 Codes to identify anticonvulsant serum concentration monitoring tests - Phenytoin (MPM-E)
Mar-48,Mytilus edulis Ab.IgE
60483-5,HEDIS 2010 Tests used in early prenatal care - Toxoplasma (PPC-C)
60484-3,CDC Immunization panel
60485-0,Interferon.gamma
60486-8,MED12 gene targeted mutation analysis
60487-6,NPHP1 gene targeted mutation analysis
60488-4,NPHS2 gene targeted mutation analysis
60489-2,Streptococcus pyogenes DNA
604-9,Bacteria identified
60490-0,UMOD gene targeted mutation analysis
Jan-49,Botrytis cinerea Ab.IgE
60491-8,LCA gene targeted mutation analysis
60492-6,Hypertrophic cardiomyopathy gene targeted mutation analysis
60493-4,Calcidiol+Calciferol
60494-2,Influenza virus A H1 2009 pandemic & Influenza virus A swine origin RNA
60495-9,MAP2K1 gene targeted mutation analysis
60496-7,MAP2K2 gene targeted mutation analysis
60497-5,SLC22A5 gene targeted mutation analysis
60498-3,Cancer identification section
60499-1,Demographic section
60500-6,Edit overrides &or Conversion history &or System admin section
60501-4,Follow-up &or Recurrence &or Death section
60502-2,Hospital-confidential section
60503-0,Hospital-specific section
60504-8,Other-confidential section
60505-5,Patient-confidential section
60506-3,Record ID section
60507-1,Special use section
60508-9,Stage &or prognostic factors section
Sep-50,Bertholletia excelsa Ab.IgE
60509-7,Text-diagnosis section
60510-5,Text-miscellaneous section
60511-3,Text-treatment section
60512-1,Treatment-1st course section
60513-9,Treatment-subsequent & other section
60514-7,6-Acetylcodeine
60515-4,Multisection^W air contrast PR
60516-2,Hormone Rx
Jul-51,Yeast brewer's Ab.IgE
60517-0,Iron/Transferrin
60518-8,Creatinine
60519-6,Fatty acids.ethyl esters
60520-4,Eosinophils
60521-2,Babesia microti Ab.IgG+IgM
60522-0,Borrelia hermsii Ab.IgG+IgM
60523-8,Carbromal
60524-6,Helicobacter pylori Ab.IgG
May-52,Brassica oleracea var italica Ab.IgE
60525-3,Parechovirus RNA
60526-1,Pseudo Pelger Huet cells
60527-9,Views+views uptake^W I-123 PO
60528-7,Enterovirus subtype
60529-5,Influenza virus A H1 2009 pandemic Ab
60530-3,Influenza virus A H9 RNA
60531-1,Japanese encephalitis virus Ab.IgM
60532-9,Japanese encephalitis virus Ab.IgM
Mar-53,Bromus inermis Ab.IgE
60533-7,Mycoplasma pneumoniae Ab
60534-5,SARS coronavirus RNA
60535-2,Doripenem
60536-0,HLA-DQ beta
60537-8,CLCN5 gene targeted mutation analysis
60538-6,Influenza virus A H1+H3+B RNA
60539-4,Tryptase.beta
60540-2,HBA2 gene targeted mutation analysis
Jan-54,Fagopyrum esculentum Ab.IgE
60541-0,Cytomegalovirus early Ag
60542-8,Mupirocin 5 ug
60543-6,Mupirocin 200 ug
60544-4,Giardia lamblia DNA
60545-1,Cryptosporidium sp DNA
60546-9,Polio virus identified
60547-7,11-Oxo-Androsterone/Creatinine
60548-5,11-Oxo-Etiocholanolone/Creatinine
60549-3,8-Estriol
60550-1,Fascin
60551-9,Interferon.beta 1a Ab
60552-7,Interferon.beta 1b Ab
60553-5,Trypanosoma cruzi Ab
60554-3,Monocytes.CD59 deficient/100 cells
60555-0,Accessories
60556-8,Assembly or installation instructions
60557-6,Calibration instructions
Aug-55,Budgerigar feather Ab.IgE
60558-4,"Cleaning, disinfecting, and sterilization instructions"
60559-2,Components
605-6,Bacteria identified
60560-0,Intended Use of the Device
60561-8,Other safety information
60562-6,"Route, method and frequency of administration"
60563-4,Summary of safety and effectiveness
60564-2,Amikacin 1.0 ug/mL
60565-9,Amikacin 4.0 ug/mL
Jun-56,Bombus terrestris Ab.IgE
60566-7,Respiratory pathogens DNA & RNA 12b panel
60567-5,Comprehensive pathology report panel
60568-3,Synoptic report
60569-1,Report addendum.synoptic
60570-9,Consultation note
60571-7,Consultation note.synoptic
60572-5,Report template ID
60573-3,Report template source
Apr-57,Matricaria chamomilla Ab.IgE
60574-1,Report template version ID
60575-8,Immunoglobulin heavy chain gene rearrangements
60576-6,"t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points"
60577-4,SERPINE1 gene targeted mutation analysis
60578-2,TCRG gene rearrangements
60579-0,TCRG gene rearrangements
60580-8,TCRG gene rearrangements
60581-6,TCRB gene rearrangements
Feb-58,Phalaris arundinacea Ab.IgE
60582-4,TCRB gene rearrangements
60583-2,TCRB gene rearrangements
60584-0,"t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript minor break points"
60585-7,Ganglioside GT1b Ab.IgG
60586-5,Ganglioside GM3 Ab.IgG
60587-3,Cell count & Differential panel
60588-1,"t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript"
60589-9,"t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript"
6059-0,Candida albicans Ab.IgE
60590-7,Medication dispensed.brief
60591-5,Patient summary
60592-3,Patient summary.unexpected contact
60593-1,Medication dispensed.extended
60594-9,Face low/Face all
60595-6,Face mid/Face all
60596-4,Face lower incisor to chin/Face mid
60597-2,Face upper/Face all
60598-0,Face all
60599-8,Face lower incisor to chin
60600-4,Face upper
60601-2,Lower incisor to A point-pogonion line
60602-0,Upper molar position
60603-8,Molar relationship
60604-6,Lower incisal edge perpendicular to nasion-B point line
60605-3,Overjet
60606-1,Incisor mandibular plane angle using menton
60607-9,Incisor mandibular plane angle using constructed Gonion
Aug-60,Amaranthus palmeri Ab.IgE
60608-7,Lower incisor to nasion-B point line
60609-5,Upper incisor to nasion-A point line
60610-3,Upper incisor to palatal plane
60611-1,Upper central incisor to sella-nasion line
60612-9,Incisor mandibular plane angle using Gnathion
60613-7,Inter incisal angle
60614-5,Condylion to gnathion
60615-2,Condylion to anterior nasal spine
Jun-61,Daucus carota Ab.IgE
60616-0,Condylion to A-point
60617-8,Infradentale to A-point
60618-6,Facial taper
60619-4,Angle of convexity
60620-2,Upper central incisor to stomion
60621-0,Chin thickness
60622-8,Subnasal sulcus
60623-6,Naso-labial angle
Apr-62,Casein Ab.IgE
60624-4,Holdaway angle
60625-1,Nasion to Frankfort horizontal plane
60626-9,Facial axis
60627-7,Facial axis using constructed Gnathion
60628-5,Y axis to Frankfort horizontal plane
60629-3,Y axis to Frankfort horizontal plane using constructed Gnathion
60630-1,Y axis to sella-nasion plane
60631-9,Posterior facial height
Feb-63,Ricinus communis Ab.IgE
60632-7,Ramus height
60633-5,Ramus height using constructed Gonion
60634-3,Anterior nasal spine to menton
60635-0,Gonial angle
60636-8,Gonial angle using constructed Gonion
60637-6,Frankfort horizontal plane to mandibular plane using constructed Gonion
60638-4,Posterior facial height using CF point
60639-2,Face low
606-4,Bacteria identified
6064-0,Cat epithelium Ab.IgE
60640-0,Lower lip to pogonion
60641-8,Stomion to menton
60642-6,Upper lip to pogonion
60643-4,Anterior facial height
60644-2,Subnasale to pogonion
60645-9,Subnasale to lower lip
60646-7,Subnasale to stomion
60647-5,Anterior nasal spine to pogonion
60648-3,Adenoid width
60649-1,Tonsilar width
60650-9,Wits analysis
60651-7,Mandibular arc
60652-5,Lower facial height angle
60653-3,Lower lip to menton
60654-1,Posterior cranial base
60655-8,Anterior cranial
60656-6,Condylion to gonion
Jul-65,Apium graveolens Ab.IgE
60657-4,Subnasale to upper lip
60658-2,Face lower incisor to chin/Face low
60659-0,Face mid/Face low
60660-8,Face lower incisor to chin/Face all
60661-6,Maxillary mandibular planes angle using menton
60662-4,Maxillary mandibular planes angle using menton and constructed gonion
60663-2,Sella-nasion plane to mandibular plane using menton
60664-0,Sella-nasion plane to mandibular plane using menton and constructed gonion
May-66,Acremonium sp Ab.IgE
60665-7,Face mid
60666-5,Sella-nasion plane to palatal plane
60667-3,Palatal plane to mandibular plane
60668-1,Palatal plane to mandibular plane constructed Gonion
60669-9,Glabella to subnasale
60670-7,Subnasale to menton
60671-5,Sella-nasion plane to nasion-pogonion line
60672-3,Upper lip thickness
Mar-67,Cheese cheddar type Ab.IgE
60673-1,Soft tissue thickness at A-point
60674-9,Nasion to A-point
60675-6,Mandibular body length
60676-4,Ethyl sulfate
60677-2,Alpha hydroxytriazolam
60678-0,Protein/Creatinine
60680-6,Cortisol.free^30M post dose corticotropin
Jan-68,Cheese mold type Ab.IgE
60681-4,Cortisol.free^1H post dose corticotropin
60682-2,Standardized allergenic
60683-0,Plasma derivative
60684-8,Cellular therapy
60685-5,Indexing - pharmacologic class
60686-3,Overbite
60687-1,Test of Infant Motor Performance Version 5.1
60688-9,TIMP cover
60689-7,Observed items
60690-5,Elicited items
60691-3,Head in midline
60692-1,Individual right finger movement
60693-9,Individual left finger movement
60694-7,Fingers objects or surfaces on right
60695-4,Fingers objects or surfaces on left
60696-2,Bilateral hip and knee flexion
60697-0,Isolated right ankle movement
60698-8,Isolated left ankle movement
Sep-69,Castanea sativa pollen Ab.IgE
60699-6,Fidgety movements
60700-2,Ballistic movements of the arms or legs (swipes or swats)
60701-0,Oscillation of arm or leg during movement
60702-8,Reaches for person or object
60703-6,Total observed item score
60704-4,Head rotation side to side
60705-1,Head control - supported sitting
60706-9,Head control - posterior neck muscles
Jul-70,Chicken feather Ab.IgE
60707-7,Head control - anterior neck muscles
60708-5,Head control - lowered from sitting
60709-3,Inhibition of neonatal neck righting (right side)
60710-1,Inhibition of neonatal neck righting (left side)
60711-9,Head in midline without visual stimulation
60712-7,Head held in midline with visual stimulation
60713-5,Supine neck rotation (right)
60714-3,Supine neck rotation (left)
May-71,Chicken meat Ab.IgE
60715-0,Defensive Reaction - Head and Neck Response
60716-8,Defensive reaction - arm movements
60717-6,Hip and knee flexion
60718-4,Rolling - elicited from the legs (right)
60719-2,Rolling - elicited from the legs (left)
607-2,Bacteria identified
60720-0,Rolling - elicited from the arms (right)
60721-8,Rolling - elicited from the arms (left)
60722-6,Pull to sit
Mar-72,Chloramin T Ab.IgE
60723-4,Lateral straightening of the head and body with arm support
60724-2,Lateral hip abduction reaction
60725-9,Prone suspension
60726-7,Head lift in prone
60727-5,Crawling
60728-3,Head turn in prone to sound (right)
60729-1,Head turn in prone to sound (left)
60730-9,Standing
Jan-73,Chocolate Ab.IgE
60731-7,Lateral head righting (right)
60732-5,Lateral head righting (left)
60733-3,Notes
60734-1,Total elicited items score
60735-8,Total score
60736-6,Reciprocal kicking
60738-2,Intraluminal
60739-0,Expiration
60740-8,Inspiration
60741-6,Desflurane target^at end expiration
60744-0,Desflurane setting^during inspiration
60746-5,Desflurane^during expiration
60747-3,Desflurane^during inspiration
60748-1,Desflurane gas delivered.case
Sep-74,Chymopapain Ab.IgE
60749-9,Enflurane target^at end expiration
60752-3,Enflurane setting^during inspiration
60754-9,Enflurane^during expiration
60755-6,Enflurane gas delivered.case
Jun-75,Cladosporium herbarum Ab.IgE
60756-4,Halothane target^at end expiration
60759-8,Halothane setting^during inspiration
60761-4,Halothane^during expiration
60762-2,Halothane gas delivered.case
60763-0,Isoflurane target^at end expiration
Apr-76,Ruditapes spp Ab.IgE
60766-3,Isoflurane setting^during inspiration
60768-9,Isoflurane^during expiration
60769-7,Isoflurane gas delivered.case
Feb-77,Xanthium commune Ab.IgE
60773-9,Nitrous oxide setting^during inspiration
60775-4,Nitrous oxide gas delivered.case
60776-2,Sevoflurane target^at end expiration
60779-6,Sevoflurane setting^during inspiration
6078-0,Blatella germanica Ab.IgE
60781-2,Sevoflurane
60782-0,Sevoflurane gas delivered.case
60786-1,Carbon dioxide setting^during inspiration
60789-5,Carbon dioxide gas delivered.case
60790-3,Carbon dioxide gas delivered.total
60791-1,Gas flow^on ventilator
60792-9,Expiratory gas flow^on ventilator
60793-7,Expiratory gas flow.max^on ventilator
60794-5,Inspiratory gas flow^on ventilator
60795-2,Inspiratory gas flow.max^on ventilator
60796-0,Oxygen target^at end expiration
Aug-79,Blatella germanica Ab.IgE
60799-4,Oxygen setting^during inspiration
608-0,Bacteria identified
60801-8,Volume.trapped^at end expiration
60802-6,Pressure.plateau dynamic
60804-2,Minimum alveolar concentration for anesthesia.XXX
60805-9,Desflurane^during inspiration
Jun-80,Theobroma cacao Ab.IgE
60807-5,Sevoflurane^during expiration
60808-3,Carbon dioxide^at end expiration
60809-1,Carbon dioxide^during expiration
60812-5,Helium^at end expiration
60813-3,Helium^during expiration
Apr-81,Cocos nucifera Ab.IgE
60815-8,Minimum alveolar concentration sum
60816-6,Minimum alveolar concentration sum^^corrected for age
60817-4,Carbon dioxide.gastric-Carbon dioxide.BldA
60818-2,Carbon dioxide.gastric-Carbon dioxide.airway^end of expiration
60819-0,Carbon dioxide
60821-6,Apnea duration
Feb-82,Gadus morhua Ab.IgE
60822-4,Shunt fraction
60823-2,Oxygen consumption/Body surface area
60824-0,Oxygen delivery/Body surface area
60825-7,Carbon dioxide production
60826-5,Compliance
60827-3,Compliance.dynamic
60828-1,Compliance.static
60829-9,Pressure.plateau
6083-0,Coffea spp Ab.IgE
60830-7,Body temperature
60832-3,Temperature.ambient
60833-1,Body temperature
60834-9,Body temperature
60835-6,Body temperature
60836-4,Body temperature
60837-2,Temperature
60838-0,Body temperature
60839-8,Body temperature^in microenvironment
60840-6,Base excess
60841-4,Oxygen content
60842-2,Oxygen consumption
60843-0,Power spectrum.mean dominant frequency
60844-8,Power spectrum.median frequency
60845-5,Power spectrum.peak frequency
60846-3,Burst count
60847-1,Seizure count
Aug-84,Colza Ab.IgE
60848-9,Power spectrum.alpha frequency/Power spectrum.total
60849-7,Power spectrum.beta frequency/Power spectrum.total
60850-5,Power spectrum.delta frequency/Power spectrum.total
60851-3,Power spectrum.theta frequency/Power spectrum.total
60852-1,Electrical potential
60853-9,Desflurane
60854-7,Enflurane
May-85,Ambrosia elatior Ab.IgE
60855-4,Enflurane^during inspiration
60856-2,Halothane
60857-0,Halothane^during inspiration
60858-8,Isoflurane
60859-6,Isoflurane^during inspiration
60860-4,Nitrous oxide
60861-2,Nitrous oxide^during expiration
60862-0,Nitrous oxide^during inspiration
Mar-86,Ambrosia elatior Ab.IgE
60863-8,Sevoflurane
60864-6,Sevoflurane^during inspiration
60866-1,Oxygen
60867-9,Oxygen^during expiration
60869-5,Physiological dead space^on ventilator
60870-3,Physiological dead space/Tidal volume^on ventilator
Jan-87,Zea mays Ab.IgE
60873-7,Anesthetic agent.XXX^at end expiration
60874-5,Anesthetic agent.XXX^during inspiration
60876-0,Desflurane
60877-8,Desflurane^at end expiration
60884-4,Enflurane^at end expiration
60885-1,Enflurane^during inspiration
Sep-88,Cotton cultivated Ab.IgE
60889-3,Halothane^at end expiration
60895-0,Isoflurane^at end expiration
Jul-89,Cottonseed Ab.IgE
60901-6,Nitrous oxide^at end expiration
May-90,Populus deltoides Ab.IgE
60907-3,Sevoflurane^during inspiration
60908-1,Sevoflurane^at end expiration
Mar-91,Cow dander Ab.IgE
60914-9,Argon
60915-6,Argon^during expiration
60916-4,Argon^during inspiration
60918-0,Argon^at end expiration
60919-8,Nitrogen
60920-6,Nitrogen^at end expiration
Jan-92,Cancer pagurus Ab.IgE
60921-4,Nitrogen^during inspiration
60924-8,Carbon dioxide^during inspiration
60926-3,Carbon dioxide
60932-1,Helium
60934-7,Helium^during inspiration
60935-4,Nitrogen^during expiration
Sep-93,Avena sativa cultivated Ab.IgE
60939-6,Nitrous oxide^during expiration
60943-8,Oxygen^at end expiration
Jul-94,Curvularia lunata Ab.IgE
60947-9,Peak expiratory flow
60948-7,Peak inspiratory flow
60949-5,Pressure.mean
60951-1,Pressure max^during inspiration
60952-9,Pressure mean^during inspiration
Apr-95,Dermatophagoides farinae Ab.IgE
60955-2,Body temperature
60956-0,Intracranial
60957-8,Intracranial diastolic
60958-6,Intracranial mean
60959-4,Intracranial systolic
60960-2,ST amplitude.lead AI
60961-0,ST amplitude.lead AS
Feb-96,Dermatophagoides pteronyssinus Ab.IgE
60962-8,ST amplitude.derived lead V1
60963-6,ST amplitude.derived lead V2
60964-4,ST amplitude.derived lead V3
60965-1,ST amplitude.derived lead V4
60966-9,ST amplitude.derived lead V5
60967-7,ST amplitude.derived lead V6
60968-5,ST amplitude.lead ES
60969-3,ST amplitude.lead MCL
6097-0,Taraxacum vulgare Ab.IgE
60970-1,ST amplitude.lead MCL1
60971-9,ST amplitude.lead MCL6
60972-7,ST amplitude.precordial lead
60973-5,Pre ejection time
60974-3,Ejection time
60975-0,Hemodynamic resistance
60976-8,Work
60977-6,Work
60978-4,Heart rate
609-8,Bacteria identified
60981-8,Intravascular
60982-6,Intravascular diastolic
60983-4,Intravascular mean
60984-2,Intravascular systolic
60985-9,Intravascular
60986-7,Intravascular diastolic
60987-5,Intravascular systolic
Aug-98,Dog dander Ab.IgE
60988-3,Intrachamber
60989-1,Intrachamber systolic
60994-1,Intravascular diastolic
60995-8,Intravascular systolic
Jun-99,Dog epithelium Ab.IgE
60996-6,Intrachamber
60997-4,Intrachamber diastolic
60998-2,Intrachamber systolic
Feb-00,Duck feather Ab.IgE
61002-2,Intravascular
61003-0,Intravascular diastolic
61004-8,Intravascular mean
61005-5,Intravascular systolic
61006-3,Perfusion index
61007-1,Oxygen.BldA-Oxygen.BldV
61008-9,Body temperature
61009-7,Body temperature
6101-0,Duck meat Ab.IgE
61010-5,Burst suppression ratio
61011-3,Intravascular
61012-1,Breaths
61014-7,Cardiac output
61017-0,Perfusion
61018-8,Oxygen
61019-6,Enflurane^during expiration
61020-4,Halothane^during expiration
61021-2,Halothane^during inspiration
61022-0,Desflurane gas delivered.total
61023-8,Enflurane gas delivered.total
61024-6,Halothane gas delivered.total
61025-3,Isoflurane gas delivered.total
61026-1,Nitrous oxide gas delivered.total
61027-9,Sevoflurane gas delivered.total
Aug-02,Dust profile Ab.IgE
61028-7,Pressure.min
61029-5,7-Aminoclonazepam
61030-3,7-Aminoclonazepam
61031-1,7-Aminoclonazepam
61032-9,7-Aminoflunitrazepam
61033-7,7-Aminoflunitrazepam
61034-5,7-Aminoflunitrazepam
61035-2,Alpha hydroxyalprazolam
Jun-03,Echinococcus sp Ab.IgE
61036-0,Alpha hydroxyalprazolam
61037-8,Alpha hydroxyalprazolam
61038-6,ALPRAZolam
61039-4,clonazePAM
61040-2,N-desalkylflurazepam
61041-0,N-desalkylflurazepam
61042-8,fentaNYL
61043-6,Ketamine
Apr-04,Echinococcus sp Ab.IgE
61044-4,LORazepam
61045-1,Methylenedioxyamphetamine
61046-9,Methylenedioxyamphetamine
61047-7,Methylenedioxyethylamphetamine
61048-5,Methylenedioxyethylamphetamine
61049-3,Methylenedioxyethylamphetamine
61050-1,Methylphenidate
Jan-05,Anguilla anguilla Ab.IgE
61051-9,Nordiazepam
61052-7,Norfentanyl
61053-5,Norfentanyl
61054-3,Normeperidine
61055-0,Oxazepam
61056-8,Pseudoephedrine
61057-6,Pseudoephedrine
61058-4,Alpha-Phenyl-2-Piperidine acetate
61059-2,Alpha-Phenyl-2-Piperidine acetate
610-6,Bacteria identified
61060-0,Temazepam
61061-8,Temazepam
61062-6,Carboxy tetrahydrocannabinol
61063-4,Carboxy tetrahydrocannabinol
61064-2,Triazolam
61065-9,Lysergate diethylamide
61066-7,Ethanol
61067-5,Barbiturates
Sep-06,Egg white Ab.IgE
61070-9,7-Aminoclonazepam
61071-7,7-Aminoflunitrazepam
61072-5,Alpha hydroxyalprazolam
61073-3,ALPRAZolam
61074-1,diazePAM
61075-8,diphenhydrAMINE
61076-6,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine"
Jul-07,Egg yolk Ab.IgE
61077-4,fentaNYL
61078-2,Flunitrazepam
61079-0,Flunitrazepam
61080-8,Flurazepam
61081-6,Ketamine
61082-4,Methylenedioxyethylamphetamine
61083-2,Methylenedioxymethamphetamine
61084-0,Methylphenidate
May-08,Sambucus nigra Ab.IgE
61085-7,Nordiazepam
61086-5,Norfentanyl
61087-3,Normeperidine
61088-1,Oxazepam
61089-9,Pseudoephedrine
61090-7,Alpha-Phenyl-2-Piperidine acetate
61091-5,Temazepam
61092-3,Triazolam
Mar-09,Ulmus americana Ab.IgE
61093-1,Triazolam
61094-9,Lysergate diethylamide
61095-6,Ethanol
61096-4,Barbiturates
61098-0,N-desalkylflurazepam
61099-8,Collection date^3rd specimen
61100-4,Collection date^2nd specimen
Jan-10,Plantago lanceolata Ab.IgE
61101-2,Influenza virus A neuraminidase RNA
61102-0,Influenza virus A & B Ag
61103-8,Prochlorperazine
61104-6,Prochlorperazine
61105-3,Prochlorperazine
61106-1,16p11.2 chromosome region deletion+duplication
61107-9,SLC25A13 gene targeted mutation analysis
61108-7,Mitochondria DNA complex I targeted mutation analysis
61109-5,Mitochondria DNA complex V targeted mutation analysis
61110-3,ACSL4 gene targeted mutation analysis
61111-1,Mitochondria tRNA targeted mutation analysis
61112-9,HTLV
61113-7,Immunoglobulin gene rearrangements
61114-5,Mitochondria DNA complex III targeted mutation analysis
61115-2,Mitochondria DNA complex IV targeted mutation analysis
61116-0,Mitochondria rRNA targeted mutation analysis
61117-8,Aquaporin 4 water channel Ab.IgG
61118-6,Lymphocytes.cytoplasmic IgG/100 lymphocytes
Sep-11,Epicoccum purpurascens Ab.IgE
61119-4,Lymphocytes.cytoplasmic IgM/100 lymphocytes
61120-2,PM-SCL-100 Ab.IgG
61121-0,Cells.CD8-CD57+/100 cells
61122-8,Cells.CD8-CD57+
61123-6,Lymphocytes/100 leukocytes
61124-4,Granulocytes/100 leukocytes
61125-1,Monocytes/100 leukocytes
61126-9,Blasts/100 cells
Jul-12,Ethylene oxide Ab.IgE
61127-7,Whitefish Ab.IgG
61128-5,Cotinine
61129-3,PhenX domain - Demographics
61130-1,PhenX domain - Anthropometrics
61131-9,Preterm time
61132-7,Gestation adjusted age
61133-5,Clinical impression
61134-3,Environment
May-13,Eucalyptus spp Ab.IgE
61135-0,Environment.other specified
61136-8,Start time
61137-6,End time
61138-4,Principal result interpreter
61139-2,Toluene diisocyanate (TDI) Ab.IgG
611-4,Bacteria identified
61140-0,Diphenylmethane diisocyanate (MDI) Ab.IgG
61141-8,Hexamethylene diisocyanate (HDI) Ab.IgG
61142-6,Trimellitic anhydride Ab.IgG
Mar-14,Euroglyphus maynei Ab.IgE
61143-4,Summary note
61144-2,Diet and nutrition
61145-9,Patient plan of care
61146-7,Goals
61147-5,Expected outcomes
61148-3,Fluid management note
61149-1,Objective
6115-0,Franseria acanthicarpa Ab.IgE
61150-9,Subjective
61151-7,Albumin
61152-5,Albumin
61153-3,Glucose^baseline
61154-1,Hepatitis B virus codon L180M
61155-8,Hepatitis B virus codon L80V
61156-6,Hepatitis B virus codon V173L
61157-4,Hepatitis B virus codon M204V
61158-2,Hepatitis B virus codon M204I
61159-0,Hepatitis B virus codon M204S
61160-8,Hepatitis B virus codon A181V
61161-6,Hepatitis B virus codon A181T
61162-4,Hepatitis B virus codon N236T
61163-2,Hepatitis B virus codon A194T
61164-0,Hepatitis B virus codon T184S
61165-7,Hepatitis B virus codon T184I
61166-5,Hepatitis B virus codon S202G
61167-3,Hepatitis B virus codon S202C
Aug-16,Ficus sp Ab.IgE
61168-1,Hepatitis B virus codon S202I
61169-9,Hepatitis B virus codon I233V
61170-7,Hepatitis B virus codon M250V
61171-5,Hepatitis B virus codon M250I
61172-3,Hepatitis B virus codon M250L
61173-1,Hepatitis B virus codon L80I
61174-9,17-Hydroxyprogesterone^20M pre XXX challenge
61175-6,Polychlorinated biphenyl.Aroclor 1242
Jun-17,Solenopsis invicta Ab.IgE
61176-4,Polychlorinated biphenyl.Aroclor 1248
61177-2,Paraneoplastic Ab
61178-0,Cells.CD79/100 cells
61179-8,Leukocyte morphology finding
61180-6,Hemoglobin
61181-4,Cells counted.total
61182-2,Leukocytes^^corrected for nucleated erythrocytes
61183-0,Cells.myeloperoxidase/100 cells
Apr-18,Kochia scoparia Ab.IgE
61184-8,Spermatozoa.broken tail/100 spermatozoa
61185-5,Spermatozoa.thick midpiece/100 spermatozoa
61186-3,Spermatozoa.thin midpiece/100 spermatozoa
61187-1,Spermatozoa.bent midpiece/100 spermatozoa
61188-9,Clindamycin.induced
61189-7,Coagulation tissue factor induced.INR
61190-5,Coagulation tissue factor induced
61191-3,Coagulation surface induced
Feb-19,Formaldehyde Ab.IgE
61192-1,Color
61193-9,Clarity
61194-7,Cells counted.total
61195-4,Albumin
61196-2,Albumin
61197-0,oxyCODONE+Oxymorphone
61198-8,Raltegravir
61199-6,HIV 1 integrase gene mutations detected
Feb-61,Carbenicillin
6120-0,Fusarium culmorum Ab.IgE
61200-2,Colorado tick fever virus Ab.IgG
61201-0,(Alternaria alternata+Aspergillus fumigatus+Cladosporium herbarum+Penicillium notatum) Ab.IgE/IgE.total
61202-8,(Ambrosia elatior+Artemisia vulgaris+Chenopodium album+Plantago lanceolata+Salsola kali) Ab.IgE/IgE.total
61203-6,(Chicken feather+Duck feather+Goose feather+Turkey feather) Ab.IgE/IgE.total
61204-4,(Cynodon dactylon+Lolium perenne+Phleum pratense+Poa pratensis+Sorghum halepense+Paspalum notatum) Ab.IgE/IgE.total
61205-1,Acer macrophyllum Ab.IgE/IgE.total
61206-9,Acer negundo Ab.IgE/IgE.total
61207-7,Acremonium sp Ab.IgE/IgE.total
61208-5,Aedes communis Ab.IgE/IgE.total
61209-3,Agaricus hortensis Ab.IgE/IgE.total
61210-1,Allium cepa Ab.IgE/IgE.total
61211-9,Allium sativum Ab.IgE/IgE.total
61212-7,Alnus incana Ab.IgE/IgE.total
61213-5,Lactalbumin alpha Ab.IgE/IgE.total
61214-3,Ambrosia elatior Ab.IgE/IgE.total
61215-0,Ambrosia trifida Ab.IgE/IgE.total
61216-8,Ananas comosus Ab.IgE/IgE.total
61217-6,Anthoxanthum odoratum Ab.IgE/IgE.total
Aug-21,Fusarium moniliforme Ab.IgE
61218-4,Apium graveolens Ab.IgE/IgE.total
61219-2,Arachis hypogaea Ab.IgE/IgE.total
612-2,Bacterial strain
61220-0,Ascaris sp Ab.IgE/IgE.total
61221-8,Aspergillus niger Ab.IgE/IgE.total
61222-6,Aspergillus sp Ab.IgE/IgE.total
61223-4,Astacus astacus Ab.IgE/IgE.total
61224-2,Atriplex lentiformis Ab.IgE/IgE.total
61225-9,Aureobasidium pullulans Ab.IgE/IgE.total
Jun-22,Allium sativum Ab.IgE
61226-7,Avena sativa Ab.IgE/IgE.total
61227-5,Betula populifolia Ab.IgE/IgE.total
61228-3,Betula verrucosa Ab.IgE/IgE.total
61229-1,Betula verrucosa recombinant (rBet v) 1 Ab.IgE/IgE.total
61230-9,Blatella germanica Ab.IgE/IgE.total
61231-7,Botrytis cinerea Ab.IgE/IgE.total
61232-5,Brassica oleracea var botrytis Ab.IgE/IgE.total
61233-3,Brassica oleracea var capitata Ab.IgE/IgE.total
Apr-23,Pelargonium sp Ab.IgE
61234-1,Brassica oleracea var italica Ab.IgE/IgE.total
61235-8,Bromus inermis Ab.IgE/IgE.total
61236-6,Budgerigar droppings Ab.IgE/IgE.total
61237-4,Budgerigar feather Ab.IgE/IgE.total
61238-2,Candida albicans Ab.IgE/IgE.total
61239-0,Capsicum annuum Ab.IgE/IgE.total
61240-8,Carya illinoinensis tree Ab.IgE/IgE.total
61241-6,Casein Ab.IgE/IgE.total
Feb-24,Ambrosia trifida Ab.IgE
61242-4,Chaetomium globosum Ab.IgE/IgE.total
61243-2,Chenopodium album Ab.IgE/IgE.total
61244-0,Cicer arietinus Ab.IgE/IgE.total
61245-7,Cinnamomum spp Ab.IgE/IgE.total
61246-5,Citrus limon Ab.IgE/IgE.total
61247-3,Citrus paradisis Ab.IgE/IgE.total
61248-1,Citrus sinensis Ab.IgE/IgE.total
61249-9,Cladosporium herbarum Ab.IgE/IgE.total
61250-7,Coffea spp Ab.IgE/IgE.total
61251-5,Cryptomeria japonica Ab.IgE/IgE.total
61252-3,Cucurbita pepo seed Ab.IgE/IgE.total
61253-1,Cupressus arizonica Ab.IgE/IgE.total
61254-9,Cupressus sempervirens Ab.IgE/IgE.total
61255-6,Cynodon dactylon Ab.IgE/IgE.total
61256-4,Dactylis glomerata Ab.IgE/IgE.total
61257-2,Dermatophagoides microceras Ab.IgE/IgE.total
61258-0,Dermatophagoides pteronyssinus Ab.IgE/IgE.total
Sep-25,Gluten Ab.IgE
61259-8,Dolichovespula maculata Ab.IgE/IgE.total
61260-6,Erythromycin Ab.IgE/IgE.total
61261-4,Eucalyptus spp Ab.IgE/IgE.total
61262-2,Fagopyrum esculentum Ab.IgE/IgE.total
61263-0,Fagus grandifolia Ab.IgE/IgE.total
61264-8,Festuca elatior Ab.IgE/IgE.total
61265-5,Foeniculum vulgare seed Ab.IgE/IgE.total
61266-3,Fragaria vesca Ab.IgE/IgE.total
Jul-26,Glycyphagus domesticus Ab.IgE
61267-1,Franseria acanthicarpa Ab.IgE/IgE.total
61268-9,Gadus morhua Ab.IgG/IgE.total
61269-7,Gelatin Ab.IgE/IgE.total
61270-5,Gluten Ab.IgE/IgE.total
61271-3,Glycine max Ab.IgE/IgE.total
61272-1,Helianthus annuus seed Ab.IgE/IgE.total
61273-9,Hordeum vulgare Ab.IgE/IgE.total
61274-7,House dust Greer Ab.IgE/IgE.total
May-27,Goat epithelium Ab.IgE
61275-4,Humulus lupus Ab.IgE/IgE.total
61276-2,Insulin porcine Ab.IgE/IgE.total
61277-0,Hexamethylene diisocyanate (HDI) Ab.IgE/IgE.total
61278-8,Toluene diisocyanate (TDI) Ab.IgE/IgE.total
61279-6,Juglans regia Ab.IgE/IgE.total
61280-4,Lactuca sativa Ab.IgE/IgE.total
61281-2,Loligo sp Ab.IgE/IgE.total
61282-0,Lolium perenne Ab.IgE/IgE.total
Mar-28,Solidago virgaurea Ab.IgE
61283-8,Macadamia spp Ab.IgE/IgE.total
61284-6,Melaleuca leucadendron Ab.IgE/IgE.total
61285-3,Micropterus salmoides Ab.IgE/IgE.total
61286-1,Morus alba Ab.IgE/IgE.total
61287-9,Musa spp Ab.IgE/IgE.total
61288-7,Ocimum basilicum Ab.IgE/IgE.total
61289-5,Oncorhynchus mykiss Ab.IgE/IgE.total
61290-3,Origanum vulgare Ab.IgE/IgE.total
Jan-29,Goose feather Ab.IgE
61291-1,Oryza sativa Ab.IgE/IgE.total
61292-9,Ostrea edulis Ab.IgE/IgE.total
61293-7,Passiflora edulis Ab.IgE/IgE.total
61294-5,Persea americana Ab.IgE/IgE.total
61295-2,Petroselinum crispum Ab.IgE/IgE.total
61296-0,Phleum pratense Ab.IgE/IgE.total
61297-8,Phthalic anhydride Ab.IgE/IgE.total
61298-6,Picea excelsa Ab.IgE/IgE.total
61299-4,Pinus strobus Ab.IgE/IgE.total
613-0,Fungal strain
61300-0,Pisum sativum Ab.IgE/IgE.total
61301-8,Plantago lanceolata Ab.IgE/IgE.total
61302-6,Platanus acerifolia Ab.IgE/IgE.total
61303-4,Poa pratensis Ab.IgE/IgE.total
61304-2,Populus deltoides Ab.IgE/IgE.total
61305-9,Prosopis juliflora Ab.IgE/IgE.total
61306-7,Prunus avium Ab.IgE/IgE.total
61307-5,Pyrus communis Ab.IgE/IgE.total
61308-3,Rhizopus nigricans Ab.IgE/IgE.total
Sep-30,Goose meat Ab.IgE
61309-1,Rumex acetosella Ab.IgE/IgE.total
61310-9,Salix caprea Ab.IgE/IgE.total
61311-7,Salsola kali Ab.IgE/IgE.total
61312-5,Secale cereale Ab.IgE/IgE.total
61313-3,Sesamum indicum Ab.IgE/IgE.total
61314-1,Sheep wool Ab.IgE/IgE.total
61315-8,Solenopsis invicta Ab.IgE/IgE.total
61316-6,Solidago virgaurea Ab.IgE/IgE.total
Jul-31,Citrus paradisis Ab.IgE
61317-4,Spinacia oleracea Ab.IgE/IgE.total
61318-2,Taraxacum vulgare Ab.IgE/IgE.total
61319-0,Theobroma cacao Ab.IgE/IgE.total
61320-8,Trachurus japonicus Ab.IgE/IgE.total
61321-6,Trimellitic anhydride Ab.IgE/IgE.total
61322-4,Ulmus americana Ab.IgE/IgE.total
61323-2,Vaccinium oxycoccos Ab.IgE/IgE.total
61324-0,Vanilla planifolia Ab.IgE/IgE.total
May-32,Coffee bean green Ab.IgE
61325-7,Vespa crabro Ab.IgE/IgE.total
61326-5,Xanthium commune Ab.IgE/IgE.total
61327-3,Zea mays Ab.IgE/IgE.total
61328-1,Zingiber officinale Ab.IgE/IgE.total
61329-9,Cucumis sativus Ab.IgE/IgE.total
61330-7,Pinus edulis Ab.IgE/IgE.total
61331-5,Beef Ab.IgE/IgE.total
61332-3,Cow milk Ab.IgE/IgE.total
Mar-33,Cladotanytarsus lewisi Ab.IgE
61333-1,Dog dander Ab.IgE/IgE.total
61334-9,Dog epithelium Ab.IgE/IgE.total
61335-6,Goat milk Ab.IgE/IgE.total
61336-4,Cochineal extract Ab.IgE/IgE.total
61337-2,Chicken feather Ab.IgE/IgE.total
61338-0,Egg white Ab.IgE/IgE.total
61339-8,Egg yolk Ab.IgE/IgE.total
61340-6,Cottonseed Ab.IgE/IgE.total
Jan-34,Guinea pig epithelium Ab.IgE
61341-4,Gerbil epithelium Ab.IgE/IgE.total
61342-2,Mouse urine proteins Ab.IgE/IgE.total
61343-0,Ferret epithelium Ab.IgE/IgE.total
61344-8,Sheep epithelium Ab.IgE/IgE.total
61345-5,Flounder Ab.IgE/IgE.total
61346-3,Rat urine proteins Ab.IgE/IgE.total
61347-1,Pork Ab.IgE/IgE.total
61348-9,Cockatiel droppings Ab.IgE/IgE.total
61349-7,Cockatiel feather Ab.IgE/IgE.total
61350-5,Lymphocyte proliferation. 2.5 ug concanavalin A stimulation
61351-3,Lymphocyte proliferation. 0.6 ug pokeweed mitogen stimulation
61352-1,Lymphocyte proliferation. 2.5 ug pokeweed mitogen stimulation
61353-9,Lymphocyte proliferation. 10 ug phytohemagglutinin stimulation
61354-7,Lymphocyte proliferation. 40 ug phytohemagglutinin stimulation
61355-4,Capreomycin 5.0 ug/mL
61356-2,Medication pharmaceutical advice.extended
61357-0,Medication pharmaceutical advice.brief
Aug-35,Hamster epithelium Ab.IgE
61358-8,Surgical operation consent
61359-6,Anesthesia consent
61360-4,Acinetobacter baumannii DNA
61361-2,Klebsiella aerogenes DNA
61362-0,Enterococcus faecalis DNA
61363-8,Adenovirus 3+4+7+21 DNA
61364-6,Echovirus+Coxsackievirus RNA
61365-3,Parainfluenza virus RNA
Jun-36,Corylus avellana Ab.IgE
61366-1,Haemophilus influenzae DNA
61367-9,Clostridioides difficile DNA
61368-7,Campylobacter jejuni DNA
61369-5,Listeria monocytogenes DNA
61370-3,Salmonella enterica DNA
61371-1,Vibrio cholerae DNA
61372-9,Human papilloma virus 16 DNA
61373-7,Human papilloma virus 18 DNA
Apr-37,Corylus avellana pollen Ab.IgE
61374-5,Human papilloma virus 26 DNA
61375-2,Human papilloma virus 31 DNA
61376-0,Human papilloma virus 33 DNA
61377-8,Human papilloma virus 35 DNA
61378-6,Human papilloma virus 39 DNA
61379-4,Human papilloma virus 44 DNA
61380-2,Human papilloma virus 45 DNA
61381-0,Human papilloma virus 51 DNA
Feb-38,Setomelanomma rostrata Ab.IgE
61382-8,Human papilloma virus 52 DNA
61383-6,Human papilloma virus 53 DNA
61384-4,Human papilloma virus 58 DNA
61385-1,Human papilloma virus 59 DNA
61386-9,Human papilloma virus 66 DNA
61387-7,Human papilloma virus 67 DNA
61388-5,Human papilloma virus 68 DNA
61389-3,Human papilloma virus 69 DNA
6139-0,Clupea harengus Ab.IgE
61390-1,Human papilloma virus 70 DNA
61391-9,Human papilloma virus 73 DNA
61392-7,Human papilloma virus 82 DNA
61393-5,Human papilloma virus 6 DNA
61394-3,Human papilloma virus 11 DNA
61395-0,Human papilloma virus 42 DNA
61396-8,Human papilloma virus 56 DNA
61397-6,Enterococcus faecium DNA
61398-4,Escherichia coli DNA
61399-2,Klebsiella pneumoniae DNA
61400-8,Proteus mirabilis DNA
61401-6,Pseudomonas aeruginosa DNA
61402-4,Serratia marcescens DNA
61403-2,Stenotrophomonas maltophilia DNA
61404-0,Staphylococcus aureus DNA
61405-7,Staphylococcus epidermidis DNA
61406-5,XXX blood group Ab
61407-3,Amitriptyline/Creatinine
Aug-40,Hickory Ab.IgE
61408-1,Cyclobenzaprine/Creatinine
61409-9,Cyclobenzaprine
61410-7,Cyclobenzaprine
61411-5,Desipramine/Creatinine
61412-3,Desipramine
61413-1,Desipramine
61414-9,Doxepin/Creatinine
61415-6,Doxepin
Jun-41,Humulus lupus Ab.IgE
61416-4,Doxepin
61417-2,Imipramine/Creatinine
61418-0,Imipramine
61419-8,Imipramine
61420-6,Norhydrocodone/Creatinine
61421-4,Norhydrocodone
61422-2,Norhydrocodone
61423-0,Noroxycodone/Creatinine
Apr-42,Hornet venom Ab.IgE
61424-8,Noroxycodone
61425-5,Noroxycodone
61426-3,Nortriptyline/Creatinine
61427-1,Nortriptyline
61428-9,Nortriptyline
61429-7,Tapentadol/Creatinine
61430-5,Aquaporin 4 water channel Ab
61431-3,PhenX measure - breastfeeding
Feb-43,Horse dander Ab.IgE
61432-1,How old was sample person when he or she was first fed something other than breast milk or water
61433-9,How old was sample person when he or she completely stopped breastfeeding or being fed breast milk
61434-7,Was sample person ever breastfed or fed breast milk
61435-4,Calcium Intake (Daily) Protocols
61436-2,PhenX - calcium intake - pediatric protocol 050201
61437-0,"How often did you eat bread, toast or dinner rolls, including bread as part of a sandwich in past 30D"
61438-8,"Each time you ate bread, toast or dinner rolls, how much did you usually eat in the past 30D"
61439-6,How often did you eat cold cereal in the past 30D
6144-0,Tabanus spp Ab.IgE
61440-4,"When you ate cold cereal, how much did you usually eat in the past 30D"
61441-2,How often did you eat cheese in the past 30D
61442-0,"Each time you ate cheese, how much did you usually eat in the past 30D"
61443-8,"How often did you eat ice cream, ice cream bars, milk shakes, or frozen yogurt in the past 30D"
61444-6,"Each time you ate ice cream, ice cream bars, milkshakes, or frozen yogurt, how much did you usually eat in the past 30D"
61445-3,How often did you eat macaroni and cheese in the past 30D
61446-1,"Each time you ate macaroni and cheese, how much did you usually eat in the past 30D"
61447-9,"How often did you eat mexican foods such as tacos, tostados, burritos, tamales, fajitas, enchiladas, quesadillas, or chimichangas in the past 30D"
61448-7,"Each time you ate mexican foods, how much did you usually eat in the past 30D"
61449-5,How often did you drink milk as a beverage in the past 30D
61450-3,"Each time you drank milk, how much did you usually drink in the past 30D"
61451-1,What kind of milk did you usually drink in the past 30D
61452-9,How often was the orange juice you drank calcium fortified in the past 30D
61453-7,How often did you drink 100 percent orange juice in the past 30D
61454-5,"Each time you drank orange juice, how much did you usually drink in the past 30D"
61455-2,How often did you eat pizza in the past 30D
61456-0,"Each time you ate pizza, how much did you usually eat in past 30D"
Jul-45,House dust Ab.IgE
61457-8,How often did you eat yogurt in past 30D
61458-6,PhenX measure - calcium intake
61459-4,"How often did you eat cooked dried beans, such as refried beans, baked beans, bean soup, and pork and beans in past 30D"
61460-2,How often did you eat hot or cold cereals in past 30D
61461-0,"When you ate cereal, which kinds did you usually eat in past 30D"
61462-8,How often did you eat any kind of cheese in past 30D
61463-6,"How often did you eat cookies, cake, pie, or brownies in past 30D"
61464-4,"How often did you eat DOUGHNUTS, sweet rolls, Danish, muffins, or pop-tarts in past 30D"
May-46,House dust Ab.IgE
61465-1,"How often did you eat french fries, home fries, or hash brown potatoes in past 30D"
61466-9,"How often did you drink fruit flavored drinks with sugar (such as kool aid, hi C, lemonade, or cranberry cocktail) in past 30D"
61467-7,How often did you eat FRUIT in past 30D
61468-5,"How often did you drink 100 percent fruit juice, such as orange, mango, apple, and grape juices in past 30D"
61469-3,"Each time you ate cold cereal, how much did you usually eat in the past 30D"
61470-1,"Not counting lettuce salads, white potatoes, cooked dried beans, and not counting rice, how often did you eat OTHER VEGETABLES in past 30D"
61471-9,"How often did you eat a green leafy or lettuce SALAD, with or without other vegetables, in past 30D"
61472-7,How often did you have salsa in past 30D
Mar-47,Insulin bovine Ab.IgE
61473-5,"How often did you drink regular, carbonated soda or soft drinks that contain sugar in past 30D"
61474-3,How often did you have tomato sauces such as spaghetti sauce or pizza with tomato sauce in past 30D
61475-0,How often did you eat other WHITE POTATOES in past 30D
61476-8,"How often did you eat whole grain bread including toast, rolls and in sandwiches in past 30D"
61477-6,PhenX measure - caffeine intake
61478-4,"How often did you drink black tea such as lipton, or earl grey"
61479-2,"What is your serving size for black tea such as lipton, or earl grey"
614-8,Mycobacterial strain
61480-0,"How often did you drink brewed coffee, not decaffeinated"
Jan-48,Insulin human Ab.IgE
61481-8,"What is your serving size for brewed coffee, not decaffeinated"
61482-6,How often did you drink decaffeinated coffee (instant & brewed)
61483-4,What is your serving size for decaffeinated coffee (instant & brewed)
61484-2,"How often did you drink decaffeinated espresso and espresso drinks (latte, mocha, americano)"
61485-9,What is your serving size for decaffeinated espresso and espresso drinks
61486-7,"How often did you drink herbal or decaffeinated tea (instant, bottled, and brewed)"
61487-5,"What is your serving size for herbal or decaffeinated tea (instant, bottled, and brewed)"
61488-3,How often did you drink diet colas and diet root beer (caffeine free)
61489-1,What is your serving size for diet colas and diet root beer (caffeine free)
61490-9,How often did you drink diet colas and diet root beer (with caffeine)
61491-7,What is your serving size for diet colas and diet root beer (with caffeine)
61492-5,"How often did you drink espresso and espresso drinks, not decaffeinated (latte, mocha, americano)"
61493-3,"What is your serving size for espresso and espresso drinks, not decaffeinated (latte, mocha, americano)"
61494-1,How often did you drink green tea
61495-8,What is your serving size for green tea
61496-6,"How often did you drink jolt, surge, mountain dew, red bull and other highly caffeinated sodas"
61497-4,"What is your serving size for jolt, surge, mountain dew, red bull and other highly caffeinated sodas"
61498-2,"How often did you drink instant coffee, not decaffeinated (including flavored types)"
Sep-49,Insulin porcine Ab.IgE
61499-0,"What is your serving size for instant coffee, not decaffeinated (including flavored types)"
61500-5,"How often did you drink regular colas and root beer (caffeine free, not diet)"
61501-3,"What is your serving size for regular colas and root beer (caffeine free, not diet)"
61502-1,"How often did you drink regular colas and root beer (with caffeine, not diet)"
61503-9,"What is your serving size for regular colas and root beer (with caffeine, not diet)"
61504-7,PhenX measure - dairy food intake
61505-4,How many Y did you take zinc
61506-2,How often did you eat whole grain bread in past 30D
Jul-50,Ispaghula laxative Ab.IgE
61507-0,"Not counting lettuce salads, white potatoes, cooked dried beans, and not counting rice, how often did you eat other vegetables in past 30D"
61508-8,"How often did you have MILK, either to drink or on cereal in past 30D"
61509-6,PhenX measure - dietary supplements
61510-4,How often did you take B complex or stress tab type multiple vitamins
61511-2,How many Y did you take B complex or stress tab type multiple vitamins
61512-0,"How often did you take calcium, alone or combined with something else such as in a bone health supplement or in an antacid"
61513-8,"How many Y did you take calcium, alone or combined with something else such as in a bone health supplement or in an antacid"
61514-6,"Did you take any dietary supplements during the past Y, at least once a W"
May-51,Cupressus sempervirens Ab.IgE
61515-3,How often did you take flaxseed
61516-1,How many Y did you take flaxseed
61517-9,"How often did you take folic acid, folate"
61518-7,"How often did you take garlic, as a pill, tablet, or capsule"
61519-5,"How many Y did you take garlic, as a pill, tablet, or capsule"
61520-3,"How often did you take glucosamine, alone or combined with something else"
61521-1,"How many Y did you take glucosamine, alone or combined with something else"
61522-9,How often did you take iron
Mar-52,Sorghum halepense Ab.IgE
61523-7,How many Y did you take iron
61524-5,How often did you take fish oil or omega 3 fatty acids
61525-2,How many Y did you take fish oil or omega 3 fatty acids
61526-0,"How often did you take regular one a day type, centrum or thera type multiple vitamins"
61527-8,"How many Y did you take regular one a day type, centrum or thera type multiple vitamins"
61528-6,How often did you take coenzyme Q 10
61529-4,How many Y did you take coenzyme Q 10
61530-2,How often did you take saw palmetto
Jan-53,Poa pratensis Ab.IgE
61531-0,How many Y did you take saw palmetto
61532-8,How often did you take selenium
61533-6,How many Y did you take selenium
61534-4,How often did you take vitamin B 12
61535-1,How many Y did you take vitamin B 12
61536-9,How often did you take vitamin B 6
61537-7,How many Y did you take vitamin B 6
61538-5,How often did you take vitamin C
61539-3,"When you took vitamin C, how much did you usually take"
61540-1,How many Y did you take vitamin C
61541-9,"How often did you take vitamin D, alone"
61542-7,"How many Y did you take vitamin D, alone"
61543-5,How often did you take vitamin E
61544-3,"When you took vitamin E, how much did you usually take"
61545-0,How many Y did you take vitamin E
61546-8,"How many Y did you take folic acid, folate"
61547-6,How often did you take zinc
61548-4,PhenX measure - fiber intake
Sep-54,Actinidia chinensis Ab.IgE
61549-2,"How often did you have milk, either to drink or on cereal in past 30D"
615-5,Viral strain
61550-0,"How often did you drink fruit flavored drinks with sugar (such as kool aid, hi C, lemonade, or cranberry cocktail) in past 30D"
61551-8,How often did you eat fruit in past 30D
61552-6,"How often did you eat a green leafy or lettuce salad, with or without other vegetables in past 30D"
61553-4,How often did you eat other white potatoes in past 30D
61554-2,"How often did you eat doughnuts, sweet rolls, danish, muffins, or pop-tarts in past 30D"
61555-9,"How often did you eat COOKIES, CAKE, PIE, or BROWNIES in past 30D"
Jun-55,Lamb Ab.IgE
61556-7,PhenX measure - fruits and vegetables intake
61557-5,PhenX measure - percent energy from fat
61558-3,How often did you eat cold cereal in the past 12Mo
61559-1,"About how often did you drink skim milk, on cereal or to drink in past 12Mo"
61560-9,"About how often did you eat eggs, fried or scrambled in margarine, butter, or oil in past 12Mo"
61561-7,"About how often did you eat sausage or bacon, regular fat, in past 12Mo"
61562-5,"About how often did you eat margarine or butter on bread, rolls, pancakes in past 12Mo"
61563-3,About how often did you drink orange juice or grapefruit juice in past 12Mo
Apr-56,Chenopodium album Ab.IgE
61564-1,About how often did you eat fruit (not juices) in past 12Mo
61565-8,"About how often did you eat beef or pork hot dogs, regular fat, in past 12Mo"
61566-6,"About how often did you eat cheese or cheese spread, regular fat, in past 12Mo"
61567-4,"About how often did you eat french fries, home fries, or hash brown potatoes in past 12Mo"
61568-2,"About how often did you eat margarine or butter on vegetables, including potatoes in past 12Mo"
61569-0,"About how often did you eat mayonnaise, regular fat, in past 12Mo"
61570-8,"About how often did you eat salad dressings, regular fat, in past 12Mo"
61571-6,About how often did you eat rice in past 12Mo
Feb-57,Mutton Ab.IgE
61572-4,"About how often did you eat margarine, butter, or oil on rice or pasta in past 12Mo"
61573-2,"When you prepared foods with margarine or ate margarine in past 12Mo, how often did you use reduced fat margarine"
61574-0,"Overall, when you think about the foods you ate over the past 12Mo, would you say your diet was high, medium, or low in fat"
61575-7,"When you ate cereal, which kinds did you usually eat in past 30D"
61576-5,PROMIS short form - global - version 1.1
61577-3,"In general, would you say your health is"
61578-1,"In general, would you say your quality of life is"
61579-9,"In general, how would you rate your physical health"
6158-0,Latex Ab.IgE
61580-7,"In general, how would you rate your mental health, including your mood and your ability to think"
61581-5,"In general, how would you rate your satisfaction with you social activities and relationships"
61582-3,"To what extent are you able to carry out your everyday physical activities such as walking, climbing stairs, carrying groceries, or moving a chair"
61583-1,How would you rate your pain on average in past 7D
61584-9,How would you rate your fatigue on average in past 7D
61585-6,"In general, please rate how well you carry out your usual social activities and roles"
61586-4,"How often have you been bothered by emotional problems such as feeling anxious, depressed or irritable in past 7D"
61587-2,PROMIS item bank - physical function - version 1.0
61588-0,"Does your health now limit you in doing vigorous activities, such as running, lifting heavy objects, participating in strenuous sports"
61589-8,"Does your health now limit you in bending, kneeling, or stooping"
61590-6,"Does your health now limit you in doing heavy work around the house like scrubbing floors, or lifting or moving heavy furniture"
61591-4,Does your health now limit you in lifting or carrying groceries
61592-2,Does your health now limit you in bathing or dressing yourself
61593-0,How much do physical health problems now limit your usual physical activities (such as walking or climbing stairs)
61594-8,Are you able to move a chair from one room to another
61595-5,Are you able to bend down and pick up clothing from the floor
61596-3,Are you able to stand for one hour
61597-1,Are you able to do chores such as vacuuming or yard work
Aug-59,Citrus limon Ab.IgE
61598-9,Are you able to push open a heavy door
61599-7,Are you able to exercise for an hour
61600-3,Are you able to carry a heavy object (over 10 pounds)
61601-1,Are you able to stand up from an armless straight chair
61602-9,"Are you able to dress yourself, including tying shoelaces and doing buttons"
61603-7,Are you able to reach into a high cupboard
61604-5,Are you able to use a hammer to pound a nail
61605-2,Are you able to run or jog for two miles
Jun-60,Lepidoglyphus destructor Ab.IgE
61606-0,Are you able to cut your food using eating utensils
61607-8,Are you able to go up and down stairs at a normal pace
61608-6,Are you able to open previously opened jars
61609-4,Are you able to go for a walk of at least 15 minutes
61610-2,"Are you able to do yard work like raking leaves, weeding, or pushing a lawn mower"
61611-0,Are you able to open a can with a hand can opener
61612-8,Are you able to pull heavy objects (10 pounds) towards yourself
61613-6,Are you able to step up and down curbs
Apr-61,Lactuca sativa Ab.IgE
61614-4,Are you able to get up off the floor from lying on your back without help
61615-1,Are you able to stand with your knees straight
61616-9,Are you able to exercise hard for half an hour
61617-7,Are you able to wash your back
61618-5,Are you able to open and close a zipper
61619-3,Are you able to put on and take off a coat or jacket
61620-1,Are you able to stand for short periods of time
61621-9,Are you able to dry your back with a towel
Feb-62,Syringa vulgaris Ab.IgE
61622-7,Are you able to run at a fast pace for two miles
61623-5,Are you able to turn a key in a lock
61624-3,Are you able to squat and get up
61625-0,Are you able to carry a laundry basket up a flight of stairs
61626-8,Are you able to write with a pen or pencil
61627-6,Are you able to put on a shirt or blouse
61628-4,Are you able to get out of bed into a chair
61629-2,Are you able to pull on trousers
616-3,Bacteria identified
6163-0,Citrus aurantifolia tree Ab.IgE
61630-0,Are you able to peel fruit
61631-8,Are you able to bend or twist your back
61632-6,Are you able to brush your teeth
61633-4,Are you able to sit on the edge of a bed
61634-2,Are you able to tie your shoelaces
61635-9,Are you able to run errands and shop
61636-7,Are you able to button your shirt
61637-5,Are you able to wash and dry your body
61638-3,Are you able to get in and out of a car
61639-1,"Does your health now limit you in doing moderate work around the house like vacuuming, sweeping floors or carrying in groceries"
61640-9,Does your health now limit you in putting a trash bag outside
61641-7,"Does your health now limit you in hiking a couple of miles on uneven surfaces, including hills"
61642-5,"Does your health now limit you in doing strenuous activities such as backpacking, skiing, playing tennis, bicycling or jogging"
61643-3,Are you able to carry two bags filled with groceries 100 yards
61644-1,Are you able to jump up and down
61645-8,Are you able to climb up five steps
61646-6,"Are you able to wash dishes, pots, and utensils by hand while standing at a sink"
61647-4,"Are you able to make a bed, including spreading and tucking in bed sheets"
Aug-64,Quercus virginiana Ab.IgE
61648-2,Are you able to carry a shopping bag or briefcase
61649-0,Are you able to take a tub bath
61650-8,Are you able to change the bulb in a table lamp
61651-6,Are you able to press with your index finger (for example ringing a doorbell)
61652-4,Are you able to put on and take off your socks
61653-2,Are you able to shave your face or apply makeup
61654-0,Are you able to squeeze a new tube of toothpaste
May-65,Homarus gammarus Ab.IgE
61655-7,Are you able to cut a piece of paper with scissors
61656-5,Are you able to pick up coins from a table top
61657-3,Are you able to hold a plate full of food
61658-1,Are you able to pour liquid from a bottle into a glass
61659-9,"Are you able to run a short distance, such as to catch a bus"
61660-7,Are you able to push open a door after turning the knob
61661-5,Are you able to shampoo your hair
61662-3,Are you able to tie a knot or a bow
Mar-66,Malt Ab.IgE
61663-1,Are you able to lift 10 pounds above your shoulder
61664-9,Are you able to lift a full cup or glass to your mouth
61665-6,Are you able to open a new milk carton
61666-4,Are you able to open car doors
61667-2,Are you able to stand unsupported for 10 minutes
61668-0,Are you able to remove something from your back pocket
61669-8,Are you able to change a light bulb overhead
61670-6,Are you able to put on a pullover sweater
Jan-67,Mangifera indica Ab.IgE
61671-4,Are you able to turn faucets on and off
61672-2,Are you able to reach and get down a 5 pound object from above your head
61673-0,Are you able to stand up on tiptoes
61674-8,Are you able to trim your fingernails
61675-5,Are you able to stand unsupported for 30 minutes
61676-3,"Does your health now limit you in taking care of your personal needs (dress, comb hair, toilet, eat, bathe)"
61677-1,"Does your health now limit you in doing moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf"
61678-9,Does your health now limit you in taking a shower
61679-7,Does your health now limit you in going for a short walk (less than 15 minutes)
61680-5,"How much difficulty do you have doing your daily physical activities, because of your health"
61681-3,"Does your health now limit you in participating in active sports such as swimming, tennis, or basketball"
61682-1,"Does your health now limit you in going outside the home, for example to shop or visit a doctor's office"
61683-9,Are you able to lift one pound (a full pint container) to shoulder level without bending your elbow
61684-7,Physical Function - Pediatric Protocol
61685-4,Are you able to walk a block on flat ground
61686-2,Are you able to run five miles
61687-0,Does your health now limit you in climbing several flights of stairs
61688-8,Does your health now limit you in doing 2H of physical labor
Sep-68,Maple Ab.IgE
61689-6,Are you able to run 100 yards
61690-4,Does your health now limit you in walking one hundred yards
61691-2,Are you able to walk up and down two steps
61692-0,Are you able to reach into a low cupboard
61693-8,Are you able to climb up 5 flights of stairs
61694-6,Are you able to run ten miles
61695-3,Does your health now limit you in walking several hundred yards
61696-1,Does your health now limit you in doing 8H of physical labor
Jul-69,Festuca elatior Ab.IgE
61697-9,Does your health now limit you in walking more than a mile
61698-7,Does your health now limit you in climbing one flight of stairs
61699-5,Are you able to walk at a normal speed
61700-1,Are you able to stand without losing your balance for several minutes
61701-9,Are you able to kneel on the floor
61702-7,"Are you able to sit down in and stand up from a low, soft couch"
61703-5,"Are you able to use your hands, such as for turning faucets, using kitchen gadgets, or sewing"
61704-3,Are you able to get on and off the toilet
May-70,Alopercurus pratensis Ab.IgE
61705-0,Are you able to transfer from a bed to a chair and back
61706-8,Are you able to be out of bed most of the day
61707-6,Are you able to water a house plant
61708-4,Are you able to wipe yourself after using the toilet
61709-2,Are you able to turn from side to side in bed
617-1,Bacteria identified
61710-0,Are you able to get in and out of bed
61711-8,Does your health now limit you in getting in and out of the bathtub
61712-6,Does your health now limit you in walking about the house
Mar-71,Melaleuca leucadendron Ab.IgE
61713-4,Pain Protocols
61714-2,When I was in pain I became irritable in past 7D
61715-9,When I was in pain I grimaced in past 7D
61716-7,When I was in pain I would lie down in past 7D
61717-5,When I was in pain I moved extremely slowly in past 7D
61718-3,When I was in pain I became angry in past 7D
61719-1,When I was in pain I clenched my teeth in past 7D
61720-9,When I was in pain I tried to stay very still in past 7D
Jan-72,Cucumis melo spp Ab.IgE
61721-7,When I was in pain I appeared upset or sad in past 7D
61722-5,When I was in pain I gasped in past 7D
61723-3,When I was in pain I asked for help doing things that needed to be done in past 7D
61724-1,"When I was in pain it showed on my face (squinching eyes, opening eyes wide, frowning) in past 7D"
61725-8,Pain caused me to bend over while walking in past 7D
61726-6,When I was in pain I asked one or more people to leave me alone in past 7D
61727-4,When I was in pain I moved stiffly in past 7D
61728-2,When I was in pain I called out for someone to help me in past 7D
61729-0,Pain caused me to curl up in a ball in past 7D
61730-8,I had pain so bad it made me cry in past 7D
61731-6,When I was in pain I squirmed in past 7D
61732-4,When I was in pain I used a cane or something else for support in past 7D
61733-2,I limped because of pain in past 7D
61734-0,When I was in pain I became quiet and withdrawn in past 7D
61735-7,When I was in pain I frowned in past 7D
61736-5,When I was in pain I asked for help when walking or changing positions in past 7D
61737-3,When I was in pain I groaned in past 7D
61738-1,When I was in pain I isolated myself from others in past 7D
Sep-73,Prosopis juliflora Ab.IgE
61739-9,When I was in pain I drew my knees up in past 7D
61740-7,"When I was in pain I moaned, whined or whimpered in past 7D"
61741-5,When I was in pain I flung my arms or limbs around in past 7D
61742-3,When I was in pain I screamed in past 7D
61743-1,When I was in pain my upper body would tense up in past 7D
61744-9,When I was in pain I walked carefully in past 7D
61745-6,When I was in pain I bit or pursed my lips in past 7D
61746-4,When I was in pain I thrashed in past 7D
Jul-74,Milk Ab.IgE
61747-2,When I was in pain I protected the part of my body that hurt in past 7D
61748-0,When I was in pain my body became stiff in past 7D
61749-8,When I was in pain I clenched my jaw or gritted my teeth in past 7D
61750-6,When I was in pain I winced in past 7D
61751-4,When I was in pain I moved my limbs protectively in past 7D
61752-2,When I was in pain I avoided physical contact with others in past 7D
61753-0,PROMIS item bank - pain interference - version 1.0
Apr-75,Panicum milliaceum Ab.IgE
61754-8,How difficult was it for you to take in new information because of pain in past 7D
61755-5,How much did pain interfere with your ability to participate in leisure activities in past 7D
61756-3,How much did pain interfere with your close personal relationships in past 7D
61757-1,How much did pain interfere with your ability to concentrate in past 7D
61758-9,How much did pain interfere with your day to day activities in past 7D
61759-7,How much did pain interfere with your enjoyment of recreational activities in past 7D
61760-5,How often did you feel emotionally tense because of your pain in past 7D
61761-3,How much did pain interfere with the things you usually do for fun in past 7D
Feb-76,Mimosa spp Ab.IgE
61762-1,How much did pain interfere with your family life in past 7D
61763-9,"How much did pain interfere with doing your tasks away from home (e.g., getting groceries, running errands) in past 7D"
61764-7,How often did pain make you feel depressed in past 7D
61765-4,How much did pain interfere with your relationships with other people in past 7D
61766-2,How much did pain interfere with your ability to work (include work at home) in past 7D
61767-0,How much did pain make it difficult to fall asleep in past 7D
61768-8,How much did pain feel like a burden to you in past 7D
61769-6,How much did pain interfere with work around the home in past 7D
6177-0,Aedes communis Ab.IgE
61770-4,How often was pain distressing to you in past 7D
61771-2,How often did pain keep you from socializing with others in past 7D
61772-0,How often was your pain so severe you could think of nothing else in past 7D
61773-8,How much did pain interfere with your ability to participate in social activities in past 7D
61774-6,How often did pain make you feel discouraged in past 7D
61775-3,How much did pain interfere with your household chores in past 7D
61776-1,How much did pain interfere with your ability to make trips from home that kept you gone for more than 2H in past 7D
61777-9,How much did pain interfere with your enjoyment of social activities in past 7D
61778-7,How often did pain make you feel anxious in past 7D
61779-5,How often did you avoid social activities because it might make you hurt more in past 7D
61780-3,How often did pain make simple tasks hard to complete in past 7D
61781-1,How often did pain prevent you from walking more than 1 mile in past 7D
61782-9,How often did pain prevent you from standing for more than one hour in past 7D
61783-7,How often did pain make it difficult for you to plan social activities in past 7D
61784-5,How often did pain prevent you from standing for more than 30 minutes in past 7D
61785-2,How much did pain interfere with your ability to do household chores in past 7D
61786-0,How much did pain interfere with your ability to remember things in past 7D
61787-8,How often did pain prevent you from sitting for more than 30 minutes in past 7D
Aug-78,Juniperus sabinoides Ab.IgE
61788-6,How often did pain prevent you from sitting for more than 10 minutes in past 7D
61789-4,How often was it hard to plan social activities because you didn't know if you would be in pain in past 7D
61790-2,How often did pain restrict your social life to your home in past 7D
61791-0,How often did pain keep you from getting into a standing position in past 7D
61792-8,How often did pain prevent you from sitting for more than one hour in past 7D
61793-6,How irritable did you feel because of pain in past 7D
61794-4,How much did pain interfere with your enjoyment of life in past 7D
61795-1,PROMIS item bank - fatigue - version 1.0
Jun-79,Mouse epithelium Ab.IgE
61796-9,To what degree did you have to push yourself to get things done because of your fatigue in past 7D
61797-7,To what degree did your fatigue make you feel slowed down in your thinking in past 7D
61798-5,How often did you have to push yourself to get things done because of your fatigue in past 7D
61799-3,How often did your fatigue interfere with your social activities in past 7D
61800-9,How often are you less effective at work due to your fatigue (include work at home) in past 7D
61801-7,How often did your fatigue make you feel slowed down in your thinking in past 7D
61802-5,How often were you too tired to watch television in past 7D
61803-3,How often did your fatigue make it difficult to plan activities ahead of time in past 7D
Apr-80,Mouse serum proteins Ab.IgE
61804-1,How often did your fatigue make it difficult to start anything new in past 7D
61805-8,How often did your fatigue make you more forgetful in past 7D
61806-6,How often were you too tired to do errands in past 7D
61807-4,How often did your fatigue make it difficult to organize your thoughts when doing things at work (include work at home) in past 7D
61808-2,How often did your fatigue interfere with your ability to engage in recreational activities in past 7D
61809-0,How often did you have trouble finishing things because of your fatigue in past 7D
61810-8,How often did your fatigue make it difficult to make decisions in past 7D
61811-6,How often did you have to limit your social activities because of your fatigue in past 7D
Feb-81,Mouse urine proteins Ab.IgE
61812-4,How often were you too tired to do your household chores in past 7D
61813-2,How often did your fatigue make you feel less alert in past 7D
61814-0,How often were you too tired to take a bath or shower in past 7D
61815-7,How often did your fatigue make it difficult to organize your thoughts when doing things at home in past 7D
61816-5,How often did you have trouble starting things because of your fatigue in past 7D
61817-3,How often was it an effort to carry on a conversation because of your fatigue in past 7D
61818-1,How often were you too tired to socialize with your family in past 7D
61819-9,To what degree did you have trouble starting things because of your fatigue in past 7D
6182-0,Mucor racemosus Ab.IgE
61820-7,How hard was it for you to carry on a conversation because of your fatigue in past 7D
61821-5,How often were you too tired to leave the house in past 7D
61822-3,How often were you too tired to think clearly in past 7D
61823-1,How often did your fatigue limit you at work (include work at home) in past 7D
61824-9,To what degree did you have to limit your social activities because of your fatigue in past 7D
61825-6,To what degree did your fatigue make it difficult to organize your thoughts when doing things at home in past 7D
61826-4,To what degree did your fatigue make it difficult to start anything new in past 7D
61827-2,Due to your fatigue were you less effective at work (include work at home) in past 7D
61828-0,To what degree did your fatigue make it difficult to make decisions in past 7D
61829-8,How often did you have enough energy to exercise strenuously in past 7D
61830-6,How often were you less effective at home due to your fatigue in past 7D
61831-4,To what degree did your fatigue make it difficult to organize your thoughts when doing things at work (include work at home) in past 7D
61832-2,To what degree did your fatigue make you more forgetful in past 7D
61833-0,To what degree did your fatigue interfere with your ability to engage in recreational activities in past 7D
61834-8,To what degree did you have to force yourself to get up and do things because of your fatigue in past 7D
61835-5,To what degree did your fatigue interfere with your social activities in past 7D
61836-3,To what degree did your fatigue interfere with your physical functioning in past 7D
61837-1,Did fatigue make you less effective at home in past 7D
Aug-83,Artemisia vulgaris Ab.IgE
61838-9,To what degree did you have trouble finishing things because of your fatigue in past 7D
61839-7,To what degree did your fatigue make you feel less alert in past 7D
61840-5,How often were you too tired to take a short walk in past 7D
61841-3,How often did you have to force yourself to get up and do things because of your fatigue in past 7D
61842-1,How often were you too tired to socialize with your friends in past 7D
61843-9,How often did you feel run-down in past 7D
61844-7,How often did you experience extreme exhaustion in past 7D
61845-4,How often did you feel tired even when you hadn't done anything in past 7D
Jun-84,Mussel Ab.IgE
61846-2,How often did you feel your fatigue was beyond your control in past 7D
61847-0,To what degree did you feel tired even when you hadn't done anything in past 7D
61848-8,How bushed were you on average in past 7D
61849-6,How often were you sluggish in past 7D
61850-4,How often did you run out of energy in past 7D
61851-2,How often were you physically drained in past 7D
61852-0,How often did you feel tired in past 7D
Mar-85,Mustard Ab.IgE
61853-8,How fatigued were you when your fatigue was at its worst in past 7D
61854-6,How often were you bothered by your fatigue in past 7D
61855-3,How often did you have enough energy to enjoy the things you do for fun in past 7D
61856-1,How often were you too tired to enjoy life in past 7D
61857-9,How often were you too tired to feel happy in past 7D
61858-7,How often did you feel totally drained in past 7D
61859-5,How often were you energetic in past 7D
61860-3,How tired did you feel on average in past 7D
Jan-86,Urtica dioica Ab.IgE
61861-1,How much were you bothered by your fatigue on average in past 7D
61862-9,How exhausted were you on average in past 7D
61863-7,How fatigued were you on the day you felt most fatigued in past 7D
61864-5,How fatigued were you on average in past 7D
61865-2,How run-down did you feel on average in past 7D
61866-0,How much mental energy did you have on average in past 7D
61867-8,How physically drained were you on average in past 7D
61868-6,How energetic were you on average in past 7D
61869-4,How sluggish were you on average in past 7D
61870-2,On how many D was your fatigue worse in the morning in past 7D
61871-0,How often did you find yourself getting tired easily in past 7D
61872-8,How often did you think about your fatigue in past 7D
61873-6,How fatigued were you on the day you felt least fatigued in past 7D
61874-4,How easily did you find yourself getting tired on average in past 7D
61875-1,How wiped out were you on average in past 7D
61876-9,How often did you have physical energy in past 7D
61877-7,What was the level of your fatigue on most D in past 7D
61878-5,I feel fatigued during the past 7D
Sep-87,Neurospora sitophila Ab.IgE
61879-3,I felt weak all over in past 7D
61880-1,I felt listless (washed out) in past 7D
61881-9,I felt tired in past 7D
61882-7,I had trouble starting things because I was tired in past 7D
61883-5,I had trouble finishing things because I was tired in past 7D
61884-3,I needed to sleep during the day in past 7D
61885-0,I was too tired to eat in past 7D
61886-8,I needed help doing my usual activities in past 7D
Jul-88,Nutmeg Ab.IgE
61887-6,I was frustrated by being too tired to do the things I want to do in past 7D
61888-4,I had to limit my social activity because I was tired in past 7D
61889-2,I had energy in past 7D
618-9,Bacteria identified
61890-0,I am able to do my usual activities in past 7D
61891-8,Emotional Distress Protocols
61892-6,PROMIS item bank - emotional distress - anger - version 1.0
61893-4,"When I was frustrated, I let it show in past 7D"
61894-2,I was irritated more than people knew in past 7D
May-89,Quercus alba Ab.IgE
61895-9,I felt envious of others in past 7D
61896-7,I disagreed with people in past 7D
61897-5,I made myself angry about something just by thinking about it in past 7D
61898-3,I tried to get even when I was angry with someone in past 7D
61899-1,I felt angry in past 7D
61900-7,"When I was mad at someone, I gave them the silent treatment in past 7D"
61901-5,I felt like breaking things in past 7D
61902-3,I felt like I was ready to explode in past 7D
Mar-90,Avena sativa Ab.IgE
61903-1,"When I was angry, I sulked in past 7D"
61904-9,I felt resentful when I didn't get my way in past 7D
61905-6,I felt guilty about my anger in past 7D
61906-4,I felt bitter about things in past 7D
61907-2,I felt people are trying to anger me in past 7D
61908-0,I stayed angry for hours in past 7D
61909-8,I held grudges towards others in past 7D
61910-6,I felt angrier than I thought I should in past 7D
Jan-91,Avena sativa cultivated Ab.IgE
61911-4,I was grouchy in past 7D
61912-2,I was stubborn with others in past 7D
61913-0,I felt annoyed in past 7D
61914-8,I had a bad temper in past 7D
61915-5,I had trouble controlling my temper in past 7D
61916-3,I was angry when I was delayed in past 7D
61917-1,"Even when I expressed my anger, I had trouble forgetting about it in past 7D"
61918-9,I felt like I needed help for my anger in past 7D
61919-7,I was angry when something blocked my plans in past 7D
61920-5,I felt like yelling at someone in past 7D
61921-3,Just being around people irritated me in past 7D
61922-1,PROMIS item bank - emotional distress - anxiety - version 1.0
61923-9,I felt fearful in past 7D
61924-7,I felt frightened in past 7D
61925-4,It scared me when I felt nervous in past 7D
61926-2,I felt anxious in past 7D
61927-0,I felt like I needed help for my anxiety in past 7D
61928-8,I was concerned about my mental health in past 7D
Sep-92,Olea europaea pollen Ab.IgE
61929-6,I felt upset in past 7D
61930-4,I had a racing or pounding heart in past 7D
61931-2,I was anxious if my normal routine was disturbed in past 7D
61932-0,I had sudden feelings of panic in past 7D
61933-8,I was easily startled in past 7D
61934-6,I had trouble paying attention in past 7D
61935-3,I avoided public places or activities in past 7D
61936-1,I felt fidgety in past 7D
Jul-93,Allium cepa Ab.IgE
61937-9,I felt something awful would happen in past 7D
61938-7,I felt worried in past 7D
61939-5,I felt terrified in past 7D
61940-3,I worried about other people's reactions to me in past 7D
61941-1,I found it hard to focus on anything other than my anxiety in past 7D
61942-9,My worries overwhelmed me in past 7D
61943-7,I had twitching or trembling muscles in past 7D
61944-5,I felt nervous in past 7D
May-94,Citrus sinensis Ab.IgE
61945-2,I felt indecisive in past 7D
61946-0,Many situations made me worry in past 7D
61947-8,I had difficulty sleeping in past 7D
61948-6,I had trouble relaxing in past 7D
61949-4,I felt uneasy in past 7D
61950-2,I felt tense in past 7D
61951-0,I had difficulty calming down in past 7D
Feb-95,Dactylis glomerata Ab.IgE
61952-8,PROMIS item bank - emotional distress - depression - version 1.0
61953-6,I felt worthless in past 7D
61954-4,I felt that I had nothing to look forward to in past 7D
61955-1,I felt helpless in past 7D
61956-9,I withdrew from other people in past 7D
61957-7,I felt that nothing could cheer me up in past 7D
61958-5,I felt that I was not as good as other people in past 7D
61959-3,I felt sad in past 7D
6196-0,Chrysanthemum leucanthemum Ab.IgE
61960-1,I felt that I wanted to give up on everything in past 7D
61961-9,I felt that I was to blame for things in past 7D
61962-7,I felt like a failure in past 7D
61963-5,I had trouble feeling close to people in past 7D
61964-3,I felt disappointed in myself in past 7D
61965-0,I felt that I was not needed in past 7D
61966-8,I felt lonely in past 7D
61967-6,I felt depressed in past 7D
61968-4,I had trouble making decisions in past 7D
61969-2,I felt discouraged about the future in past 7D
619-7,Bacteria identified
61970-0,I found that things in my life were overwhelming in past 7D
61971-8,I felt unhappy in past 7D
61972-6,I felt I had no reason for living in past 7D
61973-4,I felt hopeless in past 7D
61974-2,I felt ignored by people in past 7D
61975-9,I felt upset for no reason in past 7D
61976-7,I felt that nothing was interesting in past 7D
61977-5,I felt pessimistic in past 7D
Aug-97,Paecilomyces sp Ab.IgE
61978-3,I felt that my life was empty in past 7D
61979-1,I felt guilty in past 7D
61980-9,I felt emotionally exhausted in past 7D
61981-7,Sleep Protocols
61982-5,PROMIS item bank - sleep disturbance - version 1.0
61983-3,My sleep was restful in past 7D
61984-1,My sleep was deep in past 7D
61985-8,I was satisfied with my sleep in past 7D
Jun-98,Polistes spp Ab.IgE
61986-6,My sleep was refreshing in past 7D
61987-4,My sleep quality was...in past 7D
61988-2,I got enough sleep in past 7D
61989-0,It was easy for me to fall asleep in past 7D
61990-8,I laid in bed for hours waiting to fall asleep in past 7D
61991-6,I woke up too early and could not fall back asleep in past 7D
61992-4,I had trouble staying asleep in past 7D
61993-2,I had trouble sleeping in past 7D
Apr-99,Parietaria judaica Ab.IgE
61994-0,I woke up and had trouble falling back to sleep in past 7D
61995-7,My sleep was light in past 7D
61996-5,My sleep was restless in past 7D
61997-3,I felt lousy when I woke up in past 7D
61998-1,I had a problem with my sleep 7D
61999-9,I had difficulty falling asleep in past 7D
62-0,Carbenicillin
6200-0,Parietaria officinalis Ab.IgE
62000-5,I felt physically tense at bedtime in past 7D
62001-3,I worried about not being able to fall asleep in past 7D
62002-1,I felt worried at bedtime in past 7D
62003-9,I had trouble stopping my thoughts at bedtime in past 7D
62004-7,I felt sad at bedtime in past 7D
62005-4,I had trouble getting into a comfortable position to sleep in past 7D
62006-2,I tried hard to get to sleep in past 7D
62007-0,Stress disturbed my sleep in past 7D
62008-8,I tossed and turned at night in past 7D
62009-6,I was afraid I would not get back to sleep after waking up in past 7D
62010-4,PROMIS item bank - sleep related impairment - version 1.0
62011-2,I tried to sleep whenever I could in past 7D
62012-0,My daytime activities are disturbed by poor sleep in past 7D
62013-8,I was sleepy during the daytime in past 7D
62014-6,I had trouble staying awake during the day in past 7D
62015-3,I had a hard time getting things done because I was sleepy in past 7D
62016-1,I had a hard time concentrating because I was sleepy in past 7D
62017-9,I had problems during the day because of poor sleep in past 7D
Aug-01,Parrot droppings Ab.IgE
62018-7,I had a hard time concentrating because of poor sleep in past 7D
62019-5,I felt irritable because of poor sleep in past 7D
62020-3,I had a hard time controlling my emotions because of poor sleep in past 7D
62021-1,I had difficulty waking up in past 7D
62022-9,I still felt sleepy when I woke up in past 7D
62023-7,I had enough energy in past 7D
62024-5,I felt alert when I woke up in past 7D
62025-2,When I woke up I felt ready to start the day in past 7D
Jun-02,Parrot feather Ab.IgE
62026-0,PROMIS item bank - satisfaction with participation in DSA - version 1.0
62027-8,I was satisfied with the amount of time I spend doing leisure activities in past 7D
62028-6,I was satisfied with my current level of social activity in past 7D
62029-4,I was satisfied with my ability to do all of the community activities that Are really important to me in past 7D
62030-2,I was satisfied with my ability to do things for my friends in past 7D
62031-0,I was satisfied with my ability to do leisure activities in past 7D
62032-8,I was satisfied with my current level of activities with my friends in past 7D
62033-6,I was satisfied with my ability to do things for fun outside my home in past 7D
Apr-03,Petroselinum crispum Ab.IgE
62034-4,I felt good about my ability to do things for my friends in past 7D
62035-1,I was happy with how much I do for my friends in past 7D
62036-9,I was satisfied with the amount of time I spend visiting friends in past 7D
62037-7,"I was satisfied with my ability to do things for fun at home (like reading, listening to music, etc.) in past 7D"
62038-5,I was satisfied with my ability to do all of the leisure activities that are really important to me in past 7D
62039-3,PROMIS item bank - satisfaction with participation in roles - version 1.0
62040-1,I was satisfied with my ability to do things for my family in past 7D
62041-9,I was satisfied with how much work I can do (include work at home) in past 7D
Feb-04,Pisum sativum Ab.IgE
62042-7,I feel good about my ability to do things for my family in past 7D
62043-5,I was satisfied with my ability to do the work that is really important to me (include work at home) in past 7D
62044-3,I was satisfied with the amount of time I spend doing work (include work at home) in past 7D
62045-0,I was happy with how much I do for my family in past 7D
62046-8,I was satisfied with my ability to work (include work at home) in past 7D
62047-6,The quality of my work is as good as I want it to be (include work at home) in past 7D
62048-4,I was satisfied with the amount of time I spend performing my daily routines in past 7D
62049-2,I was satisfied with my ability to do household chores and tasks in past 7D
620-5,Bacteria identified
62050-0,I was satisfied with my ability to do regular personal and household responsibilities in past 7D
62051-8,I was satisfied with my ability to perform my daily routines in past 7D
62052-6,I was satisfied with my ability to meet the needs of those who depend on me in past 7D
62053-4,I was satisfied with my ability to run errands in past 7D
62054-2,PROMIS pediatric item bank - emotional distress - anxiety - version 1.0
62055-9,I felt like something awful might happen in past 7D
62056-7,I got scared really easy in past 7D
62057-5,I felt scared in past 7D
62058-3,I worried about what could happen to me in past 7D
Sep-05,Prunus persica Ab.IgE
62059-1,I was worried I might die in past 7D
62060-9,I woke up at night scared in past 7D
62061-7,I worried when I went to bed at night in past 7D
62062-5,I worried when I was away from home in past 7D
62063-3,I worried when I was at home in past 7D
62064-1,I thought about scary things in past 7D
62065-8,I was afraid that I would make mistakes in past 7D
62066-6,I was afraid of going to school in past 7D
Jul-06,Arachis hypogaea Ab.IgE
62067-4,It was hard for me to relax in past 7D
62068-2,PROMIS pediatric item bank - asthma - version 1.0
62069-0,I felt scared that I might have trouble breathing because of my asthma in past 7D
62070-8,My chest felt tight because of my asthma in past 7D
62071-6,I felt wheezy because of my asthma in past 7D
62072-4,I had trouble sleeping at night because of my asthma in past 7D
62073-2,It was hard for me to play sports or exercise because of my asthma in past 7D
62074-0,It was hard to take a deep breath because of my asthma in past 7D
May-07,Pyrus communis Ab.IgE
62075-7,My asthma bothered me in past 7D
62076-5,I coughed because of my asthma in past 7D
62077-3,I got tired easily because of my asthma in past 7D
62078-1,I had asthma attacks in past 7D
62079-9,I had trouble walking because of my asthma in past 7D
62080-7,I missed school because of asthma in past 7D
62081-5,I was bothered by the amount of time I spent wheezing in past 7D
62082-3,It was hard for me to play with pets because of my asthma in past 7D
Mar-08,Carya illinoinensis nut Ab.IgE
62083-1,My asthma bothered me when I was with my friends in past 7D
62084-9,My body felt bad when I was out of breath in past 7D
62085-6,PROMIS pediatric short form - depressive symptoms - version 1.0
62086-4,I felt too sad to eat in past 7D
62087-2,I didn't care about anything in past 7D
62088-0,I wanted to be by myself in past 7D
62089-8,I thought that my life was bad in past 7D
62090-6,It was hard for me to have fun in past 7D
Jan-09,Carya illinoinensis tree Ab.IgE
62091-4,I felt alone in past 7D
62092-2,I could not stop feeling sad in past 7D
62093-0,I felt like I couldn't do anything right in past 7D
62094-8,I felt everything in my life went wrong in past 7D
62095-5,I felt stressed in past 7D
62096-3,Being sad made it hard for me to do things with my friends in past 7D
62097-1,PROMIS pediatric item bank - fatigue - version 1.0
62098-9,Being tired kept me from having fun in past 7D
62099-7,Being tired made it hard for me to keep up with my schoolwork in past 7D
62100-3,Being tired made it hard for me to play or go out with my friends as much as I'd like in past 7D
62101-1,I felt more tired than usual when I woke up in the morning in past 7D
62102-9,I felt too tired to spend time with my friends in past 7D
62103-7,I felt weak in past 7D
62104-5,I got tired easily in past 7D
62105-2,I had trouble finishing things because I was too tired in past 7D
62106-0,I had trouble starting things because I was too tired in past 7D
62107-8,I was so tired it was hard for me to focus on my work in past 7D
62108-6,I was so tired it was hard for me to pay attention in past 7D
Sep-10,Penicillin V Ab.IgE
62109-4,I was too tired to do sports or exercise in past 7D
62110-2,I was too tired to do things outside in past 7D
62111-0,I was too tired to enjoy the things I like to do in past 7D
62112-8,I was too tired to go out with my family in past 7D
62113-6,I was too tired to go up and down a lot of stairs in past 7D
62114-4,I was too tired to read in past 7D
62115-1,I was too tired to take a bath or shower in past 7D
62116-9,I was too tired to watch television in past 7D
Jul-11,Penicillium brevicompactum Ab.IgE
62117-7,PROMIS pediatric item bank - physical function - mobility - version 1.0
62118-5,I could ride a bike in past 7D
62119-3,I could get in and out of a car in past 7D
62120-1,I could walk more than one block in past 7D
62121-9,I could do sports and exercise that other kids my age could do in past 7D
62122-7,I could keep up when I played with other kids in past 7D
62123-5,I could get out of bed by myself in past 7D
62124-3,I could get into bed by myself in past 7D
May-12,Penicillium notatum Ab.IgE
62125-0,I could stand up by myself in past 7D
62126-8,I could get down on my knees without holding on to something in past 7D
62127-6,I could walk up stairs without holding on to anything in past 7D
62128-4,I used a wheelchair to get around in past 7D
62129-2,"I used a walker, cane or crutches to get around in past 7D"
621-3,Bacteria identified
62130-0,I could carry my books in my backpack in past 7D
62131-8,I could move my legs in past 7D
62132-6,I could get up from a regular toilet in past 7D
Mar-13,Schinus molle Ab.IgE
62133-4,I could get up from the floor in past 7D
62134-2,I could go up one step in past 7D
62135-9,I could stand up on my tiptoes in past 7D
62136-7,I could turn my head all the way to the side in past 7D
62137-5,I have been physically able to do the activities I enjoy most in past 7D
62138-3,I could run a mile in past 7D
62139-1,I could bend over to pick something up in past 7D
62140-9,I could walk across the room in past 7D
Jan-14,Perca spp Ab.IgE
62141-7,PROMIS pediatric item bank - pain interference - version 1.0
62142-5,I felt angry when I had pain in past 7D
62143-3,I had trouble doing schoolwork when I had pain in past 7D
62144-1,I had trouble sleeping when I had pain in past 7D
62145-8,I hurt a lot in past 7D
62146-6,It was hard for me to remember things when I had pain in past 7D
62147-4,I hurt all over my body in past 7D
62148-2,It was hard for me to run when I had pain in past 7D
62149-0,It was hard for me to walk one block when I had pain in past 7D
62150-8,I missed school when I had pain in past 7D
62151-6,It was hard to get along with other people when I had pain in past 7D
62152-4,It was hard to have fun when I had pain in past 7D
62153-2,It was hard to stay standing when I had pain in past 7D
62154-0,It was hard for me to pay attention when I had pain in past 7D
62155-7,PROMIS pediatric item bank - peer relationships - version 1.0
62156-5,I felt accepted by other kids my age in past 7D
62157-3,I felt good about my friendships in past 7D
Aug-15,Lolium perenne Ab.IgE
62158-1,I liked being around other kids my age in past 7D
62159-9,I played alone and kept to myself in past 7D
62160-7,"I shared with other kids (food, games, pens, etc) in past 7D"
62161-5,I spent time with my friends in past 7D
62162-3,I was a good friend in past 7D
62163-1,I was able to count on my friends in past 7D
62164-9,I was able to have fun with my friends in past 7D
62165-6,I was able to talk about everything with my friends in past 7D
Jun-16,Phoma betae Ab.IgE
62166-4,I was good at making friends in past 7D
62167-2,My friends and I helped each other out in past 7D
62168-0,Other kids wanted to be my friend in past 7D
62169-8,Other kids wanted to be with me in past 7D
62170-6,Other kids wanted to talk to me in past 7D
62171-4,PROMIS pediatric item bank - physical function - upper extremity - version 1.0
62172-2,I could button my shirt or pants in past 7D
62173-0,I could open a jar by myself in past 7D
Apr-17,Pigeon droppings Ab.IgE
62174-8,I could open the rings in school binders in past 7D
62175-5,I could pour a drink from a full pitcher in past 7D
62176-3,I could pull a shirt on over my head by myself in past 7D
62177-1,I could pull open heavy doors in past 7D
62178-9,I could put on my shoes by myself in past 7D
62179-7,I could use a key to unlock a door in past 7D
62180-5,PROMIS pediatric short form - emotional distress - anger - version 1.0
62181-3,I felt fed up in past 7D
Feb-18,Ananas comosus Ab.IgE
62182-1,I felt mad in past 7D
62183-9,I was so angry I felt like throwing something in past 7D
62184-7,I was so angry I felt like yelling at somebody in past 7D
62185-4,"When I got mad, I stayed mad in past 7D"
62186-2,PROMIS pediatric short form - emotional distress - anxiety 8a - version 1.0
62187-0,I felt scared n past 7D
62188-8,I was afraid that I would make mistakes in past 7D
62189-6,PROMIS short form - emotional distress - anger 8a - version 1.0
6219-0,Pork Ab.IgE
62190-4,PROMIS short form - emotional distress - anxiety 7a - version 1.0
62191-2,PROMIS short form - emotional distress - depression 8b - version 1.0
62192-0,PROMIS short form - fatigue 7a - version 1.0
62193-8,PROMIS short form - pain interference 6b - version 1.0
62194-6,PROMIS short form - pain behavior 7a - version 1.0
62195-3,PROMIS short form - satisfaction with participation in DSA 7a - version 1.0
62196-1,PROMIS short form - satisfaction with participation in social roles 7a - version 1.0
62197-9,PROMIS short form - sleep disturbance 8b - version 1.0
62198-7,PROMIS short form - sleep impairment 8a - version 1.0
62199-5,PROMIS short form - physical function 10a - version 1.0
62200-1,Short Forms
62201-9,XXX microorganism DNA
62202-7,XXX microorganism DNA
62203-5,"t(10;11)(p12;q23)(MLLT10,MLL) fusion transcript"
62204-3,It was hard for me to get out of bed in the morning because I was too tired in past 7D
62205-0,I needed help with a bath in past 7D
62206-8,PROMIS pediatric short form - physical function - mobility 8a - version 1.0
62207-6,PROMIS pediatric short form - physical function - upper extremity 8a - version 1.0
Aug-20,Solanum tuberosum Ab.IgE
62208-4,PROMIS pediatric short form - asthma 8a - version 1.0
62209-2,PROMIS pediatric short form - peer relationships 8a - version 1.0
622-1,Bacteria identified
62210-0,PROMIS pediatric short form - fatigue 10a - version 1.0
62211-8,PROMIS pediatric short form - pain interference 8a - version 1.0
62212-6,PROMIS item bank - pain behavior - version 1.0
62213-4,I had trouble breathing because of my asthma in past 7D
62214-2,I could put on my socks by myself in past 7D
62215-9,I could write with a pen or pencil in past 7D
Jun-21,Primrose Ab.IgE
62216-7,I could put toothpaste on my toothbrush by myself in past 7D
62217-5,I could lift a cup to drink in past 7D
62218-3,I could zip up my clothes in past 7D
62219-1,I could pull on and fasten my seatbelt in past 7D
62220-9,I could open my clothing drawers in past 7D
62221-7,I could dial a phone in past 7D
62222-5,I could cut paper with scissors in past 7D
62223-3,I could dry my back with a towel in past 7D
Apr-22,Syagrus romanzoffianum Ab.IgE
62224-1,I could wash my face with a cloth in past 7D
62225-8,I used a pencil with a special grip to write in past 7D
62226-6,I could move my hands or fingers in past 7D
62227-4,I could tie shoelaces by myself in past 7D
62228-2,I could put on my clothes by myself in past 7D
62229-0,I could turn door handles by myself in past 7D
62230-8,I could use a mouse or touch pad for the computer in past 7D
62231-6,I could hold a full cup in past 7D
Feb-23,Rabbit epithelium Ab.IgE
62232-4,I could hold an empty cup in past 7D
62233-2,I could brush my teeth by myself in past 7D
62234-0,Albumin
62235-7,Albumin
62236-5,Pyridoxal phosphate
62237-3,Carbapenem
62238-1,Glomerular filtration rate/1.73 sq M.predicted
62239-9,Leukocytes
6224-0,Rat epithelium Ab.IgE
62240-7,Erythrocytes
62241-5,Hematocrit
62242-3,Erythrocyte mean corpuscular volume
62243-1,Erythrocyte mean corpuscular hemoglobin
62244-9,Platelets
62245-6,Erythrocytes.nucleated/100 leukocytes
62246-4,Erythrocyte mean corpuscular hemoglobin concentration
62247-2,Erythrocyte distribution width
62248-0,Erythrocytes.nucleated
62249-8,Reticulocytes
62250-6,Reticulocytes.immature/Reticulocytes.total
62251-4,Leukocytes
62252-2,Cells.CD79/100 cells
62253-0,Lipoprotein.alpha
62254-8,Lipoprotein.pre-beta
62255-5,Lipoprotein insulin resistance score
62256-3,Bacterial aminoglycoside resistance aacA gene
Jul-25,Rat serum proteins Ab.IgE
62257-1,Cephalosporin resistance gene
62258-9,Bacterial erythromyin+clindamycin resistance ermA+ermC genes
62259-7,Methicillin resistance gene
62260-5,Bacterial tetracycline resistance tetK+tetM genes
62261-3,Bacterial vancomycin resistance vanA+vanB genes
62262-1,PhenX measure - sugar intake
62263-9,PhenX domain - Nutrition and dietary supplements
62264-7,Carbon dioxide
May-26,Rat urine proteins Ab.IgE
62265-4,Desflurane^during expiration
62266-2,Enflurane
62267-0,Halothane
62268-8,Isoflurane
62269-6,Isoflurane^during expiration
62270-4,Isoflurane^during inspiration
62271-2,Nitrous oxide
62272-0,Nitrous oxide^during inspiration
Mar-27,Pepper red Ab.IgE
62274-6,Oxygen^during inspiration
62277-9,PhenX measure - vitamin D
62278-7,PhenX measure - selenium
62279-5,PhenX - breastfeeding protocol 050101
62280-3,PhenX - caffeine protocol 050301
Jan-28,Agrostis stolonifera Ab.IgE
62281-1,PhenX - dairy food protocol 050401
62282-9,PhenX - dietary supplements protocol 050501
62283-7,PhenX - fiber protocol 050601
62284-5,PhenX - fruits and veg protocol 050701
62285-2,PhenX - energy from fat protocol 050801
62286-0,PhenX - sugar protocol 051001
62287-8,PhenX - selenium protocol 050901
62288-6,PhenX - vitamin D protocol 051101
62289-4,PhenX - calcium intake - adult protocol 050202
62290-2,"1,25-Dihydroxyvitamin D"
62291-0,"1,25-Dihydroxyvitamin D2"
62292-8,Calcidiol+ercalcidiol
62293-6,PhenX - current age protocol 010101
62294-4,PhenX - standing height protocol 020703
62295-1,PhenX - recumbent length protocol 020702
62296-9,PhenX - self reported height protocol 020704
62297-7,PhenX - weight - measured weight protocol 021501
62298-5,PhenX - weight - self reported weight protocol 021502
Sep-29,Rhizopus nigricans Ab.IgE
62299-3,PhenX - ethnicity protocol 010501
62300-9,Lysosomal storage disorders newborn screening panel
62301-7,Lysosomal storage disorders
62302-5,Lysosomal storage disorders suspected
62303-3,Lysosomal storage disorders newborn screening comment-discussion
62304-1,Fabry disease newborn screening panel
62305-8,Fabry disease
62306-6,Fabry disease newborn screening comment-discussion
Jul-30,Oryza sativa Ab.IgE
62307-4,Krabbe disease newborn screening panel
62308-2,Krabbe disease
62309-0,Krabbe disease newborn screening comment-discussion
62310-8,Galactosylceramidase
62311-6,Gaucher disease newborn screening panel
62312-4,Gaucher disease
62313-2,Gaucher disease newborn screening comment-discussion
May-31,Rosa spp hip Ab.IgE
62315-7,Niemann Pick disease A+B newborn screening panel
62316-5,Acid sphingomyelinase
62317-3,Date of last blood product transfusion
62318-1,Niemann Pick disease A+B
62319-9,Niemann Pick disease A+B newborn screening comment-discussion
62320-7,T-cell receptor excision circle
62321-5,Severe combined immunodeficiency
62322-3,Severe combined immunodeficiency newborn screening comment-discussion
Mar-32,Iva ciliata Ab.IgE
62323-1,Post-discharge provider ID
62324-9,Post-discharge provider name
62325-6,Post-discharge provider practice ID
62326-4,Post-discharge provider practice name
62327-2,Post-discharge provider practice address
62328-0,Post-discharge provider practice phone number
62329-8,Birth hospital facility ID
62330-6,Birth hospital facility name
Jan-33,Pigweed rough Ab.IgE
62331-4,Birth hospital facility address
62332-2,Birth hospital facility phone number
62333-0,Severe combined immunodeficiency (SCID) newborn screening panel
62334-8,PROMIS domain - Item banks and short forms - version 1.0
62335-5,PhenX - knee height protocol 020701
62336-3,PROMIS item bank - 43 profile
62337-1,PROMIS item bank - 29 profile
62338-9,PROMIS item bank - 57 profile
62339-7,I felt sad in the past 7D
62340-5,I felt tired in the past 7D
62341-3,Borrelia burgdorferi Ab.IgG+IgM with reflex to immune blot panel
62342-1,Borrelia burgdorferi Ab.IgG & IgM
62343-9,Chromosome analysis copy number change panel
62344-7,Chromosome analysis.metaphase panel
62345-4,Chromosome analysis.interphase panel
62346-2,Chromosome analysis.interphase panel
62347-0,Chromosome analysis.prenatal panel
62348-8,Chromosome analysis panel
Sep-34,Salsola kali Ab.IgE
62349-6,Chromosome analysis panel
62350-4,Chromosome analysis panel
62351-2,Chromosome analysis panel
62352-0,Chromosome analysis panel
62353-8,Chromosome analysis panel
62354-6,Chromosome analysis.metaphase panel
62355-3,Chromosome analysis panel
Jun-35,Secale cereale Ab.IgE
62356-1,Chromosome analysis result in ISCN expression
62357-9,Chromosome analysis overall interpretation
62358-7,ISCN band level
62359-5,Chromosome banding method
62360-3,Cells analyzed
62361-1,Cells counted
62362-9,Colonies counted
62363-7,Mosaicism detected
Apr-36,Secale cereale pollen Ab.IgE
62364-5,Test performance information
62365-2,Diagnostic impression
62366-0,Recommended follow-up
62367-8,Chromosome analysis panel
62368-6,Cell phase
62369-4,FISH probe name panel
62370-2,FISH probe gene name
62371-0,FISH probe locus
Feb-37,Salmo salar Ab.IgE
62372-8,FISH probe vendor
62373-6,"Human reference assembly release, UCSC version"
62374-4,Human reference sequence assembly release number
62375-1,Microarray platform
62376-9,Microarray platform version number
62377-7,Chromosome copy number change panel
62378-5,Chromosome copy number change
62379-3,Chromosome band involved start
6238-0,Distichlis spicata Ab.IgE
62380-1,Chromosome band involved end
62381-9,Base pair start coordinate
62382-7,Base pair end coordinate
62383-5,Flanking normal region before start
62384-3,Flanking normal region after end
62385-0,Recommendation
62386-8,Chromosome analysis summary panel
62387-6,Interventions
62388-4,Hemoglobin A1c/Hemoglobin.total
62389-2,Chromosome analysis master panel
623-9,Bacteria identified
62390-0,PhenX - family history heart attack protocol 040101
62391-8,PhenX - lipid profile protocol 040201
62392-6,PhenX - blood pressure protocol 040301
62393-4,PhenX - preg high blood pressure protocol 040401
62394-2,PhenX - heart valve func protocol 040501
62395-9,PhenX - angina protocol 040601
62396-7,PhenX - sudden cardiac arrest protocol 040701
62397-5,PhenX - myocardial infarct protocol 040801
Aug-39,Atriplex lentiformis Ab.IgE
62398-3,PhenX - periph arterial disease protocol 040901
62399-1,PhenX - abd aortic aneurysm protocol 041001
62400-7,PhenX - arrhythmia protocol 041101
62401-5,PhenX - deep venous thrombosis protocol 041201
62402-3,PhenX - pulmonary embolus protocol 041301
62403-1,PhenX - rheumatic fever protocol 041401
62404-9,PhenX - arm span protocol 020101
62405-6,PhenX - birth weight protocol 020201
Jun-40,Seminal fluid Ab.IgE
62406-4,PhenX - child head circum protocol 020501
62409-8,PhenX - hip circumference protocol 020801
62410-6,PhenX - max adult ht protocol 020901
62411-4,PhenX - max adult wt protocol 021001
62412-2,PhenX - upper arm circ protocol 021101
62413-0,PhenX - neck circ protocol 021201
Apr-41,Serpula lacrymans Ab.IgE
62414-8,PhenX - pregnancy wt gain protocol 021301
62415-5,PhenX - wt loss - gain protocol 021401
62418-9,Glucose/Insulin
62419-7,Galectin 3
62420-5,Fatty acids.nonesterified^8th specimen post CFst
62421-3,Fatty acids.nonesterified^9th specimen post CFst
Feb-42,Sesamum indicum Ab.IgE
62422-1,Fatty acids.nonesterified^10th specimen post CFst
62423-9,Human coronavirus HKU1 RNA
62424-7,Human bocavirus DNA
62425-4,Creatinine^post XXX challenge
62426-2,Bordetella sp DNA panel
62427-0,Bordetella holmesii DNA
62428-8,Bordetella sp DNA
62429-6,Eastern equine encephalitis virus Ab.IgM
6243-0,Sheep epithelium Ab.IgE
62430-4,Eastern equine encephalitis virus Ab.IgM
62431-2,Eastern equine encephalitis virus Ab.IgG
62432-0,La Crosse virus Ab.IgM
62433-8,La Crosse virus Ab.IgG
62434-6,Saint Louis encephalitis virus Ab.IgM
62435-3,Saint Louis encephalitis virus Ab.IgG
62436-1,West Nile virus Ab.IgM
62437-9,Erythrocytes.nucleated
62438-7,Erythrocytes.nucleated
62439-5,Erythrocytes.nucleated
62440-3,Erythrocytes.nucleated/100 leukocytes
62441-1,Erythrocytes.nucleated/100 leukocytes
62442-9,Erythrocytes.nucleated/100 leukocytes
62443-7,View
62444-5,Views
62445-2,Views
62446-0,Views^W contrast IA
62447-8,Views^W contrast IA
Aug-44,Rumex acetosella Ab.IgE
62448-6,Views^W contrast IA
62449-4,Views^W contrast IA
62450-2,Guidance for placement of catheter
62451-0,Multisection limited
62452-8,Multisection limited
62453-6,Fatty acids.ethyl esters
62454-4,Herpes simplex virus & Varicella zoster virus identified
May-45,Sheep wool Ab.IgE
62455-1,Coccidioides sp F Ab
62456-9,HIV 2 p15 Ab
62457-7,Coccidioides sp TP Ab
62458-5,Coccidioides immitis Ab.IgM
62459-3,Coccidioides immitis Ab.IgG
62460-1,Candida sp DNA
62461-9,Trichomonas vaginalis DNA
62462-7,Influenza virus A+B RNA
Mar-46,Pandalus borealis Ab.IgE
62463-5,Enterovirus RNA
62464-3,Enterovirus RNA
62465-0,Toxoplasma gondii DNA
62466-8,BK virus Ab.IgG
62467-6,Galactomannan Ag
62468-4,"1,3 beta glucan"
62469-2,HIV 1 RNA
624-7,Bacteria identified
62470-0,Herpes simplex virus 1 DNA
Jan-47,Silk Ab.IgE
62471-8,Herpes simplex virus 1 DNA
62472-6,Herpes simplex virus 1 DNA
62473-4,Herpes simplex virus 1 DNA
62474-2,Herpes simplex virus 2 DNA
62475-9,Herpes simplex virus 2 DNA
62476-7,Herpes simplex virus 2 DNA
62477-5,Herpes simplex virus 2 DNA
62478-3,Aspergillus fumigatus DNA
62479-1,Aspergillus terreus DNA
62480-9,Adenovirus DNA
62481-7,Herpes virus 6A DNA
62482-5,Herpes virus 6B DNA
62483-3,Herpes virus 6A DNA
62484-1,Herpes virus 6B DNA
62485-8,Herpes virus 6A DNA
62486-6,Herpes virus 6B DNA
62487-4,Urobilinogen
62488-2,Ova1 test
Sep-48,Glycine max Ab.IgE
62489-0,Sulfate.inorganic
62491-6,Guidance for placement of prosthesis^W contrast IA
62492-4,Guidance for placement of prosthesis^W contrast IA
62493-2,Streptococcus pneumoniae DNA & Haemophilus influenza DNA & Streptococcus agalactiae DNA
62494-0,Guidance for percutaneous drainage+placement of drainage catheter
62495-7,PhenX - tobacco - age of initiation of use - adult protocol 030702
62496-5,PhenX measure - tobacco - 30D quantity and frequency
Jul-49,Palinurus spp Ab.IgE
62497-3,PhenX - tobacco - 30D quantity and frequency - adolescent protocol 030801
62498-1,PhenX - tobacco - 30D quantity and frequency - adult protocol 030802
62499-9,PhenX measure - tobacco - age of offset use
62500-4,PhenX - tobacco - age of offset use - adolescent protocol 030901
62501-2,PhenX - tobacco - age of offset use - adult protocol 030902
62502-0,PhenX measure - tobacco - nicotine dependence
62503-8,PhenX - tobacco - nicotine dependence protocol 031001
62504-6,PhenX measure - substance - lifetime use
May-50,Pigweed spiny Ab.IgE
62505-3,PhenX - substance - lifetime use protocol 031101
62506-1,PhenX measure - substance - age of first use
62507-9,PhenX - substance - age of first use protocol 031201
62508-7,PhenX measure - substance - 30D frequency
62509-5,PhenX - substance - 30D frequency protocol 031301
62510-3,PhenX measure - substance - lifetime abuse and dependence
62511-1,PhenX - substance - lifetime abuse and dependence protocol 031401
62512-9,PhenX domain - Environmental exposures
Mar-51,Sporobolomyces roseus Ab.IgE
62513-7,PhenX measure - environmental exposures - characteristics of current residence
62514-5,PhenX - environmental exposures - characteristics of current residence protocol 060101
62515-2,PhenX measure - environmental exposures - water source
62516-0,PhenX - environmental exposures - water source protocol 060201
62517-8,PhenX measure - environmental exposures - residential history
62518-6,PhenX - environmental exposures - residential history protocol 060301
62519-4,PhenX measure - environmental exposures - exposure at work and daily life
62520-2,PhenX - environmental exposures - exposure at work and daily life protocol 060401
Jan-52,Stemphylium botryosum Ab.IgE
62521-0,PhenX measure - environmental exposures - occupation - occupation history
62522-8,PhenX - environmental exposures - occupation - occupation history protocol 060501
62523-6,PhenX measure - environmental exposures - exposures from hobbies
62524-4,PhenX - environmental exposures - exposures from hobbies protocol 060601
62525-1,PhenX measure - environmental exposures - current environmental tobacco smoke exposure
62526-9,PhenX - environmental exposures - current environmental tobacco smoke exposure protocol 060701
62527-7,PhenX measure - environmental exposures - sibship - birth order
62528-5,PhenX - environmental exposures - sibship - birth order protocol 060801
62529-3,PhenX measure - environmental exposures - day care - pre-school attendance
62530-1,PhenX - environmental exposures - day care - pre-school attendance protocol 060901
62531-9,PhenX measure - environmental exposures - history of being breast fed
62532-7,PhenX - environmental exposures - history of being breast fed protocol 061001
62533-5,PhenX measure - environmental exposures - air contaminants in the home environment
62534-3,PhenX - environmental exposures - air contaminants in the home environment protocol 061101
62535-0,PhenX measure - environmental exposures - dust collection - vacuum bag
62536-8,PhenX - environmental exposures - dust collection - vacuum bag protocol 061201
62537-6,PhenX measure - environmental exposures - ultraviolet light exposure
62538-4,PhenX - environmental exposures - ultraviolet light exposure protocol 061301
Sep-53,Midge stinging Ab.IgE
62539-2,PhenX measure - environmental exposures - plastic exposures at work and home
625-4,Bacteria identified
62540-0,PhenX - environmental exposures - plastic exposures at work and home protocol 061401
62541-8,"PhenX domain - Alcohol, tobacco & other substances"
62542-6,PhenX measure - alcohol - lifetime use
62543-4,PhenX - alcohol - lifetime use protocol 030101
62544-2,PhenX measure - alcohol - age of first use
62545-9,PhenX - alcohol - age of first use protocol 030201
62546-7,PhenX measure - alcohol - 30D quantity - frequency
Jul-54,Acarus siro Ab.IgE
62547-5,PhenX - alcohol - 30D quantity - frequency protocol 030301
62548-3,PhenX measure - alcohol - maximum drinks in 24H
62549-1,PhenX - alcohol - maximum drinks in 24H protocol 030401
62550-9,PhenX measure - alcohol - lifetime abuse and dependence
62551-7,PhenX - alcohol - lifetime abuse and dependence protocol 030501
62552-5,PhenX measure - tobacco - smoking status
62553-3,PhenX - tobacco - smoking status - adolescent protocol 030601
Apr-55,Lepidoglyphus destructor Ab.IgE
62554-1,PhenX - tobacco - smoking status - adult protocol 030602
62555-8,PhenX measure - tobacco - age of initiation of use
62556-6,PhenX - tobacco - age of initiation of use - adolescent protocol 030701
62557-4,PhenX domain - Cancer
62558-2,PhenX measure - cumulative lifetime alcohol exposure
62559-0,PhenX - lifetime alcohol exposure protocol 070101
62560-8,PhenX measure - cumulative lifetime physical activity
62561-6,PhenX - lifetime physical activity protocol 070201
Feb-56,Tyrophagus putrescentiae Ab.IgE
62562-4,PhenX measure - passive smoke exposure
62563-2,PhenX - passive smoke exposure protocol 070301
62564-0,PhenX measure - exogenous female hormone use
62565-7,PhenX - exogenous female hormone use protocol 070401
62566-5,PhenX measure - ovulation history
62567-3,PhenX - ovulation history protocol 070501
62568-1,PhenX measure - cancer - personal and family history
62569-9,PhenX - cancer - personal and family history protocol 070601
6257-0,Fragaria vesca Ab.IgE
62570-7,PhenX measure - personal perception and knowledge of smoking-related cancer risk
62571-5,PhenX - knowledge of smoking-related cancer risk protocol 070701
62572-3,PhenX measure - pre-existing conditions associated with cancer
62573-1,PhenX - pre-existing cancer conditions protocol 070801
62574-9,PhenX measure - cancer screenings
62575-6,PhenX - cancer screenings protocol 070901
62576-4,PhenX domain - Oral health
62577-2,PhenX measure - oral health - breast or bottle feeding patterns
62578-0,PhenX - oral health - breast or bottle feeding patterns protocol 080101
62579-8,PhenX measure - oral health - consumption of sweet beverages
62580-6,PhenX - oral health - consumption of sweet beverages protocol 080201
62581-4,PhenX measure - oral health - dental caries experience - prevalence
62582-2,PhenX - oral health - dental caries experience - prevalence protocol 080301
62583-0,PhenX measure - oral health - dry mouth
62584-8,PhenX - oral health - dry mouth protocol 080401
62585-5,PhenX measure - oral health - existence of cleft lip or palate
62586-3,PhenX - oral health - existence of cleft lip or palate protocol 080501
62587-1,PhenX measure - oral health - fluoride use
Aug-58,Helianthus annuus seed Ab.IgE
62588-9,PhenX - oral health - fluoride use protocol 080601
62589-7,PhenX measure - oral health - malocclusion
62590-5,PhenX - oral health - malocclusion protocol 080701
62591-3,PhenX measure - oral health - number of natural teeth
62592-1,PhenX - oral health - number of natural teeth protocol 080801
62593-9,PhenX measure - oral health - oral hygiene - personal care
62594-7,PhenX - oral health - oral hygiene - personal care protocol 080901
62595-4,PhenX measure - oral health - oral mucosal lesions
Jun-59,Castanea sativa Ab.IgE
62596-2,PhenX - oral health - oral mucosal lesions protocol 081001
62597-0,PhenX measure - oral health - periodontal disease - prevalence
62598-8,PhenX - oral health - periodontal disease - prevalence protocol 081101
62599-6,PhenX measure - oral health - presence of dental fluorosis
62600-2,PhenX - oral health - presence of dental fluorosis protocol 081201
62601-0,PhenX measure - oral health - professional dental care
62602-8,PhenX - oral health - professional dental care protocol 081301
62603-6,PhenX measure - oral health - tobacco non-cigarette - product use
Apr-60,Liquidambar styraciflua Ab.IgE
62604-4,PhenX - oral health - tobacco non-cigarette - product use protocol 081401
62605-1,PhenX measure - oral health - toothache and orofacial pain
62606-9,PhenX - oral health - toothache and orofacial pain protocol 081501
62607-7,PhenX measure - smoking quit attempts
62608-5,PhenX - smoking quit attempts protocol 071001
62609-3,PhenX measure - cancer treatment
62610-1,PhenX - cancer treatment protocol 071101
62611-9,PhenX domain - Respiratory
Feb-61,Anthoxanthum odoratum Ab.IgE
62612-7,PhenX measure - respiratory - arterial blood gas - ABG
62613-5,PhenX - respiratory - arterial blood gas - ABG protocol 090201
62614-3,PhenX measure - respiratory - bronchodilator responsiveness - BDR
62615-0,PhenX - respiratory - bronchodilator responsiveness - BDR protocol 090301
62616-8,PhenX measure - respiratory - chest computed tomography - CT
62617-6,PhenX - respiratory - chest computed tomography - CT protocol 090401
62618-4,PhenX measure - respiratory - exercise capacity - 6M walk test
62619-2,PhenX - respiratory - exercise capacity - 6M walk test protocol 090601
626-2,Bacteria identified
6262-0,Swine epithelium Ab.IgE
62620-0,PhenX measure - respiratory - immunoglobulin E - total and specific
62621-8,PhenX - respiratory - immunoglobulin E - total and specific protocol 090701
62622-6,PhenX measure - respiratory - peak expiratory flow rate - PEFR
62623-4,PhenX - respiratory - peak expiratory flow rate - PEFR protocol 090801
62624-2,PhenX measure - respiratory - personal - family hx of respiratory symptoms - diseases
62625-9,PhenX - respiratory - personal - family hx of respiratory symptoms - diseases - adult protocol 090901
62626-7,PhenX - respiratory - personal - family hx of respiratory symptoms - diseases - child protocol 090902
62627-5,PhenX measure - respiratory - pulse oximetry - exercise
62628-3,PhenX - respiratory - pulse oximetry - exercise protocol 091001
62629-1,PhenX measure - respiratory - quality of life
62630-9,PhenX - respiratory - quality of life protocol 091301
62631-7,PhenX measure - respiratory - respiratory rate
62632-5,PhenX - respiratory - respiratory rate - infant protocol 091401
62633-3,PhenX - respiratory - respiratory rate - child protocol 091402
62634-1,PhenX - respiratory - respiratory rate - adult protocol 091403
62635-8,PhenX measure - respiratory - sleep apnea
62636-6,PhenX - respiratory - sleep apnea - adult protocol 091501
62637-4,PhenX - respiratory - sleep apnea - child protocol 091502
Aug-63,Platanus occidentalis Ab.IgE
62638-2,PhenX measure - respiratory - spirometry
62639-0,PhenX - respiratory - spirometry protocol 091601
62640-8,PhenX measure - respiratory - urine assay for tobacco smoke exposure
62641-6,PhenX - respiratory - urine assay for tobacco smoke exposure protocol 091701
62642-4,PhenX domain - Reproductive health
62643-2,PhenX measure - assessment of pubertal development
62644-0,PhenX - assessment of pubertal development - female protocol 100101
62645-7,PhenX - assessment of pubertal development - male protocol 100102
Jun-64,Camellia sinensis Ab.IgE
62646-5,PhenX measure - causes and treatments of known infertility
62647-3,PhenX - causes and treatments of known infertility - male protocol 100201
62648-1,PhenX - causes and treatments of known infertility - female protocol 100202
62649-9,PhenX measure - contraceptive methods
62650-7,PhenX - contraceptive methods - female protocol 100301
62651-5,PhenX - contraceptive methods - male protocol 100302
62652-3,PhenX measure - difficulty in conceiving
Mar-65,Phleum pratense Ab.IgE
62653-1,PhenX - difficulty in conceiving protocol 100401
62654-9,PhenX measure - female reproductive organ surgical procedures
62655-6,PhenX - female reproductive organ surgical procedures protocol 100501
62656-4,PhenX measure - history of prepubertal development
62657-2,PhenX - history of prepubertal development - female protocol 100601
62658-0,PhenX - history of prepubertal development - male protocol 100602
62659-8,PhenX measure - hormonal therapy
62660-6,PhenX - hormonal therapy protocol 100701
Jan-66,Lycopersicon lycopersicum Ab.IgE
62661-4,PhenX measure - human papillomavirus vaccine use
62662-2,PhenX - human papillomavirus vaccine use protocol 100801
62663-0,PhenX measure - male reproductive tract birth defects
62664-8,PhenX - male reproductive tract birth defects protocol 100901
62665-5,PhenX measure - male sexual function
62666-3,PhenX - male sexual function protocol 101001
62667-1,PhenX measure - menstrual history
62668-9,PhenX - menstrual history protocol 101101
62669-7,PhenX measure - prostate health
62670-5,PhenX - prostate health protocol 101201
62671-3,PhenX measure - reproductive history
62672-1,PhenX - reproductive history - female protocol 101301
62673-9,PhenX measure - sexual history
62674-7,PhenX - sexual history protocol 101401
62675-4,PhenX measure - testes development
62676-2,PhenX - testes development protocol 101501
62677-0,PhenX domain - Ocular
62678-8,PhenX measure - contact biometry
Sep-67,Trichoderma viride Ab.IgE
62679-6,PhenX - contact biometry protocol 110101
62680-4,PhenX measure - color vision
62681-2,PhenX - color vision protocol 110201
62682-0,PhenX measure - dry eye syndrome
62683-8,PhenX - dry eye syndrome protocol 110301
62684-6,PhenX measure - eye diseases - treatment in young children
62685-3,PhenX - eye diseases - treatment in young children protocol 110401
62686-1,PhenX measure - eye drop use
Jul-68,Oncorhynchus mykiss Ab.IgE
62687-9,PhenX - eye drop use protocol 110501
62688-7,PhenX measure - eye patching
62689-5,PhenX - eye patching protocol 110601
62690-3,PhenX measure - intraocular pressure
62691-1,PhenX - intraocular pressure protocol 110701
62692-9,PhenX measure - ocular exposure to ultraviolet light
62693-7,PhenX - ocular exposure to ultraviolet light protocol 110801
62694-5,PhenX measure - personal and family history of eye disease and treatments
May-69,Tulipa spp Ab.IgE
62695-2,PhenX measure - personal - family history of strabismus
62696-0,PhenX - personal - family history of strabismus protocol 111001
62697-8,PhenX measure - visual acuity
62698-6,PhenX - visual acuity protocol 111101
62699-4,PhenX measure - visual function
627-0,Bacteria identified
62700-0,PhenX - visual function protocol 111201
62701-8,PhenX measure - corrective lens use
62702-6,PhenX - contact lens use - adult protocol 111301
Mar-70,Thunnus albacares Ab.IgE
62704-2,PhenX - use of eye glasses - adult protocol 111303
62705-9,PhenX measure - refractive error measurement
62706-7,PhenX - refractive error - adult protocol 111401
62707-5,PhenX - refractive error - child protocol 111402
62708-3,PhenX measure - retinal digital photography
62709-1,PhenX - retinal digital photography protocol 111501
62710-9,PhenX domain - Psychiatric
Jan-71,Turkey meat Ab.IgE
62711-7,PhenX measure - general psychiatric assessment
62712-5,PhenX - general psychiatric assessment - adult protocol 120101
62713-3,PhenX - general psychiatric assessment - child protocol 120102
62714-1,PhenX measure - anxiety disorders screener
62715-8,PhenX - anxiety disorders screener - child protocol 120201
62716-6,PhenX - anxiety disorders screener - adult protocol 120202
62717-4,PhenX measure - compulsive disorder screener
62718-2,PhenX - obsessive compulsive disorder screener protocol 120301
62719-0,PhenX measure - hypomania - mania symptoms
62720-8,PhenX - hypomania - mania symptoms - child protocol 120401
62721-6,PhenX - hypomania - mania symptoms - adult protocol 120402
62722-4,PhenX measure - depression
62723-2,PhenX - depression - child protocol 120501
62724-0,PhenX - depression - adult protocol 120502
62725-7,PhenX measure - eating disorders screener
62726-5,PhenX - eating disorders screener protocol 120601
62727-3,PhenX - personal and family history of eye disease and treatments protocol 110901
62728-1,PhenX - use of glasses - contact lenses as child protocol 111302
Sep-72,Holcus lanatus Ab.IgE
62731-5,"PhenX measure - medications - pain relievers, statins, steroids"
62732-3,"PhenX - medications - pain relievers, statins, steroids protocol 071201"
62733-1,PhenX - respiratory - pulse oximetry - rest protocol 091101
62734-9,PhenX measure - respiratory - pulse oximetry - rest
62736-4,PhenX - schizophrenia protocol 120701
Jul-73,Juglans spp Ab.IgE
62737-2,PhenX measure - symptoms of autism spectrum disorders
62738-0,PhenX - symptoms of autism spectrum disorders - adult protocol 120901
62739-8,PhenX - symptoms of autism spectrum disorders - adolescent protocol 120902
62740-6,PhenX - symptoms of autism spectrum disorders - child protocol 120903
62741-4,PhenX measure - sleep disorders screener
62742-2,PhenX - sleep disorders screener protocol 121001
62743-0,PhenX measure - personality traits
62744-8,PhenX - personality traits protocol 121101
May-74,Juglans california Ab.IgE
62745-5,PhenX measure - general distress screener
62746-3,PhenX - general distress screener protocol 121301
62747-1,PhenX measure - posttraumatic stress disorder (PTSD)
62748-9,PhenX - posttraumatic stress disorder (PTSD) protocol 121401
62749-7,PhenX measure - attention-deficit - hyperactivity disorder symptoms
62750-5,PhenX - attention-deficit - hyperactivity disorder symptoms protocol - adult 121501
62751-3,PhenX - attention-deficit - hyperactivity disorder symptoms protocol - child 121502
Feb-75,Ambrosia psilostachya Ab.IgE
62752-1,PhenX measure - psychopathy
62753-9,PhenX - psychopathy protocol 121601
62754-7,PhenX measure - schizophrenia
62755-4,PhenX domain - Neurology
62756-2,PhenX measure - parkinsonian symptoms
62757-0,PhenX - parkinsonian protocol 130101
62758-8,PhenX measure - clinical neuropathy
62759-6,PhenX - clinical neuropathy protocol 130201
6276-0,Triticum aestivum Ab.IgE
62760-4,PhenX measure - history of stroke - ischemic infarct - hemorrhage
62761-2,PhenX - history of stroke protocol 130301
62762-0,PhenX measure - epilepsy screener
62763-8,PhenX - epilepsy screener protocol 130401
62764-6,PhenX measure - migraine
62765-3,PhenX - migraine protocol 130501
62766-1,PhenX measure - history of head trauma
62767-9,PhenX - head trauma protocol 130601
62768-7,PhenX measure - global mental status screener
62769-5,PhenX - global mental status - adult protocol 130701
62770-3,PhenX - global mental status - child protocol 130702
62771-1,PhenX measure - verbal memory
62772-9,PhenX - verbal memory protocol 130801
62773-7,PhenX measure - visual memory
62774-5,PhenX - visual memory protocol 130901
62775-2,PhenX measure - working memory
62776-0,PhenX - working memory protocol 131001
62777-8,PhenX measure - executive function
Aug-77,Triticum aestivum pollen Ab.IgE
62778-6,PhenX - executive function protocol 131101
62779-4,PhenX measure - gross motor function
62780-2,PhenX - gross motor function - 2-4Y protocol 131201
62781-0,PhenX - gross motor function - 4-6Y protocol 131202
62782-8,PhenX - gross motor function - 6-12Y protocol 131203
62783-6,PhenX measure - signs of essential tremor
62784-4,PhenX - signs of essential tremor protocol 131301
62785-1,PhenX measure - symptoms of restless legs syndrome
Jun-78,Fraxinus americana Ab.IgE
62786-9,PhenX - restless legs syndrome protocol 131401
62787-7,PhenX domain - Diabetes
62788-5,PhenX measure - autoimmune diseases related to type 1 diabetes
62789-3,PhenX - autoimmune diseases related to type 1 diabetes protocol 140101
62790-1,PhenX measure - family history of diabetes
62791-9,PhenX - family history of diabetes protocol 140201
62792-7,PhenX measure - medication inventory
62793-5,PhenX - medication inventory protocol 140301
Apr-79,Bean white Ab.IgE
62794-3,PhenX measure - diabetic peripheral neuropathy
62795-0,PhenX - diabetic peripheral neuropathy protocol 140401
62796-8,PhenX measure - personal history of type 1- type 2 diabetes
62797-6,PhenX - personal history of type 1 - type 2 diabetes protocol 140501
62798-4,PhenX measure - personal history of kidney failure
62799-2,PhenX - personal history of kidney failure protocol 140601
62800-8,PhenX measure - diabetic retinopathy
62801-6,PhenX - diabetic retinopathy protocol 140701
Feb-80,Dolichovespula maculata Ab.IgE
62802-4,PhenX measure - fasting C-peptide assay for residual beta cell function
62803-2,PhenX - fasting C-peptide assay for residual beta cell function protocol 141201
62804-0,PhenX measure - fasting serum insulin
62805-7,PhenX - fasting serum insulin protocol 141301
62806-5,PhenX measure - serum creatinine assay for kidney function
62807-3,PhenX - serum creatinine assay for kidney function protocol 141401
62808-1,PhenX measure - urinary microalbumin assay for kidney function
62809-9,PhenX - urinary microalbumin assay for kidney function protocol 141501
6281-0,Morus alba Ab.IgE
62810-7,PhenX measure - urinary creatinine assay for kidney function
62811-5,PhenX - urinary creatinine assay for kidney function protocol 141601
62812-3,PhenX domain - Physical activity and physical fitness
62813-1,PhenX measure - cardiorespiratory fitness - exercise
62814-9,PhenX - cardiorespiratory fitness - 1 mile walk protocol 150101
62815-6,PhenX - cardiorespiratory fitness - treadmill protocol 150102
62816-4,PhenX measure - integrated fitness
62817-2,PhenX - integrated fitness - adult protocol 150201
62818-0,PhenX - integrated fitness - older adult protocol 150202
62819-8,PhenX - integrated fitness - child protocol 150203
62820-6,PhenX measure - muscle strength
62821-4,PhenX - muscle strength protocol 150301
62822-2,PhenX measure - physical activity - readiness
62823-0,PhenX - physical activity - readiness protocol 150401
62824-8,PhenX measure - physical functioning - objective
62825-5,PhenX - physical functioning - objective protocol 150501
62826-3,PhenX measure - sitting - sedentary behavior
62827-1,PhenX - sitting - sedentary behavior - adult protocol 150601
Aug-82,Pinus strobus Ab.IgE
62828-9,PhenX - sitting - sedentary behavior - adolescent protocol 150602
62829-7,PhenX measure - total physical activity - comprehensive
62830-5,PhenX - total physical activity - comprehensive - adolescent protocol 150701
62831-3,PhenX - total physical activity - comprehensive - adult protocol 150702
62832-1,PhenX - total physical activity - comprehensive - older adult protocol 150703
62833-9,PhenX measure - total physical activity - objective
62834-7,PhenX - total physical activity - objective protocol 150801
62835-4,PhenX measure - total physical activity - screener
Jun-83,Elymus triticoides Ab.IgE
62836-2,PhenX - total physical activity - screener protocol 150901
62837-0,PhenX measure - walking - ambulation objective
62838-8,PhenX - walking - ambulation objective protocol 151001
62839-6,PhenX measure - physical functioning - subjective
62840-4,PhenX - physical functioning - subjective protocol 151101
62841-2,PhenX measure - physical activity - neighborhood environment
62842-0,PhenX - physical activity - neighborhood environment protocol 151201
62843-8,PhenX measure - physical activity - self efficacy
Apr-84,Silk wild Ab.IgE
62844-6,PhenX - physical activity - self efficacy - adolescent protocol 151301
62845-3,PhenX - physical activity - self efficacy - adult protocol 151302
62846-1,PhenX measure - cardiorespiratory fitness - non-exercise
62847-9,PhenX - cardiorespiratory fitness - non-exercise protocol 151401
62848-7,Mirtazapine+Normirtazapine
62849-5,Venlafaxine+O-desmethylvenlafaxine
62850-3,PhenX measure - fasting plasma glucose for diabetes screening - blood draw
Jan-85,Salix caprea Ab.IgE
62851-1,PhenX - fasting plasma glucose for diabetes screening - blood draw protocol 140801
62852-9,PhenX - fasting plasma glucose for diabetes screening - glucometer protocol 140802
62853-7,PhenX measure - glycosylated hemoglobin assay that reflects long-term glucose concentration
62854-5,PhenX - glycosylated hemoglobin assay reflecting long-term glucose concentration protocol 140901
62855-2,PhenX measure - oral glucose tolerance test
62856-0,PhenX - oral glucose tolerance test protocol 141001
62857-8,Micromegakaryocytes
62858-6,Micromegakaryocytes/100 leukocytes
62859-4,Rotavirus RNA
62860-2,Influenza virus C RNA
62861-0,Enterovirus 71 RNA
62862-8,Microsatellite instability
62863-6,PhenX domain - Infectious diseases and immunity
62864-4,PhenX measure - assay for chlamydia - gonorrhea
62865-1,PhenX - assay for chlamydia - gonorrhea protocol 160101
62866-9,PhenX measure - assay for cytokine panel 12
62867-7,PhenX - assay for cytokine panel 12 protocol 160201
62868-5,PhenX measure - assay for hepatitis C
Sep-86,Artemisia absinthium Ab.IgE
62869-3,PhenX - assay for hepatitis C protocol 160301
62870-1,PhenX measure - assay for hepatitis B
62871-9,PhenX - assay for hepatitis B protocol 160401
62872-7,PhenX measure - assay herpes simplex virus types 1 - 2
62873-5,PhenX - assay herpes simplex virus types 1 - 2 protocol 160501
62874-3,PhenX measure - assay for human leukocyte antigen (HLA) genotyping
62875-0,PhenX - assay for human leukocyte antigen (HLA) genotyping protocol 160601
62876-8,PhenX measure - assay for syphilis
Jul-87,Saccharomyces cerevisiae Ab.IgE
62877-6,PhenX - assay for syphilis protocol 160701
62878-4,PhenX measure - conditions relevant to immune response - screener
62879-2,PhenX - conditions relevant to immune response - screener - adult protocol 160801
628-8,Bacteria identified
62880-0,PhenX - conditions relevant to immune response - screener - child protocol 160802
62881-8,PhenX measure - human immunodeficiency virus (HIV)
62882-6,PhenX - human immunodeficiency virus (HIV) protocol 160901
62883-4,PhenX measure - immunizations
62884-2,PhenX - immunizations protocol 161001
May-88,Dolichovespula arenaria Ab.IgE
62885-9,PhenX measure - injection drug use
62886-7,PhenX - injection drug use protocol 161101
62887-5,PhenX measure - international travel history
62888-3,PhenX - international travel history protocol 161201
62889-1,PhenX measure - medical history
62890-9,PhenX - medical history protocol 161301
62891-7,PhenX measure - personal - family history of autoimmune - inflammatory disorders
62892-5,PhenX - personal - family history of autoimmune - inflammatory disorders protocol 161401
Mar-89,Lysozyme
62893-3,"PhenX measure - personal medical history of allergies, infectious diseases, and immunizations"
62894-1,"PhenX - personal medical history of allergies, infectious diseases, and immunizations - child protocol 161601"
62895-8,"PhenX - personal medical history of allergies, infectious diseases, and immunizations - adult protocol 161602"
62896-6,"PhenX domain - Skin, bone, muscle and joint"
62897-4,PhenX measure - alkaline phosphatase
62898-2,PhenX - alkaline phosphatase protocol 170101
62899-0,PhenX measure - arthritis - osteoarthritis
62900-6,PhenX - arthritis - osteoarthritis protocol 170201
Jan-90,Complement membrane C3b-C4b cofactor protein
62901-4,PhenX measure - eczema
62902-2,PhenX - eczema protocol 170301
62903-0,PhenX measure - pain
62904-8,PhenX - pain protocol 170401
62905-5,PhenX measure - personal and family history of psoriasis
62906-3,PhenX - personal and family history of psoriasis protocol 170501
62907-1,PhenX measure - skin cancer
62908-9,PhenX - skin cancer protocol 170601
62909-7,PhenX measure - spine - femur bone density by dual-energy x-ray absorptiometry
62910-5,PhenX - spine - femur bone density by dual-energy x-ray absorptiometry protocol 170701
62911-3,PhenX domain - Psychosocial
62912-1,PhenX measure - acculturation
62913-9,PhenX - acculturation protocol 180101
62914-7,PhenX measure - coping styles
62915-4,PhenX - coping styles - adolescent protocol 180201
62916-2,PhenX - coping styles - adult protocol 180202
62917-0,PhenX measure - current quality of life
62918-8,PhenX - current quality of life protocol 180301
Sep-91,Complement iC3b receptors
62919-6,PhenX measure - disinhibiting behaviors - impulsivity
62920-4,PhenX - disinhibiting behaviors - impulsivity - adult protocol 180401
62921-2,PhenX - disinhibiting behaviors - impulsivity - child protocol 180402
62922-0,PhenX measure - emotional state
62923-8,PhenX - emotional state - adult protocol 180501
62924-6,PhenX - emotional state - child protocol 180502
62925-3,PhenX measure - general self-efficacy
62926-1,PhenX - general self-efficacy - adult protocol 180601
Jul-92,Complement decay accelerating factor
62927-9,PhenX - general self-efficacy - child protocol 180602
62928-7,PhenX measure - perceived social support - conflict
62929-5,PhenX - perceived social support - conflict protocol 180701
62930-3,PhenX measure - self-esteem
62931-1,PhenX - self-esteem protocol 180901
62932-9,PhenX measure - social isolation
62933-7,PhenX - social isolation protocol 181001
62934-5,PhenX measure - temperament
May-93,Complement C4d
62935-2,PhenX - temperament - child protocol 181101
62936-0,PhenX - temperament - early child protocol 181102
62937-8,PhenX - temperament - infant protocol 181103
62938-6,PhenX measure - crime and delinquency
62939-4,PhenX - crime and delinquency - adolescent protocol 181201
62940-2,PhenX - crime and delinquency - adult protocol 181202
62941-0,PhenX measure - chronic stress
62942-8,PhenX - chronic stress protocol 181301
Mar-94,Complement C3d-C3d+Gg-IC3b receptors
62943-6,PhenX measure - exposures to violence
62944-4,PhenX - exposures to violence - adult protocol 181401
62945-1,PhenX - exposures to violence - child protocol 181402
62946-9,Jamestown canyon virus Ab.IgM
62947-7,MPL gene.p.Trp515Leu+Trp515Lys+Ser505Asn
62948-5,MPL gene mutations tested for
62949-3,PhenX domain - Gastrointestinal
6295-0,Complement C3d
62950-1,PhenX measure - assessment of functional gastrointestinal disorders
62951-9,PhenX - assessment of functional gastrointestinal disorders - adult protocol 190101
62952-7,PhenX - assessment of functional gastrointestinal disorders - adolescent protocol 190102
62953-5,PhenX - assessment of functional gastrointestinal disorders - child protocol 190103
62954-3,PhenX measure - assessment of gallbladder disease and related conditions
62955-0,PhenX - assessment of gallbladder disease and related conditions protocol 190201
62956-8,PhenX measure - celiac sprue assay
62957-6,PhenX - celiac sprue assay protocol 190301
62958-4,PhenX measure - colorectal procedures and outcomes
62959-2,PhenX - colorectal procedures and outcomes protocol 190401
629-6,Bacteria identified
62960-0,PhenX measure - computed tomography (CT) of the abdominal organs
62961-8,PhenX - computed tomography (CT) of the abdominal organs protocol 190501
62962-6,PhenX measure - emotional distress
62963-4,PhenX - emotional distress protocol 190601
62964-2,PhenX measure - health impact of inflammatory bowel disease
62965-9,PhenX - health impact of inflammatory bowel disease protocol 190701
62966-7,PhenX measure - liver function assay
62967-5,PhenX - liver function assay protocol 190801
Aug-96,Complement C3b-C4b receptor
62968-3,"PhenX measure - pain, abdominal - type and intensity"
62969-1,"PhenX - pain, abdominal - type and intensity protocol 190901"
62970-9,PhenX measure - personal history of gastrointestinal conditions
62971-7,PhenX - personal history of gastrointestinal conditions protocol 191001
62972-5,PhenX measure - gastroesophageal reflux disease (GERD) symptoms
62973-3,PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101
62974-1,"PhenX measure - physical, social, and mental health functioning - SF-36v2"
62975-8,"PhenX - physical, social, and mental health functioning - SF-36v2 protocol 191201"
Jun-97,Complement C1q Ag
62976-6,PhenX measure - audiogram hearing test
62977-4,PhenX - audiogram hearing test protocol 200101
62978-2,PhenX measure - ear infections - otitis media
62979-0,PhenX - ear infections - otitis media protocol 200201
62980-8,PhenX measure - early childhood speech and language assessment
62981-6,PhenX - early childhood speech and language assessment protocol - ages - stages questionnaire 200301
62982-4,PhenX - early childhood speech and language assessment protocol - speech and language assessment scale 200302
62983-2,PhenX measure - family history of speech and language impairment
Apr-98,Potassium
62984-0,PhenX - family history of speech and language impairment protocol 200401
62985-7,PhenX measure - grammatical impairments
62986-5,PhenX - grammatical impairments - clinical evaluation of language fundamentals protocol 200501
62987-3,PhenX - grammatical impairments - test of early grammatical impairment protocol 200502
62988-1,PhenX - grammatical impairments - grammaticality judgment task protocol 200503
62989-9,PhenX measure - non-word repetition
62990-7,PhenX - non-word repetition protocol 200601
62991-5,PhenX measure - phonemic inventory
Feb-99,Urea nitrogen
62992-3,PhenX - phonemic inventory protocol 200701
62993-1,PhenX measure - reading comprehension
62994-9,PhenX - reading comprehension protocol 200801
62995-6,PhenX measure - stuttering
62996-4,PhenX - stuttering protocol 200901
62997-2,PhenX measure - tinnitus
62998-0,PhenX - tinnitus protocol 201001
62999-8,PhenX measure - vertigo
63000-4,PhenX - vertigo protocol 201101
63001-2,PhenX measure - vocabulary assessment
63002-0,PhenX - vocabulary assessment protocol 201201
63003-8,PhenX measure - voice impairments
63004-6,PhenX - voice impairments protocol 201301
63005-3,PhenX measure - word decoding
63006-1,PhenX - word decoding protocol 201401
63007-9,PhenX measure - personal and family history of hearing loss
Aug-00,Glucose
63008-7,PhenX - personal and family history of hearing loss protocol 201501
63009-5,PhenX domain - Social environments
63010-3,PhenX measure - childhood maltreatment
63011-1,PhenX - childhood maltreatment protocol 210101
63012-9,PhenX measure - child-reported parental education attainment
63013-7,PhenX - child-reported parental education attainment protocol 210201
63014-5,PhenX measure - discrimination
63015-2,PhenX - discrimination protocol 210301
Jun-01,Coagulation tissue factor induced.INR
63016-0,PhenX measure - family conflict
63017-8,PhenX - family conflict - intimate-relationship protocol 210401
63018-6,PhenX - family conflict - parent - child protocol 210402
63019-4,PhenX measure - family control and organization
63020-2,PhenX - family control and organization protocol 210501
63021-0,PhenX measure - family interpersonal relationships
63022-8,PhenX - family interpersonal relationships protocol 210601
63023-6,PhenX measure - healthy food environments
Apr-02,Coagulation tissue factor induced.normal/Actual
63024-4,PhenX - healthy food environments protocol 210701
63025-1,PhenX measure - neighborhood collective efficacy - community cohesion and informal social control
63026-9,PhenX - neighborhood collective efficacy - community cohesion and informal social control protocol 210801
63027-7,PhenX measure - neighborhood safety
63028-5,PhenX - neighborhood safety protocol 210901
63029-3,PhenX measure - school social environment
63030-1,PhenX - school social environment protocol 211001
63031-9,PhenX measure - social networks
Feb-03,Coagulation dilute Russell viper venom induced
63032-7,PhenX - social networks protocol 211101
63033-5,PhenX measure - job strain
63034-3,PhenX - job strain protocol 211201
63035-0,PhenX measure - neighborhood concentrated disadvantage
63036-8,PhenX - neighborhood concentrated disadvantage protocol 211301
63037-6,PhenX measure - race - ethnic residential segregation
63038-4,PhenX - race - ethnic residential segregation protocol 211401
63039-2,PhenX measure - life events
630-4,Bacteria identified
6304-0,Budgerigar droppings Ab.IgE
63040-0,PhenX - life events - child protocol 211501
63041-8,PhenX - life events - adult protocol 211502
63042-6,17-Hydroxyprogesterone/Creatinine
63043-4,Nuclei scored
63044-2,Cotinine
63045-9,PhenX measure - birthplace
63046-7,PhenX - birthplace protocol 010201
63047-5,PhenX measure - birthplace of parents
63048-3,PhenX - birthplace of parents protocol 010301
63049-1,PhenX measure - birthplace of grandparents
63050-9,PhenX - birthplace of grandparents protocol 010401
63051-7,PhenX measure - current address
63052-5,PhenX - current address protocol 010801
63053-3,PhenX measure - current marital status
63054-1,PhenX - current marital status protocol 010901
63055-8,PhenX measure - current educational attainment
63056-6,PhenX - current educational attainment protocol 011001
Jul-05,Plasmodium malariae Ab
63057-4,PhenX measure - annual family income
63058-2,PhenX - annual family income protocol 011101
63059-0,PhenX measure - years living in the U.S.
63060-8,PhenX - years living in the U.S. protocol 011201
63061-6,PhenX measure - current employment status
63062-4,PhenX - current employment status protocol 011301
63063-2,PhenX measure - household roster-relationships
63064-0,PhenX - household roster-relationships protocol 011401
May-06,Adenovirus 40+41 Ag
63065-7,PhenX measure - health insurance coverage
63066-5,PhenX - health insurance coverage protocol 011501
63067-3,PhenX domain - Speech and hearing
63068-1,TOP2A gene copy number/Chromosome 17 copy number
63069-9,TOP2A gene
63070-7,TOP2A gene 17q21-22 deletion+duplication
63071-5,PhenX - reproductive history - male protocol 101302
63072-3,Mycobacterium tuberculosis inhA gene isoniazid low level resistance mutation
Mar-07,Adenovirus rRNA
63073-1,PhenX measure - total dietary intake
63074-9,PhenX - total dietary intake protocol 051201
63075-6,Dermatophagoides farinae Ab.IgG
63076-4,Cat dander Ab.IgG
63077-2,Dog dander Ab.IgG
63078-0,Fagopyrum esculentum Ab.IgG
63079-8,Bean white Ab.IgG
63080-6,Corylus avellana Ab.IgG
Jan-08,Adenovirus rRNA
63081-4,Bertholletia excelsa Ab.IgG
63082-2,Pepper cayenne Ab.IgG
63083-0,Rubus idaeus Ab.IgG
63084-8,Cocos nucifera Ab.IgG
63085-5,Mytilus edulis Ab.IgG
63086-3,Scomber japonicus Ab.IgG
63087-1,Panicum milliaceum Ab.IgG
63088-9,Perca spp Ab.IgG
63089-7,Cheese parmesan Ab.IgG
63090-5,Beta lactoglobulin Ab.IgG
63091-3,Gluten Ab.IgG
63092-1,Cheese cheddar type Ab.IgG
63093-9,Actinidia chinensis Ab.IgG
63094-7,Petroselinum crispum Ab.IgG
63095-4,Cucumis melo spp Ab.IgG
63096-2,Mangifera indica Ab.IgG
63097-0,Cottonseed Ab.IgG
63098-8,Venison Ab.IgG
Sep-09,Arbovirus identified
63099-6,Cheese American Ab.IgG
63100-2,Vigna sinensis Ab.IgG
63101-0,Duck meat Ab.IgG
63102-8,Prunus persica var nucipersica Ab.IgG
63103-6,Cheese swiss Ab.IgG
63104-4,Vaccinium oxycoccos Ab.IgG
63105-1,Rheum spp Ab.IgG
63106-9,Phaseolus limensis Ab.IgG
Jul-10,Arbovirus identified
63107-7,Linum usitatissimum Ab.IgG
63108-5,Carya illinoinensis nut Ab.IgG
63109-3,Anacardium occidentale Ab.IgG
63110-1,Pistacia vera Ab.IgG
63111-9,Clupea harengus Ab.IgG
63112-7,Rubus fruticosus Ab.IgG
63113-5,Rabbit Ab.IgG
63114-3,Capsicum annuum Ab.IgG
May-11,Babesia microti Ab
63115-0,Papaver somniferum Ab.IgG
63116-8,Cucurbita pepo Ab.IgG
63117-6,Carthamus tinctorius Ab.IgG
63118-4,Lens esculenta Ab.IgG
63119-2,Honey Ab.IgG
631-2,Bacteria identified
63120-0,Juglans spp Ab.IgG
63121-8,Loligo sp Ab.IgG
63122-6,Anguilla anguilla Ab.IgG
Mar-12,Bartonella henselae Ab.IgM
63123-4,Cuminum cyminum Ab.IgG
63124-2,Ocimum basilicum Ab.IgG
63125-9,Thymus vulgaris Ab.IgG
63126-7,Foeniculum vulgare fresh Ab.IgG
63127-5,Anethum graveolens Ab.IgG
63128-3,Laurus nobilis Ab.IgG
63129-1,Curry Ab.IgG
63130-9,Phoenix dactylifera Ab.IgG
Jan-13,Blastomyces dermatitidis Ag
63131-7,Carica papaya Ab.IgG
63132-5,Castanea sativa Ab.IgG
63133-3,Goat milk Ab.IgG
63134-1,Sardina pilchardus Ab.IgG
63135-8,Cicer arietinus Ab.IgG
63136-6,Pimenta dioica Ab.IgG
63137-4,Astacus astacus Ab.IgG
63138-2,Humulus lupus Ab.IgG
63139-0,Wine Vinegar Ab.IgG
63140-8,Gelatin Ab.IgG
63141-6,Yogurt Ab.IgG
63142-4,Micropterus salmoides Ab.IgG
63143-2,Ictalurus punctatus Ab.IgG
63144-0,Cichorium intybus Ab.IgG
63145-7,Gum arabic Ab.IgG
63146-5,Karaya gum Ab.IgG
63147-3,Armoracia rusticana Ab.IgG
63148-1,Maple syrup Ab.IgG
Sep-14,Bordetella pertussis Ab
63149-9,Abelmoschus esculentus Ab.IgG
63150-7,Pastinaca sativa Ab.IgG
63151-5,(Anacardium occidentale+Carya illinoinensis+Castanea sativa+Juglans spp+Pistacia vera) Ab.IgG
63152-3,Cynodon dactylon Ab.IgG
63153-1,Sorghum halepense Ab.IgG
63154-9,Secale cereale pollen Ab.IgG
63155-6,Triticum aestivum pollen Ab.IgG
Jun-15,Bordetella pertussis Ab
63156-4,Paspalum notatum Ab.IgG
63157-2,House dust Greer Ab.IgG
63158-0,House dust Hollister Stier Ab.IgG
63159-8,Ctenocephalides sp Ab.IgG
63160-6,Ricinus communis Ab.IgG
63161-4,Latex Ab.IgG
63162-2,Curvularia lunata Ab.IgG
63163-0,Paecilomyces sp Ab.IgG
Apr-16,Bordetella pertussis Ab
63164-8,Penicillium brevicompactum Ab.IgG
63165-5,Serpula lacrymans Ab.IgG
63166-3,Aspergillus terreus Ab.IgG
63167-1,Trichophyton mentagrophytes Ab.IgG
63168-9,Aspergillus amstelodami Ab.IgG
63169-7,Aspergillus nidulans Ab.IgG
63170-5,Helminthosporium interseminatum Ab.IgG
63171-3,Neurospora sitophila Ab.IgG
Feb-17,Bordetella sp identified
63172-1,Mucor plumbeus Ab.IgG
63173-9,Mycogone perniciosa Ab.IgG
63174-7,Spondylocladium sp Ab.IgG
63175-4,Epidermophyton floccosum Ab.IgG
63176-2,Algae Ab.IgG
63177-0,Acremonium sp Ab.IgG
63178-8,Chaetomium globosum Ab.IgG
63179-6,Sphacelotheca cruenta Ab.IgG
6318-0,Borrelia burgdorferi Ab
63180-4,Nicotiana tabacum Ab.IgG
63181-2,Juniperus sabinoides Ab.IgG
63182-0,Quercus alba Ab.IgG
63183-8,Populus deltoides Ab.IgG
63184-6,Fraxinus americana Ab.IgG
63185-3,Prosopis juliflora Ab.IgG
63186-1,Chenopodium album Ab.IgG
63187-9,Salsola kali Ab.IgG
63188-7,Xanthium commune Ab.IgG
63189-5,Pigweed rough Ab.IgG
63190-3,Iva ciliata Ab.IgG
63191-1,Urtica dioica Ab.IgG
63192-9,Rumex crispus Ab.IgG
63193-7,Artemisia tridentata Ab.IgG
63194-5,Medicago sativa Ab.IgG
63195-2,Helianthus annuus pollen Ab.IgG
63196-0,(Alternaria alternata+Dermatophagoides farinae) Ab.IgG
63197-8,(Ambrosia elatior+Artemisia vulgaris+Chrysanthemum leucathemum+Taraxacum vulgare+Solidago virgaurea) Ab.IgE
Aug-19,Borrelia burgdorferi Ab
63198-6,(Plantago lanceolata+Chenopodium album+Salsola kali+Rumex acetosella) Ab.IgE
63199-4,(Anacardium occidentale+Carya illinoinensis+Castanea sativa+Juglans spp+Pistacia vera) Ab.IgE
632-0,Bacteria identified
63200-0,Solidago virgaurea Ab.IgG
63201-8,Beet red Ab.IgG
63202-6,Morus alba Ab.IgG
63203-4,Alnus rugosa Ab.IgG
63204-2,Ligustrum vulgare Ab.IgG
63205-9,Populus tremula Ab.IgG
Jun-20,Borrelia burgdorferi Ab.IgG
63206-7,Ambrosia elatior Ab.IgG
63207-5,Franseria acanthicarpa Ab.IgG
63208-3,Artemisia vulgaris Ab.IgG
63209-1,Plantago lanceolata Ab.IgG
63210-9,Actin.smooth muscle Ab
63211-7,Actin.smooth muscle Ab
63212-5,Asialoganglioside GM1 Ab.IgG
63213-3,Bactericidal permeability increasing protein Ab
Apr-21,Borrelia burgdorferi Ab.IgM
63214-1,Bactericidal permeability increasing protein Ab
63215-8,Cathepsin G Ab
63216-6,CV2 Ab
63217-4,Cyclic citrullinated peptide Ab.IgG
63218-2,Desmoglein 1 Ab
63219-0,Desmoglein 3 Ab
63220-8,DNA double strand Ab
63221-6,DNA double strand Ab
Feb-22,Borrelia burgdorferi Ag
63222-4,DNA double strand Ab
63223-2,DNA double strand Ab
63224-0,DNA double strand Ab.IgG
63225-7,DNA double strand Ab.IgG
63226-5,DNA double strand Ab.IgG
63227-3,DNA double strand Ab.IgG
63228-1,DNA double strand Ab.IgG
63229-9,DNA double strand Ab.IgG
6323-0,Borrelia sp identified
63230-7,DNA double strand Ab.IgG
63231-5,DNA double strand Ab.IgG
63232-3,DNA double strand Ab.IgM
63233-1,DNA double strand Ab.IgM
63234-9,DNA double strand Ab.IgM
63235-6,DNA double strand Ab.IgM
63236-4,DNA double strand Ab.IgM
63237-2,DNA double strand Ab.IgM
63238-0,Extractable nuclear Ab
63239-8,Extractable nuclear Ab
63240-6,Ganglioside GD3 Ab.IgG+IgM
63241-4,Ganglioside GM1 Ab.IgG
63242-2,Ganglioside GM1 Ab.IgG
63243-0,Ganglioside GM1 Ab.IgG
63244-8,Ganglioside GM1 Ab.IgG+IgM
63245-5,Ganglioside GM1 Ab.IgM
63246-3,Ganglioside GM1 Ab.IgM
63247-1,Ganglioside GM1 Ab.IgM
Aug-24,Brucella abortus Ab
63248-9,Ganglioside GM2 Ab.IgG
63249-7,Ganglioside GM2 Ab.IgG+IgM
63250-5,Ganglioside GM2 Ab.IgM
63251-3,Ganglioside GM3 Ab.IgG
63252-1,Ganglioside GM3 Ab.IgG+IgM
63253-9,Ganglioside GM3 Ab.IgM
63254-7,Ganglioside GQ1b Ab.IgG
May-25,Brucella abortus Ab
63255-4,Ganglioside GQ1b Ab.IgM
63256-2,Ganglioside GT1a Ab.IgG+IgM
63257-0,Ganglioside GT1b Ab.IgG
63258-8,Ganglioside GT1b Ab.IgG+IgM
63259-6,Ganglioside GT1b Ab.IgM
63260-4,Gliadin Ab.IgA
63261-2,Gliadin Ab.IgG
63262-0,Glomerular basement membrane Ab
Mar-26,Brucella abortus Ab.IgM
63263-8,Histone Ab
63264-6,Histone Ab
63265-3,Jo-1 extractable nuclear Ab
63266-1,Jo-1 extractable nuclear Ab
63267-9,Jo-1 extractable nuclear Ab
63268-7,Keratin Ab
63269-5,Ku Ab
63270-3,Liver kidney microsomal 1 Ab
Jan-27,Brucella canis Ab
63271-1,Liver kidney microsomal 1 Ab
63272-9,Liver kidney microsomal 1 Ab
63273-7,Liver kidney microsomal 1 Ab
63274-5,Liver kidney microsomal 2 Ab
63275-2,Liver kidney microsomal 2 Ab
63276-0,Mi-2 Ab
63277-8,Mitochondria Ab
63278-6,Mitochondria Ab
63279-4,Mitochondria Ab
63280-2,Mitochondria Ab
63281-0,Mitochondria M2 Ab
63282-8,Mitochondria M2 Ab
63283-6,Mitochondria M2 Ab
63284-4,Mitochondria M5 Ab
63285-1,Mitochondria M5 Ab
63286-9,Myelin Ab
63287-7,Myelin Ab
63288-5,Myelin associated glycoprotein Ab
Sep-28,Brucella sp Ab
63289-3,Myelin associated glycoprotein Ab
63290-1,Myelin associated glycoprotein Ab
63291-9,Neuronal nuclear type 2 Ab
63292-7,Neutrophil cytoplasmic Ab
63293-5,Neutrophil cytoplasmic Ab
63294-3,Nuclear Ab
63295-0,Nuclear Ab
63296-8,Nuclear Ab
Jul-29,Campylobacter coli rRNA
63297-6,Nuclear Ab
63298-4,Nucleosome Ab
63299-2,Nucleosome Ab
63300-8,Nucleosome Ab
63301-6,Parathyrin Ab
63302-4,Parathyrin Ab
63303-2,Parietal cell Ab
63304-0,Parietal cell Ab
May-30,Campylobacter sp identified
63305-7,PCNA extractable nuclear Ab
63306-5,PCNA extractable nuclear Ab
63307-3,PM-SCL extractable nuclear Ab
63308-1,PM-SCL extractable nuclear Ab
63309-9,Proteinase 3 Ab
63310-7,Proteinase 3 Ab
63311-5,Proteinase 3 Ab
63312-3,Purkinje cells Ab
Mar-31,Campylobacter sp identified
63313-1,Rheumatoid factor
63314-9,Rheumatoid factor.IgA
63315-6,Rheumatoid factor.IgM
63316-4,U1 small nuclear ribonucleoprotein 70kD Ab
63317-2,Ribonucleoprotein extractable nuclear Ab
63318-0,Ribonucleoprotein extractable nuclear Ab
63319-8,Ribonucleoprotein extractable nuclear Ab
63320-6,Ribosomal Ab
Jan-32,Campylobacter sp identified
63321-4,Ribosomal Ab
63322-2,Ribosomal Ab
63323-0,Ribosomal Ab
63324-8,Ribosomal Ab.IgG
63325-5,Ribosomal Ab.IgG
63326-3,Ribosomal P Ab
63327-1,Ribosomal P Ab
63328-9,RNA polymerase III Ab
63329-7,RNA polymerase III Ab
63330-5,Saccharomyces cerevisiae Ab.IgA
63331-3,Saccharomyces cerevisiae Ab.IgA
63332-1,Saccharomyces cerevisiae Ab.IgG
63333-9,Saccharomyces cerevisiae Ab.IgG
63334-7,SCL-70 extractable nuclear Ab
63335-4,SCL-70 extractable nuclear Ab
63336-2,SCL-70 extractable nuclear Ab
63337-0,SCL-70 extractable nuclear Ab
63338-8,SCL-70 extractable nuclear Ab
Sep-33,Campylobacter jejuni rRNA
63339-6,Sjogrens syndrome-A extractable nuclear 52kD Ab
63340-4,Sjogrens syndrome-A extractable nuclear 52kD Ab
63341-2,Sjogrens syndrome-A extractable nuclear 52kD Ab
63342-0,Sjogrens syndrome-A extractable nuclear 52kD Ab
63343-8,Sjogrens syndrome-A extractable nuclear 60kD Ab
63344-6,Sjogrens syndrome-A extractable nuclear 60kD Ab
63345-3,Sjogrens syndrome-A extractable nuclear Ab
63346-1,Sjogrens syndrome-A extractable nuclear Ab
Jul-34,Campylobacter lari rRNA
63347-9,Sjogrens syndrome-A extractable nuclear Ab
63348-7,Sjogrens syndrome-A extractable nuclear Ab
63349-5,Sjogrens syndrome-B extractable nuclear Ab
63350-3,Sjogrens syndrome-B extractable nuclear Ab
63351-1,Sjogrens syndrome-B extractable nuclear Ab
63352-9,Smith extractable nuclear Ab
63353-7,Smith extractable nuclear Ab
Apr-35,Campylobacter sp identified
63354-5,Smith extractable nuclear Ab
63355-2,Smooth muscle Ab
63356-0,Smooth muscle Ab
63357-8,Smooth muscle Ab
63358-6,Smooth muscle Ab
63359-4,Thyroglobulin Ab
63360-2,Thyroglobulin Ab
63361-0,Thyroperoxidase Ab
Feb-36,Candida albicans Ab
63362-8,Thyroperoxidase Ab
63363-6,Thyrotropin receptor Ab
63364-4,Thyrotropin receptor Ab
63365-1,Thyrotropin receptor Ab
63366-9,Thyrotropin receptor Ab
63367-7,U1 small nuclear ribonucleoprotein Ab
63368-5,Carbapenem resistance genes
63369-3,Chronic urticaria index
6337-0,Candida albicans Ag
63370-1,Gamma tocopherol
63371-9,Ketones^1H post dose glucose
63372-7,Ketones^3H post dose glucose
63373-5,Ketones^4H post dose glucose
63374-3,Fusarium roseum Ab.IgE
63375-0,Cyclic citrullinated peptide Ab.IgA+IgG
63376-8,Lactoferrin
63378-4,Erythrocyte clumps
63379-2,DNA double strand Ab.IgG
633-8,Bacteria identified
63380-0,Methionine
63381-8,DNA double strand Ab.IgG
63382-6,Glucose^post CFst
63383-4,Amphiphysin Ab
63384-2,Asialoganglioside GM1 Ab.IgM
63385-9,DNA double strand Ab.IgG
63386-7,DNA double strand Ab.IgG
63387-5,Elastase Ab
Aug-38,Chlamydophila psittaci Ag
63388-3,Extractable nuclear Ab
63389-1,Extractable nuclear Ab
63390-9,Extractable nuclear Ab
63391-7,Extractable nuclear Ab
63392-5,Herpes gestationis Ab
63393-3,Jo-1 extractable nuclear Ab
63394-1,Jo-1 extractable nuclear Ab
63395-8,Liver cytosol Ab
Jun-39,Chlamydophila psittaci Ag
63396-6,Myelin associated glycoprotein Ab
63397-4,Myeloperoxidase Ab
63398-2,Ribonucleoprotein extractable nuclear Ab
63399-0,Ribonucleoprotein extractable nuclear Ab
63400-6,SCL-70 extractable nuclear Ab
63401-4,Sjogrens syndrome-A extractable nuclear Ab
63402-2,Sjogrens syndrome-A extractable nuclear Ab
63403-0,Sjogrens syndrome-B extractable nuclear Ab
Apr-40,Chlamydophila psittaci Ag
63404-8,Sjogrens syndrome-B extractable nuclear Ab
63405-5,Smith extractable nuclear Ab
63406-3,Smith extractable nuclear Ab
63407-1,Thyroid colloidal Ab
63408-9,DNA double strand Ab
63409-7,DNA double strand Ab
63410-5,DNA double strand Ab
63411-3,Sjogrens syndrome-A extractable nuclear 60kD Ab
Feb-41,Chlamydophila psittaci Ag
63412-1,Thyroid colloidal Ab
63413-9,Thyroid colloidal Ab
63414-7,Pompe disease newborn screening panel
63415-4,Pompe disease
63416-2,Pompe disease newborn screening comment-discussion
63417-0,Indexing - Indication
63418-8,Lactalbumin alpha Ab.IgG
63419-6,PIK3CA gene mutations tested for
6342-0,Chlamydia sp Ab
63420-4,Gliadin peptide+Tissue transglutaminase Ab.IgA+IgG
63421-2,JAK2 gene exon 12 mutations tested for
63422-0,"t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2+e1a2 fusion transcript"
63423-8,Escherichia coli eaeA gene
63424-6,Bacterial enterohemolysin (ehlyA) gene
63425-3,Bacterial heat-labile enterotoxin LT gene
63426-1,Bacterial heat-stable enterotoxin ST gene
63427-9,Escherichia coli Stx1 toxin stx1 gene
63428-7,Escherichia coli Stx2 toxin stx2 gene
63429-5,Bacterial beta-glucuronidase (uidA) gene
63430-3,Human coronavirus RNA panel
63431-1,Bordetella sp DNA
63432-9,Herpes simplex virus 1+2 Ab.IgM
63433-7,Microscopic observation
63434-5,Coxsackievirus A Ab
63435-2,Brucella abortus Ab
63436-0,Polistes spp recombinant (rPol d) 5 Ab.IgE
63437-8,Brucella abortus Ab
Aug-43,Chlamydia sp Ag
63438-6,MAPT gene mutations tested for
63439-4,Aquaporin 4 water channel Ab.IgG
63440-2,Purkinje cell cytoplasmic type Tr Ab
63441-0,Tissue polypeptide Ag
63443-6,Fasciola hepatica Ab
63444-4,Somatotropin^7H post XXX challenge
63445-1,Sjogrens syndrome-A extractable nuclear 52kD Ab
Jun-44,Chlamydia sp Ag
63446-9,Cells.CD3+CD5-/100 cells
63447-7,Cells.CD3+CD5-
63448-5,Cells.CD3+CD5+/100 cells
63449-3,Cells.CD3
63450-1,Cells.CD3+CD4+
63451-9,Cells.CD3+CD8+
63452-7,Cells.CD3-CD7+/100 cells
Mar-45,Chlamydia sp Ag
63453-5,Gliadin peptide Ab.IgA
63454-3,TPMT gene mutations tested for
63455-0,Coxiella burnetii phase 1 Ab.IgM
63456-8,Dermatophagoides pteronyssinus native (nDer p) 1 Ab.IgE
63457-6,Dermatophagoides pteronyssinus recombinant (rDer p) 2 Ab.IgE
63458-4,Artemisia vulgaris native (nArt v) 1 Ab.IgE
63459-2,Gliadin peptide Ab.IgG
634-6,Bacteria identified
63460-0,HTLV I+II Ab
Jan-46,Chlamydia sp Ag
63461-8,Ganglioside GM1 Ab.IgG
63462-6,Rubella virus Ab.IgG
63463-4,Dermatophagoides pteronyssinus recombinant (rDer p) 10 Ab.IgE
63464-2,Treponema pallidum Ab
63465-9,Brucella sp DNA
63466-7,Ganglioside GM3 Ab.IgG
63467-5,Ganglioside GM3 Ab.IgM
63468-3,Ganglioside GT1a Ab.IgG
63469-1,Ganglioside GT1b Ab.IgG
63470-9,Ganglioside GM4 Ab.IgG
63471-7,Ganglioside GD2 Ab.IgG
63472-5,Ganglioside GD3 Ab.IgG
63473-3,Gadus morhua recombinant (rGad c) 1 Ab.IgE
63474-1,Albumin
63475-8,BK virus DNA
63476-6,Glycine max recombinant (rGly m) 4 Ab.IgE
63477-4,Arachis hypogaea recombinant (rAra h) 8 Ab.IgE
63478-2,Platelet glycoprotein Ib-Ix Ab
Sep-47,Chlamydia sp Ag
63479-0,Platelet glycoprotein Ia-IIa Ab
63480-8,Pseudomonas aeruginosa.multidrug resistant isolate
63481-6,Urea
63482-4,Methotrimeprazine
63483-2,Penicillium notatum Ab
63484-0,Actin.filamentous Ab
63485-7,Computer generated recommendation
63486-5,Nut allergen panel
Jul-48,Chlamydia sp identified
63487-3,Epithelial cells.squamous
63488-1,Epithelial cells.ciliated
63490-7,Where were you born
63492-3,Birthplace
63493-1,Where was your mother's mother born
63494-9,Where was your mother's father born
May-49,Chlamydia trachomatis
63495-6,Where was your father's mother born
63496-4,Where was your father's father born
63497-2,Current street number
63498-0,Current street name
63499-8,Current apartment number
63500-3,Current city
63501-1,Current state
63502-9,Current zip code
Mar-50,Chlamydia trachomatis Ag
63503-7,Marital status
63504-5,What is the highest grade or level of school you have completed or the highest degree you have received
63506-0,"Was your total family income from all sources less than 50,000 dollars or 50,000 dollars or more"
63507-8,"Was your total family income from all sources less than 35,000 dollars or 35,000 dollars or more"
63508-6,Was your total family income from all sources less than poverty threshold or more
63509-4,"Was your total family income from all sources less than 100,000 dollars or 100,000 dollars or more"
63510-2,"Was your total family income from all sources less than 75,000 dollars or 75,000 dollars or more"
Jan-51,Chlamydia trachomatis Ag
63511-0,"Are you working now, looking for work, retired, keeping house, a student, or what"
63512-8,How many people are living or staying at this address
63513-6,Are you covered by health insurance or some other kind of health care plan
63514-4,What kind of health insurance or health care coverage do you have
63515-1,Where was your biological mother born
63516-9,What are person initials
63517-7,Relationship to patient
63518-5,DXA instrument make and model name
63519-3,PhenX measure - body composition
63520-1,PhenX - body composition by dual-energy x-ray absorptiometry protocol 020301
63521-9,PhenX measure - body image
63522-7,PhenX - body image protocol 020401
63523-5,Carboxyhemoglobin/Hemoglobin.total
63524-3,Carboxyhemoglobin/Hemoglobin.total
63526-8,Centromere Ab
63527-6,Centromere Ab
63528-4,Centromere Ab
Sep-52,Chlamydia trachomatis Ag
63529-2,Centromere Ab
635-3,Bacteria identified
63530-0,Centromere Ab
63531-8,Centromere Ab
63532-6,Centromere protein B Ab
63533-4,Centromere protein B Ab
63534-2,DNA double strand Ab.IgG
63535-9,DNA double strand Ab.IgG
63536-7,Jo-1 extractable nuclear Ab
Jul-53,Chlamydia trachomatis Ag
63537-5,Muscle specific receptor tyrosine kinase Ab.IgG
63538-3,Myeloperoxidase Ab
63539-1,Proteinase 3 Ab
63540-9,Ribonucleoprotein extractable nuclear Ab
63541-7,Ribosomal P Ab
63542-5,SCL-70 extractable nuclear Ab
63543-3,Sjogrens syndrome-A extractable nuclear 52kD Ab
63544-1,Sjogrens syndrome-A extractable nuclear 60kD Ab
May-54,Chlamydia trachomatis Ag
63545-8,Sjogrens syndrome-B extractable nuclear Ab
63546-6,Smith extractable nuclear Ab
63547-4,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab
63548-2,Smith extractable nuclear B Ab
63549-0,Albumin.serum-Albumin.periton fld
63550-8,Calcium magnesium phosphate/Total
63551-6,Pituitary Ab
Feb-55,Chlamydia trachomatis Ag
63552-4,Macrophages/100 cells
63553-2,Succinylaminoimidazole carboxamide riboside
63554-0,Leukocytes
63555-7,Leukocytes
63556-5,Fat
63557-3,Hepatitis B virus surface Ag
63558-1,HLA-DQB1*06:02
63559-9,Signal recognition particle Ab
6356-0,Chlamydia trachomatis DNA
63560-7,Somatotropin^8.5H post XXX challenge
63561-5,Coagulation surface induced actual/Normal
63562-3,Japanese encephalitis virus Ab.IgM
63563-1,Japanese encephalitis virus Ab.IgM
63564-9,Giardia lamblia Ag & Cryptosporidium parvum Ag & Entamoeba histolytica or dispar Ag
63565-6,Prothionamide
63566-4,Basement membrane Ab pattern
63567-2,Neutrophil cytoplasmic Ab pattern
63568-0,Neutrophil cytoplasmic Ab pattern
63569-8,Nuclear Ab pattern
63570-6,Nuclear Ab pattern
63571-4,Pancreatic islet cell Ab pattern
63572-2,Time received in laboratory
63574-8,Staphylococcus sp.coagulase negative DNA
63575-5,Was there ever a time when two or more of these problems occurred together
63576-3,"At what age did you begin to drink regularly - that is, drinking at least once a month for 6Mo or more"
63577-1,"How old were you the first time you got drunk, that is, your speech was slurred or you were unsteady on your feet"
Aug-57,Chlamydia trachomatis DNA
63578-9,"In your lifetime, what is the largest number of drinks you have ever had in a 24H period, including all types of alcohol"
63579-7,"Have you ever taken a drink to keep from having any of these problems, or to make them go away"
63580-5,Have you ever smoked part or all of a cigarette
63581-3,Smoked at least 100 cigarettes in entire life
63582-1,"Do you now smoke cigarettes every D, some D, or not at all"
63583-9,Has there ever been a period in your life when you smoked cigarettes every day for at least 30D
63584-7,Has there ever been a period in your life when you smoked cigarettes every day for at least 6Mo
63585-4,About how long have you been in the United States
Jun-58,Chlamydia trachomatis rRNA
63586-2,"What was your best estimate of the total income of all family members from all sources, before taxes, in last Y"
63587-0,Whole body scan image name
63588-8,Subject of body image assessment
63589-6,Scale used for body image assessment
63590-4,"Choose the picture that most closely resembles your, or your childs, body shape"
63591-2,What was the largest number of drinks that you ever drank in a single day
63592-0,Did your tolerance to alcohol increase 50 percent or more
63593-8,Did the need to drink a lot more before you got drunk increase 50 percent or more
Apr-59,Clostridioides difficile toxin A
63594-6,Were you unable to stop or cut down drinking 3 or more times
63595-3,Did you ever start drinking and become drunk when you didn't want to 3 or more times
63596-1,Did giving up or greatly reduced important activities while drinking happen 3 or more times or for a month or more
63597-9,"During the past 30D, on how many D did you drink one or more drinks of an alcoholic beverage"
63598-7,"On the D that you drank during the past 30D, how many drinks did you usually have each D"
63599-5,"Did you ever become tolerant to alcohol, that is, you drank a great deal more in order to get an effect, or found you could no longer get high on the amount you used to drink"
63600-1,"Have you ever started drinking at times you promised yourself that you wouldn't, or have you ever drunk more than you intended, for example, when you decided to drink 2 drinks and ended up drinking 4 or more"
63601-9,"Have you ever given up or greatly reduced important activities while drinking - like sports, work, or associating with friends or relatives"
Feb-60,Clostridioides difficile toxin A
63602-7,Has there ever been a period of several D or more when you spent so much time drinking or recovering from the effects of alcohol that you had little time for anything else
63604-3,Did spending so much time drinking or recovering from the effects of alcohol that you had little time for anything else happen 3 or more times or for a month or more
63605-0,Health problem resulting from long stretches of drinking
63606-8,Which of these problems occurred together
63607-6,"Did taking a drink to keep from having any of these problems, or to make them go away, happen 3 times or more"
63608-4,Age when first smoked part or all of a cigarette
63609-2,How old were you when you first started smoking cigarettes every day
636-1,Bacteria identified
6361-0,Clostridioides difficile toxin A+B
63610-0,Age when first started smoking cigarettes fairly regularly
63611-8,"During the past 30D, have you smoked part or all of a cigarette"
63612-6,"During the past 30D, on how many D did you smoke part or all of a cigarette"
63613-4,What is your best estimate of the number of D you smoked part or all of a cigarette during the past 30D
63614-2,Did you ever find you could drink a lot more before you got drunk
63615-9,Have you wanted to stop or cut down on drinking 3 or more times
63616-7,Have you ever tried to stop or cut down on drinking
63617-5,How many times were you unable to stop or cut down on drinking
63618-3,Have you ever started drinking and become drunk when you didn't want to
63619-1,Did drinking ever cause you to have any other physical health problems
63620-9,Did you continue to drink knowing that drinking caused you to have health problems
63621-7,Have you ever continued to drink when you knew you had any other serious physical illness or condition that might be made worse by drinking
63622-5,Did you continue to drink after you knew it caused you any of these emotional or psychological problems
63623-3,Other physical health problems from drinking
63624-1,Did long stretches of drinking cause you to have this health problem
63625-8,Emotional or psychological problem related to drinking
63626-6,Has drinking ever caused you this emotional or psychological problem for more than 24H to the point that it interfered with your functioning or relationships
63627-4,"When you stopped, cut down or went without drinking, did you ever experience this problem for most of the day for 2D or longer"
Aug-62,Clostridioides difficile toxin A+B
63628-2,Problem after cutting down or going without drinking
63629-0,"On the number of D you reported you smoked cigarettes during the past 30D, how many cigarettes did you smoke per D, on average"
63630-8,How long has it been since you last smoked part or all of a cigarette
63631-6,How old were you the last time you smoked part or all of a cigarette
63632-4,About how long has it been since you completely quit smoking cigarettes
63633-2,"In your entire life, have you had at least 1 drink of any kind of alcohol, not counting small tastes or sips"
63634-0,"About how old were you when you first started drinking, not counting small tastes or sips of alcohol"
63635-7,"Did drinking when you promised yourself that you wouldn't, or being drunk more than you intended happen 3 times or more"
Jun-63,Clostridioides difficile toxin A+B
63636-5,"How soon after you wake up do, or did, you smoke your first cigarette"
63637-3,"Do, or did, you find it difficult to refrain from smoking in places where it is forbidden, such as in church, at the library, in a cinema, etc"
63638-1,Smoking status
63639-9,"Which cigarette would, or did, you hate most to give up"
63640-7,"How many cigarettes per day do, or did, you smoke"
63641-5,"Do, or did, you smoke more frequently during the first Hs after waking than during the rest of the day"
63642-3,"Do, or did, you smoke if you are so ill that you are in bed most of the day"
63643-1,Drug type used in your lifetime
Apr-64,Clostridioides difficile toxin A+B
63644-9,Have you ever used any of these medicines or drugs
63645-6,How old were you when you first used this drug
63646-4,"During the past 30D, on how many D did you use drugs"
63647-2,Did you ever use marijuana at least 21 times in a single Y
63648-0,"Has there ever been a period of a Mo or more when a great deal of your time was spent using marijuana, getting marijuana, or getting over its effects"
63649-8,"Problem, related to marijuana use, that occurred for more than 24H to the point that it interfered with functioning or relationships"
Jan-65,Clostridioides difficile toxin B
63651-4,Did you continue to use marijuana after you knew it caused this problem
63652-2,Have you often wanted to stop or cut down on marijuana
63653-0,Have you ever tried to stop or cut down on marijuana but found you couldn't
63654-8,Were you unable to stop or cut down on marijuana 3 or more times
63655-5,Have you often used marijuana more frequently or in larger amounts than you intended to
63656-3,"Did you ever need larger amounts of marijuana to get an effect, or did you ever find that you could no longer get high on the amount you used to use"
63657-1,"When you stopped, cut down, or went without marijuana, did you ever experience any of these problems for most of the day for 2D or longer"
63658-9,Have you ever used marijuana to keep from having any of these problems or to make them go away
63659-7,"Did using marijuana, to keep from having any of these problems, happen 3 or more times"
63660-5,"Did these problems, related to using marijuana, ever occur together"
63661-3,"Did giving up, or greatly reducing important activities while using marijuana happen 3 or more times or last for a month or longer"
63662-1,"Medicine or drug used to feel good or high, or to feel more active or alert"
63663-9,"Have you ever used any of these medicines or drugs to feel good or high, or to feel more active or alert - or did you use any prescription drugs when they were not prescribed, or more than prescribed"
63664-7,How many times in your life have you used this medicine or drug
63665-4,Was there ever a period of a Mo or more when a great deal of your time was spent getting over this drug or its effects
63666-2,Have you often wanted to stop or cut down on this drug
63667-0,Have you ever tried to stop or cut down on this drug but found that you couldn't
63668-8,Were you unable to stop or cut down 3 or more times on this drug
Sep-66,Clostridioides difficile toxin B
63669-6,Did you ever need larger amounts of this drug to get an effect or find that you could no longer get high on the amount you used to use
63670-4,"Have you ever given up or greatly reduced important activities like sports, work, or associating with friends or relatives while using this drug"
63671-2,"Drug type used steadily, for a month or more"
63672-0,"Did giving up or greatly reducing important activities while using this drug, happen 3 or more times or more or for a month or more"
63673-8,"Have you often used this drug, used steadily, more D or in larger amounts than you intended to"
63674-6,"Problem when you stopped, cut down, or went without drugs after using drugs steadily"
63675-3,"When you stopped, cut down, or went without drugs after using drugs steadily, did you ever experience this problem"
63676-1,"Was there ever a time, because of stopping, cutting down on, or going without this drug, after using it steadily, when 2 or more of these problems occurred together"
Jul-67,Clostridium tetani Ab.IgG
63677-9,Have you ever used this drug to keep from having any of these problems or make them go away
63678-7,Did you have to use this drug to make problems go away 3 or more times
63679-5,"Did using this drug cause you to have any other problems, like an overdose that required medical treatment"
63680-3,"Did an overdose of this drug that required medical treatment, happen 3 or more times"
63681-1,"Did using this drug cause you to have any other problems, like hepatitis"
63682-9,Did you continue to use this drug knowing it caused hepatitis
63683-7,Did using this drug cause you to have any other serious health problems
63684-5,Did you continue to use this drug knowing it caused other serious health problems
May-68,Coccidioides immitis Ab
63685-2,Has use of this drug ever caused you emotional or psychological problems for more than 24H to the point that it interfered with your functioning or relationships
63686-0,Did you continue to use drug after you knew it caused any of these emotional or psychological problems
63687-8,Which specific drug of this type did you use
63688-6,Emotional or psychological problem related to drug use
63689-4,Drug used in past 30D
63690-2,"Have you given up or greatly reduced important activities like sports, work, or associating with friends or relatives while using marijuana"
63691-0,"Problem when you stopped, cut down or went without marijuana for 2D or longer"
63692-8,What is type of dwelling
Mar-69,Cryptococcus neoformans Ab
63693-6,Type of dwelling if other
63694-4,Is property actively used as a farm or ranch
63695-1,What is the approximate age of your building
63696-9,What Y was building built
63697-7,What Mo did you start living there
63698-5,What Y did you start living there
63699-3,At what age did you start living there
63700-9,What Mo did you move from there
Jan-70,Cryptococcus sp Ab
63701-7,What Y did you move from there
63702-5,What age did you move from there
63703-3,How many Ys have or did you live there
63704-1,Is there an enclosed garage attached to this house or apartment
63705-8,"Are automobiles, vans, trucks or other motor vehicles parked in this attached garage"
63706-6,"Are any gas powered devices stored in any room, basement, or attached garage in this house or apartment"
63707-4,"During the past 12Mo, has there been water or dampness in your home from broken pipes, leaks, heavy rain, or floods"
63708-2,Does your home frequently have a mildew odor or musty smell
63709-0,"Is air conditioning, refrigeration, used to cool this house or apartment"
63710-8,Which types of air conditioning units do you use
63711-6,During which Mo do you usually start using air conditioning to cool this house or apartment
63712-4,During which Mo do you usually stop using air conditioning
63713-2,Which fuels are used for heating this house or apartment
63714-0,Does this house or apartment have a central heating system with ducts that blow air into most rooms
63715-7,During which Mo do you usually start using heating devices
63716-5,During which Mo do you usually stop using heating devices
63717-3,"In the last 12Mo, did any dogs, cats or other small furry animals, such as a rabbit, guinea pig or hamster, live or spend time inside your home"
63718-1,What kind of pet lived or spent time inside your home
Sep-71,Cryptosporidium sp Ag
63719-9,What was the primary source of drinking water at your home
63720-7,What was the primary source of drinking water at your home if other
63721-5,What was the depth of the private well
63722-3,Was the private well cased
63723-1,Are any of the water treatment devices listed on this card used in your home
63724-9,Which of these water treatment devices are now used in your home
63725-6,Residence
63726-4,From what date did you live in the residence
Jul-72,Cryptosporidium sp Ag
63727-2,To what date did you live in the residence
63728-0,"What is the residence address, street - crosstreets, city, state or landmark"
63729-8,Was this on a farm
63730-6,What was your water supply
63731-4,What was your water supply if other
63732-2,Near fields or orchards
63733-0,Did you live close to the center or margin of town
63734-8,Were geocoordinates verified
May-73,Taenia solium larva Ab.IgG
63735-5,How were the geocoordinates verified
63736-3,Materials to which you were exposed in your work or daily life
63737-1,"In your work or daily life, were you regularly exposed to this material"
63738-9,How many Y were you regularly exposed to this material
63739-7,How many H did you work last W at all jobs or businesses
63740-5,Do you usually work 35H or more per W in total at all jobs or businesses
63741-3,For whom did you work for at your main job or business
63742-1,What kind of business or industry is this
Mar-74,Taenia solium larva Ab.IgG
63743-9,What kind of work were you doing
63744-7,What were your most important activities on this job
63745-4,Which of the following best describes the H you usually work at you main job or business
63746-2,About how long have you worked for your employer in your occupation
63748-8,What kind of work were you doing the longest
63749-6,What kind of business or industry did you work in for the longest period of time
6375-0,Cytomegalovirus Ag
63750-4,What were your most important activities on this job or business
63751-2,About how long did you work at that job or business
63752-0,"Since the age 16, did you ever work for 6Mo or more"
63753-8,Job number
63754-6,"What was the name of the company where you first or next worked, for 6Mo or longer"
63755-3,What was the job title of the first or next job you held at this company
63756-1,In what Y did you start working at this job
63757-9,In what Y did you stop working at this job
63758-7,What was the location of this company
63759-5,Was this a full-time or part-time job
63760-3,"What did they make, or what service did they provide - what type of business was it"
63761-1,What were your main activities or duties for this job
63762-9,What kinds of chemicals or materials did you handle in that job
63763-7,What kinds of tools and equipment did you use
63764-5,Hobby
63765-2,Have you participated for 6Mo or longer in this hobby
63766-0,In what Y were you first involved in this hobby
63767-8,In what Y were you last involved in in this hobby
Aug-76,Cytomegalovirus Ag
63768-6,"Overall, for how many Y were you involved in this hobby"
63769-4,"On average, about how many hours per W, Mo, or Y have you participated in this hobby"
63770-2,Other activities involving use of chemicals
63771-0,"Does anyone who lives here smoke cigarettes, cigars, or pipes anywhere inside this home"
63772-8,Who smokes
63773-6,How many cigarettes per D do you usually smoke anywhere inside the home
63774-4,"At this job or business, that is at your employer, in your occupation, how many H per D can you smell the smoke from other peoples cigarettes, cigars, or pipes"
63775-1,How many full brothers do you have
Jun-77,Cytomegalovirus Ag
63776-9,How many full sisters do you have
63777-7,Do you have a twin brother or sister
63778-5,Are you and your twin identical or not identical
63779-3,Sibling
63780-1,Who is the oldest or what is the first name of your next brother or sister
63781-9,Sex
63782-7,Is this brother or sister still living
63783-5,How old is this brother or sister now or how old was brother or sister when he or she died
Apr-78,Cytomegalovirus Ag
63784-3,Day care or preschool category
63785-0,In what Mo and Y did child begin the first or next attendance at day care or preschool outside the home
63786-8,In what Mo and Y did child end the first or next attendance of day care or preschool
63787-6,About how many H per W did or does child attend day care or preschool outside the home
63788-4,Childs age at reference date
63789-2,Did your mother breastfeed you
637-9,Plasmodium sp identified
63790-0,"In the past Y has there been a major renovation to this house or apartment, such as adding a room, putting up or taking down a wall, replacing windows, or refinishing floors"
63791-8,What type of renovation
Feb-79,Cytomegalovirus Ag
63792-6,When was the last renovation
63793-4,"Within the last 6Mo were rugs, drapes or furniture professionally cleaned"
63794-2,Were they cleaned inside the house
63795-9,When were they cleaned
63796-7,What items were cleaned
63797-5,"In the past Y, was the inside of this house or apartment painted"
63798-3,When was the last time the inside of this house or apartment was painted
63799-1,How many rooms of the inside of this house or apartment were painted
Aug-63,Cefadroxil
6380-0,Cytomegalovirus Ag
63800-7,Did you go to the dry cleaners during the past W
63801-5,Did you bring home any items from the cleaners that were dry-cleaned during the past W
63802-3,Air contaminant in the home
63803-1,"Have you, or has someone near you, used this air contaminant in the last 48H"
63804-9,Did you handle this air contaminant yourself
63805-6,How long did you handle this air contaminant yourself
63806-4,Were you near somebody who handled this air contaminant
63807-2,How long were you near somebody else who handled this air contaminant
63808-0,Which cleaning solutions
63809-8,"During the last 48H, the study period, did you or anyone else park a car or other motor vehicle in"
63810-6,"During the last 48H, the study period, did you or anyone else start a car or other motor vehicle in"
63811-4,"During the last 48H, the study period, was there any diesel vehicles parked around the house"
63812-2,"During the last 48H, the study period, have you operated or been near diesel engines, e.g. bus terminal, truck stop"
63813-0,Time vacuum bag was emptied
63814-8,Vacuum dust collection contaminant
63815-5,Name of vacuum dust collection contaminant
63816-3,Concentration of vacuum dust collection contaminant
63817-1,"If you spent an hour in the mid-day sun for the first time without sunscreen, which of these reactions best describes what would happen to your skin"
Aug-81,Cytomegalovirus Ag
63818-9,Who provided most of the responses in this section
63819-7,"On 3 or more different occasions have you taken a drink to keep from having fits, seizures, or convulsions or to make them go away"
63820-5,"When you stopped, cut down, or went without drinking, did you ever have the DTs, that is, where you were very confused, extremely shaky, felt very frightened or nervous, or saw things that weren't really there"
63821-3,On 3 or more different occasions have you taken a drink to keep from having the DTs or to make them go away
63822-1,"When you stopped, cut down, or went without drinking, did you ever have fits, seizures, or convulsions, where you lost consciousness, fell to the floor, and had difficulty remembering what happened"
63823-9,Did you ever get a blistering sunburn
63824-7,Did you ever get a skin rash from sun exposure
63825-4,Have you ever used a sunlamp
Jun-82,Dengue virus Ab
63826-2,Have you ever used a tanning booth
63827-0,Ultraviolet light exposure
63828-8,Age group for ultraviolet light exposure
63829-6,"On a typical weekday in the summer, about how many H did you generally spend in the mid-day sun"
63830-4,"On a typical weekend D in the summer, about how many H did you generally spend in the mid-day sun"
63831-2,Has there been renovation or repairs in your workspace because of moisture damage
63832-0,What is the floor material in your workspace
63833-8,Floor material in your workspace if other
Apr-83,Dengue virus Ab
63834-6,"Is the wall material of your work space textile, cloth, jute, etc"
63835-3,Is the wall material of your work space plastic
63836-1,Has there been renovation or repairs in your home due to moisture damage
63837-9,Has there been renovation in your home during the past 12Mo
63838-7,Which of the following repairs was done in your home during the past 12Mo
63839-5,Do you have wall-to-wall carpeting in your home
63840-3,Is the floor material in your home plastic or vinyl
63841-1,"Is the wall material in your home textile, cloth, jute, etc"
Feb-84,Dengue virus Ag
63842-9,Is the wall material in your home plastic
63843-7,Has child attended day care outside the home
63844-5,Has child attended preschool
63845-2,In the past Y were new carpets or rugs installed
63846-0,When was the installation
63847-8,On how many rooms were new carpets or rugs installed
63849-4,Number of D vacuum has been used since changing bag or emptying the collection chamber
63850-2,Weight of dust collected
63851-0,How old were you the first time you got this exposure
63852-8,About how old were you the first time you got this exposure
63853-6,How old were you the last time you got this exposure
63854-4,About how old were you the last time you got this exposure
63855-1,How many of these ultraviolet light exposures have you gotten in your life
63856-9,About how many of these ultraviolet light exposures have you gotten in your life
63857-7,How many Mo a Y did you usually have a tan
63858-5,"On the average, when you smoke, or on the last day you smoked every day, about how many cigarettes do, or did, you smoke"
Sep-85,Dengue virus Ag
63859-3,"Have you ever consumed alcoholic beverages, such as beer, wine, or liquor at least once a W for 6Mo or more"
63860-1,"In this age range, did you drink alcoholic beverages at least once a W for 6Mo or more"
63861-9,For how many Y did you drink alcoholic beverages at least once a W for 6Mo or more
63862-7,Age range for exercise
63863-5,"Average H per W you participated in strenuous exercise activities or sports like swimming laps, aerobics, calisthenics, running, jogging, basketball, cycling on hills, racquetball during this age range"
63864-3,"Average Mo per Y you participated in strenuous exercise activities or sports like swimming laps, aerobics, calisthenics, running, jogging, basketball, cycling on hills, racquetball during this age range"
63865-0,"Average H per W you participated in moderate exercise activities or sports like brisk walking, golf, volleyball, cycling on level streets, recreational tennis, or softball during this age range"
63866-8,"Average Mo per Y you participated in moderate exercise activities or sports like brisk walking, golf, volleyball, cycling on level streets, recreational tennis, or softball during this age range"
Jul-86,Dengue virus DNA
63867-6,Physical activity in past Y
63868-4,Average H per D did you spend doing this activity
63869-2,Average D per W did you spend doing this activity
638-7,Microscopic observation
63870-0,For how many H per D were you exposed to smoke from other peoples cigarettes or tobacco products during this time at this location
63871-8,For how many Y were you exposed to smoke from other peoples cigarettes or tobacco products during this time at this location
63872-6,"At the present time, how many H per D are you exposed to the smoke of others"
63873-4,"Have you ever taken estrogen, female hormones, for symptoms of menopause, the change of life, or for other reasons"
63874-2,Have you ever taken premarin by mouth as pills
May-87,Dengue virus DNA
63875-9,At what age did you first take premarin
63876-7,At what age did you last take premarin
63877-5,How many Y in total did you take premarin - exclude those periods when you temporarily stopped
63878-3,Which premarin pill did you use the longest
63879-1,At what age did you first use estrogens other than premarin pills
63880-9,At what age did you last use estrogens other than premarin pills
63881-7,How many Y in total did you take estrogens other than premarin pills - exclude any time when you temporarily stopped
63882-5,Have you ever used progesterone or a progestin
Mar-88,Eastern equine encephalitis virus Ag
63883-3,At what age did you first take progesterone or a progestin
63884-1,At what age did you last take progesterone or a progestin
63885-8,How many Y in total did you take progesterone or a progestin - excluding any time when you temporarily stopped
63886-6,"If you used provera, what was your usual dose"
63887-4,"When using progestin or progesterone, for how many D each Mo would you usually take it"
63888-2,Age at first menstrual period
63889-0,Have you had a menstrual period within the last year
63890-8,Age at last menstrual period
Jan-89,Eastern equine encephalitis virus Ag
63891-6,Cause of menopause
63892-4,Have you ever been pregnant
63893-2,Outcome of pregnancy
63894-0,Number of birth
63895-7,Breastfeeding status
63896-5,Months of breast feeding
63897-3,Relative
63898-1,Sex of relative
63899-9,Is relative alive
63900-5,Current age or age at death
63901-3,Relative never had cancer
63902-1,First cancer diagnosis
63903-9,Age at first cancer diagnosis
63904-7,Second or other cancer diagnoses
63905-4,How often do you worry about getting lung cancer
63906-2,"Compared to others your age who currently smoke, what do you think are your chances of being diagnosed with lung cancer during your lifetime"
63907-0,Clinician-diagnosed illness
63908-8,Have you had this clinician-diagnosed illness
Sep-90,Echinococcus sp Ab
63909-6,Y of diagnosis of clinician-diagnosed illness
63910-4,Angina pectoris confirmed angiography
63911-2,Fibrocystic or other benign breast disease confirmed by breast biopsy
63912-0,Fibrocystic or other benign breast disease confirmed by aspiration
63913-8,Site of other cancer
63914-6,Did you have symptoms of gallstones
63915-3,How were gallstones diagnosed
63916-1,Was endometriosis confirmed by laparoscopy
Jul-91,Echinococcus sp Ab
63917-9,Were uterine fibroids confirmed by pelvic exam
63918-7,Were uterine fibroids confirmed by ultrasound or hysterectomy
63920-3,"During the past 3Y, have you had this cancer screening test"
63921-1,Cancer screening
63922-9,Are you considering quitting smoking during the next 6Mo
63923-7,"In the past, have you ever made a serious attempt to quit smoking That is, have you stopped smoking for at least one day or longer because you were trying to quit"
63924-5,What was the longest length of time you stopped smoking because you were trying to quit
May-92,Echovirus 30 Ab
63925-2,How old were you when you most recently quit smoking
63926-0,"Thinking of the most recent time you quit smoking, did you use any of the following products"
63927-8,"During the past 12Mo, did any doctor, dentist, nurse, or any other health professional advise you to quit smoking"
63928-6,Have you ever had cancer
63929-4,Cancer site - type
63930-2,Laterality
63931-0,Date of diagnosis
63932-8,Age at diagnosis
Mar-93,Echovirus 30 Ab.Neut
63933-6,Cancer treatment
63934-4,Did you have this treatment or therapy for cancer
63935-1,Name of surgical procedure
63936-9,Start date of treatment or therapy
63937-7,Treatment hospital
63938-5,Type of chemotherapy
63939-3,End date of treatment or therapy
63940-1,Hormone treatment for cancer
Jan-94,Echovirus 40 Ab
63941-9,Did you receive any other types of therapy
63942-7,Name of other cancer therapy
63943-5,Have you had a recurrence with this cancer
63944-3,Date of cancer recurrence
63945-0,"Where did this cancer recur - example lung, breast, liver"
63946-8,Pain-relieving medication
63947-6,Do you currently take this pain-relieving medication at least once a week
63948-4,How many total tablets per W of pain-relieving medication
63949-2,Did you stop the regular use of pain-relieving medication during past 3Y
639-5,Microscopic observation
63950-0,Why did you stop regular use of pain-relieving medication
63951-8,"In the past 3Y have you taken statins, lovastatin - mevacor, atorvastatin - lipitor, rosuvastain - crestor, pravastatin - pravachol, simvastatin - zocor, fluvastatin - lescol"
63952-6,"In the past 3Y have you taken steroids, predniSONE, dexamethasone - decadron, solumedrol - medrol dose-pack"
63953-4,Age range for lifetime alcohol exposure
63954-2,"How many drinks per D, W, Mo, or Y did you usually have"
63955-9,Time and location of passive smoke exposure
63956-7,Were you exposed to smoke from other peoples cigarettes or tobacco products during this time at this location
63957-5,Premarin pill
Aug-95,Echovirus 40 Ab.Neut
63958-3,Have you ever used this premarin pill
63959-1,Estrogen administration method
63960-9,Have you ever used this estrogen administration method
63961-7,Cause of menopause if other
63962-5,Pregnancy number
63963-3,Date of end of pregnancy
63964-1,Cancer diagnosis if other
Jun-96,Entamoeba histolytica DNA
63968-2,Date of major illness or surgery
63969-0,"How often was your baby put to bed with a bottle of formula, breast milk, juice drink, or any other kind of milk in past 2W"
63970-8,Did you give your baby a bottle in the past 2W
63971-6,How often have you added this item to babys bottle or breast milk in past 2W
63972-4,Items added to babys bottle or breast milk
63973-2,Items added to babys bottle or breast milk if other
Apr-97,Entamoeba histolytica Ag
63974-0,Beverage consumed
63975-7,Did your child consume this beverage during the past W
63976-5,How many servings of this beverage per D did your child drink
63977-3,What type of container does your child most often use for beverages
63978-1,What beverage does your child most often consume at meals
63979-9,What beverage does your child most often consume between meals
63980-7,Which statement best describes your child's nighttime feedings
63981-5,Does your mouth frequently feel dry
Feb-98,Entamoeba histolytica Ag
63982-3,Does your mouth feel dry when eating
63983-1,Does the amount of saliva in your mouth seem to be
63984-9,Do you sip liquids frequently during the day to keep your mouth moist
63985-6,Do you have difficulties swallowing food if you eat without additional fluids
63986-4,Have you been diagnosed with a cleft lip or palate
63987-2,Defect location of cleft lip or palate
63988-0,Code for cleft lip or palate defect
63989-8,Does anyone in the family use toothpaste with fluoride
6399-0,Entamoeba histolytica Ag
63990-6,Who in the family uses toothpaste with fluoride
63991-4,Does anyone else in the family use toothpaste with fluoride
63992-2,"Does your child now take vitamins with fluoride in them or any other kind of fluoride tablets, drops or supplements"
63993-0,Have you ever had any orthodontic treatment
63994-8,How long did you wear fixed braces on your teeth
63995-5,How many natural teeth do you have
63996-3,How many natural teeth does your child have
63997-1,How many teeth does your baby have now
63998-9,How often do you brush your teeth
63999-7,Do you use dental floss
64000-3,"Did you have painful sores or irritations around the lips or on the tongue, cheeks, or gums more than once in past 6Mo"
64001-1,Did you first have the sores or irritations more than 6Mo ago
64002-9,About how long has it been since you last visited a dentist
64003-7,What was the main reason you last visited the dentist
64004-5,Tobacco product
64005-2,"In your entire life, have you ever smoked or used this type of tobacco"
Jun-00,Ehrlichia canis Ab
64006-0,Pain or toothache
64007-8,"Did you have this pain or toothache more than once, in past 6Mo"
64008-6,Pain severity
64009-4,"When you have this pain, does it come and go or is it continuous and uninterrupted"
64010-2,Latitude for the residence
64011-0,Longitude for the residence
64012-8,CEBPA gene targeted mutation analysis
64013-6,Escherichia coli shiga-like toxin 1 & 2
Apr-01,Ehrlichia chaffeensis Ab.IgG
64014-4,"If your baby was breastfed or fed breast milk in past 7D, about how long did an average breastfeeding session last"
64015-1,How many times in the past 7D was your baby fed pumped breast milk to drink
64016-9,The amount of this beverage per serving during the past W
64017-7,Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel
64018-5,Has any relative in your family been diagnosed with a cleft lip or palate
64019-3,Details on who has cleft lip or palate
64020-1,"If your child drinks cows milk, what type of cows milk does your child usually drink"
64021-9,How many servings of this beverage per W did your child drink
Feb-02,Ehrlichia chaffeensis Ab.IgM
64022-7,Patients activity level
64023-5,Mode of supported ventilation
64024-3,Spirometry contraindicated
64025-0,Reason for contraindication
64026-8,Pre-bronchodilator forced expiratory volume in 1 second attempt
64027-6,Pre-bronchodilator forced vital capacity attempt
64028-4,Post-bronchodilator forced expiratory volume in 1 second attempt
64029-2,Post-bronchodilator forced vital capacity attempt
640-3,Microscopic observation
6403-0,Anaplasma phagocytophilum Ab
64030-0,Percent of baseline forced expiratory volume in 1 second
64031-8,Absolute volume
64032-6,Conditions that might affect ability to comply with breathing instructions
64033-4,Supine inspiratory CT image ID
64034-2,Supine expiratory CT image ID
64035-9,Repair done in your home during the past 12Mo if other
64036-7,"What did they make, or what service did they provide"
64037-5,Gadus morhua recombinant (rGad c) 1 Ab.IgE.RAST class
64038-3,Adenovirus DNA
64039-1,Decayed tooth surfaces + filled tooth surfaces
64040-9,Tooth site - periodontal
64041-7,Tooth code - caries - periodontal
64042-5,"Distance from the free gingival margin, FGM, to the sulcus base, SB"
64043-3,"Distance from the free gingival margin, FGM, to the cement-enamel junction, CEJ"
64044-1,"Clinical observation of the presence of blood, bleeding on probing, BOP"
64045-8,Tooth position - fluorosis
64046-6,Tooth code - fluorosis
64047-4,Tooth surface index of fluorosis - TSIF
Aug-04,Anaplasma phagocytophilum Ab
64048-2,Missing teeth
64049-0,Tooth aspect - fluorosis
64051-6,Views^W radionuclide intra lymphatic
64052-4,Views^W radionuclide intra lymphatic
64053-2,Admission evaluation note
64054-0,Admission evaluation note
May-05,Ehrlichia sp Ab
64055-7,Progress note
64056-5,Consultation note
64057-3,Progress note
64058-1,Admission evaluation note
64059-9,Progress note
64060-7,Admission evaluation note
64061-5,Progress note
64062-3,Admission evaluation note
Mar-06,Flavivirus identified
64063-1,Progress note
64064-9,Evaluation note
64065-6,Initial evaluation note
64066-4,Admission evaluation note
64067-2,Progress note
64068-0,Consultation note
64069-8,Note
64070-6,Admission evaluation note
Jan-07,Francisella tularensis Ab.IgM
64071-4,Progress note
64072-2,Consultation note
64073-0,Note
64074-8,Admission evaluation note
64075-5,Progress note
64076-3,Consultation note
64077-1,Note
64078-9,Admission evaluation note
64079-7,Progress note
64080-5,Consultation note
64081-3,Cells.FMRP/100 lymphocytes
64082-1,Bilirubin.non-glucuronidated
64083-9,MGMT gene methylation score
64084-7,Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells^^corrected for background
64085-4,Cells karyotyped.total
64086-2,Cells analyzed
64087-0,ISCN band level
64088-8,Karyotype
Sep-08,Francisella tularensis Ag
64089-6,Cells counted
64090-4,Chromosome analysis overall interpretation
64091-2,Cells karyotyped.total
64092-0,Cells analyzed
64093-8,ISCN band level
64094-6,Karyotype
64095-3,Cells counted
64096-1,Colonies counted
Jul-09,Fungus identified
64097-9,Fatigue^post exercise
64098-7,Walking distance
64099-5,Peak expiratory flow attempt
64100-1,Contraindication
64101-9,Fatigue^resting
64102-7,Oxygen therapy type during walk test
64103-5,Baseline time
64104-3,Stopped or paused before 6M
May-10,Gardnerella vaginalis rRNA
64105-0,Reason stopped or paused before 6M
64106-8,Other symptoms at end of exercise
64107-6,Number of laps
64108-4,Final partial lap distance
641-1,Microscopic observation
64110-0,Interpretation
64111-8,Time at blood draw
64112-6,Dyspnea^post exercise
Mar-11,Giardia lamblia Ab.IgG
64113-4,Dyspnea^resting
64114-2,End of test time
64116-7,Hemoglobin observations newborn screening panel
64117-5,Most predominant hemoglobin
64118-3,Second most predominant hemoglobin
64119-1,Third most predominant hemoglobin
64120-9,Fourth most predominant hemoglobin
Jan-12,Giardia lamblia Ag
64121-7,Fifth most predominant hemoglobin
64122-5,Hemoglobins that can be presumptively identified based on available controls
64123-3,Indexing - adverse reaction
64124-1,Indexing - substance
64125-8,Pregabalin
64126-6,Drugs identified
64127-4,Methylenedioxyethylamphetamine/Creatinine
64128-2,Amobarbital/Creatinine
64129-0,N-desalkylflurazepam/Creatinine
64130-8,diazePAM/Creatinine
64131-6,Dihydrocodeine/Creatinine
64132-4,PENTobarbital/Creatinine
64133-2,PHENobarbital/Creatinine
64134-0,Phentermine/Creatinine
64135-7,Secobarbital/Creatinine
64136-5,Pregabalin/Creatinine
64137-3,Pregabalin
64138-1,Methylenedioxyamphetamine/Creatinine
Sep-13,Giardia lamblia Ag
64139-9,Butalbital/Creatinine
64140-7,Views^W contrast
64141-5,Views^W contrast
64142-3,Evaluation and management of smoking cessation note
64145-6,Do you usually have a cough
64146-4,"Do you usually cough as much as 4 to 6 times a D, 4 or more D out of the W"
Jul-14,Haemophilus influenzae A Ag
64147-2,"Do you usually cough at all on getting up, or first thing in the morning"
64148-0,Do you usually cough at all during the rest of the day or at night
64149-8,Do you usually cough like this on most days for 3 consecutive Mo or more during the Y
64150-6,For how many Y have you had this cough
64151-4,Do you usually bring up phlegm from your chest
64152-2,"Do you usually bring up phlegm like this as much as twice a D, 4 or more D of the W"
64153-0,Do you usually bring up phlegm at all on getting up or first thing in the morning
64154-8,Do you usually bring up phlegm at all during the rest of the D or at night
May-15,Haemophilus influenzae C Ag
64155-5,Do you bring up phlegm like this on most D for 3 consecutive Mo or more during the Y
64156-3,For how many Y have you had trouble with phlegm
64157-1,Have you had periods or episodes of increased cough and phlegm lasting for 3W or more each Y
64158-9,For how long have you had at least 1 cough and phlegm episode per Y
64159-7,Does your chest ever sound wheezy or whistling when you have a cold
64160-5,Does your chest ever sound wheezy or whistling occasionally apart from colds
64161-3,Does your chest ever sound wheezy or whistling most Ds or nights
Feb-16,Haemophilus influenzae D Ag
64162-1,For how many Y has this wheezing been present
64163-9,Have you ever had an attack of wheezing that has made you feel short of breath
64164-7,How old were you when you had your first wheezing attack leaving you short of breath
64165-4,Have you had 2 or more such episodes of wheezing
64166-2,Have you ever required medicine or treatment for these wheezing attacks
64167-0,"If disabled from walking by any condition other than heart or lung disease, please describe nature of conditions"
64168-8,Are you troubled by shortness of breath when hurrying on level ground or walking up a slight hill
64169-6,Do you have to walk slower than people of your age on the level because of breathlessness
6417-0,Haemophilus influenzae E Ag
64170-4,Do you ever have to stop for breath when walking at your own pace on the level
64171-2,"Do you ever have to stop for breath after walking about 100 yards, or after a few Ms, on the level"
64172-0,Are you too breathless to leave the house or breathless on dressing or undressing
64173-8,"If you get a cold, does it usually go to your chest"
64174-6,"During the past 3Y, have you had any chest illnesses that have kept you off work, indoors at home, or in bed"
64175-3,Did you produce phlegm with any of these chest illnesses
64176-1,"In the last 3Y, how many such illnesses, with increased phlegm, did you have which lasted a W or more"
64177-9,Did you have any lung trouble before the age of 16
64178-7,Have you ever had attacks of bronchitis
64179-5,Was bronchitis confirmed by a doctor
64180-3,At what age was your first attack of bronchitis
64181-1,"Have you ever had pneumonia, include bronchopneumonia"
64182-9,Was pneumonia confirmed by a doctor
64183-7,At what age did you first have pneumonia
64184-5,Have you ever had hay fever
64185-2,Was hay fever confirmed by a doctor
64186-0,At what age did hay fever start
64187-8,Have you ever had chronic bronchitis
Aug-18,Haemophilus influenzae F Ag
64188-6,Was chronic bronchitis confirmed by a doctor
64189-4,Do you still have chronic bronchitis
64190-2,At what age did chronic bronchitis start
64191-0,Have you ever had emphysema
64192-8,Do you still have emphysema
64193-6,Was emphysema confirmed by a doctor
64194-4,At what age did emphysema start
64195-1,Have you ever had asthma
Jun-19,Helicobacter pylori Ab
64196-9,Do you still have asthma
64197-7,Was asthma confirmed by a doctor
64198-5,At what age did asthma start
64199-3,"If you no longer have asthma, at what age did it stop"
64200-9,Have you ever had any other chest illnesses
64201-7,Other chest illnesses you had
64202-5,Have you ever had any chest injuries
64203-3,Chest injuries you had
Apr-20,Helicobacter pylori Ab.IgA
64204-1,Has doctor ever told you that you had heart trouble
64205-8,Have you ever had treatment for heart trouble in the past 10Y
64206-6,"Have you had any treatment for high blood pressure, hypertension, in the past 10Y"
64207-4,"Have you ever worked full time, 30H per W or more, for 6Mo or more"
64208-2,Have you ever worked for a Y or more in any dusty job
64209-0,Job or industry of dusty job
64210-8,Was dusty job exposure
64211-6,Have you ever been exposed to gas or chemical fumes in your work
Feb-21,Hepatitis B virus rRNA
64212-4,Job or industry with gas or chemical fumes
64213-2,Total Y worked in job or industry with gas or chemical fume
64214-0,Was gas or chemical fumes exposure
64216-5,Have you ever smoked cigarettes
64217-3,"Do you now smoke cigarettes, as of 1Mo ago"
64218-1,How many cigarettes do you smoke per D now
64219-9,"On the average of the entire time you smoked, how many cigarettes did you smoke per D"
6422-0,Hepatitis C virus rRNA
64220-7,Do or did you inhale the cigarette smoke
64221-5,Have you ever smoked a pipe regularly
64222-3,How old were you when you started to smoke a pipe regularly
64223-1,Age when stopped smoking a pipe completely
64224-9,"On the average over the entire time you smoked a pipe, how much pipe tobacco did you smoke per W"
64225-6,How much pipe tobacco are you smoking now
64226-4,Do or did you inhale the pipe smoke
64227-2,Have you ever smoked cigars regularly
64228-0,How old were you when you started smoking cigars regularly
64229-8,Age when stopped smoking cigars completely
64230-6,"On the average over the entire time you smoked cigars, how many cigars did you smoke per W"
64231-4,How many cigars are you smoking per W now
64232-2,Do or did you inhale the cigar smoke
64233-0,Benzylpiperazine
64234-8,Current smoker
64235-5,Total Y worked in dusty job
64236-3,Have you ever had any chest operations
64237-1,Chest operations you had
Aug-23,Herpes simplex virus Ag
64238-9,Natural parent
64239-7,Was your parent ever told by a doctor that he or she had chronic bronchitis
64240-5,Was your parent ever told by a doctor that he or she had emphysema
64241-3,Was your parent ever told by a doctor that he or she had asthma
64242-1,Was your parent ever told by a doctor that he or she had lung cancer
64243-9,Was your parent ever told by a doctor that he or she had other chest conditions
64244-7,Have you ever had wheezing or whistling in your chest
64245-4,About how old were you when you first had wheezing or whistling in your chest
Jun-24,Heterophile Ab
64246-2,"In the last 12Mo, have you had wheezing or whistling in your chest at any time"
64247-0,"In the last 12Mo, does your chest ever sound wheezy or whistling when you have a cold"
64248-8,"In the last 12Mo, does your chest ever sound wheezy or whistling more than once a W"
64249-6,"In the last 12Mo, does your chest ever sound wheezy or whistling most Ds and nights"
64250-4,"In the last 12Mo, have you been awakened from sleep by coughing, apart from a cough associated with a cold or chest infection"
64251-2,"In the last 12Mo, have you been awakened from sleep by shortness of breath or a feeling of tightness in your chest"
64252-0,"In the past 12Mo, have you been bothered by sneezing or a runny or blocked nose when you did not have a cold or the flu"
Mar-25,Heterophile Ab
64253-8,"In the past 12Mo, have you been bothered by watery, itchy, or burning eyes when you did not have a cold or the flu"
64254-6,"In the past 12Mo, have you had periods or episodes of cough with phlegm that lasted 1 W or more"
64255-3,For how many Y have you had at least one such episode of cough with phlegm that lasted 1 W or more per Y
64256-1,About how many such episodes of cough with phlegm that lasted 1 W or more have you had in the past 12Mo
64257-9,"In the past Y, have you been to the emergency room or hospitalized for lung problems"
64258-7,How many times have you been to the emergency room or hospitalized for lung problems
64259-5,"In the past Y, have you been treated with antibiotics for a chest illness"
64260-3,How many times have you had to be treated with antibiotics for a chest illness
Jan-26,Histoplasma capsulatum Ab
64261-1,"In the past Y, have you been treated with steroid pills or injections, such as predniSONE or solumedrol, for a chest illness"
64262-9,"How many times have you been treated with steroid pills or injections, such as predniSONE or solumedrol, for a chest illness"
64263-7,Have you ever had wheezing or whistling in the chest at any time in the past
64264-5,Have you had wheezing or whistling in the chest in the last 12Mo
64265-2,How many attacks of wheezing have you had in the last 12Mo
64266-0,"In the last 12Mo, how often, on average, has your sleep been disturbed due to wheezing"
64267-8,"In the last 12Mo, has wheezing ever been severe enough to limit your speech to only one or two words at a time between breaths"
64268-6,"In the last 12Mo, has your chest sounded wheezy during or after exercise"
64269-4,"In the last 12Mo, have you had a dry cough at night, apart from a cough associated with a cold or chest infection"
64270-2,"Have you ever had a problem with sneezing, or a runny or blocked nose, when you did not have a cold or the flu"
64271-0,"In the past 12Mo, have you had a problem with sneezing, or a runny or blocked nose, when you did not have a cold or the flu"
64272-8,"In the past 12Mo, has this nose problem been accompanied by itchy or watery eyes"
64273-6,In which of the past 12Mo did this nose problem occur
64274-4,"In the past 12Mo, how much did this nose problem interfere with your daily activities"
64275-1,Have you ever had an itchy rash which was coming and going for at least 6Mo
64276-9,Have you had this itchy rash at any time in the last 12Mo
64277-7,"Has this itchy rash at any time affected any of the following places - the folds of the elbows, behind the knees, in front of the ankles, under the buttocks, or around the neck, ears, or eyes"
64278-5,Has this itchy rash cleared completely at any time during the last 12Mo
Sep-27,Histoplasma capsulatum Ab
64279-3,"In the last 12Mo, how often, on average, have you been kept awake at night by this itchy rash"
64280-1,Have you ever had eczema
64281-9,Has your child ever had wheezing or whistling in the chest at any time in the past
64282-7,Has your child had wheezing or whistling in the chest in the last 12Mo
64283-5,How many attacks of wheezing has your child had in the last 12Mo
64284-3,Readiness for military duty assessment note
64285-0,Medical history screening form
64286-8,Diagnostic imaging order
Jul-28,Histoplasma capsulatum Ag
64287-6,Prescription
64288-4,Prescription for eyewear
64289-2,Health record cover sheet
642-9,Microscopic observation
64290-0,Health insurance card
64291-8,Health insurance-related form
64292-6,Release of information consent
64293-4,Procedure consent
64294-2,Readiness for military duty assessment letter
May-29,HIV identified
64295-9,Plan of care note
64296-7,Personal health monitoring report
64297-5,Death certificate
64298-3,Power of attorney
64299-1,Legal document
64300-7,Organ donation consent
64301-5,Full time dietitian staff positions filled at end of period
64302-3,Full time social worker staff positions filled at end of period
Mar-30,HIV identified
64303-1,Part time registered nurse staff positions filled at end of period
64304-9,Part time licensed practical nurse and licensed vocational nurse staff positions filled at end of period
64305-6,Part time patient care technician staff positions filled at end of period
64306-4,Part time advance practice nurse staff positions filled at end of period
64307-2,Part time dietitian staff positions filled at end of period
64308-0,Part time social worker staff positions filled at end of period
64309-8,Full time registered nurse staff positions vacant at end of period
64310-6,Full time licensed practical nurse and licensed vocational nurse staff positions vacant at end of period
Jan-31,HIV identified
64311-4,Full time patient care technician staff positions vacant at end of period
64312-2,Full time advanced practice nurse staff positions vacant at end of period
64313-0,Full time dietitian staff positions vacant at end of period
64314-8,Full time social worker staff positions vacant at end of period
64315-5,Part time registered nurse staff positions vacant at end of period
64316-3,Part time licensed practical nurse and licensed vocational nurse staff positions vacant at end of period
64317-1,Part time patient care technician staff positions vacant at end of period
64318-9,Part time advance practice nurse staff positions vacant at end of period
64319-7,Part time dietitian staff positions vacant at end of period
64320-5,Part time social worker staff positions vacant at end of period
64321-3,Kidney transplant center patients who received at least one kidney transplant
64322-1,Kidney transplant center patients who received at least one kidney transplant and enrolled in Medicare
64323-9,End stage renal disease facility survey - OMB CMS form 2744
64324-7,Dialysis stations
64325-4,Incenter dialysis patients at beginning of reporting period
64326-2,Home dialysis patients at beginning of reporting period
64327-0,Total dialysis patients at beginning of reporting period
64328-8,Incenter patients starting dialysis for first time ever
Sep-32,HTLV I Ab
64329-6,Home patients starting dialysis for first time ever
64330-4,Incenter patients restarting dialysis
64331-2,Home patients restarting dialysis
64332-0,Incenter patients transferred from other dialysis unit
64333-8,Home patients transferred from other dialysis unit
64334-6,Incenter patients restarting dialysis after failed transplantation
64335-3,Home patients restarting dialysis after failed transplantation
64336-1,Incenter dialysis patients who died
Jul-33,HTLV I Ab.IgG
64337-9,Home dialysis patients who died
64338-7,Incenter dialysis patients who recovered kidney function
64339-5,Home dialysis patients who recovered kidney function
64340-3,Incenter dialysis patients who received transplant
64341-1,Home dialysis patients who received transplant
64342-9,Incenter patients who transferred to other dialysis unit
64343-7,Home patients who transferred to other dialysis unit
64344-5,Incenter patients who discontinued dialysis
May-34,Influenza virus A+B Ab
64345-2,Home patients who discontinued dialysis
64346-0,Incenter dialysis patients lost to follow up
64347-8,Home dialysis patients lost to follow up
64348-6,Incenter patients receiving hemodialysis at end of reporting period
64349-4,Incenter patients receiving dialysis other than hemodialysis at end of reporting period
64350-2,Incenter patients in self-dialysis hemodialysis training at end of reporting period
64351-0,Incenter patients in self-dialysis Continuous Ambulatory Peritoneal Dialysis (CAPD) training at end of reporting period
Feb-35,Influenza virus A+B Ag
64352-8,Incenter patients in self-dialysis Continuous Cyclic Peritoneal Dialysis (CCPD) training at end of reporting period
64353-6,"Incenter patients in self-dialysis training other than hemodialysis, CAPD or CCPD at end of reporting period"
64354-4,Total incenter dialysis patients at end of reporting period
64355-1,Home patients hemodialyzing at end of reporting period
64356-9,Home patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) at end of reporting period
64357-7,Home patients on Continuous Cyclic Peritoneal Dialysis (CCPD) at end of reporting period
64358-5,"Home patients who received dialysis other than hemodialysis, CAPD or CCPD at end of reporting period"
64359-3,Total home dialysis patients at end of reporting period
6436-0,Influenza virus A+B Ag
64360-1,Total dialysis patients receiving services at end of reporting period
64361-9,Dialysis patients enrolled in Medicare at end of reporting period
64362-7,Dialysis patients who have pending enrollment in Medicare at end of reporting period
64363-5,Dialysis patients not enrolled or pending enrollment in Medicare at end of reporting period
64364-3,Incenter patients dialyzing during the day and more than 4 times per week at end of reporting period
64365-0,Home patients dialyzing during the day and more than 4 times per week at end of reporting period
64366-8,Incenter patients dialyzing nocturnally and more than 4 times per week at end of reporting period
64367-6,Home patients dialyzing nocturnally and more than 4 times per week at end of reporting period
64368-4,Total patients age 18-54 Y dialysing at facility at end of reporting period
64369-2,Dialysis patients who have received or are receiving vocational rehabilitation services
643-7,Microscopic observation
64370-0,Dialysis patients age 18 to 54 Y employed full-time or part-time at end of reporting period
64371-8,Dialysis patients age 18 to 54 Y attending school full-time or part-time at end of reporting period
64372-6,Incenter hemodialysis patients receiving treatments including training treatments
64373-4,Incenter dialysis patients receiving treatments other than hemodialysis including training treatments
64374-2,Full time registered nurse staff positions filled at end of period
64375-9,Full time licensed practical nurse and licensed vocational nurse staff positions filled at end of period
64376-7,Full time patient care technician staff positions filled at end of period
64377-5,Full time advanced practice nurse staff positions filled at end of period
Aug-37,Influenza virus A+B Ag
64378-3,Kidney transplant center patients who received at least one kidney transplant with pending enrollment in Medicare at end of period
64379-1,"Kidney transplant center patients who received at least one kidney transplant, who is US citizen or a foreign national US resident, and not eligible for enrollment in Medicare at end of period"
64380-9,Kidney transplant center patients who received at least one kidney transplant who is neither a US citizen nor a foreign national US resident and not eligible for enrollment in Medicare at end of period
64381-7,Kidney transplant center patients who received at least one kidney transplant from a living related donor
64382-5,Kidney transplant center patients who received at least one kidney transplant from a living unrelated donor
64383-3,Kidney transplant center patients who received at least one kidney transplant from a deceased donor
64384-1,Total kidney transplant center patients who received at least one kidney transplant
64385-8,Kidney transplant center dialysis patients who are awaiting a kidney transplant at end of period
Jun-38,Influenza virus A+B Ag
64386-6,Kidney transplant center non-dialysis patients who are awaiting a kidney transplant at end of period
64387-4,PhenX measure - balance
64388-2,PhenX - balance protocol 170801
64389-0,PhenX measure - fracture history
64390-8,PhenX - fracture history protocol 170901
64391-6,PhenX measure - systemic lupus erythematosus
64392-4,PhenX - systemic lupus erythematosus protocol 171001
64393-2,PhenX measure - perceived stress
Apr-39,Influenza virus A+B+C Ag
64394-0,PhenX - perceived stress protocol 180801
64395-7,PhenX measure - social capitol
64396-5,PhenX - social capitol protocol 181501
64397-3,"In the last 12Mo, how often, on average, has your childs sleep been disturbed due to wheezing"
64398-1,"In the last 12Mo, has wheezing ever been severe enough to limit your childs speech to only one or two words at a time between breaths"
64399-9,Has your child ever had asthma
64400-5,"In the last 12Mo, has your childs chest sounded wheezy during or after exercise"
64401-3,"In the last 12Mo, has your child had a dry cough at night, apart from a cough associated with a cold or chest infection"
Feb-40,Influenza virus A+B+C Ag
64402-1,"Has your child ever had a problem with sneezing, or a runny or blocked nose, when he or she did not have a cold or the flu"
64403-9,"In the past 12Mo, has your child had a problem with sneezing, or a runny or blocked nose, when he or she did not have a cold or the flu"
64404-7,"In the past 12Mo, has this nose problem been accompanied by itchy, watery eyes"
64405-4,"In the past 12Mo, how much did this nose problem interfere with your childs daily activities"
64406-2,Has your child ever had hay fever
64407-0,Has your child ever had an itchy rash that was coming and going for at least 6Mo
64408-8,Has your child had this itchy rash at any time in the last 12Mo
64409-6,At what age did this itchy rash first occur
6441-0,Influenza virus A+B+C Ag
64410-4,"In the last 12Mo, how often, on average, has your child been kept awake at night by this itchy rash"
64411-2,Has your child ever had eczema
64412-0,Mycobacterium sp
64413-8,KIR gene allele 2DL1
64414-6,KIR gene allele 2DL2
64415-3,KIR gene allele 2DL3
64416-1,KIR gene allele 2DL4
64417-9,Fragile X protein (FMRP)
64418-7,KIR genotyping panel
64419-5,KIR gene allele 2DL5
64420-3,KIR gene allele 2DS1
64421-1,KIR gene allele 2DS2
64422-9,KIR gene allele 2DS3
64423-7,KIR2DS4 gene full variant
64424-5,KIR2DS4 gene deletion variant
64425-2,KIR gene allele 2DS5
64426-0,KIR gene allele 3DL1
64427-8,KIR gene allele 3DL2
Aug-42,Influenza virus A+B+C Ag
64428-6,KIR gene allele 3DL3
64429-4,KIR gene allele 3DS1
64430-2,KIR gene allele 2DP1
64431-0,KIR3DP1 gene full variant
64432-8,KIR3DP1 gene deletion variant
64433-6,Fragile X protein (FMRP) panel
64434-4,Medication
64435-1,Medication time and date^pre exercise
Jun-43,Lactoferrin
64436-9,Clinical or research indication for test
64437-7,Contraindications for test
64438-5,How do you describe your current health
64439-3,"Over the past 3Mo, I have coughed"
64440-1,"Over the past 3Mo, I have brought up phlegm - sputum"
64441-9,"Over the past 3Mo, I have had shortness of breath"
64442-7,"Over the past 3Mo, I have had attacks of wheezing"
64443-5,"During the past 3Mo, how many severe or very unpleasant attacks of chest trouble have you had"
Apr-44,Lactoferrin
64444-3,How long did the worst attack of chest trouble last
64445-0,"Over the past 3Mo, in an average W, how many good Ds, with little chest trouble, have you had"
64446-8,"If you have a wheeze, is it worse in the morning"
64447-6,How would you describe your chest condition
64448-4,If you have ever had paid employment
64449-2,My cough hurts
644-5,Microscopic observation
64450-0,My cough makes me tired
Jan-45,Legionella pneumophila Ag
64451-8,I am breathless when I talk
64452-6,I am breathless when I bend over
64453-4,My cough or breathing disturbs my sleep
64454-2,I get exhausted easily
64455-9,My cough or breathing is embarrassing in public
64456-7,"My chest trouble is a nuisance to my family, friends or neighbors"
64457-5,I get afraid or panic when I cannot get my breath
64458-3,I feel that I am not in control of my chest problem
64459-1,I do not expect my chest to get any better
64460-9,I have become frail or an invalid because of my chest
64461-7,Exercise is not safe for me
64462-5,Everything seems too much of an effort
64463-3,My medication does not help me very much
64464-1,I get embarrassed using my medication in public
64465-8,I have unpleasant side effects from my medication
64466-6,My medication interferes with my life a lot
64467-4,I take a long time to get washed or dressed
64468-2,"I cannot take a bath or shower, or I take a long time"
Sep-46,Legionella pneumophila Ag
64469-0,"I walk slower than other people, or I stop for rests"
64470-8,"Jobs such as housework take a long time, or I have to stop for rests"
64471-6,"If I walk up one flight of stairs, I have to go slowly or stop"
64472-4,"If I hurry or walk fast, I have to stop or slow down"
64473-2,"My breathing makes it difficult to do things such as walk up hills, carrying things up stairs, light gardening such as weeding, dance, play bowls or play golf"
64474-0,"My breathing makes it difficult to do things such as carry heavy loads, dig the garden or shovel snow, jog or walk at 5 miles per H, play tennis or swim"
64475-7,"My breathing makes it difficult to do things such as very heavy manual work, run, cycle, swim fast or play competitive sport"
64476-5,I cannot play sports or games
Jul-47,Legionella pneumophila Ag
64477-3,I cannot go out for entertainment or recreation
64478-1,I cannot go out of the house to do the shopping
64479-9,I cannot do housework
64480-7,I cannot move far from my bed or chair
64481-5,Write in any other important activities that your chest trouble may stop you doing
64482-3,Which do you think best describes how your chest affects you
64483-1,Infant awake
64484-9,Respiratory depth comments
May-48,Legionella pneumophila Ag
64487-2,Do you snore
64488-0,Your snoring is
64489-8,How often do you snore
64490-6,Has your snoring ever bothered other people
64491-4,Has anyone noticed that you quit breathing during your sleep
64492-2,How often do you feel tired or fatigued after your sleep
Mar-49,Legionella pneumophila Ag
64493-0,"During your waking time, do you feel tired, fatigued, or not up to par"
64494-8,Have you ever nodded off or fallen asleep while driving a vehicle
64495-5,How often does this nodding off or falling alseep while driving occur
64496-3,Do you have high blood pressure
64497-1,Where are you completing this questionnaire
64498-9,Medication dose^pre exercise
64499-7,Medication^pre exercise
64500-2,"While sleeping, does your child ever snore"
Jan-50,Legionella sp Ab
64501-0,"While sleeping, does your child ever snore more than half the time"
64502-8,"While sleeping, does your child always snore"
64503-6,"While sleeping, does your child snore loudly"
64504-4,"While sleeping, does your child have heavy or loud breathing"
64505-1,"While sleeping, does your child have trouble breathing, or struggle to breathe"
64506-9,Have you ever seen your child stop breathing during the night
64507-7,Have you ever been concerned about your childs breathing during sleep
64508-5,"Have you ever had to shake your sleeping child to get him or her to breathe, or wake up and breathe"
64509-3,Have you ever seen your child wake up with a snorting sound
64510-1,Does your child have restless sleep
64511-9,Does your child describe restlessness of the legs when in bed
64512-7,Does your child have growing pains - unexplained leg pains
64513-5,Does your child have growing pains that are worst in bed
64514-3,"While your child sleeps, have you seen brief kicks of one leg or both legs"
64515-0,"While your child sleeps, have you seen repeated kicks or jerks of the legs at regular intervals - about every 20 to 40S"
64516-8,"At night, does your child usually become sweaty, or do the pajamas usually become wet with perspiration"
64517-6,"At night, does your child usually get out of bed for any reason"
64518-4,"At night, does your child usually get out of bed to urinate"
Sep-51,Legionella sp rRNA
64519-2,"If your child usually gets out of bed to urinate, how many times each night, on average"
645-2,Microscopic observation
64520-0,Does your child usually sleep with the mouth open
64521-8,Is your child's nose usually congested or stuffed at night
64522-6,Do any allergies affect your childs ability to breathe through the nose
64523-4,Does your child tend to breathe through the mouth during the day
64524-2,Does your child have a dry mouth on waking up in the morning
64525-9,Does your child complain of an upset stomach at night
64526-7,Does your child get a burning feeling in the throat at night
Jul-52,Leptospira interrogans Ag
64527-5,Does your child grind his or her teeth at night
64528-3,Does your child occasionally wet the bed
64529-1,Has your child ever walked during sleep - sleep walking
64530-9,Have you ever heard your child talk during sleep - sleep talking
64531-7,Does your child have nightmares once a W or more on average
64532-5,Has your child ever woken up screaming during the night
64533-3,"Has your child ever been moving or behaving, at night, in a way that made you think your child was neither completely awake nor asleep"
64534-1,Does your child have difficulty falling asleep at night
May-53,Leptospira sp identified
64535-8,How long does it take your child to fall asleep at night
64536-6,"At bedtime does your child usually have difficult routines or rituals, argue a lot, or otherwise behave badly"
64537-4,Does your child bang his or her head or rock his or her body when going to sleep
64538-2,Does your child wake up more than twice a night on average
64539-0,Does your child have trouble falling back asleep if he or she wakes up at night
64540-8,Does your child wake up early in the morning and have difficulty going back to sleep
64541-6,Does the time at which your child goes to bed change a lot from day to day
64542-4,Does the time at which your child gets up from bed change a lot from day to day
Mar-54,Leptospira sp identified
64543-2,What time does your child usually go to bed during the week
64544-0,What time does your child usually go to bed on the weekend or vacation
64545-7,What time does your child usually get out of bed on weekday mornings
64546-5,What time does your child usually get out of bed on weekend or vacation mornings
64547-3,Does your child wake up feeling unrefreshed in the morning
64548-1,Does your child have a problem with sleepiness during the day
64549-9,Does your child complain that he or she feels sleepy during the day
6455-0,Leptospira sp identified
64550-7,Has a teacher or other supervisor commented that your child appears sleepy during the day
64551-5,Does your child usually take a nap during the day
64552-3,Is it hard to wake your child up in the morning
64553-1,Does your child wake up with headaches in the morning
64554-9,"Does your child get a headache at least once a Mo, on average"
64555-6,Did your child stop growing at a normal rate at any time since birth
64556-4,Does your child still have tonsils
64557-2,When were your childs tonsils removed
64558-0,Why were your childs tonsils removed
64559-8,Has your child ever had a condition causing difficulty with breathing
64560-6,Has your child ever had surgery
64561-4,"Did any difficulties with breathing occur before, during, or after surgery"
64562-2,"Has your child ever become suddenly weak in the legs, or anywhere else, after laughing or being surprised by something"
64563-0,"Has your child ever felt unable to move for a short period, in bed, though awake and able to look around"
64564-8,"Has your child felt an irresistible urge to take a nap at times, forcing him or her to stop what he or she is doing in order to sleep"
64565-5,"Has your child ever sensed that he or she was dreaming, seeing images or hearing sounds, while still awake"
64566-3,"Does your child drink caffeinated beverages on a typical D - cola, tea, coffee"
64567-1,How many cups or cans of caffeinated beverages per D
Aug-56,Listeria monocytogenes Ab
64568-9,Does your child use any recreational drugs
64569-7,Which recreational drugs does your child use
64570-5,"Does your child use cigarettes, smokeless tobacco, snuff, or other tobacco products"
64571-3,Which tobacco products does your child use
64572-1,"How often does your child use cigarettes, smokeless tobacco, snuff, or other tobacco products"
64573-9,Is your child overweight
64574-7,At what age did this first develop
64575-4,"Has a doctor ever told you that your child has a high-arched palate, roof of the mouth"
Jun-57,DNA double strand Ab
64576-2,"Has your child ever taken Ritalin, methylphenidate, for behavioral problems"
64577-0,"Has a health professional ever said that your child has attention-deficit disorder, ADD, or attention-deficit-hyperactivity disorder, ADHD"
64578-8,"If you are currently at a clinic with your child to see a physician, what is the problem that brought you"
64579-6,"If your child has long-term medical problems, please list the three you think are most significant"
64581-2,"Please list the size, mg, or amount per dose of medication your child currently takes"
64582-0,How often does your child take this medication
64583-8,Date your child has taken this medication
Apr-58,Lymphocytic choriomeningitis virus Ab
64584-6,Effect this medication has on your child
64585-3,Sleep disorders diagnosed or suspected by a physician in your child
64586-1,Date the sleep disorder started
64587-9,Is the sleep disorder still present
64588-7,"Psychological, psychiatric, emotional, or behavioral problems diagnosed or suspected by a physician in your child"
64589-5,"Date the psychological, psychiatric, emotional, or behavioral problem started"
64590-3,How often does your child use recreational drugs
64591-1,Data type
Feb-59,Bacteria identified
64592-9,FVC quality attribute
64593-7,FEV1 quality attribute
64594-5,Effort attribute
64595-2,Deleted maneuver
64596-0,Acceptable maneuver
64597-8,Technician quality control code
64598-6,Computer quality code
64599-4,Plateau achieved
Jun-64,Cefadroxil
646-0,Microscopic observation
6460-0,Bacteria identified
64600-0,Review status
64601-8,Date of review
64603-4,Calibration result
64604-2,Technician ID
64605-9,Maneuver number
64606-7,Race - 2 character code
64607-5,Reference values source
64608-3,Testing position
64609-1,Current breast stage
64610-9,Current pubic hair stage
64611-7,Current stage of genital development
64612-5,Current stage of physical development
64613-3,Did you or your partner ever go to a doctor or other medical care provider to talk about ways to help you have a baby together
64614-1,Which of the services did you or your partner have to help you have a baby together
64615-8,"When you and your partner went for medical help to have a baby together, were you ever told that you had any of the following male infertility problems"
64616-6,Has a doctor or other medical care provider ever told you you had fibroid tumors or myomas in your uterus
64617-4,Has a doctor or other medical care provider ever told you you had endometriosis
Aug-61,Bacteria identified
64618-2,"Have you ever had both of your tubes tied, cut, or removed"
64619-0,Have you ever had any other operation that makes it impossible for you to have a baby
64620-8,"As far as you know, are you completely sterile from this operation, that is, does it make it impossible for you to have a baby in the future"
64621-6,Has your husband or partner ever had a vasectomy or any other operation that would make it impossible for him to father a baby in the future
64622-4,What type of operation did husband or partner have
64623-2,"As far as you know, is he completely sterile from this operation, that is, does it make it impossible for him to father a baby in the future"
64624-0,How old were you when you began using oral contraceptives
64625-7,For how long in total have you used oral contraceptives
Jun-62,Bacteria identified
64626-5,Have you used any other methods of contraception
64627-3,Other method of contraception
64628-1,Are you currently using any method of birth control
64629-9,Mark methods of birth control you are currently using
64630-7,"Including any methods you may have already told me about and methods you may have used only once, during the last 12Mo, which of these methods did you and she use to prevent pregnancy or sexually transmitted diseases"
64631-5,Are you and your partner currently trying to get pregnant
64632-3,"How long, how many Mo, have you and your partner been trying to get pregnant"
64633-1,Have you had a hysterectomy - womb removed
Apr-63,Bacteria identified
64634-9,How old were you when your menstrual periods began
64635-6,At about what age did you reach your full height
64636-4,Your voice changed Compared to your friends this was
64637-2,What is your age when your voice changed
64638-0,Your penis started increasing in size Compared to your friends this was
64639-8,What is your age when your penis started increasing in size
64640-6,What is your age when your testicles started increasing in size
64641-4,You developed pubic hair Compared to your friends this was
Feb-64,Microscopic observation
64642-2,What is your age when you developed pubic hair
64643-0,Would you say these physical changes
64644-8,"How old were you when you entered puberty, that is, when these changes began"
64645-5,Have you used evista - raloxifene or nolvadex - tamoxifen
64646-3,How many Mo have you used evista
64647-1,How many Mo have you used nolvadex
64648-9,Are you currently using evista or nolvadex
64649-7,"Are you currently using any over-the-counter - herbal, natural, or soy-based - preparations for hormone replacement or to treat post-menopausal symptoms"
64650-5,"What types of over-the-counter - herbal, natural, or soy-based - preparations for hormone"
64651-3,Have you used prescription female hormones
64652-1,How many Mo did you use prescription hormones
64653-9,Are you currently using them - within the last Mo
64654-7,Combined hormone treatment
64655-4,Estrogen hormone treatment
64656-2,Other estrogen you are currently using
64657-0,Progesterone-progestin hormone treatment
64658-8,Other progresterone you are currently using
Sep-65,Microscopic observation
64659-6,Other hormones currently used such as tri-est
64660-4,"If you used oral conjugated estrogen, premarin, what dose did you usually take"
64661-2,What was your D per Mo pattern of oral or patch estrogen use
64662-0,What was your D per Mo pattern of progesterone use
64663-8,Have you ever had the HPV vaccination
64664-6,Age when received human papillomavirus vaccination
64665-3,Number of human papillomavirus vaccine doses received
64666-1,Were you born with one or both of your testicles undescended - not completely down in the scrotum
Jul-66,Microscopic observation
64667-9,Which testicle was this
64668-7,Did the testicle go down to the scrotum by itself
64669-5,Did you receive treatment
64670-3,What treatment
64671-1,Other treatment for undescended testicle
64672-9,"Has your doctor or another health care provider ever told you that you had other diseases of the penis, testicles, urinary tract or scrotum"
64673-7,"Disease of the penis, testicles, urinary tract or scrotum"
64674-5,Has your doctor or another health care provider ever told you that you had hypospadius
May-67,Microscopic observation
64675-2,"What was your most recent treatment or medication, if any"
64676-0,"What Y was your most recent treatment or medication, if any"
64677-8,How often did you have difficulty with achieving an erection
64678-6,How often did you have difficulty with ejaculating too early
64679-4,How often did you have difficulty ejaculating
64680-2,How often did you have difficulty with lack of interest in sex
64681-0,Over the past 4W how often were you able to get an erection during sexual activity
64682-8,"Over the past 4W when you had erections with sexual stimulation, how often were your erections hard enough for penetration"
Mar-68,Microscopic observation
64683-6,"Over the past 4W when you attempted sexual intercourse, how often were you able to penetrate - enter your partner"
64684-4,"Over the past 4W during sexual intercourse, how often were you able to maintain your erection after you had penetrated - entered your partner"
64685-1,"Over the past 4W during sexual intercourse, how difficult was it to maintain your erection to completion of intercourse"
64686-9,Over the past 4W how many times have you attempted sexual intercourse
64687-7,"Over the past 4W when you attempted sexual intercourse, how often was it satisfactory for you"
64688-5,Over the past 4W how much have you enjoyed sexual intercourse
64689-3,"Over the past 4W when you had sexual stimulation or intercourse, how often did you ejaculate"
64690-1,"Over the past 4W when you had sexual stimulation or intercourse, how often did you have the feeling of orgasm or climax"
Jan-69,Microscopic observation
64691-9,Over the past 4W how often have you felt sexual desire
64692-7,Over the past 4W how would you rate your level of sexual desire
64693-5,Over the past 4W how satisfied have you been with your overall sex life
64694-3,Over the past 4W how satisfied have you been with your sexual relationship with your partner
64695-0,Over the past 4W how do you rate your confidence that you could get and keep an erection
64696-8,"Since the age of 18, have you ever experienced a time interval of 3 or more Mo when you did not have a menstrual period"
64697-6,Were you breastfeeding at the time
64698-4,Were you breastfeeding or pregnant every time this happened
64699-2,"During ages 18-22 what was the pattern of your menstrual cycles, excluding time around pregnancies"
64700-8,"On average, during the last Y, how many D were there in a typical menstrual cycle, that is, from the beginning of bleeding of one menstrual period to the beginning of bleeding of the next period"
64701-6,Have your menstrual periods stopped permanently
64702-4,How old were you when your periods stopped
64703-2,"How many times a night do you usually get up to urinate, pass water"
64704-0,"When you urinate, pass water, do you usually feel like you have not completely emptied your bladder"
64705-7,"Do you usually have trouble starting to urinate, pass water"
64706-5,Has the force of your urinary stream or water decreased over the Y
64707-3,Have you ever had surgery for your prostate not related to cancer
64708-1,"Including live births, stillbirths, miscarriages, abortions, and tubal and other ectopic pregnancies, how many times have you been pregnant"
Sep-70,Microscopic observation
64709-9,Pregnancy sequence
64710-7,"Was your pregnancy a live birth, stillbirth, miscarriage, abortion, or ectopic pregnancy"
64711-5,How many W or Mo did that pregnancy last
64712-3,On what date did that pregnancy end
64713-1,In which Mos of the pregnancy did you have frequent nausea or vomiting
64714-9,Was the baby a boy or a girl
64715-6,"During the 3Mo before you got pregnant, how many times did you drink 4 alcoholic drinks or more in one sitting"
64716-4,"During the last 3Mo of your pregnancy, how many alcoholic drinks did you have in an average W"
Jul-71,Microscopic observation
64717-2,"During the last 3Mo of your pregnancy, how many times did you drink 4 alcoholic drinks or more in one sitting"
64718-0,"During this pregnancy, did you receive help with an alcohol or drug problem"
64719-8,"Have you ever fathered a pregnancy, regardless of outcome"
64720-6,"How many times have you fathered a pregnancy, regardless of outcome"
64721-4,How old were you when you fathered this pregnancy
64722-2,Was this a planned pregnancy
64723-0,How many Mo did it take for your partner to achieve pregnancy
64724-8,Was this a multiple pregnancy
May-72,Microscopic observation
64726-3,What was the outcome of this pregnancy
64727-1,Date of birth or loss
64728-9,Have you ever had vaginal intercourse
64729-7,How old were you the first time you had vaginal intercourse
64730-5,"With how many partners have you ever had vaginal intercourse, even if only once"
64731-3,With how many different partners have you had vaginal intercourse in the past 12Mo
64732-1,How many times have you had vaginal intercourse in the past 12Mo
Mar-73,Microscopic observation
64733-9,On how many of these occasions did you or your partner use a condom in the past 12Mo
64734-7,"To whom have you felt sexually attracted, even if you did not take any action based on feeling attracted"
64735-4,"Have you ever had any kind of sexual experience or sexual contact with a female, for women, or male, for men"
64736-2,For females - have you ever had sex with a woman involving genital area or vaginal contact. For males - have you ever had sex with a man involving genital area or penis contact
64737-0,When was the last occasion
64738-8,Number of the largest bead that is at least as large as the right testis
64739-6,Number of the largest bead that is at least as large as the left testis
64740-4,Contact biometry instrument model
Jan-74,Microscopic observation
64741-2,Eye
64742-0,Axial length
64744-6,Cornea thickness
64745-3,Eye problem
64746-1,"In the last 12Mo, have you noticed this eye problem"
64747-9,Which eye
64748-7,Symptom duration
64749-5,Is it still ongoing
64750-3,Severity of symptoms
64751-1,During the last 12Mo have you noticed your child frequently squinting
64752-9,During the last 12Mo has your child had difficulty drawing or coloring
64753-7,During the last 12Mo has your child appeared to have difficulty seeing
64754-5,Does your child close one eye when he or she is in bright sun light
64755-2,Does your child close or cover one eye when he or she is concentrating
64756-0,"When was your childs last complete eye examination, one that included dilating of pupils where the doctor used bright lights to look in the back of his or her eyes"
64757-8,Child vision problem
Aug-75,Mobiluncus sp rRNA
64758-6,Has a doctor ever told you that your child had this vision problem
64759-4,Has the child ever been treated in the past for this vision problem
64760-2,Do or did any of his or her relatives have this vision problem
64761-0,Which relatives have vision problem
64762-8,Other relative
64763-6,"How many of his or her sisters have, had, or were suspected of having this eye problem"
64764-4,"How many of his or her brothers have, had, or were suspected of having this eye problem"
64765-1,"How many of his or her grandparents have, had, or were suspected of having this eye problem"
Jun-76,Mumps virus Ab.IgG
64766-9,"How many of his or her other relatives have, had, or were suspected of having this eye problem"
64767-7,"Does your child have strabismus - that is one or both eyes are turned in, or turned out, or up or down, or crossed or wall eyes"
64768-5,What treatment for strabismus did your child receive
64769-3,Other strabismus treatment
64770-1,What treatment for myopia did your child receive
64771-9,Other myopia treatment
64772-7,"In the past 12Mo, how many times has he or she seen an eye doctor for his or her myopia, nearsightedness"
64773-5,When did your child receive this treatment for other eye or vision problems
Apr-77,Mumps virus Ab.IgG
64774-3,Does your child have or had any other eye or vision problems
64775-0,What treatment did your child receive for other eye or vision problems
64776-8,Is the participant currently taking drops for glaucoma
64777-6,What is the name of the glaucoma drops you are using
64778-4,Other glaucoma drops you are using
64779-2,"For the past 3Mo or longer, have you had dry eyes, foreign body sensation with itching and burning, sandy feeling, not related to allergy"
647-8,Microscopic observation
64780-0,Do you currently use artificial tears or prescription medication for dry eyes regularly for 3Mo or longer
64781-8,Are you currently using steroid eye drops
Feb-78,Mumps virus Ab.IgM
64782-6,"Was your child born with any health problems, either physical or mental"
64783-4,Health problem child was born with
64784-2,"During the past 12Mo, if child less than 12Mo, the childs age in Mos, has your child appeared to have any difficulty seeing"
64785-9,Has your child ever been diagnosed with an eye problem
64786-7,When was your child first diagnosed as having an eye problem
64787-5,When was your child first diagnosed as having amblyopia
64788-3,When was your child first diagnosed as having strabismus
64789-1,Did he or she ever have an operation to straighten his or her eyes
6479-0,Mumps virus Ab.IgM
64790-9,When did your child first have this type of operation
64791-7,When did your child first start wearing an eye patch
64792-5,"In general, your childs overall health is"
64793-3,"At the present time, childs eyesight, using both eyes, is"
64794-1,"In the 3Mo before you got pregnant, how many cigarettes did you smoke on an average D"
64795-8,"In the last 3Mo of your pregnancy, how many cigarettes did you smoke on an average D"
64796-6,"During the 3Mo before you got pregnant, how many alcoholic drinks did you have in an average W"
64797-4,Oxygen content
64798-2,Oxygen content
64799-0,Oxygen content
64800-6,Oxygen content
64803-0,What Y did you move from that city or town
64804-8,What was your main daytime activity or job when you turned 18
64805-5,What was your new daytime activity or job
64806-3,What Y did your sunlight exposure change
64807-1,"When you were living in your city or town in your occupation, how many H each D during a typical 5D work week in April through September did you spend outside in direct sunlight between 10 AM and 4 PM"
Aug-80,Mumps virus Ag
64808-9,Sunlight protection
64809-7,"During your work time, when you were outside in direct sunlight, how often did you wear this sunlight protection"
64810-5,How often did you wear this sunlight protection when you were outside in direct sunlight
64811-3,"During the Mos of April through September, how many H each D of this leisure time did you spend outside in direct sunlight between 10 AM and 4 PM"
64812-1,"Did your main daytime activities during your leisure time have you over water for a total of three or more H a D, for example sailing, fishing or swimming"
64813-9,"During your leisure time, when you were outside in direct sunlight, how often did you wear this sunlight protection"
64814-7,"At the present time, would you say your eyesight using both eyes, with glasses or contact lenses, if you wear them, is"
64815-4,Adult eye problem
Jun-81,Mycoplasma pneumoniae Ab.IgG
64816-2,Has a doctor ever told you that you had this eye problem
64817-0,Did you ever have cataract surgery
64818-8,Do or did his or her relative have this eye problem
64819-6,Have you ever been treated for your glaucoma
64820-4,Has a medical doctor ever told you that diabetes has affected blood vessels in your eyes or that you had diabetic retinopathy or diabetic eye disease
64821-2,Did you ever have laser treatment or surgery for your diabetic eye disease
64822-0,How many different times have you had laser treatment or surgery for diabetic eye disease
64823-8,"Have you ever had a crossed or wandering eye, amblyopia"
Apr-82,Mycoplasma pneumoniae rRNA
64824-6,Have you ever had double vision
64825-3,Do you ever tilt your head when looking straight
64826-1,Have you ever undergone eye muscle surgery
64827-9,"Have you ever worn a patch or used eye drops, atropine penalization for eye correction"
64828-7,Have you ever worn glasses or contacts
64829-5,Details for glasses or contacts
64830-3,"Do you have a coloboma, absence or defect of ocular tissue ranging from a small pit in the optic disk to extensive defects in the iris, ciliary body, choroid, retina, or optic disk"
64831-1,"Do you have microphthalmia, abnormally small eye"
Feb-83,Mycoplasma pneumoniae rRNA
64832-9,"Do you have epibulbar dermoid, eye tumors that are not recurrent or progressive"
64833-7,Do you have any abnormal ocular features
64834-5,"Do you have any retinal defects, retinal tears, detachments, etc"
64835-2,Do you have any visual impairment other than previously noted
64836-0,Describe other visual impairment
64837-8,Relative with strabismus
64838-6,Treatment related to strabismus
64839-4,Did this relative have this strabismus treatment
6484-0,Mycoplasma pneumoniae rRNA
64840-2,Other relative with strabismus
64841-0,Line in the ETDRS visual acuity chart read by patient
64842-8,Distance from the patients eyes to the ETDRS visual acuity chart
64843-6,Letter on line read by the patient
64844-4,Equivalent visual acuity from table based on number of letters read correctly
64845-1,"In general, would you say your overall health is"
64846-9,"At the present time, how is your eyesight, using both eyes with glasses or contact lenses, if you wear them"
64847-7,How much of the time do you worry about your eyesight
64848-5,"How much pain or discomfort have you had in and around your eyes, for example, burning, itching, or aching"
64849-3,"Currently driving, at least once in a while"
64850-1,Have you never driven a car or have you given up driving
64851-9,"If you gave up driving, was that mainly because of your vision, mainly for some other reason, or because of both your vision and other reasons"
64852-7,How much difficulty do you have driving during the daytime in familiar places
64853-5,How much difficulty do you have driving at night
64854-3,"How much difficulty do you have driving in difficult conditions, such as in bad weather, during rush hour, on the freeway, or in city traffic"
64855-0,Do you accomplish less than you would like because of your vision
64856-8,Are you limited in how long you can work or do other activities because of your vision
Jul-85,Mycoplasma pneumoniae rRNA
64857-6,"How much does pain or discomfort in or around your eyes, for example, burning, itching, or aching, keep you from doing what you'd like to be doing"
64858-4,How would you rate your overall health
64859-2,"How would you rate your eyesight now, with glasses or contact lens on, if you wear them"
648-6,Microscopic observation
64860-0,Do you currently wear contact lenses
64861-8,Have you ever worn contact lenses
64862-6,Are you considering wearing contact lenses in the next year
64863-4,What type of contact lenses do you wear
64864-2,Measurement sequence
May-86,Mycoplasma sp identified
64866-7,In what city or town were you living when you were 18
64867-5,To what city or town did you move to next
64868-3,What Y did you turn 18
64869-1,City
64870-9,Do you sleep with your contact lenses in
64871-7,"Does your child currently wear glasses or contact lenses to correct, or partially correct, his or her eyesight"
64872-5,How often are the glasses or contact lenses worn
Mar-87,Neisseria gonorrhoeae Ag
64873-3,Were the glasses or contact lenses prescribed for astigmatism
64874-1,Were the glasses or contact lenses prescribed for short-sightedness or myopia
64875-8,Were the glasses or contact lenses prescribed for long-sightedness or hyperopia
64876-6,Were the glasses or contact lenses prescribed for other
64877-4,Other glasses or contact lenses prescribed
64878-2,"Has your child worn glasses or contact lenses in the past, but no longer needs to wear them"
64879-0,Date when first prescribed
64880-8,Age when first prescribed
Jan-88,Neisseria gonorrhoeae Ag
64881-6,Date stopped
64882-4,Reason stopped
64883-2,How often did your child wear their glasses - contact lenses
64884-0,Do you wear glasses of any kind
64885-7,Glasses type
64886-5,How old were you when you first needed to wear glasses to see clearly in the distance
64887-3,"How old were you when you first needed reading glasses, bifocals or multifocals"
64888-1,How long have you had your current glasses
64889-9,When did you last have the strength of your glasses checked
64890-7,"Can you read the ordinary print in the newspaper reasonably well, with or without glasses"
64891-5,When were you last able to do this
64892-3,Do you use a magnifier to read
64893-1,I am so scared of a harmless animal that I do not dare to touch it
64894-9,I worry about things working out for me
64895-6,I doubt whether I really did something
64896-4,"When frightened, I sweat a lot"
64897-2,I am a worrier
64898-0,I feel scared when I watch an operation
Sep-89,Neisseria gonorrhoeae Ag
64899-8,I try not to think about a very aversive event I once experienced
64900-4,I get really frightened for no reason
64901-2,I am afraid to be alone at home
64902-0,I get scared when I think back of a very aversive event I once experienced
64903-8,I find it hard to talk with people I don't know
64904-6,"When frightened, I feel like I am choking"
64905-3,People tell me I worry too much
64906-1,I don't like being away from my family
Jul-90,Neisseria gonorrhoeae Ag
64907-9,I worry about others not liking me
64908-7,"When frightened, I feel like passing out"
64909-5,I think that I will be contaminated with a serious disease
64910-3,I am nervous
64911-1,I follow my parents wherever they go
64912-9,I have thoughts that frighten me
64913-7,People tell me that I look nervous
64914-5,I feel nervous with people I don't know well
May-91,Neisseria gonorrhoeae rRNA
64915-2,I am afraid to visit the doctor
64916-0,I don't like going to school
64917-8,"When frightened, I feel like going crazy"
64918-6,I worry about sleeping alone
64919-4,I am afraid to visit the dentist
64920-2,I worry about being as good as other kids
64921-0,I am afraid of an animal that is not really dangerous
64922-8,I get scared when there is thunder in the air
Mar-92,Neisseria meningitidis Ag
64923-6,I do things more than twice in order to check whether I did it right
64924-4,I have frightening dreams about a very aversive event I once experienced
64925-1,I want things to be clean and tidy
64926-9,"When frightened, I feel that things are not real"
64927-7,I feel scared when I have to fly in an airplane
64928-5,I have nightmares about my parents
64929-3,I worry about going to school
64930-1,I do things to get less scared of my thoughts
Jan-93,Neisseria meningitidis serogroup A Ag
64931-9,"When frightened, my heart beats fast"
64932-7,I am scared when I get an injection
64933-5,I am afraid to get a serious disease
64934-3,I feel weak and shaky
64935-0,I have nightmares about bad things happening to me
64936-8,I am afraid of having anxiety attacks
64937-6,I worry that bad happens to my parents
64938-4,I am shy with people I don't know well
64939-2,I fantasize about hurting other people
649-4,Microscopic observation
64940-0,I worry about the future
64941-8,"When frightened, I feel like throwing up"
64942-6,I worry about how well I do things
64943-4,I am scared to go to school
64944-2,I worry about things that happened in the past
64945-9,"When frightened, I feel dizzy"
64947-5,I have thoughts that I prefer not to have
64948-3,I am afraid of the dark
Sep-94,Neisseria meningitidis serogroup A Ag
64949-1,I have unbidden thoughts about a very aversive event I once experienced
64950-9,I am afraid of an animal that most children do not fear
64951-7,I don't like being in a hospital
64952-5,"When frightened, it is hard to breathe"
64953-3,I am afraid of heights
64954-1,I get headaches or stomach aches when I am at school
64955-8,I don't like to be with people I don't know
Jun-95,Neisseria meningitidis serogroup A Ag
64956-6,"When I see blood, I get dizzy"
64957-4,I want that things are in a fixed order
64958-2,I get scared when I sleep away from home
64959-0,Actinidia deliciosa recombinant (rAct d) 8 Ab.IgE
64960-8,Apium graveolens recombinant (rApi g) 1 Ab.IgE
64961-6,Malus domestica recombinant (rMal d) 1 Ab.IgE
64962-4,Anacardium occidentale recombinant (rAna o) 2 Ab.IgE
64963-2,Bertholletia excelsa recombinant (rBer e) 1 Ab.IgE
Apr-96,Neisseria meningitidis serogroup B Ag
64964-0,Corylus avellana recombinant (rCor a) 1.0401 Ab.IgE
64965-7,Arachis hypogaea recombinant (rAra h) 9 Ab.IgE
64966-5,Triticum aestivum recombinant (rTri a) 14 Ab.IgE
64967-3,Alnus glutinosa recombinant (rAln g) 1 Ab.IgE
64968-1,Corylus avellana recombinant (rCor a) 1.0101 Ab.IgE
64969-9,Platanus acerifolia recombinant (rPla a) 1 Ab.IgE
64970-7,Platanus acerifolia recombinant (rPla a) 3 Ab.IgE
64971-5,Chenopodium album recombinant (rChe a) 1 Ab.IgE
Feb-97,Neisseria meningitidis serogroup B Ag
64972-3,Plantago lanceolata recombinant (rPla l) 1 Ab.IgE
64973-1,Dog recombinant (rCan f) 5 Ab.IgE
64974-9,Horse recombinant (rEqu c) 1 Ab.IgE
64975-6,Cat recombinant (rFel d) 1 Ab.IgE
64976-4,Cat recombinant (rFel d) 4 Ab.IgE
64977-2,Alternaria alternata recombinant (rAlt a) 6 Ab.IgE
64978-0,Cladosporium herbarum recombinant (rCla h) 8 Ab.IgE
64979-8,Blomia tropicalis recombinant (rBlo t) 5 Ab.IgE
6498-0,Neisseria meningitidis serogroup B Ag
64980-6,Dermatophagoides farinae recombinant (rDer f) 2 Ab.IgE
64981-4,Lepidoglyphus destructor recombinant (rLep d) 2 Ab.IgE
64982-2,Blatella germanica recombinant (rBla g) 1 Ab.IgE
64983-0,Blatella germanica recombinant (rBla g) 2 Ab.IgE
64984-8,Blatella germanica recombinant (rBla g) 5 Ab.IgE
64985-5,Anisakis simplex recombinant (rAni s) 1 Ab.IgE
64986-3,Anisakis simplex recombinant (rAni s) 3 Ab.IgE
64987-1,Race or ethnicity
64988-9,Has a doctor ever told you that your child ever had other eye or vision problems
64989-7,Other doctor reported eye or vision treatment
64990-5,"Grade in school, if applicable"
64991-3,Date of observation
64993-9,Guidance for placement of needle
64994-7,Vaccine funding program eligibility category
64995-4,Views^W contrast IA
64996-2,Views^W contrast intrabronchial
64997-0,Views^W contrast intrabronchial
Aug-99,Neisseria meningitidis serogroup C Ag
64998-8,Guidance for placement of catheter^transcervical
64999-6,Guidance for placement of catheter^transcervical
65000-2,Views^W contrast IA
65001-0,I prefer to do things with others rather than on my own
65002-8,I prefer to do things the same way over and over again
Mar-00,Neisseria meningitidis serogroup C Ag
65003-6,If I try to imagine something I find it very easy to create a picture in my mind
65004-4,I frequently get so strongly absorbed in one thing that I lose sight of other things
65005-1,I often notice small sounds when others do not
65006-9,I usually notice car number plates or similar strings of information
65007-7,Other people frequently tell me that what I've said is impolite even though I think it is polite
65008-5,When I'm reading a story I can easily imagine what the characters might look like
65009-3,I am fascinated by dates
65010-1,In a social group I can easily keep track of several different people's conversations
Jan-01,Neisseria meningitidis serogroup C Ag
65011-9,I find social situations easy
65012-7,I tend to notice details that others do not
65013-5,I would rather go to a library than a party
65014-3,I find making up stories easy
65015-0,I find myself drawn more strongly to people than to things
65016-8,I tend to have very strong interests which I get upset about if I can't pursue
65017-6,I enjoy social chit-chat
65018-4,"When I talk, it isn't always easy for others to get a word in edgeways"
65019-2,I am fascinated by numbers
650-2,Microscopic observation
65020-0,When I'm reading a story I find it difficult to work out the characters intentions
65021-8,I don't particularly enjoy reading fiction
65022-6,I find it hard to make new friends
65023-4,I notice patterns in things all the time
65024-2,I would rather go to the theatre than a museum
65025-9,It does not upset me if my daily routine is disturbed
65026-7,I frequently find that I don't know how to keep a conversation going
65027-5,I find it easy to read between the lines when someone is talking to me
65028-3,I usually concentrate more on the whole picture rather than the small details
Sep-02,Neisseria meningitidis serogroup Y Ab
65029-1,I am not very good at remembering phone numbers
65030-9,I don't usually notice small changes in a situation or a person's appearance
65031-7,I know how to tell if someone listening to me is getting bored
65032-5,I find it easy to do more than one thing at once
65033-3,When I talk on the phone I'm not sure when its my turn to speak
65034-1,I enjoy doing things spontaneously
65035-8,I am often the last to understand the point of a joke
65036-6,I find it easy to work out what someone is thinking or feeling just by looking at their face
Jul-03,Neisseria meningitidis serogroup Y Ag
65037-4,If there is an interruption I can switch back to what I was doing very quickly
65038-2,I am good at social chit-chat
65039-0,People often tell me that I keep going on and on about the same thing
65040-8,When I was young I used to enjoy playing games involving pretending with other children
65041-6,"I like to collect information about categories of things - types of car, types of bird, types of train, types of plant, etc"
65042-4,I find it difficult to imagine what it would be like to be someone else
65043-2,I like to plan any activities I participate in carefully
65044-0,I enjoy social occasions
May-04,Neisseria meningitidis serogroup Y Ag
65045-7,I find it difficult to work out peoples intentions
65046-5,New situations make me anxious
65047-3,I enjoy meeting new people
65048-1,I am a good diplomat
65049-9,I am not very good at remembering peoples date of birth
65050-7,I find it very easy to play games with children that involve pretending
65051-5,Your child prefers to do things with others rather than on his or her own
Feb-05,Neisseria meningitidis serogroup Y Ag
65052-3,Your child prefers to do things the same way over and over again
65053-1,"If your child tries to imagine something, your child finds it very easy to create a picture in his or her mind"
65054-9,Your child frequently gets so strongly absorbed in one thing that your child loses sight of other things
65055-6,Your child often notices small sounds when others do not
65056-4,Your child usually notices car number plates or similar strings of information
65057-2,"Other people frequently tell him or her that what your child has said is impolite, even though your child thinks it is polite"
65058-0,"When your child is reading a story, your child can easily imagine what the characters might look like"
65059-8,Your child is fascinated by dates
6506-0,Neisseria meningitidis serogroup w135 Ag
65060-6,"In a social group, your child can easily keep track of several different peoples conversations"
65061-4,Your child finds social situations easy
65062-2,Your child tends to notice details that others do not
65063-0,Your child would rather go to a library than a party
65064-8,Your child finds making up stories easy
65065-5,Your child finds him or herself drawn more strongly to people than to things
65066-3,"Your child tends to have very strong interests, which your child gets upset about if your child can't pursue"
65067-1,Your child enjoys social chit-chat
65068-9,"When your child talks, it isn't always easy for others to get a word in edgeways"
65069-7,Your child is fascinated by numbers
65070-5,"When your child is reading a story, your child finds it difficult to work out the characters' intentions"
65071-3,Your child doesn't particularly enjoy reading fiction
65072-1,Your child finds it hard to make new friends
65073-9,Your child notices patterns in things all the time
65074-7,Your child would rather go to the theatre than a museum
65075-4,It does not upset your child if the daily routine is disturbed
65076-2,Your child frequently finds that he or she doesn't know how to keep a conversation going
65077-0,Your child finds it easy to read between the lines when someone is talking to her or him
Aug-07,Neisseria meningitidis serogroup w135 Ag
65078-8,"Your child usually concentrates more on the whole picture, rather than the small details"
65079-6,Your child is not very good at remembering phone numbers
65080-4,"Your child doesn't usually notice small changes in a situation, or a person's appearance"
65081-2,Your child knows how to tell if someone listening to them is getting bored
65082-0,Your child finds it easy to do more than one thing at once
65083-8,"When your child talks on the phone, he or she is not sure when its their turn to speak"
65084-6,Your child enjoys doing things spontaneously
65085-3,Your child is often the last to understand the point of a joke
Jun-08,Neisseria meningitidis Ag
65086-1,Your child finds it easy to work out what someone is thinking or feeling just by looking at their face
65087-9,"If there is an interruption, your child can switch back to what he or she was doing very quickly"
65088-7,Your child is good at social chit-chat
65089-5,People often tell them that your child keeps going on and on about the same thing
65090-3,"When your child was younger, he or she used to enjoy playing games involving pretending with other children"
65091-1,"Your child likes to collect information about categories of things, types of car, types of bird, types of train, types of plant, etc"
65092-9,Your child finds it difficult to imagine what it would be like to be someone else
65093-7,Your child likes to plan any activities he or she participates in carefully
Apr-09,Neisseria meningitidis rRNA
65094-5,Your child enjoys social occasions
65095-2,Your child finds it difficult to work out peoples intentions
65096-0,New situations make your child anxious
65097-8,Your child enjoys meeting new people
65098-6,Your child is a good diplomat
65099-4,Your child is not very good at remembering peoples date of birth
651-0,Microscopic observation
65100-0,Does your child join in playing games with other children easily
65101-8,Does your child come up to you spontaneously for a chat
Feb-10,Human papilloma virus Ab
65102-6,Was your child speaking by 2Y old
65103-4,Does your child enjoy sports
65104-2,Is it important to your child to fit in with the peer group
65105-9,Does your child appear to notice unusual details that others miss
65106-7,Does your child tend to take things literally
65107-5,"When your child was 3Y old, did your child spend a lot of time pretending, play-acting being a superhero, or holding teddy's tea parties"
65108-3,"Does your child like to do things over and over again, in the same way all the time"
65109-1,Does your child find it easy to interact with other children
6511-0,Human papilloma virus Ab
65110-9,Can your child keep a two-way conversation going
65111-7,Can your child read appropriately for his or her age
65112-5,Does your child mostly have the same interests as his or her peers
65113-3,Does your child have an interest which takes up so much time that he or she does little else
65114-1,"Does your child have friends, rather than just acquaintances"
65115-8,Does your child often bring you things he or she is interested in to show you
65116-6,Does your child enjoy joking around
65117-4,Does your child have difficulty understanding the rules for polite behavior
65118-2,Does your child appear to have an unusual memory for details
65119-0,"Is your childs voice unusual, overly adult, flat, or very monotonous"
65120-8,Are people important to your child
65121-6,Can your child dress him or herself
65122-4,Is your child good at turn-taking in conversation
65123-2,"Does your child play imaginatively with other children, and engage in role-play"
65124-0,Does your child often do or say things that are tactless or socially inappropriate
65125-7,Can your child count to 50 without leaving out any numbers
65126-5,Does your child make normal eye-contact
65127-3,Does your child have any unusual and repetitive movements
Aug-12,Human papilloma virus Ab
65128-1,Is your childs social behavior very one-sided and always on your childs own terms
65129-9,Does your child sometimes say you or your child when he or she means I
65130-7,"Does your child prefer imaginative activities such as play-acting or story-telling, rather than numbers or lists of facts"
65131-5,Does your child sometimes lose the listener because of not explaining what your child is talking about
65132-3,"Can your child ride a bicycle, even if with stabilizers"
65133-1,"Does your child try to impose routines on him or herself, or on others, in such a way that it causes problems"
65134-9,Does your child care how he or she is perceived by the rest of the group
65135-6,Does your child often turn conversations to his or her favorite subject rather than following what the other person wants to talk about
Jun-13,Human papilloma virus Ab
65136-4,Does your child have odd or unusual phrases
65137-2,Have teachers or health visitors ever expressed any concerns about your childs development
65139-8,Teachers or health visitors concerns about your child development
65140-6,Has your child ever been diagnosed with language delay
65141-4,"Has your child ever been diagnosed with hyperactivity - attention deficit disorder, ADHD"
65142-2,Has your child ever been diagnosed with hearing or visual difficulties
65143-0,"Has your child ever been diagnosed with autism spectrum condition, including aspergers syndrome"
Apr-14,Human papilloma virus rRNA
65144-8,Has your child ever been diagnosed with a physical disability
65145-5,I see myself as someone who is talkative
65146-3,I see myself as someone who tends to find fault with others
65147-1,I see myself as someone who does a thorough job
65148-9,"I see myself as someone who is depressed, blue"
65149-7,"I see myself as someone who is original, comes up with new ideas"
65150-5,I see myself as someone who is reserved
Jan-15,Human papilloma virus rRNA
65151-3,I see myself as someone who is helpful and unselfish with others
65152-1,I see myself as someone who can be somewhat careless
65153-9,"I see myself as someone who is relaxed, handles stress well"
65154-7,I see myself as someone who is curious about many different things
65155-4,I see myself as someone who is full of energy
65156-2,I see myself as someone who starts quarrels with others
65157-0,I see myself as someone who is a reliable worker
65158-8,I see myself as someone who can be tense
65159-6,"I see myself as someone who is ingenious, a deep thinker"
65160-4,I see myself as someone who generates a lot of enthusiasm
65161-2,I see myself as someone who has a forgiving nature
65162-0,I see myself as someone who tends to be disorganized
65163-8,I see myself as someone who worries a lot
65164-6,I see myself as someone who has an active imagination
65165-3,I see myself as someone who tends to be quiet
65166-1,I see myself as someone who is generally trusting
65167-9,I see myself as someone who tends to be lazy
65168-7,"I see myself as someone who is emotionally stable, not easily upset"
Sep-16,Human papilloma virus rRNA
65169-5,I see myself as someone who is inventive
65170-3,I see myself as someone who has an assertive personality
65171-1,I see myself as someone who can be cold and aloof
65172-9,I see myself as someone who perseveres until the task is finished
65173-7,I see myself as someone who can be moody
65174-5,"I see myself as someone who values artistic, aesthetic experiences"
65175-2,"I see myself as someone who is sometimes shy, inhibited"
65176-0,"I see myself as someone who is considerate, kind to almost everyone"
Jul-17,Parvovirus B19 Ab.IgM
65177-8,I see myself as someone who does things efficiently
65178-6,I see myself as someone who remains calm in tense situations
65179-4,I see myself as someone who prefers work that is routine
65180-2,"I see myself as someone who is outgoing, sociable"
65181-0,I see myself as someone who is sometimes rude to others
65182-8,I see myself as someone who makes plans and follows through on them
65183-6,I see myself as someone who gets nervous easily
65184-4,"I see myself as someone who likes to reflect, play with ideas"
May-18,Pneumocystis jiroveci Ag
65185-1,I see myself as someone who has few artistic interests
65186-9,I see myself as someone who likes to cooperate with others
65187-7,I see myself as someone who is easily distracted
65188-5,"I see myself as someone who is sophisticated in art, music or literature"
65189-3,"During the past 30D, about how often did you feel nervous"
65190-1,"During the past 30D, about how often did you feel hopeless"
65191-9,"During the past 30D, about how often did you feel restless or fidgety"
65192-7,"During the past 30D, about how often did you feel so depressed that nothing could cheer you up"
Mar-19,Pneumocystis jiroveci Ag
65193-5,"Taking them altogether, did these feelings occur more often in the past 30D than is usual for you, about the same as usual, or less often than usual"
65194-3,"During the past 30D, how many Ds out of 30 were you totally unable to work or carry out your normal activities because of these feelings"
65195-0,"Not counting the D you reported in response to 3, how many D in the past 30 were you able to do only half or less of what you would normally have been able to do, because of these feelings"
65196-8,"During the past 30D, about how often did you feel that everything was an effort"
65197-6,"During the past 30D, how many times did you see a doctor or other health professional about these feelings"
65198-4,"During the past 30D, about how often did you feel worthless"
65199-2,"During the past 30D, how often have physical health problems been the main cause of these feelings"
65200-8,"Have you ever experienced, witnessed, or otherwise been involved in any events that could have brought serious harm or even death to you or someone else"
Jan-20,Pneumocystis carinii Ag
65201-6,"Specify, in general, what you have you ever experienced, witnessed, or otherwise been involved in any events that could have brought serious harm or even death to you or someone else"
65202-4,"Did this event cause you to have intense feelings of fear, helplessness, or horror"
65203-2,"If this event caused you to have intense feelings of fear, helplessness, or horror, specify"
65204-0,"Have you ever been bothered by unwanted thoughts, or dreams, or images that kept coming back to you, about a traumatic event that you experienced or witnessed"
65205-7,Have you ever felt as if you were reliving some traumatic event that you experienced or witnessed
65206-5,Have you ever been intensely distressed or extremely anxious when you were reminded in some way about a traumatic event that you experienced or witnessed
65207-3,Have you tried in general to avoid thinking or talking about the event
65208-1,"Have you tried in general to avoid activities, places, or people that remind you of the event"
65209-9,Are you unable to recall important parts of the event
65210-7,"Since the event, do you tend to feel detached from other people"
65211-5,"Since the event, have you been unable to experience a full range of feelings"
65212-3,"Since the event, have you found yourself unable to see a future for yourself"
65213-1,"Since this event happened, have you had problems with difficulty falling asleep or staying asleep, apart from depression or mania"
65214-9,"Since this event happened, have you had problems with irritability or angry outbursts, apart from depression or mania"
65215-6,"Since this event happened, have you had problems with difficulty concentrating, apart from depression or mania"
65216-4,"Since this event happened, have you had problems with being too much on alert"
65217-2,"Since this event happened, have you had problems with being too easily startled"
65218-0,Have you been very upset about having these symptoms
Sep-21,Pneumocystis jiroveci DNA
65219-8,"Have these symptoms interfered with your ability to work, to be with others, or to function in other areas of life"
65220-6,How long did these symptoms last
65221-4,"When did the traumatic event occur - if several, ask about the most closely associated with symptoms"
65222-2,Symptom onset
65223-0,Age of onset of symptoms
65224-8,"How often do you have trouble wrapping up the final details of a project, once the challenging parts have been done"
65225-5,How often do you have difficulty getting things in order when you have to do a task that requires organization
65226-3,How often do you have problems remembering appointments or obligations
Jul-22,Rabies virus Ab
65227-1,"When you have a task that requires a lot of thought, how often do you avoid or delay getting started"
65228-9,How often do you fidget or squirm with your hands or feet when you have to sit down for a long time
65229-7,"How often do you feel overly active and compelled to do things, like you were driven by a motor"
65230-5,How often do you make careless mistakes when you have to work on a boring or difficult project
65231-3,How often do you have difficulty keeping your attention when you are doing boring or repetitive work
65232-1,"How often do you have difficulty concentrating on what people say to you, even when they are speaking to you directly"
65233-9,How often do you misplace or have difficulty finding things at home or at work
65234-7,How often are you distracted by activity or noise around you
May-23,Rabies virus Ab.Neut
65235-4,How often do you leave your seat in meetings or other situations in which you are expected to remain seated
65236-2,How often do you feel restless or fidgety
65237-0,How often do you have difficulty unwinding and relaxing when you have time to yourself
65238-8,How often do you find yourself talking too much when you are in social situations
65239-6,"When you're in a conversation, how often do you find yourself finishing the sentences of the people you are talking to, before they can finish them themselves"
65240-4,How often do you have difficulty waiting your turn in situations when turn taking is required
65241-2,How often do you interrupt others when they are busy
65242-0,"Compared to other children, does this child give close attention to detail and avoid careless mistakes"
Mar-24,Rabies virus Ab.Neut
65243-8,"Compared to other children, does this child sustain attention on tasks or play activities"
65244-6,"Compared to other children, does this child listen when spoken to directly"
65245-3,"Compared to other children, does this child follow through on instructions and finish school work or chores"
65246-1,"Compared to other children, does this child organize tasks and activities"
65247-9,"Compared to other children, does this child engage in tasks that require sustained mental effort"
65248-7,"Compared to other children, does this child keep track of things necessary for activities"
65249-5,"Compared to other children, does this child ignore extraneous stimuli"
6525-0,Rabies virus Ab.Neut
65250-3,"Compared to other children, does this child remember daily activities"
65251-1,"Compared to other children, does this child sit still, control movement of hands or feet or control squirming"
65252-9,"Compared to other children, does this child stay seated, when required by class rules or social conventions"
65253-7,"Compared to other children, does this child modulate motor activity, inhibit inappropriate running or climbing"
65254-5,"Compared to other children, does this child play quietly, keep noise level reasonable"
65255-2,"Compared to other children, does this child settle down and rest, control constant activity"
65256-0,"Compared to other children, does this child modulate verbal activity, control excess talking"
65257-8,"Compared to other children, does this child reflect on questions, control blurting out answers"
65258-6,"Compared to other children, does this child await turn, stand in line and take turns"
65259-4,"Compared to other children, does this child enter into conversation and games, control interrupting or intruding"
65260-2,I'm optimistic more often than not
65261-0,How other people feel is important to me
65262-8,I often act on immediate needs
65263-6,I have no strong desire to parachute out of an airplane
65264-4,I've often missed things I promised to attend
65265-1,I would enjoy being in a high-speed chase
65266-9,I am well-equipped to deal with stress
65267-7,I don't mind if someone I dislike gets hurt
Aug-26,Rabies virus Ab
65268-5,My impulsive decisions have caused problems with loved ones
65269-3,I get scared easily
65270-1,I sympathize with others problems
65271-9,I have missed work without bothering to call in
65272-7,I'm a born leader
65273-5,I enjoy a good physical fight
65274-3,I jump into things without thinking
65275-0,I have a hard time making things turn out the way I want
Jun-27,Rabies virus Ab.Neut
65276-8,I return insults
65277-6,I've gotten in trouble because I missed too much school
65278-4,I have a knack for influencing people
65279-2,It doesn't bother me to see someone else in pain
652-8,Microscopic observation
65280-0,I have good control over myself
65281-8,"I function well in new situations, even when unprepared"
65282-6,I enjoy pushing people around sometimes
65283-4,I have taken money from someone's purse or wallet without asking
Apr-28,Rabies virus Ag
65284-2,I don't think of myself as talented
65285-9,I taunt people just to stir things up
65286-7,People often abuse my trust
65287-5,I'm afraid of far fewer things than most people
65288-3,I don't see any point in worrying if what I do hurts someone else
65289-1,I keep appointments I make
65290-9,I often get bored quickly and lose interest
65291-7,I can get over things that would traumatize others
Feb-29,Rabies virus Ag
65292-5,I am sensitive to the feelings of others
65293-3,I have conned people to get money from them
65294-1,It worries me to go into an unfamiliar situation without knowing all the details
65295-8,I don't have much sympathy for people
65296-6,I get in trouble for not considering the consequences of my actions
65297-4,I can convince people to do what I want
65298-2,"For me, honesty really is the best policy"
65299-0,I've injured people to see them in pain
Mar-65,Cefadroxil
6530-0,Rabies virus Ag
65300-6,I don't like to take the lead in groups
65301-4,I sometimes insult people on purpose to get a reaction from them
65302-2,I have taken items from a store without paying for them
65303-0,It's easy to embarrass me
65304-8,Things are more fun if a little danger is involved
65305-5,I have a hard time waiting patiently for things I want
65306-3,I stay away from physical danger as much as I can
65307-1,I don't care much if what I do hurts others
65308-9,I have lost a friend because of irresponsible things I've done
65309-7,I don't stack up well against most others
65310-5,Others have told me they are concerned about my lack of self-control
65311-3,It's easy for me to relate to other people's emotions
65312-1,I have robbed someone
65313-9,I never worry about making a fool of myself with others
65314-7,It doesn't bother me when people around me are hurting
65315-4,I have had problems at work because I was irresponsible
65316-2,I'm not very good at influencing people
65317-0,I have stolen something out of a vehicle
Aug-31,Rabies virus Ag
65318-8,A little t super little a Ab
65319-6,D little u super little a Ab
65320-4,F little y3 Ab
65321-2,G little e Ab
65322-0,G little y super little a Ab
65323-8,H little e Ab
65324-6,J little k3 Ab
65325-3,K little u Ab
Jun-32,Rabies virus Ag
65326-1,LAN Ab
65327-9,L little u 14 Ab
65328-7,LW super little a Ab
65329-5,M little c C super little c Ab
65330-3,MER Ab
65331-1,little c E Ab
65332-9,Rh32 Ab
65333-7,S little c 1 Ab
Apr-33,Rabies virus Ag
65334-5,S little c 2 Ab
65335-2,S little w super little a Ab
65336-0,T little m Ab
65337-8,T little r super little a Ab
65338-6,WES super little b Ab
65339-4,W little r super little b Ab
65340-2,Micafungin
Feb-34,Rabies virus Ag
65343-6,Oxygen^^saturation adjusted to 0.5
65344-4,Glucagon^pre XXX challenge
65345-1,Glucagon^1st specimen post XXX challenge
65346-9,Glucagon^2nd specimen post XXX challenge
65347-7,Glucagon^3rd specimen post XXX challenge
65348-5,Glucagon^4th specimen post XXX challenge
65349-3,Glucagon^5th specimen post XXX challenge
65350-1,Follitropin^pre or post XXX challenge
65351-9,Triiodothyronine.free^pre or post XXX challenge
65352-7,Proinsulin^1st specimen post XXX challenge
65353-5,Proinsulin^2nd specimen post XXX challenge
65354-3,Proinsulin^3rd specimen post XXX challenge
65355-0,Proinsulin^4th specimen post XXX challenge
65356-8,Proinsulin^5th specimen post XXX challenge
65357-6,Proinsulin^6th specimen post XXX challenge
65358-4,Proinsulin^7th specimen post XXX challenge
Sep-35,Rabies virus Ag
65359-2,Sex hormone binding globulin^pre or post XXX challenge
653-6,Microscopic observation
65360-0,Thyrotropin^pre or post XXX challenge
65361-8,Phenytoin^^corrected for albumin
65362-6,Magnesium^^corrected for albumin
65363-4,Glutathione
65364-2,Cortisol.free/Cortisol.total
65365-9,Did anyone ever tell you that you had a seizure or convulsion caused by a high fever when you were a child
65366-7,"Have you ever had, or has anyone ever told you that you had, a seizure disorder or epilepsy"
Jul-36,Rabies virus identified
65367-5,"Have you ever had, or has anyone ever told you that you had, a seizure, convulsion, fit or spell under any circumstances"
65368-3,"Have you ever had, or has anyone ever told you that you had, uncontrolled movements of part or all of your body such as twitching, jerking, shaking or going limp"
65369-1,"Have you ever had, or has anyone ever told you that you had, an unexplained change in your mental state or level of awareness, or an episode of spacing out that you could not control"
65370-9,"Did anyone ever tell you that when you were a small child, you would daydream or stare into space more than other children"
65371-7,"Have you ever noticed any unusual body movements or feelings when exposed to strobe lights, video games, flickering lights, or sun glare"
65372-5,"Shortly after waking up, either in the morning or after a nap, have you ever noticed uncontrollable jerking or clumsiness, such as dropping things or things suddenly flying from your hands"
65373-3,Have you ever had any other type of repeated unusual spells
65374-1,"Over the past Y, have you suffered from severe headaches"
May-37,Rabies virus identified
65375-8,"When you have a severe headache, do you experience any of the following"
65376-6,About how often do your severe headaches occur
65377-4,Which statement best describes the pain of your severe headaches
65378-2,Which best describes how you are usually affected by severe headaches
65379-0,"Each time you have a severe headache, how long are you unable to work or undertake normal activities"
65380-8,"On how many Ds in the last 3Mo did you have a headache, if headache lasted more than 1D, count each D"
65381-6,Because of your headaches on how many Ds in the last 3Mo did you miss work or school
65382-4,Because of your headaches on how many Ds in the last 3Mo was your productivity at work or school reduced by half or more
Mar-38,Rabies virus identified
65383-2,Because of your headaches on how many Ds in the last 3Mo did you not do household work
65384-0,Because of your headaches on how many Ds in the last 3Mo was your productivity in house-hold work reduced by half or more
65385-7,"Because of your headaches on how many Ds in the last 3Mo did you miss family, social, or leisure activities"
65386-5,At what age did you begin having severe headaches
65387-3,Have you ever gone to the hospital emergency room or to an urgent care clinic because of your severe headaches
65388-1,Which best describes the way you usually treat severe headaches
65389-9,"Have you ever taken prescription medication for headache on a daily basis, whether or not you have a headache, to help prevent a severe headache from happening in the first place"
65390-7,Are you currently taking any other medication on a daily basis
Jan-39,Rabies virus identified
65391-5,When did you last take prescription medication for headache on a daily basis to help prevent a severe headache from happening in the first place
65392-3,Do you consider your severe headaches to be migraines
65393-1,Have you ever been diagnosed by a physician or other health professional as suffering from
65394-9,"If diagnosed with migraines, at what age were you first diagnosed with migraines"
65395-6,Have you ever been hospitalized or treated in an emergency room following an injury to your head or neck
65396-4,"Have you ever injured your head or neck in a car accident or from some other moving vehicle accident, motorcycle, ATV"
65397-2,"If no, were you dazed or did you have a gap in your memory from the injury"
65398-0,"Have you ever injured your head or neck in a fall or from being hit by something, falling from a bike, horse, or rollerblades, falling on ice, being hit by a rock or have you ever injured your head or neck playing sports or on the playground"
65399-8,"Have you ever injured your head or neck in a fight, from being hit by someone, or from being shaken violently or have you ever been shot in the head"
65400-4,Have you ever been nearby when an explosion or a blast occurred
65401-2,How many more injuries with LOC
65402-0,"If more injuries with LOC, longest knocked out"
65403-8,"If more injuries with LOC, how many longer than 30M"
65404-6,"If more injuries with LOC, youngest age"
65405-3,Have you ever lost consciousness from a drug overdose
65406-1,Have you ever lost consciousness from being choked
65407-9,Hands resting in lap for 15S
65408-7,Arms held at 90 degrees for 15S - arm sustention
Sep-40,Rabies virus identified
65409-5,Arms held in wing position for 15S
65410-3,Pouring water from one cup to another
65411-1,Bring a spoon of water from lap level up to mouth and back again - repeat 7 additional times
65412-9,Drinking water from a full glass - repeat 7 times
65413-7,Side
65414-5,Finger-nose-finger on right - 8 times
65415-2,Open and close right hand - 10 times
65416-0,Alternatively pronate and supinate right hand - 10 times
Jul-41,Rabies virus identified
65417-8,Tap right foot - 10 times
65418-6,Jaw at rest for 5S
65419-4,Mouth open for 5S
65420-2,"Sustained phonation - first AAA for 10 s, then EEE"
65421-0,Head while patient is seated for 10S
65423-6,"Drawing 2 archimedes spirals with each hand, subject should make at least 6 full circular motions"
65424-4,"Is your fear unreasonable - that is, much stronger than it should be"
May-42,Rickettsia prowazekii Ab
65425-1,Is your fear much stronger than in other people
65426-9,"Were you ever afraid that you might faint, lose control, or embarrass yourself in other ways"
65427-7,Do you worry that you might be trapped without any way to escape
65428-5,Did any of these attacks occur when you were in a life-threatening situation
65429-3,Do you worry that help might not be available if you needed it
65430-1,Did any of these attacks occur when you were not in a life-threatening situation
65431-9,About how many attacks have you had in your life
65432-7,"Did you ever have a spell or an attack when all of a sudden you felt frightened, anxious, or very uneasy"
Mar-43,Rickettsia rickettsii Ag
65433-5,Did you ever have an attack when you were not in a situation that usually causes you to have unreasonably strong fears
65435-0,Have you ever been bothered by having certain unpleasant thoughts of your own that kept entering your mind against your wishes
65436-8,Have you ever had any unpleasant and persistent thoughts like that
65437-6,Did some of these thoughts seem to you to be unreasonable
65438-4,"Did these thoughts keep coming back again and again into your mind no matter how hard you tried to resist, ignore, or get rid of them"
65439-2,Did you ever tell a doctor about these thoughts
654-4,Microscopic observation
65440-0,"Did thinking about these ideas interfere with your life or work, or cause you difficulty with your relatives or friends, or upset you a great deal"
Jan-44,Rickettsia sp identified
65441-8,Have you ever had to do something like that over and over
65442-6,"Was there a time when you felt you had to do something in a certain order, like getting dressed perhaps, and had to start all over again if you did it in the wrong order"
65443-4,"Has there been a period of several Ws when you felt you had to count something, like the squares in a tile floor, and couldn't resist doing it even when you tried to"
65444-2,"Did you have a period when you had to say certain words over and over, either aloud or to yourself"
65445-9,Did you think that these actions were unnecessary or that you overdid it
65446-7,Did you tell a doctor about having to do these things
65447-5,"Did having to do these things interfere with your life or work, or cause you difficulty with your relatives or friends, or upset you a great deal"
65448-3,"Has your child experienced periods of several Ds or more when he or she was unable to sit still, and had to keep moving or jumping from one activity to another"
65449-1,Have there been periods of several Ds or more when your childs friends or other family members told you that your child seemed unusually happy or high
65450-9,Has your childs mood or energy shifted rapidly back and forth from happy to sad or high to low
65451-7,Has your child had periods of extreme happiness and intense energy lasting several Ds or more when he or she also felt much more anxious
65452-5,"Have there been times of several Ds or more when, although your child was feeling unusually happy and intensely energetic, he or she also had to struggle very hard to control rage"
65453-3,"Has your child had periods of extreme happiness and intense energy, when it took him or her over an H to get to sleep at night"
65454-1,"Have you found that your childs feelings or energy are generally up or down, but rarely in the middle"
65455-8,"Has your child had periods lasting several Ds or more when he or she felt depressed or irritable, and then other periods when he or she felt extremely high, elated, and overflowing with energy"
65456-6,"Have there been periods when, although your child was feeling unusually happy and intensely energetic, almost everything got on his or her nerves and made him or her irritable or angry"
65457-4,How are you feeling today compared to your usual state
Aug-45,Rickettsia sp identified
65458-2,"Compared to other people my level of activity, energy and mood"
65459-0,How did people close to you react to or comment on your highs
65460-8,"Length of your highs as a rule, on the average"
65461-6,Have you experienced such highs in the past 12Mo
65462-4,"If yes, please estimate how many D you spent in highs during the last 12Mo"
65463-2,I was bothered by things that usually don't bother me
65464-0,"I did not feel like eating, I wasn't very hungry"
65465-7,"I wasn't able to feel happy, even when my family or friends tried to help me feel better"
Jun-46,Rickettsia sp identified
65466-5,I felt like I was just as good as other kids
65467-3,I felt like I couldn't pay attention to what I was doing
65468-1,I felt down and unhappy
65469-9,I felt like I was too tired to do things
65470-7,I felt like something good was going to happen
65471-5,I felt like things I did before didn't work out right
65472-3,I felt scared
65473-1,I didn't sleep as well as I usually sleep
Apr-47,Rotavirus identified
65474-9,I was happy
65475-6,I was more quiet than usual
65476-4,"I felt lonely, like I didn't have any friends"
65477-2,I felt like kids I know were not friendly or that they didn't want to be with me
65478-0,I had a good time
65479-8,I felt like crying
65480-6,I felt sad
65481-4,I felt people didn't like me
Feb-48,Rubella virus identified
65482-2,It was hard to get started doing things
65483-0,"Have you ever had a time in your life when you felt sad, blue, or depressed for 2W or more in a row"
65484-8,"Have you ever had a time in your life lasting 2W or more when you lost interest in most things like hobbies, work, or activities that usually give you pleasure"
65485-5,How much of the D did these feelings usually last
65486-3,How often did you feel this way
65487-1,Did you feel more tired out or low on energy than is usual for you
65488-9,"Did you gain or lose weight without trying, or did you stay about the same weight"
65489-7,About how much weight did you gain
6549-0,Saint Louis encephalitis virus Ag
65490-5,About how much weight did you lose
65491-3,Did you have more trouble falling asleep than you usually do
65492-1,Did you have a lot more trouble concentrating than usual
65493-9,"People sometimes feel down on themselves, no good, or worthless - did you feel this way"
65494-7,"Did you think a lot about death - either your own, someone elses, or death in general"
65495-4,About how many Ws altogether did you feel this way - the total period of depression or loss of interest was
65496-2,"How many periods like this did you have in your life, lasting 2 or more Ws"
65497-0,About how old were you the first time you had a period of 2Ws like this
65498-8,About how old were you the last time you had a period of 2Ws like this
65499-6,"Did you ever tell a professional about these problems - medical doctor, psychologist, social worker, counselor, nurse, clergy, or other helping professional"
65500-1,Did you take medication or use drugs or alcohol more than once for these problems
65501-9,How much did these problems interfere with your life or activities
65502-7,Falling asleep in past 7D
65503-5,Sleep during the night in past 7D
65504-3,Waking up too early in past 7D
65505-0,Sleeping too much in past 7D
65506-8,Feeling sad in past 7D
65507-6,Decreased appetite in past 7D
Aug-50,Staphylococcus aureus Ab
65508-4,Increased appetite in past 7D
65509-2,Decreased weight within the last 2W
655-1,Microscopic observation
65510-0,Increased weight within the last 2W
65511-8,Concentration or decision making in past 7D
65512-6,View of myself in past 7D
65513-4,Thoughts of death or suicide in past 7D
65514-2,General interest in past 7D
65515-9,Energy level in past 7D
Jun-51,Streptococcus agalactiae Ag
65516-7,Feeling slowed down in past 7D
65517-5,Feeling restless in past 7D
65518-3,Have you felt fat
65519-1,Have you had a definite fear that you might gain weight or become fat
65520-9,Has your weight influenced how you think about or judge yourself as a person
65521-7,Has your shape influenced how you think about or judge yourself as a person
65522-5,During the past 6Mo have there been times when you felt you have eaten what other people would regard as an unusually large amount of food - a quart of ice cream - given the circumstances
65523-3,"During the times when you ate an unusually large amount of food, did you experience a loss of control - feel you couldn't stop eating or control what or how much you were eating"
Apr-52,Streptococcus pneumoniae Ab
65524-1,How many D per W on average over the past 6Mo have you eaten an unusually large amount of food and experienced a loss of control
65525-8,How many times per W on average over the past 3Mo have you eaten an unusually large amount of food and experienced a loss of control
65526-6,How long have you had any of these fears
65527-4,Are you limited in the kinds of things you can do because of your vision
65528-2,Do you have more help from others because of your vision
65529-0,Corneal vertex distance measured by retinomax
65530-8,What is the longest period of time that this kind of worrying has ever continued
65531-6,"During that period, was your worry stronger than in other people"
Feb-53,Streptococcus pneumoniae Ag
65532-4,Did you worry most D
65533-2,"Did you usually worry about one particular thing, such as your job security or the failing health of a loved one, or more than one thing"
65534-0,Did you find it difficult to stop worrying
65535-7,Did you ever have different worries on your mind at the same time
65536-5,How often was your worry so strong that you couldn't put it out of your mind no matter how hard you tried
65537-3,How often did you find it difficult to control your worry
65538-1,Did you take medication or use drugs or alcohol more than once for the worry or the problems it was causing
65539-9,How much did the worry or anxiety interfere with your life or activities
6554-0,Streptococcus pneumoniae Ag
65540-7,How often do you get upset when you are in that situation
65541-5,How many Mo have you had any of these fears
65542-3,How much have any of these fears ever interfered with your life or activities
65543-1,Have you ever been very upset with yourself for having any of these fears
65544-9,Do you or your child have any of the following diseases
65545-6,Relation with diabetes-related problem
65546-4,Problem related to diabetes
65547-2,Do you normally work or attend school during the D and sleep at night
65548-0,What is your normal work or school and sleep schedule
65549-8,"If your normal work or school and sleep schedule is other, describe"
65550-6,What shift schedule do you most often work
65551-4,At what time do you usually go to bed
65552-2,About how many M does it usually take for you to fall asleep
65553-0,At what time do you usually wake up
65554-8,"How many H and M does it take for you to become fully awake from regular sleep, after first opening your eyes in the morning"
65555-5,Do you use an alarm clock to wake up in the morning
65556-3,Do you have great difficulty waking up in the morning
Jul-55,Streptococcus pneumoniae Ag
65557-1,Do you often have so much trouble waking up that an alarm clock won't wake you and you have to use other methods to wake up
65558-9,Describe other methods used to wake up
65559-7,"When you wake up in the morning or from a nap, do you feel out of it and confused"
65560-5,How many Hs and Ms does it take for you to fully awaken from a nap
65561-3,How much sleep do you usually get on a typical night
65562-1,"Do you usually follow the same sleep schedule, that is, no more than a 1H difference in sleep and wake times, on both work or school and non-work or school D"
65563-9,How many Hs of sleep per night do you think you need to feel fully rested the next day
65564-7,Do you feel awake and refreshed after sleeping
May-56,Streptococcus pyogenes Ag
65565-4,"How often do you remember your dreams - that is, dreams that occur during your regular sleep and not while napping"
65566-2,How often do you take naps
65567-0,At what time of the D do you usually take naps
65568-8,How many H and Ms of sleep do you usually get when you take a nap
65569-6,Do you have great difficulty waking up from naps
65570-4,How often do you dream when you nap
65571-2,"Are these dreams very intense, detailed and vivid, like watching a movie"
65572-0,How difficult is it for you to adapt to a sleep loss of 3H or more - sleeping 3 or more H less than you normally do the night before
Mar-57,Streptococcus pyogenes Ag
65573-8,Does this loss of sleep affect you the next day with respect to your mood
65574-6,"How quickly after this loss of sleep, do you return to your usual self if you are allowed to sleep as much as you like"
65575-3,Do you prefer to keep a regular sleep schedule - one that does not change much from one night to the next
65576-1,"If you do not keep your regular sleep schedule, how much do you feel off - not your regular self, the next day"
65577-9,"When you are traveling east by air and you cross over several time zones, how quickly do you return to your usual sleeping pattern"
65578-7,How does this loss of sleep affect you the next D with respect to your mood
65579-5,What about when you are traveling west by air over several time zones
65580-3,"Do you consider yourself to be a morning person - early bird, an evening person - night owl, or neither"
Jan-58,Streptococcus pyogenes Ag
65581-1,How strong is your preference
65582-9,"Does respondent consistently fall asleep very late - 12 a.m. or later, at night and characterize him or herself as a night owl with a strong preference"
65583-7,At what time do you usually go to sleep - feel sleepy and ready to go to bed
65585-2,Are these usual sleep and wake times always about the same - each day during a week of vacation
65586-0,"Do you wake up on your own, without an alarm or other assistance"
65587-8,Have you ever tried to force yourself to fall asleep at an earlier time than your usual bedtime
65589-4,"When you tried to shift your sleep schedule to an earlier bedtime, at least 1 to 2H earlier, did you have difficulty falling asleep"
65590-2,Do attempts to change your sleep or wake schedule tend to make your sleeping difficulties worse
65591-0,"During the past Y, what was the longest period of time that you had these sleeping problems on most nights"
65592-8,How old were you when you first began going to sleep very late without being able to adjust your schedule when you tried
65593-6,How old were you the last time you experienced these problems
65594-4,Do you currently experience these problems
65595-1,Have you ever had frequent problems getting to sleep at the beginning of the night which has negatively affected how you function during the following day
65596-9,Have you ever had frequent problems staying asleep at night which has negatively affected how you function during the following day
65597-7,Have you ever had frequent problems falling back to sleep after waking in the middle of the night which has negatively affected how you function during the following day
65598-5,"In the past Y, have you had difficulty getting to sleep"
Sep-59,Streptococcus pyogenes Ag
65599-3,"In the past Y, have you awakened during the night and had a hard time getting back to sleep"
65600-9,"In the past Y, have you awakened too early in the morning and couldn't get back to sleep"
65601-7,Do you look at the clock frequently to see how long you have not been able to fall asleep during the night when you cannot fall asleep
65602-5,"When you are not sleeping in your usual bed, in a hotel room while on vacation, or on your couch watching television, do you still have problems initially getting to sleep, staying asleep, or falling back to sleep after waking up during the night"
65603-3,"Do you ever have trouble falling asleep or staying asleep, when there seems to be no cause or explanation for it"
65604-1,Has your difficulty with sleeping occurred or worsened during pregnancy
65605-8,Has your difficulty with sleeping occurred or worsened during menopause
65606-6,Has your difficulty with sleeping occurred or worsened during a few Ds before menstruation
Jul-60,Plasmodium ovale Ab
65607-4,Has your difficulty with sleeping occurred or worsened during menstruation
65608-2,"How many separate times in your life have you had difficulty getting to sleep, staying asleep or falling back to sleep after waking up during the night, for at least 1Mo"
65609-0,"How old were you when you first experienced this kind of difficulty with sleeping, for at least 1Mo"
65610-8,"How old were you the last time you experienced this insomnia, for at least 1Mo"
65611-6,Do you currently experience insomnia
65612-4,How frequently do you experience insomnia
65613-2,"Do you feel so sleepy during the D that it interrupts your normal activities, such as driving, reading, or concentrating at work or school, even when you have had enough sleep the night before"
65614-0,How often do you feel so sleepy during the D that it interrupts your normal activities
May-61,Treponema pallidum Ab.IgG
65615-7,What is the longest period of time that you have felt so sleepy during the D that it interrupts your normal activities on most Ds
65616-5,How often does this overwhelming desire to go to sleep occur
65617-3,"During the daytime, do you experience an overwhelming desire to go to sleep - so overwhelming that you cannot resist"
65618-1,"What is the longest period of time that you have felt this overwhelming desire to go to sleep, on most Ds"
65619-9,"When you do doze off during the D and take a nap, do you find this sleep refreshing"
65620-7,Describe refreshing sleep
65621-5,Do you feel that you are sleepier than other people your age
65622-3,"Do you ever experience periods of muscle weakness, loss of muscle strength or limp muscles in any part of your body, such as the legs or face, when you laugh"
Mar-62,Treponema pallidum Ab.IgM
65623-1,"Do you ever experience periods of muscle weakness, loss of muscle strength or limp muscles in any part of your body, such as the legs or face, when you are angry"
65624-9,"Do you ever experience periods of muscle weakness, loss of muscle strength or limp muscles in any part of your body, such as the legs or face, when you hear or tell a joke"
65625-6,Have you ever been told that you act out your dreams
65626-4,How often does acting out your dreams happen
65627-2,"Do you ever move so much during your sleep that you accidentally hit your bed partner, if any, or hurt yourself?"
65628-0,Do you have any memory of these events
65629-8,"Does moving at night disrupt your sleep, wake you up at night"
65630-6,During what part of the night do these events most often occur
Jan-63,Trichinella spiralis Ab.IgG
65631-4,Does this loss of sleep affect you the next day with respect to your tendency to be irritable
65632-2,Clozapine & Norclozapine panel
65633-0,Hepatitis B virus surface Ag
65634-8,Creatinine 24 hour urine panel
65635-5,"When you have sudden anxiety attacks, do they usually occur in specific situations that cause you unreasonably strong fear"
65637-1,Finger-nose-finger on left - 8 times
65638-9,Open and close left hand - 10 times
65639-7,Alternatively pronate and supinate left hand - 10 times
65640-5,Tap left foot - 10 times
65641-3,Activity that usually makes you feel breathless these days
65642-1,This activity usually makes you feel breathless these days
65643-9,Relative humidity
65644-7,BTPS factor
65645-4,Reviewer initials
65646-2,Manufacturer name
65647-0,City
65648-8,Zip - post code
Sep-64,Trichomonas vaginalis
65649-6,Country
65650-4,Email address
65651-2,Phone number
65652-0,Testing facility name
65653-8,Test challenge type
65654-6,Extrapolated volume
65655-3,Volume expired during 6.0 s of forced expiration
Jun-65,Trichomonas vaginalis
65656-1,Volume expired during 6.0 s of forced expiration
65657-9,Volume expired during 1.0 s of forced expiration/Forced vital capacity.predicted
65658-7,Volume expired during 1.0 s of forced expiration/Volume expired during 6.0 s of forced expiration
65660-3,Original sampling interval
65661-1,Data points
65662-9,Flow time data point
65663-7,Have you ever had sex with a partner who had a vasectomy
Apr-66,Trichomonas vaginalis Ag
65664-5,Have you ever had sex with a partner who used withdrawal or pulling out
65665-2,Doctor reported child vision problem
65666-0,What treatment did your child receive for this doctor reported vision problem
65667-8,When did your child receive this treatment for doctor reported vision problem
65668-6,Has a doctor ever told you that your child ever had this vision problem
65669-4,What Mo and Y did child first begin wearing glasses or contact lenses
65670-2,Blood relative with eye problem
65671-0,Other treatment or treatments you are receiving or you received for your eye problem
Feb-67,Trichomonas vaginalis Ag
65672-8,Did you receive this treatment for your glaucoma
65673-6,Do or did any of your relatives have this eye problem
65674-4,How does this loss of sleep affect you the next day with respect to your tendency to be irritable
65675-1,Does this loss of sleep affect you the next day with respect to your ability to get your work done
65676-9,How does this loss of sleep affect you the next day with respect to your ability to get your work done
65677-7,Does this loss of sleep affect you the next day with respect to how much you eat
65678-5,How does this loss of sleep affect you the next day with respect to how much you eat
65679-3,Does this loss of sleep affect you the next day with respect to your desire for chocolate or sweets
6568-0,Trichomonas vaginalis rRNA
65680-1,How does this loss of sleep affect you the next day with respect to your desire for chocolate or sweets
65681-9,Treatment for your glaucoma
65682-7,Things experienced during the daytime due to difficulties falling asleep or staying asleep at night
65683-5,Do you experience any of these things during the daytime due to your difficulties falling asleep or staying asleep at night
65684-3,"Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep"
65685-0,Events or conditions occurring at the same time as difficulty with insomnia
65686-8,Does your difficulty with insomnia occur at the same time as any of these events or conditions
65687-6,Other drugs or medications occurring with insomnia
65688-4,Changing schedule occurring with insomnia
65689-2,Noisy or uncomfortable surroundings occurring with insomnia
656-9,Microscopic observation
65690-0,Stress or major life event occurring with insomnia
65691-8,Other disturbances occurring with insomnia
65692-6,Emotional or mental condition occurring with insomnia
65693-4,Other medical condition occurring with insomnia
65695-9,Finger taps - right
65696-7,Finger taps - left
65697-5,Hand movements - right
Aug-69,Varicella zoster virus Ab.IgG
65698-3,Hand movements - left
65699-1,Rapid alternating hand movements - right
65700-7,Rapid alternating hand movements - left
65701-5,Leg agility - right
65702-3,Leg agility - left
65703-1,Arising from chair
65704-9,Posture
65705-6,Gait - parkinsons
Jun-70,Varicella zoster virus Ab.IgM
65706-4,Postural stability - retropulsion test
65707-2,Extent of lower extremity sensory symptoms
65708-0,Motor symptoms - legs
65709-8,Motor symptoms - arms
65710-6,Pin sensibility
65711-4,Vibration
65712-2,Strength - legs
65713-0,Strength - arms
Apr-71,Venezuelan equine encephalitis virus Ab
65714-8,Ulnar compound muscle action potential - CMAP
65715-5,Ulnar compound muscle action potential - CMAP - median
65716-3,Ulnar sensory nerve action potential - SNAP
65717-1,Ulnar sensory nerve action potential - SNAP - median
65718-9,Have you ever been told by a physician that you had a stroke
65719-7,When did the first stroke occur
65720-5,Have you ever had any sudden loss or changes in speech lasting 24 H or longer
65721-3,Did the episode come on suddenly
Feb-72,Venezuelan equine encephalitis virus Ag
65722-1,Do any of the following describe your change in speech
65723-9,Which of these most closely describes the problem
65724-7,Things occurring with episode of change in speech
65725-4,"While you were having your episode of change in speech, did any of these things occur"
65726-2,Side affected
65727-0,Visual disturbance description
65728-8,"Have you ever had any sudden loss of vision, or blurring, lasting 24 H or longer"
65729-6,Things occurring with loss of vision
6573-0,Venezuelan equine encephalitis virus Ag
65730-4,"While you were having your loss of vision, did any of these things occur"
65731-2,"Have you ever had a sudden spell of double vision, which lasted 24 H or longer"
65732-0,"If you closed one eye, did the double vision go away"
65733-8,Things occurring with double vision
65734-6,"While you were having your double vision, did any of these things occur"
65735-3,"Have you ever had sudden numbness, tingling, or loss of feeling on one side of your body, including your face, arm, or leg which lasted 24H or longer"
65736-1,Feeling of numbness or tingling occur only when kept your arms or legs in a certain position
65737-9,Body part
65738-7,Was this part of your body affected
65739-5,"During this episode, did the abnormal sensation start in one part of your body and spread to another, or did it stay in the same place"
65740-3,Things occurring with tingling and loss of sensation
65741-1,"While you were having numbness, tingling and loss of sensation, did any of these things occur"
65742-9,"Have you ever had any sudden episode of paralysis or weakness on one side of your body, including your face, arm, or leg which lasted at least 24 H"
65743-7,Things occurring with paralysis or weakness
65744-5,While you were having paralysis or weakness did any of these things occur
65745-2,"Have you had any sudden spells of dizziness, loss of balance, or sensation of spinning which lasted 24H or longer"
65746-0,"Dizziness, loss of balance or spinning sensation occur only when changing the position of your head or body"
65747-8,"Things occurring with dizziness, loss of balance or spinning sensation"
Aug-74,Escherichia coli verotoxin 1
65748-6,"While you were having sudden spells of dizziness, loss of balance or spinning sensation, did any of these things occur"
65749-4,Did you have trouble seeing
65750-2,Drugs of abuse 5 panel
65751-0,Pathology biopsy report
65752-8,Pathology biopsy report
65753-6,Pathology biopsy report
65754-4,Pathology biopsy report
May-75,Escherichia coli verotoxin 1 Ab.Neut
65755-1,Pathology biopsy report
65756-9,Salmonella sp serovar
65757-7,Pathology biopsy report
65758-5,T-cell helper (CD4) subset panel
65759-3,T-cell subsets CD4 & CD8 panel
65761-9,Lymphocyte subset interpretation
65762-7,Hantavirus Ag
Mar-76,Escherichia coli verotoxin 2
65763-5,Neisseria meningitidis Ag
65764-3,Actinidia deliciosa native (nAct d) 5 Ab.IgE
65765-0,Corylus avellana native (nCor a) 9 Ab.IgE
65766-8,Juglans regia native (nJug r) 1 Ab.IgE
65767-6,Juglans regia native (nJug r) 2 Ab.IgE
65768-4,Juglans regia native (nJug r) 3 Ab.IgE
65769-2,Arachis hypogaea native (nAra h) 1 Ab.IgE
657-7,Microscopic observation
65770-0,Arachis hypogaea native (nAra h) 2 Ab.IgE
Jan-77,Escherichia coli verotoxin 2 Ab.Neut
65771-8,Arachis hypogaea native (nAra h) 3 Ab.IgE
65772-6,Glycine max native (nGly m) 6 Ab.IgE
65773-4,Fagopyrum esculentum native (nFag e) 2 Ab.IgE
65774-2,Triticum aestivum native (nTri a) aA_TI Ab.IgE
65775-9,Cynodon dactylon native (nCyn d) 1 Ab.IgE
65776-7,Betula verrucosa native (nBet v) 1 Ab.IgE
65777-5,Cryptomeria japonica native (nCry j) 1 Ab.IgE
65778-3,Cupressus arizonica native (nCup a) 1 Ab.IgE
65779-1,Olea europaea native (nOle e) 7 Ab.IgE
65780-9,Olea europaea recombinant (rOle e) 9 Ab.IgE
65781-7,Platanus acerifolia native (nPla a) 2 Ab.IgE
65782-5,Ambrosia artemisiifolia native (nAmb a) 1 Ab.IgE
65783-3,Artemisia vulgaris native (nArt v) 3 Ab.IgE
65784-1,Salsola kali native (nSal k) 1 Ab.IgE
65785-8,Chicken CSA (livetin) serum albumin native (nGal d) 5 Ab.IgE
65786-6,Penaeus monodon native (nPen m) 2 Ab.IgE
65787-4,Penaeus monodon native (nPen m) 4 Ab.IgE
65788-2,Horse serum albumin native (nEqu c) 3 Ab.IgE
Sep-78,Vibrio sp identified
65789-0,Mouse lipocain native (nMus m) 1 Ab.IgE
65790-8,Dermatophagoides farinae native (nDer f) 1 Ab.IgE
65791-6,Apis mellifera native (nApi m) 4 Ab.IgE
65792-4,Armoracia rusticana native (nArm r) HRP Ab.IgE
65793-2,Blatella germanica native (nBla g) 7 Ab.IgE
65794-0,Penaeus monodon native (nPen m) 1 Ab.IgE
65795-7,Actinidia deliciosa native (nAct d) 1 Ab.IgE
65796-5,Actinidia deliciosa native (nAct d) 2 Ab.IgE
Jul-79,Vibrio sp identified
65797-3,Guidance for placement of stent
65798-1,Guidance for placement of stent
65799-9,View for cyst
65800-5,View for cyst
65801-3,View for cyst
65802-1,Views^W contrast IV
65803-9,Views^W contrast IV
65804-7,Views^W contrast IV
May-80,Vibrio sp identified
65805-4,Views^W contrast IV
65806-2,Inhalation challenge test report^W methacholine inhaled
Jul-80,Treponema identified
65807-0,Tapentadol
65808-8,Nortapentadol
65809-6,Kingella kingae DNA
65810-4,SEPT9 gene methylation
65811-2,Body bradykinesia - hypokinesia
65812-0,"During the episode, which of the following parts of your vision were affected"
Mar-81,Vibrio sp identified
65814-6,How many girls did you have
65815-3,How many boys did you have
65816-1,"When you were living in your city or town, did your exposure to direct sunlight in April through September stay pretty much the same for all your daytime activities between the hours of 10 AM and 4 PM."
65817-9,Reference values correction factor
65818-7,Medication XXX
65819-5,Forced expiratory time
65820-3,Time to expiratory gas flow.max
Jan-82,Microscopic observation
65821-1,Gas flow at 25% of forced expiration
65822-9,Gas flow at 50% of forced expiration
65823-7,Gas flow at 75% of forced expiration
65824-5,Gas flow at 90% of forced expiration
65825-2,How much have your late bedtime and inability to adjust your schedule upset or distressed you
65826-0,What number describes how much this eveningness tendency has affected your social life or relationships with your friends
65827-8,What number describes how much this eveningness tendency has affected your relationships with family members
65828-6,"What number describes how much this eveningness tendency has affected your performance in school or work or your relationships with your co-workers, employers, teachers or classmates"
65829-4,Were you knocked out or did you lose consciousness
65830-2,How long were you knocked out - lost consciousness
65831-0,How long ago did you have the most recent attack
65832-8,Did some of your attacks happen in a situation when you were not in danger or not the center of attention
65833-6,Address
65834-4,Facility ownership
65835-1,Facility affiliation information
65836-9,Dialysis services offered
65837-7,Facility offers dialysis shift starting at 5:00 pm
65838-5,Date submitted
Sep-83,Virus identified
65839-3,Principal result interpreter title
65840-1,Principal result interpreter phone number
65841-9,Form status
65842-7,Acceptance status
65843-5,Responsible observer
65844-3,Date of observation
65845-0,"Is the psychological, psychiatric, emotional, or behavioral problem still present"
65846-8,Relative with sleep or behavior disorders diagnosed or suspected
Jul-84,Virus identified
65847-6,"Sleep or behavior disorders diagnosed or suspected in your child's brothers, sisters, or parents"
65849-2,This child often does not seem to listen when spoken to directly
658-5,Microscopic observation
65850-0,Hard coronary heart disease 10Y risk
65851-8,Coronary heart disease 10Y risk
65852-6,Coronary heart disease 2Y risk
65853-4,General cardiovascular disease 10Y risk
Apr-85,Western equine encephalitis virus Ag
65854-2,Intermittent claudication 4Y risk
65855-9,Stroke 10Y risk
65856-7,Atrial fibrillation 10Y risk
65857-5,Coronary heart disease 10Y risk
65858-3,Coronary event 10Y risk
65859-1,Coronary event 10Y risk
65860-9,Cardiovascular disease 10Y risk
65861-7,Cardiovascular disease 10Y risk
Feb-86,Western equine encephalitis virus Ag
65862-5,Recurring coronary heart disease 2Y risk
65863-3,Heart failure 4Y risk
65864-1,Stroke after atrial fibrillation 5Y risk
65865-8,Stroke or death after atrial fibrillation 5Y risk
65866-6,Methacholine
65867-4,How many different times have you used emergency contraception
65868-2,Your testicles started increasing in size Compared to your friends was this
65869-0,Pregnancy complication
6587-0,Yellow fever virus Ab
65870-8,"During that pregnancy, did you ever develop any of these things"
65871-6,Has a doctor ever told you that your child needs to wear glasses or contact lenses
65873-2,"Has a doctor ever told you that your child had amblyopia, that is, poor vision that cannot be corrected with glasses or contact lenses"
65874-0,Did he or she ever have to wear an eye patch to improve his or her vision
65875-7,Vendor device model code
65876-5,Statistical reliability level measured
65877-3,"Did your main daytime activities during a typical work W have you on water for a total of three or more H a D, for example working on a boat"
65878-1,Do or did any of his or her other relatives have this eye problem
65879-9,Condition causing difficulty with breathing
65880-7,What happened if child stopped growing at a normal rate at any time since birth
65881-5,"In the past 12Mo, how many times have you seen an eye doctor for your glaucoma"
65882-3,Vendor model number
65883-1,Vendor model number
65884-9,Photographer ID
65885-6,"I get scared in small, closed places"
65886-4,"Have you ever had a period lasting one Mo or longer when most of the time you felt worried, tense, or anxious"
65887-2,Did you ever have a time when you worried a lot more than most people would in your situation
Aug-88,Yellow fever virus Ab
65888-0,Things accompanying a panic attack
65889-8,When you have panic attacks do you experience this thing
65890-6,Spherical power
65891-4,Cylinder axis
65892-2,Cylindrical power
65893-0,Visual acuity^best corrected
65894-8,Spherical power
65895-5,Cylinder axis
Jun-89,Yellow fever virus Ab
65896-3,Cylindrical power
65897-1,Visual acuity^best corrected
65898-9,Eye fields photographed in the retinal digital photography
65899-7,Other eye field
65900-3,Flash setting in the retinal digital photography
65901-1,Images captured in the retinal digital photography
65902-9,Estimated diameter of pupil
65903-7,Problems or unusual findings
Apr-90,Yellow fever virus Ab
65904-5,Eye fields photographed in the retinal digital photography
65905-2,Other eye field
65906-0,Estimated diameter of pupil
65907-8,Problems or unusual findings
65908-6,Other things occurring while worried or anxious
65909-4,When you were worried or anxious did this thing also occur
65910-2,Specific things you have an unreasonable fear about or avoid
65911-0,Do you have an unreasonably strong fear or avoid this specific thing
Feb-91,Yellow fever virus Ab.Neut
65912-8,Agoraphobias
65913-6,Do you have an unreasonably strong fear for or avoid this situation
65914-4,Social phobias
65915-1,Do you have an unreasonably strong fear or avoid this social situation
65916-9,Aspects of your life
65917-7,Impact of your highs on this aspect of your life
65918-5,High state behavior or feelings
65919-3,In a high state I have this behavior or feeling
6592-0,Yellow fever virus Ab.IgG
65920-1,During these episodes of overeating and loss of control did you eat much more rapidly than normal
65921-9,During these episodes of overeating and loss of control did you eat until you felt uncomfortably full
65922-7,During these episodes of overeating and loss of control did you eat large amounts of food when you didn't feel physically hungry
65923-5,During these episodes of overeating and loss of control did you eat alone because you were embarrassed by how much you were eating
65924-3,"During these episodes of overeating and loss of control did you feel disgusted with yourself, depressed or very guilty after overeating"
65925-0,During these episodes of overeating and loss of control did you feel very upset about your uncontrollable overeating or resulting weight gain
65926-8,How many times per W on average over the past 3Mo have you made yourself vomit to prevent weight gain or counteract the effects of eating
65927-6,How many times per W on average over the past 3Mo have you used laxatives or diuretics to prevent weight gain or counteract the effects of eating
65928-4,How many times per W on average over the past 3Mo have you fasted - skipped at least 2 meals in a row - to prevent weight gain or counteract the effects of eating
65929-2,How many times per W on average over the past 3Mo have you engaged in excessive exercise specifically to counteract the effects of overeating episodes
659-3,Microscopic observation
65930-0,"Over the past 3Mo, how many menstrual periods have you missed"
65931-8,Have you been taking birth control pills during the past 3Mo
65932-6,Source of rating
65933-4,Day
65934-2,Age of first psychiatric problems
65935-9,Onset psychiatric illness
65936-7,Age and mode of onset notes
65937-5,Psychological stressor prior to onset of first episode
Aug-93,Yellow fever virus Ab.IgM
65938-3,Psychological stressor notes
65939-1,Employment status at onset of illness
65940-9,Premorbid work adjustment
65941-7,Premorbid social adjustment
65942-5,Premorbid adjustment notes
65943-3,Coarse brain disorder prior to onset
65944-1,Coarse brain disorder notes
65945-8,Schizophrenia
Jun-94,Amoeba identified
65946-6,Other psychiatric disorders
65947-4,Family history notes
65948-2,Dysphoria - depression
65949-0,Dysphoria - irritable impatient
65950-8,Dysphoria notes
65951-6,Anhedonia
65952-4,Anhedonia notes
Mar-95,Klebsiella granulomatis
65953-2,Loss of energy or fatigue
65954-0,Slowed activity
65955-7,Impaired concentration
65956-5,Altered libido
65957-3,Excessive self reproach
65958-1,Depressive symptom notes
65959-9,Suicidality
65960-7,Suicidality notes
Jan-96,Diphtheria sp identified
65961-5,Decreased appetite
65962-3,Weight loss
65963-1,Increased appetite
65964-9,Weight gain
65965-6,Initial insomnia
65966-4,Middle insomnia
65967-2,Terminal insomnia
65968-0,How many Hs do you normally sleep
65969-8,How many Hs were you sleeping then
65970-6,Excessive sleep
65971-4,Diurnal variation of depression
65972-2,Appetite or sleep change notes
65973-0,Elevated mood
65974-8,Irritable mood
65975-5,Elevated or irritable mood notes
65976-3,Pressured speech
65977-1,Racing thoughts
65978-9,Distractibility
Sep-97,Troponin T.cardiac
65979-7,Reduced need for sleep
65980-5,Excessive activity
65981-3,Reckless activity
65982-1,Increased sociability
65983-9,Increased self-esteem
65984-7,Hypomanic or manic symptom notes
65985-4,Hallucinations in any modality
65986-2,Any modality hallucinations notes
Jul-98,Troponin T.cardiac
65987-0,Neutral voices or non-verbal hallucinations
65988-8,"Command, accusatory, abusive or persecusatory voices"
65989-6,Running commentary
65990-4,Third person auditory hallucinations
65991-2,Hallucination notes
65992-0,Thought insertion
65993-8,Thought broadcast
65994-6,Thought withdrawal
May-99,Haemophilus influenzae B Ag
65995-3,Thought echo
65996-1,Subjective thought disturbance notes
65997-9,Delusion screen
65998-7,Delusions of guilt
65999-5,Delusions of poverty
66000-1,Nihilistic delusions
Jan-00,Haemophilus sp identified
66001-9,Delusions of passivity
66002-7,Delusions of influence
66003-5,Persecutory delusions
66004-3,Grandiose delusions
66005-0,Delusional moods
66006-8,Primary delusional ideas
66007-6,Bizarre delusions
66008-4,Delusion notes
66009-2,Insight into illness
660-1,Microscopic observation
66010-0,Relationship between psychotic and affective symptoms
66011-8,Insight or relationship between psychotic and affective symptom notes
66012-6,Psychotic symptoms respond to antipsychotic medications
66013-4,Well organized delusions
66014-2,Widespread delusions
66015-9,Delusions and hallucinations last for one W
66016-7,Persecutory or jealous delusions and hallucinations
66017-5,Illness duration
66018-3,Impairment or incapacity
Sep-01,Influenza virus identified
66019-1,Deterioration from premorbid level of functioning
66020-9,Course of disorder
66021-7,Rapport
66022-5,Credibility of information
66023-3,Catatonia
66024-1,Bizarre behavior
66025-8,Agitated activity
66026-6,Restricted affect
Jul-02,Influenza virus identified
66027-4,Blunted affect
66028-2,Inappropriate affect
66029-0,Speech difficult to understand
66030-8,Speech incoherent
66031-6,Positive formal thought disorder
66032-4,Negative formal thought disorder
66033-2,Marital status
May-03,Influenza virus identified
66035-7,Tremor at rest
66036-5,Postural tremor
66037-3,Rigidity
66038-1,Speech
66039-9,Facial expression
66040-7,Tremor at rest
66041-5,Cause of injury
66042-3,Dominant hand
Mar-04,Influenza virus identified
66043-1,Hands hanging at sides for 10S
66044-9,Walking 20 ft and turning
66045-6,Tandem gait for 10 steps
66047-2,Do or did you have this diabetes-related problem
66048-0,Age diabetes-related problem occurred
66049-8,I stay home most of the time because of my eyesight
6605-0,Leptospira interrogans Ag
66050-6,I feel frustrated a lot of the time because of my eyesight
66051-4,"I have much less control over what I do, because of my eyesight"
66052-2,"Because of my eyesight, I have to rely too much on what other people tell me"
66053-0,I need a lot of help from others because of my eyesight
66054-8,"I worry about doing things that will embarrass myself or others, because of my eyesight"
66055-5,"Because of your eyesight, how much difficulty do you have figuring out whether bills you receive are accurate"
66056-3,"Because of your eyesight, how much difficulty do you have doing things like shaving, styling your hair, or putting on makeup"
66057-1,"Because of your eyesight, how much difficulty do you have recognizing people you know from across a room"
66058-9,"Because of your eyesight, how much difficulty do you have taking part in active sports or other outdoor activities that you enjoy, like golf, bowling, jogging, or walking"
66059-7,"Because of your eyesight, how much difficulty do you have seeing and enjoying programs on TV"
66060-5,"Because of your eyesight, how much difficulty do you have entertaining friends and family in your home"
66061-3,My child - 2-4Y
66062-1,My child - 4-6Y
66063-9,My child - 6-12Y
66064-7,Methods to prevent pregnancy
66065-4,Have you ever used this method to prevent pregnancy
66066-2,"Have you ever used oral contraceptives for 2Mo or more for any reason - contraception, acne, menstrual irregularity, etc"
66067-0,Axial length
Aug-06,Brugia malayi Ab
66068-8,Cornea thickness
66069-6,"How many of your sisters have had, or were suspected of having this eye problem"
66070-4,"How many of your brothers have had, or were suspected of having this eye problem"
66071-2,"How many of your daughters have had, or were suspected of having this eye problem"
66072-0,"How many of your sons have had, or were suspected of having this eye problem"
66073-8,"How many of your mother's sisters have had, or were suspected of having this eye problem"
66074-6,"How many of your mother's brothers have had, or were suspected of having this eye problem"
66075-3,"How many of your father's sisters have had, or were suspected of having this eye problem"
Jun-07,Microscopic observation
66076-1,"How many of your father's brothers have had, or were suspected of having this eye problem"
66077-9,How much difficulty do you have reading ordinary print in newspapers
66078-7,"How much difficulty do you have doing work or hobbies that require you to see well up close, such as cooking, sewing, fixing things around the house, or using hand tools"
66079-5,"Because of your eyesight, how much difficulty do you have finding something on a crowded shelf"
66080-3,How much difficulty do you have reading street signs or the names of stores
66081-1,"Because of your eyesight, how much difficulty do you have going down steps, stairs, or curbs in dim light or at night"
66082-9,Level of difficulty seeing objects off to the side
66083-7,"Because of your eyesight, how much difficulty do you have seeing how people react to things you say"
Apr-08,Virus identified
66084-5,"Because of your eyesight, how much difficulty do you have picking out and matching your own clothes"
66085-2,"Because of your eyesight, how much difficulty do you have visiting with people in their homes, at parties, or in restaurants"
66086-0,"Because of your eyesight, how much difficulty do you have going out to see movies, plays, or sports events"
66087-8,"Wearing glasses, how much difficulty do you have reading the small print in a telephone book, on a medicine bottle, or on legal forms"
66088-6,How often did having trouble falling asleep happen
66089-4,Have you brought this bag with you and are these all the medications that you have taken in the past 2W
66090-2,Are your legs or feet numb
66091-0,Do you ever have any burning pain in your legs or feet
Feb-09,Listeria sp identified
66092-8,Are your feet too sensitive to touch
66093-6,Do you get muscle cramps in your legs or feet
66094-4,Do you ever have any prickling feelings in your legs or feet
66095-1,Does it hurt when the bed covers touch your skin
66096-9,"When you get into the tub or shower, are you able to tell the hot water from the cold water"
66097-7,Have you ever had an open sore on your foot
66098-5,Has your doctor ever told you that you have diabetic neuropathy
66099-3,Do you feel weak all over most of the time
Jan-66,Cefadroxil
6610-0,Haemophilus influenzae A Ag
66100-9,Are your symptoms worse at night
66101-7,Do your legs hurt when you walk
66102-5,Are you able to sense your feet when you walk
66103-3,Is the skin on your feet so dry that it cracks open
66104-1,Have you ever had an amputation
66105-8,Lot distribution data
66106-6,Pharmacogenomics section
66107-4,Pathology biopsy report
66108-2,Pathology biopsy report
66109-0,Pathology biopsy report
66110-8,Pathology biopsy report
66111-6,Pathology biopsy report
66112-4,Pathology biopsy report
66113-2,Pathology biopsy report
66114-0,Pathology biopsy report
66115-7,Pathology biopsy report
66116-5,Pathology biopsy report
66117-3,Pathology biopsy report
Aug-11,Haemophilus influenzae B Ag
66118-1,Pathology biopsy report
66119-9,Pathology biopsy report
66120-7,Pathology biopsy report
66121-5,Pathology biopsy report
66122-3,Pathology biopsy report
66123-1,Pathology biopsy report
66124-9,Pathology biopsy report
66125-6,Pathology biopsy report
Jun-12,Haemophilus influenzae C Ag
66126-4,Cholesterol.in VLDL
66127-2,Amphetamine
66128-0,chlordiazePOXIDE/Creatinine
66129-8,Fentanyl+Norfentanyl
66130-6,Fentanyl+Norfentanyl
66131-4,Norbuprenorphine
66132-2,Mononuclear+Mesothelial cells/100 leukocytes
66133-0,Mononuclear cells.atypical/100 leukocytes
Apr-13,Haemophilus influenzae D Ag
66134-8,Blasts
66135-5,Promyelocytes
66136-3,Myelocytes
66137-1,Metamyelocytes
66138-9,Neutrophils.band form
66139-7,Neutrophils
66140-5,Lymphocytes
66141-3,Eosinophils
Feb-14,Haemophilus influenzae E Ag
66142-1,Basophils
66143-9,Monocytes
66144-7,Lymphocytes.variant
66145-4,Leukocytes other
66146-2,Reticulocytes
66147-0,Polymorphonuclear cells/100 leukocytes
66148-8,Mononuclear cells/100 leukocytes
66149-6,Prescribed medications
66150-4,Over the counter medications
66151-2,"On the average during the last 2W, how many of these pills, or medication items, did you take a D, W, or Mo"
66152-0,Doctor or health care professional ever told you that you have diabetes
66153-8,Are you taking medicine for diabetes
66154-6,What medication are you taking for diabetes
66155-3,At what age was diabetes first treated
66156-1,Was insulin your first diabetes medicine
66157-9,Did diabetes occur only during pregnancy
66158-7,Has a medical person ever told you that you had kidney failure
Sep-15,Haemophilus influenzae F Ag
66159-5,"If yes, are one or both working well now"
66160-3,How old were you when you were first told by a medical person that you had kidney failure
66161-1,Are you currently on renal dialysis
66162-9,Have you ever had a kidney transplant
66164-5,Did you eat or drink anything other than plain water after 11:30 last night
66165-2,Last ate or drank anything other than plain water
66166-0,Have you had coffee or tea with cream and sugar since eating or drinking anything but plain water
Jul-16,Visual acuity log MAR.right
66167-8,When did you have coffee or tea with cream and sugar
66168-6,"Have you had alcohol, such as beer, wine, or liquor since eating or drinking anything but plain water"
66169-4,"When did you have alcohol, such as beer, wine, or liquor"
66170-2,"Have you had gum, breath mints, lozenges, or cough drops, or other cough or cold remedies since eating or drinking anything but plain water"
66171-0,"When did you have gum, breath mints, lozenges, or cough drops, or other cough or cold remedies"
66172-8,"Have you had antacids, laxatives, or anti-diarrheals since eating or drinking anything but plain water"
66173-6,"When did you have antacids, laxatives, or anti-diarrheals"
66174-4,Are you currently pregnant
May-17,Visual acuity log MAR.left
66175-1,Are you now taking insulin
66176-9,Are you now taking diabetic pills to lower your blood sugar
66177-7,Hemophilia
66178-5,Cancer chemotherapy received in the past 4W or will be received in the next 4W
66179-3,Exclusion criteria for fasting plasma glucose
66180-1,Was blood drawn
66181-9,Was full sample obtained
66182-7,Have you had dietary supplements such as vitamins and minerals since eating or drinking anything but plain water
Mar-18,Acanthamoeba sp Ab
66183-5,When did you have dietary supplements such as vitamins and minerals
66184-3,"How much does your insomnia, sleep difficulties, upset or distress you"
66185-0,What number describes how much your insomnia has affected your social life or relationships with your friends
66186-8,What number describes how much your insomnia has affected your relationships with family members
66187-6,"What number describes how much your insomnia has affected your performance in school or work or your relationships with your co-workers, employers, teachers or classmates"
66189-2,Tremor at rest
661-9,Microscopic observation
66190-0,Tremor at rest
Jan-19,Acanthamoeba sp Ab
66191-8,Tremor at rest
66192-6,Rigidity
66193-4,Rigidity
66194-2,Rigidity
66195-9,Rigidity
66196-7,Postural tremor
66197-5,Injury sequence
66200-7,Repeatability of the assay
66201-5,Coefficient of variation for the assay
66202-3,Was the participant fasting
66203-1,Amount of dextrose solution administered
66204-9,Amount of dextrose solution the participant drank
66205-6,Was all of the solution was consumed in 10M
66206-4,Time between consuming dextrose solution and administering the second blood draw
66208-0,Make of the equipment used
Sep-20,Acanthamoeba sp Ab
66209-8,Manufacturer of the equipment used
66210-6,Time to complete entire 1 mile walk
66211-4,Treadmill speed during warm up
66212-2,Push-ups
66213-0,Sit and reach stretch distance
66214-8,Trial attempt
66215-5,"Inches person is short of reaching the toe, a minus score, or reaches beyond the toe, a plus score"
66216-3,Distance of overlap or distance between the tips of the middle fingers
Jul-21,Leishmania sp Ab
66217-1,"Time to rise from chair, walk 8 feet and back, and return to sitting"
66218-9,Length of laps
66219-7,Time to complete entire 1 mile run
66220-5,Curl-ups
66221-3,Floor to the childs chin
66222-1,Time child retains position
66223-9,Modified pull-ups
66224-7,Distance reached
May-22,Leishmania sp Ab
66225-4,Fingertips touch with left arm behind the back and right arm behind the head
66226-2,Which hand
66227-0,Has any pain or arthritis in your hand gotten worse recently
66228-8,Will the pain keep you from squeezing as hard as you can
66229-6,Have you had any surgery on your hands or wrists in the past 3Mo
66230-4,Hand trial
66231-2,Reason did not squeeze
66232-0,Reason did not squeeze
Mar-23,Leishmania sp Ab
66233-8,Has your doctor ever said that you have a heart condition and that you should only do physical activity recommended by a doctor
66234-6,Do you feel pain in your chest when you do physical activity
66235-3,"In the past Mo, have you had chest pain when you were not doing physical activity"
66236-1,Do you lose your balance because of dizziness or do you ever lose consciousness
66237-9,"Do you have a bone or joint problem, for example, back, knee or hip, that could be made worse by a change in your physical activity"
66238-7,"Is your doctor currently prescribing drugs, for example, water pills, for your blood pressure or heart condition"
66239-5,Do you know of any other reason why you should not do physical activity
66240-3,Blood draw
Jan-24,Naegleria fowleri Ab
66241-1,Stretch attempt
66242-9,Half sit-ups
66243-7,Fingertips touch with right arm behind the back and left arm behind the head
66245-2,Yards walked
66246-0,Reaches the minimum height
66247-8,Sit to stand
66248-6,Balance test
66249-4,Balance test score
66250-2,Why participant did not attempt test or failed
66251-0,Other reason not attempt test or failed
66252-8,"Seconds held, if less than 10S"
66253-6,Total balance tests score
66254-4,Walk test course
66255-1,Time for 3 or 4 meters
66256-9,Aids for the walk
66257-7,Shorter of the two times
Aug-25,Naegleria fowleri Ab
66258-5,Points for 4-meter walk
66259-3,Points for 3-meter walk
66260-1,Safe to stand without help
66261-9,Stood without using arms
66262-7,Used arms to stand
66263-5,Test not completed
66264-3,Safe to stand five times
66265-0,Sedentary adolescent activity
Jun-26,Schistosoma japonicum Ab
66266-8,How long you spend doing this activity on this D
66267-6,Time period
66268-4,Adolescent activity
66269-2,Number that corresponds to the main activity you actually performed during that particular time period
662-7,Microscopic observation
66270-0,Activity intensity
66271-8,Were you employed in the last 7D
66272-6,"If yes, which Ds"
66273-4,What two Ds do you consider your weekend Ds
Apr-27,Schistosoma mansoni Ab
66274-2,Adult activity
66275-9,Day sequence
66276-7,Day name
66277-5,Time adult activity starts
66278-3,Time adult activity ends
66279-1,Total time of adult activity
66280-9,Name
66281-7,"Compared to your physical activity over the past 3Mo, was last week's physical activity more, less, or about the same"
Feb-28,Schistosoma sp Ab
66282-5,Day segment
66283-3,Older adult activity
66284-1,"In a typical W, during the past 4W, did you do this activity"
66285-8,How many total Hs a W did you usually do it
66286-6,Other type of physical activity
66287-4,Problems with the 7D PAR interview
66288-2,Problem with 7D interview
66289-0,Do you think this was a valid 7D PAR interview
6629-0,Schistosoma sp Ab
66290-8,Reason not a valid 7D PAR interview
66293-2,Situations you spend sitting
66294-0,H sitting each D in this situation
66295-7,Did the participant receive an actigraph
66296-5,Last four digits of actigraph serial number
66297-3,Why didnt the participant receive an actigraph
66299-9,Other physical or medical problem
66300-5,Actigraph is connected to USB cable
66301-3,Actigraph set up for free-living
66302-1,Participant ID
66303-9,Actigraph disconnected from USB cable and OK clicked
66304-7,Participant instructed about how to wear actigraph
66305-4,Actigraph placed as close to iliac crest as possible
66306-2,Procedure for completing 7D activity diary explained to participant
66307-0,Procedure for returning actigraph explained to participant
Aug-30,Schistosoma sp Ab
66308-8,Participant asked if they have any questions
66309-6,Fills out actigraph distribution form
66310-4,Reviews form for completeness
66311-2,Date participant returned actigraph to clinic
66312-0,Returned actigraph
66313-8,How many Ds was actigraph worn
66314-6,How many of the Ds that the actiGraph was worn were valid
66315-3,Activity collected and recorded on the actigraph
Jun-31,Schistosoma sp Ab
66316-1,Reason no activity collected and recorded on the actigraph
66317-9,Other reason no activity collected and recorded on actigraph
66318-7,Diary completed
66319-5,Actigraph properly connected to USB cable
66320-3,Download button clicked on actiweb client software
66321-1,Data saved properly
66322-9,"Reviews activity diary to see if completely filled out, partially filled out, or not filled out at all"
66323-7,Correctly enters activities on computer
Apr-32,Strongyloides stercoralis Ab.IgG
66324-5,Records how many Ds the actigraph was worn on actigraph return and reading form
66325-2,Records how many valid Ds the actigraph was worn on actigraph return and reading form
66326-0,"Records whether diary was completed partially, fully, or not at all on the actiGraph return and reading form"
66327-8,Took monitor off
66328-6,Activity while not wearing monitor
66329-4,Monitor put back on
66330-2,About how much weight did you gain and lose
66331-0,Hand trial
Feb-33,Wuchereria bancrofti Ab
66332-8,End time - right before going to sleep
66333-6,Kinds of physical activity you usually performed while on the job this last Y
66334-4,Steps taken
66336-9,Framingham Risk Assessments
66337-7,Kinds of physical activity you usually performed during leisure time this last Y
66338-5,"How much difficulty do you have managing your money, such as keeping track of your expenses or paying bills"
66339-3,"How much difficulty do you have walking for a quarter of a mile, that is about 2 or 3 blocks"
6634-0,Influenza virus A Hong Kong Ab
66340-1,How much difficulty do you have walking up 10 steps without resting
66341-9,"How much difficulty do you have stooping, crouching, or kneeling"
66342-7,"How much difficulty do you have lifting or carrying something as heavy as 10 pounds, like a sack of potatoes or rice"
66343-5,"How much difficulty do you have doing chores around the house, like vacuuming, sweeping, dusting or straightening up"
66344-3,How much difficulty do you have preparing your own meals
66345-0,How much difficulty do you have standing up from an armless straight chair
66346-8,How much difficulty do you have getting in or out of bed
66347-6,"How much difficulty do you have eating, like holding a fork, cutting food or drinking from a glass"
66348-4,"How much difficulty do you have dressing yourself, including tying shoes, working zippers, and doing buttons"
66349-2,How much difficulty do you have sitting for about 2H
663-5,Microscopic observation
66350-0,How much difficulty do you have reaching up over your head
66351-8,How much difficulty do you have using your fingers to grasp or handle small objects
66352-6,"How much difficulty do you have going out to things like shopping, movies, or sporting events"
66353-4,"How much difficulty do you have participating in social activities, visiting friends, attending clubs or meetings or going to parties"
66354-2,"How much difficulty do you have doing things to relax at home or for leisure, reading, watching TV, sewing, listening to music"
66355-9,How much difficulty do you have pushing or pulling large objects like a living room chair
66356-7,What is the main type of housing in your neighborhood
Jul-35,Influenza virus A England Ab
66357-5,"Many shops, stores, markets, or other places to buy things I need are within easy walking distance of my home"
66358-3,"It is within a 10-15M walk to a transit stop, such as bus, train, trolley, or tram, from my home"
66359-1,There are sidewalks on most of the streets in my neighborhood
66360-9,"There are facilities to bicycle in or near my neighborhood, such as special lanes, separate paths or trails, shared use paths for cycles and pedestrians"
66361-7,"My neighborhood has several free or low-cost recreation facilities, such as parks, walking trails, bike paths, recreation centers, playgrounds, public swimming pools, etc"
66362-5,The crime rate in my neighborhood makes it unsafe to go on walks at night
66363-3,I can be physically active during my free time on most Ds
66364-1,I can ask my parent or other adult to do physically active things with me
May-36,Influenza virus A Port Chalmers Ab
66365-8,I can be physically active during my free time on most Ds even if I could watch TV or play video games instead
66366-6,I can be physically active during my free time on most Ds even if it is very hot or cold outside
66367-4,I can ask my best friend to be physically active with me during my free time on most Ds
66368-2,I can be physically active during my free time on most Ds even if I have a lot of homework
66369-0,I have the coordination I need to be physically active during my free time on most Ds
66370-8,I can be physically active during my free time on most Ds no matter how busy my D is
66371-6,Circumstances in which you could exercise 3 time per W in the next 3Mos
66372-4,Degree of confidence for exercising 3 times per W in the next 3Mo
Mar-37,Influenza virus A Victoria Ab
66373-2,Are you sick today
66374-0,"Do you have allergies to medications, food, or any vaccine"
66375-7,Have you ever had a serious reaction after receiving a vaccination
66376-5,"Do you have a long-term health problem with heart disease, lung disease, asthma, kidney disease, metabolic disease, diabetes, anemia, or other blood disorder"
66377-3,"Do you have cancer, leukemia, AIDS, or any other immune system problem"
66378-1,"Do you take cortisone, predniSONE, other steroids, or anticancer drugs, or have you had radiation treatments"
66379-9,"Have you had a seizure, brain, or other nervous system problem"
66380-7,"During the past Y, have you received a transfusion of blood or blood products, or have you been given immune gamma globulin or an antiviral drug"
Jan-38,Influenza virus A Texas Ab
66381-5,"Are you pregnant, or is there a chance you could become pregnant during the next Mo"
66382-3,Have you received any vaccinations in the past 4W
66383-1,Is the child sick today
66384-9,"Does the child have allergies to medications, food, or any vaccine"
66385-6,Has the child had a serious reaction to a vaccine in the past
66386-4,Has the child had a seizure or a brain problem
66387-2,"Does the child have cancer, leukemia, AIDS, or any other immune system problem"
66388-0,"Has the child take cortisone, predniSONE, other steroids, or anticancer drugs or had x-ray treatments in the past 3Mo"
66389-8,Has the child received a transfusion of blood or blood products or been given a medicine called immune gamma globulin in the past Y
66390-6,"Is the child or teen pregnant, or is there a chance she could become pregnant during the next Mo"
66391-4,Has the child received vaccinations in the past 4W
66392-2,Booster sequence
66393-0,Booster type
66394-8,Booster age
66395-5,Booster date
66396-3,Trip number
66397-1,Country number
66398-9,Trip start
Sep-39,Influenza virus A Bangkok Ab
66399-7,Trip end
66400-3,Travelled to country this Y
66401-1,Travelled to country last Y
66402-9,Travelled to country 2Ys ago
66403-7,Travelled to country 3Ys ago
66404-5,Travelled to country 4Ys ago
66405-2,Travelled to country 5Ys ago
66406-0,Stay was longer than 30 consecutive Ds this Y
Jul-40,Influenza virus A Phillipines Ab
66407-8,Stay was longer than 30 consecutive Ds last Y
66408-6,Stay was longer than 30 consecutive Ds 2Ys ago
66409-4,Stay was longer than 30 consecutive Ds 3Ys ago
66410-2,Stay was longer than 30 consecutive Ds 4Ys ago
66411-0,Stay was longer than 30 consecutive Ds 5Ys ago
66412-8,Country of exposure - other
66413-6,Country of exposure sequence
66414-4,More specific place of exposure
May-41,Influenza virus A Mississippi Ab
66415-1,Reason for travel related to current illness
66416-9,Risk level qualifier
66417-7,Clinical setting
66418-5,Patient type
66419-3,Did the patient have a pre-travel encounter with a health care provider
66420-1,Abnormal lab test
66421-9,Asymptomatic screening
66422-7,Main presenting symptom
Mar-42,Influenza virus A Leningrad Ab
66423-5,Medications
66424-3,Medication strength
66425-0,Number of medication items prescribed
66426-8,PRN medicine
66427-6,"Main presenting symptom, if other"
66428-4,Working diagnosis number
66429-2,Working diagnosis status
664-3,Microscopic observation
66430-0,Infection or disease not travel related
Jan-43,Cefepime
66431-8,Symptoms & diseases
66432-6,Date first Dx
66433-4,How much difficulty do you have standing or being on your feet for about 2Hs
66434-2,Inflammatory disorder
66435-9,Autoimmune disease
66436-7,Health problem sequence
66440-9,Heart rate
66441-7,Beta hydroxybutyrate
66444-1,Blatella germanica recombinant (rBla g) 4 Ab.IgE
66445-8,Cyprinus carpio recombinant (rCyp c) 1 Ab.IgE
66446-6,Daucus carota recombinant (rDau c) 1 Ab.IgE
66447-4,Euroglyphus maynei recombinant (rEur m) 2 Ab.IgE
66448-2,Latex recombinant (rHev b) 6 Ab.IgE
Sep-44,Cefepime
66449-0,Mercurialis annua recombinant (rMer a) 1 Ab.IgE
66450-8,Olea europaea native (nOle e) 2 Ab.IgE
66451-6,Penaeus indicus native (nPen i) 11 Ab.IgE
66452-4,Triticum aestivum native (nTri a) 18 Ab.IgE
66453-2,M little c D super little d Ab
66454-0,Infectious disease
66455-7,Condition status
66456-5,Doctor visit sequence
Jul-45,Cefepime
66457-3,Hospitalization type
66459-9,Surgery sequence
66460-7,Lab or imaging sequence
66464-9,Medical device type
May-46,Cefepime
66465-6,Physical &or occupational therapy sequence
66466-4,Physical &or occupational therapy type
66467-2,"Have you ever, even once, used a needle to inject a drug not prescribed by a doctor"
66468-0,Which of the following drugs have you injected using a needle
66469-8,How old were you when you first used a needle to inject any drug not prescribed by a doctor
66470-6,How long ago has it been since you last used a needle to inject a drug not prescribed by a doctor
66472-2,"During your life, altogether how many times have you injected drugs not prescribed by a doctor"
Mar-47,Cefpirome
66473-0,Think about the period of your life when you injected drugs the most often. How often did you inject then
66474-8,Have you ever been in a drug treatment or drug rehabilitation program
66475-5,Primary country of residency before age 10
66476-3,Country of citizenship
66477-1,Country of current residence
66478-9,Immigrant
66479-7,"If you were not born in USA, indicate as closely as possible the date you first arrived here"
66480-5,Medical history
Jan-48,Cefpirome
66481-3,Protein.monoclonal band 2
66482-1,OmpC Ab.IgA
66483-9,Heparin.unfractionated
66484-7,DNA single strand Ab
66485-4,Brucella sp Ab.IgG & IgM
66488-8,Serotonin release.heparin.unfractionated interpretation
66489-6,CYP2C19 gene targeted mutation analysis
66491-2,Urease^2nd specimen
66492-0,Urease^3rd specimen
66493-8,Epstein Barr virus nuclear 1 Ab.IgG
66494-6,Spermatozoa.acrosome defects/100 spermatozoa
66495-3,Spermatozoa.abnormal head shape/100 spermatozoa
66496-1,Spermatozoa.abnormal head size/100 spermatozoa
66497-9,Spermatozoa.double forms/100 spermatozoa
66498-7,Spermatozoa.multiple defects/100 spermatozoa
Sep-49,Cefpirome
66499-5,Cholesterol.in VLDL.beta
665-0,Microscopic observation
66500-0,Do you have this disorder
66501-8,Noninfectious major illness
66502-6,HBA1 gene targeted mutation analysis
66503-4,APC gene mutation analysis limited to known familial mutations
66504-2,Exclusion criteria present
66505-9,Exclusion criteria for fasting serum insulin
Jun-50,Cefpirome
66506-7,Image name
66507-5,Hand scanned
66508-3,Kellgren-Lawrence score
66509-1,Image name
66510-9,Knee scanned
66511-7,Kellgren-Lawrence score
66512-5,Image name
66513-3,Hip scanned
Apr-51,Meropenem
66514-1,Kellgren-Lawrence score
66515-8,Redness score
66516-6,Thickness score
66517-4,Scratching score
66518-2,Lichenification score
66519-0,Percentage area affected by eczema
66520-8,Redness score
66521-6,Thickness score
Feb-52,Meropenem
66522-4,Scratching score
66523-2,Lichenification score
66524-0,Percentage area affected by eczema
66525-7,Redness score
66526-5,Thickness score
66527-3,Scratching score
66528-1,Lichenification score
66529-9,Percentage area affected by eczema
6653-0,Meropenem
66530-7,Redness score
66531-5,Thickness score
66532-3,Scratching score
66533-1,Lichenification score
66534-9,Percentage area affected by eczema
66535-6,Is the physician who diagnosed you a dermatologist
66536-4,Have you been told by a rheumatologist that you have psoriatic arthritis
66537-2,Have you been diagnosed with crohn's disease or another inflammatory bowel disorder
66538-0,"Have you been diagnosed with any type of autoimmune disease - lupus, scleroderma, etc"
66539-8,Do you have any blood relatives affected with psoriasis
66540-6,Do you have any blood relatives with inflammatory bowel disease
66541-4,Do you have any blood relatives with any type of autoimmune disease
66542-2,What color is an average spot of your psoriasis
66543-0,How thick is an average spot of your psoriasis
66544-8,How scaly is an average spot of your psoriasis
66545-5,Do you have nail psoriasis
66546-3,Has a dermatologist told you that you have pustular psoriasis
66547-1,Things to smoke
Aug-54,Meropenem
66548-9,How many of these do you smoke per D
66549-7,Psoriasis treatment
66550-5,Psoriasis treatment duration
66551-3,Psoriasis treatment effectiveness
66552-1,Other biologicals - injected
66553-9,Other systemics
66554-7,Other topicals
May-55,Microscopic observation
66555-4,Skin type
66556-2,Freckles
66557-0,How many moles do you approximately have on the whole body
66558-8,Did you have one or more severe blistering sunburns as a child or teenager
66559-6,"Did you live for more than 1Y in a country where sunshine is high - africa, french west indies, south of united states, australia"
66560-4,"Have you been diagnosed with melanoma in the past - skin cancer, arising in melanocytes, skin cells that make skin pigment"
66561-2,"Has any of your first degree relatives, parents, children, brother or sister, ever had melanoma"
66562-0,Pregnancy test required
Mar-56,Microscopic observation
66563-8,Pregnancy test result
66564-6,Have you had sexual intercourse in the past 7Ds
66565-3,Did you use one of the following forms of birth control each time you had sexual intercourse in the past 7D
66566-1,Image name
66567-9,Image name
66568-7,Leg stand attempt
66569-5,Time participant holds position during first one leg stand
66570-3,Has a doctor ever said that you had a broken or fractured bone
Jan-57,Microscopic observation
66571-1,Broken bone
66572-9,Age when broken
66573-7,What language do you speak with most of your family
66574-5,In what language do you think
66575-2,Other language
66576-0,Would you say that in general your health is
66577-8,"Now thinking about your physical health, which includes physical illness and injury, for how many Ds during the past 30D was your physical health not good"
66578-6,"Now thinking about your mental health, which includes stress, depression, and problems with emotions, for how many Ds during the past 30D was your mental health not good"
66579-4,"During the past 30D, for about how many Ds did poor physical or mental health keep you from doing your usual activities, such as self-care, work, or recreation"
66580-2,I have a reserved and cautious attitude toward life
66581-0,I have trouble controlling my impulses
66582-8,I generally seek new and exciting experiences and sensations
66583-6,I generally like to see things through to the end
66584-4,"When I am very happy, I can't seem to stop myself from doing things that can have bad consequences"
66585-1,My thinking is usually careful and purposeful
66586-9,"I have trouble resisting my cravings for food, cigarettes, etc"
66587-7,I'll try anything once
66588-5,I tend to give up easily
Sep-58,Microscopic observation
66589-3,"When I am in a great mood, I tend to get into situations that could cause me problems"
66590-1,I am not one of those people who blurt out things without thinking
66591-9,I often get involved in things I later wish I could get out of
66592-7,I like sports and games in which you have to choose your next move very quickly
66593-5,Unfinished tasks really bother me
66594-3,"When I am very happy, I tend to do things that may cause problems in my life"
66595-0,I like to stop and think things over before I do them
66596-8,"When I feel bad, I will often do things I later regret in order to make myself feel better now"
Jul-59,Microscopic observation
66597-6,I would enjoy water skiing
66598-4,Once I get going on something I hate to stop
66599-2,I tend to lose control when I am in a great mood
66600-8,I don't like to start a project until I know exactly how to proceed
66601-6,"Sometimes when I feel bad, I can't seem to stop what I am doing even though it is making me feel worse"
66602-4,I quite enjoy taking risks
66603-2,I concentrate easily
66604-0,"When I am really ecstatic, I tend to get out of control"
May-60,Microscopic observation
66605-7,Source of fracture confirmation
66606-5,Was this the source of fracture confirmation
66607-3,Other source of fracture confirmation
66608-1,Cataract
66609-9,Retinal change or optic atrophy
66610-7,Cognitive impairment
66611-5,Seizures requiring therapy for 6Mo
66612-3,Cerebrovascular accident
Mar-61,Microscopic observation
66613-1,Cranial or peripheral neuropathy
66614-9,Transverse myelitis
66615-6,Estimated or measured glomerular filtration rate less than 50 percent
66616-4,Proteinuria greater than or equal to 3.5 gm in 24H
66617-2,End-stage renal disease
66618-0,Pulmonary hypertension
66619-8,Pulmonary fibrosis
66620-6,Shrinking lung
Jan-62,Microscopic observation
66621-4,Pleural fibrosis
66622-2,Pulmonary infarction
66623-0,Angina or coronary artery bypass
66624-8,Myocardial infarction
66625-5,Cardiomyopathy
66626-3,Valvular disease
66627-1,"Pericarditis for 6Mo, or pericardiectomy"
66628-9,Claudication for 6Mo
66629-7,I would enjoy parachute jumping
66630-5,I finish what I start
66631-3,"I tend to value and follow a rational, sensible approach to things"
66632-1,When I am upset I often act without thinking
66633-9,Others would say I make bad choices when I am extremely happy about something
66634-7,"I welcome new and exciting experiences and sensations, even if they are a little frightening and unconventional"
66635-4,I am able to pace myself so as to get things done on time
66636-2,I usually make up my mind through careful reasoning
66637-0,"When I feel rejected, I will often say things I regret later"
66638-8,Others are shocked or worried about the things I do when I am feeling very excited
Sep-63,Microscopic observation
66639-6,I would like to learn to fly an airplane
66640-4,I am a person who always gets the job done
66641-2,I am a cautious person
66642-0,It is hard for me to resist acting on my feelings
66643-8,"When I get really happy about something, I tend to do things that can have bad consequences"
66644-6,I sometimes like doing things that are a bit frightening
66645-3,I almost always finish projects that I start
66646-1,Before I get into a new situation I like to find out what to expect from it
Jul-64,Microscopic observation
66647-9,I often make matters worse because I act without thinking when I am upset
66648-7,"When overjoyed, I feel like I can't stop myself from going overboard"
66649-5,I would enjoy the sensation of skiing very fast down a high mountain slope
66650-3,Sometimes there are so many little things to be done that I just ignore them all
66651-1,I usually think carefully before doing anything
66652-9,"When I am really excited, I tend not to think of the consequences of my actions"
66653-7,"In the heat of an argument, I will often say things that I later regret"
Apr-65,Microscopic observation
66654-5,I would like to go scuba diving
66655-2,I tend to act without thinking when I am really excited
66656-0,I always keep my feelings under control
66657-8,"When I am really happy, I often find myself in situations that I normally wouldn't be comfortable with"
66658-6,"Before making up my mind, I consider all the advantages and disadvantages"
66659-4,I would enjoy fast driving
66660-2,"When I am very happy, I feel like it is ok to give in to cravings or overindulge"
66661-0,Sometimes I do impulsive things that I later regret
Feb-66,Microscopic observation
66662-8,Minor tissue loss
66663-6,Significant tissue loss
66664-4,"Venous thrombosis with swelling, ulceration, or venous stasis"
66665-1,"Gastrointestinal Infarction or resection of bowel below duodenum, spleen, liver, or gall bladder"
66666-9,Mesenteric insufficiency
66667-7,Chronic peritonitis
66668-5,Stricture or upper gastrointestinal tract surgery
66669-3,Muscle atrophy or weakness
6667-0,Microscopic observation
66670-1,Deforming or erosive arthritis
66671-9,Osteoporosis with fracture or vertebral collapse
66672-7,Avascular necrosis
66673-5,Osteomyelitis
66674-3,Scarring chronic alopecia
66675-0,Extensive scarring or panniculum other than scalp and pulp space
66676-8,Skin ulceration for >6Mo
66677-6,Premature gonadal failure
66678-4,Diabetes
66679-2,Malignancy
666-8,Microscopic observation
66680-0,How well do you speak english
66681-8,How well do you read english
66682-6,How well do you write in english
66683-4,What language do you speak with most of your friends
66684-2,I am surprised at the things I do while in a great mood
66685-9,"If I feel like doing something, I tend to do it, even if it's bad"
66686-7,"I like new, thrilling things to happen"
66687-5,I like to see things through to the end
Aug-68,Microscopic observation
66688-3,I tend to blurt out things without thinking
66689-1,I am upset when I am not finished with things
66690-9,I like to stop and think about something before I do it
66691-7,"When I feel bad, I often do things I later regret in order to make myself feel better now"
66692-5,I would like water skiing
66693-3,I like to know just what to do before I start a project
66694-1,"Sometimes when I feel bad, I keep doing something even though it is making me feel worse"
66695-8,I enjoy taking risks
Jun-69,Microscopic observation
66696-6,It is easy for me to think hard
66697-4,I would like parachute jumping
66698-2,I try to take a careful approach to things
66699-0,"I like new, thrilling things, even if they are a little scary"
66700-6,I tend to get things done on time
66701-4,"When I feel rejected, I often say things that I later regret"
66702-2,I am very careful
66703-0,"I like to know what to expect, before doing something new"
Apr-70,Microscopic observation
66704-8,I would like to ski very fast down a high mountain slope
66705-5,I tend to stop and think before doing things
66706-3,"Before making a choice, I tend to think about both the good things and the bad things about the choice"
66707-1,"When I am mad, I sometimes say things that I later regret"
66708-9,"When I am very happy, I can't stop myself from going overboard"
66709-7,"When I am really thrilled, I tend not to think about the results of my actions"
66710-5,"When I am in a great mood, I tend to do things that could cause me problems"
66711-3,"I tend to act without thinking when I am very, very happy"
Feb-71,Microscopic observation
66712-1,"When I get really happy about something, I tend to do things that can lead to trouble"
66713-9,"When I am really happy, I tend to get out of control"
66714-7,Vespula vulgaris recombinant (rVes v) 1 Ab.IgE
66715-4,Vespula vulgaris recombinant (rVes v) 1 Ab.IgE.RAST Class
66716-2,Chlorhexidine Ab.IgE.RAST class
66717-0,Chlorhexidine Ab.IgE
66718-8,Rickettsia typhi & Rickettsia spotted fever group Ab.IgG & IgM
66719-6,Adenovirus DNA
6672-0,Microscopic observation
66720-4,Adenovirus DNA
66721-2,Adenovirus DNA
66722-0,Adenovirus DNA
66723-8,Adenovirus DNA
66724-6,Adenovirus DNA
66725-3,Adenovirus DNA
66726-1,Adenovirus DNA
66727-9,Adenovirus DNA
66728-7,Adenovirus DNA
66729-5,Adenovirus DNA
66730-3,Adenovirus DNA
66731-1,Adenovirus DNA
66732-9,Corticotropin
66733-7,Cortisol^afternoon specimen
66734-5,Glucagon
66735-2,Cortisol^AM peak specimen
66736-0,Normalized silica clotting time
66737-8,CYP2C19 gene.c.1A>G(*4)
Aug-73,Microscopic observation
66738-6,CYP2C19 gene.c.358T>C(*8)
66739-4,CYP2C19 gene.c.395G>A(*6)
66740-2,CYP2C19 gene.c.636G>A(*3)
66741-0,CYP2C19 gene.c.681G>A(*2)
66742-8,CYP2C19 gene.c.806C>T(*17)
66743-6,CYP2C19 gene.c.IVS5+2T>A(*7)
66744-4,Heparin/body weight
66745-1,Coagulum lysis^30M post maximum clot amplitude
Jun-74,Ova & parasites identified
66746-9,Specimen type
66747-7,Clotting time
66748-5,Clot angle
66749-3,Circulatory assist status
66750-1,Clot angle^after addition of heparinase
66751-9,Clot strength
66752-7,Clot strength^after addition of heparinase
Mar-75,Microscopic observation
66753-5,Clot formation^after addition of heparinase
66754-3,Clot firmness^30M after maximum clot amplitude after addition of heparinase
66755-0,Maximum clot firmness^after addition of heparinase
66756-8,Clot initiation^after addition of heparinase
66757-6,Clot lysis estimate
66758-4,Clot firmness reduction^60M post maximum clot amplitude
66759-2,Heparin neutralization
667-6,Microscopic observation
66760-0,Coagulation index
Jan-76,Enterobius vermicularis
66761-8,Lymphocytes/100 leukocytes
66762-6,Choriogonadotropin.beta subunit
66763-4,Choriogonadotropin.beta subunit
66764-2,Erythrocytes.nucleated/100 leukocytes
66765-9,Albumin.pericard fld/Albumin.SerPl
66766-7,Albumin.periton fld/Albumin.SerPl
66767-5,Vanillylmandelate/body weight
66768-3,Leukocytes^^corrected for nucleated erythrocytes
66769-1,Triglyceride
66773-3,Feelings and emotions
66774-1,How much have you felt this way during the past few Ws
66775-8,I can always manage to solve difficult problems if I try hard enough
66776-6,"If someone opposes me, I can find the means and ways to get what I want"
66777-4,It is easy for me to stick to my aims and accomplish my goals
66778-2,I am confident that I could deal efficiently with unexpected events
Sep-77,Microscopic observation
66779-0,"Thanks to my resourcefulness, I know how to handle unforeseen situations"
66780-8,I can solve most problems if I invest the necessary effort
66781-6,I can remain calm when facing difficulties because I can rely on my coping abilities
66782-4,"When I am confronted with a problem, I can usually find several solutions"
66783-2,"If I am in trouble, I can usually think of a solution"
66784-0,I can usually handle whatever comes my way
66785-7,How well can you get teachers to help you when you get stuck on schoolwork
66786-5,How well can you express your opinions when other classmates disagree with you
Jul-78,Microscopic observation
66787-3,How well do you succeed in cheering yourself up when an unpleasant event has happened
66788-1,How well can you study when there are other interesting things to do
66789-9,How well do you succeed in becoming calm again when you are very scared
66790-7,How well can you become friends with other children
66791-5,How well can you study a chapter for a test
66792-3,How well can you have a chat with an unfamiliar person
66793-1,How well can you prevent becoming nervous
66794-9,How well do you succeed in finishing all your homework every day
May-79,Microscopic observation
66795-6,How well can you work in harmony with your classmates
66796-4,How well can you control your feelings
66797-2,How well can you pay attention during every class
66798-0,How well can you tell other children that they are doing something that you don't like
66799-8,How well can you give yourself a pep talk when you feel low
66800-4,How well do you succeed in understanding all subjects in school
66801-2,How well can you tell a funny event to a group of children
66802-0,How well can you tell a friend that you don't feel well
Mar-80,Microscopic observation
66803-8,How well do you succeed in satisfying your parents with your schoolwork
66804-6,How well do you succeed in staying friends with other children
66805-3,How well do you succeed in suppressing unpleasant thoughts
66806-1,How well do you succeed in passing a test
66807-9,How well do you succeed in preventing quarrels with other children
66808-7,How well do you succeed in not worrying about things that might happen
66809-5,How much does your spouse or partner really care about you
66810-3,How much does he or she understand the way you feel about things
Jan-81,Microscopic observation
66811-1,How much does he or she appreciate you
66812-9,How much can you rely on him or her for help if you have a serious problem
66813-7,How much can you open up to him or her if you need to talk about your worries
66814-5,How much can you relax and be yourself around him or her
66815-2,How often does your spouse or partner make too many demands on you
66816-0,How often does he or she make you feel tense
66817-8,How often does he or she argue with you
66818-6,How often does he or she criticize you
66819-4,How often does he or she let you down when you are counting on him or her
66820-2,How often does he or she get on your nerves
66821-0,"In the last Mo, how often have you been upset because of something that happened unexpectedly"
66822-8,"In the last Mo, how often have you felt that you were unable to control the important things in your life"
66823-6,"In the last Mo, how often have you felt nervous and stressed"
66824-4,"In the last Mo, how often have you felt confident about your ability to handle your personal problems"
66825-1,"In the last Mo, how often have you felt that things were going your way"
66826-9,"In the last Mo, how often have you found that you could not cope with all the things that you had to do"
66827-7,"In the last Mo, how often have you been able to control irritations in your life"
66828-5,"In the last Mo, how often have you felt that you were on top of things"
Sep-82,Microscopic observation
66829-3,"In the last Mo, how often have you been angered because of things that were outside of your control"
66830-1,"In the last Mo, how often have you felt difficulties were piling up so high that you could not overcome them"
66831-9,"Not including your spouse or partner, how much do members of your family really care about you"
66832-7,How much do they understand the way you feel about things
66833-5,How much can you rely on them for help if you have a serious problem
66834-3,How much can you open up to them if you need to talk about your worries
66835-0,"How much do you really care about the members of your family, not including your partner or spouse"
66836-8,How much do you understand the way they feel about things
Jul-83,Coagulation reptilase induced
66837-6,"Not including your spouse or partner, how often do members of your family make too many demands on you"
66838-4,How often do they criticize you
66839-2,How often do they let you down when you are counting on them
668-4,Microscopic observation
66840-0,How often do they get on your nerves
66841-8,How much do your friends really care about you
66842-6,How often do your friends make too many demands on you
66843-4,"I feel that I'm a person of worth, at least on an equal plane with others"
66844-2,I feel that I have a number of good qualities
May-84,Coagulation reptilase induced
66845-9,"All in all, I am inclined to feel that I am a failure"
66846-7,I am able to do things as well as most other people
66847-5,I feel I do not have much to be proud of
66848-3,I take a positive attitude toward myself
66849-1,"On the whole, I am satisfied with myself"
66850-9,I wish I could have more respect for myself
66851-7,I certainly feel useless at times
Feb-85,Apolipoprotein B/Apolipoprotein A-I
66852-5,At times I think I am no good at all
66853-3,Myeloperoxidase
66854-1,How often do you feel that you are in tune with the people around you
66855-8,How often do you feel that you lack companionship
66856-6,How often do you feel that there is no one you can turn to
66857-4,How often do you feel alone
66858-2,How often do you feel part of a group of friends
66859-0,How often do you feel that you have a lot in common with the people around you
6686-0,Ascorbate
66860-8,How often do you feel that you are no longer close to anyone
66861-6,How often do you feel that your interests and ideas are not shared by those around you
66862-4,How often do you feel outgoing and friendly
66863-2,How often do you feel close to people
66864-0,How often do you feel left out
66865-7,How often do you feel that your relationships with others are not meaningful
66866-5,How often do you feel that no one really knows you well
66867-3,How often do you feel isolated from others
66868-1,How often do you feel you can find companionship when you want it
66869-9,How often do you feel that there are people who really understand you
66870-7,How often do you feel shy
66871-5,How often do you feel that people are around you but not with you
66872-3,How often do you feel that there are people you can talk to
66874-9,FMR1 gene activation
66875-6,FMR1 gene methylation/methylated+unmethylated
66876-4,FMR1 gene premutation/premutation+full mutation
66877-2,Skin Ab pattern
Aug-87,Citrate
66878-0,Skin Ab
66879-8,Skin Ab.IgG
66880-6,Skin Ab.IgG pattern
66881-4,Skin Ab.IgG
66882-2,Skin Ab.IgG
66883-0,Skin Ab.IgG
66884-8,Skin Ab.IgG pattern
66885-5,Bacteria identified based on 16S rRNA gene
Jun-88,Coxsackievirus A16 Ab
66886-3,"Have you ever been involved in a natural disaster, such as a tornado, hurricane, flood, or earthquake"
66887-1,How old were you the first time it happened
66888-9,Were you in danger of death or serious injury
66889-7,"Did you feel intense fear, helplessness, or horror"
66890-5,Was there another time this happened
66891-3,"Have you ever been involved in a man-made disaster, such as a fire, train crash, car accident, or building collapse"
66892-1,Have you ever been involved in direct combat experience in a war
66893-9,Have you ever lived in a war zone such as the Persian Gulf or Bosnia
Apr-89,Glucose^2H post meal
66894-7,"Have you ever had a serious accident at home, at work, or somewhere else"
66895-4,Have you ever been exposed to dangerous chemicals or radioactivity
66896-2,"Have you ever been shot at, stabbed, struck, kicked, beaten, punched, slapped around, or otherwise physically harmed"
66897-0,How many times did this happen
66898-8,How old were you the last time this happened
66899-6,"Have you ever been threatened with any kind of a weapon, like a knife, gun, baseball bat, frying pan, scissors, stick, rock or bottle"
66900-2,Has anyone ever threatened you in a face-to-face confrontation
66901-0,"Have you ever been actually assaulted with any kind of a weapon, like a knife, gun, baseball bat, frying pan, scissors, stick, rock, or bottle"
Feb-90,Leukocytes
66902-8,"When you were a child - that is, when you were in elementary or middle school, before about age 12 - were you ever struck, kicked, beaten, punched, slapped around, or otherwise physically harmed"
66904-4,"When you were a child - that is, when you were in elementary or middle school, before about age 12 - were you ever physically abused"
66905-1,"Has anyone, male or female, ever forced or coerced you to engage in unwanted sexual activity"
66906-9,"Other than what we just talked about, did anyone, male or female ever attempt to, but not actually, force you to engage in unwanted sexual activity"
66909-3,"Have you ever had an immediate family member, romantic partner, or very close friend who was murdered"
6691-0,Loxapine+8-Hydroxyamoxapine
66910-1,Have you ever seen or been present when someone was murdered or seriously injured
66911-9,"Have you ever had an immediate family member, romantic partner, or very close friend commit suicide"
66912-7,"Have you ever seen a dead or mutilated body, other than at a funeral, in the movies or newspaper"
66913-5,"Have you ever seen or been present when another person was shot at, stabbed, struck, kicked, beaten, slapped around, or otherwise physically harmed"
66914-3,"Have you ever seen or been present when another person was raped, sexually attacked, or made to engage in unwanted sexual activity"
66915-0,Has anyone ever intentionally damaged or destroyed property owned by you or by someone in your household
66916-8,"Has anyone ever stolen something from you by using force or the threat of force like in a stick-up, mugging, or car-jacking"
66917-6,"Has anyone ever tried to, but not actually, steal something from you by using force or the threat of force like in a stick-up, mugging, or car-jacking"
66918-4,"Has anyone ever tried to or actually broken in to your house, garage, shed, or storage room when you were not there"
66919-2,"Has anyone ever tried to or actually broken in to your house, garage, shed, or storage room when you were there"
669-2,Microscopic observation
66920-0,Has anyone ever stolen something directly from you without the threat or use of force - purse-snatching or pick-pocket
66922-6,Have you ever been kidnapped or held captive
66923-4,Have you ever been stalked by anyone - has anyone ever followed or spied on you
66924-2,"Have you ever been in any other situation in which you were in danger of death or serious physical injury, or in which you felt intense fear, helplessness, or horror"
66925-9,"Situation in which you were in danger of death or serious physical injury, or in which you felt intense fear, helplessness, or horror"
66926-7,Were you afraid that you might die or get hurt really badly
66927-5,Were you very scared
Aug-92,Lutropin
66928-3,Did you feel like there was nothing you could do to stop what was happening
66929-1,"Before you turned 12Y old (when you were in grade school), did anyone ever hit you, kick you, beat you, punch you, slap you around, or hurt your body in some other way"
66930-9,Did anyone else ever do this to you
66932-5,"Was there any other time when anyone, male or female, tried to force or bully you into doing something sexual that you didn't want to do, but it didn't end up happening"
66933-3,"Have you ever known someone who was murdered; that is, a parent, a brother, a sister, a very close friend, a boyfriend or girlfriend, or someone who lived with you"
66934-1,Has anyone ever stolen something from you without your knowing it
66935-8,"Have you ever been in any other situation in which you were afraid you might die or get really badly hurt, or when you were very scared or felt like there was nothing you could do to stop what was happening"
Jun-93,Mercury
66936-6,Hip fracture location
66937-4,Other fracture location
66938-2,Fracture treatment
66939-0,Other fracture treatment
66940-8,Other fractures occurred at the same time
66941-6,Location of fall or trauma
66942-4,Other location of fall or trauma
66943-2,Time fracture occurred
Apr-94,quiNIDine
66944-0,Death occurred during hospitalization
66945-7,Detailed circumstances of fracture
66946-5,Data retrieval completed
66947-3,Date last reaction
66948-1,What primary non-english language or dialect do you speak or understand
66949-9,How often do you feel that there are people you can turn to
66950-7,MALT1 18q21 gene rearrangements
Jan-95,Riboflavin
66951-5,Complement C1.functional
66952-3,Circumstances of fracture
66953-1,Detailed fracture location
66954-9,How many times in the last Y have you purposely damaged or destroyed property that did not belong to you
66955-6,"How many times in the last Y have you purposely set fire to a house, building, car, or other property or tried to do so"
66956-4,How many times in the last Y have you broken city curfew laws
66957-2,"How many times in the last Y have you avoided paying for things such as movies, bus or subway rides, and food or computer services"
66958-0,How many times in the last Y have you gone into or tried to go into a building to steal something
66959-8,How many times in the last Y have you stolen or tried to steal money or things worth 5 dollars or less
66960-6,How many times in the last Y have you stolen or tried to steal money or things worth between 5 and 50 dollars
66961-4,How many times in the last Y have you stolen or tried to steal money or things worth more than 50 but less than 100 dollars
66962-2,How many times in the last Y have you stolen or tried to steal money or things worth 100 dollars or more
66963-0,How many times in the last Y have you taken something from a store without paying for it
66964-8,How many times in the last Y have you snatched someone's purse or wallet or picked someones pocket
66965-5,How many times in the last Y have you taken something from a car that did not belong to you
66966-3,"How many times in the last Y have you knowingly bought, sold or held stolen goods or tried to do any of these things"
66967-1,How many times in the last Y have you gone joyriding
66968-9,How many times in the last Y have you stolen or tried to steal a motor vehicle such as a car or motorcycle
Sep-96,Thiothixene
66969-7,How many times in the last Y have you used checks illegally or used a slug or fake money to pay for something
66970-5,How many times in the last Y have you used or tried to use a credit or bank cards without the owners permission
66971-3,How many times in the last Y have you tried to cheat someone by selling them something that was worthless or not what you said it was
66972-1,How many times in the last Y have you attacked someone with a weapon or with the idea of seriously hurting or killing them
66973-9,"How many times in the last Y have you hit someone with the idea of hurting them, other than the events just mentioned"
66974-7,"How many times in the last Y have you used a weapon, force, or strong-arm methods to get money or things from people"
66975-4,"How many times in the last Y have you thrown objects such as rocks or bottles at people, other than events you have already mentioned"
66976-2,How many times in the last Y have you been involved in gang fights
Jul-97,Amylase
66977-0,How many times in the last Y have you been paid for having sexual relations with someone
66978-8,How many times in the last Y have you physically hurt or threatened to hurt someone to get them to have sex with you
66979-6,"How many times in the last Y have you had or tried to have sexual relations with someone against their will, other than events you just mentioned"
66980-4,"How many times in the last Y have you sold marijuana or hashish, pot, grass, hash"
66981-2,"How many times in the last Y have you sold hard drugs such as heroin, cocaine, and LSD"
66982-0,Have you done anything else in the past year that could have gotten you in trouble with the police
66983-8,What kind of things did you do
66984-6,How many times in the past Y
May-98,Aldolase
66985-3,How many times in the last Y have you run away from home
66986-1,How many times in the last Y have you skipped classes or school without an excuse
66987-9,How many times in the last Y have you been suspended or sent home from school for bad behavior
66988-7,How many times in the last Y have you lied about your age to get into some place or to buy something
66989-5,How many times in the last Y have you cheated on school tests
66990-3,How many times in the last Y have you hitchhiked where it was illegal to do so
66991-1,How many times in the last Y have you carried a hidden weapon
66992-9,"How many times in the last Y have you been loud, rowdy, or unruly in a public place so that people complained about it or you got in trouble"
Mar-99,Delta 5-Pregnanetriol
66993-7,How many times in the last Y have you begged for money or things from strangers
66994-5,How many times in the last Y have you made obscene telephone calls such as calling someone and saying dirty things
66995-2,How many times in the last Y have you been drunk in a public place
66996-0,How many times in the last Y did you run away from your home and stay away overnight
07-Jun,Amantadine
670-0,Microscopic observation
67001-8,"How many times in the last Y did you break into, or try to break into a building, to steal something"
67003-4,"How many times in the last Y did you steal, or try to steal, money or things worth between 5 and 100 dollars"
67004-2,"How many times in the last Y did you steal, or try to steal, money or things worth between 100 and 500 dollars"
67005-9,"How many times in the last Y did you steal, or try to steal, money or things worth over 500 dollars"
67008-3,"How many times in the last Y have you converted a vehicle, that is, taken a motor vehicle such as a car or motorcycle for a ride or drive without the owner's permission, when you didn't mean to keep or sell it"
Sep-00,11-Hydroxyetiocholanolone
67009-1,"How many times in the last Y have you stolen, or tried to steal, a motor vehicle such as a car or motorcycle to keep or sell"
67010-9,How many times in the last Y have you used worthless checks or fake money to pay for something
67013-3,"How many times in the last Y have you been so angry with a child that you attacked them with a weapon, or with the idea of seriously hurting them"
67014-1,How many times in the last Y have you been so angry with a child that you hit them
67015-8,How many times in the last Y have you attacked an adult with a weapon or with the idea of seriously hurting or killing them
67016-6,How many times in the last Y have you hit an adult with the idea of hurting them
Jul-01,11-Hydroxyandrosterone
67017-4,"How many times in the last Y have you used a weapon, force or strong arm methods to rob a person, shop, bank, or other business"
67019-0,"How many times in the last Y have you committed a serious driving offense, such as driving while drunk, driving recklessly, or speeding 50 km per hour over the posted speed limit"
67020-8,How many times in the last Y have you embezzled money - that means used money entrusted to your care for some purpose not intended
67021-6,How many times in the last Y have you lied about your age
67022-4,"How many times in the last Y have you made obscene telephone calls, such as calling someone and saying rude things"
67024-0,"How many times in the last Y did you give false information on a tax form, an insurance claim, or on applications for a loan or bank account"
May-02,11-Ketoandrosterone
67025-7,How many times in the last Y did you use a false name or alias so you couldn't be identified
67026-5,How many times in the last Y did you move away from a flat or house without paying the final bills or rent
67027-3,How many times in the last Y have you made illegal copies of computer software or video files
67028-1,How many times in the last Y did you buy something on credit and then never made the payments
67029-9,"How many times in the last Y did you interfere with the work of the law by trying to get away from police, by hiding someone that the police were looking for, or by telling a lie to a police officer or judge"
67030-7,How many times in the last Y have you driven a vehicle when you did not have a driver's license or after your license had been suspended or disqualified
Mar-03,11-Ketoetiocholanolone
67033-1,How many times in the last Y have you used marijuana
67034-9,"How many times in the last Y have you used a harder drug, such as heroin, cocaine or LSD"
67035-6,How many times in the last Y have you paid someone to have sex with you
67036-4,"How many times in the last Y have you been paid, or received other favors for having sex with someone"
67037-2,How many times in the last Y did you threaten or hurt someone to get them to have sex with you
67038-0,How many times in the last Y have you contributed to the delinquency of a person under age 17
67039-8,How many times in the last Y have you failed to obey the courts
67040-6,Your rent or mortgage is too much
Jan-04,11-Ketopregnanetriol
67041-4,You don't have enough money to take vacations
67042-2,You don't have enough money to make a down payment on a home
67043-0,You have more work to do than most people
67044-8,Your supervisor is always monitoring what you do at work
67045-5,You want to change jobs or career but don't feel you can
67046-3,Your job often leaves you feeling both mentally and physically tired
67047-1,You want to achieve more at work but things get in the way
67048-9,You don't get paid enough for what you do
67049-7,Your work is boring and repetitive
67050-5,You are looking for a job and can't find the one you want
67051-3,You have a lot of conflict with your partner
67052-1,Your relationship restricts your freedom
67053-9,Your partner doesn't understand you
67054-7,Your partner expects too much of you
67055-4,You don't get what you deserve out of your relationship
67056-2,Your partner doesn't show enough affection
67057-0,Your partner is not committed enough to your relationship
Aug-05,Androsterone
67058-8,Your sexual needs are not fulfilled by this relationship
67059-6,Your partner is always threatening to leave or end the relationship
67060-4,You wonder whether you will ever get married
67061-2,You find it is too difficult to find someone compatible with you
67062-0,You have a lot of conflict with your ex-spouse
67063-8,You don't see your children from a former marriage as much as you would like
67064-6,You are alone too much
67065-3,You wish you could have children but you cannot
Jun-06,buPROPion
67066-1,One of your children seems very unhappy
67067-9,You feel your children don't listen to you
67068-7,A childs behavior is a source of serious concern to you
67069-5,One or more children do not do well enough at school or work
67070-3,Your children don't help around the house
67071-1,One of your children spends too much time away from the house
67072-9,You feel like being a housewife is not appreciated
67073-7,You have to go to social events alone and you don't want to
Apr-07,CD16-CD57+
67074-5,Your friends are a bad influence
67075-2,You don't have enough friends
67076-0,You don't have time for your favorite leisure time activities
67077-8,You want to live farther away from your family
67078-6,You would like to move but you cannot
67079-4,The place you live is too noisy or too polluted
67080-2,Your family lives too far away
67081-0,Someone in your family or a close friend has a long-term illness or handicap
Feb-08,Echovirus 11 Ab
67082-8,"You have a parent, a child, or a spouse or partner who is in very bad health and may die"
67083-6,Someone in your family has an alcohol or drug problem
67084-4,A long- term health problem prevents you from doing the things you like to do
67085-1,You take care of an aging parent almost every day
67086-9,You're trying to take on too many things at once
67087-7,There is too much pressure on you to be like other people
67088-5,Too much is expected of you by others
67089-3,You don't have enough money to buy the things you or your kids need
6709-0,Hippurate
67090-1,You have a long-term debt or loan
67091-9,How long were you held or not allowed to leave
67092-7,Career position
67093-5,Is there anyone you know who has this career
67094-3,Did you get to know them through your spouse or partner
67095-0,How long have you known each other
67096-8,How close are you to them
67097-6,Coagulation surface induced.lupus sensitive.factor substitution^immediately after addition of normal plasma
67098-4,Reason for test or procedure
67099-2,Vendor device name
67100-8,Therapist name
67101-6,Dermatologist name
67102-4,Diagnosing provider
67103-2,Body location affected by psoriasis now
67104-0,Body location affected by psoriasis when it was the worst
67105-7,"Have you had a hysterectomy - removal of the uterus, or tubal ligation - tubes tied"
67106-5,"Other than what we just talked about, has anyone ever actually touched private parts of your body or made you touch theirs against your wishes"
67107-3,Have you ever fought in a war
Aug-10,Hydroxyproline
67108-1,"Have you ever had a serious accident at home, at school, or somewhere else"
67109-9,"Has anyone ever shot at you, stabbed you, hit you, kicked you, beaten you, punched you, slapped you around, or hurt your body in some other way"
67110-7,"Has anyone ever threatened to hurt you with any kind of a weapon, like a knife, a gun, a baseball bat, a frying pan, scissors, a stick, a rock or a bottle"
67111-5,Has anyone ever threatened to hurt you when they were standing right in front of you
67112-3,"Has anyone ever actually hurt you with any kind of a weapon, like a knife, a gun, a baseball bat, a frying pan, scissors, a stick, a rock, or a bottle"
67113-1,"Before you turned 12Y old (when you were in grade school), were you ever physically abused"
67114-9,"Has anyone, male or female, ever forced or pressured you into doing something sexual that you didn't want to do"
67115-6,"Have there been any other times when anyone, male or female, ever tried to force or bully you into doing something sexual that you didn't want to do, but it didn't end up happening - you stopped them or someone else"
Jun-11,Acetaminophen Ab.IgE
67116-4,"Was anyone murdered who was a parent, a brother, a sister, a very close friend, a boyfriend or girlfriend, or someone who lived with you"
67117-2,Have you ever seen or been present when someone was murdered or hurt very badly
67118-0,"Have you ever known someone who committed suicide or killed themselves; that is, a parent, a sister, a brother, a very close friend, a boyfriend or girlfriend, or someone who lived with you"
67119-8,Have you ever seen a dead body
67120-6,Have you ever seen or heard another person be threatened with a weapon - a gun or a knife
67121-4,"Have you ever seen or heard another person be raped, sexually attacked, or made to do something sexual that they didn't want to do"
67122-2,Has anyone ever damaged or destroyed something on purpose that belonged to you or to someone who you lived with
67123-0,"Has anyone ever stolen something from you by using force or threatening to hurt you, like in a stick-up, a mugging, or a car-jacking"
Apr-12,Ampicillin Ab.IgE
67124-8,Has anyone ever tried to steal something from you by using force or threatening to hurt you
67125-5,"Situation in which you were afraid you might die or get really badly hurt, or when you were very scared or felt like there was nothing you could do to stop what was happening"
67126-3,Cannabinoids.synthetic
67127-1,Cellularity assessment
67128-9,Leukocytes.abnormal/100 leukocytes
67129-7,Heart rate^resting
67131-3,Age range for gallbladder disease
Feb-13,Saccharomyces cerevisiae Ab.IgG
67132-1,Area of gallbladder pain
67133-9,Has pain that has been most uncomfortable in this area the past 12Mo
67134-7,"During the past 12Mo, what is the longest time that one episode of this pain has lasted"
67135-4,On how many Ds in the past 12Mo have you had this pain
67136-2,"When you had the pain, if you moved around, did you hurt more, less, or was there no difference"
67137-0,Have you ever seen a doctor about this pain
67138-8,What did the doctor say caused the pain
67139-6,Other cause of pain
6714-0,Beef Ab.IgG
67140-4,Has a doctor ever told you that you had gallstones
67141-2,What was the reason you visited the doctor the time that he told you that you had gallstones
67142-0,Other reason you visited the doctor the time that he told you that you had gallstones
67143-8,Have you ever had medical treatment to dissolve or remove gallstones
67144-6,Have you ever had gallbladder surgery
67145-3,How old were you when you had your gallbladder surgery
67146-1,"During the past 12Mo, have you had pain in the area shaded on the diagram"
67147-9,Did the pain that caused you to visit the doctor continue after your gallbladder surgery
67148-7,Adjudication date by MD fracture coordinator
67149-5,Final adjudication
67151-1,Troponin T.cardiac
67152-9,Date abstracted
67153-7,Abstractor ID
67154-5,Nosologist ID
67155-2,Study year
67156-0,Purpose of abstract
Jul-15,Yeast brewer's Ab.IgG
67157-8,Multiple primary cancer number
67158-6,Form receipted into SMS
67159-4,Manual review completed
67160-2,Data entry of non-scannable items
67161-0,Data retrieval
67162-8,Disposition
67163-6,Diagnostic procedures performed
67164-4,Reason for initial visit for clinical assessment
May-16,Cardiolipin Ab.IgG
67165-1,Other reason for initial visit for clinical assessment
67166-9,Sigmoidoscopy or colonoscopy
67168-5,Cecum visualization
67169-3,Bowel preparation
67170-1,Hyperplastic polyps
67171-9,Procedure type
67172-7,Adenomas on sigmoidoscopy or colonoscopy
Mar-17,Cardiolipin Ab.IgM
67173-5,Multiple polyps in specimen jar
67174-3,Adenoma distance
67175-0,Longest adenoma dimension
67176-8,Adenoma description
67177-6,Adenoma histology
67178-4,Adenoma dysplasia
67179-2,Non-advanced adenomas
671-8,Microscopic observation
67180-0,Advanced adenomas
Jan-18,Anacardium occidentale Ab.IgE
67181-8,Can exact number of adenomas be determined
67182-6,Other diagnostic or staging procedures done
67183-4,Diagnostic or staging procedure
67184-2,Other diagnostic or staging procedure
67185-9,Diagnostic_staging procedures supplement form completed
67186-7,Medical complications of diagnostic evaluation and staging
67187-5,Type of complication
67188-3,Infection
67189-1,Diagnostic evaluation for colorectal cancer
67190-9,Other cancer diagnosis
67191-7,Description of colorectal carcinoma
67192-5,Procedure for primary diagnosis of colorectal carcinoma
67193-3,Gross morphology
67194-1,Verbatim description of primary colorectal cancer diagnosis
67195-8,ICD-O-2 cancer classification - topography
67196-6,ICD-O-2 cancer classification - morphology
67197-4,ICD-O-2 cancer classification - behavior
67198-2,ICD-O-2 cancer classification - grade
Sep-19,Prunus avium Ab.IgE
67199-0,Photocopy of report confirming primary colorectal cancer
67200-6,Histopathologic type for primary colorectal cancer
67201-4,Other histopathologic type for primary colorectal cancer
67202-2,Histopathologic grade for primary colorectal cancer
67203-0,AJCC cancer staging manual
67204-8,TNM clinical staging
67205-5,TNM clinical staging - primary tumor - T
67206-3,TNM clinical staging - nodal involvement - N
Jul-20,Chocolate Ab.IgG
67207-1,TNM clinical staging - distant metastases - M
67208-9,TNM pathologic staging
67209-7,TNM pathologic staging - primary tumor - T
67210-5,TNM pathologic staging - nodal involvement - N
67211-3,TNM pathologic staging - distant metastases - M
67212-1,Record stage
67213-9,Disease stage
67214-7,Dukes
May-21,Gadus morhua Ab.IgG
67215-4,Modified dukes - astler-coller
67216-2,Summary staging
67217-0,Adenomas procedure
67218-8,Location of polyps
67219-6,"In the past 2Y, have you had upper endoscopy, esophagus or stomach"
67220-4,"In the past 2Y, have you had a virtual CT colonoscopy"
67221-2,In the past 2Y have you had a colonoscopy
67222-0,"In the past 2Y, have you had a sigmoidoscopy"
Mar-22,Coffea spp Ab.IgG
67223-8,Initial reasons you had a colonoscopy or sigmoidoscopy
67224-6,Clinician diagnosed gastrointestinal conditions
67225-3,Have you had this clinician diagnosed condition
67226-1,Site of the bleeding
67227-9,Was this the site of the bleeding
67228-7,What Ys did this happen
67229-5,How often did you have a burning feeling behind your breastbone - heartburn
67230-3,How often did you have stomach contents - liquid or food moving upwards to your throat or mouth - regurgitation in the past 7D
Jan-23,Zea mays Ab.IgG
67231-1,How often did you have pain in the center of the upper stomach in the past 7D
67232-9,How often did you have nausea in the past 7D
67233-7,How often did you have difficulty getting a good night's sleep because of your heartburn or regurgitation in the past 7D
67234-5,"How often did you take additional medications for your heartburn or regurgitation other than what your physician told you to take, such as tums, rolaids, maalox in the past 7D"
67235-2,Does the examinee have hearing aids that cannot be removed
67236-0,Do you now have a tube in your right or left ear
67238-6,"Have you had a cold, sinus problem or earache in the last 24H"
67239-4,Which have you had
67240-2,Have you been exposed to loud noise or listened to music with headphone in the past 24H
67241-0,How many Hs ago did the noise or music end
67242-8,Do you hear better in one ear than the other
67243-6,Comment to describe the ear
67244-4,Comment to describe the ear
67245-1,Acoustic immittance
67246-9,Tympanogram ID
67247-7,Acoustic immittance
67248-5,Tympanogram ID
Sep-24,Cucumis sativus Ab.IgE
67249-3,Ear tested first
67250-1,"Headphones used, original test"
67251-9,Test mode
67252-7,Hz when switched to manual mode
67253-5,Frequencies
67254-3,Threshold
Jun-25,Egg white Ab.IgG
67256-8,Right or left ear
67257-6,Test mode
67258-4,Hz when switched to manual mode
67259-2,Have you ever had 3 or more ear infections
672-6,Microscopic observation
67260-0,Have you ever had a tube placed in your ear to drain the fluid from your ear
67261-8,My child's ability to ask questions properly is
67262-6,My child's ability to answer questions properly is
67263-4,My child's ability to understand what others say to him or her is-
Apr-26,Arrhenatherum elatius Ab.IgE
67264-2,My child's ability to say sentences clearly enough to be understood by strangers is
67265-9,The number of words my child knows is
67266-7,My child's ability to use his or her words correctly is
67267-5,My child's ability to get his or her messages across to others when talking is
67268-3,My child's ability to understand directions spoken to him or her is
67269-1,My child's ability to follow directions spoken to him or her is
67270-9,My child's ability to use the proper words when talking to others is
67271-7,My child's ability to get what he or she wants by talking is
Feb-27,Apis mellifera Ab.IgG
67272-5,"My child's ability to start a conversation, or start talking with other children is"
67273-3,My child's ability to keep a conversation going with other children is
67274-1,The length of this child's sentences is
67275-8,My child's ability to make grown up sentences is
67276-6,My child's ability to correctly say the sounds in individual words is
67277-4,"My child's awareness of differences in the way people act, speak, dress, etc is"
67278-2,My child usually speaks - volume
67279-0,My child usually speaks - frequency
6728-0,Latex glove extract Ab.IgE
67280-8,I tend to lose control when I am in a great mood
67281-6,I would like to learn to fly an airplane
67282-4,I am a person who always gets the job done
67283-2,I almost always finish projects that I start
67284-0,I often make matters worse because I act without thinking when I am upset
67285-7,I would enjoy fast driving
67286-5,Relationship to you
67287-3,I finish what I start
67288-1,Race or ethnicity
67289-9,"When you had this pain, was it continuous, or did it tend to come and go"
67290-7,Date of complication
67291-5,Other biopsy
67292-3,Other CT scan
67293-1,Other MRI scan
67294-9,Other resection
67295-6,Other radiograph
67296-4,Other ultrasound
67297-2,"By age 2, was your child talking in short phrases or sentences"
Aug-29,Cow milk Ab.IgG
67298-0,"When your child was 2Ys old, were you concerned that they were having difficulty learning to talk"
67299-8,"At this time, do people frequently have trouble understanding your child"
67300-4,Has anyone in your child's family had speech or language therapy
67301-2,What did anyone in your child's family have speech or language therapy for
67302-0,Has anyone in your child's family had difficulty learning to read or had problems with school work
67304-6,Details of family having difficulty reading or problems with school work
67305-3,Has anyone in your child's family been diagnosed with an intellectual disability
Jun-30,Citrus sinensis Ab.IgG
67306-1,Does anyone in your child's family have a hearing difficulty
67307-9,Has anyone in your child's family been slow in learning to talk
67308-7,Has anyone in your child's family had stuttering
67309-5,Anyone in your child's family less talkative
67310-3,Has anyone in your child's family had a hard time carrying on a conversation
67311-1,Anyone in your child's family that doesn't like to read
67312-9,Anyone in your child's family that doesn't read well
67313-7,Anyone in your child's family that has difficulty thinking of words they want to say when talking
Apr-31,Polistes spp Ab.IgG
67314-5,Anyone in your child's family that has a poorer vocabulary than other family members
67315-2,Anyone in your child's family that is a poor speller
67316-0,Anyone in your child's family that has awkward sentence structures when writing or talking
67317-8,Anyone in your child's family that mispronounces long words
67318-6,"Anyone in your child's family that is hard to follow when they tell you something, such as a personal experience"
67319-4,Anyone in your child's family that has difficulty explaining things
67320-2,Because of your tinnitus is it difficult to concentrate
67321-0,Does the loudness of your tinnitus make it difficult for you to hear people
Feb-32,Arachis hypogaea Ab.IgG
67322-8,Does your tinnitus make you angry
67323-6,Does your tinnitus make you feel confused
67324-4,Because of your tinnitus do you feel desperate
67325-1,Do you complain a great deal about your tinnitus
67326-9,Because of your tinnitus do you have trouble falling to sleep at night
67327-7,Do you feel that you cannot escape your tinnitus
67328-5,Does your tinnitus interfere with your ability to enjoy social activities
67329-3,Because of your tinnitus do you feel frustrated
6733-0,Pigeon serum Ab
67330-1,Because of your tinnitus do you feel that you have a terrible disease
67331-9,Does your tinnitus make it difficult for you to enjoy life
67332-7,Does your tinnitus interfere with your job or household duties
67333-5,Because of your tinnitus do you find that you are often irritable
67334-3,Because of your tinnitus is it difficult for you to read
67335-0,Does your tinnitus make you upset
67336-8,Do you feel that your tinnitus problem has placed stress on your relationship with members of your family and friends
67337-6,Do you find it difficult to focus your attention away from your tinnitus and on other things
67338-4,Do you feel that you have no control over your tinnitus
67339-2,Because of your tinnitus do you often feel tired
673-4,Ova & parasites identified
67340-0,Because of your tinnitus do you feel depressed
67341-8,Does your tinnitus make you feel anxious
67342-6,Do you feel that you can no longer cope with your tinnitus
67343-4,Does your tinnitus get worse when are you are under stress
67344-2,Does your tinnitus make you feel insecure
67345-9,Does looking up increase your problem
67346-7,"Because of your problem, do you feel frustrated"
67347-5,"Because of your problem, do you restrict your travel for business or recreation"
Aug-34,Pork Ab.IgG
67348-3,Does walking down the aisle of a supermarket increase your problem
67349-1,"Because of your problem, do you have difficulty getting into or out of bed"
67350-9,"Does your problem significantly restrict your participation in social activities such as going out to dinner, the movies, dancing or to parties"
67351-7,"Because of your problem, do you have difficulty reading"
67352-5,Does performing more ambitious activities such as sports or dancing or household chores such as sweeping or putting dishes away increase your problem
67353-3,"Because of your problem, are your afraid to leave your home without having someone accompany you"
67354-1,"Because of your problem, are you embarrassed in front of others"
May-35,Glycine max Ab.IgG
67355-8,Do quick movements of your head increase your problem
67356-6,"Because of your problem, do you avoid heights"
67357-4,Does turning over in bed increase your problem
67358-2,"Because of your problem, is it difficult for you to do strenuous housework or yard work"
67359-0,"Because of your problem, are you afraid people may think you are intoxicated"
67360-8,"Because of your problem, is it difficult for you to walk by yourself"
67361-6,Does walking down a sidewalk increase your problem
67362-4,"Because of your problem, is it difficult for you to concentrate"
Mar-36,Lycopersicon lycopersicum Ab.IgG
67363-2,"Because of your problem, is it difficult for you to walk around the house in the dark"
67364-0,"Because of your problem, are you afraid to stay at home alone"
67365-7,"Because of your problem, do you feel handicapped"
67366-5,Has your problem placed stress on your relationship with members of your family or friends
67367-3,"Because of your problem, are you depressed"
67368-1,Does your problem interfere with your job or household responsibilities
67369-9,Does bending over increase your problem
67370-7,My voice makes it difficult for people to hear me
Jan-37,Triticum aestivum Ab.IgG
67371-5,I run out of air when I talk
67372-3,People have difficulty understanding me in a noisy room
67373-1,The sound of my voice varies throughout the day
67374-9,My family has difficulty hearing me when I call them throughout the house
67375-6,I use the phone less often than I would like
67376-4,I'm tense when talking with others because of my voice
67377-2,I tend to avoid groups of people because of my voice
67378-0,People seem irritated with my voice
67379-8,"People ask, what's wrong with your voice"
67380-6,"I speak with friends, neighbors, or relatives less often because of my voice"
67381-4,People ask me to repeat myself when speaking face-to-face
67382-2,My voice sounds creaky and dry
67383-0,I feel as though I have to strain to produce voice
67384-8,I find other people don't understand my voice problem
67385-5,My voice difficulties restrict my personal and social life
67386-3,The clarity of my voice is unpredictable
67387-1,I try to change my voice to sound different
67388-9,I feel left out of conversations because of my voice
Sep-38,Rumex crispus Ab.IgE
67389-7,I use a great deal of effort to speak
67390-5,My voice is worse in the evening
67391-3,My voice problem causes me to lose income
67392-1,My voice problem upsets me
67393-9,I am less outgoing because of my voice problem
67394-7,My voice makes me feel handicapped
67395-4,My voice gives out on me in the middle of speaking
67396-2,I feel annoyed when people ask me to repeat
Jul-39,Dolichovespula arenaria Ab.IgG
67397-0,I feel embarrassed when people ask me to repeat
67398-8,My voice makes me feel incompetent
67399-6,I'm ashamed of my voice problem
67400-2,Do you have any difficulty with your hearing
67401-0,How quickly did your hearing difficulty develop
67402-8,Do you know the reason for your hearing difficulty
67403-6,Does your hearing vary from day to day
67404-4,Do you find it very difficult to follow a conversation if there is background noise
May-40,Vespula spp Ab.IgE
67405-1,Are you particularly sensitive to loud sounds
67406-9,Do you sometimes feel a fullness or blockage in your ears
67407-7,"Do you ever get noises in your head or ears, tinnitus, which usually last longer than 5M"
67408-5,Have you ever had an ear disease that has caused your hearing to get worse
67409-3,"Have you ever had discharge of blood or pus, or smelly discharge, not wax, from either ear"
67410-1,Have you ever had an ear operation
67411-9,Have you ever suffered from attacks of dizziness in which things seem to spin around you
67412-7,Do you feel unsteady when walking in the dark
Mar-41,Erythrocytes
67413-5,Country of origin
67414-3,Region of origin
67415-0,Does your parent have or had hearing problems
67416-8,Do you have any brothers or sisters with normal hearing
67417-6,How many of your brothers or sisters have normal hearing
67418-4,Do you have any children with normal hearing
67419-2,How many of your children have normal hearing
674-2,Microscopic observation
67420-0,"Do you have uncles, aunts, cousins, nephews, or nieces with hearing difficulties"
Jan-42,Erythrocyte morphology finding
67421-8,Do you know if any of your relatives have already participated in this investigation
67422-6,Name of your relative that have already participated in this investigation
67423-4,Do you suffer from migraine
67424-2,How often do you generally have attacks
67425-9,Have you ever suffered a hearing loss from meningitis or encephalitis
67426-7,Have you ever had a whiplash injury
67427-5,"Have you ever been knocked unconscious, in a traffic accident, contact sport, a fight or after a fall"
67428-3,Have you ever had heart surgery
67429-1,Have you ever had coronary artery catheterization
67430-9,"Type of intervention, stent, balloon dilatation"
67431-7,Have you ever had an operation on your carotid artery
67432-5,Do you suffer from intermittent claudication
67433-3,Do you have other problems with your heart or circulation
67434-1,Problems with your heart or circulation
67435-8,Do you suffer from diabetes
67436-6,Do you need insulin
67437-4,Disease history
67438-2,Disease description
Sep-43,Leukocytes
67439-0,Autoimmune diseases
67440-8,Do you have other serious health problems that are not covered by the previous questions
67441-6,Serious health problems
67442-4,"Have you ever been treated for a serious infection with an antibiotic, other than penicillin, which was administered by injection or drip for a W or more"
67443-2,Infections for which you received these antibiotics
67444-0,Have you had cancer or leukemia
67446-5,Have you been treated with chemotherapy or other medication for this condition
Jul-44,Lymphocytes
67447-3,Have you ever received radiotherapy to your head or neck for a tumor
67448-1,Tumor type treated with radiotherapy
67449-9,On average how often do you take painkillers
67450-7,Do you take aspirin on a daily basis for your heart or to dilute your blood
67451-5,How long have you been taking aspirin
67452-3,Medical reason why you had or have to take this medication
67453-1,Treatment duration
Apr-45,Neutrophils.segmented
67454-9,Have you ever fired a gun
67455-6,Weapon type
67456-4,Shots fired
67457-2,Did you use ear protection
67458-0,Type of ear protection
67459-8,"During your leisure time, have you been regularly, more than once a W, exposed to loud sound or noise, so that you have to shout to make yourself heard by someone who was more than 1 meter away from you"
67460-6,What kind of loud sound
67461-4,For how many Y have you been exposed to this loud sound
Feb-46,Prolymphocytes/100 leukocytes
67462-2,How many H per W have you been exposed
67463-0,Do you have any brothers or sisters with hearing difficulties
67464-8,How many of your brothers or sisters have hearing difficulties
67465-5,Do you have any children with hearing difficulties
67466-3,How many of your children have hearing difficulties
67467-1,Ear with hearing difficulty
67468-9,At what age did you first notice a hearing difficulty
67469-7,Chemotherapy or other medication for this condition
6747-0,Glucose^1H post 50 g lactose PO
67470-5,Which solvents
67471-3,Pregnancy
67480-4,Dispatch delay
67481-2,First EMS unit on scene
67482-0,Response mode to scene
67483-8,EMS unit primary role
67484-6,Counter or odometer reading^beginning of call
67485-3,Counter or odometer reading^patient arrival
67486-1,Counter or odometer reading^patient destination
67487-9,Counter or odometer reading^end of call
Aug-48,Glucose^1H post 75 g glucose PO
67488-7,Emergency medical dispatch performed
67489-5,Total patients at the scene
67490-3,Mass casualty incident
67491-1,Chief complaint duration
67492-9,Primary problem
67493-7,Initial patient acuity
67494-5,General mechanism of the forces which caused the injury
67495-2,CDC field triage criteria
Jun-49,Glucose^2.5H post 75 g glucose PO
67496-0,Other injury risk factors
67497-8,Location of impact on the vehicle
67498-6,Location of patient in vehicle
67499-4,Safety equipment
67500-9,Airbag deployment
67501-7,Height of fall
67502-5,Cardiac arrest
67503-3,Cardiac arrest cause
Apr-50,Glucose^2H post 50 g lactose PO
67504-1,Reason resuscitation not attempted
67505-8,Cardiac arrest witness
67506-6,CPR prior to EMS arrival
67507-4,Provider of CPR prior to EMS arrival
67508-2,AED use prior to EMS arrival
67509-0,Provider of AED use prior to EMS arrival
67510-8,Cardiopulmonary resuscitation technique
67511-6,EMS therapeutic hypothermia
Feb-51,Glucose^2H post 75 g glucose PO
67512-4,First monitored rhythm
67513-2,Return of spontaneous circulation
67514-0,Cardiac rhythm on arrival at destination
67515-7,Barriers to patient care
67516-5,Advance directive
67517-3,Last oral intake
67518-1,Obtained prior to units EMS care
67519-9,Cardiac rhythm
6752-0,Glucose^3.5H post 75 g glucose PO
67520-7,Stroke scale overall interpretation
67521-5,Stroke scale type
67522-3,Other stroke scale type
67523-1,Contraindication for thrombolytic use
67524-9,Physical findings
67525-6,Physical findings
67526-4,Physical findings
67527-2,Physical findings
67528-0,Physical findings
67529-8,Physical findings
67530-6,Physical findings
67531-4,Physical findings
67532-2,Physical findings
67533-0,Physical findings
67534-8,Physical findings
67535-5,Mental status assessment
67536-3,Neurological assessment
67537-1,Protocol used
Aug-53,Glucose^30M post 50 g lactose PO
67538-9,Protocol age category
67539-7,Medication administered prior to this unit's EMS care
67540-5,Response to medication
67541-3,Medication complication
67542-1,Procedure performed prior to this units EMS care
67543-9,Procedure attempts
67544-7,Procedure successful
67545-4,Procedure complication
Jun-54,Glucose^30M post 75 g glucose PO
67546-2,Response to procedure
67547-0,Patients transported in EMS unit
67548-8,Incident - patient disposition
67549-6,Transport method
67550-4,Transport mode from scene
67551-2,Condition of patient at destination
67552-0,Reason for choosing destination
Mar-55,Glucose^3H post 75 g glucose PO
67553-8,Condition indicating eligibility for illness or injury registry
67554-6,"Work related exposure, injury, or death"
67555-3,"Work related exposure, injury, or death"
67556-1,EMS condition code
67557-9,Response delay
67558-7,Scene delay
67559-5,Transport delay
67560-3,Turn-around delay
Jan-56,Glucose^4.5H post 75 g glucose PO
67561-1,Corynebacterium diphtheriae DNA
67562-9,Achromobacter sp DNA
67563-7,Legionella micdadei DNA
67566-0,Coagulation surface induced.factor substitution^after addition of normal plasma 2H post incubation separate tubes
67568-6,Circulating tumor cells.breast
67569-4,Streptococcus pyogenes M protein (emm) gene
67570-2,Chief complaint per dispatch
67571-0,Contraindication for thrombolytic use
67572-8,Condition indicating eligibility for illness or injury registry
67573-6,Exposure to blood or body fluids
67574-4,Reason CPR resuscitation discontinued
67575-1,Are you susceptible to sunburn
67576-9,Color
67577-7,How far in school did she go
67578-5,How far in school did he go
Sep-57,Glucose^4H post 75 g glucose PO
67579-3,"At any time in your life, have you ever been unfairly fired"
67580-1,What do you think was the main reason for this experience
67581-9,"For unfair reasons, have you ever not been hired for a job"
67582-7,Have you ever been unfairly denied a promotion
67583-5,"Have you ever been unfairly stopped, searched, questioned, physically threatened or abused by the police"
67584-3,Have you ever been unfairly denied a bank loan
67585-0,Have you ever received service from someone such as a plumber or car mechanic that was worse than what other people get
67586-8,You have been treated with less courtesy than other people
Jul-58,Glucose^5H post 75 g glucose PO
67587-6,You have been treated with less respect than other people
67588-4,You have received poorer service than other people at restaurants or stores
67589-2,People have acted as if they think you are not smart
675-9,Enterobius vermicularis
67590-0,People have acted as if they are afraid of you
67591-8,People have acted as if they think you are dishonest
67592-6,People have acted as if they're better than you are
67593-4,You have been called names or insulted
67594-2,You have been threatened or harassed
May-59,Glucose^6H post 75 g glucose PO
67595-9,You have been followed around in stores
67596-7,The fresh fruits and vegetables in my neighborhood are of high quality
67597-5,A large selection of fresh fruits and vegetables is available in my neighborhood
67598-3,A large selection of low-fat products is available in my neighborhood
67601-5,This is a close-knit neighborhood
67602-3,People around here are willing to help their neighbors
Mar-60,Glucose^6H post 75 g glucose PO
67603-1,People in this neighborhood generally don't get along with each other
67604-9,People in this neighborhood do not share the same values
67605-6,People in this neighborhood can be trusted
67606-4,"If a group of neighborhood children were skipping school and hanging out on a street corner, how likely is that your neighbors would do something about it"
67607-2,"If some children were spray-painting graffiti on a local building, how likely is it that your neighbors would do something about it"
67608-0,"If a child was showing disrespect to an adult, how likely is it that people in your neighborhood would scold that child"
67609-8,"If there was a fight in front of your house and someone was being beaten or threatened, how likely is it that your neighbors would break it up"
67610-6,Suppose that because of budget cuts the fire station closest to your home was going to be closed down by the city. How likely is it that neighborhood residents would organize to try to do something to keep the fire station open
Jan-61,Glucose^1.5H post 50 g lactose PO
67611-4,"I feel safe walking in my neighborhood, day or night"
67612-2,Violence is not a problem in my neighborhood
67613-0,My neighborhood is safe from crime
67614-8,Teachers understand my problems
67615-5,Teachers and staff seem to take a real interest in my future
67616-3,Teachers are available when I need to talk with them
67617-1,It is easy to talk with teachers
67618-9,Students get along well with teachers
67619-7,"At my school, there is a teacher or some other adult who notices when I'm not there"
67620-5,Teachers at my school help us children with our problems
67621-3,My teachers care about me
67622-1,My teacher makes me feel good about myself
67623-9,My schoolwork is exciting
67624-7,Students can make suggestions on courses that are offered
67625-4,"Students are publicly recognized for their outstanding performances in speech, drama, art, music, etc"
67626-2,"If this school had an extra period during the day, I would take an additional academic class"
67627-0,This school makes students enthusiastic about learning
67628-8,Students are frequently rewarded or praised by faculty and staff for following school rules
Sep-62,Glucose^1.5H post 50 g lactose PO
67629-6,I usually understand my homework assignments
67630-4,Teachers make it clear what work needs to be done to get the grade I want
67631-2,I believe that teachers expect all students to learn
67632-0,I feel that I can do well in this school
67633-8,My teachers believe that I can do well in my school work
67634-6,I try hard to succeed in my classes
67635-3,Classroom rules are applied equally
67636-1,Problems in this school are solved by students and staff
Jul-63,Glucose^1.5H post 75 g glucose PO
67637-9,Students get in trouble if they do not follow school rules
67638-7,The rules of the school are fair
67639-5,School rules are enforced consistently and fairly
67640-3,My teachers make it clear to me when I have misbehaved in class
67641-1,Discipline is fair
67642-9,The school grounds are kept clean
67643-7,My school is neat and clean
67644-5,My school buildings are generally pleasant and well maintained
May-64,Glucose^post CFst
67645-2,My school is usually clean and tidy
67646-0,I am happy with kinds of students who go to my school
67647-8,"I am happy, in general, with the other students who go to my school"
67648-6,"At my school, the same person always gets to help the teacher"
67649-4,"At my school, the same kids get chosen every time to take part in after-school or special activities"
67650-2,"The same kids always get to use things, like a computer, a ball or a piano, when we play"
67651-0,I am happy about the number of tests I have
Feb-65,17-Hydroxypregnenolone
67652-8,I am happy about the amount of homework I have
67653-6,How close are you to this person
67654-4,How often do you see or talk to the person
67655-1,Do they trust doctors to take care of people's problems
67656-9,Has this person done any of the following for you or helped you out
67657-7,"Does this person hassle you, cause you problems, or make your life difficult"
67658-5,EMS exposures or injuries of EMS personnel
67659-3,EMS billing
6766-0,17-Ketosteroids
67660-1,EMS dispatch
67661-9,EMS disposition
67663-5,EMS protocol
67664-3,EMS response
67665-0,EMS scene
67666-8,EMS situation
67667-6,EMS times
67668-4,EMS physical assessment
67669-2,Alcohol - drug use
676-7,Microscopic observation
67670-0,Length-based tape measure category
67671-8,Have you ever been unfairly discouraged by a teacher or advisor from continuing your education
67672-6,Have you ever been unfairly prevented from moving into a neighborhood because the landlord or a realtor refused to sell or rent you a house or apartment
67673-4,Have you ever moved into a neighborhood where neighbors made life difficult for you or your family
67674-2,Someone in family died
67675-9,Was this a good or bad experience
67676-7,How much did the event affect you
67677-5,Family member was seriously injured
Aug-67,18-Hydroxycorticosteroids
67678-3,Saw crime - accident
67679-1,Lost a close friend
67680-9,Close friend was seriously sick - injured
67681-7,Negative change in parent's financial situation
67682-5,Drug - alcohol problem
67683-3,Got seriously sick or injured
67684-1,Parents argued more than previously
67685-8,Mother or father figure lost job
Jun-68,Alkaline phosphatase
67686-6,One parent was away from home more often
67687-4,Someone in the family was arrested
67688-2,Close friend died
67689-0,Mental - emotional problem
67690-8,Brother or sister left home
67691-6,Being a victim of crime - violence - assault
67692-4,Parents separated in last 12Mo
67693-2,Parents got into trouble with the law
Apr-69,Alkaline phosphatase
67694-0,Attended a new school
67695-7,Family moved
67696-5,Parents got divorced
67697-3,One of the parents went to jail
67698-1,Got new stepmother or stepfather
67699-9,Parent got a new job
67700-5,Got new brother or sister
67701-3,Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Palmitoylcarnitine (C16)
Feb-70,Alpha 1 antitrypsin phenotype
67703-9,Other infant factors that affect newborn screening interpretation
67704-7,Feeding types
67705-4,Other feeding types
67706-2,Maternal factors that affect newborn screening interpretation
67707-0,Other maternal factors that affect newborn screening interpretation
67708-8,Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)
67709-6,Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH)
6771-0,Alpha 1 antitrypsin
67710-4,Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)
67711-2,Glutarylcarnitine (C5-DC)+3-Hydroxyhexanoylcarnitine (C6-OH)/Octanoylcarnitine (C8)
67712-0,Center - CTR - ID number
67713-8,Diagnosing provider
67714-6,Diagnosing provider phone number
67715-3,Vendor device model type
67716-1,Vendor device model
67717-9,Image ID
67718-7,Reason for your hearing difficulty
67719-5,Which ear
67720-3,Occupation
67721-1,Age of onset of health-related event
67722-9,Cause of hearing problem
67723-7,Date of health-related event
67724-5,Length-based tape measure category
67725-2,Mycobacterium sp identified
67726-0,Rickettsia sp DNA
67727-8,Heart surgery operation
Aug-72,Apolipoprotein B
67728-6,"Have you been exposed to solvents such as thrichloroethylene, toluene, evaporations from paints or lacquers, for more than one Y in one of your jobs"
67730-2,Y exposure started
67732-8,Do you suffer from white finger syndrome or raynaud's syndrome caused by excessive vibration from pneumatic hammers or drills
67733-6,Have you ever worked for more than 1Y in a place where you had to raise your voice to make yourself heard by someone standing 1 mile away from you
67734-4,Most important noise sources
67735-1,Noise level
Jun-73,Creatine kinase.MB
67736-9,Noise dose
67737-7,How many Hs per D were you exposed
67738-5,Was this a constant loud noise or an impulse noise
67739-3,Have you ever smoked regularly
67740-1,At which age did you start smoking
67741-9,Smoking tobacco use duration
67742-7,How many drinks do you have on average
67743-5,"Do you drink alcohol regularly, every W"
Apr-74,Desethylamiodarone
67744-3,Approximately how many cigarettes did you smoke on average
67745-0,Name generator
67746-8,Person
67747-6,Section generator
67748-4,Total population
67749-2,Not hispanic or latino
677-5,Microscopic observation
67750-0,White alone
Jan-75,Androstanolone
67751-8,Black or african american alone
67752-6,American indian and alaska native alone
67753-4,Asian alone
67754-2,Native hawaiian and other pacific islander alone
67755-9,Some other race alone
67756-7,Two or more races alone
67757-5,"HEDIS 2012, 2013 Codes to identify colorectal cancer screening (COL-A)"
67758-3,"HEDIS 2012, 2013 Codes to identify anticonvulsant serum concentration monitoring tests - PHENobarbital (MPM-E)"
67759-1,"HEDIS 2012, 2013 Codes to identify anticonvulsant serum concentration monitoring tests (MPM-E)"
67760-9,HEDIS 2012 Codes to identify group A Streptococcus tests (CWP-D)
67761-7,"HEDIS 2012, 2013 Codes to identify HbA1c tests (CDC-D)"
67762-5,"HEDIS 2012, 2013 Codes to identify nephropathy screening tests (CDC-J)"
67763-3,"HEDIS 2012, 2013 Codes to identify physiologic monitoring tests - Blood urea nitrogen (BUN) (MPM-A)"
67764-1,"HEDIS 2012, 2013 Codes to identify physiologic monitoring tests - Serum creatinine (SCr) (MPM-A)"
67765-8,"HEDIS 2012, 2013 Codes to identify physiologic monitoring tests (MPM-A)"
67766-6,HEDIS 2012 Codes to identify sexually active women (CHL-B)
67767-4,HEDIS 2012 panel
67768-2,"HEDIS 2012, 2013 Tests used in early prenatal care - ABO & Rh (PPC-C)"
Sep-76,Estrone
67769-0,"HEDIS 2012, 2013 Tests used in early prenatal care - Cytomegalovirus (PPC-C)"
67770-8,"HEDIS 2012, 2013 Tests used in early prenatal care (PPC-C)"
67771-6,Nature of health problem
67772-4,Hospitalization sequence
67774-0,Primary sign and symptom
67775-7,Level of responsiveness
67776-5,Other symptoms
Jul-77,Glucose
67781-5,Summarization of encounter note
67782-3,Surgical operation date
67783-1,Have you ever had other operations not covered by the previous questions
67784-9,Individuals below poverty line
May-78,IgA
67785-6,Individuals on public assistance
67786-4,Female-headed households
67787-2,Unemployed
67788-0,Less than age 18
67789-8,Black
67790-6,Thromboelastography panel
67791-4,Does the patient take any medications
67792-2,Has the patient had any significant medical procedures
Mar-79,IgA
67793-0,Has the patient had any significant medical conditions
67794-8,Does the patient have any medication allergies
67795-5,"Vital signs, weight, height, head circumference & oximetry panel"
67796-3,EMS patient care report - version 3
67797-1,Did the encounter team administer any medications
67798-9,Did the encounter team perform any procedures
67799-7,EMS cardiac arrest event
67800-3,EMS injury incident description
Jan-80,IgG
67801-1,EMS vital signs
67802-9,EMS procedures
67803-7,Procedure
67804-5,Health-related conditions
67805-2,Cytomegalovirus Ag
67806-0,Measles virus Ag
67807-8,Mumps virus Ag
67808-6,Parainfluenza virus 1 Ag
67809-4,Parainfluenza virus 2 Ag
67810-2,Parainfluenza virus 3 Ag
67811-0,Parainfluenza virus 4 Ag
67812-8,Varicella zoster virus Ag
67813-6,Fatty casts
67814-4,Granulocytic cells/100 cells
67815-1,HTLV I Ab
67816-9,Trisomy 18+Trisomy 13 risk
67818-5,Parainfluenza virus 4a RNA
Sep-81,IgG
67819-3,Parainfluenza virus 4b RNA
67820-1,Human metapneumovirus A RNA
67821-9,Human metapneumovirus B RNA
67822-7,Fentanyl & Norfentanyl panel
67826-8,Neutrophils
Jul-82,IgG/Albumin
67827-6,Lymphocytes
67828-4,Macrophages
67829-2,Eosinophils
678-3,Microscopic observation
67830-0,Leukocytes other
67831-8,Erythrocytes
67832-6,Neutrophils
67833-4,Lymphocytes
67834-2,Macrophages
May-83,IgM
67835-9,Eosinophils
67836-7,Leukocytes other
67837-5,Cells counted.total
67838-3,Mephedrone
67839-1,"HEDIS 2012, 2013 Codes to identify exclusions (CHL-D)"
67840-9,EMS advance directives
67841-7,EMS allergies and adverse reactions
67842-5,EMS past medical history
Mar-84,IgM
67843-3,EMS social history
67844-1,EMS current medications
67845-8,Glasgow coma score.motor
67846-6,Glasgow coma score.verbal
67847-4,Glasgow coma score.eye
67848-2,Leukocyte clumps
67849-0,EMS medications administered
6785-0,Immunoglobulin light chains.kappa
67850-8,Medication allergies - RxNorm code
67851-6,Admission evaluation note
67852-4,Admission evaluation note
67853-2,Plan of care
67854-0,Education note
67855-7,Education note
67856-5,History and physical note
67857-3,Note
67858-1,Note
67859-9,Note
67860-7,Postoperative evaluation and management note
67861-5,Postoperative evaluation and management note
67862-3,Preoperative evaluation and management note
67865-6,Supervisory note
67866-4,Babesia identification panel
67867-2,Babesia sp identified
Aug-86,Immunoglobulin light chains.kappa
67868-0,"End stage renal disease medical evidence report, medicare entitlement &or patient registration - OMB CMS form 2728"
67869-8,Reason for medicare entitlement
67870-6,Patient information - end stage renal disease form 2728
67871-4,Patient demographics - end stage renal disease form 2728
67872-2,Medicare end stage renal disease coverage requested
67873-0,Cause of renal failure.primary
67874-8,Employment status - 6Mo prior to renal failure
67875-5,Employment status - current
Jun-87,Immunoglobulin light chains.kappa
67876-3,End stage renal disease co-morbidities ICD code
67877-1,End stage renal disease patients in dialysis treatment - end stage renal disease form 2728
67878-9,Facility name
67879-7,Dialysis facility NPI
67880-5,Transplant facility NPI
67881-3,Self-dialysis training facility NPI
67882-1,Functional status of transplant
67883-9,Transplant information - end stage renal disease form 2728
Apr-88,Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda
67884-7,Tribal enrollment
67885-4,Received exogenous erythropoetin or equivalent prior to end stage renal disease therapy
67886-2,Care by nephrologist prior to end stage renal disease therapy
67887-0,Care by kidney dietitian prior to end stage renal disease therapy
67888-8,Vascular access for first outpatient dialysis
67889-6,Neuro-Qol item bank - anxiety - version 1.0
67890-4,Neuro-Qol item bank - depression - version 1.0
67891-2,Neuro-Qol item bank - fatigue - version 1.0
Feb-89,Immunoglobulin light chains.lambda
67892-0,Neuro-Qol item bank - upper extremity - version 1.0
67893-8,Neuro-Qol item bank - lower extremity - version 1.0
67894-6,Neuro-Qol item bank - executive function - version 1.0
67895-3,Neuro-Qol item bank - general concerns - version 1.0
67896-1,Neuro-Qol item bank - emotional - behavioral dyscontrol - version 1.0
67897-9,Neuro-Qol item bank - positive affect - version 1.0
67898-7,Neuro-Qol item bank - sleep disturbance - version 1.0
67899-5,Neuro-Qol item bank - participate in social roles - version 1.0
Sep-67,Cefamandole
6790-0,Immunoglobulin light chains.lambda
67900-1,Neuro-Qol item bank - satisfaction with social roles - version 1.0
67901-9,Neuro-Qol item bank - stigma - version 1.0
67902-7,Neuro-Qol item scale - communication - version 1.0
67903-5,Neuro-Qol short form - anxiety - version 1.0
67904-3,Neuro-Qol short form - depression - version 1.0
67905-0,Neuro-Qol short form - fatigue - version 1.0
67906-8,Neuro-Qol short form - upper extremity - version 1.0
67907-6,Neuro-Qol short form - lower extremity - version 1.0
67908-4,Neuro-Qol short form - executive function - version 1.0
67909-2,Neuro-Qol short form - general concerns - version 1.0
679-1,Microscopic observation
67910-0,Neuro-Qol short form - emotional - behavioral - version 1.0
67911-8,Neuro-Qol short form - positive affect - version 1.0
67912-6,Neuro-Qol short form - participate in social roles - version 1.0
67913-4,Neuro-Qol short form - satisfaction with social roles - version 1.0
67914-2,Neuro-Qol short form - stigma - version 1.0
67915-9,I felt nervous when my normal routine was disturbed in the past 7D
67916-7,I felt fearful about my future in the past 7D
67917-5,I felt exhausted in the past 7D
Aug-91,Immunoglobulin light chains.lambda
67918-3,I felt that I had no energy in the past 7D
67919-1,I felt fatigued in the past 7D
67920-9,I was too tired to do my household chores in the past 7D
67921-7,I was too tired to leave the house in the past 7D
67922-5,I was frustrated by being too tired to do the things I wanted to do in the past 7D
67923-3,I felt tired in the past 7D
67924-1,I had to limit my social activity because I was tired in the past 7D
67925-8,I needed help doing my usual activities because of my fatigue in the past 7D
Jun-92,Potassium
67926-6,I needed to sleep during the day in the past 7D
67927-4,I had trouble starting things because I was too tired in the past 7D
67928-2,I had trouble finishing things because I was too tired in the past 7D
67929-0,I was too tired to take a short walk in the past 7D
67930-8,I was too tired to eat in the past 7D
67931-6,I was so tired that I needed to rest during the day in the past 7D
67932-4,I felt weak all over in the past 7D
67933-2,I needed help doing my usual activities because of weakness in the past 7D
Apr-93,Prealbumin
67934-0,I had to limit my social activity because I was physically weak in the past 7D
67935-7,I had to force myself to get up and do things because I was physically too weak in the past 7D
67936-5,Are you able to make a phone call using a touch tone key-pad
67937-3,How much difficulty do you currently have using a spoon to eat a meal
67938-1,How much difficulty do you currently have putting on a pullover shirt
67939-9,How much difficulty do you currently have taking off a pullover shirt
67940-7,How much difficulty do you currently have removing wrappings from small objects
67941-5,"How much difficulty do you currently have opening medications or vitamin containers, like childproof containers, small bottles"
Feb-94,Alpha 1 globulin
67942-3,"How much difficulty do you currently have standing up from an armless straight chair, like a dining room chair"
67943-1,How much difficulty do you currently have sitting down on and standing up from a chair with arms
67944-9,How much difficulty do you currently have moving from sitting at the side of the bed to lying down on your back
67945-6,"How much difficulty do you currently have standing up from a low, soft couch"
67946-4,"How much difficulty do you currently have going up and down a flight of stairs inside, using a handrail"
67947-2,"How much difficulty do you currently have walking on uneven surfaces, like grass, dirt road or sidewalk"
67948-0,How much difficulty do you currently have walking around one floor of your home
67949-8,"How much difficulty do you currently have taking a 20M brisk walk, without stopping to rest"
67950-6,"How much difficulty do you currently have walking on a slippery surface, outdoors"
67951-4,How much difficulty do you currently have climbing stairs step over step without a handrail - alternating feet
67952-2,How much difficulty do you currently have walking in a dark room without falling
67953-0,"How much difficulty do you currently have checking the accuracy of financial documents, like bills, checkbook, or bank statements"
67954-8,How much difficulty do you currently have counting the correct amount of money when making purchases
67955-5,"How much difficulty do you currently have reading and following complex instructions, like directions for a new medication"
67956-3,"How much difficulty do you currently have planning for and keeping appointments that are not part of your weekly routine, like a therapy or doctor appointment, or a social gathering with friends and family"
67957-1,How much difficulty do you currently have managing your time to do most of your daily activities
67958-9,How much difficulty do you currently have taking care of complicated tasks like managing a checking account or getting appliances fixed
Sep-95,Alpha 2 globulin
67959-7,"How much difficulty do you currently have keeping important personal papers such as bills, insurance documents and tax forms organized"
67960-5,How much difficulty do you currently have learning new tasks or instructions
67961-3,"How much difficulty do you currently have planning an activity several D in advance, like a meal, trip, or visit to friends"
67962-1,How much difficulty do you currently have getting things organized
67963-9,"How much difficulty do you currently have remembering where things were placed or put away, like keys"
67964-7,How much difficulty do you currently have remembering a list of 4 or 5 errands without writing it down
67965-4,"How much difficulty do you currently have keeping track of time, like using a clock"
67966-2,I had to read something several times to understand it in the past 7D
Jul-96,Transferrin saturation
67967-0,I had trouble keeping track of what I was doing if I was interrupted in the past 7D
67968-8,I had difficulty doing more than one thing at a time in the past 7D
67969-6,"I had trouble remembering new information, like phone numbers or simple instructions in the past 7D"
67970-4,I had trouble thinking clearly in the past 7D
67971-2,My thinking was slow in the past 7D
67972-0,I had to work really hard to pay attention or I would make a mistake in the past 7D
67973-8,I had trouble concentrating in the past 7D
67974-6,I made simple mistakes more easily in the past 7D
May-97,Cyclobenzaprine
67975-3,Words I wanted to use seemed to be on the tip of my tongue in the past 7D
67976-1,"I had trouble remembering whether I did things I was supposed to do, like taking a medicine or buying something I needed in the past 7D"
67977-9,I walked into a room and forgot what I meant to get or do there in the past 7D
67978-7,I had trouble remembering the name of a familiar person in the past 7D
67979-5,I reacted slowly to things that were said or done in the past 7D
67980-3,I had trouble forming thoughts in the past 7D
67981-1,I had trouble getting started on very simple tasks in the past 7D
67982-9,I had trouble making decisions in the past 7D
Mar-98,Metanephrines
67983-7,I had trouble planning out steps of a task in the past 7D
67984-5,It was hard to control my behavior in the past 7D
67985-2,I said or did things without thinking in the past 7D
67986-0,I got impatient with other people in the past 7D
67987-8,I was irritable around other people in the past 7D
67988-6,I was bothered by little things in the past 7D
67989-4,I became easily upset in the past 7D
67990-2,I was in conflict with others in the past 7D
Jan-99,Tricyclic antidepressants
67991-0,I felt impulsive in the past 7D
67992-8,People told me that I talked in a loud or excessive manner in the past 7D
67993-6,I said or did things that other people probably thought were inappropriate in the past 7D
67994-4,I suddenly became emotional for no reason in the past 7D
67995-1,I felt restless in the past 7D
67996-9,It was hard to adjust to unexpected changes in the past 7D
67997-7,I had a hard time accepting criticism from other people in the past 7D
67998-5,I threatened violence toward people or property in the past 7D
67999-3,Lately I had a sense of well being
68000-9,Lately I felt hopeful
68001-7,Lately my life was satisfying
68002-5,Lately my life had purpose
68003-3,Lately my life had meaning
68004-1,Lately I felt cheerful
68005-8,Lately my life was worth living
68006-6,Lately I had a sense of balance in my life
Jul-00,Spermatozoa.motile/100 spermatozoa
68007-4,"Lately, many areas of my life were interesting to me"
68008-2,Lately I was able to enjoy life
68009-0,Lately I felt a sense of purpose in my life
68010-8,Lately I could laugh and see the humor in situations
68011-6,Lately I was able to be at ease and feel relaxed
68012-4,Lately I looked forward with enjoyment to upcoming events
68013-2,Lately I felt emotionally stable
68014-0,Lately I felt lovable
May-01,Complement C3
68015-7,Lately I felt confident
68016-5,Lately I had a good life
68017-3,Lately my life was peaceful
68018-1,Lately I was living life to the fullest
68019-9,"Lately, in most ways, my life was close to my ideal"
68020-7,Lately I had good control of my thoughts
68021-5,"Lately, even when things were going badly, I still had hope"
68022-3,I had to force myself to get up in the morning in the past 7D
Mar-02,HLA-DR10
68023-1,I had trouble stopping my thoughts at bedtime in the past 7D
68024-9,I was sleepy during the daytime in the past 7D
68025-6,I had trouble sleeping because of bad dreams in the past 7D
68026-4,I had difficulty falling asleep in the past 7D
68027-2,Pain woke me up in the past 7D
68028-0,I avoided or cancelled activities with my friends because I was tired from having a bad night's sleep
68029-8,I felt physically tense during the middle of the night or early morning hours
68030-6,I can keep up with my family responsibilities in the past 7D
Jan-03,HLA-DR15
68031-4,I am able to do all of my regular family activities in the past 7D
68032-2,I am able to socialize with my friends in the past 7D
68033-0,I am able to do all of my regular activities with friends in the past 7D
68034-8,I can keep up with my social commitments in the past 7D
68035-5,I am able to participate in leisure activities in the past 7D
68036-3,I am able to perform my daily routines in the past 7D
68037-1,I can keep up with my work in the past 7D
68038-9,I have trouble meeting the needs of my family in the past 7D
68039-7,I have to limit my regular family activities in the past 7D
68040-5,I am able to do all of the family activities that people expect me to do in the past 7D
68041-3,I am able to do all of the family activities that I want to do in the past 7D
68042-1,I am able to maintain my friendships as much as I would like in the past 7D
68043-9,I can do everything for my friends that I want to do in the past 7D
68044-7,I am able to do all of the activities with friends that people expect me to do in the past 7D
68045-4,I feel limited in my ability to visit friends in the past 7D
68046-2,I am able to do all of the activities with friends that I want to do in the past 7D
68047-0,I feel limited in the amount of time I have to visit friends in the past 7D
68048-8,"I have to limit the things I do for fun at home, like reading, listening to music, etc in the past 7D"
Sep-04,HLA-DR52
68049-6,I am able to do all of my regular leisure activities in the past 7D
68050-4,I have to limit my hobbies or leisure activities in the past 7D
68051-2,I am able to do my hobbies or leisure activities in the past 7D
68052-0,I am able to do all of the community activities that I want to do in the past 7D
68053-8,I am able to do all of the leisure activities that people expect me to do in the past 7D
68054-6,I have to do my hobbies or leisure activities for shorter periods of time than usual for me in the past 7D
68055-3,I have to limit social activities outside my home in the past 7D
Jun-05,HLA-DR53
68056-1,I have trouble keeping in touch with others in the past 7D
68057-9,I can do all the leisure activities that I want to do in the past 7D
68058-7,I am able to do all of the community activities that people expect me to do in the past 7D
68059-5,I am able to go out for entertainment as much as I want in the past 7D
68060-3,I have to limit the things I do for fun outside my home in the past 7D
68061-1,I am doing fewer social activities with groups of people than usual for me in the past 7D
68062-9,I am able to run errands without difficulty in the past 7D
68063-7,I am able to do all of my usual work in the past 7D
Apr-06,HLA-DR6
68064-5,I am accomplishing as much as usual at work for me in the past 7D
68065-2,My ability to do my work is as good as it can be in the past 7D
68066-0,I can do everything for work that I want to do in the past 7D
68067-8,I have trouble doing my regular chores or tasks in the past 7D
68068-6,I am able to do all of the work that people expect me to do in the past 7D
68069-4,I am limited in doing my work in the past 7D
68070-2,I have to do my work for shorter periods of time than usual for me in the past 7D
68071-0,I am bothered by my limitations in regular family activities in the past 7D
Feb-07,HLA-DR8
68072-8,I am disappointed in my ability to socialize with my family in the past 7D
68073-6,I am bothered by limitations in my regular activities with friends in the past 7D
68074-4,I am disappointed in my ability to meet the needs of my friends in the past 7D
68075-1,I am satisfied with my ability to do household chores or tasks in the past 7D
68076-9,I feel that my family is disappointed in my ability to socialize with them in the past 7D
68077-7,I am disappointed in my ability to meet the needs of my family in the past 7D
68078-5,I am satisfied with my current level of activity with family members in the past 7D
68079-3,I feel that my friends are disappointed in my ability to socialize with them in the past 7D
6808-0,Aspergillus fumigatus 1 Ab
68080-1,I am disappointed in my ability to do things for my friends in the past 7D
68081-9,I am disappointed in my ability to socialize with friends in the past 7D
68082-7,I am disappointed in my ability to keep in touch with others in the past 7D
68083-5,I feel that others are disappointed in my ability to do community activities in the past 7D
68084-3,I am disappointed in my ability to do leisure activities in the past 7D
68085-0,I am bothered by limitations in doing my hobbies or leisure activities in the past 7D
68086-8,I feel that I am disappointing other people at work in the past 7D
68087-6,I am disappointed in my ability to perform my daily routines in the past 7D
68088-4,I am disappointed in my ability to work in the past 7D
68089-2,I am bothered by limitations in performing my daily routines in the past 7D
680-9,Microscopic observation
68090-0,I am disappointed in my ability to take care of personal and household responsibilities in the past 7D
68091-8,I am bothered by limitations in performing my work in the past 7D
68092-6,I am satisfied with my ability to take care of personal and household responsibilities in the past 7D
68093-4,I am satisfied with my ability to work in the past 7D
68094-2,"Lately, because of my illness, some people avoided me"
68095-9,"Lately, because of my illness, I felt left out of things"
68096-7,"Lately, because of my illness, people avoided looking at me"
68097-5,"Lately, I felt embarrassed about my illness"
Aug-09,Aspergillus fumigatus 6 Ab
68098-3,"Lately, because of my illness, some people seemed uncomfortable with me"
68099-1,"Lately, I felt embarrassed because of my physical limitations"
68100-7,"Lately, because of my illness, people were unkind to me"
68101-5,"Lately, some people acted as though it was my fault I have this illness"
68102-3,"Lately, because of my illness, I felt emotionally distant from other people"
68103-1,"Lately, because of my illness, people made fun of me"
68104-9,"Lately, because of my illness, I felt embarrassed in social situations"
68105-6,"Lately, because of my illness, strangers tended to stare at me"
Jun-10,Aureobasidium pullulans Ab
68106-4,"Lately, because of my illness, I worried about other people's attitudes towards me"
68107-2,"Lately, because of my illness, I was treated unfairly by others"
68108-0,"Lately, I was unhappy about how my illness affected my appearance"
68109-8,"Lately, because of my illness, it was hard for me to stay neat and clean"
68110-6,"Lately, because of my illness, people tended to ignore my good points"
68111-4,"Lately, because of my illness, I worried that I was a burden to others"
68112-2,"Lately, I felt embarrassed about my speech"
68113-0,"Lately, because of my illness, I felt different from others"
Apr-11,Dengue virus Ab.IgG
68114-8,"Lately, I tended to blame myself for my problems"
68115-5,"Lately, I avoided making new friends to avoid telling others about my illness"
68116-3,"Lately, people with my illness lost their jobs when their employers found out about it"
68117-1,"Lately, I lost friends by telling them that I have this illness"
68118-9,"How much difficulty do you currently have writing notes to yourself, such as appointments or to do lists"
68119-7,How much difficulty do you currently have understanding family and friends on the phone
68120-5,"How much difficulty do you currently have carrying on a conversation with a small group of familiar people, like family or a few friends"
68121-3,How much difficulty do you currently have organizing what you want to say
Feb-12,Dengue virus Ab.IgM
68122-1,How much difficulty do you currently have speaking clearly enough to use the telephone
68123-9,Circulating tumor cells.prostate
68124-7,Circulating tumor cells.colon
68125-4,Neuro-Qol pediatric item bank - stigma - version 1.0
68126-2,Neuro-Qol pediatric item bank - depression - version 1.0
68127-0,Neuro-Qol pediatric item bank - anxiety - version 1.0
68128-8,Neuro-Qol pediatric item bank - anger - version 1.0
68129-6,Neuro-Qol pediatric item bank - peer interaction - version 1.0
6813-0,Echovirus 16 Ab
68130-4,Neuro-Qol pediatric item bank - adult interaction - version 1.0
68131-2,Neuro-Qol pediatric item bank - general concerns - version 1.0
68132-0,Neuro-Qol pediatric item bank - fatigue - version 1.0
68133-8,Neuro-Qol pediatric item bank - pain - version 1.0
68134-6,Neuro-Qol pediatric item scale - lower extremity - version 1.0
68135-3,Neuro-Qol pediatric item scale - upper extremity - version 1.0
68136-1,Neuro-Qol pediatric short form - anxiety - version 1.0
68137-9,Neuro-Qol pediatric short form - stigma - version 1.0
68138-7,Neuro-Qol pediatric short form - depression - version 1.0
68139-5,Neuro-Qol pediatric short form - peer interaction - version 1.0
68140-3,Neuro-Qol pediatric short form - general concerns - version 1.0
68141-1,Neuro-Qol pediatric short form - fatigue - version 1.0
68142-9,"Lately, because of my illness, others my age avoided me"
68143-7,"Lately, because of my illness, I felt left out of things"
68144-5,"Lately, because of my illness, others my age made fun of me"
68145-2,"Lately, because of my illness, I felt embarrassed when I was in front of others my age"
68146-0,"Lately, because of my illness, I was treated unfairly by others my age"
68147-8,"Lately, because of my illness, others my age tended to ignore my good points"
Aug-14,Epstein Barr virus early Ab.IgG
68148-6,"Lately, because of my illness, I felt different from others my age"
68149-4,Lately I avoided making new friends to avoid talking about my illness
68150-2,"Lately, because of my illness, others my age bullied me"
68151-0,"Lately, because of my illness, others my age seemed uncomfortable with me"
68152-8,"Lately, because of my illness, others my age were mean to me"
68153-6,"Lately, because of my illness, others my age tended to stare at me"
68154-4,"Lately, because of my illness, I worried about what others my age thought about me"
May-15,Epstein Barr virus nuclear Ab.IgM
68155-1,Lately I was unhappy about how my illness affected my appearance
68156-9,"Lately, because of my illness, I worried that I made life harder for my parents or guardians"
68157-7,Lately I felt embarrassed about my illness
68158-5,Lately I felt embarrassed about the way I talk
68159-3,Lately I lost friends by telling them that I have this illness
68160-1,I felt too sad to do things with friends in the past 7D
68161-9,I was less interested in doing things I usually enjoy in the past 7D
68162-7,It was hard for me to care about anything in the past 7D
Mar-16,Histoplasma capsulatum mycelial phase Ab
68163-5,I was bored in the past 7D
68164-3,I felt frustrated in the past 7D
68165-0,My mood swings from good feelings to bad feelings in the past 7D
68166-8,I had trouble sleeping in the past 7D
68167-6,I felt that no one loved me in the past 7D
68168-4,I cried more often than usual in the past 7D
68169-2,I felt too sad to do my schoolwork in the past 7D
681-7,Microscopic observation
68170-0,I felt afraid to go out alone in the past 7D
Jan-17,Histoplasma capsulatum yeast phase Ab
68171-8,Being worried made it hard for me to be with my friends in the past 7D
68172-6,It was hard to do schoolwork because I was nervous or worried in the past 7D
68173-4,I felt afraid in the past 7D
68174-2,I worry that my health might get worse in the past 7D
68175-9,I worry about doing well in school in the past 7D
68176-7,I become anxious when I go back to the hospital or clinic in the past 7D
68177-5,I worry about how my health will affect my future in the past 7D
68178-3,"Because of my health, I worry about having a boyfriend or girlfriend in the past 7D"
68179-1,I worry about getting a good job because of my medical condition in the past 7D
68180-9,I get nervous more easily than other people in the past 7D
68181-7,I worried when I was away from my family in the past 7D
68182-5,I got scared easily in the past 7D
68183-3,I was worried that I might die in the past 7D
68184-1,"Because of my health, I worry about being able to go to college in the past 7D"
68185-8,"Because of my health, I worry about getting a job to support myself in the past 7D"
68186-6,Being angry made it hard for me to be with my friends in the past 7D
68187-4,It was hard to do schoolwork because I was angry in the past 7D
68188-2,I felt angry in the past 7D
Sep-18,Saccharopolyspora rectivirgula Ab
68189-0,I was so mad that I felt like throwing something in the past 7D
68190-8,I was so mad that I felt like hitting something in the past 7D
68191-6,I was so mad that I felt like yelling at someone in the past 7D
68192-4,I was so mad that I felt like breaking things in the past 7D
68193-2,I was so mad that I acted grouchy towards other people in the past 7D
68194-0,I felt close to my friends in the past 7D
68195-7,I felt comfortable with others my age in the past 7D
68196-5,I was happy with the friends I had in the past 7D
Jul-19,Streptococcus sp Ab
68197-3,I felt comfortable talking with my friends in the past 7D
68198-1,I had fun with my friends in the past 7D
68199-9,I was able to talk openly with my friends in the past 7D
68200-5,I was able to stand up for myself in the past 7D
68201-3,I think I have fewer friends than other people my age in the past 7D
68202-1,My friends ignored me in the past 7D
68203-9,I wanted to spend time with my friends in the past 7D
68204-7,I did things with other kids my age in the past 7D
May-20,Streptococcus sp Ab
68205-4,I got along with my parents or guardians in the past 7D
68206-2,I felt loved by my parents or guardians in the past 7D
68207-0,I was happy at home in the past 7D
68208-8,My parents or guardians spent enough time with me in the past 7D
68209-6,I got along well with my teachers in the past 7D
68210-4,My teachers accepted me in the past 7D
68211-2,My teachers respected me in the past 7D
68212-0,My parents or guardians seem to know what's important to me in the past 7D
Mar-21,Thermoactinomyces vulgaris Ab
68213-8,I felt comfortable talking with my parents or guardians in the past 7D
68214-6,I forget schoolwork that I need to do
68215-3,I sometimes forget what I was going to say
68216-1,I react slower than most people my age when I play games
68217-9,I forget things easily
68218-7,I have trouble remembering to do things like school projects
68219-5,It is hard for me to concentrate in school
68220-3,I have trouble paying attention to the teacher
Jan-22,Nuclear Ab
68221-1,I have to work really hard to pay attention or I will make a mistake
68222-9,I have a hard time keeping track of my homework
68223-7,I forget to bring books or worksheets home that I need for homework
68224-5,I have to read something several times to understand it
68225-2,It is hard for me to find the right words to say what I mean
68226-0,It takes me longer than other people to get my schoolwork done
68227-8,I have to use written lists more often than other people my age so I will not forget things
68228-6,I felt tired in the past 7D
68229-4,I had trouble starting things because I was too tired in the past 7D
68230-2,I had trouble finishing things because I was too tired in the past 7D
68231-0,I needed to sleep during the day in the past 7D
68232-8,Being tired made it hard to play or go out with my friends as much as I would like in the past 7D
68233-6,I was too tired to eat in the past 7D
68234-4,Being tired makes me sad in the past 7D
68235-1,Being tired makes me mad in the past 7D
68236-9,I had energy or strength in the past 7D
68237-7,I could do my usual things at home in the past 7D
68238-5,I got upset by being too tired to do things I wanted to do in the past 7D
Sep-23,Rheumatoid factor
68239-3,I needed help doing my usual things at home in the past 7D
68240-1,I felt weak in the past 7D
68241-9,I had so much pain that I had to stop what I was doing in the past 7D
68242-7,I had pain in the past 7D
68243-5,"When you had pain, how long did it last in the past 7D"
68244-3,I had trouble watching TV when I had pain in the past 7D
68245-0,It was hard for me to play or hang out with my friends when I had pain in the past 7D
68246-8,I could walk for 15M in the past 7D
Jul-24,Color
68247-6,I could walk between rooms in the past 7D
68248-4,I could get on and off the toilet without using my arms in the past 7D
68249-2,I could get on and off a low chair in the past 7D
682-5,Microscopic observation
68250-0,I could get up from the floor by myself in the past 7D
68251-8,I could sit on a bench without support for 15M in the past 7D
68252-6,I could stand on my tiptoes to reach for something in the past 7D
68253-4,"I could stand on my tiptoes to put something, like a 5 lb bag of sugar, on a shelf in the past 7D"
Apr-25,Crystals
68254-2,I fall down easily in the past 7D
68255-9,I could walk on slightly uneven surfaces such as cracked pavement in the past 7D
68256-7,"I could walk on rough, uneven surfaces such as lawns, gravel driveway in the past 7D"
68257-5,I could walk up and down ramps or hills in the past 7D
68258-3,I could walk up and down curbs in the past 7D
68259-1,I could get in and out of a bus in the past 7D
68260-9,I could walk while wearing a backpack full of books in the past 7D
68261-7,I could do exercise that others my age can do in the past 7D
Feb-26,Crystals
68262-5,I could move up and down curbs using a wheelchair in the past 7D
68263-3,I could move up and down inclines or ramps using a wheelchair in the past 7D
68264-1,"I could move on rough, uneven surfaces like lawns or gravel driveway using a wheelchair in the past 7D"
68265-8,I could move between my wheelchair and another seat such as a chair or bed in the past 7D
68266-6,"I could move around within a room, including making turns in my wheelchair in the past 7D"
68267-4,I could manage getting on and off the tub bench from a wheelchair in the past 7D
68268-2,I could manage getting on and off the toilet from a wheelchair in the past 7D
68269-0,I could stand up from an armless straight chair using my wheelchair in the past 7D
6827-0,Bacitracin
68270-8,"I could move on slightly uneven surfaces, cracked pavement, using a wheelchair in the past 7D"
68271-6,I could move for 30M using a wheelchair in the past 7D
68272-4,I could park a wheelchair in a narrow space like in an elevator in the past 7D
68273-2,I could back out of an elevator in a wheelchair if there was no room to turn around in the past 7D
68274-0,"I could do a wheelie, like popping front wheels off the floor and balancing on back wheels, using my wheelchair in the past 7D"
68275-7,I could reach for a high object from my wheelchair in the past 7D
68276-5,I could reverse direction in my wheelchair in the past 7D
68277-3,I could open a door that faced away from my wheelchair in the past 7D
68278-1,I could open a door that was facing my wheelchair in the past 7D
68279-9,I could lock and unlock my wheelchair brakes in the past 7D
68280-7,I could manage the armrests on my wheelchair
68281-5,I could manage the footrests on my wheelchair
68282-3,I could move for 15M using a wheelchair in the past 7D
68283-1,"With a walking aid, I could walk for 15M in the past 7D"
68284-9,"With a walking aid, I could walk for 30M in the past 7D"
68285-6,"With a walking aid, I could walk on slightly uneven surfaces, cracked pavement in the past 7D"
68286-4,"With a walking aid, I could walk on rough, uneven surfaces like lawns or gravel driveway in the past 7D"
68287-2,"With a walking aid, I could walk up and down inclines or ramps in the past 7D"
Aug-28,Alternaria alternata Ab.IgE
68288-0,"With a walking aid, I could walk up and down curbs in the past 7D"
68289-8,"With a walking aid, I could open and close inside or outside doors to walk between rooms in the past 7D"
68290-6,"With a walking aid, I could walk within a room in the past 7D"
68291-4,"With a walking aid, I could walk across the room in the past 7D"
68292-2,"With a walking aid, I could walk up stairs without holding on to anything in the past 7D"
68293-0,With a walking aid I could get in and out of a car in the past 7D
68294-8,I was able to use my fingers to point to something in the past 7D
68295-5,I was able to take off my socks in the past 7D
Jun-29,Amoxicillin Ab.IgE
68296-3,I was able to put on and fasten my pants by myself in the past 7D
68297-1,I was able to button and unbutton my shirt in the past 7D
68298-9,I was able to use a spoon to bring food up to my mouth in the past 7D
68299-7,I was able to wipe myself thoroughly after using the toilet in the past 7D
68300-3,I was able to pull my pants back up after using the toilet in the past 7D
68301-1,I was able to hold a plate full of food in the past 7D
68302-9,I was able to cut a piece of paper in half with scissors in the past 7D
68303-7,I was able to take a shower by myself in the past 7D
Apr-30,Aspergillus niger Ab.IgE
68304-5,I was able to take a bath by myself in the past 7D
68305-2,I was able to make a phone call using a touch tone key-pad in the past 7D
68306-0,I was able to get out of bed by myself in the past 7D
68307-8,I was able to put on my shoes by myself in the past 7D
68308-6,I was able to open a jar by myself in the past 7D
68309-4,I was able to put toothpaste on my toothbrush by myself in the past 7D
68310-2,I was able to brush my teeth by myself in the past 7D
68311-0,I was able to dry my back with a towel in the past 7D
Feb-31,Bean green Ab.IgE
68312-8,I was able to put on my clothes by myself in the past 7D
68313-6,I was able to zip up my clothes in the past 7D
68314-4,Meperidine & Normeperidine panel
68315-1,Transcortin & Cortisol.free panel
68317-7,"Metanephrine, Normetanephrine & Creatinine panel"
68318-5,Hypoglycemics panel
6832-0,Fraxinus latifolia Ab.IgE
68320-1,Polio virus Ab panel
68321-9,I worried about dying in the past 7D
68322-7,I had a lot of pain in the past 7D
68323-5,My pain was so bad that I needed to take medicine for it in the past 7D
68324-3,von Willebrand factor.activity actual/Normal
68325-0,Coagulation thrombin induced actual/Normal
68326-8,Coagulation reptilase induced actual/Normal
68327-6,Age
68328-4,Previous fetus defect
68329-2,Country of origin
683-3,Mycoplasma sp.genital identified
68330-0,CMS certification number - CCN
68332-6,Donor
68333-4,Date return to dialysis after failed transplant
68334-2,Current dialysis treatment site
68335-9,Self-dialysis training facility name
68336-7,Self-dialysis training
68337-5,Self-dialysis training
Aug-33,Cat dander Ab.IgE
68338-3,Is patient expected to complete training
68339-1,Date self-dialysis training completion
68340-9,Attending physician phone number
68341-7,Dialysis at time of death
68343-3,Cause of death.primary
68344-1,Were there secondary causes of death
68345-8,Cause of death.secondary
Jun-34,Cat hair+Cat epithelium Ab.IgE
68346-6,Cause of death.other
68347-4,Renal replacement therapy discontinued prior to death
68348-2,Reason renal replacement therapy discontinued
68349-0,Date last dialysis treatment
68350-8,Discontinuation renal replacement therapy request of patient or family
68351-6,Date most recent transplant
68352-4,Graft functioning at death
Mar-35,Brassica oleracea var botrytis Ab.IgE
68353-2,Did patient resume chronic maintenance dialysis prior to death
68354-0,Hospice prior to death
68355-7,Date signed
68356-5,Form version
68357-3,Self-dialysis training physician NPI
68358-1,Date chronic dialysis began
68359-9,End stage renal disease death notification - OMB CMS form 2746
68360-7,Transplant options given to patient
Jan-36,Chicken serum proteins Ab.IgE
68361-5,Reasons patient not informed of transplant option
68362-3,Date self-dialysis training began
68363-1,Oxygen saturation
68364-9,Pincer cells
68366-4,Bacteria identified
68367-2,Bilirubin
68368-0,Leukocytes
68369-8,Nuclear Ab
68370-6,Nuclear Ab
68371-4,Nuclear Ab
68372-2,Nuclear Ab
68373-0,Nuclear Ab
68374-8,Nuclear Ab
68375-5,Nuclear Ab
68376-3,Nuclear Ab
68377-1,Ribonucleoprotein extractable nuclear 63kD Ab
68378-9,Leukocytes.disintegrated/100 leukocytes
Sep-37,Cinnamomum spp Ab.IgE
68379-7,Phenylbutazone
68380-5,Chromatin Ab
68381-3,pH
68382-1,pH
68383-9,Microscopic observation
68384-7,Specific gravity
68385-4,Glomerular basement membrane Ab
68386-2,Glomerular basement membrane Ab.IgG
Jul-38,Cockatiel droppings Ab.IgE
68387-0,Lactate dehydrogenase
68388-8,DNA double strand Ab.IgG
68389-6,DNA double strand Ab.IgG
68391-2,Specimen volume
68392-0,Basophils
68393-8,Basophils
68394-6,Basophils
May-39,Cryptostroma corticale Ab.IgE
68395-3,Basophils
68396-1,Basophils/100 leukocytes
68397-9,Basophils
68398-7,Eosinophils
68399-5,Eosinophils
68400-1,Eosinophils
68401-9,Eosinophils
68402-7,Eosinophils
Mar-40,Gerbil Ab.IgE
68403-5,Eosinophils/100 leukocytes
68404-3,Lymphocytes
68405-0,Lymphocytes
68406-8,Lymphocytes.abnormal/100 leukocytes
68407-6,Lymphocytes
68408-4,Macrophages
68409-2,Macrophages
684-1,Mycoplasma sp.respiratory identified
68410-0,Macrophages
Jan-41,Vitis vinifera Ab.IgE
68411-8,Macrophages
68412-6,Macrophages/100 leukocytes
68413-4,Macrophages
68414-2,Mesothelial cells
68415-9,Mesothelial cells
68416-7,Mesothelial cells
68417-5,Mesothelial cells
68418-3,Mesothelial cells/100 leukocytes
68419-1,Mesothelial cells
68420-9,Monocytes
68421-7,Monocytes
68422-5,Monocytes
68423-3,Monocytes/100 leukocytes
68424-1,Monocytes
68425-8,Neutrophils
68426-6,Neutrophils/100 leukocytes
68427-4,Neutrophils
68428-2,Leukocytes other
Sep-42,Hippoglossus hippoglossus Ab.IgE
68429-0,Leukocytes other
68430-8,Leukocytes other
68431-6,Leukocytes other
68432-4,Leukocytes other/100 leukocytes
68433-2,Leukocytes other
68434-0,Leukocytes
68435-7,Erythrocytes
68436-5,Appearance
Jul-43,Apis mellifera Ab.IgE
68437-3,Smudge cells
68438-1,Calcidiol+ercalcidiol
68439-9,Gabapentin
68440-7,Gamma hydroxybutyrate
68441-5,Gamma hydroxybutyrate
68442-3,Dialysis setting.primary
68443-1,Dialysis.primary
68444-9,Date chronic dialysis began at current facility
May-44,Apis mellifera Ab.IgE
68445-6,Date transplant
68446-4,Transplant facility name
68447-2,Date transplant admission
68448-0,Dialysis sessions per W
68449-8,Arteriovenous fistula maturity
68450-6,Graft maturity
68451-4,Self-dialysis training program - end stage renal disease form 2728
Feb-45,Latex glove extract ammoniated Ab.IgE
68452-2,Lactate dehydrogenase
68453-0,Lactate dehydrogenase
68454-8,Phenylbutazone
68455-5,Appearance
68456-3,Transplant preparation facility NPI
68457-1,Enterovirus & Parechovirus A RNA
68458-9,Trichomonas sp identified
68459-7,pH
6846-0,Latex glove extract buffered Ab.IgE
68460-5,Picornavirus Ag
68461-3,Payment source
68462-1,Physician information - end stage renal disease form 2728
68463-9,Rilpivirine
68464-7,Insulin^1.25H post XXX challenge
68465-4,Insulin^1.75H post XXX challenge
68466-2,Epstein-Barr virus-encoded RNA 1
68467-0,APOB+LDLR+PCSK9 gene targeted mutation analysis
68468-8,Attending physician NPI
68469-6,Consultation note
68470-4,Initial evaluation note
68471-2,Admission evaluation note
68472-0,Progress note
68473-8,Progress note
68474-6,Restraint note
68475-3,Progress note
68476-1,Restraint note
68477-9,Education note
Aug-47,Chenopodium ambrosioides Ab.IgE
68478-7,Progress note
68479-5,Progress note
68480-3,Progress note
68481-1,Progress note
68482-9,Transfer summary note
68483-7,Admission evaluation note
68484-5,Progress note
68485-2,Progress note
Jun-48,Agaricus hortensis Ab.IgE
68486-0,Consultation note
68487-8,Medical - surgical history - ICD-9 and 10 codes
68488-6,State
68489-4,Dialysis Hs per session
68490-2,Transplant preparation facility name
68491-0,Self-dialysis training physician name
68492-8,Date last prenatal visit
68493-6,Prenatal visits for this pregnancy
Apr-49,Quercus alba Ab.IgE
68494-4,Body weight^at delivery
68496-9,Live births.now dead
68497-7,Previous cesarean deliveries
68498-5,Patient medication information section
68499-3,Date last live birth
68500-8,Date last other pregnancy outcome
68501-6,Serotonin release.heparin.unfractionated & low molecular weight panel
Feb-50,Carica papaya Ab.IgE
68502-4,Treponema pallidum Ab.IgG & IgM panel
68503-2,How well do you speak English
68504-0,What language do you feel most comfortable speaking with your doctor or nurse
68505-7,Current occupational status
68506-5,What is the highest grade or level of schooling you completed
68507-3,Did you ever serve on active duty in the armed forces of the U.S.
68508-1,How many children under the age of 18 live in your household
68509-9,Not able to stop or control worrying in the last 2W
6851-0,Penicillin G Ab.IgE
68510-7,How many times a W did you eat fast food or snacks or pizza in past 7D
68511-5,How many servings of fruits-vegetables did you eat each D in past 7D
68512-3,"How many soda and sweetened drinks, regular, not diet, did you drink each D in past 7D"
68513-1,How many D in the past W did you miss taking one or more of your medications
68514-9,Reason you fail to take doses of your medications
68515-6,"How many D of moderate to strenuous exercise, like a brisk walk, did you do in the last 7D"
68516-4,"On those D that you engage in moderate to strenuous exercise, how many M, on average, do you exercise"
68517-2,How many times in the past Y have you have X or more drinks in a D
68518-0,How often do you have a drink containing alcohol
68519-8,How many standard drinks containing alcohol do you have on a typical D
68520-6,How often do you have 6 or more drinks on 1 occasion
68521-4,"How much stress have you been experiencing in the past W, including today"
68522-2,To what extent did the following common sources contributed to your overall stress in the last W
68523-0,Sources of stress
68524-8,How many times in the past Y have you used an illegal drug or used a prescription medication for non-medical reasons
68525-5,"In the past Y, have you used drugs other than those required for medical reasons"
68526-3,Do you abuse more than one drug at a time
68527-1,Are you always able to stop using drugs when you want to
Aug-52,Pepper green Ab.IgE
68528-9,Have you had blackouts or flashbacks as a result for drug use
68529-7,Do you ever feel bad or guilty about your drug use
68530-5,Does your spouse or parent ever complain about your involvement with drugs
68531-3,Have you neglected your family because of your use of drugs
68532-1,Have you engaged in illegal activities in order to obtain drugs
68533-9,"Have you ever experienced withdrawal symptoms, felt sick, when you stopped taking drugs"
68534-7,Have you had medical problems as a result of your drug use
68535-4,Have you used tobacco in the last 30D
Jun-53,Prunus domestica Ab.IgE
68536-2,Have you used smokeless tobacco product in the last 30D
68537-0,Would you be interested in quitting tobacco use within the next few W
68538-8,Did you provide brief counseling-coaching to quit
68539-6,Did you prescribe or recommend that the patient use one of the 7 FDA - approved medications for tobacco cessation
68540-4,Did you refer the patient to your states tobacco quitline
68541-2,HYDROmorphone
68542-0,Codeine
68543-8,oxyCODONE
Apr-54,Cucurbita pepo Ab.IgE
68544-6,HYDROcodone
68545-3,Erythrocytes.nucleated/100 leukocytes
68546-1,Mycoplasma hominis DNA
68547-9,Ureaplasma sp DNA
68548-7,Aquaporin 4 water channel Ab.IgG
68549-5,U2 small nuclear ribonucleoprotein Ab
68550-3,Preoperative evaluation and management note
Jan-55,Phragmites communis Ab.IgE
68551-1,Consultation note
68552-9,Admission evaluation note
68553-7,Initial evaluation note
68554-5,Progress note
68555-2,Letter
68556-0,Diagnostic study note
68557-8,Diagnostic study note
68558-6,Discharge summary note
68560-2,History and physical note
68561-0,Note
68562-8,Preoperative evaluation and management note
68563-6,Procedure note
68564-4,Progress note
68565-1,Transfer summary note
68566-9,Consultation note
68567-7,Letter
68568-5,Progress note
Sep-56,Spinacia oleracea Ab.IgE
68569-3,Transfer summary note
68570-1,Consultation note
68571-9,Letter
68572-7,Discharge summary note
68573-5,History and physical note
68574-3,Progress note
68575-0,Consultation note
68576-8,Letter
Jul-57,Picea excelsa Ab.IgE
68577-6,Diagnostic study note
68578-4,Discharge summary note
685-8,Mycoplasma sp.respiratory identified
68580-0,History and physical note
68581-8,Preoperative evaluation and management note
68582-6,Progress note
68583-4,Transfer summary note
68584-2,Consultation note
May-58,Loligo sp Ab.IgE
68585-9,Letter
68586-7,Consultation note
68587-5,Medication management note
68589-1,Progress note
68590-9,Consultation note
68591-7,Discharge summary note
68592-5,History and physical note
Mar-59,Nicotiana tabacum Ab.IgE
68593-3,Letter
68594-1,Preoperative evaluation and management note
68595-8,Progress note
68596-6,Transfer summary note
68597-4,Consultation note
68598-2,Letter
68599-0,History and physical note
Jan-60,Trichophyton rubrum Ab.IgE
68601-4,Note
68602-2,Summary note
68603-0,Summary note
68604-8,Diagnostic study note
68605-5,Education note
68606-3,Postoperative evaluation and management note
68607-1,Progress letter
68608-9,Summary note
68609-7,Letter
68610-5,Postoperative evaluation and management note
68611-3,Diagnostic study note
68612-1,Discharge summary note
68614-7,History and physical note
68615-4,Note
68616-2,Preoperative evaluation and management note
68617-0,Progress note
68618-8,Transfer summary note
Sep-61,Vanilla planifolia Ab.IgG
68619-6,Consultation note
68620-4,Letter
68621-2,Note
68622-0,History and physical note
68623-8,Preoperative evaluation and management note
68624-6,Letter
68625-3,Diagnostic study note
68626-1,Discharge summary note
Jul-62,Salix nigra Ab.IgE
68628-7,History and physical note
68629-5,Note
68630-3,Procedure note
68631-1,Progress note
68632-9,Transfer summary note
68633-7,Consultation note
68634-5,Letter
May-63,Prolymphocytes
68635-2,Diagnostic study note
68636-0,Note
68637-8,History and physical note
68638-6,Preoperative evaluation and management note
68639-4,Consultation note
68640-2,Diagnostic study note
68641-0,Diagnostic study note
68642-8,Discharge summary note
Mar-64,Hemoglobin S
68644-4,History and physical note
68645-1,Note
68646-9,Progress note
68647-7,Transfer summary note
68648-5,Consultation note
68649-3,Letter
6865-0,1-Methylhistidine
68650-1,Note
68651-9,Consultation note
68652-7,Diagnostic study note
68653-5,Discharge summary note
68655-0,History and physical note
68656-8,Note
68657-6,Preoperative evaluation and management note
68658-4,Procedure note
68659-2,Progress note
686-6,Mycoplasma sp.respiratory identified
68660-0,Transfer summary note
68661-8,Consultation note
68662-6,Letter
68663-4,Discharge summary note
68665-9,History and physical note
68666-7,Note
68667-5,Procedure note
Aug-66,17-Hydroxycorticosteroids
68668-3,Progress note
68669-1,Transfer summary note
68670-9,Consultation note
68671-7,Letter
68672-5,Note
68673-3,Diagnostic study note
68674-1,Discharge summary note
Jun-67,3-Methylhistidine
68676-6,History and physical note
68677-4,Note
68678-2,Preoperative evaluation and management note
68679-0,Progress note
68680-8,Transfer summary note
68681-6,Consultation note
68682-4,Letter
68683-2,History and physical note
Apr-68,Adenosine monophosphate.cyclic
68684-0,Letter
68685-7,Consultation note
68686-5,Letter
68687-3,Diagnostic study note
68688-1,Discharge summary note
68690-7,History and physical note
68691-5,Preoperative evaluation and management note
Feb-69,Allo-tetrahydrocortisol
68692-3,Procedure note
68693-1,Progress note
68694-9,Consultation note
68695-6,Letter
68696-4,Diagnostic study note
68697-2,Discharge summary note
68699-8,History and physical note
Jul-68,Cefamandole
6870-0,Alpha aminobutyrate
68700-4,Note
68701-2,Preoperative evaluation and management note
68702-0,Procedure note
68703-8,Progress note
68704-6,Transfer summary note
68705-3,Consultation note
68706-1,Diagnostic study note
68707-9,Letter
68708-7,Diagnostic study note
68709-5,Discharge summary note
68711-1,History and physical note
68712-9,Note
68713-7,Preoperative evaluation and management note
68714-5,Procedure note
68715-2,Transfer summary note
68716-0,Consultation note
68717-8,Letter
Aug-71,Anserine
68718-6,Diagnostic study note
68719-4,Discharge summary note
68721-0,History and physical note
68722-8,Note
68723-6,Preoperative evaluation and management note
68724-4,Procedure note
68725-1,Progress note
Jun-72,Beta alanine
68726-9,Transfer summary note
68727-7,Consultation note
68728-5,Letter
68729-3,Procedure note
68731-9,History and physical note
68732-7,Preoperative evaluation and management note
68733-5,Discharge summary note
Apr-73,Beta hydroxybutyrate
68735-0,History and physical note
68736-8,Preoperative evaluation and management note
68737-6,Transfer summary note
68738-4,Discharge summary note
687-4,Mycoplasma sp & Ureaplasma sp
68740-0,History and physical note
68741-8,Note
Feb-74,Calcium
68742-6,Preoperative evaluation and management note
68743-4,Procedure note
68744-2,Progress note
68745-9,Transfer summary note
68746-7,Consultation note
68747-5,Letter
68748-3,Diagnostic study note
68749-1,Discharge summary note
68751-7,History and physical note
68752-5,Note
68753-3,Preoperative evaluation and management note
68754-1,Procedure note
68755-8,Progress note
68756-6,Transfer summary note
68757-4,Consultation note
68758-2,Letter
Sep-75,Cancer Ag 15-3
68760-8,History and physical note
68761-6,Note
68762-4,Preoperative evaluation and management note
68763-2,Progress note
68764-0,Transfer summary note
68765-7,Consultation note
68766-5,Letter
Jul-76,Citrulline
68767-3,Diagnostic study note
68768-1,Discharge summary note
68770-7,History and physical note
68771-5,Preoperative evaluation and management note
68772-3,Transfer summary note
68773-1,Discharge summary note
May-77,Coproporphyrin 1
68775-6,History and physical note
68776-4,Preoperative evaluation and management note
68777-2,Transfer summary note
68778-0,Diagnostic study note
68779-8,Discharge summary note
68781-4,History and physical note
68782-2,Note
Mar-78,Coproporphyrin 3
68783-0,Preoperative evaluation and management note
68784-8,Procedure note
68785-5,Progress note
68786-3,Transfer summary note
68787-1,Consultation note
68788-9,Diagnostic study note
68789-7,Letter
Jan-79,Corticotropin
68791-3,History and physical note
68792-1,Preoperative evaluation and management note
68793-9,Transfer summary note
68794-7,Diagnostic study note
68795-4,Discharge summary note
68797-0,History and physical note
68798-8,Preoperative evaluation and management note
68799-6,Procedure note
68800-2,Progress note
68801-0,Transfer summary note
68802-8,Consultation note
68803-6,Letter
68804-4,Diagnostic study note
68805-1,Discharge summary note
68807-7,History and physical note
68808-5,Preoperative evaluation and management note
Sep-80,Cystathionine
68809-3,Procedure note
68810-1,Progress note
68811-9,Transfer summary note
68812-7,Consultation note
68813-5,Letter
68814-3,Evaluation note
68815-0,Discharge summary note
Jul-81,Ethanolamine
68817-6,History and physical note
68818-4,Note
68819-2,Preoperative evaluation and management note
688-2,Neisseria gonorrhoeae
68820-0,Procedure note
68821-8,Consultation note
68822-6,Diagnostic study note
68823-4,Discharge summary note
May-82,Gamma aminobutyrate
68825-9,History and physical note
68826-7,Letter
68827-5,Note
68828-3,Preoperative evaluation and management note
68829-1,Procedure note
68830-9,Progress note
68831-7,Discharge summary note
Mar-83,Glucose.protein bound
68833-3,History and physical note
68834-1,Note
68835-8,Preoperative evaluation and management note
68836-6,Procedure note
68837-4,Consultation note
68838-2,Letter
68839-0,Note
68840-8,Progress note
Jan-84,Homocystine
68841-6,Discharge summary note
68842-4,Note
68843-2,History and physical note
68844-0,Preoperative evaluation and management note
68845-7,Progress note
68846-5,Consultation note
68847-3,Letter
68848-1,Note
68849-9,History and physical note
68850-7,Preoperative evaluation and management note
68851-5,Procedure note
68852-3,Consultation note
68853-1,Letter
68854-9,Note
68855-6,Diagnostic study note
68856-4,Discharge summary note
Aug-85,Hydroxylysine
68858-0,History and physical note
68859-8,Note
68860-6,Preoperative evaluation and management note
68861-4,Procedure note
68862-2,Progress note
68863-0,Transfer summary note
68864-8,Consultation note
68865-5,Letter
Jun-86,IgA subclass 1
68866-3,Letter
68867-1,Note
68868-9,Procedure note
68869-7,Consultation note
68870-5,Letter
68871-3,Note
68872-1,Procedure note
68873-9,Progress note
Apr-87,Indicans
68874-7,Consultation note
68875-4,Letter
68876-2,Note
68877-0,Procedure note
68878-8,Progress note
68879-6,Consultation note
68880-4,Letter
68881-2,Note
Feb-88,Alpha 2 globulin
68882-0,Note
68883-8,Transfer summary note
68884-6,Transfer summary note
68887-9,Transfer summary note
68888-7,Note
68889-5,Note
6889-0,Beta globulin
68890-3,Procedure note
68891-1,Progress note
68892-9,Consultation note
68893-7,Letter
68894-5,Note
68895-2,Procedure note
68896-0,Progress note
68897-8,Consultation note
68898-6,Letter
68899-4,Core behavioral and psychosocial data elements for the electronic health record
689-0,Neisseria gonorrhoeae
68900-0,Albumin lab method
68901-8,Erythrocytes
68902-6,Erythrocytes
68903-4,Erythrocytes
Aug-90,Gamma globulin
68910-9,Teratozoospermia index
68911-7,Lactate^post exercise
68912-5,Erythrocytes
68913-3,Voltage-gated potassium channel Ab
68915-8,Spermatozoa.progressive/100 spermatozoa^post concentration
Jun-91,Testosterone.free+weakly bound/Testosterone.total
68916-6,Coagulation dilute Russell viper venom induced.excess phospholipid actual/Normal
68917-4,Parathyrin.intact^20M post excision
68919-0,Somatotropin^15M post exercise
68923-2,Cancer Ag 125
Apr-92,Thyroxine.free
68924-0,Cancer Ag 72-4
68925-7,Cancer Ag 72-4
68926-5,Cancer Ag 72-4
68927-3,Cytokeratin 19
68928-1,Cytokeratin 19
68929-9,Cytokeratin 19
68930-7,Albumin/Globulin
68931-5,Catecholamines.free
Feb-93,Urobilinogen
68932-3,IgA.secretory
68933-1,IgA.secretory
68934-9,Heat shock protein 60 Ab
68935-6,LDL.oxidized Ab
68936-4,Saccharomyces cerevisiae Ab
68937-2,Acetylcholine receptor Ab
68938-0,Cytokeratin 19
68939-8,Enolase.neuron specific
6894-0,Zidovudine
68940-6,Somatotropin^90M post exercise
68941-4,Somatotropin^110M post exercise
68942-2,Somatotropin^130M post exercise
68943-0,Voltage-gated potassium channel Ab
68944-8,Listeria monocytogenes Ab.IgG
68945-5,Cells.CD3+CD5+
68946-3,SERPINA10 gene mutations tested for
68947-1,ATP1A2 gene mutations tested for
68948-9,Candida albicans Ab
68949-7,Ehrlichia chaffeensis Ab
68950-5,Herpes virus 8 Ab.IgG
68951-3,Pyruvate^20M post XXX challenge
68952-1,Enolase.neuron specific
68954-7,Streptococcus pyogenes rRNA
68955-4,Ketones
68956-2,DNA double strand Ab.IgG
Jul-95,Butalbital
68958-8,Microscopic observation
68959-6,Specimen condition
68960-4,Myoglobin
68961-2,HIV 1 Ab
68962-0,Phenylbutazone
68963-8,Collection date & time
68964-6,Lan Ag
May-96,cloZAPine
68965-3,R little g Ag
68966-1,Respiratory syncytial virus Ag
68967-9,Dantu Ab
68968-7,H little y super little a Ab
68969-5,Activated clotting time.kaolin induced
68970-3,Gamma hydroxybutyrate
68971-1,Color
68972-9,Lupinus albus seed Ab.IgE.RAST Class
Mar-97,Norsertraline
68973-7,IgA.intrathecally synthesized/IgA.total
68974-5,IgG.intrathecally synthesized/IgG.total
68975-2,IgM.intrathecally synthesized/IgM.total
68976-0,Pseudomonas aeruginosa alkaline protease Ab
68977-8,Pseudomonas aeruginosa elastase Ab
68978-6,Pseudomonas aeruginosa exotoxin A Ab
68979-4,Rivaroxaban
68980-2,Dabigatran
Jan-98,dilTIAZem
68981-0,Argatroban
68982-8,PFGE panel
68983-6,National (USA) PFGE pattern
68985-1,Bacteria antigenic formula
68986-9,Influenza virus A H5a RNA
68987-7,Influenza virus A H5b RNA
68988-5,Local PFGE pattern
68989-3,Performing laboratory
68990-1,Performing laboratory medical director
68991-9,Epidemiologically important information for public health reporting panel
68992-7,Specimen-related information panel
68993-5,Human RNase P RNA
68994-3,Performing laboratory name
68995-0,Person completing form name
68996-8,Laboratory - end stage renal disease form 2728
68997-6,City
68998-4,U.S. standard certificate of live birth - 2003 revision
Sep-99,Felbamate
68999-2,Heart rate^supine
69000-8,Heart rate^sitting
69001-6,Heart rate^standing
69002-4,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 E6+E7 mRNA
69003-2,Mononuclear cells.atypical/100 leukocytes
69004-0,Granulocytes.immature/100 leukocytes
May-00,Glutethimide
69005-7,Malignant cells/100 cells
69006-5,Granulocytes.immature/100 leukocytes
69007-3,Carboxy tetrahydrocannabinol
69008-1,Cocaine panel
69009-9,Cocaine
69010-7,Benzoylecgonine
69011-5,Cocaethylene
69012-3,3-Hydroxybenzoylecgonine
Mar-01,Insulin.free
69013-1,Lymphocyte proliferation.phytohemagglutinin.maximum/CD3
69014-9,Lymphocyte proliferation.Candida albicans.maximum/CD45
69015-6,Lymphocyte proliferation.Candida albicans.maximum/CD3
69016-4,Lymphocyte proliferation.tetanus toxoid.maximum/CD45
69017-2,Granulocytes.immature/100 leukocytes
69018-0,Lymphocyte proliferation mitogen panel
69019-8,Lymphocyte proliferation.pokeweed mitogen stimulation/CD45
69020-6,Lymphocyte proliferation.pokeweed mitogen stimulation/CD3
Jan-02,Methadone
69021-4,Amphetamines panel
69022-2,Methamphetamine
69023-0,Methylenedioxyamphetamine
69024-8,Methylenedioxyethylamphetamine
69025-5,Methylenedioxymethamphetamine
69026-3,Opiates panel
69027-1,Morphine
69028-9,oxyMORphone
69029-7,Lymphocyte proliferation.tetanus toxoid.maximum/CD3
69030-5,Enterocyte Ab.IgG
69031-3,Enterocyte Ab.IgA
69032-1,Enterocyte Ab.IgM
69033-9,Buprenorphine & Norbuprenorphine panel
69034-7,Eastern equine encephalitis virus Ab.IgG & IgM panel
69035-4,Eastern equine encephalitis virus Ab.IgG & IgM panel
69036-2,Western equine encephalitis virus Ab.IgG & IgM panel
69037-0,Lymphocyte proliferation.pokeweed mitogen.maximum/CD19
69038-8,Lymphocyte proliferation.phytohemagglutinin.maximum/CD45
Sep-03,Norverapamil
69039-6,Enterocyte Ab panel
69040-4,Chronic urticaria index panel
69041-2,Western equine encephalitis virus Ab.IgG & IgM panel
69042-0,Lymphocyte proliferation antigen panel
69043-8,Other pregnancy outcomes
69044-6,Date first prenatal visit
69045-3,U.S. standard report of fetal death - 2003 revision
69046-1,Airway status
Jul-04,Phenothiazine
69047-9,Geneticist review
69048-7,Immunologist review
69049-5,Coagulation specialist review
69050-3,Toxicologist review
69051-1,Urinalysis specialist review
69052-9,Flow cytometry specialist review
69053-7,Endocrinologist review
Apr-05,Propafenone
69054-5,Views^W contrast IA
69055-2,Views^WO weight
69056-0,Views + obliques
69057-8,Views AP + lateral + oblique
69058-6,Views 2
69059-4,Views + lateral crosstable
69060-2,Views 2 + Sunrise
69061-0,Views 2 + tunnel
Feb-06,Sertraline
69062-8,Views 4^W standing
69063-6,Views 4 + Sunrise + tunnel
69064-4,(View Sunrise) + (views^W standing)
69065-1,Views AP + lateral crosstable
69066-9,Views^W contrast IV
69067-7,Guidance for angioplasty^W contrast
69068-5,Guidance for needle localization
69069-3,View Sunrise
6907-0,sulfADIAZINE
69070-1,Views anterior + lateral
69071-9,Views
69072-7,Views ulnar deviation + radial deviation
69073-5,Guidance for biopsy.core needle
69074-3,Guidance for percutaneous biopsy
69075-0,Guidance for percutaneous biopsy
69076-8,Guidance for percutaneous biopsy
69077-6,Views^W contrast IA
69078-4,Guidance for drainage+placement of drainage catheter
69079-2,View 45 degree cephalic angle
690-8,Neisseria gonorrhoeae
69080-0,Views 5^W flexion + W extension
69081-8,Views 5 + Swimmers
69082-6,Multisection & 3D reconstruction^WO contrast
69083-4,Guidance for percutaneous biopsy^WO contrast
69084-2,Multisection^WO contrast
69085-9,Multisection^WO & W contrast
69086-7,Multisection^WO & W contrast
69087-5,Multisection^WO contrast
Aug-08,Complement C4
69088-3,Multisection^W contrast IV
69089-1,Multisection^WO contrast
69090-9,Multisection^WO contrast
69091-7,Multisection^W contrast IV
69092-5,Guidance for percutaneous biopsy^WO contrast
69093-3,Guidance for percutaneous biopsy^W contrast IV
69094-1,Guidance for percutaneous biopsy^WO contrast
69095-8,Multisection^W contrast IV
Jun-09,Mucin clot
69096-6,Multisection limited^W contrast IV
69097-4,Guidance for biopsy.needle
69098-2,Guidance for biopsy.needle
69099-0,Guidance for biopsy.needle
69100-6,Guidance for biopsy.needle
69101-4,Guidance for biopsy.needle
69102-2,Multisection^W contrast IS
69103-0,Multisection^W contrast IS
Apr-10,Brucella abortus Ab.IgA
69104-8,Multisection^WO contrast
69105-5,Multisection^W contrast IS
69106-3,Multisection^W contrast IS
69107-1,Multisection^W contrast IS
69108-9,Multisection^WO & W contrast
69109-7,Multisection^W contrast IS
69110-5,Multisection^W contrast IS
69111-3,Multisection^WO contrast
Feb-11,Brucella abortus Ab.IgG
69112-1,Multisection^W contrast IS
69113-9,Multisection
69114-7,Multisection^W contrast IS
69115-4,Multisection^W contrast IS
69116-2,Multisection
69117-0,Multisection
69118-8,Multisection^WO contrast
69119-6,Multisection^WO contrast
6912-0,Chlamydophila pneumoniae Ab.IgA
69120-4,Guidance for drainage of abscess+placement of drainage catheter
69121-2,Guidance for percutaneous aspiration of cyst
69122-0,Guidance for drainage of abscess+placement of drainage catheter
69123-8,Guidance for drainage of abscess+placement of chest tube
69124-6,Guidance for superficial aspiration.fine needle
69125-3,Guidance for biopsy.needle
69126-1,Guidance for biopsy.needle
69127-9,Guidance for biopsy
69128-7,Guidance for biopsy.needle
69129-5,Guidance for percutaneous biopsy
69130-3,Views AP + lateral
69131-1,Views + Danelius Miller
69132-9,View Danelius Miller
69133-7,Guidance for drainage+placement of drainage catheter
69134-5,Guidance for placement of stent
69135-2,Guidance for atherectomy^W contrast
69136-0,Views Sunrise + tunnel
69137-8,Views AP + lateral + oblique^W standing
Aug-13,Chlamydophila pneumoniae Ab.IgG
69138-6,Views 3^W standing
69139-4,Views + lateral crosstable
69140-2,Views + Danelius Miller
69141-0,View Danelius Miller
69142-8,Views 2 + Sunrise
69143-6,(Views 2) + (view tunnel^W standing)
69144-4,(Views 4) + (view AP^W standing)
69145-1,Views 4 + tunnel
Jun-14,Chlamydophila pneumoniae Ab.IgM
69146-9,Views AP + lateral crosstable
69147-7,Views AP + lateral + R-oblique + L-oblique
69148-5,Views + tunnel
69149-3,(View Sunrise) + (views^W standing)
69150-1,Views diagnostic for implant
69151-9,Views 3 scaphoid
69152-7,View
Mar-15,Chlamydophila psittaci Ab.IgA
69153-5,Views AP + Grashey + axillary
69154-3,Views 3 + axillary
69155-0,Views 3 + Y
69156-8,Views Grashey + Y
69157-6,Views lateral^W flexion + W extension
69158-4,Views diagnostic for implant
69159-2,Views screening for implant
691-6,Neisseria gonorrhoeae
69160-0,Guidance for percutaneous aspiration.fine needle &or biopsy.core needle
Jan-16,Chlamydophila psittaci Ab.IgG
69161-8,Multisection^WO & W contrast IV
69162-6,Multisection^W contrast IA
69163-4,Multisection^W contrast IV
69164-2,Multisection^WO contrast
69165-9,Multisection for implant
69166-7,Multisection for implant^WO & W contrast IV
69167-5,Multisection for implant^W contrast IV
69168-3,Multisection for implant^WO contrast
69169-1,Guidance for percutaneous biopsy
69170-9,Multisection^W contrast IV
69171-7,Multisection^WO contrast
69172-5,Multisection^W contrast IV
69173-3,Multisection^WO contrast
69174-1,Multisection^WO & W contrast IV
69175-8,Multisection^W contrast IV
69176-6,Multisection^WO contrast
69177-4,Multisection^WO & W contrast IV
69178-2,Multisection^W contrast IV
Sep-17,Chlamydophila psittaci Ab.IgM
69179-0,Multisection^WO contrast
69180-8,Multisection
69181-6,Multisection^WO & W contrast IV
69182-4,Multisection^W contrast IV
69183-2,Multisection^WO contrast
69184-0,Multisection^W contrast IV
69185-7,Multisection^WO contrast
69186-5,Multisection^WO & W contrast IV
Jul-18,Chlamydia trachomatis Ab.IgA
69187-3,Multisection^W contrast IV
69188-1,Multisection^WO contrast
69189-9,Multisection for implant^WO & W contrast IV
69190-7,Multisection for implant^W contrast IV
69191-5,Multisection for implant^WO contrast
69192-3,Guidance for percutaneous aspiration of cyst
69193-1,Multisection
69194-9,Multisection^WO & W contrast IV
May-19,Chlamydia trachomatis Ab.IgG
69195-6,Multisection^W contrast IV
69196-4,Multisection^WO contrast
69197-2,Guidance for percutaneous biopsy
69198-0,Guidance for percutaneous biopsy
69199-8,Guidance for percutaneous biopsy
69200-4,Guidance for biopsy
69201-2,Guidance for biopsy
69202-0,Guidance for percutaneous biopsy
Mar-20,Chlamydia trachomatis Ab.IgM
69203-8,Guidance for percutaneous biopsy
69204-6,Multisection^WO & W contrast IV
69205-3,Multisection^W contrast IV
69206-1,Multisection^WO contrast
69207-9,Multisection^WO & W contrast IS
69208-7,Multisection^WO & W contrast IS
69209-5,Multisection
69210-3,Multisection^W contrast IS
Jan-21,Cytomegalovirus Ab.IgG
69211-1,Multisection
69212-9,Multisection limited
69213-7,Guidance for percutaneous biopsy
69214-5,Multisection^WO & W contrast IV
69215-2,Multisection^W contrast IV
69216-0,Multisection^WO contrast
69217-8,Multisection^WO & W contrast IS
69218-6,Multisection^WO & W contrast IS
69219-4,Multisection
69220-2,Multisection^WO & W contrast IV
69221-0,Multisection^W contrast IV
69222-8,Multisection
69223-6,Multisection^WO contrast
69224-4,Guidance for biopsy.needle
69225-1,Guidance for biopsy.needle
69226-9,Guidance for percutaneous biopsy
69227-7,Guidance for biopsy.needle
69228-5,Guidance for biopsy.needle
Sep-22,Echovirus 7 Ab
69229-3,Multisection^W Tc-99m SC IV
69230-1,Views^W Tc-99m SC IV
69231-9,Views^W stress+W Tc-99m IV
69232-7,Views^W stress+W Tc-99m Sestamibi IV
69233-5,Views^W Tc-99m pertechnetate IV
69234-3,Multisection^W Tc-99m tagged RBC IV
69235-0,Multisection for blood flow^W radionuclide IV
69236-8,Views+views uptake^W I-131 PO
Jul-23,Adrenal cortex Ab
69237-6,Multisection for tumor^W radionuclide IV
69238-4,Multisection^W contrast intra bladder+during voiding
69239-2,View Sunrise
692-4,Neisseria gonorrhoeae
69240-0,Guidance for percutaneous biopsy
69241-8,Guidance for percutaneous drainage of abscess+placement of drainage catheter
69242-6,Guidance for percutaneous drainage of abscess+placement of drainage catheter
69243-4,Guidance for percutaneous drainage of abscess+placement of drainage catheter
69244-2,Guidance for percutaneous drainage of abscess+placement of drainage catheter
May-24,Gliadin Ab.IgA
69245-9,Guidance for percutaneous biopsy.needle
69246-7,Guidance for percutaneous biopsy.needle
69247-5,Guidance for percutaneous biopsy.needle
69248-3,Guidance for percutaneous transluminal angioplasty^W contrast IA
69249-1,Views^W contrast IA
69250-9,Views^W contrast IV
69251-7,Views^post wire placement
Feb-25,Ganglioside GM1 Ab.IgG
69252-5,Guidance for percutaneous transluminal angioplasty^W contrast IA
69253-3,Guidance for atherectomy^W contrast
69254-1,Views 3^W standing
69255-8,(View Sunrise) + (View tunnel^W standing)
69256-6,View Sunrise
69257-4,Views 2
69258-2,Views AP + lateral
69259-0,Views diagnostic for implant
6926-0,Ganglioside GM1 Ab.IgM
69260-8,View
69261-6,Views 3
69262-4,Views AP + Grashey + axillary
69263-2,View PA^W clenched fist
69264-0,Views^W standing
69265-7,Views 4
69266-5,Views AP + Y
69267-3,Views Grashey + axillary + Y
69268-1,View^W contrast intra duct
69269-9,View AP
69270-7,View PA
69271-5,Views PA + lateral + Waters + Towne
69272-3,Views^W contrast via ileostomy
69273-1,Views 2
69274-9,Views 2^W standing
69275-6,Views^W standing
69276-4,Multisection
69277-2,Multisection
Aug-27,Platelet Ab.IgG
69278-0,Guidance for percutaneous aspiration of fluid
69279-8,Guidance for biopsy.core needle
69280-6,Multisection limited
69281-4,Multisection limited
69282-2,Multisection limited
69283-0,Multisection
69284-8,Multisection
69285-5,Multisection
Jun-28,Rheumatoid factor
69286-3,Multisection limited
69287-1,Guidance for percutaneous aspiration of fluid
69288-9,Guidance for biopsy.needle
69289-7,Guidance for biopsy.needle
69290-5,Guidance for biopsy.needle
69291-3,Guidance for biopsy.needle
69292-1,Guidance for percutaneous aspiration of fluid
69293-9,Multisection
Apr-29,Aluminum
69294-7,Multisection
69295-4,Multisection
69296-2,Guidance for percutaneous aspiration of fluid
69297-0,Multisection
69298-8,Multisection
69299-6,Multisection limited
69300-2,Multisection limited for transplanted kidney
69301-0,Guidance for percutaneous transluminal angioplasty^W contrast IV
Feb-30,Psilocybin
69302-8,View^W clenched fist
69303-6,Views ulnar deviation + radial deviation
69304-4,Views ulnar deviation
69305-1,Views 2
69306-9,Guidance for percutaneous aspiration of cyst
69307-7,View
69308-5,View
69309-3,View
6931-0,Silver
69310-1,View
69311-9,View
69312-7,View
69313-5,View
69314-3,View
69315-0,View
69316-8,View
69317-6,View
69318-4,View
69319-2,View
693-2,Neisseria gonorrhoeae
69320-0,View
69321-8,View
69322-6,Health insurance plan benefits comment
69323-4,Changed medical regimen diagnoses - OASIS - B1
69324-2,"Patient history and diagnosis - start of care, resumption of care"
69325-9,Diagnosis and severity index - OASIS B1
69326-7,Patient information - acute
69327-5,Patient history and diagnosis - follow-up
Aug-32,Penicillin
69328-3,"Patient history and diagnosis - transfer to facility, discharge from agency"
69329-1,Data items collected at inpatient facility admission or agency discharge only - death at home
69330-9,Data items collected at inpatient facility admission or agency discharge only - transfer to facility
69331-7,Data items collected at inpatient facility admission or agency discharge only - discharge from agency
69332-5,Neuro & emotional & behavioral status - discharge from agency
69333-3,Neuro & emotional & behavioral status - resumption of care
69334-1,Neuro & emotional & behavioral status - start of care
69335-8,Therapy need and plan of care - follow-up
Jun-33,Streptomycin.high potency
69336-6,ADL and IADLs - follow-up
69337-4,ADL and IADLs - discharge
69338-2,"One or more unhealed pressure ulcer(s) at stage 2 or higher - interim, post acute care discharge"
69339-0,Influenza vaccine
69340-8,"Administrative items - interim, discharge"
69341-6,Administrative items - expired
69342-4,Patient information - expired
69343-2,"Patient information - interim, discharge"
Apr-34,RAST class
69344-0,Laboratory - acute
69345-7,Physical findings - DEEDS 1.0
69346-5,Endotracheal tube activity
69347-3,Artificial airway
69348-1,Respiratory assist status
69349-9,Presence of pressure ulcers - acute
69350-7,Temporal orientation &or mental status - acute
Jan-35,Alpha aminoadipate
69351-5,"Medical coding information - admission, home health"
69352-3,Admission information - home health
69353-1,HIV 2 RNA
69354-9,HIV 2 RNA
69355-6,Parvovirus B19 DNA
69356-4,oxyCODONE
69357-2,Amylase^post CFst
69358-0,Cells.HPV E6+E7 mRNA/cells
69359-8,Amylase^2nd specimen post XXX challenge
69360-6,Amylase^1st specimen post XXX challenge
69361-4,PCA3 score
69362-2,PCA3 score
69363-0,SERPINA10 gene targeted mutation analysis
69364-8,ATP1A2 gene targeted mutation analysis
69365-5,Inpatient facility diagnoses - OASIS B1
69366-3,Bordetella pertussis Ab.IgA
69367-1,Bordetella pertussis Ab.IgG
69368-9,Bordetella pertussis Ab.IgM
Sep-36,Deoxypyridinoline
69369-7,Blood group antibody screen
69370-5,A1 Ab
69371-3,B Ab
69372-1,What is the highest level of school this patient has completed
69373-9,Passive D Ab
69374-7,"Cognitive status, mood, pain - discharge"
69375-4,"Cognitive status, mood, pain - acute"
69376-2,Current medical information - interim
Jul-37,Deoxypyridinoline
69377-0,"Current medical information - admission, home health"
69378-8,Current medical information - expired
69379-6,Bacterial vancomycin resistance vanA & vanB & vanC1 & vanC2 genes
69380-4,"t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale)"
69381-2,"t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript/control transcript (International Scale)"
69382-0,"t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript/control transcript (International Scale)"
69383-8,AGXT gene targeted mutation analysis
69384-6,AGXT gene mutation analysis limited to known familial mutations
May-38,IgA
69385-3,Multisection
69387-9,Guidance for percutaneous biopsy
69388-7,Multisection^post void
69389-5,Multisection
69390-3,Multisection
69391-1,Guidance for percutaneous aspiration of fluid
69392-9,Multisection
Mar-39,IgA subclass 2
69393-7,Multisection
69394-5,Multisection
69395-2,Multisection
69396-0,Guidance for percutaneous biopsy
69397-8,Multisection
69398-6,Multisection
69399-4,Multisection
694-0,Neisseria gonorrhoeae
69400-0,Guidance for tissue sampling of chorionic villus
Jan-40,Potassium
69401-8,Guidance for biopsy.needle
69402-6,Multisection
69403-4,OTC medical device label
69404-2,Prescription medical device label
69405-9,Glomerular filtration rate/1.73 sq M.predicted
69406-7,Adult GFR method
69407-5,Pediatric GFR method
69408-3,Orthostatic heart rate
69409-1,U.S. standard certificate of death - 2003 revision
69410-9,Haemophilus influenzae
69411-7,Medical services received in past 2Mo - Long term care hospital
69412-5,Continuity assessment record and evaluation tool - long term care hospital - version 1.0
69413-3,Continuity assessment record and evaluation tool - Long term care hospital - Planned discharge - version 1.0
69414-1,Continuity assessment record and evaluation tool - Long term care hospital - Unplanned discharge - version 1.0
69415-8,Continuity assessment record and evaluation tool - Long term care hospital - Expired - version 1.0
69416-6,Continuity assessment record and evaluation tool - Long term care hospital - Admission - version 1.0
69417-4,CMS certification number
69418-2,Reason for assessment - Long term care hospital - version 1.0
Sep-41,Albumin
69419-0,Cholesterol.in LDL
69420-8,Heterophile Ab
69421-6,Corylus avellana recombinant (rCor a) 1 Ab.IgE
69422-4,Carnitine.free (C0)
69423-2,Rosner index
69424-0,Nitrogen
69425-7,Calcium
69426-5,Medical director review
Jul-42,Albumin
69427-3,Supervisor review
69428-1,Jugular vein distension
69429-9,Metabolic rate^resting
69430-7,Expected self-care dialysis
69431-5,Medicare enrollment status
69432-3,Dialysis time period
69433-1,Citizenship status
69434-9,Location of death name
May-43,acetoHEXAMIDE
69435-6,Street address where death occurred if not facility
69436-4,Autopsy results available
69437-2,Death certifier
69438-0,Referral note
69439-8,Death certifier
69440-6,Disease onset to death interval
69441-4,Other significant causes or conditions of death
69442-2,Timing of recent pregnancy in relation to death
Mar-44,glipiZIDE
69443-0,Did tobacco use contribute to death
69444-8,Did death result from injury at work
69445-5,Injury date
69446-3,Injury date comment
69447-1,Injury location
69448-9,Injury leading to death associated with transportation event
69449-7,Manner of death
6945-0,glyBURIDE
69450-5,Place of injury
69451-3,Transportation role of decedent
69452-1,Coroner - medical examiner case number
69453-9,Cause of death
69454-7,Death date comment
69455-4,Major treatments - expired
69456-2,Major treatments - interim
69457-0,Major treatments - discharge
69458-8,Cardiology monitoring
69459-6,Care record summary panel
69460-4,Body weight^pre current pregnancy
69461-2,Body weight^at delivery
69462-0,Activation of the destination healthcare facility team
69463-8,Suspected intentional or unintentional disaster
69464-6,"Centers for medicare - medicaid, CMS, service level"
69465-3,EMS unit GPS longitude^at dispatch
69466-1,Vehicle location^at dispatch
69467-9,Possible injury
Aug-46,Imipramine
69468-7,Primary anatomic organ system of chief complaint
69469-5,911 call to public safety answering point or other designated entity requesting EMS services
69470-3,Dispatch was notified by the 911 call taker
69471-1,Responding unit was notified by dispatch
69472-9,Unit responded
69473-7,Responding unit arrived on the scene
69474-5,Responding unit arrived at the patient's side
69475-2,Responding unit left the scene with a patient
Jun-47,ISOtretinoin
69476-0,Responding unit arrived with the patient at the destination or transfer point
69477-8,Unit was back in service and available for response
69478-6,AGXT gene deletion+duplication
69479-4,BTK gene mutation analysis limited to known familial mutations
69480-2,CFTR gene deletion+duplication
69481-0,ACVRL1 gene+ENG gene deletion+duplication
69482-8,ENG gene mutation analysis limited to known familial mutations
69483-6,F9 gene mutation analysis limited to known familial mutations
Apr-48,lamoTRIgine
69484-4,FBN1 gene mutation analysis limited to known familial mutations
69485-1,LDLR gene mutation analysis limited to known familial mutations
69486-9,LDLR gene deletion+duplication
69487-7,TNFRSF13B gene full mutation analysis
69488-5,TNFRSF13B gene mutation analysis limited to known familial mutations
69489-3,VHL gene mutation analysis limited to known familial mutations
69490-1,Ethnicity
69491-9,Mobility aids
Feb-49,Metaproterenol
69492-7,Outpatient physical therapy improvement in movement assessment log
69493-5,OPTIMAL difficulty - baseline
69494-3,OPTIMAL confidence - baseline
69495-0,OPTIMAL difficulty - follow up
69496-8,OPTIMAL confidence - follow up
69497-6,Lying flat - difficulty
69498-4,Rolling over - difficulty
69499-2,Moving - lying to sitting - difficulty
May-69,Cefamandole
6950-0,raNITIdine
69500-7,Sitting - difficulty
69501-5,Squatting - difficulty
69502-3,Bending - stooping - difficulty
69503-1,Balancing - difficulty
69504-9,Kneeling - difficulty
69505-6,Walking - short distance - difficulty
69506-4,Walking - long distance - difficulty
69507-2,Walking - outdoors - difficulty
69508-0,Climbing stairs - difficulty
69509-8,Hopping - difficulty
69510-6,Jumping - difficulty
69511-4,Running - difficulty
69512-2,Pushing - difficulty
69513-0,Pulling - difficulty
69514-8,Reaching - difficulty
69515-5,Grasping - difficulty
69516-3,Lifting - difficulty
69517-1,Carrying - difficulty
Aug-51,TOLAZamide
69518-9,Choose the number of the activity you would most like to be able to do without any difficulty
69519-7,Overall level of difficulty with these activities today
69520-5,Lying flat - confidence
69521-3,Rolling over - confidence
69522-1,Moving - lying to sitting - confidence
69523-9,Sitting - confidence
69524-7,Squatting - confidence
69525-4,Bending - stooping - confidence
Jun-52,TOLBUTamide
69526-2,Balancing - confidence
69527-0,Kneeling - confidence
69528-8,Walking - short distance - confidence
69529-6,Walking - long distance - confidence
69530-4,Walking - outdoors - confidence
69531-2,Climbing stairs - confidence
69532-0,Hopping - confidence
69533-8,Jumping - confidence
Apr-53,Zolpidem
69534-6,Running - confidence
69535-3,Pushing - confidence
69536-1,Pulling - confidence
69537-9,Reaching - confidence
69538-7,Grasping - confidence
69539-5,Lifting - confidence
69540-3,Carrying - confidence
69541-1,Overall level of confidence with these activities today
Feb-54,Bartonella henselae Ab.IgG
69542-9,Secondary problem
69543-7,Cause of injury
69544-5,Chief complaint - ICD code
69545-2,DNA region of interest start
69546-0,DNA region of interest stop
69547-8,Reference nucleotide
69548-6,Genetic variant assessment
69549-4,Genetic knowledge reference
69550-2,Genetic knowledge reference
69551-0,Variable nucleotide
69552-8,Thromboelastography after addtion of heparinase panel
69553-6,Lactose tolerance
69554-4,Lactose tolerance panel^dosage unspecified
69555-1,Lactose tolerance panel^dosage unspecified
69556-9,Ku Ab
69557-7,OJ Ab
69558-5,Ma1 Ab
Sep-55,Bartonella henselae Ab.IgM
69559-3,Ma1 Ab
69560-1,Enolase.neuron specific
69561-9,Thyrotropin
69562-7,Candida albicans DNA
69563-5,Candida glabrata DNA
69564-3,Bacterial vaginosis score
69565-0,Atopobium vaginae DNA
69566-8,Bacterial vaginosis associated bacterium 2 DNA
Jul-56,Coxsackievirus A21 Ab
69567-6,Megasphaera sp type 1 DNA
69568-4,Bacterial vaginosis
69569-2,Risk of ovarian malignancy algorithm score^premenopausal
695-7,Neisseria gonorrhoeae
69570-0,Risk of ovarian malignancy algorithm score^postmenopausal
69571-8,Bacterial vaginosis DNA & score panel
69572-6,ERCC1 Ag
69573-4,Tiglylcarnitine+methylcrotonylcarnitine (C5:1)
69574-2,Furazolidone
May-57,Western equine encephalitis virus Ab.IgG
69575-9,Campylobacter jejuni Ab
69576-7,Campylobacter fetus Ab
69577-5,Hepatitis E virus RNA
69578-3,Diffusion capacity.carbon monoxide/Alveolar volume^^adjusted for hemoglobin
69579-1,Local PFGE event description
69580-9,Local assigning authority
69581-7,National (USA) PFGE cluster code or CDC cluster
69582-5,PFGE restriction enzyme
Mar-58,Western equine encephalitis virus Ab.IgM
69586-6,Carrying - confidence - score change
69587-4,Lifting - confidence - score change
69588-2,Grasping - confidence - score change
69589-0,Reaching - confidence - score change
69590-8,Pulling - confidence - score change
Jan-59,Yersinia enterocolitica O:3 Ab
69591-6,Pushing - confidence - score change
69592-4,Running - confidence - score change
69593-2,Jumping - confidence - score change
69594-0,Hopping - confidence - score change
69595-7,Climbing stairs - confidence - score change
69596-5,Walking - outdoors - confidence - score change
69597-3,Walking - long distance - confidence - score change
69598-1,Walking - short distance - confidence - score change
69599-9,Kneeling - confidence - score change
69600-5,Balancing - confidence - score change
69601-3,Bending - stooping - confidence - score change
69602-1,Squatting - confidence - score change
69603-9,Sitting - confidence - score change
69604-7,Moving - lying to sitting - confidence - score change
69605-4,Rolling over - confidence - score change
69606-2,Lying flat - confidence - score change
69607-0,Carrying - difficulty - score change
69608-8,Lifting - difficulty - score change
Sep-60,Yersinia enterocolitica O:5 Ab
69609-6,Grasping - difficulty - score change
69610-4,Reaching - difficulty - score change
69611-2,Pulling - difficulty - score change
69612-0,Pushing - difficulty - score change
69613-8,Running - difficulty - score change
69614-6,Jumping - difficulty - score change
69615-3,Hopping - difficulty - score change
69616-1,Climbing stairs - difficulty - score change
Jul-61,Yersinia enterocolitica O:8 Ab
69617-9,Walking - outdoors - difficulty - score change
69618-7,Walking - long distance - difficulty - score change
69619-5,Walking - short distance - difficulty - score change
69620-3,Kneeling - difficulty - score change
69621-1,Balancing - difficulty - score change
69622-9,Bending - stooping - difficulty - score change
69623-7,Squatting - difficulty - score change
69624-5,Sitting - difficulty - score change
May-62,Yersinia enterocolitica O:9 Ab
69625-2,Moving - lying to sitting - difficulty - score change
69626-0,Rolling over - difficulty - score change
69627-8,Lying flat - difficulty - score change
69631-0,Total change score - difficulty
69632-8,Total difficulty score - baseline
Mar-63,Yersinia enterocolitica Ab
69633-6,Total difficulty score - follow-up
Jan-64,Yersinia enterocolitica Ab.IgA
696-5,Neisseria gonorrhoeae
69652-6,Total change score - confidence
69653-4,Total confidence score - baseline
69654-2,Total confidence score - follow-up
Aug-65,Yersinia enterocolitica Ab.IgG
Jun-66,Yersinia enterocolitica Ab.IgM
69667-4,Bowel continence
69668-2,HIV 1 & 2 Ab
69669-0,Population stratification description
69670-8,Health quality measure supplemental data
69671-6,Bothered by stomach pain in last 4W
69672-4,Bothered by back pain in last 4W
69673-2,"Bothered by pain in your arms, legs, or joints - knees, hips, etc - in last 4W"
Apr-67,Yersinia pseudotuberculosis Ab
69674-0,Bothered by menstrual cramps or other problems with your period in last 4W
69675-7,Bothered by headaches in last 4W
69676-5,Bothered by chest pain in last 4W
69677-3,Bothered by dizziness in last 4W
69678-1,Bothered by fainting spells in last 4W
69679-9,Bothered by feeling your heart pound or race in last 4W
69680-7,Bothered by shortness of breath in last 4W
69681-5,"Bothered by constipation, loose stools, or diarrhea in last 4W"
Feb-68,Proteinase 3 Ab
69682-3,"Bothered by nausea, gas, or indigestion in last 4W"
69683-1,"Feeling nervous, anxious, on edge, or worrying a lot about different things in last 4W"
69684-9,Feeling restless so that it is hard to sit still in last 4W
69685-6,Getting tired very easily in last 4W
69686-4,"Muscle tension, aches, or soreness in last 4W"
69687-2,Trouble falling asleep or staying asleep in last 4W
69688-0,"Trouble concentrating on things, such as reading a book or watching TV in last 4W"
69689-8,Becoming easily annoyed or irritable in last 4W
6969-0,Myeloperoxidase Ab
69690-6,Do you often feel that you can't control what or how much you eat
69691-4,"Do you often eat, within any 2H period, what most people would regard as an unusually large amount of food"
69692-2,"Has this been as often, on average, as twice a W for the last 3Mo"
69693-0,Made yourself vomit often in last 3Mo in order to avoid gaining weight
69694-8,Took more than twice the recommended dose of laxatives often in last 3Mo in order to avoid gaining weight
69695-5,Fasted - not eaten anything at all for at least 24H - often in last 3Mo in order to avoid gaining weight
69696-3,Exercised for more than an hour specifically to avoid gaining weight after binge eating often in last 3Mo in order to avoid gaining weight
69697-1,"You drank alcohol, even though a doctor suggested that you stop drinking because of a problem with your health, more than once in last 6Mo"
69698-9,"You drank alcohol, were high from alcohol, or hung over while you were working, going to school, or taking care of children or other responsibilities more than once in last 6Mo"
69699-7,"You missed or were late for work, school, or other activities because you were drinking or hung over, more than once in last 6Mo"
69700-3,You had a problem getting along with other people while you were drinking more than once in last 6Mo
69701-1,You drove a car after having several drinks or after drinking too much more than once in last 6Mo
69702-9,Has this ever happened before
69703-7,"Do some of these attacks come suddenly out of the blue - that is, in situations where you don't expect to be nervous or uncomfortable"
69704-5,Do these attacks bother you a lot or are you worried about having another attack
69705-2,Were you short of breath
69706-0,"Did your heart race, pound, or skip"
69707-8,Did you have chest pain or pressure
Aug-70,Purkinje cells Ab
69708-6,Did you sweat
69709-4,Did you feel as if you were choking
69710-2,Did you have hot flashes or chills
69711-0,"Did you have nausea or an upset stomach, or the feeling that you were going to have diarrhea"
69712-8,"Did you feel dizzy, unsteady, or faint"
69713-6,Did you have tingling or numbness in parts of your body
69714-4,Did you tremble or shake
69715-1,Were you afraid you were dying
Jun-71,"2,4 toluenediamine"
69716-9,"In the last 4W, have you had an anxiety attack - suddenly feeling fear or panic"
69717-7,Bothered by pain or problems during sexual intercourse
69718-5,Statement of identity section
69719-3,Health claim section
69720-1,"If you checked yes to any of these ways of avoiding gaining weight, were any as often, on average, as twice a W"
69721-9,Do you ever drink alcohol - including beer or wine
69722-7,"How difficult have these made it for you to do your work, take care of things at home, or get along with other people"
69723-5,Patient health questionnaire
Apr-72,"2,6 toluenediamine"
69724-3,Patient health questionnaire 4 item
69725-0,"Feeling nervous, anxious or on edge in last 2W"
69726-8,Tissue transglutaminase Ab.IgA+gliadin peptides Ab.IgA & IgG panel
69727-6,Tissue transglutaminase Ab.IgA+gliadin peptides Ab.IgA & IgG
69728-4,Patient health questionnaire 15 item
69729-2,"Patient Health Questionnaire-somatic, anxiety, and depressive symptoms"
697-3,Neisseria gonorrhoeae
69730-0,Instructions
69731-8,Feeling tired or having low energy level in past 4W
Feb-73,Zinc
69732-6,Trouble sleeping in past 4W
69733-4,Worrying too much about different things in last 2W
69734-2,Trouble relaxing in last 2W
69735-9,Being so restless that it is hard to sit still in last 2W
69736-7,Feeling afraid as if something awful might happen in last 2W
69737-5,Generalized anxiety disorder 7 item
69738-3,"Differential panel, method unspecified"
69739-1,Drugs of abuse panel
6974-0,Zirconium
69740-9,Cell count panel
69741-7,Differential panel
69742-5,"Complete blood count W Differential panel, method unspecified"
69747-4,Does the patient have any environmental allergies
69748-2,Known allergies to food or environmental agents
69749-0,Is the patient on anticoagulants
69750-8,EMS unit GPS latitude^at dispatch
69751-6,OPTIMAL change scores - difficulty
69752-4,OPTIMAL change scores - confidence
69753-2,Bordetella pertussis+Bordetella parapertussis.filamentous hemagglutinin Ab.IgA
69754-0,Bordetella pertussis+Bordetella parapertussis.filamentous hemagglutinin Ab.IgG
69755-7,Bordetella pertussis.pertussis toxin Ab.IgG
69756-5,Bordetella sp filamentous hemagglutinin & pertussis toxin Ab.IgA & IgG panel
Jul-75,Amikacin
69757-3,Indications of drug or alcohol use by the patient
69758-1,Diagram of device
69759-9,Risks
69760-7,Compatible accessories
69761-5,Alarms
69762-3,Troubleshooting
69763-1,Disposal and waste handling
69764-9,Document type identifier
May-76,Amoxicillin
69765-6,Rubella virus Ab.IgM
69766-4,Mumps virus Ab.IgM
69767-2,La Crosse virus RNA
69768-0,2-Oxoadipate
69769-8,Dicarboxyoleylcarnitine (C18:1-DC)/Creatinine
69770-6,Dicarboxyoleylcarnitine (C18:1-DC)
69771-4,Dicarboxyoleylcarnitine (C18:1-DC)
69772-2,Orotate
Mar-77,Amoxicillin+Clavulanate
69773-0,Dicarboxyoleylcarnitine (C18:1-DC)
69774-8,Propionylcarnitine (C3)
69775-5,Stearoylcarnitine (C18)
69776-3,Suberylcarnitine (C8-DC)/Creatinine
69777-1,Suberylcarnitine (C8-DC)
69778-9,Suberylcarnitine (C8-DC)
69779-7,Suberylcarnitine (C8-DC)
69780-5,2-Hydroxyisovalerate
Jan-78,Amphotericin B
69781-3,2-Hydroxyisovalerate
69782-1,2-Hydroxyphenylacetate
69783-9,2-Hydroxyphenylacetate
69784-7,2-Hydroxysebacate
69785-4,2-Hydroxysebacate
69786-2,2-Methylacetoacetate
69787-0,2-Methylacetoacetate
69788-8,2-Methyl-3-Hydroxybutyrate
69789-6,2-Methyl-3-Hydroxybutyrate
69790-4,2-Methylbutyrylglycine
69791-2,Tetradecadienoylcarnitine (C14:2)/Creatinine
69792-0,Tetradecadienoylcarnitine (C14:2)
69793-8,Tetradecadienoylcarnitine (C14:2)
69794-6,Tetradecadienoylcarnitine (C14:2)
69795-3,Dicarboxytetradecenoylcarnitine (C14:1-DC)/Creatinine
69796-1,17-Hydroxyprogesterone
69797-9,1-Hydroxymidazolam
69798-7,"2,5-dimethoxy-4-bromoamphetamine"
Sep-79,Ampicillin
69799-5,21-Deoxycorticosterone
69800-1,Methyl ethyl ketone
69801-9,2-Oxoadipate
69802-7,Alpha ketoglutarate
69803-5,Alpha ketoglutarate
69804-3,2-Oxoisocaproate
69805-0,2-Dechloroethylifosfamide^12H post dose ifosfamide
69806-8,2-Dechloroethylifosfamide^post dose ifosfamide
Jul-80,Ampicillin+Sulbactam
69807-6,2-Dechloroethylifosfamide^pre dose ifosfamide
69808-4,2-Dechloroethylifosfamide^pre dose ifosfamide
69809-2,2-Dechloroethylifosfamide^1D post dose ifosfamide
698-1,Neisseria gonorrhoeae
69810-0,2-Dechloroethylifosfamide^1D post dose ifosfamide
69811-8,2-Dechloroethylifosfamide^2D post dose ifosfamide
69812-6,2-Dechloroethylifosfamide^2D post dose ifosfamide
69813-4,2-Dechloroethylifosfamide^3D post dose ifosfamide
69814-2,2-Dechloroethylifosfamide^3D post dose ifosfamide
May-81,Azithromycin
69815-9,2-Dechloroethylifosfamide^4D post dose ifosfamide
69816-7,2-Dechloroethylifosfamide^4D post dose ifosfamide
69817-5,2-Dechloroethylifosfamide^5D post dose ifosfamide
69818-3,2-Dechloroethylifosfamide^5D post dose ifosfamide
69819-1,2-Dechloroethylifosfamide^6D post dose ifosfamide
69820-9,2-Dechloroethylifosfamide^6D post dose ifosfamide
69821-7,2-Dechloroethylifosfamide^6D post dose ifosfamide
69822-5,2-Dechloroethylifosfamide^7D post dose ifosfamide
Mar-82,Aztreonam
69823-3,2-Dechloroethylifosfamide^7D post dose ifosfamide
69824-1,2-Dechloroethylifosfamide^7D post dose ifosfamide
69825-8,2-Ethylhydracrylate
69826-6,2-Ethylhydracrylate
69827-4,2-Methylglutarate
69828-2,Methylsuccinate
69829-0,Methylsuccinate
69830-8,"3,4-Dihydroxyphenylacetate"
Jan-83,Bacitracin
69831-6,"3,4-Dihydroxyphenylacetate/Creatinine"
69832-4,"3-Hydroxy,3-Methylglutarate"
69833-2,"3-Hydroxy,3-Methylglutarate"
69834-0,"3-Hydroxy,3-Methylglutarate"
69835-7,3-Hydroxyadipate
69836-5,3-Hydroxyadipate
69837-3,3-Hydroxyglutarate
69838-1,2-Hydroxy-3-Methylvalerate
69839-9,2-Hydroxy-3-Methylvalerate
69840-7,2-Hydroxyadipate
69841-5,2-Hydroxyadipate
69842-3,Alpha hydroxybutyrate
69843-1,Alpha hydroxybutyrate
69844-9,2-Hydroxyglutarate
69845-6,2-Hydroxyglutarate
69846-4,2-Hydroxyisobutyrate
69847-2,2-Hydroxyisobutyrate
69848-0,2-Hydroxyisocaproate
Sep-84,Beta lactamase.extended spectrum
69849-8,2-Hydroxyisocaproate
69850-6,3-Hydroxyglutarate
69851-4,3-Hydroxyglutarate
69852-2,3-Hydroxyisobutyrate
69853-0,3-Hydroxyisobutyrate
69854-8,"Hispanic, latino-a, or spanish origin"
69855-5,Race
Jun-85,Beta lactamase.usual
69856-3,"Are you deaf, or do you have serious difficulty hearing"
69857-1,"Are you blind, or do you have serious difficulty seeing, even when wearing glasses"
69858-9,"Because of a physical, mental, or emotional condition, do you have serious difficulty concentrating, remembering, or making decisions"
69859-7,Do you have serious difficulty walking or climbing stairs
69860-5,Do you have difficulty dressing or bathing
69861-3,"Because of a physical, mental, or emotional condition, do you have difficulty doing errands alone such as visiting a physician's office or shopping"
69862-1,Exclusion criteria - assays
69863-9,Process variables for assays
Apr-86,Cefaclor
69864-7,Manufacturer variables for assays
69865-4,Process variables for assays - gonorrhea-chlamydia
69866-2,Process variables for assays - human leukocyte antigen - HLA
69867-0,Active diagnoses based on review of patient records
69868-8,Service comment 41
69869-6,Service comment 42
69870-4,Service comment 43
69871-2,Service comment 44
Feb-87,Cefepime
69872-0,Service comment 45
69873-8,Service comment 46
69874-6,Service comment 47
69875-3,Service comment 48
69876-1,Service comment 49
69877-9,Service comment 50
69878-7,Service comment 51
69879-5,Service comment 52
6988-0,Cefodizime
69880-3,Service comment 53
69881-1,Service comment 54
69882-9,Service comment 55
69883-7,Service comment 56
69884-5,Service comment 57
69885-2,Service comment 58
69886-0,Service comment 59
69887-8,Service comment 60
69888-6,Service comment 61
69889-4,Service comment 62
69890-2,Service comment 63
69891-0,Service comment 64
69892-8,Service comment 65
69893-6,Service comment 66
69894-4,Service comment 67
69895-1,Service comment 68
69896-9,Service comment 69
69897-7,Service comment 70
Aug-89,Cefotaxime
69898-5,Service comment 71
69899-3,Service comment 72
69900-9,Service comment 73
69901-7,Service comment 74
69902-5,Service comment 75
69903-3,Service comment 76
69904-1,Service comment 77
69905-8,Service comment 78
Jun-90,cefoTEtan
69906-6,Service comment 79
69907-4,Service comment 80
69908-2,Multisection^W contrast IV
69910-8,Basophils+Mast cells/100 leukocytes
69913-2,Basophils+Mast cells/100 leukocytes
Apr-91,cefOXitin
69916-5,Basophils+Mast cells/100 leukocytes
69918-1,Coagulation thrombin induced.high dose
69919-9,"Race, ethnicity, sex, primary language, disability - Health & Human Services (HHS) panel"
69920-7,Adenovirus Ab.IgA
69921-5,Herpes simplex virus 1 Ab.IgM
Feb-92,Cefpirome
69922-3,(Beef+Chicken+Pork) Ab.IgE
69923-1,European tick borne encephalitis virus Ab.IgM
69924-9,European tick borne encephalitis virus Ab.IgM
69925-6,European tick borne encephalitis virus Ab.IgM index
69926-4,European tick borne encephalitis virus Ab.IgG
69927-2,European tick borne encephalitis virus Ab.IgG
69928-0,European tick borne encephalitis virus Ab.IgG index
69929-8,Respiratory syncytial virus Ab.IgA
6993-0,Cefpodoxime
69930-6,Varicella zoster virus Ab.IgM
69931-4,(Daucus carota+Phaseolus vulgaris+Pisum sativum+Solanum tuberosum) Ab.IgE
69933-0,Ureaplasma parvum DNA
69934-8,Ureaplasma urealyticum+Ureaplasma parvum DNA
69935-5,Mycoplasma genitalium DNA
69936-3,Gardnerella vaginalis DNA
69937-1,Trichomonas vaginalis DNA
69938-9,Astrovirus RNA
69939-7,Trichophyton rubrum DNA
69941-3,Glucose^20M post dose lactose PO
69942-1,Glucose^40M post dose lactose PO
69943-9,Glucose^20M post 50 g lactose PO
69944-7,Glucose^40M post 50 g lactose PO
69945-4,Insulin-like growth factor binding protein 1
69946-2,Treponema pallidum Ab.IgM
69947-0,Triglyceride
Aug-94,Cefprozil
69948-8,Bordetella parapertussis Ab.IgG
69949-6,Epstein Barr virus capsid Ab.IgG avidity
69950-4,Hemoglobin
69951-2,Amylase.pancreatic/Creatinine
69952-0,Liver kidney microsomal 1 Ab.IgG
69953-8,Purkinje cell cytoplasmic type 1 Ab.IgG
69954-6,Neuronal nuclear type 2 Ab.IgG
May-95,cefTAZidime
69955-3,Intestinal goblet cell Ab
69956-1,Human upstream binding factor Ab.IgG
69957-9,Proteinase 3 Ab.IgG
69958-7,(Citrus sinensis+Malus sylvestris+Musa spp+Prunus persica) Ab.IgE
69959-5,(Alnus incana+Corylus avellana+Ulmus americana+Salix caprea+Populus deltoides) Ab.IgE
69960-3,(Anthoxanthum odoratum+Holcus lanatus+Lolium perenne+Phragmites communis+Secale cereale) Ab.IgE
69961-1,Hepatitis E virus RNA
69962-9,Respiratory syncytial virus Ab.IgM
Mar-96,Ceftibuten
69963-7,"t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript"
69964-5,Bicarbonate^^standard
69965-2,Clinical cytogeneticist review
69966-0,Brief interview for mental status
69967-8,Procedure ICD code
69968-6,NDC labeler code inactivation
69969-4,Newborn screening report overall laboratory comment
69970-2,Volume expired during 1.0 s of forced expiration/Forced vital capacity^post bronchodilation
Jan-97,Ceftizoxime
69971-0,Gas flow at 25-75% of forced expiration
69972-8,Gas flow at 25-75% of forced expiration^pre bronchodilation
69973-6,Gas flow at 25-75% of forced expiration^post bronchodilation
69974-4,Expiratory gas flow.max
69975-1,Expiratory gas flow.max^pre bronchodilation
69976-9,Expiratory gas flow.max^post bronchodilation
69977-7,Expiratory gas flow.max/Expiratory gas flow.max.predicted^pre bronchodilation
69978-5,Expiratory gas flow.max/Expiratory gas flow.max.predicted^post bronchodilation
69979-3,Gas flow at 50% of forced expiration/Gas flow at 50% of forced inspiration^pre bronchodilation
69980-1,Gas flow at 50% of forced expiration/Gas flow at 50% of forced inspiration^post bronchodilation
69981-9,Asthma action plan
69982-7,Forced vital capacity percent change
69983-5,Volume expired during 1.0 s of forced expiration percent change
69984-3,Volume expired during 1.0 s of forced expiration/Forced vital capacity percent change
69985-0,Pressure.continuous positive airway
69986-8,Pressure.continuous positive airway.95%
69987-6,Pressure.continuous positive airway
69988-4,Positive airway pressure device usage
Sep-98,cefTRIAXone
69989-2,Positive airway pressure device usage
699-9,Organism count
69990-0,Apnea hypopnea index
69991-8,Vendor device model code
69992-6,Vendor device name
69993-4,Vendor serial number
69994-2,Vendor software version
69995-9,Class
69996-7,Leak
Jul-99,Cefuroxime.parenteral
69997-5,Leak.95%
69998-3,Leak
69999-1,Positive airway pressure panel
70000-5,Pressure.continuous positive airway
70001-3,Leak
70002-1,Obstructive apnea index
Mar-00,Cephalothin
70003-9,Central apnea index
70004-7,Diagnostic study note
70005-4,Evaluation and management of smoking cessation note
70006-2,Medication management note
70007-0,Restraint note
70008-8,Enterovirus Ab.IgM
70009-6,Enterovirus Ab.IgM
70010-4,Enterovirus Ab.IgG
Jan-01,Chloramphenicol
70011-2,Enterovirus Ab.IgG
70012-0,Coxsackievirus Ab.IgM
70013-8,Coxsackievirus Ab.IgG
70014-6,Parainfluenza virus 1+2+3+4 Ab.IgA
70015-3,Streptococcus sp DNA
70016-1,Staphylococcus sp.coagulase negative DNA
70017-9,Parainfluenza virus 1+2+3+4 Ab.IgM
70018-7,Staphylococcus haemolyticus DNA
70019-5,Klebsiella oxytoca DNA
70020-3,Bacteroides fragilis DNA
70021-1,Salmonella typhi DNA
70022-9,Candida albicans DNA
70023-7,Candida tropicalis DNA
70024-5,Candida parapsilosis DNA
70025-2,Candida krusei DNA
70026-0,Candida glabrata DNA
70027-8,Dermatophytes chitin synthase 1 (chs1) gene
70028-6,Megakaryocytic nuclei/100 leukocytes
Sep-02,Ciprofloxacin
70032-8,Platelets.reticulated/platelets.total
70033-6,Ragocytes/100 leukocytes
70034-4,Lipophages/100 leukocytes
70035-1,Siderophages/100 leukocytes
70036-9,Polymorphonuclear cells/100 leukocytes
Jul-03,Clarithromycin
70037-7,Mononuclear cells/100 leukocytes
70038-5,Mononuclear cells/100 leukocytes
70039-3,Polymorphonuclear cells/100 leukocytes
70040-1,Polymorphonuclear cells/100 leukocytes
70041-9,FSHB gene.c.-211G>T
70042-7,Mononuclear cells/100 leukocytes
70043-5,Mononuclear cells
70044-3,Polymorphonuclear cells
May-04,Clinafloxacin
70045-0,Polymorphonuclear cells
70046-8,Mononuclear cells
70047-6,Mononuclear cells
70048-4,Polymorphonuclear cells
70049-2,Polymorphonuclear cells
700-5,Pneumocystis jiroveci Ag
70050-0,Mononuclear cells
70051-8,Multiple inhalant allergen Ab.IgE
Feb-05,Clindamycin
70052-6,Hantavirus hantaan Ab.IgG
70053-4,Hantavirus hantaan Ab.IgM
70054-2,Hantavirus dobrova Ab.IgM
70055-9,Hantavirus dobrova Ab.IgG
70056-7,Hantavirus saaremaa Ab.IgG
70057-5,Hantavirus saaremaa Ab.IgM
70058-3,Hantavirus puumala Ab.IgM
70059-1,Hantavirus puumala Ab.IgG
7006-0,Demeclocycline
70060-9,Hantavirus seoul Ab.IgG
70061-7,Human papilloma virus 16 & 18 DNA
70065-8,Enterovirus Ag
70066-6,Mononuclear cells/100 leukocytes
70067-4,Polymorphonuclear cells/100 leukocytes
70068-2,Streptococcus dysgalactiae subspecies equisimilis DNA
70069-0,Streptococcus intermedius DNA
70070-8,Streptococcus anginosus DNA
70071-6,Streptococcus constellatus DNA
70072-4,Amyloid beta 40 peptide
70073-2,Amyloid beta 40 peptide
70074-0,Angiotensin II^supine
70075-7,Interleukin 1 alpha
70076-5,Interleukin 1 alpha
70077-3,Interleukin 2
Aug-07,Dirithromycin
70078-1,Interleukin 2
70079-9,Interleukin 3
70080-7,Interleukin 3
70081-5,Interleukin 3
70082-3,Interleukin 4
70083-1,Interleukin 4
70084-9,Interleukin 5
70085-6,Interleukin 5
Jun-08,Doxycycline
70086-4,Interleukin 7
70087-2,Interleukin 7
70088-0,Interleukin 7
70089-8,Interleukin 13
70090-6,Interleukin 13
70091-4,Prostaglandin E2
70092-2,Prostaglandin E1
70093-0,Prostaglandin E1
Apr-09,Erythromycin
70094-8,Prostaglandin F2 alpha
70095-5,Prostaglandin F2 alpha
70096-3,Thyrotropin releasing hormone
70097-1,Establishment de-registration
70098-9,Methotrexate^10th specimen
70099-7,Methotrexate^2nd specimen
70100-3,Methotrexate^3rd specimen
70101-1,Methotrexate^4th specimen
Feb-10,Ethambutol
70102-9,Methotrexate^5th specimen
70103-7,Methotrexate^6th specimen
70104-5,Methotrexate^7th specimen
70105-2,Methotrexate^8th specimen
70106-0,Methotrexate^9th specimen
70107-8,SERPINC1 gene mutations tested for
70108-6,Glutathione S-transferase T1 Ab
70109-4,Number of chromosome 13 present
7011-0,Ethionamide
70110-2,Number of chromosome 18 present
70111-0,Number of chromosome 21 present
70112-8,Skin conditions - Long term care hospital
70113-6,Current number of unhealed (non-epithelialized) pressure ulcers at each stage - Long term care hospital
70114-4,Functional status - usual performance - Long term care hospital
70115-1,Swallowing - nutritional status - Long term care hospital
70116-9,Bowel and bladder - Long term care hospital
70117-7,Administrative information - Long term care hospital
70118-5,"Hearing, speech, vision - Long term care hospital"
70119-3,Healed pressure ulcers - Long term care hospital
70120-1,Assessment administration - Long term care hospital
70121-9,Francisella tularensis Ab.IgG
70122-7,Epithelial cells.squamous
70123-5,Epithelial cells.ciliated
70124-3,Erythrocytes
70125-0,Yeast.hyphae
70126-8,Leukocytes^^corrected for nucleated erythrocytes
70127-6,Signature verifying assessment completion
Aug-12,Fleroxacin
70128-4,Discharge return
70129-2,"Within this acute care hospital stay, on what other units has the patient been treated prior to coming to this unit"
701-3,Yersinia sp identified
70130-0,Rickettsia typhus group & Rickettsia spotted fever group acute & convalescent Ab.IgG & IgM panel
70131-8,Rickettsia typhus group Ab.IgG^1st specimen
70132-6,Rickettsia typhus group Ab.IgG^2nd specimen
70133-4,Rickettsia typhus group Ab.IgM^1st specimen
70134-2,Rickettsia typhus group Ab.IgM^2nd specimen
70135-9,Rickettsia spotted fever group Ab.IgM^1st specimen
Jun-13,Fluconazole
70136-7,Rickettsia spotted fever group Ab.IgM^2nd specimen
70137-5,Sample icteric
70138-3,Amphetamines
70139-1,Barbiturates
70140-9,Benzodiazepines
70141-7,Benzodiazepines
70142-5,Benzodiazepines
70143-3,Cannabinoids
Apr-14,5-Fluorocytosine
70144-1,Cannabinoids
70145-8,Cannabinoids
70146-6,Benzoylecgonine
70147-4,Methadone
70148-2,Methadone
70149-0,Methadone
70150-8,Opiates
Jan-15,Fusidate
70151-6,Opiates
70152-4,Triiodothyronine/Thyroxine
70153-2,Sample hemolyzed
70154-0,Hepatitis B virus surface Ag
70155-7,Barbiturates
70156-5,"inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript"
70157-3,Form sections completed
70158-1,Date sections completed
70159-9,Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14)
70160-7,Reason for assessment - acute
70161-5,Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel
70162-3,Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel
70163-1,Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel
70164-9,Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel
70165-6,Trichomonas vaginalis rRNA
70166-4,Trichomonas vaginalis rRNA
70167-2,Trichomonas vaginalis rRNA
70168-0,Hematocrit
Sep-16,Gentamicin
70169-8,Hematocrit
70170-6,Erythrocytes.nucleated/100 cells
70171-4,Erythrocytes.nucleated/100 cells
70172-2,Neisseria meningitidis serogroup
70173-0,JC virus Ab
70174-8,Dicarboxytetradecenoylcarnitine (C14:1-DC)
70175-5,Dicarboxytetradecenoylcarnitine (C14:1-DC)
70176-3,Dicarboxytetradecenoylcarnitine (C14:1-DC)
Jul-17,Gentamicin.high potency
70177-1,Dicarboxytetradecenoylcarnitine (C14:1-DC)
70178-9,11-Hydroxy delta-9 tetrahydrocannabinol
70179-7,1-Methylhistidine
70180-5,Alpha aminoadipate
70181-3,Alpha aminobutyrate
70182-1,NIH stroke scale
70183-9,NIH stroke scale interval
70184-7,Level of consciousness
May-18,Gentamicin.high potency
70185-4,LOC questions
70186-2,LOC commands
70187-0,Best gaze
70188-8,Visual
70189-6,Facial palsy
70190-4,Motor arm
70191-2,Motor leg
70192-0,Limb ataxia
Mar-19,Imipenem
70193-8,Sensory
70194-6,Best language
70195-3,Dysarthria
70196-1,Extinction and inattention
70197-9,6-Monoacetylmorphine
70198-7,Acetaminophen
70199-5,Bilirubin
70200-1,Cholesterol.in HDL/Cholesterol.total
Jan-20,Isoniazid
70201-9,Cholesterol.in IDL
70202-7,Cholesterol.in IDL+Cholesterol.in VLDL 3
70203-5,Cholesterol.in VLDL 3
70204-3,Cholesterol.non HDL
70205-0,clonazePAM
70206-8,Codeine
70207-6,Estrogen
70208-4,Glucose^pre 100 g glucose PO
70209-2,Haptoglobin
702-1,Anisocytosis
70210-0,Morphine
70211-8,Mycophenolate
70212-6,Nordiazepam
70213-4,Nordiazepam
70214-2,Oxazepam
70215-9,oxyCODONE
70216-7,Salicylates
70217-5,Thyroxine.free
70218-3,Triglyceride
Sep-21,Itraconazole
70219-1,Basic metabolic 2008 panel with ionized calcium
70220-9,"Repeated disturbing memories, thoughts, or images of a stressful experience from the past in the last Mo"
70221-7,Post traumatic stress disorder checklist - civilian version
70222-5,Repeated disturbing dreams of a stressful experience from the past in the last Mo
70223-3,Suddenly acting or feeling as if a stressful experience were happening again - as if you were reliving it - in the last Mo
70224-1,Feeling very upset when something reminded you of a stressful experience from the past in the last Mo
70225-8,"Having physical reactions, heart pounding, trouble breathing or sweating, when something reminded you of a stressful experience from the past in the last Mo"
70226-6,Avoid thinking about or talking about a stressful experience from the past or avoid having feelings related to it in the last Mo
Jul-22,Kanamycin
70227-4,Avoid activites or situations because they remind you of a stressful experience from the past in the last Mo
70228-2,Trouble remembering important parts of a stressful experience from the past in the last Mo
70229-0,Loss of interest in things that you used to enjoy in the last Mo
70230-8,Feeling distant or cut off from other people in the last Mo
70231-6,Feeling emotionally numb or being unable to have loving feelings for those close to you in the last Mo
70232-4,Feeling as if your future will somehow be cut short in the last Mo
70233-2,Trouble falling or staying asleep in the last Mo
70234-0,Feeling irritable or having angry outbursts in the last Mo
May-23,Kanamycin.high potency
70235-7,Having difficulty concentrating in the last Mo
70236-5,Being super alert or watchful on guard in the last Mo
70237-3,Feeling jumpy or easily startled in the last Mo
70238-1,Progress note
70239-9,Testosterone
70240-7,Testosterone.free
70241-5,HIV 1 RNA
70242-3,Shigella species+EIEC invasion plasmid antigen H (ipaH) gene
Mar-24,Kanamycin.high potency
70243-1,CLN3 gene exon 7+8 deletion
70244-9,CFTR gene.c.394delTT
70245-6,PAH gene.p.Arg408Trp
70246-4,CCR2 gene.p.Val64Ile
70247-2,CCR5 gene.c.794_825del
70248-0,GALT gene.p.Gln188Arg
7025-0,Ketoconazole
70251-4,Pyruvate dehydrogenase Ab.IgG
70252-2,Islet cell 512 Ab.IgG
70253-0,Islet cell 512 Ab.IgG
70254-8,Follitropin Ab.IgG
70255-5,Follitropin Ab.IgA
70256-3,Nuclear Ab.IgG
70257-1,Sjogrens syndrome-A extractable nuclear 52kD Ab.IgG
70258-9,Amylase.pancreatic
70259-7,Triglyceride.pericard fld/Triglyceride.serum
70260-5,Triglyceride.periton fld/Triglyceride.serum
70261-3,Cholesterol.periton fld/Cholesterol.serum
70262-1,Amylase.periton fld/Amylase.serum
70263-9,Cholesterol.pericard fld/Cholesterol.serum
70264-7,Creatinine.plr fld/Creatinine.serum
70265-4,Protein.pericard fld/Protein.serum
70266-2,Creatinine.periton fld/Creatinine.serum
70267-0,Protein.periton fld/Protein.serum
Aug-26,levoFLOXacin
70268-8,Cholesterol.plr fld/Cholesterol.serum
70269-6,Triglyceride.plr fld/Triglyceride.serum
70270-4,Amylase.pancreatic
70271-2,"Patient health questionnaire-somatic, anxiety, and depressive symptoms total score"
70272-0,Patient health questionnaire 4 item total score
70273-8,Patient health questionnaire 15 item total score
70274-6,Generalized anxiety disorder 7 item total score
70275-3,"t(X;11)(q13.1;q23)(FOXO4,MLL) fusion transcript"
Jun-27,Loracarbef
70276-1,"t(1;11)(p32;q23)(EPS15,MLL) fusion transcript"
70277-9,"t(3;5)(q25.1;q35.1)(MLF1,NPM1) fusion transcript"
70278-7,"t(3;21)(q26;q22.3)(MECOM,RUNX1) fusion transcript"
70279-5,"t(5;17)(q25.1;q21.1)(NPM1,RARA) fusion transcript"
70280-3,"t(6;11)(q27;q23)(MLLT4,MLL) fusion transcript"
70281-1,"t(9;9)(q34;q34)(NUP214,SET) fusion transcript"
70282-9,"t(9;12)(q34.1;p13)(ABL1,ETV6) fusion transcript"
70283-7,"t(11;17)(q23;q21)(MLL,MLLT6) fusion transcript"
Apr-28,Amdinocillin
70284-5,"t(11;17)(q23;q21.1)(ZBTB16,RARA) fusion transcript"
70285-2,"t(11;19)(q23;p13.1)(MLL,ELL) fusion transcript"
70286-0,"t(12;22)(p13;q12.1)(ETV6,MN1) fusion transcript"
70287-8,"t(16;21)(p11.2;q22.3)(FUS,ERG) fusion transcript"
70288-6,"t(17;19)(q22;p13.3)(HLF,TCF3) fusion transcript"
70289-4,"Del(1)(p32p32)(STIL,TAL1) fusion transcript"
70291-0,"inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript"
Feb-29,Meropenem
70292-8,Blastocystis hominis DNA
70293-6,Entamoeba histolytica+Entamoeba dispar+Entamoeba ecuadoriensis+Entamoeba nuttalli DNA
70294-4,Entamoeba sp DNA
70295-1,Dientamoeba fragilis DNA
70296-9,Plesiomonas shigelloides DNA
70297-7,Patient information panel
70298-5,Mineral metabolism panel
70299-3,Anemia management panel
Mar-70,Cefamandole
7030-0,Methicillin
70300-9,Dialysis adequacy panel
70301-7,I have pain in my stomach area in the past 7D
70302-5,I get headaches in the past 7D
70303-3,I need help doing my usual activities in the past 7D
70304-1,I feel tired in the past 7D
70305-8,I have been short of breath in the past 7D
70306-6,I am self-conscious about the way I dress in the past 7D
70307-4,One or more of my arms are swollen or tender in the past 7D
70308-2,I feel sexually attractive in the past 7D
70309-0,I am bothered by hair loss in the past 7D
70310-8,I worry that other members of my family might someday get the same illness I have in the past 7D
70311-6,I worry about the effect of stress on my illness in the past 7D
70312-4,I am bothered by a change in weight in the past 7D
70313-2,I am able to feel like a woman in the past 7D
70314-0,I have trouble controlling my urine in the past 7D
70315-7,I urinate more frequently than usual in the past 7D
70316-5,It burns when I urinate in the past 7D
70317-3,I am interested in sex in the past 7D
Aug-31,metroNIDAZOLE
70318-1,For men only - I am able to have and maintain an erection in the past 7D
70319-9,I have emotional ups and downs in the past 7D
70320-7,I am able to get around by myself in the past 7D
70321-5,I have concerns about my ability to have children in the past 7D
70322-3,I have bone pain in the past 7D
70323-1,I am able to concentrate in the past 7D
70324-9,I am bothered by the change in my personality in the past 7D
70325-6,I am able to make decisions and take responsibility in the past 7D
Jun-32,Minocycline
70326-4,I am bothered by the drop in my contribution to the family in the past 7D
70327-2,I am able to put my thoughts together in the past 7D
70328-0,"I need help caring for myself - bathing, dressing, eating, etc in the past 7D"
70329-8,I am able to put my thoughts into action in the past 7D
70330-6,I am able to read like I used to in the past 7D
70331-4,I am able to write like I used to in the past 7D
70332-2,"I am able to drive a vehicle - my car, truck, etc - in the past 7D"
70333-0,"I have trouble feeling sensation in my arms, hands or legs in the past 7D"
Apr-33,Mupirocin
70334-8,I have had seizures - convulsions - in the past 7D
70335-5,I have weakness in my arms or legs in the past 7D
70336-3,I have trouble with coordination in the past 7D
70337-1,I can remember new things in the past 7D
70338-9,I get frustrated that I cannot do the things I used to in the past 7D
70339-7,I am afraid of having a seizure - convulsion - in the past 7D
70340-5,I have trouble with my eyesight in the past 7D
70341-3,I feel independent in the past 7D
Feb-34,Nalidixate
70342-1,I am able to find the right words to say what I mean in the past 7D
70343-9,I have difficulty expressing my thoughts in the past 7D
70344-7,I am bothered by fevers - episodes of high body temperature - in the past 7D
70345-4,I have swelling or cramps in my stomach area in the past 7D
70346-2,I am losing weight in the past 7D
70347-0,I have control of my bowels in the past 7D
70348-8,I can digest my food well in the past 7D
70349-6,I have diarrhea in the past 7D
70350-4,I have a good appetite in the past 7D
70351-2,I like the appearance of my body in the past 7D
70352-0,I am embarrassed by my ostomy appliance in the past 7D
70353-8,Caring for my ostomy appliance is difficult in the past 7D
70354-6,I am able to maintain my balance in the past 7D
70355-3,I am able to walk in the past 7D
70356-1,I have strength in my arms in the past 7D
70357-9,I have strength in my legs in the past 7D
70358-7,I have numbness in my legs in the past 7D
Sep-35,Netilmicin
70359-5,I have pain in my back in the past 7D
70360-3,I am bothered by discharge or bleeding from my vagina in the past 7D
70361-1,I am bothered by odor coming from my vagina in the past 7D
70362-9,I am afraid to have sex in the past 7D
70363-7,My vagina feels too narrow or short in the past 7D
70364-5,I am afraid the treatment will harm my body in the past 7D
70365-2,I am bothered by constipation in the past 7D
70366-0,I have discomfort when I urinate in the past 7D
Jul-36,Nitrofurantoin
70367-8,I have difficulty swallowing solid foods in the past 7D
70368-6,I have difficulty swallowing soft or mashed foods in the past 7D
70369-4,I have difficulty swallowing liquids in the past 7D
70370-2,I have a pain in my chest when I swallow in the past 7D
70371-0,I choke when I swallow in the past 7D
70372-8,I am able to enjoy meals with family or friends in the past 7D
70373-6,I wake at night because of coughing in the past 7D
70374-4,I have trouble digesting food in the past 7D
May-37,Norfloxacin
70375-1,I have discomfort or pain in my pelvic area in the past 7D
70376-9,I have hot flashes in the past 7D
70377-7,I have gained weight in the past 7D
70378-5,I have cold sweats in the past 7D
70379-3,I have night sweats in the past 7D
70380-1,I have vaginal discharge in the past 7D
70381-9,I have vaginal bleeding or spotting in the past 7D
70382-7,I have pain or discomfort with intercourse in the past 7D
Mar-38,Ofloxacin
70383-5,I have a loss of appetite in the past 7D
70384-3,My digestive problems interfere with my usual activities in the past 7D
70385-0,I have trouble swallowing food in the past 7D
70386-8,I am bothered by gas - flatulence - in the past 7D
70387-6,I am bothered by reflux or heartburn in the past 7D
70388-4,I am bothered by a change in my eating habits in the past 7D
70389-2,I have discomfort or pain when I eat in the past 7D
703-9,Basophilic stippling
70390-0,I have stomach problems that worry me in the past 7D
Jan-39,Oxacillin
70391-8,I avoid going out to eat because of my illness in the past 7D
70392-6,I feel sad in the past 7D
70393-4,I am satisfied with how I am coping with my illness in the past 7D
70394-2,I am losing hope in the fight against my illness in the past 7D
70395-9,I feel nervous in the past 7D
70396-7,I worry about dying in the past 7D
70397-5,I worry that my condition will get worse in the past 7D
70398-3,I am able to work - include work at home - in the past 7D
70399-1,My work - include work at home - is fulfilling in the past 7D
70400-7,I am able to enjoy life in the past 7D
70401-5,I have accepted my illness in the past 7D
70402-3,I am sleeping well in the past 7D
70403-1,I am enjoying the things I usually do for fun in the past 7D
70404-9,I am content with the quality of my life right now in the past 7D
70405-6,I have a lack of energy in the past 7D
70406-4,I have nausea in the past 7D
70407-2,"Because of my physical condition, I have trouble meeting the needs of my family in the past 7D"
70408-0,I have pain in the past 7D
Sep-40,Pefloxacin
70409-8,I am bothered by side effects of treatment in the past 7D
70410-6,I feel ill in the past 7D
70411-4,I am forced to spend time in bed in the past 7D
70412-2,I feel close to my friends in the past 7D
70413-0,I get emotional support from my family in the past 7D
70414-8,I get support from my friends in the past 7D
70415-5,My family has accepted my illness in the past 7D
70416-3,I am satisfied with family communication about my illness in the past 7D
Jul-41,Penicillin G
70417-1,"I feel close to my partner, or the person who is my main support, in the past 7D"
70418-9,I am satisfied with my sex life in the past 7D
70419-7,I am unhappy about a change in my appearance in the past 7D
70420-5,I am bothered by jaundice or yellow color to my skin in the past 7D
70421-3,I have had fevers - episodes of high body temperature - in the past 7D
70422-1,I have had a change in the way food tastes in the past 7D
70423-9,I have had chills in the past 7D
70424-7,I have discomfort or pain in my stomach area in the past 7D
May-42,Penicillin V
70425-4,I feel weak all over in the past 7D
70426-2,I feel fatigued in the past 7D
70427-0,I am able to eat the foods that I like in the past 7D
70428-8,I am able to communicate with others in the past 7D
70429-6,I can eat solid foods in the past 7D
70430-4,"I have pain in my mouth, throat or neck in the past 7D"
70431-2,My mouth is dry in the past 7D
70432-0,I have trouble breathing in the past 7D
Mar-43,Piperacillin
70433-8,My voice has its usual quality and strength in the past 7D
70434-6,I am able to eat as much food as I want in the past 7D
70435-3,I am unhappy with how my face and neck look in the past 7D
70436-1,I can swallow naturally and easily in the past 7D
70437-9,I smoke cigarettes or other tobacco products in the past 7D
70438-7,"I drink alcohol - beer, wine, etc - in the past 7D"
70439-5,I have to limit my social activity because of my condition in the past 7D
70440-3,I have to limit my physical activity because of my condition in the past 7D
Jan-44,Piperacillin+Tazobactam
70441-1,My thinking is clear in the past 7D
70442-9,I have been coughing in the past 7D
70443-7,I feel tightness in my chest in the past 7D
70444-5,Breathing is easy for me in the past 7D
70445-2,I regret my smoking in the past 7D
70446-0,"I am bothered by lumps or swelling in certain part of my body - neck, armpits, or groin - in the past 7D"
70447-8,"Because of my illness, I have difficulty planning for the future in the past 7D"
70448-6,I feel uncertain about my future health in the past 7D
70449-4,I worry that I might get new symptoms of my illness in the past 7D
70450-2,I feel isolated from others because of my illness or treatment in the past 7D
70451-0,I am bothered by itching in the past 7D
70452-8,I have trouble sleeping at night in the past 7D
70453-6,I have pain at my melanoma site or surgical site in the past 7D
70454-4,I have swelling at my melanoma site in the past 7D
70455-1,I have swelling as a result of surgery in the past 7D
70456-9,I am bothered by the amount of swelling in the past 7D
70457-7,Movement of my swollen area is painful in the past 7D
Aug-45,rifAMPin
70458-5,Swelling keeps me from doing the things I want to do in the past 7D
70459-3,Swelling keeps me from wearing clothes or shoes I want to wear in the past 7D
70460-1,I feel numbness at my surgical site in the past 7D
70461-9,I have good range of movement in my arm or leg in the past 7D
70462-7,"I have noticed new changes in my skin - lumps, bumps, color in the past 7D"
70463-5,I worry about the appearance of surgical scars in the past 7D
70464-3,I have aches and pains in my bones in the past 7D
70465-0,I have noticed blood in my stool in the past 7D
Jun-46,Roxithromycin
70466-8,I isolate myself from others because of my condition in the past 7D
70467-6,"I have difficulty thinking clearly - remembering, concentrating - in the past 7D"
70468-4,I have trouble walking because of the pain in the past 7D
70469-2,I feel overwhelmed by my condition in the past 7D
704-7,Basophils
70470-0,I worry about getting infections in the past 7D
70471-8,I have difficulty moving my neck and shoulders because of stiffness in the past 7D
70472-6,I am bothered by ringing in my ears in the past 7D
70473-4,I am bothered by worsening eyesight in the past 7D
Apr-47,Sparfloxacin
70474-2,I have trouble smelling the in past 7D
70475-9,I can enjoy the taste of food in the past 7D
70476-7,I am bothered by having a blocked nose in the past 7D
70477-5,I have trouble hearing in the past 7D
70478-3,I have swelling in my stomach area in the past 7D
70479-1,I have been vomiting in the past 7D
70480-9,I have cramps in my stomach area in the past 7D
70481-7,I have certain parts of my body where I experience pain in the past 7D
Feb-48,Streptomycin
70482-5,Do you have an ostomy appliance
70483-3,Have you ever smoked
70484-1,I bleed easily in the past 7D
70485-8,I bruise easily in the past 7D
70486-6,I am bothered by discharge or bleeding from my vulva in the past 7D
70487-4,I am bothered by odor coming from my vulva in the past 7D
70488-2,"I am bothered by swelling, fluid in my legs, in the past 7D"
70489-0,I am bothered by discomfort in my groin or legs in the past 7D
7049-0,Streptomycin.high potency
70490-8,I am bothered by itching - burning in my vulva area in the past 7D
70491-6,I am bothered by pain or numbness in my vulva area in the past 7D
70492-4,I have trouble bending in the past 7D
70493-2,I have discomfort when I'm sitting in the past 7D
70494-0,I am bothered by wearing compression stockings in the past 7D
70495-7,Functional assessment of cancer therapy - general questionnaire - version 4
70496-5,Functional assessment of cancer therapy for patients with breast cancer questionnaire - version 4
70497-3,Functional assessment of cancer therapy for patients with bladder cancer questionnaire - version 4
70498-1,Physical well being
70499-9,Social - family well being
70500-4,Emotional well being
70501-2,Functional well being
70502-0,Additional concerns
70503-8,Functional assessment of cancer therapy for patients with brain cancer questionnaire - version 4
70504-6,Functional assessment of chronic illness therapy - general measures panel
70505-3,Functional assessment of chronic illness therapy - cancer specific measures panel
70506-1,Functional assessment of chronic illness therapy - cancer specific symptom indexes panel
70507-9,Functional assessment of cancer therapy for patients with colorectal cancer questionnaire - version 4
Aug-50,sulfADIAZINE
70508-7,Functional assessment of cancer therapy for patients with cancer in the central nervous system questionnaire - version 4
70509-5,Functional assessment of cancer therapy for patients with cancer of the cervix questionnaire - version 4
70510-3,Functional assessment of cancer therapy for patients with esophageal cancer questionnaire - version 4
70511-1,Functional assessment of cancer therapy for patients with endometrial cancer questionnaire - version 4
70512-9,Functional assessment of cancer therapy for patients with gastric cancer questionnaire - version 4
70513-7,Functional assessment of cancer therapy for patients with head and neck cancer questionnaire - version 4
70514-5,Functional assessment of cancer therapy for patients with hepatobiliary cancer questionnaire - version 4
70515-2,Functional assessment of cancer therapy for patients with lung cancer questionnaire - version 4
Jun-51,Teicoplanin
70516-0,Functional assessment of cancer therapy for patients with leukemia questionnaire - version 4
70517-8,Functional assessment of cancer therapy for patients with non-hodgkins lymphoma questionnaire - version 4
70518-6,Functional assessment of cancer therapy for patients with melanoma questionnaire - version 4
70519-4,Functional assessment of cancer therapy for patient with multiple myeloma questionnaire - version 4
70520-2,Functional assessment of cancer therapy for patients with nasopharyngeal cancer questionnaire - version 4
70521-0,Functional assessment of cancer therapy for patients with ovarian cancer questionnaire - version 4
70522-8,Functional assessment of cancer therapy for patients with vulva cancer questionnaire - version 4
70523-6,Functional assessment of cancer therapy - general population questionnaire - version 4
Apr-52,Tetracycline
70524-4,Functional assessment of non-life threatening conditions questionnaire - version 4
70525-1,I have a feeling of fullness or heaviness in my stomach area in the past 7D
70526-9,I have had itching in the past 7D
70527-7,I am bothered by the chills in the past 7D
70528-5,I get tired easily in the past 7D
70530-1,I have trouble concentrating in the past 7D
70531-9,I feel discouraged about my illness in the past 7D
Feb-53,Ticarcillin
70532-7,Functional assessment of cancer therapy - prostate symptom index questionnaire - 8 items
70533-5,Functional assessment of cancer therapy - bladder symptom index questionnaire - 7 items
70534-3,National comprehensive cancer network - bladder symptom index questionnaire - 18 items
70535-0,Functional assessment of cancer therapy - brain symptom index questionnaire - 15 items
70536-8,National comprehensive cancer network - brain symptom index questionnaire - 24 items
70537-6,Functional assessment of cancer therapy - breast symptom index questionnaire - 8 items
70538-4,National comprehensive cancer network - breast symptom index questionnaire - 16 items
70539-2,Functional assessment of cancer therapy - colorectal symptom index questionnaire - 9 items
705-4,Basophils
7054-0,Ticarcillin+Clavulanate
70540-0,National comprehensive cancer network - colorectal symptom index questionnaire - 19 items
70541-8,Functional assessment of cancer therapy - head and neck symptom index questionnaire - 10 items
70542-6,National comprehensive cancer network - head and neck symptom index questionnaire - 22 items
70543-4,Functional assessment of cancer therapy - hepatibiliary symptom index questionnaire - 8 items
70544-2,National comprehensive cancer network - hepatibiliary symptom index questionnaire - 18 items
70545-9,Functional assessment of chronic illness therapy for patients with kidney cancer questionnaire - 15 items
70546-7,Functional assessment of chronic illness therapy for patients with kidney cancer questionnaire - 10 items
70547-5,Functional assessment of chronic illness therapy for patients with kidney cancer - disease related symptoms questionnaire - 9 items
70548-3,National comprehensive cancer network - kidney symptom index questionnaire - 19 items
70549-1,Functional assessment of cancer therapy - lung symptom index questionnaire - 6 items - version 4
70550-9,Functional assessment of cancer therapy - lung symptom index questionnaire - 12 items - version 4
70551-7,Functional assessment of cancer therapy - lung symptom index questionnaire - 7 items - version 4
70552-5,National comprehensive cancer network - lung symptom index questionnaire - 17 items
70553-3,National comprehensive cancer network - lymphoma symptom index questionnaire - 18 items
70554-1,Functional assessment of cancer therapy - ovarian symptom index questionnaire - 8 items
70555-8,National comprehensive cancer network - ovarian symptom index questionnaire - 18 items
70556-6,Functional assessment of cancer therapy - prostate symptom index questionnaire - 8 items
Jul-55,Tobramycin
70557-4,National comprehensive cancer network - prostate symptom index questionnaire - 17 items
70558-2,My pain keeps me from doing things I want to do in the past 7D
70559-0,My problems with urinating limit my activities in the past 7D
70560-8,"I feel light-headed, dizzy in the past 7D"
70561-6,I have mouth sores in the past 7D
70562-4,I have numbness or tingling in my hands in the past 7D
70563-2,I have pain in my hands or feet when I am exposed to cold temperatures in the past 7D
70564-0,I have had blood in my urine in the past 7D
May-56,Trimethoprim
70565-7,I am bothered by skin problems in the past 7D
70566-5,I have difficulty urinating in the past 7D
70567-3,I have trouble moving my bowels in the past 7D
70568-1,Plasmodium knowlesi DNA
70569-9,Plasmodium sp Ag
70570-7,I have weakness in my legs in the past 7D
70571-5,Functional assessment of chronic illness therapy - bone treatment convenience and satisfaction questionnaire - version 1
70572-3,I believe that treatment for bone disease will take up my time
Mar-57,Trimethoprim+Sulfamethoxazole
70573-1,I believe that my treatment for bone disease will take up my family's time
70574-9,I worry about side effects from treatment for bone disease
70575-6,I believe that my treatment for bone disease will cause me physical pain
70576-4,I believe that receiving treatment for bone disease will be inconvenient
70577-2,I worry that my treatment for bone disease will not be effective
70578-0,I believe that treatment for bone disease will be harmful to me
70579-8,I believe that my treatment schedule for bone disease will be stressful to me
70580-6,I believe that my treatment schedule for bone disease will be stressful to my family
Jan-58,Trovafloxacin
70581-4,I believe that I will be bothered by side effects of treatment for bone disease
70582-2,I believe that waiting up to 60M before eating breakfast in the morning will be inconvenient
70583-0,I believe that an infusion for my bone treatment will cause me physical pain
70584-8,I believe that having my blood drawn will be inconvenient
70585-5,Functional assessment of cancer therapy for patients receiving enteral feeding questionnaire - version 1
70586-3,I experience a pleasant feeling of fullness during or after my tube feeding in the past 7D
70587-1,I feel uncomfortably full during or after my tube feeding in the past 7D
70588-9,I have constipation during or after my tube feeding in the past 7D
70589-7,I experience vomiting during or after my tube feeding in the past 7D
70590-5,"Tube feeding limits what I can do inside the house - for example housework, watching TV or reading - in the past 7D"
70591-3,"Tube feeding limits what I can do outside of the house - for example shopping, driving or yard work - in the past 7D"
70592-1,Tube feeding limits my activities with my friends in the past 7D
70593-9,"During the use of tube feeding, I can eat and drink by mouth in the past 7D"
70594-7,I miss being able to take more food or drink by mouth now that I have a feeding tube in the past 7D
70595-4,I have the desire to eat in the past 7D
70596-2,I worry that having a feeding tube means my health is worse in the past 7D
70597-0,I worry about the tube coming out by accident in the past 7D
70598-8,I worry about the tube getting plugged or blocked in the past 7D
Sep-59,Vancomycin
70599-6,I worry about getting an infection from the feeding tube in the past 7D
70600-2,I worry about losing weight because I have a feeding tube in the past 7D
70601-0,I feel that I have lost control of my food choices because I have a feeding tube in the past 7D
70602-8,I feel dependent on others because I have a feeding tube in the past 7D
70603-6,I feel left out when others are eating in the past 7D
70604-4,I am more confident about my nutrition because of my feeding tube in the past 7D
70605-1,Getting a feeding tube was the right decision for me in the past 7D
70606-9,Functional assessment of cancer therapy for patients with EGFRI inhibitors questionnaire - 18 items
Jul-60,Haliotis spp Ab.IgE
70607-7,My skin or scalp feels irritated in the past 7D
70608-5,My skin or scalp is dry or flaky in the past 7D
70609-3,My skin or scalp itches in the past 7D
70610-1,My skin bleeds easily in the past 7D
70611-9,I am bothered by a change in my skins sensitivity to the sun in the past 7D
70612-7,My skin condition interferes with my ability to sleep in the past 7D
70613-5,My skin condition affects my mood in the past 7D
70614-3,My skin condition interferes with my social life in the past 7D
May-61,Alder Ab.IgG
70615-0,I am embarrassed by my skin condition in the past 7D
70616-8,I avoid going out in public because of how my skin looks in the past 7D
70617-6,I feel unattractive because of how my skin looks in the past 7D
70618-4,Changes in my skin condition make daily life difficult in the past 7D
70619-2,The skin side effects from treatment have interfered with household tasks in the past 7D
706-2,Basophils/100 leukocytes
70620-0,My eyes are dry in the past 7D
70621-8,I am bothered by sensitivity around my fingernails or toenails in the past 7D
70622-6,Sensitivity around my fingernails makes it difficult to perform household tasks in the past 7D
Mar-62,Alnus rubra Ab.IgE
70623-4,I am bothered by increased facial hair in the past 7D
70624-2,Functional assessment of cancer therapy for patients with neurotoxicity questionnaire - version 4
70625-9,I have numbness or tingling in my feet in the past 7D
70626-7,I feel discomfort in my hands in the past 7D
70627-5,I feel discomfort in my feet in the past 7D
70628-3,I have joint pain or muscle cramps in the past 7D
70629-1,I get a ringing or buzzing in my ears in the past 7D
70630-9,I have trouble buttoning buttons in the past 7D
Jan-63,Alnus rugosa Ab.IgE
70631-7,I have trouble feeling the shape of small objects when they are in my hand in the past 7D
70632-5,I have trouble walking in the past 7D
70633-3,Functional assessment of cancer therapy for patients with neurotoxicity questionnaire - 12 items - version 4
70634-1,I have difficulty breathing when I am exposed to cold temperatures in the past 7D
70635-8,Functional assessment of cancer therapy for patients with neurotoxicity questionnaire - 13 items - version 4
70636-6,Functional assessment of cancer therapy for patients with neurotoxicity questionnaire - 4 items - version 4
70637-4,Functional assessment of cancer therapy for patients undergoing bone marrow transplantation questionnaire - version 4
70638-2,I am concerned about keeping my job - include work at home - in the past 7D
70639-0,I feel distant from other people in the past 7D
70640-8,I worry that the transplant will not work in the past 7D
70641-6,The effects of treatment are worse than I had imagined in the past 7D
70642-4,I have confidence in my nurse-s in the past 7D
70643-2,I regret having the bone marrow transplant in the past 7D
70644-0,I have frequent colds-infections in the past 7D
70645-7,My eyesight is blurry in the past 7D
70646-5,I have tremors in the past 7D
70647-3,My illness is a personal hardship for my close family members in the past 7D
70648-1,The cost of my treatment is a burden on me or my family in the past 7D
Sep-64,Alnus rhombifolia Ab.IgE
70649-9,Functional assessment of cancer therapy for patients receiving biologic response modifiers questionnaire - version 4
70650-7,I am bothered by sweating in the past 7D
70651-5,I have trouble remembering things in the past 7D
70652-3,I get depressed easily in the past 7D
70653-1,I get annoyed easily in the past 7D
70654-9,I feel motivated to do things in the past 7D
70655-6,Functional assessment of cancer therapy - taxane questionnaire - version 4
Jun-65,Medicago sativa Ab.IgE
70656-4,I feel bloated in the past 7D
70657-2,My hands are swollen in the past 7D
70658-0,My legs or feet are swollen in the past 7D
70659-8,I have pain in my fingertips in the past 7D
70660-6,I am bothered by the way my hands or nails look in the past 7D
70663-0,I can remember things in the past 7D
Apr-66,Medicago sativa Ab.IgG
70664-8,Parathyrin.intact intraoperative percent change
70665-5,Cold agglutinin
70666-3,Cold agglutinin
70667-1,Cold agglutinin
70668-9,I am bothered by a change in the way food tastes in the past 7D
70669-7,I have trouble with my bowels in the past 7D
70670-5,I have pain in my joints in the past 7D
70671-3,Mycobacterium avium subspecies paratuberculosis Ab
Feb-67,Medicago sativa pollen Ab.IgE
70672-1,Functional assessment of chronic illness therapy - treatment specific measures panel
70673-9,Functional assessment of chronic illness therapy - non cancer specific measures panel
70674-7,Functional assessment of chronic illness therapy - symptom specific measures panel
70675-4,Functional assessment of chronic illness therapy - pediatric measures panel
70676-2,Functional assessment of anorexia-cachexia treatment questionnaire - version 4
70677-0,The amount I eat is sufficient to meet my needs in the past 7D
70678-8,I am worried about my weight in the past 7D
70679-6,Most food tastes unpleasant to me in the past 7D
7068-0,Algae Ab.IgE
70680-4,I am concerned about how thin I look in the past 7D
70681-2,My interest in food drops as soon as I try to eat in the past 7D
70682-0,I have difficulty eating rich or heavy foods in the past 7D
70683-8,My family or friends are pressuring me to eat in the past 7D
70684-6,"When I eat, I seem to get full quickly in the past 7D"
70685-3,My general health is improving in the past 7D
70686-1,Functional assessment of chronic illness therapy for patients with abdominal symptoms questionnaire - version 4
70687-9,Stomach pain interferes with my daily functioning in the past 7D
70688-7,Functional assessment of chronic illness therapy for patients with ascites questionnaire
70689-5,I have been emotionally distressed in the past 7D
70690-3,Functional assessment of chronic illness therapy for patients with cervical dysplasia questionnaire - version 4
70691-1,Treatment satisfaction
70692-9,General perceptions
70693-7,Relationships
70694-5,I have to limit my sexual activity because of the infection in the past 7D
70695-2,I worry about spreading the infection in the past 7D
70696-0,I am hopeful about the future in the past 7D
70697-8,I find comfort in my faith or spiritual beliefs in the past 7D
Aug-69,Pimenta dioica Ab.IgE
70698-6,I feel that I can manage things that come up around this infection in the past 7D
70699-4,I have accepted that I have this infection in the past 7D
707-0,Basophils/100 leukocytes
70700-0,I worry that the infection will get worse in the past 7D
70701-8,I have hidden this problem so others will not notice in the past 7D
70702-6,I have concerns about my ability to become pregnant in the past 7D
70703-4,I worry about other peoples attitudes towards me in the past 7D
70704-2,I feel embarrassed about the infection in the past 7D
70705-9,I tend to blame myself for the infection in the past 7D
Jun-70,Prunus dulcis Ab.IgG
70706-7,I was careful who I told about the infection in the past 7D
70707-5,I have had difficulty telling my partner - spouse about the infection in the past 7D
70708-3,I am frustrated by the infection in the past 7D
70709-1,I am depressed about the infection in the past 7D
70710-9,I have told my partner - spouse about my infection in the past 7D
70711-7,I get emotional support from my partner - spouse in the past 7D
70712-5,I have told family members about my infection in the past 7D
70713-3,I get emotional support from family members in the past 7D
Apr-71,Prunus dulcis basophil bound Ab
70714-1,I have people to help me if I need it in the past 7D
70715-8,Functional assessment of chronic illness therapy - diarrhea questionnaire - version 4
70716-6,I move my bowels more frequently than usual in the past 7D
70717-4,I am afraid to be far from a toilet in the past 7D
70718-2,I have to limit my social activity because of diarrhea in the past 7D
70719-0,I have to limit my physical activity because of diarrhea in the past 7D
70720-8,I have to limit my sexual activity because of diarrhea in the past 7D
70721-6,I am embarrassed by having diarrhea in the past 7D
Feb-72,Prunus dulcis tree Ab.IgE
70722-4,I have abdominal cramps or discomfort due to my diarrhea in the past 7D
70723-2,My problem with diarrhea keeps - wakes - me up at night in the past 7D
70724-0,I must move my bowels frequently to avoid accidents in the past 7D
70725-7,I wear protection for soiling of stool in the past 7D
70726-5,Functional assessment of chronic illness therapy - fatigue questionnaire - version 4
70727-3,I feel listless - washed out - in the past 7D
70728-1,I have trouble starting things because I am tired in the past 7D
70729-9,I have trouble finishing things because I am tired in the past 7D
7073-0,Amylase Ab.IgE
70730-7,I have energy in the past 7D
70731-5,I need to sleep during the day in the past 7D
70732-3,I am too tired to eat in the past 7D
70733-1,I am frustrated by being too tired to do the things I want to do in the past 7D
70734-9,I have to limit my social activity because I am tired in the past 7D
70735-6,Functional assessment of chronic illness therapy - fatigue questionnaire -13 items - version 4
70736-4,Functional assessment of cancer therapy for patients with anemia - fatigue questionnaire - version 4
70737-2,I have pain in my chest in the past 7D
70738-0,I am motivated to do my usual activities in the past 7D
70739-8,Functional assessment of cancer therapy for patients with lymphedema questionnaire - version 4
70740-6,On which side was your breast operation
70741-4,Movement of my arm on this side is painful in the past 7D
70742-2,I have a poor range of arm movements on this side in the past 7D
70743-0,My arm on this side feels numb in the past 7D
70744-8,I have stiffness of my arm on this side in the past 7D
70745-5,Functional assessment of cancer therapy for patients with bone pain questionnaire
70746-3,In how many places in your body have you felt bone pain
70747-1,It hurts when I put weight or pressure on the place where I have bone pain in the past 7D
Aug-74,Alternaria sp Ab.IgE
70748-9,I have bone pain even when I sit or lie still in the past 7D
70749-7,I need help doing my usual activities because of bone pain in the past 7D
70750-5,I am forced to rest during the day because of bone pain in the past 7D
70751-3,I have trouble walking because of bone pain in the past 7D
70752-1,"Bone pain interferes with my ability to care for myself - bathing, dressing, eating, etc - in the past 7D"
70753-9,Bone pain interferes with my social activities in the past 7D
70754-7,Bone pain wakes me up at night in the past 7D
May-75,Alternaria sp Ab.IgG
70755-4,I am frustrated by my bone pain in the past 7D
70756-2,I feel depressed about my bone pain in the past 7D
70757-0,I worry that my bone pain will get worse in the past 7D
70758-8,My family has trouble understanding when my bone pain interferes with my activity in the past 7D
70759-6,Functional assessment of cancer therapy for patients with cognitive function issues questionnaire - version 3
70760-4,I have had trouble forming thoughts in the past 7D
70761-2,My thinking has been slow in the past 7D
70762-0,I have had trouble concentrating in the past 7D
Mar-76,Alternaria alternata Ab.IgG
70763-8,I have had trouble finding my way to a familiar place in the past 7D
70764-6,"I have had trouble remembering where I put things, like my keys or my wallet in the past 7D"
70765-3,"I have had trouble remembering new information, like phone numbers or simple instructions in the past 7D"
70766-1,I have had trouble recalling the name of an object while talking to someone in the past 7D
70767-9,I have had trouble finding the right words to express myself in the past 7D
70768-7,I have used the wrong word when I referred to an object in the past 7D
70769-5,I have had trouble saying what I mean in conversations with others in the past 7D
70770-3,I have walked into a room and forgotten what I meant to get or do there in the past 7D
Jan-77,Alternaria alternata basophil bound Ab
70771-1,I have had to work really hard to pay attention or I would make a mistake in the past 7D
70772-9,I have forgotten names of people soon after being introduced in the past 7D
70773-7,My reactions in everyday situations have been slow in the past 7D
70774-5,Comments from others
70775-2,Other people have told me I seemed to have trouble remembering information in the past 7D
70776-0,I have had to work harder than usual to keep track of what I was doing in the past 7D
70777-8,My thinking has been slower than usual in the past 7D
70778-6,I have had to work harder than usual to express myself clearly in the past 7D
70779-4,I have had to use written lists more often than usual so I would not forget things in the past 7D
70780-2,I have trouble keeping track of what I am doing if I am interrupted in the past 7D
70781-0,I have trouble shifting back and forth between different activities that require thinking in the past 7D
70782-8,Other people have told me I seemed to have trouble speaking clearly in the past 7D
70783-6,Other people have told me I seemed to have trouble thinking clearly in the past 7D
70784-4,Other people have told me I seemed confused in the past 7D
70785-1,Perceived cognitive abilities
70786-9,I have been able to concentrate in the past 7D
70787-7,I have been able to bring to mind words that I wanted to use while talking to someone in the past 7D
70788-5,"I have been able to remember things, like where I left my keys or wallet, in the past 7D"
Sep-78,Ampicillin Ab.IgM
70789-3,"I have been able to remember to do things, like take medicine or buy something I needed, in the past 7D"
70790-1,I am able to pay attention and keep track of what I am doing without extra effort in the past 7D
70791-9,My mind is as sharp as it has always been in the past 7D
70792-7,My memory is as good as it has always been in the past 7D
70793-5,I am able to shift back and forth between two activities that require thinking in the past 7D
70794-3,"I am able to keep track of what I am doing, even if I am interrupted in the past 7D"
70795-0,Impact on quality of life
70796-8,I have been upset about these problems in the past 7D
Jul-79,Engraulis encrasicolus Ab.IgE
70797-6,These problems have interfered with my ability to work in the past 7D
70798-4,These problems have interfered with my ability to do things I enjoy in the past 7D
70799-2,These problems have interfered with the quality of my life in the past 7D
70800-8,Functional assessment of cancer therapy for patients with endocrine symptoms questionnaire - version 4
70801-6,I have vaginal itching - irritation - in the past 7D
70802-4,I have vaginal dryness in the past 7D
70803-2,I have lost interest in sex in the past 7D
70804-0,I have breast sensitivity - tenderness - in the past 7D
May-80,Engraulis encrasicolus Ab.IgG
70805-7,I have mood swings in the past 7D
70806-5,I am irritable in the past 7D
70807-3,Functional assessment of cancer therapy for patients with neutropenia questionnaire - version 4
70808-1,I worry about getting sick due to low blood counts in the past 7D
70809-9,I avoid public places for fear of getting an infection in the past 7D
70810-7,I get aches and pains that bother me in the past 7D
70811-5,I worry my condition will not improve if my treatment is delayed in the past 7D
70812-3,My partner worries about me when my blood counts are low in the past 7D
Mar-81,Pimpinella anisum Ab.IgE
70813-1,My low blood counts interfere with my intimate relationships in the past 7D
70814-9,I am bothered by headaches in the past 7D
70815-6,I need to rest during the day in the past 7D
70816-4,Functional assessment of cancer therapy for patients with thrombocytopenia questionnaire - 11 items - version 4
70817-2,I worry about problems with bruising or bleeding in the past 7D
70818-0,I am bothered by nosebleeds in the past 7D
70819-8,I am bothered by pinpoint bruising beneath my skin in the past 7D
70820-6,I am bothered by blood in my urine or stool in the past 7D
Jan-82,Monomorium minimum Ab.IgG
70821-4,"I avoid or limit physical activity, because of concern with bleeding or bruising, in the past 7D"
70822-2,I am frustrated by not being able to do my usual activities in the past 7D
70823-0,"I worry that my treatment will be delayed, because of low blood counts, in the past 7D"
70824-8,Functional assessment of cancer therapy for patients with thrombocytopenia questionnaire - 18 items - version 4
70825-5,I worry about the possibility of serious bleeding in the past 7D
70826-3,I am bothered by bleeding in my gums or mouth in the past 7D
70827-1,I am inconvenienced by platelet transfusions in the past 7D
70828-9,"I avoid or limit social activity, because of concern with bleeding or bruising, in the past 7D"
70829-7,"I worry that my treatment dose will be reduced, because of low blood counts, in the past 7D"
70830-5,For women only - I am bothered by vaginal bleeding in the past 7D
70831-3,Functional assessment of incontinence therapy - fecal questionnaire - version 4
70832-1,I am comfortable discussing my condition with friends in the past 7D
70833-9,I have to limit my sexual activity because of my condition in the past 7D
70834-7,I am embarrassed by my condition in the past 7D
70835-4,My condition wakes or keeps me up at night in the past 7D
70836-2,I can be far from home - work without fearing soilage in the past 7D
70837-0,Functional assessment of incontinence therapy - urinary questionnaire - version 4
70838-8,My condition wakes me up at night in the past 7D
Sep-83,Monomorium minimum basophil bound Ab
70839-6,I must urinate frequently to avoid leaking in the past 7D
70840-4,I wear protection for leakage of urine in the past 7D
70841-2,I have discomfort in my pelvic area in the past 7D
70842-0,I have pain in my pelvic area in the past 7D
70843-8,I have cramping in my pelvic area in the past 7D
70844-6,Are you sexually active or would you like to be sexually active
70845-3,I have confidence in my doctors in the past 7D
70846-1,I feel that I received the treatment that was right for me in the past 7D
Jul-84,Solenopsis geminata Ab.IgG
70847-9,My doctor gave me explanations that I could understand in the past 7D
70848-7,My doctor explained the possible benefits of my treatment in the past 7D
70849-5,Perceived cognitive impairments
70850-3,Burkholderia mallei
70851-1,Burkholderia pseudomallei
70852-9,Burkholderia pseudomallei DNA
70853-7,Burkholderia mallei DNA
Apr-85,Solenopsis invicta Ab.IgE
70854-5,Burkholderia mallei Ag
70855-2,Burkholderia pseudomallei Ag
70856-0,Rabies virus Ab
70857-8,Rabies virus Ab
70858-6,Rabies virus Ab.Neut
70859-4,Rabies virus Ab.Neut
70860-2,Rabies virus Ab.IgG
70861-0,Rabies virus Ab.IgG
Feb-86,Solenopsis richteri Ab.IgE
70862-8,Rabies virus Ab.IgM
70863-6,Rabies virus Ab.IgM
70864-4,Rabies virus Ab.IgM
70865-1,Rabies virus Ab.IgM
70866-9,Rabies virus strain identified
70867-7,Rabies virus strain identified
70868-5,Additional concerns - FACT-B
70869-3,Additional concerns - FACT-Bl
7087-0,Pogonomyrmex barbatus Ab.IgE
70870-1,Additional concerns - FACT-Br
70871-9,Additional concerns - FACT-C
70872-7,Additional concerns - FACT-CNS
70873-5,Additional concerns - FACT-Cx
70874-3,Additional concerns - FACT-E
70875-0,Additional concerns - FACT-En
70876-8,Additional concerns - FACT-Ga
70877-6,Additional concerns - FACT-Hep
70878-4,Additional concerns - FACT-H&N
70879-2,Additional concerns - FACT-L
708-8,Blasts
70880-0,Additional concerns - FACT-Leu
70881-8,Additional concerns - FACT-Lym
70882-6,Additional concerns - FACT-M
70883-4,Additional concerns - FACT-MM
70884-2,Additional concerns - FACT-NP
70885-9,Additional concerns - FACT-O
70886-7,Additional concerns - FACT-V
70887-5,Additional concerns - FACT-GOG-NTX
Aug-88,Malus sylvestris Ab.IgG
70888-3,Additional concerns - FACT-GOG-NTX-12
70889-1,Additional concerns - FACT-GOG-NTX-13
70890-9,Additional concerns - FACT-BMT
70891-7,Additional concerns - FACT-BRM
70892-5,Additional concerns - FACT-Taxane
70893-3,Additional concerns - FAACT
70894-1,Additional concerns - FACIT-D
70895-8,Additional concerns - FACIT-F
Jun-89,Malus sylvestris basophil bound Ab
70896-6,Additional concerns - FACT-An
70897-4,Additional concerns - FACT-B+4
70898-2,Additional concerns - FACT-ES
70899-0,Additional concerns - FACT-N
70900-6,Additional concerns - FACT-Th11
70901-4,Additional concerns - FACT-Th18
70902-2,Additional concerns - FAIT-F
70903-0,Additional concerns - FAIT-U
Apr-90,Malus sylvestris tree Ab.IgE
70904-8,Additional concerns - FACIT-AD
70905-5,Physical well being - FACIT-CD
70906-3,Emotional well being - FACIT-CD
70907-1,Cryptococcus sp rRNA gene
70908-9,Cryptococcus sp Ag
70909-7,Cryptococcus sp Ag
70910-5,Cryptococcus sp Ag
70911-3,Cryptococcus sp Ag
Feb-91,Prunus armeniaca Ab.IgE
70912-1,Additional concerns - physical
70913-9,Additional concerns - mental
70914-7,Would you like to answer the question referring to your sex life
70915-4,Guidance for aspiration of CSF
70916-2,Guidance for aspiration of CSF
70917-0,Guidance for aspiration of CSF
70918-8,Guidance for injection
70919-6,Guidance for injection
7092-0,Prunus armeniaca Ab.IgG
70920-4,Guidance for injection
70921-2,Guidance for nerve block
70922-0,Guidance for nerve block
70923-8,Guidance for percutaneous vertebroplasty
70924-6,Guidance for percutaneous vertebroplasty
70925-3,Guidance for percutaneous vertebroplasty
70926-1,Multisection
70927-9,Multisection
70928-7,Multisection stereotactic
70929-5,Multisection stereotactic
70930-3,Multisection stereotactic
70931-1,Multisection^W contrast intradisc
70932-9,View
70933-7,Views^W contrast intradisc
70934-5,Ocular history
70935-2,Ophthalmic medications
70936-0,Vision testing
70937-8,Visual acuity
Aug-93,Maranta arundinacea Ab.IgE
70938-6,Refractive measurements
70939-4,Lensometry measurements
70940-2,Confrontation visual field
70941-0,Eye external
70942-8,Ocular alignment and motility
70943-6,Eye anterior segment
70944-4,Eye posterior segment
70945-1,Lacrimal
Jun-94,Cynara scolymus Ab.IgE
70946-9,Ancillary eye tests
70947-7,General eye evaluation
70948-5,Ocular physical exam
70949-3,Pathology report.section heading
70950-1,Residual renal function testing performed
70951-9,Interdialytic time
70952-7,Date of peritoneal dialysis adequacy measurement
Mar-95,Fraxinus velutina Ab.IgE
70953-5,Body surface area measurement method
70954-3,Standard process followed for residual renal function assessed in calculating Kt/V
70955-0,Prescription changed following the peritoneal dialysis adequacy measurement
70956-8,Minutes of hemodialysis completed when BUN drawn
70957-6,Creatinine clearance corrected for body surface area using standard methods
70958-4,Dialysis method
70959-2,Protein catabolic rate^^adjusted for body weight
709-6,Blasts/100 leukocytes
70960-0,Kt/V.Peritoneal Dialysis
70961-8,Kt/V.Hemodialysis
70962-6,Body weight^at peritoneal dialysis adequacy measurement
70963-4,Kt/V.Peritoneal Dialysis
70964-2,Kt/V.Peritoneal Dialysis
70965-9,Kt/V.Hemodialysis
70966-7,Kt/V.Hemodialysis
70967-5,Motor arm
70968-3,Motor leg
70969-1,Glomerular filtration rate/1.73 sq M.predicted.male
70970-9,Cryoglobulin
70971-7,How short of breath did you get dressing yourself without help in the past 7D
70972-5,How short of breath did you get walking 50 steps-paces on flat ground at a normal speed without stopping in the past 7D
70973-3,How short of breath did you get walking up 20 stairs - 2 flights - without stopping in the past 7D
70974-1,How short of breath did you get preparing meals in the past 7D
70975-8,How short of breath did you get washing dishes in the past 7D
70976-6,How short of breath did you get sweeping or mopping in the past 7D
70977-4,How short of breath did you get making a bed in the past 7D
70978-2,"How short of breath did you get lifting something weighing 10-20 lbs, about 4.5-9kg , like a large bag of groceries, in the past 7D"
Sep-97,Ash Ab.IgG
70979-0,"How short of breath did you get carrying something weighing 10-20 lbs, about 4.5-9kg, like a large bag of groceries, from one room to another in the past 7D"
70980-8,"How short of breath did you get walking faster than your usual speed for half a mile, almost 1 km, without stopping in the past 7D"
70981-6,Why you did not do this in the past 7D
70982-4,Functional assessment of chronic illness therapy - dyspnea questionnaire - 10 items
70983-2,Functional assessment of chronic illness therapy - dyspnea questionnaire - 33 items
70984-0,How short of breath did you get taking a bath without help in the past 7D
70985-7,How short of breath did you get taking a shower in the past 7D
70986-5,How short of breath did you get putting on socks or stockings in the past 7D
Jul-98,Fraxinus americana basophil bound Ab
70987-3,How short of breath did you get standing for at least 5M in the past 7D
70988-1,How short of breath did you get walking 10 steps - paces on flat ground at a normal speed without stopping in the past 7D
70989-9,"How short of breath did you get walking half a mile, almost 1 km, on flat ground at a normal speed, without stopping in the past 7D"
70990-7,How short of breath did you get walking up 5 stairs without stopping in the past 7D
70991-5,"How short of breath did you get walking up 10 stairs, 1 flight, without stopping in the past 7D"
70992-3,"How short of breath did you get walking up 30 stairs, 3 flights, without stopping in the past 7D"
70993-1,"How short of breath did you get lifting something weighing less than 5 lbs, about 2 kg, like a houseplant, in the past 7D"
70994-9,"How short of breath did you get lifting something weighing 5-10 lbs, about 2-4.5 kg, like a basket of clothes in the past 7D"
May-99,Asparagus officinalis Ab.IgE
70995-6,"How short of breath did you get lifting something weighing more than 20 lbs, about 9 kg, like a medium-sized suitcase in the past 7D"
70996-4,"How short of breath did you get carrying something weighing less than 5 lbs, about 2 kg, like a houseplant, from one room to another in the past 7D"
70997-2,"How short of breath did you get carrying something weighing 5-10 lbs, about 2-4.5 kg, like a basket of clothes, from one room to another in the past 7D"
70998-0,How short of breath did you get getting in or out of a car in the past 7D
70999-8,How short of breath did you get dining out in the past 7D
71000-4,"How short of breath did you get low-intensity leisure activity - gardening, etc, in the past 7D"
Jan-00,Asparagus officinalis Ab.IgG
71001-2,"How short of breath did you get moderate-intensity leisure activity - bicycling on level terrain, etc, in the past 7D"
71002-0,"How short of breath did you get walking, faster than your usual speed, for 50 steps without stopping in the past 7D"
71003-8,"How short of breath did you get walking, faster than your usual speed, for at least 1 mile, a little more than 1.5 km, without stopping in the past 7D"
71004-6,How short of breath did you get singing or humming in the past 7D
71005-3,How short of breath did you get talking while walking in the past 7D
71006-1,How short of breath did you get scrubbing the floor or counter in the past 7D
71007-9,Functional assessment of chronic illness therapy - palliative care questionnaire
71008-7,Additional concerns - FACIT-Pal
71009-5,I maintain contact with my friends in the past 7D
71010-3,I have family members who will take on my responsibilities in the past 7D
71011-1,I feel that my family appreciates me in the past 7D
71012-9,I feel like a burden to my family in the past 7D
71013-7,I am constipated in the past 7D
71014-5,I have swelling in parts of my body in the past 7D
71015-2,My mouth and throat are dry in the past 7D
71016-0,I feel useful in the past 7D
71017-8,I make each day count in the past 7D
71018-6,I have peace of mind in the past 7D
Sep-01,Populus tremula Ab.IgE
71019-4,I feel hopeful in the past 7D
71020-2,I am able to make decisions in the past 7D
71021-0,"I have been able to reconcile, make peace, with other people in the past 7D"
71022-8,I am able to openly discuss my concerns with the people closest to me in the past 7D
71023-6,Functional assessment of chronic illness therapy - spiritual well being questionnaire - 12 items - version 4
71024-4,I feel peaceful in the past 7D
71025-1,I have a reason for living in the past 7D
71026-9,My life has been productive in the past 7D
Jul-02,Populus tremula Ab.IgG
71027-7,I have trouble feeling peace of mind in the past 7D
71028-5,I feel a sense of purpose in my life in the past 7D
71029-3,I am able to reach down deep into myself for comfort in the past 7D
71030-1,I feel a sense of harmony within myself in the past 7D
71031-9,My life lacks meaning and purpose in the past 7D
71032-7,I find strength in my faith or spiritual beliefs in the past 7D
71033-5,My illness has strengthened my faith or spiritual beliefs in the past 7D
71034-3,I know that whatever happens with my illness things will be okay in the past 7D
May-03,Aspergillus fumigatus Ab.IgG
71035-0,"Functional assessment of chronic illness therapy - spiritual well being, expanded version questionnaire - version 4"
71036-8,"I feel connected to a higher power, or God, in the past 7D"
71037-6,I feel connected to other people in the past 7D
71038-4,I feel loved in the past 7D
71039-2,I feel love for others in the past 7D
710-4,Blood smear finding positive
71040-0,I am able to forgive others for any harm they have ever caused me in the past 7D
71041-8,I feel forgiven for any harm I may have ever caused in the past 7D
71042-6,"Throughout the course of my day, I feel a sense of thankfulness for my life in the past 7D"
Mar-04,Aspergillus fumigatus basophil bound Ab
71043-4,"Throughout the course of my day, I feel a sense of thankfulness for what others bring to my life in the past 7D"
71044-2,I feel a sense of appreciation for the beauty of nature in the past 7D
71045-9,I feel compassion for others in the difficulties they are facing in the past 7D
71046-7,Functional assessment of chronic illness therapy - spiritual well being - non-illness questionnaire - version 4
71047-5,Functional assessment of chronic illness therapy - satisfaction with pharmacist scale - version 4
71048-3,My pharmacist advises me on the proper use of my medicines in the past 7D
71049-1,My pharmacist advises me on the adverse - side - effects of my medicines in the past 7D
7105-0,Aspergillus nidulans Ab.IgE
71050-9,I have confidence in my pharmacist-s in the past 7D
71051-7,My pharmacist is available to answer my questions in the past 7D
71052-5,My pharmacist helps with the arrangements necessary to obtain my medicines in the past 7D
71053-3,My pharmacist is aware of my treatment-related needs in the past 7D
71054-1,My pharmacist responds to my treatment-related needs in the past 7D
71055-8,Functional assessment of chronic illness therapy - treatment satisfaction - general questionnaire - version 1
71056-6,"Compared to what you expected, how do you rate the effectiveness of the treatment so far"
71057-4,"Compared to what you expected, how do you rate the side effects of treatment so far"
71058-2,Did your doctor-s help you evaluate the effects of your treatment so far
71059-0,Do you feel you received the treatment that was right for you
71060-8,Are you satisfied with the effects of this treatment so far
71061-6,Would you recommend this treatment to others with your illness
71062-4,Would you choose this treatment again
71063-2,How do you rate this treatment overall
71064-0,Name of treatment
71065-7,Functional assessment of chronic illness therapy - treatment satisfaction - patient satisfaction questionnaire - version 1
71066-5,Visits you would like to rate
71067-3,Explanations
Aug-06,Aspergillus sp Ab.IgE
71068-1,Did your doctor-s give explanations that you could understand
71069-9,Did your doctor-s explain the possible benefits of your treatment
71070-7,Did your doctor-s explain the possible side effects or risks of your treatment
71071-5,Did you have an opportunity to ask questions
71072-3,Interpersonal
71073-1,Did you get to say the things that were important to you
71074-9,Did your doctor-s seem to understand what was important to you
71075-6,Did your doctor-s show genuine concern for you
Jun-07,Aspergillus sp Ab.IgG
71076-4,Comprehensive care
71077-2,Did your doctor-s seem to understand your needs
71078-0,Did you feel that the treatment staff worked together towards the same goal
71079-8,Were you able to talk to your doctor-s when you needed to
71080-6,Did the treatment staff discuss how your health and treatment may affect your normal work - including housework
71081-4,Did the treatment staff discuss how your health and treatment may affect your normal daily activities
71082-2,Did the treatment staff discuss how your health and treatment may affect your personal relationships
71083-0,Did the treatment staff discuss how your health and treatment may affect you emotionally
Apr-08,Acetylsalicylate Ab.IgE
71084-8,Technical quality
71085-5,Did you feel your doctors had experience treating your illness
71086-3,Did you feel your doctor-s knew about the latest medical developments for your illness
71087-1,Was the treatment staff thorough in examining and treating you
71088-9,Decision-making
71089-7,"Did your doctor-s discuss other treatments, example, alternative medicine or new for treatments"
71090-5,Were you encouraged to participate in decisions about your health care
71091-3,Did you have enough time to make decisions about your health care
Feb-09,Persea americana Ab.IgG
71092-1,Did you have enough information to make decisions about your health care
71093-9,Did your doctor-s seem to respect your opinions
71094-7,Nurses
71095-4,Did your nurses give explanations that you could understand
71096-2,Did your nurses show genuine concern for you
71097-0,Did your nurse-s seem to understand your needs
71098-8,Trust
71099-6,Did you feel that the treatment staff answered your questions honestly
Jan-71,Cefatrizine
7110-0,Baccharis spp Ab.IgE
71100-2,Did the treatment staff respect your privacy
71101-0,Did you have confidence in your doctor-s
71102-8,Did you trust your doctor-s suggestions for treatment
71103-6,Overall
71104-4,Would you recommend this clinic or office to others
71105-1,Would you choose this clinic or office again
71106-9,How do you rate the care you received
71107-7,Functional assessment of multiple sclerosis questionnaire - version 4
71108-5,Mobility
71109-3,I have trouble getting around in public places in the past 7D
71110-1,I have to take my condition into account when making plans in the past 7D
71111-9,I am bothered by muscle pains in the past 7D
71112-7,Emotional well being - FAMS
71113-5,I feel trapped by my condition in the past 7D
71114-3,I am depressed about my condition in the past 7D
71115-0,I feel useless in the past 7D
71116-8,General contentment
71117-6,I am frustrated by my condition in the past 7D
Aug-11,Paspalum notatum basophil bound Ab
71118-4,Thinking and fatigue
71119-2,My family has trouble understanding when my condition gets worse in the past 7D
711-2,Eosinophils
71120-0,I feel left out of things in the past 7D
71121-8,Additional concerns - FAMS
71122-6,Heat worsens my symptoms in the past 7D
71123-4,I am bothered by muscle spasms in the past 7D
71124-2,Difficult times have strengthened my faith or spiritual beliefs in the past 7D
71125-9,"Even during difficult times, I know that things will be okay in the past 7D"
Jun-12,Musa spp Ab.IgG
71126-7,Physical well being - FAHI
71127-5,Emotional well being - living with HIV
71128-3,Functional and global well being
71129-1,Social well being
71130-9,Cognitive functioning
71131-7,Additional concerns - FACIT-Sp
71132-5,Additional concerns - FACIT-Sp-NI
71133-3,Functional assessment of HIV infection questionnaire - version 4
Apr-13,Musa spp basophil bound Ab
71134-1,I am unhappy with my appearance in the past 7D
71135-8,It is hard to tell other people about my infection in the past 7D
71136-6,I worry about spreading my infection in the past 7D
71137-4,I am concerned about what the future holds for me in the past 7D
71138-2,I am embarrassed by my illness in the past 7D
71139-0,My thinking is slower than before in the past 7D
71140-8,I have trouble learning new tasks or directions in the past 7D
71141-6,Social - family well being - FAMS
Feb-14,Hordeum vulgare Ab.IgG
71142-4,Pediatric - functional assessment of anorexia cachexia - adolescent questionnaire - version 1
71143-2,Pediatric - functional assessment of anorexia cachexia - child questionnaire - version 1
71144-0,Pediatric - functional assessment of anorexia cachexia - parent_adolescent questionnaire - version 1
71145-7,Pediatric - functional assessment of anorexia cachexia - parent_child questionnaire - version 1
71146-5,Pediatric - functional assessment of anorexia cachexia questionnaire - 10 items - version 2
71147-3,Pediatric - patients with brain cancer - adolescent questionnaire - version 2
71148-1,Pediatric - patients with brain cancer - child questionnaire - version 2
71149-9,Pediatric - patients with brain cancer - parent_adolescent questionnaire - version 1
71150-7,Pediatric - patients with brain cancer - parent_child questionnaire - version 1
71151-5,Pediatric - functional assessment of chronic illness therapy - fatigue questionnaire
71152-3,I eat as much as I want in the past 7D
71153-1,I eat enough food for me to do whatever I need to do in the past 7D
71154-9,Most food tastes bad to me in the past 7D
71155-6,"As soon as I start eating, I feel like stopping in the past 7D"
71156-4,I am afraid to eat because it may make me sick in the past 7D
71157-2,My family or friends try to get me to eat more in the past 7D
71158-0,I have been throwing up in the past 7D
Sep-15,Hordeum vulgare basophil bound Ab
71159-8,I have pain in my stomach in the past 7D
71160-6,I feel like I am getting better in the past 7D
71161-4,I have energy or strength in the past 7D
71162-2,I could do my usual things at home in the past 7D
71163-0,I lose balance or fall down easily in the past 7D
71164-8,I have trouble getting myself dressed in the past 7D
71165-5,I have trouble running like other people in the past 7D
71166-3,My arms or legs feel weak in the past 7D
Jul-16,Hordeum vulgare pollen Ab.IgE
71167-1,I get ill easily in the past 7D
71168-9,I have trouble writing with a pen or pencil in the past 7D
71169-7,I feel happy in the past 7D
71170-5,"When I try to do something, I usually believe I will do it well in the past 7D"
71171-3,The cancer-tumor experience makes me a stronger person in the past 7D
71172-1,The cancer-tumor experience has taught me to appreciate life in the past 7D
71173-9,I often feel that other people are better than me in the past 7D
71174-7,I worry about getting another cancer-tumor in the past 7D
May-17,(Avena sativa+Hordeum vulgare) Ab.IgE
71175-4,I often switch from good moods to bad moods in the past 7D
71176-2,I worry when I go back to the hospital or clinic in the past 7D
71177-0,I get nervous - frightened easily in the past 7D
71178-8,I worry about having a good life in the future in the past 7D
71179-6,I worry about being able to have a girlfriend or boyfriend because of my illness in the past 7D
71180-4,I worry about being able to go to college because of my illness in the past 7D
71181-2,I worry about getting a job because of my illness in the past 7D
71182-0,Other people pick on - tease me in the past 7D
Mar-18,Ocimum basilicum Ab.IgE
71183-8,I think I have fewer friends than others in the past 7D
71184-6,Other people avoid hanging out with me because I am different in the past 7D
71185-3,I feel lonely in the past 7D
71186-1,I would rather do something by myself than with other people in the past 7D
71187-9,My parents worry too much about me in the past 7D
71188-7,My parents spoil me in the past 7D
71189-5,I am worried about how thin I am in the past 7D
71190-3,"What would be important about how you feel about eating, food, and how food affects your life in the past 7D"
Jan-19,Ocimum basilicum Ab.IgG
71191-1,I often feel that other children are better than me in the past 4W
71192-9,I think I have fewer friends than other children in the past 7D
71193-7,Other children avoid playing with me because I am different in the past 7D
71194-5,I would rather play alone than with other children in the past 7D
71195-2,My child loses balance or falls down easily in the past 4W
71196-0,My child has trouble getting dressed on his-her own in the past 4W
71197-8,My child has trouble running like other people in the past 4W
71198-6,My child gets tired easily in the past 4W
71199-4,My child's arms or legs seem weak in the past 4W
712-0,Eosinophils
71200-0,My child gets ill easily in the past 4W
71201-8,My child has trouble writing with a pen or pencil in the past 4W
71202-6,My child has pain in the past 7D
71203-4,My child seems happy in the past 4W
71204-2,"When my child tries to do something, s-he usually believes s-he will do it well in the past 4W"
71205-9,The cancer-tumor experience makes my child a stronger person in the past 7D
71206-7,The cancer-tumor experience has taught my child to appreciate life in the past 7D
71207-5,My child often feels inferior to other people in the past 4W
71208-3,My child worries about getting another cancer-tumor in the past 4W
Sep-20,Micropterus salmoides Ab.IgE
71209-1,My child is moody or irritable in the past 4W
71210-9,My child worries when we go back to the hospital or clinic in the past 4W
71211-7,My child gets nervous - frightened easily in the past 4W
71212-5,My child worries about having a good life in the future in the past 4W
71213-3,My child worries about being able to have a girlfriend or boyfriend because of his-her illness in the past 4W
71214-1,My child worries about being able to go to college because of his-her illness in the past 4W
71215-8,My child worries about getting a job because of his-her illness in the past 4W
71216-6,Physical well being - FACIT-peds
Jul-21,Bassiai Ab.IgE
71217-4,Emotional well being and illness experience - FAACT-peds-adoles
71218-2,Social - family well being - FAACT-peds
71219-0,Other people pick on - tease my child in the past 4W
71220-8,My child has fewer friends than others in the past 4W
71221-6,Other people avoid hanging out with my child because s-he is different in the past 4W
71222-4,My child seems lonely in the past 4W
71223-2,My child prefers to do something alone in the past 4W
71224-0,My child thinks I worry too much about him-her in the past 7D
May-22,Tilia americana Ab.IgE
71225-7,My child thinks I spoil him-her in the past 7D
71226-5,Additional concerns - FAACT-child_adoles
71228-1,Additional concerns - FACT-Br-peds
71229-9,Additional concerns - FACT-Br-parent
71230-7,Birth certificate
71231-5,The illness experience has taught my child to appreciate life in the past 4W
71232-3,The illness experience makes my child a stronger person in the past 4W
Mar-23,Myrica spp Ab.IgE
71233-1,I often feel that other children are better than me in the past 7D
71234-9,Physical well being - FAACT-peds - parent
71235-6,Emotional well being - FAACT-peds - parent_adoles
71236-4,My child seems happy in the past 7D
71237-2,"When my child tries to do something, s-he usually believes s-he will do it well in the past 7D"
71238-0,My child often feels inferior to other people in the past 7D
71239-8,My child worries about getting another cancer-tumor in the past 7D
71240-6,My child is moody or irritable in the past 7D
Jan-24,Myrica spp pollen Ab.IgE
71241-4,My child worries when we go back to the hospital or clinic in the past 7D
71242-2,My child gets nervous - frightened easily in the past 7D
71243-0,My child worries about having a good life in the future in the past 7D
71244-8,My child worries about being able to have a girlfriend or boyfriend because of his-her illness in the past 7D
71245-5,My child worries about being able to go to college because of his-her illness in the past 7D
71246-3,My child worries about getting a job because of his-her illness in the past 7D
71247-1,My child has fewer friends than others in the past 7D
71248-9,Other people avoid hanging out with my child because s-he is different in the past 7D
71249-7,My child seems lonely in the past 7D
71250-5,My child prefers to do something alone in the past 7D
71251-3,Additional concerns - FAACT-parent
71252-1,My child eats as much as s-he wants in the past 7D
71253-9,My child eats enough to do whatever s-he needs to do in the past 7D
71254-7,My child is worried about his-her weight in the past 7D
71255-4,Most food tastes bad to my child in the past 7D
71256-2,My child is worried about how thin s-he is in the past 7D
71257-0,"As soon as my child starts eating, s-he feels like stopping in the past 7D"
Aug-25,Laurus nobilis Ab.IgE
71258-8,My child is afraid to eat because it may make her-him sick in the past 7D
71260-4,My child has been throwing up in the past 7D
71261-2,"When my child eats, s-he seems to get full quickly in the past 7D"
71262-0,My child has pain in his-her stomach in the past 7D
71263-8,My child feels like s-he is getting better in the past 7D
71264-6,Social - family well being - FAACT-parent_adoles
71265-3,My child loses balance or falls down easily in the past 7D
Jun-26,Laurus nobilis Ab.IgG
71266-1,My child has trouble getting dressed on his-her own in the past 7D
71267-9,My child has trouble running like other people in the past 7D
71268-7,My child gets tired easily in the past 7D
71269-5,My child's arms or legs seem weak in the past 7D
71270-3,My child gets ill easily in the past 7D
71271-1,My child has trouble writing with a pen or pencil in the past 7D
71272-9,Other people pick on - tease my child in the past 7D
71273-7,Family or friends try to get my child to eat more in the past 7D
Apr-27,Bean green Ab.IgG
71274-5,Emotional well being - FAACT-peds - parent_child
71275-2,Social well being - FAACT-peds - parent_child
71276-0,Other children avoid playing with my child because s-he is different in the past 7D
71277-8,My child prefers to play alone in the past 7D
71278-6,I lose my balance or fall down easily in the past 4W
71279-4,I have trouble getting myself dressed in the past 4W
71280-2,I have trouble running like other people in the past 4W
71281-0,I get tired easily in the past 4W
Feb-28,Bean green basophil bound Ab
71282-8,My arms or legs are weak in the past 4W
71283-6,I get ill easily in the past 4W
71284-4,I have trouble writing with a pen or pencil in the past 4W
71285-1,I feel happy in the past 4W
71286-9,"When I try to do something, I usually believe I will do it well in the past 4W"
71287-7,The illness experience makes me a stronger person in the past 4W
71288-5,The illness experience has taught me to appreciate life in the past 4W
71289-3,I often feel that other people are better than me in the past 4W
7129-0,Bean kidney red Ab.IgE
71290-1,I worry about being sick again in the past 4W
71291-9,I often switch from good moods to bad moods in the past 4W
71292-7,I worry when I go back to the hospital or clinic in the past 4W
71293-5,I get nervous - frightened easily in the past 4W
71294-3,I worry about having a good life in the future in the past 4W
71295-0,I worry about being able to date because of my illness history in the past 4W
71296-8,I worry about being able to go to college because of my illness history in the past 4W
71297-6,I worry about getting a job to support myself because of my illness history in the past 4W
71298-4,Other people pick on - tease me in the past 4W
71299-2,I think I have fewer friends than others in the past 4W
71300-8,Other people avoid hanging out with me because of my illness history in the past 4W
71301-6,I feel lonely in the past 4W
71302-4,I would rather do something by myself than with other people in the past 4W
71303-2,I am bothered by being shorter than other people in the past 4W
71304-0,I am bothered by being unable to see well in the past 4W
71305-7,I am bothered by being unable to hear well in the past 4W
71306-5,I am bothered by headaches in the past 4W
71307-3,"When I speak, people have trouble understanding me in the past 4W"
Aug-30,Bean kidney red Ab.IgG
71308-1,I need to work harder than other people to get my school work done in the past 4W
71309-9,My grades are worse than they were before I was sick in the past 4W
71310-7,I forget things easily in the past 4W
71311-5,It is hard for me to concentrate in school in the past 4W
71312-3,I have to read things several times so I can understand them in the past 4W
71313-1,"When I play games or sports, I react more slowly than most people my age in the past 4W"
71314-9,It is hard for me to find the right words to say what I mean in the past 4W
71315-6,Emotional well being and illness experience - FACT-Br -peds-adoles
Jun-31,Phaseolus limensis Ab.IgE
71316-4,Emotional well being and illness experience - FACT-Br -peds-child
71317-2,Social - family well being - FACT-Br-peds
71318-0,Physical well being - FACT-Br -peds-parent
71319-8,Emotional well being - FACT-Br -peds-parent_adoles
71320-6,Emotional well being - FACT-Br -peds-parent_child
71321-4,Social and family well being - FACT-Br -peds-parent_child
71322-2,Social and family well being - FACT-Br -peds-parent_adoles
71323-0,My child is bothered by being shorter than his-her peers in the past 4W
Apr-32,Phaseolus limensis Ab.IgG
71324-8,My child is bothered by poor vision in the past 4W
71325-5,My child is bothered by poor hearing in the past 4W
71326-3,My child is bothered by headaches in the past 4W
71327-1,My child's speech is hard for others to understand in the past 4W
71328-9,My child needs to work harder than his-her peers to get school work done in the past 4W
71329-7,My child's school performance is worse than it was before s-he was diagnosed in the past 4W
71330-5,My child forgets things easily in the past 4W
71331-3,It is hard for my child to concentrate in school in the past 4W
Feb-33,Vigna radiata Ab.IgE
71332-1,My child has to read things several times so s-he can understand them in the past 4W
71333-9,"When my child plays games or sports, s-he reacts more slowly than his-her peers in the past 4W"
71334-7,My child has difficulty using the right words in the past 4W
71335-4,My child often feels inferior to other children in the past 4W
71336-2,I feel weak in the past 7D
71337-0,Being tired made me sad in the past 7D
71338-8,Being tired made me mad-angry in the past 7D
71339-6,Urea renal clearance/1.73 sq M^hemodialysis
7134-0,Vigna radiata Ab.IgG
71340-4,Time between hemodialysis sessons
71341-2,Kt/V.Peritoneal Dialysis
71342-0,Kt/V.Hemodialysis
71343-8,Emotional well being and illness experience - FAACT-peds-child
71344-6,I have been able to laugh and see the funny side of things in the past 7D
71345-3,I have looked forward with enjoyment to things in the past 7D
71346-1,I have blamed myself unnecessarily when things went wrong in the past 7D
71347-9,I have been anxious or worried for no good reason in the past 7D
71348-7,I have felt scared or panicky for no very good reason in the past 7D
71349-5,Things have been getting on top of me in the past 7D
71350-3,I have been so unhappy that I have had difficulty sleeping in the past 7D
71351-1,I have felt sad or miserable in the past 7D
71352-9,I have been so unhappy that I have been crying in the past 7D
71353-7,The thought of harming myself has occurred to me in the past 7D
71354-5,Edinburgh Postnatal Depression Scale
71355-2,SLC26A5 gene.c.-53-2A>G
71356-0,TPMT gene.c.238G>C+460G>A+719A>G
Jul-35,Bean pinto Ab.IgE
71357-8,PDGFRA gene exon 18 targeted mutation analysis
71358-6,GJB3 gene targeted mutation analysis
71359-4,Y chromosome AZFa region deletion
71360-2,Y chromosome AZFb region deletion
71361-0,Y chromosome AZFc region deletion
71363-6,Alkaline phosphatase.placental 2/Alkaline phosphatase.total
May-36,Bean pinto Ab.IgG
71365-1,Alkaline phosphatase.intestinal 2
71366-9,Alkaline phosphatase.intestinal 3
71367-7,Alkaline phosphatase.placental 2
71368-5,Desmosome Ab.IgG
71369-3,Neutrophils.dysplastic
71370-1,(Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) Ab.IgE
71371-9,(Alnus incana+Betula verrucosa+Corylus avellana+Quercus alba+Salix caprea) Ab.IgE
Mar-37,Glycine max basophil bound Ab
71373-5,(Artemisia vulgaris+Betula verrucosa+Cat dander+Cladosporium herbarum+Dermatophagoides pteronyssinus+Dog dander+Phleum pratense+Secale cereale) Ab.IgE
71374-3,(Daucus carota+Lycopersicon lycopersicum+Mustard+Solanum tuberosum+Allium sativum) Ab.IgE
71375-0,(Alternaria tenuis+Artemisia vulgaris+Betula verrucosa+Cladosporium herbarum+Phleum pratense) Ab.IgE
71376-8,(Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) Ab.IgE
71377-6,Legionella sp
71378-4,Leptospira sp
71379-2,I had trouble starting things because I was too tired in the past 7D
713-8,Eosinophils/100 leukocytes
71380-0,I had trouble finishing things because I was too tired in the past 7D
Jan-38,Glycine max dust Ab.IgE
71381-8,I needed to sleep during the day in the past 7D
71382-6,I got upset by being too tired to do things I wanted to do in the past 7D
71383-4,Being tired made it hard for me to play or go out with my friends as much as I'd like in the past 7D
71384-2,I was too tired to eat in the past 7D
71385-9,I needed help doing my usual things at home in the past 7D
71386-7,Hepcidin 25 peptide
71387-5,Spermatozoa.motile^post ejaculate
71388-3,CMS - physical exam panel
71389-1,CMS - constitutional exam panel
71390-9,CMS - head & face exam panel
71391-7,CMS - eye exam panel
71392-5,CMS - ear-nose-mouth-throat exam panel
71393-3,CMS - neck exam panel
71394-1,CMS - respiratory exam panel
71395-8,CMS - cardiovascular exam panel
71396-6,CMS - breast exam panel
71397-4,CMS - gastrointestinal - abdomen - exam panel
71398-2,CMS - genitourinary exam - male panel
Sep-39,Bean string Ab.IgG
71399-0,CMS - genitourinary exam - female panel
71400-6,CMS - lymphatic exam panel
71401-4,CMS - extremities exam panel
71402-2,CMS - musculoskeletal exam panel
71403-0,CMS - skin exam panel
71404-8,CMS - neurologic exam panel
71405-5,CMS - psychiatric exam panel
71406-3,CMS - review of systems panel
Jul-40,Bean wax Ab.IgE
71407-1,CMS - constitutional symptoms panel
71408-9,CMS - eye panel
71409-7,CMS - ear-nose-mouth-throat panel
71410-5,CMS - cardiovascular panel
71411-3,CMS - respiratory panel
71412-1,CMS - gastrointestinal panel
71413-9,CMS - genitourinary panel
71414-7,CMS - musculoskeletal panel
May-41,Bean white Ab.IgG
71415-4,CMS - integumentary panel
71416-2,CMS - neurological panel
71417-0,CMS - psychiatric panel
71418-8,CMS - endocrine panel
71419-6,CMS - hematologic - lymphatic panel
71420-4,CMS - allergic - immunologic panel
71421-2,CMS - past family - social history panel
71422-0,CMS - social history panel
Mar-42,Bean yellow Ab.IgG
71423-8,CMS - family history panel
71424-6,CMS - past medical - surgical history panel
71425-3,Natriuretic peptide.B prohormone N-Terminal
71426-1,C reactive protein
71427-9,Fibrin D-dimer FEU
71428-7,CMS - history of present illness panel
71429-5,Campylobacter sp DNA.diarrheagenic
71430-3,oxyCODONE+Oxymorphone
Jan-43,Beef basophil bound Ab
71431-1,Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA
71432-9,Human papilloma virus 16 & 18 & 31+33+35+39+45+51+52+56+58+59+66+68 DNA panel
71433-7,Functional assessment of cancer therapy for patients with prostate cancer questionnaire - version 4
71434-5,Additional concerns - FACT-P
71435-2,I have aches and pains that bother me in the past 7D
71436-0,I am satisfied with my present level of comfort in the past 7D
71437-8,I am able to feel like a man in the past 7D
71438-6,I am able to have and maintain an erection in the past 7D
71439-4,Functional assessment of chronic illness therapy - spiritual well being questionnaire - version 4
71440-2,Discharge
71441-0,Level II Preadmission Screening and Resident Review (PASRR)
71442-8,Weight gain
71443-6,Preference to avoid asking Q0500B again
71444-4,Nutritional approaches during last 7D - while not a resident
71445-1,Nutritional approaches during last 7D - while a resident
71446-9,Indexing - billing unit
71447-7,Received scheduled pain medication regimen
71448-5,Received PRN pain medications or was offered and declined
Sep-44,Liver beef basophil bound Ab
71449-3,Received non-medication intervention for pain
71450-1,Skin tear(s)
71451-9,Moisture associated skin damage (MASD)
71452-7,Intellectual disability and developmental disability with organic condition
71453-5,Intellectual disability and developmental disability with no organic condition
71454-3,Conditions related to intellectual disability and developmental disability status
71455-0,Other organic condition related to intellectual disability and developmental disability status
Jun-45,Beet Ab.IgG
71456-8,Nitrofural
71457-6,Erythropoiesis-stimulating agent panel
71458-4,Was erythropoiesis-stimulating agent prescribed
71459-2,Infection panel
714-6,Eosinophils/100 leukocytes
71460-0,Outpatient antibiotics prescribed in past Mo
71461-8,Vascular infection source
71462-6,Method of identifying vascular access infection
71463-4,Date of infection onset
Apr-46,Beet red Ab.IgE
71464-2,Date first prescribed
71465-9,Date prescription changed
71466-7,Date prescription stopped
71467-5,Erythropoiesis-stimulating agent prescribed
71468-3,Route
71469-1,Medication frequency
71470-9,Antibiotic panel
71471-7,Antibiotic administered
Feb-47,Beta vulgaris Ab.IgE
71472-5,Date of blood culture
71473-3,Infected dialysis site
71474-1,Date of infection hospitalization
71475-8,New infection suspected
71476-6,Clinical sepsis symptoms present
71477-4,Did the infection require hospitalization
71478-2,Signs of soft tissue infection present
71479-0,Date access infection confirmed
7148-0,Berry Ab.IgE
71480-8,Location of death
71481-6,Did the death of this person involve injury of any kind
71482-4,Risk assessment
71483-2,Total score
71484-0,Cup-disc ratio
71485-7,Cup-disc ratio
71486-5,Optic disc or retinal nerve fiber layer structural abnormalities
71487-3,Optic disc or retinal nerve fiber layer structural abnormalities
71488-1,Macular edema
71489-9,Macular edema
71490-7,Diabetic retinopathy severity level
71491-5,Diabetic retinopathy severity level
71492-3,Total score
71493-1,Total score
71495-6,Network code
71496-4,Corporate organization code
71497-2,Dialysis organization affiliation
Aug-49,Bipolanis curvularia Ab.IgE
71498-0,Manager
71499-8,Owner
71500-3,Program
71501-1,Open-closed Status
71502-9,Profit status
71503-7,Date opened
71504-5,Date closed
71505-2,Date changed ownership
Jun-50,Birch White Ab.IgE
71506-0,Date initially certified by medicare
71507-8,Fax number
71508-6,Website
71509-4,Phone number extension
71510-2,Medicaid certified stations
71511-0,Isolation stations
71512-8,Medicare certified services offered
71513-6,Non-medicare certified services offered
Apr-51,Rubus fruticosus Ab.IgE
71514-4,Opening time
71515-1,Closing time
71516-9,Personnel job code
71518-5,Transplant referral
71519-3,On transplant waiting list
71520-1,Hospitalized due to presumptive diagnosis
71521-9,Location
Feb-52,Vaccinium myrtillus Ab.IgE
71522-7,Certified program
71523-5,Date personnel record submitted
71524-3,Partial owner organization
71525-0,Authorized batch submitting organization
71526-8,Personnel employment name
71527-6,Record status
71528-4,Personnel job description
71529-2,Back up NPI
715-3,Normoblasts
7153-0,Vaccinium myrtillus Ab.IgG
71530-0,Business name
71531-8,Hospitalization panel
71533-4,Dialysis shifts
71534-2,Phone number
71536-7,Information source
71538-3,Sent to hospital directly from dialysis facility
71539-1,Record status
71540-9,Date personnel record submission
71541-7,"I feel sad, down in the dumps or unhappy in the last 2W or more"
71542-5,Nothing seems to give me much pleasure in the last 2W or more
71543-3,I feel tired - have no energy in the last 2W or more
71544-1,I have had thoughts of suicide in the last 2W or more
71545-8,I have difficulty sleeping in the last 2W or more
71546-6,I have been sleeping too much in the last 2W or more
71547-4,I have lost some appetite in the last 2W or more
Aug-54,Vaccinium myrtillus basophil bound Ab
71548-2,I have been eating more in the last 2W or more
71549-0,"I feel tense, anxious or can't sit still in the last 2W or more"
71550-8,I feel worried or fearful in the last 2W or more
71551-6,I have attacks of anxiety or panic in the last 2W or more
71552-4,I worry about dying or losing control in the last 2W or more
71553-2,I am nervous or shaky in social situations in the last 2W or more
71554-0,I have nightmares or flashbacks in the last 2W or more
May-55,Acer negundo Ab.IgE
71555-7,I am jumpy or feel startled easily in the last 2W or more
71556-5,I avoid places that strongly remind me of a bad experience in the last 2W or more
71557-3,"I feel dull, numb, or detached in the last 2W or more"
71558-1,I can't get certain things out of my mind in the last 2W or more
71559-9,I feel I must repeat certain acts or rituals in the last 2W or more
71560-7,I feel the need to check and recheck things in the last 2W or more
71561-5,"At any time in your life, have you had more energy than usual"
71562-3,"At any time in your life, have you felt unusually irritable or angry"
Mar-56,Acer negundo Ab.IgG
71563-1,"At any time in your life have you felt unusually excited, revved up or high"
71564-9,At any time in your life have you needed less sleep than usual
71565-6,These symptoms interfere with work or school
71566-4,These symptoms affect my relationships with friends or family
71567-2,These symptoms have led to my using alcohol to get by
71568-0,These symptoms have led to my using drugs
71569-8,M3 Checklist
71570-6,Changes in sleeping patterns
Jan-57,Bertholletia excelsa Ab.IgG
71571-4,Changes in appetite
71572-2,I can't concentrate or focus in the last 2W or more
71573-0,Medication authorization
71574-8,Airway device confirmed for placement
71575-5,ECG
71576-3,Airway device placement confirmation method
71577-1,ECG interpretation method
71578-9,EMS transport destination
71579-7,Unit transport and equipment capability
71580-5,Certification
71581-3,Crew member response role
71582-1,Person performing procedure
71583-9,Service requested
71584-7,Exam finding location
71585-4,Exam finding location
71586-2,Exam finding location
71587-0,IV site
71588-8,Chief complaint
Sep-58,Bertholletia excelsa basophil bound Ab
71589-6,Exam finding location
71590-4,Hospitalized or emergency room
71591-2,Job title
71592-0,Hemoglobinopathies conditions suspected
71593-8,Glucose-6-Phosphate dehydrogenase
71594-6,Macrophages/leukocytes
71595-3,Basophils/leukocytes
71596-1,Eosinophils/leukocytes
Jul-59,Brassica oleracea var italica Ab.IgG
71597-9,Lymphocytes/leukocytes
71598-7,Neutrophils/leukocytes
71599-5,Mesothelial cells/leukocytes
71600-1,Macrophages/leukocytes
71601-9,Leukocytes other/leukocytes
71602-7,Basophils/leukocytes
71603-5,Eosinophils/leukocytes
71604-3,Monocytes/leukocytes
May-60,Brassica oleracea var gemmifera Ab.IgE
71605-0,Lymphocytes/leukocytes
71606-8,Neutrophils/leukocytes
71607-6,Mesothelial cells/leukocytes
71608-4,Polymorphonuclear cells/leukocytes
71609-2,Macrophages/leukocytes
716-1,Heinz bodies
71610-0,Mononuclear cells/leukocytes
71611-8,Leukocytes other/leukocytes
71612-6,Basophils/leukocytes
Mar-61,Brassica oleracea var gemmifera Ab.IgG
71613-4,Eosinophils/leukocytes
71614-2,Monocytes/leukocytes
71615-9,Lymphocytes/leukocytes
71616-7,Neutrophils/leukocytes
71617-5,Polymorphonuclear cells/leukocytes
71618-3,Macrophages/leukocytes
71619-1,Mononuclear cells/leukocytes
71620-9,Leukocytes other/leukocytes
Jan-62,Fagopyrum esculentum Ab.IgG
71621-7,Basophils/leukocytes
71622-5,Eosinophils/leukocytes
71623-3,Monocytes/leukocytes
71624-1,Lymphocytes/leukocytes
71625-8,Neutrophils/leukocytes
71626-6,Mesothelial cells/leukocytes
71627-4,Polymorphonuclear cells/leukocytes
71628-2,Macrophages/leukocytes
71629-0,Mononuclear cells/leukocytes
71630-8,Leukocytes other/leukocytes
71631-6,Basophils/leukocytes
71632-4,Eosinophils/leukocytes
71633-2,Monocytes/leukocytes
71634-0,Lymphocytes/leukocytes
71635-7,Neutrophils/leukocytes
71636-5,Plasma cells/leukocytes
71637-3,Unspecified cells/leukocytes
71638-1,Unidentified cells/leukocytes
Sep-63,Kochia scoparia Ab.IgE
71639-9,Monocytes+Macrophages/leukocytes
71640-7,Mesothelial cells/leukocytes
71641-5,Macrophages/leukocytes
71642-3,Promyelocytes/leukocytes
71643-1,Metamyelocytes/leukocytes
71644-9,Blasts/leukocytes
71645-6,Neutrophils.band form/leukocytes
71646-4,Eosinophils/leukocytes
Jul-64,Hymenoclea salsola Ab.IgE
71647-2,Basophils/leukocytes
71648-0,Monocytes/leukocytes
71649-8,Lymphocytes/leukocytes
71650-6,Neutrophils.segmented/leukocytes
71651-4,Macrophages/leukocytes
71652-2,Plasma cells/leukocytes
71653-0,Promyelocytes/leukocytes
Apr-65,Hymenoclea salsola Ab.IgE
71654-8,Myelocytes/leukocytes
71655-5,Metamyelocytes/leukocytes
71656-3,Blasts/leukocytes
71657-1,Neutrophils.band form/leukocytes
71658-9,Neutrophils/leukocytes
71659-7,Monocytes/leukocytes
71660-5,Lymphocytes/leukocytes
71661-3,Eosinophils/leukocytes
Feb-66,Burweed Ab.IgE
71662-1,Basophils/leukocytes
71663-9,Plasma cells/leukocytes
71664-7,Smudge cells/leukocytes
71665-4,Lymphocytes.variant/leukocytes
71666-2,Promyelocytes/leukocytes
71667-0,Myelocytes/leukocytes
71668-8,Metamyelocytes/leukocytes
71669-6,Blasts/leukocytes
7167-0,Butterfly Ab.IgE
71670-4,Neutrophils.band form/leukocytes
71671-2,Neutrophils/leukocytes
71672-0,Monocytes/leukocytes
71673-8,Lymphocytes/leukocytes
71674-6,Eosinophils/leukocytes
71675-3,Basophils/leukocytes
71676-1,Neutrophils/leukocytes
71677-9,Monocytes/leukocytes
71678-7,Lymphocytes/leukocytes
71679-5,Eosinophils/leukocytes
71680-3,Basophils/leukocytes
71681-1,PMI - Common side effects section
71682-9,PMI - Get emergency medical help section
71683-7,PMI - Stop taking and call your doctor section
71684-5,PMI - Directions for use section
71685-2,PMI - Tell your doctor before taking section
71686-0,PMI - Do not take section
71687-8,PMI - Important information section
Aug-68,Buttermilk basophil bound Ab
71688-6,PMI - Uses section
71689-4,Mononuclear cells
71690-2,Nucleated cells
71691-0,Hematopoietic progenitor cells
71692-8,Platelets.reticulated
71693-6,Platelets.reticulated/100 platelets
71694-4,Hemoglobin
71695-1,Granulocytes.immature/100 leukocytes
Jun-69,Brassica oleracea var capitata Ab.IgE
71696-9,Polymorphonuclear cells/100 leukocytes
71697-7,Mononuclear cells/100 leukocytes
71698-5,Polymorphonuclear cells
71699-3,Flavivirus Ag
71700-9,Rotavirus RNA
71701-7,Rotavirus dsRNA
71702-5,Rotavirus dsRNA
71703-3,Rotavirus Ab.IgG
Apr-70,Brassica oleracea var capitata Ab.IgG
71704-1,Rotavirus Ab.IgA
71705-8,Rotavirus Ab
71706-6,Marburg virus Ab.IgM
71707-4,Marburg virus Ab.IgG
71708-2,Marburg virus Ag
71709-0,Lassa virus Ab.IgM
71710-8,Lassa virus Ab.IgG
71711-6,Ebola virus Ab.IgM
Feb-71,Canary feather Ab.IgE
71712-4,Ebola virus Ab.IgM
71713-2,Pyruvate kinase
71714-0,Brucella abortus Ab
71715-7,Brucella abortus Ab.IgG1+IgG2
71716-5,Brucella suis Ab
71717-3,Brucella suis Ab
71718-1,Enterococcus sp DNA
71719-9,Mycobacterium avium complex DNA
7172-0,Candida albicans Ab.IgG
71720-7,Address
71722-3,Total score
71723-1,Cell phone number
71724-9,Home phone number
71725-6,Business phone number extension
71726-4,Business phone number
71727-2,Fax number
71728-0,Email address
71729-8,Nine-digit postal code
71730-6,Five-digit postal code
71731-4,State
71732-2,City
71733-0,Address 2
71734-8,Preferred mailing address
71735-5,Credentials
71736-3,Name prefix
71737-1,Name suffix
Aug-73,Candida albicans basophil bound Ab
71738-9,Middle initial
71739-7,First name
71740-5,Last name
71742-1,Date most recent record submitted
71743-9,Generic drug facility identification submission
71744-7,Health care provider letter
71745-4,Day closed
Jun-74,Candida sp Ab.IgG
71746-2,Personnel contact information panel
71747-0,Facility panel
71748-8,Total dialysis stations
71749-6,Personnel unique identifier
71750-4,Primary contact phone number extension
71751-2,Primary contact phone number
71752-0,Primary contact first name
Mar-75,Cucumis melo spp Ab.IgE
71753-8,Primary contact last name
71754-6,PTSD score
71755-3,Anxiety score
71756-1,Score out of range
71757-9,Depression score
71758-7,Bipolar score
71759-5,Rotavirus RNA
71760-3,Rotavirus identified
Jan-76,Cucumis melo spp Ab.IgG
71761-1,Rotavirus identified
71762-9,Rotavirus Ab.IgA
71763-7,Rotavirus Ab.IgA
71764-5,Rotavirus Ab
71765-2,Rotavirus Ab
71766-0,Primary contact email
71767-8,Ebola virus Ab.IgG
71768-6,Ebola virus Ag
71769-4,Marburg virus Ab.IgG
71770-2,Ebola virus Ab.IgG
71771-0,Marburg virus Ab.IgM
71772-8,Mitogen stimulated gamma interferon
71773-6,Mycobacterium tuberculosis stimulated gamma interferon
71774-4,Mitogen stimulated gamma interferon^^corrected for background
71775-1,Mycobacterium tuberculosis stimulated gamma interferon panel
71776-9,Gamma interferon background
71777-7,Total score
71778-5,Rift valley fever virus Ag
Sep-77,Cucumis melo spp basophil bound Ab
71779-3,Rift valley fever virus Ab.IgM
71780-1,Rift valley fever virus Ab.IgG
71781-9,Rift valley fever virus Ab.IgM
71782-7,Yellow fever virus Ab.IgM
71783-5,Yellow fever virus Ab.Neut
71784-3,Rift valley fever virus Ab.IgG
71785-0,Exam findings communicated to clinician managing diabetic care
71786-8,Staphylococcus aureus exfoliative toxin A eta gene
Jul-78,Carum carvi Ab.IgE
71787-6,Staphylococcus aureus exfoliative toxin B etb gene
71788-4,Neisseria meningitidis DNA
71789-2,Change in systolic blood pressure
717-9,Hemoglobin
71790-0,Calcium
71791-8,Metanephrines
71792-6,Procollagen type III.N-terminal propeptide
71793-4,Treponema pallidum Ab
71794-2,Expiratory gas flow.max^pre therapy
May-79,Ceratonia siliqua Ab.IgE
71795-9,Expiratory gas flow.max^pre therapy
71796-7,Promyelocytic leukemia protein distribution pattern
71797-5,Protoporphyrin.zinc
71798-3,Reason immunization not given
71799-1,Adherence to prescribed medication instructions
71800-7,Reason medication not prescribed
71801-5,Reason for intervention refusal
71802-3,Housing status
Mar-80,Daucus carota Ab.IgG
71803-1,Client status
71804-9,Serotonin
71805-6,Cortisol.free/Cortisone.free
71806-4,"I feel sad, down in the dumps or unhappy since I took my last screen"
71807-2,Nothing seems to give me much pleasure since I took my last screen
71808-0,I feel tired - have no energy since I took my last screen
71809-8,I have had thoughts of suicide since I took my last screen
71810-6,I have difficulty sleeping since I took my last screen
Jan-81,Daucus carota basophil bound Ab
71811-4,I have been sleeping too much since I took my last screen
71812-2,I have lost some appetite since I took my last screen
71813-0,I have been eating more since I took my last screen
71814-8,"I feel tense, anxious or can't sit still since I took my last screen"
71815-5,I feel worried or fearful since I took my last screen
71816-3,I have attacks of anxiety or panic since I took my last screen
71817-1,I worry about dying or losing control since I took my last screen
71818-9,I am nervous or shaky in social situations since I took my last screen
71819-7,I have nightmares or flashbacks since I took my last screen
71820-5,I am jumpy or feel startled easily since I took my last screen
71821-3,I avoid places that strongly remind me of a bad experience since I took my last screen
71822-1,"I feel dull, numb, or detached since I took my last screen"
71823-9,I can't get certain things out of my mind since I took my last screen
71824-7,I feel I must repeat certain acts or rituals since I took my last screen
71825-4,I feel the need to check and recheck things since I took my last screen
71826-2,I can't concentrate or focus since I took my last screen
71827-0,Score interpretation
71828-8,Hematocrit
Sep-82,Casein Ab.IgG
71829-6,Hematocrit
71830-4,Hematocrit
71831-2,Hematocrit
71832-0,Hematocrit
71833-8,Hematocrit
71834-6,Cryoglobulin/Serum.total
71835-3,Oxygen/Gas.total
71836-1,Oxyhemoglobin/Hemoglobin.total
Jul-83,Anacardium occidentale Ab.IgG
71837-9,Oxyhemoglobin/Hemoglobin.total
71838-7,Oxyhemoglobin/Hemoglobin.total
71839-5,Oxyhemoglobin/Hemoglobin.total
71840-3,Oxyhemoglobin/Hemoglobin.total
71841-1,Oxygen saturation
71842-9,Oxygen saturation
71843-7,Oxygen saturation
71844-5,Oxygen saturation
May-84,Cat dander Ab.IgG
71845-2,Oxygen saturation
71846-0,Oxygen saturation
71847-8,Oxygen saturation
71848-6,Oxygen saturation
71849-4,Oxygen saturation
71850-2,Oxygen saturation
71851-0,Oxygen saturation
Feb-85,Cat dander basophil bound Ab
71852-8,Oxygen saturation
71853-6,Oxygen saturation
71854-4,Deoxyhemoglobin/Hemoglobin.total
71855-1,Hemoglobin.other/Hemoglobin.total
71856-9,Hemoglobin.other/Hemoglobin.total
71857-7,Hemoglobin S/Hemoglobin.total
71858-5,Hemoglobin S/Hemoglobin.total
71859-3,Hemoglobin S/Hemoglobin.total
7186-0,Cat hair Ab.IgE
71860-1,Hemoglobin M/Hemoglobin.total
71861-9,Hemoglobin Lepore/Hemoglobin.total
71862-7,Hemoglobin H/Hemoglobin.total
71863-5,Hemoglobin F/Hemoglobin.total
71864-3,Hemoglobin F/Hemoglobin.total
71865-0,Hemoglobin F/Hemoglobin.total
71866-8,Hemoglobin E/Hemoglobin.total
71867-6,Hemoglobin D/Hemoglobin.total
71868-4,Hemoglobin D/Hemoglobin.total
71869-2,Hemoglobin C/Hemoglobin.total
718-7,Hemoglobin
71870-0,Hemoglobin C/Hemoglobin.total
71871-8,Hemoglobin Barts/Hemoglobin.total
71872-6,Hemoglobin A2/Hemoglobin.total
71873-4,Hemoglobin A2/Hemoglobin.total
71874-2,Hemoglobin A2/Hemoglobin.total
71875-9,Hemoglobin A1c/Hemoglobin.total
71876-7,Hemoglobin A/Hemoglobin.total
71877-5,Hemoglobin A/Hemoglobin.total
Aug-87,Ictalurus punctatus Ab.IgE
71878-3,Hemoglobin A/Hemoglobin.total
71879-1,Methemoglobin/Hemoglobin.total
71880-9,Methemoglobin/Hemoglobin.total
71881-7,Methemoglobin/Hemoglobin.total
71882-5,Methemoglobin/Hemoglobin.total
71883-3,Methemoglobin/Hemoglobin.total
71884-1,Carboxyhemoglobin/Hemoglobin.total
71885-8,Carboxyhemoglobin/Hemoglobin.total
Jun-88,Ictalurus punctatus basophil bound Ab
71886-6,Carboxyhemoglobin/Hemoglobin.total
71887-4,Carboxyhemoglobin/Hemoglobin.total
71888-2,Carboxyhemoglobin/Hemoglobin.total
71889-0,Carboxyhemoglobin/Hemoglobin.total
71890-8,Carboxyhemoglobin/Hemoglobin.total
71891-6,M3 Checklist - follow-up
71892-4,Cortisone^AM peak specimen
71893-2,Cortisone^PM trough specimen
Apr-89,Typhaceae sp Ab.IgE
71894-0,Cortisone.free
71895-7,Pediatric blood pressure screening results
71896-5,Pediatric blood pressure percentile
71897-3,"Compared to one Y ago, how would you rate your emotional problems, such as feeling anxious,depressed or irritable, now"
71898-1,"Compared to one Y ago, how would you rate your physical health in general now"
71899-9,My health is excellent
71900-5,I expect my health to get worse
71901-3,I am as healthy as anyone I know
Feb-90,Brassica oleracea var botrytis Ab.IgG
71902-1,I seem to get sick a lot easier than other people
71903-9,"During the past 4W, how much of the time has your physical health or emotional problems interfered with your social activities - like visiting with friends, relatives, etc."
71904-7,Did you feel tired during the past 4W
71905-4,Have you been a happy person during the past 4W
71906-2,Did you feel worn out during the past 4W
71907-0,Have you felt downhearted and blue during the past 4W
71908-8,Did you have a lot of energy during the past 4W
71909-6,Have you felt calm and peaceful during the past 4W
7191-0,Brassica oleracea var botrytis basophil bound Ab
71910-4,Have you felt so down in the dumps that nothing could cheer you up during the past 4W
71911-2,Have you been a very nervous person during the past 4W
71912-0,Did you feel full of pep during the past 4W
71913-8,"During the past 4W, how much did pain interfere with your normal work - including both work outside the home and house work"
71914-6,How much bodily pain have you had during the past 4W
71915-3,"During the past 4W, to what extent has your physical health or emotional problems interfered with your normal social activities with family, friends, neighbors or groups"
71916-1,"As a result of any emotional problems, you didn't do work or other activities as carefully as usual in the past 4W"
71917-9,"As a result of any emotional problems, have you accomplished less than you would like in the past 4W"
71918-7,"As a result of any emotional problems, have you cut down the amount of time you spent on work or other activities in the past 4W"
71919-5,"As a result of your physical health, have you had difficulty performing the work or other activities - for example, it took extra effort in the past 4W"
71920-3,"As a result of your physical health, were you limited in the kind of work in the past 4W"
71921-1,"As a result of your physical health, have you accomplished less than you would like in the past 4W"
71922-9,"As a result of your physical health, have you cut down the amount of time you spent on work or other activities in the past 4W"
71923-7,Does your health now limit you in bathing or dressing yourself
71924-5,Does your health now limit you in walking one block
71925-2,Does your health now limit you in walking several blocks
71926-0,Does your health now limit you in walking more than a mile
71927-8,"Does your health now limit you in bending, kneeling, stooping"
Aug-92,Cedar dust Ab.IgE
71928-6,Does your health now limit you in climbing one flight of stairs
71929-4,Does your health now limit you in climbing several flights of stairs
71930-2,Does your health now limit you in lifting or carrying groceries
71931-0,"Does your health now limit you in moderate activities, such as moving a table, pushing a vacuum cleaner, bowling or playing golf"
71932-8,"Does your health now limit you in vigorous activities, such as running, lifting heavy objects, participating in strenuous sports"
71933-6,Veterans RAND health survey - 36 item
71934-4,Veterans RAND health survey - 12 item
71935-1,Parents' evaluation of developmental status - developmental milestones
Jun-93,Juniperus sabinoides Ab.IgG
71936-9,Parents' evaluation of developmental status
71937-7,"Tolerance, worried, eye- opener, amnesia, cutdown screening test"
71938-5,Total score
71939-3,Minnesota Living with Heart Failure Questionnaire
71940-1,Overall summary score
71941-9,Kansas City cardiomyopathy questionnaire
71942-7,"Car, relax, alone, forget, friends, trouble screening test"
71943-5,Michigan alcoholism screening test - geriatric version
Apr-94,Juniperus sabinoides basophil bound Ab
71944-3,Michigan alcoholism screening test
71945-0,Ascertain dementia 8
71946-8,Short informant questionnaire on cognitive decline in the elderly
71947-6,St. Louis University mental status examination
71948-4,Hip and knee outcomes questionnaire
71949-2,Falls behavioral scale for older people
719-5,Hemoglobin
71950-0,Health assessment questionnaire
Jan-95,Juniperus virginiana Ab.IgE
71951-8,Infant development inventory
71952-6,Child development inventory
71953-4,Bayley infant neurodevelopmental screener
71954-2,Ages and stages questionnaires
71955-9,PROMIS-29 Sleep disturbance score
71956-7,PROMIS-29 Sleep disturbance score
71957-5,PROMIS-29 Satisfaction with participation in social roles score
71958-3,PROMIS-29 Satisfaction with participation in social roles score
71959-1,PROMIS-29 Physical function score
71960-9,PROMIS-29 Physical function score
71961-7,PROMIS-29 Pain interference score
71962-5,PROMIS-29 Pain interference score
71963-3,PROMIS-29 Fatigue score
71964-1,PROMIS-29 Fatigue score
71965-8,PROMIS-29 Depression score
71966-6,PROMIS-29 Depression score
71967-4,PROMIS-29 Anxiety score
71968-2,PROMIS-29 Anxiety score
Sep-96,Tamarix spp Ab.IgE
71969-0,PROMIS-10 Global Mental Health score
71970-8,PROMIS-10 Global Mental Health score
71971-6,PROMIS-10 Global Physical Health score
71972-4,PROMIS-10 Global Physical Health score
71973-2,VR-36 Mental health score - oblique method
71974-0,VR-36 Role emotion score - oblique method
71975-7,VR-36 Social functioning score - oblique method
71976-5,VR-36 Vitality score - oblique method
Jul-97,Apium graveolens Ab.IgG
71977-3,VR-36 General health score - oblique method
71978-1,VR-36 Bodily pain score - oblique method
71979-9,VR-36 Role physical score - oblique method
71980-7,VR-36 Physical functioning score - oblique method
71981-5,VR-36 Mental health score - oblique method
71982-3,VR-36 Role emotion score - oblique method
71983-1,VR-36 Social functioning score - oblique method
71984-9,VR-36 Vitality score - oblique method
May-98,Apium graveolens basophil bound Ab
71985-6,VR-36 General health score - oblique method
71986-4,VR-36 Bodily pain score - oblique method
71987-2,VR-36 Role physical score - oblique method
71988-0,VR-36 Physical functioning score - oblique method
71989-8,VR-36 Physical component summary score - oblique method
71990-6,VR-36 Mental component summary score - oblique method
71991-4,VR-36 Mental health score - orthogonal method
71992-2,VR-36 Role emotion score - orthogonal method
Mar-99,Cephalosporine mold Ab.IgE
71993-0,VR-36 Social functioning score - orthogonal method
71994-8,VR-36 Vitality score - orthogonal method
71995-5,VR-36 General health score - orthogonal method
71996-3,VR-36 Bodily pain score - orthogonal method
71997-1,VR-36 Role physical score - orthogonal method
71998-9,VR-36 Physical functioning score - orthogonal method
71999-7,VR-36 Mental health score - orthogonal method
72000-3,VR-36 Role emotion score - orthogonal method
72001-1,VR-36 Social functioning score - orthogonal method
72002-9,VR-36 Vitality score - orthogonal method
72003-7,VR-36 General health score - orthogonal method
72004-5,VR-36 Bodily pain score - orthogonal method
72005-2,VR-36 Role physical score - orthogonal method
72006-0,VR-36 Physical functioning score - orthogonal method
72007-8,VR-36 Physical component summary score - orthogonal method
72008-6,VR-36 Mental component summary score - orthogonal method
Sep-00,Chaetomium globosum Ab.IgE
72009-4,VR-12 Mental health score - oblique method
72010-2,VR-12 Role emotion score - oblique method
72011-0,VR-12 Social functioning score - oblique method
72012-8,VR-12 Vitality score - oblique method
72013-6,VR-12 General health score - oblique method
72014-4,VR-12 Bodily pain score - oblique method
72015-1,VR-12 Role physical score - oblique method
72016-9,VR-12 Physical functioning score - oblique method
Jul-01,Cheese American Ab.IgE
72017-7,VR-12 Mental health score - oblique method
72018-5,VR-12 Role emotion score - oblique method
72019-3,VR-12 Social functioning score - oblique method
72020-1,VR-12 Vitality score - oblique method
72021-9,VR-12 General health score - oblique method
72022-7,VR-12 Bodily pain score - oblique method
72023-5,VR-12 Role physical score - oblique method
72024-3,VR-12 Physical functioning score - oblique method
May-02,Cheese American Ab.IgG
72025-0,VR-12 Physical component summary score - oblique method
72026-8,VR-12 Mental component summary score - oblique method
72027-6,VR-12 Physical component summary score - orthogonal method
72028-4,VR-12 Mental component summary score - orthogonal method
72029-2,Vaccination exclusion - medical reason
720-3,Hemoglobin.free
72030-0,Type oral vitamin D analog prescribed
72031-8,Oral vitamin D analog prescribed
72032-6,Type non-oral vitamin D analog prescribed
Mar-03,Cheese blue Ab.IgE
72033-4,Non-oral vitamin D analog prescribed
72034-2,Vitamin D panel
72035-9,Arteriovenous graft assessed frequency
72036-7,Arteriovenous graft assessed using intra-access flow
72037-5,Arteriovenous graft assessed frequency
72038-3,Arteriovenous graft assessed using doppler
72039-1,How often was static venous pressure measured
72040-9,Testing of arteriovenous graft performed using static venous pressure
Jan-04,Cheese cheddar type Ab.IgG
72041-7,Testing of arteriovenous graft for access dysfunction performed
72042-5,How often was arterial pre-pump pressure measured
72043-3,Measurement of arterial pre-pump pressure performed
72044-1,Dialysis access physical exam frequency
72045-8,"Physical examination dialysis access performed prior, during and after cannulation"
72046-6,Arteriovenous graft status
72047-4,Arteriovenous fistula status
72048-2,Date arteriovenous fistula usable
72049-0,Date dialysis session
72050-8,Dialysis access
72051-6,Date catheter removal
72052-4,Date catheter placement
72053-2,Date arteriovenous fistula creation
72054-0,Date change of dialysis access type
72055-7,Vascular access panel
72056-5,Hepatitis B vaccination received
72057-3,Pneumococcal vaccination been received
Aug-05,Cheese cheddar type basophil bound Ab
72058-1,Influenza virus vaccination received
72059-9,Vaccination exclusion
72060-7,Where was vaccine received
72061-5,Vaccination panel
72062-3,Medication allergies panel
72063-1,Type oral iron prescribed
72064-9,Oral iron prescribed
72065-6,Type intravenous iron prescribed
Jun-06,Cheese cottage Ab.IgE
72066-4,Intravenous iron prescribed
72067-2,Iron prescription current
72068-0,Iron panel
72069-8,Sodium profiling-modeling prescribed for any dialysis sessions in the reporting Mo
72070-6,Left ventricular hypertrophy
72071-4,Edema present
72072-2,Breath sounds
72073-0,Post-dialysis target weight for session prescribed
Apr-07,Cheese cottage Ab.IgG
72074-8,Date last formal post dialysis weight
72075-5,Did patient provide the home blood pressure values to the dialysis unit
72076-3,Blood pressure home reading
72077-1,Sodium restriction education received
72078-9,Date of echocardiogram
72079-7,Dry weight order present
72080-5,Did prescribed dialysate sodium concentration exceed 138 mEq/L for any dialysis session during the Mo
72081-3,Date of sodium education
Feb-08,Cheese cream basophil bound Ab
72082-1,Constant dialysate sodium prescribed
72083-9,Left ventricular hypertrophy change
72084-7,Fluid and weight panel
72085-4,Vaccination exclusion - patient reason
72086-2,Brigance screens II
72087-0,Blessed orientation-memory-concentration test
72088-8,Clinical dementia rating scale
72089-6,Total score
7209-0,Cheese mozzarella Ab.IgE
72090-4,Identification of CBER-regulated generic drug facility
72091-2,Knee injury and osteoarthritis outcome score
72092-0,Hip dysfunction and osteoarthritis outcome score
72093-8,Quality of life score
72094-6,Sport-recreation score
72095-3,Activities of daily living score
72096-1,Symptoms score
72097-9,Pain score
72098-7,Quality of life score
72099-5,Sport-recreation score
72100-1,Activities of daily living score
72101-9,Symptoms score
72102-7,Pain score
72103-5,Acute & chronic leukemia fusion transcript panel
72104-3,Acute & chronic leukemia fusion transcript per control transcript panel
72105-0,"Vital signs & oximetry - admission, home health, interim, discharge"
72106-8,Total score
72107-6,Mini-mental state examination
Aug-10,Cheese mozzarella Ab.IgG
72109-2,Alcohol use disorder identification test-consumption
721-1,Hemoglobin.free
72110-0,Alcohol use disorder identification test
72111-8,Sapovirus RNA
72112-6,Reason procedure not performed
72113-4,Reason medication not given
72114-2,Complaint
72115-9,Resuscitation attempted
Jun-11,Cheese mozzarella basophil bound Ab
72116-7,Total score - Ages and stages questionnaires 36 Mo
72117-5,Total score - Ages and stages questionnaires 33 Mo
72118-3,Total score - Ages and stages questionnaires 30 Mo
72119-1,Total score - Ages and stages questionnaires 27 Mo
72120-9,Total score - Ages and stages questionnaires 24 Mo
72121-7,Total score - Ages and stages questionnaires 22 Mo
72122-5,Total score - Ages and stages questionnaires 20 Mo
72123-3,Total score - Ages and stages questionnaires 18 Mo
Apr-12,Cheese parmesan Ab.IgE
72124-1,Total score - Ages and stages questionnaires 16 Mo
72125-8,Total score - Ages and stages questionnaires 14 Mo
72126-6,Total score - Ages and stages questionnaires 12 Mo
72127-4,Total score - Ages and stages questionnaires 10 Mo
72128-2,Total score - Ages and stages questionnaires 9 Mo
72129-0,Total score - Ages and stages questionnaires 8 Mo
72130-8,Total score - Ages and stages questionnaires 6 Mo
72131-6,Total score - Ages and stages questionnaires 4 Mo
Feb-13,Cheese parmesan basophil bound Ab
72132-4,Total score - Ages and stages questionnaires 2 Mo
72133-2,Montreal cognitive assessment
72134-0,Cancer event report
72135-7,Cancer diagnosis
72136-5,Risk for venous thromboembolism
72137-3,Multisection diagnostic
72138-1,Multisection diagnostic
72139-9,Multisection diagnostic
7214-0,Cheese roquefort Ab.IgE
72140-7,Multisection screening
72141-5,Multisection screening
72142-3,Multisection screening
72143-1,Sex
72144-9,Post-natal maternal vital status
72145-6,Perineal tear classification
72146-4,Neonatal vital status at delivery
72147-2,Gestational age^at birth
72148-0,Person attending birth
72149-8,Delivery method
72150-6,Delivery location
72151-4,Arrived at clinic with partner
72152-2,Tested for HIV
72153-0,Last born child vital status
72154-8,Pregnancy risk factors
72155-5,Position in womb
72156-3,Rwandan maternal screening panel
Jul-15,Cheese swiss Ab.IgE
72157-1,Apo-transcobalamin II
72158-9,Apo-transcobalamin I
72159-7,Inulin renal clearance/1.73 sq M
72160-5,Holo-transcobalamin II
72161-3,Epithelial cells
72162-1,Erythrocytes
72163-9,Leukocytes
72164-7,Pediatric diastolic blood pressure percentile
May-16,Cheese swiss Ab.IgG
72165-4,Pediatric systolic blood pressure percentile
72166-2,Tobacco smoking status
72167-0,Name of section completed
72168-8,Ofloxacin 1.5 ug/mL
72169-6,Permission to release immunization data from school record
72170-4,Photographic image
72171-2,Glucose tolerance 2H panel
72172-0,Total score
Mar-17,Prunus avium Ab.IgG
72173-8,Total score
72174-6,Rotavirus Ag
72175-3,Physician assessment necessary
72176-1,Facility recommended for birth
72177-9,Congenital anomalies noted
72178-7,Given a mosquito net
72179-5,Given pyrimethamine sulfadoxine - starting at 4th Mo
72180-3,Given iron and folic acid
Jan-18,Prunus avium basophil bound Ab
72181-1,HIV results shared with partner
72182-9,Tested for HIV
72183-7,Treated for syphillis
72184-5,Treated for syphillis
72185-2,Medical history
72186-0,Obstetrical risk
72187-8,Date tetanus vaccine given
72188-6,Clinical summary score
72189-4,Quality of life score
72190-2,Self-efficacy score
72191-0,Total symptom score
72192-8,Symptom burden score
72193-6,Symptom frequency score
72194-4,Symptom stability score
72195-1,Physical limitation score
72196-9,Social limitation score
72197-7,HEDIS 2013 Codes to identify group A Streptococcus tests (CWP-D)
72198-5,HEDIS 2013 Codes to identify sexually active women (CHL-B)
Sep-19,Castanea sativa Ab.IgE
72199-3,HEDIS 2013 panel
72200-9,Influenza virus A neuraminidase segment sequence identifier
72201-7,Influenza virus A matrix protein segment sequence identifier
72202-5,Discharge disposition - long term care hospital
72203-3,Parathyrin.intact intraoperative panel
72204-1,Changes in appetite - follow up
72205-8,Changes in sleeping patterns - follow up
72206-6,Epstein Barr virus nuclear 1 Ab.IgG & IgM
Jul-20,Aesculus hippocastanum Ab.IgE
72207-4,"t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript"
72208-2,"t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript/control transcript"
72209-0,"inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript"
72210-8,"inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript"
72211-6,"t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript"
72212-4,"t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript"
72213-2,"t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript"
72214-0,"t(15;17)(q24.1;q21.1)(PML,RARA) bcr3 fusion transcript/control transcript"
May-21,Chewing gum Ab.IgE
72215-7,"t(15;17)(q24.1;q21.1)(PML,RARA) bcr2 fusion transcript/control transcript"
72216-5,"t(15;17)(q24.1;q21.1)(PML,RARA) bcr1 fusion transcript/control transcript"
72217-3,"t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript"
72218-1,"t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript"
72219-9,Lymphocytes
72220-7,Macrophages
72221-5,Study observation
Mar-22,Chicken Ab.IgG
72223-1,Yeast
72224-9,Pathologic casts
72225-6,Progress note - recommended C-CDA R1.1 sections
72227-2,Surgical operation note - recommended C-CDA R1.1 & R2.0 & R2.1 sections
72228-0,History and physical note - recommended C-CDA R1.1 & R2.0 & R2.1 sections
72229-8,Discharge summary - recommended C-CDA R1.1 sections
72230-6,Diagnostic imaging report - recommended C-CDA R1.1 sections
Jan-23,Chicken basophil bound Ab
72231-4,Consultation note - recommended C-CDA R1.1 sections
72232-2,Continuity of Care Document - recommended C-CDA R1.1 sections
72233-0,Total score
72234-8,Mini-Cog
72238-9,Multisection^WO & W contrast IV
72239-7,Multisection^WO contrast
72240-5,Multisection^W contrast IV
72241-3,Multisection^WO & W contrast IV
72242-1,Multisection^WO contrast
72243-9,Multisection^W contrast IV
72244-7,Multisection endorectal^WO & W contrast IV
72245-4,Multisection^W contrast PR+at rest+maximal sphincter contraction+during straining+during defecation
72246-2,Multisection^W contrast PO+WO & W contrast IV
72247-0,Multisection^W contrast PO+WO contrast IV
72248-8,Guidance for endoscopy^WO & W contrast IV
Sep-24,Chicken feather Ab.IgG
72249-6,Multisection^WO contrast
72250-4,Multisection^W contrast PO+W contrast IV
72251-2,Multisection for pulmonary embolus
72252-0,Multisection^WO & W contrast IV
72253-8,Multisection^WO contrast
72254-6,Multisection^W contrast IV
72255-3,Multisection^W contrast IV
Jun-25,Cichorium intybus Ab.IgE
72256-1,Views for motility^W radioopaque markers
72257-9,Platelet function.collagen+Adenosine diphosphate induced & EPINEPHrine induced panel
72258-7,Malondialdehyde
72259-5,Adefovir
72260-3,Tau protein.phosphorylated 181
72261-1,Bilirubin excess
72262-9,Methemoglobin
72263-7,Oxyhemoglobin
Apr-26,Sapium sebiferum Ab.IgE
72264-5,Bilirubin excess & oxyhemoglobin & methemoglobin & xanthochromia & albumin quotient panel
72265-2,Influenza virus B Ab.IgA
72266-0,Influenza virus A Ab.IgA
72267-8,Evaluation of mental and physical incapacity certificate
72268-6,Streptococcus pyogenes exotoxin B speB gene
72269-4,pH
72270-2,Urea nitrogen^pre contrast
72271-0,Creatinine^pre contrast
Feb-27,Chocolate basophil bound Ab
72272-8,Amylase & triacylglycerol lipase panel
72273-6,Blood product ordered
72274-4,"t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript"
72275-1,Dedication to Excellence + Inspiration to All
72276-9,Mycobacterium tuberculosis gyrA gene fluoroquinolone resistance mutation
72277-7,Trichomonas vaginalis
72278-5,Specimen volume
72279-3,(Chicken feather+Duck feather+Goose feather+Turkey feather) Ab.IgE
7228-0,Chymodiactin Ab.IgE
72280-1,Rh immune globulin expiration
72281-9,Days in therapeutic INR range/Days INR result determined
72282-7,Sagittal plane body position
72283-5,Nail assessment panel
72284-3,Skin assessment panel
72285-0,Dressing purpose
72286-8,Wound dressing panel
72287-6,Wound size panel
72288-4,Odor
72289-2,Color
722-9,Hemoglobin
72290-0,Appearance
72291-8,Drainage amount from device
72292-6,Wound exudate panel
72293-4,Undermining
72294-2,Undermining clock position
72295-9,Undermining
72296-7,Tunneling
72297-5,Tunneling clock position
Aug-29,Cinnamomum spp Ab.IgG
72298-3,Tunneling
72299-1,Wound tunneling & undermining panel
72300-7,Wound type
72301-5,Periwound description
72302-3,Texture
72303-1,Shape
72304-9,Edge of wound description
72305-6,Wound closure type
Jun-30,Cladosporium herbarum Ab.IgG
72306-4,Nicotinurate
72307-2,Brucella sp Ab.IgG^2nd specimen
72308-0,Brucella sp Ab.IgG^1st specimen
72309-8,NPM1 gene.c.960insCCTG transcript/control transcript
72310-6,NPM1 gene.c.960insCATG transcript/control transcript
72311-4,NPM1 gene.c.956dupTCTG transcript/control transcript
72312-2,"t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript/control transcript"
72313-0,"t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript/control transcript"
Apr-31,Cladosporium herbarum basophil bound Ab
72314-8,Th-To Ab.IgG
72315-5,Platelet-derived growth factor receptor Ab.IgG
72316-3,RNA polymerase III RP155 Ab.IgG
72317-1,RNA polymerase III RP11 Ab.IgG
72318-9,Centromere protein A Ab.IgG
72320-5,Mitochondria M2-3E Ab.IgG
72321-3,HLA-DP+DQ+DR Ab.IgG
Feb-32,Ruditapes spp Ab.IgG
72322-1,HLA-A+B+C Ab.IgG
72323-9,HLA-DP+DQ+DR Ab.IgG
72324-7,Functional shunt volume^^adjusted to patient's actual temperature
72325-4,Functional shunt volume^^adjusted to patient's actual temperature
72326-2,Functional shunt volume
72327-0,Amphiphysin Ab.IgG
72328-8,HLA-A+B+C Ab.IgG
72329-6,Anucleated bodies/100 round cells
7233-0,Ruditapes spp basophil bound Ab
72330-4,Nucleated cells/100 round cells
72331-2,Anucleated bodies/100 round cells
72332-0,Nucleated cells/100 round cells
72333-8,JAK2 gene.p.Val617Phe
72334-6,NPM1 gene.c.960insCATG transcript/control transcript
72335-3,NPM1 gene.c.956dupTCTG transcript/control transcript
72336-1,NPM1 gene.c.960insCCTG transcript/control transcript
72337-9,Protein S Ag
72338-7,Erythrocytes
72339-5,Lecithin
72340-3,Bacteria
72341-1,Amyloid bodies
72342-9,Neutrophils/100 round cells
72343-7,Monocytes/100 round cells
72344-5,Monocytes/100 round cells
72345-2,Neutrophils/100 round cells
72346-0,Round cells
72347-8,Neutrophils
Aug-34,Syzygium aromaticum Ab.IgE
72348-6,Leukocytes
72349-4,Level of fatigue on average over the past Mo
72350-2,Severity of pain on average over the past Mo
72351-0,"Social interaction with other people - family, friends, or others - over the past Mo"
72352-8,Overall emotional well being over the past 1Mo
72353-6,Overall physical well being over the past Mo
72354-4,Overall quality of life over the past Mo
May-35,Syzygium aromaticum Ab.IgG
72355-1,Patient reported outcome quality of life tool
72356-9,Influenza virus A & B Ag
72357-7,Microscopic observation
72360-1,Methemoglobin/Hemoglobin.total
72361-9,Methemoglobin/Hemoglobin.total
72362-7,Starch granules
Mar-36,Clover Ab.IgE
72364-3,Lymphocytes/100 leukocytes
72365-0,Influenza virus A & B Ag
72366-8,Influenza virus A & B Ag
72367-6,Influenza virus A+B Ag
72368-4,"t(11;14)(q13;q32)(CCND1,IGH) fusion transcript"
72369-2,Body site identification panel
723-7,Hemoglobin
72370-0,Area of identified wound bed appearance/Area of wound bed
Jan-37,Cockatoo Ab.IgE
72371-8,Appearance
72372-6,Wound bed & edge panel
72373-4,Virus identified
72374-2,Virus identified
72375-9,Microscopic method
72376-7,Hepatitis C virus Ab
72377-5,Nordiazepam
72378-3,Oxazepam
72379-1,Cannabinoids.synthetic
72380-9,LORazepam
72381-7,ALPRAZolam
72382-5,HER2
72383-3,HER2
72384-1,Meperidine+Normeperidine
72385-8,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine"
72386-6,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine"
72387-4,Methadone
72388-2,Methadone
Sep-38,Xanthium commune Ab.IgG
72389-0,Candida krusei DNA
72390-8,Candida lusitaniae DNA
72391-6,Candida tropicalis DNA
72392-4,Cortisol/Cortisone
72393-2,Cell count & Differential panel
72394-0,Cell count panel
72395-7,Differential panel
72396-5,PHENobarbital
Jul-39,Xanthium commune basophil bound Ab
72397-3,Secobarbital
72398-1,Butalbital
72399-9,Amobarbital
72400-5,Methadone
72401-3,Propoxyphene
72402-1,oxyCODONE
72403-9,3-epi-25-Hydroxyvitamin D3
72404-7,3-epi-25-Hydroxyvitamin D2
May-40,Cocos nucifera Ab.IgG
72405-4,Cocaine
72406-2,Norchlordiazepoxide
72407-0,Benzoylecgonine
72408-8,Microscopic observation
72409-6,Testosterone^post dose HCG
72410-4,Testosterone^pre dose HCG
72411-2,Monocytes+Macrophages
72412-0,BK virus subtype
Mar-41,Cocos nucifera basophil bound Ab
72413-8,BK virus subtype
72414-6,Acetoacetate^pre-meal
72415-3,Acetoacetate^post meal
72416-1,Beta hydroxybutyrate^post meal
72417-9,Beta hydroxybutyrate^pre-meal
72418-7,Beta hydroxybutyrate/Acetoacetate^pre-meal
72419-5,Beta hydroxybutyrate/Acetoacetate^post meal
72420-3,Gamma aminobutyrate.free
Jan-42,Gadus morhua basophil bound Ab
72421-1,Bacterial vancomycin resistance vanB gene
72422-9,Gamma aminobutyrate
72423-7,3-Methylhistidine
72424-5,3-Methylhistidine/Amino acids.total
72425-2,7-Hydroxyoctanoate
72426-0,5-Hydroxyhexanoate
72427-8,4-Hydroxyphenylpyruvate
72428-6,4-Hydroxyphenylpyruvate
72429-4,4-Hydroxyphenyllactate
72430-2,4-Hydroxyphenyllactate
72431-0,4-Hydroxyphenylacetate
72432-8,4-Hydroxyphenylacetate
72433-6,Gamma hydroxybutyrate
72434-4,"4,5-Dihydroxyhexanolactone"
72435-1,"4,5-Dihydroxyhexanoate"
72436-9,Phenylpyruvate
72437-7,Phenyllactate
72438-5,3-Methylglutarate
Sep-43,Coffee bean Ab.IgE
72439-3,3-Methylglutarate
72440-1,3-Methylglutaconate
72441-9,3-Methylcrotonylglycine
72442-7,3-Methylcrotonylglycine
72443-5,3-Methyladipate
72444-3,3-Hydroxytetradecanedioate
72445-0,3-Hydroxysuberate
72446-8,3-Hydroxysuberate
Jul-44,Cola Ab.IgE
72447-6,3-Hydroxysebacate
72448-4,3-Hydroxysebacate
72449-2,3-Hydroxyisovalerate
724-5,Hemoglobin
72450-0,3-Hydroxyisovalerate
72451-8,Barbiturates
72452-6,Secobarbital
72453-4,PHENobarbital
Apr-45,Cola Ab.IgG
72454-2,Butalbital
72455-9,Amobarbital
72456-7,Benzodiazepines
72457-5,Desmin Ab
72458-3,Myosin Ab
72459-1,JWH-018 4+5-hydroxypentyl
72460-9,JWH-073 3-hydroxybutyl
72461-7,JWH-018 pentanoate
Feb-46,Cola nut basophil bound Ab
72462-5,JWH-200 4-Hydroxyindole
72463-3,AM-2201 4-hydroxypentyl
72464-1,JWH-073 4-hydroxybutyl
72465-8,JWH-073 butanoate
72466-6,JWH-250 5-hydroxypentyl
72467-4,JWH-250 5-carboxypentyl
72468-2,RCS-4 5-hydroxypentyl
72469-0,RCS-4 5-carboxypentyl
7247-0,Zea mays basophil bound Ab
72470-8,MAM-2201 pentanoate
72471-6,UR-144 4+5-hydroxypentyl
72472-4,UR-144 pentanoate
72473-2,JWH-398 5-hydroxypentyl
72474-0,JWH-122 5-hydroxypentyl
72475-7,Methadone+Metabolite
72476-5,Methadone panel
72478-1,Synthetic cannabinoids panel
72479-9,Drugs of abuse panel
72480-7,Barbiturates panel
72481-5,Candida sp 6 panel
72482-3,BK virus subtype
72483-1,BK virus subtype
72484-9,BK virus subtype
72485-6,Tapentadol
72486-4,Laboratory director name
72487-2,TF gene full mutation analysis
Aug-48,Zea mays pollen Ab.IgE
72488-0,Beta 2 glycoprotein 1 Ab.IgG & IgM panel
72489-8,Androstenedione
72490-6,17-Hydroxyprogesterone
72491-4,Bile acid
72492-2,Paraoxonase-arylesterase 1
72493-0,Cytomegalovirus DNA
72494-8,Cytomegalovirus DNA
72495-5,Candida parapsilosis DNA
Jun-49,Cornish hen basophil bound Ab
72496-3,DNA double strand
72497-1,Dihydropteridine reductase
72498-9,Tripeptidyl peptidase I
72499-7,Oval fat bodies (globules)
72500-2,Homocyst(e)ine^post CFst
72501-0,Homocyst(e)ine^6H post dose methionine
72502-8,Homocyst(e)ine^6H post dose methionine - post CFst
72503-6,WT1 gene exon 1+2 transcript/control transcript
Apr-50,Cotton gin dust Ab.IgE
72504-4,CV2 Ab
72505-1,Exserohilum rostratum DNA
72506-9,ABCB1 gene.c.3435C>T
72507-7,VKORC1 gene.c.1173C>T
72508-5,UGT1A1 gene.c.A(TA)7TAA(*28)
72509-3,Reporting rate
72510-1,Performance rate
72511-9,CYP2B6 gene targeted mutation analysis
Feb-51,Cotton linters Ab.IgE
72512-7,VKORC1 gene targeted mutation analysis
72513-5,Vital signs with smoking status and pain scale
72514-3,Pain severity - 0-10 verbal numeric rating
72515-0,Myeloperoxidase Ab.IgG
72516-8,Glucose
72517-6,Spermatozoa^post ejaculate
72518-4,CHEK2 gene.c.470C>T & 1100delC
72519-2,Infections present &or treated during this pregnancy for live birth
725-2,Hemoglobin
7252-0,Cotton linters basophil bound Ab
72520-0,FLT3 gene.p.Asp835+Ile836 mutations
72521-8,p-ANCA formalin sensitive Ab.IgG
72522-6,p-ANCA formalin resistant Ab.IgG
72523-4,Glutamate decarboxylase 65 Ab
72524-2,Myelin Ab
72525-9,Raltegravir
72526-7,Elvitegravir
72527-5,Pressure ulcer stage
72528-3,Multisection
72529-1,Multisection
72530-9,Guidance for injection
72531-7,Multisection^W contrast IV+W air contrast PR
72532-5,Guidance for ambulatory phlebectomy
72533-3,Guidance for ambulatory phlebectomy
72534-1,Guidance for laser ablation
72535-8,Guidance for laser ablation
72536-6,Guidance for vascular sclerotherapy
72537-4,Guidance for vascular sclerotherapy
Aug-53,Cottonseed Ab.IgG
72538-2,Guidance for removal of peripherally-inserted central venous catheter
72539-0,Guidance for denervation
72540-8,Guidance for denervation
72541-6,Guidance for denervation
72542-4,Guidance for denervation
72543-2,Guidance for denervation
72544-0,Guidance for percutaneous device removal of nephrostomy tube^W contrast
72545-7,Guidance for percutaneous replacement of drainage catheter
Jun-54,Populus nigra Ab.IgE
72546-5,Guidance for substance removal of central venous catheter lumen obstruction
72547-3,Guidance for substance removal of central venous catheter pericatheter obstruction
72548-1,Guidance for removal of central venous catheter^W contrast IV
72549-9,Guidance for removal of tunneled central venous catheter
72550-7,Guidance for repair of central venous catheter with port or pump
72551-5,Guidance for repair of central venous catheter without port or pump
72552-3,Guidance for kyphoplasty
Mar-55,Populus fremontii Ab.IgE
72553-1,Guidance for kyphoplasty
72554-9,Guidance for trigger point injection
72555-6,Consultation note
72556-4,Progress note
72557-2,Rilpivirine
72558-0,Etravirine
72559-8,HIV integrase inhibitor susceptibility panel
72560-6,HIV integrase inhibitor susceptibility panel
Jan-56,Populus fremontii Ab.IgE
72561-4,Creatine kinase.aberrant band/Creatine kinase.total
72562-2,Creatine kinase.MM/Creatine kinase.total
72563-0,Creatine kinase.MB/Creatine kinase.total
72564-8,Creatine kinase.MB/Creatine kinase.total
72565-5,Creatine kinase.BB/Creatine kinase.total
72566-3,Cholinesterase.scoline inhibited/Cholinesterase
72567-1,Cholinesterase.RO 020683 inhibited/Cholinesterase
72568-9,Cholinesterase.fluoride inhibited/Cholinesterase
72569-7,Cholinesterase^dibucaine/Cholinesterase
72570-5,Cholinesterase.chloride inhibited/Cholinesterase
72571-3,Amylase.pancreatic/Amylase.total
72572-1,Amylase.salivary/Amylase.total
72573-9,Uroporphyrin/Porphyrins.total
72574-7,Coproporphyrin/Porphyrins.total
72575-4,Macroprolactin/Prolactin
72576-2,Prostate specific Ag.free/Prostate specific Ag.total
72577-0,Protein.monoclonal/Protein.total
72578-8,Prealbumin/Protein.total
Sep-57,Cow epithelium Ab.IgE
72579-6,Prealbumin/Protein.total
72580-4,Gamma globulin/Protein.total
72581-2,Gamma globulin/Protein.total
72582-0,Gamma globulin/Protein.total
72583-8,Gamma globulin/Protein.total
72584-6,Beta globulin/Protein.total
72585-3,Beta globulin/Protein.total
72586-1,Beta globulin/Protein.total
Jul-58,Cow milk Ab.IgE
72587-9,Beta globulin/Protein.total
72588-7,Alpha 2 globulin/Protein.total
72589-5,Alpha 2 globulin/Protein.total
72590-3,Alpha 2 globulin/Protein.total
72591-1,Alpha 2 globulin/Protein.total
72592-9,Alpha 1 globulin/Protein.total
72593-7,Alpha 1 globulin/Protein.total
72594-5,Alpha 1 globulin/Protein.total
May-59,Cow milk basophil bound Ab
72595-2,Alpha 1 globulin/Protein.total
72596-0,Albumin/Protein.total
72597-8,Albumin/Protein.total
72598-6,Albumin/Protein.total
72599-4,Albumin/Protein.total
726-0,Hemoglobin
72600-0,Albumin/Protein.total
72601-8,Beta hydroxybutyrate+Acetoacetate^pre-meal
72602-6,Beta hydroxybutyrate+Acetoacetate^post meal
Mar-60,Cancer pagurus Ab.IgG
72603-4,Beta hydroxybutyrate+Acetoacetate
72604-2,Insulin^4.5H post 75 g glucose PO
72605-9,Cytomegalovirus glycoprotein genotype
72606-7,Hepatitis D virus genotype
72607-5,Streptococcus agalactiae
72608-3,Apixaban
72609-1,Nonsteroidal antiinflammatory drugs
72610-9,diazePAM
Jan-61,Cancer pagurus basophil bound Ab
72611-7,diazePAM
72612-5,ALPRAZolam
72613-3,Oxazepam
72614-1,Oxazepam
72615-8,Nordiazepam
72616-6,Benzodiazepines
72617-4,Propoxyphene
72618-2,Propoxyphene+Norpropoxyphene
72619-0,Norpropoxyphene
72620-8,Norpropoxyphene
72621-6,Propoxyphene
72622-4,Propoxyphene
72623-2,inFLIXimab Ab
72624-0,Rivaroxaban
72625-7,Dabigatran
72626-5,Methadone
72627-3,Barbiturates
72628-1,PHENobarbital
Sep-62,Vaccinium oxycoccos Ab.IgE
72629-9,Secobarbital
72630-7,PENTobarbital
72631-5,Amobarbital
72632-3,Butalbital
72633-1,Benzodiazepines
72634-9,Temazepam
72635-6,PENTobarbital
72636-4,Total score
Jul-63,Vaccinium oxycoccos Ab.IgG
72637-2,I had uncontrollable sexual encounters of which I was later ashamed or which made me angry in last W
72638-0,I had outbreaks of uncontrolled anger or physically attacked others in last W
72639-8,"I took medication that had not been prescribed or if had been prescribed, I took more than the prescribed dose in last W"
72640-6,I took drugs in last W
72641-4,I got drunk in last W
72642-2,Guidance for vascular sclerotherapy
72643-0,Guidance for vascular sclerotherapy
72644-8,Guidance for vascular sclerotherapy
May-64,Vaccinium oxycoccos basophil bound Ab
72645-5,Guidance for vascular sclerotherapy
72646-3,Albumin.serum-albumin.pericard fld
72647-1,Albumin.serum-albumin.plr fld
72648-9,Glucose.serum-glucose.synv fld
72649-7,Glucose.serum-glucose.perition fld
72650-5,Glucose.serum-glucose.pericard fld
72651-3,Glucose.serum-glucose.plr fld
Feb-65,Astacus astacus Ab.IgE
72652-1,Subtelomere analysis.long arm
72653-9,Subtelomere analysis.short arm
72654-7,SNRPN gene 15q11 deletion+duplication
72655-4,Aldolase
72656-2,risperiDONE^trough
72657-0,Procainamide^trough
72658-8,PARoxetine^trough
72659-6,OXcarbazepine^trough
7266-0,Cricket Ab.IgE
72660-4,Beta-trace protein
72661-2,Intrinsic coagulation factor activity 4 panel
72662-0,Extrinsic coagulation factor activity 4 panel
72663-8,Bisphosphoglycerate mutase
72664-6,Phosphofructokinase
72665-3,"Trans,trans-muconate"
72666-1,Nitrazepam^trough
72667-9,Mycophenolate^trough
72668-7,Mirtazapine^trough
72669-5,Mianserin^trough
72670-3,"Metanephrine, Normetanephrine, 3-Methoxytyramine & Creatinine panel"
72671-1,Everolimus^trough
72672-9,traZODone^trough
72673-7,Theophylline^trough
72674-5,Sulfamethoxazole^trough
72675-2,Sotalol^trough
72676-0,Sirolimus^trough
72677-8,Salicylates^trough
Aug-67,Cryptococcus terreus Ab.IgE
72678-6,Venlafaxine+O-desmethylvenlafaxine^trough
72679-4,Bile acid
72680-2,Macroprolactin
72681-0,"I displayed high-risk behavior by knowingly driving too fast, running around on the roofs of high buildings, balancing on bridges, etc. in last W"
72682-8,I induced vomiting in last W
72683-6,I had episodes of binge eating in last W
72684-4,I tried to commit suicide in last W
72685-1,I told other people that I was going to kill myself in last W
Jun-68,Cucumis sativus Ab.IgG
72686-9,"I hurt myself by cutting, burning, strangling, headbanging etc. in last W"
72687-7,Now we would like to know in addition the quality of your overall personal state in the course of the last W
72688-5,Mean score
72689-3,Total score
72690-1,I felt worthless in last W
72691-9,I felt as if I was far away from myself in last W
72692-7,I felt disgusted by myself in last W
72693-5,Insulin-like growth factor-II.high molecular weight
Apr-69,Cucumis sativus basophil bound Ab
72694-3,Cholinesterase activity panel
72695-0,Erythrocyte enzyme panel
72696-8,SLC40A1 gene targeted mutation analysis
72697-6,CYP3A5 gene.c.6986A>G(*3)
72698-4,I was afraid of losing control in last W
72699-2,Everything seemed senseless to me in last W
72700-8,The idea of death had a certain fascination for me in last W
72701-6,I felt vulnerable in last W
Feb-70,Curry Ab.IgE
72702-4,Criticism had a devastating effect on me in last W
72703-2,I suffered from voices and noises from inside or outside my head in last W
72704-0,"My mood rapidly cycled in terms of anxiety, anger, and depression in last W"
72705-7,I suffered from shame in last W
72706-5,I wanted to punish myself in last W
72707-3,I hated myself in last W
72708-1,I had images that I was very much afraid of in last W
72709-9,I experienced stressful inner tension in last W
7271-0,Curvularia sp Ab.IgE
72710-7,I was lonely in last W
72711-5,I didn't believe in my right to live in last W
72712-3,I didn't trust other people in last W
72713-1,I thought of hurting myself in last W
72714-9,I felt disgust in last W
72715-6,I was absent-minded and unable to remember what I was actually doing in last W
72716-4,I felt helpless in last W
72717-2,It was hard for me to concentrate in last W
72718-0,Borderline symptom list - behavior supplement
72719-8,Borderline symptom list - 23 item
72720-6,Base excess.100% oxygenated^^standard
72721-4,Base excess.100% oxygenated^^standard
72722-2,Base excess.100% oxygenated^^standard
72723-0,Base excess.100% oxygenated^^standard
72724-8,PM-SCL-75 Ab.IgG
72725-5,"t(11;14)(q13.2;q32)(MYEOV,IGH) fusion transcript"
72726-3,"t(4;14)(p16;q32)(FGFR3,IGH) fusion transcript"
72727-1,Del(13)(q14) & del(17)(p13)
Aug-72,Taxodium distichum Ab.IgE
72728-9,Del(13)(q14)
72729-7,7-Hydroxymitragynine/Creatinine
72730-5,Mitragynine/Creatinine
72731-3,7-Hydroxymitragynine
72732-1,Mitragynine
72733-9,HYDROmorphone
72734-7,Methadone
72735-4,Methamphetamine
Jun-73,Dahlia sp Ab.IgE
72736-2,Methylenedioxyamphetamine
72737-0,Cocaine
72738-8,Temazepam
72739-6,Nordiazepam
72740-4,traMADol
72741-2,Nortramadol
72742-0,Noroxycodone
72743-8,Normeperidine
Apr-74,Bellis perennis Ab.IgE
72744-6,Norhydrocodone
72745-3,Norfentanyl
72746-1,Norbuprenorphine
72747-9,N-Nortramadol
72748-7,Meprobamate
72749-5,Meperidine
72750-3,oxyCODONE
Jan-75,Phoenix canariensis pollen Ab.IgE
72751-1,oxyCODONE
72752-9,Morphine
72753-7,HYDROcodone
72754-5,LORazepam
72755-2,clonazePAM
72756-0,ALPRAZolam
72757-8,Benzodiazepines
72758-6,Amphetamine
72759-4,Codeine
72760-2,fentaNYL
72761-0,Carisoprodol
72762-8,Buprenorphine
72763-6,6-Monoacetylmorphine
72764-4,Carboxy tetrahydrocannabinol
72765-1,Phencyclidine
72766-9,oxyMORphone
72767-7,Influenza virus A hemagglutinin segment sequence identifier
72768-5,Zolpidem phenyl-4-carboxylate
Sep-76,Dermatophagoides farinae Ab.IgG
72769-3,Zolpidem phenyl-4-carboxylate/Creatinine
72770-1,Zolpidem
72771-9,Zolpidem/Creatinine
72772-7,O-desmethylvenlafaxine
72773-5,O-desmethylvenlafaxine/Creatinine
72774-3,Venlafaxine
72775-0,Venlafaxine/Creatinine
72776-8,JWH-018 butanol
Jul-77,Dermatophagoides farinae basophil bound Ab
72777-6,JWH-018 butanol/Creatinine
72778-4,JWH-073 butanoate
72779-2,JWH-073 butanoate/Creatinine
727-8,Hemoglobin distribution width
72780-0,JWH-018 pentanol
72781-8,JWH-018 pentanol/Creatinine
72782-6,JWH-018 pentanoate
72783-4,JWH-018 pentanoate/Creatinine
72784-2,PARoxetine
May-78,Dermatophagoides pteronyssinus Ab.IgG
72785-9,PARoxetine/Creatinine
72786-7,Cotinine
72787-5,6-Beta naltrexone
72788-3,6-Beta naltrexone/Creatinine
72789-1,Naltrexone/Creatinine
72790-9,Alpha-Phenyl-2-Piperidine acetate
72791-7,Alpha-Phenyl-2-Piperidine acetate/Creatinine
72792-5,Methylphenidate/Creatinine
Mar-79,Dermatophagoides pteronyssinus basophil bound Ab
72793-3,Methylone
72794-1,Methylone/Creatinine
72795-8,Mephedrone
72796-6,Mephedrone/Creatinine
72797-4,Methylenedioxypyrovalerone
72798-2,Methylenedioxypyrovalerone/Creatinine
72799-0,Norketamine
72800-6,Norketamine/Creatinine
Jan-80,Anethum graveolens Ab.IgE
72801-4,Ketamine/Creatinine
72802-2,JWH-250 5-carboxypentyl
72803-0,JWH-250 5-carboxypentyl/Creatinine
72804-8,JWH-210 5-carboxypentyl
72805-5,JWH-210 5-carboxypentyl/Creatinine
72806-3,JWH-073 carboxylated
72807-1,JWH-073 carboxylated/Creatinine
72808-9,JWH-018 carboxylated
72809-7,JWH-018 carboxylated/Creatinine
72810-5,Gabapentin
72811-3,Gabapentin/Creatinine
72812-1,Norfluoxetine/Creatinine
72813-9,FLUoxetine/Creatinine
72814-7,DULoxetine
72815-4,DULoxetine/Creatinine
72816-2,DOPamine
72817-0,AM-2201 4-hydroxypentyl
72818-8,AM-2201 4-hydroxypentyl/Creatinine
Sep-81,Anethum graveolens Ab.IgG
72819-6,Acetaminophen/Creatinine
72820-4,5-Hydroxyindoleacetate
72821-2,Creatinine
72822-0,Staphylococcus aureus enterotoxin D sed gene
72823-8,Staphylococcus aureus enterotoxin C sec gene
72824-6,Del(17)(p13)
72825-3,Phencyclidine
72826-1,Race
Jul-82,Discase Ab.IgE
72827-9,"dic(9;20)(p11-13;q11)(wcp9+,wcp20+)"
72828-7,Chlamydia trachomatis & Neisseria gonorrhoeae DNA panel
72829-5,Stalwart of Standardization + Vocabulary Curator Virtuoso
72830-3,Multisection for physiologic artery study
72831-1,Multisection limited for physiologic artery study
72832-9,Multisection for physiologic artery study^at rest+W exercise
72833-7,Cytomegalovirus UL97 gene mutations detected
72834-5,Foscarnet
May-83,Rumex crispus basophil bound Ab
72835-2,Raltegravir
72836-0,Bacterial vancomycin resistance vanC2+vanC3 genes
72837-8,Bacterial vancomycin resistance vanC1 gene
72838-6,Herpes simplex virus DNA
72839-4,Famciclovir
72840-2,Hepatitis B virus codon 250
72841-0,Hepatitis B virus codon 237
72842-8,Hepatitis B virus codon 233
Mar-84,Dog dander Ab.IgG
72843-6,Hepatitis B virus codon 215
72844-4,Hepatitis B virus codon 214
72845-1,Hepatitis B virus codon 202
72846-9,Hepatitis B virus codon 194
72847-7,Hepatitis B virus codon 191
72848-5,Hepatitis B virus codon 184
72849-3,Hepatitis B virus codon 169
7285-0,Dog epithelium Ab.IgG
72850-1,Hepatitis B virus codon 85
72851-9,Hepatitis B virus codon 84
72852-7,Cytomegalovirus resistance panel
72853-5,Maribavir
72854-3,Ganciclovir
72855-0,Cidofovir
72856-8,Cidofovir
72857-6,Dolutegravir
72858-4,Enfuvirtide
72859-2,Boceprevir
728-6,Hypochromia
72860-0,Telaprevir
72861-8,Ganciclovir
72862-6,Hepatitis C virus resistance panel
72863-4,Mycobacterium leprae gyrB gene fluoroquinolone resistance mutation
72864-2,Mycobacterium tuberculosis rpsL+rrs genes aminoglycoside resistance mutation
72865-9,Mycobacterium tuberculosis ethB gene ethionamide resistance mutation
72866-7,Mycobacterium tuberculosis ethA gene ethionamide resistance mutation
72867-5,Mycobacterium tuberculosis gyrB gene fluoroquinolone resistance mutation
Aug-86,Dog epithelium basophil bound Ab
72868-3,Mycobacterium leprae folP1 gene dapsone resistance mutation
72869-1,Mycobacterium leprae gyrA gene fluoroquinolone resistance mutation
72870-9,Mycobacterium leprae rpoB gene rifAMPin resistance mutation
72871-7,NDC labeler code request.animal drug
72872-5,MCM6 gene.c.-13910C>T & -13915T>G
72873-3,Estradiol
72874-1,JWH-073 butanol/Creatinine
72875-8,JWH-073 butanol
Jun-87,Anthemis cotula Ab.IgE
72876-6,Views
72877-4,CYP2B6 gene drug metabolism analysis overall interpretation
72878-2,UGT2B15 gene product metabolic activity interpretation
72879-0,CYP2C19 gene drug metabolism analysis overall interpretation
72880-8,CYP2D6 gene drug metabolism analysis overall interpretation
72881-6,UGT2B15 gene targeted mutation analysis
72882-4,CYP2B6 gene allele
72883-2,CYP2E1 gene targeted mutation analysis
Apr-88,Dogwood pollen Ab.IgE
72884-0,CYP1A2 gene allele
72885-7,Respiratory syncytial virus Ag
72886-5,CYP2D6 gene & CYP2C19 gene targeted mutation analysis panel
72887-3,Staphylococcus aureus methicillin resistance SCCmec
72888-1,3-epi-25-Hydroxyvitamin D3/25-hydroxyvitamin D.total
72889-9,Progesterone.free
72890-7,Progesterone.free/Progesterone.total
72891-5,Staphylococcus protein A spa gene
Feb-89,Duck feather Ab.IgG
72892-3,Staphylococcus aureus methicillin resistance SCCmec & mecA genes panel
72893-1,Doripenem
72894-9,Telavancin
72895-6,Glucose^2.5H post dose lactose PO
72896-4,Glucose^15M post dose lactose PO
72897-2,Xanthine
72898-0,Bilirubin
72899-8,Isoleucine+Leucine
Sep-72,Cefatrizine
7290-0,Egg white basophil bound Ab
72900-4,Insulin^3H post 75 g glucose PO
72901-2,Insulin^2H post 75 g glucose PO
72902-0,Insulin^1H post 75 g glucose PO
72903-8,Urea
72904-6,Formate
72905-3,Neutrophil Ab & HLA Ab screen panel
72906-1,HNA Ab panel
72907-9,HNA genotype panel
72908-7,Drug induced platelet Ab panel
72909-5,Drug induced neutrophil Ab panel
72910-3,HNA 4a-4b Ab
72911-1,HNA 4b-4b Ab
72912-9,HNA 4a-4a Ab
72913-7,HNA 2 Ab
72914-5,HNA 1c Ab
72915-2,HNA 1a-1b Ab
72916-0,HNA 1b-1b Ab
72917-8,HNA 5 genotype
Aug-91,Egg whole Ab.IgE
72918-6,HNA 4 genotype
72919-4,HNA 3 genotype
72920-2,HNA 1c genotype
72921-0,HNA 1 genotype
72922-8,HNA 1a-1a Ab
72923-6,Specimen source
72924-4,Barium
72925-1,Bilirubin
Jun-92,Egg whole Ab.IgG
72926-9,Urea
72927-7,Urea
72928-5,Secobarbital
72929-3,Warfarin induced neutrophil Ab.IgM
72930-1,Warfarin induced neutrophil Ab.IgG
72931-9,Venlafaxine induced neutrophil Ab.IgM
72932-7,Venlafaxine induced neutrophil Ab.IgG
72933-5,Vancomycin induced neutrophil Ab.IgM
Apr-93,Egg whole basophil bound Ab
72934-3,Vancomycin induced neutrophil Ab.IgG
72935-0,Valproate induced neutrophil Ab.IgM
72936-8,Valproate induced neutrophil Ab.IgG
72937-6,Trimethoprim induced neutrophil Ab.IgM
72938-4,Trimethoprim induced neutrophil Ab.IgG
72939-2,Topiramate induced neutrophil Ab.IgM
729-4,Leukocytes other
72940-0,Topiramate induced neutrophil Ab.IgG
72941-8,Terazosin induced neutrophil Ab.IgM
Feb-94,Egg yolk Ab.IgG
72942-6,Terazosin induced neutrophil Ab.IgG
72943-4,Tazobactam induced neutrophil Ab.IgM
72944-2,Tazobactam induced neutrophil Ab.IgG
72945-9,Tacrolimus induced neutrophil Ab.IgM
72946-7,Tacrolimus induced neutrophil Ab.IgG
72947-5,Sulfamethoxazole induced neutrophil Ab.IgM
72948-3,Sulfamethoxazole induced neutrophil Ab.IgG
72949-1,Spironolactone induced neutrophil Ab.IgM
72950-9,Spironolactone induced neutrophil Ab.IgG
72951-7,Simvastatin induced neutrophil Ab.IgM
72952-5,Simvastatin induced neutrophil Ab.IgG
72953-3,Sildenafil citrate induced neutrophil Ab.IgM
72954-1,Sildenafil citrate induced neutrophil Ab.IgG
72955-8,Sertraline induced neutrophil Ab.IgM
72956-6,Sertraline induced neutrophil Ab.IgG
72957-4,risperiDONE induced neutrophil Ab.IgM
72958-2,risperiDONE induced neutrophil Ab.IgG
Sep-95,Egg yolk basophil bound Ab
72959-0,raNITIdine induced neutrophil Ab.IgM
72960-8,raNITIdine induced neutrophil Ab.IgG
72961-6,Ramipril induced neutrophil Ab.IgM
72962-4,Ramipril induced neutrophil Ab.IgG
72963-2,quiNINE induced neutrophil Ab.IgM
72964-0,quiNINE induced neutrophil Ab.IgG
72965-7,quiNIDine induced neutrophil Ab.IgM
72966-5,quiNIDine induced neutrophil Ab.IgG
Jul-96,Solanum melongena Ab.IgE
72967-3,QUEtiapine induced neutrophil Ab.IgM
72968-1,QUEtiapine induced neutrophil Ab.IgG
72969-9,Piperacillin induced neutrophil Ab.IgM
72970-7,Piperacillin induced neutrophil Ab.IgG
72971-5,Phenytoin induced neutrophil Ab.IgM
72972-3,Phenytoin induced neutrophil Ab.IgG
72973-1,PHENobarbital induced neutrophil Ab.IgM
72974-9,PHENobarbital induced neutrophil Ab.IgG
May-97,Solanum melongena Ab.IgG
72975-6,Penicillin induced neutrophil Ab.IgM
72976-4,Penicillin induced neutrophil Ab.IgG
72977-2,PARoxetine induced neutrophil Ab.IgM
72978-0,PARoxetine induced neutrophil Ab.IgG
72979-8,Pantoprazole induced neutrophil Ab.IgM
72980-6,Pantoprazole induced neutrophil Ab.IgG
72981-4,Omeprazole induced neutrophil Ab.IgM
72982-2,Omeprazole induced neutrophil Ab.IgG
Mar-98,Sambucus nigra Ab.IgG
72983-0,OLANZapine induced neutrophil Ab.IgM
72984-8,OLANZapine induced neutrophil Ab.IgG
72985-5,Mycophenolate induced neutrophil Ab.IgM
72986-3,Mycophenolate induced neutrophil Ab.IgG
72987-1,Montelukast induced neutrophil Ab.IgM
72988-9,Montelukast induced neutrophil Ab.IgG
72989-7,Metoprolol induced neutrophil Ab.IgM
72990-5,Metoprolol induced neutrophil Ab.IgG
Jan-99,Sambucus nigra Ab.IgE
72991-3,Metoclopramide induced neutrophil Ab.IgM
72992-1,Metoclopramide induced neutrophil Ab.IgG
72993-9,Methylphenidate induced neutrophil Ab.IgM
72994-7,Methylphenidate induced neutrophil Ab.IgG
72995-4,metFORMIN induced neutrophil Ab.IgM
72996-2,metFORMIN induced neutrophil Ab.IgG
72997-0,Losartan induced neutrophil Ab.IgM
72998-8,Losartan induced neutrophil Ab.IgG
72999-6,Loratadine induced neutrophil Ab.IgM
73000-2,Loratadine induced neutrophil Ab.IgG
73001-0,Lisinopril induced neutrophil Ab.IgM
73002-8,Lisinopril induced neutrophil Ab.IgG
73003-6,levoFLOXacin induced neutrophil Ab.IgM
73004-4,levoFLOXacin induced neutrophil Ab.IgG
73005-1,levETIRAcetam induced neutrophil Ab.IgM
73006-9,levETIRAcetam induced neutrophil Ab.IgG
Jul-00,Ulmus americana Ab.IgE
73007-7,Lansoprazole induced neutrophil Ab.IgM
73008-5,Lansoprazole induced neutrophil Ab.IgG
73009-3,Ibuprofen induced neutrophil Ab.IgM
73010-1,Ibuprofen induced neutrophil Ab.IgG
73011-9,hydroCHLOROthiazide induced neutrophil Ab.IgM
73012-7,hydroCHLOROthiazide induced neutrophil Ab.IgG
73013-5,Gentamicin induced neutrophil Ab.IgM
73014-3,Gentamicin induced neutrophil Ab.IgG
May-01,Ulmus americana basophil bound Ab
73015-0,Gabapentin induced neutrophil Ab.IgM
73016-8,Gabapentin induced neutrophil Ab.IgG
73017-6,Furosemide induced neutrophil Ab.IgM
73018-4,Furosemide induced neutrophil Ab.IgG
73019-2,Fluconazole induced neutrophil Ab.IgM
730-2,Leukocytes other/100 leukocytes
73020-0,Fluconazole induced neutrophil Ab.IgG
73021-8,Fexofenadine induced neutrophil Ab.IgM
73022-6,Fexofenadine induced neutrophil Ab.IgG
Mar-02,Ulmus pumila Ab.IgE
73023-4,Fenofibrate induced neutrophil Ab.IgM
73024-2,Fenofibrate induced neutrophil Ab.IgG
73025-9,Escitalopram induced neutrophil Ab.IgM
73026-7,Escitalopram induced neutrophil Ab.IgG
73027-5,Enalapril induced neutrophil Ab.IgM
73028-3,Enalapril induced neutrophil Ab.IgG
73029-1,Clopidogrel induced neutrophil Ab.IgM
73030-9,Clopidogrel induced neutrophil Ab.IgG
Jan-03,Ulmus pumila Ab.IgE
73031-7,cloNIDine induced neutrophil Ab.IgM
73032-5,cloNIDine induced neutrophil Ab.IgG
73033-3,Clindamycin induced neutrophil Ab.IgM
73034-1,Clindamycin induced neutrophil Ab.IgG
73035-8,Citalopram induced neutrophil Ab.IgM
73036-6,Citalopram induced neutrophil Ab.IgG
73037-4,Ciprofloxacin induced neutrophil Ab.IgM
73038-2,Ciprofloxacin induced neutrophil Ab.IgG
73039-0,Celecoxib induced neutrophil Ab.IgM
73040-8,Celecoxib induced neutrophil Ab.IgG
73041-6,cefTRIAXone induced neutrophil Ab.IgM
73042-4,cefTRIAXone induced neutrophil Ab.IgG
73043-2,cefTAZidime induced neutrophil Ab.IgM
73044-0,cefTAZidime induced neutrophil Ab.IgG
73045-7,Cefepime induced neutrophil Ab.IgM
73046-5,Cefepime induced neutrophil Ab.IgG
73047-3,ceFAZolin induced neutrophil Ab.IgM
73048-1,ceFAZolin induced neutrophil Ab.IgG
Sep-04,Cichorium endivia Ab.IgE
73049-9,carBAMazepine induced neutrophil Ab.IgM
73050-7,carBAMazepine induced neutrophil Ab.IgG
73051-5,buPROPion induced neutrophil Ab.IgM
73052-3,buPROPion induced neutrophil Ab.IgG
73053-1,Atorvastatin induced neutrophil Ab.IgM
73054-9,Atorvastatin induced neutrophil Ab.IgG
73055-6,Atenolol induced neutrophil Ab.IgM
Jun-05,Cichorium endivia Ab.IgG
73056-4,Atenolol induced neutrophil Ab.IgG
73057-2,Acetylsalicylate induced neutrophil Ab.IgM
73058-0,Acetylsalicylate induced neutrophil Ab.IgG
73059-8,Ampicillin induced neutrophil Ab.IgM
73060-6,Ampicillin induced neutrophil Ab.IgG
73061-4,Amoxicillin induced neutrophil Ab.IgM
73062-2,Amoxicillin induced neutrophil Ab.IgG
73063-0,amLODIPine induced neutrophil Ab.IgM
Apr-06,Epicoccum purpurascens Ab.IgE
73064-8,amLODIPine induced neutrophil Ab.IgG
73065-5,Amitriptyline induced neutrophil Ab.IgM
73066-3,Amitriptyline induced neutrophil Ab.IgG
73067-1,Amiodarone induced neutrophil Ab.IgM
73068-9,Amiodarone induced neutrophil Ab.IgG
73069-7,Allopurinol induced neutrophil Ab.IgM
73070-5,Allopurinol induced neutrophil Ab.IgG
73071-3,Alendronate induced neutrophil Ab.IgM
Feb-07,Epidermophyton floccosum Ab.IgE
73072-1,Alendronate induced neutrophil Ab.IgG
73073-9,Acetaminophen induced neutrophil Ab.IgG
73074-7,Acetaminophen induced neutrophil Ab.IgM
73075-4,Drug induced neutrophil Ab
73076-2,Neutrophil Ab.IgM
73077-0,Neutrophil Ab.IgG
73078-8,Warfarin induced platelet Ab.IgG
73079-6,Warfarin induced platelet Ab.IgM
7308-0,Esterase Ab.IgE
73080-4,Voriconazole induced platelet Ab.IgM
73081-2,Voriconazole induced platelet Ab.IgG
73082-0,Verapamil induced platelet Ab.IgM
73083-8,Verapamil induced platelet Ab.IgG
73084-6,Venlafaxine induced platelet Ab.IgM
73085-3,Venlafaxine induced platelet Ab.IgG
73086-1,Vancomycin induced platelet Ab.IgG
73087-9,Vancomycin induced platelet Ab.IgM
73088-7,Valsartan induced platelet Ab.IgG
73089-5,Valsartan induced platelet Ab.IgM
73090-3,Valproate induced platelet Ab.IgM
73091-1,Valproate induced platelet Ab.IgG
73092-9,valGANciclovir induced platelet Ab.IgM
73093-7,valGANciclovir induced platelet Ab.IgG
73094-5,Valdecoxib induced platelet Ab.IgG
73095-2,Valdecoxib induced platelet Ab.IgM
73096-0,valACYclovir induced platelet Ab.IgG
73097-8,valACYclovir induced platelet Ab.IgM
Aug-09,Ficus benjamina Ab.IgE
73098-6,Ursodeoxycholate induced platelet Ab.IgG
73099-4,Ursodeoxycholate induced platelet Ab.IgM
731-0,Lymphocytes
73100-0,Trimethoprim induced platelet Ab.IgG
73101-8,Trimethoprim induced platelet Ab.IgM
73102-6,Triazolam induced platelet Ab.IgG
73103-4,Triazolam induced platelet Ab.IgM
73104-2,Triamterene induced platelet Ab.IgG
73105-9,Triamterene induced platelet Ab.IgM
Jun-10,Pseudotsuga taxifolia Ab.IgE
73106-7,Triamcinolone induced platelet Ab.IgM
73107-5,Triamcinolone induced platelet Ab.IgG
73108-3,traMADol induced platelet Ab.IgM
73109-1,traMADol induced platelet Ab.IgG
73110-9,Topiramate induced platelet Ab.IgM
73111-7,Topiramate induced platelet Ab.IgG
73112-5,Tolterodine induced platelet Ab.IgG
73113-3,Tolterodine induced platelet Ab.IgM
Apr-11,Fish Ab.IgE
73114-1,Tobramycin induced platelet Ab.IgM
73115-8,Tobramycin induced platelet Ab.IgG
73116-6,Tirofiban induced platelet Ab.IgM
73117-4,Tirofiban induced platelet Ab.IgG
73118-2,Timolol induced platelet Ab.IgM
73119-0,Timolol induced platelet Ab.IgG
73120-8,Tetracycline induced platelet Ab.IgM
73121-6,Tetracycline induced platelet Ab.IgG
Feb-12,Linum usitatissimum Ab.IgE
73122-4,Terazosin induced platelet Ab.IgM
73123-2,Terazosin induced platelet Ab.IgG
73124-0,Telmisartan induced platelet Ab.IgM
73125-7,Telmisartan induced platelet Ab.IgG
73126-5,Tazobactam induced platelet Ab.IgM
73127-3,Tazobactam induced platelet Ab.IgG
73128-1,Tamsulosin induced platelet Ab.IgM
73129-9,Tamsulosin induced platelet Ab.IgG
7313-0,Ctenocephalides sp Ab.IgE
73130-7,Tamoxifen induced platelet Ab.IgM
73131-5,Tamoxifen induced platelet Ab.IgG
73132-3,Tacrolimus induced platelet Ab.IgM
73133-1,Tacrolimus induced platelet Ab.IgG
73134-9,Sulindac induced platelet Ab.IgM
73135-6,Sulindac induced platelet Ab.IgG
73136-4,sulfiSOXAZOLE induced platelet Ab.IgM
73137-2,sulfiSOXAZOLE induced platelet Ab.IgG
73138-0,sulfaSALAzine induced platelet Ab.IgM
73139-8,sulfaSALAzine induced platelet Ab.IgG
73140-6,Sulfamethoxazole induced platelet Ab.IgG
73141-4,Sulfamethoxazole induced platelet Ab.IgM
73142-2,Sucralfate induced platelet Ab.IgM
73143-0,Sucralfate induced platelet Ab.IgG
73144-8,Spironolactone induced platelet Ab.IgG
73145-5,Spironolactone induced platelet Ab.IgM
73146-3,Sotalol induced platelet Ab.IgG
73147-1,Sotalol induced platelet Ab.IgM
Aug-14,Ctenocephalides sp Ab.IgG
73148-9,Simvastatin induced platelet Ab.IgM
73149-7,Simvastatin induced platelet Ab.IgG
73150-5,Simethicone induced platelet Ab.IgM
73151-3,Simethicone induced platelet Ab.IgG
73152-1,Sildenafil citrate induced platelet Ab.IgM
73153-9,Sildenafil citrate induced platelet Ab.IgG
73154-7,Sertraline induced platelet Ab.IgM
May-15,Ctenocephalides sp basophil bound Ab
73155-4,Sertraline induced platelet Ab.IgG
73156-2,Rosuvastatin induced platelet Ab.IgM
73157-0,Rosuvastatin induced platelet Ab.IgG
73158-8,Rosiglitazone induced platelet Ab.IgM
73159-6,Rosiglitazone induced platelet Ab.IgG
73160-4,Rofecoxib induced platelet Ab.IgG
73161-2,Rofecoxib induced platelet Ab.IgM
73162-0,risperiDONE induced platelet Ab.IgM
Mar-16,Flounder Ab.IgE
73163-8,risperiDONE induced platelet Ab.IgG
73164-6,Risedronate induced platelet Ab.IgM
73165-3,Risedronate induced platelet Ab.IgG
73166-1,rifAMPin induced platelet Ab.IgG
73167-9,rifAMPin induced platelet Ab.IgM
73168-7,raNITIdine induced platelet Ab.IgG
73169-5,raNITIdine induced platelet Ab.IgM
73170-3,Ramipril induced platelet Ab.IgM
Jan-17,Flounder Ab.IgG
73171-1,Ramipril induced platelet Ab.IgG
73172-9,Raloxifene induced platelet Ab.IgM
73173-7,Raloxifene induced platelet Ab.IgG
73174-5,RABEprazole induced platelet Ab.IgG
73175-2,RABEprazole induced platelet Ab.IgM
73176-0,quiNINE induced platelet Ab.IgM
73177-8,quiNINE induced platelet Ab.IgG
73178-6,quiNIDine induced platelet Ab.IgG
73179-4,quiNIDine induced platelet Ab.IgM
73180-2,Quinapril induced platelet Ab.IgM
73181-0,Quinapril induced platelet Ab.IgG
73182-8,QUEtiapine induced platelet Ab.IgM
73183-6,QUEtiapine induced platelet Ab.IgG
73184-4,Pseudoephedrine induced platelet Ab.IgM
73185-1,Pseudoephedrine induced platelet Ab.IgG
73186-9,Propranolol induced platelet Ab.IgM
73187-7,Propranolol induced platelet Ab.IgG
73188-5,Propoxyphene+Acetaminophen induced platelet Ab.IgM
Sep-18,Flounder basophil bound Ab
73189-3,Propoxyphene+Acetaminophen induced platelet Ab.IgG
73190-1,Propoxyphene induced platelet Ab.IgG
73191-9,Propoxyphene induced platelet Ab.IgM
73192-7,Procainamide induced platelet Ab.IgM
73193-5,Procainamide induced platelet Ab.IgG
73194-3,Primidone induced platelet Ab.IgM
73195-0,Primidone induced platelet Ab.IgG
73196-8,predniSONE induced platelet Ab.IgM
Jul-19,Chrysops flavidus (whole body) Ab.IgE
73197-6,predniSONE induced platelet Ab.IgG
73198-4,Pravastatin induced platelet Ab.IgM
73199-2,Pravastatin induced platelet Ab.IgG
73200-8,Piperacillin+Tazobactam induced platelet Ab.IgM
73201-6,Piperacillin+Tazobactam induced platelet Ab.IgG
73202-4,Piperacillin induced platelet Ab.IgG
73203-2,Piperacillin induced platelet Ab.IgM
73204-0,Pioglitazone induced platelet Ab.IgM
May-20,Tabanus spp Ab.IgG
73205-7,Pioglitazone induced platelet Ab.IgG
73206-5,Phenytoin induced platelet Ab.IgG
73207-3,Phenytoin induced platelet Ab.IgM
73208-1,PHENobarbital induced platelet Ab.IgM
73209-9,PHENobarbital induced platelet Ab.IgG
73210-7,Perphenazine induced platelet Ab.IgM
73211-5,Perphenazine induced platelet Ab.IgG
73212-3,Penicillin induced platelet Ab.IgM
Mar-21,Musca domestica basophil bound Ab
73213-1,Penicillin induced platelet Ab.IgG
73214-9,PARoxetine induced platelet Ab.IgM
73215-6,PARoxetine induced platelet Ab.IgG
73216-4,Papaverine induced platelet Ab.IgG
73217-2,Papaverine induced platelet Ab.IgM
73218-0,Pantoprazole induced platelet Ab.IgM
73219-8,Pantoprazole induced platelet Ab.IgG
73220-6,oxyCODONE+Acetylsalicylate induced platelet Ab.IgM
Jan-22,Formaldehyde basophil bound Ab
73221-4,oxyCODONE+Acetylsalicylate induced platelet Ab.IgG
73222-2,oxyCODONE induced platelet Ab.IgG
73223-0,oxyCODONE induced platelet Ab.IgM
73224-8,OXcarbazepine induced platelet Ab.IgG
73225-5,OXcarbazepine induced platelet Ab.IgM
73226-3,Oxaliplatin induced platelet Ab.IgM
73227-1,Oxaliplatin induced platelet Ab.IgG
73228-9,Oxacillin induced platelet Ab.IgM
73229-7,Oxacillin induced platelet Ab.IgG
73230-5,Ondansetron induced platelet Ab.IgM
73231-3,Ondansetron induced platelet Ab.IgG
73232-1,Omeprazole induced platelet Ab.IgM
73233-9,Omeprazole induced platelet Ab.IgG
73234-7,OLANZapine induced platelet Ab.IgM
73235-4,OLANZapine induced platelet Ab.IgG
73236-2,Nystatin induced platelet Ab.IgM
73237-0,Nystatin induced platelet Ab.IgG
73238-8,Nizatidine induced platelet Ab.IgM
Sep-23,Fruit Ab.IgE
73239-6,Nizatidine induced platelet Ab.IgG
73240-4,Nitroglycerin induced platelet Ab.IgM
73241-2,Nitroglycerin induced platelet Ab.IgG
73242-0,Nitrofurantoin induced platelet Ab.IgM
73243-8,Nitrofurantoin induced platelet Ab.IgG
73244-6,NIFEdipine induced platelet Ab.IgM
73245-3,NIFEdipine induced platelet Ab.IgG
73246-1,Niacin+Lovastatin induced platelet Ab.IgM
Jul-24,Fusarium culmorum Ab.IgG
73247-9,Niacin+Lovastatin induced platelet Ab.IgG
73248-7,Naproxen induced platelet Ab.IgM
73249-5,Naproxen induced platelet Ab.IgG
73250-3,Nafcillin induced platelet Ab.IgM
73251-1,Nafcillin induced platelet Ab.IgG
73252-9,Mycophenolate induced platelet Ab.IgM
73253-7,Mycophenolate induced platelet Ab.IgG
Apr-25,Fusarium moniliforme Ab.IgG
73254-5,Moxifloxacin induced platelet Ab.IgG
73255-2,Moxifloxacin induced platelet Ab.IgM
73256-0,Morphine induced platelet Ab.IgM
73257-8,Morphine induced platelet Ab.IgG
73258-6,Montelukast induced platelet Ab.IgM
73259-4,Montelukast induced platelet Ab.IgG
73260-2,Mirtazapine induced platelet Ab.IgM
73261-0,Mirtazapine induced platelet Ab.IgG
Feb-26,Fusarium oxysporum Ab.IgE
73262-8,Minoxidil induced platelet Ab.IgM
73263-6,Minoxidil induced platelet Ab.IgG
73264-4,Minocycline induced platelet Ab.IgM
73265-1,Minocycline induced platelet Ab.IgG
73266-9,Milrinone induced platelet Ab.IgG
73267-7,Milrinone induced platelet Ab.IgM
73268-5,Midazolam induced platelet Ab.IgM
73269-3,Midazolam induced platelet Ab.IgG
7327-0,Fusarium solani Ab.IgE
73270-1,metroNIDAZOLE induced platelet Ab.IgM
73271-9,metroNIDAZOLE induced platelet Ab.IgG
73272-7,Metoprolol induced platelet Ab.IgM
73273-5,Metoprolol induced platelet Ab.IgG
73274-3,Metoclopramide induced platelet Ab.IgM
73275-0,Metoclopramide induced platelet Ab.IgG
73276-8,Methylprednisolone induced platelet Ab.IgM
73277-6,Methylprednisolone induced platelet Ab.IgG
73278-4,Methylphenidate induced platelet Ab.IgG
73279-2,Methylphenidate induced platelet Ab.IgM
732-8,Lymphocytes
73280-0,Methyldopa induced platelet Ab.IgM
73281-8,Methyldopa induced platelet Ab.IgG
73282-6,Methotrexate induced platelet Ab.IgM
73283-4,Methotrexate induced platelet Ab.IgG
73284-2,Methocarbamol induced platelet Ab.IgM
73285-9,Methocarbamol induced platelet Ab.IgG
73286-7,metFORMIN induced platelet Ab.IgM
73287-5,metFORMIN induced platelet Ab.IgG
Aug-28,Fusarium solani Ab.IgG
73288-3,Meropenem induced platelet Ab.IgM
73289-1,Meropenem induced platelet Ab.IgG
73290-9,Lovastatin induced platelet Ab.IgM
73291-7,Lovastatin induced platelet Ab.IgG
73292-5,Losartan induced platelet Ab.IgG
73293-3,Losartan induced platelet Ab.IgM
73294-1,LORazepam induced platelet Ab.IgM
73295-8,LORazepam induced platelet Ab.IgG
Jun-29,Fusarium oxysporum Ab.IgE
73296-6,Loratadine induced platelet Ab.IgM
73297-4,Loratadine induced platelet Ab.IgG
73298-2,Loperamide induced platelet Ab.IgM
73299-0,Loperamide induced platelet Ab.IgG
73300-6,Lisinopril induced platelet Ab.IgM
73301-4,Lisinopril induced platelet Ab.IgG
73302-2,Linezolid induced platelet Ab.IgG
73303-0,Linezolid induced platelet Ab.IgM
Apr-30,Allium sativum Ab.IgG
73304-8,Lidocaine induced platelet Ab.IgM
73305-5,Lidocaine induced platelet Ab.IgG
73306-3,levoFLOXacin induced platelet Ab.IgM
73307-1,levoFLOXacin induced platelet Ab.IgG
73308-9,Levodopa induced platelet Ab.IgM
73309-7,Levodopa induced platelet Ab.IgG
73310-5,levETIRAcetam induced platelet Ab.IgM
73311-3,levETIRAcetam induced platelet Ab.IgG
Feb-31,Allium sativum basophil bound Ab
73312-1,Levalbuterol induced platelet Ab.IgM
73313-9,Levalbuterol induced platelet Ab.IgG
73314-7,Leuprolide induced platelet Ab.IgM
73315-4,Leuprolide induced platelet Ab.IgG
73316-2,Lepirudin induced platelet Ab.IgM
73317-0,Lepirudin induced platelet Ab.IgG
73318-8,Lansoprazole induced platelet Ab.IgM
73319-6,Lansoprazole induced platelet Ab.IgG
7332-0,Gelatin Ab.IgE
73320-4,Ketorolac induced platelet Ab.IgM
73321-2,Ketorolac induced platelet Ab.IgG
73322-0,ISOtretinoin induced platelet Ab.IgM
73323-8,ISOtretinoin induced platelet Ab.IgG
73324-6,Isosorbide induced platelet Ab.IgM
73325-3,Isosorbide induced platelet Ab.IgG
73326-1,Irbesartan+hydroCHLOROthiazide induced platelet Ab.IgM
73327-9,Irbesartan+hydroCHLOROthiazide induced platelet Ab.IgG
73328-7,Irbesartan induced platelet Ab.IgM
73329-5,Irbesartan induced platelet Ab.IgG
73330-3,Ipratropium induced platelet Ab.IgM
73331-1,Ipratropium induced platelet Ab.IgG
73332-9,Imipenem+Cilastatin induced platelet Ab.IgM
73333-7,Imipenem+Cilastatin induced platelet Ab.IgG
73334-5,Imipenem induced platelet Ab.IgG
73335-2,Imipenem induced platelet Ab.IgM
73336-0,Ibuprofen induced platelet Ab.IgG
73337-8,Ibuprofen induced platelet Ab.IgM
Aug-33,Geotrichum candidum Ab.IgE
73338-6,hydrOXYzine induced platelet Ab.IgM
73339-4,hydrOXYzine induced platelet Ab.IgG
73340-2,HYDROmorphone induced platelet Ab.IgM
73341-0,HYDROmorphone induced platelet Ab.IgG
73342-8,Hydrocortisone induced platelet Ab.IgG
73343-6,Hydrocortisone induced platelet Ab.IgM
73344-4,HYDROcodone+Chlorpheniramine induced platelet Ab.IgM
73345-1,HYDROcodone+Chlorpheniramine induced platelet Ab.IgG
Jun-34,Gerbil epithelium Ab.IgE
73346-9,HYDROcodone+Acetaminophen induced platelet Ab.IgM
73347-7,HYDROcodone+Acetaminophen induced platelet Ab.IgG
73348-5,HYDROcodone induced platelet Ab.IgM
73349-3,HYDROcodone induced platelet Ab.IgG
73350-1,hydroCHLOROthiazide+Losartan induced platelet Ab.IgM
73351-9,hydroCHLOROthiazide+Losartan induced platelet Ab.IgG
73352-7,hydroCHLOROthiazide induced platelet Ab.IgM
Mar-35,Zingiber officinale Ab.IgE
73353-5,hydroCHLOROthiazide induced platelet Ab.IgG
73354-3,hydrALAZINE induced platelet Ab.IgM
73355-0,hydrALAZINE induced platelet Ab.IgG
73356-8,Haloperidol induced platelet Ab.IgG
73357-6,Haloperidol induced platelet Ab.IgM
73358-4,glyBURIDE induced platelet Ab.IgM
73359-2,glyBURIDE induced platelet Ab.IgG
733-6,Lymphocytes.variant
73360-0,glipiZIDE induced platelet Ab.IgG
Jan-36,Zingiber officinale Ab.IgG
73361-8,glipiZIDE induced platelet Ab.IgM
73362-6,Glimepiride induced platelet Ab.IgM
73363-4,Glimepiride induced platelet Ab.IgG
73364-2,Gentamicin induced platelet Ab.IgM
73365-9,Gentamicin induced platelet Ab.IgG
73366-7,Gabapentin induced platelet Ab.IgM
73367-5,Gabapentin induced platelet Ab.IgG
73368-3,Furosemide induced platelet Ab.IgM
73369-1,Furosemide induced platelet Ab.IgG
73370-9,Fosinopril induced platelet Ab.IgM
73371-7,Fosinopril induced platelet Ab.IgG
73372-5,Fluvastatin induced platelet Ab.IgG
73373-3,Fluvastatin induced platelet Ab.IgM
73374-1,FLUoxetine induced platelet Ab.IgM
73375-8,FLUoxetine induced platelet Ab.IgG
73376-6,Fluconazole induced platelet Ab.IgG
73377-4,Fluconazole induced platelet Ab.IgM
73378-2,Finasteride induced platelet Ab.IgM
Sep-37,Gladiolus sp Ab.IgE
73379-0,Finasteride induced platelet Ab.IgG
73380-8,Fexofenadine induced platelet Ab.IgM
73381-6,Fexofenadine induced platelet Ab.IgG
73382-4,fentaNYL induced platelet Ab.IgG
73383-2,fentaNYL induced platelet Ab.IgM
73384-0,Fenofibrate induced platelet Ab.IgM
73385-7,Fenofibrate induced platelet Ab.IgG
73386-5,Famotidine induced platelet Ab.IgM
Jul-38,Gluten Ab.IgG
73387-3,Famotidine induced platelet Ab.IgG
73388-1,Ezetimibe induced platelet Ab.IgM
73389-9,Ezetimibe induced platelet Ab.IgG
73390-7,Esomeprazole induced platelet Ab.IgM
73391-5,Esomeprazole induced platelet Ab.IgG
73392-3,Escitalopram induced platelet Ab.IgM
73393-1,Escitalopram induced platelet Ab.IgG
73394-9,Erythromycin induced platelet Ab.IgM
May-39,Gnat whole body Ab.IgE
73395-6,Erythromycin induced platelet Ab.IgG
73396-4,Eptifibatide induced platelet Ab.IgM
73397-2,Eptifibatide induced platelet Ab.IgG
73398-0,Erythropoietin induced platelet Ab.IgM
73399-8,Erythropoietin induced platelet Ab.IgG
73400-4,Enalapril induced platelet Ab.IgM
73401-2,Enalapril induced platelet Ab.IgG
73402-0,Doxycycline induced platelet Ab.IgG
Mar-40,Goat milk Ab.IgE
73403-8,Doxycycline induced platelet Ab.IgM
73404-6,Doxazosin induced platelet Ab.IgG
73405-3,Doxazosin induced platelet Ab.IgM
73406-1,Donepezil induced platelet Ab.IgG
73407-9,Donepezil induced platelet Ab.IgM
73408-7,Docusate induced platelet Ab.IgM
73409-5,Docusate induced platelet Ab.IgG
73410-3,Dipyridamole induced platelet Ab.IgM
Jan-41,Goat milk Ab.IgG
73411-1,Dipyridamole induced platelet Ab.IgG
73412-9,Diphenoxylate+Atropine induced platelet Ab.IgM
73413-7,Diphenoxylate+Atropine induced platelet Ab.IgG
73414-5,diphenhydrAMINE induced platelet Ab.IgM
73415-2,diphenhydrAMINE induced platelet Ab.IgG
73416-0,dilTIAZem induced platelet Ab.IgG
73417-8,dilTIAZem induced platelet Ab.IgM
73418-6,Digoxin induced platelet Ab.IgG
73419-4,Digoxin induced platelet Ab.IgM
73420-2,Dicyclomine induced platelet Ab.IgM
73421-0,Dicyclomine induced platelet Ab.IgG
73422-8,diazePAM induced platelet Ab.IgM
73423-6,diazePAM induced platelet Ab.IgG
73424-4,Amphetamine induced platelet Ab.IgM
73425-1,Amphetamine induced platelet Ab.IgG
73426-9,cycloSPORINE induced platelet Ab.IgM
73427-7,cycloSPORINE induced platelet Ab.IgG
73428-5,Colchicine induced platelet Ab.IgG
Sep-42,Solidago virgaurea Ab.IgG
73429-3,Colchicine induced platelet Ab.IgM
73430-1,Clopidogrel induced platelet Ab.IgG
73431-9,Clopidogrel induced platelet Ab.IgM
73432-7,cloNIDine induced platelet Ab.IgM
73433-5,cloNIDine induced platelet Ab.IgG
73434-3,clonazePAM induced platelet Ab.IgG
73435-0,clonazePAM induced platelet Ab.IgM
73436-8,Clindamycin induced platelet Ab.IgM
Jul-43,Solidago virgaurea basophil bound Ab
73437-6,Clindamycin induced platelet Ab.IgG
73438-4,Clavulanate induced platelet Ab.IgM
73439-2,Clavulanate induced platelet Ab.IgG
734-4,Lymphocytes.variant
73440-0,Clarithromycin induced platelet Ab.IgM
73441-8,Clarithromycin induced platelet Ab.IgG
73442-6,Citalopram induced platelet Ab.IgM
73443-4,Citalopram induced platelet Ab.IgG
73444-2,Ciprofloxacin induced platelet Ab.IgM
May-44,Goose feather Ab.IgG
73445-9,Ciprofloxacin induced platelet Ab.IgG
73446-7,Cimetidine induced platelet Ab.IgM
73447-5,Cimetidine induced platelet Ab.IgG
73448-3,Cilastatin induced platelet Ab.IgG
73449-1,Cilastatin induced platelet Ab.IgM
73450-9,Chlorthalidone induced platelet Ab.IgM
73451-7,Chlorthalidone induced platelet Ab.IgG
Feb-45,Grain Ab.IgE
73452-5,chlorproPAMIDE induced platelet Ab.IgM
73453-3,chlorproPAMIDE induced platelet Ab.IgG
73454-1,chlorproMAZINE induced platelet Ab.IgG
73455-8,chlorproMAZINE induced platelet Ab.IgM
73456-6,chlordiazePOXIDE induced platelet Ab.IgM
73457-4,chlordiazePOXIDE induced platelet Ab.IgG
73458-2,Cephalexin induced platelet Ab.IgG
73459-0,Cephalexin induced platelet Ab.IgM
7346-0,Grain dust Ab.IgE
73460-8,Celecoxib induced platelet Ab.IgM
73461-6,Celecoxib induced platelet Ab.IgG
73462-4,Cefuroxime induced platelet Ab.IgG
73463-2,Cefuroxime induced platelet Ab.IgM
73464-0,cefTRIAXone induced platelet Ab.IgG
73465-7,cefTRIAXone induced platelet Ab.IgM
73466-5,Ceftizoxime induced platelet Ab.IgG
73467-3,Ceftizoxime induced platelet Ab.IgM
73468-1,cefTAZidime induced platelet Ab.IgG
73469-9,cefTAZidime induced platelet Ab.IgM
73470-7,Cefepime induced platelet Ab.IgM
73471-5,Cefepime induced platelet Ab.IgG
73472-3,ceFAZolin induced platelet Ab.IgG
73473-1,ceFAZolin induced platelet Ab.IgM
73474-9,Cefadroxil induced platelet Ab.IgM
73475-6,Cefadroxil induced platelet Ab.IgG
73476-4,Caspofungin induced platelet Ab.IgM
73477-2,Caspofungin induced platelet Ab.IgG
Aug-47,Grain mill dust Ab.IgE
73478-0,Casanthranol induced platelet Ab.IgM
73479-8,Casanthranol induced platelet Ab.IgG
73480-6,Carvedilol induced platelet Ab.IgM
73481-4,Carvedilol induced platelet Ab.IgG
73482-2,Carisoprodol induced platelet Ab.IgM
73483-0,Carisoprodol induced platelet Ab.IgG
73484-8,Carbidopa induced platelet Ab.IgM
73485-5,Carbidopa induced platelet Ab.IgG
Jun-48,Vitis vinifera Ab.IgG
73486-3,carBAMazepine induced platelet Ab.IgG
73487-1,carBAMazepine induced platelet Ab.IgM
73488-9,Captopril induced platelet Ab.IgM
73489-7,Captopril induced platelet Ab.IgG
73490-5,Candesartan induced platelet Ab.IgM
73491-3,Candesartan induced platelet Ab.IgG
73492-1,Butalbital+Acetylsalicylate+Caffeine induced platelet Ab.IgM
73493-9,Butalbital+Acetylsalicylate+Caffeine induced platelet Ab.IgG
Apr-49,Grape raisin basophil bound Ab
73494-7,busPIRone induced platelet Ab.IgM
73495-4,busPIRone induced platelet Ab.IgG
73496-2,buPROPion induced platelet Ab.IgG
73497-0,buPROPion induced platelet Ab.IgM
73498-8,Bumetanide induced platelet Ab.IgM
73499-6,Bumetanide induced platelet Ab.IgG
73500-1,Budesonide induced platelet Ab.IgM
73501-9,Budesonide induced platelet Ab.IgG
Feb-50,Citrus paradisis Ab.IgG
73502-7,Bivalirudin induced platelet Ab.IgM
73503-5,Bivalirudin induced platelet Ab.IgG
73504-3,Benztropine induced platelet Ab.IgG
73505-0,Benztropine induced platelet Ab.IgM
73506-8,Benazepril induced platelet Ab.IgG
73507-6,Benazepril induced platelet Ab.IgM
73508-4,Aztreonam induced platelet Ab.IgM
73509-2,Aztreonam induced platelet Ab.IgG
735-1,Lymphocytes.variant/100 leukocytes
7351-0,Citrus paradisis basophil bound Ab
73510-0,Azithromycin induced platelet Ab.IgM
73511-8,Azithromycin induced platelet Ab.IgG
73512-6,Atorvastatin induced platelet Ab.IgM
73513-4,Atorvastatin induced platelet Ab.IgG
73514-2,Atomoxetine induced platelet Ab.IgM
73515-9,Atomoxetine induced platelet Ab.IgG
73516-7,Atenolol induced platelet Ab.IgG
73517-5,Atenolol induced platelet Ab.IgM
73518-3,Acetylsalicylate induced platelet Ab.IgG
73519-1,Acetylsalicylate induced platelet Ab.IgM
73520-9,Argatroban induced platelet Ab.IgG
73521-7,Argatroban induced platelet Ab.IgM
73522-5,Ampicillin induced platelet Ab.IgM
73523-3,Ampicillin induced platelet Ab.IgG
73524-1,Amoxicillin+Clavulanate induced platelet Ab.IgM
73525-8,Amoxicillin+Clavulanate induced platelet Ab.IgG
73526-6,Amoxicillin induced platelet Ab.IgM
73527-4,Amoxicillin induced platelet Ab.IgG
Aug-52,Agrostis stolonifera Ab.IgE
73528-2,amLODIPine+Benazepril induced platelet Ab.IgG
73529-0,amLODIPine+Benazepril induced platelet Ab.IgM
73530-8,amLODIPine induced platelet Ab.IgM
73531-6,amLODIPine induced platelet Ab.IgG
73532-4,Amitriptyline induced platelet Ab.IgG
73533-2,Amitriptyline induced platelet Ab.IgM
73534-0,Amiodarone induced platelet Ab.IgG
73535-7,Amiodarone induced platelet Ab.IgM
Jun-53,Cynodon dactylon Ab.IgG
73536-5,ALPRAZolam induced platelet Ab.IgM
73537-3,ALPRAZolam induced platelet Ab.IgG
73538-1,Allopurinol induced platelet Ab.IgG
73539-9,Allopurinol induced platelet Ab.IgM
73540-7,Alendronate induced platelet Ab.IgM
73541-5,Alendronate induced platelet Ab.IgG
73542-3,Albuterol induced platelet Ab.IgM
73543-1,Albuterol induced platelet Ab.IgG
Apr-54,Cynodon dactylon basophil bound Ab
73544-9,Acyclovir induced platelet Ab.IgG
73545-6,Acyclovir induced platelet Ab.IgM
73546-4,Acetaminophen induced platelet Ab.IgG
73547-2,Acetaminophen induced platelet Ab.IgM
73548-0,Acebutolol induced platelet Ab.IgM
73549-8,Acebutolol induced platelet Ab.IgG
73550-6,Acarbose induced platelet Ab.IgM
Jan-55,Poa annua Ab.IgE
73551-4,Acarbose induced platelet Ab.IgG
73552-2,Drug induced platelet Ab
73553-0,Abciximab induced platelet Ab
73554-8,Abciximab induced platelet Ab.IgM
73555-5,Abciximab induced platelet Ab.IgG
73556-3,Platelet Ab.IgM
73557-1,Thyroxine.free
73558-9,Staphylococcus aureus & Staphylococcus sp.coagulase negative rRNA
73559-7,Herpes simplex virus 1 Ab.IgG
73560-5,Mumps virus Ab.IgG & IgM
73561-3,Insulin-like growth factor-I
73562-1,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine"
73563-9,7-Aminoclonazepam
73564-7,Alpha hydroxytriazolam
73565-4,Trenbolone
73566-2,Dextrorphan
73567-0,Propoxyphene
73568-8,Communication of critical results
Sep-56,Poa compressa Ab.IgE
73569-6,Radiation exposure and protection information
73570-4,Testosterone/Epitestosterone
73571-2,Osmol gap
73572-0,Magnesium.ionized
73573-8,Magnesium.ionized^^adjusted to pH 7.4
73574-6,Acyclovir
73575-3,Consultation note
73576-1,Anion gap 4
Jul-57,Poa pratensis Ab.IgE
73577-9,Anion gap 4
73578-7,Anion gap 4
73579-5,Anion gap 4
73580-3,Anion gap 4
73581-1,Anion gap 4
73582-9,Anion gap 4
73583-7,Molybdenum/Creatinine
73584-5,Norcitalopram
May-58,Poa pratensis basophil bound Ab
73585-2,Tizoxanide
73586-0,Tedizolid
73587-8,Solithromycin
73588-6,Sarafloxacin
73589-4,rifAXIMin
73590-2,Razupenem
73591-0,Premafloxacin
73592-8,Plazomicin
Mar-59,Festuca elatior basophil bound Ab
73593-6,Ormetroprim+Sulfamethoxazole
73594-4,Omadacycline
73595-1,Nitazoxanide
73596-9,Marbofloxacin
73597-7,Iclaprim
73598-5,Finafloxacin
73599-3,Fidaxomicin
73600-9,Faropenem
Jan-60,Bouteloua gracilis Ab.IgE
73601-7,Danofloxacin
73602-5,Ceftolozane+Tazobactam
73603-3,cefTAZidime+Avibactam
73604-1,Ceftaroline+Avibactam
73605-8,Ceftaroline
73606-6,Besifloxacin
73607-4,Tizoxanide
73608-2,Tedizolid
73609-0,Solithromycin
73610-8,Sarafloxacin
73611-6,rifAXIMin
73612-4,Razupenem
73613-2,Premafloxacin
73614-0,Plazomicin
73615-7,Ormetroprim+Sulfamethoxazole
73616-5,Omadacycline
73617-3,Nitazoxanide
73618-1,Marbofloxacin
Sep-61,Sorghum halepense basophil bound Ab
73619-9,Iclaprim
73620-7,Finafloxacin
73621-5,Fidaxomicin
73622-3,Faropenem
73623-1,Danofloxacin
73624-9,Ceftolozane+Tazobactam
73625-6,cefTAZidime+Avibactam
73626-4,Ceftaroline+Avibactam
Jul-62,Grass koehlers Ab.IgE
73627-2,Ceftaroline
73628-0,Besifloxacin
73629-8,Tizoxanide
73630-6,Telavancin
73631-4,Tedizolid
73632-2,Solithromycin
73633-0,Sarafloxacin
73634-8,rifAXIMin
May-63,Festuca elatior Ab.IgE
73635-5,Razupenem
73636-3,Premafloxacin
73637-1,Plazomicin
73638-9,Ormetroprim+Sulfamethoxazole
73639-7,Omadacycline
73640-5,Nitazoxanide
73641-3,Marbofloxacin
73642-1,Iclaprim
Mar-64,Festuca elatior Ab.IgG
73643-9,Finafloxacin
73644-7,Fidaxomicin
73645-4,Faropenem
73646-2,Danofloxacin
73647-0,Ceftolozane+Tazobactam
73648-8,cefTAZidime+Avibactam
73649-6,Ceftaroline+Avibactam
7365-0,Dactylis glomerata Ab.IgG
73650-4,Ceftaroline
73651-2,Besifloxacin
73652-0,Apramycin
73653-8,Apramycin
73654-6,Hepatitis C virus NS3 gene mutations detected
73655-3,Hepatitis C virus NS5 gene mutations detected
73656-1,Varicella zoster virus ORF28 genotype
73657-9,Varicella zoster virus ORF36 genotype
73658-7,HIV 1 subtype
73659-5,HIV 2 subtype
73660-3,Propoxyphene panel
73661-1,Methadone panel
73662-9,Benzodiazepines panel
73663-7,Barbiturates panel
73664-5,Yersinia adhesion protein YadA
73665-2,Optochin
73666-0,Streptococcus.beta-hemolytic
73667-8,Bacteria producing hippuricase
Aug-66,Dactylis glomerata basophil bound Ab
73668-6,Bacteria soluble by bile
73669-4,Bacteria producing DNAse
73670-2,Bacteria producing coagulase+protein A
73671-0,Legionella pneumophila serogroup
73672-8,Salmonella sp phage type
73673-6,Yersinia enterocolitica serotype
73674-4,Streptococcus pneumoniae serotype
73675-1,Adenosine triphosphate/Adenosine diphosphate
Jun-67,Agropyron repens Ab.IgE
73676-9,Voriconazole^trough
73677-7,Valproate^peak
73678-5,Topotecan^trough
73679-3,SORAfenib
73680-1,Mycophenolate^peak
73681-9,CYP2D6 gene allele 2
73682-7,CYP2D6 gene allele 1
73683-5,Busulfan^trough
Apr-68,Agrostis stolonifera basophil bound Ab
73684-3,Atovaquone
73685-0,Streptococcus pneumoniae Ag
73686-8,Methylone
73687-6,Methylenedioxypyrovalerone
73688-4,Danazol
73689-2,Repaglinide
736-9,Lymphocytes/100 leukocytes
73690-0,Nateglinide
73691-8,Glimepiride
Feb-69,Lolium perenne Ab.IgE
73692-6,Escitalopram
73693-4,African swine fever virus DNA
73694-2,Microscopic observation
73695-9,HIV reverse transcriptase+protease+integrase gene mutations detected
73696-7,Oxygen saturation.preductal-oxygen saturation.postductal
73697-5,CCHD newborn screening protocol used
73698-3,Reason CCHD oxygen saturation screening not performed
73699-1,Number of prior CCHD screens
Jul-73,Cefatrizine
7370-0,Lolium perenne Ab.IgG
73700-7,CCHD newborn screening interpretation
73701-5,Multiple carboxylase deficiency
73702-3,Neisseria meningitidis serosubtype
73703-1,Path report.preliminary diagnosis
73704-9,Fluid output.nasogastric tube
73705-6,Intracellular fluid
73706-4,Extracellular fluid
73707-2,Visceral fat
73708-0,Body fat mass
73709-8,Prescription request
73710-6,(Ambrosia elatior+Ambrosia psilostachya+Ambrosia trifida) Ab.IgE
73711-4,(Arachis hypogaea+Glycine max+Pisum sativum) Ab.IgE
73712-2,(Artemisia dracunculus+Levisticum officinale+Origanum majorana+Thymus vulgaris) Ab.IgE
73713-0,(Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) Ab.IgE
73714-8,(Carum carvi+Elettaria cardamomum+Mace+Syzygium aromaticum) Ab.IgE
73715-5,(Chicken feather+Cow dander+Goose feather+Horse dander) Ab.IgE
73716-3,(Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) Ab.IgE
73717-1,(Cucumis sativus+Daucus carota+Solanum tuberosum+Spinacia oleracea) Ab.IgE
Aug-71,Lolium perenne Ab.IgE
73718-9,(Hexamethylene diisocyanate (HDI)+Diphenylmethane diisocyanate (MDI)+Toluene diisocyanate (TDI)+Phthalic anhydride) Ab.IgE
73719-7,Glycine max native (nGly m) 5 Ab.IgE
73720-5,Pholcodine Ab.IgE
73721-3,Rocuronium Ab.IgE
73722-1,Bile acid
73723-9,Riboflavin
73724-7,Bile acid dihydroxy & trihydroxy panel
73725-4,Bile acid panel
Jun-72,Lolium perenne Ab.IgE
73726-2,Lysergate diethylamide
73727-0,Methadone
73728-8,Norcocaine
73729-6,Meperidine
73730-4,Lysergate diethylamide
73731-2,Transaldolase
73732-0,Human papilloma virus 26+31+33+35+39+45+51+52+53+56+58+59+66+68+73+82 DNA
73733-8,Bacteria biotype
Apr-73,Lolium perenne Ab.IgG
73735-3,ACADVL gene full mutation analysis
73736-1,ACADVL gene mutation analysis limited to known familial mutations
73737-9,Phospholipase A2 receptor Ab.IgG
73738-7,Newborn screening test results panel
73739-5,Newborn hearing screen reason not performed
73740-3,Screening duration
73741-1,Newborn hearing screen panel
Feb-74,Lolium perenne basophil bound Ab
73742-9,Newborn hearing screen reason not performed
73743-7,Screening duration
73744-5,Newborn hearing screen panel
73745-2,Keyhole limpet hemocyanin Ab.IgA
73746-0,Keyhole limpet hemocyanin Ab.IgG
73747-8,Keyhole limpet hemocyanin Ab.IgM
73748-6,APOB gene.p.Arg3500Gln & Arg3500Trp
73749-4,4p16.3 chromosome deletion
73750-2,RAI1 gene 17p11.2 deletion+duplication
73751-0,5p15.2 chromosome deletion
73752-8,Reagin Ab & Treponema pallidum Ab.IgG & IgM
73753-6,oxyCODONE
73754-4,Adenovirus C DNA
73755-1,Adenovirus B+E DNA
73756-9,Infant is being breastfed at discharge
73757-7,Infant living at time of report
73758-5,Infant was transferred within 24H of delivery
Sep-75,Grass sorghum Ab.IgE
73759-3,Hysterotomy or hysterectomy was performed at delivery
73760-1,"If cesarean, a trial of labor was attempted"
73761-9,Fetal presentation^at birth
73762-7,Final route and method of delivery
73763-5,Mother was transferred for maternal medical or fetal indications for delivery
73764-3,Birth attendant title
73765-0,Planned to deliver at home
73766-8,Place where birth occurred
Jul-76,Sorghum sudanense Ab.IgE
73767-6,Histological placental examination was performed
73768-4,Autopsy was performed
73769-2,Infections present &or treated during this pregnancy for fetal death
737-7,Lymphocytes/100 leukocytes
73770-0,Name of facility infant transferred to
73771-8,Birth order
73772-6,Number of fetal deaths delivered
73773-4,Number of infants in this delivery delivered alive
73774-2,Onset of labor
May-77,Anthoxanthum odoratum basophil bound Ab
73775-9,Risk factors in this pregnancy
73776-7,No prenatal care
73777-5,Name of facility mother transferred from
73778-3,Suspected chromosomal disorder karyotype status
73779-1,Down syndrome karyotype status
73780-9,Congenital anomalies of the newborn
73781-7,Maternal morbidity
73782-5,Neonatal pressure ulcer risk evaluation
Mar-78,Grass tall oat Ab.IgE
73783-3,Neonatal pressure ulcer risk total score
73784-1,Moisture
73785-8,Nutrition
73786-6,Activity
73787-4,Mobility
73788-2,Mental status
73789-0,General physical condition
73790-8,Neonatal skin risk assessment scale panel
Jan-79,Grass wheat Ab.IgG
73792-4,Infant activity during postductal oxygen saturation measurement
73793-2,Signal quality
73794-0,Perfusion index
73795-7,Heart rate
73796-5,Infant activity during preductal oxygen saturation measurement
73797-3,Signal quality
73798-1,Perfusion index
73799-9,Heart rate
73800-5,Oxygen saturation sensor wrap size
73801-3,Oxygen saturation sensor wrap type
73802-1,Oxygen saturation sensor wrap name
73803-9,Oxygen saturation sensor type
73804-7,Oxygen saturation sensor name
73805-4,CCHD newborn screening panel
73806-2,Newborn age in hours
73807-0,B cell+T cell crossmatch.autologous
73808-8,B cell+T cell crossmatch
Sep-80,Grayfish Ab.IgE
73809-6,B cell+T cell crossmatch
73810-4,Cells.CD3-CD16+CD56+HLA-DR+/100 cells.CD3-CD16+CD56+
73811-2,Estimated timing of fetal death
73812-0,Abnormal conditions of the newborn
73813-8,Characteristics of labor and delivery
73814-6,Obstetric procedures performed
73815-3,Indexing - product concept
73816-1,Platelet factor 4 heparin complex induced Ab.IgG
Jul-81,Sarcobatus vermiculatus Ab.IgE
73817-9,Percent heparin inhibition
73818-7,Platelet factor 4 heparin complex induced Ab.IgG
73819-5,Platelet factor 4 heparin complex induced Ab.IgG
73820-3,External cephalic version outcome
73821-1,Fetal chromosome X & Y aneuploidy risk
73822-9,Fetal chromosome X & Y aneuploidy
73823-7,Cocaine+Benzoylecgonine
73824-5,Fetal trisomy 13 risk
May-82,Gum arabic Ab.IgE
73825-2,Fetal trisomy 18 risk
73826-0,Flurazepam+N-desalkylflurazepam
73827-8,Gamma hydroxybutyrate
73828-6,Flunitrazepam
73829-4,7-Aminoflunitrazepam
73830-2,Fall risk assessment
73831-0,Adolescent depression screening assessment
73832-8,Adult depression screening assessment
Mar-83,Celtis occidentalis Ab.IgE
73833-6,Legionella sp Ab
73834-4,Bacteria.carbapenem resistant identified
73835-1,Bacteria.extended spectrum beta lactamase resistant identified
73836-9,Bacteria.fluoroquinolone resistant identified
73837-7,"Galactose-alpha-1,3-galactose Ab.IgE"
73838-5,11-Dehydrotetrahydrocorticosterone
73839-3,11-Dehydrotetrahydrocorticosterone
73840-1,11-Dehydrotetrahydrocorticosterone
Jan-84,Melanogrammus aeglefinus Ab.IgE
73841-9,Tetrahydrodeoxycortisol
73842-7,Tetrahydrodeoxycortisol
73843-5,Tetrahydrodeoxycortisol
73844-3,16-Alpha hydroxydehydroepiandrosterone
73845-0,16-Alpha hydroxydehydroepiandrosterone
73846-8,16-Alpha hydroxydehydroepiandrosterone
73847-6,16-Ketoandrostenediol
73848-4,16-Ketoandrostenediol
73849-2,16-Ketoandrostenediol
738-5,Macrocytes
73850-0,18-Beta glycyrrhetinate
73851-8,18-Beta glycyrrhetinate
73852-6,7-Dehydrocholesterol & 8-Dehydrocholesterol panel
73853-4,Aldosterone-18-glucuronide
73854-2,Aldosterone-18-glucuronide
73855-9,Aldosterone-18-glucuronide
73856-7,Allo-pregnanediol
73857-5,Allo-pregnanediol
Aug-85,Melanogrammus aeglefinus Ab.IgG
73858-3,Allo-pregnanediol
73859-1,Allo-tetrahydrocorticosterone
73860-9,Allo-tetrahydrocorticosterone
73861-7,Allo-tetrahydrocorticosterone
73862-5,Allo-tetrahydrocortisol
73863-3,Allo-tetrahydrocortisol
73864-1,Allo-tetrahydrocortisol
73865-8,Catecholamines 3 panel
Jun-86,Hippoglossus hippoglossus Ab.IgG
73866-6,Catecholamines 3 & creatinine panel
73867-4,Alpha cortol
73868-2,Alpha cortol
73869-0,Alpha cortol
73870-8,Alpha cortolone
73871-6,Alpha cortolone
73872-4,Alpha cortolone
73873-2,Androstenetriol
Apr-87,Hippoglossus hippoglossus basophil bound Ab
73874-0,Androstenetriol
73875-7,Androstenetriol
73876-5,Beta cortolone
73877-3,Beta cortolone
73878-1,Beta cortolone
73879-9,Catecholamine metabolites & creatinine panel
73880-7,Cortisone.free
73881-5,Cortisone.free
Feb-88,Ham basophil bound Ab
73882-3,Glycolate
73883-1,Glycolate
73884-9,Steroid fractions interpretation
73885-6,Steroid fractions panel
73886-4,Steroid fractions panel
73887-2,Tetrahydrocorticosterone
73888-0,Tetrahydrocorticosterone
73889-8,Tetrahydrocorticosterone
7389-0,Hay Ab.IgE
73890-6,Tetrahydrocortisol
73891-4,Tetrahydrocortisol
73892-2,Tetrahydrocortisol
73893-0,Tetrahydrocortisone
73894-8,Tetrahydrocortisone
73895-5,Hemoglobin
73897-1,Chronic lyme disease panel
73898-9,Cells.CD8-CD57+/100 lymphocytes
73899-7,Cells.CD3-CD8-CD57+
73900-3,Cells.CD3-CD8-CD57+/100 leukocytes
73901-1,Cells.CD3-CD8-CD57+/100 lymphocytes
73902-9,Cells.CD3-CD57+
73903-7,Cells.CD3-CD57+/100 leukocytes
73904-5,Cells.CD3-CD57+/100 lymphocytes
73905-2,HIV 1+2 Ab.IgG
73906-0,HIV 1+2 Ab.IgG
73907-8,Polio virus identified
Aug-90,Corylus avellana Ab.IgE
73908-6,Alloisoleucine/Creatinine
73909-4,D2-40 Ag
73910-2,PAX8 Ag
73911-0,SOX10 Ag
73912-8,DOG1 Ag
73913-6,Glycine CSF/Glycine plas
73914-4,JWH-018
73915-1,"1,3-Dimethylamylamine"
Jun-91,Corylus avellana Ab.IgG
73916-9,"1,3-Dimethylamylamine"
73917-7,JWH-250 4+5-hydroxypentyl
73918-5,JWH-073
73919-3,MAM-2201 pentanoate
73920-1,JWH-018 4+5-hydroxypentyl
73921-9,JWH-073 3-hydroxybutyl
73922-7,RCS-4 5-hydroxypentyl
73923-5,JWH-018 pentanoate
Apr-92,Corylus avellana basophil bound Ab
73924-3,JWH-200 4-Hydroxyindole
73925-0,AM-2201 4-hydroxypentyl
73926-8,JWH-073 4-hydroxybutyl
73927-6,JWH-073 butanoate
73928-4,JWH-250 5-hydroxypentyl
73929-2,JWH-250 5-carboxypentyl
739-3,Metamyelocytes
73930-0,RCS-4 5-carboxypentyl
73931-8,Propanol
Feb-93,Helminthosporium interseminatum Ab.IgE
73932-6,traMADol
73933-4,Normeperidine
73934-2,Meperidine
73935-9,Tetrahydrocannabinol
73936-7,fentaNYL
73937-5,Norfentanyl
73938-3,fentaNYL
73939-1,HYDROcodone.free
7394-0,Helminthosporium maydis Ab.IgE
73940-9,HYDROmorphone.free
73941-7,6-Monoacetylmorphine.free
73942-5,Buprenorphine
73943-3,Cannabinoids.synthetic
73944-1,MAM-2201
73945-8,UR-144
73946-6,JWH-200
73947-4,JWH-398
73948-2,JWH-122
73949-0,JWH-018
73950-8,JWH-250
73951-6,RCS-4
73952-4,AM-2201
73953-2,JWH-073
73954-0,JWH-398 5-hydroxypentyl
73955-7,UR-144 4+5-hydroxypentyl
73956-5,JWH-122 5-hydroxypentyl
Jul-95,Helminthosporium sp Ab.IgE
73957-3,UR-144 pentanoate
73958-1,Cholesterol esterase
73959-9,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+66 DNA
73960-7,Bacteria identified
73961-5,Escherichia coli & Klebsiella pneumoniae & Pseudomonas aeruginosa rRNA
73962-3,Candida sp rRNA
73963-1,Enterococcus faecalis & other enterococcus sp rRNA
73964-9,Body muscle mass
May-96,Helminthosporium sp Ab.IgG
73965-6,Body muscle mass/body weight
73966-4,Fetal trisomy 21 risk
73967-2,Noninvasive prenatal fetal aneuploidy panel
73968-0,Fetal trisomy 18 risk
73969-8,Fetal trisomy 13 risk
73970-6,Fetal trisomy 21 risk
73971-4,Methylenedioxymethamphetamine+Methylenedioxyethylamphetamine+Methylenedioxyamphetamine
73972-2,Morphine.free
Mar-97,Tsuga canadensis Ab.IgE
73973-0,O-nortramadol
73974-8,Cells.CD158e/100 cells
73975-5,Cells.CD158a/100 cells
73976-3,Cells.CD158b/100 cells
73977-1,Cancer related multigene analysis
73978-9,von Willebrand factor.activity
73979-7,Keyhole limpet hemocyanin Ab panel
73980-5,Visit duration
Jan-98,Hemp Ab.IgE
73981-3,Problem alleviating &or exacerbating factors
73982-1,Bacterial carbapenem resistance blaNDM gene
73983-9,Report.section heading
73984-7,Hemoglobin.other
73985-4,Exercise activity
73986-2,Exercise aerobic category
73987-0,"2,2',3,4,4',5-Hexachlorobiphenyl"
73988-8,"2,2',4,5,5'-Pentachlorobiphenyl"
73989-6,"2,3',4,4',5-Pentachlorobiphenyl"
73990-4,"2,3',4',5-Tetrachlorobiphenyl"
73991-2,"2,2',5,5'-Tetrachlorobiphenyl"
73992-0,"2,2',5-Trichlorobiphenyl"
73993-8,Polychlorinated biphenyl
73994-6,Polychlorinated biphenyl
73995-3,Mitragynine
73996-1,oxyCODONE
73997-9,Ibuprofen
73998-7,25H-NBOMe
Sep-99,Hemp fiber Ab.IgE
73999-5,2C-C-NBOMe
74000-1,25I-NBOMe
74001-9,NBOMe
74002-7,Tungsten/Creatinine
74003-5,CYP3A4 gene.c.-392A>G (*1B)
74004-3,ABCB1 gene targeted mutation analysis
May-00,Amaranthus tuberculatus Ab.IgE
74005-0,Serotonin release 0.5 IU/mL heparin.unfractionated
74006-8,Weight difference^pre dialysis-post dialysis
74007-6,CYP3A4 gene targeted mutation analysis
74008-4,Exercise intensity
74009-2,Exercise duration/Exercise frequency
740-1,Metamyelocytes/100 leukocytes
74010-0,Date quit tobacco smoking
74011-8,Lifetime tobacco use
74012-6,Number of Y alcohol consumed
Mar-01,Clupea harengus Ab.IgG
74013-4,Alcoholic drinks per D
74014-2,Last drank alcohol
74015-9,Date recorded
74017-5,Alert status
74018-3,Alert
74019-1,Probability of developing disease assessed
74020-9,Genetic risk algorithm sensitivity
Jan-02,Carya illinoinensis nut basophil bound Ab
74021-7,Genetic risk algorithm
74022-5,Negative history for disease of interest
74023-3,Disease of interest
74024-1,Family member identifier
74025-8,Mother identifier
74026-6,Father identifier
74027-4,Family pedigree identifier
74028-2,Virtual medical record for clinical decision support panel
74029-0,Periodontal attachment - recommended CDA set
74030-8,Periodontal service attachment
74031-6,Arbovirus identified
74032-4,Arbovirus Ab.IgM panel
74033-2,Arbovirus Ab.IgM
74034-0,MAML2 11q21 gene rearrangements
74035-7,Prion protein.abnormal
74036-5,Prion protein.abnormal
74037-3,Transmissible spongiform encephalopathy
74038-1,Influenza virus A H1 RNA
Sep-03,Hickory basophil bound Ab
74039-9,Influenza virus A H3 RNA
74040-7,Influenza virus A N2 RNA
74041-5,"t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript.reduction to 0.1%^post treatment"
74042-3,Genetic diseases history panel
74043-1,Alcohol use disorder
74044-9,Disease of interest was cause of death
74045-6,Measure description
74046-4,Supplemental information about periodontal condition
Jul-04,Carya ovata Ab.IgE
74047-2,Periodontal procedure is related to orthodontic treatment plan
74048-0,Periodontal procedure is related to restorative treatment
74049-8,Periodontal condition involves frenum
74050-6,Actual route of administration - attempted or completed
74051-4,Intended route of administration
74052-2,Medication or substance was given
74053-0,Medication or substance was prescribed
Apr-05,Carya laciniosa Ab.IgE
74054-8,Dose form - RxNorm RXCUI
74055-5,Dose form
74056-3,Clinical drug component - RxNorm RXCUI
74057-1,Medication strength
74058-9,Manufacturer name
74059-7,Brand name - RxNorm RXCUI
74060-5,Brand name
74061-3,Ingredient - RxNorm RXCUI
Feb-06,Carya illinoinensis tree Ab.IgE
74062-1,Generic or investigational drug name
74063-9,"Stage in the process that the event originated, regardless of the stage at which it was discovered"
74064-7,Medication or substance contraindication - potential or actual interaction
74065-4,History of allergies or sensitivities to the medication or substance administered was documented
74066-2,Expiration date
74067-0,Best description for incorrect strength or concentration
74068-8,Best description for the incorrect rate
74069-6,Best description for the incorrect timing
7407-0,Carya tomentosa Ab.IgE
74070-4,Best description for the incorrect dose
74071-2,Incorrect action
74072-0,Best characterization of medication or other substance event
74073-8,Type of nutritional product
74074-6,Biological product
74075-3,Medication
74076-1,Medication or substance involved
74077-9,Ingredients for compounded preparations
74078-7,Medication or other substance details panel
74079-5,Event
74080-3,Patient safety event report - hospital - medication or other substance - version 1.2
74081-1,Patient safety event
74082-9,Urea
74083-7,Norolanzapine
74084-5,Glucose^15M post 50 g lactose PO
74085-2,Isocoproporphyrin
74086-0,Pentacarboxylporphyrin III
74087-8,Hexacarboxylporphyrin III
Aug-08,Histamine extract basophil bound Ab
74088-6,Heptacarboxylporphyrin III
74089-4,Pentacarboxylporphyrin III/Creatinine
74090-2,Hexacarboxylporphyrin III/Creatinine
74091-0,Heptacarboxylporphyrin III/Creatinine
74092-8,Acidity.titratable
74093-6,Gliquidone
74094-4,Gliclazide
74095-1,Didesmethylcitalopram
Jun-09,Swine basophil bound Ab
74096-9,Tacrolimus
74097-7,Tacrolimus
74098-5,Endothelin
74099-3,Neutrophil gelatinase-associated lipocalin
74100-9,Nitrate+Nitrite
74101-7,Tissue inhibitor of metalloproteinases 1
74102-5,Matrix metallopeptidase 2
74103-3,Neutrophil gelatinase-associated lipocalin
Apr-10,Swine epithelium Ab.IgG
74104-1,Alpha-amanitin+gamma-amanitin
74105-8,Oxygen saturation
74106-6,Proteinase 3 Ab.IgG
74107-4,Warfarin
74108-2,Meperidine
74109-0,4-hydroxycoumarins
74110-8,traMADol
74111-6,Brodifacoum
Feb-11,Honey Ab.IgG
74112-4,Bromadiolone
74113-2,Coumafuryl
74114-0,Coumatetralyl
74115-7,Difenacoum
74116-5,Adalimumab Ab
74117-3,Adalimumab
74118-1,P27 Ag
74119-9,P504S Ag
7412-0,Honey Ab.IgE
74120-7,PDGFR-alpha Ag
74121-5,Perforin Ag
74122-3,Ubiquitin Ag
74123-1,Phospho-S6 ribosomal protein Ag
74124-9,Blood group 8 Ag
74125-6,Mesothelin Ag
74126-4,Mucin-4 Ag
74127-2,Akt1 phosphate Ag
74128-0,Neuroblastoma 84 Ag
74129-8,Transforming growth factor alpha Ag
74130-6,6-Monoacetylmorphine
74131-4,Morphine
74132-2,Aromatic solvents
74133-0,Volatiles
74134-8,Ezogabine
74135-5,N-acetyl ezogabine
74136-3,fentaNYL
74137-1,Norfentanyl
Aug-13,Honeysuckle Ab.IgE
74138-9,Monocytes.immature
74139-7,Mononuclear cells
74140-5,Granulocytes
74141-3,Granulocytes/100 leukocytes
74142-1,Granulocytes
74143-9,Granulocytes/100 leukocytes
74144-7,Complex medical conditions action plan
74145-4,Multiple sclerosis action plan
Jun-14,Humulus lupus Ab.IgG
74146-2,Heart disease action plan
74147-0,Muscular dystrophy action plan
74148-8,Cystic fibrosis action plan
74149-6,Inflammatory bowel disease action plan
74150-4,Diabetes type I action plan
74151-2,Diabetes type II action plan
74152-0,Anaphylaxis action plan
Mar-15,Cladosporium sphaerospermum Ab.IgE
74153-8,Seizure disorder action plan
74154-6,Autism action plan
74155-3,ADHD action plan
74156-1,Plan of care+summary note
74157-9,Cannabinoids
74159-5,Work schedule
74160-3,Work Ds per W
Jan-16,Carpinus betulus Ab.IgE
74161-1,Work Hs per W
74162-9,Usual industry duration
74163-7,Usual occupation duration
74164-5,Usual occupation and industry
74165-2,History of employment status
74166-0,Occupational summary note
74167-8,Opiates
74168-6,Barbiturates
74169-4,Cocaine
74170-2,Ceftaroline
74171-0,Total number of staff completing the job satisfaction survey
74172-8,"Generally speaking, I am very satisfied with my own level of autonomy"
74173-6,"Generally speaking, I am very satisfied with interactions with non-physician health care team members"
74174-4,"Generally speaking, I am very satisfied with interactions with physicians"
74175-1,"Generally speaking, I am very satisfied with nursing administration"
74176-9,"Generally speaking, I am very satisfied with nursing management"
74177-7,Nursing staff on this job rarely think of quitting
74178-5,Most nursing staff on this job are very satisfied with the job
Sep-17,Dolichovespula maculata Ab.IgG
74179-3,I am generally satisfied with the kind of work I do in this job
74180-1,I rarely think of quitting this job
74181-9,"Generally speaking, I am very satisfied with this job"
74182-7,Job satisfaction panel
74183-5,Nursing job class
74184-3,Lymphocytes.clefted
74185-0,Percent of U.S. federal poverty level
74186-8,Health insurance funding was provided
Jul-18,Horse dander basophil bound Ab
74187-6,interRAI emergency screener for psychiatry
74188-4,interRAI acute care
74189-2,interRAI palliative care
741-9,Microcytes
74190-0,interRAI community health assessment - deafblind supplement
74191-8,interRAI community health assessment - assisted living supplement
74192-6,interRAI community health assessment - mental health supplement
74193-4,interRAI community health assessment - functional supplement
74194-2,interRAI community health assessment
May-19,Horse epithelium Ab.IgE
74195-9,interRAI long term care facility
74196-7,interRAI home care
74197-5,interRAI contact assessment
74198-3,Summary registry report
74199-1,Transferred from another acute care facility
74200-7,Ds in intensive care unit
74201-5,Ds on ventilator
74202-3,Payment source.primary
Mar-20,Armoracia rusticana Ab.IgE
74203-1,Signs of life at arrival
74204-9,Drug use
74205-6,Alcohol use
74206-4,Oxygen therapy was given
74207-2,Prehospital summary
74208-0,Demographic information+history of occupation
74209-8,Injury event summary
74210-6,Breath rate was assisted by respiratory device
Jan-21,House dust AP Ab.IgE
74211-4,Summary of episode note
74213-0,Discharge instructions
74214-8,Apixaban
74215-5,Rivaroxaban
74216-3,Fondaparinux
74217-1,Fondaparinux
74218-9,Apixaban
74219-7,Weight difference pre dialysis & post dialysis panel
74220-5,Dabigatran
74221-3,Referring physician address
74222-1,Reviewed material & summary of stains
74223-9,Immunohistochemical stains
74224-7,Disease category
74225-4,Cytochemical stains
74226-2,Plasma cells assessment
74227-0,Other observations
74228-8,Myelopoiesis assessment
Sep-22,House dust AP Ab.IgG
74229-6,Megakaryopoiesis assessment
74230-4,Lymphocytes assessment
74231-2,Erythropoiesis assessment
74232-0,Cellularity assessment
74233-8,Blasts assessment
74234-6,HEDIS 2014 Value Sets
74235-3,HEDIS 2014-2019 Value Set - ABO
74236-1,Unidentified cells/100 leukocytes
Jul-23,House dust basophil bound Ab
74237-9,"HEDIS 2014, 2015 Value Set - ABO and Rh"
74238-7,HEDIS 2014 Value Set - Blood Urea Nitrogen
74239-5,HEDIS 2014 Value Set - carBAMazepine Level
74240-3,HEDIS 2014-2020 Value Set - Cervical Cytology
74241-1,HEDIS 2014-2016 Value Set - Chlamydia Tests
74242-9,HEDIS 2014-2016 Value Set - Cytomegalovirus Antibody
74243-7,HEDIS 2014-2016 Value Set - FOBT
74244-5,HEDIS 2014 Value Set - Glucose Tests
May-24,House dust Greer Ab.IgG
74245-2,HEDIS 2014-2016 Value Set - Group A Strep Tests
74246-0,HEDIS 2014 Value Set - HbA1c Tests
74247-8,HEDIS 2014-2019 Value Set - Herpes Simplex Antibody
74248-6,"HEDIS 2014, 2015 Value Set - HPV Vaccine Administered"
74249-4,HEDIS 2014 Value Set - LDL-C Tests
74250-2,"HEDIS 2014, 2015 Value Set - Lead Tests"
74251-0,"HEDIS 2014, 2015 Value Set - Nephropathy Screening Tests"
Feb-25,House dust Hollister Stier Ab.IgE
74252-8,HEDIS 2014 Value Set - PHENobarbital Level
74253-6,HEDIS 2014 Value Set - Pregnancy Tests
74254-4,HEDIS 2014-2018 Value Set - Rh
74255-1,HEDIS 2014-2018 Value Set - Rubella Antibody
74256-9,HEDIS 2014-2019 Value Set - Serum Creatinine
74257-7,HEDIS 2014-2016 Value Set - Serum Potassium
74258-5,HEDIS 2014 Value Set - Sexual Activity
74259-3,"HEDIS 2014, 2015 Value Set - Urine Macroalbumin Tests"
7426-0,House dust Hollister Stier Ab.IgG
74260-1,HEDIS 2014 Value Set - Valproic Acid Level
74261-9,HEDIS 2014 Value Set - Phenytoin Level
74262-7,HEDIS 2014-2018 Value Set - Toxoplasma Antibody
74263-5,Dabigatran
74264-3,Summary registry report
742-7,Monocytes
74277-5,Mycobacterium tuberculosis stimulated gamma interferon.CFP10 Ag spot count
Aug-27,Hymenopterase Ab.IgE
74278-3,Mycobacterium tuberculosis stimulated gamma interferon.ESAT-6 Ag spot count
74279-1,Gamma interferon.negative control spot count
74280-9,Mitogen stimulated gamma interferon.positive control spot count
74281-7,Mycobacterium tuberculosis stimulated gamma interferon & spot count panel
74282-5,Individual counseling note
74283-3,Alternate residence status
74284-1,Type of complication
74285-8,ED discharge disposition
Jun-28,Allenrolfea occidentalis Ab.IgE
74286-6,Transport mode to hospital
74287-4,Occupation
74288-2,Occupation industry
74289-0,Pre-hospital transport mode.other
74290-8,Hospital discharge disposition
74291-6,Comorbidities relevant to trauma care
74292-4,Additional cause of injury
74293-2,Oncology plan of care and summary - recommended CDA set
Apr-29,Hexamethylene diisocyanate (HDI) Ab.IgE
74294-0,Isovaleric acidemia
74295-7,Hydroxymethylglutaryl CoA lyase deficiency
74296-5,3-Methylcrotonyl-CoA carboxylase deficiency
74297-3,Isobutyryl-CoA dehydrogenase deficiency
74298-1,Short-chain acyl-CoA dehydrogenase deficiency
74299-9,Tyrosine/Phenylalanine^post therapeutic diet
74300-5,Phenylalanine/Tyrosine^post therapeutic diet
74301-3,Succinylacetone^post therapeutic diet
Feb-30,Diphenylmethane diisocyanate (MDI) Ab.IgE
74302-1,Tyrosine^post therapeutic diet
74303-9,Phenylalanine^post therapeutic diet
74304-7,Porcine reproductive and respiratory syndrome virus Ab.Neut
74305-4,Porcine reproductive and respiratory syndrome virus Ag
74306-2,Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to Fostera
74307-0,Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to Lelystad
74308-8,Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to Ingelvac ATP
74309-6,Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to Ingelvac MLV
7431-0,Toluene diisocyanate (TDI) Ab.IgE
74310-4,Porcine reproductive and respiratory syndrome virus strain identified
74311-2,Porcine reproductive and respiratory syndrome virus ORF5 gene sequence
74312-0,Porcine reproductive and respiratory syndrome virus
74313-8,Porcine reproductive and respiratory syndrome virus Ab/Positive control
74314-6,Porcine reproductive and respiratory syndrome virus ORF5 gene RNA pattern
74315-3,Porcine reproductive and respiratory syndrome virus RNA
74316-1,Porcine reproductive and respiratory syndrome virus ORF5 gene RNA
74317-9,Porcine reproductive and respiratory syndrome virus European strain RNA
74318-7,Porcine reproductive and respiratory syndrome virus North American strain RNA
74319-5,MICA*051 Ab.IgG
74320-3,MICA*050 Ab.IgG
74321-1,MICA*046 Ab.IgG
74322-9,MICA*043 Ab.IgG
74323-7,MICA*042 Ab.IgG
74324-5,MICA*041 Ab.IgG
74325-2,MICA*037 Ab.IgG
74326-0,MICA*036 Ab.IgG
74327-8,MICA*033 Ab.IgG
Aug-32,Juniper Ab.IgE
74328-6,MICA*030 Ab.IgG
74329-4,MICA*029 Ab.IgG
74330-2,MICA*028 Ab.IgG
74331-0,MICA*024 Ab.IgG
74332-8,MICA*019 Ab.IgG
74333-6,MICA*018 Ab.IgG
74334-4,MICA*017 Ab.IgG
74335-1,MICA*016 Ab.IgG
Jun-33,Juniper basophil bound Ab
74336-9,MICA*015 Ab.IgG
74337-7,MICA*012 Ab.IgG
74338-5,MICA*011 Ab.IgG
74339-3,MICA*009 Ab.IgG
74340-1,MICA*008 Ab.IgG
74341-9,MICA*007 Ab.IgG
74342-7,MICA*006 Ab.IgG
74343-5,MICA*005 Ab.IgG
Apr-34,Juniperus pinchotii Ab.IgE
74344-3,MICA*004 Ab.IgG
74345-0,MICA*002 Ab.IgG
74346-8,MICA*001 Ab.IgG
74347-6,Leukocyte aggregates
74348-4,Bacteria identified
74349-2,Lactose^post CFst
743-5,Monocytes
74350-0,17-Hydroxyprogesterone^20M post dose corticotropin
Jan-35,Juniperus occidentalis Ab.IgE
74351-8,Glucose
74352-6,Cryoglobulin & cryofibrinogen panel
74353-4,Sodium & Potassium panel
74354-2,Epithelial cells/100 leukocytes
74355-9,Bacteria identified
74356-7,Bacteria identified
74357-5,Lymphocytes.immunoblastic
74358-3,Adenine phosphoribosyltransferase
74359-1,Cholesterol ester transfer protein actual/normal
74360-9,Cortisone
74361-7,Dehydroepiandrosterone
74362-5,Lecithin cholesterol acyltransferase actual/normal
74363-3,"N,N-dimethylarginine"
74364-1,Oxytocin
74365-8,Palmitoyl protein thioesterase
74366-6,Clorazepate^trough
74367-4,Norfluoxetine^trough
74368-2,Apelin
Sep-36,Chorchorus capsularis Ab.IgE
74369-0,Nitric oxide
74370-8,Cotinine
74371-6,Cotinine
74372-4,Acetyl fentanyl
74373-2,cloNIDine
74374-0,"2,4,4'-Trichlorobiphenyl"
74375-7,"2,2',3,5'-Tetrachlorobiphenyl"
74376-5,"2,2',4,4',5,5'-Hexachlorobiphenyl"
Jul-37,Kapok Ab.IgE
74377-3,Baclofen
74378-1,Meperidine
74379-9,Morphine
74380-7,HYDROmorphone
74381-5,Midazolam
74382-3,Bupivacaine
74383-1,fentaNYL
74384-9,Specimen container
May-38,Kapok basophil bound Ab
74385-6,Normirtazapine
74386-4,Normirtazapine
74387-2,Normirtazapine
74388-0,Normirtazapine
74389-8,Normirtazapine
74390-6,Baclofen
74391-4,Baclofen
74392-2,Zopiclone
Mar-39,Karaya gum Ab.IgE
74393-0,Reticulocytes.immature/100 erythrocytes
74394-8,Normoblasts
74395-5,Blasts
74396-3,Large unstained cells/100 leukocytes
74397-1,Reticulocytes/100 erythrocytes
74398-9,Neutrophils
74399-7,Monocytes
74400-3,Monocytes/100 leukocytes
Jan-40,Actinidia chinensis Ab.IgG
74401-1,Lymphocytes
74402-9,Lymphocytes/100 leukocytes
74403-7,Normoblasts/100 leukocytes
74404-5,Eosinophils
74405-2,Eosinophils/100 leukocytes
74406-0,Basophils
74407-8,Basophils/100 leukocytes
74408-6,Middle east respiratory syndrome coronavirus RNA panel
74409-4,MICA Ab.IgG panel
74410-2,Polychlorinated biphenyl panel
74411-0,Consistency
74412-8,Complete blood count W Differential panel
74413-6,Differential panel
74414-4,Varicella zoster virus Ab.IgM
74415-1,Rubella virus Ab.IgG
74416-9,Measles virus Ab.IgM
74417-7,Measles virus Ab.IgM
74418-5,Measles virus Ab.IgG
Sep-41,Actinidia chinensis basophil bound Ab
74419-3,Parvovirus B19 DNA
74420-1,Parvovirus B19 DNA
74421-9,Mumps virus Ab.IgM
74422-7,Mumps virus Ab.IgG
74423-5,Enterovirus RNA
74424-3,Enterovirus RNA
74425-0,Myelocytes.neutrophilic/100 leukocytes
74426-8,Myelocytes.neutrophilic/100 cells
Jul-42,Kochia scoparia Ab.IgA
74427-6,Myelocytes.eosinophilic/100 leukocytes
74428-4,Metamyelocytes.neutrophilic/100 leukocytes
74429-2,Metamyelocytes.eosinophilic/100 cells
744-3,Monocytes/100 leukocytes
74430-0,3-Hydroxykynurenin
74431-8,Acetoacetate
74432-6,Cholestanol
74433-4,Cholestanol/Cholesterol
74434-2,Bilirubin/Total
May-43,Kochia scoparia Ab.IgE
74435-9,Cholesterol.non-esterified/Cholesterol.total
74436-7,D-lactate
74437-5,Galactokinase
74438-3,Lactose/Creatinine
74439-1,Gamma aminobutyrate free and total panel
74440-9,Pemptoporphyrin
74441-7,Porphobilinogen/Creatinine
74442-5,Pyridoxal phosphate
Mar-44,Lactalbumin Ab.IgG
74443-3,Sucrose/Creatinine^post XXX g sugar solution PO
74444-1,Thiamine pyrophosphate
74445-8,Porphyrin fractions panel
74446-6,Calculus analysis panel
74447-4,Sugars and polyols panel
74448-2,Sugars and polyols pattern
74449-0,Patient plan of care - recommended IHE set
7445-0,Lactalbumin alpha Ab.IgE
74450-8,Other cells
74451-6,Other cells/100 leukocytes
74452-4,Platelet distribution width
74453-2,Histiocytes/100 cells
74454-0,Normoblasts
74455-7,Blasts/100 leukocytes
74456-5,Plasma cells/100 leukocytes
74457-3,Neutrophils/100 leukocytes
74458-1,Large unstained cells/100 leukocytes
74459-9,Granulocytes.immature/100 leukocytes
74460-7,Blasts/100 leukocytes
74461-5,Lymphocytes/100 leukocytes
74462-3,Basophils/100 leukocytes
74463-1,Normoblasts/100 leukocytes
74464-9,Platelets
74465-6,Questionnaire response
74466-4,Feedback to user^post question response
74467-2,Number of allowed answer responses interval
Aug-46,Lactalbumin basophil bound Ab
74468-0,Questionnaire form definition
74469-8,Glucose-6-Phosphate dehydrogenase/Pyruvate kinase
74470-6,Injury severity score body region
74471-4,Injury severity score
74472-2,Middle east respiratory syndrome coronavirus N3 gene RNA
74473-0,Middle east respiratory syndrome coronavirus N2 gene RNA
74474-8,Middle east respiratory syndrome coronavirus upE gene RNA
74475-5,Middle east respiratory syndrome coronavirus RNA
Jun-47,Lactoglobulin Ab.IgG
74476-3,Setting
74477-1,Kind of document
74478-9,Type of service
74479-7,Role
74480-5,Subject matter domain
74481-3,Tyrosine/Phenylalanine
74482-1,Reason for unsatisfactory specimen not related to sample quality of dried blood spot
74483-9,Homocitrulline
Apr-48,Lamb Ab.IgG
74484-7,Argininosuccinate
74485-4,CD3 & CD20 Ag
74486-2,Cytokeratin 5 & p63 & Cytokeratin AE1 Ag
74487-0,P504S & p63 & Cytokeratin 903 Ag
74488-8,p63 & Smooth muscle myosin heavy chain & Cytokeratin 8 Ag
74489-6,Melan-A & Ki67 Ag
74490-4,PAX5 & BCL2 Ag
74491-2,Cytokeratin 7 & Thyroid transcription factor 1 Ag
Feb-49,Lamb basophil bound Ab
74492-0,PAX5 & CD43 Ag
74493-8,PAX5 & CD5 Ag
74494-6,CD34 & Coagulation factor XIII Ag
74495-3,Patient safety event report - hospital - healthcare event reporting form - version 1.2
74496-1,Injury location ICD code
74497-9,Medical examiner or coroner was contacted
74498-7,Autopsy or histological placental examination results were used
74499-5,Death pronouncer
May-74,Cefatrizine
745-0,Myeloblasts
7450-0,Chenopodium album basophil bound Ab
74500-0,Age at time of event
74501-8,Patient safety event report - hospital - summary of initial report - version 1.2
74502-6,Patient safety event report - hospital - patient information form - version 1.2
74503-4,"16-Beta,18-dihydroxydehydroepiandrosterone"
74504-2,"16-Beta,18-dihydroxydehydroepiandrosterone"
74505-9,"16-Beta,18-dihydroxydehydroepiandrosterone"
74506-7,16-Alpha hydroxypregnenolone
74507-5,16-Alpha hydroxypregnenolone
74508-3,16-Alpha hydroxypregnenolone
74509-1,3-Hydroxydecanoylcarnitine (C10-OH)
74510-9,3-Hydroxyeicosanoylcarnitine (C20-OH)
74511-7,COMT gene.c.1947G>A
74512-5,Chemokine (C-C motif) ligand 18
74513-3,Alpha tocopherol
74514-1,Amino acids panel
74515-8,Bile acid
74516-6,Calcium
74517-4,Cholesterol sulfate
Aug-51,Latex ALK basophil bound Ab
74518-2,Clara cell protein 16
74519-0,Complement activity panel
74520-8,Complement alternate pathway AH50 actual/normal
74521-6,Complement total hemolytic CH50 actual/normal
74522-4,Complement lectin pathway actual/normal
74523-2,Nonanoylcarnitine (C9)
74524-0,Decatrienoylcarnitine (C10:3)
74525-7,Dehydrosebacylcarnitine (C10:1-DC)
Jun-52,Latex Bencard basophil bound Ab
74526-5,"Delta aminolevulinate, porphobilinogen and creatinine panel"
74527-3,"Delta aminolevulinate, porphobilinogen and creatinine panel"
74528-1,Dicarboxyeicosanoylcarnitine (C20-DC)
74529-9,Dicarboxyhexenoylcarnitine (C6:1-DC)
74530-7,Dicarboxypalmitoleylcarnitine (C16:1-DC)
74531-5,Dicarboxytetradecanoylcarnitine (C14-DC)
74532-3,Energy content
74533-1,Fatty acid oxidation panel
Apr-53,Latex Greer basophil bound Ab
74534-9,Neisseria meningitidis serogroup Y DNA
74535-6,Neisseria meningitidis serogroup X DNA
74536-4,Neisseria meningitidis serogroup w135 DNA
74537-2,Neisseria meningitidis serogroup C DNA
74538-0,Neisseria meningitidis serogroup B DNA
74539-8,Neisseria meningitidis serogroup A DNA
74540-6,Hexenoylcarnitine (C6:1)
74541-4,Surfactant pulmonary-associated protein D
Feb-54,Latex Stallerg basophil bound Ab
74542-2,Pyruvate kinase/Glucose-6-Phosphate dehydrogenase
74544-8,Tocopherols
74545-5,Tryptophan-related indole profiling panel
74546-3,Reporter job or position
74547-1,Reporter email
74548-9,Reporter phone number
74549-7,Reporter of adverse event or unsafe condition
74550-5,Anonymous reporter
74551-3,Perinatal incident that affected a neonate
74552-1,Categories associated with patient safety event or unsafe condition
74553-9,Location of patient safety event or unsafe condition
74554-7,Description of patient safety event or unsafe condition
74555-4,Event discovery date & time
74556-2,Family or guardian was notified
74557-0,Increased length of stay due to incident
74558-8,Timing of harm assessment
Sep-55,Citrus limon Ab.IgG
74559-6,Anticipated duration of harm to the patient
74560-4,Extent of harm to the patient
74561-2,Documented rescue interventions
74562-0,Rescue intervention was attempted
74563-8,Incident preventability
74564-6,National Quality Forum (NQF) serious reportable event
74565-3,Event was a National Quality Forum (NQF) serious reportable event
74566-1,Contributing factors for event
Jul-56,Citrus limon basophil bound Ab
74567-9,Contributing factors for event were known
74568-7,Event was associated with a handover
74569-5,Action that prevented the near miss incident from reaching the patient
74570-3,Additional details of event or unsafe condition
74571-1,Healthcare professional
74572-9,Reporter of adverse event or unsafe condition
74573-7,Location of patient safety event or unsafe condition
74574-5,Macroscopic observation
May-57,Atriplex lentiformis Ab.IgE
74575-2,Pyruvate dehydrogenase E1
74576-0,Tripeptidyl peptidase I
74577-8,Pyruvate dehydrogenase complex
74578-6,Pyruvate dehydrogenase complex
74579-4,Pyruvate dehydrogenase E1
74580-2,Fumarase
74581-0,Fumarase
74582-8,Fatty acids.very long chain.C26:0/C22:0
Mar-58,Lens esculenta Ab.IgE
74583-6,Fatty acids.very long chain.C24:0/C22:0
74584-4,Cytochrome C oxidase/Citrate synthase
74585-1,Coenzyme Q cytochrome C reductase/Citrate synthase
74586-9,Coenzyme Q cytochrome C reductase
74587-7,Succinate cytochrome C reductase/Citrate synthase
74588-5,Succinate cytochrome C reductase
74589-3,Succinate dehydrogenase/Citrate synthase
74590-1,NADH cytochrome C reductase/Citrate synthase
Jan-59,Lens esculenta Ab.IgG
74591-9,Suberylcarnitine (C8-DC)
74592-7,Octanoylcarnitine (C8)
74593-5,Adipoylcarnitine (C6-DC)
74594-3,Hexanoylcarnitine (C6)
74595-0,3-Hydroxybutyrylcarnitine (C4-OH)
74596-8,Butyrylcarnitine (C4)
74597-6,3-Hydroxypalmitoylcarnitine (C16-OH)
74598-4,Dicarboxypalmitoylcarnitine (C16-DC)
74599-2,3-Hydroxypalmitoleylcarnitine (C16:1-OH)
74600-8,Palmitoleylcarnitine (C16:1)
74601-6,Palmitoylcarnitine (C16)
74602-4,3-Hydroxytetradecanoylcarnitine (C14-OH)
74603-2,Tetradecadienoylcarnitine (C14:2)
74604-0,3-Hydroxymyristoleylcarnitine (C14:1-OH)
74605-7,Tetradecenoylcarnitine (C14:1)
74606-5,Tetradecanoylcarnitine (C14)
74607-3,Dodecenoylcarnitine (C12:1)
74608-1,Dodecanoylcarnitine (C12)
Sep-60,Lactuca sativa Ab.IgG
74609-9,Sebacylcarnitine (C10-DC)
74610-7,Decadienoylcarnitine (C10:2)
74611-5,Decenoylcarnitine (C10:1)
74612-3,Decanoylcarnitine (C10)
74613-1,Fatty acids.very long chain.C24:0
74614-9,Fatty acids.very long chain.C26:0
74615-6,Fatty acids.very long chain.C22:0
74616-4,"1,1-Dimethoxyoctadecane/octadecanoate"
Jul-61,Lactuca sativa basophil bound Ab
74617-2,"1,1-Dimethoxyoctadecane/octadecanoate"
74618-0,"1,1-Dimethoxyoctadecane"
74619-8,"1,1-Dimethoxyoctadecane"
74620-6,"1,1-Dimethoxy-(9Z)octadecene/oleate"
74621-4,"1,1-Dimethoxy-(9Z)octadecene/oleate"
74622-2,"1,1-Dimethoxy-(9Z)octadecene"
74623-0,"1,1-Dimethoxy-(9Z)octadecene"
74624-8,"1,1-Dimethoxyhexadecane/palmitate"
May-62,Glycyrrhiza lepidota Ab.IgE
74625-5,"1,1-Dimethoxyhexadecane/palmitate"
74626-3,"1,1-Dimethoxyhexadecane"
74627-1,"1,1-Dimethoxyhexadecane"
74628-9,Adipoylcarnitine (C6-DC)
74629-7,Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH)
74630-5,Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)
74631-3,Glycosaminoglycans/Creatinine
74632-1,Glycosaminoglycans
Mar-63,Lilium longiflorum Ab.IgE
74633-9,Dimethylacetal panel
74634-7,Dimethylacetal panel
74635-4,Bacterial vaginosis DNA panel
74636-2,Protein.monoclonal band 3
74637-0,Protein.monoclonal band 2
74638-8,Monoclonal band 3 observed
74639-6,Monoclonal band 2 observed
74640-4,Monoclonal band 3 observed
Jan-64,Citrus aurantifolia Ab.IgE
74641-2,Monoclonal band 2 observed
74642-0,"1,3-Dichlorobenzene"
74643-8,Aromatic solvents
74644-6,HYDROcodone
74645-3,HYDROmorphone
74646-1,Methamphetamine
74647-9,Methylenedioxyamphetamine
74648-7,Methylenedioxyamphetamine
74649-5,Methylenedioxyethylamphetamine
74650-3,Methylenedioxyethylamphetamine
74651-1,Methylenedioxymethamphetamine
74652-9,Methylenedioxymethamphetamine
74653-7,Methylenedioxymethamphetamine
74654-5,Morphine
74655-2,Norsertraline
74656-0,Opiates
74657-8,oxyCODONE
Aug-65,Citrus aurantifolia Ab.IgG
74658-6,oxyCODONE+Oxymorphone
74659-4,oxyMORphone
74660-2,Phencyclidine
74661-0,Phosphatidylethanol
74662-8,Sertraline
74663-6,Zaleplon
74664-4,Zolpidem
74665-1,Monoclonal band observed
Jun-66,Linen Ab.IgE
74666-9,Monoclonal band observed
74667-7,Atopobium vaginae DNA
74668-5,Gardnerella vaginalis DNA
74669-3,Lactobacillus sp DNA
74670-1,Cocaine+Metabolites
74671-9,Cocaine
74672-7,Carisoprodol+Meprobamate
74673-5,Ethanol
Apr-67,Lipolase Ab.IgE
74674-3,Chlorinated solvents
74675-0,Codeine
74676-8,Carbapenemase
74677-6,6-Monoacetylmorphine
74678-4,Carboxy tetrahydrocannabinol
74679-2,Benzoylecgonine
746-8,Myeloblasts
74680-0,Amphetamine
74681-8,Amphetamines
Feb-68,Liver Ab.IgE
74682-6,Trichloroethanol.free
74683-4,Ethyl sulfate
74684-2,Carbon dioxide^post dialysis
74685-9,Sodium
74686-7,Glucose
74687-5,Glucose
74688-3,Sodium^post dialysis
74689-1,Nucleated cells
7469-0,Liver calf Ab.IgE
74690-9,Weak D Ag
74691-7,Round Cells
74692-5,MT-ND6 gene.m.14459G>A
74693-3,Race
74694-1,Ethnicity
74695-8,Nurse name
74696-6,Magnesium
74697-4,Acamprosate
74698-2,Sex
74699-0,Cefuroxime
74700-6,Ergonomics or human &or device interface issue
74701-4,Problem that resulted from the equipment or device function problem
74702-2,Circumstances involving the health information technology device in the event or unsafe condition
74703-0,Electronic health record system component
74704-8,Administrative or billing system component
74705-5,Best characterization of health information technology device
74706-3,Health information technology device was involved
74707-1,Medication or other substance was involved
Aug-70,Llama fur Ab.IgE
74708-9,Device intended for single use was reused in the event or unsafe condition
74709-7,Device intended for single use was involved in the event or unsafe condition
74710-5,Asset tag number
74711-3,Unique device identifier
74712-1,Expiration date
74713-9,Other unique product identifier
74714-7,Lot or batch number
74715-4,Vendor serial number
Jun-71,Homarus gammarus Ab.IgG
74716-2,Vendor firmware version
74717-0,Vendor model number
74718-8,Device identifier
74719-6,Manufacturer name
74720-4,Device name
74721-2,Event resulted in the device being removed
74722-0,"At the time of the event, the device was placed within the patient's tissue"
74723-8,Device involved in patient safety event or unsafe condition
Apr-72,Locust tree Ab.IgE
74724-6,Best description of the event or unsafe condition
74725-3,"Patient safety event report - hospital - device or medical &or surgical supply, including health information technology - version 1.2"
74726-1,Other unique product identifier
74727-9,Body condition score
74728-7,"Vital signs, weight, height, head circumference, oximetry, BMI, & BSA panel"
74729-5,Adrenoleukodystrophy protein
74730-3,Oligosaccharides pattern
74731-1,Gram positive bacteria identified
Feb-73,Robinia pseudoacacia Ab.IgE
74732-9,Listeria sp (tuf) gene
74733-7,Mycobacterium sp rRNA
74734-5,Death certifier details
74735-2,Health data repository
74736-0,Streptococcus pyogenes hsp60 gene
74737-8,Streptococcus pneumoniae gryB gene
74738-6,Streptococcus anginosus group gyrB gene
74739-4,Streptococcus agalactiae hsp60 gene
7474-0,Scomber scombrus Ab.IgE
74740-2,Streptococcus sp tuf gene
74741-0,Bacterial vancomycin resistance vanB gene
74742-8,Bacterial vancomycin resistance vanA gene
74743-6,Enterococcus faecalis hsp60 gene
74744-4,Staphylococcus lugdunensis sodA gene
74745-1,Bacterial methicillin resistance (mecA) gene
74746-9,Staphylococcus epidermidis hsp60 gene
74747-7,Staphylococcus aureus gyrB gene
74748-5,Staphylococcus sp tuf gene
74749-3,Gram positive blood culture panel
74750-1,Lymphocytes.clefted
74751-9,Collection time
74752-7,Porcine epidemic diarrhea virus RNA
74753-5,Blood group antigens present
74754-3,Blood group antigens present
74755-0,Placental growth factor
74756-8,Soluble fms-like tyrosine kinase-1
Jul-75,Scomber scombrus basophil bound Ab
74757-6,Soluble fms-like tyrosine kinase-1/placental growth factor
74758-4,Ethyl sulfate+Ethyl glucuronide
74759-2,Yeast
747-6,Myeloblasts/100 leukocytes
74760-0,HYDROcodone & metabolites panel
74761-8,Microcytes/100 erythrocytes
74762-6,Megasphaera sp DNA
74763-4,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 E6+E7 mRNA
74764-2,Soluble fms-like tyrosine kinase-1 & placental growth factor panel
May-76,Malt Ab.IgG
74765-9,Bordetella pertussis.pertussis toxin Ab.IgA
74766-7,Bordetella pertussis.pertussis toxin 100 Ab.IgG
74767-5,Tryptophan
74768-3,5-hydroxytryptophan
74769-1,5-Hydroxyindoleacetate
74770-9,Reporter information
74771-7,Neonatal patient information
74772-5,Patient information
Mar-77,Mangifera indica pollen Ab.IgE
74773-3,Immunoglobulin light chains & heavy chains panel
74774-1,Glucose
74775-8,Platelets
74776-6,Human papilloma virus 6 DNA
74777-4,Human papilloma virus 6 DNA
74778-2,Human papilloma virus 11 DNA
74779-0,Human papilloma virus 11 DNA
74780-8,CPT1A gene.c.1436C>T
Jan-78,Acer macrophyllum Ab.IgE
74781-6,Vacuum dust collection contaminant panel
74782-4,Arterial pulse intensity
74783-2,Malignant cells
74784-0,Influenza virus B lineage RNA
74785-7,Influenza virus B Victoria lineage RNA
74786-5,Influenza virus B Yamagata lineage RNA
74787-3,Influenza virus B Victoria & Yamagata lineage RNA panel
74788-1,Lactulose challenge panel
74789-9,Fructose challenge panel
74790-7,Glucose challenge panel
74791-5,Lactulose challenge
74792-3,Fructose.PO
74793-1,Thyroid hormone uptake
74794-9,Thyroid hormone binding ratio
74795-6,Total thyroxine binding capacity
Sep-79,Acer rubrum Ab.IgE
74802-0,Glucose challenge
74803-8,Lactose challenge
74804-6,Fructose challenge
74805-3,Penicillium sp Ab.IgG
74806-1,Lithium^trough
Jul-80,Acer rubrum basophil bound Ab
74807-9,Transferrin receptor.soluble/log Ferritin index
74808-7,von Willebrand factor.activity actual/Normal^immediately after 1:1 addition of normal plasma
74809-5,von Willebrand factor.activity actual/Normal
74810-3,Acetyl fentanyl
74811-1,Dihydrocodeine
74812-9,Mirtazapine
74813-7,Nucleated cells
74814-5,Plasma cells.centroblasts/100 leukocytes
May-81,Maple red+Silver Ab.IgE
74815-2,Ascaris sp Ab.IgG
74816-0,Bacteria identified
74817-8,Desomorphine
74818-6,Desomorphine
74819-4,Promazine
74820-2,Plasma cells.centrocytes/100 leukocytes
74821-0,Chikungunya virus Ab
74822-8,Clostridioides difficile toxin B tcdB gene
Mar-82,Maple sugar Ab.IgE
74823-6,Jamestown canyon virus Ab
74824-4,Powassan virus Ab
74825-1,Saint Louis encephalitis virus Ab
74826-9,Semliki forest virus Ab
74827-7,Snowshoe hare virus Ab
74828-5,Snowshoe hare virus Ab.Neut
74829-3,Snowshoe hare virus Ab.IgG
74830-1,Toxoplasma gondii Ab.IgA
Jan-83,Maple syrup Ab.IgE
74831-9,Metanephrine & Normetanephrine panel
74832-7,OLANZapine
74833-5,ACAT1 gene full mutation analysis
74834-3,MARS2 gene full mutation analysis
74835-0,Porphyrin fractions panel
74836-8,Transplant type
74837-6,Cells.CD20
74838-4,Cells.CD34
74839-2,Cells.CD3-CD4+/100 cells
748-4,Myelocytes
74840-0,Cells.CD56
74841-8,Cells.CD8+CD57+/100 cells
74842-6,Cells.CD25
74843-4,Baylisascaris sp Ab.IgG
74844-2,Baylisascaris sp Ab.IgG
74845-9,Sindbis virus Ab
74846-7,Snowshoe hare virus Ab.IgM
74847-5,Toxoplasma gondii Ab.IgE
74848-3,Lymphocytes/100 cells
Sep-84,Iva xanthifolia Ab.IgE
74849-1,Plasma cells/100 cells
74850-9,Lymphoblasts/100 cells
74851-7,Blasts/100 cells
74852-5,Mesothelial cells/100 cells
74853-3,HIV 1 proviral DNA
74854-1,HIV 1 proviral DNA
74855-8,HIV 1 proviral DNA
Jun-85,Iva xanthifolia Ab.IgG
74856-6,HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA
74857-4,West Nile Virus RNA
74858-2,Hepatitis E virus genotypes 1+2+3+4 RNA
74859-0,Ethanol
74860-8,ERBB2 gene copy number/nucleus
74861-6,Chromosome 17 copy number/nucleus
74862-4,IgG.kappa
74863-2,IgG.lambda
Apr-86,Mattress dust Ab.IgE
74864-0,IgA.kappa
74865-7,IgA.lambda
74866-5,IgM.kappa
74867-3,IgM.lambda
74868-1,IgG.kappa/IgG.lambda
74869-9,IgA.kappa/IgA.lambda
74870-7,IgM.kappa/IgM.lambda
74871-5,Rivaroxaban
Feb-87,Mayfly Ab.IgE
74872-3,21-Deoxycortisol
74873-1,Metabolic disorder being monitored
74874-9,Metabolic disorder therapy monitoring panel
74875-6,Alloisoleucine^post therapeutic diet
74876-4,Arginine^post therapeutic diet
74877-2,Argininosuccinate^post therapeutic diet
74878-0,Carnitine.free (C0)^post therapeutic diet
74879-8,Galactose 1 phosphate^post therapeutic diet
7488-0,Mayfly basophil bound Ab
74880-6,Hydroxyproline^post therapeutic diet
74881-4,Isoleucine^post therapeutic diet
74882-2,Leucine^post therapeutic diet
74883-0,Ornithine^post therapeutic diet
74884-8,Valine^post therapeutic diet
74885-5,ERBB2 gene duplication associated observations panel
74886-3,Stigmasterol
74887-1,Stigmastanol
74888-9,Sterols panel
74889-7,Phosphate
74890-5,Inositol.free/Creatinine
74891-3,Medium-chain Acyl CoA dehydrogenase
74892-1,Medium-chain Acyl CoA dehydrogenase
74893-9,Mannose/Creatinine
74894-7,Mannitol^post XXX g sugar solution PO
74895-4,Maltose/Creatinine
74896-2,Lactate
74897-0,Lithocholate
Aug-89,Melaleuca leucadendron basophil bound Ab
74898-8,Lanosterol
74899-6,Lactulose/mannitol^post XXX g sugar solution PO
74900-2,Lactulose/Creatinine^post XXX g sugar solution PO
74901-0,Gamma tocopherol
74902-8,Galactose 1 phosphate uridyl transferase
74903-6,Fatty acids
74904-4,DOPamine
74905-1,Desmosterol
Jun-90,Cucumis melo spp Ab.IgG
74906-9,Bilirubin
74907-7,Beta sitosterol
74908-5,3-ketoacyl-CoA thiolase
74909-3,Calcium oxalate dihydrate/Total
74910-1,Porphyrin fractions & creatinine panel
74911-9,Sertraline^trough
74912-7,Primidone^trough
74913-5,Escitalopram^trough
Apr-91,Firebush mexican Ab.IgE
74914-3,Acylglycines panel
74915-0,Sulpiride^trough
74916-8,Metoprolol^trough
74917-6,CXCL13 Ag
74918-4,Fatty acids
74919-2,Caffeine^trough
749-2,Myelocytes/100 leukocytes
74920-0,Gamma hydroxybutyrate
74921-8,Norclobazam^trough
Feb-92,Multiple inhalant allergen Ab.IgE
74922-6,N-acetyl-L-aspartate
74923-4,Temazepam^trough
74924-2,Nortriptyline^trough
74925-9,Flupenthixol^trough
74926-7,PHENobarbital^trough
74927-5,Pipamperone^trough
74928-3,Allopurinol^trough
74929-1,Fluspirilene^trough
7493-0,Milk evaporated Ab.IgE
74930-9,3-Hydroxykynurenin
74931-7,ARIPiprazole^trough
74932-5,Citalopram^trough
74933-3,N-desalkylflurazepam^trough
74934-1,fluPHENAZine^trough
74935-8,Palmitoyl protein thioesterase
74936-6,QUEtiapine^trough
74937-4,Chlorprothixene^trough
74938-2,Lidocaine^trough
74939-0,Vigabatrin^trough
74940-8,Moclobemide^trough
74941-6,Moclobemide
74942-4,Kynurenin
74943-2,busPIRone^trough
74944-0,lamoTRIgine^trough
74945-7,clomiPRAMINE+Norclomipramine^trough
74946-5,Normirtazapine^trough
74947-3,Norclomipramine^trough
Aug-94,Panicum milliaceum Ab.IgG
74948-1,Fluoxetine+Norfluoxetine^trough
74949-9,Perphenazine^trough
74950-7,Galactocerebrosidase
74951-5,E-10-Hydroxynortriptyline^trough
74952-3,Lymphocyte proliferation
74953-1,Macroprolactin
74954-9,Isomaltase
May-95,Mite dust Ab.IgE
74955-6,Cyproheptadine^trough
74956-4,chlordiazePOXIDE^trough
74957-2,Succinylacetone
74958-0,clomiPRAMINE^trough
74959-8,fluvoxaMINE^trough
74960-6,valGANciclovir^trough
74961-4,10-Hydroxycarbazepine^trough
74962-2,Maprotiline^trough
Mar-96,Cheese mold type Ab.IgG
74963-0,Promethazine^trough
74964-8,Gabapentin^trough
74965-5,Haloperidol^trough
74966-3,Acetaminophen^trough
74967-1,Adrenal cortex Ab.IgG
74968-9,Norsertraline^trough
74969-7,Methotrimeprazine^trough
74970-5,Acetylsalicylate^trough
Jan-97,Cheese mold type basophil bound Ab
74971-3,Clopenthixol^trough
74972-1,9-Hydroxyrisperidone^trough
74973-9,carBAMazepine^trough
74974-7,carBAMazepine.free^trough
74975-4,Nordiazepam^trough
74976-2,Phenytoin^trough
74977-0,Transferrin
74978-8,Cerebroside sulfatase & N-Acetylgalactosamine-4-Sulfatase panel
74979-6,Urate
74980-4,LORazepam^trough
74981-2,Pimozide^trough
74982-0,FLUoxetine^trough
74983-8,Phenytoin.free^trough
74984-6,"5,10-Methylenetetrahydrofolate reductase"
74985-3,ALPRAZolam^trough
74986-1,Hydroxychloroquine^trough
74987-9,Pericyazine^trough
74988-7,Hexacarboxylporphyrin
Sep-98,Chrysonilia sitophila Ab.IgE
74989-5,Pentacarboxylporphyrins
74990-3,Alpha 1 antitrypsin
74991-1,Amino acids panel
74992-9,Amylase
74993-7,Chloride & sodium panel
74994-5,Collagen crosslinked C-telopeptide
74995-2,Osteocalcin
74996-0,Alkaline phosphatase.bone
Jul-99,Monkey epithelium Ab.IgE
74997-8,Alpha 1 antitrypsin
74998-6,"5,10-Methylenetetrahydrofolate reductase"
74999-4,"5,10-Methylenetetrahydrofolate reductase"
05-Jul,Amdinocillin
750-0,Myelocytes/100 leukocytes
75000-0,Coproporphyrin 3/Coproporphyrin.total
75001-8,Coproporphyrin 3/Coproporphyrin.total
Feb-00,Aedes communis basophil bound Ab
75002-6,(Actinidia chinensis+Ananas comosus+Musa spp+Mangifera indica) Ab.IgE
75003-4,(Arachis hypogaea+Cow milk+Egg white+Glycine max+Triticum aestivum+Oryza sativa) Ab.IgE
75004-2,(Beef+Chicken+Pork+Lamb) Ab.IgE
75005-9,(Brassica oleracea var capitata+Capsicum annuum+Lycopersicon lycopersicum+Spinacia oleracea) Ab.IgE
75006-7,(Cancer pagurus+Fagopyrum esculentum+Pandalus borealis+Sesamum indicum+Zea mays) Ab.IgE
75007-5,Aspergillus restrictus native (nAsp r) 1 Ab.IgE
75008-3,Canis familiaris native (nCan f) 1 Ab.IgE
75009-1,CEBPA gene full mutation analysis
7501-0,Tillandsia usneoides Ab.IgE
75010-9,"inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript"
75011-7,"t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript"
75012-5,"t(4;11)(q21.3;q23)(AFF1,MLL) fusion transcript"
75013-3,"t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript"
75014-1,"t(9;12)(q34.1;p13)(ABL1,ETV6) fusion transcript"
75015-8,"t(9;22)(q34.1;q11)(ABL1,BCR) b2a2 fusion transcript"
75016-6,"t(9;22)(q34.1;q11)(ABL1,BCR) b3a2 fusion transcript"
75017-4,"t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript"
75018-2,"t(9;22)(q34.1;q11)(ABL1,BCR) e19a2 fusion transcript"
75019-0,"t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript"
75020-8,"t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript"
75021-6,OLANZapine panel
75022-4,Fat.Microscopic Observation
75023-2,Basophils.CD63/100 basophils
75024-0,Coproporphyrin 1/Porphyrins.total
75025-7,Coproporphyrin 3/Porphyrins.total
75026-5,Deuteroporphyrin/Porphyrins.total
75027-3,Mesoporphyrin/Porphyrins.total
Aug-02,Moth Ab.IgE
75028-1,Protoporphyrin/Porphyrins.total
75029-9,Zanamivir
75030-7,Wholesale drug distributors and third-party logistics facility registration
75031-5,Human compounded drug label
75032-3,CEBPA gene full mutation analysis
75033-1,MPL gene mutations tested for
75034-9,NPM1 gene targeted mutation analysis
75035-6,Oxytocin
Jun-03,Moth basophil bound Ab
75036-4,2-Hydroxyglutarate
75037-2,2-Hydroxyglutarate
75038-0,Bile acid pattern
75039-8,Biopterin
75040-6,D-lactate
75041-4,Pyridoxal
75042-2,Pyridoxal
75043-0,Pyridoxine
Apr-04,Mouse hair Ab.IgE
75044-8,Sepiapterin/Creatinine
75045-5,Sialate
75046-3,Sialate
75047-1,Sialate
75048-9,Tetrahydrofolate
75049-7,Thiosulfate
75050-5,Ubiquinone 10
Jan-05,Mouse multi Ab.IgE
75051-3,Xylose/Creatinine
75052-1,Adenosine deaminase
75053-9,Alpha-L-iduronidase
75054-7,Glutaryl CoA dehydrogenase
75055-4,Glutaryl CoA dehydrogenase
75056-2,Pyridoxal phosphate
75057-0,Sialidase
75058-8,Thymidine phosphorylase
75059-6,Transaldolase
75060-4,Pantothenate/Creatinine
75061-2,Malonate
75062-0,Phenylacetate
75063-8,Glycerate
75064-6,Vanillylmandelate
75065-3,Benzoate
75066-1,Pantothenate
75067-9,Indole-3-Acetate
75068-7,Malate
Sep-06,Mucor plumbeus Ab.IgE
75069-5,Hippurate
75070-3,Catechol
75071-1,Acetaminophen/Creatinine
75072-9,Mandelate
75073-7,Suberate
75075-2,4-Hydroxybenzoate
75076-0,Vanillate
Jul-07,Mucor racemosus Ab.IgG
75077-8,Quinolinate
75078-6,3-Hydroxydodecanoate/Creatinine
75079-4,Succinylacetone
75080-2,N-acetyl-L-aspartate
75081-0,Fumarate
75083-6,Aconitate
75084-4,Sebacate
May-08,Mucor racemosus basophil bound Ab
75085-1,Homogentisate/Creatinine
75086-9,Catecholamine metabolites pattern
75087-7,Adipate
75088-5,3-Indolelactate
75089-3,5-Oxoproline
75090-1,Isocitrate
75091-9,Catechol/Creatinine
75092-7,Birth date
Mar-09,Mucor sp Ab.IgG
75093-5,Galactose^post therapeutic diet
75094-3,Galactose 1 phosphate uridyl transferase^post therapeutic diet
75095-0,Docosahexaenoate
75096-8,Fatty acids.very long chain.C26:0
75097-6,Eicosapentaenoate
75098-4,Nervonate
75099-2,Laurate
75100-8,Fatty acids
Jan-10,Artemisia vulgaris basophil bound Ab
75101-6,Fatty acids.very long chain.C22:0
75102-4,Oleate
75103-2,Myristate
75104-0,Fatty acids.very long chain.C24:0
75105-7,Fatty acids.very long chain.C26:1
75106-5,Mead acid
75107-3,Pentadecanoate
75108-1,Arachidate
75109-9,Fatty acids.very long chain.C22:1n9
75110-7,Arachidonate
75111-5,Palmitoleate
75112-3,Docosatetraenoate
75113-1,Alpha linolenate
75114-9,Fatty acids pattern
75115-6,Palmitate
75116-4,Decanoate
75117-2,Linoleate
75118-0,Octadecanoate
Sep-11,Artemisia douglasiana Ab.IgE
75119-8,Gamma linolenate
75120-6,Octanoate
75121-4,Thymine
75122-2,Deoxyadenosine
75123-0,Hypoxanthine
75124-8,Deoxyadenosine
75125-5,Orotidine
75126-3,Orotate
Jul-12,Morus alba Ab.IgE
75127-1,Deoxyinosine
75128-9,Uracil
75129-7,Xanthine
75130-5,Uridine
75131-3,Adenine
75132-1,Oxipurinol/Creatinine
75133-9,Adenine
75134-7,Deoxyguanosine
May-13,Morus alba Ab.IgG
75135-4,Hypoxanthine
75136-2,Adenosine
75137-0,Acadesine
75138-8,Succinylaminoimidazole carboxamide riboside/Creatinine
75139-6,Urate
75140-4,Allantoine
75141-2,Acadesine
75142-0,Adenosine
Mar-14,Morus rubra Ab.IgE
75143-8,Deoxyuridine
75144-6,Xanthine
75145-3,Succinyladenosine
75146-1,Succinylaminoimidazole carboxamide riboside
75147-9,Succinylaminoimidazole carboxamide riboside
75148-7,Orotidine
75149-5,Deoxyguanosine
7515-0,Agaricus hortensis Ab.IgG
75150-3,Inosine
75151-1,Acadesine/Creatinine
75152-9,Uracil
75153-7,Thymine
75154-5,Inosine
75155-2,Allantoine/Creatinine
75156-0,Thymidine
75157-8,Deoxyinosine
75158-6,Allantoine
75159-4,Uridine
75160-2,Adenosine/Creatinine
75161-0,BPAP activity
75162-8,BIPAP activity
75163-6,Trimester of first prenatal visit
75164-4,Non-treponemal or treponemal test was performed at first prenatal visit
75165-1,Non-treponemal or treponemal test was performed at 28-32 weeks gestation
75166-9,Non-treponemal or treponemal test was performed at delivery
75167-7,Date of most recent non-treponemal test
Aug-16,Agaricus hortensis basophil bound Ab
75168-5,Most recent non-treponemal test result
75169-3,Most recent non-treponemal test titer
75170-1,Date first non-treponemal test
75171-9,First non-treponemal test result
75172-7,First non-treponemal test titer
75173-5,Date of first treponemal test
75174-3,First treponemal test type
75175-0,First treponemal test result
Jun-17,Pleurotus ostreatus Ab.IgE
75176-8,Date of most recent treponemal test
75177-6,Most recent treponemal test type
75178-4,Most recent treponemal result
75179-2,HIV status during pregnancy
751-8,Neutrophils
75180-0,Clinical stage of syphilis during pregnancy
75181-8,Surveillance stage of syphilis during pregnancy
75182-6,Date of first syphilis treatment during pregnancy
75183-4,When mother received first dose of benzathine penicillin
Apr-18,Cucumis melo spp Ab.IgE
75184-2,Amount of benzathine penicillin treatment
75185-9,Mother had appropriate serologic response following syphilis treatment
75186-7,Vital status
75187-5,Non-treponemal test was reactive
75188-3,Date of first reactive non-treponemal test
75189-1,First reactive non-treponemal test titer
75190-9,Treponemal test was reactive
75191-7,Date of first reactive treponemal test
Feb-19,Mytilus edulis Ab.IgG
75192-5,"Darkfield exam, DFA, or special stain was performed & test findings"
75193-3,Clinical signs of congenital syphilis
75194-1,Long bone x-rays were performed and consistent with congenital syphilis
75195-8,CSF Venereal Disease Research Laboratory test was performed & test findings
75196-6,Leukocyte count or protein test was performed on CSF & test findings
75197-4,Syphilis treatment was given & treatment description
75198-2,Congenital syphilis case classification status
75199-0,Congenital syphilis case investigation and report panel
Feb-75,ceFAZolin
7520-0,Mytilus edulis basophil bound Ab
75200-6,Date first prenatal visit
75201-4,Pregnancies
75202-2,Births.live
75203-0,Date last menstrual period^pre delivery
75204-8,Prenatal care indicator
75205-5,Birth weight indicator
75206-3,Gestational age indicator
75207-1,Stillbirth indicator
75208-9,Maternal information section
75209-7,Infant or child information section
75210-5,Congenital syphilis case classification section
75211-3,Propionylcarnitine (C3)+Palmitoylcarnitine (C16)
75212-1,Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10)
75213-9,Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10)
75214-7,Arginine/Ornithine
75215-4,Ornithine/Citrulline
75216-2,Glutarylcarnitine (C5-DC)/Malonylcarnitine (C3-DC)
75217-0,Biotinidase
Aug-21,Mustard Ab.IgG
75218-8,Case report
75219-6,Summary registry report
75220-4,Progress note
75221-2,Progress note
75222-0,Microscopic observation
75223-8,Dengue virus Ab.IgG & IgM
75224-6,Chediak-Higashi cells
75225-3,Glutarylcarnitine (C5-DC)/Carnitine (C0)
Jun-22,Mycogone sp Ab.IgE
75226-1,8-Hydroxyamoxapine
75227-9,Baclofen
75228-7,Carisoprodol+Meprobamate
75229-5,DULoxetine
75230-3,m-Chlorophenylpiperazine
75231-1,Nefazodone
75232-9,Norcitalopram
75233-7,Norsertraline
Apr-23,Prunus persica var nucipersica Ab.IgE
75234-5,O-desmethylvenlafaxine
75235-2,Vilazodone
75236-0,Crystals
75237-8,Erythrocytes
75238-6,Procedure note
75239-4,Albumin.ischemia modified
75240-2,Meat fibers
75241-0,Procalcitonin
Feb-24,Prunus persica var nucipersica Ab.IgG
75242-8,Antipsychotics
75243-6,Norton scale panel
75244-4,Physical condition
75245-1,Mental condition
75246-9,Activity
75247-7,Mobility
75248-5,Incontinence
75249-3,Norton scale score.total
75250-1,Are you deaf or do you have difficulty hearing
75251-9,Are you blind or do you have difficulty seeing
75252-7,Do you have difficulty walking or climbing stairs
75253-5,"Because of a physical, mental, or emotional condition, do you have difficulty doing errands such as visiting a doctor's office or shopping"
75254-3,"Do you have difficulty communicating, reading, or do you have limited proficiency in English"
75255-0,Assistance needed
75256-8,Disability information & assistance needed panel
75257-6,Marital status
75258-4,PROMIS short form - sleep disturbance 4a - version 1.0
Sep-25,Nigrospora oryzae Ab.IgE
75259-2,PROMIS short form - pain intensity 3a - version 1.0
752-6,Neutrophils
75260-0,What is your level of pain right now
75261-8,How intense was your average pain in the past 7D
75262-6,How intense was your pain at its worse in the past 7D
75263-4,Blood group antibody screen
75264-2,Blood group antibody screen
75265-9,Blood group antibody screen
75266-7,Glutarylcarnitine (C5-DC)/Octanoylcarnitine+Decanoylcarnitine (C8+C10)
Jul-26,Nigrospora sphaerica Ab.IgE
75267-5,Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16)
75268-3,Leucine/Phenylalanine
75269-1,Bacteria identified
75270-9,Promethazine
75271-7,Other cells/100 cells
75272-5,Age at event onset
75273-3,Age at event onset
75274-1,Characteristics of residence
May-27,Nutmeg Ab.IgG
75275-8,Cognitive function
75276-6,Functional status
75277-4,Number of pressure injuries
75278-2,Advance directive status
75279-0,Provider responsible for medication monitoring
75280-8,Sequence number in substance administration series
75281-6,Personal belief
75282-4,Nutrition assessment panel
Mar-28,Quercus velutina Ab.IgE
75283-2,Food and nutrition history panel
75284-0,Food and nutrient intake panel
75285-7,Comparative nutrition assessment standards panel
75286-5,Nutrition related anthropometric measurements panel
75287-3,Food and beverage intake panel
75288-1,Carbohydrate need
75289-9,Fat need
75290-7,Protein need
Jan-29,Quercus kelloggii Ab.IgE
75291-5,Fluid need
75292-3,Body weight^usual
75293-1,Physical findings.nutrition
75294-9,Adequacy of breastmilk &or formula
75295-6,Fluid intake.oral
75296-4,Carbohydrate intake
75297-2,Fat intake
75298-0,Calorie intake
75299-8,Protein intake
75300-4,Fluid intake
75301-2,Fluid intake
75302-0,Calorie intake
75303-8,Nutrition assessment
75304-6,Nutrition status observation panel
75305-3,Nutrition status
75306-1,Nutrition status etiology
75307-9,Nutrition status signs and symptoms
75308-7,Fetal blood
Sep-30,Quercus gambelii Ab.IgE
75309-5,Mental function
75310-3,Health concerns
75311-1,Discharge medications
75312-9,Clinical finding
75313-7,Complaint
75314-5,Diagnosis
75315-2,Condition
75316-0,Functional performance
Jul-31,Chenopodium botrys Ab.IgE
75317-8,Symptom
75318-6,Problem
75319-4,Mental function
75320-2,Advance directive
75321-0,Clinical finding
75322-8,Complaint
75323-6,Condition
75324-4,Functional performance
May-32,Quercus agrifolia Ab.IgE
75325-1,Symptom
75326-9,Problem
75327-7,Life expectancy
75328-5,Prognosis
75329-3,Date of intrauterine device insertion
75330-1,Environmental condition panel
75331-9,Total number of staff completing the environmental conditions survey
75332-7,To what extent do you agree or disagree with cultural factors contributing to the phenomenon of complexity
Mar-33,Quercus wislizeni Ab.IgE
75333-5,"Within the last Mo, how often have you experienced cultural factors"
75334-3,To what extent do you agree or disagree with psychosocial factors contributing to the phenomenon of complexity
75335-0,"Within the last Mo, how often have you experienced psychosocial factors"
75336-8,To what extent do you agree or disagree with physical factors contributing to the phenomenon of complexity
75337-6,"Within the last Mo, how often have you experienced physical factors"
75338-4,Cognitive judgment
75339-2,Ability to comprehend
753-4,Neutrophils
75340-0,Ability to plan
Jan-34,Quercus rubra Ab.IgE
75341-8,Ability to process information
75342-6,Ability to reason
75343-4,Ability to think abstractly
75344-2,Ability to verbalize understanding
75345-9,Ability to sequence logically
75346-7,Promethazine
75347-5,Tapentadol
75348-3,Cognitive function
75349-1,Other cells
75350-9,Other cells/100 leukocytes
75351-7,Other cells
75352-5,Other cells/100 leukocytes
75353-3,Other cells/100 leukocytes
75354-1,Other cells
75355-8,Other cells/100 leukocytes
75356-6,Other cells/100 leukocytes
75357-4,Bacteria identified
Aug-35,Quercus lobata Ab.IgE
75358-2,Bacteria identified
75359-0,Bacteria identified
75360-8,Date of supracervical hysterectomy
75361-6,Date of total hysterectomy
75362-4,Tapentadol glucuronide
75363-2,Creatinine
75364-0,Urea
75365-7,First & Second trimester integrated maternal screen
Jun-36,Quercus alba Ab.IgG
75366-5,Lactate
75367-3,Buprenorphine
75368-1,Buprenorphine
75369-9,Diuretics
75370-7,Norbuprenorphine
75371-5,Bartlett score
75372-3,Hexane
75373-1,Erythrocytes.fetal/2000 erythrocytes
Apr-37,Quercus alba basophil bound Ab
75374-9,Other cells/100 leukocytes
75375-6,Other cells/100 leukocytes
75376-4,Siderocytes.HPF
75377-2,Dengue virus NS1 Ag
75378-0,Hepatitis B virus core Ab
75379-8,Norbuprenorphine
75380-6,SERPING1 gene targeted mutation analysis
75381-4,TTR gene mutation analysis limited to known familial mutations
Feb-38,Avena sativa Ab.IgG
75382-2,ATP7B gene mutation analysis limited to known familial mutations
75383-0,DMD gene deletion+duplication
75384-8,PMP22 gene deletion+duplication
75385-5,DMD gene deletion+duplication
75386-3,MEN1 gene mutation analysis limited to known familial mutations
75387-1,INS gene full mutation analysis
75388-9,CDKN1B gene mutation analysis limited to known familial mutations
75389-7,CDKN1B gene full mutation analysis
7539-0,Avena sativa basophil bound Ab
75390-5,APP gene targeted mutation analysis
75391-3,FGFR3 gene targeted mutation analysis
75392-1,FXN gene.GAA repeats
75393-9,HTT gene.CAG repeats
75394-7,Chromosome uniparental disomy
75395-4,AIP gene full mutation analysis
75396-2,AIP gene mutation analysis limited to known familial mutations
75397-0,HNF1A gene full mutation analysis
75398-8,HNF1B gene full mutation analysis
75399-6,HNF4A gene full mutation analysis
75400-2,KCNJ11 gene full mutation analysis
75401-0,GCDH gene full mutation analysis
75402-8,GCDH gene targeted mutation analysis
75403-6,PDHA1 gene full mutation analysis
75404-4,West Nile virus Ab
75405-1,Glucose^1.5H post dose triple bolus
75406-9,Human papilloma virus 16 & 18+45 E6+E7 mRNA
75407-7,Hepatitis B virus little e Ab
Aug-40,Avena sativa cultivated Ab.IgE
75408-5,Hepatitis B virus little e Ag
75409-3,Hepatitis B virus surface Ab
75410-1,Hepatitis B virus surface Ag
75411-9,Ebola Zaire virus RNA
75412-7,Rate all your health care in the last 12Mo
75413-5,I have a good life
75414-3,How often do your parents listen to your ideas
75415-0,How often do you have fun with friends
Jun-41,Avena sativa Ab.IgE
75416-8,How often do you feel really sad
75417-6,I have trouble doing all of my regular leisure activities with others
75418-4,PCORI patient-reported outcomes common measures - core and recommended
75419-2,PCORI patient-reported outcomes recommended measures
754-2,Neutrophils
75420-0,PCORI patient-reported outcomes core pediatric measures
75421-8,PCORI patient-reported outcomes core adult measures
75422-6,Group counseling note
75423-4,Note
Apr-42,Trisetum paniceum Ab.IgE
75424-2,Consultation note
75425-9,Diagnostic study note
75426-7,Procedure note
75427-5,Note
75428-3,Note
75429-1,Note
75430-9,Note
75431-7,Fall risk assessment note
Feb-43,Oidiodendrum spp Ab.IgE
75432-5,Note
75433-3,Education note
75434-1,Note
75435-8,Note
75436-6,Note
75437-4,Note
75438-2,Note
75439-0,Note
7544-0,Abelmoschus esculentus Ab.IgE
75440-8,Administrative note
75441-6,Diagnostic study note
75442-4,Medication management note
75443-2,Note
75444-0,Note
75445-7,Note
75446-5,Education note
75447-3,Fall risk assessment note
75448-1,Flowsheet
75449-9,Note
75450-7,Note
75451-5,Note
75452-3,Medication management note
75453-1,Note
75454-9,Note
75455-6,Procedure note
75456-4,Risk assessment and screening note
Jul-45,Olive Ab.IgE
75457-2,Triage note
75458-0,Triage note
75459-8,Note
75460-6,Note
75461-4,Note
75462-2,Note
75463-0,Consultation note
75464-8,Note
May-46,Olea europaea Ab.IgG
75465-5,Consultation note
75466-3,Note
75467-1,Evaluation and management of anticoagulation note
75468-9,Medication management note
75469-7,Note
75470-5,Note
75471-3,Note
75472-1,Note
Mar-47,Olive green Ab.IgE
75473-9,Note
75474-7,Note
75475-4,Letter
75476-2,Note
75477-0,Note
75478-8,Note
75479-6,Note
75480-4,Note
Jan-48,Allium cepa Ab.IgG
75481-2,Education note
75482-0,Note
75483-8,Note
75484-6,Risk assessment and screening note
75485-3,Administrative note
75486-1,Education note
75487-9,Letter
75488-7,Medication management note
75489-5,Note
75490-3,Note
75491-1,Note
75492-9,Risk assessment and screening note
75493-7,Note
75494-5,Note
75495-2,Note
75496-0,Note
75497-8,Progress note
75498-6,Summary note
Sep-49,Allium cepa basophil bound Ab
75499-4,Triage note
75500-9,Triage note
75501-7,Note
75502-5,Note
75503-3,Note
75504-1,Note
75505-8,Diseases with serologic evidence of immunity
75506-6,Coagulation surface induced.lupus sensitive.excess phospholipid
Jul-50,Citrus sinensis basophil bound Ab
75507-4,Coagulation surface induced.lupus sensitive percent correction
75508-2,Coagulation surface induced.lupus sensitive.excess phospholipid actual/Normal
75509-0,Coagulation surface induced.lupus sensitive with 1:1 Pooled Normal Plasma actual/Normal
75510-8,Coagulation surface induced.lupus sensitive with 1:1 Pooled Normal Plasma
75511-6,DRVVT percent correction
75512-4,DRVVT with 1:1 Pooled Normal Plasma actual/Normal
75513-2,DRVVT with 1:1 Pooled Normal Plasma
75514-0,Lupus anticoagulant two screening tests W Reflex
May-51,Citrus sinensis tree Ab.IgE
75515-7,Lupus anticoagulant two screening tests W Reflex panel
75516-5,Cortisol.free
75517-3,Protein.monoclonal band 4
75518-1,Bacteria identified
75519-9,Encounter identifier
75520-7,Biobank specimens are stored and available for research
75521-5,Information source for data
75522-3,Admission time
Mar-52,Origanum vulgare Ab.IgE
75523-1,Discharge time
75524-9,Facility identifier
75525-6,Type of encounter
75526-4,Internal identifier
75527-2,Vital status^at discharge
75528-0,Discharge disposition
75529-8,Admitted from
75530-6,Able to request or review patient chart
Jan-53,Origanum vulgare Ab.IgG
75531-4,Enrollment basis
75532-2,Applicable accrediting agency for unit
75533-0,"Accreditation, certification, & licensure panel"
75534-8,Accreditation received
75535-5,Certification received
75536-3,Applicable certification agency for unit
75537-1,Applicable licensing agency for unit
75538-9,Licensing received
75539-7,Body temperature
75540-5,Hepatitis A virus RNA+Parvovirus B19 DNA
75541-3,Parvovirus B19 DNA
75542-1,Hepatitis A virus RNA
75543-9,Parvovirus B19 DNA
75544-7,Noninvasive prenatal testing overall interpretation
75545-4,Noninvasive prenatal testing comment
75546-2,Trisomy 13 prior risk
75547-0,Noninvasive prenatal fetal aneuploidy and microdeletion panel
75548-8,Fetal trisomy 13 risk
Sep-54,Origanum vulgare basophil bound Ab
75549-6,Performing laboratory phone number
75550-4,Trisomy 13 prior risk
75551-2,Fetal trisomy 13 risk
75552-0,Fetal trisomy 13 risk
75553-8,Comment on fetal Trisomy 13 risk
75554-6,Trisomy 18 prior risk
75555-3,Fetal trisomy 18 risk
Jun-55,Iris germanica var florentina Ab.IgE
75556-1,Trisomy 18 prior risk
75557-9,Fetal trisomy 18 risk
75558-7,Fetal trisomy 18 risk
75559-5,Comment on fetal Trisomy 18 risk
75560-3,Trisomy 21 prior risk
75561-1,Fetal trisomy 21 risk
75562-9,Trisomy 21 prior risk
75563-7,Fetal trisomy 21 risk
Apr-56,Ovalbumin Ab.IgE
75564-5,Fetal trisomy 21 risk
75565-2,Comment on fetal Trisomy 21 risk
75566-0,Monosomy X prior risk
75567-8,Fetal monosomy X risk
75568-6,Monosomy X prior risk
75569-4,Fetal monosomy X risk
75570-2,Fetal monosomy X risk
75571-0,Comment on fetal Monosomy X risk
Feb-57,Ovomucoid Ab.IgE
75572-8,Fetal triploidy risk
75573-6,Comment on fetal Triploidy risk
75574-4,22q11.2 deletion prior risk
75575-1,22q11.2 deletion prior risk
75576-9,Fetal 22q11.2 deletion risk
75577-7,Fetal 22q11.2 deletion risk
75578-5,Fetal 22q11.2 deletion risk
75579-3,Comment on fetal 22q11.2 deletion risk
7558-0,Ostrea edulis Ab.IgE
75580-1,Prader-Willi syndrome prior risk
75581-9,Prader-Willi syndrome prior risk
75582-7,Fetal Prader-Willi syndrome risk
75583-5,Fetal Prader-Willi syndrome risk
75584-3,Fetal Prader-Willi syndrome risk
75585-0,Comment on fetal Prader-Willi syndrome risk
75586-8,Angelman syndrome prior risk
75587-6,Angelman syndrome prior risk
75588-4,Fetal Angelman syndrome risk
75589-2,Fetal Angelman syndrome risk
755-9,Neutrophils
75590-0,Fetal Angelman syndrome risk
75591-8,Comment on fetal Angelman syndrome risk
75592-6,5p deletion prior risk
75593-4,5p deletion prior risk
75594-2,Fetal 5p deletion risk
75595-9,Fetal 5p deletion risk
75596-7,Fetal 5p deletion risk
75597-5,Comment on fetal 5p deletion risk
Aug-59,Ostrea edulis Ab.IgG
75598-3,1p36 deletion prior risk
75599-1,1p36 deletion prior risk
75600-7,Fetal 1p36 deletion risk
75601-5,Fetal 1p36 deletion risk
75602-3,Fetal 1p36 deletion risk
75603-1,Comment on fetal 1p36 deletion risk
75604-9,Fetal sex
75605-6,Cell-free DNA.fetal/Cell-free DNA.total
Jun-60,Ostrea edulis basophil bound Ab
75606-4,Cell-free DNA.fetal/Cell-free DNA.total
75607-2,Paternal sample received
75608-0,Citation
75609-8,Registry report
75610-6,Oxygen therapy at arrival
75611-4,Patient seen in this ED in last 72H and discharged
75612-2,Number of visits to this healthcare entity in the last 12Mo
75613-0,ED episode of care
Apr-61,Amaranthus palmeri Ab.IgE
75614-8,Three level triage system
75615-5,Four level triage system
75616-3,Generic five level triage system
75617-1,Residence
75618-9,Comorbid condition
75619-7,National health care surveys report
75620-5,TNM clinical staging before treatment panel
75621-3,TNM pathologic staging after surgery panel
Feb-62,Paper Ab.IgE
75622-1,HIV 1 & 2 tests - Meaningful Use set
75624-7,Total score
75626-2,Total score
75627-0,Vascular adhesion protein 1
75628-8,Vascular endothelial growth factor A
75629-6,Tumor necrosis factor receptor superfamily member 1A
7563-0,Capsicum annuum Ab.IgE
75630-4,Interstitial collagenase
75631-2,Stromelysin-1
75632-0,Resistin
75633-8,Rheumatoid arthritis disease activity score
75634-6,Rheumatoid arthritis disease activity score level
75635-3,Rheumatoid arthritis disease activity panel
75636-1,Emergency severity index
75637-9,Glucose^45M post 50 g lactose PO
75638-7,Homocarnosine
75639-5,Lactate dehydrogenase.body fld/Lactate dehydrogenase.serum
75640-3,Lysozyme
75641-1,Electrolytes 3 panel
75642-9,Urate/Creatinine
75643-7,7-Hydroxymitragynine
75644-5,Amphetamine+Methamphetamine
75645-2,Butabarbital
75646-0,Ethylene glycol
75647-8,Meperidine
Aug-64,Parakeet droppings Ab.IgE
75648-6,Methylenedioxymethamphetamine+Methylenedioxyamphetamine
75649-4,Mitragynine+7-Hydroxymitragynine
75650-2,Sulfonamide
75651-0,Tetrahydrocannabivarin
75652-8,Lymphocytes.immature
75653-6,Manual differential comment
75654-4,Manual differential comment
May-65,Parakeet feather Ab.IgE
75655-1,Mononuclear cells
75656-9,Mononuclear cells
75657-7,Mononuclear cells
75658-5,Plasma cells/100 leukocytes
75659-3,Polymorphonuclear cells
75660-1,Polymorphonuclear cells
75661-9,Polymorphonuclear cells
75662-7,Polymorphonuclear cells
Mar-66,Parakeet serum Ab.IgE
75663-5,Prolymphocytes
75664-3,Human papilloma virus 16 DNA
75665-0,Ova & parasites identified
75666-8,HIV 1+2 Ab & HIV1 p24 Ag
75667-6,Electrolytes 3 panel
75668-4,Fetal sex
75669-2,Guidance for percutaneous biopsy
756-7,Neutrophils
75670-0,Views^W contrast EP
Jan-67,Parrot serum Ab.IgE
75671-8,Multisection^WO & W contrast IV
75672-6,Guidance for placement of nephrostomy tube
75673-4,Gram negative blood culture panel
75674-2,Acinetobacter sp (rpsA) gene
75675-9,Citrobacter sp (ompA+mrkC) genes
75676-7,Enterobacter sp (gyrB+metB) genes
75677-5,Proteus sp (atpD) gene
75678-3,Escherichia coli (oppA) gene
75679-1,Klebsiella pneumoniae yggE gene
75680-9,Klebsiella oxytoca (ompA) gene
75681-7,Pseudomonas aeruginosa (sodA) gene
75682-5,Bacterial cephalosporin resistance (bla(CTX-M)) gene
75683-3,Bacterial carbapenem resistance blaKPC gene
75684-1,Bacterial carbapenem resistance blaNDM gene
75685-8,Bacterial carbapenem resistance blaVIM gene
75686-6,Bacterial carbapenem resistance blaIMP gene
75687-4,Bacterial carbapenem resistance blaOXA gene
75688-2,Gram negative bacteria identified
Sep-68,Petroselinum crispum Ab.IgG
75689-0,Iron panel
75690-8,Enterococcus faecium hsp60 gene
75691-6,Peripheral sensory neuropathy grade
75692-4,Cancer detection basis
75693-2,Fetal sex
75694-0,Human papilloma virus 18+45 E6+E7 mRNA
75695-7,Human papilloma virus 18 DNA
75696-5,Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA
Jul-69,Pastinaca sativa Ab.IgE
75697-3,Bilirubin fractions panel
75698-1,Total score
75699-9,"During the past 2Ws, what was the hardest physical activity you could do for at least 2 minutes"
75700-5,"During the past 2Ws, how much have you been bothered by emotional problems such as feeling anxious, depressed, irritable or downhearted and blue"
75701-3,"During the past 2Ws, how much difficulty have you had doing your usual activities or tasks, both inside and outside the house because of your physical and emotional health"
75702-1,"During the past 2Ws, has your physical and emotional health limited your social activities with family, friends, neighbors or groups"
75703-9,"During the past 2Ws, how much bodily pain have you generally had"
75704-7,How would you rate your overall health now compared to 2Ws ago
May-70,Pisum sativum Ab.IgG
75705-4,"During the past 2Ws, how would you rate your health in general"
75706-2,"During the past 2Ws, was someone available to help you if you needed and wanted help"
75707-0,How have things been going for you during the past 2Ws
75708-8,Bruton tyrosine kinase
75709-6,Calcitonin
75710-4,Coccidioides immitis+posadasii Ab.IgM
75711-2,Date of autopsy
75712-0,Microscopic description
Mar-71,Vigna sinensis Ab.IgE
75713-8,CYP1A2 gene.c.125C>G
75714-6,CYP1A2 gene.c.-2467delT
75715-3,CYP1A2 gene.c.2473G>A
75716-1,CYP1A2 gene.c.2499A>T
75717-9,CYP1A2 gene.c.3497G>A
75718-7,CYP1A2 gene.c.3533G>A
75719-5,CYP1A2 gene.c.-3860G>A
75720-3,CYP1A2 gene.c.5090C>T
Jan-72,Vigna sinensis Ab.IgG
75721-1,CYP1A2 gene.c.5166G>A
75722-9,CYP1A2 gene.c.-163C>A
75723-7,CYP1A2 gene.c.2385G>A
75724-5,CYP1A2 gene.c.558C>A
75725-2,CYP1A2 gene.c.-729C>T
75726-0,HTR2A gene.c.-1438G>A
75727-8,HTR2A gene.c.IVS2+54538A>G
75728-6,HTR2A gene.c.74C>A
75729-4,HTR2A gene.c.1354C>T
75730-2,HTR2C gene.c.796G>C
75731-0,HTR2A gene.c.102T>C
75732-8,HTR2C gene.c.-759C>T
75733-6,AXIN2 gene mutation analysis limited to known familial mutations
75734-4,AXIN2 gene deletion+duplication & full mutation analysis
75735-1,BMPR1A gene mutation analysis limited to known familial mutations
75736-9,Lysophosphatidylcholine(16:0)
75737-7,Lysophosphatidylcholine(18:0)
75738-5,Campesterol
Sep-73,Cicer arietinus Ab.IgE
75739-3,Desmosterol
75740-1,Lathosterol
75741-9,Beta sitosterol
75742-7,Dartmouth COOP Functional Assessment Charts - 2 weeks
75743-5,Dartmouth COOP Functional Assessment Charts - 4 weeks
75744-3,Electronic health record implementation stage panel
75745-0,Electronic health record implementation stage
75746-8,Guidance for drainage of abscess+placement of chest tube
Jul-74,Pisum sativum basophil bound Ab
75747-6,Guidance for drainage of abscess+placement of chest tube
75748-4,Guidance for percutaneous aspiration of fluid
75749-2,Guidance for percutaneous aspiration of fluid
757-5,Neutrophils
75750-0,Guidance for percutaneous biopsy
75751-8,Guidance for drainage of abscess+placement of chest tube
75752-6,Guidance for drainage of abscess+placement of chest tube
75753-4,Bacterial vancomycin resistance vanD gene
Apr-75,Prunus persica Ab.IgG
75754-2,Streptobacillus moniliformis DNA
75755-9,Staphylococcus aureus.methicillin susceptible DNA
75756-7,Bacteria identified
75757-5,Chlamydia sp Ab
75758-3,Brompheniramine
75759-1,Chlorpheniramine
75760-9,Haloperidol
75761-7,Doxylamine
Feb-76,Prunus persica basophil bound Ab
75762-5,Methapyrilene
75763-3,Orphenadrine
75764-1,Tripelennamine
75765-8,Triprolidine
75766-6,fluPHENAZine
75767-4,Mesoridazine
75768-2,Prochlorperazine
75769-0,Promazine
7577-0,Arachis hypogaea basophil bound Ab
75770-8,Thioridazine
75771-6,Trifluoperazine
75772-4,Advance directives panel
75773-2,"Goals, preferences, and priorities for medical treatment"
75774-0,Allowance to change advance directive preferences in the future regardless of mental state
75775-7,"Decision to inform doctors and nurses about the role religion, faith, or spirituality play in my life"
75776-5,"Preference on consulting a supportive and palliative care team to help treat physical, emotional, and spiritual discomfort and support family"
75777-3,"Information to tell doctors if my health deteriorates due to a terminal illness and I am unable to interact meaningfully with family, friends, or surroundings"
75778-1,"Information to tell doctors if I have a severe, irreversible brain injury or illness and can't dress, feed, or bathe myself, or communicate my medical wishes, but can be kept alive"
75779-9,Thoughts on cardiopulmonary resuscitation
75780-7,Preferred location to spend final days if possible to choose
75781-5,Thoughts on organ and tissue donations
75782-3,Thoughts regarding autopsy
75783-1,Primary healthcare agent
75784-9,First alternate healthcare agent
75785-6,Second alternate healthcare agent
75786-4,Powers granted to healthcare agent
75787-2,Advance directive - request for intubation
Aug-78,Pyrus communis Ab.IgG
75788-0,Advance directive - request for tube feeding
75789-8,Advance directive - request for life support
75790-6,Advance directive - request for IV fluid and support
75791-4,Advance directive - request for antibiotics
75792-2,Advance directive - request for resuscitation that differs from cardiopulmonary resuscitation
75793-0,Other directives that have not otherwise been documented
75794-8,Assessment reference date
75795-5,Special treatments &or programs - none of above
Jun-79,Pyrus communis pollen Ab.IgE
75796-3,Physical well being - FACT-GP
75797-1,Social - family well being - FACT-GP
75798-9,Emotional well being - FANLTC
75799-7,Functional well being - FACT-GP
75800-3,Emotional well being - FACT-GP
75801-1,How have things been going for you during the past 4Ws
75802-9,"During the past 4Ws, was someone available to help you if you needed and wanted help"
75803-7,"During the past 4Ws, how would you rate your health in general"
Apr-80,Carya illinoinensis nut Ab.IgG
75804-5,How would you rate your overall health now compared to 4Ws ago
75805-2,"During the past 4Ws, how much bodily pain have you generally had"
75806-0,"During the past 4Ws, has your physical and emotional health limited your social activities with family, friends, neighbors or groups"
75807-8,"During the past 4Ws, how much difficulty have you had doing your usual activities or tasks, both inside and outside the house because of your physical and emotional health"
75808-6,"During the past 4Ws, how much have you been bothered by emotional problems such as feeling anxious, depressed, irritable or downhearted and blue"
75809-4,"During the past 4Ws, what was the hardest physical activity you could do for at least 2 minutes"
75810-2,Total score
75811-0,Antipsychotics
Feb-81,Carya illinoinensis nut basophil bound Ab
75812-8,Antihistamines
75813-6,Promethazine
75814-4,Antihistamines panel
75815-1,Antipsychotics drug panel
75816-9,Views^W contrast EP
75817-7,Guidance for drainage of abscess+placement of chest tube
75818-5,Guidance for drainage of abscess+placement of chest tube
75819-3,Erythrocyte chromasia
7582-0,Carya illinoinensis nut Ab.IgE
75820-1,"Over the past W, are you able to dress yourself, including shoelaces and buttons"
75821-9,"Over the past W, are you able to shampoo your hair"
75822-7,"Over the past W, are you able to stand up from a straight chair"
75823-5,"Over the past W, are you able to get in and out of bed"
75824-3,"Over the past W, are you able to cut your meat"
75825-0,"Over the past W, are you able to lift a full cup or glass to your mouth"
75826-8,"Over the past W, are you able to open a new milk carton"
75827-6,"Over the past W, are you able to walk outdoors on flat ground"
75828-4,"Over the past W, are you able to climb up five steps"
75829-2,"Over the past W, are you able to wash and dry your body"
758-3,Neutrophils
75830-0,"Over the past W, are you able to take a tub bath"
75831-8,"Over the past W, are you able to get on and off the toilet"
75832-6,"Over the past W, are you able to reach and get down a 5 pound object (such as a bag of sugar) from just above your head"
75833-4,"Over the past W, are you able to bend down and pick up clothing from the floor"
75834-2,"Over the past W, are you able to open car doors"
75835-9,"Over the past W, are you able to open jars which have been previously opened"
75836-7,"Over the past W, are you able to turn faucets on and off"
75837-5,"Over the past W, are you able to run errands and shop"
Aug-83,Penicillium sp Ab.IgG
75838-3,"Over the past W, are you able to get in and out of a car"
75839-1,"Over the past W, are you able to do chores such as vacuuming or yard work"
75840-9,Total score
75841-7,Total score
75842-5,Clinical disease activity index
75843-3,Simplified disease activity index
75844-1,Patient global assessment of disease activity - 0-10 numeric rating
75845-8,Total score
Jun-84,Penicillium notatum Ab.IgG
75846-6,Evaluator global assessment of disease activity - 0-10 (0.5 increments) numeric rating
75847-4,Total score
75848-2,"Over the past W, are you able to do outside work (such as yard work)"
75849-0,"Over the past W, are you able to wait in line for 15 minutes"
75850-8,"Over the past W, are you able to lift heavy objects"
75851-6,"Over the past W, are you able to move heavy objects"
75852-4,"Over the past W, are you able to go up two or more flights of stairs"
Mar-85,Penicillium notatum basophil bound Ab
75853-2,Views^W contrast VG
75854-0,PCORnet common data model set - version 1.0
75855-7,Do you sometimes drink alcoholic beverages
75856-5,Number of falls in the past 12Mo
75857-3,Access restriction by regulation
75858-1,Sterols panel
75859-9,Modified rankin scale
75860-7,Hepatitis A virus RNA & Parvovirus B19 DNA panel
Jan-86,Pepper bell Ab.IgE
75861-5,HEDIS 2015-2020 Value Set - LDL-C Tests
75862-3,HEDIS 2015-2020 Value Set - HbA1c Tests
75863-1,HEDIS 2015-2018 Value Set - Digoxin Level
75864-9,HEDIS 2015-2018 Value Set - Glucose Tests
75865-6,HEDIS 2015-2018 Value Set - PSA Test Exclusion
75866-4,HEDIS 2015-2018 Value Set - PSA Tests
75867-2,HEDIS 2015-2018 Value Set - Cholesterol Tests Other Than LDL
75868-0,HEDIS 2015 Value Sets
75869-8,"HEDIS 2015, 2016 Value Set - Pregnancy Test Exclusion"
75870-6,PROMIS short form - pain interference 8a - version 1.0
75871-4,PROMIS short form - pain interference 8a - version 1.0 raw score
75872-2,"Aids or devices usually used for dressing & grooming, arising, eating, &or walking"
75873-0,"Help from another person is usually needed for dressing & grooming, arising, eating, &or walking"
75874-8,Total score
75875-5,Total score
75876-3,Patient activity scale II
75877-1,Patient activity scale
75878-9,"Help from another person usually needed for hygiene, reach, gripping and opening things, &or errands and chores"
Sep-87,Pepper bell Ab.IgG
75879-7,"Aids or devices usually used for hygiene, reach, grip, &or activities"
75880-5,14-3-3 eta Ag
75881-3,Lupus anticoagulant three screening tests W Reflex panel
75882-1,Lupus anticoagulant three screening tests W Reflex
75883-9,dRVVT.hexagonal phase phospholipid
75884-7,Coagulation surface induced.lupus sensitive/Coagulation surface induced.lupus sensitive.excess phospholipid
75885-4,IEEE Rosetta panel
75886-2,HCV antibody screening tests - Meaningful Use set
Jul-88,Piper nigrum Ab.IgG
75887-0,HCV antibody RIBA tests - Meaningful Use set
75888-8,HCV RNA screening tests - Meaningful Use set
75889-6,How often have you had four or more drinks in one D during the past Y
75890-4,Abbreviated Injury Scale predot code
75891-2,Abbreviated Injury Scale severity score
75892-0,"t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript break points"
75893-8,Pain severity in the past W - 0-10 numeric rating
75894-6,Patient global assessment of disease activity - 0-10 (0.5 increments) numeric rating
May-89,Piper nigrum basophil bound Ab
75895-3,My child felt uneasy in past 7D
75896-1,How often does your child feel that you listen to his or her ideas
75897-9,How often does your child have fun with friends
75898-7,"In general, would you say your child's health is"
75899-5,My child got tired easily in past 7D
75900-1,"In general, how would you rate your child's mental health, including mood and ability to think"
75901-9,Rate all your child's health care in the last 12Mo
75902-7,How many D in the past W did your child miss taking one or more medications
Mar-90,Pepper cayenne Ab.IgG
75903-5,My child has a good life
75904-3,How often does your child feel really sad
75905-0,My child felt stressed in past 7D
75906-8,My child had trouble sleeping when he or she had pain in past 7D
75907-6,"In general, would you say your child's quality of life is"
75908-4,"In general, how would you rate your child's physical health"
75909-2,Are you able to reach and get down an object (such as a can of soup) from above your head
759-1,Neutrophils
75910-0,Canadian triage and acuity scale
Jan-91,Capsicum frutescens Ab.IgE
75911-8,Advance directives panel
75912-6,Observation unit stay discharge
75913-4,dRVVT.hexagonal phase phospholipid actual/Normal
75914-2,Coagulation surface induced.hexagonal phase phospholipid actual/Normal
75915-9,Air curtain status
75916-7,Bed type
75917-5,Bed state
75918-3,Bispectral index
75919-1,Cardiac output/Body surface area
75920-9,Impedance
75921-7,Electrical potential
75922-5,Fan speed
75923-3,Fresh gas.air flow
75924-1,Fresh gas.nitrous oxide flow
75925-8,Fresh gas.oxygen flow
75926-6,Heater type
75927-4,Heater power
75928-2,Hemoglobin
Sep-92,Capsicum frutescens Ab.IgG
75929-0,Relative humidity
75930-8,Relative humidity setting
75931-6,Inspiration/Expiration
75932-4,Inspiration/Inspiration+Expiration
75933-2,Intrachamber diastolic
75934-0,Nitrogen dioxide
75935-7,Nitrogen dioxide^during expiration
75936-5,Nitrogen dioxide^during inspiration
Jul-93,Capsicum frutescens basophil bound Ab
75937-3,Nitrogen dioxide^at end expiration
75938-1,Oxygen/Gas.total
75939-9,Oxygen/Gas.total setting
75940-7,Potassium
75941-5,Power spectrum.total
75942-3,Pressure^during inspiration
75943-1,Pressure^during respiratory pause
75944-9,Pupil reaction
May-94,Pepper green Ab.IgG
75945-6,Pupil reaction
75946-4,Resistance.airway
75947-2,Resistance.airway^during expiration
75948-0,Resistance.airway^during inspiration
75949-8,Response entropy
75950-6,Signal quality index
75951-4,Skin temperature setting
Feb-95,Pepper red basophil bound Ab
75952-2,SNAP index
75953-0,Spike count
75954-8,State entropy
75955-5,Temperature
75956-3,Temperature sensor
75957-1,Temperature setting
75958-9,Tidal volume.expired
75959-7,Volume.expired per minute
7596-0,Pepper white Ab.IgE
75960-5,Volume.inspired per minute
75961-3,Temperature control mode
75962-1,IEEE Rosetta cardiovascular panel
75963-9,IEEE Rosetta gas monitoring panel
75964-7,IEEE Rosetta gas delivery panel
75965-4,IEEE Rosetta temperature panel
75967-0,IEEE Rosetta laboratory panel
75968-8,IEEE Rosetta infusion panel
75969-6,IEEE Rosetta respiratory panel
75970-4,IEEE Rosetta central nervous system panel
75971-2,IEEE Rosetta skin transcutaneous panel
75973-8,IEEE Rosetta infant microenvironment panel
75974-6,KRAS gene targeted mutation analysis
75975-3,Fetal chromosome 13+18+21 trisomy
75976-1,Fetal chromosome 21 trisomy
75977-9,Fetal chromosome X & Y aneuploidy
Aug-97,Pepper white Ab.IgG
75978-7,Fetal chromosome 18 trisomy
75979-5,Fetal chromosome 13 trisomy
75980-3,Fetal chromosome 13+18+21+X+Y aneuploidy
75981-1,Fetal chromosome 13 trisomy
75982-9,Fetal chromosome 18 trisomy
75983-7,Fetal chromosome 21 trisomy
75984-5,Air delivered.case
75985-2,Air delivered.total
Jun-98,Perca spp Ab.IgG
75986-0,Velocity index
75987-8,Body temperature
75988-6,End-diastolic volume
75989-4,End-systolic volume
75990-2,Energy expended
75991-0,Oxygen extraction
75992-8,Heater power
75993-6,Intravascular
Apr-99,Phadiatop Ab.IgE
75994-4,Intravascular
75995-1,Intravascular diastolic
75996-9,Intravascular mean
75997-7,Intravascular systolic
75998-5,Oxygen gas delivered.case
75999-3,Oxygen gas delivered.total
76-0,ceFAZolin
7600-0,Phospholipase Ab.IgE
76000-9,Beats.paced
76001-7,Physiological dead space
76002-5,Physiological dead space/Tidal volume
76003-3,Pressure^during inspiration on ventilator
76004-1,Pressure.occlusion
76005-8,Temperature
76006-6,Temperature difference
76007-4,Tidal volume.expired^on ventilator
76008-2,Volume.expired per minute^on ventilator
76009-0,Volume.inspired per minute^on ventilator
76010-8,Body temperature
76011-6,Body temperature
76012-4,Desflurane liquid delivered.case
76013-2,Desflurane liquid delivered.total
76014-0,Enflurane liquid delivered.case
76015-7,Enflurane liquid delivered.total
76016-5,Halothane liquid delivered.case
76017-3,Halothane liquid delivered.total
Aug-01,Phthalic anhydride Ab.IgE
76018-1,Sevoflurane liquid delivered.case
76019-9,Sevoflurane liquid delivered.total
76020-7,Delta dRVVT
76021-5,Delta aPTT
76022-3,8(9)-Cholestenol
76023-1,N-acetyl-L-aspartate/Creatinine
76024-9,Sialate/Creatinine
76025-6,Arylsulfatase C
Jun-02,Salicornia spp Ab.IgE
76026-4,Phosphomannomutase 2
76027-2,Mannose-6-phosphate isomerase
76028-0,IDUA gene full mutation analysis
76029-8,HEXB gene full mutation analysis
76030-6,IDS gene full mutation analysis
76031-4,NPC1 gene full mutation analysis
76032-2,SGSH gene full mutation analysis
76033-0,HEXA gene full mutation analysis
Apr-03,Pigeon droppings Ab.IgG
76034-8,GAA gene full mutation analysis
76035-5,ARSA gene full mutation analysis
76036-3,GLA gene full mutation analysis
76037-1,GALT gene full mutation analysis
76038-9,Tripeptidyl peptidase I
76039-7,Interleukin 2 receptor.soluble
76040-5,levoFLOXacin 1.0 ug/mL
76041-3,levoFLOXacin 2.0 ug/mL
Feb-04,Pigweed common Ab.IgE
76042-1,levoFLOXacin 4.0 ug/mL
76043-9,Moxifloxacin 0.5 ug/mL
76044-7,Moxifloxacin 1.0 ug/mL
76045-4,Moxifloxacin 2.0 ug/mL
76046-2,IEEE Rosetta body measurement panel
76047-0,ST amplitude.lead V1
76048-8,ST amplitude.lead V2
76049-6,ST amplitude.lead V3
76050-4,ST amplitude.lead V4
76051-2,ST amplitude.lead V5
76052-0,ST amplitude.lead V6
76053-8,ST amplitude.lead I
76054-6,ST amplitude.lead II
76055-3,ST amplitude.lead III
76056-1,ST amplitude.lead aVF
76057-9,ST amplitude.lead aVL
76058-7,ST amplitude.lead aVR
Sep-05,Pigweed Ab.IgG
76059-5,Anesthetic agent.XXX
76060-3,Initiating cause or condition of death
76061-1,Other significant causes or conditions of death
76062-9,Schistocytes/100 cells
76063-7,MSH2 gene+MLH1 gene+MSH6 gene mutation analysis limited to known familial mutations
76064-5,Rheumatoid arthritis disease activity score confidence interval
76065-2,6p25 & 6q23 & 11q & 8q24 & 9p21 chromosome partial aneuploidy
76066-0,Abbreviated Injury Scale version code
Jul-06,Pigweed basophil bound Ab
76067-8,Abbreviated Injury Scale panel
76068-6,MBL2 gene targeted mutation analysis
76069-4,Erythrocytes.hypochromic/100 erythrocytes
76070-2,Adenovirus DNA
76071-0,Aspergillus sp DNA
76072-8,Enterovirus D68 RNA
76073-6,Fungus identified
76074-4,Enterovirus RNA
May-07,Pinus strobus Ab.IgE
76075-1,Galactomannan Ag
76076-9,Haemophilus ducreyi DNA
76077-7,Influenza virus A RNA
76078-5,Influenza virus A RNA
76079-3,Influenza virus B RNA
76080-1,Influenza virus B RNA
76081-9,Staphylococcus aureus.methicillin resistant isolate
76082-7,Microscopic observation
Mar-08,Pinus taeda Ab.IgE
76083-5,Microscopic observation
76084-3,Parainfluenza virus 1 RNA
76085-0,Parainfluenza virus 2 RNA
76086-8,Parainfluenza virus 3 RNA
76087-6,Parainfluenza virus 4 RNA
76088-4,Respiratory syncytial virus RNA
76089-2,Respiratory syncytial virus RNA
760-9,Neutrophils
76090-0,Erythrocytes.hyperchromic/100 erythrocytes
Jan-09,Pinus radiata Ab.IgE
76091-8,Respiratory pathogens DNA & RNA 4 panel
76092-6,Gradient.systole.max
76093-4,Nitric oxide
76094-2,Xenon
76095-9,Carbon dioxide^during expiration
76096-7,Carbon dioxide^during inspiration
76097-5,Helium^during expiration
76098-3,Helium^during inspiration
76099-1,Nitric oxide^during expiration
76100-7,Nitric oxide^during inspiration
76101-5,Nitrogen dioxide^during expiration
76102-3,Nitrogen dioxide^during inspiration
76103-1,Nitrogen^during expiration
76104-9,Nitrogen^during inspiration
76105-6,Oxygen^during expiration
76106-4,Oxygen^during inspiration
76107-2,Sevoflurane^during expiration
76108-0,Xenon^during expiration
Sep-10,Pinus ponderosa Ab.IgE
76109-8,Xenon^during inspiration
76110-6,Helium
76111-4,Nitric oxide
76112-2,Nitrogen
76113-0,Nitrogen dioxide
76114-8,Xenon
76115-5,Nitric oxide^at end expiration
76116-3,Xenon^at end expiration
Jul-11,Pinus monticola Ab.IgE
76117-1,Nitric oxide^during expiration
76118-9,Xenon^during expiration
76119-7,Helium gas delivered.case
76120-5,Nitric oxide^during inspiration
76121-3,Xenon^during inspiration
76122-1,Helium gas delivered.total
76123-9,Nitric oxide gas delivered.total
76124-7,Xenon gas delivered.case
May-12,Ananas comosus Ab.IgG
76125-4,Xenon gas delivered.total
76126-2,Premature ventricular contractions
76127-0,Argon
76128-8,Argon^during inspiration
76129-6,Argon^during expiration
76130-4,Isoflurane liquid delivered.case
76131-2,Isoflurane liquid delivered.total
76132-0,Sucrose/Creatinine
Mar-13,Pistacia vera Ab.IgE
76133-8,Sugar absorption test panel
76134-6,Sucrose^post XXX g sugar solution PO
76135-3,Inositol.free/Creatinine^post XXX g sugar solution PO
76136-1,Lactulose^post XXX g sugar solution PO
76137-9,Platelet component distribution width
76138-7,Reticulocyte distribution width
76139-5,Reticulocyte hemoglobin distribution width
76140-3,Reticulocytes.hypochromic/100 erythrocytes
Jan-14,Pitosporium basophil bound Ab
76141-1,Reticulocyte corpuscular hemoglobin concentration mean
76142-9,Lymphocytes.immature
76143-7,Cefcapene
76144-5,Cefteram
76145-2,Prulifloxacin
76146-0,Tosufloxacin
76147-8,Cefovecin
76148-6,Pradofloxacin
76149-4,Tulathromycin
76150-2,Cefquinome
76151-0,Airway pressure backup setting
76152-8,Airway pressure delta setting
76154-4,Airway pressure delta^on ventilator
Aug-15,Plantain Ab.IgE
76164-3,Pressure^on ventilator
76165-0,Alveolar ventilation^on ventilator
Jun-16,Plantago lanceolata basophil bound Ab
76166-8,Apnea duration setting
76168-4,Pressure.baseline setting
76169-2,Pressure.baseline^on ventilator
761-7,Neutrophils
76170-0,Breaths
76171-8,Breaths
76172-6,Breaths
76173-4,Breaths
Apr-17,Prunus domestica Ab.IgG
76174-2,Breaths
Feb-18,Prunus domestica pollen Ab.IgE
76184-1,Carbon dioxide
76185-8,Central apnea duration
76186-6,Expiratory hold time
76187-4,Expiratory hold time setting
76188-2,Expiratory pause time
7619-0,Poison ivy Ab.IgE
76190-8,High pressure hold time setting
76191-6,High pressure hold time
76194-0,Inflation trigger flow
76195-7,Gas flow
76196-5,Inflation trigger flow setting
76197-3,Breaths.multiple sigh delivered
76198-1,Breaths.sigh delivered
76203-9,Pressure.occlusion^negative inspiratory force maneuver
76206-2,Pressure.min^on ventilator
Aug-20,Populus nigra Ab.IgE
76210-4,Inspiratory hold time setting
76211-2,Inspiratory hold time
76212-0,Intravascular
76213-8,Intravascular diastolic
76214-6,Intravascular mean
76215-3,Intravascular systolic
Jun-21,Poplar sp Ab.IgE
76221-1,Tidal volume.inspired
76222-9,Tidal volume^on ventilator
76223-7,Inflation trigger pressure
Apr-22,Populus alba basophil bound Ab
76224-5,Inflation trigger pressure setting
76226-0,Inspiratory pause time setting
76227-8,Inspiratory pause time
76228-6,Low pressure hold time
76229-4,Low pressure hold time setting
Feb-23,Papaver somniferum Ab.IgE
76239-3,Mixed apnea duration
7624-0,Pork basophil bound Ab
76240-1,Pressure.occlusion
76241-9,Nitric oxide gas delivered.case
76242-7,Obstructive apnea duration
76243-5,Oxygen.inspiratory-oxygen.expiratory
76244-3,Positive pressure phase duration
76246-8,Pressure.positive end expiratory.intrinsic dynamic
76247-6,Pressure.positive end expiratory.total
76248-4,Pressure.positive end expiratory^on ventilator
76249-2,Expiratory pressure.max
762-5,Neutrophils
76250-0,Expiratory pressure.min
76251-8,Inspiratory pressure.min
76252-6,Pressure
76253-4,Pressure
76254-2,Pressure
76255-9,Pressure
76256-7,Pressure
Jul-25,Solanum tuberosum Ab.IgG
76257-5,Pressure
76258-3,Pressure
76259-1,Pressure.plateau^on ventilator
76260-9,Expiratory pressure
76263-3,Expiratory gas flow.max
76264-1,Inspiratory gas flow
May-26,Solanum tuberosum basophil bound Ab
76265-8,Carbon dioxide production/Body surface area
76266-6,Carbon dioxide production/Ideal body weight
76267-4,Oxygen consumption/Ideal body weight
76268-2,Pressure.ambient
76269-0,Respiratory quotient
76270-8,Breaths
76271-6,Bias flow
76272-4,Bias flow setting
Mar-27,Ipomoea batatas Ab.IgE
76273-2,Continuous flow
76274-0,Ventilation-perfusion index
76275-7,Inspiratory flow setting
76276-5,Continuous flow setting
76278-1,Body temperature
76280-7,Intramucosal pH
Jan-28,Ipomoea batatas Ab.IgG
76281-5,Arrhythmia
76282-3,Heart rate.beat-to-beat
76283-1,Blood flow rate
76284-9,Intravascular
76285-6,Intravascular
76286-4,Intravascular diastolic
76287-2,Intravascular mean
76288-0,Intravascular systolic
76295-5,Inflation phase duration
76296-3,Leak
76297-1,Stroke volume/Body surface area
76298-9,Pressure
Sep-29,Ipomoea batatas basophil bound Ab
76299-7,Time interval between start of doses
76300-3,Doses.delivered
76301-1,Doses.requested
76302-9,Infused volume.segment
76303-7,Infused volume.single container
76304-5,Infused volume.total
76305-2,Infusion dose.programmed
76306-0,Infusion dose.remaining
Jul-30,Solanum tuberosum Ab.IgG
76307-8,Infusion time.programmed
76308-6,Infusion time.remaining
76309-4,Infusion time.remaining
76310-2,Infusion volume.programmed
76311-0,Infusion volume.remaining
76312-8,PCA dose number.max
76313-6,PCA dose volume.max
76314-4,PCA lockout time
May-31,Iva axillaris Ab.IgE
76315-1,Volume.actual
76316-9,Volume.remaining
76317-7,Volume.start
76318-5,Manufacturer name
76319-3,Pump status
76320-1,Expiratory gas flow
76322-7,Systolic time ratio
Mar-32,Ligustrum vulgare Ab.IgE
76323-5,Acceleration index
76324-3,Alert type
76325-0,Communication status
76326-8,Alarm state
76327-6,Alarm trigger
76328-4,Alert priority
76329-2,Pump mode
763-3,Neutrophils.band form
76330-0,Pump mode.current
Jan-33,Ligustrum vulgare Ab.IgG
76331-8,Pump mode.set
76332-6,Reason pump stopped infusing
76334-2,Inspiratory time setting
76338-3,Porcine epidemic diarrhea virus RNA
76339-1,Porcine deltacoronavirus RNA
76340-9,Porcine deltacoronavirus RNA
76341-7,Protoporphyrin
76342-5,PROMIS short form - fatigue 4a - version 1.0
76343-3,PROMIS short form - emotional distress - depression 4a - version 1.0
76344-1,PROMIS short form - emotional distress - anxiety 4a - version 1.0
76345-8,I have trouble starting things because I am tired during the past 7D
76346-6,Microorganism identified
76347-4,Dehydroepiandrosterone sulfate/cortisol
76348-2,Pregnancy associated plasma protein A^^adjusted
Sep-34,Prune Ab.IgE
76349-0,clonazePAM
76350-8,Other cells/100 leukocytes
76351-6,Methotrexate polyglutamates
76352-4,Testosterone/Cortisol
76353-2,Licensed nursing staff
76354-0,Nurse demographics per unit or service panel
76355-7,Employment position panel
Jun-35,Psyllium seed Ab.IgE
76356-5,Nurse employment position
76357-3,Licensed nursing staff.employment position
76358-1,Licensed nursing staff.employment position/Licensed nursing staff
76359-9,Licensed nursing staff & sex panel
76360-7,Licensed nursing staff.sex
76361-5,Licensed nursing staff.sex/Licensed nursing staff
76362-3,Race or ethnicity panel
76363-1,Licensed nursing staff.race or ethnicity
Apr-36,Pullularia pullulans Ab.IgE
76364-9,Licensed nursing staff.race or ethnicity/Licensed nursing staff
76365-6,Age category panel
76366-4,Nurse age range
76367-2,Licensed nursing staff.age range
76368-0,Licensed nursing staff.age range/Licensed nursing staff
76369-8,Entry level nursing degree panel
76370-6,Entry level nursing degree
76371-4,Licensed nursing staff.entry level nursing degree
Feb-37,Pullularia sp Ab.IgE
76372-2,Licensed nursing staff.entry level nursing degree/Licensed nursing staff
76373-0,Highest level of education in a nursing degree panel
76374-8,Highest level of education in a nursing degree
76375-5,Licensed nursing staff.highest level of education in a nursing degree
76376-3,Licensed nursing staff.highest level of education in a nursing degree/Licensed nursing staff
76377-1,Highest level of education in a non-nursing degree panel
76378-9,Highest level of education in a non-nursing degree
76379-7,Licensed nursing staff.highest level of education in a non-nursing degree
7638-0,Pullularia sp Ab.IgG
76380-5,Licensed nursing staff.highest level of education in a non-nursing degree/Licensed nursing staff
76381-3,Nursing license type panel
76382-1,Primary nursing license type
76383-9,Licensed nursing staff.primary nursing license type
76384-7,Licensed nursing staff.primary nursing license type/Licensed nursing staff
76385-4,Nursing certification panel
76386-2,Nursing certification
76387-0,Licensed nursing staff.nursing certification
76388-8,Licensed nursing staff.nursing certification/Licensed nursing staff
76389-6,Employment specialty panel
76390-4,Nurse employment specialty
76391-2,Licensed nursing staff.employment specialty
76392-0,Licensed nursing staff
76393-8,National provider indentifier panel
76394-6,Registered nurse staff
76395-3,Registered nurse staff with national provider ID
76396-1,Registered nurse staff with national provider ID/Registered nurse staff
76397-9,Lymph node involvement
Aug-39,Chrysanthemum cinerariifolium Ab.IgE
76398-7,Provider has a national provider ID
76399-5,Troponin I.cardiac
76400-1,Fetal delivery information
76401-9,Albumin/Creatinine
76402-7,Myelocytes
76403-5,Blasts
76404-3,Promyelocytes
76405-0,Metamyelocytes
Jun-40,Chrysanthemum cinerariifolium basophil bound Ab
76406-8,Basophils
76407-6,Eosinophils
76408-4,Monocytes+Macrophages
76409-2,Lymphocytes
764-1,Neutrophils.band form/100 leukocytes
76410-0,Neutrophils.band form
76411-8,Neutrophils
76412-6,Sheep prion protein codon 141
76413-4,Sheep prion protein codon 112
Apr-41,Chrysothamnus nauseosus Ab.IgE
76414-2,Sheep prion protein codon 136
76415-9,Sheep prion protein codon 154
76416-7,Sheep prion protein codon 171
76417-5,First Name
76418-3,Middle Initial
76419-1,Last name
76420-9,Graduation year
76421-7,Physical therapy provider type
Feb-42,Rabbit meat Ab.IgE
76422-5,Physical therapy provider specialty
76423-3,Date of first visit
76425-8,Date of onset
76426-6,Start date for episode of care
76427-4,Visit date
76428-2,Visit charge
76429-0,Physical therapy discharge date
7643-0,Raphanus sativus Ab.IgE
76430-8,CPT units
76431-6,Physical therapy location registry ID
76432-4,Episode of care unique identifier
76433-2,Physical therapy organization registry ID
76434-0,Physical therapist registry ID
76435-7,Identifier
76437-3,Primary insurance
76438-1,Secondary insurance
76439-9,Physical therapy referral source
76440-7,Care transfer location
76441-5,Medical history relevant to physical therapy treatment
76442-3,Primary health condition
76444-9,Body function ICF code
76445-6,Body structure ICF code
76446-4,Activities and participation ICF code
76447-2,General Health
Aug-44,Raphanus sativus Ab.IgG
76448-0,CPT billing code
76449-8,Primary functional limitation
76450-6,Current severity of limitation
76451-4,Projected goal of limitation
76452-2,APTA Registry patient registration panel
76453-0,Physical therapy initial visit panel
76454-8,Physical therapy subsequent visit panel
May-45,Ambrosia ambrosioides Ab.IgE
76455-5,Physical therapy reexamination panel
76456-3,Physical therapy conclusion of care panel
76457-1,Physical therapy provider residency or fellowship
76458-9,Email address
76459-7,Physical therapy billing diagnosis code
76460-5,Physical Activity
76462-1,Reason for discharge
Mar-46,Ambrosia elatior Ab.IgG
76463-9,APTA Registry provider data panel
76464-7,American Physical Therapy Association Registry panel
76465-4,Surgical history relevant to physical therapy ICD9 diagnosis code
76466-2,Surgical history relevant to physical therapy ICD9 procedure code
76467-0,Surgical history relevant to physical therapy treatment
76468-8,National provider ID
76469-6,Name
76470-4,Federal employer tax ID
Jan-47,Ambrosia dumosa Ab.IgE
76471-2,Organization episode of care unique identifier
76472-0,Other health condition
76473-8,APTA Registry patient episode of care panel
76474-6,Ghrelin
76475-3,Cortisone.free
76476-1,Heart rate
76477-9,Heart rate
76478-7,Acetylcholinesterase panel
76479-5,Acetylcholinesterase
76480-3,Albumin
76481-1,Alpha 1 antitrypsin
76482-9,Apolipoprotein B
76483-7,Apolipoprotein A-I
76484-5,Beta-2-Microglobulin
76485-2,C reactive protein
76486-0,C reactive protein
76487-8,IgA
76488-6,IgE
Sep-48,Franseria acanthicarpa basophil bound Ab
76489-4,IgG
76490-2,IgG
76491-0,IgM
76492-8,Amphetamine+Methamphetamine
76493-6,Nitrazepam
76494-4,Tacrolimus
76495-1,Titanium
76496-9,Complement C4
Jul-49,Ambrosia trifida basophil bound Ab
76497-7,Polymorphonuclear cells
76498-5,Cervical cells.overexpressing HPV E6+E7 mRNA/cervical cells
76499-3,"Humiliation, Afraid, Rape, and Kick questionnaire"
76500-8,"Within the last Y, have you been humiliated or emotionally abused in other ways by your partner or ex-partner"
76501-6,"Within the last Y, have you been afraid of your partner or ex-partner"
76502-4,"Within the last Y, have you been raped or forced to have any kind of sexual activity by your partner or ex-partner"
76503-2,"Within the last Y, have you been kicked, hit, slapped, or otherwise physically hurt by your partner or ex-partner"
76504-0,Total score
May-50,Ambrosia elatior Ab.IgE
76505-7,Highest pressure ulcer stage
76506-5,Social connection and isolation panel
76508-1,"In a typical W, how many times do you talk on the telephone with family, friends, or neighbors"
76509-9,How often do you get together with friends or relatives
76510-7,How often do you attend church or religious services
76511-5,"Do you belong to any clubs or organizations such as church groups unions, fraternal or athletic groups, or school groups"
76512-3,Social isolation score
Mar-51,Ambrosia elatior Ab.IgG
76513-1,"How hard is it for you to pay for the very basics like food, housing, medical care, and heating"
76514-9,Study observation.general
76515-6,Whether requested procedure is appropriate
76516-4,Gestational age^at birth
76517-2,Premature infant
76519-8,Cardiac output
76520-6,Transmission.infrared
Jan-52,Ambrosia elatior basophil bound Ab
76521-4,Transmission.red
76522-2,Transmission
76523-0,Plethysmogram
76524-8,Acetone
76525-5,Thoracic fluid conductivity
76526-3,Breaths^on ventilator
76527-1,Work/Body surface area
76528-9,Breaths.spontaneous
76529-7,Pressure
76530-5,Pressure.mean^on ventilator
76531-3,Pressure.max^on ventilator
76532-1,Cuff pressure
76533-9,Intravascular
76534-7,Intravascular systolic
76535-4,Intravascular diastolic
76536-2,Intravascular mean
76537-0,Cuff pressure.mean
76538-8,Cuff pressure.systolic
Sep-53,Ambrosia elatior+Ambrosia trifida Ab.IgG
76539-6,Cuff pressure.diastolic
76540-4,Pathology diagnosis ICD code
76541-2,Indication ICD code
76542-0,"Do you feel stress - tense, restless, nervous, or anxious, or unable to sleep at night because your mind is troubled all the time - these days"
76543-8,Weight management summary report
76544-6,Breast cancer 10Y risk of distant recurrence score
76545-3,Breast cancer 10Y risk of distant recurrence classification
76546-1,Breast cancer 10Y risk of distant recurrence panel
Jul-54,Ambrosia confertiflora Ab.IgE
76547-9,End-diastolic volume
76548-7,End-diastolic volume
76549-5,End-diastolic volume
76550-3,End-diastolic volume
76551-1,End-diastolic volume
76552-9,End-systolic volume
76553-7,End-systolic volume
Apr-55,Ambrosia bidentata Ab.IgE
76554-5,End-systolic volume
76555-2,End-systolic volume
76556-0,End-systolic volume
76557-8,End-systolic volume
76558-6,Stroke volume
76559-4,Stroke volume
76560-2,Stroke volume
76561-0,Stroke volume
Feb-56,Rubus idaeus Ab.IgE
76562-8,Stroke volume
76563-6,Stroke volume
76564-4,Cardiac output
76565-1,Cardiac output
76566-9,Cardiac output
76567-7,Cardiac output
76568-5,Cardiac output
76569-3,Cardiac output
7657-0,Rubus idaeus Ab.IgG
76570-1,Cardiac output
76571-9,Cardiac output
76572-7,Streptococcus pneumoniae nanA gene
76573-5,Moraxella catarrhalis g1b gene
76574-3,Haemophilus influenzae lex2 gene
76575-0,Bacterial 16S rRNA
76576-8,Serratia marcescens gyrB gene
76577-6,Staphylococcus aureus sau3AI gene
76578-4,Pseudomonas aeruginosa regA gene
76579-2,Enterococcus faecium sodA gene
765-8,Neutrophils.hypersegmented
76580-0,Candida albicans its gene
76581-8,Streptococcus pyogenes csrS gene
76582-6,Streptococcus agalactiae cfb gene
76583-4,Klebsiella pneumoniae phoE gene
76584-2,Enterococcus faecalis cpn60 gene
76585-9,Wound microorganism gene identification panel
76586-7,ENT microorganism gene identification panel
76587-5,Streptococcus pneumoniae nanA gene
Aug-58,Rubus idaeus basophil bound Ab
76588-3,Moraxella catarrhalis g1b gene
76589-1,Haemophilus influenzae lex2 gene
76590-9,Bacterial 16S rRNA
76591-7,Serratia marcescens gyrB gene
76592-5,Staphylococcus aureus sau3AI gene
76593-3,Pseudomonas aeruginosa regA gene
76594-1,Enterococcus faecium sodA gene
76595-8,Candida albicans its gene
Jun-59,Rat hair Ab.IgE
76596-6,Streptococcus pyogenes csrS gene
76597-4,Streptococcus agalactiae cfb gene
76598-2,Klebsiella pneumoniae phoE gene
76599-0,Enterococcus faecalis cpn60 gene
76600-6,Streptococcus pneumoniae nanA gene
76601-4,Moraxella catarrhalis g1b gene
76602-2,Haemophilus influenzae lex2 gene
76603-0,Bacterial 16S rRNA
Apr-60,Rat muliialgro Ab.IgE
76604-8,Serratia marcescens gyrB gene
76605-5,Staphylococcus aureus sau3AI gene
76606-3,Pseudomonas aeruginosa regA gene
76607-1,Enterococcus faecium sodA gene
76608-9,Candida albicans its gene
76609-7,Streptococcus pyogenes csrS gene
76610-5,Streptococcus agalactiae cfb gene
76611-3,Klebsiella pneumoniae phoE gene
Feb-61,Snapper red Ab.IgE
76612-1,Enterococcus faecalis cpn60 gene
76613-9,Transferrin.carbohydrate deficient.pentasialo+hexasialo/Transferrin.total
76614-7,Lysosomal acid lipase
76615-4,Lysosomal acid lipase
76616-2,Mitochondrial respiratory chain enzymes
76617-0,Mitochondrial respiratory chain enzymes
76618-8,Mitochondrial respiratory chain enzymes
76619-6,Mitochondrial respiratory chain enzymes
7662-0,Snapper red Ab.IgG
76620-4,Mitochondrial respiratory chain enzymes
76621-2,Lysosomal acid lipase panel
76622-0,Lysosomal acid lipase
76623-8,Mitochondrial respiratory chain enzyme analysis panel
76624-6,Mitochondrial respiratory chain enzyme analysis
76625-3,Alanine aminotransferase
76626-1,Measles virus
76627-9,Rifapentine
76628-7,Norovirus genogroup I & II RNA
76629-5,Glucose^post CFst
76630-3,Amylase
76631-1,Albumin
76632-9,Enterovirus sp
76633-7,Glomerular filtration rate/1.73 sq M.predicted
76634-5,QTc interval
76635-2,QTc interval
76636-0,R wave amplitude.V5+S wave amplitude.V1
76637-8,Beats.total
Aug-63,Sequoia spp dust Ab.IgE
76638-6,RR interval
76639-4,RR interval
76640-2,Coronary artery catheterization study
76641-0,Neurology study
76642-8,Percutaneous coronary intervention study
76643-6,RR interval.standard deviation
76644-4,RR interval.coefficient of variation
76645-1,Stress test type
Jun-64,Sequoia spp Ab.IgE
76646-9,R wave amplitude.V6+S wave amplitude.V1
76647-7,Strontium
76648-5,Palladium
76649-3,Germanium
76650-1,Gadolinium
76651-9,Zinc transporter 8 Ab
76652-7,Thorium
Mar-65,Rhodotorula spp Ab.IgE
76653-5,Barium
76654-3,Beryllium
76655-0,Tungsten
76656-8,Phosphate
76657-6,Iodine
76658-4,Zirconium
76659-2,Antipsychotics drug panel
766-6,Neutrophils.hypersegmented
76660-0,Phosphatidylethanol
Jan-66,Rhodotorula spp Ab.IgE
76661-8,Sex
76662-6,Instructions
76663-4,Race or ethnicity
76664-2,Fetal chromosome X & Y aneuploidy
76665-9,Protein^1st tube
76666-7,Protein^2nd tube
76667-5,Protein^3rd tube
76668-3,Protein^4th tube
76669-1,Glucose^1st tube
76670-9,Glucose^2nd tube
76671-7,Glucose^3rd tube
76672-5,Glucose^4th tube
76673-3,Erythrocytes^1st tube
76674-1,Leukocytes^1st tube
76675-8,Appearance^1st tube
76676-6,Appearance^2nd tube
76677-4,Appearance^3rd tube
76678-2,Appearance^4th tube
Sep-67,Rheum spp Ab.IgE
76679-0,Color^1st tube
76680-8,Color^2nd tube
76681-6,Color^3rd tube
76682-4,Color^4th tube
76683-2,Mean platelet component
76684-0,Mean platelet dry mass
76685-7,Platelet dry mass distribution width
76686-5,Reticulocyte cellular hemoglobin distribution width
Jul-68,Oryza sativa Ab.IgG
76687-3,Mycobacterium sp identified
76688-1,Alpha-1-acid glycoprotein/Creatinine
76689-9,Sex assigned^at birth
76690-7,Sexual orientation
76691-5,Gender identity
76692-3,Fungus identified
76693-1,Bacteria identified
76694-9,APTA Registry organization data panel
May-69,Oryza sativa basophil bound Ab
76695-6,Postal code
76696-4,Name
76697-2,APTA Registry identifiers panel
76698-0,Identifier assigning authority
76699-8,Filaria identified
76700-4,PROMIS short form - physical function 4a - version 1.0
76701-2,PROMIS short form - satisfaction with participation in social roles 8a - version 1.0
76702-0,PROMIS short form - physical function 20a - version 1.0
Mar-70,Rubber tree brazilian Ab.IgE
76703-8,PROMIS short form - sleep disturbance 6a - version 1.0
76704-6,PROMIS short form - satisfaction with participation in social roles 4a - version 1.0
76705-3,Trichomonas vaginalis
76706-1,I have to limit my regular family activities
76707-9,I have to limit the things I do for fun with others
76708-7,I have trouble doing all of the family activities that I want to do
76709-5,I have trouble doing all of my usual work (include work at home)
76710-3,I have trouble doing all of the work that is really important to me (include work at home)
Jan-71,Salsola kali Ab.IgG
76711-1,I have to limit my regular activities with friends
76712-9,I have trouble doing all of the activities with friends that I want to do
76713-7,Do you have someone with whom to have fun
76714-5,Do you have someone with whom to relax
76715-2,Do you have someone with whom you can do something enjoyable
76716-0,Do you have someone to keep you company at home
76717-8,Do you have someone to go with you to an event
76718-6,Can you find companionship when you want it
76719-4,I have someone who will listen to me when I need to talk
76720-2,I have someone to confide in or talk to about myself or my problems
76721-0,I have someone with whom to share my most private worries and fears
76722-8,I have someone who understands my problems
76723-6,I have someone who makes me feel appreciated
76724-4,I have someone I trust to talk with about my feelings
76725-1,I have someone to talk with when I have a bad day
76726-9,I have someone I trust to talk with about my problems
76727-7,I have someone to give me good advice about a crisis if I need it
76728-5,I have someone to turn to for suggestions about how to deal with a problem
Sep-72,Puccinia graminis triticu Ab.IgE
76729-3,I have someone to give me information if I need it
76730-1,I get useful advice about important things in life
76731-9,PROMIS short form - ability to participate in social roles and activities 8a - version 2.0
76732-7,PROMIS short form - companionship 4a - version 2.0
76733-5,PROMIS short form - companionship 6a - version 2.0
76734-3,PROMIS short form - emotional support 6a - version 2.0
76735-0,PROMIS short form - emotional support 4a - version 2.0
76736-8,PROMIS short form - emotional support 8a - version 2.0
Jul-73,Secale cereale basophil bound Ab
76737-6,I am satisfied with my ability to do things for my family
76738-4,I am satisfied with my ability to do the work that is really important to me (include work at home)
76739-2,I am satisfied with my ability to do things for fun outside my home
767-4,Neutrophils.hypersegmented/100 leukocytes
76740-0,I am satisfied with my ability to do things for fun with others
76741-8,I feel good about my ability to do things for my friends
76742-6,I am satisfied with my ability to meet the needs of my family
76743-4,I am satisfied with my ability to meet the needs of my friends
76744-2,I am satisfied with my ability to perform my daily routines
May-74,Secale cereale Ab.IgE
76745-9,I can get helpful advice from others when dealing with a problem
76746-7,I have people I can turn to for help with my problems
76747-5,Other people help me get information when I have a problem
76748-3,My friends have useful information to help me with my problems
76749-1,Is someone available to help you if you need it
76750-9,Do you have someone to help you if you are confined to bed
76751-7,Do you have someone to take you to the doctor if you need it
Feb-75,Secale cereale Ab.IgG
76752-5,Do you have someone to prepare your meals if you are unable to do it yourself
76753-3,Do you have someone to help with your daily chores if you are sick
76754-1,Do you have someone to help you clean up around the home if you need it
76755-8,Do you have someone to run errands if you need it
76756-6,Do you have someone to take over all of your responsibilities at home if you need it
76757-4,I feel isolated even when I am not alone
76758-2,I feel that people avoid talking to me
76759-0,I feel detached from other people
7676-0,Carthamus tinctorius Ab.IgE
76760-8,I feel like a stranger to those around me
76761-6,I feel left out
76762-4,I feel that people barely know me
76763-2,I feel isolated from others
76764-0,I feel that people are around me but not with me
76765-7,Phosphatidylcholine.saturated
76766-5,Treponema pallidum PolA gene
76767-3,Schistosoma sp identified
76768-1,Hemoglobin
76769-9,Hemoglobin
76770-7,Trace elements panel
76771-5,Respiratory pathogens RNA 8 panel
76772-3,Plasmodium falciparum Ag
76773-1,Heptacarboxylporphyrin
76774-9,PROMIS item bank - satisfaction with social roles and activities - version 2.0
76775-6,I am satisfied with the extent of my social activities outside my home
76776-4,I am satisfied with my current level of family activities
76777-2,I am satisfied with my ability to maintain friendships
Aug-77,Carthamus tinctorius Ab.IgG
76778-0,I am satisfied with how often I go out for entertainment
76779-8,I am satisfied with my ability to socialize with friends
76780-6,I am satisfied with the amount of time I spend doing leisure activities
76781-4,I am satisfied with the amount of time I spend doing leisure activities with others
76782-2,I am satisfied with how much work I can do (include work at home)
76783-0,I feel good about my ability to do things for my family
76784-8,I am satisfied with my current level of social activity
76785-5,I am satisfied with my ability to participate in family activities
Jun-78,Salvia officinalis Ab.IgE
76786-3,I am satisfied with my ability to do all of the community activities that are really important to me
76787-1,PROMIS item bank - ability to participate in social roles and activities - version 2.0
76788-9,PROMIS item bank - companionship - version 2.0
76789-7,PROMIS item bank - emotional support - version 2.0
76790-5,PROMIS item bank - informational support - version 2.0
76791-3,PROMIS item bank - instrumental support - version 2.0
76792-1,PROMIS short form - informational support 4a - version 2.0
76793-9,PROMIS short form - informational support 6a - version 2.0
Apr-79,Salvia officinalis Ab.IgE
76794-7,PROMIS short form - informational support 8a - version 2.0
76795-4,PROMIS short form - instrumental support 4a - version 2.0
76796-2,PROMIS short form - instrumental support 6a - version 2.0
76797-0,PROMIS short form - instrumental support 8a - version 2.0
76798-8,PROMIS short form - satisfaction with social roles and activities 4a - version 2.0
76799-6,PROMIS short form - satisfaction with social roles and activities 6a - version 2.0
76800-2,PROMIS short form - satisfaction with social roles and activities 8a - version 2.0
76801-0,PROMIS short form - social isolation 4a - version 2.0
Feb-80,Salvia officinalis Ab.IgG
76802-8,PROMIS short form - social isolation 6a - version 2.0
76803-6,PROMIS short form - social isolation 8a - version 2.0
76804-4,PROMIS short form - physical function 6b - version 1.2
76805-1,PROMIS short form - physical function 8b - version 1.2
76806-9,PROMIS item bank - social isolation - version 2.0
76807-7,I am satisfied with my ability to do things for my friends
76808-5,I am satisfied with the amount of time I spend doing work (include work at home)
76809-3,I am happy with how much I do for my family
7681-0,Artemisia tridentata Ab.IgE
76810-1,I am satisfied with my ability to do leisure activities
76811-9,I am satisfied with my ability to do leisure activities with others
76812-7,I am satisfied with my ability to work (include work at home)
76813-5,I am satisfied with my current level of activities with my friends
76814-3,I am satisfied with my ability to engage in activities with friends
76815-0,The quality of my work is as good as I want it to be (include work at home)
76816-8,I am happy with how much I do for my friends
76817-6,I am satisfied with the amount of time I spend visiting friends
76818-4,I am satisfied with the amount of time I spend performing my daily routines
76819-2,I am satisfied with the amount of time I spend doing things for my family
768-2,Neutrophils.segmented
76820-0,I am satisfied with my ability to do household chores and tasks
76821-8,I am satisfied with the extent of my social activities with groups of people
76822-6,I am satisfied with my ability to keep in touch with others
76823-4,I am satisfied with my ability to do regular personal and household responsibilities
76824-2,I am satisfied with my ability to do regular personal responsibilities
76825-9,"I am satisfied with my ability to do things for fun at home (like reading, listening to music, etc.)"
76826-7,I am satisfied with my ability to meet the needs of those who depend on me
76827-5,I am satisfied with my ability to run errands
Aug-82,Artemisia tridentata Ab.IgG
76828-3,I am satisfied with my ability to run errands for others
76829-1,I am satisfied with my ability to do all of the leisure activities that are really important to me
76830-9,I am satisfied with my ability to do all of the group activities that are really important to me
76831-7,I have trouble doing my regular daily work around the house
76832-5,I have trouble meeting the needs of my friends
76833-3,I have to limit social activities at home
76834-1,I have trouble meeting the needs of my family
76835-8,I am limited in doing my work (include work at home)
Jun-83,Artemisia californica Ab.IgE
76836-6,I have to limit social activities outside my home
76837-4,I have trouble participating in recreational activities with others
76838-2,I have trouble doing everything for my family that I feel I should do
76839-0,I have trouble accomplishing my usual work (include work at home)
76840-8,I have trouble doing all of the family activities that I feel I should do
76841-6,I have trouble doing all of the family activities that are really important to me
76842-4,I have trouble doing everything for work that I want to do (include work at home)
76843-2,I have to limit social activities with groups of people
Apr-84,Artemisia tridentata Ab.IgE
76844-0,I have to do my work for shorter periods of time than usual (include work at home)
76845-7,I feel limited in the amount of time I have for my family
76846-5,I have trouble doing all of the activities with friends that are really important to me
76847-3,I have trouble doing all the leisure activities with others that I want to do
76848-1,I have trouble keeping up with my family responsibilities
76849-9,I have trouble taking care of my regular personal responsibilities
76850-7,I have trouble doing everything for my friends that I want to do
Jan-85,Salmo salar Ab.IgG
76851-5,I have trouble doing all of the activities with friends that I feel I should do
76852-3,I have trouble doing all of the work that I feel I should do (include work at home)
76853-1,I feel limited in my ability to visit friends
76854-9,I have trouble keeping in touch with others
76855-6,I have trouble keeping up with my work responsibilities (include work at home)
76856-4,I have trouble doing everything for my friends that I feel I should do
76857-2,I feel limited in the amount of time I have to visit friends
76858-0,Do you have someone to help you get your mind off things if you need it
76859-8,Do you have someone you can call when you want to chat
76860-6,Do you have someone with whom you can celebrate holidays
76861-4,Do you have someone with whom you can celebrate special occasions
76862-2,Do you have someone to call if you are bored
76863-0,Do you get invitations to go out and do things with other people
76864-8,I have people who I can talk to about my health
76865-5,I feel close to my friends
76866-3,I get emotional support from my family
76867-1,I have someone who makes me feel needed
76868-9,I have people who care about what happens to me
Sep-86,Saltbush Ab.IgE
76869-7,I get love and affection
76870-5,I feel there are people who really understand me
76871-3,There are people I can talk to
76872-1,I get support from my friends
76873-9,I feel close to my partner (or the person who is my main support)
76874-7,My family has useful information to help me with my problems
76875-4,I have someone to talk with about money matters
76876-2,Do you have someone to bring you to an appointment if you need it
Jul-87,Saltbush annual Ab.IgE
76877-0,Could you get a friend or family member to help move furniture around your home if you need it
76878-8,Do you have someone to pick up a prescription if you need it
76879-6,Could you get a friend or family member to help fix something at home if you need it
76880-4,Could you get a friend or family member to help you with your finances if you need it
76881-2,Could you get a friend or family member to help you if you have financial problems
76882-0,I find that friends or relatives have difficulty talking with me about my health
76883-8,People get the wrong idea about my situation
76884-6,I feel that some of my friends avoid me
May-88,Sardine Ab.IgG
76885-3,I feel that some of my family members avoid me
76886-1,I feel that I am no longer close to anyone
76887-9,I feel that I am alone in my interests and ideas
76888-7,I like being alone
76889-5,PROMIS item bank - alcohol - positive expectancies - version 1.0
76890-3,People are outgoing when they drink
76891-1,People have more desire for sex when they drink
76892-9,People sleep better when they drink
Mar-89,Savinase Ab.IgE
76893-7,People have more fun at social occasions when they drink
76894-5,Alcohol makes it easier to talk to people
76895-2,Drinking eases physical pain
76896-0,People forget their problems when they drink
76897-8,Drinking improves a person's mood
76898-6,People feel happy when they drink
76899-4,PROMIS item bank - alcohol - alcohol use - version 1.0
769-0,Neutrophils.segmented/100 leukocytes
76900-0,Did you drink any type of alcoholic beverage in past 30D
Jan-90,Atriplex polycarpa Ab.IgE
76901-8,I spent too much time drinking in past 30D
76902-6,I finished several drinks fast to get a quick effect in past 30D
76903-4,I became drunk or intoxicated in past 30D
76904-2,"On a typical day when I drank alcohol, I had..."
76905-9,I spent a whole weekend drinking in past 30D
76906-7,I drank heavily at a single sitting in past 30D
76907-5,I drank too much in past 30D
76908-3,I drank throughout the day in past 30D
76909-1,The largest number of drinks that I had in a single day in past 30D was...
76910-9,I used alcohol and other drugs together to get high in past 30D
76911-7,"In a typical week in past 30D, I drank..."
76912-5,I drank more than planned in past 30D
76913-3,I had an urge to continue drinking once I started in past 30D
76914-1,I felt that I should cut down on my drinking in past 30D
76915-8,I had trouble controlling my drinking in past 30D
76916-6,It was difficult for me to stop drinking after one or two drinks in past 30D
76917-4,I had urges to drink in past 30D
76918-2,I had cravings for alcohol in past 30D
Sep-91,Pecten spp Ab.IgE
76919-0,I felt I needed help for my drinking in past 30D
76920-8,I had trouble stopping drinking when I wanted to in past 30D
76921-6,It was difficult to get the thought of drinking out of my mind in past 30D
76922-4,I drank when I was alone in past 30D
76923-2,I drank because I had nothing to do in past 30D
76924-0,I drank when I arrived at home in past 30D
76925-7,I drank because I was angry with myself in past 30D
76926-5,I drank because someone made me angry in past 30D
Jul-92,Pecten spp Ab.IgG
76927-3,I drank because I was irritable in past 30D
76928-1,I drank because I deserved it in past 30D
76929-9,I drank because I was annoyed in past 30D
76930-7,I drank because I felt tense in past 30D
76931-5,I drank at the end of a busy day in past 30D
76932-3,I drank because I was nervous in past 30D
76933-1,I drank because I was sad in past 30D
76934-9,I drank because I was lonely in past 30D
May-93,Schistosoma sp Ab.IgE
76935-6,I drank because I was depressed in past 30D
76936-4,I drank because I had physical pain in past 30D
76937-2,I drank because I was bored in past 30D
76938-0,PROMIS item bank - alcohol - negative consequences - version 1.0
76939-8,PROMIS item bank - alcohol - positive outcomes - version 1.0
76940-6,PROMIS item bank - alcohol - negative expectancies - version 1.0
76941-4,People have trouble thinking when they drink
76942-2,People feel sick the day after drinking
Mar-94,Scorpion Ab.IgE
76943-0,People do things they regret while drinking
76944-8,People make bad decisions when they drink
76945-5,Drinking is harmful to mental health
76946-3,People are careless when they drink
76947-1,People are irresponsible when they drink
76948-9,People are pushy when they drink
76949-7,People are rude when they drink
7695-0,Cytisus scoparius Ab.IgE
76950-5,Drinking can be harmful to physical health
76951-3,People are selfish when they drink
76952-1,I worried when I drank in past 30D
76953-9,I felt angry when I drank in past 30D
76954-7,I felt nervous when I drank in past 30D
76955-4,My problems seemed worse when I drank in past 30D
76956-2,I had trouble keeping appointments after I drank in past 30D
76957-0,I got confused when I drank in past 30D
76958-8,I took risks when I drank in past 30D
76959-6,I was critical of myself when I drank in past 30D
76960-4,I felt guilty when I drank in past 30D
76961-2,I had a headache after I drank in past 30D
76962-0,I got sick when I drank in past 30D
76963-8,I felt anxious when I drank in past 30D
76964-6,I was clumsy when I drank in past 30D
76965-3,I was unreliable after I drank in past 30D
76966-1,Others complained about my drinking in past 30D
76967-9,I was criticized about my drinking in past 30D
Aug-96,Sesamum indicum Ab.IgG
76968-7,I got in an argument when I drank in past 30D
76969-5,I was loud when I drank in past 30D
76970-3,I felt sad when I drank in past 30D
76971-1,Drinking created problems between me and others in past 30D
76972-9,I said or did embarrassing things when I drank in past 30D
76973-7,I lied about my drinking in past 30D
76974-5,I disappointed others when I drank in past 30D
76975-2,Others had trouble counting on me when I drank in past 30D
Jun-97,Sesamum indicum basophil bound Ab
76976-0,I looked sloppy when I drank in past 30D
76977-8,I felt dizzy when I drank in past 30D
76978-6,I had a hangover after I drank in past 30D
76979-4,I used poor judgment when I drank in past 30D
76980-2,I had trouble getting things done after I drank in past 30D
76981-0,I was inconsiderate when I drank in past 30D
76982-8,I had trouble trusting other people when I drank in past 30D
76983-6,My future seemed better when I drank in past 30D
Apr-98,Sheep epithelium basophil bound Ab
76984-4,I was able to express myself better when I drank in past 30D
76985-1,I felt comfortable around others when I drank in past 30D
76986-9,I felt relaxed when I drank in past 30D
76987-7,I felt at ease when I drank in past 30D
76988-5,I felt good about myself when I drank in past 30D
76989-3,I felt happy when I drank in past 30D
76990-1,I felt a sense of control when I drank in past 30D
76991-9,I felt like I could do anything when I drank in past 30D
Feb-99,Rumex acetosella basophil bound Ab
76992-7,I calmed down when I drank in past 30D
76993-5,I felt creative when I drank in past 30D
76994-3,I felt outgoing when I drank in past 30D
76995-0,I enjoyed life when I drank in past 30D
76996-8,I felt confident when I drank in past 30D
76997-6,I slept better after I drank in past 30D
76998-4,I could relax when I drank in past 30D
76999-2,I fit in better when I drank in past 30D
77000-8,I had more fun when I drank in past 30D
77001-6,I had more desire for sex when I drank in past 30D
77002-4,It was easier to talk to people when I drank in past 30D
77003-2,PROMIS short form - alcohol - alcohol use 7a - version 1.0
77004-0,PROMIS short form - alcohol - negative consequences 7a - version 1.0
77005-7,PROMIS short form - alcohol - negative expectancies 7a - version 1.0
77006-5,PROMIS short form - alcohol - positive expectancies 7a - version 1.0
77007-3,PROMIS short form - alcohol - positive consequences 7a - version 1.0
Aug-00,Pandalus borealis Ab.IgG
77008-1,Human coronavirus 229E+OC43 RNA
77009-9,Porphyrin fractions panel
77010-7,Urea^post dialysis/pre dialysis
77011-5,Fetal chromosome 21 trisomy
77012-3,Fetal chromosome 18 trisomy
77013-1,Fetal chromosome 13 trisomy
77014-9,Fetal trisomy 21 risk
77015-6,Fetal trisomy 18 risk
Jun-01,Pandalus borealis basophil bound Ab
77016-4,Fetal RhD antigen
77017-2,CFTR gene targeted mutation analysis
77018-0,Noninvasive prenatal fetal 13 & 18 & 21 aneuploidy panel
77019-8,Noninvasive prenatal fetal 18 & 21 aneuploidy panel
77020-6,Fetal Y chromosome
77021-4,Fetal Y chromosome
77022-2,Respiratory syncytial virus A RNA
77023-0,Respiratory syncytial virus B RNA
Apr-02,Smelt Ab.IgE
77024-8,Human metapneumovirus RNA
77025-5,Rhinovirus RNA
77026-3,Influenza virus A H1 RNA
77027-1,Influenza virus A H3 RNA
77028-9,Influenza virus A H1 2009 pandemic RNA
77029-7,Respiratory pathogens DNA & RNA 14 panel
77030-5,"t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript"
77031-3,"t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript"
Feb-03,Ustilago maydis Ab.IgE
77032-1,"t(8;14)(q24;q32)(MYC,IGH) fusion transcript"
77033-9,"t(14;16)(q32;q23)(IGH,MAF) fusion transcript"
77034-7,"inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript"
77035-4,"t(14;18)(q32;q21)(IGH,MALT1) fusion transcript"
77036-2,"t(11;18)(q21;q21)(BIRC3,MALT1) fusion transcript"
77037-0,"t(11;14)(q13;q32)(CCND1,IGH) fusion transcript"
77038-8,"t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript"
77039-6,"t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript"
7704-0,Ustilago cynodontis Ab.IgE
77040-4,"t(8;21)(q22;q22.3)(RUNX1T1,RUNX1) fusion transcript"
77041-2,"inv(3)(q21;q26.2)+t(3;3)(q21;q26.2)(PSMD2,MECOM) fusion transcript"
77042-0,"t(6;9)(p22;q34)(DEK,NUP214) fusion transcript"
77043-8,ACAD8 gene full mutation analysis
77044-6,ACAD8 gene mutation analysis limited to known familial mutations
77045-3,ACADSB gene full mutation analysis
77046-1,ACADSB gene mutation analysis limited to known familial mutations
77047-9,ACSF3 gene full mutation analysis
77048-7,ACSF3 gene mutation analysis limited to known familial mutations
77049-5,SUGCT gene full mutation analysis
77050-3,SUGCT gene mutation analysis limited to known familial mutations
77051-1,IFITM5 gene full mutation analysis
77052-9,IFITM5 gene mutation analysis limited to known familial mutations
77053-7,MTR gene full mutation analysis
77054-5,MTR gene mutation analysis limited to known familial mutations
77055-2,CYP11B1 gene full mutation analysis
77056-0,CYP11B1 gene mutation analysis limited to known familial mutations
Jul-05,Sphacelotheca cruenta Ab.IgE
77057-8,CYP17A1 gene full mutation analysis
77058-6,CYP17A1 gene mutation analysis limited to known familial mutations
77059-4,GNMT gene full mutation analysis
77060-2,GNMT gene mutation analysis limited to known familial mutations
77061-0,HPD gene full mutation analysis
77062-8,HPD gene mutation analysis limited to known familial mutations
77063-6,TAT gene full mutation analysis
77064-4,TAT gene mutation analysis limited to known familial mutations
May-06,Sphacelotheca cruenta Ab.IgG
77065-1,AHCY gene full mutation analysis
77066-9,AHCY gene mutation analysis limited to known familial mutations
77067-7,SEPT9 gene targeted mutation analysis
77068-5,AGA gene full mutation analysis
77069-3,AGA gene mutation analysis limited to known familial mutations
77070-1,PLOD2 gene full mutation analysis
77071-9,PLOD2 gene mutation analysis limited to known familial mutations
77072-7,ATP5A1 gene full mutation analysis
Mar-07,Ustilago avenae Ab.IgE
77073-5,ATP5A1 gene mutation analysis limited to known familial mutations
77074-3,C12orf65 gene full mutation analysis
77075-0,C12orf65 gene mutation analysis limited to known familial mutations
77076-8,MRPL40 gene full mutation analysis
77077-6,MRPL40 gene mutation analysis limited to known familial mutations
77078-4,MTFMT gene full mutation analysis
77079-2,MTFMT gene mutation analysis limited to known familial mutations
770-8,Neutrophils/100 leukocytes
77080-0,SERPINF1 gene full mutation analysis
Jan-08,Ustilago tritici Ab.IgE
77081-8,SERPINF1 gene mutation analysis limited to known familial mutations
77082-6,FARS2 gene full mutation analysis
77083-4,FARS2 gene mutation analysis limited to known familial mutations
77084-2,ALPL gene full mutation analysis
77085-9,ALPL gene mutation analysis limited to known familial mutations
77086-7,TYROBP gene full mutation analysis
77087-5,TYROBP gene mutation analysis limited to known familial mutations
77088-3,GFM1 gene full mutation analysis
77089-1,GFM1 gene mutation analysis limited to known familial mutations
77090-9,TFB1M gene full mutation analysis
77091-7,TFB1M gene mutation analysis limited to known familial mutations
77092-5,MRRF gene full mutation analysis
77093-3,MRRF gene mutation analysis limited to known familial mutations
77094-1,MRPS2 gene full mutation analysis
77095-8,MRPS2 gene mutation analysis limited to known familial mutations
77096-6,MRPS22 gene full mutation analysis
77097-4,MRPS22 gene mutation analysis limited to known familial mutations
77098-2,MRPL44 gene full mutation analysis
Sep-09,Solea solea Ab.IgE
77099-0,MRPL44 gene mutation analysis limited to known familial mutations
77100-6,MRPS18A gene full mutation analysis
77101-4,MRPS18A gene mutation analysis limited to known familial mutations
77102-2,NARS2 gene full mutation analysis
77103-0,NARS2 gene mutation analysis limited to known familial mutations
77104-8,HARS2 gene full mutation analysis
77105-5,HARS2 gene mutation analysis limited to known familial mutations
77106-3,SARS2 gene full mutation analysis
Jul-10,Solea solea Ab.IgG
77107-1,SARS2 gene mutation analysis limited to known familial mutations
77108-9,AARS2 gene full mutation analysis
77109-7,AARS2 gene mutation analysis limited to known familial mutations
77110-5,KARS gene full mutation analysis
77111-3,KARS gene mutation analysis limited to known familial mutations
77112-1,PLOD3 gene full mutation analysis
77113-9,PLOD3 gene mutation analysis limited to known familial mutations
77114-7,FBN1 gene full mutation analysis
May-11,Spinacia oleracea Ab.IgG
77115-4,FKBP10 gene full mutation analysis
77116-2,FKBP10 gene mutation analysis limited to known familial mutations
77117-0,RPGRIP1 gene full mutation analysis
77118-8,RPGRIP1 gene mutation analysis limited to known familial mutations
77119-6,RPGR gene full mutation analysis
77120-4,RPGR gene mutation analysis limited to known familial mutations
77121-2,DFNB31 gene full mutation analysis
77122-0,DFNB31 gene mutation analysis limited to known familial mutations
Mar-12,Spondylocladium atrovirens Ab.IgE
77123-8,GPR98 gene full mutation analysis
77124-6,GPR98 gene mutation analysis limited to known familial mutations
77125-3,PCDH15 gene full mutation analysis
77126-1,PCDH15 gene mutation analysis limited to known familial mutations
77127-9,USH1C gene full mutation analysis
77128-7,USH1C gene mutation analysis limited to known familial mutations
77129-5,CERKL gene full mutation analysis
77130-3,CERKL gene mutation analysis limited to known familial mutations
Jan-13,Squash Ab.IgE
77131-1,CDHR1 gene full mutation analysis
77132-9,CDHR1 gene mutation analysis limited to known familial mutations
77133-7,LCA5 gene full mutation analysis
77134-5,LCA5 gene mutation analysis limited to known familial mutations
77135-2,Glucose
77136-0,Urea
77137-8,Bilirubin
77138-6,Chloride
77139-4,Sodium
77140-2,Creatinine
77141-0,Alkaline phosphatase
77142-8,Potassium
77143-6,Carbon dioxide
77144-4,Alanine aminotransferase
77145-1,Glucose^post CFst
77146-9,Amylase
77147-7,Glomerular filtration rate/1.73 sq M.predicted
77148-5,Albumin
Sep-14,Squash summer Ab.IgE
77149-3,Specimen.dry weight/total
77150-1,Energy content
77151-9,Energy content panel
77152-7,Cardiac arrest event outcome
77153-5,Transport mode descriptors
77154-3,Hospital inpatient destination
77155-0,Hospital designation capability
Jun-15,Squash summer Ab.IgG
77156-8,EMS level of care capability
77157-6,Response mode descriptors
77158-4,Albumin
77159-2,Erythrocytes.ghost cells
771-6,Erythrocytes.nucleated
77160-0,Functional outcome score
77161-8,Prothrombin.activity^immediately after addition of factor II depleted plasma
77162-6,Anidulafungin
77163-4,Alpha-1-Microglobulin
Apr-16,Squash yellow Ab.IgE
77164-2,Karyotype
77165-9,Anaplasma phagocytophilum & Ehrlichia chaffeensis IgG panel
77166-7,Chlamydia sp Ab.IgG & IgM panel
77167-5,cycloSPORINE^3H post dose
77168-3,cycloSPORINE^4H post dose
77169-1,cycloSPORINE^1H post dose
77170-9,PDGFRA gene.p.Asp842Val
77171-7,KIT gene exon 11 targeted mutation analysis
Feb-17,Squash yellow Ab.IgG
77172-5,KIT gene exon 9 targeted mutation analysis
77173-3,Hepatocyte growth factor receptor Ag
77174-1,CALR gene exon 9 targeted mutation analysis
77175-8,Coxiella burnetii phase 1 & 2 Ab.IgG & IgM panel
77176-6,Hepatitis B virus little e Ag & Ab panel
77177-4,IgG
77178-2,Boron
77179-0,Niobium
7718-0,Squash zucchini Ab.IgE
77180-8,Niobium
77181-6,Niobium
77182-4,Niobium
77183-2,Niobium
77184-0,Niobium/Creatinine
77185-7,Uranium
77186-5,Uranium
77187-3,Zirconium
77188-1,Zirconium
77189-9,Zirconium/Creatinine
77190-7,Hepatitis B virus core & surface Ab & surface Ag panel
77191-5,Human epididymis protein 4
77192-3,Prealbumin
77193-1,Bacteria identified
77194-9,Intravascular systolic.tibial artery/Brachial artery
77195-6,Cardio-ankle vascular index
77196-4,Pulse wave velocity
77197-2,Noninvasive arteriosclerosis studies panel
Aug-19,Staphylococcus aureus Ab.IgE
77198-0,Noninvasive arteriosclerosis study
77199-8,Evoked potential study
77200-4,SI gene targeted mutation analysis
77201-2,Buprenorphine+Norbuprenorphine
77202-0,Laboratory comment
77203-8,Ustilago nuda+Ustilago tritici+Ustilago maydis+Tilletia tritici Ab.IgE
77204-6,Buprenorphine
77205-3,Buprenorphine
Jun-20,Stemphylium solani Ab.IgE
77206-1,Norbuprenorphine
77207-9,Naloxone
77208-7,Salivary gland protein 1 Ab.IgA
77209-5,Salivary gland protein 1 Ab.IgM
77210-3,Salivary gland protein 1 Ab.IgG
77211-1,Carbonic anhydrase 6 Ab.IgA
77212-9,Carbonic anhydrase 6 Ab.IgG
77213-7,Carbonic anhydrase 6 Ab.IgM
Apr-21,Fragaria vesca Ab.IgG
77214-5,Parotid secretory protein Ab.IgA
77215-2,Parotid secretory protein Ab.IgG
77216-0,Parotid secretory protein Ab.IgM
77217-8,Salivary gland protein 1 & Carbonic anhydrase 6 & Parotid secretory protein Ab.IgA & IgG & IgM panel
77218-6,Patient satisfaction with healthcare delivery
77219-4,Provider satisfaction with healthcare delivery
77220-2,Niobium
77221-0,"Clinical knowledge, decision making, & mental workload panel"
Feb-22,Fragaria vesca basophil bound Ab
77222-8,Knowledge required level
77223-6,Nursing staff.knowledge required level/Nursing staff
77224-4,Decision making required level
77225-1,Nursing staff.decision making required level/Nursing staff
77226-9,Workload dimensions panel
77227-7,Time load level
77228-5,Nursing staff.time load level/Nursing staff
77229-3,Mental effort load level
7723-0,Saccharum officinarum Ab.IgE
77230-1,Nursing staff.mental effort load level/Nursing staff
77231-9,Psychological stress load level
77232-7,Nursing staff.psychological stress load level/Nursing staff
77233-5,Body fat percentage
77234-3,How often in the past 12Mo would you say the patient was worried or stressed about having enough money to buy nutritious meals
77235-0,"On a typical weekday in the past W, how much time did the patient spend watching TV &or DVDs"
77236-8,"On a typical weekend D in the past W, how much time did the patient spend watching TV &or DVDs"
77237-6,"On a typical weekday in the past W, how much time did the patient spend playing video games and computer games"
77238-4,"On a typical weekend D in the past W, how much time did the patient spend playing video games and computer games"
77239-2,Is the patient fed something other than breast milk or formula
772-4,Erythrocytes.nucleated
77240-0,How much formula does the patient drink per D
77241-8,Is the patient having any problems breastfeeding
77242-6,Physical activity behavior
77243-4,Dietary behavior
77244-2,Total combined household income range in last 12Mo
77245-9,Readiness for change for improved nutrition
77246-7,Readiness for change for improved sleep patterns
77247-5,Readiness for change for improved exercise
Aug-24,Saccharum officinarum Ab.IgG
77248-3,Readiness for change for improved screen-time
77249-1,Weight management summary - recommended IHE set
77250-9,Mumps virus IgG & IgM panel
77251-7,Percent impairment - confidence
77252-5,Percent impairment - difficulty
77253-3,Albumin/Creatinine
77254-1,Albumin/Creatinine
May-25,Helianthus annuus Ab.IgG
77255-8,"Nursing staff job positions, quantity, turnover, & retention panel"
77256-6,Nursing staff quantity panel
77257-4,Actual nursing staff
77258-2,Full time equivalent hours of actual nursing staff
77259-0,Budgeted nursing staff
77260-8,Full time equivalent hours of budgeted nursing staff
77261-6,Nursing staff.voluntary turnover.transfer/nursing staff
77262-4,Nursing staff.voluntary turnover/nursing staff
Mar-26,Helianthus annuus pollen Ab.IgE
77263-2,Productive staff
77264-0,New nursing staff
77265-7,New nursing staff who remained
77266-5,New nursing staff who left
77267-3,Nursing staff at beginning
77268-1,Nursing staff at beginning who remained
77269-9,Nursing staff at beginning who left
77270-7,Nursing staff who left
Jan-27,Helianthus annuus seed basophil bound Ab
77271-5,Mean number of nursing staff
77272-3,Unfilled nursing staff job positions
77273-1,Nursing staff turnover panel
77274-9,Nursing staff.voluntary turnover.terminate/nursing staff
77275-6,Nursing staff.involuntary turnover/nursing staff
77276-4,Nursing staff who left/Mean number of nursing staff
77277-2,Unfilled nursing staff job positions/Mean number of nursing staff
77278-0,Budgeted nursing staff job positions filled
77279-8,Nursing staff retention panel
77280-6,New nursing staff/Mean number of nursing staff
77281-4,Nursing staff at beginning who remained/Mean number of nursing staff
77282-2,Nursing staff at beginning who left/Mean number of nursing staff
77283-0,New nursing staff who remained/Mean number of nursing staff
77284-8,Nursing staff job positions panel
77285-5,New nursing staff who left/Mean number of nursing staff
77286-3,Direct care staff
77287-1,"Management, administrative, &or support staff"
77288-9,Indexing - warning letter alert
Sep-28,Xiphias gladius Ab.IgE
77289-7,Identification of suspect product & notification
77290-5,Lactation
77291-3,Females & males of reproductive potential
77292-1,eFacility
77293-9,Ds per W of moderate to vigorous physical activity
77294-7,"Yesterday, how many times did the patient eat any vegetables"
77295-4,"Yesterday, how many times did the patient drink bottles or glasses of water"
77296-2,"Yesterday, how many times did the patient drink 100% fruit juice"
Jul-29,Xiphias gladius Ab.IgG
77297-0,"Yesterday, how many times did the patient drink any punch, Kool-Aid, Tampico, other fruit-flavored drinks, or sports drinks"
77298-8,"Yesterday, how many times did the patient eat food from any type of restaurant"
77299-6,"Yesterday, how many times the patient eat fruit"
77300-2,"Yesterday, how many times did the patient drink any regular (not diet) sodas or soft drinks"
77301-0,Reason care action performed or not
77302-8,Patient preference for care action
77303-6,Provider preference for care action
77304-4,Radiation dose
May-30,Platanus occidentalis Ab.IgE
77305-1,Transferred from
77306-9,Discharge disposition
77307-7,Lead
77308-5,"Yesterday, did the patient eat French fries or chips"
77309-3,Acylcarnitine pattern
77310-1,Measles virus Ab.IgG associated observations panel
77311-9,Multisection for endograft
77312-7,Multisection^W contrast IV
Mar-31,Citrus reticulata Ab.IgE
77313-5,DNA analysis discrete sequence variation basic associated observations panel
77314-3,Chromosome analysis basic associated observations panel
77315-0,"Yesterday, what percent of snacks were healthy"
77316-8,How often have you added cereal to your baby's bottle of formula or pumped (or expressed) breast milk in the past 2W
77317-6,"In the past W, how many times were dinners prepared at home and eaten together"
77318-4,Is the patient breastfed
77319-2,Allergen.miscellaneous Ab.IgE.RAST class
773-2,Erythrocytes.nucleated/100 erythrocytes
77320-0,Benzoylecgonine
Jan-32,Citrus reticulata Ab.IgG
77321-8,Cyanide
77322-6,Amitriptyline+Nortriptyline
77323-4,diazePAM
77324-2,Flurazepam
77325-9,N-desalkylflurazepam
77326-7,LORazepam
77327-5,Triazolam
77328-3,Methadone
77329-1,Temazepam
77330-9,Protriptyline
77331-7,Nortrimipramine
77332-5,Morphine
77333-3,Imipramine+Desipramine
77334-1,Norpropoxyphene
77335-8,Propoxyphene+Norpropoxyphene
77336-6,Oxazepam
77337-4,Trimipramine+Nortrimipramine
77338-2,Indocyanine green^1M post dose indocyanine green
Sep-33,Manihot esculenta crantz Ab.IgE
77339-0,Indocyanine green^15M post dose indocyanine green
77340-8,Alpha 1 globulin
77341-6,Anion gap 4
77342-4,Beta 1 globulin
77343-2,Gamma globulin
77344-0,Colony count
77345-7,Enterobius vermicularis^2nd specimen
77346-5,Enterobius vermicularis^3rd specimen
Jul-34,Manihot esculenta crantz Ab.IgG
77347-3,Beta-2 transferrin panel
77348-1,Tacrolimus^trough
77349-9,Everolimus^trough
77350-7,Erythropoietin Ab
77351-5,Probability of suspected pulmonary embolism prior to imaging
77352-3,Thoughts on artificial nutrition and hydration
77353-1,Noninvasive colorectal cancer DNA+occult blood screening
Apr-35,Camellia sinensis Ab.IgG
77354-9,Noninvasive colorectal cancer DNA+occult blood screening
77355-6,Non-hematopoietic stem cells/100 leukocytes
77356-4,Non-hematopoietic stem cells/100 leukocytes
77357-2,Nitrogen
77358-0,Nitrogen
77359-8,Protein
77360-6,Triglyceride
77361-4,Triglyceride
Feb-36,Termamyl Ab.IgE
77362-2,N-tau methylimidazoleacetate/Creatinine
77363-0,N-tau methylimidazoleacetate/Creatinine
77364-8,"Tryptophan, kynurenin & 3-hydroxykynurenin panel"
77365-5,Nitrogen panel
77366-3,Metanephrine.free & Normetanephrine.free & 3-Methoxytyramine.free panel
77367-1,Cholinesterase^dibucaine
77368-9,HIV 1 proviral DNA
77369-7,HIV 1 RNA
7737-0,Thymus vulgaris Ab.IgE
77370-5,Procollagen type I.N-terminal propeptide
77371-3,Brassicasterol
77372-1,3-Methoxytyramine.free
77373-9,Lathosterol
77374-7,clomiPRAMINE trough & clomiPRAMINE+Norclomipramine trough & Norclomipramine panel
77375-4,Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA
77376-2,Human papilloma virus 16 & 18 & 31+33+35+39+45+51+52+56+58+59+66+68 DNA panel
77377-0,Human papilloma virus 16 & 18 & 31+33+35+39+45+51+52+56+58+59+66+68 DNA
77378-8,Human papilloma virus 16 & 18 & 31+33+35+39+45+51+52+56+58+59+66+68 DNA panel
77379-6,Human papilloma virus 16 & 18 & 31+33+35+39+45+51+52+56+58+59+66+68 DNA
77380-4,Human papilloma virus 16 & 18 & 31+33+35+39+45+51+52+56+58+59+66+68 DNA
77381-2,Protein fractions panel
77382-0,Adenovirus Ag
77383-8,Influenza virus A Ag
77384-6,Influenza virus B Ag
77385-3,Parainfluenza virus 1 Ag
77386-1,Parainfluenza virus 2 Ag
77387-9,Parainfluenza virus 3 Ag
Aug-38,Phleum pratense basophil bound Ab
77388-7,Cytomegalovirus Ag
77389-5,Respiratory syncytial virus Ag
77390-3,Respiratory syncytial virus Ag
77391-1,Parainfluenza virus 2 Ag
77392-9,Parainfluenza virus 3 Ag
77393-7,"Yesterday, how many 8-ounce portions of milk did the patient drink"
77394-5,Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA
77395-2,Human papilloma virus 18 DNA
Jun-39,Nicotiana tabacum Ab.IgG
77396-0,Human papilloma virus 16 DNA
77397-8,ABO & Rh group
77398-6,Mumps virus IgG & IgM index associated observations panel
77399-4,Human papilloma virus 16 DNA
774-0,Ovalocytes
77400-0,Human papilloma virus 18 DNA
77401-8,Admission history and physical note
77402-6,Evaluation note
77403-4,Consultation note
Apr-40,Nicotiana tabacum basophil bound Ab
77404-2,Education note
77405-9,Referral note
77406-7,Transfer summary note
77407-5,Evaluation note
77408-3,Discharge instructions
77409-1,Discharge summary note
77410-9,Discharge teaching note
77411-7,Education note
Feb-41,Nicotiana tabacum cigarette Ab.IgE
77412-5,History and physical note
77413-3,Initial evaluation note
77414-1,Transfer summary note
77415-8,Admission history and physical note
77416-6,Discharge instructions
77417-4,Discharge summary note
77418-2,Discharge teaching note
77419-0,Education note
7742-0,Lycopersicon lycopersicum basophil bound Ab
77420-8,History and physical note
77421-6,Initial evaluation note
77422-4,Procedure note
77423-2,Education note
77424-0,Initial evaluation note
77425-7,Procedure note
77426-5,Progress note
77427-3,Referral note
77428-1,Treatment plan note
77429-9,Consultation note
77430-7,Education note
77431-5,Initial evaluation note
77432-3,Referral note
77433-1,Treatment plan note
77434-9,Evaluation note
77435-6,Evaluation note
77436-4,Summary note
77437-2,Flowsheet
Aug-43,Astragalus spp Ab.IgE
77438-0,Flowsheet
77439-8,Flowsheet
77440-6,Flowsheet
77441-4,Flowsheet
77442-2,Plan of care note
77443-0,Plan of care note
77444-8,Plan of care note
77445-5,Plan of care note
Jun-44,Ailanthus altissima Ab.IgE
77446-3,Plan of care note
77447-1,Nordiazepam
77448-9,Multisection
77450-5,Multisection^W contrast IV
77451-3,Multisection for endograft
77452-1,Bilirubin
Mar-45,Trichophyton Ab.IgE
77453-9,Bone density
77454-7,Bone density
77455-4,Multisection
77456-2,Multisection^W contrast IV
77457-0,Multisection^WO & W contrast IV
77458-8,Multisection^WO contrast
77459-6,View 1
77460-4,Views
Jan-46,Trimellitic anhydride Ab.IgE
77461-2,Views 2
77462-0,Views AP+lateral+oblique
77463-8,Views Broden
77464-6,Views ski jump
77465-3,Views^standing
77466-1,Multisection^W contrast IV
77467-9,Multisection^W contrast IV
77468-7,Multisection^WO & W contrast IV
77469-5,Multisection^WO & W contrast IV
77470-3,Multisection^WO contrast
77471-1,Multisection^WO contrast
77472-9,View 1
77473-7,View 1
77474-5,View Harris
77475-2,View Harris
77476-0,View Harris
77477-8,View^standing
77478-6,Views
Sep-47,Oncorhynchus mykiss Ab.IgG
77479-4,Views
77480-2,Views
77481-0,Views 2
77482-8,Views 2
77483-6,Views 2
77484-4,Views AP+lateral
77485-1,Views AP+lateral
77486-9,Views AP+lateral
Jul-48,Tryptase Ab.IgE
77487-7,Views Broden
77488-5,Views Broden
77489-3,Views Broden
77490-1,Views ski jump
77491-9,Views ski jump
77492-7,Views ski jump
77493-5,Views^standing
77494-3,Views^standing
May-49,Thunnus albacares Ab.IgG
77495-0,Bacillus cereus
77496-8,Clostridium perfringens
77497-6,Institution inventory number
77498-4,Can pronounce ache
77499-2,Can pronounce aisle
77500-7,Can pronounce capon
77501-5,Can pronounce debt
77502-3,Can pronounce chord
Mar-50,Thunnus albacares basophil bound Ab
77503-1,Can pronounce heir
77504-9,Can pronounce deny
77505-6,Can pronounce bouquet
77506-4,Can pronounce caprice
77507-2,Can pronounce gauge
77508-0,Can pronounce worsted
77509-8,Can pronounce depot
77510-6,Can pronounce nausea
Jan-51,Turkey Ab.IgG
77511-4,Can pronounce naive
77512-2,Can pronounce subtle
77513-0,Can pronounce pugilist
77514-8,Can pronounce fetal
77515-5,Can pronounce blatant
77516-3,Can pronounce placebo
77517-1,Can pronounce hiatus
77518-9,Can pronounce smile
77519-7,Can pronounce meringue
77520-5,Can pronounce sieve
77521-3,Can pronounce chassis
77522-1,Can pronounce cellist
77523-9,Can pronounce algae
77524-7,Can pronounce superfluous
77525-4,Can pronounce chamois
77526-2,Can pronounce thyme
77527-0,Can pronounce apropos
77528-8,Can pronounce virulent
Sep-52,Turkey basophil bound Ab
77529-6,Can pronounce zealot
77530-4,Can pronounce facade
77531-2,Can pronounce cabal
77532-0,Can pronounce abstemious
77533-8,Can pronounce detente
77534-6,Can pronounce scion
77535-3,Can pronounce papyrus
77536-1,Can pronounce quadruped
Jul-53,Turkey feather Ab.IgE
77537-9,Can pronounce prelate
77538-7,Can pronounce epitome
77539-5,Can pronounce beautify
77540-3,Can pronounce hyperbole
77541-1,Can pronounce imbroglio
77542-9,Can pronounce syncope
77543-7,Correct responses count
77544-5,Data collected
May-54,Turnip Ab.IgE
77545-2,Premorbid estimate
77546-0,Incorrect responses count
77547-8,American National Adult Reading Test panel
77548-6,Client accessibility panel
77549-4,Time to access a patient
77550-2,Time to access all patients
77551-0,All patient encounters
Feb-55,Upholstery dust Ab.IgE
77552-8,Mean time to access a patient
77553-6,Distance to access a patient
77554-4,Distance to access all patients
77555-1,Mean distance to access a patient
77556-9,Method used to connect with a patient
77557-7,Time required to gather essential resources for a patient encounter
77558-5,Time required to gather essential resources for all patient encounters
77559-3,Mean time required to gather essential resources for a patient encounter
7756-0,Vanilla planifolia Ab.IgE
77560-1,Distance required to gather essential resources for a patient encounter
77561-9,Distance required to gather essential resources for all patient encounters
77562-7,Mean distance required to gather essential resources for a patient encounter
77563-5,Leukocyte esterase
77564-3,Brief Pain Inventory short form - pain interference panel
77565-0,Pain interference score
77566-8,"During the past 24H, how has pain interfered with your general activity"
77567-6,"During the past 24H, how has pain interfered with your mood"
77568-4,"During the past 24H, how has pain interfered with your walking ability"
77569-2,"During the past 24H, how has pain interfered with your normal work"
775-7,Platelet mean diameter
77570-0,"During the past 24H, how has pain interfered with your relations with other people"
77571-8,"During the past 24H, how has pain interfered with your sleep"
77572-6,"During the past 24H, how has pain interfered with your enjoyment of life"
77573-4,Withdrawal of wholesale drug distributors and third-party logistics facility report
77574-2,Global measure of physical function panel
77575-9,Condition- or population-specific panel
77576-7,Self-care and mobility panel
77577-5,Chlamydia trachomatis & Neisseria gonorrhoeae DNA panel
Aug-57,Veal Ab.IgE
77578-3,PROMIS parent proxy mobility - version 1.0 T-score
77579-1,PROMIS pediatric physical function - mobility - version 1.0 T-score
77580-9,PROMIS physical function w mobility aids - version 1.0 T-score
77581-7,Alpha 2 globulin
77582-5,International Physical Activity Questionnaire self-administered short form
77583-3,"During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, digging, aerobics, or fast bicycling for at least 10M at a time"
77584-1,How much time did you usually spend doing vigorous physical activities on one of those D
77585-8,"During the last 7D, on how many D did you do moderate physical activities like carrying light loads, bicycling at a regular pace, or doubles tennis for at least 10M at a time"
Jun-58,Veal basophil bound Ab
77586-6,How much time did you usually spend doing moderate physical activities on one of those D
77587-4,"During the last 7D, on how many D did you walk for at least 10M at a time"
77588-2,How much time did you usually spend walking on one of those D
77589-0,"During the last 7D, how much time did you usually spend sitting on a weekday"
77591-6,Walking physical activity
77592-4,Moderate physical activity
77593-2,Vigorous physical activity
Apr-59,Venison Ab.IgE
77594-0,Total physical activity
77595-7,Total physical activity score
77596-5,Transportation summary
77597-3,Orders placed
77598-1,Externally defined clinical data elements
77599-9,Additional documentation
77600-5,Interval note
77601-3,Enhanced note
Feb-60,Wall pellitory Ab.IgE
77602-1,Research study consent
77603-9,Medication treatment plan.extended
77604-7,Medication treatment plan.brief
77605-4,Influenza virus A H5 icA RNA
77606-2,Weight-for-length
77607-0,Cortisol^1M post XXX challenge
77608-8,Androstenedione^30M post XXX challenge
77609-6,Aldosterone^4H post XXX challenge
7761-0,Stizostedion vitreum Ab.IgE
77610-4,C peptide^15M post XXX challenge
77611-2,C peptide^4H post XXX challenge
77612-0,C peptide^45M post XXX challenge
77613-8,Calcitonin^1M post XXX challenge
77614-6,Calcitonin^10M post XXX challenge
77615-3,Liver stiffness
77616-1,Liver fibrosis score
77617-9,Intravascular systolic.digital artery toe left/Brachial artery
77618-7,Intravascular systolic.digital artery toe right/Brachial artery
77619-5,Fetal chromosome 13+18+21+Y aneuploidy
77620-3,Arginase-1
77621-1,Natriuretic peptide.B prohormone N-Terminal
77622-9,Natriuretic peptide.B prohormone N-Terminal
77623-7,Thyrotropin^2.5H post XXX challenge
77624-5,SMAD4 gene full mutation analysis
77625-2,ENG gene full mutation analysis
77626-0,Pyruvate kinase
77627-8,HBB gene full mutation analysis
Aug-62,Juglans spp basophil bound Ab
77628-6,PSEN2 gene targeted mutation analysis
77629-4,PARK7 gene targeted mutation analysis
77630-2,ALS2 gene targeted mutation analysis
77631-0,VAPB gene targeted mutation analysis
77632-8,ANG gene targeted mutation analysis
77633-6,TARDBP gene targeted mutation analysis
77634-4,FUS gene targeted mutation analysis
77635-1,C9orf72 gene.GGGGCC repeats
Jun-63,Juglans nigra Ab.IgE
77636-9,HLA-C
77637-7,HLA-A & B & C (class I) Ab.IgG panel
77638-5,HLA-DP & DQ & DR (class II) Ab.IgG panel
77639-3,HLA class I & II Ab.IgG panel
77640-1,HLA class I & II Ab.IgG
77641-9,HLA-A Ab.IgG
77642-7,HLA-B Ab.IgG
77643-5,HLA-C Ab.IgG
Apr-64,Walnut black western Ab.IgE
77644-3,HLA-DP Ab.IgG
77645-0,HLA-DQ Ab.IgG
77646-8,HLA-DR Ab.IgG
77647-6,Animal compounded drug label
77648-4,Indexing - biologic or drug substance
77649-2,17-Hydroxyprogesterone^10M post XXX challenge
776-5,Platelet mean volume
77650-0,17-Hydroxyprogesterone^15M post XXX challenge
Jan-65,Juglans regia Ab.IgE
77651-8,C peptide^75M post XXX challenge
77652-6,C peptide^5H post XXX challenge
77653-4,Microscopic observation
77654-2,Cells.diploid.G2 phase/100 cells
77655-9,Cells.diploid/100 cells
77656-7,Cells.diploid.S phase/100 cells
77657-5,Cells.diploid.G1 phase/100 cells
77658-3,Cells.aneuploid.G2 phase population/100 cells
77659-1,Cells.aneuploid.S phase population/100 cells
77660-9,Cells.aneuploid.G2 phase population 2/100 cells
77661-7,Cells.aneuploid.S phase population 2/100 cells
77662-5,Diploid G1 phase cell population peak channel
77663-3,Aneuploid G1 phase cell population peak channel
77664-1,Aneuploid G1 phase cell population 2 peak channel
77665-8,Dexamethasone
77666-6,Bacterial methicillin resistance mecA mRNA
77667-4,Calcitonin^2M post XXX challenge
77668-2,Calcitonin^5M post XXX challenge
Sep-66,Juglans regia pollen Ab.IgE
77669-0,Calcitonin^30M post XXX challenge
77670-8,Gastrin^pre XXX challenge
77671-6,Gastrin^1M post XXX challenge
77672-4,Gastrin^3M post XXX challenge
77673-2,Gastrin^5M post XXX challenge
77674-0,Gastrin^10M post XXX challenge
77675-7,Gastrin^15M post XXX challenge
77676-5,Gastrin^30M post XXX challenge
Jul-67,Juglans spp Ab.IgG
77677-3,Glucose^2H post meal
77678-1,Insulin-like growth factor-I^2.5H post XXX challenge
77679-9,Insulin-like growth factor-I^3H post XXX challenge
77680-7,Renin^4H post XXX challenge
77681-5,Glucose^11H post XXX challenge
77682-3,Staphylococcus aureus methicillin resistance SCCmec+orfX junction
77683-1,Thrombin activatable fibrinolysis inhibitor
77684-9,Legionella pneumophila 1 Ag
May-68,Vespula spp Ab.IgG
77685-6,HIV 1 & 2 Ab.IgG
77686-4,Intellectual impairment scale
77687-2,Thought disorder scale
77688-0,Depression scale
77689-8,Motivation or initiative scale
77690-6,Speech scale
77691-4,Salivation scale
77692-2,Swallowing scale
Mar-69,Trapa natans Ab.IgE
77693-0,Handwriting scale
77694-8,Utensils scale
77695-5,Dressing scale
77696-3,Hygiene scale
77697-1,Turning in bed and adjusting bed clothes scale
77698-9,Falling scale
77699-7,Walking freeze scale
77700-3,Walking scale
Jan-70,Citrullus lanatus Ab.IgE
77701-1,Tremor scale
77702-9,Sensory complaints related to parkinsonism scale
77703-7,Dyskinesia duration per D
77704-5,Dyskinesia disability
77705-2,Dyskinesia pain
77706-0,Early morning dystonia
77707-8,Predictable off period indicator
77708-6,Unpredictable off period indicator
77709-4,Sudden off period indicator
77710-2,Average proportion of waking day the patient is off
77711-0,"Patient has anorexia, nausea or vomiting"
77712-8,Sleep disturbances indicator
77713-6,Symptomatic orthostasis indicator
77714-4,Modified Hoen and Yahr stage
77715-1,Schwab England activities of daily living scale
77716-9,Schwab England activities of daily living with dyskinesia scale
77717-7,Unified Parkinson's Disease Rating Scale panel
77718-5,"Mentation, behavior and mood panel"
Sep-71,Citrullus lanatus Ab.IgG
77719-3,Activities of daily living panel
77720-1,Motor examination panel
77721-9,Complications of therapy panel
77722-7,Dyskinesias panel
77723-5,Clinical fluctuations panel
77724-3,Other complications panel
77725-0,Factor VIII+von Willebrand factor.ristocetin cofactor given
77726-8,Factor VIII+von Willebrand factor.ristocetin cofactor given
Jul-72,Triticum aestivum basophil bound Ab
77727-6,XXX allergen basophil bound Ab
77728-4,Serotonin release 0.2 IU/mL heparin.unfractionated
77729-2,oxyMORphone
777-3,Platelets
77730-0,oxyCODONE
77731-8,oxyCODONE+oxymorphone
77732-6,oxyCODONE+oxymorphone
77733-4,Gamma hydroxybutyrate
77734-2,Mycobacterium abscessus complex clarithromycin resistance erm(41) full length gene
May-73,Triticum aestivum pollen Ab.IgE
77735-9,Mycobacterium abscessus complex clarithromycin resistance erm(41) truncated gene
77736-7,Mycobacterium abscessus complex clarithromycin resistance erm(41) gene
77737-5,Mycobacterium abscessus complex clarithromycin resistance erm(41) gene panel
77738-3,Flush
77739-1,Hepatitis B virus surface Ag
77740-9,Norcotinine
77741-7,Streptavidin
77742-5,HTLV I & II panel
Mar-74,Cow whey Ab.IgE
77743-3,Toxocara sp Ab
77744-1,HTLV I & II Ab band pattern
77745-8,HTLV I p19-I Ab
77746-6,HTLV I gp46-I Ab
77747-4,HTLV II gp46-II Ab
77748-2,PCDH15 gene.c.733C>T
77749-0,CLRN1 gene.c.144T>G
7775-0,Whitefish Ab.IgE
77750-8,DLD gene targeted mutation analysis
77751-6,TMEM216 gene.c.218G>T
77752-4,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine cutoff"
77753-2,Tumor morphology panel
77754-0,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine cutoff"
77755-7,6-Monoacetylmorphine cutoff
77756-5,7-Aminoclonazepam cutoff
77757-3,7-Hydroxyquetiapine
77758-1,7-Hydroxyquetiapine cutoff
77759-9,9-Hydroxyrisperidone cutoff
77760-7,ARIPiprazole cutoff
77761-5,ARIPiprazole
77762-3,Alpha hydroxyalprazolam cutoff
77763-1,ALPRAZolam cutoff
77764-9,Buprenorphine cutoff
77765-6,Citalopram+Escitalopram
77766-4,clonazePAM cutoff
77767-2,Codeine cutoff
Aug-76,Whitefish Ab.IgG
77768-0,Ethanol cutoff
77769-8,Ethyl glucuronide cutoff
77770-6,HYDROmorphone cutoff
77771-4,JWH-081 5-hydroxypentyl
77772-2,Methylenedioxyethylamphetamine cutoff
77773-0,Morphine cutoff
77774-8,Norbuprenorphine cutoff
77775-5,Norfentanyl cutoff
Jun-77,Zizania spp Ab.IgE
77776-3,Norhydrocodone cutoff
77777-1,Normeperidine cutoff
77778-9,Noroxycodone cutoff
77779-7,Noroxycodone cutoff
77780-5,oxyMORphone cutoff
77781-3,Pregabalin cutoff
77782-1,PROMIS short form - alcohol - positive consequences 7a - version 1.0 raw score
77783-9,PROMIS short form - alcohol - positive expectancies 7a - version 1.0 raw score
Apr-78,Salix discolor Ab.IgE
77784-7,PROMIS alcohol - positive outcomes - version 1.0 T-score
77785-4,PROMIS alcohol - negative consequences - version 1.0 T-score
77786-2,PROMIS alcohol - positive expectancies - version 1.0 T-score
77787-0,Buprenorphine cutoff
77788-8,cloZAPine cutoff
77789-6,PROMIS alcohol - negative expectancies - version 1.0 T-score
77790-4,Cocaine cutoff
77791-2,Benzoylecgonine cutoff
Feb-79,Atriplex canescens Ab.IgE
77792-0,PROMIS short form - emotional support 4a - version 2.0 raw score
77793-8,PROMIS short form - alcohol - negative expectancies 7a - version 1.0 raw score
77794-6,PROMIS short form - alcohol - negative consequences 7a - version 1.0 raw score
77795-3,PROMIS short form - alcohol - alcohol use 7a - version 1.0 raw score
77796-1,PROMIS short form - physical function 8b - version 1.2 raw score
77797-9,PROMIS short form - physical function 6b - version 1.2 raw score
77798-7,PROMIS short form - social isolation 8a - version 2.0 raw score
77799-5,PROMIS short form - social isolation 6a - version 2.0 raw score
Aug-77,ceFAZolin
7780-0,Ceratoides arborescens Ab.IgE
77800-1,PROMIS short form - social isolation 4a - version 2.0 raw score
77801-9,PROMIS short form - satisfaction with social roles and activities 8a - version 2.0 raw score
77802-7,PROMIS short form - satisfaction with social roles and activities 6a - version 2.0 raw score
77803-5,PROMIS short form - satisfaction with social roles and activities 4a - version 2.0 raw score
77804-3,PROMIS short form - instrumental support 8a - version 2.0 raw score
77805-0,PROMIS short form - instrumental support 6a - version 2.0 raw score
77806-8,PROMIS short form - instrumental support 4a - version 2.0 raw score
77807-6,PROMIS short form - informational support 8a - version 2.0 raw score
77808-4,PROMIS short form - informational support 6a - version 2.0 raw score
77809-2,PROMIS short form - informational support 4a - version 2.0 raw score
778-1,Platelets
77810-0,PROMIS short form - emotional support 8a - version 2.0 raw score
77811-8,PROMIS short form - emotional support 6a - version 2.0 raw score
77812-6,PROMIS short form - companionship 6a - version 2.0 raw score
77813-4,PROMIS short form - companionship 4a - version 2.0 raw score
77814-2,PROMIS short form - ability to participate in social roles and activities 8a - version 2.0 raw score
77815-9,PROMIS short form - satisfaction with participation in social roles 4a - version 1.0 raw score
77816-7,PROMIS short form - sleep disturbance 6a - version 1.0 raw score
77817-5,PROMIS short form - physical function 20a - version 1.0 raw score
Aug-81,Artemisia absinthium Ab.IgG
77818-3,PROMIS short form - satisfaction with participation in social roles 8a - version 1.0 raw score
77819-1,PROMIS short form - physical function 4a - version 1.0 raw score
77820-9,PROMIS short form - emotional distress - anxiety 4a - version 1.0 raw score
77821-7,PROMIS short form - emotional distress - depression 4a - version 1.0 raw score
77822-5,PROMIS short form - fatigue 4a - version 1.0 raw score
77824-1,PROMIS short form - pain interference 8a - version 1.0 raw score
77825-8,PROMIS short form - pain intensity 3a - version 1.0 raw score
Jun-82,Dioscorea batatas Ab.IgE
77826-6,PROMIS short form - sleep disturbance 4a - version 1.0 raw score
77827-4,PROMIS short form - physical function 10a - version 1.0 raw score
77828-2,PROMIS short form - sleep impairment 8a - version 1.0 raw score
77829-0,PROMIS short form - sleep disturbance 8b - version 1.0 raw score
77830-8,PROMIS short form - satisfaction with participation in social roles 7a - version 1.0 raw score
77831-6,PROMIS short form - satisfaction with participation in DSA 7a - version 1.0 raw score
77832-4,PROMIS short form - pain behavior 7a - version 1.0 raw score
77833-2,PROMIS short form - pain interference 6b - version 1.0 raw score
Apr-83,Yeast bakers Ab.IgE
77834-0,PROMIS short form - fatigue 7a - version 1.0 raw score
77835-7,PROMIS short form - emotional distress - depression 8b - version 1.0 raw score
77836-5,PROMIS short form - emotional distress - anxiety 7a - version 1.0 raw score
77837-3,PROMIS short form - emotional distress - anger 8a - version 1.0 raw score
77838-1,PROMIS short form - global - version 1.1 raw score
77839-9,PROMIS pediatric short form - pain interference 8a - version 1.0 raw score
77840-7,PROMIS pediatric short form - fatigue 10a - version 1.0 raw score
77841-5,PROMIS pediatric short form - peer relationships 8a - version 1.0 raw score
Feb-84,Saccharomyces cerevisiae basophil bound Ab
77842-3,PROMIS pediatric short form - asthma 8a - version 1.0 raw score
77843-1,PROMIS pediatric short form - physical function - upper extremity 8a - version 1.0 raw score
77844-9,PROMIS pediatric short form - physical function - mobility 8a - version 1.0 raw score
77845-6,PROMIS pediatric short form - emotional distress - anxiety 8a - version 1.0 raw score
77846-4,PROMIS pediatric short form - emotional distress - anger - version 1.0 raw score
77847-2,PROMIS pediatric short form - depressive symptoms - version 1.0 raw score
77848-0,PROMIS alcohol - alcohol use - version 1.0 T-score
77849-8,PROMIS social isolation - version 2.0 T-score
77850-6,PROMIS instrumental support - version 2.0 T-score
77851-4,PROMIS informational support - version 2.0 T-score
77852-2,PROMIS emotional support - version 2.0 T-score
77853-0,PROMIS companionship - version 2.0 T-score
77854-8,PROMIS ability to participate in social roles and activities - version 2.0 T-score
77855-5,PROMIS satisfaction with social roles and activities - version 2.0 T-score
77856-3,PROMIS pain behavior - version 1.0 T-score
77857-1,PROMIS satisfaction with participation in roles - version 1.0 T-score
77858-9,PROMIS satisfaction with participation in DSA - version 1.0 T-score
Sep-85,Yeast brewer's basophil bound Ab
77859-7,PROMIS sleep related impairment - version 1.0 T-score
77860-5,PROMIS sleep disturbance - version 1.0 T-score
77861-3,PROMIS emotional distress - depression - version 1.0 T-score
77862-1,PROMIS emotional distress - anxiety - version 1.0 T-score
77863-9,PROMIS emotional distress - anger - version 1.0 T-score
77864-7,PROMIS fatigue - version 1.0 T-score
77865-4,PROMIS pain interference - version 1.0 T-score
77866-2,PROMIS physical function - version 1.0 T-score
Jul-86,Taxus spp Ab.IgE
77867-0,PROMIS pediatric physical function - upper extremity - version 1.0 T-score
77868-8,PROMIS pediatric peer relationships - version 1.0 T-score
77869-6,PROMIS pediatric pain interference - version 1.0 T-score
77870-4,PROMIS pediatric physical function: mobility - version 1.0 T-score
77871-2,PROMIS pediatric fatigue - version 1.0 T-score
77872-0,PROMIS pediatric asthma - version 1.0 T-score
77873-8,PROMIS pediatric emotional distress - anxiety - version 1.0 T-score
77874-6,PROMIS physical function - version 1.2 T-score
May-87,Yogurt Ab.IgE
77875-3,PROMIS pediatric short form - emotional distress - anxiety 8b - version 1.1
77876-1,Phencyclidine cutoff
77877-9,Ziprasidone
77878-7,Ziprasidone cutoff
77879-5,Tapentadol cutoff
77880-3,risperiDONE
77881-1,risperiDONE cutoff
77882-9,Dehydroaripiprazole cutoff
Mar-88,Yogurt Ab.IgG
77883-7,QUEtiapine cutoff
77884-5,Dehydroaripiprazole
77885-2,Ethyl sulfate cutoff
77886-0,Nortriptyline cutoff
77887-8,OLANZapine cutoff
77888-6,OLANZapine
77889-4,Ejection fraction
77890-2,Ejection fraction
Jan-89,Acanthocytes
77891-0,Ejection fraction
77892-8,Ejection fraction
77893-6,Myocardial mass
77894-4,Myocardial mass
77895-1,Myocardial mass
77896-9,Myocardial mass
77897-7,Myocardial mass/Body surface area
77898-5,Myocardial mass/Body surface area
77899-3,Myocardial mass/Body surface area
77900-9,Myocardial mass/Body surface area
77901-7,Minor axis.end diastole.parasternal long axis
77902-5,Minor axis.end diastole
77903-3,Excursion distance.systole
77904-1,End-systolic volume
77905-8,End-systolic volume
77906-6,End-systolic volume/Body surface area
77907-4,End-systolic volume/Body surface area
77908-2,Vena contracta diameter
Sep-90,Burr cells
77909-0,Effective regurgitant orifice area
77910-8,Effective regurgitant orifice area
77911-6,Regurgitation degree
77912-4,Stenosis degree
77913-2,Vena contracta diameter
77914-0,Effective regurgitant orifice area
77915-7,Regurgitation degree
77916-5,Stenosis degree
Jul-91,Dacryocytes
77917-3,Vena contracta diameter
77918-1,Vena contracta diameter
77919-9,Regurgitation degree
77920-7,Myocardial mass/Height exp 2.7
77921-5,Myocardial mass/Height exp 2.7
77922-3,Myocardial mass/Height exp 2.7
77923-1,Myocardial mass/Height exp 2.7
77924-9,Enterobacteriaceae.carbapenem resistant
May-92,Dohle body
77925-6,Cortisol^10M post XXX challenge
77926-4,Cortisol^3M post XXX challenge
77927-2,Cortisol^5M post XXX challenge
77928-0,Cortisol^75M post XXX challenge
77929-8,Cortisol^3.5H post XXX challenge
77930-6,Cortisol^4H post XXX challenge
77931-4,Cortisol^6H post XXX challenge
77932-2,Cortisol^8H post XXX challenge
Mar-93,Howell-Jolly bodies
77933-0,Cortisol^9H post XXX challenge
77934-8,Cortisol^9.5H post XXX challenge
77935-5,Cortisol^10H post XXX challenge
77936-3,Cortisol^10.5H post XXX challenge
77937-1,Cortisol^12H post XXX challenge
77938-9,Cortisol^124H post XXX challenge
77939-7,Corticotropin^45M post XXX challenge
77940-5,Albumin
Jan-94,Normocytic/Normochromic polychromasia
77941-3,Final patient acuity
77942-1,Cells.CD8+CD3-/100 cells
77943-9,Schistosoma mansoni+haematobium+intercalatum
77944-7,Cells.CD11a/100 cells
77945-4,Cells.CD4+CD3-/100 cells
77946-2,Cells.CD42b/100 cells
77947-0,Cells.CD9/100 cells
77948-8,Cells.FLAER/100 cells
77949-6,Streptococcus pneumoniae Ag
77950-4,Toscana virus Ab.IgM
77951-2,Toscana virus Ab.IgG
77952-0,Trypanosoma cruzi Ab
77953-8,West Nile virus Ab.IgG
77954-6,Yellow fever virus Ab.IgG
77955-3,Yellow fever virus Ab.IgM
77956-1,Yersinia enterocolitica O:3 Ab.IgG
77957-9,Yersinia enterocolitica O:9 Ab.IgG
Aug-95,Pappenheimer bodies
77958-7,Dengue virus 1 & 2 & 3 & 4 RNA
77959-5,Yellow fever virus ns5 gene
77960-3,Penicillin.parenteral
77961-1,cloZAPine
77962-9,Summary note
77963-7,Birth defects diagnosis
77964-5,Cholesterol crystals
77965-2,Immediate national notifiable condition
Jun-96,Platelet clump
77966-0,Reporting state
77967-8,Reporting county
77968-6,National reporting jurisdiction
77969-4,Jurisdiction code
77970-2,Date of initial report
77972-8,Earliest date reported to county
77973-6,Earliest date reported to state
Apr-97,Rouleaux
77974-4,Hospitalized for condition of interest
77975-1,Earliest date of diagnosis
77976-9,Illness or injury end date
77977-7,Illness duration
77978-5,Patient died from illness of interest
77979-3,Case investigation start date
77980-1,Case is associated with a known outbreak
77981-9,Case outbreak name
Feb-98,Smudge cells
77982-7,Jurisdiction where disease acquired
77983-5,Country of usual residence
77984-3,Country of exposure to illness
77985-0,State or province of exposure to illness
77986-8,City of exposure to illness
77987-6,County of exposure to illness
77988-4,Binational reporting criteria
77989-2,Disease transmission mode
779-9,Poikilocytosis
7799-0,Fibrin D-dimer
77990-0,Case class status
77991-8,Week counted for Morbidity and Mortality Weekly Report
77992-6,Year included in Morbidity and Mortality Weekly Report
77993-4,State notifiable condition case identifier
77994-2,Date of first report to Centers for Disease Control and Prevention
77995-9,Date of first report to public health department
77996-7,Pregnancy status at time of illness or condition
77997-5,Legacy case identifier
77998-3,Age at time of case investigation
77999-1,Case notification comment
78000-7,Case notification panel
78001-5,Cytomegalovirus pp65 Ag/100000 PMN cells
78002-3,CD34 dose in hematopoietic progenitor cell transfusion
78003-1,Nucleated cell dose in hematopoietic progenitor cell transfusion
78004-9,Staphylococcus aureus.vancomycin resistance
78005-6,Summary registry report
Jun-00,Phospholipid Ab
78006-4,Glomerular filtration rate/1.73 sq M
78007-2,HIV 1 proviral DNA
78008-0,HIV 1 proviral DNA
78009-8,HIV 1 proviral DNA
78010-6,HIV 1 proviral DNA
78011-4,Schistocytes/100 cells
78012-2,Streptococcus pyogenes Ag
78013-0,HLA-A & B & DRB & DQB1 panel
Apr-01,Phospholipid Ab.IgG
78014-8,HLA-A
78015-5,HLA-B
78016-3,HLA-DRB
78017-1,HLA-DQB1
78018-9,Toscana virus Ab.IgG
78019-7,Toscana virus Ab.IgM
78020-5,Admission priority
78021-3,Specialty care unit
Feb-02,Phospholipid Ab.IgM
78022-1,Care setting
78023-9,Hospital discharge disposition
78024-7,ED discharge disposition
78025-4,Outpatient visit discharge disposition
78026-2,Diagnosis present on admission
78027-0,Follow-up attempt within 24H
78028-8,Follow-up attempt outcome
78029-6,Arrived from
7803-0,Acanthamoeba sp Ab
78030-4,Type of encounter
78031-2,Multisection^WO & W contrast IV
78032-0,Multisection^WO & W contrast IV
78033-8,Hospital stay duration
78034-6,Procedure that confirmed birth defect diagnosis
78035-3,Fibers
78036-1,Fibers
78037-9,Multisection^W contrast IV
78038-7,Multisection^W contrast IV
78039-5,Discharge teaching note
78040-3,FISH probe target gene
78041-1,FISH probe target locus
78042-9,Vendor FISH product name
78043-7,Gene mutations tested for
78044-5,Disease assessed
78045-2,Disease analysis overall interpretation
78046-0,Pharmacogenomic analysis basic associated observations panel
78047-8,Cortisol^24H post XXX challenge
Aug-04,Actinomyces sp Ab
78048-6,"Are you able to dress yourself, including tying shoelaces and buttoning your clothes"
78049-4,Are you able to run or jog for two miles (3 km)
78050-2,Are you able to get up from the floor from lying on your back without help
78051-0,Are you able to run at a fast pace for two miles (3 km)
78052-8,"Does your health now limit you in hiking a couple of miles (3 km) on uneven surfaces, including hills"
78053-6,Are you able to carry two bags filled with groceries 100 yards (100 m)
78054-4,Are you able to lift 10 pounds (5 kg) above your shoulder
May-05,Adenovirus Ab
78055-1,Are you able to reach and get down a 5 pound (2 kg) object from above your head
78056-9,Are you able to lift one pound (0.5 kg) to shoulder level without bending your elbow
78057-7,Are you able to walk a block (about 100 m) on flat ground
78058-5,Are you able to run five miles (8 km)
78059-3,Does your health now limit you in climbing several flights of stairs
78060-1,Does your health now limit you in doing 2H of physical labor
78061-9,Are you able to run 100 yards (100 m)
78062-7,Are you able to run ten miles (16 km)
Mar-06,Ascaris lumbricoides Ab
78063-5,Does your health now limit you in doing 8H of physical labor
78064-3,Does your health now limit you in walking more than a mile (1.6 km)
78065-0,Does your health now limit you in climbing one flight of stairs
78066-8,Are you able to sit on and get up from the toilet
78067-6,Does your health now limit you in getting in and out of the bathtub
78068-4,Does your health now limit you in walking about the house
78069-2,I could pick up coins from a table in past 7D
780-7,Promyelocytes
78070-0,I could wash my hair by myself in past 7D
Jan-07,Aspergillus sp Ab
78071-8,I could put beads on a string in past 7D
78072-6,I could comb my hair by myself in past 7D
78073-4,I could thread a needle in past 7D
78074-2,I could jump up and down in past 7D
78075-9,I needed to sleep during the day in past 7D
78076-7,I was too tired to eat in past 7D
78077-5,Being tired made it hard for me to remember things in past 7D
78078-3,I felt tired even when I had not done anything in past 7D
78079-1,I felt sad for no reason in past 7D
78081-7,Are you able to carry a heavy object (over 10 pounds or 5 kg)
78082-5,Are you able to pull heavy objects (10 pounds or 5 kg) towards yourself
78083-3,I felt really respected by my family in past 4W
78084-1,I felt important in my family in past 4W
78085-8,I felt my family believed in me in past 4W
78086-6,My family was interested in what I was doing in past 4W
78087-4,People in my family made me feel good about myself in past 4W
78088-2,I felt totally accepted by my family in past 4W
Sep-08,Aspergillus sp Ab
78089-0,I felt that my family understood me in past 4W
78090-8,I could depend on my family in past 4W
78091-6,I got the support I needed from my family in past 4W
78092-4,I knew what I could expect from others in my family in past 4W
78093-2,I got all the help I needed from my family in past 4W
78094-0,I could talk to someone in my family if something was bothering me in past 4W
78095-7,I could talk to someone in my family about my problems in past 4W
78096-5,I knew my family would help me if I needed it in past 4W
Jul-09,Astrovirus
78097-3,I felt that I could trust the people in my family in past 4W
78098-1,I could trust others in my family in past 4W
78099-9,My family treated me fairly in past 4W
78100-5,I knew that my family would be there if I needed them in past 4W
78101-3,I felt everyone in my family loved me in past 4W
78102-1,Everyone in my family loved each other in past 4W
78103-9,I felt loved by my family in past 4W
78104-7,My family showed that they cared about me in past 4W
May-10,Astrovirus Ag
78105-4,I felt I really belonged in my family in past 4W
78106-2,I felt I had a strong relationship with my family in past 4W
78107-0,I felt very close to my family in past 4W
78108-8,It was easy to be close to everyone in my family in past 4W
78109-6,I felt a sense of togetherness with my family in past 4W
78110-4,"I believed in helping my family, no matter what in past 4W"
78111-2,I wanted to help my family however I could in past 4W
78112-0,I felt that I had similar values and beliefs as others in my family in past 4W
Mar-11,Astrovirus RNA
78113-8,I could rely on my family in past 4W
78114-6,I felt really important to my family in past 4W
78115-3,People in my family helped each other in past 4W
78116-1,I felt that my family really respected me in past 4W
78117-9,I could talk to someone in my family if I needed to in past 4W
78118-7,Everyone in my family could be completely trusted in past 4W
78119-5,Everyone in my family loved me in past 4W
78120-3,I felt that my family loved me in past 4W
Jan-12,Babesia microti Ab
78123-7,My child felt really respected by our family in past 4W
78124-5,My child felt important in our family in past 4W
78125-2,My child felt that our family believed in him or her in past 4W
78126-0,My child knew our family was interested in what he or she was doing in past 4W
78127-8,People in our family made my child feel good about himself or herself in past 4W
78128-6,My child felt totally accepted by our family in past 4W
78129-4,My child felt that our family understood him or her in past 4W
78130-2,My child felt he or she could depend on our family in past 4W
78131-0,My child felt he or she got the support he or she needed from our family in past 4W
78132-8,My child knew what he or she could expect from others in our family in past 4W
78133-6,My child felt he or she got all the help he or she needed from our family in past 4W
78134-4,My child felt he or she could talk to someone in our family if something was bothering him or her in past 4W
78135-1,My child knew he or she could talk to someone in our family about his or her problems in past 4W
78136-9,My child knew our family would help if he or she needed it in past 4W
78137-7,My child felt that he or she could trust the people in our family in past 4W
78138-5,My child knew he or she could trust others in our family in past 4W
Sep-13,Babesia sp Ab
78139-3,My child felt our family treated him or her fairly in past 4W
78140-1,My child knew that our family would be there if he or she needed them in past 4W
78141-9,My child felt everyone in our family loved him or her in past 4W
78142-7,My child felt everyone in our family loved each other in past 4W
78143-5,My child felt loved by our family in past 4W
78144-3,My child felt that our family showed that they cared about him or her in past 4W
78145-0,My child felt he or she really belonged in our family in past 4W
78146-8,My child felt he or she had a strong relationship with our family in past 4W
Jul-14,Bacillus anthracis Ab
78147-6,My child felt very close to our family in past 4W
78148-4,My child felt it was easy for him or her to be close to everyone in our family in past 4W
78149-2,My child felt a sense of togetherness with our family in past 4W
781-5,Promyelocytes
78150-0,"My child believed in helping our family, no matter what in past 4W"
78151-8,My child wanted to help our family however he or she could in past 4W
78152-6,My child felt that he or she had similar values and beliefs as others in our family in past 4W
78153-4,My child knew he or she could rely on our family in past 4W
Apr-15,Bartonella henselae Ab.IgG
78154-2,My child felt he or she was really important to our family in past 4W
78155-9,My child felt that people in our family helped each other in past 4W
78156-7,My child felt that our family really respected him or her in past 4W
78157-5,My child knew he or she could talk to someone in our family if he or she needed to in past 4W
78158-3,My child knew that everyone in our family could be completely trusted in past 4W
78159-1,My child knew everyone in our family loved him or her in past 4W
78160-9,My child felt that our family loved him or her in past 4W
78161-7,PROMIS pediatric item bank - physical function - upper extremity - version 2.0
Feb-16,Blastomyces dermatitidis Ab
78162-5,It was hard for me to be away from home because I had pain in past 7D
78163-3,It was hard to have fun with friends because I was in pain in past 7D
78164-1,I needed help walking when I was in pain in past 7D
78165-8,I walked carefully when I was in pain in past 7D
78166-6,My pain was so bad that I needed to take medicine to treat it in past 7D
78167-4,It was hard to do things with my family because I had pain in past 7D
78168-2,I felt too nervous to be with a group of kids my age in past 7D
78169-0,I worried that something might happen to my parents or guardians in past 7D
7817-0,Borrelia burgdorferi Ab.IgG
78170-8,PROMIS pediatric short form - emotional distress - anxiety 8b - version 1.1 raw score
78171-6,I was angry when things didn't go my way in past 7D
78172-4,I wanted to be alone because I was so angry in past 7D
78173-2,I was so mad I did not want to talk to people in past 7D
78174-0,I had a bad temper in past 7D
78175-7,Fractional area change
78176-5,Diameter
78177-3,Regurgitant pressure gradient.diastole.mean
78178-1,Regurgitant pressure gradient.mean
78179-9,Orifice area
78180-7,Intrachamber.systole.max
78181-5,Regurgitant velocity during diastolic rapid inflow
78182-3,Regurgitant pressure gradient.diastole.max
78183-1,Stenosis degree
78184-9,A wave duration
78185-6,Tissue velocity.E wave.max
78186-4,Tissue velocity.E wave.max
78187-2,Tissue velocity.S wave.max
Aug-18,Borrelia burgdorferi Ab.IgM
78188-0,Tissue velocity.S wave.max
78189-8,E wave/Tissue velocity.E wave.max
78190-6,E wave/Tissue velocity.E wave.max
78191-4,Blood flow.deceleration time.E wave
78192-2,Segmental wall motion
78193-0,Segmental wall motion
78194-8,Segmental wall motion
78195-5,Segmental wall motion
Jun-19,Brugia malayi Ab
78196-3,Segmental wall motion
78197-1,Segmental wall motion
78198-9,Segmental wall motion
78199-7,Study diagnosis
78200-3,Resource identifier
78201-1,4q12 chromosome region rearrangements
78202-9,9q34 chromosome region deletion
78203-7,BCL6 gene rearrangements
Apr-20,Candida albicans Ab
78204-5,CCND1 gene duplication
78205-2,ALK gene rearrangements
78206-0,4q12 chromosome region rearrangements
78207-8,9q34 chromosome region deletion
78208-6,BCL6 gene rearrangements
78209-4,CCND1 gene duplication
78210-2,ALK gene rearrangements
78211-0,Cells.4q12 chromosome region rearrangements/Cells counted
Feb-21,Chlamydophila pneumoniae rRNA
78212-8,Cells.9q34 chromosome region deletion/Cells counted
78213-6,Cells.BCL6 gene rearrangements/Cells counted
78214-4,Cells.CCND1 gene duplication/Cells counted
78215-1,MYC gene rearrangements
78216-9,TRA+TRD gene rearrangements
78217-7,RARA gene rearrangements
78218-5,BCL2 gene rearrangements
78219-3,MLL gene rearrangements
7822-0,Chlamydophila psittaci Ab
78220-1,PDGFRB gene rearrangements
78221-9,IGH gene rearrangements
78222-7,MYC gene rearrangements
78223-5,TRA+TRD gene rearrangements
78224-3,RARA gene rearrangements
78225-0,BCL2 gene rearrangements
78226-8,MLL gene rearrangements
78227-6,PDGFRB gene rearrangements
78228-4,IGH gene rearrangements
78229-2,Cells.MYC gene rearrangements/Cells counted
782-3,Promyelocytes/100 leukocytes
78230-0,Cells.RARA gene rearrangements/Cells counted
78231-8,Cells.TRA+TRD gene rearrangements/Cells counted
78232-6,Cells.BCL2 gene rearrangements/Cells counted
78233-4,Cells.ALK gene rearrangements/Cells counted
78234-2,Cells.MLL gene rearrangements/Cells counted
78235-9,Cells.PDGFRB gene rearrangements/Cells counted
78236-7,Cells.IGH gene rearrangements/Cells counted
78237-5,Chromosome 8 copy number/nucleus
Aug-23,Chlamydia sp Ab
78238-3,Chromosome 3 copy number/nucleus
78239-1,Resource identifier
78240-9,Surgical operation note
78241-7,Surgical operation note
78242-5,Surgical operation note
78243-3,Surgical operation note
78244-1,Surgical operation note
78245-8,MYB gene deletion
Jun-24,Chlamydia trachomatis Ab
78246-6,Admission history and physical note
78247-4,Admission history and physical note
78248-2,Admission history and physical note
78249-0,Admission history and physical note
78250-8,Consultation note
78251-6,Consultation note
78252-4,Consultation note
Mar-25,Coccidioides immitis Ab
78253-2,Consultation note
78254-0,Consultation note
78255-7,Diagnostic study note
78256-5,Diagnostic study note
78257-3,Diagnostic study note
78258-1,Diagnostic study note
78259-9,Diagnostic study note
78260-7,Diagnostic study note
Jan-26,Coccidioides immitis Ab.IgG
78261-5,Discharge instructions
78262-3,Discharge instructions
78263-1,Discharge summary note
78264-9,Discharge summary note
78265-6,Discharge teaching note
78266-4,Discharge teaching note
78267-2,Discharge teaching note
78268-0,Education note
78269-8,Education note
78270-6,Education note
78271-4,Education note
78272-2,Education note
78273-0,Education note
78274-8,Education note
78275-5,Education note
78276-3,Education note
78277-1,Education note
78278-9,Education note
Sep-27,Coccidioides immitis Ab.IgM
78279-7,Education note
78280-5,Education note
78281-3,Education note
Jul-28,Coxiella burnetii Ab
78290-4,Initial evaluation note
78291-2,Flowsheet
78292-0,Flowsheet
78293-8,Flowsheet
78294-6,Flowsheet
May-29,Coxiella burnetii phase 1 Ab.IgG
78295-3,Flowsheet
78296-1,Flowsheet
78297-9,Flowsheet
78298-7,Flowsheet
78299-5,Flowsheet
78300-1,Flowsheet
78301-9,Flowsheet
78302-7,Flowsheet
Mar-30,Coxiella burnetii phase 2 Ab.IgG
78303-5,Flowsheet
78304-3,Flowsheet
78305-0,Form
78306-8,History and physical note
78307-6,History and physical note
78308-4,History and physical note
78309-2,Individual counseling note
783-1,Promyelocytes/100 leukocytes
78310-0,Initial evaluation note
Jan-31,Coxiella burnetii phase 1 Ab.IgM
78311-8,Initial evaluation note
78312-6,Initial evaluation note
78313-4,Preoperative evaluation and management note
78314-2,Procedure note
78315-9,Procedure note
78316-7,Procedure note
78317-5,Procedure note
78318-3,Procedure note
78319-1,Procedure note
78320-9,Procedure note
78321-7,Procedure note
78322-5,Procedure note
78323-3,Progress note
78324-1,Progress note
78325-8,Progress note
78326-6,Progress note
78327-4,Progress note
78328-2,Progress note
Sep-32,Coxiella burnetii phase 2 Ab.IgM
78329-0,Referral note
78330-8,Referral note
78331-6,Referral note
78332-4,Referral note
78333-2,Initial evaluation note
78334-0,Initial evaluation note
78335-7,Initial evaluation note
78336-5,Initial evaluation note
Jul-33,Coxsackievirus A16 Ab
78337-3,Initial evaluation note
78338-1,Initial evaluation note
78339-9,Initial evaluation note
78340-7,Transfer summary note
78341-5,Transfer summary note
78342-3,MYB gene deletion
78343-1,Cells.MYB gene deletion/Cells counted
78344-9,Fatty acid panel.comprehensive C8-C26
May-34,Coxsackievirus A7 Ab
78345-6,Docosenoate
78346-4,Hexadecenoate
78347-2,Docosapentaenate w3
78348-0,Docosapentaenate w6
78349-8,Lauroleate
78350-6,Decenoate
78351-4,Tetradecadienoate
Feb-35,Coxsackievirus A9 Ab
78352-2,Vaccenate
78353-0,Hexadecadienoate
78354-8,Oxygen.arterial/Oxygen.alveolar
78355-5,Lymphocytes.abnormal
78356-3,Bacteria identified
78357-1,Mycobacterium tuberculosis DNA
78358-9,Acyl CoA dehydrogenases
78359-7,Acyl CoA dehydrogenases.palmitate substrate/Acyl CoA dehydrogenases.myristate substrate
7836-0,Coxsackievirus B1 Ab
78360-5,Acyl CoA dehydrogenases
78361-3,Fatty acid & triglyceride panel
78362-1,Imipramine+Desipramine^trough
78363-9,Norhydrocodone
78364-7,Amphetamine cutoff
78365-4,Imipramine trough & Imipramine+desimipramine trough & Desipramine panel
78366-2,Goose feather Ab.IgG
78367-0,Pigeon serum proteins+feathers+droppings Ab.IgG
78368-8,Parrot serum proteins+feathers+droppings Ab.IgG
78369-6,ADHD hyperactive symptoms mean score difference
78370-4,ADHD diagnostic rating scale interpretation
78371-2,ADHD inattentive symptoms mean score
78372-0,ADHD hyperactive symptoms mean score
78373-8,ADHD inattentive symptoms mean score difference
78374-6,Dermatophagoides farinae native (nDer f) 2 Ab.IgE
78375-3,Discharge diagnosis
78376-1,Epipregnanolone
78377-9,Epipregnanolone
Aug-37,Coxsackievirus B2 Ab
78378-7,PON1 gene.c.575A>G
78379-5,Epipregnanolone
78380-3,Surgical operation note
78381-1,Surgical operation note
78382-9,CFTR gene targeted mutation analysis
78383-7,Discharge teaching note
78384-5,Cat dander native (nFel d) 1 Ab.IgE
78385-2,Budgerigar serum proteins+feathers+droppings Ab.IgG
Jun-38,Coxsackievirus B3 Ab
78386-0,Admission history and physical note
78387-8,Admission history and physical note
78388-6,Admission history and physical note
78389-4,Admission history and physical note
78390-2,Admission history and physical note
78391-0,Admission history and physical note
78392-8,Admission history and physical note
Apr-39,Coxsackievirus B4 Ab
Feb-40,Coxsackievirus B5 Ab
78405-8,Consultation note
78406-6,Consultation note
78407-4,Counseling note
78408-2,Counseling note
78409-0,Daily or end of shift signout note
7841-0,Coxsackievirus B6 Ab
78410-8,Discharge instructions
78411-6,Discharge instructions
78412-4,Discharge instructions
78413-2,Discharge instructions
78414-0,Discharge instructions
78415-7,Discharge instructions
78416-5,Discharge instructions
78417-3,Discharge instructions
78418-1,Discharge summary note
78419-9,Discharge summary note
78420-7,Discharge summary note
78421-5,Discharge summary note
78422-3,Discharge teaching note
78423-1,Discharge teaching note
78424-9,Discharge teaching note
78425-6,Discharge teaching note
78426-4,Discharge teaching note
78427-2,Discharge teaching note
Aug-42,Cryptococcus neoformans Ab
78428-0,Discharge teaching note
78429-8,Education note
78430-6,Education note
78431-4,Education note
78432-2,Education note
78433-0,Soluble liver Ab.IgG
78434-8,"carBAMazepine free & total trough & 10,11-Epoxide panel"
78435-5,Mirtazapine trough & Normirtazapine panel
Jun-43,Cryptococcus sp Ab
78436-3,Primidone & PHENobarbital trough panel
78437-1,Fluoxetine trough & Fluoxetine+norfluoxetine trough & Norfluoxetine panel
78438-9,Sertraline trough & Norsertraline panel
78439-7,Phenytoin free & total trough panel
78440-5,Risperidone trough & 9-Hydroxyrisperidone panel
78441-3,Bilirubin.glucuronidated
78442-1,Bilirubin.non-glucuronidated
78443-9,"Carbamazepine 10,11-Epoxide^trough"
Apr-44,Taenia solium larva Ab.IgA
78444-7,Hepatitis A virus Ab.IgG+IgM
78445-4,Cytomegalovirus Ab.IgG avidity
78446-2,Flowsheet
78447-0,Checklist
78448-8,Checklist
78449-6,Checklist
78450-4,Education note
Jan-45,Taenia solium larva Ab.IgA
78451-2,Education note
78452-0,Education note
78453-8,Education note
78454-6,Flowsheet
78455-3,Flowsheet
78456-1,Flowsheet
78457-9,Flowsheet
78458-7,Flowsheet
78459-5,Flowsheet
78460-3,Flowsheet
78461-1,Flowsheet
78462-9,Flowsheet
78463-7,History and physical note
78464-5,History and physical note
78465-2,History and physical note
78466-0,Initial evaluation note
78467-8,Initial evaluation note
78468-6,Initial evaluation note
Sep-46,Taenia solium larva Ab.IgG
78469-4,Initial evaluation note
78470-2,Initial evaluation note
78471-0,Initial evaluation note
78472-8,Procedure note
78473-6,Procedure note
78474-4,Procedure note
78475-1,Procedure note
78476-9,Procedure note
Jul-47,Taenia solium larva Ab.IgG
78477-7,Procedure note
78478-5,Procedure note
78479-3,Progress note
78480-1,Progress note
78481-9,Progress note
78482-7,Progress note
78483-5,Referral note
78484-3,Referral note
May-48,Taenia solium larva Ab.IgM
78485-0,Restraint note
78486-8,Risk assessment and screening note
78487-6,Surgical operation note
78488-4,Transfer summary note
78489-2,Transfer summary note
784-9,Erythrocyte mean corpuscular diameter
78490-0,Transfer summary note
78491-8,Transfer summary note
78492-6,Transfer summary note
Mar-49,Taenia solium larva Ab.IgM
78493-4,Transfer summary note
78494-2,Procedure note
78495-9,Checklist
78496-7,Consultation note
78497-5,Admission history and physical note
78498-3,Consultation note
78499-1,Education note
78500-6,Flowsheet
Jan-50,Taenia solium larva Ab
78501-4,Referral note
78502-2,Transfer summary note
78503-0,Checklist
78504-8,Checklist
78505-5,Checklist
78506-3,Legal letter
78507-1,Admission history and physical note
78508-9,Admission history and physical note
78509-7,Admission history and physical note
78510-5,Admission history and physical note
78511-3,Admission history and physical note
78512-1,Summary note
78513-9,Summary of encounters note
78514-7,Neisseria meningitidis serogroups A+B+C+w135+Y+Escherichia coli K1 Ag
78515-4,Lactose^15M post dose lactose PO
78516-2,Lactose^45M post dose lactose PO
78517-0,Renin^2H post XXX challenge
78518-8,Cholesterol
Sep-51,Cytomegalovirus Ab
78519-6,Platelet aggregation.adenosine diphosphate induced^2 umol/L
78520-4,Platelet aggregation.adenosine diphosphate induced^2.5 umol/L
78521-2,Platelet aggregation.adenosine diphosphate induced^4 umol/L
78522-0,Platelet aggregation.adenosine diphosphate induced^5 umol/L
78523-8,Platelet aggregation.EPINEPHrine induced^100 umol/L
78524-6,Platelet aggregation.EPINEPHrine induced^6 umol/L
78525-3,Platelet aggregation.arachidonate induced^1.6 mmol/L
78526-1,Platelet aggregation.collagen induced^1.25 ug/mL
Jul-52,Cytomegalovirus Ab.IgG
78527-9,Platelet aggregation.collagen induced^5 ug/mL
78528-7,Platelet aggregation.ristocetin induced^1.25 mg/mL
78529-5,Adenovirus Ag
78530-3,Vesicular stomatitis New Jersey virus RNA
78531-1,Vesicular stomatitis Indiana virus RNA
78532-9,Creatinine^2H dwell specimen
78533-7,Creatinine^4H dwell specimen
78534-5,Glucose^2H dwell specimen
May-53,Cytomegalovirus Ab.IgM
78535-2,Glucose^4H dwell specimen
78536-0,Urea nitrogen^2H dwell specimen
78537-8,Urea nitrogen^4H dwell specimen
78538-6,Admission history and physical note
78539-4,Checklist
78540-2,Checklist
78541-0,Checklist
78542-8,Checklist
Mar-54,Dengue virus 1 Ab
78543-6,Checklist
78544-4,Checklist
78545-1,Checklist
7855-0,Dengue virus 1+2+3+4 RNA
785-6,Erythrocyte mean corpuscular hemoglobin
78567-5,Consultation note
Aug-56,Dengue virus 2 Ab
78568-3,Consultation note
78569-1,Counseling note
78570-9,Counseling note
78571-7,Diagnostic study note
78572-5,Diagnostic study note
78573-3,Diagnostic study note
78574-1,Diagnostic study note
78575-8,Diagnostic study note
Jun-57,Dengue virus 3 Ab
78576-6,Diagnostic study note
78577-4,Diagnostic study note
78578-2,Discharge instructions
78579-0,Discharge instructions
78580-8,Discharge instructions
78581-6,Discharge instructions
78582-4,Discharge instructions
78583-2,Discharge instructions
Apr-58,Dengue virus 4 Ab
78584-0,Discharge instructions
78585-7,Discharge summary note
78586-5,Discharge teaching note
78587-3,Discharge teaching note
78588-1,Discharge teaching note
78589-9,Discharge teaching note
78590-7,Discharge teaching note
78591-5,Discharge teaching note
Feb-59,Dengue virus Ab
78592-3,Discharge teaching note
78593-1,Education note
78594-9,Education note
78595-6,Education note
78596-4,Education note
78597-2,Education note
78598-0,Education note
78599-8,Education note
Jun-78,ceFAZolin
7860-0,Eastern equine encephalitis virus Ab.IgG
78600-4,Education note
78601-2,Education note
78602-0,Education note
78603-8,Education note
78604-6,Education note
78605-3,Education note
78606-1,Education note
78607-9,Education note
78608-7,Education note
78609-5,Education note
78610-3,Education note
78611-1,Education note
78612-9,Education note
78613-7,Education note
78614-5,Education note
78615-2,Education note
78616-0,Flowsheet
78617-8,Flowsheet
Aug-61,Eastern equine encephalitis virus Ab.IgM
78618-6,Flowsheet
78619-4,Flowsheet
78620-2,Flowsheet
78621-0,Flowsheet
78622-8,Flowsheet
78623-6,Flowsheet
78624-4,Flowsheet
78625-1,Flowsheet
Jun-62,Ebola virus Ab
78626-9,Flowsheet
78627-7,Flowsheet
78628-5,Flowsheet
78629-3,Flowsheet
78630-1,Flowsheet
78631-9,Flowsheet
78632-7,Flowsheet
78633-5,Flowsheet
Apr-63,Echinococcus sp Ab
78634-3,Flowsheet
78635-0,Flowsheet
78636-8,Flowsheet
78637-6,Flowsheet
78638-4,Flowsheet
78639-2,Flowsheet
786-4,Erythrocyte mean corpuscular hemoglobin concentration
78640-0,Flowsheet
78641-8,Flowsheet
Feb-64,Echovirus 1 Ab
78642-6,Form
78643-4,History and physical note
78644-2,Initial evaluation note
78645-9,Initial evaluation note
78646-7,Initial evaluation note
78647-5,Initial evaluation note
78648-3,Initial evaluation note
78649-1,Initial evaluation note
78650-9,Initial evaluation note
78651-7,Initial evaluation note
78652-5,Initial evaluation note
78653-3,Initial evaluation note
78654-1,Procedure note
78655-8,Procedure note
78656-6,Procedure note
78657-4,Procedure note
78658-2,Procedure note
Sep-65,Echovirus 11 Ab
78659-0,Procedure note
78660-8,Procedure note
78661-6,Procedure note
78662-4,Procedure note
78663-2,Progress note
78664-0,Progress note
78665-7,Progress note
78666-5,Progress note
Jul-66,Echovirus 19 Ab
78667-3,Progress note
78668-1,Progress note
78669-9,Progress note
78670-7,Referral note
78671-5,Referral note
78672-3,Referral note
78673-1,Referral note
78674-9,Referral note
May-67,Echovirus 3 Ab
78675-6,Referral note
78676-4,Referral note
78677-2,Referral note
78678-0,Surgical operation note
78679-8,Surgical operation note
78680-6,Transfer summary note
78681-4,Transfer summary note
78682-2,Transfer summary note
Mar-68,Echovirus 30 Ab
78683-0,Transfer summary note
78684-8,Transfer summary note
78685-5,Platelet aggregation.collagen induced
78686-3,Platelet aggregation.ristocetin induced^high dose
78687-1,Platelet aggregation.thrombin receptor activating peptide-6 induced
78688-9,Platelet aggregation.adenosine diphosphate+prostaglandin E1 induced
78689-7,Adenylosuccinate/Creatinine
78690-5,5-hydroxymethyluracil/Creatinine
Jan-69,Echovirus 4 Ab
78691-3,Guanosine/Creatinine
78692-1,Pseudouridine/Creatinine
78693-9,Dihydrothymine/Creatinine
78694-7,Dihydroorotate/Creatinine
78695-4,Guanine/Creatinine
78696-2,Selenium
78697-0,Olea europaea Ab.IgG
78698-8,Liver fibrosis score panel
78699-6,Liver fibrosis score panel
78700-2,Referral note
78701-0,Ulmus crassifolia Ab.IgE
78702-8,Multiple drug resistant gram negative organism
78703-6,Diagnostic study note
78704-4,Initial evaluation note
78705-1,Progress note
78706-9,Form
78707-7,Crisis intervention note
78708-5,Daily or end of shift signout note
Sep-70,Echovirus 40 Ab
78709-3,Crisis intervention note
78710-1,Progress note
78711-9,Flowsheet
78712-7,Checklist
78713-5,Admission history and physical note
78714-3,Surgical operation note
78715-0,Preoperative evaluation and management note
78716-8,Counseling note
Jul-71,Echovirus 6 Ab
78717-6,Checklist
78718-4,Admission history and physical note
78719-2,Surgical operation note
787-2,Erythrocyte mean corpuscular volume
78720-0,Discharge instructions
78721-8,Discharge teaching note
78722-6,Education note
78723-4,Initial evaluation note
78724-2,Admission history and physical note
May-72,Echovirus 9 Ab
78725-9,Surgical operation note
78726-7,Consultation note
78727-5,Admission history and physical note
78728-3,Initial evaluation note
78729-1,Transfer summary note
78730-9,Preoperative evaluation and management note
78731-7,Admission history and physical note
78732-5,Consultation note
Mar-73,Echovirus NOS Ab
78733-3,Admission history and physical note
78734-1,Checklist
78735-8,Preoperative evaluation and management note
78736-6,Transfer summary note
78737-4,Preoperative evaluation and management note
78738-2,Consultation note
78739-0,Platelet aggregation.ristocetin induced^low dose
78740-8,Pathologic casts
Jan-74,Ehrlichia canis Ab
78741-6,Pathologic casts
78742-4,Yeast
78743-2,Steroid fractions interpretation
78744-0,Drug for further processing label
78745-7,Recombinant deoxyribonucleic acid construct label
78746-5,Country of birth
78747-3,Peritoneal equilibration test panel
78748-1,Hemoglobin pattern
78749-9,Glycolate
78750-7,Hepatitis E virus RNA
78751-5,11-Hydroxy delta-9 tetrahydrocannabinol
78752-3,11-Hydroxy delta-9 tetrahydrocannabinol
78753-1,11-Hydroxy delta-9 tetrahydrocannabinol
78754-9,11-Hydroxy delta-9 tetrahydrocannabinol
78755-6,1-Hydroxymidazolam
78756-4,2-Oxo-3-Hydroxy-Lysergate diethylamide
78757-2,2-Oxo-3-Hydroxy-Lysergate diethylamide
Aug-75,Ehrlichia chaffeensis Ab.IgG
78758-0,4-Hydroxymidazolam
78759-8,6-Monoacetylmorphine
78760-6,6-Monoacetylmorphine
78761-4,7-Aminoclonazepam
78762-2,7-Aminoflunitrazepam
78763-0,OPC3373^^adjusted for lean body mass+urine creatinine
78764-8,7-Hydroxyquetiapine^^adjusted for lean body mass+urine creatinine
78765-5,oxyMORphone^^adjusted for lean body mass+urine creatinine
Jun-76,Ehrlichia chaffeensis Ab.IgM
78766-3,fentaNYL^^adjusted for lean body mass+urine creatinine
78767-1,oxyCODONE^^adjusted for lean body mass+urine creatinine
78768-9,Morphine^^adjusted for lean body mass+urine creatinine
78769-7,HYDROcodone^^adjusted for lean body mass+urine creatinine
78770-5,Methadone^^adjusted for lean body mass+urine creatinine
78771-3,9-Hydroxyrisperidone
78772-1,Abacavir
78773-9,Abacavir
Apr-77,Anaplasma phagocytophilum Ab
78774-7,Acenocoumarol
78775-4,Acenocoumarol
78776-2,Acepromazine
78777-0,Alfentanil
78778-8,Alfentanil
78779-6,Alizapride
78780-4,Alminoprofen
78781-2,ALPRAZolam cutoff
Feb-78,Anaplasma phagocytophilum Ab
78782-0,Aluminum
78783-8,AM-2201 4-hydroxypentyl cutoff
78784-6,Amiodarone
78785-3,Amitriptyline
78786-1,Amitriptyline
78787-9,amLODIPine
78788-7,amLODIPine
78789-5,Amoxapine
7879-0,Ehrlichia sp Ab
78790-3,Amphetamine
78791-1,Amprenavir^trough
78792-9,Anakinra
78793-7,ARIPiprazole
78794-5,ARIPiprazole
78795-2,Arsenic
78796-0,Atazanavir
78797-8,Atazanavir^trough
78798-6,Atenolol
78799-4,Atenolol
788-0,Erythrocyte distribution width
78800-0,Atropine
78801-8,Atropine
78802-6,Baclofen
78803-4,Barbital
78804-2,Barbital
78805-9,Barium
78806-7,Alminoprofen
78807-5,Barium
Aug-80,Entamoeba histolytica Ab
78808-3,Benzodiazepines
78809-1,Benzylpiperazine
78810-9,Beryllium
78811-7,Buprenorphine cutoff
78812-5,buPROPion cutoff
78813-3,Cannabicyclohexanol
78814-1,Cannabicyclohexanol cutoff
78815-8,Carisoprodol
Jun-81,Enterovirus RNA
78816-6,Carisoprodol+Meprobamate
78817-4,Cathinone
78818-2,Citalopram cutoff
78819-0,clomiPRAMINE cutoff
78820-8,Cyclobenzaprine cutoff
78821-6,Desipramine cutoff
78822-4,Doxepin cutoff
78823-2,DULoxetine
Apr-82,Epstein Barr virus early Ab
78824-0,DULoxetine cutoff
78825-7,Ecgonine methyl ester
78826-5,Ethyl acetate
78827-3,fentaNYL cutoff
78828-1,fentaNYL
78829-9,Gamma hydroxybutyrate
78830-7,HYDROcodone
78831-5,Hydroxybupropion
Feb-83,Epstein Barr virus nuclear Ab.IgG
78832-3,Hydroxybupropion cutoff
78833-1,Hydroxylurasidone
78834-9,Hydroxylurasidone cutoff
78835-6,Imipramine cutoff
78836-4,JWH-018 5-hydroxypentyl cutoff
78837-2,JWH-018 pentanoate cutoff
78838-0,JWH-073 4-hydroxybutyl cutoff
78839-8,JWH-073 butanoate cutoff
7884-0,Epstein Barr virus nuclear Ab.IgM
78840-6,JWH-081 5-hydroxypentyl cutoff
78841-4,JWH-122 5-hydroxypentyl
78842-2,JWH-122 5-hydroxypentyl cutoff
78843-0,JWH-200 4-Hydroxyindole
78844-8,JWH-200 4-Hydroxyindole cutoff
78845-5,JWH-200 6-Hydroxyindole
78846-3,JWH-200 6-Hydroxyindole cutoff
78847-1,JWH-210 5-carboxypentyl cutoff
78848-9,JWH-210 5-Hydroxypentyl
78849-7,JWH-210 5-hydroxypentyl cutoff
78850-5,JWH-250 5-hydroxypentyl cutoff
78851-3,M-chlorophenylpiperazine
78852-1,M-chlorophenylpiperazine
78853-9,M-chlorophenylpiperazine
78854-7,M-chlorophenylpiperazine
78855-4,M-chlorophenylpiperazine
78856-2,Meprobamate
Jul-85,Epstein Barr virus capsid Ab.IgG
78857-0,Methadone
78858-8,Methcathinone
78859-6,Mirtazapine
78860-4,Mirtazapine cutoff
78861-2,Morphine
78862-0,Naloxol
78863-8,Naloxol cutoff
78864-6,Naloxone cutoff
May-86,Epstein Barr virus capsid Ab.IgM
78865-3,Naltrexol cutoff
78866-1,Norbuprenorphine cutoff
78867-9,Norfentanyl cutoff
78868-7,Norhydrocodone cutoff
78869-5,O-desmethylvenlafaxine cutoff
78870-3,OPC3373
78871-1,OPC3373 cutoff
78872-9,OPC3373
Mar-87,Filaria Ab
78873-7,oxyCODONE
78874-5,oxyMORphone
78875-2,PARoxetine cutoff
78876-0,Pheniramine
78877-8,QUEtiapine
78878-6,RCS-4 5-carboxypentyl
78879-4,RCS-4 5-carboxypentyl cutoff
78880-2,RCS-4 5-hydroxypentyl
Jan-88,Francisella tularensis Ab
78881-0,RCS-4 5-hydroxypentyl cutoff
78882-8,Sertraline cutoff
78883-6,Triazolam
78884-4,Lurasidone
78885-1,traZODone cutoff
78886-9,Venlafaxine cutoff
78887-7,Trans-3-Hydroxycotinine
78888-5,Trimeprazine
78889-3,Tricyclic antidepressants
78890-1,Barium
78891-9,Tricyclic antidepressants
78892-7,Silver
78893-5,Tricyclic antidepressants
78894-3,Liver fibrosis score
78895-0,Coronary segment stenosis panel
78896-8,Number of diseased coronary segments
78897-6,Stenosis degree
78898-4,Stenosis degree
Sep-89,Francisella tularensis Ab.IgG
78899-2,Stenosis degree
78900-8,Stenosis degree
78901-6,Stenosis degree
78902-4,Stenosis degree
78903-2,Stenosis degree
78904-0,Stenosis degree
78905-7,Stenosis degree
78906-5,Stenosis degree
Jul-90,Francisella tularensis Ab.IgM
78907-3,Stenosis degree
78908-1,Stenosis degree
78909-9,Stenosis degree
78910-7,Stenosis degree
78911-5,Stenosis degree
78912-3,Stenosis degree
78913-1,Stenosis degree
78914-9,Percutaneous coronary intervention panel
May-91,Giardia lamblia Ab.IgG
78915-6,FGFR1 gene rearrangements
78916-4,FGFR1 gene rearrangements
78917-2,Cells.FGFR1 gene rearrangements/Cells counted
78918-0,7-Hydroxyquetiapine
78919-8,Sensory or speech status
78920-6,cycloSPORINE
78921-4,Bordetella pertussis & Bordetella parapertussis panel
78922-2,Respiratory pathogens DNA & RNA panel
Mar-92,Giardia lamblia Ab.IgM
78923-0,Comorbid condition panel
78924-8,Hyperuricemia
78925-5,Cerebrovascular accident
78926-3,Myocardial infarction in past 24H
78927-1,Procedure urgency
78928-9,Teaching physician name
78929-7,Peripheral vessels fluoroscopic angiogram performed
78930-5,Right heart catheterization performed
Jan-93,Gliadin Ab
78931-3,Spasm load test performed
78932-1,Optical coherence tomography performed
78933-9,Assisted circulation procedures performed panel
78934-7,Temporary pacing performed
78935-4,Percutaneous cardiopulmonary support performed
78936-2,Cardiac procedure complication
78937-0,Cardiac procedure complication
78938-8,Cardiac procedure complication
78939-6,Percutaneous coronary intervention device panel
78940-4,Coronary artery disease risk factor panel
78941-2,Cardiovascular disease history panel
78942-0,Catheterization & angiography device panel
78943-8,Cardiac procedure complications panel
78944-6,Procedure start time
78945-3,Guiding catheter size
78946-1,Coronary stent diameter
78947-9,Coronary stent length
78948-7,Brinkman index
Sep-94,Haemophilus influenzae Ab
78949-5,Catheterization & angiography procedures performed panel
78950-3,Segmental wall motion panel
78951-1,Segmental wall motion
78952-9,Segmental wall motion
78953-7,Segmental wall motion
78954-5,Segmental wall motion
78955-2,Segmental wall motion
Jun-95,Hantavirus hantaan Ab.IgG
78956-0,Segmental wall motion
78957-8,Segmental wall motion
78958-6,Cathepsin A
78959-4,Hyocholate
78960-2,Aldosterone & renin concentration panel
78961-0,IgG clearance/Albumin clearance
78962-8,IgG clearance/Transferrin clearance
78963-6,Mannose-6-phosphate isomerase
Apr-96,Hantavirus hantaan Ab.IgM
78964-4,N-acetylaspartylglutamate
78965-1,Neurofilament medium chain Ab
78966-9,S-adenosylmethionine
78967-7,Sedoheptulose/Creatinine
78968-5,Benperidol
78969-3,Neurofilament heavy chain Ab
78970-1,Phosphomannomutase 1
78971-9,Phosphomannomutase 1
Feb-97,Hantavirus puumala Ab.IgG
78972-7,CYP2C8 gene allele
78973-5,Multisection for leg measurement^WO contrast
78974-3,Intravenous contrast given
78975-0,Intravenous contrast given
78976-8,Hospital admission ischemic heart disease dx
78977-6,Cardiologist name
78978-4,Guiding catheter product name
78979-2,Guide wire product name
789-8,Erythrocytes
7898-0,Hantavirus puumala Ab.IgM
78980-0,Angioplasty balloon product name
78981-8,Coronary stent product name
78982-6,D-3-phosphoglycerate dehydrogenase
78983-4,4-Hydroxy-3-Methoxyphenyllactate
78984-2,Macroprolactin/Prolactin
78985-9,Prolactin.dimeric
78986-7,Prolactin.dimeric/Prolactin
78987-5,Provasopressin.C-terminal
78988-3,Cortisol
78989-1,Cryoglobulin
78990-9,Flavin adenine dinucleotide
78991-7,Flavin adenine dinucleotide
78992-5,Melatonin
78993-3,Prolactin isoforms panel
78994-1,Prolactin.monomeric
78995-8,Prolactin.monomeric/Prolactin
78997-4,Can you walk 25 feet on a level surface (with or without support)
Aug-99,Hantavirus RNA
78998-2,"Are you able to go OUTSIDE the home, for example to shop or visit a doctor's office"
78999-0,Are you able to dial a number on a phone with large buttons
79000-6,Are you able to clean up after a meal
79001-4,How much difficulty do you currently have opening previously opened jars
79002-2,Are you able to dial a number on the keypad of a cell phone
79003-0,Are you able to roll onto your stomach while lying in bed
Apr-00,Helicobacter pylori Ab
79004-8,Are you able to pull up covers while lying in bed
79005-5,"Are you able to hike a couple of miles on uneven surfaces, including hills"
79006-3,Are you able to walk more than a mile
79007-1,Are you able to open and squeeze a new tube of toothpaste
79008-9,How much difficulty do you currently have pulling up and fastening your pants after a bowel movement
79009-7,Are you able to fasten and unfasten a seatbelt
79010-5,Are you able to do chores such as vacuuming carpet or mopping floors
79011-3,Are you able to go up and down stairs
Feb-01,Helicobacter pylori Ab.IgA
79012-1,Are you able to lift small objects (such as a can of soup) above your shoulder
79013-9,Are you able to carry a bag of groceries for a short distance
79014-7,Are you able to put on socks
79015-4,Are you able to pull a sweater or t-shirt over your head
79016-2,How much difficulty do you currently have cleaning yourself after a bowel movement
79017-0,Are you able to do an exercise of your choice for 20 minutes several times a week
79018-8,Are you able to do strenuous tasks around the house like cleaning the bathroom or scrubbing floors
79019-6,Are you able to stand on a moving escalator
7902-0,Helicobacter pylori Ab.IgG
79020-4,Are you able to pour liquid from a container into a cup
79021-2,Are you able to turn pages in a book
79022-0,Are you able to prepare simple meals for yourself or for others
79023-8,Are you able to reach above your head
79024-6,Are you able to do housework like vacuuming or sweeping floors
79025-3,Are you able to do yard work like raking leaves or sweeping the driveway
79026-1,Are you able to take a letter out of an envelope
79027-9,Are you able to push the buttons on a television remote control
79028-7,Are you able to get items in and out of a wallet
79029-5,Are you able to turn a key to unlock a door
79030-3,Are you able to take a shower
79031-1,Are you able to turn sink faucets on and off
79032-9,Are you able to type a few sentences on a computer keyboard
79033-7,Are you able to move about the house
79034-5,Are you able to use a regular computer mouse
79035-2,Are you able to move wet clothes from the washer to the dryer
79036-0,Are you able to move around on a slippery surface outdoors
79037-8,Are you able to move about in a dark room or hallway without falling
Aug-03,Helicobacter pylori Ab.IgM
79038-6,"Are you able to do vigorous activities, such as playing sports"
79039-4,Are you able to carry a shopping bag
79040-2,Are you able to dress yourself
79041-0,Are you able to wash and dry your feet
79042-8,Are you able to wash dishes and utensils by hand
79043-6,"How much difficulty do you currently have sitting down on a low, soft couch"
79044-4,"How much difficulty do you currently have standing up from a low, soft couch"
79045-1,Are you able to stand upright briefly without support
Jun-04,Hepatitis A virus RNA
79046-9,Are you able to transfer from a bed to a chair or a wheelchair
79047-7,"If you need to, are you physically able to rush for a short distance, such as to cross a street"
79048-5,Are you able to move from the street to the sidewalk without a curb cut
79049-3,Are you able to use a moving escalator safely
79050-1,Are you able to fasten buttons on a shirt or blouse
79051-9,Are you able to hold a card or letter in order to read it
79052-7,Are you able to cut your toenails
Mar-05,Hepatitis B virus surface Ag
79053-5,Are you able to fold clean laundry
79054-3,Are you able to get into a vehicle
79055-0,"How much difficulty do you currently have getting into and out of a truck, bus, shuttle van or sport utility vehicle"
79056-8,How much difficulty do you currently have applying spreads to breads using a knife
79057-6,How much difficulty do you currently have playing cards or Bingo or other light recreational activities
79058-4,How much difficulty do you currently have removing wrappings from small objects
79059-2,Are you able to exercise regularly
790-6,Erythrocytes
79060-0,Are you able to receive a call on a cell phone
Jan-06,Hepatitis D virus RNA
79061-8,Are you able to open a tight or new jar
79062-6,PROMIS item bank - physical function w mobility aids - version 1.0
79063-4,PROMIS short form - physical function w mobility aids - version 1.0
79064-2,PROMIS short form - physical function w mobility aids - version 1.0 raw score
79065-9,Multisection 3D post processing^WO contrast
79066-7,Multisection 3D post processing^WO contrast
79067-5,Multisection^WO contrast
79068-3,Multisection for screening^W contrast IV
79069-1,Multisection for screening^WO contrast IV+W air contrast PR
79070-9,Multisection^W contrast IV
79071-7,Multisection^WO contrast IV+W air contrast PR
79072-5,Guidance for radiation treatment
79073-3,Multisection^W contrast IV
79074-1,Multisection 3D post processing^WO & W contrast IV
79075-8,Multisection by reconstruction^W contrast IV
79076-6,Multisection by reconstruction^WO contrast
79077-4,Multisection for pulmonary embolus^W contrast IV
79078-2,Multisection by reconstruction^W contrast IV
Sep-07,Herpes simplex virus Ab
79079-0,Multisection by reconstruction^WO contrast
79080-8,Multisection by reconstruction^W contrast IV
79081-6,Multisection by reconstruction^WO contrast
79082-4,Multisection by reconstruction^W contrast IV
79083-2,Multisection by reconstruction^W contrast IV
79084-0,Multisection by reconstruction^WO contrast
79085-7,Multisection^WO & W contrast IV
79086-5,Multisection for screening^WO contrast
Jul-08,Herpes simplex virus 1 Ab
79087-3,Multisection for calcium score^WO contrast
79088-1,Multisection for congenital disease^W contrast IV
79089-9,Multisection^W contrast IV
79090-7,Multisection^WO contrast
79091-5,Multisection by reconstruction^WO contrast
79092-3,Multisection^WO contrast
79093-1,Multisection 3D post processing
79094-9,Multisection^W contrast intra bladder
May-09,Herpes simplex virus 1 Ab.IgG
79095-6,Multisection
79096-4,Multisection 3D post processing^WO contrast
79097-2,Multisection 3D post processing^WO contrast
79098-0,Multisection 3D post processing^WO contrast
79099-8,Multisection 3D post processing^WO contrast
79100-4,Multisection^WO contrast
79101-2,Multisection for screening^W air contrast PR
79102-0,Heart transplant acute cellular rejection risk
Mar-10,Herpes simplex virus 1 Ab.IgM
79103-8,Multisection^W contrast IV
79104-6,Recall
79105-3,Can provide correct date
79106-1,Can correctly draw all the numbers to indicate the hours of a clock
79107-9,Can correctly draw hands to show 10M past eleven o'clock
79108-7,Can report something that happened in the news recently
79109-5,Can recall John
79110-3,Can recall Brown
Jan-11,Herpes simplex virus 2 Ab
79111-1,Can recall 42
79112-9,Can recall West
79113-7,Can recall Kensington
79114-5,Total score - Patient examination
79115-2,General Practitioner Assessment of Cognition
79116-0,Informant interview panel
79117-8,Patient examination panel
79118-6,"Compared to a few Y ago, does the patient have more trouble remembering things that have happened recently than she or he used to"
79119-4,"Compared to a few Y ago, does he or she have more trouble recalling conversations a few days later"
79120-2,"Compared to a few Y ago, when speaking, does the patient have more difficulty in finding the right word or tend to use the wrong words more often"
79121-0,"Compared to a few Y ago, is the patient less able to manage money and financial affairs (e.g. paying bills, budgeting)"
79122-8,"Compared to a few Y ago, is the patient less able to manage his or her medication independently"
79123-6,"Compared to a few Y ago, does the patient need more assistance with transport (either private or public)"
79124-4,Total score - Informant interview
79125-1,Hawkinsin
79126-9,Uroporphyrin 1 isomer
79127-7,Uroporphyrin 1 isomer/Creatinine
79128-5,Uroporphyrin 3 isomer
Sep-12,Herpes simplex virus 2 Ab.IgG
79129-3,Uroporphyrin 3 isomer/Creatinine
79130-1,Platelet aggregation.ristocetin induced^500 ug/mL
79131-9,1-Hydroxymidazolam
79132-7,4-Hydroxymidazolam
79133-5,9-Hydroxyrisperidone
79134-3,Abacavir
79135-0,Acebutolol
79136-8,Acepromazine
Jul-13,Herpes simplex virus 2 Ab.IgM
79137-6,Benzylpiperazine
79138-4,Buprenorphine
79139-2,Buprenorphine
791-4,Erythrocytes
79140-0,Carisoprodol+Meprobamate
79141-8,Cathinone
79142-6,Gamma hydroxybutyrate
79143-4,Mercury
79144-2,Methcathinone
May-14,Heterophile Ab after beef cell absorption
79145-9,Tapentadol
79146-7,Tapentadol
79147-5,traMADol
79148-3,traMADol
79149-1,Trimeprazine
79150-9,Clock drawing panel
79151-7,Known allergies to food or environmental agents
Feb-15,Heterophile Ab after guinea pig cell absorption
79152-5,Acenocoumarol
79153-3,Alfentanil
79154-1,Alizapride
79155-8,HIV 1 tropism
79156-6,Cold agglutinin^1H post incubation
79157-4,Cold agglutinin^1H post incubation
79158-2,Cold agglutinin^1H post incubation
79159-0,Cold agglutinin^24H post incubation
7916-0,Histoplasma capsulatum Ab
79160-8,Cold agglutinin panel
79161-6,Nortriptyline & E-10-hydroxynortriptyline & Z-10-hydroxynortriptyline panel
79162-4,Chlordiazepoxide & Norchlordiazepoxide panel
79163-2,Z-10-Hydroxynortriptyline
79164-0,CES1 gene.c.428G>A
79165-7,OXcarbazepine trough & 10-hydroxycarbazepine panel
79166-5,Prunus persica native (nPru p) 3 Ab.IgE
79167-3,Apis mellifera recombinant (rApi m) 2 Ab.IgE
79168-1,Prunus avium recombinant (rPru av) 4 Ab.IgE
79169-9,Prunus avium recombinant (rPru av) 3 Ab.IgE
79170-7,Prunus avium recombinant (rPru av) 1 Ab.IgE
79171-5,Malus domestica recombinant (rMal d) 4 Ab.IgE
79172-3,Somatotropin^2.5H post XXX challenge
79173-1,Somatotropin^2H post XXX challenge
79174-9,Somatotropin^1.5H post XXX challenge
79175-6,Somatotropin^1H post XXX challenge
79176-4,Somatotropin^30M post XXX challenge
79177-2,Clostridioides difficile glutamate dehydrogenase & toxins A+B
Aug-17,HIV 1 Ab
79178-0,4-Hydroxycyclohexylacetate/creatinine
79179-8,Somatotropin^75M post XXX challenge
79180-6,Somatotropin^45M post XXX challenge
79181-4,Somatotropin^15M post XXX challenge
79182-2,RNA polymerase III Ab.IgG
79183-0,First name
79184-8,Last name
Jun-18,HIV 1+2 Ab
79186-3,Cells.CD3+CD4+CD8+/100 cells
79187-1,Cells.CD3+CD4+CD8+
79188-9,Platelet aggregation.adenosine diphosphate induced^10 umol/L
79189-7,Hepatitis C virus core Ag
79190-5,Zika virus RNA
79191-3,Patient demographics panel
79192-1,Pregnancy information
79193-9,Glucose^15M post dose arginine+insulin
Apr-19,HIV 2 Ab
79194-7,Glucose^30M post dose arginine+insulin
79195-4,Glucose^45M post dose arginine+insulin
79196-2,Glucose^1H post dose arginine+insulin
79197-0,Somatotropin^2H post dose arginine+insulin
79198-8,Somatotropin^2.25H post dose arginine+insulin
79199-6,Somatotropin^15M post dose arginine+insulin
79200-2,Somatotropin^2.5H post dose arginine+insulin
79201-0,Somatotropin^30M post dose arginine+insulin
Feb-20,Influenza virus A Ab
79202-8,Somatotropin^45M post dose arginine+insulin
79203-6,Somatotropin^1H post dose arginine+insulin
79204-4,Somatotropin^1.25H post dose arginine+insulin
79205-1,Somatotropin^1.5H post dose arginine+insulin
79206-9,"inv(2)(p21;p23)(EML4,ALK) fusion transcript"
79207-7,BRCA1 gene mutation analysis limited to known familial mutations
79208-5,BRCA2 gene mutation analysis limited to known familial mutations
79209-3,"t(2;3)(q13;p25)(PAX8,PPARG) fusion transcript"
7921-0,Influenza virus A Bangkok Ab
79210-1,FLT3 gene internal tandem duplication
79211-9,Fetal chromosome X & Y aneuploidy risk
79212-7,Fetal microdeletions risk
79213-5,Education program assigned to patient
79214-3,Resource identifier
79215-0,Education program online access code
79216-8,Date education program assigned
79217-6,Date education program started
79218-4,Date education program completed
79219-2,Date education program expires
792-2,Erythrocytes
79220-0,Steroid fractions interpretation
79221-8,Steroid fractions panel
79222-6,Benzodiazepines
79223-4,Atenolol
79224-2,Baclofen
79225-9,Barbital
79226-7,ARIPiprazole
79227-5,Amobarbital
Aug-22,Influenza virus A England Ab
79228-3,amLODIPine
79229-1,Amitriptyline
79230-9,Amiodarone
79231-7,Amoxapine
79232-5,Naphyrone
79233-3,Naphyrone cutoff
79234-1,Butylone
79235-8,Butylone cutoff
Jun-23,Influenza virus A Hong Kong Ab
79236-6,Methcathinone cutoff
79237-4,Mephedrone cutoff
79238-2,Methylenedioxypyrovalerone cutoff
79239-0,Ethyl glucuronide cutoff
79240-8,Tapentadol cutoff
79241-6,Methedrone cutoff
79242-4,Methylone cutoff
79243-2,Ethylone
Apr-24,Influenza virus A Leningrad Ab
79244-0,Ethylone cutoff
79245-7,Triazolam cutoff
79246-5,Methedrone
79247-3,Methylenedioxymethamphetamine cutoff
79248-1,Methylenedioxyethylamphetamine cutoff
79249-9,Methadone cutoff
79250-7,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine cutoff"
Jan-25,Influenza virus A Mississippi Ab
79251-5,diazePAM cutoff
79252-3,Nordiazepam cutoff
79253-1,Oxazepam cutoff
79254-9,LORazepam cutoff
79255-6,oxyCODONE cutoff
79256-4,Carisoprodol+Meprobamate cutoff
79257-2,Methylenedioxyamphetamine cutoff
79258-0,Meprobamate cutoff
79259-8,fentaNYL cutoff
79260-6,fentaNYL cutoff
79261-4,HYDROcodone cutoff
79262-2,Methamphetamine cutoff
79263-0,Creatinine^overnight dwell
79264-8,Glucose^overnight dwell
79265-5,Urea nitrogen^overnight dwell
79266-3,Lead
79267-1,Procedure note
79268-9,3-Hydroxytrimethyl-L-lysine
Sep-26,Influenza virus A Phillipines Ab
79269-7,3-Hydroxytrimethyl-L-lysine
79270-5,3-Hydroxytrimethyl-L-lysine
79271-3,3-Hydroxytrimethyl-L-lysine/Creatinine
79272-1,3-Hydroxytrimethyl-L-lysine/Trimethyllysine
79273-9,3-Hydroxytrimethyl-L-lysine/Trimethyllysine
79274-7,3-Hydroxytrimethyl-L-lysine/Trimethyllysine
79275-4,3-Hydroxytrimethyl-L-lysine/Trimethyllysine
79276-2,"7,8-Dihydrobiopterin"
Jul-27,Influenza virus A Port Chalmers Ab
79277-0,7-lathosterol
79278-8,8-lathosterol
79279-6,Alpha-aminoadipic semialdehyde
79280-4,Alpha-aminoadipic semialdehyde
79281-2,Arabinose/Creatinine
79282-0,Biopterin/Biopterin+Neopterin
79283-8,C29 dicarboxylate
79284-6,Carnitine biosynthesis intermediates panel
May-28,Influenza virus A Texas Ab
79285-3,Carnitine biosynthesis intermediates panel
79286-1,Carnitine biosynthesis intermediates panel
79287-9,Carnitine biosynthesis intermediates panel
79288-7,Creatine & guanidinoacetate panel
79289-5,Creatine & guanidinoacetate panel
79290-3,"Creatine, guanidinoacetate & creatinine panel"
79291-1,Creatine & guanidinoacetate pattern
79292-9,"Creatine, guanidinoacetate & creatinine pattern"
Mar-29,Influenza virus A Victoria Ab
79293-7,Creatine & guanidinoacetate pattern
79294-5,D- & L-2-hydroxyglutarate panel
79295-2,D- & L-2-hydroxyglutarate panel
79296-0,D- & L-2-hydroxyglutarate panel
79297-8,D- & L-2-hydroxyglutarate panel
79298-6,D- & L-2-hydroxyglutarate panel
79299-4,D- & L-2-hydroxyglutarate pattern
793-0,Erythrocytes
79300-0,D- & L-2-hydroxyglutarate pattern
Jan-30,Influenza virus A+B Ab
79301-8,D- & L-2-hydroxyglutarate pattern
79302-6,D- & L-2-hydroxyglutarate pattern
79303-4,D- & L-2-hydroxyglutarate pattern
79304-2,D-2-hydroxyglutarate
79305-9,D-2-hydroxyglutarate
79306-7,D-2-hydroxyglutarate
79307-5,D-2-hydroxyglutarate
79308-3,Gamma butyrobetaine
79309-1,Gamma butyrobetaine
79310-9,Gamma butyrobetaine
79311-7,Gamma butyrobetaine/Creatinine
79312-5,Gamma butyrobetaine/Trimethyllysine
79313-3,Gamma butyrobetaine/Trimethyllysine
79314-1,Gamma butyrobetaine/Trimethyllysine
79315-8,Gamma butyrobetaine/Trimethyllysine
79316-6,Isoxanthopterin
79317-4,L-2-hydroxyglutarate
79318-2,L-2-hydroxyglutarate
Sep-31,Influenza virus B Ab
79319-0,L-2-hydroxyglutarate
79320-8,Lysophosphatidylcholine(26:0)
79321-6,Lysophosphatidylcholine(26:0)
79322-4,Lysophosphatidylcholine(26:0)
79323-2,7-Isobiopterin/Creatinine
79324-0,Pyridoxal phosphate & pyridoxal & pyridoxine panel
79325-7,Pyridoxal phosphate & pyridoxal & pyridoxine panel
79326-5,Squalene
Jul-32,Influenza virus C Ab
79327-3,Sterols pattern
79328-1,Trimethyllysine
79329-9,Trimethyllysine
79330-7,Trimethyllysine
79331-5,Trimethyllysine/Creatinine
79332-3,L-2-hydroxyglutarate
79333-1,Viscosity
79334-9,Hypoglycemics.oral
May-33,Japanese encephalitis virus Ab
79335-6,Hypoglycemics.oral
79336-4,Hypoglycemics.oral
79337-2,Hypoglycemics.oral
79338-0,Hypoglycemics.oral
79339-8,Carnitine biosynthesis intermediates pattern
79340-6,Carnitine biosynthesis intermediates pattern
79341-4,Carnitine biosynthesis intermediates pattern
79342-2,Carnitine biosynthesis intermediates pattern
Mar-34,Japanese encephalitis virus Ab
79343-0,Dimethylacetals pattern
79344-8,Pyridoxal phosphate & pyridoxal & pyridoxine pattern
79345-5,Pyridoxal phosphate & pyridoxal & pyridoxine pattern
79346-3,Alpha-aminoadipic semialdehyde/Creatinine
79347-1,Sulfate.total/Creatinine
79348-9,Body weight^used for drug calculation
79349-7,Views GE 6
7935-0,Japanese encephalitis virus Ab
79350-5,Views GE 3
79351-3,Views GE 2
79352-1,Views GE 6
79353-9,Views GE 3
79354-7,Views GE 2
79355-4,Views 3^W standing
79356-2,Views 1 or 2
79357-0,Views GE 3
79358-8,Views GE 4
79359-6,Views GE 2
79360-4,Views GE 2
79361-2,Views GE 2
79362-0,Views GE 2
79363-8,(Views AP + lateral + Merchants) + (views^W standing)
79364-6,Views GE 4
79365-3,Views GE 3
79366-1,Views 2
79367-9,Views GE 2
Aug-36,Japanese encephalitis virus RNA
79368-7,Views GE 2
79369-5,Views GE 2
79370-3,Views GE 2
79371-1,Views GE 2
79372-9,Views GE 4
79373-7,Views GE 2
79374-5,Multisection for screening
79375-2,Microscopic observation^2nd specimen
Jun-37,Junin virus Ab
79376-0,Microscopic observation^3rd specimen
79377-8,Naltrexol
79378-6,Cause of death
79379-4,HIV 1 RNA+proviral DNA
79380-2,HIV 1 RNA+proviral DNA
79381-0,Gastrointestinal pathogens panel
79382-8,Campylobacter coli+jejuni+lari fusA gene
79383-6,Salmonella sp rpoD gene
Apr-38,La Crosse virus Ab
79384-4,Vibrio cholerae+parahaemolyticus rfbL+trkH+tnaA genes
79385-1,Yersinia enterocolitica recN gene
79386-9,Escherichia coli Stx1 toxin stx1 gene
79387-7,Escherichia coli Stx2 toxin stx2 gene
79388-5,Norovirus genogroup I+II orf1-orf2 junction region
79389-3,Rotavirus A nsp5 gene
79390-1,Gastrointestinal pathogens identified
79391-9,Catecholamine metabolites panel
Feb-39,La Crosse virus Ab
79392-7,Catecholamine metabolites pattern
79393-5,Flavin mononucleotide
79394-3,Hepatocyte growth factor
79395-0,NADH:ubiquinone reductase
79396-8,NADH:ubiquinone reductase
79397-6,Pistacia lentiscus Ab.IgE
79398-4,Prolactin isoforms pattern
79399-2,Synovial fluid analysis panel
Apr-79,Cefixime
7940-0,La Crosse virus Ab.IgG
79400-8,Vanillylmandelate
79401-6,HBB gene full mutation analysis
79402-4,Niacin
79403-2,Nitrogen
79404-0,Adenosine deaminase
79405-7,"1,4-Alpha glucan branching enzyme"
79406-5,IgM clearance/Albumin clearance
79407-3,Catecholamine metabolites pattern
79408-1,Clobazam & norclobazam panel
79409-9,Dothiepin+nordothiepin trough & dothiepin sulfoxide panel
79410-7,Penfluridol^trough
79411-5,Creatine transport protein
79412-3,Mianserin trough & Normianserin panel
79413-1,Dothiepin+Nordothiepin^trough
79414-9,MSH6 gene deletion+duplication
79415-6,MSH2 gene deletion+duplication
79416-4,MLH1 gene deletion+duplication
79417-2,PMS2 gene deletion+duplication
Aug-41,La Crosse virus Ab.IgM
79418-0,EPCAM gene exons 8 & 9 deletion+duplication
79419-8,PMS2 gene deletion+duplication & full mutation analysis
79420-6,Allergen.miscellaneous Ab.IgE
79421-4,Neuromuscular functional index
79422-2,Orthopedic functional index
79423-0,Cardiovascular disease 10Y risk
79424-8,Serial smears for diagnosing pulmonary tuberculosis panel
79425-5,Bacteria identified
Jun-42,Lassa virus Ab.IgG
79426-3,Plasma cells/100 leukocytes
79427-1,Platelets
79428-9,Consultation note
79429-7,Admission notification note
79430-5,Discharge notification note
79431-3,Quality of life score change
79432-1,Sport-recreation score change
79433-9,Activities of daily living score change
Apr-43,Lassa virus Ab.IgG
79434-7,Symptoms score change
79435-4,Pain score change
79436-2,Quality of life score change
79437-0,Sport-recreation score change
79438-8,Activities of daily living score change
79439-6,Symptoms score change
79440-4,Pain score change
79441-2,VR-12 Physical component summary score change - oblique method
Feb-44,Lassa virus Ab.IgM
79442-0,VR-12 Physical component summary score change - orthogonal method
79443-8,VR-12 Mental component summary score change - oblique method
79444-6,VR-12 Mental component summary score change - orthogonal method
79445-3,Fluspirilene
79446-1,Pericyazine
79447-9,Staphylococcus aureus capsular polysaccharide enzyme (cpe) gene
79448-7,Staphylococcus aureus & Methicillin-resistant Staphylococcus aureus panel
79449-5,Formate
79450-3,Adenine phosphoribosyltransferase
79451-1,Adenosine deaminase
79452-9,Adenylosuccinate lyase
79453-7,Alcohol dehydrogenase
79454-5,Alpha fucosidase
79455-2,Alpha-N-acetylgalactosaminidase
79456-0,Arginase
79457-8,Beta glucuronidase
79458-6,Beta-N-acetylhexosaminidase
Sep-45,Lassa virus Ab.IgM
79459-4,Dihydropteridine reductase
79460-2,Galactose 1 phosphate uridyl transferase
79461-0,Hypoxanthine phosphoribosyltransferase
79462-8,Iduronate-2-Sulfatase
79463-6,N-Acetylgalactosamine-4-Sulfatase
79464-4,Phosphorylase
79465-1,Porphobilinogen synthase
79466-9,Purine nucleoside phosphorylase
Jul-46,Lassa virus Ag
79467-7,Purine nucleoside phosphorylase
79468-5,Thiopurine methyltransferase
79469-3,Uridine diphosphate glucose-4-Epimerase
79470-1,Uridine monophosphate synthetase
79471-9,"1,4-Cyclohexanediol/Creatinine"
79472-7,Phenylpropionylglycine
79473-5,Hexanoylglycine
79474-3,"3,4-Dihydroxybutyrate/Creatinine"
May-47,Legionella pneumophila Ab
79475-0,"2,5-Furandicarboxylate"
79476-8,Ethylmalonate
79477-6,5-Hydroxymethyl-2-Furoate/Creatinine
79478-4,Salicylurate/Creatinine
79479-2,"3-Hydroxyadipate 3,6-lactone"
794-8,Erythrocytes
79480-0,"3,4-Dihydroxyhydrocinnamate"
79481-8,Hydantoin-5-propionate/Creatinine
79482-6,3-(3-Hydroxyphenyl)propanoate/Creatinine
Mar-48,Legionella pneumophila 1 Ab
79483-4,Vanilloylglycine/Creatinine
79484-2,Levulinate
79485-9,4-Hydroxyvalerate/Creatinine
79486-7,"3,5-Dihydroxybenzoate/Creatinine"
79487-5,Lactyl lactate/Creatinine
79488-3,"3,4-Dihydroxybutyrate"
79489-1,Salicylurate
79490-9,"3,4-Dihydroxyhydrocinnamate/Creatinine"
Jan-49,Legionella pneumophila 2 Ab
79491-7,3-Hydroxyphenylacetate
79492-5,Furoylglycine
79493-3,3-Hydroxysuberate.unsaturated
79494-1,Pimelate/Creatinine
79495-8,Azelate
79496-6,Hydantoin-5-propionate
79497-4,3-Hydroxybenzoate
79498-2,4-Hydroxyhippurate/Creatinine
79499-0,Catecholamine metabolites panel
79500-5,Furoylglycine/Creatinine
79501-3,3-Hydroxyhippurate/Creatinine
79502-1,4-Hydroxyvalerate
79503-9,4-Hydroxyhippurate
79504-7,Levulinate/Creatinine
79505-4,4-Hydroxy-3-Methoxyphenyllactate
79506-2,Desaminotyrosine
79507-0,P-cresol/Creatinine
79508-8,4-Hydroxymandelate
Sep-50,Legionella pneumophila 3 Ab
79509-6,Decenedioate
79510-4,3-Hydroxyhippurate
79511-2,Suberylglycine
79512-0,Vanilloylglycine
79513-8,"1,4-Cyclohexanediol"
79514-6,N-acetyltyrosine
79515-3,Gentisate
79516-1,Octenedioate
Jul-51,Legionella pneumophila 4 Ab
79517-9,Desaminotyrosine/Creatinine
79518-7,3-Hydroxybenzoate/Creatinine
79519-5,Pimelate
79520-3,4-Deoxythreonate
79521-1,Lactyl lactate
79522-9,"2,5-Furandicarboxylate/Creatinine"
79523-7,3-(3-Hydroxyphenyl)propanoate
79524-5,P-cresol
May-52,Legionella pneumophila 5 Ab
79525-2,3-Hydroxysebacate.unsaturated
79526-0,"3,5-Dihydroxybenzoate"
79527-8,4-Deoxythreonate/Creatinine
79528-6,5-Hydroxymethyl-2-Furoate
79529-4,Basic mobility score
79530-2,Basic mobility score standard error
79531-0,Basic mobility items
79532-8,Daily activity score
Mar-53,Legionella pneumophila 6 Ab
79533-6,Daily activity score standard error
79534-4,Daily activity items
79535-1,Applied cognitive score
79536-9,Applied cognitive score standard error
79537-7,Applied cognitive items
79538-5,Formate
79539-3,HEDIS 2016-2018 Value Set - Urine Protein Tests
79540-1,HEDIS 2016-2018 Value Set - PHQ-9 Total Score
Jan-54,Legionella pneumophila 7 Ab
79541-9,HEDIS 2016-2020 Value Set - Lead Tests
79542-7,HEDIS 2016 Value Set - HPV Vaccine Administered
79543-5,HEDIS 2016-2019 Value Set - ABO and Rh
79544-3,HEDIS 2016 Value Sets
79545-0,Fluid intake.oral.medication
79546-8,Fluid intake.enteral tube.nutritional formula
79547-6,Fluid intake.intravascular.lipids
79548-4,Fluid intake.total intraoperative
79549-2,Fluid output.urine nephrostomy
795-5,Erythrocytes
79550-0,Voids
79551-8,Stools
79552-6,Stools.incontinent
79553-4,Fluid output.emesis
79554-2,Sanitary pads
79555-9,Fluid output.total intraoperative
79556-7,Fluid output.neurological drain
79557-5,Fluid output.musculoskeletal drain
Aug-55,Legionella pneumophila 8 Ab
79558-3,Fluid output.pressure injury
79559-1,Fluid output.gastrointestinal drain
79560-9,Fluid output.gastrointestinal ostomy
79561-7,Fluid output.enteral tube
79562-5,Endotracheal tube diameter
79563-3,Mucopolysaccharidosis type I newborn screening panel
79564-1,Mucopolysaccharidosis type I
79565-8,Mucopolysaccharidosis type I newborn screening comment-discussion
Jun-56,Legionella pneumophila 9 Ab
79566-6,Collection method
79567-4,Lysophosphatidylcholine(26:0)
79568-2,ABCD1 gene targeted mutation analysis
79569-0,Blood product given
79570-8,MLH1+MSH2+MSH6+PMS2 gene deletion+duplication & full mutation analysis
79571-6,BCHE gene full mutation analysis
79572-4,Folate & tryptophan & metabolites panel
79573-2,Riboflavin & flavin mononucleotide & flavin adenine dinucleotide panel
Apr-57,Legionella sp Ab
79574-0,Folate & tryptophan & metabolites pattern
79575-7,"Metanephrine, Normetanephrine, 3-methoxytyramine & Creatinine panel"
79576-5,Allocystathionine
79577-3,Levodopa/Creatinine
79578-1,N6-Acetyl-L-lysine
79579-9,Alanylproline/Creatinine
79580-7,R- & S-beta aminoisobutyrate & D- & L-serine pattern
79581-5,Alanylproline
Feb-58,Leishmania sp Ab
79582-3,Beta-ureidoisobutyrate
79583-1,R- & S-beta aminoisobutyrate & D- & L-serine panel
79584-9,Beta alanine & Beta aminoisobutyrate & Gamma aminobutyrate panel
79585-6,Aspartylglycine
79586-4,R- & S-beta aminoisobutyrate & D- & L-serine panel
79587-2,L-homoarginine/Creatinine
79588-0,Prolylhydroxyproline
79589-8,Aspartylglycosamine
7959-0,Leptospira sp Ab
79590-6,Alpha aminoisobutyrate
79591-4,N-alpha acetyllysine
79592-2,Homocitrulline/Creatinine
79593-0,Allocystathionine/Creatinine
79594-8,Glycylproline/Creatinine
79595-5,"N,N'-dimethylarginine"
79596-3,D-serine/Creatinine
79597-1,N-monomethylarginine/Creatinine
79598-9,Beta alanine & Beta aminoisobutyrate & Gamma aminobutyrate pattern
79599-7,Cysteate/Creatinine
79600-3,Glutathione.reduced
79601-1,L-serine
79602-9,Homocarnosine
79603-7,Beta alanine & Beta aminoisobutyrate & Gamma aminobutyrate panel
79604-5,S-beta aminoisobutyrate
79605-2,R- & S-beta aminoisobutyrate & D- & L-serine panel
79606-0,Cysteate
79607-8,Saccharopine
Aug-60,Leptospira interrogans Ab
79608-6,2-Methyltyrosine
79609-4,Glutathione.oxidized
79610-2,D-serine
79611-0,Prolylhydroxyproline/Creatinine
79612-8,L-homoarginine
79613-6,R- & S-beta aminoisobutyrate & D- & L-serine pattern
79614-4,N-monomethylarginine
79615-1,R-beta aminoisobutyrate
Jun-61,Measles virus Ab
79616-9,S-beta aminoisobutyrate
79617-7,Glycylproline
79618-5,L-serine
79619-3,S-beta aminoisobutyrate/Creatinine
79620-1,Formiminoglutamate/Creatinine
79621-9,Phenylalanine & Tyrosine panel
79622-7,R-beta aminoisobutyrate/Creatinine
79623-5,Alpha aminoisobutyrate/Creatinine
Apr-62,Measles virus Ab.IgG
79624-3,5-S-cysteinyldopa
79625-0,Aspartylglycine/Creatinine
79626-8,L-leucyl-L-proline/Creatinine
79627-6,N-alpha acetyllysine/Creatinine
79628-4,Formiminoglutamate
79629-2,R-beta aminoisobutyrate
796-3,Erythrocytes
79630-0,R- & S-beta aminoisobutyrate & D- & L-serine pattern
79631-8,L-homoserine
Feb-63,Measles virus Ab.IgM
79632-6,Homocarnosine/Creatinine
79633-4,L-leucyl-L-proline
79634-2,N6-Acetyl-L-lysine/Creatinine
79635-9,"N,N-dimethylarginine/Creatinine"
79636-7,Aspartylglycosamine/Creatinine
79637-5,Glutathione.oxidized/Creatinine
79638-3,Beta alanine & Beta aminoisobutyrate & Gamma aminobutyrate pattern
79639-1,"N,N'-dimethylarginine/Creatinine"
7964-0,Measles virus RNA
79640-9,Saccharopine/Creatinine
79641-7,Glutathione.reduced/Creatinine
79642-5,Beta alanine & Beta aminoisobutyrate & Gamma aminobutyrate pattern
79643-3,5-S-cysteinyldopa/Creatinine
79644-1,L-homoserine/Creatinine
79645-8,L-serine/Creatinine
79646-6,Delta aminolevulinate
79647-4,Beta-ureidoisobutyrate/Creatinine
79648-2,D-serine
79649-0,Homocysteine cysteine disulfide/Creatinine
79650-8,Beta alanine & Beta aminoisobutyrate & Gamma aminobutyrate panel
79651-6,Dihydrothymine
79652-4,5-Aminoimidazole-4-carboxamide
79653-2,Dihydroorotate
79654-0,Dihydroorotate
79655-7,Cytosine
79656-5,N-carbamoyl beta alanine
Jul-65,Mumps virus Ab
79657-3,Pseudouridine
79658-1,Cytosine/Creatinine
79659-9,Purine & Pyrimidine pattern
79660-7,Guanosine
79661-5,Dihydroorotate
79662-3,Allopurinol
79663-1,Guanine
79664-9,N-carbamoyl beta alanine
May-66,Mumps virus Ab.IgG
79665-6,Purine & Pyrimidine panel
79666-4,Purine & Pyrimidine pattern
79667-2,"5,6-Dihydrouridine"
79668-0,Purine & Pyrimidine panel
79669-8,Dihydrothymine
79670-6,Guanosine
79671-4,Cytidine
79672-2,5-Aminoimidazole-4-carboxamide/Creatinine
Mar-67,Mumps virus Ab.IgM
79673-0,Purine & Pyrimidine panel
79674-8,Pseudouridine
79675-5,Cytidine
79676-3,"5,6-Dihydrouridine"
79677-1,Purine & Pyrimidine pattern
79678-9,"5,6-Dihydrouridine/Creatinine"
79679-7,5-Aminoimidazole-4-carboxamide
79680-5,"2,8-Dihydroxyadenine"
Jan-68,Mumps virus RNA
79681-3,Allopurinol/Creatinine
79682-1,"5,6-Dihydrouracil"
79683-9,Cytosine
79684-7,Cytidine/Creatinine
79685-4,"5,6-Dihydrouracil/Creatinine"
79686-2,5-hydroxymethyluracil
79687-0,"2,8-Dihydroxyadenine/Creatinine"
79688-8,5-hydroxymethyluracil
79689-6,Allopurinol
79690-4,Guanine
79691-2,Oxipurinol
79692-0,"2,8-Dihydroxyadenine"
79693-8,"5,6-Dihydrouracil"
79694-6,Eicosadienoate
79695-3,Octadecatetraenoate
79696-1,cis-11-Eicosenoate
79697-9,Docosadienoate
79698-7,Docosadienoate
Sep-69,Mycoplasma pneumoniae Ab
79699-5,cis-11-Eicosenoate
79700-1,"cis-11,14-Eicosadienoate"
79701-9,Fatty acids.very long chain.C22:1n9
79702-7,cis-13-Eicosenoate
79703-5,cis-13-Eicosenoate
79704-3,Homo-gamma linolenate
79705-0,Eicosadienoate
79706-8,Octadecatetraenoate
Jul-70,Mycoplasma pneumoniae Ab.IgG
79707-6,Fatty acids.very long chain.C26:1/C22:0
79708-4,Borrelia burgdorferi Ab.IgG
79709-2,Borrelia burgdorferi Ab.IgG
797-1,Erythrocytes
79710-0,Potassium
79711-8,HLA-B*58:01
79712-6,HLA-A*31:01
79713-4,TPMT gene product metabolic activity interpretation
79714-2,CYP2C19 gene product metabolic activity interpretation
May-71,Naegleria fowleri Ab
79715-9,CYP2D6 gene product metabolic activity interpretation
79716-7,CYP2C9 gene product metabolic activity interpretation
79717-5,CYP3A5 gene product metabolic activity interpretation
79718-3,UGT1A1 gene product metabolic activity interpretation
79719-1,DPYD gene product metabolic activity interpretation
79720-9,CYP2B6 gene product metabolic activity interpretation
79721-7,CYP4F2 gene product metabolic activity interpretation
79722-5,SLCO1B1 gene product functional interpretation
Mar-72,Neisseria meningitidis serogroup Y Ab
79723-3,Age at 2nd eye involvement in a patient with initial unilateral retinoblastoma
79724-1,Age at first awareness of night blindness
79725-8,Amblyopia
79726-6,Can elevate above midline
79727-4,Can elevate above midline
79728-2,Coloboma location
79729-0,Coloboma location
79730-8,Color vision
Jan-73,Norovirus
79731-6,Color vision
79732-4,Color vision exam method
79733-2,Visual convergence exam
79734-0,Initial unilateral retinoblastoma that later developed into bilateral disease
79735-7,Evidence supporting myopathy
79736-5,Congenital cranial dysinnervation syndrome (CCDS) suspected
79737-3,Gross defects
79738-1,Gross defects
79739-9,Horizontal diameter
79740-7,Horizontal diameter
79741-5,Eye-related brain MRI findings
79742-3,Inheritance pattern based on family history
79743-1,Intraocular retinoblastoma classification^at initial diagnosis
79744-9,Intraocular retinoblastoma classification^at initial diagnosis
79745-6,Intraocular retinoblastoma classification^at final disease stage
79746-4,Intraocular retinoblastoma classification^at final disease stage
79747-2,Extraocular retinoblastoma classification^at final disease stage
79748-0,Extraocular retinoblastoma classification^at final disease stage
Sep-74,Norovirus RNA
79749-8,Jaw winking
79750-6,Jaw winking
79751-4,Eye problem
79752-2,Eye problem
79753-0,Eye problem
79754-8,Corneal dystrophy suspected
79755-5,Ophthalmologic treatment
Jun-75,Human papilloma virus Ab
79756-3,Ophthalmologic treatment
79757-1,Prior molecular testing related to ophthalmological condition
79758-9,Progression of problem since birth
79759-7,Strabismus
79760-5,Systemic findings and diseases associated with ophthalmological condition
79761-3,Use of supplemental oxygen^at birth
79762-1,Vertical diameter
79763-9,Vertical diameter
Apr-76,Paracoccidioides brasiliensis Ab
79764-7,Tonometer
79765-4,Ocular alignment
79766-2,Head posture for nystagmus null-point
79767-0,Nystagmus frequency
79768-8,Platelet dense bodies
79769-6,Arden ratio
79770-4,Arden ratio
79771-2,Study observation.overall
Feb-77,Paragonimus sp Ab
79772-0,Study observation.overall
79773-8,a-wave amplitude^dark-adapted
79774-6,a-wave amplitude^dark-adapted
79775-3,a-wave amplitude^light-adapted
79776-1,a-wave amplitude^light-adapted
79777-9,a-wave implicit time^dark-adapted
79778-7,a-wave implicit time^dark-adapted
79779-5,a-wave implicit time^light-adapted
7978-0,Parainfluenza virus 1 Ab
79780-3,a-wave implicit time^light-adapted
79781-1,b-wave amplitude^dark-adapted
79782-9,b-wave amplitude^dark-adapted
79783-7,b-wave amplitude^light-adapted
79784-5,b-wave amplitude^light-adapted
79785-2,b-wave implicit time^dark-adapted
79786-0,b-wave implicit time^dark-adapted
79787-8,b-wave implicit time^light-adapted
79788-6,b-wave implicit time^light-adapted
79789-4,Oscillatory potentials
79790-2,Oscillatory potentials
79791-0,Reference electrode
79792-8,Study observation.overall
79793-6,Study observation.overall
79794-4,Electroretinogram procedure standard followed
79795-1,Flicker response wave amplitude^light-adapted
79796-9,Flicker response wave amplitude^light-adapted
79797-7,Flicker response wave implicit time^light-adapted
Aug-79,Parainfluenza virus 2 Ab
79798-5,Flicker response wave implicit time^light-adapted
79799-3,Vendor name
79800-9,ISCEV standard protocol used
79801-7,Recording electrode
79802-5,Reference electrode
79803-3,Ocular motility
79804-1,Visual field defects
79805-8,Visual field defects
Jun-80,Parainfluenza virus 3 Ab
79806-6,Visual field exam method
79807-4,Visual field defects
79808-2,Visual field defects
79809-0,Study observation^W fluorescein IV
79810-8,Study observation^W fluorescein IV
79811-6,Study observation^W indocyanine green IV
79812-4,Study observation^W indocyanine green IV
79813-2,Corneal curvature
Apr-81,Parvovirus B19 Ab.IgM
79814-0,Corneal curvature
79815-7,Pupillary response
79816-5,Foveal thickness
79817-3,Foveal thickness
79818-1,Study observation
79819-9,Study observation
79820-7,Physical findings
79821-5,Physical findings
Feb-82,Parvovirus B19 Ab
79822-3,Fundus hypopigmentation
79823-1,Glaucoma
79824-9,Ophthalmoscopy method
79825-6,Central corneal thickness
79826-4,Central corneal thickness
79827-2,Contrast sensitivity
79828-0,Contrast sensitivity
79829-8,Axis^W cycloplegia
7983-0,Parvovirus B19 Ab.IgG
79830-6,Axis^W cycloplegia
79831-4,Axis^WO cycloplegia
79832-2,Axis^WO cycloplegia
79833-0,Cylinder^W cycloplegia
79834-8,Cylinder^W cycloplegia
79835-5,Cylinder^WO cycloplegia
79836-3,Cylinder^WO cycloplegia
79837-1,Sphere^W cycloplegia
79838-9,Sphere^W cycloplegia
79839-7,Sphere^WO cycloplegia
79840-5,Sphere^WO cycloplegia
79841-3,Objective refraction method
79842-1,Axis^W cycloplegia
79843-9,Axis^W cycloplegia
79844-7,Axis^WO cycloplegia
79845-4,Axis^WO cycloplegia
79846-2,Cylinder^W cycloplegia
79847-0,Cylinder^W cycloplegia
Aug-84,Parvovirus B19 Ab.IgM
79848-8,Cylinder^WO cycloplegia
79849-6,Cylinder^WO cycloplegia
79850-4,Sphere^W cycloplegia
79851-2,Sphere^W cycloplegia
79852-0,Sphere^WO cycloplegia
79853-8,Sphere^WO cycloplegia
79854-6,Subjective refraction method
May-85,Polio virus 1 Ab
79855-3,Opening height
79856-1,Opening height
79857-9,Study observation
79858-7,Study observation
79859-5,Study observation
79860-3,Study observation
79861-1,Study observation
79862-9,Study observation
Mar-86,Polio virus 2 Ab
79863-7,Study observation
79864-5,Study observation
79865-2,Study observation
79866-0,Study observation
79867-8,Opacity
79868-6,Opacity
79869-4,Study observation
79870-2,Pupil shape
Jan-87,Polio virus 3 Ab
79871-0,Pupil shape
79872-8,Study observation
79873-6,Study observation
79874-4,Transillumination
79875-1,Transillumination
79876-9,Visual acuity^best corrected
79877-7,Visual acuity^best corrected
79878-5,Visual acuity^uncorrected
79879-3,Visual acuity^uncorrected
79880-1,Visual acuity^best corrected
79881-9,Visual acuity^best corrected
79882-7,Visual acuity^uncorrected
79883-5,Visual acuity^uncorrected
79884-3,Study observation
79885-0,Study observation
79886-8,Cells
79887-6,Cells
79888-4,Flare
Sep-88,Burkholderia pseudomallei Ab.IgG
79889-2,Flare
798-9,Erythrocytes
79890-0,Axial length
79891-8,Nystagmus
79892-6,Intraocular pressure
79893-4,Intraocular pressure
79894-2,Electroretinography panel
79895-9,Subjective refraction panel
79896-7,Tonometry panel
Jul-89,Burkholderia pseudomallei Ab.IgM
79897-5,Physical findings panel
79898-3,Objective refraction panel
79899-1,Pupillary response
79900-7,Nystagmus amplitude
79901-5,Nystagmus direction
79902-3,Physical findings
79903-1,Physical findings
79904-9,Pediatric visual acuity^uncorrected
May-90,Respiratory syncytial virus Ab
79905-6,Pediatric visual acuity^uncorrected
79906-4,Pediatric visual acuity^best corrected
79907-2,Pediatric visual acuity^best corrected
79908-0,Visual acuity exam method
79909-8,Diameter.end systole
79910-6,Blood velocity-time integral.systole
79911-4,Tissue velocity.E wave.max
79912-2,Pressure half time.diastole
Mar-91,Respiratory syncytial virus Ab.IgG
79913-0,Blood flow velocity.diastole.max
79914-8,Blood velocity-time integral.diastole
79915-5,Blood flow velocity.A wave.max
79916-3,Blood flow velocity.D wave.max
79917-1,Blood flow velocity.S wave.max
79918-9,Regurgitant blood flow velocity.end diastole
79919-7,Regurgitant blood flow velocity.E wave.max
79920-5,Blood flow velocity.systole.max
Jan-92,Respiratory syncytial virus Ab.IgM
79921-3,Regurgitant blood flow velocity.systole.max
79922-1,Tissue velocity.A wave.max
79923-9,Blood flow velocity.A wave.max
79924-7,Tissue velocity.E wave.max
79925-4,Blood flow velocity.E wave.max
79926-2,Tissue velocity.S wave.max
79927-0,Blood flow velocity.diastole.max
79928-8,Blood flow.acceleration time.systole
79929-6,Ejection time
79930-4,Closure to opening
79931-2,Blood flow.deceleration time.diastole
79932-0,PISA radius.systole
79933-8,Vena contracta diameter.systole
79934-6,Pressure gradient.end diastole.max
79935-3,Pressure gradient.systole.max
79936-1,Fractional area change
79937-9,Pressure gradient.systole.max
79938-7,Pressure gradient.diastole.mean
Sep-93,Rhinovirus RNA
79939-5,Pressure gradient.diastole.max
79940-3,Diameter.end systole
79941-1,Regurgitant blood flow rate.diastole
79942-9,Regurgitant fraction
79943-7,Regurgitant jet area/Left ventricular outflow tract area
79944-5,Regurgitant jet width/Left ventricular outflow tract width
79945-2,PISA radius.diastole
79946-0,PISA velocity.diastole
Jul-94,Rickettsia sp Ab
79947-8,Pressure half time.diastole
79948-6,Vena contracta diameter.diastole
79949-4,Regurgitant blood flow velocity.diastole.max
79950-2,Regurgitant blood flow volume.diastole
79951-0,Regurgitant blood flow volume.diastole
79952-8,Blood velocity-time integral.diastole
79953-6,Diameter.end systole
Apr-95,Rickettsia prowazekii Ab
79954-4,Diameter.end systole/Body surface area
79955-1,Diameter.end systole
79956-9,Effective orifice area.systole
79957-7,Effective orifice area.systole/Body surface area
79958-5,Effective orifice area.systole
79959-3,Effective orifice area.systole/Body surface area
79960-1,Effective regurgitant orifice area.diastole
79961-9,Blood flow velocity.systole.mean
Feb-96,Rickettsia prowazekii RNA
79962-7,Pressure gradient.systole.mean
79963-5,Gradient.systole.max
79964-3,Blood flow velocity.systole.max
79965-0,Blood velocity-time integral.systole
79966-8,Diameter.systole
79967-6,Diameter.end expiration
79968-4,Thickness.end diastole
79969-2,Thickness.end diastole
799-7,Erythrocytes
7997-0,Rickettsia spotted fever group Ab
79970-0,Thickness.end systole
79971-8,Thickness.end systole
79972-6,Time to peak displacement.systole
79973-4,Area.end systole
79974-2,Area.end systole
79975-9,Minor axis.end systole
79976-7,Minor axis.end systole/Body surface area
79977-5,Minor axis.end systole
79978-3,Minor axis.end systole/Body surface area
79979-1,Length.end systole
79980-9,Length.end systole
79981-7,End-systolic volume
79982-5,End-systolic volume/Body surface area
79983-3,End-systolic volume
79984-1,End-systolic volume/Body surface area
79985-8,End-systolic volume
79986-6,End-systolic volume
79987-4,Diameter.end systole
Aug-98,Rickettsia spotted fever group Ab.IgG
79988-2,Time to peak displacement.systole
79989-0,Pre ejection time
79990-8,Ejection fraction
79991-6,Ejection fraction
79992-4,Ejection fraction
79993-2,Ejection fraction
79994-0,Length.end diastole
79995-7,End-diastolic volume
Jun-99,Rickettsia spotted fever group Ab.IgM
79996-5,End-diastolic volume
79997-3,End-diastolic volume/Body surface area
79998-1,End-diastolic volume
79999-9,End-diastolic volume
80000-3,End-systolic volume
80001-1,End-systolic volume
Feb-00,Rickettsia typhus group Ab
80002-9,End-systolic volume/Body surface area
80003-7,End-systolic volume
80004-5,End-systolic volume
80005-2,Area.end diastole
80006-0,Epicardial area.end diastole
80007-8,Minor axis.end diastole
80008-6,Minor axis.end diastole
80009-4,Minor axis.end diastole/Body surface area
8001-0,Rickettsia typhus group Ab.IgG
80010-2,Minor axis.end diastole/Body surface area
80011-0,Minor axis.end systole
80012-8,Minor axis.end systole
80013-6,Minor axis.end systole/Body surface area
80014-4,Minor axis.end systole/Body surface area
80015-1,Isovolumic relaxation time
80016-9,Myocardial mass.end diastole
80017-7,Myocardial mass.end diastole/Body surface area
80018-5,Myocardial mass.end diastole/Height exp 2.7
80019-3,Myocardial mass.end diastole
80020-1,Myocardial mass.end diastole/Body surface area
80021-9,Myocardial mass.end diastole/Height exp 2.7
80022-7,Myocardial mass.end diastole
80023-5,Myocardial mass.end diastole/Body surface area
80024-3,Myocardial mass.end diastole/Height exp 2.7
80025-0,Myocardial mass.end diastole
80026-8,Myocardial mass.end diastole/Body surface area
80027-6,Myocardial mass.end diastole/Height exp 2.7
Aug-02,Rickettsia typhus group Ab.IgM
80028-4,Diameter.end diastole
80029-2,Blood flow velocity.systole.max
800-3,Schistocytes
80030-0,Blood velocity-time integral.systole
80031-8,Thickness.end diastole
80032-6,Thickness.end diastole
80033-4,Thickness.end systole
80034-2,Thickness.end systole
80035-9,Stroke volume
Jun-03,Rickettsia rickettsii Ab.IgG
80036-7,Time to max tissue velocity.systole
80037-5,Time to max tissue velocity.systole
80038-3,Time to max tissue velocity.systole
80039-1,Time to max tissue velocity.systole
80040-9,Time to max tissue velocity.systole
80041-7,Time to max tissue velocity.systole
80042-5,Time to max tissue velocity.systole
80043-3,Time to max tissue velocity.systole
Apr-04,Rickettsia rickettsii Ab.IgM
80044-1,Time to max tissue velocity.systole
80045-8,Time to max tissue velocity.systole
80046-6,Time to max tissue velocity.systole
80047-4,Time to max tissue velocity.systole
80048-2,Dyssynchrony index.systole
80049-0,Diameter.end systole
80050-8,Diameter.end diastole
Jan-05,Rickettsia rickettsii RNA
80051-6,Diameter.end diastole
80052-4,Diameter.end diastole
80053-2,Blood velocity-time integral.diastole
80054-0,Tissue velocity.E wave.max
80055-7,Regurgitant fraction
80056-5,Regurgitant fraction
80057-3,Regurgitant blood flow rate.systole.max
80058-1,Pressure gradient.systole.max
80059-9,PISA radius.systole
80060-7,PISA velocity.systole
80061-5,Vena contracta diameter.systole
80062-3,Regurgitant blood flow velocity.systole.max
80063-1,Regurgitant blood flow volume.systole
80064-9,Regurgitant blood flow volume.systole
80065-6,A wave duration
80066-4,Blood flow velocity.A wave.max
80067-2,Effective orifice area.diastole
80068-0,Orifice area.diastole.max
Sep-06,Orientia tsutsugamushi Ab
80069-8,Effective orifice area.diastole
80070-6,Blood flow velocity.E wave.max
80071-4,Effective regurgitant orifice area.systole
80072-2,Flow propagation velocity.E wave
80073-0,Pressure gradient.diastole.mean
80074-8,Pressure gradient.diastole.max
80075-5,Area.end systole
80076-3,Major axis.end systole
Jul-07,Rickettsia typhi Ab.IgG
80077-1,Minor axis.end systole
80078-9,Minor axis.end systole/Body surface area
80079-7,Diameter.end systole
80080-5,Minor axis.end diastole
80081-3,Area.end diastole
80082-1,Area.end systole
80083-9,Thickness.end diastole
80084-7,Thickness.end diastole
May-08,Rickettsia typhi Ab.IgM
80085-4,Minor axis.end diastole
80086-2,Myocardial Performance Index
80087-0,Diameter.end diastole
80088-8,Diameter.end diastole
80089-6,Blood velocity-time integral.systole
80090-4,Pre ejection time
80091-2,Diameter.end diastole
80092-0,Glycyl-4-hydroxyproline/Creatinine
Mar-09,Bartonella quintana Ab.IgG
80093-8,Glucosamine
80094-6,Glutamylphenylalanine/Creatinine
80095-3,Galactosamine/Creatinine
80096-1,Glutamylphenylalanine
80097-9,Glycyl-4-hydroxyproline
80098-7,Glucosamine/Creatinine
80099-5,L-2-hydroxyglutarate/Creatinine
80100-1,D-2-hydroxyglutarate/Creatinine
Jan-10,Bartonella quintana Ab.IgM
80101-9,Anterior chamber angle
80102-7,Anterior chamber angle
80103-5,Physical findings
80104-3,Physical findings
80105-0,Physical findings
80106-8,Physical findings
80107-6,Stereopsis
80108-4,Stereopsis
80109-2,Pregnancy risk factors for prenatal genetic testing
801-1,Sickle cells
80110-0,Visit notification note
80111-8,11-Hydroxy delta-9 tetrahydrocannabinol
80112-6,11-Hydroxy delta-9 tetrahydrocannabinol
80113-4,11-Hydroxy delta-9 tetrahydrocannabinol
80114-2,2-Oxo-3-Hydroxy-Lysergate diethylamide
80115-9,6-Monoacetylmorphine
80116-7,6-Monoacetylmorphine
80117-5,7-Aminoflunitrazepam
80118-3,Abacavir
Sep-11,Rotavirus
80119-1,Acebutolol
80120-9,Acenocoumarol
80121-7,Acyclovir
80122-5,Alfentanil
80123-3,Alizapride
80124-1,Alminoprofen
80125-8,Aluminum
80126-6,Aluminum
Jul-12,Rotavirus dsRNA
80127-4,Aluminum
80128-2,Amisulpride
80129-0,Amisulpride
80130-8,Amisulpride
80131-6,Amisulpride
80132-4,amLODIPine
80133-2,Amoxicillin
80134-0,Amphetamine
May-13,Rubella virus Ab
80135-7,Amphetamine
80136-5,Antihistamines
80137-3,Antihistamines
80138-1,Antimony
80139-9,Antimony
80140-7,Antimony
80141-5,Arsenic
80142-3,Atazanavir
Mar-14,Rubella virus Ab.IgG
80143-1,Atazanavir
80144-9,Ecgonine methyl ester
80145-6,Silver
80146-4,Tricyclic antidepressants
80147-2,Tricyclic antidepressants
80148-0,Tricyclic antidepressants
80149-8,Tricyclic antidepressants
8015-0,Rubella virus Ab.IgM
80150-6,Trimeprazine
80151-4,Brucella abortus Ab.IgG
80152-2,N-methylhistamine/Creatinine
80153-0,Soluble CD27
80154-8,Monolysocardiolipin/cardiolipin
80155-5,Soluble CD27
80156-3,3-Methoxytyramine/Creatinine
80157-1,Etiocholanolone
80158-9,Galactosylhydroxylysine/Creatinine
80159-7,27-Norcholestanehexol/Creatinine
80160-5,"5-beta-cholestane-3-alpha,7-alpha,12-alpha,23-tetrol/Creatinine"
80161-3,"5-beta-cholestane-3-alpha,7-alpha,12-alpha,24,25-pentol/Creatinine"
80162-1,Bile alcohols
80163-9,Bile alcohols panel
80164-7,Bile alcohols pattern
80165-4,2-Amino-4-hydroxypteridine
80166-2,2-Amino-4-hydroxypteridine
80167-0,2-Amino-4-hydroxypteridine/Creatinine
Aug-16,Saint Louis encephalitis virus Ab.IgG
80168-8,Pterins panel
80169-6,Pterins panel
80170-4,Pterins panel
80171-2,Pterins pattern
80172-0,Pterins pattern
80173-8,Pterins pattern
80174-6,S-adenosylhomocysteine
80175-3,S-adenosylhomocysteine
Jun-17,Saint Louis encephalitis virus Ab.IgM
80176-1,S-adenosylhomocysteine/Creatinine
80177-9,S-adenosylmethionine
80178-7,S-adenosylmethionine & S-adenosylhomocystine panel
80179-5,S-adenosylmethionine & S-adenosylhomocystine panel
80180-3,S-adenosylmethionine & S-adenosylhomocystine pattern
80181-1,S-adenosylmethionine & S-adenosylhomocystine pattern
80182-9,S-adenosylmethionine/Creatinine
80183-7,Xanthopterin
Apr-18,Schistosoma japonicum Ab
80184-5,Xanthopterin
80185-2,Xanthopterin/Creatinine
80186-0,JAK2 gene exon 12 targeted mutation analysis
80187-8,JAK2 gene exon 14 targeted mutation analysis
80188-6,JAK2 gene exon 14 targeted mutation analysis
80189-4,Galactosamine
80190-2,Catheterization & angiography procedure details panel
80191-0,Spasm stress test panel
Feb-19,Schistosoma mansoni Ab
80192-8,Coronary segment additional details panel
80193-6,Ecgonine methyl ester
80194-4,Ecgonine methyl ester
80195-1,Ecgonine methyl ester
80196-9,Ecgonine methyl ester
80197-7,Antihistamines
80198-5,Nonsteroidal antiinflammatory drugs
80199-3,Nonsteroidal antiinflammatory drugs
Feb-80,Cefixime
8020-0,Schistosoma sp Ab
80200-9,Nonsteroidal antiinflammatory drugs
80201-7,Alizapride
80202-5,Clotting time of depleted plasma with 1:1 phospholipid^after addition of factor X activated
80203-3,HIV 1 & 2 Ab
80204-1,Influenza virus A & B identified
80205-8,Japanese encephalitis+Tick-borne encephalitis+West Nile+Yellow fever virus Ab.IgG
80206-6,Japanese encephalitis+Tick-borne encephalitis+West Nile+Yellow fever virus Ab.IgM
80207-4,Leishmania infantum+donovani Ab.IgM
80208-2,Leishmania infantum+donovani Ab.IgG
80209-0,Barium
80210-8,Beryllium
80211-6,Beryllium
80212-4,Beta blockers
80213-2,Beta blockers
80214-0,Beta blockers
80215-7,Beta blockers
80216-5,"Social, psychological & behavioral observations - 2015 Edition Health IT Certification Criteria set"
80217-3,Mycoplasma hyopneumoniae Ag
Aug-21,Saint Louis encephalitis virus Ab
80218-1,Mycoplasma hyopneumoniae Ab sample/Buffer control
80219-9,Mycoplasma hyopneumoniae Ab sample/Positive control
80220-7,N-methyl-D-aspartate receptor Ab.IgG
80221-5,N-methyl-D-aspartate receptor Ab.IgG
80222-3,Cells.CD8/100 lymphocytes
80223-1,Cells.CD4/100 lymphocytes
80224-9,Right coronary artery catheter
80225-6,Left coronary artery catheter
Jun-22,Saint Louis encephalitis virus Ab
80226-4,Pigtail catheter
80227-2,Stenosis degree
80228-0,Stenosis degree
80229-8,Stenosis degree
80230-6,Orifice area
80231-4,Orifice area
80232-2,A wave amplitude
80233-0,V wave amplitude
Apr-23,Saint Louis encephalitis virus Ab
80234-8,A wave amplitude
80235-5,V wave amplitude
80236-3,A wave amplitude
80237-1,V wave amplitude
80238-9,Drug given for spasm stress test
80239-7,Stenosis degree^post procedure
80240-5,Coronary stent expansion pressure
80241-3,Coronary stent expansion time
Feb-24,Saint Louis encephalitis virus Ab
80242-1,Intravenous contrast given
80243-9,Cardiac catheterization access site
80244-7,Mycoplasma hyopneumoniae DNA
80245-4,Procedure sequence
80246-2,Atrioventricular nodal artery
80247-0,Posterior descending from right coronary artery
80248-8,Posterolateral from right coronary artery
80249-6,Diagonal artery 1
80250-4,Diagonal artery 1a
80251-2,Diagonal artery 2
80252-0,Diagonal artery 2a
80253-8,Obtuse marginal artery
80254-6,Mid distal left circumflex artery
80255-3,Posterolateral from left circumflex artery
80256-1,Posterior descending from left circumflex artery
80257-9,Ramus intermedius from left main coronary artery
80258-7,Pre-cardiac catheterization diagnosis
Sep-25,Saint Louis encephalitis virus RNA
80259-5,Gastrointestinal assessment panel
80260-3,Bowel elimination pattern
80261-1,Bowel movement frequency
80262-9,Bowel movement usual time of day
80263-7,Bowel movement regularity
80264-5,Usual consistency
80265-2,Date of last bowel movement
80266-0,Bowel sounds
Jul-26,Stain method
80267-8,Bowel sounds quality
80268-6,Bowel sounds quadrant
80269-4,Appearance
80270-2,Passing flatus
80271-0,Physical findings
80272-8,Amount
80273-6,Gastrointestinal assessment
80274-4,Surgical procedures of gastrointestinal system
May-27,Streptococcus pneumoniae 14 Ab.IgG
80275-1,Cardiovascular assessment panel
80276-9,Heart sounds
80277-7,Heart murmur assessment panel
80278-5,Murmur grade
80279-3,Murmur quality
80280-1,Murmur pitch
80281-9,Murmur timing
80282-7,Murmur location
Mar-28,Streptococcus pneumoniae Danish serotype 7F Ab.IgG
80283-5,Murmur radiating to body location
80284-3,Pulse intensity assessment panel
80285-0,Cardiovascular assessment
80286-8,Surgical procedures of cardiovascular system
80287-6,Neurological assessment panel
80288-4,Level of consciousness
80289-2,Temporal orientation panel
802-9,Spherocytes
80290-0,Temporal orientation - person
Jan-29,Streptococcus pneumoniae 9 Ab.IgG
80291-8,Temporal orientation - place
80292-6,Temporal orientation - time
80293-4,Temporal orientation assessment
80294-2,Level of arousal
80295-9,Speech clarity
80296-7,Mood
80297-5,Memory
80298-3,Ability to concentrate
80299-1,Ability to direct attention
80300-7,Cranial nerve assessment panel
80301-5,Olfactory nerve (CNI) exam
80302-3,Oculomotor+trochlear+abducens nerves (CN III+IV+VI) exam
80303-1,Trigeminal nerve (CN V) exam
80304-9,Facial nerve (CN VII) exam
80305-6,Vestibulocochlear nerve (CN VIII) exam
80306-4,Glossopharyngeal nerve (CN IX) exam
80307-2,Vagus nerve (CN X) exam
80308-0,Accessory nerve (CN XI) exam
Sep-30,Streptococcus pneumoniae Ab
80309-8,Hypoglossal nerve (CN XII) exam
80310-6,Pupil assessment panel
80311-4,Pupil shape
80312-2,Pupil shape
80313-0,Pupil assessment
80314-8,Neurological assessment
80315-5,Surgical procedures of neurological system
80316-3,Pain scale
Jul-31,Streptococcus pneumoniae Ab.IgG
80317-1,Pain Assessment
80318-9,Respiratory assessment panel
80319-7,Breath sounds
80320-5,Respiratory assessment
80321-3,Musculoskeletal assessment panel
80322-1,Strength
80323-9,Involuntary movements
80324-7,Tendon reflex assessment panel
May-32,Streptococcus pneumoniae Ab.IgM
80325-4,Oculocephalic reflex
80326-2,Paralysis
80327-0,Paresthesia
80328-8,Musculoskeletal assessment
80329-6,Surgical procedures of musculoskeletal system
80330-4,Genitourinary Assessment Panel
80331-2,Date and time of last void
80332-0,Voiding pattern
Mar-33,Streptococcus pneumoniae 3 Ab.IgG
80333-8,Other elements
80334-6,Urine collection device
80335-3,Genitourinary assessment
80336-1,Surgical procedures of genitourinary system
80337-9,Symptoms & diseases of genitourinary system
80338-7,Wound assessment
80339-5,Vital signs assessment
80340-3,Nonpharmacologic intervention for pain
Jan-34,Strongyloides sp Ab
80341-1,Respiratory effort
80342-9,Breath sounds location
80343-7,Skin assessment
80344-5,Skin integrity
80345-2,Pressure points examined
80346-0,Nursing physiologic assessment panel
80347-8,Mucous membrane integrity
80348-6,Escherichia coli enteropathogenic eae gene
80349-4,Escherichia coli enteroaggregative pAA plasmid aggR+aatA genes
80350-2,Shigella species+EIEC invasion plasmid antigen H (ipaH) gene
80351-0,Escherichia coli enterotoxigenic ltA+st1a+st1b genes
80352-8,Environment temperature during transport
80353-6,Herpes simplex virus 1 genome DNA polymerase region B+thymidine kinase region C
80354-4,Herpes simplex virus 1 & 2 DNA panel
80355-1,Herpes simplex virus 2 genome glycoprotein B 3' end region+thymidine kinase region C
80356-9,Cause of death entity axis code
80357-7,Cause of death record axis code
Aug-35,Strongyloides stercoralis Ab.IgG
80358-5,Cause of death.underlying
80359-3,Cause of death.underlying
80360-1,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA
80361-9,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA
80362-7,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA
80363-5,Chlamydia trachomatis DNA
80364-3,Chlamydia trachomatis rRNA
80365-0,Chlamydia trachomatis+Neisseria gonorrhoeae rRNA
Jun-36,Taenia saginata Ab
80366-8,Neisseria gonorrhoeae rRNA
80367-6,Chlamydia trachomatis
80368-4,Neisseria gonorrhoeae
80369-2,Neisseria sp identified
803-7,Toxic granules
80370-0,Biotinidase
80371-8,Chitotriosidase
80372-6,Hemoglobin.gastrointestinal
80373-4,Helicobacter pylori Ag
Apr-37,Taenia solium adult Ab
80374-2,Adenovirus & Norovirus & Rotavirus Ag panel
80375-9,Norovirus Ag
80376-7,Rotavirus & Adenovirus Ag panel
80381-7,Influenza virus A & B Ag panel
Feb-38,Toxocara canis Ab
80382-5,Influenza virus A Ag
80383-3,Influenza virus B Ag
80384-1,Choriogonadotropin (pregnancy test)
80385-8,Choriogonadotropin (pregnancy test)
80386-6,Bladder tumor Ag
80387-4,HIV 1+2 Ab
80389-0,Special medical equipment &or resuscitation needs
8039-0,Toxoplasma gondii Ab.IgG
80390-8,Family unification code
80391-6,Level of care
80392-4,Special accommodation
80393-2,Emergency management incident name
80394-0,Emergency management incident type
80395-7,Date of gestational age estimate
80396-5,Consultation note
80397-3,Number of W postpartum
80398-1,Unique identifier
80399-9,Occupational exposure information panel
80400-5,Testing facility panel
80401-3,Employment information panel
80402-1,Egg source
80403-9,Respiratory wave amplitude
80404-7,RR interval.standard deviation
80405-4,Certification
80406-2,Date and time of initial encounter
80407-0,Contamination+radiation+contagion status
Aug-40,Toxoplasma gondii Ab.IgM
80408-8,Meets CDC field triage criteria
80409-6,Bed type
80410-4,Date and time of transfer departure
80411-2,Emergency management incident location
80412-0,Encounter location
80413-8,Transferred to
80414-6,Head circumference/Abdominal circumference
80415-3,Body weight growth percentile
Jun-41,Treponema pallidum Ab
80416-1,Head circumference/Abdominal circumference
80417-9,Risk assessment and screening note
80418-7,Medical equipment or product list
80419-5,Referral note
80420-3,Mandatory reporting form
80421-1,Mandatory reporting form
80422-9,Report
80423-7,Safety issue assessment note
Apr-42,Trichinella spiralis Ab
80424-5,Inosine triphosphate pyrophosphatase
80425-2,Beta-N-acetylhexosaminidase.A
80426-0,Hepatitis D virus RNA
80427-8,Employer name
80428-6,Past employer name
80429-4,Employer address
80430-2,Past employer address
80431-0,Employer city
Feb-43,Trichinella spiralis Ab.IgG
80432-8,Past employer city
80433-6,Employer state
80434-4,Past employer state
80435-1,Employer postal code
80436-9,Past employer postal code
80437-7,Employer country
80438-5,Past employer country
80439-3,Alcohol intake panel
8044-0,Trypanosoma brucei Ab
80440-1,Bioactive compound intake panel
80441-9,Breast milk &or formula intake panel
80442-7,Breast milk intake panel
80443-5,Calorie intake panel
80444-3,Fluid intake panel
80445-0,Food amounts panel
80446-8,Infant formula intake panel
80447-6,Meal &or snack pattern panel
80448-4,Enteral tube flush volume
80449-2,Adequacy of infant formula intake
804-5,Leukocytes
80450-0,Beer intake
80451-8,Beta glucan intake
80452-6,Beta glucan intake
80453-4,Food intake panel
80454-2,Enteral tube.nutritional intake panel
80455-9,Grain servings
80456-7,Grain servings
Jul-45,Trypanosoma cruzi Ab
80457-5,Fruit servings
80458-3,Fruit servings
80459-1,Vegetable servings
80460-9,Vegetable servings
80461-7,Dairy servings
80462-5,Dairy servings
80463-3,Protein servings
80464-1,Protein servings
May-46,Varicella zoster virus Ab
80465-8,Oil servings
80466-6,Oil servings
80467-4,Empty calorie servings
80468-2,Empty calorie servings
80469-0,Infant formula intake
80470-8,Plant stanol ester intake
80471-6,Plant stanol ester intake
80472-4,Psyllium intake
Mar-47,Varicella zoster virus Ab.IgG
80473-2,Psyllium intake
80474-0,Infant formula intake
80475-7,Fluid intake.enteral tube.nutritional formula composition
80476-5,Enteral tube.nutritional formula concentration
80477-3,Fluid intake.enteral tube.nutritional formula volume
80478-1,Distilled alcohol intake
80479-9,Wine intake
80480-7,Soy protein intake
Jan-48,Varicella zoster virus Ab.IgM
80481-5,Soy protein intake
80482-3,Breast milk feeding attempts
80483-1,Breast milk intake volume
80484-9,Breast milk intake volume
80485-6,Breast milk intake adequacy
80486-4,Snacks
80487-2,Snacks
80488-0,Infant formula feedings
80489-8,Caffeine intake
80490-6,Caffeine intake
80491-4,Meals
80492-2,Meals
80493-0,Activity level
80494-8,Calorie intake
80495-5,Multisection^WO contrast
80496-3,Multisection 3D post processing
80497-1,Guidance for needle localization
80498-9,Guidance for needle localization
Sep-49,Varicella zoster virus DNA
80499-7,Multisection^WO & W Contrast IV
80500-2,Multisection^W stress+WO contrast
80501-0,Multisection^W contrast PO+WO contrast IV
80502-8,Multisection^WO & W contrast IV
80503-6,Multisection^W contrast PO+WO & W contrast IV
80504-4,Guidance for percutaneous biopsy
80505-1,Multisection for new diagnosis tumor^WO & W contrast IV
80506-9,Multisection for low grade tumor^WO & W contrast IV
Jul-50,Venezuelan equine encephalitis virus Ab.IgG
80507-7,Multisection for high grade tumor^WO & W contrast IV
80508-5,Multisection^W contrast IS
80509-3,Guidance for placement of clip
80510-1,Multisection for metastasis^WO & W contrast IV
80511-9,Multisection for postoperative
80512-7,Multisection^WO contrast
80513-5,Multisection^W contrast IV
80514-3,Multisection^WO & W contrast IV
May-51,Venezuelan equine encephalitis virus Ab.IgM
80515-0,Immunoglobulin light chains.kappa.free
80516-8,Immunoglobulin light chains.lambda.free
80517-6,Immunoglobulin light chains.kappa.free/Immunoglobulin light chains.lambda.free
80518-4,Clostridium baratii toxin F bont gene
80519-2,Urine flow.max
805-2,Leukocytes
80520-0,Flow time
80521-8,Uroflowmetry study
80522-6,Urine flow.mean
Mar-52,Western equine encephalitis virus Ab.IgG
80523-4,Fluid output.urine
80524-2,Voiding time
80525-9,Uroflowmetry panel
80526-7,Time to max urine flow
80527-5,Percutaneous coronary intervention individual lesion procedure details panel
80528-3,Catheterization & angiography preoperative information panel
80529-1,Everolimus
80530-9,Fluconazole
Jan-53,Western equine encephalitis virus Ab.IgM
80531-7,Itraconazole
80532-5,Methadone
80533-3,Methamphetamine
80534-1,Methylenedioxyamphetamine
80535-8,Methylenedioxyethylamphetamine
80536-6,Methylenedioxyethylamphetamine
80537-4,Methylenedioxymethamphetamine
80538-2,Methylphenidate
80539-0,Morphine
80540-8,Moxifloxacin
80541-6,Nicotine
80542-4,Norcitalopram
80543-2,Norclozapine
80544-0,Nortriptyline
80545-7,Posaconazole
80546-5,rifAMPin
80547-3,Rilpivirine
80548-1,Sirolimus
Sep-54,Yellow fever virus Ab
80549-9,Sulfamethoxazole
80550-7,Tacrolimus
80551-5,Tetrahydrocannabinol
80552-3,Trimethoprim
80553-1,Voriconazole
80554-9,Zopiclone
80555-6,Diamorphine
Jun-55,Yellow fever virus Ab.IgG
80556-4,cloZAPine
80557-2,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine"
80558-0,Amitriptyline
80559-8,Clarithromycin
80560-6,Citalopram
80561-4,cycloSPORINE
80562-2,Diagram
80563-0,Report
Apr-56,Yellow fever virus Ab.IgM
80564-8,Mandatory reporting form
80565-5,Medication administration flowsheet
80566-3,Checklist
80567-1,Flowsheet
80568-9,Form
80569-7,Progress note
80570-5,Agreement
80571-3,Certificate
Feb-57,Yellow fever virus RNA
80572-1,Flowsheet
80573-9,Checklist
80574-7,Admission history and physical note
80575-4,Consultation note
80576-2,Education note
80577-0,Referral note
80578-8,Preoperative evaluation and management note
80579-6,Surgical operation note
8058-0,Acetylcholine receptor Ab
80580-4,Transfer summary note
80581-2,Incubation date & time range
80582-0,LOINC Document Ontology associated observations panel
80583-8,Multisection for motor function
80584-6,Multisection endovaginal^WO contrast
80585-3,Multisection endorectal^W contrast IV
80586-1,Adenovirus hexon gene
80587-9,Human metapneumovirus A+B L+N genes
80588-7,Influenza virus A M gene
80589-5,Influenza virus A H1 HA gene
80590-3,Influenza virus A H3 HA gene
80591-1,Influenza virus B NS gene
80592-9,Parainfluenza virus 1 F gene
80593-7,Parainfluenza virus 2 L gene
80594-5,Parainfluenza virus 3 NP gene
80595-2,Parainfluenza virus 4 P gene
80596-0,Rhinovirus 5' UTR RNA
80597-8,Respiratory syncytial virus A 5' UTR RNA
Aug-59,Adrenal Ab
80598-6,Respiratory syncytial virus B F gene
80599-4,Bordetella holmesii fumC gene
806-0,Leukocytes
80600-0,Bordetella pertussis.pertussis toxin promoter region
80601-8,Bordetella pertussis+parapertussis+bronchiseptica gidA gene
80602-6,Respiratory pathogens identified
80603-4,Coagulation factor XI inhibitor
80604-2,Desacetylrifampicin
80605-9,Desacetylrifampicin
Jun-60,Adrenal cortex Ab
80606-7,14-Hydroxyclarithromycin
80607-5,14-Hydroxyclarithromycin
80608-3,Cefuroxime
80609-1,Linezolid
80610-9,A Ab.IgG
80611-7,Phosphate
80612-5,B Ab.IgG
80613-3,Bicarbonate
Apr-61,Nuclear Ab
80614-1,Baclofen
80615-8,Recommended follow-up
80616-6,Date and time pronounced dead
80617-4,Cefuroxime.free
80618-2,Zika virus Ab.IgM
80619-0,Zika virus Ab.IgM
80620-8,Zika virus Ab.Neut
80621-6,Zika virus Ab.Neut
Feb-62,Cardiolipin Ab
80622-4,Zika virus Ab.Neut^1st specimen
80623-2,Zika virus Ab.Neut^2nd specimen
80624-0,Zika virus Ab.Neut^1st specimen
80625-7,Zika virus Ab.Neut^2nd specimen
80626-5,Activity at time of death
80627-3,Coagulation factor X activated inhibitor
80628-1,"1,1'-Sulfonylbis-2-Methylthioethane"
80629-9,"1,2,2-Trimethylpropyl methylphosphonate"
8063-0,Cardiolipin Ab.IgA
80630-7,"1,2-Dichloroethane"
80631-5,"1,3-Dimethylbenzene+1,4-Dimethylbenzene"
80632-3,2-Methylpropyl methylphosphonate
80633-1,Aldicarb
80634-9,Aldicarb sulfone
80635-6,Aldicarb sulfoxide
80636-4,Alpha-amanitin
80637-2,Bedaquiline
80638-0,Beta-amanitin
80639-8,Gamma-amanitin
80640-6,Disopyramide+Nordisopyramide
80641-4,Dothiepin+nordothiepin
80642-2,Floxacillin.free
80643-0,Gadolinium
80644-8,Isopropyl methylphosphonate
80645-5,Maprotiline+Normaprotiline
80646-3,Monocyclohexyl methylphosphonate
80647-1,Monoethyl methylphosphonate
Aug-64,Cardiolipin Ab.IgG
80648-9,N-monodesmethyl bedaquiline
80649-7,Tetramethylenedisulfotetramine
80650-5,Tin
80651-3,Voriconazole N-oxide
80652-1,Everolimus
80653-9,Spermatozoa.normal chromatin/100 spermatozoa
80654-7,Spermatozoa.progressive.grade 1+2/100 spermatozoa
May-65,Cardiolipin Ab.IgG
80655-4,Hemoglobin G-Philadelphia/Hemoglobin.total
80656-2,Hemoglobin Hope/Hemoglobin.total
80657-0,Hemoglobin Q/Hemoglobin.total
80658-8,Activated clotting time.diatomaceous earth induced
80659-6,Activated clotting time.kaolin induced
80660-4,Strongyloides sp Ab.IgG
80661-2,Color
80662-0,Specimen volume
Mar-66,Cardiolipin Ab.IgM
80663-8,4-Hydroxy 3-Nitrophenylacetate
80664-6,Consultation note
80665-3,Progress note
80666-1,Consultation note
80667-9,Progress note
80668-7,Surgical operation note
80669-5,Procedure note
80670-3,Procedure note
Jan-67,Cardiolipin Ab.IgM
80671-1,Progress note
80672-9,Conference note
80673-7,Consultation note
80674-5,Adenovirus 40+41 fiber protein gene
80675-2,Rotavirus A VP6 gene
80676-0,Escherichia coli O157 rfbE gene
80677-8,Escherichia coli enterotoxigenic eltA+estB genes
80678-6,Salmonella sp invA+fliC genes
80679-4,Escherichia coli Stx1+Stx2 toxin stx1+stx2 genes
80680-2,Vibrio cholerae toxin ctxA gene
80681-0,Cryptosporidium parvum+hominis oocyst wall protein (COWP) gene
80682-8,Entamoeba histolytica 18S rRNA
80683-6,Giardia lamblia 18S rRNA
80684-4,Campylobacter coli+jejuni+lari 16S rRNA
80685-1,Clostridioides difficile toxin A+B tcdA+tcdB genes
80686-9,CYP2C9 gene targeted mutation analysis
80687-7,CYP1A2 gene targeted mutation analysis
80688-5,HIV 1 RNA tropism
Sep-68,Centromere Ab
80689-3,HIV 1 RNA reverse transcriptase & protease & integrase gene mutations detected
80690-1,HIV 1 proviral DNA tropism
80691-9,HIV 1 proviral DNA integrase gene mutations detected
80692-7,HIV 1 proviral DNA reverse transcriptase & protease gene mutations detected
80693-5,HIV 1 proviral DNA reverse transcriptase & protease & integrase gene mutations detected
80694-3,HIV 1 proviral DNA genotype
80695-0,HIV 1 proviral DNA genotype
80696-8,2-Chlorovinyl arsonous acid
Jul-69,Epidermis Ab
80697-6,Mycophenolate acyl-glucuronide
80698-4,Viable CD34 cells/100 cells.CD34
80699-2,Cells.CD4-CD8-/100 Cells.CD3+TCR alpha beta+
80700-8,Cells.CD25+CD127-/100 cells.CD3+CD4+
80701-6,Cells.CD27-/100 Cells.CD3+CD8+
80702-4,Cells.CD27+CD45RA-/100 Cells.CD3+CD4+
80703-2,Cells.CD27+CD45RA-/100 Cells.CD3+CD8+
80704-0,Cells.CD27+CD45RA+/100 Cells.CD3+CD4+
May-70,Gliadin Ab.IgM
80705-7,Cells.CD27+CD45RA+/100 Cells.CD3+CD8+
80706-5,Cells.CD27+IgD-/100 Cells.CD19+CD20+
80707-3,Cells.CD27+IgD+/100 Cells.CD19+CD20+
80708-1,Cells.CD27-CD45RA-/100 Cells.CD3+CD4+
80709-9,Cells.CD27-CD45RA+/100 Cells.CD3+CD4+
80710-7,Cells.CD27-IgD+/100 Cells.CD19+CD20+
80711-5,Cells.CD38+HLA-DR+/100 Cells.CD3+CD4+
80712-3,Cells.CD38+HLA-DR+/100 Cells.CD3+CD8+
Mar-71,Histone Ab
80713-1,Cells.TCR alpha beta/100 Cells.CD3
80714-9,Cells.TCR gamma delta/100 Cells.CD3
80715-6,FSHR gene targeted mutation analysis
80716-4,T-cell activated (CD38+HLA-DR+) subsets panel
80717-2,B-cell CD27 & IgD subsets panel
80718-0,Lymphocyte TCR gamma delta & alpha beta subsets panel
80719-8,T-cell naive & memory & effector (CD27 and CD45RA) subsets
80720-6,T-cell naive & memory & effector (CD27 and CD45RA) subsets panel
Jan-72,Insulin Ab
80721-4,Lymphocyte T-cell & B-cell & Natural killer subsets panel
80722-2,Lymphocyte T-cell & B-cell & Natural killer subsets
80723-0,B-cell CD27 & IgD subsets
80724-8,Non-liquefied volume/Volume.total
80725-5,Trichomonas sp
80726-3,Blood sampling performed
80727-1,Percutaneous coronary intervention performed
80728-9,Stenosis degree^pre procedure
80729-7,New or recurrent stenosis
80730-5,Stenosis classification
80731-3,Percutaneous coronary intervention individual lesion procedure results panel
80732-1,Checklist
80733-9,Admission history and physical note
80734-7,Preoperative evaluation and management note
80735-4,Transfer summary note
80736-2,Consultation note
80737-0,Calculated panel reactive antibody
80738-8,TPMT gene targeted mutation analysis
Sep-73,Insulin bovine Ab
80739-6,Plan of care note
80740-4,Plan of care note
80741-2,Plan of care note
80742-0,Plan of care note
80743-8,Plan of care note
80744-6,Plan of care note
80745-3,Plan of care note
80746-1,Plan of care note
Jul-74,Insulin human Ab
80747-9,Plan of care note
80748-7,Plan of care note
80749-5,Plan of care note
80750-3,Plan of care note
80751-1,Plan of care note
80752-9,Plan of care note
80753-7,Plan of care note
Apr-75,Insulin porcine Ab
80754-5,Plan of care note
80755-2,Plan of care note
80756-0,Plan of care note
80757-8,Plan of care note
80758-6,Plan of care note
80759-4,Plan of care note
80760-2,Plan of care note
80761-0,Plan of care note
Feb-76,Jo-1 extractable nuclear Ab
80762-8,Plan of care note
80763-6,Plan of care note
80764-4,Plan of care note
80765-1,Plan of care note
80766-9,Plan of care note
80767-7,Plan of care note
80768-5,Plan of care note
80769-3,Plan of care note
8077-0,Mitochondria Ab
80770-1,Plan of care note
80771-9,Plan of care note
80772-7,Plan of care note
80773-5,Plan of care note
80774-3,Plan of care note
80775-0,Plan of care note
80776-8,Plan of care note
80777-6,Plan of care note
80778-4,Plan of care note
80779-2,Plan of care note
807-8,Leukocytes
80780-0,Plan of care note
80781-8,Plan of care note
80782-6,Plan of care note
80783-4,Plan of care note
80784-2,Plan of care note
80785-9,Plan of care note
80786-7,Plan of care note
80787-5,Plan of care note
Aug-78,Mycoplasma pneumoniae Ab.IgM
80788-3,Plan of care note
80789-1,Plan of care note
80790-9,Plan of care note
80791-7,Plan of care note
80792-5,Diagnostic study note
80793-3,Education note
80794-1,Flowsheet
80795-8,Initial evaluation note
Jun-79,Myelin Ab.IgA
80796-6,Plan of care note
80797-4,Plan of care note
80798-2,Procedure note
80799-0,Admission history and physical note
80800-6,Checklist
80801-4,Consultation note
80802-2,Education note
80803-0,Flowsheet
Apr-80,Myelin Ab.IgG
80804-8,Plan of care note
80805-5,Preoperative evaluation and management note
80806-3,Referral note
80807-1,Surgical operation note
80808-9,Transfer summary note
80809-7,Admission history and physical note
80810-5,Discharge instructions
80811-3,Discharge summary note
Feb-81,Myelin Ab.IgM
80812-1,Discharge teaching note
80813-9,History and physical note
80814-7,Initial evaluation note
80815-4,Progress note
80816-2,Transfer summary note
80817-0,Flowsheet
80818-8,Plan of care note
80819-6,Progress note
8082-0,Myelin basic protein Ab
80820-4,Medication reconciliation form
80821-2,Zika virus Ab.Neut
80822-0,Zika virus Ab.Neut
80823-8,Zika virus Ab.IgM
80824-6,Zika virus Ab.IgM
80825-3,Zika virus envelope (E) gene
80826-1,Zika virus envelope (E) gene
80827-9,Clostridium botulinum & Clostridium baratii toxins gene panel
80828-7,Pepsin A+Pepsinogen A
80829-5,Pepsin A+Pepsinogen A
80830-3,pH
80831-1,Pepsin A Panel
80832-9,Protein
80833-7,Multisection limited for multiple gestation pregnancy
80834-5,Multisection for multiple gestation pregnancy+first trimester
80835-2,Multisection transabdominal + transvaginal for multiple gestation pregnancy+first trimester
80836-0,Multisection for multiple gestation pregnancy+second or third trimester
80837-8,Multisection for multiple gestation pregnancy+fetal abnormality
Aug-83,Myocardium Ab
80838-6,Multisection limited
80839-4,Multisection limited
80840-2,Multisection limited
80841-0,Guidance for placement of needle
80842-8,Guidance additional for aspiration of cyst
80843-6,Guidance for biopsy.vacuum
80844-4,Guidance for percutaneous biopsy.fine needle
80845-1,Guidance for biopsy.core needle
Jun-84,Neutrophil cytoplasmic Ab.classic
80846-9,Guidance additional for aspiration of cyst
80847-7,Guidance for biopsy.vacuum
80848-5,Guidance for percutaneous biopsy.fine needle
80849-3,Guidance for biopsy.core needle
80850-1,Multisection limited
80851-9,Multisection for pregnancy
80852-7,Multisection
Mar-85,Neutrophil cytoplasmic Ab.perinuclear
80853-5,Guidance for injection
80854-3,Multisection limited
80855-0,Multisection
80856-8,Multisection limited
80857-6,Multisection
80858-4,Multisection
80859-2,Multisection
808-6,Leukocytes
80860-0,Multisection limited
Jan-86,Pancreatic islet cell Ab
80861-8,Multisection
80862-6,Multisection for in vitro fertilization
80863-4,Multisection for transplanted kidney
80864-2,Multisection for pregnancy
80865-9,Multisection transvaginal for pregnancy
80866-7,Multisection for pregnancy+second or third trimester
80867-5,Multisection transabdominal + transvaginal for pregnancy+first trimester
80868-3,Multisection for pregnancy+fetal abnormality
80869-1,Multisection for pregnancy+first trimester
80870-9,Multisection limited for pregnancy
80871-7,Multisection for torsion
80872-5,Multisection^W saline IU
80873-3,Multisection limited
80874-1,Multisection
80875-8,Multisection
80876-6,Multisection transrectal for volume measurement
80877-4,Multisection for torsion
80878-2,Multisection for pregnancy
Sep-87,Parietal cell Ab
80879-0,Multisection limited
80880-8,Guidance for injection
80881-6,Multisection
80882-4,Guidance^during surgery
80883-2,American Urological Association Symptom Index
80884-0,How often have you had a sensation of not emptying your bladder completely after you finished urinating over the past Mo
80885-7,How often have you had to urinate again less than 2H after you finished urinating over the past Mo
80886-5,How often have you found you stopped and started again several times when you urinated over the past Mo
Jul-88,PCNA extractable nuclear Ab
80887-3,How often have you found it difficult to postpone urination over the past Mo
80888-1,How often have you had a weak urinary stream over the past MO
80889-9,How often have you had to push or strain to begin urination over the past MO
80890-7,How many times did you most typically get up to urinate from the time you went to bed at night until the time you got up in the morning over the past Mo
80891-5,Symptom score
80892-3,Heparin.unfractionated
80893-1,Projected heparin concentration to reach target ACT
80894-9,2-Methyltyrosine/Creatinine
May-89,Platelet associated Ab.IgG
80895-6,Multisection
80896-4,Multisection
80897-2,Multisection limited
80898-0,Multisection
80899-8,Plant sterol ester intake
80900-4,Plant sterol ester intake
80901-2,Paternal information
80902-0,Surfactant replacement given
Mar-90,Platelet associated Ab.IgM
80903-8,Birth certificate number
80904-6,Birth year
80905-3,Body disposition method
80906-1,Bridged race
80907-9,Death registration date
80908-7,Ethnicity
80909-5,Father's last name
80910-3,State or province of birth
Jan-91,Ribonucleoprotein extractable nuclear Ab
80911-1,Death pronouncer
80912-9,Gadolinium
80913-7,Highest level of education
80914-5,Start coordinates
80915-2,Stenosis degree
80916-0,Lesion start segment
80917-8,Lesion start coordinates
80918-6,Lesion start segment position
80919-4,Lesion end segment
80920-2,Lesion end coordinates
80921-0,Lesion end segment position
80922-8,Lesion located at vessel bifurcation
80923-6,Bifurcated lesion end segment
80924-4,Bifurcated lesion end coordinates
80925-1,Bifurcated lesion end segment position
80926-9,Coronary stent start segment
80927-7,Coronary stent end segment
80928-5,Coronary stent start segment position
Sep-92,SCL-70 extractable nuclear Ab
80929-3,Coronary stent start coordinates
80930-1,Coronary stent end coordinates
80931-9,Coronary stent end segment position
80932-7,Views for bone density
80933-5,Views for bone density
80934-3,Views for bone density
80935-0,Views for bone density
80936-8,Views for bone density
Jul-93,Sjogrens syndrome-A extractable nuclear Ab
80937-6,Views for bone density
80938-4,Views for bone density
80939-2,Views for bone density
809-4,Leukocytes
80940-0,Views for bone density
80941-8,Views for bone density
80942-6,Views for bone density
80943-4,Views for bone density
80944-2,Views for bone density
May-94,Sjogrens syndrome-B extractable nuclear Ab
80945-9,Views for bone density
80946-7,Views for bone density
80947-5,Views for bone density
80948-3,Views for bone density
80949-1,Views for bone density
80950-9,Views for bone density
80951-7,Views for bone density
Feb-95,Smooth muscle Ab
80952-5,Views for bone density
80953-3,Views for bone density
80954-1,Views for bone density
80955-8,Views for bone density
80956-6,Views for bone density
80957-4,cefTRIAXone.free
80958-2,Fractional excretion of magnesium
80959-0,Glucose^1.5H post meal
8096-0,Somatotropin Ab
80960-8,cefTAZidime.free
80961-6,Cefotaxime.free
80962-4,ceFAZolin.free
80963-2,Salicylates.free
80964-0,Acetaminophen.free
80965-7,Topiramate.free
80966-5,Tobramycin.free
80967-3,Theophylline.free
80968-1,Teicoplanin.free
80969-9,Methotrexate.free
80970-7,Lithium.free
80971-5,Gentamicin.free
80972-3,Amikacin.free
80973-1,Trimethoprim.free
80974-9,Sulfamethoxazole.free
80975-6,Calcium intake
80976-4,International Prostate Symptom Score
80977-2,Tabulated race
Aug-97,Striated muscle Ab
80978-0,Tabulated ethnicity
80979-8,Frataxin
80980-6,Frataxin
80981-4,"N,N-dimethylarginine"
80982-2,Phytanoyl CoA hydroxlase
80983-0,Chloride intake
80984-8,Fluoride intake
80985-5,Premature coronary artery disease
Jun-98,Thyroglobulin Ab
80986-3,Cardiac arrest within 24H prior to procedure
80987-1,Cardiogenic shock within 24H prior to procedure
80988-9,Thrombus
80989-7,Date of procedure
80990-5,Fluoroscopy duration
80991-3,Fluoroscopy dose
80992-1,Date and time of surgery
80993-9,Date and time of first balloon inflation
Apr-99,Thyroperoxidase Ab
80994-7,Coronary angiography performed
80995-4,Left ventriculography performed
80996-2,Intravascular ultrasound performed
80997-0,Fractional flow reserve performed
80998-8,Intra-aortic balloon pump used
80999-6,Segment(s) affected by lesion
81-0,Cefixime
8100-0,Specimen preparation
81000-2,TIMI grade^pre procedure
81001-0,TIMI grade^post procedure
81002-8,Devices used
81003-6,Iodine intake
81004-4,Iodine intake
81005-1,Magnesium intake
81006-9,Magnesium intake
81007-7,Manganese intake
81008-5,Manganese intake
81009-3,Potassium intake
81010-1,Potassium intake
81011-9,Sodium intake
81012-7,Sodium intake
81013-5,Alpha linolenate intake
81014-3,Alpha linolenate intake
81015-0,Arginine intake
81016-8,Arginine intake
81017-6,Vitamin B7 intake
Aug-01,Cells.CD3+CD8+/100 cells
81018-4,Vitamin B7 intake
81019-2,Casein intake
810-2,Leukocytes
81020-0,Casein intake
81021-8,Cholesterol intake
81022-6,Cholesterol intake
81023-4,Chromium intake
81024-2,Chromium intake
81025-9,Complex carbohydrate intake
Jun-02,Cells.CD33/100 cells
81026-7,Complex carbohydrate intake
81027-5,Copper intake
81028-3,Copper intake
81029-1,Eicosapentaenoate intake
81030-9,Eicosapentaenoate intake
81031-7,Alpha-linoate+Linoleate intake
81032-5,D per W alcoholic drinks consumed
81033-3,Fat.saturated intake
Apr-03,Cells.CD45+CD14+/100 cells
81034-1,Trans fat intake
81035-8,Trans fat intake
81036-6,Polyunsaturated fat intake
81037-4,Docosahexaenoate intake
81038-2,Docosahexaenoate intake
81039-0,Gluten intake
81040-8,Gluten intake
81041-6,Isoleucine intake
Feb-04,Cells.CD5+CD20+/100 cells
81042-4,Isoleucine intake
81043-2,Leucine intake
81044-0,Leucine intake
81045-7,Threonine intake
81046-5,Threonine intake
81047-3,Valine intake
81048-1,Valine intake
81049-9,Sucrose intake
81050-7,Sucrose intake
81051-5,Lactose intake
81052-3,Lactose intake
81053-1,Galactose intake
81054-9,Galactose intake
81055-6,Fructose intake
81056-4,Fructose intake
81057-2,Fiber intake
81058-0,Fiber.soluble intake
Sep-05,Cells.CD5+CD8+/100 cells
81059-8,Fiber.soluble intake
81060-6,Fiber.insoluble intake
81061-4,Fiber.insoluble intake
81062-2,Vitamin B12 intake
81063-0,Vitamin B12 intake
81064-8,Vitamin B6 intake
81065-5,Vitamin B6 intake
81066-3,Vitamin B9 intake
Jul-06,Cells.CD1/100 cells
81067-1,Vitamin B3 intake
81068-9,Vitamin B5 intake
81069-7,Vitamin B5 intake
81070-5,Vitamin B2 intake
81071-3,Vitamin B2 intake
81072-1,Vitamin A intake
81073-9,Vitamin A intake
81074-7,Vitamin C intake
May-07,Cells.CD10/100 cells
81075-4,Vitamin C intake
81076-2,Vitamin E intake
81077-0,Vitamin E intake
81078-8,Vitamin K intake
81079-6,Vitamin K intake
81080-4,Chloride intake
81081-2,Fluoride intake
81082-0,Iron intake
Mar-08,Cells.CD11c+CD20+/100 cells
81083-8,Iron intake
81084-6,Molybdenum intake
81085-3,Molybdenum intake
81086-1,Selenium intake
81087-9,Selenium intake
81088-7,Zinc intake
81089-5,Zinc intake
81090-3,"If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that"
Jan-09,Cells.CD11c/100 cells
81091-1,Orifice area
81092-9,Orifice area
81093-7,Effective regurgitant orifice area
81094-5,Effective regurgitant orifice area
81095-2,Myocardial mass/Body surface area
81096-0,West Nile virus Kunjin strain Ab.IgM
81097-8,West Nile virus Kunjin strain Ab
81098-6,Leptospira borgpetersenii serovar Arborea Ab
81099-4,Leptospira interrogans serovar Bulgarica Ab
811-0,Leukocytes
81100-0,Leptospira interrogans serovar Celledoni Ab
81101-8,Leptospira interrogans serovar Copenhageni Ab
81102-6,Leptospira interrogans serovar Cynopteri Ab
81103-4,Leptospira interrogans serovar Kremastos Ab
81104-2,Leptospira interrogans serovar Medanensis Ab
81105-9,Leptospira interrogans serovar Panama Ab
81106-7,Leptospira interrogans serovar Robinsoni Ab
81107-5,Leptospira interrogans serovar Shermani Ab
81108-3,Leptospira interrogans serovar Szwajizak Ab
Sep-10,Cells.CD13/100 cells
81109-1,Leptospira interrogans serovar Zanoni Ab
81110-9,Leptospira weilii serovar Topaz Ab
81111-7,Murray Valley encephalitis virus Ab.IgG
81112-5,Murray Valley encephalitis virus Ab.IgG
81113-3,Murray Valley encephalitis virus Ab.IgM
81114-1,Murray Valley encephalitis virus Ab.IgM
81115-8,Murray Valley encephalitis virus Ab
81116-6,Hepatitis C virus core Ab+Ag
Jul-11,Cells.CD14/100 cells
81117-4,Ross river virus RNA
81118-2,Legionella sp Ab.IgM
81119-0,Epstein Barr virus capsid Ab.IgG avidity
81120-8,Barmah forest virus Ab
81121-6,Murray Valley encephalitis virus Ab
81122-4,HIV 1 RNA reverse transcriptase & protease gene
81123-2,Coagulation factor VII inhibitor
81124-0,Coagulation factor V inhibitor
May-12,Cells.CD3-CD16+CD56+/100 cells
81125-7,Platelet aggregation.ristocetin inhibitor
81126-5,Cobalt intake
81127-3,Cobalt intake
81128-1,Alpha-linoate+Linoleate intake
81129-9,Glutamine intake
81130-7,Glutamine intake
81131-5,Polyunsaturated fat intake
81132-3,Phosphorus intake
Mar-13,Cells.CD16+CD57-/100 cells
81133-1,Fiber intake
81134-9,Vitamin B9 intake
81135-6,Vitamin B3 intake
81136-4,Fat.saturated intake
81137-2,Calcium intake
81138-0,Spermatozoa.aggregated
81139-8,CYP3A4 gene allele
81140-6,CYP3A5 gene allele
Jan-14,Cells.CD16-CD57+/100 cells
81141-4,Spermatozoa motility
81142-2,PTPN22 gene.c.1858C>T
81143-0,Galactokinase
81144-8,Cerium
81145-5,CYP3A4 gene product metabolic activity interpretation
81146-3,CYP3A4 & CYP3A5 gene targeted mutation analysis
81147-1,Specimen source identification
81148-9,Zika virus envelope (E) gene
81149-7,Zika virus envelope (E) gene
81150-5,Dengue virus 1+2+3+4 5' UTR RNA
81151-3,Dengue virus 1+2+3+4 5' UTR RNA
81152-1,Chikungunya virus non-structural protein 1 (nsP1) RNA
81153-9,Chikungunya virus non-structural protein 1 (nsP1) RNA
81154-7,Dengue & Chikungunya & Zika virus panel
81155-4,Islet cell 512 Ab
81156-2,Ubiquinone 10.reduced/Ubiquinone 10
81157-0,Ubiquinone 10.reduced
Aug-15,Cells.CD16/100 cells
81158-8,Multisection for pediatrics
81159-6,Multisection for pediatrics
81160-4,Multisection limited for pediatrics
81161-2,Multisection for blood flow
81162-0,Guidance for needle localization && Views
81163-8,Guidance for needle localization && Views
81164-6,Multisection limited for pediatrics
81165-3,Guidance for peripheral venous access
Jun-16,Cells.CD19
81166-1,Surgical resection
81167-9,Cancer treatment^preoperative
81168-7,Site of adjacent organ or tissue involvement
81169-5,Residual tumor^postoperative
81170-3,Stomach.greater curvature
81171-1,Stomach.lesser curvature
81172-9,Esophagus length
81173-7,Duodenum length
Apr-17,Cells.CD19/100 cells
81174-5,Tumor type
81175-2,Distance of tumor from closest margin
81176-0,Distance of tumor from circumferential resection margin
81177-8,Serosal classification
81178-6,Tissue block description and site
81179-4,Histologic type
81180-2,Growth pattern
81181-0,Serosal surface involvement
Feb-18,Cells.CD2/100 cells
81182-8,Distance of tumor from closest proximal margin
81183-6,Distance of tumor from closest distal margin
81184-4,Distance of tumor from circumferential resection margin
81185-1,Non-regional lymph nodes positive
81186-9,Cancer pathology panel
81187-7,Non-regional lymph nodes examined
81188-5,Tumor site
81189-3,Tumor regression^post preoperative therapy
8119-0,Cells.CD20/100 cells
81190-1,Histologic type
81191-9,Consultation note
81192-7,Consultation note
81193-5,Consultation note
81194-3,Evaluation and management of workers compensation note
81195-0,Evaluation and management of workers compensation form
81196-8,Consultation note
81197-6,Amino acid intake
81198-4,Amino acid intake
81199-2,Beta-ureidopropionase
81200-8,Plan of care note
81201-6,Phospholipase A2 receptor Ab.IgG
81202-4,Micronutrient form
81203-2,Bulk ingredient - animal drug
81204-0,NDC labeler code inactivation - animal drug
81205-7,Cryoglobulin IgA & IgG & IgM & C3 panel
81206-5,Views^W Tc-99m SC IV
81207-3,Amitriptyline & nortriptyline panel
Aug-20,Cells.CD21/100 cells
81208-1,Amitriptyline & nortriptyline panel
81209-9,clomiPRAMINE & Norclomipramine panel
81210-7,clomiPRAMINE & Norclomipramine panel
81211-5,Amitriptyline & nortriptyline panel
81212-3,clomiPRAMINE & Norclomipramine panel
81213-1,Laboratory communication about newborn screening
81214-9,Continuity of Care Document - recommended C-CDA R2.0 & R2.1 sections
81215-6,Care plan - recommended C-CDA R2.0 & R2.1 sections
Jun-21,Cells.CD25/100 cells
81216-4,Progress note - recommended C-CDA R2.0 & R2.1 sections
81217-2,Procedure note - recommended C-CDA R2.0 & R2.1 sections
81218-0,Discharge summary - recommended C-CDA R2.1 sections
81219-8,Discharge summary - recommended C-CDA R2.0 sections
81220-6,Diagnostic imaging report - recommended C-CDA R2.0 & R2.1 sections
81221-4,Transfer summary note - recommended C-CDA R2.0 sections
81222-2,Consultation note - recommended C-CDA R2.0 & R2.1 sections
81223-0,Referral note - recommended C-CDA R2.0 & R2.1 sections
Apr-22,Cells.CD3
81224-8,Vomiting
81225-5,Bleeding risk
81226-3,Electrolyte imbalance
81227-1,Fall risk
81228-9,Tobacco product
81229-7,Tobacco smoking status.tobacco smoker
81230-5,Referring physician phone number
81231-3,Protein fractions panel
Feb-23,Cells.CD3+CD4+/100 cells
81232-1,Supersaturation panel
81233-9,Influenza virus types A & B & subtypes RNA panel
81234-7,Varicella zoster virus Ab.IgG & IgM panel
81235-4,Varicella zoster virus surveillance panel
81236-2,Send document that conforms to C-CDA R1.1 template
81237-0,Send document that conforms to C-CDA R2.1 template
81238-8,Send document that conforms to CDP Set 1 R1.0 template
81239-6,Send document that conforms to CDP Set 1 R1.1 template
8124-0,Cells.CD3/100 cells
81240-4,Document template attachment request modifier codes
81241-2,Enhanced surgical operation note - recommended CDP Set 1 R1.0 & R1.1 sections
81242-0,Enhanced discharge summary - recommended CDP Set 1 R1.0 sections
81243-8,Enhanced encounter note - recommended CDP Set 1 R1.0 & R1.1 sections
81244-6,Enhanced procedure note - recommended CDP Set 1 R1.0 & R1.1 sections
81245-3,Interval document - recommended CDP Set 1 R1.0 & R1.1 sections
81246-1,HIV 2 RNA panel
81247-9,Master HL7 genetic variant reporting panel
81248-7,Default transcript reference sequence coding system
81249-5,Default genomic reference sequence coding system
81250-3,Simple variant panel
81251-1,Complex variant panel
81252-9,Simple variant
81253-7,Simple variant name
81254-5,Variant exact start-end
81255-2,dbSNP
81256-0,COSMIC simple variant
Jul-25,Cells.CD34/100 cells
81257-8,CIGAR
81258-6,Sample variant allelic frequency
81259-4,Associated phenotype
81260-2,Complex variant
81261-0,Complex variant name
81262-8,Complex variant HGVS name
81263-6,Complex variant type
81264-4,Fever duration
May-26,Cells.CD38/100 cells
81265-1,Body temperature.max
81266-9,Date of fever onset
81267-7,Setting of exposure to illness
81268-5,Date of rash onset
81269-3,Rash duration
81270-1,Gestational age in W^at onset of illness
81271-9,Trimester at onset of illness
81272-7,Cell Count & Differential panel
Mar-27,Cells.CD4
81273-5,Fentanyl & Norfentanyl panel
81274-3,Doxepin & Nordoxepin panel
81275-0,Fentanyl & Norfentanyl panel
81276-8,Doxepin & Nordoxepin panel
81277-6,Fentanyl & Norfentanyl panel
81278-4,Meperidine & Normeperidine panel
81279-2,Meperidine & Normeperidine panel
812-8,Leukocytes
81280-0,Differential panel
Jan-28,Cells.CD4/100 cells
81281-8,Heparin dose response panel
81282-6,Spermatozoa.motile
81283-4,Spermatozoa.nonprogressive
81284-2,Malignant cells/100 cells
81285-9,Escherichia coli Stx1 & Stx2 toxin stx1 & stx2 genes
81286-7,Structural variant
81287-5,Structural variant reported start-end
81288-3,Precision of boundaries
81289-1,Structural variant
81290-9,Genomic DNA change
81291-7,Structural variant ISCN name
81292-5,Simple variant
81293-3,Range(s) of DNA sequences examined
81294-1,Genetic form configuration controls
81295-8,Other transcript reference sequence coding system OID
81296-6,Other genomic reference sequence coding system OID
81297-4,Structural variant panel
81298-2,Structural variant cytogenetic location
Sep-29,Cells.CD4/Cells.CD8
81299-0,Structural variant reported arrCGH
81300-6,Structural variant
81301-4,Variant outer start-end
81302-2,Variant inner start-end
81303-0,HGVS version
81304-8,Structural variant analysis method
81305-5,Influenza virus A H1 2009 pandemic RNA
81306-3,Variables that apply to the overall study
Jul-30,Cells.CD45/100 cells
81307-1,Influenza virus A H7 Eurasia RNA
81308-9,Influenza virus A RNA
81309-7,Influenza virus B RNA
81310-5,Carbonic anhydrase 2 Ab
81311-3,Cryoglobulin.IgA
81312-1,Cryoglobulin.IgM
81313-9,Cryoglobulin.complement C3
81314-7,Palatinase
May-31,Cells.CD5+CD19+/100 cells
81315-4,Lactase
81316-2,Trichomonas vaginalis
81317-0,Additional pathological findings
81318-8,Spermatozoa.normal morphology
81319-6,Spermatozoa.progressive
81320-4,Influenza virus A H5 Asian RNA
81321-2,Influenza virus A H5 Asian RNA
81322-0,"Glucan 1,4 alpha glucosidase"
Mar-32,Cells.CD5/100 cells
81323-8,Urine collection associated observations panel
81324-6,Glucose tolerance 2H gestational panel
81325-3,Influenza virus B Yamagata lineage RNA
81326-1,Human RNase P RNA
81327-9,Influenza virus B Victoria lineage RNA
81328-7,Cytomegalovirus
81329-5,Thoughts on resuscitation
81330-3,Thoughts on intubation
Jan-33,Cells.CD56/100 cells
81331-1,Thoughts on tube feeding
81332-9,Thoughts on IV fluid and support
81333-7,Thoughts on antibiotics
81334-5,Personal advance care plan
81335-2,Healthcare agent
81336-0,"Goals, preferences, and priorities under certain health conditions"
81337-8,"Goals, preferences, and priorities upon death"
81338-6,"Goals, preferences, and priorities for care experience"
81339-4,Witness and notary
81340-2,Goals &or preferences in order of priority
81341-0,Circumstances that activate healthcare agent's powers
81342-8,Healthcare agent appointment intended to be valid in any jurisdiction
81343-6,Healthcare agent advisor
81344-4,Healthcare agent authority to inspect and disclose mental and physical health information
81345-1,Healthcare agent authority to inspect and disclose specially protected health information
81346-9,Limitations placed on healthcare agent
81347-7,"Consent for healthcare agent to deviate from stated goals, preferences and priorities"
81348-5,Compensation for healthcare agent
Sep-34,Cells.CD57/100 cells
81349-3,Thoughts on life-sustaining procedures if pregnant
81350-1,Thoughts on pain management
81351-9,"Do Not Resuscitate, Do Not Attempt Resuscitation, or Allow Natural Death order is in place"
81352-7,"Medical Order for Life-Sustaining Treatment, Physician Order for Life-Sustaining Treatment, or a similar medical order is in place"
81353-5,Thoughts on hastening death
81354-3,Prescribed anticipatory medication
81355-0,Location of prescribed anticipatory medication
Jun-35,Cells.CD7/100 cells
81356-8,Death arrangements
81357-6,Messages to be delivered after death
81358-4,Person(s) to notify upon death
81359-2,Near death thoughts and feelings to be shared
813-6,Leukocytes
81360-0,My likes and joys
81361-8,Things that make me laugh
81362-6,My dislikes and fears
81363-4,Things that matter to me
Apr-36,Cells.CD71/100 cells
81364-2,Religious beliefs
81365-9,Religious affiliation contact to notify
81366-7,Unfinished business
81367-5,Personal advance care plan signer for declarant
81368-3,Statement of witness
81369-1,First witness
81370-9,Second witness
81371-7,Third witness
Feb-37,Cells.CD8
81372-5,Notary
81373-3,Notary commission expiration date
81374-1,Notary seal ID
81375-8,Self assessment of health status
81376-6,Mental health treatment preferences
81377-4,"Goals, preferences, and priorities regarding the appointment of healthcare agents"
81378-2,"Goals, preferences, and priorities under certain health conditions"
81379-0,"Goals, preferences, and priorities upon death"
8138-0,Cells.CD8/100 cells
81380-8,"Goals, preferences, and priorities for care experience"
81381-6,Administrative information associated with this personal advance care plan
81382-4,Statement of document creator
81383-2,Tissue velocity.S wave.max
81384-0,Tissue velocity.E wave.max
81385-7,Tissue velocity.A wave.max
81386-5,Blood flow velocity.E wave.max/Tissue velocity.E wave.max
81387-3,Regurgitant blood duration of 1 to 3 meters per second flow velocity
81388-1,Ejection fraction
81389-9,Stroke volume
81390-7,Cardiac output
81391-5,Ejection time
81392-3,Orifice area/Body surface area
81393-1,Myocardial performance index
81394-9,Regurgitant volume
81395-6,Regurgitant fraction
81396-4,Tissue velocity.A wave.max
81397-2,Tissue velocity.A wave.max
Aug-39,Amphetamines
81398-0,Blood flow velocity.E wave.max/Flow propagation velocity.E wave
81399-8,Longitudinal strain.max
81400-4,Radial strain.max
81401-2,Circumferential strain.max
81402-0,Strain.max
81403-8,Longitudinal strain rate.systole.max
81404-6,Radial strain rate.systole.max
81405-3,Circumferential strain rate.systole.max
Jun-40,Amphetamines
81406-1,Strain rate.max
81407-9,Longitudinal strain rate.early diastole.max
81408-7,Radial strain rate.early diastole.max
81409-5,Circumferential strain rate.early diastole.max
81410-3,Strain rate.early diastole.max
81411-1,Longitudinal strain rate.diastole.max
81412-9,Radial strain rate.diastole.max
81413-7,Circumferential strain rate.diastole.max
Apr-41,Amphetamines
81414-5,Strain rate.diastole.max
81415-2,Apical rotation.max
81416-0,Basal rotation.max
81417-8,Torsion.max
81418-6,Twist rate.max
81419-4,Untwist rate.max
81420-2,KRAS & NRAS gene targeted mutation analysis
81421-0,Saccharomyces cerevisiae Ab.IgG
Feb-42,Amphetamines
81422-8,GATA1 gene exon 2 targeted mutation analysis
81423-6,Microscopic observation
81424-4,Microscopic observation
81425-1,Microscopic observation
81426-9,Microscopic observation
81427-7,Microscopic observation
81428-5,Influenza virus A H7 Eurasia RNA
81429-3,Bismuth
8143-0,Amphetamines
81430-1,Lactate dehydrogenase
81431-9,Regurgitation degree
81432-7,Regurgitation degree
81433-5,Spasm induced
81434-3,Spasm symptom induced
81435-0,Lesion treatment duration
81436-8,Percutaneous coronary intervention site
81437-6,Lesion treatment sequence
81438-4,Coronary stent number
81439-2,Human papilloma virus 31+33 DNA
814-4,Leukocytes
81440-0,Vital capacity^pre bronchodilation
81441-8,Vital capacity^post bronchodilation
81442-6,Resistance.airway^post bronchodilation
81443-4,Resistance.airway^pre bronchodilation
81444-2,Inspiratory pressure.max^pre bronchodilation
81445-9,Inspiratory pressure.max^post bronchodilation
81446-7,Expiratory pressure.max^pre bronchodilation
81447-5,Expiratory pressure.max^post bronchodilation
Aug-44,Amphetamines
81448-3,Inspiratory gas flow.max^pre bronchodilation
81449-1,Inspiratory gas flow.max^post bronchodilation
81450-9,Capacity.total^pre bronchodilation
81451-7,Capacity.total^post bronchodilation
81452-5,Volume.residual^pre bronchodilation
81453-3,Volume.residual^post bronchodilation
81454-1,Volume.residual/Capacity.total^pre bronchodilation
May-45,Amphetamines
81455-8,Volume.residual/Capacity.total^post bronchodilation
81456-6,Capacity.functional residual^pre bronchodilation
81457-4,Capacity.functional residual^post bronchodilation
81458-2,Pulmonary function test panel
81459-0,Spirometry panel
81460-8,I have had trouble forming thoughts in past 7D
81461-6,My thinking has been slow in past 7D
81462-4,My thinking has been foggy in past 7D
Mar-46,Amphetamines
81463-2,I have had trouble adding or subtracting numbers in my head in past 7D
81464-0,I have made mistakes when writing down phone numbers in past 7D
81465-7,I have had trouble concentrating in past 7D
81466-5,I have had trouble finding my way to a familiar place in past 7D
81467-3,"I have had trouble remembering where I put things, like my keys or my wallet in past 7D"
81468-1,"I have had trouble remembering whether I did things I was supposed to do, like taking a medicine or buying something I needed in past 7D"
81469-9,"I have had trouble remembering new information, like phone numbers or simple instructions in past 7D"
81470-7,I have had trouble recalling the name of an object while talking to someone in past 7D
Jan-47,Amphetamines
81471-5,I have had trouble speaking fluently in past 7D
81472-3,I have walked into a room and forgotten what I meant to get or do there in past 7D
81473-1,I have needed medical instructions repeated because I could not keep them straight in past 7D
81474-9,I have had to work really hard to pay attention or I would make a mistake in past 7D
81475-6,I have forgotten names of people soon after being introduced in past 7D
81476-4,My reactions in everyday situations have been slow in past 7D
81477-2,Other people have told me I seemed to have trouble remembering information in past 7D
81478-0,It has seemed like my brain was not working as well as usual in past 7D
81479-8,I have had to work harder than usual to keep track of what I was doing in past 7D
81480-6,My thinking has been slower than usual in past 7D
81481-4,I have had to work harder than usual to express myself clearly in past 7D
81482-2,I have had more problems conversing with others in past 7D
81483-0,I have had to use written lists more often than usual so I would not forget things in past 7D
81484-8,I have had trouble keeping track of what I was doing when interrupted in past 7D
81485-5,I have had trouble shifting back and forth between different activities that require thinking in past 7D
81486-3,"I have hidden my problems with memory, concentration, or making mental mistakes so that others would not notice in past 7D"
81487-1,"I have been upset about my problems with memory, concentration, or making mental mistakes in past 7D"
81488-9,"My problems with memory, concentration, or making mental mistakes have interfered with my ability to work in past 7D"
Sep-48,Amphetamines
81489-7,"My problems with memory, concentration, or making mental mistakes have interfered with my ability to do things I enjoy in past 7D"
81490-5,"My problems with memory, concentration, or making mental mistakes have interfered with the quality of my life in past 7D"
81491-3,I have had difficulty multi-tasking in past 7D
81492-1,PROMIS item bank - cognitive function - abilities subset - version 2.0
81493-9,I have been able to bring to mind words that I wanted to use while talking to someone in past 7D
81494-7,"I have been able to remember to do things, like take medicine or buy something I needed in past 7D"
81495-4,I have been able to pay attention and keep track of what I am doing without extra effort in past 7D
81496-2,I have been able to think clearly in past 7D
Jul-49,Amphetamines
81497-0,My mind has been as sharp as usual in past 7D
81498-8,My memory has been as good as usual in past 7D
81499-6,My thinking has been as fast as usual in past 7D
81500-1,I have been able to shift back and forth between two activities that require thinking in past 7D
81501-9,"I have been able to keep track of what I am doing, even if I am interrupted in past 7D"
81502-7,I have been able to concentrate in past 7D
81503-5,I have been able to form thoughts clearly in past 7D
81504-3,I have been able to remember telephone numbers in past 7D
May-50,Amphetamines
81505-0,I have been able to get my point across when talking with someone in past 7D
81506-8,I have been able to remember the name of a familiar object in past 7D
81507-6,I have been able to think as clearly as usual without extra effort in past 7D
81508-4,I have been able to remember things as easily as usual without extra effort in past 7D
81509-2,My ability to remember important dates has been as good as usual in past 7D
815-1,A Ab
81510-0,My ability to remember names has been as good as usual in past 7D
81511-8,My ability to keep track of lists has been as good as usual in past 7D
81512-6,My thinking has been clear in past 7D
Mar-51,Amphetamines
81513-4,My ability to count money has been as good as usual in past 7D
81514-2,My ability to follow driving directions has been as good as usual in past 7D
81515-9,I have been able to handle many tasks at once without losing track of what I was doing in past 7D
81516-7,My ability to remember things that I need to do has been as good as usual in past 7D
81517-5,I have been able to multi-task as easily as usual without extra effort in past 7D
81518-3,I have been able to think clearly without extra effort in past 7D
81519-1,My ability to concentrate has been good in past 7D
81520-9,I have been able to focus my attention in past 7D
Jan-52,Amphetamines
81521-7,I have been able to mentally focus in past 7D
81522-5,I have been able to remember the name of a familiar person in past 7D
81523-3,"I have been able to learn new things easily, like telephone numbers or instructions in past 7D"
81524-1,PROMIS item bank - cognitive function - version 2.0
81525-8,PROMIS short form - cognitive function - abilities subset 4a - version 2.0
81526-6,PROMIS short form - cognitive function - abilities subset 6a - version 2.0
81527-4,PROMIS short form - cognitive function - abilities subset 8a - version 2.0
81528-2,PROMIS short form - cognitive function 4a - version 2.0
81529-0,PROMIS short form - cognitive function 6a - version 2.0
81530-8,PROMIS short form - cognitive function 8a - version 2.0
81531-6,PROMIS short form - cognitive function 8a - version 2.0 raw score
81532-4,PROMIS short form - cognitive function 6a - version 2.0 raw score
81533-2,PROMIS short form - cognitive function 4a - version 2.0 raw score
81534-0,PROMIS short form - cognitive function - abilities subset 4a - version 2.0 raw score
81535-7,PROMIS short form - cognitive function - abilities subset 6a - version 2.0 raw score
81536-5,PROMIS short form - cognitive function - abilities subset 8a - version 2.0 raw score
81537-3,PROMIS cognitive function - abilities subset - version 2.0 T-score
81538-1,PROMIS cognitive function - version 2.0 T-score
Sep-53,Amphetamines
81541-5,Resource identifier
81542-3,Views for CSF leak post lumbar puncture^W radionuclide IT
81543-1,Views for CSF leak with rhinorrhea or otorrhea^W radionuclide IT
81544-9,Views for gastrointestinal bleeding^W radionuclide IV
81545-6,Views for shunt patency^W radionuclide IV
81546-4,Views for blood flow+kidney function^W radionuclide IV
Jul-54,Amphetamines
81547-2,Multisection^W In-111 pentetreotide IV
81548-0,Multisection^W tagged WBC IV
81549-8,Multisection^W radionuclide IV
81550-6,Multisection^W radionuclide IV
81551-4,Multisection^W 18F-NaF IV
81552-2,Multisection^W 18F-NaF IV
81553-0,Guidance limited for localization of tumor^W 18F-FDG IV
Apr-55,Amphetamines
81554-8,Guidance for localization of tumor^W 18F-FDG IV
81555-5,Guidance for localization of tumor^W 18F-FDG IV
81556-3,Multisection for infection or inflammation^W radionuclide IV
81557-1,Multisection^W florbetapir IV
81558-9,Multisection^W Tc-99m IV
81559-7,Multisection limited for simulation^W radionuclide IV
81560-5,Multisection^W In-111 capromab pendetide IV
81561-3,Multisection^W multiple states of exercise+W radionuclide IV
Feb-56,Amphetamines
81562-1,Multisection^W single state of exercise+W radionuclide IV
81563-9,Views first pass+blood pool^W radionuclide IV
81564-7,Multisection for sarcoidosis^W radionuclide IV
81565-4,Multisection for tissue viability^W radionuclide IV
81566-2,Views gated+blood pool+ejection fraction+wall motion^W multiple states of exercise+W radionuclide IV
81567-0,Views gated+blood pool+ejection fraction+wall motion^W single state of exercise+W radionuclide IV
81568-8,Multisection^W multiple states of exercise
81569-6,Multisection^W single state of exercise
8157-0,Arsenic
81570-4,Views perfusion^W single state of exercise+W radionuclide IV
81571-2,Views perfusion^W multiple states of exercise+W radionuclide IV
81572-0,Views for function^W radionuclide IV
81573-8,Views brain death protocol^W radionuclide IV
81574-6,Views GE 4^W radionuclide IV
81575-3,Views for blood flow GE 4^W radionuclide IV
81576-1,Views for blood flow LT 4^W radionuclide IV
81577-9,Multisection for amyloidosis^W radionuclide IV
81578-7,Multisection metabolic^W radionuclide IV
81579-5,Multisection^W radionuclide IV
81580-3,Views for therapy^W I-131 PO
81581-1,Views for dosimetry^W radionuclide PO
81582-9,Uptake^W radionuclide IV
81583-7,Views^W Sm-153 IV
81584-5,Views^W tagged WBC IV
81585-2,Views^W tagged WBC IV
81586-0,Views^W Y-90 ibritumomab tiuxetan IV
81587-8,Views limited for infection or inflammation^W radionuclide IV
Aug-58,Arsenic
81588-6,Views for thyroid tumor metastasis^W radionuclide IV
81589-4,Views for infection or inflammation^W radionuclide IV
81590-2,Views for thrombosis^W radionuclide IV
81591-0,Views for thrombosis^W radionuclide IV
81592-8,Views for transplanted kidney^W radionuclide IV
81593-6,Views^W radionuclide IV
81594-4,Views^W radionuclide IV
81595-1,Views for lymphedema^W radionuclide IV
Jun-59,Beryllium
81596-9,Views ventilation+perfusion quantitative^W radionuclide IV
81597-7,Views for metastasis^W Ra-223 IV
81598-5,Views for thyroid tumor metastasis post therapy^W radionuclide IV
81599-3,Guidance multiple days for localization of tumor^W radionuclide IV
81600-9,Views limited for infection or inflammation^W Tc-99m tagged WBC IV
81601-7,Views limited for thyroid tumor metastasis^W radionuclide IV
81602-5,Views for gastric emptying solid phase^W radionuclide PO
81603-3,Views for blood flow+kidney function^W diuretic IV+W radionuclide IV
Apr-60,Beryllium
81604-1,Views for glomerular filtration rate^W radionuclide IV
81605-8,Views^W radionuclide IV
81606-6,Views^W cholecystokinetic+W radionuclide IV
81607-4,Views^W radionuclide IV
81608-2,Views for blood flow+kidney function^W ACE inhibitor PO+W radionuclide IV
81609-0,Views^W SIR-spheres intraarterial hepatic injection
81610-8,Views^W Theraspheres intraarterial hepatic injection
81611-6,Views for shunt patency^W radionuclide IV
Feb-61,Bismuth
81612-4,Views blood pool+ejection fraction+first pass^W radionuclide IV
81613-2,Multisection for hemangioma^W radionuclide IV
81614-0,Transfer summary note - recommended C-CDA R2.1 sections
81615-7,Enhanced discharge summary - recommended CDP Set 1 R1.1 sections
8162-0,Tetrahydrocannabinol
81620-7,Differential panel
81621-5,Herpes simplex virus 1 & 2 Ab.IgG panel
81622-3,Hydroxyapatite
81623-1,Calcium oxalate
81624-9,Methotrexate pentaglutamate
81625-6,Methotrexate tetraglutamate
81626-4,Methotrexate triglutamate
81627-2,Methotrexate diglutamate
81628-0,Methotrexate monoglutamate
81629-8,Gamma hydroxybutyrate
81630-6,Methotrexate polyglutamates 1-5 & total panel
81631-4,Methotrexate polyglutamates
81632-2,Immunoglobulin light chains.free panel
81633-0,Recommended follow-up tests or procedures
81634-8,Recommended cancer surveillance
81635-5,Service &or equipment &or product note
81636-3,Pressure ulcer risk level
81637-1,Glucose meter to reference method correlation
Aug-63,Tetrahydrocannabinol
81638-9,Clotting time
81639-7,Heparin dose response slope
81640-5,Erythrocytes
81641-3,HIV 2 Ab
81642-1,CYP3A4 & CYP3A5 gene targeted mutation analysis panel
81643-9,von Willebrand factor.ristocetin cofactor activity/von Willebrand factor Ag
81644-7,Clostridium botulinum toxin C botC gene
81645-4,Clostridium botulinum toxin D botD gene
Jun-64,Tetrahydrocannabinol
81646-2,Clostridium botulinum toxin E botE gene
81647-0,Clostridium botulinum toxin F botF gene
81648-8,Clostridium botulinum toxin G botG gene
81649-6,Cryptococcus sp rRNA gene
81650-4,West Nile virus Kunjin strain RNA
81651-2,Murray Valley Encephalitis virus RNA
81652-0,HIV 2 RNA
Mar-65,Tetrahydrocannabinol
81653-8,Blastomyces dermatitidis drk1 & Histoplasma capsulatum gapdh genes
81654-6,Repiratory pathogens DNA & RNA
81655-3,Respiratory pathogens DNA & RNA identified
81656-1,Campylobacter coli+jejuni tuf gene
81657-9,Salmonella sp spaO gene
81658-7,Suspected organism
81659-5,Escherichia coli Stx1 & Stx2 toxin stx1 & stx2 genes panel
81660-3,Nausea
Jan-66,Tetrahydrocannabinol
81661-1,Blood loss
81662-9,Meal eaten
81663-7,Diet
81664-5,Drain number
81665-2,IV number
81666-0,Wound number
81667-8,Output count panel
81668-6,Voids.incontinent
81669-4,Diaper count
81670-2,Perineal pad count
81671-0,Tissue perfusion assessment panel
81672-8,Tissue perfusion assessment
81673-6,Temperature
81674-4,Nutrition and fluid intake assessment panel
81675-1,Nutrition and fluid intake assessment
81676-9,Hydration status
81677-7,Output assessment panel
81678-5,Output assessment
Sep-67,Tetrahydrocannabinol
81679-3,Preoperative measures for patient safety panel
81680-1,Preoperative verification process panel
81681-9,Verified two types of patient identification
81682-7,Verified side &or site of procedure
81683-5,Verified procedure
81684-3,Verified patient position
81685-0,Verified availability of correct implants and any special equipment or requirements
81686-8,Performed preoperative time-out assessment
Jul-68,Tetrahydrocannabinol
81687-6,Marked operative site
81688-4,Barmah forest virus RNA
81689-2,Hendra virus RNA
816-9,A Ab
81690-0,Legionella longbeachae 1 & 2 DNA
81691-8,DNA mismatch repair protein Mlh1
81692-6,DNA mismatch repair protein Msh2
81693-4,DNA mismatch repair protein Msh6
81694-2,Mismatch repair endonuclease PMS2
May-69,Tetrahydrocannabinol
81695-9,Microsatellite instability
81696-7,Microsatellite instability markers assessed
81697-5,Microsatellite instability marker BAT25
81698-3,Microsatellite instability marker BAT26
81699-1,Microsatellite instability marker NR21
81700-7,Microsatellite instability marker NR24
81701-5,Microsatellite instability marker MONO27
81702-3,Microsatellite instability marker D2S123
Mar-70,Cannabinoids
81703-1,Microsatellite instability marker D5S346
81704-9,Microsatellite instability marker D17S250
81705-6,Serine-threonine protein kinase B-raf
81706-4,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN"
81707-2,Dissection technique
81708-0,Microsatellite markers exhibiting instability/Microsatellite instability markers assessed
81709-8,Microsatellite markers exhibiting instability
81710-6,PTEN gene
Jan-71,Cannabinoids
81711-4,Microsatellite instability marker panel
81712-2,Actin.filamentous Ab
81713-0,Actin.smooth muscle Ab
81714-8,Centromere protein A Ab
81715-5,Centromere protein B Ab
81716-3,DNA double strand Ab
81717-1,Ganglioside GM1 Ab.IgG
81718-9,Ganglioside GM1 Ab.IgG+IgM
81719-7,Ganglioside GM1 Ab.IgM
81720-5,Ganglioside GM1 Ab.IgM
81721-3,Ganglioside GM2 Ab.IgG+IgM
81722-1,Ganglioside GT1b Ab.IgG+IgM
81723-9,Ganglioside GT1b Ab.IgM
81724-7,Glomerular basement membrane Ab
81725-4,Glutamate decarboxylase 65 Ab
81726-2,Mitochondria M2 Ab
81727-0,Mitochondria M2-3E Ab
81728-8,Neuronal nuclear Ab
Sep-72,Cannabinoids
81729-6,Neuronal nuclear type 2 Ab
81730-4,PCNA extractable nuclear Ab
81731-2,PM-SCL extractable nuclear Ab
81732-0,PM-SCL-100 Ab
81733-8,PM-SCL-75 Ab
81734-6,Ribonucleoprotein extractable nuclear Ab
81735-3,Ribosomal P Ab
81736-1,RNA polymerase III Ab
Jul-73,Tetrahydrocannabinol
81737-9,RNA polymerase III RP11 Ab
81738-7,RNA polymerase III RP155 Ab
81739-5,SCL-70 extractable nuclear Ab
81740-3,Sjogrens syndrome-A extractable nuclear 52kD Ab
81741-1,Smith extractable nuclear Ab
81742-9,Th-To Ab
81743-7,Th-To Ab
81744-5,Submitter's laboratory test method
May-74,Tetrahydrocannabinol
81745-2,Personal advance care plan R1.0 - recommended CDA sections
81746-0,Chromosome region 17p13.1 deletion
81747-8,Chromosome region 6q22 rearrangements
81748-6,Chromosome region Yp11.3 deletion &or rearrangement
81749-4,Chromosome region 13q14 deletion
81750-2,"t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript"
81751-0,Chromosome region 17p13.1 deletion & chromosome region 14q32 rearrangements
Feb-75,Tetrahydrocannabinol
81752-8,Chromosome region 1q21 duplication
81753-6,Somatotropin^1.75H post dose arginine+insulin
81754-4,Nortapentadol
81755-1,Lymphocyte proliferation.Interleukin 2.maximum/CD45
81756-9,Lymphocyte proliferation.anti-CD3.maximum/CD3
81757-7,Lymphocyte proliferation.Interleukin 2.maximum/CD3
81758-5,Lymphocyte proliferation.anti-CD28.maximum/CD3
81759-3,Lymphocyte proliferation.anti-CD28.maximum/CD45
8176-0,Cannabinoids
81760-1,Lymphocyte proliferation.anti-CD3.maximum/CD45
81761-9,F8 gene intron 1 & 22 inversion targeted mutation analysis
81762-7,F8 gene intron 1 inversion targeted mutation analysis
81763-5,Phytanate & pristanate panel
81764-3,Docosatrienoate
81765-0,Docosatrienoate
81766-8,Eicosatrienoate
81767-6,Eicosatrienoate
81768-4,U1 small nuclear ribonucleoprotein 70kD Ab.IgG
81769-2,Adipoylcarnitine (C6-DC)/Creatinine
817-7,A Ab
81770-0,Tiglylcarnitine (C5:1)/Creatinine
81771-8,Myeloperoxidase Ab.IgG
81772-6,Dermatophagoides pteronyssinus Ab.IgG
81773-4,Amyloid A
81774-2,Actin.smooth muscle Ab.IgG
81775-9,Epipregnanolone/Creatinine
81776-7,Ureidopropionate/Creatinine
81777-5,Nonanoylcarnitine (C9)/Creatinine
Aug-77,Cannabinoids
81778-3,Methylmalonylcarnitine (C4-DC)+3-Hydroxyisovalerylcarnitine (C5-OH)/Creatinine
81779-1,Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Creatinine
81780-9,Tetradecenoylcarnitine (C14:1)/Creatinine
81781-7,Saccharopine
81782-5,Phleum pratense Ab.IgG
81783-3,Chicken feather Ab.IgG
81784-1,Canary droppings Ab.IgG
81785-8,Duck feather Ab.IgG
Jun-78,Cannabinoids
81786-6,Chemokine (C-C motif) ligand 17
81787-4,Myeloperoxidase Ab.IgG
81788-2,Corylus avellana recombinant (rCor a) 14 Ab.IgE
81789-0,Juglans regia recombinant (rJug r) 3 Ab.IgE
81790-8,Juglans regia recombinant (rJug r) 1 Ab.IgE
81791-6,Malus domestica recombinant (rMal d) 3 Ab.IgE
81792-4,Dermatophagoides pteronyssinus native (nDer p) 2 Ab.IgE
81793-2,Tetrahydrodeoxycortisol/Creatinine
Apr-79,Cannabinoids
81794-0,Tetrahydrocortisol/Creatinine
81795-7,Tetrahydrocortisone/Creatinine
81796-5,Tetrahydrocorticosterone/Creatinine
81797-3,11-Dehydrotetrahydrocorticosterone/Creatinine
81798-1,Pregnanediolone/Creatinine
81799-9,16-Alpha hydroxypregnenolone/Creatinine
81800-5,16-Ketoandrostenediol/Creatinine
81801-3,16-Alpha hydroxydehydroepiandrosterone/Creatinine
Feb-80,Chlorobenzene
81802-1,"16-Beta,18-dihydroxydehydroepiandrosterone/Creatinine"
81803-9,Beta cortolone/Creatinine
81804-7,Allo-tetrahydrocortisol/Creatinine
81805-4,Allo-tetrahydrocorticosterone/Creatinine
81806-2,Alpha cortolone/Creatinine
81807-0,Alpha cortol/Creatinine
81808-8,Androstenetriol/Creatinine
81809-6,3-Hydroxydodecanoylcarnitine (C12-OH)/Creatinine
8181-0,Chromium
81810-4,3-Hydroxydecanoylcarnitine (C10-OH)/creatinine
81811-2,3-Hydroxydecanoylcarnitine (C10-OH)
81812-0,TPP1 gene targeted mutation analysis
81813-8,F11 gene targeted mutation analysis
81814-6,HSD17B4 gene targeted mutation analysis
81815-3,CTNS gene targeted mutation analysis
81816-1,OPA3 gene targeted mutation analysis
81817-9,MPI gene targeted mutation analysis
81818-7,PMM2 gene targeted mutation analysis
81819-5,CLN5 gene targeted mutation analysis
81820-3,ASS1 gene targeted mutation analysis
81821-1,RMRP gene targeted mutation analysis
81822-9,BBS10 gene targeted mutation analysis
81823-7,SACS gene targeted mutation analysis
81824-5,SLC12A6 gene targeted mutation analysis
81825-2,MAN2B1 gene targeted mutation analysis
81826-0,HGD gene targeted mutation analysis
81827-8,CNGB3 gene targeted mutation analysis
Aug-82,Benzoylecgonine
81828-6,SLC37A4 gene targeted mutation analysis
81829-4,SDHA gene full mutation analysis
81830-2,AGL gene targeted mutation analysis
81831-0,LAMB3 gene targeted mutation analysis
81832-8,SLC26A2 gene targeted mutation analysis
81833-6,ALDH3A2 gene full mutation analysis
81834-4,SLC17A5 gene full mutation analysis
81835-1,PEX7 gene targeted mutation analysis
Jun-83,Benzoylecgonine
81836-9,CTSK gene targeted mutation analysis
81837-7,GRHPR gene targeted mutation analysis
81838-5,PEX1 gene targeted mutation analysis
81839-3,CLN8 gene targeted mutation analysis
81840-1,POMGNT1 gene full mutation analysis
81841-9,MLC1 gene targeted mutation analysis
81842-7,BCKDHB gene targeted mutation analysis
81843-5,GALC gene targeted mutation analysis
Apr-84,Benzoylecgonine
81844-3,IVD gene full mutation analysis
81845-0,PALB2 gene full mutation analysis
81846-8,C9orf72 gene GGGGCC repeat analysis
81847-6,C9orf72 gene GGGGCC repeat analysis
81848-4,"t(1;13)(p36.13;q14.1)(PAX7,FOXO1) & t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript"
81849-2,"t(1;13)(p36.13;q14.1)(PAX7,FOXO1) & t(2;13)(q36.1;q14.4)(PAX3,FOXO1) fusion transcript"
818-5,A Ag
81850-0,Chromosome region 11p15 methylation & deletion+duplication
Jan-85,Benzoylecgonine
81851-8,Chromosome region 11p15 methylation & deletion+duplication
81852-6,Chromosome region 7q11.23 deletion+duplication
81853-4,Chromosome 15 & 16 & 22 aneuploidy
81854-2,CYP21A2 gene mutation analysis limited to known familial mutations
81855-9,DMPK gene CTG repeat analysis
81856-7,FMR1 gene CGG repeat analysis
81857-5,GDAP1 gene targeted mutation analysis
81858-3,GJB1 gene mutation analysis limited to known familial mutations
81859-1,GRN gene full mutation analysis
81860-9,Hypertrophic cardiomyopathy gene targeted mutation analysis
81861-7,Karyotype
81862-5,Karyotype^post mitogen stimulation
81863-3,KCNH2 gene mutation analysis limited to known familial mutations
81864-1,KCNQ1 gene mutation analysis limited to known familial mutations
81865-8,MYBPC3 gene mutation analysis limited to known familial mutations
81866-6,MYH7 gene mutation analysis limited to known familial mutations
81867-4,NOTCH3 gene mutation analysis limited to known familial mutations
81868-2,PRNP gene targeted mutation analysis
Sep-86,Benzoylecgonine
81869-0,PRNP gene mutation analysis limited to known familial mutations
81870-8,PSEN1 gene mutation analysis limited to known familial mutations
81871-6,PSEN2 gene mutation analysis limited to known familial mutations
81872-4,SCN5A gene mutation analysis limited to known familial mutations
81873-2,Chromosome region Xp22.33 &or Yp11.32 deletion+duplication
81874-0,SLC12A3 gene full mutation analysis
81875-7,SPAST gene mutation analysis limited to known familial mutations
81876-5,SPG11 gene deletion+duplication & mutation analysis
Jul-87,Benzoylecgonine
81877-3,SPG3A gene mutation analysis limited to known familial mutations
81878-1,Subtelomere analysis
81879-9,"t(11;22)(q24;q12.2)(FLI1,EWSR1) & t(21;22)(q22.3;q12.2)(ERG,EWSR1) fusion transcript"
81880-7,TNNT2 gene mutation analysis limited to known familial mutations
81881-5,TNNT3 gene mutation analysis limited to known familial mutations
81882-3,TSC2 gene & PKD1 gene deletion+duplication
81883-1,CNBP gene CCTG repeat analysis
81884-9,NIPA1 gene & REEP1 gene full mutation analysis
May-88,Benzoylecgonine
81885-6,Diagnosis.secondary
81886-4,Sex
81887-2,Race
81888-0,Ethnicity
81889-8,Physical therapy entry-level degree
81890-6,Physical therapy highest level of education
81891-4,Episode of care diagnosis.secondary
81892-2,Episode of care diagnosis.primary
Mar-89,Benzoylecgonine
81893-0,Patient satisfaction with healthcare delivery
81894-8,Ultrasound attenuation
81895-5,Macronutrient intake panel
81896-3,Fat intake panel
81897-1,Monounsaturated fat intake
81898-9,Composite triage and nursing note - recommended IHE set
81899-7,Monounsaturated fat intake
81900-3,Omega-3 fatty acid intake
Jan-90,Cocaine
81901-1,Omega-3 fatty acid intake
81902-9,Medium chain triglyceride intake
81903-7,Medium chain triglyceride intake
81904-5,Protein intake panel
81905-2,High biological value protein intake
81906-0,High biological value protein intake
81907-8,Send document that conforms to C-CDA R2.0 template
81908-6,Whey intake
81909-4,Whey intake
81910-2,Protein intake/body weight
81911-0,Protein intake/body weight
81912-8,Amino acid intake panel
81913-6,Amino acid.essential intake panel
81914-4,Amino acid.essential intake
81915-1,Amino acid.essential intake
81916-9,Histidine intake
81917-7,Histidine intake
81918-5,Methionine intake
Sep-91,Cocaine
81919-3,Methionine intake
81920-1,Lysine intake
81921-9,Lysine intake
81922-7,Tryptophan intake
81923-5,Tryptophan intake
81924-3,Phenylalanine intake
81925-0,Phenylalanine intake
81926-8,Fiber intake panel
Jul-92,Benzoylecgonine
81927-6,Vitamin B1 intake
81928-4,Vitamin B1 intake
81929-2,Vitamin D intake
819-3,A Ag
81930-0,Vitamin D intake
81931-8,Amino acid.nonessential intake panel
81932-6,Amino acid.nonessential intake
81933-4,Amino acid.nonessential intake
81934-2,Homocysteine intake
May-93,Benzoylecgonine
81935-9,Homocysteine intake
81936-7,Tyramine intake
81937-5,Tyramine intake
81938-3,Tyrosine intake
81939-1,Tyrosine intake
81940-9,Carbohydrate intake panel
81941-7,Micronutrient intake panel
81942-5,Vitamin intake panel
Mar-94,Cocaine
81943-3,Mineral &or trace element intake panel
81944-1,Boron intake
81945-8,Boron intake
81946-6,Phosphorus intake
81947-4,Sulfate intake
81948-2,Sulfate intake
81949-0,Multi-trace element supplement intake
8195-0,Cocaine
81950-8,Multivitamin &or mineral supplement intake
81951-6,Fluid intake
81952-4,Fat intake
81953-2,Carbohydrate intake
81954-0,Date of death
81955-7,Time of death
81956-5,Date and time of death
81957-3,Overall Plan of Care &or Advance Care Directives panel
81958-1,National health care surveys report R1 - recommended CDA set
81959-9,Public health laboratory ask at order entry panel
81960-7,Olea europaea native (nOle e) 7 Ab.IgE.RAST class
81961-5,Chamaecyparis obtusa Ab.IgE.RAST class
81962-3,Olea europaea recombinant (rOle e) 9 Ab.IgE.RAST class
81963-1,Platanus acerifolia recombinant (rPla a) 1 Ab.IgE.RAST class
81964-9,Parietaria judaica recombinant (rPar j) 2 Ab.IgE.RAST class
81965-6,Ambrosia artemisiifolia native (nAmb a) 1 Ab.IgE.RAST class
81966-4,Artemisia vulgaris native (nArt v) 1 Ab.IgE.RAST class
81967-2,Salsola kali native (nSal k) 1 Ab.IgE.RAST class
Aug-96,Cocaine
81968-0,Artemisia vulgaris native (nArt v) 3 Ab.IgE.RAST class
81969-8,Plantago lanceolata recombinant (rPla l) 1 Ab.IgE.RAST class
81970-6,Codeine Ab.IgE.RAST class
81971-4,Pholcodine Ab.IgE.RAST class
81972-2,Dermatophagoides pteronyssinus native (nDer p) 1 Ab.IgE.RAST class
81973-0,Dermatophagoides pteronyssinus recombinant (rDer p) 2 Ab.IgE.RAST class
81974-8,Dermatophagoides pteronyssinus recombinant (rDer p) 10 Ab.IgE.RAST class
81975-5,Dog recombinant (rCan f) 1 Ab.IgE.RAST class
Jun-97,Cocaine
81976-3,Dog recombinant (rCan f) 2 Ab.IgE.RAST class
81977-1,Dog recombinant (rCan f) 5 Ab.IgE.RAST class
81978-9,Horse recombinant (rEqu c) 1 Ab.IgE.RAST class
81979-7,Cat recombinant (rFel d) 4 Ab.IgE.RAST class
81980-5,Cat recombinant (rFel d) 1 Ab.IgE.RAST class
81981-3,Conalbumin native (nGal d) 3 Ab.IgE.RAST class
81982-1,Arachis hypogaea recombinant (rAra h) 8 Ab.IgE.RAST class
81983-9,Glycine max recombinant (rGly m) 4 Ab.IgE.RAST class
Apr-98,Copper
81984-7,Bertholletia excelsa recombinant (rBer e) 1 Ab.IgE.RAST class
81985-4,Cyprinus carpio recombinant (rCyp c) 1 Ab.IgE.RAST class
81986-2,Triticum aestivum recombinant (rTri a) 19 Ab.IgE.RAST class
81987-0,Prunus persica recombinant (rPru p) 1 Ab.IgE.RAST class
81988-8,Prunus persica recombinant (rPru p) 3 Ab.IgE.RAST class
81989-6,Prunus persica recombinant (rPru p) 4 Ab.IgE.RAST class
81990-4,Arachis hypogaea recombinant (rAra h) 1 Ab.IgE.RAST class
81991-2,Arachis hypogaea recombinant (rAra h) 2 Ab.IgE.RAST class
Feb-99,Ethyl benzene
81992-0,Arachis hypogaea recombinant (rAra h) 3 Ab.IgE.RAST class
81993-8,Corylus avellana recombinant (rCor a) 8 Ab.IgE.RAST class
81994-6,Arachis hypogaea recombinant (rAra h) 9 Ab.IgE.RAST class
81995-3,Corylus avellana recombinant (rCor a) 1 Ab.IgE.RAST class
81996-1,Actinidia deliciosa recombinant (rAct d) 8 Ab.IgE.RAST class
81997-9,Glycine max native (nGly m) 5 Ab.IgE.RAST class
81998-7,Glycine max native (nGly m) 6 Ab.IgE.RAST class
81999-5,Triticum aestivum recombinant (rTri a) 14 Ab.IgE.RAST class
82000-1,Malus domestica recombinant (rMal d) 1 Ab.IgE.RAST class
82001-9,Actinidia deliciosa native (nAct d) 1 Ab.IgE.RAST class
82002-7,Corylus avellana native (nCor a) 9 Ab.IgE.RAST class
82003-5,Dioscorea batatas Ab.IgE.RAST class
82004-3,(Allium cepa+Allium sativum+Sesamum indicum+Yeast) Ab.IgE.RAST class
82005-0,Cynodon dactylon native (nCyn d) 1 Ab.IgE.RAST class
82006-8,House dust Bencard Ab.IgE.RAST class
82007-6,Polistes spp recombinant (rPol d) 5 Ab.IgE.RAST class
Aug-00,Gadolinium
82008-4,Polistes dominulus Ab.IgE.RAST class
82009-2,Apis mellifera phospholipase A2 native (nApi m) 1 Ab.IgE.RAST class
820-1,A Ag
82010-0,Latex recombinant (rHev b) 1 Ab.IgE.RAST class
82011-8,Latex recombinant (rHev b) 3 Ab.IgE.RAST class
82012-6,Latex recombinant (rHev b) 5 Ab.IgE.RAST class
82013-4,Latex recombinant (rHev b) 6.01 Ab.IgE.RAST class
82014-2,Latex recombinant (rHev b) 6.02 Ab.IgE.RAST class
82015-9,Latex recombinant (rHev b) 8 Ab.IgE.RAST class
Jun-01,Gadolinium
82016-7,Latex recombinant (rHev b) 9 Ab.IgE.RAST class
82017-5,Latex recombinant (rHev b) 11 Ab.IgE.RAST class
82018-3,Lipolase Ab.IgE.RAST class
82019-1,Termamyl Ab.IgE.RAST class
82020-9,Aspergillus flavus Ab.IgE.RAST class
82021-7,Alternaria alternata recombinant (rAlt a) 1 Ab.IgE.RAST class
82022-5,"Galactose-alpha-1,3-galactose Ab.IgE.RAST class"
82023-3,Phadiatop Ab.IgE.RAST class
Apr-02,Lead
82024-1,Phadiatop Infant Ab.IgE.RAST class
82025-8,Epinephelus lanceolatus Ab.IgE.RAST class
82026-6,Bromelin MUXF3 Ab.IgE.RAST class
82027-4,Ulmus crassifolia Ab.IgE.RAST class
82028-2,Elaeagnus angustifolia Ab.IgE.RAST class
82029-0,Olea europaea native (nOle e) 1 Ab.IgE.RAST class
82030-8,Cupressus arizonica native (nCup a) 1 Ab.IgE.RAST class
82031-6,(Acer negundo+Quercus alba+Ulmus americana+Populus deltoides+Carya illinoinensis) Ab.IgE
Feb-03,Manganese
82032-4,(Juniperus sabinoides+Quercus alba+Ulmus americana+Populus deltoides+Prosopis juliflora) Ab.IgE
82033-2,(Alnus incana+Corylus avellana+Ulmus americana+Salix caprea+Populus deltoides) Ab.IgE.RAST class
82034-0,(Acer negundo+Betula verrucosa+Fagus grandifolia+Quercus alba+Juglans californica) Ab.IgE.RAST class
82035-7,(Acer negundo+Betula verrucosa+Fagus grandifolia+Quercus alba+Juglans californica) Ab.IgE
82036-5,(Olea europaea+Salix caprea+Pinus strobus+Eucalyptus spp+Acacia longifolia+Melaleuca leucadendron) Ab.IgE.RAST class
82037-3,(Acer negundo+Betula verrucosa+Corylus avellana+Quercus alba+Platanus acerifolia) Ab.IgE.RAST class
82038-1,(Alnus incana+Betula verrucosa+Corylus avellana+Quercus alba+Salix caprea) Ab.IgE.RAST class
82039-9,(Ambrosia elatior+Ambrosia psilostachya+Ambrosia trifida) Ab.IgE.RAST class
8204-0,Mercury
82040-7,(Artemisia vulgaris+Chenopodium album+Plantago lanceolata+Solidago virgaurea+Urtica dioica) Ab.IgE.RAST class
82041-5,(Artemisia vulgaris+Chenopodium album+Plantago lanceolata+Solidago virgaurea+Urtica dioica) Ab.IgE
82042-3,(Ambrosia elatior+Artemisia vulgaris+Chrysanthemum leucathemum+Taraxacum vulgare+Solidago virgaurea) Ab.IgE.RAST class
82043-1,(Plantago lanceolata+Chenopodium album+Salsola kali+Rumex acetosella) Ab.IgE.RAST class
82044-9,(Chrysanthemum leucanthemum+Taraxacum vulgare+Plantago lanceolata+Chenopodium album+Solidago virgaurea) Ab.IgE.RAST class
82045-6,(Chrysanthemum leucanthemum+Taraxacum vulgare+Plantago lanceolata+Chenopodium album+Solidago virgaurea) Ab.IgE
82046-4,(Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) Ab.IgE.RAST class
82047-2,(Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) Ab.IgE
82048-0,(Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) Ab.IgE.RAST class
82049-8,(Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) Ab.IgE.RAST class
82050-6,(Arachis hypogaea+Bertholletia excelsa+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE.RAST class
82051-4,(Beef+Chicken meat+Egg yolk+Pork+Turkey meat) Ab.IgE.RAST class
82052-2,(Beef+Chicken meat+Egg yolk+Pork+Turkey meat) Ab.IgE
82053-0,(Agaricus hortensis+Cucurbita pepo+Oryza sativa+Secale cereale+Solanum tuberosum) Ab.IgE.RAST class
82054-8,(Agaricus hortensis+Cucurbita pepo+Oryza sativa+Secale cereale+Solanum tuberosum) Ab.IgE
82055-5,(Daucus carota+Phaseolus vulgaris+Pisum sativum+Solanum tuberosum) Ab.IgE.RAST class
82056-3,(Brassica oleracea var capitata+Capsicum annuum+Lycopersicon lycopersicum+Spinacia oleracea) Ab.IgE.RAST class
Jul-05,Mercury
82057-1,(Citrus sinensis+Malus sylvestris+Musa spp+Prunus persica) Ab.IgE.RAST class
82058-9,(Ananas comosus+ Citrus limon+ Fragaria vesca+ Pyrus communis) Ab.IgE.RAST class
82059-7,(Ananas comosus+ Citrus limon+ Fragaria vesca+ Pyrus communis) Ab.IgE
82060-5,(Arachis hypogaea+Glycine max+Pisum sativum) Ab.IgE.RAST class
82061-3,(Cucumis sativus+Daucus carota+Solanum tuberosum+Spinacia oleracea) Ab.IgE.RAST class
82062-1,(Beef+Chicken meat+Pork+Turkey meat) Ab.IgE.RAST class
82063-9,(Actinidia chinensis+Corylus avellana+Musa spp+Pandalus borealis) Ab.IgE.RAST class
82064-7,(Arachis hypogaea+Cow milk+Egg white+Mustard) Ab.IgE.RAST class
May-06,Molybdenum
82065-4,(Corylus avellana+Gadus morhua+Glycine max+Triticum aestivum) Ab.IgE.RAST class
82066-2,(Actinidia chinensis+Beef+Pandalus borealis+Sesamum indicum) Ab.IgE.RAST class
82067-0,(Citrus sinensis+Citrus limon+Citrus paradisi+Citrus reticulata) Ab.IgE.RAST class
82068-8,(Citrus sinensis+Citrus limon+Citrus paradisi+Citrus reticulata) Ab.IgE
82069-6,(Avena sativa+Fagopyrum esculentum+Sesamum indicum+Triticum aestivum+Zea mays) Ab.IgE.RAST class
82070-4,(Allium cepa+Allium sativum+Apium graveolens+Lycopersicon lycopersicum+Yeast) Ab.IgE.RAST class
82071-2,(Artemisia dracunculus+Levisticum officinale+Origanum majorana+Thymus vulgaris) Ab.IgE.RAST class
82072-0,(Carum carvi+Elettaria cardamomum+Mace+Syzygium aromaticum) Ab.IgE.RAST class
Mar-07,Nickel
82073-8,(Foeniculum vulgare seed+Ocimum basilicum+Pimpinella anisum+Zingiber officinale) Ab.IgE.RAST class
82074-6,(Foeniculum vulgare seed+Ocimum basilicum+Pimpinella anisum+Zingiber officinale) Ab.IgE
82075-3,(Beef+Chicken+Pork) Ab.IgE.RAST class
82076-1,(Clupea harengus+Gadus morhua+Pleuronectes platessa+Scomber scombrus) Ab.IgE.RAST class
82077-9,(Bertholletia excelsa+Citrus sinensis+Corylus avellana+Malus sylvestris+Theobroma cacao) Ab.IgE.RAST class
82078-7,(Bertholletia excelsa+Citrus sinensis+Corylus avellana+Malus sylvestris+Theobroma cacao) Ab.IgE
82079-5,(Actinidia chinensis+Cucumis melo+Musa spp+Prunus dulcis+Vitis vinifera) Ab.IgE.RAST class
82080-3,(Actinidia chinensis+Cucumis melo+Musa spp+Prunus dulcis+Vitis vinifera) Ab.IgE
Jan-08,Nickel
82081-1,(Anthoxanthum odoratum+Lolium perenne+Phleum pratense+Secale cereale+Holcus lanatus) Ab.IgE.RAST class
82082-9,(Anthoxanthum odoratum+Holcus lanatus+Lolium perenne+Phragmites communis+Secale cereale) Ab.IgE.RAST class
82083-7,(Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) Ab.IgE.RAST class
82084-5,(Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) Ab.IgE.RAST class
82085-2,(Aspergillus fumigatus+Aspergillus niger+Aspergillus terreus+Aspergillus flavus) Ab.IgE
82086-0,(Chicken feather+Cow dander+Goose feather+Horse dander) Ab.IgE.RAST class
82087-8,(Acarus siro+Lepidoglyphus destructor+Gasterophilus intestinalis+Sitophilus granarius) Ab.IgE.RAST class
82088-6,(Acarus siro+Lepidoglyphus destructor+Gasterophilus intestinalis+Sitophilus granarius) Ab.IgE
82089-4,(Alternaria alternata+Aspergillus fumigatus+Rye pollen+Wheat pollen) Ab.IgE.RAST class
82090-2,(Alternaria alternata+Aspergillus fumigatus+Rye pollen+Wheat pollen) Ab.IgE
82091-0,(Amylase+Glycine max+Sitophilus granarius+Triticum sativum) Ab.IgE.RAST class
82092-8,(Amylase+Glycine max+Sitophilus granarius+Triticum sativum) Ab.IgE
82093-6,(Hexamethylene diisocyanate (HDI)+Diphenylmethane diisocyanate (MDI)+Toluene diisocyanate (TDI)+Phthalic anhydride) Ab.IgE.RAST class
82094-4,(Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) Ab.IgE.RAST class
82095-1,(Brassica oleracea var italica+Daucus carota+Phaseolus vulgaris+Pisum sativum+Zea mays) Ab.IgE.RAST class
82096-9,(Malus sylvestris+Musa spp+Prunus persica+Pyrus communis) Ab.IgE.RAST class
82097-7,(Actinidia chinensis+Ananas comosus+Cucumis melo+Musa spp+Prunus persica) Ab.IgE.RAST class
82098-5,(Actinidia chinensis+Ananas comosus+Cucumis melo+Musa spp+Prunus persica) Ab.IgE
Sep-09,Opiates
82099-3,(Anacardium occidentale+Carya illinoinensis+Juglans spp+Pistacia vera) Ab.IgE.RAST class
82100-9,(Bromus inermis+Cynodon dactylon+Holcus lanatus+Lolium perenne+Paspalum notatum+Sorghum halepense) Ab.IgE.RAST class
82101-7,(Bromus inermis+Cynodon dactylon+Holcus lanatus+Lolium perenne+Paspalum notatum+Sorghum halepense) Ab.IgE
82102-5,(Artemisia vulgaris+Betula verrucosa+Parietaria judaica+phleum pratense+Plantago lanceolata) Ab.IgE.RAST class
82103-3,(Artemisia vulgaris+Betula verrucosa+Parietaria judaica+phleum pratense+Plantago lanceolata) Ab.IgE
82104-1,(Alternaria alternata+Cat dander+Dermatophagoides farinae+Dog dander+Horse dander) Ab.IgE.RAST class
82105-8,(Alternaria alternata+Cat dander+Dermatophagoides farinae+Dog dander+Horse dander) Ab.IgE
82106-6,(Ambrosia elatior+Chenopodium album+Cynodon dactylon+Lolium perenne+Plantago lanceolata+Paspalum notatum) Ab.IgE.RAST class
Jul-10,Opiates
82107-4,(Ambrosia elatior+Chenopodium album+Cynodon dactylon+Lolium perenne+Plantago lanceolata+Paspalum notatum) Ab.IgE
82108-2,(Cynodon dactylon+Lolium perenne+Bromus inermis+Ambrosia elatior+Artemisia vulgaris+Plantago lanceolata) Ab.IgE.RAST class
82109-0,(Cynodon dactylon+Lolium perenne+Bromus inermis+Ambrosia elatior+Artemisia vulgaris+Plantago lanceolata) Ab.IgE
82110-8,(Alnus incana+Betula verrucosa+Corylus avellana+Fraxinus americana) Ab.IgE.RAST class
82111-6,(Alnus incana+Betula verrucosa+Corylus avellana+Fraxinus americana) Ab.IgE
82112-4,(Aspergillus fumigatus+Blatella germanica+Cat dander+Dermatophagoides pteronyssinus) Ab.IgE.RAST class
82113-2,(Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) Ab.IgE.RAST class
82114-0,(Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) Ab.IgE
May-11,Opiates
82115-7,dbSNP version
82116-5,Medication usage suggestion
82117-3,Medication usage implications panel
82118-1,Pharmacogenomics result panel
82119-9,COSMIC structural variant
82120-7,Allelic phase
82121-5,Allelic read depth
82122-3,Variant coding system
Mar-12,Opiates
82123-1,Guidance for radiation treatment
82124-9,Guidance for radiation treatment
82125-6,Respiratory pathogens DNA & RNA tested for
82126-4,Guidance for radiation treatment
82127-2,Respiratory pathogens DNA & RNA identified
82128-0,Multisection^WO contrast
82129-8,Multisection^WO & W contrast IV
82130-6,Multisection^WO contrast
Jan-13,Opiates
82131-4,Multisection^WO & W contrast IV
82132-2,Multisection^WO & W contrast IV
82133-0,Multisection^WO contrast
82134-8,Respiratory pathogens DNA & RNA tested for
82135-5,Respiratory pathogens DNA & RNA tested for
82136-3,Views for tumor^W I-123 MIBG IV
82137-1,FGFR3 gene.p.Gly380Arg targeted mutation analysis
82138-9,GJB2 gene.c.35delG targeted mutation analysis
82139-7,LRRK2 gene.p.Arg1441Gly & p.Gly2019Ser targeted mutation analysis
82140-5,MYD88 gene.p.Leu265Pro targeted mutation analysis
82141-3,"Did you live with anyone who was depressed, mentally ill, or suicidal^pre 18Yo"
82142-1,Did you live with anyone who was a problem drinker or alcoholic^pre 18Yo
82143-9,Did you live with anyone who used illegal street drugs or who abused prescription medications^pre 18Yo
82144-7,"Did you live with anyone who served time or was sentenced to serve time in a prison, jail, or other correctional facility^pre 18Yo"
82145-4,Were your parents separated or divorced^pre 18Yo
82146-2,"How often did your parents or adults in your home ever slap, hit, kick, punch or beat each other up^pre 18Yo"
82147-0,"How often did a parent or adult in your home ever hit, beat, kick, or physically hurt you in any way^pre 18Yo"
82148-8,"How often did a parent or adult in your home ever swear at you, insult you, or put you down^pre 18Yo"
Sep-14,Opiates
82149-6,"How often did anyone at least 5Y older than you or an adult, ever touch you sexually^pre 18Yo"
82150-4,"How often did anyone at least 5Y older than you or an adult, try to make you touch sexually^pre 18Yo"
82151-2,"How often did anyone at least 5Y older than you or an adult, force you to have sex^pre 18Yo"
82152-0,BRFSS Adverse Childhood Experience Module
82153-8,Total score
82154-6,Genomic structural variant name
82155-3,Genomic structural variant copy number
Jun-15,Opiates
82156-1,Protein intake
82157-9,Birth date
82158-7,Graduation state
82159-5,Respiratory pathogens DNA & RNA panel
82160-3,Adenovirus DNA
82161-1,Human coronavirus HKU1 RNA
82162-9,Human coronavirus NL63 RNA
82163-7,Human coronavirus 229E RNA
Apr-16,Opiates
82164-5,Human coronavirus OC43 RNA
82165-2,Human metapneumovirus RNA
82166-0,Influenza virus A RNA
82167-8,Influenza virus A H1 RNA
82168-6,Influenza virus A H1 2009 pandemic RNA
82169-4,Influenza virus A H3 RNA
82170-2,Influenza virus B RNA
82171-0,Parainfluenza virus 1 RNA
Feb-17,Opiates
82172-8,Parainfluenza virus 2 RNA
82173-6,Parainfluenza virus 3 RNA
82174-4,Parainfluenza virus 4 RNA
82175-1,Rhinovirus+Enterovirus RNA
82176-9,Respiratory syncytial virus RNA
82177-7,Mycoplasma pneumoniae DNA
82178-5,Chlamydophila pneumoniae DNA
82179-3,Bordetella pertussis.pertussis toxin promoter region
8218-0,Opiates
82180-1,Meningitis+Encephalitis pathogens panel
82181-9,Cryptococcus gattii+neoformans DNA
82182-7,Escherichia coli K1 DNA
82183-5,Haemophilus influenzae DNA
82184-3,Listeria monocytogenes DNA
82185-0,Neisseria meningitidis DNA
82186-8,Streptococcus agalactiae DNA
82187-6,Streptococcus pneumoniae DNA
82188-4,Varicella zoster virus DNA
82189-2,Cytomegalovirus DNA
821-9,A little u super little a Ab
82190-0,Herpes simplex virus 1 DNA
82191-8,Herpes simplex virus 2 DNA
82192-6,Herpes virus 6 DNA
82193-4,Parechovirus A RNA
82194-2,Enterovirus RNA
82195-9,Gastrointestinal pathogens DNA & RNA panel
82196-7,Campylobacter coli+jejuni+upsaliensis DNA
82197-5,Clostridioides difficile toxin A+B tcdA+tcdB genes
Aug-19,Opiates
82198-3,Plesiomonas shigelloides DNA
82199-1,Salmonella enterica+bongori DNA
82200-7,Vibrio cholerae+parahaemolyticus+vulnificus DNA
82201-5,Vibrio cholerae DNA
82202-3,Yersinia enterocolitica DNA
82203-1,Escherichia coli Stx1+Stx2 toxin stx1+stx2 genes
82204-9,Escherichia coli O157 DNA
82205-6,Cryptosporidium sp DNA
Jun-20,Opiates
82206-4,Cyclospora cayetanensis DNA
82207-2,Entamoeba histolytica DNA
82208-0,Giardia lamblia DNA
82209-8,Adenovirus 40+41 DNA
82210-6,Astrovirus subtypes 1-8 RNA
82211-4,Norovirus genogroup I+II RNA
82212-2,Rotavirus A RNA
82213-0,Sapovirus genogroups I+II+IV+V RNA
Apr-21,Opiates
82214-8,Safety issue assessment note
82215-5,Medical equipment or product list
82216-3,3-Hydroxyisobutyrate dehydrogenase
82217-1,3-Hydroxyisobutyryl-CoA hydrolase
82218-9,3-Methylcrotonyl-CoA carboxylase
82219-7,3-Methylglutaconyl-CoA hydratase
82220-5,Alkyl-dihydroxyacetonephosphate synthase
82221-3,Alpha-methylacyl CoA racemase
Feb-22,Opiates
82222-1,"Amylo-alpha-1,6-glucosidase"
82223-9,Cystathionine beta synthase
82224-7,Ribose-5-phosphate isomerase
82225-4,Ribose-5-phosphate isomerase
82226-2,Neck Disability Index
82227-0,Pain intensity
82228-8,"Personal care (washing, dressing, etc)"
82229-6,Lifting
8223-0,Opiates
82230-4,Reading
82231-2,Headaches
82232-0,Concentration
82233-8,Work
82234-6,Driving
82235-3,Sleeping
82236-1,Recreation
82237-9,Total score
82238-7,Chromosome region 15q11-13 deletion+duplication
82239-5,Chromosome region 16p13.3 deletion
82240-3,Chromosome region 16p13.3 deletion
82241-1,Chromosome region 17p11.2 deletion
82242-9,Chromosome region 17p13.3 deletion
82243-7,Chromosome region 17p13.3 deletion
82244-5,Chromosome region 1p36 deletion
82245-2,Chromosome region 22q11.2 deletion+duplication
82246-0,Chromosome region 22q11.2 deletion+duplication
82247-8,Chromosome region 7q11.23 deletion
Aug-24,Opiates
82248-6,Chromosome region 7q11.23 deletion
82249-4,Chromosome region 8q23.3-24.13 deletion
82250-2,Chromosome region 1p subtelomere & 1p36 deletion & 1q25 rearrangement
82251-0,Chromosome 3 & 7 & 17 aneuploidy & chromosome region 9p21 deletion
82252-8,Constitutive heterochromatin analysis
82253-6,JAG1 gene deletion
82254-4,Marker & derivative chromosome analysis
May-25,Opiates
82255-1,Marker & derivative chromosome analysis
82256-9,Chromosome 12 trisomy & chromosome region 11q22.3 & 13q14 & 17p13.1 deletion
82257-7,SRY gene deletion
82258-5,Subtelomere analysis
82259-3,Metabolic equivalent of task & Resting metabolic rate panel
82260-1,Metabolic equivalent of task by standard resting metabolic rate panel
82261-9,Activity metabolic rate/Standard resting metabolic rate
82262-7,Activity metabolic rate/Standard resting metabolic rate
Mar-26,Opiates
82263-5,Activity metabolic rate/Standard resting metabolic rate
82264-3,Metabolic equivalent of task by measured resting metabolic rate panel
82265-0,Activity metabolic rate/Measured resting metabolic rate
82266-8,Activity metabolic rate/Measured resting metabolic rate
82267-6,Activity metabolic rate/Measured resting metabolic rate
82268-4,Metabolic equivalent of task by population resting metabolic rate panel
82269-2,Activity metabolic rate/Population resting metabolic rate
822-7,A little u super little a Ab
82270-0,Activity metabolic rate/Population resting metabolic rate
Jan-27,Phencyclidine
82271-8,Activity metabolic rate/Standard resting metabolic rate^^adjusted for age+sex+race+BMI
82272-6,Activity metabolic rate/Population resting metabolic rate
82273-4,Metabolic equivalent of task by predicted resting metabolic rate panel
82274-2,Activity metabolic rate/Predicted resting metabolic rate
82275-9,Activity metabolic rate/Predicted resting metabolic rate
82276-7,Activity metabolic rate/Predicted resting metabolic rate
82277-5,Source used for predicted RMR
82278-3,Metabolic rate^resting
82279-1,Resting metabolic rate panel
82280-9,Source used to estimate activity metabolic rate
82281-7,Source used for reported activity metabolic rate
82282-5,Source used for population RMR
82283-3,Source used to adjust activity MET
82284-1,Standard resting metabolic rate
82285-8,Population resting metabolic rate
82286-6,Predicted resting metabolic rate
82287-4,Physical activity panel
82288-2,Absolute aerobic exercise intensity
Sep-28,Phencyclidine
82289-0,Rating of perceived exertion
82290-8,Frequency of moderate to vigorous aerobic physical activity
82291-6,Frequency of muscle-strengthening physical activity
82292-4,Meeting recommended guidelines for physical activity
82293-2,Frequency of bone-strengthening physical activity
82294-0,Physical activity guideline used
82295-7,Chromosome region Xp22.33 &or Yp11.32 deletion+duplication
82296-5,Method used to measure RMR
Jul-29,Phencyclidine
82297-3,Chikungunya virus structural proteins (E1+E2) Ab.IgG
82298-1,Yersinia enterocolitica
82299-9,Escherichia coli shiga-like toxin 1+2
82300-5,Shigella sp
82301-3,Salmonella sp
82302-1,Campylobacter sp
82303-9,Escherichia coli O157
82304-7,Plesiomonas shigelloides
May-30,Phencyclidine
82305-4,Gastrointestinal pathogens panel
82306-2,Chlamydia trachomatis rRNA
82307-0,Vendor device information panel
82308-8,Oncology plan of care and summary - recommended CDA R1.2 sections
82309-6,Basis for allelic phase
82310-4,Duration of stay outside the U.S.
82311-2,Time between start of treatment and onset of adverse event
82312-0,Blood transfusion &or organ transplant
Mar-31,Phencyclidine
82314-6,Specimen sent to CDC
82315-3,Level 3 emergency medical services patient care report - recommended CDA R1 & R2 sections
82316-1,Hip dysfunction and osteoarthritis outcome score for joint replacement
82317-9,Amount of hip pain experienced while going up or down stairs in the last W
82318-7,Amount of hip pain experienced while walking on an uneven surface in the last W
82319-5,Degree of difficulty experienced due to your hip while rising from sitting in the last W
82320-3,Degree of difficulty experienced due to your hip while bending to floor &or pick up an object in the last W
Jan-32,Phencyclidine
82321-1,"Degree of difficulty experienced due to your hip while lying in bed (turning over, maintaining hip position) in the last W"
82322-9,Degree of difficulty experienced due to your hip while sitting in the last W
82323-7,Total interval score
82324-5,Knee injury and osteoarthritis outcome score for joint replacement
82325-2,How severe is your knee stiffness after first wakening in the morning during the last W
82326-0,Amount of knee pain experienced while twisting &or pivoting on your knee in the last W
82327-8,Amount of knee pain experienced while straightening knee fully in the last W
82328-6,Amount of knee pain experienced while going up or down stairs in the last W
82329-4,Amount of knee pain experienced while standing upright in the last W
82330-2,Degree of difficulty experienced due to your knee while rising from sitting in the last W
82331-0,Degree of difficulty experienced due to your knee while bending to floor &or pick up an object in the last W
82332-8,Total interval score
82334-4,Interleukin 17A
82335-1,Cytokines panel
82336-9,REMS header
82337-7,Intrachamber
82338-5,Diameter
Sep-33,Phencyclidine
82339-3,Diameter
82340-1,Closure to opening
82341-9,Intrachamber systolic
82342-7,F8 gene intron 1 inversion targeted mutation analysis
82343-5,F8 gene intron 1 & 22 inversion targeted mutation analysis
82344-3,REMS communication plan
82345-0,REMS elements to assure safe use
82346-8,REMS material
Jul-34,Phencyclidine
82347-6,REMS summary
82348-4,REMS elements
82349-2,REMS goals
823-5,A little u super little a Ab
82350-0,REMS implementation system
82351-8,Risk evaluation & mitigation strategies
82352-6,REMS timetable for submission assessments
82353-4,Indexing - risk evaluation & mitigation strategies
Apr-35,Phencyclidine
82354-2,Human papilloma virus 16 & 18+45 E6+E7 mRNA
82355-9,Procedure note
82356-7,Consultation note
82357-5,Procedure note
82358-3,Referral note
82359-1,Consultation note
82360-9,Diagnostic study note
82361-7,Education note
Feb-36,Phencyclidine
82362-5,Flowsheet
82363-3,Initial evaluation note
82364-1,Plan of care note
82365-8,Progress note
82366-6,Procedure note
82367-4,Peripheral deiodinase activity
82368-2,Thyroid secretory capacity
82369-0,Buprenorphine
8237-0,Phencyclidine
82370-8,Norbuprenorphine
82371-6,Norbuprenorphine
82372-4,Buprenorphine
82373-2,Buprenorphine
82374-0,Norbuprenorphine
82375-7,Norbuprenorphine
82376-5,Elbasvir
82377-3,Ledipasvir
82378-1,Ombitasvir
82379-9,Daclatasvir
82380-7,Hepatitis C virus genotype 1 NS5a gene mutations detected
82381-5,Hepatitis C virus genotype 1 NS5b gene mutations detected
82382-3,Sofosbuvir
82383-1,Dengue virus 2+4 RNA
82384-9,Dengue virus 1+3 RNA
82385-6,Methylmalonate
82386-4,2-Methylcitrate
82387-2,Mycobacterium avium tuberculin stimulated gamma interferon
Aug-38,Phencyclidine
82388-0,3-Hydroxy-3-Methylglutaryl-coenzyme A reductase Ab
82389-8,3-Hydroxy-3-methylglutaryl-coenzyme A reductase Ab
82390-6,Centromere protein A Ab
82391-4,Centromere protein B Ab
82392-2,Ej Ab
82393-0,Fibrillarin Ab
82394-8,Fibrillarin Ab
82395-5,Ganglioside GD1a Ab.IgG
Jun-39,Phencyclidine
82396-3,Ganglioside GD1a Ab.IgG+IgM
82397-1,Ganglioside GD1a Ab.IgM
82398-9,Ganglioside GD1b Ab.IgG+IgM
82399-7,Ganglioside GD2 Ab.IgG
82400-3,Ganglioside GD2 Ab.IgG+IgM
82401-1,Ganglioside GD2 Ab.IgM
82402-9,Ganglioside GD3 Ab.IgG
82403-7,Ganglioside GD3 Ab.IgG+IgM
Apr-40,Phencyclidine
82404-5,Ganglioside GD3 Ab.IgM
82405-2,Ganglioside GM3 Ab.IgG+IgM
82406-0,Ganglioside GM3 Ab.IgM
82407-8,Ganglioside GM4 Ab.IgG
82408-6,Ganglioside GM4 Ab.IgG+IgM
82409-4,Ganglioside GM4 Ab.IgM
82410-2,Ganglioside GQ1b Ab.IgG+IgM
82411-0,Ganglioside GT1a Ab.IgG
Feb-41,Phencyclidine
82412-8,Ganglioside GT1a Ab.IgG+IgM
82413-6,Ganglioside GT1a Ab.IgM
82414-4,Ha Ab
82415-1,Ha Ab
82416-9,Histone Ab
82417-7,Human upstream binding factor Ab
82418-5,Human upstream binding factor Ab
82419-3,Intrinsic factor Ab
8242-0,Phencyclidine
82420-1,Jo-1 extractable nuclear Ab
82421-9,Ks Ab
82422-7,Ks Ab
82423-5,Ma+Ta Ab
82424-3,MDA5 Ab
82425-0,MJ Ab
82426-8,MJ Ab
82427-6,Myeloperoxidase Ab
82428-4,Nucleosome Ab
82429-2,Nucleosome Ab
824-3,A little u super little a Ag
82430-0,OJ Ab
82431-8,Platelet-derived growth factor receptor Ab
82432-6,Platelet-derived growth factor receptor Ab
82433-4,Proteinase 3 Ab
82434-2,Ribosomal Ab
82435-9,RNA polymerase III Ab
82436-7,SCL-70 extractable nuclear Ab
82437-5,Sjogrens syndrome-A extractable nuclear Ab
Aug-43,Styrene
82438-3,Sjogrens syndrome-B extractable nuclear Ab
82439-1,SUMO-activating enzyme subunit 1 Ab
82440-9,SUMO-activating enzyme subunit 1 Ab
82441-7,SUMO-activating enzyme subunit 2 Ab
82442-5,SUMO-activating enzyme subunit 2 Ab
82443-3,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab
82444-1,Glial nuclear type 1 ab
82445-8,Sulfatide Ab
Jun-44,Titanium
82446-6,Sulfatide Ab.IgG
82447-4,Sulfatide Ab.IgM
82448-2,TIF1-gamma Ab
82449-0,Titin Ab
82450-8,U1 small nuclear ribonucleoprotein 70kD Ab
82451-6,U1 small nuclear ribonucleoprotein A Ab
82452-4,U1 small nuclear ribonucleoprotein C Ab
Mar-45,Zinc
82453-2,Zo ab
82454-0,Ganglioside Ab panel
82455-7,Ganglioside Ab panel
82456-5,Human papilloma virus 16 E6+E7 mRNA
82457-3,Human papilloma virus 16 & 18+45 E6+E7 mRNA panel
82458-1,Gadus chalcogrammus roe Ab.IgE
82459-9,Gadus chalcogrammus roe Ab.IgE.RAST class
82460-7,Malus domestica recombinant (rMal d) 3 Ab.IgE.RAST class
Jan-46,Amorphous sediment
82461-5,Influenza virus A & B & H1 2009 pandemic RNA
82462-3,Silver
82463-1,Aluminum
82464-9,Mosquitoes tested
82465-6,Mosquito identified
82466-4,riTUXimab Ab
82467-2,riTUXimab
82468-0,Edoxaban
82469-8,Etanercept Ab
82470-6,Etanercept
82471-4,Borrelia garinii+afzelii oppA1 gene
82472-2,Borrelia garinii+afzelii oppA1 gene
82473-0,Borrelia mayonii oppA1 gene
82474-8,Borrelia mayonii oppA1 gene
82475-5,Borrelia miyamotoi glpQ gene
82476-3,Borrelia miyamotoi glpQ gene
82477-1,Erythrocyte sedimentation rate
82478-9,3-Hydroxydecenoylcarnitine (C10:1-OH)
Sep-47,Mucus
82479-7,TRBV30 gene segment/TRBV gene segments.total
82480-5,TRBV29 gene segments/TRBV gene segments.total
82481-3,TRBV28 gene segment/TRBV gene segments.total
82482-1,TRBV27 gene segment/TRBV gene segments.total
82483-9,TRBV25 gene segments/TRBV gene segments.total
82484-7,TRBV24-1 gene segment/TRBV gene segments.total
82485-4,TRBV20-1 gene segment/TRBV gene segments.total
82486-2,TRBV19 gene segments/TRBV gene segments.total
Jul-48,Spermatozoa
82487-0,TRBV18 gene segments/TRBV gene segments.total
82488-8,TRBV16 gene segments/TRBV gene segments.total
82489-6,TRBV15 gene segments/TRBV gene segments.total
82490-4,TRBV14 gene segments/TRBV gene segments.total
82491-2,TRBV13 gene segments/TRBV gene segments.total
82492-0,TRBV12 gene segments/TRBV gene segments.total
82493-8,TRBV11 gene segments/TRBV gene segments.total
82494-6,TRBV10 gene segments/TRBV gene segments.total
May-49,Transitional cells
82495-3,TRBV9 gene segments/TRBV gene segments.total
82496-1,TRBV7 gene segments/TRBV gene segments.total
82497-9,TRBV6 gene segments/TRBV gene segments.total
82498-7,TRBV5 gene segments/TRBV gene segments.total
82499-5,TRBV4 gene segments/TRBV gene segments.total
825-0,A little u super little a Ag
82500-0,TRBV3-1 gene segment/TRBV gene segments.total
82501-8,TRBV2 gene segments/TRBV gene segments.total
82502-6,Ethylmalonate
Mar-50,Microscopic observation
82503-4,Methylsuccinate
82504-2,Glutarate
82505-9,3-Hydroxyglutarate
82506-7,Oligosaccharides pattern
82507-5,Oligosaccharides pattern
82508-3,Ethyl sulfate
82509-1,Gamma interferon.negative control
82510-9,Mycobacterium bovis tuberculin stimulated gamma interferon
Jan-51,Service comment
82511-7,Mycobacterium bovis tuberculin stimulated gamma interferon
82512-5,Hepatitis C virus genotype 1
82513-3,Hepatitis C virus genotype 3
82514-1,Hepatitis C virus genotype 3 NS5a gene mutations detected
82515-8,NBN gene targeted mutation analysis
82516-6,LAMC2 gene targeted mutation analysis
82517-4,LAMA3 gene targeted mutation analysis
82518-2,IVD gene targeted mutation analysis
82519-0,Dengue virus 1+3 & 2+4 panel
82520-8,Velpatasvir
82521-6,Paritaprevir
82522-4,Simeprevir
82523-2,Grazoprevir
82524-0,6-Beta naltrexol
82525-7,Hepatitis C virus genotype & drug resistance panel
82526-5,6-Beta naltrexol
82527-3,6-Beta naltrexol/Creatinine
82528-1,VHL gene full mutation analysis
Sep-52,Service comment 10
82529-9,SDHD gene deletion+duplication & full mutation analysis
82530-7,SDHB gene deletion+duplication & full mutation analysis
82531-5,SDHC gene deletion+duplication & full mutation analysis
82532-3,SDHB & SDHC & SDHD gene deletion+duplication & full mutation analysis
82533-1,VHL gene deletion+duplication & full mutation analysis
82534-9,CASR gene full mutation analysis
82535-6,KRAS gene full mutation analysis
82536-4,SOS1 gene full mutation analysis
Jul-53,Service comment 11
82537-2,RAF1 gene full mutation analysis
82538-0,CALR gene exon 9 full mutation analysis
82539-8,Anacardium occidentale recombinant (rAna o) 3 Ab.IgE
82540-6,Anacardium occidentale recombinant (rAna o) 3 Ab.IgE.RAST class
82541-4,Cetuximab Ab.IgE
82542-2,Cetuximab Ab.IgE.RAST class
82543-0,Dog recombinant (rCan f) 4 Ab.IgE
82544-8,Dog recombinant (rCan f) 4 Ab.IgE.RAST class
May-54,Service comment 12
82545-5,Juglans regia recombinant (rJug r) 3 Ab.IgE.RAST class
82546-3,Juglans regia recombinant (rJug r) 1 Ab.IgE.RAST class
82547-1,(Actinidia deliciosa+Carica papaya+Mangifera indica+Musa spp+Persea americana) Ab.IgE
82548-9,(Actinidia deliciosa+Carica papaya+Mangifera indica+Musa spp+Persea americana) Ab.IgE.RAST class
82549-7,(Actinidia deliciosa+Carica papaya+Mangifera indica+Musa spp+Persea americana) Ab.IgE
82550-5,(Ceratonia siliqua+Lens esculenta+Phaseolus vulgaris+Pisum sativum) Ab.IgE
82551-3,(Ceratonia siliqua+Lens esculenta+Phaseolus vulgaris+Pisum sativum) Ab.IgE.RAST class
Feb-55,Service comment 13
82552-1,(Ceratonia siliqua+Lens esculenta+Phaseolus vulgaris+Pisum sativum) Ab.IgE
82553-9,(Fagopyrum esculentum+Oryza sativa+Sesamum indicum+Triticum aestivum+Zea mays) Ab.IgE
82554-7,(Fagopyrum esculentum+Oryza sativa+Sesamum indicum+Triticum aestivum+Zea mays) Ab.IgE.RAST class
82555-4,(Fagopyrum esculentum+Oryza sativa+Sesamum indicum+Triticum aestivum+Zea mays) Ab.IgE
82556-2,(Alternaria tenuis+Artemisia vulgaris+Betula verrucosa+Cladosporium herbarum+Phleum pratense) Ab.IgE.RAST class
82557-0,(Cow milk+Egg white+Gadus morhua+Triticum aestivum) Ab.IgE
82558-8,(Cow milk+Egg white+Gadus morhua+Triticum aestivum) Ab.IgE.RAST class
82559-6,(Cow milk+Egg white+Gadus morhua+Triticum aestivum) Ab.IgE
8256-0,Service comment 14
82560-4,(Bertholletia excels+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE
82561-2,(Bertholletia excels+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE.RAST class
82562-0,(Bertholletia excels+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE
82563-8,(Actinidia chinensis+Anacardium occidentale+Corylus avellana+Lycopersicon lycopersicum+Sesamum indicum) Ab.IgE
82564-6,(Actinidia chinensis+Anacardium occidentale+Corylus avellana+Lycopersicon lycopersicum+Sesamum indicum) Ab.IgE.RAST class
82565-3,(Actinidia chinensis+Anacardium occidentale+Corylus avellana+Lycopersicon lycopersicum+Sesamum indicum) Ab.IgE
82566-1,(Anthoxanthum odoratum+Cynodon dactylon+Dactylis glomerata+Phleum pratense+Phragmites communis) Ab.IgE
82567-9,(Anthoxanthum odoratum+Cynodon dactylon+Dactylis glomerata+Phleum pratense+Phragmites communis) Ab.IgE.RAST class
82568-7,(Anthoxanthum odoratum+Cynodon dactylon+Dactylis glomerata+Phleum pratense+Phragmites communis) Ab.IgE
82569-5,Corylus avellana recombinant (rCor a) 14 Ab.IgE.RAST class
82570-3,Coryphaena hippurus Ab.IgE
82571-1,Coryphaena hippurus Ab.IgE.RAST class
82572-9,Betula verrucosa recombinant (rBet v) 6 Ab.IgE
82573-7,Betula verrucosa recombinant (rBet v) 6 Ab.IgE.RAST class
82574-5,Staphylococcus aureus enterotoxin E Ab.IgE
82575-2,Urobilinogen
82576-0,Cyclic citrullinated peptide Ab.IgA
82577-8,(Malus domestica+Prunus avium+Prunus domestica+Prunus persica+Pyrus communis) Ab.IgE
Aug-57,Service comment 15
82578-6,(Malus domestica+Prunus avium+Prunus domestica+Prunus persica+Pyrus communis) Ab.IgE.RAST class
82579-4,(Malus domestica+Prunus avium+Prunus domestica+Prunus persica+Pyrus communis) Ab.IgE
82580-2,(Allium sativum+Apium graveolens+Sesamum indicum+Yeast) Ab.IgE
82581-0,(Allium sativum+Apium graveolens+Sesamum indicum+Yeast) Ab.IgE.RAST class
82582-8,(Allium sativum+Apium graveolens+Sesamum indicum+Yeast) Ab.IgE
82583-6,Triticum aestivum native (nTri a) 19+20+21 Ab.IgE
82584-4,Dicarboxyhexenoylcarnitine (C6:1-DC)/Creatinine
82585-1,Dicarboxyhexenoylcarnitine (C6:1-DC)
Jun-58,Service comment 16
82586-9,Nucleated cells
82587-7,Leukocytes
82588-5,Erythrocytes
82589-3,Highest level of education
82590-1,Y of education
82591-9,Reticulocytes.low light scatter/Reticulocytes.total
82592-7,Reticulocytes.mid light scatter/Reticulocytes.total
82593-5,Immunization summary report
Apr-59,Service comment 17
82594-3,Blood velocity-time integral.E wave
82595-0,Blood velocity-time integral.A wave
82596-8,Strain rate.systole.max
82597-6,Chromosome painting analysis
82598-4,REMS medication guide
82599-2,Oncorhynchus keta roe Ab.IgE
82600-8,Oncorhynchus keta roe Ab.IgE.RAST class
82601-6,Latex recombinant (rHev b) 10 Ab.IgE
Feb-60,Service comment 18
82602-4,Latex recombinant (rHev b) 10 Ab.IgE.RAST class
82603-2,Latex recombinant (rHev b) 2 Ab.IgE
82604-0,Latex recombinant (rHev b) 2 Ab.IgE.RAST class
82605-7,Triticum aestivum native (nTri a) 19+20+21 Ab.IgE.RAST class
82606-5,Allergy or intolerance criticality
82607-3,Clinical data
82608-1,Advancing care information
82609-9,Clinical practice improvement activity
8261-0,Service comment 19
82610-7,Note
82611-5,Wearable device external physiologic monitoring panel
82612-3,(Cynodon dactylon+Festuca elatior+Lolium perenne+Phleum pratense+Secale cereale pollen) Ab.IgE
82613-1,Apis mellifera recombinant (rApi m) 10 Ab.IgE
82614-9,Apis mellifera recombinant (rApi m) 10 Ab.IgE.RAST class
82615-6,Vital capacity^pre bronchodilation
82616-4,Vital capacity^post bronchodilation
82617-2,Capacity.total^pre bronchodilation
82618-0,Capacity.total^post bronchodilation
82619-8,Diffusion capacity/Alveolar volume^pre bronchodilation
82620-6,Diffusion capacity/Alveolar volume^post bronchodilation
82621-4,Time to end-systole
82622-2,Filling rate.diastole.max^W stress
82623-0,Filling rate.diastole.max^resting
82624-8,Filling rate.first third of diastole.mean^resting
82625-5,Time to peak filling rate^resting
82626-3,Phase.max^W stress
82627-1,Phase.mean^W stress
Aug-62,Service comment 02
82628-9,Phase.standard deviation^W stress
82629-7,Phase bandwidth^W stress
82630-5,Phase entropy^W stress
82631-3,Time to end-systole.difference.max^W stress
82632-1,Time to end-systole.difference.lateral and septal wall^W stress
82633-9,Time to end-systole.standard deviation^W stress
82634-7,Phase.max^resting
82635-4,Phase.mean^resting
Jun-63,Service comment 20
82636-2,Phase.standard deviation^resting
82637-0,Phase bandwidth^resting
82638-8,Phase entropy^resting
82639-6,Time to end-systole.difference.max^resting
82640-4,Time to end-systole.difference.lateral and septal wall^resting
82641-2,Time to end-systole.standard deviation^resting
82642-0,Summed stress score.17 segment model
82643-8,Summed rest score.17 segment model
Apr-64,Service comment 03
82644-6,Summed difference score.17 segment model
82645-3,Summed stress score.20 segment model
82646-1,Summed rest score.20 segment model
82647-9,Summed difference score.20 segment model
82648-7,Summed stress score
82649-5,Summed rest score
82650-3,Summed difference score
Jan-65,Service comment 04
82651-1,Washout rate
82652-9,Transient ischemic dilation
82653-7,Time to peak filling rate/RR interval^resting
82654-5,Cardiac nuclear imaging panel
82655-2,Gated cardiac measurement panel
82656-0,Cardiac summed score panel
82657-8,Cardiac phase measurement panel
82658-6,Glutamate decarboxylase Ab
82659-4,Thyrotropin receptor Ab
82660-2,Glutamate decarboxylase Ab
82661-0,Intrachamber systolic^post procedure
82662-8,Intrachamber diastolic^post procedure
82663-6,Intravascular end diastolic^post procedure
82664-4,Drug Abuse Screening Test
82665-1,Total Score
82666-9,Drug Abuse Screening Test-10
82667-7,Total Score
82668-5,Total score
Sep-66,Service comment 05
82669-3,"How much of the time did your asthma keep you from getting as much done at work, school or at home in the past 4W"
82670-1,How often have you had shortness of breath during the past 4W
82671-9,"How often did your asthma symptoms (wheezing, coughing, shortness of breath, chest tightness or pain) wake you up at night or earlier than usual in the morning during the past 4W"
82672-7,How often have you used your rescue inhaler or nebulizer medication (such as albuterol) during the past 4W
82673-5,How would you rate your asthma control during the past 4W
82674-3,Asthma Control Test
82675-0,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA
82676-8,Guidance for percutaneous aspiration of fluid
Jul-67,Service comment 06
82677-6,Multisection^W contrast IV
82678-4,Multisection^WO & W contrast IV
82679-2,Multisection^WO & W contrast IV
826-8,A little u super little a Ag
82680-0,Multisection^WO & W contrast IV
82681-8,Guidance for percutaneous biopsy
82682-6,Multisection^WO Contrast
82683-4,Multisection^WO Contrast
82684-2,Multisection^WO & W contrast IV
May-68,Service comment 07
82685-9,Multisection^W Contrast IV
82686-7,Multisection^W Contrast IV
82687-5,Multisection^WO Contrast
82688-3,Multisection^WO & W contrast IV+W air contrast PR
82689-1,Multisection^W contrast PO+WO & W contrast IV
82690-9,Multisection^WO contrast
82691-7,Multisection^W contrast IV
82692-5,Multisection^WO contrast
Mar-69,Service comment 08
82693-3,Multisection^W contrast IV
82694-1,Multisection^WO & W contrast IV
82695-8,Multisection^W contrast IV
82696-6,Multisection^W contrast IV
82697-4,Multisection^WO contrast
82698-2,Multisection^W contrast IV
82699-0,Multisection^WO contrast
82700-6,Multisection^W contrast IV
Jan-70,Service comment 09
82701-4,Multisection^WO contrast
82702-2,Multisection^WO & W contrast IV
82703-0,Multisection^WO & W contrast IV
82704-8,Multisection^W contrast IV
82705-5,Multisection^WO contrast
82706-3,Multisection^WO contrast
82707-1,Multisection^WO & W contrast IV
82708-9,Multisection^WO & W contrast IV
82709-7,Multisection
82710-5,Multisection
82711-3,Multisection
82712-1,Multisection
82713-9,Multisection
82714-7,Multisection
82715-4,Guidance for percutaneous aspiration of fluid
82716-2,Multisection^W contrast IV
82717-0,Multisection^WO & W contrast IV
82718-8,Multisection^WO & W contrast IV
Sep-71,Haemophilus influenzae C Ag
82719-6,Enfuvirtide
82720-4,Natural killer cell cytotoxicity panel
82721-2,Intravenous lipid emulsion
82722-0,Potassium
82723-8,Cocaine+Benzoylecgonine+Cocaethylene
82724-6,Natural killer cell cytotoxicity.3.13:1 effector to target cell ratio/Positive control
82725-3,Natural killer cell cytotoxicity.6.25:1 effector to target cell ratio/Positive control
82726-1,Natural killer cell cytotoxicity.12.5:1 effector to target cell ratio/Positive control
Jul-72,Cefepime
82727-9,Natural killer cell cytotoxicity.25:1 effector to target cell ratio/Positive control
82728-7,Natural killer cell cytotoxicity.50:1 effector to target cell ratio/Positive control
82729-5,Natural killer cell cytotoxicity.100:1 effector to target cell ratio/Positive control
82730-3,GlycA
82731-1,Zika virus Ab.IgM
82732-9,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1+2 Ab.IgG
82733-7,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1+2 Ab.IgG
82734-5,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab.IgG
May-73,Cefepime
82735-2,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab.IgG
82736-0,Calcium-calmodulin-dependent protein kinase II activity actual/Normal
82737-8,Beta tubulin Ab.IgG
82738-6,Dopamine receptor D2 long Ab.IgG
82739-4,Dopamine receptor D1 Ab.IgG
82740-2,Lysoganglioside GM1 Ab.IgG
82741-0,Pediatric autoimmune neuropsychiatric disorder associated with streptococcus diagnosis panel
82742-8,Multisection^WO & W contrast IV && Multisection^W contrast IV
Mar-74,Cefpirome
82743-6,Cells.CD8+CD45RA+
82744-4,Cells.CD8+CD45RA+/100 cells.CD8
82745-1,Doses of vaccine given^pre symptom onset
82746-9,Varicella zoster virus strain
82747-7,Babesia microti Ab.IgG
82748-5,Erythrocytes.Babesia sp infected/100 erythrocytes
82749-3,Date diagnosis confirmed
8275-0,Cefpirome
82750-1,Diagnosis confirmed before or after delivery
82751-9,Babesiosis during pregnancy
82752-7,Date travel started
82753-5,County of travel
82754-3,State of travel
82755-0,Geographic location where tick bite occurred
82756-8,Date of blood donation
82757-6,Immunodeficiency
82758-4,Date of previous diagnosis
82759-2,Reason for splenectomy
827-6,Am Ag
82760-0,Date of splenectomy
82761-8,Identified based on transfusion investigation post blood product donation
82762-6,Outdoor activity^8 weeks pre symptom onset or diagnosis
82763-4,Outdoor activity
82764-2,Country of travel outside the U.S.
82765-9,Date prescription dispensed
82766-7,Days' supply dispensed
82767-5,Amount dispensed
Aug-76,Cefpirome
82768-3,Lab order priority
82769-1,Smoked or non-smoked tobacco
82770-9,Patient reported outcome Computer Adaptive Testing used
82771-7,Lab test location performed
82772-5,Lab result date reported
82773-3,Lab result time reported
82774-1,Quantity prescribed
82775-8,Refills prescribed
Jun-77,Body surface
82776-6,Days' supply prescribed
82777-4,Frequency prescribed
82778-2,Trial enrollment date
82779-0,Trial participation end date
82780-8,Borrelia miyamotoi flaB gene
82781-6,Borrelia miyamotoi flaB gene
82782-4,Patient reported outcome item identifier
82783-2,Patient reported outcome response
Apr-78,Formula used to compute body surface area
82784-0,Patient reported outcome response method
82785-7,Lab order date
82786-5,Identifier
82787-3,Participant identifier
82788-1,Study site identifier
82789-9,Trial early withdrawal date
82790-7,Trial invitation code
82791-5,Cause of death sequence
Feb-79,Circumference.at nipple line
82792-3,Clot density
82793-1,Clot size^30M post incubation
82794-9,Clot formation.spontaneous
82795-6,Clot growth
82796-4,Clot growth.stationary
82797-2,Clot growth.initial
82798-0,Clot formation lag time
82799-8,Spatial clot growth analysis panel
Aug-82,Cefixime
8280-0,Circumference.at umbilicus
82800-4,Multisection^W radionuclide IV+W contrast IV
82801-2,Multisection^W radionuclide IV+WO contrast
82802-0,Multisection^WO & W contrast IV && Multisection^W contrast IV
82803-8,Multisection^WO & W contrast IV && Multisection^W contrast IV
82804-6,Multisection^WO & W contrast IV && Multisection^W contrast IV
82805-3,Guidance for localization of tumor^W 18F-FDG IV+WO Contrast
82806-1,Guidance for localization of tumor^W 18F-FDG IV+W contrast IV
82807-9,Guidance for localization of tumor^W 18F-FDG IV+WO Contrast
82808-7,Guidance for localization of tumor^W 18F-FDG IV+WO Contrast
82809-5,Guidance for localization of tumor^W 18F-FDG IV+W contrast IV
82810-3,Pregnancy status
82811-1,Nurse summary note - recommended sections
82812-9,Sodium
82813-7,Adverse Childhood Experiences
82814-5,Emotional abuse^pre 18Yo
82815-2,Physical abuse^pre 18Yo
82816-0,Sexual abuse^pre 18Yo
82817-8,Emotional neglect^pre 18Yo
Aug-81,Circumference.at umbilicus
82818-6,Physical neglect^pre 18Yo
82819-4,Parental separation or divorce^pre 18Yo
82820-2,Domestic violence^pre 18Yo
82821-0,Household substance abuse^pre 18Yo
82822-8,Mental illness in household^pre 18Yo
82823-6,Criminal household member^pre 18Yo
82824-4,Surgical operation note
82825-1,Initial evaluation note
Jun-82,Circumference.max
82826-9,Initial evaluation note
82827-7,Initial evaluation note
82828-5,Initial evaluation note
82829-3,Initial evaluation note
82830-1,Initial evaluation note
82832-7,Initial evaluation note
82833-5,Initial evaluation note
Apr-83,Circumference.max
82834-3,Initial evaluation note
82835-0,Initial evaluation note
82836-8,Initial evaluation note
82837-6,Initial evaluation note
82838-4,Initial evaluation note
82839-2,Initial evaluation note
828-4,Am Ag
82840-0,Mitochondria Ab.IgG
82841-8,PCNA extractable nuclear Ab.IgG
Feb-84,Circumference.max
82842-6,Liver kidney microsomal Ab.IgG
82843-4,Number dead from condition
82844-2,Number affected by condition
82845-9,Campylobacter jejuni Ab.IgA & IgG & IgM panel
82846-7,11-Dehydrocorticosterone+tetrahydrocorticosterone+Allo-tetrahydrocorticosterone/Androsterone+etiocholanolone
82847-5,11-Dehydrocorticosterone+tetrahydrocorticosterone+Allo-tetrahydrocorticosterone/Androsterone+etiocholanolone
82848-3,11-Dehydrocorticosterone+tetrahydrocorticosterone+Allo-tetrahydrocorticosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82849-1,11-Dehydrocorticosterone+tetrahydrocorticosterone+Allo-tetrahydrocorticosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82850-9,Androsterone+etiocholanolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82851-7,Androsterone+etiocholanolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82852-5,Pregnanediolone+pregnanetriol/Androsterone+etiocholanolone
82853-3,Pregnanediolone+pregnanetriol/Androsterone+etiocholanolone
82854-1,Pregnanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82855-8,Pregnanediolone+pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82856-6,Tetrahydrocortisol+allo-tetrahydrocortisol/Tetrahydrocortisone
82857-4,Tetrahydrocortisol+allo-tetrahydrocortisol/Tetrahydrocortisone
82858-2,11-Deoxytetrahydrocorticosterone
Sep-85,Circumference.max
82859-0,11-Deoxytetrahydrocorticosterone
82860-8,11-Deoxytetrahydrocorticosterone
82861-6,11-Deoxytetrahydrocortisol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82862-4,11-Deoxytetrahydrocortisol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82863-2,"3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone"
82864-0,"3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone"
82865-7,"3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone"
82866-5,Allo-pregnanediolone
Jul-86,Circumference.max
82867-3,Allo-pregnanediolone
82868-1,Allo-pregnanediolone
82869-9,6-Thioguanine & 6-methylmercaptopurine panel
82870-7,A little u super little b Ab
82871-5,Adenosine diphosphate
82872-3,A little n W little j Ab
82873-1,Brallobarbital
82874-9,Calprotectin
May-87,Circumference.occipital-frontal
82875-6,Campylobacter jejuni Ab.IgA
82876-4,Complement C1 esterase inhibitor
82877-2,Cytochrome C oxidase
82878-0,Dehydroepiandrosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82879-8,Dehydroepiandrosterone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82880-6,Escitalopram+norescitalopram
82881-4,Etiocholanolone/Androsterone
82882-2,Etiocholanolone/Androsterone
Mar-88,Circumference.occipital-frontal
82883-0,Lysosomal acid lipase
82884-8,MAOA gene.upstream VNTR repeats
82885-5,Meta methylhippurate
82886-3,Meta methylhippurate/Creatinine
82887-1,Ortho methylhippurate
82888-9,Ortho methylhippurate/Creatinine
82889-7,Meta methylhippurate+ortho methylhippurate+para methylhippurate
82890-5,Meta methylhippurate+ortho methylhippurate+para methylhippurate/Creatinine
Jan-89,Circumference.occipital-frontal
82891-3,Para methylhippurate
82892-1,Para methylhippurate/Creatinine
82893-9,Penfluridol
82894-7,Pregnanediol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82895-4,Pregnanediol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82896-2,Pregnanediolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82897-0,Pregnanediolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82898-8,Pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82899-6,Pregnanetriol/Tetrahydrocortisone+tetrahydrocortisol+5-Alpha tetrahydrocortisol
82900-2,Pregnanetriolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82901-0,Pregnanetriolone/Tetrahydrocortisone+tetrahydrocortisol+5-alpha tetrahydrocortisol
82902-8,Somatotropin^15M pre XXX challenge
82903-6,"t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript"
82904-4,"t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript"
82905-1,"t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript"
82906-9,Tetrahydrocorticosterone/Allo-tetrahydrocorticosterone
82907-7,Tetrahydrocorticosterone/Allo-tetrahydrocorticosterone
82908-5,Tetrahydrocortisol/5-alpha tetrahydrocortisol
Sep-90,Circumference.occipital-frontal^at birth
82909-3,Tetrahydrocortisol/5-alpha tetrahydrocortisol
82910-1,Thromboxane beta 2
82911-9,Vascular endothelial growth factor D
82913-5,Centromere protein B Ab.IgG
82914-3,Dothiepin^trough
82915-0,Fibrillarin Ab.IgG
82916-8,Flurazepam^trough
Jul-91,Circumference.occipital-frontal^at birth
82917-6,Bromperidol^trough
82918-4,Jo-1 extractable nuclear Ab.IgG
82919-2,Ku Ab.IgG
829-2,Am Ag
82920-0,Legionella pneumophila Ab.IgA
82921-8,Liver cytosol Ab.IgG
82923-4,PML Ab.IgG
82924-2,Pl-7 Ab.IgG
May-92,Circumference^expiration
82925-9,PM-SCL-100 Ab.IgG
82926-7,Phospholipase A2 receptor Ab.IgG
82928-3,Mitochondria M2 Ab.IgG
82931-7,Nuclear pore protein gp210 Ab.IgG
82932-5,sp100 Ab.IgG
Mar-93,Circumference^inspiration
82933-3,Sjogrens syndrome-A extractable nuclear 52kD Ab.IgG
82934-1,clonazePAM^trough
82935-8,Oxazepam^trough
82936-6,Signal recognition particle Ab.IgG
82937-4,Signaling lymphocytic activation molecule (SLAM)-associated & X-linked inhibitor of apoptosis protein
82938-2,Smith extractable nuclear D Ab.IgG
82939-0,Genetic variant details
82940-8,Speech
Jan-94,Diameter.anterior-posterior
82941-6,Salivation
82942-4,Swallowing
82943-2,Handwriting
82944-0,Cutting food and handling utensils (patients without gastrostomy)
82945-7,Cutting food and handling utensils (patients with gastrostomy)
82946-5,Dressing and hygiene
82947-3,Turning in bed and adjusting bed clothes
82948-1,Walking
82949-9,Climbing stairs
82950-7,Dyspnea
82951-5,Orthopnea
82952-3,Respiratory insufficiency
82953-1,Total score
82954-9,Amyotrophic lateral sclerosis functional rating scale - revised (ALSFRS-R)
82955-6,HEDIS 2017 Value Sets
82956-4,HEDIS 2017-2020 Value Set - FIT-DNA
82957-2,"HEDIS 2017, 2018 Value Set - Chlamydia Tests"
Aug-95,Diameter.anterior-posterior^W expiration
82958-0,"HEDIS 2017, 2018 Value Set - Cytomegalovirus Antibody"
82959-8,HEDIS 2017-2020 Value Set - FOBT
82960-6,"HEDIS 2017, 2018 Value Set - Group A Strep Tests"
82961-4,"HEDIS 2017, 2018 Value Set - Pregnancy Test Exclusion"
82962-2,"HEDIS 2017, 2018 Value Set - Serum Potassium"
82963-0,"HEDIS 2017, 2018 Value Set - HPV Vaccine Administered"
82964-8,Cannabidiol
82965-5,Methylenedioxyethylamphetamine
Jun-96,Diameter.anterior-posterior^W inspiration
82966-3,Methamphetamine
82967-1,Amphetamine
82968-9,Secobarbital
82969-7,PENTobarbital
82970-5,PHENobarbital
82971-3,Butalbital
82972-1,Butabarbital
82973-9,Amobarbital
Apr-97,Volume
82974-7,O-nortramadol
82975-4,Desmosome Ab.IgG
82976-2,Dipeptidyl aminopeptidase-like protein 6 Ab.IgG
82977-0,Gamma aminobutyrate B receptor Ab.IgG
82978-8,Leucine-rich glioma-inactivated protein 1 Ab.IgG
82979-6,Contactin-associated protein 2 Ab.IgG
82980-4,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG
82981-2,N-methyl-D-aspartate receptor Ab.IgG
Feb-98,Volume
82982-0,Exocrine pancreas Ab.IgA+IgG
82983-8,Ma+Ta Ab.IgG
82984-6,Gamma aminobutyrate B receptor Ab.IgG
82985-3,Leucine-rich glioma-inactivated protein 1 Ab.IgG
82986-1,Contactin-associated protein 2 Ab.IgG
82987-9,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG
82988-7,N-methyl-D-aspartate receptor Ab.IgG
82989-5,Dipeptidyl aminopeptidase-like protein 6 Ab.IgG
8299-0,Volume
82990-3,3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Ab.IgG
82991-1,Phospholipase A2 receptor Ab.IgG
82992-9,SUMO-activating enzyme subunit 1 Ab.IgG
82993-7,MJ Ab.IgG
82994-5,MDA5 Ab.IgG
82995-2,TIF1-gamma Ab.IgG
82996-0,Mi-2 beta Ab.IgG
82997-8,Mi-2 alpha Ab.IgG
82998-6,Dense fine speckled 70 protein Ab.IgG
82999-4,Purkinje cell cytoplasmic type Tr Ab.IgG
03-Aug,Amdinocillin
830-0,A variant subtype
83000-0,Titin Ab.IgG
83001-8,Glial nuclear type 1 Ab.IgG
83002-6,Zinc finger protein of the cerebellum 4 Ab.IgG
83003-4,Recoverin Ab.IgG
83004-2,Glutamate decarboxylase 65 Ab.IgG
83005-9,Variant category
Jun-00,Volume
83006-7,Deletion-duplication overall interpretation
83007-5,COSMIC version
83008-3,ClinVar version
83009-1,Genetic variation effect on high-risk allele
83010-9,Medication usage suggestion
83011-7,Haplotype definition panel
83012-5,Views for bone density
83013-3,Views for bone density
Apr-01,Body height
83014-1,Views for bone density+vertebral fracture
83015-8,Views 2 for renal calculus
83016-6,Views GE 3 AP + oblique + cone
83017-4,View && Views supine + upright
83018-2,Views 1 or 2
83019-0,View babygram
83020-8,Views survey complete
83021-6,(Views 2 or 3) + (Views^W flexion + W extension)
Feb-02,Body height
83022-4,(Views 2 or 3) + (Views^W flexion + W extension) + (Views oblique)
83023-2,Views 4 or 5
83024-0,Views 2 + Views lateral-decubitus
83025-7,Views GE 2
83026-5,Views 1 or 2
83027-3,Views GE 4
83028-1,Views GE 2
83029-9,Views 1 or 2
8303-0,Body height
83030-7,Views 1 or 2
83031-5,View AP && Views GE 2
83032-3,Views GE 2^preoperative
83033-1,View^during surgery
83034-9,Views GE 2 for pediatrics
83035-6,Views 1 or 2^during surgery
83036-4,Views GE 2
83037-2,View^during surgery
83038-0,(Views GE 5) + (Views GE 1^W R-bending + W L-bending)
83039-8,Views GE 3
83040-6,Views 2
83041-4,Views 2 && View
83042-2,Views 2 && View AP
83043-0,Views 1 or 2
83044-8,Views GE 2
83045-5,Views AP + lateral
83046-3,Views LE 3 AP + lateral
83047-1,Views GE 2
Aug-04,Body height special circumstances
83048-9,Views GE 3
83049-7,Views GE 2
83050-5,Views 1 or 2
83051-3,Views for vertebral fracture
83052-1,Programmed cell death ligand 1 by clone 22C3
83053-9,Cells.programmed cell death ligand 1/100 viable tumor cells
83054-7,Programmed cell death ligand 1 by clone 22C3
May-05,Body height^post partum
83055-4,Programmed cell death ligand 1 by clone 28-8
83056-2,Programmed cell death ligand 1 by clone 28-8
83057-0,Programmed cell death ligand 1 by clone SP142
83058-8,Nucleoprotein expression
83059-6,KRAS gene
83060-4,NRAS gene
83061-2,BRAF gene
83062-0,PIK3CA gene
Mar-06,Body height^lying
83063-8,PTEN gene
83064-6,Calcium.ionized
83065-3,Cytomegalovirus DNA
83066-1,Mycobacterium tuberculosis complex immunogenic protein MPB64
83067-9,Chikungunya virus structural proteins (E1+E2) Ab.IgM
83068-7,Chikungunya virus structural proteins (E1+E2) Ab.IgG
83069-5,Zika virus non-structural protein 1 Ab.IgG
83070-3,Calcidiol+ercalcidiol
Jan-07,Body height^preoperative
83071-1,Calcidiol+ercalcidiol
83072-9,Alpha-1-Fetoprotein
83073-7,Alpha-1-Fetoprotein
83074-5,Alpha-1-Fetoprotein
83075-2,Alpha-1-Fetoprotein
83076-0,Beta-2-Microglobulin
83077-8,Beta-2-Microglobulin
83078-6,Beta-2-Microglobulin
83079-4,Beta-2-Microglobulin
83080-2,Borrelia burgdorferi Ab.IgG
83081-0,Borrelia burgdorferi Ab.IgG+IgM
83082-8,Cancer Ag 125
83083-6,Cancer Ag 15-3
83084-4,Cancer Ag 19-9
83085-1,Carcinoembryonic Ag
83086-9,Choriogonadotropin
83087-7,Clostridioides difficile glutamate dehydrogenase
83088-5,Cortisol
Sep-08,Body height^standing
83089-3,Cortisol
83090-1,Cortisol
83091-9,Cortisol
83092-7,Creatine kinase.MB
83093-5,Digoxin
83094-3,Digoxin
83095-0,Epstein Barr virus capsid+early Ab.IgG
83096-8,Estradiol
Jul-09,Body temperature
83097-6,Estradiol
83098-4,Follitropin
83099-2,Galectin 3
83100-8,Hepatitis B virus core Ab.IgG+IgM
83101-6,HIV 1+2 Ab & HIV1 p24 Ag panel
83102-4,IgE
83103-2,Lutropin
83104-0,Mullerian inhibiting substance
May-10,Body temperature
83105-7,Mullerian inhibiting substance
83106-5,Myoglobin
83107-3,Natriuretic peptide.B prohormone N-Terminal
83108-1,Natriuretic peptide.B prohormone N-Terminal
83109-9,Progesterone
83110-7,Progesterone
83111-5,Prolactin
83112-3,Prostate specific Ag
Mar-11,Body temperature
83113-1,Prostate specific Ag.free
83114-9,S100 calcium binding protein B
83115-6,Testosterone
83116-4,Testosterone
83117-2,Thyroglobulin Ab.IgG
83118-0,Thyroperoxidase Ab.IgG
83119-8,Thyroxine
83120-6,Thyroxine
Jan-12,Body temperature
83121-4,Thyroxine.free
83122-2,Thyroxine.free
83123-0,Toxoplasma gondii Ab.IgG+IgM
83124-8,Triiodothyronine
83125-5,Triiodothyronine
83126-3,Triiodothyronine.free
83127-1,Triiodothyronine.free
83128-9,Hepatitis E virus Ab.IgM
83129-7,Respondent type
83130-5,11-Deoxytetrahydrocorticosterone/Creatinine
83131-3,Pregnanolone
83132-1,Pregnanolone
83133-9,Pregnanolone/Creatinine
83134-7,"3 alpha, 15 beta, 17 alpha-Trihydroxypregnanediolone/Creatinine"
83135-4,Allo-pregnanediolone/Creatinine
83136-2,Allo-pregnanediol/Creatinine
83137-0,OJ Ab.IgG
83138-8,17-Hydroxypregnenetriol
Sep-13,Body temperature
83139-6,17-Hydroxypregnenetriol/Creatinine
83140-4,17-Hydroxypregnenetriol
83141-2,9-Hole Pegboard Dexterity Test
83142-0,Standing Balance Test
83143-8,2-Minute Walk Endurance Test
83144-6,4-Meter Walk Gait Speed Test
83145-3,Grip Strength Test
83146-1,Able to hold position for 50S - trial 1^eyes open+on solid surface
Jul-14,Body temperature
83147-9,Able to hold position for 50S - trial 2^eyes open+on solid surface
83148-7,Able to hold position for 50S - trial 1^eyes closed+on solid surface
83149-5,Able to hold position for 50S - trial 2^eyes closed+on solid surface
83150-3,Able to hold position for 50S - trial 1^eyes open+on foam surface
83151-1,Able to hold position for 50S - trial 2^eyes open+on foam surface
83152-9,Able to hold position for 50S - trial 1^eyes closed+on foam surface
83153-7,Able to hold position for 50S - trial 2^eyes closed+on foam surface
Apr-15,Body temperature
83154-5,Able to hold position for 50S - trial 1^eyes open+tandem stance+on solid surface
83155-2,Able to hold position for 50S - trial 2^eyes open+tandem stance+on solid surface
83156-0,9-Hole Pegboard Dexterity Test
83157-8,9-Hole Pegboard Dexterity Test
83158-6,9-Hole Pegboard Dexterity - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
83159-4,9-Hole Pegboard Dexterity - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
83160-2,AP postural sway score^eyes open+on solid surface
83161-0,AP postural sway score^eyes closed+on foam surface
Feb-16,Body temperature
83162-8,Standing Balance Test computed score
83163-6,Number of 10 [ft_i] marks^2M post trial start
83164-4,Additional [ft_i] past last 10 [ft_i] mark^2M post trial start
83165-1,Remainder [in_i] past last 10 [ft_i] mark^2M post trial start
83166-9,Number of turns in 2M
83167-7,Walk distance score
83168-5,2-minute Walk Endurance Test - unadjusted scale score
83169-3,Walk 4 meters at usual pace - trial 1
8317-0,Body temperature
83170-1,Walk 4 meters at usual pace - trial 2
83171-9,2-minute Walk Endurance Test - scale score^^adjusted for age
83172-7,4-Meter Walk Gait Speed Test - computed score
83173-5,Grip strength
83174-3,Grip strength
83175-0,Grip Strength Test - scale score^^adjusted for age
83176-8,Grip Strength Test - scale score^^adjusted for age
83177-6,AP postural sway score^eyes closed+on solid surface
83178-4,AP postural sway score^eyes open+on foam surface
83179-2,AP postural sway score^eyes open+tandem stance+on solid surface
831-8,A variant subtype
83180-0,Self-care activities - functional ability panel
83181-8,Bathing - functional ability
83182-6,Dressing - functional ability
83183-4,Toileting - functional ability
83184-2,Feeding or eating - functional ability
83185-9,Transferring - functional ability
83186-7,Ambulation - functional ability
83187-5,Wheel 50 feet with two turns - functional goal recorded during 3D assessment period
Aug-18,Body temperature
83188-3,Wheel 50 feet with two turns - functional ability during 3D assessment period
83189-1,Picking up object - functional goal recorded during 3D assessment period
83190-9,Picking up object - functional ability during 3D assessment period
83191-7,12 steps - functional goal recorded during 3D assessment period
83192-5,12 steps - functional ability during 3D assessment period
83193-3,4 steps - functional goal recorded during 3D assessment period
83194-1,4 steps - functional ability during 3D assessment period
83195-8,1 step (curb) - functional goal recorded during 3D assessment period
Jun-19,Body temperature
83196-6,1 step (curb) - functional ability during 3D assessment period
83197-4,Walking 10 feet on uneven surfaces - functional goal recorded during 3D assessment period
83198-2,Walking 10 feet on uneven surfaces - functional ability during 3D assessment period
83199-0,Walk 150 feet - functional goal recorded during 3D assessment period
83200-6,Walk 150 feet - functional ability during 3D assessment period
83201-4,Walk 50 feet with two turns - functional goal recorded during 3D assessment period
83202-2,Walk 50 feet with two turns - functional ability during 3D assessment period
83203-0,Walk 10 feet - functional goal recorded during 3D assessment period
Apr-20,Body temperature
83204-8,Walk 10 feet - functional ability during 3D assessment period
83205-5,Car transfer - functional goal recorded during 3D assessment period
83206-3,Car transfer - functional ability during 3D assessment period
83207-1,Toilet transfer - functional goal recorded during 3D assessment period
83208-9,Toilet transfer - functional ability during 3D assessment period
83209-7,Bed-to-chair transfer - functional goal recorded during 3D assessment period
83210-5,Bed-to-chair transfer - functional ability during 3D assessment period
83211-3,Sit to stand - functional goal recorded during 3D assessment period
Feb-21,Body temperature
83212-1,Sit to stand - functional ability during 3D assessment period
83213-9,Lying to sitting on side of bed - functional goal recorded during 3D assessment period
83214-7,Lying to sitting on side of bed - functional ability during 3D assessment period
83215-4,Sit to lying - functional goal recorded during 3D assessment period
83216-2,Sit to lying - functional ability during 3D assessment period
83217-0,Roll left and right - functional goal recorded during 3D assessment period
83218-8,Roll left and right - functional ability during 3D assessment period
83219-6,Putting on and taking off footwear - functional goal recorded during 3D assessment period
8322-0,Body temperature
83220-4,Putting on and taking off footwear - functional ability during 3D assessment period
83221-2,Lower body dressing - functional goal recorded during 3D assessment period
83222-0,Lower body dressing - functional ability during 3D assessment period
83223-8,Upper body dressing - functional goal recorded during 3D assessment period
83224-6,Upper body dressing - functional ability during 3D assessment period
83225-3,Shower &or bathe self - functional goal recorded during 3D assessment period
83226-1,Shower &or bathe self - functional ability during 3D assessment period
83227-9,Toileting hygiene - functional goal recorded during 3D assessment period
83228-7,Toileting hygiene - functional ability during 3D assessment period
83229-5,Oral hygiene - functional goal recorded during 3D assessment period
83230-3,Oral hygiene - functional ability during 3D assessment period
83231-1,Eating - functional goal recorded during 3D assessment period
83232-9,Eating - functional ability during 3D assessment period
83233-7,Self-care - admission performance
83234-5,Prior device use
83235-2,Wheel 150 feet - functional ability during 3D assessment period
83236-0,Wheel 150 feet - functional goal recorded during 3D assessment period
83237-8,Bladder and bowel
Aug-23,Body temperature
83238-6,Bladder continence during 3D assessment period
83239-4,"IRF-PAI v3.0, MDS v1.17.1, 1.17.2, OASIS E - Prior functioning: everyday activities"
83240-2,Memory &or recall ability
83241-0,IRF-PAI - Staff assessment for mental status
83242-8,Bowel continence during 3D assessment period
83243-6,Comorbidities and coexisting conditions
83244-4,IRF-PAI v2.0 - Swallowing &or nutritional status - admission
83245-1,Usual ability to swallow during 3D assessment period
Jun-24,Body temperature
83246-9,"IRF-PAI v3.0, LCDS v4.00 - Current number of unhealed pressure injuries at each stage - admission"
83247-7,"IRF-PAI v2.0, LCDS v4.00 - Special treatments, procedures, and programs - discharge"
83248-5,Should brief interview for mental status be conducted during 3D assessment period
83249-3,Understanding verbal content during 3D assessment period
83250-1,Expression of ideas and wants during 3D assessment period
83251-9,"IRF-PAI - Hearing, speech, and vision - admission"
83252-7,"Special treatments, procedures, and programs at admission"
Mar-25,Body temperature
83254-3,Self-care - discharge performance
83256-8,"IRF-PAI v3.0, LCDS v4.00 - Current number of unhealed pressure injuries at each stage - discharge"
83258-4,IRF-PAI - Healed pressure injuries
832-6,A variant subtype
83260-0,Number of pressure injuries noted on prior assessment that have completely closed - stage 1
Jan-26,Class
83261-8,"IRF-PAI v3.0 - Special treatments, procedures, and programs - admission"
83264-2,IRF-PAI - Active diagnoses
83265-9,Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 1.4
83266-7,IRF-PAI - Quality indicators - admission
83267-5,IRF-PAI - Cognitive patterns - admission
83268-3,IRF-PAI - Functional abilities and goals - admission
83269-1,IRF-PAI - Mobility - admission performance during 3D assessment period
83270-9,Does the patient walk - admission performance during 3D assessment period
83271-7,Does the patient use a wheelchair or scooter during 3D assessment period
83272-5,Indicate the type of wheelchair or scooter used during 3D assessment period
83273-3,IRF-PAI - Health conditions - admission
83274-1,Did the patient have major surgery during the 100D prior to admission
83275-8,IRF-PAI - Quality indicators - discharge
83276-6,IRF-PAI - Functional abilities and goals - discharge
83277-4,IRF-PAI - Mobility - discharge performance during 3D assessment period
83278-2,Does the patient walk - discharge performance during 3D assessment period
Sep-27,Body temperature measurement site
83279-0,"IRF-PAI v3.0, LCDS v4.00, OASIS E - Health conditions - discharge or expired or transfer"
83280-8,Has the patient had any falls since admission
83281-6,IRF-PAI - Skin conditions - discharge
83282-4,Worsening in pressure injury status since admission
83283-2,Stage 2 pressure injuries not present or at a lesser stage on admission &or reentry
83284-0,Stage 3 pressure injuries not present or at a lesser stage on admission &or reentry
83285-7,Stage 4 pressure injuries not present or at a lesser stage on admission &or reentry
83286-5,Unstageable pressure injuries due to non-removable dressing not present or at a lesser stage on admission &or reentry
Jul-28,Body temperature
83287-3,Unstageable pressure injury due to slough &or eschar not present or at a lesser stage on admission &or reenty
83288-1,Unstageable pressure injury due to deep tissue injury not present or at a lesser stage on admission &or reentry
83289-9,Multisection for calcium score^WO contrast && Multisection^W contrast IV
83290-7,Multisection for pulmonary embolus+deep vein thrombosis^W contrast IV
83291-5,Multisection^ WO Contrast
83292-3,Multisection^W contrast
83293-1,Multisection^W contrast IV
83294-9,Multisection^W contrast IV
May-29,Body temperature
83295-6,Multisection^W contrast IV
83296-4,Multisection^W contrast IV && Multisection^WO & W contrast IV
83297-2,Multisection^WO & W contrast IV
83298-0,Multisection^WO & W contrast IV
83299-8,Multisection^WO & W contrast IV
83300-4,Multisection^WO & W Contrast IV
83301-2,Multisection^WO & W contrast IV
83302-0,Multisection^WO contrast
Mar-30,Body temperature
83303-8,Multisection^WO contrast
83304-6,Multisection^WO contrast
83305-3,Multisection^WO contrast
83306-1,Multisection^WO contrast
83307-9,Multisection^WO contrast
83308-7,Multisection^WO contrast
83309-5,Multisection^WO contrast
83310-3,Multisection^WO contrast
Jan-31,Body temperature
83311-1,Bone density quantitative measurement panel
83312-9,Exchanged drugs &or money for sex in the past Y
83313-7,Injection drug use in the past Y
83314-5,Sexual activity while intoxicated &or high on drugs in the past Y
83315-2,Sexual activity with a female in the past Y
83316-0,Sexual activity with a male in the past Y
83317-8,Sexual activity with anonymous partner in the past Y
83318-6,Sexual activity with known IV drug user in the past Y
83319-4,Syphilis neurological involvement
83320-2,Adverse event note
83321-0,Pathology report.intraoperative observation
83322-8,Home environment safety and stability
83323-6,Daily activities impact on well-being
83324-4,Social network
83325-1,HIV 1 RNA genotype
83326-9,HIV 1 RNA genotype & phenotype
83327-7,HIV 1 RNA phenotype
83328-5,Physical health needs that require further investigation
Sep-32,Body temperature
83329-3,Health and well-being panel
83330-1,Physical health impacting mental well-being
83331-9,Patient Centered Assessment Method panel
83332-7,Lifestyle behaviors impacting physical or mental well-being
83333-5,Other mental well-being concerns
83334-3,Social environmental panel
83335-0,Financial resources
83336-8,Health literacy and communication panel
Jul-33,Body temperature
83337-6,Understand health and well-being and what they need to do to manage their health
83338-4,Can engage in healthcare discussions
83339-2,Service coordination panel
833-4,A variant NOS Ag
83340-0,Do other services need to be involved to help this client
83341-8,Are current services involved with this client well-coordinated
83342-6,Barriers to action
83343-4,Who needs to be involved
83344-2,What action is required
May-34,Body temperature
83345-9,What action will be taken
Feb-35,Body weight
8336-0,Body weight
83366-5,Burst rate
83367-3,Fresh gas.air flow setting
83368-1,Expiratory gas flow.max.personal best
83369-9,Fresh gas.nitrous oxide flow setting
83370-7,Fresh gas.oxygen flow setting
83371-5,Cycles.remaining
83372-3,Cycles setting
83373-1,Mode setting
83374-9,Class
83375-6,Current nebulization cycle time.elapsed
83376-4,Current set of nebulization cycles time.elapsed
83377-2,Pause time setting
Aug-37,Body weight special circumstances
83378-0,Run time setting
83379-8,Current nebulization cycle time.remaining
83380-6,Current set of nebulization cycles time.remaining
83381-4,Current nebulization cycle volume.given
83382-2,Current set of nebulization cycles volume.given
83383-0,Cycle volume setting
83384-8,Current nebulization cycle volume.remaining
83385-5,Current set of nebulization cycles volume.remaining
Jun-38,Body weight^ante partum
83386-3,Pressure.positive end expiratory.extrinsic
83387-1,Pressure.positive end expiratory.extrinsic dynamic
83388-9,Pressure.positive end expiratory.total dynamic
83389-7,Intravascular
83390-5,Tube cuff pressure^at end expiration
Apr-39,Body weight^at birth
Feb-40,Dry body weight
8341-0,Dry body weight
834-2,A variant NOS Ag
Aug-42,Lean body weight
Jun-43,Lean body weight
Apr-44,Body weight^post dialysis
83446-5,How difficult is it for you to read small print
Jan-45,Body weight^post partum
Sep-46,Body weight^postoperative
Jul-47,Body weight^pre dialysis
May-48,Body weight^pre pregnancy
Mar-49,Body weight^preoperative
Jan-50,Body weight^with clothes
83516-5,Admission evaluation note
83517-3,Note
83518-1,Note
Sep-51,Body weight^without clothes
83519-9,Note
83520-7,Note
83521-5,Note
83522-3,Admission evaluation note
83523-1,Discharge summary note
83524-9,Note
83525-6,Procedure note
83526-4,Transfer summary note
Jul-52,Clothing worn during measure
83527-2,Note
83528-0,Note
83529-8,Note
83530-6,Note
83531-4,Note
83532-2,Note
83533-0,Procedure note
83534-8,Note
May-53,Skin fold thickness
83535-5,Surgical operation note
83536-3,Note
83537-1,Preoperative evaluation and management note
83538-9,Note
83539-7,Risk assessment and screening note
83540-5,Note
83541-3,Transplant candidate evaluation note
83542-1,Note
Mar-54,Skin fold thickness
83543-9,Note
83544-7,Note
83545-4,Note
83546-2,Note
83547-0,Note
83548-8,Note
83549-6,Note
8355-0,Skin fold thickness
83550-4,Admission evaluation note
83551-2,Discharge summary note
83552-0,History and physical note
83553-8,Note
83554-6,Note
83555-3,Note
83556-1,Note
83557-9,Note
83558-7,Note
83559-5,Note
83560-3,Note
83561-1,Note
83562-9,Note
83563-7,Note
83564-5,Note
83565-2,Note
83566-0,Note
83567-8,Note
Aug-56,Class
83568-6,Note
83569-4,Note
83570-2,Consultation note
83571-0,Note
83572-8,Note
83573-6,Note
83574-4,Note
83575-1,Note
Jun-57,Blood pressure method
83576-9,Note
83577-7,Procedure note
83578-5,Consultation note
83579-3,Note
83580-1,Note
83581-9,Note
83582-7,Note
83583-5,Note
Apr-58,Cuff size
83584-3,Note
83585-0,Note
83586-8,Note
83587-6,Note
83588-4,Note
83589-2,Note
835-9,A variant subtype
83590-0,Note
83591-8,Note
Feb-59,Measurement site
83592-6,Note
83593-4,Education note
83594-2,Note
83595-9,Note
83596-7,Note
83597-5,Note
83598-3,Note
83599-1,Procedure note
Jun-83,Cefaclor
8360-0,Body position head tilt
83600-7,Note
83601-5,Note
83602-3,Note
83603-1,Note
83604-9,Note
83605-6,Note
83606-4,Note
83607-2,Note
83608-0,Note
83609-8,Consultation note
83610-6,Note
83611-4,Note
83612-2,Note
83613-0,Note
83614-8,Surgical operation note
83615-5,Note
83616-3,Procedure note
83617-1,Procedure note
Aug-61,Body position with respect to gravity
83618-9,Note
83619-7,Note
83620-5,Note
83621-3,Consultation note
83622-1,Note
83623-9,Note
83624-7,Risk assessment and screening note
83625-4,Note
Jun-62,Phase of heart cycle
83626-2,Note
83627-0,Note
83628-8,Admission evaluation note
83629-6,Note
83630-4,Group counseling note
83631-2,Note
83632-0,Note
83633-8,Medication management note
Apr-63,Respiratory phase
83634-6,Note
83635-3,Plan of care note
83636-1,Triage note
83637-9,Note
83638-7,Note
83639-5,Note
83640-3,Procedure note
83641-1,Note
Feb-64,Selection aggregation
83642-9,Triage note
83643-7,Note
83644-5,Note
83645-2,Note
83646-0,Medication management note
83647-8,Note
83648-6,Note
83649-4,Initial evaluation note
83650-2,Note
83651-0,Procedure note
83652-8,Risk assessment and screening note
83653-6,Consultation note
83654-4,Note
83655-1,Note
83656-9,Admission evaluation note
83657-7,Note
83658-5,Note
Sep-65,Intravascular diastolic
83659-3,Admission evaluation note
83660-1,Note
83661-9,Preoperative evaluation and management note
83662-7,Note
83663-5,Note
83664-3,Preoperative evaluation and management note
83665-0,Admission evaluation note
83666-8,Note
Jul-66,Intravascular diastolic
83667-6,Preoperative evaluation and management note
83668-4,Admission evaluation note
83669-2,Note
836-7,Ax Ag
83670-0,Admission evaluation note
83671-8,Admission evaluation note
83672-6,Note
83673-4,Surgical operation note
83674-2,Note
May-67,Intravascular diastolic
83675-9,Postoperative evaluation and management note
83676-7,Note
83677-5,Admission evaluation note
83678-3,Note
83679-1,Preoperative evaluation and management note
83680-9,Note
83681-7,Preoperative evaluation and management note
83682-5,Note
Mar-68,Intravascular diastolic
83683-3,Note
83684-1,Note
83685-8,Consultation note
83686-6,Note
83687-4,Note
83688-2,Admission evaluation note
83689-0,Note
83690-8,Note
Jan-69,Intravascular diastolic
83691-6,Note
83692-4,Surgical operation note
83693-2,Preoperative evaluation and management note
83694-0,Admission evaluation note
83695-7,Note
83696-5,Preoperative evaluation and management note
83697-3,Note
83698-1,Note
83699-9,Admission evaluation note
83700-5,Note
83701-3,Preoperative evaluation and management note
83702-1,Note
83703-9,Note
83704-7,Note
83705-4,Note
83706-2,Initial evaluation note
83707-0,Administrative note
83708-8,Admission evaluation note
83709-6,Note
83710-4,Note
83711-2,Conference note
83712-0,Discharge summary note
83713-8,Note
83714-6,Education note
83715-3,History and physical note
83716-1,Note
83717-9,Initial evaluation note
83718-7,Admission evaluation note
83719-5,Note
83720-3,Consultation note
83721-1,Note
83722-9,Consultation note
83723-7,Note
83724-5,Initial evaluation note
83725-2,Note
83726-0,Initial evaluation note
83727-8,Note
83728-6,Procedure note
83729-4,Note
83730-2,Risk assessment and screening note
83731-0,Conference note
83732-8,Note
83733-6,Note
83734-4,Plan of care note
83735-1,Note
83736-9,Note
83737-7,Note
83738-5,Note
83739-3,Note
83740-1,Note
83741-9,Note
83742-7,Note
83743-5,Note
83744-3,Note
83745-0,Note
83746-8,Note
83747-6,Note
83748-4,Note
83749-2,Note
837-5,Ax Ag
83750-0,Note
83751-8,Note
83752-6,Note
83753-4,Note
83754-2,Note
83755-9,Note
83756-7,Note
83757-5,Note
Aug-75,Intrachamber diastolic
83758-3,Note
83759-1,Note
83760-9,Note
83761-7,Note
83762-5,Note
83763-3,Note
83764-1,Note
83765-8,Note
Jun-76,Intrachamber diastolic
83766-6,Note
83767-4,Note
83768-2,Note
83769-0,Note
83770-8,Note
83771-6,Note
83772-4,Note
83773-2,Note
Apr-77,Intrachamber diastolic
83774-0,Note
83775-7,Note
83776-5,Note
83777-3,Note
83778-1,Admission evaluation note
83779-9,Note
83780-7,Note
83781-5,Note
Feb-78,Intravascular diastolic
83782-3,Note
83783-1,Note
83784-9,Note
83785-6,Note
83786-4,History and physical note
83787-2,Note
83788-0,Note
83789-8,Procedure note
8379-0,Intravascular diastolic
83790-6,Note
83791-4,Note
83792-2,Admission evaluation note
83793-0,Note
83794-8,Note
83795-5,Note
83796-3,Summary of death note
83797-1,Referral note
83798-9,Note
83799-7,Transplant candidate evaluation note
83800-3,Note
83801-1,Note
83802-9,Discharge instructions
83803-7,Note
83804-5,Administrative note
83805-2,Admission evaluation note
83806-0,Note
83807-8,Note
Aug-80,Intravascular diastolic
83808-6,Note
83809-4,Admission evaluation note
83810-2,Discharge summary note
83811-0,Note
83812-8,History and physical note
83813-6,Note
83814-4,Note
83815-1,Surgical operation note
Jun-81,Intravascular diastolic
83816-9,Admission evaluation note
83817-7,Note
83818-5,Note
83819-3,History and physical note
83820-1,Preoperative evaluation and management note
83821-9,Note
83822-7,Note
83823-5,Note
Apr-82,Intravascular diastolic
83824-3,Admission evaluation note
83825-0,Note
83826-8,Admission evaluation note
83827-6,Note
83828-4,Preoperative evaluation and management note
83829-2,Administrative note
838-3,Ax Ag
83830-0,History and physical note
83831-8,Note
Feb-83,Intravascular diastolic
83832-6,Note
83833-4,Postoperative evaluation and management note
83834-2,Note
83835-9,Risk assessment and screening note
83836-7,Summary note
83837-5,Note
83838-3,Note
83839-1,Transplant candidate evaluation note
8384-0,Intravascular diastolic
83840-9,Note
83841-7,Note
83842-5,Note
83843-3,Note
83844-1,Body height method
83845-8,Body height
83846-6,Body height
83847-4,Dose changed since previous visit
83848-2,Provider stopped treatment
83849-0,Reason for dose change
83850-8,Admission evaluation note
83851-6,Note
83852-4,Note
83853-2,Postoperative evaluation and management note
83854-0,Procedure note
83855-7,Note
83856-5,Administrative note
Jul-85,Intravascular diastolic
83857-3,Admission evaluation note
83858-1,History and physical note
83859-9,Note
83860-7,Risk assessment and screening note
83861-5,Postoperative evaluation and management note
83862-3,Preoperative evaluation and management note
83863-1,Risk assessment and screening note
83864-9,Note
May-86,Intravascular diastolic
83865-6,Transfer summary note
83866-4,Group counseling note
83867-2,Annual evaluation note
83868-0,Consultation note
83869-8,Counseling note
83870-6,Admission evaluation note
83871-4,Annual evaluation note
83872-2,Note
Mar-87,Intravascular diastolic
83873-0,Consultation note
83874-8,Note
83875-5,Initial evaluation note
83876-3,Risk assessment and screening note
83877-1,Triage note
83878-9,Note
83879-7,Administrative note
83880-5,Admission evaluation note
Jan-88,Intravascular diastolic
83881-3,Note
83882-1,Note
83883-9,Education note
83884-7,Note
83885-4,Group counseling note
83886-2,History and physical note
83887-0,Note
83888-8,Consultation note
83889-6,Medication management note
83890-4,Group counseling note
83891-2,Procedure note
83892-0,Risk assessment and screening note
83893-8,Note
83894-6,Note
83895-3,Plan of care note
83896-1,Triage note
83897-9,Administrative note
83898-7,Discharge summary note
Sep-89,Intravascular diastolic
83899-5,Note
83900-1,Education note
83901-9,History and physical note
83902-7,Note
83903-5,Note
83904-3,Note
83905-0,Note
83906-8,Risk assessment and screening note
Jul-90,Intravascular diastolic
83907-6,Note
83908-4,Note
83909-2,Consultation note
839-1,A1 Ab
83910-0,Note
83911-8,Admission evaluation note
83912-6,Consultation note
83913-4,Note
83914-2,Transfer summary note
May-91,Intravascular end diastolic
83915-9,Note
83916-7,Note
83917-5,Note
83918-3,Note
83919-1,Note
83920-9,Note
83921-7,Discharge summary note
83922-5,Note
Mar-92,Intravascular end diastolic
83923-3,Education note
83924-1,Note
83925-8,Note
83926-6,Consultation note
83927-4,Note
83928-2,Note
83929-0,Risk assessment and screening note
83930-8,Consent
Jan-93,Intravascular end diastolic
83931-6,Consultation note
83932-4,Discharge summary note
83933-2,Evaluation and management of hypertension note
83934-0,Initial evaluation note
83935-7,Medication management note
83936-5,Note
83937-3,Note
83938-1,Procedure note
83939-9,Note
83940-7,Note
83941-5,Consultation note
83942-3,Note
83943-1,Note
83944-9,Note
83945-6,Note
83946-4,Note
83947-2,Note
83948-0,Note
Sep-94,Intravascular mean
83949-8,Note
83950-6,Transfer summary note
83951-4,Risk assessment and screening note
83952-2,Note
83953-0,Evaluation and management of smoking cessation note
83954-8,Admission evaluation note
83955-5,Annual evaluation note
Jun-95,Intravascular mean
83956-3,Discharge summary note
83957-1,Note
83958-9,Note
83959-7,History and physical note
83960-5,Consultation note
83961-3,Discharge summary note
83962-1,Initial evaluation note
83963-9,Note
Apr-96,Intravascular mean
83964-7,Referral note
83965-4,Note
83966-2,Note
83967-0,Consultation note
83968-8,Discharge summary note
83969-6,Initial evaluation note
83970-4,Note
83971-2,Referral note
Feb-97,Intravascular mean
83972-0,Respite note
83973-8,Risk assessment and screening note
83974-6,Note
83975-3,Group counseling note
83976-1,Note
83977-9,Outreach note
83978-7,Respite note
83979-5,Risk assessment and screening note
8398-0,Intravascular mean
83980-3,Note
83981-1,Transfer summary note
83982-9,Transplant candidate evaluation note
83983-7,Plan of care note
83984-5,Consultation note
83985-2,Note
83986-0,Risk assessment and screening note
83987-8,Note
83988-6,Note
83989-4,Admission evaluation note
83990-2,Annual evaluation note
83991-0,Conference note
83992-8,Consultation note
83993-6,Discharge summary note
83994-4,Education note
83995-1,History and physical note
83996-9,Consultation note
83997-7,Note
Aug-99,Intrachamber mean
83998-5,Initial evaluation note
83999-3,Note
84000-9,Note
84001-7,Note
84002-5,Note
84003-3,Note
Apr-00,Intrachamber mean
84004-1,Annual evaluation note
84005-8,Note
84006-6,Procedure note
84007-4,Risk assessment and screening note
84008-2,Note
84009-0,Note
84010-8,Note
84011-6,Plan of care note
84012-4,Admission evaluation note
84013-2,Discharge summary note
84014-0,Note
84015-7,Procedure note
84016-5,Transfer summary note
84017-3,Discharge summary note
84018-1,Discharge summary note
84019-9,History and physical note
84020-7,Surgical operation note
84021-5,Procedure note
84022-3,Note
84023-1,Conference note
84024-9,Discharge summary note
84025-6,Note
84026-4,Conference note
84027-2,Note
84028-0,Letter
84029-8,Conference note
84030-6,Note
84031-4,Referral note
84032-2,Note
84033-0,Note
84034-8,Plan of care note
84035-5,Consultation note
84036-3,Note
84037-1,Note
84038-9,Administrative note
84039-7,Admission evaluation note
84040-5,Discharge summary note
84041-3,History and physical note
84042-1,Note
84043-9,Note
84044-7,Procedure note
84045-4,Postoperative evaluation and management note
Jun-04,Intrachamber mean
84046-2,Note
84047-0,Admission evaluation note
84048-8,History and physical note
84049-6,Note
84050-4,Note
84051-2,Postoperative evaluation and management note
84052-0,Postoperative evaluation and management note
Mar-05,Intrachamber mean
84053-8,Procedure note
84054-6,Note
84055-3,Annual evaluation note
84056-1,Note
84057-9,Note
84058-7,Flowsheet
84059-5,Note
84060-3,Note
Jan-06,Intrachamber mean
84061-1,Postoperative evaluation and management note
84062-9,Procedure note
84063-7,Note
84064-5,Annual evaluation note
84065-2,Administrative note
84066-0,Note
84067-8,Note
84068-6,Admission evaluation note
84069-4,Summary note
84070-2,Plan of care note
84071-0,Consultation note
84072-8,Note
84073-6,Note
84074-4,Procedure note
84075-1,Admission evaluation note
84076-9,Administrative note
84077-7,History and physical note
84078-5,Note
Sep-07,Intravascular mean
84079-3,Surgical operation note
84080-1,Note
84081-9,Procedure note
84082-7,Note
84083-5,Transfer summary note
84084-3,Note
84085-0,Group counseling note
84086-8,Initial evaluation note
Jul-08,Intravascular mean
84087-6,Note
84088-4,Medication management note
84089-2,Group counseling note
840-9,A1 Ab
84090-0,Initial evaluation note
84091-8,Risk assessment and screening note
84092-6,Risk assessment and screening note
84093-4,Note
84094-2,Plan of care note
May-09,Intravascular mean
84095-9,Do not resuscitate
84096-7,Note
84097-5,History and physical note
84098-3,Note
84099-1,Note
84100-7,Note
84101-5,Administrative note
84102-3,Admission evaluation note
Mar-10,Intravascular mean
84103-1,Note
84104-9,History and physical note
84105-6,Note
84106-4,Letter
84107-2,Note
84108-0,Note
84109-8,Admission evaluation note
84110-6,Annual evaluation note
Jan-11,Intravascular mean
84111-4,Note
84112-2,Group counseling note
84113-0,Note
84114-8,Note
84115-5,Consultation note
84116-3,Note
84117-1,Plan of care note
84118-9,Initial evaluation note
84119-7,Note
84120-5,Note
84121-3,Risk assessment and screening note
84122-1,Note
84123-9,Note
84124-7,Plan of care note
84125-4,Admission evaluation note
84126-2,Consultation note
84127-0,Note
84128-8,Note
Sep-12,Intravascular mean
84129-6,Note
84130-4,Annual evaluation note
84131-2,Consultation note
84132-0,Discharge summary note
84133-8,Medication management note
84134-6,Note
84135-3,Plan of care note
84136-1,Plan of care note
Jul-13,Intravascular mean
84137-9,Note
84138-7,Conference note
84139-5,Discharge summary note
84140-3,Education note
84141-1,Group counseling note
84142-9,Consultation note
84143-7,Note
84144-5,Medication management note
May-14,Intravascular mean
84145-2,Consultation note
84146-0,Note
84147-8,Procedure note
84148-6,Risk assessment and screening note
84149-4,Note
84150-2,Note
84151-0,Plan of care note
Feb-15,Intravascular mean
84152-8,Consultation note
84153-6,Counseling note
84154-4,Education note
84155-1,Initial evaluation note
84156-9,Note
84157-7,Note
84158-5,Procedure note
84159-3,Note
8416-0,Intravascular mean
84160-1,Transplant candidate evaluation note
84161-9,Administrative note
84162-7,Admission evaluation note
84163-5,Note
84164-3,Plan of care note
84165-0,Plan of care note
84166-8,Counseling note
84167-6,Group counseling note
84168-4,Note
84169-2,Note
841-7,A1 Ab
84170-0,Risk assessment and screening note
84171-8,Note
84172-6,Plan of care note
84173-4,Consultation note
84174-2,Note
84175-9,Surgical operation note
84176-7,Postoperative evaluation and management note
84177-5,Preoperative evaluation and management note
Aug-17,Intravascular mean
84178-3,Note
84179-1,Discharge summary note
84180-9,Education note
84181-7,Note
84182-5,Initial evaluation note
84183-3,Plan of care note
84184-1,Note
84185-8,Plan of care note
Jun-18,Intravascular mean
84186-6,Note
84187-4,Plan of care note
84188-2,Note
84189-0,Note
84190-8,Consultation note
84191-6,Note
84192-4,Admission evaluation note
84193-2,Conference note
Apr-19,Intravascular mean
84194-0,Agreement
84195-7,Note
84196-5,Note
84197-3,Plan of care note
84198-1,Note
84199-9,Note
84200-5,Admission evaluation note
84201-3,Group counseling note
Feb-20,Intravascular systolic
84202-1,Note
84203-9,Plan of care note
84204-7,Note
84205-4,Note
84206-2,Note
84207-0,Group counseling note
84208-8,Initial evaluation note
84209-6,Risk assessment and screening note
8421-0,Intravascular systolic
84210-4,Plan of care note
84211-2,Outreach note
84212-0,Conference note
84213-8,Consultation note
84214-6,Note
84215-3,Note
84216-1,Transplant candidate evaluation note
84217-9,Plan of care note
84218-7,Triage note
84219-5,Note
84220-3,Note
84221-1,Transfer summary note
84222-9,Note
84223-7,Note
84224-5,Note
84225-2,Administrative note
84226-0,Admission evaluation note
84227-8,Note
Aug-22,Intravascular systolic
84228-6,Transfer summary note
84229-4,Note
84230-2,Note
84231-0,Consultation note
84232-8,Note
84233-6,Initial evaluation note
84234-4,Note
84235-1,Admission evaluation note
Jun-23,Intravascular systolic
84236-9,Note
84237-7,Note
84238-5,Postoperative evaluation and management note
84239-3,Note
84240-1,Administrative note
84241-9,Consultation note
84242-7,Crisis intervention note
84243-5,Flowsheet
Apr-24,Intravascular systolic
84244-3,Plan of care note
84245-0,Diagram
84246-8,Note
84247-6,Evaluation and management of anticoagulation note
84248-4,Discharge summary note
84249-2,Triage note
842-5,A1 Ag
84250-0,Group counseling note
84251-8,Note
84252-6,Initial evaluation note
84253-4,Admission evaluation note
84254-2,Discharge summary note
84255-9,Admission evaluation note
84256-7,Annual evaluation note
84257-5,Discharge summary note
84258-3,Initial evaluation note
84259-1,Referral note
84260-9,Risk assessment and screening note
84261-7,Admission evaluation note
84262-5,Discharge summary note
84263-3,Note
84264-1,Surgical operation note
84265-8,Evaluation and management of anticoagulation note
84266-6,Initial evaluation note
84267-4,Medication management note
84268-2,Surgical operation note
84269-0,Triage note
84270-8,Postoperative evaluation and management note
84271-6,Referral note
84272-4,Respite note
84273-2,Summary of death note
84274-0,Note
84275-7,Note
84276-5,Triage note
84277-3,Administrative note
84278-1,Discharge summary note
84279-9,Group counseling note
84280-7,Consultation note
84281-5,Initial evaluation note
84282-3,Note
84283-1,Risk assessment and screening note
84284-9,Note
84285-6,Initial evaluation note
84286-4,Note
84287-2,Referral note
84288-0,Initial evaluation note
84289-8,Note
84290-6,Risk assessment and screening note
84291-4,Risk assessment and screening note
84292-2,Consultation note
84293-0,Note
84294-8,Note
84295-5,Plan of care note
84296-3,Dose form changed since previous visit
84297-1,Dose(s) missed since previous visit
84298-9,Treatment stopped for at least 1W
84299-7,Reason for missed treatment
84300-3,Medication administered by
Jan-30,Intrachamber systolic
84301-1,Dose adjusted after temporary treatment stop
84302-9,Note
84303-7,Consultation note
84304-5,Note
84305-2,Administrative note
84306-0,Plan of care note
84308-6,Initial evaluation note
84309-4,Note
84310-2,Discharge summary note
84311-0,Counseling note
84312-8,Consultation note
84313-6,Admission evaluation note
84314-4,Plan of care note
84315-1,Note
84316-9,Note
84317-7,Risk assessment and screening note
84318-5,Note
Sep-31,Intrachamber systolic
84319-3,Initial evaluation note
84320-1,Education note
84321-9,Discharge summary note
84322-7,Medication management note
84323-5,Note
84324-3,Consultation note
84325-0,Note
84326-8,Note
Jul-32,Intrachamber systolic
84327-6,Initial evaluation note
84328-4,Discharge summary note
84329-2,Note
843-3,A1 Ag
84330-0,Initial evaluation note
84331-8,Discharge summary note
84332-6,Administrative note
84333-4,Note
84334-2,Note
May-33,Intravascular systolic
84335-9,Note
84336-7,Letter
84337-5,Plan of care note
84338-3,Note
84339-1,Note
84340-9,Risk assessment and screening note
84341-7,Note
84342-5,Note
Mar-34,Intravascular systolic
84343-3,Note
84344-1,Initial evaluation note
84345-8,Note
84346-6,Group counseling note
84347-4,Education note
84348-2,Counseling note
84349-0,Consultation note
8435-0,Intravascular systolic
84350-8,Note
84351-6,Note
84352-4,Consultation note
84353-2,Risk assessment and screening note
84354-0,Note
84355-7,Note
84356-5,Note
84357-3,Note
84358-1,Consultation note
84359-9,Group counseling note
84360-7,Counseling note
84361-5,Note
84362-3,Note
84363-1,Postoperative evaluation and management note
84364-9,Note
84365-6,Note
84366-4,History and physical note
84367-2,Discharge summary note
Aug-36,Intravascular systolic
84368-0,Admission evaluation note
84369-8,Note
84370-6,Note
84371-4,Note
84372-2,Education note
84373-0,Note
84374-8,Procedure note
84375-5,Procedure note
Jun-37,Intravascular systolic
84376-3,Note
84377-1,Note
84378-9,Admission evaluation note
84379-7,Procedure note
84380-5,Postoperative evaluation and management note
84381-3,Note
84382-1,Admission evaluation note
84383-9,Note
Apr-38,Intravascular systolic
84384-7,Note
84385-4,Postoperative evaluation and management note
84386-2,Note
84387-0,Admission evaluation note
84388-8,Admission evaluation note
84389-6,Note
84390-4,Note
84391-2,Procedure note
Feb-39,Intravascular systolic
84392-0,Note
84393-8,Discharge summary note
84394-6,Consultation note
84395-3,Initial evaluation note
84396-1,Note
84397-9,Note
84398-7,Consultation note
84399-5,Note
Apr-84,Cefaclor
8440-0,Intravascular systolic
84400-1,Note
84401-9,Risk assessment and screening note
84402-7,Note
84403-5,Note
84404-3,Note
84405-0,Admission evaluation note
84406-8,Diagram
84407-6,Note
84408-4,Procedure note
84409-2,Note
844-1,A1 Ag
84410-0,Note
84411-8,Note
84412-6,Risk assessment and screening note
84413-4,Genotype display name
84414-2,Haplotype name
84415-9,2-minute Walk Endurance Test - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
84416-7,Grip Strength Test - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
84417-5,Grip Strength Test - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
Aug-41,Intravascular systolic
84418-3,Grip Strength Test - unadjusted scale score
84419-1,Grip Strength Test - national percentile
84420-9,2-minute Walk Endurance Test - national percentile
84421-7,Standing Balance Test - unadjusted scale score
84422-5,Standing Balance Test - scale score^^adjusted for age
84423-3,Standing Balance Test - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
84424-1,Standing Balance Test - national percentile
84425-8,9-Hole Pegboard Dexterity - scale score^^adjusted for age
Jun-42,Intravascular systolic
84426-6,9-Hole Pegboard Dexterity - scale score^^adjusted for age
84427-4,9-Hole Pegboard Dexterity - unadjusted scale score
84428-2,National EMS Information System - version 3 set
84429-0,Level 3 emergency medical services patient care report - recommended CDA R1 & R2 set
84430-8,Note
84431-6,Note
84432-4,Dimensional Change Card Sort Test
84433-2,Flanker Inhibitory Control and Attention Test
Apr-43,Intravascular systolic
84434-0,List Sorting Working Memory Test
84435-7,Oral Reading Recognition Test
84436-5,Pattern Comparison Processing Speed Test
84437-3,Picture Sequence Memory Test
84438-1,Picture Vocabulary Test - English
84439-9,Picture Sequence Memory Test - national percentile
84440-7,Picture Sequence Memory Test - scale score^^adjusted for age
84441-5,Picture Sequence Memory Test - computed score
Feb-44,Intravascular systolic
84442-3,Picture Sequence Memory Test - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
84443-1,Picture Sequence Memory Test - raw score
84444-9,Picture Sequence Memory Test - theta score
84445-6,Picture Sequence Memory Test - unadjusted scale score
84446-4,Picture Vocabulary Test - English - national percentile
84447-2,Picture Vocabulary Test - English - scale score^^adjusted for age
84448-0,Picture Vocabulary Test - English - computed score
84449-8,Picture Vocabulary Test - English - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
84450-6,Picture Vocabulary Test - English - theta score
84451-4,Picture Vocabulary Test - English - unadjusted scale score
84452-2,Dimensional Change Card Sort Test - national percentile
84453-0,Dimensional Change Card Sort Test - scale score^^adjusted for age
84454-8,Dimensional Change Card Sort Test - computed score
84455-5,Dimensional Change Card Sort Test - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
84456-3,Dimensional Change Card Sort Test - raw score
84457-1,Dimensional Change Card Sort Test - unadjusted scale score
84458-9,Able to point to the letter b
Sep-45,Intravascular systolic
84459-7,Able to point to the letter e
84460-5,Able to point to the letter D
84461-3,Able to point to the letter S
84462-1,Can pronounce potable
84463-9,Flanker Inhibitory Control and Attention Test - national percentile
84464-7,Flanker Inhibitory Control and Attention Test - scale score^^adjusted for age
84465-4,Flanker Inhibitory Control and Attention Test - computed score
84466-2,Flanker Inhibitory Control and Attention Test - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
Jul-46,Intravascular diastolic^expiration
84467-0,Flanker Inhibitory Control and Attention Test - raw score
84468-8,Flanker Inhibitory Control and Attention Test - unadjusted scale score
84469-6,Can pronounce ballistics
84470-4,Can pronounce nihilism
84471-2,List Sorting Working Memory Test - national percentile
84472-0,List Sorting Working Memory Test - scale score^^adjusted for age
84473-8,List Sorting Working Memory Test - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
84474-6,List Sorting Working Memory Test - raw score
May-47,Intravascular diastolic^inspiration
84475-3,List Sorting Working Memory Test - unadjusted scale score
84476-1,Oral Reading Recognition Test - English - national percentile
84477-9,Oral Reading Recognition Test - English - computed score
84478-7,Oral Reading Recognition Test - English - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
84479-5,Oral Reading Recognition Test - English - theta score
84480-3,Oral Reading Recognition Test - English - scale score^^adjusted for age
84481-1,Oral Reading Recognition Test - English - unadjusted scale score
84482-9,Can pronounce pat
Mar-48,Intravascular mean^expiration
84483-7,Pattern Comparison Processing Speed Test - national percentile
84484-5,Pattern Comparison Processing Speed Test - scale score^^adjusted for age
84485-2,Pattern Comparison Processing Speed Test - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
84486-0,Pattern Comparison Processing Speed Test - raw score
84487-8,Pattern Comparison Processing Speed Test - unadjusted scale score
84488-6,Can pronounce abate
84489-4,Can pronounce ablation
84490-2,Can pronounce about
Jan-49,Intravascular mean^inspiration
84491-0,Can pronounce abstemiously
84492-8,Can pronounce abysm
84493-6,Can pronounce amicability
84494-4,Can pronounce bad
84495-1,Can pronounce band
84496-9,Can pronounce bank
84497-7,Can pronounce be
84498-5,Can pronounce beau
84499-3,Can pronounce beguile
84500-8,Can pronounce belie
84501-6,Can pronounce belligerent
84502-4,Can pronounce bet
84503-2,Can pronounce biscuit
84504-0,Can pronounce both
84505-7,Can pronounce box
84506-5,Can pronounce brobdingnagian
84507-3,Can pronounce bucolic
84508-1,Can pronounce bureau
Sep-50,Intravascular systolic^expiration
84509-9,Can pronounce cucurbitaceous
84510-7,Can pronounce debauchery
84511-5,Can pronounce dissolubility
84512-3,Can pronounce exacerbating
84513-1,Can pronounce hyperbole
84514-9,Can pronounce imbroglio
84515-6,Can pronounce incorrigible
84516-4,Can pronounce indebted
Jul-51,Intravascular systolic^inspiration
84517-2,Can pronounce irrevocability
84518-0,Can pronounce libel
84519-8,Can pronounce lugubriousness
84520-6,Can pronounce obsequious
84521-4,Can pronounce ostensibly
84522-2,Can pronounce subjugate
84523-0,Can pronounce tenebrous
84524-8,Can pronounce adjudicate
May-52,Intravascular systolic.inspiration - expiration
84525-5,Can pronounce androgynous
84526-3,Can pronounce credulous
84527-1,Can pronounce cylindrical
84528-9,Can pronounce d
84529-7,Can pronounce deferential
84530-5,Can pronounce deliquescence
84531-3,Can pronounce demur
84532-1,Can pronounce deny
Mar-53,Intravascular diastolic^sitting
84533-9,Can pronounce diamantiferous
84534-7,Can pronounce did
84535-4,Can pronounce dilemma
84536-2,Can pronounce doctrine
84537-0,Can pronounce dodecahedral
84538-8,Can pronounce dolorific
84539-6,Can pronounce doting
84540-4,Can pronounce dowager
Jan-54,Intravascular diastolic^standing
84541-2,Can pronounce during
84542-0,Can pronounce edict
84543-8,Can pronounce feed
84544-6,Can pronounce gold
84545-3,Can pronounce imparidigitate
84546-1,Can pronounce innuendo
84547-9,Can pronounce laid
84548-7,Can pronounce pedagogue
84549-5,Can pronounce platitudinous
84550-3,Can pronounce preponderance
84551-1,Can pronounce pseudonym
84552-9,Can pronounce recrudescence
84553-7,Can pronounce repudiate
84554-5,Can pronounce sedate
84555-2,Can pronounce sesquipedalian
84556-0,Can pronounce side
84557-8,Can pronounce stevedore
Aug-55,Intravascular diastolic^supine
84558-6,Can pronounce synechdochism
84559-4,Can pronounce valedictory
84560-2,Can pronounce valetudinarian
84561-0,Can pronounce verisimilitude
84562-8,Can pronounce vicissitude
84563-6,Can pronounce would
84564-4,Can pronounce amplify
84565-1,Can pronounce circumference
Jun-56,Intravascular mean^sitting
84566-9,Can pronounce effete
84567-7,Can pronounce effigial
84568-5,Can pronounce facetious
84569-3,Can pronounce fascist
84570-1,Can pronounce fenestration
84571-9,Can pronounce flux
84572-7,Can pronounce fly
84573-5,Can pronounce foment
Apr-57,Intravascular mean^standing
84574-3,Can pronounce for
84575-0,Can pronounce forisfamiliate
84576-8,Can pronounce fringillaceous
84577-6,Can pronounce fumigant
84578-4,Can pronounce perfunctorily
84579-2,Can pronounce safe
845-8,A1 B Ab
84580-0,Can pronounce saxifragaceous
84581-8,Can pronounce stifle
Feb-58,Intravascular mean^supine
84582-6,Can pronounce suffrutescent
84583-4,Can pronounce of
84584-2,Can pronounce achromatism
84585-9,Can pronounce aesthetic
84586-7,Can pronounce anachronistic
84587-5,Can pronounce apocryphal
84588-3,Can pronounce chassis
84589-1,Can pronounce choreographer
8459-0,Intravascular systolic^sitting
84590-9,Can pronounce chorus
84591-7,Can pronounce echelon
84592-5,Can pronounce gingham
84593-3,Can pronounce have
84594-1,Can pronounce he
84595-8,Can pronounce heat
84596-6,Can pronounce her
84597-4,Can pronounce heretic
84598-2,Can pronounce heuristic
84599-0,Can pronounce hone
84600-6,Can pronounce lymph
84601-4,Can pronounce mischievous
84602-2,Can pronounce much
84603-0,Can pronounce myth
84604-8,Can pronounce nonchalant
84605-5,Can pronounce penchant
84606-3,Can pronounce plethora
84607-1,Can pronounce rhythm
Aug-60,Intravascular systolic^standing
84608-9,Can pronounce stochastic
84609-7,Can pronounce synthesis
84610-5,Can pronounce their
84611-3,Can pronounce these
84612-1,Can pronounce this
84613-9,Can pronounce tough
84614-7,Can pronounce vehement
84615-4,Can pronounce vehicular
Jun-61,Intravascular systolic^supine
84616-2,Can pronounce whelp
84617-0,Can pronounce writhe
84618-8,Can pronounce accrementitial
84619-6,Can pronounce acolyte
84620-4,Can pronounce all
84621-2,Can pronounce allotment
84622-0,Can pronounce annul
84623-8,Can pronounce anomalous
Apr-62,Intravascular diastolic
84624-6,Can pronounce appellate
84625-3,Can pronounce cello
84626-1,Can pronounce clarity
84627-9,Can pronounce conviviality
84628-7,Can pronounce ecclesiastical
84629-5,Can pronounce eclecticism
84630-3,Can pronounce ecstatically
84631-1,Can pronounce empirical
Feb-63,Intravascular diastolic
84632-9,Can pronounce epilogue
84633-7,Can pronounce etymological
84634-5,Can pronounce expostulate
84635-2,Can pronounce gel
84636-0,Can pronounce gelastic
84637-8,Can pronounce interstitial
84638-6,Can pronounce lieutenant
84639-4,Can pronounce liver
8464-0,Intravascular diastolic
84640-2,Can pronounce loquacious
84641-0,Can pronounce lull
84642-8,Can pronounce magniloquently
84643-6,Can pronounce malapropism
84644-4,Can pronounce malevolence
84645-1,Can pronounce manila
84646-9,Can pronounce oscillating
84647-7,Can pronounce palate
84648-5,Can pronounce pale
84649-3,Can pronounce penultimate
84650-1,Can pronounce pool
84651-9,Can pronounce pupil
84652-7,Can pronounce ranunculaceous
84653-5,Can pronounce recalcitrant
84654-3,Can pronounce recapitulatory
84655-0,Can pronounce reliquary
84656-8,Can pronounce scintillating
Jul-65,Intravascular diastolic
84657-6,Can pronounce supercilious
84658-4,Can pronounce titular
84659-2,Can pronounce trestle
846-6,A1 B Ab
84660-0,Can pronounce vassal
84661-8,Can pronounce annunciating
84662-6,Can pronounce antagonizing
84663-4,Can pronounce assuage
84664-2,Can pronounce campaign
May-66,Intravascular diastolic
84665-9,Can pronounce exaggeration
84666-7,Can pronounce excruciating
84667-5,Can pronounce germane
84668-3,Can pronounce regent
84669-1,Can pronounce regime
84670-9,Can pronounce sanguineous
84671-7,Can pronounce sergeant
84672-5,Can pronounce zeitgeist
Mar-67,Intravascular diastolic
84673-3,Can pronounce j
84674-1,Can pronounce joist
84675-8,Can pronounce juncous
84676-6,Can pronounce kayak
84677-4,Can pronounce poky
84678-2,Can pronounce rock
84679-0,Can pronounce seek
84680-8,Can pronounce apopemptic
Jan-68,Intravascular diastolic
84681-6,Can pronounce automatism
84682-4,Can pronounce camp
84683-2,Can pronounce imperiousness
84684-0,Can pronounce imperspicuity
84685-7,Can pronounce imprimatur
84686-5,Can pronounce m
84687-3,Can pronounce may
84688-1,Can pronounce meant
84689-9,Can pronounce men
84690-7,Can pronounce mere
84691-5,Can pronounce minion
84692-3,Can pronounce munity
84693-1,Can pronounce mystique
84694-9,Can pronounce parsimonious
84695-6,Can pronounce some
84696-4,Can pronounce temerity
84697-2,Can pronounce acquiescence
84698-0,Can pronounce as
Sep-69,Intravascular diastolic
84699-8,Can pronounce circuitous
84700-4,Can pronounce conscious
84701-2,Can pronounce eccentricities
84702-0,Can pronounce ersatz
84703-8,Can pronounce inauspicious
84704-6,Can pronounce insinuation
84705-3,Can pronounce insouciant
84706-1,Can pronounce is
Jul-70,Intravascular diastolic
84707-9,Can pronounce issuant
84708-7,Can pronounce pernicious
84709-5,Can pronounce perspicuity
84710-3,Can pronounce pious
84711-1,Can pronounce poser
84712-9,Can pronounce reconnaissance
84713-7,Can pronounce resin
84714-5,Can pronounce respite
May-71,Intravascular diastolic
84715-2,Can pronounce s
84716-0,Can pronounce satiety
84717-8,Can pronounce sinew
84718-6,Can pronounce sir
84719-4,Can pronounce spa
84720-2,Can pronounce stay
84721-0,Can pronounce succinct
84722-8,Can pronounce suite
Mar-72,Intravascular diastolic
84723-6,Can pronounce surreptitious
84724-4,Can pronounce transposition
84725-1,Can pronounce usury
84726-9,Can pronounce viscera
84727-7,Can pronounce viscous
84728-5,Can pronounce a
84729-3,Can pronounce ancient
84730-1,Can pronounce any
Jan-73,Intravascular diastolic
84731-9,Can pronounce art
84732-7,Can pronounce at
84733-5,Can pronounce c
84734-3,Can pronounce coercive
84735-0,Can pronounce crux
84736-8,Can pronounce entrepreneur
84737-6,Can pronounce enunciate
84738-4,Can pronounce era
84739-2,Can pronounce in
847-4,A1 B Ab
84740-0,Can pronounce it
84741-8,Can pronounce n
84742-6,Can pronounce nature
84743-4,Can pronounce nutate
84744-2,Can pronounce o
84745-9,Can pronounce on
84746-7,Can pronounce one
84747-5,Can pronounce or
84748-3,Can pronounce our
Sep-74,Intravascular diastolic
84749-1,Can pronounce p
84750-9,Can pronounce picayune
84751-7,Can pronounce poet
84752-5,Can pronounce precipice
84753-3,Can pronounce purport
84754-1,Can pronounce quip
84755-8,Can pronounce quixotic
Jun-75,Intravascular diastolic
84756-6,Can pronounce r
84757-4,Can pronounce renown
84758-2,Can pronounce tax
84759-0,Can pronounce tea
84760-8,Can pronounce to
84761-6,Can pronounce town
84762-4,Can pronounce try
84763-2,Can pronounce type
Apr-76,Intravascular diastolic
84764-0,Can pronounce u
84765-7,Can pronounce utopian
84766-5,Can pronounce w
84767-3,Can pronounce were
84768-1,Can pronounce x
84769-9,Can pronounce y
84770-7,Can pronounce you
84771-5,Can pronounce z
Feb-77,Intravascular diastolic
84772-3,Total Score
84773-1,Total Score
84775-6,Positive Affect Survey - unadjusted scale score
84777-2,Positive Affect Survey - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
84779-8,Positive Affect Survey version 2.0 - ages 8-12 - T-score
8478-0,Intravascular mean
84781-4,Positive Affect Survey - age 18+ - T-score
84782-2,Positive Affect Survey - scale score^^adjusted for age
84787-1,Positive Affect Survey version 2.0 - ages 13-17 - T-score
84788-9,Positive Affect Survey - parent report - unadjusted scale score
84789-7,Positive Affect Survey - parent report - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
84793-9,Positive Affect Survey version 2.0 - parent report - ages 3-7 - T-score
84794-7,Positive Affect Survey - parent report - scale score^^adjusted for age
84795-4,Positive Affect Survey - parent report - national percentile
84796-2,Positive Affect Survey - national percentile
Aug-79,Intravascular systolic
84798-8,Perceived Stress Survey - parent report - fixed length form - ages 8-12
84799-6,Positive Affect Survey - CAT item bank - ages 18+
84800-2,Positive Affect Survey - fixed length form - ages 18+
84801-0,Positive Affect Survey version 2.0 - CAT item bank - ages 13-17
84802-8,Positive Affect Survey version 2.0 - parent report - fixed length form - ages 3-7
Jun-80,Intravascular systolic
Apr-81,Intravascular systolic
848-2,A1 B Ag
Feb-82,Intravascular systolic
8483-0,Intravascular systolic
Aug-84,Intravascular systolic
May-85,Intravascular systolic
Mar-86,Intravascular systolic
Jan-87,Intravascular systolic
84871-3,Epstein Barr virus capsid p18 Ab.IgG
84872-1,Epstein Barr virus nuclear 1 Ab.IgG
84873-9,Myelin oligodendrocyte glycoprotein Ab.IgG
84874-7,Perforation into peritoneal cavity
84875-4,Tumor perforation
84876-2,Obstruction
84877-0,Synchronous tumor site
84878-8,Recurrence or distant metastases details
84879-6,Tumor perforation
84880-4,Position of rectal tumor in relation to anterior peritoneal reflection
84881-2,Polyps
84882-0,Histologic type
84883-8,Deepest extent of tumor invasion
84884-6,Distal &or proximal margin involvement
84885-3,Surgical margin tumor involvement.circumferential
84886-1,Satellite nodules
84887-9,Apical lymph node involvement
84888-7,Intramural vein invasion
Sep-88,Intravascular systolic
84889-5,Extramural vein invasion
84890-3,Distant metastases confirmed by histology
84891-1,Response to neoadjuvant therapy
84892-9,Residual tumor classification
84893-7,Supporting information about local extention &or metastasis for staging
84894-5,Dimension
84895-2,Seminal vesicles
84896-0,Lymph node(s)
Jul-89,Intravascular systolic
84897-8,Dominant nodule quadrant
84898-6,Dominant nodule plane
84899-4,Other nodules greater than 10mm in diameter
849-0,A1 B Ag
84900-0,Other nodule quadrant
84901-8,Other nodule plane
84902-6,Extraprostatic extension site
84903-4,Extraprostatic extension extent
84904-2,Gleason score at positive margin
May-90,Intravascular systolic
84905-9,Margin involvement
84906-7,Bladder neck involvement
84907-5,Cancer pathology panel
84908-3,Cancer pathology panel
84910-9,Positive Affect Survey version 2.0 - fixed length form - ages 13-17
84912-5,Cells.chromosome region 5q31 deletion/Cells counted
Mar-91,Intravascular systolic
84913-3,Cells.chromosome 12 trisomy/Cells counted
84914-1,Cells.chromosome region 13q14 deletion/Cells counted
84915-8,Cells.chromosome region 11q22.3 deletion/Cells counted
84916-6,Cells.chromosome region 17p13.1 deletion/Cells counted
84917-4,Chromosome Y aneuploidy
84918-2,Chromosome X aneuploidy
84919-0,Chromosome 21 aneuploidy
84920-8,Cells.chromosome region 5q31 deletion/Cells counted
Jan-92,Intravascular systolic
84921-6,Cells.chromosome region 7q31 deletion/Cells counted
84922-4,Cells.chromosome 7 monosomy/Cells counted
84923-2,Purkinje cell cytoplasmic type 1 Ab
84924-0,Purkinje cell cytoplasmic type 1 Ab
84925-7,Purkinje cell cytoplasmic type 2 Ab
84926-5,Purkinje cell cytoplasmic type Tr Ab
84927-3,Glial nuclear type 1 Ab
84928-1,N-methyl-D-aspartate receptor subunit 1 Ab
84929-9,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab
84930-7,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab
84931-5,Gamma aminobutyrate B receptor Ab
84932-3,Friendship Survey - fixed length form - ages 18+
84933-1,Friendship Survey version 2.0 - fixed length form - ages 8-17
Sep-93,Intravascular systolic
Jul-94,Intravascular systolic
Apr-95,Intravascular systolic
84956-2,Instrumental Support Survey - fixed length form - ages 18+
84957-0,Loneliness Survey - fixed length form - ages 18+
84958-8,Loneliness Survey version 2.0 - fixed length form - ages 8-17
Feb-96,Intravascular diastolic
84962-0,Friendship Survey - national percentile
84963-8,Friendship Survey - scale score^^adjusted for age
84964-6,Friendship Survey - age 18+ - T-score
84966-1,Friendship Survey version 2.0 - ages 8-17 - T-score
84968-7,Friendship Survey - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
84969-5,Friendship Survey - unadjusted scale score
8497-0,Intravascular diastolic
84970-3,Instrumental Support Survey - national percentile
84971-1,Instrumental Support Survey - scale score^^adjusted for age
84972-9,Instrumental Support Survey - age 18+ - T-score
84974-5,Instrumental Support Survey - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
84975-2,Instrumental Support Survey - unadjusted scale score
84976-0,Loneliness Survey - national percentile
84977-8,Loneliness Survey - scale score^^adjusted for age
84978-6,Loneliness Survey - age 18+ - T-score
84980-2,Loneliness Survey version 2.0 - ages 8-17 - T-score
84982-8,Loneliness Survey - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
84983-6,Loneliness Survey - unadjusted scale score
Aug-98,Intravascular diastolic
Jun-99,Intravascular diastolic
Jan-00,Intravascular diastolic
85008-1,General Life Satisfaction Survey - unadjusted scale score
85009-9,General Life Satisfaction Survey version 2.0 - parent report - fixed length form- ages 3-12
85011-5,General Life Satisfaction Survey version 2.0 - parent report - ages 3-12 - T-score
85012-3,General Life Satisfaction Survey - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
85013-1,General Life Satisfaction Survey - fixed length form B - ages 18+
85016-4,General Life Satisfaction Survey - fixed length form A - ages 18+
Sep-01,Intravascular diastolic
85019-8,General Life Satisfaction Survey version 2.0 - CAT item bank - ages 8-12
85021-4,General Life Satisfaction Survey version 2.0 - ages 8-12 - T-score
85022-2,General Life Satisfaction Survey - CAT item bank - ages 18+
85024-8,General Life Satisfaction Survey - age 18+ - T-score
85025-5,General Life Satisfaction Survey - scale score^^adjusted for age
85026-3,General Life Satisfaction Survey - national percentile
Jul-02,Intravascular mean
85027-1,Emotional Support Survey - unadjusted scale score
85028-9,Emotional Support Survey - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
85029-7,Emotional Support Survey version 2.0 - fixed length form - ages 8-17
85031-3,Emotional Support Survey version 2.0 - ages 8-17 - T-score
85032-1,Emotional Support Survey - fixed length form - ages 18+
85034-7,Emotional Support Survey - age 18+ - T-score
May-03,Intravascular mean
85035-4,Emotional Support Survey - scale score^^adjusted for age
85036-2,Emotional Support Survey - national percentile
85037-0,HIV 1 & 2 Ab & HIV 1 p24 Ag panel
85038-8,Somatotropin monitoring panel
85039-6,JAK2 gene.p.Val617Phe mutant/normal
85040-4,3D printed model
85041-2,3D printed model
85042-0,Staphylococcus aureus.glycopeptide resistant identified
Mar-04,Intravascular mean
85043-8,Extended-spectrum beta lactamase by cefepime to cefepime+clavulanate inhibitory concentration ratio
85044-6,Staphylococcus aureus glycopeptide resistance panel
85045-3,Staphylococcus aureus glycopeptide resistant based on vancomycin & teicoplanin inhibitory concentration
85046-1,AmpC beta-lactamase by cefoTEtan to cefoTEtan+cloxacillin inhibitory concentration ratio
85047-9,Metallo beta-lactamase by meropenem to meropenem+EDTA inhibitory concentration ratio
85048-7,Micafungin
85049-5,Extended-spectrum beta lactamase by cefotaxime to cefotaxime+clavulanate inhibitory concentration ratio
8505-0,Intravascular mean
85050-3,Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio
85051-1,Telavancin
85052-9,Ceftobiprole
85053-7,Metallo beta-lactamase by imipenem to imipenem+EDTA inhibitory concentration ratio
85054-5,Self-care - discharge goal
85055-2,"IRF-PAI v3.0, LCDS v4.00 - Skin conditions - admission"
85056-0,Mobility - discharge goal during 3D assessment period
85057-8,PCORnet common data model set - version 3.0
85058-6,Imputed values for date of death
85059-4,Confidence in date of death
85060-2,Confidence in cause of death
85061-0,Door-to-balloon time
85062-8,Anticoagulant given^preoperative
85063-6,Platelet aggregation inhibitor given^preoperative
85064-4,Procedure(s) performed^preoperative
85065-1,Estradiol^post dose follitropin
85066-9,Estradiol^post dose lutropin
85067-7,Estradiol^post dose gonadotropin releasing hormone
Aug-06,Intravascular mean
85068-5,Estradiol^post dose dexamethasone
85069-3,Lab test method
85070-1,Prior functioning.self care
85071-9,Prior functioning.indoor mobility-ambulation
85072-7,Prior functioning.stairs
85073-5,Prior functioning.functional cognition
85074-3,General Life Satisfaction Survey - parent report - national percentile
85075-0,General Life Satisfaction Survey - parent report - scale score^^adjusted for age
Jun-07,Intravascular mean
85076-8,General Life Satisfaction Survey - parent report - scale score^^adjusted for age+sex+race+ethnicity+educational attainment
85077-6,General Life Satisfaction Survey - parent report - unadjusted scale score
85078-4,Occupation industry
85079-2,Nuclear Ab.IgG pattern.other
850-8,A1 B Ag
85080-0,Nuclear Ab.IgG pattern.nucleolar
85081-8,Nuclear Ab.IgG pattern.multiple nuclear dots
85082-6,Nuclear Ab.IgG pattern.nuclear membrane pores
85083-4,Nuclear Ab.IgG pattern.homogeneous
Apr-08,Intravascular systolic
85084-2,Nuclear Ab.IgG pattern.coarse speckled
85085-9,Nuclear Ab.IgG pattern.centrosomal
85086-7,Elastase Ab.IgG
85087-5,Hexanoate
85088-3,Maprotiline & normaprotiline panel
85089-1,Dothiepin & nordothiepin & dothiepin sulfoxide panel
85090-9,Citalopram & norcitalopram & didesmethylcitalopram panel
85091-7,HBA2 gene alpha 3.7kb triplication
Feb-09,Intravascular systolic
85092-5,Liver diseases autoimmune Ab.IgG panel
85093-3,Crystal casts
85094-1,Escitalopram & norescitalopram panel
85095-8,D-3-phosphoglycerate dehydrogenase Ab.IgG
85096-6,Myoglobin casts
85097-4,Meta methylhippurate & ortho methylhippurate & para methylhippurate & Creatinine panel
85098-2,Nitisinone
85099-0,Norescitalopram
Jan-85,Cefaclor
8510-0,Intravascular systolic
85100-6,FLT3 gene internal tandem duplication
85101-4,BRAF gene.p.Val600Glu
85102-2,Mood Disorder Questionnaire
85103-0,Bipolar Spectrum Diagnostic Scale
85104-8,Employment type.compensation and sector
85105-5,Anger-Affect Survey - CAT item bank - age 18+
85106-3,Peer Rejection Survey version 2.0 - parent report - fixed length form - ages 3-12
85108-9,Positive Peer Interaction Survey version 2.0 - parent report - ages 3-12 - T-score
85109-7,Positive Peer Interaction Survey version 2.0 - parent report - fixed length form - ages 3-12
85110-5,Peer Rejection Survey version 2.0 - parent report - ages 3-12 - T-score
85111-3,Social Withdrawal Survey version 2.0 - parent report - ages 3-12 - T-score
85112-1,Social Withdrawal Survey version 2.0 - parent report - fixed length form - ages 3-12
85115-4,Positive Affect Survey version 2.0 - parent report - CAT item bank - ages 3-7
85117-0,Sadness Survey version 2.0 - parent report - ages 3-7 - T-score
Aug-11,Intravascular systolic
85118-8,Sadness Survey version 2.0 - parent report - fixed length form - ages 3-7
85120-4,Fear-Separation Anxiety Survey version 2.0 - parent report - ages 3-7 - T-score
85121-2,Fear-Separation Anxiety Survey version 2.0 - parent report - fixed length form - ages 3-7
85123-8,Fear-Over Anxious Survey version 2.0 - parent report - ages 3-7 - T-score
85124-6,Fear-Over Anxious Survey version 2.0 - parent report - fixed length form - ages 3-7
Jun-12,Intravascular systolic
85126-1,Self-Efficacy Survey version 2.0 - ages 8-12 - T-score
85127-9,Self-Efficacy Survey version 2.0 - CAT item bank - ages 8-12
85129-5,Self-Efficacy Survey version 2.0 - ages 13-17 - T-score
85130-3,Anger-Affect Survey - age 18+ - T-score
85132-9,General Life Satisfaction Survey version 2.0 - ages 13-17 - T-score
85133-7,General Life Satisfaction Survey version 2.0 - CAT item bank - ages 13-17
Apr-13,Intravascular systolic
85135-2,Positive Affect Survey version 2.0 - fixed length form - ages 8-12
85136-0,Sadness Survey version 2.0 - fixed length form - ages 8-17
85137-8,Sadness Survey version 2.0 - ages 8-17 - T-score
85139-4,Fear Survey version 2.0 - ages 8-17 - T-score
85140-2,Sadness Survey - CAT item bank - age 18+
85141-0,Sadness Survey - age 18+ - T-score
Feb-14,Intravascular diastolic
85143-6,Fear Survey version 2.0 - fixed length form - ages 8-17
85145-1,Meaning and Purpose Survey - age 18+ - T-score
85146-9,Meaning and Purpose Survey - CAT item bank - age 18+
85147-7,Programmed cell death ligand 1 by clone 22C3
85148-5,Programmed cell death ligand 1 by clone 28-8
85149-3,Programmed cell death ligand 1 by clone SP142
85150-1,Bone age method
85151-9,Bone age
85152-7,Employment status
85153-5,Admission evaluation note
85154-3,Discharge summary note
85155-0,Evaluation and management of hyperlipidemia note
85156-8,Evaluation and management of hypertension note
85157-6,Note
85158-4,Letter
Sep-15,Intravascular diastolic
85159-2,Admission evaluation note
851-6,A2 Ab
85160-0,Medication management note
85161-8,Note
85162-6,Evaluation and management of anticoagulation note
85163-4,Counseling note
85164-2,Evaluation and management of anticoagulation note
85165-9,Evaluation and management of hyperlipidemia note
85166-7,Medication management note
Jul-16,Intravascular diastolic
85167-5,Medication management note
85168-3,Note
85169-1,Note
85170-9,Note
85171-7,Education note
85172-5,Note
85173-3,Admission evaluation note
85174-1,Consultation note
May-17,Intravascular diastolic
85175-8,Counseling note
85176-6,Discharge summary note
85177-4,Administrative note
85178-2,Group counseling note
85179-0,History and physical note
85180-8,Risk assessment and screening note
85181-6,Transfer summary note
85182-4,Plan of care note
Mar-18,Intravascular diastolic
85183-2,Note
85184-0,Transfer summary note
85185-7,Initial evaluation note
85186-5,Plan of care note
85187-3,Transfer summary note
85188-1,Respite note
85189-9,Admission evaluation note
85190-7,Annual evaluation note
Jan-19,Intravascular diastolic
85191-5,Conference note
85192-3,Discharge summary note
85193-1,Education note
85194-9,Fall risk assessment note
85195-6,Group counseling note
85196-4,History and physical note
85197-2,Risk assessment and screening note
85198-0,Living will
85199-8,Referral note
85200-4,Discharge summary note
85201-2,History and physical note
85202-0,Evaluation and management of smoking cessation note
85203-8,History and physical note
85204-6,Risk assessment and screening note
85205-3,Referral note
85206-1,Initial evaluation note
85207-9,Education note
85208-7,Consultation note
Sep-20,Intravascular diastolic
85209-5,Evaluation and management of smoking cessation note
85210-3,Triage note
85211-1,Discharge instructions
85212-9,Respite note
85213-7,Outreach note
85214-5,Transplant candidate evaluation note
85215-2,Transplant donor evaluation note
85216-0,Disability examination note
Jul-21,Intravascular diastolic
85217-8,VA C&P exam.multiple exam note
85218-6,Note
85219-4,Transfer summary note
85220-2,Note
85221-0,Note
85222-8,Consultation note
85223-6,Discharge summary note
85224-4,Note
May-22,Intravascular diastolic
85225-1,Note
85226-9,Referral note
85227-7,Note
85228-5,Plan of care note
85229-3,Note
85230-1,Procedure note
85231-9,Note
85232-7,Consultation note
Mar-23,Intravascular diastolic
85233-5,Admission evaluation note
85234-3,Admission evaluation note
85235-0,Note
85236-8,Procedure note
85237-6,Consultation note
85238-4,Consultation note
85239-2,Admission evaluation note
852-4,A2 Ab
85240-0,Discharge summary note
Jan-24,Intravascular diastolic
85241-8,Note
85242-6,Procedure note
85243-4,Discharge summary note
85244-2,Education note
85245-9,History and physical note
85246-7,Admission evaluation note
85247-5,Note
85248-3,Note
85249-1,Note
85250-9,Admission evaluation note
85251-7,Admission evaluation note
85252-5,Note
85253-3,Transfer summary note
85254-1,Plan of care note
85255-8,Administrative note
85256-6,Note
85257-4,Education note
Aug-25,Intravascular diastolic
85258-2,Education note
85259-0,Note
85260-8,Procedure note
85261-6,Procedure note
85262-4,Note
85263-2,Note
85264-0,Transplant candidate evaluation note
85265-7,Medication management note
Jun-26,Intravascular diastolic
85266-5,Note
85267-3,X-linked adrenoleukodystrophy (X-ALD) newborn screening panel
85268-1,X-linked adrenoleukodystrophy newborn screening comment-discussion
85269-9,X-linked adrenoleukodystrophy
85270-7,Furcation site
85271-5,Frenum involvement site
85272-3,Bleeding on probing
85273-1,REMS Conversion to Shared System
Apr-27,Intravascular diastolic
85274-9,REMS Release
85275-6,Adjacent structure invaded by tumor
85276-4,Closest surgical margin when all margins are uninvolved
85277-2,Distance of carcinoma from closest mucosal margin when all mucosal margins are uninvolved
85278-0,Distance of carcinoma from closest surgical margin when all margins are uninvolved
85279-8,Excised length
85281-4,Intratumoral lymphocytic response
Feb-28,Intravascular diastolic
85282-2,Mucinous fraction
85283-0,Organ tumor is adherent to
85284-8,Peritumoral lymphocytic response
85285-5,Polyp in which invasive carcinoma arose
85286-3,Promoter methylation testing method
85287-1,Radial position of closest mucosal margin involved by invasive carcinoma
85288-9,Radial position of closest mucosal margin when mucosal margin uninvolved by invasive carcinoma
85289-7,Signet ring cells/100 cells
8529-0,Intravascular diastolic
85290-5,Surgical margin tumor involvement
85291-3,Surgical margin tumor involvement.deep
85292-1,Surgical margin tumor involvement.distant
85293-9,Surgical margin tumor involvement.mesenteric
85294-7,Surgical margin tumor involvement.mucosal
85295-4,Surgical margin tumor involvement.proximal
85296-2,Tumor budding
85297-0,Tumor buds
85298-8,Body structure included in specimen
85299-6,Serine-threonine protein kinase B-raf V600E
85300-2,Mitotic rate
85301-0,Adjacent structure invaded by tumor
85302-8,Growth pattern of DCIS
85303-6,Body structure of origin
85304-4,Distance of carcinoma from uninvolved anterior margin
85305-1,Distance of carcinoma from uninvolved inferior margin
85306-9,Distance of carcinoma from uninvolved lateral margin
85307-7,Distance of carcinoma from uninvolved medial margin
Aug-30,Intravascular mean
85308-5,Distance of carcinoma from uninvolved posterior margin
85309-3,Distance of carcinoma from uninvolved superior margin
85310-1,Estrogen receptor fluorescence intensity
85311-9,Extent of anterior margin carcinoma involvement
85312-7,Extent of inferior margin carcinoma involvement
85313-5,Extent of lateral margin carcinoma involvement
85314-3,Extent of medial margin carcinoma involvement
85315-0,Extent of posterior margin carcinoma involvement
Jun-31,Intravascular mean
85316-8,Extent of superior margin carcinoma involvement
85317-6,DCIS.max dimension
85318-4,ERBB2 gene duplication
85319-2,HER2
853-2,A2 Ab
85320-0,Foci
85321-8,Glandular differentiation
85322-6,Adjacent structure invaded by tumor
85323-4,Response to neoadjuvant therapy
Apr-32,Intravascular mean
85325-9,Cells.progesterone receptor/100 cells
85326-7,Tissue blocks positive for DCIS
85327-5,Foci
85328-3,Cells.HER2 uniform intense membrane staining/100 cells
85329-1,Cells.estrogen receptor/100 cells
85330-9,Cells.Ki-67 nuclear Ag/100 cells
85331-7,Progesterone receptor fluorescence intensity
Feb-33,Intravascular mean
85332-5,Radial position within breast
85333-3,DCIS.additional dimension 1
85334-1,Surgical margin DCIS involvement
85335-8,DCIS.additional dimension 2
85336-6,DCIS intraductal extension
85337-4,Estrogen receptor Ag
85338-2,Lobular carcinoma in situ
85339-0,Progesterone receptor Ag
8534-0,Intravascular mean
85340-8,DCIS necrosis
85341-6,Pathology report reviewed
85342-4,Lymph node site of origin
85343-2,Lymph nodes with macrometastases
85344-0,Lymph nodes with micrometastases
85345-7,Dermal lymph-vascular invasion
85346-5,Tissue blocks examined
85347-3,Sentinel lymph nodes examined
85348-1,Procedure used to obtain tumor specimen
85349-9,Lymph node response to neoadjuvant therapy
85350-7,Extranodal extension of carcinoma
85351-5,Lymph node metastatic deposit.max dimension
85352-3,Lymph nodes with isolated tumor cells
85353-1,"Vital signs, weight, height, head circumference, oxygen saturation & BMI panel"
85354-9,Blood pressure panel with all children optional
85355-6,Porcine epidemic diarrhea virus S INDEL strain S gene
85356-4,Porcine epidemic diarrhea virus prototype strain S gene
Jul-35,Intravascular mean
85357-2,Porcine epidemic diarrhea virus prototype & S INDEL strain S gene panel
85358-0,Phosphatidylserine-prothrombin complex Ab.IgM
85359-8,Phosphatidylserine-prothrombin complex Ab.IgG
85360-6,Bordetella pertussis+bronchiseptica+holmesii IS481 DNA
85361-4,HIV 1+2 RNA
85362-2,Mycobacterium tuberculosis complex DNA
85363-0,21-Hydroxylase Ab
85364-8,Muscarinic acetylcholine receptor M3 Ab
May-36,Intravascular mean
85365-5,Neutrophil membrane Ab
85366-3,Neutrophil membrane Ab.IgM
85367-1,Neutrophil membrane Ab.IgG
85368-9,HIV 1+2 RNA
85369-7,Neutrophils
85370-5,Neutrophil.fMLP stimulated.DHR mean fluorescence intensity
85371-3,Neutrophil.fMLP stimulated.DHR mean fluorescence intensity
85372-1,Neutrophil.fMLP stimulated.DHR/Neutrophil.fMLP stimulated.total
Mar-37,Intravascular mean
85373-9,Neutrophil.fMLP stimulated.DHR/Neutrophil.fMLP stimulated.total
85374-7,Neutrophil.PMA stimulated.DHR mean fluorescence intensity
85375-4,Neutrophil.PMA stimulated.DHR mean fluorescence intensity
85376-2,Neutrophil.PMA stimulated.DHR/Neutrophil.PMA stimulated.total
85377-0,Neutrophil.PMA stimulated.DHR/Neutrophil.PMA stimulated.total
85378-8,Erythrocytes.EMA mean fluorescence intensity actual/normal
85379-6,Purine/pyrimidine
85380-4,HIV immunoassay testing algorithm interpretation
Jan-38,Intravascular mean
85381-2,Isavuconazole
85382-0,Osmolarity
85383-8,EGFR gene.c.2369C>T actual/normal
85384-6,Amisulpride
85385-3,Views for bone density
85386-1,Views for bone density
85387-9,Views for bone density
85388-7,Views for bone density
85389-5,Views for bone density
85390-3,Views for bone density
85391-1,Views for bone density
85392-9,Views for bone density
85393-7,Views for bone density
85394-5,Views for bone density
85395-2,IRF-PAI v3.0 - Identification information
85396-0,IRF-PAI - Facility information
85397-8,Inpatient rehabilitation facility admission
85398-6,Admitted from
Sep-39,Intravascular mean
85399-4,Prior residence
854-0,A2 Ag
85400-0,Prior living arrangement
85401-8,IRF-PAI - Payer information
85402-6,Payment source.primary
85403-4,Payment source.secondary
85404-2,IRF-PAI - Medical information
85405-9,IRF-PAI - Impairment group - admission
85406-7,IRF-PAI - Impairment group - discharge
Jul-40,Intravascular mean
85407-5,Arthritis conditions recorded
85408-3,Swallowing status - admission
85409-1,Swallowing status - discharge
85410-9,IRF-PAI - Discharge information
85411-7,Patient discharged against medical advice
85412-5,Program interruption(s)
85413-3,Program interruption date
85414-1,Program return date
May-41,Intravascular mean
85415-8,Patient discharged alive
85416-6,Discharge location
85417-4,Discharge living arrangement
85418-2,Diagnosis for interruption or death
85419-0,Complications during rehabilitation stay
85420-8,IRF-PAI - Therapy information
85421-6,Bacterial identification & susceptibility panel
85422-4,ceFAZolin
Mar-42,Intravascular mean
85423-2,Eravacycline
85424-0,Imipenem+Relebactam
85425-7,Lefamulin
85426-5,Meropenem
85427-3,Meropenem+Vaborbactam
85428-1,Penicillin
85429-9,Penicillin
85430-7,Diagnostic imaging report - example sections & entries
Jan-43,Intravascular mean
85431-5,Marital status
85432-3,Relationship to patient
85433-1,Discharge summary note
85434-9,Discharge summary note
85435-6,Note
85436-4,Note
85437-2,Note
85438-0,Note
85439-8,Note
85440-6,Discharge summary note
85441-4,Progress note
85442-2,Discharge summary note
85443-0,Note
85444-8,Note
85445-5,Note
85446-3,Health and well-being total
85447-1,Health and well-being domain risk level
85448-9,Social enviromental total
Sep-44,Intravascular mean
85449-7,Social enviromental domain risk level
85450-5,Health literacy and communication total
85451-3,Health literacy and communication domain risk level
85452-1,Service coordination total
85453-9,Service coordination domain risk level
85454-7,ePCAM Social Complexity
85455-4,Health and well-being panel
Jun-45,Intravascular mean
85456-2,Physical health needs that require further investigation - visual analog rating
85457-0,Physical health impacting mental well-being - visual analog rating
85458-8,Lifestyle behaviors impacting physical or mental well-being - visual analog rating
85459-6,Other mental well-being concerns - visual analog rating
85460-4,Social environmental panel
85461-2,Home environment safety and stability - visual analog rating
85462-0,Daily activities impact on well-being - visual analog rating
85463-8,Social network - visual analog rating
Apr-46,Intravascular systolic
85464-6,Financial resources - visual analog rating
85465-3,Health literacy and communication panel
85466-1,Understand health and well-being and what they need to do to manage their health - visual analog rating
85467-9,Can engage in healthcare discussions - visual analog rating
85468-7,Do other services need to be involved to help this client - visual analog rating
85469-5,Are current services involved with this client well-coordinated - visual analog rating
85470-3,Medication management note
85471-1,Medication management note
Feb-47,Intravascular systolic
85472-9,Note
85473-7,Male sexual partner in last 12Mo
85474-5,Cardiac implantable loop monitor study
85475-2,Multisection transesophageal
85476-0,Influenza virus A & B & Respiratory syncytial virus RNA panel
85477-8,Influenza virus A RNA
85478-6,Influenza virus B RNA
85479-4,Respiratory syncytial virus RNA
8548-0,Intravascular systolic
85480-2,Establishment registration exempt notification
85481-0,Blood establishment registration & product listing
85482-8,Human cell and tissue establishment registration & product listing
85483-6,"IRF-PAI v3.0, LCDS v3.00 - Program interruption dates"
85484-4,Establishment temporary inactivation notification
85485-1,B little g super little b Ag
85486-9,B little g super little c Ag
85487-7,S little c 1 Ag
85488-5,S little c 2 Ag
85489-3,Speech-language pathology services - co-treatment minutes^week 1
85490-1,Speech-language pathology services - group minutes^week 1
85491-9,Speech-language pathology services - concurrent minutes^week 1
85492-7,Speech-language pathology services - individual minutes^week 1
85493-5,IRF-PAI - Speech-language pathology services - week 1
85494-3,IRF-PAI - Therapy provided - week 1
85495-0,IRF-PAI - Therapy provided - week 2
85496-8,Streptococcus pneumoniae serotype
85497-6,cloZAPine N-oxide
Aug-49,Intravascular systolic
85498-4,Bacterial carbapenem resistance blaIMP gene
85499-2,Bacterial carbapenem resistance blaKPC gene
85500-7,Bacterial carbapenem resistance blaNDM gene
85501-5,Bacterial carbapenem resistance blaVIM gene
85502-3,Bacterial carbapenem resistance genes panel
85503-1,Bacterial carbapenem resistance blaOXA-48 gene
85504-9,ABO group.presumptive
85505-6,Rh.presumptive
Jun-50,Intravascular systolic
85506-4,PTEN gene targeted mutation analysis
85507-2,PIK3CA gene targeted mutation analysis
85508-0,Satellite nodules
85509-8,KRAS gene targeted mutation analysis
85510-6,NRAS gene targeted mutation analysis
85511-4,BRAF gene targeted mutation analysis
85512-2,Hepatitis D virus RNA
85513-0,Hepatitis D virus RNA
Apr-51,Intravascular systolic
85514-8,Discharge summary note
85515-5,Progress note
85516-3,Note
85517-1,Consultation note
85518-9,Initial evaluation note
85519-7,Consultation note
85520-5,Discharge summary note
85521-3,Note
Feb-52,Intravascular systolic
85522-1,Initial evaluation note
85523-9,PROMIS short form - global - version 1.2 raw score
85524-7,PROMIS short form - global - version 1.2
85525-4,Porcine reproductive and respiratory syndrome virus North American strain Ab.IgG
85526-2,Influenza virus D PB2 gene
85527-0,Mycoplasma hyopneumoniae P146 gene sequence & phylogenetic analysis
85528-8,Porcine reproductive and respiratory syndrome virus European strain Ab.IgG
85529-6,Porcine reproductive and respiratory syndrome virus North American strain Ab.IgG
8553-0,Intravascular systolic
85530-4,Porcine reproductive and respiratory syndrome virus European strain Ab.IgG
85531-2,Porcine reproductive and respiratory syndrome virus whole genome
85532-0,Influenza virus A whole genome
85533-8,Influenza virus A porcine origin nucleoprotein Ab.IgG/Positive control
85534-6,Influenza virus A avian origin nucleoprotein Ab/Negative control
85535-3,Influenza virus A RNA tissue culture infective dose 50
85536-1,Mycoplasma hyopneumoniae DNA
85537-9,Mycoplasma hyosynoviae 16S rRNA gene
85538-7,Mycoplasma hyorhinis 16S rRNA gene
85539-5,Porcine reproductive and respiratory syndrome virus North American strain RNA
85540-3,Porcine reproductive and respiratory syndrome virus European strain RNA
85541-1,Porcine reproductive and respiratory syndrome virus Ingelvac MLV strain ORF5 gene
85542-9,Porcine reproductive and respiratory syndrome virus Ingelvac ATP strain ORF5 gene
85543-7,Porcine reproductive and respiratory syndrome virus Ab.IgG/Positive control
85544-5,Porcine reproductive and respiratory syndrome virus Ab/Positive control
85545-2,Porcine reproductive and respiratory syndrome virus North American strain RNA
85546-0,Porcine reproductive and respiratory syndrome virus European strain RNA
85547-8,Porcine reproductive and respiratory syndrome virus North American strain Ab.Neut
Aug-54,Intravascular systolic
85548-6,Porcine reproductive and respiratory syndrome virus European strain Ab.Neut
85549-4,Porcine reproductive and respiratory syndrome virus European strain Ab.Neut
85550-2,Porcine reproductive and respiratory syndrome virus North American strain Ab.Neut
85551-0,Porcine reproductive and respiratory syndrome virus European & North American strains Ab.Neut panel
85552-8,Influenza virus A porcine origin nucleoprotein Ab.IgA/Positive control
85553-6,Mycoplasma flocculare 16S rRNA gene
85554-4,Electronic Patient Centered Assessment Method panel
May-55,Intravascular systolic
85555-1,Service coordination panel
85556-9,Rothman Index
85557-7,Physical therapy - individual minutes^week 1
85558-5,Physical therapy - concurrent minutes^week 1
85559-3,Physical therapy - group minutes^week 1
85560-1,Physical therapy - co-treatment minutes^week 1
85561-9,IRF-PAI - Occupational therapy - week 1
85562-7,Occupational therapy - individual minutes^week 1
Mar-56,Intravascular systolic
85563-5,Occupational therapy - concurrent minutes^week 1
85564-3,Occupational therapy - group minutes^week 1
85565-0,Occupational therapy - co-treatment minutes^week 1
85566-8,IRF-PAI - Physical therapy - week 1
85567-6,Physical therapy - individual minutes^week 2
85568-4,Physical therapy - concurrent minutes^week 2
85569-2,Physical therapy - group minutes^week 2
855-7,A2 Ag
85570-0,Physical therapy - co-treatment minutes^week 2
Jan-57,Intravascular systolic
85571-8,Occupational therapy - individual minutes^week 2
85572-6,Occupational therapy - concurrent minutes^week 2
85573-4,Occupational therapy - group minutes^week 2
85574-2,Occupational Therapy - co-treatment minutes^week 2
85575-9,Speech-language pathology services - individual minutes^week 2
85576-7,Speech-language pathology services - concurrent minutes^week 2
85577-5,Speech-language pathology services - group minutes^week 2
85578-3,Speech-language pathology services - co-treatment minutes^week 2
85579-1,Porcine reproductive and respiratory syndrome virus European strain ORF5 gene
85580-9,Registry report
85581-7,Mycobacterium avium & Mycobacterium intracellulare DNA
85582-5,Chikungunya virus RNA+Dengue virus RNA
85583-3,Chikungunya virus RNA
85584-1,Dengue virus RNA
85585-8,Date of condition onset
85586-6,Porcine reproductive and respiratory syndrome virus European & North American strains Ab.IgG panel
85587-4,Note
85588-2,Diagnostic study note
Sep-58,Intravascular systolic
85589-0,IRF-PAI - Physical therapy - week 2
85590-8,IRF-PAI - Occupational therapy - week 2
85591-6,IRF-PAI - Speech-language pathology services - week 2
85592-4,Planned location for hemodialysis
85593-2,Type of donor kidney
85594-0,Preferred type of dialysis if required before transplant
85595-7,Will hospice care be provided
85596-5,Preferred kidney failure treatment if kidney disease progresses to kidney failure
Jul-59,Intravascular systolic
85597-3,Renal replacement therapy goals panel
85598-1,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by causing swelling in your ankles or legs
85599-9,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your walking about or climbing stairs difficult
85600-5,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your working around the house or yard difficult
85601-3,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your going places away from home difficult
85602-1,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your sleeping well at night difficult
85603-9,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your relating to or doing things with your friends or family difficult
85604-7,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your working to earn a living difficult
May-60,Intravascular systolic
85605-4,"Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your recreational pastimes, sports or hobbies difficult"
85606-2,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your sexual activities difficult
85607-0,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you eat less of the foods you like
85608-8,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you short of breath
85609-6,Emotional score
85610-4,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you stay in a hospital
85611-2,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by costing you money for medical care
85612-0,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by giving you side effects from treatments
Mar-61,Intravascular systolic
85613-8,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you feel you are a burden to your family or friends
85614-6,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you feel a loss of self-control in your life
85615-3,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you worry
85616-1,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making it difficult for you to concentrate or remember things
85617-9,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you feel depressed
85618-7,Physical score
85619-5,Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you sit or lie down to rest during the day
85620-3,"Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you tired, fatigued or low on energy"
Jan-62,Intravascular systolic
85621-1,Zika virus RNA
85622-9,Zika virus RNA
85623-7,Zika virus RNA
85624-5,Kidney failure 2Y risk
85625-2,Kidney failure 5Y risk
85626-0,Kidney failure 2Y & 5Y risk panel
85627-8,Haemophilus influenzae hpd gene
85628-6,Neisseria meningitidis sodC gene
85629-4,Comatose during 3D assessment period
85630-2,"Did the (abnormal) behavior fluctuate during the day, that is, tend to come and go or increase and decrease in severity during 3D assessment period"
85631-0,"Did the patient have difficulty focusing attention, for example, being easily distractible or having difficulty keeping track of what was being said during 3D assessment period"
85632-8,Facility type
85633-6,Indicate the patient's primary medical condition category during 3D assessment period
85634-4,Is there evidence of an acute change in mental status from the patient's baseline during 3D assessment period
85635-1,LCDS v3.00 - Active diagnoses
85636-9,LCDS v4.00 - Administrative information - admission
85637-7,LCDS v3.00 - Assessment administration
85638-5,LCDS v3.00 - Cognitive patterns
Sep-63,Intravascular systolic
85639-3,LCDS v3.00 - Functional abilities and goals
85640-1,"LCDS v3.00 - Hearing, speech, and vision"
85641-9,LCDS v3.00 - Mobility - admission performance during 3D assessment period
85642-7,LCDS - Prior functioning: everyday activities
85643-5,"LCDS v3.00 - Special treatments, procedures, and programs - admission"
85644-3,LCDS v3.00 - Swallowing &or nutritional status
85645-0,Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 3.00
85646-8,Level of consciousness - Alert (normal) during 3D assessment
Jul-64,Intravascular systolic
85647-6,Signature of person collecting or coordinating collection of assessment information
85648-4,Signature of persons completing the assessment
85649-2,LCDS v3.00 - Signs and Symptoms of Delirium (from CAM)
856-5,A2 Ag
85650-0,Title of person collecting or coordinating collection of assessment information
85651-8,"Was the patient's thinking disorganized or incoherent, such as rambling or irrelevant conversation, unclear or illogical flow of ideas, or unpredictable switching from subject to subject during 3D assessment period"
85652-6,Wash upper body - functional ability during 3D assessment period
85653-4,Wash upper body - functional goal during 3D assessment period
Apr-65,Intravascular systolic
85654-2,Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 3.00
85655-9,Level of consciousness - Vigilant or lethargic or stupor or coma during 3D assessment
85656-7,Sexual activity with a new partner in past 60D
85657-5,Occupation industry CDC Census code
85658-3,Occupation
85659-1,Occupation CDC Census code
85660-9,LCDS v3.00 - Mobility - discharge goal during 3D assessment period
85661-7,LCDS v3.00 - Self-care - discharge goal
Feb-66,Intravascular systolic
85662-5,Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 3.00
85663-3,LCDS v3.00 - Administrative information - discharge
85664-1,LCDS v3.00 - Functional abilities and goals - planned discharge
85665-8,LCDS v3.00 - Self-care - discharge performance
85666-6,LCDS v3.00 - Bladder and bowel - planned discharge
85667-4,LCDS v3.00 - Self-care - admission performance
85668-2,Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 3.00
85669-0,Number of program interruptions
8567-0,Intravascular systolic
85670-8,LCDS v3.00 - Skin conditions - discharge
85671-6,Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 3.00
85672-4,LCDS v3.00 - Mobility - discharge performance during 3D assessment period
85673-2,LCDS v4.00 - Administrative information - expired
85674-0,Date of serology test^pre pregnancy
85675-7,Serologic test result^pre pregnancy
85676-5,Previous illness diagnosed by
85677-3,Congenital rubella syndrome case classification
85678-1,Haemophilus influenzae acs gene
85679-9,Haemophilus influenzae bex gene
85680-7,Haemophilus influenzae ecs gene
85681-5,Haemophilus influenzae dcs gene
85682-3,Haemophilus influenzae ccs gene
85683-1,Haemophilus influenzae bcs gene
85684-9,Bordetella pertussis.pertussis toxin Ab.IgG
85685-6,Mycoplasma hyopneumoniae P146 gene
85686-4,HIV 1 Ab
85687-2,Treated for Chlamydia trachomatis or Neisseria gonorrhoeae in last 3 to 12Mo
Aug-68,Intravascular systolic
85688-0,Streptococcus pneumoniae lytA gene
85689-8,Sexual activity with known Chlamydia trachomatis &or Neisseria gonorhoeae case
85690-6,Rubella virus genotype
85691-4,Autopsy result
85692-2,Year previously tested for rubella virus immunity
85693-0,Previous rubella virus test result
85694-8,Documentation of previous rubella immunity testing
85695-5,Prior condition onset year
Jun-69,Intravascular systolic
85696-3,Previous rubella disease was serologically confirmed
85697-1,Rubella diagnosis^pre pregnancy
85698-9,Age at time of immunity testing
85699-7,Autopsy was performed
85700-3,Age and setting of exposure to illness verified
85701-1,Rubella surveillance panel
85702-9,Received vaccination for illness of interest
85703-7,Number of deliveries in the U.S.
Apr-70,Intravascular systolic
85704-5,Year of previous delivery in the U.S.
85705-2,Has had previous deliveries in the U.S.
85706-0,Date of exposure to individual with confirmed illness
85707-8,Relationship to individual with confirmed illness
85708-6,Directly exposed to a confirmed case
85709-4,Traveled outside the U.S. during first trimester of pregnancy
85710-2,Knows location of exposure to illness
85711-0,Rubella was serologically confirmed at time of illness
Feb-71,Intravascular systolic
85712-8,Expected delivery location
85713-6,Vaccinated based on recommended guidelines
85714-4,Reason vaccine not received
85715-1,Mo of pregnancy when rubella-like symptoms appeared
85716-9,Rubella-like illness during the pregnancy
85717-7,Serologic testing was performed^pre pregnancy
85718-5,Prenatal care location
85719-3,Gestational age in W^at cessation of pregnancy
8572-0,Intravascular systolic
85720-1,Number of children under the age of 18 living in household during the pregnancy who received a rubella vaccine
85721-9,Rubella vaccine was received by children under the age of 18 in the household during the pregnancy
85722-7,Number of children under the age of 18 living in household during the pregnancy
85723-5,Attended a family planning clinic prior to conception
85724-3,Age^at delivery
85725-0,Duration in the U.S.
85726-8,Other symptoms of illness
85727-6,Lymphadenopathy
85728-4,Fever duration
85729-2,Date of fever onset
857-3,A2 B Ab
85730-0,Fever
85731-8,Rash duration
85732-6,Date of rash onset
85733-4,Maculopapular rash
85734-2,Date of last evaluation
85735-9,Congenital rubella case report panel
85736-7,Number of sexual partners in last 12Mo
85737-5,Bombay phenotype
Aug-73,Intravascular systolic
85738-3,Bombay phenotype
85739-1,Bombay phenotype
85740-9,Streptococcus pneumoniae Danish serotype 5 DNA
85741-7,Streptococcus pneumoniae Danish serotype 4 DNA
85742-5,Streptococcus pneumoniae Danish serotype 3 DNA
85743-3,Streptococcus pneumoniae Danish serotype 23F DNA
85744-1,Streptococcus pneumoniae Danish serotype 2 DNA
85745-8,Streptococcus pneumoniae Danish serotype 19F DNA
Jun-74,Intravascular systolic
85746-6,Streptococcus pneumoniae Danish serotype 14 DNA
85747-4,Streptococcus pneumoniae Danish serotype 1 DNA
85748-2,Streptococcus pneumoniae Danish serotypes 7A+7F DNA
85749-0,Streptococcus pneumoniae Danish serotypes 22A+22F DNA
85750-8,Streptococcus pneumoniae Danish serotype 23A DNA
85751-6,Streptococcus pneumoniae Danish serotype 16F DNA
85752-4,Streptococcus pneumoniae Danish serotypes 9A+9V DNA
Mar-75,Intravascular systolic
85753-2,Streptococcus pneumoniae Danish serotypes 6C+6D DNA
85754-0,Streptococcus pneumoniae Danish serotypes 6A+6B+6C+6D DNA
85755-7,Streptococcus pneumoniae Danish serotypes 33A+33F+37 DNA
85756-5,Streptococcus pneumoniae Danish serotypes 18A+18B+18C+18F DNA
85757-3,Streptococcus pneumoniae Danish serotypes 15A+15F DNA
85758-1,Streptococcus pneumoniae Danish serotypes 12A+12F+44+46 DNA
85759-9,Streptococcus pneumoniae Danish serotypes 11A+11D DNA
85760-7,Streptococcus pneumoniae Danish serotype 19A DNA
Jan-76,Intravascular systolic
85761-5,Klebsiella pneumoniae DNA
85762-3,Blood pathogens panel
85763-1,Listeria monocytogenes DNA
85764-9,Staphylococcus sp DNA
85765-6,Staphylococcus aureus DNA
85766-4,Streptococcus sp DNA
85767-2,Streptococcus agalactiae DNA
85768-0,Streptococcus pneumoniae DNA
85769-8,Streptococcus pyogenes DNA
85770-6,Acinetobacter baumannii DNA
85771-4,Enterobacteriaceae DNA
85772-2,Enterobacter cloacae complex DNA
85773-0,Escherichia coli DNA
85774-8,Klebsiella oxytoca DNA
85775-5,Enterococcus sp DNA
85776-3,Proteus sp DNA
85777-1,Serratia marcescens DNA
85778-9,Haemophilus influenzae DNA
Sep-77,Intravascular systolic.brachial artery right/Brachial artery
85779-7,Neisseria meningitidis DNA
85780-5,Pseudomonas aeruginosa DNA
85781-3,Candida albicans DNA
85782-1,Candida glabrata DNA
85783-9,Candida krusei DNA
85784-7,Candida parapsilosis DNA
85785-4,Candida tropicalis DNA
85786-2,Bacterial methicillin resistance mecA gene
Jul-78,Intravascular systolic.penile artery/Brachial artery
85787-0,Bacterial vancomycin resistance vanA+vanB genes
85788-8,Bacterial carbapenem resistance blaKPC gene
85789-6,Cells.CD3+CD8+CD45RO+/100 cells.CD3
85790-4,Cells.CD3+CD8+CD45RO+
85791-2,Cells.CD3+CD4+CD45RO+/100 cells.CD3
85792-0,Cells.CD3+CD4+CD45RO+
85793-8,Specimen source subject
85794-6,Arthralgia &or arthritis
May-79,Intravascular systolic.posterior tibial artery left/Brachial artery
85795-3,Rubella virus E1 gene & genotype panel
85796-1,Rubella virus E1 gene
85797-9,Neisseria meningitidis serogroup DNA panel
85798-7,Measles virus N gene
85799-5,Bordetella pertussis+bronchiseptica+holmesii IS481 DNA
85800-1,Mumps virus SH gene
85801-9,Influenza virus B Yamagata lineage Ag
85802-7,Influenza virus A H1 Ag
Mar-80,Intravascular systolic.posterior tibial artery right/Brachial artery
85803-5,Influenza virus A H3 Ag
85804-3,Influenza virus A H5 Ag
85805-0,Influenza virus A H7 Ag
85806-8,Measles virus RNA & N gene panel
85807-6,Mumps virus genotype
85808-4,Mumps virus RNA & SH gene panel
85809-2,Bordetella pertussis & parapertussis & holmesii DNA panel
858-1,A2 B Ab
85810-0,Adenovirus serotype DNA panel
Jan-81,Intravascular systolic.posterior tibial artery/Brachial artery
85811-8,LCDS v3.00 - Altered level of consciousness
85812-6,LCDS v3.00 - Acute onset and fluctuating course
85813-4,IRF-PAI - Payment source
85814-2,IRF-PAI - Signature of persons completing the assessment
85815-9,LCDS - Pre-admission service use
85816-7,LCDS v4.00 - Patient demographic information - admission
85817-5,LCDS v4.00 - Patient demographic information - discharge and expired
85818-3,Clot formation+Clotting time
85819-1,Clot firmness reduction^60M after maximum clot amplitude after addition of heparinase
85820-9,Clot firmness reduction^30M after maximum clot amplitude after addition of heparinase
85821-7,Influenza Virus B Victoria lineage Ag
85822-5,Bacterial beta-lactam resistance AmpC blaCMY+blaMOX genes
85823-3,Bacterial carbapenem resistance blaGES gene
85824-1,Bacterial carbapenem resistance blaIMP gene
85825-8,Bacterial carbapenem resistance blaOXA-23-like gene
85826-6,Bacterial carbapenem resistance blaOXA-24-like gene
85827-4,Bacterial carbapenem resistance blaOXA-48-like gene
85828-2,Bacterial carbapenem resistance blaOXA-58-like gene
Sep-82,A wave amplitude
85829-0,Bacterial carbapenem resistance blaSPM gene
85830-8,Bacterial carbapenem resistance blaVIM gene
85831-6,Bacterial beta-lactam resistance ESBL blaBEL gene
85832-4,Bacterial beta-lactam resistance ESBL blaCTX-M-1 group gene
85833-2,Bacterial carbapenem resistance blaGIM gene
85834-0,Bacterial beta-lactam resistance ESBL blaCTX-M-9 group gene
85835-7,Bacterial beta-lactam resistance ESBL blaCTX-M-8+blaCTX-M-25 group genes
85836-5,Bacterial beta-lactam resistance ESBL blaGES gene
Jul-83,A wave amplitude
85837-3,Bacterial beta-lactam resistance ESBL blaPER gene
85838-1,Bacterial beta-lactam resistance ESBL blaSHV gene
85839-9,Bacterial beta-lactam resistance ESBL blaTEM gene
85840-7,Bacterial beta-lactam resistance ESBL blaVEB gene
85841-5,Bacterial beta-lactam resistance AmpC blaACC gene
85842-3,Bacterial beta-lactam resistance AmpC blaACT+blaMIR genes
85843-1,Bacterial beta-lactam resistance AmpC blaFOX gene
85844-9,Bacterial beta-lactam resistance ESBL blaCTX-M-2 group gene
May-84,A wave amplitude
85845-6,Impairment group
85846-4,Swallowing status
85847-2,Care team information
85848-0,Restraint note
85849-8,Discharge summary note
85850-6,History and physical note
85851-4,Note
Feb-85,Intravascular mean
85852-2,Note
85853-0,Postoperative evaluation and management note
85854-8,Procedure note
85855-5,Note
85856-3,Risk assessment and screening note
85857-1,Procedure note
85858-9,Note
85859-7,Letter
8586-0,Intravascular mean
85860-5,History and physical note
85861-3,Note
85862-1,Note
85863-9,Note
85864-7,Note
85865-4,Diagnostic study note
85866-2,Consultation note
85867-0,History and physical note
85868-8,Group counseling note
85869-6,Education note
85870-4,Note
85871-2,Consultation note
85872-0,Restraint note
85873-8,Restraint note
85874-6,Note
85875-3,Discharge summary note
85876-1,Note
85877-9,Initial evaluation note
Aug-87,Intravascular mean
85878-7,Discharge summary note
85879-5,Restraint note
85880-3,Restraint note
85881-1,Note
85882-9,Consultation note
85883-7,Note
85884-5,Consultation note
Jun-88,Intravascular mean
85886-0,Consultation note
85887-8,Postoperative evaluation and management note
85888-6,Note
85889-4,Note
85890-2,Consultation note
85891-0,Note
85892-8,Note
85893-6,Adverse event note
Apr-89,Intravascular mean
85894-4,Counseling note
85895-1,Diagnostic study note
85896-9,Diagnostic study note
85898-5,Diagnostic study note
85899-3,Consultation note
85900-9,Note
85901-7,Note
Feb-90,Intravascular mean
85902-5,Note
85903-3,Note
85904-1,Cancer pathology panel
85905-8,Cancer pathology panel
85906-6,Home health patient tracking sheet - resumption of care
85907-4,Outcome and assessment information set (OASIS) form - version C2 - Start of care
85908-2,Home health patient tracking sheet - start of care
85909-0,OASIS C2 - Patient history and diagnoses - start of care or resumption of care
8591-0,Intravascular mean
85910-8,Physical findings
85911-6,"Diagnoses, symptom control, and optional diagnoses"
85912-4,Primary diagnosis
85913-2,Other diagnoses
85914-0,Underlying resolved condition ICD code
85915-7,Episode of care includes influenza vaccination season
85916-5,Pneumococcal vaccination received
85917-3,OASIS C2 - Integumentary status - start of care or resumption of care
85918-1,Unhealed pressure injury at stage 2 or higher or designated as unstageable
85919-9,OASIS C2 - Current number of unhealed pressure injuries at each stage - start of care or resumption of care
85920-7,Symptom control rating
85921-5,OASIS C2 - Respiratory status - start of care or resumption of care
85922-3,OASIS C2 - Elimination status - start of care or resumption of care
85923-1,OASIS C2 - ADL and IADLs - start of care or resumption of care
85924-9,OASIS C2 - Functional abilities and goals - start of care or resumption of care
85925-6,OASIS C2 - Mobility
85926-4,Lying to sitting on side of bed - functional ability
85927-2,Lying to sitting on side of bed - functional goal
Aug-92,V wave amplitude
85928-0,OASIS C2 - Medications - start of care or resumption of care
85929-8,Salivary gland swelling duration
85930-6,Date specimen sent to CDC
85931-4,Date of salivary gland swelling onset
85932-2,Date of cough onset
85933-0,Cough duration
85934-8,Age at cough onset
85935-5,Education note
Jun-93,V wave amplitude
85936-3,Risk assessment and screening note
85937-1,Note
85938-9,Postoperative evaluation and management note
85939-7,Preoperative evaluation and management note
85940-5,Postoperative evaluation and management note
85941-3,Postoperative evaluation and management note
85942-1,Preoperative evaluation and management note
85943-9,Postoperative evaluation and management note
Apr-94,V wave amplitude
85944-7,Preoperative evaluation and management note
85945-4,Postoperative evaluation and management note
85946-2,Preoperative evaluation and management note
85947-0,Preoperative evaluation and management note
85948-8,Preoperative evaluation and management note
85949-6,Age at rash onset
85950-4,Living situation and availability of assistance
Jan-95,V wave amplitude
85951-2,Living Arrangements
85952-0,Streptococcus pneumoniae Danish serotype 1 Ab
85953-8,Streptococcus pneumoniae Danish serotype 1 Ab
85954-6,Streptococcus pneumoniae Danish serotype 1 Ab.IgG
85955-3,Streptococcus pneumoniae Danish serotype 1 Ab.IgG
85956-1,Streptococcus pneumoniae Danish serotype 1 Ab.IgG
85957-9,Streptococcus pneumoniae Danish serotype 1 Ab.IgG
85958-7,Streptococcus pneumoniae Danish serotype 1 Ab.IgG^1st specimen
85959-5,Streptococcus pneumoniae Danish serotype 1 Ab.IgG^1st specimen
85960-3,Streptococcus pneumoniae Danish serotype 1 Ab.IgG^1st specimen
85961-1,Streptococcus pneumoniae Danish serotype 1 Ab.IgG^2nd specimen
85962-9,Streptococcus pneumoniae Danish serotype 1 Ab.IgG^2nd specimen
85963-7,Streptococcus pneumoniae Danish serotype 1 Ab.IgG^2nd specimen
85964-5,Streptococcus pneumoniae Danish serotype 1 Ab.IgG^2nd specimen/1st specimen
85965-2,Streptococcus pneumoniae Danish serotype 1 Ab^1st specimen
85966-0,Streptococcus pneumoniae Danish serotype 1 Ab^1st specimen
85967-8,Streptococcus pneumoniae Danish serotype 1 Ab^1st specimen
85968-6,Streptococcus pneumoniae Danish serotype 1 Ab^2nd specimen
Sep-96,V wave amplitude
85969-4,Streptococcus pneumoniae Danish serotype 1 Ab^2nd specimen
85970-2,Streptococcus pneumoniae Danish serotype 1 Ab^2nd specimen
85971-0,Streptococcus pneumoniae Danish serotype 12F Ab
85972-8,Streptococcus pneumoniae Danish serotype 12F Ab
85973-6,Streptococcus pneumoniae Danish serotype 12F Ab
85974-4,Streptococcus pneumoniae Danish serotype 12F Ab.IgG
85975-1,Streptococcus pneumoniae Danish serotype 12F Ab.IgG
85976-9,Streptococcus pneumoniae Danish serotype 12F Ab.IgG
Jul-97,V wave amplitude
85977-7,Streptococcus pneumoniae Danish serotype 12F Ab.IgG
85978-5,Streptococcus pneumoniae Danish serotype 12F Ab.IgG^1st specimen
85979-3,Streptococcus pneumoniae Danish serotype 12F Ab.IgG^1st specimen
85980-1,Streptococcus pneumoniae Danish serotype 12F Ab.IgG^1st specimen
85981-9,Streptococcus pneumoniae Danish serotype 12F Ab.IgG^2nd specimen
85982-7,Streptococcus pneumoniae Danish serotype 12F Ab.IgG^2nd specimen
85983-5,Streptococcus pneumoniae Danish serotype 12F Ab.IgG^2nd specimen
85984-3,Streptococcus pneumoniae Danish serotype 12F Ab^1st specimen
May-98,Comparison.study
85985-0,Streptococcus pneumoniae Danish serotype 12F Ab^1st specimen
85986-8,Streptococcus pneumoniae Danish serotype 12F Ab^2nd specimen
85987-6,Streptococcus pneumoniae Danish serotype 12F Ab^2nd specimen
85988-4,Streptococcus pneumoniae Danish serotype 12F Ab^2nd specimen/1st specimen
85989-2,Streptococcus pneumoniae Danish serotype 14 Ab
859-9,A2 B Ab
85990-0,Streptococcus pneumoniae Danish serotype 14 Ab
85991-8,Streptococcus pneumoniae Danish serotype 14 Ab.IgG
85992-6,Streptococcus pneumoniae Danish serotype 14 Ab.IgG
Mar-99,Comparison.study
85993-4,Streptococcus pneumoniae Danish serotype 14 Ab.IgG
85994-2,Streptococcus pneumoniae Danish serotype 14 Ab.IgG
85995-9,Streptococcus pneumoniae Danish serotype 14 Ab.IgG^1st specimen
85996-7,Streptococcus pneumoniae Danish serotype 14 Ab.IgG^1st specimen
85997-5,Streptococcus pneumoniae Danish serotype 14 Ab.IgG^1st specimen
85998-3,Streptococcus pneumoniae Danish serotype 14 Ab.IgG^2nd specimen
85999-1,Streptococcus pneumoniae Danish serotype 14 Ab.IgG^2nd specimen
86000-7,Streptococcus pneumoniae Danish serotype 14 Ab.IgG^2nd specimen
86001-5,Streptococcus pneumoniae Danish serotype 14 Ab^1st specimen
86002-3,Streptococcus pneumoniae Danish serotype 14 Ab^1st specimen
86003-1,Streptococcus pneumoniae Danish serotype 14 Ab^1st specimen
86004-9,Streptococcus pneumoniae Danish serotype 14 Ab^2nd specimen
86005-6,Streptococcus pneumoniae Danish serotype 14 Ab^2nd specimen
86006-4,Streptococcus pneumoniae Danish serotype 14 Ab^2nd specimen
86007-2,Streptococcus pneumoniae Danish serotype 14 Ab^2nd specimen/1st specimen
86008-0,Streptococcus pneumoniae Danish serotype 14 Ab^2nd specimen/1st specimen
Sep-00,Class
86009-8,Streptococcus pneumoniae Danish serotype 17F Ab.IgG
86010-6,Streptococcus pneumoniae Danish serotype 17F Ab.IgG
86011-4,Streptococcus pneumoniae Danish serotype 17F Ab.IgG^1st specimen
86012-2,Streptococcus pneumoniae Danish serotype 17F Ab.IgG^1st specimen
86013-0,Streptococcus pneumoniae Danish serotype 17F Ab.IgG^2nd specimen
86014-8,Streptococcus pneumoniae Danish serotype 17F Ab.IgG^2nd specimen
86015-5,Streptococcus pneumoniae Danish serotype 17F Ab.IgG^2nd specimen/1st specimen
86016-3,Streptococcus pneumoniae Danish serotype 18F Ab.IgG
Jul-01,EKG impression
86017-1,Streptococcus pneumoniae Danish serotype 18F Ab.IgG
86018-9,Streptococcus pneumoniae Danish serotype 18F Ab^1st specimen
86019-7,Streptococcus pneumoniae Danish serotype 19F Ab
86020-5,Streptococcus pneumoniae Danish serotype 19F Ab
86021-3,Streptococcus pneumoniae Danish serotype 19F Ab.IgG
86022-1,Streptococcus pneumoniae Danish serotype 19F Ab.IgG
86023-9,Streptococcus pneumoniae Danish serotype 19F Ab.IgG
86024-7,Streptococcus pneumoniae Danish serotype 19F Ab.IgG
May-02,Vendor model number
86025-4,Streptococcus pneumoniae Danish serotype 19F Ab.IgG^1st specimen
86026-2,Streptococcus pneumoniae Danish serotype 19F Ab.IgG^1st specimen
86027-0,Streptococcus pneumoniae Danish serotype 19F Ab.IgG^1st specimen
86028-8,Streptococcus pneumoniae Danish serotype 19F Ab.IgG^2nd specimen
86029-6,Streptococcus pneumoniae Danish serotype 19F Ab.IgG^2nd specimen
86030-4,Streptococcus pneumoniae Danish serotype 19F Ab.IgG^2nd specimen
86031-2,Streptococcus pneumoniae Danish serotype 19F Ab.IgG^2nd specimen/1st specimen
86032-0,Streptococcus pneumoniae Danish serotype 19F Ab^1st specimen
Mar-03,Vendor serial number
86033-8,Streptococcus pneumoniae Danish serotype 19F Ab^1st specimen
86034-6,Streptococcus pneumoniae Danish serotype 19F Ab^1st specimen
86035-3,Streptococcus pneumoniae Danish serotype 19F Ab^2nd specimen
86036-1,Streptococcus pneumoniae Danish serotype 19F Ab^2nd specimen
86037-9,Streptococcus pneumoniae Danish serotype 19F Ab^2nd specimen
86038-7,Streptococcus pneumoniae Danish serotype 2 Ab.IgG
86039-5,Streptococcus pneumoniae Danish serotype 2 Ab.IgG
86040-3,Streptococcus pneumoniae Danish serotype 2 Ab.IgG^1st specimen
Jan-04,Class
86041-1,Streptococcus pneumoniae Danish serotype 2 Ab.IgG^1st specimen
86042-9,Streptococcus pneumoniae Danish serotype 2 Ab.IgG^2nd specimen
86043-7,Streptococcus pneumoniae Danish serotype 2 Ab.IgG^2nd specimen
86044-5,Streptococcus pneumoniae Danish serotype 2 Ab.IgG^2nd specimen/1st specimen
86045-2,Streptococcus pneumoniae Danish serotype 20A Ab.IgG
86046-0,Streptococcus pneumoniae Danish serotype 20A Ab.IgG
86047-8,Streptococcus pneumoniae Danish serotype 20A Ab.IgG^1st specimen
86048-6,Streptococcus pneumoniae Danish serotype 20A Ab.IgG^1st specimen
86049-4,Streptococcus pneumoniae Danish serotype 20A Ab.IgG^2nd specimen
86050-2,Streptococcus pneumoniae Danish serotype 20A Ab.IgG^2nd specimen
86051-0,Streptococcus pneumoniae Danish serotype 20A Ab.IgG^2nd specimen/1st specimen
86052-8,Streptococcus pneumoniae Danish serotype 22F Ab.IgG
86053-6,Streptococcus pneumoniae Danish serotype 22F Ab.IgG
86054-4,Streptococcus pneumoniae Danish serotype 22F Ab.IgG^1st specimen
86055-1,Streptococcus pneumoniae Danish serotype 22F Ab.IgG^1st specimen
86056-9,Streptococcus pneumoniae Danish serotype 22F Ab.IgG^2nd specimen
86057-7,Streptococcus pneumoniae Danish serotype 22F Ab.IgG^2nd specimen
Aug-05,Class
86058-5,Streptococcus pneumoniae Danish serotype 22F Ab.IgG^2nd specimen/1st specimen
86059-3,Streptococcus pneumoniae Danish serotype 23F Ab
86060-1,Streptococcus pneumoniae Danish serotype 23F Ab
86061-9,Streptococcus pneumoniae Danish serotype 23F Ab.IgG
86062-7,Streptococcus pneumoniae Danish serotype 23F Ab.IgG
86063-5,Streptococcus pneumoniae Danish serotype 23F Ab.IgG
86064-3,Streptococcus pneumoniae Danish serotype 23F Ab.IgG
86065-0,Streptococcus pneumoniae Danish serotype 23F Ab.IgG^1st specimen
Jun-06,Study duration
86066-8,Streptococcus pneumoniae Danish serotype 23F Ab.IgG^1st specimen
86067-6,Streptococcus pneumoniae Danish serotype 23F Ab.IgG^1st specimen
86068-4,Streptococcus pneumoniae Danish serotype 23F Ab.IgG^2nd specimen
86069-2,Streptococcus pneumoniae Danish serotype 23F Ab.IgG^2nd specimen
860-7,A2 B Ag
86070-0,Streptococcus pneumoniae Danish serotype 23F Ab.IgG^2nd specimen
86071-8,Streptococcus pneumoniae Danish serotype 23F Ab.IgG^2nd specimen/1st specimen
86072-6,Streptococcus pneumoniae Danish serotype 23F Ab^1st specimen
86073-4,Streptococcus pneumoniae Danish serotype 23F Ab^1st specimen
Apr-07,Axis
86074-2,Streptococcus pneumoniae Danish serotype 23F Ab^1st specimen
86075-9,Streptococcus pneumoniae Danish serotype 23F Ab^2nd specimen
86076-7,Streptococcus pneumoniae Danish serotype 23F Ab^2nd specimen
86077-5,Streptococcus pneumoniae Danish serotype 23F Ab^2nd specimen
86078-3,Streptococcus pneumoniae Danish serotype 3 Ab
86079-1,Streptococcus pneumoniae Danish serotype 3 Ab
86080-9,Streptococcus pneumoniae Danish serotype 3 Ab.IgG
86081-7,Streptococcus pneumoniae Danish serotype 3 Ab.IgG
Feb-08,Conduction
86082-5,Streptococcus pneumoniae Danish serotype 3 Ab.IgG
86083-3,Streptococcus pneumoniae Danish serotype 3 Ab.IgG
86084-1,Streptococcus pneumoniae Danish serotype 3 Ab.IgG^1st specimen
86085-8,Streptococcus pneumoniae Danish serotype 3 Ab.IgG^1st specimen
86086-6,Streptococcus pneumoniae Danish serotype 3 Ab.IgG^1st specimen
86087-4,Streptococcus pneumoniae Danish serotype 3 Ab.IgG^2nd specimen
86088-2,Streptococcus pneumoniae Danish serotype 3 Ab.IgG^2nd specimen
86089-0,Streptococcus pneumoniae Danish serotype 3 Ab.IgG^2nd specimen
8609-0,Hypertrophy
86090-8,Streptococcus pneumoniae Danish serotype 3 Ab.IgG^2nd specimen/1st specimen
86091-6,Streptococcus pneumoniae Danish serotype 3 Ab^1st specimen
86092-4,Streptococcus pneumoniae Danish serotype 3 Ab^1st specimen
86093-2,Streptococcus pneumoniae Danish serotype 3 Ab^1st specimen
86094-0,Streptococcus pneumoniae Danish serotype 3 Ab^2nd specimen
86095-7,Streptococcus pneumoniae Danish serotype 3 Ab^2nd specimen
86096-5,Streptococcus pneumoniae Danish serotype 3 Ab^2nd specimen
86097-3,Streptococcus pneumoniae Danish serotype 3 Ab^2nd specimen/1st specimen
86098-1,Streptococcus pneumoniae Danish serotype 10A Ab.IgG
86099-9,Streptococcus pneumoniae Danish serotype 10A Ab.IgG
86100-5,Streptococcus pneumoniae Danish serotype 10A Ab.IgG^1st specimen
86101-3,Streptococcus pneumoniae Danish serotype 10A Ab.IgG^1st specimen
86102-1,Streptococcus pneumoniae Danish serotype 10A Ab.IgG^2nd specimen
86103-9,Streptococcus pneumoniae Danish serotype 10A Ab.IgG^2nd specimen
86104-7,Streptococcus pneumoniae Danish serotype 10A Ab.IgG^2nd specimen/1st specimen
86105-4,Streptococcus pneumoniae Danish serotype 4 Ab
86106-2,Streptococcus pneumoniae Danish serotype 4 Ab
86107-0,Streptococcus pneumoniae Danish serotype 4 Ab.IgG
Aug-10,Myocardial ischemia
86108-8,Streptococcus pneumoniae Danish serotype 4 Ab.IgG
86109-6,Streptococcus pneumoniae Danish serotype 4 Ab.IgG
86110-4,Streptococcus pneumoniae Danish serotype 4 Ab.IgG
86111-2,Streptococcus pneumoniae Danish serotype 4 Ab.IgG^1st specimen
86112-0,Streptococcus pneumoniae Danish serotype 4 Ab.IgG^1st specimen
86113-8,Streptococcus pneumoniae Danish serotype 4 Ab.IgG^1st specimen
86114-6,Streptococcus pneumoniae Danish serotype 4 Ab.IgG^2nd specimen
86115-3,Streptococcus pneumoniae Danish serotype 4 Ab.IgG^2nd specimen
Jun-11,Myocardial infarction age
86116-1,Streptococcus pneumoniae Danish serotype 4 Ab.IgG^2nd specimen
86117-9,Streptococcus pneumoniae Danish serotype 4 Ab.IgG^2nd specimen/1st specimen
86118-7,Streptococcus pneumoniae Danish serotype 4 Ab^1st specimen
86119-5,Streptococcus pneumoniae Danish serotype 4 Ab^1st specimen
86120-3,Streptococcus pneumoniae Danish serotype 4 Ab^2nd specimen
86121-1,Streptococcus pneumoniae Danish serotype 4 Ab^2nd specimen
86122-9,Streptococcus pneumoniae Danish serotype 11A Ab.IgG
86123-7,Streptococcus pneumoniae Danish serotype 11A Ab.IgG
Apr-12,Study observation.overall
86124-5,Streptococcus pneumoniae Danish serotype 11A Ab.IgG^1st specimen
86125-2,Streptococcus pneumoniae Danish serotype 11A Ab.IgG^1st specimen
86126-0,Streptococcus pneumoniae Danish serotype 11A Ab.IgG^2nd specimen
86127-8,Streptococcus pneumoniae Danish serotype 11A Ab.IgG^2nd specimen
86128-6,Streptococcus pneumoniae Danish serotype 11A Ab.IgG^2nd specimen/1st specimen
86129-4,Streptococcus pneumoniae Danish serotype 5 Ab.IgG
86130-2,Streptococcus pneumoniae Danish serotype 5 Ab.IgG
86131-0,Streptococcus pneumoniae Danish serotype 5 Ab.IgG^1st specimen
Feb-13,Cardiac pacemaker prosthetic
86132-8,Streptococcus pneumoniae Danish serotype 5 Ab.IgG^1st specimen
86133-6,Streptococcus pneumoniae Danish serotype 5 Ab.IgG^2nd specimen
86134-4,Streptococcus pneumoniae Danish serotype 5 Ab.IgG^2nd specimen
86135-1,Streptococcus pneumoniae Danish serotype 5 Ab.IgG^2nd specimen/1st specimen
86136-9,Streptococcus pneumoniae Danish serotype 6A Ab.IgG
86137-7,Streptococcus pneumoniae Danish serotype 6A Ab.IgG
86138-5,Streptococcus pneumoniae Danish serotype 6A Ab.IgG
86139-3,Streptococcus pneumoniae Danish serotype 6A Ab^2nd specimen
8614-0,Pauses
86140-1,Streptococcus pneumoniae Danish serotype 6A Ab^2nd specimen
86141-9,Streptococcus pneumoniae Danish serotype 7A Ab.IgG
86142-7,Streptococcus pneumoniae Danish serotype 7A Ab.IgG
86143-5,Streptococcus pneumoniae Danish serotype 8 Ab
86144-3,Streptococcus pneumoniae Danish serotype 8 Ab
86145-0,Streptococcus pneumoniae Danish serotype 8 Ab
86146-8,Streptococcus pneumoniae Danish serotype 8 Ab
86147-6,Streptococcus pneumoniae Danish serotype 8 Ab.IgG
86148-4,Streptococcus pneumoniae Danish serotype 8 Ab.IgG
86149-2,Streptococcus pneumoniae Danish serotype 8 Ab.IgG
861-5,A2 B Ag
86150-0,Streptococcus pneumoniae Danish serotype 8 Ab.IgG
86151-8,Streptococcus pneumoniae Danish serotype 8 Ab.IgG^1st specimen
86152-6,Streptococcus pneumoniae Danish serotype 8 Ab.IgG^1st specimen
86153-4,Streptococcus pneumoniae Danish serotype 8 Ab.IgG^1st specimen
86154-2,Streptococcus pneumoniae Danish serotype 8 Ab.IgG^2nd specimen
86155-9,Streptococcus pneumoniae Danish serotype 8 Ab.IgG^2nd specimen
86156-7,Streptococcus pneumoniae Danish serotype 8 Ab.IgG^2nd specimen
Jul-15,Premature atrial contractions
86157-5,Streptococcus pneumoniae Danish serotype 8 Ab.IgG^2nd specimen/1st specimen
86158-3,Streptococcus pneumoniae Danish serotype 8 Ab^1st specimen
86159-1,Streptococcus pneumoniae Danish serotype 8 Ab^1st specimen
86160-9,Streptococcus pneumoniae Danish serotype 8 Ab^2nd specimen
86161-7,Streptococcus pneumoniae Danish serotype 8 Ab^2nd specimen
86162-5,Streptococcus pneumoniae Danish serotype 9N Ab
86163-3,Streptococcus pneumoniae Danish serotype 9N Ab
86164-1,Streptococcus pneumoniae Danish serotype 9N Ab
May-16,Premature ventricular contractions
86165-8,Streptococcus pneumoniae Danish serotype 9N Ab
86166-6,Streptococcus pneumoniae Danish serotype 9N Ab.IgG
86167-4,Streptococcus pneumoniae Danish serotype 9N Ab.IgG
86168-2,Streptococcus pneumoniae Danish serotype 9N Ab.IgG
86169-0,Streptococcus pneumoniae Danish serotype 9N Ab.IgG
86170-8,Streptococcus pneumoniae Danish serotype 9N Ab.IgG^1st specimen
86171-6,Streptococcus pneumoniae Danish serotype 9N Ab.IgG^1st specimen
86172-4,Streptococcus pneumoniae Danish serotype 9N Ab.IgG^1st specimen
Mar-17,QRS complex
86173-2,Streptococcus pneumoniae Danish serotype 9N Ab.IgG^2nd specimen
86174-0,Streptococcus pneumoniae Danish serotype 9N Ab.IgG^2nd specimen
86175-7,Streptococcus pneumoniae Danish serotype 9N Ab.IgG^2nd specimen
86176-5,Streptococcus pneumoniae Danish serotype 9N Ab.IgG^2nd specimen/1st specimen
86177-3,Streptococcus pneumoniae Danish serotype 9N Ab^1st specimen
86178-1,Streptococcus pneumoniae Danish serotype 9N Ab^1st specimen
86179-9,Streptococcus pneumoniae Danish serotype 9N Ab^1st specimen
86180-7,Streptococcus pneumoniae Danish serotype 9N Ab^1st specimen/2nd specimen
Jan-18,Recording duration
86181-5,Streptococcus pneumoniae Danish serotype 9N Ab^1st specimen/2nd specimen
86182-3,Streptococcus pneumoniae Danish serotype 9N Ab^2nd specimen
86183-1,Streptococcus pneumoniae Danish serotype 9N Ab^2nd specimen
86184-9,Streptococcus pneumoniae Danish serotype 9N Ab^2nd specimen
86185-6,Prior functioning.ambulation
86186-4,Prior functioning.transfer
86187-2,Prior functioning.household tasks
86188-0,Occupation industry
86189-8,Outcome and assessment information set (OASIS) form - version C2 - Resumption of care
86190-6,Zika virus RNA
86191-4,Eutylone
86192-2,4-Methylethcathinone
86193-0,Pentedrone
86194-8,"3,4-Dimethylmethcathinone"
86195-5,4-Ethylmethcathinone
86196-3,Alpha pyrrolidinovalerophenone
86197-1,Pentylone
86198-9,Neisseria meningitidis serogroup Y synF gene
Sep-19,Rhythm segment
86199-7,Rotavirus A Ag
86200-3,Porcine epidemic diarrhea virus
86201-1,Porcine epidemic diarrhea virus gene sequence & phylogenetic analysis
86202-9,Porcine epidemic diarrhea virus
86203-7,Lawsonia intracellularis Ag
86204-5,Porcine deltacoronavirus
86205-2,Whole exome sequence analysis
86206-0,Whole genome sequence analysis
Jul-20,ST-T segment
86207-8,Porcine epidemic diarrhea virus Ab.IgG
86208-6,Note
86209-4,Note
86210-2,Medical clearance note
86211-0,Note
86212-8,Note
86213-6,Medical clearance note
86214-4,Annual evaluation note
May-21,Ventricular ectopics
86215-1,Disease staging note
86216-9,Porcine epidemic diarrhea virus Ab.Neut
86217-7,Rotavirus A VP6 capsid protein
86218-5,Transmissible gastroenteritis virus RNA
86219-3,Porcine epidemic diarrhea virus Ab.IgG
86220-1,Bacterial carbapenem resistance blaOXA-48 gene
86221-9,Bacterial colistin resistance mcr-1 gene
86222-7,Lipoprotein.alpha 3
Mar-22,Ventricular morphology
86223-5,Acetyl norfentanyl
86224-3,ALPRAZolam/Creatinine
86225-0,clonazePAM/Creatinine
86226-8,Codeine
86227-6,Dihydrocodeine
86228-4,Ethyl sulfate
86229-2,HYDROcodone
862-3,A2 B Ag
86230-0,HYDROmorphone
86231-8,Midazolam/Creatinine
86232-6,Norsufentanil
86233-4,HIV 1 Ab
86234-2,Neisseria meningitidis serogroup A sacB gene
86235-9,Neisseria meningitidis serogroup B synD gene
86236-7,Neisseria meningitidis serogroup C synE gene
86237-5,Neisseria meningitidis serogroup w135 synG gene
86238-3,Neisseria meningitidis serogroup X xcbB gene
86239-1,Cells.chromosome 3 monosomy/cells counted
86240-9,Aquaporin 4 water channel Ab.IgG
86241-7,Aquaporin 4 water channel Ab.IgG
86242-5,Color
86243-3,Color
86244-1,Outcome and assessment information set (OASIS) form - version C2 - Follow-up - recertification or other follow-up
86245-8,OASIS E - Administrative Information - FU
86246-6,OASIS C2 - Patient history and diagnoses - follow-up
86247-4,Sensory status - follow-up
86248-2,OASIS C2 - Integumentary status - follow-up
Sep-24,PP interval
86249-0,"OASIS C2, D - Respiratory status - follow-up or discharge"
86250-8,"OASIS C2, D - Elimination status - follow-up"
86251-6,"OASIS C2, D - ADL and IADLs - follow-up"
86252-4,"OASIS C2, D - Medications - follow-up"
86253-2,Therapy need and plan of care - follow-up
86254-0,Underlying resolved condition.multiple coding ICD code
86255-7,Primary diagnosis ICD code
Jun-25,PR interval
86256-5,Patient history and diagnoses - transfer or discharge from agency
86257-3,Clinical record items - transfer or discharge
86258-1,"OASIS C2, D - Medications - transfer to inpatient facility"
86259-9,Outcome and assessment information set (OASIS) form - version C2 - Transfer to inpatient facility - patient discharged or not discharged
86260-7,Data items collected at inpatient facility admission or agency discharge only - transfer
86261-5,Outcome and assessment information set (OASIS) form - version C2 - Discharged from agency - death at home
86262-3,OASIS E - Medications - TRN
86263-1,Data items collected at inpatient facility admission or agency discharge only - discharge from agency - death at home
Apr-26,P wave axis
86264-9,Outcome and assessment information set (OASIS) form - version C2 - Discharged from agency
86265-6,OASIS C2 - Medications - discharge from agency
86266-4,Sensory status - discharge from agency
86267-2,OASIS C2 - Integumentary status - discharge from agency
86268-0,Worsening in pressure injury status since start or resumption of home care
86269-8,OASIS C2 - Elimination status - discharge from agency
86270-6,Current number of unhealed pressure injuries at each stage - follow-up or discharge
86271-4,Transferrin.gastrointestinal
Feb-27,P wave duration
86272-2,Retinal nerve fiber layer.nasal inferior thickness
86273-0,Retinal nerve fiber layer.temporal thickness
86274-8,Retinal nerve fiber layer.temporal superior thickness
86275-5,Retinal nerve fiber layer.temporal superior thickness
86276-3,Retinal nerve fiber layer.superior thickness
86277-1,Retinal nerve fiber layer.superior thickness
86278-9,Retinal nerve fiber layer.temporal thickness
86279-7,Retinal nerve fiber layer.nasal thickness
8628-0,Pacing interval
86280-5,Retinal nerve fiber layer.nasal superior thickness
86281-3,Retinal nerve fiber layer.nasal superior thickness
86282-1,Retinal nerve fiber layer.nasal inferior thickness
86283-9,Retinal nerve fiber layer.inferior thickness
86284-7,Retinal nerve fiber layer.nasal thickness
86285-4,Erythrocyte deformability
86286-2,Retinal nerve fiber layer.clock hour 9 thickness
86287-0,Retinal nerve fiber layer.inferior temporal thickness
86288-8,Retinal nerve fiber layer.inferior thickness
86289-6,Retinal nerve fiber layer.inferior temporal thickness
86290-4,Retinal nerve fiber layer.mean thickness
86291-2,Retinal nerve fiber layer panel
86292-0,Retinal nerve fiber layer.clock hour 12 thickness
86293-8,Retinal nerve fiber layer.clock hour 1 thickness
86294-6,Retinal nerve fiber layer.clock hour 2 thickness
86295-3,Retinal nerve fiber layer.clock hour 3 thickness
86296-1,Retinal nerve fiber layer.clock hour 4 thickness
86297-9,Retinal nerve fiber layer.clock hour 5 thickness
Aug-29,Q wave depth
86298-7,Retinal nerve fiber layer.clock hour 6 thickness
86299-5,Retinal nerve fiber layer.clock hour 7 thickness
86300-1,Retinal nerve fiber layer.clock hour 8 thickness
86301-9,Retinal nerve fiber layer.mean thickness
86302-7,Retinal nerve fiber layer.clock hour 10 thickness
86303-5,Retinal nerve fiber layer.clock hour 11 thickness
86304-3,Retinal nerve fiber layer.clock hour 12 thickness
86305-0,Retinal nerve fiber layer.clock hour 1 thickness
Jun-30,Q wave depth.lead
86306-8,Retinal nerve fiber layer.clock hour 2 thickness
86307-6,Retinal nerve fiber layer.clock hour 3 thickness
86308-4,Retinal nerve fiber layer.clock hour 4 thickness
86309-2,Retinal nerve fiber layer.clock hour 5 thickness
863-1,A3 Ab
86310-0,Retinal nerve fiber layer.clock hour 6 thickness
86311-8,Retinal nerve fiber layer.clock hour 7 thickness
86312-6,Retinal nerve fiber layer.clock hour 8 thickness
86313-4,Retinal nerve fiber layer.clock hour 9 thickness
Apr-31,Q wave duration
86314-2,Retinal nerve fiber layer.clock hour 10 thickness
86315-9,Retinal nerve fiber layer.clock hour 11 thickness
86316-7,Human RNase P RNA
86317-5,Influenza virus A H1 2009 pandemic RNA
86318-3,Influenza Virus B Yamagata lineage Ag
86319-1,Staphylococcus aureus
86320-9,Zika virus Ab.Neut
86321-7,Zika virus Ab.Neut
Feb-32,QRS axis
86322-5,Enterovirus
86323-3,Enterovirus Ag
86324-1,Coliform bacteria
86325-8,Bordetella pertussis+parapertussis ptxS1 gene
86326-6,Bordetella holmesii hIS1001 DNA
86327-4,Bordetella parapertussis IS1001 DNA
86328-2,Adenovirus 21 DNA
86329-0,Adenovirus 16 DNA
8633-0,QRS duration
86330-8,Adenovirus 11 DNA
86331-6,Adenovirus 14 DNA
86332-4,Adenovirus 7 DNA
86333-2,Adenovirus 4 DNA
86334-0,Adenovirus 3 DNA
86335-7,Total interval score change
86336-5,Total interval score change
86337-3,Virus identified
86338-1,Streptococcus pneumoniae Danish serotype 6A+6B Ab
86339-9,Streptococcus pneumoniae Danish serotype 6A+6B IgG Ab
86340-7,Streptococcus pneumoniae Danish serotype 6A+6B IgG Ab
86341-5,Streptococcus pneumoniae Danish serotype 6A+6B Ab^1st specimen
86342-3,Streptococcus pneumoniae Danish serotype 6A+6B Ab
86343-1,Streptococcus pneumoniae Danish serotype 6A+6B Ab^1st specimen
86345-6,U.S. standard certificate of death - recommended 2003 revision set
86346-4,U.S. standard report of fetal death - recommended 2003 revision set
86347-2,U.S. standard certificate of live birth - recommended 2003 revision set
Aug-34,QT interval
86348-0,Guidance for needle localization && Views
86349-8,Diagnostic mammogram & ultrasound panel
86350-6,View for clip placement
86351-4,Guidance additional for aspiration of cyst
86352-2,Guidance additional for aspiration of cyst
86353-0,Guidance for placement of clip
86354-8,Guidance for placement of clip
86355-5,Guidance additional for needle localization
86356-3,Guidance additional for needle localization
86357-1,Guidance for needle localization
86358-9,Guidance for needle localization
86359-7,Diagnostic mammogram & ultrasound panel
86360-5,Guidance for needle localization && Views
86361-3,Guidance additional for biopsy
86362-1,Guidance additional for biopsy
Mar-36,QTC interval
86363-9,Guidance additional for biopsy.vacuum
86364-7,Guidance additional for biopsy.vacuum
86365-4,Guidance for biopsy.vacuum
86366-2,Guidance for biopsy.vacuum
86367-0,Views diagnostic for clinical call back
86368-8,Views diagnostic for clinical call back
86369-6,Views diagnostic for clinical call back
86370-4,Views diagnostic for technical call back
Jan-37,RR interval
86371-2,Interpretation of outside study
86372-0,Views^W contrast IV
86373-8,Views^W contrast via additional puncture
86374-6,Views^W contrast intra lymphatic
86375-3,Views^W contrast intra lymphatic
86376-1,Views^W contrast via existing catheter
86377-9,Guidance for advancement of feeding tube
86378-7,Views for fistula
86379-5,Views for loop diversion
86380-3,Views for fistula
86381-1,Views screening^W air contrast PR+W barium contrast PR
86382-9,Views limited^during surgery
86383-7,Views^W contrast IV
86384-5,Views^post fatty meal+W contrast PO
86385-2,Views^W contrast PO
86386-0,Views^W barium contrast PO
86387-8,Views^W contrast antegrade
86388-6,Views^W contrast retrograde
Sep-38,T wave axis
86389-4,Views^during surgery W contrast retrograde
86390-2,Views^W contrast via nephrostomy tube
86391-0,Views^W contrast via existing catheter
86392-8,Views limited^W contrast IV
86393-6,Views^W contrast retrograde
86394-4,Views^W contrast IA
86395-1,Views for swallowing function^W speech+W barium contrast PO
86396-9,Views^W contrast IV
Jul-39,Pupillary distance.binocular
86397-7,Guidance for drainage+placement of suprapubic catheter
86398-5,Views^W contrast IT
86399-3,Views & Guidance for injection of non-vascular shunt
86400-9,Guidance for placement of needle
86401-7,Views^W contrast intra bladder
86402-5,Views limited^W contrast IS
86403-3,Guidance for placement of catheter
86404-1,Guidance for percutaneous aspiration of fluid
May-40,Diameter
86405-8,Guidance for exchange of tube
86406-6,Views^during surgery
86407-4,Guidance
86408-2,Views for urinary pouch
86409-0,Views for rectal dysfunction^W barium contrast PR
86410-8,Views^W barium contrast PO
86411-6,Views^W contrast IT
86412-4,Views^W contrast intra lymphatic
Mar-41,Pupil diameter
86413-2,Guidance for placement of long feeding tube
86414-0,Views^W contrast IA
86415-7,Views^W contrast IV
86416-5,Guidance for needle localization && Views
86417-3,Views^W contrast IA
86418-1,Views^W contrast IA
86419-9,Views^W contrast IA
86420-7,Views^W air contrast PO+W barium contrast PO
Jan-42,Diameter
86421-5,View && Views^W air contrast PO+W barium contrast PO
86422-3,View && Views^W water soluble contrast PO
86423-1,View && Views^W contrast PO
86424-9,View && Views^W barium contrast PO
86425-6,Guidance for manometry
86426-4,Views^W contrast IV
86427-2,Views^W air contrast PO+W barium contrast PO
86428-0,Views^W contrast IA
86429-8,Views^W contrast IA
86430-6,Views^W contrast IT
86431-4,Views^W contrast IA
86432-2,Views^W contrast IA
86433-0,Views^W contrast IA
86434-8,Views^W contrast IA
86435-5,Views^W contrast IV
86436-3,Guidance for treatment^W contrast intra fistula
86437-1,Views diagnostic^W contrast intra fistula
86438-9,Guidance for check of feeding tube
Sep-43,Pupil diameter
86439-7,Views^W contrast IV
86440-5,Views^W contrast intra seminal vesicle
86441-3,Guidance for manometry
86442-1,Views^W contrast IA
86443-9,Views^W contrast intra ureter
86444-7,Manufacturing establishment information
86445-4,Blanket no changes certification of product listing
86446-2,Blood establishment registration & product listing change in information
Jul-44,Visual acuity log mar
86447-0,Human cell and tissue establishment registration & product listing change in information
86448-8,Human salvaged drug
86449-6,Against medical advice note
86450-4,Preoperative evaluation and management note
86451-2,Consultation note
86452-0,Note
86453-8,O-nortramadol
Apr-45,Visual acuity log mar
86454-6,N-nortramadol
86455-3,Brucella sp Ab
86456-1,Brucella sp Ab
86457-9,Brucella sp Ab
86458-7,Brucella sp Ab
86459-5,Brucella sp Ab
86460-3,Views
86461-1,Views
Feb-46,Hospital admission Dx
86462-9,Multisection
86463-7,Multisection
86464-5,Guidance for repair of aneurysm or dissection
86465-2,AST to platelet ratio index
86466-0,Maestro of scalable information infrastructure
86467-8,Report comment
86468-6,Report comment section
86469-4,Conditions prior to medical or treatment regimen change or inpatient stay that took place within past 14D
8647-0,Hospital consultations
86470-2,Most recent inpatient discharge date in the last 14D
86471-0,Ostomy for bowel elimination in the last 14D
86472-8,Shortness of breath limited your ability to do what you wanted over the past 2W
86473-6,Dressing yourself was limited by heart failure over the past 2W
86474-4,Walking 1 block on level ground was limited by heart failure over the past 2W
86475-1,"Doing yardwork, housework or carrying groceries was limited by heart failure over the past 2W"
86476-9,Climbing a flight of stairs without stopping was limited by heart failure over the past 2W
86477-7,Hurrying or jogging (as if to catch a bus) was limited by heart failure over the past 2W
86478-5,Change in symptoms of heart failure compared with 2W ago
86479-3,"Swelling in your feet, ankles or legs when you woke up over the past 2W"
86480-1,"Bothered by swelling in your feet, ankles or legs over the past 2W"
86481-9,Fatigue limited your ability to do what you wanted over the past 2W
86482-7,Bothered by fatigue over the past 2W
86483-5,Showering or bathing was limited by heart failure over the past 2W
86484-3,Bothered by shortness of breath over the past 2W
86485-0,Sleep sitting up in a chair or with at least 3 pillows to prop you up because of shortness of breath over the past 2W
86486-8,"You know what to do, or whom to call, if your heart failure gets worse"
86487-6,Understand what things you are able to do to keep your heart failure symptoms from getting worse
Aug-48,Hospital course
86488-4,Enjoyment of life limited by heart failure over the past 2W
86489-2,How would you feel if you had to spend the rest of your life with your heart failure the way it is right now
864-9,A3 Ab
86490-0,Felt discouraged or down in the dumps because of heart failure over the past 2W
86491-8,"Participation in hobbies, recreational activities limited by heart failure over the past 2W"
86492-6,Participation in working or doing household chores limited by heart failure over the past 2W
86493-4,Participation in visiting family or friends out of your home limited by heart failure over the past 2W
86494-2,Participation in intimate relationships with loved ones limited by heart failure over the past 2W
86495-9,When anxious within the last 14D
Jun-49,Hospital discharge date
86502-2,Varicella zoster virus strain DNA
86503-0,Streptococcus pneumoniae serotype DNA
Apr-50,Hospital discharge disposition
86504-8,These questions three panel
86505-5,Quest
86506-3,Color.favorite
86507-1,Capital of Assyria
86508-9,Airspeed^unladen
86509-7,Varicella zoster virus clade
86510-5,Adenovirus DNA
86511-3,Adenovirus DNA
Feb-51,Hospital discharge Dx
86512-1,Adenovirus DNA
86513-9,Adenovirus Ab.IgM
86514-7,Chikungunya virus RNA
86515-4,Chikungunya virus RNA
86516-2,Coxsackievirus A Ab
86517-0,Cytomegalovirus Ag
86518-8,Ebola virus RNA
86519-6,European tick borne encephalitis virus RNA
8652-0,Hospital discharge history
86520-4,Hantavirus RNA
86521-2,Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.14.1
86522-0,MDS v3.0 - RAI v1.14.1 - Nursing home comprehensive (NC) item set
86523-8,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information"
86524-6,Type of assessment
86525-3,SNF Part A PPS discharge assessment
86526-1,Unit certification or licensure designation
86527-9,Conditions related to intellectual disability and developmental disability status
86528-7,Most recent admission &or entry or reentry into this facility
86529-5,MDS v3.0 - RAI v1.17.2 - Cognitive patterns
86530-3,Visit notification note
86531-1,Discharge notification note
86532-9,Admission notification note
86533-7,Living will
86534-5,Disease staging note
86535-2,Healthcare associated infection report - recommended CDA R3 set
86536-0,Hantavirus RNA
86537-8,Hantavirus RNA
Aug-53,Discharge instructions
86538-6,Hantavirus RNA
86539-4,Herpes simplex virus 1 DNA
86540-2,Herpes simplex virus 2 Ag
86541-0,Herpes simplex virus 2 DNA
86542-8,Herpes simplex virus DNA
86543-6,Herpes virus 6 DNA
86544-4,Herpes virus 7 DNA
86545-1,Herpes virus 8 DNA
Jun-54,Hospital discharge medications
86546-9,Herpes virus 8 DNA
86547-7,HIV 2 RNA
86548-5,HIV 2 RNA
86549-3,HIV 2 RNA
86550-1,HTLV I+II RNA
86551-9,Influenza vaccine cycle
86552-7,Staff who worked at facility at least one day from October 1 through March 31
Mar-55,Hospital discharge procedures
86553-5,Staff who received influenza vaccination at the facility
86554-3,Staff who provided documentation of influenza vaccine receipt
86555-0,Staff who had a medical contraindication to the influenza vaccine
86556-8,Staff who declined influenza vaccine
86557-6,Staff with unknown influenza vaccination status
86558-4,Healthcare personnel influenza vaccination summary report
86559-2,Human bocavirus DNA
865-6,A3 Ab
86560-0,Human papilloma virus 16 DNA
Jan-56,Hospital admission date
86561-8,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA
86562-6,Human papilloma virus 18 DNA
86563-4,Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA
86564-2,Human papilloma virus DNA
86565-9,Influenza virus A Ag
86566-7,Influenza virus A Ab.IgG
86567-5,Influenza virus A Ab.IgM
86568-3,Influenza virus A RNA
86569-1,Influenza virus A RNA
86570-9,Influenza virus B Ab.IgM
86571-7,Influenza virus B RNA
86572-5,Influenza virus B RNA
86573-3,JC virus DNA
86574-1,Marburg virus RNA
86575-8,Measles virus RNA
86576-6,Measles virus RNA
86577-4,Measles virus RNA
86578-2,Middle East respiratory syndrome coronavirus RNA
Sep-57,Hospital discharge physical findings
86579-0,Middle East respiratory syndrome coronavirus RNA
86580-8,Mumps virus RNA
86581-6,Neisseria meningitidis
86582-4,Parechovirus A RNA
86583-2,Memory &or recall ability in the last 7D
86584-0,Delirium
86585-7,"MDS v3.0 - RAI v1.17.2, OASIS E - Signs and symptoms of delirium (from CAM)"
86586-5,Parechovirus A RNA
Jul-58,Allergies
86587-3,Rabies virus Ab.IgG
86588-1,Rabies virus RNA
86589-9,Rubella virus RNA
86590-7,Streptococcus pneumoniae Ag
86591-5,Toscana virus RNA
86592-3,Varicella zoster virus Ag
86593-1,Varicella zoster virus DNA
86594-9,Zika virus RNA
May-59,Birth control method
86595-6,MDS v3.0 - RAI v1.16.1 - Staff assessment for mental status
86596-4,Behavior
86597-2,Potential indicators of psychosis
86598-0,Influenza season
86599-8,Staff assessment of daily and activity preferences
86600-4,Preferences for customary routine and activities
86601-2,Functional status
86602-0,Mobility devices normally used during assessment period
Mar-60,Symptoms & diseases
86603-8,Periodontal attachment - recommended CDA R1 set
86604-6,Alfentanil/Creatinine
86605-3,Alpha hydroxytriazolam/Creatinine
86606-1,Cocaethylene/Creatinine
86607-9,Cocaine/Creatinine
86608-7,Norcodeine/Creatinine
86609-5,Noroxymorphone/Creatinine
86610-3,SUFentanil/Creatinine
Jan-61,Chief complaint
86611-1,Chromosome analysis
86612-9,"MDS v3.0 - RAI v1.14.1, v1.15.1 - Functional abilities and goals - admission"
86613-7,"MDS v3.0 - RAI v1.14.1, v1.15.1 - Self-care - admission performance"
86614-5,"MDS v3.0 - RAI v1.14.1, v1.15.1 - Mobility - admission performance during 3D assessment period"
86615-2,"MDS v3.0 - RAI v1.14.1, v1.15.1 - Functional abilities and goals - discharge"
86616-0,"MDS v3.0 - RAI v1.14.1, v1.15.1 - Self-care - discharge performance"
86617-8,"MDS v3.0 - RAI v1.14.1, v1.15.1 - Mobility - discharge performance during 3D assessment period"
86618-6,"MDS v3.0 - RAI v1.14.1, v1.15.1 - Self-care - discharge goal"
86619-4,"MDS v3.0 - RAI v1.14.1, v1.15.1 - Mobility - discharge goal during 3D assessment period"
86620-2,Bacterial methicillin resistance mecA+mecC genes
86621-0,Bacterial methicillin resistance mecC gene
86622-8,Staphylococcus aureus methicillin resistance SCCmec & mecA+mecC genes panel
86623-6,MDS v3.0 - RAI v1.14.1 - Bladder and bowel
86624-4,Bladder and bowel appliances used
86625-1,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status"
86626-9,Send document that conforms to Level 3 EMS R2 template
86627-7,Send document that conforms to Oncology Treatment Plan Summary R1.3 template
86628-5,Send document that conforms to Oncology Treatment Plan Summary R1.2.1 template
Sep-62,Childhood diseases
86629-3,Send document that conforms to Oncology Treatment Plan Summary R1.2 template
86630-1,Send document that conforms to Level 3 EMS R1 template
86631-9,Pain panel
86632-7,Function and daily living panel
86633-5,Pain panel
86634-3,Function and daily living panel
86635-0,Family planning report
86636-8,Family planning report - FPAR 2.0 set
Jul-63,Cigarettes smoked.current (pack per day)
86637-6,Provider role
86638-4,Patient demographic & administrative information panel
86639-2,Household size
866-4,A3 Ag
86640-0,Limited English proficiency
86641-8,"Height, weight & blood pressure panel"
86642-6,Pregnancy and contraception panel
86643-4,Information source for pregnancy status
86644-2,Pregnancy lab tests - FPAR 2.0 set
May-64,Cigarettes smoked.total (pack per year)
86645-9,Pregnancy intention in the next Y
86646-7,Ever had sex
86647-5,Sexual activity in the last 3Mo
86648-3,Sexual activity in the last Y
86649-1,Birth control method^at intake
86650-9,Reason for no birth control use^at intake
86651-7,Birth control method^at exit
Feb-65,Date last menstrual period
86652-5,How birth control method was provided
86653-3,Reason for no birth control use^at exit
86654-1,Contraceptive counseling was provided
86655-8,Counseling to achieve pregnancy was provided
86656-6,Lab tests - FPAR 2.0 sets
86657-4,HIV 1 & 2 tests - FPAR 2.0 set
86658-2,HPV tests - FPAR 2.0 set
86659-0,Chlamydia sp tests - FPAR 2.0 set
8666-0,Symptoms & diseases
86660-8,Neisseria gonorrhoeae tests - FPAR 2.0 set
86661-6,Chlamydia trachomatis+Neisseria gonorrhoeae tests - FPAR 2.0 set
86662-4,Pap smear tests - FPAR 2.0 set
86663-2,HIV referral information panel
86664-0,Referral note
86666-5,Location within lymph node
86667-3,Level of tumor invasion
86668-1,Depth of deep margin involved by invasive melanoma
86669-9,Mitotic figures
86670-7,MDS v3.0 - RAI v1.17.2 - Active diagnoses - ND
86671-5,Active diagnoses
86672-3,Staff assessment for pain
86673-1,Indicators of pain or possible pain
86674-9,Other health conditions
86675-6,Shortness of breath
86676-4,Problem conditions
86677-2,Signs and symptoms of swallowing disorder
Aug-67,Symptoms & diseases
86678-0,Weight gain of 5% or more in the last month or gain of 10% or more in last 6Mo
86679-8,Percent intake by artificial route
86680-6,Proportion of total calories the resident received through parenteral or tube feeding in the 7D - while not a resident
86681-4,Proportion of total calories the resident received through parenteral or tube feeding in last 7D - while a resident
86682-2,Mean fluid intake per day by IV or tube feeding in last 7D - while not a resident
86683-0,Mean fluid intake per day by IV or tube feeding in last 7D - while a resident
86684-8,Mean fluid intake per day by IV or tube feeding during entire 7D
86685-5,Oral &or dental status
Jun-68,Symptoms & diseases
86686-3,"MDS v3.0 - RAI v1.14.1, v1.15.1 - Health conditions"
86687-1,Proportion of total calories the resident received through parenteral or tube feeding during entire 7D
86688-9,Rotavirus C
86689-7,Rotavirus A
86690-5,Rotavirus C RNA
86691-3,Rotavirus B RNA
86692-1,Rotavirus A RNA
86693-9,Porcine epidemic diarrhea virus Ab.IgA/Positive control
Apr-69,Symptoms & diseases
86694-7,Porcine epidemic diarrhea virus Ab.IgG/Positive control
86695-4,Porcine epidemic diarrhea virus Ab/Positive control
86696-2,Rotavirus B RNA
86697-0,Rotavirus A RNA
86698-8,Porcine epidemic diarrhea virus RNA
86699-6,Rotavirus C RNA
86700-2,Rotavirus C RNA
86701-0,Rotavirus A RNA
Feb-70,History of family member diseases
86702-8,Rotavirus B RNA
86703-6,Porcine respiratory coronavirus RNA
86704-4,Lawsonia intracellularis RNA
86705-1,Lawsonia intracellularis Ab
86706-9,Dental problems during assessment period
86707-7,MDS v3.00 - RAI v1.14.1 - Skin conditions
86708-5,Determination of pressure injury risk in last 7D
86709-3,Lawsonia intracellularis RNA
8671-0,Functional status
86710-1,Porcine epidemic diarrhea virus RNA
86711-9,Porcine deltacoronavirus Ag
86712-7,Bacterial carbapenem resistance blaOXA gene
86713-5,Bacterial carbapenem resistance blaOXA-134-like gene
86714-3,Bacterial carbapenem resistance blaOXA-51-like gene
86715-0,Actinobacillus pleuropneumoniae Ab
86716-8,Actinobacillus pleuropneumoniae DNA
86717-6,Actinobacillus pleuropneumoniae serotype 1 Ab
86718-4,Actinobacillus pleuropneumoniae serotype 3 Ab
86719-2,Actinobacillus pleuropneumoniae serotype 5 Ab
867-2,A3 Ag
86720-0,Actinobacillus pleuropneumoniae serotype 7 Ab
86721-8,Actinobacillus pleuropneumoniae serotype identified
86722-6,Actinobacillus suis DNA
86723-4,Actinobacillus suis DNA
86724-2,Erysipelothrix rhusiopathiae
86725-9,Erysipelothrix rhusiopathiae Ag
86726-7,Erysipelothrix rhusiopathiae DNA
86727-5,Erysipelothrix sp strain 2 DNA
Aug-72,Symptoms & diseases
86728-3,Erysipelothrix tonsillarum DNA
86729-1,Haemophilus parasuis DNA
86730-9,Leptospira borgpetersenii serovar Hardjo-bovis DNA
86731-7,Leptospira sp DNA
86732-5,Leptospira sp identified
86733-3,Porcine parvovirus
86734-1,Porcine parvovirus Ab
86735-8,Porcine parvovirus DNA
Jun-73,Symptoms & diseases
86736-6,Porcine parvovirus type 1 DNA
86737-4,Toxoplasma gondii Ag
86738-2,Toxoplasma gondii Ab.IgG
86739-0,Streptococcus suis DNA
86740-8,Streptococcus suis Ag
86741-6,Porcine parvovirus type 2 DNA
86742-4,Growth phase
86743-2,Surgical margin tumor involvement.deep
Apr-74,History source
86744-0,Care team
86745-7,"MDS v3.0 - RAI v1.14.1, v1.15.1 - Current number of unhealed pressure injuries at each stage"
86746-5,Dimensions of unhealed stage 3 or 4 pressure injuries or eschar
86747-3,"Ulcers, wounds and skin problems"
86748-1,Skin and ulcer &or injury treatments during assessment period
86749-9,Medications
86750-7,Medications received
Jan-75,History taker
86751-5,Number of D antipsychotic received in last 7D or since admission &or reentry if less than 7D
86752-3,Number of D antianxiety received in last 7D or since admission &or reentry if less than 7D
86753-1,Number of D antidepressant received in last 7D or since admission &or reentry if less than 7D
86754-9,Number of D hypnotic received in last 7D or since admission &or reentry if less than 7D
86755-6,Number of D anticoagulant received in last 7D or since admission &or reentry if less than 7D
86756-4,Number of D antibiotic received in last 7D or since admission &or reentry if less than 7D
86757-2,Number of D diuretic received in last 7D or since admission &or reentry if less than 7D
86758-0,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs"
86759-8,"Special treatments, procedures, and programs"
86760-6,Procedures performed during last 14D - while not a resident
86761-4,Procedures performed during last 14D - while a resident
86762-2,Therapies
86763-0,Speech-language pathology and audiology services
86764-8,Occupational therapy - co-treatment minutes during 7D assessment period
86765-5,Speech-language pathology and audiology services - co-treatment minutes during 7D assessment period
86766-3,Physical therapy - co-treatment minutes during 7D assessment period
86767-1,Occupational therapy
86768-9,Physical therapy
Sep-76,Industrial exposure
86769-7,Distinct calendar days of therapy in last 7D
86770-5,Resumption of therapy
86771-3,Date therapy regimen resumed
86772-1,"Previous rehabilitation therapy regimen (speech, occupational, &or physical therapy) ended, & regimen now resumed at exactly the same level for each discipline"
86773-9,Restorative nursing programs
86774-7,Number of D of passive range of motion in last 7 calendar D
86775-4,Number of D of active range of motion in last 7 calendar D
86776-2,Number of D of splint or brace assistance in last 7 calendar D
Jul-77,Medication use
86777-0,Number of D of training & skill practice in bed mobility in last 7 calendar D
86778-8,Number of D of training & skill practice in transfer in last 7 calendar D
86779-6,Number of D of training & skill practice in walking in last 7 calendar D
86780-4,Number of D of training & skill practice in dressing or grooming in last 7 calendar D
86781-2,Number of D of training & skill practice in eating or swallowing in last 7 calendar D
86782-0,Number of D of training & skill practice in amputation or prosthesis care in last 7 calendar D
86783-8,Number of D of training & skill practice in communication in last 7 calendar D
86784-6,Restraints
May-78,Menstrual status
86785-3,Physical restraints
86786-1,Physical restraints used in bed - bed rail used during assessment period
86787-9,Physical restraints used in bed - trunk restraint used during assessment period
86788-7,Physical restraints used in bed - limb restraint during assessment period
86789-5,Other physical restraints used in bed during assessment period
86790-3,Physical restraints used in chair or out of bed - trunk restraint used during assessment period
86791-1,Physical restraints used in chair or out of bed - limb restraint used during assessment period
86792-9,Physical restraints used in chair or out of bed - chair prevents rising used during assessment period
Mar-79,Symptoms & diseases
86793-7,Other physical restraints used in chair or out of bed used during assessment period
86794-5,Participation in assessment and goal setting
86795-2,Clinical record documents a request that questions regarding possible return to the community be asked only on comprehensive assessments
86796-0,Resident's preference regarding being asked about returning to the community
86797-8,Resident (or legally authorized representative) wants to be asked about returning to the community on all assessments
86798-6,Information source for preference on return to community queries
86799-4,Coded cause of death - recommended CDA R1 sections
868-0,A3 Ag
86800-0,Coded race and ethnicity - recommended CDA R1 sections
Jan-80,Symptoms & diseases
86801-8,Jurisdiction death information - recommended CDA R1 sections
86802-6,Cause of death+related information
86803-4,Provider death registration - recommended CDA R1 sections
86804-2,Cause of death classification+related information
86805-9,Race and ethnicity information
86806-7,Jurisdiction death registration
86807-5,Death administrative information
86808-3,Provider death registration
86809-1,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information - NP, NQ"
86810-9,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information - NS, SS"
86811-7,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information - NO, NSD, ND, NOD, SP, SO, SSD, SD, SOD, NPE"
86812-5,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information - NT, ST"
86813-3,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Hearing, speech, and vision - NO, NOD, SO, SOD"
86814-1,"MDS v3.0 - RAI v1.17.2 - Staff assessment for mental status - ND, SD, IPA, OSA"
86815-8,"MDS v3.0 - RAI v1.17.2 - Behavior - NP, NQ, ND, SD, SP, IPA, OSA"
86816-6,"MDS v3.0 - RAI v1.17.2 - Functional status - NP, NQ, SP"
86817-4,MDS v3.0 - RAI v1.17.2 - Functional status - OSA
86818-2,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Functional status - NSD, NOD, SSD, SOD"
Sep-81,Symptoms & diseases
86819-0,"MDS v3.0 - RAI v1.17.2 - Functional status - ND, SD"
86820-8,"MDS v3.0 - RAI v1.14.1 - Bladder and bowel - NP, NQ, NSD, NOD, SP, SSD, SOD"
86821-6,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Active diagnoses - NO, SO"
86822-4,"MDS v3.0 - RAI v1.17.2 - Health conditions - ND, SD"
86823-2,MDS v3.0 - RAI v1.17.2 - Health Conditions - NPE
86824-0,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status - NO, SO"
86825-7,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status - NSD, ND, SSD, SD"
86826-5,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status - NOD, SP, SOD"
Jul-82,Symptoms & diseases
86827-3,"MDS v3.0 - RAI v1.14.1 - Skin conditions - NO, SO"
86828-1,"MDS v3.0 - RAI v1.14.1, v1.15.1 - Skin conditions - NSD, ND, SSD, SD"
86829-9,"MDS v3.0 - RAI v1.14.1 - Skin conditions - NOD, SOD"
86830-7,MDS v3.0 - RAI v1.17.2 - Skin conditions - NPE
86831-5,MDS v3.0 - RAI v1.17.2 - Medications - OSA
86832-3,"MDS v3.0 - RAI v1.14.1 - Medications - NSD, ND, SSD, SD"
86833-1,Staff assessment of resident mood (PHQ-9-OV) - symptom presence in the last 2W
86834-9,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - NP, NQ"
May-83,Occupational exposure
86835-6,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - NS, SS"
86836-4,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - NO, SO"
86837-2,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - NSD, SSD"
86838-0,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - ND, SD"
86839-8,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - NOD, SOD"
86840-6,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - SP"
86841-4,"MDS v3.0 - RAI v1.17.2 - Therapies - NP, NQ"
86842-2,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Therapies - NS, NSD, SS, SSD"
Mar-84,Present illness
86843-0,Resident mood interview (PHQ-9) - symptom presence in the last 2W
86844-8,Resident mood interview (PHQ-9) - symptom frequency in the last 2W
86845-5,MDS v3.0 - RAI v1.17.2 - Therapies - ND
86846-3,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Therapies - NOD, SOD"
86847-1,MDS v3.0 - RAI v1.17.2 - Therapies - SP
86848-9,MDS v3.0 - RAI v1.17.2 - Occupational therapy - ND
86849-7,"MDS v3.0 - RAI v1.17.2 - Respiratory therapy - NP, NQ, SP, IPA, OSA"
8685-0,History of psychiatric symptoms & diseases
86850-5,"MDS v3.0 - RAI v1.17.2 - Psychological therapy - NP, NQ"
86851-3,Invasive mechanical ventilator liberation status at discharge
86852-1,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Participation in assessment and goal setting - NS, NO, SS, SO"
86853-9,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Participation in assessment and goal setting - NSD, NOD, SSD, SOD"
86854-7,"MDS v3.0 - RAI v1.17.2 - Participation in assessment and goal setting - ND, SD"
86855-4,MDS v3.0 - RAI v1.17.2 - Speech-language pathology and audiology services - ND
86856-2,MDS v3.0 - RAI v1.14.1 - Nursing home PPS (NP) & Nursing home quarterly (NQ) item set
86857-0,Flavivirus Ab.Neut
86858-8,Dengue virus 2 Ab.Neut
86859-6,Dengue virus 3 Ab.Neut
86860-4,Dengue virus 1 Ab.Neut
86861-2,Dengue virus 4 Ab.Neut
86862-0,Dengue virus 4 Ab.Neut
86863-8,Dengue virus 3 Ab.Neut
86864-6,Dengue virus 2 Ab.Neut
86865-3,Dengue virus 1 Ab.Neut
86866-1,"MDS v3.0 - RAI v1.17.2 - Urinary toileting program - NP, NQ, SP"
86867-9,"MDS v3.0 - RAI v1.14.1, v1.15.1 - Health conditions - NP, NQ, SP"
Aug-86,Symptoms & diseases
86868-7,"MDS v3.0 - RAI v1.17.2 - Other health conditions - NP, NQ, SP"
86869-5,"MDS v3.0 - RAI v1.17.2 - Hearing, speech, and vision - ND, SD"
86870-3,MDS v3.0 - RAI v1.14.1 - Nursing home & Swing bed OMRA (NO & SO) item set
86871-1,MDS v3.0 - RAI v1.14.1 - Nursing home OMRA start of therapy and discharge (NSD) & Swing bed OMRA start of therapy and discharge (SSD) item set
86872-9,MDS v3.0 - RAI v1.14.1 - Nursing home discharge (ND) & Swing bed discharge (SD) item set
86873-7,MDS v3.0 - RAI v1.14.1 - Nursing home OMRA-discharge (NOD) & Swing bed OMRA-discharge (SOD) item set
86874-5,MDS v3.0 - RAI v1.14.1 - Nursing home & Swing bed OMRA start of therapy (NS & SS) item set
86875-2,MDS v3.0 - RAI v1.14.1 - Nursing home & Swing bed tracking (NT & ST) item set
Jun-87,Review of systems
86876-0,MDS v3.0 - RAI v1.14.1 - Swing bed PPS (SP) item set
86877-8,MDS v3.0 - RAI v1.14.1 - Nursing home part A PPS discharge (NPE) item set
86878-6,"MDS v3.0 - RAI v1.14.1 - Bladder and bowel - NS, NO, SS, SO"
86879-4,"MDS v3.0 - RAI v1.16.1 - Bladder and bowel - ND, SD"
86880-2,MDS v3.0 - RAI v1.17.2 - Activities of daily living (ADL) assistance - self-performance
86881-0,MDS v3.0 - RAI v1.17.2 - Activities of daily living (ADL) assistance - support provided
86882-8,"MDS v3.0 - RAI v1.16.1 - Cognitive patterns - ND, SD"
86883-6,"MDS v3.0 - RAI v1.14.1, v1.15.1 - Cognitive patterns - NO, SO"
Apr-88,Symptoms & diseases
86884-4,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Activities of daily living (ADL) assistance - support provided - NSD, NOD, SSD, SOD"
86885-1,MDS v3.0 - RAI v1.17.2 - Activities of daily living (ADL) assistance - self-performance - OSA
86886-9,MDS v3.0 - RAI v1.17.2 - Activities of daily living (ADL) assistance - support provided - OSA
86887-7,"MDS v3.0 - RAI v1.17.2 - Bathing - ND, SD"
86888-5,MDS v3.0 - RAI v1.17.2 - Health conditions - OSA
86889-3,"MDS v3.0 - RAI v1.17.2 - Other health conditions - IPA, OSA"
86890-1,"MDS v3.0 - RAI v1.17.2 - Other health conditions - ND, SD"
86891-9,Staff assessment of resident mood (PHQ-9-OV) - symptom frequency in the last 2W
Feb-89,Social function
86892-7,MDS v3.0 - RAI v1.17.2 - Current number of unhealed pressure injuries at each stage - IPA
86893-5,"MDS v3.0 - RAI v1.17.2 - Physical therapy - ND, SD"
86894-3,Adalimumab
86895-0,Adalimumab Ab
86896-8,inFLIXimab
86897-6,inFLIXimab Ab
86898-4,Vedolizumab
86899-2,Vedolizumab Ab
Sep-86,Cefaclor
8690-0,Surgical procedures
86900-8,Plasma cells.monotypic population
86901-6,Length
86902-4,Width
86903-2,Tissue type
86904-0,Carboxyhemoglobin/Hemoglobin.total
86905-7,Outcome and assessment information set (OASIS) form - version C2
86906-5,Chronic kidney disease education topic(s) discussed during this visit
86907-3,Provider's perception of patient comprehension of discussion
86908-1,Intravascular systolic goal
86909-9,Intravascular diastolic goal
86910-7,Hemoglobin A1c/Hemoglobin.total goal
86911-5,Cholesterol.in LDL goal
86912-3,Hemoglobin goal
86913-1,Iron saturation goal
86914-9,Ferritin goal
86915-6,Calcium goal
86916-4,Phosphate goal
86917-2,Parathyrin.intact goal
Aug-91,Travel
86918-0,Calcidiol+ercalcidiol goal
86919-8,Potassium goal
86920-6,Bicarbonate goal
86921-4,Albumin goal
86922-2,Therapeutic goals panel
86923-0,Kansas City Cardiomyopathy Questionnaire - 12 item
86924-8,Overall summary score
86925-5,Lawsonia intracellularis Ab
Jun-92,Symptoms & diseases
86926-3,Transmissible gastroenteritis virus Ab/Negative control
86927-1,Porcine respiratory coronavirus Ab/Negative control
86928-9,Porcine epidemic diarrhea virus whole genome
86929-7,Lawsonia intracellularis Ab/Negative control
86930-5,Carbapenemase
86931-3,"Metanephrine, Normetanephrine & Creatinine panel"
86932-1,I am confident that I can follow through on medical treatments I may need to do at home
86933-9,Patient Activation Measure - 13
Apr-93,Mental status
86934-7,I am confident I can figure out solutions when new problems arise with my health
86935-4,I know how to prevent problems with my health
86936-2,"I have been able to maintain (keep up with) lifestyle changes, like eating right or exercising"
86937-0,I know what treatments are available for my health problems
86938-8,Taking an active role in my own health care is the most important thing that affects my health
86939-6,"I am confident that I can maintain lifestyle changes, like eating right and exercising, even during times of stress"
86940-4,I am confident that I can tell a doctor concerns I have even when he or she does not ask
86941-2,I am confident that I can tell whether I need to go to the doctor or whether I can take care of a health problem myself
Feb-94,Physical findings
86942-0,I know what each of my prescribed medications do
86943-8,I am confident I can help prevent or reduce problems associated with my health
86944-6,"When all is said and done, I am the person who is responsible for taking care of my health"
86945-3,I understand my health problems and what causes them
86946-1,Patient Activation Measure - 10
86947-9,Reason for hospitalization
86948-7,Date treatment or therapy started
86949-5,Trichomonas vaginalis & Mycoplasma genitalium DNA panel
86950-3,Thymus Ab.IgG
86951-1,Lipoprotein associated phospholipase A2
86952-9,Preliminary testing done
86953-7,Preliminary testing result
86954-5,Foreign material
86955-2,Preliminary testing affected submission for further testing
86956-0,(Multisection^WO contrast) + (Multisection for left ventricular function^W contrast IV)
86957-8,Multisection^WO & W contrast IV
86958-6,Multisection^WO & W contrast IV
Sep-95,Physical findings
86959-4,Multisection^WO & W contrast IV
86960-2,Multisection^W contrast IV
86961-0,Multisection^W contrast IV
86962-8,Multisection^W contrast IV
86963-6,Multisection^W contrast IV
86964-4,Multisection^W contrast IV
86965-1,Multisection^W contrast IV
86966-9,Multisection^WO contrast
Jul-96,Physical findings
86967-7,Multisection^WO Contrast
86968-5,Multisection^W contrast IV
86969-3,Multisection^W contrast IV
86970-1,Multisection^WO contrast
86971-9,Multisection^WO & W contrast IV
86972-7,Multisection^WO & W contrast IV
86973-5,Multisection^W contrast IV
86974-3,Multisection^WO & W contrast IV
May-97,Physical findings
86975-0,Multisection for left ventricular function^W contrast IV
86976-8,Multisection metabolic^W radionuclide IV
86977-6,Multisection^W contrast IV
86978-4,Multisection^W contrast IV
86979-2,Multisection^WO contrast
869-8,A3 B Ab
86980-0,Multisection^WO & W Contrast IV
86981-8,Multisection
86982-6,Multisection^W contrast IV
Mar-98,Physical findings
86983-4,Multisection^W contrast IV
86984-2,Multisection^W contrast IV
86985-9,Multisection^W contrast IV
86986-7,Multisection^W contrast IV
86987-5,Multisection^WO contrast
86988-3,Multisection^WO contrast
86989-1,Multisection^W contrast IV
86990-9,Multisection^WO contrast
Jan-99,Physical findings
86991-7,Multisection^WO contrast
86992-5,Multisection^WO contrast
86993-3,Guidance 1 level for kyphoplasty
86994-1,Guidance 1 or 2 for injection of trigger point
86995-8,Guidance for abscess
86996-6,Guidance additional for augmentation
86997-4,Guidance additional day for infusion of thrombolytic^W thrombolytic via catheter
86998-2,Guidance additional for percutaneous mechanical thrombectomy
86999-0,Guidance additional for percutaneous mechanical thrombectomy
87000-6,Guidance additional for placement of endovascular device
87001-4,Guidance additional for placement of stent
87002-2,Guidance additional for placement of wire
87003-0,Guidance additional for vertebroplasty
87004-8,Guidance for percutaneous aspiration of fluid
87005-5,Guidance for percutaneous aspiration of fluid
87006-3,Guidance for percutaneous aspiration of fluid
Jul-00,Physical findings
87007-1,Guidance for percutaneous aspiration of fluid
87008-9,Guidance for percutaneous aspiration of fluid
87009-7,Guidance for percutaneous aspiration of cyst
87010-5,Guidance for percutaneous aspiration of cyst
87011-3,Guidance for percutaneous aspiration of ganglion cyst
87012-1,Guidance for percutaneous aspiration of fluid
87013-9,Guidance for percutaneous biopsy
87014-7,Guidance for percutaneous biopsy
May-01,Physical findings
87015-4,Guidance for percutaneous biopsy
87016-2,Guidance for percutaneous biopsy
87017-0,Guidance for check of drainage catheter for abscess
87018-8,Guidance for deep biopsy
87019-6,Guidance for drainage+placement of drainage catheter
87020-4,Guidance for embolization
87021-2,Guidance for embolization
87022-0,Guidance for embolization
Mar-02,Physical findings
87023-8,Guidance for exchange of drainage catheter for abscess
87024-6,Guidance additional day for infusion of thrombolytic^W thrombolytic via chest tube
87025-3,Guidance additional level for kyphoplasty
87026-1,Guidance additional for vertebroplasty
87027-9,Guidance for percutaneous biopsy
87028-7,Guidance for percutaneous biopsy
87029-5,Guidance for percutaneous biopsy
87030-3,Guidance for percutaneous biopsy
Jan-03,Physical findings
87031-1,Guidance for check of peritoneovenous shunt
87032-9,Guidance for cryoablation
87033-7,Guidance for drainage+placement of chest tube
87034-5,Guidance for exchange of catheter portion only of central venous catheter with port
87035-2,Guidance for exchange of central venous catheter with port
87036-0,Guidance additional level for kyphoplasty
87037-8,Guidance additional for placement of stent
87038-6,Guidance additional for percutaneous transluminal angioplasty
87039-4,Guidance additional for vertebroplasty
87040-2,Guidance for percutaneous aspiration of cyst
87041-0,Guidance for percutaneous biopsy
87042-8,Guidance for percutaneous biopsy
87043-6,Guidance for percutaneous biopsy
87044-4,Guidance for check of tube
87045-1,Guidance for cholangioscopy+removal of calculus
87046-9,Guidance for cholangioscopy
87047-7,Guidance for cholecystostomy
87048-5,Guidance for conversion of gastrostomy tube to gastrojejunostomy tube
Sep-04,Physical findings
87049-3,Guidance for cryoablation
87050-1,Guidance for cryoablation
87051-9,Guidance for dilation of stricture
87052-7,Guidance for exchange of gastrostomy tube
87053-5,Guidance for exchange of jejunostomy tube
87054-3,Guidance for percutaneous exchange of nephrostomy tube
87055-0,Guidance for percutaneous biopsy
Jun-05,Physical findings
87056-8,Guidance for percutaneous biopsy
87057-6,Guidance for placement of fiducial marker
87058-4,Guidance for radiofrequency ablation
87059-2,Guidance for percutaneous biopsy
870-6,A3 B Ab
87060-0,Guidance for removal of calculus
87061-8,Guidance for injection of contrast
87062-6,Guidance for nerve block
87063-4,Guidance for removal of gastrojejunostomy tube
Apr-06,Physical findings
87064-2,Guidance for placement of gastrojejunostomy tube
87065-9,Guidance for placement of gastrostomy tube
87066-7,Guidance for percutaneous placement of nephrostomy tube
87067-5,Guidance for transjugular biopsy
87068-3,Guidance for transjugular biopsy+venography
87069-1,Guidance for hemodynamic evaluation
87070-9,Guidance for microwave ablation
87071-7,Guidance for radiofrequency ablation
Feb-07,Physical findings
87072-5,Guidance for transjugular placement of transjugular intrahepatic portosystemic shunt
87073-3,Guidance for transjugular revision of transjugular intrahepatic portosystemic shunt
87074-1,Guidance for transhepatic revision of tube
87075-8,Guidance for transjugular biopsy
87076-6,Guidance for transjugular biopsy+hemodynamic evaluation
87077-4,Guidance for transjugular biopsy+venography
87078-2,Guidance for percutaneous drainage+placement of drainage catheter
87079-0,Guidance for paracentesis+insertion of tube
8708-0,Physical findings
87080-8,Guidance for paracentesis
87081-6,Guidance for placement of catheter
87082-4,Guidance for removal of catheter
87083-2,Guidance for reposition of catheter
87084-0,Guidance for removal of foreign body
87085-7,Guidance for placement of port
87086-5,Guidance for removal of port
87087-3,Guidance for percutaneous transluminal angioplasty
87088-1,Guidance for puncture
87089-9,Guidance for kyphoplasty
87090-7,Guidance for myelography
87091-5,Guidance for vertebroplasty
87092-3,Guidance for placement of venous filter
87093-1,Guidance for removal of venous filter
87094-9,Guidance for reposition of venous filter
87095-6,Guidance for percutaneous transluminal angioplasty
87096-4,Guidance for placement of stent
87097-2,Guidance for placement of peritoneovenous shunt
Aug-09,Physical findings
87098-0,Guidance for removal of peritoneovenous shunt
87099-8,Guidance for revision of peritoneovenous shunt
87100-4,Guidance for percutaneous transluminal angioplasty
87101-2,Guidance for percutaneous transluminal angioplasty
87102-0,Guidance initial day for infusion of thrombolytic^W thrombolytic via chest tube
87103-8,Guidance for infusion of thrombolytic^W thrombolytic via central venous catheter
87104-6,Guidance for injection of central venous catheter
87105-3,Guidance for reposition of central venous catheter
Jun-10,Physical findings
87106-1,Guidance for placement of central venous catheter with port
87107-9,Guidance for removal of central venous catheter with port
87108-7,Guidance for repair of central venous catheter with port
87109-5,Guidance for placement of Swan-Ganz catheter
87110-3,Guidance for thoracentesis+insertion of tube
87111-1,Guidance for thoracentesis
87112-9,Guidance for exchange of tunneled central venous catheter without port
87113-7,Guidance for placement of tunneled central venous catheter without port
Apr-11,Physical findings
87114-5,Guidance for removal of tunneled central venous catheter without port
87115-2,Guidance for repair of non-tunneled central venous catheter without port
87116-0,Guidance for placement of chest tube
87117-8,Guidance for pericardiocentesis
87118-6,Guidance for placement of fiducial marker
87119-4,Guidance for microwave ablation
87120-2,Guidance for radiofrequency ablation
87121-0,Guidance for placement of tunneled catheter
Feb-12,Physical findings
87122-8,Guidance for kyphoplasty
87123-6,Guidance for myelography
87124-4,Guidance for vertebroplasty
87125-1,Guidance for nerve block
87126-9,Guidance for removal of venous filter
87127-7,Guidance for reposition of venous filter
87128-5,Guidance for placement of venous filter
87129-3,Guidance for percutaneous transluminal angioplasty
8713-0,Physical findings
87130-1,Guidance for laser ablation
87131-9,Guidance GE 21 for stab phlebectomy
87132-7,Guidance for injection
87133-5,Guidance for percutaneous transluminal angioplasty
87134-3,Guidance for placement of stent
87135-0,Guidance for injection
87136-8,Guidance for percutaneous aspiration of fluid
87137-6,Guidance for injection
87138-4,Guidance additional for laser ablation
87139-2,Guidance additional for percutaneous transluminal angioplasty
871-4,A3 B Ab
87140-0,Guidance additional for placement of stent
87141-8,Guidance for placement of central venous catheter with port
87142-6,Guidance for exchange of central venous catheter with port
87143-4,Guidance for exchange of peripherally-inserted central venous catheter
87144-2,Guidance for placement of peripherally-inserted central venous catheter
87145-9,Guidance for embolization
87146-7,Guidance for injection
87147-5,Guidance for injection
Aug-14,Physical findings
87148-3,Guidance for injection of thrombin for pseudoaneurysm
87149-1,Guidance for exchange of chest tube
87150-9,Guidance for percutaneous transluminal angioplasty
87151-7,Guidance for placement of stent
87152-5,Guidance for exchange of ureterostomy through ileal conduit
87153-3,Guidance therapeutic for puncture+drainage
87154-1,Guidance diagnostic for puncture
May-15,Physical findings
87155-8,Guidance for percutaneous aspiration.fine needle
87156-6,Guidance for percutaneous biopsy.core needle
87157-4,Guidance for injection of platelet rich plasma
87158-2,Guidance for injection
87159-0,Guidance for injection
87160-8,Guidance for injection
87161-6,Guidance for injection
87162-4,Guidance for placement of needle
Mar-16,Vital signs
87163-2,Guidance for placement of endovascular device
87164-0,Guidance secondary for percutaneous mechanical thrombectomy
87165-7,Guidance for placement of endograft
87166-5,Guidance for percutaneous transluminal angioplasty
87167-3,Guidance for transcatheter biopsy
87168-1,Guidance for transcatheter placement of stent
87169-9,Guidance initial for percutaneous mechanical thrombectomy
87170-7,Guidance for ligation
Jan-17,Surgical operation note estimated blood loss
87171-5,Guidance for placement of clip
87172-3,Guidance for placement of clip^preoperative
87173-1,Guidance for biopsy
87174-9,Guidance for percutaneous biopsy
87175-6,Guidance for deep drainage+placement of drainage catheter
87176-4,Guidance for radiofrequency ablation
87177-2,Guidance for radiofrequency ablation
87178-0,Guidance final day for infusion of thrombolytic^W thrombolytic via catheter
87179-8,Guidance for percutaneous aspiration.fine needle
87180-6,Guidance for dilation
87181-4,Guidance for embolization
87182-2,Guidance for placement of wire
87183-0,Guidance GE 3 for injection of trigger point
87184-8,Guidance for percutaneous transluminal angioplasty of arterial anastomosis
87185-5,Guidance for percutaneous sympathectomy
87186-3,Guidance for mechanical thrombectomy of central venous catheter lumen obstruction
87187-1,Guidance for nerve block
87188-9,Guidance for percutaneous exchange of nephroureteral stent
Sep-18,Surgical operation note fluids
87189-7,Guidance for transurethral removal of nephroureteral stent
87190-5,Guidance for percutaneous placement of nephroureteral stent
87191-3,Guidance for percutaneous removal of nephroureteral stent
87192-1,Guidance for thrombectomy
87193-9,Guidance initial day for infusion of thrombolytic^W thrombolytic via catheter
87194-7,Guidance initial for percutaneous mechanical thrombectomy
87195-4,Guidance initial day for infusion of thrombolytic^W thrombolytic via catheter
87196-2,Guidance for infusion of non-thrombolytic
Jul-19,Surgical operation note postoperative Dx
87197-0,Guidance for retrieval of foreign body
87198-8,Guidance for drainage of abscess+placement of drainage catheter
87199-6,Guidance for substance removal of central venous catheter pericatheter obstruction
87200-2,Guidance for placement of stent
87201-0,Guidance for treatment
87202-8,Guidance for venous sampling
87203-6,Guidance for transurethral exchange of nephroureteral stent
May-20,Surgical operation note preoperative Dx
87205-1,Guidance for exchange of non-tunneled central venous catheter
87206-9,Guidance for nerve block
87207-7,Care Area Assessment (CAA) Summary
87208-5,Items from the most recent prior OBRA or scheduled PPS Assessment
87209-3,Correction attestation section
87210-1,Care Area Assessment (CAA) and Care Planning
87211-9,Care Area Assessment (CAA) results
87212-7,Care area triggered
Mar-21,Surgical operation note specimens taken
87213-5,Triggered care area included in care plan
87214-3,"LCDS v4.00 - Special treatments, procedures, and programs - discharge"
87215-0,"LCDS v4.00 - Hearing, speech, and vision"
87216-8,Date on existing record to be modified or inactivated
87217-6,Reasons for modification
87218-4,RN asessment coordinator attestation of completion
87219-2,Attesting individual first name
872-2,A3 B Ag
87220-0,Attesting individual last name
Jan-22,Surgical operation note anesthesia
87221-8,Attesting individual title
87222-6,Attestation date
87223-4,Assessment administration
87224-2,Correction Request
87225-9,Reasons for inactivation
87226-7,Legal name of patient - first and last
87227-5,Type of assessment on existing record to be modified or inactivated
87228-3,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Assessment administration - NS, NO, NSD, NOD, SP, SS, SO, SSD, SOD"
87229-1,"MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Assessment administration - ND, SD"
87230-9,"LCDS v4.00 - Special treatments, procedures, and programs - admission"
87231-7,Medication administration.extended
87232-5,Medication administration.brief
87233-3,Consultation note
87234-1,Education note
87235-8,Discharge summary note
87236-6,Summary note
87237-4,Plan of care note
87238-2,Note
Sep-23,Surgical operation note date
87239-0,Postoperative evaluation and management note
87240-8,Preoperative evaluation and management note
87241-6,Bacillus atrophaeus
87242-4,Geobacillus stearothermophilus
87243-2,Microscopic observation
87244-0,Note
87245-7,Note
87246-5,Note
Jul-24,Surgical operation note description
87247-3,Medication management note
87248-1,Education note
87249-9,Note
87250-7,Referral note
87251-5,Administrative note
87252-3,Admission evaluation note
87253-1,Plan of care note
Apr-25,Surgical operation note open closing duration
87254-9,Consultation note
87255-6,Counseling note
87256-4,Discharge summary note
87257-2,Group counseling note
87258-0,Risk assessment and screening note
87259-8,History and physical note
87260-6,Initial evaluation note
87261-4,Note
Feb-26,Surgical operation note findings
87262-2,Note
87263-0,Note
87264-8,Note
87265-5,Plan of care note
87266-3,Note
87267-1,Note
87268-9,Immunization note
87269-7,Immunization note
8727-0,Surgical operation note indications
87270-5,Immunization note
87271-3,Immunization note
87272-1,Immunization note
87273-9,Immunization note
87274-7,Borrelia afzelii+burgdorferi+garinii Ab.IgG & IgM panel
87275-4,Borrelia afzelii+burgdorferi+garinii Ab.IgG
87276-2,Borrelia afzelii+burgdorferi+garinii Ab.IgG band pattern
87277-0,Borrelia afzelii+burgdorferi+garinii Ab.IgM
87278-8,Borrelia afzelii+burgdorferi+garinii Ab.IgM band pattern
87279-6,Multisection for screening
87280-4,Multisection^W contrast IV
87281-2,Multisection^W contrast IV
87282-0,Brachyspira hyodysenteriae DNA
87283-8,Brachyspira hampsonii DNA
87284-6,Brachyspira hyodysenteriae DNA
87285-3,Brachyspira pilosicoli DNA
87286-1,Birth attendant
87287-9,Birth certifier
Aug-28,Operative note complications
87288-7,Date of birth certification
87289-5,Date of fetal death registration
87290-3,Date of Social Security Number request
87291-1,Information source
87292-9,Name not yet chosen
87293-7,Relationship to patient's mother
87294-5,Signature for Social Security Number request
87295-2,Social Security Number was requested
Jun-29,Surgical operation note procedure
87296-0,Age^at delivery
87297-8,Birth registration date
87298-6,Cigarettes smoked per D^1st trimester
87299-4,Cigarettes smoked per D^2nd trimester
873-0,A3 B Ag
87300-0,Highest level of education
87301-8,Married at any time during pregnancy
87302-6,Paternity acknowledgment form signed
87303-4,WIC services recipient
Apr-30,Class
87304-2,Clostridium perfringens cpa gene
87305-9,Clostridium perfringens cpb2 gene
87306-7,Clostridium perfringens cpe gene
87307-5,Clostridium perfringens etx gene
87308-3,Guidance for transhepatic removal of catheter
87309-1,Guidance for transhepatic placement of catheter
87310-9,Guidance for transhepatic exchange of catheter
87311-7,Guidance for embolization for tumor or ischemia or infarction
Feb-31,Cardiac output
87312-5,Guidance for percutaneous transluminal angioplasty for dialysis
87313-3,Clostridium perfringens iota toxin DNA
87314-1,Encephalomyocarditis virus
87315-8,Encephalomyocarditis virus RNA
87316-6,Enterovirus G RNA
87317-4,Escherichia coli
87318-2,Escherichia coli eaeA gene
87319-0,Escherichia coli enteroaggregative astA gene
8732-0,Cardiac output
87320-8,Escherichia coli enterotoxigenic heat-labile toxin DNA
87321-6,Escherichia coli enterotoxigenic sta gene
87322-4,Escherichia coli enterotoxigenic stb gene
87323-2,Porcine circovirus type 1 DNA
87324-0,Porcine circovirus type 2
87325-7,Porcine circovirus type 2 Ab
87326-5,Porcine circovirus type 2 Ab.IgG
87327-3,Porcine circovirus type 2 Ab.IgG+IgM
87328-1,Porcine circovirus type 2 Ab.IgG+IgM
87329-9,Porcine circovirus type 2 Ab.IgG/Positive control
87330-7,Porcine Circovirus type 2 Ab.Neut
87331-5,Porcine circovirus type 2 Ab/Negative control
87332-3,Porcine circovirus type 2 Ag
87333-1,Porcine circovirus type 2 ORF2 gene
87334-9,Porcine circovirus type 2 DNA
87335-6,Porcine circovirus type 2 DNA
87336-4,Porcine circovirus type 2 DNA
87337-2,Porcine circovirus type 2 RFLP pattern
Aug-33,Cardiac output
87338-0,Porcine circovirus type 2 strain identified
87339-8,Porcine circovirus type 2a DNA
87340-6,Porcine circovirus type 2b DNA
87341-4,Pseudorabies virus
87342-2,Pseudorabies virus DNA
87343-0,Pseudorabies virus glycoprotein 1 Ab/Negative control
87344-8,Pseudorabies virus glycoprotein B Ab/Negative control
87345-5,Senecavirus A
Jun-34,Cardiac output
87346-3,Senecavirus A Ab
87347-1,Senecavirus A Ab.IgG/Positive control
87348-9,Senecavirus A RNA
87349-7,Senecavirus A VP1 gene
87350-5,Senecavirus A RNA
87351-3,Senecavirus A RNA
87352-1,Senecavirus A whole genome
Mar-35,Cardiac output
87353-9,Actinobacillus pleuropneumoniae Ab.IgG/Positive control
87354-7,Actinobacillus pleuropneumoniae Ab/Positive control
87355-4,Actinobacillus pleuropneumoniae serotype 10 Ab/Positive control
87356-2,Actinobacillus pleuropneumoniae serotype 12 Ab/Positive control
87357-0,Actinobacillus pleuropneumoniae serotype 2 Ab/Positive control
87358-8,Actinobacillus pleuropneumoniae serotype 5 Ab/Positive control
87359-6,Actinobacillus pleuropneumoniae serotypes 3+6+8 Ab/Positive control
87360-4,Actinobacillus pleuropneumoniae serotypes 4+5+7 Ab/Positive control
Jan-36,Cardiac output
87361-2,Toxoplasma gondii Ab/Negative control
87362-0,Actinobacillus pleuropneumoniae serotypes 1+2+9+11 Ab/Positive control
87363-8,Actinobacillus pleuropneumoniae serotypes 3+6+8+15 Ab/Positive control
87364-6,Haemophilus parasuis Ab/Positive control
87365-3,Actinobacillus pleuropneumoniae serotypes 4+7 Ab/Positive control
87366-1,Actinobacillus pleuropneumoniae serotypes 1+9+11 Ab/Positive control
87367-9,Erysipelothrix rhusiopathiae Ab/Positive control
87368-7,Actinobacillus pleuropneumoniae serotypes 10+12 Ab/Positive control
87369-5,Lawsonia intracellularis VNTR pattern
87370-3,Escherichia coli fasA gene
87371-1,Escherichia coli fedF gene
87372-9,Escherichia coli FimF41a gene
87373-7,Escherichia coli K88 DNA
87374-5,Escherichia coli K99 DNA
87375-2,Escherichia coli paa gene
87376-0,Escherichia coli Stx1 toxin stx1 gene
87377-8,Escherichia coli Stx2 toxin stx2 gene
87378-6,Tubular extraction rate/1.73 sq M
Sep-37,Cardiac output
87379-4,Cannabinol
87380-2,Escherichia coli Stx2e toxin stx2e gene
87381-0,Porcine Adenovirus Ab
87382-8,Porcine cytomegalovirus DNA
87383-6,Porcine hemagglutinating encephalomyelitis virus RNA
87384-4,Porcine parainfluenza virus 1 HN gene
87385-1,Porcine parainfluenza virus 1 F gene
87386-9,Porcine parainfluenza virus 1 RNA
Jul-38,Cardiac output
87387-7,Porcine parainfluenza virus 1 RNA
87388-5,Porcine sapelovirus
87389-3,Porcine sapelovirus RNA
87390-1,Porcine sapelovirus RNA
87391-9,Porcine teschovirus RNA
87392-7,Porcine teschovirus RNA
87393-5,Salmonella sp Ab/Positive control
87394-3,Salmonella sp DNA
May-39,Cardiac output
87395-0,West Nile virus RNA
87396-8,GenBank sequence accession number
87397-6,Clostridium perfringens cpb gene
87398-4,Brachyspira sp DNA
87399-2,Porcine teschovirus
87400-8,Brachyspira sp Ag
87401-6,Brachyspira pilosicoli DNA
87402-4,Escherichia coli aidA-I gene
87403-2,Platelet aggregation.ristocetin induced^750 ug/mL
87404-0,Certolizumab
87405-7,Certolizumab Ab
87406-5,Golimumab
87407-3,Golimumab Ab
87408-1,Ustekinumab
87409-9,Ustekinumab Ab
87410-7,Thymidine synthase activity interpretation
Jan-41,Cardiac output
87411-5,Brachyspira hyodysenteriae DNA
87412-3,Brachyspira sp nox gene
87413-1,Brachyspira sp
87414-9,Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 1.5
87415-6,IRF-PAI v3.0 - Medical information
87416-4,Diagnostic imaging report - recommended DICOM PS3.20 sections
87417-2,Cytolethal distending toxin B & Vinculin Ab panel
87418-0,Cytolethal distending toxin B Ab
87419-8,Cytolethal distending toxin B+Vinculin Ab
87420-6,Vinculin Ab
87421-4,Glucose^pre-meal
87422-2,Glucose^post meal
87423-0,Borrelia burgdorferi Ab.IgG & IgM panel
87424-8,Cytomegalovirus Ab.IgG & IgM Panel
87426-3,Inhibin A & B panel
87427-1,Neutrophil cytoplasmic Ab panel
87428-9,Drugs of abuse screen W Reflex confirm panel
Sep-42,Cardiac output ventricle right/Ventricle left
87429-7,Cortisol AM & PM panel
87430-5,Cystatin C & Glomerular filtration rate by Cystatin-based formula panel
87431-3,Herpes simplex virus 1 & 2 DNA panel
87432-1,Mycophenolate & mycophenolate glucuronide panel
87433-9,Hemoglobin.free & oxyhemoglobin panel
87434-7,Protein & creatinine panel
87435-4,Coccidioides immitis Ab.IgG & IgM panel
87436-2,Chromosome X & Y aneuploidy
Jul-43,Cardiac output ventricle right/Ventricle left
87437-0,Oxyhemoglobin
87438-8,Dengue virus 1+2+3+4 & Zika virus Ab.IgA+IgG+IgM
87439-6,Zika virus Ab.IgA+IgG+IgM
87440-4,Dengue virus 1+2+3+4 Ab.IgA+IgG+IgM
87441-2,Dengue virus 1+2+3+4 & Zika virus Ab.IgA+IgG+IgM panel
87442-0,Turbidity
87443-8,Hardness
87444-6,Electrical conductivity
May-44,Cardiac output ventricle right/Ventricle left
87445-3,Fungus
87446-1,Zinc
87447-9,Vanadium
87448-7,Vanadium
87449-5,Sulfur
87450-3,Sulfur
87451-1,Sodium
Feb-45,Cardiac output/Body surface area
87452-9,Sodium
87453-7,Selenium
87454-5,Potassium
87455-2,Potassium
87456-0,Phosphate
87457-8,Phosphate
87458-6,Particle diameter.mean
87459-4,Nitrite
8746-0,Cardiac output/Body surface area
87460-2,Nitrite
87461-0,Nitrate
87462-8,Nitrate
87463-6,Nickel
87464-4,Monensin
87465-1,Monensin
87466-9,Molybdenum
87467-7,Manganese
87468-5,Manganese
87469-3,Magnesium
87470-1,Magnesium
87471-9,Iron
87472-7,Copper
87473-5,Cobalt
87474-3,Chromium
87475-0,Chloride
87476-8,Chloride
87477-6,Calcium
Aug-47,Cardiac output/Body surface area
87478-4,Cadmium
87479-2,Boron
874-8,A3 B Ag
87480-0,Bone ash/Bone.total
87481-8,Arsenic
87482-6,Aluminum
87483-4,Aluminum
87484-2,BB-22 3-carboxyindole
87485-9,ADBICA N-pentanoate
Jun-48,Cardiac output/Body surface area
87486-7,PB-22 3-carboxyindole
87487-5,MAB-CHMINACA butanoate
87488-3,AM694 N-5-hydroxypentyl
87489-1,AKB48 N-pentanoate
87490-9,ADB-PINACA pentanoate
87491-7,ADBICA N-4-hydroxypentyl
87492-5,AB-PINACA pentanoate
87493-3,AB-FUBINACA oxobutanoate
Apr-49,Cardiac output/Body surface area
87494-1,AB-CHMINACA hydroxycyclohexyl
87495-8,AB-CHMINACA butanoate
87496-6,Gabapentin
87497-4,Meperidine
87498-2,3-Methoxytyramine.free/Creatinine
87499-0,3-Methoxytyramine.free
87500-5,LCDS v4.00 - Skin conditions - discharge
87501-3,LCDS v4.00 - Mobility - discharge performance
Feb-50,Cardiac output/Body surface area
87502-1,LCDS v4.00 - Mobility - admission performance
87503-9,Understanding verbal and non-verbal content during 3D assessment period
87504-7,LCDS v4.00 - Administrative information - discharge
87505-4,Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 4.00
87506-2,Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 4.00
87507-0,Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 4.00
87508-8,Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 4.00
87509-6,Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 4.00
8751-0,Cardiac output/Body surface area
87510-4,Date of retirement
87511-2,Combat zone &or hazardous duty work dates
87512-0,Work Hs per D
87513-8,Process of care measures
87514-6,Cerebral monitor
87515-3,Pupillary response^at admission
87516-1,Life support was discontinued
87517-9,Physical abuse was reported
87518-7,Discharged to caregiver other than caregiver at admission due to suspected abuse
87519-5,Physical abuse investigation was initiated
87520-3,Coverage type
87521-1,"IRF-PAI v3.0, LCDS v4.00 - Medications - admission"
87522-9,"IRF-PAI v3.0, LCDS v4.00 - Medications - discharge and expired"
87523-7,REMS Administrative Information
87524-5,REMS requirements
87525-2,REMS participant requirements
87526-0,REMS applicant requirements
87527-8,Fasting duration
Aug-52,Cardiac output/Body surface area
87528-6,Personal health goal
87529-4,Most important functional area
87530-2,Most important health event to avoid
87531-0,Most important symptom to manage
87532-8,Most important mental health issue to address
87533-6,Chronic kidney disease management personal goals panel
87534-4,Challenges for treatment plan maintenance panel
87535-1,Challenges to maintaining treatments or health behaviors
Jun-53,Cardiac output/Body surface area
87536-9,Treatment or health behavior affected by challenges
87537-7,LCDS v4.00 - Spontaneous breathing trial
87538-5,Assessed for readiness for SBT by day 2 of stay
87539-3,Invasive mechanical ventilation support upon admission
87540-1,Deemed medically ready for SBT by day 2 of stay
87541-9,Is there documentation of reason(s) in the patient's medical record that the patient was deemed medically unready for SBT by day 2 of stay
87542-7,SBT performed by day 2 of stay
87543-5,Beta-N-acetylhexosaminidase.A & beta-N-acetylhexosaminidase with reflex to HEXA gene panel
87544-3,Beta-N-acetylhexosaminidase.A & beta-N-acetylhexosaminidase panel
87545-0,Beta-N-acetylhexosaminidase.A & beta-N-acetylhexosaminidase panel
87546-8,Dengue virus Ab.IgG & IgM panel
87547-6,Borrelia burgdorferi Ab & Anaplasma phagocytophilum & Babesia microti & Ehrlichia chaffeensis Ab.IgG panel
87548-4,Anaplasma phagocytophilum & Ehrlichia sp groEL gene panel
87549-2,"1,25-Dihydroxyvitamin D & 1,25-Dihydroxyvitamin D2 & 1,25-Dihydroxyvitamin D3 panel"
875-5,"A,B Ab"
87550-0,Haloperidol & haloperidol.reduced panel
Jan-55,Cardiac output/Body surface area
87551-8,Neutrophil cytoplasmic Ab.IgG & Saccharomyces cerevisiae Ab.IgA & IgG
87552-6,IgA & IgA subclass 1 & IgA subclass 2 panel
87553-4,Aspergillus fumigatus & Saccharopolyspora rectivirgula & Thermoactinomyces vulgaris Ab.IgG panel
87554-2,Epstein Barr virus Ab panel
87555-9,Sjogrens syndrome-A & B extractable nuclear Ab.IgG panel
87556-7,Thyroglobulin & thyroperoxidase Ab panel
87557-5,Protein S Ag & protein S Ag.free panel
87558-3,Anaplasma phagocytophilum groEL gene
87559-1,Ehrlichia chaffeensis groEL gene
87560-9,Ehrlichia canis+ewingii groEL gene
87561-7,Ehrlichia muris eauclairensis groEL gene
87562-5,Ammonia nitrogen
87563-3,Antimony
87564-1,Zearalenone
87565-8,Zearalenol
87566-6,Deoxynivalenol
87567-4,T-2 toxin
87568-2,Ochratoxin A
Sep-56,Cardiac output/Body surface area
87569-0,Nivalenol
87570-8,Narasin
87571-6,Fumonisin B3
87572-4,Fumonisin B2
87573-2,Fumonisin B1
87574-0,Ergovaline
87575-7,Ergotamine
87576-5,Ergosine
Jul-57,Cardiac output/Body surface area
87577-3,Ergocryptine
87578-1,Ergocristine
87579-9,Ergocornine
87580-7,Aflatoxin M1
87581-5,Aflatoxin G2
87582-3,Aflatoxin G1
87583-1,Aflatoxin B2
87584-9,Aflatoxin B1
May-58,Cardiac output/Body surface area
87585-6,Virginiamycin
87586-4,Tylvalosin
87587-2,Tylosin
87588-0,Tilmicosin
87589-8,Tiamulin
87590-6,Tetracycline
87591-4,Sulfathiazole
87592-2,Sulfamethazine
Mar-59,Cardiac output/Body surface area
87593-0,Salinomycin
87594-8,Penicillin
87595-5,Oxytetracycline
87596-3,Nicotine
87597-1,Lincomycin
87598-9,Lasalocid
87599-7,Florfenicol
87600-3,Chlortetracycline
Jan-60,Cardiac output/Body surface area
87601-1,Carbadox
87602-9,Bambermycins
87603-7,Bacitracin zinc
87604-5,Ampicillin
87605-2,Warfarin
87606-0,Diphacinone
87607-8,Difethialone
87608-6,Difenacoum
87609-4,Dicoumarol
87610-2,Chlorophacinone
87611-0,Bromadiolone
87612-8,Brodifacoum
87613-6,Urea
87614-4,Thallium
87615-1,Sulfate
87616-9,Gossypol
87617-7,Ethylene glycol
87618-5,Cyanide
Sep-61,Cardiac output/Body surface area
87619-3,Barium
87620-1,Candida auris ITS2 gene
87621-9,Bordetella parapertussis IS1001 DNA
87622-7,Zika virus Ab.IgM
87623-5,HEDIS 2018 Value Set - Depression Screen
87624-3,HEDIS 2018 Value Set - Alcohol Screening
87625-0,HEDIS 2018 Value Sets
87626-8,Suicide prevention note
Jul-62,Cardiac output/Body surface area
87627-6,Consultation note
87628-4,Note
87629-2,Plan of care note
876-3,"A,B Ab"
87630-0,Mevinphos
87631-8,Mexacarbate
87632-6,Toxaphene
87633-4,Phorate
87634-2,Aldicarb
May-63,Cardiac output/Body surface area
87635-9,Aldicarb sulfone
87636-7,Crufomate
87637-5,Fenchlorphos
87638-3,"p,p'- Dichlorodiphenyldichloroethane"
87639-1,Dichlorodiphenyltrichloroethane
87640-9,Dichlorodiphenyldichloroethylene
87641-7,"o,p'- Dichlorodiphenyltrichloroethane"
87642-5,"o,p'- Dichlorodiphenyldichloroethylene"
87643-3,"o,p'- Dichlorodiphenyldichloroethane"
87644-1,Ethoprop
87645-8,Dechlorane
87646-6,Methyl parathion
87647-4,Methoxychlor
87648-2,Malathion
87649-0,Lindane
8765-0,Stroke volume
87650-8,Methomyl
87651-6,"2,3,5-trimethylphenyl methylcarbamate"
87652-4,Isofenphos
87653-2,Hexachlorobenzene
87654-0,Heptachlor
87655-7,Heptachlor epoxide
87656-5,Carbofuran
87657-3,Fenthion
87658-1,Famphur
87659-9,Parathion
87660-7,Endrin
87661-5,Endosulfan I
87662-3,Fonofos
87663-1,Disulfoton
87664-9,Dimethoate
87665-6,Dieldrin
87666-4,Diazinon
87667-2,Alpha benzene hexachloride
Aug-66,Stroke volume
87668-0,Aldrin
87669-8,Chlorinated hydrocarbon panel
87670-6,Carbamate panel
87671-4,Cholecalciferol
87672-2,Tocopherol+tocotrienol
87673-0,Retinal+retinol+retinoic acid
87674-8,Optical coherence tomography study
87675-5,Parent Patient Activation Measure - 13
Jun-67,Stroke volume
87676-3,"When all is said and done, I am the person who is responsible for taking care of my child's health"
87677-1,Taking an active role in my child's health care is the most important thing that affects his or her health
87678-9,I am confident I can help prevent or reduce problems associated with my child's health
87679-7,I know what each of my child's prescribed medications do
87680-5,I am confident that I can tell whether I need to go to the doctor or whether I can take care of my child's health problem myself
87681-3,I am confident that I can tell a doctor concerns I have abou my child's health even when he or she does not ask
87682-1,I am confident that I can follow through on medical treatments I need to do for my child at home
87683-9,I understand my child's health problems and what causes them
Apr-68,Stroke volume
87684-7,I know what treatments are available for my child's health problems
87685-4,"I have been able to help my child maintain (keep up with) lifestyle changes, like eating right or exercising"
87686-2,I know how to prevent problems with my child's health
87687-0,I am confident I can figure out solutions when new problems arise with my child's health
87688-8,"I am confident that I can help my child maintain lifestyle changes, like eating right and exercising, even during times of stress"
87689-6,Parent Patient Activation Measure - 10
87690-4,"When all is said and done, I am responsible for seeing that this person's health is managed properly"
87691-2,Taking an active role in this person's health care is one of the most important factors in determining her or his health and ability to function
Feb-69,Stroke volume
87692-0,I am confident that I can take actions that will help prevent or minimize some symptoms or problems associated with this person's health
87693-8,I know what each of this person's prescribed medications do
87694-6,I am confident that I can tell when this person needs to get medical care and when I can handle the problem myself
87695-3,I am confident I can tell a doctor the concerns that I have about this person's health even when he or she does not ask
87696-1,I am confident that I can follow through on medical treatments I need to do for this person at home
87697-9,I understand the nature and causes of this person's health
87698-7,I know the different medical treatment options available for this person's health
87699-5,I am able to help this person maintain lifestyle changes (like eating right or exercising) for her or his condition
Jul-87,Cefmetazole
8770-0,Stroke volume
87700-1,I know how to prevent problems with this person's health
87701-9,I am confident I can figure out solutions when new situations or problems arise with this person's health
87702-7,"I am confident I can help this person with lifestyle changes, like diet and exercise, even during times of stress"
87703-5,Caregiver Patient Activation Measure - 13
87704-3,Caregiver Patient Activation Measure - 10
87705-0,Sedentary activity
87706-8,Detection limit
87707-6,Job supervisory level or pay grade
87708-4,Beta-2-Microglobulin^post dialysis
87709-2,Virus identified
877-1,"A,B Ab"
87710-0,Rotavirus C VP7 gene
87711-8,Rotavirus B VP7 gene
87712-6,Rotavirus A VP7 gene
87713-4,Rotavirus A VP4 gene
87714-2,Influenza virus A M gene
87715-9,Influenza virus A HA gene
87716-7,Influenza virus A NA gene
87717-5,Apis mellifera recombinant (rApi m) 2 Ab.IgE.RAST class
Aug-71,Stroke volume
87718-3,Arachis hypogaea recombinant (rAra h) 6 Ab.IgE.RAST class
87719-1,Arachis hypogaea recombinant (rAra h) 5 Ab.IgE.RAST class
87720-9,Postal code
87721-7,County of residence
87722-5,Complement C1q.functional
87723-3,Complement C3.functional
87724-1,Complement C7.functional
87725-8,Cytomegalovirus Ab.IgM
Jun-72,Stroke volume
87726-6,Cytomegalovirus Ab.IgG
87727-4,Complement C9.functional
87728-2,Appearance
87729-0,Occupational hazard
87730-8,HBA1 & HBA2 gene full mutation analysis
87731-6,KIT gene exon 17 targeted mutation analysis
87732-4,KIT gene exon 13 targeted mutation analysis
87733-2,KIT gene exon 8 targeted mutation analysis
Apr-73,Stroke volume
87734-0,cefTAZidime+Avibactam
87735-7,Ceftolozane+Tazobactam
87736-5,Intravascular diastolic^post exercise
87737-3,"3,4,5-trimethylphenyl methylcarbamate"
87738-1,GALC gene deletion+duplication & full mutation analysis
87739-9,Intravascular systolic^W exercise
87740-7,Intravascular diastolic^W exercise
87741-5,Intravascular systolic^post exercise
87742-3,Adalimumab Ab
87743-1,Bufencarb
87744-9,Carbaryl
87745-6,Carbophenothion
87746-4,Chlordane
87747-2,Chlorpyrifos
87748-0,Coumaphos
87749-8,Crotoxyphos
87750-6,Dichlorvos
87751-4,Endosulfan II
87752-2,O-Ethyl O-(p-nitrophenyl) phenylphosphonothionate
87753-0,Propoxur
87754-8,Terbufos
87755-5,Clostridioides difficile BI-NAP1-027 strain DNA
87756-3,BMPR1A & SMAD4 gene deletion+duplication & full mutation analysis
87757-1,Platelet glycoprotein IV Ab
87758-9,Naegleria fowleri DNA
Sep-75,Stroke volume
87759-7,Lifetime risk for developing genetic disease assessed
87760-5,N-Nortramadol/Creatinine
87761-3,Atomoxetine/Creatinine
87762-1,Methcathinone/Creatinine
87763-9,Ezogabine/Creatinine
87764-7,Pregabalin/Creatinine
87765-4,levETIRAcetam/Creatinine
87766-2,10-Hydroxycarbazepine/Creatinine
Jul-76,Stroke volume
87767-0,Primidone/Creatinine
87768-8,Rufinamide/Creatinine
87769-6,tiaGABine/Creatinine
87770-4,Topiramate/Creatinine
87771-2,Zonisamide/Creatinine
87772-0,lamoTRIgine/Creatinine
87773-8,Baclofen/Creatinine
87774-6,tiZANidine/Creatinine
May-77,Stroke volume
87775-3,Metaxalone/Creatinine
87776-1,Zaleplon/Creatinine
87777-9,8-Hydroxyloxapine/Creatinine
87778-7,Molindone/Creatinine
87779-5,Pimozide/Creatinine
87780-3,Ziprasidone/Creatinine
87781-1,ARIPiprazole/Creatinine
87782-9,Diclofenac/Creatinine
Mar-78,Stroke volume
87783-7,Ketoprofen/Creatinine
87784-5,Naproxen/Creatinine
87785-2,Oxaprozin/Creatinine
87786-0,Bupivacaine/Creatinine
87787-8,guaiFENesin/Creatinine
87788-6,Milnacipran/Creatinine
87789-4,Theophylline/Creatinine
87790-2,Carbadox
Jan-79,Stroke volume
87791-0,Carbadox
87792-8,Cefovecin
87793-6,Nitrofurazone
87794-4,Furazolidone
87795-1,Ormetoprim+Sulfadimethoxine
87796-9,Sulfathiazole
87797-7,Sulfathiazole
87798-5,Tulathromycin
87799-3,Sulfadimethoxine
87800-9,Pradofloxacin
87801-7,Ormetoprim+Sulfadimethoxine
87802-5,Sulfachloropyridazine
87803-3,Sulfadimethoxine
87804-1,Sulfachloropyridazine
87805-8,Methylphenidate
87806-6,Methylphenidate
87807-4,Naloxone
87808-2,chlordiazePOXIDE
Sep-80,Stroke volume
87809-0,Benzoylecgonine
87810-8,Methylenedioxymethamphetamine
87811-6,Meprobamate
87812-4,Flunitrazepam
87813-2,Flurazepam
87814-0,Midazolam
87815-7,fentaNYL
87816-5,6-Monoacetylmorphine
Jul-81,Stroke volume
87817-3,Propoxyphene
87818-1,Tapentadol
87819-9,Tapentadol
87820-7,Zolpidem
87821-5,Zolpidem
87822-3,Naltrexone
87823-1,Naltrexone
87824-9,6-Beta naltrexol
May-82,Stroke volume
87825-6,National Trauma Data Standard - version 2018 set
87826-4,"t(11;18)(q21;q21)(BIRC3,MALT1) fusion transcript"
87827-2,Casts
87828-0,Crystals
87829-8,Bacteria
87830-6,Epithelial cells
87831-4,Yeast
87832-2,Fibroblast growth factor 21.intact
Mar-83,Stroke volume
87833-0,Protein.monoclonal band 3
87834-8,Protein.monoclonal band 2
87835-5,Protein.monoclonal
87836-3,Multisection^WO & W contrast IV
87837-1,Multisection^W contrast IV
87838-9,Multisection^W contrast IV
87839-7,Multisection^W contrast IV
87840-5,Multisection^W contrast IV
87841-3,Multisection^W contrast IV
87842-1,Multisection^W contrast IV
87843-9,Multisection
87844-7,Multisection
87845-4,Multisection
87846-2,Multisection^WO & W contrast IV
87847-0,Multisection^WO contrast && Multisection^W contrast IV
87848-8,Multisection for pulmonary embolus+deep vein thrombosis^W contrast IV
87849-6,Multisection for pulmonary embolus+deep vein thrombosis
87850-4,Multisection^WO & W contrast IV
87851-2,Multisection^W contrast IV
87852-0,Multisection^WO & W contrast IV
87853-8,Multisection^WO & W contrast IV
87854-6,Multisection^W contrast IV
87855-3,Multisection^WO & W contrast IV
87856-1,Multisection^W contrast IV
87857-9,Multisection^WO & W contrast IV
Aug-85,Stroke volume/Body surface area
87858-7,Multisection^W contrast IV
87859-5,Multisection^WO & W contrast IV
87860-3,Multisection^WO contrast
87861-1,Multisection^WO & W contrast IV
87862-9,Multisection^WO contrast && Multisection^W contrast IV
87863-7,Multisection^WO contrast && Multisection^W contrast IV
87864-5,Multisection^WO contrast && Multisection^W contrast IV
87865-2,Multisection^WO contrast && Multisection^W contrast IV
Jun-86,Stroke volume/Body surface area
87866-0,Multisection^WO & W contrast IV
87867-8,Multisection by reconstruction
87868-6,Multisection by reconstruction^WO & W contrast IV
87869-4,Multisection
87870-2,Multisection^WO & W contrast IV
87871-0,Multisection
87872-8,Multisection
87873-6,Multisection^WO & W contrast IV
Apr-87,Stroke volume/Body surface area
87874-4,Multisection^W contrast IV
87875-1,Multisection by reconstruction
87876-9,Multisection
87877-7,Multisection^WO contrast
87878-5,Multisection^W contrast IS
87879-3,Multisection^WO contrast
87880-1,Multisection^W contrast IV
87881-9,Multisection^WO contrast
Feb-88,Stroke volume/Body surface area
87882-7,Multisection
87883-5,Multisection^WO & W contrast IV
87884-3,Multisection^W contrast IS
87885-0,Multisection^WO contrast
87886-8,Multisection^WO contrast
87887-6,Multisection^W Contrast IV
87888-4,Multisection^WO contrast
87889-2,Multisection^WO contrast
878-9,"A,B Ag"
8789-0,Stroke volume/Body surface area
87890-0,Multisection^WO contrast
87891-8,Multisection^WO contrast
87892-6,Multisection^WO contrast
87893-4,Multisection^WO contrast
87894-2,Multisection^WO contrast
87895-9,Multisection^WO contrast
87896-7,Multisection^W contrast IV
87897-5,Multisection^W contrast IV
87898-3,Multisection^WO contrast
87899-1,Multisection^WO contrast
87900-7,Multisection^W contrast IV
87901-5,Multisection^WO & W contrast IV
87902-3,Multisection^W contrast IV
87903-1,Multisection^WO contrast
87904-9,Multisection^WO contrast
87905-6,Guidance for localization of tumor^W 18F-FDG IV
87906-4,Multisection^W contrast IV
87907-2,Multisection for amyloidosis^W radionuclide IV
Aug-90,Stroke volume/Body surface area
87908-0,Multisection^W contrast IV
87909-8,Multisection^W contrast IS
87910-6,Multisection^WO & W contrast IV
87911-4,Multisection^WO & W contrast IV
87912-2,Multisection^WO contrast
87913-0,Multisection by reconstruction
87914-8,Multisection^WO & W contrast IV
87915-5,Guidance for localization of tumor^W 18F-FDG IV+W Contrast IV
Jun-91,Stroke volume/Body surface area
87916-3,Guidance for injection of cyst
87917-1,Multisection^WO contrast
87918-9,Multisection^WO & W contrast IV
87919-7,Multisection
87920-5,Multisection^W contrast IV
87921-3,Multisection^WO contrast
87922-1,Multisection^W contrast IT
87923-9,Rickettsia conorii Ab.IgM
Apr-92,Stroke volume/Body surface area
87924-7,Rickettsia conorii Ab.IgG
87925-4,Reagin Ab
87926-2,Epithelial cells
87927-0,Bacterial susceptibility panel
87928-8,Macroscopic observation
87929-6,Bacteria identified
87930-4,Bacteria identified
87931-2,Bacteria identified
Feb-93,Stroke volume/Body surface area
87932-0,Bacteria identified
87933-8,Bacteria identified
87934-6,Bacteria identified
87935-3,Bacteria identified
87936-1,Bacteria identified
87937-9,Bacteria identified
87938-7,Bacteria identified
87939-5,Bacteria identified
87940-3,Bacteria identified
87941-1,Bacteria identified
87942-9,Bacteria identified
87943-7,Bacteria identified
87944-5,Bacteria identified
87945-2,Borrelia sp identified
87946-0,Borrelia sp identified
87947-8,Borrelia sp DNA
87948-6,Clostridium botulinum
87949-4,Chlamydia trachomatis DNA
87950-2,Chlamydia trachomatis
87951-0,Escherichia coli eaeA gene
87952-8,Helicobacter pylori
87953-6,Helicobacter pylori
87954-4,Bacteria identified
87955-1,Bacteria identified
87956-9,Legionella sp identified
Jul-95,Stroke volume/Body surface area
87957-7,Legionella sp identified
87958-5,Neisseria meningitidis
87959-3,Adenovirus Ag
87960-1,Enterovirus RNA
87961-9,Varicella zoster virus DNA
87962-7,HIV 1 subtype
87963-5,HIV 1 RNA tropism
87964-3,Respiratory pathogens panel
May-96,Stroke volume/Body surface area
87965-0,Microscopic observation
87966-8,Microscopic observation
87967-6,Microscopic observation
87968-4,Microscopic observation
87969-2,Microscopic observation
879-7,"A,B Ag"
87970-0,Microscopic observation
87971-8,Microscopic observation
87972-6,Microscopic observation
Mar-97,Stroke volume/Body surface area
87973-4,Microscopic observation
87974-2,Microscopic observation
87975-9,Microscopic observation
87976-7,Fungus identified
87977-5,Fungus identified
87978-3,Fungus identified
87979-1,Fungus identified
87980-9,Fungus identified
Jan-98,Stroke volume/Body surface area
87981-7,Fungus identified
87982-5,Toxoplasma gondii
87983-3,Toxoplasma gondii DNA
87984-1,Toxoplasma gondii DNA
87985-8,Trichinella spiralis DNA
87986-6,Leishmania sp identified
87987-4,Leishmania sp identified
87988-2,Acanthamoeba sp DNA
87989-0,Toxoplasma gondii DNA
87990-8,Acanthamoeba sp identified
87991-6,Acanthamoeba sp identified
87992-4,Onchocerca sp Ab.IgG
87993-2,Toxoplasma gondii DNA
87994-0,Trypanosoma cruzi Ab.IgG
87995-7,Strongyloides sp identified
87996-5,Fasciola hepatica Ab
87997-3,Trypanosoma cruzi Ab.IgM
87998-1,Amoeba identified
Sep-99,Stroke volume/Body surface area
87999-9,Microscopic observation
88000-5,Microscopic observation
88001-3,Microscopic observation
88002-1,Kanamycin 2.5 ug/mL
88003-9,Acute ischemic stroke subtype
88004-7,Trisomy 18 risk based on maternal age + Pregnancy associated plasma protein A + Choriogonadotropin + Nuchal translucency
May-00,Stroke volume/Body surface area
88005-4,Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2)
88006-2,Octanoylcarnitine (C8)/Carnitine.free (C0)
88007-0,Isovalerylcarnitine+Methylbutyrylcarnitine (C5)/Carnitine.free (C0)
88008-8,Palmitoylcarnitine (C16)/Carnitine.free (C0)
88009-6,Palmitoylcarnitine (C16)/Acetylcarnitine (C2)
88010-4,Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2)
88011-2,Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0)
88012-0,Sialate.lipid bound/Creatinine
Mar-01,Stroke volume/Body surface area
88013-8,Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16)
88014-6,Octanoylcarnitine (C8)/Carnitine.free (C0)
88015-3,Palmitoylcarnitine (C16)/Acetylcarnitine (C2)
88016-1,Glutarylcarnitine (C5-DC)/Acetylcarnitine (C2)
88017-9,Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3)
88018-7,Alanine/Lysine
88019-5,N-acetylgalactosamine-6-sulfatase
88020-3,Functional capacity
Jan-02,Stroke volume/Body surface area
88021-1,Objective assessment of cardiovascular disease
88022-9,5-fluoro PB-22 3-carboxyindole
88023-7,XLR-11 N-(4-hydroxypentyl)
88024-5,Palmitoylcarnitine (C16)/Carnitine.free (C0)
88025-2,Tetradecenoylcarnitine (C14:1)/Carnitine.free (C0)
88026-0,Glutarylcarnitine (C5-DC)/Propionylcarnitine (C3)
88027-8,Rh group Ag
88028-6,Tobacco use panel
88029-4,Tobacco use duration
88030-2,Date quit smokeless tobacco
88031-0,Smokeless tobacco status
88032-8,Organophosphate panel
88033-6,Safety checklist
88034-4,Settings
88035-1,Settings
88036-9,Ventilator alarm events
88037-7,How often have you had five or more drinks in one D during the past Y
88038-5,H little y Ab
Sep-03,Stroke volume/Body surface area
88039-3,little p phenotype
88040-1,Response to cancer treatment
88041-9,little p phenotype
88042-7,little p phenotype
88043-5,P super little k Ab
88044-3,P super little k Ab
88045-0,P super little k Ab
88046-8,P super little k Ag
Jul-04,Stroke volume/Body surface area
88047-6,P super little k Ag
88048-4,P super little k Ag
88049-2,P2 phenotype
880-5,"A,B Ag"
88050-0,P2 phenotype
88051-8,P2 phenotype
88052-6,Cells.CD4-CD8-CD45R+TCR alpha beta+/100 cells.CD3
88053-4,Cells.CD4-CD8-CD45R+TCR alpha beta+
88054-2,Lipopolysaccharide binding protein
88055-9,Liver fibrosis score
88056-7,Aquaporin 4 water channel Ab.IgG
88057-5,Treatment for abnormal Pap test
88058-3,Respiratory measurements
88059-1,Acetaminophen
88060-9,Chemotherapy infusion start time
88061-7,Chemotherapy infusion stop time
Feb-06,Ejection fraction
88062-5,Chemotherapy infusion stop date
88063-3,Chemotherapy infusion start date
88064-1,Porcine epidemic diarrhea virus S1 gene
88065-8,Time of defibrillation
88066-6,EMS physician qualification
88067-4,Unit on scene
88068-2,Cause of intoxication
88069-0,Time of initial encounter
8807-0,Ejection fraction
88070-8,Time of extubation
88071-6,Time of intubation
88072-4,Dispatch center
88073-2,EMS physician vehicle arrived before the paramedics
88074-0,Vehicle name
88075-7,EMS personnel drove themselves to scene
88076-5,Injury severity score
88077-3,Height range of fall
88078-1,Provider assuming care for patient
88079-9,Transport start time
88080-7,Multiple birth set identifier
88081-5,Person completing form title
88082-3,Initial case report processing information
88083-1,Reportable condition response description.brief
88084-9,Reportable condition response information and summary
88085-6,Reportability response report
88086-4,Age range for infant less than 1Mo old
88087-2,Estimated body mass index greater than 40
Aug-08,Ejection fraction
88088-0,EMS transport destination name
88089-8,Specialty services available
88090-6,Physician specialty
88091-4,Bystander observed collapse
88092-2,Rescue operation end
88093-0,Health status prior to emergency incident
88094-8,Sufficiency of procedures performed by bystander
88095-5,Time of arrival of first responder
Jun-09,Ejection fraction
88096-3,Known bacterial drug resistant infection
88097-1,First degree burn area/Body surface area
88098-9,Second degree burn area/Body surface area
88099-7,Third degree burn area/Body surface area
88100-3,Fourth degree burn area/Body surface area
88101-1,Cardiopulmonary resuscitation stop time
88102-9,Provider who performed cardiopulmonary resuscitation
88103-7,Cardiopulmonary resuscitation was being given on arrival at destination
Apr-10,Ejection fraction
88104-5,Rhythmic or arrhythmic heart rate
88105-2,Injured body site
88106-0,Parathyrin.intact
88107-8,Suctioning frequency
88108-6,Symptoms present for at least 24H
88109-4,Role in accident
88110-2,OXcarbazepine^trough
88111-0,Gentamicin^random post extended interval dosing
Feb-11,Ejection fraction
88112-8,Aspartate aminotransferase
88113-6,Erythrocytes
88114-4,Leukocytes
88115-1,Round cells
88116-9,Escherichia coli gene panel
88117-7,Tabulated ethnicity
88118-5,Tabulated ethnicity
88119-3,Bridged race
8812-0,Ejection fraction
88120-1,Bridged race
88121-9,Hunger Vital Sign
88122-7,Within the past 12Mo we worried whether our food would run out before we got money to buy more
88123-5,Within the past 12Mo the food we bought just didn't last and we didn't have money to get more
88124-3,Food insecurity risk
88125-0,Escherichia coli enterotoxigenic gene panel
88126-8,Injury severity
88127-6,Herpes simplex virus identified
88128-4,Herpes simplex virus 1 DNA
88129-2,Respiratory pathogens panel
881-3,ABO & Rh group
88130-0,Cytomegalovirus DNA
88131-8,Cytomegalovirus DNA
88132-6,Varicella zoster virus DNA
88133-4,Herpes simplex virus 2 DNA
88134-2,Varicella zoster virus DNA
88135-9,Varicella zoster virus
88136-7,Varicella zoster virus
88137-5,Respiratory pathogens panel
Aug-13,Ejection fraction
88138-3,Herpes simplex virus DNA
88139-1,Bacteria identified
88140-9,Tropheryma whipplei DNA
88141-7,Bacteria identified
88142-5,Bacteria identified
88143-3,Fungus identified
88144-1,Microscopic observation
88145-8,Microscopic observation
Jun-14,Ejection fraction
88146-6,Microscopic observation
88147-4,Microscopic observation
88148-2,Microscopic observation
88149-0,Microscopic observation
88150-8,Microscopic observation
88151-6,Microscopic observation
88152-4,Microscopic observation
Mar-15,Ejection fraction
88153-2,Microscopic observation
88154-0,Microscopic observation
88155-7,Microscopic observation
88156-5,Microscopic observation
88157-3,Microscopic observation
88158-1,Microscopic observation
88159-9,Microscopic observation
88160-7,Microsporidia DNA
Jan-16,Ejection fraction
88161-5,Toxoplasma gondii
88162-3,Acanthamoeba sp identified
88163-1,Acanthamoeba sp DNA
88164-9,Toxoplasma gondii DNA
88165-6,Mycobacterium tuberculosis DNA
88166-4,Mycobacterium tuberculosis DNA
88167-2,Mycobacterium sp identified
88168-0,Mycobacterium sp identified
88169-8,Microscopic observation
88170-6,Microscopic observation
88171-4,Microscopic observation
88172-2,Microscopic observation
88173-0,Microscopic observation
88174-8,Total score
88175-5,Total score
88176-3,Total score
88177-1,Coxiella burnetii DNA
88178-9,Coxiella burnetii DNA
Sep-17,Ejection fraction
88179-7,Wuchereria bancrofti+Brugia malayi Ab.IgG4
88180-5,Wuchereria bancrofti+Brugia malayi Ab.IgG3
88181-3,Wuchereria bancrofti+Brugia malayi Ab.IgG2
88182-1,Wuchereria bancrofti+Brugia malayi Ab.IgG1
88183-9,Mycobacterium sp identified
88184-7,IgG+IgM.porcine
88185-4,IgG+IgM.porcine
88186-2,Ebola & Marburg virus RNA panel
Jul-18,Ejection fraction
88187-0,Influenza virus A subtype
88188-8,Dengue virus 1+2+3+4 RNA
88189-6,Dengue virus 1+2+3+4 RNA
88190-4,Crimean-Congo hemorrhagic fever virus Ab.IgM
88191-2,Crimean-Congo hemorrhagic fever virus Ab.IgG
88192-0,Crimean-Congo hemorrhagic fever virus RNA
88193-8,Influenza virus A RNA
88194-6,Influenza virus B Ag
May-19,Ejection fraction
88195-3,Influenza virus B RNA
88196-1,Middle East respiratory syndrome coronavirus RNA
88197-9,Middle East respiratory syndrome coronavirus RNA
88198-7,Middle East respiratory syndrome coronavirus RNA
88199-5,Middle East respiratory syndrome coronavirus RNA
88200-1,Influenza virus identified
88201-9,Herpes simplex virus 1 Ag
88202-7,Respiratory syncytial virus B RNA
Mar-20,Ejection fraction geometry formula
88203-5,Dengue virus 1 & 2 & 3 & 4 RNA
88204-3,Respiratory syncytial virus A RNA
88205-0,Lymphocytic choriomeningitis virus Ab.IgM
88206-8,Lymphocytic choriomeningitis virus Ab.IgG
88207-6,Lymphocytic choriomeningitis virus RNA
88208-4,Parainfluenza virus 1 RNA
88209-2,Parainfluenza virus 2 RNA
882-1,ABO & Rh group
88210-0,Parainfluenza virus 3 RNA
Jan-21,End-diastolic volume
88211-8,Rabies virus Ag
88212-6,HIV 1 proviral DNA
88213-4,Rhinovirus RNA
88214-2,Rabies virus RNA
88215-9,Rabies virus RNA
88216-7,Hantavirus puumala RNA
88217-5,Parechovirus RNA
88218-3,Parechovirus RNA
88219-1,Parechovirus RNA
88220-9,Hantavirus puumala RNA
88221-7,Chlamydia trachomatis DNA
88222-5,Human metapneumovirus Ag
88223-3,Francisella sp DNA
88224-1,Neisseria gonorrhoeae DNA
88225-8,Neisseria gonorrhoeae DNA
88226-6,Mycoplasma genitalium DNA
88227-4,Mycoplasma genitalium DNA
88228-2,Mycoplasma genitalium DNA
Sep-22,End-diastolic volume
88229-0,Mycoplasma genitalium DNA
88230-8,Mycoplasma genitalium DNA
88231-6,Microscopic observation
88232-4,Trypanosoma cruzi DNA
88233-2,Babesia sp DNA
88234-0,Microscopic observation
88235-7,Microscopic observation
88236-5,Bacteria identified
Jul-23,End-systolic volume
88237-3,LCDS v4.00 - Functional abilities and goals - planned discharge
88238-1,LCDS v4.00 - Functional abilities and goals
88239-9,Dialysis unit visit as part of chronic kidney disease education
88240-7,Chronic kidney disease education panel
88241-5,Fetal remains disposition method
88242-3,Guidance for infusion of non-thrombolytic
88243-1,Guidance for removal of tunneled catheter
88244-9,Acinetobacter sp (rpsA) gene
May-24,End-systolic volume
88245-6,Bacterial carbapenem resistance blaIMP gene
88246-4,Bacterial carbapenem resistance blaKPC gene
88247-2,Bacterial carbapenem resistance blaNDM gene
88248-0,Bacterial carbapenem resistance blaOXA gene
88249-8,Bacterial carbapenem resistance blaVIM gene
88250-6,Bacterial cephalosporin resistance blaCTX-M gene
88251-4,Bacterial methicillin resistance mecA gene
Feb-25,Hemodynamic measurement method
88252-2,Bacterial vancomycin resistance vanA gene
88253-0,Bacterial vancomycin resistance vanB gene
88254-8,Citrobacter sp (ompA+mrkC) genes
88255-5,Enterobacter sp (gyrB+metB) genes
88256-3,Enterococcus faecalis hsp60 gene
88257-1,Enterococcus faecium hsp60 gene
88258-9,Escherichia coli oppA gene
88259-7,Gram negative bacteria identified
8826-0,Hemodynamic resistance
88260-5,Gram negative blood culture panel
88261-3,Gram positive bacteria identified
88262-1,Gram positive blood culture panel
88263-9,Klebsiella oxytoca (ompA) gene
88264-7,Klebsiella pneumoniae yggE gene
88265-4,Listeria sp (tuf) gene
88266-2,Mycobacterium sp rRNA
88267-0,Proteus sp (atpD) gene
88268-8,Pseudomonas aeruginosa (sodA) gene
88269-6,Staphylococcus aureus gyrB gene
88270-4,Staphylococcus epidermidis hsp60 gene
88271-2,Staphylococcus lugdunensis sodA gene
88272-0,Staphylococcus sp tuf gene
88273-8,Streptococcus agalactiae hsp60 gene
88274-6,Streptococcus anginosus group gyrB gene
88275-3,Streptococcus pneumoniae gryB gene
88276-1,Streptococcus pyogenes hsp60 gene
88277-9,Streptococcus sp tuf gene
Aug-27,Hemodynamic resistance
88278-7,Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.15.1
88279-5,MDS v3.0 - RAI v1.15.1 - Nursing home & Swing bed OMRA (NO & SO) item set
88280-3,MDS v3.0 - RAI v1.15.1 - Nursing home & Swing bed OMRA start of therapy (NS & SS) item set
88281-1,MDS v3.0 - RAI v1.15.1 - Nursing home & Swing bed tracking (NT & ST) item set
88282-9,MDS v3.0 - RAI v1.15.1 - Nursing home comprehensive (NC) item set
88283-7,MDS v3.0 - RAI v1.15.1 - Nursing home discharge (ND) & Swing bed discharge (SD) item set
88284-5,MDS v3.0 - RAI v1.15.1 - Nursing home OMRA start of therapy and discharge (NSD) & Swing bed OMRA start of therapy and discharge (SSD) item set
88285-2,MDS v3.0 - RAI v1.15.1 - Nursing home OMRA-discharge (NOD) & Swing bed OMRA-discharge (SOD) item set
Jun-28,Hemodynamic resistance
88286-0,MDS v3.0 - RAI v1.15.1 - Nursing home part A PPS discharge (NPE) item set
88287-8,MDS v3.0 - RAI v1.15.1 - Nursing home PPS (NP) item set
88288-6,MDS v3.0 - RAI v1.15.1 - Swing bed PPS (SP) item set
88289-4,MDS v3.0 - RAI v1.15.1 - Medications
88290-2,MDS v3.0 - RAI v1.17.2 - Medications received
88291-0,Number of D opiod received in last 7D or since admission &or reentry if less than 7D
88292-8,MDS v3.0 - RAI v1.15.1 - Nursing home quarterly (NQ) item set
88293-6,Glomerular filtration rate/1.73 sq M.predicted.black
Apr-29,Hemodynamic resistance
88294-4,Glomerular filtration rate/1.73 sq M.predicted.non black
88295-1,Antipsychotic medication review
88296-9,"Antipsychotic medications since admission or entry or reentry or the prior OBRA assessment, whichever is more recent"
88297-7,Gradual dose reduction (GDR) attempted
88298-5,Date of last attempted gradual dose reduction
88299-3,Physician documented GDR as clinically contraindicated
88300-9,Date physician documented GDR as clinically contraindicated
88301-7,Immunoglobulin light chains.kappa.free
Feb-30,Hemodynamic resistance
88302-5,Immunoglobulin light chains.lambda.free
88303-3,Immunoglobulin light chains.lambda
88304-1,Immunoglobulin light chains.kappa
88305-8,"MDS v3.0 - RAI v1.15.1 - Medications - NOD, NP, SOD, SP"
88306-6,"MDS v3.0 - RAI v1.15.1 - Medications - NSD, ND, SSD, SD"
88307-4,Restraints and alarms
88308-2,Other alarm used during assessment period
88309-0,Alarms
8831-0,Hemodynamic resistance
88310-8,Bed alarm used during assessment period
88311-6,Chair alarm used during assessment period
88312-4,Floor mat alarm used during assessment period
88313-2,Motion sensor alarm used during assessment period
88314-0,Wander or elopement alarm used during assessment period
88315-7,Multisection for perfusion^WO & W contrast IV && Multisection^W contrast IV
88316-5,Guidance for percutaneous biopsy
88317-3,Guidance for percutaneous aspiration of fluid
88318-1,Multisection^W contrast IV
88319-9,Multisection^W contrast IV
88320-7,Multisection^W contrast IV
88321-5,Guidance for stereotactic localization
88322-3,Multisection^W contrast IV && Multisection for pulmonary embolus^W contrast IV
88323-1,Guidance for percutaneous biopsy
88324-9,Guidance for percutaneous biopsy
88325-6,Guidance for percutaneous biopsy
88326-4,Multisection^WO & W contrast IV
88327-2,Multisection^W contrast IV
Aug-32,Hemodynamic resistance/Body surface area
88328-0,"MDS v3.0 - RAI v1.17.2 - Restraints and alarms - NP, ND, SP, SD"
88329-8,Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 2.0
88330-6,Mobility - admission performance during 3D assessment period
88331-4,Mobility - discharge performance during 3D assessment period
88332-2,IRF-PAI v3.0 - Skin conditions - discharge
88333-0,Memory &or recall ability during 3D assessment period
88334-8,Lean body weight
88335-5,Predominant leukocyte identified
Jun-33,Hemodynamic resistance/Body surface area
88336-3,Microscopic observation
88337-1,Mite identified
88338-9,Coccal bacteria
88339-7,Bacilliform bacteria
88340-5,Mite
88341-3,Cerumen
88342-1,Malassezia sp
88343-9,Leukocytes
Apr-34,Hemodynamic resistance/Body surface area
88344-7,Intracellular bacteria
88345-4,Microscopic exam panel
88346-2,Blood pressure with exercise & post exercise panel
88347-0,Procedure note
88348-8,Transfer summary note
88349-6,Guidance^during surgery
88350-4,Note
Jan-35,Hemodynamic resistance/Body surface area
88351-2,Consultation note
88352-0,Education note
88353-8,History and physical note
88354-6,Note
88355-3,Note
88356-1,Note
88357-9,Alert
88358-7,Alert
88359-5,Alert
88360-3,Alert
88361-1,Alert
88362-9,Medical equipment or product note
88363-7,Medical equipment or product note
88364-5,Actinobacillus pleuropneumoniae Ab.IgG/Positive control
88365-2,Glucose^pre-meal
88366-0,Microscopic observation
88367-8,"Outcome and assessment information set (OASIS) form - version D, D1 - Transfer to inpatient facility - patient discharged or not discharged"
88368-6,"Outcome and assessment information set (OASIS) form - version D, D1 - Resumption of care"
Sep-36,Hemodynamic resistance/Body surface area
88369-4,Outcome and assessment information set (OASIS) form - version D - Follow-up - recertification or other follow-up
88370-2,"Outcome and assessment information set (OASIS) form - version D, D1 - Discharged from agency - death at home"
88371-0,"Outcome and assessment information set (OASIS) form - version D, D1 - Discharged from agency"
88372-8,Outcome and assessment information set (OASIS) form - version D
88373-6,"Outcome and assessment information set (OASIS) form - version D, D1 - Start of care"
88374-4,Chemotherapy infusion start & stop date and time panel
88375-1,Tildipirosin
88376-9,Gamithromycin
Jul-37,Hemodynamic resistance/Body surface area
88377-7,Tildipirosin
88378-5,Gamithromycin
88379-3,International Physical Activity Questionnaire self-administered long form
88380-1,Job-related physical activity panel
88381-9,Do you currently have a job or do any unpaid work outside your home
88382-7,"During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, digging, heavy construction, or climbing up stairs as part of your work for at least 10M at a time"
88383-5,How much time did you usually spend on one of those D doing vigorous physical activities as part of your work during the last 7D
88384-3,"During the last 7D, on how many D did you do moderate physical activities like carrying light loads as part of your work, not including walking, for at least 10M at a time"
May-38,Observation duration
88385-0,How much time did you usually spend on one of those D doing moderate physical activities as part of your work during the last 7D
88386-8,"During the last 7D, on how many D did you walk for at least 10M at a time as a part of your work, not counting any walking you did to travel to or from work"
88387-6,How much time did you usually spend on one of those D walking as part of your work during the last 7D
88388-4,Transportation physical activity panel
88389-2,"During the last 7D, on how many D did you travel in a motor vehicle like a train, bus, car, or tram"
883-9,ABO group
88390-0,"How much time did you usually spend on one of those D traveling in a train, bus, car, tram, or other kind of motor vehicle during the last 7D"
88391-8,"During the last 7D, on how many D did you bicycle for at least 10M at a time to go from place to place"
88392-6,How much time did you usually spend on one of those D to bicycle from place to place during the last 7D
Mar-39,Oxygen saturation
88393-4,"During the last 7D, on how many D did you walk for at least 10M at a time to go from place to place"
88394-2,How much time did you usually spend on one of those D walking from place to place during the last 7D
88395-9,"Housework, house maintenance, and caring for family panel"
88396-7,"During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, chopping wood, shoveling snow, or digging in the garden or yard for at least 10M at a time"
88397-5,How much time did you usually spend on one of those D doing vigorous physical activities in the garden or yard during the last 7D
88398-3,"During the last 7D, on how many D did you do moderate activities like carrying light loads, sweeping, washing windows, and raking in the garden or yard for at least 10M at a time"
88399-1,How much time did you usually spend on one of those D doing moderate physical activities in the garden or yard during the last 7D
88400-7,"During the last 7D, on how many D did you do moderate activities like carrying light loads, washing windows, scrubbing floors and sweeping inside your home for at least 10M at a time"
Jan-40,Oxygen saturation
88401-5,How much time did you usually spend on one of those D doing moderate physical activities inside your home during the last 7D
88402-3,"Recreation, sport, and leisure-time physical activity panel"
88403-1,"Not counting any walking you have already mentioned, during the last 7D, on how many D did you walk for at least 10M at a time in your leisure time"
88404-9,How much time did you usually spend on one of those D walking in your leisure time during the last 7D
88405-6,"During the last 7D, on how many D did you do vigorous physical activities like aerobics, running, fast bicycling, or fast swimming in your leisure time for at least 10M at a time"
88406-4,How much time did you usually spend on one of those D doing vigorous physical activities in your leisure time during the last 7D
88407-2,"During the last 7D, on how many D did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time for at least 10M at a time"
88408-0,How much time did you usually spend on one of those D doing moderate physical activities in your leisure time during the last 7D
88409-8,Time spent sitting panel
88411-4,"During the last 7D, how much time did you usually spend sitting on a weekend D"
88412-2,International Physical Activity Questionnaire telephone short form
Sep-41,Oxygen saturation
88419-7,Vigorous physical activity.work domain
88420-5,Moderate physical activity.work domain
88421-3,Walking physical activity.work domain
88422-1,Total physical activity.work domain
88423-9,Cycle physical activity.active transportation domain
88424-7,Walking physical activity.active transportation domain
88425-4,Total physical activity.active transportation domain
88426-2,Vigorous physical activity.yard work
Jul-42,Oxygen saturation
88427-0,Moderate physical activity.yard work
88428-8,Moderate physical activity.inside chores
88429-6,Total physical activity.domestic and garden domain
88430-4,Walking physical activity.leisure-time domain
88431-2,Vigorous physical activity.leisure-time domain
88432-0,Moderate physical activity.leisure-time domain
88433-8,Total physical activity.leisure-time domain
88434-6,International Physical Activity Questionnaire telephone long form
May-43,Oxygen saturation
88435-3,Cardiac compression start time
88436-1,Patient counseling information
88437-9,How supplied & storage & handling section
88438-7,Cardiopulmonary resuscitation start time
88439-5,Hydrogen/Expired gas^10M post dose fructose PO
88440-3,Hydrogen/Expired gas^10M post dose lactose PO
88441-1,Hydrogen/Expired gas^20M post dose fructose PO
88442-9,Hydrogen/Expired gas^40M post dose lactose PO
Mar-44,Oxygen saturation
88443-7,Hydrogen/Expired gas^40M post dose fructose PO
88444-5,Hydrogen/Expired gas^50M post dose fructose PO
88445-2,Hydrogen/Expired gas^50M post dose lactose PO
88446-0,Hydrogen/Expired gas^20M post dose lactose PO
88447-8,Liver fibrosis interpretation
88448-6,Necroinflammatory activity interpretation
88449-4,Coagulation factor IX activity actual/Normal
8845-0,Oxygen saturation
88450-2,Babesia divergens+MO-1 strain 18S rRNA gene
88451-0,Babesia duncani 18S rRNA gene
88452-8,Babesia microti 18S rRNA gene
88453-6,HIV 1 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA
88454-4,Mumps virus Ab.IgG+IgM
88455-1,California encephalitis virus Ab.IgG & IgM panel
88456-9,California encephalitis virus Ab.IgG+IgM
88457-7,Herpes simplex virus 1 Ab.IgM
88458-5,Mumps virus Ab.IgG & IgM panel
88459-3,Serotonin release 1.0 IU/mL heparin.low molecular weight
88460-1,Serotonin release 50 IU/mL heparin.low molecular weight
88461-9,Babesia microti & divergens+MO-1 strain & duncani 18S rRNA gene panel
88462-7,Carbapenem
88463-5,"OASIS E - Skin Conditions - SOC, ROC"
88464-3,OASIS D - Integumentary status - discharge from agency
88465-0,Types and sources of assistance - start of care or resumption of care
88466-8,Care management - start of care or resumption of care
88467-6,Care management - discharge from agency
Aug-46,Oxygen saturation
88468-4,Types and sources of assistance - discarge from agency
88469-2,"How much has your chest pain, chest tightness or angina limited your enjoyment of life over the past 4W"
884-7,ABO & Rh group
88470-0,Quality of life score
88471-8,Symptom frequency score
88472-6,Physical limitation score
88473-4,"If you had to spend the rest of your life with your chest pain, chest tightness or angina the way it is right now, how would you feel about this"
88474-2,Overall summary score
88475-9,"How many times have you had to take nitroglycerin (nitroglycerin tablets or spray) for your chest pain, chest tightness or angina on average over the past 4W"
Jun-47,Oxygen saturation
88476-7,"How many times have you had chest pain, chest tightness or angina on average over the past 4W"
88477-5,"Lifting or moving heavy objects limited by chest pain, chest tightness or angina over the past 4W"
88478-3,"Gardening, vacuuming, or carrying groceries limited by chest pain, chest tightness or angina over the past 4W"
88479-1,Seattle Angina Questionnaire - 7 items
88480-9,"Walking indoors on level ground limited by chest pain, chest tightness or angina over the past 4W"
88481-7,Activity limitations panel
88482-5,Functional abilities and goals - admission
88483-3,Functional abilities and goals - discharge
Apr-48,Oxygen saturation
88484-1,OASIS D - Functional abilities and goals - follow-up
88485-8,OASIS D - Self-care - follow-up performance
88486-6,OASIS D - Mobility - follow-up performance
88487-4,OASIS D - Patient history and diagnoses - start of care or resumption of care
88488-2,OASIS E - Diagnoses and symptom control
88489-0,OASIS E - Primary diagnosis
88490-8,OASIS E - Other diagnoses
88491-6,OASIS D - Patient history and diagnoses - follow-up
Feb-49,Oxygen saturation
88492-4,OASIS D - Sensory status - start of care or resumption of care or follow-up
88493-2,OASIS D - Integumentary status - start of care or resumption of care
88494-0,"OASIS E - Current number of unhealed pressure injuries at each stage - SOC, ROC, FU"
88495-7,OASIS D - Respiratory status - start of care or resumption of care
88496-5,"OASIS E - Bladder and Bowel - SOC, ROC"
88497-3,OASIS E - Bladder and Bowel - DC
88498-1,OASIS D - Neuro & emotional & behavioral status - start of care or resumption of care
88499-9,OASIS D - ADL and IADLs - start of care or resumption of care
May-88,Cefmetazole
8850-0,Oxygen saturation
88500-4,OASIS D - ADL and IADLs - discharge from agency
88501-2,OASIS D - Medications - start of care or resumption of care
88502-0,OASIS E - Preferences for Customary Routine Activities - DC
88503-8,OASIS D - Therapy need and plan of care
88504-6,OASIS D - Data items collected at inpatient facility admission or agency discharge only - transfer
88505-3,OASIS D - Data items collected at inpatient facility admission or agency discharge only - discharge from agency - death at home
88506-1,OASIS D - Data items collected at inpatient facility admission or agency discharge only - discharge from agency
88507-9,OASIS D - Sensory status - discharge from agency
88508-7,OASIS D - Current number of unhealed pressure injuries at each stage - discharge from agency
88509-5,Helicobacter pylori 23S rRNA clarithromycin resistance mutation
88510-3,Natural killer cell cytotoxicity.30:1 effector to target cell ratio/Positive control
88511-1,Natural killer cell cytotoxicity.0.9:1 effector to target cell ratio/Positive control
88512-9,Natural killer cell cytotoxicity.15:1 effector to target cell ratio/Positive control
88513-7,Natural killer cell cytotoxicity.7.5:1 effector to target cell ratio/Positive control
88514-5,Natural killer cell cytotoxicity.1.88:1 effector to target cell ratio/Positive control
88515-2,Natural killer cell cytotoxicity.3.75:1 effector to target cell ratio/Positive control
88516-0,Gastrointestinal pathogens identified
88517-8,Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells^^corrected for background
Aug-51,Oxygen saturation
88518-6,Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells
88519-4,KIT gene.c.2447A>T
88520-2,OASIS D - Medications - discharge from agency
88521-0,IRF-PAI v2.0 - Staff assessment for mental status
88522-8,"IRF-PAI v2.0 - Hearing, speech, and vision - admission"
88523-6,IRF-PAI v2.0 - Quality indicators - admission
88524-4,IRF-PAI v2.0 - Cognitive patterns - admission
88525-1,IRF-PAI v2.0 - Quality indicators - discharge
Jun-52,Oxygen saturation
88526-9,Guidance for percutaneous biopsy
88527-7,Respiratory syncytial virus
88528-5,Respiratory syncytial virus RNA
88529-3,Parainfluenza virus RNA
88530-1,Parainfluenza virus 4 RNA
88531-9,Parainfluenza virus identified
88532-7,Human metapneumovirus Identified
88533-5,Adenovirus DNA
Apr-53,Oxygen saturation
88534-3,Human metapneumovirus RNA
88535-0,Cytomegalovirus DNA
88536-8,Varicella zoster virus DNA
88537-6,Enterovirus identified
88538-4,Enterovirus RNA
88539-2,Adenovirus DNA
885-4,Am Ab
88540-0,Enterovirus RNA
88541-8,Adenovirus DNA
Feb-54,Oxygen saturation
88542-6,HIV 1 RNA integrase gene mutations detected
88543-4,HIV 1 RNA protease gene mutations detected
88544-2,HIV 1 RNA reverse transcriptase gene mutations detected
88545-9,Cytomegalovirus DNA
88546-7,Chlamydophila pneumoniae DNA
88547-5,Chlamydophila pneumoniae DNA
88548-3,Scedosporium apiospermum DNA
88549-1,Scedosporium apiospermum DNA
88550-9,Scedosporium apiospermum DNA
88551-7,Scedosporium apiospermum DNA
88552-5,Scedosporium prolificans DNA
88553-3,Scedosporium prolificans DNA
88554-1,Scedosporium prolificans DNA
88555-8,Galactomannan Ag
88556-6,Scedosporium prolificans DNA
88557-4,Scedosporium apiospermum DNA
88558-2,Cytomegalovirus DNA
Sep-55,Oxygen saturation
88559-0,Parainfluenza virus 2 RNA
88560-8,Parainfluenza virus 3 RNA
88561-6,Parainfluenza virus 4 RNA
88562-4,Parainfluenza virus RNA
88563-2,Parainfluenza virus 1 RNA
88564-0,Cytomegalovirus
88565-7,Varicella zoster virus DNA
88566-5,Cytomegalovirus Ag
Jul-56,Measurement site
88567-3,Cytomegalovirus DNA
88568-1,Influenza virus identified
88569-9,Ocular pathogens panel
88570-7,Acanthamoeba sp DNA
88571-5,Fetal monosomy X risk
88572-3,Fetal 22q11.2 deletion risk
88573-1,Onchocerca sp Ab.IgG2
88574-9,Onchocerca sp Ab.IgG3
May-57,Hemodynamic shunt method
88575-6,Onchocerca sp Ab.IgG4
88576-4,Bordetella holmesii hIS1001 DNA
88577-2,Legionella pneumophila DNA
88578-0,Clostridium botulinum toxin
88579-8,Mycoplasma pneumoniae DNA
88580-6,Burkholderia sp identified
88581-4,Borrelia sp DNA
88582-2,Bordetella sp identified
Mar-58,Shunt intrapulmonary
88583-0,Bordetella sp DNA
88584-8,Corynebacterium diphtheriae
88585-5,Legionella sp identified
88586-3,Shigella sp identified
88587-1,Legionella sp DNA
88588-9,Legionella sp DNA
88589-7,Clostridium botulinum toxin
88590-5,Legionella pneumophila DNA
Jan-59,Shunt left-right intracardiac
88591-3,Scedosporium prolificans DNA
88592-1,Influenza virus B RNA
88593-9,Human bocavirus DNA
88594-7,Human coronavirus HKU1 RNA
88595-4,Respiratory syncytial virus A RNA
88596-2,Influenza virus B RNA
88597-0,Respiratory syncytial virus B RNA
88598-8,Toscana virus RNA
88599-6,Influenza virus A RNA
88600-2,Influenza virus A RNA
88601-0,Influenza virus A & B RNA panel
88602-8,Adenovirus Ag
88603-6,Adenovirus Ag
88604-4,Human coronavirus HKU1 RNA
88605-1,Human coronavirus OC43 RNA
88606-9,Herpes simplex virus identified
88607-7,Human coronavirus 229E RNA
88608-5,Human coronavirus 229E RNA
Sep-60,Shunt right-left intracardiac
88609-3,Human coronavirus 229E RNA
88610-1,Human coronavirus 229E RNA
88611-9,Human coronavirus HKU1 RNA
88612-7,Human coronavirus HKU1 RNA
88613-5,Human bocavirus DNA
88614-3,Human coronavirus RNA
88615-0,Human coronavirus NL63 RNA
88616-8,Human coronavirus NL63 RNA
Jul-61,Work/Heart rate
88617-6,Human coronavirus NL63 RNA
88618-4,Human coronavirus NL63 RNA
88619-2,Human coronavirus OC43 RNA
886-2,Am Ab
88620-0,Human coronavirus RNA
88621-8,Human coronavirus OC43 RNA
88622-6,Cytomegalovirus
88623-4,Cytomegalovirus
88624-2,Cytomegalovirus
May-62,Work/Heart rate
88625-9,Cytomegalovirus
88626-7,Human coronavirus OC43 RNA
88627-5,Human coronavirus RNA
88628-3,Human coronavirus RNA
88629-1,Chikungunya virus Ab.IgM
88630-9,Chikungunya virus Ab.IgG
88631-7,Microscopic observation
88632-5,Microscopic observation
Mar-63,Work/Heart rate/Body surface area
88633-3,Microscopic observation
88634-1,Microscopic observation
88635-8,Microscopic observation
88636-6,Known exposure
88637-4,Agreement
88638-2,Agreement
88639-0,Controlled substance agreement
88640-8,Consultation note
Jan-64,Work/Heart rate/Body surface area
88641-6,Discharge summary note
88642-4,Note
88643-2,Note
88644-0,Consultation note
88645-7,Discharge summary note
88646-5,Note
88647-3,Parenteral therapy note
88648-1,Parenteral therapy note
88649-9,Parenteral therapy note
88650-7,Parenteral therapy note
88651-5,Parenteral therapy note
88652-3,Parenteral therapy note
88653-1,Acute heart failure within 24H prior to procedure
88654-9,Coronary artery bypass graft surgery
88655-6,Hyperlipidemia
88656-4,Percutaneous coronary intervention
88657-2,Time elapsed since stroke
Aug-65,Arterial pulse intensity
88658-0,Use of supplemental oxygen
88659-8,Timing of thrombolytic administration in relation to cardiac arrest
88660-6,Needle gauge
88661-4,Number of unsuccessful attempts
88662-2,Defibrillator type
88663-0,Person who performed defibrillation
88664-8,Mode of defibrillation
88665-5,Time of return of spontaneous circulation
Jun-66,Arterial pulse quality
88666-3,Number of defibrillation shocks given
88667-1,Defibrillation dose.max
88668-9,Prehospital therapeutic hypothermia method
88669-7,CPR guidance provided by dispatch prior to EMS arrival
88670-5,Return of spontaneous circulation
88671-3,Position &or immobilizer used during EMS transport
88672-1,Warming method
88673-9,Handover
Apr-67,Heart rate
88674-7,Factors related to rescue
88675-4,EMS physician responsible for management at scene
88676-2,Wound coverage status
88677-0,German Interdisciplinary Association of Intensive Care and Emergency Care Medicine - recommended MIND protocol set
88678-8,Herpes simplex virus 1 Ag
88679-6,Herpes simplex virus 2 Ag
88680-4,Herpes simplex virus Ag
88681-2,Herpes simplex virus Ag
88682-0,Leishmania sp Ab.IgM
88683-8,Bacteria identified
88684-6,Microscopic observation
88685-3,Microscopic observation
88686-1,Fungus identified
88687-9,Fungus identified
88688-7,Pneumocystis jiroveci DNA
88689-5,Pneumocystis jiroveci
8869-0,Heart rate
88690-3,Pneumocystis jiroveci DNA
88691-1,Pneumocystis jiroveci Ag
88692-9,Admission evaluation note
88693-7,Discharge summary note
88694-5,Discharge teaching note
88695-2,Used bowel toileting program
88696-0,"Ulcers, wounds and skin problems in the last 7D"
88697-8,Electrolytes & Osmolality panel
88698-6,Protein fractions panel
88699-4,Procainamide & N-acetylprocainamide panel
887-0,Am Ab
88700-0,Babesia microti Ab.IgG & IgM
88701-8,Norovirus genogroups I & II RNA panel
88702-6,Systemic sclerosis panel
88703-4,Bedaquiline
88704-2,Bedaquiline
88705-9,Kanamycin 3.5 ug/mL
88706-7,Linezolid 1.0 ug/mL
88707-5,Moxifloxacin 0.25 ug/mL
Aug-70,Heart rate
88708-3,Dermatophagoides pteronyssinus recombinant (rDer p) 1 Ab.IgE
88709-1,Albumin/Globulin
88710-9,Amylase.pancreatic
88711-7,Beta-2-Microglobulin
88712-5,Triacylglycerol lipase
88713-3,Phosphate
88714-1,Dehydroaripiprazole
88715-8,Norquetiapine
Jun-71,Heart rate
88716-6,Adenovirus A+B+C+D+E+F DNA
88717-4,Candida sp identified
88718-2,Chlamydophila pneumoniae DNA
88719-0,Human coronavirus 229E+HKU1+NL63+OC43 RNA
88720-8,Mycoplasma pneumoniae DNA
88721-6,Rhinovirus+enterovirus RNA
88722-4,Streptococcus pneumoniae serotype
88723-2,Asialoganglioside GM1 Ab.IgG+IgM
Apr-72,Heart rate
88724-0,Ganglioside GD1a Ab.IgG+IgM
88725-7,MDA5 Ab
88726-5,Glial nuclear type 1 Ab
88727-3,Recoverin Ab
88728-1,Babesia microti Ab.IgG & IgM panel
88729-9,Ganglioside GQ1b Ab.IgG+IgM
88730-7,Ganglioside GD1b Ab.IgG+IgM
88731-5,Ganglioside GM2 Ab.IgG+IgM
Feb-73,Heart rate
88732-3,Mi-2 alpha Ab
88733-1,Mi-2 beta Ab
88734-9,Purkinje cell cytoplasmic type Tr Ab
88735-6,PM-SCL-100 Ab
88736-4,PM-SCL-75 Ab
88737-2,RNA polymerase III RP11 Ab
88738-0,RNA polymerase III RP155 Ab
88739-8,TIF1-gamma Ab
8874-0,Heart rate
88740-6,Titin Ab
88741-4,U1 small nuclear ribonucleoprotein A Ab
88742-2,U1 small nuclear ribonucleoprotein C Ab
88743-0,Zinc finger protein of the cerebellum 4 Ab
88744-8,"inv(2)(p21;p23)(EML4,ALK) fusion transcript"
88745-5,Coccidioides immitis Ab.IgG & IgM panel
88746-3,Toxoplasma gondii Ab.IgG & IgM panel
88747-1,Degree of difficulty experienced due to your hip while walking on uneven surface during the last W
88748-9,Degree of difficulty experienced due to your hip while twisting or pivoting on loaded leg during the last W
88749-7,Degree of difficulty experienced due to your hip while running during the last W
88750-5,Degree of difficulty experienced due to your hip while squatting during the last W
88751-3,"How severe is your hip stiffness after sitting, lying or resting later in the day during the last W"
88752-1,How severe is your hip joint stiffness after first wakening in the morning during the last W
88753-9,Difficulties to stride out when walking during the last W
88754-7,Difficulties spreading legs wide apart during the last W
88755-4,"Do you feel grinding, hear clicking or any other type of noise from your hip during the last W"
88756-2,"In general, how much difficulty do you have with your hip"
Jul-75,Heart rate
88757-0,How much are you troubled with lack of confidence in your hip
88758-8,Have you modified your life style to avoid activities potentially damaging to your hip
88759-6,How often are you aware of your hip problem
88760-4,"Amount of hip pain experienced while walking of a hard surface (asphalt, concrete, etc.) in the last W"
88761-2,Amount of hip pain experienced while standing upgright in the last W
88762-0,Degree of difficulty experienced due to your hip while sitting or lying during the last W
88763-8,Amount of hip pain experienced at night while in bed in the last W
88764-6,Amount of hip pain experienced while walking on flat surface in the last W
May-76,Heart rate
88765-3,Amount of hip pain experienced while bending your hip fully in the last W
88766-1,Amount of hip pain experienced while straightening your hip fully in the last W
88767-9,How often is your hip painful
88768-7,Degree of difficulty experienced due to your hip while putting on socks or stockings in the last W
88769-5,Degree of difficulty experienced due to your hip while going shopping in the last W
88770-3,Degree of difficulty experienced due to your hip while getting in or out of car in the last W
88771-1,Degree of difficulty experienced due to your hip while walking on a flat surface in the last W
88772-9,Degree of difficulty experienced due to your hip while standing in the last W
Mar-77,Heart rate
88773-7,Degree of difficulty experienced due to your hip while ascending stairs in the last W
88774-5,"Degree of difficulty experienced due to your hip while doing light domestic duties (cooking, dusting, etc) in the last W"
88775-2,"Degree of difficulty experienced due to your hip while doing heavy domestic duties (moving heavy boxes, scrubbing floors, etc) in the last W"
88776-0,Degree of difficulty experienced due to your hip while getting on or off toilet in the last W
88777-8,Degree of difficulty experienced due to your hip while getting in or out of bath in the last W
88778-6,Degree of difficulty experienced due to your hip while taking off socks or stockings in the last W
88779-4,Degree of difficulty experienced due to your hip while rising from bed in the last W
88780-2,Degree of difficulty experienced due to your hip while descending stairs in the last W
Jan-78,Heart rate
88781-0,Quality of life panel
88782-8,"Function, sports and recreational activities panel"
88783-6,Pain panel
88784-4,Function and daily living panel
88785-1,Stiffness panel
88786-9,Symptoms panel
88787-7,Degree of difficulty experienced due to your knee while kneeling during the last W
88788-5,Degree of difficulty experienced due to your knee while twisting or pivoting on your injured knee during the last W
88789-3,Degree of difficulty experienced due to your knee while jumping during the last W
88790-1,Degree of difficulty experienced due to your knee while running during the last W
88791-9,Degree of difficulty experienced due to your knee while squatting during the last W
88792-7,"How severe is your knee stiffness after sitting, lying or resting later in the day during the last W"
88793-5,Can you bend your knee fully during the last W
88794-3,Can you straighten your knee fully during the last W
88795-0,Does your knee catch or hang up when moving during the last W
88796-8,"Do you feel grinding, hear clicking or any other type of noise when your knee moves during the last W"
88797-6,Do you have swelling in your knee during the last W
88798-4,"In general, how much difficulty do you have with your knee"
Sep-79,Heart rate
88799-2,How much are you troubled with lack of confidence in your knee
88800-8,Have you modified your life style to avoid activities potentially damaging to your knee
88801-6,How often are you aware of your knee problem
88802-4,Amount of knee pain experienced while sitting or lying in the last W
88803-2,Amount of knee pain experienced at night while in bed in the last W
88804-0,Amount of knee pain experienced while walking on flat surface in the last W
88805-7,Amount of knee pain experienced while bending knee fully in the last W
88806-5,How often do you experience knee pain
Jul-80,Heart rate
88807-3,Degree of difficulty experienced due to your knee while putting on socks or stockings in the last W
88808-1,Degree of difficulty experienced due to your knee while going shopping in the last W
88809-9,Degree of difficulty experienced due to your knee while getting in or out of car in the last W
88810-7,Degree of difficulty experienced due to your knee while walking on a flat surface in the last W
88811-5,Degree of difficulty experienced due to your knee while standing in the last W
88812-3,Degree of difficulty experienced due to your knee while ascending stairs in the last W
88813-1,"Degree of difficulty experienced due to your knee while doing light domestic duties (cooking, dusting, etc) in the last W"
88814-9,"Degree of difficulty experienced due to your knee while doing heavy domestic duties (moving heavy boxes, scrubbing floors, etc) in the last W"
May-81,Heart rate
88815-6,Degree of difficulty experienced due to your knee while getting on or off toilet in the last W
88816-4,Degree of difficulty experienced due to your knee while sitting in the last W
88817-2,Degree of difficulty experienced due to your knee while getting in or out of bath in the last W
88818-0,"Degree of difficulty experienced due to your knee while lying in bed (turning over, maintaining hip position) in the last W"
88819-8,Degree of difficulty experienced due to your knee while taking off socks or stockings in the last W
88820-6,Degree of difficulty experienced due to your knee while rising from bed in the last W
88821-4,Degree of difficulty experienced due to your knee while descending stairs in the last W
88822-2,Quality of life panel
Mar-82,Heart rate
88823-0,"Function, sports and recreational activities panel"
88824-8,Pain panel
88825-5,Function and daily living panel
88826-3,Stiffness panel
88827-1,Symptoms panel
88828-9,Renal Impairment subsection
88829-7,Hepatic Impairment subsection
88830-5,Immunogenicity
Jan-83,Heart rate
88831-3,Views^W contrast retrograde intra ureter
88832-1,Views^W contrast retrograde intra ureter
88833-9,Views^W contrast retrograde intra ureter
88834-7,Guidance for dilation
88835-4,Influenza virus A swine origin RNA
88836-2,Microbiology CNAMTS panel
88837-0,Microbiology CNAMTS panel
88838-8,Microbiology CNAMTS panel
88839-6,Microbiology CNAMTS panel
88840-4,Microbiology CNAMTS panel
88841-2,Microbiology CNAMTS panel
88842-0,Microbiology CNAMTS panel
88843-8,Metabolic panel.dialysis patient
88844-6,Microbiology CNAMTS panel
88845-3,Microbiology CNAMTS panel
88846-1,Urinary cell count CNAMTS panel
88847-9,Microbiology CNAMTS panel
88848-7,Microbiology CNAMTS panel
Sep-84,Heart rate rhythm
88849-5,Microbiology CNAMTS panel
88850-3,Microbiology CNAMTS panel
88851-1,PROMIS cognitive function - abilities subset - version 1.0 T-score
88852-9,PROMIS item bank - applied cognition - abilities subset - version 1.0
88853-7,"I have been able to remember where I put things, like my keys or my wallet in past 7D"
88854-5,I have been able to add and subtract numbers in my head without difficulty in past 7D
88855-2,Diagnosis to transplant time duration score for risk calculation
Jun-85,Heart rate measurement site
88856-0,Hematopoietic stem cell transplantation risk score
88857-8,Donor-recipient gender combination score for risk calculation
88858-6,Donor type score for risk calculation
88859-4,Disease stage score for risk calculation
88860-2,Age score for risk calculation
88861-0,Hematopoietic stem cell transplantation risk panel
88862-8,Hematopoietic stem cell transplantation risk score interpretation
88863-6,Lung cancer antibody panel
Apr-86,Heart rate method
88864-4,Microbiology CNAMTS panel
88865-1,Chemical XXX
88866-9,Chemical XXX
88867-7,Chemical XXX
88868-5,Veterinary toxicology panel
88869-3,Veterinary toxicology panel
88870-1,Drug regimen review identified potential medication issues in the last 3D
88871-9,Medication follow-up in the last 3D
Feb-87,Class
88872-7,IRF-PAI v2.0 - Medications - admission
88873-5,Sympathomimetics
88874-3,Mycobacterium tuberculosis complex DNA
88875-0,Measles virus genotype A vaccine strain N gene
88876-8,Measles virus genotype A vaccine strain N gene
88877-6,Date vaccination indication effective
88878-4,Date of condition abatement
88879-2,Date vaccination indication expires
888-8,Blood group antibodies identified
8888-0,Heart rate measure duration
88880-0,Monocyte distribution width
88881-8,Smith extractable nuclear D Ab
88882-6,Smith extractable nuclear B Ab
88883-4,Connective tissue autoimmune Ab panel
88884-2,Fatty acid omega-3 & omega-6 panel
88885-9,Delafloxacin
88886-7,Telavancin
88887-5,Isavuconazole
88888-3,Pancreatic stone protein
88889-1,Middle east respiratory syndrome coronavirus RNA
88890-9,Parainfluenza virus 1+2+3+4 RNA
88891-7,Human coronavirus 229E+HKU1+NL63+OC43 RNA
88892-5,Meropenem+Vaborbactam
88893-3,Coagulation tissue factor induced.PIVKA sensitive
88894-1,Brivaracetam
88895-8,Perampanel
88896-6,Reboxetine
88897-4,Adenovirus Ag
Aug-89,Heart rate
88898-2,Adenovirus
88899-0,Adenovirus
88900-6,Adenovirus
88901-4,Adenovirus
88902-2,Adenovirus
88903-0,Influenza virus B Ab.IgG
88904-8,Influenza virus A Ag
88905-5,Influenza virus B Ag
Jun-90,Heart rate
88906-3,Parainfluenza virus 1 Ag
88907-1,Parainfluenza virus 2 Ag
88908-9,Parainfluenza virus 3 Ag
88909-7,Respiratory syncytial virus Ag
88910-5,Taenia sp DNA
88911-3,Taenia solium larva DNA
88912-1,Taenia solium larva DNA
88913-9,Strongyloides stercoralis DNA
Apr-91,Heart rate
88914-7,Acanthamoeba sp DNA
88915-4,Filaria DNA
88916-2,Leishmania sp DNA
88917-0,Leishmania sp DNA
88918-8,Filaria DNA
88919-6,Taenia solium larva Ab.IgG
88920-4,Taenia solium larva Ag
88921-2,Echinococcus granulosus Ab
Feb-92,Heart rate
88922-0,Actinomyces sp identified
88923-8,"1,3 beta glucan"
88924-6,Microsporidia DNA
88925-3,Microsporidia DNA
88926-1,Histoplasma capsulatum DNA
88927-9,Cryptosporidium sp DNA
88928-7,Cryptosporidium sp DNA
88929-5,Guidance additional for percutaneous transluminal angioplasty
8893-0,Heart rate
88930-3,Guidance for dilation of stricture+placement of stent^W contrast IV
88931-1,Guidance for embolization for tumor^W embolic agent IA
88932-9,Guidance for embolization for tumor^W embolic agent IA
88933-7,Guidance for embolization^W embolic agent IV
88934-5,Guidance for embolization^W embolic agent IA
88935-2,Guidance for chemoembolization for tumor^W chemotherapy IA+W embolic agent IA
88936-0,Guidance for injection^W Tc-99m MAA IA
88937-8,Guidance for placement of stent
88938-6,Guidance for placement of stent
88939-4,Guidance for radioembolization for tumor^W Yttrium-90 IA
88940-2,Guidance for repair of aneurysm
88941-0,Guidance for repair of aneurysm
88942-8,Guidance for repair of endoleak
88943-6,Guidance for venous sampling
88944-4,Views for AV shunt^W Tc-99m MAA+W intraarterial hepatic injection
88945-1,MDS v3.0 - RAI v1.16.1 - Nursing home discharge (ND) & Swing bed discharge (SD) item set
88946-9,MDS v3.0 - RAI v1.16.1 - Nursing home OMRA start of therapy and discharge (NSD) & Swing bed OMRA start of therapy and discharge (SSD) item set
88947-7,MDS v3.0 - RAI v1.16.1 - Nursing home OMRA-discharge (NOD) & Swing bed OMRA-discharge (SOD) item set
Aug-94,P wave
88948-5,MDS v3.0 - RAI v1.16.1 - Nursing home part A PPS discharge (NPE) item set
88949-3,MDS v3.0 - RAI v1.16.1 - Nursing home PPS (NP) item set
88950-1,MDS v3.0 - RAI v1.16.1 - Swing bed PPS (SP) item set
88951-9,MDS v3.0 - RAI v1.16.1 - Nursing home & Swing bed OMRA (NO & SO) item set
88952-7,MDS v3.0 - RAI v1.16.1 - Nursing home & Swing bed OMRA start of therapy (NS & SS) item set
88953-5,MDS v3.0 - RAI v1.16.1 - Nursing home & Swing bed tracking (NT & ST) item set
88954-3,MDS v3.0 - RAI v1.16.1 - Nursing home comprehensive (NC) item set
May-95,P wave
88955-0,MDS v3.0 - RAI v1.16.1 - Nursing home quarterly (NQ) item set
88956-8,Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.16.1
88957-6,MDS v3.0 - RAI v1.16.1 - Active diagnoses
88958-4,MDS v3.0 - RAI v1.16.1 - Health conditions
88959-2,"MDS v3.0 - RAI v1.16.1 - Health conditions - NP, NQ, SP"
889-6,Blood group antibodies identified
88960-0,MDS v3.0 - RAI v1.17.2 - Skin conditions
88961-8,MDS v3.0 - RAI v1.17.2 - Current number of unhealed pressure injuries at each stage
88962-6,MDS v3.0 - RAI v1.17.2 - Medications
Mar-96,P wave
88963-4,"MDS v3.0 - RAI v1.17.2 - Medications - ND, SD"
88964-2,"MDS v3.0 - RAI v1.16.1 - Medications - NOD, SOD"
88965-9,"MDS v3.0 - RAI v1.17.2 - Medications - NP, SP"
88966-7,Hyaline casts
88967-5,Leucine crystals
88968-3,Waxy casts
88969-1,Tyrosine crystals
88970-9,Erythrocyte casts
Jan-97,QRS complex
88971-7,Mixed cellular casts
88972-5,Broad casts
88973-3,Crystals.amorphous
88974-1,Granular casts
88975-8,Fatty casts
88976-6,Leukocyte casts
88977-4,Epithelial casts
88978-2,Fat
88979-0,Mucus
88980-8,Swollen joint
88981-6,Tender joint
88982-4,Rheumatoid arthritis disease activity level
88983-2,Tender joint
88984-0,Swollen joint
88985-7,Alpha-amanitin+gamma-amanitin
88986-5,Elvitegravir
88987-3,Maraviroc
88988-1,Melperone
Sep-98,Arterial pulse intensity
88989-9,Perazine
88990-7,Sertindole
88991-5,Zotepine
88992-3,Ustekinumab Ab
88993-1,Acute kidney injury risk
88994-9,Arachidonate/Fatty acids.C14-C24
88995-6,Docosahexaenoate/Fatty acids.C14-C24
88996-4,Eicosapentaenoate/Arachidonate
Jul-99,Arterial pulse intensity
88997-2,Eicosapentaenoate/Fatty acids.C14-C24
88998-0,Eicosapentaenoate+Docosahexaenoate/Fatty acids.C14-C24
88999-8,Eicosapentaenoate+docosahexaenoate/Fatty acids.C14-C24 index risk
89000-4,Ethyl glucuronide
89001-2,Cancer-associated gene Ab
89002-0,GBU4-5 Ab
Mar-00,Arterial pulse intensity
89003-8,HuD Ab
89004-6,Melanoma-associated antigen A4 Ab
89005-3,NY-ESO-1 Ab
89006-1,p53 Ab
89007-9,SOX-2 Ab
89008-7,Station name
89009-5,Encounter location
89010-3,EMS physician name
Jan-01,Arterial pulse intensity
89011-1,EMS assistant name
89012-9,EMS assistant qualification
89013-7,Certified first responder was on site when EMS unit arrived
89014-5,Oxygen was used for preoxygenation
89015-2,Pure tone threshold audiometry panel
89016-0,Hearing threshold^1000 Hz
89017-8,Hearing threshold^1000 Hz
89018-6,Hearing threshold^2000 Hz
89019-4,Hearing threshold^2000 Hz
89020-2,Hearing threshold^3000 Hz
89021-0,Hearing threshold^3000 Hz
89022-8,Hearing threshold^4000 Hz
89023-6,Hearing threshold^4000 Hz
89024-4,Hearing threshold^500 Hz
89025-1,Hearing threshold^500 Hz
89026-9,Hearing threshold^6000 Hz
89027-7,Hearing threshold^6000 Hz
89028-5,Hearing threshold^8000 Hz
Sep-02,Arterial pulse intensity
89029-3,Hearing threshold^8000 Hz
89030-1,Progress note
89031-9,Consultation note
89032-7,Consultation note
89033-5,Consultation note
89034-3,Initial evaluation note
89035-0,Note
89036-8,Note
Jul-03,Arterial pulse intensity
89037-6,CDKN2A gene deletion+duplication & full mutation analysis
89038-4,CHEK2 gene deletion+duplication & full mutation analysis
89039-2,MSH2 gene deletion+duplication & full mutation analysis & EPCAM gene exons 8 & 9 deletion+duplication
890-4,Blood group antibody screen
89040-0,Rubella virus Ab
89041-8,Lung cancer antibody
89042-6,Eszopiclone
89043-4,Zopiclone-N-oxide
89044-2,Basic metabolic & albumin panel
May-04,Arterial pulse intensity
89045-9,Indicate the patient's primary medical condition category
89046-7,"MDS v3.0 - RAI v1.17.2 - Skin conditions - ND, SD"
89047-5,"MDS v3.0 - RAI v1.16.1 - Skin conditions - NOD, SOD"
89048-3,MDS v3.0 - RAI v1.16.1 - Bladder and bowel - NC
89049-1,"MDS v3.0 - RAI v1.16.1 - Bladder and bowel - NP, NQ, SP"
89050-9,"MDS v3.0 - RAI v1.15.1, v1.16.1 - Bladder and bowel - NS, NO, SS, SO"
89051-7,MDS v3.0 - RAI v1.17.2 - Skin conditions - IPA
Feb-05,Arterial pulse intensity
89052-5,MDS v3.00 - RAI v1.15.1 - Skin conditions
89053-3,"MDS v3.0 - RAI v1.15.1 - Skin conditions - NOD, SOD"
89054-1,Circulatory assistive device(s) used^preoperative
89055-8,Circulatory assistive device(s) used^postoperative
89056-6,Circulatory assistive device(s) used^during surgery
89057-4,Permission to receive text messages
89058-2,Email address
89059-0,Secondary contact name
8906-0,Arterial pulse intensity
89060-8,Phone number
89061-6,Insurance group number
89062-4,Severe bleeding related to aspirin use
89063-2,Type of anticoagulant medication used
89064-0,Type of medication used for stomach upset
89065-7,Type of nonsteroidal anti-inflammatory drugs (NSAIDs) used several times a week
89066-5,Year aspirin regimen began
89067-3,Type of blood thinning medication used
89068-1,Date aspirin discontinued
89069-9,Enteric coated aspirin tablet
89070-7,ADAPTABLE patient reported item set
89071-5,Enrollment item set
89072-3,Aspirin dose^post enrollment in ADAPTABLE study
89073-1,Reason for discontinuing aspirin use
89074-9,Aspirin usage^post enrollment in ADAPTABLE study
89075-6,Willing to change aspirin dose
89076-4,Aspirin usage^pre enrollment in ADAPTABLE study
89077-2,Adequacy of information on+time spent reading ADAPTABLE web site
Aug-07,Arterial pulse intensity
89078-0,Hospitalization^post enrollment in ADAPTABLE study
89079-8,Events^during hospitalization
89080-6,Satisfaction with using ADAPTABLE web site
89081-4,Aspirin dose^pre enrollment in ADAPTABLE study
89082-2,Early visit item set
89083-0,Follow-up visit item set
89084-8,I have trouble doing all of my regular leisure activities with others in the past 7D
89085-5,Capacity.total/Capacity.predicted
Jun-08,Arterial pulse intensity
89086-3,Diameter
89087-1,Body weight
89088-9,WIC services recipient
89089-7,Immigration status
89090-5,Everyday Cognition - Study Partner Report Form
89092-1,"Compared to 10Y ago, has there been any change in thinking things through before acting"
89093-9,"Compared to 10Y ago, has there been any change in cooking or working and talking at the same time"
Apr-09,Arterial pulse intensity
89094-7,"Compared to 10Y ago, has there been any change in the ability to concentrate on a task without being distracted by external things in the environment"
89095-4,"Compared to 10Y ago, has there been any change in returning to a task after being interrupted"
89096-2,"Compared to 10Y ago, has there been any change in the ability to do two things at once"
89097-0,"Compared to 10Y ago, has there been any change in using an organized strategy to manage a medication schedule involving multiple medications"
89098-8,"Compared to 10Y ago, has there been any change in keeping mail and papers organized"
89099-6,"Compared to 10Y ago, has there been any change in prioritizing tasks by importance"
89100-2,"Compared to 10Y ago, has there been any change in keeping financial records organized"
89101-0,"Compared to 10Y ago, has there been any change in balancing the checkbook without error"
Feb-10,Arterial pulse intensity
89102-8,"Compared to 10Y ago, has there been any change in keeping living and work space organized"
89103-6,"Compared to 10Y ago, has there been any change in thinking ahead"
89104-4,"Compared to 10Y ago, has there been any change in developing a schedule in advance of anticipated events"
89105-1,"Compared to 10Y ago, has there been any change in the ability to anticipate weather changes and plan accordingly (i.e., bring a coat or umbrella)"
89106-9,"Compared to 10Y ago, has there been any change in planning the sequence of stops on a shopping trip"
89107-7,"Compared to 10Y ago, has there been any change in finding his or her way around a house visited many times"
89108-5,"Compared to 10Y ago, has there been any change in finding his or her way around a familiar store"
89109-3,"Compared to 10Y ago, has there been any change in remembering things that happened recently (such as recent outings, events in the news)"
8911-0,Arterial pulse intensity
89110-1,"Compared to 10Y ago, has there been any change in finding the way back to a meeting spot in the mall or other location"
89111-9,"Compared to 10Y ago, has there been any change in finding one's car in a parking lot"
89112-7,"Compared to 10Y ago, has there been any change in reading a map and helping with directions when someone else is driving"
89113-5,"Compared to 10Y ago, has there been any change in following a map to find a new location"
89114-3,"Compared to 10Y ago, has there been any change in understanding spoken directions or instructions"
89115-0,"Compared to 10Y ago, has there been any change in describing a program he or she has watched on TV"
89116-8,"Compared to 10Y ago, has there been any change in remembering the meaning of common words"
89117-6,"Compared to 10Y ago, has there been any change in understanding the point of what other people are trying to say"
89118-4,"Compared to 10Y ago, has there been any change in following a story in a book or on TV"
89119-2,"Compared to 10Y ago, has there been any change in communicating thoughts in a conversation"
891-2,Blood group antibody screen.cell I
89120-0,"Compared to 10Y ago, has there been any change in finding the right words to use in a conversation"
89121-8,"Compared to 10Y ago, has there been any change in verbally giving instructions to others"
89122-6,"Compared to 10Y ago, has there been any change in forgetting the names of objects"
89123-4,"Compared to 10Y ago, has there been any change in remembering appointments, meetings, or engagements"
89124-2,"Compared to 10Y ago, has there been any change in remembering he or she has already told someone something"
89125-9,"Compared to 10Y ago, has there been any change in remembering the current date or day of the week"
89126-7,"Compared to 10Y ago, has there been any change in repeating stories &or questions"
89127-5,"Compared to 10Y ago, has there been any change in remembering where he or she has placed objects"
Aug-12,Arterial pulse intensity
89128-3,"Compared to 10Y ago, has there been any change in recalling conversations a few days later"
89129-1,"Compared to 10Y ago, has there been any change in remembering a few shopping items without a list"
89130-9,"Compared to 10Y ago, has there been any change in finding his or her way around a familiar neighborhood"
89133-3,Everyday Cognition - Participant Self Report Form
89135-8,"Compared to 10Y ago, has there been any change in verbally giving instructions to others"
Jun-13,Arterial pulse intensity
89136-6,"Compared to 10Y ago, has there been any change in using an organized strategy to manage a medication schedule involving multiple medications"
89137-4,"Compared to 10Y ago, has there been any change in understanding the point of what other people are trying to say"
89138-2,"Compared to 10Y ago, has there been any change in understanding spoken directions or instructions"
89139-0,"Compared to 10Y ago, has there been any change in thinking things through before acting"
89140-8,"Compared to 10Y ago, has there been any change in thinking ahead"
89141-6,"Compared to 10Y ago, has there been any change in the ability to do two things at once"
89142-4,"Compared to 10Y ago, has there been any change in the ability to concentrate on a task without being distracted by external things in the environment"
89143-2,"Compared to 10Y ago, has there been any change in the ability to anticipate weather changes and plan accordingly (i.e. bring a coat or umbrella)"
Apr-14,Pulse wave form
89144-0,"Compared to 10Y ago, has there been any change in returning to a task after being interrupted"
89145-7,"Compared to 10Y ago, has there been any change in repeating stories &or questions"
89146-5,"Compared to 10Y ago, has there been any change in remembering where I have placed objects"
89147-3,"Compared to 10Y ago, has there been any change in remembering things that happened recently (such as recent outings, events in the news)"
89148-1,"Compared to 10Y ago, has there been any change in remembering the meaning of common words"
89149-9,"Compared to 10Y ago, has there been any change in remembering the current date or day of the week"
89150-7,"Compared to 10Y ago, has there been any change in remembering I have already told someone something"
Jan-15,Pulse wave form
89151-5,"Compared to 10Y ago, has there been any change in remembering appointments, meetings, or engagements"
89152-3,"Compared to 10Y ago, has there been any change in remembering a few shopping items without a list"
89153-1,"Compared to 10Y ago, has there been any change in recalling conversations a few days later"
89154-9,"Compared to 10Y ago, has there been any change in reading a map and helping with directions when someone else is driving"
89155-6,"Compared to 10Y ago, has there been any change in prioritizing tasks by importance"
89156-4,"Compared to 10Y ago, has there been any change in planning a sequence of stops on a shopping trip"
89157-2,"Compared to 10Y ago, has there been any change in keeping mail and papers organized"
89158-0,"Compared to 10Y ago, has there been any change in keeping living and work space organized"
89159-8,"Compared to 10Y ago, has there been any change in keeping financial records organized"
89160-6,"Compared to 10Y ago, has there been any change in forgetting the names of objects"
89161-4,"Compared to 10Y ago, has there been any change in following a story in a book or on TV"
89162-2,"Compared to 10Y ago, has there been any change in following a map to find a new location"
89163-0,"Compared to 10Y ago, has there been any change in finding the right words to use in a conversation"
89164-8,"Compared to 10Y ago, has there been any change in finding my way back to a meeting spot in the mall or other location"
89165-5,"Compared to 10Y ago, has there been any change in finding my way around a house visited many times"
89166-3,"Compared to 10Y ago, has there been any change in finding my way around a familiar store"
89167-1,"Compared to 10Y ago, has there been any change in finding my way around a familiar neighborhood"
89168-9,"Compared to 10Y ago, has there been any change in finding my car in a parking lot"
Sep-16,Pulse wave form
89169-7,"Compared to 10Y ago, has there been any change in developing a schedule in advance of anticipated events"
89170-5,"Compared to 10Y ago, has there been any change in describing a program I have watched on TV"
89171-3,"Compared to 10Y ago, has there been any change in cooking or working and talking at the same time"
89172-1,"Compared to 10Y ago, has there been any change in communicating thoughts in a conversation"
89173-9,"Compared to 10Y ago, has there been any change in balancing the checkbook without error"
89174-7,Are you concerned that you have a memory or other thinking problem
89175-4,Billing information panel
89176-2,Intervention &or services provided panel
Jul-17,Pulse wave form
89177-0,Movement system diagnosis
89178-8,Financial responsibility amount
89179-6,Therapeutic exercise performed
89180-4,Motor function training performed
89181-2,Manual therapy technique used
89182-0,Integumentary repair and protection technique used
89183-8,Functional training performed
89184-6,Biophysical agent used
May-18,Pulse wave form
89185-3,Assistive technology provided
89186-1,Airway clearance technique performed
89187-9,Instructions provided
89188-7,Medication documentation status
89189-5,Clinical presentation status
89190-3,Performance-based measure name
89191-1,Performance-based measure score
89192-9,Performance-based measure score interpretation
Mar-19,Pulse wave form
89193-7,Patient reported outcome measure score interpretation
89194-5,Patient reported outcome measure score
89195-2,Patient reported outcome measure name
89196-0,Patient reported outcome measure panel
89197-8,Performance-based measure panel
89198-6,Mean score
89199-4,Mean score
892-0,Blood group antibody screen.cell III
89200-0,Phenotypic lab test method used to determine resistance
Jan-20,Pulse wave form
89201-8,Molecular lab test method used to determine resistance
89202-6,County
89203-4,Airway suction device
89204-2,Patient Health Questionnaire-9: Modified for Teens total score
89205-9,Center for Epidemiologic Studies Depression Scale-Revised total score
89206-7,Patient Health Questionnaire-9: Modified for Teens
89207-5,Center for Epidemiologic Studies Depression Scale-Revised
89208-3,Beck Depression Inventory Fast Screen total score
89209-1,Beck Depression Inventory II total score
89210-9,Beck Depression Inventory II
89211-7,Beck Depression Inventory Fast Screen
89212-5,Reason for difficult intubation
89213-3,History and physical note
89214-1,Discharge summary note
89215-8,Admission history and physical note
89216-6,Consultation note
89217-4,Discharge instructions
89218-2,Discharge summary note
Sep-21,Pulse wave form
89219-0,Discharge teaching note
89220-8,Education note
89221-6,History and physical note
89222-4,Initial evaluation note
89223-2,Procedure note
89224-0,Progress note
89225-7,Referral note
89226-5,Transfer summary note
Jul-22,Pulse wave form
89227-3,Consultation note
89228-1,Discharge instructions
89229-9,Discharge teaching note
89230-7,Education note
89231-5,Initial evaluation note
89232-3,Procedure note
89233-1,Progress note
89234-9,Referral note
May-23,Pulse wave form
89235-6,Transfer summary note
89236-4,Diagnostic study note
89237-2,Flowsheet
89238-0,Flowsheet
89239-8,Plan of care note
89240-6,Plan of care note
89241-4,Note
89242-2,Discharge checklist
Mar-24,Pulse wave form
89243-0,Performance status
89244-8,Performance status panel
89245-5,Performance status
89246-3,Performance status panel
89247-1,Performance status
89248-9,Microorganism identified
89249-7,Carbapenem resistance gene identified
8925-0,Pulse wave form
89250-5,Device or anatomic structure visible in wound
89251-3,Condition present on admission
89252-1,Episode
89253-9,Trend
89254-7,Wound bed panel
89255-4,Area of identified wound bed color/Area of wound bed
89256-2,Wound edge panel
89257-0,Wound tunneling panel
89258-8,Wound undermining panel
89259-6,Exudate
89260-4,Area of wound
89261-2,Clinical course
89262-0,Performance status
89263-8,Special circumstances associated observations panel
89264-6,Date specimen sent to public health laboratory
89265-3,"Procedures, Services, or Supplies modifier"
89266-1,"Procedures, Services, or Supplies code"
89267-9,Intravascular diastolic^lying in L-lateral position
Aug-26,Pulse wave form
89268-7,Intravascular systolic^lying in L-lateral position
89269-5,Body height^at birth
89270-3,Body mass index
89271-1,Heart rate^during apnea
89272-9,Oxygen saturation^during apnea
89273-7,Heart rate^W exercise
89274-5,Breaths^W exercise
89275-2,Reason rescue operation was canceled
Jun-27,Pulse wave form
89276-0,Oxygen saturation^W exercise
89277-8,Oxygen saturation^during anesthesia
89278-6,Heart rate^during anesthesia
89279-4,Breaths^during anesthesia
89280-2,Intravascular systolic^during anesthesia
89281-0,Intravascular diastolic^during anesthesia
89282-8,Heart rate^post bronchodilation
89283-6,Multisection^W contrast IV
Apr-28,Pulse wave form
89284-4,Multisection^W contrast IV
89285-1,Executive functioning: divided attention panel
89286-9,Memory panel
89287-7,Language panel
89288-5,Visual-spatial and perceptual abilities panel
89289-3,Executive functioning: planning panel
89290-1,Executive functioning: organization panel
89291-9,Heart rate^W pain
Feb-29,Pulse wave form
89292-7,Breaths^W pain
89293-5,Executive functioning: organization panel
89294-3,Executive functioning: planning panel
89295-0,Visual-spatial and perceptual abilities panel
89296-8,Language panel
89297-6,Memory panel
89298-4,Executive functioning: divided attention panel
89299-2,Heart rate special circumstances
Mar-89,Cefmetazole
8930-0,Class
89300-8,Tapentadol glucuronide
89301-6,oxyMORphone-3-glucuronide
89302-4,Noroxymorphone
89303-2,Noroxycodone
89304-0,Norhydrocodone
89305-7,Norbuprenorphine-3-glucuronide
89306-5,Nortapentadol
89307-3,Naloxone-3-glucuronide
89308-1,Morphine-6-glucuronide
89309-9,HYDROmorphone-3-glucuronide
89310-7,Codeine-6-glucuronide
89311-5,Cells.CD3-CD45+/100 cells
89312-3,Cells.CD3+CD45+
89313-1,Cells.CD3-CD45+
89314-9,Bacterial 23S rRNA gene azithromycin resistance mutation
89315-6,Cells.CD4+CD25+CD45RA+CD127Low+
89316-4,Cells.CD4+CD25+CD45RO+CD127Low+
89317-2,Cells.CD4+CD25-CD127+
Aug-31,Chest tube site
89318-0,Cells.CD25-CD127+/100 Cells.CD4
89319-8,Cells.CD25+CD45RA+CD127Low+/100 Cells.CD4
89320-6,Cells.CD25+CD45RO+CD127Low+/100 Cells.CD4
89321-4,Buprenorphine-3-glucuronide
89322-2,Norbuprenorphine-3-glucuronide
89323-0,APOB gene targeted mutation analysis
89324-8,Insulin.intact
89325-5,Cells.CD3+CD8+CD28+HLA DR+
Jun-32,Class
89326-3,Cells.CD3+CD4+CD28+HLA DR+
89327-1,Cells.CD3+CD8+CD27-CD45RO+CD62L-
89328-9,Cells.CD3+CD4+CD27-CD45RO+CD62L-
89329-7,Cells.CD3+CD4+CD27+CD45RO+CD62L+
89330-5,Cells.CD3+CD8+CD27+CD62L+
89331-3,Cells.CD3+CD4+CD27+CD62L+
89332-1,Cells.CD28+HLA DR+/100 Cells.CD3+CD8+
89333-9,Cells.CD28+HLA DR+/100 Cells.CD3+CD4+
Apr-33,Class
89334-7,Cells.CD27-CD45RO+CD62L-CCR7-/100 Cells.CD3+CD8+
89335-4,Cells.CD27+CD45RO+CD62L+CCR7+/100 Cells.CD3+CD8+
89336-2,Cells.CD45RO/100 Cells.CD3+CD8+
89337-0,Cells.CD27-CD45RO+CD62L-CCR7-/100 Cells.CD3+CD4+
89338-8,Cells.CD27+CD45RO+CD62L+CCR7+/100 Cells.CD3+CD4+
89339-6,Cells.CD27+CD62L+/100 Cells.CD3+CD8+
89340-4,Cells.CD27+CD62L+/100 Cells.CD3+CD4+
89341-2,Cells.CD38+IgM+/100 Cells.CD19
Feb-34,Enteral tube site
89342-0,Babesia sp 18S rRNA
89343-8,Cells.CD19+CD38+IgM-
89344-6,Cells.CD38+IgM-/100 Cells.CD19
89345-3,Cells.CD19+IgM+
89346-1,Cells.IgM/100 Cells.CD19
89347-9,Cells.CD19+CD27+IgD-IgM+
89348-7,Cells.CD27+IgD-IgM+/100 Cells.CD19
89349-5,Cells.CD19+CD27+IgD-IgM-
89350-3,Cells.CD27+IgD-IgM-/100 Cells.CD19
89351-1,Cells.CD19+CD27+IgD+IgM+
89352-9,Cells.CD27+IgD+IgM+/100 Cells.CD19
89353-7,Cells.CD19+CD27+
89354-5,Cells.CD19+CD21-
89355-2,Cells.CD21-/100 Cells.CD19
89356-0,Cells.CD21/100 Cells.CD19
89357-8,Cells.CD19+CD38+IgM+
89358-6,Cells.CD27/100 Cells.CD19
Sep-35,IO tube site
89359-4,Hepatitis C virus Ab.IgG
89360-2,Cells.CD45RA/100 Cells.CD4
89362-8,Cells.CD45RO/100 Cells.CD4
89363-6,Cholinesterase
89364-4,Hemoglobin.free
89365-1,HIV 1 & 2 Ab panel
89366-9,von Willebrand factor collagen binding adhesion inhibitor
Jul-36,Fluid intake.chest tube
89367-7,von Willebrand factor.ristocetin cofactor inhibitor
89368-5,Zika virus non-structural protein 1 Ab.IgM panel
89369-3,Zika virus non-structural protein 1 Ab.IgM
89370-1,Zika virus non-structural protein 1 Ab.IgM
89371-9,Mycobacterium tuberculosis complex DNA & rpoB gene rifAMPin resistance mutation panel
89372-7,Mycobacterium tuberculosis complex rpoB gene rifAMPin resistance mutation
89373-5,Hepatitis A virus genotype
89374-3,HIV 1 Ab
May-37,Fluid intake.chest tube
89375-0,Wheel 50 feet with two turns - functional goal
89376-8,Wheel 50 feet with two turns - functional ability
89377-6,Wheel 150 feet - functional goal
89378-4,Wheel 150 feet - functional ability
89379-2,Walking 10 feet on uneven surfaces - functional goal
893-8,Blood group antibody screen.autologous
89380-0,Walking 10 feet on uneven surfaces - functional ability
89381-8,Walk 50 feet with two turns - functional goal
89382-6,Walk 50 feet with two turns - functional ability
Mar-38,Fluid intake.chest tube
89383-4,Walk 150 feet - functional goal
89384-2,Walk 150 feet - functional ability
89385-9,Walk 10 feet - functional goal
89386-7,Walk 10 feet - functional ability
89387-5,Upper body dressing - functional goal
89388-3,Upper body dressing - functional ability
89389-1,Toileting hygiene - functional goal
89390-9,Toilet transfer - functional goal
Jan-39,Fluid intake.chest tube
89391-7,OASIS E - Functional abilities and goals - DC
89392-5,Sit to stand - functional goal
89393-3,Sit to stand - functional ability
89394-1,Sit to lying - functional goal
89395-8,Sit to lying - functional ability
89396-6,Shower &or bathe self - functional goal
89397-4,Shower &or bathe self - functional ability
89398-2,Roll left and right - functional goal
89399-0,Roll left and right - functional ability
89400-6,Putting on and taking off footwear - functional goal
89401-4,Putting on and taking off footwear - functional ability
89402-2,Picking up object - functional goal
89403-0,Picking up object - functional ability
89404-8,Oral hygiene - functional goal
89405-5,Oral hygiene - functional ability
89406-3,Lower body dressing - functional goal
89407-1,Lower body dressing - functional ability
89408-9,Indicate the type of wheelchair or scooter used
Sep-40,Fluid intake.chest tube
89409-7,Eating - functional goal
89410-5,Eating - functional ability
89411-3,Does the patient use a wheelchair or scooter
89412-1,Car transfer - functional goal
89413-9,Car transfer - functional ability
89414-7,Chair &or bed-to-chair transfer - functional goal
89415-4,Bed-to-chair transfer - functional ability
89416-2,Go up and down 4 steps - functional goal
Jul-41,Fluid intake.chest tube
89417-0,4 steps - functional ability
89418-8,Go up and down 12 steps - functional goal
89419-6,12 steps - functional ability
89420-4,Go up and down a curb &or step - functional goal
89421-2,1 step (curb) - functional ability
89422-0,Timed Up and Go test & physical findings of gait panel
89423-8,"Time to rise from chair, walk 10 feet and back, and return to sitting"
89424-6,Long-term opioid therapy for pain consent
May-42,Fluid intake.chest tube
89425-3,Cardiopulmonary resuscitation flowsheet
89426-1,Cardiopulmonary resuscitation note
89427-9,Evaluation and management consent
89428-7,Blood or blood product transfusion consent
89429-5,Surgical operation order
89430-3,Medical history screening form
89431-1,Cells.CD25/100 Cells.CD4
89432-9,Group counseling note
Mar-43,Fluid intake.enema
89433-7,Group counseling note
89434-5,Group counseling note
89435-2,Disabled from walking by any condition other than heart or lung disease
89436-0,Total score
89437-8,Are you short of breath on washing or dressing
89438-6,Do you have to stop for breath when walking at your own pace on level ground
89439-4,Do you get short of breath walking with other people of your own age on level ground
89440-2,Rose Dyspnea Scale panel
Jan-44,Fluid intake.enema
89441-0,Note
89442-8,Administrative note
89443-6,Admission history and physical note
89444-4,Checklist
89445-1,Checklist
89446-9,Consultation note
89447-7,Consultation note
89448-5,Letter
89449-3,Letter
89450-1,Note
89451-9,Note
89452-7,Note
89453-5,Note
89454-3,Note
89455-0,Note
89456-8,Note
89457-6,Surgical operation note
Aug-45,Fluid intake.enema
89458-4,Note
89459-2,Note
894-6,Blood group antibody screen.cell II
89460-0,Note
89461-8,Note
89462-6,Note
89463-4,Note
89464-2,Note
89465-9,Note
Jun-46,Fluid intake.enema
89466-7,Postoperative evaluation and management note
89467-5,Postoperative evaluation and management note
89468-3,Preoperative evaluation and management note
89469-1,Preoperative evaluation and management note
89470-9,Summary note
89471-7,Summary note
89472-5,Surgical operation note
89473-3,Administrative note
Apr-47,Fluid intake.enema
89474-1,OASIS E - Mobility - discharge performance
89475-8,OASIS E - Self-care - discharge performance
89476-6,Mobility - discharge goal
89477-4,OASIS E - Mobility - SOC and ROC performance
89478-2,"IRF-PAI v3.0, MDS v1.17.1, 1.17.2, OASIS E - Self-care - discharge goal"
89479-0,OASIS E - Self-care - SOC and ROC performance
89480-8,Azithromycin
89481-6,Gentamicin
Feb-48,Fluid intake.enema
89482-4,Kanamycin
89483-2,Capreomycin
89484-0,Amikacin
89485-7,Clarithromycin
89486-5,Mycobacterial susceptibility panel
89487-3,Fluoroquinolone
89488-1,Isoniazid
89489-9,rifAMPin
8949-0,Fluid intake.enema
89490-7,Aminoglycoside
89491-5,Ethambutol
89492-3,Examination findings
89493-1,Examination findings
89494-9,Diagnosis
89495-6,Drug use^during pregnancy
89496-4,Known exposure^during pregnancy
89497-2,Prenatal tests
89498-0,Prenatal diagnosis
89499-8,Diagnostic study note
89500-3,Sulfatide Ab.IgG
89501-1,Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab
89502-9,SCL-70 extractable nuclear Ab
89503-7,RNA polymerase III Ab
89504-5,Ribosomal Ab
89505-2,Proteinase 3 Ab
89506-0,Nucleosome Ab
89507-8,Myeloperoxidase Ab
Aug-50,Class
89508-6,Intrinsic factor Ab
89509-4,Ganglioside GT1a Ab.IgG+IgM
89510-2,Ganglioside GM3 Ab.IgM
89511-0,Ganglioside GM3 Ab.IgG+IgM
89512-8,Ganglioside GD3 Ab.IgG+IgM
89513-6,RNA polymerase III Ab
89514-4,Glomerular basement membrane Ab
89515-1,Ganglioside GT1b Ab.IgM
Jun-51,Enema device site
89516-9,Ganglioside GT1b Ab.IgG+IgM
89517-7,Ganglioside GM2 Ab.IgG+IgM
89518-5,Ganglioside GM1 Ab.IgM
89519-3,Ganglioside GM1 Ab.IgG+IgM
89520-1,Actin.smooth muscle Ab
89521-9,Ganglioside GM1 Ab.IgG
89522-7,Ganglioside GM3 Ab.IgG
89523-5,Ganglioside GT1b Ab.IgG
Apr-52,Fluid intake.enteral tube
89524-3,Ganglioside GM2 Ab.IgM
89525-0,Ganglioside GM2 Ab.IgG
89526-8,Sjogrens syndrome-B extractable nuclear Ab
89527-6,Sjogrens syndrome-A extractable nuclear Ab
89528-4,Nucleosome Ab
89529-2,Jo-1 extractable nuclear Ab
895-3,Blood group antibody screen.cells I+II+III
89530-0,Histone Ab
89531-8,Smith extractable nuclear Ab
Feb-53,Fluid intake.enteral tube
89532-6,Sjogrens syndrome-A extractable nuclear 52kD Ab
89533-4,SCL-70 extractable nuclear Ab
89534-2,Ribosomal P Ab
89535-9,Ribonucleoprotein extractable nuclear Ab
89536-7,PM-SCL extractable nuclear Ab
89537-5,PCNA extractable nuclear Ab
89538-3,Neuronal nuclear type 2 Ab
89539-1,Mitochondria M2 Ab
8954-0,Fluid intake.enteral tube
89540-9,Ganglioside GM1 Ab.IgM
89541-7,Ganglioside GM1 Ab.IgG
89542-5,Centromere protein B Ab
89543-3,Laboratory ask at order entry panel
89544-1,Pulmonary Embolism Rule-out Criteria panel
89545-8,Total score
89546-6,Wells pulmonary embolism risk calculator panel
89547-4,Total score
89548-2,Total score
89549-0,Revised Geneva Score panel
89550-8,Middle name
89551-6,Consultation note
89552-4,Note
89553-2,Evaluation and management of radiation exposure note
89554-0,Evaluation and management of radiation exposure note
89555-7,How many D per W did you engage in moderate to strenuous physical activity in the last 30D
89556-5,Comprehensive Universal Behavior Health Screen
Jul-55,Fluid intake.enteral tube
89557-3,Depression symptoms
89558-1,Anxiety symptoms
89559-9,Suicide risk
89560-7,Suicide risk
89561-5,Trauma symptoms
89562-3,Substance abuse symptoms
89563-1,Eating disorder symptoms
89564-9,Employment status
May-56,Fluid intake.enteral tube
89565-6,Housing status
89566-4,Income status
89567-2,Food insecurity status
89568-0,Child care availability status
89569-8,Access to transportation &or mobility status
89570-6,Involvement with criminal justice
89571-4,Disability status
89572-2,"OASIS E - Functional abilities and goals - SOC, ROC"
Mar-57,Fluid intake.enteral tube
89573-0,"MDS v3.0 - RAI v1.16.1 - Cognitive patterns - NO, SO"
89574-8,Exercise Vital Sign (EVS)
89575-5,Troponin T.cardiac
89576-3,Troponin T.cardiac panel
89577-1,Troponin I.cardiac panel
89578-9,Troponin I.cardiac
89579-7,Troponin I.cardiac
89580-5,Coefficient of variation at 99th percentile URL
Jan-58,Fluid intake.enteral tube
89581-3,99th percentile upper reference limit
89582-1,Microscopic observation
89583-9,Cytomegalovirus Ag
89584-7,Herpes simplex virus DNA
89585-4,Herpes simplex virus 1 DNA
89586-2,Herpes simplex virus 1 Ag
89587-0,Herpes simplex virus 2 DNA
89588-8,Herpes simplex virus 2 Ag
89589-6,Varicella zoster virus Ag
89590-4,Zika virus Ab.IgG
89591-2,Zika virus Ab.IgM
89592-0,Bartonella quintana DNA
89593-8,Bartonella sp DNA
89594-6,Legionella pneumophila Ag
89595-3,Legionella pneumophila Ag
89596-1,Listeria monocytogenes DNA
89597-9,Mycoplasma genitalium DNA
89598-7,Mycoplasma hominis DNA
Sep-59,Fluid intake.gastrostomy tube
89599-5,Toxoplasma gondii
89600-1,FDA-initiated compliance action drug registration and listing inactivation
89601-9,Proof of encounter certificate
89602-7,Guidance for percutaneous aspiration of cyst
89603-5,Guidance for percutaneous aspiration of cyst
89604-3,Guidance for percutaneous aspiration of cyst
89605-0,Guidance for ablation of tissue
89606-8,Guidance for ablation of tissue
Jul-60,Fluid intake.gastrostomy tube
89607-6,Guidance for percutaneous aspiration of fluid
89608-4,Guidance for percutaneous aspiration of fluid
89609-2,Guidance for percutaneous aspiration of fluid
896-1,Blood group antibody screen
89610-0,Guidance for placement of catheter
89611-8,Guidance for percutaneous aspiration of fluid
89612-6,Guidance for percutaneous aspiration of fluid
89613-4,Guidance for drainage+placement of drainage catheter^WO contrast
89614-2,Guidance for percutaneous biopsy^WO contrast
May-61,Fluid intake.gastrostomy tube
89615-9,Guidance for drainage+placement of drainage catheter^W contrast IV
89616-7,Guidance for percutaneous aspiration of cyst^WO contrast
89617-5,Guidance for percutaneous aspiration of cyst^W contrast IV
89618-3,Guidance for percutaneous aspiration of cyst^WO contrast
89619-1,Guidance for percutaneous biopsy^W contrast IV
89620-9,Guidance for percutaneous biopsy^W contrast IV
89621-7,Guidance for percutaneous biopsy^W contrast IV
89622-5,Guidance for percutaneous aspiration of fluid
Mar-62,Fluid intake.gastrostomy tube
89623-3,Guidance for drainage+placement of drainage catheter
89624-1,Guidance for drainage of abscess+placement of drainage catheter
89625-8,Guidance for percutaneous aspiration of cyst
89626-6,Multisection^W contrast IV
89627-4,Guidance for percutaneous aspiration of cyst
89628-2,Guidance for percutaneous aspiration of cyst
89629-0,Guidance for percutaneous aspiration of cyst
89630-8,Guidance for percutaneous aspiration of cyst
Jan-63,Fluid intake.gastrostomy tube
89631-6,Guidance for localization of tumor^W Radionuclide IV
89632-4,Toxoplasma gondii
89633-2,Actinomyces sp identified
89634-0,Actinomyces sp identified
89635-7,Mycobacterium tuberculosis DNA
89636-5,Mycobacterium sp identified
89637-3,Mycobacterium sp identified
89638-1,Nocardia sp identified
89639-9,Nocardia sp identified
89640-7,Chlamydophila pneumoniae Ab.IgM
89641-5,Chlamydophila pneumoniae Ab.IgG
89642-3,Corynebacterium diphtheriae toxin Ab.IgG
89643-1,Bacteria identified
89644-9,Bacteria identified
89645-6,Bartonella henselae DNA
89646-4,Bartonella quintana DNA
89647-2,Bartonella sp DNA
89648-0,Chlamydia trachomatis
Sep-64,Fluid intake.gastrostomy tube
89649-8,Coxiella burnetii DNA
89650-6,Tropheryma whipplei DNA
89651-4,Human metapneumovirus RNA
89652-2,Human metapneumovirus Identified
89653-0,Parainfluenza virus identified
89654-8,Parainfluenza virus identified
89655-5,Virus identified
Jun-65,Fluid intake.gastrostomy tube
89656-3,Fungus identified
89657-1,Microscopic observation
89658-9,Microscopic observation
89659-7,Microscopic observation
89660-5,Microscopic observation
89661-3,Microscopic observation
89662-1,Microscopic observation
89663-9,I felt irritable in past 7D
Apr-66,Class
89664-7,I felt lonely even when I was with other people in past 7D
89665-4,I had mood swings in past 7D
89666-2,I felt like crying in past 7D
89667-0,I felt unloved in past 7D
89668-8,I felt like I needed help for my depression in past 7D
89669-6,PROMIS cancer emotional distress - depression - version 1.0 T-score
89670-4,PROMIS cancer item bank - emotional distress - depression - version 1.0
89671-2,How much did pain interfere with your ability to pay attention in past 7D
Feb-67,Fluid intake.upper GI tube
89672-0,How often did pain make it hard for you to walk more than 5 minutes at a time in past 7D
89673-8,How much did you worry about pain in past 7D
89674-6,PROMIS cancer item bank - pain interference - version 1.1
89675-3,PROMIS cancer pain interference - version 1.1 T-score
89676-1,PROMIS cancer fatigue - version 1.0 T-score
89677-9,PROMIS cancer item bank - fatigue - version 1.0
89678-7,I had unpleasant thoughts that wouldn't leave my mind in past 7D
89679-5,PROMIS cancer item bank - emotional distress - anxiety - version 1.0
8968-0,Fluid intake.upper GI tube
89680-3,PROMIS cancer emotional distress - anxiety - version 1.0 T-score
89681-1,Does your health now limit you in exercising regularly
89682-9,Are you able to climb several flights of stairs
89683-7,Are you able to do 2H of physical labor
89684-5,Are you able to run on uneven ground
89685-2,Does your health now limit you in doing housework or jobs around the house
89686-0,"Does your health now limit you in doing recreational activities which require little exertion (e.g., card playing, knitting, etc.)"
89687-8,Does your health now limit you in pursuing your hobbies or other leisure activities
89688-6,Does your health now limit you in traveling out of town for an overnight stay
89689-4,PROMIS cancer item bank - physical function - version 1.1
89690-2,PROMIS cancer physical function - version 1.1 T-score
89691-0,Pseudocasts
89692-8,Heart rate
89693-6,Total score
89694-4,Pulmonary Embolism Severity Index panel
89695-1,Guidance for drainage+placement of drainage catheter^WO contrast
89696-9,Guidance for drainage+placement of drainage catheter^W contrast IV
89697-7,Guidance for drainage of pseudocyst+placement of drainage catheter
Aug-69,Fluid intake.upper GI tube
89698-5,Guidance for injection
89699-3,Guidance for injection
89700-9,Guidance for injection
89701-7,Guidance for injection
89702-5,Guidance for injection
89703-3,Guidance for injection
89704-1,Guidance for injection
89705-8,Guidance for injection
Jun-70,Fluid intake.upper GI tube
89706-6,Guidance for injection
89707-4,Guidance for injection
89708-2,Guidance for injection
89709-0,Guidance GE 3 levels for injection
89710-8,Guidance 2 levels for injection
89711-6,Guidance 1 level for injection
89712-4,Guidance limited for localization of tumor^W 18F-FDG IV+W contrast IV
89713-2,Multisection^W contrast IS
Apr-71,Fluid intake.upper GI tube
89714-0,Multisection^W contrast IS
89715-7,Multisection^W contrast IS
89716-5,Multisection^W contrast IS
89717-3,Guidance for stereotactic localization^WO & W contrast IV
89718-1,Guidance for stereotactic localization^W contrast IV
89719-9,Guidance for drainage of abscess+placement of drainage catheter
89720-7,Guidance for drainage of abscess+placement of drainage catheter
89721-5,Guidance for drainage of abscess+placement of drainage catheter
Feb-72,Fluid intake.upper GI tube
89722-3,Multisection^W contrast IV
89723-1,Multisection^W contrast IV
89724-9,Minimum Data Set (MDS) for Public Health Emergency Operations Centers (EOC)
89725-6,Managing and commanding
89726-4,Operating
89727-2,Planning and intelligence
89728-0,Logistics
89729-8,Finance and administration
8973-0,Fluid intake.upper GI tube
89730-6,Decisions and approvals
89731-4,Coordination
89732-2,Communication
89733-0,Leadership assigned
89734-8,Response status and response team
89735-5,Activate and deactivate decision
89736-3,Plan approval
89737-1,Partners list
89738-9,Partner tasking
89739-7,Public communication
89740-5,Inter-agency communication
89741-3,Intra-agency communication
89742-1,Incident commander information
89743-9,Response section information
89744-7,Response plan
89745-4,Daily schedule
89746-2,Start and terminate response
89747-0,Response team
Aug-74,Fluid intake.intravascular
89748-8,Reporting to leadership
89749-6,Standard operating procedures inventory
89750-4,Task tracing
89751-2,Event investigation
89752-0,Controlling
89753-8,Task information
89754-6,Event status
May-75,Fluid intake.intravascular
89755-3,Risk assessments
89756-1,Laboratory operations report
89757-9,Countermeasures operations
89758-7,Situation analysis
89759-5,Planning
89760-3,After action review
89761-1,Information management
89762-9,Infectious diseases reporting and surveillance
Mar-76,Fluid intake.intravascular
89763-7,Laboratory reporting
89764-5,Public health emergency event surveillance
89765-2,Rumors surveillance
89766-0,Daily watch-keeping record
89767-8,Risk assessment and consultation
89768-6,Situational report
89769-4,Plan development
89770-2,Authority to plan
Jan-77,Fluid intake.intravascular
89771-0,Plan components
89772-8,After action report
89773-6,Improvement plan
89774-4,Document management
89775-1,Resources management
89776-9,Information and communications technology support
89777-7,Health agencies
89778-5,Experts and staff
89779-3,Rapid response team
89780-1,Volunteers
89781-9,Reserves of emergency supplies
89782-7,Shelters
89783-5,Technology assessment
89784-3,Budget management
89785-0,Purchase and dispatch
89786-8,Human resources management
89787-6,Budget
89788-4,Donor
Sep-78,Fluid intake.intravascular
89789-2,Human resources
897-9,Blood group antibody screen
89790-0,Purchase
89791-8,Dispatch
89792-6,Event activation or deactivation
89793-4,Event description
89794-2,Conference note
89795-9,Progress note
89796-7,Procedure note
Jul-79,Fluid intake.intravascular
89797-5,Note
89798-3,Conference note
89799-1,Conference note
89800-7,Note
89801-5,Conference note
89802-3,Progress note
89803-1,Procedure note
89804-9,Note
May-80,Fluid intake.intravascular
89805-6,Initial evaluation note
89806-4,Note
89807-2,Progress note
89808-0,Note
89809-8,Note
89810-6,Conference note
89811-4,Progress note
89812-2,Procedure note
Mar-81,Intravascular tube site
89813-0,Progress note
89814-8,Procedure note
89815-5,Initial evaluation note
89816-3,Progress note
89817-1,Procedure note
89818-9,Note
89819-7,Conference note
89820-5,Initial evaluation note
Jan-82,Class
89821-3,Progress note
89822-1,Procedure note
89823-9,Conference note
89824-7,Note
89825-4,Conference note
89826-2,Procedure note
89827-0,Multisection^WO & W contrast IV
89828-8,Guidance for superficial biopsy
89829-6,Guidance for biopsy^WO contrast
89830-4,Guidance for biopsy^W contrast IV
89831-2,Guidance for drainage+placement of drainage catheter
89832-0,Guidance for deep biopsy
89833-8,Multisection by reconstruction
89834-6,Multisection^WO Contrast
89835-3,Multisection^W contrast IV
89836-1,Multisection^WO contrast
89837-9,Multisection^WO & W contrast IV
89838-7,Multisection^WO & W contrast IV
Sep-83,Class
89839-5,Guidance for biopsy
89840-3,Multisection^WO contrast
89841-1,Multisection^WO & W contrast IV
89842-9,Multisection^W radionuclide IV
89843-7,Emoji skin tone modifier
89844-5,Multisection^WO & W contrast IV
89845-2,Multisection^WO & W contrast IV
89846-0,Multisection^WO & W contrast IV
Jul-84,Fluid intake
89847-8,Multisection
89848-6,Multisection^WO & W contrast IV
89849-4,Multisection^WO Contrast
89850-2,Multisection^WO Contrast
89851-0,Multisection limited
89852-8,Multisection limited^W Contrast IV
89853-6,Multisection limited^WO Contrast
Apr-85,Fluid intake
89854-4,Guidance for drainage of abscess+placement of drainage catheter
89855-1,Guidance for drainage of abscess+placement of drainage catheter
89856-9,Guidance for stereotactic localization^WO contrast
89857-7,Guidance for biopsy
89858-5,Guidance for biopsy
89859-3,Guidance for transrectal drainage of abscess
89860-1,Multisection^W inspiration + W expiration
89861-9,BRAF gene.p.Val600Lys
Feb-86,Fluid intake
89862-7,Patient-Oriented Eczema Measure
89863-5,"Over the last W, on how many D has your or your child's skin been itchy because of eczema"
89864-3,"Over the last W, on how many nights has your or your child's sleep been disturbed because of the eczema"
89865-0,"Over the last W, on how many D has your or your child's skin been bleeding because of the eczema"
89866-8,"Over the last W, on how many D has your or your child's skin been weeping or oozing clear fluid because of the eczema"
89867-6,"Over the last W, on how many D has your or your child's skin been cracked because of the eczema"
89868-4,"Over the last W, on how many D has your or your child's skin been flaking off because of the eczema"
89869-2,"Over the last W, on how many D has your or your child's skin felt dry or rough because of the eczema"
898-7,Blood group antibody screen.cell I
8987-0,Fluid intake
89870-0,Total score
89871-8,Bilirubin
89872-6,Bilirubin
89873-4,Unique identifier
89874-2,Anesthesia duration
89875-9,Procedure duration
89876-7,Mycobacterium tuberculosis complex rifAMPin & isoniazid resistance panel
89877-5,Note
89878-3,Note
89879-1,Note
89880-9,Note
89881-7,Note
89882-5,Note
89883-3,Note
89884-1,Note
89885-8,Note
89886-6,Note
89887-4,Note
Aug-88,Fluid intake
89888-2,Note
89889-0,Note
89890-8,Note
89891-6,Note
89892-4,Note
89893-2,Note
89894-0,Note
89895-7,Note
Jun-89,Fluid intake
89896-5,Note
89897-3,Note
89898-1,Note
89899-9,Note
89900-5,Note
89901-3,Note
89902-1,Note
89903-9,Note
Apr-90,Fluid intake
89904-7,Total score
89905-4,Chronic Respiratory Questionnaire Self-Administered Standardized Format
89906-2,Chronic Respiratory Questionnaire Self-Administered Individualized Format
89907-0,Total score
89908-8,Insulin was taken in last 8H
89909-6,Takes creatine supplements
89910-4,Regular use of birth control when got pregnant
89911-2,Emergency management plan name
Feb-91,Fluid intake route
89912-0,Emergency management plan purpose
89913-8,Event identifier
89914-6,Condition triggering emergency operation center response activation
89915-3,Condition triggering emergency operation center response termination
89916-1,Emergency management plan approved date
89917-9,Emergency management plan estimated fulfillment date
89918-7,Emergency management plan approver name
89919-5,Emergency response capabilities
8992-0,Fluid intake.nasogastric tube
89920-3,PROMIS item bank - anger - version 1.1
89921-1,PROMIS anger - version 1.1 T-score
89922-9,I worried about dying in past 7D
89923-7,PROMIS item bank - pain interference - version 1.1
89924-5,PROMIS pain interference - version 1.1 T-score
89925-2,Multisection^WO & W contrast IV
89926-0,Note
89927-8,Multisection for calcium score^WO contrast && Multisection^W contrast IV
89928-6,Guidance for percutaneous aspiration of fluid
89929-4,Guidance for percutaneous aspiration of fluid
89930-2,Guidance for radiofrequency ablation
89931-0,Guidance for drainage+placement of drainage catheter
89932-8,Guidance for deep placement of needle
89933-6,Relative risk of developing disease assessed
89934-4,I had so much pain I had to stop what I was doing in past 7D
89935-1,PROMIS pediatric item bank - pain interference - version 2.0
89936-9,PROMIS pediatric pain interference - version 2.0 T-score
89937-7,It was hard for my child to walk one block when he or she had pain in past 7D
Aug-93,Fluid intake.nasogastric tube
89938-5,My child had trouble doing schoolwork when he or she had pain in past 7D
89939-3,It was hard for my child to run when he or she had pain in past 7D
89940-1,It was hard for my child to pay attention when he or she had pain in past 7D
89941-9,It was hard for my child to have fun when he or she had pain in past 7D
89942-7,My child hurt all over his or her body in past 7D
89943-5,My child felt angry when he or she had pain in past 7D
89944-3,My child hurt a lot in past 7D
89945-0,It was hard for my child to remember things when he or she had pain in past 7D
Jun-94,Fluid intake.nasogastric tube
89946-8,It was hard for my child to get along with other people when he or she had pain in past 7D
89947-6,My child missed school when he or she had pain in past 7D
89948-4,It was hard for my child to stay standing when he or she had pain in past 7D
89949-2,PROMIS parent proxy item bank - pain interference - version 2.0
899-5,Blood group antibody screen.cell II
89950-0,PROMIS parent proxy pain interference - version 2.0 T-score
89951-8,Procedure note
89952-6,Guidance for percutaneous aspiration of fluid
Mar-95,Fluid intake.nasogastric tube
89953-4,Guidance for percutaneous aspiration of fluid
89954-2,Guidance for percutaneous aspiration of fluid
89955-9,Guidance for percutaneous aspiration of fluid
89956-7,Guidance for percutaneous aspiration of fluid
89957-5,Guidance for percutaneous aspiration of fluid
89958-3,Guidance for cryoablation
89959-1,Guidance for percutaneous biopsy
89960-9,Guidance for drainage of abscess+placement of drainage catheter
Jan-96,Fluid intake.nasogastric tube
89961-7,Guidance for drainage of abscess+placement of drainage catheter
89962-5,Guidance for radiofrequency ablation
89963-3,Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 3.0
89964-1,Ziprasidone
89965-8,Trifluoperazine
89966-6,Norquetiapine
89967-4,Norquetiapine
89968-2,Norolanzapine
89969-0,Norolanzapine
89970-8,Molindone
89971-6,8-Hydroxyloxapine
89972-4,Loxapine
89973-2,7-Hydroxyfluphenazine
89974-0,7-Hydroxyfluphenazine
89975-7,Norclozapine
89976-5,7-Hydroxychlorpromazine
89977-3,7-Hydroxychlorpromazine
89978-1,ARIPiprazole
Sep-97,Fluid intake.nasogastric tube
89979-9,Ziprasidone
89980-7,Thiothixene
89981-5,QUEtiapine
89982-3,9-Hydroxyrisperidone
89983-1,OLANZapine
89984-9,Molindone
89985-6,ARIPiprazole
89986-4,Vortioxetine
Jul-98,Fluid intake.nasogastric tube
89987-2,Vortioxetine
89988-0,Vilazodone
89989-8,Vilazodone
89990-6,fluvoxaMINE
89991-4,Citalopram+Escitalopram
89992-2,Hydroxybupropion
89993-0,Counseling note
89994-8,Trypanosoma cruzi Ab.IgG
May-99,Fluid intake.oral
89995-5,Trypanosoma cruzi Ab.IgG
89996-3,Pneumocystis jiroveci DNA
89997-1,SUMF1 gene full mutation analysis
89998-9,Albumin/Creatinine
89999-7,Albumin
90000-1,Albumin
Jan-00,Fluid intake.oral
90001-9,Staphylococcus aureus.methicillin resistant DNA
90002-7,Candida auris
90003-5,Acinetobacter sp identified
90004-3,Clinical significance of updated information
90005-0,Note
90006-8,Consultation note
90007-6,Progress note
90008-4,Note
90009-2,Conference note
900-1,Blood group antibody screen.cell III
90010-0,Procedure note
90011-8,Progress note
90012-6,Consultation note
90013-4,Initial evaluation note
90014-2,Progress note
90015-9,Note
90016-7,IRF-PAI v3.0 - Quality indicators - discharge
90017-5,"Amount of beef, pork, tuna, or salmon eaten the last time you had anything to eat"
90018-3,Psoriasis care satisfaction questionnaire
Sep-01,Fluid intake.oral
90019-1,My current treatment meets my expectations
90020-9,I am satisfied with the treatment
90021-7,I wish for a better treatment
90022-5,There has been no progress in my treatment for quite some time
90023-3,The side effects are causing me discomfort
90024-1,The current treatment has been going on for too long without success
90025-8,The treatment itself is putting a great strain on me
90026-6,I am dependent on other people's assistance for my treatment
Jul-02,Fluid intake.oral
90027-4,Total score
90028-2,Routine Assessment of Patient Index Data 3
90030-8,"Over the past W, are you able to get in and out of a car, bus, train, or airplane"
90031-6,"Over the past W, are you able to walk two miles or three kilometers, if you wish"
90032-4,"Over the past W, are you able to participate in recreational activities and sports as you would like, if you wish"
90033-2,"Over the past W, are you able to get a good night's sleep"
90034-0,"Over the past W, are you able to deal with feelings of anxiety or being nervous"
May-03,Fluid intake.oral
90035-7,"Over the past W, are you able to deal with feelings of depression or feeling blue"
90036-5,Pain severity in the past W - 0-10 (0.5 increments) numeric rating
90037-3,Assessment of global health - 0-10 (0.5 increments) numeric rating
90038-1,Weighted score
90039-9,ABO & Rh group^post transfusion reaction
90040-7,Alpha globin gene cluster & HS-40 region deletion+duplication
90041-5,Collection setting
90042-3,Borrelia sp DNA
Mar-04,Fluid intake.oral
90043-1,"t(14;20)(q32;q12)(IGH,MAFB) fusion transcript"
90044-9,Epithelial cells.renal
90045-6,Treatment history of specimen
90046-4,Spermatozoa.abnormal principal pieces/100 spermatozoa
90047-2,Spermatozoa.excess residual cytoplasm/100 spermatozoa
90048-0,Somatotropin binding protein
90049-8,Guidance for placement of chest tube
90050-6,Guidance for placement of chest tube
90051-4,Guidance for placement of chest tube
90052-2,Address
90053-0,Phone number
90054-8,Email address
90055-5,Organization contact information panel
90056-3,Date and time lab result reported
90057-1,Contact name
90058-9,Person responsible for generating report
90059-7,Task description
90060-5,Date task due
90061-3,Public communication document type
90062-1,Public communication document
90063-9,Date and time task assigned
90064-7,Public health emergency event name
90066-2,Corynebacterium sp identified
90067-0,Enterobacteriaceae identified
90068-8,Gram negative bacilli identified
90069-6,Gram positive bacilli identified
90070-4,Gram positive catalase producing cocci identified
90071-2,Gram positive non-catalase producing cocci identified
90072-0,Haemophilus sp & Neisseria sp identified
90073-8,Lactobacillales identified
90075-3,Non-Enterobacteriaceae identified
Jun-07,Fluid intake.oral
90076-1,Staphylococcus sp identified
90077-9,Urinary pathogens identified
90078-7,Yeast identified
90079-5,Were you trying to get pregnant
90080-3,Bictegravir
90081-1,Public communication document name
90082-9,Public communication template
90083-7,Public communication target group
Apr-08,Fluid intake.peritoneal
90084-5,Report identifier
90085-2,Report name
90087-8,Date range of report
90088-6,Public communication target region
90089-4,Date and time report was released
90090-2,Inter-agency communication document type
90091-0,Date and time of incident management system activation
Feb-09,Fluid intake.peritoneal
90093-6,Name
90094-4,Rheumatoid arthritis disease severity level
90095-1,Event managing group at lead department or agency
90096-9,Event managing group at co-lead department or agency
90097-7,Person responsible for generating report
90098-5,Report distribution frequency
90099-3,Emergency response report
Jan-90,Cefmetazole
9010-0,Fluid intake.peritoneal
90100-9,Listeria sp identified
90101-7,Internal control result
90102-5,Date of emergency response plan release
90103-3,Emergency response plan identifier
90104-1,Emergency operations center standard operating procedure name
90105-8,Emergency operations center standard operating procedure identifier
90106-6,Date emergency operations center standard operating procedure issued
90107-4,Date emergency operations center standard operating procedure released
90108-2,Incident commander name
90109-0,Incident commander qualification
90110-8,Incident commander phone number
90111-6,Incident commander email address
90112-4,Response section or team responsibility
90113-2,Chief of staff name
90114-0,Chief of staff phone number
90115-7,Chief of staff email address
90116-5,Emergency response plan
90117-3,Estimated date of next emergency response plan release
Aug-11,Fluid intake.peritoneal
90118-1,Date and time of scheduled task
90119-9,Location of task
90120-7,Date and time of event response status
90121-5,Event response description
90122-3,Response team participation status
90123-1,Response team leader name
90124-9,Response team leader title
90125-6,Response team member name
Jun-12,Fluid intake.peritoneal
90126-4,Response team member title
90127-2,It is hard for your child to find his or her way to a place that he or she has visited several times before in past 4W
90128-0,"Your child has trouble remembering where he or she put things, like his or her watch or his or her homework in past 4W"
90130-6,It is hard for your child to take notes in class in past 4W
90131-4,It is hard for your child to learn new things in past 4W
90132-2,It is hard for your child to understand pictures that show how to make something in past 4W
90133-0,It is hard for your child to pay attention to something boring he or she has to do in past 4W
Apr-13,Fluid intake.peritoneal
90134-8,It is hard for your child to pay attention to one thing for more than 5-10 minutes in past 4W
90135-5,Your child has trouble remembering the names of people he or she has just met in past 4W
90136-3,Your child has trouble keeping track of what he or she is doing if he or she gets interrupted in past 4W
90137-1,It is hard for your child to do more than one thing at a time in past 4W
90138-9,Your child forgets what his or her parents or teachers ask him or her to do in past 4W
90139-7,Your child walks into a room and forgets what he or she wanted to get or do in past 4W
90140-5,Your child has trouble remembering the names of people he or she knows in past 4W
90141-3,It is hard for your child to add or subtract numbers in his or her head in past 4W
Feb-14,Fluid intake.peritoneal
90142-1,Your child has trouble remembering the date or day of the week in past 4W
90143-9,"When your child has a big project to do, he or she has trouble deciding where to start in past 4W"
90144-7,Your child has to read things several times to understand them in past 4W - frequency
90145-4,Your child has to read things several times to understand them in past 4W - severity
90146-2,Your child reacts slower than most people his or her age when he or she plays games in past 4W - frequency
90147-0,Your child reacts slower than most people his or her age when he or she plays games in past 4W - severity
90148-8,It is hard for your child to find the right words to say what he or she means in past 4W - frequency
90149-6,It is hard for your child to find the right words to say what he or she means in past 4W - severity
90150-4,Your child forgets things easily in past 4W - frequency
90151-2,Your child forgets things easily in past 4W - severity
90152-0,It is hard for your child to concentrate in school in past 4W - frequency
90153-8,It is hard for your child to concentrate in school in past 4W - severity
90154-6,Your child has a hard time keeping track of his or her homework in past 4W - frequency
90155-3,Your child has a hard time keeping track of his or her homework in past 4W - severity
90156-1,Your child forgets to bring things to and from school that he or she needs for homework in past 4W - frequency
90157-9,Your child forgets to bring things to and from school that he or she needs for homework in past 4W - severity
90158-7,Your child forgets what he or she is going to say in past 4W - frequency
Sep-15,Class
90159-5,Your child forgets what he or she is going to say in past 4W - severity
90160-3,It takes your child longer than other people to get his or her school work done in past 4W - frequency
90161-1,It takes your child longer than other people to get his or her school work done in past 4W - severity
90162-9,Your child has to use written lists more often than other people his or her age so he or she will not forget things in past 4W - frequency
90163-7,Your child has to use written lists more often than other people his or her age so he or she will not forget things in past 4W - severity
90164-5,Your child has trouble remembering to do things like school projects or chores in past 4W - frequency
90165-2,Your child has trouble remembering to do things like school projects or chores in past 4W - severity
90166-0,Your child has trouble paying attention to the teacher in past 4W - frequency
90167-8,Your child has trouble paying attention to the teacher in past 4W - severity
90168-6,Your child has to work really hard to pay attention or he or she makes mistakes in past 4W - frequency
90169-4,Your child has to work really hard to pay attention or he or she makes mistakes in past 4W - severity
90170-2,PROMIS parent proxy item bank - cognitive function - version 1.0
90171-0,PROMIS parent proxy cognitive function - version 1.0 T-score
90172-8,PROMIS parent proxy cognitive function - frequency - version 1.0
90173-6,PROMIS parent proxy cognitive function - severity - version 1.0
90174-4,It is hard for me to find my way to a place that I have visited several times before in past 4W
May-17,Fluid intake.synovial
90175-1,"I have trouble remembering where I put things, like my watch or my homework in past 4W"
90176-9,I have trouble remembering the names of people I have just met in past 4W
90177-7,It is hard for me to take notes in class in past 4W
90178-5,It is hard for me to learn new things in past 4W
90179-3,It is hard for me to understand pictures that show how to make something in past 4W
90180-1,It is hard for me to pay attention to something boring I have to do in past 4W
90181-9,It is hard for me to pay attention to one thing for more than 5-10 minutes in past 4W
90182-7,I have trouble recalling the names of things in past 4W
Mar-18,Fluid intake.synovial
90183-5,I have trouble keeping track of what I am doing if I get interrupted in past 4W
90184-3,It is hard for me to do more than one thing at a time in past 4W
90185-0,I forget what my parents or teachers ask me to do in past 4W
90186-8,I walk into a room and forget what I wanted to get or do in past 4W
90187-6,I have trouble remembering the names of people I know in past 4W
90188-4,It is hard for me to add or subtract numbers in my head in past 4W
90189-2,I have trouble remembering the date or day of the week in past 4W
901-9,Blood group antibody screen.cells I+II+III
90190-0,"When I have a big project to do, I have trouble deciding where to start in past 4W"
Jan-19,Fluid intake.synovial
90191-8,I have to read things several times to understand them in past 4W - frequency
90192-6,I have to read things several times to understand them in past 4W - severity
90193-4,I react slower than most people my age when I play games in past 4W - frequency
90194-2,I react slower than most people my age when I play games in past 4W - severity
90195-9,It is hard for me to find the right words to say what I mean in past 4W - frequency
90196-7,It is hard for me to find the right words to say what I mean in past 4W - severity
90197-5,I forget things easily in past 4W - frequency
90198-3,I forget things easily in past 4W - severity
90199-1,It is hard for me to concentrate in school in past 4W - frequency
90200-7,It is hard for me to concentrate in school in past 4W - severity
90201-5,I have a hard time keeping track of my homework in past 4W - frequency
90202-3,I have a hard time keeping track of my homework in past 4W - severity
90203-1,I forget to bring things to and from school that I need for homework in past 4W - frequency
90204-9,I forget to bring things to and from school that I need for homework in past 4W - severity
90205-6,I forget what I am going to say in past 4W - frequency
90206-4,I forget what I am going to say in past 4W - severity
90207-2,It takes me longer than other people to get my school work done in past 4W - frequency
90208-0,It takes me longer than other people to get my school work done in past 4W - severity
Sep-20,Fluid intake.synovial
90209-8,I have to use written lists more often than other people my age so I will not forget things in past 4W - frequency
90210-6,I have to use written lists more often than other people my age so I will not forget things in past 4W - severity
90211-4,I have trouble remembering to do things like school projects or chores in past 4W - frequency
90212-2,I have trouble remembering to do things like school projects or chores in past 4W - severity
90213-0,I have trouble paying attention to the teacher in past 4W - frequency
90214-8,I have trouble paying attention to the teacher in past 4W - severity
90215-5,I have to work really hard to pay attention or I make mistakes in past 4W - frequency
90216-3,I have to work really hard to pay attention or I make mistakes in past 4W - severity
Jul-21,Fluid intake.synovial
90217-1,PROMIS pediatric item bank - cognitive function - version 1.0
90218-9,PROMIS pediatric cognitive function - version 1.0 T-score
90219-7,PROMIS pediatric cognitive function - frequency - version 1.0
90220-5,PROMIS pediatric cognitive function - severity - version 1.0
90221-3,Total score
90222-1,Clinically Useful Depression Outcome Scale
90223-9,Neutrophils.immature/Neutrophils.total
90224-7,Thyroxine & Thyroxine.free panel
May-22,Fluid intake.synovial
90225-4,Coagulation factor VII activity & inhibitor panel
90226-2,Nicotine & Cotinine panel
90227-0,Histoplasma capsulatum H & M Ab panel
90228-8,Extractable nuclear antigen Ab.IgG panel
90229-6,Herpes simplex virus 1 & 2 Ab.IgG & IgM panel
90230-4,Myeloperoxidase Ab.IgG & Proteinase 3 Ab.IgG Panel
90231-2,Thymoma & myasthenia gravis antibody panel
90232-0,Histoplasma capsulatum Ab
Mar-23,Fluid intake.synovial
90233-8,Dermatan sulfate
90234-6,Globotriaosylsphingosine
90235-3,Heparan sulfate
90236-1,Keratan sulfate
90237-9,Phenylacetylcarnitine (PheC2)
90238-7,Salicylcarnitine
90239-5,Suppression of tumorigenicity 2.soluble
90240-3,Eculizumab
Jan-24,Class
90241-1,Natural killer cell cytotoxicity.IL-2 stimulated 30:1 effector to target cell ratio/Positive control
90242-9,Natural killer cell cytotoxicity.IL-2 stimulated 0.9:1 effector to target cell ratio/Positive control
90243-7,Natural killer cell cytotoxicity.IL-2 stimulated 1.88:1 effector to target cell ratio/Positive control
90244-5,Natural killer cell cytotoxicity.IL-2 stimulated 15:1 effector to target cell ratio/Positive control
90245-2,Natural killer cell cytotoxicity.IL-2 stimulated 3.75:1 effector to target cell ratio/Positive control
90246-0,Bacterial whole genome
90247-8,Trypanosoma cruzi Ab.IgG
90248-6,Myelin oligodendrocyte glycoprotein Ab.IgG1
90249-4,Natural killer cell cytotoxicity.IL-2 stimulated 7.5:1 effector to target cell ratio/Positive control
90250-2,Vanillylmandelate & Homovanillate panel
90251-0,Bartonella henselae & Bartonella quintana Ab.IgG & IgM panel
90252-8,Report no events
90253-6,Measles virus Ab.IgG & IgM panel
90254-4,Measles virus Ab.IgG & IgM panel
90255-1,Satisfaction with knee &or hip replacement result
90256-9,CFTR gene full mutation analysis
90257-7,GLA gene full mutation analysis
Aug-25,Fluid intake.urinary bladder irrigation
90258-5,LDLR gene full mutation analysis
90259-3,NAT2 gene full mutation analysis
90260-1,Rickettsia spotted fever group Ab.IgG & IgM panel
90261-9,Microscopic observation
90262-7,Microscopic observation
90263-5,Microscopic observation
90264-3,Fracture Risk Assessment
90265-0,Major osteoporotic fracture 10Y probability
Jun-26,Fluid intake.urinary bladder irrigation
90266-8,Hip fracture 10Y probability
90267-6,Microscopic observation
90268-4,Microscopic observation
90269-2,Microscopic observation
902-7,Blood group antibody screen.autologous
90270-0,Bacteria identified
90271-8,Bacteria identified
90272-6,Streptococcus agalactiae DNA
90273-4,Bacteria identified
Apr-27,Fluid intake.urinary bladder irrigation
90274-2,Bacteria identified
90275-9,Gardnerella vaginalis
90276-7,Bacteria identified
90277-5,Bacteria identified
90278-3,Bacteria identified
90279-1,Bacteria identified
90280-9,Bacteria identified
90281-7,Bacteria identified
Feb-28,Fluid intake.urinary bladder irrigation
90282-5,Microscopic observation
90283-3,Mycobacterium tuberculosis DNA
90284-1,Mycobacterium sp identified
90285-8,Trichomonas vaginalis
90286-6,Trichomonas vaginalis
90287-4,Norovirus RNA
90288-2,Norovirus genogroup I RNA
90289-0,Norovirus genogroup II RNA
9029-0,Fluid intake.urinary bladder irrigation
90290-8,Alpha-1-Fetoprotein Ab
90291-6,Epithelial cell adhesion molecule Ab
90292-4,Liver cancer antibodies & Alpha-1-Fetoprotein
90293-2,Liver cancer antibodies & Alpha-1-Fetoprotein panel
90294-0,Matrix metalloproteinases-9 Ab
90295-7,RalA Ab
90296-5,Microscopic observation
90297-3,Entamoeba histolytica Ab
90298-1,Entamoeba sp DNA
90299-9,Giardia sp DNA
90300-5,Helminth identified
90301-3,Toxoplasma gondii
90302-1,Trichomonas vaginalis DNA
90303-9,Trichomonas vaginalis
90304-7,Cells.CD3/100 lymphocytes
90305-4,"t(2;5)(p23;q35.1)(ALK,NPM1) fusion transcript"
90306-2,Mycobacterium sp identified
90307-0,Guidance for injection
Aug-30,Fluid intake.urinary bladder irrigation
90308-8,Guidance for needle localization
90309-6,Guidance for drainage+placement of drainage catheter
90310-4,Guidance for drainage+placement of drainage catheter^WO contrast
90311-2,Guidance for percutaneous replacement of drainage catheter
90312-0,Multisection^W radionuclide IV
90313-8,Guidance for drainage+placement of chest tube
90314-6,Guidance for drainage+placement of drainage catheter^W contrast IV
90315-3,Guidance for deep biopsy
Jun-31,Fluid intake.urinary bladder irrigation
90316-1,Guidance for superficial biopsy
90317-9,Guidance for drainage+placement of drainage catheter
90318-7,Guidance for drainage+placement of drainage catheter
90319-5,Guidance for drainage+placement of drainage catheter
90320-3,Aichivirus C RNA
90321-1,Aichivirus C RNA
90322-9,Haemophilus parasuis serotype
90323-7,Influenza virus A Ab/Positive control
Apr-32,Gastrostomy tube site
90324-5,Mycoplasma hyopneumoniae DNA
90325-2,Mycoplasma suis DNA
90326-0,Porcine circovirus type 2d DNA
90327-8,Porcine circovirus type 2d DNA
90328-6,Porcine circovirus type 3 DNA
90329-4,Porcine deltacoronavirus Ab.IgG/Positive control
90330-2,Porcine parainfluenza virus 1 RNA
90331-0,Porcine reproductive and respiratory syndrome virus Ab.IgA+IgM/Positive control
Feb-33,Class
90332-8,Porcine reproductive and respiratory syndrome virus Ab.IgA/Positive control
90333-6,Porcine reproductive and respiratory syndrome virus Ab.IgM/Positive control
90334-4,Guidance for injection
90335-1,Guidance for injection
90336-9,Guidance for injection
90337-7,Cryptococcus sp rRNA gene
90338-5,Cryptococcus sp rRNA gene
90339-3,Aspergillus sp DNA
90340-1,Aspergillus sp DNA
90341-9,Administrative note
90342-7,Note
90343-5,Consultation note
90344-3,Note
90345-0,Note
90346-8,Postoperative evaluation and management note
90347-6,Preoperative evaluation and management note
90348-4,Note
90349-2,Note
903-5,Blood group antibody screen
90350-0,Procedure note
90351-8,Postoperative evaluation and management note
90352-6,Multisection^WO & W contrast IV
90353-4,Conscious sedation procedure note
90354-2,Consultation note
90355-9,Group counseling note
90356-7,Initial evaluation note
90357-5,Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel
90358-3,Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel
90359-1,Fluid management note
90360-9,Trimethylamine N-oxide
90361-7,Chlamydia trachomatis L1 Ab.IgA
90362-5,Chlamydia trachomatis L1 Ab.IgG
90363-3,Chlamydia trachomatis L1 Ab.IgM
90364-1,Cholesterol.in LDL.small dense
May-36,Nasogastric tube site
90365-8,Chlamydia trachomatis L1 Ab.IgG+IgA+IgM Interpretation
90366-6,Received healthcare outside the U.S.
90367-4,Gestational age
90368-2,Delivery date
90369-0,Sample collection timing related to drug dose
90370-8,Vendor test code to LOINC mapping data set
90371-6,Note
90372-4,Guidance for injection
Mar-37,Class
90373-2,Guidance for injection
90374-0,Clinical trials experience section
90375-7,Postmarketing experience section
90376-5,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when dressing yourself without help"
90377-3,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking 50 steps or paces on flat ground at a normal speed without stopping"
90378-1,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking up 20 stairs (2 flights) without stopping"
90379-9,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when preparing meals"
90380-7,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when washing dishes"
Jan-38,Class
90381-5,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when sweeping or mopping"
90382-3,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when making a bed"
90383-1,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when lifting something weighing 10-20 lbs (about 4.5-9 kg, like a large bag of groceries)"
90384-9,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when carrying something weighing 10-20 lbs (about 4.5-9 kg, like a large bag of groceries) from one room to another"
90385-6,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking (faster than your usual speed) for a half mile (almost 1 km) without stopping"
90386-4,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when taking a bath without help"
90387-2,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when taking a shower"
90388-0,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when putting on socks or stockings"
90389-8,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when standing for at least 5 minutes"
90390-6,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking 10 steps or paces on flat ground at a normal speed without stopping"
90391-4,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking a half mile (almost 1 km) on flat ground at a normal speed without stopping"
90392-2,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking up 5 stairs without stopping"
90393-0,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking up 10 stairs (1 flight) without stopping"
90394-8,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking up 30 stairs (3 flights) without stopping"
90395-5,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when scrubbing the floor or counter"
90396-3,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when lifting something weighing less than 5 lbs (about 2 kg, like a houseplant)"
90397-1,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes)"
90398-9,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase)"
Sep-39,Oral tube site
90399-7,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another"
90400-3,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another"
90401-1,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when getting in or out of a car"
90402-9,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when dining out"
90403-7,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when low-intensity leisure activity (gardening, etc.)"
90404-5,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when moderate-intensity leisure activity (bicycling on level terrain, etc.)"
90405-2,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking (faster than your usual speed) for 50 steps without stopping"
90406-0,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking (faster than your usual speed) for at least 1 mile (a little more than 1.5 km) without stopping"
Jul-40,Peritoneal tube site
90407-8,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had singing or humming"
90408-6,"Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when talking while walking"
90409-4,PROMIS item bank - dyspnea functional limitations - version 1.0
90410-2,PROMIS dyspnea functional limitations - version 1.0 T-score
90411-0,Words I wanted to use have seemed to be on the tip of my tongue in past 7D
90412-8,I have had trouble finding the right words to express myself in past 7D
90413-6,T-cell regulatory subsets panel
90414-4,B-cell phenotyping panel
May-41,Class
90415-1,B-cell TACI & BAFF-R subsets panel
90416-9,Lymphocyte subset & B-cell phenotyping panel
90417-7,Transferrin.carbohydrate deficient & Apolipoprotein CIII panel
90418-5,BAFF-R Cells/100 cells.CD19
90419-3,Apolipoprotein CIII-0/Apolipoprotein CIII-2
90420-1,Transferrin.carbohydrate deficient.trisialo/Transferrin.carbohydrate deficient.tetrasialo
90421-9,Apolipoprotein CIII-1/Apolipoprotein CIII-2
90422-7,Cells.TACI/100 cells.CD19
Mar-42,Synovial drain site
90423-5,Microorganism preliminary growth detection panel
90424-3,Microorganism preliminary growth detection panel
90425-0,Microorganism preliminary growth detection panel
90426-8,Microorganism preliminary growth
90427-6,Microorganism preliminary growth
90428-4,Microorganism preliminary growth
90429-2,Microorganism preliminary growth
904-3,Blood group antibody screen
90430-0,Microorganism preliminary growth
Jan-43,Class
90431-8,Microorganism preliminary growth
90432-6,Microorganism preliminary growth
90433-4,Mycobacterium preliminary growth
90434-2,Microorganism preliminary growth
90435-9,Microorganism preliminary growth
90436-7,Microorganism preliminary growth
90437-5,Microorganism preliminary growth
90438-3,Mycobacterium preliminary growth
90439-1,Atypical pneumonia pathogens panel
90440-9,BK virus+JC Virus DNA
90441-7,Bordetella pertussis & Bordetella parapertussis DNA panel
90442-5,Coxiella burnetii aroE gene
90443-3,Coxiella burnetii aroE gene
90444-1,Diethylpropion
90445-8,ePHEDrine
90446-6,Pseudoephedrine
90447-4,Delafloxacin
90448-2,Coccidioides sp Ab.IgM
Sep-44,Urinary bladder irrigation tube site
90449-0,Norovirus genogroup I & II RNA
90450-8,Herpes simplex virus DNA
90451-6,Herpes simplex virus 1 DNA
90452-4,Herpes simplex virus 1 DNA
90453-2,Herpes simplex virus 2 DNA
90454-0,Herpes simplex virus 2 DNA
90455-7,Influenza virus A & B RNA panel
Jun-45,Calcium intake
90456-5,Influenza virus A & B RNA panel
90457-3,Influenza virus A & B RNA panel
90458-1,Actinomyces sp identified
90459-9,Yellow fever virus RNA
90460-7,Hepatitis E virus RNA
90461-5,Herpes simplex virus 1+2 Ab.IgG
90462-3,Zika virus RNA
90463-1,Adenovirus DNA
Apr-46,Calcium intake
90464-9,Herpes simplex virus 1+2 Ab.IgM
90465-6,3-(4-fluorobenzoyl)propionate
90466-4,3-(4-fluorobenzoyl)propionate
90467-2,Hydroxyaripiprazole
90468-0,Hydroxyaripiprazole
90469-8,Norfluvoxamine
90470-6,Norfluvoxamine
90471-4,9-Hydroxyrisperidone
Feb-47,Calcium intake
90472-2,"Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.17.1, 1.17.2"
90473-0,"MDS v3.0 - RAI v1.17.1, 1.17.2 - Nursing home comprehensive (NC) item set"
90474-8,"MDS v3.0 - RAI v1.17.1, 1.17.2 - Nursing home PPS (NP) item set"
90475-5,"MDS v3.0 - RAI v1.17.1, 1.17.2 - Nursing home quarterly (NQ) item set"
90476-3,"MDS v3.0 - RAI v1.17.1, 1.17.2 - Swing bed PPS (SP) item set"
90477-1,"MDS v3.0 - RAI v1.17.1, 1.17.2 - Nursing home discharge (ND) item set"
90478-9,"MDS v3.0 - RAI v1.17.1, 1.17.2 - Nursing home part A PPS discharge (NPE) item set"
90479-7,"MDS v3.0 - RAI v1.17.1, 1.17.2 - Nursing home & Swing bed tracking (NT & ST) item set"
9048-0,Calcium intake
90480-5,"MDS v3.0 - RAI v1.17.1, 1.17.2 - Interim Payment Assessment (IPA) item set"
90481-3,"MDS v3.0 - RAI v1.17.1, 1.17.2 - Optional State Assessment (OSA) item set"
90482-1,"MDS v3.0 - RAI v1.17.1, 1.17.2 - Mood"
90483-9,MDS v3.0 - RAI v1.17.2 - Swallowing &or nutritional status
90484-7,"MDS v3.0 - RAI v1.17.2 - Swallowing &or nutritional status - ND, SD"
90485-4,MDS v3.0 - RAI v1.17.2 - Active diagnoses
90486-2,MDS v3.0 - RAI v1.17.2 - Health conditions
90487-0,"MDS v3.0 - RAI v1.17.2 - Health conditions - NP, NQ, SP"
90488-8,MDS v3.0 - RAI v1.17.2 - Health conditions - IPA
90489-6,MDS v3.0 - RAI v1.17.2 - Type of assessment
90490-4,MDS v3.0 - RAI v1.17.2 - Correction request
90491-2,MDS v3.0 - RAI v1.17.2 - Correction request - OSA
90492-0,MDS v3.0 - RAI v1.17.2 - Type of assessment on existing record to be modified or inactivated
90493-8,MDS v3.0 - RAI v1.17.2 - Assessment administration - SP
90494-6,MDS v3.0 - RAI v1.17.2 - Medicare stay - OSA
90495-3,MDS v3.0 - RAI v1.17.2 - Assessment administration - IPA
90496-1,MDS v3.0 - RAI v1.17.2 - Assessment administration - OSA
90497-9,MDS v3.0 - RAI v1.17.2 - Assessment administration
Aug-49,Calcium intake
90498-7,MDS v3.0 - RAI v1.17.2 - Medicare part A billing
90499-5,MDS v3.0 - RAI v1.17.2 - Identification information
905-0,Blood group antigens absent
90500-0,"MDS v3.0 - RAI v1.17.2 - Identification information - NP, NQ"
90501-8,"MDS v3.0 - RAI v1.17.2 - Identification information - SD, SP"
90502-6,"MDS v3.0 - RAI v1.17.2 - Identification information - NT, ST"
90503-4,MDS v3.0 - RAI v1.17.2 - Identification information - IPA
90504-2,MDS v3.0 - RAI v1.17.2 - Identification information - OSA
90505-9,"MDS v3.0 - RAI v1.17.2 - Hearing, speech, and vision - IPA, OSA"
Jun-50,Calcium intake
90506-7,MDS v3.0 - RAI v1.17.2 - Bladder and bowel - OSA
90507-5,MDS v3.0 - RAI v1.17.2 - Bladder and bowel - IPA
90508-3,MDS v3.0 - RAI v1.17.2 - Active diagnoses - OSA
90509-1,MDS v3.0 - RAI v1.17.2 - Swallowing &or nutritional status - IPA
90510-9,MDS v3.0 - RAI v1.17.2 - Swallowing &or nutritional status - OSA
90511-7,MDS v3.0 - RAI v1.17.2 - Current number of unhealed pressure injuries at each stage - OSA
90512-5,MDS v3.0 - RAI v1.17.2 - Skin conditions - OSA
90513-3,MDS v3.0 - RAI v1.17.2 - Medications - IPA
Apr-51,Calcium intake
90514-1,"MDS v3.0 - RAI v1.17.2 - Special treatments, procedures, and programs"
90515-8,"MDS v3.0 - RAI v1.17.2 - Special treatments, procedures, and programs - NP, NQ"
90516-6,"MDS v3.0 - RAI v1.17.2 - Special treatments, procedures, and programs - ND"
90517-4,"MDS v3.0 - RAI v1.17.2 - Special treatments, procedures, and programs - NPE"
90518-2,"MDS v3.0 - RAI v1.17.2 - Special treatments, procedures, and programs - OSA"
90519-0,"MDS v3.0 - RAI v1.17.2 - Special treatments, procedures, and programs - IPA"
90520-8,"MDS v3.0 - RAI v1.17.2 - Special treatments, procedures, and programs - SP"
90521-6,Optional state assessment
Feb-52,Calorie intake.total
90522-4,Assessment for state payment
90523-2,MDS v3.0 - RAI v1.17.2 - Optional state assessment
90524-0,Type of assessment for state payment
90525-7,SNF Part A Interrupted Stay
90526-5,Functional abilities and goals - IPA
90527-3,Occupational therapy - concurrent minutes during assessment period
90528-1,Occupational therapy - co-treatment minutes during assessment period
90529-9,Occupational therapy - group minutes during assessment period
9053-0,Calorie intake.total
90530-7,Number of D with at least 15M of occupational therapy during assessment period
90531-5,Occupational therapy - individual minutes during assessment period
90532-3,Physical therapy - concurrent minutes during assessment period
90533-1,Physical therapy - co-treatment minutes during assessment period
90534-9,Physical therapy - group minutes during assessment period
90535-6,Physical therapy - individual minutes during assessment period
90536-4,Speech-language pathology and audiology services - concurrent minutes during assessment period
90537-2,Speech-language pathology and audiology services - co-treatment minutes during assessment period
90538-0,Speech-language pathology and audiology services - group minutes during assessment period
90539-8,Speech-language pathology and audiology services - individual minutes during assessment period
90540-6,"MDS v1.17.1, 1.17.2 - Self-care - interim performance - IPA"
90541-4,Mobility - interim performance during assessment period
90542-2,Did the resident have a major surgical procedure during the prior inpatient hospital stay that requires active care during the SNF stay
90543-0,Percent intake by artificial route while a resident and during the last 7D
90544-8,Therapies during Part A Medicare stay
90545-5,Speech-language pathology and audiology services since the start date of the residents most recent Medicare Part A stay
90546-3,Occupational therapy since the start date of the residents most recent Medicare Part A stay
90547-1,Physical therapy since the start date of the residents most recent Medicare Part A stay
Aug-54,Calorie intake.total
90548-9,Distinct calendar days of therapy during assessment period
90549-7,Short stay assessment
90550-5,Number of D with at least 15M of physical therapy during assessment period
90551-3,Number of D with at least 15M of speech language pathology and audiology services during assessment period
90552-1,Mixed apnea
90553-9,Central apnea
90554-7,Oxygen desaturation
May-55,Calorie intake.total
90555-4,Hypopnea
90556-2,Obstructive hypopnea
90557-0,Respiratory effort-related arousal
90558-8,Central hypopnea
90559-6,Apnea+hypopnea
90560-4,Obstructive apnea
90561-2,Hypopnea index
90562-0,Apnea index
Mar-56,Calorie intake.total
90563-8,Obstructive apnea hypopnea index
90564-6,Central apnea hypopnea index
90565-3,Respiratory effort-related arousal index
90566-1,Respiratory disturbance index
90567-9,Oxygen desaturation index
90568-7,Polysomnography panel
90569-5,MDS v3.0 - RAI v1.17.2 - Identification information - NPE
90570-3,"MDS v3.0 - RAI v1.17.2 - Type of assessment - NT, NPE, ST"
Jan-57,Calorie intake.total
90571-1,MDS v3.0 - RAI v1.17.2 - Type of assessment - IPA
90572-9,PROMIS parent proxy life satisfaction - version 1.0 T-Score
90573-7,"Thinking about the past 4W, my child's life was ideal"
90574-5,"Thinking about the past 4W, my child was satisfied with his or her life in general"
90575-2,"Thinking about the past 4W, my child felt he or she lived his or her life well"
90576-0,"Thinking about the past 4W, my child's life went well"
90577-8,"Thinking about the past 4W, my child's life was worthwhile"
90578-6,"Thinking about the past 4W, my child liked the way he or she lived his or her life"
90579-4,"Thinking about the past 4W, my child enjoyed his or her life"
90580-2,"Thinking about the past 4W, my child had a lot of fun"
90581-0,"Thinking about the past 4W, my child had fun"
90582-8,"Thinking about the past 4W, my child felt positive about his or her life"
90583-6,"Thinking about the past 4W, my child had a good life"
90584-4,"Thinking about the past 4W, my child felt good about his or her life"
90585-1,"Thinking about the past 4W, my child felt very good about his or her life"
90586-9,"Thinking about the past 4W, my child was happy with his or her life"
90587-7,"Thinking about the past 4W, my child felt extremely positive about his or her life"
90588-5,"Thinking about the past 4W, my child was satisfied with his or her life"
Sep-58,Calorie need
90589-3,"Thinking about the past 4W, my child was satisfied with his or her skills and talents"
90590-1,"Thinking about the past 4W, my child was satisfied with his or her free time"
90591-9,"Thinking about the past 4W, my child was happy with life in his or her community"
90592-7,"Thinking about the past 4W, my child was happy with life in his or her neighborhood"
90593-5,"Thinking about the past 4W, my child was happy with his or her life at home"
90594-3,"Thinking about the past 4W, my child was happy with his or her life at school"
90595-0,"Thinking about the past 4W, my child was happy with his or her family life"
90596-8,"Thinking about the past 4W, my child was happy with his or her social life"
Jul-59,Carbohydrate intake
90597-6,"Thinking about the past 4W, my child was satisfied with the friends he or she has"
90598-4,"Thinking about the past 4W, my child's life was as good as most kids' lives"
90599-2,"Thinking about the past 4W, my child felt he or she lived as well as other kids"
90600-8,"Thinking about the past 4W, my child enjoyed his or her life more than most kids enjoyed their lives"
90601-6,"Thinking about the past 4W, my child felt that his or her life was better than most kids' lives"
90602-4,"Thinking about the past 4W, my child got the things he or she wanted in life"
90603-2,"Thinking about the past 4W, my child had what he or she needed in life"
90604-0,"Thinking about the past 4W, my child had what he or she wanted in life"
May-60,Carbohydrate intake
90605-7,"Thinking about the past 4W, my child was happy with the way things were"
90606-5,"Thinking about the past 4W, my child's life situation was excellent"
90607-3,"Thinking about the past 4W, the conditions of my child's life were excellent"
90608-1,"Thinking about the past 4W, my child's life was just right"
90609-9,"Thinking about the past 4W, my child's life was going very well"
90610-7,"Thinking about the past 4W, my child's life was good"
90611-5,"Thinking about the past 4W, my child's life was great"
90612-3,"Thinking about the past 4W, my child's life was excellent"
Mar-61,Carbohydrate intake
90613-1,"Thinking about the past 4W, my child's life was outstanding"
90614-9,"Thinking about the past 4W, my child's life was the best"
90615-6,PROMIS parent proxy item bank - life satisfaction - version 1.0
90616-4,PROMIS pediatric item bank - life satisfaction - version 1.0
90617-2,PROMIS pediatric life satisfaction - version 1.0 T-Score
90618-0,"Thinking about the past 4W, my life was ideal"
90619-8,"Thinking about the past 4W, I was satisfied with my life in general"
90620-6,"Thinking about the past 4W, I lived my life well"
Jan-62,Carbohydrate intake
90621-4,"Thinking about the past 4W, my life went well"
90622-2,"Thinking about the past 4W, my life was worthwhile"
90623-0,"Thinking about the past 4W, I liked the way I lived my life"
90624-8,"Thinking about the past 4W, I enjoyed my life"
90625-5,"Thinking about the past 4W, I had a lot of fun"
90626-3,"Thinking about the past 4W, I had fun"
90627-1,"Thinking about the past 4W, I felt positive about my life"
90628-9,"Thinking about the past 4W, I had a good life"
90629-7,"Thinking about the past 4W, I felt good about my life"
90630-5,"Thinking about the past 4W, I felt very good about my life"
90631-3,"Thinking about the past 4W, I was happy with my life"
90632-1,"Thinking about the past 4W, I felt extremely positive about my life"
90633-9,"Thinking about the past 4W, I was satisfied with my life"
90634-7,"Thinking about the past 4W, I was satisfied with my skills and talents"
90635-4,"Thinking about the past 4W, I was satified with my free time"
90636-2,"Thinking about the past 4W, I was happy with my life in my community"
90637-0,"Thinking about the past 4W, I was happy with my life in my neighborhood"
90638-8,"Thinking about the past 4W, I was happy with my life at home"
Sep-63,Carbohydrate intake
90639-6,"Thinking about the past 4W, I was happy with my life at school"
90640-4,"Thinking about the past 4W, I was happy with my family life"
90641-2,"Thinking about the past 4W, I was happy with my social life"
90642-0,"Thinking about the past 4W, I was satisfied with the friends I have"
90643-8,"Thinking about the past 4W, my life was as good as most kids' lives"
90644-6,"Thinking about the past 4W, I lived as well as other kids"
90645-3,"Thinking about the past 4W, I enjoyed my life more than most kids enjoyed their lives"
90646-1,"Thinking about the past 4W, my life was better than most kids' lives"
Jul-64,Carbohydrate intake
90647-9,"Thinking about the past 4W, I got the things I wanted in life"
90648-7,"Thinking about the past 4W, I had what I needed in life"
90649-5,"Thinking about the past 4W, I had what I wanted in life"
90650-3,"Thinking about the past 4W, I was happy with the way things were"
90651-1,"Thinking about the past 4W, my life situation was excellent"
90652-9,"Thinking about the past 4W, the conditions of my life were excellent"
90653-7,"Thinking about the past 4W, my life was just right"
Apr-65,Carbohydrate intake
90654-5,"Thinking about the past 4W, my life was going very well"
90655-2,"Thinking about the past 4W, my life was good"
90656-0,"Thinking about the past 4W, my life was great"
90657-8,"Thinking about the past 4W, my life was excellent"
90658-6,"Thinking about the past 4W, my life was outstanding"
90659-4,"Thinking about the past 4W, my life was the best"
90660-2,Pulmonary Embolism Severity Index score interpretation
90661-0,Revised Geneva score interpretation
Feb-66,Fat intake
90662-8,Wells pulmonary embolism risk score interpretation
90663-6,Pulmonary Embolism Rule-out Criteria score interpretation
90664-4,Other kids wanted to be my child's friend in past 7D
90665-1,My child felt good about his or her friendships in past 7D
90666-9,My child was able to have fun with his or her friends in past 7D
90667-7,"My child shared with other kids (food, games, pens, etc.) in past 7D"
90668-5,My child was a good friend in past 7D
90669-3,Other kids wanted to talk to my child in past 7D
9067-0,Fat intake
90670-1,My child and his or her friends helped each other out in past 7D
90671-9,My child was good at making friends in past 7D
90672-7,My child felt accepted by other kids his or her age in past 7D
90673-5,Other kids wanted to be with my child in past 7D
90674-3,My child was able to talk about everything with his or her friends in past 7D
90675-0,My child was able to count on his or her friends in past 7D
90676-8,My child played alone and kept to himself or herself in past 7D
90677-6,My child liked being around other kids his or her age in past 7D
90678-4,My child spent time with his or her friends in past 7D
90679-2,PROMIS parent proxy item bank - peer relationships - version 2.0
906-8,Blood group antigens present
90680-0,PROMIS parent proxy peer relationships - version 2.0 T-score
90681-8,My child has been physically able to do the activities he or she enjoys most in past 7D
90682-6,My child could ride a bike in past 7D
90683-4,My child could do sports and exercise that other kids his or her age could do in past 7D
90684-2,My child could get down on his or her knees without holding on to something in past 7D
90685-9,My child could go up one step in past 7D
90686-7,My child could run a mile in past 7D
90687-5,My child could walk up stairs without holding on to anything in past 7D
Aug-68,Fat intake
90688-3,My child could get up from a regular toilet in past 7D
90689-1,My child could stand up on his or her tiptoes in past 7D
90690-9,My child could turn his or her head all the way to the side in past 7D
90691-7,My child could walk across the room in past 7D
90692-5,My child could get into bed by himself or herself in past 7D
90693-3,My child could stand up without help in past 7D
90694-1,"My child used a walker, cane or crutches to get around in past 7D"
90695-8,My child could move his or her legs in past 7D
Jun-69,Fat intake
90696-6,My child could get up from the floor in past 7D
90697-4,My child could bend over to pick something up in past 7D
90698-2,My child could get in and out of a car in past 7D
90699-0,My child could walk more than one block in past 7D
90700-6,My child could keep up when he or she played with other kids in past 7D
90701-4,My child could get out of bed by himself or herself in past 7D
90702-2,My child used a wheelchair to get around in past 7D
90703-0,My child could carry his or her books in a backpack in past 7D
Apr-70,Fat intake
90704-8,PROMIS parent proxy item bank - mobility - version 2.0
90705-5,PROMIS parent proxy mobility - version 2.0 T-score
90706-3,PROMIS pediatric item bank - peer relationships - version 2.0
90707-1,PROMIS pediatric peer relationships - version 2.0 T-score
90708-9,Note
90709-7,Consultation note
90710-5,Consultation note
90711-3,Note
Feb-71,Fat intake
90712-1,Consultation note
90713-9,Note
90714-7,Consultation note
90715-4,Consultation note
90716-2,Note
90717-0,Consultation note
90718-8,"During the past Mo, how often did you eat hot or cold cereals"
90719-6,"During the past Mo, how often did you drink regular soda or pop that contains sugar"
9072-0,Fat intake
90720-4,"During the past Mo, how often did you drink coffee or tea that had sugar or honey added to it"
90721-2,"During the past Mo, how often did you eat a green leafy or lettuce salad, with or without other vegetables"
90722-0,"During the past Mo, how often did you eat any kind of fried potatoes, including french fries, home fries, or hash brown potatoes"
90723-8,"During the past Mo, how often did you eat any other kind of potatoes, such as baked, boiled, mashed potatoes, sweet potatoes, or potato salad"
90724-6,"During the past Mo, how often did you eat refried beans, baked beans, beans in soup, pork and beans or any other type of cooked dried beans"
90725-3,"During the past Mo, how often did you eat brown rice or other cooked whole grains, such as bulgur, cracked wheat, or millet"
90726-1,"During the past Mo, how often did you eat pizza"
90727-9,"During the past Mo, how often did you eat any kind of cheese"
90728-7,"During the past Mo, how often did you eat red meat, such as beef, pork, ham, or sausage"
90729-5,"During the past Mo, how often did you eat ice cream or other frozen desserts"
90730-3,Self-perception of body weight
90731-1,Frequency of creatine used to improve muscle mass or strength in past Y
90732-9,"Frequency of DHEA, androstenedione, or human growth hormone used to improve muscle mass or strength in past Y"
90733-7,Frequency of anabolic steroids used to improve muscle mass or strength in past Y
90734-5,Body weight change goal
90735-2,Paroxysmal nocturnal hemoglobinuria GPI-Linked WBC & RBC Ag Panel
90736-0,Cells.CD14-FLAER-/100 cells.CD33
90737-8,Cells.CD24-FLAER-/100 cells.CD15
Aug-73,Potassium intake
90738-6,Erythrocytes.CD59 complete loss/100 Cells.235a
90739-4,Paroxysmal nocturnal hemoglobinuria GPI-Linked WBC & RBC Ag
90740-2,Aggressive prostate cancer risk
90741-0,Parathyrin.1-84
90742-8,Bovine Mullerian inhibiting substance
90743-6,CYBB gene full & NCF1 gene c.75_76delGT analysis
90744-4,Youth Risk Behavior Survey - body weight panel
90745-1,Surgical procedures requiring active SNF care
Jun-74,Potassium intake
90746-9,5-fluoro ADB-M7
90747-7,MDMB-FUBINACA-M1
90748-5,Atomoxetine
90749-3,4-Hydroxyatomoxetine
90750-1,O-Nortramadol
90751-9,Note
90752-7,Note
Mar-75,Potassium intake
90753-5,Note
90754-3,Note
90755-0,Note
90756-8,Note
90757-6,Note
90758-4,Note
90759-2,Note
907-6,Blood group antigens present
90760-0,Note
Jan-76,Potassium intake
90761-8,PROMIS item bank - applied cognitive - general concerns - version 1.0
90762-6,PROMIS applied cognitive - general concerns - version 1.0 T-Score
90763-4,HEDIS 2019-2020 Value Set - Chlamydia Tests
90764-2,HEDIS 2019 Value Set - Toxoplasma Antibody
90765-9,HEDIS 2019 Value Set - Rh
90766-7,HEDIS 2019 Value Sets
90767-5,Pregnancy summary
90768-3,Donor blood study
90769-1,Plan of care note
90770-9,Initial evaluation note
90771-7,Consultation note
90772-5,Progress note
90773-3,Note
90774-1,Conference note
90775-8,Disease severity level
90776-6,HEDIS 2019 Value Set - Rubella Antibody
90777-4,HEDIS 2019 Value Set - Cytomegalovirus Antibody
90778-2,Personal pronouns
Sep-77,Potassium intake
90779-0,Adalimumab Ab
90780-8,inFLIXimab Ab
90781-6,"N,N'-Dimethylarginine"
90782-4,F2-Isoprostanes
90783-2,F2-Isoprostanes/Creatinine
90784-0,Cystinuria panel
90785-7,Cystinuria panel
90786-5,Note
Jul-78,Potassium intake
90787-3,Note
90788-1,Note
90789-9,Note
90790-7,Note
90791-5,Note
90792-3,Preoperative evaluation and management note
90793-1,Note
90794-9,Vedolizumab & Vedolizumab Ab Panel
May-79,Protein intake
90795-6,Levothyroxine absorption panel
90796-4,Thyroxine^1H post dose levothyroxine
90797-2,Thyroxine^2H post dose levothyroxine
90798-0,Thyroxine^3H post dose levothyroxine
90799-8,Thyroxine^4H post dose levothyroxine
90800-4,Thyroxine^6H post dose levothyroxine
90801-2,Thyrotropin^6H post dose levothyroxine
90802-0,Medication volume of distribution
Mar-80,Protein intake
90803-8,Peak concentration post XXX challenge - baseline concentration increment
90804-6,Levothyroxine absorption
90805-3,Vedolizumab^trough
90806-1,Candida albicans DNA
90807-9,Candida glabrata DNA
90808-7,Candida krusei DNA
90809-5,Candida parapsilosis DNA
90810-3,Candida tropicalis DNA
Jan-81,Protein intake
90811-1,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab
90812-9,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab
90813-7,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab
90814-5,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab
90815-2,Amphiphysin Ab
90816-0,Amphiphysin Ab
90817-8,Aquaporin 4 water channel Ab
90818-6,Aquaporin 4 water channel Ab.IgG
90819-4,Aquaporin 4 water channel Ab.IgG
90820-2,Contactin-associated protein 2 Ab
90821-0,Contactin-associated protein 2 Ab
90822-8,CV2 Ab
90823-6,Dipeptidyl aminopeptidase-like protein 6 Ab
90824-4,Dipeptidyl aminopeptidase-like protein 6 Ab
90825-1,Gamma aminobutyrate B receptor Ab
90826-9,Gamma aminobutyrate B receptor Ab
90827-7,Glial nuclear type 1 Ab
90828-5,Glial nuclear type 1 Ab
Sep-82,Protein intake
90829-3,Glutamate decarboxylase 65 Ab
90830-1,Leucine-rich glioma-inactivated protein 1 Ab
90831-9,Leucine-rich glioma-inactivated protein 1 Ab
90832-7,Ma+Ta Ab
90833-5,Ma+Ta Ab
90834-3,Myelin Ab
90835-0,Myelin associated glycoprotein Ab.IgM
90836-8,Neuronal nuclear type 3 Ab
Jul-83,Protein intake
90837-6,Neuronal nuclear type 3 Ab
90838-4,Neuronal nuclear type 3 Ab
90839-2,N-methyl-D-aspartate receptor subunit 1 Ab
908-4,Ax Ab
90840-0,N-methyl-D-aspartate receptor subunit 1 Ab
90841-8,Purkinje cell cytoplasmic type 1 Ab
90842-6,Purkinje cell cytoplasmic type 1 Ab
90843-4,Purkinje cell cytoplasmic type 2 Ab
90844-2,Purkinje cell cytoplasmic type Tr Ab
May-84,Protein intake
90845-9,Purkinje cell cytoplasmic type Tr Ab
90846-7,Purkinje cell cytoplasmic type Tr Ab
90847-5,Zinc finger protein of the cerebellum 4 Ab
90848-3,Myelin associated glycoprotein-sulfated glucuronic paragloboside Ab.IgM
90849-1,Cefpodoxime 4.0 ug/mL
90850-9,cefTAZidime 1.0 ug/mL
90851-7,GJB2 gene full mutation analysis
Feb-85,Protein intake
90852-5,Fax number
90853-3,Final score
90854-1,Duke Anxiety Depression Scale
90855-8,Posterior inter-arch deviation
90856-6,Crossbite teeth
90857-4,Closed-spaced teeth
90858-2,Open-spaced teeth
90859-0,Rotated teeth
9086-0,Sodium intake
90860-8,Crowded teeth
90861-6,Missing teeth
90862-4,Malocclusion index
90863-2,Labio-lingual spread
90864-0,Dental abnormalities impacting orthodontic care
90865-7,Craniofacial anomalies impacting orthodontic care
90866-5,Orthodontic preconditions
90867-3,Airway problem impacting orthodontic treatment
90868-1,Orthognathic surgery consideration summary
90869-9,Asymmetry of lower face
90870-7,Habits impacting orthodontic condition
90871-5,Medical conditions impacting orthodontic condition
90872-3,Supplemental information about orthodontic condition
90873-1,Malocclusion severity assessment
90874-9,Orthodontic evaluation summary
90875-6,Orthodontic service attachment
90876-4,Progress note
90877-2,Procedure note
Aug-87,Sodium intake
90878-0,Note
90879-8,Conference note
90880-6,Arachis hypogaea recombinant (rAra h) 6 Ab.IgE
90881-4,(Alternaria tenuis+Artemisia vulgaris+Betula verrucosa+Cladosporium herbarum+Phleum pratense) Ab.IgE
90882-2,Staphylococcus aureus enterotoxin E Ab.IgE.RAST class
90883-0,PROMIS pediatric item bank - mobility - version 2.0
90884-8,PROMIS pediatric mobility - version 2.0 T-Score
90885-5,Influenza virus D RNA
Jun-88,Sodium intake
90886-3,Influenza virus B RNA
90887-1,Porcine circovirus type 3 ORF2 gene
90888-9,Porcine circovirus type 3 DNA
90889-7,Porcine circovirus type 2 Ab.IgG
90890-5,Benzodiazepines panel
90891-3,Estradiol^2H post XXX challenge
90892-1,Borrelia sp panel
90893-9,Borrelia burgdorferi bba64 gene
Apr-89,Sodium intake
90894-7,Noroxymorphone
90895-4,Task identifier
90896-2,Person assigned to task
90897-0,Percent of task completed
90898-8,HIV 1 proviral DNA reverse transcriptase & protease & integrase gene
90899-6,HIV 1 proviral DNA reverse transcriptase & protease gene
90900-2,HIV 1 proviral DNA integrase gene
90901-0,HIV 1 RNA reverse transcriptase & protease & integrase gene
Feb-90,Sodium intake
90902-8,HIV 1 RNA reverse transcriptase gene
90903-6,HIV 1 RNA integrase gene
90904-4,HIV 1 RNA protease gene
90905-1,ABO & Rh group
90906-9,ABO & Rh group
90907-7,Direct antiglobulin test.IgG specific reagent^post transfusion reaction
90908-5,Eicosapentaenoate+Docosapentaenate w3+Docosahexaenoate/Fatty acids.C14-C22 risk
90909-3,Arachidonate/Eicosapentaenoate
9091-0,Sodium intake
90910-1,Fatty acids.omega 6/Fatty acids.omega 3
90911-9,Eicosapentaenoate+Docosapentaenate w3+Docosahexaenoate/Fatty acids.C14-C22
90912-7,Eicosapentaenoate/Fatty acids.C14-C22
90913-5,Docosapentaenate w3/Fatty acids.C14-C22
90914-3,Docosahexaenoate/Fatty acids.C14-C22
90915-0,Arachidonate+Linoleate/Fatty acids.C14-C22
90916-8,Arachidonate/Fatty acids.C14-C22
90917-6,Linoleate/Fatty acids.C14-C22
90918-4,Fatty acid omega-3 & omega-6 panel
90919-2,Coagulation factor VIII.recombinant.bound/von Willebrand factor Ag
909-2,Ax Ab
90920-0,Lysophosphatidylcholine(20:0)
90921-8,Lysophosphatidylcholine(22:0)
90922-6,Lysophosphatidylcholine(24:0)
90923-4,Lysophosphatidylcholine(26:0)
90924-2,BK virus DNA
90925-9,HBB gene full mutation analysis
90926-7,MET gene amplification
90927-5,RET gene rearrangements
Aug-92,Sodium intake
90928-3,Physical findings.mandibular condyle
90929-1,Overjet teeth
90930-9,Overbite teeth
90931-7,Openbite teeth
90932-5,Severe traumatic deviations impacting orthodontic condition
90933-3,PROMIS pediatric short form - cognitive function 7a - version 1.0
90934-1,PROMIS parent proxy short form - cognitive function 7a - version 1.0
90935-8,PROMIS parent proxy short form - cognitive function 7a - version 1.0 raw score
Jun-93,Fluid balance
90936-6,PROMIS parent proxy short form - life satisfaction 4a - version 1.0
90937-4,PROMIS parent proxy short form - life satisfaction 4a - version 1.0 raw score
90938-2,PROMIS parent proxy short form - life satisfaction 8a - version 1.0
90939-0,PROMIS parent proxy short form - life satisfaction 8a - version 1.0 raw score
90940-8,PROMIS parent proxy short form - mobility 8a - version 2.0
90941-6,PROMIS parent proxy short form - mobility 8a - version 2.0 raw score
90942-4,PROMIS parent proxy short form - pain interference 8a - version 2.0
90943-2,PROMIS parent proxy short form - pain interference 8a - version 2.0 raw score
Apr-94,Fluid balance
90944-0,PROMIS parent proxy short form - peer relationship 7a - version 2.0
90945-7,PROMIS parent proxy short form - peer relationship 7a - version 2.0 raw score
90946-5,Date of laboratory phone call to provider to communicate test result
90947-3,Pathology case identifier
90948-1,PROMIS pediatric short form - cognitive function 7a - version 1.0 raw score
90949-9,PROMIS pediatric short form - depressive symptoms 8a - version 2.0
90950-7,PROMIS pediatric short form - depressive symptoms 8a - version 2.0 raw score
Jan-95,Fluid balance
90951-5,PROMIS pediatric short form - life satisfaction 4a - version 1.0
90952-3,PROMIS pediatric short form - life satisfaction 4a - version 1.0 raw score
90953-1,PROMIS pediatric short form - life satisfaction 8a - version 1.0
90954-9,PROMIS pediatric short form - life satisfaction 8a - version 1.0 raw score
90955-6,PROMIS pediatric short form - mobility 8a - version 2.0
90956-4,PROMIS pediatric short form - mobility 8a - version 2.0 raw score
90957-2,PROMIS pediatric short form - pain interference 8a - version 2.0
90958-0,PROMIS pediatric short form - pain interference 8a - version 2.0 raw score
90959-8,PROMIS pediatric short form - peer relationships 8a - version 2.0
90960-6,PROMIS pediatric short form - peer relationships 8a - version 2.0 raw score
90961-4,PROMIS short form - applied cognition - general concerns 4a - version 1.0
90962-2,PROMIS short form - applied cognition - general concerns 4a - version 1.0 raw score
90963-0,PROMIS short form - applied cognition - general concerns 6a - version 1.0
90964-8,PROMIS short form - applied cognition - general concerns 6a - version 1.0 raw score
90965-5,PROMIS short form - applied cognition - general concerns 8a - version 1.0
90966-3,PROMIS short form - applied cognition - general concerns 8a - version 1.0 raw score
90967-1,PROMIS short form - dyspnea functional limitations 10a - version 1.0
90968-9,PROMIS short form - dyspnea functional limitations 10a - version 1.0 raw score
Sep-96,Fluid balance
90969-7,PROMIS short form - emotional distress - anger 5a - version 1.1
90970-5,PROMIS short form - emotional distress - anger 5a - version 1.1 raw score
90971-3,PROMIS short form - pain interference 4a - version 1.0
90972-1,PROMIS short form - pain interference 4a - version 1.0 raw score
90973-9,PROMIS short form - pain interference 6a - version 1.0
90974-7,PROMIS short form - pain interference 6a - version 1.0 raw score
90975-4,Clomethiazole
90976-2,Opipramol
Jul-97,Fluid balance
90977-0,Tianeptine
90978-8,Vilazodone
90979-6,Vortioxetine
90980-4,Meropenem+Vaborbactam
90981-2,Pressure Ulcer Scale for Healing Tool 3.0 total score
90982-0,Pressure Ulcer Scale for Healing Tool 3.0
90983-8,HEDIS 2019-2020 Value Set - PSA Tests
90984-6,HEDIS 2019-2020 Value Set - PSA Test Exclusion
May-98,Class
90985-3,HEDIS 2019-2020 Value Set - Pregnancy Test Exclusion
90986-1,HEDIS 2019 Value Set - Serum Potassium
90987-9,HEDIS 2019-2020 Value Set - Cholesterol Tests Other Than LDL
90988-7,HEDIS 2019-2020 Value Set - HPV Tests
90989-5,HEDIS 2019 Value Set - Urine Protein Tests
90990-3,Protein.monoclonal isotype
90991-1,Protein electrophoresis & monoclonal protein isotype panel
90992-9,Monoclonal gammopathy panel
Mar-99,Method
90993-7,Iothalamate clearance panel
90994-5,Iothalamate clearance
90995-2,Iothalamate clearance/Body surface area
90996-0,HEDIS 2019-2020 Value Set - Glucose Tests
90997-8,HEDIS 2019-2020 Value Set - Group A Strep Tests
90998-6,Analysis of information sources
90999-4,Analysis of emergency department visits
01-Sep,Amdinocillin
910-0,Ax Ab
91000-0,Cases
91001-8,Myelin associated glycoprotein Ab.IgM
91002-6,Job position
91003-4,Personnel contact information panel
91004-2,Email address
91005-9,Organization assigned to task
91006-7,New cases per D
91007-5,Total cases
91008-3,Date and time of deaths assessment
Sep-00,Class
91009-1,Deaths
91010-9,Epidemiological investigation report
91011-7,Etiology of a public health emergency
91012-5,Symptoms related to incident or outbreak
91013-3,Impact level
91014-1,Status of water supply systems
91015-8,Status of waste water systems
91016-6,Regional hospitals closed due to event or incident
Jul-01,Class
91017-4,Regional hospitals closed due to event or incident/Regional hospitals.total
91018-2,Status of regional dialysis centers
91019-0,Status of regional human shelters
91020-8,Status of critical regional infrastructure
91021-6,Emergency department visits
91022-4,Date and time of risk assessment
91023-2,Reason for risk assessment
91024-0,Risk assessment report
May-02,Fluid intake.total
91025-7,Lead department or agency name
91026-5,Inter-agency communication document
91027-3,Buprenorphine-3-glucuronide
91028-1,Barbiturates
91029-9,Cocaine+Benzoylecgonine
91030-7,Methadone+Metabolite
91031-5,Methamphetamine+Methylenedioxymethamphetamine
91032-3,oxyCODONE+Oxymorphone
Mar-03,Fluid intake.total
91033-1,Methadone+Metabolite
91034-9,Methamphetamine+Methylenedioxymethamphetamine
91035-6,Phencyclidine
91036-4,Benzodiazepines
91037-2,Methamphetamine+Methylenedioxymethamphetamine
91038-0,Cocaine+Benzoylecgonine
91039-8,Methadone+Metabolite
91040-6,Phencyclidine
Jan-04,Fluid intake.total
91041-4,Cannabinoids
91042-2,Methamphetamine+Methylenedioxymethamphetamine
91043-0,Opiates
91044-8,oxyCODONE+Oxymorphone
91045-5,Methamphetamine+Methylenedioxymethamphetamine
91046-3,Methadone+Metabolite
91047-1,Barbiturates
91048-9,Cannabinoids
91049-7,Cocaine+Benzoylecgonine
91050-5,Methadone+Metabolite
91051-3,Methamphetamine+Methylenedioxymethamphetamine
91052-1,Opiates
91053-9,oxyCODONE+Oxymorphone
91054-7,Drugs of abuse panel
91055-4,Drugs of abuse panel
91056-2,Drugs of abuse panel
91057-0,Tropheryma whipplei DNA
Aug-05,Fluid intake.total
91058-8,Kingella kingae DNA
91059-6,Kingella kingae DNA
91060-4,Helicobacter pylori DNA
91061-2,Helicobacter pylori DNA
91062-0,Bacteria identified
91063-8,Bacteria identified
91064-6,Dengue virus NS1 Ag
91065-3,14-3-3 protein
Jun-06,Fluid intake.total
91066-1,Enterovirus RNA
91067-9,Enterovirus RNA
91068-7,Enterovirus RNA
91069-5,Enterovirus RNA
91070-3,Hepatitis A virus RNA
91071-1,Hepatitis E virus RNA
91072-9,Influenza virus A subtype
91073-7,Human papilloma virus genotype
Apr-07,Fluid intake.total
91074-5,Phlebovirus sp RNA
91075-2,Rabies virus Ag
91076-0,Rabies virus Ag
91077-8,Measles virus RNA
91078-6,Zika virus RNA
91079-4,Zika virus RNA
91080-2,Zika virus Ab.IgG
91081-0,Candida sp DNA
Feb-08,Fluid intake.total
91082-8,Fungal 18S rRNA gene
91083-6,Fungal 18S rRNA gene
91084-4,Fungal 18S rRNA gene
91085-1,Fungal 18S rRNA gene
91086-9,Fungal BT2 gene
91087-7,Fungal BT2 gene
91088-5,Fungal BT2 gene
91089-3,Fungal BT2 gene
9109-0,Blood loss.total intraoperative
91090-1,Fungal ITS region
91091-9,Fungal ITS region
91092-7,Fungal ITS region
91093-5,Fungal ITS region
91094-3,Cause of deaths
91095-0,Analysis of pharmaceutical needs in a region
91096-8,Countermeasure description
91097-6,Countermeasure implementation progress
91098-4,Countermeasure name
91099-2,People tested
91100-8,People with confirmed positive lab results
91101-6,People with preliminary positive lab results
91102-4,People with confirmed negative lab results
91103-2,Date next report due
91104-0,Coagulation surface induced.factor sensitive with 1:1 Pooled Normal Plasma
91105-7,Cholesterol.in LDL 1
91106-5,Cholesterol.in LDL 2
91107-3,Cholesterol.in LDL 3
Aug-10,Blood loss.total intraoperative
91108-1,Cholesterol.in LDL 4
91109-9,Cholesterol.in LDL 5
91110-7,Cholesterol.in LDL 6
91111-5,Cholesterol.in LDL 7
91112-3,Cholesterol.in LDL 1
91113-1,Cholesterol.in LDL 2
91114-9,Cholesterol.in LDL 3
91115-6,Cholesterol.in LDL 4
Jun-11,Cerebral ventricle drain site
91116-4,Cholesterol.in LDL 5
91117-2,Cholesterol.in LDL 6
91118-0,Cholesterol.in LDL 7
91119-8,Coagulation surface induced.factor substitution^immediately after 1:1 addition of normal plasma
91120-6,Antithrombin
91121-4,Maltose binding protein Ab.IgE.RAST class
91122-2,Maltose binding protein Ab.IgE
91123-0,Apium graveolens recombinant (rApi g) 1 Ab.IgE.RAST class
Apr-12,Chest tube site
91124-8,Platelet function with adenosine diphosphate induction panel
91125-5,Maximum clot strength amplitude.kaolin induced^after addition of heparinase
91126-3,Maximum clot strength amplitude.activator F induced
91127-1,Maximum clot strength amplitude.adenosine diphosphate induced
91128-9,Clot strength.platelet adenosine diphosphate receptor inhibited
91129-7,Clot strength.adenosine diphosphate induced
91130-5,Hantavirus RNA
91131-3,Rhinovirus RNA
Feb-13,Fluid output.biliary drain
91132-1,Measles virus RNA
91133-9,Respiratory syncytial virus RNA
91134-7,Sexually transmitted pathogens panel
91135-4,Acanthocytes
91136-2,Lipoprotein metabolism panel
91137-0,ITPA gene.g.9330C>A
91138-8,ITPA gene.g.9381A>C
91139-6,Thiopurine methyltransferase activity panel
9114-0,Fluid output.biliary drain
91140-4,Brucella sp Ab.IgG & IgM panel
91141-2,Thiopurine methyltransferase
91142-0,Thiopurine methyltransferase
91143-8,Thiopurine methyltransferase
91144-6,Pregnancy prevention intention
91145-3,What number best describes how pain has interfered with your enjoyment of life during the past W
91146-1,What number best describes how pain has interfered with your general activity during the past W
91147-9,Mean score
91148-7,"Pain intensity, Enjoyment of life, General activity scale"
91149-5,Reevaluation note
91150-3,Pressure injury stage
91151-1,Pregnancy complication
91152-9,When my child was in pain he or she tried not to move in past 7D
91153-7,When my child was in pain his or her face looked sad in past 7D
91154-5,When my child was in pain he or she asked for help with doing things in past 7D
91155-2,When my child was in pain he or she asked people to let him or her be by himself or herself in past 7D
91156-0,When my child was in pain he or she moved stiffly in past 7D
Jul-15,Fluid output.biliary drain
91157-8,When my child was in pain he or she yelled for someone to help him or her in past 7D
91158-6,When my child was in pain he or she cried in past 7D
91159-4,"When my child was in pain he or she used something for support (cane, crutches, wheelchair) to move from place to place in past 7D"
91160-2,When my child was in pain he or she limped in past 7D
91161-0,When my child was in pain he or she became quiet in past 7D
91162-8,When my child was in pain he or she asked for help getting around in past 7D
91163-6,When my child was in pain he or she groaned in past 7D
91164-4,When my child was in pain he or she stayed away from other people in past 7D
May-16,Fluid output.biliary drain
91165-1,When my child was in pain he or she asked for medicine in past 7D
91166-9,When my child was in pain he or she screamed in past 7D
91167-7,When my child was in pain he or she protected the part of his or her body that hurt in past 7D
91168-5,When my child was in pain he or she tightened his or her jaw in past 7D
91169-3,When my child was in pain he or she talked about his or her pain in past 7D
91170-1,When my child was in pain he or she didn't let anyone touch him or her in past 7D
91171-9,When my child was in pain he or she rubbed his or her body where it hurt in past 7D
91172-7,When my child was in pain he or she moved slower in past 7D
Mar-17,Fluid output.biliary drain
91173-5,When my child was in pain he or she got angry at people in past 7D
91174-3,When my child was in pain he or she didn't want anyone to touch him or her in past 7D
91175-0,When my child was in pain he or she avoided standing in past 7D
91176-8,"When my child was in pain he or she asked people to bring him or her things (food, games) in past 7D"
91177-6,When my child was in pain he or she couldn't stay still in past 7D
91178-4,When my child was in pain he or she was restless in past 7D
91179-2,When my child was in pain he or she tried to think of something nice or fun in past 7D
911-8,B Ab
91180-0,When my child was in pain he or she went to sleep in past 7D
Jan-18,Fluid output.biliary drain
91181-8,When my child was in pain he or she had to stop what he or she was doing in past 7D
91182-6,When my child was in pain he or she avoided lifting or carrying heavy things in past 7D
91183-4,When my child was in pain he or she stayed near to someone who cares about him or her in past 7D
91184-2,When my child was in pain he or she tried to rest or relax in past 7D
91185-9,When my child was in pain he or she complained in past 7D
91186-7,When my child was in pain he or she asked to see a doctor in past 7D
91187-5,When my child was in pain he or she pulled away if someone touched him or her where it hurt in past 7D
91188-3,When my child was in pain he or she argued with people in past 7D
91189-1,When my child was in pain he or she avoided using the part of his or her body that hurt in past 7D
91190-9,When my child was in pain he or she said mean words to people in past 7D
91191-7,When my child was in pain he or she got mad and threw or hit something in past 7D
91192-5,When my child was in pain he or she had a fixed or dazed expression in past 7D
91193-3,When my child was in pain he or she had tears in his or her eyes in past 7D
91194-1,When my child was in pain he or she had circles under his or her eyes in past 7D
91195-8,When my child was in pain he or she sighed in past 7D
91196-6,When my child was in pain he or she took breaks from what he or she was doing in past 7D
91197-4,When my child was in pain he or she told people he or she couldn't do his or her usual chores in past 7D
91198-2,When my child was in pain it showed on his or her face in past 7D
Sep-19,Fluid output.burn
91199-0,When my child was in pain he or she told people he or she couldn't do things with them in past 7D
91200-6,When my child was in pain he or she asked for someone to help him or her in past 7D
91201-4,When my child was in pain he or she lay down in past 7D
91202-2,When my child was in pain he or she felt his or her body get tense in past 7D
91203-0,PROMIS parent proxy pain behavior - version 1.0 T-score
91204-8,PROMIS parent proxy item bank - pain behavior - version 1.0
91205-5,How many D did your child run for 10M or more in past 7D
91206-3,How many D was your child physically active for 10M or more in past 7D
Jul-20,Fluid output.burn
91207-1,How many D did your child exercise really hard for 10M or more in past 7D
91208-9,"On a usual day, how physically active was your child in past 7D"
91209-7,How many D did your child exercise or play so hard that he or she felt tired in past 7D
91210-5,How many D did your child exercise or play so hard that his or her muscles burned in past 7D
91211-3,How many D did your child exercise or play so hard that his or her body got tired in past 7D
91212-1,How many D was your child so physically active that he or she sweated in past 7D
91213-9,How many D did your child play sports for 10M or more in past 7D
91214-7,How many D did your child exercise so much that he or she breathed hard in past 7D
May-21,Fluid output.burn
91215-4,PROMIS parent proxy item bank - physical activity - version 1.0
91216-2,PROMIS parent proxy physical activity - version 1.0 T-score
91217-0,How many D did you run for 10M or more in past 7D
91218-8,How many D were you physically active for 10M or more in past 7D
91219-6,How many D did you exercise really hard for 10M or more in past 7D
91220-4,"On a usual day, how physically active were you in past 7D"
91221-2,How many D did you exercise or play so hard that you felt tired in past 7D
91222-0,How many D did you exercise or play so hard that your muscles burned in past 7D
Mar-22,Fluid output.cerebral ventricle drain
91223-8,How many D did you exercise or play so hard that your body got tired in past 7D
91224-6,How many D were you so physically active that you sweated in past 7D
91225-3,How many D did you play sports for 10M or more in past 7D
91226-1,How many D did you exercise so much that you breathed hard in past 7D
91227-9,PROMIS pediatric physical activity - version 1.0 T-score
91228-7,PROMIS pediatric item bank - physical activity - version 1.0
91229-5,I felt healthy in past 7D
91230-3,I felt strong in past 7D
Jan-23,Fluid output.cerebral ventricle drain
91231-1,I felt full of pep in past 7D
91232-9,I felt active in past 7D
91233-7,I felt refreshed in past 7D
91234-5,I felt wide awake in past 7D
91235-2,I had a lot of energy in past 7D
91236-0,I felt energetic in past 7D
91237-8,I felt enthusiastic in past 7D
91238-6,I felt blissful in past 7D
91239-4,I felt good in past 7D
91240-2,I was in good spirits in past 7D
91241-0,I was in a good mood in past 7D
91242-8,I was merry in past 7D
91243-6,I laughed a lot in past 7D
91244-4,I smiled a lot in past 7D
91245-1,My life was pleasurable in past 7D
91246-9,I felt delighted in past 7D
91247-7,I felt joyful in past 7D
91248-5,I had very strong happy feelings in past 7D
Sep-24,Fluid output.cerebral ventricle drain
91249-3,I felt happy in past 7D
91250-1,I felt cheerful in past 7D
91251-9,I felt great in past 7D
91252-7,I felt pleased in past 7D
91253-5,I had much to be proud about in past 7D
91254-3,I felt proud in past 7D
91255-0,I felt appreciated in past 7D
Jun-25,Fluid output.cerebral ventricle drain
91256-8,I felt respected in past 7D
91257-6,I felt fulfilled in past 7D
91258-4,I felt comfortable in past 7D
91259-2,I felt relaxed in past 7D
912-6,B Ab
91260-0,I felt carefree in past 7D
91261-8,I felt positive in past 7D
91262-6,I felt thankful in past 7D
91263-4,I felt grateful in past 7D
Apr-26,Fluid output.cerebral ventricle drain
91264-2,I felt content in past 7D
91265-9,I felt satisfied in past 7D
91266-7,I felt peaceful in past 7D
91267-5,My child felt healthy in past 7D
91268-3,My child felt strong in past 7D
91269-1,My child felt full of pep in past 7D
91270-9,My child felt active in past 7D
91271-7,My child felt refreshed in past 7D
Feb-27,Fluid output.cerebral ventricle drain
91272-5,My child felt wide awake in past 7D
91273-3,My child had a lot of energy in past 7D
91274-1,My child felt energetic in past 7D
91275-8,My child felt enthusiastic in past 7D
91276-6,My child felt blissful in past 7D
91277-4,My child felt good in past 7D
91278-2,My child was in good spirits in past 7D
91279-0,My child was in a good mood in past 7D
9128-0,Fluid output.subarachnoid drain
91280-8,My child felt merry in past 7D
91281-6,My child laughed a lot in past 7D
91282-4,My child smiled a lot in past 7D
91283-2,My child felt his or her life was pleasurable in past 7D
91284-0,My child felt delighted in past 7D
91285-7,My child felt joyful in past 7D
91286-5,My child had very strong happy feelings in past 7D
91287-3,My child felt happy in past 7D
91288-1,My child felt cheerful in past 7D
91289-9,My child felt great in past 7D
91290-7,My child felt pleased in past 7D
91291-5,My child felt he or she had much to be proud about in past 7D
91292-3,My child felt proud in past 7D
91293-1,My child felt appreciated in past 7D
91294-9,My child felt respected in past 7D
91295-6,My child felt fulfilled in past 7D
91296-4,My child felt comfortable in past 7D
91297-2,My child felt relaxed in past 7D
Aug-29,Fluid output.chest tube
91298-0,My child felt carefree in past 7D
91299-8,My child felt positive in past 7D
91300-4,My child felt thankful in past 7D
91301-2,My child felt grateful in past 7D
91302-0,My child felt content in past 7D
91303-8,My child felt satisfied in past 7D
91304-6,My child felt peaceful in past 7D
91305-3,My child felt calm in past 7D
Jun-30,Fluid output.chest tube
91306-1,PROMIS parent proxy positive affect - version 1.0 T-score
91307-9,PROMIS parent proxy item bank - positive affect - version 1.0
91308-7,I felt I had too much going on in past 7D
91309-5,I felt unable to manage things in my life in past 7D
91310-3,I felt unable to react to something that bothered me in past 7D
91311-1,I was slow to react to things in past 7D
91312-9,My thoughts went very fast in past 7D
91313-7,I had trouble concentrating in past 7D
Apr-31,Fluid output.chest tube
91314-5,I felt so upset that I could not remember what happened or what I did in past 7D
91315-2,"I felt unable to remember answers, even for questions I knew the answer to in past 7D"
91316-0,I felt like my thinking was slower than usual in past 7D
91317-8,I forgot things in past 7D
91318-6,I felt overwhelmed in past 7D
91319-4,I felt that my problems kept piling up in past 7D
91320-2,I felt under pressure in past 7D
91321-0,Everything bothered me in past 7D
Feb-32,Fluid output.chest tube
91322-8,Small things upset me in past 7D
91323-6,I felt concerned about what was going on in my life in past 7D
91324-4,PROMIS pediatric item bank - psychological stress experiences - version 1.0
91325-1,PROMIS pediatric psychological stress experiences - version 1.0 T-score
91326-9,How many D was your child strong enough to lift heavy things over his or her head in past 7D
91327-7,How many D was your child strong enough to get down on the floor in past 7D
91328-5,How many D was your child strong enough to carry his or her school books in past 7D
91329-3,How many D was your child strong enough to open a jar by himself or herself in past 7D
9133-0,Fluid output.chest tube
91330-1,How many D was your child strong enough to pour a drink from a full pitcher or carton in past 7D
91331-9,How many D was your child strong enough to jump up and down in past 7D
91332-7,How many D was your child strong enough to get out of bed and stand without help in past 7D
91333-5,How many D was your child strong enough to hold a full plate or tray of food in past 7D
91334-3,How many D was your child strong enough to open a heavy door in past 7D
91335-0,How many D was your child strong enough to reach above his or her head to get heavy things in past 7D
91336-8,How many D was your child strong enough to go up and down stairs in past 7D
91337-6,How many D was your child strong enough to carry heavy things with his or her hands in past 7D
91338-4,PROMIS parent proxy item bank - strength impact - version 1.0
91339-2,PROMIS parent proxy strength impact - version 1.0 T-score
913-4,B Ab
91340-0,My back pain has spread down my leg(s) at some time in the last 2W
91341-8,I have had pain in the shoulder or neck at some time in the last 2W
91342-6,I have only walked short distances because of my back pain in the last 2W
91343-4,I have dressed more slowly than usual because of back pain in the last 2W
91344-2,"Thinking about the last 2W, it's not really safe for a person with a condition like mine to be physically active"
91345-9,Worrying thoughts have been going through my mind a lot of the time in the last 2W
91346-7,"Thinking about the last 2W, I feel that my back pain is terrible and it's never going to get any better"
91347-5,"Thinking about the last 2W, in general I have not enjoyed all the things I used to enjoy"
Aug-34,Fluid output.chest tube
91348-3,"Overall, how bothersome has your back pain been in the last 2W"
91349-1,STarT Back Screening Tool panel
91350-9,Distress subscore
91351-7,Total score
91352-5,STarT Back Screening risk level
91353-3,I felt calm in past 7D
91354-1,PROMIS pediatric positive affect - version 1.0 T-score
May-35,Fluid output.chest tube
91355-8,PROMIS pediatric item bank - positive affect - version 1.0
91356-6,My child felt concerned about what was going on in his or her life in past 7D
91357-4,Small things upset my child in past 7D
91358-2,Everything bothered my child in past 7D
91359-0,My child felt under pressure in past 7D
91360-8,My child felt that his or her problems kept piling up in past 7D
91361-6,My child felt overwhelmed in past 7D
91362-4,My child felt so upset that he or she could not remember what happened or what he or she did in past 7D
91363-2,My child had trouble concentrating in past 7D
91364-0,My child's thoughts went very fast in past 7D
91365-7,My child felt unable to manage things in his or her life in past 7D
91366-5,My child felt he or she had too much going on in past 7D
91367-3,PROMIS parent proxy item bank - psychological stress experiences - version 1.0
91368-1,PROMIS parent proxy psychological stress experiences - version 1.0 T-score
91369-9,I had trouble controlling my thoughts in past 7D
91370-7,Body height^used for drug calculation
Jan-37,Fluid output.emesis
91371-5,Body Temperature
91372-3,Hearing threshold^1500 Hz
91373-1,Hearing threshold^1500 Hz
91374-9,Hearing threshold^250 Hz
91375-6,Hearing threshold^250 Hz
91376-4,Hearing threshold^5000 Hz
91377-2,Hearing threshold^5000 Hz
91378-0,Hearing threshold^750 Hz
91379-8,Hearing threshold^750 Hz
91380-6,Number of falls in the past 3Mo
91381-4,Date medication started
91382-2,Date medication stopped
91383-0,Medication duration
91384-8,Age when first used marijuana
91385-5,Age when first used cocaine or crack
91386-3,Age when first used heroin
91387-1,Has valid driver license
91388-9,Has automobile available for use
Sep-38,Fluid output.emesis
91389-7,Substance abused
91390-5,Preadolescent sexual abuse
91391-3,Mental health diagnosis
91392-1,Total score
91393-9,Opioid risk tool panel
91394-7,It was hard for my child to do school work because he or she felt sad in past 7D
91395-4,It was hard for my child to have fun in past 7D
91396-2,My child could not stop feeling sad in past 7D
Jul-39,Fluid output.emesis
91397-0,My child didn't care about anything in past 7D
91398-8,My child felt alone in past 7D
91399-6,My child felt everything in his or her life went wrong in past 7D
91400-2,My child felt like he or she couldn't do anything right in past 7D
91401-0,My child felt lonely in past 7D
91402-8,My child felt sad in past 7D
91403-6,My child felt too sad to eat in past 7D
91404-4,My child felt unhappy in past 7D
May-40,Fluid output.emesis
91405-1,My child wanted to be by himself or herself in past 7D
91406-9,PROMIS parent proxy depressive symptoms - version 2.0 T-score
91407-7,PROMIS parent proxy item bank - depressive symptoms - version 2.0
91408-5,It was hard for my child to play sports or exercise because of asthma in past 7D
91409-3,It was hard for my child to play with pets because of asthma in past 7D
91410-1,It was hard for my child to take a deep breath because of asthma in past 7D
91411-9,My child coughed because of his or her asthma in past 7D
91412-7,My child felt scared that he or she might have trouble breathing because of asthma in past 7D
Mar-41,Fluid output.emesis
91413-5,My child felt wheezy because of his or her asthma in past 7D
91414-3,My child got tired easily because of his or her asthma in past 7D
91415-0,My child had asthma attacks in past 7D
91416-8,My child had trouble breathing because of his or her asthma in past 7D
91417-6,My child had trouble sleeping at night because of asthma in past 7D
91418-4,My child had trouble walking because of asthma in past 7D
91419-2,My child missed school because of asthma in past 7D
914-2,B Ag
91420-0,My child was bothered by asthma when he or she was with friends in past 7D
Jan-42,Fluid output.emesis
91421-8,My child was bothered by the amount of time he or she spent wheezing in past 7D
91422-6,My child's asthma bothered him or her in past 7D
91423-4,My child's body felt bad when he or she was out of breath in past 7D
91424-2,My child's chest felt tight because of asthma in past 7D
91425-9,PROMIS parent proxy asthma impact - version 2.0 T-score
91426-7,PROMIS parent proxy item bank - asthma impact - version 2.0
91427-5,A sudden noise made me jump in past 7D
91428-3,I could not stay still for long in past 7D
91429-1,I felt as if I needed to move my legs a lot in past 7D
91430-9,I felt dizzy in past 7D
91431-7,I felt some food coming up into my throat in past 7D
91432-5,I had a bad stomach ache in past 7D
91433-3,I had a headache in past 7D
91434-1,I had pain that really bothered me in past 7D
91435-8,"I had trouble breathing, even when I was not exercising or playing hard in past 7D"
91436-6,I threw up in past 7D
91437-4,"I was sweaty, even when I was not exercising or playing hard in past 7D"
91438-2,My appetite changed in past 7D
Sep-43,Fluid output.emesis
91439-0,My back hurt in past 7D
91440-8,My body shook in past 7D
91441-6,My breathing was fast in past 7D
91442-4,"My breathing was fast, even when I was not exercising or playing hard in past 7D"
91443-2,My hands shook in past 7D
91444-0,"My heart beat faster than usual, even when I was not exercising or playing hard in past 7D"
91445-7,"My heart pounded, even when I was not exercising or playing hard in past 7D"
91446-5,My legs shook in past 7D
Jul-44,Fluid output.emesis
91447-3,My mouth was dry in past 7D
91448-1,My muscles felt tight in past 7D
91449-9,My neck felt tight in past 7D
91450-7,My neck hurt in past 7D
91451-5,My palms were sweaty in past 7D
91452-3,PROMIS pediatric item bank - physical stress experiences - version 1.0
91453-1,PROMIS pediatric physical stress experiences - version 1.0 T-score
Apr-45,Fluid output.emesis
91454-9,PROMIS pediatric item bank - meaning and purpose - version 1.0
91455-6,PROMIS pediatric meaning and purpose - version 1.0 T-score
91456-4,"Thinking about my life, I always have hope"
91457-2,"Thinking about my life, I am full of hope"
91458-0,"Thinking about my life, I am positive about my future"
91459-8,"Thinking about my life, I am satisfied with my purpose in life"
91460-6,"Thinking about my life, I can do almost anything if I have enough faith in myself"
91461-4,"Thinking about my life, I can reach my goals in life"
Feb-46,Fluid output.emesis
91462-2,"Thinking about my life, I expect amazing things to happen to me"
91463-0,"Thinking about my life, I expect things to work out for the best"
91464-8,"Thinking about my life, I expect to achieve my goals"
91465-5,"Thinking about my life, I expect to achieve what I want in life"
91466-3,"Thinking about my life, I expect to be successful in the future"
91467-1,"Thinking about my life, I expect to enjoy my future life"
91468-9,"Thinking about my life, I expect to have a family in the future"
91469-7,"Thinking about my life, I expect to have a job in the future"
9147-0,Fluid output.emesis
91470-5,"Thinking about my life, I expect to have a long life"
91471-3,"Thinking about my life, I expect to have success in the future"
91472-1,"Thinking about my life, I expect to succeed at what I try to do"
91473-9,"Thinking about my life, I feel hopeful about my future"
91474-7,"Thinking about my life, I feel hopeful about my plans for the future"
91475-4,"Thinking about my life, I have a clear purpose in life"
91476-2,"Thinking about my life, I have a reason for living"
91477-0,"Thinking about my life, I have goals for myself"
91478-8,"Thinking about my life, I have hope"
91479-6,"Thinking about my life, I have things I need to do in life"
91480-4,"Thinking about my life, I have things I want to accomplish in life"
91481-2,"Thinking about my life, I have things I want to do in life"
91482-0,"Thinking about my life, I know what makes my life meaningful"
91483-8,"Thinking about my life, I know where I am going in life"
91484-6,"Thinking about my life, I look forward to what will happen in the future"
91485-3,"Thinking about my life, I make plans for my future"
91486-1,"Thinking about my life, I try to find meaning in life"
91487-9,"Thinking about my life, I try to find purpose in life"
Aug-48,Fluid output.emesis
91488-7,"Thinking about my life, I want to do what is important"
91489-5,"Thinking about my life, I want to make the most out of my life"
91490-3,"Thinking about my life, my life has meaning"
91491-1,"Thinking about my life, my life has purpose"
91492-9,"Thinking about my life, my life is filled with important things"
91493-7,"Thinking about my life, my life is filled with meaning"
91494-5,"Thinking about my life, my life is filled with purpose"
91495-2,"Thinking about my life, my life is filled with things that interest me"
Jun-49,Fluid output.gastric tube
91496-0,"Thinking about my life, my life is important"
91497-8,"Thinking about my life, people will remember me when I die"
91498-6,"Thinking about my life, the things I have done in the past will help me in the future"
91499-4,"Thinking about my life, when bad things happen, I expect them to get better"
91500-9,How many D were you strong enough to carry heavy things with your hands in past 7D
91501-7,How many D were you strong enough to carry your school books in past 7D
91502-5,How many D were you strong enough to get down on the floor in past 7D
91503-3,How many D were you strong enough to get out of bed and stand without help in past 7D
Apr-50,Fluid output.gastric tube
91504-1,How many D were you strong enough to go up and down stairs in past 7D
91505-8,How many D were you strong enough to hold a full plate or tray of food in past 7D
91506-6,How many D were you strong enough to jump up and down in past 7D
91507-4,How many D were you strong enough to lift heavy things over your head in past 7D
91508-2,How many D were you strong enough to open a heavy door in past 7D
91509-0,How many D were you strong enough to open a jar by yourself in past 7D
91510-8,How many D were you strong enough to pour a drink from a full pitcher or carton in past 7D
91511-6,How many D were you strong enough to reach above your head to get heavy things in past 7D
Feb-51,Fluid output.gastric tube
91512-4,PROMIS pediatric item bank - strength impact - version 1.0
91513-2,PROMIS pediatric strength impact - version 1.0 T-score
91514-0,Country where healthcare received outside U.S.
91515-7,Received healthcare in U.S. but outside resident state
91516-5,State where healthcare received outside resident state
91517-3,Multisection diagnostic for implant
91518-1,Multisection diagnostic for implant
91519-9,Multisection diagnostic for implant
9152-0,Fluid output.gastric tube
91520-7,Multisection screening for implant
91521-5,Multisection screening for implant
91522-3,Multisection screening for implant
91523-1,Multisection^W contrast IV
91524-9,Multisection^WO & W contrast IV
91525-6,Multisection^WO contrast
91526-4,Fear-Affect Survey - age 18+ - T-score
91527-2,Perceived Stress Survey - age 18+ - T-score
91528-0,Perceived Stress Survey - fixed length form - age 18+
91529-8,Fear-Affect Survey - CAT item bank - age 18+
91530-6,Self-Efficacy Survey version 2.0 - CAT item bank - ages 13-17
91531-4,Note
91532-2,Age when first injected non-prescription drug
91533-0,PROMIS pediatric fatigue - version 2.0 T-score
91534-8,PROMIS pediatric item bank - fatigue - version 2.0
91535-5,PROMIS pediatric depressive symptoms - version 2.0 T-score
91536-3,PROMIS pediatric item bank - depressive symptoms - version 2.0
91537-1,PROMIS pediatric asthma impact - version 2.0 T-score
Aug-53,Fluid output.gastric tube
91538-9,PROMIS pediatric item bank - asthma impact - version 2.0
91539-7,PROMIS pediatric anxiety - version 2.0 T-score
91540-5,PROMIS pediatric item bank - anxiety - version 2.0
91541-3,Disease outcome
91542-1,Myelin oligodendrocyte glycoprotein Ab
91543-9,Myelin oligodendrocyte glycoprotein Ab
91544-7,Myelin oligodendrocyte glycoprotein Ab
91545-4,Myelin oligodendrocyte glycoprotein Ab
Jun-54,Fluid output.gastric tube
91546-2,ST deviation
91547-0,Treadmill angina
91548-8,Duke Treadmill Score risk level
91549-6,Duke Treadmill Score
91550-4,Duke Treadmill Score panel
91551-2,Other cells/100 leukocytes
91552-0,"MDS v3.0 - RAI v1.17.1, 1.17.2 - Swing bed discharge (SD) item set"
Mar-55,Fluid output.gastric tube
91553-8,Duration that patient was able to hold balance position
91554-6,MDS v3.0 - RAI v1.17.2 - Identification information - ND
91555-3,Percent intake by artificial route during the last 7D
91556-1,Fibrin D-dimer DDU
91557-9,Lean body weight
91558-7,Coinfection
91559-5,Date of arrival at travel destination
91560-3,Date of departure from travel destination
Jan-56,Fluid output.insensible
91561-1,Multisection^W contrast IV
91562-9,Performing laboratory identifier
91563-7,Casualties
91564-5,Information source for rumor related to public health emergency
91565-2,Key words related to public health emergency
91566-0,Rumor related to public health emergency
91567-8,"MDS v3.0 - RAI v1.17.2 - Special treatments, procedures, and programs - SD"
91568-6,Shot up or injected any non-prescription drugs
91569-4,Frequency of medicine or drug injection with needle during time period with highest use
91570-2,Employment net income
91571-0,Frequency of drug injection
91572-8,Used erectile dysfunction drug
91573-6,Twelve or more drinks in a D
91574-4,Four or more drinks in 2H or less
91575-1,Eight or more drinks in a D
91576-9,Five or more drinks in a period of 2H or less
91577-7,MDS v3.0 - RAI v1.17.2 - Therapies - OSA
91578-5,Probability of an event occurring
Sep-57,Fluid output.insensible
91579-3,MDS v3.0 - RAI v1.17.2 - Correction request - IPA
91580-1,MDS v3.0 - RAI v1.17.2 - Type of assessment on existing record to be modified or inactivated - IPA
91581-9,MDS v3.0 - RAI v1.17.2 - State Medicaid billing - OSA
91582-7,Report status
91583-5,Date and time of public health emergency
91584-3,Date and time rumor record was released
91585-0,Reliability of information source
91586-8,Coding system
Jul-58,Fluid output.insensible
91587-6,Accuracy of information from source
91588-4,Latitude
91589-2,Longitude
915-9,B Ag
91590-0,Mycobacterium preliminary growth
91591-8,Multisection^W contrast IV
91592-6,Multisection^WO & W contrast IV
91593-4,Multisection^WO contrast
91594-2,Multisection^W contrast IV
May-59,Fluid output.insensible
91595-9,Multisection^WO & W contrast IV
91596-7,Multisection^WO contrast
91597-5,Multisection^WO & W contrast IV
91598-3,Views GE 2
91599-1,Emergency operations center activation level
91600-7,Operational objectives related to the emergency response activation
91601-5,Priorities related to the emergency response activation
91602-3,Critical information requirements related to the emergency response activation
Mar-60,Fluid output.misc
91603-1,Summary of current situation related to public health emergency
91604-9,Device count
91606-4,clomiPRAMINE+Norclomipramine
91607-2,Does your health now limit you in opening a previously opened jar
91608-0,Are you able to pass a 20-pound (10 kg) turkey or ham to other people at the table
91609-8,Are you able to continuously swing a baseball bat or tennis racket back and forth for 5M
91610-6,Are you able to lift a heavy painting or picture to hang on your wall above eye-level
Jan-61,Fluid output.misc
91611-4,PROMIS item bank - upper extremity - version 2.0
91612-2,PROMIS upper extremity version 2.0 T-score
91613-0,PROMIS item bank - mobility - version 2.0
91614-8,PROMIS mobility - version 2.0 T-score
91615-5,How depressed or cheerful have you been during the past Mo
91616-3,"How much energy, pep, and vitality have you felt during the past Mo"
91617-1,How relaxed or tense have you been during the past Mo
91618-9,How concerned or worried about your health have you been during the past Mo
91619-7,"Have you felt tired, worn out, used-up, or exhausted during the past Mo"
91620-5,Have you been feeling emotionally stable and sure of yourself during the past Mo
91621-3,Has your daily life been full of things that were interesting to you during the past Mo
91622-1,Have you been waking up fresh and rested during the past Mo
91623-9,"Have you had any reason to wonder if you were losing your mind, or losing control over the way you act, talk, think, feel, or of your memory during the past Mo"
91624-7,"How happy, satisfied, or pleased have you been with your personal life during the past Mo"
91625-4,"Have you felt so sad, discouraged, hopeless, or had so many problems that you wondered if anything was worthwhile during the past Mo"
91626-2,"Have you been in firm control of your behavior, thoughts, emotions, or feelings during the past Mo"
91627-0,Have you been bothered by nervousness or your nerves during the past Mo
91628-8,How have you been feeling in general during the past Mo
Sep-62,Fluid output.misc
91629-6,General Well-Being Schedule - 18 item
91630-4,Have you felt down-hearted and blue during the past Mo
91631-2,"Have you been bothered by any illness, bodily disorder, pains, or fears about your health during the past Mo"
91632-0,"Have you been anxious, worried, or upset during the past Mo"
91633-8,"Have you been under or felt you were under any strain, stress, or pressure during the past Mo"
91634-6,How often is the following kind of support available to you if you need it - someone you can count on to listen to you when you need to talk
91635-3,How often is the following kind of support available to you if you need it - someone to give you good advice about a crisis
91636-1,How often is the following kind of support available to you if you need it - someone who shows you love and affection
Jul-63,Fluid output.misc
91637-9,How often is the following kind of support available to you if you need it - someone to confide in or talk to about yourself or your problems
91638-7,How often is the following kind of support available to you if you need it - someone whose advice you really want
91639-5,How often is the following kind of support available to you if you need it - someone to help with daily chores if you were sick
91640-3,How often is the following kind of support available to you if you need it - someone to share your most private worries and fears with
91641-1,How often is the following kind of support available to you if you need it - someone to love and make you feel wanted
91642-9,Medical Outcomes Study Social Support Survey panel
91643-7,Emotional+informational support
91644-5,Tangible support
May-64,Fluid output.misc
91645-2,Affectionate support
91646-0,Positive social interaction
91647-8,Emotional+informational support score
91648-6,Tangible support score
91649-4,Affectionate support score
91650-2,Positive social interaction score
91651-0,General Well-Being Schedule - 18 item - total score
Feb-65,Fluid output.misc
91652-8,How often is the following kind of support available to you if you need it - someone to help you if you were confined to bed
91653-6,How often is the following kind of support available to you if you need it - someone to take you to the doctor if you needed it
91654-4,How often is the following kind of support available to you if you need it - someone to have a good time with
91655-1,How often is the following kind of support available to you if you need it - someone to give you information to help you understand a situation
91656-9,How often is the following kind of support available to you if you need it - someone who hugs you
91657-7,How often is the following kind of support available to you if you need it - someone to get together with for relaxation
91658-5,How often is the following kind of support available to you if you need it - someone to prepare your meals if you were unable to do it yourself
91659-3,How often is the following kind of support available to you if you need it - someone to do things with to help get your mind off things
9166-0,Fluid output.misc
91660-1,How often is the following kind of support available to you if you need it - someone to turn to for suggestions about how to deal with a personal problem
91661-9,How often is the following kind of support available to you if you need it - someone to do something enjoyable with
91662-7,How often is the following kind of support available to you if you need it - someone who understands your problems
91663-5,Social support index
91664-3,Ambrosia deltoidea Ab.IgE
91665-0,Ascorbate oxidase Ab.IgE
91666-8,Ascorbate oxidase Ab.IgE.RAST class
91667-6,Aspergillus clavatus Ab
91668-4,Aspergillus oryzae Ab
91669-2,CYP3A7 gene targeted mutation analysis
916-7,B Ag
91670-0,Orexin-A
91671-8,Transferrin.carbohydrate deficient.disialo/Transferrin.total^^standardized per IFCC-RMP for CDT
91672-6,ABCB1 gene targeted mutation analysis
91673-4,Cells.CD3+CD16+CD56+/100 cells
91674-2,Cells.CD3+CD16+CD56+
91675-9,Giardia lamblia & Cryptosporidium parvum Ag panel
91676-7,Giardia lamblia Ag
91677-5,Cryptosporidium parvum Ag
Aug-67,Fluid output.misc.route
91678-3,Zika virus Ab.IgM
91679-1,F8 gene intron 22 inversion targeted mutation analysis
91680-9,F8 gene intron 22 inversion targeted mutation analysis
91681-7,F9 gene mutation analysis limited to known familial mutations
91682-5,Histoplasma capsulatum Ab
91683-3,Histoplasma capsulatum H & M Ab & Blastomyces dermatitidis Ab panel
91684-1,Histoplasma capsulatum H & M Ab panel
91685-8,Glutathione
Jun-68,Fluid output.pericardial drain
91686-6,Adult self-report short form total score
91687-4,Adult self-report long form total score
91688-2,Mood and Feelings Questionnaire Adult self-report long form
91689-0,Mood and Feelings Questionnaire Adult self-report short form
91690-8,Testing services available
91691-6,Age
91692-4,Sex
91693-2,Specialty
Apr-69,Fluid output.pericardial drain
91694-0,Highest level of education
91695-7,Qualification
91696-5,Response team name
91697-3,Name
91698-1,Age
91699-9,Sex
91700-5,Specialty
91701-3,Shelter category
Feb-70,Fluid output.pericardial drain
91702-1,Shelter name
91703-9,Shelter address
91704-7,Primary contact information panel
91705-4,Corticotropin^5M pre 1 ug/kg CRH IV
91706-2,Corticotropin^1M pre 1 ug/kg CRH IV
91707-0,Corticotropin post corticotropin releasing hormone stimulation panel
91708-8,Corticotropin^10M post 1 ug/kg CRH IV
91709-6,Corticotropin^2M post 1 ug/kg CRH IV
9171-0,Fluid output.pericardial drain
91712-0,F5 gene.c.1691G>A
91714-6,Date of interview
91715-3,Multisection^W contrast IV
91716-1,Multisection^WO & W contrast IV
91717-9,Multisection^WO contrast
91718-7,Multisection post mortem
91719-5,Multisection post mortem
91720-3,Views for shunt patency
91721-1,PROMIS physical function - version 2.0 T-score
91722-9,PROMIS item bank - physical function - version 2.0
91723-7,Are you able to rake leaves or sweep for 1H without stopping to rest
91724-5,Are you able to complete 5 push-ups without stopping
91725-2,Are you able to hand wash and wax a car for 2H without stopping to rest
91726-0,Are you able to dance energetically for 1H
91727-8,Are you able to swim laps for 30M at a moderate pace
Aug-72,Fluid output.pericardial drain
91728-6,Are you able to stand up from a push-up position five times quickly
91729-4,Are you able to pull a sled or a wagon with two children (total 100 lbs or 50 kg) for 100 yards (100 m)
91730-2,Are you able to carry a 50 lb (25 kg) bag of sand 25 yards (25 m)
91731-0,Are you able to push an empty refrigerator forward 1 yard (1 m)
91732-8,Are you able to climb a 6-foot (2 m) ladder
91733-6,Are you able to row a boat for 30M without stopping to rest
91734-4,Are you able to lift and load one 50-pound (25 kg) bag of sand into a car
91735-1,Are you able to carry a large baby (15 lbs or 7 kg) out of the house to a car or taxi
Jun-73,Fluid output.pericardial drain
91736-9,Are you able to put your hands flat on the floor with both feet flat on the ground
91737-7,Are you able to walk in a straight line putting one foot in front of the other (heel to toe) for 5 yards (5 m)
91738-5,Are you able to stand on one foot with your eyes closed for 30S
91739-3,Are you able to walk across a balance beam
91740-1,Are you able to jump 2 feet (60 cm) high
91741-9,Are you able to paint the walls of a room with a brush or roller for 2H without stopping to rest
91742-7,Are you able to jump over a puddle that is 3 feet (1 m) wide
91743-5,Are you able to jump over an object that is 1 foot (30 cm) tall
Apr-74,Fluid output.peritoneal drain
91744-3,Are you able to jump rope for 10M without stopping
91745-0,Are you able to make sharp turns while running fast
91746-8,Are you able to come to a complete stop while running
91747-6,Are you able to walk briskly for 20M without stopping to rest
91748-4,Are you able to climb the stairs of a 10-story building without stopping
91749-2,Are you able to complete 10 sit-ups without stopping
917-5,B variant subtype Ab
91750-0,Are you able to remove a heavy suitcase (50 lbs or 25 kg) from an overhead bin on an airplane or bus
Jan-75,Fluid output.peritoneal drain
91751-8,Are you able to hit the backboard with a basketball from the free-throw line (13 ft or 4 m)
91752-6,Are you able to lift a heavy object (20 lbs or 10 kg) above your head
91753-4,Are you able to do a pull-up
91754-2,Are you able to dig a 2-foot (.5 m) deep hole in the dirt with a shovel
91755-9,"Are you able to carry household items, such as heavy boxes or furniture, up a flight of stairs"
91756-7,Are you able to carry a suitcase up a flight of stairs
91757-5,Are you able to run on even ground
91758-3,"Does your health now limit you in doing yard work like raking leaves, weeding, or pushing a lawn mower"
91759-1,"Does your health now limit you in taking part in any sports (swimming, bowling, and so forth)"
91760-9,Does your health now limit you in dancing for half an hour
91761-7,Giardia sp Ag
91762-5,Watch record details
91763-3,Mycobacterium tuberculosis DNA
91764-1,Nocardia sp identified
91765-8,Entamoeba sp DNA
91766-6,Entamoeba histolytica DNA
91767-4,Giardia sp DNA
91768-2,Ova & parasites identified
Sep-76,Fluid output.peritoneal drain
91769-0,Enterovirus RNA
91770-8,Enterovirus identified
91771-6,Influenza virus A subtype
91772-4,Influenza virus identified
91773-2,Herpes simplex virus identified
91774-0,Varicella zoster virus Ag
91775-7,Bordetella sp identified
91776-5,Mycoplasma sp.respiratory identified
Jul-77,Fluid output.peritoneal drain
91777-3,Bordetella sp identified
91778-1,Human metapneumovirus identified
91779-9,Yeast identified
91780-7,Measles virus
91781-5,Neisseria gonorrhoeae
91782-3,Respiratory syncytial virus
91783-1,Cytomegalovirus
91784-9,Varicella zoster virus
May-78,Fluid output.peritoneal drain
91785-6,Respiratory syncytial virus
91786-4,Measles virus
91787-2,Mumps virus
91788-0,Neisseria meningitidis
91789-8,Haemophilus ducreyi
91790-6,Trichomonas vaginalis
91791-4,Varicella zoster virus DNA
91792-2,Rubella virus RNA
Mar-79,Fluid output.peritoneal drain
91793-0,Rhinovirus RNA
91794-8,Respiratory syncytial virus B RNA
91795-5,Respiratory syncytial virus A RNA
91796-3,Parvovirus B19 DNA
91797-1,Parvovirus B19 DNA
91798-9,Parainfluenza virus RNA
91799-7,Parainfluenza virus 4 RNA
91800-3,Parainfluenza virus 3 RNA
Jan-80,Fluid output.subarachnoid drain
91801-1,Parainfluenza virus 2 RNA
91802-9,Parainfluenza virus 1 RNA
91803-7,Neisseria meningitidis DNA
91804-5,Mycoplasma pneumoniae DNA
91805-2,Mycobacterium leprae DNA
91806-0,Mumps virus RNA
91807-8,Middle east respiratory syndrome coronavirus RNA
91808-6,Microscopic observation
91809-4,Human metapneumovirus RNA
91810-2,Human metapneumovirus Ag
91811-0,Human bocavirus Ag
91812-8,Fungus identified
91813-6,Bordetella sp DNA
91814-4,Bordetella sp Ag
91815-1,Bordetella pertussis DNA
91816-9,Bordetella parapertussis DNA
91817-7,Bordetella holmesii DNA
91818-5,Bacteria identified
Sep-81,Fluid output.subarachnoid drain
91819-3,Bacteria identified
91820-1,Adenovirus DNA
91821-9,Adenovirus Ag
91822-7,Adenovirus Ag
91823-5,Rubella virus RNA
91824-3,Pneumocystis jiroveci Ag
91825-0,Parechovirus RNA
91826-8,Ova & parasites identified
Jul-82,Fluid output.subarachnoid drain
91827-6,Mycoplasma hominis DNA
91828-4,Mycoplasma genitalium DNA
91829-2,Mycobacterium tuberculosis DNA
918-3,B variant subtype Ab
91830-0,Middle east respiratory syndrome coronavirus RNA
91831-8,Human metapneumovirus Ag
91832-6,Human bocavirus Ag
91833-4,Herpes simplex virus Ag
91834-2,Herpes simplex virus 2 Ag
May-83,Fluid output.subarachnoid drain
91835-9,Herpes simplex virus 1 Ag
91836-7,Giardia sp DNA
91837-5,Francisella sp DNA
91838-3,Bordetella sp DNA
91839-1,Bordetella sp Ag
91840-9,Bordetella holmesii DNA
91841-7,Adenovirus Ag
91842-5,Ureaplasma urealyticum DNA
Mar-84,Fluid output.subarachnoid drain
91843-3,Ureaplasma parvum DNA
91844-1,Trichomonas vaginalis DNA
91845-8,Trichomonas vaginalis
91846-6,Treponema pallidum DNA
91847-4,Streptococcus agalactiae DNA
91848-2,Mycoplasma hominis DNA
91849-0,Mycoplasma genitalium DNA
9185-0,Fluid output.urinary incontinence
91850-8,Microscopic observation
91851-6,Human papilloma virus genotype
91852-4,Human papilloma virus DNA
91853-2,Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA
91854-0,Human papilloma virus 18 DNA
91855-7,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA
91856-5,Human papilloma virus 16 DNA
91857-3,Herpes simplex virus DNA
91858-1,Herpes simplex virus 2 DNA
91859-9,Herpes simplex virus 1 DNA
91860-7,Chlamydia trachomatis Ag
91861-5,Chlamydia trachomatis Ag
91862-3,Bartonella sp DNA
91863-1,Bartonella quintana DNA
91864-9,Bartonella henselae DNA
91865-6,Bacteria identified
91866-4,Bacteria identified
91867-2,Bordetella holmesii DNA
Aug-86,Fluid output.urinary incontinence
91868-0,Bordetella parapertussis DNA
91869-8,Bordetella pertussis DNA
91870-6,Bordetella sp Ag
91871-4,Bordetella sp DNA
91872-2,Bordetella sp identified
91873-0,Chlamydia trachomatis Ag
91874-8,Mycoplasma genitalium DNA
91875-5,Streptococcus agalactiae DNA
Jun-87,Fluid output.urine
91876-3,Brucella sp Ab
91877-1,Date and time report was received
91878-9,Mode of communication
91879-7,Reporter information
91880-5,Date and time of risk assessment meeting
91881-3,Location of meeting
91882-1,Emergency response plan objective
91883-9,Emergency response plan target outcome
Apr-88,Fluid output.urine
91884-7,Emergency response plan problem analysis
91885-4,Emergency response plan success analysis
91886-2,Document name
91887-0,Agency type
91888-8,Qualification
91889-6,Volunteer contact information panel
91890-4,Emergency supply category
91891-2,Bed type
Feb-89,Fluid output.urine
91892-0,Address
91893-8,Email address
91894-6,Phone number
91895-3,Bacterial strain
91896-1,Mycoplasma pneumoniae Ab
91897-9,Doravirine
91898-7,Epizootic hemorrhagic disease virus RNA
91899-5,Anaplasma phagocytophilum & Ehrlichia chaffeensis DNA panel
Sep-91,Cefodizime
9190-0,Fluid output.urine
91900-1,Parasite
91901-9,Response team
91902-7,Supply item
91903-5,Supply identifier
91904-3,Response team member qualification
91905-0,Response team leader information panel
91906-8,Response team leader qualification
91907-6,Storage location
91908-4,Supply stockpile
91909-2,Expiration date
919-1,B variant subtype Ab
91910-0,My child was too tired to read in past 7D
91911-8,My child was too tired to eat in past 7D
91912-6,My child needed to sleep during the day in past 7D
91913-4,My child had trouble finishing things because he or she was too tired in past 7D
91914-2,My child felt too tired to spend time with his or her friends in past 7D
91915-9,Being tired made it hard for my child to keep up with schoolwork in past 7D
91916-7,My child was too tired to go out with his or her family in past 7D
91917-5,My child felt more tired than usual when he or she woke up in the morning in past 7D
Aug-91,Fluid output.urine
91918-3,My child was so tired it was hard for him or her to pay attention in past 7D
91919-1,My child felt tired in past 7D
91920-9,My child was too tired to do things outside in past 7D
91921-7,Being tired kept my child from having fun in past 7D
91922-5,My child had trouble starting things because he or she was too tired in past 7D
91923-3,My child was too tired to do sports or exercise in past 7D
91924-1,My child was too tired to go up and down a lot of stairs in past 7D
91925-8,It was hard for my child to get out of bed in the morning because he or she was too tired in past 7D
Jun-92,Fluid output.urine
91926-6,Being tired made it hard for my child to play or go out with friends as much as he or she would like in past 7D
91927-4,My child was too tired to focus on his or her work in past 7D
91929-0,My child was too tired to enjoy the things he or she likes to do in past 7D
91930-8,My child was too tired to watch television in past 7D
91931-6,My child was too tired to take a bath or shower in past 7D
91932-4,My child felt weak in past 7D
91933-2,PROMIS parent proxy item bank - fatigue - version 2.0
Apr-93,Fluid output.urine
91934-0,PROMIS parent proxy fatigue - version 2.0 T-score
91935-7,PROMIS pediatric pain behavior - version 1.0 T-score
91936-5,PROMIS pediatric item bank - pain behavior - version 1.0
91937-3,When I was in pain I felt my body get tense in past 7D
91938-1,When I was in pain I lay down in past 7D
91939-9,When I was in pain I asked for someone to help me in past 7D
91940-7,When I was in pain I told people I couldn't do things with them in past 7D
91941-5,When I was in pain it showed on my face in past 7D
Feb-94,Class
91942-3,When I was in pain I told people I couldn't do my usual chores in past 7D
91943-1,When I was in pain I took breaks from what I was doing in past 7D
91944-9,When I was in pain I sighed in past 7D
91945-6,When I was in pain I got mad and threw or hit something in past 7D
91946-4,When I was in pain I said mean words to people in past 7D
91947-2,When I was in pain I avoided using the part of my body that hurt in past 7D
91948-0,When I was in pain I argued with people in past 7D
91949-8,When I was in pain I pulled away if someone touched me where it hurt in past 7D
91950-6,When I was in pain I asked to see a doctor in past 7D
91951-4,When I was in pain I complained in past 7D
91952-2,When I was in pain I tried to rest or relax in past 7D
91953-0,When I was in pain I stayed near to someone who cares about me in past 7D
91954-8,When I was in pain I avoided lifting or carrying heavy things in past 7D
91955-5,When I was in pain I had to stop what I was doing in past 7D
91956-3,When I was in pain I went to sleep in past 7D
91957-1,When I was in pain I tried to think of something nice or fun in past 7D
91958-9,When I was in pain I was restless in past 7D
Sep-95,Fluid output.urine in and out urethral catheter
91959-7,When I was in pain I couldn't stay still in past 7D
91960-5,"When I was in pain I asked people to bring me things (food, games) in past 7D"
91961-3,When I was in pain I avoided standing in past 7D
91962-1,When I was in pain I didn't want anyone to touch me in past 7D
91963-9,When I was in pain I got angry at people in past 7D
91964-7,When I was in pain I moved slower in past 7D
91965-4,When I was in pain I rubbed my body where it hurt in past 7D
91966-2,When I was in pain I didn't let anyone touch me in past 7D
Jul-96,Class
91967-0,When I was in pain I talked about my pain in past 7D
91968-8,When I was in pain I tightened my jaw in past 7D
91969-6,When I was in pain I asked for medicine in past 7D
91970-4,When I was in pain I stayed away from other people in past 7D
91971-2,When I was in pain I asked for help getting around in past 7D
91972-0,When I was in pain I became quiet in past 7D
91973-8,When I was in pain I limped in past 7D
91974-6,"When I was in pain I used something for support (cane, crutches, wheelchair) to move from place to place in past 7D"
May-97,Fluid output.urine^post void
91975-3,When I was in pain I criedin past 7D
91976-1,When I was in pain I yelled for someone to help me in past 7D
91977-9,When I was in pain I asked people to let me be by myself in past 7D
91978-7,When I was in pain I asked for help with doing things in past 7D
91979-5,When I was in pain I tried not to move in past 7D
91980-3,Specific resistance.airway
91981-1,Resistance.airway/predicted
91982-9,Specific resistance.airway/predicted
Mar-98,Fluid output.wound drain
91983-7,Care management note
91984-5,Care management note
91985-2,Note
91986-0,Consultation note
91987-8,PROMIS parent proxy anxiety - version 2.0 T-score
91988-6,PROMIS parent proxy item bank - anxiety - version 2.0
91989-4,My child felt worried in past 7D
91990-2,My child was afraid of going to school in past 7D
Jan-99,Fluid output.wound drain
91991-0,My child worried when he or she was at home in past 7D
91992-8,My child worried when he or she went to bed at night in past 7D
91993-6,My child was worried he or she might die in past 7D
91994-4,My child felt scared in past 7D
91995-1,My child felt like something awful might happen in past 7D
91996-9,It was hard for my child to relax in past 7D
91997-7,My child felt nervous in past 7D
91998-5,My child worried when he or she was away from home in past 7D
91999-3,My child woke up at night scared in past 7D
92000-9,My child worried about what could happen to him or her in past 7D
92001-7,My child got scared really easy in past 7D
92002-5,SMN1 gene
92003-3,Spinal muscular atrophy newborn screening comment-discussion
92004-1,Spinal muscular atrophy
92005-8,Spinal muscular atrophy newborn screening panel
92006-6,T-cell receptor excision circle
Jul-00,Fluid output.wound drain
92007-4,T-cell receptor excision circle
92008-2,T-cell receptor excision circle
92009-0,Birth date
92010-8,Jurisdiction fetal death report
92011-6,Jurisdiction live birth report
92012-4,Edit flags
92013-2,Administrative information
92014-0,Administrative information
May-01,Fluid output.wound drain
92015-7,Newborn administrative information
92016-5,Pregnancy risk factors
92017-3,Pregnancy summary
92018-1,Provider supplied mother's live birth report
92019-9,Provider supplied mother's fetal death report
92020-7,Provider supplied facility live birth report
92021-5,Provider supplied facility fetal death report
92022-3,Coded initiating cause or condition of death
Mar-02,Fluid output.wound drain
92023-1,Coded other significant causes or conditions of death
92024-9,Plazomicin^trough
92025-6,Multisection^W contrast IV
92026-4,Supervisor contact information panel
92027-2,Report action level
92028-0,Supervisor name
92029-8,Supervisor email address
92030-6,Supervisor address
Jan-03,Fluid output.wound drain
92031-4,Supervisor title
92032-2,Supervisor phone number
92033-0,Purchase cost
92034-8,Quantity distributed
92035-5,Job experience
92036-3,Action taken based on risk assessment meeting
92037-1,Significant activities related to public health emergency event
92038-9,Information communication technology type
92039-7,Information communication technology name
92040-5,Information communication technology description
92041-3,Physical security assessment system
92042-1,Physical security assessment system type
92043-9,Physical security assessment system name
92044-7,Physical security assessment system details
92045-4,Name
92046-2,Donor contact information panel
92047-0,Donated item
92048-8,Donated item
Sep-04,Fluid output.wound drain identifier
92049-6,Staphylococcus sp.methicillin resistant identified
92050-4,Video electroencephalography study
92051-2,My child had trouble staying asleep in past 7D
92052-0,My child's neck felt tight in past 7D
92053-8,My child felt as if he or she needed to move his or her legs a lot in past 7D
92054-6,A sudden noise made my child jump in past 7D
92055-3,My child's muscles felt tight in past 7D
Jun-05,Wound drain site
92056-1,My child could not stay still for long in past 7D
92057-9,My child's mouth was dry in past 7D
92058-7,"My child's breathing was fast, even when he or she was not exercising or playing hard in past 7D"
92059-5,My child's palms were sweaty in past 7D
92060-3,"My child was sweaty, even when he or she was not exercising or playing hard in past 7D"
92061-1,"My child's heart pounded, even when he or she was not exercising or playing hard in past 7D"
92062-9,"My child's heart beat faster than usual, even when he or she was not exercising or playing hard in past 7D"
92063-7,"My child had trouble breathing, even when he or she was not exercising or playing hard in past 7D"
Apr-06,Fluid output.wound drain
92064-5,My child felt dizzy in past 7D
92065-2,My child's breathing was fast in past 7D
92066-0,My child's hands shook in past 7D
92067-8,My child's legs shook in past 7D
92068-6,My child's body shook in past 7D
92069-4,My child had a headache in past 7D
92070-2,My child's neck hurt in past 7D
92071-0,My child's back hurt in past 7D
Feb-07,Fluid output.wound drain
92072-8,My child had a bad stomach ache in past 7D
92073-6,My child had pain that really bothered him or her in past 7D
92074-4,My child's appetite changed in past 7D
92075-1,My child felt some food coming up into his or her throat in past 7D
92076-9,My child threw up in past 7D
92077-7,PROMIS parent proxy item bank - physical stress experiences - version 1.0
92078-5,PROMIS parent proxy physical stress experiences - version 1.0 T-score
92079-3,PROMIS parent proxy meaning purpose - version 1.0 T-score
9208-0,Fluid output.wound drain
92080-1,PROMIS parent proxy item bank - meaning purpose - version 1.0
92081-9,"Thinking about your child's life, people will remember my child when he or she dies"
92082-7,"Thinking about your child's life, my child is satisfied with his or her purpose in life"
92083-5,"Thinking about your child's life, my child has a reason for living"
92084-3,"Thinking about your child's life, my child's life is filled with things that interest him or her"
92085-0,"Thinking about your child's life, my child knows what makes his or her life meaningful"
92086-8,"Thinking about your child's life, my child has a clear purpose in life"
92087-6,"Thinking about your child's life, my child thinks his or her life is filled with purpose"
92088-4,"Thinking about your child's life, my child thinks his or her life has purpose"
92089-2,"Thinking about your child's life, my child tries to find purpose in life"
920-9,B variant NOS Ag
92090-0,"Thinking about your child's life, my child thinks his or her life is filled with meaning"
92091-8,"Thinking about your child's life, my child thinks his or her life has meaning"
92092-6,"Thinking about your child's life, my child tries to find meaning in life"
92093-4,"Thinking about your child's life, my child wants to do what is important"
92094-2,"Thinking about your child's life, my child thinks his or her life is important"
92095-9,"Thinking about your child's life, my child's life is filled with important things"
92096-7,"Thinking about your child's life, my child wants to make the most out of his or her life"
92097-5,"Thinking about your child's life, my child can reach his or her goals in life"
Aug-09,Fluid output.wound drain
92098-3,"Thinking about your child's life, my child knows where he or she is going in life"
92099-1,"Thinking about your child's life, my child expects to achieve his or her goals"
92100-7,"Thinking about your child's life, the things my child has done in the past will help him or her in the future"
92101-5,"Thinking about your child's life, my child has things he or she wants to accomplish in life"
92102-3,"Thinking about your child's life, my child has things he or she needs to do in life"
92103-1,"Thinking about your child's life, my child has things he or she wants to do in life"
92104-9,"Thinking about your child's life, my child makes plans for his or her future"
92105-6,"Thinking about your child's life, my child has goals for himself or herself"
Jun-10,Fluid output.wound drain
92106-4,"Thinking about your child's life, my child can do almost anything if he or she has enough faith in himself or herself"
92107-2,"Thinking about your child's life, my child is positive about his or her future"
92108-0,"Thinking about your child's life, my child is hopeful about his or her future"
92109-8,"Thinking about your child's life, my child is hopeful about his or her plans for the future"
92110-6,"Thinking about your child's life, my child always has hope"
92111-4,"Thinking about your child's life, my child is full of hope"
92112-2,"Thinking about your child's life, my child has hope"
92113-0,"Thinking about your child's life, when bad things happen, my child expects them to get better"
Apr-11,Output.stool
92114-8,"Thinking about your child's life, my child expects to succeed at what he or she tries to do"
92115-5,"Thinking about your child's life, my child looks forward to what will happen in the future"
92116-3,"Thinking about your child's life, my child expects to achieve what he or she wants in life"
92117-1,"Thinking about your child's life, my child expects to have success in the future"
92118-9,"Thinking about your child's life, my child expects to have a long life"
92119-7,"Thinking about your child's life, my child expects to enjoy his or her future life"
92120-5,"Thinking about your child's life, my child expects to be successful in the future"
92121-3,"Thinking about your child's life, my child expects to have a family in the future"
Feb-12,Output.stool
92122-1,"Thinking about your child's life, my child expects to have a job in the future"
92123-9,"Thinking about your child's life, my child expects things to work out for the best"
92124-7,"Thinking about your child's life, my child expects amazing things to happen to him or her"
92125-4,Streptococcus pneumoniae DNA
92126-2,Mycoplasma pneumoniae DNA
92127-0,Haemophilus influenzae DNA
92128-8,Bordetella pertussis DNA
92129-6,Bordetella parapertussis DNA
9213-0,Output.stool
92130-4,Rhinovirus RNA
92131-2,Respiratory syncytial virus RNA
92132-0,Enterovirus A+B+C RNA
92133-8,Chlamydophila pneumoniae DNA
92134-6,Human metapneumovirus RNA
92135-3,Human bocavirus 1+2+3 DNA
92136-1,Adenovirus B+C+E DNA
92137-9,Parainfluenza virus 4 RNA
92138-7,Parainfluenza virus 3 RNA
92139-5,Parainfluenza virus 2 RNA
92140-3,Parainfluenza virus 1 RNA
92141-1,Influenza virus B RNA
92142-9,Influenza virus A RNA
92143-7,Respiratory pathogens DNA & RNA panel
92144-5,Moraxella catarrhalis DNA
92145-2,Legionella pneumophila DNA
92146-0,Human coronavirus 229E+NL63 RNA
92147-8,Human coronavirus HKU1+OC43 RNA
Aug-14,Output.stool
92148-6,PROMIS item bank - dyspnea severity - version 1.0
92149-4,PROMIS dyspnea severity - version 1.0 T-score
92150-2,How short of breath did you get washing dishes over past 7D
92151-0,How short of breath did you get walking up 5 stairs without stopping over past 7D
92152-8,How short of breath did you get walking up 30 stairs (3 flights) without stopping over past 7D
92153-6,How short of breath did you get walking up 20 stairs (2 flights) without stopping over past 7D
92154-4,How short of breath did you get walking up 10 stairs (1 flight) without stopping over past 7D
May-15,Output.stool
92155-1,How short of breath did you get walking 50 steps or paces on flat ground at a normal speed without stopping over past 7D
92156-9,How short of breath did you get walking 10 steps or paces on flat ground at a normal speed without stopping over past 7D
92157-7,How short of breath did you get walking .5 mile (almost 1 km) on flat ground at a normal speed without stopping over past 7D
92158-5,How short of breath did you get walking (faster than your usual speed) for at least 1 mile (a little more than 1.5 km) without stopping over past 7D
92159-3,How short of breath did you get walking (faster than your usual speed) for 50 steps without stopping over past 7D
92160-1,How short of breath did you get walking (faster than your usual speed) for .5 mile (almost 1 km) without stopping over past 7D
92161-9,How short of breath did you get talking while walking over past 7D
92162-7,How short of breath did you get taking a shower over past 7D
Mar-16,Output.stool
92163-5,How short of breath did you get taking a bath without help over past 7D
92164-3,How short of breath did you get sweeping or mopping over past 7D
92165-0,How short of breath did you get standing for at least 5M over past 7D
92166-8,How short of breath did you get singing or humming over past 7D
92167-6,How short of breath did you get scrubbing the floor or counter over past 7D
92168-4,How short of breath did you get putting on socks or stockings over past 7D
92169-2,How short of breath did you get preparing meals over past 7D
921-7,B variant NOS Ag
92170-0,"How short of breath did you get moderate-intensity leisure activity (bicycling on level terrain, etc.) over past 7D"
Jan-17,Output.stool
92171-8,How short of breath did you get making a bed over past 7D
92172-6,"How short of breath did you get low-intensity leisure activity (gardening, etc.) over past 7D"
92173-4,"How short of breath did you get lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase) over past 7D"
92174-2,"How short of breath did you get lifting something weighing less than 5 lbs (about 2 kg, like a houseplant) over past 7D"
92175-9,"How short of breath did you get lifting something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) over past 7D"
92176-7,"How short of breath did you get lifting something weighing 10-20 lbs (about 4.5-9 kg, like a large bag of groceries) over past 7D"
92177-5,How short of breath did you get getting in or out of a car over past 7D
92178-3,How short of breath did you get dressing yourself without help over past 7D
92179-1,How short of breath did you get dining out over past 7D
92180-9,"How short of breath did you get carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another over past 7D"
92181-7,"How short of breath did you get carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another over past 7D"
92182-5,"How short of breath did you get carrying something weighing 10-20 lbs (about 4.5-9 kg, like a large bag of groceries) from one room to another over past 7D"
92183-3,Document type
92184-1,Action taken based on watch record
92185-8,Report type
92186-6,Watch team report
92187-4,Mission related to the emergency response activation
92188-2,Emergency activation decision
Sep-18,Output.stool
92189-0,Date range for emergency response plan
92190-8,Emergency response improvement activity
92191-6,Staff
92192-4,Equipment type available
92193-2,Bed type
92194-0,Bed category
92195-7,Bed category
92196-5,Supply owner
Jul-19,Output.stool
92197-3,Public health emergency budget
92198-1,Public health emergency budget source
92199-9,Public health emergency budget breakdown details
92200-5,Public health emergency budget implementing unit name
92201-3,Purchase activity
92202-1,Recipient of supply
92203-9,Bed category panel
92204-7,Bed type panel
May-20,Output.stool
92205-4,"When I'm upset with someone, a cigarette helps me cope"
92206-2,"When I'm angry, a cigarette can calm me down"
92207-0,"When I am worrying about something, a cigarette is helpful"
92208-8,Smoking helps me when I'm upset about something
92209-6,Smoking helps me reduce tension
92210-4,Smoking helps me deal with anxiety
92211-2,Smoking calms me down
92212-0,Smoking allows me to take a break from my problems for a few minutes
Mar-21,Output.stool
92213-8,PROMIS smoking - coping expectancies for all smokers - version 1.0 T-score
92214-6,PROMIS item bank - smoking - coping expectancies for all smokers - version 1.0
92215-3,I rely on smoking to deal with stress
92216-1,I am tempted to smoke when I feel depressed
92217-9,I am tempted to smoke when I am anxious
92218-7,When I stop what I'm doing to have a cigarette it feels like 'my time'
92219-5,Smoking stimulates me
92220-3,Smoking makes me less depressed
Jan-22,Output.stool
92221-1,Smoking makes me feel content
92222-9,Smoking is the fastest way to reward myself
92223-7,Smoking is relaxing
92224-5,Smoking helps me concentrate
92225-2,PROMIS smoking - emotional and sensory expectancies for all smokers - version 1.0 T-score
92226-0,PROMIS item bank - smoking - emotional and sensory expectancies for all smokers - version 1.0
92227-8,I smoke to get a sense of pleasure
92228-6,I smoke because smoking feels good
92229-4,I smoke because it is self-satisfying
92230-2,I love the feel of inhaling the smoke into my mouth
92231-0,I like the way a cigarette makes me feel physically
92232-8,I feel better after smoking a cigarette
92233-6,"I enjoy the sensations of a long, slow exhalation of smoke"
92234-4,"Even when I feel good, smoking helps me feel better"
92235-1,Lab order result status
92236-9,Lab observation result status
92237-7,Lab observation sub-type
92238-5,Differential diagnosis
Sep-23,Output.colostomy
92239-3,Infectious pathogen carried
92240-1,Healthcare-associated infection flag
92241-9,Vancomycin
92242-7,Pyrazinamide
92243-5,Microorganism resistance mutation tested for
92244-3,Microorganism resistance mutation nucleic acid change type
92245-0,Microorganism resistance mutation nucleic acid change
92246-8,Microorganism resistance mutation detected
Jul-24,Output.colostomy
92247-6,Microorganism resistance mutation amino acid change type
92248-4,Microorganism resistance mutation amino acid change
92249-2,Microorganism gene tested for
922-5,B variant NOS Ag
92250-0,Microorganism gene target region
92251-8,Microorganism gene detected
92252-6,Microorganism molecular resistance panel
92253-4,Microorganism identified
Apr-25,Output.colostomy
92254-2,Microorganism identification & resistance pattern determination panel
92255-9,Methicillin
92256-7,Has infectious disease or illness
92257-5,Number of visits with usual provider
92258-3,Smoking makes my lungs hurt
92259-1,Smoking makes me worry about getting heart troubles
92260-9,Smoking makes me worry about getting emphysema
92261-7,Smoking makes me short of breath
Feb-26,Output.colostomy
92262-5,Smoking is taking years off my life
92263-3,Smoking irritates my mouth and throat
92264-1,Smoking causes me to get tired easily
92265-8,Smoking causes damage to my gums and teeth
92266-6,PROMIS smoking - negative health expectancies for all smokers - version 1.0 T-score
92267-4,PROMIS item bank - smoking - negative health expectancies for all smokers - version 1.0
92268-2,It takes me longer to recover from a cold because I smoke
92269-0,If I quit smoking I will feel more energetic
9227-0,Output.colostomy
92270-8,If I quit smoking I will breathe easier
92271-6,I worry that smoking will lower my quality of life
92272-4,Stayed in intensive care unit
92273-2,Hospital stay duration
92274-0,Rules for using smoked tobacco products inside home
92275-7,Cigarettes smoked per D^during pregnancy
92276-5,Vital status
92277-3,Is your baby living with you
92278-1,Lived with someone who smoked regularly inside the home during childhood
92279-9,Rules for using smokeless tobacco products inside home
92280-7,PhenX - house rules about tobacco use protocol 711101
92281-5,Brand name of cigarettes smoked most often
92282-3,PROMIS smoking - negative psychosocial expectancies for all smokers - version 1.0 T-score
92283-1,People think less of me if they see me smoking
92284-9,People think I'm foolish for ignoring the warnings about cigarette smoking
92285-6,People I care about respect me less because I smoke
92286-4,My smoking makes me respect myself less
92287-2,My smoking makes me less attractive to other people
Aug-28,Output.colostomy
92288-0,My smoking makes me feel less attractive
92289-8,My need for cigarettes makes me feel disappointed in myself
92290-6,My cigarette smoking bothers others
92291-4,If I quit smoking my friends will respect me more
92292-2,If I quit smoking I will be more in control of my life
92293-0,If I quit smoking I will be more attractive to others
92294-8,I look ridiculous while smoking
92295-5,I get upset when I think about my smoking
Jun-29,Output.colostomy
92296-3,I feel embarrassed when I smoke
92297-1,PROMIS item bank - smoking - negative psychosocial expectancies for all smokers - version 1.0
92298-9,"When I'm really craving a cigarette, it feels like I'm in the grip of some unknown force that I cannot control"
92299-7,"When I run out of cigarettes, I find it almost unbearable"
92300-3,"When I haven't been able to smoke for a few hours, the craving gets intolerable"
92301-1,"When I go without a cigarette for a few hours, I experience craving"
92302-9,When I go too long without a cigarette I get strong urges that are hard to get rid of
92303-7,When I go too long without a cigarette I feel impatient
Apr-30,Output.colostomy
92304-5,The idea of not having any cigarettes causes me stress
92305-2,PROMIS smoking - nicotine dependence for all smokers - version 1.0 T-score
92306-0,PROMIS item bank - smoking - nicotine dependence for all smokers - version v1.0
92307-8,My urges to smoke keep getting stronger if I don't smoke
92308-6,My desire to smoke seems overpowering
92309-4,It is hard to ignore urges to smoke
92310-2,I smoke more before going into a situation where smoking is not allowed
92311-0,I smoke even when I am so ill that I am in bed most of the day
Feb-31,Output.colostomy
92312-8,I get a real gnawing hunger for a cigarette when l haven't smoked in a while
92313-6,I frequently crave cigarettes
92314-4,I find myself reaching for cigarettes without thinking about it
92315-1,I drop everything to go out and buy cigarettes
92316-9,I crave cigarettes at certain times of day
92317-7,I am tempted to smoke when I realize I haven't smoked for a while
92318-5,Cravings for a cigarette make it difficult for me to quit
92319-3,"After not smoking for a while, I need to smoke in order to avoid feeling any discomfort"
9232-0,Output.colostomy
92320-1,Smoking makes me feel better in social situations
92321-9,Smoking is a part of my self-image
92322-7,Smoking helps me feel more relaxed when I'm with other people
92323-5,PROMIS smoking - social motivations for all smokers - version 1.0 T-score
92324-3,PROMIS item bank - smoking - social motivations for all smokers - version 1.0
92325-0,If I quit smoking I will be less welcome around my friends who smoke
92326-8,I feel like part of a group when I'm around other smokers
92327-6,I feel a bond with other smokers
92328-4,I enjoy the social aspect of smoking with other smokers
92329-2,PROMIS self-efficacy for managing emotions - version 1.0 T-score
923-3,Blood collection bag lot identifier
92330-0,PROMIS item bank - self-efficacy for managing emotions - version 1.0
92331-8,"Current level of confidence when I'm feeling down, I can find ways to make myself feel better"
92332-6,Current level of confidence I can use relaxation to deal with worries
92333-4,"Current level of confidence I can use a strategy (for example: humor, leaving a situation) to keep from getting upset"
92334-2,Current level of confidence I can stay positive when I feel like I am the only one going through this
92335-9,Current level of confidence I can relax my body to reduce my anxiety
92336-7,Current level of confidence I can prevent my illness from making me feel discouraged
92337-5,"Current level of confidence I can manage the loss of my ability to do things that are important to me (for example: parenting, work, hobbies, attend school)"
Aug-33,Output.colostomy
92338-3,Current level of confidence I can manage my frustration
92339-1,Current level of confidence I can manage my anxiety about telling others I have health problems
92340-9,Current level of confidence I can manage my anger when others make insensitive comments about my health problems
92341-7,Current level of confidence I can manage my anger when others don't understand what I am going through
92342-5,"Current level of confidence I can manage anxiety about injuring myself or others (for example: falling, dropping a child, a driving accident)"
92343-3,Current level of confidence I can keep emotional distress from interfering with things I want to do
92344-1,Current level of confidence I can keep anxiety from becoming overwhelming
92345-8,Current level of confidence I can hear about symptoms and side effects without getting discouraged
Jun-34,Output.colostomy
92346-6,Current level of confidence I can handle upsetting situations
92347-4,Current level of confidence I can handle the stress of going for treatment of my medical conditions
92348-2,Current level of confidence I can handle negative feelings
92349-0,Current level of confidence I can focus on something else to decrease anxiety
92350-8,Current level of confidence I can find ways to manage stress
92351-6,Current level of confidence I can bounce back from disappointment
92352-4,Current level of confidence I can avoid upsetting thoughts
Mar-35,Output.ileostomy
92353-2,Current level of confidence I can avoid feeling helpless
92354-0,Current level of confidence I can avoid feeling discouraged
92355-7,Current level of confidence I can avoid becoming angry
92356-5,Current level of confidence I can walk around inside my house
92357-3,Current level of confidence I can walk a block (about 300 feet or 100 meters) on flat ground
92358-1,Current level of confidence I can use public transportation
92359-9,Current level of confidence I can use a telephone to schedule an appointment
92360-7,"Current level of confidence I can use a computer (for example: use keyboard, see screen, login)"
Jan-36,Output.ileostomy
92361-5,Current level of confidence I can travel to a new destination alone
92362-3,Current level of confidence I can take my medications in the right doses and at the right times
92363-1,"Current level of confidence I can take care of others (for example: cook for others, help them dress, watch children)"
92364-9,"Current level of confidence I can take care of my personal hygiene without help from anyone (for example: brush my teeth, comb my hair, shave, apply makeup)"
92365-6,Current level of confidence I can take a bath or shower
92366-4,"Current level of confidence I can stand for 5 minutes (for example: waiting in a line, waiting for a bus)"
92367-2,"Current level of confidence I can recognize risks (for example: handling hot liquids, walking on uneven ground) and take steps to prevent accidents"
92368-0,Current level of confidence I can prepare my own meals (for example: plan and cook full meals by myself)
92369-8,Current level of confidence I can perform my household chores
92370-6,Current level of confidence I can perform my daily activities even if someone is rushing me
92371-4,Current level of confidence I can manage my clothes when I need to use the toilet
92372-2,"Current level of confidence I can maintain my finances (for example: write checks, pay bills)"
92373-0,Current level of confidence I can maintain a regular exercise program
92374-8,Current level of confidence I can lift and carry groceries
92375-5,Current level of confidence I can keep doing my usual activities at work
92376-3,Current level of confidence I can go shopping and run errands
92377-1,Current level of confidence I can go outside in challenging weather for me
92378-9,Current level of confidence I can get to the bathroom in time
Sep-37,Output.ileostomy
92379-7,Current level of confidence I can get in and out of bed without falling
92380-5,Current level of confidence I can get in and out of a chair
92381-3,Current level of confidence I can get around in an unfamiliar environment
92382-1,Current level of confidence I can find new ways to manage daily activities when the old way doesn't work
92383-9,"Current level of confidence I can exercise at a vigorous level for 10 minutes (for example: running, jogging)"
92384-7,"Current level of confidence I can exercise at a moderate level for 10 minutes (for example: walking briskly, biking, swimming, aerobics)"
92385-4,Current level of confidence I can engage in hobbies or recreational activities
92386-2,Current level of confidence I can eat without help from anyone
Jul-38,Output.ileostomy
92387-0,Current level of confidence I can drive a car
92388-8,Current level of confidence I can dress myself in the way I want to be dressed (including buttoning clothes and putting on shoes)
92389-6,Current level of confidence I can concentrate on something difficult
92390-4,Current level of confidence I can climb one flight of stairs (with or without rails)
92391-2,PROMIS self-efficacy for managing daily activities - version 1.0 T-score
92392-0,PROMIS item bank - self-efficacy for managing daily activities - version 1.0
92393-8,PROMIS self-efficacy for managing social interactions - version 1.0 T-score
92394-6,PROMIS item bank - self-efficacy for managing social interactions - version 1.0
May-39,Output.ileostomy
92395-3,Current level of confidence people understand when I need help and when I don't need help
92396-1,Current level of confidence people are concerned about my health
92397-9,Current level of confidence people are accepting of my condition
92398-7,Current level of confidence my doctors and nurses listen to my needs
92399-5,"Current level of confidence if I need help, I have someone to help with my financial affairs"
92400-1,"Current level of confidence if I need help, I have someone to help me manage my daily activities"
92401-9,"Current level of confidence if I need help, I can find someone to take me to the doctor's office"
92402-7,Current level of confidence I know when to stop talking about my condition
Mar-40,Output.ileostomy
92403-5,Current level of confidence I have someone who will go out and do things with me
92404-3,Current level of confidence I have someone who helps me understand medical information
92405-0,Current level of confidence I have someone to help me plan and make decisions related to my illness
92406-8,Current level of confidence I can tell others about my health problems
92407-6,Current level of confidence I can talk to others about my condition without being embarrassed
92408-4,Current level of confidence I can talk about my health problems with someone
92409-2,Current level of confidence I can stay involved in community or religious activities
924-1,Blood product dispensed
92410-0,Current level of confidence I can refuse help when I don't need it
Jan-41,Output.ileostomy
92411-8,Current level of confidence I can maintain my usual social activities
92412-6,Current level of confidence I can keep in touch with friends and family
92413-4,Current level of confidence I can get emotional support when I need it
92414-2,Current level of confidence I can communicate well with my doctors and nurses
92415-9,Current level of confidence I can attend social events without being embarrassed
92416-7,Current level of confidence I can ask for help when I don't understand something
92417-5,Current level of confidence friends and family will come to see me when I am sick
92418-3,PROMIS self-efficacy for managing medications and treatments - version 1.0 T-score
92419-1,PROMIS item bank - self-efficacy for managing medications and treatments - version 1.0
92420-9,Current level of confidence I understand the difference between my symptoms and medication side effects
92421-7,Current level of confidence I know when and how to take my medications
92422-5,Current level of confidence I know what to do when my medication refill looks different than usual
92423-3,Current level of confidence I know what to do if I forget to take my medication(s)
92424-1,Current level of confidence I can work with my doctor to choose the treatment that seems right for me
92425-8,"Current level of confidence I can use technology to help me manage my medication and treatments (for example: to get information, avoid side-effects, schedule reminders)"
92426-6,Current level of confidence I can use my own judgment regarding treatment alternatives (including not having treatment)
92427-4,Current level of confidence I can travel to my local pharmacy to fill my prescriptions
92428-2,Current level of confidence I can take several medications on different schedules
Sep-42,Output.ileostomy
92429-0,Current level of confidence I can take my medicine even if it causes mild side effects
92430-8,Current level of confidence I can take my medication when there is a change in my usual day (unexpected things happen)
92431-6,Current level of confidence I can take my medication when I am working or away from home
92432-4,Current level of confidence I can remember to take my medications when there is no one to remind me
92433-2,Current level of confidence I can remember to take my medication as prescribed
92434-0,Current level of confidence I can remember to refill my prescriptions before they run out
92435-7,Current level of confidence I can manage my medication without help
92436-5,"Current level of confidence I can list my medications, including the doses and schedule"
Jul-43,Output.ileostomy
92437-3,Current level of confidence I can get help when I am not sure how to take my medicine
92438-1,Current level of confidence I can follow directions when my doctor changes my medications
92439-9,"Current level of confidence I can follow a full treatment plan (including medication, diet, physical activity)"
92440-7,Current level of confidence I can fit my medication schedule into my daily routine
92441-5,Current level of confidence I can find information to learn more about my treatment
92442-3,Current level of confidence I can figure out what treatment I need when my symptoms change
92443-1,Current level of confidence I can continue my treatment when traveling
92444-9,Current level of confidence I can continue my treatment when I am not feeling well
May-44,Output.ileostomy
92445-6,Current level of confidence I can actively participate in decisions about my treatment
92446-4,Document key words
92447-2,Document synopsis
92448-0,PROMIS self-efficacy for managing symptoms - version 1.0 T-score
92449-8,PROMIS item bank - self-efficacy for managing symptoms - version 1.0
92450-6,Current level of confidence I know what to do when my symptoms worsen
92451-4,Current level of confidence I can work with my doctor to manage my symptoms
Feb-45,Output.ileostomy
92452-2,"Current level of confidence I can still accomplish most of my goals in life, despite my symptoms"
92453-0,"Current level of confidence I can rely on my judgment to manage my symptoms, even when others disagree with me"
92454-8,Current level of confidence I can reduce my symptoms to my satisfaction
92455-5,Current level of confidence I can recognize when my symptoms change
92456-3,Current level of confidence I can manage unexpected or new symptoms
92457-1,Current level of confidence I can manage my symptoms when I am tired
92458-9,Current level of confidence I can manage my symptoms when I am in an unfamiliar place
92459-7,Current level of confidence I can manage my symptoms when I am at home
9246-0,Output.ileostomy
92460-5,Current level of confidence I can manage my symptoms in a public place
92461-3,Current level of confidence I can manage my symptoms during my daily activities
92462-1,Current level of confidence I can manage my symptoms as well as other people with symptoms like mine
92463-9,Current level of confidence I can make a moderate reduction in my symptoms
92464-7,"Current level of confidence I can maintain my sense of humor, despite my symptoms"
92465-4,"Current level of confidence I can live a normal life, despite my symptoms"
92466-2,Current level of confidence I can keep my symptoms from interfering with the work I need to do
92467-0,Current level of confidence I can keep my symptoms from interfering with relationships with friends and family
92468-8,Current level of confidence I can keep my symptoms from interfering with my sleep
92469-6,Current level of confidence I can keep my symptoms from interfering with my recreational activities
92470-4,Current level of confidence I can keep my symptoms from interfering with my personal care
92471-2,Current level of confidence I can find the information I need to manage my symptoms
92472-0,"Current level of confidence I can enjoy things, despite my symptoms"
92473-8,Current level of confidence I can do something to reduce my symptoms when they worsen
92474-6,Current level of confidence I can do something to prevent my symptoms from worsening
92475-3,"Current level of confidence I can control my symptoms by using methods other than taking medication (for example: relaxation exercises, distraction)"
92476-1,Current level of confidence I can control my symptoms by taking my medications
92477-9,"Current level of confidence I can be physically active, despite my symptoms"
Aug-47,Output.ileostomy
92478-7,VS Ag inferred phenotype
92479-5,V Ag inferred phenotype
92480-3,U Ag inferred phenotype
92481-1,S little c 2 Ag inferred phenotype
92482-9,S little c 1 Ag inferred phenotype
92483-7,S Ag inferred phenotype
92484-5,N Ag inferred phenotype
92485-2,M Ag inferred phenotype
Jun-48,Class
92486-0,LW super little b Ag inferred phenotype
92487-8,LW super little a Ag inferred phenotype
92488-6,little s Ag inferred phenotype
92489-4,little k Ag inferred phenotype
92490-2,little e Ag inferred phenotype
92491-0,little c Ag inferred phenotype
92492-8,L little u super little b Ag inferred phenotype
92493-6,L little u super little a Ag inferred phenotype
Apr-49,Stools
92494-4,K little p super little b Ag inferred phenotype
92495-1,K little p super little a Ag inferred phenotype
92496-9,K Ag inferred phenotype
92497-7,J little s super little b Ag inferred phenotype
92498-5,J little s super little a Ag inferred phenotype
92499-3,J little o super little a Ag inferred phenotype
92500-8,J little k super little b Ag inferred phenotype
92501-6,J little k super little a Ag inferred phenotype
Feb-50,Stools
92502-4,Hemoglobin S inferred
92503-2,H little y Ag inferred phenotype
92504-0,F little y super little b Ag inferred phenotype
92505-7,F little y super little a Ag inferred phenotype
92506-5,E Ag inferred phenotype
92507-3,D little o super little b Ag inferred phenotype
92508-1,D little o super little a Ag inferred phenotype
92509-9,D little i super little b Ag inferred phenotype
9251-0,Stools
92510-7,D little i super little a Ag inferred phenotype
92511-5,C little o super little b Ag inferred phenotype
92512-3,C little o super little a Ag inferred phenotype
92513-1,C Ag inferred phenotype
92514-9,Blood group Ag & Hemoglobin S inferred phenotype panel
92515-6,Number of cigarettes smoked
92516-4,VS Ag inferred phenotype
92517-2,V Ag inferred phenotype
92518-0,U Ag inferred phenotype
92519-8,S little c 2 Ag inferred phenotype
92520-6,S little c 1 Ag inferred phenotype
92521-4,S Ag inferred phenotype
92522-2,N Ag inferred phenotype
92523-0,M Ag inferred phenotype
92524-8,LW super little b Ag inferred phenotype
92525-5,LW super little a Ag inferred phenotype
92526-3,little s Ag inferred phenotype
92527-1,little k Ag inferred phenotype
Aug-52,Stools
92528-9,little e Ag inferred phenotype
92529-7,little c Ag inferred phenotype
92530-5,L little u super little b Ag inferred phenotype
92531-3,L little u super little a Ag inferred phenotype
92532-1,K little p super little b Ag inferred phenotype
92533-9,K little p super little a Ag inferred phenotype
92534-7,K Ag inferred phenotype
92535-4,J little s super little b Ag inferred phenotype
Jun-53,Stools
92536-2,J little s super little a Ag inferred phenotype
92537-0,J little o super little a Ag inferred phenotype
92538-8,J little k super little b Ag inferred phenotype
92539-6,J little k super little a Ag inferred phenotype
92540-4,Hemoglobin S inferred
92541-2,H little y Ag inferred phenotype
92542-0,F little y super little b Ag inferred phenotype
92543-8,F little y super little a Ag inferred phenotype
Apr-54,Class
92544-6,E Ag inferred phenotype
92545-3,D little o super little b Ag inferred phenotype
92546-1,D little o super little a Ag inferred phenotype
92547-9,D little i super little b Ag inferred phenotype
92548-7,D little i super little a Ag inferred phenotype
92549-5,C little o super little b Ag inferred phenotype
92550-3,C little o super little a Ag inferred phenotype
Jan-55,Fluid output
92551-1,C Ag inferred phenotype
92552-9,Blood group Ag & Hemoglobin S inferred phenotype panel
92553-7,Airway clearance technique plan to perform
92554-5,Assistive technology plan to provide
92555-2,Biophysical agent plan to use
92556-0,Functional training plan to perform
92557-8,Instructions plan to provide
92558-6,Integumentary repair and protection technique plan to use
92559-4,Manual therapy technique plan to use
92560-2,Motor function training plan to perform
92561-0,Other intervention &or service provided
92562-8,Physical therapy goals panel
92563-6,Physical therapy health concerns panel
92564-4,Physical therapy plan of care panel
92565-1,Therapeutic exercise plan to perform
92566-9,Planned intervention &or services panel
92567-7,Guidance for percutaneous drainage+placement of drainage catheter
92568-5,Chorion
Sep-56,Fluid output.total
92569-3,Guidance for drainage+placement of chest tube
92571-9,Guidance for drainage+placement of chest tube
92572-7,Sodium
92573-5,Resident of region that is endemic for the disease of interest
92574-3,Labor and delivery summary - recommended IHE set
92575-0,Labor and delivery admission history and physical - recommended IHE set
92576-8,Maternal discharge summary - recommended IHE set
Jul-57,Fluid output.total
92577-6,Chlamydophila pneumoniae DNA
92578-4,PROMIS short form - dyspnea severity 10a - version 1.0
92579-2,PROMIS short form - physical function 10b - version 2.0
925-8,Blood product disposition
92580-0,PROMIS short form - physical function 10a - version 2.0
92581-8,PROMIS pediatric short form - pain behavior 8a - version 1.0
92582-6,PROMIS parent proxy short form - meaning and purpose 8a - version 1.0
92583-4,PROMIS parent proxy short form - meaning and purpose 4a - version 1.0
92584-2,PROMIS parent proxy short form - physical stress experiences 8a - version 1.0
May-58,Fluid output.total
92585-9,PROMIS parent proxy short form - physical stress experiences 4a - version 1.0
92586-7,PROMIS parent proxy short form - anxiety 8a - version 2.0
92587-5,PROMIS parent proxy short form - fatigue 10a - version 2.0
92588-3,PROMIS short form - self-efficacy for managing symptoms 8a - version 1.0
92589-1,PROMIS short form - self-efficacy for managing symptoms 4a - version 1.0
92590-9,PROMIS short form - self-efficacy for managing social interactions 8a - version 1.0
92591-7,PROMIS short form - self-efficacy for managing social interactions 4a - version 1.0
92592-5,PROMIS short form - self-efficacy for managing medications and treatments 8a - version 1.0
Mar-59,Fluid output.total
92593-3,PROMIS short form - self-efficacy for managing medications and treatments 4a - version 1.0
92594-1,PROMIS short form - self-efficacy for managing emotions 8a - version 1.0
92595-8,PROMIS short form - self-efficacy for managing emotions 4a - version 1.0
92596-6,PROMIS short form - self-efficacy for managing daily activities 8a - version 1.0
92597-4,PROMIS short form - self-efficacy for managing daily activities 4a - version 1.0
92598-2,PROMIS short form - smoking - social motivations for all smokers 4a - version 1.0
92599-0,PROMIS short form - smoking - nicotine dependence for all smokers 8a - version 1.0
92600-6,PROMIS short form - smoking - nicotine dependence for all smokers 4a - version 1.0
Jan-60,Fluid output.total
92601-4,PROMIS short form - smoking - negative psychosocial expectancies for all smokers 6a - version 1.0
92602-2,PROMIS short form - smoking - negative health expectancies for all smokers 6a - version 1.0
92603-0,PROMIS short form - smoking - emotional and sensory expectancies for all smokers 6a - version 1.0
92604-8,PROMIS short form - smoking - coping expectancies for all smokers 4a - version 1.0
92605-5,PROMIS short form - upper extremity 7a - version 2.0
92606-3,PROMIS short form - dyspnea severity 10a - version 1.0 raw score
92607-1,PROMIS short form - physical function 10b - version 2.0 raw score
92608-9,PROMIS short form - physical function 10a - version 2.0 raw score
92609-7,PROMIS pediatric short form - pain behavior 8a - version 1.0 raw score
92610-5,PROMIS parent proxy short form - meaning and purpose 8a - version 1.0 raw score
92611-3,PROMIS parent proxy short form - meaning and purpose 4a - version 1.0 raw score
92612-1,PROMIS parent proxy short form - physical stress experiences 8a - version 1.0 raw score
92613-9,PROMIS parent proxy short form - physical stress experiences 4a - version 1.0 raw score
92614-7,PROMIS parent proxy short form - anxiety 8a - version 2.0 raw score
92615-4,PROMIS parent proxy short form - fatigue 10a - version 2.0 raw score
92616-2,PROMIS short form - self-efficacy for managing symptoms 8a - version 1.0 raw score
92617-0,PROMIS short form - self-efficacy for managing symptoms 4a - version 1.0 raw score
92618-8,PROMIS short form - self-efficacy for managing social interactions 8a - version 1.0 raw score
Sep-61,Fluid output.total
92619-6,PROMIS short form - self-efficacy for managing social interactions 4a - version 1.0 raw score
92620-4,PROMIS short form - self-efficacy for managing medications and treatments 8a - version 1.0 raw score
92621-2,PROMIS short form - self-efficacy for managing medications and treatments 4a - version 1.0 raw score
92622-0,PROMIS short form - self-efficacy for managing emotions 8a - version 1.0 raw score
92623-8,PROMIS short form - self-efficacy for managing emotions 4a - version 1.0 raw score
92624-6,PROMIS short form - self-efficacy for managing daily activities 8a - version 1.0 raw score
92625-3,PROMIS short form - self-efficacy for managing daily activities 4a - version 1.0 raw score
92626-1,PROMIS short form - smoking - social motivations for all smokers 4a - version 1.0 raw score
Jul-62,Fluid output.total
92627-9,PROMIS short form - smoking - nicotine dependence for all smokers 8a - version 1.0 raw score
92628-7,PROMIS short form - smoking - nicotine dependence for all smokers 4a - version 1.0 raw score
92629-5,PROMIS short form - smoking - negative psychosocial expectancies for all smokers 6a - version 1.0 raw score
92630-3,PROMIS short form - smoking - negative health expectancies for all smokers 6a - version 1.0 raw score
92631-1,PROMIS short form - smoking - emotional and sensory expectancies for all smokers 6a - version 1.0 raw score
92632-9,PROMIS short form - smoking - coping expectancies for all smokers 4a - version 1.0 raw score
92633-7,PROMIS short form - upper extremity 7a - version 2.0 raw score
92634-5,Address type
May-63,Fluid output route
92635-2,Leukocytes
92636-0,APOL1 inferred genotype
92637-8,traZODone
92638-6,Sertraline
92639-4,O-nortramadol
92640-2,M-chlorophenylpiperazine
92641-0,diphenhydrAMINE
92642-8,Dextromethorphan
Mar-64,Apache II score
92643-6,Cotinine
92644-4,Phentermine
92645-1,Citalopram
92646-9,Dextromethorphan
92647-7,diphenhydrAMINE
92648-5,Gabapentin
92649-3,Naloxone
9265-0,Apache III score
92650-1,PARoxetine
92651-9,Pregabalin
92652-7,Sertraline
92653-5,traZODone
92654-3,9-hydroxyrisperidone
92655-0,Age diabetes-related problem occurred
92656-8,Number of menstrual periods per Y
92657-6,Age when first fed formula
92658-4,Had both ovaries removed
92659-2,Age when stopped smoking cigarettes completely
926-6,Blood product.other given
92660-0,Time range until next menstrual period
92661-8,Age when first fed something other than breast milk or formula
92662-6,Current age or age at death
92663-4,Problem related to diabetes
92664-2,Power of attorney+Living will
92665-9,Growth and differentiation factor 15
92666-7,Growth hormone & glucose post cloNIDine stimulation panel
92667-5,Glucose^30M post dose cloNIDine
Aug-66,Acute physiology score
92668-3,Glucose^1H post dose cloNIDine
92669-1,Glucose^1.5H post dose cloNIDine
92670-9,Glucose^2H post dose cloNIDine
92671-7,Basement membrane zone BP180 & BP230 Ab.IgG panel
92672-5,Hydroxyglutarates & Glutarate & Ethylmalonate & Methylsuccinate panel
92673-3,Hydroxyglutarates & Glutarate & Ethylmalonate & Methylsuccinate panel
92674-1,CSF3R gene exons 14 & 17 targeted mutation analysis
92675-8,MSH2 gene deletion+duplication & full mutation analysis
Jun-67,Glasgow coma score.eye opening
92676-6,MLH1 gene deletion+duplication & full mutation analysis
92677-4,Views GE 4
92678-2,Multisection
92679-0,Multisection for lesion
92680-8,Multisection additional for lesion
92681-6,Guidance for dilation of existing nephrostomy tract
92682-4,Guidance for dilation of existing nephrostomy tract+placement of nephrostomy tube at new site
92683-2,Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA panel
Apr-68,Glasgow coma score.motor
92684-0,Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA panel
92685-7,Trichomonas vaginalis DNA
92686-5,Vibrio cholerae+parahaemolyticus+vulnificus DNA
92687-3,Giardia lamblia DNA
92688-1,Cryptosporidium parvum+hominis DNA
92689-9,Entamoeba histolytica DNA
92690-7,Adenovirus 40+41 DNA
92691-5,Astrovirus RNA
Feb-69,Glasgow coma score.total
92692-3,Norovirus genogroup I+II RNA
92693-1,Rotavirus A RNA
92694-9,Sapovirus genogroups I+II+IV+V RNA
92695-6,Gastrointestinal bacterial pathogens panel
92696-4,Gastrointestinal viral pathogens panel
92697-2,Gastrointestinal parasitic pathogens panel
92698-0,Gardnerella vaginalis DNA
92699-8,Candida sp DNA
Jul-92,Cefodizime
9270-0,Glasgow coma score.verbal
92700-4,Trichomonas vaginalis DNA
92701-2,Staphylococcus aureus DNA
92702-0,Lactobacillus crispatus+jensenii+Gardnerella vaginalis+Atopobium vaginae+Bacterial Vaginosis Associated Bacteria-2+Megasphaera sp type 1 DNA
92703-8,Vaginal pathogens panel
92704-6,Planned intervention &or services visit frequency
92705-3,Planned intervention &or services duration - time frame
92706-1,Other intervention &or service plan to provide
92707-9,Care team information panel
92708-7,Physical therapy goal attainment expected duration - visits
92709-5,Physical therapy goal attainment expected duration - time frame
92710-3,Physical therapy goal
92711-1,Lipoprotein.alpha.subparticle.small
92712-9,Lipoprotein.beta.subparticle.very small-d
92713-7,Lipoprotein.beta.subparticle.very small-c
92714-5,Lipoprotein.beta.subparticle.very small-b
92715-2,Lipoprotein.beta.subparticle.very small-a
92716-0,Lipoprotein.beta.subparticle.large-b
92717-8,Lipoprotein.beta.subparticle.large-a
Aug-71,Score^10M post birth
92718-6,Lipoprotein.broad beta.subparticle.small
92719-4,Lipoprotein.broad beta.subparticle.large
92720-2,Lipoprotein.pre-beta.subparticle.small
92721-0,Lipoprotein.pre-beta.subparticle.medium
92722-8,Lipoprotein subparticle profile panel
92723-6,Yersinia enterocolitica DNA
92724-4,Candida sp & Gardnerella vaginalis & Trichomonas vaginalis DNA panel
92725-1,Prognosis for rehabilitation
Jun-72,Score^1M post birth
92726-9,17-Hydroxyprogesterone
92727-7,Tacrolimus
92728-5,Tacrolimus^4H post dose
92729-3,Tacrolimus^2H post dose
92730-1,Tacrolimus^1H post dose
92731-9,Hepatitis C virus genotype
92732-7,Codon &or region with poor sequence quality
92733-5,Glecaprevir
Apr-73,Score^2M post birth
92734-3,Voxilaprevir
92735-0,Pibrentasvir
92736-8,Cells.CD3+CD4+
92737-6,"7-Alpha,12-alpha dihydroxycholest-4-en-3-one & 7-Alpha hydroxy-4-cholesten-3-one panel"
92738-4,"Cholestane-3-beta, 5-alpha, 6-beta triol & Lyso-sphingomyelin panel"
92739-2,"7-Alpha,12-alpha dihydroxycholest-4-en-3-one & 7-Alpha hydroxy-4-cholesten-3-one panel"
927-4,Blood product identifier.pooled
92740-0,Oxysterols panel
92741-8,"Cholestane-3-beta, 5-alpha, 6-beta triol & Lyso-sphingomyelin panel"
Feb-74,Score^5M post birth
92742-6,Iron.microscopic observation
92743-4,Hepatosplenomegaly due to lysosomal storage disorders screening panel
92744-2,Hepatosplenomegaly due to lysosomal storage disorders screening panel
92745-9,Hepatosplenomegaly due to lysosomal storage disorders screening panel
92746-7,"7-Alpha,12-alpha dihydroxycholest-4-en-3-one & 7-Alpha hydroxy-4-cholesten-3-one panel"
92747-5,Lyso-sphingomyelin
92748-3,Lyso-sphingomyelin
92749-1,Lyso-sphingomyelin
92750-9,Glucopsychosine
92751-7,Glucopsychosine
92752-5,Glucopsychosine
92753-3,Globotriaosylsphingosine
92754-1,Globotriaosylsphingosine
92755-8,"Cholestane-3-beta, 5-alpha, 6-beta triol"
92756-6,"Cholestane-3-beta, 5-alpha, 6-beta triol"
92757-4,"Cholestane-3-beta, 5-alpha, 6-beta triol"
92758-2,"7-Alpha,12-alpha dihydroxycholest-4-en-3-one"
Sep-75,Breath rate method
92759-0,"7-Alpha,12-alpha dihydroxycholest-4-en-3-one"
92760-8,"7-Alpha,12-alpha dihydroxycholest-4-en-3-one"
92761-6,7-Alpha hydroxy-4-cholesten-3-one
92762-4,7-Alpha hydroxy-4-cholesten-3-one
92763-2,7-Alpha hydroxy-4-cholesten-3-one
92764-0,7-Ketocholesterol
92765-7,Adalimumab Ab.Neut
92766-5,Alpha-aminoadipic semialdehyde+Delta-1-Piperideine-6-carboxylate
92767-3,Listeria sp DNA
92768-1,Candida albicans+glabrata+krusei+parapsilosis DNA
92769-9,Gram negative bacteria DNA
92770-7,Streptococcus pyogenes DNA
92771-5,Streptococcus pneumoniae DNA
92772-3,Streptococcus anginosus group DNA
92773-1,Streptococcus agalactiae DNA
92774-9,Streptococcus sp DNA
May-77,Class
92775-6,Staphylococcus lugdunensis DNA
92776-4,Staphylococcus epidermidis DNA
92777-2,Staphylococcus aureus DNA
92778-0,Staphylococcus sp DNA
92779-8,Micrococcus sp DNA
92780-6,Listeria monocytogenes DNA
92781-4,Lactobacillus sp DNA
92782-2,Enterococcus faecium DNA
Mar-78,Breath rate special circumstances
92783-0,Enterococcus faecalis DNA
92784-8,Enterococcus sp DNA
92785-5,Cutibacterium acnes DNA
92786-3,Corynebacterium sp DNA
92787-1,Bacillus subtilis group DNA
92788-9,Bacillus cereus group DNA
92789-7,Gram positive blood culture panel
92790-5,Candida albicans DNA
Jan-79,Breaths
92791-3,Candida auris DNA
92792-1,Candida dubliniensis DNA
92793-9,Candida famata DNA
92794-7,Candida glabrata DNA
92795-4,Candida guilliermondii DNA
92796-2,Candida kefyr DNA
92797-0,Candida krusei DNA
92798-8,Candida lusitaniae DNA
92799-6,Candida parapsilosis DNA
92800-2,Candida tropicalis DNA
92801-0,Cryptococcus gattii DNA
92802-8,Cryptococcus neoformans DNA
92803-6,Fusarium sp DNA
92804-4,Rhodotorula spp DNA
92805-1,Blood fungal pathogens panel
92806-9,Keratan sulfate/Creatinine
92807-7,Rhinovirus+Enterovirus RNA
92808-5,Influenza virus A H3 RNA
Sep-80,Breaths
92809-3,Influenza virus A H1 RNA
92810-1,Borrelia afzelii+burgdorferi+garinii Ab.IgG
92811-9,Borrelia afzelii+burgdorferi+garinii Ab.IgG index
92812-7,Borrelia afzelii+burgdorferi+garinii Ab.IgG
92813-5,Borrelia afzelii+burgdorferi+garinii Ab.IgG
92814-3,Borrelia afzelii+burgdorferi+garinii Ab.IgG
92815-0,Borrelia afzelii+burgdorferi+garinii Ab.IgG panel
92816-8,Phencyclidine
Jul-81,Breaths
92817-6,Glucose^30M post dose glucagon
92818-4,Glucose^20M post dose glucagon
92819-2,Glucose^10M post dose glucagon
928-2,Blood product reaction
92820-0,Glucose post glucagon stimulation panel
92821-8,Allelic frequency
92822-6,Genomic coordinate system
92823-4,Planned intervention &or services duration - visits
92824-2,Source of population allelic frequency data
May-82,Breaths
92825-9,Renin^upright
92826-7,Renin^supine
92827-5,Mycobacterium tuberculosis complex species identified
92828-3,Adenovirus B+E DNA
92829-1,Location of metastasis within sentinel lymph node
92830-9,Sentinel lymph node extranodal extension
92831-7,Lymph nodes with metastasis
92832-5,Sentinel lymph nodes with metastasis
Mar-83,Breaths
92833-3,Lymph nodes examined
92834-1,Tumor regression at peripheral margin
92835-8,Associated nevus
92836-6,Desmoplastic melanoma
92837-4,Perineural invasion
92838-2,Satellite nodules
92839-0,Breslow thickness
92840-8,Emergency operations standard operating procedure
Jan-84,Breaths
92841-6,Countermeasure report
92842-4,Situational report
92843-2,FLT3 gene.p.Asp835 mutations
92844-0,FLT3 gene internal tandem duplication/normal
92845-7,Insulin resistance score
92846-5,Ambulatory blood pressure monitor study
92847-3,Herpes simplex virus 1 & 2 & Varicella zoster virus DNA panel
92848-1,Varicella zoster virus DNA
92849-9,Herpes simplex virus 1 & 2 & Varicella zoster virus DNA panel
92850-7,Range of motion
92851-5,Range of motion
92852-3,Adenovirus & Bocavirus DNA panel
92853-1,Adenovirus & Bocavirus DNA panel
92854-9,Adenovirus DNA
92855-6,Bordetella parapertussis IS1001 DNA
92856-4,Bordetella parapertussis IS1001 DNA
92857-2,Bordetella pertussis+bronchiseptica+holmesii IS481 DNA
Aug-85,Breaths
92858-0,Bordetella pertussis+bronchiseptica+holmesii IS481 DNA
92859-8,Chlamydophila pneumoniae & Mycoplasma pneumoniae DNA panel
92860-6,Chlamydophila pneumoniae & Mycoplasma pneumoniae DNA panel
92861-4,Herpes simplex virus 1 & 2 & Varicella zoster virus DNA panel
92862-2,Herpes simplex virus 1 & 2 & Varicella zoster virus DNA panel
92863-0,Herpes simplex virus 1 & 2 DNA panel
92864-8,Herpes simplex virus 1 & 2 DNA panel
92865-5,Herpes simplex virus 1 & 2 DNA panel
Jun-86,Breaths
92866-3,Herpes simplex virus 1 & 2 DNA panel
92867-1,Herpes simplex virus 1 & 2 DNA panel
92868-9,Herpes simplex virus 1 & 2 DNA panel
92869-7,Herpes simplex virus 1 & 2 DNA panel
92870-5,Herpes simplex virus 1 DNA
92871-3,Herpes simplex virus 1 DNA
92872-1,Herpes simplex virus 1 DNA
92873-9,Herpes simplex virus 2 DNA
Apr-87,Breaths
92874-7,Herpes simplex virus 2 DNA
92875-4,Herpes simplex virus 2 DNA
92876-2,Human coronavirus 229E+HKU1+NL63+OC43 & Parainfluenza virus 1+2+3+4 RNA panel
92877-0,Human coronavirus 229E+HKU1+NL63+OC43 & Parainfluenza virus 1+2+3+4 RNA panel
92878-8,Human coronavirus 229E+HKU1+NL63+OC43 RNA
92879-6,Human coronavirus 229E+HKU1+NL63+OC43 RNA
92880-4,Human metapneumovirus & Respiratory syncytial virus RNA panel
92881-2,Human metapneumovirus & Respiratory syncytial virus RNA panel
Feb-88,Breaths
92882-0,Influenza virus A & B RNA panel
92883-8,Parainfluenza virus 1+2+3+4 RNA
92884-6,Parainfluenza virus 1+2+3+4 RNA
92885-3,Rhinovirus+Enterovirus RNA
92886-1,Torque teno virus DNA
92887-9,Torque teno virus DNA
92888-7,Varicella zoster virus DNA
92889-5,Chronic hepatitis differentiation between B & C virus panel
9289-0,Breaths
92890-3,Hepatitis A & B & C virus immunity &or previous exposure panel
92891-1,Coagulation tissue factor induced.INR goal
92892-9,Microbiology - parasitic studies
92893-7,Microbiology - viral studies
92894-5,Microbiology - bacterial studies
92895-2,Endocrinology studies
92896-0,Aldosterone
92897-8,Aldosterone
92898-6,Hepatitis B virus core Ab & surface and little e Ab & Ag panel
92899-4,Fetal chromosome region 11q23 deletion
929-0,Blood product release time
92900-0,Fetal chromosome region 4p16 deletion
92901-8,Noninvasive prenatal fetal aneuploidy and microdeletion panel
92902-6,Fetal chromosome region 8q24 deletion
92903-4,Fetal chromosome region 15q11 deletion
92904-2,N-nortramadol
92905-9,Chromosome 7 copy number/nucleus
92906-7,MET gene copy number/nucleus
92907-5,MET gene copy number/Chromosome 7 copy number
Aug-90,Breaths
92908-3,Functional limitation in range of motion
92909-1,Note
92910-9,Consultation note
92911-7,Note
92912-5,Consultation note
92913-3,Note
92914-1,Note
92915-8,Consultation note
Jun-91,Breaths
92916-6,Guidance for aspiration
92917-4,Guidance for aspiration
92918-2,Guidance for aspiration
92919-0,Guidance 2 levels for injection
92920-8,Guidance 1 level for injection
92921-6,Guidance 1 level for injection
92922-4,Guidance for intrathecal injection
92923-2,Guidance for aspiration
Apr-92,Breaths
92924-0,Guidance for aspiration
92925-7,Guidance for injection
92926-5,Guidance for radiation treatment^WO & W contrast IV
92927-3,Multisection for tau protein^W radionuclide IV
92928-1,Guidance for injection
92929-9,Measles & Mumps & Rubella virus Ab.IgG panel
92930-7,LPA gene.c.3947+467T>C
92931-5,LPA gene.c.5673A>G
Feb-93,Breaths
92932-3,KIF6 gene.c.2155T>C
92933-1,9p21 g.22125503G>C
92934-9,9p21 g.22124478A>G
92935-6,4q25 g.111720761T>G
92936-4,4q25 g.111710169C>T
92937-2,Eslicarbazepine
92938-0,Catecholamines 3 panel
92939-8,Number of residence renovations
9294-0,Breaths
92940-6,Residence renovation completion date
92941-4,Residence renovation start date
92942-2,Poison control record
92943-0,Severe weather event
92944-8,Exposure source
92945-5,Intent of carbon monoxide exposure
92946-3,Streptococcus pyogenes DNA
92947-1,Streptococcus pyogenes DNA
92948-9,Streptococcus pneumoniae DNA
92949-7,Streptococcus pneumoniae DNA
92950-5,Streptococcus agalactiae DNA
92951-3,Streptococcus agalactiae DNA
92952-1,Staphylococcus aureus DNA
92953-9,Staphylococcus aureus DNA
92954-7,Serratia marcescens DNA
92955-4,Serratia marcescens DNA
92956-2,Rhinovirus+Enterovirus RNA
Jul-95,Breaths^post bronchoscopy
92957-0,Respiratory syncytial virus RNA
92958-8,Respiratory pathogens DNA & RNA panel
92959-6,Pseudomonas aeruginosa DNA
92960-4,Pseudomonas aeruginosa DNA
92961-2,Proteus sp DNA
92962-0,Proteus sp DNA
92963-8,Parainfluenza virus RNA
92964-6,Mycoplasma pneumoniae DNA
May-96,Breaths^post cardioversion
92965-3,Moraxella catarrhalis DNA
92966-1,Moraxella catarrhalis DNA
92967-9,Middle East respiratory syndrome coronavirus RNA
92968-7,Bacterial methicillin resistance mecA+mecC genes
92969-5,Legionella pneumophila DNA
92970-3,Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA
92971-1,Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA
92972-9,Klebsiella oxytoca DNA
Mar-97,Breaths^post conscious sedation
92973-7,Klebsiella oxytoca DNA
92974-5,Klebsiella aerogenes DNA
92975-2,Klebsiella aerogenes DNA
92976-0,Influenza virus B RNA
92977-8,Influenza virus A RNA
92978-6,Human Metapneumovirus RNA
92979-4,Human Coronavirus RNA
92980-2,Haemophilus influenzae DNA
Jan-98,Breaths^post inhalation therapy
92981-0,Haemophilus influenzae DNA
92982-8,Escherichia coli DNA
92983-6,Escherichia coli DNA
92984-4,Enterobacter cloacae complex DNA
92985-1,Enterobacter cloacae complex DNA
92986-9,Chlamydophila pneumoniae DNA
92987-7,Adenovirus DNA
92988-5,Acinetobacter calcoaceticus-baumannii complex DNA
92989-3,Acinetobacter calcoaceticus-baumannii complex DNA
92990-1,F10 gene full mutation analysis
92991-9,F13A1 gene & F13B gene full mutation analysis
92992-7,FGA gene & FGB gene & FGG gene full mutation analysis
92993-5,PROCR gene full mutation analysis
92994-3,PROS1 gene full mutation analysis
92995-0,THBD gene full mutation analysis
92996-8,Upper segment/Lower segment
92997-6,Upper segment
92998-4,Lower segment
Sep-99,Breaths^pre bronchoscopy
92999-2,Body height^sitting
93000-8,PhenX - body proportions protocol 220201
93001-6,Total ataxia score
93002-4,Heel-shin slide - left+right mean
93003-2,Heel-shin slide - left
93004-0,Heel-shin slide - right
May-00,Breaths^pre cardioversion
93005-7,Rapid alternating hand movements - left+right mean
93006-5,Finger-nose-finger - left+right mean
93007-3,Finger-nose-finger - left
93008-1,Finger-nose-finger - right
93009-9,Finger chase - left+right mean
93010-7,Finger chase - left
93011-5,Finger chase - right
93012-3,Speech disturbance
Mar-01,Breaths^pre conscious sedation
93013-1,Sitting ability
93014-9,Natural & feet together & tandem stance assessment
93015-6,Gait & turn & tandem gait assessment
93016-4,Scale for the Assessment and Rating of Ataxia
93017-2,Plasma cells.abnormal marker pattern
93018-0,Plasma cells.polyclonal
93019-8,Plasma cells
93020-6,Plasma cells.polyclonal/Plasma cells.total
Jan-02,Breaths^pre inhalation therapy
93021-4,Plasma cells.abnormal marker pattern/Cells counted
93022-2,Multiple myeloma minimal residual disease panel
93023-0,Plan of care note
93024-8,Consultation note
93025-5,"Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences"
93026-3,Do you feel physically and emotionally safe where you currently live
93027-1,Are you a refugee
93028-9,"Have you spent more than 2 nights in a row in a jail, prison, detention center, or juvenile correctional facility in past 1Y"
93029-7,How often do you see or talk to people that you care about and feel close to
93030-5,"Has lack of transportation kept you from medical appointments, meetings, work, or from getting things needed for daily living"
93031-3,Have you or any family members you live with been unable to get any of the following when it was really needed in past 1Y
93033-9,Are you worried about losing your housing
93034-7,Discharged from the U.S. Armed Forces
93035-4,Has season or migrant farm work been your or your family's main source of income at any point in past 2Y
93036-2,Note
93037-0,Portable medical order form
93038-8,Stress level
Sep-03,Breaths^resting
93039-6,Optional additional questions
93040-4,Social and emotional health
93041-2,Money and resources
93042-0,Family and home
93043-8,Personal characteristics
93044-6,Level of evidence
93045-3,Carbon monoxide
93046-1,Exposure treatment site
Jul-04,Respiration rhythm
93047-9,Specimen condition
93048-7,Reason for specimen rejection
93049-5,"MDS v3.0 - RAI v1.17.2 - Correction request - SP, SD"
93050-3,"MDS v3.0 - RAI v1.17.2 - Cognitive patterns - IPA, OSA"
93051-1,MDS v3.0 - RAI v1.17.2 - Insurance billing
93052-9,MDS v3.0 - RAI v1.17.2 - Alternate state Medicaid billing
93053-7,MDS v3.0 - RAI v1.17.2 - State Medicaid billing
Apr-05,Mononuclear cells/100 leukocytes
93054-5,"MDS v3.0 - RAI v1.17.2 - Assessment administration - ND, SD"
93055-2,Outcome and assessment information set (OASIS) form - version D1
93056-0,OASIS D1 - Patient history and diagnoses - follow-up
93057-8,OASIS D1 - ADL and IADLs - follow-up
93058-6,Outcome and assessment information set (OASIS) form - version D1 - Follow-up - recertification or other follow-up
93059-4,"Are you feeling bothered, upset, or worried at this point in your pregnancy about the effect of ongoing health problems such as high blood pressure or diabetes on your pregnancy"
93060-2,"Are you feeling bothered, upset, or worried at this point in your pregnancy about feeling tired and having low energy during your pregnancy"
93061-0,"Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for your medical care during pregnancy"
Feb-06,Polymorphonuclear cells/100 leukocytes
93062-8,"Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your weight and body shape during pregnancy"
93063-6,"Are you feeling bothered, upset, or worried at this point in your pregnancy about whether you might have an unhealthy baby"
93064-4,"Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting"
93065-1,"Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as swollen feet"
93066-9,"Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as backaches"
93067-7,"Are you feeling bothered, upset, or worried at this point in your pregnancy about the quality of your medical care during pregnancy"
93068-5,"Are you feeling bothered, upset, or worried at this point in your pregnancy about working or caring for your family during your pregnancy"
93069-3,"Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might be affected by alcohol, cigarettes, or drugs that you have taken"
9307-0,Insulin^30M post 75 g glucose PO
93070-1,"Are there other things that you are bothered, upset or worried about that have to do with your pregnancy, the birth, or the baby"
93071-9,"Other things you are feeling bothered, upset or worried about"
93072-7,"Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for the baby's clothes, food, or medical care"
93073-5,"Are you feeling bothered, upset, or worried at this point in your pregnancy about taking care of a newborn baby"
93074-3,"Are you feeling bothered, upset, or worried at this point in your pregnancy about pain during labor and delivery"
93075-0,"Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might come too early"
93076-8,"Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting, swollen feet, or backaches"
93077-6,"Physical symptom of pregnancy that you are feeling bothered, upset or worried about"
93078-4,"Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby"
93079-2,"Person who you are feeling bothered, upset or worried about having a relationship change with due to having a baby"
930-8,Blood product reservation
93080-0,"Are you feeling bothered, upset, or worried at this point in your pregnancy about what will happen during labor and delivery"
93081-8,"Are you feeling bothered, upset, or worried at this point in your pregnancy about working at a job after the baby comes"
93082-6,"Are you feeling bothered, upset, or worried at this point in your pregnancy about getting day care, babysitters, or help to watch the baby after it comes"
93083-4,Revised Prenatal Distress Questionnaire - Concurrent Self-Administered Version
93084-2,Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-Be Difficulties in Pregnancy form
93085-9,Dirofilaria immitis Ab.IgG
93086-7,Emergency procedure note
93087-5,Total score
Aug-08,"2,4-Dinitrophenylhydrazine reacting substances"
93088-3,Quality of Working Life Questionnaire for Cancer Survivors
93089-1,"During the past 4W, working gives me structure in my life"
93090-9,"During the past 4W, I think it is good to work"
93091-7,"During the past 4W, I consider that my work gives me a goal in life"
93092-5,"During the past 4W, I consider my work important"
93093-3,"During the past 4W, I do my work well"
93094-1,"During the past 4W, I am self-confident in my work"
93095-8,"During the past 4W, I am suited to my work"
Jun-09,Ammonia
93096-6,"During the past 4W, I have control over the work I do"
93097-4,"During the past 4W, I feel powerless in my work"
93098-2,"During the past 4W, I feel there is a positive atmosphere in my working environment"
93099-0,"During the past 4W, I have the feeling I am taken seriously by people in my working environment"
93100-6,"During the past 4W, I am content with my work"
93101-4,"During the past 4W, I have good relations with my colleagues"
93102-2,"During the past 4W, I feel valuable to my colleagues"
93103-0,"During the past 4W, my immediate superior understands my health situation and possible health problems"
Apr-10,Androstenedione
93104-8,"During the past 4W, I have good relations with my immediate superior"
93105-5,"During the past 4W, I consider that employees with health problems are treated well in my organization"
93106-3,"During the past 4W, I am content with the fringe benefits provided by my employer"
93107-1,"During the past 4W, I am content with my current income"
93108-9,"During the past 4W, because of my health situation I have problems in my work with fatigue AndOr lack of energy"
93109-7,"During the past 4W, I am limited in my work"
93110-5,"During the past 4W, because of my health situation I have little trust in my own body"
93111-3,"During the past 4W, because of my health situation I feel uncertain about the future"
Feb-11,Albuterol
93112-1,Total score
93113-9,Meaning of work
93114-7,Perception of your work situation
93115-4,Atmosphere in your working environment
93116-2,Understanding and recognition in your organization
93117-0,Problems due to your health situation
93118-8,Difficulties in Pregnancy total score
93119-6,Dark-mediated rod adaptation time
9312-0,Aminocaproate
93120-4,Dark-mediated rod adaptation time
93121-2,Gabapentin
93122-0,Contraindicated vaccine type
93123-8,Preferred vaccine type
93124-6,New York Heart Association Functional Classification
93125-3,Sit to stand^with use of upper extremities
93126-1,Comparison with previous results
93127-9,Risk adjustment factor
93128-7,Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.0
93129-5,Bone development stage
93130-3,Bone development stage
93131-1,Bone development stage
93132-9,Bone development stage
93133-7,Bone development stage
93134-5,Bone development stage
93135-2,Bone development stage
93136-0,Bone development stage
93137-8,Bone development stage
Aug-13,Butorphanol
93138-6,Bone development stage
93139-4,Bone development stage
93140-2,Bone development stage
93141-0,Bone development stage
93142-8,Bone development stage
93143-6,Bone development stage
93144-4,Bone development stage
93145-1,Bone development stage
Jun-14,Western equine encephalitis virus Ab
93146-9,Bone development stage
93147-7,Bone development stage
93148-5,Bone development stage
93149-3,PhenX - bone age protocol 220301
93150-1,Procedure note
93151-9,Conference note
93152-7,Initial evaluation note
Mar-15,Western equine encephalitis virus Ab.IgG
93153-5,Drug classes of medications taken
93154-3,Drug classes that have an indication documented
93155-0,"IRF-PAI v4.0, LCDS v5.00, OASIS E - High risk drug classes - use and indication"
93156-8,How much of the time has pain made it hard for you to sleep at night over the past 5D
93157-6,"How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy"
93158-4,How often have you limited your day-to-day activities because of pain over the past 5D
93159-2,How often do you feel lonely or isolated from those around you
931-6,Blood product source
93160-0,How often have you limited your participation in rehabilitation therapy sessions due to pain over the past 5D
Jan-16,Western equine encephalitis virus Ab.IgM
93161-8,IRF-PAI v4.0 - Administrative information
93162-6,IRF-PAI v4.0 - Cognitive patterns - admission
93163-4,IRF-PAI v4.0 - Cognitive patterns - discharge
93164-2,IRF-PAI v4.0 - Health conditions - admission
93165-9,"IRF-PAI v4.0 - Hearing, speech, and vision - admission"
93166-7,"IRF-PAI v4.0, OASIS E - Hearing, speech, and vision - ROC, DC"
93167-5,IRF-PAI v4.0 - Identification information
93168-3,"IRF-PAI v4.0, LCDS v5.00 - Medications - admission"
93169-1,"IRF-PAI v4.0, LCDS v5.00 - Medications - discharge"
93170-9,"IRF-PAI v4.0, LCDS v5.00, OASIS E - Mood"
93171-7,IRF-PAI v4.0 - Quality indicators - admission
93172-5,IRF-PAI v4.0 - Quality indicators - discharge
93173-3,"IRF-PAI v4.0 - Special treatments, procedures, and programs - admission"
93174-1,"IRF-PAI v4.0 - Special treatments, procedures, and programs - discharge"
93175-8,IRF-PAI v4.0 - Swallowing &or nutritional status - admission
93176-6,"IRF-PAI v4.0, LCDS v5.00 - Swallowing &or nutritional status - discharge"
93177-4,"IRF-PAI v4.0, LCDS v5.00 - Health conditions - discharge or expired"
93178-2,Nutritional approaches
Sep-17,Platelets
93180-8,"IRF-PAI v4.0, LCDS v5.00 - Nutritional approaches - last 7D and discharge"
93181-6,Provision of current reconciled medication list to patient at discharge
93182-4,Provision of current reconciled medication list to subsequent provider at discharge
93183-2,Route of current reconciled medication list transmission to patient
93184-0,Route of current reconciled medication list transmission to subsequent provider
93185-7,"Special treatments, procedures, and programs at discharge"
93186-5,Preferred language & interpreter need
Jul-18,Albumin/Creatinine
93187-3,Bone age assessment - Tanner-Whitehouse (TW2) associated observations panel
93188-1,IRF-PAI v4.0 - Administrative information - discharge
93189-9,Total skeletal maturity score
93190-7,HTR2A gene.c.614-2211T>C
93191-5,HTR2C gene.c.-759C>T
93192-3,HTR2C gene.c.551-3008C>G
93193-1,TPMT gene & NUDT15 gene targeted mutation analysis
93194-9,NUDT15 gene targeted mutation analysis
May-19,Androstenedione
93195-6,NUDT15 gene product metabolic activity interpretation
93196-4,Warfarin response genotype panel
93197-2,CYP4F2 gene.c.1297G>A
93198-0,10q23 g.94645745G>A
93199-8,DPYD gene targeted mutation analysis
93200-4,Ehlers-Danlos syndrome multigene analysis
93201-2,Coronary heart disease multigene analysis
93202-0,Ventilator weaning status
Mar-20,Beta aminoisobutyrate
93203-8,LCDS v5.00 - Spontaneous breathing trial
93204-6,"LCDS v5.00 - Special treatments, procedures, and programs - discharge"
93205-3,"LCDS v5.00 - Special treatments, procedures, and programs - admission"
93207-9,LCDS v5.00 - Swallowing &or nutritional status - admission
93208-7,LCDS v5.00 - Health conditions - admission
93209-5,LCDS v5.00 - Functional abilities and goals - planned discharge
93210-3,LCDS v5.00 - Functional abilities and goals - admission
Jan-21,Calcium/Creatinine
93211-1,LCDS v5.00 - Cognitive patterns - unplanned discharge
93212-9,LCDS v5.00 - Cognitive patterns - planned discharge
93213-7,LCDS v5.00 - Cognitive patterns - admission and planned discharge
93214-5,"LCDS v5.00 - Hearing, speech, and vision - discharge"
93215-2,"LCDS v5.00 - Hearing, speech, and vision - admission"
93216-0,LCDS v5.00 - Administrative information - expired
93217-8,LCDS v5.00 - Administrative information - planned discharge
93218-6,LCDS v5.00 - Administrative information - admission
93219-4,Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.00
93220-2,Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.00
93221-0,Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.00
93222-8,Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.00
93223-6,Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 5.00
93224-4,Coccidioides sp Ag
93225-1,Coccidioides sp Ag
93226-9,Coccidioides sp Ag
93227-7,Coccidioides sp Ag
93228-5,LCDS v5.00 - Patient demographic information - unplanned discharge and expired
Sep-22,Cholesterol.total/Cholesterol.in HDL
93229-3,LCDS v5.00 - Patient demographic information - admission
93230-1,LCDS v5.00 - Patient demographic information - planned discharge
93231-9,LCDS v5.00 - Administrative information - unplanned discharge
93232-7,Imipenem+Relebactam
93233-5,Intercellular substance Ab.IgG
93234-3,Coagulation dilute Russell viper venom induced^post heparin neutralization
93235-0,Coagulation surface induced.lupus sensitive^post heparin neutralization
93236-8,Coagulation surface induced.lupus sensitive.excess phospholipid^post heparin neutralization
Jul-23,Sarcosine
93237-6,Coagulation surface induced.lupus sensitive.excess phospholipid actual/Normal^post heparin neutralization
93238-4,Coagulation dilute Russell viper venom induced.excess phospholipid^post heparin neutralization
93239-2,Coagulation dilute Russell viper venom induced.excess phospholipid actual/normal^post heparin neutralization
932-4,Blood product type
93240-0,Coagulation dilute Russell viper venom induced.factor substitution^immediately after 1:1 addition of normal plasma+heparin neutralization
93241-8,Multisection
93242-6,11-Ketotestosterone
93243-4,11-Hydroxytestosterone
93244-2,Complement Sc5b-9
May-24,Taurine
93245-9,Columbia - suicide severity rating scale - lifetime recent
93246-7,Wish to be dead
93247-5,Non-specific active suicidal thoughts
93248-3,Active suicidal ideation with any methods (not plan) without intent to act
93249-1,"Active suicidal ideation with some intent to act, without specific plan"
93250-9,Active suicidal ideation with specific plan and intent
93251-7,Duration of most severe suicidal ideation
Feb-25,Tryptophan
93252-5,Duration of most severe suicidal ideation
93253-3,Actual suicide attempt
93254-1,Actual suicide attempts
93255-8,Actual suicide attempt
93256-6,Actual suicide attempts
93257-4,Has subject engaged in non-suicidal self-injurious behavior
93258-2,Has subject engaged in non-suicidal self-injurious behavior
93259-0,Interrupted suicide attempt
9326-0,Phosphatidylserine Ab.IgG
93260-8,Interrupted suicide attempts
93261-6,Interrupted suicide attempt
93262-4,Interrupted suicide attempts
93263-2,Aborted or self-interrupted suicide attempt
93264-0,Aborted or self-interrupted suicide attempts
93265-7,Aborted or self-interrupted suicide attempt
93266-5,Aborted or self-interrupted suicide attempts
93267-3,Preparatory acts or suicidal behavior
93268-1,Preparatory acts or suicidal behaviors
93269-9,Preparatory acts or suicidal behavior
93270-7,Preparatory acts or suicidal behaviors
93271-5,Actual lethality or medical damage most lethal suicide attempt
93272-3,Potential lethality most lethal suicide attempt
93275-6,Date of most lethal suicide attempt
Aug-27,Phosphatidylserine Ab.IgM
93278-0,Suicidal ideation
93279-8,Most severe suicidal ideation description
93280-6,Most severe suicidal ideation description
93281-4,Potential lethality initial or first suicide attempt
93282-2,Potential lethality most recent suicide attempt
93283-0,Actual lethality or medical damage initial or first suicide attempt
93284-8,Actual lethality or medical damage most recent suicide attempt
93285-5,Reasons for most severe suicidal ideation
Jun-28,Carbidopa
93286-3,Reasons for most severe suicidal ideation
93287-1,Deterrents of most severe suicidal ideation
93288-9,Deterrents of most severe suicidal ideation
93289-7,Controllability of most severe suicidal ideation
93290-5,Controllability of most severe suicidal ideation
93291-3,Frequency of most severe suicidal ideation
93292-1,Frequency of most severe suicidal ideation
93293-9,Most severe suicidal ideation
Apr-29,Basement membrane Ab
93294-7,Most severe suicidal ideation
93295-4,Active suicidal ideation with specific plan and intent
93296-2,"Active suicidal ideation with some intent to act, without specific plan"
93297-0,Active suicidal ideation with any methods (not plan) without intent to act
93298-8,Non-specific active suicidal thoughts
93299-6,Wish to be dead
93301-0,Date of initial or first suicide attempt
Feb-30,Benzene
93302-8,Date of most recent suicide attempt
93303-6,Intensity of ideation
93304-4,Suicidal behavior
93305-1,Lethality
93306-9,Genetic risk score for coronary heart disease
93307-7,Lifetime risk for developing coronary heart disease based on genetic risk score
93308-5,Risk of adverse drug reaction sequence variation interpretation
93309-3,Hearing.ability to hear during 3D assessment period
9331-0,Boron
93310-1,Vision.ability to see in adequate light during 3D assessment period
93313-5,Platelet glycoprotein disorder
93314-3,Platelet glycoprotein VI actual/normal
93315-0,Platelet CD49b actual/normal
93316-8,Platelet CD42b actual/normal
93317-6,Platelet CD42a actual/normal
93318-4,Platelet CD61 actual/normal
93319-2,Platelet CD41 actual/normal
933-2,Blood product type
93320-0,Platelet glycoprotein disorder panel
93321-8,PT mixing study panel
93323-4,Tauroursodeoxycholate
93324-2,Taurolithocholate
93325-9,Taurohyodeoxycholate
93326-7,Taurodeoxycholate
93327-5,Taurocholate
Aug-32,Carbon tetrachloride
93328-3,Taurochenodeoxycholate
93329-1,Hyodeoxycholate
93330-9,Glycoursodeoxycholate
93331-7,Glycolithocholate
93332-5,Glycohyodeoxycholate
93333-3,Glycodeoxycholate
93334-1,Glycocholate
93335-8,Glycochenodeoxycholate
Jun-33,Chloroform
93336-6,Bile acid
93337-4,Chenodeoxycholate+Cholate/Bile acid.total
93338-2,Bile acid panel
93339-0,Thrombospondin type I domain-containing 7A Ab.IgG
93340-8,PhenX - complete blood count protocol 220501
93341-6,Medication recommendation
93342-4,Power level^peak during exercise
93343-2,Treatment to which interaction between genetic variants confers synergy
Apr-34,Methanol
93344-0,Treatment to which genetic variant confers resistance
93345-7,Genetic variant effect on drug resistance
93346-5,Genetic variant effect on drug sensitivity
93347-3,Available treatment related to genetic variant and not to patient diagnosis
93348-1,Available treatment related to genetic variant and to patient diagnosis
93349-9,Treatment to which interaction between genetic variants confers resistance
93350-7,Monocytes.HLA-DR/100 Monocytes
Jan-35,Appearance
93351-5,HLA-DR Ag
93352-3,Neutrophils.CD64/100 Neutrophils
93353-1,CD64 Ag
93354-9,Neutrophil CD64 & Monocyte HLA DR panel
93356-4,Cells.cytogenetic abnormality
93357-2,Monotypic plasma cell identification & risk stratification panel
93358-0,Plasma cells.polyclonal/Cells counted
93359-8,Monotypic plasma cell DNA ploidy
93360-6,Monotypic plasma cell DNA index
93361-4,Plasma cells.monotypic.S phase/100 cells
93362-2,Plasma cells.monotypic population
93363-0,Plasma cell DNA content & proliferation panel
93364-8,Genetic variant diagnostic significance
93365-5,Genetic variant prognostic significance
93366-3,Gene studied with no variant found
93367-1,Variant of unknown significance
93368-9,Summary of interaction between genetic variants
Sep-36,IgA subclass 1/IgA.total
93369-7,Krebs von den Lungen-6
93370-5,Anaplasma phagocytophilum & Ehrlichia chaffeensis Ab.IgG & IgM panel
93371-3,von Willebrand factor cleaving protease activity
93372-1,Indexing - national clinical trial number
93373-9,Columbia - suicide severity rating scale screener - recent
93374-7,Suicide risk level
Jul-37,IgA subclass 1/IgA.total
93384-6,Serratia sp DNA
May-38,Rheumatoid factor.IgM
93385-3,Salmonella sp DNA
93386-1,Pseudomonas aeruginosa DNA
93387-9,Proteus mirabilis DNA
93388-7,Neisseria meningitidis DNA
93389-5,Gram positive bacteria DNA
93390-3,Bacterial carbapenem resistance blaOXA-23-like+blaOXA-48-like genes
93391-1,Stenotrophomonas maltophilia DNA
93392-9,Serratia marcescens DNA
Mar-39,Insulin^6H post 75 g glucose PO
93393-7,Proteus sp DNA
93394-5,Morganella morganii DNA
93395-2,Klebsiella pneumoniae DNA
93396-0,Fusobacterium nucleatum DNA
93397-8,Haemophilus influenzae DNA
93398-6,Klebsiella oxytoca DNA
93399-4,Fusobacterium necrophorum DNA
934-0,Blood product unit ID
93400-0,Enterobacter aerogenes+Enterobacter amnigenus+Enterobacter gergoviae DNA
Jan-40,Apolipoprotein B/Apolipoprotein A-I
93401-8,Escherichia coli DNA
93402-6,Cronobacter sakazakii DNA
93403-4,Citrobacter sp DNA
93404-2,Enterobacter cloacae complex DNA
93405-9,Bacteroides fragilis DNA
93406-7,Acinetobacter baumannii DNA
93407-5,Gram negative blood culture panel
93408-3,Platelet aggregation.epinephrine induced^10 umol/L
93409-1,Platelet aggregation.epinephrine induced^5 umol/L
93410-9,Platelet aggregation.ristocetin induced^5 ug/mL
93411-7,COMT gene product metabolic activity interpretation
93412-5,SLCO1B1 gene targeted mutation analysis
93413-3,Mechanical circulatory support+consultation note
93414-1,Altered level of consciousness in last 3D
93415-8,Disorganized thinking in last 3D
93416-6,Inattention in last 3D
93417-4,"IRF-PAI v4.0, LCDS v5.00 - Signs and Symptoms of Delirium (from CAM)"
93418-2,"(8;8)(q13;q21)(HEY1,NCOA2) fusion transcript"
Sep-41,Cerebroside sulfatase
93419-0,Alpha 1 antitrypsin fecal clearance panel
93420-8,APOA1 gene full mutation analysis
93421-6,Glial fibrillary acidic protein.alpha subunit Ab.IgG
93422-4,Glial fibrillary acidic protein.alpha subunit Ab.IgG
93423-2,Glial fibrillary acidic protein.alpha subunit Ab.IgG
93424-0,Glial fibrillary acidic protein.alpha subunit Ab.IgG
93425-7,Gamma aminobutyrate B receptor Ab.IgG
93426-5,Gamma aminobutyrate B receptor Ab.IgG
Jul-42,Cholesterol
93427-3,Gamma aminobutyrate B receptor Ab.IgG
93428-1,Gamma aminobutyrate B receptor Ab.IgG
93429-9,Blastomyces sp Ag
93430-7,Blastomyces sp Ag
93431-5,Blastomyces sp Ag
93432-3,Blastomyces sp Ag
93433-1,Busulfan^4H post busulfan infusion completion
93434-9,Busulfan^2H post busulfan infusion completion
May-43,Coproporphyrin 1
93435-6,Busulfan^1H post busulfan infusion completion
93436-4,Busulfan^immediately post busulfan infusion completion
93437-2,Lurasidone
93438-0,Herpes Simplex Virus 2 DNA
93439-8,Herpes Simplex Virus 1 DNA
93440-6,Herpes Simplex Virus 1 & 2 DNA Panel
93441-4,Home accessibility modification date
93442-2,Advance directive document format
Mar-44,Coproporphyrin 1/Coproporphyrin.total
93443-0,Self-care abilities
93444-8,Accessibility of home entrance
93445-5,Accessibility note
93446-3,Accessibility of home interior
93447-1,Home accessibility modification responsible party
93448-9,Home accessibility evaluation status
93449-7,Appointment of legal guardian
9345-0,Coproporphyrin 3
93450-5,Coagulation factor VIII Inhibitor
93451-3,Nor-W-18+Nor-W-15
93452-1,W-19
93453-9,W-15
93454-7,W-18
93455-4,IC-26
93456-2,MT-45
93457-0,AH-8529
93458-8,AH-8533
93459-6,U-47700
93460-4,AH-7921
93461-2,4-Methoxybutyrylfentanyl
93462-0,Norcarfentanil
93463-8,Ocfentanil
93464-6,4-Fluorofentanyl
93465-3,3-Methylfentanyl
93466-1,Valerylfentanyl
93467-9,Butyrylfentanyl
Aug-46,Lipoprotein.beta
93468-7,Acrylfentanyl
93469-5,4-Fluorobutyrylfentanyl
93470-3,Furanylfentanyl
93471-1,Acetyl norfentanyl
93472-9,4-Methylphenethylacetylfentanyl
93473-7,Beta hydroxythiofentanyl
93474-5,Synthetic opioids panel
93475-2,Busulfan clearance
Jun-47,pH.combined acid
93476-0,Busulfan
93477-8,Busulfan given
93478-6,Busulfan area under the curve panel
93479-4,Observation interpretation
93480-2,Cortisol post corticotropin releasing hormone stimulation panel
93481-0,Cortisol^10M post 1 ug/kg CRH IV
93482-8,Cortisol^1M pre 1 ug/kg CRH IV
93483-6,Cortisol^2M post 1 ug/kg CRH IV
Apr-48,pH.free acid
93484-4,Cortisol^5M pre 1 ug/kg CRH IV
93485-1,Columbia - suicide severity rating scale - very young child or cognitively impaired - lifetime recent
93486-9,"Has subject engaged in self-injurious behavior, intent unknown"
93487-7,"Has subject engaged in self-injurious behavior, intent unknown"
93488-5,Guanidinoacetate
93489-3,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG
93490-1,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG
93491-9,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG
Feb-49,pH.total acid
93492-7,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG
93493-5,3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Ab.IgG
93494-3,Buprenorphine
93495-0,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine"
93496-8,Nortriptyline
93497-6,Moxifloxacin 3.0 ug/mL
93498-4,Metabotropic glutamate receptor 1 Ab.IgG
93499-2,Metabotropic glutamate receptor 1 Ab.IgG
May-93,Cefodizime
9350-0,Sulfhydryls
93500-7,Metabotropic glutamate receptor 1 Ab.IgG
93501-5,Metabotropic glutamate receptor 1 Ab.IgG
93502-3,N-methyl-D-aspartate receptor subunit 1 Ab.IgG
93503-1,N-methyl-D-aspartate receptor subunit 1 Ab.IgG
93504-9,Cholesterol crystals
93505-6,Heptacarboxylporphyrin I
93506-4,Heptacarboxylporphyrin III
93507-2,Hexacarboxylporphyrin I
93508-0,Hexacarboxylporphyrin III
93509-8,Pentacarboxylporphyrin I
93510-6,Pentacarboxylporphyrin III
93511-4,Rickettsia rickettsii & Coxiella burnetii phase 1 & Coxiella burnetii phase 2 Ab.IgG panel
Aug-51,ALPRAZolam
Jun-52,Amphetamines
Apr-53,Baclofen
Feb-54,Benztropine
Sep-55,Bumetanide
Jul-56,busPIRone
935-7,Blood product unit expiration
May-57,Disulfiram
Mar-58,Lithium
Jan-59,Tacrine
93598-1,Intensity of ideation
93599-9,Frequency of most severe suicidal ideation
93600-5,Frequency of most severe suicidal ideation
93603-9,Multisection^WO & W contrast IV
93604-7,Multisection
93605-4,Views 2 or 3
93606-2,Views 4 or 5
93607-0,Views GE 6
93608-8,Atrial contraction strain rate.max
Sep-60,Bartonella quintana Ab.IgG
93609-6,Atrial contraction strain rate.circumferential.max
93610-4,Atrial contraction strain rate.longitudinal.max
93611-2,Circumferential strain rate.early diastole.max
93612-0,Longitudinal strain rate.early diastole.max
93613-8,Circumferential strain rate.systole.max
93614-6,Longitudinal strain rate.systole.max
93615-3,Area strain.max
93616-1,Circumferential strain.max
Jul-61,Bartonella quintana Ab.IgM
93617-9,Longitudinal strain.max
93618-7,Regurgitant volume
93619-5,Blood flow reversal.systolic
93620-3,Regurgitant blood velocity-time integral
93621-1,Regurgitant orifice area
93622-9,Systolic time
93623-7,Blood flow reversal.diastolic
93624-5,Pressure gradient.early diastole.max
May-62,Bordetella pertussis Ab.IgA
93625-2,Regurgitant blood flow velocity.early diastole
93626-0,Blood flow velocity.S2 wave
93627-8,Blood flow velocity.S1 wave
93628-6,Regurgitant blood velocity-time integral
93629-4,Blood flow reversal.holodiastolic
93630-2,Regurgitant fraction
93631-0,Regurgitant blood velocity-time integral
93632-8,Velocity-time integral.left ventricular outflow tract/velocity-time integral.aortic valve
Mar-63,Bordetella pertussis Ab.IgG
93633-6,Blood flow velocity.max.left ventricular outflow tract/blood flow.max.aortic valve
93634-4,Collapse
93635-1,End-systolic volume
93636-9,End-systolic volume/Body surface area
93637-7,End-systolic volume/Body surface area
93638-5,End-systolic volume/Body surface area
93639-3,End-systolic volume/Body surface area
93640-1,End-systolic volume
Jan-64,Bordetella pertussis Ab.IgM
93641-9,End-systolic volume
93642-7,Diameter
93643-5,Major axis.diastole
93644-3,Ejection fraction
93645-0,Ejection fraction
93646-8,Ejection fraction
93647-6,Cardiac output
93648-4,Cardiac output
93649-2,Cardiac output
936-5,Blood product unit identifier
93650-0,Cardiac output
93651-8,Cardiac output
93652-6,Stroke volume
93653-4,Stroke volume
93654-2,Stroke volume
93655-9,Stroke volume
93656-7,Stroke volume
93657-5,End-systolic volume
Aug-65,Clostridioides difficile Ab
93658-3,End-systolic volume
93659-1,End-systolic volume
93660-9,End-diastolic volume
93661-7,End-diastolic volume
93662-5,End-diastolic volume
93663-3,Sphericity index.end diastole
93664-1,Pericardial effusion
93665-8,Regurgitant blood flow pressure half-time
Jun-66,Arsenic
93666-6,Home accessibility modification panel
93667-4,WellRx Questionnaire - revised
93668-2,Did you or others you live with eat smaller meals or skip meals because you didn't have money for food in the past 2M
93669-0,Are you homeless or worried that you might be in the future
93670-8,Do you have trouble paying for your gas or electricity bills
93671-6,Do you have trouble finding or paying for transportation
93672-4,"Do you need daycare, or better daycare, for your kids"
93673-2,Are you unemployed or without regular income
Apr-67,Borate
93674-0,Do you need help finding a better job
93675-7,Do you need help getting more education
93676-5,Are you concerned about someone in your home using drugs or alcohol
93677-3,Do you need help with legal issues
93678-1,Have you been at the emergency department more than twice in the last 6Mo
93679-9,Emergency department visits in last 6Mo
93680-7,Hospitalized in the last 6Mo
93681-5,Number of times hospitalized in last 6Mo
Feb-68,Boron
93682-3,Do you feel unsafe in your daily life
93683-1,Is anyone in your home threatening or abusing you
93684-9,Ammonia
93685-6,Gas & CO & electrolytes panel
93686-4,Psychosine
93687-2,Psychosine
93688-0,Psychosine
93689-8,Thrombospondin type I domain-containing 7A Ab.IgG
9369-0,Camphor
93690-6,BRAF gene.p.Val600 mutations
93691-4,Nonalcoholic steatohepatitis & fibrosis panel
93692-2,Nonalcoholic steatohepatitis score
93693-0,Nonalcoholic steatohepatitis grade
93694-8,Nonalcoholic steatohepatitis interpretation
93695-5,Liver steatosis score
93696-3,Liver steatosis grade
93697-1,Liver steatosis interpretation
93698-9,Gram negative bacterial resistance panel
93699-7,Bacterial beta-lactam resistance AmpC blaCMY-2 gene
93700-3,Bacterial beta-lactam resistance AmpC blaDHA gene
93701-1,Bacterial colistin resistance mcr-2 gene
93702-9,Platelet aggregation.ristocetin induced^15 ug/mL
93703-7,Palmitoyl protein thioesterase 1 & Tripeptidyl peptidase 1 panel
93704-5,Palmitoyl protein thioesterase 1 & Tripeptidyl peptidase 1 panel
93705-2,Ethyl sulfate & Ethyl glucuronide panel
93706-0,Ethyl sulfate+Ethyl glucuronide
93707-8,Porphyrin fractions panel
Aug-70,Carbon tetrachloride
93708-6,Heptacarboxylporphyrin I/Creatinine
93709-4,Hexacarboxylporphyrin I/Creatinine
93710-2,Pentacarboxylporphyrin I/Creatinine
93711-0,Epstein Barr virus Ab panel
93712-8,Epstein Barr virus nuclear Ab
93713-6,Epstein Barr virus capsid Ab.IgG
93714-4,Epstein Barr virus capsid Ab.IgM
93715-1,Francisella tularensis Ab.IgG & IgM panel
Jun-71,Chlorpyrifos
93716-9,Francisella tularensis Ab.IgM
93717-7,Francisella tularensis Ab.IgG
93718-5,Francisella tularensis Ab.IgG & IgM
93719-3,traMADol
93720-1,traMADol
93721-9,O-Nortramadol
93722-7,N-Nortramadol
93723-5,Indexing - drug interactions
Apr-72,Cotinine
93724-3,Keratan sulfate
93725-0,Heparan sulfate
93726-8,Dermatan sulfate & heparan sulfate & keratan sulfate panel
93727-6,Insulin^post meal
93728-4,Copper
93729-2,Beta-2-Microglobulin/Creatinine
937-3,Bombay Ab
93730-0,Testosterone
93731-8,Androstenedione
Feb-73,Methanol
93732-6,IgE
93733-4,Creatinine
93734-2,Creatinine
93735-9,Creatinine
93736-7,Creatinine panel
93737-5,Brassica oleracea var gongylodes Ab.IgE
93738-3,Brassica oleracea var botrytis cooked Ab.IgE
93739-1,Brassica oleracea var capitata f rubra Ab.IgE
9374-0,Character
93740-9,Allium schoenoprasum Ab.IgE
93741-7,Melissa officinalis Ab.IgE
93742-5,HTLV I & II Ab band pattern
93743-3,HTLV I & II Ab.IgG band
93744-1,HTLV I & II Ab.IgG panel
93745-8,HTLV I+II Ab.IgG
93746-6,Protein catabolic rate
93747-4,Parainfluenza virus 1+2+3+4 Ab.IgG
93748-2,Fibrin monomer
93749-0,Mumps virus N gene
93750-8,Mumps virus RNA & N gene panel
93751-6,Atypical porcine pestivirus RNA
93752-4,Atypical porcine pestivirus RNA
93753-2,Porcine cytomegalovirus DNA
93754-0,Encephalomyocarditis virus RNA
93755-7,Porcine circovirus type 3 DNA
93756-5,Mycoplasma hyorhinis Ab.IgG/Positive control
Jul-75,Glucose^2.5H post 100 g glucose PO
93757-3,Salmonella choleraesuis+infantis+typhimurium Ab/Positive control
93758-1,Erysipelothrix sp
93759-9,Influenza virus A PB2 gene
93760-7,Influenza virus A PB1 gene
93761-5,Influenza virus A PA gene
93762-3,Influenza virus A NP gene
93763-1,Influenza virus A NS1 gene
93764-9,Porcine astrovirus type 3 RNA
May-76,Glucose^3.5H post 100 g glucose PO
93765-6,Trimethylamine N-oxide
93766-4,Cryptococcus sp Ag
93767-2,Eravacycline
93768-0,Acarboxyprothrombin
93769-8,Choriogonadotropin.intact+Beta subunit
93770-6,Ceramide trihexoside
93771-4,Calprotectin
93772-2,4-hydroxyglutamate/Creatinine
Mar-77,Glucose^4.5H post 100 g glucose PO
93773-0,11-Deoxycortisol
93774-8,Trans-cinnamoylglycine/Creatinine
93775-5,2-Octenoate/Creatinine
93776-3,Babesia duncani Ab.IgG
93777-1,Human papilloma virus 16+18 E6+E7 mRNA
93778-9,Human papilloma virus 6+11 E6+E7 mRNA
93779-7,Large B-cell lymphoma and cell of origin
93780-5,Primary mediastinal large B-cell lymphoma
Jan-78,Glucose^5.5H post 100 g glucose PO
93781-3,Diffuse large B-cell lymphoma.activated B-cell subtype
93782-1,Large B-cell lymphoma
93783-9,Diffuse large B-cell lymphoma cell of origin
93784-7,Diffuse large B-Cell lymphoma cell of origin subclassification panel
93785-4,Large B-cell lymphoma classification panel
93786-2,Varicella zoster virus Ab.IgM+total
93787-0,Lymphocytic choriomeningitis virus Ab.IgG+IgM
93788-8,F5 gene HR2 haplotype
93789-6,Time to microorganism growth detection
93790-4,Delafloxacin
93791-2,Glucose
93792-0,Insulin sensitivity index
93793-8,Insulin
93794-6,Glucose tolerance & insulin sensitivity 2H panel
93795-3,NOP56 gene.GGCCTG repeats
93796-1,MYCN gene amplification
93797-9,MYCN gene copy number/Chromosome 2 copy number
93798-7,MYCN gene copy number/nucleus
Sep-79,Glutathione reductase
93799-5,Chromosome 2 copy number/nucleus
93800-1,1p chromosome deletion/1q chromosome deletion
93801-9,Chromosome 1 polysomy
93802-7,19q chromosome deletion/19p chromosome deletion
93803-5,Chromosome 19 polysomy
93804-3,Chromosome 12 copy number/nucleus
93805-0,MDM2 gene copy number/nucleus
93806-8,EWSR1 gene rearrangements
Jul-80,Heptacarboxylporphyrin
93807-6,FOXO1 gene rearrangements
93808-4,MDM2 gene amplification
93809-2,MDM2 gene copy number/Chromosome 12 copy number
938-1,Bombay Ab
93810-0,SS18 gene rearrangements
93811-8,F9 gene full mutation analysis
93812-6,"1,3 beta glucan"
93813-4,NTRK1 gene & NTRK2 gene & NTRK3 gene rearrangements
93814-2,SERPINC1 gene full mutation analysis
May-81,Pyridinoline
93815-9,PROC gene full mutation analysis
93816-7,Swimming distance
93817-5,Running distance
93818-3,Cycling distance
93819-1,Calories burned^during activity
93820-9,Calories burned^during weight training
93821-7,Calories burned^during aerobic activity
93822-5,Calories burned^while playing a sport
Mar-82,Coproporphyrin
93823-3,Calories burned^during swimming
93824-1,Calories burned^during cycling
93825-8,Calories burned^during running
93826-6,Calories burned^during walking
93827-4,Nighttime awakening
93828-2,Nighttime awakening duration
93829-0,REM sleep duration
93830-8,Light sleep duration
Jan-83,9-Hydroxyrisperidone
93831-6,Deep sleep duration
93832-4,Sleep duration
93833-2,Flights climbed
93834-0,Coccidioides sp Ab.IgM
93835-7,Coccidioides sp Ab.IgM
93836-5,Coccidioides sp Ab.IgG
93837-3,Coccidioides sp Ab.IgG
93838-1,Histoplasma capsulatum Ab.IgM
93839-9,Histoplasma capsulatum Ab.IgG
93840-7,Epstein Barr virus DNA
93841-5,Epstein Barr virus DNA
93842-3,HOGA1 gene full mutation analysis
93843-1,Primary hyperoxaluria multigene analysis
93844-9,UGT1A1 gene full mutation analysis
93845-6,UGT1A1 gene allele
93846-4,Hemoglobin
93847-2,Aspergillus oryzae Ab.IgE
93848-0,Setting of exposure to environmental or occupational hazard
Sep-84,Benztropine
93849-8,Exercise distance
93850-6,Pretomanid
93851-4,Delamanid
93852-2,N-acetylgalactosamine-4-sulfatase/N-acetylgalactosamine-6-sulfatase
93853-0,N-Acetylgalactosamine-6-Sulfatase
93854-8,Gadolinium/Creatinine
93855-5,Iothalamate
Jun-85,Levodopa
93856-3,Enterovirus RNA
93857-1,Date and time of obstetric delivery
93858-9,Toxoplasma gondii Ab.IgG panel
93859-7,Toxoplasma gondii Ab.IgG
93860-5,Toxoplasma gondii Ab.IgG
93861-3,Temperature
93862-1,Temperature setting
93863-9,Oxygen/Gas.total
Apr-86,NIFEdipine
93864-7,Oxygen/Gas.total setting
93865-4,Conference note
93866-2,C4 nephritic factor
93867-0,Gamma aminobutyrate B receptor Ab
93868-8,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab
93869-6,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab
93870-4,N-methyl-D-aspartate receptor subunit 1 Ab
93871-2,Borrelia miyamotoi Ab.IgG+IgM
Feb-87,Procyclidine
93872-0,Tamoxifen metabolites pattern
93873-8,Borrelia miyamotoi Ab.IgG
93874-6,Borrelia miyamotoi Ab.IgM
93875-3,Phosphohistone H3
93876-1,Ceramide risk score
93877-9,N-Nervonoylsphingosine/N-Lignoceroylsphingosine
93878-7,N-Stearoylsphingosine/N-Lignoceroylsphingosine
93879-5,N-Palmitoylsphingosine/N-Lignoceroylsphingosine
9388-0,Propylthiouracil
93880-3,N-Nervonoylsphingosine
93881-1,N-Stearoylsphingosine
93882-9,N-Palmitoylsphingosine
93883-7,Ceramide panel
93884-5,Methane/Expired gas^2H post dose carbohydrate
93885-2,Methane/Expired gas^1.5H post dose carbohydrate
93886-0,Methane/Expired gas^1H post dose carbohydrate
93887-8,Methane/Expired gas^45M post dose carbohydrate
93888-6,Methane/Expired gas^30M post dose carbohydrate
93889-4,Methane/Expired gas^15M post dose carbohydrate
93890-2,Methane/Expired gas^pre dose carbohydrate
93891-0,Methane/Expired gas^post dose carbohydrate
93892-8,Progress note
93893-6,Conference note
93894-4,Conference note
93895-1,Conference note
93896-9,Note
93897-7,Progress note
Aug-89,Pseudoephedrine
93898-5,Note
93899-3,Letter
93900-9,Progress note
93901-7,Note
93902-5,Plan of care note
93903-3,Discharge summary note
93904-1,Transfusion reaction panel
93905-8,ABO group^during infancy
Jun-90,Pyridostigmine
93906-6,ABO & Rh group^during infancy
93907-4,L little u 20 Ag
93908-2,A little u super little b Ag
93909-0,J little k3 Ag
93910-8,F little y3 Ag
93911-6,little c E Ag
93912-4,CE Ag
93913-2,VS Ag
Apr-91,Quazepam
93914-0,Blood group antigens panel
93915-7,Rh antigens & K Ag panel
93916-5,ABO & Rh group panel
93917-3,K Ag^post transfusion reaction
93918-1,little e Ag^post transfusion reaction
93919-9,little c Ag^post transfusion reaction
93920-7,E Ag^post transfusion reaction
93921-5,C Ag^post transfusion reaction
Feb-92,Quinethazone
93922-3,Rh antigens & K Ag post transfusion reaction panel
93923-1,ABO & Rh group post transfusion reaction panel
93924-9,K Ag^post hematopoietic stem cell transplant
93925-6,little e Ag^post hematopoietic stem cell transplant
93926-4,little c Ag^post hematopoietic stem cell transplant
93927-2,E Ag^post hematopoietic stem cell transplant
93928-0,C Ag^post hematopoietic stem cell transplant
93929-8,Rh antigens & K Ag post hematopoietic stem cell transplant panel
9393-0,risperiDONE
93930-6,D Ag^post hematopoietic stem cell transplant
93931-4,ABO group^post hematopoietic stem cell transplant
93932-2,ABO & Rh group^post hematopoietic stem cell transplant
93933-0,ABO & Rh group post hematopoietic stem cell transplant panel
93934-8,K Ag^during infancy
93935-5,little e Ag^during infancy
93936-3,little c Ag^during infancy
93937-1,E Ag^during infancy
93938-9,C Ag^during infancy
93939-7,Rh antigens & K Ag during infancy panel
93940-5,D Ag^during infancy
93941-3,ABO & Rh group during infancy panel
93942-1,K Ag
93943-9,little e Ag
93944-7,little c Ag
93945-4,E Ag
93946-2,C Ag
93947-0,Rh antigens & K Ag panel
Aug-94,Risperidone+9-Hydroxyrisperidone
93948-8,D Ag
93949-6,ABO & Rh group panel
93950-4,D variant Ag
93951-2,Rh antigens & K Ag panel
93952-0,Metamyelocytes.neutrophilic/100 leukocytes
93953-8,Lymphocytes.villous
93954-6,Note
May-95,SUFentanil
93955-3,Consultation note
93956-1,Letter
93957-9,Diagnostic study note
93958-7,Diagnostic study note
93959-5,Diagnostic study note
93960-3,Diagnostic study note
93961-1,Diagnostic study note
93962-9,Diagnostic study note
Mar-96,SUFentanil
93963-7,Diagnostic study note
93964-5,Diagnostic study note
93965-2,Diagnostic study note
93966-0,Diagnostic study note
93967-8,Diagnostic study note
93968-6,Diagnostic study note
93969-4,Diagnostic study note
93970-2,Diagnostic study note
Jan-97,Color
93971-0,Elevation climbed
93972-8,Acetaminophen-cysteine adduct
93973-6,Iohexol
93974-4,Iohexol
93975-1,Urea nitrogen^1H specimen
93976-9,Chikungunya virus Ab.IgM & IgG panel
93977-7,Complement C2.functional
93978-5,Complement C4.functional
93979-3,Chikungunya virus Ab.IgG
93980-1,Iothalamate
93981-9,Hydrogen/Expired gas^2H post dose carbohydrate
93982-7,Hydrogen/Expired gas^1.5H post dose carbohydrate
93983-5,Hydrogen/Expired gas^1H post dose carbohydrate
93984-3,Hydrogen/Expired gas^45M post dose carbohydrate
93985-0,Hydrogen/Expired gas^30M post dose carbohydrate
93986-8,Hydrogen/Expired gas^15M post dose carbohydrate
93987-6,Hydrogen/Expired gas^pre dose carbohydrate
93988-4,Hydrogen/Expired gas^post dose carbohydrate
Sep-98,Reticulin Ab
93989-2,Carbohydrate challenge panel
939-9,Bombay Ab
93990-0,Osmolality^post 1H FFst
93991-8,Osmolality^post 2H FFst
93992-6,Osmolality^post 3H FFst
93993-4,Osmolality^post 4H FFst
93994-2,Osmolality^post 5H FFst
93995-9,Osmolality^post 6H FFst
93996-7,Osmolality^post 7H FFst
Jul-99,Ribonucleoprotein extractable nuclear Ab
93997-5,Sodium^1H post dose vasopressin
93998-3,Potassium^1H post dose vasopressin
93999-1,Creatinine^1H post dose vasopressin
94000-7,Chloride^1H post dose vasopressin
94001-5,Bicarbonate^1H post dose vasopressin
94002-3,Anion Gap 3^1H post dose vasopressin
Mar-00,Platinum
94003-1,Urea nitrogen^1H post dose vasopressin
94004-9,Osmolality^1H post dose vasopressin
94005-6,Osmolality^1H post dose vasopressin
94006-4,Sodium^2H post dose vasopressin
94007-2,Potassium^2H post dose vasopressin
94008-0,Creatinine^2H post dose vasopressin
94009-8,Chloride^2H post dose vasopressin
94010-6,Bicarbonate^2H post dose vasopressin
Jan-01,Silicon
94011-4,Anion Gap 3^2H post dose vasopressin
94012-2,Urea nitrogen^2H post dose vasopressin
94013-0,Osmolality^2H post dose vasopressin
94014-8,Osmolality^2H post dose vasopressin
94015-5,Mental health screening report
94016-3,Depression screening report
94017-1,Anxiety screening report
94018-9,ADHD screening report
94019-7,Bipolar screening report
94020-5,Somatic symptom disorder screening report
94021-3,Substance use disorder screening report
94022-1,Depression score
94023-9,Depression severity
94024-7,Anxiety score
94025-4,Anxiety severity
94026-2,Bipolar disorder type
94027-0,Somatic symptom disorder score
94028-8,Somatic symptom disorder severity
Sep-02,Acyl carnitine
94029-6,Substance use disorder score
94030-4,Substance use disorder severity
94031-2,ADHD type
94032-0,ADHD inattentive symptoms severity
94033-8,ADHD hyperactive symptoms severity
94034-6,Suicidal intent
94035-3,Suicide plan
94036-1,Suicide risk factor
Jul-03,Acylcarnitine
94037-9,Suicidal ideation
94038-7,Substance use disorder question consistency score
94039-5,ADHD question consistency score
94040-3,Adenovirus A+B+C+D+E DNA
94041-1,My practice makes it easy for me to get care
94042-9,My practice is able to provide most of my care
94043-7,"In caring for me, my doctor considers all the factors that affect my health"
94044-5,My practice coordinates the care I get from multiple places
May-04,Adenosine deaminase
94045-2,My doctor or practice knows me as a person
94046-0,My doctor and I have been through a lot together
94047-8,My doctor or practice stands up for me
94048-6,The care I get takes into account knowledge of my family
94049-4,The care I get in this practice is informed by knowledge of my community
94050-2,"Over time, my practice helps me to stay healthy"
94051-0,"Over time, my practice helps me to meet my goals"
Feb-05,Albumin/Globulin
94052-8,Mean score
94053-6,Mycobacterium tuberculosis complex resistance panel
94054-4,Bacterial katG gene drug resistance mutation
94055-1,Bacterial inhA gene drug resistance mutation
94056-9,Bacterial fabG1 gene drug resistance mutation
94057-7,Bacterial ahpC gene drug resistance mutation
94058-5,Bacterial embB gene drug resistance mutation
94059-3,Bacterial pncA gene drug resistance mutation
9406-0,Albumin/Globulin
94060-1,Bacterial gyrA gene drug resistance mutation
94061-9,Bacterial gidB gene drug resistance mutation
94062-7,Bacterial rrs gene drug resistance mutation
94063-5,Bacterial rpsL gene drug resistance mutation
94064-3,Bacterial eis gene drug resistance mutation
94065-0,Bacterial rpoB gene drug resistance mutation
94066-8,Person-Centered Primary Care Measure
94067-6,Color Me Healthy - children's symptom assessment app panel
94068-4,Symptom distress level
94069-2,Emesis occurred
940-7,Bombay Ag
94070-0,Emesis count
94072-6,Attended school today
94073-4,Best thing about your day
94074-2,Most bothersome concern
94075-9,Cause of sick feeling
94076-7,Mutations/Megabase
94077-5,Tumor mutation burden
Aug-07,Alpha 1 antitrypsin
94078-3,PDX1 gene full mutation analysis
94079-1,TYMP gene full mutation analysis
94080-9,RRM2B gene full mutation analysis
94081-7,Validation error details
94082-5,Validation error summary
94083-3,Wound volume
94084-1,Nonverbal pain indicators
94085-8,Pain category
Jun-08,Aminobenzoate
94086-6,Wound shape
94087-4,Chromosome analysis
94088-2,Multisection^WO & W contrast
94089-0,Multisection^WO & W contrast IV && Multisection^W contrast IV
94090-8,Views for dialysis fistula^W contrast IA & Guidance for percutaneous transluminal angioplasty + transcatheter placement of stent
94091-6,Views for dialysis fistula^W contrast IA & Guidance for percutaneous transluminal angioplasty
94092-4,Views for dialysis fistula^W contrast IA
94093-2,Itemized bill
Apr-09,Anabolic steroids
94094-0,Views limited for therapy or embolization or infusion^W contrast via existing catheter
94095-7,Views^W contrast IV
94096-5,Collagen type VII Ab.IgG
94097-3,Cytosolic 5'-nucleotidase 1A Ab.IgG
94098-1,Dense fine speckled 70 protein Ab.IgG
94099-9,Hantavirus Ab.IgM
94100-5,Hantavirus seoul Ab.IgM
94101-3,Hantavirus seoul Ab.IgG
Feb-10,Histamine
94102-1,Epstein Barr virus early diffuse Ab.IgA
94103-9,Zolpidem phenyl-4-carboxylate
94104-7,Zolpidem
94105-4,Alpha hydroxytriazolam
94106-2,Temazepam glucuronide
94107-0,Oxazepam glucuronide
94108-8,1-Hydroxymidazolam
94109-6,LORazepam glucuronide
9411-0,Hydrocorticosterone
94110-4,2-Hydroxyethylflurazepam
94111-2,7-Aminoflunitrazepam
94112-0,7-Aminoclonazepam
94113-8,Norclobazam
94114-6,cloBAZam
94115-3,Alpha hydroxyalprazolam glucuronide
94116-1,ALPRAZolam
94117-9,Benzodiazepines panel
94118-7,Medical records in response to authorization denial
94119-5,Volume.expired per minute/Carbon dioxide production^W exercise
94120-3,Oxygen consumption/Heart rate^peak during exercise
94121-1,Intravascular
94122-9,Oxygen consumption/Body weight^peak during exercise
94123-7,Intravascular end diastolic
94124-5,Ventilatory threshold
94125-2,Volume.residual/Predicted
94126-0,Ventilatory equivalent for carbon dioxide^W exercise
94127-8,Clarity
Aug-12,Leucine
94128-6,Vasopressin challenge post water deprivation panel
94129-4,Water deprivation challenge panel
94130-2,Body disposition facility name
94131-0,Body disposition facility address
94132-8,Funeral facility name
94133-6,Funeral facility address
94134-4,Funeral service licensee or other agent assuming custody of the body of the deceased
94135-1,Funeral service licensee identifier
Jun-13,Lipids
94136-9,Controlled substance agreement
94137-7,HEDIS 2020 Value Sets
94138-5,HEDIS 2020 Value Set - BMI
94139-3,HEDIS 2020 Value Set - BMI percentile
94140-1,HEDIS 2020 Value Set - CT Colonography
94141-9,HEDIS 2020 Value Set - Mammography
94142-7,HEDIS 2020 Value Set - Urine Protein Tests
94143-5,HEDIS 2020 Value Set - Diastolic Blood Pressure
Apr-14,Phosphoserine
94144-3,HEDIS 2020 Value Set - Systolic Blood Pressure
94145-0,Crotonylglycine/Creatinine
94146-8,2-Decenedioate/Creatinine
94147-6,B-bump
94148-4,Blood flow reversal.holodiastolic
94149-2,Heterophile Ab
941-5,Bombay Ag
Jan-15,"carBAMazepine 10,11-Epoxide"
94151-8,Bacteria.carbapenem resistant identified
94157-5,PhenX - age of initiation of first cigarette use - adult protocol 030703
94158-3,PhenX - ethnicity protocol 010502
94161-7,PROMIS parent proxy item bank - mobility - version 1.0
94162-5,PROMIS parent proxy item bank - pain interference - version 1.0
94163-3,PROMIS parent proxy pain interference - version 1.0 T-score
94164-1,PROMIS parent proxy - global health 7 - version 1.0 raw score
94165-8,PROMIS parent proxy - global health 7 - version 1.0
94166-6,PROMIS parent proxy short form - mobility 8 - version 1.0
94167-4,PROMIS parent proxy short form mobility 8 - version 1.0 raw score
Sep-16,Acyclovir
94169-0,PROMIS parent proxy short form - physical function - upper extremity 8 - version 1.0
94170-8,PROMIS parent proxy physical function - upper extremity - version 1.0 raw score
94171-6,My child could pour a drink from a full pitcher in past 7D
94172-4,My child could open a jar by himself or herself in past 7D
94173-2,My child could pull open heavy doors in past 7D
94174-0,My child could use a key to unlock a door in past 7D
94175-7,My child could pull a shirt on over his or her head without help in past 7D
94176-5,My child could open the rings in school binders in past 7D
Jul-17,Anthraquinone
94177-3,My child could button his or her shirt or pants in past 7D
94178-1,My child could put on his or her shoes without help in past 7D
94179-9,PROMIS parent proxy short form - pain interference 8 - version 1.0 raw score
94180-7,PROMIS parent proxy short form - pain interference 8 - version 1.0
94181-5,PROMIS parent proxy global health - version 1.0 T-score
94182-3,PROMIS parent proxy physical function - upper extremity - version 1.0 T-score
94183-1,Heartland banyangvirus RNA
94184-9,Yellow fever virus RNA
May-18,Hydroxybupropion
94185-6,Borrelia miyamotoi glpQ gene
94186-4,Origin of germline genetic variant
94187-2,Platelet aggregation
94188-0,APC gene deletion+duplication & full mutation analysis
94189-8,APOA2 gene full mutation analysis
94190-6,BPGM gene full mutation analysis
94191-4,BRCA1+BRCA2 gene deletion+duplication & full mutation analysis
94192-2,SLC25A20 gene full mutation analysis
Mar-19,HLA-DQ6
94193-0,CDKN1C gene full mutation analysis
94194-8,CPOX gene full mutation analysis
94195-5,CPT2 gene full mutation analysis
94196-3,CTRC gene full mutation analysis
94197-1,CYP21A2 gene deletion+duplication & full mutation analysis
94198-9,DPYD gene full mutation analysis
94199-7,FGA gene full mutation analysis
94200-3,FTCD gene full mutation analysis
Jan-20,Entamoeba histolytica Ab
94201-1,GNPTAB gene full mutation analysis
94202-9,GRHPR gene deletion+duplication & full mutation analysis
94203-7,GSN gene full mutation analysis
94204-5,HMBS gene full mutation analysis
94205-2,LYZ gene full mutation analysis
94206-0,MMACHC gene full mutation analysis
94207-8,MMADHC gene full mutation analysis
94208-6,MLYCD gene deletion+duplication & full mutation analysis
94209-4,NAGLU gene full mutation analysis
94210-2,ARSB gene full mutation analysis
94211-0,NPC1 gene+NPC2 gene deletion+duplication & full mutation analysis
94212-8,PKLR gene deletion+duplication & full mutation analysis
94213-6,PPOX gene full mutation analysis
94214-4,PRKAR1A gene deletion+duplication & full mutation analysis
94215-1,PRSS1 gene full mutation analysis
94216-9,STK11 gene deletion+duplication & full mutation analysis
94217-7,TP53 gene deletion+duplication & full mutation analysis
94218-5,UBE3A gene full mutation analysis
Sep-21,Entamoeba histolytica Ab
94219-3,VWF gene full mutation analysis
94220-1,SPINK1 gene full mutation analysis
94221-9,SMN1 gene full mutation analysis
94222-7,SERPINA1 gene full mutation analysis
94223-5,PTEN gene deletion+duplication & full mutation analysis
94224-3,RET gene full mutation analysis
94225-0,TTR gene full mutation analysis
94226-8,PKHD1 gene full mutation analysis
Jul-22,Herpes simplex virus Ab.IgG
94227-6,AGXT gene deletion+duplication & full mutation analysis
94228-4,MUTYH gene full mutation analysis
94229-2,MECP2 gene deletion+duplication & full mutation analysis
942-3,Bombay Ag
94230-0,GBA gene full mutation analysis
94231-8,G6PD gene full mutation analysis
94232-6,FLCN gene deletion+duplication & full mutation analysis
94233-4,FECH gene full mutation analysis
94234-2,F8 gene full mutation analysis
May-23,Nuclear Ab
94235-9,F7 gene full mutation analysis
94236-7,F5 gene full mutation analysis
94237-5,F2 gene full mutation analysis
94238-3,F12 gene full mutation analysis
94239-1,F11 gene full mutation analysis
94240-9,CDH1 gene deletion+duplication & full mutation analysis
94241-7,BTK gene full mutation analysis
94242-5,BTD gene full mutation analysis
Mar-24,Intercellular substance Ab
94243-3,Note
94244-1,Plan of care note
94245-8,Progress note
94246-6,Note
94247-4,Borrelia burgdorferi oppA2 gene
94248-2,Borrelia mayonii oppA2 gene
94249-0,Borrelia garinii+afzelii oppA2 gene
9425-0,Acetone
94250-8,Borrelia burgdorferi oppA2 gene
94251-6,Borrelia mayonii oppA2 gene
94252-4,Borrelia garinii+afzelii oppA2 gene
94253-2,Borrelia sp panel
94254-0,CYP1A2 gene product metabolic activity interpretation
94255-7,Calcium
94256-5,Magnesium
94257-3,PROMIS pediatric - global health 7 - version 1.0
94258-1,PROMIS pediatric - global health 7 - version 1.0 raw score
94263-1,PROMIS pediatric - global health 7 - version 1.0 T-score
94264-9,Brucella sp Ab
94265-6,Cells.CD18
94266-4,CD11a & CD11b & CD18 phenotyping panel
94267-2,Cells.CD11b
Aug-26,Barbiturates
94268-0,Cells.CD11a
94269-8,Platelet aggregation.EPINEPHrine induced^50 umol/L
94270-6,Ubiquinone 10
94271-4,Purkinje cell cytoplasmic type 1 Ab.IgG
94272-2,Purkinje cell cytoplasmic type 1 Ab.IgG
94273-0,Muscle specific receptor tyrosine kinase Ab.IgG
94274-8,Bedaquiline
94275-5,Apis mellifera acid phosphatase recombinant (rApi m) 3 Ab.IgE
Jun-27,Barbiturates
94276-3,Apis mellifera dipeptidyl peptidase recombinant (rApi m) 5 Ab.IgE
94277-1,Dog recombinant (rCan f) 6 Ab.IgE
94278-9,Cat recombinant (rFel d) 7 Ab.IgE
94279-7,Apis mellifera acid phosphatase recombinant (rApi m) 3 Ab.IgE.RAST class
94280-5,Apis mellifera dipeptidyl peptidase recombinant (rApi m) 5 Ab.IgE.RAST class
94281-3,Dog recombinant (rCan f) 6 Ab.IgE.RAST class
94282-1,Cat recombinant (rFel d) 7 Ab.IgE.RAST class
94283-9,Dipeptidyl aminopeptidase-like protein 6 Ab.IgG
Apr-28,Benzodiazepines
94284-7,Dipeptidyl aminopeptidase-like protein 6 Ab.IgG
94285-4,Contactin-associated protein 2 Ab.IgG
94286-2,Contactin-associated protein 2 Ab.IgG
94287-0,Leucine-rich glioma-inactivated protein 1 Ab.IgG
94288-8,Leucine-rich glioma-inactivated protein 1 Ab.IgG
94289-6,West Nile virus Ab.Neut
94290-4,Saint Louis encephalitis virus Ab.Neut
94291-2,Hydroxybupropion
Feb-29,Indium
94292-0,Citalopram+Escitalopram
94293-8,Citalopram+Escitalopram
94294-6,Norcitalopram
94295-3,Duloxetine
94296-1,Norfluvoxamine
94297-9,Norfluvoxamine
94298-7,O-desmethylvenlafaxine
94299-5,Vilazodone
Mar-94,Cefodizime
9430-0,Isobutylcarbinol
94300-1,Vilazodone
94301-9,Vortioxetine
94302-7,Vortioxetine
94303-5,Pregnenolone & 17-Hydroxypregnenolone panel
94304-3,OxyCODONE & metabolites panel
94305-0,OxyMORphone & Noroxymorphone panel
94306-8,SARS coronavirus 2 RNA panel
94307-6,SARS coronavirus 2 N gene
94308-4,SARS coronavirus 2 N gene
94309-2,SARS coronavirus 2 RNA
943-1,C Ab
94310-0,SARS-related coronavirus N gene
94311-8,SARS coronavirus 2 N gene
94312-6,SARS coronavirus 2 N gene
94313-4,SARS-related coronavirus N gene
94314-2,SARS coronavirus 2 RdRp gene
94315-9,SARS-related coronavirus E gene
94316-7,SARS coronavirus 2 N gene
Aug-31,Isobutanol
94318-3,Plan of care note
94319-1,Consultation note
94320-9,Procedure note
94321-7,Note
94322-5,Note
94323-3,Conference note
94324-1,Care management note
Jun-32,Isobutyl acetate
94327-4,PhenX - human papillomavirus vaccine use protocol 100802
94328-2,Patient health questionnaire 8 item total score
94329-0,Patient Health Questionnaire 8 item
94330-8,Processing comment
94331-6,Collection procedure comment
94332-4,Microsporidia sp 18S rRNA gene panel
94333-2,Encephalitozoon sp 18S rRNA gene
Apr-33,Isoflurane
94334-0,Enterocytozoon bieneusi 18S rRNA gene
94335-7,Desmoglein 1 & Desmoglein 3 Ab.IgG panel
94336-5,Desmoglein 1 Ab.IgG
94337-3,Desmoglein 3 Ab.IgG
94338-1,Chromosome 13+15+16+18+21+22+X+Y aneuploidy
94339-9,Myelopathy autoimmune Ab panel
94340-7,Amphiphysin Ab.IgG
94341-5,Glial nuclear type 1 Ab.IgG
Feb-34,Isopropanol
94342-3,Neuronal nuclear type 1 Ab.IgG
94343-1,Neuronal nuclear type 2 Ab.IgG
94344-9,Neuronal nuclear type 3 Ab.IgG
94345-6,Glutamate decarboxylase 65 Ab.IgG+IgM
94346-4,Glial fibrillary acidic protein.alpha subunit Ab.IgG
94347-2,Metabotropic glutamate receptor 1 Ab.IgG
94348-0,Voltage-gated calcium channel N type binding Ab.IgG+IgM
94349-8,Voltage-gated calcium channel PQ type binding Ab.IgG+IgM
94350-6,Purkinje cell cytoplasmic type 1 Ab.IgG
94351-4,Purkinje cell cytoplasmic type 2 Ab.IgG
94352-2,Purkinje cell cytoplasmic type Tr Ab.IgG
94353-0,Myelopathy autoimmune Ab panel
94354-8,Amphiphysin Ab.IgG
94355-5,Glial nuclear type 1 Ab.IgG
94356-3,Neuronal nuclear type 1 Ab.IgG
94357-1,Neuronal nuclear type 2 Ab.IgG
94358-9,Neuronal nuclear type 3 Ab.IgG
Sep-35,Isopropanol
94359-7,Glutamate decarboxylase 65 Ab.IgG+IgM
94360-5,Glial fibrillary acidic protein.alpha subunit Ab.IgG
94361-3,Metabotropic glutamate receptor 1 Ab.IgG
94362-1,Purkinje cell cytoplasmic type Tr Ab.IgG
94363-9,Purkinje cell cytoplasmic type 1 Ab.IgG
94364-7,Purkinje cell cytoplasmic type 2 Ab.IgG
94365-4,Bordetella pertussis DNA
94366-2,Streptococcus pyogenes DNA
Jul-36,Lead
94367-0,Streptococcus pneumoniae DNA
94368-8,Streptococcus agalactiae DNA
94369-6,Staphylococcus aureus DNA
94370-4,Serratia marcescens DNA
94371-2,Pseudomonas aeruginosa DNA
94372-0,Proteus sp DNA
94373-8,Moraxella catarrhalis DNA
94374-6,Klebsiella pneumoniae DNA
May-37,Methylhippurate
94375-3,Klebsiella oxytoca DNA
94376-1,Klebsiella aerogenes DNA
94377-9,Haemophilus influenzae DNA
94378-7,Escherichia coli DNA
94379-5,Enterobacter cloacae complex DNA
94380-3,Acinetobacter baumannii DNA
94381-1,"2,3-dinor 11 beta-Prostaglandin F2 alpha/Creatinine"
94382-9,Glial nuclear type 1 Ab.IgG
Mar-38,Morphine
94383-7,Glial nuclear type 1 Ab.IgG
94384-5,Amphiphysin Ab.IgG
94385-2,Amphiphysin Ab.IgG
94386-0,Purkinje cell cytoplasmic type Tr Ab.IgG
94387-8,Neuronal nuclear type 2 Ab.IgG
94388-6,Neuronal nuclear type 2 Ab.IgG
94389-4,Neuronal nuclear type 1 Ab.IgG
94390-2,Neuronal nuclear type 1 Ab.IgG
Jan-39,Casts
94391-0,Respiratory viral pathogens DNA & RNA panel
94392-8,Bordetella pertussis+parapertussis+bronchiseptica gidA gene
94393-6,Respiratory pathogens DNA & RNA panel
94394-4,Influenza virus A H3 RNA
94395-1,Influenza virus A H1 2009 pandemic RNA
94396-9,Influenza virus A H1 RNA
94397-7,"Sulfocysteine, Hypoxanthine, Xanthine, Urate & Creatinine panel"
94398-5,Ethyl sulfate
94399-3,Ethyl glucuronide
94400-9,Protein.monoclonal
94401-7,ADRA2A gene.c.-1252G>C
94402-5,ANKK1 gene.c.2137G>A
94403-3,CHRNA3 gene.c.645C>T
Sep-40,Lymphocytes.IgA/100 lymphocytes
94411-6,DRD2 gene.c.-585A>G
94412-4,EPHX1 gene.c.416A>G
94413-2,GRIK4 gene.c.83-10039T>C
94414-0,MTHFR gene.c.677C>T & c.1298A>C
94415-7,OPRM1 gene.c.118A>G
94416-5,SCN1A gene.c.603-91G>A
Jul-41,Lymphocytes.IgD/100 lymphocytes
94417-3,SLC6A4 gene 5-HTTLPR variant
94418-1,UGT2B15 gene.c.253G>T
94419-9,Candida auris
94420-7,Lactobacillus crispatus+gasseri+jensenii+Gardnerella vaginalis+Atopobium vaginae rRNA
94421-5,Candida glabrata RNA
94422-3,Candida albicans+dubliniensis+parapsilosis+tropicalis RNA
94423-1,Lysosomal enzymes screen
94424-9,Staphylococcus aureus methicillin resistance SCCmec+orfX junction
May-42,Lymphocytes.IgG/100 lymphocytes
94425-6,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 E6+E7 mRNA
94426-4,Dengue virus 1+2+3+4 3' UTR RNA
94427-2,Dengue virus 1+2+3+4 3' UTR RNA
94428-0,HLA class I & II Ab.IgG panel
94429-8,HLA-DP & DQ & DR (class II) Ab.IgG low risk
94430-6,HLA-A & B & C (class I) Ab.IgG low risk
94431-4,Dilution factor
94432-2,HLA-DP & DQ & DR (class II) Ab.IgG
Mar-43,Lymphocytes.IgM/100 lymphocytes
94433-0,HLA-DP & DQ & DR (class II) Ab.IgG with prozone effect
94434-8,HLA-DPB1 Ab.IgG
94435-5,HLA-DPA1 Ab.IgG
94436-3,HLA-DQB1 Ab.IgG
94437-1,HLA-DQA1 Ab.IgG
94438-9,HLA-DRB3 & HLA-DRB4 & HLA DRB5 Ab.IgG
94439-7,HLA-DRB1 Ab.IgG
94440-5,HLA-DP & DQ & DR (class II) Ab.IgG panel
Jan-44,House dust Hausstaub Ab.IgE
94441-3,HLA-A & B & C (class I) Ab.IgG
94442-1,HLA-A & B & C (class I) Ab.IgG with prozone effect
94443-9,HLA-C Ab.IgG
94444-7,HLA-B Ab.IgG
94445-4,HLA-A Ab.IgG
94446-2,HLA-A & B & C (class I) Ab.IgG panel
94447-0,HLA-DP & DQ & DR (class II) Ab.IgG high risk
94448-8,HLA-DP & DQ & DR (class II) Ab.IgG intermediate risk
94449-6,HLA-A & B & C (class I) Ab.IgG high risk
94450-4,HLA-A & B & C (class I) Ab.IgG intermediate risk
94451-2,PhenX - Use of creatine growth hormone and steroids protocol 230801
94454-6,Arsenite
94455-3,Arsenobetaine
94456-1,Arsenocholine
94457-9,Dimethylarsinate
Aug-45,11-Oxopregnanetriol
94458-7,Monomethylarsonate
94459-5,Date treatment prescribed
94460-3,Conference note
94461-1,Consultation note
94462-9,Consultation note
94463-7,Consultation note
94464-5,Discharge summary note
94465-2,Discharge summary note
Jun-46,Heptacarboxylporphyrin
94466-0,Progress note
94467-8,Progress note
94468-6,Progress note
94469-4,F2 gene.c.20210G>A & F5 gene.c.1691G>A panel
94470-2,VEGFA gene targeted mutation analysis
94471-0,VEGFA gene.c.-1154A>G
94472-8,VEGFA gene.c.-1498C>G & c.-1498C>T
94473-6,VEGFA gene.c.-2578A>C & c.-2578A>T
Apr-47,Heptacarboxylporphyrin
94474-4,VEGFA gene.c.-634C>G
94475-1,Borrelia burgdorferi Ab.IgA & IgG & IgM
94476-9,Borrelia burgdorferi G39_40 Ab.IgG bands
94477-7,Borrelia burgdorferi 49736 Ab.IgG bands
94478-5,Bordetella pertussis.pertussis toxin promoter region
94479-3,Human coronavirus 229E RNA
94480-1,Human coronavirus HKU1 RNA
94481-9,Human coronavirus NL63 RNA
Feb-48,Heptaporphyrin
94482-7,Human coronavirus OC43 RNA
94483-5,Parainfluenza virus 1 RNA
94484-3,Parainfluenza virus 2 RNA
94485-0,Parainfluenza virus 3 RNA
94486-8,Parainfluenza virus 4 RNA
94487-6,Galactosylceramidase
94488-4,Acid alpha glucosidase
94489-2,Lysosomal storage disorders panel
944-9,C Ab
9449-0,Heptaporphyrin
94490-0,Protoporphyrin fractions panel
94491-8,Protoporphyrin.free
94492-6,HLA-DQA1 & HLA-DQB1 typing panel
94493-4,Celiac disease IgA & HLA typing & serology panel
94494-2,Celiac disease serology panel
94495-9,HLA-DQA1
94496-7,Cell suspension
94497-5,Packed erythrocytes
94499-1,Respiratory viral pathogens DNA & RNA panel
94500-6,SARS coronavirus 2 RNA
94501-4,Middle east respiratory syndrome coronavirus RNA
94502-2,SARS-related coronavirus RNA
94503-0,SARS coronavirus 2 Ab panel
94504-8,SARS coronavirus 2 Ab panel
94505-5,SARS coronavirus 2 Ab.IgG
94506-3,SARS coronavirus 2 Ab.IgM
94507-1,SARS coronavirus 2 Ab.IgG
Aug-50,Hexacarboxylporphyrin
94508-9,SARS coronavirus 2 Ab.IgM
94509-7,SARS-related coronavirus E gene
94510-5,SARS coronavirus 2 N gene
94511-3,SARS coronavirus 2 ORF1ab region
94512-1,Staphylococcus aureus & Staphylococcus aureus.methicillin resistant identified
94515-4,Discharge summary note
Jun-51,Hexacarboxylporphyrin
94516-2,Discharge summary note
94517-0,Discharge summary note
94518-8,Progress note
94519-6,Discharge summary note
94520-4,Discharge summary note
94521-2,Discharge summary note
94522-0,Discharge summary note
94523-8,Discharge summary note
Apr-52,Hexaporphyrin
94524-6,Discharge summary note
94525-3,Discharge summary note
94526-1,Discharge summary note
94527-9,Discharge summary note
94528-7,Consultation note
94529-5,Discharge summary note
94530-3,Discharge summary note
94531-1,SARS coronavirus 2 RNA panel
Feb-53,Histidine
94532-9,SARS-related coronavirus+MERS coronavirus RNA
94533-7,SARS coronavirus 2 N gene
94534-5,SARS coronavirus 2 RdRp gene
94535-2,Skin tone
94536-0,Natural color
94537-8,Hemoglobin panel
94538-6,Hemoglobin HPLC & electrophoresis panel
94539-4,Hepatitis A virus Ab.IgM & total panel
9454-0,Herpes simplex virus Ab
94540-2,Mycobacterial stain & culture panel
94541-0,Mycobacterial identification panel
94542-8,Leprosy
94543-6,Microscopic observation
94544-4,Exposure source in 30D prior to onset of illness
94545-1,Household contacts
94546-9,Relationship to individual with confirmed or suspected illness
94547-7,SARS coronavirus 2 Ab.IgG+IgM
94548-5,Porphyrin fractions panel
94549-3,Isoheptacarboxylporphyrin
94550-1,Hexacarboxylporphyrin I
94551-9,Hexacarboxylporphyrin III
94552-7,Isohexacarboxylporphyrin
94553-5,Isopentacarboxylporphyrin
94554-3,Soluble CD14 subtype
94555-0,Coagulation dilute Russell viper venom induced/Coagulation dilute Russell viper venom induced.excess phospholipid^post DOAC neutralization
94556-8,Coagulation dilute Russell viper venom induced.excess phospholipid^post DOAC neutralization
Jul-55,Streptococcus pneumoniae 1 Ab.IgG
94557-6,Coagulation dilute Russell viper venom induced^post DOAC neutralization
94558-4,SARS coronavirus 2 Ag
94559-2,SARS coronavirus 2 ORF1ab region
945-6,C Ab
94560-0,Diabetes risk
94561-8,Risk calculation method used
94562-6,SARS coronavirus 2 Ab.IgA
94563-4,SARS coronavirus 2 Ab.IgG
94564-2,SARS coronavirus 2 Ab.IgM
May-56,Streptococcus pneumoniae 12 Ab.IgG
94565-9,SARS coronavirus 2 RNA
94566-7,Maple syrup urine disease therapy monitoring panel
94567-5,Valine^post therapeutic diet
94568-3,Isoleucine^post therapeutic diet
94569-1,Leucine^post therapeutic diet
94570-9,Alloisoleucine^post therapeutic diet
94571-7,Branched chain amino acid panel
94572-5,Alloisoleucine
Mar-57,Streptococcus pneumoniae 19 Ab.IgG
94573-3,Tyrosinemia newborn screening follow-up & therapeutic monitoring panel
94574-1,Heavy metals panel
94575-8,Heavy metals panel
94576-6,Mycobacterium tuberculosis complex species identified
94577-4,Maximum clot strength amplitude.arachidonate induced
94578-2,Clot strength.platelet thromboxane A2 receptor inhibited
94579-0,Clot strength.arachidonate induced
94580-8,Herpes simplex virus 1 & 2 DNA panel
Jan-58,Streptococcus pneumoniae 23 Ab.IgG
94581-6,Herpes simplex virus 1 DNA
94582-4,Herpes simplex virus 2 DNA
94583-2,Herpes simplex virus 1 & 2 DNA panel
94584-0,Varicella zoster virus DNA
94585-7,Herpes simplex virus 1 & 2 & Varicella zoster virus DNA panel
94586-5,Dermatan sulfate & heparan sulfate & keratan sulfate panel
94587-3,Germline disorder chromosome analysis
94588-1,Myeloid neoplasm chromosome analysis
94589-9,Hematologic neoplasm chromosome analysis
94590-7,Oncologic chromosome analysis
94591-5,Chromosome rearrangement
94592-3,Chromosome rearrangement
94593-1,Multiplex allergen panel
94594-9,Note
94595-6,Medication management note
94596-4,Equine infectious anemia virus Ab
94597-2,Equine adenovirus 1 RNA
94598-0,Equine herpesvirus 2 RNA
Sep-59,Streptococcus pneumoniae 4 Ab.IgG
94599-8,Equine herpesvirus 3 RNA
94600-4,Equine influenza virus
94601-2,Listeria monocytogenes Ag
94602-0,West Nile virus Ab.IgM/Positive control
94603-8,Bacterial 16S rRNA gene
94604-6,Equine arteritis virus RNA
94605-3,Equine herpesvirus 1 RNA
94606-1,Equine herpesvirus 4 RNA
Jul-60,Streptococcus pneumoniae 6+26 Ab.IgG
94607-9,Equine rhinitis A virus RNA
94608-7,Erbovirus A RNA
94609-5,Bovine leukemia virus Ab
94610-3,Bovine diarrhea virus subtype
94611-1,Pasteurella multocida toxin toxA gene
94612-9,Mycoplasma bovis Ag
94613-7,Bovine respiratory syncytial virus Ag
94614-5,Bovine parainfluenza virus 3 RNA
May-61,Streptococcus pneumoniae 8 Ab.IgG
94615-2,Bovine herpesvirus 1 DNA
94616-0,Bovine coronavirus RNA
94617-8,Anaplasma marginale DNA
94618-6,Bovine respiratory syncytial virus
94619-4,Bovine herpesvirus 1
94620-2,Bovine diarrhea virus
94621-0,Mycobacterium avium subspecies paratuberculosis Ab/Positive control
94622-8,Bovine diarrhea virus Ag/Positive control
Mar-62,Aluminum
94623-6,Ureaplasma diversum DNA
94624-4,Tritrichomonas foetus DNA
94625-1,Pasteurella multocida DNA
94626-9,Ovine herpesvirus 2 DNA
94627-7,Neospora caninum DNA
94628-5,Mycoplasma bovis DNA
94629-3,Mycobacterium avium subspecies paratuberculosis DNA
94630-1,Mannheimia haemolytica DNA
Jan-63,Arsenic
94631-9,Haemophilus somnus DNA
94632-7,Escherichia coli K99 DNA
94633-5,Cryptosporidium parvum DNA
94634-3,Coxiella burnetii DNA
94635-0,Bovine diarrhea virus RNA
94636-8,Bovine respiratory syncytial virus RNA
94637-6,Mycobacterium avium subspecies paratuberculosis Ab
94638-4,Bovine respiratory syncytial virus Ab.Neut
94639-2,SARS coronavirus 2 ORF1ab region
946-4,C Ag
94640-0,SARS coronavirus 2 S gene
94641-8,SARS coronavirus 2 S gene
94642-6,SARS coronavirus 2 S gene
94643-4,SARS coronavirus 2 S gene
94644-2,SARS coronavirus 2 ORF1ab region
94645-9,SARS coronavirus 2 RdRp gene
94646-7,SARS coronavirus 2 RdRp gene
94647-5,SARS-related coronavirus RNA
94648-3,Date of case confirmation
Sep-64,Barium
94649-1,Health department
94650-9,Contact identifier
94651-7,Country of travel
94652-5,Known exposure date
94653-3,City of travel
94654-1,Known exposure panel
94655-8,Identifier & Assigning authority panel
Jun-65,Benzene
94656-6,State of known exposure
94657-4,Case identifier
94658-2,City of known exposure
94659-0,Case identifier
94660-8,SARS coronavirus 2 RNA
94661-6,SARS coronavirus 2 Ab
94662-4,Coccidioides immitis Ab.IgG
94663-2,Coccidioides immitis Ab.IgM
Apr-66,Cadmium
94664-0,Anticipated discharge date
94665-7,Granulomatous prostatitis
94666-5,High grade prostatic intraepithelial neoplasia
94667-3,Delayed hypersensitivity anergy panel
94668-1,Reaction wheal^1D post control ID
94669-9,Reaction wheal^2D post control ID
94670-7,Tetanus reaction wheal^1D post tetanus toxoid ID
94671-5,Tetanus reaction wheal^2D post tetanus toxoid ID
Feb-67,Calcium
94672-3,24r-Hydroxycalcidiol+24r-Hydroxyercalcidiol
94673-1,Calcidiol+ercalcidiol/24r-Hydroxycalcidiol+24r-Hydroxyercalcidiol
94674-9,Calcidiol+ercalcidiol/24r-Hydroxycalcidiol+24r-Hydroxyercalcidiol ratio panel
94675-6,Dipeptidyl aminopeptidase-like protein 6 Ab.IgG
94676-4,Dipeptidyl aminopeptidase-like protein 6 Ab.IgG
94677-2,Glomerular filtration rate/1.73 sq M.predicted
94678-0,Views for patency^W radionuclide IV
94679-8,View && Views supine + upright + lateral-decubitus
9468-0,Chloramines
94680-6,Multisection limited
94681-4,Multisection
94682-2,Views GE 2
94683-0,Views GE 2
94684-8,Views GE 6^W R-bending + W L-bending
94685-5,Views GE 3 && view PA
94686-3,Multisection^WO & W contrast IV && Multisection^WO contrast
94687-1,Multisection^WO contrast
94688-9,Multisection^WO & W contrast IV
94689-7,Cells.CD20/100 cells.CD19
94690-5,Chondroitin-6-sulfate/Creatinine
94691-3,Dermatan sulfate & heparan sulfate & chondroitin-6-sulfate & keratan sulfate panel
94692-1,Dermatan sulfate/Creatinine
94693-9,Heparan sulfate/Creatinine
94694-7,Acetylcholine receptor ganglionic neuronal Ab
94695-4,Axonal autoimmune Ab panel
94696-2,Dementia autoimmune Ab panel
94697-0,Encephalopathy autoimmune Ab panel
Aug-69,Chromium
94698-8,Epilepsy autoimmune Ab panel
94699-6,Glutamate decarboxylase 65 Ab
94700-2,Liver diseases autoimmune Ab panel
94701-0,Movement disorder autoimmune Ab panel
94702-8,Purkinje cell cytoplasmic type 1 Ab
94703-6,Purkinje cell cytoplasmic type 2 Ab
94704-4,Voltage-gated calcium channel N type binding Ab
94705-1,Voltage-gated calcium channel PQ type binding Ab
Jun-70,Copper
94706-9,CV2 Ab.IgG
94707-7,Dementia autoimmune Ab panel
94708-5,Encephalopathy autoimmune Ab panel
94709-3,Epilepsy autoimmune Ab panel
94711-9,Glutamate decarboxylase 65 Ab
94712-7,Movement disorder autoimmune Ab panel
94713-5,Aspartylglycosamine
Apr-71,Fluoride
94714-3,Beta globulin
94715-0,Gamma globulin
94716-8,AGTR1 gene.c.1166A>C
94717-6,SLC25A15 gene.c.562_564delTTC
94718-4,Alpha defensins 1+2+3
94719-2,Plazomicin
947-2,C Ag
94720-0,SARS coronavirus 2 Ab.IgA
94721-8,COVID-19+Evaluation note
Feb-72,Heptachlor
94722-6,COVID-19+Initial evaluation form
94723-4,COVID-19+Initial evaluation form
94724-2,Note
94725-9,Note
94726-7,Note
94727-5,Gabapentin
94728-3,DULoxetine
94729-1,Cyclobenzaprine
9473-0,Heptachlorepoxide
94730-9,Hypnotics
94731-7,Narcotics
94732-5,DULoxetine
94733-3,Anticonvulsants
94734-1,Prostate cancer grade group
94735-8,Prostate tumor area with Gleason pattern 4+5/Total tumor area
94736-6,Tissue block identifier
94737-4,Intraductal carcinoma of prostate
94738-2,Biopsy site
94739-0,Prostate cancer grade group basis
94740-8,Gleason scoring basis
94741-6,Cancer chemotherapy received in the past 4W
94742-4,Disease stage classification method
94743-2,Evaluation note
94744-0,Evaluation note
94745-7,SARS coronavirus 2 RNA
94746-5,SARS coronavirus 2 RNA
94747-3,Evaluation note
Aug-74,Hexachlorobenzene
94748-1,Consent
94749-9,Progress note
94750-7,Evaluation note
94751-5,RHCE gene allele Ee
94752-3,RHCE gene allele Cc
94753-1,Psychotropic medication pharmacogenomic analysis
94754-9,Cells.CD21lowCD38-/100 Cells.CD19
May-75,Hexane
94755-6,Cells.CD21lowCD38-
94756-4,SARS coronavirus 2 N gene
94757-2,SARS coronavirus 2 N gene
94758-0,SARS-related coronavirus E gene
94759-8,SARS coronavirus 2 RNA
94760-6,SARS coronavirus 2 N gene
94761-4,SARS coronavirus 2 Ab.IgG
94762-2,SARS coronavirus 2 Ab
Mar-76,Hexanoylglycine
94763-0,SARS coronavirus 2
94764-8,SARS coronavirus 2 whole genome
94765-5,SARS-related coronavirus E gene
94766-3,SARS coronavirus 2 N gene
94767-1,SARS coronavirus 2 S gene
94768-9,SARS coronavirus 2 Ab.IgA
94769-7,SARS coronavirus 2 Ab
94770-5,Note
Jan-77,Lead
94771-3,Note
94772-1,Note
94773-9,Note
94774-7,Note
94775-4,Note
94776-2,Note
94777-0,Note
94778-8,Note
94779-6,Note
94780-4,Note
94781-2,Note
94782-0,Note
94783-8,Note
94784-6,Note
94785-3,Note
94786-1,Note
94787-9,Note
94788-7,Note
Sep-78,Magnesium
94789-5,Note
94790-3,Note
94791-1,Note
94792-9,Note
94793-7,Note
94794-5,Note
94795-2,Note
94796-0,Note
Jul-79,Mercury
94797-8,Note
94798-6,Note
94799-4,Note
948-0,C Ag
94800-0,Note
94801-8,Note
94802-6,Note
94803-4,Note
94804-2,Note
May-80,Nitrate
94805-9,Note
94806-7,COVID-19+Intubation+Consultation note
94807-5,COVID-19+Intubation+Consultation note
94808-3,COVID-19+Intubation+Consultation note
94809-1,COVID-19+Intubation+Progress note
94810-9,COVID-19+Intubation+Procedure note
94811-7,COVID-19+Intubation+Evaluation note
94812-5,COVID-19+Intubation+Cardiopulmonary resuscitation note
Mar-81,pH
94813-3,COVID-19+Intubation+Conference note
94814-1,COVID-19+Consultation note
94815-8,CV2 Ab.IgG
94816-6,Voltage-gated potassium channel Ab
94817-4,Striated muscle Ab
94818-2,Paraneoplastic Ab panel
94819-0,SARS coronavirus 2 RNA
94820-8,Whole mRNA transcriptome sequence analysis
Jan-82,Potassium
94821-6,COVID-19+Intubation advance directives
94822-4,SARS coronavirus 2 RNA
94823-2,Cytomegalovirus DNA
94824-0,Parvovirus B19 DNA
94825-7,Parvovirus B19 DNA
94826-5,Parvovirus B19 DNA
94827-3,Epstein Barr virus DNA
94828-1,Epstein Barr virus DNA
94829-9,Epstein Barr virus DNA
94830-7,Epstein Barr virus DNA
94831-5,Varicella zoster virus DNA
94832-3,Varicella zoster virus DNA
94833-1,Varicella zoster virus DNA
94834-9,Herpes simplex virus 1+2 DNA
94835-6,Herpes simplex virus 1 DNA
94836-4,Herpes simplex virus 2 DNA
94837-2,Dengue virus 1+2+3+4 RNA
94838-0,Enterovirus RNA
Sep-83,Selenium
94839-8,Calcium
94840-6,Chloride
94841-4,Potassium
94842-2,Sodium
94843-0,Osmolality
94844-8,Creatinine
94845-5,SARS coronavirus 2 RNA
94846-3,Specimen collection problem
Jul-84,Silver
94847-1,Reason specimen not collected
94848-9,Functional assessment standardized items (FASI) - version 1.0
94849-7,FASI v1.0 - Self-care - usual performance
94850-5,FASI v1.0 - Self-care - most dependent performance
94851-3,FASI v1.0 - Mobility - usual performance
94852-1,FASI v1.0 - Mobility - most dependent performance
94853-9,West Nile virus Ab.IgG & IgM panel
Apr-85,Sodium
94854-7,West Nile virus Ab.IgG & IgM panel
94855-4,Carbamazepine hypersensitivity genotype panel
94856-2,Microscopic observation^2nd specimen
94857-0,Microscopic observation^3rd specimen
94858-8,Glycerol
94859-6,Glycerol & Glycerol-corrected triglyceride panel
94860-4,Transthyretin
94861-2,Transthyretin - transthyretin peak 2
Feb-86,Sulfate
94862-0,Transthyretin peak 2
94863-8,Transthyretin width at half peak height
94864-6,Transthyretin-associated familial amyloidosis panel
94865-3,Triglyceride^^corrected for glycerol
94866-1,7-Alpha hydroxy-4-cholesten-3-one
94867-9,Ganglioside GD1b Ab.IgG
94868-7,Ganglioside GD1b Ab.IgG
94869-5,Ganglioside GD1b Ab.IgM
9487-0,Zinc
94870-3,Ganglioside GD1b Ab.IgM
94871-1,Aldosterone & sodium panel
94872-9,Cholesterol & triglyceride panel
94873-7,Cortisol.free post corticotropin stimulation panel
94874-5,Cyclic citrullinated peptide Ab.IgG
94875-2,Nuclear Ab.IgG
94876-0,Self-care priorities for the next 6Mo
94877-8,Mobility priorities for the next 6Mo
94878-6,Instrumental activities of daily living priorities for the next 6Mo
94879-4,Need for and availability of a cane &or crutch
94880-2,Need for and availability of a walker
94881-0,Need for and availability of a standard folding walker
94882-8,Need for and availability of a walker with seat
94883-6,Need for and availability of a walker with wheels
94884-4,Need for and availability of a wheelchair
94885-1,Need for and availability of a manual wheelchair
94886-9,Need for and availability of a motorized wheelchair &or scooter
94887-7,Need for and availability of a limb prosthesis
94888-5,Need for and availability of a specialized seating pad
94889-3,Need for and availability of a mechanical lift
94890-1,Need for and availability of a reacher &or grabber
94891-9,Need for and availability of a sock aid
94892-7,Need for and availability of an orthotic &or brace
94893-5,Need for and availability of a bed rail
94894-3,Need for and availability of an electronic bed
94895-0,Need for and availability of grab bars
Jun-89,Arsenic
94896-8,Need for and availability of a transfer board
94897-6,Need for and availability of a shower &or commode chair
94898-4,Need for and availability of a walk or wheel-in shower
94899-2,Need for and availability of glasses or contact lenses
94900-8,Need for and availability of a hearing aid
94901-6,Need for and availability of a communication device
94902-4,Need for and availability of stair rails
94903-2,Need for and availability of a lift chair
Apr-90,Aspergillus flavus Ab
94904-0,Need for and availability of ramps
94905-7,Need for and availability of a raised toilet seat
94906-5,Need for and availability of a glucometer
94907-3,Need for and availability of Continuous Positive Airway Pressure device
94908-1,Need for and availability of an oxygen concentrator
94909-9,Assistive devices needed
94910-7,Need for and availability of other assistive devices
94911-5,Living arrangement priorities for the next 6Mo
Feb-91,Aspergillus sp Ab.IgA
94912-3,Availability of caregiver assistance
94913-1,Level of paid caregiver assistance in the past Mo
94914-9,Level of unpaid caregiver assistance in the past Mo
94915-6,Paid caregiver's ability and willingness to provide self-care assistance
94916-4,Unpaid caregiver's ability and willingness to provide self-care assistance
94917-2,Paid caregiver's ability and willingness to provide mobility assistance
94918-0,Unpaid caregiver's ability and willingness to provide mobility assistance
94919-8,Paid caregiver's ability and willingness to provide instrumental activities of daily living assistance
9492-0,Aspergillus sp Ab.IgM
94920-6,Unpaid caregiver's ability and willingness to provide instrumental activities of daily living assistance
94921-4,Paid caregiver's ability and willingness to provide medication administration assistance
94922-2,Unpaid caregiver's ability and willingness to provide medication administration assistance
94923-0,Paid caregiver's ability and willingness to provide medical procedure &or treatment assistance
94924-8,Unpaid caregiver's ability and willingness to provide medical procedure &or treatment assistance
94925-5,Paid caregiver's ability and willingness to provide management of equipment assistance
94926-3,Unpaid caregiver's ability and willingness to provide management of equipment assistance
94927-1,Paid caregiver's ability and willingness to provide supervision
94928-9,Unpaid caregiver's ability and willingness to provide supervision
94929-7,Paid caregiver's ability and willingness to provide advocacy or facilitation of person's participation
94930-5,Unpaid caregiver's ability and willingness to provide advocacy or facilitation of person's participation
94931-3,Caregiving priorities for the next 6Mo
94932-1,Does the patient walk
94933-9,Eating - most dependent performance during the past Mo
94934-7,Oral hygiene - most dependent performance during the past Mo
94935-4,Wash upper body - most dependent performance during the past Mo
94936-2,Shower &or bathe self - most dependent performance during the past Mo
94937-0,Upper body dressing - most dependent performance during the past Mo
Aug-93,Bismuth
94938-8,Lower body dressing - most dependent performance during the past Mo
94939-6,Putting on and taking off footwear - most dependent performance during the past Mo
94940-4,Roll left and right - most dependent performance during the past Mo
94941-2,Sit to lying - most dependent performance during the past Mo
94942-0,Lying to sitting on side of bed - most dependent performance during the past Mo
94943-8,Sit to stand - most dependent performance during the past Mo
94944-6,Chair &or bed-to-chair transfer - most dependent performance during the past Mo
94945-3,Toilet transfer - most dependent performance during the past Mo
Jun-94,Blastomyces dermatitidis Ab.IgG
94946-1,Car transfer - most dependent performance during the past Mo
94947-9,Walk 10 feet - most dependent performance during the past Mo
94948-7,Walk 50 feet with two turns - most dependent performance during the past Mo
94949-5,Walk 150 feet - most dependent performance during the past Mo
94950-3,Walking 10 feet on uneven surfaces - most dependent performance during the past Mo
94951-1,Go up and down a curb &or step - most dependent performance during the past Mo
94952-9,Go up and down 4 steps - most dependent performance during the past Mo
Mar-95,Brucella canis Ab.IgG
94953-7,Go up and down 12 steps - most dependent performance during the past Mo
94954-5,Picking up object - most dependent performance during the past Mo
94955-2,Walks indoors - most dependent performance during the past Mo
94956-0,Carries something in both hands - most dependent performance during the past Mo
94957-8,Walks for 15M - most dependent performance during the past Mo
94958-6,Walks across a street - most dependent performance during the past Mo
94959-4,Wheel 50 feet with two turns - most dependent performance during the past Mo
94960-2,Wheel 150 feet - most dependent performance during the past Mo
Jan-96,Brucella canis Ab.IgM
94961-0,Wheels for 15M - most dependent performance during the past Mo
94962-8,Wheels across a street - most dependent performance during the past Mo
94963-6,Makes a light cold meal - most dependent performance during the past Mo
94964-4,Makes a light hot meal - most dependent performance during the past Mo
94965-1,Light daily housework - most dependent performance during the past Mo
94966-9,Heavier periodic housework - most dependent performance during the past Mo
94967-7,Light shopping- most dependent performance during the past Mo
94968-5,Answering telephone call - most dependent performance during the past Mo
94969-3,Placing telephone call - most dependent performance during the past Mo
94970-1,Medication management.oral medications - most dependent performance during the past Mo
94971-9,Medication management.inhalant &or mist medications - most dependent performance during the past Mo
94972-7,Medication management.injectable medications - most dependent performance during the past Mo
94973-5,Simple financial management - most dependent performance during the past Mo
94974-3,Complex financial management - most dependent performance during the past Mo
94975-0,Living arrangement during the past 1Mo
94976-8,Makes a light cold meal - usual functional ability
94977-6,Makes a light hot meal - usual functional ability
94978-4,Light daily housework - usual functional ability
Sep-97,Butane
94979-2,Heavier periodic housework - usual functional ability
949-8,C little e Ab
94980-0,Light shopping - usual functional ability
94981-8,Answering telephone call - usual functional ability
94982-6,Placing telephone call - usual functional ability
94983-4,Medication management.oral medications - usual functional ability
94984-2,Medication management.inhalant &or mist medications - usual functional ability
94985-9,Medication management.injectable medications - usual functional ability
94986-7,Simple financial management - usual functional ability
Jul-98,Candida sp Ab.IgA
94987-5,Complex financial management - usual functional ability
94988-3,Living arrangement
94989-1,Wheels across a street - usual functional ability
94990-9,Wheels for 15 minutes - usual functional ability
94991-7,Wheel 150 feet - usual functional ability
94992-5,Wheel 50 feet with two turns - usual functional ability
94993-3,Walks across a street - usual functional ability
94994-1,Walks for 15M - usual functional ability
May-99,Candida sp Ab.IgG
94995-8,Carries something in both hands - usual functional ability
94996-6,Walks indoors - usual functional ability
94997-4,Picking up object - usual functional ability
94998-2,Go up and down 12 steps - usual functional ability
94999-0,Go up and down 4 steps - usual functional ability
95-0,Cefonicid
9500-0,Candida sp Ab.IgM
95000-6,Go up and down a curb &or step - usual functional ability
95001-4,Walking 10 feet on uneven surfaces - usual functional ability
95002-2,Walk 150 feet - usual functional ability
95003-0,Walk 50 feet with two turns - usual functional ability
95004-8,Walk 10 feet - usual functional ability
95005-5,Car transfer - usual functional ability
95006-3,Toilet transfer - usual functional ability
95007-1,Chair &or bed-to-chair transfer - usual functional ability
95008-9,Sit to stand - usual functional ability
95009-7,Lying to sitting on side of bed - usual functional ability
95010-5,Sit to lying - usual functional ability
95011-3,Roll left and right - usual functional ability
95012-1,Putting on &or taking off footwear - usual functional ability
95013-9,Lower body dressing - usual functional ability
95014-7,Upper body dressing - usual functional ability
95015-4,Shower &or bathe self - usual functional ability
95016-2,Wash upper body - usual functional ability
95017-0,Toileting hygiene - usual functional ability
Aug-01,Candida sp Ag
95018-8,Oral hygiene - usual functional ability
95019-6,Eating - usual functional ability
95020-4,FASI v1.0 - Self-care
95021-2,Manual wheelchair use
95022-0,Motorized wheelchair &or scooter use
95023-8,FASI v1.0 - Mobility
95024-6,FASI v1.0 - Manual wheelchair - usual performance
95025-3,FASI v1.0 - Manual wheelchair - most dependent performance
Jun-02,Carbophenothion
95026-1,FASI v1.0 - Motorized wheelchair &or scooter - most dependent performance
95027-9,FASI v1.0 - Motorized wheelchair &or scooter - usual performance
95028-7,FASI v1.0 - Instrumental Activities of Daily Living
95029-5,FASI v1.0 - Instrumental Activities of Daily Living - usual performance
95030-3,FASI v1.0 - Instrumental Activities of Daily Living - most dependent performance
95031-1,FASI v1.0 - Assistive Devices for Everyday Activities
95032-9,FASI v1.0 - Functional Abilities and Goals
95033-7,FASI v1.0 - Preferences for Customary Routine and Activities
Apr-03,Chloral hydrate
95034-5,FASI v1.0 - Availability of Assistance
95035-2,FASI v1.0 - Availability of Paid and Unpaid Assistance
95036-0,FASI v1.0 - Availability of Paid Assistance
95037-8,FASI v1.0 - Availability of Unpaid Assistance
95038-6,Fracture reduction was performed
95039-4,Type of catheter placed during EMS transport
95040-2,EMS crisis intervention
95041-0,COVID-19+Progress note
Feb-04,Chloral hydrate
95042-8,Used or needed assistive devices in the past Mo
95043-6,Toileting hygiene - most dependent performance during the past Mo
95044-4,Refused specimen collection
95045-1,Entrapment
95046-9,Peripheral venous access available
95047-7,Medication was administered transnasally
95048-5,Airway was suctioned &or cleared
95049-3,Type of bag-mask ventilation used
95050-1,Difficult intubation
95051-9,Intubation necessary
95052-7,Medical technology used during EMS transport
95053-5,DOPamine^supine
95054-3,EPINEPHrine^standing
95055-0,DOPamine^standing
95056-8,Catecholamines supine and standing panel
Sep-05,Chlorobenzene
950-6,C little e Ab
Jul-06,Chloroethane
95068-3,ADRB2 gene targeted mutation analysis
95069-1,Chromosome 1q & 9 & 11 & 15 aneuploidy & chromosome region 13q deletion
95070-9,Chromosome 9 & 11 & 15 aneuploidy
95071-7,Chromosome region 14q32 rearrangements
95072-5,"1,3 beta glucan"
95073-3,Histoplasma capsulatum Ag
95074-1,Bacteria
May-07,Chloromethane
95075-8,Cannabidiol/Tetrahydrocannabinol
95076-6,C peptide^15M post meal
95077-4,Glucagon^5H post meal
95078-2,Glucose^15M post meal
95079-0,Insulin^15M post meal
95080-8,C peptide post fasting and meal stimulation panel
95081-6,C peptide^1.5H post meal
95082-4,C peptide^1H post meal
Mar-08,Chlorothiazide
95083-2,C peptide^2.5H post meal
95084-0,C peptide^2H post meal
95085-7,C peptide^3.5H post meal
95086-5,C peptide^30M post meal
95087-3,C peptide^3H post meal
95088-1,C peptide^4.5H post meal
95089-9,C peptide^4H post meal
95090-7,C peptide^5H post meal
Jan-09,Cholinesterase
95091-5,Glucagon post fasting and meal stimulation panel
95092-3,Glucagon^1.5H post meal
95093-1,Glucagon^1H post meal
95094-9,Glucagon^2.5H post meal
95095-6,Glucagon^2H post meal
95096-4,Glucagon^3.5H post meal
95097-2,Glucagon^30M post meal
95098-0,Glucagon^3H post meal
95099-8,Glucagon^4.5H post meal
95100-4,Glucagon^4H post meal
95101-2,Glucagon^post Cfst
95102-0,Glucose post fasting and meal stimulation panel
95103-8,Glucose^2.5H post meal
95104-6,Glucose^3.5H post meal
95105-3,Glucose^30M post meal
95106-1,Glucose^3H post meal
95107-9,Glucose^4.5H post meal
95108-7,Glucose^4H post meal
Sep-10,Chromium
95109-5,Glucose^5H post meal
95110-3,Insulin post fasting and meal stimulation panel
95111-1,Insulin^1.5H post meal
95112-9,Insulin^1H post meal
95113-7,Insulin^2.5H post meal
95114-5,Insulin^2H post meal
95115-2,Insulin^3.5H post meal
95116-0,Insulin^30M post meal
Jul-11,Citrulline
95117-8,Insulin^3H post meal
95118-6,Insulin^4.5H post meal
95119-4,Insulin^4H post meal
95120-2,Insulin^5H post meal
95121-0,Coagulation factor VIII activity & inhibitor panel
95122-8,Coagulation factor VIII inhibitor
95123-6,Gene fusion transcript details
95124-4,Sarcoma targeted gene fusion transcript analysis
May-12,Creosol
95125-1,SARS coronavirus 2 Ab.IgA+IgM
95126-9,Lipid & glucose panel
95127-7,Mycobacterium tuberculosis lipoarabinomannan Ag
95128-5,Edoxaban
95129-3,Dense fine speckled 70 protein Ab.IgG
95130-1,Aggressive prostate cancer risk
95131-9,FASI v1.0 - Mobility (Wheelchair)
95132-7,Consultation note
Mar-13,Cytomegalovirus Ab
95133-5,Discharge summary note
95134-3,Progress note
95135-0,Noroxycodone
95136-8,Cytomegalovirus DNA panel
95137-6,Parvovirus B19 DNA panel
95138-4,Epstein Barr virus DNA panel
95139-2,Varicella zoster virus DNA panel
951-4,C little e Ab
95140-0,Herpes simplex virus 1 & 2 DNA panel
Jan-14,Cytomegalovirus Ab
95141-8,Hepatitis D virus Ab panel
95142-6,Hepatitis A virus Ab.IgM panel
95143-4,UGT1A1 gene.TA repeats
95144-2,Hepatitis D virus RNA panel
95145-9,Hepatitis B virus core Ab panel
95146-7,Hepatitis B virus core Ab.IgM panel
95147-5,Hepatitis B virus DNA panel
95148-3,Hepatitis B virus surface Ag & little e Ab & Ag panel
95149-1,Hepatitis B virus surface Ag panel
95150-9,Avian infectious laryngotracheitis virus RNA
95151-7,Infectious bronchitis virus RNA
95152-5,Mycoplasma synoviae DNA
95153-3,Ornithobacterium rhinotracheale RNA
95154-1,Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to Prime Pac
95155-8,Porcine reproductive and respiratory syndrome virus ORF5 gene sequence homology to Prevacent
95156-6,Hepatitis E virus RNA
95157-4,Salmonella gallinarum+Salmonella pullorum Ab
Aug-15,Diclofenac
95158-2,Avian encephalomyelitis virus Ab/Positive control
95159-0,Avian metapneumovirus Ab/Positive control
95160-8,Avian paramyxovirus 1 Ab/Positive control
95161-6,Avian reovirus Ab/Positive control
95162-4,Bordetella avium Ab/Positive control
95163-2,Infectious bronchitis virus Ab/Positive control
95164-0,Infectious bursal disease virus Ab/positive control
95165-7,Mycoplasma gallisepticum Ab/Positive control
Jun-16,Echovirus 11 Ab
95166-5,Mycoplasma synoviae Ab/Positive control
95167-3,Ornithobacterium rhinotracheale Ab/Positive control
95168-1,Avian infectious laryngotracheitis virus RNA
95169-9,Infectious bronchitis virus RNA
95170-7,Mycoplasma gallisepticum DNA
95171-5,Mycoplasma synoviae DNA
95172-3,Mycoplasma iowae DNA
95173-1,Mycoplasma meleagridis DNA
Apr-17,Echovirus 18 Ab
95174-9,Ornithobacterium rhinotracheale RNA
95175-6,Avian encephalomyelitis virus Ab
95176-4,Avian metapneumovirus Ab
95177-2,Avian reovirus Ab
95178-0,Bordetella avium Ab
95179-8,Infectious bursal disease virus Ab
95180-6,Mycoplasma gallisepticum Ab
95181-4,Mycoplasma synoviae Ab
Feb-18,Echovirus 30 Ab
95182-2,Ornithobacterium rhinotracheale Ab
95183-0,Clostridioides difficile toxin & BI-NAP1-027 strain DNA panel
95184-8,Cytomegalovirus T-cell immunodeficiency panel
95185-5,Cells.CD8.HLA-A1 CMV specific
95186-3,Cells.CD8.CMV specific.CMV antigen stimulated CD107a+b expressing
95187-1,Cells.CD8.HLA-B35 CMV specific.CMV antigen stimulated CD107a+b expressing
95188-9,Cells.CD8.HLA-B8 CMV specific.CMV antigen stimulated CD107a+b expressing
95189-7,Cells.CD8.HLA-B7 CMV specific.CMV antigen stimulated CD107a+b expressing
9519-0,Echovirus 4 Ab
95190-5,Cells.CD8.HLA-A2 CMV specific.CMV antigen stimulated CD107a+b expressing
95191-3,Cells.CD8.HLA-A1 CMV specific.CMV antigen stimulated CD107a+b expressing
95192-1,Cells.CD8.CMV specific.CMV antigen stimulated gamma interferon producing
95193-9,Cells.CD8.HLA-B35 CMV specific.CMV antigen stimulated gamma interferon producing
95194-7,Cells.CD8.HLA-B8 CMV specific.CMV antigen stimulated gamma interferon producing
95195-4,Cells.CD8.HLA-B7 CMV specific.CMV antigen stimulated gamma interferon producing
95196-2,Cells.CD8.HLA-A2 CMV specific.CMV antigen stimulated gamma interferon producing
95197-0,Cells.CD8.HLA-A1 CMV specific.CMV antigen stimulated gamma interferon producing
95198-8,Cells.CD8.CMV specific
95199-6,Cells.CD8.HLA-B35 CMV specific
95200-2,Cells.CD8.HLA-B8 CMV specific
95201-0,Cells.CD8.HLA-B7 CMV specific
95202-8,Cells.CD8.HLA-A2 CMV specific
95203-6,Cells.CD8.PMA+ionomycin stimulated CD107a+b expressing/100 cells.CD3+CD8+
95204-4,Cells.CD8.PMA+ionomycin stimulated gamma interferon producing/100 cells.CD3+CD8+
95205-1,Hepatitis B virus surface Ab panel
95206-9,Hepatitis C virus Ab panel
95207-7,Hepatitis E virus RNA panel
Aug-20,Echovirus 9 Ab
95208-5,Bandage applied
95209-3,SARS coronavirus+SARS coronavirus 2 Ag
95210-1,Anaplasma marginale Ab/Negative control
95211-9,Bluetongue virus Ag/Negative control
95212-7,Neospora caninum Ab/Negative control
95213-5,Basophils/100 leukocytes
95214-3,Blasts/100 leukocytes
95215-0,Complete blood count W Differential panel
Jun-21,Entamoeba histolytica Ab.IgA
95216-8,Eosinophils/100 leukocytes
95217-6,Erythrocytes.nucleated/100 leukocytes
95218-4,Leukocytes
95219-2,Lymphocytes.variant/100 leukocytes
952-2,C little e Ag
95220-0,Lymphocytes/100 leukocytes
95221-8,Metamyelocytes/100 leukocytes
95222-6,Monocytes/100 leukocytes
95223-4,Mononuclear cells/100 leukocytes
Apr-22,Entamoeba histolytica Ab.IgG
95224-2,Myelocytes/100 leukocytes
95225-9,Neutrophils.band form/100 leukocytes
95226-7,Neutrophils.segmented/100 leukocytes
95227-5,Other cells/100 leukocytes
95228-3,Promyelocytes/100 leukocytes
95229-1,Biliary tract neoplasm chromosome analysis
95230-9,Biliary tract neoplasm chromosome aneuploidy & cytology analysis
95231-7,Chromosome aneuploidy details
Feb-23,Entamoeba histolytica Ab.IgM
95232-5,Albumin
95233-3,Albumin/Creatinine
95234-1,Hepatitis B virus surface Ag
95235-8,Hepatitis B virus Ab
95236-6,Hepatitis B virus DNA
95237-4,Hepatitis C virus Ab
95238-2,Hepatitis D virus Ab
95239-0,Hepatitis D virus Ab.IgM panel
9524-0,Giardia lamblia Ab
95240-8,Hepatitis E virus Ab
95241-6,Platelet aggregation.adenosine diphosphate induced^0.6 umol/L
95242-4,Platelet aggregation.adenosine diphosphate induced^1.2 umol/L
95243-2,Platelet aggregation.epinephrine induced^0.5 umol/L
95244-0,Platelet aggregation.EPINEPHrine induced^1 umol/L
95245-7,Platelet aggregation.ristocetin induced^375 ug/mL
95246-5,U.S. Household Food Security Survey
95247-3,Which of these statements best describes the food eaten in your household in the last 12Mo
95248-1,"In the last 12Mo, we couldn't afford to eat balanced meals"
95249-9,"In the last 12Mo, did you ever cut the size of your meals or skip meals because there wasn't enough money for food"
95250-7,"In the last 12Mo, how often did you cut the size of your meals or skip meals because there wasn't enough money for food"
95251-5,"In the last 12Mo, did you ever eat less than you felt you should because there wasn't enough money for food"
95252-3,"In the last 12Mo, were you ever hungry but didn't eat because there wasn't enough money for food"
95253-1,"In the last 12Mo, did you lose weight because there wasn't enough money for food"
95254-9,"In the last 12Mo, did you ever not eat for a whole day because there wasn't enough money for food"
95255-6,"In the last 12Mo, how often did you not eat for a whole day because there wasn't enough money for food"
95256-4,"In the last 12Mo, I relied on only a few kinds of low-cost food to feed my children because I was running out of money to buy food"
Jul-25,Hepatitis D virus Ab.IgM
95257-2,"In the last 12Mo, I couldn't feed my children a balanced meal, because I couldn't afford that"
95258-0,"In the last 12Mo, my children were not eating enough because I just couldn't afford enough food"
95259-8,"In the last 12Mo, did any of the children ever skip meals because there wasn't enough money for food"
95260-6,"In the last 12Mo, how often did any of the children skip meals because there wasn't enough money for food"
95261-4,"In the last 12Mo, were the children ever hungry but you just couldn't afford more food"
95262-2,"In the last 12Mo, did any of the children ever not eat for a whole day because there wasn't enough money for food"
95263-0,U.S. Household Food Security Survey Score
95264-8,Food security status
May-26,Hepatitis D virus Ag
95265-5,"In the last 12Mo, did you ever cut the size of any of the children's meals or skip meals because there wasn't enough money for food"
95266-3,Vitamin B6 & metabolites panel
95267-1,Connective tissue autoimmune Ab.IgG panel
95268-9,Clinical factors affecting result interpretation
95269-7,HLA-A+B+C Ab
95270-5,Platelet & HLA glycoprotein antibody panel
95271-3,Bicarbonate^post secretin
95272-1,Aquaporin 4 water channel Ab.IgG
Mar-27,Hexacarboxylporphyrin
95273-9,Aquaporin 4 water channel Ab.IgG
95274-7,DNM2 gene full mutation analysis
95275-4,FGD4 gene full mutation analysis
95276-2,GARS gene full mutation analysis
95277-0,GJB1 gene deletion+duplication & full mutation analysis
95278-8,HSPB1 gene full mutation analysis
95279-6,HSPB8 gene full mutation analysis
95280-4,MTMR2 gene full mutation analysis
Jan-28,Histoplasma capsulatum Ab.IgA
95281-2,NDRG1 gene full mutation analysis
95282-0,PARK2 gene deletion+duplication
95283-8,PARK7 gene deletion
95284-6,PINK1 gene deletion
95285-3,RAB7A gene full mutation analysis
95286-1,SBF2 gene full mutation analysis
95287-9,TRPV4 gene full mutation analysis
95288-7,YARS gene full mutation analysis
95289-5,Corneal vertex distance
95290-3,Sphere measurement increment
95291-1,Axis measurement increment
95292-9,Cylinder mode
95293-7,Device measurement mode
95294-5,Spherical equivalent
95295-2,Spherical equivalent
95296-0,Pupillary distance.binocular near
95297-8,Pupillary distance.binocular far
95298-6,Keratometry panel
Sep-29,Histoplasma capsulatum Ab.IgG
95299-4,Refractive power measurement increment
953-0,C little e Ag
95300-0,Axis measurement increment
95301-8,Cylinder mode
95302-6,Curvature radius.flat
95303-4,Curvature radius.steep
95304-2,Curvature radius.mean
95305-9,Curvature radius.flat
95306-7,Curvature radius.steep
Jul-30,Histoplasma capsulatum Ab.IgM
95307-5,Curvature radius.mean
95308-3,Refractive power.mean
95309-1,Cylinder
95310-9,Refractive power.mean
95311-7,Cylinder
95314-1,Diameter
May-31,Influenza virus A Ab
95315-8,Diameter
95316-6,Horizontal diameter
95317-4,Horizontal diameter
95318-2,Lensmeter panel
95319-0,Type of lens
95320-8,Sphere measurement increment
95321-6,Axis measurement increment
95322-4,Cylinder mode
Mar-32,Influenza virus A Ab.IgG
95323-2,Prism measurement increment
95324-0,Prism mode
95325-7,Axis
95326-5,Spherical equivalent
95327-3,Spherical equivalent
95328-1,Spherical equivalent
95329-9,Sphere near 1
95330-7,Sphere near 2
Jan-33,Influenza virus A Ab.IgM
95331-5,Prism
95332-3,Prism
95333-1,Prism
95334-9,Horizontal prism.in
95335-6,Horizontal prism.out
95336-4,Horizontal prism.in
95337-2,Horizontal prism.out
95338-0,Horizontal prism.in
95339-8,Horizontal prism.out
95340-6,Vertical prism.up
95341-4,Vertical prism.down
95342-2,Vertical prism.up
95343-0,Vertical prism.down
95344-8,Vertical prism.up
95345-5,Vertical prism.down
95346-3,UV transmittance
95347-1,UV transmittance
95348-9,UV transmittance
Sep-34,Influenza virus B Ab
95349-7,Pupillary distance.binocular near
95350-5,Pupillary distance.monocular near
95351-3,Axis
95352-1,Axis
95353-9,U.S. Adult Food Security Survey
95354-7,Transfuse convalescent plasma
95355-4,Convalescent plasma given
Jun-35,Influenza virus B Ab.IgG
95356-2,Pretransplant assessment of mortality score panel
95357-0,Total score
95358-8,Rabbit hemorrhagic disease virus RNA panel
95359-6,Rabbit hemorrhagic disease virus type 1 RNA
95360-4,Rabbit hemorrhagic disease virus type 2 RNA
95361-2,U.S. Household Food Security Survey - Six-Item Short Form
95362-0,Pancreatic exocrine function panel
95363-8,Bicarbonate post secretin stimulation panel
Apr-36,Influenza virus B Ab.IgM
95364-6,Organization
95365-3,Criteria used for case classification
95366-1,Date of first positive specimen collection
95367-9,Intensive care unit admission date
95368-7,Intensive care unit discharge date
95369-5,Affiliated with a tribe
95370-3,Tribal affiliation
95371-1,Enrolled in a tribe
Feb-37,Intrinsic factor blocking Ab
95372-9,Workplace setting
95373-7,Workplace is a part of critical infrastructure
95374-5,Critical infrastructure workplace setting
95375-2,Contact was with U.S. or international case
95376-0,Type of animal exposed to
95377-8,Disability
95378-6,U.S. Adult Food Security Survey Score
95379-4,U.S. Household Food Security Survey - Six-Item Short Form Score
9538-0,La Crosse virus Ab
95380-2,Influenza virus A & Influenza virus B & SARS coronavirus 2 & SARS-related coronavirus RNA panel
95381-0,COVID-19 note
95382-8,Date and time of symptom resolution
95383-6,Symptom resolution status
95384-4,Symptoms in the last 24H
95385-1,"Caregiver for person with age-related complaints, chronic diseases or frailty"
95386-9,Date and time of most recent contact with confirmed case
95387-7,Safe Environment for Every Kid Impression
95388-5,Other things you'd like help with today
95389-3,Have you used an illegal drug or a prescription medication for nonmedical reasons in the past 3Mo
95390-1,Four or more drinks in 1D in the past 3Mo
95391-9,"Has a partner threatened, shoved, hit or kicked you or hurt you physically in any way in the past 3Mo"
95392-7,Have you and a partner fought a lot in the past 3Mo
95393-5,Little interest or pleasure in doing things in last 2W
95394-3,"Feeling down, depressed, or hopeless in last 2W"
95395-0,Do you often feel under extreme stress
95396-8,Do you wish you had more help with your child
95397-6,Do you sometimes find you need to slap or hit your child
Aug-39,La Crosse virus Ab.IgG
95398-4,Do you often feel your child is difficult to take care of
95399-2,Within the past 12Mo the food we bought just didn't last and we didn't have money to get more
95400-8,Within the past 12Mo we worried whether our food would run out before we got money to buy more
95401-6,Needs smoke detector for home
95402-4,Would you like us to give you the phone number for poison control
95403-2,Safe Environment for Every Kid parent questionnaire - revised
95404-0,Suicidal behavior
95405-7,Assay related variables panel
Jun-40,La Crosse virus Ab.IgM
95406-5,SARS coronavirus 2 RNA
95407-3,Note
95408-1,Note
95409-9,SARS coronavirus 2 N gene
95410-7,SARS coronavirus 2 Ab.neut
95411-5,SARS coronavirus 2 Ab.neut
95412-3,COVID-19 case report
95413-1,Living arrangement panel
Apr-41,Legionella pneumophila 1 Ab.IgG
95414-9,Level of paid and unpaid caregiver assistance
95415-6,Admitted as an inpatient
95416-4,SARS coronavirus 2 Ab.IgM
95417-2,First test for condition of interest
95418-0,Employed in a healthcare setting
95419-8,Has symptoms related to condition of interest
95420-6,Admitted to intensive care unit for condition of interest
95421-4,Resides in a congregate care setting
Feb-42,Legionella pneumophila 1 Ab.IgM
95422-2,Influenza virus A & Influenza virus B & SARS coronavirus 2 RNA panel
95423-0,Influenza virus A & Influenza virus B & SARS coronavirus 2 identified
95424-8,SARS coronavirus 2 RNA
95425-5,SARS coronavirus 2 N gene
95426-3,Level of independence
95427-1,SARS coronavirus 2 Ab.IgA
95428-9,SARS coronavirus 2 Ab.IgM
95429-7,SARS coronavirus 2 Ab.IgG
9543-0,Legionella pneumophila 1 Ag
95430-5,"During the past 3Mo, how often have you used cannabis"
95431-3,"During the past 3Mo, how often have you used cocaine"
95432-1,"During the past 3Mo, how often have you used prescription stimulants"
95433-9,"During the past 3Mo, how often have you used methamphetamine"
95434-7,"During the past 3Mo, how often have you used inhalants"
95435-4,"During the past 3Mo, how often have you used sedatives or sleeping pills"
95436-2,"During the past 3Mo, how often have you used hallucinogens"
95437-0,"During the past 3Mo, how often have you used street opioids"
95438-8,"During the past 3Mo, how often have you used prescription opioids"
95439-6,"During the past 3Mo, how often have you used other substances"
95440-4,"During the past 3Mo, how often have you had a strong desire or urge to use cannabis"
95441-2,"During the past 3Mo, how often have you had a strong desire or urge to use cocaine"
95442-0,"During the past 3Mo, how often have you had a strong desire or urge to use prescription stimulants"
95443-8,"During the past 3Mo, how often have you had a strong desire or urge to use methamphetamine"
95444-6,"During the past 3Mo, how often have you had a strong desire or urge to use inhalants"
95445-3,"During the past 3Mo, how often have you had a strong desire or urge to use sedatives or sleeping pills"
95446-1,"During the past 3Mo, how often have you had a strong desire or urge to use hallucinogens"
95447-9,"During the past 3Mo, how often have you had a strong desire or urge to use street opioids"
Aug-44,Legionella pneumophila 2 Ab.IgG
95448-7,"During the past 3Mo, how often have you had a strong desire or urge to use prescription opioids"
95449-5,"During the past 3Mo, how often have you had a strong desire or urge to use other substances"
95450-3,"During the past 3Mo, how often has your use of cannabis led to health, social, legal or financial problems"
95451-1,"During the past 3Mo, how often has your use of cocaine led to health, social, legal or financial problems"
95452-9,"During the past 3Mo, how often has your use of prescription stimulants led to health, social, legal or financial problems"
95453-7,"During the past 3Mo, how often has your use of methamphetamine led to health, social, legal or financial problems"
95454-5,"During the past 3Mo, how often has your use of inhalants led to health, social, legal or financial problems"
May-45,Legionella pneumophila 2 Ab.IgM
95455-2,"During the past 3Mo, how often has your use of sedatives or sleeping pills led to health, social, legal or financial problems"
95456-0,"During the past 3Mo, how often has your use of hallucinogens led to health, social, legal or financial problems"
95457-8,"During the past 3Mo, how often has your use of street opioids led to health, social, legal or financial problems"
95458-6,"During the past 3Mo, how often has your use of prescription opioids led to health, social, legal or financial problems"
95459-4,"During the past 3Mo, how often has your use of other substances led to health, social, legal or financial problems"
95460-2,"During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of cannabis"
95461-0,"During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of cocaine"
95462-8,"During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of prescribed Amphetamine type stimulants"
Mar-46,Legionella pneumophila 3 Ab.IgG
95463-6,"During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of methamphetamine"
95464-4,"During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of inhalants"
95465-1,"During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of sedatives or sleeping pills"
95466-9,"During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of hallucinogens"
95467-7,"During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of street opioids"
95468-5,"During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of prescription opioids"
95469-3,"During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of other substances"
95470-1,Has a friend or relative or anyone else ever expressed concern about your use of cannabis
Jan-47,Legionella pneumophila 3 Ab.IgM
95471-9,Has a friend or relative or anyone else ever expressed concern about your use of cocaine
95472-7,Has a friend or relative or anyone else ever expressed concern about your use of prescribed Amphetamine type stimulants
95473-5,Has a friend or relative or anyone else ever expressed concern about your use of methamphetamine
95474-3,Has a friend or relative or anyone else ever expressed concern about your use of inhalants
95475-0,Has a friend or relative or anyone else ever expressed concern about your use of sedatives or sleeping pills
95476-8,Has a friend or relative or anyone else ever expressed concern about your use of hallucinogens
95477-6,Has a friend or relative or anyone else ever expressed concern about your use of street opioids
95478-4,Has a friend or relative or anyone else ever expressed concern about your use of prescription opioids
95479-2,Has a friend or relative or anyone else ever expressed concern about your use of other substances
954-8,C little e Ag
95480-0,Other substances that have caused a friend or relative or anyone else to ever express concern about your use of other substances
95481-8,Substances that have caused a friend or relative or anyone else to ever express concern about your use
95482-6,"Have you ever tried and failed to control, cut down or stop using cannabis"
95483-4,"Have you ever tried and failed to control, cut down or stop using cocaine"
95484-2,"Have you ever tried and failed to control, cut down or stop using prescribed Amphetamine type stimulants"
95485-9,"Have you ever tried and failed to control, cut down or stop using methamphetamine"
95486-7,"Have you ever tried and failed to control, cut down or stop using inhalants"
95487-5,"Have you ever tried and failed to control, cut down or stop using sedatives or sleeping pills"
95488-3,"Have you ever tried and failed to control, cut down or stop using hallucinogens"
Sep-48,Legionella pneumophila 4 Ab.IgG
95489-1,"Have you ever tried and failed to control, cut down or stop using street opioids"
95490-9,"Have you ever tried and failed to control, cut down or stop using prescription opioids"
95491-7,"Have you ever tried and failed to control, cut down or stop using other substances"
95492-5,Injection drug use
95493-3,Cannabis substance involvement score
95494-1,Substances used during the past 3Mo
95495-8,Other substances used during the past 3Mo
95496-6,Other substances that you have had a strong desire or urge to use in the past 3Mo
Jul-49,Legionella pneumophila 4 Ab.IgM
95497-4,"Other substances that have led to health, social, legal or financial problems in the past 3Mo"
95498-2,Other substances that have caused you to fail to do what was normally expected of you in the past 3Mo
95499-0,"Other substances that you have ever tried and failed to control, cut down or stop using"
95500-5,Substances you have had a strong desire or urge to use during the past 3Mo
95501-3,"Substances that have led to health, social, legal or financial problems during the past 3Mo"
95502-1,Substances that have caused you to fail to do what was normally expected of you during the past 3Mo
95503-9,"Substances that you have ever tried and failed to control, cut down or stop using"
95504-7,Cocaine substance involvement score
May-50,Legionella pneumophila 5 Ab.IgG
95505-4,Prescription stimulants substance involvement score
95506-2,Methamphetamine substance involvement score
95507-0,Inhalants substance involvement score
95508-8,Sedatives or sleeping pills substance involvement score
95509-6,Hallucinogens substance involvement score
95510-4,Street opioids substance involvement score
95511-2,Prescription opioids substance involvement score
95512-0,Other substance involvement score
Mar-51,Legionella pneumophila 5 Ab.IgM
95513-8,NIDA-Modified ASSIST version 2.0
95514-6,Refractive index
95515-3,Angiotensin II & angiotensin (1-7) panel
95516-1,Angiotensin (1-7)
95520-3,Note
Jan-52,Legionella pneumophila 6 Ab.IgG
95521-1,SARS coronavirus 2 N gene
95522-9,SARS coronavirus 2 N gene
95523-7,HIV 1 & 2 Ab panel
95524-5,HIV 1 & 2 Ab
95525-2,Chromium & cobalt panel
95526-0,Chromium
95527-8,Cytomegalovirus Ab.IgG
95528-6,NIDA Quick Screen
95529-4,Tobacco use in the past 1Y
95530-2,Prescription drug use for non-medical reasons in the past 1Y
95531-0,Illegal drug use in the past 1Y
95532-8,Human papilloma virus high-risk genotypes panel
95533-6,Human papilloma virus 56+59+66 DNA
95534-4,Human papilloma virus 52 DNA
95535-1,Human papilloma virus 51 DNA
95536-9,Human papilloma virus 45 DNA
95537-7,Human papilloma virus 35+39+68 DNA
95538-5,Human papilloma virus 33+58 DNA
Sep-53,Legionella pneumophila 6 Ab.IgM
95539-3,Human papilloma virus 31 DNA
95540-1,Bacterial carbapenem resistance blaIMP+blaVIM genes
95541-9,Care experience preference
95542-7,SARS coronavirus 2 Ab
95543-5,Aspergillus terreus Ab.IgG
95544-3,HTLV I DNA
95545-0,Loprazolam
95546-8,Diabetes 8Y risk
Jul-54,Cells.CD10
95547-6,Patient is being treated for high blood pressure
95548-4,Cardiovascular disease 10Y risk goal
95549-2,Cardiovascular disease lifetime risk
955-5,C super little w Ab
95550-0,ABL1 gene.c.944C>T
95551-8,Chromosome region 17p11.2 deletion
95552-6,4p16.3 chromosome deletion
95553-4,5p15.2 chromosome deletion
Apr-55,Cells.CD11c
95554-2,Pancreatic exocrine cell Ab
95555-9,F7 gene.p.Arg353Gln
95556-7,Adrenal cancer risk assessment & urine steroid fractions panel
95557-5,Detection basis
95558-3,CT attenuation of mass
95559-1,Evidence of adrenal cortical hormone excess
95560-9,Androsterone
95561-7,Etiocholanolone
Feb-56,Cells.CD11c+20c+
95562-5,Dehydroepiandrosterone
95563-3,16-Alpha hydroxydehydroepiandrosterone
95564-1,16-Alpha hydroxydehydroepiandrosterone
95565-8,5-Pregnenetriol
95566-6,5-Pregnenetriol
95567-4,5-Pregnenediol
95568-2,5-Pregnenediol
95569-0,Tetrahydro-11-corticosterone
9557-0,Cells.CD2
95570-8,Tetrahydro-11-corticosterone
95571-6,11-Deoxytetrahydrocorticosterone
95572-4,11-Deoxytetrahydrocorticosterone
95573-2,Pregnanediol
95574-0,17 alpha-Hydroxypregnanolone
95575-7,17 alpha-Hydroxypregnanolone
95576-5,Pregnanetriol
95577-3,Pregnanetriolone
95578-1,Tetrahydrodeoxycortisol
95579-9,Cortisol
95580-7,6-Beta-Hydroxycortisol
95581-5,Tetrahydrocortisol
95582-3,5-Alpha tetrahydrocortisol
95583-1,Beta cortol
95584-9,11-Hydroxyandrosterone
95585-6,11-Hydroxyetiocholanolone
95586-4,Cortisone
95587-2,Tetrahydrocortisone
Aug-58,Cells.CD20
95588-0,Alpha cortolone
95589-8,Beta cortolone
95590-6,Beta cortolone
95591-4,11-Ketoetiocholanolone
95592-2,Note
95593-0,Ercalcidiol
95594-8,Calcidiol
95595-5,Calcidiol+ercalcidiol
Jun-59,Cells.CD5
95596-3,Purkinje cell cytoplasmic type Tr Ab
95597-1,Gelatinous bodies
95598-9,Mucus strands
95599-7,Dipeptidyl aminopeptidase-like protein 6 Ab
95600-3,Contactin-associated protein 2 Ab
95601-1,Leucine-rich glioma-inactivated protein 1 Ab
95602-9,Gamma aminobutyrate B receptor Ab
95603-7,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab
Apr-60,Lymphocytes.CD5
95604-5,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab
95605-2,N-methyl-D-aspartate receptor subunit 1 Ab
95606-0,Stress level - 0-10 numeric rating
95607-8,Sleep quality - 1-5 numeric rating
95608-6,SARS coronavirus 2 RNA
95609-4,SARS coronavirus 2 S gene
95610-2,Views complete
95611-0,Views occlusal
Feb-61,Cells.CD5+CD19+
95612-8,Views
95613-6,Unpaid caregiver relationship
95614-4,Total score
95615-1,Scream or curse at you
95616-9,Threaten you with physical harm
95617-7,Insult you or talk down to you
95618-5,Physically hurt you
95619-3,"Hurts, insults, threatens, and screams"
9562-0,Lymphocytes.CD5+CD19+
95620-1,"Neonatal pain, agitation, & sedation scale panel"
95621-9,Pain &or agitation panel
95622-7,Pain &or agitation severity.crying or irritability
95623-5,Pain &or agitation severity.behavior state
95624-3,Pain &or agitation severity.facial expression
95625-0,Pain &or agitation severity.extremities tone
95626-8,Pain &or agitation severity.vital signs variability
95627-6,Pain &or agitation total score
95628-4,Pain &or agitation severity level
95629-2,Sedation panel
956-3,C super little w Ab
95630-0,Sedation level.crying or irritability
95631-8,Sedation level.behavior state
95632-6,Sedation level.facial expression
95633-4,Sedation level.extremities tone
95634-2,Sedation level.vital signs variability
95635-9,Sedation total score
95636-7,Sedation level
95637-5,Jamestown Canyon virus Ab.Neut
Aug-63,Cells.CD7
95638-3,California encephalitis virus Ab.Neut
95639-1,Cache Valley virus Ab.Neut
95640-9,Colorado tick fever virus Ab.Neut
95641-7,Barmah forest virus Ab.Neut
95642-5,Snowshoe hare virus Ab.Neut
95643-3,Tahyna virus Ab.Neut
95644-1,Japanese encephalitis virus Ab.Neut
95645-8,Murray Valley encephalitis virus Ab.Neut
Jun-64,Lymphocytic choriomeningitis virus Ab
95646-6,Ross River virus Ab.Neut
95647-4,Powassan virus Ab.Neut
95648-2,Sindbis virus Ab.Neut
95649-0,Chikungunya virus Ab.Neut
95650-8,Mayaro virus Ab.Neut
95651-6,Yellow Fever virus Ab.Neut
95652-4,Venezuelan equine encephalitis virus Ab.Neut
Mar-65,Measles virus Ab
95653-2,La Crosse virus Ab.Neut
95654-0,Eastern equine encephalitis virus Ab.Neut
95655-7,Western equine encephalitis virus Ab.Neut
95656-5,Gestational age <30 weeks
95657-3,Flavivirus identified
95658-1,Influenza virus A H7 Eurasia RNA
95659-9,Adenovirus RNA
95660-7,Eastern equine encephalitis virus Ab.IgM
Jan-66,Measles virus Ab.IgG
95661-5,Barmah forest virus Ab.IgG
95662-3,Japanese encephalitis virus Ab.IgA
95663-1,Zika virus Ab.IgG
95664-9,Jamestown Canyon virus Ab.IgG
95665-6,Snowshoe hare virus Ab.IgG
95666-4,Tahyna virus Ab.IgG
95667-2,Japanese encephalitis virus Ab.IgG
95668-0,Highlands J virus Ab.IgG
95669-8,Murray Valley encephalitis virus Ab.IgG
95670-6,Ross River virus Ab.IgG
95671-4,Sindbis virus Ab.IgG
95672-2,Chikungunya virus Ab.IgG
95673-0,Dengue virus 1+2+3+4 Ab.IgG
95674-8,Mayaro virus Ab.IgG
95675-5,Yellow Fever virus Ab.IgG
95676-3,Venezuelan equine encephalitis virus Ab.IgG
95677-1,Saint Louis encephalitis virus Ab.IgG
95678-9,Western equine encephalitis virus Ab.IgG
Sep-67,Mumps virus Ab
95679-7,Barmah forest virus Ab.IgM
95680-5,Snowshoe hare virus Ab.IgM
95681-3,Tahyna virus Ab.IgM
95682-1,Japanese encephalitis virus Ab.IgM
95683-9,Highlands J virus Ab.IgM
95684-7,Murray Valley encephalitis virus Ab.IgM
95685-4,Ross River virus Ab.IgM
95686-2,Sindbis virus Ab.IgM
Jul-68,Neisseria gonorrhoeae Ab
95687-0,Chikungunya virus Ab.IgM
95688-8,Dengue virus 1+2+3+4 Ab.IgM
95689-6,Mayaro virus Ab.IgM
95690-4,Yellow Fever virus Ab.IgM
95691-2,Venezuelan equine encephalitis virus Ab.IgM
95692-0,Saint Louis encephalitis virus Ab.IgM
95693-8,Western equine encephalitis virus Ab.IgM
95694-6,Cache valley virus Ab.IgA
May-69,Nocardia sp Ab.IgG
95695-3,Colorado tick fever virus Ab.IgA
95696-1,Barmah forest virus Ab.IgA
95697-9,Snowshoe hare virus Ab.IgA
95698-7,Tahyna virus Ab.IgA
95699-5,Highlands J virus Ab.IgA
95700-1,Murray Valley encephalitis virus Ab.IgA
95701-9,Ross River virus Ab.IgA
95702-7,Powassan virus Ab.IgA
Mar-70,Para aminobenzoate^6H post 500 mg bentiromide PO
95703-5,West Nile virus Ab.IgA
95704-3,Sindbis virus Ab.IgA
95705-0,Chikungunya virus Ab.IgA
95706-8,Dengue virus Ab.IgA
95707-6,Mayaro virus Ab.IgA
95708-4,Yellow Fever virus Ab.IgA
95709-2,Venezuelan equine encephalitis virus Ab.IgA
957-1,C super little w Ab
95710-0,La Crosse virus Ab.IgA
Jan-71,Parvovirus B19 DNA
95711-8,Saint Louis encephalitis virus Ab.IgA
95712-6,Eastern equine encephalitis virus Ab.IgA
95713-4,Western equine encephalitis virus Ab.IgA
95714-2,Varicella zoster virus Ab.IgG
95715-9,Population group
95716-7,17 alpha-Hydroxylase Ab
95717-5,Barmah forest virus Ab
95718-3,Anion gap 3
95719-1,Flavivirus Ab
95720-9,Glycine receptor Ab
95721-7,Glycine receptor Ab
95722-5,Glycine receptor Ab
95723-3,Glycine receptor Ab
95724-1,Glycine receptor Ab
95725-8,Glycine receptor Ab
95726-6,3-Hydroxy-3-Methylglutaryl-Coenzyme A reductase Ab
95727-4,Name
95728-2,Address
Sep-72,Parvovirus B19 DNA
95729-0,Relationship to decedent
95730-8,Surviving spouse name
95731-6,Maiden name
95732-4,"IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Self-care - admission performance"
95733-2,"IRF-PAI v3.0, LCDS v4.00 - Bladder and bowel - admission"
95734-0,"IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Self-care - discharge performance"
95735-7,Bladder continence
95736-5,Bowel continence
Jul-73,Respiratory syncytial virus Ab.IgG
95737-3,Expression of ideas and wants
95738-1,Does the patient use a wheelchair or scooter
95739-9,Indicate the type of wheelchair or scooter used
95740-7,Understanding verbal and non-verbal content
95741-5,"IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Mobility - admission performance"
95742-3,"IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Mobility - discharge performance"
95743-1,Memory &or recall ability
95744-9,Hearing.ability to hear
May-74,Respiratory syncytial virus Ab.IgM
95745-6,Vision.ability to see in adequate light
95746-4,Progress note
95747-2,Referral note
95748-0,Education note
95749-8,Initial evaluation note
95750-6,Procedure note
95751-4,Flowsheet
Feb-75,Rotavirus Ab
95752-2,Plan of care note
95753-0,Evaluation note
95754-8,Referral note
95755-5,Initial evaluation note
95756-3,Procedure note
95757-1,Progress note
95758-9,Flowsheet
95759-7,Plan of care note
9576-0,Rubella virus Ab
95760-5,Education note
95761-3,Consultation note
95762-1,Diagnostic study note
95763-9,Evaluation note
95764-7,Candida auris DNA
95765-4,Candida auris DNA
95766-2,Candida auris DNA
95767-0,Cefiderocol
95768-8,Parathyrin.1-84
95769-6,BMPR1A gene deletion+duplication & full mutation analysis
95770-4,GALT gene targeted mutation analysis
95771-2,GATA2 gene full mutation analysis
95772-0,IDH1 gene & IDH2 gene targeted mutation analysis
95773-8,ACADM gene full mutation analysis
95774-6,MSH6 gene deletion+duplication & full mutation analysis
95775-3,HGSNAT gene full mutation analysis
95776-1,GNS gene full mutation analysis
95777-9,ACADS gene full mutation analysis
Aug-77,Saint Louis encephalitis virus Ab
95778-7,TERT gene promotor region targeted mutation analysis
95779-5,TFE3 gene rearrangements
95780-3,TFEB gene rearrangements
95781-1,ATP7B gene full mutation analysis
95782-9,ABCD1 gene full mutation analysis
95783-7,ETV6 gene rearrangements
95784-5,FGFR2 gene rearrangements
95785-2,FOXL2 gene targeted mutation analysis
Jun-78,Saint Louis encephalitis virus Ab
95786-0,Gene XXX mutation analysis limited to known familial mutations
95787-8,Adrenal cortical carcinoma probability
95788-6,Adrenal malignancy other than adrenal cortical carcinoma probability
95789-4,Benign mass probability
95790-2,Adrenal cortical carcinoma probability
95791-0,Adrenal malignancy other than adrenal cortical carcinoma probability
95792-8,Benign mass probability
95793-6,Immunization priority tier
Apr-79,Tetrahydrocorticosterone
95794-4,Adrenal insufficiency emergency action plan
95795-1,HBG1 gene & HBG2 gene full mutation analysis
95796-9,Opioids panel
95797-7,Norfentanyl
95798-5,Normeperidine
95799-3,O-nortramadol
95800-9,Immunoglobulin light chains.free panel
95801-7,Immunoglobulin light chains.free & immunofixation panel
Feb-80,Thyroxine Ab
95802-5,Progress note
95803-3,Note
95804-1,Note
95805-8,Evaluation note
95806-6,Consultation note
95807-4,Chylomicrons
95808-2,Cholesterol & triglyceride & chylomicrons panel
95809-0,Carbapenem resistance genes
9581-0,Western equine encephalitis virus Ab
95810-8,"IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Functional abilities and goals - discharge"
95811-6,"IRF-PAI v3.0, MDS v1.17.1, 1.17.2 - Functional abilities and goals - admission"
95812-4,"Did the patient have difficulty focusing attention, for example, being easily distractible or having difficulty keeping track of what was being said"
95813-2,Is there evidence of an acute change in mental status from the patient's baseline
95814-0,"Was the patient's thinking disorganized or incoherent, such as rambling or irrelevant conversation, unclear or illogical flow of ideas, or unpredictable switching from subject to subject"
95815-7,Altered level of consciousness
95816-5,Signs and Symptoms of Delirium (from CAM)
95817-3,Oxygen/Gas.total
95818-1,Intravascular mean^during anesthesia
95819-9,Intravascular diastolic^during anesthesia
95820-7,Intravascular systolic^during anesthesia
95821-5,Intravascular mean^during anesthesia
95822-3,Intravascular mean^during anesthesia
95823-1,SARS-related coronavirus E gene
95824-9,SARS coronavirus 2 ORF1ab region
95825-6,SARS coronavirus 2 Ab
95826-4,SARS coronavirus 2 RNA panel
95827-2,Viable CD3 cells/100 cells.CD3
Aug-82,Afipia felis Ab.IgG
95828-0,T cell product characterization panel
95829-8,Viable CD45 cells/100 cells.CD45
95830-6,Hematopoietic progenitor cell product characterization panel
95831-4,Lymphocyte dose in hematopoietic progenitor cell transfusion
95832-2,CD3 dose in hematopoietic progenitor cell transfusion
95833-0,Nucleated cells
95834-8,Mononuclear cells
95835-5,Cells.CD34
Jun-83,Afipia felis Ab.IgM
95836-3,Cells.CD3
95837-1,Mononuclear cell dose in hematopoietic progenitor cell transfusion
95838-9,Nucleated cells.recovered/Nucleated cells.total
95839-7,Mononuclear cells.recovered/Mononuclear cells.total
95840-5,Microscopic exam
95841-3,Monocytes+Macrophages/100 leukocytes
95842-1,Lymphocytes/100 leukocytes
95843-9,Neutrophils/100 leukocytes
Apr-84,Babesia sp Ab.IgG
95844-7,Epithelial cells.squamous
95845-4,Nucleated cells
95846-2,Cell count & Differential panel
95847-0,Somatotropin^90M post dose macimorelin
95848-8,Somatotropin^60M post dose macimorelin
95849-6,Somatotropin^45M post dose macimorelin
95850-4,Somatotropin^30M post dose macimorelin
Jan-85,Babesia sp Ab.IgM
95851-2,Somatotropin post macimorelin stimulation panel
95852-0,LCDS v4.00 - Signs and Symptoms of Delirium (from CAM)
95853-8,LCDS v4.00 - Acute onset and fluctuating course
95854-6,LCDS v4.00 - Cognitive patterns
95855-3,"Did the (abnormal) behavior fluctuate during the day, that is, tend to come and go or increase and decrease in severity"
95856-1,LCDS v4.00 - Altered level of consciousness
95857-9,Level of consciousness - Alert (normal)
95858-7,Level of consciousness - Vigilant or lethargic or stupor or coma
95859-5,LCDS v4.00 - Self-care - admission performance
95860-3,LCDS v4.00 - Self-care - discharge goal
95861-1,LCDS v4.00 - Self-care - discharge performance
95862-9,LCDS v4.00 - Mobility - discharge goal
95863-7,LCDS v4.00 - Bladder and bowel - planned discharge
95864-5,LCDS v4.00 - Active diagnoses
95865-2,LCDS v4.00 - Swallowing &or nutritional status
95866-0,BRIEF health literacy screening tool
95867-8,Help reading hospital materials
95868-6,Difficulty understanding written information about medical condition
Sep-86,Borrelia burgdorferi Ab
95869-4,Problem understanding medical condition
95870-2,Confidence filling out medical forms
95871-0,Total score
95872-8,Brief cognitive assessment tool short form
95873-6,BCAT short form total score
95874-4,BCAT short form memory score
95875-1,Brief anxiety and depression scale
95876-9,Total score
Jul-87,Borrelia burgdorferi 41kD Ab.IgM
95877-7,Depression score
95878-5,Anxiety score
95879-3,Healthcare personnel with known health status
95880-1,"Hospitalizations/100,000 population"
95881-9,Laboratory test results reported
95882-7,Positive laboratory test results reported
95883-5,Positive laboratory test results reported/Laboratory test results reported
95884-3,Data collected
May-88,Borrelia burgdorferi 18kD Ab.IgG
95885-0,Inpatient beds
95886-8,Inpatient beds occupied
95887-6,Inpatient beds occupied/Inpatient beds
95888-4,Inpatient beds occupied by patients with disease of interest
95889-2,Inpatient beds occupied by patients with disease of interest/Inpatient beds occupied
958-9,C super little w Ag
95890-0,Intensive care unit beds occupied
95891-8,Intensive care unit beds occupied/Intensive care unit beds
95892-6,Healthcare personnel status
Mar-89,Borrelia burgdorferi 23kD Ab.IgG
95893-4,Hospital or facility beds utilization panel
95894-2,"Deaths/100,000 population"
95895-9,Start date
95896-7,Increase or decrease in cases compared to previous reporting period
95897-5,Percent increase or decrease in cases compared to previous reporting period
95898-3,All-cause deaths since start of event
95899-1,Deaths
95900-7,Percent increase or decrease in deaths compared to previous reporting period
Jan-90,Borrelia burgdorferi 28kD Ab.IgG
95901-5,Hospitalizations
95902-3,Hospitalizations
95903-1,Cases among healthcare personnel
95904-9,Cases among healthcare personnel
95905-6,Increase or decrease in cases among healthcare personnel compared to previous reporting period
95906-4,Percent increase or decrease in cases among healthcare personnel compared to previous reporting period
95907-2,Deaths among healthcare personnel
95908-0,Deaths among healthcare personnel
95909-8,Increase or decrease in deaths among healthcare personnel compared to previous reporting period
95910-6,Percent increase or decrease in deaths among healthcare personnel compared to previous reporting period
95911-4,Increase or decrease in deaths compared to previous reporting period
95912-2,Pneumocystis jiroveci DNA
95913-0,Coccidioides sp DNA
95914-8,Blastomyces sp DNA
95915-5,Coccidioides sp DNA
95916-3,Blastomyces sp DNA
95917-1,Histoplasma capsulatum DNA
95918-9,Fungal pathogens panel
Sep-91,Borrelia burgdorferi 30kD Ab.IgG
95919-7,Fungal pathogens panel
95920-5,Galantamine
95921-3,Hydroxychloroquine
95922-1,Tocilizumab
95923-9,Multisection^W stress+W contrast IV
95924-7,Multisection for bone density
95925-4,Multisection for bone density
95926-2,Multisection for bone density
Jul-92,Borrelia burgdorferi 39kD Ab.IgG
95927-0,Multisection for bone density
95928-8,Multisection for bone density
95929-6,Multisection for bone density
95930-4,Pulmonary vasodilator test panel
95931-2,Drug given for pulmonary vasodilator test
95932-0,Pulmonary hypertension
95933-8,Transpulmonary pressure gradient
95934-6,Volume
May-93,Borrelia burgdorferi 41kD Ab.IgG
95935-3,Volume
95936-1,Contractility
95937-9,Pulmonary vasodilation induced
95938-7,Diameter.transverse
95939-5,Length.crown rump
95940-3,Diameter.biparietal
95941-1,Influenza virus A & Influenza virus B & SARS coronavirus 2 & Respiratory syncytial virus RNA panel
95942-9,Influenza virus A & Influenza virus B & SARS coronavirus+SARS coronavirus 2 Ag panel
Mar-94,Borrelia burgdorferi 45kD Ab.IgG
95943-7,"IRF-PAI v3.0 - Hearing, speech, and vision - admission"
95944-5,IRF-PAI v3.0 - Staff assessment for mental status
95945-2,IRF-PAI v3.0 - Swallowing &or nutritional status - admission
95946-0,Usual ability to swallow
95947-8,Alcuronium Ab.IgE
95948-6,Aloe vera Ab.IgE
95949-4,"Glucan 1,4 alpha glucosidase Ab.IgE"
9595-0,Borrelia burgdorferi 58kD Ab.IgG
95950-2,Arnica montana Ab.IgE
95951-0,Azalea spp Ab.IgE
95952-8,Azorubine Ab.IgE
95953-6,(Gentamycin+Lincomycin+Neomycin+Streptomycin+Tobramycin) Ab.IgE
95954-4,Pinus pinea Ab.IgE
95955-1,Butylparaben Ab.IgE
95956-9,Cymbopogon citratus Ab.IgE
95957-7,Aspalathus linearis Ab.IgE
95958-5,Cichorium intybus var foliosum Ab.IgE
95959-3,Scorzonera hispanica Ab.IgE
95960-1,Tetrachlorophthalic anhydride Ab.IgE
95961-9,House dust Japan Ab.IgE
95962-7,(Quercus alba+Quercus rubra+Quercus velutina) Ab.IgE
95963-5,Cydonia oblonga Ab.IgE
95964-3,Ribes uva-crispa Ab.IgE
95965-0,Ethylparaben Ab.IgE
95966-8,Aspergillus glaucus Ab.IgE
95967-6,Freesia spp Ab.IgE
Aug-96,Borrelia burgdorferi 66kD Ab.IgG
95968-4,Gerbera spp Ab.IgE
95969-2,Intensive care unit beds
959-7,C super little w Ag
95970-0,SARS coronavirus 2 specific TCRB gene rearrangements
95971-8,SARS coronavirus 2 stimulated gamma interferon
95972-6,SARS coronavirus 2 stimulated gamma interferon release by T-cells^^corrected for background
95973-4,SARS coronavirus 2 stimulated gamma interferon release by T-cells
95974-2,SARS coronavirus 2 stimulated gamma interferon panel
95975-9,Skindex-16
Jun-97,Borrelia burgdorferi 93kD Ab.IgG
95976-7,Symptom score
95977-5,Emotion score
95978-3,Function score
95979-1,Total score
95980-9,"During the past 1W, how often have you been bothered by your skin condition itching"
95981-7,"During the past 1W, how often have you been bothered by your skin condition burning or stinging"
95982-5,"During the past 1W, how often have you been bothered by your skin condition being irritated"
95983-3,"During the past 1W, how often have you been bothered by the persistence or reoccurrence of your skin condition"
Apr-98,Borrelia burgdorferi 23kD Ab.IgM
95984-1,"During the past 1W, how often have you been bothered by worry about your skin condition"
95985-8,"During the past 1W, how often have you been bothered by the appearance of your skin condition"
95986-6,"During the past 1W, how often have you been bothered by frustration about your skin condition"
95987-4,"During the past 1W, how often have you been bothered by embarrassment about your skin condition"
95988-2,"During the past 1W, how often have you been bothered by being annoyed about your skin condition"
95989-0,"During the past 1W, how often have you been bothered by feeling depressed about your skin condition"
95990-8,"During the past 1W, how often have you been bothered by the effects of your skin condition on your interactions with others"
95991-6,"During the past 1W, how often have you been bothered by the effects of your skin condition on your desire to be with people"
Feb-99,Borrelia burgdorferi 39kD Ab.IgM
95992-4,"During the past 1W, how often have you been bothered by your skin condition making it hard to show affection"
95993-2,"During the past 1W, how often have you been bothered by the effects of your skin condition on your daily activities"
95994-0,"During the past 1W, how often have you been bothered by your skin condition making it hard to work or do what you enjoy"
95995-7,"During the past 1W, how often have you been bothered by your skin condition hurting"
95996-5,Skindex-29
95997-3,Symptom score
95998-1,Emotion score
95999-9,Function score
96000-5,Total score
96001-3,"During the past 4W, my skin hurts"
96002-1,"During the past 4W, my skin condition affects how well I sleep"
96003-9,"During the past 4W, I worry that my skin condition may be serious"
96004-7,"During the past 4W, my skin condition makes it hard to work or do hobbies"
96005-4,"During the past 4W, my skin condition affects my social life"
96006-2,"During the past 4W, my skin condition makes me feel depressed"
96007-0,"During the past 4W, my skin condition burns or stings"
Aug-00,Taenia solium larva Ab
96008-8,"During the past 4W, I tend to stay at home because of my skin condition"
96009-6,"During the past 4W, I worry about getting scars from my skin condition"
96010-4,"During the past 4W, my skin itches"
96011-2,"During the past 4W, my skin condition affects how close I can be with those I love"
96012-0,"During the past 4W, I am ashamed of my skin condition"
96013-8,"During the past 4W, I worry that my skin condition may get worse"
96014-6,"During the past 4W, I tend to do things by myself because of my skin condition"
96015-3,"During the past 4W, my skin condition makes me tired"
Jun-01,Taenia solium larva 13kD Ab
96016-1,"During the past 4W, my skin condition interferes with my sex life"
96017-9,"During the past 4W, I am annoyed by my skin condition"
96018-7,"During the past 4W, my skin condition bleeds"
96019-5,"During the past 4W, I am humiliated by my skin condition"
96020-3,"During the past 4W, my skin condition affects my desire to be with people"
96021-1,"During the past 4W, my skin is sensitive"
96022-9,"During the past 4W, I am frustrated by my skin condition"
96023-7,"During the past 4W, my skin condition is a problem for the people I love"
Apr-02,Taenia solium larva 14kD Ab
96024-5,"During the past 4W, I am embarrassed by my skin condition"
96025-2,"During the past 4W, my skin condition affects my interactions with others"
96026-0,"During the past 4W, my skin is irritated"
96027-8,"During the past 4W, I worry about side-effects from skin medications or treatments"
96028-6,"During the past 4W, my skin condition makes showing affection difficult"
96029-4,"During the past 4W, water bothers my skin condition (bathing, washing hands)"
96030-2,"During the past 4W, I am angry about my skin condition"
96031-0,"During the past 1W, how often have you been bothered by symptoms of your skin problem"
Feb-03,Taenia solium larva 18kD Ab
96032-8,"During the past 1W, how often have you been emotionally bothered by your skin problem"
96033-6,"During the past 1W, how often have you been bothered by effects of your skin problem on your activities"
96034-4,Skindex mini
96035-1,Microscopic observation
96036-9,"Wound, ischemia, and foot infection classification system panel"
96037-7,Wound grade
96038-5,Ischemia grade
96039-3,Infection grade
9604-0,Taenia solium larva 21kD Ab
96040-1,WIfI classification
96041-9,Amputation risk
96042-7,Focus distance during near pupillary distance measurement
96043-5,Uracil
96044-3,Human epididymis protein 4
96045-0,Osmotic fragility^10% glucose 48H 37 deg C incubation
96046-8,B & T cell crossmatch panel
96047-6,T cell crossmatch
96048-4,T cell median channel shift
96049-2,B cell crossmatch
960-5,C super little w Ag
96050-0,B cell median channel shift
96051-8,Prism base direction measurement increment
96052-6,Additional power mode
96053-4,Sphere far
96054-2,Cylinder far
96055-9,Prism base direction
96056-7,Borrelia sp DNA
Jul-05,Taenia solium larva 24kD Ab
96057-5,Interferon.beta Ab.IgG
96058-3,Mitragynine
96059-1,Mitragynine
96060-9,Hematologic cancer
96061-7,HLA donor match status
96062-5,HEDIS Measurement Year 2020 Value Set - BMI percentile
96063-3,HEDIS Measurement Year 2020 Value Set - CT Colonography
96064-1,HEDIS Measurement Year 2020 Value Set - Diastolic Blood Pressure
May-06,Taenia solium larva 39-42kD Ab
96065-8,HEDIS Measurement Year 2020 Value Set - Mammography
96066-6,HEDIS Measurement Year 2020 Value Set - Systolic Blood Pressure
96067-4,HEDIS Measurement Year 2020 Value Set - Urine Protein Tests
96068-2,HEDIS Measurement Year 2020 Value Sets
96069-0,HEDIS Measurement Year 2020 Value Set - Cervical Cytology
96070-8,HEDIS Measurement Year 2020 Value Set - HbA1c Tests
96071-6,HEDIS Measurement Year 2020 Value Set - LDL-C Tests
96072-4,HEDIS Measurement Year 2020 Value Set - Lead Tests
Mar-07,Taenia solium larva 50kD Ab
96073-2,HEDIS Measurement Year 2020 Value Set - FIT-DNA
96074-0,HEDIS Measurement Year 2020 Value Set - FOBT
96075-7,HEDIS Measurement Year 2020 Value Set - Chlamydia Tests
96076-5,HEDIS Measurement Year 2020 Value Set - Cholesterol Tests Other Than LDL
96077-3,HEDIS Measurement Year 2020 Value Set - Glucose Tests
96078-1,HEDIS Measurement Year 2020 Value Set - Group A Strep Tests
96079-9,HEDIS Measurement Year 2020 Value Set - HPV Tests
96080-7,HEDIS Measurement Year 2020 Value Set - Pregnancy Test Exclusion
Jan-08,Hepatitis C virus 100-3 Ab
96081-5,HEDIS Measurement Year 2020 Value Set - PSA Test Exclusion
96082-3,HEDIS Measurement Year 2020 Value Set - PSA Tests
96083-1,HEDIS Measurement Year 2020 Value Set - Estimated Glomerular Filtration Rate Lab Test
96084-9,HEDIS Measurement Year 2020 Value Set - Quantitative Urine Albumin Lab Test
96085-6,HEDIS Measurement Year 2020 Value Set - Urine Albumin Creatinine Ratio Lab Test
96086-4,HEDIS Measurement Year 2020 Value Set - Urine Creatinine Lab Test
96087-2,Standard thickness parameter
96088-0,Standard thickness parameter
96089-8,Volume adjustment parameter
96090-6,Volume adjustment parameter
96091-4,SARS coronavirus 2 RdRp gene
96092-2,Intraocular pressure^compensated
96093-0,Intraocular pressure^compensated
96094-8,SARS coronavirus 2 & SARS-related coronavirus RNA panel
96095-5,Indicate the patient's primary medical condition category
96098-9,Wash upper body - functional goal
Sep-09,Hepatitis C virus 22-3 Ab
96099-7,LCDS v5.00 - Mobility - admission performance
96100-3,LCDS v5.00 - Mobility - discharge performance
96101-1,Tobacco use frequency
96102-9,Age when stopped substance abuse
96103-7,Tobacco amount per D
96104-5,Wound stage
96105-2,Wound grade
96106-0,University of Texas diabetic wound classification system panel
Jul-10,Hepatitis C virus c33c Ab
96107-8,Bedaquiline
96108-6,Clofazimine
96109-4,Delamanid
96110-2,Ethionamide
96111-0,Linezolid
96112-8,Moxifloxacin
96113-6,Rifabutin
96114-4,Streptomycin
May-11,Streptococcus pneumoniae Danish serotype 18C Ab.IgG
96115-1,Level of tumor invasion
96116-9,Anterior surgical resection
96117-7,Resection adequacy of non-malignant polyp
96118-5,SARS coronavirus 2 Ab panel
96119-3,SARS coronavirus 2 Ag
96120-1,SARS coronavirus 2 RdRp gene
96121-9,SARS-related coronavirus E gene
96122-7,SARS-related coronavirus E gene
Mar-12,Cortisol^15M post 250 ug corticotropin IM
96123-5,SARS coronavirus 2 RdRp gene
96124-3,Long axis
96125-0,Perimeter
96126-8,Evaluation note
96127-6,Evaluation note
96128-4,Evaluation note
96129-2,Evaluation note
961-3,C super little x Ab
96130-0,Evaluation note
Jan-13,Cortisol^2H post 250 ug corticotropin IM
96131-8,Evaluation note
96132-6,Evaluation note
96133-4,Evaluation note
96134-2,Evaluation note
96135-9,Evaluation note
96136-7,Evaluation note
96137-5,Evaluation note
96138-3,Evaluation note
96139-1,Evaluation note
96140-9,Evaluation note
96141-7,Evaluation note
96142-5,Evaluation note
96143-3,Evaluation note
96144-1,Evaluation note
96145-8,Evaluation note
96146-6,Evaluation note
96147-4,Evaluation note
96148-2,Evaluation note
Sep-14,Cortisol^45M post 250 ug corticotropin IM
96149-0,Evaluation note
96150-8,Evaluation note
96151-6,Evaluation note
96152-4,Evaluation note
96153-2,Evaluation note
96154-0,Evaluation note
96155-7,Evaluation note
Jun-15,Cortisol^1.5H post 250 ug corticotropin IM
96156-5,Evaluation note
96157-3,Evaluation note
96158-1,Evaluation note
96159-9,Evaluation note
96160-7,Evaluation note
96161-5,Evaluation note
96162-3,Evaluation note
96163-1,Evaluation note
Apr-16,17-Hydroxyprogesterone
96164-9,Evaluation note
96165-6,Evaluation note
96166-4,Evaluation note
96167-2,Evaluation note
96168-0,Evaluation note
96169-8,Evaluation note
96170-6,Evaluation note
96171-4,Evaluation note
Feb-17,Chylomicrons
96172-2,Evaluation note
96173-0,Evaluation note
96174-8,Evaluation note
96175-5,Evaluation note
96176-3,Evaluation note
96177-1,Evaluation note
96178-9,Evaluation note
96179-7,Evaluation note
9618-0,Cholesterol
96180-5,Evaluation note
96181-3,Evaluation note
96182-1,Photographic image
96183-9,Photographic image
96184-7,Photographic image
96185-4,Indoor respiratory allergen Ab.IgE panel
96186-2,Dermatology autoimmune Ab panel
96187-0,Function
96188-8,Function
96189-6,Function
96190-4,Function
96191-2,Function
96192-0,Function
96193-8,Function
96194-6,Function
96195-3,Function
96196-1,Function
96197-9,Function
Aug-19,Triglyceride
96198-7,Function
96199-5,Function
96200-1,Function
96201-9,Function
96202-7,Function
96203-5,Function compared to previous assessment
96204-3,Function compared to previous assessment
96205-0,Function compared to previous assessment
Jun-20,Lipoprotein.beta
96206-8,Function compared to previous assessment
96207-6,Function compared to previous assessment
96208-4,Function compared to previous assessment
96209-2,Function compared to previous assessment
962-1,C super little x Ab
96210-0,Function compared to previous assessment
96211-8,Function compared to previous assessment
96212-6,Function compared to previous assessment
96213-4,Function compared to previous assessment
Apr-21,Lipoprotein.pre-beta
96214-2,Function compared to previous assessment
96215-9,Function compared to previous assessment
96216-7,Function compared to previous assessment
96217-5,Function compared to previous assessment
96218-3,Function compared to previous assessment
96219-1,Functional findings
96220-9,Functional findings
96221-7,Functional findings
Feb-22,Phytonadione
96222-5,Functional findings
96223-3,Functional findings
96224-1,Functional findings
96225-8,Functional findings
96226-6,Functional findings
96227-4,Multifocal electroretinography panel
96228-2,N1 amplitude ^light-adapted
96229-0,N1 amplitude^light-adapted
9623-0,Valine
96230-8,N1 implicit time^light-adapted
96231-6,N1 implicit time^light-adapted
96232-4,N2 amplitude^light-adapted
96233-2,N2 amplitude^light-adapted
96234-0,N2 implicit time^light-adapted
96235-7,N2 implicit time^light-adapted
96236-5,N95 amplitude^light-adapted
96237-3,N95 amplitude^light-adapted
96238-1,P1 amplitude^light-adapted
96239-9,P1 amplitude^light-adapted
96240-7,P1 implicit time^light-adapted
96241-5,P1 implicit time^light-adapted
96242-3,P50 amplitude^light-adapted
96243-1,P50 amplitude^light-adapted
96244-9,P50 peak time^light-adapted
96245-6,P50 peak time^light-adapted
96246-4,Pattern electroretinography panel
96247-2,Phase shift^light-adapted
Aug-24,Vanillylmandelate
96248-0,Phase shift^light-adapted
96249-8,Artifact
96250-6,Arsenic.inorganic+methylated
96251-4,Arsenic.inorganic+methylated
96252-2,Arsenic.methylated
96253-0,Arsenic fractions panel
96254-8,Saint Louis encephalitis virus Ab.IgG & IgM panel
May-25,Amoxapine+8-Hydroxyamoxapine
96255-5,Saint Louis encephalitis virus Ab.IgG & IgM panel
96256-3,Copper.free
96257-1,Copper.free
96258-9,Cholesterol.in LDL
96259-7,Cholesterol.in LDL
96260-5,Coagulation tissue factor induced.factor substitution^2H post incubation after 1:1 addition of normal plasma
96261-3,Coagulation tissue factor induced.factor substitution^1H post incubation after 1:1 addition of normal plasma
96262-1,Coagulation tissue factor induced.factor substitution^immediately after 1:1 addition of normal plasma
Mar-26,Propoxyphene+Norpropoxyphene
96263-9,Coagulation surface induced.lupus sensitive.factor substitution^2H post incubation after 1:1 addition of normal plasma
96264-7,Coagulation surface induced.lupus sensitive.factor substitution^1H post incubation after 1:1 addition of normal plasma
96265-4,Coagulation surface induced.factor substitution^2H post incubation after 1:1 addition of normal plasma
96266-2,Coagulation surface induced.factor substitution^1H post incubation after 1:1 addition of normal plasma
96267-0,Delta coagulation surface induced.hexagonal phase phospholipid
96268-8,Monocytes.programmed cell death ligand 1/100 monocytes
96269-6,Nitric oxide/Expired gas
96270-4,Cyclin-dependent kinase 4
Jan-27,Imipramine+Desipramine
96271-2,DNA mismatch repair protein Msh3
96272-0,DNA mismatch repair protein Mlh3
96273-8,HIV 1 RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA
96274-6,Fagus grandifolia wood dust Ab.IgE
96275-3,Ammonium persulfate Ab.IgE
96276-1,Ribes nigrum Ab.IgE
96277-9,carBAMazepine Ab.IgE
96278-7,Dermatophagoides pteronyssinus recombinant (rDer p) 23 Ab.IgE
96279-5,Abies alba wood dust Ab.IgE
96280-3,Fraxinus excelsior wood dust Ab.IgE
96281-1,Argas reflexus Ab.IgE
96282-9,Coagulation factor XII inhibitor
96283-7,Gliadin Ab.IgE
96284-5,Hay dust Ab.IgE
96285-2,Indomethacin Ab.IgE
96286-0,Ketoprofen Ab.IgE
96287-8,(Amphotericin B+Erythromycin+Nystatin+Spiramycin) Ab.IgE
96288-6,Methylene blue Ab.IgE
Sep-28,O-desmethylvenlafaxine
96289-4,Morphine Ab.IgE
96290-2,predniSONE Ab.IgE
96291-0,Pregnenolone sulfate
96292-8,Quinoline Ab.IgE
96293-6,Sodium nitrite Ab.IgE
96294-4,Straw dust Ab.IgE
96295-1,Streptomycin Ab.IgE
96296-9,Thuja spp Ab.IgE
Jul-29,TOLAZamide
96297-7,Cobalamins Ab.IgE
96298-5,IRF-PAI v3.0 - Quality indicators - admission
96299-3,IRF-PAI v3.0 - Cognitive patterns - admission
96300-9,Cell growth
96301-7,Bacteroides fragilis DNA
96302-5,Candida auris DNA
96303-3,Cryptococcus gattii+neoformans DNA
96304-1,Enterococcus faecalis DNA
May-30,Venlafaxine
96305-8,Enterococcus faecium DNA
96306-6,Enterobacterales DNA
96307-4,Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA
96308-2,Klebsiella aerogenes DNA
96309-0,Bacterial methicillin resistance mecA+mecC genes+SCCmec+OrfX junction
96310-8,Staphylococcus epidermidis DNA
96311-6,Staphylococcus lugdunensis DNA
96312-4,Stenotrophomonas maltophilia DNA
Mar-31,Viscosity
96313-2,Salmonella sp DNA
96314-0,Work or school D missed due to illness
96315-7,Gaps in care report
96316-5,Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1+2 Ab.IgG
96317-3,Acinetobacter calcoaceticus-baumannii complex DNA
96318-1,Enterobacter cloacae complex DNA
96319-9,Escherichia coli DNA
96320-7,Streptococcus agalactiae DNA
Jan-32,Aspergillus fumigatus Ab
96321-5,Haemophilus influenzae DNA
96322-3,Klebsiella oxytoca DNA
96323-1,Klebsiella aerogenes DNA
96324-9,Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA
96325-6,Moraxella catarrhalis DNA
96326-4,Pseudomonas aeruginosa DNA
96327-2,Proteus sp DNA
96328-0,Staphylococcus aureus DNA
96329-8,Serratia marcescens DNA
96330-6,Streptococcus pneumoniae DNA
96331-4,Streptococcus pyogenes DNA
96332-2,Note
96333-0,Procedure note
96334-8,Diagnostic study note
96335-5,Summary note
96336-3,Note
96337-1,Note
96338-9,Progress note
Sep-33,Epstein Barr virus capsid Ab.IgA
96339-7,Summary note
96340-5,Note
96341-3,Note
96342-1,Progress note
96343-9,Note
96344-7,Summary note
96345-4,Summary note
96346-2,Administrative note
Jul-34,Saint Louis encephalitis virus Ab.IgG
96347-0,Consent
96348-8,Note
96349-6,Referral letter
96350-4,Progress note
96351-2,Procedure note
96352-0,Note
96353-8,Procedure note
Apr-35,Saint Louis encephalitis virus Ab.IgM
96354-6,Platelets.large
96355-3,Equine herpesvirus 1
96356-1,Equine herpesvirus 3
96357-9,Equine herpesvirus 4
96358-7,Bovine parainfluenza virus 3
96359-5,7-Aminoclonazepam
96360-3,Dextromethorphan
96361-1,Dextromethorphan
Feb-36,Varicella zoster virus Ab
96362-9,Dextrorphan
96363-7,Dextrorphan+Levorphanol
96364-5,Gabapentin
96365-2,Naltrexol
96366-0,Naltrexone
96367-8,Pregabalin
96368-6,Pregabalin
96369-4,Sertraline
9637-0,Toluene
96370-2,Sertraline
96371-0,Tapentadol
96372-8,Imipenem+Relebactam
96373-6,Admission evaluation note
96374-4,Admission evaluation note
96375-1,Surgical operation note
96376-9,Surgical operation note
96377-7,Surgical operation note
96378-5,Discharge summary note
96379-3,History and physical note
96380-1,Wound duration
96381-9,Immune status
96382-7,Healed wound information
96383-5,Health-related behaviors and treatment compliance
96384-3,Health-related behaviors
96385-0,Adherence to treatment
96386-8,Physical impairment information
96387-6,Sensory symptoms
Aug-38,Toluene
96388-4,Psychosocial effect of wound odor
96389-2,Wound impact on quality of life
963-9,C super little x Ab
96390-0,Wound impact on emotional health
96391-8,Wound classification and diagnoses
96392-6,Debridement method
96393-4,Wound care instructions
96394-2,Education completion status
96395-9,Acceptance of treatment
Jun-39,18-Hydroxycorticosterone
96396-7,Cytomegalovirus DNA
96397-5,Microbiology - mycobacteriology studies
96398-3,Microbiology - mycology studies
96399-1,Retinol binding protein panel
96400-7,Retinol binding protein/Creatinine
96401-5,Retinol binding protein panel
96402-3,Retinol binding protein/Creatinine
96403-1,Renal clearance & Renal plasma flow panel
Apr-40,Androstanediol
96404-9,Para aminohippurate renal clearance/1.73 sq M
96405-6,Filtration Fraction
96406-4,Retinol binding protein
96407-2,Pancreatic polypeptide^30M post sham feeding
96408-0,Pancreatic polypeptide^25M post sham feeding
96409-8,Pancreatic polypeptide^20M post sham feeding
96410-6,Pancreatic polypeptide^15M post sham feeding
96411-4,Pancreatic polypeptide^10M post sham feeding
Feb-41,Catecholamines/Creatinine
96412-2,Pancreatic polypeptide^5M post sham feeding
96413-0,Pancreatic polypeptide^post CFst
96414-8,Pancreatic polypeptide sham feeding panel
96415-5,DOCK8 expression panel
96416-3,Cells.CD3+CD14-CD45+DOCK8+/100 Cells.CD3+CD14-CD45+
96417-1,Cells.CD3-CD14-CD19+CD45+DOCK8+/100 Cells.CD3-CD14-CD19+CD45+
96418-9,Cells.CD3-CD14-CD45+CD56+DOCK8+/100 Cells.CD3-CD14-CD45+CD56+
96419-7,Cells.CD3-CD14+CD45+DOCK8+/100 Cells.CD3-CD14+CD45+
9642-0,Creatine kinase.BB/Creatine kinase.total
96420-5,Daratumumab
96421-3,Testosterone
96422-1,Cortisone
96423-9,Progesterone
96424-7,Testosterone/Cortisol
96425-4,Cortisol/Cortisone
96426-2,Nasal bone
96427-0,Borrelia burgdorferi Ab.IgM
96428-8,Borrelia burgdorferi Ab.IgA
96429-6,Borrelia burgdorferi G39_40 Ab.IgG bands
96430-4,Borrelia burgdorferi G39_40 Ab.IgG bands
96431-2,Borrelia burgdorferi 49736 Ab.IgG bands
96432-0,Borrelia burgdorferi 49736 Ab.IgG bands
96433-8,Would like help finding daycare for child
96434-6,Always has enough food for family
96435-3,At risk of having utilities shut off in the next week
96436-1,Trouble paying heating bill &or electricity bill
96437-9,Needs help getting food for family for tonight
Aug-43,Creatine kinase.MM/Creatine kinase.total
96438-7,Would like help getting food for family
96439-5,Emergent risk of becoming homeless
96440-3,Would like help for being at risk of becoming homeless
96441-1,At risk of becoming homeless
96442-9,Needs daycare for child
96443-7,Would like help finding employment &or job training
96444-5,Has a job
96445-2,Would like help to get a GED
Jun-44,Cystine
96446-0,High school degree
96447-8,WE CARE Survey
96448-6,SARS coronavirus 2 N gene
96449-4,Cell growth
96450-2,Hepatocellular carcinoma risk
96451-0,Alpha-1-Fetoprotein & Alpha-1-Fetoprotein.L3 panel
96452-8,Hepatocellular carcinoma risk panel
Mar-45,Metanephrine/Creatinine
96453-6,Coagulation factor XI activity & inhibitor panel
96454-4,Coagulation factor II inhibitor
96455-1,Coagulation factor II activity & inhibitor panel
96456-9,Coagulation factor VIII activity & inhibitor panel
96457-7,Coagulation factor X activity & inhibitor panel
96458-5,Coagulation factor V activity & inhibitor panel
96459-3,Coagulation factor IX activity & inhibitor panel
96460-1,Thyroglobulin^post thyroglobulin antibody neutralization
Jan-46,Sulfide
96461-9,Gastrin releasing polypeptide prohormone
96462-7,Sirolimus
96463-5,Copper.free/Copper.total
96464-3,"Inositol 1,4,5-trisphosphate receptor type 1 Ab.IgG"
96465-0,"Inositol 1,4,5-trisphosphate receptor type 1 Ab.IgG"
96466-8,"Inositol 1,4,5-trisphosphate receptor type 1 Ab.IgG"
96467-6,"Inositol 1,4,5-trisphosphate receptor type 1 Ab.IgG"
96468-4,"Inositol 1,4,5-trisphosphate receptor type 1 Ab.IgG"
96469-2,"Inositol 1,4,5-trisphosphate receptor type 1 Ab.IgG"
964-7,C super little x Ag
96470-0,Rho GTPase-activating protein 26 Ab.IgG
96471-8,Rho GTPase-activating protein 26 Ab.IgG
96472-6,Rho GTPase-activating protein 26 Ab.IgG
96473-4,Rho GTPase-activating protein 26 Ab.IgG
96474-2,Rho GTPase-activating protein 26 Ab.IgG
96475-9,Rho GTPase-activating protein 26 Ab.IgG
96476-7,IgLON family member 5 Ab.IgG
96477-5,IgLON family member 5 Ab.IgG
96478-3,IgLON family member 5 Ab.IgG
Sep-47,Thiosulfate
96479-1,IgLON family member 5 Ab.IgG
96480-9,IgLON family member 5 Ab.IgG
96481-7,IgLON family member 5 Ab.IgG
96482-5,Alpha-internexin Ab.IgG
96483-3,Alpha-internexin Ab.IgG
96484-1,Neuronal intermediate filament heavy chain Ab.IgG
96485-8,Neuronal intermediate filament light chain Ab.IgG
96486-6,Neuronal intermediate filament Ab.IgG
Jul-48,Chlorothiazide
96487-4,Neuronal intermediate filament Ab.IgG
96488-2,Neuronal intermediate filament heavy chain Ab.IgG
96489-0,Neuronal intermediate filament light chain Ab.IgG
96490-8,Neuronal intermediate filament Ab.IgG
96491-6,Neuronal intermediate filament Ab.IgG
96492-4,Cells.CD3+CD8+CD27+CD45RO+CD62L+
96493-2,T-cell naive & memory & activated subsets panel
96494-0,ABL1 & ABL2 & PDGFRB gene rearrangements
May-49,Hydroflumethiazide
96495-7,ABL2 gene rearrangements
96496-5,Glycine receptor alpha-1 subunit Ab.IgG
96497-3,Glycine receptor alpha-1 subunit Ab.IgG
96498-1,La Crosse virus Ab.IgG & IgM panel
96499-9,La Crosse virus Ab.IgG & IgM panel
96500-4,Hyperoxaluria panel
96501-2,TIF1-gamma Ab
96502-0,Number of wheelchair pushes
Mar-50,Methyclothiazide
96503-8,Adenovirus DNA
96504-6,Protein/Osmolality
96505-3,Colorado tick fever virus Ab.IgM
96506-1,Oropouche virus Ab.IgG
96507-9,California encephalitis virus Ab.IgG
96508-7,Bunyamwera virus Ab.IgG
96509-5,Tick-borne encephalitis virus Ab.IgG
96510-3,Heartland banyangvirus Ab.IgG
Jan-51,metOLazone
96511-1,Bwamba virus Ab.IgG
96512-9,Rift Valley fever virus Ab.IgG
96513-7,Sandfly fever Naples virus Ab.IgG
96514-5,Cache Valley virus Ab.IgM
96515-2,Sandfly fever Sicilian virus Ab.IgG
96516-0,Toscana virus Ab.IgG
96517-8,Bourbon virus Ab.IgG
96518-6,Onyong-nyong virus Ab.IgG
96519-4,Semliki forest virus Ab.IgG
96520-2,Ilheus virus Ab.IgG
96521-0,Cache Valley virus Ab.IgG
96522-8,Colorado tick fever virus Ab.IgG
96523-6,Ilheus virus Ab.IgM
96524-4,Rocio virus Ab.IgM
96525-1,Semliki forest virus Ab.IgM
96526-9,Onyong-nyong virus Ab.IgM
96527-7,Bourbon virus Ab.IgM
96528-5,Toscana virus Ab.IgM
Sep-52,N-desalkylflurazepam
96529-3,Sandfly fever Sicilian virus Ab.IgM
96530-1,Sandfly fever Naples virus Ab.IgM
96531-9,Oropouche virus Ab.IgM
96532-7,Rift Valley fever virus Ab.IgM
96533-5,Bwamba virus Ab.IgM
96534-3,Heartland banyangvirus Ab.IgM
96535-0,Tick-borne encephalitis virus Ab.IgM
96536-8,Bunyamwera virus Ab.IgM
Jul-53,Trichlormethiazide
96537-6,California encephalitis virus Ab.IgM
96538-4,Rocio virus Ab.IgG
96539-2,Mechanical ventilation for condition of interest
965-4,C super little x Ag
96540-0,Extracorporeal membrane oxygenation for condition of interest
96541-8,Patient is within 6 weeks postpartum
96542-6,Travel in 14 days prior to symptom onset
96543-4,Visited healthcare facility in 14 days prior to symptom onset
96544-2,Contact with confirmed case in 14 days prior to symptom onset
May-54,Interleukin 2 receptor.soluble
96545-9,Date and time of first contact with confirmed case
96546-7,Country where diagnosed
96547-5,"Province, state, or region where diagnosed"
96548-3,Isolated per Infection Prevention and Control guidelines
96549-1,Date and time of infection control isolation
96550-9,Date of most recent lab test for condition of interest
96551-7,Number of contacts followed for contact tracing
Feb-55,Campylobacter jejuni Ab
96552-5,Result of most recent lab test for condition of interest
96553-3,Date of subsequent report to public health department
96554-1,Eutylone
96555-8,Eutylone
96556-6,HIV 1 & 2 RNA
96557-4,HIV 1 & 2 RNA panel
96558-2,Wound healing stage
96559-0,Testosterone.free
9656-0,Echinococcus sp Ab.IgG
96560-8,Nuclear pore protein gp210 Ab
96561-6,Citrullinated alpha enolase peptide 1 Ab
96562-4,Cytosolic 5'-nucleotidase 1A Ab
96563-2,Inner ear 68kD Ab.IgG
96564-0,Inner ear Ab
96565-7,sp100 Ab
96566-5,Cabotegravir
96567-3,Toxocara sp Ab.IgG
96568-1,Toxocara sp Ab.IgG
96569-9,LACE index panel
96571-5,Admitted via emergency department
96574-9,LACE index score
96575-6,During the last Mo did you not eat for a whole day because your family didn't have enough money for food
96576-4,U.S. Child Food Security Survey
96577-2,During the last Mo were you hungry but didn't eat because your family didn't have enough food
Aug-57,Echinococcus sp Ab.IgM
96578-0,U.S. Child Food Security Survey Score
96579-8,During the last Mo did you have to skip a meal because your family didn't have enough money for food
96580-6,During the last Mo has the size of your meals been cut because your family didn't have enough money for food
96581-4,During the last Mo did you have to eat less because your family didn't have enough money to buy food
96582-2,During the last Mo how often were you not able to eat a balanced meal because your family didn't have enough money
96583-0,During the last Mo did your meals only include a few kinds of cheap foods because your family was running out of money to buy food
96584-8,"During the last Mo did the food that your family bought run out, and you didn't have money to get more"
96585-5,During the last Mo did you worry that food at home would run out before your family got money to buy more
Jun-58,Giardia lamblia Ab.IgA
96586-3,Alanine aminotransferase
96587-1,Aspartate aminotransferase
96588-9,Cholesterol
96589-7,Cholesterol.total/Cholesterol.in HDL
96590-5,Creatinine
96591-3,Glomerular filtration rate/1.73 sq M.predicted.black
96592-1,Glomerular filtration rate/1.73 sq M.predicted.non black
96593-9,Gamma glutamyl transferase
Apr-59,Herpes simplex virus Ab.IgG
96594-7,Glucose
96595-4,Hemoglobin A1c/Hemoglobin.total
96596-2,Cholesterol.in HDL
96597-0,Cholesterol.in LDL
96598-8,Triglyceride
96599-6,Neisseria gonorrhoeae DNA
96600-2,Retinol & Alpha tocopherol panel
96601-0,Bacilliform bacteria
Feb-60,HIV 1 gp160 Ab
96602-8,"Methadone & 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine panel"
96603-6,SARS coronavirus 2 spike protein RBD Ab.neut
96604-4,Acrylic fiber Ab.IgE
96605-1,Saccharum officinarum pollen Ab.IgE
96606-9,Treated sheep wool Ab.IgE
96607-7,Blood pressure panel
96608-5,Intravascular systolic
96609-3,Intravascular diastolic
9661-0,HIV 1 gp120 Ab
96610-1,Observation setting
96611-9,Treponema pallidum & Haemophilus ducreyi & Herpes simplex virus DNA panel
96612-7,Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA panel
96613-5,HLA-A
96614-3,HLA-A & B & C (class I) typing panel
96615-0,HLA-A & B & C (class I) typing panel
96616-8,HLA-A unresolved alleles
96617-6,HLA-A unresolved alleles
96618-4,HLA-B
96619-2,HLA-B unresolved alleles
966-2,C super little x Ag
96620-0,HLA-B unresolved alleles
96621-8,HLA-C
96622-6,HLA-C unresolved alleles
96623-4,HLA-C unresolved alleles
96624-2,HLA typing comment
96625-9,HLA typing comment
96626-7,HLA-A
96627-5,HLA-A
Aug-62,HIV 1 gp41 Ab
96628-3,HLA-A & B & C (class I) typing panel
96629-1,HLA-A & B & C (class I) typing panel
96630-9,HLA-B
96631-7,HLA-B
96632-5,HLA-Bw
96633-3,HLA-Bw
96634-1,HLA-C
96635-8,HLA-C
Jun-63,HIV 1 p17 Ab
96636-6,HLA-C
96637-4,HLA-DP & DQ & DR (class II) typing panel
96638-2,HLA-DP & DQ & DR (class II) typing panel
96639-0,HLA-DP & DQ & DR (class II) typing panel
96640-8,HLA-DP & DQ & DR (class II) typing panel
96641-6,HLA-DPA1
96642-4,HLA-DPA1
96643-2,HLA-DPA1
Apr-64,HIV 1 p24 Ab
96644-0,HLA-DPA1 unresolved alleles
96645-7,HLA-DPA1 unresolved alleles
96646-5,HLA-DPB1
96647-3,HLA-DPB1
96648-1,HLA-DPB1
96649-9,HLA-DPB1 T-cell epitope match
96650-7,HLA-DPB1 unresolved alleles
Jan-65,HIV 1 p24 Ag
96651-5,HLA-DPB1 unresolved alleles
96652-3,HLA-DQA1
96653-1,HLA-DQA1
96654-9,HLA-DQA1
96655-6,HLA-DQA1 unresolved alleles
96656-4,HLA-DQA1 unresolved alleles
96657-2,HLA-DQB1
96658-0,HLA-DQB1
96659-8,HLA-DQB1
96660-6,HLA-DQB1 unresolved alleles
96661-4,HLA-DQB1 unresolved alleles
96662-2,HLA-DRB1
96663-0,HLA-DRB1
96664-8,HLA-DRB1
96665-5,HLA-DRB1
96666-3,HLA-DRB1 unresolved alleles
96667-1,HLA-DRB1 unresolved alleles
96668-9,HLA-DRB3 & HLA-DRB4 & HLA DRB5
Sep-66,HIV 1 p31 Ab
96669-7,HLA-DRB3 & HLA-DRB4 & HLA DRB5
96670-5,HLA-DRB3 & HLA-DRB4 & HLA DRB5
96671-3,HLA-DRB3 & HLA-DRB4 & HLA DRB5
96672-1,HLA-DRB3 & HLA-DRB4 & HLA DRB5
96673-9,HLA-DRB3 & HLA-DRB4 & HLA DRB5
96674-7,HLA-DRB3 & HLA-DRB4 & HLA DRB5 unresolved alleles
96675-4,HLA-DRB3 & HLA-DRB4 & HLA DRB5 unresolved alleles
96676-2,Employer phone number
Jul-67,HIV 1 p51 Ab
96677-0,Address
96678-8,School code
96679-6,Identifier assigning authority
96680-4,Activated clotting time.diatomaceous earth induced
96681-2,Activated clotting time.diatomaceous earth+clay induced
96682-0,Activated clotting time.glass bead induced
96683-8,Activated clotting time.glass bead induced^post heparin neutralization
96684-6,Activated clotting time.kaolin induced
May-68,HIV 1 p55 Ab
96685-3,Clot formation & Platelet function.glass bead induced post heparin neutralization panel
96686-1,Clot formation & Platelet function.glass bead induced panel
96687-9,Clot formation.diatomaceous earth induced panel
96688-7,Clot formation.diatomaceous earth+clay induced panel
96689-5,Clot formation.glass bead induced panel
96690-3,Clot formation.kaolin induced panel
96691-1,Coagulation viscoelastic tracing
96692-9,Platelet-induced clot retraction.glass bead induced
Mar-69,HIV 1 p66 Ab
96693-7,Platelet-induced clot retraction.glass bead induced^post heparin neutralization
96694-5,Rate of fibrin formation.diatomaceous earth induced
96695-2,Rate of fibrin formation.diatomaceous earth+clay induced
96696-0,Rate of fibrin formation.glass bead induced
96697-8,Rate of fibrin formation.glass bead induced^post heparin neutralization
96698-6,Rate of fibrin formation.kaolin induced
96699-4,Total score
967-0,D little u Ab
96700-0,MyMemCheck assessment panel
Jan-70,Plasmodium malariae Ab.IgG
96701-8,Carbon monoxide/gas.total^at end expiration^corrected for ambient CO
96702-6,Clot initiation.kaolin induced
96703-4,Clot initiation.kaolin induced/Clot initiation.kaolin induced^post heparin neutralization
96704-2,Clot initiation.kaolin induced^post heparin neutralization
96705-9,Clot stiffness reduction due to fibrinolysis
96706-7,Clot stiffness.platelet contribution
96707-5,Clot stiffness.fibrinogen contribution.tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited^post heparin neutralization
96708-3,Clot stiffness.tissue factor induced^post heparin neutralization
96709-1,Probability of developing hepatocellular carcinoma
96710-9,Clot
96711-7,Erythrocytes
96712-5,Leukocytes
96713-3,Microscopic observation
96714-1,Epithelial cells.squamous
96715-8,Color
96716-6,Odor
96717-4,pH
96718-2,Leukocytes
Sep-71,Plasmodium malariae Ab.IgM
96719-0,Erythrocytes
96720-8,Epithelial cells
96721-6,Macrophages
96722-4,Amyloid bodies
96723-2,Odor
96724-0,Macrophages.alveolar
96725-7,Xanthoma cells
96726-5,Epithelial cells.ciliated
Jul-72,Salmonella sp Ab.IgA
96727-3,Erythrocytes
96728-1,Elastic fibers
96729-9,Coral fibers
96730-7,Elastic fibers.calcified
96731-5,Curschmann's spirals & crystals
96732-3,Spermine
96733-1,Connective tissue
96734-9,Fatty acid salts
May-73,Salmonella sp Ab.IgG
96735-6,Lipoprotein.beta.subparticle.medium
96736-4,COVID-19+Procedure note
96737-2,COVID-19+Consultation note
96738-0,COVID-19 letter
96739-8,COVID-19 note
96740-6,COVID-19 note
96741-4,SARS coronavirus 2 variant
96742-2,SARS coronavirus 2 Ab.IgG
Mar-74,Salmonella sp Ab.IgM
96743-0,Cannot read or write in primary language
96744-8,Intervention or enabling service minutes
96745-5,Intervention or enabling service group size
96746-3,Appointment type
96747-1,Service provided in a language other than English
96748-9,Interventions or enabling services provided
96749-7,Association of Asian Pacific Community Health Organizations enabling services and social intervention panel
9675-0,Silicone Ab.IgA
96750-5,Comorbidity score
96751-3,SARS coronavirus 2 S gene mutation detected
96752-1,SARS coronavirus 2 S gene mutation
96753-9,Would like help with paying heating &or electricity bill
96754-7,Mycobacterium tuberculosis stimulated gamma interferon release by T-cells^^corrected for background
96755-4,SARS coronavirus 2 variant interpretation
96756-2,SARS coronavirus 2 S gene codon N501=
96757-0,SARS coronavirus 2 S gene codon N501Y
96758-8,Stairs - functional ability
96759-6,Bowel control - functional ability
96760-4,Bladder control - functional ability
96761-2,Total score
96762-0,Barthel index panel
96763-8,SARS coronavirus 2 E gene
96764-6,SARS coronavirus 2 E gene
96765-3,SARS coronavirus 2 S gene
96766-1,GISAID sequence accession number
96767-9,Grooming - functional ability
Aug-76,Silicone Ab.IgE
96768-7,Pregnancy outcome related to illness or condition
96769-5,Type of immunosuppressive medication used
96770-3,Fresh water supply was treated prior to use
96771-1,Service integration panel
96772-9,Service integration total score
96773-7,How well do services work together: services talk to each other
96774-5,How well do services work together: staff know what other services do
96775-2,How well do services work together: I don't have to repeat my story
Jun-77,Silicone Ab.IgG
96776-0,How well do services work together: different services work well together
96777-8,Accountable health communities health-related social needs screening tool
96778-6,Problems with place where you live
96779-4,"Has the electric, gas, oil, or water company threatened to shut off services in your home in past 12Mo"
96780-2,Wants help finding or keeping work or a job
96781-0,Able to get help with daily activities when needed
96782-8,Wants help with school or training
96783-6,howRwe panel
Apr-78,Silicone Ab.IgM
96784-4,howRwe score
96785-1,How are we doing: treat you kindly
96786-9,How are we doing: listen and explain
96787-7,How are we doing: see you promptly
96788-5,How are we doing: well organized
96789-3,Sequential Organ Failure Assessment
96790-1,SOFA total score
96791-9,Quick SOFA score
Feb-79,Squamous cell carcinoma Ag
96792-7,Modified SOFA score
96793-5,(Fagus grandifolia+Pinus strobus+Thuja plicata+Abies alba) Ab.IgE
96794-3,(Quercus alba+Swietenia+Thuja plicata+Triplochiton scleroxylon) Ab.IgE
96795-0,Hexacarboxylporphyrins
96797-6,SARS coronavirus 2 RNA
96798-4,Cortisol & glucose & somatotropin post arginine stimulation panel
96799-2,Glucose^30M post dose arginine
Aug-96,Cefonicid
9680-0,Cells.CD16+CD57+/100 cells
96800-8,Glucose^1H post dose arginine
96801-6,Cortisol^1H post dose arginine
96802-4,Glucose^1.5H post dose arginine
96803-2,24H predicted protein
96804-0,24H predicted protein
96805-7,Cobalamins & folate panel
96806-5,Panax ginseng Ab.IgE
96807-3,Vancomycin Ab.IgE
96808-1,Thiamine Ab.IgE
96809-9,Cyanocobalamin Ab.IgE
96810-7,Salix alba Ab.IgE
96811-5,Calluna vulgaris Ab.IgE
96812-3,Anthriscus cerefolium Ab.IgE
96813-1,Goat milk cheese Ab.IgE
96814-9,Sheep milk cheese Ab.IgE
96815-6,Trigla spp Ab.IgE
96816-4,Tetracaine Ab.IgE
96817-2,Thermoactinomyces candidus Ab.IgE
Aug-81,1-Naphthol
96818-0,Taxus baccata Ab.IgE
96819-8,Roxithromycin Ab.IgE
96820-6,Eruca vesicaria subspecies sativa Ab.IgE
96821-4,Propylparaben Ab.IgE
96822-2,Euphorbia spp. Ab.IgE
96823-0,Respiration
96824-8,Coagulation
96825-5,Liver
Jun-82,2-Butanol
96826-3,Cardiovascular
96827-1,Central nervous system
96828-9,Renal
96829-7,SARS coronavirus 2 RNA
96830-5,Specimen source
96831-3,Coronavirus racial bias scale
96832-1,Due to the coronavirus I have been cyberbullied because of my race or ethnicity
96833-9,Since the coronavirus I have seen a lot more cyberbullying of people of my race or ethnicity
Apr-83,2-Methyl-2-Propanol
96834-7,Coronavirus anxiety scale
96835-4,"Dizzy, lightheaded, or faint, when exposed to news about the coronavirus in past 2W"
96836-2,Trouble falling or staying asleep due to thinking about the coronavirus in past 2W
96837-0,Paralyzed or frozen when I thought about or was exposed to information about the coronavirus in past 2W
96838-8,Lost interest in eating when I thought about or was exposed to information about the coronavirus in past 2W
96839-6,Nauseous or had stomach problems when I thought about or was exposed to information about the coronavirus in past 2W
96841-2,"Tobacco, Alcohol, Prescription medications, and other Substance use screen"
Feb-84,Bendiocarb
96842-0,How often have you used any tobacco product in past 12Mo
96843-8,How often have you used illegal or recreational drugs in past 12Mo
96844-6,"How often have you used any prescription medications just for the feeling, more than prescribed or that were not prescribed for you in past 12Mo"
96845-3,"Tobacco, Alcohol, Prescription medications, and other Substance use assessment"
96846-1,Smoked at least one cigarette containing tobacco in past 3Mo
96847-9,Smoked more than 10 cigarettes per D in past 3Mo
96848-7,Smoked cigarette within 30M after waking in past 3Mo
96849-5,At least one drink in past 3Mo
96850-3,Four or more drinks in 1D in the past 3Mo
96851-1,Five or more drinks in 1D in the past 3Mo
96852-9,"Have you tried and failed to control, cut down or stop drinking in past 3Mo"
96853-7,Has anyone expressed concern about your drinking in past 3Mo
96854-5,Used marijuana in past 3Mo
96855-2,Have you had a strong desire or urge to use marijuana at least once a week or more often in past 3Mo
96856-0,Has anyone expressed concern about your use of marijuana in past 3Mo
96857-8,"Used cocaine, crack, or methamphetamine in past 3Mo"
96858-6,"Used cocaine, crack, or methamphetamine at least once a week in past 3Mo"
Sep-85,Butanol
96859-4,"Has anyone expressed concern about your use of cocaine, crack, or methamphetamine in past 3Mo"
96860-2,Used heroin in past 3Mo
96861-0,"Have you tried and failed to control, cut down or stop using heroin in past 3Mo"
96862-8,Has anyone expressed concern about your use of heroin in past 3Mo
96863-6,Used prescription opiate pain reliever not as prescribed or not prescribed for you in past 3Mo
96864-4,"Have you tried and failed to control, cut down or stop using an opiate pain reliever in past 3Mo"
96865-1,Has anyone expressed concern about your use of an opiate pain reliever in past 3Mo
96866-9,Used medication for anxiety or sleep not as prescribed or not prescribed for you in past 3Mo
Jul-86,Cadmium
96867-7,Have you had a strong desire or urge to use medications for anxiety or sleep at least once a week or more often in past 3Mo
96868-5,Has anyone expressed concern about your use of medication for anxiety or sleep in past 3Mo
96869-3,Used medication for ADHD not as prescribed or not prescribed for you in past 3Mo
96870-1,Used medication for ADHD not as prescribed or not prescribed for you at least once a week in past 3Mo
96871-9,Has anyone expressed concern about your use of a medication for ADHD in past 3Mo
96872-7,Used other illegal or recreational drug in past 3Mo
96873-5,Illegal or recreational drug(s) used in past 3Mo
96874-3,COVID-19+Immunization note
May-87,Cadmium
96875-0,I believe the country has become more dangerous for people in my racial or ethnic group because of fear of the coronavirus
96876-8,People of my race or ethnicity are more likely to lose their job because of the coronavirus
96877-6,I worry about people thinking I have the coronavirus simply because of my race or ethnicity
96878-4,Most social and mass media reports about the coronavirus create bias against people of my racial or ethnic group
96879-2,People of my race or ethnicity are more likely to get the coronavirus
968-8,D little u Ab
96880-0,People of my race or ethnicity will not receive coronavirus healthcare as good as the care received by other groups
96881-8,Negative social media posts against people of my race or ethnicity have increased because of the coronavirus
96882-6,"In the past Mo, have recommendations for socially distancing caused stress for you"
Mar-88,Carbaryl
96883-4,Stayed home all day
96884-2,Went to workplace or volunteer site outside home
96885-9,Attended social gatherings outside my home of more than 10 people
96886-7,Attended social gatherings outside my home of less than 10 people
96887-5,Gone on shopping trips or outings that were just for fun
96888-3,Visited nursing homes or long-term care facilities (outside of work duties)
96889-1,Close contact with someone who is in a risk group for COVID-19
96890-9,Frequency of social interaction with people outside my home
Jan-89,Carbofuran
96891-7,How often in the past Mo are you doing the recommended pandemic hygiene
96892-5,COVID-19 participant experience survey
96893-3,ERBB2 gene duplication
96894-1,SARS coronavirus 2 sequencing & identification panel
96895-8,SARS coronavirus 2 lineage
96896-6,SARS coronavirus 2 clade
96897-4,SARS coronavirus 2 RNA panel
96898-2,SARS coronavirus 2 N gene
96899-0,SARS coronavirus 2 ORF1ab region
96900-6,SARS coronavirus 2 S gene
96901-4,MDS v3.0 - RAI v1.17.2 - Delirium
96902-2,"MDS v3.0 - RAI v1.17.2 - Hearing, speech, and vision - NC, NP, NQ, SP"
96903-0,"MDS v3.0 - RAI v1.17.2 - Cognitive patterns - NC, NP, NQ, SP"
96904-8,MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NC
96905-5,"MDS v3.0 - RAI v1.17.2 - Bladder and bowel - ND, SD"
96906-3,"MDS v3.0 - RAI v1.17.2 - Bladder and bowel - NP, NQ, SP"
96907-1,"MDS v3.0 - RAI v1.17.2 - Cognitive patterns - ND, SD"
96908-9,MDS v3.0 - RAI v1.17.2 - Staff assessment for mental status
Sep-90,Chromium
96909-7,Cenobamate
96910-5,Acanthamoeba sp & Naegleria fowleri & Balamuthia mandrillaris DNA panel
96911-3,Delta aminolevulinate & porphobilinogen panel
96912-1,CT global noise
96913-9,CT size-adjusted dose
96914-7,CT dose & image quality category
96915-4,CT quality measure out of range
96916-2,Average diameter on axial mid-scan image
Jul-91,Cobalt
96917-0,Average diameter on frontal scout image
96918-8,Fodrin.alpha subunit Ab.IgA
96919-6,Nuclear Ab pattern.homogeneous
96920-4,Nuclear Ab pattern.nucleolar
96921-2,Nuclear Ab pattern.speckled
96922-0,Nuclear Ab pattern.spindle fibers
96923-8,Nuclear Ab pattern.smooth nuclear envelope
96924-6,Nuclear Ab pattern.intercellular bridge
May-92,Isobutanol
96925-3,Nuclear Ab pattern.nuclear dots
96926-1,PCNA extractable nuclear Ab
96927-9,Nuclear Ab pattern.centrosomal
96928-7,Fodrin.alpha subunit Ab.IgG
96929-5,Personal well-being panel
96930-3,Personal well-being score
96931-1,How are you feeling in general: I am satisfied with my life
96932-9,How are you feeling in general: what I do in my life is worthwhile
Mar-93,Mercury
96933-7,How are you feeling in general: I was happy yesterday
96934-5,How are you feeling in general: I was not anxious yesterday
96935-2,Heart rate
96936-0,Person-specific outcome panel
96937-8,Issue you would like help with
96938-6,How much concern does the issue you would like help with cause
96939-4,Loneliness panel
96940-2,Loneliness score
Jan-94,Propoxur
96941-0,Thinking about your friends and family: I have people to talk to
96942-8,Thinking about your friends and family: I have someone I can confide in
96943-6,Thinking about your friends and family: I have people who will help me
96944-4,Thinking about your friends and family: I do things with others
96945-1,Health confidence panel
96946-9,Health confidence score
96947-7,How do you feel about caring for your health: I can look after my health
96948-5,How do you feel about caring for your health: I can get the right help if I need it
96949-3,How do you feel about caring for your health: I am involved in decisions about me
96950-1,How do you feel about caring for your health: I know enough about my health
96951-9,Social determinants of health panel
96952-7,Social determinants of health score
96953-5,Thinking about how you live: I have had a good education
96954-3,Thinking about how you live: I am valued for what I do
96955-0,Thinking about how you live: I am happy about where I live
96956-8,Thinking about how you live: I have enough money to cope
96957-6,SARS coronavirus 2 M gene
Aug-95,3-Methoxy-4-Hydroxyphenylglycol
96958-4,SARS coronavirus 2 N gene
96959-2,Cholesterol.in LDL.small dense
969-6,D little u Ab
96960-0,Varicella zoster virus Ab.IgM Index
96961-8,Varicella zoster virus Ab.IgG Index
96962-6,Bordetella pertussis.pertussis toxin promoter region
96963-4,Grimontia holisae & Vibrio fluvialis & Vibrio harveyi DNA
96964-2,EZH2 gene targeted mutation analysis
96965-9,CARD11 gene targeted mutation analysis
Jun-96,8-Hydroxyloxapine
96966-7,CD79A gene targeted mutation analysis
96967-5,CD79B gene targeted mutation analysis
96968-3,TNFAIP3 gene targeted mutation analysis
96969-1,MYD88 gene targeted mutation analysis
96970-9,TP53 gene deletion+duplication
96971-7,STK11 gene deletion+duplication
96972-5,PTEN gene deletion+duplication
96973-3,CDH1 gene deletion+duplication
Apr-97,"carBAMazepine 10,11-Epoxide"
96974-1,PALB2 gene deletion+duplication
96975-8,Sub-maximal exercise stress test study
96976-6,Carbon dioxide^at end expiration-Carbon dioxide^at end expiration+W sub-maximal exercise
96977-4,Noninvasive prenatal fetal aneuploidy panel
96978-2,Noninvasive prenatal fetal aneuploidy & 22q11.2 deletion panel
96979-0,Fetal trisomy 13+trisomy 18+triploidy risk
96980-8,Comment on overall fetal aneuploidy risk
96981-6,Fetal trisomy 13+trisomy 18+triploidy risk
Feb-98,Desmethylclomipramine
96982-4,Test result delivery method
96983-2,Twin pregnancy
96984-0,Chromosome analysis
96985-7,Fetal sex
96986-5,SARS coronavirus 2 N gene
96987-3,Mass vaccination status
96988-1,CVX code
96989-9,MVX code
9699-0,PARoxetine
96990-7,Vaccine administration location
96991-5,Vaccine administration county
96992-3,Vaccine administration state
96993-1,Federal agency code
96994-9,Vaccine doses distributed
96995-6,"Vaccine doses distributed/100,000 population"
96996-4,People who have received first dose of vaccine
96997-2,"People who have received first dose of vaccine/100,000 population"
96998-0,People who are fully vaccinated
96999-8,"People who are fully vaccinated/100,000 population"
97000-4,Vaccine doses distributed for use in long term care facilities
97001-2,Vaccine administration tier
97002-0,People in long-term care facilities who have received first dose of vaccine
97003-8,People in long-term care facilities who are fully vaccinated
97004-6,Insulin type
97005-3,Maximum clot strength amplitude.kaolin+tissue factor induced
Jun-00,Procaine
97006-1,Maximum clot strength amplitude.kaolin+tissue factor induced
97007-9,Clot initiation.kaolin induced^post heparin neutralization
97008-7,Clot initiation.kaolin+tissue factor induced
97009-5,Activated clotting time.kaolin+tissue factor induced
97010-3,Clot formation.kaolin+tissue factor induced
97011-1,Clot angle.kaolin+tissue factor induced
97012-9,Reduction in clot strength.kaolin+tissue factor induced^30M post maximum clot amplitude
97013-7,Reduction in clot strength.kaolin induced^30M post maximum clot amplitude
Apr-01,sulfiSOXAZOLE
97014-5,Maximum clot strength amplitude.tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited
97015-2,Maximum clot strength amplitude.tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited
97016-0,Fibrinogen
97017-8,Maximum clot strength amplitude.kaolin induced^after addition of heparinase
97018-6,Maximum clot strength amplitude.activator F induced
97019-4,Maximum clot strength amplitude.adenosine diphosphate induced
97020-2,Maximum clot strength amplitude.arachidonate induced
97021-0,Reduction in clot strength.kaolin induced^30M post maximum clot amplitude
Feb-02,Terbutaline
97022-8,Clot strength.arachidonate inhibited
97023-6,Accountable health communities health-related social needs supplemental questions
97024-4,aPTT mixing study panel
97025-1,BRAF gene.p.Val600 mutations
97026-9,Phosphatidylserine-prothrombin complex Ab.IgG & IgM panel
97027-7,Speaks a language other than English at home
97029-3,Spine Tango surgery follow-up 2017
9703-0,Trihexyphenidyl
97030-1,Level of spine intervention
97031-9,Follow-up panel
97032-7,Postoperative follow-up interval
97033-5,Postoperative work status
97034-3,Postoperative therapeutic goals or measures that were achieved
97035-0,Postoperative therapeutic goals or measures that were partially achieved
97036-8,Postoperative therapeutic goals or measures that were not achieved
97037-6,Medication for spinal surgery or pathology
97038-4,Postoperative rehabilitation
97039-2,Overall outcome of spine surgery
970-4,Weak D Ag
97040-0,Postoperative follow-up care decision
97041-8,Comments regarding postoperative follow-up
97042-6,Complications panel
97043-4,Postoperative complication occurred
97044-2,Postoperative complication timing
97045-9,Postoperative complication type
97046-7,Postoperative complication treatment needed
97047-5,Postoperative complication effect on recovery
Aug-04,Spermatozoa
97048-3,Comments regarding postoperative complications
97049-1,p53 Ab
97050-9,Acinetobacter calcoaceticus-baumannii complex DNA
97051-7,Interferon.beta
97052-5,Chemokine (C-C motif) ligand 2
97053-3,Macrophage inflammatory protein 1.alpha
97054-1,Granulocyte macrophage colony stimulating factor
May-05,Coccidioides immitis Ab.IgA
97055-8,Finnish diabetes risk score panel
97057-4,BMI score for risk calculation
97058-2,Waist circumference score for risk calculation
97059-0,Physical activity at least 30M per D
97060-8,Vegetable &or fruit frequency
97062-4,High blood glucose
Mar-06,Coxiella burnetii phase 1 Ab.IgA
97063-2,Diabetes
97064-0,Total risk score
97065-7,Medical history for preventive vaccination against COVID-19 (Coronavirus Disease 2019) - with mRNA vaccine
97066-5,Acute illness with fever
97067-3,Allergic reaction to first COVID-19 vaccine dose
97068-1,Chronic diseases &or immunodeficiency
97069-9,Coagulation disorder &or blood-thinning medication use
97070-7,Adverse event following prior vaccination
Jan-07,Coxiella burnetii phase 2 Ab.IgA
97071-5,Pregnant or nursing
97072-3,Vaccinated in last 14 D
97073-1,Received COVID-19 vaccine
97074-9,Mean score
97075-6,Total score
97076-4,Common news sources
97077-2,Time spent per day getting information about COVID-19 &or its impact
97078-0,"Effect of friends, family or neighbors as source of information on mental health"
97079-8,Effect of local government officials as source of information on mental health
97080-6,Effect of national government officials as source of information on mental health
97081-4,Effect of national and international health officials as source of information on mental health
97082-2,Effect of print or online news as source of information on mental health
97083-0,Effect of radio or podcast as source of information on mental health
97084-8,Effect of Facebook as source of information on mental health
97085-5,Effect of Instagram or Snapchat as source of information on mental health
97086-3,Effect of Twitter as source of information on mental health
97087-1,"Effect of social media (e.g., TikTok, Reddit) as source of information on mental health"
97088-9,"How often friends, family or neighbors used as source of information for COVID-19"
Sep-08,Coxiella burnetii phase 1 Ab.IgG
97089-7,How often medical providers used as source of information for COVID-19
97090-5,How often local government officials used as source of information for COVID-19
97091-3,How often Federal Government used as source of information for COVID-19
97092-1,How often medical or health websites used as source of information for COVID-19
97093-9,How often print or online news used as source of information for COVID-19
97094-7,How often TV or radio used as source of information for COVID-19
97095-4,How often social media used as source of information for COVID-19
97096-2,COVID-19 experiences - media use panel
Jul-09,Coxiella burnetii phase 2 Ab.IgG
97097-0,SARS coronavirus 2 Ag
97098-8,SARS coronavirus 2 Nsp2 gene
97099-6,Influenza virus A & Influenza virus B & SARS coronavirus 2 Ag panel
97100-2,Colonoscopy and endoscopic ultrasound study
97101-0,Flexible sigmoidoscopy and endoscopic ultrasound study
97102-8,Tau protein.phosphorylated 181/Amyloid beta 42 peptide
97103-6,Zygosity
97104-4,SARS coronavirus 2 ORF1ab region
May-10,Coxiella burnetii phase 1 Ab.IgM
97105-1,Chemokine (C-C motif) ligand 2
97106-9,Hepatitis A virus cellular receptor 1
97107-7,Fibroblast growth factor 19
97108-5,Employment status in the 2W prior to COVID-19 outbreak
97109-3,New employment during the COVID-19 outbreak
97110-1,Work setting in the 2W before the COVID-19 outbreak
97111-9,Job loss during the COVID-19 outbreak
97112-7,Worked during the COVID-19 outbreak
Mar-11,Coxiella burnetii phase 2 Ab.IgM
97113-5,Significant job changes during the COVID-19 outbreak
97114-3,Work setting during the COVID-19 outbreak
97115-0,Student in the few weeks before COVID-19 outbreak
97116-8,Student during the COVID-19 outbreak
97117-6,School has offered classes remotely during the COVID-19 outbreak
97118-4,Increase or decrease in schoolwork during the COVID-19 outbreak
97119-2,Difficulty getting work or schoolwork done because of other responsibilities at home during the COVID-19 outbreak
971-2,Weak D Ag
97120-0,Difficulty getting work or schoolwork done because of your home environment during the COIVD-19 outbreak
Jan-12,Shigella boydii Ab
97121-8,Household job or income loss due to the COVID-19 outbreak
97122-6,Person who lost job or income due to COVID-19 outbreak
97123-4,COVID-19 experiences - employment and school changes panel
97124-2,"How helpful has texting, calling or video-calling family members or friends been as a coping strategy during the COVID-19 outbreak"
97125-9,How helpful has talking to a therapist been as a coping strategy during the COVID-19 outbreak
97126-7,How helpful has exercising or walking been as a coping strategy during the COVID-19 outbreak
97127-5,How helpful has cooking or baking been as a coping strategy during the COVID-19 outbreak
97128-3,How helpful have arts and crafts projects been as a coping strategy during the COVID-19 outbreak
97129-1,How helpful has cleaning or doing household chores been as a coping strategy during the COVID-19 outbreak
97130-9,How helpful has playing games with family members been as a coping strategy during the COVID-19 outbreak
97131-7,How helpful has playing online games been as a coping strategy during the COVID-19 outbreak
97132-5,How helpful has virtual entertainment been as a coping strategy during the COVID-19 outbreak
97133-3,Helpful coping strategy used during the COVID-19 outbreak
97134-1,How helpful was your coping strategy during the COVID-19 outbreak
97135-8,Impact of COVID-19 outbreak on life
97136-6,"How helpful has texting, calling or video-calling family members or friends been as a coping strategy to your child during the COVID-19 outbreak"
97137-4,How helpful has virtual learning or school been as a coping strategy to your child during the COVID-19 outbreak
97138-2,How helpful has talking to a therapist been as a coping strategy to your child during the COVID-19 outbreak
Sep-13,Shigella dysenteriae Ab
97139-0,How helpful has exercising or walking been as a coping strategy to your child during the COVID-19 outbreak
97140-8,How helpful has cooking or baking been as a coping strategy to your child during the COVID-19 outbreak
97141-6,How helpful have arts and crafts projects been as a coping strategy to your child during the COVID-19 outbreak
97142-4,"How helpful has playing board games, cards with family members been as a coping strategy to your child during the COVID-19 outbreak"
97143-2,How helpful has playing online games been as a coping strategy to your child during the COVID-19 outbreak
97144-0,How helpful has virtual entertainment been as a coping strategy to your child during the COVID-19 outbreak
97145-7,Helpful coping strategy your child used during the COVID-19 outbreak
97146-5,How helpful was your child's coping strategy during the COVID-19 outbreak
Jul-14,Shigella flexneri Ab
97147-3,COVID-19 experiences - coping panel
97148-1,Guanidinoacetate
97149-9,Pro prostate specific Ag isoform 2
97150-7,Prostate health index
97151-5,Enterovirus RNA
97152-3,Hepatitis B virus core+little e+p22cr Ag
97153-1,Primidone
Apr-15,Shigella sonnei Ab
97154-9,Ecgonine methyl ester
97155-6,SARS coronavirus 2 immunization status
97156-4,Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA
97157-2,Human papilloma virus 6+11+42+43+44 DNA
97158-0,Cytokeratin 8 Ag
97159-8,2-Hydroxyethylflurazepam
97160-6,Norclobazam
97161-4,Amphetamines panel
Feb-16,Streptococcal hyaluronidase Ab
97162-2,Titin Ab
97163-0,Theophylline^peak
97164-8,Triiodothyronine
97165-5,Triiodothyronine
97166-3,Thyroxine
97167-1,Thyroxine
97168-9,Vasopressin
97169-7,Vasopressin
9717-0,Toxocara canis Ab.IgA
97170-5,Adalimumab^trough
97171-3,Hexacarboxylporphyrin/Creatinine
97172-1,Yersinia outer protein Ab panel
97173-9,Yersinia outer protein M Ab
97174-7,Yersinia outer protein H Ab
97175-4,Yersinia LcrV protein Ab
97176-2,Yersinia outer protein D Ab
97177-0,Yersinia outer protein N Ab
97178-8,Yersinia outer protein P Ab
97179-6,Yersinia outer protein E Ab
97180-4,Yersinia outer protein Ab band pattern
97181-2,Muscle relaxants
97182-0,Carnitine free & total & acylcarnitine panel
97183-8,Mephobarbital & PHENobarbital panel
97184-6,Ravulizumab
97185-3,West Nile virus RNA
97186-1,Bordetella parapertussis IS1001 DNA
97187-9,Urea/Creatinine
Aug-18,Toxocara canis Ab.IgG
97188-7,Ryanodine receptor Ab
97189-5,Alpha-2-Macroglobulin
97190-3,carBAMazepine^peak
97191-1,carBAMazepine^peak
97192-9,carBAMazepine^trough
97193-7,Phenytoin^peak
97194-5,Phenytoin^peak
97195-2,Phenytoin^trough
Jun-19,Toxocara canis Ab.IgM
97196-0,quiNIDine^peak
97197-8,quiNIDine^trough
97198-6,Hemolysis interference index
97199-4,Icteric interference index
972-0,Weak D Ag
97200-0,Lipemic interference index
97201-8,Hemolysis interference index
97202-6,Icteric interference index
97203-4,Lipemic interference index
Apr-20,Reticulin Ab.IgA
97204-2,Oxidants
97205-9,Tropheryma whipplei DNA
97206-7,Tropheryma whipplei DNA
97207-5,Purkinje cell cytoplasmic type Tr Ab
97208-3,Shipping date
97209-1,Shipment tracking number
97210-9,6-Monoacetylmorphine.free
97211-7,6-Monoacetylmorphine.free
Feb-21,Salivary gland Ab
97212-5,7-Aminoclonazepam
97213-3,7-Aminoclonazepam
97214-1,Acetyl Fentanyl
97215-8,Acetyl Fentanyl
97216-6,Alpha pyrrolidinovalerophenone
97217-4,Alpha pyrrolidinovalerophenone
97218-2,Alprazolam
97219-0,Alprazolam
9722-0,Smith extractable nuclear Ab
97220-8,Amphetamine
97221-6,Amphetamine
97222-4,Benzoylecgonine
97223-2,Benzoylecgonine
97224-0,Butalbital
97225-7,Butalbital
97226-5,Carisoprodol
97227-3,Carisoprodol
97228-1,Chlordiazepoxide
97229-9,Chlordiazepoxide
97230-7,Clonazepam
97231-5,Clonazepam
97232-3,Cocaethylene
97233-1,Cocaethylene
97234-9,Cocaine
97235-6,Cocaine
97236-4,Codeine.free
97237-2,Codeine.free
Aug-23,Spermatozoa Ab.IgA
97238-0,N-desalkylflurazepam
97239-8,N-desalkylflurazepam
97240-6,Diazepam
97241-4,Diazepam
97242-2,Dihydrocodeine.free+Hydrocodol.free
97243-0,Dihydrocodeine.free+Hydrocodol.free
97244-8,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine"
97245-5,"2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine"
Jun-24,Spermatozoa Ab.IgG
97246-3,Ethylone
97247-1,Ethylone
97248-9,Fentanyl
97249-7,Fentanyl
97250-5,Flunitrazepam
97251-3,Flunitrazepam
97252-1,Flurazepam
Mar-25,Spermatozoa Ab.IgM
97253-9,Flurazepam
97254-7,Hydrocodone.free
97255-4,Hydrocodone.free
97256-2,Hydromorphone.free
97257-0,Hydromorphone.free
97258-8,Hydroxytriazolam
97259-6,Hydroxytriazolam
97260-4,Lorazepam
Jan-26,Mescaline
97261-2,Lorazepam
97262-0,Methylenedioxyamphetamine
97263-8,Methylenedioxyamphetamine
97264-6,Methylenedioxyethylamphetamine
97265-3,Methylenedioxyethylamphetamine
97266-1,Methylenedioxymethamphetamine
97267-9,Methylenedioxymethamphetamine
97268-7,Meperidine
97269-5,Meperidine
97270-3,Meprobamate
97271-1,Meprobamate
97272-9,Methadone
97273-7,Methadone
97274-5,Methamphetamine
97275-2,Methamphetamine
97276-0,Methylone
97277-8,Methylone
97278-6,Midazolam
Sep-27,Eosinophils/100 leukocytes
97279-4,Midazolam
97280-2,Morphine.free
97281-0,Morphine.free
97282-8,Nordiazepam
97283-6,Nordiazepam
97284-4,Norfentanyl
97285-1,Norfentanyl
97286-9,Norhydrocodone
Jul-28,Cells.CD3-CD16+CD56+
97287-7,Norhydrocodone
97288-5,Normeperidine
97289-3,Normeperidine
97290-1,Noroxycodone
97291-9,Noroxycodone
97292-7,O-Nortramadol
97293-5,O-Nortramadol
97294-3,Oxazepam
May-29,Canary serum proteins Ab.IgE
97295-0,Oxycodone.free
97296-8,Oxymorphone.free
97297-6,Oxymorphone.free
97298-4,Phencyclidine
97299-2,Phencyclidine
97300-8,Phenobarbital
97301-6,Phenobarbital
97302-4,Tapentadol
Mar-30,Pentacarboxylporphyrins
97303-2,Tapentadol
97304-0,Temazepam
97305-7,Temazepam
97306-5,Tramadol
97307-3,Tramadol
97308-1,Triazolam
97309-9,Triazolam
97310-7,Zolpidem
Jan-31,Phosphoethanolamine
97311-5,Zolpidem
97312-3,Campylobacter coli+jejuni+upsaliensis DNA
97313-1,Salmonella sp DNA
97314-9,Vibrio cholerae DNA
97315-6,Vibrio parahaemolyticus DNA
97316-4,Vibrio vulnificus DNA
97317-2,Escherichia coli enteroaggregative DNA
97318-0,Escherichia coli enteropathogenic DNA
97319-8,Escherichia coli enterotoxigenic DNA
97320-6,Escherichia coli O157 DNA
97321-4,Cyclospora cayetanensis DNA
97322-2,Oxazepam
97323-0,Oxycodone.free
97324-8,Carbapenem resistant bacteria identification & resistance panel
97325-5,Staphylococcus aureus VNTR pattern
97326-3,Staphylococcus aureus identification & resistance panel
97327-1,Core Outcome Measures Index for the Neck
97328-9,Interval between surgery and examination
Sep-32,Phosphoserine
97329-7,Which of the following problems related to your neck condition troubles you the most
97330-5,How much did health condition interfere with normal work in past W
97331-3,If you had to spend the rest of your life with the symptoms you have right now how would you feel about it
97332-1,Quality of life in past W
97333-9,Number of D cut down on usual activities because of health condition in past 4W
97334-7,Number of D did not go to work because of health condition in past 4W
97335-4,Type of postoperative complication
97336-2,Postoperative complication distress level
Jul-33,Porphyrins
97337-0,Subsequent operation for same health condition
97338-8,Treatment effectiveness
97339-6,Pain severity & Body site panel
97340-4,View AP
97341-2,View AP
97342-0,View PA
97343-8,View PA
97344-6,View PA
May-34,Alpha 1 globulin
97345-3,View lateral
97346-1,View AP
97347-9,View AP
97348-7,View oblique
97349-5,View axial
97350-3,View lateral
97351-1,View AP
Feb-35,Uroporphyrin/Porphyrins.total
97352-9,View lateral
97353-7,View AP
97354-5,View AP external rotation
97355-2,View AP internal rotation
97356-0,View oblique
97357-8,View AP
97358-6,View PA
97359-4,View PA
9736-0,Allopurinol
97360-2,View lateral
97361-0,View AP
97362-8,View AP
97363-6,View oblique
97364-4,View axial
97365-1,View oblique
97366-9,View PA
97367-7,View AP external rotation
97368-5,View AP internal rotation
97369-3,View oblique
97370-1,View PA
97371-9,View AP
97372-7,View AP
97373-5,View PA
97374-3,View lateral
97375-0,Views AP + oblique
97376-8,View AP
97377-6,View oblique
Aug-37,Propoxyphene
97378-4,View lateral
97379-2,View AP
973-8,D Ab
97380-0,View AP
97381-8,View AP external rotation
97382-6,View AP internal rotation
97383-4,View oblique
97384-2,View lateral
97385-9,View AP
Jun-38,Gabapentin
97386-7,View lateral
97387-5,View AP
97388-3,Views lateral^W manual stress
97389-1,Views lateral^W manual stress
97390-9,Views lateral^W manual stress
97391-7,Multisection^WO contrast
97392-5,Multisection^WO & W contrast IV
97393-3,Multisection^W contrast IV
Apr-39,Morphine
97394-1,Guidance for injection
97395-8,Guidance for injection
97396-6,Guidance for injection
97397-4,Views AP + lateral
97398-2,Views AP + lateral
97399-0,Views AP + lateral
97400-6,Views AP + lateral
97401-4,View PA
Feb-40,Neopterin
97402-2,Views AP + lateral
97403-0,Views AP + lateral
97404-8,Views AP + lateral
97405-5,Views AP + lateral
97406-3,View PA
97407-1,View Bernageau
97408-9,View Bernageau
97409-7,Views AP + lateral + oblique
9741-0,Toxoplasma gondii Ab.IgG
97410-5,Views AP + lateral + oblique
97411-3,Views AP + lateral + oblique
97412-1,Views AP + lateral + oblique
97413-9,Views AP + lateral + oblique
97414-7,Views AP + lateral
97415-4,Views AP + lateral
97416-2,Views AP + lateral
97417-0,Views AP + lateral
97418-8,Views AP + lateral
97419-6,Views AP + lateral + oblique
97420-4,Views AP + lateral + oblique
97421-2,View PA
97422-0,View AP
97423-8,View AP
97424-6,View PA
97425-3,View AP
97426-1,View AP
97427-9,View AP
Aug-42,Chloride
97428-7,View AP
97429-5,View AP
97430-3,View AP
97431-1,View lateral
97432-9,View lateral
97433-7,View lateral
97434-5,View lateral
97435-2,View lateral
Jun-43,Isoleucine
97436-0,View lateral
97437-8,View lateral
97438-6,View lateral
97439-4,View oblique
97440-2,View oblique
97441-0,View oblique
97442-8,View oblique
97443-6,View oblique
Apr-44,Beta globulin
97444-4,View oblique
97445-1,View oblique
97446-9,View oblique
97447-7,View oblique
97448-5,View PA
97449-3,View AP
97450-1,View oblique
Jan-45,Gamma globulin
97451-9,View lateral
97452-7,View oblique
97453-5,View oblique
97454-3,View oblique
97455-0,View AP
97456-8,View oblique
97457-6,View AP
97458-4,View AP
97459-2,View AP
974-6,D Ab
97460-0,View oblique
97461-8,View AP
97462-6,View lateral
97463-4,View lateral
97464-2,View AP
97465-9,View oblique
97466-7,view oblique
97467-5,View lateral
97468-3,View AP
Sep-46,Dantrolene
97469-1,View AP
97470-9,View lateral
97471-7,View oblique
97472-5,View lateral
97473-3,View oblique
97474-1,View AP
97475-8,View AP
97476-6,View lateral
Jul-47,Dapsone
97477-4,View oblique
97478-2,View oblique
97479-0,View AP
97480-8,View lateral
97481-6,View lateral
97482-4,View AP
97483-2,View oblique
97484-0,View oblique
May-48,Dipyridamole
97485-7,View lateral
97486-5,View AP
97487-3,View oblique
97488-1,View lateral
97489-9,View AP
97490-7,View AP
97491-5,View lateral
97492-3,Views AP + lateral + oblique
Mar-49,Hemoglobin F
97493-1,Views AP + lateral + oblique
97494-9,Views AP + lateral
97495-6,Views AP + lateral
97496-4,Views AP + lateral
97497-2,Views AP + lateral
97498-0,Views AP + lateral
97499-8,Proof of COVID-19 recovery certificate
97500-3,Proof of COVID-19 immunization or negative status certificate
Jan-50,Coxsackievirus A10 Ab
97501-1,REVEAL 2.0
97502-9,Prion disease biomarker panel
97503-7,Prion protein.abnormal
97504-5,Percent sensor usage
97505-2,Glucose standard deviation
97506-0,Glucose management indicator
97507-8,Glucose
97508-6,Number of providers seen for condition of interest
97509-4,Cancer disease progression
97510-2,Glucose measurements in range/Total glucose measurements
97511-0,Fungal Ab panel
97512-8,Rabies virus Ab.IgM
97513-6,Campylobacter sp
97514-4,Entamoeba moshkovskii DNA
97515-1,Entamoeba bangladeshi DNA
97516-9,Acanthamoeba sp Ab
97517-7,Rabies virus Ab.IgG
97518-5,Paracoccidioides sp Ab band pattern
Sep-51,Coxsackievirus A10 Ab
97519-3,Blastomyces sp Ab band pattern
97520-1,Histoplasma capsulatum mycelial phase Ab band pattern
97521-9,Coccidioides sp Ab band pattern
97522-7,Giardia sp
97523-5,Hepatitis A virus RNA
97524-3,Cryptosporidium sp
97525-0,Norovirus genogroup I RNA
97526-8,Balamuthia mandrillaris Ag
Jul-52,Coxsackievirus A16 Ab
97527-6,Acanthamoeba sp Ag
97528-4,Naegleria fowleri Ag
97529-2,Naegleria fowleri
975-3,D Ab
97530-0,Naegleria fowleri Ab
97531-8,Balamuthia mandrillaris Ab
97532-6,Norovirus genogroup II RNA
97533-4,Somatotropin post glucose stimulation panel
97534-2,Somatotropin^3H post dose glucose
May-53,Coxsackievirus A2 Ab
97535-9,Gas panel
97536-7,pH
97537-5,pH^^adjusted to patient's actual temperature
97538-3,Carbon dioxide
97539-1,Carbon dioxide^^adjusted to patient's actual temperature
97540-9,Oxygen
97541-7,Oxygen^^adjusted to patient's actual temperature
97542-5,Oxygen content
Mar-54,Coxsackievirus A4 Ab
97543-3,Bicarbonate
97544-1,Bicarbonate^^standard
97545-8,Carbon dioxide
97546-6,Base excess
97547-4,Base excess^^standard
97548-2,Base deficit
97549-0,Oxygen saturation
9755-0,Coxsackievirus A7 Ab
97550-8,Hemoglobin
97551-6,Carboxyhemoglobin/Hemoglobin.total
97552-4,Oxyhemoglobin/Hemoglobin.total
97553-2,Deoxyhemoglobin/Hemoglobin.total
97554-0,Methemoglobin/Hemoglobin.total
97555-7,Hemoglobin
97556-5,Hemoglobin
97557-3,Gastrointestinal dysmotility autoimmune Ab panel
97558-1,Acetylcholine receptor binding Ab.IgG+IgM
97559-9,Acetylcholine receptor ganglionic neuronal Ab.IgG+IgM
97560-7,Voltage-gated potassium channel Ab.IgG+IgM
97561-5,Necrotizing myopathy autoimmune Ab panel
97562-3,Signal recognition particle Ab.IgG
97563-1,Signal recognition particle Ab.IgG
97564-9,Nuclear antibody panel
97565-6,B-cell primary immunodeficiency multigene analysis
97566-4,Myasthenia gravis & Lambert-Eaton syndrome autoimmune Ab panel
Aug-56,Coxsackievirus A7 Ab
97568-0,Owner of animal patient was exposed to
97569-8,Note
97570-6,Progress note
97571-4,Progress note
97572-2,Progress note
97573-0,Mechanical circulatory support+progress note
97574-8,Progress note
97575-5,Progress note
Jun-57,Coxsackievirus A9 Ab
97576-3,Progress note
97577-1,Progress note
97578-9,Progress note
97579-7,Progress note
97580-5,Progress note
97582-1,Buprenorphine.free
97583-9,Buprenorphine.free
Apr-58,Coxsackievirus A9 Ab
97584-7,Carboxy tetrahydrocannabinol
97585-4,Carboxy tetrahydrocannabinol
97586-2,Tetrahydrocannabinol
97587-0,Tetrahydrocannabinol
97588-8,Dextromethorphan+Levomethorphan
97589-6,Dextromethorphan+Levomethorphan
97590-4,Norbuprenorphine.free
97591-2,Norbuprenorphine.free
Feb-59,Coxsackievirus B1 Ab
97592-0,Predicted response to cancer treatment
97593-8,Lymphocyte T-cell & B-cell & Natural killer subsets panel
97594-6,Cells.CD3/100 lymphocytes
97595-3,Cells.CD3+CD4+/100 lymphocytes
97596-1,Cells.CD3+CD8+/100 lymphocytes
97597-9,Cells.CD19/100 lymphocytes
97598-7,Cells.CD3-CD16+CD56+/100 lymphocytes
97599-5,Cells.CD3+CD4+/Cells.CD3+CD8+
Jun-97,Cefonicid
9760-0,Coxsackievirus B2 Ab
97600-1,Cells.CD45
97601-9,Microorganism of interest sequence
97602-7,Glial fibrillary acidic protein & Ubiquitin carboxyl-terminal hydrolase-L1 panel
97603-5,Glial fibrillary acidic protein+Ubiquitin carboxyl-terminal hydrolase-L1
97604-3,Glial fibrillary acidic protein
97605-0,Ubiquitin carboxyl-terminal hydrolase-L1
97606-8,Phosphatidylethanol 16:0-18:2
97607-6,Phosphatidylethanol 16:0-18:1
97608-4,Joint pathogens panel
97609-2,Anaerococcus prevotii+vaginalis DNA
976-1,D Ag
97610-0,Bacteroides fragilis DNA
97611-8,Candida albicans DNA
97612-6,Candida sp DNA
97613-4,Citrobacter sp DNA
97614-2,Clostridium perfringens
97615-9,Cutibacterium avidum+granulosum DNA
97616-7,Enterobacter cloacae complex DNA
97617-5,Enterococcus faecalis DNA
Aug-61,Coxsackievirus B3 Ab
97618-3,Enterococcus faecium DNA
97619-1,Escherichia coli DNA
97620-9,Finegoldia magna DNA
97621-7,Haemophilus influenzae DNA
97622-5,Kingella kingae DNA
97623-3,Klebsiella aerogenes DNA
97624-1,Klebsiella pneumoniae+Klebsiella variicola+Klebsiella quasipneumoniae DNA
97625-8,Morganella morganii DNA
Jun-62,Coxsackievirus B4 Ab
97626-6,Neisseria gonorrhoeae DNA
97627-4,Parvimonas micra DNA
97628-2,Peptoniphilus sp DNA
97629-0,Peptostreptococcus anaerobius DNA
97630-8,Proteus sp DNA
97631-6,Pseudomonas aeruginosa DNA
97632-4,Salmonella sp DNA
97633-2,Serratia marcescens DNA
Apr-63,Coxsackievirus B5 Ab
97634-0,Staphylococcus aureus DNA
97635-7,Staphylococcus lugdunensis DNA
97636-5,Streptococcus agalactiae DNA
97637-3,Streptococcus pneumoniae DNA
97638-1,Streptococcus pyogenes DNA
97639-9,Streptococcus sp DNA
97640-7,Thyroglobulin
97641-5,Coagulation dilute Russell viper venom induced/Coagulation dilute Russell viper venom induced.excess phospholipid^post DOAC neutralization^normalized
Feb-64,Coxsackievirus B6 Ab
97642-3,Coagulation dilute Russell viper venom induced/Coagulation dilute Russell viper venom induced.excess phospholipid^^normalized
97643-1,Barmah forest virus Ab.IgG
97644-9,Barmah forest virus Ab.IgM
97645-6,Parainfluenza virus 1+2+3+4 RNA
97646-4,Lassa virus RNA
97647-2,Asenapine
97648-0,Iloperidone
97649-8,2-Amino-5-chloropyridine
97650-6,Desmethylcyclobenzaprine
97651-4,Pigeon serum Ab.IgG
97652-2,(Alternaria alternata+Cladosporium herbarum+Mucor racemosus+Penicillium notatum) Ab.IgG
97653-0,Vespa velutina Ab.IgE
97654-8,SMN2 gene copy number
97655-5,Hereditary breast & gynecologic cancer multigene analysis
97656-3,Hereditary cancer multigene analysis
97657-1,Vancomycin^2H post dose
97658-9,"2,3-dinor 11 beta-Prostaglandin F2 alpha/Creatinine"
Sep-65,Lymphocytic choriomeningitis virus Ab.IgG
97659-7,Admission history and physical note
97660-5,Evaluation note
97661-3,Checklist
97662-1,Discharge instructions
97663-9,Discharge summary note
97664-7,Discharge teaching note
97665-4,Education note
97666-2,History and physical note
Jul-66,Lymphocytic choriomeningitis virus Ab.IgG
97667-0,Initial evaluation note
97668-8,Procedure note
97669-6,Progress note
97670-4,Transfer summary note
97671-2,Triage note
97672-0,History and physical note
97673-8,History and physical note
97674-6,History and physical note
May-67,Lymphocytic choriomeningitis virus Ab.IgM
97675-3,History and physical note
97676-1,History and physical note
97677-9,History and physical note
97678-7,History and physical note
97679-5,History and physical note
97680-3,History and physical note
97681-1,History and physical note
97682-9,History and physical note
Mar-68,Lymphocytic choriomeningitis virus Ab.IgM
97683-7,History and physical note
97684-5,History and physical note
97685-2,History and physical note
97686-0,History and physical note
97687-8,Evaluation note
97688-6,Evaluation note
97689-4,Evaluation note
97690-2,Discharge summary note
Jan-69,Thermoactinomyces candidus Ab
97691-0,Progress note
97692-8,Procedure note
97693-6,Surgical operation note
97694-4,Evaluation note
97695-1,Evaluation note
97696-9,Evaluation note
97697-7,Evaluation note
97698-5,Evaluation note
97699-3,Evaluation note
97700-9,Discharge summary note
97701-7,Discharge summary note
97702-5,Discharge summary note
97703-3,Discharge summary note
97704-1,Discharge summary note
97705-8,Surgical operation note
97706-6,Procedure note
97707-4,Procedure note
97708-2,Evaluation note
Sep-70,Thermoactinomyces sacchari Ab
97709-0,Letter
97710-8,Conference note
97711-6,Note
97712-4,Procedure note
97713-2,Evaluation note
97714-0,Discharge summary note
97715-7,History and physical note
97716-5,Procedure note
Jul-71,Cells.CD5+CD20+
97717-3,Surgical operation note
97718-1,Evaluation note
97719-9,Discharge summary note
97720-7,History and physical note
97721-5,Surgical operation note
97722-3,Evaluation note
97723-1,History and physical note
97724-9,Evaluation note
May-72,Xylose^1H post 25 g xylose PO
97725-6,Discharge summary note
97726-4,History and physical note
97727-2,Procedure note
97728-0,History and physical note
97729-8,History and physical note
97730-6,History and physical note
97731-4,Stroke prevention note
97732-2,Enterovirus VP1 gene
Mar-73,Ergotamine
97733-0,Influenza virus types A & B & subtypes RNA panel
97734-8,Inability to stop drinking once started
97735-5,Failed expectations due to drinking
97736-3,Drink needed in morning to begin activities after drinking session
97737-1,Guilt or remorse after drinking
97738-9,Inability to recall events from night before due to drinking
97739-7,Injury to you or someone else resulting from drinking
97740-5,Has anyone expressed concern about your drinking or suggested you cut down
Jan-74,Metoclopramide
97741-3,Estradiol
97742-1,Estradiol
97743-9,Cancer Ag 125
97744-7,Enolase.neuron specific
97745-4,Alpha-1-Fetoprotein
97746-2,Alpha-1-Fetoprotein
97747-0,Carcinoembryonic Ag
97748-8,Cytokeratin 19
97749-6,Cancer Ag 15-3
97750-4,Cancer Ag 19-9
97751-2,Amiodarone+Desethylamiodarone
97752-0,Herpes virus 6 DNA
97753-8,Ammonia
97754-6,Oxalate
97755-3,Oxalate
97756-1,Androstenedione
97757-9,Androstenedione
Aug-75,Moricizine
97758-7,Fungus & Mycobacterium sp identified
97759-5,Magnesium & phosphate & lactate panel
97760-3,MLH1 gene methylation analysis
97761-1,MLH1 gene methylation analysis
97762-9,Parathyrin.intact
97763-7,Beta 2 globulin/Protein.total
97764-5,Beta 1 globulin/Protein.total
97765-2,Cortisol^post dose dexamethasone PO overnight
Jun-76,Norchlordiazepoxide
97766-0,IgG subclass 2
97767-8,IgG subclass 4
97768-6,Artifact
97769-4,Erythrocytes.nucleated
97770-2,Bilirubin
97771-0,Protein.monoclonal band 1
97772-8,Protein.monoclonal band 1
97773-6,Base excess^^standard
Apr-77,Nalbuphine
97774-4,Base excess^^standard
97775-1,Base excess^^standard
97776-9,Urea^1H specimen
97777-7,Creatinine^1H specimen
97778-5,Glucose^1H specimen
97779-3,Sodium^1H specimen
97780-1,Sodium^2H specimen
97781-9,Sodium^4H specimen
Feb-78,Phenelzine
97782-7,Spine Tango Surgery 2017
97783-5,Admission or pathology panel
97784-3,Specification of main pathology panel
97785-0,Spine degeneration.primary
97786-8,Spine degeneration.secondary
97787-6,Spine deformity
97788-4,Primary etiology of spine deformity
97789-2,Fracture or trauma
977-9,D Ag
9779-0,quiNIDine.free
97790-0,Dens fracture
97791-8,C3-L5 or S1 AO fracture
97792-6,AO neurologic injury
97793-4,AO modifiers
97794-2,Cause of pathological spine fracture
97795-9,Fracture age
97796-7,Osteoporotic vertebral fractures classification
97797-5,Spondylolisthesis
97798-3,Spondylolisthesis grade
97799-1,Spine infection
97800-7,Structure affected by spine infection
97801-5,Spine tumor
97802-3,Spine tumor localization
97803-1,Reason for repeat spine surgery
97804-9,Most severely affected spine segment or vertebral body
97805-6,Extent of spine segment or vertebral body lesion
97806-4,Additional spine pathology
97807-2,Number of previous spine surgeries at same or adjacent level
Aug-80,Spermatozoa
97808-0,Number of previous spine surgeries at other level
97809-8,Surgery panel
97810-6,Surgeon
97811-4,Surgery assistant
97812-2,Therapeutic goals of spine surgery
97813-0,Implant component
97814-8,Anterior surgical access
97815-5,Posterior surgical access
Jun-81,Acanthamoeba sp identified
97816-3,American society of anesthesiologists morbidity state
97817-1,Surgical technology used
97818-9,Blood product volume &or cell saver
97819-7,Surgical measures panel
97820-5,Spine decompression
97821-3,Level of spine decompression
97822-1,Spine fusion
97823-9,Level of spine fusion
Apr-82,Adenovirus sp identified
97824-7,Spine fusion material
97825-4,Rigid spine stabilization
97826-2,Level of rigid spine stabilization
97827-0,Spine deformity correction
97828-8,Level of deformity correction
97829-6,Motion preserving spine stablization
97830-4,Level of motion preserving spine stablization
97831-2,Spine surgery measures
Feb-83,Ehrlichia chaffeensis Ab.IgG
97832-0,Level of spine surgery measures
97833-8,Surgical complication^during surgery
97834-6,Measures used during spine surgery
97835-3,Medical complication^during surgery
97836-1,Hospital stay panel
97837-9,Postoperative surgical complication before discharge
97838-7,Postoperative medical complication before discharge
97839-5,Additional procedure after spine surgery
9784-0,Ehrlichia chaffeensis Ab.IgM
97840-3,Hospital stay description
97841-1,Status of surgical &or medical complication at discharge
97842-9,Achievement of therapeutic goals by discharge
97843-7,ASIA impairment scale
97844-5,Blood pressure panel
97845-2,Name panel
97846-0,Name use
97847-8,Last name
97848-6,First name
97849-4,Name prefix
97850-2,Name suffix
97851-0,Subject
97852-8,COVID-19 clinical status
97853-6,Anticomplementary activity
97854-4,Paracoccidioides sp Ab
97855-1,Blastomyces sp Ab
97856-9,Histoplasma capsulatum yeast phase Ab
Jul-85,Microscopic observation
97857-7,Histoplasma capsulatum mycelial phase Ab
97858-5,Coccidioides sp Ab
97859-3,Fungal Ab panel
97860-1,HIV 1 Ab panel
97861-9,HIV 2 Ab panel
97862-7,Herpes virus 8 Ab.IgG & IgM panel
97863-5,Herpes virus 8 Ab.IgM
97864-3,Parainfluenza virus 1 & 2 & 3 Ab panel
May-86,Microscopic observation
97865-0,Chikungunya virus Ab.IgM & IgG panel
97866-8,Chikungunya virus Ab.IgG
97867-6,Chikungunya virus Ab.IgM
97868-4,Yellow fever virus Ab panel
97869-2,Zika virus Ab panel
978-7,D Ag
97870-0,Zika virus Ab.IgG
97871-8,Hantavirus Ab.IgG & IgM panel
97872-6,Rabies virus Ab panel
Mar-87,Sarcoptes scabiei identified
97873-4,Herpes virus 8 Ab.IgM
97874-2,Stay Independent panel
97875-9,Use or advised to use cane or walker for safety
97876-7,Sometimes feel unsteady when walking
97877-5,Use furniture to steady when walking
97878-3,Worried about falling
97879-1,Push with hands to stand up from chair
97880-9,Trouble stepping up onto curb
Jan-88,Streptolysin O Ab
97881-7,Often rush to toilet
97882-5,Loss of feeling in feet
97883-3,Medication causes light-headedness or fatigue
97884-1,Taking medicine for sleep or mood
97885-8,Stay Independent total score
97886-6,Core Outcome Measures Index for the Neck score
97887-4,Core Outcome Measures Index for the Back
97888-2,Which of the following problems related to your back condition troubles you the most
97889-0,Core Outcome Measures Index for the Back score
97890-8,Sleep Panel
97891-6,Sleep total score
97892-4,Go to sleep at the same time
97893-2,Wake up at the same time
97894-0,Wake up feeling refreshed
97895-7,Sleep well
97896-5,Self-care panel
97897-3,Self-care total score
97898-1,Manage diet well
Sep-89,Carbamate pesticides
97899-9,Manage physical activity well
97900-5,Manage weight well
97901-3,Manage medication well
97902-1,Fatigue panel
97903-9,Fatigue total score
97904-7,Usually have enough energy
97905-4,Do not tire too quickly
97906-2,Usually concentrate well
Jul-90,Methyl bromide
97907-0,Can keep going if needed
97908-8,Oswestry Disability Index
97909-6,Oswestry disability index score
97910-4,Endogenous thrombin potential
97911-2,Endogenous thrombin potential^after addition of Factor VIII Ab
97912-0,Thrombin peak
97913-8,Thrombin peak^after addition of Factor VIII Ab
97914-6,Time to thrombin peak
May-91,Organochlorine pesticides
97915-3,Thrombin generation test panel
97916-1,Coccidioides sp DNA
97917-9,Oropouche virus RNA
97918-7,Rift valley fever virus RNA
97919-5,Bwamba virus RNA
97920-3,Tick-borne encephalitis virus RNA
97921-1,Bunyamwera virus RNA
97922-9,California encephalitis virus RNA
Mar-92,Organophosphate pesticides
97923-7,Sandfly fever Naples virus RNA
97924-5,Jamestown canyon virus RNA
97925-2,Barmah forest virus RNA
97926-0,Snowshoe hare virus RNA
97927-8,Tahyna virus RNA
97928-6,Highlands J virus RNA
97929-4,Ross River virus RNA
97930-2,Sindbis virus RNA
Jan-93,Trichloroethylene
97931-0,Mayaro virus RNA
97932-8,Colorado tick fever virus RNA
97933-6,Sandfly fever Sicilian virus RNA
97934-4,Toscana virus RNA
97935-1,Bourbon virus RNA
97936-9,Candida auris DNA
97937-7,Thermotolerance
97938-5,Color.reverse pigment
97939-3,Medium induced in vitro yeast conversion
97940-1,Cryptococcus sp
97941-9,Cycloheximide
97942-7,Texture.yeast colony
97943-5,Color.yeast colony
97944-3,Color.yeast colony^with canavanine glycine+bromothymol blue
97945-0,Color.mold colony
97946-8,Color.fungal colony^with Chromogenic agar
97947-6,Rocio virus RNA
97948-4,Ilheus virus RNA
Sep-94,Cathepsin D
97949-2,Semliki Forest virus RNA
979-5,D little i super little a Ab
97950-0,Onyong-nyong virus RNA
97951-8,Venezuelan equine encephalitis virus RNA
97952-6,Glomerular filtration rate/Body surface area
97953-4,Risk level of developing disease after exposure
97954-2,Rhinovirus+Enterovirus A+B+C RNA
97955-9,Vespa crabro Ab.IgG4
Jun-95,Composition
97956-7,Lysozyme Ab.IgG4
97957-5,Anisakis Ab.IgG4
97958-3,Platanus acerifolia Ab.IgG4
97959-1,Betula verrucosa recombinant (rBet v) 1 Ab.IgG4
97960-9,Olea europaea native (nOle e) 1 Ab.IgG4
97961-7,Fraxinus excelsior Ab.IgG4
97962-5,Alnus incana Ab.IgG4
97963-3,Betula verrucosa Ab.IgG4
Apr-96,Color
97964-1,Parietaria judaica Ab.IgG4
97965-8,Dermatophagoides pteronyssinus recombinant (rDer p) 1 Ab.IgG4
97966-6,Dermatophagoides pteronyssinus recombinant (rDer p) 2 Ab.IgG4
97967-4,Chicken droppings Ab.IgG4
97968-2,Ovalbumin Ab.IgG4
97969-0,Ovomucoid Ab.IgG4
97970-8,Turkey meat Ab.IgG4
97971-6,Conalbumin Ab.IgG4
Feb-97,Consistency
97972-4,Arachis hypogaea recombinant (rAra h) 8 Ab.IgG4
97973-2,Arachis hypogaea recombinant (rAra h) 1 Ab.IgG4
97974-0,Arachis hypogaea recombinant (rAra h) 2 Ab.IgG4
97975-7,Arachis hypogaea recombinant (rAra h) 3 Ab.IgG4
97976-5,Gadus morhua recombinant (rGad c) 1 Ab.IgG4
97977-3,Arachis hypogaea recombinant (rAra h) 9 Ab.IgG4
97978-1,Malus domestica recombinant (rMal d) 1 Ab.IgG4
97979-9,Malus domestica recombinant (rMal d) 3 Ab.IgG4
9798-0,Depth
97980-7,Corylus avellana recombinant (rCor a) 14 Ab.IgG4
97981-5,Corylus avellana recombinant (rCor a) 9 Ab.IgG4
97982-3,Zea mays pollen Ab.IgG4
97983-1,Phleum pratense recombinant (rPhl p) 1 Ab.IgG4
97984-9,Phleum pratense recombinant (rPhl p) 1+5b Ab.IgG4
97985-6,Apis mellifera phospholipase A2 recombinant (rApi m) 1 Ab.IgG4
97986-4,Vespula vulgaris recombinant (rVes v) 5 Ab.IgG4
97987-2,Apis mellifera recombinant (rApi m) 10 Ab.IgG4
97988-0,Chicken meat Ab.IgG4
97989-8,Culex pipiens Ab.IgG4
97990-6,von Willebrand factor cleaving protease actual/normal
97991-4,Herpes virus 6 Ab.IgG
97992-2,Herpes virus 6 Ab.IgM
97993-0,Epstein Barr virus early Ab.IgM
97994-8,Platelets.large/Platelets
97995-5,Platelets
97996-3,Myeloperoxidase Ab.IgG
97997-1,HPA & HLA Ab
Aug-99,Length
97998-9,HPA Ab
97999-7,HLA-DP & DQ & DR (class II) Ab.IgG donor specific
98000-3,HLA-A & B & C (class I) & HLA-DP & DQ & DR (class II)
98001-1,HLA-DP & DQ & DR (class II)
98002-9,HLA-A & B & C (class I)
98003-7,HLA-A & B & C (class I) Ab.IgG donor specific
Apr-00,Number
98004-5,HLA-A & B & C (class I) & HLA-DP & DQ & DR (class II)
98005-2,HLA-A & B & C (class I) & HLA-DP & DQ & DR (class II)
98006-0,HLA-A & B & C (class I) & HLA-DP & DQ & DR (class II) Ab
98007-8,B cell+T cell crossmatch
98008-6,Neonatal infant pain scale panel
98009-4,Pain &or agitation severity.breathing pattern
98010-2,Pain &or agitation severity.arm rigidity
98011-0,Pain &or agitation severity.leg rigidity
Feb-01,Shape
98012-8,Total score
98013-6,Neonatal infant pain scale interpretation
98014-4,Plasma cell proliferation analysis
98015-1,Triiodothyronine^1st specimen post XXX challenge
98016-9,Fat
98017-7,Megakaryocytes
98018-5,Megakaryoblasts/100 cells
98019-3,Promegakaryocytes/100 cells
9802-0,Size
98020-1,Leukocytes
98021-9,Rivalta test
98022-7,Lymphocytes.abnormal
98023-5,Epithelial cells
98024-3,Lecithin
98025-0,Fungus
98026-8,Parasite identified
98027-6,Lecithin
98028-4,Crystals
98029-2,Crystals
980-3,D little i super little a Ab
98030-0,Natural killer cell cytotoxicity.IL-2 stimulated panel
98031-8,Body weight discordance
98032-6,Body weight.current fetus/Body weight.heaviest fetus
98033-4,Multisection^W radionuclide IV
98034-2,Views limited
98035-9,Multisection
98036-7,Views for therapy^W Tc-99m SC IV
98037-5,Jewish descent preconception &or prenatal carrier screening multigene analysis
Aug-03,Texture
98038-3,CFTR gene & FMR1 gene CGG repeat & SMN1 gene mutation analysis
98039-1,Preconception &or prenatal carrier screening multigene analysis
98040-9,Urothelial carcinoma recurrence score
98041-7,Cortisone Ab.IgE
98042-5,Cantharellus cibarius Ab.IgE
98043-3,5-Aminosalicylate Ab.IgE
98044-1,Benzoate Ab.IgE
98045-8,Linum usitatissimum seed Ab.IgE
Jun-04,Weight
98046-6,Lincomycin Ab.IgE
98047-4,Lipoxygenase Ab.IgE
98048-2,Levothyroxine Ab.IgE
98050-8,European roe venison Ab.IgE
98051-6,Microsporum canis Ab.IgE
98052-4,Minocycline Ab.IgE
Mar-05,Width
98053-2,Eriobotrya japonica Ab.IgE
98054-0,Mouse droppings Ab.IgE
98055-7,Nystatin Ab.IgE
98056-5,Oxacillin Ab.IgE
98057-3,Penicillium digitatum Ab.IgE
98058-1,Penicillium expansum Ab.IgE
98059-9,Sparus aurata Ab.IgE
98060-7,Penicillamine Ab.IgE
Jan-06,"2,4-Dichlorophenoxyacetate"
98061-5,Allium ursinum Ab.IgE
98062-3,Sequencing study identifier
98063-1,Bacterial beta-lactam resistance ESBL blaCTX-M-15 gene
98064-9,Bacterial beta-lactam resistance ESBL blaCTX-M-14 gene
98065-6,Bacterial carbapenem resistance blaOXA-143 gene
98066-4,Bacterial colistin resistance mcr-3+mcr-4+mcr-5 genes
98067-2,Patient-centered disability questionnaire
98068-0,Difficulty communicating in usual language
98069-8,SARS coronavirus 2 Ab
98070-6,Medical Research Council breathlessness scale grade
98071-4,Post COVID-19 functional status scale
98072-2,Post COVID-19 functional status grade
98073-0,Natural killer & natural killer T cell subsets panel
98074-8,Multisection^W contrast
98075-5,"Animal cells, tissues, and cell and tissue based product label"
98076-3,Do you want to talk about contraception or pregnancy prevention during your visit today
98077-1,Whether the patient previously met the case definition for condition of interest
98078-9,Difficulty reading or writing
Sep-07,Chlordane
98079-7,Do you need any additional assistance or accommodations during your visit
98080-5,SARS coronavirus 2 & SARS-related coronavirus RNA panel
98081-3,Cytomegalovirus DNA
98082-1,Specific resistance.airway^pre bronchodilation
98083-9,Specific resistance.airway^post bronchodilation
98084-7,Specific effective resistance.airway
98085-4,Specific effective resistance.airway^pre bronchodilation
98086-2,Specific effective resistance.airway^post bronchodilation
Jul-08,Phenothiazines
98087-0,Specific effective resistance.airway/predicted
98088-8,Vital capacity/Vital capacity.predicted
98089-6,Capacity.inspiratory^pre bronchodilation
98090-4,Capacity.inspiratory^post bronchodilation
98091-2,Diffusion capacity.carbon monoxide^pre bronchodilation
98092-0,Diffusion capacity.carbon monoxide^post bronchodilation
98093-8,Rowland Universal Dementia Assessment Scale
98094-6,Total score
May-09,Propoxyphene
98095-3,Cells.FOXP3 Ag/100 cells
98096-1,Interleukin 33
98097-9,Thymic stromal lymphopoietin
98098-7,Interleukin 17F
98099-5,Interleukin 21
98100-1,Interleukin 22
98101-9,Interleukin 23
98102-7,Chemokine (C-X-C motif) ligand 10
Mar-10,quiNINE
98103-5,Interleukin 9
98104-3,Interleukin 15
98105-0,Interleukin 16
98106-8,Brain-derived neurotrophic factor
98107-6,Macrophage colony-stimulating factor
98108-4,Chemokine (C-C motif) ligand 11
98109-2,Chemokine (C-C motif) ligand 8
981-1,D little i super little a Ab
98110-0,Chemokine (C-C motif) ligand 7
Jan-11,Chromogranin A
98111-8,Chemokine (C-C motif) ligand 4
98112-6,Chemokine (C-C motif) ligand 20
98113-4,Chemokine (C-C motif) ligand 5
98114-2,Chemokine (C-X3-C motif) ligand 1
98115-9,Chemokine (C-X-C motif) ligand 9
98116-7,Chemokine (C-C motif) ligand 27
98117-5,Fibroblast growth factor 2
98118-3,Vascular endothelial growth factor C
98119-1,Angiopoietin 2 receptor
98120-9,Intercellular adhesion molecule 1
98121-7,Protein/Creatinine
98122-5,Neutrophil.fMLP & PMA stimulated DHR panel
98123-3,Neutrophil.fMLP stimulated DHR panel
98124-1,Neutrophil.PMA stimulated DHR panel
98125-8,Intravascular coagulation and fibrinolysis panel
98126-6,Zimnitsky urine concentration panel
98127-4,Normoblasts.oxyphilic+polychromatophilic/Normoblasts.total
98128-2,Neutrophils.immature/Neutrophils.segmented
Sep-12,Cortisol^PM trough specimen
98129-0,Thymol turbidity test
98130-8,Diffusion capacity.carbon monoxide/predicted
98131-6,SARS coronavirus 2 ORF1b region
98132-4,SARS coronavirus 2 ORF1a region
98133-2,Osteoporosis Index of Risk panel
98134-0,Estrogen use
98135-7,Low impact fracture
98136-5,Total score
Jul-13,Cortisol^AM peak specimen
98137-3,Pain assessment report
98138-1,Amyloid plaques probability score
98139-9,Osteoporosis Risk Assessment Instrument
98140-7,Total score
98141-5,Admission notification note
98142-3,Discharge notification note
98143-1,Arrival notification note
98144-9,Departure notification note
May-14,Dextroamphetamine
98145-6,Visit notification note
98146-4,Osteoporosis Self-Assessment Tool
98147-2,Total score
98148-0,Oxygen saturation
98149-8,Body temperature
98150-6,Encephalopathy grade
98151-4,Degree of ascites
Feb-15,Lithium
98152-2,Total score
98153-0,Child-Pugh panel
98154-8,SARS-CoV-2-related socioeconomic questionnaire for adults
98155-5,Number of children under the age of 14 living in household
98156-3,Routine doctor's visits &or check-ups cancelled since the beginning of the pandemic
98157-1,Routine doctor's visits &or check-ups postponed since the beginning of the pandemic
98158-9,Problems accessing medication since the beginning of the pandemic
98159-7,Treatment sessions postponed by doctor or patient since the beginning of the pandemic
9816-0,Actinomyces sp identified
98160-5,Treatment sessions cancelled by doctor or patient since the beginning of the pandemic
98161-3,Monthly household net income
98162-1,Financial problems since the beginning of the pandemic
98163-9,Received any financial or material aid since the beginning of the pandemic
98164-7,How often have you recently looked for information on COVID-19
98165-4,What do you think is your current risk of infection or re-infection
98166-2,"What do you think is your current risk that, in case of infection or re-infection, you will experience severe complications or even death"
98167-0,How often do you wash your hands with hand-soap or hydro-alcoholic solutions
98168-8,How often do you keep a distance of at least 2 meters from others
98169-6,Stay at home to avoid social contact
98170-4,Wear face mask in public
98171-2,Has been offered COVID-19 vaccine
98172-0,Accepted or will accept COVID-19 vaccination once offered
98173-8,Reasons for not accepting COVID-19 vaccine
98174-6,Routine doctor's visits &or check-ups cancelled in the last 12Mo
98175-3,Routine doctor's visits &or check-ups postponed in the last 12Mo
98176-1,Problems accessing medication in last 12Mo
98177-9,Treatment sessions postponed by doctor or patient in the last 12Mo
Aug-17,Cryptococcus sp Ag
98178-7,Treatment sessions cancelled by doctor or patient in the last 12Mo
98179-5,Financial problems in last 12 Mo
98180-3,Received any financial or material aid in last 12 Mo
98181-1,Medical equipment used
98182-9,Thyroxine.free
98183-7,Wild boar dander Ab.IgE
98184-5,Acetylcysteine Ab.IgE
98185-2,Ambroxol Ab.IgE
Jun-18,Cryptococcus sp Ag
98186-0,Aspartame Ab.IgE
98187-8,Aspergillus repens Ab.IgE
98188-6,Bacampicillin Ab.IgE
98189-4,Benzocaine Ab.IgE
98190-2,Bromhexine Ab.IgE
98191-0,Azlocillin Ab.IgE
98192-8,Cephalothin Ab.IgE
98193-6,Begonia semperflorens Ab.IgE
Apr-19,Cryptococcus sp Ag
98194-4,Hibiscus tea Ab.IgE
98195-1,Diatrizoate Ab.IgE
98196-9,Echinacea Ab.IgE
98197-7,EPINEPHrine Ab.IgE
98198-5,Erythrosine B Ab.IgE
98199-3,Phenacetin Ab.IgE
98200-9,Paraphenylenediamine Ab.IgE
98201-7,Fuchsia spp Ab.IgE
Feb-20,Cryptococcus sp Ag
98202-5,Ginkgo Ab.IgE
98203-3,(Diffusion capacity/Alveolar volume)/predicted
98204-1,Borrelia burgdorferi Ab.IgG & IgM bands panel
98205-8,Borrelia burgdorferi Ab.IgG & IgM & total panel
98206-6,Borrelia burgdorferi 21kD Ab.IgG
98207-4,Borrelia burgdorferi Ab.IgG & IgM panel
98208-2,Borrelia burgdorferi Ab.IgM
98209-0,Legionella pneumophila Ab.IgG & IgM panel
9821-0,HIV 1 p24 Ag
98210-8,Legionella pneumophila Ab.IgM
98211-6,Salmonella spp Ab panel
98212-4,Reagin Ab & Treponema pallidum Ab.IgG & IgM & total panel
98213-2,Treponema pallidum Ab.IgG & IgM & bands panel
98214-0,Reagin Ab & Treponema pallidum Ab.IgG & IgM & total panel
98215-7,Treponema pallidum Ab
98216-5,Treponema pallidum Ab
98217-3,Treponema pallidum Ab.IgG
98218-1,Treponema pallidum Ab.IgM
98219-9,Treponema pallidum Ab.IgG & IgM & bands panel
98220-7,Treponema pallidum Ab.IgG
98221-5,Treponema pallidum Ab.IgG bands
98222-3,Treponema pallidum Ab.IgG bands
98223-1,Treponema pallidum Ab.IgM bands
98224-9,Treponema pallidum Ab.IgM bands
98225-6,Piperacillin Ab.IgE
98226-4,Prednisolone Ab.IgE
98227-2,Prilocaine Ab.IgE
Aug-22,Bacteria identified
98228-0,Procaine Ab.IgE
98229-8,Ofloxacin Ab.IgE
98230-6,Zea mays starch Ab.IgE
98231-4,Sorbic acid Ab.IgE
98232-2,Hypericum perforatum Ab.IgE
98233-0,Physalis peruviana Ab.IgE
98234-8,Quail meat Ab.IgE
98235-5,Wild boar meat Ab.IgE
Jun-23,Mycobacterium sp identified
98236-3,Norfloxacin Ab.IgE
98237-1,Chemokine (C-X-C motif) ligand 1
98238-9,Platelet-derived growth factor B+BB
98239-7,CD154 expression & function panel
98240-5,Cells.CD154
98241-3,CD154 function (binding to CD40)
98242-1,Spermatozoa.motile^post ejaculation
98243-9,Spermatozoa^post ejaculation
Apr-24,Mycobacterium sp identified
98244-7,Spermatozoa.motile/100 spermatozoa^post ejaculation
98245-4,Spermatozoa motility^post ejaculation
98246-2,Spermatozoa.motile^post ejaculation
98247-0,Spermatozoa.agglutinated^post ejaculation
98248-8,Primary or recurrent or distant metastasis
98249-6,Cancer pathology panel
98250-4,Neuroendocrine tumor
Jan-25,Mycobacterium sp identified
98251-2,Stage
98252-0,Histologic grade
98253-8,Myometrial invasion
98254-6,Depth of myometrial invasion
98255-3,Depth of myometrial invasion/Myometrial thickness
98256-1,Extent of myometrial invasion
98257-9,Microcystic elongated and fragmented invasion pattern
98258-7,Distance of myoinvasive tumor from serosa
98259-5,Vessels involved in lymphovascular invasion
98260-3,Lymphovascular invasion extent
98261-1,Stromal invasion
98262-9,Distance of tumor from cervical resection margins
98263-7,Vaginal involvement
98264-5,Omental involvement
98265-2,Involvement of peritoneal biopsy specimen
98266-0,Uterine serosa involvement
98267-8,Parametrial involvement
98268-6,Adnexal involvement
Sep-26,Treponema pallidum Ab
98269-4,Site of adnexal involvement
98270-2,Background endometrium findings
98271-0,Cyclic hormonal phase of endometrium
98272-8,Left pelvic lymph nodes examined
98273-6,Left pelvic lymph nodes positive
98274-4,Right pelvic lymph nodes examined
98275-1,Right pelvic lymph nodes positive
98276-9,Para-aortic lymph nodes examined
Jul-27,Paraquat
98277-7,Para-aortic lymph nodes positive
98278-5,Protocol used for examination of sentinel lymph nodes
98279-3,DNA mismatch repair
98280-1,Optimal tissue block
98281-9,Structured reporting protocol used
98282-7,Views
98283-5,Views
98284-3,Guidance for myelography
May-28,House dust Greer Ab.IgE
98285-0,Guidance for myelography
98286-8,Multisection
98287-6,Multisection
98288-4,Multisection
98289-2,Multisection
982-9,D little i super little a Ag
98290-0,Multisection
98291-8,Multisection
98292-6,Multisection
Mar-29,Beta globulin
98293-4,Multisection
98294-2,Views lateral^W manual stress
98295-9,Views lateral^W manual stress
98296-7,Views lateral^W manual stress
98297-5,Views
98298-3,Views
98299-1,View Mortise^W gravity stress
98300-7,Views LE 3 Broden
Jan-30,Cholesterol.total/Cholesterol.in HDL
98301-5,View AP^W varus stress
98302-3,View AP^W valgus stress
98303-1,View lateral
98304-9,View Canale
98305-6,Views
98306-4,Views
98307-2,View Mortise^W gravity stress
98308-0,Views LE 3 Broden
98309-8,View AP^W valgus stress
98310-6,View AP^W varus stress
98311-4,View lateral
98312-2,View Canale
98313-0,Views
98314-8,Views
98315-5,View lateral
98316-3,View^W valgus stress
98317-1,View AP^W varus stress
98318-9,View Mortise^W gravity stress
Sep-31,Gamma globulin
98319-7,Views LE 3 Broden
98320-5,View lateral
98321-3,View lateral
98322-1,View lateral
98323-9,View lateral
98324-7,Views AP
98325-4,Views lateral
98326-2,Views PA for scoliosis^W standing
Jul-32,Cholesterol.in HDL 2
98327-0,Views AP for scoliosis^W standing
98328-8,View lateral
98329-6,View AP
98330-4,Views PA
98331-2,Views oblique
98332-0,View reverse oblique
98333-8,View
98334-6,View
May-33,Cholesterol.in HDL 3
98335-3,View
98336-1,View AP
98337-9,View lateral
98338-7,View lateral
98339-5,View AP
98340-3,View reverse oblique
98341-1,View
98342-9,View
Mar-34,HYDROmorphone
98343-7,View
98344-5,View AP
98345-2,View lateral
98346-0,Views
98347-8,Views
98348-6,Views
98349-4,Views ulnar deviation
9835-0,HYDROmorphone
98350-2,Views radial deviation
98351-0,Views radial deviation
98352-8,View PA
98353-6,View oblique
98354-4,View PA
98355-1,View PA
98356-9,View AP
98357-7,View lateral
98358-5,View^W flexion
98359-3,View odontoid
98360-1,View^W extension
98361-9,Views radial deviation
98362-7,View oblique
98363-5,Views AP + oblique
98364-3,Views AP + oblique
98365-0,View^W extension
98366-8,View^W flexion
98367-6,Refraction type
Aug-36,HIV proviral DNA
98368-4,Corneal vertex distance
98369-2,Vision distance being tested
983-7,D little i super little a Ag
98370-0,Viewing distance
98371-8,Cylinder mode far
98372-6,Prism far
98373-4,Prism far
98374-2,Prism base direction far
98375-9,Prism base direction far
Jun-37,HIV 1 proviral DNA
98376-7,Horizontal prism.out far
98377-5,Horizontal prism.out far
98378-3,Horizontal prism.in far
98379-1,Horizontal prism.in far
98380-9,Vertical prism.up far
98381-7,Vertical prism.up far
98382-5,Vertical prism.down far
98383-3,Vertical prism.down far
Apr-38,Liver kidney microsomal Ab
98384-1,Visual acuity far testing condition
98385-8,Contrast ratio for far visual acuity measurement
98386-6,Pupillary distance.monocular far
98387-4,Pupillary distance.monocular far
98388-2,Pupillary distance.binocular far
98389-0,Depth of stromal invasion/Cervical thickness
98390-8,Epithelial component of carcinosarcoma
98391-6,Sarcomatous component of carcinosarcoma
Feb-39,Rheumatoid arthritis nuclear Ab
98392-4,Sarcomatous pattern in carcinosarcoma
98393-2,Candida sp
98394-0,Candida sp
98395-7,Color.candida colony
98396-5,Aspergillus sp CYP51 gene
98397-3,Color.aspergillus colony
98398-1,Fungus identified
98399-9,Fungus identified
Apr-98,Cefonicid
9840-0,Cells.CD11+CD20+
98400-5,Fungus identified
98401-3,Yeast
98402-1,Mold
98403-9,Yeast identified
98404-7,Mold identified
98405-4,Malassezia sp identified
98406-2,Color.yeast colony^with Sabouraud Dextrose Agar
98407-0,Conidia morphology
98408-8,Yeast identified
98409-6,Mold identified
98410-4,Cryptococcus molecular type
98411-2,Cryptosporidium sp
98412-0,Retrograde ejaculation evaluation panel
98413-8,lamoTRIgine
98414-6,lamoTRIgine
98415-3,Sertraline/Creatinine
98416-1,traZODone/Creatinine
98417-9,Eutylone/Creatinine
Aug-41,Casts
98418-7,Diagnostic audiology results panel
98419-5,Diagnostic audiology test performed
98420-3,Comment
98421-1,Hearing loss type
98422-9,Hearing loss degree
98423-7,Hearing loss degree.min
98424-5,Hearing loss degree.max
98425-2,Hearing loss configuration
Jun-42,Casts
98426-0,Hearing loss type
98427-8,Hearing loss degree
98428-6,Hearing loss degree.min
98429-4,Hearing loss degree.max
98430-2,Hearing loss configuration
98431-0,Diagnostic audiology follow-up recommendation
98432-8,Reason diagnostic audiology assessment not performed
98433-6,Cylinder mode intermediate
Apr-43,Circumference.occipital-frontal
98434-4,Sphere intermediate
98435-1,Sphere intermediate
98436-9,Cylinder intermediate
98437-7,Cylinder intermediate
98438-5,Axis intermediate
98439-3,Axis intermediate
98440-1,Add intermediate
98441-9,Add intermediate
Feb-44,Circumference
98442-7,Prism intermediate
98443-5,Prism intermediate
98444-3,Prism base direction intermediate
98445-0,Prism base direction intermediate
98446-8,Horizontal prism.out intermediate
98447-6,Horizontal prism.out intermediate
98448-4,Horizontal prism.in intermediate
98449-2,Horizontal prism.in intermediate
984-5,D little i super little a Ag
98450-0,Vertical prism.up intermediate
98451-8,Vertical prism.up intermediate
98452-6,Vertical prism.down intermediate
98453-4,Vertical prism.down intermediate
98454-2,Visual acuity intermediate testing condition
98455-9,Contrast ratio for intermediate visual acuity measurement
98456-7,Visual acuity.intermediate
98457-5,Visual acuity.intermediate
98458-3,Visual acuity.intermediate
Sep-45,Circumference
98459-1,Pupillary distance.monocular intermediate
98460-9,Pupillary distance.monocular intermediate
98461-7,Pupillary distance.binocular intermediate
98462-5,Cylinder mode near
98463-3,Prism near
98464-1,Prism near
98465-8,Prism base direction near
98466-6,Prism base direction near
Jul-46,Circumference method
98467-4,Horizontal prism.out near
98468-2,Horizontal prism.out near
98469-0,Horizontal prism.in near
98470-8,Horizontal prism.in near
98471-6,Vertical prism.up near
98472-4,Vertical prism.up near
98473-2,Vertical prism.down near
98474-0,Vertical prism.down near
May-47,Circumference site
98475-7,Visual acuity near testing condition
98476-5,Contrast ratio for near visual acuity measurement
98477-3,Pupillary distance.monocular near
98478-1,Pupillary distance.monocular near
98479-9,Pupillary distance.binocular near
98480-7,Auditory brainstem response panel
98481-5,Auditory brainstem response threshold^click
98482-3,Auditory brainstem response threshold^click
Mar-48,Body temperature special circumstances
98483-1,Apolipoprotein E phenotype
98484-9,Apolipoprotein E phenotype
98485-6,Amyloid beta 42 peptide/Amyloid beta 40 peptide
98486-4,Apolipoprotein E
98487-2,Alzheimer's disease risk
98488-0,Liver fibrosis score
98489-8,FLT3 gene internal tandem duplication length
98490-6,FLT3 gene.p.Asp835+Ile836 mutations/normal
Jan-49,Institution inventory number
98491-4,Liver fibrosis score panel
98492-2,Apolipoprotein E & beta amyloid Alzheimer's risk panel
98493-0,SARS coronavirus 2 ORF1b region
98494-8,SARS coronavirus 2 ORF1a region
98495-5,Color vision panel
98496-3,Color blindness
98497-1,Visual acuity panel
98498-9,Visual acuity^uncorrected
98499-7,Visual acuity^uncorrected
98500-2,Visual acuity.binocular^uncorrected
98501-0,Visual acuity.near^uncorrected
98502-8,Visual acuity.near^uncorrected
98503-6,Visual acuity.binocular near^uncorrected
98504-4,Visual acuity.far^uncorrected
98505-1,Visual acuity.far^uncorrected
98506-9,Visual acuity.binocular far^uncorrected
98507-7,Visual acuity.binocular^best corrected
98508-5,Visual acuity.near^best corrected
Sep-50,Vendor model number
98509-3,Visual acuity.near^best corrected
98510-1,Visual acuity.binocular near^best corrected
98511-9,Visual acuity.far^best corrected
98512-7,Visual acuity.far^best corrected
98513-5,Visual acuity.binocular far^best corrected
98514-3,Intensity of shortness of breath in past 7D
98515-0,PROMIS dyspnea characteristics - version 1.0 T-score
98516-8,Frequency of shortness of breath in past 7D
Jul-51,Vendor serial number
98517-6,Duration of shortness of breath in past 7D
98518-4,Shortness of breath in general in past 7D
985-2,D little i super little b Ab
98520-0,PROMIS item bank - dyspnea characteristics - version 1.0
98521-8,I worry about becoming short of breath in past 7D
98522-6,I become afraid when I have trouble catching my breath in past 7D
98523-4,Exercise seems unsafe for me in past 7D
98524-2,I am embarrassed by using my inhaled medication in public in past 7D
May-52,Institution inventory number
98525-9,I am embarrassed by using my oxygen in public in past 7D
98526-7,I am embarrassed by my shortness of breath in past 7D
98527-5,Things are in the house that trigger breathing problems
98528-3,Things are outside that trigger breathing problems
98529-1,"Exposed to pesticides, household cleaning products or substances with irritating odors in past 7D"
98530-9,Regularly exposed to other people's smoke
98531-7,Lives in an environment with extreme changes in temperature
98532-5,There are pets in the household
Mar-53,Vendor model number
98533-3,PROMIS item bank - dyspnea airborne exposure - version 1.0
98534-1,PROMIS dyspnea airborne exposure - version 1.0 T-score
98535-8,I get upset when I can't do something because of my shortness of breath in past 7D
98536-6,PROMIS item bank - dyspnea emotional response - version 1.0
98537-4,PROMIS dyspnea emotional response - version 1.0 T-score
98538-2,Feel like a failure since illness
98539-0,Felt like a failure before illness
98540-8,Feel useless since illness
Jan-54,Vendor serial number
98541-6,Felt useless before illness
98542-4,Feel lack of respect since illness
98543-2,Felt lack of respect before illness
98544-0,Feel worthless since illness
98545-7,Felt worthless before illness
98546-5,Feel inferior to others since illness
98547-3,Felt inferior to others before illness
98548-1,Lack confidence since illness
98549-9,Lacked confidence before illness
98550-7,Negative attitude toward self since illness
98551-5,Negative attitude toward self before illness
98552-3,Feel helpless since illness
98553-1,Felt helpless before illness
98554-9,Feel like a burden to family since illness
98555-6,Felt like a burden to family before illness
98556-4,Trouble asking others for help since illness
98557-2,Trouble asking others for help before illness
Aug-55,Blood pressure special circumstances
98558-0,Feel isolated from others since illness
98559-8,Felt isolated from others before illness
98560-6,Feel disconnected from others since illness
98561-4,Felt disconnected from others before illness
98562-2,Feel like a burden to others since illness
98563-0,Felt like a burden to others before illness
98564-8,Lost some close relationships since illness
98565-5,Lost some close relationships before illness
Jun-56,Institution inventory number
98566-3,Feel avoided since illness
98567-1,Felt avoided before illness
98568-9,Feel guilty for being unavailable to family and friends since illness
98569-7,Felt guilty for being unavailable to family and friends before illness
98570-5,Hard to get close to people since illness
98571-3,Hard to get close to people before illness
98572-1,Trouble relating to others since illness
98573-9,Trouble relating to others before illness
Apr-57,Vendor model number
98574-7,Feel the need to hide true feelings since illness
98575-4,Felt the need to hide true feelings before illness
98576-2,Worry about the future since illness
98577-0,Worried about the future before illness
98578-8,Bothered by little things since illness
98579-6,Bothered by little things before illness
98580-4,Have difficulty accepting that things aren't always in my control since illness
98581-2,Had difficulty accepting that things weren't always in my control before illness
Feb-58,Vendor serial number
98582-0,Upset by small changes in health since illness
98583-8,Upset by small changes in health before illness
98584-6,Worry about health interfering with life since illness
98585-3,Worried about health interfering with life before illness
98586-1,Fear what will happen in the future since illness
98587-9,Feared what would happen in the future before illness
98588-7,Worry about health interfering with sleep since illness
98589-5,Worried about health interfering with sleep before illness
9859-0,Class
98590-3,Get nervous before going to the doctor since illness
98591-1,Got nervous before going to the doctor before illness
98592-9,Feel I have been given more than I can take since illness
98593-7,Felt I had been given more than I could take before illness
98594-5,Trouble feeling peace of mind since illness
98595-2,Trouble feeling peace of mind before illness
98596-0,Life lacks meaning since illness
98597-8,Life lacked meaning before illness
98598-6,Life lacks purpose since illness
98599-4,Life lacked purpose before illness
986-0,D little i super little b Ab
98600-0,Question the purpose of life since illness
98601-8,Questioned the purpose of life before illness
98602-6,PROMIS item bank - psychosocial illness impact - negative - version 1.0
98603-4,PROMIS psychosocial illness impact - negative - version 1.0 T-score
98604-2,Nerve conduction study panel
98605-9,Sensory nerve conduction panel
98606-7,Stimulation site
98607-5,Sensory nerve action potential amplitude
Aug-60,Institution inventory number
98608-3,Peak sensory nerve conduction latency
98609-1,Sensory nerve conduction velocity
98610-9,Sensory nerve action potential area
98611-7,Sensory nerve conduction panel
98612-5,Recording site
98613-3,Sensory nerve action potential amplitude
98614-1,Peak sensory nerve conduction latency
98615-8,Sensory nerve conduction velocity
Jun-61,Style
98616-6,Sensory nerve action potential area
98617-4,Sensory nerve conduction panel
98618-2,Sensory nerve action potential amplitude
98619-0,Peak sensory nerve conduction latency
98620-8,Sensory nerve conduction velocity
98621-6,Sensory nerve action potential area
98622-4,Sensory nerve conduction panel
98623-2,Sensory nerve action potential amplitude
Apr-62,Vendor model number
98624-0,Peak sensory nerve conduction latency
98625-7,Sensory nerve conduction velocity
98626-5,Sensory nerve action potential area
98627-3,Sensory nerve conduction panel
98628-1,Sensory nerve action potential amplitude
98629-9,Peak sensory nerve conduction latency
98630-7,Sensory nerve conduction velocity
98631-5,Sensory nerve action potential area
Feb-63,Vendor model number
98632-3,Sensory nerve conduction panel
98633-1,Sensory nerve action potential amplitude
98634-9,Peak sensory nerve conduction latency
98635-6,Sensory nerve conduction velocity
98636-4,Sensory nerve action potential area
98637-2,Sensory nerve conduction panel
98638-0,Sensory nerve action potential amplitude
98639-8,Peak sensory nerve conduction latency
9864-0,Vendor serial number
98640-6,Sensory nerve conduction velocity
98641-4,Sensory nerve action potential area
98642-2,Sensory nerve conduction panel
98643-0,Sensory nerve action potential amplitude
98644-8,Peak sensory nerve conduction latency
98645-5,Sensory nerve conduction velocity
98646-3,Sensory nerve action potential area
98647-1,Sensory nerve conduction panel
98648-9,Sensory nerve action potential amplitude
98649-7,Peak sensory nerve conduction latency
98650-5,Sensory nerve conduction velocity
98651-3,Sensory nerve action potential area
98652-1,Sensory nerve conduction panel
98653-9,Sensory nerve action potential amplitude
98654-7,Peak sensory nerve conduction latency
98655-4,Sensory nerve conduction velocity
98656-2,Sensory nerve action potential area
Jul-65,Vendor serial number
98657-0,Body temperature
98658-8,Sensory nerve conduction panel
98659-6,Sensory nerve action potential amplitude
98660-4,Peak sensory nerve conduction latency
98661-2,Sensory nerve conduction velocity
98662-0,Sensory nerve action potential area
98663-8,Body temperature
98664-6,Sensory nerve conduction panel
May-66,Axis
98665-3,Sensory nerve action potential amplitude
98666-1,Peak sensory nerve conduction latency
98667-9,Sensory nerve conduction velocity
98668-7,Sensory nerve action potential area
98669-5,Motor nerve conduction panel
98670-3,Distance from nerve stimulation to muscle recording site
98671-1,Peak motor nerve conduction latency
98672-9,Motor nerve conduction velocity
Mar-67,Cardiac pacemaker prosthetic
98673-7,Motor nerve conduction panel
98674-5,Peak motor nerve conduction latency
98675-2,Motor nerve conduction velocity
98676-0,Nerve segment where motor conduction velocity measured
98677-8,Compound muscle action potential area
98678-6,Motor nerve conduction panel
98679-4,Peak motor nerve conduction latency
98680-2,Motor nerve conduction velocity
Jan-68,Conduction
98681-0,Motor nerve conduction panel
98682-8,Peak motor nerve conduction latency
98683-6,Motor nerve conduction velocity
98684-4,Motor nerve conduction panel
98685-1,Peak motor nerve conduction latency
98686-9,Motor nerve conduction velocity
98687-7,Motor nerve conduction panel
98688-5,Peak motor nerve conduction latency
98689-3,Motor nerve conduction velocity
98690-1,Motor nerve conduction panel
98691-9,Peak motor nerve conduction latency
98692-7,Motor nerve conduction velocity
98693-5,Motor nerve conduction panel
98694-3,Peak motor nerve conduction latency
98695-0,Motor nerve conduction velocity
98696-8,Sensory nerve conduction panel
98697-6,Distance from nerve stimulation to recording site
98698-4,Sensory nerve action potential amplitude
Sep-69,Hypertrophy
98699-2,Peak sensory nerve conduction latency
98700-8,Sensory nerve conduction velocity
98701-6,Nerve segment where sensory conduction velocity measured
98702-4,Sensory nerve action potential area
98703-2,Motor nerve conduction panel
98704-0,F-wave motor nerve conduction panel
98705-7,Minimum F-wave latency
98706-5,Repetitive motor nerve stimulation panel
Jul-70,Intraventricular conduction
98707-3,Nerve studied
98708-1,Muscle state at time of nerve stimulation
98709-9,Duration of muscle exercise
98710-7,Time since muscle exercise
98711-5,Number of stimuli
98712-3,Rate of stimuli
98713-1,Compound muscle action potential amplitude
98714-9,Percent change in action potential amplitude^post repetitive stimulation
May-71,Intraventricular conduction
98715-6,Percent change in action potential area^post repetitive stimulation
98716-4,Electromyography panel
98717-2,Muscle studied
98718-0,Insertional activity
98719-8,Spontaneous activity
98720-6,Spontaneous activity.positive sharp waves
98721-4,Spontaneous activity.fibrillation
98722-2,Spontaneous activity.fasciculation
Mar-72,Myocardial ischemia
98723-0,Voluntary activity.amplitude
98724-8,Voluntary activity.duration
98725-5,Voluntary activity.polyphasics
98726-3,Voluntary activity.recruitment
98727-1,Voluntary activity pattern
98728-9,Voluntary activity effort
98729-7,Recording site
98730-5,Peak motor nerve conduction latency
Jan-73,QRS complex
98731-3,Motor nerve conduction velocity
98732-1,SARS coronavirus 2 spike protein RBD Ab.neut
98733-9,Percent neutralization by SARS coronavirus 2 spike protein RBD Ab.neut
98734-7,SARS coronavirus 2 spike protein RBD Ab.neut
98735-4,Worth 4 dot test far
98736-2,Eye that was covered with red lens during test
98737-0,Worth 4 dot test near
98738-8,Accommodative convergence to accommodation ratio
98739-6,Accommodative convergence to accommodation ratio
98740-4,Phoria exam method
98741-2,Lens used for testing
98742-0,Prism for far phoria
98743-8,Prism for far phoria
98744-6,Prism base direction for far phoria
98745-3,Prism base direction for far phoria
98746-1,Horizontal prism.out for far phoria
98747-9,Horizontal prism.out for far phoria
98748-7,Horizontal prism.in for far phoria
Sep-74,Rhythm segment
98749-5,Horizontal prism.in for far phoria
98750-3,Vertical prism.up for far phoria
98751-1,Vertical prism.up for far phoria
98752-9,Vertical prism.down for far phoria
98753-7,Vertical prism.down for far phoria
98754-5,Prism for near phoria
98755-2,Prism for near phoria
Jun-75,ST-T segment
98756-0,Prism base direction for near phoria
98757-8,Prism base direction for near phoria
98758-6,Horizontal prism.out for near phoria
98759-4,Horizontal prism.out for near phoria
98760-2,Horizontal prism.in for near phoria
98761-0,Horizontal prism.in for near phoria
98762-8,Vertical prism.up for near phoria
98763-6,Vertical prism.up for near phoria
Apr-76,Ventricular morphology
98764-4,Vertical prism.down for near phoria
98765-1,Vertical prism.down for near phoria
98766-9,Far divergence blur
98767-7,Far divergence break
98768-5,Far divergence recovery
98769-3,Far convergence blur
98770-1,Far convergence break
98771-9,Far convergence recovery
Feb-77,J point depression.lead AVF
98772-7,Eye for far infravergence measurement
98773-5,Far infravergence break
98774-3,Far infravergence recovery
98775-0,Eye for far supravergence measurement
98776-8,Far supravergence break
98777-6,Far supravergence recovery
98778-4,Near divergence blur
98779-2,Near divergence break
987-8,D little i super little b Ab
9878-0,J point depression.lead AVL
98780-0,Near divergence recovery
98781-8,Near convergence blur
98782-6,Near convergence recovery
98783-4,Eye for near infravergence measurement
98784-2,Near infravergence break
98785-9,Near infravergence recovery
98786-7,Eye for near supravergence measurement
98787-5,Near supravergence break
98788-3,Near supravergence recovery
98789-1,Horizontal prism.in far for Sheard
98790-9,Horizontal prism.out far for Sheard
98791-7,Sphere far for Sheard
98792-5,Horizontal prism.in near for Sheard
98793-3,Horizontal prism.out near for Sheard
98794-1,Sphere near for Sheard
98795-8,Horizontal prism.in far for Percival
98796-6,Horizontal prism.out far for Percival
98797-4,Sphere far for Percival
Aug-79,J point depression.lead AVR
98798-2,Horizontal prism.in near for Percival
98799-0,Horizontal prism.out near for Percival
98800-6,Sphere near for Percival
98801-4,Horizontal aniseikonia
98802-2,Eye that sees the larger image in horizontal aniseikonia
98803-0,Vertical aniseikonia
98804-8,Eye that sees the larger image in vertical aniseikonia
98805-5,Add for monocular accommodative lag
Jun-80,J point depression.lead I
98806-3,Add for monocular accommodative lag
98807-1,Add for binocular accommodative lag
98808-9,Add for binocular accommodative lag
98809-7,Horizontal prism.out for monocular accommodative lag
98810-5,Horizontal prism.out for monocular accommodative lag
98811-3,Horizontal prism.in for monocular accommodative lag
98812-1,Horizontal prism.in for monocular accommodative lag
98813-9,Horizontal prism.in for binocular accommodative lag
Apr-81,J point depression.lead II
98814-7,Horizontal prism.in for binocular accommodative lag
98815-4,Horizontal prism.out for binocular accommodative lag
98816-2,Horizontal prism.out for binocular accommodative lag
98817-0,Meter angle for near point convergence
98818-8,Prism for near point convergence
98819-6,Prism for near point accommodation
98820-4,Prism for near point accommodation
98821-2,Prism for near point accommodation
Feb-82,J point depression.lead III
98822-0,Prism for far fixation disparity
98823-8,Prism for far fixation disparity
98824-6,Prism base direction for far fixation disparity
98825-3,Prism base direction for far fixation disparity
98826-1,Horizontal prism.out for far fixation disparity
98827-9,Horizontal prism.out for far fixation disparity
98828-7,Horizontal prism.in for far fixation disparity
98829-5,Horizontal prism.in for far fixation disparity
9883-0,J point depression.lead V1
98830-3,Vertical prism.up for far fixation disparity
98831-1,Vertical prism.up for far fixation disparity
98832-9,Vertical prism.down for far fixation disparity
98833-7,Vertical prism.down for far fixation disparity
98834-5,Prism for near fixation disparity
98835-2,Prism for near fixation disparity
98836-0,Prism base direction for near fixation disparity
98837-8,Prism base direction for near fixation disparity
98838-6,Horizontal prism.out for near fixation disparity
98839-4,Horizontal prism.out for near fixation disparity
98840-2,Horizontal prism.in for near fixation disparity
98841-0,Horizontal prism.in for near fixation disparity
98842-8,Vertical prism.up for near fixation disparity
98843-6,Vertical prism.up for near fixation disparity
98844-4,Vertical prism.down for near fixation disparity
98845-1,Vertical prism.down for near fixation disparity
98846-9,SARS coronavirus 2 stimulated gamma interferon release by Helper (CD4+) T-cells^^corrected for background
98847-7,SARS coronavirus 2 stimulated gamma interferon release by lymphocytes^^corrected for background
Aug-84,J point depression.lead V2
98848-5,Minimum stereopsis angle
98849-3,Depth perception
98850-1,Threshold angle for measuring depth perception
98851-9,Accommodation using minus lens
98852-7,Physical intensity of work
98853-5,Phoropter panel
98854-3,Urothelial carcinoma probability score
May-85,J point depression.lead V3
98855-0,Type of therapeutic antibody administered
98856-8,Volume^post void
98857-6,Cardiac stress EKG study
98858-4,Esophageal pH monitoring study
98859-2,Anorectal manometry study
988-6,D little i super little b Ag
98860-0,Transforming growth factor beta.free
98861-8,Transforming growth factor beta
98862-6,Taking medication for condition of interest
Mar-86,J point depression.lead V4
98864-2,Days' supply remaining
98865-9,Made arrangements to get medication refilled
98866-7,Postponed medical procedures since the beginning of the pandemic
98867-5,Missed scheduled appointment with healthcare provider in past Mo
98868-3,Reason for missed appointment with healthcare provider in past Mo
98869-1,Missed taking medication in past Mo
98870-9,Reason for missed medications in past Mo
Jan-87,J point depression.lead V5
98871-7,COVID-19 comorbidity and healthcare questionnaire
98872-5,SARS-CoV-2-related socioeconomic questionnaire for school-age children
98873-3,Were classes suspended
98874-1,How long were classes suspended
98875-8,Able to participate in remote learning
98876-6,Reason for not participating in remote learning
98877-4,Amount of school lost
98878-2,Received or applied for other assistance since the beginning of the pandemic
98879-0,Received or applied for assistance from a food pantry since the beginning of the pandemic
98880-8,Received or applied for assistance from community organization since the beginning of the pandemic
98881-6,Received or applied for assistance from a religious organization since the beginning of the pandemic
98882-4,Received or applied for assistance from a union since the beginning of the pandemic
98883-2,Received or applied for other government aid since the beginning of the pandemic
98884-0,Received or applied for paycheck protection since the beginning of the pandemic
98885-7,Received or applied for government health insurance since the beginning of the pandemic
98886-5,Received or applied for supplemental social security since the beginning of the pandemic
98887-3,Received or applied for social security since the beginning of the pandemic
98888-1,Received or applied for nutrition assistance since the beginning of the pandemic
Sep-88,J point depression.lead V6
98889-9,COVID-19 related household finances
98890-7,Received or applied for unemployment insurance since the beginning of the pandemic
98891-5,Methods using or plan to use to cover expenses
98892-3,Emergency expense payment method
98893-1,Difficulty level of paying expenses in past Mo
98894-9,Level of worry that asset value has been or will be negatively impacted by COVID-19
98895-6,Level of worry that household income has been or will be negatively impacted by COVID-19
98896-4,Household income changed significantly since the beginning of the pandemic
Jul-89,P wave amplitude.lead AVF
98897-2,Views abduction + internal rotation
98898-0,Views abduction + internal rotation
98899-8,View pronated oblique
98900-4,View pronated oblique
98901-2,Received or applied for temporary assistance since the beginning of the pandemic
98902-0,Methemoglobin & sulfhemoglobin panel
98903-8,Hemolytic anemia panel
98904-6,Osmotic fragility panel
May-90,P wave amplitude.lead AVL
98905-3,Red blood cell membrane evaluation panel
98906-1,Band 3
98907-9,Hemoglobinopathy panel
98908-7,Room brightness level during testing
98909-5,Shock index
98910-3,Modified shock index
98911-1,Negative relative accommodation blur
98912-9,Positive relative accommodation blur
Mar-91,P wave amplitude.lead AVR
98913-7,Negative relative accommodation recovery
98914-5,Positive relative accommodation recovery
98915-2,Knee injury and osteoarthritis outcome score - physical function shortform panel
98916-0,Total score
98917-8,WHO Quality of life-BREF
98918-6,Quality of life in last 2W
98919-4,Satisfaction with health in last 2W
98920-2,Extent that physical pain prevents activity in last 2W
Jan-92,P wave amplitude.lead I
98921-0,Dependency on medical treatment to function in daily life in last 2W
98922-8,Enjoyment of life in last 2W
98923-6,Extent to which life is meaningful in last 2W
98924-4,Ability to concentrate in last 2W
98925-1,How safe do you feel in your daily life in last 2W
98926-9,Healthiness of physical environment in last 2W
98927-7,Have enough energy for everyday life in last 2W
98928-5,Able to accept body appearance in last 2W
98929-3,Have enough money to meet needs in last 2W
98930-1,Availability of information needed in daily life in last 2W
98931-9,Extent of opportunity for leisure activities in last 2W
98932-7,Ability to get around in last 2W
98933-5,Satisfaction with sleep in last 2W
98934-3,Satisfaction with ability to perform daily living activities in last 2W
98935-0,Satisfaction with capacity for work in last 2W
98936-8,Satisfaction with self in last 2W
98937-6,Satisfaction with personal relationships in last 2W
98938-4,Satisfaction with sex life in last 2W
Sep-93,P wave amplitude.lead II
98939-2,Satisfaction with support from friends in last 2W
989-4,D little i super little b Ag
98940-0,Satisfaction with condition of living place in last 2W
98941-8,Satisfaction with access to health services in last 2W
98942-6,Satisfaction with access to transportation in last 2W
98943-4,Frequency of negative feelings in last 2W
98944-2,Total Score
98945-9,Hip disability and osteoarthritis outcome score - physical function shortform panel
98946-7,Total score
Jul-94,P wave amplitude.lead III
98947-5,SARS-CoV-2-related socioeconomic questionnaire for school-age children intake questions
98948-3,SARS-CoV-2-related socioeconomic questionnaire for school-age children 12Mo follow-up
98949-1,Were classes suspended in last 12Mo
98950-9,How long were classes suspended in last 12Mo
98951-7,Amount of school lost in last 12Mo
98952-5,Reason for not participating in remote learning in last 12Mo
98953-3,Able to participate in remote learning in last 12Mo
Apr-95,P wave amplitude.lead V1
98954-1,KCNN4 gene full mutation analysis
98955-8,Burkholderia pseudomallei Ab
98956-6,Coccidioides immitis Ab.IgM
98957-4,Coccidioides immitis Ab.IgG
98958-2,Periostin
98959-0,Aspergillus fumigatus
98960-8,Dehydroaripiprazole
98961-6,Lurasidone
Feb-96,P wave amplitude.lead V2
98962-4,Cariprazine
98963-2,Cariprazine
98964-0,Brexpiprazole
98965-7,Brexpiprazole
98966-5,Antipsychotics drug panel
98967-3,Nutritional Risk Screening 2002 panel
98968-1,Initial screening
98969-9,Lost weight in last 3Mo
9897-0,P wave amplitude.lead V3
98970-7,Reduced nutritional intake in last W
98971-5,Severely ill
98972-3,Final screening
98973-1,Impaired nutritional status
98974-9,Total score
98975-6,Children's Health Watch Housing Stability Vital Signs panel
98976-4,Behind on rent or mortgage in past 12Mo
98977-2,Number of residential moves in past 12Mo
98978-0,Homeless in past 12Mo
98979-8,Glomerular filtration rate/1.73 sq M.predicted
98980-6,Glomerular filtration rate/1.73 sq M.predicted
98981-4,Urate
98982-2,6-Hydroxybuspirone
98983-0,Methocarbamol
98984-8,OXcarbazepine
98985-5,10-Hydroxycarbazepine
98986-3,Chloride/Creatinine
98987-1,C reactive protein
Aug-98,P wave amplitude.lead V4
98988-9,Prolactin^45M post dose TRH IV
98989-7,Neutrophils.band form/leukocytes
98990-5,Methotrexate^18H post dose
98991-3,Methotrexate^5M post dose
98992-1,Alpha-1-Acid glycoprotein/Protein.total
98993-9,Alpha 1 antitrypsin/Protein.total
98994-7,Alpha 1 antitrypsin
98995-4,Transferrin/Protein.total
Jun-99,P wave amplitude.lead V5
98996-2,Transferrin
98997-0,Haptoglobin/Protein.total
98998-8,Hematocrit
98999-6,Nucleated cells
99000-2,Dysautonomia autoimmune Ab panel
99001-0,Leptospira weilii serovar Celledoni Ab
Feb-00,P wave amplitude.lead V6
99002-8,Leptospira santarosai serovar Alexi Ab
99003-6,Leptospira santarosai serovar Georgia Ab
99004-4,Leptospira santarosai serovar Borincana Ab
99005-1,Leptospira kirschneri serovar Cynopteri Ab
99006-9,Leptospira interrogans serovar Wolffi Ab
99007-7,Leptospira interrogans serovar Mankarso Ab
99008-5,Leptospira interrogans serovar Djasiman Ab
9901-0,P wave duration.lead AVF
99010-1,Leptospira borgpetersenii serovar Javanica Ab
99011-9,Leptospira sp Ab panel
99012-7,Urinary tract pathogens panel
99013-5,Acinetobacter baumannii DNA
99014-3,Citrobacter freundii DNA
99015-0,Citrobacter koseri DNA
99016-8,Enterobacter cloacae complex DNA
99017-6,Enterococcus faecalis DNA
99018-4,Enterococcus faecium DNA
99019-2,Escherichia coli DNA
990-2,D little i super little b Ag
99020-0,Klebsiella aerogenes DNA
99021-8,Klebsiella oxytoca DNA
99022-6,Klebsiella pneumoniae DNA
99023-4,Morganella morganii DNA
99024-2,Proteus sp DNA
99025-9,Providencia rettgeri DNA
99026-7,Providencia stuartii DNA
99027-5,Pseudomonas aeruginosa DNA
Aug-02,P wave duration.lead AVL
99028-3,Serratia marcescens DNA
99029-1,Staphylococcus aureus DNA
99030-9,Staphylococcus epidermidis DNA
99031-7,Staphylococcus saprophyticus DNA
99032-5,Streptococcus agalactiae DNA
99033-3,Candida albicans DNA
99034-1,Bacterial trimethoprim resistance dfrA1 gene
99035-8,Bacterial trimethoprim resistance dfrA5 gene
Jun-03,P wave duration.lead AVR
99036-6,Bacterial trimethoprim resistance dfrA7+dfrA17 genes
99037-4,Bacterial trimethoprim resistance dfrA12 gene
99041-6,Trajectory of foreign object at wound entry panel
99042-4,Trajectory deviation.vertical
99043-2,Trajectory deviation.lateral
Apr-04,P wave duration.lead I
99044-0,Trajectory deviation.anterior-posterior
99045-7,Donated organ
99046-5,Total score
99047-3,Metanephrine.free
99048-1,Metanephrine.free
99049-9,Acidity.titratable
99050-7,Erythrocytes
Jan-05,P wave duration.lead II
99051-5,Leukocytes
99052-3,Epithelial cells
99053-1,Cells counted.total
99054-9,Manual differential comment
99055-6,Cardiovascular disease 10Y risk
99056-4,Cardiovascular disease 10Y risk
99057-2,SLC12A1 gene full mutation analysis
99058-0,DHCR7 gene full mutation analysis
99059-8,n-Acetylglycine/Creatinine
99060-6,Cerebroventricular lining cells/100 leukocytes
99061-4,Cholesterol.esterified actual/normal
99062-2,Acetylcholine receptor modulation Ab
99063-0,Free water clearance
99064-8,Programmed cell death ligand 1 by clone SP263
99065-5,EJ Ab
99066-3,PL-12 Ab
99067-1,PL-7 Ab
99068-9,Ku Ab
Sep-06,P wave duration.lead III
99069-7,Jo-1 extractable nuclear Ab
99070-5,Kelch-like protein 11 Ab.IgG
99071-3,Kelch-like protein 11 Ab.IgG
99072-1,Kelch-like protein 11 Ab.IgG
99073-9,Kelch-like protein 11 Ab.IgG
99074-7,Calcium/Creatinine
99075-4,Alpha-1-Microglobulin/Creatinine
99076-2,Alpha-1-Microglobulin
Jul-07,P wave duration.lead V1
99077-0,Alpha-1-Fetoprotein.L3
99078-8,Thyrotropin blocking Ab
99079-6,Acrylfentanyl
99080-4,O-Nortramadol
99081-2,Furanylfentanyl
99082-0,Coccidioides sp Ag
99083-8,Blastomyces sp
99084-6,Aspergillus sp Ag
May-08,P wave duration.lead V2
99085-3,Napsin A Ag
99086-1,p40 Ag
99087-9,Meningitis+Encephalitis pathogens panel
99088-7,Cryptococcus gattii+neoformans DNA
99089-5,Escherichia coli K1 DNA
99090-3,Haemophilus influenzae DNA
99091-1,Listeria monocytogenes DNA
99092-9,Neisseria meningitidis DNA
Mar-09,P wave duration.lead V3
99093-7,Streptococcus agalactiae DNA
99094-5,Streptococcus pneumoniae DNA
99095-2,Streptococcus pyogenes DNA
99096-0,Mycoplasma pneumoniae DNA
99097-8,Blastomyces dermatitidis Ab.IgG
99098-6,Blastomyces dermatitidis Ab.IgG
99099-4,Procalcitonin
991-0,D little o super little a Ab
99100-0,Norepinephrine
Jan-10,P wave duration.lead V4
99101-8,Cancer Ag 242
99102-6,Gastrin releasing polypeptide
99103-4,Tumor necrosis factor.alpha
99104-2,Choriogonadotropin
99105-9,Chlamydia trachomatis Ag
99106-7,How often do you attend meetings of the clubs or organizations you belong to
99107-5,Stimulants drug panel
99108-3,ePHEDrine
99109-1,Pseudoephedrine
99110-9,Alpha-Phenyl-2-Piperidine acetate
99111-7,Dengue virus Ab.Neut
99112-5,Rocio virus Ab.Neut
99113-3,Ilheus virus Ab.Neut
99114-1,Semliki Forest virus Ab.Neut
99115-8,Onyong-nyong virus Ab.Neut
99116-6,Bourbon virus Ab.Neut
99117-4,Toscana virus Ab.Neut
99118-2,Sandfly fever Sicilian virus Ab.Neut
Sep-11,P wave duration.lead V5
99119-0,Sandfly fever Naples virus Ab.Neut
99120-8,Oropouche virus Ab.Neut
99121-6,Rift Valley fever virus Ab.Neut
99122-4,Bwamba virus Ab.Neut
99123-2,Heartland banyangvirus Ab.Neut
99124-0,Tick-borne encephalitis virus Ab.Neut
99125-7,Bunyamwera virus Ab.Neut
99126-5,NOTCH1 gene targeted mutation analysis
Jul-12,P wave duration.lead V6
99127-3,BIRC3 gene targeted mutation analysis
99128-1,PLCG2 gene targeted mutation analysis
99129-9,SF3B1 gene targeted mutation analysis
99130-7,Outcome and assessment information set (OASIS) form - version E
99131-5,Outcome and assessment information set (OASIS) form - version E - Start of Care
99132-3,OASIS E - Administrative information - SOC
99133-1,Near convergence break
99134-9,You or your families' health is affected by environmental conditions at home
May-13,P' wave amplitude.lead AVF
99135-6,Environmental conditions in the home that affect you or your families' health
99136-4,Rabies virus Ab.IgM
99137-2,Rabies virus Ab.IgG
99138-0,"OASIS E - Hearing, speech, and vision - SOC"
99139-8,Sjogrens syndrome-A extractable nuclear 52kD Ab
99140-6,"OASIS E - Cognitive Patterns - SOC, ROC, DC"
99142-2,"OASIS E - Health Conditions - SOC, ROC"
Mar-14,P' wave amplitude.lead AVL
99143-0,"OASIS E - Special Treatment, Procedures, and Programs - SOC"
99144-8,"OASIS E - Behavior - SOC, ROC, DC"
99146-3,OASIS E - Active Diagnoses - SOC
99147-1,"OASIS E - Preferences for Customary Routine Activities - SOC, ROC"
99148-9,"OASIS E - Functional Status - SOC, ROC, DC"
99149-7,OASIS E - Self-care - follow-up performance
9915-0,P' wave amplitude.lead AVR
99150-5,OASIS E - Mobility - follow-up performance
99151-3,"OASIS E - Medications - SOC, ROC"
99152-1,OASIS E - Swallowing And Or Nutritional Status - SOC
99153-9,Outcome and assessment information set (OASIS) form - version E - Follow Up
99154-7,OASIS E - Functional abilities and goals - FU
99155-4,OASIS E - Functional Status - follow up
99156-2,OASIS E - Health Conditions - FU
99157-0,OASIS E - Skin Conditions - FU
99158-8,Outcome and assessment information set (OASIS) form - version E - Death at Home
99159-6,OASIS E - Administrative information - DAH
99160-4,Outcome and assessment information set (OASIS) form - version E - Resumption of Care
99161-2,OASIS E - Administrative information - ROC
Aug-16,P' wave amplitude.lead I
99169-5,OASIS E - Active Diagnoses - ROC
99170-3,OASIS E - Health Conditions - DC
99171-1,OASIS E - Swallowing And Or Nutritional Status - ROC
99173-7,"OASIS E - Special Treatment, Procedures, and Programs - ROC"
99174-5,Outcome and assessment information set (OASIS) form - version E - Transfer to an Inpatient Facility
99175-2,OASIS E - Administrative information - TRN
Jun-17,P' wave amplitude.lead II
99176-0,"OASIS E - Special Treatment, Procedures, and Programs - transfer to an inpatient facility"
99177-8,"OASIS E - Participation in Assessment and Goal Setting - TRN, DC"
99178-6,Outcome and assessment information set (OASIS) form - version E - Discharge from Agency
99179-4,OASIS E - Administrative information - DC
Apr-18,P' wave amplitude.lead III
99188-5,OASIS E - Swallowing And Or Nutritional Status - DC
99189-3,OASIS E - Skin Conditions - DC
99190-1,"OASIS E - Special Treatment, Procedures, and Programs - discharge from agency"
99191-9,OASIS E - Medications - DC
Feb-19,P' wave amplitude.lead V1
99192-7,Patient-reported outcomes with LASIK - pre-operative panel
99193-5,Frequency of noticing or thinking about eyesight or vision
99194-3,Could accept less than perfect vision if able to see well enough to drive without corrective lenses
99195-0,Expected corrective lens use frequency after healing from LASIK.distance
99196-8,Expected corrective lens use frequency after healing from LASIK.near
99197-6,Expect clear vision after healing from LASIK
99198-4,Expect perfect vision after healing from LASIK
99199-2,Could accept less than perfect vision without corrective lenses after healing from LASIK
Feb-99,Cefoperazone
9920-0,P' wave amplitude.lead V2
99200-8,Ever driven a car
99202-4,Level of difficulty when driving at night because of vision
99203-2,Level of difficulty with daily activities because of vision
99204-0,Participate less in active sports or other outdoor activities because of vision
99205-7,Were recreational or sports activities avoided because of vision
99206-5,Daily activities that are difficult because of vision
99207-3,Are daily activities not done because of vision
99208-1,Level of difficulty judging distances
99209-9,Level of difficulty getting used to the dark when moving from a lighted area into a dark place
99210-7,Level of difficulty seeing because of changes in vision clarity during the course of the day
99211-5,Frequency of being bothered by changes in the clarity of vision over the course of the day
99212-3,Frequency of seeing starbursts or halos that are bothersome or make it difficult to see when around bright lights at night
99213-1,Experienced glare in past 7D
99214-9,How bothersome has glare been in past 7D
99215-6,Experienced distorted vision in past 7D
99216-4,How bothersome has distorted vision been in past 7D
99217-2,Experienced blurry vision in past 7D
Aug-21,P' wave amplitude.lead V3
99218-0,How bothersome has blurry vision been in past 7D
99219-8,Experienced trouble seeing in past 7D
99220-6,How bothersome has trouble seeing been in past 7D
99221-4,Satisfaction level with present vision
99222-2,Employed
99223-0,H missed from work because of eye problems in past 7D
99224-8,H missed from work because of any non vision related reasons in past 7D
99225-5,H worked in past 7D
Jun-22,P' wave amplitude.lead V4
99226-3,Level that eye problems affected productivity while working in past 7D
99227-1,"Level that eye problems affected ability to do regular daily activities, other than work at a job in past 7D"
99228-9,Use of corrective lenses in a typical day
99229-7,Seen double images in past 7D
99230-5,Frequency of seeing double images when wearing best corrective lenses in past 7D
99231-3,Frequency of seeing double images when not wearing corrective lenses in past 7D
99232-1,How bothersome have double images been when wearing best corrective lenses in past 7D
99233-9,How bothersome have double images been when not wearing corrective lenses in past 7D
Apr-23,P' wave amplitude.lead V5
99234-7,Level of difficulty doing usual activities because of double images when wearing best corrective lenses in past 7D
99235-4,Level of difficulty doing usual activities because of double images when not wearing corrective lenses in past 7D
99236-2,Impact of best corrective lenses on double images
99237-0,Frequency of noticing glare when wearing best corrective lenses in past 7D
99238-8,Frequency of noticing glare when not wearing corrective lenses in past 7D
99239-6,How bothersome has glare been when wearing best corrective lenses in past 7D
99240-4,How bothersome has glare been when not wearing corrective lenses in past 7D
99241-2,Level of difficulty doing usual activities because of glare when wearing best corrective lenses in past 7D
Feb-24,P' wave amplitude.lead V6
99242-0,Level of difficulty doing usual activities because of glare when not wearing corrective lenses in past 7D
99243-8,Impact of best corrective lenses on glare
99244-6,Seen halos in past 7D
99245-3,Frequency of seeing halos when wearing best corrective lenses in past 7D
99246-1,Frequency of seeing halos when not wearing corrective lenses in past 7D
99247-9,How bothersome have halos been when wearing best corrective lenses in past 7D
99248-7,How bothersome have halos been when not wearing corrective lenses in past 7D
99249-5,Level of difficulty doing usual activities because of halos when wearing best corrective lenses in past 7D
99250-3,Level of difficulty doing usual activities because of halos when not wearing corrective lenses in past 7D
99251-1,Impact of best corrective lenses on halos
99252-9,Seen starbursts in past 7D
99253-7,Frequency of seeing starbursts when wearing best corrective lenses in past 7D
99254-5,Frequency of seeing starbursts when not wearing corrective lenses in past 7D
99255-2,How bothersome have starbursts been when wearing best corrective lenses in past 7D
99256-0,How bothersome have starbursts been when not wearing corrective lenses in past 7D
99257-8,Level of difficulty doing usual activities because of starbursts when wearing best corrective lenses in past 7D
99258-6,Level of difficulty doing usual activities because of starbursts when not wearing corrective lenses in past 7D
Sep-25,Q wave depth.lead AVF
99259-4,Impact of best corrective lenses on starbursts
99260-2,Information source for medical procedure
99261-0,Told not to have LASIK by an eye care professional
99262-8,Designer benzodiazepines
99263-6,Delorazepam
99264-4,Etizolam
99265-1,Alpha hydroxyetizolam
99266-9,Deschloroetizolam
Jul-26,Q wave depth.lead AVL
99267-7,Nifoxipam
99268-5,Diclazepam
99269-3,Clonazolam
99270-1,8-Aminoclonazolam
99271-9,Flualprazolam
99272-7,Alpha-hydroxy flualprazolam
99273-5,Meclonazepam
99274-3,Flubromazepam
May-27,Q wave depth.lead AVR
99275-0,Phenazepam
99276-8,3-Hydroxyphenazepam
99277-6,Pyrazolam
99278-4,Flubromazolam
99279-2,Alpha-hydroxy flubromazolam
992-8,D little o super little a Ab
99280-0,Cefiderocol
99281-8,Lefamulin
99282-6,FDA-initiated compliance action drug registration and listing inactivation - animal drug
Mar-28,Q wave depth.lead I
99283-4,Tegner activity scale panel
99284-2,Activity level before injury
99285-9,Current activity level
99286-7,Provision of current reconciled medication list to subsequent provider at transfer
99287-5,Checklist of nonverbal pain indicators panel
99288-3,Checklist of nonverbal pain indicators with movement panel
99289-1,Nonverbal vocal complaints during movement
99290-9,Facial grimaces or winces during movement
Jan-29,Q wave depth.lead II
99291-7,Bracing during movement
99292-5,Rubbing during movement
99293-3,Restlessness during movement
99294-1,Verbal complaints during movement
99295-8,With movement score
99296-6,Checklist of nonverbal pain indicators at rest panel
99297-4,Nonverbal vocal complaints while at rest
99298-2,Facial grimaces or winces while at rest
99299-0,Bracing while at rest
99300-6,Restlessness while at rest
99301-4,Rubbing while at rest
99302-2,Verbal complaints while at rest
99303-0,At rest score
99304-8,Total score
99305-5,Checklist of nonverbal pain indicators assessment
99306-3,Choriogonadotropin.beta subunit heterophile Ab interference panel
99307-1,Choriogonadotropin.beta subunit heterophile Ab interference
99308-9,Acid alpha glucosidase cross-reactive immunologic material (CRIM)
Sep-30,Q wave depth.lead III
99309-7,Acid alpha glucosidase cross-reactive immunologic material (CRIM)
99310-5,Total score^^adjusted for age
99311-3,Seizure onset
99312-1,Seizure frequency
99313-9,Time since last seizure
99314-7,SARS coronavirus 2 RdRp gene mutation detected
99315-4,"OASIS E - Intervention synopsis - DC, TRN"
Jul-31,Q wave depth.lead V1
May-32,Q wave depth.lead V2
Mar-33,Q wave depth.lead V3
Jan-34,Q wave depth.lead V4
99342-8,Days since symptom started
99343-6,Days since symptom finished
99344-4,Sought medical attention for symptoms
99345-1,Type of medical attention accessed
99346-9,Temperature taken
99347-7,Body temperature.max
99348-5,Close contact with COVID-19 in last 2W
99349-3,Has or had COVID-19
99350-1,Date of first infection onset
99351-9,Informed of being at severe risk from COVID-19 due to an underlying health condition
99352-7,Has health problems that require activity limits
99353-5,Has health problems that require staying at home
99354-3,Mobility device or aid is regularly used
99355-0,Takes routine medication
99356-8,Influenza virus vaccination received in last 12Mo
99357-6,COVID-19 health questions panel
Aug-35,Q wave depth.lead V5
99359-2,Person who performed clinical measurement
993-6,D little o super little a Ab
99360-0,Bovine serum albumin Ab.IgG
99361-8,Horse hair+Horse dander Ab.IgG
99362-6,Euroglyphus maynei Ab.IgG
99363-4,Triticum spelta Ab.IgG
99364-2,Ovalbumin Ab.IgG
99365-9,Sheep milk Ab.IgG
Jun-36,Q wave depth.lead V6
99366-7,Chicken meat Ab.IgG
99367-5,Theobroma cacao Ab.IgG
99368-3,Gliadin Ab.IgG
99369-1,Dactylis glomerata Ab.IgG
99370-9,Tabanus spp Ab.IgG
99371-7,Culex pipiens Ab.IgG
99372-5,Platanus acerifolia Ab.IgG
99373-3,Alnus incana Ab.IgG
Apr-37,Q wave duration.lead AVF
99374-1,Betula verrucosa Ab.IgG
99375-8,Corylus avellana pollen Ab.IgG
99376-6,Olea europaea pollen Ab.IgG
99377-4,Parietaria judaica Ab.IgG
99378-2,Vasopressin
99379-0,Mercury
99380-8,Mercury
99381-6,Mercury
Feb-38,Q wave duration.lead AVL
99382-4,Cancer Ag 50
99383-2,Copper
99384-0,Creatinine
99385-7,Hepatitis B virus surface Ag
99386-5,Adenovirus DNA
99387-3,Carbon monoxide
99388-1,Choriogonadotropin.tumor marker
99389-9,Choriogonadotropin.tumor marker
9939-0,Q wave duration.lead AVR
99390-7,Progesterone
99391-5,Progesterone
99392-3,Sulfocysteine
99393-1,Siderocytes panel
99394-9,Siderocytes
99395-6,Siderocytes/100 Erythroblasts
99396-4,Siderocytes.Type 1/100 Erythroblasts
99397-2,Siderocytes.Type 2/100 Erythroblasts
99398-0,Siderocytes.Type 3/100 Erythroblasts
99399-8,Zonulin
99400-4,Cells.CD19+CD23+/100 cells
99401-2,Cells.CD19+FMC7+/100 cells
99402-0,Cells.CD19+CD79b+/100 cells
99403-8,Cells.CD19+CD22+/100 cells
99404-6,Cells.CD19+CD38+/100 cells
99405-3,Cells.CD19+FMC7+/100 cells
99406-1,Cells.CD19+CD79b+/100 cells
99407-9,Myeloperoxidase
Aug-40,Q wave duration.lead I
99408-7,Matrix metallopeptidase 9
99409-5,Acetaminophen-cysteine adduct
99410-3,Cupressus sempervirens Ab.IgG
99411-1,Voltage-gated calcium channel Ab
99412-9,Beta globulin
99413-7,cycloSPORINE
99414-5,Gamma globulin
99415-2,Protein.monoclonal band 1
Jun-41,Q wave duration.lead II
99416-0,Protein.monoclonal band 2
99417-8,Shared decision making panel
99418-6,Shared decision making total score
99419-4,Know possible benefits of treatment plan
99420-2,Know possible downside of treatment plan
99421-0,Know available choices for treatment plan
99422-8,Feel fully involved in treatment plan
99423-6,Time to complete survey
Apr-42,Q wave duration.lead III
99424-4,Penicillin G Ab.IgG4
99425-1,Penicillin V Ab.IgG4
99426-9,Amoxicillin Ab.IgG4
99427-7,Blomia tropicalis Ab.IgG4
99428-5,Dermatophagoides microceras Ab.IgG4
99429-3,Tyrophagus putrescentiae Ab.IgG4
99430-1,Euroglyphus maynei Ab.IgG4
99431-9,Goat epithelium Ab.IgG4
Feb-43,Q wave duration.lead V1
99432-7,Cat recombinant (rFel d) 1 Ab.IgG4
99433-5,Beta vulgaris seed Ab.IgG4
99434-3,Chenopodium quinoa Ab.IgG4
99435-0,Cyprinus carpio recombinant (rCyp c) 1 Ab.IgG4
99436-8,Prunus persica recombinant (rPru p) 3 Ab.IgG4
99437-6,Juglans regia recombinant (rJug r) 1 Ab.IgG4
99438-4,Juglans regia recombinant (rJug r) 3 Ab.IgG4
99439-2,Anacardium occidentale recombinant (rAna o) 3 Ab.IgG4
994-4,D little o super little a Ag
9944-0,Q wave duration.lead V2
99440-0,Arachis hypogaea recombinant (rAra h) 6 Ab.IgG4
99441-8,Theobroma cacao Ab.IgG4
99442-6,Hordeum vulgare pollen Ab.IgG4
99443-4,(Dactylis glomerata+Festuca elatior+Lolium perenne+Phleum pratense+Poa pratensis) Ab.IgG4
99444-2,(Anthoxanthum odoratum+Lolium perenne+Phleum pratense+Secale cereale+Holcus lanatus) Ab.IgG4
99445-9,Bombus terrestris Ab.IgG4
99446-7,Polistes spp recombinant (rPol d) 5 Ab.IgG4
99447-5,Vespula vulgaris recombinant (rVes v) 1 Ab.IgG4
99448-3,Cladotanytarsus lewisi Ab.IgG4
99449-1,Polistes dominulus Ab.IgG4
99450-9,Botrytis cinerea Ab.IgG4
99451-7,Carpinus betulus Ab.IgG4
99452-5,Betula verrucosa recombinant (rBet v) 2 Ab.IgG4
99453-3,Penicillin V Ab.IgG
99454-1,Clostridium tetani toxoid Ab.IgG
99455-8,Amoxicillin Ab.IgG
99456-6,Blomia tropicalis Ab.IgG
Jul-45,Q wave duration.lead V3
99457-4,Tyrophagus putrescentiae Ab.IgG
99458-2,Rabbit urine proteins Ab.IgG
99459-0,Budgerigar droppings Ab.IgG
99460-8,Rabbit epithelium Ab.IgG
99461-6,Rat epithelium+Serum proteins+Urine proteins Ab.IgG
99462-4,Beta vulgaris seed Ab.IgG
99463-2,(Anacardium occidentale+Carya illinoinensis+Juglans spp+Pistacia vera) Ab.IgG
99464-0,Anthoxanthum odoratum Ab.IgG
May-46,Q wave duration.lead V4
99465-7,Holcus lanatus Ab.IgG
99466-5,Avena sativa cultivated Ab.IgG
99467-3,Zea mays pollen Ab.IgG
99468-1,(Dactylis glomerata+Festuca elatior+Lolium perenne+Phleum pratense+Poa pratensis) Ab.IgG
99469-9,Gasterophilus intestinalis Ab.IgG
99470-7,Polistes spp recombinant (rPol d) 5 Ab.IgG
99471-5,Vespula vulgaris recombinant (rVes v) 1 Ab.IgG
99472-3,Blatella germanica Ab.IgG
Mar-47,Q wave duration.lead V5
99473-1,Solenopsis invicta Ab.IgG
99474-9,Amylase Ab.IgG
99475-6,Penicillium frequentans Ab.IgG
99476-4,Aspergillus flavus Ab.IgG
99477-2,Rumex acetosella Ab.IgG
99478-0,Cardiac loop monitor study
99479-8,Note
99480-6,History and physical note
Jan-48,Q wave duration.lead V6
99481-4,History and physical note
99482-2,History and physical note
99483-0,Discharge summary note
99484-8,Procedure note
99485-5,History and physical note
99486-3,History and physical note
99487-1,History and physical note
99488-9,Discharge summary note
99489-7,Discharge summary note
99490-5,Discharge summary note
99491-3,Procedure note
99492-1,Evaluation note
99493-9,Condition clinical status
99494-7,Diagnosis type
99495-4,Speed of condition onset
99496-2,Condition cause
99498-8,Condition verification status
Sep-49,QRS duration.lead AVF
99499-6,Condition severity
99500-1,Clinical trial vaccine received
99501-9,Sex for clinical use
99502-7,Recorded sex or gender
99503-5,Cefiderocol
99504-3,Glucose
99505-0,View PA
99506-8,View PA
Jul-50,QRS duration.lead AVL
99507-6,View Judet external oblique
99508-4,View Judet external oblique
99509-2,View Judet internal oblique
995-1,D little o super little a Ag
99510-0,View Judet internal oblique
99511-8,Views
99512-6,Weight
99513-4,Weight
99514-2,Weight
May-51,QRS duration.lead AVR
99515-9,Weight
99516-7,Weight
99517-5,Weight
99518-3,Weight
99519-1,Volume
99520-9,Weight
99521-7,Weight
99522-5,Circumference
Mar-52,QRS duration.lead I
99523-3,Circumference
99524-1,Circumference
99525-8,Circumference
99526-6,Thickness
99527-4,Thickness
99528-2,Thickness
99529-0,Volume
99530-8,Volume
Jan-53,QRS duration.lead II
99531-6,Volume
99532-4,Volume
99533-2,Length.crown rump
99534-0,Length.crown heel
99535-7,Length.palm
99536-5,Length.heel toe
99537-3,Stenosis degree
99538-1,Stenosis degree
99539-9,Stenosis degree
99540-7,Stenosis degree
99541-5,Stenosis degree
99542-3,Stenosis degree
99543-1,Stenosis degree
99544-9,Stenosis degree
99545-6,Stenosis degree
99546-4,Circumference
99547-2,Stenosis degree
99548-0,Gas & electrolytes panel
Sep-54,QRS duration.lead III
99549-8,Health Leads screening panel
99550-6,Worried about housing stability in next 2Mo
99551-4,Problems getting child care make work or study difficult
99552-2,Could not see doctor due to cost in past 12Mo
99553-0,Went without health care due to lack of transportation in last 12Mo
99554-8,Personal needs are urgent
99555-5,Want assistance with personal needs
Jun-55,QRS duration.lead V1
99556-3,Behavior change panel
99557-1,Behavior change total score
99558-9,Skills and tools to change behavior
99559-7,Nothing prevents behavior change
99560-5,Choose to change behavior
99561-3,Change behavior without thinking
99562-1,Adherence panel
99563-9,Adherence total score
Apr-56,QRS duration.lead V2
99564-7,Remember to follow treatment instructions
99565-4,Follow treatment instructions if feel bad
99566-2,Follow treatment instructions if feel better
99567-0,Acceptance of loss panel
99568-8,Acceptance of loss total score
99569-6,Know capabilities following loss
99570-4,Recognize life changes following loss
99571-2,Activities done differently following loss
Feb-57,QRS duration.lead V3
99572-0,Moved on following loss
99573-8,Often feel lack of companionship
99574-6,Roland Morris Disability Questionnaire panel
99575-3,Total Score
99576-1,Impact of back pain today
99577-9,Columbia Behavior Scale for Dementia panel
99578-7,Total score
99579-5,Psychosis factor score
9958-0,QRS duration.lead V4
99580-3,Aggression factor score
99581-1,Motor disinhibition factor score
99582-9,Symptom and timing panel
99583-7,Lysholm Knee Scoring Scale
99584-5,Limp severity
99585-2,Level of cane or crutch use
99586-0,Knee locking frequency
99587-8,Knee instability frequency
99588-6,Knee pain severity
99589-4,Knee swelling frequency
99592-8,Total score
99593-6,American Academy of Family Physicians Social Needs Screening Tool
99594-4,Delayed medical care due to distance or lack of transportation
99595-1,American Academy of Family Physicians Social Needs Screening Tool - short form
99596-9,SARS coronavirus 2 nucleocapsid protein Ab.IgG
99597-7,SARS coronavirus 2 spike protein Ab.IgG
Aug-59,QRS duration.lead V5
99598-5,Erythrocytes.dysmorphic/100 erythrocytes
99599-3,Protein.monoclonal band 1/Protein.total
99600-9,Beta 1 globulin
99601-7,Beta 2 globulin
99602-5,Glucose/Creatinine
99603-3,Neutrophils.band form/100 leukocytes
99604-1,Neutrophils.band form/100 leukocytes
99605-8,Multisection for venous mapping
Jun-60,QRS duration.lead V6
99606-6,Multisection for venous mapping
99607-4,Multisection for venous mapping
99608-2,Multisection^WO & W contrast IV
99609-0,Multisection^W contrast IV
99610-8,Multisection^W contrast PO
99611-6,Multisection^WO contrast
99612-4,Multisection^WO contrast
99613-2,Multisection^WO & W contrast IV
Apr-61,QRS initial amplitude.lead AVF
99614-0,Emicizumab
99615-7,Current anti-inflammatory drug use
99616-5,Trienoate/Arachidonate
99617-3,Fatty acids.saturated
99618-1,Fatty acids.monounsaturated
99619-9,Fatty acids.polyunsaturated
99620-7,Fatty acids.omega 3
99621-5,Fatty acids.omega 6
Feb-62,QRS initial amplitude.lead AVL
99622-3,Resource information for patient
99623-1,Influenza virus A N1 RNA
99624-9,Japanese encephalitis virus Ab.IgG
99625-6,Purkinje cell cytoplasmic type 2 Ab
99626-4,Purkinje cell cytoplasmic type 2 Ab
99627-2,"How often does this describe you, I don't have enough money to pay my bills"
99628-0,Multisection
99629-8,Multisection^WO contrast
9963-0,QRS initial amplitude.lead AVR
99630-6,Multisection^WO & W contrast IV
99631-4,Multisection
99632-2,Multisection^WO & W contrast IV
99633-0,Multisection
99634-8,"Federal, state, or local governments required limiting non-essential travel"
99635-5,Main symptoms experienced by people infected with condition of interest
99636-3,Activity related to possible exposure to condition of interest
99637-1,Measures taken to keep safe from condition of interest
99638-9,"Federal, state, or local governments encouraged limiting non-essential travel"
99639-7,Effectiveness of wearing a face mask to keep safe from condition of interest
99640-5,Effectiveness of praying to keep safe from condition of interest
99641-3,Effectiveness of washing your hands with soap or using hand sanitizer frequently to keep safe from condition of interest
99642-1,Effectiveness of seeing a doctor if you feel sick to keep safe from condition of interest
99643-9,Effectiveness of seeing a doctor if you feel healthy but worry that you were exposed to keep safe from condition of interest
99644-7,"Effectiveness of avoiding public spaces, gatherings, and crowds to keep safe from condition of interest"
99645-4,Effectiveness of avoiding contact with people who could be high-risk to keep safe from condition of interest
99646-2,Effectiveness of avoiding hospitals and clinics to keep safe from condition of interest
99647-0,Effectiveness of avoiding restaurants to keep safe from condition of interest
Aug-64,QRS initial amplitude.lead I
99648-8,Effectiveness of avoiding airplanes to keep safe from condition of interest
99649-6,Safety of grocery shopping for avoiding exposure to condition of interest
99650-4,Safety of attending gatherings of more than 100 people for avoiding exposure to condition of interest
99651-2,Safety of going to the hospital for avoiding exposure to condition of interest
99652-0,Safety of dining in at restaurants for avoiding exposure to condition of interest
99653-8,Safety of eating take-out meals from restaurants for avoiding exposure to condition of interest
99654-6,Safety of visiting with relatives or friends in their home for avoiding exposure to condition of interest
May-65,QRS initial amplitude.lead II
99655-3,Safety of handling packages that have been delivered for avoiding exposure to condition of interest
99656-1,Safety of playing on playground equipment for avoiding exposure to condition of interest
99657-9,"Safety of touching door knobs, countertops, and other surfaces in your home for avoiding exposure to condition of interest"
99658-7,Safety of interacting closely with other members of your household for avoiding exposure to condition of interest
99659-5,"Safety of going outside to walk, hike, or exercise for avoiding exposure to condition of interest"
99660-3,Number of family members or close friends
99661-1,Number of family members or close friends that have been infected with condition of interest
99662-9,Percent chance of contracting condition of interest in next 3Mo
Mar-66,QRS initial amplitude.lead III
99663-7,Percent chance of death from condition of interest if infected
99664-5,Agreement with statement: childhood vaccines have many known harmful side effects
99665-2,Agreement with statement: childhood vaccines provide important benefits to society
99666-0,Agreement with statement: childhood vaccines may lead to illness and death
99667-8,Agreement with statement: childhood vaccines are useful and effective
99668-6,Likelihood of getting vaccinated for condition of interest when available
99669-4,Agreement with statement: most people believe that people with condition of interest are dangerous
99670-2,Agreement with statement: most people believe that people who used to have condition of interest are dangerous
Jan-67,QRS initial amplitude.lead V1
99671-0,Agreement with statement: most people believe that having condition of interest is a sign of personal weakness or failure
99672-8,"Agreement with statement: if I caught condition of interest, I would consider it a sign of my personal weakness or failure"
99673-6,"COVID-19 Knowledge, Attitudes, and Avoidant Behaviors panel"
99674-4,Temporary pacemaker panel
99675-1,Atrial electrical activity captured
99676-9,Atrial electrical activity sensed
99677-7,Atrial sensitivity setting
99678-5,Atrial sensitivity threshold
99679-3,Atrial stimulation setting
99680-1,Atrial stimulation threshold
99681-9,Atrial wire
99682-7,Atrioventricular interval
99683-5,Ground wire
99684-3,Pacemaker mode
99685-0,Pacemaker rate
99686-8,Pacemaker type
99687-6,Pacing method
99688-4,Post-ventricular atrial refractory period setting
Sep-68,QRS initial amplitude.lead V2
99689-2,Ventricular electrical activity captured
996-9,D little o super little a Ag
99690-0,Ventricular electrical activity sensed
99691-8,Ventricular sensitivity setting
99692-6,Ventricular sensitivity threshold
99693-4,Ventricular stimulation setting
99694-2,Ventricular stimulation threshold
99695-9,Ventricular wire
99696-7,Wire status
Jul-69,QRS initial amplitude.lead V3
99697-5,Permanent pacemaker panel
99698-3,Atrial stimulation setting
99699-1,Atrial stimulation threshold
99700-7,Ventricular stimulation setting
99701-5,Ventricular stimulation threshold
99702-3,Multisection
99703-1,Multisection
99704-9,Multisection for stroke mapping
May-70,QRS initial amplitude.lead V4
99705-6,Multisection for seizure mapping
99706-4,Hepatocellular carcinoma screening
99707-2,Continuous renal replacement therapy panel
99708-0,Continuous renal replacement therapy mode
99709-8,Continuous renal replacement therapy fluid removal goal
99710-6,Venous lumen volume
99711-4,Blood flow rate
99712-2,Dialysate flow rate
Mar-71,QRS initial amplitude.lead V5
99713-0,Post-filter replacement fluid rate
99714-8,Pre-filter replacement fluid rate
99715-5,Dialysis access site
99716-3,Dialysis access site appearance
99717-1,Access pressure
99718-9,Effluent pressure
99719-7,Filter pressure
99720-5,Transmembrane pressure
Jan-72,QRS initial amplitude.lead V6
99721-3,Return pressure
99722-1,Medication added to peritoneal dialysis fluid
99723-9,Medication added to peritoneal dialysis fluid
99724-7,Peritoneal dialysis fluid infused
99725-4,Peritoneal dialysis fluid drained
99726-2,Peritoneal dialysis fluid
99727-0,Peritoneal dialysis fluid infusion start time
99728-8,Peritoneal dialysis fluid infusion stop time
99729-6,Peritoneal dialysis fluid drainage start time
99730-4,Peritoneal dialysis fluid drainage stop time
99731-2,Pressure drop
99732-0,Dialysate fluid
99733-8,Replacement fluid
99734-6,Arterial lumen volume
99735-3,Ultrafiltrate volume removed
99736-1,Reason for filter change
99737-9,Intermittent hemodialysis panel
99738-7,Hemodialysis fluid removal goal
Sep-73,QRS terminal amplitude.lead AVF
99739-5,Hemodialysis fluid removed
99740-3,Hemodialysis fluid removed
99741-1,Ultrafiltrate volume removed
99742-9,Peritoneal dialysis panel
99743-7,Peritoneal dialysis dwell time
99744-5,Peritoneal dialysis catheter type
99745-2,Patient reported outcomes with LASIK - post-operative panel
99746-0,New problem or limitation after LASIK
Jul-74,QRS terminal amplitude.lead AVL
99747-8,Problem or limitation because of LASIK
99748-6,Problem or limitation after LASIK affected quality of life
99749-4,Surgery provider explained what to expect during LASIK recovery period
99750-2,Satisfaction level with LASIK result
99751-0,Satisfaction level with length of time for vision improvement after LASIK
99752-8,Satisfaction level with length of time it took for improvement in post-operative discomfort after LASIK
99753-6,Level of understanding risk and benefit of LASIK before treatment
Apr-75,QRS terminal amplitude.lead AVR
99754-4,"When not wearing corrective lenses, distance vision is as good as anticipated after LASIK"
99755-1,Wear corrective lenses to see in the distance
99756-9,Goal for LASIK achieved
99757-7,Happiness level of having LASIK
99759-3,Would recommend LASIK to friend or family member
99760-1,Reason not to have or recommend LASIK
99761-9,Clot initiation.kaolin induced
Feb-76,QRS terminal amplitude.lead I
99762-7,Clot angle.kaolin induced
99763-5,Clot formation.kaolin induced
99764-3,Interferon.gamma
99765-0,Interleukin 12
99766-8,Interleukin 17
99767-6,Interleukin 1 beta
99768-4,Interleukin 2 receptor.soluble
99769-2,Interleukin 8
997-7,DBG Ag
9977-0,QRS terminal amplitude.lead II
99770-0,Tumor necrosis factor.alpha
99771-8,SARS coronavirus 2 spike & nucleocapsid protein stimulated gamma interferon panel
99772-6,SARS coronavirus 2 stimulated gamma interferon
99773-4,SARS coronavirus 2 stimulated gamma interferon release by T-cells.Spike Ag spot count^^corrected for background
99774-2,SARS coronavirus 2 stimulated gamma interferon release by T-cells.Nucleocapsid Ag spot count^^corrected for background
99775-9,Leukocytes
99776-7,Leukocytes
99777-5,Erythrocytes
99778-3,Chlamydia trachomatis rRNA
99779-1,Neisseria gonorrhoeae rRNA
99780-9,Multidrug resistant gram-negative organism classification
99781-7,Adalimumab & Adalimumab Ab panel
99782-5,Months^post transplant
99783-3,Negative predictive value
99784-1,Positive predictive value
99785-8,Cell-free DNA.donor/Cell-free DNA.total^post cardiac transplant
99786-6,Cell-free DNA.donor/Cell-free DNA.total^post lung transplant
99787-4,Cell-free DNA.donor/Cell-free DNA.total^post kidney transplant
Aug-78,QRS terminal amplitude.lead III
99788-2,Functional Communication Measure - Cognition ages 6 or older panel
99789-0,Frequency of demonstrating cognitive-communication skills for completing rote &or simple routine living tasks
99790-8,Frequency of demonstrating cognitive-communication skills for completing age-appropriate common daily living tasks
99791-6,Frequency of demonstrating cognitive-communication skills for completing age-appropriate complex living tasks
99792-4,Frequency of demonstrating cognitive-communication skills to independently function safely without supervision &or assistance
99793-2,Functional Communication Measure - Cognition ages 6 or older score
99794-0,Number of household members enrolled in preschool or day care
99795-7,Number of household members enrolled in elementary school
Jun-79,QRS terminal amplitude.lead V1
99796-5,Number of household members enrolled in middle school or junior high
99797-3,Number of household members enrolled in high school
99798-1,"Number of household members enrolled in college or trade school, including four-year colleges, community colleges, technical institutes, and vocational schools"
99799-9,"Enrolled in college or trade school, including four-year colleges, community colleges"
99800-5,Do children in this household have access to the internet during the day to support learning
99801-3,Type of internet available to children in household to support learning
99802-1,Devices used in household to access the internet for learning
99803-9,Number of laptops or desktops used in household for learning
Apr-80,QRS terminal amplitude.lead V2
99804-7,Number of tablets used in household for learning
99805-4,Number of smartphones used in household use for learning
99806-2,Number of household members enrolled in preschool or day care that had school suspended or canceled because of the condition of interest
99807-0,Number of household members enrolled in elementary school that had school suspended or canceled because of the condition of interest
99808-8,Household members in elementary school do educational activities at home
99809-6,Provider of educational activities
99810-4,Number of household members enrolled in middle school or junior high that had school suspended or canceled because of the condition of interest
99811-2,Household members in middle school or junior high do educational activities at home
Feb-81,QRS terminal amplitude.lead V3
99812-0,Number of household members enrolled in high school that have had school suspended or canceled because of the condition of interest
99813-8,Household members in high school do educational activities at home
99814-6,Number of household members in grade 12
99815-3,Name of the household member in grade 12
99816-1,Plans for after high school
99817-9,Post high school plans changed due to condition of interest or school closures
99818-7,Previous plans for after high school
99819-5,Primary child care provider while school is suspended or canceled
9982-0,QRS terminal amplitude.lead V4
99820-3,Level of difficulty finding affordable child care while school is suspended or canceled
99821-1,Agreement with statement: School closures made it difficult for me to work or do other household tasks
99822-9,Agreement with statement: I am satisfied with the communication to support learning from my child's school
99823-7,Agreement with statement: My child will be prepared for school in the next school year
99824-5,Earliest date school will resume in person
99825-2,Educational impact due to COVID-19 panel
99826-0,Multisection
99827-8,Multisection
99828-6,Functional Communication Measure - Multi-Modal Functional Communication panel
99829-4,Frequency of conveying meaningful simple messages in routine low demand situations
99830-2,Frequency of participating in meaningful short structured conversations in low demand situations
99831-0,Frequency of conveying meaningful complex messages in low demand situations
99832-8,Frequency of conveying meaningful simple messages in routine high demand situations
99833-6,Frequency of participating in meaningful short structured conversations in high demand situations
99834-4,Frequency of conveying meaningful complex messages in high demand situations
99835-1,Functional Communication Measure - Multi-Modal Functional Communication score
99836-9,Functional Communication Measure - Spoken Language Comprehension ages 6 or older panel
99837-7,Frequency of understanding simple messages in routine low demand situations
Aug-83,QRS terminal amplitude.lead V5
99838-5,Frequency of understanding complex messages in low demand situations
99839-3,Frequency of understanding simple messages in routine high demand situations
99840-1,Frequency of understanding complex messages in high demand situations
99841-9,Frequency of functioning without assistance due to comprehension deficit
99842-7,Frequency of participating in communication without assistance
99843-5,Functional Communication Measure - Spoken Language Comprehension ages 6 or older score
99844-3,Functional Communication Measure - Spoken Language Expression ages 6 or older panel
99845-0,Frequency of noticeable spoken language expression difficulties
Jun-84,QRS terminal amplitude.lead V6
99846-8,Frequency of simple meaningful word or phrase expression
99847-6,Frequency of producing verbal messages with appropriate form in low demand situations
99848-4,Frequency of producing verbal messages with appropriate content in low demand situations
99849-2,Frequency of producing verbal messages with appropriate form in high demand situations
998-5,DBG Ag
99850-0,Frequency of producing verbal messages with appropriate content in high demand situations
99851-8,Functional Communication Measure - Spoken Language Expression ages 6 or older score
99852-6,Functional Communication Measure - Swallowing panel
Mar-85,R wave amplitude.lead AVF
99853-4,Recommended modified solids diet
99854-2,Recommended modified liquids diet
99855-9,Percentage of daily diet delivered through non-oral means
99856-7,Frequency of difficulties with oral containment or secretion management
99857-5,Frequency of required supervision or assistance for swallowing safety
99858-3,Functional Communication Measure - Swallowing score
99859-1,Erythrocytes.non-dysmorphic
99860-9,Erythrocytes.non-dysmorphic
Jan-86,R wave amplitude.lead AVL
99861-7,Erythrocytes.non-dysmorphic
99862-5,Erythrocytes.dysmorphic
99863-3,Erythrocytes.dysmorphic
99864-1,Erythrocytes.dysmorphic
99865-8,Acanthocytes
99866-6,Acanthocytes/100 erythrocytes
99867-4,Acanthocytes
99868-2,Acanthocytes
99869-0,Erythrocytes.ghost cells
99870-8,Erythrocytes.ghost cells
99871-6,Erythrocytes.ghost cells
99872-4,Transitional cells.superficial
99873-2,Transitional cells.superficial
99874-0,Transitional cells.superficial
99875-7,Transitional cells.deep
99876-5,Transitional cells.deep
99877-3,Transitional cells.deep
99878-1,Lipids
Sep-87,R wave amplitude.lead AVR
99879-9,Lipids
99880-7,Lipids
99881-5,Free lipid droplets
99882-3,Free lipid droplets
99883-1,Free lipid droplets
99884-9,Cholesterol crystals
99885-6,Hyaline-granular casts
99886-4,Hyaline-granular casts
Jul-88,R wave amplitude.lead I
99887-2,Hyaline-granular casts
99888-0,Crystal casts
99889-8,Crystal casts
99890-6,Crystal casts
99891-4,Microorganism casts
99892-2,Microorganism casts
99893-0,Microorganism casts
99894-8,Calcium oxalate monohydrate crystals
May-89,R wave amplitude.lead II
99895-5,Calcium oxalate monohydrate crystals
99896-3,Calcium oxalate monohydrate crystals
99897-1,Calcium oxalate dihydrate crystals
99898-9,Calcium oxalate dihydrate crystals
99899-7,Calcium oxalate dihydrate crystals
99900-3,Triple phosphate crystals
99901-1,Triple phosphate crystals
99902-9,Triple phosphate crystals
Mar-90,R wave amplitude.lead III
99903-7,Urate crystals
99904-5,Urate crystals
99905-2,Urate crystals
99906-0,Urate crystals.amorphous
99907-8,Urate crystals.amorphous
99908-6,Phosphate crystals.amorphous
99909-4,Atypical crystals
99910-2,Atypical crystals
Jan-91,R wave amplitude.lead V1
99911-0,Atypical crystals
99912-8,Bacilliform bacteria
99913-6,Bacilliform bacteria
99914-4,Bacilliform bacteria
99915-1,Cocci bacteria
99916-9,Cocci bacteria
99917-7,Cocci bacteria
99918-5,Amorphous sediment
99919-3,Amorphous sediment
99920-1,Amorphous sediment
99921-9,Schistosoma haematobium
99922-7,Schistosoma haematobium
99923-5,Schistosoma haematobium
99924-3,Artifact
99925-0,Artifact
99926-8,Erythrocytes
99927-6,Erythrocytes
99928-4,Leukocytes
Sep-92,R wave amplitude.lead V2
99929-2,Leukocytes
999-3,DBG Ag
99930-0,Nucleated cells
99931-8,Nucleated cells
99932-6,Bacteria
99933-4,Leukocyte clumps
99934-2,Mainz pain staging system panel
99935-9,Average frequency of primary pain in past 4W
99936-7,Average duration of primary pain in past 4W
Jul-93,R wave amplitude.lead V3
99937-5,Fluctuation of primary pain intensity in past 4W
99938-3,Variation of episodic pain intensity in past 4W
99939-1,Pain distribution in past 4W
99940-9,Pain medication in the past 4W
99941-7,Withdrawn from or reduced dose of pain medication
99942-5,Change of physician responsible for pain treatment
99943-3,Frequency of pain related hospitalizations
99944-1,Number of surgical procedures for pain
May-94,R wave amplitude.lead V4
99945-8,Number of pain related stays at treatment facility
99946-6,Total score
99947-4,Telecommunication type
99948-2,Telecommunication panel
99949-0,Telecommunication mode
99950-8,State
99951-6,Postal code
Feb-95,R wave amplitude.lead V5
99952-4,Address panel
99953-2,Address
99954-0,City
99955-7,Country
99956-5,Complete address
99957-3,Address type
99958-1,Address use
99959-9,Urothelial carcinoma gene expression score
9996-0,R wave amplitude.lead V6
99960-7,ADAMTS13 gene full mutation analysis
99961-5,Myeloproliferative neoplasm multigene analysis
99962-3,JAK2 gene exon 12 full mutation analysis
99963-1,JAK2 gene exon 14 full mutation analysis
99964-9,MPL gene exon 10 full mutation analysis
99965-6,ASXL1 gene exon 13 full mutation analysis
99966-4,KIT gene exon 17 full mutation analysis
99967-2,Atypical hemolytic uremic syndrome multigene analysis
99968-0,Thrombotic microangiopathy multigene analysis
99969-8,PLG gene full mutation analysis
99970-6,Hereditary thrombocytopenia multigene analysis
99971-4,Hemophagocytic lymphohistiocytosis multigene analysis
99972-2,Hearing loss multigene analysis
99974-8,No injury due to a thermal source
99975-5,No injury related to a chemical source
99976-3,No injury related to a radiation source
99977-1,No injury related to transfer &or transport during care
Aug-97,R wave axis
99978-9,No harm related to medications administered
99979-7,No injury related to unintended retained surgical item
99980-5,Wound is healing or improved from baseline levels
99981-3,Culture and demographics incorporated into plan of care
99982-1,Care provided is consistent with established plan of care
99983-9,Patient's right to privacy is maintained
99984-7,Patient receives competent and ethical care within legal standards of practice
99985-4,Patient receives consistent and comparable care regardless of the setting
Jun-98,R wave duration.lead AVF
99986-2,Tissue perfusion is maintained at or improved from baseline levels
99987-0,Gastrointestinal status is maintained at or improved from baseline levels
99988-8,Genitourinary status is maintained at or improved from baseline levels
99989-6,Musculoskeletal status is maintained at or improved from baseline levels
99990-4,Endocrine status is maintained at or improved from baseline levels
99991-2,No signs and symptoms of infection
99992-0,Thermoregulation maintained core body temperature at desired range
99993-8,No injury related to an incorrect procedure performed
Apr-99,R wave duration.lead AVL
99994-6,"Fluid, electrolyte, and acid-base balances are maintained at or improved from baseline levels"
99995-3,Respiratory status is maintained at or improved from baseline levels
99996-1,Cardiovascular status is maintained at or improved from baseline levels
99997-9,Demonstrates &or reports adequate pain control
99998-7,Neurological status is maintained at or improved from baseline levels
